PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Nottingham, LK; Yan, CH; Yang, X; Si, H; Coupar, J; Bian, Y; Cheng, TF; Allen, C; Arun, P; Gius, D; Dang, L; Van Waes, C; Chen, Z				Nottingham, L. K.; Yan, C. H.; Yang, X.; Si, H.; Coupar, J.; Bian, Y.; Cheng, T-F; Allen, C.; Arun, P.; Gius, D.; Dang, L.; Van Waes, C.; Chen, Z.			Aberrant IKK alpha and IKK beta cooperatively activate NF-kappa B and induce EGFR/AP1 signaling to promote survival and migration of head and neck cancer	ONCOGENE			English	Article						IKK alpha; IKK beta; NF-kappa B; AP1; head and neck cancers	SQUAMOUS-CELL CARCINOMA; GROWTH-FACTOR RECEPTOR; INDUCED GENE-EXPRESSION; PROSTATE-CANCER; KINASE-ALPHA; TGF-BETA; CONSTITUTIVE ACTIVATION; TRANSCRIPTION FACTORS; TUMOR-GROWTH; IN-VIVO	The inhibitor-kappa B kinase-nuclear factor-kappa B (IKK-NF-kappa B) and epidermal growth factor receptor-activator protein-1 (EGFR-AP1) pathways are often co-activated and promote malignant behavior, but the underlying basis for this relationship is unclear. Resistance to inhibitors of IKK beta or EGFR is observed in head and neck squamous cell carcinomas (HNSCC). Here, we reveal that both IKK alpha and beta contribute to nuclear activation of canonical and alternate NF-kappa B/REL family transcription factors, and overexpression of signal components that enhance co-activation of the EGFR-AP1 pathway. We observed that IKK alpha and IKK beta exhibit increased protein expression, nuclear localization, and phosphorylation in HNSCC tissues and cell lines. Individually, IKK activity varied among different cell lines, but overexpression of both IKKs induced the strongest NF-kappa B activation. Conversely, siRNA knock down of both IKKs significantly decreased nuclear localization and phosphorylation of canonical RELA and I kappa B alpha and alternative p52 and RELB subunits. Knock down of both IKKs more effectively inhibited NF-kappa B activation, broadly modulated gene expression and suppressed cell proliferation and migration. Global expression profiling revealed that NF-kappa B, cytokine, inflammatory response and growth factor signaling are among the top pathways and networks regulated by IKKs. Importantly, IKK alpha and IKK beta together promoted the expression and activity of transforming growth factor a, EGFR and AP1 transcription factors cJun, JunB and Fra1. Knock down of AP1 subunits individually decreased 8/15 (53%) of IKK-targeted genes sampled and similarly inhibited cell proliferation and migration. Mutations of NF-kappa B and AP1-binding sites abolished or decreased IKK-induced interleukin-8 (IL-8) promoter activity. Compounds such as wedelactone with dual IKK inhibitory activity and geldanomycins that block IKK alpha/beta and EGFR pathways were more active than IKK beta-specific inhibitors in suppressing NF-kappa B activation and proliferation and inducing cell death. We conclude that IKK alpha and IKK beta cooperatively activate NF-kappa B and EGFR/AP1 networks of signaling pathways and contribute to the malignant phenotype and the intrinsic or acquired therapeutic resistance of HNSCC.	[Nottingham, L. K.; Yan, C. H.; Yang, X.; Si, H.; Coupar, J.; Bian, Y.; Cheng, T-F; Allen, C.; Arun, P.; Van Waes, C.; Chen, Z.] NIDCD, Tumor Biol Sect, Head & Neck Surg Branch, NIH, Bethesda, MD 20892 USA; [Yan, C. H.] NIH, Howard Hughes Med Inst, Res Scholars Program, Bethesda, MD 20892 USA; [Allen, C.] Clin Res Training Program, Bethesda, MD USA; [Allen, C.] Pfizer Inc, Bethesda, MD USA; [Gius, D.] Vanderbilt Univ, Med Ctr, Dept Radiat Oncol, Nashville, TN USA; [Dang, L.] Millennium Pharmaceut Inc, Cambridge, MA USA	National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); Howard Hughes Medical Institute; National Institutes of Health (NIH) - USA; Pfizer; Pfizer; Vanderbilt University; Takeda Pharmaceutical Company Ltd; Millennium Pharmaceuticals	Chen, Z (corresponding author), NIDCD, Tumor Biol Sect, Head & Neck Surg Branch, NIH, 10-5D55,MSC-1419, Bethesda, MD 20892 USA.	vanwaesc@nidcd.nih.gov; chenz@nidcd.nih.gov	Allen, Clint/AAD-7016-2021	Allen, Clint/0000-0001-6586-5804; Dang, Lenny/0000-0002-2073-6109; Yan, Carol/0000-0003-1934-4922	NIDCD [Z01-DC-00016, Z01-DC-00073, Z01-DC-00074]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [ZIADC000016, K08DC000073] Funding Source: NIH RePORTER	NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This project is supported by NIDCD Intramural projects Z01-DC-00016, Z01-DC-00073 and Z01-DC-00074. We thank Dr Michael Karin (UC San Diego) and Dr Ulrich Siebenlist (NIH/NIAID) for kindly providing the IKK plasmids; Dr Neil Perkins (Newcastle University, UK) for kindly providing anti-p-p52 antibody; Dr Jialing Zhang for technical assistance; and Dr Michael Karin, Dr Christophe Cataisson (NCI/NIH) and Dr Claire Sauvageot (Millennium Pharmaceuticals, Inc) for critique of the manuscript.	Adams J, 2004, NAT REV CANCER, V4, P349, DOI 10.1038/nrc1361; Allen C, 2008, CLIN CANCER RES, V14, P4175, DOI 10.1158/1078-0432.CCR-07-4470; Ammirante M, 2010, NATURE, V464, P302, DOI 10.1038/nature08782; Anest V, 2003, NATURE, V423, P659, DOI 10.1038/nature01648; Anest V, 2004, J BIOL CHEM, V279, P31183, DOI 10.1074/jbc.M404380200; Argiris A, 2011, CLIN CANCER RES, V17, P5755, DOI 10.1158/1078-0432.CCR-11-0861; Barre B, 2010, CELL CYCLE, V9, P4774, DOI 10.4161/cc.9.24.14246; Barre B, 2010, MOL CELL, V38, P524, DOI 10.1016/j.molcel.2010.03.018; Basak S, 2008, CYTOKINE GROWTH F R, V19, P187, DOI 10.1016/j.cytogfr.2008.04.005; Basak S, 2008, MOL CELL BIOL, V28, P3139, DOI 10.1128/MCB.01469-07; Bednarski BK, 2008, MOL CANCER THER, V7, P1827, DOI 10.1158/1535-7163.MCT-08-0321; Bian Y, 2012, ONCOGENE, V31, P3322, DOI 10.1038/onc.2011.494; Bivona TG, 2011, NATURE, V471, P523, DOI 10.1038/nature09870; Carayol N, 2006, J BIOL CHEM, V281, P31142, DOI 10.1074/jbc.M603417200; Chen Z, 2008, MOL CANCER THER, V7, P1949, DOI 10.1158/1535-7163.MCT-07-2046; Cohen J, 2009, CANCER RES, V69, P3415, DOI 10.1158/0008-5472.CAN-08-3704; Debinski W, 2011, CANCER BIOL THER, V11, P254, DOI 10.4161/cbt.11.2.13953; Delhase M, 1999, SCIENCE, V284, P309, DOI 10.1126/science.284.5412.309; Duffey DC, 1999, CANCER RES, V59, P3468; Egorin MJ, 2002, CANCER CHEMOTH PHARM, V49, P7, DOI 10.1007/s00280-001-0380-8; Freudlsperger C, 2013, ONCOGENE, V32, P1549, DOI 10.1038/onc.2012.171; Fusco AJ, 2008, J BIOL CHEM, V283, P12324, DOI 10.1074/jbc.M707898200; Gomard T, 2010, PLOS ONE, V5, pA178, DOI 10.1371/journal.pone.0009585; GRANDIS JR, 1993, CANCER RES, V53, P3579; Hacker H., 2006, SCI STKE, V2006, P13, DOI [10.1126/stke.3572006re13, DOI 10.1126/STKE.3572006RE13]; Hertlein E, 2010, BLOOD, V116, P45, DOI 10.1182/blood-2010-01-263756; Hinz M, 2012, IMMUNOL REV, V246, P59, DOI 10.1111/j.1600-065X.2012.01102.x; Hu YL, 1999, SCIENCE, V284, P316, DOI 10.1126/science.284.5412.316; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Kobori M, 2004, CELL DEATH DIFFER, V11, P123, DOI 10.1038/sj.cdd.4401325; Krappmann D, 2004, MOL CELL BIOL, V24, P6488, DOI 10.1128/MCB.24.14.6488-6500.2004; Lam LT, 2008, P NATL ACAD SCI USA, V105, P20798, DOI 10.1073/pnas.0806491106; Lam LT, 2005, CLIN CANCER RES, V11, P28; Lee TL, 2006, MOL CANCER THER, V5, P8, DOI 10.1158/1535-7163.MCT-05-0069; Liu BG, 2008, CANCER CELL, V14, P212, DOI 10.1016/j.ccr.2008.07.017; Madge LA, 2008, J IMMUNOL, V180, P3467, DOI 10.4049/jimmunol.180.5.3467; Madge LA, 2010, J BIOL CHEM, V285, P38069, DOI 10.1074/jbc.M110.147207; Marinari B, 2008, P NATL ACAD SCI USA, V105, P17091, DOI 10.1073/pnas.0809288105; Mishra A, 2010, INT J CANCER, V126, P819, DOI 10.1002/ijc.24807; Nagashima K, 2006, BLOOD, V107, P4266, DOI 10.1182/blood-2005-09-3852; Ndlovu MN, 2009, MOL CELL BIOL, V29, P5488, DOI 10.1128/MCB.01657-08; Ondrey FG, 1999, MOL CARCINOGEN, V26, P119, DOI 10.1002/(SICI)1098-2744(199910)26:2<119::AID-MC6>3.0.CO;2-N; Park EM, 2011, FUTURE ONCOL, V7, P123, DOI [10.2217/fon.10.166, 10.2217/FON.10.166]; Pernas FG, 2009, CLIN CANCER RES, V15, P2361, DOI 10.1158/1078-0432.CCR-08-1011; Savinova OV, 2009, MOL CELL, V34, P591, DOI 10.1016/j.molcel.2009.04.033; Scheidereit C, 2012, KEYST S NF KAPPAB SI; Scheidereit C, 2006, ONCOGENE, V25, P6685, DOI 10.1038/sj.onc.1209934; Sharafinski ME, 2010, HEAD NECK-J SCI SPEC, V32, P1412, DOI 10.1002/hed.21365; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Sunwoo JB, 2001, CLIN CANCER RES, V7, P1419; Van Waes C, 2007, CLIN CANCER RES, V13, P1076, DOI 10.1158/1078-0432.CCR-06-2221; Wolf MJ, 2010, ONCOGENE, V29, P5006, DOI 10.1038/onc.2010.260; Yamamoto Y, 2000, MOL CELL BIOL, V20, P3655, DOI 10.1128/MCB.20.10.3655-3666.2000; Yang XP, 2011, CANCER RES, V71, P3688, DOI 10.1158/0008-5472.CAN-10-3445; Yemelyanov A, 2006, ONCOGENE, V25, P387, DOI 10.1038/sj.onc.1209066; Younes F, 1996, Oral Dis, V2, P25; Zandi E, 1997, CELL, V91, P243, DOI 10.1016/S0092-8674(00)80406-7; Zerbini LF, 2003, CANCER RES, V63, P2206	58	63	67	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 27	2014	33	9					1135	1147		10.1038/onc.2013.49	http://dx.doi.org/10.1038/onc.2013.49			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AB6XT	23455325	Green Accepted			2022-12-25	WOS:000331933800007
J	Pozzi, N; Chen, ZW; Zapata, F; Niu, WL; Barranco-Medina, S; Pelc, LA; Di Cera, E				Pozzi, Nicola; Chen, Zhiwei; Zapata, Fatima; Niu, Weiling; Barranco-Medina, Sergio; Pelc, Leslie A.; Di Cera, Enrico			Autoactivation of Thrombin Precursors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAY CRYSTAL-STRUCTURE; HUMAN ALPHA-THROMBIN; BOVINE TRYPSINOGEN; CONFORMATIONAL SELECTION; PROTEIN-C; ACTIVATION; BINDING; PROTHROMBIN; PROTEASES; PRETHROMBIN-2	Trypsin-like proteases are synthesized as inactive zymogens and convert to the mature form upon activation by specific enzymes, often assisted by cofactors. Central to this paradigm is that the zymogen does not convert spontaneously to the mature enzyme, which in turn does not feed back to activate its zymogen form. In the blood, the zymogens prothrombin and prethrombin-2 require the prothrombinase complex to be converted to the mature protease thrombin, which is unable to activate prothrombin or prethrombin-2. Here, we show that replacement of key residues within the activation domain causes these zymogens to spontaneously convert to thrombin. The conversion is started by the zymogen itself, which is capable of binding ligands at the active site, and is abrogated by inactivation of the catalytic residue Ser-195. The product of autoactivation is functionally and structurally equivalent to wild-type thrombin. Zymogen autoactivation is explained by conformational selection, a basic property of the trypsin fold uncovered by structural and rapid kinetics studies. Both the zymogen and protease undergo a preexisting equilibrium between active and inactive forms. The equilibrium regulates catalytic activity in the protease and has the potential to unleash activity in the zymogen to produce autoactivation. A new strategy emerges for the facile production of enzymes through zymogen autoactivation that is broadly applicable to trypsin-like proteases of biotechnological and clinical interest.	[Pozzi, Nicola; Chen, Zhiwei; Zapata, Fatima; Niu, Weiling; Barranco-Medina, Sergio; Pelc, Leslie A.; Di Cera, Enrico] St Louis Univ, Sch Med, Edward A Doisy Dept Biochem & Mol Biol, St Louis, MO 63104 USA	Saint Louis University	Di Cera, E (corresponding author), St Louis Univ, Sch Med, Dept Biochem & Mol Biol, St Louis, MO 63104 USA.	enrico@slu.edu	Pozzi, Nicola/AAV-4876-2021; Pozzi, Nicola/AAE-4910-2020	Pozzi, Nicola/0000-0003-2309-7100; 	National Institutes of Health [HL49413, HL73813, HL112303]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL049413, R29HL049413, U54HL112303, R01HL073813] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by National Institutes of Health Research Grants HL49413, HL73813, and HL112303 (to E.D.C.).	Aizawa P, 2008, THROMB RES, V122, P560, DOI 10.1016/j.thromres.2007.12.027; Artenstein AW, 2011, NEW ENGL J MED, V365, P2507, DOI 10.1056/NEJMra1106700; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BAJAJ SP, 1973, J BIOL CHEM, V248, P7729; BODE W, 1978, J MOL BIOL, V118, P99, DOI 10.1016/0022-2836(78)90246-2; BODE W, 1992, PROTEIN SCI, V1, P426; Boehr DD, 2009, NAT CHEM BIOL, V5, P789, DOI 10.1038/nchembio.232; Carroll MC, 2012, IMMUNITY, V37, P199, DOI 10.1016/j.immuni.2012.08.002; Chen ZW, 2010, P NATL ACAD SCI USA, V107, P19278, DOI 10.1073/pnas.1010262107; CLAESON G, 1994, BLOOD COAGUL FIBRIN, V5, P411; Craik CS, 2011, BIOCHEM J, V435, P1, DOI 10.1042/BJ20100965; DAVIE EW, 1991, BIOCHEMISTRY-US, V30, P10363, DOI 10.1021/bi00107a001; Di Cera E, 2011, PROG MOL BIOL TRANSL, V99, P145, DOI 10.1016/B978-0-12-385504-6.00004-X; DIBELLA EE, 1995, J BIOL CHEM, V270, P163, DOI 10.1074/jbc.270.1.163; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FEHLHAMMER H, 1977, J MOL BIOL, V111, P415, DOI 10.1016/S0022-2836(77)80062-4; FENTON JW, 1977, J BIOL CHEM, V252, P3587; Fersht A.R., 1999, ENZYME STRUCTURE MEC; FERSHT AR, 1971, J MOL BIOL, V60, P279, DOI 10.1016/0022-2836(71)90294-4; Gal P, 2005, J BIOL CHEM, V280, P33435, DOI 10.1074/jbc.M506051200; Gandhi PS, 2010, J BIOL CHEM, V285, P15393, DOI 10.1074/jbc.M110.115337; Gawlik K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005031; Gohara DW, 2011, TRENDS BIOTECHNOL, V29, P577, DOI 10.1016/j.tibtech.2011.06.001; Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x; Heffernan JK, 2007, REGUL TOXICOL PHARM, V47, P48, DOI 10.1016/j.yrtph.2006.07.006; James LC, 2003, TRENDS BIOCHEM SCI, V28, P361, DOI 10.1016/S0968-0004(03)00135-X; KOSSIAKOFF AA, 1977, BIOCHEMISTRY-US, V16, P654, DOI 10.1021/bi00623a016; Krem MM, 2002, TRENDS BIOCHEM SCI, V27, P67, DOI 10.1016/S0968-0004(01)02007-2; LEBONNIEC BF, 1991, P NATL ACAD SCI USA, V88, P7371, DOI 10.1073/pnas.88.16.7371; LOTTENBERG R, 1983, BIOCHIM BIOPHYS ACTA, V742, P539, DOI 10.1016/0167-4838(83)90272-8; Marino F, 2010, J BIOL CHEM, V285, P19145, DOI 10.1074/jbc.M110.119875; Milder FJ, 2007, NAT STRUCT MOL BIOL, V14, P224, DOI 10.1038/nsmb1210; MORRIS AL, 1992, PROTEINS, V12, P345, DOI 10.1002/prot.340120407; NEURATH H, 1957, FED PROC, V16, P791; NGAI PK, 1991, BIOCHEM J, V280, P805, DOI 10.1042/bj2800805; Niu WL, 2011, BIOCHEMISTRY-US, V50, P6301, DOI 10.1021/bi200878c; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Page MJ, 2008, CELL MOL LIFE SCI, V65, P1220, DOI 10.1007/s00018-008-7565-9; Papagrigoriou E, 2006, NAT STRUCT MOL BIOL, V13, P557, DOI 10.1038/nsmb1095; Pineda AO, 2004, J BIOL CHEM, V279, P31842, DOI 10.1074/jbc.M401756200; Piper DE, 2007, STRUCTURE, V15, P545, DOI 10.1016/j.str.2007.04.004; Pozzi N, 2012, CURR OPIN STRUC BIOL, V22, P421, DOI 10.1016/j.sbi.2012.05.006; Pozzi N, 2012, BLOOD, V120, P664, DOI 10.1182/blood-2012-03-415323; Pozzi N, 2011, BIOCHEMISTRY-US, V50, P10195, DOI 10.1021/bi2015019; Prasad S, 2004, J BIOL CHEM, V279, P10103, DOI 10.1074/jbc.M312614200; Sichler K, 2002, J MOL BIOL, V322, P591, DOI 10.1016/S0022-2836(02)00747-7; Stirnberg M, 2010, BIOCHEM J, V430, P87, DOI 10.1042/BJ20091565; Vindigni A, 1997, NAT BIOTECHNOL, V15, P891, DOI 10.1038/nbt0997-891; Virel A, 2012, ANAL CHEM, V84, P2380, DOI 10.1021/ac203138y; Vogt AD, 2012, BIOCHEMISTRY-US, V51, P5894, DOI 10.1021/bi3006913; WANG DC, 1985, J MOL BIOL, V185, P595, DOI 10.1016/0022-2836(85)90074-9; Whitcomb DC, 1996, NAT GENET, V14, P141, DOI 10.1038/ng1096-141; Wolan DW, 2009, SCIENCE, V326, P853, DOI 10.1126/science.1177585; WU QY, 1991, P NATL ACAD SCI USA, V88, P6775, DOI 10.1073/pnas.88.15.6775; Yamamoto E, 2011, BIOSCI BIOTECH BIOCH, V75, P2070, DOI 10.1271/bbb.110515	55	31	31	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2013	288	16					11601	11610		10.1074/jbc.M113.451542	http://dx.doi.org/10.1074/jbc.M113.451542			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	130KW	23467412	Green Published, hybrid			2022-12-25	WOS:000317915500065
J	Lu, M; Sarruf, DA; Li, PP; Osborn, O; Sanchez-Alavez, M; Talukdar, S; Chen, A; Bandyopadhyay, G; Xu, JF; Morinaga, H; Dines, K; Watkins, S; Kaiyala, K; Schwartz, MW; Olefsky, JM				Lu, Min; Sarruf, David A.; Li, Pingping; Osborn, Olivia; Sanchez-Alavez, Manuel; Talukdar, Saswata; Chen, Ai; Bandyopadhyay, Gautam; Xu, Jianfeng; Morinaga, Hidetaka; Dines, Kevin; Watkins, Steven; Kaiyala, Karl; Schwartz, Michael W.; Olefsky, Jerrold M.			Neuronal Sirt1 Deficiency Increases Insulin Sensitivity in Both Brain and Peripheral Tissues	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATES FOOD-INTAKE; ADIPOSE-TISSUE; CELLULAR-METABOLISM; HYPOTHALAMIC SIRT1; ENERGY-BALANCE; AGRP NEURONS; PROTECTS; DEACETYLASE; EXPRESSION; DISEASE	Sirt1 is a NAD(+)-dependent class III deacetylase that functions as a cellular energy sensor. In addition to its well-characterized effects in peripheral tissues, emerging evidence suggests that neuronal Sirt1 activity plays a role in the central regulation of energy balance and glucose metabolism. To assess this idea, we generated Sirt1 neuron-specific knockout (SINKO) mice. On both standard chow and HFD, SINKO mice were more insulin sensitive than Sirt1(f/f) mice. Thus, SINKO mice had lower fasting insulin levels, improved glucose tolerance and insulin tolerance, and enhanced systemic insulin sensitivity during hyperinsuline-mic euglycemic clamp studies. Hypothalamic insulin sensitivity of SINKO mice was also increased over controls, as assessed by hypothalamic activation of PI3K, phosphorylation of Akt and FoxO1 following systemic insulin injection. Intracerebroventricular injection of insulin led to a greater systemic effect to improve glucose tolerance and insulin sensitivity in SINKO mice compared with controls. In line with the in vivo results, insulin-induced AKT and FoxO1 phosphorylation were potentiated by inhibition of Sirt1 in a cultured hypothalamic cell line. Mechanistically, this effect was traced to a reduced effect of Sirt1 to directly deacetylate and repress IRS-1 function. The enhanced central insulin signaling in SINKO mice was accompanied by increased insulin receptor signal transduction in liver, muscle, and adipose tissue. In summary, we conclude that neuronal Sirt1 negatively regulates hypothalamic insulin signaling, leading to systemic insulin resistance. Interventions that reduce neuronal Sirt1 activity have the potential to improve systemic insulin action and limit weight gain on an obesigenic diet.	[Lu, Min; Li, Pingping; Osborn, Olivia; Talukdar, Saswata; Chen, Ai; Bandyopadhyay, Gautam; Xu, Jianfeng; Morinaga, Hidetaka; Olefsky, Jerrold M.] Univ Calif San Diego, Dept Med, San Diego, CA 92093 USA; [Sarruf, David A.; Kaiyala, Karl; Schwartz, Michael W.] Univ Washington, Diabet & Obes Ctr Excellence, Seattle, WA 98104 USA; [Sanchez-Alavez, Manuel] Scripps Res Inst, La Jolla, CA 92037 USA; [Dines, Kevin] Tanabe Res Lab Inc, San Diego, CA 92121 USA; [Watkins, Steven] Lipom Technol, West Sacramento, CA 95691 USA	University of California System; University of California San Diego; University of Washington; University of Washington Seattle; Scripps Research Institute	Olefsky, JM (corresponding author), Univ Calif San Diego, Dept Med, San Diego, CA 92093 USA.	jolefsky@ucsd.edu	Li, Pingping/F-1109-2019; osborn, olivia/R-1460-2018	Li, Pingping/0000-0003-0679-270X; osborn, olivia/0000-0003-0516-7937; Sanchez-Alavez, Manuel/0000-0002-8164-8452	National Institutes of Health (NIH) [DK033651, DK063491, DK074868, DK09062, DK068384, DK083042, DK052989]; Eunice Kennedy Shriver National Institutes of Child Health and Human Development/NIH [U54 HD012303-25]; Ruth L. Kirschstein National Research Service Award Fellowship [F32DK080604-01]; Nutrition Obesity Research Center [DK035816]; Mouse Metabolic Phenotyping Center at the University of Washington [U24 DK076126]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD012303, P50HD012303] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA023100] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090320, F32DK009062, P01DK068384, R01DK083042, U24DK076126, R01DK033651, P01DK074868, R01DK052989, P30DK035816, R37DK033651, P30DK063491, F32DK080604] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eunice Kennedy Shriver National Institutes of Child Health and Human Development/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Ruth L. Kirschstein National Research Service Award Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nutrition Obesity Research Center; Mouse Metabolic Phenotyping Center at the University of Washington; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by the National Institutes of Health (NIH) Grants DK033651, DK063491, DK074868, and DK09062 (to J. O.) and by the Eunice Kennedy Shriver National Institutes of Child Health and Human Development/NIH through cooperative agreement of U54 HD012303-25 as part of the specialized Cooperative Centers Program in Reproduction and Infertility Research. This work was also supported by NIH Grants DK068384, DK083042, and DK052989 (to M. S.), by Ruth L. Kirschstein National Research Service Award Fellowship F32DK080604-01 (to D. S.), and by the Nutrition Obesity Research Center Grant DK035816 and the Mouse Metabolic Phenotyping Center (U24 DK076126) at the University of Washington.	Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; An J, 2004, NAT MED, V10, P268, DOI 10.1038/nm995; Bartness TJ, 2007, J LIPID RES, V48, P1655, DOI 10.1194/jlr.R700006-JLR200; Bielawska A, 2001, ANAL BIOCHEM, V298, P141, DOI 10.1006/abio.2001.5342; Cakir I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008322; Cao HM, 2008, CELL, V134, P933, DOI 10.1016/j.cell.2008.07.048; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Christianson JL, 2008, J BIOL CHEM, V283, P2906, DOI 10.1074/jbc.M705656200; Cohen DE, 2009, GENE DEV, V23, P2812, DOI 10.1101/gad.1839209; Dietrich MO, 2010, J NEUROSCI, V30, P11815, DOI 10.1523/JNEUROSCI.2234-10.2010; Erion DM, 2010, NAT MED, V16, P400, DOI 10.1038/nm0410-400; Esler M, 2001, AM J HYPERTENS, V14, p304S, DOI 10.1016/S0895-7061(01)02236-1; Foster MT, 2006, AM J PHYSIOL-REG I, V291, pR1630, DOI 10.1152/ajpregu.00197.2006; Garcia-Serrano S, 2011, MOL MED, V17, P273, DOI 10.2119/molmed.2010.00078; Girard J, 2006, J CLIN INVEST, V116, P302, DOI 10.1172/JCI27743; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; Hallschmid M, 2009, DIABETOLOGIA, V52, P2264, DOI 10.1007/s00125-009-1501-x; He W, 2006, NAT NEUROSCI, V9, P227, DOI 10.1038/nn1626; Hyun CK, 2010, BIOCHEM BIOPH RES CO, V399, P480, DOI 10.1016/j.bbrc.2010.07.072; Kaiser C, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-23; Kim D, 2007, EMBO J, V26, P3169, DOI 10.1038/sj.emboj.7601758; Knight CM, 2011, DIABETES, V60, P2691, DOI 10.2337/db10-0987; Konner AC, 2007, CELL METAB, V5, P438, DOI 10.1016/j.cmet.2007.05.004; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lam TKT, 2005, NAT NEUROSCI, V8, P579, DOI 10.1038/nn1456; Li PP, 2010, J BIOL CHEM, V285, P15333, DOI 10.1074/jbc.M110.100263; Li Y, 2008, CELL METAB, V8, P38, DOI 10.1016/j.cmet.2008.05.004; Lu M, 2006, AM J PHYSIOL-CELL PH, V290, pC1477, DOI 10.1152/ajpcell.00374.2005; Lu M, 2011, NAT MED, V17, P618, DOI 10.1038/nm.2332; Lu M, 2010, AM J PHYSIOL-ENDOC M, V298, pE1036, DOI 10.1152/ajpendo.00668.2009; Mattagajasingh I, 2007, P NATL ACAD SCI USA, V104, P14855, DOI 10.1073/pnas.0704329104; Mayer CM, 2009, FRONT NEUROENDOCRIN, V30, P405, DOI 10.1016/j.yfrne.2009.03.005; MELLON PL, 1990, NEURON, V5, P1, DOI 10.1016/0896-6273(90)90028-E; Minokoshi Y, 2004, NATURE, V428, P569, DOI 10.1038/nature02440; Nemoto S, 2005, J BIOL CHEM, V280, P16456, DOI 10.1074/jbc.M501485200; Purushotham A, 2009, CELL METAB, V9, P327, DOI 10.1016/j.cmet.2009.02.006; Ramadori G, 2011, CELL METAB, V14, P301, DOI 10.1016/j.cmet.2011.06.014; Ramadori G, 2010, CELL METAB, V12, P78, DOI 10.1016/j.cmet.2010.05.010; Ren HX, 2012, CELL, V149, P1314, DOI 10.1016/j.cell.2012.04.032; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Sanchez-Alavez M, 2011, J BIOL CHEM, V286, P14983, DOI 10.1074/jbc.M110.188540; Schenk S, 2008, J CLIN INVEST, V118, P2992, DOI 10.1172/JCI34260; Schenk S, 2011, J CLIN INVEST, V121, P4281, DOI 10.1172/JCI58554; Scherer T, 2011, CELL METAB, V13, P183, DOI 10.1016/j.cmet.2011.01.008; STEELE R, 1959, ANN NY ACAD SCI, V82, P420, DOI 10.1111/j.1749-6632.1959.tb44923.x; Stefater MA, 2010, ANNU REV NUTR, V30, P219, DOI 10.1146/annurev.nutr.012809.104723; Wang RH, 2011, J CLIN INVEST, V121, P4477, DOI 10.1172/JCI46243; Wei D, 2011, AM J PHYSIOL-ENDOC M, V300, pE312, DOI 10.1152/ajpendo.00524.2010; Wu DS, 2011, ANN OPER RES, V185, P1, DOI 10.1007/s10479-010-0822-y; Yang CS, 2010, DIABETES, V59, P2435, DOI 10.2337/db10-0221; Youngstrom TG, 1998, AM J PHYSIOL-REG I, V275, pR1488, DOI 10.1152/ajpregu.1998.275.5.R1488; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689; Zhu Y, 2001, GENE DEV, V15, P859, DOI 10.1101/gad.862101	54	45	45	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2013	288	15					10722	10735		10.1074/jbc.M112.443606	http://dx.doi.org/10.1074/jbc.M112.443606			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	125TU	23457303	hybrid, Green Published			2022-12-25	WOS:000317565000050
J	Martin, JA; Witzell, J; Blumenstein, K; Rozpedowska, E; Helander, M; Sieber, TN; Gil, L				Martin, Juan A.; Witzell, Johanna; Blumenstein, Kathrin; Rozpedowska, Elzbieta; Helander, Marjo; Sieber, Thomas N.; Gil, Luis			Resistance to Dutch Elm Disease Reduces Presence of Xylem Endophytic Fungi in Elms (Ulmus spp.)	PLOS ONE			English	Article							RUGULOSIN-PRODUCING ENDOPHYTE; DEFENSIVE MUTUALISM; OPHIOSTOMA-ULMI; PICEA-GLAUCA; FOREST TREES; NOVO-ULMI; U-MINOR; HOST; COMMUNITIES; DIVERSITY	Efforts to introduce pathogen resistance into landscape tree species by breeding may have unintended consequences for fungal diversity. To address this issue, we compared the frequency and diversity of endophytic fungi and defensive phenolic metabolites in elm (Ulmus spp.) trees with genotypes known to differ in resistance to Dutch elm disease. Our results indicate that resistant U. minor and U. pumila genotypes exhibit a lower frequency and diversity of fungal endophytes in the xylem than susceptible U. minor genotypes. However, resistant and susceptible genotypes showed a similar frequency and diversity of endophytes in the leaves and bark. The resistant and susceptible genotypes could be discriminated on the basis of the phenolic profile of the xylem, but not on basis of phenolics in the leaves or bark. As the Dutch elm disease pathogen develops within xylem tissues, the defensive chemistry of resistant elm genotypes thus appears to be one of the factors that may limit colonization by both the pathogen and endophytes. We discuss a potential trade-off between the benefits of breeding resistance into tree species, versus concomitant losses of fungal endophytes and the ecosystem services they provide.	[Martin, Juan A.; Gil, Luis] Univ Politecn Madrid, Escuela Tecn Super Ingn Montes, Dept Silvopascicultura, Madrid, Spain; [Witzell, Johanna; Blumenstein, Kathrin] Swedish Univ Agr Sci, Fac Forest Sci, Southern Swedish Forest Res Ctr, Alnarp, Sweden; [Rozpedowska, Elzbieta] Swedish Univ Agr Sci, Alnarp, Sweden; [Helander, Marjo] Univ Turku, Dept Biol, Sect Ecol, SF-20500 Turku, Finland; [Sieber, Thomas N.] ETH, Inst Integrat Biol, Zurich, Switzerland	Universidad Politecnica de Madrid; Swedish University of Agricultural Sciences; Swedish University of Agricultural Sciences; University of Turku; Swiss Federal Institutes of Technology Domain; ETH Zurich	Witzell, J (corresponding author), Swedish Univ Agr Sci, Fac Forest Sci, Southern Swedish Forest Res Ctr, Alnarp, Sweden.	johanna.witzell@slu.se	Martín, Juan A./B-9729-2012; Witzell, Johanna/H-9987-2019; Gil, Luis/E-3216-2014	Martín, Juan A./0000-0002-3207-1319; Witzell, Johanna/0000-0003-1741-443X; Gil, Luis/0000-0002-5252-2607; Helander, Marjo/0000-0002-9759-4321; Blumenstein, Kathrin/0000-0002-0677-7799	Swedish Research Council FORMAS [2008-1090]; Crafoord Foundation, Sweden [20070906]; Stiftelsen Konsul Faxes Donation, Sweden [KF 23, KF 29]; Ministerio de Ciencia e Innovacion, Spain [AGL2009-09289]; Ministerio de Economia y Competitividad, Spain [CTQ2011-28503-C02-02]; Spanish elm breeding program (Ministerio de Agricultura, Alimentacion y Medio Ambiente) Universidad Politecnica de Madrid); Joint Doctoral Program "Forest and Nature for Society", FONASO; Spanish elm breeding program Universidad Politecnica de Madrid	Swedish Research Council FORMAS(Swedish Research CouncilSwedish Research Council Formas); Crafoord Foundation, Sweden; Stiftelsen Konsul Faxes Donation, Sweden; Ministerio de Ciencia e Innovacion, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Ministerio de Economia y Competitividad, Spain(Spanish Government); Spanish elm breeding program (Ministerio de Agricultura, Alimentacion y Medio Ambiente) Universidad Politecnica de Madrid); Joint Doctoral Program "Forest and Nature for Society", FONASO; Spanish elm breeding program Universidad Politecnica de Madrid	This work was supported by the Swedish Research Council FORMAS (www.formas.se), project 2008-1090; the Crafoord Foundation, Sweden (www.crafoord.se), grant 20070906; Stiftelsen Konsul Faxes Donation, Sweden (http://skogstradsforadling.se/stiftelsen-konsul-faxes-donation), projects KF 23 and KF 29; Ministerio de Ciencia e Innovacion, Spain, project AGL2009-09289; Ministerio de Economia y Competitividad, Spain (http://www.mineco.gob.es), project CTQ2011-28503-C02-02; the Spanish elm breeding program (Ministerio de Agricultura, Alimentacion y Medio Ambiente; Universidad Politecnica de Madrid); and the Joint Doctoral Program "Forest and Nature for Society", FONASO (www.fonaso.eu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlholm J, 2002, ECOL LETT, V5, P648, DOI 10.1046/j.1461-0248.2002.00368.x; Albrectsen BR, 2010, FUNGAL DIVERS, V41, P17, DOI 10.1007/s13225-009-0011-y; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Alvarez-Loayza P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016386; Amend AS, 2010, MOL ECOL, V19, P5555, DOI 10.1111/j.1365-294X.2010.04898.x; Anderson MJ, 2011, ECOL LETT, V14, P19, DOI 10.1111/j.1461-0248.2010.01552.x; Aoun M, 2010, PHYSIOL MOL PLANT P, V74, P254, DOI 10.1016/j.pmpp.2010.04.003; Aoun M, 2009, PHYTOPATHOLOGY, V99, P642, DOI 10.1094/PHYTO-99-6-0642; Arnold AE, 2003, P NATL ACAD SCI USA, V100, P15649, DOI 10.1073/pnas.2533483100; Arnold AE, 2000, ECOL LETT, V3, P267, DOI 10.1046/j.1461-0248.2000.00159.x; Atlas RM., 1998, MICROBIAL ECOLOGY FU, V4; Bailey JK, 2005, CAN J BOT, V83, P356, DOI [10.1139/b05-008, 10.1139/B05-008]; Bais HP, 2002, PLANT PHYSIOL BIOCH, V40, P983, DOI 10.1016/S0981-9428(02)01460-2; BERNSTEIN ME, 1977, CAN J BOT, V55, P644, DOI 10.1139/b77-079; Bills Gerald F., 1996, P31; Blaalid R, 2012, MOL ECOL, V21, P1897, DOI 10.1111/j.1365-294X.2011.05214.x; BOEREMA GH, 1973, STUD MYCOL, V3, P1; Brun H, 2010, NEW PHYTOL, V185, P285, DOI 10.1111/j.1469-8137.2009.03049.x; CLAY K, 1988, ECOLOGY, V69, P10, DOI 10.2307/1943155; Cogolludo-Agustin MA, 2000, HEREDITY, V85, P157, DOI 10.1046/j.1365-2540.2000.00740.x; COLHOUN J, 1973, ANNU REV PHYTOPATHOL, V11, P343, DOI 10.1146/annurev.py.11.090173.002015; Collin E, 2000, ELMS BREEDING CONSER, P281, DOI DOI 10.1007/978-1-4615-4507-1; Colwell RK, 2013, ESTIMATES STAT ESTIM; Cordier T, 2012, FUNGAL ECOL, V5, P509, DOI 10.1016/j.funeco.2011.12.004; de Gruyter J, 2010, MYCOLOGIA, V102, P1066, DOI 10.3852/09-240; DEHOOG GS, 1977, STUD MYCOL, V15, P1; Dvorak M., 2006, Journal of Forest Science, V52, P531; FISHER PJ, 1990, MYCOL RES, V94, P313, DOI 10.1016/S0953-7562(09)80356-0; GAMS W, 1980, NETH J PLANT PATHOL, V86, P45, DOI 10.1007/BF02650394; Ganley RJ, 2008, FOREST ECOL MANAG, V255, P2751, DOI 10.1016/j.foreco.2008.01.052; Gennaro M, 2003, J PHYTOPATHOL, V151, P529, DOI 10.1046/j.1439-0434.2003.00763.x; Gil L, 2004, NATURE, V431, P1053, DOI 10.1038/4311053a; Gotelli Nicholas J., 2011, P39; GRIFFITH GS, 1990, NEW PHYTOL, V116, P407, DOI 10.1111/j.1469-8137.1990.tb00526.x; Guo LD, 2004, FUNGAL DIVERS, V16, P53; Helander M, 2007, NEW PHYTOL, V175, P547, DOI 10.1111/j.1469-8137.2007.02110.x; Hoshino T, 2009, MYCOSCIENCE, V50, P26, DOI 10.1007/s10267-008-0452-2; Knapp DG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032570; Kowalski Tadeusz, 1996, P67; Li YC, 2009, CELL BIOL INT, V33, P106, DOI 10.1016/j.cellbi.2008.10.007; Linaldeddu BT, 2005, J PLANT PATHOL, V87, P296; Martin JA, 2008, FOREST PATHOL, V38, P244, DOI 10.1111/j.1439-0329.2007.00542.x; Martin J. A., 2006, Investigacion Agraria, Sistemas y Recursos Forestales, V15, P208; Martin JA, 2008, ENVIRON EXP BOT, V64, P97, DOI 10.1016/j.envexpbot.2008.05.004; Martin JA, 2010, ENVIRON EXP BOT, V69, P175, DOI 10.1016/j.envexpbot.2010.04.001; Martin JA, 2010, EUR J PLANT PATHOL, V127, P21, DOI 10.1007/s10658-009-9567-3; Martin JA, 2009, CAN J FOREST RES, V39, P420, DOI 10.1139/X08-183; Martin-Garcia J, 2012, ANN FOREST SCI, V69, P49, DOI 10.1007/s13595-011-0129-4; Martin-Garcia J, 2011, SILVA FENN, V45, P169, DOI 10.14214/sf.40; McGuire KL, 2010, SOIL BIOL BIOCHEM, V42, P529, DOI 10.1016/j.soilbio.2009.11.016; Mejia LC, 2008, BIOL CONTROL, V46, P4, DOI 10.1016/j.biocontrol.2008.01.012; Miller JD, 2008, J CHEM ECOL, V34, P362, DOI 10.1007/s10886-007-9412-0; Mittempergher L, 2004, INVEST AGRAR-SIST R, V13, P161, DOI DOI 10.5424/821; Mucciarelli M, 2003, NEW PHYTOL, V158, P579, DOI 10.1046/j.1469-8137.2003.00762.x; Mucciarelli M, 2002, MYCOLOGIA, V94, P28, DOI 10.2307/3761843; Newcombe G, 2011, FOR SCI, V80, P251, DOI 10.1007/978-94-007-1599-8_16; Newhouse AE, 2007, PLANT CELL REP, V26, P977, DOI 10.1007/s00299-007-0313-z; NICHOLSON RL, 1992, ANNU REV PHYTOPATHOL, V30, P369, DOI 10.1146/annurev.py.30.090192.002101; Ouellette GB, 2004, FOREST SYST, V13, P119; PETRINI O, 1982, CAN J BOT, V60, P789, DOI 10.1139/b82-102; Promputtha I, 2007, MICROB ECOL, V53, P579, DOI 10.1007/s00248-006-9117-x; Ragazzi A, 1999, J PHYTOPATHOL, V147, P437, DOI 10.1111/j.1439-0434.1999.tb03847.x; RIOUX D, 1991, CAN J BOT, V69, P2055, DOI 10.1139/b91-258; RODRIGUES KF, 1994, MYCOLOGIA, V86, P376, DOI 10.2307/3760568; Rodriguez RJ, 1997, ADV BOT RES, V24, P169; Rodriguez RJ, 2008, ISME J, V2, P404, DOI 10.1038/ismej.2007.106; Saikkonen K., 2007, Fungal Biology Reviews, V21, P67, DOI 10.1016/j.fbr.2007.05.001; Schulz B, 2005, MYCOL RES, V109, P661, DOI 10.1017/S095375620500273X; Schulz B, 1999, MYCOL RES, V103, P1275, DOI 10.1017/S0953756299008540; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.1093/biomet/52.3-4.591; SIEBER T, 1988, J PHYTOPATHOL, V122, P289, DOI 10.1111/j.1439-0434.1988.tb01021.x; Sieber Thomas N., 2007, Fungal Biology Reviews, V21, P75, DOI 10.1016/j.fbr.2007.05.004; SINCLAIR WA, 1975, PHYTOPATHOLOGY, V65, P349, DOI 10.1094/Phyto-65-349; Smith SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003052; Solla A, 2008, PLANT PATHOL, V57, P33, DOI 10.1111/j.1365-3059.2007.01692.x; Solla A, 2005, NEW PHYTOL, V166, P1025, DOI 10.1111/j.1469-8137.2005.01384.x; Srivastava V, 2007, PLANT J, V49, P135, DOI 10.1111/j.1365-313X.2006.02943.x; Stuart RM, 2010, ARCH MICROBIOL, V192, P307, DOI 10.1007/s00203-010-0557-9; Sumarah MW, 2008, MYCOL RES, V112, P731, DOI 10.1016/j.mycres.2008.01.007; Van Wees SCM, 2008, CURR OPIN PLANT BIOL, V11, P443, DOI 10.1016/j.pbi.2008.05.005; Vieira P. D. de S., 2011, Mycology - An International Journal on Fungal Biology, V2, P91, DOI 10.1080/21501203.2011.584390; WEBBER J, 1981, NATURE, V292, P449, DOI 10.1038/292449a0; White JF, 2010, PHYSIOL PLANTARUM, V138, P440, DOI 10.1111/j.1399-3054.2009.01332.x; White T.J., 1990, PCR PROTOCOLS GUIDE, P315, DOI DOI 10.1016/B978-0-12-372180-8.50042-1; Whitham TG, 2006, NAT REV GENET, V7, P510, DOI 10.1038/nrg1877; Witzell J, 2008, CAN J FOREST RES, V38, P2711, DOI 10.1139/X08-112; Zalar P, 2008, STUD MYCOL, P21, DOI 10.3114/sim.2008.61.02	87	49	50	1	96	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e56987	10.1371/journal.pone.0056987	http://dx.doi.org/10.1371/journal.pone.0056987			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23468900	Green Published, gold, Green Submitted			2022-12-25	WOS:000315524900047
J	Behrends, J; Renauld, JC; Ehlers, S; Holscher, C				Behrends, Jochen; Renauld, Jean-Christophe; Ehlers, Stefan; Hoelscher, Christoph			IL-22 Is Mainly Produced by IFN gamma-Secreting Cells but Is Dispensable for Host Protection against Mycobacterium tuberculosis Infection	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; NITRIC-OXIDE SYNTHASE; CD4(+) T-CELLS; IMMUNE-RESPONSE; INTERFERON-GAMMA; AUTOIMMUNE INFLAMMATION; DERMAL INFLAMMATION; INDUCIBLE FACTOR; IL-TIF; INTERLEUKIN-22	Anti-inflammatory treatment of autoimmune diseases is associated with an increased risk of reactivation tuberculosis (TB). Besides interleukin (IL-17) A, IL-22 represents a classical T helper (TH) 17 cytokine and shares similar pathological effects in inflammatory diseases such as psoriasis or arthritis. Whereas IL-17A supports protective immune responses during mycobacterial infections, the role of IL-22 after infection with Mycobacterium tuberculosis (Mtb) is yet poorly characterized. Therefore, we here characterize the cell types producing IL-22 and the protective function of this cytokine during experimental TB in mice. Like IL-17A, IL-22 is expressed early after infection with Mtb in an IL-23-dependent manner. Surprisingly, the majority of IL-22-producing cells are not positive for IL-17A but have rather functional characteristics of interferon-gamma-producing TH1 cells. Although we found minor differences in the number of naive and central memory T cells as well as in the frequency of TH1 and polyfunctional T cells in mice deficient for IL-22, the absence of IL-22 does not affect the outcome of Mtb infection. Our study revealed that although produced by TH1 cells, IL-22 is dispensable for protective immune responses during TB. Therefore, targeting of IL-22 in inflammatory disease may represent a therapeutic approach that does not incur the danger of reactivation TB.	[Behrends, Jochen; Ehlers, Stefan; Hoelscher, Christoph] RCB, Borstel, Germany; [Renauld, Jean-Christophe] Catholic Univ Louvain, Ludwig Inst Canc Res, B-1200 Brussels, Belgium; [Renauld, Jean-Christophe] Catholic Univ Louvain, Expt Med Unit, B-1200 Brussels, Belgium; [Ehlers, Stefan] Univ Kiel, Kiel, Germany	Forschungszentrum Borstel; Ludwig Institute for Cancer Research; Universite Catholique Louvain; Universite Catholique Louvain; University of Kiel	Holscher, C (corresponding author), RCB, Borstel, Germany.	choelscher@fz-borstel.de	Ehlers, Stefan/B-4075-2010; Hölscher, Christoph/O-1732-2018; Renauld, Jean-Christophe/B-7268-2012	Hölscher, Christoph/0000-0002-7520-9146; Renauld, Jean-Christophe/0000-0003-1736-2131	BMBF grant [01KI0784]; German Research Foundation Cluster of Excellence "Inflammation at Interfaces'' [EXC306]	BMBF grant(Federal Ministry of Education & Research (BMBF)); German Research Foundation Cluster of Excellence "Inflammation at Interfaces''	This study was supported by a BMBF grant 01KI0784 to C.H. and S.E. and the German Research Foundation Cluster of Excellence "Inflammation at Interfaces'' EXC306 to C.H. and S.E. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afif W, 2009, GASTROENTEROL CLIN N, V38, P691, DOI 10.1016/j.gtc.2009.07.005; Aujla SJ, 2008, NAT MED, V14, P275, DOI 10.1038/nm1710; Benson HL, 2011, AM J RESP CELL MOL, V44, P700, DOI 10.1165/rcmb.2010-0125OC; Boniface K, 2005, J IMMUNOL, V174, P3695, DOI 10.4049/jimmunol.174.6.3695; COOPER AM, 1995, CURR OPIN IMMUNOL, V7, P512, DOI 10.1016/0952-7915(95)80096-4; Cooper AM, 2009, ANNU REV IMMUNOL, V27, P393, DOI 10.1146/annurev.immunol.021908.132703; Cruz A, 2010, J EXP MED, V207, P1609, DOI 10.1084/jem.20100265; Davis JM, 2009, CELL, V136, P37, DOI 10.1016/j.cell.2008.11.014; Dhiman R, 2012, J IMMUNOL, V189, P897, DOI 10.4049/jimmunol.1102833; Dhiman R, 2009, J IMMUNOL, V183, P6639, DOI 10.4049/jimmunol.0902587; Dumoutier L, 2000, J IMMUNOL, V164, P1814, DOI 10.4049/jimmunol.164.4.1814; Ehlers S, 2005, CLIN INFECT DIS, V41, pS199, DOI 10.1086/429998; Ehlers S, 2001, J EXP MED, V194, P1847, DOI 10.1084/jem.194.12.1847; Ehlers S, 2010, CELL HOST MICROBE, V7, P6, DOI 10.1016/j.chom.2009.12.010; Eyerich S, 2009, J CLIN INVEST, V119, P3573, DOI 10.1172/JCI40202; FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; FLYNN JL, 1995, IMMUNITY, V2, P561, DOI 10.1016/1074-7613(95)90001-2; Hansch HCR, 1996, INT IMMUNOL, V8, P1299, DOI 10.1093/intimm/8.8.1299; Henao-Tamayo MI, 2010, CLIN VACCINE IMMUNOL, V17, P618, DOI 10.1128/CVI.00368-09; Hirota K, 2011, NAT IMMUNOL, V12, P255, DOI 10.1038/ni.1993; Holscher C, 2001, J IMMUNOL, V167, P6957, DOI 10.4049/jimmunol.167.12.6957; Ikeuchi H, 2005, ARTHRITIS RHEUM-US, V52, P1037, DOI 10.1002/art.20965; Keane J, 2001, NEW ENGL J MED, V345, P1098, DOI 10.1056/NEJMoa011110; Khader SA, 2005, J IMMUNOL, V175, P788, DOI 10.4049/jimmunol.175.2.788; Khader SA, 2007, NAT IMMUNOL, V8, P369, DOI 10.1038/ni1449; Khader SA, 2011, J IMMUNOL, V187, P5402, DOI 10.4049/jimmunol.1101377; Kotenko SV, 2001, J BIOL CHEM, V276, P2725, DOI 10.1074/jbc.M007837200; Kumar P, 2013, MUCOSAL IMMUNOL, V6, P69, DOI 10.1038/mi.2012.49; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Lee YK, 2009, CURR OPIN IMMUNOL, V21, P274, DOI 10.1016/j.coi.2009.05.021; Lee YK, 2009, IMMUNITY, V30, P92, DOI 10.1016/j.immuni.2008.11.005; Lejeune D, 2002, J BIOL CHEM, V277, P33676, DOI 10.1074/jbc.M204204200; Li W, 2009, J BIOL CHEM, V284, P218, DOI 10.1074/jbc.M806267200; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Lockhart E, 2006, J IMMUNOL, V177, P4662, DOI 10.4049/jimmunol.177.7.4662; MacMicking JD, 1997, P NATL ACAD SCI USA, V94, P5243, DOI 10.1073/pnas.94.10.5243; MacMicking JD, 2003, SCIENCE, V302, P654, DOI 10.1126/science.1088063; Maglione PJ, 2007, J IMMUNOL, V178, P7222, DOI 10.4049/jimmunol.178.11.7222; Maglione PJ, 2009, EUR J IMMUNOL, V39, P676, DOI 10.1002/eji.200839148; Mitra A, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3781; Mohan AK, 2004, CLIN INFECT DIS, V39, P295, DOI 10.1086/421494; Mohan K, 2005, EUR J IMMUNOL, V35, P1702, DOI 10.1002/eji.200425885; Murphy CA, 2003, J EXP MED, V198, P1951, DOI 10.1084/jem.20030896; Nakagome K, 2011, J IMMUNOL, V187, P5077, DOI 10.4049/jimmunol.1001560; ORME IM, 1993, J INFECT DIS, V167, P1481, DOI 10.1093/infdis/167.6.1481; Ouyang WJ, 2011, ANNU REV IMMUNOL, V29, P71, DOI 10.1146/annurev-immunol-031210-101312; Pearl JE, 2001, CELL IMMUNOL, V211, P43, DOI 10.1006/cimm.2001.1819; Reiling N, 2008, IMMUNOL LETT, V116, P15, DOI 10.1016/j.imlet.2007.11.015; Renauld JC, 2003, NAT REV IMMUNOL, V3, P667, DOI 10.1038/nri1153; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Solovic I, 2010, EUR RESPIR J, V36, P1185, DOI 10.1183/09031936.00028510; Stallmach A, 2010, BEST PRACT RES CL GA, V24, P167, DOI 10.1016/j.bpg.2010.01.002; Stange J, 2012, J IMMUNOL, V188, P2410, DOI 10.4049/jimmunol.1102062; Stumhofer JS, 2007, SEMIN IMMUNOL, V19, P394, DOI 10.1016/j.smim.2007.11.006; Torrado E, 2011, TRENDS IMMUNOL, V32, P66, DOI 10.1016/j.it.2010.12.001; Tsai MC, 2006, CELL MICROBIOL, V8, P218, DOI 10.1111/j.1462-5822.2005.00612.x; Umemura M, 2007, J IMMUNOL, V178, P3786, DOI 10.4049/jimmunol.178.6.3786; Van Belle AB, 2012, J IMMUNOL, V188, P462, DOI 10.4049/jimmunol.1102224; Volkman HE, 2010, SCIENCE, V327, P466, DOI 10.1126/science.1179663; Werninghaus K, 2009, J EXP MED, V206, P89, DOI 10.1084/jem.20081445; Wilson MS, 2010, J IMMUNOL, V184, P4378, DOI 10.4049/jimmunol.0903416; Wolk K, 2004, IMMUNITY, V21, P241, DOI 10.1016/j.immuni.2004.07.007; Wolk K, 2006, CYTOKINE GROWTH F R, V17, P367, DOI 10.1016/j.cytogfr.2006.09.001; Wolk K, 2009, J MOL MED, V87, P523, DOI 10.1007/s00109-009-0457-0; Yoshida YO, 2010, J IMMUNOL, V184, P4414, DOI 10.4049/jimmunol.0903332; Zenewicz LA, 2011, INT IMMUNOL, V23, P159, DOI 10.1093/intimm/dxr001; Zeng GC, 2011, J IMMUNOL, V187, P190, DOI 10.4049/jimmunol.1004129; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505; Zhou L, 2009, IMMUNITY, V30, P646, DOI 10.1016/j.immuni.2009.05.001; Zhu JF, 2008, BLOOD, V112, P1557, DOI 10.1182/blood-2008-05-078154	72	33	34	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57379	10.1371/journal.pone.0057379	http://dx.doi.org/10.1371/journal.pone.0057379			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460846	Green Submitted, gold, Green Published			2022-12-25	WOS:000315519000100
J	Burgos-Robles, A; Bravo-Rivera, H; Quirk, GJ				Burgos-Robles, Anthony; Bravo-Rivera, Hector; Quirk, Gregory J.			Prelimbic and Infralimbic Neurons Signal Distinct Aspects of Appetitive Instrumental Behavior	PLOS ONE			English	Article							MEDIAL PREFRONTAL CORTEX; FEAR EXTINCTION; NUCLEUS-ACCUMBENS; EXPRESSION; AMYGDALA; RAT; RESPONSES; MEMORY; NMDA; CONSOLIDATION	It is thought that discrete subregions of the medial prefrontal cortex (mPFC) regulate different aspects of appetitive behavior, however, physiological support for this hypothesis has been lacking. In the present study, we used multichannel single-unit recording to compare the response of neurons in the prelimbic (PL) and infralimbic (IL) subregions of the mPFC, in rats pressing a lever to obtain sucrose pellets on a variable interval schedule of reinforcement (VI-60). Approximately 25% of neurons in both structures exhibited prominent excitatory responses during rewarded, but not unrewarded, lever presses. The time courses of reward responses in PL and IL, however, were markedly different. Most PL neurons exhibited fast and transient responses at the delivery of sucrose pellets, whereas most IL neurons exhibited delayed and prolonged responses associated with the collection of earned sucrose pellets. We further examined the functional significance of reward responses in IL and PL with local pharmacological inactivation. IL inactivation significantly delayed the collection of earned sucrose pellets, whereas PL inactivation produced no discernible effects. These findings support the hypothesis that PL and IL signal distinct aspects of appetitive behavior, and suggest that IL signaling facilitates reward collection.	[Quirk, Gregory J.] Univ Puerto Rico, Sch Med, Dept Psychiat, San Juan, PR 00936 USA; Univ Puerto Rico, Sch Med, Dept Anat & Neurobiol, San Juan, PR 00936 USA	University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus	Quirk, GJ (corresponding author), Univ Puerto Rico, Sch Med, Dept Psychiat, San Juan, PR 00936 USA.	gregoryjquirk@gmail.com		Bravo-Rivera, Hector/0000-0001-7882-3945	National Institutes of Health [R01-MH058883, R01-MH081975, P50-MH086400]; University of Puerto Rico President's Office; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH081975, P50MH086400, R01MH058883] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Puerto Rico President's Office; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by the National Institutes of Health grants R01-MH058883 and R01-MH081975 to G.J.Q., P50-MH086400 to S.N. Haber, and the University of Puerto Rico President's Office. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano T, 2010, NAT NEUROSCI, V13, P489, DOI 10.1038/nn.2499; Baldwin AE, 2002, J NEUROSCI, V22, P1063, DOI 10.1523/JNEUROSCI.22-03-01063.2002; Balleine BW, 2010, NEUROPSYCHOPHARMACOL, V35, P48, DOI 10.1038/npp.2009.131; Burgos-Robles A, 2007, NEURON, V53, P871, DOI 10.1016/j.neuron.2007.02.021; Burgos-Robles A, 2009, J NEUROSCI, V29, P8474, DOI 10.1523/JNEUROSCI.0378-09.2009; Chang JY, 2002, EXP BRAIN RES, V142, P67, DOI 10.1007/s00221-001-0918-3; Choi JS, 2010, P NATL ACAD SCI USA, V107, P21773, DOI 10.1073/pnas.1010079108; Coutureau E, 2003, BEHAV BRAIN RES, V146, P167, DOI 10.1016/j.bbr.2003.09.025; Gabbott PLA, 2005, J COMP NEUROL, V492, P145, DOI 10.1002/cne.20738; Graybiel AM, 2008, ANNU REV NEUROSCI, P31359; Hefner K, 2008, J NEUROSCI, V28, P8074, DOI 10.1523/JNEUROSCI.4904-07.2008; Ishikawa A, 2008, NEUROSCIENCE, V155, P573, DOI 10.1016/j.neuroscience.2008.06.037; Ishikawa A, 2008, J NEUROSCI, V28, P5088, DOI 10.1523/JNEUROSCI.0253-08.2008; Kelly MP, 2002, NEUROSCIENCE, V110, P617, DOI 10.1016/S0306-4522(01)00605-4; Killcross S, 2003, CEREB CORTEX, V13, P400, DOI 10.1093/cercor/13.4.400; Knapska E, 2009, LEARN MEMORY, V16, P486, DOI 10.1101/lm.1463909; Laurent V, 2009, LEARN MEMORY, V16, P520, DOI 10.1101/lm.1474609; Milad MR, 2002, NATURE, V420, P70, DOI 10.1038/nature01138; Miyazaki K, 2004, NEUROREPORT, V15, P721, DOI 10.1097/00001756-200403220-00030; Mulder AB, 2003, BEHAV BRAIN RES, V146, P77, DOI 10.1016/j.bbr.2003.09.016; Murphy ER, 2012, PSYCHOPHARMACOLOGY, V219, P401, DOI 10.1007/s00213-011-2572-1; Ostlund SB, 2005, J NEUROSCI, V25, P7763, DOI 10.1523/JNEUROSCI.1921-05.2005; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Pennartz CMA, 2009, J NEUROSCI, V29, P12831, DOI 10.1523/JNEUROSCI.3177-09.2009; Petrovich GD, 2001, BRAIN RES REV, V38, P247, DOI 10.1016/S0165-0173(01)00080-7; Petrovich GD, 2007, PHYSIOL BEHAV, V91, P397, DOI 10.1016/j.physbeh.2007.04.014; Pratt WE, 2001, BEHAV BRAIN RES, V123, P165, DOI 10.1016/S0166-4328(01)00204-2; Quirk GJ, 2008, NEUROPSYCHOPHARMACOL, V33, P56, DOI 10.1038/sj.npp.1301555; Rapanelli M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008656; Sierra-Mercado D, 2011, NEUROPSYCHOPHARMACOL, V36, P529, DOI 10.1038/npp.2010.184; Swanson L. W., 1992, BRAIN MAPS STRUCTURE; Valdes JL, 2006, EUR J NEUROSCI, V23, P1352, DOI 10.1111/j.1460-9568.2006.04659.x; Vertes RP, 2004, SYNAPSE, V51, P32, DOI 10.1002/syn.10279	33	64	64	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57575	10.1371/journal.pone.0057575	http://dx.doi.org/10.1371/journal.pone.0057575			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460877	gold, Green Published, Green Submitted			2022-12-25	WOS:000315519000132
J	Srinivasan, L; Asaad, WF; Ginat, DT; Gale, JT; Dougherty, DD; Williams, ZM; Sejnowski, TJ; Eskandar, EN				Srinivasan, Lakshminarayan; Asaad, Wael F.; Ginat, Daniel T.; Gale, John T.; Dougherty, Darin D.; Williams, Ziv M.; Sejnowski, Terrence J.; Eskandar, Emad N.			Action Initiation in the Human Dorsal Anterior Cingulate Cortex	PLOS ONE			English	Article							MEDIAL FRONTAL-CORTEX; SUPPLEMENTARY MOTOR AREA; PREFRONTAL CORTEX; NEURAL ACTIVITY; SELECTIVE ATTENTION; RESPONSE-INHIBITION; NEURONAL-ACTIVITY; ARM MOVEMENTS; MONKEY; CINGULOTOMY	The dorsal anterior cingulate cortex (dACC) has previously been implicated in processes that influence action initiation. In humans however, there has been little direct evidence connecting dACC to the temporal onset of actions. We studied reactive behavior in patients undergoing therapeutic bilateral cingulotomy to determine the immediate effects of dACC ablation on action initiation. In a simple reaction task, three patients were instructed to respond to a specific visual cue with the movement of a joystick. Within minutes of dACC ablation, the frequency of false starts increased, where movements occurred prior to presentation of the visual cue. In a decision making task with three separate patients, the ablation effect on action initiation persisted even when action selection was intact. These findings suggest that human dACC influences action initiation, apart from its role in action selection.	[Srinivasan, Lakshminarayan] Univ Calif Los Angeles, Neural Signal Proc Lab, Dept Radiol, Los Angeles, CA 90024 USA; [Asaad, Wael F.] Brown Univ, Dept Neurosurg, Alpert Med Sch, Providence, RI 02912 USA; [Asaad, Wael F.] Rhode Isl Hosp, Brown Inst Brain Sci, Providence, RI 02912 USA; [Asaad, Wael F.] Norman Prince Neurosci Inst, Providence, RI 02912 USA; [Ginat, Daniel T.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Gale, John T.; Dougherty, Darin D.; Williams, Ziv M.; Eskandar, Emad N.] Harvard Univ, Sch Med, Boston, MA USA; [Gale, John T.] Cleveland Clin, Dept Neurosci, Cleveland, OH 44106 USA; [Gale, John T.] Cleveland Clin, Ctr Neurol Restorat, Cleveland, OH 44106 USA; [Dougherty, Darin D.] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA; [Williams, Ziv M.; Eskandar, Emad N.] Massachusetts Gen Hosp, Dept Neurosurg, Boston, MA 02114 USA; [Sejnowski, Terrence J.] Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; [Sejnowski, Terrence J.] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA	University of California System; University of California Los Angeles; Brown University; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute; Salk Institute; University of California System; University of California San Diego	Srinivasan, L (corresponding author), Univ Calif Los Angeles, Neural Signal Proc Lab, Dept Radiol, Los Angeles, CA 90024 USA.	ls2@nsplab.org	Asaad, Wael/I-8485-2012; Dougherty, Darin D./G-9896-2012; Sejnowski, Terrence/AAV-5558-2021	Asaad, Wael/0000-0003-4406-9096; 	American Heart Association Scientist Development Grant [11SDG7550015]; DARPA Reliable Neural-Interface Technology (RE-NET) Program; UCLA Radiology Exploratory Development Grant; Massachusetts Biomedical Research Corporation; Howard Hughes Medical Institute; National Science Foundation [IOB 0645886]; National Institutes of Health [NEI R01EY017658, NIDA R01DA026297, NIMH MH086400]; Klingenstein Foundation; NATIONAL EYE INSTITUTE [R01EY017658] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH086400] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA026297] Funding Source: NIH RePORTER	American Heart Association Scientist Development Grant(American Heart Association); DARPA Reliable Neural-Interface Technology (RE-NET) Program; UCLA Radiology Exploratory Development Grant; Massachusetts Biomedical Research Corporation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Klingenstein Foundation(Klingenstein Philanthropies); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	LS is supported by the American Heart Association Scientist Development Grant (11SDG7550015), the DARPA Reliable Neural-Interface Technology (RE-NET) Program, and the UCLA Radiology Exploratory Development Grant. WFA is supported by a Tosteson award from the Massachusetts Biomedical Research Corporation. TJS is supported by the Howard Hughes Medical Institute. EE is supported by grants from the National Science Foundation (IOB 0645886), the National Institutes of Health (NEI R01EY017658, NIDA R01DA026297, NIMH MH086400), the Howard Hughes Medical Institute, and the Klingenstein Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiez C, 2006, CEREB CORTEX, V16, P1040, DOI 10.1093/cercor/bhj046; Aron AR, 2003, NAT NEUROSCI, V6, P115, DOI 10.1038/nn1003; Backus DA, 2001, EXP BRAIN RES, V140, P182, DOI 10.1007/s002210100807; Baird A, 2006, BRAIN COGNITION, V60, P166, DOI 10.1016/j.bandc.2005.11.003; Botvinick M, 1999, NATURE, V402, P179, DOI 10.1038/46035; Brown JW, 2005, SCIENCE, V307, P1118, DOI 10.1126/science.1105783; BRUTKOWSKI S, 1961, SCIENCE, V134, P2040, DOI 10.1126/science.134.3495.2040; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; CHOLLET F, 1991, ANN NEUROL, V29, P63, DOI 10.1002/ana.410290112; Coe B, 2002, J NEUROSCI, V22, P5081, DOI 10.1523/JNEUROSCI.22-12-05081.2002; Cohen RA, 1999, J NEUROPSYCH CLIN N, V11, P444, DOI 10.1176/jnp.11.4.444; Cohen RA, 1999, NEUROLOGY, V53, P819, DOI 10.1212/WNL.53.4.819; Crutcher MD, 2004, EXP BRAIN RES, V158, P278, DOI 10.1007/s00221-004-1895-0; Davis KD, 2000, J NEUROPHYSIOL, V83, P3575, DOI 10.1152/jn.2000.83.6.3575; Davis KD, 2005, J NEUROSCI, V25, P8402, DOI 10.1523/JNEUROSCI.2315-05.2005; Deiber MP, 1999, J NEUROPHYSIOL, V81, P3065, DOI 10.1152/jn.1999.81.6.3065; Delorme A, 2007, J NEUROSCI, V27, P11949, DOI 10.1523/JNEUROSCI.3477-07.2007; Dougherty DD, 2002, AM J PSYCHIAT, V159, P269, DOI 10.1176/appi.ajp.159.2.269; DREWE E A, 1975, Cortex, V11, P8; DREWE EA, 1975, NEUROPSYCHOLOGIA, V13, P421, DOI 10.1016/0028-3932(75)90065-2; Figner B, 2010, NAT NEUROSCI, V13, P538, DOI 10.1038/nn.2516; Frank MJ, 2007, SCIENCE, V318, P1309, DOI 10.1126/science.1146157; Gaymard B, 1998, EXP BRAIN RES, V120, P173, DOI 10.1007/s002210050391; Hutchison WD, 1999, NAT NEUROSCI, V2, P403, DOI 10.1038/8065; Isoda M, 2007, NAT NEUROSCI, V10, P240, DOI 10.1038/nn1830; Isomura Y, 2004, REV NEUROSCIENCE, V15, P279; JANER KW, 1991, J COGNITIVE NEUROSCI, V3, P231, DOI 10.1162/jocn.1991.3.3.231; Janssen P, 2005, NAT NEUROSCI, V8, P234, DOI 10.1038/nn1386; Kuehn S, 2009, NEUROIMAGE, V46, P1187, DOI 10.1016/j.neuroimage.2009.03.020; Lau H, 2006, NEUROIMAGE, V29, P446, DOI 10.1016/j.neuroimage.2005.07.050; LEIMKUHLER ME, 1985, ANN NEUROL, V18, P617, DOI 10.1002/ana.410180518; LUPPINO G, 1991, J COMP NEUROL, V311, P463, DOI 10.1002/cne.903110403; Milea D, 2003, NEUROREPORT, V14, P283, DOI 10.1097/00001756-200302100-00026; Mulert C, 2003, INT J PSYCHOPHYSIOL, V47, P175, DOI 10.1016/S0167-8760(02)00125-3; Nachev P, 2005, CURR BIOL, V15, P122, DOI 10.1016/j.cub.2005.01.006; Naito E, 2000, J NEUROPHYSIOL, V83, P1701, DOI 10.1152/jn.2000.83.3.1701; Narayanan NS, 2006, NEUROSCIENCE, V139, P865, DOI 10.1016/j.neuroscience.2005.11.072; Oswal A, 2007, J NEUROPHYSIOL, V97, P2722, DOI 10.1152/jn.01238.2006; PARDO JV, 1990, P NATL ACAD SCI USA, V87, P256, DOI 10.1073/pnas.87.1.256; Passingham RE., 1993, FRONTAL LOBES VOLUNT; Paus T, 2001, NAT REV NEUROSCI, V2, P417, DOI 10.1038/35077500; Picard N, 1996, CEREB CORTEX, V6, P342, DOI 10.1093/cercor/6.3.342; Picard N, 2001, CURR OPIN NEUROBIOL, V11, P663, DOI 10.1016/S0959-4388(01)00266-5; Picton TW, 2007, CEREB CORTEX, V17, P826, DOI 10.1093/cercor/bhk031; Procyk E, 2000, NAT NEUROSCI, V3, P502, DOI 10.1038/74880; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Richardson AG, 2008, J NEUROPHYSIOL, V99, P1253, DOI 10.1152/jn.01096.2007; ROMO R, 1987, EXP BRAIN RES, V67, P656; Rushworth MFS, 2008, NAT NEUROSCI, V11, P389, DOI 10.1038/nn2066; Rushworth MFS, 2007, NEURON, V54, P669, DOI 10.1016/j.neuron.2007.05.025; Russo GS, 2002, J NEUROPHYSIOL, V88, P2612, DOI 10.1152/jn.00306.2002; Seamans JK, 2008, NEUROTOX RES, V14, P249, DOI 10.1007/BF03033814; Sheth SA, 2012, NATURE, V488, P218, DOI 10.1038/nature11239; Shidara M, 2002, SCIENCE, V296, P1709, DOI 10.1126/science.1069504; Shima K, 1998, SCIENCE, V282, P1335, DOI 10.1126/science.282.5392.1335; Spangler WJ, 1996, NEUROSURGERY, V38, P1071, DOI 10.1227/00006123-199606000-00001; Sumner P, 2007, NEURON, V54, P697, DOI 10.1016/j.neuron.2007.05.016; TANJI J, 1994, NATURE, V371, P413, DOI 10.1038/371413a0; VERFAELLIE M, 1987, ARCH NEUROL-CHICAGO, V44, P1265, DOI 10.1001/archneur.1987.00520240045010; Williams ZM, 2004, NAT NEUROSCI, V7, P1370, DOI 10.1038/nn1354; Yoshiura T, 1997, AM J NEURORADIOL, V18, P865	61	19	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e55247	10.1371/journal.pone.0055247	http://dx.doi.org/10.1371/journal.pone.0055247			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460783	Green Published, gold, Green Submitted			2022-12-25	WOS:000315519000006
J	Suchorolski, MT; Paulson, TG; Sanchez, CA; Hockenbery, D; Reid, BJ				Suchorolski, Martin T.; Paulson, Thomas G.; Sanchez, Carissa A.; Hockenbery, David; Reid, Brian J.			Warburg and Crabtree Effects in Premalignant Barrett's Esophagus Cell Lines with Active Mitochondria	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; GROWTH-FACTOR; CANCER; EXPRESSION; METABOLISM; ADENOCARCINOMA; HYPOXIA-INDUCIBLE-FACTOR-1-ALPHA; ANGIOGENESIS; GLYCOLYSIS; STRATEGY	Background: Increased glycolysis is a hallmark of cancer metabolism, yet relatively little is known about this phenotype at premalignant stages of progression. Periodic ischemia occurs in the premalignant condition Barrett's esophagus (BE) due to tissue damage from chronic acid-bile reflux and may select for early adaptations to hypoxia, including upregulation of glycolysis. Methodology/Principal Findings: We compared rates of glycolysis and oxidative phosphorylation in four cell lines derived from patients with BE (CP-A, CP-B, CP-C and CP-D) in response to metabolic inhibitors and changes in glucose concentration. We report that cell lines derived from patients with more advanced genetically unstable BE have up to twofold higher glycolysis compared to a cell line derived from a patient with early genetically stable BE; however, all cell lines preserve active mitochondria. In response to the glycolytic inhibitor 2-deoxyglucose, the most glycolytic cell lines (CP-C and CP-D) had the greatest suppression of extra-cellular acidification, but were able to compensate with upregulation of oxidative phosphorylation. In addition, these cell lines showed the lowest compensatory increases in glycolysis in response to mitochondrial uncoupling by 2,4-dinitrophenol. Finally, these cell lines also upregulated their oxidative phosphorylation in response to glucose via the Crabtree effect, and demonstrate a greater range of modulation of oxygen consumption. Conclusions/Significance: Our findings suggest that cells from premalignant Barrett's esophagus tissue may adapt to an ever-changing selective microenvironment through changes in energy metabolic pathways typically associated with cancer cells.	[Suchorolski, Martin T.] Univ Washington, Dept Mol & Cellular Biol, Seattle, WA 98195 USA; [Suchorolski, Martin T.; Paulson, Thomas G.; Sanchez, Carissa A.; Reid, Brian J.] Fred Hutchinson Canc Res Ctr, Human Biol Div, Seattle, WA 98104 USA; [Paulson, Thomas G.; Sanchez, Carissa A.; Reid, Brian J.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA; [Hockenbery, David] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98104 USA; [Reid, Brian J.] Univ Washington, Dept Med, Seattle, WA USA; [Reid, Brian J.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Suchorolski, MT (corresponding author), Univ Washington, Dept Mol & Cellular Biol, Seattle, WA 98195 USA.	msuchoro@uw.edu	Reid, Brian John/AFT-8587-2022	Reid, Brian John/0000-0002-9613-979X	NIH [P01 CA91955, 1 P50HG02360]; NATIONAL CANCER INSTITUTE [P01CA091955] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG002360] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	Funding for this study was generously provided by the following grants: NIH grant no. P01 CA91955 and NIH grant no. 1 P50HG02360. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baatar D, 2002, AM J PATHOL, V161, P1449, DOI 10.1016/S0002-9440(10)64420-3; Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Berridge MV, 2010, MITOCHONDRION, V10, P584, DOI 10.1016/j.mito.2010.08.002; Birner P, 2001, CLIN CANCER RES, V7, P1661; Boonstra JJ, 2010, JNCI-J NATL CANCER I, V102, P271, DOI 10.1093/jnci/djp499; Bos R, 2001, JNCI-J NATL CANCER I, V93, P309, DOI 10.1093/jnci/93.4.309; Brandon MC, 2009, HUM MUTAT, V30, P1, DOI 10.1002/humu.20801; Chen G, 2009, ANTIOXID REDOX SIGN, V11, P1083, DOI [10.1089/ars.2008.2321, 10.1089/ARS.2008.2321]; Chen Z, 2007, J BIOENERG BIOMEMBR, V39, P267, DOI 10.1007/s10863-007-9086-x; Chinopoulos C, 2010, FASEB J, V24, P2405, DOI 10.1096/fj.09-149898; Cook MB, 2007, CANCER EPIDEM BIOMAR, V16, P2090, DOI 10.1158/1055-9965.EPI-07-0432; Crabtree HG, 1929, BIOCHEM J, V23, P536, DOI 10.1042/bj0230536; Diaz-Ruiz R, 2011, BBA-BIOENERGETICS, V1807, P568, DOI 10.1016/j.bbabio.2010.08.010; Diers AR, 2012, BIOCH J; Frezza C, 2009, SEMIN CANCER BIOL, V19, P4, DOI 10.1016/j.semcancer.2008.11.008; Galipeau PC, 2007, PLOS MED, V4, P342, DOI 10.1371/jourmal.pmed.0040067; Georgakoudi I, 2002, CANCER RES, V62, P682; Griffiths EA, 2007, BRIT J CANCER, V96, P1377, DOI 10.1038/sj.bjc.6603744; Harper ME, 2002, FASEB J, V16, P1550, DOI 10.1096/fj.02-0541com; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hudson CC, 2002, MOL CELL BIOL, V22, P7004, DOI 10.1128/MCB.22.20.7004-7014.2002; Koss K, 2004, J CLIN PATHOL, V57, P1156, DOI 10.1136/jcp.2004.018150; Kunz WS, 2003, EXP PHYSIOL, V88, P149, DOI 10.1113/eph8802512; Levine DS, 1992, GASTROINTEST ENDOSC, P395; Lord RVN, 2003, J THORAC CARDIOV SUR, V125, P246, DOI 10.1067/mtc.2003.203; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; Neto CACP, 2001, CLIN NUCL MED, V26, P1060, DOI 10.1097/00003072-200112000-00025; Palanca-Wessels MC, 1998, GASTROENTEROLOGY, V114, P295, DOI 10.1016/S0016-5085(98)70480-9; Possemato R, 2011, NATURE; Rockett JC, 1997, BRIT J CANCER, V75, P258, DOI 10.1038/bjc.1997.42; Stoeltzing O, 2004, JNCI-J NATL CANCER I, V96, P946, DOI 10.1093/jnci/djh168; Suganuma K, 2010, LEUKEMIA LYMPHOMA, V51, P2112, DOI 10.3109/10428194.2010.512966; Taylor MD, 2009, EUR J CARDIO-THORAC, V35, P699, DOI 10.1016/j.ejcts.2008.11.029; Wang KK, 2008, AM J GASTROENTEROL, V103, P788, DOI 10.1111/j.1572-0241.2008.01835.x; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Warburg O, 1927, J GEN PHYSIOL, V8, P519, DOI 10.1085/jgp.8.6.519; WEINHOUSE S, 1956, SCIENCE, V124, P267, DOI 10.1126/science.124.3215.267; Whitaker-Menezes D, 2011, CELL CYCLE, V10, P4047, DOI 10.4161/cc.10.23.18151; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006; Xie H, 2009, MOL CANCER THER, V8, P626, DOI 10.1158/1535-7163.MCT-08-1049; Younes M, 1997, CANCER EPIDEM BIOMAR, V6, P303; Zu XL, 2004, BIOCHEM BIOPH RES CO, V313, P459, DOI 10.1016/j.bbrc.2003.11.136	42	23	23	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e56884	10.1371/journal.pone.0056884	http://dx.doi.org/10.1371/journal.pone.0056884			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460817	Green Published, gold, Green Submitted			2022-12-25	WOS:000315519000042
J	Schmidt, A; Muller, N; Schink, B; Schleheck, D				Schmidt, Alexander; Mueller, Nicolai; Schink, Bernhard; Schleheck, David			A Proteomic View at the Biochemistry of Syntrophic Butyrate Oxidation in Syntrophomonas wolfei	PLOS ONE			English	Article							NOV SP-NOV; GEN-NOV; FUMARATE RESPIRATION; ELECTRON-TRANSPORT; BACILLUS-SUBTILIS; ESCHERICHIA-COLI; SIGNAL PEPTIDES; FATTY-ACIDS; METABOLISM; SEQUENCE	In syntrophic conversion of butyrate to methane and CO2, butyrate is oxidized to acetate by secondary fermenting bacteria such as Syntrophomonas wolfei in close cooperation with methanogenic partner organisms, e. g., Methanospirillum hungatei. This process involves an energetically unfavourable shift of electrons from the level of butyryl-CoA oxidation to the substantially lower redox potential of proton and/or CO2 reduction, in order to transfer these electrons to the methanogenic partner via hydrogen and/or formate. In the present study, all prominent membrane-bound and soluble proteins expressed in S. wolfei specifically during syntrophic growth with butyrate, in comparison to pure-culture growth with crotonate, were examined by one-and two-dimensional gel electrophoresis, and identified by peptide fingerprinting-mass spectrometry. A membrane-bound, externally oriented, quinone-linked formate dehydrogenase complex was expressed at high level specifically during syntrophic butyrate oxidation, comprising a selenocystein-linked catalytic subunit with a membrane-translocation pathway signal (TAT), a membrane-bound iron-sulfur subunit, and a membrane-bound cytochrome. Soluble hydrogenases were expressed at high levels specifically during growth with crotonate. The results were confirmed by native protein gel electrophoresis, by formate dehydrogenase and hydrogenase-activity staining, and by analysis of formate dehydrogenase and hydrogenase activities in intact cells and cell extracts. Furthermore, constitutive expression of a membrane-bound, internally oriented iron-sulfur oxidoreductase (DUF224) was confirmed, together with expression of soluble electron-transfer flavoproteins (EtfAB) and two previously identified butyryl-CoA dehydrogenases. Our findings allow to depict an electron flow scheme for syntrophic butyrate oxidation in S. wolfei. Electrons derived from butyryl-CoA are transferred through a membrane-bound EtfAB: quinone oxidoreductase (DUF224) to a menaquinone cycle and further via a b-type cytochrome to an externally oriented formate dehydrogenase. Hence, an ATP hydrolysisdriven proton-motive force across the cytoplasmatic membrane would provide the energy input for the electron potential shift necessary for formate formation.	[Schmidt, Alexander; Mueller, Nicolai; Schink, Bernhard; Schleheck, David] Univ Konstanz, Dept Biol, Constance, Germany; [Schmidt, Alexander; Schink, Bernhard; Schleheck, David] Univ Konstanz, Konstanz Res Sch Chem Biol KoRS CB, Constance, Germany	University of Konstanz; University of Konstanz	Schleheck, D (corresponding author), Univ Konstanz, Dept Biol, Constance, Germany.	david.schleheck@uni-konstanz.de			Deutsche Forschungsgemeinschaft (DFG) [SCHI 180/10, SCHL 1936/1]; University of Konstanz; Konstanz Young Scholar Fund; Konstanz Research School Chemical Biology	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); University of Konstanz; Konstanz Young Scholar Fund; Konstanz Research School Chemical Biology	This work was funded by the Deutsche Forschungsgemeinschaft (DFG grants SCHI 180/10 to B. S. and SCHL 1936/1 to D. S.), by the University of Konstanz, the Konstanz Young Scholar Fund, and the Konstanz Research School Chemical Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagos PG, 2010, BIOINFORMATICS, V26, P2811, DOI 10.1093/bioinformatics/btq530; BEATY PS, 1990, APPL ENVIRON MICROB, V56, P3223, DOI 10.1128/AEM.56.10.3223-3224.1990; BEATY PS, 1989, APPL ENVIRON MICROB, V55, P977, DOI 10.1128/AEM.55.4.977-983.1989; BEATY PS, 1987, APPL ENVIRON MICROB, V53, P1183, DOI 10.1128/AEM.53.5.1183-1185.1987; Bendtsen JD, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-167; BERGMEYER HU, 1975, Z KLIN CHEM KLIN BIO, V13, P507; Beveridge TJ, 1997, FEMS MICROBIOL REV, V20, P99, DOI 10.1016/S0168-6445(97)00043-0; Biel S, 2002, EUR J BIOCHEM, V269, P1974, DOI 10.1046/j.1432-1033.2002.02842.x; Biswas R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041415; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Calamita HG, 2002, MOL MICROBIOL, V44, P601, DOI 10.1046/j.1365-2958.2002.02872.x; Calamita HG, 2001, P NATL ACAD SCI USA, V98, P15260, DOI 10.1073/pnas.261483798; DIEKERT GB, 1978, J BACTERIOL, V136, P597, DOI 10.1128/JB.136.2.597-606.1978; Dzioba J, 2003, J BACTERIOL, V185, P674, DOI 10.1128/JB.185.2.674-678.2003; Engelhardt H, 2007, J STRUCT BIOL, V160, P115, DOI 10.1016/j.jsb.2007.08.003; Falke D, 2010, FEMS MICROBIOL LETT, V303, P69, DOI 10.1111/j.1574-6968.2009.01862.x; Geer LY, 2002, GENOME RES, V12, P1619, DOI 10.1101/gr.278202; GUSTAFSON WG, 1986, J BIOL CHEM, V261, P7733; JONES RW, 1976, BIOCHEM SOC T, V4, P671, DOI 10.1042/bst0040671; Kroger A, 2002, BBA-BIOENERGETICS, V1553, P23, DOI 10.1016/S0005-2728(01)00234-1; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee JW, 2012, BIOENERGETICS, V1, pe104; Marchler-Bauer A, 2004, NUCLEIC ACIDS RES, V32, pW327, DOI 10.1093/nar/gkh454; MCINERNEY MJ, 1981, APPL ENVIRON MICROB, V41, P826, DOI 10.1128/AEM.41.3.826-828.1981; MCINERNEY MJ, 1981, APPL ENVIRON MICROB, V41, P1029, DOI 10.1128/AEM.41.4.1029-1039.1981; MCINERNEY MJ, 1979, ARCH MICROBIOL, V122, P129, DOI 10.1007/BF00411351; MCINERNEY MJ, 1992, ARCH MICROBIOL, V158, P344, DOI 10.1007/BF00245363; MCINERNEY MJ, 1988, BIOL ANAEROBIC MICRO, P374; MCKELLAR RC, 1979, J BACTERIOL, V139, P231, DOI 10.1128/JB.139.1.231-238.1979; Muller N, 2010, ENV MICROBIOL REP, V2, P489, DOI 10.1111/j.1758-2229.2010.00147.x; Muller N, 2009, J BACTERIOL, V191, P6167, DOI 10.1128/JB.01605-08; Muller N, 2008, ENVIRON MICROBIOL, V10, P1501, DOI 10.1111/j.1462-2920.2007.01565.x; NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Rahlfs S, 1997, FEBS LETT, V404, P269, DOI 10.1016/S0014-5793(97)00088-4; Sara M, 2000, J BACTERIOL, V182, P859, DOI 10.1128/JB.182.4.859-868.2000; Sato K, 2003, J BIOCHEM, V134, P719, DOI 10.1093/jb/mvg199; Sato K, 1999, J BIOCHEM-TOKYO, V126, P668, DOI 10.1093/oxfordjournals.jbchem.a022501; Schaffer C, 2004, GLYCOBIOLOGY, V14, p31R, DOI 10.1093/glycob/cwh064; Schink B, 1997, MICROBIOL MOL BIOL R, V61, P262, DOI 10.1128/.61.2.262-280.1997; Schut GJ, 2009, J BACTERIOL, V191, P4451, DOI 10.1128/JB.01582-08; Sieber JR, 2012, ANNU REV MICROBIOL, V66, P429, DOI 10.1146/annurev-micro-090110-102844; Sieber JR, 2010, ENVIRON MICROBIOL, V12, P2289, DOI 10.1111/j.1462-2920.2010.02237.x; Sleytr UB, 1999, TRENDS MICROBIOL, V7, P253, DOI 10.1016/S0966-842X(99)01513-9; THAUER RK, 1977, BACTERIOL REV, V41, P100, DOI 10.1128/MMBR.41.1.100-180.1977; WALLRABENSTEIN C, 1994, ARCH MICROBIOL, V162, P136; WIDDEL F, 1983, ARCH MICROBIOL, V134, P286, DOI 10.1007/BF00407804; Widdel F., 1992, PROKARYOTES, P3352, DOI DOI 10.1007/978-1-4757-2191-1_21; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; WOFFORD NQ, 1986, J BACTERIOL, V167, P179, DOI 10.1128/jb.167.1.179-185.1986; Worm P, 2011, MICROBIOL-SGM, V157, P280, DOI 10.1099/mic.0.043927-0; ZHAO HX, 1990, INT J SYST BACTERIOL, V40, P40, DOI 10.1099/00207713-40-1-40; [No title captured]	54	53	62	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2013	8	2							e56905	10.1371/journal.pone.0056905	http://dx.doi.org/10.1371/journal.pone.0056905			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098PO	23468890	Green Submitted, Green Published, gold			2022-12-25	WOS:000315561400017
J	Aragao, GC; Mascarenhas, JDP; Kaiano, JHL; de Lucena, MSS; Siqueira, JAM; Fumian, TM; Hernandez, JD; de Oliveira, CS; Oliveira, DD; Araujo, ED; Soares, LD; Linhares, AC; Gabbay, YB				Aragao, Glicelia Cruz; Pereira Mascarenhas, Joana D'Arc; Lima Kaiano, Jane Haruko; Sousa de Lucena, Maria Silvia; Monteiro Siqueira, Jones Anderson; Fumian, Tulio Machado; Hernandez, Juliana das Merces; de Oliveira, Consuelo Silva; Oliveira, Darleise de Souza; Araujo, Eliete da Cunha; Soares, Luana da Silva; Linhares, Alexandre Costa; Gabbay, Yvone Benchimol			Norovirus Diversity in Diarrheic Children from an African-Descendant Settlement in Belem, Northern Brazil	PLOS ONE			English	Article							ACUTE GASTROENTERITIS; MOLECULAR EPIDEMIOLOGY; GENETIC DIVERSITY; HOSPITALIZED CHILDREN; INFANTILE GASTROENTERITIS; ENZYME-IMMUNOASSAY; UNITED-STATES; OUTBREAKS; COMMUNITY; CALICIVIRUSES	Norovirus (NoV), sapovirus (SaV) and human astrovirus (HAstV) are viral pathogens that are associated with outbreaks and sporadic cases of gastroenteritis. However, little is known about the occurrence of these pathogens in relatively isolated communities, such as the remnants of African-descendant villages ("Quilombola"). The objective of this study was the frequency determination of these viruses in children under 10 years, with and without gastroenteritis, from a "Quilombola" Community, Northern Brazil. A total of 159 stool samples were obtained from April/2008 to July/2010 and tested by an enzyme immunoassay (EIA) and reverse transcription-polymerase chain reaction (RT-PCR) to detect NoV, SaV and HAstV, and further molecular characterization was performed. These viruses were detected only in the diarrheic group. NoV was the most frequent viral agent detected (19.7%-16/81), followed by SaV (2.5%-2/81) and HAstV (1.2%-1/81). Of the 16 NoV-positive samples, 14 were sequenced with primers targeting the B region of the polymerase (ORF1) and the D region of the capsid (ORF2). The results showed a broad genetic diversity of NoV, with 12 strains being classified as GII-4 (5-41.7%), GII-6 (3-25%), GII-7 (2-16.7%), GII-17 (1-8.3%) and GI-2 (1-8.3%), as based on the polymerase region; 12 samples were classified, based on the capsid region, as GII-4 (6-50%, being 3-2006b variant and 3-2010 variant), GII-6 (3-25%), GII-17 (2-16.7%) and GII-20 (1-8.3%). One NoV-strain showed dual genotype specificity, based on the polymerase and capsid region (GII-7/GII-20). This study provides, for the first time, epidemiological and molecular information on the circulation of NoV, SaV and HAstV in African-descendant communities in Northern Brazil and identifies NoV genotypes that were different from those detected previously in studies conducted in the urban area of Belem. It remains to be determined why a broader NoV diversity was observed in such a semi-isolated community.	[Aragao, Glicelia Cruz] Univ Estado Para, Belem, Para, Brazil; [Pereira Mascarenhas, Joana D'Arc; Sousa de Lucena, Maria Silvia; Fumian, Tulio Machado; Hernandez, Juliana das Merces; de Oliveira, Consuelo Silva; Oliveira, Darleise de Souza; Soares, Luana da Silva; Linhares, Alexandre Costa; Gabbay, Yvone Benchimol] Inst Evandro Chagas, Ananindeua, Para, Brazil; [Lima Kaiano, Jane Haruko; Monteiro Siqueira, Jones Anderson] UFPA, Nucleo Med Trop, Belem, Para, Brazil; [Araujo, Eliete da Cunha] UFPA, Inst Ciencias Saude, Belem, Para, Brazil	Universidade do Estado do Para (UEPA); Instituto Evandro Chagas; Universidade Federal do Para; Universidade Federal do Para	Gabbay, YB (corresponding author), Inst Evandro Chagas, Ananindeua, Para, Brazil.	yvonegabbay@iec.pa.gov.br	Soares, Luana Silva/AAC-9134-2019; Fumian, Tulio/AAC-4724-2021	Soares, Luana Silva/0000-0001-9509-4019; Siqueira, Jones Anderson Monteiro/0000-0002-6491-6590	Fundacao de Amparo a Pesquisa do Estado do Para (FAPESPA); Instituto Evandro Chagas, Secretaria de Vigilancia em Saude, Ministerio da Saude; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Fundacao de Amparo a Pesquisa do Estado do Para (FAPESPA)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Instituto Evandro Chagas, Secretaria de Vigilancia em Saude, Ministerio da Saude; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This research was financially supported by Fundacao de Amparo a Pesquisa do Estado do Para (FAPESPA), and Instituto Evandro Chagas, Secretaria de Vigilancia em Saude, Ministerio da Saude and also received a grant from the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson AD, 2001, AM J EPIDEMIOL, V154, P1013, DOI 10.1093/aje/154.11.1013; Aragao GC., 2010, BRAZIL REV PAN AMAZ, V1, P149, DOI [10.5123/s2176-62232010000100021, DOI 10.5123/S2176-]; Ayres M, 2007, BIOESTAT 5 0 STAT AP; Bae JY, 2011, J FOOD PROTECT, V74, P1908, DOI 10.4315/0362-028X.JFP-11-063; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Blanton LH, 2006, J INFECT DIS, V193, P413, DOI 10.1086/499315; BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990; Bruggink L, 2010, INTERVIROLOGY, V53, P167, DOI 10.1159/000279764; Chan-It W, 2011, CLIN LAB, V57, P213; Donaldson EF, 2010, NAT REV MICROBIOL, V8, P231, DOI 10.1038/nrmicro2296; Eden JS, 2010, J CLIN VIROL, V49, P265, DOI 10.1016/j.jcv.2010.09.001; FELSENSTEIN J, 1995, PHYLIP PHYLOGENY INF; Ferreira MSR, 2008, J MED VIROL, V80, P338, DOI 10.1002/jmv.21059; Ferreira MSR, 2010, J MED VIROL, V82, P1442, DOI 10.1002/jmv.21831; Fioretti JM, 2011, MEM I OSWALDO CRUZ, V106, P942, DOI 10.1590/S0074-02762011000800008; Fumian TM, 2012, ARCH VIROL, V157, P2389, DOI 10.1007/s00705-012-1428-2; GABBAY YB, 1994, AM J EPIDEMIOL, V139, P728, DOI 10.1093/oxfordjournals.aje.a117063; Gabbay YB, 2007, VIRUS RES, V129, P166, DOI 10.1016/j.virusres.2007.07.006; Glass RI, 2001, NOVART FDN SYMP, V238, P5; Barreira DMPG, 2010, J CLIN VIROL, V47, P60, DOI 10.1016/j.jcv.2009.11.012; Gonzalez-Galan V, 2011, CLIN MICROBIOL INFEC, V17, P1895, DOI 10.1111/j.1469-0691.2011.03506.x; Green K. Y., 2007, FIELDS VIROLOGY, V1, P949; Jiang X, 1999, J VIROL METHODS, V83, P145, DOI 10.1016/S0166-0934(99)00114-7; Karst SM, 2010, VIRUSES-BASEL, V2, P748, DOI 10.3390/v2030748; Kayano JHL, 2010, 16 C BRAS INF PED; Kroneman A, 2011, J CLIN VIROL, V51, P121, DOI 10.1016/j.jcv.2011.03.006; Levidiotou S, 2009, CLIN MICROBIOL INFEC, V15, P596, DOI 10.1111/j.1469-0691.2009.02855.x; Lopman BA, 2011, CLIN INFECT DIS, V52, P466, DOI 10.1093/cid/ciq163; Lysen M, 2009, J CLIN MICROBIOL, V47, P2411, DOI 10.1128/JCM.02168-08; Mathijs E, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-310; Siqueira JAM, 2011, DIAGN MICR INFEC DIS, V71, P391, DOI 10.1016/j.diagmicrobio.2011.08.023; Nakamura LS, 2006, VIRUS REV RES, V11, P95; Nataraju SM, 2011, EPIDEMIOL INFECT, V139, P910, DOI 10.1017/S0950268810001731; NOEL JS, 1995, J CLIN MICROBIOL, V33, P797, DOI 10.1128/JCM.33.4.797-801.1995; Pang XLL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011599; Siebenga JJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000884; Siebenga JJ, 2009, J INFECT DIS, V200, P802, DOI 10.1086/605127; Silva José Antonio Novaes da, 2007, Saude soc., V16, P111; Siqueira JAM, 2010, 62 REUN AN SOC BRAS; Svraka S, 2007, J CLIN MICROBIOL, V45, P1389, DOI 10.1128/JCM.02305-06; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Vega E, 2011, EMERG INFECT DIS, V17, P1389, DOI 10.3201/eid1708.101837; Vernacchio L, 2006, PEDIATR INFECT DIS J, V25, P2, DOI 10.1097/01.inf.0000195623.57945.87; Vicentini F, 2011, VIRUS REV RES, V16, P159; Vinje J, 2004, J VIROL METHODS, V116, P109, DOI 10.1016/j.jviromet.2003.11.001; Wardlaw T, 2010, LANCET, V375, P870, DOI 10.1016/S0140-6736(09)61798-0; Wiegering V, 2011, INT J INFECT DIS, V15, pE401, DOI 10.1016/j.ijid.2011.02.006; Xavier MPTP, 2009, BRAZ J MED BIOL RES, V42, P438, DOI 10.1590/S0100-879X2009000500007; Zeng M, 2012, J MED VIROL, V84, P145, DOI 10.1002/jmv.22248; Zeng M, 2011, JPN J INFECT DIS, V64, P417; Zheng DP, 2006, VIROLOGY, V346, P312, DOI 10.1016/j.virol.2005.11.015; Zheng DP, 2010, J CLIN MICROBIOL, V48, P168, DOI 10.1128/JCM.01622-09; Zhou X, 2012, EPIDEMIOLOGY INFECT, V8, P1	53	29	30	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56608	10.1371/journal.pone.0056608	http://dx.doi.org/10.1371/journal.pone.0056608			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457593	gold, Green Submitted, Green Published			2022-12-25	WOS:000315603700065
J	Li, YY; Fu, KH; Gao, SG; Wu, Q; Fan, LL; Li, YQ; Chen, J				Li, Yingying; Fu, Kehe; Gao, Shigang; Wu, Qiong; Fan, Lili; Li, Yaqian; Chen, Jie			Impact on Bacterial Community in Midguts of the Asian Corn Borer Larvae by Transgenic Trichoderma Strain Overexpressing a Heterologous chit42 Gene with Chitin-Binding Domain	PLOS ONE			English	Article							PHYLOGENETIC ANALYSIS; DIVERSITY; MICROBIOTA; GUT; DISEASE; IDENTIFICATION; ENDOSYMBIONTS; CATERPILLARS; MICROFLORA; FORMOSANUS	This paper is the first report of the impact on the bacterial community in the midgut of the Asian corn borer (Ostrinia furnacalis) by the chitinase from the transgenic Trichoderma strain. In this study, we detected a change of the bacterial community in the midgut of the fourth instar larvae by using a culture-independent method. Results suggested that Proteobacteria and Firmicutes were the most highly represented phyla, being present in all the midgut bacterial communities. The observed species richness was simple, ranging from four to five of all the 16S rRNA clone libraries. When using Trichoderma fermentation liquids as additives, the percentages of the dominant flora in the total bacterial community in larval midgut changed significantly. The community of the genus Ochrobactrum in the midgut decreased significantly when the larvae were fed with the fermentation liquids of the transgenic Trichoderma strain Mc4. However, the Enterococcus community increased and then occupied the vacated niche of the Ochrobactrum members. Furthermore, the Shannon-Wiener (H) and the Simpson (1-D) indexes of the larval midgut bacterial library treated by feeding fermentation liquids of the transgenic Trichoderma strain Mc4 was the lowest compared with the culture medium, fermentation liquids of the wild type strain T30, and the sterile artificial diet. The Enterococcus sp. strain was isolated and characterized from the healthy larvae midgut of the Asian corn borer. An infection study of the Asian corn borer larvae using Enterococcus sp. ACB-1 revealed that a correlation existed between the increased Enterococcus community in the larval midgut and larval mortality. These results demonstrated that the transgenic Trichoderma strain could affect the composition of the midgut bacterial community. The change of the midgut bacterial community might be viewed as one of the factors resulting in the increased mortality of the Asian corn borer larvae.	[Li, Yingying; Fu, Kehe; Gao, Shigang; Wu, Qiong; Fan, Lili; Li, Yaqian; Chen, Jie] Shanghai Jiao Tong Univ, Dept Resource & Environm Sci, Sch Agr & Biol, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Chen, J (corresponding author), Shanghai Jiao Tong Univ, Dept Resource & Environm Sci, Sch Agr & Biol, Shanghai 200030, Peoples R China.	jiechen59@sjtu.edu.cn			China Agriculture Research System [CARS-02]; "948'' project of the Ministry of Agriculture of China [2011-G4]; key project from Shanghai Municipal Science and Technology Commission [09391910900]; National Department Public Benefit Research Foundation of China [200903052]; ministry of education research fund for the doctoral specialty [20090073110048]; "863'' national projects [2011AA10A205]	China Agriculture Research System; "948'' project of the Ministry of Agriculture of China; key project from Shanghai Municipal Science and Technology Commission; National Department Public Benefit Research Foundation of China; ministry of education research fund for the doctoral specialty; "863'' national projects	The research was supported by China Agriculture Research System (CARS-02), the "948'' project of the Ministry of Agriculture of China (2011-G4), the key project from Shanghai Municipal Science and Technology Commission (09391910900), the National Department Public Benefit Research Foundation of China (No. 200903052). The ministry of education research fund for the doctoral specialty (No. 20090073110048) and the "863'' national projects (2011AA10A205). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bogo MR, 1998, CURR MICROBIOL, V37, P221, DOI 10.1007/s002849900368; BREZNAK JA, 1982, ANNU REV MICROBIOL, V36, P323, DOI 10.1146/annurev.mi.36.100182.001543; Broderick NA, 2004, APPL ENVIRON MICROB, V70, P293, DOI 10.1128/AEM.70.1.293-300.2004; Burgmann H, 2001, J MICROBIOL METH, V45, P7, DOI 10.1016/S0167-7012(01)00213-5; Butler JL, 2003, APPL ENVIRON MICROB, V69, P6793, DOI 10.1128/AEM.69.11.6793-6800.2003; Cappellozza S, 2011, J INVERTEBR PATHOL, V106, P386, DOI 10.1016/j.jip.2010.12.007; Cardenas A, 2012, ISME J, V6, P502, DOI 10.1038/ismej.2011.123; Chen DQ, 1997, CURR MICROBIOL, V34, P220, DOI 10.1007/s002849900172; Dillon R, 2002, RES MICROBIOL, V153, P503, DOI 10.1016/S0923-2508(02)01361-X; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Gilliam M, 1997, FEMS MICROBIOL LETT, V155, P1; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hayashi H, 2005, J MED MICROBIOL, V54, P1093, DOI 10.1099/jmm.0.45935-0; Haynes S, 2003, APPL ENVIRON MICROB, V69, P7216, DOI 10.1128/AEM.69.12.7216-7223.2003; Hui XA, 2006, CAN J MICROBIOL, V52, P1085, DOI 10.1139/W06-064; Kelly D, 2005, TRENDS IMMUNOL, V26, P326, DOI 10.1016/j.it.2005.04.008; Kennedy TA, 2002, NATURE, V417, P636, DOI 10.1038/nature00776; Kiorboe T, 2003, APPL ENVIRON MICROB, V69, P3036, DOI 10.1128/AEM.69.6.3036-3047.2003; LANE DJ, 1991, NUCL ACID TECHNIQUES, P5; Li YY, 2013, J ENV SCI B IN PRESS, V48, P1; Limon MC, 2004, APPL MICROBIOL BIOT, V64, P675, DOI 10.1007/s00253-003-1538-6; LYSENKO O, 1958, J GEN MICROBIOL, V18, P774, DOI 10.1099/00221287-18-3-774; Manichanh C, 2006, GUT, V55, P205, DOI 10.1136/gut.2005.073817; Militza CCN, 2006, APPL ENVIRON MICROB, V72, P3175, DOI 10.1128/AEM.72.5.3175-3183.2006; NAFUS DM, 1991, TROP PEST MANAGE, V37, P41, DOI 10.1080/09670879109371535; Nardi JB, 2002, J INSECT PHYSIOL, V48, P751, DOI 10.1016/S0022-1910(02)00105-1; Noda S, 2005, APPL ENVIRON MICROB, V71, P8811, DOI 10.1128/AEM.71.12.8811-8817.2005; Ohkuma M, 2006, SOIL BIOL, P303; Ohkuma M, 1996, APPL ENVIRON MICROB, V62, P461, DOI 10.1128/AEM.62.2.461-468.1996; ONEILL SL, 1992, P NATL ACAD SCI USA, V89, P2699, DOI 10.1073/pnas.89.7.2699; Pinto-Tomas AA, 2011, ENVIRON ENTOMOL, V40, P1111, DOI 10.1603/EN11083; Ravenschlag K, 1999, APPL ENVIRON MICROB, V65, P3982; Robinson CJ, 2010, MICROB ECOL, V59, P199, DOI 10.1007/s00248-009-9595-8; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SCHLEIFER KH, 1984, INT J SYST BACTERIOL, V34, P31, DOI 10.1099/00207713-34-1-31; Shinzato N, 2007, BIOSCI BIOTECH BIOCH, V71, P906, DOI 10.1271/bbb.60540; Stachowicz JJ, 1999, SCIENCE, V286, P1577, DOI 10.1126/science.286.5444.1577; Xiang Hui, 2007, Acta Entomologica Sinica, V50, P222	39	8	8	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e55555	10.1371/journal.pone.0055555	http://dx.doi.org/10.1371/journal.pone.0055555			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457472	gold, Green Published, Green Submitted			2022-12-25	WOS:000315603700014
J	Lim, JH; Kim, MH; Han, YJ; Lee, DE; Park, SY; Han, JY; Kim, MY; Ryu, HM				Lim, Ji Hyae; Kim, Min Hyoung; Han, You Jung; Lee, Da Eun; Park, So Yeon; Han, Jung Yeol; Kim, Moon Young; Ryu, Hyun Mee			Cell-Free Fetal DNA and Cell-Free Total DNA Levels in Spontaneous Abortion with Fetal Chromosomal Aneuploidy	PLOS ONE			English	Article							MATERNAL PLASMA; HEART-RATE; SERUM; PREGNANCY; TRIMESTER; PLACENTA; METHYLATION; WOMEN; RISK	Background: Cell-free fetal DNA and cell-free total DNA in maternal circulation have been proposed as potential markers for noninvasive monitoring of the placental condition during the pregnancy. However, the correlation of and change in cell-free fetal DNA and cell-free total DNA in spontaneous abortion (SA) with fetal chromosomal aneuploidy have not yet been reported. Therefore, we investigated cell-free fetal DNA and cell-free total DNA levels in SA women with fetal chromosomal aneuploidy. Methodology/Principal Findings: A nested case-control study was conducted with maternal plasma collected from 268 women in their first trimester of pregnancy. Subjects included 41 SA with normal fetal karyotype, 26 SA with fetal chromosomal aneuploidy, and 201 normal controls. The unmethylated PDE9A gene was used to measure the maternal plasma levels of cell-free fetal DNA. The GAPDH gene was used to measure the maternal plasma levels of cell-free total DNA. The diagnostic accuracy was measured using receiver-operating characteristic (ROC) curves. Levels of cell-free fetal DNA and cell-free total DNA were significantly higher in both SA women with normal fetal karyotype and SA women with fetal chromosomal aneuploidy in comparison with the normal controls (P<0.001 in both). The correlation between cell-free fetal DNA and cell-free total DNA levels was stronger in the normal controls (r = 0.843, P<0.001) than in SA women with normal karyotype (r = 0.465, P = 0.002) and SA women with fetal chromosomal aneuploidy (r = 0.412, P = 0.037). The area under the ROC curve for cell-free fetal DNA and cell-free total DNA was 0.898 (95% CI, 0.852-0.945) and 0.939 (95% CI, 0.903-0.975), respectively. Conclusions: Significantly high levels of cell-free fetal DNA and cell-free total DNA were found in SA women with fetal chromosomal aneuploidy. Our findings suggest that cell-free fetal DNA and cell-free total DNA may be useful biomarkers for the prediction of SA with fetal chromosomal aneuploidy, regardless of fetal gender.	[Lim, Ji Hyae; Lee, Da Eun; Park, So Yeon; Ryu, Hyun Mee] Cheil Gen Hosp, Med Res Inst, Med Genet Lab, Seoul, South Korea; [Lim, Ji Hyae; Lee, Da Eun; Park, So Yeon; Ryu, Hyun Mee] Womens Healthcare Ctr, Seoul, South Korea; [Kim, Min Hyoung; Han, You Jung; Han, Jung Yeol; Kim, Moon Young; Ryu, Hyun Mee] Cheil Gen Hosp, Dept Obstet & Gynecol, Seoul, South Korea; [Kim, Min Hyoung; Han, You Jung; Han, Jung Yeol; Kim, Moon Young; Ryu, Hyun Mee] KwanDong Univ, Coll Med, Womens Healthcare Ctr, Seoul, South Korea	Catholic Kwandong University	Ryu, HM (corresponding author), Cheil Gen Hosp, Med Res Inst, Med Genet Lab, Seoul, South Korea.	hmryu@yahoo.com	Han, You Jung/W-3659-2019; Lim, Ji Hyae/N-4634-2013	Han, You Jung/0000-0003-4087-9198; Lim, Ji Hyae/0000-0002-1105-7235	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [A111550]	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea	This study was supported by a grant of the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (A111550). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barch MJ, 1997, AGT CYTOGENETICS LAB; Bauer M, 2006, PRENATAL DIAG, V26, P831, DOI 10.1002/pd.1513; Bianchi DW, 1998, AM J HUM GENET, V62, P763, DOI 10.1086/301809; BROMLEY B, 1991, RADIOLOGY, V178, P375, DOI 10.1148/radiology.178.2.1987595; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Caramelli E, 2003, PRENATAL DIAG, V23, P367, DOI 10.1002/pd.596; Chim SSC, 2008, CLIN CHEM, V54, P500, DOI 10.1373/clinchem.2007.098731; Chittacharoen A, 2004, FERTIL STERIL, V82, P227, DOI 10.1016/j.fertnstert.2003.12.026; EVANS EP, 1964, CYTOGENETICS, V3, P289, DOI 10.1159/000129818; Farina A, 2005, AM J OBSTET GYNECOL, V193, P421, DOI 10.1016/j.ajog.2004.12.023; Flori E, 2004, HUM REPROD, V19, P723, DOI 10.1093/humrep/deh117; GAMASOSA MA, 1983, BIOCHIM BIOPHYS ACTA, V740, P212, DOI 10.1016/0167-4781(83)90079-9; Jimbo M, 2003, CLIN CHEM, V49, P1540, DOI 10.1373/49.9.1540; Leung TN, 2001, CLIN CHEM, V47, P137; Lim JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027709; Lim JH, 2012, FASEB J, V26, P250, DOI 10.1096/fj.11-191429; Lo YMD, 1998, AM J HUM GENET, V62, P768, DOI 10.1086/301800; Lui YNYN, 2002, CLIN CHEM, V48, P421; Maccani MA, 2009, AM J REPROD IMMUNOL, V62, P78, DOI 10.1111/j.1600-0897.2009.00716.x; Miura K, 2006, CLIN CHEM, V52, P2121, DOI 10.1373/clinchem.2006.075697; Nagaishi M, 2004, J OBSTET GYNAECOL RE, V30, P237, DOI 10.1111/j.1447-0756.2004.00191.x; Reis FM, 2002, ENDOCR REV, V23, P230, DOI 10.1210/er.23.2.230; Scheffer PG, 2010, OBSTET GYNECOL, V115, P117, DOI 10.1097/AOG.0b013e3181c3c938; Sekizawa A, 2002, CLIN CHEM, V48, P353; Skinner J, 2001, OBSTET GYNECOL, V97, P460, DOI 10.1016/S0029-7844(00)01173-X; TADMOR OP, 1994, J REPROD MED, V39, P459; Urato AC, 2008, PRENATAL DIAG, V28, P186, DOI 10.1002/pd.1950; Vora NL, 2010, PRENATAL DIAG, V30, P325, DOI 10.1002/pd.2456; WARBURTON D, 1964, AM J HUM GENET, V16, P1; WILSON RD, 1984, LANCET, V2, P920; Yin AH, 2007, HUM REPROD, V22, P1736, DOI 10.1093/humrep/dem058; Zhong XY, 2006, PRENATAL DIAG, V26, P1272, DOI 10.1002/pd	32	19	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56787	10.1371/journal.pone.0056787	http://dx.doi.org/10.1371/journal.pone.0056787			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457614	Green Published, Green Submitted, gold			2022-12-25	WOS:000315603700080
J	Canet, E; Zafrani, L; Lambert, J; Thieblemont, C; Galicier, L; Schnell, D; Raffoux, E; Lengline, E; Chevret, S; Darmon, M; Azoulay, E				Canet, Emmanuel; Zafrani, Lara; Lambert, Jerome; Thieblemont, Catherine; Galicier, Lionel; Schnell, David; Raffoux, Emmanuel; Lengline, Etienne; Chevret, Sylvie; Darmon, Michael; Azoulay, Elie			Acute Kidney Injury in Patients with Newly Diagnosed High-Grade Hematological Malignancies: Impact on Remission and Survival	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; ACUTE-RENAL-FAILURE; ACUTE LYMPHOBLASTIC-LEUKEMIA; CRITICALLY-ILL PATIENTS; ACUTE RESPIRATORY-FAILURE; REPLACEMENT THERAPY; CANCER-PATIENTS; HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; CELL TRANSPLANTATION; BURKITTS-LYMPHOMA	Background: Optimal chemotherapy with minimal toxicity is the main determinant of complete remission in patients with newly diagnosed hematological malignancies. Acute organ dysfunctions may impair the patient's ability to receive optimal chemotherapy. Design and Methods: To compare 6-month complete remission rates in patients with and without acute kidney injury (AKI), we collected prospective data on 200 patients with newly diagnosed high-grade malignancies (non-Hodgkin lymphoma, 53.5%; acute myeloid leukemia, 29%; acute lymphoblastic leukemia, 11.5%; and Hodgkin disease, 6%). Results: According to RIFLE criteria, 137 (68.5%) patients had AKI. Five causes of AKI accounted for 91.4% of cases: hypoperfusion, tumor lysis syndrome, tubular necrosis, nephrotoxic agents, and hemophagocytic lymphohistiocytosis. Half of the AKI patients received renal replacement therapy and 14.6% received suboptimal chemotherapy. AKI was associated with a lower 6-month complete remission rate (39.4% vs. 68.3%, P<0.01) and a higher mortality rate (47.4% vs. 30.2%, P<0.01) than patients without AKI. By multivariate analysis, independent determinants of 6-month complete remission were older age, poor performance status, number of organ dysfunctions, and AKI. Conclusion: AKI is common in patients with newly diagnosed high-grade malignancies and is associated with lower complete remission rates and higher mortality.	[Canet, Emmanuel; Zafrani, Lara; Schnell, David; Azoulay, Elie] St Louis Univ Hosp, Med Intens Care Unit, Paris, France; [Lambert, Jerome; Chevret, Sylvie] St Louis Univ Hosp, Dept Biostat, Paris, France; [Thieblemont, Catherine] St Louis Univ Hosp, Dept Hematol & Oncol, Paris, France; [Galicier, Lionel] St Louis Univ Hosp, Dept Clin Immunol, Paris, France; [Raffoux, Emmanuel; Lengline, Etienne] St Louis Univ Hosp, Dept Hematol, Paris, France; [Darmon, Michael] St Etienne Univ Hosp, Med Surg Intens Care Unit, St Etienne, France; [Chevret, Sylvie; Azoulay, Elie] Univ Paris Diderot, Sorbonne Paris Cite, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU de St Etienne; UDICE-French Research Universities; Universite Paris Cite	Canet, E (corresponding author), St Louis Univ Hosp, Med Intens Care Unit, Paris, France.	emmanuel.canet@sls.aphp.fr	schnell, david/AAG-2208-2020; Lambert, Jerome/AAN-3582-2020; Thieblemont, Catherine/AAZ-8423-2020; LENGLINE, Etienne/GZG-5476-2022	Thieblemont, Catherine/0000-0002-9941-2448; chevret, sylvie/0000-0001-6449-4730; Lengline, Etienne/0000-0003-0965-6615; Darmon, Michael/0000-0003-4198-8038	French Ministry of Health, Assistance-Publique Hopitaux de Paris [AOM 09006]	French Ministry of Health, Assistance-Publique Hopitaux de Paris	This work was supported by a grant from the French Ministry of Health, Assistance-Publique Hopitaux de Paris (AOM 09006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azoulay E, 2001, CRIT CARE MED, V29, P2132, DOI 10.1097/00003246-200111000-00014; Azoulay E, 2010, AM J RESP CRIT CARE, V182, P1038, DOI 10.1164/rccm.201001-0018OC; Bagshaw SM, 2008, NEPHROL DIAL TRANSPL, V23, P1203, DOI 10.1093/ndt/gfm744; Bassan R, 2011, J CLIN ONCOL, V29, P532, DOI 10.1200/JCO.2010.30.1382; Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; Bellomo R, 1998, KIDNEY INT, V53, pS106; Benoit DD, 2005, NEPHROL DIAL TRANSPL, V20, P552, DOI 10.1093/ndt/gfh637; Benoit DD, 2003, CRIT CARE MED, V31, P104, DOI 10.1097/00003246-200301000-00017; Benoit DD, 2010, CRIT CARE CLIN, V26, P151, DOI 10.1016/j.ccc.2009.09.002; Blum KA, 2004, BLOOD, V104, P3009, DOI 10.1182/blood-2004-02-0405; Buemi M, 2009, J INVEST MED, V57, P892, DOI 10.2310/JIM.0b013e3181c5e762; Buyse S, 2010, INTENS CARE MED, V36, P1695, DOI 10.1007/s00134-010-1936-z; Chertow GM, 2005, J AM SOC NEPHROL, V16, P3365, DOI 10.1681/ASN.2004090740; Cheson BD, 2003, J CLIN ONCOL, V21, P4642, DOI 10.1200/JCO.2003.04.036; Cheson BD, 2008, NEW ENGL J MED, V359, P613, DOI 10.1056/NEJMra0708875; Cheson BD, 2007, J CLIN ONCOL, V25, P579, DOI 10.1200/JCO.2006.09.2403; Darmon M, 2007, INTENS CARE MED, V33, P765, DOI 10.1007/s00134-007-0579-1; Galicier L, 2007, BLOOD, V110, P2846, DOI 10.1182/blood-2006-10-051771; Howard SC, 2011, NEW ENGL J MED, V364, P1844, DOI 10.1056/NEJMra0904569; Janka GE, 2005, HEMATOLOGY, V10, P104, DOI 10.1080/10245330512331390087; Karras A, 2009, NAT REV NEPHROL, V5, P329, DOI 10.1038/nrneph.2009.73; Khassawneh BY, 2002, CHEST, V121, P185, DOI 10.1378/chest.121.1.185; Lameire NH, 2005, ANN MED, V37, P13, DOI 10.1080/07853890510007205; Lecuyer L, 2008, EUR RESPIR J, V32, P748, DOI 10.1183/09031936.00142907; Legrand M, 2012, CRIT CARE MED, V40, P43, DOI 10.1097/CCM.0b013e31822b50c2; Lengline E, 2012, LEUK LYMPHOMA; Lim ST, 2005, J CLIN ONCOL, V23, P4430, DOI 10.1200/JCO.2005.11.973; McGregor S, 2012, SEMIN DIAGN PATHOL, V29, P2, DOI 10.1053/j.semdp.2011.07.004; Mead GM, 2002, ANN ONCOL, V13, P1264, DOI 10.1093/annonc/mdf253; Mead GM, 2008, BLOOD, V112, P2248, DOI 10.1182/blood-2008-03-145128; Ostermann M, 2007, CRIT CARE MED, V35, P1837, DOI 10.1097/01.CCM.0000277041.13090.0A; Parikh CR, 2006, KIDNEY INT, V69, P430, DOI 10.1038/sj.ki.5000055; Pulte D, 2009, BLOOD, V113, P1408, DOI 10.1182/blood-2008-06-164863; Sanz MA, 2011, J CLIN ONCOL, V29, P495, DOI 10.1200/JCO.2010.32.1067; Schafer ES, 2011, NAT REV CLIN ONCOL, V8, P417, DOI 10.1038/nrclinonc.2011.77; Smeland S, 2004, ANN ONCOL, V15, P1072, DOI 10.1093/annonc/mdh262; Soares M, 2006, J CLIN ONCOL, V24, P4003, DOI 10.1200/JCO.2006.05.7869; Thaunat O, 2006, KIDNEY INT, V69, P1892, DOI 10.1038/sj.ki.5000352; Thiery G, 2005, J CLIN ONCOL, V23, P4406, DOI 10.1200/JCO.2005.01.487; Uchino S, 2007, INTENS CARE MED, V33, P1563, DOI 10.1007/s00134-007-0754-4; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751	41	84	87	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e55870	10.1371/journal.pone.0055870	http://dx.doi.org/10.1371/journal.pone.0055870			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457485	Green Published, Green Submitted, gold			2022-12-25	WOS:000315602700026
J	Chibebe, J; Fuchs, BB; Sabino, CP; Junqueira, JC; Jorge, AC; Ribeiro, MS; Gilmore, MS; Rice, LB; Tegos, GP; Hamblin, MR; Mylonakis, E				Chibebe Junior, Jose; Fuchs, Beth B.; Sabino, Caetano P.; Junqueira, Juliana C.; Jorge, AntonioO. C.; Ribeiro, Martha S.; Gilmore, Michael S.; Rice, Louis B.; Tegos, George P.; Hamblin, Michael R.; Mylonakis, Eleftherios			Photodynamic and Antibiotic Therapy Impair the Pathogenesis of Enterococcus faecium in a Whole Animal Insect Model	PLOS ONE			English	Article							LOW-POWER LASER; GALLERIA-MELLONELLA; CRYPTOCOCCUS-NEOFORMANS; CAENORHABDITIS-ELEGANS; VIRULENCE; FAECALIS; CANDIDA; SUSCEPTIBILITY; HOST; PATHOGENICITY	Enterococcus faecium has emerged as one of the most important pathogens in healthcare-associated infections worldwide due to its intrinsic and acquired resistance to many antibiotics, including vancomycin. Antimicrobial photodynamic therapy (aPDT) is an alternative therapeutic platform that is currently under investigation for the control and treatment of infections. PDT is based on the use of photoactive dye molecules, widely known as photosensitizer (PS). PS, upon irradiation with visible light, produces reactive oxygen species that can destroy lipids and proteins causing cell death. We employed Galleria mellonella (the greater wax moth) caterpillar fatally infected with E. faecium to develop an invertebrate host model system that can be used to study the antimicrobial PDT (alone or combined with antibiotics). In the establishment of infection by E. faecium in G. mellonella, we found that the G. mellonella death rate was dependent on the number of bacterial cells injected into the insect hemocoel and all E. faecium strains tested were capable of infecting and killing G. mellonella. Antibiotic treatment with ampicillin, gentamicin or the combination of ampicillin and gentamicin prolonged caterpillar survival infected by E. faecium (P = 0.0003, P = 0.0001 and P = 0.0001, respectively). In the study of antimicrobial PDT, we verified that methylene blue (MB) injected into the insect followed by whole body illumination prolonged the caterpillar survival (P = 0.0192). Interestingly, combination therapy of larvae infected with vancomycin-resistant E. faecium, with antimicrobial PDT followed by vancomycin, significantly prolonged the survival of the caterpillars when compared to either antimicrobial PDT (P = 0.0095) or vancomycin treatment alone (P = 0.0025), suggesting that the aPDT made the vancomycin resistant E. faecium strain more susceptible to vancomycin action. In summary, G. mellonella provides an invertebrate model host to study the antimicrobial PDT and to explore combinatorial aPDT-based treatments.	[Chibebe Junior, Jose; Junqueira, Juliana C.; Jorge, AntonioO. C.] Univ Estadual Paulista UNESP, Dept Biosci & Oral Diag, Sao Paulo, Brazil; [Chibebe Junior, Jose; Fuchs, Beth B.] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA; [Chibebe Junior, Jose] Fac Pindamonhangaba, Dept Restorat Dent, Sao Paulo, Brazil; [Sabino, Caetano P.; Tegos, George P.; Hamblin, Michael R.] Massachusetts Gen Hosp, Wellman Ctr Photomed, Boston, MA 02114 USA; [Sabino, Caetano P.; Ribeiro, Martha S.] Ctr Lasers & Applicat, Nucl & Energy Res Inst, Sao Paulo, Brazil; [Gilmore, Michael S.] Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Boston, MA USA; [Rice, Louis B.; Mylonakis, Eleftherios] Brown Univ, Rhode Isl Hosp, Warren Alpert Med Sch, Providence, RI 02903 USA; [Rice, Louis B.; Mylonakis, Eleftherios] Brown Univ, Miriam Hosp, Warren Alpert Med Sch, Providence, RI USA; [Tegos, George P.; Hamblin, Michael R.] Harvard Univ, Sch Med, Dept Dermatol, Boston, MA 02115 USA; [Tegos, George P.] Univ New Mexico, Dept Pathol, Albuquerque, NM 87131 USA; [Tegos, George P.] Univ New Mexico, Ctr Mol Discovery, Albuquerque, NM 87131 USA; [Hamblin, Michael R.] Harvard Massachusetts Inst Technol, Div Hlth Sci & Technol, Cambridge, MA USA	Universidade Estadual Paulista; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Comissao Nacional de Energia Nuclear (CNEN); Instituto de Pesquisas Energeticas e Nucleares (IPEN); Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Brown University; Lifespan Health Rhode Island; Miriam Hospital; Harvard University; Harvard Medical School; University of New Mexico; University of New Mexico; Harvard University	Chibebe, J (corresponding author), Univ Estadual Paulista UNESP, Dept Biosci & Oral Diag, Sao Paulo, Brazil.	juliana@fosjc.unesp.br; emylonakis@lifespan.org	Sabino, Caetano P/K-8356-2013; Junqueira, Juliana JC/F-7785-2012; Junqueira, Juliana/GQZ-4509-2022; Junqueira, Juliana Campos/Q-3108-2019; Ribeiro, Martha Simões/G-3517-2012; Hamblin, Michael R/H-2758-2019; Hamblin, Mike/AAB-2511-2022; Sabino, Caetano/D-4196-2016	Junqueira, Juliana JC/0000-0001-6646-6856; Junqueira, Juliana Campos/0000-0001-6646-6856; Ribeiro, Martha Simões/0000-0002-4203-1134; Hamblin, Michael R/0000-0001-6431-4605; Sabino, Caetano/0000-0002-2048-2823	CAPES [PDEE 2507-11-0]; NIH [RO1 AI050875, 5U54MH084690-02]; Harvard-wide Program on Antibiotic Resistance [P01 AI083214]; US Air Force MFEL Program [FA9550-04-1-0079]; DTRA [HDTRA1-13-C-0005]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI083214, R01AI050875] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH084690] Funding Source: NIH RePORTER	CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard-wide Program on Antibiotic Resistance; US Air Force MFEL Program; DTRA(United States Department of DefenseDefense Threat Reduction Agency); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The first author thanks CAPES (PDEE 2507-11-0) for the scholarship during the "Sandwich'' PhD Program at Harvard Medical School. Research conducted in the Mylonakis Laboratory was supported by NIH (RO1 AI050875 to EM, and the Harvard-wide Program on Antibiotic Resistance [P01 AI083214] to EM and MSG). Research conducted in the Hamblin Laboratory was supported by NIH (RO1 AI050875 to MRH) and US Air Force MFEL Program (FA9550-04-1-0079). George P. Tegos is supported by the NIH (grant 5U54MH084690-02) and DTRA (contract HDTRA1-13-C-0005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abranches J, 2011, INFECT IMMUN, V79, P2277, DOI 10.1128/IAI.00767-10; Vera DMA, 2012, PHOTOCHEM PHOTOBIOL, V88, P499, DOI 10.1111/j.1751-1097.2012.01087.x; Lins RDAU, 2010, AN BRAS DERMATOL, V85, P849, DOI 10.1590/S0365-05962010000600011; Aperis G, 2007, MICROBES INFECT, V9, P729, DOI 10.1016/j.micinf.2007.02.016; Banville N, 2012, VIRULENCE, V3, P497, DOI 10.4161/viru.21972; Bhardwaj A, 2009, INT J FOOD MICROBIOL, V128, P513, DOI 10.1016/j.ijfoodmicro.2008.10.010; Costa ACBP, 2012, OR SURG OR MED OR PA, V114, P67, DOI 10.1016/j.oooo.2012.02.002; Castano AP, 2004, PHOTODIAGN PHOTODYN, V1, P279, DOI 10.1016/S1572-1000(05)00007-4; Chabrier-Rosello Y, 2008, PHOTOCHEM PHOTOBIOL, V84, P1141, DOI 10.1111/j.1751-1097.2007.00280.x; Champion OL, 2009, MICROBIOL-SGM, V155, P1516, DOI 10.1099/mic.0.026823-0; Coleman JJ, 2011, FUNGAL BIOL-UK, V115, P1279, DOI 10.1016/j.funbio.2011.09.005; Dahlen Gunnar, 2012, J Oral Microbiol, V4, DOI 10.3402/jom.v4i0.10855; de Regt MJA, 2010, ANTIMICROB AGENTS CH, V54, P2801, DOI 10.1128/AAC.01765-09; Denis TGS, 2011, VIRULENCE, V2, P509, DOI 10.4161/viru.2.6.17889; Desalermos A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002451; Desbois AP, 2011, J ANTIMICROB CHEMOTH, V66, P1785, DOI 10.1093/jac/dkr198; Di Poto A, 2009, BIOMATERIALS, V30, P3158, DOI 10.1016/j.biomaterials.2009.02.038; Dougherty TJ, 1998, JNCI-J NATL CANCER I, V90, P889, DOI 10.1093/jnci/90.12.889; DUNNY GM, 1978, P NATL ACAD SCI USA, V75, P3479, DOI 10.1073/pnas.75.7.3479; Fuchs BB, 2007, ANTIMICROB AGENTS CH, V51, P2929, DOI 10.1128/AAC.00121-07; Fuchs BB, 2006, CURR OPIN MICROBIOL, V9, P346, DOI 10.1016/j.mib.2006.06.004; Fuchs BB, 2010, MICROBES INFECT, V12, P488, DOI 10.1016/j.micinf.2010.03.001; Gaddy JA, 2012, INFECT IMMUN, V80, P1015, DOI 10.1128/IAI.06279-11; Gao XJ, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-4; Garsin DA, 2001, P NATL ACAD SCI USA, V98, P10892, DOI 10.1073/pnas.191378698; Gaspar F, 2009, MICROBIOL-SGM, V155, P3564, DOI 10.1099/mic.0.030775-0; Hamblin MR, 2004, PHOTOCH PHOTOBIO SCI, V3, P436, DOI 10.1039/b311900a; Hamblin MR, 2002, J ANTIMICROB CHEMOTH, V49, P941, DOI 10.1093/jac/dkf053; Huang L, 2010, ANTIMICROB AGENTS CH, V54, P3834, DOI 10.1128/AAC.00125-10; Jander G, 2000, J BACTERIOL, V182, P3843, DOI 10.1128/JB.182.13.3843-3845.2000; Junqueira JC, 2012, LASERS MED SCI; Junqueira JC, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-247; Junqueira JC, 2009, LASER MED SCI, V24, P877, DOI 10.1007/s10103-009-0673-4; Kavanagh K, 2004, FEMS MICROBIOL REV, V28, P101, DOI 10.1016/j.femsre.2003.09.002; Kharkwal GB, 2011, LASER SURG MED, V43, P755, DOI 10.1002/lsm.21080; Kristich CJ, 2011, MBIO, V2, DOI 10.1128/mBio.00199-11; Lebreton F, 2011, J MOL MICROB BIOTECH, V21, P191, DOI 10.1159/000332737; Lindenstrauss AG, 2011, SYST APPL MICROBIOL, V34, P553, DOI 10.1016/j.syapm.2011.05.002; Maadani A, 2007, INFECT IMMUN, V75, P2634, DOI 10.1128/IAI.01372-06; Maisch T, 2011, J DTSCH DERMATOL GES, V9, P360, DOI 10.1111/j.1610-0387.2010.07577.x; Martins JD, 2011, ORAL SURG ORAL MED O, V111, P71, DOI 10.1016/j.tripleo.2010.08.012; Michaux C, 2011, INFECT IMMUN, V79, P2638, DOI 10.1128/IAI.01132-10; Mitton D, 2008, PHOTODIAGN PHOTODYN, V5, P103, DOI 10.1016/j.pdpdt.2008.04.004; Miyata S, 2003, INFECT IMMUN, V71, P2404, DOI 10.1128/IAI.71.5.2404-2413.2003; Moy TI, 2004, INFECT IMMUN, V72, P4512, DOI 10.1128/IAI.72.8.4512-4520.2004; Murray PR, 2009, MED MICROBIOLOGY, Vx; Mylonakis E, 2005, INFECT IMMUN, V73, P3842, DOI 10.1128/IAI.73.7.3842-3850.2005; Nandakumar R, 2009, ORAL MICROBIOL IMMUN, V24, P347, DOI 10.1111/j.1399-302X.2009.00520.x; Olsen RJ, 2011, VIRULENCE, V2, P111, DOI 10.4161/viru.2.2.14338; Paganelli FL, 2012, TRENDS MICROBIOL, V20, P40, DOI 10.1016/j.tim.2011.11.001; Panesso D, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-20; Peleg AY, 2009, ANTIMICROB AGENTS CH, V53, P2605, DOI 10.1128/AAC.01533-08; Peleg AY, 2009, J INFECT DIS, V199, P532, DOI 10.1086/596511; Pereira CA, 2011, LASER MED SCI, V26, P341, DOI 10.1007/s10103-010-0852-3; Rice LB, 2008, J INFECT DIS, V197, P1079, DOI 10.1086/533452; Rice LB, 2009, J BACTERIOL, V191, P3649, DOI 10.1128/JB.01834-08; SAHM DF, 1989, ANTIMICROB AGENTS CH, V33, P1588, DOI 10.1128/AAC.33.9.1588; Sifri CD, 2002, INFECT IMMUN, V70, P5647, DOI 10.1128/IAI.70.10.5647-5650.2002; Snell SB, 2012, PHOTOCHEM PHOTOBIOL, V88, P596, DOI 10.1111/j.1751-1097.2011.01039.x; St Denis TG, 2011, PHOTOCHEM PHOTOBIOL, V87, P707, DOI 10.1111/j.1751-1097.2011.00902.x; Wainwright M, 1997, J PHOTOCH PHOTOBIO B, V40, P233, DOI 10.1016/S1011-1344(97)00061-4; Wainwright M, 2006, J PHOTOCH PHOTOBIO B, V84, P227, DOI 10.1016/j.jphotobiol.2006.03.002; Willems RJL, 2011, FEMS MICROBIOL REV, V35, P872, DOI 10.1111/j.1574-6976.2011.00284.x; Yasmin A, 2010, J BACTERIOL, V192, P1122, DOI 10.1128/JB.01293-09; Zhu XF, 2010, J ENDODONT, V36, P1950, DOI 10.1016/j.joen.2010.08.053	65	39	40	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e55926	10.1371/journal.pone.0055926	http://dx.doi.org/10.1371/journal.pone.0055926			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457486	Green Published, Green Submitted, gold			2022-12-25	WOS:000315602700027
J	Frisch, S; Dukart, J; Vogt, B; Horstmann, A; Becker, G; Villringer, A; Barthel, H; Sabri, O; Muller, K; Schroeter, ML				Frisch, Stefan; Dukart, Juergen; Vogt, Barbara; Horstmann, Annette; Becker, Georg; Villringer, Arno; Barthel, Henryk; Sabri, Osama; Mueller, Karsten; Schroeter, Matthias L.			Dissociating Memory Networks in Early Alzheimer's Disease and Frontotemporal Lobar Degeneration - A Combined Study of Hypometabolism and Atrophy	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; EPISODIC MEMORY; SEMANTIC DEMENTIA; FRONTAL VARIANT; HIPPOCAMPAL ATROPHY; NEUROPSYCHOLOGICAL PERFORMANCE; AUTOBIOGRAPHICAL MEMORIES; ENTORHINAL CORTEX; BRIEF BATTERY; FDG-PET	Introduction: We aimed at dissociating the neural correlates of memory disorders in Alzheimer's disease (AD) and frontotemporal lobar degeneration (FTLD). Methods: We included patients with AD (n = 19, 11 female, mean age 61 years) and FTLD (n = 11, 5 female, mean age 61 years) in early stages of their diseases. Memory performance was assessed by means of verbal and visual memory subtests from the Wechsler Memory Scale (WMS-R), including forgetting rates. Brain glucose utilization was measured by [18F] fluorodeoxyglucose positron emission tomography (FDG-PET) and brain atrophy by voxel-based morphometry (VBM) of T1-weighted magnetic resonance imaging (MRI) scans. Using a whole brain approach, correlations between test performance and imaging data were computed separately in each dementia group, including a group of control subjects (n = 13, 6 female, mean age 54 years) in both analyses. The three groups did not differ with respect to education and gender. Results: Patients in both dementia groups generally performed worse than controls, but AD and FTLD patients did not differ from each other in any of the test parameters. However, memory performance was associated with different brain regions in the patient groups, with respect to both hypometabolism and atrophy: Whereas in AD patients test performance was mainly correlated with changes in the parieto-mesial cortex, performance in FTLD patients was correlated with changes in frontal cortical as well as subcortical regions. There were practically no overlapping regions associated with memory disorders in AD and FTLD as revealed by a conjunction analysis. Conclusion: Memory test performance may not distinguish between both dementia syndromes. In clinical practice, this may lead to misdiagnosis of FTLD patients with poor memory performance. Nevertheless, memory problems are associated with almost completely different neural correlates in both dementia syndromes. Obviously, memory functions are carried out by distributed networks which break down in brain degeneration.	[Frisch, Stefan] Goethe Univ Frankfurt, Dept Neurol, D-60054 Frankfurt, Germany; [Frisch, Stefan; Dukart, Juergen; Vogt, Barbara; Horstmann, Annette; Villringer, Arno; Mueller, Karsten; Schroeter, Matthias L.] Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany; [Dukart, Juergen] CHU Vaudois, LREN, Dept Neurosci, Lausanne, Switzerland; [Becker, Georg; Barthel, Henryk; Sabri, Osama] Univ Leipzig, Dept Nucl Med, D-04109 Leipzig, Germany; [Villringer, Arno; Schroeter, Matthias L.] Univ Leipzig, Day Clin Cognit Neurol, D-04109 Leipzig, Germany; [Dukart, Juergen; Villringer, Arno; Sabri, Osama; Schroeter, Matthias L.] Univ Leipzig, LIFE Leipzig Res Ctr Civilizat Dis, D-04109 Leipzig, Germany	Goethe University Frankfurt; Max Planck Society; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Leipzig University; Leipzig University; Leipzig University	Frisch, S (corresponding author), Goethe Univ Frankfurt, Dept Neurol, D-60054 Frankfurt, Germany.	stefan.frisch@kgu.de	Horstmann, Annette/C-9083-2011	Horstmann, Annette/0000-0001-6184-8484; Villringer, Arno/0000-0003-2604-2404; Sabri, Osama/0000-0002-6425-3504; Kruse, Barbara/0000-0002-6050-314X; Frisch, Stefan/0000-0002-7294-4786; Dukart, Juergen/0000-0003-0492-5644	LIFE - Leipzig Research Center for Civilization Diseases at the University of Leipzig; European Union, European Regional Development Fund; Free State of Saxony; German Consortium for Frontotemporal Lobar Degeneration; German Federal Ministry of Education and Research	LIFE - Leipzig Research Center for Civilization Diseases at the University of Leipzig; European Union, European Regional Development Fund; Free State of Saxony; German Consortium for Frontotemporal Lobar Degeneration; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This study has been supported by LIFE - Leipzig Research Center for Civilization Diseases at the University of Leipzig - funded by the European Union, European Regional Development Fund and by the Free State of Saxony within the framework of the excellence initiative (AV, OS and MLS) and by the German Consortium for Frontotemporal Lobar Degeneration, funded by the German Federal Ministry of Education and Research (MLS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 1998, J NEUROL NEUROSUR PS, V65, P126, DOI 10.1136/jnnp.65.1.126; Alstott J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000408; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Barnes J, 2006, ARCH NEUROL-CHICAGO, V63, P1434, DOI 10.1001/archneur.63.10.1434; Boxer AL, 2003, ARCH NEUROL-CHICAGO, V60, P949, DOI 10.1001/archneur.60.7.949; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P1, DOI 10.1162/08989290051137585; Caroli A, 2007, J NEUROL, V254, P1698, DOI 10.1007/s00415-007-0631-7; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Chetelat G, 2008, BRAIN, V131, P60, DOI 10.1093/brain/awm288; Chetelat G, 2003, BRAIN, V126, P1955, DOI 10.1093/brain/awg196; Desgranges B, 2002, BRAIN, V125, P1116, DOI 10.1093/brain/awf097; Desgranges B, 1998, BRAIN, V121, P611, DOI 10.1093/brain/121.4.611; Desgranges B, 2007, NEUROBIOL AGING, V28, P1904, DOI 10.1016/j.neurobiolaging.2006.08.006; DEWEER B, 1995, J NEUROL NEUROSUR PS, V58, P590, DOI 10.1136/jnnp.58.5.590; Di Paola M, 2008, HIPPOCAMPUS, V18, P719, DOI 10.1002/hipo.20432; Diehl J, 2004, NEUROBIOL AGING, V25, P1051, DOI 10.1016/j.neurobiolaging.2003.10.007; Diehl J, 2005, J GERIATR PSYCH NEUR, V18, P39, DOI 10.1177/0891988704272309; Dubois B, 2007, LANCET NEUROL, V6, P734, DOI 10.1016/S1474-4422(07)70178-3; Dukart J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018111; Dukart J, 2010, NEUROIMAGE, V49, P1490, DOI 10.1016/j.neuroimage.2009.09.017; Eustache F, 2004, BRAIN, V127, P1549, DOI 10.1093/brain/awh166; Fletcher PC, 2001, BRAIN, V124, P849, DOI 10.1093/brain/124.5.849; Fox NC, 1996, BRAIN, V119, P2001, DOI 10.1093/brain/119.6.2001; Galton CJ, 2001, NEUROLOGY, V57, P216, DOI 10.1212/WNL.57.2.216; Giovagnoli AR, 2008, NEUROPSYCHOLOGIA, V46, P1495, DOI 10.1016/j.neuropsychologia.2007.12.023; Glosser G, 2002, NEUROPSYCHOLOGY, V16, P190, DOI 10.1037//0894-4105.16.2.190; Goldenberg G, 1999, J NEUROL NEUROSUR PS, V67, P163, DOI 10.1136/jnnp.67.2.163; Good CD, 2002, NEUROIMAGE, V17, P29, DOI 10.1006/nimg.2002.1202; Graham A, 2005, BRAIN, V128, P597, DOI 10.1093/brain/awh348; Gregory CA, 1997, INT J GERIATR PSYCH, V12, P375, DOI 10.1002/(SICI)1099-1166(199703)12:3<375::AID-GPS518>3.0.CO;2-#; H?rting, 2000, WECHSLER GEDACHTNIST; Hodges JR, 2004, ANN NEUROL, V56, P399, DOI 10.1002/ana.20203; Hodges JR, 1999, NEUROPSYCHOLOGY, V13, P31, DOI 10.1037/0894-4105.13.1.31; Hornberger M, 2010, NEUROLOGY, V74, P472, DOI 10.1212/WNL.0b013e3181cef85d; Hornberger M, 2012, BRAIN, V135, P3015, DOI 10.1093/brain/aws239; Hornberger M, 2012, BRAIN, V135, P678, DOI 10.1093/brain/aws011; Horstmann A, 2010, NEUROLOGY, V74, P306, DOI 10.1212/WNL.0b013e3181cbcd6f; Hutchinson AD, 2007, J NEUROL NEUROSUR PS, V78, P917, DOI 10.1136/jnnp.2006.100669; Ibanez V, 1998, NEUROLOGY, V50, P1585, DOI 10.1212/WNL.50.6.1585; Juva K, 1995, Int Psychogeriatr, V7, P17, DOI 10.1017/S1041610295001815; Karas G, 2007, NEURORADIOLOGY, V49, P967, DOI 10.1007/s00234-007-0269-2; Kertesz A, 2003, ALZ DIS ASSOC DIS, V17, P223, DOI 10.1097/00002093-200310000-00005; Kim H, 2011, NEUROIMAGE, V54, P2446, DOI 10.1016/j.neuroimage.2010.09.045; Kramer Joel H, 2003, Cogn Behav Neurol, V16, P211, DOI 10.1097/00146965-200312000-00002; Leube DT, 2008, INT J GERIATR PSYCH, V23, P1114, DOI 10.1002/gps.2036; Levy JA, 2007, J GERIATR PSYCH NEUR, V20, P227, DOI 10.1177/0891988707308806; Lezak M.D., 1995, NEUROPSYCHOLOGICAL A; Libon DJ, 2007, NEUROLOGY, V68, P369, DOI 10.1212/01.wnl.0000252820.81313.9b; Mathuranath PS, 2000, NEUROLOGY, V55, P1613, DOI 10.1212/01.wnl.0000434309.85312.19; Matuszewski V, 2006, NEUROPSYCHOLOGIA, V44, P2386, DOI 10.1016/j.neuropsychologia.2006.04.031; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Mendez MF, 2007, ARCH NEUROL-CHICAGO, V64, P830, DOI 10.1001/archneur.64.6.830; Morris JC, 1997, ALZ DIS ASSOC DIS, V11, P1, DOI 10.1097/00002093-199706001-00001; Neary D, 1998, NEUROLOGY, V51, P1546, DOI 10.1212/WNL.51.6.1546; Neary D, 2005, LANCET NEUROL, V4, P771, DOI 10.1016/S1474-4422(05)70223-4; Pennanen C, 2004, NEUROBIOL AGING, V25, P303, DOI 10.1016/S0197-4580(03)00084-8; Pennington C, 2011, J ALZHEIMERS DIS, V24, P261, DOI 10.3233/JAD-2011-101668; Pereira JMS, 2009, NEUROLOGY, V72, P1653, DOI 10.1212/WNL.0b013e3181a55fa2; Perri R, 2005, J NEUROL, V252, P1238, DOI 10.1007/s00415-005-0849-1; Piolino P, 2007, NEUROPSYCHOLOGIA, V45, P2730, DOI 10.1016/j.neuropsychologia.2007.04.013; Raczka KA, 2010, PSYCHIAT RES-NEUROIM, V182, P274, DOI 10.1016/j.pscychresns.2010.02.009; Razani J, 2001, J INT NEUROPSYCH SOC, V7, P468, DOI 10.1017/S1355617701744037; Rousset OG, 1998, J NUCL MED, V39, P904; Salmon E, 2008, NEUROPSYCHOLOGIA, V46, P1613, DOI 10.1016/j.neuropsychologia.2007.11.022; Schroeter ML, 2008, NEUROBIOL AGING, V29, P418, DOI 10.1016/j.neurobiolaging.2006.10.023; Schroeter ML, 2007, NEUROIMAGE, V36, P497, DOI 10.1016/j.neuroimage.2007.03.024; Schroeter ML, 2012, BRAIN, V135, DOI 10.1093/brain/aws030; Schroeter ML, 2012, BRAIN, V135, P201, DOI 10.1093/brain/awr311; Schroeter ML, 2011, FRONT AGING NEUROSCI, V3, DOI 10.3389/fnagi.2011.00010; Schroeter ML, 2009, NEUROIMAGE, V47, P1196, DOI 10.1016/j.neuroimage.2009.05.037; Sporns O., 2009, NETWORKS BRAIN; Tekin S, 2002, J PSYCHOSOM RES, V53, P647, DOI 10.1016/S0022-3999(02)00428-2; Thompson JC, 2005, J NEUROL NEUROSUR PS, V76, P920, DOI 10.1136/jnnp.2003.033779; Vann SD, 2009, NAT REV NEUROSCI, V10, P792, DOI 10.1038/nrn2733; Wagner AD, 2005, TRENDS COGN SCI, V9, P445, DOI 10.1016/j.tics.2005.07.001; Whitwell JL, 2007, BRAIN, V130, P1777, DOI 10.1093/brain/awm112; Wicklund AH, 2006, ALZ DIS ASSOC DIS, V20, P86, DOI 10.1097/01.wad.0000213811.97305.49; Xu Y, 2000, NEUROLOGY, V54, P1760, DOI 10.1212/WNL.54.9.1760; Zakzanis KK, 1998, J CLIN EXP NEUROPSYC, V20, P259, DOI 10.1076/jcen.20.2.259.1174	80	47	48	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e55251	10.1371/journal.pone.0055251	http://dx.doi.org/10.1371/journal.pone.0055251			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	099EJ	23457466	Green Published, Green Submitted, gold			2022-12-25	WOS:000315602700015
J	Kim, DH; Cotton, SL; Manna, D; Welte, M				Kim, Dae-Hwan; Cotton, Sean L.; Manna, Dipak; Welte, Michael			Novel Isoforms of the Transport Regulator Klar	PLOS ONE			English	Article							DOMAIN PROTEINS MSP-300; NUCLEAR MIGRATION; INTRACELLULAR-TRANSPORT; DROSOPHILA; KLARSICHT; ENVELOPE; CONSEQUENCES; LOCALIZATION; MEMBRANE; ADAPTER	Klar is a regulator of microtubule-motor dependent transport processes in Drosophila, including nuclear migration, vesicle motility, and lipid-droplet transport. The single klar locus gives rise to multiple isoforms that presumably have unique functions. Up to now, three Klar isoforms (alpha, beta, gamma) were known. Here we describe two novel isoforms, delta and epsilon, whose expression depends on a previously uncharacterized promoter. Klar delta and/or epsilon are widely expressed during development, including in the embryonic and larval nervous system as well as in ovaries. When we specifically ablate Klar delta and epsilon expression genetically, no gross organismal phenotypes are apparent. However, ectopic expression of these isoforms causes nuclear mispositioning in developing photoreceptors and in oocytes, demonstrating their biological activity. Our analysis identifies novel forms of the Klar protein and provides new tools for functionally dissecting the complex klar locus.	[Kim, Dae-Hwan; Cotton, Sean L.; Welte, Michael] Brandeis Univ, Dept Biol, Waltham, MA 02254 USA; [Manna, Dipak; Welte, Michael] Univ Rochester, Dept Biol, Rochester, NY 14627 USA	Brandeis University; University of Rochester	Welte, M (corresponding author), Brandeis Univ, Dept Biol, Waltham, MA 02254 USA.	michael.welte@rochester.edu	Manna, Dipak/AAH-7306-2019; Welte, Michael/AAH-5589-2019	Welte, Michael/0000-0001-5741-4720	National Institutes of Health through NIGMS grant [GM64687]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024577] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064687] Funding Source: NIH RePORTER	National Institutes of Health through NIGMS grant; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health (http://www.nih.gov/) through NIGMS grant GM64687 to MAW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbeitman MN, 2002, SCIENCE, V297, P2270, DOI 10.1126/science.1072152; Duncan JE, 2002, CURR BIOL, V12, P1982, DOI 10.1016/S0960-9822(02)01303-9; Dworkin I, 2009, GENETICS, V181, P1065, DOI 10.1534/genetics.108.096453; Elhanany-Tamir H, 2012, J CELL BIOL, V198, P833, DOI 10.1083/jcb.201204102; Fischer JA, 2004, GENETICS, V168, P1385, DOI 10.1534/genetics.104.028662; FISCHERVIZE JA, 1994, DEVELOPMENT, V120, P2609; Fridolfsson HN, 2010, DEV BIOL, V338, P237, DOI 10.1016/j.ydbio.2009.12.004; Guo Y, 2005, MOL BIOL CELL, V16, P1406, DOI 10.1091/mbc.E04-10-0920; Harbison ST, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-4-r36; Kracklauer MP, 2007, FLY, V1, P75, DOI 10.4161/fly.4254; McQuilton P, 2012, NUCLEIC ACIDS RES, V40, pD706, DOI 10.1093/nar/gkr1030; Meyerzon M, 2009, DEVELOPMENT, V136, P2725, DOI 10.1242/dev.038596; Mosley-Bishop KL, 1999, CURR BIOL, V9, P1211, DOI 10.1016/S0960-9822(99)80501-6; Myat MM, 2005, DEV BIOL, V281, P38, DOI 10.1016/j.ydbio.2005.02.005; Myat MM, 2002, CELL, V111, P879, DOI 10.1016/S0092-8674(02)01140-6; Ohler U, 2002, GENOME BIOL, V3, DOI [10.1186/gb-2002-3-12-research0087, DOI 10.1186/GB-2002-3-12-RESEARCH0087]; Ohler U, 2006, NUCLEIC ACIDS RES, V34, P5943, DOI 10.1093/nar/gkl608; Patterson K, 2004, MOL BIOL CELL, V15, P600, DOI 10.1091/mbc.E03-06-0374; ROIHA H, 1988, GENETICS, V119, P75; Roux KJ, 2009, P NATL ACAD SCI USA, V106, P2194, DOI 10.1073/pnas.0808602106; Shubeita GT, 2008, CELL, V135, P1098, DOI 10.1016/j.cell.2008.10.021; Starr DA, 2005, BIOESSAYS, V27, P1136, DOI 10.1002/bies.20312; Starr DA, 2010, ANNU REV CELL DEV BI, V26, P421, DOI 10.1146/annurev-cellbio-100109-104037; Technau M, 2008, FLY, V2, P82, DOI 10.4161/fly.6288; van Eeden F, 1999, CURR OPIN GENET DEV, V9, P396, DOI 10.1016/S0959-437X(99)80060-4; Welte MA, 1998, CELL, V92, P547, DOI 10.1016/S0092-8674(00)80947-2; Wolff Tanya, 1993, P1277; Xie XH, 2008, FLY, V2, P74, DOI 10.4161/fly.6108; Yu YXV, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-9; Zhang QP, 2001, J CELL SCI, V114, P4485; Zhao T, 2008, GENETICS, V178, P883, DOI 10.1534/genetics.107.082487	31	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e55070	10.1371/journal.pone.0055070	http://dx.doi.org/10.1371/journal.pone.0055070			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457459	gold, Green Published, Green Submitted			2022-12-25	WOS:000315602700013
J	Jaeggi, T; Moretti, D; Kvalsvig, J; Holding, PA; Tjalsma, H; Kortman, GAM; Joosten, I; Mwangi, A; Zimmermann, MB				Jaeggi, Tanja; Moretti, Diego; Kvalsvig, Jane; Holding, Penny A.; Tjalsma, Harold; Kortman, Guus A. M.; Joosten, Irma; Mwangi, Alice; Zimmermann, Michael B.			Iron Status and Systemic Inflammation, but Not Gut Inflammation, Strongly Predict Gender-Specific Concentrations of Serum Hepcidin in Infants in Rural Kenya	PLOS ONE			English	Article							SEX-DIFFERENCES; RISK-FACTORS; DEFICIENCY; HOMEOSTASIS; CHILDREN; HEALTHY; ANEMIA; ERYTHROPOIETIN; EXPRESSION; INDICATORS	Hepcidin regulation by competing stimuli such as infection and iron deficiency has not been studied in infants and it's yet unknown whether hepcidin regulatory pathways are fully functional in infants. In this cross-sectional study including 339 Kenyan infants aged 6.0 +/- 1.1 months (mean +/- SD), we assessed serum hepcidin-25, biomarkers of iron status and inflammation, and fecal calprotectin. Prevalence of inflammation, anemia, and iron deficiency was 31%, 71%, 26%, respectively. Geometric mean (+/- SD) serum hepcidin was 6.0 (+/- 3.4) ng/mL, and was significantly lower in males than females. Inflammation (C-reactive protein and interleukin-6) and iron status (serum ferritin, zinc protoporphyrin and soluble transferrin receptor) were significant predictors of serum hepcidin, explaining nearly 60% of its variance. There were small, but significant differences in serum hepcidin comparing iron deficient anemic (IDA) infants without inflammation to iron-deficient anemic infants with inflammation (1.2 (+/- 4.9) vs. 3.4 (+/- 4.9) ng/mL; P<0.001). Fecal calprotectin correlated with blood/mucus in the stool but not with hepcidin. Similarly, the gut-linked cytokines IL-12 and IL-17 did not correlate with hepcidin. We conclude that hepcidin regulatory pathways are already functional in infancy, but serum hepcidin alone may not clearly discriminate between iron-deficient anemic infants with and without infection. We propose gender-specific reference values for serum hepcidin in iron-replete infants without inflammation.	[Jaeggi, Tanja; Moretti, Diego; Zimmermann, Michael B.] ETH, Inst Food Nutr & Hlth, Zurich, Switzerland; [Kvalsvig, Jane] Univ KwaZulu Natal, Durban, South Africa; [Holding, Penny A.] Int Ctr Behav Studies, Mombasa, Kenya; [Tjalsma, Harold; Kortman, Guus A. M.; Joosten, Irma] Radboud Univ Nijmegen, Dept Lab Med, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Tjalsma, Harold] Hepcidinanal Com, Nijmegen, Netherlands; [Mwangi, Alice] Univ Nairobi, Dept Food Technol & Nutr, Nairobi, Kenya	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Kwazulu Natal; Radboud University Nijmegen; University of Nairobi	Jaeggi, T (corresponding author), ETH, Inst Food Nutr & Hlth, Zurich, Switzerland.	Tanja.jaeggi@hest.ethz.ch	Kortman, Guus AM/F-9690-2010; Moretti, Diego/AAC-9028-2019; Zimmermann, Michael B/C-3062-2016; Moretti, Diego/G-5212-2013; Joosten, Irma/N-4418-2013	Moretti, Diego/0000-0002-7366-2182; Moretti, Diego/0000-0002-7366-2182; Joosten, Irma/0000-0003-2950-4977; Kortman, Guus/0000-0002-8076-0661	National Institutes of Health (NIH) [1U01HD064921-01/202/203]; INSTAPA Project; European Union's Seventh Framework Programme (Fp7) [211484]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U01HD064921] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); INSTAPA Project; European Union's Seventh Framework Programme (Fp7); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This project was supported by National Institutes of Health (NIH, Grant Number 1U01HD064921-01/202/203) and realized in collaboration with the INSTAPA Project, funded by the European Union's Seventh Framework Programme (Fp7/2007-2013) under grant agreement Nr 211484. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berglund S, 2011, AM J CLIN NUTR, V94, P1553, DOI 10.3945/ajcn.111.013938; Beutler E, 2007, BLOOD CELL MOL DIS, V39, P140, DOI 10.1016/j.bcmd.2007.03.009; Brasse-Lagnel C, 2011, GASTROENTEROLOGY, V140, P1261, DOI 10.1053/j.gastro.2010.12.037; Cherayil BJ, 2011, CURR OPIN GASTROEN, V27, P523, DOI 10.1097/MOG.0b013e32834a4cd1; de Mast Q, 2010, HAEMATOL-HEMATOL J, V95, P1068, DOI 10.3324/haematol.2009.019331; de Mast Q, 2009, J INFECT DIS, V199, P253, DOI 10.1086/595790; Domellof M, 2002, PEDIATRICS, V110, P545, DOI 10.1542/peds.110.3.545; Galesloot TE, 2011, BLOOD, V117, pE218, DOI 10.1182/blood-2011-02-337907; Ganz T, 2008, BLOOD, V112, P4292, DOI 10.1182/blood-2008-02-139915; Grant FKE, 2012, AM J CLIN NUTR, V95, P1231, DOI 10.3945/ajcn.111.029900; Grant FKE, 2012, J NUTR, V142, P105, DOI 10.3945/jn.111.146316; Hentze MW, 2010, CELL, V142, P24, DOI 10.1016/j.cell.2010.06.028; Hestvik E, 2011, BMC PEDIATR, V11, DOI 10.1186/1471-2431-11-9; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Kemna E, 2005, BLOOD, V106, P1864, DOI 10.1182/blood-2005-03-1159; Kemna EHJM, 2008, BLOOD CELL MOL DIS, V40, P339, DOI 10.1016/j.bcmd.2007.10.002; Kemna EHJM, 2007, HAEMATOLOGICA, V93, P90, DOI 10.3324/haematol.11705; Kortman GAM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029968; Krijt J, 2010, BLOOD CELL MOL DIS, V44, P257, DOI 10.1016/j.bcmd.2010.02.012; Kroot JJC, 2011, CLIN CHEM, V57, P1650, DOI 10.1373/clinchem.2009.140053; Kroot JJC, 2010, CLIN CHEM, V56, P1570, DOI 10.1373/clinchem.2010.149187; Kung'u JK, 2009, J NUTR, V139, P2124, DOI 10.3945/jn.108.104026; Loennerdal B, 2007, FOOD NUTR BULL, V28, pS491, DOI 10.1177/15648265070284S402; Muller KF, 2012, J PEDIATR-US, V160, P949, DOI 10.1016/j.jpeds.2011.12.030; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Nemeth E, 2004, J CLIN INVEST, V113, P1271, DOI 10.1172/JCI200420945; Nemeth E, 2009, ACTA HAEMATOL-BASEL, V122, P78, DOI 10.1159/000243791; Pasricha SR, 2010, PEDIATRICS, V126, pE140, DOI 10.1542/peds.2009-3108; Pigeon C, 2001, J BIOL CHEM, V276, P7811, DOI 10.1074/jbc.M008923200; Prentice AM, 2012, BLOOD, V119, P1922, DOI 10.1182/blood-2011-11-391219; Sarra M, 2010, INFLAMM BOWEL DIS, V16, P1808, DOI 10.1002/ibd.21248; Savino F, 2010, NEONATOLOGY, V97, P299, DOI 10.1159/000255161; Schneider JM, 2008, AM J CLIN NUTR, V87, P614, DOI 10.1093/ajcn/87.3.614; Siegemund S, 2009, INT IMMUNOL, V21, P555, DOI 10.1093/intimm/dxp025; Soh P, 2004, EUR J CLIN NUTR, V58, P71, DOI 10.1038/sj.ejcn.1601751; Swinkels DW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002706; Ulukol B, 2007, ACTA HAEMATOL-BASEL, V118, P70, DOI 10.1159/000102606; Vendt N, 2009, INT J LAB HEMATOL, V31, P440, DOI 10.1111/j.1751-553X.2008.01060.x; Victora CG, 2000, LANCET, V355, P451, DOI 10.1016/S0140-6736(00)82011-5; Werner T, 2011, GUT, V60, P325, DOI 10.1136/gut.2010.216929; Wessling-Resnick M, 2010, ANNU REV NUTR, V30, P105, DOI 10.1146/annurev.nutr.012809.104804; WHO, 2001, IRON DEFICIENCY ANAE; Wieringa FT, 2007, BRIT J NUTR, V98, P1070, DOI 10.1017/S0007114507756945; World Health Organization, 2007, WHO ANTHR PERS COMP; Wrighting DM, 2006, BLOOD, V108, P3204, DOI 10.1182/blood-2006-06-027631; Zimmermann MB, 2005, AM J CLIN NUTR, V81, P615	46	44	44	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57513	10.1371/journal.pone.0057513	http://dx.doi.org/10.1371/journal.pone.0057513			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460869	Green Published, gold, Green Submitted			2022-12-25	WOS:000315519000124
J	Karpusas, M; Axarli, I; Chiniadis, L; Papakyriakou, A; Bethanis, K; Scopelitou, K; Clonis, YD; Labrou, NE				Karpusas, Michael; Axarli, Irine; Chiniadis, Lykourgos; Papakyriakou, Athanasios; Bethanis, Kostas; Scopelitou, Katholiki; Clonis, Yannis D.; Labrou, Nikolaos E.			The Interaction of the Chemotherapeutic Drug Chlorambucil with Human Glutathione Transferase A1-1: Kinetic and Structural Analysis	PLOS ONE			English	Article							RESISTANCE PROTEIN-1 MRP1; S-TRANSFERASE; CATALYTIC MECHANISM; BINDING-SITE; CRYSTAL-STRUCTURE; ETHACRYNIC-ACID; AFFINITY LABEL; ACTIVE-SITES; RAT-LIVER; WILD-TYPE	Glutathione transferases (GSTs) are enzymes that contribute to cellular detoxification by catalysing the nucleophilic attack of glutathione (GSH) on the electrophilic centre of a number of xenobiotic compounds, including several chemotherapeutic drugs. In the present work we investigated the interaction of the chemotherapeutic drug chlorambucil (CBL) with human GSTA1-1 (hGSTA1-1) using kinetic analysis, protein crystallography and molecular dynamics. In the presence of GSH, CBL behaves as an efficient substrate for hGSTA1-1. The rate-limiting step of the catalytic reaction between CBL and GSH is viscosity-dependent and kinetic data suggest that product release is rate-limiting. The crystal structure of the hGSTA1-1/CBL-GSH complex was solved at 2.1 angstrom resolution by molecular replacement. CBL is bound at the H-site attached to the thiol group of GSH, is partially ordered and exposed to the solvent, making specific interactions with the enzyme. Molecular dynamics simulations based on the crystal structure indicated high mobility of the CBL moiety and stabilization of the C-terminal helix due to the presence of the adduct. In the absence of GSH, CBL is shown to be an alkylating irreversible inhibitor for hGSTA1-1. Inactivation of the enzyme by CBL followed a biphasic pseudo-first-order saturation kinetics with approximately 1 mol of CBL per mol of dimeric enzyme being incorporated. Structural analysis suggested that the modifying residue is Cys112 which is located at the entrance of the H-site. The results are indicative of a structural communication between the subunits on the basis of mutually exclusive modification of Cys112, indicating that the two enzyme active sites are presumably coordinated.	[Karpusas, Michael; Chiniadis, Lykourgos; Bethanis, Kostas] Agr Univ Athens, Phys Lab, Dept Sci, Athens, Greece; [Axarli, Irine; Scopelitou, Katholiki; Clonis, Yannis D.; Labrou, Nikolaos E.] Agr Univ Athens, Dept Agr Biotechnol, Lab Enzyme Technol, Athens, Greece; [Papakyriakou, Athanasios] NCSR Demokritos, Biol Chem Lab, Inst Phys Chem, Athens, Greece	Agricultural University of Athens; Agricultural University of Athens; National Centre of Scientific Research "Demokritos"	Labrou, NE (corresponding author), Agr Univ Athens, Dept Agr Biotechnol, Lab Enzyme Technol, Athens, Greece.	lambrou@aua.gr	Karpusas, Michael/AAP-5547-2021; Clonis, Yannis/AAI-2420-2019; Labrou, Nikolaos/B-1089-2011; Papakyriakou, Athanasios/K-7033-2012; Chiniadis, Lykourgos/O-4254-2019; Bethanis, Kostas/G-5673-2019	Clonis, Yannis/0000-0001-7626-8212; Labrou, Nikolaos/0000-0003-1925-9867; Papakyriakou, Athanasios/0000-0003-3931-6232; Chiniadis, Lykourgos/0000-0002-7118-9942; Bethanis, Kostas/0000-0002-7402-0798	European Union (European Social Fund - ESF); Greek national funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework (NSRF) - Research Funding Program: Heracleitus II; action THALES: 'Glutathione transferases: multifunctional molecular tools in red and green biotechnology', falling under the Operational Programme "Education and Lifelong Learning"; European Social Fund	European Union (European Social Fund - ESF)(European Social Fund (ESF)); Greek national funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework (NSRF) - Research Funding Program: Heracleitus II; action THALES: 'Glutathione transferases: multifunctional molecular tools in red and green biotechnology', falling under the Operational Programme "Education and Lifelong Learning"; European Social Fund(European Social Fund (ESF))	This research has been co-financed by the European Union (European Social Fund - ESF) and Greek national funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework (NSRF) - Research Funding Program: Heracleitus II. The work was also supported by the action THALES: 'Glutathione transferases: multifunctional molecular tools in red and green biotechnology', falling under the Operational Programme "Education and Lifelong Learning" and is co-financed by the European Social Fund and National Resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Axarli I, 2009, EUR J MED CHEM, V44, P2009, DOI 10.1016/j.ejmech.2008.10.009; Axarli I, 2009, BIOCHEM J, V422, P247, DOI 10.1042/BJ20090224; BAILEY J, 1985, BIOCHEMISTRY-US, V35, P2658; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Caccuri AM, 2001, J BIOL CHEM, V276, P5432, DOI 10.1074/jbc.M002818200; Caccuri AM, 1996, J BIOL CHEM, V271, P16193, DOI 10.1074/jbc.271.27.16193; Caccuri AM, 1997, J BIOL CHEM, V272, P29681, DOI 10.1074/jbc.272.47.29681; CAMERON AD, 1995, STRUCTURE, V3, P717, DOI 10.1016/S0969-2126(01)00206-4; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; CIACCIO PJ, 1991, BIOCHEM PHARMACOL, V42, P1504, DOI 10.1016/0006-2952(91)90468-K; DULIK DM, 1986, BIOCHEM PHARMACOL, V35, P3405, DOI 10.1016/0006-2952(86)90444-2; DULIK DM, 1990, BIOMED ENVIRON MASS, V19, P248, DOI 10.1002/bms.1200190408; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Eyer P, 2003, ANAL BIOCHEM, V312, P224, DOI 10.1016/S0003-2697(02)00506-7; Grahn E, 2006, ACTA CRYSTALLOGR D, V62, P197, DOI 10.1107/S0907444905039296; HU LQ, 1995, J BIOL CHEM, V270, P21875, DOI 10.1074/jbc.270.37.21875; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; ISHIKAWA T, 1993, J BIOL CHEM, V268, P20116; IVANETICH KM, 1990, BIOCHEM PHARMACOL, V39, P1999, DOI 10.1016/0006-2952(90)90621-Q; Jakalian A, 2002, J COMPUT CHEM, V23, P1623, DOI 10.1002/jcc.10128; JAKOBSON I, 1979, BIOCHEM J, V177, P861, DOI 10.1042/bj1770861; JOHNSON WW, 1993, J BIOL CHEM, V268, P11508; KING MM, 1983, BIOCHEMISTRY-US, V22, P1656, DOI 10.1021/bi00276a021; Koeplinger KA, 1999, DRUG METAB DISPOS, V27, P986; Kotzia GA, 2004, EUR J BIOCHEM, V271, P3503, DOI 10.1111/j.0014-2956.2004.04285.x; Koutsoumpli GE, 2012, J MED CHEM, V55, P6802, DOI 10.1021/jm300385f; Kuhnert DC, 2005, J MOL BIOL, V349, P825, DOI 10.1016/j.jmb.2005.04.025; Labrou NE, 2000, EUR J BIOCHEM, V267, P6657, DOI 10.1046/j.1432-1327.2000.01761.x; Lamanna N, 2010, CURR HEMATOL MALIG R, V5, P45, DOI 10.1007/s11899-009-0040-3; Le Trong I, 2002, PROTEINS, V48, P618, DOI 10.1002/prot.10162; Leatherbarrow R.J., 2009, GRAFIT VERSION 7; Lien S, 2001, J BIOL CHEM, V276, P35599, DOI 10.1074/jbc.M103789200; Lo HW, 2007, CURR OPIN PHARMACOL, V7, P367, DOI 10.1016/j.coph.2007.06.009; Lyon RP, 2002, BIOCHEMISTRY-US, V41, P10920, DOI 10.1021/bi0262810; McIlwain CC, 2006, ONCOGENE, V25, P1639, DOI 10.1038/sj.onc.1209373; MEYER DJ, 1992, BRIT J CANCER, V66, P433, DOI 10.1038/bjc.1992.292; Misquitta SA, 2005, BIOCHEMISTRY-US, V44, P8608, DOI 10.1021/bi050449a; Morrow CS, 1998, J BIOL CHEM, V273, P20114, DOI 10.1074/jbc.273.32.20114; Nebert Daniel W., 2004, Human Genomics, V1, P460; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parker LJ, 2008, J MOL BIOL, V380, P131, DOI 10.1016/j.jmb.2008.04.066; Paumi CM, 2001, J BIOL CHEM, V276, P7952, DOI 10.1074/jbc.M009400200; Ricci G, 2003, BIOCHEM J, V376, P71, DOI 10.1042/BJ20030860; Ricci G, 1996, J BIOL CHEM, V271, P16187, DOI 10.1074/jbc.271.27.16187; Romero L, 2006, BIOCHEM J, V400, P135, DOI 10.1042/BJ20060110; SAMPSON NS, 1992, BIOCHEMISTRY-US, V31, P8488, DOI 10.1021/bi00151a015; Sau A, 2010, ARCH BIOCHEM BIOPHYS, V500, P116, DOI 10.1016/j.abb.2010.05.012; Segel I.H., 1975, ENZYME KINETICS; Sheehan D, 2001, BIOCHEM J, V360, P1, DOI 10.1042/0264-6021:3600001; SINHA U, 1985, ANAL BIOCHEM, V151, P327, DOI 10.1016/0003-2697(85)90183-6; Skopelitou K, 2009, FRONTIERS DRUG DESIG, V4, P23; Skopelitou K, 2010, ANAL BIOCHEM, V405, P201, DOI 10.1016/j.ab.2010.06.007; Smitherman PK, 2004, J PHARMACOL EXP THER, V308, P260, DOI 10.1124/jpet.103.057729; Vargo MA, 2004, PROTEIN SCI, V13, P1586, DOI 10.1110/ps.04694004; Wang JB, 1998, BIOCHEMISTRY-US, V37, P15671, DOI 10.1021/bi981381k; Widersten M, 1996, BIOCHEMISTRY-US, V35, P7731, DOI 10.1021/bi9601619; WILCE MCJ, 1994, BBA-PROTEIN STRUCT M, V1205, P1, DOI 10.1016/0167-4838(94)90086-8; Wolf AV, 1985, HDB CHEM PHYSICS, pD; Xiao B, 1999, BIOCHEMISTRY-US, V38, P11887, DOI 10.1021/bi990468i; Zhao ZY, 1999, DRUG METAB DISPOS, V27, P992	60	18	18	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e56337	10.1371/journal.pone.0056337	http://dx.doi.org/10.1371/journal.pone.0056337			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460799	gold, Green Published, Green Submitted			2022-12-25	WOS:000315519000022
J	Major, LD; Partridge, TS; Gardner, J; Kent, SJ; de Rose, R; Suhrbier, A; Schroder, WA				Major, Lee D.; Partridge, Thomas S.; Gardner, Joy; Kent, Stephen J.; de Rose, Robert; Suhrbier, Andreas; Schroder, Wayne A.			Induction of SerpinB2 and Th1/Th2 Modulation by SerpinB2 during Lentiviral Infections In Vivo	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; SYSTEMIC-LUPUS-ERYTHEMATOSUS; BLOOD MONONUCLEAR-CELLS; CORONARY-HEART-DISEASE; RHESUS MACAQUES; HIV-INFECTION; SIMIAN-HUMAN; EARLY-STAGE; GENE; EXPRESSION	SerpinB2, also known as plasminogen activator inhibitor type 2, is a major product of activated monocytes/macrophages and is often strongly induced during infection and inflammation; however, its physiological function remains somewhat elusive. Herein we show that SerpinB2 is induced in peripheral blood mononuclear cells following infection of pigtail macaques with CCR5-utilizing (macrophage-tropic) SIVmac239, but not the rapidly pathogenic CXCR4-utilizing (T cell-tropic) SHIVmn229. To investigate the role of SerpinB2 in lentiviral infections, SerpinB2(-/-) mice were infected with EcoHIV, a chimeric HIV in which HIV gp120 has been replaced with gp80 from ecotropic murine leukemia virus. EcoHIV infected SerpinB2(-/-) mice produced significantly lower anti-gag IgG1 antibody titres than infected SerpinB2(+/+) mice, and showed slightly delayed clearance of EcoHIV. Analyses of published microarray studies showed significantly higher levels of SerpinB2 mRNA in monocytes from HIV-1 infected patients when compared with uninfected controls, as well as a significant negative correlation between SerpinB2 and T-bet mRNA levels in peripheral blood mononuclear cells. These data illustrate that SerpinB2 can be induced by lentiviral infection in vivo and support the emerging notion that a physiological role of SerpinB2 is modulation of Th1/Th2 responses.	[Major, Lee D.; Partridge, Thomas S.; Gardner, Joy; Suhrbier, Andreas; Schroder, Wayne A.] Queensland Inst Med Res, Dept Immunol, Brisbane, Qld 4006, Australia; [Partridge, Thomas S.; Suhrbier, Andreas] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld, Australia; [Kent, Stephen J.; de Rose, Robert] Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic 3010, Australia; [Suhrbier, Andreas] Griffith Univ, Sch Biomol & Phys Sci, Nathan, Qld 4111, Australia	QIMR Berghofer Medical Research Institute; University of Queensland; University of Melbourne; Griffith University	Suhrbier, A (corresponding author), Queensland Inst Med Res, Dept Immunol, Brisbane, Qld 4006, Australia.	andreasS@qimr.edu.au	Kent, Stephen/AAL-5101-2020	Kent, Stephen/0000-0002-8539-4891; De Rose, Robert/0000-0003-4316-3910; Suhrbier, Andreas/0000-0001-8986-9025	Australian National Health and Medical Research Council (NHMRC); Australian Centre for HIV and Hepatitis Virology Research; QIMR	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Centre for HIV and Hepatitis Virology Research; QIMR	Funding was provided by the Australian National Health and Medical Research Council (NH&MRC) and the Australian Centre for HIV and Hepatitis Virology Research. TSP received a QIMR honours scholarship for this work. AS is a Principle Research Fellow with the NH&MRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee K, 2010, AIDS RES HUM RETROV, V26, P445, DOI 10.1089/aid.2009.0223; Batten CJ, 2006, AIDS RES HUM RETROV, V22, P580, DOI 10.1089/aid.2006.22.580; Belisle SE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019681; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Buonaguro L, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S2-S5; CLAYETTE P, 1995, J MED PRIMATOL, V24, P94, DOI 10.1111/j.1600-0684.1995.tb00152.x; Croucher DR, 2008, NAT REV CANCER, V8, P535, DOI 10.1038/nrc2400; Dale CJ, 2004, J VIROL, V78, P13819, DOI 10.1128/JVI.78.24.13819-13828.2004; Darnell GA, 2006, J BIOL CHEM, V281, P31348, DOI 10.1074/jbc.M604220200; De Rose R, 2007, J VIROL, V81, P292, DOI 10.1128/JVI.01727-06; Demberg T, 2011, VACCINE, V29, P6017, DOI 10.1016/j.vaccine.2011.06.032; Donahoe SM, 2000, VIROLOGY, V272, P347, DOI 10.1006/viro.2000.0404; Freedman BD, 2003, IMMUNOL RES, V27, P261, DOI 10.1385/IR:27:2-3:261; Gauduin MC, 2004, J IMMUNOL METHODS, V288, P61, DOI 10.1016/j.jim.2004.02.007; Gekonge B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041153; Giri MS, 2009, J IMMUNOL, V182, P4459, DOI 10.4049/jimmunol.0801450; Giri MS, 2006, J LEUKOCYTE BIOL, V80, P1031, DOI 10.1189/jlb.0306157; Grivel JC, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-S1-S6; Igarashi T, 2001, P NATL ACAD SCI USA, V98, P658, DOI 10.1073/pnas.021551798; Kasyapa CS, 2006, BLOOD, V107, P3693, DOI 10.1182/blood-2005-04-1505; Katsikis PD, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002055; Kelschenbach JL, 2012, J NEUROIMMUNE PHARM, V7, P380, DOI 10.1007/s11481-011-9316-1; Kent SJ, 2008, VIROLOGY, V374, P528, DOI 10.1016/j.virol.2008.01.006; Kim WK, 2010, J LEUKOCYTE BIOL, V87, P557, DOI 10.1189/jlb.0209082; Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032; KRUITHOF EKO, 1995, BLOOD, V86, P4007, DOI 10.1182/blood.V86.11.4007.bloodjournal86114007; Lund R, 2003, J IMMUNOL, V171, P5328, DOI 10.4049/jimmunol.171.10.5328; Major L, 2011, EXP CELL RES, V317, P338, DOI 10.1016/j.yexcr.2010.10.016; Mannioui A, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-106; McCarthy JJ, 2004, J MED GENET, V41, P334, DOI 10.1136/jmg.2003.016584; Mehla R, 2012, CURR HIV-AIDS REP, V9, P34, DOI 10.1007/s11904-011-0100-x; Nilsson J, 2007, AIDS, V21, P565, DOI 10.1097/QAD.0b013e3280117204; Ockenhouse CF, 2005, J INFECT DIS, V191, P2064, DOI 10.1086/430321; Palacios R, 2002, LUPUS, V11, P60, DOI 10.1191/0961203302lu141cr; Palafox-Sanchez CA, 2009, CLIN APPL THROMB-HEM, V15, P233, DOI 10.1177/1076029607308868; Potash MJ, 2005, P NATL ACAD SCI USA, V102, P3760, DOI 10.1073/pnas.0500649102; Reuter MA, 2012, CYTOKINE GROWTH FACT; Sacha JB, 2007, J IMMUNOL, V178, P2746, DOI 10.4049/jimmunol.178.5.2746; Schroder WA, 2010, PARASITE IMMUNOL, V32, P764, DOI 10.1111/j.1365-3024.2010.01241.x; Schroder WA, 2011, CRIT REV IMMUNOL, V31, P15, DOI 10.1615/CritRevImmunol.v31.i1.20; Schroder WA, 2010, J IMMUNOL, V184, P2663, DOI 10.4049/jimmunol.0902187; Shetty RD, 2012, J CLIN INVEST, V122, P1712, DOI 10.1172/JCI60612; Shimizu Y, 2005, VIROLOGY, V343, P151, DOI 10.1016/j.virol.2005.08.025; Solis M, 2006, VIROLOGY, V352, P86, DOI 10.1016/j.virol.2006.04.010; Stasinopoulos S, 2010, FEBS J, V277, P1331, DOI 10.1111/j.1742-4658.2010.07563.x; Thuong Nguyen Thuy Thuong, 2008, PLoS Pathog, V4, pe1000229, DOI 10.1371/journal.ppat.1000229; Triant VA, 2012, J INFECT DIS, V205, pS355, DOI 10.1093/infdis/jis195; Van den Bergh R, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-53; Vigneault F, 2011, J VIROL, V85, P3015, DOI 10.1128/JVI.01846-10; Zhou HL, 2008, CELL HOST MICROBE, V4, P495, DOI 10.1016/j.chom.2008.10.004	50	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57343	10.1371/journal.pone.0057343	http://dx.doi.org/10.1371/journal.pone.0057343			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460840	Green Submitted, gold, Green Published			2022-12-25	WOS:000315519000094
J	Maslova, E; Strom, M; Olsen, SF; Halldorsson, TI				Maslova, Ekaterina; Strom, Marin; Olsen, Sjurdur F.; Halldorsson, Thorhallur I.			Consumption of Artificially-Sweetened Soft Drinks in Pregnancy and Risk of Child Asthma and Allergic Rhinitis	PLOS ONE			English	Article							MATERNAL FOOD-CONSUMPTION; MEDITERRANEAN DIET; FISH CONSUMPTION; DOUBLE-BLIND; ASPARTAME; WHEEZE; ECZEMA; DERMATITIS; VEGETABLES; EXPOSURE	Background: Past evidence has suggested a role of artificial sweeteners in allergic disease; yet, the evidence has been inconsistent and unclear. Objective: To examine relation of intake of artificially-sweetened beverages during pregnancy with child asthma and allergic rhinitis at 18 months and 7 years. Methods: We analyzed data from 60,466 women enrolled during pregnancy in the prospective longitudinal Danish National Birth Cohort between 1996 and 2003. At the 25th week of gestation we administered a validated Food Frequency Questionnaire which asked in detail about intake of artificially-sweetened soft drinks. At 18 months, we evaluated child asthma using interview data. We also assessed asthma and allergic rhinitis through a questionnaire at age 7 and by using national registries. Current asthma was defined as self-reported asthma diagnosis and wheeze in the past 12 months. We examined the relation between intake of artificially-sweetened soft drinks and child allergic disease outcomes and present here odds ratios with 95% CI comparing daily vs. no intake. Results: At 18 months, we found that mothers who consumed more artificially-sweetened non-carbonated soft drinks were 1.23 (95% CI: 1.13, 1.33) times more likely to report a child asthma diagnosis compared to non-consumers. Similar results were found for child wheeze. Consumers of artificially-sweetened carbonated drinks were more likely to have a child asthma diagnosis in the patient (1.30, 95% CI: 1.01, 1.66) and medication (1.13, 95% CI: 0.98, 1.29) registry, as well as self-reported allergic rhinitis (1.31, 95% CI: 0.98, 1.74) during the first 7 years of follow-up. We found no associations for sugar-sweetened soft drinks. Conclusion: Carbonated artificially- sweetened soft drinks were associated with registry-based asthma and self-reported allergic rhinitis, while early childhood outcomes were related to non-carbonated soft drinks. These results suggest that consumption of artificially-sweetened soft drinks during pregnancy may play a role in offspring allergic disease development.	[Maslova, Ekaterina; Strom, Marin; Olsen, Sjurdur F.; Halldorsson, Thorhallur I.] Statens Serum Inst, Ctr Fetal Programming, Dept Epidemiol, DK-2300 Copenhagen, Denmark; [Maslova, Ekaterina; Olsen, Sjurdur F.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Halldorsson, Thorhallur I.] Univ Iceland, Fac Food Sci & Nutr, Sch Hlth Sci, Reykjavik, Iceland; [Halldorsson, Thorhallur I.] Landspitali Univ Hosp, Unit Nutr Res, Reykjavik, Iceland	Statens Serum Institut; Harvard University; Harvard T.H. Chan School of Public Health; University of Iceland; Landspitali National University Hospital	Maslova, E (corresponding author), Statens Serum Inst, Ctr Fetal Programming, Dept Epidemiol, DK-2300 Copenhagen, Denmark.	emaslova@post.harvard.edu	Halldorsson, Tohrhallur/M-1823-2015	Halldorsson, Tohrhallur/0000-0001-5115-0162; Halldorsson, Thorhallur/0000-0002-3488-0777; Strom, Marin/0000-0003-1926-6610; Olsen, Sjurdur/0000-0003-3017-7096	Danish Council for Stra-tegic Research [09-067124]; Danish Council for Independent Research \ Medical Sciences, Danish Agency for Science, Technology and Innovation [09-063410]; Lundbeck foundation [R13-A907]; European Union (EU) Integrated Research Project EARNEST [FOOD-CT-2005-007036]; Commission of the European Communities under the FP 6 priority 5: food quality and safety; March of Dimes Birth Defects Foundation; Danish Heart Association; Danish Medical Research Council; Sygekassernes Helsefond; Danish Pharmaceutical Association; Ministry of Health; National Board of Health; Statens Serum Institut; Danish National Research Foundation	Danish Council for Stra-tegic Research(Danske Strategiske Forskningsrad (DSF)); Danish Council for Independent Research \ Medical Sciences, Danish Agency for Science, Technology and Innovation; Lundbeck foundation(Lundbeckfonden); European Union (EU) Integrated Research Project EARNEST; Commission of the European Communities under the FP 6 priority 5: food quality and safety; March of Dimes Birth Defects Foundation(March of Dimes); Danish Heart Association; Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Sygekassernes Helsefond; Danish Pharmaceutical Association; Ministry of Health; National Board of Health; Statens Serum Institut; Danish National Research Foundation(Danmarks Grundforskningsfond)	Declaration of all sources of funding: the study was supported by the Danish Council for Stra-tegic Research (09-067124); the Danish Council for Independent Research vertical bar Medical Sciences, Danish Agency for Science, Technology and Innovation (09-063410); the Lundbeck foundation (R13-A907); and the European Union (EU) Integrated Research Project EARNEST (FOOD-CT-2005-007036). The EU project EARNEST (http://www.metabolic-programming.org) receives financial support from the Commission of the European Communities under the FP 6 priority 5: food quality and safety. The Danish National Birth Cohort has been financed by the March of Dimes Birth Defects Foundation, the Danish Heart Association, the Danish Medical Research Council, and the Sygekassernes Helsefond, Danish National Research Foundation, Danish Pharmaceutical Association, Ministry of Health, National Board of Health, Statens Serum Institut. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Salam OME, 2011, NEUROTOX RES; ASHER MI, 1995, EUR RESPIR J, V8, P483, DOI 10.1183/09031936.95.08030483; Calvani M, 2006, PEDIAT ALLERG IMM-UK, V17, P94, DOI 10.1111/j.1399-3038.2005.00367.x; Chatzi L, 2008, THORAX, V63, P507, DOI 10.1136/thx.2007.081745; Chatzi L, 2007, THORAX, V62, P677, DOI 10.1136/thx.2006.069419; Duffy VB, 2004, J AM DIET ASSOC, V104, P255, DOI 10.1016/j.jada.2003.12.001; Forskningsdatabaser, 2002, DAT DANM STAT; GARRIGA MM, 1991, J ALLERGY CLIN IMMUN, V87, P821, DOI 10.1016/0091-6749(91)90128-B; GEHA R, 1993, J ALLERGY CLIN IMMUN, V92, P513, DOI 10.1016/0091-6749(93)90075-Q; Gultekin F, 2012, CLIN REV ALLERGY IMM; Halldorsson TI, 2010, AM J CLIN NUTR, V92, P626, DOI 10.3945/ajcn.2009.28968; Hansen S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036328; Hederos CA, 2007, PEDIAT ALLERG IMM-UK, V18, P135, DOI 10.1111/j.1399-3038.2006.00474.x; Hernandez-Diaz S, 2006, AM J EPIDEMIOL, V164, P1115, DOI 10.1093/aje/kwj275; Hill AM, 2003, CONTACT DERMATITIS, V49, P258, DOI 10.1111/j.0105-1873.2003.0225a.x; Jacob Sharon E, 2008, Dermatitis, V19, pE10; Jedrychowski W, 2011, INT ARCH ALLERGY IMM, V155, P275, DOI 10.1159/000320376; Kim JY, 2011, FOOD CHEM TOXICOL, V49, P2899, DOI 10.1016/j.fct.2011.08.001; LaBuda CJ, 2001, LIFE SCI, V69, P443, DOI 10.1016/S0024-3205(01)01136-5; Leth T, 2008, FOOD ADDIT CONTAM A, V25, P662, DOI 10.1080/02652030701765749; Maslova E, 2012, J NUTR SCI, V1, DOI 10.1017/jns.2012.5; Mikkelsen TB, 2006, PUBLIC HEALTH NUTR, V9, P771, DOI 10.1079/PHN2005883; Miyake Y, 2010, EUR RESPIR J, V35, P1228, DOI 10.1183/09031936.00100609; Miyake Y, 2010, ALLERGY, V65, P758, DOI 10.1111/j.1398-9995.2009.02267.x; Miyake Y, 2009, THORAX, V64, P815, DOI 10.1136/thx.2009.115931; Moth G, 2007, ACTA PAEDIATR, V96, P1470, DOI 10.1111/j.1651-2227.2007.00460.x; Moth G, 2007, EUR J CLIN PHARMACOL, V63, P605, DOI 10.1007/s00228-007-0286-4; Nurmatov U, 2012, ALLERGY, V67, P1041, DOI 10.1111/j.1398-9995.2012.02858.x; Nwaru BI, 2010, PEDIAT ALLERG IMM-UK, V21, P29, DOI 10.1111/j.1399-3038.2009.00949.x; Olsen J, 2001, SCAND J PUBLIC HEALT, V29, P300, DOI 10.1177/14034948010290040201; Olsen SF, 2008, AM J CLIN NUTR, V88, P167, DOI 10.1093/ajcn/88.1.167; Pitrez PMC, 2005, BRAZ J MED BIOL RES, V38, P51, DOI 10.1590/S0100-879X2005000100008; Psarras Stelios, 2004, Paediatr Respir Rev, V5 Suppl A, pS179, DOI 10.1016/S1526-0542(04)90034-6; Ramsland PA, 1999, J MOL RECOGNIT, V12, P249, DOI 10.1002/(SICI)1099-1352(199907/08)12:4<249::AID-JMR463>3.0.CO;2-B; Reese I, 2009, J DTSCH DERMATOL GES, V7, P70, DOI 10.1111/j.1610-0387.2008.06894.x; Romieu I, 2007, CLIN EXP ALLERGY, V37, P518, DOI 10.1111/j.1365-2222.2007.02685.x; Salam MT, 2005, J ASTHMA, V42, P513, DOI 10.1081/JAS-200067619; Sausenthaler S, 2007, AM J CLIN NUTR, V85, P530; Saxholt E., 2008, DANISH FOOD COMPOSIT; SCHIFFMAN SS, 1987, NEW ENGL J MED, V317, P1181, DOI 10.1056/NEJM198711053171903; Schisterman EF, 2009, EPIDEMIOLOGY, V20, P488, DOI 10.1097/EDE.0b013e3181a819a1; SZUCS EF, 1986, FOOD CHEM TOXICOL, V24, P171, DOI 10.1016/0278-6915(86)90353-4; Veien NK, 2012, CONTACT DERMATITIS, V67, P315, DOI 10.1111/j.1600-0536.2012.02147.x; Willers SM, 2007, THORAX, V62, P773, DOI 10.1136/thx.2006.074187; Willers SM, 2008, AM J RESP CRIT CARE, V178, P124, DOI 10.1164/rccm.200710-1544OC	45	45	49	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57261	10.1371/journal.pone.0057261	http://dx.doi.org/10.1371/journal.pone.0057261			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460835	gold, Green Published, Green Submitted			2022-12-25	WOS:000315519000085
J	Silvent, J; Nassif, N; Helary, C; Azais, T; Sire, JY; Guille, MMG				Silvent, Jeremie; Nassif, Nadine; Helary, Christophe; Azais, Thierry; Sire, Jean-Yves; Guille, Marie Madeleine Giraud			Collagen Osteoid-Like Model Allows Kinetic Gene Expression Studies of Non-Collagenous Proteins in Relation with Mineral Development to Understand Bone Biomineralization	PLOS ONE			English	Article							DENTIN MATRIX PROTEIN-1; OSTEOBLAST-LIKE CELLS; IN-VITRO; HYDROXYAPATITE FORMATION; INHIBITION; DIFFERENTIATION; NUCLEATION; CRYSTALS; CULTURE; STATE	Among persisting questions on bone calcification, a major one is the link between protein expression and mineral deposition. A cell culture system is here proposed opening new integrative studies on biomineralization, improving our knowledge on the role played by non-collagenous proteins in bone. This experimental in vitro model consisted in human primary osteoblasts cultured for 60 days at the surface of a 3D collagen scaffold mimicking an osteoid matrix. Various techniques were used to analyze the results at the cellular and molecular level (adhesion and viability tests, histology and electron microscopy, RT- and qPCR) and to characterize the mineral phase (histological staining, EDX, ATG, SAED and RMN). On long term cultures human bone cells seeded on the osteoid-like matrix displayed a clear osteoblast phenotype as revealed by the osteoblast-like morphology, expression of specific protein such as alkaline phosphatase and expression of eight genes classically considered as osteoblast markers, including BGLAP, COL1A1, and BMP2. Von Kossa and alizarine red allowed us to identify divalent calcium ions at the surface of the matrix, EDX revealed the correct Ca/P ratio, and SAED showed the apatite crystal diffraction pattern. In addition RMN led to the conclusion that contaminant phases were absent and that the hydration state of the mineral was similar to fresh bone. A temporal correlation was established between quantified gene expression of DMP1 and IBSP, and the presence of hydroxyapatite, confirming the contribution of these proteins to the mineralization process. In parallel a difference was observed in the expression pattern of SPP1 and BGLAP, which questioned their attributed role in the literature. The present model opens new experimental possibilities to study spatio-temporal relations between bone cells, dense collagen scaffolds, NCPs and hydroxyapatite mineral deposition. It also emphasizes the importance of high collagen density environment in bone cell physiology.	[Silvent, Jeremie; Nassif, Nadine; Helary, Christophe; Azais, Thierry; Guille, Marie Madeleine Giraud] Univ Paris 06, UMR Chim Mat Condensee Paris 7574, Ecole Prat Hautes Etud, Paris, France; [Silvent, Jeremie; Sire, Jean-Yves] Univ Paris 06, UMR 7138, Equipe Evolut & Dev Squelette, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Sorbonne Universite; Chimie ParisTech; College de France; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite	Sire, JY (corresponding author), Univ Paris 06, UMR 7138, Equipe Evolut & Dev Squelette, Paris, France.	jean-yves.sire@upmc.fr; mmgiraud@snv.jussieu.fr	Helary, Christophe/AAD-3476-2022; Helary, Christophe/AAD-9437-2022; Helary, Christophe/J-8128-2013	Helary, Christophe/0000-0001-9312-7278				Addison WN, 2008, J BONE MINER RES, V23, P1638, DOI 10.1359/JBMR.080601; Anselme K, 1999, J MATER SCI-MATER M, V10, P815, DOI 10.1023/A:1008992109670; AUBIN JE, 1995, BONE, V17, pS77, DOI 10.1016/8756-3282(95)00183-E; Aubin JE, 1998, BIOCHEM CELL BIOL, V76, P899, DOI 10.1139/bcb-76-6-899; BERGMAN I, 1963, ANAL CHEM, V35, P1961, DOI 10.1021/ac60205a053; Besseau L, 2002, BIOMATERIALS, V23, P27, DOI 10.1016/S0142-9612(01)00075-8; Bonewald LF, 2003, CALCIFIED TISSUE INT, V72, P537, DOI 10.1007/s00223-002-1057-y; Boskey AL, 2008, CHEM REV, V108, P4716, DOI 10.1021/cr0782473; BOSKEY AL, 1995, ANN NY ACAD SCI, V760, P249, DOI 10.1111/j.1749-6632.1995.tb44635.x; Boskey AL, 1998, J CELL BIOCHEM, P83, DOI 10.1002/(SICI)1097-4644(1998)72:30/31+<83::AID-JCB12>3.0.CO;2-F; Boskey AL, 1996, CALCIFIED TISSUE INT, V58, P177, DOI 10.1007/s002239900030; Cho GY, 2003, SCIENCE, V300, P1123, DOI 10.1126/science.1078470; Christenson RH, 1997, CLIN BIOCHEM, V30, P573, DOI 10.1016/S0009-9120(97)00113-6; CIAPETTI G, 1993, BIOMATERIALS, V14, P359, DOI 10.1016/0142-9612(93)90055-7; Coelho MJ, 2000, BIOMATERIALS, V21, P1095, DOI 10.1016/S0142-9612(99)00192-1; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Dorozhkin SV, 2002, ANGEW CHEM INT EDIT, V41, P3130, DOI 10.1002/1521-3773(20020902)41:17<3130::AID-ANIE3130>3.0.CO;2-1; DSouza RN, 1997, J BONE MINER RES, V12, P2040, DOI 10.1359/jbmr.1997.12.12.2040; Feng JQ, 2002, J BONE MINER RES, V17, P1822, DOI 10.1359/jbmr.2002.17.10.1822; Franz-Odendaal TA, 2006, DEV DYNAM, V235, P176, DOI 10.1002/dvdy.20603; Fratzl-Zelman N, 1998, BONE, V23, P511, DOI 10.1016/S8756-3282(98)00139-2; George A, 1995, Connect Tissue Res, V33, P67, DOI 10.3109/03008209509016984; Glimcher MJ, 2006, REV MINERAL GEOCHEM, V64, P223, DOI 10.2138/rmg.2006.64.8; Gobeaux F, 2007, LANGMUIR, V23, P6411, DOI 10.1021/la070093z; Gordon JAR, 2007, BONE, V41, P462, DOI 10.1016/j.bone.2007.04.191; Guille MMG, 2010, SOFT MATTER, V6, P4963, DOI 10.1039/c0sm00260g; Hadjipanayi E, 2009, J TISSUE ENG REGEN M, V3, P77, DOI 10.1002/term.136; He G, 2003, NAT MATER, V2, P552, DOI 10.1038/nmat945; He G, 2004, J BIOL CHEM, V279, P11649, DOI 10.1074/jbc.M309296200; Hoang QQ, 2003, NATURE, V425, P977, DOI 10.1038/nature02079; Huang SJ, 2009, CHEM MATER, V21, P2583, DOI 10.1021/cm9006537; Hunter GK, 1996, BIOCHEM J, V317, P59, DOI 10.1042/bj3170059; HUNTER GK, 1993, P NATL ACAD SCI USA, V90, P8562, DOI 10.1073/pnas.90.18.8562; HUNTER GK, 1994, BIOCHEM J, V300, P723, DOI 10.1042/bj3000723; JACKSON SF, 1957, J BIOPHYS BIOCHEM CY, V3, P897, DOI 10.1083/jcb.3.6.897; Jager C, 2006, MAGN RESON CHEM, V44, P573, DOI 10.1002/mrc.1774; Kumaran S Thanga, 2010, Indian J Dent Res, V21, P3, DOI 10.4103/0970-9290.62796; LIAN JB, 2001, OSTEOPOROSIS, P21; Mauney JR, 2004, TISSUE ENG, V10, P81, DOI 10.1089/107632704322791727; MILLER SC, 1989, SCANNING MICROSCOPY, V3, P953; Nampei A, 2004, J BONE MINER METAB, V22, P176, DOI 10.1007/s00774-003-0468-9; Nassif N, 2010, CHEM MATER, V22, P3653, DOI 10.1021/cm903596q; Nassif N, 2010, CHEM MATER, V22, P3307, DOI 10.1021/cm903594n; Petite H, 2000, NAT BIOTECHNOL, V18, P959, DOI 10.1038/79449; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ramires PA, 2002, J MATER SCI-MATER M, V13, P797, DOI 10.1023/A:1016183326864; Ramtani S, 2010, J MECH MED BIOL, V10, P35, DOI 10.1142/S0219519410003290; ROMBERG RW, 1986, BIOCHEMISTRY-US, V25, P1176, DOI 10.1021/bi00353a035; Rozen S, 2000, Methods Mol Biol, V132, P365; Stains Joseph P, 2005, Birth Defects Res C Embryo Today, V75, P72, DOI 10.1002/bdrc.20034; Tadic D, 2002, BIOMATERIALS, V23, P2553, DOI 10.1016/S0142-9612(01)00390-8; Takitoh T, 2010, J BIOSCI BIOENG, V110, P471, DOI 10.1016/j.jbiosc.2010.04.009; Thula TT, 2011, ACTA BIOMATER, V7, P3158, DOI 10.1016/j.actbio.2011.04.014; Tsai SW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031200; Vigier S, 2010, J BIOMED MATER RES A, V94A, P556, DOI 10.1002/jbm.a.32717; Wiesmann HP, 2003, J ORAL MAXIL SURG, V61, P1455, DOI 10.1016/j.joms.2003.05.001; Wu YT, 2002, J BONE MINER RES, V17, P472, DOI 10.1359/jbmr.2002.17.3.472; Yamanouchi K, 2001, J BONE MINER RES, V16, P857, DOI 10.1359/jbmr.2001.16.5.857; Zhang LJ, 2004, MATER LETT, V58, P719, DOI 10.1016/j.matlet.2003.07.009	59	18	19	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57344	10.1371/journal.pone.0057344	http://dx.doi.org/10.1371/journal.pone.0057344			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460841	gold, Green Published, Green Submitted			2022-12-25	WOS:000315519000095
J	Lutermann, H; Bennett, NC; Speakman, JR; Scantlebury, M				Lutermann, Heike; Bennett, Nigel C.; Speakman, John R.; Scantlebury, Michael			Energetic Benefits of Sociality Offset the Costs of Parasitism in a Cooperative Mammal	PLOS ONE			English	Article							CRYPTOMYS-HOTTENTOTUS; HELMINTH-PARASITES; HOST; INFECTION; BEHAVIOR; RISK; CONSEQUENCES; DETERMINANTS; PHYSIOLOGY; EVOLUTION	Sociality and particularly advanced forms of sociality such as cooperative breeding (living in permanent groups with reproductive division of labour) is relatively rare among vertebrates. A suggested constraint on the evolution of sociality is the elevated transmission rate of parasites between group members. Despite such apparent costs, sociality has evolved independently in a number of vertebrate taxa including humans. However, how the costs of parasitism are overcome in such cases remains uncertain. We evaluated the potential role of parasites in the evolution of sociality in a member of the African mole-rats, the only mammal family that exhibits the entire range of social systems from solitary to eusocial. Here we show that resting metabolic rates decrease whilst daily energy expenditure and energy stores (i.e. body fat) increase with group size in social Natal mole rats (Cryptomys hottentotus natalensis). Critically, larger groups also had reduced parasite abundance and infested individuals only showed measurable increases in energy metabolism at high parasite abundance. Thus, in some circumstances, sociality appears to provide energetic benefits that may be diverted into parasite defence. This mechanism is likely to be self-reinforcing and an important factor in the evolution of sociality.	[Lutermann, Heike; Bennett, Nigel C.; Scantlebury, Michael] Univ Pretoria, Mammal Res Inst, Dept Zool & Entomol, Hatfield, South Africa; [Speakman, John R.] Univ Aberdeen, Inst Biol & Environm Sci, Aberdeen, Scotland; [Scantlebury, Michael] Queens Univ Belfast, Sch Biol Sci, Belfast, Antrim, North Ireland; [Speakman, John R.] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Mol & Dev Biol, Beijing, Peoples R China	University of Pretoria; University of Aberdeen; Queens University Belfast; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS	Lutermann, H (corresponding author), Univ Pretoria, Mammal Res Inst, Dept Zool & Entomol, Hatfield, South Africa.	hlutermann@zoology.up.ac.za; m.scantlebury@qub.ac.uk	Speakman, John R./A-9494-2008; Lutermann, Heike/A-4692-2008; Bennett, Nigel/E-4238-2010	Speakman, John R./0000-0002-2457-1823; Lutermann, Heike/0000-0002-7521-2302; Bennett, Nigel/0000-0001-9748-2947	Department of Science and Technology/National Research Foundation-South African Research Chairs Initiative Chair for Mammalian Behavioural Ecology and Physiology; University of Pretoria Postdoctoral Research Fellowships; NRF-SAR Chair for Mammalian Behavioural Ecology and Physiology; University of Pretoria PDRF	Department of Science and Technology/National Research Foundation-South African Research Chairs Initiative Chair for Mammalian Behavioural Ecology and Physiology; University of Pretoria Postdoctoral Research Fellowships; NRF-SAR Chair for Mammalian Behavioural Ecology and Physiology; University of Pretoria PDRF	This research was funded by the Department of Science and Technology/National Research Foundation-South African Research Chairs Initiative Chair for Mammalian Behavioural Ecology and Physiology to N.C.B. and University of Pretoria Postdoctoral Research Fellowships to M.S. and H.L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the owners for access to their property for animal capture and KwaZulu-Natal Nature Conservation Service for issuing the capture permit. This research was funded by the NRF-SAR Chair for Mammalian Behavioural Ecology and Physiology to NCB and University of Pretoria PDRF's to MS and HL. Many assistants were involved with fieldwork but we would especially like to thank Marietjie Oosthuizen and Craig Jackson for their help.	Alexander R.D., 1974, Annual Rev Ecol Syst, V5, P325, DOI 10.1146/annurev.es.05.110174.001545; Altizer S, 2003, ANNU REV ECOL EVOL S, V34, P517, DOI 10.1146/annurev.ecolsys.34.030102.151725; Anderson DR., 2002, PRACTICAL INFORM THE, DOI DOI 10.1007/B97636; ANDERSON RM, 1978, J ANIM ECOL, V47, P219, DOI 10.2307/3933; Arneberg P, 1998, P ROY SOC B-BIOL SCI, V265, P1283, DOI 10.1098/rspb.1998.0431; Bennett N.C., 2000, AFRICAN MOLE RATS EC; BENNETT NC, 1993, Z SAUGETIERKD, V58, P362; Bordes F, 2007, BIOL LETTERS, V3, P692, DOI 10.1098/rsbl.2007.0393; Bordes Frederic, 2011, Infect Ecol Epidemiol, V1, DOI 10.3402/iee.v1i0.7346; Colditz IG, 2008, PARASITE IMMUNOL, V30, P63, DOI 10.1111/j.1365-3024.2007.00964.x; COTE IM, 1995, BEHAV ECOL, V6, P159, DOI 10.1093/beheco/6.2.159; Crawley M.J., 2007, J CHEM INF MODEL, DOI DOI 10.1002/9780470515075; Degen AA, 2006, MICROMAMMALS AND MACROPARASITES: FROM EVOLUTIONARY ECOLOGY TO MANAGEMENT, P371, DOI 10.1007/978-4-431-36025-4_19; DELAHAY RJ, 1995, PARASITOLOGY, V110, P473, DOI 10.1017/S0031182000064817; Demas GE, 1997, AM J PHYSIOL-REG I, V273, pR1631, DOI 10.1152/ajpregu.1997.273.5.R1631; Elsheikha HM, 2011, ESSENTIALS OF VETERINARY PARASITOLOGY, P1; Ewald PW, 1994, EVOLUTION INFECT DIS; Giorgi MS, 2001, P ROY SOC B-BIOL SCI, V268, P2071, DOI 10.1098/rspb.2001.1686; Hafner MS, 2000, LIFE UNDERGROUND, P370; Hart BL, 2011, PHILOS T R SOC B, V366, P3406, DOI 10.1098/rstb.2011.0092; HART BL, 1988, NEUROSCI BIOBEHAV R, V12, P123, DOI 10.1016/S0149-7634(88)80004-6; HICKMAN GC, 1979, Z SAUGETIERKD, V44, P153; HOOGLAND JL, 1979, BEHAVIOUR, V69, P1, DOI 10.1163/156853979X00377; Hoste H, 2001, INT J PARASITOL, V31, P231, DOI 10.1016/S0020-7519(00)00167-3; Kam M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013686; Kleiber M., 1961, FIRE LIFE, DOI DOI 10.1002/JPS.2600510525; Kotze J, 2008, PHYSIOL BEHAV, V93, P215, DOI 10.1016/j.physbeh.2007.08.016; Kristan DM, 2004, J EXP BIOL, V207, P2351, DOI 10.1242/jeb.01020; Kristan DM, 2002, J EXP BIOL, V205, P3955; Kristan DM, 2001, AM J PHYSIOL-REG I, V281, pR502, DOI 10.1152/ajpregu.2001.281.2.R502; Kyriazakis I, 1998, ANIM BEHAV, V56, P265, DOI 10.1006/anbe.1998.0761; Le Comber SC, 2002, CAN J ZOOL, V80, P436, DOI 10.1139/Z02-026; Lemen C, MLWPROGRAM DLWUSERGU; LIFSON N, 1966, J THEOR BIOL, V12, P46, DOI 10.1016/0022-5193(66)90185-8; Luna F, 2006, CAN J ZOOL, V84, P661, DOI 10.1139/Z06-040; Lutermann H, 2008, J ZOOL, V275, P26, DOI 10.1111/j.1469-7998.2007.00403.x; Lutermann H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052077; Maizels RM, 2004, IMMUNOL REV, V201, P89, DOI 10.1111/j.0105-2896.2004.00191.x; Maizels RM, 2003, NAT REV IMMUNOL, V3, P733, DOI 10.1038/nri1183; Meldrum GE, 2009, ANIM BEHAV, V77, P919, DOI 10.1016/j.anbehav.2008.12.023; Morand S, 2000, P ROY SOC B-BIOL SCI, V267, P1999, DOI 10.1098/rspb.2000.1241; Mosser A, 2009, ANIM BEHAV, V78, P359, DOI 10.1016/j.anbehav.2009.04.024; Neilson R, 2005, PARASITOLOGY, V131, P279, DOI 10.1017/S0031182005007717; Oosthuizen MK, 2008, GEN COMP ENDOCR, V159, P236, DOI 10.1016/j.ygcen.2008.09.004; Petney TN, 1998, INT J PARASITOL, V28, P377, DOI 10.1016/S0020-7519(97)00189-6; Robar N, 2011, CAN J ZOOL, V89, P1146, DOI 10.1139/Z11-084; Rogerson JD, 2008, J WILDLIFE DIS, V44, P28, DOI 10.7589/0090-3558-44.1.28; Rossin MA, 2010, PARASITOLOGY, V137, P1569, DOI 10.1017/S0031182010000351; Scantlebury M, 2007, P ROY SOC B-BIOL SCI, V274, P2169, DOI 10.1098/rspb.2007.0690; Schwanz LE, 2006, J EXP BIOL, V209, P5029, DOI 10.1242/jeb.02601; SHERMAN PW, 1995, BEHAV ECOL, V6, P102, DOI 10.1093/beheco/6.1.102; Sichilima AM, 2008, J ZOOL, V275, P276, DOI 10.1111/j.1469-7998.2008.00439.x; Speakman J.R., 1997, DOUBLY LABELLED WATE; Speakman JR, 2010, J ANIM ECOL, V79, P726, DOI 10.1111/j.1365-2656.2010.01689.x; Speakman JR, 2003, P NATL ACAD SCI USA, V100, P14057, DOI 10.1073/pnas.2235671100; Svensson E, 1998, FUNCT ECOL, V12, P912, DOI 10.1046/j.1365-2435.1998.00271.x; Vicente J, 2006, PARASITOL RES, V98, P77, DOI 10.1007/s00436-005-0001-2; Viljoen H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027003; Vitone ND, 2004, EVOL ECOL RES, V6, P183; Wey T, 2008, ANIM BEHAV, V75, P333, DOI 10.1016/j.anbehav.2007.06.020; Zelova J, 2010, PHYSIOL BEHAV, V99, P54, DOI 10.1016/j.physbeh.2009.10.007	61	18	18	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57969	10.1371/journal.pone.0057969	http://dx.doi.org/10.1371/journal.pone.0057969			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451285	Green Published, gold			2022-12-25	WOS:000316849500146
J	Ueda, P; Bonamy, AKE; Granath, F; Cnattingius, S				Ueda, Peter; Bonamy, Anna-Karin Edstedt; Granath, Fredrik; Cnattingius, Sven			Month of Birth and Mortality in Sweden: A Nation-Wide Population-Based Cohort Study	PLOS ONE			English	Article							VITAMIN-D DEFICIENCY; HIGH PREVALENCE; PREGNANT-WOMEN; SEASONALITY; WEIGHT; RISK; ADIPOSITY; LONGEVITY; PATTERNS; DISEASE	Background: Month of birth - an indicator for a variety of prenatal and early postnatal exposures - has been associated with life expectancy in adulthood. On the northern hemisphere, people born in the autumn live longer than those born during the spring. Only one study has followed a population longitudinally and no study has investigated the relation between month of birth and mortality risk below 50 years. Methods and results: In this nation-wide Swedish study, we included 6,194,745 subjects, using data from population-based health and administrative registries. The relation between month of birth ( January - December) and mortality risk was assessed by fitting Cox proportional hazard regression models using attained age as the underlying time scale. Analyses were made for ages >30, >30 to 50, >50 to 80 and >80 years. Month of birth was a significant predictor of mortality in the age-spans >30, >50 to 80, and >80 years. In models adjusted for gender and education for ages >30 and >50 to 80 years, the lowest mortality was seen for people born in November and the highest mortality in those born in the spring/summer, peaking in May for mortality >30 years (25 parts per thousand excess hazard ratio compared to November, [95% confidence interval = 16-34]) and in April for mortality >50 to 80 years (42 parts per thousand excess hazard ratio compared to November, [95% confidence interval = 30-55]). In the ages >80 years the pattern was similar but the differences in mortality between birth months were smaller. For mortality within the age-span >30 to 50 years, results were inconclusive. Conclusion: Month of birth is associated to risk of mortality in ages above 50 years in Sweden. Further studies should aim at clarifying the mechanisms behind this association.	[Ueda, Peter; Bonamy, Anna-Karin Edstedt; Granath, Fredrik; Cnattingius, Sven] Karolinska Inst, Dept Med, Clin Epidemiol Unit, Stockholm, Sweden	Karolinska Institutet	Ueda, P (corresponding author), Karolinska Inst, Dept Med, Clin Epidemiol Unit, Stockholm, Sweden.	peter.ueda@gmail.com	Ueda, Peter/AAB-8961-2020; Bonamy, Anna-Karin E/B-7106-2012; Ueda, Peter/AGH-9915-2022	Ueda, Peter/0000-0002-3275-8743; Bonamy, Anna-Karin E/0000-0003-4552-9912; Ueda, Peter/0000-0002-3275-8743	MD-PhD Program at Karolinska Institutet	MD-PhD Program at Karolinska Institutet	The study was funded by the MD-PhD Program at Karolinska Institutet. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker D, 1986, LANCET, V327, P1077, DOI DOI 10.1016/S0140-6736(86)91340-1; Basile LA, 2007, J PERINATOL, V27, P568, DOI 10.1038/sj.jp.7211796; Bobak M, 2001, HUM REPROD, V16, P1512, DOI 10.1093/humrep/16.7.1512; Bodnar LM, 2007, J NUTR, V137, P447, DOI 10.1093/jn/137.2.447; Chodick G, 2009, HUM BIOL, V81, P463, DOI 10.3378/027.081.0405; Crimmins EM, 2006, P NATL ACAD SCI USA, V103, P498, DOI 10.1073/pnas.0501470103; Crozier SR, 2012, AM J CLIN NUTR, V96, P57, DOI 10.3945/ajcn.112.037473; Doblhammer G, 2001, P NATL ACAD SCI USA, V98, P2934, DOI 10.1073/pnas.041431898; Doblhammer G., 2014, LATE LIFE LEGACY VER; FORSDAHL A, 1978, J EPIDEMIOL COMMUN H, V32, P34, DOI 10.1136/jech.32.1.34; Gezmish O, 2010, REPROD SCI, V17, P168, DOI 10.1177/1933719109349536; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; KELLER CA, 1983, AM J EPIDEMIOL, V118, P689, DOI 10.1093/oxfordjournals.aje.a113679; Kihlbom M, 2004, J BIOSOC SCI, V36, P561, DOI 10.1017/S002193200300628X; Krishnaveni GV, 2011, AM J CLIN NUTR, V93, P628, DOI 10.3945/ajcn.110.003921; Ludvigsson JF, 2009, EUR J EPIDEMIOL, V24, P659, DOI 10.1007/s10654-009-9350-y; McGrath JJ, 2010, ARCH GEN PSYCHIAT, V67, P889, DOI 10.1001/archgenpsychiatry.2010.110; Mirzaei F, 2011, ANN NEUROL, V70, P30, DOI 10.1002/ana.22456; Moore SE, 1997, NATURE, V388, P434, DOI 10.1038/41245; Nascimento FAM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041740; OECD, 2008, ED GLANC; ORME JE, 1963, BRIT J PSYCHOL, V54, P273, DOI 10.1111/j.2044-8295.1963.tb00882.x; Painter RC, 2005, REPROD TOXICOL, V20, P345, DOI 10.1016/j.reprotox.2005.04.005; Pasco JA, 2008, MED HYPOTHESES, V71, P266, DOI 10.1016/j.mehy.2008.01.033; Reffelmann T, 2011, J AM COLL CARDIOL, V57, P887, DOI 10.1016/j.jacc.2010.10.021; Rinaudo P, 2012, ANNU REV PHYSIOL, V74, P107, DOI 10.1146/annurev-physiol-020911-153245; Rousham EK, 1998, AUST NZ J PUBL HEAL, V22, P669, DOI 10.1111/j.1467-842X.1998.tb01467.x; Sachan A, 2005, AM J CLIN NUTR, V81, P1060; Sirin SR, 2005, REV EDUC RES, V75, P417, DOI 10.3102/00346543075003417; Socialstyrelsen, 2011, DODS 2010 CAUS DEATH; Vaiserman AM, 2003, J ANTI-AGING MED, V6, P11, DOI 10.1089/109454503765361542; van der Meer IM, 2006, AM J CLIN NUTR, V84, P350; Villar J, 1982, Obstet Gynecol Surv, V37, P499, DOI 10.1097/00006254-198208000-00001; WARD WP, 1987, ANN HUM BIOL, V14, P495, DOI 10.1080/03014468700009341	34	24	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56425	10.1371/journal.pone.0056425	http://dx.doi.org/10.1371/journal.pone.0056425			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	099EQ	23457566	Green Submitted, Green Published, gold			2022-12-25	WOS:000315603700053
J	Argimon, S; Alekseyenko, AV; DeSalle, R; Caufield, PW				Argimon, Silvia; Alekseyenko, Alexander V.; DeSalle, Rob; Caufield, Page W.			Phylogenetic Analysis of Glucosyltransferases and Implications for the Coevolution of Mutans Streptococci with Their Mammalian Hosts	PLOS ONE			English	Article							FUNCTIONAL DIVERGENCE; SOLUBLE GLUCAN; SWISS-MODEL; GTFC GENE; IN-SITU; EVOLUTION; BINDING; HYDROXYAPATITE; CARIOGENICITY; DIVERSITY	Glucosyltransferases (Gtfs) catalyze the synthesis of glucans from sucrose and are produced by several species of lactic-acid bacteria. The oral bacterium Streptococcus mutans produces large amounts of glucans through the action of three Gtfs. GtfD produces water-soluble glucan (WSG), GtfB synthesizes water-insoluble glucans (WIG) and GtfC produces mainly WIG but also WSG. These enzymes, especially those synthesizing WIG, are of particular interest because of their role in the formation of dental plaque, an environment where S. mutans can thrive and produce lactic acid, promoting the formation of dental caries. We sequenced the gtfB, gtfC and gtfD genes from several mutans streptococcal strains isolated from the oral cavity of humans and searched for their homologues in strains isolated from chimpanzees and macaque monkeys. The sequence data were analyzed in conjunction with the available Gtf sequences from other bacteria in the genera Streptococcus, Lactobacillus and Leuconostoc to gain insights into the evolutionary history of this family of enzymes, with a particular emphasis on S. mutans Gtfs. Our analyses indicate that streptococcal Gtfs arose from a common ancestral progenitor gene, and that they expanded to form two clades according to the type of glucan they synthesize. We also show that the clade of streptococcal Gtfs synthesizing WIG appeared shortly after the divergence of viviparous, dentate mammals, which potentially contributed to the formation of dental plaque and the establishment of several streptococci in the oral cavity. The two S. mutans Gtfs capable of WIG synthesis, GtfB and GtfC, are likely the product of a gene duplication event. We dated this event to coincide with the divergence of the genomes of ancestral early primates. Thus, the acquisition and diversification of S. mutans Gtfs predates modern humans and is unrelated to the increase in dietary sucrose consumption.	[Argimon, Silvia; Caufield, Page W.] NYU, Coll Dent, Dept Cariol & Comprehens Care, New York, NY 10003 USA; [Alekseyenko, Alexander V.] NYU, Sch Med, Ctr Hlth Informat & Bioinformat, New York, NY USA; [DeSalle, Rob] Amer Museum Nat Hist, Sackler Inst Comparat Genom, New York, NY 10024 USA	New York University; New York University; American Museum of Natural History (AMNH)	Argimon, S (corresponding author), NYU, Coll Dent, Dept Cariol & Comprehens Care, New York, NY 10003 USA.	sa91@nyu.edu		Alekseyenko, Alexander/0000-0002-5748-2085	National Institutes of Health (NIH)/National Institute of Dental and Craniofacial Research (NIDCR) [R01 DE13937]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE013937] Funding Source: NIH RePORTER	National Institutes of Health (NIH)/National Institute of Dental and Craniofacial Research (NIDCR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was funded by grant R01 DE13937 National Institutes of Health (NIH)/National Institute of Dental and Craniofacial Research (NIDCR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Abascal F, 2010, NUCLEIC ACIDS RES, V38, pW7, DOI 10.1093/nar/gkq291; Argimon S, 2011, J CLIN MICROBIOL, V49, P984, DOI 10.1128/JCM.01993-10; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; BEIGHTON D, 1977, J DENT RES, V56, P995, DOI 10.1177/00220345770560083101; BEIGHTON D, 1984, INT J SYST BACTERIOL, V34, P332, DOI 10.1099/00207713-34-3-332; Benton MJ, 2007, MOL BIOL EVOL, V24, P26, DOI 10.1093/molbev/msl150; Caufield PW, 2007, J BACTERIOL, V189, P1238, DOI 10.1128/JB.01183-06; CAUFIELD PW, 1989, J CLIN MICROBIOL, V27, P274, DOI 10.1128/JCM.27.2.274-278.1989; CAUFIELD PW, 1993, J DENT RES, V72, P37, DOI 10.1177/00220345930720010501; Chia JS, 1998, INFECT IMMUN, V66, P4797, DOI 10.1128/IAI.66.10.4797-4803.1998; Cordain L, 2005, AM J CLIN NUTR, V81, P341, DOI 10.1093/ajcn.81.2.341; Dean AM, 2007, NAT REV GENET, V8, P675, DOI 10.1038/nrg2160; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Gernhard T, 2008, J MATH BIOL, V57, P713, DOI 10.1007/s00285-008-0186-y; Gregoire S, 2011, APPL ENVIRON MICROB, V77, P6357, DOI 10.1128/AEM.05203-11; Gu X, 1999, MOL BIOL EVOL, V16, P1664, DOI 10.1093/oxfordjournals.molbev.a026080; Gu X, 2001, MOL BIOL EVOL, V18, P453, DOI 10.1093/oxfordjournals.molbev.a003824; Gu X, 2006, MOL BIOL EVOL, V23, P1937, DOI 10.1093/molbev/msl056; HAMADA S, 1980, MICROBIOL REV, V44, P331, DOI 10.1128/MMBR.44.2.331-384.1980; HANADA N, 1989, INFECT IMMUN, V57, P2079, DOI 10.1128/IAI.57.7.2079-2085.1989; HANADA N, 1988, INFECT IMMUN, V56, P1999, DOI 10.1128/IAI.56.8.1999-2005.1988; Hannig C, 2008, ARCH ORAL BIOL, V53, P1003, DOI 10.1016/j.archoralbio.2008.04.005; Hoekstra HE, 2007, EVOLUTION, V61, P995, DOI 10.1111/j.1558-5646.2007.00105.x; HOTZ P, 1972, CARIES RES, V6, P103, DOI 10.1159/000259783; Huelsenbeck JP, 1997, ANNU REV ECOL SYST, V28, P437, DOI 10.1146/annurev.ecolsys.28.1.437; Ito K, 2011, J MOL BIOL, V408, P177, DOI 10.1016/j.jmb.2011.02.028; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Kopec LK, 1997, GLYCOBIOLOGY, V7, P929, DOI 10.1093/glycob/7.7.929; KURAMITSU HK, 1993, CRIT REV ORAL BIOL M, V4, P159, DOI 10.1177/10454411930040020201; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Loesche W.J., 1993, DENT CARIES TREATABL; LOESCHE WJ, 1986, MICROBIOL REV, V50, P353, DOI 10.1128/MMBR.50.4.353-380.1986; Matsumoto M, 2006, ORAL MICROBIOL IMMUN, V21, P42, DOI 10.1111/j.1399-302X.2005.00252.x; Mattos-Graner RO, 2004, J CLIN MICROBIOL, V42, P4586, DOI 10.1128/JCM.42.10.4586-4592.2004; Mattos-Graner RO, 2000, J DENT RES, V79, P1371, DOI 10.1177/00220345000790060401; Milton K, 1999, NUTRITION, V15, P488, DOI 10.1016/S0899-9007(99)00078-7; Monchois V, 1999, FEMS MICROBIOL REV, V23, P131, DOI 10.1016/S0168-6445(98)00041-2; Monsan P, 2001, INT DAIRY J, V11, P675, DOI 10.1016/S0958-6946(01)00113-3; MUNRO C, 1991, INFECT IMMUN, V59, P2316, DOI 10.1128/IAI.59.7.2316-2323.1991; Okamoto M, 2012, INT J SYST EVOL MICR; Ooshima T, 2001, J DENT RES, V80, P1672, DOI 10.1177/00220345010800071401; Pond SLK, 2006, BIOINFORMATICS, V22, P3096, DOI 10.1093/bioinformatics/btl474; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Pond SLK, 2005, BIOINFORMATICS, V21, P2531, DOI 10.1093/bioinformatics/bti320; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Porollo A, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-316; SCHILLING KM, 1992, INFECT IMMUN, V60, P284, DOI 10.1128/IAI.60.1.284-295.1992; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; SHIMAMURA A, 1994, J BACTERIOL, V176, P4845, DOI 10.1128/jb.176.16.4845-4850.1994; Simpson Christine L, 1995, Microbiology (Reading), V141 ( Pt 6), P1451, DOI 10.1099/13500872-141-6-1451; SWOFFORD DL, 2001, PHYLOGENETIC ANAL US; Tamesada M, 2004, J DENT RES, V83, P874, DOI 10.1177/154405910408301110; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thurnheer T, 2006, CARIES RES, V40, P163, DOI 10.1159/000091065; Tsumori H, 1997, ORAL MICROBIOL IMMUN, V12, P274, DOI 10.1111/j.1399-302X.1997.tb00391.x; UEDA S, 1988, MOL MICROBIOL, V2, P135, DOI 10.1111/j.1365-2958.1988.tb00014.x; UEDA S, 1988, GENE, V69, P101, DOI 10.1016/0378-1119(88)90382-4; Vacca-Smith AM, 1998, ARCH ORAL BIOL, V43, P103, DOI 10.1016/S0003-9969(97)00111-8; VaccaSmith AM, 1996, ARCH ORAL BIOL, V41, P291, DOI 10.1016/0003-9969(95)00129-8; van Hijum SAFT, 2006, MICROBIOL MOL BIOL R, V70, P157, DOI 10.1128/MMBR.70.1.157-176.2006; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Wilkinson RD, 2011, SYST BIOL, V60, P16, DOI 10.1093/sysbio/syq054; YAMASHITA Y, 1992, INFECT IMMUN, V60, P1618, DOI 10.1128/IAI.60.4.1618-1624.1992; Zhang JZ, 2003, TRENDS ECOL EVOL, V18, P292, DOI 10.1016/S0169-5347(03)00033-8; Zheng Y, 2007, J EXP ZOOL PART B, V308B, P85, DOI 10.1002/jez.b.21140; [No title captured]	71	23	25	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56305	10.1371/journal.pone.0056305	http://dx.doi.org/10.1371/journal.pone.0056305			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457545	Green Published, gold, Green Submitted			2022-12-25	WOS:000315602700064
J	Ji, HX; Zou, YL; Duan, JJ; Jia, ZR; Li, XJ; Wang, Z; Li, L; Li, YW; Liu, GY; Tong, MQ; Li, XY; Zhang, GH; Dai, XR; He, L; Li, ZY; Cao, C; Yang, Y				Ji, Hai-xia; Zou, Yu-lian; Duan, Jing-jing; Jia, Zhi-rong; Li, Xian-jing; Wang, Zhuo; Li, Li; Li, Yong-wen; Liu, Gen-yan; Tong, Ming-Qing; Li, Xiao-yi; Zhang, Guo-hui; Dai, Xiang-rong; He, Ling; Li, Zhi-yu; Cao, Cong; Yang, Yong			The Synthetic Melanocortin (CKPV)(2) Exerts Anti-Fungal and Anti-Inflammatory Effects against Candida albicans Vaginitis via Inducing Macrophage M-2 Polarization	PLOS ONE			English	Article							VULVO-VAGINAL CANDIDIASIS; STIMULATING HORMONE PEPTIDES; ALPHA-MSH; TNF-ALPHA; ACTIVATION; CELLS; RECEPTOR; LIPOPOLYSACCHARIDE; EXPRESSION; SYSTEM	In this study, we examined anti-fungal and anti-inflammatory effects of the synthetic melanocortin peptide (Ac-Cys-Lys-Pro-Val-NH2)(2) or (CKPV)(2) against Candida albicans vaginitis. Our in vitro results showed that (CKPV)(2) dose-dependently inhibited Candida albicans colonies formation. In a rat Candida albicans vaginitis model, (CKPV)(2) significantly inhibited vaginal Candida albicans survival and macrophages sub-epithelial mucosa infiltration. For mechanisms study, we observed that (CKPV)(2) inhibited macrophages phagocytosis of Candida albicans. Meanwhile, (CKPV)(2) administration inhibited macrophage pro-inflammatory cytokines (TNF-alpha, IL-1 beta and IL-6) release, while increasing the arginase activity and anti-inflammatory cytokine IL-10 production, suggesting macrophages M1 to M2 polarization. Cyclic AMP (cAMP) production was also induced by (CKPV)(2) administration in macrophages. These above effects on macrophages by (CKPV)(2) were almost reversed by melanocortin receptor-1(MC1R) siRNA knockdown, indicating the requirement of MC1R in the process. Altogether, our results suggest that (CKPV)(2) exerted anti-fungal and anti-inflammatory activities against Candida albicans vaginitis probably through inducing macrophages M1 to M2 polarization and MC1R activation.	[Ji, Hai-xia; Zou, Yu-lian; Duan, Jing-jing; Jia, Zhi-rong; Li, Xian-jing; Wang, Zhuo; He, Ling; Li, Zhi-yu; Yang, Yong] China Pharmaceut Univ, State Key Lab Nat Med, Acad Inst Pharmaceut Sci, Nanjing, Jiangsu, Peoples R China; [Li, Li; Li, Yong-wen] Guilin Med Univ, Dept Pharmacol, Dept Physiol, Guilin, Guangxi, Peoples R China; [Liu, Gen-yan; Tong, Ming-Qing] Nanjing Med Univ, Dept Lab Med, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China; [Cao, Cong] Soochow Univ, Inst Neurosci, Suzhou, Jiangsu, Peoples R China; [Li, Xiao-yi; Zhang, Guo-hui; Dai, Xiang-rong] Hefei Zhaoke Pharmaceut, Hefei, Peoples R China	China Pharmaceutical University; Guilin Medical University; Nanjing Medical University; Soochow University - China	Li, ZY (corresponding author), China Pharmaceut Univ, State Key Lab Nat Med, Acad Inst Pharmaceut Sci, Nanjing, Jiangsu, Peoples R China.	zhiyuli@263.net; caocong@suda.edu.cn; valianty@hotmail.com			National Natural Science Foundation of China [91129731, 81072661]; Project Program of State Key Laboratory of Natural Medicines, China Pharmaceutical University [JKGZ201102]; New Century Excellent Talents Program for YY; Ministry of Education of China [NCET-09-0771]; Natural Science Foundation of Jiangsu Province [BK2012025, BK2011632]; "Major Drug Discovery" science and technology major projects of China [2011ZX09102-001-20]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Project Program of State Key Laboratory of Natural Medicines, China Pharmaceutical University; New Century Excellent Talents Program for YY(Program for New Century Excellent Talents in University (NCET)); Ministry of Education of China(Ministry of Education, China); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); "Major Drug Discovery" science and technology major projects of China	This work was supported by the National Natural Science Foundation of China (Nos. 91129731 and 81072661), the Project Program of State Key Laboratory of Natural Medicines, China Pharmaceutical University (No. JKGZ201102), the New Century Excellent Talents Program for YY supported by Ministry of Education of China (NCET-09-0771), the Natural Science Foundation of Jiangsu Province (No. BK2012025 and BK2011632), "Major Drug Discovery" science and technology major projects of China (No. 2011ZX09102-001-20). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badylak SF, 2008, TISSUE ENG PT A, V14, P1835, DOI 10.1089/ten.tea.2007.0264; Ballinger MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013962; Bonetto S, 2005, PEPTIDES, V26, P2302, DOI 10.1016/j.peptides.2005.04.002; Capsoni F, 2007, PEPTIDES, V28, P2016, DOI 10.1016/j.peptides.2007.08.001; Capsoni F, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2827; Carrara MA, 2010, MYCOPATHOLOGIA, V170, P331, DOI 10.1007/s11046-010-9326-1; Catania A, 2006, THESCIENTIFICWORLDJO, V6, P1241, DOI 10.1100/tsw.2006.227; Catania A, 2005, J PEPT RES, V66, P19, DOI 10.1111/j.1399-3011.2005.00265.x; Chen JY, 2009, J WOMENS HEALTH, V18, P1997, DOI 10.1089/jwh.2008.1088; Cragnolini AB, 2006, NEUROSCI LETT, V409, P168, DOI 10.1016/j.neulet.2006.09.034; Cutuli M, 2000, J LEUKOCYTE BIOL, V67, P233, DOI 10.1002/jlb.67.2.233; Fidel Paul L Jr, 2002, Int Rev Immunol, V21, P515, DOI 10.1080/08830180215015; Fidel PL, 1996, CLIN MICROBIOL REV, V9, P335, DOI 10.1128/CMR.9.3.335; FIDEL PL, 1993, INFECT IMMUN, V61, P1990, DOI 10.1128/IAI.61.5.1990-1995.1993; Fong IW, 1996, PHARMACOECONOMICS, V9, P497, DOI 10.2165/00019053-199609060-00004; Gatti S, 2006, J SURG RES, V131, P209, DOI 10.1016/j.jss.2005.08.009; Getting SJ, 2002, TRENDS PHARMACOL SCI, V23, P447, DOI 10.1016/S0165-6147(02)02103-X; Getting SJ, 2003, J PHARMACOL EXP THER, V306, P631, DOI 10.1124/jpet.103.051623; Hill RP, 2006, PEPTIDES, V27, P421, DOI 10.1016/j.peptides.2005.03.061; Humphreys DT, 1999, CYTOKINE, V11, P773, DOI 10.1006/cyto.1998.0492; Kim J, 2011, J MICROBIOL, V49, P171, DOI 10.1007/s12275-011-1064-7; Lam CW, 2006, PEPTIDES, V27, P404, DOI 10.1016/j.peptides.2005.01.031; Li DY, 2008, J LEUKOCYTE BIOL, V84, P191, DOI 10.1189/jlb.0707463; Liu X, 2012, EUR J CELL BIOL; Maaser C, 2006, GUT, V55, P1415, DOI 10.1136/gut.2005.083634; Madhuri, 2009, PEPTIDES, V30, P1627, DOI 10.1016/j.peptides.2009.06.020; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692; MCGILLIS JP, 1989, BIOCHEM BIOPH RES CO, V165, P935, DOI 10.1016/0006-291X(89)92693-4; Medrek C, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-306; Moon EY, 2007, IMMUNOL LETT, V110, P121, DOI 10.1016/j.imlet.2007.04.002; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Motran CC, 2002, J LEUKOCYTE BIOL, V72, P512; Newton RA, 2005, PEPTIDES, V26, P1818, DOI 10.1016/j.peptides.2004.11.031; Pander J, 2011, CLIN CANCER RES, V17, P5668, DOI 10.1158/1078-0432.CCR-11-0239; Prabhu NV, 1999, J PEPT RES, V54, P394, DOI 10.1034/j.1399-3011.1999.00113.x; Quayle AJ, 2002, J REPROD IMMUNOL, V57, P61, DOI 10.1016/S0165-0378(02)00019-0; Raap U, 2003, J IMMUNOL, V171, P353, DOI 10.4049/jimmunol.171.1.353; Schenk M, 2007, SEMIN IMMUNOL, V19, P84, DOI 10.1016/j.smim.2006.09.002; Schleicher Ulrike, 2009, V531, P203, DOI 10.1007/978-1-59745-396-7_14; Seong I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031477; Shiau MY, 2001, MEDIAT INFLAMM, V10, P199, DOI 10.1080/09629350120080393; Singh V, 2005, BIOCHEM BIOPH RES CO, V334, P1149, DOI 10.1016/j.bbrc.2005.07.018; Sobel JD, 1998, AM J OBSTET GYNECOL, V178, P203, DOI 10.1016/S0002-9378(98)80001-X; SOBEL JD, 1985, AM J OBSTET GYNECOL, V152, P924, DOI 10.1016/S0002-9378(85)80003-X; Stringaro A, 1998, MYCOPATHOLOGIA, V144, P147, DOI 10.1023/A:1007017012547; Szardenings M, 2000, PEPTIDES, V21, P239, DOI 10.1016/S0196-9781(99)00207-7; Tansini A, 2009, SCAND J IMMUNOL, V69, P310, DOI 10.1111/j.1365-3083.2008.02212.x; Ydens E, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-176; Yoon SW, 2003, J BIOL CHEM, V278, P32914, DOI 10.1074/jbc.M302444200	50	10	13	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56004	10.1371/journal.pone.0056004	http://dx.doi.org/10.1371/journal.pone.0056004			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457491	Green Submitted, gold, Green Published			2022-12-25	WOS:000315602700031
J	Moll, S; Ebeling, M; Weibel, F; Farina, A; Del Rosario, AA; Hoflack, JC; Pomposiello, S; Prunotto, M				Moll, Solange; Ebeling, Martin; Weibel, Franziska; Farina, Annarita; Del Rosario, Andrea Araujo; Hoflack, Jean Christophe; Pomposiello, Silvia; Prunotto, Marco			Epithelial Cells as Active Player In Fibrosis: Findings from an In Vitro Model	PLOS ONE			English	Article							ACUTE KIDNEY INJURY; PROXIMAL TUBULE; GROWTH-FACTOR; BETA ANTIBODY; TISSUE; FIBROBLASTS; PROGRESSION; EXPRESSION; INDUCTION; AUTOPHAGY	Kidney fibrosis, a scarring of the tubulo-interstitial space, is due to activation of interstitial myofibroblasts recruited locally or systemically with consecutive extracellular matrix deposition. Newly published clinical studies correlating acute kidney injury (AKI) to chronic kidney disease (CKD) challenge this pathological concept putting tubular epithelial cells into the spotlight. In this work we investigated the role of epithelial cells in fibrosis using a simple controlled in vitro system. An epithelial/mesenchymal 3D cell culture model composed of human proximal renal tubular cells and fibroblasts was challenged with toxic doses of Cisplatin, thus injuring epithelial cells. RT-PCR for classical fibrotic markers was performed on fibroblasts to assess their modulation toward an activated myofibroblast phenotype in presence or absence of that stimulus. Epithelial cell lesion triggered a phenotypical modulation of fibroblasts toward activated myofibroblasts as assessed by main fibrotic marker analysis. Uninjured 3D cell culture as well as fibroblasts alone treated with toxic stimulus in the absence of epithelial cells were used as control. Our results, with the caveats due to the limited, but highly controllable and reproducible in vitro approach, suggest that epithelial cells can control and regulate fibroblast phenotype. Therefore they emerge as relevant target cells for the development of new preventive anti-fibrotic therapeutic approaches.	[Moll, Solange] Univ Hosp Geneva, Inst Clin Pathol, Geneva, Switzerland; [Weibel, Franziska; Del Rosario, Andrea Araujo] F Hoffmann La Roche & Co Ltd, CV & Metab DTA Dept, CH-4002 Basel, Switzerland; [Farina, Annarita] Univ Geneva, Bioinformat & Struct Biol Dept, Geneva, Switzerland	University of Geneva; Roche Holding; University of Geneva	Prunotto, M (corresponding author), F Hoffmann La Roche & Co Ltd, Nonclin Safety, CH-4002 Basel, Switzerland.	marco.prunotto@roche.com	Farina, Annarita/Y-7835-2019	Farina, Annarita/0000-0002-0099-4557				Abbate M, 2002, KIDNEY INT, V61, P2066, DOI 10.1046/j.1523-1755.2002.00380.x; ALPERS CE, 1994, J AM SOC NEPHROL, V5, P201; Breit SN, 2012, NEPHROL DIAL TRANSPL, V27, P70, DOI 10.1093/ndt/gfr575; Chawla LS, 2012, KIDNEY INT, V82, P516, DOI 10.1038/ki.2012.208; Chawla LS, 2011, KIDNEY INT, V79, P1361, DOI 10.1038/ki.2011.42; Denton CP, 2007, ARTHRITIS RHEUM-US, V56, P323, DOI 10.1002/art.22289; Ebrahimkhani MR, 2011, NAT MED, V17, P1668, DOI 10.1038/nm.2490; Farris AB, 2011, J AM SOC NEPHROL, V22, P176, DOI 10.1681/ASN.2009091005; FINE LG, 1995, KIDNEY INT, V47, pS48; Fukasawa H, 2004, KIDNEY INT, V65, P63, DOI 10.1111/j.1523-1755.2004.00393.x; GABBIANI G, 1971, EXPERIENTIA, V27, P549, DOI 10.1007/BF02147594; Goffin JM, 2006, J CELL BIOL, V172, P259, DOI 10.1083/jcb.200506179; Grgic I, 2012, KIDNEY INT, V82, P172, DOI 10.1038/ki.2012.20; HARPER JW, 1993, CELL, V75, P805; Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112; Inoue T, 2002, FASEB J, V16, P268, DOI 10.1096/fj.02-0442fje; Jiang HJ, 2009, DIABETES-METAB RES, V25, P232, DOI 10.1002/dmrr.940; Johnson DW, 1998, KIDNEY INT, V54, P747, DOI 10.1046/j.1523-1755.1998.00048.x; Kern EFO, 2010, AM J KIDNEY DIS, V55, P824, DOI 10.1053/j.ajkd.2009.11.009; Kilic A, 2011, J ALLERGY CLIN IMMUN, V128, P1058, DOI 10.1016/j.jaci.2011.06.017; Koesters R, 2010, AM J PATHOL, V177, P632, DOI 10.2353/ajpath.2010.091012; Lewis MP, 1996, KIDNEY INT, V49, P48, DOI 10.1038/ki.1996.7; Li YJ, 2012, KIDNEY INT, V81, P880, DOI 10.1038/ki.2011.469; McCormick LL, 1999, J IMMUNOL, V163, P5693; Megyesi J, 1999, P NATL ACAD SCI USA, V96, P10830, DOI 10.1073/pnas.96.19.10830; Nath KA, 2000, KIDNEY INT, V57, P2423, DOI 10.1046/j.1523-1755.2000.00101.x; Simonson MS, 2012, AM J PHYSIOL-RENAL, V302, pF820, DOI 10.1152/ajprenal.00424.2011; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Takahashi A, 2012, AM J PATHOL, V180, P517, DOI 10.1016/j.ajpath.2011.11.001; Tu ZD, 2007, NEPHROLOGY, V12, P166, DOI 10.1111/j.1440-1797.2007.00772.x; Udo K, 2010, KIDNEY INT, V78, P60, DOI 10.1038/ki.2010.68; Vallon V, 2011, AM J PHYSIOL-REG I, V300, pR1009, DOI 10.1152/ajpregu.00809.2010; Waalen J, 2011, EUR J HAEMATOL, V87, P107, DOI 10.1111/j.1600-0609.2011.01631.x; Wang ZY, 2011, KIDNEY INT, V79, P861, DOI 10.1038/ki.2010.527; Yang L., NAT MED, V16, P143; Yang L, 2010, NAT MED, V16, P535, DOI 10.1038/nm.2144; Ziyadeh FN, 2000, P NATL ACAD SCI USA, V97, P8015, DOI 10.1073/pnas.120055097	37	35	38	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56575	10.1371/journal.pone.0056575	http://dx.doi.org/10.1371/journal.pone.0056575			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457584	gold, Green Published, Green Submitted			2022-12-25	WOS:000315602700080
J	Makris, EA; MacBarb, RF; Responte, DJ; Hu, JC; Athanasiou, KA				Makris, Eleftherios A.; MacBarb, Regina F.; Responte, Donald J.; Hu, Jerry C.; Athanasiou, Kyriacos A.			A copper sulfate and hydroxylysine treatment regimen for enhancing collagen cross-linking and biomechanical properties in engineered neocartilage	FASEB JOURNAL			English	Article						articular cartilage regeneration; covalent intermolecular bonds; scaffoldless self-assembly	BOVINE ARTICULAR-CARTILAGE; MECHANICAL-PROPERTIES; LYSYL OXIDASE; CHONDROITINASE-ABC; IN-VITRO; STREPTOCOCCUS FAECALIS; EXTRACELLULAR-MATRIX; CHONDROCYTES; NETWORK; PROTEOGLYCAN	The objective of this study was to improve the biomechanical properties of engineered neotissues through promoting the development of collagen cross-links. It was hypothesized that supplementing medium with copper sulfate and the amino acid hydroxylysine would enhance the activity of lysyl oxidase enzyme to form collagen cross-links, increasing the strength and integrity of the neotissue. Neocartilage constructs were generated using a scaffoldless, self-assembling process and treated with copper sulfate and hydroxylysine, either alone or in combination, following a 2-factor, full-factorial study design. Following a 6-wk culture period, the biomechanical and biochemical properties of the constructs were measured. Results found copper sulfate to significantly increase pyridinoline (PYR) cross-links in all copper sulfate-containing groups over controls. When copper sulfate and hydroxylysine were combined, the result was synergistic, with a 10-fold increase in PYR content over controls. This increase in PYR cross-links manifested in a 3.3-fold significant increase in the tensile properties of the copper sulfate + hydroxylysine group. In addition, an 123% increase over control values was detected in the copper sulfate group in terms of the aggregate modulus. These data elucidate the role of copper sulfate and hydroxylysine toward improving the biomechanical properties of neotissues through collagen cross-linking enhancement.-Makris, E. A., MacBarb, R. F., Responte, D. J., Hu, J. C., Athanasiou, K. A. A copper sulfate and hydroxylysine treatment regimen for enhancing collagen cross-linking and biomechanical properties in engineered neocartilage.	[Makris, Eleftherios A.; MacBarb, Regina F.; Responte, Donald J.; Hu, Jerry C.; Athanasiou, Kyriacos A.] Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA; [Makris, Eleftherios A.] Univ Thessaly Biomed, Dept Orthoped Surg & Musculoskeletal Trauma, Larisa, Greece	University of California System; University of California Davis	Athanasiou, KA (corresponding author), Univ Calif Davis, Dept Biomed Engn, 1 Shields Ave, Davis, CA 95616 USA.	athanasiou@ucdavis.edu			U.S. National Institutes of Health [R01AR053286]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053286] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was funded by U.S. National Institutes of Health grant R01AR053286. The funding source did not have a role in the collection, analysis, and interpretation of data. The authors declare no conflicts of interest.	Asanbaeva A, 2008, OSTEOARTHR CARTILAGE, V16, P1, DOI 10.1016/j.joca.2007.05.019; Asanbaeva A, 2007, ARTHRITIS RHEUM, V56, P188, DOI 10.1002/art.22298; ATHANASIOU KA, 1995, CLIN ORTHOP RELAT R, P254; Bank RA, 1997, J CHROMATOGR B, V703, P37, DOI 10.1016/S0378-4347(97)00391-5; Basser PJ, 1998, ARCH BIOCHEM BIOPHYS, V351, P207, DOI 10.1006/abbi.1997.0507; Bassleer CT, 1998, OSTEOARTHR CARTILAGE, V6, P196, DOI 10.1053/joca.1998.0112; Bastiaansen-Jenniskens YM, 2008, OSTEOARTHR CARTILAGE, V16, P359, DOI 10.1016/j.joca.2007.07.003; Beekman B, 1997, EXP CELL RES, V237, P135, DOI 10.1006/excr.1997.3771; Buckwalter JA, 1998, AAOS INSTR COURS LEC, V47, P477; Chen AC, 2001, J BIOMECH, V34, P1, DOI 10.1016/S0021-9290(00)00170-6; Cox TR, 2011, DIS MODEL MECH, V4, P165, DOI 10.1242/dmm.004077; Dahl SLM, 2005, CELL TRANSPLANT, V14, P861; Eyre DR, 2008, METHODS, V45, P65, DOI 10.1016/j.ymeth.2008.01.002; EYRE DR, 1991, J RHEUMATOL, V18, P49; Ficklin T, 2007, J BIOMECH, V40, P3607, DOI 10.1016/j.jbiomech.2007.06.005; Gabay C, 2011, ARTHRITIS RHEUM-US, V63, P3383, DOI 10.1002/art.30574; Greenwood D., 2003, ANTIBIOT CHEMOTHER, V8, P11; Heraud F, 2002, SCAND J RHEUMATOL, V31, P279, DOI 10.1080/030097402760375179; Hootman JM, 2006, ARTHRITIS RHEUM-US, V54, P226, DOI 10.1002/art.21562; Hu JC, 2006, TISSUE ENG, V12, P969, DOI 10.1089/ten.2006.12.969; KAGAN HM, 1982, METHOD ENZYMOL, V82, P637; Khalsa PS, 1997, J BIOMECH, V30, P589, DOI 10.1016/S0021-9290(97)84508-3; Lawrence RC, 1998, ARTHRITIS RHEUM-US, V41, P778, DOI 10.1002/1529-0131(199805)41:5<778::AID-ART4>3.0.CO;2-V; MacBarb RF, 2013, ACTA BIOMATER, V9, P4626, DOI 10.1016/j.actbio.2012.09.037; MECHANIC G, 1971, BIOCHEM BIOPH RES CO, V45, P644, DOI 10.1016/0006-291X(71)90465-7; Mow Van C., 1997, P113; MOW VC, 1992, BIOMATERIALS, V13, P67, DOI 10.1016/0142-9612(92)90001-5; Ofek G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002795; OPSAHL W, 1982, J NUTR, V112, P708, DOI 10.1093/jn/112.4.708; Pasqualicchio M, 1996, MEDIAT INFLAMM, V5, P95, DOI 10.1155/S0962935196000154; POLAN CE, 1967, J NUTR, V91, P143, DOI 10.1093/jn/91.2.143; Responte DJ, 2012, FASEB J, V26, P3614, DOI 10.1096/fj.12-207241; Responte DJ, 2012, BIOMATERIALS, V33, P3187, DOI 10.1016/j.biomaterials.2012.01.028; Riesle J, 1998, J CELL BIOCHEM, V71, P313, DOI 10.1002/(SICI)1097-4644(19981201)71:3<313::AID-JCB1>3.0.CO;2-C; Rivard CH, 1996, ANN CHIR, V50, P651; ROSENBLOOM J, 1971, J BIOL CHEM, V246, P1549; Rosenzweig DH, 2012, TISSUE ENG PT A, V18, P2466, DOI [10.1089/ten.tea.2012.0215, 10.1089/ten.TEA.2012.0215]; ROWLEY DA, 1983, ARCH BIOCHEM BIOPHYS, V225, P279, DOI 10.1016/0003-9861(83)90031-0; ROWLEY DA, 1983, CLIN SCI, V64, P649, DOI 10.1042/cs0640649; Royce PM, 2002, CONNECTIVE TISSUE IT; SCARPA M, 1983, J BIOL CHEM, V258, P6695; Siegel R C, 1979, Int Rev Connect Tissue Res, V8, P73; SIEGEL RC, 1976, J BIOL CHEM, V251, P5779; Sieibel M. J., 2006, DYNAMICS BONE CARTIL; SINEX FM, 1955, J BIOL CHEM, V216, P245; SMITH WG, 1964, J BIOL CHEM, V239, P1867; Summey BT, 2002, J ORTHOP RES, V20, P76, DOI 10.1016/S0736-0266(01)00064-X; TINKER D, 1985, PHYSIOL REV, V65, P607, DOI 10.1152/physrev.1985.65.3.607; TSUNG CM, 1962, J BIOL CHEM, V237, P1194; Wandel S, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4675; Wang SX, 1996, SCIENCE, V273, P1078, DOI 10.1126/science.273.5278.1078; Williamson AK, 2003, J ORTHOPAED RES, V21, P872, DOI 10.1016/S0736-0266(03)00030-5; Williamson AK, 2001, J ORTHOPAED RES, V19, P1113, DOI 10.1016/S0736-0266(01)00052-3	53	46	46	0	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	JUN	2013	27	6					2421	2430		10.1096/fj.12-224030	http://dx.doi.org/10.1096/fj.12-224030			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	154II	23457219	Green Published			2022-12-25	WOS:000319667600029
J	Yang, JW; Huang, HS; Yang, HP; He, XB; Jiang, X; Shi, Y; Alatangaole, D; Shi, LG; Zhou, NM				Yang, Jingwen; Huang, Haishan; Yang, Huipeng; He, Xiaobai; Jiang, Xue; Shi, Ying; Alatangaole, Damirin; Shi, Liangen; Zhou, Naiming			Specific Activation of the G Protein-coupled Receptor BNGR-A21 by the Neuropeptide Corazonin from the Silkworm, Bombyx mori, Dually Couples to the G(q) and G(s) Signaling Cascades	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-GAMMA-SUBUNITS; FUNCTIONAL-CHARACTERIZATION; ADIPOKINETIC HORMONE; NONVISUAL ARRESTIN; DARK-COLOR; IDENTIFICATION; EXPRESSION; STIMULATION; GENE; NEUROHORMONE	Corazonin, an undecapeptide neurohormone sharing a highly conserved amino acid sequence across Insecta, plays different physiological roles in the regulation of heart contraction rates, silk spinning rates, the induction of dark color and morphometric phase changes, and ecdysis. Corazonin receptors have been identified in Drosophila melanogaster, Manduca sexta, and Musca domestica. However, detailed information on the signaling and major physiological functions of corazonin and its receptor is largely unknown. In the current study, using both the mammalian cell line HEK293 and insect cell lines BmN and Sf21, we paired the Bombyx corazonin neuropeptide as a specific endogenous ligand for the Bombyx neuropeptide G protein-coupled receptor A21 (BNGR-A21), and we therefore designated this receptor as BmCrzR. Further characterization indicated that synthetic BmCrz demonstrated a high affinity for and activated BmCrzR, resulting in intracellular cAMP accumulation, Ca2+ mobilization, and ERK1/2 phosphorylation via the G(q)- and G(s)-coupled signaling pathways. The direct interaction of BmCrzR with BmCrz was confirmed by a rhodamine-labeled BmCrz peptide. Moreover, experiments with double-stranded RNA and synthetic peptide injection suggested a possible role of BmCrz/BmCrzR in the regulation of larval growth and spinning rate. Our present results provide the first in-depth information on BmCrzR-mediated signaling for further elucidation of the BmCrz/BmCrzR system in the regulation of fundamental physiological processes.	[Yang, Jingwen; Jiang, Xue; Shi, Liangen] Zhejiang Univ, Coll Anim Sci, Dept Econ Zool, Hangzhou 310058, Zhejiang, Peoples R China; [Yang, Huipeng; He, Xiaobai; Shi, Ying; Zhou, Naiming] Zhejiang Univ, Coll Life Sci, Inst Biochem, Hangzhou 310058, Zhejiang, Peoples R China; [Huang, Haishan] Wenzhou Med Coll, Sch Life Sci, Zhejiang Prov Key Lab Model Organisms, Wenzhou 325035, Zhejiang, Peoples R China; [Alatangaole, Damirin] Inner Mongolia Univ, Coll Life Sci, Dept Biochem & Mol Biol, Hohhot 010021, Inner Mongolia, Peoples R China	Zhejiang University; Zhejiang University; Wenzhou Medical University; Inner Mongolia University	Shi, LG (corresponding author), Zhejiang Univ, Coll Anim Sci, Dept Econ Zool, Zijingang Campus, Hangzhou 310058, Zhejiang, Peoples R China.	slgsilk@zju.edu.cn; znm2000@yahoo.com	Zhou, Naiming/AHC-1121-2022		Ministry of Science and Technology of China [2012CB910402]; National Natural Science Foundation of China [31072090, 31272375]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Ministry of Science and Technology of China Grants 2012CB910402 and the National Natural Science Foundation of China Grants 31072090 and 31272375.	Barak LS, 1997, J BIOL CHEM, V272, P27497, DOI 10.1074/jbc.272.44.27497; Belmont M, 2006, BIOCHEM BIOPH RES CO, V344, P160, DOI 10.1016/j.bbrc.2006.03.117; Bergland AO, 2012, PLOS GENET, V8, P215, DOI 10.1371/journal.pgen.1002631; Boerjan B, 2010, GEN COMP ENDOCR, V166, P222, DOI 10.1016/j.ygcen.2009.09.004; Callaghan B, 2006, AM J PHYSIOL-HEART C, V291, pH2541, DOI 10.1152/ajpheart.00420.2006; Cazzamali G, 2002, BIOCHEM BIOPH RES CO, V298, P31, DOI 10.1016/S0006-291X(02)02398-7; Chen Z, 2001, CHEM REV, V101, P2449, DOI 10.1021/cr000241p; Choi SH, 2008, J COMP NEUROL, V507, P1184, DOI 10.1002/cne.21594; Cvejic S, 2004, NAT CELL BIOL, V6, P540, DOI 10.1038/ncb1133; Fan Y, 2010, INSECT BIOCHEM MOLEC, V40, P581, DOI 10.1016/j.ibmb.2010.05.005; Gade G, 1997, PHYSIOL REV, V77, P963, DOI 10.1152/physrev.1997.77.4.963; Grach C, 2004, PHYSIOL ENTOMOL, V29, P97, DOI 10.1111/j.1365-3032.2004.00370.x; Hansen KK, 2010, J BIOL CHEM, V285, P10736, DOI 10.1074/jbc.M109.045369; Hauser F, 2008, FRONT NEUROENDOCRIN, V29, P142, DOI 10.1016/j.yfrne.2007.10.003; Hillyer JF, 2012, INSECT MOL BIOL, V21, P343, DOI 10.1111/j.1365-2583.2012.01140.x; HORIE K, 1995, MOL PHARMACOL, V48, P392; Hua YJ, 2000, J INSECT PHYSIOL, V46, P853, DOI 10.1016/S0022-1910(99)00173-0; Johnson EC, 2003, J BIOL CHEM, V278, P52172, DOI 10.1074/jbc.M306756200; Johnson EC, 2008, INSECT BIOCHEM MOLEC, V38, P1016, DOI 10.1016/j.ibmb.2008.09.003; Kapan N, 2012, CELL MOL LIFE SCI, V69, P4051, DOI 10.1007/s00018-012-1097-z; Kaufmann C, 2009, INSECT BIOCHEM MOLEC, V39, P770, DOI 10.1016/j.ibmb.2009.09.002; Kim YJ, 2004, P NATL ACAD SCI USA, V101, P6704, DOI 10.1073/pnas.0305291101; Kuhn B, 1996, MOL ENDOCRINOL, V10, P1697, DOI 10.1210/me.10.12.1697; Lee G, 2008, CELL TISSUE RES, V331, P659, DOI 10.1007/s00441-007-0549-5; Li G, 2011, J BIOL CHEM, V286, P31199, DOI 10.1074/jbc.M111.241372; Maruko T, 2005, N-S ARCH PHARMACOL, V372, P153, DOI 10.1007/s00210-005-0001-x; Park Y, 2002, P NATL ACAD SCI USA, V99, P11423, DOI 10.1073/pnas.162276199; Pierce KL, 2001, ONCOGENE, V20, P1532, DOI 10.1038/sj.onc.1204184; Predel R, 2007, PEPTIDES, V28, P3, DOI 10.1016/j.peptides.2006.10.011; Qi-Miao S, 2003, EUR J ENTOMOL, V100, P283, DOI 10.14411/eje.2003.044; Roch GJ, 2011, GEN COMP ENDOCR, V171, P1, DOI 10.1016/j.ygcen.2010.12.014; Roller L, 2008, INSECT BIOCHEM MOLEC, V38, P1147, DOI 10.1016/j.ibmb.2008.04.009; Roman G, 2000, GENETICS, V155, P1281; Roy SJ, 2010, EUR J PHARMACOL, V630, P10, DOI 10.1016/j.ejphar.2009.12.022; Rubovitch V, 2003, MOL BRAIN RES, V110, P261, DOI 10.1016/S0169-328X(02)00656-3; Sha K, 2012, GENE, V497, P191, DOI 10.1016/j.gene.2012.01.052; Shenoy SK, 2003, J BIOL CHEM, V278, P14498, DOI 10.1074/jbc.M209626200; Shi Y, 2011, J BIOL CHEM, V286, P42390, DOI 10.1074/jbc.M111.275602; Smrcka AV, 2008, CELL MOL LIFE SCI, V65, P2191, DOI 10.1007/s00018-008-8006-5; Tanaka Y, 2003, PEPTIDES, V24, P837, DOI 10.1016/S0196-9781(03)00169-4; Tanaka Y, 2002, J INSECT PHYSIOL, V48, P707, DOI 10.1016/S0022-1910(02)00094-X; Tawfik AI, 1999, P NATL ACAD SCI USA, V96, P7083, DOI 10.1073/pnas.96.12.7083; VEENSTRA JA, 1989, FEBS LETT, V250, P231, DOI 10.1016/0014-5793(89)80727-6; Veenstra JA, 2012, INSECT BIOCHEM MOLEC, V42, P277, DOI 10.1016/j.ibmb.2011.12.009; Veenstra JA, 2009, INSECT BIOCHEM MOLEC, V39, P755, DOI 10.1016/j.ibmb.2009.09.008; Viard P, 2001, BRIT J PHARMACOL, V132, P669, DOI 10.1038/sj.bjp.0703864; Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260; Werry TD, 2005, TRENDS ENDOCRIN MET, V16, P26, DOI 10.1016/j.tem.2004.11.008; Wise S, 2002, J COMP NEUROL, V447, P366, DOI 10.1002/cne.10242; Yamanaka N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003048; Yamaoka K, 2009, BIOCHEM BIOPH RES CO, V389, P678, DOI 10.1016/j.bbrc.2009.09.064; Yerushalmi Y., 2002, PHYSIOL ENTOMOL, V25, P127; Zhao Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009141; Zhu CG, 2009, FEBS LETT, V583, P1463, DOI 10.1016/j.febslet.2009.03.060	54	25	27	2	39	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2013	288	17					11662	11675		10.1074/jbc.M112.441675	http://dx.doi.org/10.1074/jbc.M112.441675			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	133RP	23457297	hybrid, Green Published			2022-12-25	WOS:000318157600005
J	Yu, ZH; Xu, J; Walls, CD; Chen, L; Zhang, S; Zhang, RY; Wu, L; Wang, LN; Liu, SJ; Zhang, ZY				Yu, Zhi-Hong; Xu, Jie; Walls, Chad D.; Chen, Lan; Zhang, Sheng; Zhang, Ruoyu; Wu, Li; Wang, Lina; Liu, Sijiu; Zhang, Zhong-Yin			Structural and Mechanistic Insights into LEOPARD Syndrome-Associated SHP2 Mutations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; GROWTH-FACTOR RECEPTOR; NOONAN-SYNDROME; GERMLINE MUTATIONS; KINASE ACTIVATION; PTPN11 MUTATIONS; MOUSE MODEL; BINDING; SH-PTP2; KRAS	SHP2 is an allosteric phosphatase essential for growth factor-mediated Ras activation. Germ-line mutations in SHP2 cause clinically similar LEOPARD and Noonan syndromes, two of several autosomal-dominant conditions characterized by gain-of-function mutations in the Ras pathway. Interestingly, Noonan syndrome SHP2 mutants are constitutively active, whereas LEOPARD syndrome SHP2 mutants exhibit reduced phosphatase activity. How do catalytically impaired LEOPARD syndrome mutants engender gain-of-function phenotypes? Our study reveals that LEOPARD syndrome mutations weaken the intramolecular interaction between the N-SH2 and phosphatase domains, leading to a change in SHP2 molecular switching mechanism. Consequently, LEOPARD syndrome SHP2 mutants bind upstream activators preferentially and are hypersensitive to growth factor stimulation. They also stay longer with scaffolding adapters, thus prolonging substrate turnover, which compensates for the reduced phosphatase activity. The study provides a solid framework for understanding how individual SHP2 mutations cause diseases.	[Yu, Zhi-Hong; Xu, Jie; Walls, Chad D.; Chen, Lan; Zhang, Sheng; Zhang, Ruoyu; Wu, Li; Wang, Lina; Liu, Sijiu; Zhang, Zhong-Yin] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Chen, Lan; Wu, Li] Indiana Univ Sch Med, Chem Genom Core Facil, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Zhang, ZY (corresponding author), Indiana Univ Sch Med, Dept Biochem & Mol Biol, 635 Barnhill Dr, Indianapolis, IN 46202 USA.	zyzhang@iu.edu			National Institutes of Health [CA69202]; NATIONAL CANCER INSTITUTE [R01CA069202] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA69202.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aoki Y, 2005, NAT GENET, V37, P1038, DOI 10.1038/ng1641; Araki T, 2004, NAT MED, V10, P849, DOI 10.1038/nm1084; Bentires-Alj M, 2004, CANCER RES, V64, P8816, DOI 10.1158/0008-5472.CAN-04-1923; Carta C, 2006, AM J HUM GENET, V79, P129, DOI 10.1086/504394; Carvajal-Vergara X, 2010, NATURE, V465, P808, DOI 10.1038/nature09005; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chen BB, 2000, NAT GENET, V24, P296, DOI 10.1038/73528; Cunnick JM, 2000, J BIOL CHEM, V275, P13842, DOI 10.1074/jbc.275.18.13842; Cunnick JM, 2001, J BIOL CHEM, V276, P24380, DOI 10.1074/jbc.M010275200; Deb TB, 1998, J BIOL CHEM, V273, P16643, DOI 10.1074/jbc.273.27.16643; Digilio MC, 2002, AM J HUM GENET, V71, P389, DOI 10.1086/341528; Fragale A, 2004, HUM MUTAT, V23, P267, DOI 10.1002/humu.20005; Gelb BD, 2006, HUM MOL GENET, V15, pR220, DOI 10.1093/hmg/ddl197; Hanna N, 2006, FEBS LETT, V580, P2477, DOI 10.1016/j.febslet.2006.03.088; Hof P, 1998, CELL, V92, P441, DOI 10.1016/S0092-8674(00)80938-1; Hoofnagle AN, 2003, ANNU REV BIOPH BIOM, V32, P1, DOI 10.1146/annurev.biophys.32.110601.142417; JIA ZC, 1995, SCIENCE, V268, P1754, DOI 10.1126/science.7540771; Keilhack H, 2005, J BIOL CHEM, V280, P30984, DOI 10.1074/jbc.M504699200; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; Kontaridis MI, 2006, J BIOL CHEM, V281, P6785, DOI 10.1074/jbc.M513068200; Krenz M, 2008, P NATL ACAD SCI USA, V105, P18930, DOI 10.1073/pnas.0806556105; LECHLEIDER RJ, 1993, J BIOL CHEM, V268, P21478; Legius E, 2002, J MED GENET, V39, P571, DOI 10.1136/jmg.39.8.571; Martinelli S, 2008, HUM MOL GENET, V17, P2018, DOI 10.1093/hmg/ddn099; Mohi MG, 2005, CANCER CELL, V7, P179, DOI 10.1016/j.ccr.2005.01.010; Neel BG, 2003, TRENDS BIOCHEM SCI, V28, P284, DOI 10.1016/S0968-0004(03)00091-4; Niihori T, 2006, NAT GENET, V38, P294, DOI 10.1038/ng1749; Oishi K, 2006, HUM MOL GENET, V15, P543, DOI 10.1093/hmg/ddi471; Oishi K, 2009, HUM MOL GENET, V18, P193, DOI 10.1093/hmg/ddn336; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pandit B, 2007, NAT GENET, V39, P1007, DOI 10.1038/ng2073; Pei DH, 1996, P NATL ACAD SCI USA, V93, P1141, DOI 10.1073/pnas.93.3.1141; PLUSKEY S, 1995, J BIOL CHEM, V270, P2897, DOI 10.1074/jbc.270.7.2897; Qu CK, 1999, P NATL ACAD SCI USA, V96, P8528, DOI 10.1073/pnas.96.15.8528; Ren Y, 2004, J BIOL CHEM, V279, P8497, DOI 10.1074/jbc.M312575200; Roberts AE, 2007, NAT GENET, V39, P70, DOI 10.1038/ng1926; Rodriguez-Viciana P, 2006, SCIENCE, V311, P1287, DOI 10.1126/science.1124642; Sarmiento M, 1998, J BIOL CHEM, V273, P26368, DOI 10.1074/jbc.273.41.26368; Schubbert S, 2006, NAT GENET, V38, P331, DOI 10.1038/ng1748; SUGIMOTO S, 1994, J BIOL CHEM, V269, P13614; Tartaglia M, 2006, AM J HUM GENET, V78, P279, DOI 10.1086/499925; Tartaglia M, 2005, ANNU REV GENOM HUM G, V6, P45, DOI 10.1146/annurev.genom.6.080604.162305; Tartaglia M, 2003, NAT GENET, V34, P148, DOI 10.1038/ng1156; Tartaglia M, 2007, NAT GENET, V39, P75, DOI 10.1038/ng1939; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Weis DD, 2006, J AM SOC MASS SPECTR, V17, P1700, DOI 10.1016/j.jasms.2006.07.025	47	76	80	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2013	288	15					10472	10482		10.1074/jbc.M113.450023	http://dx.doi.org/10.1074/jbc.M113.450023			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	125TU	23457302	hybrid, Green Published			2022-12-25	WOS:000317565000027
J	Loftis, JM; Wilhelm, CJ; Vandenbark, AA; Huckans, M				Loftis, Jennifer M.; Wilhelm, Clare J.; Vandenbark, Arthur A.; Huckans, Marilyn			Partial MHC/Neuroantigen Peptide Constructs: A Potential Neuroimmune-Based Treatment for Methamphetamine Addiction	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; BLOOD-BRAIN-BARRIER; MIGRATION INHIBITORY FACTOR; CELL-RECEPTOR LIGAND; WHITE-MATTER; DEPENDENT INDIVIDUALS; MICROGLIAL ACTIVATION; COGNITIVE ENHANCEMENT; PSYCHIATRIC-SYMPTOMS; STIMULANT ADDICTION	Relapse rates following current methamphetamine abuse treatments are very high (similar to 40-60%), and the neuropsychiatric impairments (e. g., cognitive deficits, mood disorders) that arise and persist during remission from methamphetamine addiction likely contribute to these high relapse rates. Pharmacotherapeutic development of medications to treat addiction has focused on neurotransmitter systems with only limited success, and there are no Food and Drug Administration approved pharmacotherapies for methamphetamine addiction. A growing literature shows that methamphetamine alters peripheral and central immune functions and that immune factors such as cytokines, chemokines, and adhesion molecules play a role in the development and persistence of methamphetamine induced neuronal injury and neuropsychiatric impairments. The objective of this study was to evaluate the efficacy of a new immunotherapy, partial MHC/neuroantigen peptide construct (RTL551; pI-A(b)/mMOG-35-55), in treating learning and memory impairments induced by repeated methamphetamine exposure. C57BL/6J mice were exposed to two different methamphetamine treatment regimens (using repeated doses of 4 mg/kg or 10 mg/kg, s.c.). Cognitive performance was assessed using the Morris water maze and CNS cytokine levels were measured by multiplex assay. Immunotherapy with RTL551 improved the memory impairments induced by repeated methamphetamine exposure in both mouse models of chronic methamphetamine addiction. Treatment with RTL551 also attenuated the methamphetamine induced increases in hypothalamic interleukin-2 (IL-2) levels. Collectively, these initial results indicate that neuroimmune targeted therapies, and specifically RTL551, may have potential as treatments for methamphetamine-induced neuropsychiatric impairments.	[Loftis, Jennifer M.; Wilhelm, Clare J.; Vandenbark, Arthur A.; Huckans, Marilyn] Portland VA Med Ctr, Portland, OR USA; [Huckans, Marilyn] Portland VA Med Ctr, Behav Hlth & Clin Neurosci Div, Portland, OR USA; [Loftis, Jennifer M.; Wilhelm, Clare J.; Huckans, Marilyn] Oregon Hlth & Sci Univ, Dept Psychiat, Sch Med, Portland, OR 97201 USA; [Vandenbark, Arthur A.] Oregon Hlth & Sci Univ, Sch Med, Dept Neurol, Portland, OR 97201 USA; [Vandenbark, Arthur A.] Oregon Hlth & Sci Univ, Sch Med, Dept Mol Microbiol & Immunol, Portland, OR 97201 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Portland VA Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Portland VA Medical Center; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University	Loftis, JM (corresponding author), Portland VA Med Ctr, Portland, OR USA.	loftisj@ohsu.edu	Loftis, Jennifer/AAI-5054-2020	Wilhelm, Clare/0000-0003-2437-5387; Loftis, Jennifer/0000-0003-1773-9365	National Institutes of Health [RC1DA028537, R41DA029345]; Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Clinical Sciences Research and Development; Methamphetamine Abuse Research Center, Portland, OR [NIDA P50DA018165]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047661] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P50DA018165, RC1DA028537, R41DA029345] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Clinical Sciences Research and Development(US Department of Veterans Affairs); Methamphetamine Abuse Research Center, Portland, OR; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health grants RC1DA028537 and R41DA029345 to JML and MH. JML (Research Scientist) and MH (Staff Psychologist and Neuropsychologist) are supported by career development awards from the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Clinical Sciences Research and Development. This research was supported, in part, by the Methamphetamine Abuse Research Center, Portland, OR (NIDA P50DA018165). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertson DN, 2004, J NEUROCHEM, V88, P1211, DOI 10.1046/j.1471-4159.2003.02247.x; Bae SC, 2006, DRUG ALCOHOL DEPEN, V81, P83, DOI 10.1016/j.drugalcdep.2005.05.016; Berman S, 2008, ANN NY ACAD SCI, V1141, P195, DOI 10.1196/annals.1441.031; Bowyer JF, 2006, SYNAPSE, V60, P521, DOI 10.1002/syn.20324; Calandra T, 1997, CRIT REV IMMUNOL, V17, P77, DOI 10.1615/CritRevImmunol.v17.i1.30; Calandra T, 1998, P NATL ACAD SCI USA, V95, P11383, DOI 10.1073/pnas.95.19.11383; Carson DS, 2010, ADDICT BIOL, V15, P448, DOI 10.1111/j.1369-1600.2010.00247.x; Chung A, 2007, INT J NEUROPSYCHOPH, V10, P765, DOI 10.1017/Sl461145706007395; Cloak CC, 2009, NEUROLOGY, V72, P2068, DOI 10.1212/01.wnl.0000346516.49126.20; Dai HM, 2004, ANN NY ACAD SCI, V1025, P257, DOI 10.1196/annals.1316.032; Darke S, 2008, DRUG ALCOHOL REV, V27, P253, DOI 10.1080/09595230801923702; Duvoisin RM, 2010, BEHAV BRAIN RES, V209, P21, DOI 10.1016/j.bbr.2010.01.006; Glasner-Edwards S, 2010, DRUG ALCOHOL REV, V29, P12, DOI 10.1111/j.1465-3362.2009.00081.x; Goncalves J, 2010, EUR J NEUROSCI, V31, P315, DOI 10.1111/j.1460-9568.2009.07059.x; Heinzerling KG, 2010, DRUG ALCOHOL DEPEN, V109, P20, DOI 10.1016/j.drugalcdep.2009.11.023; Hoffman W, 2008, PSYCHOPHARMACOLOGY, V201, P183, DOI 10.1007/s00213-008-1261-1; Hoffman WF, 2006, PSYCHOPHARMACOLOGY, V188, P162, DOI 10.1007/s00213-006-0494-0; Huckans MS, 2011, BRAIN BEHAV IMMUN, V25, pS227; Hulse RE, 2004, J NEUROSCI METH, V136, P87, DOI 10.1016/j.jneumeth.2003.12.023; In SW, 2005, J TOXICOL ENV HEAL A, V68, P2133, DOI 10.1080/15287390500177156; In SW, 2004, J TOXICOL ENV HEAL A, V67, P1923, DOI 10.1080/15287390490514589; Jia F, 2008, J PHARMACOL SCI, V107, P167, DOI 10.1254/jphs.FP0072424; Johnson BA, 2008, INT J NEUROPSYCHOPH, V11, P1, DOI 10.1017/S1461145707007778; King G, 2010, J NEUROIMMUNE PHARM, V5, P582, DOI 10.1007/s11481-010-9206-y; Kuroda KO, 2010, NEUROPSYCHOPHARMACOL, V35, P641, DOI 10.1038/npp.2009.169; Liang H, 2008, AM J PATHOL, V172, P1617, DOI 10.2353/ajpath.2008.070971; Loftis JM, 2011, NEUROTOX RES, V20, P59, DOI 10.1007/s12640-010-9223-x; Loftis JM, 2011, ADDICTION, V106, P1021, DOI 10.1111/j.1360-0443.2010.03354.x; London ED, 2004, ARCH GEN PSYCHIAT, V61, P73, DOI 10.1001/archpsyc.61.1.73; Madden LJ, 2005, NEUROPSYCHOPHARMACOL, V30, P350, DOI 10.1038/sj.npp.1300575; Mahajan SD, 2008, BRAIN RES, V1203, P133, DOI 10.1016/j.brainres.2008.01.093; Martinez LR, 2009, J INFECT DIS, V200, P131, DOI 10.1086/599328; McLellan AT, 2000, JAMA-J AM MED ASSOC, V284, P1689, DOI 10.1001/jama.284.13.1689; Newton TF, 2009, AM J ADDICTION, V18, P294, DOI 10.1080/10550490902925920; Oh JS, 2005, NEUROSCI LETT, V384, P76, DOI 10.1016/j.neulet.2005.04.082; Ramirez SH, 2009, J CEREBR BLOOD F MET, V29, P1933, DOI 10.1038/jcbfm.2009.112; Remondes M, 2004, NATURE, V431, P699, DOI 10.1038/nature02965; Salo R, 2009, BIOL PSYCHIAT, V65, P122, DOI 10.1016/j.biopsych.2008.08.004; Schwartz DL, 2010, NEUROIMAGE, V50, P1392, DOI 10.1016/j.neuroimage.2010.01.056; Scott JC, 2007, NEUROPSYCHOL REV, V17, P275, DOI 10.1007/s11065-007-9031-0; Sekine Y, 2008, J NEUROSCI, V28, P5756, DOI 10.1523/JNEUROSCI.1179-08.2008; Shah A, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-52; Sharma HS, 2009, J CHEM NEUROANAT, V37, P18, DOI 10.1016/j.jchemneu.2008.08.002; Shoptaw S, 2003, J PSYCHOACTIVE DRUGS, P161, DOI 10.1080/02791072.2003.10400511; Silverstein PS, 2011, J NEUROVIROL, V17, P401, DOI 10.1007/s13365-011-0043-4; Sinha S, 2007, J NEUROSCI, V27, P12531, DOI 10.1523/JNEUROSCI.3599-07.2007; Sinha S, 2009, J NEUROSCI, V29, P3816, DOI 10.1523/JNEUROSCI.5812-08.2009; Sofuoglu M, 2010, ADDICTION, V105, P38, DOI 10.1111/j.1360-0443.2009.02791.x; Subramanian S, 2009, STROKE, V40, P2539, DOI 10.1161/STROKEAHA.108.543991; Thomas DM, 2004, J PHARMACOL EXP THER, V311, P1, DOI 10.1124/jpet.104.070961; Vandenbark AA, 2003, J IMMUNOL, V171, P127, DOI 10.4049/jimmunol.171.1.127; Vandenbark AA, 2012, J AUTOIMMUN; Volkow ND, 2009, JAMA-J AM MED ASSOC, V301, P1148, DOI 10.1001/jama.2009.351; Wang CH, 2006, J NEUROCHEM, V98, P1817, DOI 10.1111/j.1471-4159.2006.04081.x; Wilhelm CJ, 2012, NEUROPHARMACOLOGY, V62, P313, DOI 10.1016/j.neuropharm.2011.07.040; Wires ES, 2012, J NEUROVIROL; Wisor JP, 2011, BRAIN BEHAV IMMUN, V25, P767, DOI 10.1016/j.bbi.2011.02.002; Yamamoto BK, 2008, J NEUROIMMUNE PHARM, V3, P203, DOI 10.1007/s11481-008-9121-7; Yamamoto BK, 2010, ANN NY ACAD SCI, V1187, P101, DOI 10.1111/j.1749-6632.2009.05141.x; Ye L, 2008, J VIRAL HEPATITIS, V15, P261, DOI 10.1111/j.1365-2893.2007.00940.x; Zweben JE, 2004, AM J ADDICTION, V13, P181, DOI 10.1080/10550490490436055	61	12	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e56306	10.1371/journal.pone.0056306	http://dx.doi.org/10.1371/journal.pone.0056306			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460798	Green Published, gold, Green Submitted			2022-12-25	WOS:000315519000021
J	Tasset-Cuevas, I; Fernandez-Bedmar, Z; Lozano-Baena, MD; Campos-Sanchez, J; de Haro-Bailon, A; Munoz-Serrano, A; Alonso-Moraga, A				Tasset-Cuevas, Inmaculada; Fernandez-Bedmar, Zahira; Dolores Lozano-Baena, Maria; Campos-Sanchez, Juan; de Haro-Bailon, Antonio; Munoz-Serrano, Andres; Alonso-Moraga, Angeles			Protective Effect of Borage Seed Oil and Gamma Linolenic Acid on DNA: In Vivo and In Vitro Studies	PLOS ONE			English	Article							DROSOPHILA-MELANOGASTER; EICOSAPENTAENOIC ACID; SOMATIC MUTATION; OXIDATIVE STRESS; FATTY-ACIDS; ARACHIDONIC-ACID; LIFE-SPAN; MODEL; CYTOTOXICITY; GENOTOXICITY	Borage (Borago officinalis L.) seed oil has been used as a treatment for various degenerative diseases. Many useful properties of this oil are attributed to its high gamma linolenic acid content (GLA, 18:3 omega-6). The purpose of this study was to demonstrate the safety and suitability of the use of borage seed oil, along with one of its active components, GLA, with respect to DNA integrity, and to establish possible in vivo toxic and in vitro cytotoxic effects. In order to measure these properties, five types of assays were carried out: toxicity, genotoxicity, antigenotoxicity, cytotoxicity (using the promyelocytic leukaemia HL60 cell line), and life span (in vivo analysis using the Drosophila model). Results showed that i) Borage seed oil is not toxic to D. melanogaster at physiological concentrations below 125 ml/ml and the studies on GLA indicated non-toxicity at the lowest concentration analyzed ii) Borage seed oil and GLA are DNA safe (non-genotoxic) and antimutagenic compared to hydrogen peroxide, thereby confirming its antioxidant capacity; iii) Borage seed oil and GLA exhibited cytotoxic activity in low doses (IC50 of 1 mu l/ml and 0.087 mM, respectively) iv) Low doses of borage seed oil (0.19%) increased the health span of D. melanogaster; and v) GLA significantly decreased the life span of D. melanogaster. Based on the antimutagenic and cytotoxic effects along with the ability to increase the health span, we propose supplementation with borage seed oil rather than GLA, because it protects DNA by modulating oxidative genetic damage in D. melanogaster, increases the health span and exerts cytotoxic activity towards promyelocytic HL60 cells.	[Tasset-Cuevas, Inmaculada] Univ Cordoba, Fac Med, Inst Maimonides Invest Biomed Cordoba IMIBIC, Dept Bioquim & Biol Mol, Cordoba, Spain; [Fernandez-Bedmar, Zahira; Campos-Sanchez, Juan; Munoz-Serrano, Andres; Alonso-Moraga, Angeles] Univ Cordoba, Fac Ciencias, Dept Genet, E-14004 Cordoba, Spain; [Dolores Lozano-Baena, Maria; de Haro-Bailon, Antonio] CSIC, Inst Agr Sostenible, Cordoba, Spain	Universidad de Cordoba; Universidad de Cordoba; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Agricultura Sostenible (IAS)	Tasset-Cuevas, I (corresponding author), Univ Cordoba, Fac Med, Inst Maimonides Invest Biomed Cordoba IMIBIC, Dept Bioquim & Biol Mol, Cordoba, Spain.	b72tacui@uco.es	Cuevas, Inmaculada Tasset/R-4509-2019	Cuevas, Inmaculada Tasset/0000-0003-0730-6750; de Haro-Bailon, Antonio/0000-0001-6726-5343; Lozano-Baena, Maria-Dolores/0000-0001-6249-0955				ABRAHAM SK, 1994, MUTAGENESIS, V9, P383, DOI 10.1093/mutage/9.4.383; Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Al-Khamees WA, 2011, J MED TOXICOL, V7, P154, DOI 10.1007/s13181-011-0135-9; Allen RG, 2000, FREE RADICAL BIO MED, V28, P463, DOI 10.1016/S0891-5849(99)00242-7; Anter J, 2011, MUTAT RES-GEN TOX EN, V723, P165, DOI 10.1016/j.mrgentox.2011.05.005; Avanesian A, 2010, BIOGERONTOLOGY, V11, P45, DOI 10.1007/s10522-009-9227-1; Bahadorani S, 2008, NUTR RES, V28, P377, DOI 10.1016/j.nutres.2008.03.018; Bier E, 2004, GENE, V342, P1, DOI 10.1016/j.gene.2004.07.018; Bilen J, 2005, ANNU REV GENET, V39, P153, DOI 10.1146/annurev.genet.39.110304.095804; Boyd O, 2011, FREE RADICAL BIO MED, V50, P1669, DOI 10.1016/j.freeradbiomed.2011.03.011; Brosche T, 2000, ARCH GERONTOL GERIAT, V30, P139, DOI 10.1016/S0167-4943(00)00046-7; CAIRNS J, 1981, NATURE, V289, P353, DOI 10.1038/289353a0; Cameron M., 2011, COCHRANE DB SYST REV, V16; Chavous DA, 2001, P NATL ACAD SCI USA, V98, P14814, DOI 10.1073/pnas.251446498; Chen Q, 1998, ALCOHOL CLIN EXP RES, V22, P782, DOI 10.1097/00000374-199806000-00002; Das UN, 2007, MED SCI MONITOR, V13, pRA119; Das UN, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-130; De Haro A, 2004, ACTA HORTIC, P231, DOI 10.17660/ActaHortic.2004.629.29; del Rio-Celestino M, 2008, J SCI FOOD AGR, V88, P248, DOI 10.1002/jsfa.3080; DELRIO M, 1993, GRASAS ACEITES, V44, P125; Dionne MS, 2008, DIS MODEL MECH, V1, P43, DOI 10.1242/dmm.000307; Festing MFW, 1998, ATLA-ALTERN LAB ANIM, V26, P283; FLEMING JE, 1992, MUTAT RES, V275, P267, DOI 10.1016/0921-8734(92)90031-J; FRANKEL E N, 1980, Progress in Lipid Research, V19, P1, DOI 10.1016/0163-7827(80)90006-5; FREI H, 1995, MUTAT RES-ENVIR MUTA, V334, P247, DOI 10.1016/0165-1161(95)90018-7; FREI H, 1988, MUTAT RES, V203, P297, DOI 10.1016/0165-1161(88)90019-2; GARCES R, 1993, ANAL BIOCHEM, V211, P139, DOI 10.1006/abio.1993.1244; Ge HT, 2009, CELL BIOL INT, V33, P402, DOI 10.1016/j.cellbi.2009.01.014; Gilani AH, 2007, J ETHNOPHARMACOL, V114, P393, DOI 10.1016/j.jep.2007.08.032; Gillis RC, 2002, J SURG RES, V107, P145, DOI 10.1006/jsre.2002.6496; GRAF U, 1984, ENVIRON MUTAGEN, V6, P153, DOI 10.1002/em.2860060206; GUNSTONE FD, 1992, PROG LIPID RES, V31, P145, DOI 10.1016/0163-7827(92)90007-6; Gunstone FD, 1994, LIPID HDB, P561; Guo Y, 2001, Wei Sheng Yan Jiu, V30, P50; Halliwell B, 1996, ANNU REV NUTR, V16, P33, DOI 10.1146/annurev.nu.16.070196.000341; Hamilton LA, 2011, NUTR CLIN PRACT, V26, P26, DOI 10.1177/0884533610392922; Helfand SL, 2003, ADV GENET, V49, P67, DOI 10.1016/S0065-2660(03)01002-2; Horrobin D F, 1983, Rev Pure Appl Pharmacol Sci, V4, P339; HORROBIN DF, 1992, PROG LIPID RES, V31, P163, DOI 10.1016/0163-7827(92)90008-7; International Olive Council (COI), 2006, 25 COIT20DOC; Itoh S, 2010, J CLIN BIOCHEM NUTR, V47, P81, DOI 10.3164/jcbn.10-24; Janick J, 1989, HERBS SPICES MED PLA, P210; Jones MA, 2011, EXP GERONTOL, V46, P320, DOI 10.1016/j.exger.2010.08.012; Kim T, 2005, J BIOCHEM MOL BIOL, V38, P121; Kruger MC, 1998, AGING-CLIN EXP RES, V10, P385, DOI 10.1007/BF03339885; LEVENTHAL LJ, 1993, ANN INTERN MED, V119, P867, DOI 10.7326/0003-4819-119-9-199311010-00001; Li YM, 2008, J NUTR BIOCHEM, V19, P376, DOI 10.1016/j.jnutbio.2007.05.009; Lindsley D.L., 1992, GENOME DROSOPHILA ME, Veighth; Mancuso P, 1997, CRIT CARE MED, V25, P523, DOI 10.1097/00003246-199703000-00024; Menendez JA, 2004, ONCOL REP, V11, P1241; Mockett RJ, 2006, EXP GERONTOL, V41, P566, DOI 10.1016/j.exger.2006.03.015; Olendzki BC, 2011, EVID-BASED COMPL ALT, V2011, DOI 10.1155/2011/827286; Ortiz JGM, 2009, TOXICOL SCI, V107, P416, DOI 10.1093/toxsci/kfn192; Paquot C, 1987, STANDARD METHODS ANA; Pham H, 2006, PROSTAG LEUKOTR ESS, V74, P271, DOI 10.1016/j.plefa.2006.01.004; Pompeia C, 2002, BIOL CELL, V94, P251, DOI 10.1016/S0248-4900(02)01200-5; Pontes-Arruda A, 2011, CRIT CARE, V15, DOI 10.1186/cc10267; PRITCHARD GA, 1989, BRIT J SURG, V76, P1069, DOI 10.1002/bjs.1800761028; Rand MD, 2010, NEUROTOXICOL TERATOL, V32, P74, DOI 10.1016/j.ntt.2009.06.004; Ravichandran D, 1998, EUR J CANCER, V34, P188, DOI 10.1016/S0959-8049(97)00369-9; Ren N, 2007, GENETICS, V176, P2223, DOI 10.1534/genetics.107.072959; Rojas-Molina M, 2005, ENVIRON MOL MUTAGEN, V45, P90, DOI 10.1002/em.20078; Romero-Jimenez M, 2005, MUTAT RES-GEN TOX EN, V585, P147, DOI 10.1016/j.mrgentox.2005.05.004; Saxena Ronika, 2011, Toxicol Int, V18, P73, DOI 10.4103/0971-6580.75871; Scheim DE, 2009, LIPIDS HEALTH DIS, V8, DOI 10.1186/1476-511X-8-54; Shichiri M, 2012, J BIOL CHEM, V287, P2926, DOI 10.1074/jbc.M111.321281; Siddique HR, 2005, MUTAGENESIS, V20, P285, DOI 10.1093/mutage/gei032; Soh JW, 2007, MECH AGEING DEV, V128, P581, DOI 10.1016/j.mad.2007.08.004; Tiwari AK, 2011, THERIOGENOLOGY, V76, P197, DOI 10.1016/j.theriogenology.2010.12.027; Trotta V, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-67; Tso P, 2002, J NUTR, V132, P218, DOI 10.1093/jn/132.2.218; USDA, 2010, DIET GUID AM, DOI DOI 10.HTTP://WWW.CNPP.USDA.G0V/PUBLICATI0NS/DIETARYGUIDELINES/2010/P0LICYD0C/P0LICYD0C.PDF; Velasco L, 1999, PHYTOCHEMISTRY, V52, P423, DOI 10.1016/S0031-9422(99)00203-4; Villatoro-Pulido M, 2009, MUTAGENESIS, V24, P51, DOI 10.1093/mutage/gen051; Wauquier F, 2012, BONE, V50, P553, DOI 10.1016/j.bone.2011.05.030; Yan J, 2008, GENETICS, V180, P219, DOI 10.1534/genetics.108.091314	76	46	46	5	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e56986	10.1371/journal.pone.0056986	http://dx.doi.org/10.1371/journal.pone.0056986			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460824	Green Published, gold			2022-12-25	WOS:000315519000052
J	Wadelin, FR; Fulton, J; Collins, HM; Tertipis, N; Bottley, A; Spriggs, KA; Falcone, FH; Heery, DM				Wadelin, Frances R.; Fulton, Joel; Collins, Hilary M.; Tertipis, Nikolaos; Bottley, Andrew; Spriggs, Keith A.; Falcone, Franco H.; Heery, David M.			PRAME Is a Golgi-Targeted Protein That Associates with the Elongin BC Complex and Is Upregulated by Interferon-Gamma and Bacterial PAMPs	PLOS ONE			English	Article							MINIMAL RESIDUAL DISEASE; PREFERENTIALLY EXPRESSED ANTIGEN; MESSENGER-RNA LEVELS; GENE-EXPRESSION; CLINICAL IMPORTANCE; UBIQUITIN LIGASE; IDENTIFICATION; LEUKEMIA; PEPTIDOGLYCAN; RECEPTORS	Preferentially expressed antigen in melanoma (PRAME) has been described as a cancer-testis antigen and is associated with leukaemias and solid tumours. Here we show that PRAME gene transcription in leukaemic cell lines is rapidly induced by exposure of cells to bacterial PAMPs (pathogen associated molecular patterns) in combination with type 2 interferon (IFN gamma). Treatment of HL60 cells with lipopolysaccharide or peptidoglycan in combination with IFN gamma resulted in a rapid and transient induction of PRAME transcription, and increased association of PRAME transcripts with polysomes. Moreover, treatment with AMPs/IFN gamma also modulated the subcellular localisation of PRAME proteins in HL60 and U937 cells, resulting in targeting of cytoplasmic PRAME to the Golgi. Affinity purification studies revealed that PRAME associates with Elongin B and Elongin C, components of Cullin E3 ubiquitin ligase complexes. This occurs via direct interaction of PRAME with Elongin C, and PRAME colocalises with Elongins in the Golgi after PAMP/IFN gamma treatment. PRAME was also found to co-immunoprecipitate core histones, consistent with its partial localisation to the nucleus, and was found to bind directly to histone H3 in vitro. Thus, PRAME is upregulated by signalling pathways that are activated in response to infection/inflammation, and its product may have dual functions as a histone-binding protein, and in directing ubiquitylation of target proteins for processing in the Golgi.	[Wadelin, Frances R.; Fulton, Joel; Collins, Hilary M.; Tertipis, Nikolaos; Bottley, Andrew; Spriggs, Keith A.; Falcone, Franco H.; Heery, David M.] Univ Nottingham, Sch Pharm, Ctr Biomol Sci, Nottingham NG7 2RD, England	University of Nottingham	Heery, DM (corresponding author), Univ Nottingham, Sch Pharm, Ctr Biomol Sci, Univ Pk, Nottingham NG7 2RD, England.	david.heery@nottingham.ac.uk	Falcone, Franco H/F-9210-2013; Falcone, Franco/AAE-8026-2021	Falcone, Franco H/0000-0002-1732-9932; Falcone, Franco/0000-0002-1732-9932; Heery, David/0000-0002-5035-2392; Collins, Hilary/0000-0001-6220-1236	Leukaemia Lymphoma Research via a clinical training fellowship [07064]; Royal Pharmaceutical Society of Great Britain via an Academic Excellence Award	Leukaemia Lymphoma Research via a clinical training fellowship; Royal Pharmaceutical Society of Great Britain via an Academic Excellence Award	This work was funded by Leukaemia Lymphoma Research via a clinical training fellowship to FRW (07064). JF was funded by the Royal Pharmaceutical Society of Great Britain via an Academic Excellence Award to DMH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atanackovic D, 2011, AM J HEMATOL, V86, P918, DOI 10.1002/ajh.22141; Birtle Zoe, 2005, BMC Genomics, V6, P120, DOI 10.1186/1471-2164-6-120; Costessi A, 2011, EMBO J, V30, P3786, DOI 10.1038/emboj.2011.262; Doolan P, 2008, BREAST CANCER RES TR, V109, P359, DOI 10.1007/s10549-007-9643-3; Epping MT, 2008, BRIT J CANCER, V99, P398, DOI 10.1038/sj.bjc.6604494; Epping MT, 2005, CELL, V122, P835, DOI 10.1016/j.cell.2005.07.003; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Harreman M, 2009, P NATL ACAD SCI USA, V106, P20705, DOI 10.1073/pnas.0907052106; Ikeda H, 1997, IMMUNITY, V6, P199, DOI 10.1016/S1074-7613(00)80426-4; Johannes G, 1999, P NATL ACAD SCI USA, V96, P13118, DOI 10.1073/pnas.96.23.13118; Johannes G, 1998, RNA, V4, P1500, DOI 10.1017/S1355838298981080; Kessler JH, 2001, J EXP MED, V193, P73, DOI 10.1084/jem.193.1.73; Kindle KB, 2005, MOL CELL BIOL, V25, P988, DOI 10.1128/MCB.25.3.988-1002.2005; Le Douarin B, 2001, METH MOL B, V176, P227; Lee SA, 2011, BIOCHEM BIOPH RES CO, V408, P132, DOI 10.1016/j.bbrc.2011.03.136; Li XS, 2010, MOL CELL BIOL, V30, P1673, DOI 10.1128/MCB.00540-09; Litterman N, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001060; Liu Y, 2001, INFECT IMMUN, V69, P2788, DOI 10.1128/IAI.69.5.2788-2796.2001; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matsushita M, 2001, BRIT J HAEMATOL, V112, P916, DOI 10.1046/j.1365-2141.2001.02670.x; Olins AL, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-30; Ortmann CA, 2008, ANN HEMATOL, V87, P809, DOI 10.1007/s00277-008-0514-8; PAPPIN DJC, 1993, CURR BIOL, V3, P327, DOI 10.1016/0960-9822(93)90195-T; Paydas S, 2005, AM J HEMATOL, V79, P257, DOI 10.1002/ajh.20425; Paydas S, 2007, LEUKEMIA RES, V31, P365, DOI 10.1016/j.leukres.2006.06.022; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Qin YZ, 2009, LEUKEMIA RES, V33, P384, DOI 10.1016/j.leukres.2008.08.026; Quintarelli C, 2008, BLOOD, V112, P1876, DOI 10.1182/blood-2008-04-150045; Quintarelli C, 2011, BLOOD, V117, P3353, DOI 10.1182/blood-2010-08-300376; Roman-Gomez O, 2007, LEUKEMIA RES, V31, P1521, DOI 10.1016/j.leukres.2007.02.016; Sasagawa Y, 2009, J CELL SCI, V122, P3663, DOI 10.1242/jcs.052415; Schroder K, 2006, IMMUNOBIOLOGY, V211, P511, DOI 10.1016/j.imbio.2006.05.007; Shilatifard A, 2003, ANNU REV BIOCHEM, V72, P693, DOI 10.1146/annurev.biochem.72.121801.161551; Singer JD, 1999, GENE DEV, V13, P2375, DOI 10.1101/gad.13.18.2375; Starczynowski DT, 2010, HEMATOL ONCOL CLIN N, V24, P343, DOI 10.1016/j.hoc.2010.02.008; Steinbach D, 2006, CLIN CANCER RES, V12, P2434, DOI 10.1158/1078-0432.CCR-05-2552; Tajeddine N, 2005, CANCER RES, V65, P7348, DOI 10.1158/0008-5472.CAN-04-4011; Tajeddine N, 2006, CLIN CHEM LAB MED, V44, P548, DOI 10.1515/CCLM.2006.106; Tian X, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-202; Wadelin F, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-226; Williams JM, 1998, MOL MICROBIOL, V27, P171, DOI 10.1046/j.1365-2958.1998.00670.x; Wolska A, 2009, CURR MOL MED, V9, P324, DOI 10.2174/156652409787847182; Yuan Z, 2002, BIOINFORMATICS, V18, P1109, DOI 10.1093/bioinformatics/18.8.1109	43	17	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e58052	10.1371/journal.pone.0058052	http://dx.doi.org/10.1371/journal.pone.0058052			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460923	Green Published, Green Submitted			2022-12-25	WOS:000315519000178
J	Liu, YY; Du, YS; Liu, WW; Yang, CH; Liu, Y; Wang, HY; Gong, XH				Liu, Yanyan; Du, Yasong; Liu, Wenwen; Yang, Caohua; Liu, Yan; Wang, Hongyan; Gong, Xiaohong			Lack of Association between NLGN3, NLGN4, SHANK2 and SHANK3 Gene Variants and Autism Spectrum Disorder in a Chinese Population	PLOS ONE			English	Article							MENTAL-RETARDATION; X-CHROMOSOME; NEUROLIGIN GENES; MUTATIONS	Autism spectrum disorder (ASD) is a neurodevelopmental disorder characterized by deficits in social communication, absence or delay in language development, and stereotyped or repetitive behaviors. Genetic studies show that neurexin-neuroligin (NRXN-NLGN) pathway genes contribute susceptibility to ASD, which include cell adhesion molecules NLGN3, NLGN4 and scaffolding proteins SHANK2 and SHANK3. Neuroligin proteins play an important role in synaptic function and trans-synaptic signaling by interacting with presynaptic neurexins. Shank proteins are scaffolding molecules of excitatory synapses, which function as central organizers of the postsynaptic density. Sequence level mutations and structural variations in these genes have been identified in ASD cases, while few studies were performed in Chinese population. In this study, we examined the copy numbers of four genes NLGN4, NLGN3, SHANK2, and SHANK3 in 285 ASD cases using multiplex fluorescence competitive polymerase chain reaction (PCR). We also screened the regulatory region including the promoter region and 59/39 untranslated regions (UTR) and the entire coding region of NLGN4 in a cohort of 285 ASD patients and 384 controls by direct sequencing of genomic DNA using the Sanger method. DNA copy number calculation in four genes showed no deletion or duplication in our cases. No missense mutations in NLGN4 were identified in our cohort. Association analysis of 6 common SNPs in NLGN4 did not find significant difference between ASD cases and controls. These findings showed that these genes may not be major disease genes in Chinese ASD cases.	[Liu, Yanyan; Wang, Hongyan; Gong, Xiaohong] Fudan Univ, MOE Key Lab Contemporary Anthropol, Sch Life Sci, Shanghai 200433, Peoples R China; [Liu, Yanyan; Wang, Hongyan; Gong, Xiaohong] Fudan Univ, State Key Lab Genet Engn, Sch Life Sci, Shanghai 200433, Peoples R China; [Du, Yasong; Liu, Wenwen; Yang, Caohua] Shanghai Mental Hlth Ctr, Dept Child & Adolescent Psychiat, Shanghai, Peoples R China; [Du, Yasong; Liu, Wenwen; Yang, Caohua] Shanghai Jiao Tong Univ, Sch Med, Shanghai 200030, Peoples R China; [Liu, Yan] Genesky Biotechnol Inc, Shanghai, Peoples R China	Fudan University; Fudan University; Shanghai Jiao Tong University	Gong, XH (corresponding author), Fudan Univ, MOE Key Lab Contemporary Anthropol, Sch Life Sci, Shanghai 200433, Peoples R China.	gongxh@fudan.edu.cn			National Natural Science Foundation of China [30900404]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (30900404). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT, V4th ed.; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Berkel S, 2010, NAT GENET, V42, P489, DOI 10.1038/ng.589; Blasi F, 2006, AM J MED GENET B, V141B, P220, DOI 10.1002/ajmg.b.30287; Bourgeron T, 2009, CURR OPIN NEUROBIOL, V19, P231, DOI 10.1016/j.conb.2009.06.003; Bozdagi O, 2010, MOL AUTISM, V1, DOI 10.1186/2040-2392-1-15; Buxbaum Joseph D, 2009, Dialogues Clin Neurosci, V11, P35; Craig AM, 2007, CURR OPIN NEUROBIOL, V17, P43, DOI 10.1016/j.conb.2007.01.011; Daoud H, 2009, BIOL PSYCHIAT, V66, P906, DOI 10.1016/j.biopsych.2009.05.008; Du R, 2012, J HUM GENET; Durand CM, 2007, NAT GENET, V39, P25, DOI 10.1038/ng1933; Fombonne E, 2002, MOL PSYCHIATR, V7, pS4, DOI 10.1038/sj.mp.4001162; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gauthier J, 2006, MOL PSYCHIATR, V11, P206, DOI 10.1038/sj.mp.4001756; Gauthier J, 2005, AM J MED GENET B, V132B, P74, DOI 10.1002/ajmg.b.30066; Gauthier J, 2009, AM J MED GENET B, V150B, P421, DOI 10.1002/ajmg.b.30822; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Jamain S, 2008, P NATL ACAD SCI USA, V105, P1710, DOI 10.1073/pnas.0711555105; Kelemenova S, 2010, PSYCHIAT GENET, V20, P137, DOI 10.1097/YPG.0b013e32833a1eb3; Laumonnier F, 2004, AM J HUM GENET, V74, P552, DOI 10.1086/382137; Lawson-Yuen A, 2008, EUR J HUM GENET, V16, P614, DOI 10.1038/sj.ejhg.5202006; Leblond CS, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002521; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; Moessner R, 2007, AM J HUM GENET, V81, P1289, DOI 10.1086/522590; Pampanos A, 2009, GENET TEST MOL BIOMA, V13, P611, DOI 10.1089/gtmb.2009.0005; Peca J, 2011, NATURE, V472, P437, DOI 10.1038/nature09965; Petit E, 1996, BIOL PSYCHIAT, V40, P457, DOI 10.1016/0006-3223(96)85270-X; Sato D, 2012, AM J HUM GENET; State MW, 2010, NAT GENET, V42, P478, DOI 10.1038/ng0610-478; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Vaags AK, 2012, AM J HUM GENET, V90, P133, DOI 10.1016/j.ajhg.2011.11.025; Vincent JB, 2005, PSYCHIAT GENET, V15, P83, DOI 10.1097/00041444-200506000-00004; Yan J, 2005, MOL PSYCHIATR, V10, P329, DOI 10.1038/sj.mp.4001629; Ylisaukko-oja T, 2005, EUR J HUM GENET, V13, P1285, DOI 10.1038/sj.ejhg.5201474; Yu JD, 2011, BEHAV BRAIN FUNCT, V7, DOI 10.1186/1744-9081-7-13; Zhang C, 2009, J NEUROSCI, V29, P10843, DOI 10.1523/JNEUROSCI.1248-09.2009	36	20	23	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2013	8	2							e56639	10.1371/journal.pone.0056639	http://dx.doi.org/10.1371/journal.pone.0056639			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098PO	23468870	Green Published, Green Submitted, gold			2022-12-25	WOS:000315561400012
J	Cai, QF; Wan, F; Huang, K; Zhang, HW				Cai, Qianfang; Wan, Fei; Huang, Kai; Zhang, Hanwang			Does the Number of Oocytes Retrieved Influence Pregnancy after Fresh Embryo Transfer?	PLOS ONE			English	Article							IN-VITRO FERTILIZATION; OVARIAN STIMULATION; CLOMIPHENE CITRATE; PREDICTIVE FACTORS; POOR RESPONDER; IVF TREATMENT; MATERNAL AGE; RATES; MORPHOLOGY; OUTCOMES	Background: The nature of the association between the number of oocytes retrieved and in vitro fertilization (IVF) outcomes after fresh embryo transfer remains unclear because of conflicting results reported in the studies on this subject. In addition, the influence of the quality of the embryos transferred is usually neglected. The objective of this study is to assess the relationships of the number of oocytes retrieved, the number and quality of embryos transferred, and the prospects of pregnancy after fresh embryo transfer. Methods: The data on 3131 infertile women undergoing their first IVF treatment cycle between January 2009 and December 2010 were collected retrospectively. Restricted cubic splines and stratified analyses were used to explore the relationships between the number of oocytes retrieved, the number and quality of embryos transferred, and the IVF outcomes. Results: When stratified by the number and quality of transferred embryos, no significant differences in the chances for clinical pregnancy and live birth were found in three groups of oocytes yielded (<= 6, 7-14, or >= 15). The relationship between the number of oocytes retrieved and pregnancy is nearly a reflection of the pattern of the relationship between the number of oocytes retrieved and the probability of having two good-quality embryos transferred. The patients with the "optimal" number of oocytes were not only younger but also had the highest probability of having two good-quality embryos replaced. Conclusions: Similarly aged patients have similar pregnancy prospects after fresh embryo transfer when the same number and quality of embryos are replaced, irrespective of their number of oocytes. Selecting the desired number of good-quality embryos for transfer is the key to IVF success. Thus, aiming at retrieving an optimal number of oocytes to maximize IVF outcomes in a fresh cycle could place undue stress on the patients and may not be the best medical decision.	[Cai, Qianfang] Women & Childrens Hosp Guangdong Prov, Reprod Med Ctr, Guangzhou, Guangdong, Peoples R China; [Wan, Fei] Univ Penn, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; [Huang, Kai; Zhang, Hanwang] Huazhong Univ Sci & Technol, Reprod Med Ctr, Tongji Hosp, Tongji Med Coll, Wuhan 430074, Hubei, Peoples R China	University of Pennsylvania; Huazhong University of Science & Technology	Zhang, HW (corresponding author), Huazhong Univ Sci & Technol, Reprod Med Ctr, Tongji Hosp, Tongji Med Coll, Wuhan 430074, Hubei, Peoples R China.	hwzhang605@126.com	; Sampaolesi, Maurilio/H-6509-2013	Huang, Kai/0000-0003-0102-6862; Sampaolesi, Maurilio/0000-0002-2422-3757				Baruffi RLR, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-36; Bosch E, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-82; Cai QF, 2011, HUM REPROD, V26, P2532, DOI 10.1093/humrep/der228; Collins J, 2009, HUM REPROD UPDATE, V15, P1, DOI 10.1093/humupd/dmn054; De Sutter P, 2003, FERTIL STERIL, V79, P1294, DOI 10.1016/S0015-0282(03)00264-4; Fisch JD, 2003, FERTIL STERIL, V80, P1352, DOI 10.1016/j.fertnstert.2003.05.013; Gleicher N, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-48; HARRELL FE, 2001, REGRESSION MODELING, P20; Hosmer D. W., 2000, APPL LOGISTIC REGRES, P223; Hunault CC, 2002, FERTIL STERIL, V77, P725, DOI 10.1016/S0015-0282(01)03243-5; Marquez C, 2000, Reprod Biomed Online, V1, P17; Meniru GI, 1997, HUM REPROD, V12, P2129, DOI 10.1093/humrep/12.10.2129; Munne S, 2007, REPROD BIOMED ONLINE, V14, P628, DOI 10.1016/S1472-6483(10)61057-7; MUNNE S, 1995, FERTIL STERIL, V64, P382, DOI 10.1016/S0015-0282(16)57739-5; Ottosen LDM, 2007, J ASSIST REPROD GEN, V24, P29, DOI 10.1007/s10815-006-9082-9; Oudendijk JF, 2012, HUM REPROD UPDATE, V18, P1, DOI 10.1093/humupd/dmr037; Pandian Z, 2005, HUM REPROD, V20, P2681, DOI 10.1093/humrep/dei153; Pelinck MJ, 2008, HUM REPROD, V23, P1808, DOI 10.1093/humrep/den155; Popovic-Todorovic B, 2003, HUM REPROD, V18, P2275, DOI 10.1093/humrep/deg472; Roberts SA, 2010, HUM REPROD, V25, P2792, DOI 10.1093/humrep/deq213; Roberts SA, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14380; Roberts SA, 2009, HUM REPROD, V24, P122, DOI 10.1093/humrep/den355; Schimberni M, 2009, FERTIL STERIL, V92, P1297, DOI 10.1016/j.fertnstert.2008.07.1765; Segawa T, 2007, FERTIL STERIL, V88, pS286, DOI 10.1016/j.fertnstert.2007.07.967; Strandell A, 2000, HUM REPROD, V15, P2520, DOI 10.1093/humrep/15.12.2520; Sunkara SK, 2011, HUM REPROD, V26, P1768, DOI 10.1093/humrep/der106; TASDEMIR M, 1995, HUM REPROD, V10, P2155; Teramoto S, 2007, REPROD BIOMED ONLINE, V15, P134, DOI 10.1016/S1472-6483(10)60701-8; Terriou P, 2001, FERTIL STERIL, V75, P525, DOI 10.1016/S0015-0282(00)01741-6; Thurin A, 2004, NEW ENGL J MED, V351, P2392, DOI 10.1056/NEJMoa041032; van der Gaast MH, 2006, REPROD BIOMED ONLINE, V13, P476, DOI 10.1016/S1472-6483(10)60633-5; van Loendersloot LL, 2010, HUM REPROD UPDATE, V16, P577, DOI 10.1093/humupd/dmq015; Yih MC, 2005, FERTIL STERIL, V83, P24, DOI 10.1016/j.fertnstert.2004.05.096	33	36	38	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56189	10.1371/journal.pone.0056189	http://dx.doi.org/10.1371/journal.pone.0056189			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457525	gold, Green Published, Green Submitted			2022-12-25	WOS:000315603700025
J	Chi, YG; Xu, M; Shen, RC; Yang, QP; Huang, BR; Wan, SQ				Chi, Yonggang; Xu, Ming; Shen, Ruichang; Yang, Qingpeng; Huang, Bingru; Wan, Shiqiang			Acclimation of Foliar Respiration and Photosynthesis in Response to Experimental Warming in a Temperate Steppe in Northern China	PLOS ONE			English	Article							ELEVATED ATMOSPHERIC CO2; ELECTRON-TRANSPORT RATE; LEAF RESPIRATION; THERMAL-ACCLIMATION; MESOPHYLL CONDUCTANCE; RUBISCO-ACTIVASE; CARBON-DIOXIDE; INTERNAL CONDUCTANCE; GROWTH TEMPERATURE; SEASONAL-VARIATION	Background: Thermal acclimation of foliar respiration and photosynthesis is critical for projection of changes in carbon exchange of terrestrial ecosystems under global warming. Methodology/Principal Findings: A field manipulative experiment was conducted to elevate foliar temperature (T-leaf) by 2.07 degrees C in a temperate steppe in northern China. R-d/T-leaf curves (responses of dark respiration to T-leaf), A(n)/T-leaf curves (responses of light-saturated net CO2 assimilation rates to T-leaf), responses of biochemical limitations and diffusion limitations in gross CO2 assimilation rates (A(g)) to T-leaf, and foliar nitrogen (N) concentration in Stipa krylovii Roshev. were measured in 2010 (a dry year) and 2011 (a wet year). Significant thermal acclimation of R-d to 6-year experimental warming was found. However, A(n) had a limited ability to acclimate to a warmer climate regime. Thermal acclimation of R-d was associated with not only the direct effects of warming, but also the changes in foliar N concentration induced by warming. Conclusions/Significance: Warming decreased the temperature sensitivity (Q(10)) of the response of R-d/A(g) ratio to T-leaf. Our findings may have important implications for improving ecosystem models in simulating carbon cycles and advancing understanding on the interactions between climate change and ecosystem functions.	[Chi, Yonggang; Xu, Ming; Shen, Ruichang; Yang, Qingpeng] Chinese Acad Sci, Key Lab Ecosyst Network Observat & Modeling, Inst Geog Sci & Nat Resources Res, Beijing, Peoples R China; [Chi, Yonggang; Shen, Ruichang] Univ Chinese Acad Sci, Beijing, Peoples R China; [Xu, Ming] Rutgers State Univ, Dept Ecol Evolut & Nat Resources, Ctr Remote Sensing & Spatial Anal, New Brunswick, NJ 08903 USA; [Yang, Qingpeng] Chinese Acad Sci, Inst Appl Ecol, Huitong Expt Stn Forest Ecol, State Key Lab Forest & Soil Ecol, Shenyang 110016, Peoples R China; [Huang, Bingru] Rutgers State Univ, Dept Plant Biol & Pathol, New Brunswick, NJ 08903 USA; [Wan, Shiqiang] Henan Univ, Key Lab Plant Stress Biol, Coll Life Sci, Kaifeng, Henan, Peoples R China	Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Rutgers State University New Brunswick; Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS; Rutgers State University New Brunswick; Henan University	Xu, M (corresponding author), Chinese Acad Sci, Key Lab Ecosyst Network Observat & Modeling, Inst Geog Sci & Nat Resources Res, Beijing, Peoples R China.	mingxu@igsnrr.ac.cn	Yang, Qingpeng/B-3632-2014; Wan, Shiqiang/L-9166-2019; Wan, Shiqiang/B-5799-2009; Shen, Ruichang/O-4305-2017	Yang, Qingpeng/0000-0003-2471-6233; Wan, Shiqiang/0000-0003-0631-1232; Wan, Shiqiang/0000-0003-0631-1232; Shen, Ruichang/0000-0003-0055-8058; /0000-0002-3418-1992	National Key Research and Development Program of China [2010CB833500]; 100 Talents Program of the Chinese Academy of Sciences; National Natural Science Foundation [30925009]	National Key Research and Development Program of China; 100 Talents Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	Financial support came from the National Key Research and Development Program of China (2010CB833500, http://www.973.gov.cn), the 100 Talents Program of the Chinese Academy of Sciences supported M. Xu's work (http://www.cas.cn) and National Natural Science Foundation (30925009, http://www.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JM, 1995, PHOTOSYNTH RES, V46, P129, DOI 10.1007/BF00020423; ARMOND PA, 1978, PLANT PHYSIOL, V61, P411, DOI 10.1104/pp.61.3.411; Armstrong AF, 2008, PLANT CELL ENVIRON, V31, P1156, DOI 10.1111/j.1365-3040.2008.01830.x; Armstrong AF, 2006, AM J BOT, V93, P1633, DOI 10.3732/ajb.93.11.1633; Atkin OK, 2006, GLOBAL CHANGE BIOL, V12, P500, DOI 10.1111/j.1365-2486.2006.01114.x; Atkin OK, 2005, FUNCT PLANT BIOL, V32, P87, DOI 10.1071/FP03176; Atkin OK, 2000, PLANT PHYSIOL, V122, P915, DOI 10.1104/pp.122.3.915; Atkin OK, 2003, TRENDS PLANT SCI, V8, P343, DOI 10.1016/S1360-1385(03)00136-5; Atkin OK, 2009, ANN BOT-LONDON, V103, P581, DOI 10.1093/aob/mcn094; BADGER MR, 1982, PLANT CELL ENVIRON, V5, P85; Bernacchi CJ, 2002, PLANT PHYSIOL, V130, P1992, DOI 10.1104/pp.008250; BERRY J, 1980, ANNU REV PLANT PHYS, V31, P491, DOI 10.1146/annurev.pp.31.060180.002423; Bolstad PV, 2003, TREE PHYSIOL, V23, P969, DOI 10.1093/treephys/23.14.969; Campbell C, 2007, NEW PHYTOL, V176, P375, DOI 10.1111/j.1469-8137.2007.02183.x; Cen YP, 2005, PLANT PHYSIOL, V139, P979, DOI 10.1104/pp.105.066233; Crafts-Brandner SJ, 2000, P NATL ACAD SCI USA, V97, P13430, DOI 10.1073/pnas.230451497; Crous KY, 2011, GLOBAL CHANGE BIOL, V17, P1560, DOI 10.1111/j.1365-2486.2010.02325.x; Davidson EA, 2006, GLOBAL CHANGE BIOL, V12, P154, DOI 10.1111/j.1365-2486.2005.01065.x; Delatorre J, 2008, J PHOTOCH PHOTOBIO B, V92, P67, DOI 10.1016/j.jphotobiol.2008.04.004; Dewar RC, 1999, GLOBAL CHANGE BIOL, V5, P615, DOI 10.1046/j.1365-2486.1999.00253.x; Dillaway DN, 2010, PLANT CELL ENVIRON, V33, P888, DOI 10.1111/j.1365-3040.2010.02114.x; Dreyer E, 2001, TREE PHYSIOL, V21, P223, DOI 10.1093/treephys/21.4.223; Ethier GJ, 2004, PLANT CELL ENVIRON, V27, P137, DOI 10.1111/j.1365-3040.2004.01140.x; FARQUHAR GD, 1980, PLANTA, V149, P78, DOI 10.1007/BF00386231; FERRAR PJ, 1989, AUST J PLANT PHYSIOL, V16, P199, DOI 10.1071/PP9890199; Flexas J, 2007, NEW PHYTOL, V175, P501, DOI 10.1111/j.1469-8137.2007.02111.x; Flexas J, 2004, PLANT BIOLOGY, V6, P269, DOI 10.1055/s-2004-820867; Flexas J, 2008, PLANT CELL ENVIRON, V31, P602, DOI 10.1111/j.1365-3040.2007.01757.x; Galmes J, 2007, NEW PHYTOL, V175, P81, DOI 10.1111/j.1469-8137.2007.02087.x; Galmes J, 2011, J EXP BOT, V62, P653, DOI 10.1093/jxb/erq303; Gifford RM, 1995, GLOBAL CHANGE BIOL, V1, P385, DOI 10.1111/j.1365-2486.1995.tb00037.x; Griffin KL, 2002, NEW PHYTOL, V154, P609, DOI 10.1046/j.1469-8137.2002.00410.x; Gunderson CA, 2000, TREE PHYSIOL, V20, P87; Gunderson CA, 2010, GLOBAL CHANGE BIOL, V16, P2272, DOI 10.1111/j.1365-2486.2009.02090.x; GUTTERIDGE S, 1995, PLANT CELL, V7, P809, DOI 10.1105/tpc.7.7.809; HARLEY PC, 1992, PLANT CELL ENVIRON, V15, P271, DOI 10.1111/j.1365-3040.1992.tb00974.x; Harley PC, 1991, MODELING CROP PHOTOS, P1; Hartley IP, 2006, GLOBAL CHANGE BIOL, V12, P1954, DOI 10.1111/j.1365-2486.2006.01214.x; Hendrickson L, 2004, PLANT CELL ENVIRON, V27, P795, DOI 10.1111/j.1365-3040.2004.01184.x; Hikosaka K, 2006, J EXP BOT, V57, P291, DOI 10.1093/jxb/erj049; Hikosaka K, 2005, PLANT CELL PHYSIOL, V46, P1283, DOI 10.1093/pcp/pci137; Hikosaka K, 1999, PLANT CELL ENVIRON, V22, P841, DOI 10.1046/j.1365-3040.1999.00442.x; Hikosaka K, 1997, ANN BOT-LONDON, V80, P721, DOI 10.1006/anbo.1997.0512; Kattge J, 2007, PLANT CELL ENVIRON, V30, P1176, DOI 10.1111/j.1365-3040.2007.01690.x; KIRSCHBAUM MUF, 1984, AUST J PLANT PHYSIOL, V11, P519, DOI 10.1071/PP9840519; Lee TD, 2005, FUNCT ECOL, V19, P640, DOI 10.1111/j.1365-2435.2005.01023.x; Leuning R, 2002, PLANT CELL ENVIRON, V25, P1205, DOI 10.1046/j.1365-3040.2002.00898.x; Lin YS, 2012, TREE PHYSIOL, V32, P219, DOI 10.1093/treephys/tpr141; Loveys BR, 2003, GLOBAL CHANGE BIOL, V9, P895, DOI 10.1046/j.1365-2486.2003.00611.x; Luo HB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023033; Luo YQ, 2007, ANNU REV ECOL EVOL S, V38, P683, DOI 10.1146/annurev.ecolsys.38.091206.095808; Luo YQ, 2011, TRENDS ECOL EVOL, V26, P96, DOI 10.1016/j.tree.2010.11.003; MAKINO A, 1994, PLANT PHYSIOL, V105, P173, DOI 10.1104/pp.105.1.173; Medlyn BE, 2002, PLANT CELL ENVIRON, V25, P1155, DOI 10.1046/j.1365-3040.2002.00890.x; Melillo JM, 2002, SCIENCE, V298, P2173, DOI 10.1126/science.1074153; Miao ZW, 2009, PLANT CELL ENVIRON, V32, P109, DOI 10.1111/j.1365-3040.2008.01900.x; MIROSLAVOV EA, 1991, ANN BOT-LONDON, V68, P195, DOI 10.1093/oxfordjournals.aob.a088244; MITCHELL RAC, 1986, PLANTA, V169, P429, DOI 10.1007/BF00392141; MOONEY HA, 1978, PLANT PHYSIOL, V61, P406, DOI 10.1104/pp.61.3.406; Niu SL, 2008, ENVIRON EXP BOT, V63, P91, DOI 10.1016/j.envexpbot.2007.10.016; Niu SL, 2012, NEW PHYTOL, V194, P775, DOI 10.1111/j.1469-8137.2012.04095.x; Onoda Y, 2005, FUNCT PLANT BIOL, V32, P903, DOI 10.1071/FP05024; Ow LF, 2008, NEW PHYTOL, V178, P123, DOI 10.1111/j.1469-8137.2007.02357.x; Ow LF, 2010, GLOBAL CHANGE BIOL, V16, P288, DOI 10.1111/j.1365-2486.2009.01892.x; Rachmilevitch S, 2006, J EXP BOT, V57, P623, DOI 10.1093/jxb/erj047; Rachmilevitch S, 2008, J EXP BOT, V59, P3803, DOI 10.1093/jxb/ern233; Sage RF, 2008, J EXP BOT, V59, P1581, DOI 10.1093/jxb/ern053; Sage RF, 2007, PLANT CELL ENVIRON, V30, P1086, DOI 10.1111/j.1365-3040.2007.01682.x; SHARKEY TD, 1985, PLANT PHYSIOL, V78, P71, DOI 10.1104/pp.78.1.71; Sharkey TD, 2007, PLANT CELL ENVIRON, V30, P1035, DOI 10.1111/j.1365-3040.2007.01710.x; Teskey RO, 1999, TREE PHYSIOL, V19, P519, DOI 10.1093/treephys/19.8.519; Thornton PE, 2002, AGR FOREST METEOROL, V113, P185, DOI 10.1016/S0168-1923(02)00108-9; Tjoelker MG, 2008, GLOBAL CHANGE BIOL, V14, P782, DOI 10.1111/j.1365-2486.2008.01548.x; Tjoelker MG, 2001, GLOBAL CHANGE BIOL, V7, P223, DOI 10.1046/j.1365-2486.2001.00397.x; Turnbull MH, 2005, OECOLOGIA, V143, P271, DOI 10.1007/s00442-004-1803-0; VONCAEMMERER S, 1981, PLANTA, V153, P376, DOI 10.1007/BF00384257; Walcroft AS, 1997, PLANT CELL ENVIRON, V20, P1338, DOI 10.1046/j.1365-3040.1997.d01-31.x; Wan SQ, 2009, ECOLOGY, V90, P2700, DOI 10.1890/08-2026.1; Wang XZ, 2001, P NATL ACAD SCI USA, V98, P2479, DOI 10.1073/pnas.051622998; Warren CR, 2008, TREE PHYSIOL, V28, P11, DOI 10.1093/treephys/28.1.11; Way DA, 2008, PLANT CELL ENVIRON, V31, P1250, DOI 10.1111/j.1365-3040.2008.01842.x; Weston DJ, 2007, AM J BOT, V94, P926, DOI 10.3732/ajb.94.6.926; WILLIAMS DG, 1993, FUNCT ECOL, V7, P623, DOI 10.2307/2390140; WULLSCHLEGER SD, 1993, J EXP BOT, V44, P907, DOI 10.1093/jxb/44.5.907; Xia JY, 2009, GLOBAL CHANGE BIOL, V15, P1544, DOI 10.1111/j.1365-2486.2008.01807.x; Xu CY, 2006, FUNCT ECOL, V20, P778, DOI 10.1111/j.1365-2435.2006.01161.x; Xu M, 2001, GLOBAL BIOGEOCHEM CY, V15, P687, DOI 10.1029/2000GB001365; Yamasaki T, 2002, PLANT PHYSIOL, V128, P1087, DOI 10.1104/pp.010919; Yamori W, 2005, PLANT CELL ENVIRON, V28, P536, DOI 10.1111/j.1365-3040.2004.01299.x; Yamori W, 2006, PLANT CELL PHYSIOL, V47, P1069, DOI 10.1093/pcp/pcj077; Yamori W, 2010, PLANT PHYSIOL, V152, P388, DOI 10.1104/pp.109.145862; Yan LM, 2011, GLOBAL CHANGE BIOL, V17, P1990, DOI 10.1111/j.1365-2486.2010.02365.x; Zhou XH, 2007, J INTEGR PLANT BIOL, V49, P270, DOI 10.1111/j.1744-7909.2007.00374.x	93	31	33	3	103	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56482	10.1371/journal.pone.0056482	http://dx.doi.org/10.1371/journal.pone.0056482			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457574	Green Published, gold, Green Submitted			2022-12-25	WOS:000315603700058
J	Johnsen, MT; Wynn, R; Bratlid, T				Johnsen, May Trude; Wynn, Rolf; Bratlid, Trond			Optimal Sleep Duration in the Subarctic with Respect to Obesity Risk Is 8-9 Hours	PLOS ONE			English	Article							BODY-MASS INDEX; SOCIAL JETLAG; WEIGHT-GAIN; ASSOCIATION; OVERWEIGHT; PATTERNS; CHILDREN; LONG	Introduction: Sleep duration, chronotype and social jetlag have been associated with body mass index (BMI) and abdominal obesity. The optimal sleep duration regarding BMI has previously been found to be 7-8 hours, but these studies have not been carried out in the subarctic or have lacked some central variables. The aims of our study were to examine the associations between sleep variables and body composition for people living in the subarctic, taking a range of variables into consideration, including lifestyle variables, health variables and biological factors. Methods: The cross sectional population Tromso Study was conducted in northern Norway, above the Arctic Circle. 6413 persons aged 30-65 years completed questionnaires including self-reported sleep times, lifestyle and health. They also measured height, weight, waist and hip circumference, and biological factors (non-fasting serum level of cholesterol, HDL-cholesterol, LDL-cholesterol, triglycerides and glucose). The study period was from 1 October 2007 to 19 December 2008. Results: The optimal sleep length regarding BMI and waist circumference was found to be 8-9 hours. Short sleepers (<6 h) had about 80% increased risk of being in the BMI >= 25 kg/m2 group and male short sleepers had doubled risk of having waist circumference >= 102 cm compared to 8-9 hours sleepers. We found no impact of chronotype or social jetlag on BMI or abdominal obesity after controlling for health, lifestyle, and biological parameters. Conclusions: In our subarctic population, the optimal sleep duration time regarding risk of overweight and abdominal obesity was 8-9 hours, which is one hour longer compared to findings from other studies. Short sleepers had 80% increased risk of being overweight, and men had a doubled risk of having abdominal obesity. We found no associations between chronotype or social jetlag and BMI or abdominal obesity, when we took a range of life-style, health and biological variables into consideration.	[Johnsen, May Trude; Wynn, Rolf; Bratlid, Trond] Univ Tromso, Fac Hlth Sci, Dept Clin Med, Tromso, Norway; [Wynn, Rolf; Bratlid, Trond] Univ Hosp North Norway, Tromso, Norway	UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; University Hospital of North Norway	Johnsen, MT (corresponding author), Univ Tromso, Fac Hlth Sci, Dept Clin Med, Tromso, Norway.	maytrude@online.no	Wynn, Rolf/ABE-8410-2020	Wynn, Rolf/0000-0002-2254-3343	North Norway Regional Health Authority	North Norway Regional Health Authority	This was not an industry supported study. The study was funded by the North Norway Regional Health Authority (http://www.helse-nord.no). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baron KG, 2011, OBESITY, V19, P1374, DOI 10.1038/oby.2011.100; Bjorvatn B, 2007, J SLEEP RES, V16, P66, DOI 10.1111/j.1365-2869.2007.00569.x; Buxton OM, 2010, SOC SCI MED, V71, P1027, DOI 10.1016/j.socscimed.2010.05.041; Cappuccio FP, 2008, SLEEP, V31, P619, DOI 10.1093/sleep/31.5.619; Cournot M, 2004, EUR J CARDIOV PREV R, V11, P291, DOI 10.1097/01.hjr.0000129738.22970.62; CZEISLER CA, 1981, PHOTOCHEM PHOTOBIOL, V34, P239; DEROGATIS LR, 1974, BEHAV SCI, V19, P1, DOI 10.1002/bs.3830190102; Evans DS, 2011, SLEEP, V34, P661, DOI 10.1093/sleep/34.5.661; Fogelholm M, 2007, INT J OBESITY, V31, P1713, DOI 10.1038/sj.ijo.0803663; Gangwisch JE, 2005, SLEEP, V28, P1289, DOI 10.1093/sleep/28.10.1289; Groholt EK, 2008, J PUBLIC HEALTH-UK, V30, P258, DOI 10.1093/pubmed/fdn037; HAMMOND EC, 1964, AM J PUBLIC HEALTH N, V54, P11, DOI 10.2105/AJPH.54.1.11; Horne J, 2008, BIOL PSYCHOL, V77, P266, DOI 10.1016/j.biopsycho.2007.12.003; Howel D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048528; Jacobsen BK, 2012, INT J EPIDEMIOL, V41, P961, DOI 10.1093/ije/dyr049; Johnsen M, 2012, SLEEP MED IN PRESS; Kobayashi D, 2012, SLEEP BREATH, V16, P829, DOI 10.1007/s11325-011-0583-0; Kohatsu ND, 2006, ARCH INTERN MED, V166, P1701, DOI 10.1001/archinte.166.16.1701; Kokkvoll A, 2012, ACTA PAEDIATR, V101, P924, DOI 10.1111/j.1651-2227.2012.02735.x; Kripke DF, 2011, SLEEP MED, V12, P28, DOI 10.1016/j.sleep.2010.04.016; Lauderdale DS, 2009, AM J EPIDEMIOL, V170, P805, DOI 10.1093/aje/kwp230; Leitzmann MF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018582; Magee CA, 2008, PUBLIC HEALTH, V122, P1373, DOI 10.1016/j.puhe.2008.05.010; Magee CA, 2011, SLEEP MED, V12, P346, DOI 10.1016/j.sleep.2010.09.013; Magee L, 2012, SLEEP MED REV, V16, P231, DOI 10.1016/j.smrv.2011.05.005; Marshall NS, 2008, SLEEP MED REV, V12, P289, DOI 10.1016/j.smrv.2008.03.001; Niedhammer I, 2000, INT J OBESITY, V24, P1111, DOI 10.1038/sj.ijo.0801375; Nielsen LS, 2011, OBES REV, V12, P78, DOI 10.1111/j.1467-789X.2010.00724.x; Patel SR, 2008, OBESITY, V16, P643, DOI 10.1038/oby.2007.118; REYNER A, 1995, SLEEP, V18, P127; Rodgers GP, 2012, JAMA-J AM MED ASSOC, V308, P1095, DOI 10.1001/2012.jama.11853; Roenneberg T, 2004, CURR BIOL, V14, pR1038, DOI 10.1016/j.cub.2004.11.039; Roenneberg T, 2003, J BIOL RHYTHM, V18, P80, DOI 10.1177/0748730402239679; Roenneberg T, 2007, SLEEP MED REV, V11, P429, DOI 10.1016/j.smrv.2007.07.005; Roenneberg T, 2012, CURR BIOL, V22, P939, DOI 10.1016/j.cub.2012.03.038; Rontoyanni VG, 2007, NUTRITION, V23, P773, DOI 10.1016/j.nut.2007.07.005; Sogaard Anne Johanne, 2004, Int J Equity Health, V3, P3; Spiegel K, 2005, J APPL PHYSIOL, V99, P2008, DOI 10.1152/japplphysiol.00660.2005; St-Onge MP, 2010, INT J ENDOCRINOL, V2010, DOI 10.1155/2010/726071; Stranges S, 2008, AM J EPIDEMIOL, V167, P321, DOI 10.1093/aje/kwm302; Taheri S, 2004, PLOS MED, V1, P210, DOI 10.1371/journal.pmed.0010062; Theorell-Haglow J, 2010, SLEEP, V33, P593; Trenell MI, 2007, CLIN EXP PHARMACOL P, V34, P1, DOI 10.1111/j.1440-1681.2007.04541.x; Ursin R, 2005, SLEEP, V28, P1260, DOI 10.1093/sleep/28.10.1260; WEVER RA, 1983, PFLUG ARCH EUR J PHY, V396, P85, DOI 10.1007/BF00584704; Wittmann M, 2006, CHRONOBIOL INT, V23, P497, DOI 10.1080/07420520500545979; Yi S, 2012, INT J OBES LOND	47	16	16	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56756	10.1371/journal.pone.0056756	http://dx.doi.org/10.1371/journal.pone.0056756			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457611	Green Submitted, Green Published, gold			2022-12-25	WOS:000315603700079
J	Lai, CF; Chen, YM; Chiang, WC; Lin, SL; Kuo, ML; Tsai, TJ				Lai, Chun-Fu; Chen, Yung-Ming; Chiang, Wen-Chih; Lin, Shuei-Liong; Kuo, Min-Liang; Tsai, Tun-Jun			Cysteine-Rich Protein 61 Plays a Proinflammatory Role in Obstructive Kidney Fibrosis	PLOS ONE			English	Article							TISSUE-GROWTH-FACTOR; UNILATERAL URETERAL OBSTRUCTION; RENAL INTERSTITIAL FIBROSIS; TUBULOINTERSTITIAL FIBROSIS; TGF-BETA; CYR61 CCN1; NEPHROPATHY; CELLS; FIBROBLASTS; MECHANISMS	Cysteine-rich protein 61 (Cyr61) is a secreted matrix-associated protein that regulates a broad spectrum of biological and cellular activities. This study aimed to investigate the role of Cyr61 in progressive kidney fibrosis induced by unilateral ureteral obstruction (UUO) surgery in mice. The expression of Cyr61 transcripts and proteins in the obstructed kidneys were increased from day 1 and remained high until day 10 after surgery. Immunohistochemistry indicated that Cyr61 was expressed mainly in renal tubular epithelial cells. The upregulated Cyr61 in UUO kidneys was reduced in mice treated with pan-transforming growth factor-beta (TGF-beta) antibody. The role of TGF-beta in tubular Cyr61 upregulation after obstructive kidney injury was further supported by experiments showing that TGF-beta 1 stimulated Cyr61 expression in cultured tubular epithelial cells. Notably, the upregulation of Cyr61 in UUO kidneys was followed by a marked increase in monocyte chemoattractant protein 1 (MCP-1) transcripts and macrophage infiltration, which were attenuated in mice treated with anti-Cyr61 antibodies. This proinflammatory property of Cyr61 in inducing MCP-1 expression was further confirmed in tubular epithelial cells cultured with Cyr61 protein. The anti-Cyr61 antibody in UUO mice also reduced the levels of collagen type 1-alpha 1 transcripts, collagen fibril accumulation evaluated by picrosirius red staining, and the levels of alpha-smooth muscle actin (alpha-SMA) transcripts and proteins on day 4 after surgery; however, the antifibrotic effect was not sustained. In conclusion, the TGF-beta-mediated increase in tubular Cyr61 expression involved renal inflammatory cell infiltration through MCP-1 induction during obstructive kidney injury. The Cyr61 blockade attenuated kidney fibrosis in the early phase, but the antifibrotic effect could not be sustained.	[Lai, Chun-Fu; Chen, Yung-Ming; Chiang, Wen-Chih; Lin, Shuei-Liong; Tsai, Tun-Jun] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Lai, Chun-Fu; Chen, Yung-Ming; Chiang, Wen-Chih; Lin, Shuei-Liong; Tsai, Tun-Jun] Coll Med, Taipei, Taiwan; [Lai, Chun-Fu] Natl Taiwan Univ, Grad Inst Clin Med, Coll Med, Taipei 10764, Taiwan; [Lin, Shuei-Liong] Natl Taiwan Univ, Grad Inst Physiol, Coll Med, Taipei 10764, Taiwan; [Kuo, Min-Liang] Natl Taiwan Univ, Grad Inst Toxicol, Coll Med, Taipei 10764, Taiwan; [Chen, Yung-Ming] Natl Taiwan Univ Hosp, Yun Lin Branch, Dept Internal Med, Douliou City, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital	Tsai, TJ (corresponding author), Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan.	tjtsai@ntuh.gov.tw	Lin, Shuei-Liong/AGR-2002-2022	Lin, Shuei-Liong/0000-0002-1041-5571; Chiang, Wen Chih/0000-0002-8844-0988; CHEN, YUNG-MING/0000-0002-9241-1258; TSAI, TUN-JUN/0000-0002-1666-8940; LAI, CHUN-FU/0000-0003-2109-1522; KUO, MIN-LIANG/0000-0002-7139-0144	National Science Council [NSC 96-2628-B-002-015-MY3]; Far Eastern Memorial Hospital [FEMH-95-C-024]; Ta-Tung Kidney Foundation; Mrs. Hsiu-Chin Lee Kidney Research Fund	National Science Council(Ministry of Science and Technology, Taiwan); Far Eastern Memorial Hospital; Ta-Tung Kidney Foundation; Mrs. Hsiu-Chin Lee Kidney Research Fund	This study was supported by grants from the National Science Council (NSC 96-2628-B-002-015-MY3), Far Eastern Memorial Hospital (FEMH-95-C-024), Ta-Tung Kidney Foundation and Mrs. Hsiu-Chin Lee Kidney Research Fund for supporting this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai T, 2010, J IMMUNOL, V184, P3223, DOI 10.4049/jimmunol.0902792; Bartholin L, 2007, CANCER LETT, V246, P230, DOI 10.1016/j.canlet.2006.02.019; Bascands JL, 2005, KIDNEY INT, V68, P925, DOI 10.1111/j.1523-1755.2005.00486.x; Boor P, 2007, J AM SOC NEPHROL, V18, P1508, DOI 10.1681/ASN.2006121343; Bottinger EP, 1997, KIDNEY INT, V51, P1355, DOI 10.1038/ki.1997.185; Chen CC, 2001, J BIOL CHEM, V276, P47329, DOI 10.1074/jbc.M107666200; Chen CC, 2009, INT J BIOCHEM CELL B, V41, P771, DOI 10.1016/j.biocel.2008.07.025; Chen Y, 2007, J CELL BIOCHEM, V100, P1337, DOI 10.1002/jcb.21194; Chen YM, 2003, KIDNEY INT, V63, P474, DOI 10.1046/j.1523-1755.2003.00766.x; Chevalier RL, 2009, KIDNEY INT, V75, P1145, DOI 10.1038/ki.2009.86; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Duffield JS, 2010, SEMIN NEPHROL, V30, P234, DOI 10.1016/j.semnephrol.2010.03.003; El Chaar M, 2007, AM J PHYSIOL-RENAL, V292, pF1291, DOI 10.1152/ajprenal.00327.2005; Garcia-Sanchez O, 2010, KIDNEY INT, V77, P950, DOI 10.1038/ki.2010.88; Grande MT, 2009, NAT REV NEPHROL, V5, P319, DOI 10.1038/nrneph.2009.74; Isaka Y, 2000, KIDNEY INT, V58, P1885, DOI 10.1046/j.1523-1755.2000.00360.x; Jones LK, 2009, NEPHROL DIAL TRANSPL, V24, P3024, DOI 10.1093/ndt/gfp214; Jun JI, 2010, NAT CELL BIOL, V12, P676, DOI 10.1038/ncb2070; Kitagawa K, 2004, AM J PATHOL, V165, P237, DOI 10.1016/S0002-9440(10)63292-0; Klahr S, 2002, AM J PHYSIOL-RENAL, V283, pF861, DOI 10.1152/ajprenal.00362.2001; Kular L, 2011, BIOCHIMIE, V93, P377, DOI 10.1016/j.biochi.2010.11.010; KUNCIO GS, 1991, KIDNEY INT, V39, P550, DOI 10.1038/ki.1991.63; Leask A, 2006, J CELL SCI, V119, P4803, DOI 10.1242/jcs.03270; Leu SJ, 2002, J BIOL CHEM, V277, P46248, DOI 10.1074/jbc.M209288200; Lin S. L., 2012, ACTA NEPHROL, V26, P45; Lin SL, 2009, J IMMUNOL, V183, P6733, DOI 10.4049/jimmunol.0901473; Lin SL, 2010, P NATL ACAD SCI USA, V107, P4194, DOI 10.1073/pnas.0912228107; Lin SL, 2008, AM J PATHOL, V173, P1617, DOI 10.2353/ajpath.2008.080433; Lin SL, 2002, J AM SOC NEPHROL, V13, P2916, DOI 10.1097/01.ASN.0000034909.10994.8A; Lin SL, 2005, J AM SOC NEPHROL, V16, P2702, DOI 10.1681/ASN.2005040435; Ling H, 2003, J AM SOC NEPHROL, V14, P377, DOI 10.1097/01.ASN.0000042168.43665.9B; Miyajima A, 2000, KIDNEY INT, V58, P2301, DOI 10.1046/j.1523-1755.2000.00414.x; Mo FE, 2002, MOL CELL BIOL, V22, P8709, DOI 10.1128/MCB.22.24.8709-8720.2002; Muramatsu Y, 2002, KIDNEY INT, V62, P1601, DOI 10.1046/j.1523-1755.2002.00633.x; Nguyen TQ, 2008, PHARM RES-DORDR, V25, P2416, DOI 10.1007/s11095-008-9548-9; Perbal B, 2004, LANCET, V363, P62, DOI 10.1016/S0140-6736(03)15172-0; Qi W, 2008, INT J BIOCHEM CELL B, V40, P9, DOI 10.1016/j.biocel.2007.01.006; Ricardo SD, 2008, J CLIN INVEST, V118, P3522, DOI 10.1172/JCI36150; Sawai K, 2003, J AM SOC NEPHROL, V14, P1154, DOI 10.1097/01.ASN.0000060576.61218.3D; Sawai K, 2007, AM J PHYSIOL-RENAL, V293, pF1363, DOI 10.1152/ajprenal.00205.2007; Schlondorff DO, 2008, KIDNEY INT, V74, P860, DOI 10.1038/ki.2008.351; Todorovic V, 2005, J CELL BIOL, V171, P559, DOI 10.1083/jcb.200504015; Wang WM, 2009, ACTA PHARMACOL SIN, V30, P107, DOI 10.1038/aps.2008.15; Wolf G, 2006, KIDNEY INT, V70, P1914, DOI 10.1038/sj.ki.5001846; Yokoi H, 2002, AM J PHYSIOL-RENAL, V282, pF933, DOI 10.1152/ajprenal.00122.2001; Zeisberg M, 2010, J AM SOC NEPHROL, V21, P1819, DOI 10.1681/ASN.2010080793	46	23	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56481	10.1371/journal.pone.0056481	http://dx.doi.org/10.1371/journal.pone.0056481			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457573	Green Submitted, Green Published, gold			2022-12-25	WOS:000315603700057
J	Mohapatra, NP; Soni, S; Rajaram, MVS; Strandberg, KL; Gunn, JS				Mohapatra, Nrusingh P.; Soni, Shilpa; Rajaram, Murugesan V. S.; Strandberg, Kristi L.; Gunn, John S.			Type A Francisella tularensis Acid Phosphatases Contribute to Pathogenesis	PLOS ONE			English	Article							VIRULENCE GENE-EXPRESSION; PNEUMONIC TULAREMIA; LEISHMANIA-DONOVANI; PHAGOSOMAL ESCAPE; NADPH OXIDASE; WILD-TYPE; IN-VITRO; IDENTIFICATION; MACROPHAGES; APOPTOSIS	Different Francisella spp. produce five or six predicted acid phosphatases (AcpA, AcpB, AcpC, AcpD, HapA and HapB). The genes encoding the histidine acid phosphatases (hapA, hapB) and acpD of F. tularensis subsp. Schu S4 strain are truncated or disrupted. However, deletion of HapA (FTT1064) in F. tularensis Schu S4 resulted in a 33% reduction in acid phosphatase activity and loss of the four functional acid phosphatases in F. tularensis Schu S4 (Delta ABCH) resulted in a>99% reduction in acid phosphatase activity compared to the wild type strain. All single, double and triple mutants tested, demonstrated a moderate decrease in mouse virulence and survival and growth within human and murine phagocytes, whereas the Delta ABCH mutant showed >3.5-fold decrease in intramacrophage survival and 100% attenuation of virulence in mouse. While the Schu S4 Delta ABCH strain was attenuated in the mouse model, it showed only limited protection against wild type challenge. F. tularensis Schu S4 failed to stimulate reactive oxygen species production in phagocytes, whereas infection by the Delta ABCH strain stimulated 5- and 56-fold increase in reactive oxygen species production in neutrophils and human monocyte-derived macrophages, respectively. The Delta ABCH mutant but not the wild type strain strongly co-localized with p47(phox) and replicated in macrophages isolated from p47(phox) knockout mice. Thus, F. tularensis Schu S4 acid phosphatases, including the truncated HapA, play a major role in intramacrophage survival and virulence of this human pathogen.	[Mohapatra, Nrusingh P.; Soni, Shilpa; Rajaram, Murugesan V. S.; Strandberg, Kristi L.; Gunn, John S.] Ohio State Univ, Dept Microbial Infect & Immun, Ctr Microbial Interface Biol, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	Gunn, JS (corresponding author), Ohio State Univ, Dept Microbial Infect & Immun, Ctr Microbial Interface Biol, Columbus, OH 43210 USA.	gunn.43@osu.edu	Gunn, John/E-3167-2011; Rajaram, Murugesan/E-5203-2013	Rajaram, Murugesan/0000-0002-1515-1122	NIH/NIAID Regional Center of Excellence for Bio-defense and Emerging Infectious Diseases Research (RCE) Program; Region V "Great Lakes" RCE (NIH) [2-U54-AI-057153]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057153] Funding Source: NIH RePORTER	NIH/NIAID Regional Center of Excellence for Bio-defense and Emerging Infectious Diseases Research (RCE) Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Region V "Great Lakes" RCE (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was sponsored by the NIH/NIAID Regional Center of Excellence for Bio-defense and Emerging Infectious Diseases Research (RCE) Program. The authors wish to acknowledge membership within and support from the Region V "Great Lakes" RCE (NIH award 2-U54-AI-057153). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aragon V, 2000, INFECT IMMUN, V68, P1855, DOI 10.1128/IAI.68.4.1855-1863.2000; BACA OG, 1993, INFECT IMMUN, V61, P4232, DOI 10.1128/IAI.61.10.4232-4239.1993; Balagopal A, 2006, INFECT IMMUN, V74, P5114, DOI 10.1128/IAI.00795-06; Barker JH, 2009, MICROBES INFECT, V11, P762, DOI 10.1016/j.micinf.2009.04.016; Barker JR, 2009, MOL MICROBIOL, V74, P1459, DOI 10.1111/j.1365-2958.2009.06947.x; Baron GS, 1998, MOL MICROBIOL, V29, P247, DOI 10.1046/j.1365-2958.1998.00926.x; Bell BL, 2010, INFECT IMMUN, V78, P2189, DOI 10.1128/IAI.00021-10; Ben Nasr A, 2006, J LEUKOCYTE BIOL, V80, P774, DOI 10.1189/jlb.1205755; Broekhuijsen M, 2003, J CLIN MICROBIOL, V41, P2924, DOI 10.1128/JCM.41.7.2924-2931.2003; Brotcke A, 2006, INFECT IMMUN, V74, P6642, DOI 10.1128/IAI.01250-06; Broteke A, 2008, INFECT IMMUN, V76, P3473, DOI 10.1128/IAI.00430-08; Buchan BW, 2009, INFECT IMMUN, V77, P2517, DOI 10.1128/IAI.00229-09; Burtnick MN, 2001, MICROBIOL-UK, V147, P111, DOI 10.1099/00221287-147-1-111; Charity JC, 2007, PLOS PATHOG, V3, P770, DOI 10.1371/journal.ppat.0030084; Charity JC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000641; Checroun C, 2006, P NATL ACAD SCI USA, V103, P14578, DOI 10.1073/pnas.0601838103; Child R, 2010, INFECT IMMUN, V78, P59, DOI 10.1128/IAI.00965-09; Chong A, 2008, INFECT IMMUN, V76, P5488, DOI 10.1128/IAI.00682-08; Clay CD, 2008, J IMMUNOL, V181, P5568, DOI 10.4049/jimmunol.181.8.5568; Clemens DL, 2009, INFECT IMMUN, V77, P1757, DOI 10.1128/IAI.01485-08; Clemens DL, 2005, INFECT IMMUN, V73, P5892, DOI 10.1128/IAI.73.9.5892-5902.2005; CONLAN JW, 1992, INFECT IMMUN, V60, P5164, DOI 10.1128/IAI.60.12.5164-5171.1992; Dai SP, 2012, INFECT IMMUN, V80, P1088, DOI 10.1128/IAI.06245-11; de Bruin OM, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-1; Dennis DT, 2001, JAMA-J AM MED ASSOC, V285, P2763, DOI 10.1001/jama.285.21.2763; Elkins KL, 2007, ANN NY ACAD SCI, V1105, P284, DOI 10.1196/annals.1409.014; Feldman KA, 2001, NEW ENGL J MED, V345, P1601, DOI 10.1056/NEJMoa011374; FORTIER AH, 1992, INFECT IMMUN, V60, P817, DOI 10.1128/IAI.60.3.817-825.1992; Fuller JR, 2008, INFECT IMMUN, V76, P4934, DOI 10.1128/IAI.00475-08; Fuller JR, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-216; Geier H, 2011, INFECT IMMUN; Golovliov I, 2003, INFECT IMMUN, V71, P5940, DOI 10.1128/IAI.71.10.5940-5950.2003; Hager AJ, 2006, MOL MICROBIOL, V62, P227, DOI 10.1111/j.1365-2958.2006.05365.x; Hall JD, 2007, INFECT IMMUN, V75, P1034, DOI 10.1128/IAI.01254-06; HEYWORTH PG, 1991, J CLIN INVEST, V87, P352, DOI 10.1172/JCI114993; Jones CL, 2012, MICROBIOL MOL BIOL R, V76, P383, DOI 10.1128/MMBR.05027-11; Jungnitz H, 1998, INFECT IMMUN, V66, P4640, DOI 10.1128/IAI.66.10.4640-4650.1998; Konecna K, 2010, PROTEOMICS, V10, P4501, DOI 10.1002/pmic.201000248; KUOLEE R, 2011, MICROBES INFECT; Lai XH, 2001, INFECT IMMUN, V69, P4691, DOI 10.1128/IAI.69.7.4691-4694.2001; Lai XH, 2003, INFECT IMMUN, V71, P4642, DOI 10.1128/IAI.71.8.4642-4646.2003; Lauriano CM, 2004, P NATL ACAD SCI USA, V101, P4246, DOI 10.1073/pnas.0307690101; LOFGREN S, 1980, INFECT IMMUN, V29, P335; LOFGREN S, 1980, INFECT IMMUN, V29, P329; LOFGREN S, 1983, INFECT IMMUN, V39, P715; Ludu JS, 2008, J BACTERIOL, V190, P4584, DOI 10.1128/JB.00198-08; Maier TM, 2004, APPL ENVIRON MICROB, V70, P7511, DOI 10.1128/AEM.70.12.7511-7519.2004; Matyas BI, 2007, ANN NY ACAD SCI, V1105, P351, DOI 10.1196/annals.1409.013; McCaffrey RL, 2010, J LEUKOCYTE BIOL, V88, P791, DOI 10.1189/jlb.1209811; McRae S, 2010, J BIOL CHEM, V285, P5171, DOI 10.1074/jbc.M109.039511; Meibom KL, 2009, INFECT IMMUN, V77, P1866, DOI 10.1128/IAI.01496-08; Mohapatra NP, 2008, INFECT IMMUN, V76, P3690, DOI 10.1128/IAI.00262-08; Mohapatra NP, 2007, INFECT IMMUN, V75, P3305, DOI 10.1128/IAI.00351-07; Mohapatra NP, 2007, INFECT IMMUN, V75, P390, DOI 10.1128/IAI.01226-06; Mohapatra NP, 2010, J IMMUNOL, V184, P5141, DOI 10.4049/jimmunol.0903413; Peng KT, 2011, CELL MICROBIOL, V13, P1586, DOI 10.1111/j.1462-5822.2011.01643.x; Pierini R, 2012, CELL DEATH DIFFER, V19, P1709, DOI 10.1038/cdd.2012.51; Pierson T, 2011, J PROTEOME RES, V10, P954, DOI 10.1021/pr1009756; Rajaram MVS, 2006, J IMMUNOL, V177, P6317, DOI 10.4049/jimmunol.177.9.6317; Reilly TJ, 1996, J BIOL CHEM, V271, P10973, DOI 10.1074/jbc.271.18.10973; REMALEY AT, 1985, J BIOL CHEM, V260, P880; REMALEY AT, 1985, EXP PARASITOL, V60, P331, DOI 10.1016/0014-4894(85)90039-6; SAHA AK, 1985, ARCH BIOCHEM BIOPHYS, V243, P150, DOI 10.1016/0003-9861(85)90783-0; Saleh MT, 2000, J BACTERIOL, V182, P6850, DOI 10.1128/JB.182.23.6850-6853.2000; Santic M, 2005, CELL MICROBIOL, V7, P969, DOI 10.1111/j.1462-5822.2005.00526.x; Santic M, 2005, CELL MICROBIOL, V7, P957, DOI 10.1111/j.1462-5822.2005.00529.x; Santic M, 2008, INFECT IMMUN, V76, P2671, DOI 10.1128/IAI.00185-08; Santic M, 2007, CELL MICROBIOL, V9, P2391, DOI 10.1111/j.1462-5822.2007.00968.x; Santic M, 2010, MICROBES INFECT, V12, P126, DOI 10.1016/j.micinf.2009.11.003; Schmerk CL, 2009, MICROBIOL-SGM, V155, P1489, DOI 10.1099/mic.0.025379-0; Schulert GS, 2006, J LEUKOCYTE BIOL, V80, P563, DOI 10.1189/jlb.0306219; Schwartz JT, 2012, J IMMUNOL, V188, P3351, DOI 10.4049/jimmunol.1102863; Tarnvik A, 2004, SCAND J INFECT DIS, V36, P350, DOI 10.1080/00365540410020442; Tempel R, 2006, INFECT IMMUN, V74, P5095, DOI 10.1128/IAI.00598-06; Twine SM, 2006, MICROB PATHOGENESIS, V40, P133, DOI 10.1016/j.micpath.2005.12.004; UHLINGER DJ, 1992, BIOCHEM BIOPH RES CO, V187, P940, DOI 10.1016/0006-291X(92)91288-2; VINCENT JB, 1992, TRENDS BIOCHEM SCI, V17, P105, DOI 10.1016/0968-0004(92)90246-6; Wehrly TD, 2009, CELL MICROBIOL, V11, P1128, DOI 10.1111/j.1462-5822.2009.01316.x	78	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56834	10.1371/journal.pone.0056834	http://dx.doi.org/10.1371/journal.pone.0056834			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457625	Green Published, gold, Green Submitted			2022-12-25	WOS:000315603700087
J	Xiao, J; Song, C; Liu, SJ; Tao, M; Hu, J; Wang, J; Liu, W; Zeng, M; Liu, Y				Xiao, Jun; Song, Can; Liu, Shaojun; Tao, Min; Hu, Jie; Wang, Jun; Liu, Wei; Zeng, Ming; Liu, Yun			DNA Methylation Analysis of Allotetraploid Hybrids of Red Crucian Carp (Carassius auratus red var.) and Common Carp (Cyprinus carpio L.)	PLOS ONE			English	Article							CYTOSINE METHYLATION; GENE-EXPRESSION; GENOME DUPLICATION; HYBRIDIZATION; AFLP; PATTERNS; RNA; TRANSCRIPTION; CONSEQUENCES; POLYPLOIDY	Hybridization and polyploidization may lead to divergence in adaptation and boost speciation in angiosperms and some lower animals. Epigenetic change plays a significant role in the formation and adaptation of polyploidy. Studies of the effects of methylation on genomic recombination and gene expression in allopolyploid plants have achieved good progress. However, relevant advances in polyploid animals have been relatively slower. In the present study, we used the bisexual, fertile, genetically stable allotetraploid generated by hybridization of Carassius auratus red var. and Cyprinus carpio L. to investigate cytosine methylation level using methylation-sensitive amplification polymorphism (MSAP) analysis. We observed 38.31% of the methylation changes in the allotetraploid compared with the parents at 355 randomly selected CCGG sites. In terms of methylation status, these results indicate that the level of methylation modification in the allotetraploid may have increased relative to that in the parents. We also found that the major methylation changes were hypermethylation on some genomic fragments and genes related to metabolism or cell cycle regulation. These results provide circumstantial evidence that DNA methylation might be related to the gene expression and phenotype variation in allotetraploid hybrids. Our study partly fulfils the need for epigenetic research in polyploid animals, and provides evidence for the epigenetic regulation of allopolyploids.	[Xiao, Jun; Song, Can; Liu, Shaojun; Tao, Min; Hu, Jie; Wang, Jun; Liu, Wei; Zeng, Ming; Liu, Yun] Hunan Normal Univ, Minist Educ China, Coll Life Sci, Key Lab Prot Chem & Fish Dev Biol, Changsha, Hunan, Peoples R China	Hunan Normal University; Ministry of Education, China	Liu, SJ (corresponding author), Hunan Normal Univ, Minist Educ China, Coll Life Sci, Key Lab Prot Chem & Fish Dev Biol, Changsha, Hunan, Peoples R China.	lsj@hunnu.edu.cn		xiao, Jun/0000-0002-8310-319X	National Special Fund for Scientific Research in public benefits [200903046]; National Natural Science Foundation of China [30930071, 31210103918, 31201980]; Pre-project of the National Key Basic Research and Development Program [2012CB722305]; Natural Science Fund for Innovative Research Team of Hunan Province [10JJ7004]; Doctoral Fund of Ministry of Education of China [20104306110004]; Construction Project of Key Discipline of Hunan Province; Construction Project of Key Discipline of China	National Special Fund for Scientific Research in public benefits; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Pre-project of the National Key Basic Research and Development Program; Natural Science Fund for Innovative Research Team of Hunan Province; Doctoral Fund of Ministry of Education of China(Ministry of Education, China); Construction Project of Key Discipline of Hunan Province; Construction Project of Key Discipline of China	This work was funded by the National Special Fund for Scientific Research in public benefits (Grant No.: 200903046), the National Natural Science Foundation of China (Grant No. : 30930071, 31210103918 and 31201980), Pre-project of the National Key Basic Research and Development Program (Grant No. : 2012CB722305), the Natural Science Fund for Innovative Research Team of Hunan Province (Grant No. : 10JJ7004), the Doctoral Fund of Ministry of Education of China (Grant No. : 20104306110004), and the Construction Project of Key Discipline of Hunan Province and China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cervera MT, 2002, MOL GENET GENOMICS, V268, P543, DOI 10.1007/s00438-002-0772-4; Chen L, 2009, MOL CELL PROBE, V23, P157, DOI 10.1016/j.mcp.2009.03.001; Chen ZJ, 2007, ANNU REV PLANT BIOL, V58, P377, DOI 10.1146/annurev.arplant.58.032806.103835; Chen ZJ, 1997, GENE DEV, V11, P2124, DOI 10.1101/gad.11.16.2124; Chen ZJ, 1998, P NATL ACAD SCI USA, V95, P14891, DOI 10.1073/pnas.95.25.14891; Comai L, 2005, NAT REV GENET, V6, P836, DOI 10.1038/nrg1711; Comai L, 2000, PLANT CELL, V12, P1551, DOI 10.1105/tpc.12.9.1551; COSTELLO JF, 1994, MOL CELL BIOL, V14, P6515, DOI 10.1128/MCB.14.10.6515; Domann FE, 2000, INT J CANCER, V85, P805, DOI 10.1002/(SICI)1097-0215(20000315)85:6<805::AID-IJC12>3.0.CO;2-5; Fang JG, 2010, ACTA PHYSIOL PLANT, V32, P1023, DOI 10.1007/s11738-010-0491-0; Futscher BW, 2002, NAT GENET, V31, P175, DOI 10.1038/ng886; Gaeta RT, 2007, PLANT CELL, V19, P3403, DOI 10.1105/tpc.107.054346; Hegarty MJ, 2011, MOL ECOL, V20, P105, DOI 10.1111/j.1365-294X.2010.04926.x; Johannes F, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000530; Kashkush K, 2002, GENETICS, V160, P1651; Koroma AP, 2011, PHYSIOL GENOMICS, V43, P1276, DOI 10.1152/physiolgenomics.00110.2011; Lee HS, 2001, P NATL ACAD SCI USA, V98, P6753, DOI 10.1073/pnas.121064698; Liu B, 2000, GENOME, V43, P874, DOI 10.1139/gen-43-5-874; Liu B, 2003, MOL PHYLOGENET EVOL, V29, P365, DOI 10.1016/S1055-7903(03)00213-6; Liu JF, 2007, MAR BIOTECHNOL, V9, P329, DOI 10.1007/s10126-006-6123-4; Liu LG, 2009, CHINESE SCI BULL, V54, P2849, DOI 10.1007/s11434-009-0476-9; Liu SJ, 2010, SCI CHINA LIFE SCI, V53, P416, DOI 10.1007/s11427-010-0057-9; Liu SJ, 2001, AQUACULTURE, V192, P171, DOI 10.1016/S0044-8486(00)00451-8; Ma XF, 2005, CYTOGENET GENOME RES, V109, P236, DOI 10.1159/000082406; Madlung A, 2002, PLANT PHYSIOL, V129, P733, DOI 10.1104/pp.003095; Mallet J, 2007, NATURE, V446, P279, DOI 10.1038/nature05706; MCCLELLAND M, 1994, NUCLEIC ACIDS RES, V22, P3640, DOI 10.1093/nar/22.17.3640; Ochogavia AC, 2009, PLANT MOL BIOL, V70, P17, DOI 10.1007/s11103-009-9454-5; Ohno S., 1970, EVOLUTION GENE DUPLI; Otto SP, 2007, CELL, V131, P452, DOI 10.1016/j.cell.2007.10.022; Paun O, 2010, MOL BIOL EVOL, V27, P2465, DOI 10.1093/molbev/msq150; Rice JC, 1998, ONCOGENE, V17, P1807, DOI 10.1038/sj.onc.1202086; Salmon A, 2005, MOL ECOL, V14, P1163, DOI 10.1111/j.1365-294X.2005.02488.x; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Soltis DE, 2004, NEW PHYTOL, V161, P173, DOI 10.1046/j.1469-8137.2003.00948.x; Song C, 2012, SCI CHINA LIFE SCI, V55, P301, DOI 10.1007/s11427-012-4310-2; Taylor JS, 2001, PHILOS T R SOC B, V356, P1661, DOI 10.1098/rstb.2001.0975; Verhoeven KJF, 2010, MOL ECOL, V19, P315, DOI 10.1111/j.1365-294X.2009.04460.x; Volff JN, 2005, HEREDITY, V94, P280, DOI 10.1038/sj.hdy.6800635; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; WATTS GS, 1995, NUCLEIC ACIDS RES, V23, P4740, DOI 10.1093/nar/23.22.4740; Xiong LZ, 1999, MOL GEN GENET, V261, P439, DOI 10.1007/s004380050986; Xu ML, 2000, PLANT MOL BIOL REP, V18, P361, DOI 10.1007/BF02825064	43	27	34	1	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56409	10.1371/journal.pone.0056409	http://dx.doi.org/10.1371/journal.pone.0056409			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457564	Green Submitted, Green Published, gold			2022-12-25	WOS:000315603700051
J	Nakaso, K; Tajima, N; Ito, S; Teraoka, M; Yamashita, A; Horikoshi, Y; Kikuchi, D; Mochida, S; Nakashima, K; Matsura, T				Nakaso, Kazuhiro; Tajima, Naoko; Ito, Satoru; Teraoka, Mari; Yamashita, Atsushi; Horikoshi, Yosuke; Kikuchi, Daisuke; Mochida, Shinsuke; Nakashima, Kenji; Matsura, Tatsuya			Dopamine-Mediated Oxidation of Methionine 127 in alpha-Synuclein Causes Cytotoxicity and Oligomerization of alpha-Synuclein	PLOS ONE			English	Article							SULFOXIDE-REDUCTASE-A; PARKINSONS-DISEASE; NERVOUS-SYSTEM; NEURODEGENERATION; NEUROTOXICITY; PATHOGENESIS; TYROSINASE; COMPONENT; RESIDUES; GENETICS	Parkinson's disease (PD) is a neurodegenerative disorder characterized by the selective loss of dopaminergic neurons and the presence of Lewy bodies. Many recent studies focused on the interaction between alpha-synuclein (alpha-syn) and dopamine in the pathogenesis of PD, and fluorescent anisotropy suggested that the C-terminal region of alpha-syn may be a target for modification by dopamine. However, it is not well understood why PD-related pathogenesis occurs selectively in dopaminergic neurons. We investigated the interaction between dopamine and alpha-syn with regard to cytotoxicity. A soluble oligomer was formed by co-incubating alpha-syn and dopamine in vitro. To clarify the effect of dopamine on alpha-syn in cells, we generated PC12 cells expressing human alpha-syn, as well as the alpha-syn mutants, M116A, Y125D, M127A, S129A, and M116A/M127A, in a tetracycline-inducible manner (PC12-TetOFF-alpha-syn). Overexpression of wildtype alpha-syn in catecholaminergic PC12 cells decreased cell viability in long-term cultures, while a competitive inhibitor of tyrosine hydroxylase blocked this vulnerability, suggesting that alpha-syn-related cytotoxicity is associated with dopamine metabolism. The vulnerabilities of all mutant cell lines were lower than that of wildtype alpha-syn-expressing cells. Moreover, alpha-syn containing dopamine-mediated oxidized methionine (Met(O)) was detected in PC12-TetOFF-alpha-syn. Met(O) was lower in methionine mutant cells, especially in the M127A or M116A/M127A mutants, but also in the Y125D and S129A mutants. Co-incubation of dopamine and the 125YEMPS129 peptide enhanced the production of H2O2, which may oxidize methionine residues and convert them to Met(O). Y125- or S129-lacking peptides did not enhance the dopamine-related production of H2O2. Our results suggest that M127 is the major target for oxidative modification by dopamine, and that Y125 and S129 may act as enhancers of this modification. These results may describe a mechanism of dopaminergic neuron-specific toxicity of alpha-syn in the pathogenesis of PD.	[Nakaso, Kazuhiro; Tajima, Naoko; Teraoka, Mari; Yamashita, Atsushi; Horikoshi, Yosuke; Kikuchi, Daisuke; Matsura, Tatsuya] Tottori Univ, Fac Med, Dept Pathophysiol & Therapeut Sci, Div Med Biochem, Yonago, Tottori 683, Japan; [Ito, Satoru; Nakashima, Kenji] Tottori Univ, Fac Med, Dept Brain & Neurosci, Div Neurol, Yonago, Tottori 683, Japan; [Teraoka, Mari] Tottori Univ, Fac Med, Dept Surg, Div Emergency & Disaster Med, Yonago, Tottori 683, Japan; [Mochida, Shinsuke] Tottori Univ, Fac Med, Dept Surg, Div Anesthesiol & Crit Med, Yonago, Tottori 683, Japan	Tottori University; Tottori University; Tottori University; Tottori University	Nakaso, K (corresponding author), Tottori Univ, Fac Med, Dept Pathophysiol & Therapeut Sci, Div Med Biochem, Yonago, Tottori 683, Japan.	kazuhiro@med.tottori-u.ac.jp		Horikoshi, Yosuke/0000-0001-6587-644X	Ministry of Education, Science, and Culture of Japan [24591262, 23592288, 23580168]; Grants-in-Aid for Scientific Research [23580168, 23590881] Funding Source: KAKEN	Ministry of Education, Science, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Kazuhiro Nakaso: a Grant-in-Aid for Scientific Research from the Ministry of Education, Science, and Culture of Japan (No. 24591262), Shinsuke Mochida: a Grant-in-Aid for Scientific Research from the Ministry of Education, Science, and Culture of Japan (No. 23592288), Tatsuya Matsura: a Grant-in-Aid for Scientific Research from the Ministry of Education, Science, and Culture of Japan (No. 23580168). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Wandi A, 2010, NEUROBIOL AGING, V31, P796, DOI 10.1016/j.neurobiolaging.2008.11.001; Asanuma M, 2003, NEUROTOX RES, V5, P165, DOI 10.1007/BF03033137; Beyer K, 2006, ACTA NEUROPATHOL, V112, P237, DOI 10.1007/s00401-006-0104-6; Bisaglia M, 2007, J BIOL CHEM, V282, P15597, DOI 10.1074/jbc.M610893200; Chadchankar H, 2011, BRAIN RES, V1382, P37, DOI 10.1016/j.brainres.2011.01.064; Chandra S, 2005, CELL, V123, P383, DOI 10.1016/j.cell.2005.09.028; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Chen L, 2009, J CLIN INVEST, V119, P3257, DOI 10.1172/JCI39088; Conway KA, 2001, SCIENCE, V294, P1346, DOI 10.1126/science.1063522; Crosiers D, 2011, J CHEM NEUROANAT, V42, P131, DOI 10.1016/j.jchemneu.2011.07.003; Derkinderen P, 2011, NEUROLOGY, V77, P1761, DOI 10.1212/WNL.0b013e318236ef60; Dickson DW, 1999, AM J PATHOL, V155, P1241, DOI 10.1016/S0002-9440(10)65226-1; Fujiwara H, 2002, NAT CELL BIOL, V4, P160, DOI 10.1038/ncb748; Giasson BI, 2000, SCIENCE, V290, P985, DOI 10.1126/science.290.5493.985; Glaser CB, 2005, BBA-PROTEINS PROTEOM, V1703, P157, DOI 10.1016/j.bbapap.2004.10.008; Ibanez P, 2004, LANCET, V364, P1169, DOI 10.1016/S0140-6736(04)17104-3; Ito S, 2010, NEUROSCI RES, V66, P124, DOI 10.1016/j.neures.2009.10.005; IWAI A, 1995, BIOCHEMISTRY-US, V34, P10139, DOI 10.1021/bi00032a006; LaVoie MJ, 2005, NAT MED, V11, P1214, DOI 10.1038/nm1314; Lees AJ, 2009, LANCET, V373, P2055, DOI 10.1016/S0140-6736(09)60492-X; Leong SL, 2009, FREE RADICAL BIO MED, V46, P1328, DOI 10.1016/j.freeradbiomed.2009.02.009; Liu F, 2008, FREE RADICAL BIO MED, V45, P242, DOI 10.1016/j.freeradbiomed.2008.03.022; MAROTEAUX L, 1988, J NEUROSCI, V8, P2804; Martin I, 2011, ANNU REV GENOM HUM G, V12, P301, DOI 10.1146/annurev-genom-082410-101440; Mazzulli JR, 2007, J BIOL CHEM, V282, P31621, DOI 10.1074/jbc.M704737200; Micieli G, 2003, NEUROL SCI, V24, pS32, DOI 10.1007/s100720300035; Mizuno Y, 2008, PHILOS T R SOC B, V363, P2215, DOI 10.1098/rstb.2008.2273; Nuytemans K, 2010, HUM MUTAT, V31, P763, DOI 10.1002/humu.21277; Oien DB, 2009, J MOL NEUROSCI, V39, P323, DOI 10.1007/s12031-009-9274-8; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Saiki S, 2012, J NEUROL NEUROSUR PS, V83, P430, DOI 10.1136/jnnp-2011-301205; Satake W, 2009, NAT GENET, V41, P1303, DOI 10.1038/ng.485; Shimura H, 2001, SCIENCE, V293, P263, DOI 10.1126/science.1060627; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Teraoka M, 2012, J CLIN BIOCHEM NUTR, V51, P122, DOI 10.3164/jcbn.D-11-00030; UEDA K, 1993, P NATL ACAD SCI USA, V90, P11282, DOI 10.1073/pnas.90.23.11282; Venda LL, 2010, TRENDS NEUROSCI, V33, P559, DOI 10.1016/j.tins.2010.09.004; VOGT W, 1995, FREE RADICAL BIO MED, V18, P93, DOI 10.1016/0891-5849(94)00158-G; Wakabayashi K, 1997, EUR NEUROL, V38, P2, DOI 10.1159/000113469; Wassef R, 2007, J NEUROSCI, V27, P12808, DOI 10.1523/JNEUROSCI.0322-07.2007; Whitehead RE, 2001, J NEUROCHEM, V76, P1242, DOI 10.1046/j.1471-4159.2001.00125.x; Xu J, 2002, NAT MED, V8, P600, DOI 10.1038/nm0602-600; Xu YM, 1998, J NEUROSCI RES, V54, P691, DOI 10.1002/(SICI)1097-4547(19981201)54:5<691::AID-JNR14>3.0.CO;2-F; Yoshimoto Y, 2005, FEBS LETT, V579, P1197, DOI 10.1016/j.febslet.2004.12.091; Zhou WB, 2010, BBA-MOL BASIS DIS, V1802, P322, DOI 10.1016/j.bbadis.2009.12.004	47	28	29	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e55068	10.1371/journal.pone.0055068	http://dx.doi.org/10.1371/journal.pone.0055068			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457458	Green Published, gold, Green Submitted			2022-12-25	WOS:000315602700012
J	Birrane, G; Mulvaney, EP; Pal, R; Kinsella, BT; Kocher, O				Birrane, Gabriel; Mulvaney, Eamon P.; Pal, Rinku; Kinsella, B. Therese; Kocher, Olivier			Molecular Analysis of the Prostacyclin Receptor's Interaction with the PDZ1 Domain of Its Adaptor Protein PDZK1	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; B TYPE-I; TARGET BINDING; C-TERMINUS; SR-BI; ISOPRENYLATION; IDENTIFICATION; RECOGNITION; SCAFFOLD; COMPLEX	The prostanoid prostacyclin, or prostaglandin I-2, plays an essential role in many aspects of cardiovascular disease. The actions of prostacyclin are mainly mediated through its activation of the prostacyclin receptor or, in short, the IP. In recent studies, the cytoplasmic carboxy-terminal domain of the IP was shown to bind several PDZ domains of the multi-PDZ adaptor PDZK1. The interaction between the two proteins was found to enhance cell surface expression of the IP and to be functionally important in promoting prostacyclin-induced endothelial cell migration and angiogenesis. To investigate the interaction of the IP with the first PDZ domain (PDZ1) of PDZK1, we generated a nine residue peptide (KK(411)IAACSLC(417)) containing the seven carboxy-terminal amino acids of the IP and measured its binding affinity to a recombinant protein corresponding to PDZ1 by isothermal titration calorimetry. We determined that the IP interacts with PDZ1 with a binding affinity of 8.2 mu M. Using the same technique, we also determined that the farnesylated form of carboxy-terminus of the IP does not bind to PDZ1. To understand the molecular basis of these findings, we solved the high resolution crystal structure of PDZ1 bound to a 7-residue peptide derived from the carboxy-terminus of the non-farnesylated form of IP ((411)IAACSLC(417)). Analysis of the structure demonstrates a critical role for the three carboxy-terminal amino acids in establishing a strong interaction with PDZ1 and explains the inability of the farnesylated form of IP to interact with the PDZ1 domain of PDZK1 at least in vitro.	[Birrane, Gabriel] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Expt Med, Boston, MA 02215 USA; [Mulvaney, Eamon P.; Kinsella, B. Therese] Univ Coll Dublin, Sch Biomol & Biomed Sci, Conway Inst Biomol & Biomed Res, Dublin 2, Ireland; [Pal, Rinku; Kocher, Olivier] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Pathol, Boston, MA 02215 USA; [Pal, Rinku; Kocher, Olivier] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Vasc Biol Res Ctr, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University College Dublin; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Kocher, O (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Pathol, Boston, MA 02215 USA.	okocher@bidmc.harvard.edu		Kinsella, B. Therese/0000-0003-3072-941X; Mulvaney, Eamon/0000-0003-3661-2116; Birrane, Gabriel/0000-0002-1759-5499	National Institute of Health [HL077780]; Science Foundation of Ireland [SFI:05/IN.1/B19]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077780] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Science Foundation of Ireland(Science Foundation Ireland); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by the National Institute of Health Grant HL077780 (to O.K.) and by the Science Foundation of Ireland Grant SFI:05/IN.1/B19 (to B. T. K). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birrane G, 2003, J BIOL CHEM, V278, P1399, DOI 10.1074/jbc.C200571200; Burack WR, 2000, CURR OPIN CELL BIOL, V12, P211, DOI 10.1016/S0955-0674(99)00078-2; CLARKE S, 1992, ANNU REV BIOCHEM, V61, P355, DOI 10.1146/annurev.bi.61.070192.002035; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feng W, 2003, NAT STRUCT BIOL, V10, P972, DOI 10.1038/nsb992; Fenn TD, 2003, J APPL CRYSTALLOGR, V36, P944, DOI 10.1107/S0021889803006721; Good MC, 2011, SCIENCE, V332, P680, DOI 10.1126/science.1198701; Grootjans JJ, 2000, J BIOL CHEM, V275, P19933, DOI 10.1074/jbc.M002459200; Gryglewski RJ, 2008, PHARMACOL REP, V60, P3; Hayes JS, 1999, J BIOL CHEM, V274, P23707, DOI 10.1074/jbc.274.34.23707; Hu SQ, 2009, CELL PHYSIOL BIOCHEM, V24, P231, DOI 10.1159/000233258; Jannatipour M, 2001, J BIOL CHEM, V276, P33093, DOI 10.1074/jbc.M105792200; Jemth P, 2007, BIOCHEMISTRY-US, V46, P8701, DOI 10.1021/bi7008618; Kang BS, 2003, STRUCTURE, V11, P845, DOI 10.1016/S0969-2126(03)00125-4; Karthikeyan S, 2002, J BIOL CHEM, V277, P18973, DOI 10.1074/jbc.M201507200; Karthikeyan S, 2001, J BIOL CHEM, V276, P19683, DOI 10.1074/jbc.C100154200; Kato Y, 2005, MOL PHARMACOL, V67, P734, DOI 10.1124/mol.104.002212; Kawabe J, 2010, CIRC J, V74, P836, DOI 10.1253/circj.CJ-10-0195; Kim JK, 2012, J BIOL CHEM, V287, P21012, DOI 10.1074/jbc.M111.337865; Kocher O, 1998, LAB INVEST, V78, P117; Kocher O, 1999, LAB INVEST, V79, P1161; Kocher O, 2011, J BIOL CHEM, V286, P25171, DOI 10.1074/jbc.M111.242362; Kocher O, 2010, J BIOL CHEM, V285, P34999, DOI 10.1074/jbc.M110.164418; Kocher O, 2009, CURR OPIN LIPIDOL, V20, P236, DOI 10.1097/MOL.0b013e32832aee82; LaLonde DP, 2009, BIOCHEMISTRY-US, V48, P2261, DOI 10.1021/bi802089k; Lamprecht G, 2006, AM J PHYSIOL-GASTR L, V291, pG766, DOI 10.1152/ajpgi.00135.2006; Lee HJ, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-8; Long JF, 2003, J MOL BIOL, V327, P203, DOI 10.1016/S0022-2836(03)00113-X; MALTESE WA, 1990, FASEB J, V4, P3319, DOI 10.1096/fasebj.4.15.2123808; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miggin SM, 2002, EUR J BIOCHEM, V269, P1714, DOI 10.1046/j.1432-1327.2002.02817.x; O'Meara SJ, 2005, BIOCHEM J, V386, P177, DOI 10.1042/BJ20041290; O'Meara SJ, 2004, BRIT J PHARMACOL, V143, P318, DOI 10.1038/sj.bjp.0705956; O'Meara SJ, 2004, BRIT J PHARMACOL, V143, P292, DOI 10.1038/sj.bjp.0705947; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Raghuram V, 2001, P NATL ACAD SCI USA, V98, P1300, DOI 10.1073/pnas.031538898; RIBEIRO LGT, 1981, AM J CARDIOL, V47, P835, DOI 10.1016/0002-9149(81)90182-X; Romero G, 2011, ADV PHARMACOL, V62, P279, DOI 10.1016/B978-0-12-385952-5.00003-8; Turner EC, 2011, MOL BIOL CELL, V22, P2664, DOI 10.1091/mbc.E11-04-0374; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; von Ossowski I, 2006, FEBS J, V273, P5219, DOI 10.1111/j.1742-4658.2006.05521.x; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Wang SS, 2000, CELL, V103, P169, DOI 10.1016/S0092-8674(00)00096-9; Wente W, 2005, J BIOL CHEM, V280, P32419, DOI 10.1074/jbc.M507198200; Zeke A, 2009, TRENDS CELL BIOL, V19, P364, DOI 10.1016/j.tcb.2009.05.007; Zhang Q, 2001, J BIOL CHEM, V276, P43216, DOI 10.1074/jbc.M105996200; Zhu WF, 2008, CIRC RES, V102, P480, DOI 10.1161/CIRCRESAHA.107.159079	49	5	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e53819	10.1371/journal.pone.0053819	http://dx.doi.org/10.1371/journal.pone.0053819			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23457445	Green Submitted, gold, Green Published			2022-12-25	WOS:000315153400017
J	Wang, RW; Wang, YQ; He, JZ; Li, YT				Wang, Rui-Wu; Wang, Ya-Qiang; He, Jun-Zhou; Li, Yao-Tang			Resource Elasticity of Offspring Survival and the Optimal Evolution of Sex Ratios	PLOS ONE			English	Article							STABLE REPRODUCTIVE STRATEGIES; POPULATION-GROWTH RATE; ORGANISMS; PATTERNS	The fitness of any organisms includes the survival and reproductive rate of adults and the survival of their offspring. Environmental selection pressures might not affect these two aspects of an organism equally. Assuming that an organism first allocates its limited resources to maintain its survival under environmental selection pressure, our model, based on the evolutionarily stable strategy theory, surprisingly shows that the sex ratio is greatly affected by the environmental pressure intensity and by the reproductive resource elasticity of offspring survival. Moreover, the concept of the resource elasticity of offspring survival intrinsically integrates the ecological concepts of K selection and r selection. The model shows that in a species with reproductive strategy K, increased environmental selection pressure will reduce resource allocation to the male function. By contrast, in a species with reproductive strategy r, harsher environmental selection pressure will increase allocation to the male function. The elasticity of offspring survival might vary not only across species, but also across many other factors affecting the same species (e.g., age structure, spatial heterogeneity), which explains sex ratio differences across species or age structures and spatial heterogeneity in the same species.	[Wang, Rui-Wu; Wang, Ya-Qiang] Chinese Acad Sci, Kunming Inst Zool, Kunming, Yunnan, Peoples R China; [Wang, Ya-Qiang; Li, Yao-Tang] Yunnan Univ, Sch Math & Stat, Kunming, Yunnan, Peoples R China; [He, Jun-Zhou] Yunnan Univ Finance & Econ, Stat & Math Coll, Kunming, Yunnan, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Zoology; Yunnan University; Yunnan University of Finance & Economics	Wang, RW (corresponding author), Chinese Acad Sci, Kunming Inst Zool, Kunming, Yunnan, Peoples R China.	ruiwukiz@hotmail.com; liyaotang@ynu.edu.cn	Li, Yao/AAE-3550-2019		National Natural Science Foundation of China [31170408, 71161020]; Yunnan Natural Science Foundation [2009CD104]; Postgraduate Science Foundation of the Yunnan University [ynuy201038]; West Light Foundation of the Chinese Academy of Sciences; Special Fund for the Excellent Youth of the Chinese Academy of Sciences [KSCX2-EW-Q-9]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Yunnan Natural Science Foundation(Natural Science Foundation of Yunnan Province); Postgraduate Science Foundation of the Yunnan University; West Light Foundation of the Chinese Academy of Sciences(Chinese Academy of Sciences); Special Fund for the Excellent Youth of the Chinese Academy of Sciences	This research was supported by the National Natural Science Foundation of China (31170408, 71161020), the Yunnan Natural Science Foundation (2009CD104), the Postgraduate Science Foundation of the Yunnan University (Grant No. ynuy201038), the West Light Foundation of the Chinese Academy of Sciences, Special Fund for the Excellent Youth of the Chinese Academy of Sciences (KSCX2-EW-Q-9). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BELL G, 1980, AM NAT, V116, P45, DOI 10.1086/283611; CHARNOV EL, 1979, AM NAT, V113, P465, DOI 10.1086/283407; Faust LJ, 2000, ZOO BIOL, V19, P11, DOI 10.1002/(SICI)1098-2361(2000)19:1<11::AID-ZOO2>3.0.CO;2-V; Fisher R.A., 1930, GENETICAL THEORY NAT; MAC ARTHUR ROBERT H., 1967; MEIKLE DB, 1986, J REPROD FERTIL, V78, P587, DOI 10.1530/jrf.0.0780587; MURRAY BG, 1985, OIKOS, V44, P509, DOI 10.2307/3565794; NUR N, 1987, OIKOS, V48, P338, DOI 10.2307/3565523; Otto S.P., 2011, BIOLOGISTS GUIDE MAT; PIANKA ER, 1974, P NATL ACAD SCI USA, V71, P2141, DOI 10.1073/pnas.71.5.2141; Samuelson PA, 1992, ECONOMICS; SCHAFFER WM, 1974, AM NAT, V108, P783, DOI 10.1086/282954; Sibly RM, 2002, PHILOS T R SOC B, V357, P1153, DOI 10.1098/rstb.2002.1117; Stearns S.C., 1992, pi; STENSETH NC, 1983, OIKOS, V41, P152, DOI 10.2307/3544364; Sun R, 1992, ESSENTIAL ANIMAL ECO; TRIVERS RL, 1974, AM ZOOL, V14, P249; Vali U, 2004, BIRD STUDY, V51, P189; Zhang DY, 1996, AM NAT, V147, P1115, DOI 10.1086/285898; ZHANG DY, 1994, AM NAT, V144, P65, DOI 10.1086/285661; Zhang DY, 1997, J THEOR BIOL, V185, P223, DOI 10.1006/jtbi.1996.0304; Zhang DY, 2000, AM NAT, V155, P187, DOI 10.1086/303310	22	9	10	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e53904	10.1371/journal.pone.0053904	http://dx.doi.org/10.1371/journal.pone.0053904			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23468826	Green Published, Green Submitted, gold			2022-12-25	WOS:000314021500029
J	Marques, N; Sese, M; Canovas, V; Valente, F; Bermudo, R; de Torres, I; Fernandez, Y; Abasolo, I; Fernandez, PL; Contreras, H; Castellon, E; Celia-Terrassa, T; Mendez, R; Cajal, SRY; Thomson, TM; Paciucci, R				Marques, N.; Sese, M.; Canovas, V.; Valente, F.; Bermudo, R.; de Torres, I.; Fernandez, Y.; Abasolo, I.; Fernandez, P. L.; Contreras, H.; Castellon, E.; Celia-Terrassa, T.; Mendez, R.; Ramon y Cajal, S.; Thomson, T. M.; Paciucci, R.			Regulation of protein translation and c-Jun expression by prostate tumor overexpressed 1	ONCOGENE			English	Article						PTOV1; c-Jun; translation; prostate cancer; invasion	RECEPTOR-INTERACTING PROTEIN; TRANSCRIPTION FACTOR SNAIL; GENE-EXPRESSION; KINASE-C; RACK1; ACTIVATION; CANCER; INVASION; GROWTH; VP16	Prostate tumor overexpressed-1 (PTOV1), a modulator of the Mediator transcriptional regulatory complex, is expressed at high levels in prostate cancer and other neoplasias in association with a more aggressive disease. Here we show that PTOV1 interacts directly with receptor of activated protein C kinase 1 (RACK1), a regulator of protein kinase C and Jun signaling and also a component of the 40S ribosome. Consistent with this interaction, PTOV1 was associated with ribosomes and its overexpression promoted global protein synthesis in prostate cancer cells and COS-7 fibroblasts in a mTORC1-dependent manner. Transfection of ectopic PTOV1 enhanced the expression of c-Jun protein without affecting the levels of c-Jun or RACK1 mRNA. Conversely, knockdown of PTOV1 caused significant declines in global protein synthesis and c-Jun protein levels. High levels of PTOV1 stimulated the motility and invasiveness of prostate cancer cells, which required c-Jun, whereas knockdown of PTOV1 strongly inhibited the tumorigenic and metastatic potentials of PC-3 prostate cancer cells. In human prostate cancer samples, the expression of high levels of PTOV1 in primary and metastatic tumors was significantly associated with increased nuclear localization of active c-Jun. These results unveil new functions of PTOV1 in the regulation of protein translation and in the progression of prostate cancer to an invasive and metastatic disease.	[Marques, N.; Sese, M.; Canovas, V.; Valente, F.; Paciucci, R.] Univ Autonoma Barcelona, Vall dHebron Inst Res, Res Unit Biomed Translat & Pediat Onco, E-08193 Barcelona, Spain; [Bermudo, R.; Celia-Terrassa, T.; Thomson, T. M.] CSIC, Inst Mol Biol, Dept Cell Biol, Barcelona, Spain; [Bermudo, R.; Fernandez, P. L.] Univ Barcelona, Inst Invest Biomed August Pi i Sunyer, Dept Pathol & Tumour Bank, Hosp Clin, Barcelona, Spain; [de Torres, I.; Ramon y Cajal, S.] Univ Autonoma Barcelona, Vall dHebron Hosp, Dept Pathol, E-08193 Barcelona, Spain; [Fernandez, Y.; Abasolo, I.] Vall dHebron Inst Recerca, Mol Imaging Platform CIBBIM Nanomed, Barcelona, Spain; [Contreras, H.; Castellon, E.] Univ Chile, Dept Physiol & Biophys, Lab Mol & Cellular Androl, Fac Med, Santiago, Chile; [Mendez, R.] Univ Barcelona, Inst Res Biomed, Barcelona, Spain	Autonomous University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB); University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Universidad de Chile; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; University of Barcelona	Paciucci, R (corresponding author), Translat & Pediat Oncol Vall dHebron Inst Res, Res Unit Biomed, Collserola Bldg,Pg Vall dHebron 119-129, Barcelona 08035, Spain.		Paciucci, Rosanna/AGP-3844-2022; Thomson, Timothy/Z-6271-2019; Ramon y Cajal, Santiago/H-4955-2016; Abasolo, Ibane/H-7741-2012; Contreras, Hector/CAE-9087-2022; Fernandez, Pedro L/H-2594-2017; Sese, Marta/AAH-9749-2021; Castellon, Enrique A/D-3436-2014; Celia-Terrassa, Toni/M-4808-2014	Paciucci, Rosanna/0000-0001-5651-5933; Thomson, Timothy/0000-0002-4670-9440; Ramon y Cajal, Santiago/0000-0002-3867-1390; Abasolo, Ibane/0000-0001-5970-6276; Sese, Marta/0000-0003-1473-4833; Castellon, Enrique/0000-0002-3770-8550; Mendez, Raul/0000-0002-1952-6905; Celia-Terrassa, Toni/0000-0002-0615-8744; Valente, Filippo/0000-0001-5760-5949; Canovas, Veronica/0000-0002-1994-5763; Contreras, Hector/0000-0003-4012-2662	Ministry of Science and Innovation; MINECO [SAF2008-03936, SAF2011-30496]; TV3 Telemarathon; Instituto Carlos III [RD06/0020/0058 RETICS]; AGAUR [2009SGR1482]; Red Nacional de Biobancos, Instituto Carlos III; Fondo de Investigaciones de la Seguridad Social [PI20231];  [SAF2008-04136-C02-01];  [SAF2011-24686]	Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); MINECO(Spanish Government); TV3 Telemarathon; Instituto Carlos III(Instituto de Salud Carlos III); AGAUR(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); Red Nacional de Biobancos, Instituto Carlos III; Fondo de Investigaciones de la Seguridad Social; ; 	We thank A. Esquerra, T. Moline and P. Guijarro for excellent technical help, J.J. Lozano for help with statistical analysis and J. Reventos for advice and support. This study was supported by Ministry of Science and Innovation and MINECO SAF2008-03936, SAF2011-30496, TV3 Telemarathon, and Instituto Carlos III RD06/0020/0058 RETICS (to RP); SAF2008-04136-C02-01 and SAF2011-24686 (to TMT); AGAUR 2009SGR1482 (to RP and TMT); Red Nacional de Biobancos, Instituto Carlos III (to RB); and Fondo de Investigaciones de la Seguridad Social PI20231 (to PLF).	Adams DR, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-22; Antonyak MA, 2002, ONCOGENE, V21, P5038, DOI 10.1038/sj.onc.1205593; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Benedit P, 2001, ONCOGENE, V20, P1455, DOI 10.1038/sj.onc.1204233; Benzinger A, 2005, CELL RES, V15, P219, DOI 10.1038/sj.cr.7290290; Bilanges B, 2007, MOL CELL BIOL, V27, P5746, DOI 10.1128/MCB.02136-06; Bontems F, 2011, J STRUCT BIOL, V174, P245, DOI 10.1016/j.jsb.2010.10.011; Buensuceso CS, 2001, J CELL SCI, V114, P1691; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Chantrel Y, 1998, GENETICS, V148, P559; Coleman LJ, 2009, BRIT J CANCER, V100, P1393, DOI 10.1038/sj.bjc.6605044; Coyle SM, 2009, MOL CELL BIOL, V29, P1626, DOI 10.1128/MCB.01718-08; Diaz VM, 2002, GASTROENTEROLOGY, V122, P806, DOI 10.1053/gast.2002.31885; Dresios J, 2006, MOL MICROBIOL, V59, P1651, DOI 10.1111/j.1365-2958.2006.05054.x; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; Fernandez S, 2011, VIRCHOWS ARCH, V458, P323, DOI 10.1007/s00428-010-1018-1; Graff JR, 2009, CANCER RES, V69, P3866, DOI 10.1158/0008-5472.CAN-08-3472; Grosso S, 2008, BIOCHEM J, V415, P77, DOI 10.1042/BJ20080463; Hermanto U, 2002, MOL CELL BIOL, V22, P2345, DOI 10.1128/MCB.22.7.2345-2365.2002; Hong IK, 2006, J BIOL CHEM, V281, P24279, DOI 10.1074/jbc.M601209200; Hovland R, 1996, INT J BIOCHEM CELL B, V28, P1089, DOI 10.1016/1357-2725(96)00059-3; Ikenoue T, 2008, EMBO J, V27, P1919, DOI 10.1038/emboj.2008.119; Janulis M, 1999, J BIOL CHEM, V274, P801, DOI 10.1074/jbc.274.2.801; Jiao XM, 2010, J BIOL CHEM, V285, P8218, DOI 10.1074/jbc.M110.100792; Kiely PA, 2002, J BIOL CHEM, V277, P22581, DOI 10.1074/jbc.M201758200; Knirsh R, 2009, MOL BIOL CELL, V20, P2121, DOI 10.1091/mbc.E08-12-1196; Kozak M, 2005, GENE, V361, P13, DOI 10.1016/j.gene.2005.06.037; Lee HK, 2007, EMBO J, V26, P3545, DOI 10.1038/sj.emboj.7601797; Li Y, 2010, J DERMATOL SCI, V60, P105, DOI 10.1016/j.jdermsci.2010.08.003; Lopez T, 2002, CANCER CELL, V1, P339, DOI 10.1016/S1535-6108(02)00055-7; Lopez-Bergami P, 2005, MOL CELL, V19, P309, DOI 10.1016/j.molcel.2005.06.025; Lynch M, 2004, J BIOL CHEM, V279, P3327, DOI 10.1074/jbc.M310872200; Malliri A, 1998, J CELL BIOL, V143, P1087, DOI 10.1083/jcb.143.4.1087; Merrick WC, 2004, GENE, V332, P1, DOI 10.1016/j.gene.2004.02.051; Milbradt AG, 2011, NAT STRUCT MOL BIOL, V18, P410, DOI 10.1038/nsmb.1999; Mittler G, 2003, EMBO J, V22, P6494, DOI 10.1093/emboj/cdg619; Nateri AS, 2005, NATURE, V437, P281, DOI 10.1038/nature03914; Nilsson J, 2004, EMBO REP, V5, P1137, DOI 10.1038/sj.embor.7400291; Ozanne BW, 2007, ONCOGENE, V26, P1, DOI 10.1038/sj.onc.1209759; PETRAK D, 1994, J IMMUNOL, V153, P2046; Regmi S, 2008, MOL MICROBIOL, V70, P724, DOI 10.1111/j.1365-2958.2008.06443.x; RON D, 1994, P NATL ACAD SCI USA, V91, P839, DOI 10.1073/pnas.91.3.839; Ruan YY, 2012, J CLIN INVEST, V122, P2554, DOI 10.1172/JCI58488; Santamaria A, 2005, MOL CELL BIOL, V25, P1900, DOI 10.1128/MCB.25.5.1900-1911.2005; Santamaria A, 2003, AM J PATHOL, V162, P897, DOI 10.1016/S0002-9440(10)63885-0; Sengupta J, 2004, NAT STRUCT MOL BIOL, V11, P957, DOI 10.1038/nsmb822; Stemmer V, 2008, ONCOGENE, V27, P5075, DOI 10.1038/onc.2008.140; Vesely PW, 2009, MUTAT RES-REV MUTAT, V682, P7, DOI 10.1016/j.mrrev.2009.01.001; Vojnic E, 2011, NAT STRUCT MOL BIOL, V18, P404, DOI 10.1038/nsmb.1997; Wang JH, 2010, MOL CANCER RES, V8, P266, DOI 10.1158/1541-7786.MCR-09-0221; Yan LQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016515; Yang FJ, 2004, P NATL ACAD SCI USA, V101, P2339, DOI 10.1073/pnas.0308676100; Yang YM, 2003, CLIN CANCER RES, V9, P391; Zhang J, 2012, ONCOGENE, V31, P1835, DOI 10.1038/onc.2011.369; Zhang WZ, 2006, MOL CELL BIOL, V26, P413, DOI 10.1128/MCB.26.2.413-424.2006; Zolotukhin AS, 2009, NUCLEIC ACIDS RES, V37, P7151, DOI 10.1093/nar/gkp782	56	25	25	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 27	2014	33	9					1124	1134		10.1038/onc.2013.51	http://dx.doi.org/10.1038/onc.2013.51			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AB6XT	23455324				2022-12-25	WOS:000331933800006
J	Metcalf, JL; Bradshaw, PS; Komosa, M; Greer, SN; Meyn, MS; Ohh, M				Metcalf, J. L.; Bradshaw, P. S.; Komosa, M.; Greer, S. N.; Meyn, M. Stephen; Ohh, M.			K63-Ubiquitylation of VHL by SOCS1 mediates DNA double-strand break repair	ONCOGENE			English	Article						DNA repair; K63-ubiquitylation; RCC; SOCS1; VHL	TUMOR-SUPPRESSOR PROTEIN; HOMOLOGOUS RECOMBINATION; CYTOPLASMIC LOCALIZATION; ATM ACTIVATION; HIF-ALPHA; NUCLEAR; FIBRONECTIN; PATHWAY; COMPLEX; PHOSPHORYLATION	DNA repair is essential for maintaining genomic stability, and defects in this process significantly increase the risk of cancer. Clear-cell renal cell carcinoma (CCRCC) caused by inactivation of the von Hippel-Lindau (VHL) tumor suppressor gene is characterized by high genomic instability. However, the molecular mechanism underlying the association between the loss of VHL and genomic instability remains unclear. Here, we show that suppressor of cytokine signaling 1 (SOCS1) promotes nuclear redistribution and K63-ubiquitylation of VHL in response to DNA double-strand breaks (DSBs). Loss of VHL or VHL mutations that compromise its K63-ubiquitylation attenuates the DNA-damage response (DDR), resulting in decreased homologous recombination repair and persistence of DSBs. These results identify VHL as a component of the DDR network, inactivation of which contributes to the genomic instability associated with CCRCC.	[Metcalf, J. L.; Greer, S. N.; Ohh, M.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5S 1A8, Canada; [Bradshaw, P. S.; Meyn, M. Stephen] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Komosa, M.; Meyn, M. Stephen] Hosp Sick Children, Res Inst, Program Genet & Genome Biol, Toronto, ON M5G 1X8, Canada; [Meyn, M. Stephen] Hosp Sick Children, Dept Paediat, Toronto, ON M5G 1X8, Canada	University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Ohh, M (corresponding author), Univ Toronto, Dept Lab Med & Pathobiol, Med Sci Bldg,Room 6306,1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada.	michael.ohh@utoronto.ca			Canadian Institutes of Health Research [MOP77718]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by funds from the Canadian Institutes of Health Research (MOP77718).	Allen C, 2003, MOL CANCER RES, V1, P913; Arai E, 2011, INT J CLIN EXP PATHO, V4, P58; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Bartek J, 2003, CANCER CELL, V3, P421, DOI 10.1016/S1535-6108(03)00110-7; Ben-Zvi T, 2006, J CELL SCI, V119, P380, DOI 10.1242/jcs.02740; Bluyssen HAR, 2004, FEBS LETT, V556, P137, DOI 10.1016/S0014-5793(03)01392-9; Cai QL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009720; Calabrese V, 2009, MOL CELL, V36, P754, DOI 10.1016/j.molcel.2009.09.044; Celeste A, 2002, SCIENCE, V296, P922, DOI 10.1126/science.1069398; Christensen DE, 2007, NAT STRUCT MOL BIOL, V14, P941, DOI 10.1038/nsmb1295; Couedel C, 2004, GENE DEV, V18, P1293, DOI 10.1101/gad.1209204; Delacote F, 2002, NUCLEIC ACIDS RES, V30, P3454, DOI 10.1093/nar/gkf452; Evans AJ, 2007, MOL CELL BIOL, V27, P157, DOI 10.1128/MCB.00892-06; Fernandez-Capetillo O, 2004, DNA REPAIR, V3, P959, DOI 10.1016/j.dnarep.2004.03.024; Fukushima T, 2001, J BIOL CHEM, V276, P44413, DOI 10.1074/jbc.M106295200; Hoffman MA, 2001, HUM MOL GENET, V10, P1019, DOI 10.1093/hmg/10.10.1019; Hofmann RM, 1999, CELL, V96, P645, DOI 10.1016/S0092-8674(00)80575-9; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kastan MB, 2000, NAT REV MOL CELL BIO, V1, P179, DOI 10.1038/35043058; Kim JS, 2005, J CELL BIOL, V170, P341, DOI 10.1083/jcb.200411083; Koshiji M, 2005, MOL CELL, V17, P793, DOI 10.1016/j.molcel.2005.02.015; Lavin MF, 2007, CELL CYCLE, V6, P931, DOI 10.4161/cc.6.8.4180; Lee JH, 2005, SCIENCE, V308, P551, DOI 10.1126/science.1108297; Lee S, 1996, P NATL ACAD SCI USA, V93, P1770, DOI 10.1073/pnas.93.5.1770; Lee S, 1999, MOL CELL BIOL, V19, P1486; Lewis MD, 2003, ONCOGENE, V22, P3992, DOI 10.1038/sj.onc.1206683; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; O'Donovan PJ, 2010, CARCINOGENESIS, V31, P961, DOI 10.1093/carcin/bgq069; Ohh M, 1998, MOL CELL, V1, P959, DOI 10.1016/S1097-2765(00)80096-9; Panier S, 2009, DNA REPAIR, V8, P436, DOI 10.1016/j.dnarep.2009.01.013; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Pierce AJ, 2001, GENE DEV, V15, P3237, DOI 10.1101/gad.946401; Plans V, 2006, J CELL BIOCHEM, V97, P572, DOI 10.1002/jcb.20587; Qi H, 2003, CANCER RES, V63, P7076; Rezvani HR, 2010, NUCLEIC ACIDS RES, V38, P797, DOI 10.1093/nar/gkp1072; Riballo E, 2004, MOL CELL, V16, P715, DOI 10.1016/j.molcel.2004.10.029; Roberts AM, 2009, CANCER RES, V69, P9056, DOI 10.1158/0008-5472.CAN-09-1770; Russell RC, 2011, NAT MED, V17, P845, DOI 10.1038/nm.2370; Schermer B, 2006, J CELL BIOL, V175, P547, DOI 10.1083/jcb.200605092; Shiloh Y, 2001, ADV CANCER RES, V83, P209, DOI 10.1016/S0065-230X(01)83007-4; Stewart GS, 2009, CELL, V136, P420, DOI 10.1016/j.cell.2008.12.042; Stewart GS, 1999, CELL, V99, P577, DOI 10.1016/S0092-8674(00)81547-0; Stickle NH, 2004, MOL CELL BIOL, V24, P3251, DOI 10.1128/MCB.24.8.3251-3261.2004; Takata M, 1998, EMBO J, V17, P5497, DOI 10.1093/emboj/17.18.5497; Ungureanu D, 2002, MOL CELL BIOL, V22, P3316, DOI 10.1128/MCB.22.10.3316-3326.2002; van Gent DC, 2001, NAT REV GENET, V2, P196, DOI 10.1038/35056049; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Wang Y, 2009, NAT MED, V15, P319, DOI 10.1038/nm.1922; Weinstock DM, 2006, METHOD ENZYMOL, V409, P524, DOI 10.1016/S0076-6879(05)09031-2; Yang H, 2007, MOL CELL, V28, P15, DOI 10.1016/j.molcel.2007.09.010; Young AP, 2008, NAT CELL BIOL, V10, P361, DOI 10.1038/ncb1699; Zhao GY, 2007, MOL CELL, V25, P663, DOI 10.1016/j.molcel.2007.01.029	53	34	34	1	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 20	2014	33	8					1055	1065		10.1038/onc.2013.22	http://dx.doi.org/10.1038/onc.2013.22			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AB6XO	23455319				2022-12-25	WOS:000331933200013
J	Zhuang, Q; Qing, XB; Ying, Y; Wu, HT; Benda, C; Lin, J; Huang, ZJ; Liu, LQ; Xu, Y; Bao, XC; Qin, BM; Pei, DQ; Esteban, MA				Zhuang, Qiang; Qing, Xiaobing; Ying, Yue; Wu, Haitao; Benda, Christina; Lin, Jiao; Huang, Zhijian; Liu, Longqi; Xu, Yan; Bao, Xichen; Qin, Baoming; Pei, Duanqing; Esteban, Miguel A.			Class IIa Histone Deacetylases and Myocyte Enhancer Factor 2 Proteins Regulate the Mesenchymal-to-Epithelial Transition of Somatic Cell Reprogramming	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLURIPOTENT STEM-CELLS; MOUSE FIBROBLASTS; DEFINED FACTORS; DIFFERENTIATION; CARDIOMYOCYTES; HYPERTROPHY; GENERATION; EFFICIENT; MEF2; MYC	Class IIa histone deacetylases (HDACs) and myocyte enhancer factor 2 (MEF2) proteins compose a signaling module that orchestrates lineage specification during embryogenesis. We show here that this module also regulates the generation of mouse induced pluripotent stem cells by defined transcription factors. Class IIa HDACs and MEF2 proteins rise steadily during fibroblast reprogramming to induced pluripotent stem cells. MEF2 proteins tend to block the process by inducing the expression of Tgf beta cytokines, which impairs the necessary phase of mesenchymal-to-epithelial transition (MET). Conversely, class IIa HDACs endeavor to suppress the activity of MEF2 proteins, thus enhancing the MET and colony formation efficiency. Our work highlights an unexpected role for a developmental axis in somatic cell reprogramming and provides new insight into how the MET is regulated in this context.	[Zhuang, Qiang; Qing, Xiaobing; Ying, Yue; Wu, Haitao; Benda, Christina; Lin, Jiao; Huang, Zhijian; Liu, Longqi; Xu, Yan; Bao, Xichen; Qin, Baoming; Pei, Duanqing; Esteban, Miguel A.] Chinese Acad Sci, Key Lab Regenerat Biol, Guangzhou 510530, Guangdong, Peoples R China; [Zhuang, Qiang; Qing, Xiaobing; Ying, Yue; Wu, Haitao; Benda, Christina; Lin, Jiao; Huang, Zhijian; Liu, Longqi; Xu, Yan; Bao, Xichen; Qin, Baoming; Pei, Duanqing; Esteban, Miguel A.] Guangzhou Inst Biomed, South China Inst Stem Cell Biol & Regenerat Med, Guangdong Prov Key Lab Stem Cells & Regenerat Med, Guangzhou 510530, Guangdong, Peoples R China; [Zhuang, Qiang; Qing, Xiaobing; Ying, Yue; Wu, Haitao; Benda, Christina; Lin, Jiao; Huang, Zhijian; Liu, Longqi; Xu, Yan; Bao, Xichen; Qin, Baoming; Pei, Duanqing; Esteban, Miguel A.] Guangzhou Inst Hlth, Guangdong Prov Key Lab Stem Cells & Regenerat Med, South China Inst Stem Cell Biol & Regenerat Med, Guangzhou 510530, Guangdong, Peoples R China; [Qing, Xiaobing] Univ Sci & Technol China, Sch Life Sci, Hefei 230027, Anhui, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Esteban, MA (corresponding author), Chinese Acad Sci, Key Lab Regenerat Biol, Guangzhou 510530, Guangdong, Peoples R China.	esteban@gibh.org	Qin, Baoming/G-1553-2015; Qing, Xiaobing/ABF-5539-2020	Qin, Baoming/0000-0001-7652-161X; Xu, Yan/0000-0001-5653-291X	Chinese Academy of Sciences [XDA01020106]; Ministry of Science and Technology of China 973 Program Grants [2011CB965200]; National Natural Science Foundation of China [31071309]	Chinese Academy of Sciences(Chinese Academy of Sciences); Ministry of Science and Technology of China 973 Program Grants; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Strategic Priority Research Program of the Chinese Academy of Sciences Grant XDA01020106, by Ministry of Science and Technology of China 973 Program Grants 2011CB965200, and by National Natural Science Foundation of China Grant 31071309.	Chang SR, 2006, CELL, V126, P321, DOI 10.1016/j.cell.2006.05.040; Chen JK, 2013, NAT GENET, V45, P34, DOI 10.1038/ng.2491; Chen JK, 2011, CELL RES, V21, P205, DOI 10.1038/cr.2010.172; Efe JA, 2011, NAT CELL BIOL, V13, P215, DOI 10.1038/ncb2164; Esteban MA, 2010, CELL STEM CELL, V6, P71, DOI 10.1016/j.stem.2009.12.001; Fischle W, 2002, MOL CELL, V9, P45, DOI 10.1016/S1097-2765(01)00429-4; GOSSETT LA, 1989, MOL CELL BIOL, V9, P5022, DOI 10.1128/MCB.9.11.5022; Gottlicher M, 2001, EMBO J, V20, P6969, DOI 10.1093/emboj/20.24.6969; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Han AD, 2005, J MOL BIOL, V345, P91, DOI 10.1016/j.jmb.2004.10.033; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Ichida JK, 2009, CELL STEM CELL, V5, P491, DOI 10.1016/j.stem.2009.09.012; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Kim J, 2011, P NATL ACAD SCI USA, V108, P7838, DOI 10.1073/pnas.1103113108; Kim JB, 2008, NATURE, V454, P646, DOI 10.1038/nature07061; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Lahm A, 2007, P NATL ACAD SCI USA, V104, P17335, DOI 10.1073/pnas.0706487104; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; Li ZH, 2011, EMBO J, V30, P823, DOI 10.1038/emboj.2011.2; Liao BJ, 2011, J BIOL CHEM, V286, P17359, DOI 10.1074/jbc.C111.235960; Liu D, 2004, EMBO J, V23, P1557, DOI 10.1038/sj.emboj.7600179; Maherali N, 2009, CURR BIOL, V19, P1718, DOI 10.1016/j.cub.2009.08.025; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Mihaylova MM, 2011, CELL, V145, P607, DOI 10.1016/j.cell.2011.03.043; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Plath K, 2011, NAT REV GENET, V12, P253, DOI 10.1038/nrg2955; Potthoff MJ, 2007, DEVELOPMENT, V134, P4131, DOI 10.1242/dev.008367; Qin DJ, 2008, J BIOL CHEM, V283, P33730, DOI 10.1074/jbc.M806788200; Quinn ZA, 2001, NUCLEIC ACIDS RES, V29, P732, DOI 10.1093/nar/29.3.732; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Subramanyam D, 2011, NAT BIOTECHNOL, V29, P443, DOI 10.1038/nbt.1862; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Vega RB, 2004, CELL, V119, P555, DOI 10.1016/j.cell.2004.10.024; Wang B, 2011, CELL, V145, P596, DOI 10.1016/j.cell.2011.04.013; Wernig M, 2008, CELL STEM CELL, V2, P10, DOI 10.1016/j.stem.2007.12.001; Yang XJ, 2008, NAT REV MOL CELL BIO, V9, P206, DOI 10.1038/nrm2346; Yori JL, 2010, J BIOL CHEM, V285, P16854, DOI 10.1074/jbc.M110.114546; Zhang CL, 2002, CELL, V110, P479, DOI 10.1016/S0092-8674(02)00861-9	41	9	10	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2013	288	17					12022	12031		10.1074/jbc.M113.460766	http://dx.doi.org/10.1074/jbc.M113.460766			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	133RP	23467414	hybrid, Green Published			2022-12-25	WOS:000318157600036
J	Diab, HI; Kane, PM				Diab, Heba I.; Kane, Patricia M.			Loss of Vacuolar H+-ATPase (V-ATPase) Activity in Yeast Generates an Iron Deprivation Signal That Is Moderated by Induction of the Peroxiredoxin TSA2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE-STRESS-RESPONSE; SACCHAROMYCES-CEREVISIAE; MONOTHIOL GLUTAREDOXIN; PH HOMEOSTASIS; TRANSCRIPTION; RECEPTOR; REVEALS; PEROXIDASE; OXIDASE; REGULON	Vacuolar H+-ATPases (V-ATPases) acidify intracellular organelles and help to regulate overall cellular pH. Yeast vma mutants lack V-ATPase activity and allow exploration of connections between cellular pH, iron, and redox homeostasis common to all eukaryotes. A previous microarray study in a vma mutant demonstrated up-regulation of multiple iron uptake genes under control of Aft1p (the iron regulon) and only one antioxidant gene, the peroxiredoxin TSA2 (Milgrom, E., Diab, H., Middleton, F., and Kane, P. M. (2007) Loss of vacuolar proton-translocating ATPase activity in yeast results in chronic oxidative stress. J. Biol. Chem. 282, 7125-7136). Fluorescent biosensors placing GFP under transcriptional control of either an Aft1-dependent promoter (P-FIT2-GFP) or the TSA2 promoter (P-TSA2-GFP) were constructed to monitor transcriptional signaling. Both biosensors were up-regulated in the vma2 Delta mutant, and acute V-ATPase inhibition with concanamycin A induced coordinate up-regulation from both promoters. P-TSA2-GFP induction was Yap1p-dependent, indicating an oxidative stress signal. Total cell iron measurements indicate that the vma2 Delta mutant is iron-replete, despite up-regulation of the iron regulon. Acetic acid up-regulated P-FIT2-GFP expression in wildtype cells, suggesting that loss of pH control contributes to an iron deficiency signal in the mutant. Iron supplementation significantly decreased P-FIT2-GFP expression and, surprisingly, restored P-TSA2-GFP to wild-type levels. A tsa2 Delta mutation induced both nuclear localization of Aft1p and P-FIT2-GFP expression. The data suggest a novel function for Tsa2p as a negative regulator of Aft1p-driven transcription, which is induced in V-ATPase mutants to limit transcription of the iron regulon. This represents a new mechanism bridging the antioxidant and iron-regulatory pathways that is intimately linked to pH homeostasis.	[Diab, Heba I.; Kane, Patricia M.] SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Kane, PM (corresponding author), SUNY Upstate Med Univ, Dept Biochem & Mol Biol, 750 E Adams St, Syracuse, NY 13210 USA.	kanepm@upstate.edu			National Institutes of Health [R01 GM50322]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050322] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM50322 (to P. M. K.).	Allan AK, 2005, PHYSIOL GENOMICS, V22, P128, DOI 10.1152/physiolgenomics.00233.2004; BALI PK, 1992, BIOCHEMISTRY-US, V31, P3963, DOI 10.1021/bi00131a011; Banuelos MA, 1998, MICROBIOL-UK, V144, P2749, DOI 10.1099/00221287-144-10-2749; BEAUVOIT B, 1991, BIOCHEMISTRY-US, V30, P11212, DOI 10.1021/bi00111a004; Berggren MI, 2001, ARCH BIOCHEM BIOPHYS, V392, P103, DOI 10.1006/abbi.2001.2435; Breton S, 2007, AM J PHYSIOL-RENAL, V292, pF1, DOI 10.1152/ajprenal.00340.2006; Brombacher K, 2006, YEAST, V23, P741, DOI 10.1002/yea.1392; Chen OS, 2004, J BIOL CHEM, V279, P29513, DOI 10.1074/jbc.M403209200; Cipriano DJ, 2008, BBA-BIOENERGETICS, V1777, P599, DOI 10.1016/j.bbabio.2008.03.013; Cockrell AL, 2011, BIOCHEMISTRY-US, V50, P10275, DOI 10.1021/bi2014954; Courel M, 2005, MOL CELL BIOL, V25, P6760, DOI 10.1128/MCB.25.15.6760-6771.2005; DAUTRYVARSAT A, 1983, P NATL ACAD SCI-BIOL, V80, P2258, DOI 10.1073/pnas.80.8.2258; Davis-Kaplan SR, 2004, J BIOL CHEM, V279, P4322, DOI 10.1074/jbc.M310680200; Davis-Kaplan SR, 1998, P NATL ACAD SCI USA, V95, P13641, DOI 10.1073/pnas.95.23.13641; Delaunay A, 2002, CELL, V111, P471, DOI 10.1016/S0092-8674(02)01048-6; Follmann M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-621; Fomenko DE, 2011, P NATL ACAD SCI USA, V108, P2729, DOI 10.1073/pnas.1010721108; Freimoser FM, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-11-r109; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Herrero E, 2008, BBA-GEN SUBJECTS, V1780, P1217, DOI 10.1016/j.bbagen.2007.12.004; Hirsch J, 2006, BIOCHIMIE, V88, P1767, DOI 10.1016/j.biochi.2006.05.007; Iraqui I, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000524; Irazusta V, 2008, FREE RADICAL BIO MED, V44, P1712, DOI 10.1016/j.freeradbiomed.2008.01.014; Iwai K, 2010, J BIOL CHEM, V285, P10597, DOI 10.1074/jbc.M109.090142; Jamieson DJ, 1998, YEAST, V14, P1511, DOI 10.1002/(SICI)1097-0061(199812)14:16<1511::AID-YEA356>3.3.CO;2-J; Jang HH, 2004, CELL, V117, P625, DOI 10.1016/j.cell.2004.05.002; Jbel M, 2011, EUKARYOT CELL, V10, P629, DOI 10.1128/EC.00015-11; Kane PA, 2006, MICROBIOL MOL BIOL R, V70, P177, DOI 10.1128/MMBR.70.1.177-191.2006; KANE PM, 1992, J BIOL CHEM, V267, P447; Karmazyn M, 1999, CIRC RES, V85, P777, DOI 10.1161/01.RES.85.9.777; Kinouchi K, 2010, CIRC RES, V107, P30, DOI 10.1161/CIRCRESAHA.110.224667; Kumanovics A, 2008, J BIOL CHEM, V283, P10276, DOI 10.1074/jbc.M801160200; Li HR, 2011, J BIOL CHEM, V286, P867, DOI 10.1074/jbc.M110.184176; Li HR, 2009, BIOCHEMISTRY-US, V48, P9569, DOI 10.1021/bi901182w; Li LT, 2010, J BIOL CHEM, V285, P10232, DOI 10.1074/jbc.M109.096859; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Martinez-Munoz GA, 2008, J BIOL CHEM, V283, P20309, DOI 10.1074/jbc.M710470200; Milgrom E, 2007, J BIOL CHEM, V282, P7125, DOI 10.1074/jbc.M608293200; Munhoz DC, 2004, J BIOL CHEM, V279, P35219, DOI 10.1074/jbc.M313773200; Nishi T, 2002, NAT REV MOL CELL BIO, V3, P94, DOI 10.1038/nrm729; Ojeda L, 2006, J BIOL CHEM, V281, P17661, DOI 10.1074/jbc.M602165200; Pardo JM, 2006, J EXP BOT, V57, P1181, DOI 10.1093/jxb/erj114; Philpott CC, 2008, EUKARYOT CELL, V7, P20, DOI 10.1128/EC.00354-07; Pierik AJ, 2009, NAT PROTOC, V4, P753, DOI 10.1038/nprot.2009.39; Pujol-Carrion N, 2006, J CELL SCI, V119, P4554, DOI 10.1242/jcs.03229; Rand JD, 2006, MOL BIOL CELL, V17, P387, DOI 10.1091/mbc.E05-06-0520; Rutherford JC, 2005, J BIOL CHEM, V280, P10135, DOI 10.1074/jbc.M413731200; Serrano R, 2004, J BIOL CHEM, V279, P19698, DOI 10.1074/jbc.M313746200; Sideri TC, 2010, P NATL ACAD SCI USA, V107, P6394, DOI 10.1073/pnas.1000347107; Sorkin A, 2002, NAT REV MOL CELL BIO, V3, P600, DOI 10.1038/nrm883; Spizzo T, 1997, MOL GEN GENET, V256, P547; Sun-Wada GH, 2000, DEV BIOL, V228, P315, DOI 10.1006/dbio.2000.9963; Tarsio M, 2011, J BIOL CHEM, V286, P28089, DOI 10.1074/jbc.M111.251363; Thorpe GW, 2004, P NATL ACAD SCI USA, V101, P6564, DOI 10.1073/pnas.0305888101; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Trotter EW, 2008, BIOCHEM J, V412, P73, DOI 10.1042/BJ20071634; Urbanowski JL, 1999, J BIOL CHEM, V274, P38061, DOI 10.1074/jbc.274.53.38061; Vachon P, 2012, EUKARYOT CELL, V11, P806, DOI 10.1128/EC.00060-12; Valko M, 2005, CURR MED CHEM, V12, P1161, DOI 10.2174/0929867053764635; Williamson W Ryan, 2010, Commun Integr Biol, V3, P604, DOI 10.4161/cib.3.6.13364; Williamson WR, 2010, J CELL BIOL, V189, P885, DOI 10.1083/jcb.201003062; Wong CM, 2003, FREE RADICAL BIO MED, V34, P585, DOI 10.1016/S0891-5849(02)01354-0; Wong CM, 2002, J BIOL CHEM, V277, P5385, DOI 10.1074/jbc.M106846200; Yamaguchi-Iwai Y, 2002, J BIOL CHEM, V277, P18914, DOI 10.1074/jbc.M200949200; Yang KS, 2002, J BIOL CHEM, V277, P38029, DOI 10.1074/jbc.M206626200	65	34	37	0	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2013	288	16					11366	11377		10.1074/jbc.M112.419259	http://dx.doi.org/10.1074/jbc.M112.419259			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	130KW	23457300	Green Published, hybrid			2022-12-25	WOS:000317915500039
J	Musumeci, MA; Hug, I; Scott, NE; Ielmini, MV; Foster, LJ; Wang, PG; Feldman, MF				Musumeci, Matias A.; Hug, Isabelle; Scott, Nichollas E.; Ielmini, M. Veronica; Foster, Leonard J.; Wang, Peng G.; Feldman, Mario F.			In Vitro Activity of Neisseria meningitidis PglL O-Oligosaccharyltransferase with Diverse Synthetic Lipid Donors and a UDP-activated Sugar	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LINKED PROTEIN GLYCOSYLATION; CAMPYLOBACTER-JEJUNI; BACTERIAL OLIGOSACCHARYLTRANSFERASES; ANTIGEN BIOSYNTHESIS; PILIN GLYCOSYLATION; GLYCAN; SYSTEM; IDENTIFICATION; FRACTIONATION; SPECIFICITY	Oligosaccharyltransferases (OTases) are enzymes that catalyze the transfer of an oligosaccharide from a lipid carrier to an acceptor molecule, commonly a protein. OTases are classified as N-OTases and O-OTases, depending on the nature of the glycosylation reaction. The N-OTases catalyze the glycan transfer to amide groups in asparagines in a reaction named N-linked glycosylation. The O-OTases are responsible for protein O-linked glycosylation, which involves the attachment of glycans to hydroxyl groups of serine or threonine residues. These enzymes exhibit a relaxed specificity and are able to transfer a variety of glycan structures to different protein acceptors. This property confers OTases with great biotechnological potential as these enzymes can produce glycoconjugates relevant to the pharmaceutical industry. Furthermore, OTases are thought to be involved in pathogenesis mechanisms. Several aspects of the functionality of OTases are not fully understood. In this work, we developed a novel approach to perform kinetic studies on PglL, the O-OTase from Neisseria meningitidis. We investigated the importance of the acyl moiety of the lipid glycan donor substrate on the functionality of PglL by testing the efficiency of glycosylation reactions using synthetic substrates carrying the same glycan structure but different acyl moieties. We found that PglL can function with many lipids as glycan donors, although the length and the conformation of the lipid moiety significantly influenced the catalytic efficiency. Interestingly, PglL was also able to transfer a monosaccharide employing its nucleotide-activated form, acting as a Leloir glycosyltransferase. These results provide new insights on the function and the evolution of oligosaccharyltransferases.	[Musumeci, Matias A.; Hug, Isabelle; Ielmini, M. Veronica; Feldman, Mario F.] Univ Alberta, Dept Biol Sci, Alberta Glyc Ctr, Edmonton, AB T6G 2E9, Canada; [Scott, Nichollas E.; Foster, Leonard J.] Univ British Columbia, Ctr High Throughput Biol, Vancouver, BC V6T 14, Canada; [Scott, Nichollas E.; Foster, Leonard J.] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 14, Canada; [Wang, Peng G.] Georgia State Univ, Dept Chem, Atlanta, GA 30303 USA	University of Alberta; University of British Columbia; University of British Columbia; University System of Georgia; Georgia State University	Feldman, MF (corresponding author), Univ Alberta, CW 405 Biol Sci Bldg, Edmonton, AB T6G 2E9, Canada.	mfeldman@ualberta.ca	Feldman, Mario/A-2637-2014; WANG, Peng/GSN-5263-2022	Feldman, Mario/0000-0003-4497-0976; Scott, Nichollas/0000-0003-2556-8316; Musumeci, Matias/0000-0003-2358-1365; Hug, Isabelle/0000-0002-4524-9569	Natural Sciences and Engineering Research Council of Canada; Alberta Glycomics Center; National Health and Medical Research Council of Australia Overseas Biomedical Fellowship [APP1037373]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Alberta Glycomics Center; National Health and Medical Research Council of Australia Overseas Biomedical Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported in part by grants from the Natural Sciences and Engineering Research Council of Canada and the Alberta Glycomics Center (to M. F. F.).; Supported by National Health and Medical Research Council of Australia Overseas Biomedical Fellowship APP1037373.	Aas FE, 2007, MOL MICROBIOL, V65, P607, DOI 10.1111/j.1365-2958.2007.05806.x; Asakura H, 2010, MOL MICROBIOL, V78, P1130, DOI 10.1111/j.1365-2958.2010.07393.x; Borud B, 2010, J BACTERIOL, V192, P2816, DOI 10.1128/JB.00101-10; Calo D, 2010, GLYCOBIOLOGY, V20, P1065, DOI 10.1093/glycob/cwq055; Ciesla WP, 1998, J BIOL CHEM, V273, P16021, DOI 10.1074/jbc.273.26.16021; Cristobal A, 2012, ANALYST, V137, P3541, DOI 10.1039/c2an35445d; Faridmoayer A, 2007, J BACTERIOL, V189, P8088, DOI 10.1128/JB.01318-07; Faridmoayer A, 2008, J BIOL CHEM, V283, P34596, DOI 10.1074/jbc.M807113200; Feldman MF, 2009, MICROBIAL GLYCOBIOLOGY: STRUCTURES, RELEVANCE AND APPLICATIONS, P903; Feldman MF, 2005, P NATL ACAD SCI USA, V102, P3016, DOI 10.1073/pnas.0500044102; Fletcher CM, 2009, CELL, V137, P321, DOI 10.1016/j.cell.2009.02.041; Gebhart C, 2012, GLYCOBIOLOGY, V22, P962, DOI 10.1093/glycob/cws059; Glover KJ, 2005, CHEM BIOL, V12, P1311, DOI 10.1016/j.chembiol.2005.10.004; Grass S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000919; Han WQ, 2012, J BIOL CHEM, V287, P5357, DOI 10.1074/jbc.M111.308486; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Ielmini MV, 2011, GLYCOBIOLOGY, V21, P734, DOI 10.1093/glycob/cwq192; Ishihama Y, 2006, J PROTEOME RES, V5, P988, DOI 10.1021/pr050385q; Iwashkiw JA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002758; Iwashkiw JA, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-13; Jennings MP, 2011, CELL MICROBIOL, V13, P885, DOI 10.1111/j.1462-5822.2011.01586.x; Joshua GWP, 2006, MICROBIOL-SGM, V152, P387, DOI 10.1099/mic.0.28358-0; Kowarik M, 2006, SCIENCE, V314, P1148, DOI 10.1126/science.1134351; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Langdon RH, 2009, FUTURE MICROBIOL, V4, P401, DOI 10.2217/FMB.09.10; LAUGHLIN MR, 1988, J BIOL CHEM, V263, P2285; Li M, 2008, BIOCHEMISTRY-US, V47, P11590, DOI 10.1021/bi801067s; Lizak C, 2011, NATURE, V474, P350, DOI 10.1038/nature10151; Markovic D, 2008, MOL ENDOCRINOL, V22, P689, DOI 10.1210/me.2007-0136; Nothaft H, 2010, NAT REV MICROBIOL, V8, P765, DOI 10.1038/nrmicro2383; Olsen JV, 2007, NAT METHODS, V4, P709, DOI 10.1038/NMETH1060; Power PM, 2006, BIOCHEM BIOPH RES CO, V347, P904, DOI 10.1016/j.bbrc.2006.06.182; Ramsay AJ, 2008, J BIOL CHEM, V283, P12293, DOI 10.1074/jbc.M709493200; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; ROEPSTORFF P, 1984, BIOMED MASS SPECTROM, V11, P601, DOI 10.1002/bms.1200111109; Schwarz F, 2011, GLYCOBIOLOGY, V21, P45, DOI 10.1093/glycob/cwq130; Scott NE, 2012, J BIOL CHEM, V287, P29384, DOI 10.1074/jbc.M112.380212; Scott NE, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M000031-MCP201; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; STIMSON E, 1995, MOL MICROBIOL, V17, P1201, DOI 10.1111/j.1365-2958.1995.mmi_17061201.x; Thomas RM, 2011, J BACTERIOL, V193, P5498, DOI 10.1128/JB.00438-11; Twine SM, 2009, J BACTERIOL, V191, P7050, DOI 10.1128/JB.00861-09; Vik A, 2009, P NATL ACAD SCI USA, V106, P4447, DOI 10.1073/pnas.0809504106; Wacker M, 2002, SCIENCE, V298, P1790, DOI 10.1126/science.298.5599.1790; Wang YV, 2007, P NATL ACAD SCI USA, V104, P12365, DOI 10.1073/pnas.0701497104; Weerapana E, 2006, GLYCOBIOLOGY, V16, p91R, DOI 10.1093/glycob/cwj099; Wishart TM, 2007, MOL CELL PROTEOMICS, V6, P1318, DOI 10.1074/mcp.M600457-MCP200; Woodward R, 2010, NAT CHEM BIOL, V6, P418, DOI 10.1038/nchembio.351; Young NM, 2002, J BIOL CHEM, V277, P42530, DOI 10.1074/jbc.M206114200	49	19	23	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2013	288	15					10578	10587		10.1074/jbc.M112.432815	http://dx.doi.org/10.1074/jbc.M112.432815			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	125TU	23460642	Green Published, hybrid			2022-12-25	WOS:000317565000037
J	Munzbergova, Z; Hadincova, V; Wild, J; Kindlmannova, J				Muenzbergova, Zuzana; Hadincova, Vera; Wild, Jan; Kindlmannova, Jana			Variability in the Contribution of Different Life Stages to Population Growth as a Key Factor in the Invasion Success of Pinus strobus	PLOS ONE			English	Article							COMPARATIVE DEMOGRAPHY; MATRIX ANALYSIS; DYNAMICS; PLANT; MODELS; RATES; DISPERSAL; LANDSCAPE; SPREAD; SHRUB	Background: Despite the increasing number of studies attempting to model population growth in various organisms, we still know relatively little about the population dynamics of long-lived species that reproduce only in the later stages of their life cycle, such as trees. Predictions of the dynamics of these species are, however, urgently needed for planning management actions when species are either endangered or invasive. In long-lived species, a single management intervention may have consequences for several decades, and detailed knowledge of long-term performance can therefore elucidate possible outcomes during the management planning phase. Methodology and Principal Findings: We studied the population dynamics of an invasive tree species, Pinus strobus, in three habitat types represented by their position along the elevation gradient occupied by the species. In agreement with previous studies on the population dynamics of long-lived perennials, our results show that the survival of the largest trees exhibits the highest elasticity in all of the studied habitats. In contrast, life table response experiments (LTRE) analysis showed that different stages contribute the most to population growth rates in different habitats, with generative reproduction being more important in lower slopes and valley bottoms and survival being more important on rock tops and upper slopes. Conclusions: The results indicate that P. strobus exhibits different growth strategies in different habitats that result in similar population growth rates. We propose that this plasticity in growth strategies is a key factor in the invasion success of the white pine. In all of the investigated habitats, the population growth rates are above 1, indicating that the population of the species is still increasing and has the ability to spread and occupy a wide range of habitats.	[Muenzbergova, Zuzana; Hadincova, Vera; Wild, Jan] Acad Sci Czech Republ, Inst Bot, CS-25243 Pruhonice, Czech Republic; [Muenzbergova, Zuzana; Kindlmannova, Jana] Charles Univ Prague, Fac Sci, Dept Bot, Prague, Czech Republic; [Wild, Jan] Czech Univ Life Sci, Fac Environm Sci, Prague, Czech Republic	Czech Academy of Sciences; Institute of Botany of the Czech Academy of Sciences; Charles University Prague; Czech University of Life Sciences Prague	Munzbergova, Z (corresponding author), Acad Sci Czech Republ, Inst Bot, CS-25243 Pruhonice, Czech Republic.	zuzmun@natur.cuni.cz	Münzbergová, Zuzana/F-6321-2013; Wild, Jan/G-2380-2010; Hadincova, Veroslava/D-4572-2013	Münzbergová, Zuzana/0000-0002-4026-6220; Wild, Jan/0000-0003-3007-4070; Hadincova, Veroslava/0000-0002-3825-1919	GACR [526/05/0430, P504/10/0456]; Academy of Sciences RVO [67985939]; MSMT	GACR(Grant Agency of the Czech Republic); Academy of Sciences RVO; MSMT(Ministry of Education, Youth & Sports - Czech Republic)	This project was supported by GACR 526/05/0430 and P504/10/0456 (www.gacr.cz) and partly by the institutional research project of the Academy of Sciences RVO 67985939 (www.cas.cz) and institutional resources of MSMT (www.msmt.cz). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2008, PLANT ECOL, V198, P169, DOI 10.1007/s11258-007-9393-7; Al-Khafaji K, 2007, J ECOL, V95, P1370, DOI 10.1111/j.1365-2745.2007.01296.x; ALVAREZBUYLLA ER, 1994, ECOLOGY, V75, P255, DOI 10.2307/1939401; Beer V., 2007, SANDSTONE LANDSCAPES, P109; Brown KA, 2008, J APPL ECOL, V45, P1639, DOI 10.1111/j.1365-2664.2008.01550.x; Buckley YM, 2005, J APPL ECOL, V42, P1020, DOI 10.1111/j.1365-2664.2005.01100.x; Buckley YM, 2010, ECOL LETT, V13, P1182, DOI 10.1111/j.1461-0248.2010.01506.x; Burns JH, 2010, J ECOL, V98, P334, DOI 10.1111/j.1365-2745.2009.01634.x; Caplat P, 2012, ECOLOGY, V93, P368, DOI 10.1890/11-0820.1; Caswell H, 2000, ECOLOGY, V81, P619, DOI 10.2307/177364; Caswell H., 2001, MATRIX POPULATION MO, V2nd ed.; Cilek V., 2007, SANDSTONE LANDSCAPES, P97; Colling G, 2006, J ECOL, V94, P959, DOI 10.1111/j.1365-2745.2006.01147.x; Cropper WP, 2006, ECOL MODEL, V198, P487, DOI 10.1016/j.ecolmodel.2006.05.034; de Kroon H, 2000, ECOLOGY, V81, P607, DOI 10.1890/0012-9658(2000)081[0607:EAROMA]2.0.CO;2; De-Camino-Beck T, 2009, ECOL MODEL, V220, P3394, DOI 10.1016/j.ecolmodel.2009.09.003; DeWalt SJ, 2006, BIOL INVASIONS, V8, P1145, DOI 10.1007/s10530-005-5277-8; Dostalek T, 2013, FOLIA GEOBOT, V48, P75, DOI 10.1007/s12224-012-9132-2; Dovciak M, 2005, ECOL MONOGR, V75, P363, DOI 10.1890/03-0802; Efron B., 1994, INTRO BOOTSTRAP; Ehrlen J, 2003, AM NAT, V162, P796, DOI 10.1086/379350; Elton C. S., 1958, ECOLOGY INVASIONS AN; Emery SM, 2005, J APPL ECOL, V42, P60, DOI 10.1111/j.1365-2664.2004.00990.x; Franco M, 2004, ECOLOGY, V85, P531, DOI 10.1890/02-0651; Freville H, 2004, ECOLOGY, V85, P694, DOI 10.1890/03-0119; Glockner P, 1995, VLASTIVEDA OKRESU P, P1; Hadincova V, 2007, SANDSTONES LANDSCAPE, P219; Harper J. L, 1977, POPULATION BIOL PLAN; Heinken-Smidova A, 2012, FOLIA GEOBOT, V47, P193, DOI 10.1007/s12224-011-9116-7; Herben T, 2006, J ECOL, V94, P131, DOI 10.1111/j.1365-2745.2005.01063.x; Higgins SI, 1996, ECOL MODEL, V87, P249, DOI 10.1016/0304-3800(95)00022-4; Ibanez I, 2009, ECOL APPL, V19, P359, DOI 10.1890/07-2095.1; Jacquemyn H, 2005, ECOL APPL, V15, P2097, DOI 10.1890/04-1762; Jongejans E, 2005, J ECOL, V93, P681, DOI 10.1111/j.1365-2745.2005.01003.x; Jongejans E, 2008, J ECOL, V96, P687, DOI 10.1111/j.1365-2745.2008.01367.x; Jongejans E, 2008, PERSPECT PLANT ECOL, V9, P153, DOI 10.1016/j.ppees.2007.09.005; Kaneko Y, 2002, J PLANT RES, V115, P341, DOI 10.1007/s10265-002-0042-x; Kaneko Yuko, 1999, Plant Species Biology, V14, P47, DOI 10.1046/j.1442-1984.1999.00007.x; Kolar CS, 2001, TRENDS ECOL EVOL, V16, P199, DOI 10.1016/S0169-5347(01)02101-2; Kolb A, 2010, ECOLOGY, V91, P3210, DOI 10.1890/09-2207.1; Koop AL, 2005, ECOLOGY, V86, P2661, DOI 10.1890/04-1483; Kozlowski T.T., 1991, PHYSL ECOLOGY WOODY, DOI 10.1016/B978-0-12-424160-2.50005-7; Kozlowski TT., 1971, GROWTH DEV TREES; Kwit C, 2004, CONSERV BIOL, V18, P432, DOI 10.1111/j.1523-1739.2004.00567.x; Lambrecht-McDowell SC, 2005, BIOL INVASIONS, V7, P281, DOI 10.1007/s10530-004-0870-9; Lehtila K, 2006, CONSERV BIOL, V20, P833, DOI 10.1111/j.1523-1739.2006.00368.x; Lloyd AH, 2005, CAN J FOREST RES, V35, P2073, DOI 10.1139/X05-119; LODGE DM, 1993, TRENDS ECOL EVOL, V8, P133, DOI 10.1016/0169-5347(93)90025-K; Munzbergova Z, 2007, ANN BOT-LONDON, V100, P1259, DOI 10.1093/aob/mcm204; Marco DE, 2000, ENVIRON MANAGE, V26, P409, DOI 10.1007/s002670010098; Moller AP, 2002, OECOLOGIA, V132, P492, DOI 10.1007/s00442-002-0952-2; Munzbergova Z, 2006, FOLIA GEOBOT, V41, P137, DOI 10.1007/BF02806475; Munzbergova Z, 2005, AM J BOT, V92, P1987, DOI 10.3732/ajb.92.12.1987; Munzbergova Z, 2005, J APPL ECOL, V42, P1115, DOI 10.1111/j.1365-2664.2005.01099.x; Munzbergova Z, 2005, ECOL APPL, V15, P1377, DOI 10.1890/04-1464; Munzbergova Z, 2010, BIOL INVASIONS, V12, P2471, DOI 10.1007/s10530-009-9656-4; Musil I, 1971, ACTA MUSEI SILESIA C, V1971, P168; Nehrbass N, 2007, ECOL MODEL, V201, P377, DOI 10.1016/j.ecolmodel.2006.10.004; NOZICKA J, 1965, PRACE VYZKUMNEHO UST, V31, P41; Octavio-Aguilar P, 2008, BOT J LINN SOC, V157, P381, DOI 10.1111/j.1095-8339.2008.00814.x; Oostermeijer JGB, 1996, J ECOL, V84, P153, DOI 10.2307/2261351; Pankova H, 2011, AM J BOT, V98, P850, DOI 10.3732/ajb.0900350; Parker IM, 2000, ECOL APPL, V10, P726, DOI 10.1890/1051-0761(2000)010[0726:IDOCSA]2.0.CO;2; Pergl J, 2011, DIVERS DISTRIB, V17, P725, DOI 10.1111/j.1472-4642.2011.00771.x; Pimentel D, 2000, BIOSCIENCE, V50, P53, DOI 10.1641/0006-3568(2000)050[0053:EAECON]2.3.CO;2; Pysek Petr, 2002, Preslia (Prague), V74, P97; Ramula S, 2008, J APPL ECOL, V45, P1124, DOI 10.1111/j.1365-2664.2008.01502.x; Richardson DM, 2004, DIVERS DISTRIB, V10, P321, DOI 10.1111/j.1366-9516.2004.00096.x; Rydgren K, 2007, ECOLOGY, V88, P2320, DOI 10.1890/06-1634.1; Sakai AK, 2001, ANNU REV ECOL SYST, V32, P305, DOI 10.1146/annurev.ecolsys.32.081501.114037; Schutzenhofer MR, 2007, ECOL APPL, V17, P965, DOI 10.1890/06-1282; Sebert-Cuvillier E, 2007, ECOL MODEL, V201, P127, DOI 10.1016/j.ecolmodel.2006.09.005; SILVERTOWN J, 1993, J ECOL, V81, P465, DOI 10.2307/2261525; Sintes T, 2007, ECOL MODEL, V206, P110, DOI 10.1016/j.ecolmodel.2007.03.027; Stott I, 2010, J ECOL, V98, P302, DOI 10.1111/j.1365-2745.2009.01632.x; Tanaka H, 2008, J VEG SCI, V19, P127, DOI 10.3170/2007-8-18342; The Mathworks Inc, 2001, MATLAB VERS 6 1; Van Mantgem PJ, 2005, J ECOL, V93, P737, DOI 10.1111/j.1365-2745.2005.01007.x; Vila M, 2006, ANN BOT-LONDON, V97, P1055, DOI 10.1093/aob/mcl052; Wendel G. W., 1990, AGR HDB, V654, P476; WERNER PA, 1977, ECOLOGY, V58, P1103, DOI 10.2307/1936930	81	10	11	0	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e56953	10.1371/journal.pone.0056953	http://dx.doi.org/10.1371/journal.pone.0056953			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23468896	gold, Green Published, Green Submitted			2022-12-25	WOS:000315524900046
J	Kotnik, P; Keuper, M; Wabitsch, M; Fischer-Posovszky, P				Kotnik, Primoz; Keuper, Michaela; Wabitsch, Martin; Fischer-Posovszky, Pamela			Interleukin-1 beta Downregulates RBP4 Secretion in Human Adipocytes	PLOS ONE			English	Article							INSULIN-RESISTANCE; SERUM RETINOL-BINDING-PROTEIN-4; CYTOKINES; INFLAMMATION; ASSOCIATION; ADIPONECTIN; EXPRESSION; CONSENSUS; OBESITY	Aims/hypothesis: The excessive accumulation of adipose tissue in the obese state is linked to an altered secretion profile of adipocytes, chronic low-grade inflammation and metabolic complications. RBP4 has been implicated in these alterations, especially insulin resistance. The aim of the present study was to determine if a local inflammatory micro-environment in adipose tissue regulates RBP4 expression and secretion. Methods: Human SGBS and primary adipocytes cultured with conditioned media from human THP-1 macrophages were used as an in vitro model for adipose inflammation. Adipocytes were exposed to recombinant TNF-alpha, IL-1 beta, IL-6 or IL-8. In addition, coexpression of IL-1 beta and RBP4 was measured in adipose tissue samples from 18 healthy females. RBP4 expression was studied by quantitative PCR and ELISA. Results: RBP4 mRNA expression and secretion was significantly reduced upon incubation with macrophage-conditioned media in SGBS adipocytes and human primary adipocytes. Out of several factors studied we identified IL-1 beta as a new factor regulating RBP4. IL-1 beta significantly downregulated RBP4 mRNA and secretion in a time-and dose-dependent manner. IL-1 beta mediated its inhibitory effects on RBP4 expression via IL-1 receptor and NF-kappa B, as incubation with the IL-1 receptor blocking antibody and the NF-kappa B inhibitors CAPE and SC-514 reversed its effect. Most interestingly, RBP4 mRNA was negatively correlated with IL-1 beta mRNA in subcutaneous adipose tissue. Conclusions: Adipose tissue inflammation as found in the obese state might lead to a downregulation in local RBP4 levels. IL-1 beta was identified as a major factor contributing to the decrease in RBP4. The increase in circulating RBP4 that often precedes the development of systemic insulin resistance is most likely unrelated to inflammatory processes in adipose tissue.	[Kotnik, Primoz; Keuper, Michaela; Wabitsch, Martin; Fischer-Posovszky, Pamela] Univ Ulm, Dept Pediat & Adolescent Med, Div Pediat Endocrinol & Diabet, D-89069 Ulm, Germany; [Kotnik, Primoz] UKC Ljubljana, Univ Childrens Hosp, Dept Pediat Endocrinol Diabet & Metab, Ljubljana, Slovenia	Ulm University; University Medical Centre Ljubljana	Wabitsch, M (corresponding author), Univ Ulm, Dept Pediat & Adolescent Med, Div Pediat Endocrinol & Diabet, D-89069 Ulm, Germany.	martin.wabitsch@uniklinik-ulm.de; pamela.fischer@uniklinik-ulm.de		Keuper, Michaela/0000-0003-0319-3509; Fischer-Posovszky, Pamela/0000-0003-3402-9840	Margarete von Wrangell scholarship; Baden-Wuerttemberg Ministry of Science, Research and Arts; European Social Fund; Das zuckerkranke Kind; Centre of Excellence Baden-Wuerttemberg "Metabolic Disorders"	Margarete von Wrangell scholarship; Baden-Wuerttemberg Ministry of Science, Research and Arts; European Social Fund(European Social Fund (ESF)); Das zuckerkranke Kind; Centre of Excellence Baden-Wuerttemberg "Metabolic Disorders"	PFP is funded by a Margarete von Wrangell scholarship financed by the Baden-Wuerttemberg Ministry of Science, Research and Arts and the European Social Fund. This study was supported by "Das zuckerkranke Kind" to PFP and the Centre of Excellence Baden-Wuerttemberg "Metabolic Disorders" to MW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bruun JM, 2002, MOL CELL ENDOCRINOL, V190, P91, DOI 10.1016/S0303-7207(02)00007-2; Cho YM, 2006, DIABETES CARE, V29, P2457, DOI 10.2337/dc06-0360; Constant VA, 2006, DIABETOLOGIA, V49, P1402, DOI 10.1007/s00125-006-0253-0; Dinarello CA, 2011, J INTERN MED, V269, P16, DOI 10.1111/j.1365-2796.2010.02313.x; Dinarello CA, 2011, BLOOD, V117, P3720, DOI 10.1182/blood-2010-07-273417; Dinarello CA, 2010, CURR OPIN ENDOCRINOL, V17, P314, DOI 10.1097/MED.0b013e32833bf6dc; Flower DR, 1996, BIOCHEM J, V318, P1; Friebe D, 2011, INT J PEDIATR OBES, V6, pE345, DOI 10.3109/17477166.2010.491228; Graham TE, 2006, NEW ENGL J MED, V354, P2552, DOI 10.1056/NEJMoa054862; Hauner H, 2000, METH MOL B, V155, P239; Keuper M, 2011, MOL CELL ENDOCRINOL, V339, P105, DOI 10.1016/j.mce.2011.04.004; Klein S, 2007, DIABETES CARE, V30, P1647, DOI 10.2337/dc07-9921; Kotnik P, 2011, EUR J ENDOCRINOL, V165, P703, DOI 10.1530/EJE-11-0431; Lee DC, 2007, METABOLISM, V56, P327, DOI 10.1016/j.metabol.2006.10.011; Levy-Marchal C, 2010, J CLIN ENDOCR METAB, V95, P5189, DOI 10.1210/jc.2010-1047; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maury E, 2010, MOL CELL ENDOCRINOL, V314, P1, DOI 10.1016/j.mce.2009.07.031; Norseen J, 2012, MOL CELL BIOL, V32, P2010, DOI 10.1128/MCB.06193-11; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Patsouris D, 2008, CELL METAB, V8, P301, DOI 10.1016/j.cmet.2008.08.015; Sell H, 2007, DIABETOLOGIA, V50, P2221, DOI 10.1007/s00125-007-0764-3; Sethi JK, 1999, SEMIN CELL DEV BIOL, V10, P19, DOI 10.1006/scdb.1998.0273; Simons PJ, 2007, J ENDOCRINOL, V192, P289, DOI 10.1677/JOE-06-0047; Wabitsch M, 2001, INT J OBESITY, V25, P8, DOI 10.1038/sj.ijo.0801520; Weber A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3105cm1; Yang Q, 2005, NATURE, V436, P356, DOI 10.1038/nature03711; Yao-Borengasser A, 2007, J CLIN ENDOCR METAB, V92, P2590, DOI 10.1210/jc.2006-0816	27	19	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57796	10.1371/journal.pone.0057796	http://dx.doi.org/10.1371/journal.pone.0057796			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460908	Green Submitted, Green Published, gold			2022-12-25	WOS:000315519000163
J	Olson, DH; Aanensen, DM; Ronnenberg, KL; Powell, CI; Walker, SF; Bielby, J; Garner, TWJ; Weaver, G; Fisher, MC				Olson, Deanna H.; Aanensen, David M.; Ronnenberg, Kathryn L.; Powell, Christopher I.; Walker, Susan F.; Bielby, Jon; Garner, Trenton W. J.; Weaver, George; Fisher, Matthew C.		Bd Mapping Grp	Mapping the Global Emergence of Batrachochytrium dendrobatidis, the Amphibian Chytrid Fungus	PLOS ONE			English	Article							EMERGING INFECTIOUS-DISEASE; CHYTRIDIOMYCOSIS; PATHOGEN; DECLINES; EXTINCTION; SUSCEPTIBILITY; EPIDEMIOLOGY; BIODIVERSITY; BULLFROG; DYNAMICS	The rapid worldwide emergence of the amphibian pathogen Batrachochytrium dendrobatidis (Bd) is having a profound negative impact on biodiversity. However, global research efforts are fragmented and an overarching synthesis of global infection data is lacking. Here, we provide results from a community tool for the compilation of worldwide Bd presence and report on the analyses of data collated over a four-year period. Using this online database, we analysed: 1) spatial and taxonomic patterns of infection, including amphibian families that appear over-and under-infected; 2) relationships between Bd occurrence and declining amphibian species, including associations among Bd occurrence, species richness, and enigmatic population declines; and 3) patterns of environmental correlates with Bd, including climate metrics for all species combined and three families (Hylidae, Bufonidae, Ranidae) separately, at both a global scale and regional (U. S. A.) scale. These associations provide new insights for downscaled hypothesis testing. The pathogen has been detected in 52 of 82 countries in which sampling was reported, and it has been detected in 516 of 1240 (42%) amphibian species. We show that detected Bd infections are related to amphibian biodiversity and locations experiencing rapid enigmatic declines, supporting the hypothesis that greater complexity of amphibian communities increases the likelihood of emergence of infection and transmission of Bd. Using a global model including all sampled species, the odds of Bd detection decreased with increasing temperature range at a site. Further consideration of temperature range, rather than maximum or minimum temperatures, may provide new insights into Bd-host ecology. Whereas caution is necessary when interpreting such a broad global dataset, the use of our pathogen database is helping to inform studies of the epidemiology of Bd, as well as enabling regional, national, and international prioritization of conservation efforts. We provide recommendations for adaptive management to enhance the database utility and relevance.	[Olson, Deanna H.; Ronnenberg, Kathryn L.; Weaver, George] US Forest Serv, Pacific NW Res Stn, Corvallis, OR 97331 USA; [Aanensen, David M.; Powell, Christopher I.; Walker, Susan F.; Fisher, Matthew C.] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London, England; [Bielby, Jon] Zool Soc London, Inst Zool, London NW1 4RY, England; [Garner, Trenton W. J.] Oregon State Univ, Dept Stat, Corvallis, OR 97331 USA	United States Department of Agriculture (USDA); United States Forest Service; Imperial College London; Zoological Society of London; Oregon State University	Olson, DH (corresponding author), US Forest Serv, Pacific NW Res Stn, Corvallis, OR 97331 USA.	dedeolson@fs.fed.us	Fisher, Matthew/B-9094-2011; Garner, Trenton WJ/D-6873-2011; Cunningham, Andrew A/E-7536-2010	Fisher, Matthew/0000-0002-1862-6402; Garner, Trenton WJ/0000-0002-0336-9706; Bielby, Jon/0000-0003-4586-0429	UK Natural Environmental Research Council [E006701/1]; ERAnet BIODIVERSA project RACE; Wellcome Trust [WT08972]; US Forest Service, Pacific Northwest Research Station; Natural Environment Research Council [NE/G001944/1, NE/G002193/1] Funding Source: researchfish; NERC [NE/G002193/1, NE/G001944/1] Funding Source: UKRI	UK Natural Environmental Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); ERAnet BIODIVERSA project RACE; Wellcome Trust(Wellcome TrustEuropean Commission); US Forest Service, Pacific Northwest Research Station(United States Department of Agriculture (USDA)United States Forest Service); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Funds were provided by the UK Natural Environmental Research Council (E006701/1), The ERAnet BIODIVERSA project RACE, The Wellcome Trust (WT08972), and the US Forest Service, Pacific Northwest Research Station. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aanensen DM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006968; Aanensen DM, 2009, THESIS; Bancroft BA, 2011, BIODIVERS CONSERV, V20, P1911, DOI 10.1007/s10531-011-0066-4; Berger L, 1998, P NATL ACAD SCI USA, V95, P9031, DOI 10.1073/pnas.95.15.9031; Bielby J, 2008, CONSERV LETT, V1, P82, DOI 10.1111/j.1755-263X.2008.00015.x; Bosch J, 2007, P ROY SOC B-BIOL SCI, V274, P253, DOI 10.1098/rspb.2006.3713; Briggs CJ, 2005, ECOLOGY, V86, P3149, DOI 10.1890/04-1428; Colon-Gaud C, 2009, LIMNOL OCEANOGR, V54, P331, DOI 10.4319/lo.2009.54.1.0331; Colon-Gaud C, 2010, J N AM BENTHOL SOC, V29, P1185, DOI 10.1899/09-102.1; Connelly S, 2011, FRESHWATER BIOL, V56, P1863, DOI 10.1111/j.1365-2427.2011.02626.x; Daszak P, 2004, HERPETOL J, V14, P201; de Castro F, 2005, ECOL LETT, V8, P117, DOI 10.1111/j.1461-0248.2004.00693.x; Duffus A, 2011, FROGLOG, V96, P37; El Mouden E. H., 2011, Herpetological Review, V42, P71; Farrer RA, 2011, P NATL ACAD SCI USA, V108, P18732, DOI 10.1073/pnas.1111915108; Fenton A, 2005, EMERG INFECT DIS, V11, P1815, DOI 10.3201/eid1112.050306; Ferguson NM, 2001, NATURE, V413, P542, DOI 10.1038/35097116; Fisher Matthew C., 2007, Fungal Biology Reviews, V21, P2, DOI 10.1016/j.fbr.2007.02.002; Fisher MC, 2012, NATURE, V484, P186, DOI 10.1038/nature10947; Fisher MC, 2009, ANNU REV MICROBIOL, V63, P291, DOI 10.1146/annurev.micro.091208.073435; Forrest MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028444; Garmyn A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035038; Garner TWJ, 2006, BIOL LETTERS, V2, P455, DOI 10.1098/rsbl.2006.0494; Garner TWJ, 2009, OIKOS, V118, P783, DOI 10.1111/j.1600-0706.2008.17202.x; GASCON C, 2007, AMPHIBIAN CONSERVATI; James TY, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000458; Johnson PTJ, 2006, P NATL ACAD SCI USA, V103, P3011, DOI 10.1073/pnas.0600293103; Kinney VC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016708; Kirshtein JD, 2007, DIS AQUAT ORGAN, V77, P11, DOI 10.3354/dao01831; Kriger KM, 2007, J ZOOL, V271, P352, DOI 10.1111/j.1469-7998.2006.00220.x; Lips KR, 2008, PLOS BIOL, V6, P441, DOI 10.1371/journal.pbio.0060072; Lips KR, 2006, P NATL ACAD SCI USA, V103, P3165, DOI 10.1073/pnas.0506889103; Longcore JE, 1999, MYCOLOGIA, V91, P219, DOI 10.2307/3761366; Lovich Robert, 2008, Herpetological Review, V39, P315; Lubick N, 2010, NATURE, V465, P680, DOI 10.1038/465680a; Marschang RE, 2011, J HERPETOL MED SURG, V21, P1; McCallum ML, 2007, J HERPETOL, V41, P483, DOI 10.1670/0022-1511(2007)41[483:ADOECD]2.0.CO;2; Mitchell KM, 2008, P ROY SOC B-BIOL SCI, V275, P329, DOI 10.1098/rspb.2007.1356; Mitchell T. D., 2004, TYNDALL CTR CLIMATE, V55, P25; Murray KA, 2011, J APPL ECOL, V48, P163, DOI 10.1111/j.1365-2664.2010.01890.x; Murray KA, 2009, CONSERV BIOL, V23, P1242, DOI 10.1111/j.1523-1739.2009.01211.x; Muths E, 2008, BIOL CONSERV, V141, P1484, DOI 10.1016/j.biocon.2008.03.011; OIE, 2008, M OIE AQ AN HLTH STA; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Picco AM, 2008, CONSERV BIOL, V22, P1582, DOI 10.1111/j.1523-1739.2008.01025.x; Piotrowski JS, 2004, MYCOLOGIA, V96, P9, DOI 10.2307/3761981; Pounds JA, 2006, NATURE, V439, P161, DOI 10.1038/nature04246; R Development Core Team, 2009, R FDN STAT COMP; Reeder NMM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033567; Retallick RWR, 2004, PLOS BIOL, V2, P1965, DOI 10.1371/journal.pbio.0020351; Ron SR, 2005, BIOTROPICA, V37, P209, DOI 10.1111/j.1744-7429.2005.00028.x; Skerratt LF, 2008, DIS AQUAT ORGAN, V80, P85, DOI 10.3354/dao01923; Skerratt LF, 2007, ECOHEALTH, V4, P125, DOI 10.1007/s10393-007-0093-5; Speare R, 2004, AUST VET J, V82, P300, DOI 10.1111/j.1751-0813.2004.tb12710.x; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Swei A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023179; USGS [United States Geological Survey], 2006, GLOB DIG EL MOD GTOP; Vredenburg VT, 2010, P NATL ACAD SCI USA, V107, P9689, DOI 10.1073/pnas.0914111107; Wake DB, 2008, P NATL ACAD SCI USA, V105, P11466, DOI 10.1073/pnas.0801921105; Woodhams DC, 2007, ANIM CONSERV, V10, P409, DOI 10.1111/j.1469-1795.2007.00130.x; Woodhams DC, 2005, CONSERV BIOL, V19, P1449, DOI 10.1111/j.1523-1739.2005.004403.x	61	271	300	1	346	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e56802	10.1371/journal.pone.0056802	http://dx.doi.org/10.1371/journal.pone.0056802			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23463502	Green Published, gold, Green Submitted			2022-12-25	WOS:000315519000039
J	Sousa, SA; Feliciano, JR; Pinheiro, PF; Leitao, JH				Sousa, Silvia A.; Feliciano, Joana R.; Pinheiro, Pedro F.; Leitao, Jorge H.			Biochemical and Functional Studies on the Burkholderia cepacia Complex bceN Gene, Encoding a GDP-D-Mannose 4,6-Dehydratase	PLOS ONE			English	Article							L-FUCOSE; EXOPOLYSACCHARIDE; BIOSYNTHESIS; ENZYMES; PROTEIN; LIPOPOLYSACCHARIDE; RESISTANCE; SYSTEM; CHAIN; POLYSACCHARIDE	This work reports the biochemical and functional analysis of the Burkholderia cenocepacia J2315 bceN gene, encoding a protein with GDP-D-mannose 4,6-dehydratase enzyme activity (E.C.4.2.1.47). Data presented indicate that the protein is active when in the tetrameric form, catalyzing the conversion of GDP-D-mannose into GDP-4-keto-6-deoxy-D-mannose. This sugar nucleotide is the intermediary necessary for the biosynthesis of GDP-D-rhamnose, one of the sugar residues of cepacian, the major exopolysaccharide produced by environmental and human, animal and plant pathogenic isolates of the Burkholderia cepacia complex species. V-max and K-m values of 1.5 +/- 0.2 mu mol.min(-1).mg(-1) and 1024 +/- 123 mu M, respectively, were obtained from the kinetic characterization of the B. cenocepacia J2315 BceN protein by NMR spectroscopy, at 25 degrees C and in the presence of 1 mol MgCl2 per mol of protein. The enzyme activity was strongly inhibited by the substrate, with an estimated K-i of 2913 +/- 350 mu M. The lack of a functional bceN gene in a mutant derived from B. cepacia IST408 slightly reduced cepacian production. However, in the B. multivorans ATCC17616 with bceN as the single gene in its genome with predicted GMD activity, a bceN mutant did not produce cepacian, indicating that this gene product is required for cepacian biosynthesis.	[Sousa, Silvia A.; Feliciano, Joana R.; Pinheiro, Pedro F.; Leitao, Jorge H.] Inst Super Tecn, Inst Biotechnol & Bioengn, Ctr Biol & Chem Engn, Lisbon, Portugal; [Leitao, Jorge H.] Univ Tecn Lisboa, Inst Super Tecn, Dept Bioengn, P-1096 Lisbon, Portugal	Universidade de Lisboa; Instituto Superior Tecnico; Universidade de Lisboa; Instituto Superior Tecnico	Leitao, JH (corresponding author), Inst Super Tecn, Inst Biotechnol & Bioengn, Ctr Biol & Chem Engn, Lisbon, Portugal.	jorgeleitao@ist.utl.pt	Feliciano, Joana R/K-1473-2016; Leitão, Jorge H./A-5122-2012; Pinheiro, Pedro F/B-4234-2014; Sousa, Sílvia A./G-8502-2011	Feliciano, Joana R/0000-0002-4906-676X; Leitão, Jorge H./0000-0001-8850-274X; Pinheiro, Pedro F/0000-0001-5584-7856; Sousa, Sílvia A./0000-0001-9291-9169	FEDER; FCT, Portugal [PTDC/EBB-BIO/098352/2008, PTDC/BIA-MIC/119091/2010]	FEDER(European Commission); FCT, Portugal(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was partially funded by FEDER and FCT, Portugal (contracts PTDC/EBB-BIO/098352/2008 and PTDC/BIA-MIC/119091/2010, and a doctoral and post-doctoral grant to J. R. F. and S. A. S., respectively). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albermann C, 2000, GLYCOBIOLOGY, V10, P875, DOI 10.1093/glycob/10.9.875; Bisso A, 1999, FEBS LETT, V456, P370, DOI 10.1016/S0014-5793(99)00982-5; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bylund J, 2006, J BIOL CHEM, V281, P2526, DOI 10.1074/jbc.M510692200; Cescutti P, 2000, BIOCHEM BIOPH RES CO, V273, P1088, DOI 10.1006/bbrc.2000.3059; Conway BAD, 2004, J INFECT DIS, V190, P957, DOI 10.1086/423141; Cunha MV, 2004, J CLIN MICROBIOL, V42, P3052, DOI 10.1128/JCM.42.7.3052-3058.2004; Cuzzi B, 2012, INNATE IMMUN-LONDON, V18, P661, DOI 10.1177/1753425911435954; Exnowitz F, 2012, BBA-PROTEINS PROTEOM, V1824, P443, DOI 10.1016/j.bbapap.2011.10.011; Ferreira AS, 2010, APPL ENVIRON MICROB, V76, P441, DOI 10.1128/AEM.01828-09; HECK HDA, 1971, J AM CHEM SOC, V93, P23, DOI 10.1021/ja00730a004; JORNVALL H, 1995, BIOCHEMISTRY-US, V34, P6003, DOI 10.1021/bi00018a001; Kavanagh K, 2008, CELL MOL LIFE SCI, V65, P3895, DOI 10.1007/s00018-008-8588-y; King JD, 2009, FEBS J, V276, P2686, DOI 10.1111/j.1742-4658.2009.06993.x; Kocharova NA, 2000, BIOCHEMISTRY-US, V39, P4755, DOI 10.1021/bi992635k; Leitao J.H., 2011, INT J MICROBIOL, V2011; Leitao JH, 2010, APPL MICROBIOL BIOT, V87, P31, DOI 10.1007/s00253-010-2528-0; Loutet SA, 2009, MICROBIOL-SGM, V155, P2029, DOI 10.1099/mic.0.027607-0; Markowitz VM, 2008, NUCLEIC ACIDS RES, V36, pD528, DOI 10.1093/nar/gkm846; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Molinaro A, 2003, CARBOHYD RES, V338, P277, DOI 10.1016/S0008-6215(02)00433-0; Moreira LM, 2003, BIOCHEM BIOPH RES CO, V312, P323, DOI 10.1016/j.bbrc.2003.10.118; Niepmann M, 2006, ELECTROPHORESIS, V27, P3949, DOI 10.1002/elps.200600172; OTHS PJ, 1990, CARBOHYD RES, V198, P91, DOI 10.1016/0008-6215(90)84279-4; Parish T, 1997, FEMS MICROBIOL LETT, V154, P151, DOI 10.1016/S0378-1097(97)00317-0; Ramos CG, 2011, J BACTERIOL, V193, P1515, DOI 10.1128/JB.01375-10; Ren Y, 2010, BIOCHEM BIOPH RES CO, V391, P1663, DOI 10.1016/j.bbrc.2009.12.116; Richau JA, 2000, J CLIN MICROBIOL, V38, P1651, DOI 10.1128/JCM.38.4.1651-1655.2000; Richau JA, 2000, BIOCHEM BIOPH RES CO, V276, P71, DOI 10.1006/bbrc.2000.3438; Sambrook J, 2001, MOL CLONING LAB MANU; Senchenkova SN, 1996, EUR J BIOCHEM, V239, P434, DOI 10.1111/j.1432-1033.1996.0434u.x; Somoza JR, 2000, STRUCTURE, V8, P123, DOI 10.1016/S0969-2126(00)00088-5; Sousa SA, 2007, CELL MICROBIOL, V9, P2817, DOI 10.1111/j.1462-5822.2007.00998.x; Sousa SA, 2007, BIOCHEM BIOPH RES CO, V353, P200, DOI 10.1016/j.bbrc.2006.12.016; Sturla L, 1997, FEBS LETT, V412, P126, DOI 10.1016/S0014-5793(97)00762-X; Thompson Julie D, 2002, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0203s00; Vinion-Dubiel AD, 2003, J ENDOTOXIN RES, V9, P201, DOI 10.1179/096805103225001404; Wang B, 2003, FEMS MICROBIOL LETT, V220, P171, DOI 10.1016/S0378-1097(03)00128-9; Webb NA, 2004, PROTEIN SCI, V13, P529, DOI 10.1110/ps.03393904; Wu BY, 2001, BIOCHEM BIOPH RES CO, V285, P364, DOI 10.1006/bbrc.2001.5137; YAMAMOTO K, 1993, ARCH BIOCHEM BIOPHYS, V300, P694, DOI 10.1006/abbi.1993.1096; Zhang Y, 2009, PROTEINS, V77, P100, DOI 10.1002/prot.22588; Zlosnik JEA, 2008, J CLIN MICROBIOL, V46, P1470, DOI 10.1128/JCM.02273-07; Zlosnik JEA, 2010, J INFECT DIS, V202, P770, DOI 10.1086/655663	44	7	7	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e56902	10.1371/journal.pone.0056902	http://dx.doi.org/10.1371/journal.pone.0056902			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460819	gold, Green Published, Green Submitted			2022-12-25	WOS:000315519000044
J	Tanaka, H; Zaima, N; Sasaki, T; Hayasaka, T; Goto-Inoue, N; Onoue, K; Ikegami, K; Morita, Y; Yamamoto, N; Mano, Y; Sano, M; Saito, T; Sato, K; Konno, H; Setou, M; Unno, N				Tanaka, Hiroki; Zaima, Nobuhiro; Sasaki, Takeshi; Hayasaka, Takahiro; Goto-Inoue, Naoko; Onoue, Kenji; Ikegami, Koji; Morita, Yoshifumi; Yamamoto, Naoto; Mano, Yuuki; Sano, Masaki; Saito, Takaaki; Sato, Kohji; Konno, Hiroyuki; Setou, Mitsutoshi; Unno, Naoki			Adventitial Vasa Vasorum Arteriosclerosis in Abdominal Aortic Aneurysm	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; SITE-SPECIFICITY; DISTURBED FLOW; CELLS; PROLIFERATION; PATHOGENESIS; EXPRESSION; RESPONSES	Abdominal aortic aneurysm (AAA) is a common disease among elderly individuals. However, the precise pathophysiology of AAA remains unknown. In AAA, an intraluminal thrombus prevents luminal perfusion of oxygen, allowing only the adventitial vaso vasorum (VV) to deliver oxygen and nutrients to the aortic wall. In this study, we examined changes in the adventitial VV wall in AAA to clarify the histopathological mechanisms underlying AAA. We found marked intimal hyperplasia of the adventitial VV in the AAA sac; further, immunohistological studies revealed proliferation of smooth muscle cells, which caused luminal stenosis of the VV. We also found decreased HemeB signals in the aortic wall of the sac as compared with those in the aortic wall of the neck region in AAA. The stenosis of adventitial VV in the AAA sac and the malperfusion of the aortic wall observed in the present study are new aspects of AAA pathology that are expected to enhance our understanding of this disease.	[Tanaka, Hiroki; Morita, Yoshifumi; Yamamoto, Naoto; Mano, Yuuki; Sano, Masaki; Saito, Takaaki; Konno, Hiroyuki; Unno, Naoki] Hamamatsu Univ Sch Med, Dept Surg 2, Hamamatsu, Shizuoka 4313192, Japan; [Tanaka, Hiroki; Zaima, Nobuhiro; Hayasaka, Takahiro; Goto-Inoue, Naoko; Onoue, Kenji; Ikegami, Koji; Morita, Yoshifumi; Setou, Mitsutoshi] Hamamatsu Univ Sch Med, Dept Cell Biol & Anat, Hamamatsu, Shizuoka 4313192, Japan; [Sasaki, Takeshi; Sato, Kohji] Hamamatsu Univ Sch Med, Dept Anat & Neurosci, Hamamatsu, Shizuoka 4313192, Japan; [Zaima, Nobuhiro] Kinki Univ, Dept Appl Biol Chem, Higashiosaka, Osaka 577, Japan	Hamamatsu University School of Medicine; Hamamatsu University School of Medicine; Hamamatsu University School of Medicine; Kindai University (Kinki University)	Setou, M (corresponding author), Hamamatsu Univ Sch Med, Dept Cell Biol & Anat, Hamamatsu, Shizuoka 4313192, Japan.	setou@hama-med.ac.jp; unno@hama-med.ac.jp	Onoue, Kenji/GRJ-6704-2022		Project of Hamamatsu University Research Promotion; Japan Science and Technology Agency; Tokutei Lipid Machinery and Young Scientists [2067004];  [22590522]; Grants-in-Aid for Scientific Research [23650174, 23390289, 22590522] Funding Source: KAKEN	Project of Hamamatsu University Research Promotion; Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Tokutei Lipid Machinery and Young Scientists; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the following grants: a Grant-in-Aid for Scientific Research (C) (22590522) (to NZ); Project of Hamamatsu University Research Promotion (to NU); a Grant-in-Aid for SENTAN from the Japan Science and Technology Agency; and Tokutei Lipid Machinery and Young Scientists S (2067004) (to MS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Back M, 2005, P NATL ACAD SCI USA, V102, P17501, DOI 10.1073/pnas.0505845102; Chiu JJ, 2011, PHYSIOL REV, V91, P327, DOI 10.1152/physrev.00047.2009; Choke E, 2006, ANN NY ACAD SCI, V1085, P306, DOI 10.1196/annals.1383.005; CLARKE JA, 1965, J ANAT, V99, P877; Doran AC, 2008, ARTERIOSCL THROM VAS, V28, P812, DOI 10.1161/ATVBAHA.107.159327; Eltzschig HK, 2011, NEW ENGL J MED, V364, P656, DOI 10.1056/NEJMra0910283; Erdozain OJ, 2011, J VASC RES, V48, P163, DOI 10.1159/000318806; Fan LJ, 2010, BIORHEOLOGY, V47, P31, DOI 10.3233/BIR-2010-0561; Ikesue M, 2011, ARTERIOSCL THROM VAS, V31, P1066, DOI 10.1161/ATVBAHA.110.217703; Isoda K, 2003, CIRCULATION, V108, P516, DOI 10.1161/01.CIR.0000085567.18648.21; Kent KC, 2010, J VASC SURG, V52, P539, DOI 10.1016/j.jvs.2010.05.090; Koizumi S, 2010, NEUROSCIENCE, V168, P219, DOI 10.1016/j.neuroscience.2010.03.056; Lindsay ME, 2011, NATURE, V473, P308, DOI 10.1038/nature10145; Michel JB, 2007, ARTERIOSCL THROM VAS, V27, P1259, DOI 10.1161/ATVBAHA.106.137851; Norman PE, 2010, CIRCULATION, V121, P560, DOI 10.1161/CIRCULATIONAHA.109.880724; Ponka P, 1997, BLOOD, V89, P1; Ramos-Mozo P, 2011, ARTERIOSCL THROM VAS, V31, P3011, DOI 10.1161/ATVBAHA.111.237537; Riccioni G, 2009, MEDIAT INFLAMM, V2009, DOI 10.1155/2009/737282; Ritman EL, 2007, CARDIOVASC RES, V75, P649, DOI 10.1016/j.cardiores.2007.06.020; Sakai M, 1996, ARTERIOSCL THROM VAS, V16, P600, DOI 10.1161/01.ATV.16.4.600; Sakalihasan N, 2005, LANCET, V365, P1577, DOI 10.1016/S0140-6736(05)66459-8; Schultz K, 2006, AM J PHYSIOL-HEART C, V290, pH2528, DOI 10.1152/ajpheart.01077.2005; Shai SY, 2010, ARTERIOSCL THROM VAS, V30, P1916, DOI 10.1161/ATVBAHA.110.210831; Shimma S, 2008, ANAL CHEM, V80, P878, DOI 10.1021/ac071301v; Stoeckli M, 2001, NAT MED, V7, P493, DOI 10.1038/86573; Tanaka H, 2010, EUR J VASC ENDOVASC, V40, P657, DOI 10.1016/j.ejvs.2010.08.001; Tanaka H, 2011, ANAL BIOANAL CHEM, V400, P1873, DOI 10.1007/s00216-011-4850-5; VanderLaan PA, 2004, ARTERIOSCL THROM VAS, V24, P12, DOI 10.1161/01.ATV.0000105054.43931.f0; Vorp DA, 2001, J VASC SURG, V34, P291, DOI 10.1067/mva.2001.114813; Wan R, 2011, NANOTOXICOLOGY, V5, P568, DOI 10.3109/17435390.2010.537791; WOLINSKY H, 1969, CIRC RES, V25, P677, DOI 10.1161/01.RES.25.6.677; Yang HJ, 2011, J BIOL CHEM; Yang HJ, 2010, MED MOL MORPHOL, V43, P158, DOI 10.1007/s00795-009-0487-2; YOKOTE K, 1993, EUR J BIOCHEM, V217, P723, DOI 10.1111/j.1432-1033.1993.tb18298.x; Zhao L, 2004, NAT MED, V10, P966, DOI 10.1038/nm1099	36	49	49	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57398	10.1371/journal.pone.0057398	http://dx.doi.org/10.1371/journal.pone.0057398			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460850	gold, Green Published, Green Submitted			2022-12-25	WOS:000315519000104
J	You, H; Chen, JH; Bogg, L; Wu, Y; Duan, SN; Ye, CY; Liu, XF; Yu, H; Diwan, V; Dong, HJ				You, Hua; Chen, Jianhua; Bogg, Lennart; Wu, Yuan; Duan, Shengnan; Ye, Chiyu; Liu, Xiaofang; Yu, Hai; Diwan, Vinod; Dong, Hengjin			Study on the Factors Associated with Postpartum Visits in Rural China	PLOS ONE			English	Article							HOME VISIT; POSTNATAL CARE; PREDICTORS; BANGLADESH; MOTHERS; TRIAL	Background: Postpartum visits (PPVs) have been advocated as a way to improve health outcomes for mothers and their infants, but the rate of PPVs is still low in rural China. This study aims to investigate the utilization of PPVs and to explore the factors associated with PPVs in rural China. Parity is the most concerned factor in this study. Methods: A cross-sectional household survey was performed in two counties of Zhejiang province. Questions include socioeconomic, health services and women's delivery data. Chi-square tests and multivariate logistic regression analyses were performed to identify factors associated with PPVs. Results: 223 women who had a delivery history in the recent five years were enrolled in analyses. 173 (78%) of them were primiparous. Among the primiparous women, 43 (25%) had not received any PPVs. The majority, 27 (55%) of the 49 multiparous women, had not received any PPVs. Multiparous women were less likely to receive PPVs than primiparous women. Among 223 puerperal women, 47 (21%) had been compensated for delivery fee expenses. Women who received compensation were found to be more likely to receive standard (at least 3) PPVs. Conclusions: It was found that women with "second babies" were less likely to use PPVs. This could be an unintended consequence of the "one-child policy", due to fear that contact with public health facilities could result in sanctions. This phenomenon should be taken seriously by government in order to improve the health of babies and their mothers. Financial compensation for delivery fee charges can improve the use of PPVs, thus free-of-charge delivery should be promoted.	[You, Hua; Chen, Jianhua; Wu, Yuan; Duan, Shengnan; Ye, Chiyu; Liu, Xiaofang; Yu, Hai; Dong, Hengjin] Zhejiang Univ, Sch Med, Ctr Hlth Policy Studies, Hangzhou 310003, Zhejiang, Peoples R China; [Bogg, Lennart; Diwan, Vinod] Karolinska Inst, Inst Global Hlth, Stockholm, Sweden; [Bogg, Lennart] Malardalen Univ, Sch Hlth Care & Welf, Vasteras, Sweden; [Dong, Hengjin] Heidelberg Univ, Inst Publ Hlth, Heidelberg, Germany	Zhejiang University; Karolinska Institutet; Malardalen University; Ruprecht Karls University Heidelberg	Dong, HJ (corresponding author), Zhejiang Univ, Sch Med, Ctr Hlth Policy Studies, Hangzhou 310003, Zhejiang, Peoples R China.	donghj@zju.edu.cn		Bogg, Lennart/0000-0003-0368-050X	China Medical Board [09-989]; European Union [261304]	China Medical Board; European Union(European Commission)	Funded by China Medical Board: 09-989 (http://www.chinamedicalboard.org/); and European Union: 261304 (http://europa.eu/index_en.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers LL, 2000, J MIDWIFERY WOM HEAL, V45, P55, DOI 10.1016/S1526-9523(99)00003-3; Apgar BS, 2005, AM FAM PHYSICIAN, V72, P2443; Baqui AH, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2826; Bogg L, 1998, AM J PUBLIC HEALTH, V88, P649, DOI 10.2105/AJPH.88.4.649; Brown MS, 1984, NURSE PRACT, V9, P46; Brown MS, 1984, NURSE PRACT, V9, P42; Bryant AS, 2006, MATERN CHILD HLTH J, V10, P511, DOI 10.1007/s10995-006-0128-5; Bryce J, 2008, LANCET, V371, P1247, DOI 10.1016/S0140-6736(08)60559-0; Chakraborty N, 2002, HEALTH SOC CARE COMM, V10, P492, DOI 10.1046/j.1365-2524.2002.00389.x; Christie J, 2011, INT J NURS STUD, V48, P689, DOI 10.1016/j.ijnurstu.2010.10.011; Dhakal Sulochana, 2007, BMC Pregnancy Childbirth, V7, P19, DOI 10.1186/1471-2393-7-19; Gorlin R, 1979, Female Patient, V4, P89; Hamburg M V, 1981, SIECUS Rep, V10, P3; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Jing Y, 2012, ZHONG GUO FU YOU BAO, V27, P170; Kabakian-Khasholian Tamar, 2006, Health Care Women Int, V27, P839, DOI 10.1080/07399330600880392; Li WJ, 2009, ZHONG GUO FU YOU BAO, V33, P4645; Lu MC, 2002, AM J OBSTET GYNECOL, V187, P1329, DOI 10.1067/mob.2002.126848; Ministry of Health of China, 1989, MAN MEAS SYST MAT HE; Ministry of Health of China, 2004, REP 3 NAT HLTH SERV; Ministry of Health of China UNICEF WHO UNFPA, 2006, JOINT REV MAT CHILD; Quinlivan JA, 2003, LANCET, V361, P893, DOI 10.1016/S0140-6736(03)12770-5; Sword WA, 2006, CAN J PUBLIC HEALTH, V97, P191, DOI 10.1007/BF03405582; Tao FB, 2011, MIDWIFERY, V27, P707, DOI 10.1016/j.midw.2009.10.001; Tian DZ, 2012, 7 MONTH PREGNANT WOM; Wager KA, 2004, PUBLIC HEALTH NURS, V21, P541, DOI 10.1111/j.0737-1209.2004.21606.x; World Health Organization, 1998, BAS NEWB RES PRACT G	27	11	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e55955	10.1371/journal.pone.0055955	http://dx.doi.org/10.1371/journal.pone.0055955			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	098BN	23460789	Green Published, gold, Green Submitted			2022-12-25	WOS:000315519000012
J	Li, W; Hu, XP				Li, Wu; Hu, Xiaoping			Robust Tract Skeleton Extraction of Cingulum Based on Active Contour Model from Diffusion Tensor MR Imaging	PLOS ONE			English	Article							WHITE-MATTER; HUMAN BRAIN; TRACTOGRAPHY; TRACKING; SEGMENTATION; CONNECTIVITY; DEFLECTION; CORTEX	Cingulum is widely studied in healthy and psychiatric subjects. For cingulum analysis from diffusion tensor MR imaging, tractography and tract of interest method have been adopted for tract-based analysis. Because tractography performs fiber tracking according to local diffusion measures, they can be sensitive to noise and tracking errors can be accumulated along the fiber. For more accurate localization of cingulum, we attempt to define it by skeleton extraction using the tensors' information throughout the tract of cingulum simultaneously, which is quite different from the idea of tractography. In this study, we introduce an approach to extract the skeleton of cingulum using active contour model, which allows us to optimize the location of cingulum in a global sense based on the diffusion measurements along the entire tract and contour regularity. Validation of this method on synthetic and experimental data proved that our approach is able to reduce the influence of noise and partial volume effect, and extract the skeleton of cingulum robustly and reliably. Our proposed method provides an approach to localize cingulum robustly, which is a very important feature for tract-based analysis and can be of important practical utility.	[Li, Wu] Chinese Acad Sci, State Key Lab Management & Control Complex Syst, Inst Automat, Beijing, Peoples R China; [Li, Wu; Hu, Xiaoping] Georgia Tech, Dept Biomed Engn, Atlanta, GA USA; [Li, Wu; Hu, Xiaoping] Emory Univ, Atlanta, GA 30322 USA	Chinese Academy of Sciences; Institute of Automation, CAS; University System of Georgia; Georgia Institute of Technology; Emory University	Li, W (corresponding author), Chinese Acad Sci, State Key Lab Management & Control Complex Syst, Inst Automat, Beijing, Peoples R China.	wu.li@ia.ac.cn; xhu@bme.gatech.edu	zhang, feng/L-7009-2016; Li, Wu/AHA-4320-2022	Hu, Xiaoping/0000-0001-7014-5983	National Institutes of Health [PO1AG026423, P50MH058922]; National Natural Science Foundation of China [30970769, 81171314]; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH058922] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG026423] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was kindly supported by the National Institutes of Health (PO1AG026423, P50MH058922) and the National Natural Science Foundation of China (30970769, 81171314). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awate SP, 2007, IEEE T MED IMAGING, V26, P1525, DOI 10.1109/TMI.2007.907301; Basser PJ, 2000, MAGNET RESON MED, V44, P625, DOI 10.1002/1522-2594(200010)44:4<625::AID-MRM17>3.0.CO;2-O; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Bresson X, 2007, J MATH IMAGING VIS, V28, P151, DOI 10.1007/s10851-007-0002-0; Catani M, 2002, NEUROIMAGE, V17, P77, DOI 10.1006/nimg.2002.1136; Catheline G, 2010, NEUROBIOL AGING, V31, P1582, DOI 10.1016/j.neurobiolaging.2008.08.012; Cheng P, 2006, NEUROIMAGE, V31, P1075, DOI 10.1016/j.neuroimage.2006.01.028; Chou MC, 2006, J MAGN RESON IMAGING, V24, P451, DOI 10.1002/jmri.20652; Clayden JD, 2007, IEEE T MED IMAGING, V26, P1555, DOI 10.1109/TMI.2007.905826; Cohen LD, 1997, INT J COMPUT VISION, V24, P57, DOI 10.1023/A:1007922224810; Conturo TE, 1999, P NATL ACAD SCI USA, V96, P10422, DOI 10.1073/pnas.96.18.10422; CRICK F, 1993, NATURE, V361, P109, DOI 10.1038/361109a0; Fillard P, 2011, NEUROIMAGE, V56, P220, DOI 10.1016/j.neuroimage.2011.01.032; Gong GL, 2005, HUM BRAIN MAPP, V24, P92, DOI 10.1002/hbm.20072; Hamani C, 2011, BIOL PSYCHIAT, V69, P301, DOI 10.1016/j.biopsych.2010.09.034; Jellison BJ, 2004, AM J NEURORADIOL, V25, P356; Jones DK, 2005, NEUROIMAGE, V26, P546, DOI 10.1016/j.neuroimage.2005.02.013; KASS M, 1987, INT J COMPUT VISION, V1, P321, DOI 10.1007/BF00133570; Lazar M, 2003, NEUROIMAGE, V20, P1140, DOI 10.1016/S1053-8119(03)00277-5; Lazar M, 2003, HUM BRAIN MAPP, V18, P306, DOI 10.1002/hbm.10102; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; Lebel C, 2008, NEUROIMAGE, V40, P1044, DOI 10.1016/j.neuroimage.2007.12.053; Li W, 2004, NEUROIMAGE, V23, P1507, DOI 10.1016/j.neuroimage.2004.08.009; Lori NF, 2002, NMR BIOMED, V15, P493, DOI 10.1002/nbm.779; McCormick LM, 2006, NEUROIMAGE, V32, P1167, DOI 10.1016/j.neuroimage.2006.04.227; Melonakos J, 2008, IEEE T PATTERN ANAL, V30, P412, DOI 10.1109/TPAMI.2007.70713; Melonakos J, 2007, LECT NOTES COMPUT SC, V4791, P36; Mori S, 2002, MAGN RESON MED, V47, P215, DOI 10.1002/mrm.10074; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Mori S, 2002, NMR BIOMED, V15, P468, DOI 10.1002/nbm.781; Niethammer M, 2009, NEUROIMAGE, V45, pS123, DOI 10.1016/j.neuroimage.2008.11.001; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Stenset V, 2011, NEUROBIOL AGING, V32, P581, DOI 10.1016/j.neurobiolaging.2009.04.014; Thomas C, 2009, NAT NEUROSCI, V12, P29, DOI 10.1038/nn.2224; Wang F, 2004, AM J PSYCHIAT, V161, P573, DOI 10.1176/appi.ajp.161.3.573; Weinstein DM, 1999, 10 IEEE VIS 1999 VIS, P40; Westin CF, 2002, MED IMAGE ANAL, V6, P93, DOI 10.1016/S1361-8415(02)00053-1; Zhang Y, 2009, BRAIN, V132, P2579, DOI 10.1093/brain/awp071	41	0	1	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2013	8	2							e56113	10.1371/journal.pone.0056113	http://dx.doi.org/10.1371/journal.pone.0056113			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098PO	23468855	Green Published, Green Submitted, gold			2022-12-25	WOS:000315561400007
J	Lin, SC; Chen, WY; Lin, KY; Chen, SH; Chang, CC; Lin, SE; Fang, CL				Lin, Shee-Chan; Chen, Wei-Yu; Lin, Kai-Yuan; Chen, Sheng-Hsuan; Chang, Chun-Chao; Lin, Sey-En; Fang, Chia-Lang			Clinicopathological Correlation and Prognostic Significance of Protein Kinase C alpha Overexpression in Human Gastric Carcinoma	PLOS ONE			English	Article							PKC-ALPHA; CELL-PROLIFERATION; MESSENGER-RNA; EXPRESSION; CANCER; BREAST; INVASION; MARKER	Objectives: This study investigated the PKC alpha protein expression in gastric carcinoma, and correlated it with clinicopathological parameters. The prognostic significance of PKC alpha protein expression in gastric carcinoma was analyzed. Methods: Quantitative real-time PCR test was applied to compare the PKC alpha mRNA expression in tumorous and nontumorous tissues of gastric carcinoma in ten randomly selected cases. Then PKC alpha protein expression was evaluated in 215 cases of gastric carcinoma using immunohistochemical method. The immunoreactivity was scored semiquantitatively as: 0 = absent; 1 = weak; 2 = moderate; and 3 = strong. All cases were further classified into two groups, namely PKC alpha overexpression group with score 2 or 3, and non-overexpression group with score 0 or 1. The PKC alpha protein expression was correlated with clinicopathological parameters. Survival analysis was performed to determine the prognostic significance of PKC alpha protein expression in patients with gastric carcinoma. Results: PKC alpha mRNA expression was upregulated in all ten cases of gastric carcinoma via quantitative real-time PCR test. In immunohistochemical study, eighty-eight out of 215 cases (41%) of gastric carcinoma revealed PKC alpha protein overexpression, which was statistically correlated with age (P = 0.0073), histologic type (P < 0.0001), tumor differentiation (P = 0.0110), depth of invasion (P = 0.0003), angiolymphatic invasion (P = 0.0373), pathologic stage (P = 0.0047), and distant metastasis (P = 0.0048). We found no significant difference in overall and disease free survival rates between PKC alpha overexpression and non-overexpression groups (P = 0.0680 and 0.0587). However, PKC alpha protein overexpression emerged as a significant independent prognostic factor in multivariate Cox regression analysis (hazard ratio 0.632, P = 0.0415). Conclusions: PKC alpha protein is upregulated in gastric carcinoma. PKC alpha protein expression is statistically correlated with age, histologic type, tumor differentiation, depth of invasion, angiolymphatic invasion, pathologic stage, and distant metastasis. The PKC alpha protein overexpression in patients with gastric carcinoma is a significant independent prognostic factor in multivariate Cox regression analysis.	[Lin, Shee-Chan] Mackay Mem Hosp, Dept Internal Med, Div Gastroenterol, Taipei, Taiwan; [Chen, Wei-Yu; Lin, Sey-En; Fang, Chia-Lang] Taipei Med Univ, Dept Pathol, Sch Med, Coll Med, Taipei, Taiwan; [Chen, Wei-Yu; Fang, Chia-Lang] Taipei Med Univ, Wan Fang Hosp, Dept Pathol, Taipei, Taiwan; [Lin, Kai-Yuan] Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan; [Lin, Kai-Yuan] Chia Nan Univ Pharm & Sci, Dept Biotechnol, Tainan, Taiwan; [Chen, Sheng-Hsuan; Chang, Chun-Chao] Taipei Med Univ, Coll Med, Dept Internal Med, Sch Med, Taipei, Taiwan; [Chen, Sheng-Hsuan; Chang, Chun-Chao] Taipei Med Univ Hosp, Dept Internal Med, Div Gastroenterol, Taipei, Taiwan; [Lin, Sey-En] Taipei Med Univ Hosp, Dept Pathol, Taipei, Taiwan	Mackay Memorial Hospital; Taipei Medical University; Taipei Medical University; Taipei Municipal WanFang Hospital; Chi Mei Hospital; Chia Nan University of Pharmacy & Science; Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University Hospital	Fang, CL (corresponding author), Taipei Med Univ, Dept Pathol, Sch Med, Coll Med, Taipei, Taiwan.	ccllfang@tmu.edu.tw		Lin, Sey-En/0000-0002-8994-9452	Mackay Memorial Hospital [94MMH-TMU-16]	Mackay Memorial Hospital	This work was supported by the grant (94MMH-TMU-16) from Mackay Memorial Hospital (www.mmh.org.tw). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth PD, 2004, EUR J CANCER, V40, P2269, DOI 10.1016/j.ejca.2004.06.027; Cameron AJ, 2008, INT J CANCER, V123, P769, DOI 10.1002/ijc.23560; Dempsey EC, 2000, AM J PHYSIOL-LUNG C, V279, pL429, DOI 10.1152/ajplung.2000.279.3.L429; Furness JB, 2006, HISTOCHEM CELL BIOL, V126, P537, DOI 10.1007/s00418-006-0190-5; Garcia M, 2007, GLOBAL CANC FACTS FI; Haughian JM, 2009, J CELL PHYSIOL, V220, P112, DOI 10.1002/jcp.21741; Jiang XH, 2004, CANCER RES, V64, P5787, DOI 10.1158/0008-5472.CAN-03-1172; Jinawath N, 2004, ONCOGENE, V23, P6830, DOI 10.1038/sj.onc.1207886; Kamangar F, 2006, J CLIN ONCOL, V24, P2137, DOI 10.1200/JCO.2005.05.2308; Kerfoot C, 2004, J HISTOCHEM CYTOCHEM, V52, P419, DOI 10.1177/002215540405200314; Koivunen J, 2004, CANCER RES, V64, P5693, DOI 10.1158/0008-5472.CAN-03-3511; Kong CZ, 2005, UROLOGY, V65, P1228, DOI 10.1016/j.urology.2005.01.007; Konopatskaya O, 2010, TRENDS PHARMACOL SCI, V31, P8, DOI 10.1016/j.tips.2009.10.006; Kuniyasu H, 1997, JPN J CANCER RES, V88, P103, DOI 10.1111/j.1349-7006.1997.tb00353.x; Lahn M, 2004, EUR J CANCER, V40, P10, DOI 10.1016/j.ejca.2003.08.020; Lahn MM, 2004, MELANOMA RES, V14, P85, DOI 10.1097/00008390-200404000-00002; Lan J, 2003, WORLD J GASTROENTERO, V9, P54, DOI 10.3748/wjg.v9.i1.54; Lin KY, 2008, J SURG ONCOL, V97, P538, DOI 10.1002/jso.20997; Lin X, 2006, CARCINOGENESIS, V27, P1538, DOI 10.1093/carcin/bgl002; Lonne GK, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-76; Martiny-Baron G, 2007, PHARMACOL RES, V55, P477, DOI 10.1016/j.phrs.2007.04.001; Masur K, 2001, MOL BIOL CELL, V12, P1973, DOI 10.1091/mbc.12.7.1973; Michie AM, 2005, IMMUNOL LETT, V96, P155, DOI 10.1016/j.imlet.2004.08.013; Ng T, 1999, SCIENCE, V283, P2085, DOI 10.1126/science.283.5410.2085; Oster H, 2006, CANCER RES, V66, P6955, DOI 10.1158/0008-5472.CAN-06-0268; Pfeifer J.D., 2006, MOL GENETIC TESTING; Teicher BA, 2006, CLIN CANCER RES, V12, P5336, DOI 10.1158/1078-0432.CCR-06-0945; Weichert W, 2003, INT J ONCOL, V23, P633; Wu TT, 2008, J CELL BIOCHEM, V103, P9, DOI 10.1002/jcb.21378; Wu TT, 2007, CLIN CHIM ACTA, V382, P54, DOI 10.1016/j.cca.2007.03.018; Zhang B, 2003, WORLD J GASTROENTERO, V9, P2413	31	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2013	8	2							e56675	10.1371/journal.pone.0056675	http://dx.doi.org/10.1371/journal.pone.0056675			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098PO	23468872	Green Published, gold, Green Submitted			2022-12-25	WOS:000315561400013
J	Clark, ES; Stelkens, RB; Wedekind, C				Clark, Emily S.; Stelkens, Rike B.; Wedekind, Claus			Parental Influences on Pathogen Resistance in Brown Trout Embryos and Effects of Outcrossing within a River Network	PLOS ONE			English	Article							LIFE-HISTORY TRAITS; ADAPTIVE PHENOTYPIC PLASTICITY; GENETIC-VARIATION; LOCAL ADAPTATION; ATLANTIC SALMON; CHINOOK SALMON; REACTION NORMS; OUTBREEDING DEPRESSION; QUANTITATIVE GENETICS; RANA-TEMPORARIA	Phenotypic plasticity can increase tolerance to heterogeneous environments but the elevations and slopes of reaction norms are often population specific. Disruption of locally adapted reaction norms through outcrossing can lower individual viability. Here, we sampled five genetically distinct populations of brown trout (Salmo trutta) from within a river network, crossed them in a full-factorial design, and challenged the embryos with the opportunistic pathogen Pseudomonas fluorescens. By virtue of our design, we were able to disentangle effects of genetic crossing distance from sire and dam effects on early life-history traits. While pathogen infection did not increase mortality, it was associated with delayed hatching of smaller larvae with reduced yolk sac reserves. We found no evidence of a relationship between genetic distance (W, F-ST) and the expression of early-life history traits. Moreover, hybrids did not differ in phenotypic means or reaction norms in comparison to offspring from within-population crosses. Heritable variation in early life-history traits was found to remain stable across the control and pathogen environments. Our findings show that outcrossing within a rather narrow geographical scale can have neutral effects on F-1 hybrid viability at the embryonic stage, i.e. at a stage when environmental and genetic effects on phenotypes are usually large.	[Clark, Emily S.; Stelkens, Rike B.; Wedekind, Claus] Univ Lausanne, Dept Ecol & Evolut, Lausanne, Switzerland; [Stelkens, Rike B.] Univ Liverpool, Inst Integrat Biol, Liverpool L69 3BX, Merseyside, England	University of Lausanne; University of Liverpool	Wedekind, C (corresponding author), Univ Lausanne, Dept Ecol & Evolut, Lausanne, Switzerland.	claus.wedekind@unil.ch	Wedekind, Claus/S-3353-2016; Clark, Emily/GVR-7159-2022	Wedekind, Claus/0000-0001-6143-4716; 	Swiss National Science Foundation; Foundation Maison de la Riviere; Marie Curie Intra-European Fellowship; Fischereiinspektorat Bern	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Foundation Maison de la Riviere; Marie Curie Intra-European Fellowship(European Commission); Fischereiinspektorat Bern	This work was supported by the Swiss National Science Foundation, the Foundation Maison de la Riviere, and a Marie Curie Intra-European Fellowship to RBS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank the Fischereiinspektorat Bern for their permissions and support, including B. Bracher, U. Gutmann, C. Kung, M. Schmid and H. Walther. We also wish to acknowledge E. Baumgartner, A. Brechon, P. Christe, J. Guthruf, M. dos Santos, L. Kocjancic-Curty, L. Muller, R. Nicolet, M. Pompini, A. Ross-Gillespie, C. van Oosterhout, and L. Wilkins for help in the field and/or useful discussions and two reviewers for comments on the manuscript.	Agrawal AA, 2002, EVOLUTION, V56, P2206, DOI 10.1111/j.0014-3820.2002.tb00145.x; Allendorf FW, 2004, CONSERV BIOL, V18, P1203, DOI 10.1111/j.1523-1739.2004.00305.x; Araki H, 2007, SCIENCE, V318, P100, DOI 10.1126/science.1145621; Austin B., 1999, BACTERIAL PATHOGENS, V3rd, P13; Bates D., 2011, PACKAGE LME4 LINEAR, V1; BROWN AF, 1991, BIOL BULL, V181, P123, DOI 10.2307/1542494; Bubliy OA, 2001, HEREDITY, V86, P363, DOI 10.1046/j.1365-2540.2001.00837.x; Byrne GI, 2010, J INFECT DIS, V201, pS126, DOI 10.1086/652398; Carlsson J, 2001, T AM FISH SOC, V130, P36, DOI 10.1577/1548-8659(2001)130<0036:EOGSOG>2.0.CO;2; Darwish TL, 2009, CAN J FISH AQUAT SCI, V66, P83, DOI 10.1139/F08-185; Daszak P, 2000, SCIENCE, V287, P1756; Dobson A, 2001, PHILOS T R SOC B, V356, P1001, DOI 10.1098/rstb.2001.0900; Edmands S, 1999, EVOLUTION, V53, P1757, DOI 10.1111/j.1558-5646.1999.tb04560.x; Edmands S, 2002, TRENDS ECOL EVOL, V17, P520, DOI 10.1016/S0169-5347(02)02585-5; Edmands S, 2007, MOL ECOL, V16, P463, DOI 10.1111/j.1365-294X.2006.03148.x; Einum S, 2000, EVOLUTION, V54, P628, DOI 10.1111/j.0014-3820.2000.tb00064.x; Einum S, 1999, P ROY SOC B-BIOL SCI, V266, P2095, DOI 10.1098/rspb.1999.0893; Evans ML, 2010, HEREDITY, V104, P449, DOI 10.1038/hdy.2009.121; Evans ML, 2010, J EVOLUTION BIOL, V23, P687, DOI 10.1111/j.1420-9101.2010.01934.x; Forbes ML, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001969; Fraser DJ, 2008, EVOL APPL, V1, P501, DOI 10.1111/j.1752-4571.2008.00037.x; Garigliany MM, 2010, EMERG INFECT DIS, V16, P595, DOI 10.3201/eid1604.091061; Goldberg TL, 2005, CONSERV BIOL, V19, P455, DOI 10.1111/j.1523-1739.2005.00091.x; GOTTHARD K, 1995, OIKOS, V74, P3, DOI 10.2307/3545669; Goudet J, 2002, FSTAT 2 9 3 2 PROGRA; Griffiths AM, 2009, EVOL APPL, V2, P537, DOI 10.1111/j.1752-4571.2009.00092.x; Harvell CD, 2002, SCIENCE, V296, P2158, DOI 10.1126/science.1063699; Heath DD, 1999, EVOLUTION, V53, P1605, DOI 10.1111/j.1558-5646.1999.tb05424.x; Heggenes J, 2006, ECOL FRESHW FISH, V15, P366, DOI 10.1111/j.1600-0633.2006.00146.x; Hermida M, 2009, GENET MOL BIOL, V32, P42, DOI 10.1590/S1415-47572009005000014; Hoffmann AA, 1999, TRENDS ECOL EVOL, V14, P96, DOI 10.1016/S0169-5347(99)01595-5; HOULE D, 1992, GENETICS, V130, P195; Hutchings JA, 2011, HEREDITY, V106, P421, DOI 10.1038/hdy.2010.166; Hutchings JA, 2007, P ROY SOC B-BIOL SCI, V274, P1693, DOI 10.1098/rspb.2007.0263; Jacob A, 2010, MOL ECOL, V19, P5296, DOI 10.1111/j.1365-294X.2010.04884.x; Jacob A, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-207; Jensen LF, 2008, P ROY SOC B-BIOL SCI, V275, P2859, DOI 10.1098/rspb.2008.0870; Jensen LF, 2005, CONSERV GENET, V6, P615, DOI 10.1007/s10592-005-9014-8; Johnson PTJ, 2011, FUNCT ECOL, V25, P726, DOI 10.1111/j.1365-2435.2010.01830.x; Junge C, 2011, HEREDITY, V106, P460, DOI 10.1038/hdy.2010.160; Kearsey M.J., 1996, GENETIC ANAL QUANTIT, DOI [10.1007/978-1-4899-4441-2, DOI 10.1007/978-1-4899-4441-2]; Kelly DW, 2010, J ANIM ECOL, V79, P445, DOI 10.1111/j.1365-2656.2009.01636.x; Kinnison MT, 2008, MOL ECOL, V17, P405, DOI 10.1111/j.1365-294X.2007.03495.x; Krkosek M, 2006, P NATL ACAD SCI USA, V103, P15506, DOI 10.1073/pnas.0603525103; Laugen AT, 2005, GENET RES, V86, P161, DOI 10.1017/S0016672305007810; Laurila A, 2002, EVOLUTION, V56, P617; LEARY RF, 1995, AM FISH S S, V15, P91; LYNCH M, 1991, EVOLUTION, V45, P622, DOI [10.1111/j.1558-5646.1991.tb04333.x, 10.2307/2409915]; Lynch M., 1998, GENETICS ANAL QUANTI; McGinnity P, 2003, P ROY SOC B-BIOL SCI, V270, P2443, DOI 10.1098/rspb.2003.2520; Merila J, 2004, CONSERV GENET, V5, P513, DOI 10.1023/B:COGE.0000041026.71104.0a; Merila J, 1999, HEREDITY, V83, P103, DOI 10.1038/sj.hdy.6885850; Merila J, 1998, GENETICS, V148, P1233; Merila J, 1997, EVOLUTION, V51, P526, DOI 10.1111/j.1558-5646.1997.tb02440.x; MOUSSEAU TA, 1987, HEREDITY, V59, P181, DOI 10.1038/hdy.1987.113; Muhlfeld CC, 2009, BIOL LETTERS, V5, P328, DOI 10.1098/rsbl.2009.0033; Neff BD, 2004, P NATL ACAD SCI USA, V101, P2381, DOI 10.1073/pnas.0307522100; Nielsen C, 2003, J FISH BIOL, V63, P1184, DOI 10.1046/j.1095-8649.2003.00237.x; Nussey DH, 2007, J EVOLUTION BIOL, V20, P831, DOI 10.1111/j.1420-9101.2007.01300.x; Nussey DH, 2005, SCIENCE, V310, P304, DOI 10.1126/science.1117004; OECD, 1992, OECD GUID TEST CHEM, P9; Orizaola G, 2009, EVOL ECOL, V23, P979, DOI 10.1007/s10682-008-9285-x; Pakkasmaa S, 2003, HEREDITY, V91, P117, DOI 10.1038/sj.hdy.6800289; Piche J, 2008, P ROY SOC B-BIOL SCI, V275, P1571, DOI 10.1098/rspb.2008.0251; Pigliucci M., 2001, SYN ECO EVO; Pitcher TE, 2007, CONSERV GENET, V8, P607, DOI 10.1007/s10592-006-9204-z; Pompini M, BEHAV ECOLO IN PRESS; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Relyea RA, 2005, J EVOLUTION BIOL, V18, P856, DOI 10.1111/j.1420-9101.2005.00882.x; Roff D.A., 1997, EVOLUTIONARY QUANTIT; Rohr JR, 2010, FUNCT ECOL, V24, P1110, DOI 10.1111/j.1365-2435.2010.01709.x; Ryce EKN, 2005, DIS AQUAT ORGAN, V63, P69, DOI 10.3354/dao063069; Sagvik J, 2005, CONSERV GENET, V6, P205, DOI 10.1007/s10592-004-7829-3; Schlichting CD, 1998, PHENOTYPIC EVOLUTION; Schotthoefer AM, 2003, CAN J ZOOL, V81, P1144, DOI [10.1139/z03-099, 10.1139/Z03-099]; Smith TB, 2008, MOL ECOL, V17, P1, DOI 10.1111/j.1365-294X.2007.03607.x; Snow AA, 2001, ECOL APPL, V11, P934, DOI 10.1890/1051-0761(2001)011[0934:FOHBWA]2.0.CO;2; Sollid SA, 2003, J AQUAT ANIM HEALTH, V15, P136, DOI 10.1577/H02-038; Spiers AJ, 2000, MICROBIOL-SGM, V146, P2345, DOI 10.1099/00221287-146-10-2345; Stelkens RB, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-247; Stelkens RB, 2012, MOL ECOL, V21, P2896, DOI 10.1111/j.1365-294X.2012.05581.x; Stinchcombe JR, 2004, J EVOLUTION BIOL, V17, P197, DOI 10.1046/j.1420-9101.2003.00641.x; Uller T, 2009, OECOLOGIA, V160, P9, DOI 10.1007/s00442-009-1280-6; Uribe C, 2011, VET MED-CZECH, V56, P486, DOI 10.17221/3294-VETMED; VIA S, 1995, TRENDS ECOL EVOL, V10, P212, DOI 10.1016/S0169-5347(00)89061-8; VIA S, 1984, EVOLUTION, V38, P896, DOI 10.1111/j.1558-5646.1984.tb00360.x; von Siebenthal BA, 2009, FISH SHELLFISH IMMUN, V26, P531, DOI 10.1016/j.fsi.2009.02.008; Wang J, 2004, MOL ECOL, V13, P3169, DOI 10.1111/j.1365-294X.2004.02298.x; Warkentin KM, 2011, INTEGR COMP BIOL, V51, P14, DOI 10.1093/icb/icr017; Wedekind C, 2005, GENETICS, V170, P1427, DOI 10.1534/genetics.105.040683; Wedekind C, 2004, J EVOLUTION BIOL, V17, P11, DOI 10.1046/j.1420-9101.2004.00669.x; Wedekind C, 2002, CURR BIOL, V12, P69, DOI 10.1016/S0960-9822(01)00627-3; Wedekind C, 2008, P ROY SOC B-BIOL SCI, V275, P1737, DOI 10.1098/rspb.2008.0072; Wedekind C, 2007, ENVIRON POLLUT, V148, P385, DOI 10.1016/j.envpol.2006.11.022; Zhang WW, 2009, VET MICROBIOL, V139, P183, DOI 10.1016/j.vetmic.2009.04.026; Zuur Alain F., 2009, P1	96	17	17	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e57832	10.1371/journal.pone.0057832	http://dx.doi.org/10.1371/journal.pone.0057832			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451273	gold, Green Published, Green Submitted			2022-12-25	WOS:000316658800118
J	Salomaki, H; Vahatalo, LH; Laurila, K; Jappinen, NT; Penttinen, AM; Ailanen, L; Ilyasizadeh, J; Pesonen, U; Koulu, M				Salomaki, Henriikka; Vahatalo, Laura H.; Laurila, Kirsti; Jappinen, Norma T.; Penttinen, Anna-Maija; Ailanen, Liisa; Ilyasizadeh, Juan; Pesonen, Ullamari; Koulu, Markku			Prenatal Metformin Exposure in Mice Programs the Metabolic Phenotype of the Offspring during a High Fat Diet at Adulthood	PLOS ONE			English	Article							POLYCYSTIC-OVARY-SYNDROME; ACTIVATED PROTEIN-KINASE; INSULIN-SENSITIZING DRUGS; NEONATAL LEPTIN TREATMENT; EPIGENETIC MECHANISMS; GENE-EXPRESSION; INDUCED OBESITY; PREGNANCY; WOMEN; INSIG-1	Aims: The antidiabetic drug metformin is currently used prior and during pregnancy for polycystic ovary syndrome, as well as during gestational diabetes mellitus. We investigated the effects of prenatal metformin exposure on the metabolic phenotype of the offspring during adulthood in mice. Methods: Metformin (300 mg/kg) or vehicle was administered orally to dams on regular diet from the embryonic day E0.5 to E17.5. Gene expression profiles in liver and brain were analysed from 4-day old offspring by microarray. Body weight development and several metabolic parameters of offspring were monitored both during regular diet (RD-phase) and high fat diet (HFD-phase). At the end of the study, two doses of metformin or vehicle were given acutely to mice at the age of 20 weeks, and Insig-1 and GLUT4 mRNA expressions in liver and fat tissue were analysed using qRT-PCR. Results: Metformin exposed fetuses were lighter at E18.5. There was no effect of metformin on the maternal body weight development or food intake. Metformin exposed offspring gained more body weight and mesenteric fat during the HFD-phase. The male offspring also had impaired glucose tolerance and elevated fasting glucose during the HFD-phase. Moreover, the expression of GLUT4 mRNA was down-regulated in epididymal fat in male offspring prenatally exposed to metformin. Based on the microarray and subsequent qRT-PCR analyses, the expression of Insig-1 was changed in the liver of neonatal mice exposed to metformin prenatally. Furthermore, metformin up-regulated the expression of Insig-1 later in development. Gene set enrichment analysis based on preliminary microarray data identified several differentially enriched pathways both in control and metformin exposed mice. Conclusions: The present study shows that prenatal metformin exposure causes long-term programming effects on the metabolic phenotype during high fat diet in mice. This should be taken into consideration when using metformin as a therapeutic agent during pregnancy.	[Salomaki, Henriikka; Vahatalo, Laura H.; Jappinen, Norma T.; Penttinen, Anna-Maija; Ailanen, Liisa; Ilyasizadeh, Juan; Pesonen, Ullamari; Koulu, Markku] Univ Turku, Inst Biomed, Dept Pharmacol Drug Dev & Therapeut, Turku, Finland; [Laurila, Kirsti] Aalto Univ, Sch Econ, Dept Informat & Serv Econ, Helsinki, Finland; [Laurila, Kirsti] Aalto Univ, Sch Sci, Dept Informat & Comp Sci, Helsinki, Finland	University of Turku; Aalto University; Aalto University	Koulu, M (corresponding author), Univ Turku, Inst Biomed, Dept Pharmacol Drug Dev & Therapeut, Turku, Finland.	markku.koulu@utu.fi		Pesonen, Ullamari/0000-0002-9962-212X	Academy of Finland [134131]; FinPharma Doctoral Program (Finland)	Academy of Finland(Academy of Finland); FinPharma Doctoral Program (Finland)	This work was supported by The Academy of Finland (grant number 134131 to MK) and partially by FinPharma Doctoral Program (Finland). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel ED, 2001, NATURE, V409, P729, DOI 10.1038/35055575; Attig L, 2008, INT J OBESITY, V32, P1153, DOI 10.1038/ijo.2008.39; BARKER DJP, 1990, BRIT MED J, V301, P1111, DOI 10.1136/bmj.301.6761.1111; Bhalla K, 2012, CANCER PREV RES, V5, P544, DOI 10.1158/1940-6207.CAPR-11-0228; Bouret SG, 2004, SCIENCE, V304, P108, DOI 10.1126/science.1095004; Carone BR, 2010, CELL, V143, P1084, DOI 10.1016/j.cell.2010.12.008; Caton PW, 2011, DIABETES OBES METAB, V13, P1097, DOI 10.1111/j.1463-1326.2011.01466.x; Dhahbi JM, 2005, PHYSIOL GENOMICS, V23, P343, DOI 10.1152/physiolgenomics.00069.2005; Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371; Gabory A, 2009, MOL CELL ENDOCRINOL, V304, P8, DOI 10.1016/j.mce.2009.02.015; Gluckman PD, 2009, NAT REV ENDOCRINOL, V5, P401, DOI 10.1038/nrendo.2009.102; Glueck CJ, 2004, HUM REPROD, V19, P1323, DOI 10.1093/humrep/deh263; Glueck CJ, 2004, DIABETIC MED, V21, P829, DOI 10.1111/j.1464-5491.2004.01251.x; Goh JEL, 2011, DIABETIC MED, V28, P1082, DOI 10.1111/j.1464-5491.2011.03361.x; Goodarzi MO, 2011, NAT REV ENDOCRINOL, V7, P219, DOI 10.1038/nrendo.2010.217; Hawley SA, 2002, DIABETES, V51, P2420, DOI 10.2337/diabetes.51.8.2420; Hou M, 2010, BIOCHEM BIOPH RES CO, V397, P537, DOI 10.1016/j.bbrc.2010.05.152; Hundal RS, 2003, DRUGS, V63, P1879, DOI 10.2165/00003495-200363180-00001; Hundal RS, 2000, DIABETES, V49, P2063, DOI 10.2337/diabetes.49.12.2063; Ijas H, 2011, BJOG-INT J OBSTET GY, V118, P880, DOI 10.1111/j.1471-0528.2010.02763.x; Itoh H, 2011, ACTA PHYSIOL, V202, P159, DOI 10.1111/j.1748-1716.2011.02268.x; Jakubowicz DJ, 2002, J CLIN ENDOCR METAB, V87, P524, DOI 10.1210/jc.87.2.524; Kabir M, 2005, AM J PHYSIOL-ENDOC M, V288, pE454, DOI 10.1152/ajpendo.00203.2004; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Legro RS, 2010, J CLIN ENDOCR METAB, V95, P5199, DOI 10.1210/jc.2010-2301; Leonie E, 2012, ENDOCRINOLOGY, V153, P2861, DOI 10.1210/en.2011-1754; Levin BE, 2006, PHILOS T R SOC B, V361, P1107, DOI 10.1098/rstb.2006.1851; Li JP, 2003, P NATL ACAD SCI USA, V100, P9476, DOI 10.1073/pnas.1133426100; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Long YC, 2006, J CLIN INVEST, V116, P1776, DOI 10.1172/JCI29044; Maida A, 2011, DIABETOLOGIA, V54, P339, DOI 10.1007/s00125-010-1937-z; Matthews L, 2009, NUCLEIC ACIDS RES, V37, pD619, DOI 10.1093/nar/gkn863; Meaney MJ, 2007, TRENDS MOL MED, V13, P269, DOI 10.1016/j.molmed.2007.05.003; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Morin-Papunen L, 2012, J CLIN ENDOCR METAB, V97, P1492, DOI 10.1210/jc.2011-3061; Nestler JE, 2002, FERTIL STERIL, V77, P209, DOI 10.1016/S0015-0282(01)02963-6; Nishimura D, 2001, BIOTECH SOFTWARE INT, V2, P117, DOI DOI 10.1089/152791601750294344; Norman RJ, 2004, CURR OPIN OBSTET GYN, V16, P245, DOI 10.1097/00001703-200406000-00007; Onken B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008758; Pinney SE, 2010, TRENDS ENDOCRIN MET, V21, P223, DOI 10.1016/j.tem.2009.10.002; Raychaudhuri N, 2008, J BIOL CHEM, V283, P13611, DOI 10.1074/jbc.M800128200; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Roth A, 2008, MOL PHARMACOL, V73, P1282, DOI 10.1124/mol.107.041012; Rowan JA, 2011, DIABETES CARE, V34, P2279, DOI 10.2337/dc11-0660; Sandovici I, 2011, P NATL ACAD SCI USA, V108, P5449, DOI 10.1073/pnas.1019007108; Shang LB, 2011, P NATL ACAD SCI USA, V108, P4788, DOI 10.1073/pnas.1100844108; Sinnett-Smith J, 2013, BIOCHEM BIOPH RES CO, V430, P352, DOI 10.1016/j.bbrc.2012.11.010; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Symonds ME, 2009, NAT REV ENDOCRINOL, V5, P604, DOI 10.1038/nrendo.2009.195; Tertti Kristiina, 2008, Rev Diabet Stud, V5, P95, DOI 10.1900/RDS.2008.5.95; Vanky E, 2005, FERTIL STERIL, V83, P1575, DOI 10.1016/j.fertnstert.2004.11.051; Velazquez EM, 1997, METABOLISM, V46, P454, DOI 10.1016/S0026-0495(97)90066-4; Vickers MH, 2008, ENDOCRINOLOGY, V149, P1906, DOI 10.1210/en.2007-0981; Vickers MH, 2005, ENDOCRINOLOGY, V146, P4211, DOI 10.1210/en.2005-0581; Vickers MH, 2000, AM J PHYSIOL-ENDOC M, V279, pE83; Xie ZL, 2011, DIABETES, V60, P1770, DOI 10.2337/db10-0351; Yang T, 2002, CELL, V110, P489, DOI 10.1016/S0092-8674(02)00872-3; Yura S, 2005, CELL METAB, V1, P371, DOI 10.1016/j.cmet.2005.05.005; Yura S, 2008, OBESITY, V16, P1289, DOI 10.1038/oby.2008.57; Zakikhani M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049513; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	63	59	62	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56594	10.1371/journal.pone.0056594	http://dx.doi.org/10.1371/journal.pone.0056594			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457588	Green Published, gold			2022-12-25	WOS:000315603700063
J	Treer, D; Van Bocxlaer, I; Matthijs, S; Du Four, D; Janssenswillen, S; Willaert, B; Bossuyt, F				Treer, Dag; Van Bocxlaer, Ines; Matthijs, Severine; Du Four, Dimitri; Janssenswillen, Sunita; Willaert, Bert; Bossuyt, Franky			Love Is Blind: Indiscriminate Female Mating Responses to Male Courtship Pheromones in Newts (Salamandridae)	PLOS ONE			English	Article							TRITURUS-VULGARIS-VULGARIS; RED-SPOTTED NEWT; SMOOTH NEWT; SEXUAL-BEHAVIOR; MATE CHOICE; AMPHIBIA-SALAMANDRIDAE; TERRESTRIAL SALAMANDER; CYNOPS-PYRRHOGASTER; FECUND FEMALES; PALMATE NEWT	Internal fertilization without copulation or prolonged physical contact is a rare reproductive mode among vertebrates. In many newts (Salamandridae), the male deposits a spermatophore on the substrate in the water, which the female subsequently takes up with her cloaca. Because such an insemination requires intense coordination of both sexes, male newts have evolved a courtship display, essentially consisting of sending pheromones under water by tail-fanning towards their potential partner. Behavioral experiments until now mostly focused on an attractant function, i.e. showing that olfactory cues are able to bring both sexes together. However, since males start their display only after an initial contact phase, courtship pheromones are expected to have an alternative function. Here we developed a series of intraspecific and interspecific two-female experiments with alpine newt (Ichthyosaura alpestris) and palmate newt (Lissotriton helveticus) females, comparing behavior in male courtship water and control water. We show that male olfactory cues emitted during tail-fanning are pheromones that can induce all typical features of natural female mating behavior. Interestingly, females exposed to male pheromones of their own species show indiscriminate mating responses to conspecific and heterospecific females, indicating that visual cues are subordinate to olfactory cues during courtship.	[Treer, Dag; Van Bocxlaer, Ines; Matthijs, Severine; Du Four, Dimitri; Janssenswillen, Sunita; Willaert, Bert; Bossuyt, Franky] Vrije Univ Brussel, Amphibian Evolut Lab, Brussels, Belgium	Vrije Universiteit Brussel	Bossuyt, F (corresponding author), Vrije Univ Brussel, Amphibian Evolut Lab, Brussels, Belgium.	fbossuyt@vub.ac.be	Van Bocxlaer, Ines/L-4852-2015; Treer, Dag/D-8098-2017	Treer, Dag/0000-0003-4847-7361; Bossuyt, Franky/0000-0001-6804-9271	Fonds voor Wetenschappelijk Onderzoek Vlaanderen (FWO); European Research Council (ERC) [204509]	Fonds voor Wetenschappelijk Onderzoek Vlaanderen (FWO)(FWO); European Research Council (ERC)(European Research Council (ERC))	This work was supported by Fonds voor Wetenschappelijk Onderzoek Vlaanderen (FWO) and the European Research Council (ERC-starting grant 204509 - project TAPAS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, PHEROMONES ANIMAL BE; Arnold S.J., 1977, P141; ARNOLD SJ, 1976, Z TIERPSYCHOL, V42, P247; Arnold SJ., 1982, BIOCH ASP EVOL BIOL, P173; BELVEDERE P, 1988, MONIT ZOOL ITAL, V22, P397; Denoel M, 2001, J HERPETOL, V35, P62, DOI 10.2307/1566024; Denoel Mathieu, 1996, Cahiers d'Ethologie, V16, P133; Denoel M, 2010, BEHAV ECOL SOCIOBIOL, V64, P1171, DOI 10.1007/s00265-010-0933-0; Denoel Mathieu, 1999, Cahiers d'Ethologie, V19, P221; Drechsler Axel, 2010, Herpetology Notes, V3, P13; Dytham C., 2011, CHOOSING USING STAT; Gabor CR, 1997, BEHAV ECOL, V8, P162, DOI 10.1093/beheco/8.2.162; GREEN AJ, 1992, ANIM BEHAV, V43, P170, DOI 10.1016/S0003-3472(05)80086-7; GREEN AJ, 1991, ANIM BEHAV, V41, P367, DOI 10.1016/S0003-3472(05)80489-0; GRIFFITHS RA, 1985, ANIM BEHAV, V33, P573, DOI 10.1016/S0003-3472(85)80081-6; Griffiths RA, 1996, NEWTS SALAMANDERS EU; Halliday T, 1974, J HERPETOL, P277; Halliday T.R., 1983, P3; Halliday T.R., 1990, Advances in the Study of Behavior, V19, P137, DOI 10.1016/S0065-3454(08)60202-8; HALLIDAY TR, 1975, ANIM BEHAV, V23, P291, DOI 10.1016/0003-3472(75)90078-0; HIMSTEDT W, 1979, COPEIA, P40; Houck LD, 2007, ANIM BEHAV, V73, P315, DOI 10.1016/j.anbehav.2006.07.008; Houck LD, 2003, REPROD BIOL PHYLOGEN, V1, P383; Houck LD, 2008, CHEM SIGNAL, V11, P213, DOI 10.1007/978-0-387-73945-8_20; Iwata T, 1999, FEBS LETT, V457, P400, DOI 10.1016/S0014-5793(99)01062-5; Iwata T, 2004, PEPTIDES, V25, P1537, DOI 10.1016/j.peptides.2003.10.027; Kiemnec-Tyburczy KM, 2009, GENE, V432, P75, DOI 10.1016/j.gene.2008.11.007; Kikuyama S, 1999, REV REPROD, V4, P1; MACGREGOR HC, 1990, J EVOLUTION BIOL, V3, P329, DOI 10.1046/j.1420-9101.1990.3050329.x; MALACARNE G, 1986, B ZOOL, V53, P79, DOI 10.1080/11250008609355487; MALACARNE G, 1987, COPEIA, P245; MALACARNE G, 1982, BEHAV PROCESS, V7, P307, DOI 10.1016/0376-6357(82)90003-1; Malmgren JC, 2008, ETHOL ECOL EVOL, V20, P71, DOI 10.1080/08927014.2008.9522545; Nakada T, 2007, PEPTIDES, V28, P774, DOI 10.1016/j.peptides.2006.12.006; NOBLE G. K., 1927, ANN NEW YORK ACAD SCI, V30, P31, DOI 10.1111/j.1749-6632.1927.tb55359.x; Ortiz-Santaliestra ME, 2009, ENVIRON TOXICOL CHEM, V28, P1500, DOI 10.1897/08-580.1; Osikowski A, 2012, ZOOL SCI, V29, P390, DOI 10.2108/zsj.29.390; Palmer CA, 2007, EVOLUTION, V61, P202, DOI 10.1111/j.1558-5646.2007.00017.x; Park D, 2001, ENVIRON HEALTH PERSP, V109, P669, DOI 10.2307/3454782; Poschadel JR, 2007, ACTA ETHOL, V10, P35, DOI 10.1007/s10211-007-0025-y; RAFINSKI J, 1992, FOLIA BIOL-KRAKOW, V40, P155; Robalo J.I., 2002, Acta Ethologica, V4, P81; Rollmann SM, 1999, SCIENCE, V285, P1907, DOI 10.1126/science.285.5435.1907; Rusconi M, 1821, AMOURS SALAMANDRES A; Secondi J, 2005, ETHOLOGY, V111, P726, DOI 10.1111/j.1439-0310.2005.01096.x; Secondi J, 2007, ETHOLOGY, V113, P711, DOI 10.1111/j.1439-0310.2007.01375.x; Secondi J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030391; SEVER DM, 1990, HERPETOLOGICA, V46, P160; Spallanzani L, 1780, THESIS; Sparreboom M, 1996, ETHOLOGY, V102, P672; *SPSS INC, 2005, SPSS WIND REL 14 0 0; TEYSSEDRE C, 1986, ETHOLOGY, V71, P89; Tinbergen N., 1938, Levende Natuur Amsterdam, V43, P232; TOYODA F, 1994, PHYSIOL BEHAV, V55, P569, DOI 10.1016/0031-9384(94)90118-X; Toyoda F, 2004, PEPTIDES, V25, P1531, DOI 10.1016/j.peptides.2003.10.025; Vaccaro EA, 2009, ANIM BEHAV, V78, P1421, DOI 10.1016/j.anbehav.2009.09.018; VERRELL P, 1988, J ZOOL, V214, P533, DOI 10.1111/j.1469-7998.1988.tb03758.x; VERRELL PA, 1986, J HERPETOL, V20, P416, DOI 10.2307/1564504; VERRELL PA, 1986, J ZOOL, V210, P101; VERRELL PA, 1985, HERPETOLOGICA, V41, P382; Verrell PA, 1983, THESIS OPEN U MILTON; Waights V, 1996, ETHOLOGY, V102, P736; Wambreuse P., 1985, Cahiers d'Ethologie Appliquee, V4, P193; Wells DK., 2007, ECOLOGY BEHAV AMPHIB; Wilburn DB, 2012, EVOLUTION IN PRESS; Woodley SK, 2010, J COMP PHYSIOL A, V196, P713, DOI 10.1007/s00359-010-0540-6; Zippelius H, 1948, VERH DTSCH ZOOL KIEL, V1948, P127	67	33	33	2	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56538	10.1371/journal.pone.0056538	http://dx.doi.org/10.1371/journal.pone.0056538			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	099EQ	23457580	Green Published, Green Submitted, gold			2022-12-25	WOS:000315603700061
J	Bitencourt, AR; Vicentin, EC; Jimenez, MC; Ricci, R; Leite, JA; Costa, FT; Ferreira, LC; Russell, B; Nosten, F; Renia, L; Galinski, MR; Barnwell, JW; Rodrigues, MM; Soares, IS				Bitencourt, Amanda R.; Vicentin, Elaine C.; Jimenez, Maria C.; Ricci, Ricardo; Leite, Juliana A.; Costa, Fabio T.; Ferreira, Luis C.; Russell, Bruce; Nosten, Francois; Renia, Laurent; Galinski, Mary R.; Barnwell, John W.; Rodrigues, Mauricio M.; Soares, Irene S.			Antigenicity and Immunogenicity of Plasmodium vivax Merozoite Surface Protein-3	PLOS ONE			English	Article							LONG SYNTHETIC PEPTIDES; DUFFY BINDING-PROTEIN; BLOOD-STAGE VACCINE; C-TERMINAL REGIONS; MALARIA VACCINE; IMMUNE-RESPONSES; CIRCUMSPOROZOITE PROTEIN; PROTECTIVE EFFICACY; CANDIDATE MSP1(19); ANTIBODY-RESPONSE	A recent clinical trial in African children demonstrated the potential utility of merozoite surface protein (MSP)-3 as a vaccine against Plasmodium falciparum malaria. The present study evaluated the use of Plasmodium vivax MSP-3 (PvMSP-3) as a target antigen in vaccine formulations against malaria caused by P. vivax. Recombinant proteins representing MSP-3 alpha and MSP-3 beta of P. vivax were expressed as soluble histidine-tagged bacterial fusions. Antigenicity during natural infection was evaluated by detecting specific antibodies using sera from individuals living in endemic areas of Brazil. A large proportion of infected individuals presented IgG antibodies to PvMSP-3 alpha (68.2%) and at least 1 recombinant protein representing PvMSP-3 beta (79.1%). In spite of the large responder frequency, reactivity to both antigens was significantly lower than was observed for the immunodominant epitope present on the 19-kDa C-terminal region of PvMSP-1. Immunogenicity of the recombinant proteins was studied in mice in the absence or presence of different adjuvant formulations. PvMSP-3 beta, but not PvMSP-3 alpha, induced a TLR4-independent humoral immune response in the absence of any adjuvant formulation. The immunogenicity of the recombinant antigens were also tested in formulations containing different adjuvants (Alum, Salmonella enterica flagellin, CpG, Quil A, TiterMax (R) and incomplete Freunds adjuvant) and combinations of two adjuvants (Alum plus flagellin, and CpG plus flagellin). Recombinant PvMSP-3 alpha and PvMSP-3 beta elicited higher antibody titers capable of recognizing P. vivax-infected erythrocytes harvested from malaria patients. Our results confirm that P. vivax MSP-3 antigens are immunogenic during natural infection, and the corresponding recombinant proteins may be useful in elucidating their vaccine potential.	[Bitencourt, Amanda R.; Vicentin, Elaine C.; Jimenez, Maria C.; Ricci, Ricardo; Soares, Irene S.] Univ Sao Paulo, Fac Ciencias Farmaceut, Dept Anal Clin & Toxicol, Sao Paulo, Brazil; [Leite, Juliana A.; Costa, Fabio T.] Univ Estadual Campinas, Dept Genet Evolucao & Bioagentes, Inst Biol, Campinas, SP, Brazil; [Ferreira, Luis C.] Univ Sao Paulo, Inst Ciencias Biomed, Dept Microbiol, BR-05508 Sao Paulo, Brazil; [Russell, Bruce] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol, Singapore 117595, Singapore; [Russell, Bruce; Renia, Laurent] Agcy Sci Technol & Res, Singapore Immunol Network, Biopolis, Singapore, Singapore; [Nosten, Francois] Churchill Hosp, Ctr Vaccinol & Trop Med, Oxford OX3 7LJ, England; [Nosten, Francois] Mahidol Oxford Univ Trop Med Res Programme, Shoklo Malaria Res Unit, Mae Sot, Thailand; [Galinski, Mary R.] Emory Univ, Emory Vaccine Ctr, Atlanta, GA 30322 USA; [Galinski, Mary R.] Emory Univ, Yerkes Natl Primate Res Ctr, Atlanta, GA 30322 USA; [Galinski, Mary R.] Emory Univ, Dept Med, Div Infect Dis, Atlanta, GA 30322 USA; [Barnwell, John W.] Ctr Dis Control & Prevent, Malaria Branch, Div Parasit Dis, Chamblee, GA USA; [Rodrigues, Mauricio M.] Univ Fed Sao Paulo, CTCMOL, Dept Microbiol Imunol & Parasitol, Escola Paulista Med, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade de Sao Paulo; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); University of Oxford; Mahidol University; Emory University; Emory University; Emory University; Centers for Disease Control & Prevention - USA; Universidade Federal de Sao Paulo (UNIFESP)	Soares, IS (corresponding author), Univ Sao Paulo, Fac Ciencias Farmaceut, Dept Anal Clin & Toxicol, Sao Paulo, Brazil.	isoares@usp.br	Soares, Irene Silva/C-5974-2012; Russell, Bruce/A-9240-2011; Soares, Irene/GQF-1984-2022; Leite, Juliana/G-2563-2013; Rodrigues, Mauricio M./B-8512-2012; Renia, Laurent/E-2117-2011; Costa, Fabio/E-1181-2012; Vicentin, Elaine/F-2651-2013; Nosten, Francois/AAC-5509-2019; Ferreira, Luis/M-3954-2014	Soares, Irene Silva/0000-0002-3336-6856; Russell, Bruce/0000-0003-2333-4348; Renia, Laurent/0000-0003-0349-1557; Costa, Fabio/0000-0001-9969-7300; Nosten, Francois/0000-0002-7951-0745; Ferreira, Luis/0000-0002-4883-1693	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2010/09893-0]; National Institute for Vaccine Development and Technology (CNPq - INCTV); FAPESP; CNPq; US National Institutes of Health, National Institute for Allergy and Infectious Diseases [1R01AI24710]; SIgN; Horizontal Programme on Infectious Diseases under the Agency for Science, Technology and Research (A*STAR, Singapore); Wellcome Trust of Great Britain, as part of the Oxford Tropical Medicine Research Programme of Wellcome Trust-Mahidol University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI024710] Funding Source: NIH RePORTER	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Institute for Vaccine Development and Technology (CNPq - INCTV)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); US National Institutes of Health, National Institute for Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); SIgN; Horizontal Programme on Infectious Diseases under the Agency for Science, Technology and Research (A*STAR, Singapore)(Agency for Science Technology & Research (A*STAR)); Wellcome Trust of Great Britain, as part of the Oxford Tropical Medicine Research Programme of Wellcome Trust-Mahidol University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, 2010/09893-0) and The National Institute for Vaccine Development and Technology (CNPq - INCTV). ARB, MCJ and JAL were supported by fellowships from FAPESP. ECV, RR, FTC, LCF, MMR and ISS were supported by fellowships from CNPq. Support is also acknowledged from the US National Institutes of Health, National Institute for Allergy and Infectious Diseases to MRG (1R01AI24710), from SIgN and from the Horizontal Programme on Infectious Diseases under the Agency for Science, Technology and Research (A*STAR, Singapore). SMRU is sponsored by The Wellcome Trust of Great Britain, as part of the Oxford Tropical Medicine Research Programme of Wellcome Trust-Mahidol University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnandji ST, 2011, NEW ENGL J MED, V365, P1863, DOI 10.1056/NEJMoa1102287; Arevalo-Herrera M, 2005, AM J TROP MED HYG, V73, P25; Arevalo-Herrera M, 2011, AM J TROP MED HYG, V84, P35, DOI 10.4269/ajtmh.2011.09-0507; Barbedo MB, 2007, MEM I OSWALDO CRUZ, V102, P335, DOI 10.1590/S0074-02762007005000040; Bargieri DY, 2008, VACCINE, V26, P6132, DOI 10.1016/j.vaccine.2008.08.070; Carlton JM, 2008, NATURE, V455, P757, DOI 10.1038/nature07327; Ceravolo IP, 2009, CLIN EXP IMMUNOL, V156, P502, DOI 10.1111/j.1365-2249.2009.03931.x; Coler RN, 2009, PARASITE IMMUNOL, V31, P520, DOI 10.1111/j.1365-3024.2009.01142.x; Cunha MG, 2001, VACCINE, V20, P385, DOI 10.1016/S0264-410X(01)00359-0; Ellis RD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008787; Galinski MR, 1999, MOL BIOCHEM PARASIT, V101, P131, DOI 10.1016/S0166-6851(99)00063-8; Galinski MR, 2001, MOL BIOCHEM PARASIT, V115, P41, DOI 10.1016/S0166-6851(01)00267-5; Gentil F, 2010, VACCINE, V28, P6183, DOI 10.1016/j.vaccine.2010.07.017; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Herrera S, 2005, AM J TROP MED HYG, V73, P44, DOI 10.4269/ajtmh.2005.73.44; Herrera S, 2004, INT J PARASITOL, V34, P1535, DOI 10.1016/j.ijpara.2004.10.009; Herrera S, 2011, AM J TROP MED HYG, V84, P12, DOI 10.4269/ajtmh.2011.09-0516; Jimenez MCS, 2008, BBA-GEN SUBJECTS, V1780, P983, DOI 10.1016/j.bbagen.2008.03.016; Lima JC, 2011, VACCINE, V29, P1801, DOI 10.1016/j.vaccine.2010.12.099; Bouillet LEM, 2011, INFECT IMMUN, V79, P3642, DOI 10.1128/IAI.05048-11; malERA Consultative Group on Vaccines, 2011, PLoS Med, V8, pe1000398, DOI 10.1371/journal.pmed.1000398; Michon PA, 1998, AM J TROP MED HYG, V59, P597, DOI 10.4269/ajtmh.1998.59.597; Morais CG, 2005, PARASITOL RES, V95, P420, DOI 10.1007/s00436-005-1314-x; Morais CG, 2006, AM J TROP MED HYG, V75, P582, DOI 10.4269/ajtmh.2006.75.582; Mourao LC, 2012, MICROBES INFECT, V14, P730, DOI 10.1016/j.micinf.2012.02.011; Mullen GED, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002940; Rayner JC, 2002, PARASITOLOGY, V125, P393, DOI 10.1017/S0031182002002317; Rayner JC, 2004, INFECT GENET EVOL, V4, P309, DOI 10.1016/j.meegid.2004.03.003; Ribeiro RS, 2011, MEM I OSWALDO CRUZ, V106, P27, DOI 10.1590/S0074-02762011000900004; Rodrigues MHC, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-39; Rodriguesa MHC, 2005, INT J PARASITOL, V35, P185, DOI 10.1016/j.ijpara.2004.11.003; Rosa DS, 2006, MICROBES INFECT, V8, P2130, DOI 10.1016/j.micinf.2006.03.012; Russell B, 2011, BLOOD, V118, pE74, DOI 10.1182/blood-2011-04-348748; Sagara I, 2009, VACCINE, V27, P7292, DOI 10.1016/j.vaccine.2009.10.087; Singh S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005410; Sirima SB, 2011, NEW ENGL J MED, V365, P1062, DOI 10.1056/NEJMc1100670; Soares IS, 1999, AM J TROP MED HYG, V60, P357, DOI 10.4269/ajtmh.1999.60.357; Soares IS, 1997, INFECT IMMUN, V65, P1606, DOI 10.1128/IAI.65.5.1606-1614.1997; Storti-Melo LM, 2011, AM J TROP MED HYG, V84, P58, DOI 10.4269/ajtmh.2011.10-0044; Thera MA, 2011, NEW ENGL J MED, V365, P1004, DOI 10.1056/NEJMoa1008115; Traore B, 2009, VACCINE, V27, P7299, DOI 10.1016/j.vaccine.2009.08.023; Valderrama-Aguirre A, 2005, AM J TROP MED HYG, V73, P16, DOI 10.4269/ajtmh.2005.73.16; Wu Yu-Huan, 2008, P3	43	18	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56061	10.1371/journal.pone.0056061	http://dx.doi.org/10.1371/journal.pone.0056061			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457498	Green Published, Green Submitted, gold			2022-12-25	WOS:000315602700037
J	Erickson, RP; Gross, SP; Yu, CC				Erickson, Robert P.; Gross, Steven P.; Yu, Clare C.			Filament-Filament Switching Can Be Regulated by Separation Between Filaments Together with Cargo Motor Number	PLOS ONE			English	Article							MOLECULAR MOTORS; MYOSIN-V; ACTIN; INTERSECTIONS; TRANSPORT; PROTEINS	How intracellular transport controls the probability that cargos switch at intersections between filaments is not well understood. In one hypothesis some motors on the cargo attach to one filament while others attach to the intersecting filament, and the ensuing tug-of-war determines which filament is chosen. We investigate this hypothesis using 3D computer simulations, and discover that switching at intersections increases with the number of motors on the cargo, but is not strongly dependent on motor number when the filaments touch. Thus, simply controlling the number of active motors on the cargo cannot account for in vivo observations that found reduced switching with increasing motor number, suggesting additional mechanisms of regulation. We use simulations to show that one possible way to regulate switching is by simultaneously adjusting the separation between planes containing the crossing filaments and the total number of active motors on the cargo. Heretofore, the effect of filament-filament separation on switching has been unexplored. We find that the switching probability decreases with increasing filament separation. This effect is particularly strong for cargos with only a modest number of motors. As the filament separation increases past the maximum head-to-head distance of the motor, individual motors walking along a filament will be unable to reach the intersecting filament. Thus, any switching requires that other motors on the cargo attach to the intersecting filament and haul the cargo along it, while motor(s) engaged on the original filament detach. Further, if the filament separation is large enough, the cargo can have difficulty proceeding along the initial filament because the engaged motors can walk underneath the intersecting filament, but the cargo itself cannot fit between the filaments. Thus, the cargo either detaches entirely from the original filament, or must dip to the side of the initial filament and then pass below the crossing filament.	[Erickson, Robert P.; Gross, Steven P.; Yu, Clare C.] Univ Calif Irvine, Dept Phys & Astron, Irvine, CA 92717 USA; [Gross, Steven P.] Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92717 USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Gross, SP (corresponding author), Univ Calif Irvine, Dept Phys & Astron, Irvine, CA 92717 USA.	sgross@uci.edu; cyu@uci.edu		Erickson, Robert/0000-0001-9683-5149	NIH/NIGMS [5R01GM079156]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079156] Funding Source: NIH RePORTER	NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH/NIGMS grant number 5R01GM079156 (www.nih.gov) to CCYu and SPGross. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali MY, 2007, P NATL ACAD SCI USA, V104, P4332, DOI 10.1073/pnas.0611471104; Cassimeris L, 2011, LEWINS CELLS, Vxxiv; CHENEY RE, 1993, CELL, V75, P13, DOI 10.1016/0092-8674(93)90675-G; Erickson RP, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002032; Gross SP, 2002, J CELL BIOL, V156, P855, DOI 10.1083/jcb.200105055; Gross SP, 2007, CURR BIOL, V17, pR478, DOI 10.1016/j.cub.2007.04.025; ISAMBERT H, 1995, J BIOL CHEM, V270, P11437, DOI 10.1074/jbc.270.19.11437; Ross JL, 2008, CURR OPIN CELL BIOL, V20, P41, DOI 10.1016/j.ceb.2007.11.006; Schroeder HW, 2012, BIOPHYS J, V103, P48, DOI 10.1016/j.bpj.2012.05.037; Schroeder HW, 2010, CURR BIOL, V20, P687, DOI 10.1016/j.cub.2010.03.024; Snider J, 2004, P NATL ACAD SCI USA, V101, P13204, DOI 10.1073/pnas.0403092101; TAYLOR KA, 1994, BIOPHYS J, V67, P1976, DOI 10.1016/S0006-3495(94)80680-0; Winder SJ, 2005, J CELL SCI, V118, P651, DOI 10.1242/jcs.01670; Yildiz A, 2003, SCIENCE, V300, P2061, DOI 10.1126/science.1084398	14	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e54298	10.1371/journal.pone.0054298	http://dx.doi.org/10.1371/journal.pone.0054298			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457447	Green Published, gold			2022-12-25	WOS:000315602700004
J	Frola, E; Patrizi, A; Goetz, T; Medrihan, L; Petrini, EM; Barberis, A; Wulff, P; Wisden, W; Sassoe-Pognetto, M				Frola, Elena; Patrizi, Annarita; Goetz, Thomas; Medrihan, Lucian; Petrini, Enrica Maria; Barberis, Andrea; Wulff, Peer; Wisden, William; Sassoe-Pognetto, Marco			Synaptic Competition Sculpts the Development of GABAergic Axo-Dendritic but Not Perisomatic Synapses	PLOS ONE			English	Article							GLUTAMIC-ACID DECARBOXYLASE; POSTSYNAPTIC GABA(A) RECEPTORS; WINNER CLIMBING FIBER; INHIBITORY SYNAPSES; PURKINJE-CELLS; GAMMA-2 SUBUNIT; A RECEPTORS; IN-VIVO; POSITIVE INTERNEURONS; MONOCLONAL-ANTIBODIES	The neurotransmitter GABA regulates many aspects of inhibitory synapse development. We tested the hypothesis that GABA(A) receptors (GABA(A)Rs) work together with the synaptic adhesion molecule neuroligin 2 (NL2) to regulate synapse formation in different subcellular compartments. We investigated mice ("gamma 2 knockdown mice'') with an engineered allele of the GABA(A)R gamma 2 subunit gene which produced a mosaic expression of synaptic GABAARs in neighboring neurons, causing a strong imbalance in synaptic inhibition. Deletion of the gamma 2 subunit did not abolish synapse formation or the targeting of NL2 to distinct types of perisomatic and axo-dendritic contacts. Thus synaptic localization of NL2 does not require synaptic GABA(A)Rs. However, loss of the gamma 2 subunit caused a selective decrease in the number of axo-dendritic synapses on cerebellar Purkinje cells and cortical pyramidal neurons, whereas perisomatic synapses were not significantly affected. Notably, gamma 2-positive cells had increased axo-dendritic innervation compared with both gamma 2-negative and wild-type counterparts. Moreover heterologous synapses on spines, that are found after total deletion of GABA(A)Rs from all Purkinje cells, were rare in cerebella of gamma 2 knockdown mice. These findings reveal a selective role of gamma 2 subunit-containing GABA(A)Rs in regulating synapse development in distinct subcellular compartments, and support the hypothesis that the refinement of axo-dendritic synapses is regulated by activity-dependent competition between neighboring neurons.	[Frola, Elena; Patrizi, Annarita; Sassoe-Pognetto, Marco] Univ Turin, Dept Neurosci, Turin, Italy; [Frola, Elena; Patrizi, Annarita; Sassoe-Pognetto, Marco] Natl Inst Neurosci Italy, Turin, Italy; [Goetz, Thomas; Wulff, Peer; Wisden, William] Univ Aberdeen, Inst Med Sci, Aberdeen, Scotland; [Medrihan, Lucian; Petrini, Enrica Maria; Barberis, Andrea] Italian Inst Technol, Dept Neurosci & Brain Technol, Genoa, Italy	University of Turin; University of Aberdeen; Istituto Italiano di Tecnologia - IIT	Wisden, W (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, London, England.	w.wisden@imperial.ac.uk; marco.sassoe@unito.it	Barberis, Andrea/AAB-8806-2019; Sassoe-Pognetto, Marco/AAE-3536-2022; Wisden, William/A-4071-2011	Wisden, William/0000-0003-4743-0334; Wulff, Peer/0000-0002-0282-7832; Frola, Elena/0000-0002-9706-4603; Medrihan, Lucian/0000-0002-8252-2595; Sassoe-Pognetto, Marco/0000-0001-8906-0613; Barberis, Andrea/0000-0002-5054-6517	Compagnia di San Paolo; Regione Piemonte (Ricerca Scientifica Applicata A218 and Ricerca Sanitaria Finalizzata); Volkswagen Foundation [I/78 554]; Medical Research Council [G0800399]; Developmental Studies Hybridoma Bank developed under the auspices of the National Institute of Child Health and Human Development; MRC [G0800399, G0601498] Funding Source: UKRI; Medical Research Council [G0601498] Funding Source: researchfish	Compagnia di San Paolo(Compagnia di San Paolo); Regione Piemonte (Ricerca Scientifica Applicata A218 and Ricerca Sanitaria Finalizzata)(Regione Piemonte); Volkswagen Foundation(Volkswagen); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Developmental Studies Hybridoma Bank developed under the auspices of the National Institute of Child Health and Human Development; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by grants from Compagnia di San Paolo (2007) and Regione Piemonte (Ricerca Scientifica Applicata A218 and Ricerca Sanitaria Finalizzata 2009) to MSP; J. Ernest Tait Estate to WW and TG; Volkswagen Foundation (grant I/78 554) to WW; Medical Research Council (grant G0800399) to PW and WW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Drs. Frederique Varoqueaux (Max Planck Institute for Experimental Medicine, Gottingen, Germany), Jean-Marc Fritschy (University of Zurich, Zurich, Switzerland), Masahiko Watanabe (Hokkaido University, Sapporo, Japan) and Rita Garbelli (Besta Neurological Institute, Milan) for their generous gift of the antibodies. The GAD-6 monoclonal antibody, developed by David I. Gottlieb (Washington University, St. Louis, MO), was obtained from the Developmental Studies Hybridoma Bank developed under the auspices of the National Institute of Child Health and Human Development and maintained by the University of Iowa, Department of Biological Sciences, Iowa City, IA 52242.	Airaksinen MS, 1997, P NATL ACAD SCI USA, V94, P1488, DOI 10.1073/pnas.94.4.1488; Akerman CJ, 2007, TRENDS NEUROSCI, V30, P382, DOI 10.1016/j.tins.2007.06.002; Alldred MJ, 2005, J NEUROSCI, V25, P594, DOI 10.1523/JNEUROSCI.4011-04.2005; Behar TN, 2000, CEREB CORTEX, V10, P899, DOI 10.1093/cercor/10.9.899; Benke D, 1996, NEUROPHARMACOLOGY, V35, P1413, DOI 10.1016/S0028-3908(96)00068-8; Bosman LWJ, 2008, J NEUROSCI, V28, P798, DOI 10.1523/JNEUROSCI.4074-07.2008; Briatore F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012119; Bu J, 2003, EXP NEUROL, V182, P220, DOI 10.1016/S0014-4886(03)00094-3; Burke SN, 2010, TRENDS NEUROSCI, V33, P153, DOI 10.1016/j.tins.2009.12.003; Burkhalter A, 2008, FRONT NEUROSCI-SWITZ, V2, P155, DOI 10.3389/neuro.01.026.2008; BUTLER MH, 1993, J EXP MED, V178, P2097, DOI 10.1084/jem.178.6.2097; CELIO MR, 1990, NEUROSCIENCE, V35, P375, DOI 10.1016/0306-4522(90)90091-H; CELIO MR, 1988, CELL CALCIUM, V9, P81, DOI 10.1016/0143-4160(88)90027-9; CHANG YC, 1988, J NEUROSCI, V8, P2123; Chattopadhyaya B, 2007, NEURON, V54, P889, DOI 10.1016/j.neuron.2007.05.015; Chubykin AA, 2007, NEURON, V54, P919, DOI 10.1016/j.neuron.2007.05.029; Cipelletti B, 2002, NEUROSCIENCE, V115, P657, DOI 10.1016/S0306-4522(02)00531-6; COBB SR, 1995, NATURE, V378, P75, DOI 10.1038/378075a0; Cohen-Cory S, 2002, SCIENCE, V298, P770, DOI 10.1126/science.1075510; Cope DW, 2004, NEUROPHARMACOLOGY, V47, P17, DOI 10.1016/j.neuropharm.2004.03.007; Cossart R, 2005, TRENDS NEUROSCI, V28, P108, DOI 10.1016/j.tins.2004.11.011; D'Angelo E, 1998, J NEUROPHYSIOL, V80, P493, DOI 10.1152/jn.1998.80.2.493; ERVASTI JM, 1990, NATURE, V345, P315, DOI 10.1038/345315a0; Essrich C, 1998, NAT NEUROSCI, V1, P563, DOI 10.1038/2798; Fang C, 2006, J NEUROSCI, V26, P12758, DOI 10.1523/JNEUROSCI.4214-06.2006; Ferraguti F, 2004, HIPPOCAMPUS, V14, P193, DOI 10.1002/hipo.10163; Flavell SW, 2008, ANNU REV NEUROSCI, V31, P563, DOI 10.1146/annurev.neuro.31.060407.125631; Freund TF, 2007, NEURON, V56, P33, DOI 10.1016/j.neuron.2007.09.012; Fritschy JM, 2006, J NEUROSCI, V26, P3245, DOI 10.1523/JNEUROSCI.5118-05.2006; GAO B, 1993, NEUROSCIENCE, V54, P881, DOI 10.1016/0306-4522(93)90582-Z; Garbelli R, 2008, J COMP NEUROL, V506, P373, DOI 10.1002/cne.21505; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Gibson JR, 2009, J NEUROSCI, V29, P13883, DOI 10.1523/JNEUROSCI.2457-09.2009; GOLDSTEIN ME, 1983, P NATL ACAD SCI-BIOL, V80, P3101, DOI 10.1073/pnas.80.10.3101; GUNTHER U, 1995, P NATL ACAD SCI USA, V92, P7749, DOI 10.1073/pnas.92.17.7749; Halasy K, 1996, HIPPOCAMPUS, V6, P306, DOI 10.1002/(SICI)1098-1063(1996)6:3<306::AID-HIPO8>3.0.CO;2-K; Hashimoto K, 2009, NEURON, V63, P106, DOI 10.1016/j.neuron.2009.06.008; Haydar TF, 2000, J NEUROSCI, V20, P5764, DOI 10.1523/JNEUROSCI.20-15-05764.2000; Heck N, 2007, CEREB CORTEX, V17, P138, DOI 10.1093/cercor/bhj135; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Homanics GE, 1997, P NATL ACAD SCI USA, V94, P4143, DOI 10.1073/pnas.94.8.4143; Hoon M, 2009, J NEUROSCI, V29, P8039, DOI 10.1523/JNEUROSCI.0534-09.2009; Huang ZJ, 2008, CURR OPIN NEUROBIOL, V18, P77, DOI 10.1016/j.conb.2008.05.008; Huang ZJ, 2006, NAT NEUROSCI, V9, P163, DOI 10.1038/nn1638; Huesa G, 2002, CELL TISSUE RES, V309, P355, DOI 10.1007/s00441-002-0608-x; Jedlicka P, 2011, CEREB CORTEX, V21, P357, DOI 10.1093/cercor/bhq100; Ji FY, 1999, NEUROSCI RES, V33, P187, DOI 10.1016/S0168-0102(99)00011-5; Kash SF, 1997, P NATL ACAD SCI USA, V94, P14060, DOI 10.1073/pnas.94.25.14060; Kerschensteiner D, 2009, NATURE, V460, P1016, DOI 10.1038/nature08236; KIM J, 1993, DIABETES, V42, P1799, DOI 10.2337/diabetes.42.12.1799; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Kralic JE, 2006, J COMP NEUROL, V495, P408, DOI 10.1002/cne.20866; LAURIE DJ, 1992, J NEUROSCI, V12, P4151; Leppa E, 2011, EUR J PHARMACOL, V666, P111, DOI 10.1016/j.ejphar.2011.05.011; Levi S, 2002, J NEUROSCI, V22, P4274, DOI 10.1523/JNEUROSCI.22-11-04274.2002; Li RW, 2005, J NEUROCHEM, V95, P756, DOI 10.1111/j.1471-4159.2005.03426.x; Lichtman JW, 2000, NEURON, V25, P269, DOI 10.1016/S0896-6273(00)80893-4; Liu XX, 2005, NAT NEUROSCI, V8, P1179, DOI 10.1038/nn1522; Lorez Matthias, 2000, Journal of Physiology (Cambridge), V527, P11, DOI 10.1111/j.1469-7793.2000.t01-1-00011.x; LoTurco JJ, 1995, NEURON, V15, P1287, DOI 10.1016/0896-6273(95)90008-X; Luscher B, 2011, NEURON, V70, P385, DOI 10.1016/j.neuron.2011.03.024; Marchionni I, 2009, J PHYSIOL-LONDON, V587, P5691, DOI 10.1113/jphysiol.2009.179945; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Miles R, 1996, NEURON, V16, P815, DOI 10.1016/S0896-6273(00)80101-4; Mu WT, 1999, MOL BRAIN RES, V67, P137, DOI 10.1016/S0169-328X(99)00049-2; Ohtsuki G, 2008, EUR J NEUROSCI, V28, P2393, DOI 10.1111/j.1460-9568.2008.06539.x; Panzanelli P, 2011, J PHYSIOL-LONDON, V589, P4959, DOI 10.1113/jphysiol.2011.216028; Patrizi A, 2008, P NATL ACAD SCI USA, V105, P13151, DOI 10.1073/pnas.0802390105; Pouille F, 2004, NATURE, V429, P717, DOI 10.1038/nature02615; Poulopoulos A, 2009, NEURON, V63, P628, DOI 10.1016/j.neuron.2009.08.023; Represa A, 2005, TRENDS NEUROSCI, V28, P278, DOI 10.1016/j.tins.2005.03.010; Sassoe-Pognetto M, 2011, FRONT CELL NEUROSCI, V5, DOI 10.3389/fncel.2011.00004; Schweizer C, 2003, MOL CELL NEUROSCI, V24, P442, DOI 10.1016/S1044-7431(03)00202-1; Shen K, 2010, ANNU REV NEUROSCI, V33, P473, DOI 10.1146/annurev.neuro.051508.135302; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Somogyi P, 1998, BRAIN RES REV, V26, P113, DOI 10.1016/S0165-0173(97)00061-1; Sudhof TC, 2008, NEURON, V60, P469, DOI 10.1016/j.neuron.2008.10.011; Tamas G, 2004, EUR J NEUROSCI, V20, P2681, DOI 10.1111/j.1460-9568.2004.03719.x; Tamas G, 1997, J PHYSIOL-LONDON, V500, P715, DOI 10.1113/jphysiol.1997.sp022054; Tanaka J, 2000, EUR J NEUROSCI, V12, P781, DOI 10.1046/j.1460-9568.2000.00959.x; Trigo FF, 2010, NEURON, V66, P235, DOI 10.1016/j.neuron.2010.03.030; Varoqueaux F, 2004, EUR J CELL BIOL, V83, P449, DOI 10.1078/0171-9335-00410; Viltono L, 2008, J COMP NEUROL, V508, P579, DOI 10.1002/cne.21713; Wang DD, 2009, J PHYSIOL-LONDON, V587, P1873, DOI 10.1113/jphysiol.2008.167635; Wisden W, 1994, BIOL TECHNIQUES IN S, P9; Wojcik SM, 2006, NEURON, V50, P575, DOI 10.1016/j.neuron.2006.04.016; Wulff P, 2007, NAT NEUROSCI, V10, P923, DOI 10.1038/nn1927; Wulff P, 2009, NAT NEUROSCI, V12, P1042, DOI 10.1038/nn.2348; Wulff P, 2009, P NATL ACAD SCI USA, V106, P3561, DOI 10.1073/pnas.0813176106; Yuan X, 2008, MOL CELL NEUROSCI, V38, P277, DOI 10.1016/j.mcn.2008.03.002	90	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56311	10.1371/journal.pone.0056311	http://dx.doi.org/10.1371/journal.pone.0056311			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457547	Green Published, gold			2022-12-25	WOS:000315602700066
J	Zhi, H; Tang, LH; Xia, YJ; Zhang, JH				Zhi, Hui; Tang, Leihan; Xia, Yiji; Zhang, Jianhua			Ssk1p-Independent Activation of Ssk2p Plays an Important Role in the Osmotic Stress Response in Saccharomyces cerevisiae: Alternative Activation of Ssk2p in Osmotic Stress	PLOS ONE			English	Article							KINASE KINASE KINASE; HOG MAPK PATHWAY; SIGNAL-TRANSDUCTION PATHWAY; ACTIN RECOVERY; GENE DELETION; DOCKING SITE; PBS2 MAPKK; YEAST; OSMOSENSOR; SCAFFOLD	In Saccharomyces cerevisiae, external high osmolarity activates the HOG MAPK pathway, which controls various aspects of osmoregulation. MAPKKK Ssk2 is activated by Ssk1 in the SLN1 branch of the osmoregulatory HOG MAPK pathway under hyperosmotic stress. We observed that Ssk2 can be activated independent of Ssk1 upon osmotic shock by an unidentified mechanism. The domain for the Ssk1p-independent activation was identified to be located between the amino acids 177 similar to 240. This region might be involved in the binding of an unknown regulator to Ssk2 which in turn activates Ssk2p without Ssk1p under hyperosmotic stress. The osmotic stress response through the Ssk1p-independent Ssk2p activation is strong, although its duration is short compared with the Ssk1p-dependent activation. The alternative Ssk2p activation is also important for the salt resistance.	[Zhi, Hui; Xia, Yiji] Hong Kong Baptist Univ, Dept Biol, Hong Kong, Hong Kong, Peoples R China; [Tang, Leihan] Hong Kong Baptist Univ, Dept Phys, Hong Kong, Hong Kong, Peoples R China; [Tang, Leihan] Hong Kong Baptist Univ, Ctr Quantitat Syst Biol, Hong Kong, Hong Kong, Peoples R China; [Zhang, Jianhua] Chinese Univ Hong Kong, Sch Life Sci, Hong Kong, Hong Kong, Peoples R China	Hong Kong Baptist University; Hong Kong Baptist University; Hong Kong Baptist University; Chinese University of Hong Kong	Tang, LH (corresponding author), Hong Kong Baptist Univ, Dept Phys, Hong Kong, Hong Kong, Peoples R China.	lhtang@hkbu.edu.hk; yxia@hkbu.edu.hk; jhzhang@cuhk.edu.hk	Tang, Lei-Han/ABB-3219-2020; Xia, Yiji/GRR-5126-2022	Tang, Lei-Han/0000-0002-2925-4691; Xia, Yiji/0000-0002-9543-8341; Zhang, Jianhua/0000-0002-3819-2437	Hong Kong Baptist University [FSRS/0708/01, SDF080603/P01]; Research Grants Council of the HKSAR [HKBU 201910]	Hong Kong Baptist University; Research Grants Council of the HKSAR(Hong Kong Research Grants Council)	The work was supported in part by the Hong Kong Baptist University through grants FSRS/0708/01 and SDF080603/P01 and by the Research Grants Council of the HKSAR under grant HKBU 201910. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayscough KR, 1997, J CELL BIOL, V137, P399, DOI 10.1083/jcb.137.2.399; BAUDIN A, 1993, NUCLEIC ACIDS RES, V21, P3329, DOI 10.1093/nar/21.14.3329; Bettinger BT, 2007, GENETICS, V175, P1637, DOI 10.1534/genetics.106.063370; Bi E, 1998, J CELL BIOL, V142, P1301, DOI 10.1083/jcb.142.5.1301; BREWSTER JL, 1993, SCIENCE, V259, P1760, DOI 10.1126/science.7681220; Burke D., 2000, METHODS YEAST GENETI, pxvii; Chen RE, 2007, BBA-MOL CELL RES, V1773, P1311, DOI 10.1016/j.bbamcr.2007.05.003; CHOWDHURY S, 1992, J CELL BIOL, V118, P561, DOI 10.1083/jcb.118.3.561; DAVENPORT KR, 1995, J BIOL CHEM, V270, P30157; Ekiel I, 2009, MOL BIOL CELL, V20, P5117, DOI 10.1091/mbc.E09-07-0645; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Gustin MC, 1998, MICROBIOL MOL BIOL R, V62, P1264, DOI 10.1128/MMBR.62.4.1264-1300.1998; Hohmann S, 2002, MICROBIOL MOL BIOL R, V66, P300, DOI 10.1128/MMBR.66.2.300-372.2002; Horie T, 2008, MOL CELL BIOL, V28, P5172, DOI 10.1128/MCB.00589-08; KOSHLAND DE, 1982, SCIENCE, V217, P220, DOI 10.1126/science.7089556; Lamson RE, 2002, MOL CELL BIOL, V22, P2939, DOI 10.1128/MCB.22.9.2939-2951.2002; MAEDA T, 1994, NATURE, V369, P242, DOI 10.1038/369242a0; MAEDA T, 1995, SCIENCE, V269, P554, DOI 10.1126/science.7624781; O'Rourke SM, 2004, MOL BIOL CELL, V15, P532, DOI 10.1091/mbc.E03-07-0521; O'Rourke SM, 2002, TRENDS GENET, V18, P405, DOI 10.1016/S0168-9525(02)02723-3; OTA IM, 1993, SCIENCE, V262, P566, DOI 10.1126/science.8211183; Petrezselyova S, 2010, FUNGAL BIOL-UK, V114, P144, DOI 10.1016/j.funbio.2009.11.002; Porter SW, 2005, BBA-PROTEINS PROTEOM, V1748, P138, DOI 10.1016/j.bbapap.2004.12.009; Porter SW, 2003, EUKARYOT CELL, V2, P27, DOI 10.1128/EC.2.1.27-33.2003; Posas F, 1997, SCIENCE, V276, P1702, DOI 10.1126/science.276.5319.1702; Posas F, 1996, CELL, V86, P865, DOI 10.1016/S0092-8674(00)80162-2; Posas F, 1998, EMBO J, V17, P1385, DOI 10.1093/emboj/17.5.1385; Reiser V, 2003, J CELL BIOL, V161, P1035, DOI 10.1083/jcb.200301099; Tatebayashi K, 2003, EMBO J, V22, P3624, DOI 10.1093/emboj/cdg353; Tatebayashi K, 2007, EMBO J, V26, P3521, DOI 10.1038/sj.emboj.7601796; Tatebayashi K, 2006, EMBO J, V25, P3033, DOI 10.1038/sj.emboj.7601192; van Drogen F, 2000, CURR BIOL, V10, P630, DOI 10.1016/S0960-9822(00)00511-X; Van Wuytswinkel O, 2000, MOL MICROBIOL, V37, P382, DOI 10.1046/j.1365-2958.2000.02002.x; Wach A, 1997, YEAST, V13, P1065, DOI 10.1002/(SICI)1097-0061(19970915)13:11<1065::AID-YEA159>3.3.CO;2-B; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Xu OP, 2003, STRUCTURE, V11, P1569, DOI 10.1016/j.str.2003.10.016; Yamamoto K, 2010, MOL CELL, V40, P87, DOI 10.1016/j.molcel.2010.09.011; Yuzyuk T, 2003, MOL BIOL CELL, V14, P3013, DOI 10.1091/mbc.E02-11-0747; Yuzyuk T, 2002, MOL BIOL CELL, V13, P2869, DOI 10.1091/mbc.02-01-0004	39	38	38	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e54867	10.1371/journal.pone.0054867	http://dx.doi.org/10.1371/journal.pone.0054867			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457455	Green Submitted, Green Published, gold			2022-12-25	WOS:000315602700009
J	Taylor, CR; Hanna, M; Behnke, BJ; Stabley, JN; McCullough, DJ; Davis, RT; Ghosh, P; Papadopoulos, A; Muller-Delp, JM; Delp, MD				Taylor, Curtis R.; Hanna, Mina; Behnke, Bradley J.; Stabley, John N.; McCullough, Danielle J.; Davis, Robert T., III; Ghosh, Payal; Papadopoulos, Anthony; Muller-Delp, Judy M.; Delp, Michael D.			Spaceflight-induced alterations in cerebral artery vasoconstrictor, mechanical, and structural properties: implications for elevated cerebral perfusion and intracranial pressure	FASEB JOURNAL			English	Article						microgravity; brain blood flow; hemodynamics	REGIONAL BLOOD-FLOW; HEAD-DOWN-TILT; SIMULATED MICROGRAVITY; HINDLIMB SUSPENSION; MESENTERIC-ARTERY; CO2 REACTIVITY; AUTOREGULATION; RESPONSIVENESS; RESISTANCE; ADAPTATION	Evidence indicates that cerebral blood flow is both increased and diminished in astronauts on return to Earth. Data from ground-based animal models simulating the effects of microgravity have shown that decrements in cerebral perfusion are associated with enhanced vasoconstriction and structural remodeling of cerebral arteries. Based on these results, the purpose of this study was to test the hypothesis that 13 d of spaceflight [Space Transportation System (STS)-135 shuttle mission] enhances myogenic vasoconstriction, increases medial wall thickness, and elicits no change in the mechanical properties of mouse cerebral arteries. Basilar and posterior communicating arteries (PCAs) were isolated from 9-wk-old female C57BL/6 mice for in vitro vascular and mechanical testing. Contrary to that hypothesized, myogenic vasoconstrictor responses were lower and vascular distensibility greater in arteries from spaceflight group (SF) mice (n = 7) relative to ground-based control group (GC) mice (n = 12). Basilar artery maximal diameter was greater in SF mice (SF: 236 +/- 9 mu m and GC: 215 +/- 5 mu m) with no difference in medial wall thickness (SF: 12.4 +/- 1.6 mu m; GC: 12.2 +/- 1.2 mu m). Stiffness of the PCA, as characterized via nanoindentation, was lower in SF mice (SF: 3.4 +/- 0.3 N/m; GC: 5.4 +/- 0.8 N/m). Collectively, spaceflight-induced reductions in myogenic vasoconstriction and stiffness and increases in maximal diameter of cerebral arteries signify that elevations in brain blood flow may occur during spaceflight. Such changes in cerebral vascular control of perfusion could contribute to increases in intracranial pressure and an associated impairment of visual acuity in astronauts during spaceflight.-Taylor, C. R., Hanna, M., Behnke, B. J., Stabley, J. N., McCullough, D. J., Davis III, R. T., Ghosh, P., Papadopoulos, A., Muller-Delp, J. M., Delp, M. D. Spaceflight-induced alterations in cerebral artery vasoconstrictor, mechanical, and structural properties: implications for elevated cerebral perfusion and intracranial pressure.	[Taylor, Curtis R.; Hanna, Mina] Univ Florida, Dept Mech & Aerosp Engn, Gainesville, FL USA; [Hanna, Mina] Univ Florida, Dept Mat Sci & Engn, Gainesville, FL 32611 USA; [Behnke, Bradley J.; Stabley, John N.; McCullough, Danielle J.; Davis, Robert T., III; Ghosh, Payal; Delp, Michael D.] Univ Florida, Dept Appl Physiol & Kinesiol, Gainesville, FL 32610 USA; [Behnke, Bradley J.; Stabley, John N.; McCullough, Danielle J.; Davis, Robert T., III; Ghosh, Payal; Delp, Michael D.] Univ Florida, Ctr Exercise Sci, Gainesville, FL 32611 USA; [Muller-Delp, Judy M.] Univ Florida, Dept Physiol & Funct Genom, Gainesville, FL USA; [Papadopoulos, Anthony] Texas Tech Univ, Dept Biol Sci, Lubbock, TX 79409 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Texas Tech University System; Texas Tech University	Delp, MD (corresponding author), Univ Florida, Dept Appl Physiol & Kinesiol, Gainesville, FL 32610 USA.	mdelp@ufl.edu	Taylor, Curtis/GWR-1891-2022; Taylor, Curtis/J-6236-2013	Taylor, Curtis/0000-0001-9184-5487; /0000-0002-1825-7846; Delp, Michael/0000-0002-2916-0783; Muller-Delp, Judy/0000-0001-5322-0611	NASA [NNX08AQ62G, NNX09AP06G]; U.S. National Institutes of Health [AG-31317]; Florida Biomedical Research Program [1BN-02]; Department of Applied Physiology and Kinesiology, University of Florida	NASA(National Aeronautics & Space Administration (NASA)); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Florida Biomedical Research Program; Department of Applied Physiology and Kinesiology, University of Florida	These studies were originally flown on space shuttle mission STS-107, on which the orbiter Columbia tragically disintegrated during its return flight to Earth. This article is dedicated to the STS-107 crew, who were willing to risk their lives to advance our understanding of the effects of microgravity on human health. The authors thank Paula Dumars, Marilyn Vasquez, Vera Vizir, Marianne Steele, Richard Boyle, and Ken Souza [U.S. National Aeronautics and Space Administration (NASA) Ames Research Center, Mountain View, CA, USA] and the Life Sciences staff at NASA Kennedy Space Center (Kennedy Space Center, FL, USA) for logistical support; Thomas Wyrobek, Richard Nay, Lance Kuhn, and Amanda Simpson (Hysitron, Minneapolis, MN, USA) and Donna Ebenstein (Bucknell University, Lewisburg, PA, USA) for assistance with nanoindentation experiments; Dr. Olga Tarasova (Moscow State University, Moscow, Russia) for assistance with the Russian cosmonaut literature; and NASA for providing shuttle CO<INF>2</INF> data from the STS-135 mission. This study was supported by grants from NASA (NNX08AQ62G and NNX09AP06G), U.S. National Institutes of Health (AG-31317), and the Florida Biomedical Research Program (1BN-02) and the Jane Adams Edmonds endowed doctoral fellowship (Department of Applied Physiology and Kinesiology, University of Florida).	Aaslid R, 2006, FRONT NEUROL NEUROSC, V21, P216, DOI 10.1159/000092434; Akhtar R, 2009, J MATER RES, V24, P638, DOI 10.1557/JMR.2009.0130; Arbeille P, 1995, ACTA ASTRONAUT, V36, P753, DOI 10.1016/0094-5765(95)00166-2; Arbeille P, 2001, EUR J APPL PHYSIOL, V86, P157, DOI 10.1007/s004210100473; Arbeille P, 1996, MED SCI SPORT EXER, V28, pS70; BAGIAN JP, 1991, J CLIN PHARMACOL, V31, P1036, DOI 10.1002/j.1552-4604.1991.tb03668.x; Behnke BJ, 2008, J APPL PHYSIOL, V104, P1273, DOI 10.1152/japplphysiol.00954.2006; Behnke BJ, 2013, FASEB J, V27, P399, DOI 10.1096/fj.12-218503; Blaber AP, 2011, STROKE, V42, P1844, DOI 10.1161/STROKEAHA.110.610576; Buckey JC, 1996, J APPL PHYSIOL, V81, P19, DOI 10.1152/jappl.1996.81.1.19; Colleran PN, 2008, AM J PHYSIOL-REG I, V294, pR1577, DOI 10.1152/ajpregu.00084.2008; Colleran PN, 2000, J APPL PHYSIOL, V89, P1046, DOI 10.1152/jappl.2000.89.3.1046; DELP MD, 1993, J APPL PHYSIOL, V75, P2620, DOI 10.1152/jappl.1993.75.6.2620; Delp MD, 2000, AM J PHYSIOL-HEART C, V278, pH1866, DOI 10.1152/ajpheart.2000.278.6.H1866; Delp MD, 1999, J APPL PHYSIOL, V86, P1178, DOI 10.1152/jappl.1999.86.4.1178; DESPLANCHES D, 1987, J APPL PHYSIOL, V63, P1739, DOI 10.1152/jappl.1987.63.5.1739; Dunbar SL, 2000, J APPL PHYSIOL, V89, P2073, DOI 10.1152/jappl.2000.89.5.2073; Ebenstein DM, 2004, J BIOMED MATER RES A, V69A, P222, DOI 10.1002/jbm.a.20096; Ebenstein DM, 2004, J MATER RES, V19, P273, DOI 10.1557/jmr.2004.19.1.273; Ebenstein DM, 2009, J BIOMED MATER RES A, V91A, P1028, DOI 10.1002/jbm.a.32321; FARACI FM, 1990, CIRC RES, V66, P8, DOI 10.1161/01.RES.66.1.8; Gashev AA, 2006, AM J PHYSIOL-HEART C, V290, pH2295, DOI 10.1152/ajpheart.00260.2005; Geary GG, 1998, J APPL PHYSIOL, V85, P1615, DOI 10.1152/jappl.1998.85.5.1615; Hargens AR., 1984, PHYSIOLOGIST, V27, pS37; Hatton DC, 2002, J APPL PHYSIOL, V92, P13, DOI 10.1152/jappl.2002.92.1.13; Iwasaki KI, 2007, J PHYSIOL-LONDON, V579, P799, DOI 10.1113/jphysiol.2006.119636; Jain V, 2011, J CEREBR BLOOD F MET, V31, P1504, DOI 10.1038/jcbfm.2011.34; Kondo T, 1999, CHEST, V115, P1402, DOI 10.1378/chest.115.5.1402; Kramer LA, 2012, RADIOLOGY, V263, P819, DOI 10.1148/radiol.12111986; Lakin WD, 2007, AVIAT SPACE ENVIR MD, V78, P932, DOI 10.3357/ASEM.2060.2007; Lin DC, 2008, SOFT MATTER, V4, P669, DOI 10.1039/b714637j; Mader TH, 2011, OPHTHALMOLOGY, V118, P2058, DOI 10.1016/j.ophtha.2011.06.021; Maurel D, 1996, BRAIN RES, V736, P165, DOI 10.1016/0006-8993(96)00676-2; McCurdy MR, 2000, J APPL PHYSIOL, V89, P398, DOI 10.1152/jappl.2000.89.1.398; MCDONALD KS, 1992, J APPL PHYSIOL, V72, P2210, DOI 10.1152/jappl.1992.72.6.2210; MOSKALENKO YE, 1975, AVIAT SPACE ENVIR MD, V46, P1023; NASA, 2012, EVIDENCE REPORT RISK; Oliver WC, 2004, J MATER RES, V19, P3, DOI 10.1557/jmr.2004.19.1.3; OVERTON JM, 1989, J APPL PHYSIOL, V66, P653, DOI 10.1152/jappl.1989.66.2.653; Pourcelot L, 1984, ESA, P119; Powers J, 2004, J APPL PHYSIOL, V97, P1686, DOI 10.1152/japplphysiol.00925.2003; Prisby RD, 2006, J APPL PHYSIOL, V101, P348, DOI 10.1152/japplphysiol.00941.2005; Provost S B, 1992, Physiologist, V35, pS105; Purdy RE, 1998, J APPL PHYSIOL, V85, P1307, DOI 10.1152/jappl.1998.85.4.1307; SANDLER H, 1987, AVIAT SPACE ENVIR MD, V58, P529; Schob OM, 1996, AM J SURG, V172, P248, DOI 10.1016/S0002-9610(96)00101-8; Small SA, 2004, J CLIN INVEST, V114, P1046, DOI 10.1172/JCI200423159; SNEDDON IN, 1948, P CAMB PHILOS SOC, V44, P492, DOI 10.1017/S0305004100024518; Stabley JN, 2012, J APPL PHYSIOL, V113, P1439, DOI 10.1152/japplphysiol.00772.2012; Sun B, 2004, J APPL PHYSIOL, V97, P1022, DOI 10.1152/japplphysiol.00188.2004; Sun GS, 2010, NUTRITION, V26, P1163, DOI 10.1016/j.nut.2009.09.018; Tuday EC, 2007, J APPL PHYSIOL, V102, P853, DOI 10.1152/japplphysiol.00950.2006; Turchaninova V F, 1989, Kosm Biol Aviakosm Med, V23, P19; Ursino M, 1998, AM J PHYSIOL-HEART C, V274, pH1715, DOI 10.1152/ajpheart.1998.274.5.H1715; VASILYEVA TD, 1982, KOSM BIOL AVIAK MED+, V16, P12; Vavilala Monica S, 2002, Anesthesiol Clin North Am, V20, P247, DOI 10.1016/S0889-8537(01)00012-8; WATENPAUGH DE, 1996, HDB PHYSIOL SECT 4, V1, P631; Wilkerson MK, 2005, AM J PHYSIOL-HEART C, V288, pH1652, DOI 10.1152/ajpheart.00925.2004; Wilkerson MK, 2002, AM J PHYSIOL-HEART C, V282, pH328, DOI 10.1152/ajpheart.00727.2001; Wilkerson MK, 1999, J APPL PHYSIOL, V87, P2115, DOI 10.1152/jappl.1999.87.6.2115; Willie CK, 2012, J PHYSIOL-LONDON, V590, P3261, DOI 10.1113/jphysiol.2012.228551; Xue JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019775; YARULLIN KK, 1984, KOSM BIOL AVIAK MED+, V18, P22; Yegorov AD., 1982, IZVESTIYA AKAD NAUK, V4, P485; Zhang LN, 2001, J APPL PHYSIOL, V90, P2296, DOI 10.1152/jappl.2001.90.6.2296; Zhang R, 1997, J APPL PHYSIOL, V83, P2139, DOI 10.1152/jappl.1997.83.6.2139; Zuj KA, 2012, AM J PHYSIOL-HEART C, V302, pH2592, DOI 10.1152/ajpheart.00029.2012	67	62	66	0	27	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2013	27	6					2282	2292		10.1096/fj.12-222687	http://dx.doi.org/10.1096/fj.12-222687			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	154II	23457215	Green Published			2022-12-25	WOS:000319667600018
J	Eren, E; Parkin, J; Adelanwa, A; Cheneke, B; Movileanu, L; Khalid, S; van den Berg, B				Eren, Elif; Parkin, Jamie; Adelanwa, Ayodele; Cheneke, Belete; Movileanu, Liviu; Khalid, Syma; van den Berg, Bert			Toward Understanding the Outer Membrane Uptake of Small Molecules by Pseudomonas aeruginosa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GRAM-NEGATIVE BACTERIA; AUTOMATED DOCKING; EFFLUX PUMPS; ACINETOBACTER-BAUMANNII; MULTIDRUG-RESISTANCE; DYNAMICS SIMULATIONS; CRYSTAL-STRUCTURES; ESCHERICHIA-COLI; FORCE-FIELD; CHANNEL	Because small molecules enter Gram-negative bacteria via outer membrane (OM) channels, understanding OM transport is essential for the rational design of improved and new antibiotics. In the human pathogen Pseudomonas aeruginosa, most small molecules are taken up by outer membrane carboxylate channel (Occ) proteins, which can be divided into two distinct subfamilies, OccD and OccK. Here we characterize substrate transport mediated by Occ proteins belonging to both subfamilies. Based on the determination of the OccK2-glucuronate co-crystal structure, we identify the channel residues that are essential for substrate transport. We further show that the pore regions of the channels are rigid in the OccK subfamily and highly dynamic in the OccD subfamily. We also demonstrate that the substrate carboxylate group interacts with central residues of the basic ladder, a row of arginine and lysine residues that leads to and away from the binding site at the channel constriction. Moreover, the importance of the basic ladder residues corresponds to their degree of conservation. Finally, we apply the generated insights by converting the archetype of the entire family, OccD1, from a basic amino acid-specific channel into a channel with a preference for negatively charged amino acids.	[Eren, Elif; Adelanwa, Ayodele; van den Berg, Bert] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; [Parkin, Jamie; Khalid, Syma] Univ Southampton, Sch Chem, Syst & Synthet Biol Modelling Grp, Southampton SO17 1BJ, Hants, England; [Cheneke, Belete; Movileanu, Liviu] Syracuse Univ, Dept Phys, Syracuse, NY 13244 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Southampton; Syracuse University	van den Berg, B (corresponding author), Newcastle Univ, Sch Med, Inst Cellular & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	bert.van-den-berg@ncl.ac.uk		van den Berg, Bert/0000-0003-1966-8804; Eren, Elif/0000-0002-7942-4943	National Institutes of Health [R01 GM088403, R01 GM085785]; National Science Foundation [DMR-1006332]; EPSRC [EP/L000253/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [1094646, EP/L000253/1] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085785, R01GM088403] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM088403 (to L. M.) and R01 GM085785 (to B. v. d. B.). This work was also supported by National Science Foundation Grant DMR-1006332 (to L. M.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Berendsen HJC, 1981, INTERMOLECULAR FORCE, P331, DOI [DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658-1_21]; Biswas S, 2008, STRUCTURE, V16, P1027, DOI 10.1016/j.str.2008.04.009; Biswas S, 2007, NAT STRUCT MOL BIOL, V14, P1108, DOI 10.1038/nsmb1304; Bolla JM, 2011, FEBS LETT, V585, P1682, DOI 10.1016/j.febslet.2011.04.054; Bou G, 2010, J AM CHEM SOC, V132, P13320, DOI 10.1021/ja104092z; Breidenstein EBM, 2011, TRENDS MICROBIOL, V19, P419, DOI 10.1016/j.tim.2011.04.005; Cheneke BR, 2011, BIOCHEMISTRY-US, V50, P4987, DOI 10.1021/bi200454j; Delcour AH, 2009, BBA-PROTEINS PROTEOM, V1794, P808, DOI 10.1016/j.bbapap.2008.11.005; Dutzler R, 1996, STRUCTURE, V4, P127, DOI 10.1016/S0969-2126(96)00016-0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eren E, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001242; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Webb Benjamin, 2016, Curr Protoc Bioinformatics, V54, DOI [10.1002/0471140864.ps0209s50, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/cpbi.3]; FUKUOKA T, 1991, ANTIMICROB AGENTS CH, V35, P529, DOI 10.1128/AAC.35.3.529; Goo KS, 2011, CURR COMPUT-AID DRUG, V7, P53, DOI 10.2174/157340911793743538; GOODSELL DS, 1990, PROTEINS, V8, P195, DOI 10.1002/prot.340080302; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hess B, 2008, J CHEM THEORY COMPUT, V4, P116, DOI 10.1021/ct700200b; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Huang HJ, 1996, J BACTERIOL, V178, P3085, DOI 10.1128/jb.178.11.3085-3090.1996; Huey R, 2007, J COMPUT CHEM, V28, P1145, DOI 10.1002/jcc.20634; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Khalid S, 2008, BBA-BIOMEMBRANES, V1778, P1871, DOI 10.1016/j.bbamem.2007.05.024; Kukol A, 2009, J CHEM THEORY COMPUT, V5, P615, DOI 10.1021/ct8003468; Kumar A, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/45/454125; Laskowski RA, 1997, TRENDS BIOCHEM SCI, V22, P488, DOI 10.1016/S0968-0004(97)01140-7; Laskowski RA, 2001, NUCLEIC ACIDS RES, V29, P221, DOI 10.1093/nar/29.1.221; Lister PD, 2009, CLIN MICROBIOL REV, V22, P582, DOI 10.1128/CMR.00040-09; Liu JM, 2012, BIOCHEMISTRY-US, V51, P2319, DOI 10.1021/bi300066w; Lou HB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025825; Mahendran KR, 2010, J BIOMOL SCREEN, V15, P302, DOI 10.1177/1087057109357791; Mesaros N, 2007, CLIN MICROBIOL INFEC, V13, P560, DOI 10.1111/j.1469-0691.2007.01681.x; Morris GM, 1996, J COMPUT AID MOL DES, V10, P293, DOI 10.1007/BF00124499; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Nestorovich EM, 2002, P NATL ACAD SCI USA, V99, P9789, DOI 10.1073/pnas.152206799; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; Nikaido H, 2012, FEMS MICROBIOL REV, V36, P340, DOI 10.1111/j.1574-6976.2011.00290.x; Nikaido H, 2009, BBA-PROTEINS PROTEOM, V1794, P769, DOI 10.1016/j.bbapap.2008.10.004; NOSE S, 1984, J CHEM PHYS, V81, P511, DOI 10.1063/1.447334; NOSE S, 1983, MOL PHYS, V50, P1055, DOI 10.1080/00268978300102851; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pages JM, 2008, NAT REV MICROBIOL, V6, P893, DOI 10.1038/nrmicro1994; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Pongprayoon P, 2009, P NATL ACAD SCI USA, V106, P21614, DOI 10.1073/pnas.0907315106; Prilipov A, 1998, FEMS MICROBIOL LETT, V163, P65, DOI 10.1111/j.1574-6968.1998.tb13027.x; Schmid N, 2011, EUR BIOPHYS J BIOPHY, V40, P843, DOI 10.1007/s00249-011-0700-9; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Symmons MF, 2009, P NATL ACAD SCI USA, V106, P7173, DOI 10.1073/pnas.0900693106; Tamber S, 2006, J BACTERIOL, V188, P45, DOI 10.1128/JB.188.1.45-54.2006; TRIAS J, 1990, ANTIMICROB AGENTS CH, V34, P52, DOI 10.1128/AAC.34.1.52; van den Berg B, 2010, CHEMBIOCHEM, V11, P1339, DOI 10.1002/cbic.201000105; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Vila J, 2007, J ANTIMICROB CHEMOTH, V59, P1210, DOI 10.1093/jac/dkl509; Wang YF, 1997, J MOL BIOL, V272, P56, DOI 10.1006/jmbi.1997.1224; Ziervogel BK, 2013, STRUCTURE, V21, P76, DOI 10.1016/j.str.2012.10.014	59	44	44	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2013	288	17					12042	12053		10.1074/jbc.M113.463570	http://dx.doi.org/10.1074/jbc.M113.463570			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	133RP	23467408	hybrid, Green Published			2022-12-25	WOS:000318157600038
J	Korytowski, W; Pilat, A; Schmitt, JC; Girotti, AW				Korytowski, Witold; Pilat, Anna; Schmitt, Jared C.; Girotti, Albert W.			Deleterious Cholesterol Hydroperoxide Trafficking in Steroidogenic Acute Regulatory (StAR) Protein-expressing MA-10 Leydig Cells IMPLICATIONS FOR OXIDATIVE STRESS-IMPAIRED STEROIDOGENESIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BENZODIAZEPINE RECEPTOR; GLUTATHIONE-PEROXIDASE; INTERMEMBRANE TRANSFER; TUMOR-CELLS; TRANSPORT; MITOCHONDRIA; MECHANISMS; OXYSTEROLS; INDUCTION; MEMBRANES	Steroidogenic acute regulatory (StAR) proteins in steroidogenic cells are implicated in the delivery of cholesterol (Ch) from internal or external sources to mitochondria (Mito) for initiation of steroid hormone synthesis. In this study, we tested the hypothesis that under oxidative stress, StAR-mediated trafficking of redox-active cholesterol hydroperoxides (ChOOHs) can result in site-specific Mito damage and dysfunction. Steroidogenic stimulation of mouse MA-10 Leydig cells with dibutyryl-cAMP (Bt(2)cAMP) resulted in strong expression of StarD1 and StarD4 proteins over insignificant levels in nonstimulated controls. During incubation with the ChOOH 3 beta-hydroxycholest-5-ene-7 alpha-hydroperoxide (7 alpha-OOH) in liposomes, stimulated cells took up substantially more hydroperoxide in Mito than controls, with a resulting loss of membrane potential (Delta Psi(m)) and ability to drive progesterone synthesis. 7 alpha-OOH uptake and Delta Psi(m) loss were greatly reduced by StarD1 knockdown, thus establishing the role of this protein in 7 alpha-OOH delivery. Moreover, 7 alpha-OOH was substantially more toxic to stimulated than nonstimulated cells, the former dying mainly by apoptosis and the latter dying by necrosis. Importantly, tert-butyl hydroperoxide, which is not a StAR protein ligand, was equally toxic to stimulated and nonstimulated cells. These findings support the notion that like Ch itself, 7 alpha-OOH can be transported to/into Mito of steroidogenic cells by StAR proteins and therein induce free radical damage, which compromises steroid hormone synthesis.	[Korytowski, Witold; Pilat, Anna; Schmitt, Jared C.; Girotti, Albert W.] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA; [Korytowski, Witold; Pilat, Anna] Jagiellonian Univ, Dept Biophys, Fac Biochem Biophys & Biotechnol, PL-30387 Krakow, Poland	Medical College of Wisconsin; Jagiellonian University	Korytowski, W (corresponding author), Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA.	witekkor@mcw.edu; agirotti@mcw.edu	Girotti, Albert/AAF-6910-2020		National Institutes of Health [HL85677]; Polish National Science Center [2011/01/B/NZ3/02167]; Medical College of Wisconsin Research Affairs Committee [3726]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085677] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Polish National Science Center; Medical College of Wisconsin Research Affairs Committee; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL85677 (to A. W. G.) and by Polish National Science Center Grant 2011/01/B/NZ3/02167 and Medical College of Wisconsin Research Affairs Committee Grant 3726 (to W. K.).	Abidi P, 2008, J ENDOCRINOL, V198, P193, DOI 10.1677/JOE-07-0570; Ariyoshi K, 2002, FREE RADICAL RES, V36, P661, DOI 10.1080/10715760290029100; ASCOLI M, 1981, ENDOCRINOLOGY, V108, P88, DOI 10.1210/endo-108-1-88; Astort F, 2009, DIABETES-METAB RES, V25, P477, DOI 10.1002/dmrr.978; AZHAR S, 1995, J CLIN INVEST, V96, P1414, DOI 10.1172/JCI118177; Bhowmick R, 2010, FREE RADICAL BIO MED, V48, P1296, DOI 10.1016/j.freeradbiomed.2010.01.040; Chen H, 2008, ENDOCRINOLOGY, V149, P2612, DOI 10.1210/en.2007-1245; Chen HL, 2009, MOL CELL ENDOCRINOL, V306, P9, DOI 10.1016/j.mce.2009.01.023; CLARK BJ, 1995, MOL ENDOCRINOL, V9, P1346, DOI 10.1210/me.9.10.1346; Connelly MA, 2003, TRENDS ENDOCRIN MET, V14, P467, DOI 10.1016/j.tem.2003.10.002; Culty M, 2002, J ANDROL, V23, P439; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Diemer T, 2003, ENDOCRINOLOGY, V144, P2882, DOI 10.1210/en.2002-0090; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Fluiter K, 1999, J BIOL CHEM, V274, P8893, DOI 10.1074/jbc.274.13.8893; Girotti AW, 2008, FREE RADICAL BIO MED, V44, P956, DOI 10.1016/j.freeradbiomed.2007.12.004; Girotti AW, 1998, J LIPID RES, V39, P1529; Girotti AW, 2000, METHOD ENZYMOL, V319, P85; Girotti AW, 2002, STEROLS OXYSTEROLS C, P121; Hales DB, 1999, ENDOCRINE, V10, P201, DOI 10.1007/BF02738619; HALLIWELL B, 1990, METHOD ENZYMOL, V186, P1; Hauet T, 2005, MOL ENDOCRINOL, V19, P540, DOI 10.1210/me.2004-0307; Imai H, 2003, FREE RADICAL BIO MED, V34, P145, DOI 10.1016/S0891-5849(02)01197-8; Kallen CB, 1998, J BIOL CHEM, V273, P26285, DOI 10.1074/jbc.273.41.26285; KODAMAN PH, 1994, ENDOCRINOLOGY, V135, P2723, DOI 10.1210/en.135.6.2723; Korytowski W, 1996, BIOCHEMISTRY-US, V35, P8670, DOI 10.1021/bi960522k; Korytowski W, 1999, METHOD ENZYMOL, V300, P23; KORYTOWSKI W, 1991, ANAL BIOCHEM, V197, P149, DOI 10.1016/0003-2697(91)90371-Y; Korytowski W, 2010, BIOCHEM BIOPH RES CO, V392, P58, DOI 10.1016/j.bbrc.2009.12.165; Kraemer FB, 2002, J LIPID RES, V43, P1585, DOI 10.1194/jlr.R200009-JLR200; Kriska T, 2006, J BIOL CHEM, V281, P23643, DOI 10.1074/jbc.M600744200; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Luo LD, 2006, J ANDROL, V27, P240, DOI 10.2164/jandrol.05075; MAYER LD, 1986, BIOCHIM BIOPHYS ACTA, V858, P161, DOI 10.1016/0005-2736(86)90302-0; Midzak AS, 2009, MOL CELL ENDOCRINOL, V299, P23, DOI 10.1016/j.mce.2008.07.016; Miller WL, 2007, BBA-MOL CELL BIOL L, V1771, P663, DOI 10.1016/j.bbalip.2007.02.012; Miller WL, 2007, MOL ENDOCRINOL, V21, P589, DOI 10.1210/me.2006-0303; MILLER WL, 1988, ENDOCR REV, V9, P295, DOI 10.1210/edrv-9-3-295; Payne AH, 2004, ENDOCR REV, V25, P947, DOI 10.1210/er.2003-0030; PORTER NA, 1995, LIPIDS, V30, P277, DOI 10.1007/BF02536034; PRADELLES P, 1985, ANAL CHEM, V57, P1170, DOI 10.1021/ac00284a003; Reers M, 1995, METHOD ENZYMOL, V260, P406, DOI 10.1016/0076-6879(95)60154-6; Rodriguez-Agudo D, 2005, J LIPID RES, V46, P1615, DOI 10.1194/jlr.M400501-JLR200; Rodriguez-Agudo D, 2008, J LIPID RES, V49, P1409, DOI 10.1194/jlr.M700537-JLR200; Rone MB, 2009, BBA-MOL CELL BIOL L, V1791, P646, DOI 10.1016/j.bbalip.2009.03.001; Schulze-Osthoff K, 1998, EUR J BIOCHEM, V254, P439, DOI 10.1046/j.1432-1327.1998.2540439.x; Smith RAJ, 2010, ANN NY ACAD SCI, V1201, P96, DOI 10.1111/j.1749-6632.2010.05627.x; Soccio RE, 2004, ARTERIOSCL THROM VAS, V24, P1150, DOI 10.1161/01.ATV.0000131264.66417.d5; Soccio RE, 2003, J BIOL CHEM, V278, P22183, DOI 10.1074/jbc.R300003200; SPECTOR DL, 1997, CELLS LAB MANUAL, V1; Steinberg D, 2002, CIRCULATION, V105, P2107, DOI 10.1161/01.CIR.0000014762.06201.06; STOCCO DM, 1988, BIOCHEM J, V249, P95, DOI 10.1042/bj2490095; THOMAS JP, 1990, J BIOL CHEM, V265, P454; Tsujishita Y, 2000, NAT STRUCT BIOL, V7, P408; Papp LV, 2007, ANTIOXID REDOX SIGN, V9, P775, DOI 10.1089/ars.2007.1528; Vila A, 2004, BIOCHEMISTRY-US, V43, P12592, DOI 10.1021/bi0491200; Vila A, 2002, BIOCHEMISTRY-US, V41, P13705, DOI 10.1021/bi026467z; Vila A, 2001, BIOCHEMISTRY-US, V40, P14715, DOI 10.1021/bi011408r; Wang XJ, 2002, MOL CELL ENDOCRINOL, V188, P55, DOI 10.1016/S0303-7207(01)00748-1; Yoshioka N, 2005, FREE RADICAL RES, V39, P299, DOI 10.1080/10715760400023002; Zirkin BR, 2000, BIOL REPROD, V63, P977, DOI 10.1095/biolreprod63.4.977	61	18	20	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2013	288	16					11509	11519		10.1074/jbc.M113.452151	http://dx.doi.org/10.1074/jbc.M113.452151			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	130KW	23467407	Green Published, hybrid			2022-12-25	WOS:000317915500057
J	Hubbi, ME; Hu, HX; Kshitiz; Ahmed, I; Levchenko, A; Semenza, GL				Hubbi, Maimon E.; Hu, Hongxia; Kshitiz; Ahmed, Ishrat; Levchenko, Andre; Semenza, Gregg L.			Chaperone-mediated Autophagy Targets Hypoxia-inducible Factor-1 alpha (HIF-1 alpha) for Lysosomal Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL ACTIVITY; PYRUVATE-KINASE; FACTOR 1-ALPHA; HIF-ALPHA; EXPRESSION; GENE; PROTEIN; GROWTH; TRANSACTIVATION; INHIBITOR	Hypoxia-inducible factor-1 (HIF-1) is a heterodimeric transcription factor that mediates adaptive responses to hypoxia. We demonstrate that lysosomal degradation of the HIF-1 alpha subunit by chaperone-mediated autophagy (CMA) is a major regulator of HIF-1 activity. Pharmacological inhibitors of lysosomal degradation, such as bafilomycin and chloroquine, increased HIF-1 alpha levels and HIF-1 activity, whereas activators of chaper-one-mediated autophagy, including 6-aminonicotinamide and nutrient starvation, decreased HIF-1 alpha levels and HIF-1 activity. In contrast, macroautophagy inhibitors did not increase HIF-1 activity. Transcription factor EB, a master regulator of lysosomal biogenesis, also negatively regulated HIF-1 activity. HIF-1 alpha interacts with HSC70 and LAMP2A, which are core components of the CMA machinery. Overexpression of HSC70 or LAMP2A decreased HIF-1 alpha protein levels, whereas knockdown had the opposite effect. Finally, hypoxia increased the transcription of genes involved in CMA and lysosomal biogenesis in cancer cells. Thus, pharmacological and genetic approaches identify CMA as a major regulator of HIF-1 activity and identify interplay between autophagy and the response to hypoxia.	[Hubbi, Maimon E.; Hu, Hongxia; Kshitiz; Levchenko, Andre; Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, Vasc Program, Inst Cell Engn, Baltimore, MD 21205 USA; [Hubbi, Maimon E.; Hu, Hongxia; Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA; [Hu, Hongxia] Johns Hopkins Univ, Sch Med, Predoctoral Training Program Human Genet, Baltimore, MD 21205 USA; [Kshitiz; Levchenko, Andre] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA; [Ahmed, Ishrat] Johns Hopkins Univ, Sch Med, Med Scientist Training Program, Baltimore, MD 21205 USA; [Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; [Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; [Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, Dept Radiat Oncol, Baltimore, MD 21205 USA; [Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Semenza, GL (corresponding author), Johns Hopkins Univ, Sch Med, Vasc Program, Inst Cell Engn, Baltimore, MD 21205 USA.	gsemenza@jhmi.edu	Kz, Kshitiz/I-3657-2013; Kz, Kshitiz/B-9143-2013; Hu, Hongxia/Q-7765-2016	Kz, Kshitiz/0000-0003-4241-9427; Kz, Kshitiz/0000-0003-4241-9427; Hubbi, Maimon/0000-0001-9763-287X	National Institutes of Health from the United States Public Health Service [N01-HV28180, HHS-N268201000032c]; Johns Hopkins Institute for Cell Engineering and Dean's Research Funding; American Heart Association Predoctoral Fellowship [10PRE4160120]; DIVISION OF HEART AND VASCULAR DISEASES [N01HV028180] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007814] Funding Source: NIH RePORTER	National Institutes of Health from the United States Public Health Service; Johns Hopkins Institute for Cell Engineering and Dean's Research Funding; American Heart Association Predoctoral Fellowship(American Heart Association); DIVISION OF HEART AND VASCULAR DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Contracts N01-HV28180 and HHS-N268201000032c from the United States Public Health Service. This work was also supported by the Johns Hopkins Institute for Cell Engineering and Dean's Research Funding and American Heart Association Predoctoral Fellowship 10PRE4160120.	Argani P, 2005, CLIN LAB MED, V25, P363, DOI 10.1016/j.cll.2005.01.008; Baek JH, 2007, J BIOL CHEM, V282, P33358, DOI 10.1074/jbc.M705627200; Baek JH, 2007, J BIOL CHEM, V282, P23572, DOI 10.1074/jbc.M703504200; Bruick RK, 2000, P NATL ACAD SCI USA, V97, P9082, DOI 10.1073/pnas.97.16.9082; Chaturvedi P, 2013, J CLIN INVEST, V123, P189, DOI 10.1172/JCI64993; CHIANG HL, 1989, SCIENCE, V246, P382, DOI 10.1126/science.2799391; Cuervo AM, 1996, SCIENCE, V273, P501, DOI 10.1126/science.273.5274.501; Dice J., 2000, MOL BIOL INTELLIGENC; Dohi E, 2012, NEUROCHEM INT, V60, P431, DOI 10.1016/j.neuint.2012.01.020; EBERT BL, 1995, J BIOL CHEM, V270, P29083, DOI 10.1074/jbc.270.49.29083; EKSTROM P, 1984, J NEUROCHEM, V43, P1342, DOI 10.1111/j.1471-4159.1984.tb05392.x; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Finn PE, 2005, AUTOPHAGY, V1, P141, DOI 10.4161/auto.1.3.2000; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Foxler DE, 2012, NAT CELL BIOL, V14, P201, DOI 10.1038/ncb2424; Fujiwara Y, 2013, AUTOPHAGY, V9, P403, DOI 10.4161/auto.23002; Hubbi ME, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003417; Hubbi ME, 2012, J BIOL CHEM, V287, P6139, DOI 10.1074/jbc.M111.278630; Hubbi ME, 2011, MOL CELL, V42, P700, DOI 10.1016/j.molcel.2011.03.029; Hundeshagen P, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-38; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jiang BH, 1997, J BIOL CHEM, V272, P19253, DOI 10.1074/jbc.272.31.19253; Kaushik S, 2011, J CELL SCI, V124, P495, DOI 10.1242/jcs.073874; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Koh MY, 2008, MOL CELL BIOL, V28, P7081, DOI 10.1128/MCB.00773-08; Kon M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003182; KONECKI DS, 1995, BIOCHEM BIOPH RES CO, V215, P757, DOI 10.1006/bbrc.1995.2528; Kshitiz, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003002; Lando D, 2002, GENE DEV, V16, P1466, DOI 10.1101/gad.991402; Lando D, 2002, SCIENCE, V295, P858, DOI 10.1126/science.1068592; Lee K, 2009, P NATL ACAD SCI USA, V106, P17910, DOI 10.1073/pnas.0909353106; Lin J, 2012, IUBMB LIFE, V64, P921, DOI 10.1002/iub.1089; Liu YV, 2007, J BIOL CHEM, V282, P37064, DOI 10.1074/jbc.M705015200; Liu YV, 2007, MOL CELL, V25, P207, DOI 10.1016/j.molcel.2007.01.001; Luo WB, 2011, CELL, V145, P732, DOI 10.1016/j.cell.2011.03.054; Luo WB, 2010, J BIOL CHEM, V285, P3651, DOI 10.1074/jbc.M109.068577; Lv L, 2011, MOL CELL, V42, P719, DOI 10.1016/j.molcel.2011.04.025; Montagner M, 2012, NATURE, V487, P380, DOI 10.1038/nature11207; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; Patel SA, 2008, CELL DEATH DIFFER, V15, P628, DOI 10.1038/cdd.2008.17; Pena-Llopis S, 2011, EMBO J, V30, P3242, DOI 10.1038/emboj.2011.257; Platz EA, 2011, CANCER DISCOV, V1, P68, DOI 10.1158/2159-8274.CD-10-0020; Rubinsztein DC, 2007, NAT REV DRUG DISCOV, V6, P304, DOI 10.1038/nrd2272; Sardiello M, 2009, SCIENCE, V325, P473, DOI 10.1126/science.1174447; Schito L, 2012, P NATL ACAD SCI USA, V109, pE2707, DOI 10.1073/pnas.1214019109; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; SEMENZA GL, 1992, MOL CELL BIOL, V12, P5447, DOI 10.1128/MCB.12.12.5447; Semenza GL, 1996, J BIOL CHEM, V271, P32529, DOI 10.1074/jbc.271.51.32529; Semenza GL, 2009, PHYSIOLOGY, V24, P97, DOI 10.1152/physiol.00045.2008; Settembre C, 2011, SCIENCE, V332, P1429, DOI 10.1126/science.1204592; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wong CCL, 2012, J MOL MED, V90, P803, DOI 10.1007/s00109-011-0855-y; Yu AY, 1999, J CLIN INVEST, V103, P691, DOI 10.1172/JCI5912; Yu F, 2001, P NATL ACAD SCI USA, V98, P9630, DOI 10.1073/pnas.181341498; Zhang H, 2012, ONCOGENE, V31, P1757, DOI 10.1038/onc.2011.365; Zhang HF, 2008, J BIOL CHEM, V283, P10892, DOI 10.1074/jbc.M800102200; Zhang HF, 2008, P NATL ACAD SCI USA, V105, P19579, DOI 10.1073/pnas.0809763105; Zhong H, 1999, CANCER RES, V59, P5830	60	161	167	0	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2013	288	15					10703	10714		10.1074/jbc.M112.414771	http://dx.doi.org/10.1074/jbc.M112.414771			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	125TU	23457305	hybrid, Green Published			2022-12-25	WOS:000317565000048
J	Lang, XE; Wang, X; Zhang, KR; Lv, JY; Jin, JH; Li, QS				Lang, Xiao-E; Wang, Xiong; Zhang, Ke-Rang; Lv, Ji-Yuan; Jin, Jian-Hua; Li, Qing-Shan			Isoflurane Preconditioning Confers Cardioprotection by Activation of ALDH2	PLOS ONE			English	Article							PROTEIN-KINASE-C; MYOCARDIAL INFARCT SIZE; ISCHEMIA-REPERFUSION INJURY; K-ATP CHANNELS; CARDIAC PROTECTION; PKC-EPSILON; ALDEHYDE DEHYDROGENASE; RABBIT CARDIOMYOCYTES; FREE-RADICALS; CELL INJURY	The volatile anesthetic, isoflurane, protects the heart from ischemia/reperfusion (I/R) injury. Aldehyde dehydrogenase 2 (ALDH2) is thought to be an endogenous mechanism against ischemia-reperfusion injury possibly through detoxification of toxic aldehydes. We investigated whether cardioprotection by isoflurane depends on activation of ALDH2. Anesthetized rats underwent 40 min of coronary artery occlusion followed by 120 min of reperfusion and were randomly assigned to the following groups: untreated controls, isoflurane preconditioning with and without an ALDH2 inhibitor, the direct activator of ALDH2 or a protein kinase C (PKC epsilon) inhibitor. Pretreatment with isoflurane prior to ischemia reduced LDH and CK-MB levels and infarct size, while it increased phosphorylation of ALDH2, which could be blocked by the ALDH2 inhibitor, cyanamide. Isolated neonatal cardiomyocytes were treated with hypoxia followed by reoxygenation. Hypoxia/reoxygenation (H/R) increased cardiomyocyte apoptosis and injury which were attenuated by isoflurane and forced the activation of ALDH2. In contrast, the effect of isoflurane-induced protection was almost abolished by knockdown of ALDH2. Activation of ALDH2 and cardioprotection by isoflurane were substantially blocked by the PKC epsilon inhibitor. Activation of ALDH2 by mitochondrial PKC epsilon plays an important role in the cardioprotection of isoflurane in myocardium I/R injury.	[Lang, Xiao-E; Wang, Xiong; Lv, Ji-Yuan] Shanxi Med Univ, Clin Med Coll 1, Dept Cardiol, Taiyuan, Shanxi, Peoples R China; [Zhang, Ke-Rang] Shanxi Med Univ, Clin Med Coll 1, Dept Psychiat, Taiyuan, Shanxi, Peoples R China; [Jin, Jian-Hua] Shanxi Med Univ, Clin Med Coll 1, Dept Nucl Med, Taiyuan, Shanxi, Peoples R China; [Li, Qing-Shan] Shanxi Med Univ, Sch Pharmaceut Sci, Taiyuan, Shanxi, Peoples R China	Shanxi Medical University; Shanxi Medical University; Shanxi Medical University; Shanxi Medical University	Lang, XE (corresponding author), Shanxi Med Univ, Clin Med Coll 1, Dept Cardiol, Taiyuan, Shanxi, Peoples R China.	langxiaoe2007@126.com			National Natural Science Foundation of China [81172938]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study is supported by National Natural Science Foundation of China (81172938). The funder's website is www.nsfc.gov.cn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baines CP, 2002, CIRC RES, V90, P390, DOI 10.1161/01.RES.0000012702.90501.8D; Bian Y, 2010, TOHOKU J EXP MED, V221, P107, DOI 10.1620/tjem.221.107; Bouwman RA, 2010, EUR J PHARMACOL, V647, P132, DOI 10.1016/j.ejphar.2010.08.014; Budas GR, 2010, CARDIOVASC RES, V88, P83, DOI 10.1093/cvr/cvq154; Budas GR, 2010, J MOL CELL CARDIOL, V48, P757, DOI 10.1016/j.yjmcc.2009.10.030; Cason BA, 1997, ANESTHESIOLOGY, V87, P1182, DOI 10.1097/00000542-199711000-00023; Chen CH, 2008, SCIENCE, V321, P1493, DOI 10.1126/science.1158554; Chen CH, 2010, CARDIOVASC RES, V88, P51, DOI 10.1093/cvr/cvq192; Churchill EN, 2009, J MOL CELL CARDIOL, V46, P278, DOI 10.1016/j.yjmcc.2008.09.713; Cortinez G, 2009, ALCOHOL, V43, P97, DOI 10.1016/j.alcohol.2008.12.007; De Hert SG, 2002, ANESTHESIOLOGY, V97, P42, DOI 10.1097/00000542-200207000-00007; de Peppo AP, 1999, ANN THORAC SURG, V68, P112, DOI 10.1016/S0003-4975(99)00466-X; Dorn GW, 1999, P NATL ACAD SCI USA, V96, P12798, DOI 10.1073/pnas.96.22.12798; Endo J, 2009, CIRC RES, V105, P1118, DOI 10.1161/CIRCRESAHA.109.206607; Fliss H, 1996, CIRC RES, V79, P949, DOI 10.1161/01.RES.79.5.949; GOTTLIEB RA, 1994, J CLIN INVEST, V94, P1621, DOI 10.1172/JCI117504; Hu ZY, 2009, ANAESTH INTENS CARE, V37, P532, DOI 10.1177/0310057X0903700402; Keeley EC, 2003, LANCET, V361, P13, DOI 10.1016/S0140-6736(03)12113-7; Kersten JR, 1996, ANESTHESIOLOGY, V85, P794, DOI 10.1097/00000542-199610000-00015; Kersten JR, 1997, ANESTHESIOLOGY, V87, P361, DOI 10.1097/00000542-199708000-00024; Kimura M, 2006, ALCOHOL ALCOHOLISM, V41, P368, DOI 10.1093/alcalc/agl028; Lagranha CJ, 2010, CIRC RES, V106, P1681, DOI 10.1161/CIRCRESAHA.109.213645; Lamberts RR, 2009, CIRCULATION, V120, pS10, DOI 10.1161/CIRCULATIONAHA.108.828426; Li SY, 2006, J MOL CELL CARDIOL, V40, P283, DOI 10.1016/j.yjmcc.2005.11.006; Liu GS, 1999, J MOL CELL CARDIOL, V31, P1937, DOI 10.1006/jmcc.1999.1026; Ljubkovic M, 2007, AM J PHYSIOL-CELL PH, V292, pC1583, DOI 10.1152/ajpcell.00221.2006; Ma H, 2011, EUR HEART J, V32, P1025, DOI 10.1093/eurheartj/ehq253; Meldrum DR, 1998, CIRCULATION, V98, pII214; Mio Y, 2008, ANESTHESIOLOGY, V108, P612, DOI 10.1097/ALN.0b013e318167af2d; Mullenheim J, 2002, ANESTHESIOLOGY, V96, P934; MURRY CE, 1986, CIRCULATION, V74, P1124, DOI 10.1161/01.CIR.74.5.1124; Novalija E, 2003, ANESTHESIOLOGY, V99, P421, DOI 10.1097/00000542-200308000-00024; Obal D, 2005, BRIT J ANAESTH, V94, P166, DOI 10.1093/bja/aei022; Ogbi M, 2004, BIOCHEM J, V382, P923, DOI 10.1042/BJ20040468; Pain T, 2000, CIRC RES, V87, P460; Park M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019143; Pravdic D, 2010, BRIT J PHARMACOL, V160, P220, DOI 10.1111/j.1476-5381.2010.00698.x; Raphael J, 2005, BRIT J ANAESTH, V95, P756, DOI 10.1093/bja/aei264; Singh KK, 2011, BIOCHEM BIOPH RES CO, V411, P421, DOI 10.1016/j.bbrc.2011.06.169; Sun LH, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002067; Suzuki K, 2001, CIRCULATION, V104, pI308; Tanaka K, 2002, ANESTHESIOLOGY, V97, P1485, DOI 10.1097/00000542-200212000-00021; Toller WG, 1999, ANESTHESIOLOGY, V91, P1437, DOI 10.1097/00000542-199911000-00037; Toma O, 2004, ANESTHESIOLOGY, V101, P1372; Tsutsumi YM, 2006, ANESTHESIOLOGY, V104, P495, DOI 10.1097/00000542-200603000-00017; Uecker M, 2003, ANESTHESIOLOGY, V99, P138, DOI 10.1097/00000542-200307000-00023; Xu F, 2007, TOHOKU J EXP MED, V213, P215, DOI 10.1620/tjem.213.215; Zhang H, 2012, EUR HEART J, V33, P1606, DOI 10.1093/eurheartj/ehs061	48	33	37	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e52469	10.1371/journal.pone.0052469	http://dx.doi.org/10.1371/journal.pone.0052469			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23468836	Green Submitted, Green Published, gold			2022-12-25	WOS:000315524900004
J	Latek, D; Pasznik, P; Carlomagno, T; Filipek, S				Latek, Dorota; Pasznik, Pawel; Carlomagno, Teresa; Filipek, Slawomir			Towards Improved Quality of GPCR Models by Usage of Multiple Templates and Profile-Profile Comparison	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; HIDDEN MARKOV-MODELS; STRUCTURE PREDICTION; MEMBRANE-PROTEINS; CRYSTAL-STRUCTURE; SEQUENCE ALIGNMENT; HOMOLOGY MODELS; LIGAND-BINDING; SERVER; GENERATION	G-protein coupled receptors (GPCRs) are targets of nearly one third of the drugs at the current pharmaceutical market. Despite their importance in many cellular processes the crystal structures are available for less than 20 unique GPCRs of the Rhodopsin-like class. Fortunately, even though involved in different signaling cascades, this large group of membrane proteins has preserved a uniform structure comprising seven transmembrane helices that allows quite reliable comparative modeling. Nevertheless, low sequence similarity between the GPCR family members is still a serious obstacle not only in template selection but also in providing theoretical models of acceptable quality. An additional level of difficulty is the prediction of kinks and bulges in transmembrane helices. Usage of multiple templates and generation of alignments based on sequence profiles may increase the rate of success in difficult cases of comparative modeling in which the sequence similarity between GPCRs is exceptionally low. Here, we present GPCRM, a novel method for fast and accurate generation of GPCR models using averaging of multiple template structures and profile-profile comparison. In particular, GPCRM is the first GPCR structure predictor incorporating two distinct loop modeling techniques: Modeller and Rosetta together with the filtering of models based on the Z-coordinate. We tested our approach on all unique GPCR structures determined to date and report its performance in comparison with other computational methods targeting the Rhodopsin-like class. We also provide a database of precomputed GPCR models of the human receptors from that class. Availability: GPCRM server and database: http://gpcrm.biomodellab.eu	[Latek, Dorota; Pasznik, Pawel] Int Inst Mol & Cell Biol, Warsaw, Poland; [Carlomagno, Teresa] EMBL, Struct & Computat Biol Unit, Heidelberg, Germany; [Filipek, Slawomir] Univ Warsaw, Fac Chem, Warsaw, Poland	Miedzynarodowy Instytut Biologii Molekularnej i Komorkowej; European Molecular Biology Laboratory (EMBL); University of Warsaw	Latek, D (corresponding author), Int Inst Mol & Cell Biol, Warsaw, Poland.	dlatek@iimcb.gov.pl; sfilipek@chem.uw.edu.pl	; Filipek, Slawomir/A-2985-2008	Latek, Dorota/0000-0002-0429-0637; Filipek, Slawomir/0000-0003-3147-3858; Carlomagno, Teresa/0000-0002-2437-2760	National Center of Science [DEC-2011/03/B/NZ1/03204]; POIG 'Dotacje na innowacje' [02.03.00-00-003-09]	National Center of Science(National Science Centre, Poland); POIG 'Dotacje na innowacje'	The research leading to the described results has received funding from the National Center of Science DEC-2011/03/B/NZ1/03204 and a POIG 'Dotacje na innowacje' grant No. 02.03.00-00-003-09. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrol R, 2011, METHODS MOL BIOL; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bera I, 2011, J MOL MODEL, V17, P1207, DOI 10.1007/s00894-010-0803-8; Bokoch MP, 2010, NATURE, V463, P108, DOI 10.1038/nature08650; Canutescu AA, 2003, PROTEIN SCI, V12, P963, DOI 10.1110/ps.0242703; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Cock PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Forrest LR, 2006, BIOPHYS J, V91, P508, DOI 10.1529/biophysj.106.082313; GRIBSKOV M, 1987, P NATL ACAD SCI USA, V84, P4355, DOI 10.1073/pnas.84.13.4355; Hanson RM, 2010, J APPL CRYSTALLOGR, V43, P1250, DOI 10.1107/S0021889810030256; Hildebrand PW, 2009, NUCLEIC ACIDS RES, V37, pW571, DOI 10.1093/nar/gkp338; Hopf TA, 2012, CELL, V149, P1607, DOI 10.1016/j.cell.2012.04.012; Huber T, 2008, BIOCHEMISTRY-US, V47, P11013, DOI 10.1021/bi800891r; Jaroszewski L, 2011, NUCLEIC ACIDS RES, V39, pW38, DOI 10.1093/nar/gkr441; JONES DT, 1994, FEBS LETT, V339, P269, DOI 10.1016/0014-5793(94)80429-X; Kelm S, 2010, BIOINFORMATICS, V26, P2833, DOI 10.1093/bioinformatics/btq554; Kneissl B, 2009, J MED CHEM, V52, P3166, DOI 10.1021/jm8014487; Kolinski A, 2004, ACTA BIOCHIM POL, V51, P349; Kruse AC, 2012, NATURE, V482, P552, DOI 10.1038/nature10867; Kufareva I, 2011, STRUCTURE, V19, P1108, DOI 10.1016/j.str.2011.05.012; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Larsson P, 2008, PROTEIN SCI, V17, P990, DOI 10.1110/ps.073344908; Margelevicius M, 2010, BIOINFORMATICS, V26, P1905, DOI 10.1093/bioinformatics/btq306; Marti-Renom MA, 2004, PROTEIN SCI, V13, P1071, DOI 10.1110/ps.03379804; Mobarec JC, 2009, J MED CHEM, V52, P5207, DOI 10.1021/jm9005252; Muller T, 2001, Bioinformatics, V17 Suppl 1, pS182; Ng PC, 2000, BIOINFORMATICS, V16, P760, DOI 10.1093/bioinformatics/16.9.760; Nugent T, 2012, P NATL ACAD SCI USA, V109, pE1540, DOI 10.1073/pnas.1120036109; Oldziej S, 2005, P NATL ACAD SCI USA, V102, P7547, DOI 10.1073/pnas.0502655102; Pabuwal V, 2011, BIOPOLYMERS, V95, P31, DOI 10.1002/bip.21528; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Panchenko AR, 2003, NUCLEIC ACIDS RES, V31, P683, DOI 10.1093/nar/gkg154; Papasaikas PK, 2003, SAR QSAR ENVIRON RES, V14, P413, DOI 10.1080/10629360310001623999; Pieper U, 2011, NUCLEIC ACIDS RES, V39, pD465, DOI 10.1093/nar/gkq1091; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Rodriguez D, 2012, MOL INFORM, V31, P334, DOI 10.1002/minf.201100162; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Rost B, 1999, PROTEIN ENG, V12, P85, DOI 10.1093/protein/12.2.85; Rychlewski L, 2000, PROTEIN SCI, V9, P232, DOI 10.1110/ps.9.2.232; Schioth HB, 2005, GEN COMP ENDOCR, V142, P94, DOI 10.1016/j.ygcen.2004.12.018; Sgourakis NG, 2005, BIOINFORMATICS, V21, P4101, DOI 10.1093/bioinformatics/bti679; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Tomii K, 2004, BIOINFORMATICS, V20, P594, DOI 10.1093/bioinformatics/btg474; Trzaskowski B, 2012, CURR MED CHEM, V19, P1090, DOI 10.2174/092986712799320556; Wang C, 2007, J MOL BIOL, V373, P503, DOI 10.1016/j.jmb.2007.07.050; Wistrand M, 2006, PROTEIN SCI, V15, P509, DOI 10.1110/ps.051745906; Worth CL, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-185; Worth CL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007011; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Wu HX, 2012, NATURE, V485, P327, DOI 10.1038/nature10939; Xu JR, 2010, BIOINFORMATICS, V26, P889, DOI 10.1093/bioinformatics/btq066; Yarov-Yarovoy V, 2006, PROTEINS, V62, P1010, DOI 10.1002/prot.20817; Zhang J, 2010, BIOINFORMATICS, V26, P3004, DOI 10.1093/bioinformatics/btq563; Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	60	44	44	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e56742	10.1371/journal.pone.0056742	http://dx.doi.org/10.1371/journal.pone.0056742			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23468878	Green Published, gold, Green Submitted			2022-12-25	WOS:000315524900035
J	Lin, CY; Lin, TY; Lee, MC; Chen, SC; Chang, JS				Lin, Ching-Yuang; Lin, Tze-Yi; Lee, Min-Chun; Chen, Shih-Chieh; Chang, Jeng-Shou			Hyperglycemia: GDNF-EGR1 Pathway Target Renal Epithelial Cell Migration and Apoptosis in Diabetic Renal Embryopathy	PLOS ONE			English	Article							CONGENITAL-MALFORMATIONS; GLYCEMIC CONTROL; GROWTH; MORPHOGENESIS; EXPRESSION; DEFECTS; GENE; PREGNANCY; AGENESIS; RECEPTOR	Maternal hyperglycemia can inhibit morphogenesis of ureteric bud branching, Glial cell line-derived neurotrophilic factor (GDNF) is a key regulator of the initiation of ureteric branching. Early growth response gene-1 (EGR-1) is an immediate early gene. Preliminary study found EGR-1 persistently expressed with GDNF in hyperglycemic environment. To evaluate the potential relationship of hyperglycemia-GDNF-EGR-1 pathway, in vitro human renal proximal tubular epithelial (HRPTE) cells as target and in vivo streptozotocin-induced mice model were used. Our in vivo microarray, real time-PCR and confocal morphological observation confirmed apoptosis in hyperglycemia-induced fetal nephropathy via activation of the GDNF/MAPK/EGR-1 pathway at E12-E15. Detachment between ureteric branch and metanephrons, coupled with decreasing number and collapse of nephrons on Day 1 newborn mice indicate hyperglycemic environment suppress ureteric bud to invade metanephric rudiment. In vitro evidence proved that high glucose suppressed HRPTE cell migration and enhanced GDNF-EGR-1 pathway, inducing HRPTE cell apoptosis. Knockdown of EGR-1 by siRNA negated hyperglycemic suppressed GDNF-induced HRPTE cells. EGR-1 siRNA also reduced GDNF/EGR-1-induced cRaf/MEK/ERK phosphorylation by 80%. Our findings reveal a novel mechanism of GDNF/MAPK/EGR-1 activation playing a critical role in HRPTE cell migration, apoptosis and fetal hyperglycemic nephropathy.	[Lin, Ching-Yuang; Chen, Shih-Chieh; Chang, Jeng-Shou] China Med Univ Hosp, Clin Immunol Ctr, Taichung, Taiwan; [Lin, Tze-Yi] China Med Univ Hosp, Dept Pathol, Taichung, Taiwan; [Lin, Ching-Yuang; Lin, Tze-Yi] China Med Univ, Coll Med, Taichung, Taiwan; [Lee, Min-Chun] Buddhist Tzu Chi Gen Hosp, Dept Pediat, Taichung, Taiwan	China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; Buddhist Tzu Chi General Hospital; Taichung Tzu Chi Hospital	Lin, CY (corresponding author), China Med Univ Hosp, Clin Immunol Ctr, Taichung, Taiwan.	cylin@mail.cmuh.org.tw			National Science council, Taiwan [NSC94-2314-B309-005, NSC 96-2314-B-039-050-MY3]	National Science council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by the grant of National Science council, Taiwan. (NSC94-2314-B309-005 and NSC 96-2314-B-039-050-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amri R, 1999, DIABETES, V48, P2240, DOI 10.2337/diabetes.48.11.2240; BECERRA JE, 1990, PEDIATRICS, V85, P1; Blessing E, 2008, ATHEROSCLEROSIS, V199, P295, DOI 10.1016/j.atherosclerosis.2007.10.037; Bridgewater D, 2009, PEDIATR NEPHROL, V24, P1611, DOI 10.1007/s00467-008-1048-y; CAO XM, 1993, J BIOL CHEM, V268, P16949; Cao Y, 2011, TNF ALPHA INDUCES EA, DOI [10.1007/s00592-010-0248-7, DOI 10.1007/S00592-010-0248-7]; Chiu YC, 2009, J IMMUNOL, V183, P2785, DOI 10.4049/jimmunol.0802826; CHRISTY B, 1989, MOL CELL BIOL, V9, P4889, DOI 10.1128/MCB.9.11.4889; CROSBY SD, 1991, MOL CELL BIOL, V11, P3835, DOI 10.1128/MCB.11.8.3835; Davies JA, 1999, PEDIATR NEPHROL, V482, P1; ERIKSSON UJ, 1995, DIABETES METAB REV, V11, P63, DOI 10.1002/dmr.5610110106; Fan HY, 2010, EXP LUNG RES, V36, P323; GASHLER A, 1995, PROG NUCLEIC ACID RE, V50, P191, DOI 10.1016/S0079-6603(08)60815-6; Gururajan M, 2008, J IMMUNOL, V181, P4590, DOI 10.4049/jimmunol.181.7.4590; Hieda Y, 1997, DEV GROWTH DIFFER, V39, P1; Jain S, 2006, GENE DEV, V20, P321, DOI 10.1101/gad.1387206; Kashimata M, 2000, DEV BIOL, V220, P183, DOI 10.1006/dbio.2000.9639; Khwaja A, 1998, J BIOL CHEM, V273, P18793, DOI 10.1074/jbc.273.30.18793; KITZMILLER JL, 1991, JAMA-J AM MED ASSOC, V265, P731, DOI 10.1001/jama.265.6.731; Kuure S, 2000, MECH DEVELOP, V92, P31, DOI 10.1016/S0925-4773(99)00323-8; Liu CT, 1998, CANCER GENE THER, V5, P3; Lynch SA, 1997, CLIN DYSMORPHOL, V6, P75; Marose TD, 2008, DEV BIOL, V314, P112, DOI 10.1016/j.ydbio.2007.11.016; MELLSTROM B, 1994, ENDOCRINOLOGY, V135, P583, DOI 10.1210/en.135.2.583; MILLS JL, 1982, TERATOLOGY, V25, P385, DOI 10.1002/tera.1420250316; Pichel JG, 1996, NATURE, V382, P73, DOI 10.1038/382073a0; Pignatelli M, 2003, BIOCHEM J, V373, P739, DOI 10.1042/BJ20021918; Pignatelli M, 1999, FEBS LETT, V461, P37, DOI 10.1016/S0014-5793(99)01420-9; Rukhsana N, 2008, CIRC RES, V102, P42, DOI [10.1161/CIRCRESAHA.107.155143, DOI 10.1161/CIRCRESAHA.107.155143]; Sainio K, 1997, DEVELOPMENT, V124, P4077; Sanchez MP, 1996, NATURE, V382, P70, DOI 10.1038/382070a0; SAXEN L, 1987, PEDIATR NEPHROL, V1, P385, DOI 10.1007/BF00849241; SCHMIDT RE, 1989, LAB INVEST, V61, P77; SOLER NG, 1976, Q J MED, V45, P303; Suhonen L, 2000, DIABETOLOGIA, V43, P79, DOI 10.1007/s001250050010; Tran S, 2008, J AM SOC NEPHROL, V19, P943, DOI 10.1681/ASN.2007080864; Treanor JJS, 1996, NATURE, V382, P80, DOI 10.1038/382080a0; Wang HH, 2008, KIDNEY INT, V74, P808, DOI 10.1038/ki.2008.330; Wang HH, 2011, J CELL PHYSIOL, V226, P94, DOI 10.1002/jcp.22309; Watkins CC, 2000, J CLIN INVEST, V106, P373, DOI 10.1172/JCI8273; Woolf AS, 1997, ARCH DIS CHILD, V77, P471, DOI 10.1136/adc.77.6.471; Wrzos HF, 1997, DIGEST DIS SCI, V42, P2106, DOI 10.1023/A:1018830820537; Zandi-Nejad K, 2006, HYPERTENSION, V47, P502, DOI 10.1161/01.HYP.0000198544.09909.1a	43	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e56731	10.1371/journal.pone.0056731	http://dx.doi.org/10.1371/journal.pone.0056731			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23468876	Green Published, gold, Green Submitted			2022-12-25	WOS:000315524900033
J	Obuku, EA; Parikh, SM; Nankabirwa, V; Kakande, NI; Mafigiri, DK; Mayanja-Kizza, H; Kityo, CM; Mugyenyi, PN; Salata, RA				Obuku, Ekwaro A.; Parikh, Sujal M.; Nankabirwa, Victoria; Kakande, Nelson I.; Mafigiri, David K.; Mayanja-Kizza, Harriet; Kityo, Cissy M.; Mugyenyi, Peter N.; Salata, Robert A.			Determinants of Clinician Knowledge on Aging and HIV/AIDS: A Survey of Practitioners and Policy Makers in Kampala District, Uganda	PLOS ONE			English	Article							HIV-INFECTION; DOUBLE-BLIND; ATTITUDES; EFFICACY; OLDER; TRANSMISSION; PREVENTION; ZIDOVUDINE; PROVIDERS; REGIMEN	Objective: The HIV/AIDS epidemic has evolved with an increasing burden in older adults. We assessed for knowledge about aging and HIV/AIDS, among clinicians in Kampala district, Uganda. Methods: A cross-sectional survey of 301 clinicians complemented by 9 key-informant interviews between May and October 2011. Data was analyzed by multivariable logistic regression for potential determinants of clinician knowledge about HIV/AIDS in older adults, estimating their adjusted Odds Ratios (aOR) and 95% confidence intervals (95% CI) using Stata 11.2 software. Results: Two-hundred and sixty-two questionnaires (87.7%) were returned. Respondents had a median age of 30 years (IQR 27-34) and 57.8% were general medical doctors. The mean knowledge score was 49% (range 8.8%-79.4%). Questions related to co-morbidities in HIV/AIDS (non-AIDS related cancers and systemic diseases) and chronic antiretroviral treatment toxicities (metabolic disorders) accounted for significantly lower scores (mean, 41.7%, 95% CI: 39.3%-44%) compared to HIV/AIDS epidemiology and prevention (mean, 65.7%, 95% CI: 63.7%-67.7%). Determinants of clinician knowledge in the multivariable analysis included (category, aOR, 95% CI): clinician age (30-39 years; 3.28: 1.65-9.75), number of persons with HIV/AIDS seen in the past year (less than 50; 0.34: 0.14-0.86) and clinical profession (clinical nurse practitioner; 0.31: 0.11-0.83). Having diploma level education had a marginal association with lower knowledge about HIV and aging (p = 0.09). Conclusion: Our study identified gaps and determinants of knowledge about HIV/AIDS in older adults among clinicians in Kampala district, Uganda. Clinicians in low and middle income countries could benefit from targeted training in chronic care for older adults with HIV/AIDS and long-term complications of antiretroviral treatment.	[Obuku, Ekwaro A.; Kakande, Nelson I.; Kityo, Cissy M.; Mugyenyi, Peter N.] Joint Clin Res Ctr, Kampala, Uganda; [Salata, Robert A.] Case Western Reserve Univ, Dept Med, Div Infect Dis & HIV Med, Cleveland, OH 44106 USA; [Parikh, Sujal M.] Univ Michigan, Sch Med, Ann Arbor, MI USA; [Nankabirwa, Victoria] Columbia Univ, Dept Epidemiol, Mailman Sch Publ Hlth, New York, NY USA; [Mafigiri, David K.] Makerere Univ, Coll Humanities & Social Sci, Dept Social Work & Social Adm, Kampala, Uganda; [Mayanja-Kizza, Harriet] Makerere Univ, Coll Hlth Sci, Dept Med, Kampala, Uganda; [Mafigiri, David K.] Case Western Reserve Univ, Dept Anthropol, Ctr Social Sci Res AIDS, Coll Arts & Sci, Cleveland, OH 44106 USA	Joint Clinic Research Center - United Arab Emirates; Case Western Reserve University; University of Michigan System; University of Michigan; Columbia University; Makerere University; Makerere University; Case Western Reserve University	Obuku, EA (corresponding author), Joint Clin Res Ctr, Kampala, Uganda.	eobuku@jcrc.org.ug	Obuku, Ekwaro A./H-4988-2011; Mayanja-Kizza, Harriet/AAM-5372-2020	Mayanja-Kizza, Harriet/0000-0002-9297-6208; Mafigiri, David/0000-0002-2699-4248; Nankabirwa, Victoria/0000-0002-9952-8942	Fogarty International Clinical Research Scholars and Fellows Program at Vanderbilt University [R24 TW007988]; Fogarty International Centre, National Institutes of Health, USA; FOGARTY INTERNATIONAL CENTER [R24TW007988] Funding Source: NIH RePORTER	Fogarty International Clinical Research Scholars and Fellows Program at Vanderbilt University; Fogarty International Centre, National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported by the Fogarty International Clinical Research Scholars and Fellows Program at Vanderbilt University (R24 TW007988) and the American Relief and Recovery Act, Fogarty International Centre, National Institutes of Health, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Africa Health Workforce Observatory, 2009, HUM RES HLTH COUNTR; [Anonymous], 2012, WHAT IS THE 80 20 RU; Bakanda C, 2011, AIDS, V25, P701, DOI 10.1097/QAD.0b013e3283437ed7; Cochran W. G., 1963, SAMPLING TECHNIQUES, DOI [10.1002/bimj.19650070312, DOI 10.1002/BIMJ.19650070312]; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; Dabis F, 1999, LANCET, V353, P786, DOI 10.1016/S0140-6736(98)11046-2; Deeks SG, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a3172; Delobelle P, 2009, J ADV NURS, V65, P1061, DOI 10.1111/j.1365-2648.2009.04973.x; Demographic and Health Surveys, 2010, KEN DHS 2008 09 FIN; Demographic and Health Surveys, 2004, KEN DHS 2003 FIN REP; Effros RB, 2008, CLIN INFECT DIS, V47, P542, DOI 10.1086/590150; FISCHL MA, 1988, JAMA-J AM MED ASSOC, V259, P1185, DOI 10.1001/jama.259.8.1185; FISCHL MA, 1987, NEW ENGL J MED, V317, P185, DOI 10.1056/NEJM198707233170401; GEMSON DH, 1991, ARCH INTERN MED, V151, P1102, DOI 10.1001/archinte.151.6.1102; Goulet JL, 2007, CLIN INFECT DIS, V45, P1593, DOI 10.1086/523577; Guay LA, 1999, LANCET, V354, P795, DOI 10.1016/S0140-6736(99)80008-7; HEREK GM, 1984, J HOMOSEXUAL, V10, P39, DOI 10.1300/J082v10n01_03; Hillman JL, 1998, SEX DISABIL, V16, P181, DOI 10.1023/A:1023094909068; Holmes MD, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000244; Hughes AK, 2009, THESIS U MARYLAND BA; Hughes AK, 2011, AIDS PATIENT CARE ST, V25, P539, DOI 10.1089/apc.2011.0026; JAFFE HW, 1983, J INFECT DIS, V148, P339, DOI 10.1093/infdis/148.2.339; Killingley B, 2007, DRUG TODAY, V43, P427, DOI 10.1358/dot.2007.43.7.1086178; Meissner H, 2011, BEST PRACTICES MIXED; Mills EJ, 2011, BMJ, V343; Ministry of Health Department of Planning, 2007, UG HLTH FAC INV SPRE; Ministry of Health (MOH) Uganda and Macro International Inc, 2008, UG SERV PROV ASS SUR; Ministry of Health (MOH) [Uganda] and ORC Macro, 2006, UG HIV AIDS SER BEH; Morgan D, 2002, BRIT MED J, V324, P193, DOI 10.1136/bmj.324.7331.193; Mugyenyi P, 2010, LANCET, V375, P123, DOI 10.1016/S0140-6736(09)62067-5; Negin J, 2012, AIDS BEHAV, V16, P63, DOI 10.1007/s10461-011-9994-y; Negin J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026546; Negin J, 2010, B WORLD HEALTH ORGAN, V88, P847, DOI 10.2471/BLT.10.076349; Palamountain K, 2012, MONTR ADV TB DIAGN R; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Schmid GP, 2009, B WORLD HEALTH ORGAN, V87, P162, DOI 10.2471/BLT.09.064030; SERWADDA D, 1985, LANCET, V2, P849, DOI 10.1016/S0140-6736(85)90122-9; Skiest DJ, 1997, ARCH FAM MED, V6, P289, DOI 10.1001/archfami.6.3.289; Walusimbi M, 2004, APPL NURS RES, V17, P92, DOI 10.1016/j.apnr.2004.02.005; WHO UNAIDS Unicef, 2011, GLOB HIV AIDS RESP E; World Health Organization, 2012, KNOWL TRANSL AG HLTH	42	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57028	10.1371/journal.pone.0057028	http://dx.doi.org/10.1371/journal.pone.0057028			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	098DA	23468905	gold, Green Published, Green Submitted			2022-12-25	WOS:000315524900048
J	Ruiz, GRS				Ruiz, Gustavo R. S.			Proposal and Phylogenetic Relationships of Lapsamita, a New Genus of Lapsiines, and Description of a New Species (Araneae, Salticidae)	PLOS ONE			English	Article							SPIDERS	Lapsamita maddisoni gen. et sp. nov. is described from Bahia, Brazil. The presence of palpal claws in females, long ventral spines on front tibiae and metatarsi and long retrolateral tibial apophyses in male palps suggested that the species was closely related to or even nested within Soesiladeepakius Makhan, 2007. To evaluate its phylogenetic position, a cladistic analysis was carried out using a data matrix comprising 24 morphological characters, scored for 13 taxa. The analysis showed L. maddisoni as the sister group of Soesiladeepakius, supporting the proposal of the new genus. Character evolution is discussed and compared to a previous study on the group.	Fed Univ Para, Inst Ciencias Biol, BR-66059 Belem, Para, Brazil	Universidade Federal do Para	Ruiz, GRS (corresponding author), Fed Univ Para, Inst Ciencias Biol, BR-66059 Belem, Para, Brazil.	gustavoruiz86@hotmail.com	Ruiz, Gustavo/AAB-4928-2019	Ruiz, Gustavo/0000-0002-7326-7000				Edwards G.B., 2004, OCCAS PAP FLORIDA ST, V11, P1; FITCH WM, 1971, SYST ZOOL, V20, P406, DOI 10.2307/2412116; GOLOBOFF P, 2000, TNT TREE ANAL USING; HUBER BA, 1995, ZOOL J LINN SOC-LOND, V113, P151, DOI 10.1111/j.1096-3642.1995.tb00931.x; Maddison WP, 2007, ZOOTAXA, P23; Maddison WP, 2006, ZOOTAXA, P37; Maddison WP, 2006, ZOOTAXA, P29; Maddison WP, 2006, ZOOTAXA, P17; Maddison WP, 2003, INVERTEBR SYST, V17, P529, DOI 10.1071/IS02044; MADDISON WP, 2006, MESQUITE MODULAR SYS; Makhan Dewanand, 2007, Calodema, P1; Nixon K. C., 2002, WINCLADA VER 1 00 08; Petrunkevitch A., 1925, Transactions of the Connecticut Academy of Arts and Science, V27, P51; Ruiz GRS, 2012, ZOOL J LINN SOC-LOND, V165, P274, DOI 10.1111/j.1096-3642.2012.00815.x; SWOFFORD DL, 1987, MATH BIOSCI, V87, P199, DOI 10.1016/0025-5564(87)90074-5	15	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e56188	10.1371/journal.pone.0056188	http://dx.doi.org/10.1371/journal.pone.0056188			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23468857	Green Published, gold, Green Submitted			2022-12-25	WOS:000315524900019
J	Ascunce, MS; Toups, MA; Kassu, G; Fane, J; Scholl, K; Reed, DL				Ascunce, Marina S.; Toups, Melissa A.; Kassu, Gebreyes; Fane, Jackie; Scholl, Katlyn; Reed, David L.			Nuclear Genetic Diversity in Human Lice (Pediculus humanus) Reveals Continental Differences and High Inbreeding among Worldwide Populations	PLOS ONE			English	Article							BARTONELLA-QUINTANA; HEAD LICE; BODY LICE; CARBONIC-ANHYDRASE; HOMELESS PERSONS; RESISTANCE; SOFTWARE; ORIGIN; LOUSE; EVOLUTION	Understanding the evolution of parasites is important to both basic and applied evolutionary biology. Knowledge of the genetic structure of parasite populations is critical for our ability to predict how an infection can spread through a host population and for the design of effective control methods. However, very little is known about the genetic structure of most human parasites, including the human louse (Pediculus humanus). This species is composed of two ecotypes: the head louse (Pediculus humanus capitis De Geer), and the clothing (body) louse (Pediculus humanus humanus Linnaeus). Hundreds of millions of head louse infestations affect children every year, and this number is on the rise, in part because of increased resistance to insecticides. Clothing lice affect mostly homeless and refugee-camp populations and although they are less prevalent than head lice, the medical consequences are more severe because they vector deadly bacterial pathogens. In this study we present the first assessment of the genetic structure of human louse populations by analyzing the nuclear genetic variation at 15 newly developed microsatellite loci in 93 human lice from 11 sites in four world regions. Both ecotypes showed heterozygote deficits relative to Hardy-Weinberg equilibrium and high inbreeding values, an expected pattern given their parasitic life history. Bayesian clustering analyses assigned lice to four distinct genetic clusters that were geographically structured. The low levels of gene flow among louse populations suggested that the evolution of insecticide resistance in lice would most likely be affected by local selection pressures, underscoring the importance of tailoring control strategies to population-specific genetic makeup and evolutionary history. Our panel of microsatellite markers provides powerful data to investigate not only ecological and evolutionary processes in lice, but also those in their human hosts because of the long-term coevolutionary association between lice and humans.	[Ascunce, Marina S.; Toups, Melissa A.; Kassu, Gebreyes; Fane, Jackie; Scholl, Katlyn; Reed, David L.] Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA	State University System of Florida; University of Florida	Ascunce, MS (corresponding author), Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA.	ascunce@ufl.edu	Ascunce, Marina/AAW-2139-2020	Toups, Melissa/0000-0002-9752-7380	National Science Foundation [DEB 0717165, DEB 0845392]; University of Florida; Division Of Environmental Biology [0845392] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); University of Florida(University of Florida); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported in part by grants to DLR from the National Science Foundation (www.nsf.gov: DEB 0717165 and DEB 0845392) and the University of Florida (www.research.ufl.edu: SEED Fund Program). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abi-Rached L, 2011, SCIENCE, V334, P89, DOI 10.1126/science.1209202; Alves I, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002837; Angelakis E, 2011, EMERG INFECT DIS, V17, P2357, DOI 10.3201/eid1712.110453; Araujo A, 2000, PARASITOL TODAY, V16, P269, DOI 10.1016/S0169-4758(00)01694-X; Balding DJ, 2003, THEOR POPUL BIOL, V63, P221, DOI 10.1016/S0040-5809(03)00007-8; BALDING DJ, 1995, GENETICA, V96, P3, DOI 10.1007/BF01441146; BARTON NH, 1986, HEREDITY, V56, P409, DOI 10.1038/hdy.1986.63; Bialek R, 2011, NEW ENGL J MED, V364, P386, DOI 10.1056/NEJMc1007171; Bonilla DL, 2009, EMERG INFECT DIS, V15, P912, DOI 10.3201/eid1506.090054; Burgess Ian F., 1995, Advances in Parasitology, V36, P271, DOI 10.1016/S0065-308X(08)60493-5; Burgess IE, 2004, ANNU REV ENTOMOL, V49, P457, DOI 10.1146/annurev.ento.49.061802.123253; Clark J. Marshall, 2009, Journal of Asia-Pacific Entomology, V12, P1, DOI 10.1016/j.aspen.2008.10.007; Corena MD, 2002, J EXP BIOL, V205, P591; Cutler S, 2012, COMP IMMUNOL MICROB, V35, P17, DOI 10.1016/j.cimid.2011.09.007; Dittmar K, 2012, BLACKW COMPANION ANT, P170; Drali R, 2012, J CLIN MICROBIOL, V50, P2229, DOI 10.1128/JCM.00808-12; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Figueroa CC, 2007, INSECT SCI, V14, P29, DOI 10.1111/j.1744-7917.2007.00123.x; Foll M, 2008, GENETICS, V180, P977, DOI 10.1534/genetics.108.092221; Foucault C, 2006, EMERG INFECT DIS, V12, P217, DOI 10.3201/eid1202.050874; Goldberger J, 1896, PUB HLTH REP, V27, P297, DOI [10.2307/4567527, DOI 10.2307/4567527]; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Goudet J, 2002, FSTAT PROGRAM ESTIMA, DOI DOI 10.1093/OXFORDJOURNALS.JHERED.A111627; Gratz NG, 1997, HUMAN LICE THEIR PRE; Hammer MF, 2011, P NATL ACAD SCI USA, V108, P15123, DOI 10.1073/pnas.1109300108; Hartley CJ, 2006, P NATL ACAD SCI USA, V103, P8757, DOI 10.1073/pnas.0509590103; Hodgdon HE, 2010, PEST MANAG SCI, V66, P1031, DOI 10.1002/ps.1979; Jeffreys H., 1961, THEORY PROBABILITY, V3rd ed.; Kirkness EF, 2010, P NATL ACAD SCI USA, V107, P12168, DOI 10.1073/pnas.1003379107; Kittler R, 2004, CURR BIOL, V14, P2309, DOI 10.1016/j.cub.2004.12.024; Kittler R, 2003, CURR BIOL, V13, P1414, DOI 10.1016/S0960-9822(03)00507-4; Kolman CJ, 1996, GENETICS, V142, P1321; Lalueza-Fox C, 2011, CURR BIOL, V21, pR1002, DOI 10.1016/j.cub.2011.11.021; Lawson D, 2009, NUCLEIC ACIDS RES, V37, pD583, DOI 10.1093/nar/gkn857; Lee SH, 2000, PESTIC BIOCHEM PHYS, V66, P130, DOI 10.1006/pest.1999.2460; Lee SH, 2010, PESTIC BIOCHEM PHYS, V97, P109, DOI 10.1016/j.pestbp.2009.04.017; Leo NP, 2005, HEREDITY, V95, P34, DOI 10.1038/sj.hdy.6800663; Li WJ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000641; Light JE, 2008, MOL PHYLOGENET EVOL, V47, P1203, DOI 10.1016/j.ympev.2008.03.014; Light JE, 2008, J PARASITOL, V94, P1275, DOI 10.1645/GE-1618.1; Linser PJ, 2009, J EXP BIOL, V212, P1662, DOI 10.1242/jeb.028084; Mita T, 2009, PARASITOL INT, V58, P201, DOI 10.1016/j.parint.2009.04.004; MURRAY ES, 1975, ANN NY ACAD SCI, V266, P25, DOI 10.1111/j.1749-6632.1975.tb35086.x; Nair S, 2003, MOL BIOL EVOL, V20, P1526, DOI 10.1093/molbev/msg162; Nozais JP, 2003, MEM I OSWALDO CRUZ, V98, P13, DOI 10.1590/S0074-02762003000900004; Oakeshott JG, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-1-202; Pannebakker BA, 2010, INSECT MOL BIOL, V19, P91, DOI 10.1111/j.1365-2583.2009.00915.x; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pedra JHF, 2004, P NATL ACAD SCI USA, V101, P7034, DOI 10.1073/pnas.0400580101; Pritchard JK, 2000, GENETICS, V155, P945; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI 10.1111/j.1558-5646.1989.tb04226.x; Ramachandran S, 2005, P NATL ACAD SCI USA, V102, P15942, DOI 10.1073/pnas.0507611102; Rannala B, 1996, GENET RES, V67, P147, DOI 10.1017/S0016672300033607; Raoult D, 1997, EMERG INFECT DIS, V3, P357, DOI 10.3201/eid0303.970313; Raoult D, 2008, J INFECT DIS, V197, P535, DOI 10.1086/526520; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Reed DL, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-7; Reed DL, 2004, PLOS BIOL, V2, P1972, DOI 10.1371/journal.pbio.0020340; Reed DL, 2009, PRIMATE PARASITE ECO, P531; Roper C, 2003, LANCET, V361, P1174, DOI 10.1016/S0140-6736(03)12951-0; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Rydkina EB, 1999, EMERG INFECT DIS, V5, P176, DOI 10.3201/eid0501.990126; Sankararaman S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002947; Sasaki T, 2006, J MED ENTOMOL, V43, P110, DOI 10.1603/0022-2585(2006)043[0110:FMEOBQ]2.0.CO;2; Seki N, 2006, JPN J INFECT DIS, V59, P31; TORRONI A, 1993, AM J HUM GENET, V53, P591; Toups MA, 2011, MOL BIOL EVOL, V28, P29, DOI 10.1093/molbev/msq234; TURBECK BO, 1970, BIOCHIM BIOPHYS ACTA, V212, P139, DOI 10.1016/0005-2744(70)90187-7; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Veracx A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037804; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Yang MA, 2012, MOL BIOL EVOL, V29, P2987, DOI 10.1093/molbev/mss117	76	35	37	1	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57619	10.1371/journal.pone.0057619	http://dx.doi.org/10.1371/journal.pone.0057619			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460886	Green Published, Green Submitted, gold			2022-12-25	WOS:000315519000141
J	Chu, CYS; King, JC; Berrini, M; Alexander, RT; Cordat, E				Chu, Carmen Y. S.; King, Jennifer C.; Berrini, Mattia; Alexander, R. Todd; Cordat, Emmanuelle			Functional Rescue of a Kidney Anion Exchanger 1 Trafficking Mutant in Renal Epithelial Cells	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; TUBULAR-ACIDOSIS; CYSTIC-FIBROSIS; HEREDITARY SPHEROCYTOSIS; AUTOSOMAL-DOMINANT; CL-/HCO3-EXCHANGER; ASIAN OVALOCYTOSIS; INTRACELLULAR PH; PLASMA-MEMBRANE; GLYCOPHORIN-A	Mutations in the SLC4A1 gene encoding the anion exchanger 1 (AE1) can cause distal renal tubular acidosis (dRTA), a disease often due to mis-trafficking of the mutant protein. In this study, we investigated whether trafficking of a Golgi-retained dRTA mutant, G701D kAE1, or two dRTA mutants retained in the endoplasmic reticulum, C479W and R589H kAE1, could be functionally rescued to the plasma membrane of Madin-Darby Canine Kidney (MDCK) cells. Treatments with DMSO, glycerol, the corrector VX-809, or low temperature incubations restored the basolateral trafficking of G701D kAE1 mutant. These treatments had no significant rescuing effect on trafficking of the mis-folded C479W or R589H kAE1 mutants. DMSO was the only treatment that partially restored G701D kAE1 function in the plasma membrane of MDCK cells. Our experiments show that trafficking of intracellularly retained dRTA kAE1 mutants can be partially restored, and that one chemical treatment rescued both trafficking and function of a dRTA mutant. These studies provide an opportunity to develop alternative therapeutic solutions for dRTA patients.	[Chu, Carmen Y. S.; King, Jennifer C.; Berrini, Mattia; Alexander, R. Todd; Cordat, Emmanuelle] Univ Alberta, Dept Physiol, Edmonton, AB, Canada	University of Alberta	Cordat, E (corresponding author), Univ Alberta, Dept Physiol, Edmonton, AB, Canada.	cordat@ualberta.ca	Alexander, R. Todd/G-1373-2012		Canadian Institutes of Health Research [MOP 106565]; Alberta Innovates Health Solution Graduate studentship; KRESCENT; Canadian Institutes of Health Research; Alberta Innovates Health Solution Clinical Investigator award	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Innovates Health Solution Graduate studentship; KRESCENT; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Innovates Health Solution Clinical Investigator award	This work was supported by funding from the Canadian Institutes of Health Research (MOP 106565) (http://www.cihr-irsc.gc.ca). C.Y.S.C. is the recipient of an Alberta Innovates Health Solution Graduate studentship (http://www.aihealthsolutions.ca). E. C. is supported by a KRESCENT New Investigator award (http://www.krescent.ca). R. T. A. is the recipient of a Clinician Scientist award from the Canadian Institutes of Health Research and an Alberta Innovates Health Solution Clinical Investigator award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alloisio N, 1997, BLOOD, V90, P414; Almomani EY, 2011, BIOCHEM CELL BIOL, V89, P157, DOI [10.1139/O10-153, 10.1139/o10-153]; Alper SL, 2010, J NEPHROL, V23, pS57; BALIGA BS, 1969, J BIOL CHEM, V244, P4480; Brown CR, 1996, CELL STRESS CHAPERON, V1, P117, DOI 10.1379/1466-1268(1996)001<0117:CCCTMP>2.3.CO;2; Bruce LJ, 2000, BIOCHEM J, V350, P41, DOI 10.1042/0264-6021:3500041; Bruce LJ, 1997, J CLIN INVEST, V100, P1693, DOI 10.1172/JCI119694; Chang YH, 2009, KIDNEY INT, V76, P774, DOI 10.1038/ki.2009.258; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; Chu C, 2010, BIOCHEM J, V426, P379, DOI 10.1042/BJ20091525; Cordat E, 2006, TRAFFIC, V7, P117, DOI 10.1111/j.1600-0854.2005.00366.x; Cordat E, 2003, TRAFFIC, V4, P642, DOI 10.1034/j.1600-0854.2003.00123.x; Cordat E, 2006, BIOCHEM CELL BIOL, V84, P949, DOI 10.1139/O06-200; DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0; Fry AC, 2012, J AM SOC NEPHROL; GROVES JD, 1992, J BIOL CHEM, V267, P22163; Jarolim P, 1998, J BIOL CHEM, V273, P6380, DOI 10.1074/jbc.273.11.6380; Jurkuvenaite A, 2010, AM J RESP CELL MOL, V42, P363, DOI 10.1165/rcmb.2008-0434OC; Karet FE, 1998, P NATL ACAD SCI USA, V95, P6337, DOI 10.1073/pnas.95.11.6337; Keskanokwong T, 2007, J BIOL CHEM, V282, P23205, DOI 10.1074/jbc.M702139200; Kittanakom S, 2004, J BIOL CHEM, V279, P40960, DOI 10.1074/jbc.M405356200; Loiselle FB, 2010, METHODS MOL BIOL, V637, P311, DOI 10.1007/978-1-60761-700-6_17; Okiyoneda T, 2010, SCIENCE, V329, P805, DOI 10.1126/science.1191542; Patterson ST, 2010, J BIOL CHEM, V285, P33423, DOI 10.1074/jbc.M110.144261; PIMPLIKAR SW, 1986, J BIOL CHEM, V261, P9770; Quilty JA, 2002, AM J PHYSIOL-RENAL, V282, pF810, DOI 10.1152/ajprenal.00216.2001; RAMJEESINGH M, 1981, BIOCHIM BIOPHYS ACTA, V641, P173, DOI 10.1016/0005-2736(81)90581-2; Ribeiro ML, 2000, BLOOD, V96, P1602; Sawasdee N, 2010, BIOCHEM BIOPH RES CO, V401, P85, DOI 10.1016/j.bbrc.2010.09.015; Shao LP, 2010, ENDOCRINE, V37, P473, DOI 10.1007/s12020-010-9340-6; Sterling D, 1999, BIOCHEM J, V344, P221, DOI 10.1042/0264-6021:3440221; Su Y, 2011, AM J PHYSIOL-RENAL, V300, pF157, DOI 10.1152/ajprenal.00228.2010; Tanphaichitr VS, 1998, J CLIN INVEST, V102, P2173, DOI 10.1172/JCI4836; Toye AM, 2004, J CELL SCI, V117, P1399, DOI 10.1242/jcs.00974; Ungsupravate D, 2010, MOL MEMBR BIOL, V27, P92, DOI 10.3109/09687681003588020; Van Goor F, 2011, P NATL ACAD SCI USA, V108, P18843, DOI 10.1073/pnas.1105787108; Vasuvattakul S, 1999, KIDNEY INT, V56, P1674, DOI 10.1046/j.1523-1755.1999.00756.x; Vince JW, 1998, J BIOL CHEM, V273, P28430, DOI 10.1074/jbc.273.43.28430; Wu F, 2010, J AM SOC NEPHROL, V21, P1456, DOI 10.1681/ASN.2009090921	39	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57062	10.1371/journal.pone.0057062	http://dx.doi.org/10.1371/journal.pone.0057062			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460825	gold, Green Published, Green Submitted			2022-12-25	WOS:000315519000057
J	Emery, JA; Hermon, K; Hamid, NKA; Donald, JA; Turchini, GM				Emery, James A.; Hermon, Karen; Hamid, Noor K. A.; Donald, John A.; Turchini, Giovanni M.			Delta-6 Desaturase Substrate Competition: Dietary Linoleic Acid (18:2n-6) Has Only Trivial Effects on alpha-Linolenic Acid (18:3n-3) Bioconversion in the Teleost Rainbow Trout	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; FISH-OIL REPLACEMENT; IN-VIVO; ACYL DESATURASE; MURRAY COD; METABOLISM; PUFA; N-3; BIOSYNTHESIS; HEPATOCYTES	It is generally accepted that, in vertebrates, omega-3 (n-3) and omega-6 (n-6) poly-unsaturated fatty acids (PUFA) compete for Delta-6 desaturase enzyme in order to be bioconverted into long-chain PUFA (LC-PUFA). However, recent studies into teleost fatty acid metabolism suggest that these metabolic processes may not conform entirely to what has been previously observed in mammals and other animal models. Recent work on rainbow trout has led us to question specifically if linoleic acid (LA, 18:2n-6) and alpha-linolenic acid (ALA, 18:3n-3) (Delta-6 desaturase substrates) are in direct competition for access to Delta-6 desaturase. Two experimental diets were formulated with fixed levels of ALA, while LA levels were varied (high and low) to examine if increased availability of LA would result in decreased bioconversion of ALA to its LC-PUFA products through substrate competition. No significant difference in ALA metabolism towards n-3 LC-PUFA was exhibited between diets while significant differences were observed in LA metabolism towards n-6 LC-PUFA. These results are evidence for minor if any competition between substrates for Delta-6 desaturase, suggesting that, paradoxically, the activity of Delta-6 desaturase on n-3 and n-6 substrates is independent. These results call for a paradigm shift in the way we approach teleost fatty acid metabolism. The findings are also important with regard to diet formulation in the aquaculture industry as they indicate that there should be no concern for possible substrate competition between 18: 3n-3 and 18:2n-6, when aiming at increased n-3 LC-PUFA bioconversion in vivo.	[Emery, James A.; Hermon, Karen; Turchini, Giovanni M.] Deakin Univ, Sch Life & Environm Sci, Warrnambool, Vic, Australia; [Hamid, Noor K. A.; Donald, John A.] Deakin Univ, Sch Life & Environm Sci, Geelong, Vic 3217, Australia	Deakin University; Deakin University	Turchini, GM (corresponding author), Deakin Univ, Sch Life & Environm Sci, Warrnambool, Vic, Australia.	giovanni.turchini@deakin.edu.au	Hamid, Noor K. A/Q-9142-2018; Turchini, Giovanni M/A-9147-2008; Donald, John/B-4656-2012	Turchini, Giovanni M/0000-0003-0694-4283; Donald, John/0000-0001-5930-2642	Australian Research Council's Discovery Projects funding scheme [DP1093570]	Australian Research Council's Discovery Projects funding scheme(Australian Research Council)	This research was supported under the Australian Research Council's Discovery Projects funding scheme (Project DP1093570). The views expressed herein are those of the authors and are not necessarily those of the Australian Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATKINSON JL, 1984, CAN J FISH AQUAT SCI, V41, P1384, DOI 10.1139/f84-170; Barcelo-Coblijn G, 2009, PROG LIPID RES, V48, P355, DOI 10.1016/j.plipres.2009.07.002; Bell J.G., 2011, FISH OIL REPLACEMENT; Brenna JT, 2009, PROSTAG LEUKOTR ESS, V80, P85, DOI 10.1016/j.plefa.2009.01.004; Brown TD, 2010, AQUACULTURE, V300, P148, DOI 10.1016/j.aquaculture.2009.12.020; Buzzi M, 1996, BBA-LIPID LIPID MET, V1299, P235, DOI 10.1016/0005-2760(95)00211-1; Cleveland BJ, 2012, J NUTR, V142, P1449, DOI 10.3945/jn.112.161497; de Antueno RJ, 2001, FEBS LETT, V509, P77, DOI 10.1016/S0014-5793(01)03135-0; EMKEN EA, 1994, BBA-LIPID LIPID MET, V1213, P277, DOI 10.1016/0005-2760(94)00054-9; FOLCH J, 1957, J BIOL CHEM, V226, P497; Francis DS, 2009, J AGR FOOD CHEM, V57, P4381, DOI 10.1021/jf900094w; Gurr MI, 2002, LIPID BIOCH, P13; Hastings N, 2001, P NATL ACAD SCI USA, V98, P14304, DOI 10.1073/pnas.251516598; Li YY, 2010, P NATL ACAD SCI USA, V107, P16840, DOI 10.1073/pnas.1008429107; Mathias RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044926; MOHRHAUER H, 1963, J NUTR, V81, P67, DOI 10.1093/jn/81.1.67; Monroig O, 2011, COMP BIOCHEM PHYS B, V159, P206, DOI 10.1016/j.cbpb.2011.04.007; Morais S, 2012, BBA-MOL CELL BIOL L, V1821, P660, DOI 10.1016/j.bbalip.2011.12.011; Olsen Y, 2011, AQUACULT ENV INTERAC, V1, P187, DOI 10.3354/aei00019; Palmeri G, 2007, FOOD CHEM, V102, P796, DOI 10.1016/j.foodchem.2006.06.018; Pickova J, 2007, EUR J LIPID SCI TECH, V109, P256, DOI 10.1002/ejlt.200600222; Poureslami R, 2010, BRIT J NUTR, V104, P189, DOI 10.1017/S0007114510000395; RAHM JJ, 1964, J NUTR, V84, P15, DOI 10.1093/jn/84.1.15; Ramsden Christopher E, 2009, Curr Treat Options Cardiovasc Med, V11, P289; Riediger ND, 2009, J AM DIET ASSOC, V109, P668, DOI 10.1016/j.jada.2008.12.022; Rosenlund G., 2011, FISH OIL REPLACEMENT, P487; Sprecher H, 1995, J LIPID RES, V36, P2471; Sprecher H, 2000, BBA-MOL CELL BIOL L, V1486, P219, DOI 10.1016/S1388-1981(00)00077-9; Tacon AGJ, 2008, AQUACULTURE, V285, P146, DOI 10.1016/j.aquaculture.2008.08.015; Thanuthong T, 2011, LIPIDS, V46, P1111, DOI 10.1007/s11745-011-3607-4; Thanuthong T, 2011, AQUACULTURE, V322, P99, DOI 10.1016/j.aquaculture.2011.09.026; Tocher D., 2009, Lipid Technology, V21, P13, DOI 10.1002/lite.200800079; Torstensen B. E., 2011, FISH OIL REPLACEMENT, P405, DOI 10.1201/9781439808634-c13; Turchini GM, 2008, LIPIDS, V43, P977, DOI 10.1007/s11745-008-3213-2; Turchini GM, 2007, LIPIDS, V42, P1065, DOI 10.1007/s11745-007-3105-x; Turchini GM, 2009, REV AQUACULT, V1, P10, DOI 10.1111/j.1753-5131.2008.01001.x; Turchini GM, 2009, BRIT J NUTR, V102, P69, DOI 10.1017/S0007114508137874; Vagner M, 2011, AQUACULTURE, V315, P131, DOI 10.1016/j.aquaculture.2010.11.031; VOSS A, 1991, J BIOL CHEM, V266, P19995; WAYS P, 1964, J LIPID RES, V5, P318; Williams CM, 2006, P NUTR SOC, V65, P42, DOI 10.1079/PNS2005473	42	39	42	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57463	10.1371/journal.pone.0057463	http://dx.doi.org/10.1371/journal.pone.0057463			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460861	Green Published, gold, Green Submitted			2022-12-25	WOS:000315519000115
J	Gill, SS; Gupta, N; Bell, CM; Rochon, PA; Austin, PC; Laupacis, A				Gill, Sudeep S.; Gupta, Neeraj; Bell, Chaim M.; Rochon, Paula A.; Austin, Peter C.; Laupacis, Andreas			The Timing of Drug Funding Announcements Relative to Elections: A Case Study Involving Dementia Medications	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; DOUBLE-BLIND; CHOLINESTERASE-INHIBITORS; SCIENTIFIC EVIDENCE; COST-EFFECTIVENESS; CANCER DRUGS; DONEPEZIL; POLICY; COVERAGE; MEMANTINE	Background: Following initial regulatory approval of prescription drugs, many factors may influence insurers and health systems when they decide whether to add these drugs to their formularies. The role of political pressures on drug funding announcements has received relatively little attention, and elections represent an especially powerful form of political pressure. We examined the temporal relationship between decisions to add one class of drugs to publicly funded formularies in Canada's ten provinces and elections in these jurisdictions. Methods: Dates of provincial formulary listings for cholinesterase inhibitors, which are drugs used to treat Alzheimer's disease and related dementias, were compared to the dates of provincial elections. Medical journal articles, media reports, and proceedings from provincial legislatures were reviewed to assemble information on the chronology of events. We tested whether there was a statistically significant increase in the probability of drug funding announcements within the 60-day intervals preceding provincial elections. Results: Decisions to fund the cholinesterase inhibitors were made over a nine-year span from 1999 to 2007 in the ten provinces. In four of ten provinces, the drugs were added to formularies in a time period closely preceding a provincial election (P = 0.032); funding announcements in these provinces were made between 2 and 47 days prior to elections. Statements made in provincial legislatures highlight the key role of political pressures in these funding announcements. Conclusions: Impending elections appeared to affect the timing of drug funding announcements in this case study. Despite an established structure for evidence-based decision-making, drug funding remains a complex process open to influence from many sources. Awareness of such influences is critical to maintain effective drug policy and public health decision-making.	[Gill, Sudeep S.; Gupta, Neeraj] Queens Univ, Dept Med, Kingston, ON K7L 3N6, Canada; [Gill, Sudeep S.; Bell, Chaim M.; Rochon, Paula A.; Austin, Peter C.; Laupacis, Andreas] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Bell, Chaim M.; Rochon, Paula A.; Austin, Peter C.; Laupacis, Andreas] Univ Toronto, Dept Med, Toronto, ON, Canada; [Bell, Chaim M.; Rochon, Paula A.; Austin, Peter C.; Laupacis, Andreas] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Bell, Chaim M.] Mt Sinai Hosp, Dept Med, Toronto, ON M5G 1X5, Canada; [Rochon, Paula A.] Womens Coll Hosp, Womens Coll Res Inst, Toronto, ON M5S 1B2, Canada; [Laupacis, Andreas] St Michaels Hosp, Keenan Res Ctr, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada	Queens University - Canada; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Womens College Hospital; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto	Gill, SS (corresponding author), Queens Univ, Dept Med, Kingston, ON K7L 3N6, Canada.	sudeep.gill@ices.on.ca	Rochon, Paula A/J-2918-2016; Bell, Chaim/C-4611-2015	Rochon, Paula A/0000-0002-5973-4151; Bell, Chaim/0000-0002-3778-9469; Austin, Peter/0000-0003-3337-233X	Canadian Institutes of Health Research (CIHR); CIHR; Canadian Patient Safety Institute Chair in Patient Safety and Continuity of Care; Heart and Stroke Foundation	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR(Canadian Institutes of Health Research (CIHR)); Canadian Patient Safety Institute Chair in Patient Safety and Continuity of Care; Heart and Stroke Foundation(Heart & Stroke Foundation of Canada)	SSG is supported by a Canadian Institutes of Health Research (CIHR) New Investigator Award. CMB is supported by a CIHR and Canadian Patient Safety Institute Chair in Patient Safety and Continuity of Care. PCA is supported by a Career Investigator award from the Heart and Stroke Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The opinions, results and conclusions are those of the authors. No endorsement by the Ontario Ministry of Health and Long-Term Care, the Institute for Clinical Evaluative Sciences (ICES), ICES@Queen's or the funding sources is intended or should be inferred.	Ames D, 2008, INT PSYCHOGERIATR, V20, P259, DOI 10.1017/S1041610207006680; Andrews E, 2004, PHARMACOEPIDEM DR S, V13, P599, DOI 10.1002/pds.899; Anis AH, 2001, MED CARE, V39, P315, DOI 10.1097/00005650-200104000-00003; [Anonymous], 1998, GLOBE MAIL A    0813, P9; [Anonymous], 1999, CBC NEWS; [Anonymous], 2009, CBS NEWS 60 MIN; Bach PB, 2009, NEW ENGL J MED, V360, P626, DOI 10.1056/NEJMhpr0807774; BC Therapeutics Initiative, 2005, THERAPEUTICS LET APR; Bentham P, 2004, LANCET, V363, P2105; Booth CM, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-110; Carpenter D, 2008, NEW ENGL J MED, V358, P1354, DOI 10.1056/NEJMsa0706341; Chambers JD, 2011, NEW ENGL J MED, V364, P1687, DOI 10.1056/NEJMp1103057; Choi BCK, 2005, J EPIDEMIOL COMMUN H, V59, P632, DOI 10.1136/jech.2004.031765; Clement FM, 2009, JAMA-J AM MED ASSOC, V302, P1437, DOI 10.1001/jama.2009.1409; Detsky AS, 2007, JAMA-J AM MED ASSOC, V298, P221, DOI 10.1001/jama.298.2.221; Dhalla I, 2008, CAN MED ASSOC J, V178, P428, DOI 10.1503/cmaj.070799; Doyle Y, 2001, BRIT MED J, V323, P222, DOI 10.1136/bmj.323.7306.222; Elie LM, 1998, CAN MED ASSOC J, V158, P1014; Foy R, 1999, BRIT MED J, V318, P456, DOI 10.1136/bmj.318.7181.456; Gellad WF, 2008, J GEN INTERN MED, V23, P1435, DOI 10.1007/s11606-008-0689-7; Goldberg DS, 2012, AM J PUBLIC HEALTH, V102, P44, DOI 10.2105/AJPH.2011.300325; Gostin LO, 2012, JAMA-J AM MED ASSOC, V308, P571, DOI 10.1001/jama.2012.9061; Government of Newfoundland and Labrador Department of Health and Community Services, 2003, GOV CREAT NEW SEN DR; Government of Nova Scotia Department of Health, 2003, PLAN ALZH DRUG COV R; Haas M, 2009, HEALTH POLICY, V92, P288, DOI 10.1016/j.healthpol.2009.05.002; Howard R, 2012, NEW ENGL J MED, V366, P893, DOI 10.1056/NEJMoa1106668; Huang YD, 2012, CELL, V148, P1204, DOI 10.1016/j.cell.2012.02.040; Humphreys K, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1316; IMS Healthlink Incorporated, 2011, TOP 20 GLOB PROD 201; Jewell CJ, 2008, MILBANK Q, V86, P177, DOI 10.1111/j.1468-0009.2008.00519.x; Mah CL, 2011, AM J PUBLIC HEALTH, V101, P1850, DOI 10.2105/AJPH.2011.300205; Martin DK, 2001, LANCET, V358, P1676, DOI 10.1016/S0140-6736(01)06714-9; Menon D, 2005, CAN J PUBLIC HEALTH, V96, P454, DOI 10.1007/BF03405189; Morden NE, 2007, J AM GERIATR SOC, V55, P622, DOI 10.1111/j.1532-5415.2007.01106.x; Morrison S, 1998, HAMILTON SPECTA 0718; Neuman P, 2009, NEW ENGL J MED, V361, P406, DOI 10.1056/NEJMhpr0809949; Neumann PJ, 2012, NEW ENGL J MED, V366, P585, DOI 10.1056/NEJMp1200390; Okie S, 2011, NEW ENGL J MED, V365, P1069, DOI 10.1056/NEJMp1107288; Oliver TR, 2006, ANNU REV PUBL HEALTH, V27, P195, DOI 10.1146/annurev.publhealth.25.101802.123126; Ontario Ministry of Health and Long-Term Care, 1999, ONT STRAT ALZH DIS R; Province of Newfoundland and Labrador, 2000, NEWF LABR HOUS ASS P, VXLIV; Province of Newfoundland and Labrador, 2005, NEWF LABR HOUS ASS P, VXLV; Province of Newfoundland and Labrador, 1999, NEWF LABR HOUS ASS P, VXLIV; Province of Newfoundland and Labrador, 2006, NEWF LABR HOUS ASS P, VXLV; Province of Nova Scotia, 2002, NOV SCOT HOUS ASS DE; Raina P, 2008, ANN INTERN MED, V148, P379, DOI 10.7326/0003-4819-148-5-200803040-00009; Rogers SL, 1998, NEUROLOGY, V50, P136, DOI 10.1212/WNL.50.1.136; Rogers SL, 1998, ARCH INTERN MED, V158, P1021, DOI 10.1001/archinte.158.9.1021; Rogers SL, 1996, DEMENTIA, V7, P293, DOI 10.1159/000106895; Schiff GD, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001220; Schwartz LM, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e1086; Simon GE, 2005, J GEN INTERN MED, V20, P964, DOI 10.1111/j.1525-1497.2005.0232.x; Voelker R, 2008, JAMA-J AM MED ASSOC, V299, P1763, DOI 10.1001/jama.299.15.1763	53	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e56921	10.1371/journal.pone.0056921	http://dx.doi.org/10.1371/journal.pone.0056921			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	098BN	23460820	Green Submitted, gold, Green Published			2022-12-25	WOS:000315519000045
J	Moustafa, ME; Carlson, BA; Anver, MR; Bobe, G; Zhong, NX; Ward, JM; Perella, CM; Hoffmann, VJ; Rogers, K; Combs, GF; Schweizer, U; Merlino, G; Gladyshev, VN; Hatfield, DL				Moustafa, Mohamed E.; Carlson, Bradley A.; Anver, Miriam R.; Bobe, Gerd; Zhong, Nianxin; Ward, Jerrold M.; Perella, Christine M.; Hoffmann, Victoria J.; Rogers, Keith; Combs, Gerald F., Jr.; Schweizer, Ulrich; Merlino, Glenn; Gladyshev, Vadim N.; Hatfield, Dolph L.			Selenium and Selenoprotein Deficiencies Induce Widespread Pyogranuloma Formation in Mice, while High Levels of Dietary Selenium Decrease Liver Tumor Size Driven by TGF alpha	PLOS ONE			English	Article							SELENOCYSTEINE TRANSFER-RNA; EXPRESSION; HEPATOCARCINOGENESIS; INFLAMMATION; POPULATION; DELETION; DISEASES; LACKING; RESCUE; COLON	Changes in dietary selenium and selenoprotein status may influence both anti- and pro-cancer pathways, making the outcome of interventions different from one study to another. To characterize such outcomes in a defined setting, we undertook a controlled hepatocarcinogenesis study involving varying levels of dietary selenium and altered selenoprotein status using mice carrying a mutant (A37G) selenocysteine tRNA transgene (Trsp(tG37)) and/or a cancer driver TGF alpha transgene. The use of Trsp(tG37) altered selenoprotein expression in a selenoprotein and tissue specific manner and, at sufficient dietary selenium levels, separate the effect of diet and selenoprotein status. Mice were maintained on diets deficient in selenium (0.02 ppm selenium) or supplemented with 0.1, 0.4 or 2.25 ppm selenium or 30 ppm triphenylselenonium chloride (TPSC), a non-metabolized selenium compound. Trsp(tG37) transgenic and TGF alpha/Trsp(tG37) bi-transgenic mice subjected to selenium-deficient or TPSC diets developed a neurological phenotype associated with early morbidity and mortality prior to hepatocarcinoma development. Pathology analyses revealed widespread disseminated pyogranulomatous inflammation. Pyogranulomas occurred in liver, lungs, heart, spleen, small and large intestine, and mesenteric lymph nodes in these transgenic and bi-transgenic mice. The incidence of liver tumors was significantly increased in mice carrying the TGF alpha transgene, while dietary selenium and selenoprotein status did not affect tumor number and multiplicity. However, adenoma and carcinoma size and area were smaller in TGF alpha transgenic mice that were fed 0.4 and 2.25 versus 0.1 ppm of selenium. Thus, selenium and selenoprotein deficiencies led to widespread pyogranuloma formation, while high selenium levels inhibited the size of TGF alpha-induced liver tumors.	[Moustafa, Mohamed E.; Carlson, Bradley A.; Zhong, Nianxin; Hatfield, Dolph L.] NCI, Mol Biol Selenium Sect, Lab Canc Prevent, NIH, Bethesda, MD 20892 USA; [Anver, Miriam R.; Rogers, Keith] Sci Applicat Int Corp Frederick Inc, Pathol Histotechnol Lab, Frederick Natl Lab Canc Res, Frederick, MD USA; [Bobe, Gerd] Oregon State Univ, Dept Anim & Rangeland Sci, Coll Agr, Corvallis, OR 97331 USA; [Bobe, Gerd] Oregon State Univ, Linus Pauling Inst, Corvallis, OR 97331 USA; [Ward, Jerrold M.] NIAID, Immunopathol Sect, NIH, Bethesda, MD 20892 USA; [Perella, Christine M.] Sci Applicat Int Corp Frederick Inc, Lab Anim Sci Program, Frederick Natl Lab Canc Res, Frederick, MD USA; [Hoffmann, Victoria J.] NCI, Off Director, Diagnost & Res Serv Branch, Ctr Canc Res,NIH, Bethesda, MD 20892 USA; [Combs, Gerald F., Jr.] USDA ARS, Grand Forks Human Nutr Res Ctr, Grand Forks, ND 58202 USA; [Schweizer, Ulrich] Charite, Inst Expt Endokrinol, D-13353 Berlin, Germany; [Merlino, Glenn] NCI, Lab Canc Biol & Genet, NIH, Bethesda, MD 20892 USA; [Gladyshev, Vadim N.] Brigham & Womens Hosp, Dept Med, Div Genet, Boston, MA 02115 USA; [Gladyshev, Vadim N.] Harvard Univ, Sch Med, Boston, MA USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); Oregon State University; Oregon State University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); United States Department of Agriculture (USDA); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Hatfield, DL (corresponding author), NCI, Mol Biol Selenium Sect, Lab Canc Prevent, NIH, Bethesda, MD 20892 USA.	hatfield@dc37a.nci.nih.gov	Moustafa, Mohamed E/E-9002-2018; Gladyshev, Vadim N/J-6187-2013; Schweizer, Ulrich/E-8105-2013; Moustafa, Mohamed/AAM-2211-2021; Gladyshev, Vadim N/A-9894-2013	Schweizer, Ulrich/0000-0003-1380-4780; Moustafa, Mohamed/0000-0003-1308-6221; Gladyshev, Vadim/0000-0002-0372-7016	Intramural Research Program of the National Institutes of Health (NIH); National Cancer Institute; Center for Cancer Research; NIH; National Cancer Institute, National Institutes of Health [HHSN261200800001E]; NATIONAL CANCER INSTITUTE [R01CA080946, ZIABC005317] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM065204, R01GM061603] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG038004] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the Intramural Research Program of the National Institutes of Health (NIH), National Cancer Institute, Center for Cancer Research to DLH, NIH grants to VNG and the National Cancer Institute, National Institutes of Health, under Contract No. HHSN261200800001E. The authors express their sincere appreciation to BAC, R. Irons and C. D. Davis who made the video shown in the Online Supplementary Information in DLH's laboratory. The content of this publication does not necessarily reflect the views of policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brigelius-Flohe R, 2008, CHEM BIODIVERS, V5, P389, DOI 10.1002/cbdv.200890039; Brigelius-Flohe R, 2009, BBA-GEN SUBJECTS, V1790, P1555, DOI 10.1016/j.bbagen.2009.03.006; Carlson BA, 2005, J BIOL CHEM, V280, P5542, DOI 10.1074/jbc.M411725200; Carlson BA, 2007, J BIOL CHEM, V282, P32591, DOI 10.1074/jbc.M707036200; Carlson BA, 2012, CARCINOGENESIS, V33, P1806, DOI 10.1093/carcin/bgs230; Carlson BA, 2010, P NUTR SOC, V69, P300, DOI 10.1017/S002966511000176X; Carlson BA, 2009, MOLECULES, V14, P3509, DOI 10.3390/molecules14093509; Coash M, 2012, J FORMOS MED ASSOC, V111, P3, DOI 10.1016/j.jfma.2011.11.023; Conrad M, 2010, ANTIOXID REDOX SIGN, V12, P851, DOI 10.1089/ars.2009.2912; Davis CD, 2002, J NUTR, V132, P292, DOI 10.1093/jn/132.2.292; Diwadkar-Navsariwala V, 2006, P NATL ACAD SCI USA, V103, P8179, DOI 10.1073/pnas.0508218103; Felix K, 2004, CANCER RES, V64, P2910, DOI 10.1158/0008-5472.CAN-03-2672; HATFIELD D, 1979, BIOCHIM BIOPHYS ACTA, V564, P414, DOI 10.1016/0005-2787(79)90032-7; HATFIELD D, 1991, NUCLEIC ACIDS RES, V19, P939, DOI 10.1093/nar/19.4.939; Hatfield DL, 2012, SELENIUM: ITS MOLECULAR BIOLOGY AND ROLE IN HUMAN HEALTH, THIRD EDITION, P1, DOI 10.1007/978-1-4614-1025-6; Hatfield DL, 2006, PROG NUCLEIC ACID RE, V81, P97, DOI 10.1016/S0079-6603(06)81003-2; Hatfield DL, 2009, BBA-GEN SUBJECTS, V1790, P1541, DOI 10.1016/j.bbagen.2009.03.001; Hill KE, 2004, J NUTR, V134, P157, DOI 10.1093/jn/134.1.157; Hudson TS, 2012, CARCINOGENESIS, V33, P1225, DOI 10.1093/carcin/bgs129; Ip C, 2000, ANTICANCER RES, V20, P4179; Irons R, 2006, J NUTR, V136, P1311, DOI 10.1093/jn/136.5.1311; JHAPPAN C, 1990, CELL, V61, P1137, DOI 10.1016/0092-8674(90)90076-Q; Kasaikina MV, 2012, BBA-MOL CELL RES, V1823, P1633, DOI 10.1016/j.bbamcr.2012.02.018; KELMERS AD, 1971, ANAL BIOCHEM, V44, P486, DOI 10.1016/0003-2697(71)90236-3; MCSHANE LM, 1991, AM J CLIN NUTR, V53, P1354, DOI 10.1093/ajcn/53.6.1354; Moustafa ME, 2001, MOL CELL BIOL, V21, P3840, DOI 10.1128/MCB.21.11.3840-3852.2001; MURAKAMI H, 1993, CANCER RES, V53, P1719; Novoselov SV, 2005, ONCOGENE, V24, P8003, DOI 10.1038/sj.onc.1208940; Rayman MP, 2005, P NUTR SOC, V64, P527, DOI 10.1079/PNS2005467; Santoro D, 2008, J SMALL ANIM PRACT, V49, P552, DOI 10.1111/j.1748-5827.2008.00638.x; Schomburg L, 2003, BIOCHEM J, V370, P397, DOI 10.1042/BJ20021853; Schweizer U, 2004, BIOCHEM J, V378, P21, DOI 10.1042/BJ20031795; Song E, 2011, CLIN MOL ALLERGY, V9, P10, DOI [10.1186/1476-7961-9-10, DOI 10.1186/1476-7961-9-10]; Sunde RA, 2009, BIOSCIENCE REP, V29, P329, DOI 10.1042/BSR20080146; Tsuji PA, 2012, PLOS ONE IN PRESS; Valentine WM, 2005, TOXICOL PATHOL, V33, P570, DOI 10.1080/01926230500243045; Vunta H, 2007, J BIOL CHEM, V282, P17964, DOI 10.1074/jbc.M703075200; WILLIAMS GT, 1983, J CLIN PATHOL, V36, P723, DOI 10.1136/jcp.36.7.723; Wirth EK, 2010, FASEB J, V24, P844, DOI 10.1096/fj.09-143974	39	20	21	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57389	10.1371/journal.pone.0057389	http://dx.doi.org/10.1371/journal.pone.0057389			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460847	gold, Green Published, Green Submitted			2022-12-25	WOS:000315519000101
J	Yadav, UCS; Naura, AS; Aguilera-Aguirre, L; Boldogh, I; Boulares, HA; Calhoun, WJ; Ramana, KV; Srivastava, SK				Yadav, Umesh C. S.; Naura, Amarjit S.; Aguilera-Aguirre, Leopoldo; Boldogh, Istvan; Boulares, Hamid A.; Calhoun, William J.; Ramana, Kota V.; Srivastava, Satish K.			Aldose Reductase Inhibition Prevents Allergic Airway Remodeling through PI3K/AKT/GSK3 beta Pathway in Mice	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; PHOSPHATIDYLINOSITOL 3-KINASE/AKT PATHWAY; EPITHELIAL-MESENCHYMAL TRANSITION; TRANSFORMING GROWTH-FACTOR-BETA-1; OXIDATIVE STRESS; LUNG FIBROBLASTS; FLOW LIMITATION; SMOOTH-MUSCLE; P38 MAPK; ASTHMA	Background: Long-term and unresolved airway inflammation and airway remodeling, characteristic features of chronic asthma, if not treated could lead to permanent structural changes in the airways. Aldose reductase (AR), an aldo-sugar and lipid aldehyde metabolizing enzyme, mediates allergen- induced airway inflammation in mice, but its role in the airway remodeling is not known. In the present study, we have examined the role of AR on airway remodeling using ovalbumin (OVA)-induced chronic asthma mouse model and cultured human primary airway epithelial cells (SAECs) and mouse lung fibroblasts (mLFs). Methods: Airway remodeling in chronic asthma model was established in mice sensitized and challenged twice a week with OVA for 6 weeks. AR inhibitor, fidarestat, was administered orally in drinking water after first challenge. Inflammatory cells infiltration in the lungs and goblet cell metaplasia, airway thickening, collagen deposition and airway hyper- responsiveness (AHR) in response to increasing doses of methacholine were assessed. The TGF beta 1-induced epithelial-mesenchymal transition (EMT) in SAECs and changes in mLFs were examined to investigate AR- mediated molecular mechanism(s) of airway remodeling. Results: In the OVA-exposed mice for 6 wks inflammatory cells infiltration, levels of inflammatory cytokines and chemokines, goblet cell metaplasia, collagen deposition and AHR were significantly decreased by treatment with AR inhibitor, fidarestat. Further, inhibition of AR prevented TGF beta 1-induced altered expression of E-cadherin, Vimentin, Occludin, and MMP-2 in SAECs, and alpha-smooth muscle actin and fibronectin in mLFs. Further, in SAECs, AR inhibition prevented TGF beta 1-induced activation of PI3K/AKT/GSK3 beta pathway but not the phosphorylation of Smad2/3. Conclusion: Our results demonstrate that allergen-induced airway remodeling is mediated by AR and its inhibition blocks the progression of remodeling via inhibiting TGF beta 1-induced Smad-independent and PI3K/AKT/GSK3 beta-dependent pathway.	[Yadav, Umesh C. S.; Ramana, Kota V.; Srivastava, Satish K.] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA; [Aguilera-Aguirre, Leopoldo; Boldogh, Istvan] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA; [Boulares, Hamid A.] Louisiana State Univ, Hlth Sci Ctr, Dept Pharmacol & Expt Therapeut, New Orleans, LA USA; [Naura, Amarjit S.; Boulares, Hamid A.] Louisiana State Univ, Hlth Sci Ctr, Stanley Scot Canc Ctr, New Orleans, LA USA; [Naura, Amarjit S.] Louisiana State Univ, Hlth Sci Ctr, Dept Med, New Orleans, LA USA; [Calhoun, William J.] Univ Texas Med Branch, Dept Internal Med Pulm Crit Care, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; University of Texas System; University of Texas Medical Branch Galveston	Srivastava, SK (corresponding author), Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.	ssrivast@utmb.edu	Aguilera-Aguirre, Leopoldo/B-9864-2012	Aguilera-Aguirre, Leopoldo/0000-0001-7964-7402; Calhoun, William/0000-0001-7075-712X	American Asthma Foundation grant [AAF 08-0219]; National Institutes of Health [HL072889]; American Cancer Society [RSG-116608]; National Institute of Environmental Health Sciences (NIEHS) grant [ES018948]; NIEHS core facility grant [ES00667616A1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL072889] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI062885] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES018948] Funding Source: NIH RePORTER	American Asthma Foundation grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); National Institute of Environmental Health Sciences (NIEHS) grant; NIEHS core facility grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was supported by funds from American Asthma Foundation grant (AAF 08-0219) to SKS. SKS is a William Bowes Senior Fellow of the American Asthma Foundation. HAB is supported by grants from National Institutes of Health (HL072889) and from American Cancer Society (RSG-116608). IB is supported from National Institute of Environmental Health Sciences (NIEHS) grant (ES018948). This study was also supported by NIEHS core facility grant (ES00667616A1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcorn JF, 2007, AM J RESP CRIT CARE, V176, P974, DOI 10.1164/rccm.200702-334OC; Alexiou P, 2009, CURR MED CHEM, V16, P734, DOI 10.2174/092986709787458362; Bai TR, 2010, CURR OPIN ALLERGY CL, V10, P82, DOI 10.1097/ACI.0b013e32833363b2; Bergeron C, 2010, CAN RESPIR J, V17, pE85, DOI 10.1155/2010/318029; Bergeron Celine, 2009, Proc Am Thorac Soc, V6, P301, DOI 10.1513/pats.200808-089RM; Brown SD, 2012, J ALLERGY CLIN IMMUN, V129, P388, DOI 10.1016/j.jaci.2011.11.037; Chen RH, 1998, ONCOGENE, V17, P1959, DOI 10.1038/sj.onc.1202111; Chen XF, 2012, MOL BIOL REP, V39, P3549, DOI 10.1007/s11033-011-1128-0; Davies Donna E, 2009, Proc Am Thorac Soc, V6, P678, DOI 10.1513/pats.200907-067DP; Fahy J V, 2000, Curr Opin Pulm Med, V6, P15, DOI 10.1097/00063198-200001000-00004; Farghaly HSM, 2008, MOL PHARMACOL, V73, P1530, DOI 10.1124/mol.108.045419; Hackett TL, 2009, AM J RESP CRIT CARE, V180, P122, DOI 10.1164/rccm.200811-1730OC; Halwani R, 2011, AM J RESP CELL MOL, V44, P127, DOI 10.1165/rcmb.2010-0027TR; Hesselmar B, 2000, PEDIATR ALLERGY IMMU, V11, P74, DOI 10.1034/j.1399-3038.2000.00070.x; Horowitz JC, 2004, J BIOL CHEM, V279, P1359, DOI 10.1074/jbc.M306248200; Hwang YYC, 2004, FASEB J, V18, P1192, DOI 10.1096/fj.03-1400com; Kador PF, 2011, J PERIODONTOL, V82, P926, DOI 10.1902/jop.2010.100442; Laprise C, 1999, EUR RESPIR J, V14, P63, DOI 10.1034/j.1399-3003.1999.14a12.x; Le Saux CJ, 2008, J BIOL CHEM, V283, P5760, DOI 10.1074/jbc.M701572200; Lien SC, 2006, CELL SIGNAL, V18, P1270, DOI 10.1016/j.cellsig.2005.10.013; Lim DH, 2009, AM J PHYSIOL-LUNG C, V296, pL210, DOI 10.1152/ajplung.90275.2008; Makinde T, 2007, IMMUNOL CELL BIOL, V85, P348, DOI 10.1038/sj.icb.7100044; Martin MM, 2007, AM J PHYSIOL-LUNG C, V293, pL790, DOI 10.1152/ajplung.00099.2007; Mauad T, 2007, J ALLERGY CLIN IMMUN, V120, P997, DOI 10.1016/j.jaci.2007.06.031; MEYER WR, 1992, AM J OBSTET GYNECOL, V167, P1837, DOI 10.1016/0002-9378(92)91784-8; Moir LM, 2011, J PHARMACOL EXP THER, V337, P557, DOI 10.1124/jpet.110.173583; Morcillo EJ, 2006, CURR OPIN PULM MED, V12, P1, DOI 10.1097/01.mcp.0000198064.27586.37; Nadeem A, 2003, J ALLERGY CLIN IMMUN, V111, P72, DOI 10.1067/mai.2003.17; Nadeem Ahmed, 2008, Ther Adv Respir Dis, V2, P215, DOI 10.1177/1753465808094971; Narula M K, 2007, Indian J Physiol Pharmacol, V51, P289; Naura AS, 2010, J IMMUNOL, V185, P3076, DOI 10.4049/jimmunol.0904214; Pascual RM, 2005, J ALLERGY CLIN IMMUN, V116, P477, DOI 10.1016/j.jaci.2005.07.011; Rahman I, 2003, J BIOCHEM MOL BIOL, V36, P95; Ramana KV, 2006, J BIOL CHEM, V281, P33019, DOI 10.1074/jbc.M603819200; Ravindranath TM, 2009, J IMMUNOL, V183, P8128, DOI 10.4049/jimmunol.0900720; Rhyu DY, 2005, J AM SOC NEPHROL, V16, P667, DOI 10.1681/ASN.2004050425; Rogers DF, 2004, CURR OPIN PHARMACOL, V4, P241, DOI 10.1016/j.coph.2004.01.011; Rowan WC, 2012, BIOCHEM SOC T, V40, P240, DOI 10.1042/BST20110665; Sagara H, 2002, J ALLERGY CLIN IMMUN, V110, P249, DOI 10.1067/mai.2002.126078; Shimizu K, 2010, RESP MED, V104, P1809, DOI 10.1016/j.rmed.2010.06.013; Shiraishi Y, 2009, J ALLERGY CLIN IMMUN, V123, pS56, DOI 10.1016/j.jaci.2008.11.047; Srivastava SK, 2011, CHEM-BIOL INTERACT, V191, P330, DOI 10.1016/j.cbi.2011.02.023; Steiling Katrina, 2009, Proc Am Thorac Soc, V6, P697, DOI 10.1513/pats.200907-076DP; Sugiura H, 2008, ANTIOXID REDOX SIGN, V10, P785, DOI 10.1089/ars.2007.1937; Sumi Yuki, 2007, Allergol Int, V56, P341, DOI 10.2332/allergolint.R-07-153; Tagaya Etsuko, 2007, Allergol Int, V56, P331; Takahashi K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030134; Tammali R, 2011, CARCINOGENESIS, V32, P1259, DOI 10.1093/carcin/bgr102; Tsukagoshi H, 2002, TOXICOL APPL PHARM, V184, P127, DOI 10.1006/taap.2002.9514; Undevia NS, 2004, AM J PHYSIOL-LUNG C, V287, pL515, DOI 10.1152/ajplung.00044.2004; Vedantham Srinivasan, 2012, Cardiovascular & Hematological Agents in Medicinal Chemistry, V10, P234; Willis Brigham C, 2006, Proc Am Thorac Soc, V3, P377, DOI 10.1513/pats.200601-004TK; Yadav UCS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014440; Yadav UCS, 2009, J IMMUNOL, V183, P4723, DOI 10.4049/jimmunol.0901177; Yadav UCS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006535; Yamaguchi M, 2008, J INVEST ALLERG CLIN, V18, P202	56	30	36	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57442	10.1371/journal.pone.0057442	http://dx.doi.org/10.1371/journal.pone.0057442			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460857	Green Published, Green Submitted, gold			2022-12-25	WOS:000315519000111
J	Barr, TP; Albrecht, PJ; Hou, QZ; Mongin, AA; Strichartz, GR; Rice, FL				Barr, Travis P.; Albrecht, Phillip J.; Hou, Quanzhi; Mongin, Alexander A.; Strichartz, Gary R.; Rice, Frank L.			Air-Stimulated ATP Release from Keratinocytes Occurs through Connexin Hemichannels	PLOS ONE			English	Article							HUMAN EPIDERMAL-KERATINOCYTES; P2X(3)/P2X(2/3) RECEPTOR ANTAGONIST; HUMAN SKIN; GLUTAMATE RELEASE; NEUROPATHIC PAIN; INFLAMMATORY MEDIATORS; INTRACELLULAR CALCIUM; PURINERGIC RECEPTORS; BARRIER DISRUPTION; MOUSE ASTROCYTES	Cutaneous ATP release plays an important role in both epidermal stratification and chronic pain, but little is known about ATP release mechanisms in keratinocytes that comprise the epidermis. In this study, we analyzed ATP release from cultured human neonatal keratinocytes briefly exposed to air, a process previously demonstrated to trigger ATP release from these cells. We show that exposing keratinocytes to air by removing media for 15 seconds causes a robust, long-lasting ATP release. This air-stimulated ATP release was increased in calcium differentiated cultures which showed a corresponding increase in connexin 43 mRNA, a major component of keratinocyte hemichannels. The known connexin hemichannel inhibitors 1-octanol and carbenoxolone both significantly reduced air-stimulated ATP release, as did two drugs traditionally used as ABC transporter inhibitors (glibenclamide and verapamil). These same 4 inhibitors also prevented an increase in the uptake of a connexin permeable dye induced by air exposure, confirming that connexin hemichannels are open during air-stimulated ATP release. In contrast, activity of the MDR1 ABC transporter was reduced by air exposure and the drugs that inhibited air-stimulated ATP release had differential effects on this transporter. These results indicate that air exposure elicits non-vesicular release of ATP from keratinocytes through connexin hemichannels and that drugs used to target connexin hemichannels and ABC transporters may cross-inhibit. Connexins represent a novel, peripheral target for the treatment of chronic pain and dermatological disease.	[Barr, Travis P.; Strichartz, Gary R.] Brigham & Womens Hosp, Dept Anesthesiol Perioperat & Pain Med, Pain Res Ctr, Boston, MA 02115 USA; [Albrecht, Phillip J.; Hou, Quanzhi; Mongin, Alexander A.; Rice, Frank L.] Albany Med Coll, Ctr Neurosci & Neuropharmacol, Albany, NY 12208 USA; [Strichartz, Gary R.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Albany Medical College; Harvard University; Harvard Medical School	Rice, FL (corresponding author), Albany Med Coll, Ctr Neurosci & Neuropharmacol, Albany, NY 12208 USA.	ricef@mail.amc.edu	Albrecht, Phillip J./AAC-6144-2021; Mongin, Alexander A./A-5526-2008	Mongin, Alexander A./0000-0002-2501-3778	Rosenblatt Fund for Neurofibromytosis Research; United States Public Health Service [R-01 CA080153]; NATIONAL CANCER INSTITUTE [R01CA080153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS061953] Funding Source: NIH RePORTER	Rosenblatt Fund for Neurofibromytosis Research; United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded in part by the Rosenblatt Fund for Neurofibromytosis Research (to FLR) and United States Public Health Service grant R-01 CA080153 (to GRS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CM, 2006, TRENDS NEUROSCI, V29, P257, DOI 10.1016/j.tins.2006.03.003; Azorin N, 2011, EXP DERMATOL, V20, P401, DOI 10.1111/j.1600-0625.2010.01219.x; Ballerini P, 2002, NEUROREPORT, V13, P1789, DOI 10.1097/00001756-200210070-00019; Bao L, 2004, AM J PHYSIOL-CELL PH, V287, pC1389, DOI 10.1152/ajpcell.00220.2004; Barclay J, 2002, J NEUROSCI, V22, P8139; Bruzzone R, 2005, J NEUROCHEM, V92, P1033, DOI 10.1111/j.1471-4159.2004.02947.x; Burnstock G, 2009, CURR PHARM DESIGN, V15, P1717, DOI 10.2174/138161209788186335; Burrell HE, 2005, J BIOL CHEM, V280, P29667, DOI 10.1074/jbc.M505381200; Cao C, 2007, J CELL PHYSIOL, V212, P252, DOI 10.1002/jcp.21026; Celetti SJ, 2010, J CELL SCI, V123, P1363, DOI 10.1242/jcs.056093; Chen Y, 2005, PAIN, V119, P38, DOI 10.1016/j.pain.2005.09.007; Cook SP, 2002, PAIN, V95, P41, DOI 10.1016/S0304-3959(01)00372-4; Denda M, 2006, EXP DERMATOL, V15, P455, DOI 10.1111/j.0906-6705.2006.00430.x; Denda M, 2002, J INVEST DERMATOL, V119, P1034, DOI 10.1046/j.1523-1747.2002.19505.x; Denda M, 1998, J INVEST DERMATOL, V111, P873, DOI 10.1046/j.1523-1747.1998.00364.x; Denda M, 1998, J INVEST DERMATOL, V111, P858, DOI 10.1046/j.1523-1747.1998.00333.x; Denda M, 2007, SKIN RES TECHNOL, V13, P195, DOI 10.1111/j.1600-0846.2007.00210.x; Denda M, 2007, EXP DERMATOL, V16, P157, DOI 10.1111/j.1600-0625.2006.00529.x; Djalilian AR, 2006, J CLIN INVEST, V116, P1243, DOI 10.1172/JCI27186; Dussor G, 2009, BRAIN RES REV, V60, P24, DOI 10.1016/j.brainresrev.2008.12.013; Fan HT, 2001, BRIT J PHARMACOL, V133, P1096, DOI 10.1038/sj.bjp.0704159; Gangatirkar P, 2007, NAT PROTOC, V2, P178, DOI 10.1038/nprot.2006.448; GOLIGER JA, 1994, DEV DYNAM, V200, P1, DOI 10.1002/aja.1002000102; Golstein PE, 1999, PFLUG ARCH EUR J PHY, V437, P652, DOI 10.1007/s004240050829; Greig AVH, 2003, J INVEST DERMATOL, V120, P1007, DOI 10.1046/j.1523-1747.2003.12261.x; Hamilton SG, 2000, BRAIN, V123, P1238, DOI 10.1093/brain/123.6.1238; Hamilton SG, 1999, BRIT J PHARMACOL, V126, P326, DOI 10.1038/sj.bjp.0702258; Hanstein Regina, 2010, Open Pain J, V3, P123; Henry PD, 1979, PRACTICAL CARDIOL, V5, P145; Honore P, 2002, PAIN, V99, P11, DOI 10.1016/S0304-3959(02)00032-5; Hou Q, 2011, PAIN; Huang SM, 2008, J NEUROSCI, V28, P13727, DOI 10.1523/JNEUROSCI.5741-07.2008; Ibrahim MM, 2005, P NATL ACAD SCI USA, V102, P3093, DOI 10.1073/pnas.0409888102; Jarvis MF, 2002, P NATL ACAD SCI USA, V99, P17179, DOI 10.1073/pnas.252537299; Kang J, 2008, J NEUROSCI, V28, P4702, DOI 10.1523/JNEUROSCI.5048-07.2008; Khodorova A, 2003, NAT MED, V9, P1055, DOI 10.1038/nm885; Kielar D, 2003, J INVEST DERMATOL, V121, P465, DOI 10.1046/j.1523-1747.2003.12404.x; Kwan KY, 2009, J NEUROSCI, V29, P4808, DOI 10.1523/JNEUROSCI.5380-08.2009; Lee H, 2005, PFLUG ARCH EUR J PHY, V451, P160, DOI 10.1007/s00424-005-1438-y; Liu HT, 2008, CELL RES, V18, P558, DOI 10.1038/cr.2008.49; Liu HT, 2006, GLIA, V54, P343, DOI 10.1002/glia.20400; Malarkey EB, 2008, NEUROCHEM INT, V52, P142, DOI 10.1016/j.neuint.2007.06.005; Malin SA, 2008, PAIN, V138, P484, DOI 10.1016/j.pain.2008.01.026; Mandadi S, 2009, PFLUG ARCH EUR J PHY, V458, P1093, DOI 10.1007/s00424-009-0703-x; McGaraughty S, 2003, BRIT J PHARMACOL, V140, P1381, DOI 10.1038/sj.bjp.0705574; Minich T, 2006, J NEUROCHEM, V97, P373, DOI 10.1111/j.1471-4159.2006.03737.x; Paukert M, 2001, J BIOL CHEM, V276, P21077, DOI 10.1074/jbc.M101465200; PILLAI S, 1992, J CLIN INVEST, V90, P42, DOI 10.1172/JCI115854; Roman RM, 2001, J MEMBRANE BIOL, V183, P165, DOI 10.1007/s00232-001-0064-7; SALOMON D, 1994, J INVEST DERMATOL, V103, P240, DOI 10.1111/1523-1747.ep12393218; Scheckenbach K. L., 2010, AM J RESP CELL MOL B; SCHMIDANTOMARCHI H, 1987, BIOCHEM BIOPH RES CO, V146, P21, DOI 10.1016/0006-291X(87)90684-X; SHEPPARD DN, 1992, J GEN PHYSIOL, V100, P573, DOI 10.1085/jgp.100.4.573; Silverman W, 2008, AM J PHYSIOL-CELL PH, V295, pC761, DOI 10.1152/ajpcell.00227.2008; Simpson CL, 2010, METHODS MOL BIOL, V585, P127, DOI 10.1007/978-1-60761-380-0_10; Tsutsumi M, 2009, CELL TISSUE RES, V338, P99, DOI 10.1007/s00441-009-0848-0; Wirkner K, 2007, MOL NEUROBIOL, V36, P165, DOI 10.1007/s12035-007-0033-y; Wu G, 2004, EUR J PHARMACOL, V504, P45, DOI 10.1016/j.ejphar.2004.09.056; Xu GY, 2002, J NEUROSCI, V22, P93, DOI 10.1523/JNEUROSCI.22-01-00093.2002; Yamamura H, 2008, BIOCHEM BIOPH RES CO, V373, P155, DOI 10.1016/j.bbrc.2008.06.008; Ye ZC, 2003, J NEUROSCI, V23, P3588, DOI 10.1523/jneurosci.23-09-03588.2003; Zhao P, 2008, PAIN, V139, P90, DOI 10.1016/j.pain.2008.03.016; Zimmermann H, 2000, N-S ARCH PHARMACOL, V362, P299, DOI 10.1007/s002100000309; Zylka MJ, 2005, NEURON, V45, P17, DOI 10.1016/j.neuron.2004.12.015	64	39	42	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56744	10.1371/journal.pone.0056744	http://dx.doi.org/10.1371/journal.pone.0056744			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457608	Green Published, gold, Green Submitted			2022-12-25	WOS:000315603700076
J	Gray, RT; Prestage, GP; Down, I; Ghaus, MH; Hoare, A; Bradley, J; Wilson, DP				Gray, Richard T.; Prestage, Garrett P.; Down, Ian; Ghaus, Muhammad Haris; Hoare, Alexander; Bradley, Jack; Wilson, David P.			Increased HIV Testing Will Modestly Reduce HIV Incidence among Gay Men in NSW and Would Be Acceptable if HIV Testing Becomes Convenient	PLOS ONE			English	Article							HOMOSEXUAL-MEN; SEX; AUSTRALIA; RISK; INFECTION; SYDNEY; COHORT	Objective: Determine the acceptability and epidemiological impact of increases in HIV testing in gay men in New South Wales (NSW), Australia- particularly pertinent when considering treatment as prevention and the need to reduce undiagnosed infections. Methods: We conducted an online survey and focus groups to assess whether increases in HIV testing would be acceptable to gay men in NSW. In parallel, we assessed the potential impact of increases in testing coverage and/or frequency using an individual-based model of HIV transmission. Results: If sexual practices and the rate of initiating HIV treatment are unchanged then increasing HIV testing reduces infections. Increasing testing frequency has the largest impact, with a 13.8% reduction in HIV infections over 10 years if the similar to 55-75% of men who test at least once per year increased their testing frequency to four times per year. If testing levels decrease from current levels then we expect an increase in HIV infections with a sharply rising trend over time. Increasing HIV testing would be acceptable if testing was more convenient. However, only similar to 25% of men surveyed were 'very likely' to increase their level of HIV testing. Men delayed or avoided testing due to the slowness in obtaining results and if they believed they had not put themselves at risk. Conclusions: An increase in HIV testing alone is unlikely to reduce HIV incidence substantially in NSW gay men-however, the relatively high testing levels need to continue to prevent an increase in HIV infections. In jurisdictions with lower levels of HIV testing, increases in testing coverage and frequency are likely to have a larger impact. Successful treatment as prevention interventions will require increases in testing rates; such increases would be acceptable to gay men in NSW but only if more convenient testing and rapid communication of results were available.	[Gray, Richard T.; Prestage, Garrett P.; Down, Ian; Ghaus, Muhammad Haris; Hoare, Alexander; Bradley, Jack; Wilson, David P.] Univ New S Wales, Kirby Inst, Sydney, NSW, Australia; [Prestage, Garrett P.] La Trobe Univ, Australian Res Ctr Sex Hlth & Soc, Melbourne, Vic, Australia	University of New South Wales Sydney; Kirby Institute; La Trobe University	Gray, RT (corresponding author), Univ New S Wales, Kirby Inst, Sydney, NSW, Australia.	rgray@kirby.unsw.edu.au	Wilson, David P/G-4614-2013	Prestage, Garrett/0000-0003-3917-8992; Gray, Richard/0000-0002-2885-0483; Down, Ian/0000-0001-9275-8692	Australian Government Department of Health and Ageing; Australian Research Council [FT0991990]; National Health and Medical Research Council [630495]; University of New South Wales	Australian Government Department of Health and Ageing(Australian GovernmentDepartment of Health & Ageing); Australian Research Council(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); University of New South Wales	This study was funded from the following sources: the Australian Government Department of Health and Ageing; Australian Research Council (FT0991990); the National Health and Medical Research Council (630495); the University of New South Wales. The views expressed in this publication do not necessarily represent the position of the Australian Government. The Kirby Institute is affiliated with the Faculty of Medicine, University of New South Wales. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Dept Health and Ageing, 2010, 6 NAT HIV STRAT 2010; Fogarty A., 2006, HLTH MEN POSITIVE HL; Fox J, 2009, HIV MED, V10, P432, DOI 10.1111/j.1468-1293.2009.00708.x; Gray RT, 2011, VACCINE, V29, P6125, DOI 10.1016/j.vaccine.2011.06.061; Grulich AE, 2008, SEX HEALTH, V5, P113, DOI 10.1071/SH07075; Guy R, 2010, SEX TRANSM INFECT, V86, P371, DOI 10.1136/sti.2009.040972; Hammer SM, 2011, NEW ENGL J MED, V4, P1; Jin FY, 2009, AIDS, V23, P243, DOI 10.1097/QAD.0b013e32831fb51a; Kirby Institute, 2011, HIV VIR HEP SEX TRAN; Mao LM, 2006, AIDS, V20, P1204, DOI 10.1097/01.aids.0000226964.17966.75; National Centre in HIV Social Research, 2009, SYDN GAY COMM PER SU; Prestage G, 2008, SEX HEALTH, V5, P97, DOI 10.1071/SH07080; Prestage G, 2012, SEX TRANSM DIS, V39, P167, DOI 10.1097/OLQ.0b013e31823e67a9; Steward WT, 2009, AIDS BEHAV, V13, P1054, DOI 10.1007/s10461-009-9582-6; Strauss AL., 1987, QUALITATIVE ANAL SOC, Vxv, P319; The Ministerial Advisory Committee on AIDS, 2006, NAT HIV TEST POL 200; Wilson DP, 2010, SEX TRANSM DIS, V37, P13, DOI 10.1097/OLQ.0b013e3181b35549; Wilson DP, 2009, SEX HEALTH, V6, P19, DOI 10.1071/SH08081; Wilson DP, 2011, NSW HIV MODELLING AC; Zablotska I, 2007, SYDNEY GAY COMMUNITY; Zablotska IB, 2008, INT J STD AIDS, V19, P758, DOI 10.1258/ijsa.2008.008193; Zablotska IB, 2012, AIDS BEHAV, V16, P669, DOI 10.1007/s10461-011-9919-9	23	42	44	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e55449	10.1371/journal.pone.0055449	http://dx.doi.org/10.1371/journal.pone.0055449			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457470	Green Published, Green Submitted, gold			2022-12-25	WOS:000315603700013
J	Serriere, J; Fenel, D; Schoehn, G; Gouet, P; Guillon, C				Serriere, Jennifer; Fenel, Daphna; Schoehn, Guy; Gouet, Patrice; Guillon, Christophe			Biophysical Characterization of the Feline Immunodeficiency Virus p24 Capsid Protein Conformation and In Vitro Capsid Assembly	PLOS ONE			English	Article							ROUS-SARCOMA-VIRUS; C-TERMINAL DOMAIN; DIMERIZATION DOMAIN; ELECTRON-MICROSCOPY; PEPTIDE INHIBITOR; SELF-ASSOCIATION; HIV-1CA PROTEIN; TYPE-1; CORE; PARTICLES	The Feline Immunodeficiency Virus (FIV) capsid protein p24 oligomerizes to form a closed capsid that protects the viral genome. Because of its crucial role in the virion, FIV p24 is an interesting target for the development of therapeutic strategies, although little is known about its structure and assembly. We defined and optimized a protocol to overexpress recombinant FIV capsid protein in a bacterial system. Circular dichroism and isothermal titration calorimetry experiments showed that the structure of the purified FIV p24 protein was comprised mainly of alpha-helices. Dynamic light scattering (DLS) and cross-linking experiments demonstrated that p24 was monomeric at low concentration and dimeric at high concentration. We developed a protocol for the in vitro assembly of the FIV capsid. As with HIV, an increased ionic strength resulted in FIV p24 assembly in vitro. Assembly appeared to be dependent on temperature, salt concentration, and protein concentration. The FIV p24 assembly kinetics was monitored by DLS. A limit end-point diameter suggested assembly into objects of definite shapes. This was confirmed by electron microscopy, where FIV p24 assembled into spherical particles. Comparison of FIV p24 with other retroviral capsid proteins showed that FIV assembly is particular and requires further specific study.	[Serriere, Jennifer; Gouet, Patrice; Guillon, Christophe] Univ Lyon, Lab Biocristallog & Biol Struct Cibles Therapeut, IBCP, SFR BioSci Gerland Lyon Sud,BMSSI,CNRS,UMR 5086, Lyon, France; [Fenel, Daphna; Schoehn, Guy] CEA, Inst Biol Struct Jean Pierre Ebel, UMR 5075, Grenoble, France; [Fenel, Daphna; Schoehn, Guy] CNRS, Inst Biol Struct Jean Pierre Ebel, UMR 5075, Grenoble, France; [Fenel, Daphna; Schoehn, Guy] Univ Grenoble 1, Inst Biol Struct Jean Pierre Ebel, UMR 5075, Grenoble, France; [Schoehn, Guy] UJF, Unit Virus Host Cell Interact, UMI 3265, CNRS,EMBL, Grenoble, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); European Molecular Biology Laboratory (EMBL); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Guillon, C (corresponding author), Univ Lyon, Lab Biocristallog & Biol Struct Cibles Therapeut, IBCP, SFR BioSci Gerland Lyon Sud,BMSSI,CNRS,UMR 5086, Lyon, France.	christophe.guillon@ibcp.fr	Guillon, Christophe/A-4084-2015	Guillon, Christophe/0000-0001-6378-3303; Schoehn, Guy/0000-0002-1459-3201; gouet, patrice/0000-0001-9485-6157	Agence Nationale de Recherche sur le SIDA; Ministere de l'Enseignement Superieur et de la Recherche	Agence Nationale de Recherche sur le SIDA(ANRSFrench National Research Agency (ANR)); Ministere de l'Enseignement Superieur et de la Recherche	This project was supported by the Agence Nationale de Recherche sur le SIDA. J.S. was the recipient of a grant from the Ministere de l'Enseignement Superieur et de la Recherche. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdurahman S, 2008, ANTIMICROB AGENTS CH, V52, P3737, DOI 10.1128/AAC.00265-08; Adamson CS, 2007, ADV PHARMACOL, V55, P347, DOI 10.1016/S1054-3589(07)55010-6; Affranchino JL, 2010, VIRUS RES, V150, P153, DOI 10.1016/j.virusres.2010.03.012; Bailey GD, 2009, STRUCTURE, V17, P737, DOI 10.1016/j.str.2009.03.010; Barklis E, 2009, J MOL BIOL, V387, P376, DOI 10.1016/j.jmb.2009.01.058; Bartonova V, 2008, J BIOL CHEM, V283, P32024, DOI 10.1074/jbc.M804230200; BENDINELLI M, 1995, CLIN MICROBIOL REV, V8, P87, DOI 10.1128/CMR.8.1.87; Benjamin J, 2005, J MOL BIOL, V346, P577, DOI 10.1016/j.jmb.2004.11.064; Bharat T.A.M., 2012, NATURE; Bhattacharya S, 2008, J BIOL CHEM, V283, P16274, DOI 10.1074/jbc.C800048200; Bocanegra R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023877; Briggs JAG, 2006, STRUCTURE, V14, P15, DOI 10.1016/j.str.2005.09.010; Briggs JAG, 2003, EMBO J, V22, P1707, DOI 10.1093/emboj/cdg143; Campbell S, 1999, J VIROL, V73, P2270, DOI 10.1128/JVI.73.3.2270-2279.1999; CAMPBELL S, 1995, J VIROL, V69, P6487, DOI 10.1128/JVI.69.10.6487-6497.1995; Chen B, 2010, PROTEIN SCI, V19, P716, DOI 10.1002/pro.348; Cortines JR, 2011, J MOL BIOL, V410, P641, DOI 10.1016/j.jmb.2011.03.052; del Alamo M, 2005, J VIROL, V79, P14271, DOI 10.1128/JVI.79.22.14271-14281.2005; Dickson C, 1984, MOL BIOL TUMOR VIRUS, P513; DORFMAN T, 1994, J VIROL, V68, P8180, DOI 10.1128/JVI.68.12.8180-8187.1994; EHRLICH LS, 1992, J VIROL, V66, P4874, DOI 10.1128/JVI.66.8.4874-4883.1992; Ehrlich LS, 2001, BIOPHYS J, V81, P586, DOI 10.1016/S0006-3495(01)75725-6; Fuller SD, 1997, CURR BIOL, V7, P729, DOI 10.1016/S0960-9822(06)00331-9; Gamble TR, 1997, SCIENCE, V278, P849, DOI 10.1126/science.278.5339.849; Ganser BK, 1999, SCIENCE, V283, P80, DOI 10.1126/science.283.5398.80; Ganser-Pornillos BK, 2007, CELL, V131, P70, DOI 10.1016/j.cell.2007.08.018; Ganser-Pornillos BK, 2012, ADV EXP MED BIOL, V726, P441, DOI 10.1007/978-1-4614-0980-9_20; Ganser-Pornillos BK, 2004, J VIROL, V78, P2545, DOI 10.1128/JVI.78.5.2545-2552.2004; Garzon MT, 2004, PROTEIN SCI, V13, P1512, DOI 10.1110/ps.03555304; GELDERBLOM HR, 1987, VIROLOGY, V156, P171, DOI 10.1016/0042-6822(87)90449-1; Grattinger M, 1999, VIROLOGY, V257, P247, DOI 10.1006/viro.1999.9668; Gross I, 1998, J VIROL, V72, P4798, DOI 10.1128/JVI.72.6.4798-4810.1998; Gross I, 1997, EUR J BIOCHEM, V249, P592, DOI 10.1111/j.1432-1033.1997.t01-1-00592.x; Gross I, 2000, EMBO J, V19, P103, DOI 10.1093/emboj/19.1.103; Hoglund S, 2002, ANTIMICROB AGENTS CH, V46, P3597, DOI 10.1128/AAC.46.11.3597-3605.2002; Hyun JK, 2010, J BIOL CHEM, V285, P15056, DOI 10.1074/jbc.M110.108209; Kelly BN, 2007, J MOL BIOL, V373, P355, DOI 10.1016/j.jmb.2007.07.070; Kingston RL, 2000, STRUCTURE, V8, P617, DOI 10.1016/S0969-2126(00)00148-9; Krausslich HG, 1996, CURR TOP MICROBIOL, V214, P25; Lanman J, 2002, J VIROL, V76, P6900, DOI 10.1128/JVI.76.14.6900-6908.2002; Li S, 2000, NATURE, V407, P409, DOI 10.1038/35030177; Manrique ML, 2001, VIRUS RES, V76, P103, DOI 10.1016/S0168-1702(01)00249-0; Mayo K, 2003, J MOL BIOL, V325, P225, DOI 10.1016/S0022-2836(02)01176-2; Monaco-Malbet S, 2000, STRUCTURE, V8, P1069, DOI 10.1016/S0969-2126(00)00507-4; NERMUT MV, 1994, VIROLOGY, V198, P288, DOI 10.1006/viro.1994.1032; NIEDRIG M, 1994, J GEN VIROL, V75, P1469, DOI 10.1099/0022-1317-75-6-1469; Purdy JG, 2008, J VIROL, V82, P5951, DOI 10.1128/JVI.00214-08; Purdy JG, 2009, J MOL BIOL, V389, P438, DOI 10.1016/j.jmb.2009.04.006; REICIN AS, 1995, J VIROL, V69, P642, DOI 10.1128/JVI.69.2.642-650.1995; ROSE S, 1992, PROTEINS, V13, P112, DOI 10.1002/prot.340130204; Sticht J, 2005, NAT STRUCT MOL BIOL, V12, P671, DOI 10.1038/nsmb964; Sundquist WI, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006924; Tang C, 2003, J MOL BIOL, V327, P1013, DOI 10.1016/S0022-2836(03)00289-4; Ternois F, 2005, NAT STRUCT MOL BIOL, V12, P678, DOI 10.1038/nsmb967; Vogt V. M., 1997, P27; Vogt VM, 1999, J VIROL, V73, P7050, DOI 10.1128/JVI.73.8.7050-7055.1999; von Schwedler UK, 2003, J VIROL, V77, P5439, DOI 10.1128/JVI.77.9.5439-5450.2003; von Schwedler UK, 1998, EMBO J, V17, P1555, DOI 10.1093/emboj/17.6.1555; Wilk T, 2001, J VIROL, V75, P759, DOI 10.1128/JVI.75.2.759-771.2001; Wilkins DK, 1999, BIOCHEMISTRY-US, V38, P16424, DOI 10.1021/bi991765q; Willett BJ, 1997, IMMUNOL TODAY, V18, P182, DOI 10.1016/S0167-5699(97)84665-8; Worthylake DK, 1999, ACTA CRYSTALLOGR D, V55, P85, DOI 10.1107/S0907444998007689; Yelamos B, 1999, EUR J BIOCHEM, V266, P1081, DOI 10.1046/j.1432-1327.1999.00952.x; Zhang H, 2008, J MOL BIOL, V378, P565, DOI 10.1016/j.jmb.2008.02.066; Zhang YQ, 1998, J VIROL, V72, P1782, DOI 10.1128/JVI.72.3.1782-1789.1998	65	13	13	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56424	10.1371/journal.pone.0056424	http://dx.doi.org/10.1371/journal.pone.0056424			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457565	Green Published, Green Submitted, gold			2022-12-25	WOS:000315603700052
J	Sun, Z; Zou, L; Zhang, JJ; Mo, SN; Shao, SS; Zhong, R; Ke, JT; Lu, XZ; Miao, XP; Song, RR				Sun, Zhao; Zou, Li; Zhang, Jiajia; Mo, Shengnan; Shao, Shanshan; Zhong, Rong; Ke, Juntao; Lu, Xuzai; Miao, Xiaoping; Song, Ranran			Prevalence and Associated Risk Factors of Dyslexic Children in a Middle-Sized City of China: A Cross-Sectional Study	PLOS ONE			English	Article							READING-DISABILITY; DEVELOPMENTAL DYSLEXIA; DEFICIT HYPOTHESIS; DIFFICULTIES; BEHAVIOR	Background: There are many discussions about dyslexia based on studies conducted in western countries, and some risk factors to dyslexia, such as gender and home literacy environment, have been widely accepted based on these studies. However, to our knowledge, there are few studies focusing on the risk factors of dyslexia in China. Therefore, the aim of our study was to investigate the prevalence of dyslexia and its potential risk factors. Methods: A cross-sectional study was conducted in Qianjiang, a city in Hubei province, China. Two stages sampling strategy was applied to randomly selected 5 districts and 9 primary schools in Qianjiang. In total, 6,350 students participated in this study and there were 5,063 valid student questionnaires obtained for the final analyses. Additional questionnaires (such as Dyslexia Checklist for Chinese Children and Pupil Rating Scale) were used to identify dyslexic children. The chi-square test and multivariate logistic regression were employed to reveal the potential risk factors to dyslexia. Results: Our study revealed that the prevalence of dyslexia was 3.9% in Qianjiang city, which is a middle-sized city in China. Among dyslexic children, the gender ratio (boys to girls) was nearly 3:1. According to the P-value in the multivariate logistic regression, the gender (P<0.01), mother's education level (P<0.01), and learning habits (P<0.01) (active learning, scheduled reading time) were associated with dyslexia. Conclusion: The prevalence rate of dyslexic children in middle-sized cities is 3.9%. The potential risk factors of dyslexic children revealed in this study will have a great impact on detecting and treating dyslexic children in China as early as possible, although more studies are still needed to further investigate the risk factors of dyslexic children in China.	[Sun, Zhao; Zou, Li; Shao, Shanshan; Song, Ranran] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Maternal & Child Hlth, Wuhan 430074, Peoples R China; [Zou, Li; Zhong, Rong; Ke, Juntao; Lu, Xuzai; Miao, Xiaoping] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Epidemiol & Biostat, Wuhan 430074, Peoples R China; [Zou, Li; Zhong, Rong; Ke, Juntao; Lu, Xuzai; Miao, Xiaoping] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, MOE Key Lab Environm & Hlth, Wuhan 430074, Peoples R China; [Zhang, Jiajia] Univ S Carolina, Dept Epidemiol & Biostat, Arnold Sch Publ Hlth, Columbia, SC 29208 USA; [Mo, Shengnan] Wuhan Univ, Renmin Hosp, Adm Off, Wuhan 430072, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Wuhan University	Song, RR (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Maternal & Child Hlth, Wuhan 430074, Peoples R China.	ranransong@gmail.com	Song, Ranran/Z-3997-2019; Zhong, Rong/Q-1813-2019; miao, xiaoping/C-4336-2011	Song, Ranran/0000-0002-8354-7698; miao, xiaoping/0000-0002-6818-9722	National Natural Science Foundation of China [81273092]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Natural Science Foundation of China, Project No. 81273092. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badian NA, 1999, J LEARN DISABIL, V32, P138, DOI 10.1177/002221949903200204; Beitchman JH, 1996, J AM ACAD CHILD PSY, V35, P815, DOI 10.1097/00004583-199606000-00022; CASEY R, 1992, J DEV BEHAV PEDIATR, V13, P256; DEFRIES JC, 1989, J LEARN DISABIL-US, V22, P544, DOI 10.1177/002221948902200905; Donfrancesco R, 2010, ANN DYSLEXIA, V60, P175, DOI 10.1007/s11881-010-0037-6; Fisher SE, 2002, NAT GENET, V30, P86, DOI 10.1038/ng792; Heiervang E, 2001, NORD J PSYCHIAT, V55, P251; Ho CSH, 2007, J EXP CHILD PSYCHOL, V97, P61, DOI 10.1016/j.jecp.2007.01.002; Ho CSH, 2000, READ WRIT, V13, P57, DOI 10.1023/A:1008040922662; Ho CSH, 2004, COGNITION, V91, P43, DOI 10.1016/S0010-0277(03)00163-X; Ho CSH, 2002, DEV PSYCHOL, V38, P543, DOI 10.1037//0012-1649.38.4.543; Jin H, 2009, J S CHINA NORMAL U, V5, P39; Katusic SK, 2001, MAYO CLIN PROC, V76, P1081, DOI 10.4065/76.11.1081; Kempe C, 2011, SCAND J PSYCHOL, V52, P242, DOI 10.1111/j.1467-9450.2011.00870.x; Lyytinen P, 2003, J LEARN DISABIL-US, V36, P74, DOI 10.1177/00222194030360010901; Maughan B, 2003, J ABNORM CHILD PSYCH, V31, P219, DOI 10.1023/A:1022534527021; McBride-Chang C, 2011, J CHILD PSYCHOL PSYC, V52, P204, DOI 10.1111/j.1469-7610.2010.02299.x; Meng XZ, 2007, BRAIN RES, V1179, P119, DOI 10.1016/j.brainres.2007.08.046; Morgan PL, 2008, J LEARN DISABIL-US, V41, P387, DOI 10.1177/0022219408321112; National Bureau of Statistics of China, 2011, CHIN CIT STAT YB; Nicolson RI, 2001, TRENDS NEUROSCI, V24, P508, DOI 10.1016/S0166-2236(00)01896-8; Normand MT, 2008, CLIN LINGUIST PHONET, V22, P47; Rashid FL, 2005, J LEARN DISABIL-US, V38, P2, DOI 10.1177/00222194050380010101; Rutter M, 2004, JAMA-J AM MED ASSOC, V291, P2007, DOI 10.1001/jama.291.16.2007; Shaywitz SE, 1998, NEW ENGL J MED, V338, P307, DOI 10.1056/NEJM199801293380507; SHAYWITZ SE, 1990, JAMA-J AM MED ASSOC, V264, P998, DOI 10.1001/jama.264.8.998; Shu H, 2006, J EDUC PSYCHOL, V98, P122, DOI 10.1037/0022-0663.98.1.122; Shu H., 2003, READING DEV CHINESE, P199; Siok WT, 2008, P NATL ACAD SCI USA, V105, P5561, DOI 10.1073/pnas.0801750105; Siok WT, 2004, NATURE, V431, P71, DOI 10.1038/nature02865; STEVENSON HW, 1982, CHILD DEV, V53, P1164, DOI 10.2307/1129005; Undheim AM, 2008, SCAND J PSYCHOL, V49, P377, DOI 10.1111/j.1467-9450.2008.00661.x; Willcutt EG, 2000, J CHILD PSYCHOL PSYC, V41, P1039, DOI 10.1017/S0021963099006368; Zhang C., 1996, J PSYCHOL SCI, V19, P222	34	36	39	2	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56688	10.1371/journal.pone.0056688	http://dx.doi.org/10.1371/journal.pone.0056688			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	099EQ	23457604	gold, Green Published, Green Submitted			2022-12-25	WOS:000315603700073
J	Van Ly, D; Faiz, A; Jenkins, C; Crossett, B; Black, JL; McParland, B; Burgess, JK; Oliver, BGG				Van Ly, David; Faiz, Alen; Jenkins, Christine; Crossett, Ben; Black, Judith L.; McParland, Brent; Burgess, Janette K.; Oliver, Brian G. G.			Characterising the Mechanism of Airway Smooth Muscle beta(2) Adrenoceptor Desensitization by Rhinovirus Infected Bronchial Epithelial Cells	PLOS ONE			English	Article							INNATE IMMUNE-RESPONSE; NF-KAPPA-B; INDUCED EXACERBATIONS; RECEPTOR; EXPRESSION; ASTHMA; MACROPHAGES; RELAXATION; CHILDREN; SEQUENCE	Rhinovirus (RV) infections account for approximately two thirds of all virus-induced asthma exacerbations and often result in an impaired response to beta 2 agonist therapy. Using an in vitro model of RV infection, we investigated the mechanisms underlying RV-induced beta 2 adrenoceptor desensitization in primary human airway smooth muscle cells (ASMC). RV infection of primary human bronchial epithelial cells (HBEC) for 24 hours produced conditioned medium that caused beta 2 adrenoceptor desensitization on ASMCs without an effect on ASMCs viability. Less than 3 kDa size fractionation together with trypsin digestion of RV-induced conditioned medium did not prevent beta 2 adrenoceptor desensitization, suggesting it could potentially be mediated by a small peptide or lipid. RV infection of BECs, ASMCs and fibroblasts produced prostaglandins, of which PGE(2), PGF(2 alpha) and PGI(2) had the ability to cause beta(2) adrenoceptor desensitization on ASMCs. RV-induced conditioned medium from HBECs depleted of PGE(2) did not prevent ASMC beta(2) adrenoceptor desensitization; however this medium induced PGE(2) from ASMCs, suggesting that autocrine prostaglandin production may be responsible. Using inhibitors of cyclooxygenase and prostaglandin receptor antagonists, we found that beta(2) adrenoceptor desensitization was mediated through ASMC derived COX-2 induced prostaglandins. Since ASMC prostaglandin production is unlikely to be caused by RV-induced epithelial derived proteins or lipids we next investigated activation of toll-like receptors (TLR) by viral RNA. The combination of TLR agonists poly I:C and imiquimod induced PGE(2) and beta(2) adrenoceptor desensitization on ASMC as did the RNA extracted from RV-induced conditioned medium. Viral RNA but not epithelial RNA caused beta(2) adrenoceptor desensitization confirming that viral RNA and not endogenous human RNA was responsible. It was deduced that the mechanism by which beta(2) adrenoceptor desensitization occurs was by pattern recognition receptor activation of COX-2 induced prostaglandins.	[Van Ly, David; Faiz, Alen; Jenkins, Christine; Black, Judith L.; McParland, Brent; Burgess, Janette K.; Oliver, Brian G. G.] Woolcock Inst Med Res, Sydney, NSW, Australia; [Van Ly, David; Faiz, Alen; Black, Judith L.; McParland, Brent; Burgess, Janette K.; Oliver, Brian G. G.] Univ Sydney, Resp Res Grp, Discipline Pharmacol, Sydney, NSW 2006, Australia; [Jenkins, Christine] Concord Gen Hosp, Dept Resp Med, Sydney, NSW, Australia; [Crossett, Ben] Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia	University of Sydney; Woolcock Institute of Medical Research; University of Sydney; Concord Repatriation General Hospital; University of Sydney	Van Ly, D (corresponding author), Woolcock Inst Med Res, Sydney, NSW, Australia.	dvan7422@gmail.com	Faiz, Alen/AAB-7132-2019; McParland, Brent E/A-2841-2012; Faiz, Alen/HII-9884-2022; Burgess, Janette/M-7117-2019; Burgess, Janette K/A-3597-2010; Black, Judith L/C-6559-2008; Oliver, Brian/E-7939-2010; Crossett, Ben/G-2316-2011	Faiz, Alen/0000-0003-1740-3538; Faiz, Alen/0000-0003-1740-3538; Oliver, Brian/0000-0002-7122-9262; Burgess, Janette/0000-0001-9868-9966; Van Ly, David/0000-0001-8807-7448	National Health and Medical Research Council Career Development Fellowship [1032695, APP1026880]; National Health and Medical Research Council Senior Principal Research Fellowship [571098]; University of Sydney	National Health and Medical Research Council Career Development Fellowship(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council Senior Principal Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia); University of Sydney(University of Sydney)	JKB is supported by a National Health and Medical Research Council Career Development Fellowship #1032695. JLB is supported by a National Health and Medical Research Council Senior Principal Research Fellowship #571098. BGGO is supported by a National Health and Medical Research Council Career Development Fellowship APP1026880. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge the collaborative effort of the cardiopulmonary transplant team and the pathologists at St Vincent's Hospital, Sydney; the thoracic physicians and pathologists at Royal Prince Alfred Hospital, Strathfield Private Hospital and Rhodes Pathology, Sydney; and Dr Lucy Morgan and Professor Matthew Peters at Concord Repatriation General Hospital, Sydney. The mass spectrometry was facilitated by access to the Sydney University Proteome Research Unit established under the Australian Government's Major National Research Facilities program and supported by the University of Sydney.	Bartlett NW, 2008, NAT MED, V14, P199, DOI 10.1038/nm1713; Belsham GJ, 1996, MICROBIOL REV, V60, P499, DOI 10.1128/MMBR.60.3.499-511.1996; Clarke DL, 2005, MOL PHARMACOL, V67, P383, DOI 10.1124/mol.104.006486; Cooper PR, 2009, AM J PHYSIOL-LUNG C, V297, pL530, DOI 10.1152/ajplung.00133.2009; Cordey S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010588; Cuthbert AW, 2011, BRIT J PHARMACOL, V162, P508, DOI 10.1111/j.1476-5381.2010.01058.x; Edwards MR, 2006, PULM PHARMACOL THER, V19, P320, DOI 10.1016/j.pupt.2005.09.005; GINA GIFA, 2011, GINA REP; Girotti M, 2009, AM J PHYSIOL-ENDOC M, V296, pE888, DOI 10.1152/ajpendo.90946.2008; Gomez E, 2008, AM J PHYSIOL-HEART C, V295, pH2198, DOI 10.1152/ajpheart.00507.2008; Griffin BW, 1999, J PHARMACOL EXP THER, V290, P1278; Guo MH, 2005, BIOCHEMISTRY-US, V44, P13771, DOI 10.1021/bi051255y; HIRST SJ, 1992, AM J RESP CELL MOL, V7, P574, DOI 10.1165/ajrcmb/7.6.574; Judge AD, 2005, NAT BIOTECHNOL, V23, P457, DOI 10.1038/nbt1081; Kang Kyung Ho, 1996, Korean Journal of Internal Medicine (English Edition), V11, P74; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kelly E, 2008, BRIT J PHARMACOL, V153, pS379, DOI 10.1038/sj.bjp.0707604; Kelsen SG, 1997, AM J PHYSIOL-LUNG C, V273, pL694, DOI 10.1152/ajplung.1997.273.3.L694; Kong KC, 2008, BIOCHEMISTRY-US, V47, P9279, DOI 10.1021/bi801056w; Kuper C, 2012, AM J PHYSIOL-RENAL, V302, pF38, DOI 10.1152/ajprenal.00590.2010; Kuo C, 2011, AM J PHYSIOL-LUNG C, V300, pL951, DOI 10.1152/ajplung.00411.2010; Kuo C, 2011, RESPIROLOGY, V16, P367, DOI 10.1111/j.1440-1843.2010.01918.x; Ly L, 2011, J PROTEOME RES, V10, P4855, DOI 10.1021/pr200672n; Mak JCW, 2002, BRIT J PHARMACOL, V135, P987, DOI 10.1038/sj.bjp.0704545; MARCH CJ, 1985, NATURE, V315, P641, DOI 10.1038/315641a0; Oliver BGG, 2008, THORAX, V63, P519, DOI 10.1136/thx.2007.081752; Olman MA, 2009, NAT MED, V15, P1360, DOI 10.1038/nm1209-1360; Papadopoulos NG, 2000, J INFECT DIS, V181, P1875, DOI 10.1086/315513; Papi A, 1999, J BIOL CHEM, V274, P9707, DOI 10.1074/jbc.274.14.9707; Penn RB, 1998, AM J RESP CELL MOL, V19, P338, DOI 10.1165/ajrcmb.19.2.3025; Reddel H, 1999, LANCET, V353, P364, DOI 10.1016/S0140-6736(98)06128-5; ROTH M, 1992, TISSUE CELL, V24, P455, DOI 10.1016/0040-8166(92)90061-B; Rovati GE, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-103; Rueter K, 2012, J PEDIATR-US, V160, P82, DOI 10.1016/j.jpeds.2011.06.025; Seymour ML, 2002, J INFECT DIS, V185, P540, DOI 10.1086/338570; Seymour ML, 2001, AM J RESP CRIT CARE, V164, P2051, DOI 10.1164/ajrccm.164.11.2008137; Slater L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001178; Sukkar MB, 2006, J ALLERGY CLIN IMMUN, V118, P641, DOI 10.1016/j.jaci.2006.05.013; Trian T, 2010, AM J RESP CELL MOL, V43, P227, DOI 10.1165/rcmb.2009-0126OC; Van Ly David, 2011, J Allergy (Cairo), V2011, P457169, DOI 10.1155/2011/457169; Villamon E, 2005, RES MICROBIOL, V156, P115, DOI 10.1016/j.resmic.2004.08.003; Wark PAB, 2005, J EXP MED, V201, P937, DOI 10.1084/jem.20041901; Wark PAB, 2009, RESPIROLOGY, V14, P180, DOI 10.1111/j.1440-1843.2009.01480.x; Wos M, 2008, AM J RESP CRIT CARE; Xatzipsaiti M, 2005, AM J RESP CRIT CARE, V172, P1037, DOI 10.1164/rccm.200502-315OC; Zhang AH, 2006, AM J PHYSIOL-RENAL, V291, pF1332, DOI 10.1152/ajprenal.00131.2006	46	29	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56058	10.1371/journal.pone.0056058	http://dx.doi.org/10.1371/journal.pone.0056058			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457497	Green Submitted, Green Published, gold			2022-12-25	WOS:000315603700020
J	Yakkundi, A; McCallum, L; O'Kane, A; Dyer, H; Worthington, J; McKeen, HD; McClements, L; Elliott, C; McCarthy, HO; Hirst, DG; Robson, T				Yakkundi, Anita; McCallum, Lynn; O'Kane, Anthony; Dyer, Hayder; Worthington, Jenny; McKeen, Hayley D.; McClements, Lana; Elliott, Christopher; McCarthy, Helen O.; Hirst, David G.; Robson, Tracy			The Anti-Migratory Effects of FKBPL and Its Peptide Derivative, AD-01: Regulation of CD44 and the Cytoskeletal Pathway	PLOS ONE			English	Article							BREAST-CANCER; CELL-MIGRATION; ANGIOGENESIS; EXPRESSION; INVASION; BEVACIZUMAB; INVOLVEMENT; METASTASIS; ACTIVATION; INHIBITOR	FK506 binding protein-like (FKBPL) and its peptide derivatives exert potent anti-angiogenic activity in vitro and in vivo and control tumour growth in xenograft models, when administered exogenously. However, the role of endogenous FKBPL in angiogenesis is not well characterised. Here we investigated the molecular effects of the endogenous protein and its peptide derivative, AD-01, leading to their anti-migratory activity. Inhibition of secreted FKBPL using a blocking antibody or siRNA-mediated knockdown of FKBPL accelerated the migration of human microvascular endothelial cells (HMEC-1). Furthermore, MDA-MB-231 tumour cells stably overexpressing FKBPL inhibited tumour vascular development in vivo suggesting that FKBPL secreted from tumour cells could inhibit angiogenesis. Whilst FKBPL and AD-01 target CD44, the nature of this interaction is not known and here we have further interrogated this aspect. We have demonstrated that FKBPL and AD-01 bind to the CD44 receptor and inhibit tumour cell migration in a CD44 dependant manner; CD44 knockdown abrogated AD-01 binding as well as its anti-migratory activity. Interestingly, FKBPL overexpression and knockdown or treatment with AD-01, regulated CD44 expression, suggesting a co-regulatory pathway for these two proteins. Downstream of CD44, alterations in the actin cytoskeleton, indicated by intense cortical actin staining and a lack of cell spreading and communication were observed following treatment with AD-01, explaining the anti-migratory phenotype. Concomitantly, AD-01 inhibited Rac-1 activity, up-regulated RhoA and the actin binding proteins, profilin and vinculin. Thus the anti-angiogenic protein, FKBPL, and AD-01, offer a promising and alternative approach for targeting both CD44 positive tumours and vasculature networks.	[Yakkundi, Anita; McCallum, Lynn; Dyer, Hayder; McKeen, Hayley D.; McClements, Lana; McCarthy, Helen O.; Hirst, David G.; Robson, Tracy] Queens Univ Belfast, Sch Pharm, Belfast, Antrim, North Ireland; [O'Kane, Anthony; Elliott, Christopher] Queens Univ Belfast, Inst Global Food Secur, Sch Biol Sci, Belfast, Antrim, North Ireland; [Worthington, Jenny] Univ Ulster, Coleraine BT52 1SA, Londonderry, North Ireland	Queens University Belfast; Queens University Belfast; Ulster University	Robson, T (corresponding author), Queens Univ Belfast, Sch Pharm, Belfast, Antrim, North Ireland.	T.Robson@qub.ac.uk	McCallum, Lynn/AAE-9232-2020; O'Kane, Anthony/AAE-6100-2020; McClements, Lana/S-9458-2019	McClements, Lana/0000-0002-4911-1014; O'Kane, Anthony/0000-0001-7969-388X; Robson, Tracy/0000-0003-4262-6872; McCarthy, Helen/0000-0002-1254-3745	Almac Discovery, Northern Ireland, United Kingdom; Biotechnological and Biological Research Council, United Kingdom [BB/I006958/1]; Department of Education and Learning, Northern Ireland; BBSRC; Almac Discovery, Northern Ireland; BBSRC [BB/I006958/1] Funding Source: UKRI; MRC [G1001473] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I006958/1] Funding Source: researchfish; Medical Research Council [G1001473] Funding Source: researchfish	Almac Discovery, Northern Ireland, United Kingdom; Biotechnological and Biological Research Council, United Kingdom; Department of Education and Learning, Northern Ireland; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Almac Discovery, Northern Ireland; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Financial support was recieved from Almac Discovery, Northern Ireland, United Kingdom, Biotechnological and Biological Research Council, United Kingdom (grant number BB/I006958/1) and Department of Education and Learning, Northern Ireland. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.; The authors have received financial support from BBSRC and Almac Discovery, Northern Ireland for consumables and salaries of authors AY, L. McCallum, HD at various times. Furthermore TR and DGH are patent holders on: Robson T, Hirst GH, Valentine A, O'Rourke M. FKBP- L AND USES THEREOF. PCT/GB2007/002107 ( WO/2007/141533). AU, CA, EP, JP, NZ, US. 2007. This patent was licensed to Almac Discovery from QUB in 2006. The authors declare that this does not alter their adherence to PLOS ONE's policies on sharing data and materials.	Maxwell CA, 2008, J CELL SCI, V121, P925, DOI 10.1242/jcs.022038; Ashton AW, 1999, J BIOL CHEM, V274, P35562, DOI 10.1074/jbc.274.50.35562; Ballestrem C, 2000, MOL BIOL CELL, V11, P2999, DOI 10.1091/mbc.11.9.2999; Bourguignon LYW, 2008, SEMIN CANCER BIOL, V18, P251, DOI 10.1016/j.semcancer.2008.03.007; Brew CT, 2009, INT J CANCER, V124, P2294, DOI 10.1002/ijc.24210; Bryan BA, 2007, CELL MOL LIFE SCI, V64, P2053, DOI 10.1007/s00018-007-7008-z; Cao GY, 2006, AM J PATHOL, V169, P325, DOI 10.2353/ajpath.2006.060206; Cao Y, 2010, EXP CELL RES, V316, P1304, DOI 10.1016/j.yexcr.2010.02.031; Carisey A, 2011, EUR J CELL BIOL, V90, P157, DOI 10.1016/j.ejcb.2010.06.007; Carl-Mcgrath S, 2008, PATHOLOGY, V40, P13, DOI 10.1080/00313020701716250; Choi SH, 2000, INT J CANCER, V85, P523, DOI 10.1002/(SICI)1097-0215(20000215)85:4<523::AID-IJC13>3.0.CO;2-6; Couzin-Frankel J, 2011, SCIENCE, V333, P143, DOI 10.1126/science.333.6039.143; Ebos JML, 2009, CANCER CELL, V15, P232, DOI 10.1016/j.ccr.2009.01.021; Ferrara N, 2004, NAT REV DRUG DISCOV, V3, P391, DOI 10.1038/nrd1381; Ghosh SC, 2012, EXPERT OPIN THER TAR, V16, P635, DOI 10.1517/14728222.2012.687374; Gong Y, 2005, HISTOPATHOLOGY, V46, P24, DOI 10.1111/j.1365-2559.2004.01981.x; Guidolin D, 2010, EXPERT OPIN THER TAR, V14, P1135, DOI 10.1517/14728222.2010.524048; Huang QH, 2008, NAT CELL BIOL, V10, P202, DOI 10.1038/ncb1681; Huveneers S, 2009, J CELL SCI, V122, P1059, DOI 10.1242/jcs.039446; Jaeger EB, 2001, CANCER METAST REV, V20, P279, DOI 10.1023/A:1015587411668; Jascur T, 2005, MOL CELL, V17, P237, DOI 10.1016/j.molcel.2004.11.049; Kang CB, 2008, NEUROSIGNALS, V16, P318, DOI 10.1159/000123041; Lenzer J, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d4244; Lopez JI, 2005, CANCER RES, V65, P6755, DOI 10.1158/0008-5472.CAN-05-0863; Louderbough JMV, 2011, MOL CANCER RES, V9, P1573, DOI 10.1158/1541-7786.MCR-11-0156; McCallum L, 2006, BLOOD, V108, P1716, DOI 10.1182/blood-2006-04-016113; McKeen HD, 2008, ENDOCRINOLOGY, V149, P5724, DOI 10.1210/en.2008-0168; McKeen HD, 2011, BIOCHEM SOC T, V39, P663, DOI 10.1042/BST0390663; McKeen HD, 2010, CANCER RES, V70, P1090, DOI 10.1158/0008-5472.CAN-09-2515; Motzer RJ, 2006, J CLIN ONCOL, V24, P5601, DOI 10.1200/JCO.2006.08.5415; Nagano O, 2004, CANCER SCI, V95, P930, DOI 10.1111/j.1349-7006.2004.tb03179.x; Naor D, 2008, SEMIN CANCER BIOL, V18, P260, DOI 10.1016/j.semcancer.2008.03.015; Olsson E, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-418; Orian-Rousseau V, 2010, EUR J CANCER, V46, P1271, DOI 10.1016/j.ejca.2010.02.024; Robson T, 2000, INT J RADIAT BIOL, V76, P617, DOI 10.1080/095530000138277; Robson T, 1999, RADIAT RES, V152, P451, DOI 10.2307/3580140; Sbai O, 2010, GLIA, V58, P344, DOI 10.1002/glia.20927; Stone EM, 2006, NEW ENGL J MED, V355, P1493, DOI 10.1056/NEJMe068191; Sun HM, 2013, CLIN TRANSL ONCOL, V15, P46, DOI 10.1007/s12094-012-0891-2; Sunnotel O, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-22; Takahashi N, 2010, ARTHRITIS RHEUM-US, V62, P1338, DOI 10.1002/art.27410; Turley EA, 2012, FRONT BIOSCI-LANDMRK, V17, P1775, DOI 10.2741/4018; Valentine A, 2011, CLIN CANCER RES, V17, P1044, DOI 10.1158/1078-0432.CCR-10-2241; Verheul HMW, 2007, NAT REV CANCER, V7, P475, DOI 10.1038/nrc2152; Wilhelm S, 2006, NAT REV DRUG DISCOV, V5, P835, DOI 10.1038/nrd2130; Yang K, 2009, INT J CLIN EXP PATHO, V2, P361; Yu FSX, 1998, INVEST OPHTH VIS SCI, V39, P710; Zhang LJ, 2011, DEVELOPMENT, V138, P455, DOI 10.1242/dev.046870; Zoller M, 2011, NAT REV CANCER, V11, P254, DOI 10.1038/nrc3023; Zou L, 2007, BRIT J CANCER, V97, P1361, DOI 10.1038/sj.bjc.6604038	50	17	17	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e55075	10.1371/journal.pone.0055075	http://dx.doi.org/10.1371/journal.pone.0055075			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457460	Green Published, Green Submitted, gold			2022-12-25	WOS:000315603700008
J	Farnie, G; Willan, PM; Clarke, RB; Bundred, NJ				Farnie, Gillian; Willan, Pamela M.; Clarke, Robert B.; Bundred, Nigel J.			Combined Inhibition of ErbB1/2 and Notch Receptors Effectively Targets Breast Ductal Carcinoma In Situ (DCIS) Stem/Progenitor Cell Activity Regardless of ErbB2 Status	PLOS ONE			English	Article							CANCER CELLS; INITIATING CELLS; STEM-CELLS; RADIOTHERAPY; POPULATION	Pathways involved in DCIS stem and progenitor signalling are poorly understood yet are critical to understand DCIS biology and to develop new therapies. Notch and ErbB1/2 receptor signalling cross talk has been demonstrated in invasive breast cancer, but their role in DCIS stem and progenitor cells has not been investigated. We have utilised 2 DCIS cell lines, MCF10DCIS.com (ErbB2-normal) and SUM225 (ErbB2-overexpressing) and 7 human primary DCIS samples were cultured in 3D matrigel and as mammospheres in the presence, absence or combination of the Notch inhibitor, DAPT, and ErbB1/2 inhibitors, lapatinib or gefitinib. Western blotting was applied to assess downstream signalling. In this study we demonstrate that DAPT reduced acini size and mammosphere formation in MCF10DCIS.com whereas there was no effect in SUM225. Lapatinb reduced acini size and mammosphere formation in SUM225, whereas mammosphere formation and Notch1 activity were increased in MCF10DCIS.com. Combined DAPT/lapatinib treatment was more effective at reducing acini size in both DCIS cell lines. Mammosphere formation in cell lines and human primary DCIS was reduced further by DAPT/lapatinib or DAPT/gefitinib regardless of ErbB2 receptor status. Our pre-clinical human models of DCIS demonstrate that Notch and ErbB1/2 both play a role in DCIS acini growth and stem cell activity. We report for the first time that cross talk between the two pathways in DCIS occurs regardless of ErbB2 receptor status and inhibition of Notch and ErbB1/2 was more efficacious than either alone. These data provide further understanding of DCIS biology and suggest treatment strategies combining Notch and ErbB1/2 inhibitors should be investigated regardless of ErbB2 receptor status.	[Farnie, Gillian; Willan, Pamela M.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Paterson Inst Canc Res, Inst Canc Sci,Christie NHS Fdn Trust, Manchester, Lancs, England; [Clarke, Robert B.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Paterson Inst Canc Res,Inst Canc Sci, Breast Biol Grp,Christie NHS Fdn Trust, Manchester, Lancs, England; [Bundred, Nigel J.] Wythenshawe Hosp, Acad Dept Surg, Univ Hosp South Manchester NHS Fdn Trust, Educ & Res Ctr, Manchester M23 9LT, Lancs, England	Christie NHS Foundation Trust; Paterson Institute for Cancer Research; University of Manchester; Christie NHS Foundation Trust; Paterson Institute for Cancer Research; University of Manchester; Wythenshawe Hospital NHS Foundation Trust; Wythenshawe Hospital	Farnie, G (corresponding author), Univ Manchester, Manchester Acad Hlth Sci Ctr, Paterson Inst Canc Res, Inst Canc Sci,Christie NHS Fdn Trust, Manchester, Lancs, England.	gfarnie@picr.man.ac.uk	farnie, gillian/GLT-8777-2022; Clarke, Robert/AAA-3442-2021	Clarke, Robert/0000-0001-5407-3123; Farnie, Gillian/0000-0002-1407-2529	Breast Cancer Campaign; Breast Cancer Now [MAN-Q1] Funding Source: researchfish	Breast Cancer Campaign; Breast Cancer Now	The authors would like to acknowledge the Breast Cancer Campaign for funding this project. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Bijker N, 2006, J CLIN ONCOL, V24, P3381, DOI 10.1200/JCO.2006.06.1366; Diehn M, 2006, J NATL CANCER I, V98, P1755, DOI 10.1093/jnci/djj505; Dong YY, 2010, CANCER RES, V70, P5465, DOI 10.1158/0008-5472.CAN-10-0173; Farnie G, 2007, JNCI-J NATL CANCER I, V99, P616, DOI 10.1093/jnci/djk133; Grudzien P, 2010, ANTICANCER RES, V30, P3853; Harrison H, 2010, CANCER RES, V70, P709, DOI 10.1158/0008-5472.CAN-09-1681; Korkaya H, 2008, ONCOGENE, V27, P6120, DOI 10.1038/onc.2008.207; Leonard GD, 2004, JNCI-J NATL CANCER I, V96, P906, DOI 10.1093/jnci/djh164; Li XX, 2008, JNCI-J NATL CANCER I, V100, P672, DOI 10.1093/jnci/djn123; Magnifico A, 2009, CLIN CANCER RES, V15, P2010, DOI 10.1158/1078-0432.CCR-08-1327; Meurette O, 2009, CANCER RES, V69, P5015, DOI 10.1158/0008-5472.CAN-08-3478; Muthuswamy SK, 2001, NAT CELL BIOL, V3, P785, DOI 10.1038/ncb0901-785; Osipo C, 2008, ONCOGENE, V27, P5019, DOI 10.1038/onc.2008.149; PAGE DL, 1995, CANCER, V76, P1197, DOI 10.1002/1097-0142(19951001)76:7<1197::AID-CNCR2820760715>3.0.CO;2-0; Pandya K, 2011, BRIT J CANCER, V105, P796, DOI 10.1038/bjc.2011.321; Phillips TM, 2006, JNCI-J NATL CANCER I, V98, P1777, DOI 10.1093/jnci/djj495; Pradeep CR, 2012, ONCOGENE, V31, P907, DOI 10.1038/onc.2011.279; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Sakorafas GH, 2008, CANCER TREAT REV, V34, P483, DOI 10.1016/j.ctrv.2008.03.001	20	28	28	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56840	10.1371/journal.pone.0056840	http://dx.doi.org/10.1371/journal.pone.0056840			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457626	Green Submitted, Green Published, gold			2022-12-25	WOS:000315602700098
J	Massey, J; Rothwell, S; Rusbridge, C; Tauro, A; Addicott, D; Chinoy, H; Cooper, RG; Ollier, WER; Kennedy, LJ				Massey, Jonathan; Rothwell, Simon; Rusbridge, Clare; Tauro, Anna; Addicott, Diane; Chinoy, Hector; Cooper, Robert G.; Ollier, William E. R.; Kennedy, Lorna J.			Association of an MHC Class II Haplotype with Increased Risk of Polymyositis in Hungarian Vizsla Dogs	PLOS ONE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; CANINE INFLAMMATORY MYOPATHIES; MULTIPLE-SCLEROSIS; DERMATOMYOSITIS; SUSCEPTIBILITY; MYOSITIS	A breed-specific polymyositis is frequently observed in the Hungarian Vizsla. Beneficial clinical response to immunosuppressive therapies has been demonstrated which points to an immune-mediated aetiology. Canine inflammatory myopathies share clinical and histological similarities with the human immune-mediated myopathies. As MHC class II associations have been reported in the human conditions we investigated whether an MHC class II association was present in the canine myopathy seen in this breed. 212 Hungarian Vizsla pedigree dogs were stratified both on disease status and degree of relatedness to an affected dog. This generated a group of 29 cases and 183 "graded" controls: 93 unaffected dogs with a first degree affected relative, 44 unaffected dogs with a second degree affected relative, and 46 unaffected dogs with no known affected relatives. Eleven DLA class II haplotypes were identified, of which, DLA-DRB1* 02001/DQA1*00401/DQB1*01303, was at significantly raised frequency in cases compared to controls (OR = 1.92, p = 0.032). When only control dogs with no family history of the disease were compared to cases, the association was further strengthened (OR = 4.08, p = 0.00011). Additionally, a single copy of the risk haplotype was sufficient to increase disease risk, with the risk substantially increasing for homozygotes. There was a trend of increasing frequency of this haplotype with degree of relatedness, indicating low disease penetrance. These findings support the hypothesis of an immune-mediated aetiology for this canine myopathy and give credibility to potentially using the Hungarian Vizsla as a genetic model for comparative studies with human myositis.	[Massey, Jonathan; Rothwell, Simon; Cooper, Robert G.; Ollier, William E. R.; Kennedy, Lorna J.] Univ Manchester, CIGMR, Inst Populat Hlth, Fac Med & Human Sci, Manchester, Lancs, England; [Rusbridge, Clare] Stone Lion Vet Hosp, London, England; [Tauro, Anna] Alcombe Vet Surg, London, England; [Addicott, Diane] Hungarian Vizsla Breed Club, Royal Tunbridge Wells, England; [Chinoy, Hector; Cooper, Robert G.] 6 Univ Manchester, Ctr Rheumat Dis, Manchester Acad Hlth Sci Ctr, Salford Royal NHS Fdn Trust, Salford, Lancs, England	University of Manchester; Salford Royal NHS Foundation Trust	Massey, J (corresponding author), Univ Manchester, CIGMR, Inst Populat Hlth, Fac Med & Human Sci, Manchester, Lancs, England.	jonathan.massey@manchester.ac.uk	Rusbridge, Clare/A-3794-2019; Rusbridge, Clare/K-6560-2019; Kennedy, Lorna/AAK-8767-2020; Chinoy, Hector/C-7832-2013	Rusbridge, Clare/0000-0002-3366-2110; Rusbridge, Clare/0000-0002-3366-2110; Kennedy, Lorna/0000-0002-3087-4548; Massey, Jonathan/0000-0002-4576-1124; Chinoy, Hector/0000-0001-6492-1288; Rothwell, Simon/0000-0003-2123-9902	Arthritis Research UK [18474] Funding Source: Medline; National Institute for Health Research [CL-2006-06-010] Funding Source: researchfish	Arthritis Research UK(Versus Arthritis); National Institute for Health Research(National Institute for Health Research (NIHR))		Aguirre-Hernandez J, 2010, TISSUE ANTIGENS, V76, P476, DOI 10.1111/j.1399-0039.2010.01554.x; Barcellos LF, 2003, AM J HUM GENET, V72, P710, DOI 10.1086/367781; Clark LA, 2005, VET DERMATOL, V16, P392, DOI 10.1111/j.1365-3164.2005.00469.x; Evans J, 2004, J VET INTERN MED, V18, P679, DOI 10.1892/0891-6640(2004)18&lt;679:CIMACR&gt;2.0.CO;2; Foale RD, 2008, P 50 BSAVA C BIRM CL; Greer KA, 2010, TISSUE ANTIGENS, V76, P110, DOI 10.1111/j.1399-0039.2010.01484.x; Haley AC, 2011, J VET INTERN MED, V25, P393, DOI 10.1111/j.1939-1676.2010.0660.x; Hankel S, 2006, VET IMMUNOL IMMUNOP, V113, P1, DOI 10.1016/j.vetimm.2006.03.025; HARGIS AM, 1986, AM J PATHOL, V123, P480; Karlsson EK, 2008, NAT REV GENET, V9, P713, DOI 10.1038/nrg2382; Kennedy LJ, 2008, TISSUE ANTIGENS, V71, P51, DOI 10.1111/j.1399-0039.2007.00964.x; Kennedy LJ, 2007, TISSUE ANTIGENS, V69, P272, DOI 10.1111/j.1399-0039.2006.00779.x; Kennedy LJ, 2006, TISSUE ANTIGENS, V68, P467, DOI 10.1111/j.1399-0039.2006.00716.x; Kennedy LJ, 2006, TISSUE ANTIGENS, V68, P82, DOI 10.1111/j.1399-0039.2006.00614.x; MACGREGOR A, 1995, J RHEUMATOL, V22, P1032; O'Hanlon TP, 2005, MEDICINE, V84, P338, DOI 10.1097/01.md.0000189818.63141.8c; ODDIS CV, 1990, J RHEUMATOL, V17, P1329; Paciello O, 2007, NEUROMUSCULAR DISORD, V17, P313, DOI 10.1016/j.nmd.2007.01.012; Rusbridge C, 2011, VET REC, V168, P85, DOI 10.1136/vr.d372; Shelton GD, 2006, VET IMMUNOL IMMUNOP, V113, P200, DOI 10.1016/j.vetimm.2006.05.005; Wahl JM, 2008, VET DERMATOL, V19, P52, DOI 10.1111/j.1365-3164.2008.00655.x; Wilbe M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012332; Wilbe M, 2010, NAT GENET, V42, P250, DOI 10.1038/ng.525; Wilbe M, 2009, IMMUNOGENETICS, V61, P557, DOI 10.1007/s00251-009-0387-6	24	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56490	10.1371/journal.pone.0056490	http://dx.doi.org/10.1371/journal.pone.0056490			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457575	Green Submitted, Green Published, gold			2022-12-25	WOS:000315602700075
J	Trotter, CL; Yaro, S; Njanpop-Lafourcade, BM; Drabo, A; Kroman, SS; Idohou, RS; Sanou, O; Bowen, L; Findlow, H; Diagbouga, S; Gessner, BD; Borrow, R; Mueller, JE				Trotter, Caroline L.; Yaro, Seydou; Njanpop-Lafourcade, Berthe-Marie; Drabo, Aly; Kroman, Sita S.; Idohou, Regina S.; Sanou, Oumarou; Bowen, Leah; Findlow, Helen; Diagbouga, Serge; Gessner, Bradford D.; Borrow, Ray; Mueller, Judith E.			Seroprevalence of Bactericidal, Specific IgG Antibodies and Incidence of Meningitis Due to Group A Neisseria meningitidis by Age in Burkina Faso 2008	PLOS ONE			English	Article							MENINGOCOCCAL MENINGITIS; SEROGROUP-C; CAPSULAR POLYSACCHARIDE; IMMUNITY; VACCINES; ENGLAND; CARRIAGE; EPIDEMIC; BELT; VACCINATION	Background: We investigated serological correlates of protection against Neisseria meningitidis serogroup A (NmA) in Burkina Faso before the introduction of NmA conjugate vaccine. Methodology/Principal Findings: We collected blood from a representative sample (N = 1022) of Bobo-Dioulasso residents. Sera were evaluated for serum bactericidal antibody (SBA) activity against NmA strains of immunotype L11 (F8238) and L10 (3125) and NmA-specific IgG. Seroprevalence was compared to the age-specific NmA meningitis incidence in Bobo-Dioulasso during March 2007-February 2008. Meningococcal carriage was evaluated in a subset (N = 538). Geometric mean titres (GMT)/concentrations (GMC) of SBA and NmA-specific IgG increased with age, peaking around age 20 years. Overall, 70% of our sample had NmA-specific IgG >= 2 ug/mL. Meningitis incidence was highest in those aged <6 months and 5-19 years. No NmA carriers were found. Compared to the reference strain SBA, GMTs were higher against a locally isolated strain and around 40-fold lower against Dutch strain 3125. Conclusions/Significance: This study provides estimates of natural immunity to NmA, according to a variety of antibody measures, which will be helpful in ascertaining antibody persistence after MenAfriVac (TM) introduction. Age-specific seroprevalence of reference strain SBA titres most likely reflects exposure to meningococci and consecutive reactive immunity. We could not define any serological correlate of protection.	[Trotter, Caroline L.; Bowen, Leah] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Yaro, Seydou; Drabo, Aly; Diagbouga, Serge] Ctr Muraz, Bobo Dioulasso, Burkina Faso; [Njanpop-Lafourcade, Berthe-Marie; Kroman, Sita S.; Idohou, Regina S.; Sanou, Oumarou; Gessner, Bradford D.; Mueller, Judith E.] Agence Med Prevent, Paris, France; [Findlow, Helen; Borrow, Ray] Manchester Royal Infirm, Hlth Protect Agcy, Vaccine Evaluat Unit, Manchester M13 9WL, Lancs, England; [Diagbouga, Serge] Inst Natl Rech Sci Sante, Ouagadougou, Burkina Faso; [Borrow, Ray] Univ Manchester, Sch Translat Med, Inflammat Sci Res Grp, Manchester, Lancs, England; [Mueller, Judith E.] Ecole Hautes Etud Sante Publ, Dept Epidemiol & Biostat, Paris, France	University of Bristol; Centre Muraz; Agence de Medecine Preventive; Health Protection Agency; University of Manchester; University of Manchester	Trotter, CL (corresponding author), Univ Bristol, Sch Social & Community Med, Bristol, Avon, England.	caroline.trotter@bristol.ac.uk	Trotter, Caroline L/H-5077-2013	DIAGBOUGA, Serge/0000-0003-0920-1725; Trotter, Caroline/0000-0003-4000-2708	UK Medical Research Council [G0701269]; Sanofi Pasteur; GlaxoSmithKline; Pfizer; Merck; Novartis Vaccines; Baxter Bioscience; Sanofi Pasteur MSD; Alexion Pharmaceuticals Inc; MRC [G0701269] Funding Source: UKRI; Medical Research Council [G0701269] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Sanofi Pasteur; GlaxoSmithKline(GlaxoSmithKline); Pfizer(Pfizer); Merck(Merck & Company); Novartis Vaccines; Baxter Bioscience; Sanofi Pasteur MSD; Alexion Pharmaceuticals Inc; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was funded by the UK Medical Research Council (Grant G0701269). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; BL, SSK, OS, RSI, and BDG work, and JEM until recently worked, for the Agence de Medecine Preventive, which receives unrestricted support from Sanofi Pasteur as well as grant specific support from Sanofi Pasteur, GlaxoSmithKline, Pfizer, and Merck. RB and HF have performed contract research on behalf of the Health Protection Agency, funded by Pfizer, Novartis Vaccines, Baxter Bioscience, GlaxoSmithKline, Sanofi Pasteur, Sanofi Pasteur MSD, Alexion Pharmaceuticals Inc, and Merck. All other authors declare no conflicts of interest. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Amir J, 2005, VACCINE, V23, P977, DOI 10.1016/j.vaccine.2004.07.042; Baril L, 2004, CLIN EXP IMMUNOL, V135, P474, DOI 10.1111/j.1365-2249.2003.02357.x; Boisier P, 2007, CLIN INFECT DIS, V44, P657, DOI 10.1086/511646; BROOME CV, 1983, B WORLD HEALTH ORGAN, V61, P325; Burrage M, 2002, INFECT IMMUN, V70, P4946, DOI 10.1128/IAI.70.9.4946-4954.2002; Delrieu I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019513; du Chatelet IP, 2005, CLIN INFECT DIS, V40, P17, DOI 10.1086/426436; ENGLUND JA, 1995, J INFECT DIS, V171, P99, DOI 10.1093/infdis/171.1.99; Frasch CE, 2009, VACCINE, V27, pB112, DOI 10.1016/j.vaccine.2009.04.065; GOLDSCHNEIDER I, 1969, J EXP MED, V129, P1307, DOI 10.1084/jem.129.6.1307; Granoff DM, 2001, METH MOLEC MED, V66, P305, DOI 10.1385/1-59259-148-5:305; Greenwood B, 1999, T ROY SOC TROP MED H, V93, P341, DOI 10.1016/S0035-9203(99)90106-2; GUIRGUIS N, 1985, J EXP MED, V162, P1837, DOI 10.1084/jem.162.6.1837; Irving TJ, 2012, EPIDEMIOL INFECT, V140, P897, DOI 10.1017/S0950268811001385; Kristiansen PA, 2011, CLIN VACCINE IMMUNOL, V18, P435, DOI 10.1128/CVI.00479-10; LaForce FM, 2007, VACCINE, V25, pA97, DOI 10.1016/j.vaccine.2007.04.049; Lal G, 2004, CLIN DIAGN LAB IMMUN, V11, P272, DOI 10.1128/CDLI.11.2.272-279.2004; Lapeyssonnie L., 1963, B WHO              S, V28, P3; MAKELA PH, 1975, LANCET, V2, P883; Maslanka SE, 1997, CLIN DIAGN LAB IMMUN, V4, P156, DOI 10.1128/CDLI.4.2.156-167.1997; Mueller JE, 2006, J INFECT DIS, V193, P812, DOI 10.1086/500511; Mueller JE, 2007, EMERG INFECT DIS, V13, P847, DOI 10.3201/eid1306.061395; Mueller JE, 2006, EXPERT REV VACCINES, V5, P319, DOI 10.1586/14760584.5.3.319; Mueller JE, 2011, J INFECT DIS, V204, P1787, DOI 10.1093/infdis/jir623; Mueller JE, 2010, INT J INFECT DIS, V14, pE553, DOI 10.1016/j.ijid.2009.08.013; Norheim G, 2006, J CLIN MICROBIOL, V44, P861, DOI 10.1128/JCM.44.3.861-871.2006; PELTOLA H, 1977, NEW ENGL J MED, V297, P686, DOI 10.1056/NEJM197709292971302; Poolman JT, 2011, CLIN VACCINE IMMUNOL, V18, P1108, DOI 10.1128/CVI.00549-10; ROBBINS JB, 1975, J ALLERGY CLIN IMMUN, V56, P141, DOI 10.1016/0091-6749(75)90119-0; Sikkema DJ, 2000, CLIN DIAGN LAB IMMUN, V7, P764, DOI 10.1128/CDLI.7.5.764-768.2000; Sow SO, 2011, NEW ENGL J MED, V364, P2293, DOI 10.1056/NEJMoa1003812; Taha MK, 2000, J CLIN MICROBIOL, V38, P855, DOI 10.1128/JCM.38.2.855-857.2000; Trotter C, 2003, VACCINE, V21, P1094, DOI 10.1016/S0264-410X(02)00630-8; Trotter C, 2007, CLIN VACCINE IMMUNOL, V14, P863, DOI 10.1128/CVI.00102-07; Trotter CL, 2008, CLIN VACCINE IMMUNOL, V15, P1694, DOI 10.1128/CVI.00279-08; Trotter CL, 2012, CLIN VACCINE IMMUNOL, V19, P219, DOI 10.1128/CVI.05515-11; VANN WF, 1976, INFECT IMMUN, V13, P1654, DOI 10.1128/IAI.13.6.1654-1662.1976; *WHO, 2010, LAUNCH MEN CONJ VACC; WHO, 1998, WHO PRACT GUID; World Health Organization, 2012, CHILD GROWTH STAND W	40	27	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e55486	10.1371/journal.pone.0055486	http://dx.doi.org/10.1371/journal.pone.0055486			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457471	Green Published, Green Submitted, gold			2022-12-25	WOS:000315602700018
J	Uzarski, JS; Scott, EW; McFetridge, PS				Uzarski, Joseph S.; Scott, Edward W.; McFetridge, Peter S.			Adaptation of Endothelial Cells to Physiologically-Modeled, Variable Shear Stress	PLOS ONE			English	Article							NITRIC-OXIDE PRODUCTION; WALL SHEAR; IN-VIVO; VASCULAR ENDOTHELIUM; HEMODYNAMIC FORCES; STEADY SHEAR; WAVE-FORMS; EXPRESSION; ATHEROSCLEROSIS; ATHEROGENESIS	Endothelial cell (EC) function is mediated by variable hemodynamic shear stress patterns at the vascular wall, where complex shear stress profiles directly correlate with blood flow conditions that vary temporally based on metabolic demand. The interactions of these more complex and variable shear fields with EC have not been represented in hemodynamic flow models. We hypothesized that EC exposed to pulsatile shear stress that changes in magnitude and duration, modeled directly from real-time physiological variations in heart rate, would elicit phenotypic changes as relevant to their critical roles in thrombosis, hemostasis, and inflammation. Here we designed a physiological flow (PF) model based on short-term temporal changes in blood flow observed in vivo and compared it to static culture and steady flow (SF) at a fixed pulse frequency of 1.3 Hz. Results show significant changes in gene regulation as a function of temporally variable flow, indicating a reduced wound phenotype more representative of quiescence. EC cultured under PF exhibited significantly higher endothelial nitric oxide synthase (eNOS) activity (PF: 176.0 +/- 11.9 nmol/10(5) EC; SF: 115.0 +/- 12.5 nmol/10(5) EC, p = 0.002) and lower TNF-a-induced HL-60 leukocyte adhesion (PF: 37 +/- 6 HL-60 cells/mm(2); SF: 111 +/- 18 HL-60/mm(2), p = 0.003) than cells cultured under SF which is consistent with a more quiescent anti-inflammatory and anti-thrombotic phenotype. In vitro models have become increasingly adept at mimicking natural physiology and in doing so have clarified the importance of both chemical and physical cues that drive cell function. These data illustrate that the variability in metabolic demand and subsequent changes in perfusion resulting in constantly variable shear stress plays a key role in EC function that has not previously been described.	[Uzarski, Joseph S.; McFetridge, Peter S.] Univ Florida, J Crayton Pruitt Family Dept Biomed Engn, Gainesville, FL 32611 USA; [Scott, Edward W.] Univ Florida, Dept Mol Genet & Microbiol, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	McFetridge, PS (corresponding author), Univ Florida, J Crayton Pruitt Family Dept Biomed Engn, Gainesville, FL 32611 USA.	pmcfetridge@bme.ufl.edu	Stefanadis, Christodoulos/ABH-2232-2020	Stefanadis, Christodoulos/0000-0001-5974-6454	National Institutes of Health [R01-HL088207, R01-HL088207-S1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088207] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institutes of Health (grants R01-HL088207 and R01-HL088207-S1) (http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alef MJ, 2012, NITRIC OXIDE; Bagi Z, 2005, ARTERIOSCL THROM VAS, V25, P1590, DOI 10.1161/01.ATV.0000170136.71970.5f; Blackman BR, 2002, J BIOMECH ENG-T ASME, V124, P397, DOI 10.1115/1.1486468; Boon RA, 2009, HAMOSTASEOLOGIE, V29, P39, DOI 10.1055/s-0037-1616937; Butler PJ, 2000, MICROCIRCULATION, V7, P53, DOI 10.1038/sj.mn.7300093; CARO CG, 1969, NATURE, V223, P1159, DOI 10.1038/2231159a0; Chi JT, 2003, P NATL ACAD SCI USA, V100, P10623, DOI 10.1073/pnas.1434429100; Chien S, 2007, AM J PHYSIOL-HEART C, V292, pH1209, DOI 10.1152/ajpheart.01047.2006; Dai GH, 2004, P NATL ACAD SCI USA, V101, P14871, DOI 10.1073/pnas.0406073101; Dai G, 2007, CIRC RES, V101, P723, DOI 10.1161/CIRCRESAHA.107.152942; Davies PF, 2009, NAT CLIN PRACT CARD, V6, P16, DOI 10.1038/ncpcardio1397; Davies PF, 2008, ANN BIOMED ENG, V36, P563, DOI [10.1007/s10439-007-9400-0, 10.1007/S10439-007-9400-0]; DAVIES PF, 1995, PHYSIOL REV, V75, P519, DOI 10.1152/physrev.1995.75.3.519; Dekker RJ, 2005, AM J PATHOL, V167, P609, DOI 10.1016/S0002-9440(10)63002-7; DEWEY CF, 1981, J BIOMECH ENG-T ASME, V103, P177, DOI 10.1115/1.3138276; Doriot PA, 2000, CORONARY ARTERY DIS, V11, P495, DOI 10.1097/00019501-200009000-00008; FRANGOS JA, 1988, BIOTECHNOL BIOENG, V32, P1053, DOI 10.1002/bit.260320812; Frangos JA, 1996, BIOCHEM BIOPH RES CO, V224, P660, DOI 10.1006/bbrc.1996.1081; FURLONG B, 1987, BRIT J PHARMACOL, V90, P687, DOI 10.1111/j.1476-5381.1987.tb11221.x; GARG UC, 1989, J CLIN INVEST, V83, P1774, DOI 10.1172/JCI114081; Gimbrone MA, 1999, AM J PATHOL, V155, P1, DOI 10.1016/S0002-9440(10)65090-0; Gimbrone MA, 2000, ANN NY ACAD SCI, V902, P230; Hahn C, 2008, ARTERIOSCL THROM VAS, V28, P2101, DOI 10.1161/ATVBAHA.108.165951; Himburg HA, 2007, AM J PHYSIOL-HEART C, V293, pH645, DOI 10.1152/ajpheart.01087.2006; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; KUBES P, 1991, P NATL ACAD SCI USA, V88, P4651, DOI 10.1073/pnas.88.11.4651; KUCHAN MJ, 1994, AM J PHYSIOL, V267, pC753, DOI 10.1152/ajpcell.1994.267.3.C753; Li M, 2009, ANN BIOMED ENG, V37, P1082, DOI 10.1007/s10439-009-9684-3; Li Y, 2004, BIOL REPROD, V70, P785, DOI 10.1095/biolreprod.103.022293; Lindemann S, 2000, THROMB RES, V97, P113, DOI 10.1016/S0049-3848(99)00162-0; Luu NT, 2010, J VASC RES, V47, P451, DOI 10.1159/000302613; Michel T, 2010, PFLUG ARCH EUR J PHY, V459, P807, DOI 10.1007/s00424-009-0765-9; Mount PF, 2007, J MOL CELL CARDIOL, V42, P271, DOI 10.1016/j.yjmcc.2006.05.023; Naseem Khalid M., 2005, Molecular Aspects of Medicine, V26, P33, DOI 10.1016/j.mam.2004.09.003; NEREM RM, 1983, ANN NY ACAD SCI, V416, P709, DOI 10.1111/j.1749-6632.1983.tb35222.x; Newcomer SC, 2011, J APPL PHYSIOL, V111, P311, DOI 10.1152/japplphysiol.00033.2011; Papaioannou TG, 2006, INT J CARDIOL, V113, P12, DOI 10.1016/j.ijcard.2006.03.035; RANJAN V, 1995, AM J PHYSIOL-HEART C, V269, pH550, DOI 10.1152/ajpheart.1995.269.2.H550; Reneman RS, 2008, MED BIOL ENG COMPUT, V46, P499, DOI 10.1007/s11517-008-0330-2; Rouleau L, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4001891; Rouleau L, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4001217; Sakamoto N, 2010, BIOCHEM BIOPH RES CO, V398, P426, DOI 10.1016/j.bbrc.2010.06.092; Schulz E, 2009, CIRC RES, V104, P422, DOI 10.1161/CIRCRESAHA.109.194274; Searles CD, 2006, AM J PHYSIOL-CELL PH, V291, pC803, DOI 10.1152/ajpcell.00457.2005; SenBanerjee S, 2004, J EXP MED, V199, P1305, DOI 10.1084/jem.20031132; Sparacino-Watkins CE, 2012, CIRCULATION; Syedain ZH, 2008, P NATL ACAD SCI USA, V105, P6537, DOI 10.1073/pnas.0711217105; Thorin E, 2010, PFLUG ARCH EUR J PHY, V459, P951, DOI 10.1007/s00424-009-0763-y; Wang NP, 2006, BIOCHEM BIOPH RES CO, V341, P1244, DOI 10.1016/j.bbrc.2006.01.089; White CR, 2007, PHILOS T R SOC B, V362, P1459, DOI 10.1098/rstb.2007.2128; Wu KK, 1996, ANNU REV MED, V47, P315; Yee A, 2008, ANN BIOMED ENG, V36, P571, DOI 10.1007/s10439-008-9452-9	52	52	54	3	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e57004	10.1371/journal.pone.0057004	http://dx.doi.org/10.1371/journal.pone.0057004			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457646	Green Submitted, Green Published, gold			2022-12-25	WOS:000315602700105
J	Seffouh, A; Milz, F; Przybylski, C; Laguri, C; Oosterhof, A; Bourcier, S; Sadir, R; Dutkowski, E; Daniel, R; van Kuppevelt, TH; Dierks, T; Lortat-Jacob, H; Vives, RR				Seffouh, Amal; Milz, Fabian; Przybylski, Cedric; Laguri, Cedric; Oosterhof, Arie; Bourcier, Sebastien; Sadir, Rabia; Dutkowski, Elodie; Daniel, Regis; van Kuppevelt, Toin H.; Dierks, Thomas; Lortat-Jacob, Hugues; Vives, Romain R.			HSulf sulfatases catalyze processive and oriented 6-O-desulfation of heparan sulfate that differentially regulates fibroblast growth factor activity	FASEB JOURNAL			English	Article						proteoglycan; glycosaminoglycan; enzymatic mechanism; interaction; structure/function relationships	BINDING; SULF-2; FGF-1; 6-O-ENDOSULFATASES; OLIGOSACCHARIDES; IDENTIFICATION; PROTEOGLYCANS; 6-O-SULFATION; REQUIREMENTS; SEQUENCES	Sulfs are extracellular sulfatases that have emerged recently as critical regulators of heparan sulfate (HS) activities through their ability to catalyze specific 6-O-desulfation of the polysaccharide. Consequently, Sulfs have been involved in many physiological and pathological processes, and notably for Sulf-2, in the development of cancers with poor prognosis. Despite growing interest, little is known about the structure and activity of these enzymes and the way they induce dynamic remodeling of HS 6-O-sulfation status. Here, we have combined an array of analytical approaches, including mass spectrometry, NMR, HS oligosaccharide sequencing, and FACS, to dissect HSulf-2 sulfatase activity, either on a purified octasaccharide used as a mimic of HS functional domains, or on intact cell-surface HS chains. In parallel, we have studied the functional consequences of HSulf-2 activity on fibroblast growth factor (FGF)-induced mitogenesis and found that the enzyme could differentially regulate FGF1 and FGF2 activities. Notably, these data supported the existence of precise 6-O-sulfation patterns for FGF activation and provided new insights into the saccharide structures involved. Altogether, our data bring to light an original processive enzymatic mechanism, by which HSulfs catalyze oriented alteration of HS 6-O-desulfation patterns and direct fine and differential regulation of HS functions.-Seffouh, A., Milz, F., Przybylski, C., Laguri, C., Oosterhof, A., Bourcier, S., Sadir, R., Dutkowski, E., Daniel, R., van Kuppevelt, T. H., Dierks, T., Lortat-Jacob, H., Vives, R. R. HSulf sulfatases catalyze processive and oriented 6-O-desulfation of heparan sulfate that differentially regulates fibroblast growth factor activity.	[Seffouh, Amal; Laguri, Cedric; Bourcier, Sebastien; Sadir, Rabia; Dutkowski, Elodie; Lortat-Jacob, Hugues; Vives, Romain R.] Univ Grenoble 1, CNRS, UMR 5075, Inst Biol Struct Jean Pierre Ebel,Commissariat En, Grenoble, France; [Milz, Fabian; Dierks, Thomas] Univ Bielefeld, Dept Chem, D-33615 Bielefeld, Germany; [Przybylski, Cedric; Daniel, Regis] Univ Evry Val dEssonne, Lab Anal & Modelisat Biol & Environm, CNRS, UMR 8587, Evry, France; [Oosterhof, Arie; van Kuppevelt, Toin H.] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Biochem, NL-6525 ED Nijmegen, Netherlands	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; University of Bielefeld; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Saclay; CEA; CY Cergy Paris Universite; Radboud University Nijmegen	Vives, RR (corresponding author), Inst Biol Struct, 41 Rue Horowitz, F-38027 Grenoble, France.	romain.vives@ibs.fr	van Kuppevelt, A.H.M.S.M./L-4463-2015; Daniel, Regis/S-7890-2016; Dierks, Thomas/A-3596-2012	Daniel, Regis/0000-0003-0725-5439; Dierks, Thomas/0000-0001-6426-1339; laguri, cedric/0000-0002-5429-6914				Ai XB, 2003, J CELL BIOL, V162, P341, DOI 10.1083/jcb.200212083; Capila I, 2002, ANGEW CHEM INT EDIT, V41, P391; Chabrol E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050722; Dai YM, 2005, J BIOL CHEM, V280, P40066, DOI 10.1074/jbc.M508136200; Dhoot GK, 2001, SCIENCE, V293, P1663, DOI 10.1126/science.293.5535.1663; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Freeman SD, 2008, DEV BIOL, V320, P436, DOI 10.1016/j.ydbio.2008.05.554; Frese MA, 2009, J BIOL CHEM, V284, P28033, DOI 10.1074/jbc.M109.035808; GUIMOND S, 1993, J BIOL CHEM, V268, P23906; Hossain MM, 2010, GLYCOBIOLOGY, V20, P175, DOI 10.1093/glycob/cwp159; ISHIHARA M, 1995, J BIOCHEM-TOKYO, V118, P1255, DOI 10.1093/oxfordjournals.jbchem.a125015; Jemth P, 2002, J BIOL CHEM, V277, P30567, DOI 10.1074/jbc.M203404200; Kalus I, 2009, J CELL MOL MED, V13, P4505, DOI 10.1111/j.1582-4934.2008.00558.x; Kudchadkar R, 2008, EXPERT OPIN INV DRUG, V17, P1769, DOI 10.1517/13543784.17.11.1769 ; Lamanna WC, 2008, J BIOL CHEM, V283, P27724, DOI 10.1074/jbc.M802130200; Lamanna WC, 2006, BIOCHEM J, V400, P63, DOI 10.1042/BJ20060848; Lemjabbar-Alaoui H, 2010, ONCOGENE, V29, P635, DOI 10.1038/onc.2009.365; Lindahl U, 2009, INT REV CEL MOL BIO, V276, P105, DOI 10.1016/S1937-6448(09)76003-4; Lortat-Jacob H, 2009, CURR OPIN STRUC BIOL, V19, P543, DOI 10.1016/j.sbi.2009.09.003; Lum DH, 2007, MOL CELL BIOL, V27, P678, DOI 10.1128/MCB.01279-06; Morimoto-Tomita M, 2005, NEOPLASIA, V7, P1001, DOI 10.1593/neo.05496; Morimoto-Tomita M, 2002, J BIOL CHEM, V277, P49175, DOI 10.1074/jbc.M205131200; Narita K, 2006, CANCER RES, V66, P6025, DOI 10.1158/0008-5472.CAN-05-3582; Nawroth R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000392; Ohto T, 2002, GENES CELLS, V7, P173, DOI 10.1046/j.1356-9597.2001.00502.x; Ori A, 2008, FRONT BIOSCI-LANDMRK, V13, P4309, DOI 10.2741/3007; Pempe EH, 2012, GLYCOBIOLOGY, V22, P1353, DOI 10.1093/glycob/cws092; Przybylski C, 2010, GLYCOBIOLOGY, V20, P224, DOI 10.1093/glycob/cwp169; Pye DA, 2000, GLYCOBIOLOGY, V10, P1183, DOI 10.1093/glycob/10.11.1183; Pye DA, 1998, J BIOL CHEM, V273, P22936, DOI 10.1074/jbc.273.36.22936; Rosen SD, 2010, EXPERT OPIN THER TAR, V14, P935, DOI 10.1517/14728222.2010.504718; Sarrazin S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004952; Staples GO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016689; Uchimura Kenji, 2006, BMC Biochem, V7, P2, DOI 10.1186/1471-2091-7-2; Vives RR, 1999, BIOCHEM J, V339, P767, DOI 10.1042/0264-6021:3390767; Viviano BL, 2004, J BIOL CHEM, V279, P5604, DOI 10.1074/jbc.M310691200; Yates EA, 1996, CARBOHYD RES, V294, P15	37	42	42	1	36	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2013	27	6					2431	2439		10.1096/fj.12-226373	http://dx.doi.org/10.1096/fj.12-226373			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	154II	23457216				2022-12-25	WOS:000319667600030
J	Shi, ZY; Wedd, AG; Gras, SL				Shi, Zhenyu; Wedd, Anthony G.; Gras, Sally L.			Parallel In Vivo DNA Assembly by Recombination: Experimental Demonstration and Theoretical Approaches	PLOS ONE			English	Article							METABOLIC FLUX ANALYSIS; IDENTIFYING DETERMINANTS; SACCHAROMYCES-CEREVISIAE; CHEMICAL-SYNTHESIS; FLP RECOMBINASE; CLONING; CONSTRUCTION; GENES; PLASMID; PROTEIN	The development of synthetic biology requires rapid batch construction of large gene networks from combinations of smaller units. Despite the availability of computational predictions for well-characterized enzymes, the optimization of most synthetic biology projects requires combinational constructions and tests. A new building-brick-style parallel DNA assembly framework for simple and flexible batch construction is presented here. It is based on robust recombination steps and allows a variety of DNA assembly techniques to be organized for complex constructions (with or without scars). The assembly of five DNA fragments into a host genome was performed as an experimental demonstration.	[Shi, Zhenyu; Wedd, Anthony G.] Univ Melbourne, Sch Chem, Parkville, Vic 3052, Australia; [Gras, Sally L.] Univ Melbourne, Dept Chem & Biomol Engn, Parkville, Vic 3052, Australia; [Shi, Zhenyu; Wedd, Anthony G.; Gras, Sally L.] Bio21 Mol Sci & Biotechnol Inst, Parkville, Vic, Australia	University of Melbourne; University of Melbourne	Shi, ZY (corresponding author), Univ Melbourne, Sch Chem, Parkville, Vic 3052, Australia.	shiz@student.unimelb.edu.au	Gras, Sally L/G-2025-2014	Gras, Sally L/0000-0002-4660-1245	University of Melbourne; Bio21 Molecular Science and Biotechnology Institute, School of Chemistry, University of Melbourne; Bio21 Molecular Science and Biotechnology Institute, University of Melbourne	University of Melbourne(University of Melbourne); Bio21 Molecular Science and Biotechnology Institute, School of Chemistry, University of Melbourne; Bio21 Molecular Science and Biotechnology Institute, University of Melbourne	This research was supported from funds provided by the University of Melbourne and the Bio21 Molecular Science and Biotechnology Institute, School of Chemistry, University of Melbourne (http://www.chemistry.unimelb.edu.au) and Bio21 Molecular Science and Biotechnology Institute, University of Melbourne (http://www.bio21.unimelb.edu.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson J Christopher, 2010, J Biol Eng, V4, P1, DOI 10.1186/1754-1611-4-1; ASLANIDIS C, 1990, NUCLEIC ACIDS RES, V18, P6069, DOI 10.1093/nar/18.20.6069; Bennett GN, 2003, United States Patent, Patent No. 7267984; Bitinaite J, 2007, NUCLEIC ACIDS RES, V35, P1992, DOI 10.1093/nar/gkm041; Chen QJ, 2010, PLANT PHYSIOL, V153, P41, DOI 10.1104/pp.109.152249; Chiang CJ, 2008, BIOTECHNOL BIOENG, V101, P985, DOI 10.1002/bit.21976; Chitale M, 2011, COMPUTATIONAL PROTEI; Czar MJ, 2009, NUCLEIC ACIDS RES, V37, pW40, DOI 10.1093/nar/gkp361; Dafhnis-Calas F, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni192; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DORGAI L, 1995, J MOL BIOL, V252, P178, DOI 10.1006/jmbi.1995.0486; Ellis HM, 2001, P NATL ACAD SCI USA, V98, P6742, DOI 10.1073/pnas.121164898; Ellis T, 2011, INTEGR BIOL-UK, V3, P109, DOI 10.1039/c0ib00070a; Engler C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005553; Esposito Dominic, 2009, V498, P31, DOI 10.1007/978-1-59745-196-3_3; Fleishman SJ, 2011, J MOL BIOL, V414, P289, DOI 10.1016/j.jmb.2011.09.031; Fu CL, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn167; Fu J, 2012, NAT BIOTECHNOL; Gahan CGM, 2012, CURR GENE THER, V12, P12; Gibson DG, 2008, SCIENCE, V319, P1215, DOI 10.1126/science.1151721; Gibson DG, 2010, NAT METHODS, V7, P901, DOI 10.1038/nmeth.1515; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gibson DG, 2008, P NATL ACAD SCI USA, V105, P20404, DOI 10.1073/pnas.0811011106; Goler JA, 2004, 2004003 AITR; Griffiths A.J.F., 2000, INTRO GENETIC ANAL; Haldimann A, 2001, J BACTERIOL, V183, P6384, DOI 10.1128/JB.183.21.6384-6393.2001; Hartley JL, 1999, United States Patent, Patent No. [US5888732, 5888732]; Husseiny MI, 2005, INFECT IMMUN, V73, P1598, DOI 10.1128/IAI.73.3.1598-1605.2005; Itaya M, 1999, J BACTERIOL, V181, P1045, DOI 10.1128/JB.181.3.1045-1048.1999; Itaya M, 2008, NAT METHODS, V5, P41, DOI 10.1038/NMETH1143; Jang YS, 2012, BIOTECHNOL J, V7, P186, DOI 10.1002/biot.201100059; Kirby J, 2008, NAT PROD REP, V25, P656, DOI 10.1039/b802939c; Knight T., 2003, IDEMPOTENT VECTOR DE; Kouprina N, 2003, EMBO REP, V4, P257, DOI 10.1038/sj.embor.embor766; Kuhlman TE, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1193; Kuhn Ralf, 2002, Methods Mol Biol, V180, P175; Leem SH, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng029; Lesic B, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-20; Li B, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-7; Li MZ, 2007, NAT METHODS, V4, P251, DOI 10.1038/NMETH1010; Li MZ, 2005, NAT GENET, V37, P311, DOI 10.1038/ng1505; Lin L, 2003, P NATL ACAD SCI USA, V100, P5962, DOI 10.1073/pnas.0931425100; LOBBAN PE, 1973, J MOL BIOL, V78, P453, DOI 10.1016/0022-2836(73)90468-3; Ma L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019883; Minaeva NI, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-63; Mirschel S, 2009, BIOINFORMATICS, V25, P687, DOI 10.1093/bioinformatics/btp029; Niklas J, 2010, CURR OPIN BIOTECH, V21, P63, DOI 10.1016/j.copbio.2010.01.011; Noh K, 2011, APPL MICROBIOL BIOT, V91, P1247, DOI 10.1007/s00253-011-3390-4; Norville Julie E, 2010, J Biol Eng, V4, P17, DOI 10.1186/1754-1611-4-17; Noskov VN, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-16; PAN GH, 1993, MOL CELL BIOL, V13, P3167, DOI 10.1128/MCB.13.6.3167; Petersen LK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024531; Posfai G, 2006, SCIENCE, V312, P1044, DOI 10.1126/science.1126439; Ravin NV, 2011, PLASMID, V65, P102, DOI 10.1016/j.plasmid.2010.12.004; Sael Lee, 2012, Journal of Structural and Functional Genomics, V13, P111, DOI 10.1007/s10969-012-9126-6; Schweizer HP, 2003, J MOL MICROB BIOTECH, V5, P67, DOI 10.1159/000069976; Schwender J, 2008, CURR OPIN BIOTECH, V19, P131, DOI 10.1016/j.copbio.2008.02.006; SENECOFF JF, 1985, P NATL ACAD SCI USA, V82, P7270, DOI 10.1073/pnas.82.21.7270; Sharan SK, 2009, NAT PROTOC, V4, P206, DOI 10.1038/nprot.2008.227; Shetty R, 2011, METHOD ENZYMOL, V498, P311, DOI 10.1016/B978-0-12-385120-8.00013-9; Shetty Reshma P, 2008, J Biol Eng, V2, P5, DOI 10.1186/1754-1611-2-5; Shi Z, 2012, VEXCUTOR ALL I UNPUB; Sleight SC, 2010, NUCLEIC ACIDS RES, V38, P2624, DOI 10.1093/nar/gkq179; Spiekermann P, 1999, ARCH MICROBIOL, V171, P73, DOI 10.1007/s002030050681; Steen EJ, 2008, MICROB CELL FACT, V7, DOI 10.1186/1475-2859-7-36; Trinh CT, 2009, APPL MICROBIOL BIOT, V81, P813, DOI 10.1007/s00253-008-1770-1; Trost B, 2011, BIOINFORMATICS, V27, P2927, DOI 10.1093/bioinformatics/btr525; Van Duyne GD, 2001, ANNU REV BIOPH BIOM, V30, P87, DOI 10.1146/annurev.biophys.30.1.87; Villalobos A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-285; Wiechert W, 2002, GENET ENG P, V24, P215; Winson MK, 1998, FEMS MICROBIOL LETT, V163, P185, DOI 10.1111/j.1574-6968.1998.tb13044.x; Winson MK, 1998, FEMS MICROBIOL LETT, V163, P193, DOI 10.1111/j.1574-6968.1998.tb13045.x; YAGIL E, 1995, J MOL BIOL, V252, P163, DOI 10.1006/jmbi.1995.0485; Zamboni N, 2011, CURR OPIN BIOTECH, V22, P103, DOI 10.1016/j.copbio.2010.08.009; Zhang L, 2011, SCI REP-UK, V1, DOI 10.1038/srep00141	75	2	2	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e56854	10.1371/journal.pone.0056854	http://dx.doi.org/10.1371/journal.pone.0056854			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23468883	gold, Green Submitted, Green Published			2022-12-25	WOS:000315524900039
J	Dudschig, C; Souman, J; Lachmair, M; de la Vega, I; Kaup, B				Dudschig, Carolin; Souman, Jan; Lachmair, Martin; de la Vega, Irmgard; Kaup, Barbara			Reading "Sun" and Looking Up: The Influence of Language on Saccadic Eye Movements in the Vertical Dimension	PLOS ONE			English	Article							COVERT SHIFTS; ATTENTION; INFORMATION	Traditionally, language processing has been attributed to a separate system in the brain, which supposedly works in an abstract propositional manner. However, there is increasing evidence suggesting that language processing is strongly interrelated with sensorimotor processing. Evidence for such an interrelation is typically drawn from interactions between language and perception or action. In the current study, the effect of words that refer to entities in the world with a typical location (e. g., sun, worm) on the planning of saccadic eye movements was investigated. Participants had to perform a lexical decision task on visually presented words and non-words. They responded by moving their eyes to a target in an upper (lower) screen position for a word (non-word) or vice versa. Eye movements were faster to locations compatible with the word's referent in the real world. These results provide evidence for the importance of linguistic stimuli in directing eye movements, even if the words do not directly transfer directional information.	[Dudschig, Carolin; Souman, Jan; Lachmair, Martin; de la Vega, Irmgard; Kaup, Barbara] Univ Tubingen, Dept Psychol, Tubingen, Germany	Eberhard Karls University of Tubingen	Dudschig, C (corresponding author), Univ Tubingen, Dept Psychol, Tubingen, Germany.	carolin.dudschig@uni-tuebingen.de	Kaup, Barbara/M-6786-2013; Lachmair, Martin/HCH-2667-2022	Kaup, Barbara/0000-0002-7400-0789; Souman, Jan L./0000-0003-3027-1090; Lachmair, Martin/0000-0002-0469-9168	Margarete-von-Wrangell Fellowship (European Social Fund); Ministry of Science, Research and the Arts Baden-Wurttemberg; German Research Foundation [SFB833/B4]; German Research Foundation; University of Tuebingen	Margarete-von-Wrangell Fellowship (European Social Fund); Ministry of Science, Research and the Arts Baden-Wurttemberg; German Research Foundation(German Research Foundation (DFG)); German Research Foundation(German Research Foundation (DFG)); University of Tuebingen	This project was supported by a Margarete-von-Wrangell Fellowship appointed to Carolin Dudschig (European Social Fund and the Ministry of Science, Research and the Arts Baden-Wurttemberg) and by the SFB833/B4 project of Barbara Kaup (German Research Foundation). The authors also acknowledge support by the German Research Foundation and the Open Access Publishing Fund of the University of Tuebingen for funding publication fees. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann GTM, 1999, COGNITION, V73, P247, DOI 10.1016/S0010-0277(99)00059-1; Barsalou LW, 1999, BEHAV BRAIN SCI, V22, P577, DOI 10.1017/S0140525X99532147; Bergen BK, 2007, COGNITIVE SCI, V31, P733, DOI 10.1080/03640210701530748; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Chun MM, 2011, ANNU REV PSYCHOL, V62, P73, DOI 10.1146/annurev.psych.093008.100427; Corbetta M, 1998, NEURON, V21, P761, DOI 10.1016/S0896-6273(00)80593-0; Cornelissen FW, 2002, BEHAV RES METH INS C, V34, P613, DOI 10.3758/BF03195489; DEHAENE S, 1993, J EXP PSYCHOL GEN, V122, P371, DOI 10.1037/0278-7393.21.2.314; Deubel H, 1996, VISION RES, V36, P1827, DOI 10.1016/0042-6989(95)00294-4; Dudschig C, 2012, MEM COGNITION, V40, P1081, DOI 10.3758/s13421-012-0201-9; Dudschig C, 2012, COGN PROCESS, V13, pS151, DOI 10.1007/s10339-012-0480-x; EBERHARD KM, 1995, J PSYCHOLINGUIST RES, V24, P409, DOI 10.1007/BF02143160; Estes Z, 2008, PSYCHOL SCI, V19, P93, DOI 10.1111/j.1467-9280.2008.02051.x; Glenberg AM, 2002, PSYCHON B REV, V9, P558, DOI 10.3758/BF03196313; Goldring J, 1997, EXP BRAIN RES, V113, P88, DOI 10.1007/BF02454145; Gozli DG, 2013, J EXP PSYCHOL GEN, V142, P1028, DOI 10.1037/a0030362; Hanna JE, 2007, J MEM LANG, V57, P596, DOI 10.1016/j.jml.2007.01.008; Hodgson T, 2007, BRAIN, V130, P1525, DOI 10.1093/brain/awm064; HOFFMAN JE, 1995, PERCEPT PSYCHOPHYS, V57, P787, DOI 10.3758/BF03206794; Hommel B, 2001, BEHAV BRAIN SCI, V24, P849, DOI 10.1017/S0140525X01000103; Hommel B, 2001, PSYCHOL SCI, V12, P360, DOI 10.1111/1467-9280.00367; Huettig F, 2011, ACTA PSYCHOL, V137, P151, DOI 10.1016/j.actpsy.2010.11.003; Itti L, 2000, VISION RES, V40, P1489, DOI 10.1016/S0042-6989(99)00163-7; Kleiner M, 2007, WHATS NEW PSYCHOTO S, V36; Kosslyn SM, 2001, NAT REV NEUROSCI, V2, P635, DOI 10.1038/35090055; Lachmair M, 2011, PSYCHON B REV, V18, P1180, DOI 10.3758/s13423-011-0158-x; LAKOFF G, 1980, COGNITIVE SCI, V4, P195, DOI 10.1207/s15516709cog0402_4; LOFTUS GR, 1994, PSYCHON B REV, V1, P476, DOI 10.3758/BF03210951; LOGAN GD, 1995, COGNITIVE PSYCHOL, V28, P103, DOI 10.1006/cogp.1995.1004; Lu CH, 2001, Q J EXP PSYCHOL-A, V54, P95, DOI 10.1080/02724980042000048; Maddox WT, 2001, PERCEPT PSYCHOPHYS, V63, P1183, DOI 10.3758/BF03194533; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Peterson MS, 2004, PERCEPT PSYCHOPHYS, V66, P398, DOI 10.3758/BF03194888; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; R Core Team, 2012, R LANG ENV STAT COMP; Richardson DC, 2007, PSYCHOL SCI, V18, P407, DOI 10.1111/j.1467-9280.2007.01914.x; Schwarz W, 2004, PERCEPT PSYCHOPHYS, V66, P651, DOI 10.3758/BF03194909; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Tanenhaus MK, 2008, PHILOS T R SOC B, V363, P1105, DOI 10.1098/rstb.2007.2162; TANENHAUS MK, 1995, SCIENCE, V268, P1632, DOI 10.1126/science.7777863; Thornton T, 2013, J EXP PSYCHOL HUMAN, V39, P964, DOI 10.1037/a0030467; Verges M, 2009, COGNITIVE SCI, V33, P1157, DOI 10.1111/j.1551-6709.2009.01038.x; Zwaan RA, 2002, PSYCHOL SCI, V13, P168, DOI 10.1111/1467-9280.00430; Zwaan RolfA., 2005, GROUNDING COGNITION, P224, DOI DOI 10.1017/CBO9780511499968.010	44	46	46	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e56872	10.1371/journal.pone.0056872	http://dx.doi.org/10.1371/journal.pone.0056872			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	098BN	23460816	Green Published, gold, Green Submitted			2022-12-25	WOS:000315519000040
J	Qian, J; Song, JY; Gao, HH; Zhu, YJ; Xu, J; Pang, XH; Yao, H; Sun, C; Li, XE; Li, CY; Liu, JA; Xu, HB; Chen, SL				Qian, Jun; Song, Jingyuan; Gao, Huanhuan; Zhu, Yingjie; Xu, Jiang; Pang, Xiaohui; Yao, Hui; Sun, Chao; Li, Xian'en; Li, Chuyuan; Liu, Juyan; Xu, Haibin; Chen, Shilin			The Complete Chloroplast Genome Sequence of the Medicinal Plant Salvia miltiorrhiza	PLOS ONE			English	Article							COMPLETE NUCLEOTIDE-SEQUENCE; PLASTID GENOME; PHYLOGENETIC-RELATIONSHIPS; TRANSFER-RNAS; DNA; EVOLUTION; IDENTIFICATION; ORGANIZATION; BIOTECHNOLOGY; MULTIPLE	Salvia miltiorrhiza is an important medicinal plant with great economic and medicinal value. The complete chloroplast (cp) genome sequence of Salvia miltiorrhiza, the first sequenced member of the Lamiaceae family, is reported here. The genome is 151,328 bp in length and exhibits a typical quadripartite structure of the large (LSC, 82,695 bp) and small (SSC, 17,555 bp) single-copy regions, separated by a pair of inverted repeats (IRs, 25,539 bp). It contains 114 unique genes, including 80 protein-coding genes, 30 tRNAs and four rRNAs. The genome structure, gene order, GC content and codon usage are similar to the typical angiosperm cp genomes. Four forward, three inverted and seven tandem repeats were detected in the Salvia miltiorrhiza cp genome. Simple sequence repeat (SSR) analysis among the 30 asterid cp genomes revealed that most SSRs are AT-rich, which contribute to the overall AT richness of these cp genomes. Additionally, fewer SSRs are distributed in the protein-coding sequences compared to the non-coding regions, indicating an uneven distribution of SSRs within the cp genomes. Entire cp genome comparison of Salvia miltiorrhiza and three other Lamiales cp genomes showed a high degree of sequence similarity and a relatively high divergence of intergenic spacers. Sequence divergence analysis discovered the ten most divergent and ten most conserved genes as well as their length variation, which will be helpful for phylogenetic studies in asterids. Our analysis also supports that both regional and functional constraints affect gene sequence evolution. Further, phylogenetic analysis demonstrated a sister relationship between Salvia miltiorrhiza and Sesamum indicum. The complete cp genome sequence of Salvia miltiorrhiza reported in this paper will facilitate population, phylogenetic and cp genetic engineering studies of this medicinal plant.	[Qian, Jun; Song, Jingyuan; Gao, Huanhuan; Zhu, Yingjie; Xu, Jiang; Pang, Xiaohui; Yao, Hui; Sun, Chao; Li, Xian'en; Xu, Haibin; Chen, Shilin] Chinese Acad Med Sci, Natl Engn Lab Breeding Endangered Med Mat, Inst Med Plant Dev, Beijing 100730, Peoples R China; [Qian, Jun; Song, Jingyuan; Gao, Huanhuan; Zhu, Yingjie; Xu, Jiang; Pang, Xiaohui; Yao, Hui; Sun, Chao; Li, Xian'en; Xu, Haibin; Chen, Shilin] Peking Union Med Coll, Beijing 100021, Peoples R China; [Li, Chuyuan; Liu, Juyan] Guangzhou Pharmaceut Holding Ltd, Guangzhou, Guangdong, Peoples R China; [Chen, Shilin] China Acad Chinese Med Sci, Inst Chinese Mat Med, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Plant Development - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; China Academy of Chinese Medical Sciences; Institute of Chinese Materia Medica, CACMS	Xu, HB (corresponding author), Chinese Acad Med Sci, Natl Engn Lab Breeding Endangered Med Mat, Inst Med Plant Dev, Beijing 100730, Peoples R China.	xuhaibin@implad.ac.cn; slchen@implad.ac.cn	Yao, hui/AAM-2391-2021; Zhu, Yingjie/W-3315-2017	Zhu, Yingjie/0000-0003-1849-6019	Key National Natural Science Foundation of China [81130069]; National Key Technology RD Program [2012BAI29B01]; Program for Changjiang Scholars and Innovative Research Team of the University of Ministry of Education of China [IRT1150]	Key National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technology RD Program(National Key Technology R&D Program); Program for Changjiang Scholars and Innovative Research Team of the University of Ministry of Education of China	This work was supported by the Key National Natural Science Foundation of China (Grant no. 81130069), the National Key Technology R&D Program (Grant no. 2012BAI29B01) and the Program for Changjiang Scholars and Innovative Research Team of the University of Ministry of Education of China (Grant no. IRT1150). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BENDICH AJ, 1987, BIOESSAYS, V6, P279, DOI 10.1002/bies.950060608; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Bock R, 2004, TRENDS BIOTECHNOL, V22, P311, DOI 10.1016/j.tibtech.2004.03.005; Chan E, 2010, CURR OPIN DRUG DISC, V13, P50; Cheng TO, 2007, INT J CARDIOL, V121, P9, DOI 10.1016/j.ijcard.2007.01.004; Chumley TW, 2006, MOL BIOL EVOL, V23, P2175, DOI 10.1093/molbev/msl089; CLEGG MT, 1994, P NATL ACAD SCI USA, V91, P6795, DOI 10.1073/pnas.91.15.6795; Cui LY, 2006, NUCLEIC ACIDS RES, V34, pD692, DOI 10.1093/nar/gkj055; Daniell H, 2007, P NATL ACAD SCI USA, V104, P6879, DOI 10.1073/pnas.0702219104; Dyall SD, 2004, SCIENCE, V304, P253, DOI 10.1126/science.1094884; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; Goulding SE, 1996, MOL GEN GENET, V252, P195, DOI 10.1007/BF02173220; Haberle RC, 2008, J MOL EVOL, V66, P350, DOI 10.1007/s00239-008-9086-4; Hirao T, 2009, CURR GENET, V55, P311, DOI 10.1007/s00294-009-0247-9; Hollingsworth PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019254; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Hung YC, 2010, BBA-PROTEINS PROTEOM, V1804, P1310, DOI 10.1016/j.bbapap.2010.02.001; Huotari T, 2012, GENE, V508, P96, DOI 10.1016/j.gene.2012.07.020; Jansen RK, 2005, METHOD ENZYMOL, V395, P348, DOI 10.1016/S0076-6879(05)95020-9; Jansen RK, 2007, P NATL ACAD SCI USA, V104, P19369, DOI 10.1073/pnas.0709121104; Kim KJ, 2004, DNA RES, V11, P247, DOI 10.1093/dnares/11.4.247; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kuang DY, 2011, GENOME, V54, P663, DOI [10.1139/G11-026, 10.1139/g11-026]; Kumar S, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-131; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Kurtz S, 2001, NUCLEIC ACIDS RES, V29, P4633, DOI 10.1093/nar/29.22.4633; Lee CY, 2008, PLANTA MED, V74, P780, DOI 10.1055/s-2008-1074527; Lee HL, 2007, MOL BIOL EVOL, V24, P1161, DOI 10.1093/molbev/msm036; Leebens-Mack J, 2005, MOL BIOL EVOL, V22, P1948, DOI 10.1093/molbev/msi191; Li MH, 2008, J ETHNOPHARMACOL, V120, P419, DOI 10.1016/j.jep.2008.09.013; Li YG, 2009, J CHROMATOGR A, V1216, P1941, DOI 10.1016/j.chroma.2008.12.032; Lohse M, 2007, CURR GENET, V52, P267, DOI 10.1007/s00294-007-0161-y; Ma XY, 2010, BIOL PHARM BULL, V33, P1919, DOI 10.1248/bpb.33.1919; Ma YMA, 2012, J EXP BOT, V63, P2809, DOI 10.1093/jxb/err466; Mariotti R, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-211; Moore MJ, 2007, P NATL ACAD SCI USA, V104, P19363, DOI 10.1073/pnas.0708072104; Moore MJ, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-17; Neuhaus HE, 2000, ANNU REV PLANT PHYS, V51, P111, DOI 10.1146/annurev.arplant.51.1.111; Nie XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036869; Pauwels M, 2012, NEW PHYTOL, V193, P916, DOI 10.1111/j.1469-8137.2011.04003.x; Pombert JF, 2005, MOL BIOL EVOL, V22, P1903, DOI 10.1093/molbev/msi182; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; POWELL W, 1995, P NATL ACAD SCI USA, V92, P7759, DOI 10.1073/pnas.92.17.7759; Provan J, 1997, GENOME, V40, P104, DOI 10.1139/g97-014; Raubeson LA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-174; Rose O, 1998, MOL BIOL EVOL, V15, P613, DOI 10.1093/oxfordjournals.molbev.a025964; Ruhlman T, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-222; Samson N, 2007, PLANT BIOTECHNOL J, V5, P339, DOI 10.1111/j.1467-7652.2007.00245.x; Schaferhoff B, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-352; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; SHINOZAKI K, 1986, EMBO J, V5, P2043, DOI 10.1002/j.1460-2075.1986.tb04464.x; Stevens P.F., 2012, ANGIOSPERM PHYLOGENY; Swofford D. L., 2003, PAUP PHYLOGENETIC AN; Takano A, 2011, J PLANT RES, V124, P245, DOI 10.1007/s10265-010-0367-9; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tangphatsornruang S, 2010, DNA RES, V17, P11, DOI 10.1093/dnares/dsp025; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; UMESONO K, 1984, NUCLEIC ACIDS RES, V12, P9551, DOI 10.1093/nar/12.24.9551; Verma D, 2008, NAT PROTOC, V3, P739, DOI 10.1038/nprot.2007.522; Verma D, 2007, PLANT PHYSIOL, V145, P1129, DOI 10.1104/pp.107.106690; Walker JB, 2007, ANN BOT-LONDON, V100, P375, DOI 10.1093/aob/mcl176; Walker JB, 2004, AM J BOT, V91, P1115, DOI 10.3732/ajb.91.7.1115; Wang BQ, 2010, J MED PLANTS RES, V4, P2813; Wang RJ, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-36; Wicke S, 2011, PLANT MOL BIOL, V76, P273, DOI 10.1007/s11103-011-9762-4; WOLFE KH, 1992, J MOL EVOL, V35, P304, DOI 10.1007/BF00161168; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Xiao Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029713; Xue JH, 2012, AM J BOT, V99, pE240, DOI 10.3732/ajb.1100547; Yan YP, 2007, PLANT CELL TISS ORG, V88, P175, DOI 10.1007/s11240-006-9187-y; Yang M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012762; Yao H, 2009, PLANTA MED, V75, P667, DOI 10.1055/s-0029-1185385; Yi DK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035872; Yue F, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S1-S25; Zhang TW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030531; Zhang TW, 2011, PLANT METHODS, V7, DOI 10.1186/1746-4811-7-38; Zhong GX, 2009, J AGR FOOD CHEM, V57, P6879, DOI 10.1021/jf901462s; Zhou LM, 2005, J CLIN PHARMACOL, V45, P1345, DOI 10.1177/0091270005282630	79	218	240	5	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57607	10.1371/journal.pone.0057607	http://dx.doi.org/10.1371/journal.pone.0057607			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460883	Green Published, Green Submitted, gold			2022-12-25	WOS:000315519000138
J	Skaaby, T; Husemoen, LLN; Martinussen, T; Thyssen, JP; Melgaard, M; Thuesen, BH; Pisinger, C; Jorgensen, T; Johansen, JD; Menne, T; Carlsen, B; Szecsi, PB; Stender, S; Fenger, RV; Fenger, M; Linneberg, A				Skaaby, Tea; Husemoen, Lise Lotte Nystrup; Martinussen, Torben; Thyssen, Jacob P.; Melgaard, Michael; Thuesen, Betina Heinsbaek; Pisinger, Charlotta; Jorgensen, Torben; Johansen, Jeanne D.; Menne, Torkil; Carlsen, Berit; Szecsi, Pal B.; Stender, Steen; Fenger, Runa Vavia; Fenger, Mogens; Linneberg, Allan			Vitamin D Status, Filaggrin Genotype, and Cardiovascular Risk Factors: A Mendelian Randomization Approach	PLOS ONE			English	Article							METABOLIC SYNDROME; GENERAL-POPULATION; BLOOD-PRESSURE; SERUM; 25-HYDROXYVITAMIN-D; SUPPLEMENTATION; SENSITIVITY; PROTEIN; DETERMINANTS; OVERWEIGHT	Background: Vitamin D deficiency is associated with increased cardiovascular disease risk in observational studies. Whether these associations are causal is not clear. Loss-of-function mutations in the filaggrin gene result in up to 10% higher serum vitamin D concentrations, supposedly due to a decreased UV-protection of the keratinocytes. We used a Mendelian randomization approach to estimate the causal effect of vitamin D status on serum lipids, blood pressure, body mass index, waist circumference, and the metabolic syndrome. Methods: Three population based studies were included, Monica10 (2,656 individuals aged 40-71 years), Inter99 (6,784 individuals aged 30-60 years), and Health2006 (3,471 individuals aged 18-69 years) conducted in 1993-94, 1999-2001, and 2006-2008, respectively. Participants were genotyped for the two most common filaggrin gene mutations in European descendants R501X and 2282del4, in all three studies and further for the R2447X mutation in the Inter99 and Health2006 studies. Filaggrin genotype was used as instrumental variable for vitamin D status. Baseline measurements of serum 25-hydroxyvitamin D were performed in all three studies. Results: Instrumental variable analyses showed a 23.8% (95% confidence interval, CI 3.0, 48.6) higher HDL cholesterol level and a 30.5% (95% CI: 0.8, 51.3) lower serum level of triglycerides per doubling of vitamin D. These associations were, however, not statistically significant when applying the Bonferroni adjusted significance level. The remaining lipids showed non-significant changes in a favorable direction. Doubling of vitamin D gave a non-significantly lower odds ratio = 0.26 (95% CI: 0.06, 1.17) of the metabolic syndrome. There were no statistically significant causal effects of vitamin D status on blood pressure, body mass index, or waist circumference. Conclusion: Our results support a causal effect of higher vitamin D status on a more favorable lipid profile, although more studies in other populations are needed to confirm our results.	[Skaaby, Tea; Husemoen, Lise Lotte Nystrup; Thuesen, Betina Heinsbaek; Pisinger, Charlotta; Jorgensen, Torben; Fenger, Runa Vavia; Linneberg, Allan] Glostrup Cty Hosp, Res Ctr Prevent & Hlth, Glostrup, Denmark; [Martinussen, Torben] Univ Copenhagen, Dept Biostat, Copenhagen, Denmark; [Thyssen, Jacob P.; Johansen, Jeanne D.; Menne, Torkil; Carlsen, Berit] Univ Copenhagen, Gentofte Hosp, Dept Dermatoallergol, Natl Allergy Res Ctr, Hellerup, Denmark; [Melgaard, Michael; Szecsi, Pal B.; Stender, Steen] Univ Copenhagen, Gentofte Hosp, Dept Clin Biochem, Hellerup, Denmark; [Jorgensen, Torben] Univ Copenhagen, Fac Hlth Sci, Copenhagen, Denmark; [Jorgensen, Torben] Aalborg Univ, Fac Med, Aalborg, Denmark; [Fenger, Mogens] Univ Copenhagen, Hvidovre Hosp, Dept Clin Biochem, DK-2650 Hvidovre, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; Aalborg University; University of Copenhagen	Skaaby, T (corresponding author), Glostrup Cty Hosp, Res Ctr Prevent & Hlth, Glostrup, Denmark.	tea.skaaby.01@regionh.dk	Thyssen, Jacob/ABD-8517-2020; Johansen, Jeanne/AAM-6382-2021; Jørgensen, Torben/Z-1335-2018	Johansen, Jeanne/0000-0002-3537-8463; Thyssen, Jacob Pontoppidan/0000-0003-3770-1743; Pisinger, Charlotta/0000-0002-7970-3168; Linneberg, Allan/0000-0002-0994-0184; Thuesen, Betina/0000-0001-9772-4344; Skaaby, Tea/0000-0003-0031-5726; Szecsi, Pal/0000-0003-3446-0411	Health Insurance Foundation [2010 B 131]	Health Insurance Foundation	The study was supported by The Health Insurance Foundation (grant number 2010 B 131). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aadahl M, 2009, PREV MED, V48, P326, DOI 10.1016/j.ypmed.2009.01.015; Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Ambye L, 2005, DIABETES RES CLIN PR, V67, P175, DOI 10.1016/j.diabres.2004.06.013; Berg ND, 2012, J ALLERGY CLIN IMMUN, V129, P374, DOI 10.1016/j.jaci.2011.08.045; Carter GD, 2004, CLIN CHEM, V50, P2195, DOI 10.1373/clinchem.2004.040683; Cho HJ, 2005, BIOL PHARM BULL, V28, P1418, DOI 10.1248/bpb.28.1418; Clarke R, 1999, AM J EPIDEMIOL, V150, P341; Conen D, 2010, AM J EPIDEMIOL, V172, P1431, DOI 10.1093/aje/kwq308; Davey Smith G, 2008, ANN MED, V40, P524, DOI 10.1080/07853890802010709; Didelez V, 2007, STAT METHODS MED RES, V16, P309, DOI 10.1177/0962280206077743; Ford ES, 2005, DIABETES CARE, V28, P1228, DOI 10.2337/diacare.28.5.1228; Friedrich N, 2012, DIABETES CARE, V35, P768, DOI 10.2337/dc11-1833; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Hypponen E, 2008, DIABETES, V57, P298, DOI 10.2337/db07-1122; Jorde R, 2010, EUR J CLIN NUTR, V64, P1457, DOI 10.1038/ejcn.2010.176; Jorde R, 2010, J INTERN MED, V267, P462, DOI 10.1111/j.1365-2796.2009.02181.x; Jorde R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037295; Jorde R, 2011, PROG LIPID RES, V50, P303, DOI 10.1016/j.plipres.2011.05.001; Jorgensen Torben, 2003, Eur J Cardiovasc Prev Rehabil, V10, P377; Kamycheva E, 2007, J ENDOCRINOL INVEST, V30, P126, DOI 10.1007/BF03347410; Konradsen S, 2008, EUR J NUTR, V47, P87, DOI 10.1007/s00394-008-0700-4; Lawlor DA, 2008, STAT MED, V27, P1133, DOI 10.1002/sim.3034; Maki KC, 2011, INT J FOOD SCI NUTR, V62, P318, DOI 10.3109/09637486.2010.536146; Maki KC, 2009, J CLIN LIPIDOL, V3, P289, DOI 10.1016/j.jacl.2009.07.003; Martins D, 2007, ARCH INTERN MED, V167, P1159, DOI 10.1001/archinte.167.11.1159; McGill AT, 2008, NUTR J, V7, DOI 10.1186/1475-2891-7-4; Meldgaard M, 2012, CLIN CHIM ACTA, V413, P1488, DOI 10.1016/j.cca.2012.06.014; Mildner M, 2010, J INVEST DERMATOL, V130, P2286, DOI 10.1038/jid.2010.115; OCKE MC, 1995, J CLIN EPIDEMIOL, V48, P1077, DOI 10.1016/0895-4356(94)00232-F; Ogbuanu IU, 2009, EMERG THEMES EPIDEMI, V6, DOI 10.1186/1742-7622-6-3; Olsen MH, 2007, EUR HEART J, V28, P1374, DOI 10.1093/eurheartj/ehl448; Palmer CNA, 2006, NAT GENET, V38, P441, DOI 10.1038/ng1767; Palmer TM, 2012, STAT METHODS MED RES, V21, P223, DOI 10.1177/0962280210394459; Palmer TM, 2011, AM J EPIDEMIOL, V173, P1392, DOI 10.1093/aje/kwr026; Pittas AG, 2010, ANN INTERN MED, V152, P307, DOI 10.7326/0003-4819-152-5-201003020-00009; SCRAGG R, 1995, EUR J CLIN NUTR, V49, P640; Skaaby T., 2012, PLOS ONE, V7; Skaaby T., 2012, ENDOCRINE; Skaaby T, 2012, CARDIOLOGY, V123, P62, DOI 10.1159/000341277; Smith GD, 2003, INT J EPIDEMIOL, V32, P1, DOI 10.1093/ije/dyg070; Snellman G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011555; Thuesen B, 2012, BONE, V50, P605, DOI 10.1016/j.bone.2011.12.016; Thyssen JP, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000062; Thyssen JP, 2012, J ALLERGY CLIN IMMUN; van den Oord RAHM, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2433; Wielders JPM, 2009, CLIN CHEM, V55, P1584, DOI 10.1373/clinchem.2008.117366; Witham MD, 2009, J HYPERTENS, V27, P1948, DOI 10.1097/HJH.0b013e32832f075b; Zemel MB, 2000, FASEB J, V14, P1132, DOI 10.1096/fasebj.14.9.1132; Zittermann A, 2009, AM J CLIN NUTR, V89, P1321, DOI 10.3945/ajcn.2008.27004	49	47	50	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57647	10.1371/journal.pone.0057647	http://dx.doi.org/10.1371/journal.pone.0057647			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460889	gold, Green Published, Green Submitted			2022-12-25	WOS:000315519000144
J	Qiao, JB; Lee, S; Paul, P; Qiao, L; Taylor, CJ; Schlegel, C; Colon, NC; Chung, DH				Qiao, Jingbo; Lee, Sora; Paul, Pritha; Qiao, Lan; Taylor, Chase J.; Schlegel, Cameron; Colon, Nadja C.; Chung, Dai H.			Akt2 Regulates Metastatic Potential in Neuroblastoma	PLOS ONE			English	Article							GASTRIN-RELEASING-PEPTIDE; GROWTH-FACTOR; N-MYC; OVEREXPRESSION; EXPRESSION; INVASION; BREAST	Activation of PI3K/AKT pathway correlates with poor prognosis in patients with neuroblastoma. Our previous studies have demonstrated that PI3K/AKT signaling is critical for the oncogenic transformations induced by gastrin-releasing peptide (GRP) and its receptor, GRP-R, in neuroblastoma. Moreover, PI3K/AKT-dependent oncogenic transformations require N-myc, an extensively studied oncogene in neuroblastoma. Whether AKT directly regulates the expression of N-myc oncogene is yet to be determined. Here, we report a novel finding that of the three AKT isoforms, AKT2 specifically regulated N-myc expression in neuroblastoma cells. We also confirmed that GRP-R is upstream of AKT2 and in turn, regulated N-myc expression via AKT2 in neuroblastoma cells. Functional assays demonstrated that attenuation of AKT2 impaired cell proliferation and anchorage-independent cell growth, and decreased the secretion of angiogenic factor VEGF in vitro. Furthermore, silencing AKT2 inhibited migration and invasion of neuroblastoma cells in vitro. Xenografts established by injecting AKT2 silenced human neuroblastoma cells into murine spleen expressed decreased levels of AKT2 and resulted in fewer liver metastases compared to controls in vivo. Hence, our study highlights the potential molecular mechanism(s) mediating the oncogenic role of GRP/GRP-R and demonstrates a novel role for AKT2 in neuroblastoma tumorigenesis, indicating that targeting the GRP/GRP-R/AKT2 axis may be important for developing novel therapeutics in the treatment of clinically aggressive neuroblastoma.	[Qiao, Jingbo; Lee, Sora; Paul, Pritha; Qiao, Lan; Taylor, Chase J.; Schlegel, Cameron; Colon, Nadja C.; Chung, Dai H.] Vanderbilt Univ, Med Ctr, Dept Pediat Surg, Nashville, TN 37203 USA; [Lee, Sora; Paul, Pritha; Chung, Dai H.] Vanderbilt Univ, Med Ctr, Dept Canc Biol, Nashville, TN USA	Vanderbilt University; Vanderbilt University	Chung, DH (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pediat Surg, Nashville, TN 37203 USA.	dai.chung@vanderbilt.edu			National Institutes of Health [R01 DK61470]; Rally Foundation for Cancer Research; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061470] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rally Foundation for Cancer Research; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the National Institutes of Health (R01 DK61470) and Rally Foundation for Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Rally Foundation: http://rallyfoundation.org. NIH RO1: http://grants.nih.gov/grants/funding/r01.htm.	Altomare DA, 2003, J CELL BIOCHEM, V88, P470, DOI 10.1002/jcb.10287; Arboleda MJ, 2003, CANCER RES, V63, P196; Bordow SB, 1998, J CLIN ONCOL, V16, P3286, DOI 10.1200/JCO.1998.16.10.3286; Chanthery YH, 2012, SCI TRANSL MED, V4; Cheng GZ, 2007, CANCER RES, V67, P1979, DOI 10.1158/0008-5472.CAN-06-1479; Dummler B, 2007, BIOCHEM SOC T, V35, P231, DOI 10.1042/BST0350231; Foley NH, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-83; Gonzalez E, 2009, CELL CYCLE, V8, P2502, DOI 10.4161/cc.8.16.9335; Gustafson WC, 2010, ONCOGENE, V29, P1249, DOI 10.1038/onc.2009.512; Gustafson WC, 2005, WORLD J SURG, V29, P281, DOI 10.1007/s00268-004-7815-4; Ishola TA, 2007, BBA-GEN SUBJECTS, V1770, P927, DOI 10.1016/j.bbagen.2007.02.002; Kang J, 2008, ONCOGENE, V27, P3999, DOI 10.1038/onc.2008.15; Kang JH, 2007, CANCER LETT, V253, P273, DOI 10.1016/j.canlet.2007.02.007; Kim S, 2002, ANN SURG, V235, P621, DOI 10.1097/00000658-200205000-00003; Maris JM, 2010, NEW ENGL J MED, V362, P2202, DOI 10.1056/NEJMra0804577; Misawa A, 2000, CANCER RES, V60, P64; Opel D, 2007, CANCER RES, V67, P735, DOI 10.1158/0008-5472.CAN-06-2201; Pei HD, 2009, CANCER CELL, V16, P259, DOI 10.1016/j.ccr.2009.07.016; Qiao JB, 2005, ANN SURG, V241, P684, DOI 10.1097/01.sla.0000161173.47717.71; Qiao JB, 2008, P NATL ACAD SCI USA, V105, P12891, DOI 10.1073/pnas.0711861105; Riley RD, 2004, CLIN CANCER RES, V10, P4, DOI 10.1158/1078-0432.CCR-1051-2; Rychahou PG, 2008, P NATL ACAD SCI USA, V105, P20315, DOI 10.1073/pnas.0810715105	22	24	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2013	8	2							e56382	10.1371/journal.pone.0056382	http://dx.doi.org/10.1371/journal.pone.0056382			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098PO	23468863	Green Published, Green Submitted, gold			2022-12-25	WOS:000315561400009
J	Phillips, MJ; Haouchar, D; Pratt, RC; Gibb, GC; Bunce, M				Phillips, Matthew J.; Haouchar, Dalal; Pratt, Renae C.; Gibb, Gillian C.; Bunce, Michael			Inferring Kangaroo Phylogeny from Incongruent Nuclear and Mitochondrial Genes	PLOS ONE			English	Article							ROCK-WALLABIES; DNA-SEQUENCES; MARSUPIALIA; MACROPODIDAE; INTROGRESSION; EVOLUTION; INFERENCE; HYBRIDIZATION; PETROGALE; HISTORY	The marsupial genus Macropus includes three subgenera, the familiar large grazing kangaroos and wallaroos of M. (Macropus) and M. (Osphranter), as well as the smaller mixed grazing/browsing wallabies of M. (Notamacropus). A recent study of five concatenated nuclear genes recommended subsuming the predominantly browsing Wallabia bicolor (swamp wallaby) into Macropus. To further examine this proposal we sequenced partial mitochondrial genomes for kangaroos and wallabies. These sequences strongly favour the morphological placement of W. bicolor as sister to Macropus, although place M. irma (black-gloved wallaby) within M. (Osphranter) rather than as expected, with M. (Notamacropus). Species tree estimation from separately analysed mitochondrial and nuclear genes favours retaining Macropus and Wallabia as separate genera. A simulation study finds that incomplete lineage sorting among nuclear genes is a plausible explanation for incongruence with the mitochondrial placement of W. bicolor, while mitochondrial introgression from a wallaroo into M. irma is the deepest such event identified in marsupials. Similar such coalescent simulations for interpreting gene tree conflicts will increase in both relevance and statistical power as species-level phylogenetics enters the genomic age. Ecological considerations in turn, hint at a role for selection in accelerating the fixation of introgressed or incompletely sorted loci. More generally the inclusion of the mitochondrial sequences substantially enhanced phylogenetic resolution. However, we caution that the evolutionary dynamics that enhance mitochondria as speciation indicators in the presence of incomplete lineage sorting may also render them especially susceptible to introgression.	[Phillips, Matthew J.] Queensland Univ Technol, Sch Earth Environm & Biol Sci, Brisbane, Qld 4001, Australia; [Haouchar, Dalal; Bunce, Michael] Murdoch Univ, Sch Vet & Life Sci, Perth, WA, Australia; [Pratt, Renae C.] Australian Natl Univ, Res Sch Biol, Canberra, ACT, Australia; [Gibb, Gillian C.] Massey Univ, Inst Agr & Environm, Palmerston North, New Zealand	Queensland University of Technology (QUT); Murdoch University; Australian National University; Massey University	Phillips, MJ (corresponding author), Queensland Univ Technol, Sch Earth Environm & Biol Sci, Brisbane, Qld 4001, Australia.	mphillips.biol@gmail.com	Gibb, Gillian/AAF-9175-2020	Gibb, Gillian/0000-0002-4283-9790; Bunce, Michael/0000-0002-0302-4206	Australian Research Council [DP07745015, FT0991741]	Australian Research Council(Australian Research Council)	This work has been supported by Australian Research Council grants to MJP (DP07745015) and MB (FT0991741). The website for the funder is www.arc.gov.au. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ane C, 2007, MOL BIOL EVOL, V24, P412; ARCHER M, 1984, VERTEBRATE ZOOGEOGRA, P385; Ballard JWO, 2000, MOL BIOL EVOL, V17, P1126, DOI 10.1093/oxfordjournals.molbev.a026394; Ballard JWO, 2004, MOL ECOL, V13, P729, DOI 10.1046/j.1365-294X.2003.02063.x; Barker FK, 2002, SYST BIOL, V51, P625, DOI 10.1080/10635150290102302; BAVERSTOCK PR, 1989, SYST ZOOL, V38, P38, DOI 10.2307/2992434; BEE CA, 1993, GENET RES, V61, P21, DOI 10.1017/S0016672300031074; Briscoe D.A., 1982, P73; Buckley TR, 2006, SYST BIOL, V55, P411, DOI 10.1080/10635150600697283; Bulazel KV, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r170; Burk Angela, 2000, Journal of Mammalian Evolution, V7, P213, DOI 10.1023/A:1009488431055; Calvignac S, 2011, MITOCHONDRION, V11, P246, DOI 10.1016/j.mito.2010.10.004; Cardillo M, 2004, J ZOOL, V264, P11, DOI 10.1017/S0952836904005539; Christensen P., 1995, MAMMALS AUSTR, P341; Chung YJ, 2011, SYST BIOL, V60, P261, DOI 10.1093/sysbio/syr003; CLOSE RL, 1990, AUST J ZOOL, V37, P259, DOI 10.1071/ZO9890259; DAWSON L, 1985, AUST J ZOOL, V33, P473, DOI 10.1071/ZO9850473; de Magalhaes JP, 2009, J EVOLUTION BIOL, V22, P1770, DOI 10.1111/j.1420-9101.2009.01783.x; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Edwards SV, 2009, EVOLUTION, V63, P1, DOI 10.1111/j.1558-5646.2008.00549.x; ELDRIDGE MDB, 1992, AUST J ZOOL, V40, P605, DOI 10.1071/ZO9920605; FARRIS JS, 1994, CLADISTICS, V10, P315, DOI 10.1111/j.1096-0031.1996.tb00196.x; FLANNERY TF, 1989, KANGAROOS, WALLABIES AND RAT-KANGAROOS, VOLS 1 AND 2, P1; Flannery TF, 1992, FIELDIANA GEOLOGY, V25, P1; Galtier N, 2009, MOL ECOL, V18, P4541, DOI 10.1111/j.1365-294X.2009.04380.x; GANSLOSSER U, 1992, Australian Mammalogy, V15, P89; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; Hey J, 2004, GENETICS, V167, P747, DOI 10.1534/genetics.103.024182; Ho SYW, 2009, SYST BIOL, V58, P367, DOI 10.1093/sysbio/syp035; HOLLIS CJ, 1986, AUST WILDLIFE RES, V13, P355, DOI 10.1071/WR9860355; Jesus FF, 2006, GENET MOL RES, V5, P466; Joly S, 2009, AM NAT, V174, pE54, DOI 10.1086/600082; Jones Kate E., 2009, Ecology (Washington D C), V90, P2648, DOI 10.1890/08-1494.1; Kear BP, 2007, AUST J ZOOL, V55, P331, DOI 10.1071/ZO08002; Kear BP, 2002, ALCHERINGA, V26, P299, DOI 10.1080/03115510208619259; KIRSCH JAW, 1977, AUST J ZOOL, P1; KIRSCH JAW, 1995, BIOL J LINN SOC, V55, P309, DOI 10.1111/j.1095-8312.1995.tb01068.x; KISHINO H, 1989, J MOL EVOL, V29, P170, DOI 10.1007/BF02100115; Knowles LL, 2010, ESTIMATING SPECIES T, P1; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lynch M, 1998, GENETICA, V102-3, P29, DOI 10.1023/A:1017022522486; Maddison WP, 1997, SYST BIOL, V46, P523, DOI 10.2307/2413694; Melo-Ferreira J, 2012, SYST BIOL, V61, P367, DOI 10.1093/sysbio/syr114; Meng C, 2009, THEOR POPUL BIOL, V75, P35, DOI 10.1016/j.tpb.2008.10.004; Meredith RW, 2008, AUST J ZOOL, V56, P395, DOI 10.1071/ZO08044; Milne N, 2002, J ZOOL, V256, P523, DOI 10.1017/S0952836902000572; Moran NA, 1996, P NATL ACAD SCI USA, V93, P2873, DOI 10.1073/pnas.93.7.2873; Moritz C, 2004, PLOS BIOL, V2, P1529, DOI 10.1371/journal.pbio.0020354; Mueller RL, 2006, SYST BIOL, V55, P289, DOI 10.1080/10635150500541672; Neaves LE, 2010, HEREDITY, V104, P502, DOI 10.1038/hdy.2009.137; Neaves LE, 2012, J BIOGEOGR, V39, P1545, DOI 10.1111/j.1365-2699.2012.02702.x; Phillips MJ, 2008, MOL PHYLOGENET EVOL, V46, P594, DOI 10.1016/j.ympev.2007.09.008; Phillips MJ, 2006, SYST BIOL, V55, P122, DOI 10.1080/10635150500481614; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Prideaux GJ, 2010, ZOOL J LINN SOC-LOND, V159, P954, DOI 10.1111/j.1096-3642.2009.00607.x; Rambaut A, 1997, COMPUT APPL BIOSCI, V13, P235; RAMBAUT A, 1996, SEQUENCE ALIGMENT ED; Rambaut A., 2007, TRACER V1 5; Rannala B, 2003, GENETICS, V164, P1645; Raven H. C., 1946, AMER MUS NOVITATCS, V1309, P1; Retief JD, 1995, J MOL EVOL, V37, P426; RICHARSON B J, 1978, Australian Mammalogy, V2, P43; RIDE W. D. L., 1957, PROC ZOOL SOC LONDON, V128, P327; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ropiquet A, 2006, MOL PHYLOGENET EVOL, V41, P395, DOI 10.1016/j.ympev.2006.05.033; Rubinoff D, 2005, SYST BIOL, V54, P952, DOI 10.1080/10635150500234674; SANSON GD, 1989, KANGAROOS, WALLABIES AND RAT-KANGAROOS, VOLS 1 AND 2, P151; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Strahan R., 1995, MAMMALS AUSTR, V2nd; Sunnucks P, 1996, MOL BIOL EVOL, V13, P510, DOI 10.1093/oxfordjournals.molbev.a025612; Suzuki Y, 2002, P NATL ACAD SCI USA, V99, P16138, DOI 10.1073/pnas.212646199; Swofford D.L., 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/j.0014-3820.2002.tb00191.x; Tate G. H. H., 1948, Bulletin of the American Museum of Natural History, V91, P233; Than C, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-322; van Gelder R. G., 1977, American Mus. Novit., VNo. 2635, P1; Wann J. M., 1997, Journal of the Royal Society of Western Australia, V80, P55; Westerman Michael, 2002, Journal of Mammalian Evolution, V9, P209, DOI 10.1023/A:1022697300092; Westerman M, 2010, J HERED, V101, P690, DOI 10.1093/jhered/esq076; Woodburne Michael O., 1993, Journal of Vertebrate Paleontology, V13, P483; Yang ZH, 2010, P NATL ACAD SCI USA, V107, P9264, DOI 10.1073/pnas.0913022107; Zink RM, 2008, MOL ECOL, V17, P2107, DOI 10.1111/j.1365-294X.2008.03737.x	84	52	52	3	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e57745	10.1371/journal.pone.0057745	http://dx.doi.org/10.1371/journal.pone.0057745			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451266	Green Submitted, Green Published, gold			2022-12-25	WOS:000316658800117
J	Geissmann, Q				Geissmann, Quentin			OpenCFU, a New Free and Open-Source Software to Count Cell Colonies and Other Circular Objects	PLOS ONE			English	Article							ALGORITHM	Counting circular objects such as cell colonies is an important source of information for biologists. Although this task is often time-consuming and subjective, it is still predominantly performed manually. The aim of the present work is to provide a new tool to enumerate circular objects from digital pictures and video streams. Here, I demonstrate that the created program, OpenCFU, is very robust, accurate and fast. In addition, it provides control over the processing parameters and is implemented in an intuitive and modern interface. OpenCFU is a cross-platform and open-source software freely available at http://opencfu.sourceforge.net.	[Geissmann, Quentin] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England; [Geissmann, Quentin] Free Univ Berlin, Inst Biol, Berlin, Germany	University of Sheffield; Free University of Berlin	Geissmann, Q (corresponding author), Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England.	qgeissmann@gmail.com	Geissmann, Quentin/J-3120-2019	Geissmann, Quentin/0000-0001-6546-4306	European Research Council	European Research Council(European Research Council (ERC)European Commission)	This study is part of the project "Multidrug resistance and the evolutionary ecology of insect immunity'' (http://cordis.europa.eu/projects/rcn/ 96082_en.html) funded by the European Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, OPENMP APPL PROGR IN; Bewes JM, 2008, PHYS MED BIOL, V53, P5991, DOI 10.1088/0031-9155/53/21/007; Bradski G, 2000, DOBBS J SOFTWARE TOO; Brugger SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033695; Cai ZL, 2011, INT J RADIAT BIOL, V87, P1135, DOI 10.3109/09553002.2011.622033; Clarke ML, 2010, CYTOM PART A, V77A, P790, DOI 10.1002/cyto.a.20864; Costa CM, 2009, ANN BOT-LONDON, V104, P1005, DOI 10.1093/aob/mcp186; Forero MG, 2010, CYTOM PART A, V77A, P371, DOI 10.1002/cyto.a.20877; Kachouie NN, 2009, BIOTECHNIQUES, V47, pIX, DOI 10.2144/000113202; MANSBERG HP, 1957, SCIENCE, V126, P823, DOI 10.1126/science.126.3278.823; Marotz J, 2001, COMPUT METH PROG BIO, V66, P183, DOI 10.1016/S0169-2607(00)00128-0; Mello CAB, 2008, IEEE ENG MED BIO, P3103, DOI 10.1109/IEMBS.2008.4649860; MUKHERJEE DP, 1995, INT J BIOMED COMPUT, V38, P131, DOI 10.1016/0020-7101(94)01043-Z; Niyazi M, 2007, RADIAT ONCOL, V2, DOI 10.1186/1748-717X-2-4; Putman M, 2005, J IMMUNOL METHODS, V302, P99, DOI 10.1016/j.jim.2005.05.003; R Core Team, 2021, R LANG ENV STAT COMP; Severini AD, 2011, CROP SCI, V51, P2796, DOI 10.2135/cropsci2011.03.0147; Sieuwerts S, 2008, LETT APPL MICROBIOL, V47, P275, DOI 10.1111/j.1472-765X.2008.02417.x; Vokes Martha S, 2008, Curr Protoc Mol Biol, VChapter 14, DOI 10.1002/0471142727.mb1417s82; Yati A, 2011, BIOTECHNIQUES, V51, P347, DOI 10.2144/000113753	20	208	215	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e54072	10.1371/journal.pone.0054072	http://dx.doi.org/10.1371/journal.pone.0054072			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457446	Green Submitted, Green Published, gold			2022-12-25	WOS:000315603700004
J	Liao, MH; Shih, CC; Tsao, CM; Chen, SJ; Wu, CC				Liao, Mei-Hui; Shih, Chih-Chin; Tsao, Cheng-Ming; Chen, Shiu-Jen; Wu, Chin-Chen			RhoA/Rho-Kinase and Nitric Oxide in Vascular Reactivity in Rats with Endotoxaemia	PLOS ONE			English	Article							INDUCED CA2+ SENSITIZATION; SMOOTH-MUSCLE; MYOSIN PHOSPHATASE; PROTEIN-KINASE; SEPTIC SHOCK; RHO-KINASE; INDUCED HYPOTENSION; IN-VIVO; PHOSPHORYLATION; CONTRACTION	RhoA/Rho-kinase (RhoA/ROK) pathway promotes vasoconstriction by calcium sensitivity mechanism. LPS causes nitric oxide (NO) overproduction to induce vascular hyporeactivity. Thus, we tried to examine the role of RhoA/ROK and NO in the regulation of vascular reactivity in different time-point of endotoxaemia. Male Wistar rats were intravenously infused for 10 min with saline or E. coli endotoxin (lipopolysaccharide, LPS, 10 mg/kg) and divided to five groups (n = 8 in each group): (i) Control, sacrificed at 6 h after saline infusion; (ii) LPS1h, sacrificed at 1 h after LPS infusion; (iii) LPS2h, sacrificed at 2 h after LPS infusion; (iv) LPS4h, sacrificed at 4 h after LPS infusion; and (v) LPS6h, sacrificed at 6 h after LPS infusion. LPS1h and LPS2h were regarded as early endotoxaemia, whereas LPS4h and LPS6h were regarded as late endotoxaemia. Indeed, our results showed that LPS reproduced a biphasic hypotension and sustained vascular hyporeactivity to noradrenaline (NA) in vivo. Interestingly, this hyporeactivity did not occur in ex vivo during early endotoxaemia. This could be due to increases of aortic RhoA activity (n = 5, P<0.05) and myosin phosphatase targeting subunit 1 phosphorylation (n = 3, P<0.05). In addition, pressor response to NA and vascular reactivity in early endotoxaemia were inhibited by ROK inhibitor, Y27632. Furthermore, plasma bradykinin was increased at 10 min (24.6 +/- 13.7 ng/mL, n = 5, P<0.05) and aortic endothelial NO synthase expression was increased at 1 h (+200%. n = 3, P<0.05) after LPS. In late endotoxaemia, the vascular hyporeactivity was associated with aortic inducible NO synthase expression (n = 3, P<0.05) and an increased serum NO level (n = 8, P<0.05). Thus, an increased RhoA activity could compensate vascular hyporeactivity in early endotoxaemia, and the large NO production inhibiting RhoA activity would lead to vascular hyporeactivity eventually.	[Liao, Mei-Hui; Shih, Chih-Chin] Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan; [Shih, Chih-Chin; Wu, Chin-Chen] Natl Def Med Ctr, Dept Pharmacol, Taipei, Taiwan; [Tsao, Cheng-Ming] Natl Yang Ming Univ, Dept Anesthesiol, Taipei Vet Gen Hosp, Taipei 112, Taiwan; [Tsao, Cheng-Ming] Natl Def Med Ctr, Taipei, Taiwan; [Chen, Shiu-Jen] Kang Ning Jr Coll Med Care & Management, Dept Nursing, Taipei, Taiwan; [Chen, Shiu-Jen] Natl Def Med Ctr, Dept Physiol, Taipei, Taiwan	National Defense Medical Center; National Defense Medical Center; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Defense Medical Center; National Defense Medical Center	Chen, SJ (corresponding author), Kang Ning Jr Coll Med Care & Management, Dept Nursing, Taipei, Taiwan.	sjchen@knjc.edu.tw; ccwu@ndmctsgh.edu.tw			National Science Council, R.O.C., Taiwan [NSC 97-2320-B-345-001-MY2, 97-2320-B-016-006-MY3]	National Science Council, R.O.C., Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by grants NSC 97-2320-B-345-001-MY2 and 97-2320-B-016-006-MY3 from the National Science Council, R.O.C., Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cayla C, 2007, FASEB J, V21, P1689, DOI 10.1096/fj.06-7175com; Chen SJ, 2010, SHOCK, V33, P473, DOI 10.1097/SHK.0b013e3181bea334; Chitaley K, 2002, HYPERTENSION, V39, P438, DOI 10.1161/hy02t2.102960; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; Connelly L, 2005, J BIOL CHEM, V280, P10040, DOI 10.1074/jbc.M411991200; Dimopoulos GJ, 2007, CIRC RES, V100, P121, DOI 10.1161/01.RES.0000253902.90489.df; da Silva-Santos JE, 2009, CRIT CARE MED, V37, P1716, DOI 10.1097/CCM.0b013e31819efb43; Feng JH, 1999, J BIOL CHEM, V274, P37385, DOI 10.1074/jbc.274.52.37385; FLEMING I, 1991, EUR J PHARMACOL, V200, P375, DOI 10.1016/0014-2999(91)90602-M; Hartshorne DJ, 2004, J BIOL CHEM, V279, P37211, DOI 10.1074/jbc.R400018200; Ito K, 2003, J PHYSIOL-LONDON, V546, P823, DOI 10.1113/jphysiol.2002.030775; JONES SB, 1994, SHOCK, V2, P370, DOI 10.1097/00024382-199411000-00012; JULOUSCHAEFFER G, 1990, AM J PHYSIOL, V259, pH1038, DOI 10.1152/ajpheart.1990.259.4.H1038; Katoh H, 1998, J BIOL CHEM, V273, P28700, DOI 10.1074/jbc.273.44.28700; KATORI M, 1989, BRIT J PHARMACOL, V98, P1383, DOI 10.1111/j.1476-5381.1989.tb12688.x; Kawano Y, 1999, J CELL BIOL, V147, P1023, DOI 10.1083/jcb.147.5.1023; Muranyi A, 2005, FEBS LETT, V579, P6611, DOI 10.1016/j.febslet.2005.10.055; PALSSON J, 1988, CIRC SHOCK, V24, P133; RAETZ CRH, 1990, ANNU REV BIOCHEM, V59, P129, DOI 10.1146/annurev.bi.59.070190.001021; Sauzeau V, 2000, J BIOL CHEM, V275, P21722, DOI 10.1074/jbc.M000753200; Shih CC, 2008, CRIT CARE MED, V36, P1864, DOI 10.1097/CCM.0b013e318173f982; Somlyo AP, 2003, PHYSIOL REV, V83, P1325, DOI 10.1152/physrev.00023.2003; SZABO C, 1993, BRIT J PHARMACOL, V108, P786, DOI 10.1111/j.1476-5381.1993.tb12879.x; Takakura K, 2003, ANESTHESIOLOGY, V98, P928, DOI 10.1097/00000542-200304000-00020; Takakura K, 2002, CRIT CARE MED, V30, P894, DOI 10.1097/00003246-200204000-00030; THIEMERMANN C, 1990, EUR J PHARMACOL, V182, P591, DOI 10.1016/0014-2999(90)90062-B; Tsao CM, 2011, SHOCK, V35, P210, DOI 10.1097/SHK.0b013e3181f229f8; UENO A, 1995, BRIT J PHARMACOL, V114, P1250, DOI 10.1111/j.1476-5381.1995.tb13340.x; VanBavel E, 2001, EXP PHYSIOL, V86, P585, DOI 10.1113/eph8602217; Velasco G, 2002, FEBS LETT, V527, P101, DOI 10.1016/S0014-5793(02)03175-7; Wu CC, 1999, EUR J PHARMACOL, V373, P41, DOI 10.1016/S0014-2999(99)00265-4; Wu XQ, 1996, BIOCHEM BIOPH RES CO, V220, P658, DOI 10.1006/bbrc.1996.0460; Yamashita T, 2000, CIRCULATION, V101, P931, DOI 10.1161/01.CIR.101.8.931; Yeon DS, 2002, CARDIOVASC RES, V53, P431, DOI 10.1016/S0008-6363(01)00496-5	34	21	23	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56331	10.1371/journal.pone.0056331	http://dx.doi.org/10.1371/journal.pone.0056331			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457552	gold, Green Submitted, Green Published			2022-12-25	WOS:000315603700042
J	Becker, TM; Boyd, SC; Mijatov, B; Gowrishankar, K; Snoyman, S; Pupo, GM; Scolyer, RA; Mann, GJ; Kefford, RF; Zhang, XD; Rizos, H				Becker, T. M.; Boyd, S. C.; Mijatov, B.; Gowrishankar, K.; Snoyman, S.; Pupo, G. M.; Scolyer, R. A.; Mann, G. J.; Kefford, R. F.; Zhang, X. D.; Rizos, H.			Mutant B-RAF-Mcl-1 survival signaling depends on the STAT3 transcription factor	ONCOGENE			English	Article						MAPK; B-RAF; STAT3; Mcl-1; anoikis	HUMAN-MELANOMA CELLS; DNA-BINDING ACTIVITY; SERINE PHOSPHORYLATION; MCL-1 EXPRESSION; FAMILY KINASES; INHIBITION; CANCER; APOPTOSIS; SRC; ACTIVATION	Approximately 50% of melanomas depend on mutant B-RAF for proliferation, metastasis and survival. The inhibition of oncogenic B-RAF with highly targeted compounds has produced remarkable albeit short-lived clinical responses in B-RAF mutant melanoma patients. Reactivation of signaling downstream of B-RAF is frequently associated with acquired resistance to B-RAF inhibitors, and the identification of B-RAF targets may provide new strategies for managing melanoma. Oncogenic B-RAF(V600E) is known to promote the stabilizing phosphorylation of the anti-apoptotic protein Mcl-1, implicated in melanoma survival and chemoresistance. We now show that B-RAFV600E signaling also induces the transcription of Mcl-1 in melanocytes and melanoma. We demonstrate that activation of STAT3 serine-727 and tyrosine-705 phosphorylations is promoted by B-RAF(V600E) activity and that the Mcl-1 promoter is dependent on a STAT consensus-site for B-RAF-mediated activation. Consequently, suppression of STAT3 activity disrupted B-RAF(V600E)-mediated induction of Mcl-1 and reduced melanoma cell survival. We propose that STAT3 has a central role in the survival and contributes to chemoresistance of B-RAF(V600E) melanoma.	[Becker, T. M.; Boyd, S. C.; Mijatov, B.; Gowrishankar, K.; Snoyman, S.; Pupo, G. M.; Mann, G. J.; Kefford, R. F.; Rizos, H.] Univ Sydney, Westmead Hosp, Westmead Millennium Inst, Westmead Inst Canc Res, Sydney, NSW 2145, Australia; [Scolyer, R. A.; Mann, G. J.; Kefford, R. F.] Melanoma Inst Australia, Sydney, NSW, Australia; [Zhang, X. D.] Univ Newcastle, Immunol & Oncol Unit, Newcastle, NSW 2300, Australia	University of Sydney; Westmead Institute for Medical Research; Melanoma Institute Australia; University of Newcastle	Becker, TM (corresponding author), Univ Sydney, Westmead Hosp, Westmead Millennium Inst, Westmead Inst Canc Res, Sydney, NSW 2145, Australia.	therese.becker@sydney.edu.au	Mann, Graham J/G-4758-2014; Zhang, xiaoyu/GXA-3206-2022; zhang, xu/GYE-3558-2022; zhang, xu/GRX-9733-2022; zhang, xian/GYA-0290-2022; Rizos, Helen/AAE-5010-2020; Scolyer, Richard/AAE-8511-2019	Mann, Graham J/0000-0003-1301-405X; Rizos, Helen/0000-0002-2094-9198; Scolyer, Richard/0000-0002-8991-0013; Becker, Therese/0000-0002-5636-9902; Powter, Branka/0000-0003-2814-456X; Zhang, Xu Dong/0000-0001-9457-8003; Kefford, Richard/0000-0001-9251-9229	National Health and Medical Research Council of Australia (NHMRC) [633004]; Cancer Institute New South Wales [10/TPG/1-02]; Health Department of NSW through Sydney West Area Health Service; Australian Cancer Research Foundation; Cancer Institute New South Wales, Research Fellowship; NHMRC Senior Research Fellowship	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Cancer Institute New South Wales; Health Department of NSW through Sydney West Area Health Service; Australian Cancer Research Foundation; Cancer Institute New South Wales, Research Fellowship; NHMRC Senior Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This work is supported by the Program Grant 633004 and project grants of the National Health and Medical Research Council of Australia (NHMRC), Translational Research Program Grant 10/TPG/1-02 of the Cancer Institute New South Wales and an infrastructure grant to Westmead Millennium Institute by the Health Department of NSW through Sydney West Area Health Service. Westmead Institute for Cancer Research is the recipient of capital grant funding from the Australian Cancer Research Foundation. HR is a recipient of a Cancer Institute New South Wales, Research Fellowship and a NHMRC Senior Research Fellowship. RAS is a recipient of a Cancer Institute New South Wales, Research Fellowship.	Aggarwal BB, 2009, ANN NY ACAD SCI, V1171, P59, DOI 10.1111/j.1749-6632.2009.04911.x; Akgul C, 2009, CELL MOL LIFE SCI, V66, P1326, DOI 10.1007/s00018-008-8637-6; Alshamsan A, 2011, TRANSL ONCOL, V4, P178, DOI 10.1593/tlo.11100; Balch CM, 2001, J CLIN ONCOL, V19, P3622, DOI 10.1200/JCO.2001.19.16.3622; Becker TM, 2010, J INVEST DERMATOL, V130, P2144, DOI 10.1038/jid.2010.117; Bill MA, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-165; Boisvert-Adamo K, 2009, MOL CANCER RES, V7, P549, DOI 10.1158/1541-7786.MCR-08-0358; Buettner R, 2008, MOL CANCER RES, V6, P1766, DOI 10.1158/1541-7786.MCR-08-0169; Burdelya L, 2005, J IMMUNOL, V174, P3925, DOI 10.4049/jimmunol.174.7.3925; Chung JK, 1997, MOL CELL BIOL, V17, P6508, DOI 10.1128/MCB.17.11.6508; Cirri P, 1997, BIOCHEM BIOPH RES CO, V239, P493, DOI 10.1006/bbrc.1997.7493; Cummins DL, 2006, MAYO CLIN PROC, V81, P500, DOI 10.4065/81.4.500; Curtis LM, 2009, MOL CANCER THER, V8, DOI 10.1158/1535-7163.TARG-09-B89; Dhomen N, 2009, HEMATOL ONCOL CLIN N, V23, P529, DOI 10.1016/j.hoc.2009.04.001; Ding YL, 2006, CANCER-AM CANCER SOC, V106, P1123, DOI 10.1002/cncr.21727; Falchook GS, 2012, LANCET, V379, P1893, DOI 10.1016/S0140-6736(12)60398-5; Fuh B, 2009, BRIT J CANCER, V100, P106, DOI 10.1038/sj.bjc.6604793; Grandis JR, 1998, J CLIN INVEST, V102, P1385, DOI 10.1172/JCI3785; Haferkamp S, 2009, J INVEST DERMATOL, V129, P1983, DOI 10.1038/jid.2009.5; Hong DS, 2008, J CLIN ONCOL, V26; Horiguchi A, 2010, BRIT J CANCER, V102, P1592, DOI 10.1038/sj.bjc.6605691; Jensen TO, 2011, CANCER, V118, P2476; Jiang CC, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.48; Kong LY, 2010, CLIN CANCER RES, V16, P2550, DOI 10.1158/1078-0432.CCR-10-0279; Kortylewski M, 2005, CANCER METAST REV, V24, P315, DOI 10.1007/s10555-005-1580-1; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Lin L, 2009, ONCOGENE, V28, P961, DOI 10.1038/onc.2008.448; Lin L, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-217; Liu HT, 2003, BLOOD, V102, P344, DOI 10.1182/blood-2002-11-3396; Long GV, 2010, 35 EUR SOC MED ONC E; McMurray JS, 2006, CHEM BIOL, V13, P1123, DOI 10.1016/j.chembiol.2006.11.001; Messina Jane L, 2008, Cancer Control, V15, P196; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Niu G, 2002, ONCOGENE, V21, P7001, DOI 10.1038/sj.onc.1205859; OCONNOR TJ, 1995, CELL GROWTH DIFFER, V6, P123; Paraiso K, 2012, PIGM CELL MELANOMA R, P878; Platz A, 2008, MOL ONCOL, V1, P395, DOI 10.1016/j.molonc.2007.12.003; Scurr LL, 2010, CELL, V141, P717, DOI 10.1016/j.cell.2010.04.021; Shao YP, 2010, CANCER RES, V70, P6670, DOI 10.1158/0008-5472.CAN-09-4471; Shepherd C, 2010, CURR ONCOL REP, V12, P146, DOI 10.1007/s11912-010-0095-2; Siddiquee K, 2007, P NATL ACAD SCI USA, V104, P7391, DOI 10.1073/pnas.0609757104; Sumimoto H, 2006, J EXP MED, V203, P1651, DOI 10.1084/jem.20051848; Tang LR, 1998, CLIN CANCER RES, V4, P1865; Venkatasubbarao K, 2005, CANCER RES, V65, P2861, DOI 10.1158/0008-5472.CAN-04-2396; Vignais ML, 1996, MOL CELL BIOL, V16, P1759; Wang YF, 2007, CLIN CANCER RES, V13, P4934, DOI 10.1158/1078-0432.CCR-07-0665; Wellbrock C, 2010, BIOCHEM PHARMACOL, V80, P561, DOI 10.1016/j.bcp.2010.03.019; Wilmott JS, 2012, CLIN CANCER RES, V18, P1386, DOI 10.1158/1078-0432.CCR-11-2479; Wong RPC, 2008, ONCOL REP, V19, P933; Xie TX, 2006, CANCER RES, V66, P3188, DOI 10.1158/0008-5472.CAN-05-2674; Yeh HH, 2006, ONCOGENE, V25, P4300, DOI 10.1038/sj.onc.1209464; YU CL, 1995, SCIENCE, V269, P81, DOI 10.1126/science.7541555; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275; Zhuang LQ, 2007, MODERN PATHOL, V20, P416, DOI 10.1038/modpathol.3800750	54	51	51	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 27	2014	33	9					1158	1166		10.1038/onc.2013.45	http://dx.doi.org/10.1038/onc.2013.45			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AB6XT	23455323				2022-12-25	WOS:000331933800009
J	Chen, EJH; Shaffer, MH; Williamson, EK; Huang, YP; Burkhardt, JK				Chen, Emily J. H.; Shaffer, Meredith H.; Williamson, Edward K.; Huang, Yanping; Burkhardt, Janis K.			Ezrin and Moesin Are Required for Efficient T Cell Adhesion and Homing to Lymphoid Organs	PLOS ONE			English	Article							PROTEIN-KINASE-C; L-SELECTIN CD62L; ERM PROTEINS; ENDOTHELIAL-CELLS; IN-VIVO; TRANSENDOTHELIAL MIGRATION; RAP1-INDUCED ADHESION; CHEMOKINE STIMULATION; VASCULAR ENDOTHELIUM; INTEGRIN ACTIVATION	T cell trafficking between the blood and lymphoid organs is a complex, multistep process that requires several highly dynamic and coordinated changes in cyto-architecture. Members of the ezrin, radixin and moesin (ERM) family of actin-binding proteins have been implicated in several aspects of this process, but studies have yielded conflicting results. Using mice with a conditional deletion of ezrin in CD4+ cells and moesin-specific siRNA, we generated T cells lacking ERM proteins, and investigated the effect on specific events required for T cell trafficking. ERM-deficient T cells migrated normally in multiple in vitro and in vivo assays, and could undergo efficient diapedesis in vitro. However, these cells were impaired in their ability to adhere to the beta 1 integrin ligand fibronectin, and to polarize appropriately in response to fibronectin and VCAM-1 binding. This defect was specific for beta 1 integrins, as adhesion and polarization in response to ICAM-1 were normal. In vivo, ERM-deficient T cells showed defects in homing to lymphoid organs. Taken together, these results show that ERM proteins are largely dispensable for T cell chemotaxis, but are important for beta 1 integrin function and homing to lymphoid organs.	[Burkhardt, Janis K.] Univ Penn, Childrens Hosp Philadelphia, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine	Burkhardt, JK (corresponding author), Univ Penn, Childrens Hosp Philadelphia, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.	jburkhar@mail.med.upenn.edu	Shaffer, Meredith/N-5984-2017	Burkhardt, Janis/0000-0002-8176-1375; Shaffer, Meredith/0000-0002-6982-7968	National Institutes of Health [PO1CA093615]; Cancer Research Institute, Predoctoral Emphasis Pathway in Tumor Immunology; NATIONAL CANCER INSTITUTE [P01CA093615, P30CA016520] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research Institute, Predoctoral Emphasis Pathway in Tumor Immunology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health PO1CA093615 to JKB and by a Cancer Research Institute, Predoctoral Emphasis Pathway in Tumor Immunology to EJHC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allport JR, 1997, J EXP MED, V186, P517, DOI 10.1084/jem.186.4.517; Alon R, 2002, SEMIN IMMUNOL, V14, P93, DOI 10.1006/smim.2001.0346; Baekkevold ES, 2001, J EXP MED, V193, P1105, DOI 10.1084/jem.193.9.1105; Baluk P, 2007, J EXP MED, V204, P2349, DOI 10.1084/jem.20062596; Banerjee P, 2008, LAB INVEST, V88, P196, DOI 10.1038/labinvest.3700703; Belkina NV, 2009, P NATL ACAD SCI USA, V106, P4707, DOI 10.1073/pnas.0805963106; Bretscher A, 1997, J CELL SCI, V110, P3011; Brown MJ, 2003, BLOOD, V102, P3890, DOI 10.1182/blood-2002-12-3807; Burbach BJ, 2007, IMMUNOL REV, V218, P65, DOI 10.1111/j.1600-065X.2007.00527.x; Campbell JJ, 1998, J CELL BIOL, V141, P1053, DOI 10.1083/jcb.141.4.1053; Cannon JL, 2011, MOL BIOL CELL, V22, P954, DOI 10.1091/mbc.E10-07-0586; Carman CV, 2007, IMMUNITY, V26, P784, DOI 10.1016/j.immuni.2007.04.015; Conant CG, 2010, J BIOMOL SCREEN, V15, P102, DOI 10.1177/1087057109353789; Cullinan P, 2002, IMMUNOL REV, V189, P111, DOI 10.1034/j.1600-065X.2002.18910.x; de Bruyn KMT, 2002, J BIOL CHEM, V277, P29468, DOI 10.1074/jbc.M204990200; Duchniewicz M, 2006, MOL CELL BIOL, V26, P643, DOI 10.1128/MCB.26.2.643-653.2006; Escotte S, 2006, AM J RESP CELL MOL, V34, P348, DOI 10.1165/rcmb.2005-0191OC; Evans R, 2011, BLOOD, V117, P3331, DOI 10.1182/blood-2010-06-289140; Faure S, 2004, NAT IMMUNOL, V5, P272, DOI 10.1038/ni1039; Ferreira AM, 2006, MICROCIRCULATION, V13, P439, DOI 10.1080/10739680600776062; Fievet BT, 2004, J CELL BIOL, V164, P653, DOI 10.1083/jcb.200307032; Finkelstein LD, 2005, J IMMUNOL, V175, P5923, DOI 10.4049/jimmunol.175.9.5923; Flint MS, 2011, BRAIN BEHAV IMMUN, V25, P1187, DOI 10.1016/j.bbi.2011.03.009; Galkina E, 2007, EUR J IMMUNOL, V37, P1243, DOI 10.1002/eji.200636481; Garcia-Bernal D, 2009, IMMUNITY, V31, P953, DOI 10.1016/j.immuni.2009.09.021; GARY R, 1995, MOL BIOL CELL, V6, P1061, DOI 10.1091/mbc.6.8.1061; Gez S, 2007, BBA-PROTEINS PROTEOM, V1774, P1173, DOI 10.1016/j.bbapap.2007.06.011; Ghandour H, 2007, BLOOD, V110, P3682, DOI 10.1182/blood-2007-03-077628; Goodman SL, 2012, TRENDS PHARMACOL SCI, V33, P405, DOI 10.1016/j.tips.2012.04.002; Griffiths EK, 2001, SCIENCE, V293, P2260, DOI 10.1126/science.1063397; HAMANN A, 1988, J IMMUNOL, V140, P693; Hao JJ, 2009, J CELL BIOL, V184, P451, DOI 10.1083/jcb.200807047; HASSLEN SR, 1995, HISTOCHEM J, V27, P547; Katagiri K, 2002, MOL CELL BIOL, V22, P1001, DOI 10.1128/MCB.22.4.1001-1015.2002; Katagiri K, 2003, NAT IMMUNOL, V4, P741, DOI 10.1038/ni950; Katagiri K, 2000, MOL CELL BIOL, V20, P1956, DOI 10.1128/MCB.20.6.1956-1969.2000; Kuijpers TW, 1997, J CLIN INVEST, V100, P1725, DOI 10.1172/JCI119697; Kunkel EJ, 2002, IMMUNITY, V16, P1, DOI 10.1016/S1074-7613(01)00261-8; Lammermann T, 2008, NATURE, V453, P51, DOI 10.1038/nature06887; Legg JW, 2002, NAT CELL BIOL, V4, P399, DOI 10.1038/ncb797; Li YS, 2007, J IMMUNOL, V178, P1938, DOI 10.4049/jimmunol.178.3.1938; Liu Y, 2012, BLOOD, V119, P445, DOI 10.1182/blood-2011-07-368860; Matsui T, 1998, J CELL BIOL, V140, P647, DOI 10.1083/jcb.140.3.647; Nagira M, 1997, J BIOL CHEM, V272, P19518, DOI 10.1074/jbc.272.31.19518; Ng T, 2001, EMBO J, V20, P2723, DOI 10.1093/emboj/20.11.2723; Nijhara R, 2004, J IMMUNOL, V173, P4985, DOI 10.4049/jimmunol.173.8.4985; OCONNELL KA, 1990, J IMMUNOL, V144, P521; Ohta K, 2012, J STRUCT BIOL, V177, P513, DOI 10.1016/j.jsb.2011.10.012; OPPENHEIMERMARKS N, 1990, J IMMUNOL, V145, P140; OPPENHEIMERMARKS N, 1991, J IMMUNOL, V147, P2913; Parameswaran N, 2011, J IMMUNOL, V186, P4088, DOI 10.4049/jimmunol.1001139; Peterson EJ, 2001, SCIENCE, V293, P2263, DOI 10.1126/science.1063486; Pietromonaco SF, 1998, J BIOL CHEM, V273, P7594, DOI 10.1074/jbc.273.13.7594; Ploix CC, 2011, BRAIN BEHAV IMMUN, V25, P883, DOI 10.1016/j.bbi.2010.09.014; Sanchez-Madrid F, 2009, NAT REV MOL CELL BIO, V10, P353, DOI 10.1038/nrm2680; Saotome I, 2004, DEV CELL, V6, P855, DOI 10.1016/j.devcel.2004.05.007; Schenkel AR, 2004, NAT IMMUNOL, V5, P393, DOI 10.1038/ni1051; Shaffer MH, 2009, J IMMUNOL, V182, P1021, DOI 10.4049/jimmunol.182.2.1021; Shamri R, 2002, J BIOL CHEM, V277, P40027, DOI 10.1074/jbc.M206806200; Shcherbina A, 1999, BLOOD, V93, P2128; Shimonaka M, 2003, J CELL BIOL, V161, P417, DOI 10.1083/jcb.200301133; Simons PC, 1998, BIOCHEM BIOPH RES CO, V253, P561, DOI 10.1006/bbrc.1998.9823; Soriano SF, 2011, J IMMUNOL, V187, P2356, DOI 10.4049/jimmunol.1100935; Stewart MP, 1996, J IMMUNOL, V156, P1810; Tangemann K, 1998, J IMMUNOL, V161, P6330; Tohyama Y, 2003, MOL BIOL CELL, V14, P2570, DOI 10.1091/mbc.E02-09-0615; Tsukita S, 1999, J BIOL CHEM, V274, P34507, DOI 10.1074/jbc.274.49.34507; Verrills NM, 2006, PROTEOMICS, V6, P1681, DOI 10.1002/pmic.200500417; Wang HY, 2009, P NATL ACAD SCI USA, V106, P12436, DOI 10.1073/pnas.0900510106; Werner L, 2011, J LEUKOCYTE BIOL, V90, P583, DOI 10.1189/jlb.0111101; Wong D, 1999, J NEUROPATH EXP NEUR, V58, P138, DOI 10.1097/00005072-199902000-00004; Woods ML, 2001, J LEUKOCYTE BIOL, V69, P874; Yang L, 2005, BLOOD, V106, P584, DOI 10.1182/blood-2004-12-4942; Yonemura S, 1999, J CELL BIOL, V145, P1497, DOI 10.1083/jcb.145.7.1497	74	24	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e52368	10.1371/journal.pone.0052368	http://dx.doi.org/10.1371/journal.pone.0052368			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23468835	Green Published, gold, Green Submitted			2022-12-25	WOS:000315524900003
J	Friis, CM; Qvigstad, E; Roland, MCP; Godang, K; Voldner, N; Bollerslev, J; Henriksen, T				Friis, Camilla M.; Qvigstad, Elisabeth; Roland, Marie Cecilie Paasche; Godang, Kristin; Voldner, Nanna; Bollerslev, Jens; Henriksen, Tore			Newborn Body Fat: Associations with Maternal Metabolic State and Placental Size	PLOS ONE			English	Article							FETAL-GROWTH; NUTRIENT TRANSPORT; TROPHOBLAST CELLS; MASS INDEX; BIRTH; PREGNANCY; INSULIN; WEIGHT; DETERMINANTS; ADIPOSITY	Background: Neonatal body composition has implications for the health of the newborn both in short and long term perspective. The objective of the current study was first to explore the association between maternal BMI and metabolic parameters associated with BMI and neonatal percentage body fat and to determine to which extent any associations were modified if adjusting for placental weight. Secondly, we examined the relations between maternal metabolic parameters associated with BMI and placental weight. Methods: The present work was performed in a subcohort (n = 207) of the STORK study, an observational, prospective study on the determinants of fetal growth and birthweight in healthy pregnancies at Oslo University Hospital, Norway. Fasting glucose, insulin, triglycerides, free fatty acids, HDL- and total cholesterol were measured at week 30-32. Newborn body composition was determined by Dual-Energy X-Ray Absorptiometry (DXA). Placenta was weighed at birth. Linear regression models were used with newborn fat percentage and placental weight as main outcomes. Results: Maternal BMI, fasting glucose and gestational age were independently associated with neonatal fat percentage. However, if placental weight was introduced as a covariate, only placental weight and gestational age remained significant. In the univariate model, the determinants of placenta weight included BMI, insulin, triglycerides, total- and HDL-cholesterol (negatively), gestational weight gain and parity. In the multivariable model, BMI, total cholesterol HDL-cholesterol, gestational weight gain and parity remained independent covariates. Conclusion: Maternal BMI and fasting glucose were independently associated with newborn percentage fat. This effect disappeared by introducing placental weight as a covariate. Several metabolic factors associated with maternal BMI were associated with placental weight, but not with neonatal body fat. Our findings are consistent with a concept that the effects of maternal BMI and a number of BMI-related metabolic factors on fetal fat accretion to a significant extent act by modifying placental weight.	[Friis, Camilla M.; Roland, Marie Cecilie Paasche; Voldner, Nanna; Henriksen, Tore] Oslo Univ Hosp, Rikshosp, Women & Childrens Div, Sect Obstet, Oslo, Norway; [Qvigstad, Elisabeth; Godang, Kristin; Bollerslev, Jens] Oslo Univ Hosp, Rikshosp, Div Med, Outpatient Clin Specialized Endocrinol, Oslo, Norway; [Bollerslev, Jens; Henriksen, Tore] Univ Oslo, Fac Med, Oslo, Norway	University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo	Friis, CM (corresponding author), Oslo Univ Hosp, Rikshosp, Women & Childrens Div, Sect Obstet, Oslo, Norway.	camilla.friis@ous-hf.no		Qvigstad, Elisabeth/0000-0002-9119-9187	South-Eastern Norway Regional Health Authority, The National Resource Centre for Women's Health, Division of Obstetrics and Gynaecology, Oslo University Hospital, Rikshospitalet; Department of Obstetrics, Women and Children's Division, Oslo University Hospital, Rikshospitalet, Oslo, Norway; Faculty of Medicine, Thematic Research Area, University of Oslo	South-Eastern Norway Regional Health Authority, The National Resource Centre for Women's Health, Division of Obstetrics and Gynaecology, Oslo University Hospital, Rikshospitalet; Department of Obstetrics, Women and Children's Division, Oslo University Hospital, Rikshospitalet, Oslo, Norway; Faculty of Medicine, Thematic Research Area, University of Oslo	The project has been financially supported by South-Eastern Norway Regional Health Authority, The National Resource Centre for Women's Health, Division of Obstetrics and Gynaecology, Oslo University Hospital, Rikshospitalet; The Department of Obstetrics, Women and Children's Division, Oslo University Hospital, Rikshospitalet, Oslo, Norway; The Faculty of Medicine, Thematic Research Area, University of Oslo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, BJOG; Catalano PM, 2011, AM J OBSTET GYNECOL, V204, P479, DOI 10.1016/j.ajog.2010.11.039; Catalano PM, 2003, AM J OBSTET GYNECOL, V189, P1698, DOI 10.1016/S0002-9378(03)00828-7; CATALANO PM, 1995, AM J OBSTET GYNECOL, V172, P1464, DOI 10.1016/0002-9378(95)90479-4; Challier JC, 2008, PLACENTA, V29, P274, DOI 10.1016/j.placenta.2007.12.010; Coall DA, 2009, PEDIATR DEVEL PATHOL, V12, P200, DOI 10.2350/08-02-0413.1; Di Cianni G, 2005, DIABETIC MED, V22, P21, DOI 10.1111/j.1464-5491.2004.01336.x; Fowden AL, 2009, J PHYSIOL-LONDON, V587, P3459, DOI 10.1113/jphysiol.2009.173013; Fowden AL, 2006, J PHYSIOL-LONDON, V572, P5, DOI 10.1113/jphysiol.2005.104141; Friis CM, INTERLEUKINS IL 6 IL; Godang K, 2010, J CLIN DENSITOM, V13, P151, DOI 10.1016/j.jocd.2010.01.121; Godfrey KM, 2000, AM J CLIN NUTR, V71, p1344S, DOI 10.1093/ajcn/71.5.1344s; Harvey NC, 2007, J CLIN ENDOCR METAB, V92, P523, DOI 10.1210/jc.2006-0456; Jansson T, 2006, PLACENTA, V27, pS91, DOI 10.1016/j.placenta.2005.11.010; Jansson T, 2007, CLIN SCI, V113, P1, DOI 10.1042/CS20060339; Jones HN, 2007, PLACENTA, V28, P763, DOI 10.1016/j.placenta.2007.05.002; Jones HN, 2009, AM J PHYSIOL-CELL PH, V297, pC1228, DOI 10.1152/ajpcell.00195.2009; KARL PI, 1992, AM J PHYSIOL, V262, pC834, DOI 10.1152/ajpcell.1992.262.4.C834; Lager S, 2010, PLACENTA; Lain Kristine Y., 2006, Metabolic Syndrome and Related Disorders, V4, P91, DOI 10.1089/met.2006.4.91; Langley-Evans AJ, 2003, J R SOC PROMO HEALTH, V123, P210, DOI 10.1177/146642400312300409; Leary SD, 2003, PLACENTA, V24, P276, DOI 10.1053/plac.2002.0888; Lewis GF, 2005, CIRC RES, V96, P1221, DOI 10.1161/01.RES.0000170946.56981.5c; Magnusson-Olsson AL, 2006, J LIPID RES, V47, P2551, DOI 10.1194/jlr.M600098-JLR200; Metzger BE, 2009, DIABETES, V58, P453, DOI 10.2337/db08-1112; Modi N, 2011, PEDIATR RES, V70, P287, DOI 10.1203/PDR.0b013e318225f9b1; MOLTENI RA, 1978, J REPROD MED, V21, P327; Nathanielsz PW, CLIN PERINATOL, V34, P515; Ong KK, 2008, DIABETES CARE, V31, P2193, DOI 10.2337/dc08-1111; Ouyang F, 2012, OBESITY SILVER SPRIN; Radaelli T, 2006, J SOC GYNECOL INVEST, V13, P53, DOI 10.1016/j.jsgi.2005.10.003; Radaelli T, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.04.019; Ramsay JE, 2002, J CLIN ENDOCR METAB, V87, P4231, DOI 10.1210/jc.2002-020311; ROBINSON JS, 1994, AUST NZ J OBSTET GYN, V34, P240, DOI 10.1111/j.1479-828X.1994.tb01065.x; Roland MCP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039324; Roos S, 2009, AM J PHYSIOL-CELL PH, V297, pC723, DOI 10.1152/ajpcell.00191.2009; Salafia CM, 2008, PAEDIATR PERINAT EP, V22, P229, DOI 10.1111/j.1365-3016.2008.00935.x; Schaefer-Graf UM, 2011, DIABETIC MED, V28, P1053, DOI 10.1111/j.1464-5491.2011.03346.x; Sewell MF, 2007, J REPROD MED, V52, P907; Sewell MF, 2006, AM J OBSTET GYNECOL, V195, P1100, DOI 10.1016/j.ajog.2006.06.014; SPARKS JW, 1984, SEMIN PERINATOL, V8, P74; Thompson JMD, 2007, BJOG-INT J OBSTET GY, V114, P715, DOI 10.1111/j.1471-0528.2007.01327.x; Voldner N, 2008, ACTA OBSTET GYN SCAN, V87, P423, DOI 10.1080/00016340801989825; Wallace JM, 2012, PLACENTA	44	44	45	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57467	10.1371/journal.pone.0057467	http://dx.doi.org/10.1371/journal.pone.0057467			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460863	Green Submitted, Green Published, gold			2022-12-25	WOS:000315519000118
J	Gallmeier, E; Bader, DC; Kriegl, L; Berezowska, S; Seeliger, H; Goke, B; Kirchner, T; Bruns, C; De Toni, EN				Gallmeier, Eike; Bader, Dominik C.; Kriegl, Lydia; Berezowska, Sabina; Seeliger, Hendrik; Goeke, Burkhard; Kirchner, Thomas; Bruns, Christiane; De Toni, Enrico N.			Loss of TRAIL-Receptors Is a Recurrent Feature in Pancreatic Cancer and Determines the Prognosis of Patients with No Nodal Metastasis after Surgery	PLOS ONE			English	Article							APOPTOSIS-INDUCING LIGAND; DEATH-RECEPTORS; MONOCLONAL-ANTIBODY; PHASE-II; EXPRESSION; RESISTANCE; PATHWAYS; CELLS; CARCINOMA; TRIAL	Introduction: Agonistic antibodies targeting TRAIL-receptors 1 and 2 (TRAIL-R1 and TRAIL-R2) are being developed as a novel therapeutic approach in cancer therapy including pancreatic cancer. However, the cellular distribution of these receptors in primary pancreatic cancer samples has not been sufficiently investigated and no study has yet addressed the issue of their prognostic significance in this tumor entity. Aims and Methods: Applying tissue microarray (TMA) analysis, we performed an immunohistochemical assessment of TRAIL-receptors in surgical samples from 84 consecutive patients affected by pancreatic adenocarcinoma and in 26 additional selected specimens from patients with no lymph nodes metastasis at the time of surgery. The prognostic significance of membrane staining and staining intensity for TRAIL-receptors was evaluated. Results: The fraction of pancreatic cancer samples with positive membrane staining for TRAIL-R1 and TRAIL-R2 was lower than that of cells from surrounding non-tumor tissues (TRAIL-R1: p < 0.001, TRAIL-R2: p = 0.006). In addition, subgroup analyses showed that loss of membrane staining for TRAIL-R2 was associated with poorer prognosis in patients without nodal metastases (multivariate Cox regression analysis, Hazard Ratio: 0.44 [95% confidence interval: 0.2220.87]; p = 0.019). In contrast, analysis of decoy receptors TRAIL-R3 and -R4 in tumor samples showed an exclusively cytoplasmatic staining pattern and no prognostic relevance. Conclusion: This is a first report on the prognostic significance of TRAIL-receptors expression in pancreatic cancer showing that TRAIL-R2 might represent a prognostic marker for patients with early stage disease. In addition, our data suggest that loss of membrane-bound TRAIL-receptors could represent a molecular mechanism for therapeutic failure upon administration of TRAIL-receptors-targeting antibodies in pancreatic cancer. This hypothesis should be evaluated in future clinical trials.	[Gallmeier, Eike; Bader, Dominik C.; Goeke, Burkhard; De Toni, Enrico N.] Univ Munich, Dept Med 2, Univ Hosp Grosshadern, Munich, Germany; [Kriegl, Lydia; Berezowska, Sabina; Kirchner, Thomas] Univ Munich, Inst Pathol, D-80539 Munich, Germany; [Seeliger, Hendrik; Bruns, Christiane] Univ Munich, Dept Surg, Univ Hosp Grosshadern, Munich, Germany	University of Munich; University of Munich; University of Munich	De Toni, EN (corresponding author), Univ Munich, Dept Med 2, Univ Hosp Grosshadern, Munich, Germany.	Enrico.deToni@med.uni-muenchen.de	Berezowska, Sabina/AAJ-4557-2021; De Toni, Enrico N/C-6496-2008	Berezowska, Sabina/0000-0001-5442-9791; 	Deutsche Forschungsgemeinschaft (DFG) [DFG TO 605/2-1, DFG GA762/3-2]; Else Kroner-Fresenius Stiftung [2011_A226]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Else Kroner-Fresenius Stiftung	This work was supported by the Deutsche Forschungsgemeinschaft (DFG) with grants DFG TO 605/2-1 to EDT and DFG GA762/3-2 to EG and by the Else Kroner-Fresenius Stiftung with the grant 2011_A226 to EDT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arlt A, 2010, CANC LETT; Ashkenazi A, 2008, J CLIN ONCOL, V26, P3621, DOI 10.1200/JCO.2007.15.7198; Bae SI, 2008, ONCOGENE, V27, P490, DOI 10.1038/sj.onc.1210655; Bavi P, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-203; Chen JJ, 2012, ONCOTARGET, V3, P833; Cretney E, 2002, J IMMUNOL, V168, P1356, DOI 10.4049/jimmunol.168.3.1356; De Toni EN, 2008, CLIN CANCER RES, V14, P4713, DOI 10.1158/1078-0432.CCR-07-5019; Forero-Torres A, 2010, CANCER BIOTHER RADIO, V25, P13, DOI 10.1089/cbr.2009.0673; Fulda S, 2012, EXP CELL RES, V318, P1208, DOI 10.1016/j.yexcr.2012.02.005; Fulda S, 2009, J CELL MOL MED, V13, P1221, DOI 10.1111/j.1582-4934.2009.00748.x; Ganten TM, 2009, J MOL MED, V87, P995, DOI 10.1007/s00109-009-0510-z; Gonzalvez F, 2010, ONCOGENE, V29, P4752, DOI 10.1038/onc.2010.221; Granci V, 2008, EUR J CANCER, V44, P2312, DOI 10.1016/j.ejca.2008.06.042; Grosse-Wilde A, 2008, J CLIN INVEST, V118, P100, DOI 10.1172/JCI33061; Guo F, 2004, CANCER RES, V64, P2580, DOI 10.1158/0008-5472.CAN-03-2629; Hamacher R, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-64; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Jeng YM, 2002, CANCER LETT, V181, P205, DOI 10.1016/S0304-3835(02)00051-4; Johnstone RW, 2008, NAT REV CANCER, V8, P782, DOI 10.1038/nrc2465; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Khanbolooki S, 2006, MOL CANCER THER, V5, P2251, DOI 10.1158/1535-7163.MCT-06-0075; Kong R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037222; Kriegl L, 2010, CLIN CANCER RES, V16, P5529, DOI 10.1158/1078-0432.CCR-09-3403; McCarthy MM, 2005, CLIN CANCER RES, V11, P5188, DOI 10.1158/1078-0432.CCR-05-0158; Merchant MS, 2004, CANCER RES, V64, P8349, DOI 10.1158/0008-5472.CAN-04-1705; Niemoller O, 2009, RESULTS PROBL CELL D, V49, P219, DOI 10.1007/400_2009_17; Niemoeller OM, 2011, CANC LETT; Pennarun B, 2010, BBA-REV CANCER, V1805, P123, DOI 10.1016/j.bbcan.2009.11.004; Pineda DM, 2012, CANCER BIOL THER, V13, P946, DOI 10.4161/cbt.20952; Roder C, 2011, EUR J CELL BIOL, V90, P450, DOI 10.1016/j.ejcb.2010.10.008; Sanlioglu AD, 2009, PANCREAS, V38, P154, DOI 10.1097/MPA.0b013e31818db9e3; Schafer C, 2012, J CELL MOL MED, V16, P1776, DOI 10.1111/j.1582-4934.2011.01473.x; Schuler S, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-80; Shankar S, 2005, PROSTATE, V62, P165, DOI 10.1002/pros.20126; Shin MS, 2001, CANCER RES, V61, P4942; Soria JC, 2011, J CLIN ONCOL, V29, P4442, DOI 10.1200/JCO.2011.37.2623; Stadel D, 2010, CLIN CANCER RES, V16, P5734, DOI 10.1158/1078-0432.CCR-10-0985; Strater J, 2002, CLIN CANCER RES, V8, P3734; Takeda K, 2001, NAT MED, V7, P94, DOI 10.1038/83416; Trarbach T, 2010, BRIT J CANCER, V102, P506, DOI 10.1038/sj.bjc.6605507; van Noesel MM, 2002, CANCER RES, V62, P2157; Walczak H, 2006, APOPTOSIS CANC THERA, P31; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515; Yue HH, 2005, CELL DEATH DIFFER, V12, P94, DOI 10.1038/sj.cdd.4401523; Zhang YQ, 2008, MOL CANCER RES, V6, P1861, DOI 10.1158/1541-7786.MCR-08-0313; Zhu H, 2010, CANCER LETT, V297, P155, DOI 10.1016/j.canlet.2010.04.030	46	20	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e56760	10.1371/journal.pone.0056760	http://dx.doi.org/10.1371/journal.pone.0056760			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460812	Green Submitted, Green Published, gold			2022-12-25	WOS:000315519000035
J	Jourdi, H; Kabbaj, M				Jourdi, Hussam; Kabbaj, Mohamed			Acute BDNF Treatment Upregulates GluR1-SAP97 and GluR2-GRIP1 Interactions: Implications for Sustained AMPA Receptor Expression	PLOS ONE			English	Article							LONG-TERM POTENTIATION; IONOTROPIC GLUTAMATE RECEPTORS; SYNAPSE-ASSOCIATED PROTEIN-97; METHYL-D-ASPARTATE; NEUROTROPHIC FACTOR; DOWN-REGULATION; PKM-ZETA; TYROSINE PHOSPHORYLATION; SURFACE EXPRESSION; ACID RECEPTORS	Brain-derived neurotrophic factor (BDNF) plays several prominent roles in synaptic plasticity and in learning and memory formation. Reduced BDNF levels and altered BDNF signaling have been reported in several brain diseases and behavioral disorders, which also exhibit reduced levels of AMPAr subunits. BDNF treatment acutely regulates AMPA receptor expression and function, including synaptic AMPAr subunit trafficking, and implicates several well defined signaling molecules that are required to elicit long term potentiation and depression (LTP and LTD, respectively). Long term encoding of synaptic events, as in long term memory formation, requires AMPAr stabilization and maintenance. However, factors regulating AMPAr stabilization in neuronal cell membranes and synaptic sites are not well characterized. In this study, we examine the effects of acute BDNF treatment on levels of AMPAr-associated scaffolding proteins and on AMPAr subunit-scaffolding protein interactions. We also examine the effects of BDNF-dependent enhanced interactions between AMPAr subunits with their specific scaffolding proteins on the accumulation of both types of proteins. Our results show that acute BDNF treatment upregulates the interactions between AMPAr subunits (GluR1 and GluR2) with their scaffold proteins SAP97 and GRIP1, respectively, leading to prolonged increased accumulation of both categories of proteins, albeit with distinct mechanisms for GluR1 and GluR2. Our findings reveal a new role for BDNF in the long term maintenance of AMPA receptor subunits and associated scaffolding proteins at synapses and further support the role of BDNF as a key regulator of synaptic consolidation. These results have potential implications for recent findings implicating BDNF and AMPAr subunits in various brain diseases and behavioral disorders.	[Jourdi, Hussam; Kabbaj, Mohamed] Florida State Univ, Coll Med, Dept Biomed Sci, Tallahassee, FL 32306 USA	State University System of Florida; Florida State University	Jourdi, H (corresponding author), Florida State Univ, Coll Med, Dept Biomed Sci, Tallahassee, FL 32306 USA.	hjourdi@fsu.edu	Kabbaj, Mohamed/M-9240-2016; Jourdi, Hussam/ABI-4842-2020	Jourdi, Hussam/0000-0003-0712-5693	Japanese Ministry of Education, Culture, Sports, Science, and Technology; College of Medicine, Florida State University	Japanese Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); College of Medicine, Florida State University	This work was partially supported by a doctoral fellowship from the Japanese Ministry of Education, Culture, Sports, Science, and Technology to HJ while at the laboratory of Dr. H. Nawa, Niigata University (Niigata, Japan) and by an SGP grant from the College of Medicine, Florida State University to HJ. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaneya Y, 1997, J NEUROSCI, V17, P6707; Bi RF, 1998, BRAIN RES, V797, P154, DOI 10.1016/S0006-8993(98)00433-8; Bi XN, 1998, INT REV NEUROBIOL, V42, P227, DOI 10.1016/S0074-7742(08)60612-1; Bowie D, 2008, CNS NEUROL DISORD-DR, V7, P129, DOI 10.2174/187152708784083821; Bramham CR, 2005, PROG NEUROBIOL, V76, P99, DOI 10.1016/j.pneurobio.2005.06.003; Broutman G, 2001, J NEUROSCI, V21, P27, DOI 10.1523/JNEUROSCI.21-01-00027.2001; Castren E, 2010, DEV NEUROBIOL, V70, P289, DOI 10.1002/dneu.20758; Choi KH, 2009, J PSYCHIATR NEUROSCI, V34, P450; Chung HJ, 2000, J NEUROSCI, V20, P7258; Duman RS, 2006, BIOL PSYCHIAT, V59, P1116, DOI 10.1016/j.biopsych.2006.02.013; Duman RS, 2012, PHILOS T R SOC B, V367, P2475, DOI 10.1098/rstb.2011.0357; Fortin DA, 2012, J NEUROSCI, V32, P8127, DOI 10.1523/JNEUROSCI.6034-11.2012; Greger IH, 2003, NEURON, V40, P763, DOI 10.1016/S0896-6273(03)00668-8; Greger IH, 2007, TRENDS NEUROSCI, V30, P407, DOI 10.1016/j.tins.2007.06.005; Hanley JG, 2008, CELL ADHES MIGR, V2, P276, DOI 10.4161/cam.2.4.6510; Hayashi T, 2004, J NEUROSCI, V24, P6152, DOI 10.1523/JNEUROSCI.0799-04.2004; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Henley JM, 2003, NEUROSCI RES, V45, P243, DOI 10.1016/S0168-0102(02)00229-8; Ibaraki K, 1999, J NEUROCHEM, V73, P408, DOI 10.1046/j.1471-4159.1999.0730408.x; Iwakura Y, 2001, J BIOL CHEM, V276, P40025, DOI 10.1074/jbc.M103125200; Jia YS, 2010, J NEUROSCI, V30, P14440, DOI 10.1523/JNEUROSCI.3310-10.2010; Jourdi H, 2005, J PHARMACOL EXP THER, V314, P16, DOI 10.1124/jpet.105.083873; Jourdi H, 2005, NEUROCHEM INT, V46, P31, DOI 10.1016/j.neuint.2004.07.002; Jourdi H, 2003, DEV BIOL, V263, P216, DOI 10.1016/j.ydbio.2003.07.008; Jourdi H, 2010, J NEUROSCI, V30; Jourdi Hussam, 2002, Acta Medica et Biologica, V50, P107; Jourdi H, 2009, J NEUROSCI, V29, P8688, DOI 10.1523/JNEUROSCI.6078-08.2009; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; Koike H, 2011, NEUROPHARMACOLOGY, V61, P1419, DOI 10.1016/j.neuropharm.2011.08.034; Koike H, 2011, BEHAV BRAIN RES, V224, P107, DOI 10.1016/j.bbr.2011.05.035; Kulangara K, 2007, J BIOL CHEM, V282, P2395, DOI 10.1074/jbc.M606471200; Li NX, 2011, BIOL PSYCHIAT, V69, P754, DOI 10.1016/j.biopsych.2010.12.015; Li NX, 2010, SCIENCE, V329, P959, DOI 10.1126/science.1190287; Lu W, 2005, NEURON, V47, P407, DOI 10.1016/j.neuron.2005.07.006; Lu XY, 2000, NEUROSCI LETT, V286, P149, DOI 10.1016/S0304-3940(00)01101-0; Lu XY, 2001, J NEUROCHEM, V77, P1553, DOI 10.1046/j.1471-4159.2001.00359.x; Lynch G, 2008, EUR J PHARMACOL, V585, P2, DOI 10.1016/j.ejphar.2007.11.082; Maeng S, 2008, BIOL PSYCHIAT, V63, P349, DOI 10.1016/j.biopsych.2007.05.028; Marcello E, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.09.015; MASSICOTTE G, 1990, MOL PHARMACOL, V37, P278; Mauceri D, 2004, J BIOL CHEM, V279, P23813, DOI 10.1074/jbc.M402796200; MCNEILL RB, 1995, J BIOL CHEM, V270, P10043, DOI 10.1074/jbc.270.17.10043; Migues PV, 2010, NAT NEUROSCI, V13, P630, DOI 10.1038/nn.2531; Minichiello L, 1999, NEURON, V24, P401, DOI 10.1016/S0896-6273(00)80853-3; Minichiello L, 2002, NEURON, V36, P121, DOI 10.1016/S0896-6273(02)00942-X; MULLER BM, 1995, J NEUROSCI, V15, P2354, DOI 10.1523/JNEUROSCI.15-03-02354.1995; Nagano T, 2003, MOL CELL NEUROSCI, V24, P340, DOI 10.1016/S1044-7431(03)00172-6; Nagano T, 1998, J BIOCHEM-TOKYO, V124, P869, DOI 10.1093/oxfordjournals.jbchem.a022200; Namba H, 2006, MOL CELL NEUROSCI, V31, P628, DOI 10.1016/j.mcn.2005.12.002; Narisawa-Saito M, 1999, NEUROSCIENCE, V88, P1009, DOI 10.1016/S0306-4522(98)00496-5; Narisawa-Saito M, 1999, P NATL ACAD SCI USA, V96, P2461, DOI 10.1073/pnas.96.5.2461; Narisawa-Saito M, 2002, J BIOL CHEM, V277, P40901, DOI 10.1074/jbc.M202158200; Nash JE, 2005, FASEB J, V19, P583, DOI 10.1096/fj.04-1854fje; Nawa H, 2006, NEUROSCI RES, V56, P2, DOI 10.1016/j.neures.2006.06.002; Osten P, 2000, NEURON, V27, P313, DOI 10.1016/S0896-6273(00)00039-8; Rex CS, 2007, J NEUROSCI, V27, P3017, DOI 10.1523/JNEUROSCI.4037-06.2007; Rex CS, 2006, J NEUROPHYSIOL, V96, P677, DOI 10.1152/jn.00336.2006; Rong YQ, 2001, J NEUROCHEM, V79, P382, DOI 10.1046/j.1471-4159.2001.00565.x; Rumbaugh G, 2003, J NEUROSCI, V23, P4567; Sacktor TC, 2008, PROG BRAIN RES, V169, P27, DOI 10.1016/S0079-6123(07)00002-7; Sans N, 2001, J NEUROSCI, V21, P7506, DOI 10.1523/JNEUROSCI.21-19-07506.2001; Sato J, 2008, J NEURAL TRANSM, V115, P1355, DOI 10.1007/s00702-008-0085-9; Takahashi M, 2000, MOL PSYCHIATR, V5, P293, DOI 10.1038/sj.mp.4000718; Takei N, 2009, J BIOL CHEM, V284, P26340, DOI 10.1074/jbc.M109.023010; Toyooka K, 2002, PSYCHIAT RES, V110, P249, DOI 10.1016/S0165-1781(02)00127-0; Toyooka K, 2002, J NEUROCHEM, V83, P797, DOI 10.1046/j.1471-4159.2002.01181.x; Waites CL, 2009, J NEUROSCI, V29, P4332, DOI 10.1523/JNEUROSCI.4431-08.2009; Wakabayashi K, 1999, NEUROBIOL AGING, V20, P287, DOI 10.1016/S0197-4580(99)00035-4; Watanabe Y, 2010, PSYCHIAT CLIN NEUROS, V64, P217, DOI 10.1111/j.1440-1819.2010.02094.x; Wu S, 2007, NEUR M PLANN SAN DIE; Wu SH, 2010, J BIOL CHEM, V285, P40472, DOI 10.1074/jbc.M110.171371; Xiong H, 2002, NEUROPHARMACOLOGY, V42, P903, DOI 10.1016/S0028-3908(02)00043-6; Yao YD, 2008, J NEUROSCI, V28, P7820, DOI 10.1523/JNEUROSCI.0223-08.2008; Yokomaku D, 2005, NEUROSCIENCE, V136, P1037, DOI 10.1016/j.neuroscience.2005.08.014; Zheng CY, 2011, NEUROSCIENTIST, V17, P493, DOI 10.1177/1073858410386384; Ziff EB, 2007, NEURON, V53, P627, DOI 10.1016/j.neuron.2007.02.006	76	18	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57124	10.1371/journal.pone.0057124	http://dx.doi.org/10.1371/journal.pone.0057124			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460828	Green Submitted, Green Published, gold			2022-12-25	WOS:000315519000065
J	Rao, SAK; Carolan, JC; Wilkinson, TL				Rao, Sohail A. K.; Carolan, James C.; Wilkinson, Tom L.			Proteomic Profiling of Cereal Aphid Saliva Reveals Both Ubiquitous and Adaptive Secreted Proteins	PLOS ONE			English	Article							PEA APHID; ACYRTHOSIPHON-PISUM; GLUCOSE-OXIDASE; EVOLUTION; IDENTIFICATION; LOCALIZATION; HEMIPTERA; FAMILY; BLOOD; GENE	The secreted salivary proteins from two cereal aphid species, Sitobion avenae and Metopolophium dirhodum, were collected from artificial diets and analysed by tandem mass spectrometry. Protein identification was performed by searching MS data against the official protein set from the current pea aphid (Acyrthosiphon pisum) genome assembly and revealed 12 and 7 proteins in the saliva of S. avenae and M. dirhodum, respectively. When combined with a comparable dataset from A. pisum, only three individual proteins were common to all the aphid species; two paralogues of the GMC oxidoreductase family (glucose dehydrogenase; GLD) and ACYPI009881, an aphid specific protein previously identified as a putative component of the salivary sheath. Antibodies were designed from translated protein sequences obtained from partial cDNA sequences for ACYPI009881 and both saliva associated GLDs. The antibodies detected all parent proteins in secreted saliva from the three aphid species, but could only detect ACYPI009881, and not saliva associated GLDs, in protein extractions from the salivary glands. This result was confirmed by immunohistochemistry using whole and sectioned salivary glands, and in addition, localised ACYPI009881 to specific cell types within the principal salivary gland. The implications of these findings for the origin of salivary components and the putative role of the proteins identified are discussed in the context of our limited understanding of the functional relationship between aphid saliva and the plants they feed on. The mass spectrometry data have been deposited to the ProteomeXchange and can be accessed under the identifier PXD000113.	[Rao, Sohail A. K.; Carolan, James C.; Wilkinson, Tom L.] Univ Coll Dublin, Sch Biol & Environm Sci, Dublin 2, Ireland	University College Dublin	Wilkinson, TL (corresponding author), Univ Coll Dublin, Sch Biol & Environm Sci, Dublin 2, Ireland.	tom.wilkinson@ucd.ie	Khan, Rao Sohail Ahmad/AAA-6364-2019	Khan, Rao Sohail Ahmad/0000-0002-1118-9000; Carolan, James/0000-0001-5092-674X; Wilkinson, Tom/0000-0003-4353-1103	Department of Agriculture, Food and the Marine Research Stimulus Grant [07/553]; Science Foundation Ireland Principal Investigator Grant [03/IN3/B381]; UCD [SF268]	Department of Agriculture, Food and the Marine Research Stimulus Grant; Science Foundation Ireland Principal Investigator Grant(Science Foundation Ireland); UCD	Financial support was provided through Department of Agriculture, Food and the Marine Research Stimulus Grant 07/553, and in part by Science Foundation Ireland Principal Investigator Grant 03/IN3/B381 and UCD Seed Funding SF268. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blackman RL, 2000, APHIDS WORLDS CROPS, V2nd, DOI 10.1016/0261-2194(96)89825-5; Bos JIB, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001216; Carolan JC, 2011, J PROTEOME RES, V10, P1505, DOI 10.1021/pr100881q; Carolan JC, 2009, PROTEOMICS, V9, P2457, DOI 10.1002/pmic.200800692; Cherqui A, 2000, J INSECT PHYSIOL, V46, P1177, DOI 10.1016/S0022-1910(00)00037-8; Cooper WR, 2011, ENVIRON ENTOMOL, V40, P151, DOI 10.1603/EN10153; Corena MD, 2002, J EXP BIOL, V205, P591; COXFOSTER DL, 1994, J INSECT PHYSIOL, V40, P235, DOI 10.1016/0022-1910(94)90047-7; Cui F, 2012, INSECT SCI, V19, P429, DOI 10.1111/j.1744-7917.2011.01487.x; Dat J, 2000, CELL MOL LIFE SCI, V57, P779, DOI 10.1007/s000180050041; Douglas AE, 2006, J EXP BIOL, V209, P1395, DOI 10.1242/jeb.02148; Drapeau MD, 2006, GENOME RES, V16, P1385, DOI 10.1101/gr.5012006; Drapeau MD, 2003, BIOCHEM BIOPH RES CO, V311, P1, DOI 10.1016/j.bbrc.2003.09.106; Eichenseer H, 1999, ARCH INSECT BIOCHEM, V42, P99, DOI 10.1002/(SICI)1520-6327(199909)42:1&lt;99::AID-ARCH10&gt;3.0.CO;2-B; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Ferguson LC, 2011, MOL BIOL EVOL, V28, P257, DOI 10.1093/molbev/msq192; Fitzroy CIJ, 2010, THESIS U COLL DUBLIN; Francis F, 2006, INSECT BIOCHEM MOLEC, V36, P219, DOI 10.1016/j.ibmb.2006.01.018; Garcia-Brugger A, 2006, MOL PLANT MICROBE IN, V19, P711, DOI 10.1094/MPMI-19-0711; Han D, 2002, BIOCHEM J, V368, P333; Harmel N, 2008, INSECT MOL BIOL, V17, P165, DOI 10.1111/j.1365-2583.2008.00790.x; Hewer A, 2010, J EXP BIOL, V213, P4030, DOI 10.1242/jeb.046326; Hovius JWR, 2008, PLOS MED, V5, P202, DOI 10.1371/journal.pmed.0050043; Iida K, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-75; Iordachescu M, 2008, J INTEGR PLANT BIOL, V50, P1223, DOI 10.1111/j.1744-7909.2008.00736.x; Kiernan JA., 2015, HISTOLOGICAL HISTOCH, P184; Krober T., 1991, Biocontrol News and Information, V12, P357; Madhusudhan VV, 1998, ENTOMOL EXP APPL, V86, P25, DOI 10.1023/A:1003053327444; Martin B, 1997, J GEN VIROL, V78, P2701, DOI 10.1099/0022-1317-78-10-2701; Miles PW, 1999, BIOL REV, V74, P41, DOI 10.1017/S0006323198005271; MILES PW, 1993, ENTOMOL EXP APPL, V67, P275, DOI 10.1007/BF02383437; MILES PW, 1970, EXPERIENTIA, V26, P611, DOI 10.1007/BF01898717; MILES PW, 1968, ANNU REV PHYTOPATHOL, V6, P137, DOI 10.1146/annurev.py.06.090168.001033; MILES PW, 1989, J INSECT PHYSIOL, V35, P865, DOI 10.1016/0022-1910(89)90102-9; Musser RO, 2005, ARCH INSECT BIOCHEM, V58, P128, DOI 10.1002/arch.20039; Musser RO, 2002, NATURE, V416, P599, DOI 10.1038/416599a; Mutti NS, 2008, P NATL ACAD SCI USA, V105, P9965, DOI 10.1073/pnas.0708958105; Mutti NS, 2006, J INSECT SCI, V6, DOI 10.1673/031.006.3801; Nakajima Y, 2000, J BIOCHEM-TOKYO, V127, P901, DOI 10.1093/oxfordjournals.jbchem.a022685; Nicholson SJ, 2012, J PROTEOMICS, V75, P2252, DOI 10.1016/j.jprot.2012.01.031; Oerke E. C., 1994, CROP PRODUCTION CROP, P179; Paul MJ, 2008, ANNU REV PLANT BIOL, V59, P417, DOI 10.1146/annurev.arplant.59.032607.092945; Pitino M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025709; PONSEN M B, 1972, Mededelingen Landbouwhogeschool Wageningen, V72, P1; Ponsen M.B., 1987, World Crop Pests, V2A, P79; Prud'homme B, 2006, NATURE, V440, P1050, DOI 10.1038/nature04597; Quan GX, 2001, INSECT BIOCHEM MOLEC, V31, P97, DOI 10.1016/S0965-1748(00)00112-0; Rao SAK, 2011, THESIS U COLL DUBLIN; Ribeiro JMC, 2003, ANNU REV ENTOMOL, V48, P73, DOI 10.1146/annurev.ento.48.060402.102812; Richards S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000313; SCHALLER GERHARD, 1960, ENT EXPTL ET APPL, V3, P128; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Shima S, 2007, FEBS J, V274, P1192, DOI 10.1111/j.1742-4658.2007.05658.x; Tian DL, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0036168, 10.1371/journal.pone.0042833]; Tjallingii WF, 2006, J EXP BOT, V57, P739, DOI 10.1093/jxb/erj088; Urbanska A, 1998, ENTOMOL EXP APPL, V86, P197, DOI 10.1023/A:1003119900578; Valenzuela JG, 2004, PARASITOLOGY, V129, pS83, DOI 10.1017/S0031182004005189; van Emden H, 2007, APHIDS AS CROP PESTS, pXXI; VICKERMAN GP, 1979, B ENTOMOL RES, V69, P1, DOI 10.1017/S0007485300017855; Vizcaino JA, 2010, NUCLEIC ACIDS RES, V38, pD736, DOI 10.1093/nar/gkp964; WEIDEMANN HL, 1968, ENTOMOL EXP APPL, V11, P450, DOI 10.1111/j.1570-7458.1968.tb02073.x; Will T, 2012, BIOCH PHLOE IN PRESS; Will T, 2007, P NATL ACAD SCI USA, V104, P10536, DOI 10.1073/pnas.0703535104; Xia AH, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-195	64	85	94	2	96	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57413	10.1371/journal.pone.0057413	http://dx.doi.org/10.1371/journal.pone.0057413			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460852	gold, Green Accepted, Green Published, Green Submitted			2022-12-25	WOS:000315519000106
J	Xu, ZQ; Wei, K; Wu, Y; Shen, FX; Chen, Q; Li, MZ; Yao, MS				Xu, Zhenqiang; Wei, Kai; Wu, Yan; Shen, Fangxia; Chen, Qi; Li, Mingzhen; Yao, Maosheng			Enhancing Bioaerosol Sampling by Andersen Impactors Using Mineral-Oil-Spread Agar Plate	PLOS ONE			English	Article							PORTABLE MICROBIAL IMPACTORS; SAMPLERS; TIME; ENUMERATION; COLLECTION; BACTERIA; BIOEFFICIENCY; PERFORMANCE; EXPOSURE; LIQUID	As a bioaerosol sampling standard, Andersen type impactor is widely used since its invention in 1950s, including the investigation of the anthrax attacks in the United States in 2001. However, its related problems such as impaction and desiccation stress as well as particle bounce have not been solved. Here, we improved its biological collection efficiencies by plating a mineral oil layer (100 mL) onto the agar plate. An Andersen six-stage sampler and a BioStage impactor were tested with mineral-oil-spread agar plates in collecting indoor and outdoor bacterial and fungal aerosols. The effects of sampling times (5, 10 and 20 min) were also studied using the BioStage impactor when sampling environmental bioaerosols as well as aerosolized Bacillus subtilis (G+) and Escherichia coli (G-). In addition, particle bounce reduction by mineral-oil-plate was also investigated using an optical particle counter (OPC). Experimental results revealed that use of mineral-oil-spread agar plate can substantially enhance culturable bioaerosol recoveries by Andersen type impactors (p-values<0.05). The recovery enhancement was shown to depend on bioaerosol size, type, sampling time and environment. In general, more enhancements (extra 20%) were observed for last stage of the Andersen six-stage samplers compared to the BioStage impactor for 10 min sampling. When sampling aerosolized B. subtilis, E. coli and environmental aerosols, the enhancement was shown to increase with increasing sampling time, ranging from 50% increase at 5 min to similar to 100% at 20 min. OPC results indicated that use of mineral oil can effectively reduce the particle bounce with an average of 66% for 10 min sampling. Our work suggests that enhancements for fungal aerosols were primarily attributed to the reduced impaction stress, while for bacterial aerosols reduced impaction, desiccation and particle bounce played major roles. The developed technology can readily enhance the agar-based techniques including those high volume portable samplers for bioaerosol monitoring.	[Xu, Zhenqiang; Wei, Kai; Wu, Yan; Shen, Fangxia; Chen, Qi; Li, Mingzhen; Yao, Maosheng] Peking Univ, State Key Joint Lab Environm Simulat & Pollut Con, Coll Environm Sci & Engn, Beijing 100871, Peoples R China	Peking University	Yao, MS (corresponding author), Peking Univ, State Key Joint Lab Environm Simulat & Pollut Con, Coll Environm Sci & Engn, Beijing 100871, Peoples R China.	yao@pku.edu.cn	Chen, QH/GXH-3158-2022; Shen, Fangxia/F-3718-2018; shen, fangxia/HGA-6200-2022; Shen, Fangxia/I-5774-2016	Shen, Fangxia/0000-0003-4166-4615; shen, fangxia/0000-0003-4166-4615; 	National Science Foundation of China [21277007, 21077005, 20877004]; State Key Joint Laboratory of Environment Simulation and Pollution Control	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Joint Laboratory of Environment Simulation and Pollution Control	This study was supported by the National Science Foundation of China (Grants 21277007, 21077005 and 20877004), and special fund of State Key Joint Laboratory of Environment Simulation and Pollution Control. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN AA, 1958, J BACTERIOL, V76, P471, DOI 10.1128/JB.76.5.471-484.1958; Ayres JG, 2009, EUR RESPIR J, V34, P295, DOI 10.1183/09031936.00003409; BRACHMAN PS, 1964, SCIENCE, V144, P1295; Bundy KW, 2009, ANN ALLERG ASTHMA IM, V103, P26, DOI 10.1016/S1081-1206(10)60139-1; Christner BC, 2008, SCIENCE, V319, P1214, DOI 10.1126/science.1149757; COWN WB, 1957, APPL MICROBIOL, V5, P119, DOI 10.1128/AEM.5.2.119-124.1957; Douwes J, 2003, ANN OCCUP HYG, V47, P187, DOI 10.1093/annhyg/meg032; Durand KTH, 2002, ANN OCCUP HYG, V46, P113, DOI 10.1093/annhyg/mef007; Greenburg L, 1992, NEW INSTRUMENT SAMPL; Guan Y, 2003, SCIENCE, V302, P276, DOI 10.1126/science.1087139; He QS, 2011, J ENVIRON MONITOR, V13, P706, DOI 10.1039/c0em00559b; Lin WH, 1998, AEROSOL SCI TECH, V28, P511, DOI 10.1080/02786829808965542; Lin XJ, 1999, ATMOS ENVIRON, V33, P4291, DOI 10.1016/S1352-2310(99)00169-7; Mainelis G, 2010, AEROSOL SCI TECH, V44, P75, DOI 10.1080/02786820903390372; Morris CE, 2007, INFECT GENET EVOL, V7, P84, DOI 10.1016/j.meegid.2006.05.002; Perez-Padilla R, 2009, NEW ENGL J MED, V361, P680, DOI 10.1056/NEJMoa0904252; ROOKS R, 1948, J ALLERGY, V19, P200, DOI 10.1016/0021-8707(48)90053-7; STEWART SL, 1995, APPL ENVIRON MICROB, V61, P1232, DOI 10.1128/AEM.61.4.1232-1239.1995; Wang Z, 2001, J AEROSOL SCI, V32, P661, DOI 10.1016/S0021-8502(00)00108-7; Weis CP, 2002, JAMA-J AM MED ASSOC, V288, P2853, DOI 10.1001/jama.288.22.2853; WILLEKE K, 1995, J AEROSOL SCI, V26, pS883; Winslow CEA, 1908, SCIENCE, V28, P28, DOI 10.1126/science.28.705.28; Xu ZQ, 2011, AEROSOL SCI TECH, V45, P1143, DOI 10.1080/02786826.2011.582195; Yao MS, 2007, J OCCUP ENVIRON HYG, V4, P514, DOI 10.1080/15459620701407388; Yao MS, 2007, J EXPO SCI ENV EPID, V17, P31, DOI 10.1038/sj.jes.7500517; Yao MH, 2006, J AEROSOL SCI, V37, P1467, DOI 10.1016/j.jaerosci.2006.06.005; Yao MS, 2006, AEROSOL SCI TECH, V40, P595, DOI 10.1080/02786820600729146; Zhen SQ, 2009, J AEROSOL SCI, V40, P503, DOI 10.1016/j.jaerosci.2009.02.003	28	25	29	3	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e56896	10.1371/journal.pone.0056896	http://dx.doi.org/10.1371/journal.pone.0056896			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460818	Green Published, Green Submitted, gold			2022-12-25	WOS:000315519000043
J	Chan, PC; Huang, SH; Yu, MC; Lee, SW; Huang, YW; Chien, ST; Lee, JJ				Chan, Pei-Chun; Huang, Su-Hua; Yu, Ming-Chih; Lee, Shih-Wei; Huang, Yi-Wen; Chien, Shun-Tien; Lee, Jen-Jyh		TMTC	Effectiveness of a Government-Organized and Hospital-Initiated Treatment for Multidrug-Resistant Tuberculosis Patients-A Retrospective Cohort Study	PLOS ONE			English	Article							TREATMENT OUTCOMES; TAIWAN; SURVIVAL; THERAPY; LATVIA	Background: In contrast to the conventional model of hospital-treated and government directly observed treatment (DOT) for multidrug-resistant tuberculosis (MDR-TB) patient care, the Taiwan MDR-TB Consortium (TMTC) was launched in May 2007 with the collaboration of five medical care groups that have provided both care and DOT. This study aimed to determine whether the TMTC provided a better care model for MDR-TB patients than the conventional model. Methods and Findings: A total of 651 pulmonary MDR-TB patients that were diagnosed nation-wide from January 2000-August 2008 were enrolled. Of those, 290 (45%) MDR-TB patients whose initial sputum sample was taken in January 2007 or later were classified as patients in the TMTC era. All others were classified as patients in the pre-TMTC era. The treatment success rate at 36 months was better in the TMTC era group (82%) than in the pre-TMTC era group (61%) (p<0.001). With multiple logistic regressions, diagnosis in the TMTC era (adjusted odds ratio (aOR) 2.8, 95% confidence interval (CI) 1.9-4.2) was an independent predictor of a higher treatment success rate at 36 months. With the time-dependent proportional hazards method, a higher treatment success rate was still observed in the TMTC era group compared to the pre-TMTC era group (adjusted hazard ratio 6.3, 95% CI 4.2-9.5). Conclusion: The improved treatment success observed in the TMTC era compared to the pre-TMTC era is encouraging. The detailed TMTC components that contribute the most to the improved outcome will need confirmation in follow-up studies with large numbers of MDR-TB patients.	[Chan, Pei-Chun; Huang, Su-Hua] Ctr Dis Control, Div 3, Taipei, Taiwan; [Yu, Ming-Chih] Taipei Med Univ, Dept Internal Med, Wan Fang Hosp, Taipei, Taiwan; [Lee, Shih-Wei] Tao Yuan Gen Hosp, Dept Hlth, Pulm & Crit Care Unit, Tao Yuan, Taiwan; [Huang, Yi-Wen] Chang Hua Hosp, Dept Hlth, Pulm & Crit Care Unit, Changhua, Taiwan; [Chien, Shun-Tien] Chest Hosp, Dept Hlth, Pulm & Crit Care Unit, Tainan, Taiwan; [Lee, Jen-Jyh] Tzu Chi Univ, Buddhist Tzu Chi Gen Hosp, Dept Internal Med, Hualien, Taiwan	Centers For Disease Control - Taiwan; Taipei Medical University; Taipei Municipal WanFang Hospital; Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Tzu Chi University	Chan, PC (corresponding author), Ctr Dis Control, Div 3, Taipei, Taiwan.	pcanita.tw@cdc.gov.tw			Centers for Disease Control, Taiwan [DOH 100-DC-2005]	Centers for Disease Control, Taiwan	This study was supported by the Centers for Disease Control, Taiwan (Grant DOH 100-DC-2005), to which interim progress reports were submitted. The funding body had no role in study design, data analysis, data interpretation or writing of the report, except data collection.	[Anonymous], 2008, GUID PROGR MAN DRUG; Bloss E, 2012, INT J TUBERC LUNG D, V16, P462, DOI 10.5588/ijtld.11.0121; Chiang CY, 2006, EUR RESPIR J, V28, P980, DOI 10.1183/09031936.06.00125705; Chiang CY, 2009, INT J TUBERC LUNG D, V13, P548; Chiang CY, 2002, INT J TUBERC LUNG D, V6, P974; Furin J, 2011, INT J TUBERC LUNG D, V15, P1294, DOI 10.5588/ijtld.10.0591; Huang SH, 2012, TAIWAN EPIDEMIOL B, V28, P269; Huang SH, 2009, TAIWAN EPIDEMIOLOGY, V25, P86; Jeon DS, 2011, J KOREAN MED SCI, V26, P33, DOI 10.3346/jkms.2011.26.1.33; Johnston JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006914; Kim DH, 2008, AM J RESP CRIT CARE, V178, P1075, DOI 10.1164/rccm.200801-132OC; Kim DH, 2010, AM J RESP CRIT CARE, V182, P113, DOI 10.1164/rccm.200911-1656OC; Laserson KF, 2005, INT J TUBERC LUNG D, V9, P640; Leimane V, 2005, LANCET, V365, P318, DOI 10.1016/S0140-6736(05)17786-1; Leimane V, 2010, EUR RESPIR J, V36, P584, DOI 10.1183/09031936.00003710; Li YH, 2010, HEALTH POLICY PLANN, V25, P334, DOI 10.1093/heapol/czq006; Mitnick CD, 2008, NEW ENGL J MED, V359, P563, DOI 10.1056/NEJMoa0800106; Qazi F, 2011, INT J TUBERC LUNG D, V15, P1556, DOI 10.5588/ijtld.10.0679; Sadaphal P, 2001, CLIN INFECT DIS, V33, P1687, DOI 10.1086/323896; Su CT, 2010, TAIWAN EPIDEMIOLOGY, V26, P400; Taiwan CDC, 2009, TAIW TUB CONTR REP 2; Tang SJ, 2011, SCAND J INFECT DIS, V43, P280, DOI 10.3109/00365548.2010.548080; Tsai WC, 2010, J INFECTION, V61, P235, DOI 10.1016/j.jinf.2010.06.016; World Health Organization, 2006, GUID PROGR MAN DRUG; World Health Organization (WHO), 2008, ANT DRUG RES WORLD 4	25	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57719	10.1371/journal.pone.0057719	http://dx.doi.org/10.1371/journal.pone.0057719			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451263	Green Submitted, Green Published, gold			2022-12-25	WOS:000316849500130
J	Chen, T; Guo, ZP; Li, L; Li, MM; Wang, TT; Jia, RZ; Cao, N; Li, JY				Chen, Tao; Guo, Zai-pei; Li, Li; Li, Meng-meng; Wang, Ting-ting; Jia, Rui-zhen; Cao, Na; Li, Jing-yi			TWEAK Enhances E-selectin and ICAM-1 Expression, and May Contribute to the Development of Cutaneous Vasculitis	PLOS ONE			English	Article							GENERALIZED SHWARTZMAN REACTION; CENTRAL-NERVOUS-SYSTEM; ENDOTHELIAL-CELLS; NEUTROPHIL RECRUITMENT; WEAK INDUCER; APOPTOSIS; PATHWAYS; ADHESION; LIGAND; GROWTH	Our previous work indicated that TWEAK is associated with various types of cutaneous vasculitis (CV). Herein, we investigate the effects of TWEAK on vascular injury and adhesion molecule expression in CV mice. We showed that TWEAK priming in mice induced a local CV. Furthermore, TWEAK priming also increased the extravasation of FITC-BSA, myeloperoxidase activity and the expression of E-selectin and ICAM-1. Conversely, TWEAK blockade ameliorated the LPS-induced vascular damage, leukocyte infiltrates and adhesion molecules expression in LPS-induced CV. In addition, TWEAK treatment of HDMECs up-regulated E-selectin and ICAM-1 expression at both mRNA and protein levels. TWEAK also enhanced the adhesion of PMNs to HDMECs. Finally, western blot data revealed that TWEAK can induce phosphorylation of p38, JNK and ERK in HDMECs. These data suggest that TWEAK acted as an inducer of E-selectin and ICAM-1 expression in CV mice and HDMECs, may contribute to the development of CV.	[Chen, Tao; Guo, Zai-pei; Li, Li; Li, Meng-meng; Wang, Ting-ting; Cao, Na; Li, Jing-yi] Sichuan Univ, West China Hosp, Dept Dermatovenereol, Chengdu 610064, Sichuan, Peoples R China; [Jia, Rui-zhen] Sichuan Univ, West China Hosp 2, Open Lab, Chengdu 610064, Sichuan, Peoples R China	Sichuan University; Sichuan University	Guo, ZP (corresponding author), Sichuan Univ, West China Hosp, Dept Dermatovenereol, Chengdu 610064, Sichuan, Peoples R China.	guozp930@163.com	li, mengmeng/GRS-6883-2022; wang, tingting/AAK-2640-2020		Natural Science Foundation of China [81101198, 81271752]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Natural Science Foundation of China (NO. 81101198) to TC and NO. 81271752 to Z-PG). URL: http://www.nsfc.gov.cn/Portal0/default152.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basuroy S, 2011, AM J PHYSIOL-CELL PH, V300, pC256, DOI 10.1152/ajpcell.00272.2010; Blanco-Colio LM, 2007, FRONT BIOSCI-LANDMRK, V12, P3648, DOI 10.2741/2341; Campbell S, 2006, J IMMUNOL, V176, P1889, DOI 10.4049/jimmunol.176.3.1889; Chen CY, 2008, BLOOD, V112, P3205, DOI 10.1182/blood-2008-03-143479; Chen T, 2011, CLIN EXP IMMUNOL, V166, P64, DOI 10.1111/j.1365-2249.2011.04442.x; Chen T, 2011, RHEUMATOL INT, V31, P321, DOI 10.1007/s00296-009-1254-3; Chicheportiche Y, 1997, J BIOL CHEM, V272, P32401, DOI 10.1074/jbc.272.51.32401; Croce K, 2009, CIRCULATION, V120, P427, DOI 10.1161/CIRCULATIONAHA.108.814582; Desplat-Jego S, 2005, CLIN IMMUNOL, V117, P15, DOI 10.1016/j.clim.2005.06.005; Donohue PJ, 2003, ARTERIOSCL THROM VAS, V23, P594, DOI 10.1161/01.ATV.0000062883.93715.37; Hotta K, 2011, KIDNEY INT, V79, P179, DOI 10.1038/ki.2010.379; Jain M, 2009, CIRCULATION, V119, P2058, DOI 10.1161/CIRCULATIONAHA.108.837286; Jakubowski A, 2002, J CELL SCI, V115, P267; Kerfoot SM, 2001, AM J PATHOL, V159, P1531, DOI 10.1016/S0002-9440(10)62538-2; Koide N, 1996, FEMS IMMUNOL MED MIC, V16, P205, DOI 10.1111/j.1574-695X.1996.tb00137.x; Koide N, 1999, INFECT IMMUN, V67, P4112, DOI 10.1128/IAI.67.8.4112-4118.1999; Kralisch S, 2008, ATHEROSCLEROSIS, V199, P440, DOI 10.1016/j.atherosclerosis.2007.10.022; Li H, 2009, J BIOL CHEM, V284, P4439, DOI 10.1074/jbc.M805546200; Li XY, 2009, J ETHNOPHARMACOL, V125, P83, DOI 10.1016/j.jep.2009.06.008; Lynch CN, 1999, J BIOL CHEM, V274, P8455, DOI 10.1074/jbc.274.13.8455; Meyer T, 2010, PLATELETS, V21, P571, DOI 10.3109/09537104.2010.512403; Munoz-Garcia B, 2011, CARDIOVASC RES, V89, P225, DOI 10.1093/cvr/cvq278; Munoz-Garcia B, 2009, ARTERIOSCL THROM VAS, V29, P2061, DOI 10.1161/ATVBAHA.109.194852; Nakayama M, 2003, J IMMUNOL, V170, P341, DOI 10.4049/jimmunol.170.1.341; Nakayama M, 2000, J EXP MED, V192, P1373, DOI 10.1084/jem.192.9.1373; Onur E, 2011, CUTAN OCUL TOXICOL, V30, P217, DOI 10.3109/15569527.2011.554480; Perper SJ, 2006, J IMMUNOL, V177, P2610, DOI 10.4049/jimmunol.177.4.2610; Qian F, 2009, EMBO J, V28, P2896, DOI 10.1038/emboj.2009.234; Scholzen TE, 2003, ENDOCRINOLOGY, V144, P360, DOI 10.1210/en.2002-220651; Schwartz N, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2816; Sunderkotter C, 2001, EXP DERMATOL, V10, P391, DOI 10.1034/j.1600-0625.2001.100602.x; van Kuijk AWR, 2010, ANN RHEUM DIS, V69, P301, DOI 10.1136/ard.2008.090548; Wang C, 2012, CLIN RHEUMATOL, V31, P335, DOI 10.1007/s10067-011-1865-4; Wang YL, 2010, J BIOL CHEM, V285, P37872, DOI 10.1074/jbc.M110.146290; Watabe D, 2007, BRIT J DERMATOL, V157, P259, DOI 10.1111/j.1365-2133.2007.08039.x; Wiley SR, 2001, IMMUNITY, V15, P837, DOI 10.1016/S1074-7613(01)00232-1; Wiley SR, 2003, CYTOKINE GROWTH F R, V14, P241, DOI 10.1016/S1359-6101(03)00019-4; Williams MR, 2011, AM J PHYSIOL-CELL PH, V301, pC777, DOI 10.1152/ajpcell.00250.2011; Yazid S, 2010, ARTERIOSCL THROM VAS, V30, P1718, DOI 10.1161/ATVBAHA.110.209536; Yepes M, 2007, MOL NEUROBIOL, V35, P255, DOI 10.1007/s12035-007-0024-z; Yilmaz MI, 2009, CLIN J AM SOC NEPHRO, V4, P1716, DOI 10.2215/CJN.02760409; Zhao Z, 2007, J IMMUNOL, V179, P7949, DOI 10.4049/jimmunol.179.11.7949; Zimmermann M, 2011, J ALLERGY CLIN IMMUN, V127, P200, DOI 10.1016/j.jaci.2010.11.005	43	4	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56830	10.1371/journal.pone.0056830	http://dx.doi.org/10.1371/journal.pone.0056830			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457623	Green Submitted, Green Published, gold			2022-12-25	WOS:000315603700085
J	Hu, LD; Wang, LM				Hu, Liangdong; Wang, Limin			Using Consensus Bayesian Network to Model the Reactive Oxygen Species Regulatory Pathway	PLOS ONE			English	Article							DNA-DAMAGE; DATABASE; REPAIR	Bayesian network is one of the most successful graph models for representing the reactive oxygen species regulatory pathway. With the increasing number of microarray measurements, it is possible to construct the Bayesian network from microarray data directly. Although large numbers of Bayesian network learning algorithms have been developed, when applying them to learn Bayesian networks from microarray data, the accuracies are low due to that the databases they used to learn Bayesian networks contain too few microarray data. In this paper, we propose a consensus Bayesian network which is constructed by combining Bayesian networks from relevant literatures and Bayesian networks learned from microarray data. It would have a higher accuracy than the Bayesian networks learned from one database. In the experiment, we validated the Bayesian network combination algorithm on several classic machine learning databases and used the consensus Bayesian network to model the Escherichia coli's ROS pathway.	[Hu, Liangdong; Wang, Limin] Jilin Univ, Key Lab Symbol Computat & Knowledge Engn, Minist Educ, Changchun 130023, Jilin, Peoples R China	Jilin University	Wang, LM (corresponding author), Jilin Univ, Key Lab Symbol Computat & Knowledge Engn, Minist Educ, Changchun 130023, Jilin, Peoples R China.	wanglim@jlu.edu.cn			Special Science Foundation for the Doctoral Program of China [200801831011]; Postdoctoral Science Foundation of China [20100481053]	Special Science Foundation for the Doctoral Program of China; Postdoctoral Science Foundation of China(China Postdoctoral Science Foundation)	This research is supported by Special Science Foundation for the Doctoral Program of China (No. 200801831011) and Postdoctoral Science Foundation of China (No. 20100481053). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bansal M, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100120; Beal MJ, 2005, BIOINFORMATICS, V21, P349, DOI 10.1093/bioinformatics/bti014; Bohr VA, 1999, BIOCHIMIE, V81, P155, DOI 10.1016/S0300-9084(99)80048-0; Cano A, 2011, IEEE T SYST MAN CY B, V41, P1382, DOI 10.1109/TSMCB.2011.2148197; Cheng J, 2002, ARTIF INTELL, V137, P43, DOI 10.1016/S0004-3702(02)00191-1; CHOW CK, 1968, IEEE T INFORM THEORY, V14, P462, DOI 10.1109/TIT.1968.1054142; COOPER GF, 1992, MACH LEARN, V9, P309, DOI 10.1007/BF00994110; del Sagrado J, 2003, INT J INTELL SYST, V18, P237, DOI 10.1002/int.10086; DEMPLE B, 1994, ANNU REV BIOCHEM, V63, P915, DOI 10.1146/annurev.biochem.63.1.915; Faith JJ, 2008, NUCLEIC ACIDS RES, V36, pD866, DOI 10.1093/nar/gkm815; Friedman N, 2000, J COMPUT BIOL, V7, P601, DOI 10.1089/106652700750050961; Hodges AP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009513; Irene M, 2002, BIOINFORMATICS, V18, pS241; Jensen FV, 2007, BAYESIAN NETWORKS DE; Keseler IM, 2005, NUCLEIC ACIDS RES, V33, pD334, DOI 10.1093/nar/gki108; Pavlin G, 2010, INFORM FUSION, V11, P267, DOI 10.1016/j.inffus.2009.09.007; PEARL J, 1986, ARTIF INTELL, V29, P241, DOI 10.1016/0004-3702(86)90072-X; RAMOTAR D, 1991, MOL CELL BIOL, V11, P4537, DOI 10.1128/MCB.11.9.4537; Tsamardinos I, 2006, MACH LEARN, V65, P31, DOI 10.1007/s10994-006-6889-7; Utz CM, 2010, THESIS U OKLAHOMA; Wai Lam, 1994, Computational Intelligence, V10, P269, DOI 10.1111/j.1467-8640.1994.tb00166.x; Wong SKM, 2001, IEEE T KNOWL DATA EN, V13, P395, DOI 10.1109/69.929898; Yang ZQ, 2006, IEEE T KNOWL DATA EN, V18, P1253, DOI 10.1109/TKDE.2006.147; Zhang L W, 2006, INTRO BAYESIAN NETWO; Zhang Y., 2011, J INFORM COMPUTATION, V8, P194	25	2	2	10	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56832	10.1371/journal.pone.0056832	http://dx.doi.org/10.1371/journal.pone.0056832			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457624	Green Published, gold, Green Submitted			2022-12-25	WOS:000315603700086
J	Jensen, R; Stanojevic, S; Gibney, K; Salazar, JG; Gustafsson, P; Subbarao, P; Ratjen, F				Jensen, Renee; Stanojevic, Sanja; Gibney, Karyn; Salazar, Juliana Giraldo; Gustafsson, Per; Subbarao, Padmaja; Ratjen, Felix			Multiple Breath Nitrogen Washout: A Feasible Alternative to Mass Spectrometry	PLOS ONE			English	Article							LUNG CLEARANCE INDEX; INERT-GAS WASHOUT; CYSTIC-FIBROSIS; PRESCHOOL-CHILDREN; PULMONARY-FUNCTION; YOUNG-CHILDREN; DISEASE; SPIROMETRY; STANDARDIZATION; INFANTS	Background: The lung clearance index (LCI), measured by multiple breath washout (MBW), reflects global ventilation inhomogeneity and is a sensitive marker of early cystic fibrosis (CF) lung disease. Current evidence is based on a customized mass spectrometry system that uses sulfur hexafluoride (SF6) as a tracer gas, which is not widely available. Nitrogen (N-2) washout may be better suited for clinical use and multi-center trials. Objective: To compare the results obtained from a N-2 washout system to those generated by the SF6 based system in healthy children and children with CF. Methods: Children with CF were recruited from outpatient clinics; healthy children were recruited from the Research4Kids online portal. Participants performed MBWSF6 (Amis 2000, Innovision, Denmark) and MBWN2 (ExhalyzerD, EcoMedics, Switzerland) in triplicate, in random order on the same day. Agreement between systems was assessed by Bland-Altman plot. Results: Sixty-two healthy and 61 children with CF completed measurements on both systems. In health there was good agreement between systems (limits of agreement -0.7 to 1.9); on average N-2 produced higher values of LCI (mean difference 0.58 (95% CI 0.42 to 0.74)). In CF the difference between systems was double that in health with a clear bias towards disproportionately higher LCIN2 compared to LCISF6 at higher mean values of LCI. Conclusion: LCIN2 and LCISF6 have similar discriminative power and intra-session repeatability but are not interchangeable. MBWN2 offers a valid new tool to investigate early obstructive lung disease in CF, but requires independent normative values.	[Jensen, Renee; Stanojevic, Sanja; Gibney, Karyn; Salazar, Juliana Giraldo; Subbarao, Padmaja; Ratjen, Felix] Univ Toronto, Hosp Sick Children, Dept Pediat, Div Resp Med, Toronto, ON M5G 1X8, Canada; [Stanojevic, Sanja] Univ Toronto, Hosp Sick Children, Child Hlth Evaluat Sci, Res Inst, Toronto, ON M5G 1X8, Canada; [Gustafsson, Per] Cent Hosp Skovde, Dept Pediat, S-54185 Skovde, Sweden	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Ratjen, F (corresponding author), Univ Toronto, Hosp Sick Children, Dept Pediat, Div Resp Med, Toronto, ON M5G 1X8, Canada.	felix.ratjen@sickkids.ca	Stanojevic, Sanja/A-4243-2010	Jensen, Renee/0000-0002-0877-9579; Subbarao, Padmaja/0000-0003-0394-1933; Stanojevic, Sanja/0000-0001-7931-8051; Ratjen, Felix/0000-0003-4057-6592	Cystic Fibrosis Foundation Therapeutics	Cystic Fibrosis Foundation Therapeutics(Italian Cystic Fibrosis Research Foundation)	This study was funded by Cystic Fibrosis Foundation Therapeutics (www.cff.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aurora P, 2004, THORAX, V59, P1068, DOI 10.1136/thx.2004.022590; Aurora P, 2005, AM J RESP CRIT CARE, V171, P249, DOI 10.1164/rccm.200407-895OC; Aurora P, 2011, AM J RESP CRIT CARE, V183, P752, DOI 10.1164/rccm.200911-1646OC; Beydon N, 2007, AM J RESP CRIT CARE, V175, P1304, DOI 10.1164/rccm.200605-642ST; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bush A, 2005, CURR OPIN PULM MED, V11, P534, DOI 10.1097/01.mcp.0000181477.30929.3f; COREY M, 1976, AM REV RESPIR DIS, V114, P1085; Ellemunter H, 2010, RESP MED, V104, P1834, DOI 10.1016/j.rmed.2010.06.010; Fuchs SI, 2006, PEDIATR PULM, V41, P1218, DOI 10.1002/ppul.20524; Fuchs SI, 2010, PEDIATR PULM, V45, P301, DOI 10.1002/ppul.21180; Gustafsson PM, 2008, THORAX, V63, P129, DOI 10.1136/thx.2007.077784; Gustafsson Per M, 2005, Paediatr Respir Rev, V6, P239, DOI 10.1016/j.prrv.2005.09.009; Gustafsson PM, 2003, EUR RESPIR J, V22, P972, DOI 10.1183/09031936.03.00049502; KEREM E, 1992, NEW ENGL J MED, V326, P1187, DOI 10.1056/NEJM199204303261804; Kuczmarski RJ, 2000, ADV DATA, V314, P1; Latzin P, 2007, PEDIATR PULM, V42, P888, DOI 10.1002/ppul.20674; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Mott LS, 2012, THORAX, V67, P509, DOI 10.1136/thoraxjnl-2011-200912; Owens CM, 2011, THORAX, V66, P481, DOI 10.1136/thx.2010.150375; Pillow JJ, 2004, EUR RESPIR J, V23, P763, DOI 10.1183/09031936.04.00091504; Robinson PD, 2012, EUR RESP J IN PRESS; Rosenfeld Margaret, 2007, Proc Am Thorac Soc, V4, P299, DOI 10.1513/pats.200611-178HT; Singer F, 2012, PEDIAT PULMONOL; Singer F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036083; Stanojevic S, 2009, AM J RESP CRIT CARE, V180, P547, DOI 10.1164/rccm.200903-0323OC; Wanger J, 2005, EUR RESPIR J, V26, P511, DOI 10.1183/09031936.05.00035005; Yammine S, 2012, THORAX	27	88	88	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56868	10.1371/journal.pone.0056868	http://dx.doi.org/10.1371/journal.pone.0056868			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457632	Green Published, gold, Green Submitted			2022-12-25	WOS:000315603700092
J	Maulik, U; Sarkar, A				Maulik, Ujjwal; Sarkar, Anasua			Searching Remote Homology with Spectral Clustering with Symmetry in Neighborhood Cluster Kernels	PLOS ONE			English	Article							PROTEIN; SEQUENCE; IDENTIFICATION; ALGORITHM	Remote homology detection among proteins utilizing only the unlabelled sequences is a central problem in comparative genomics. The existing cluster kernel methods based on neighborhoods and profiles and the Markov clustering algorithms are currently the most popular methods for protein family recognition. The deviation from random walks with inflation or dependency on hard threshold in similarity measure in those methods requires an enhancement for homology detection among multi-domain proteins. We propose to combine spectral clustering with neighborhood kernels in Markov similarity for enhancing sensitivity in detecting homology independent of "recent'' paralogs. The spectral clustering approach with new combined local alignment kernels more effectively exploits the unsupervised protein sequences globally reducing inter-cluster walks. When combined with the corrections based on modified symmetry based proximity norm deemphasizing outliers, the technique proposed in this article outperforms other state-of-the-art cluster kernels among all twelve implemented kernels. The comparison with the state-of-the-art string and mismatch kernels also show the superior performance scores provided by the proposed kernels. Similar performance improvement also is found over an existing large dataset. Therefore the proposed spectral clustering framework over combined local alignment kernels with modified symmetry based correction achieves superior performance for unsupervised remote homolog detection even in multi-domain and promiscuous domain proteins from Genolevures database families with better biological relevance. Source code available upon request. Contact: sarkar@labri.fr.	[Maulik, Ujjwal] Jadavpur Univ, Dept Comp Sci & Engn, Kolkata, W Bengal, India; [Maulik, Ujjwal] German Canc Res Ctr, Heidelberg, Germany; [Sarkar, Anasua] Univ Bordeaux 1, LaBRI, F-33405 Talence, France	Jadavpur University; Helmholtz Association; German Cancer Research Center (DKFZ); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux	Maulik, U (corresponding author), Jadavpur Univ, Dept Comp Sci & Engn, Kolkata, W Bengal, India.	umaulik@cse.jdvu.ac.in	Maulik, Ujjwal/AAO-8754-2020; Sarkar, Anasua/L-7314-2013	Sarkar, Anasua/0000-0001-7365-3924; Maulik, Ujjwal/0000-0003-1167-0774				ALTSCHUL SF, 1994, NAT GENET, V6, P119, DOI 10.1038/ng0294-119; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; B S J SA, 2002, LEARNING KERNELS; Ballard DH, 1982, COMPUTER VISION; BERG C, 1984, HARMONIC ANAL SEMIGR; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; DAVIES DL, 1979, IEEE T PATTERN ANAL, V1, P224, DOI 10.1109/TPAMI.1979.4766909; Dunn J. C., 1973, Journal of Cybernetics, V3, P32, DOI 10.1080/01969727308546046; Enright AJ, 2000, BIOINFORMATICS, V16, P451, DOI 10.1093/bioinformatics/16.5.451; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Fox J, 2005, J BEHAV EDUC, V14, P1, DOI 10.1007/s10864-005-0957-0; GOODMAN LA, 1954, J AM STAT ASSOC, V49, P732, DOI 10.2307/2281536; Hofmann T, 2008, ANN STAT, V36, P1171, DOI 10.1214/009053607000000677; Hue M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-144; Jaakkola T, 2000, J COMPUT BIOL, V7, P95, DOI 10.1089/10665270050081405; Jaccard P., 1912, NEW PHYTOL, V11, P37, DOI [DOI 10.1111/J.1469-8137.1912.TB05611.X, 10.1111/j.1469-8137.1912.tb05611.x]; Ji XN, 2010, NEUROCOMPUTING, V73, P2363, DOI 10.1016/j.neucom.2009.12.038; Karatzoglou A, 2004, J STAT SOFTW, V11, P1, DOI [10.18637/jss.v011.i09, DOI 10.18637/JSS.V011.I09]; Kestler HA, 2001, COMPUT METH PROG BIO, V64, P133, DOI 10.1016/S0169-2607(00)00098-5; KROGH A, 1994, J MOL BIOL, V235, P1501, DOI 10.1006/jmbi.1994.1104; Lanckriet GRG, 2003, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2004, P300; Leslie C., 2003, ADV NEURAL INFORMATI, P1417; Leslie CS, 2004, BIOINFORMATICS, V20, P467, DOI 10.1093/bioinformatics/btg431; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; LIAO L, 2002, P 6 ANN INT C COMP M, P225, DOI DOI 10.1145/565196.565225; Melia M, 2001, P INT WORKSH AI STAT; Morgado L, 2009, LECT NOTES ARTIF INT, V5572, P409, DOI 10.1007/978-3-642-02319-4_49; Mu-Chun Su, 2005, International Journal of Fuzzy Systems, V7, P175; Ng AY, 2001, NEUR INF PROC S 2001, V2001; Nikolski M, 2007, BIOINFORMATICS, V23, pE71, DOI 10.1093/bioinformatics/btl314; Paccanaro A, 2006, NUCLEIC ACIDS RES, V34, P1571, DOI 10.1093/nar/gkj515; Park J, 1998, J MOL BIOL, V284, P1201, DOI 10.1006/jmbi.1998.2221; R Core Team, 2021, R LANG ENV STAT COMP; RAND WM, 1971, J AM STAT ASSOC, V66, P846, DOI 10.2307/2284239; Rangwala H, 2005, BIOINFORMATICS, V21, P4239, DOI 10.1093/bioinformatics/bti687; Saigo H, 2004, BIOINFORMATICS, V20, P1682, DOI 10.1093/bioinformatics/bth141; Schaffer AA, 2001, NUCLEIC ACIDS RES, V29, P2994, DOI 10.1093/nar/29.14.2994; Sherman D, 2006, NUCLEIC ACIDS RES, V34, pD432, DOI 10.1093/nar/gkj160; Sherman DJ, 2009, NUCLEIC ACIDS RES, V37, pD550, DOI 10.1093/nar/gkn859; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Su MS, 2001, IEEE T PATTERN ANAL, V23, P674, DOI 10.1109/34.927466; van Dongen S, 2000, THESIS U UTRECHT; Weston J, 2005, BIOINFORMATICS, V21, P3241, DOI 10.1093/bioinformatics/bti497; Weston J, 2005, SPIDER MACHINE LEARN; Weston J, 2004, ADV NEURAL INFORM PR, V16; Wieser Daniela, 2009, In Silico Biology, V9, P89, DOI 10.3233/ISB-2009-0390	48	4	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e46468	10.1371/journal.pone.0046468	http://dx.doi.org/10.1371/journal.pone.0046468			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457439	Green Published, gold			2022-12-25	WOS:000315603700001
J	Chen, CC; Chen, CM; Tyler, CW				Chen, Chien-Chung; Chen, Chin-Mei; Tyler, Christopher W.			Depth Structure from Asymmetric Shading Supports Face Discrimination	PLOS ONE			English	Article							LIGHTING DIRECTION; FACIAL SURFACES; RECOGNITION; SHAPE; PERCEPTION; IDENTIFICATION; SYMMETRY; POSITION; PARAMETERS; SELECTION	To examine the effect of illumination direction on the ability of observers to discriminate between faces, we manipulated the direction of illumination on scanned 3D face models. In order to dissociate the surface reflectance and illumination components of front-view face images, we introduce a symmetry algorithm that can separate the symmetric and asymmetric components of the face in both low and high spatial frequency bands. Based on this approach, hybrid faces stimuli were constructed with different combinations of symmetric and asymmetric spatial content. Discrimination results with these images showed that asymmetric illumination information biased face perception toward the structure of the shading component, while the symmetric illumination information had little, if any, effect. Measures of perceived depth showed that this property increased systematically with the asymmetric but not the symmetric low spatial frequency component. Together, these results suggest that (1) the asymmetric 3D shading information dramatically affects both the perceived facial information and the perceived depth of the facial structure; and (2) these effects both increase as the illumination direction is shifted to the side. Thus, our results support the hypothesis that face processing has a strong 3D component.	[Chen, Chien-Chung; Chen, Chin-Mei] Natl Taiwan Univ, Dept Psychol, Taipei 10764, Taiwan; [Chen, Chien-Chung] Natl Taiwan Univ, Neurobiol & Cognit Sci Ctr, Taipei 10764, Taiwan; [Tyler, Christopher W.] Smith Kettlewell Eye Res Inst, San Francisco, CA 94115 USA	National Taiwan University; National Taiwan University; The Smith-Kettlewell Eye Research Institute	Chen, CC (corresponding author), Natl Taiwan Univ, Dept Psychol, Taipei 10764, Taiwan.	c3chen@ntu.edu.tw		Chen, Chien-Chung/0000-0002-3848-0180	NSC (Taiwan) [96-2413-H-002-006-MY3]; AFOSR (USA) [09-NL-072]; Minister of Education (Taiwan) AIM for Top University Excellent Research Project [102R892101]	NSC (Taiwan)(Ministry of Science and Technology, Taiwan); AFOSR (USA)(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Minister of Education (Taiwan) AIM for Top University Excellent Research Project	Supported by NSC (Taiwan) 96-2413-H-002-006-MY3 to CCC and AFOSR (USA) grant 09-NL-072 to CWT. Minister of Education (Taiwan) AIM for Top University Excellent Research Project 102R892101. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atick JJ, 1996, NEURAL COMPUT, V8, P1321, DOI 10.1162/neco.1996.8.6.1321; Biswas S, 2009, IEEE T PATTERN ANAL, V31, P884, DOI 10.1109/TPAMI.2007.12.0830; Blinn JF, 1977, SIGGRAPH 77 P 4 ANN; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Braje WL, 1998, PSYCHOBIOLOGY, V26, P371; Braje WL, 2003, J VISION, V3, P161, DOI 10.1167/3.2.4; Brewster D, 1868, LETT NATURAL MAGIC; Brewster D., 1826, EDINBURGH J SCI, V4, P99; BRUCE V, 1993, PERCEPTION, V22, P131, DOI 10.1068/p220131; BRUCE V, 1991, PERCEPTION, V20, P755, DOI 10.1068/p200755; Chen CC, 2009, SPIE P, V7242; Collin CA, 2006, PERCEPT PSYCHOPHYS, V68, P879, DOI 10.3758/BF03193351; Curran W, 1996, VISION RES, V36, P1399, DOI 10.1016/0042-6989(95)00213-8; Dovgard R, 2004, LECT NOTES COMPUT SC, V3022, P99; Gaspar C, 2008, VISION RES, V48, P2817, DOI 10.1016/j.visres.2008.09.015; Gibson JJ, 1950, PERCEPTION VISUAL WO; Gilad S, 2009, P NATL ACAD SCI USA, V106, P5353, DOI 10.1073/pnas.0812396106; Gold J, 1999, VISION RES, V39, P3537, DOI 10.1016/S0042-6989(99)00080-2; GRAMMER K, 1994, J COMP PSYCHOL, V108, P233, DOI 10.1037/0735-7036.108.3.233; Gregory RL, 1966, EYE BRAIN PSYCHOL SE; Gregory RL, 1970, INTELLIGENT EYE; HARMON LD, 1973, SCIENCE, V180, P1194, DOI 10.1126/science.180.4091.1194; Hill H, 1996, J EXP PSYCHOL HUMAN, V22, P986, DOI 10.1037/0096-1523.22.4.986; Horn B., 1986, ROBOT VISION; Horn BKP, 1989, SHAPE SHADING; JOHNSTON A, 1992, PERCEPTION, V21, P365, DOI 10.1068/p210365; Kemp R, 1996, PERCEPTION, V25, P37, DOI 10.1068/p250037; Lin IC, 2005, VISUAL COMPUT, V21, P355, DOI 10.1007/s00371-005-0291-5; Lin IC, 2002, IEEE COMPUT GRAPH, V22, P72, DOI 10.1109/MCG.2002.1046631; Liu CH, 1997, PERCEPTION, V26, P1289, DOI 10.1068/p261289; Liu CH, 1999, VISION RES, V39, P4003, DOI 10.1016/S0042-6989(99)00109-1; Liu CH, 2000, PERCEPTION, V29, P729, DOI 10.1068/p3065; Mamassian P, 2001, COGNITION, V81, pB1, DOI 10.1016/S0010-0277(01)00116-0; Nasanen R, 1999, VISION RES, V39, P3824, DOI 10.1016/S0042-6989(99)00096-6; Parker DM, 1999, CURR PSYCHOL, V18, P118, DOI 10.1007/s12144-999-1021-3; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; RAMACHANDRAN VS, 1988, SCI AM, V259, P76, DOI 10.1038/scientificamerican0888-76; RAMACHANDRAN VS, 1988, NATURE, V331, P163, DOI 10.1038/331163a0; Rhodes G, 2005, P ROY SOC B-BIOL SCI, V272, P1379, DOI 10.1098/rspb.2005.3093; Rhodes G, 2002, PERCEPTION, V31, P315, DOI 10.1068/p3129; RHODES G, 1988, PERCEPTION, V17, P43, DOI 10.1068/p170043; Rhodes G, 2009, PERCEPTION, V38, P232, DOI 10.1068/p6110; Ruiz-Soler M, 2006, PSYCHOL RES-PSYCH FO, V70, P273, DOI 10.1007/s00426-005-0215-z; Schyns PG, 1997, PERCEPTION, V26, P1027, DOI 10.1068/p261027; Schyns PG, 1999, COGNITION, V69, P243, DOI 10.1016/S0010-0277(98)00069-9; Shyi GC-W, 2010, DATABASE FACIAL EXPR; Sun J, 1998, NAT NEUROSCI, V1, P183, DOI 10.1038/630; Troje NF, 1998, VISION RES, V38, P79, DOI 10.1016/S0042-6989(97)00165-X; Tyler CW, 1997, SPATIAL VISION, V10, P479, DOI 10.1163/156856897X00410; Walker PM, 2003, PERCEPTION, V32, P1117, DOI 10.1068/p5098	51	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e55865	10.1371/journal.pone.0055865	http://dx.doi.org/10.1371/journal.pone.0055865			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	099EJ	23457484	Green Submitted, Green Accepted, gold, Green Published			2022-12-25	WOS:000315602700025
J	Levy-Assaraf, M; Voronov-Goldman, M; Grinberg, IR; Weiserman, G; Shimon, LJW; Jindou, S; Borovok, I; White, BA; Bayer, EA; Lamed, R; Frolow, F				Levy-Assaraf, Maly; Voronov-Goldman, Milana; Grinberg, Inna Rozman; Weiserman, Gloria; Shimon, Linda J. W.; Jindou, Sadanari; Borovok, Ilya; White, Bryan A.; Bayer, Edward A.; Lamed, Raphael; Frolow, Felix			Crystal Structure of an Uncommon Cellulosome-Related Protein Module from Ruminococcus flavefaciens That Resembles Papain-Like Cysteine Peptidases	PLOS ONE			English	Article							L-ALANINE AMIDASE; CELL-SEPARATION; GENE-CLUSTER; DIVERSITY; IDENTIFICATION; ENZYMES; BINDING; SUPERFAMILY; SPECIFICITY; FEATURES	Background: Ruminococcus flavefaciens is one of the predominant fiber-degrading bacteria found in the rumen of herbivores. Bioinformatic analysis of the recently sequenced genome indicated that this bacterium produces one of the most intricate cellulosome systems known to date. A distinct ORF, encoding for a multi-modular protein, RflaF_05439, was discovered during mining of the genome sequence. It is composed of two tandem modules of currently undefined function that share 45% identity and a C-terminal X-dockerin modular dyad. Gaining insight into the diversity, architecture and organization of different types of proteins in the cellulosome system is essential for broadening our understanding of a multi-enzyme complex, considered to be one of the most efficient systems for plant cell wall polysaccharide degradation in nature. Methodology/Principal Findings: Following bioinformatic analysis, the second tandem module of RflaF_05439 was cloned and its selenium-labeled derivative was expressed and crystallized. The crystals belong to space group P21 with unit-cell parameters of alpha = 65.81, b = 60.61, c = 66.13 angstrom, beta = 107.66 degrees and contain two protein molecules in the asymmetric unit. The crystal structure was determined at 1.38-angstrom resolution by X-ray diffraction using the single-wavelength anomalous dispersion (SAD) method and was refined to R-factor and R-free of 0.127 and 0.152 respectively. The protein molecule mainly comprises a beta-sheet flanked by short alpha-helixes, and a globular a-helical domain. The structure was found to be structurally similar to members of the NlpC/P60 superfamily of cysteine peptidases. Conclusions/Significance: The 3D structure of the second repeat of the RflaF_05439 enabled us to propose a role for the currently undefined function of this protein. Its putative function as a cysteine peptidase is inferred from in silico structural homology studies. It is therefore apparent that cellulosomes integrate proteins with other functions in addition to the classic well-defined carbohydrate active enzymes.	[Levy-Assaraf, Maly; Voronov-Goldman, Milana; Grinberg, Inna Rozman; Weiserman, Gloria; Jindou, Sadanari; Borovok, Ilya; Lamed, Raphael; Frolow, Felix] Tel Aviv Univ, Dept Mol Microbiol & Biotechnol, IL-69978 Tel Aviv, Israel; [Levy-Assaraf, Maly; Voronov-Goldman, Milana; Grinberg, Inna Rozman; Lamed, Raphael; Frolow, Felix] Tel Aviv Univ, Daniella Rich Inst Struct Biol, IL-69978 Tel Aviv, Israel; [Shimon, Linda J. W.] Weizmann Inst Sci, Dept Chem Res Support, IL-76100 Rehovot, Israel; [Jindou, Sadanari] Meijo Univ, Fac Agr, Nagoya, Aichi, Japan; [White, Bryan A.] Univ Illinois, Inst Genom Biol, Urbana, IL USA; [Bayer, Edward A.] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel	Tel Aviv University; Tel Aviv University; Weizmann Institute of Science; Meijo University; University of Illinois System; University of Illinois Urbana-Champaign; Weizmann Institute of Science	Frolow, F (corresponding author), Tel Aviv Univ, Dept Mol Microbiol & Biotechnol, IL-69978 Tel Aviv, Israel.	mbfrolow@post.tau.ac.il	BOROVOK, ILYA/ABB-7370-2022	BOROVOK, ILYA/0000-0003-1602-4499; Shimon, Linda/0000-0002-7861-9247	United States-Israel Binational Science Foundation (BSF), Jerusalem, Israel; Israel Science Foundation [291/08, 159/07, 966/09]; Sidney E. Frank Foundation through the Israel Science Foundation (ISF) [24/11]	United States-Israel Binational Science Foundation (BSF), Jerusalem, Israel(US-Israel Binational Science Foundation); Israel Science Foundation(Israel Science Foundation); Sidney E. Frank Foundation through the Israel Science Foundation (ISF)	This was supported by regular and energy grants from the United States-Israel Binational Science Foundation (BSF), Jerusalem, Israel and by the Israel Science Foundation (grants 291/08, 159/07 and 966/09). Additional support was received by a grant (No. 24/11) issued to RL by the Sidney E. Frank Foundation through the Israel Science Foundation (ISF). (http://www.isf.org.il/) (http://www.bsf.org.il/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alber O, 2009, PROTEINS, V77, P699, DOI 10.1002/prot.22483; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anantharaman V, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-r11; Aramini JM, 2008, BIOCHEMISTRY-US, V47, P9715, DOI 10.1021/bi8010779; Bayer EA, 2008, CHEM REC, V8, P364, DOI 10.1002/tcr.20160; Bergfors T, 2003, J STRUCT BIOL, V142, P66, DOI 10.1016/S1047-8477(03)00039-X; Chayen Naomi E., 2003, Journal of Structural and Functional Genomics, V4, P115, DOI 10.1023/A:1026174727482; CHAYEN NE, 1990, J APPL CRYSTALLOGR, V23, P297, DOI 10.1107/S0021889890003260; Copley SD, 2003, CURR OPIN CHEM BIOL, V7, P265, DOI 10.1016/S1367-5931(03)00032-2; COSIER J, 1986, J APPL CRYSTALLOGR, V19, P105, DOI 10.1107/S0021889886089835; Cowtan K, 1998, ACTA CRYSTALLOGR D, V54, P487, DOI 10.1107/S0907444997011980; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Flint HJ, 1997, TRENDS MICROBIOL, V5, P483, DOI 10.1016/S0966-842X(97)01159-1; Gallo M, 2009, J MOL BIOL, V385, P1142, DOI 10.1016/j.jmb.2008.11.017; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Jindou S, 2008, FEMS MICROBIOL LETT, V285, P188, DOI 10.1111/j.1574-6968.2008.01234.x; Jindou S, 2006, J BACTERIOL, V188, P7971, DOI 10.1128/JB.00973-06; Julliand V, 1999, APPL ENVIRON MICROB, V65, P3738; Kajimura J, 2005, MOL MICROBIOL, V58, P1087, DOI 10.1111/j.1365-2958.2005.04881.x; Kang SH, 2006, MOL MICROBIOL, V60, P1344, DOI 10.1111/j.1365-2958.2006.05182.x; Krause DO, 1999, MICROBIOL-UK, V145, P1797, DOI 10.1099/13500872-145-7-1797; Llull D, 2006, FEBS LETT, V580, P1959, DOI 10.1016/j.febslet.2006.02.060; Margot P, 1999, MICROBIOL-SGM, V145, P57, DOI 10.1099/13500872-145-1-57; McGrath ME, 1999, ANNU REV BIOPH BIOM, V28, P181, DOI 10.1146/annurev.biophys.28.1.181; Miller MEB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006650; Nelson KE, 2003, ENVIRON MICROBIOL, V5, P1212, DOI 10.1046/j.1462-2920.2003.00526.x; Ohnishi R, 1999, J BACTERIOL, V181, P3178, DOI 10.1128/JB.181.10.3178-3184.1999; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Rincon MT, 2007, J BACTERIOL, V189, P4774, DOI 10.1128/JB.00143-07; Rincon MT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012476; Rincon MT, 2005, J BACTERIOL, V187, P7569, DOI 10.1128/JB.187.22.7569-7578.2005; Rincon MT, 2003, J BACTERIOL, V185, P703, DOI 10.1128/JB.185.3.703-713.2003; Rossi P, 2009, PROTEINS, V74, P515, DOI 10.1002/prot.22267; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Stout G. H., 1968, XRAY STRUCTURE DETER; Suzuki T, 2003, J BACTERIOL, V185, P2379, DOI 10.1128/JB.185.7.2379-2382.2003; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; WEDEKIND KJ, 1988, APPL ENVIRON MICROB, V54, P1530, DOI 10.1128/AEM.54.6.1530-1535.1988; Xu QP, 2009, STRUCTURE, V17, P303, DOI 10.1016/j.str.2008.12.008; Yamaguchi H, 2004, J BIOSCI BIOENG, V98, P174, DOI 10.1263/jbb.98.174; Zverlov VV, 2005, PROTEOMICS, V5, P3646, DOI 10.1002/pmic.200401199	44	14	14	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56138	10.1371/journal.pone.0056138	http://dx.doi.org/10.1371/journal.pone.0056138			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457513	Green Submitted, Green Published, gold			2022-12-25	WOS:000315602700047
J	Spallotta, F; Cencioni, C; Straino, S; Nanni, S; Rosati, J; Artuso, S; Manni, I; Colussi, C; Piaggio, G; Martelli, F; Valente, S; Mai, A; Capogrossi, MC; Farsetti, A; Gaetano, C				Spallotta, Francesco; Cencioni, Chiara; Straino, Stefania; Nanni, Simona; Rosati, Jessica; Artuso, Simona; Manni, Isabella; Colussi, Claudia; Piaggio, Giulia; Martelli, Fabio; Valente, Sergio; Mai, Antonello; Capogrossi, Maurizio C.; Farsetti, Antonella; Gaetano, Carlo			A Nitric Oxide-dependent Cross-talk between Class I and III Histone Deacetylases Accelerates Skin Repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CULTURED KERATINOCYTES; DIFFERENTIATION; INHIBITORS; CELLS; SIRT1; PROLIFERATION; RESVERATROL; FIBROBLASTS; RELAXATION; ACTIVATION	In a mouse model of skin repair we found that the class I-IIa histone deacetylase inhibitor trichostatin A accelerated tissue regeneration. Unexpectedly, this effect was suppressed by Sirtinol, a class III histone deacetylase (HDAC) (sirtuin)-selective inhibitor. The role of sirtuins (SIRTs) was then investigated by using resveratrol and a novel SIRT1-2-3 activator, the MC2562 compound we synthesized recently. Both resveratrol and MC2562 were effective in accelerating wound repair. The local administration of natural or synthetic SIRT activators, in fact, significantly accelerated skin regeneration by increasing keratinocyte proliferation. In vitro experiments revealed that the activation of SIRTs stimulated keratinocyte proliferation via endothelial NO synthase phosphorylation and NO production. In this condition, the class I member HDAC2 was found S-nitrosylated on cysteine, a post-transduction modification associated with loss of activity and DNA binding capacity. After deacetylase inhibitor or SIRT activator treatment, ChIP showed, in fact, a significant HDAC2 detachment from the promoter region of insulin growth factor I (IGF-I), fibroblast growth factor 10 (FGF-10), and Epithelial Growth Factor (EGF), which may be the final recipients and effectors of the SIRT-NO-HDAC signaling cascade. Consistently, the effect of SIRT activators was reduced in the presence of NG-nitro-L-arginine methyl ester (L-NAME), a general inhibitor of NO synthesis. In conclusion, the NO-dependent cross-talk among class III and I histone deacetylases suggests an unprecedented signaling pathway important for skin repair.	[Spallotta, Francesco; Cencioni, Chiara] Ist Ric & Cura Carattere Sci, Ctr Cardiol Monzino, Lab Biol Vasc & Med Rigenerat, I-20138 Milan, Italy; [Straino, Stefania; Capogrossi, Maurizio C.] IRCCS, Ist Dermopat Immacolata, Lab Patol Vasc, I-00167 Rome, Italy; [Nanni, Simona; Colussi, Claudia] Univ Cattolica Sacro Cuore, Ist Patol Med, I-00168 Rome, Italy; [Rosati, Jessica] Ist CSS Mendel, Unita Neurogenet, I-00198 Rome, Italy; [Artuso, Simona; Manni, Isabella; Piaggio, Giulia] Ist Nazl Tumori Regina Elena, Dipartimento Oncol Sperimentale, I-00144 Rome, Italy; [Martelli, Fabio] IRCCS, Policlin San Donato, Lab Cardiol Mol, I-20097 Milan, Italy; [Valente, Sergio; Mai, Antonello] Univ Roma La Sapienza, Dipartimento Chim & Tecnol Farmaco, I-00185 Rome, Italy; [Farsetti, Antonella] CNR, Ist Biol Cellulare & Neurobiol, I-00185 Rome, Italy; [Gaetano, Carlo] Goethe Univ Frankfurt, Dept Cardiol, Div Cardiovasc Epigenet, D-60590 Frankfurt, Germany	IRCCS Centro Cardiologico Monzino; IRCCS Istituto Dermopatico dell'Immacolata (IDI); Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; IRCCS Casa Sollievo Della Sofferenza; Istituto CSS Mendel; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; IRCCS Policlinico San Donato; Sapienza University Rome; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia Cellulare e Neurobiologia (IBCN-CNR); Goethe University Frankfurt	Gaetano, C (corresponding author), Goethe Univ Frankfurt, Div Cardiovasc Epigenet, Dept Cardiol, Internal Med Clin 3, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.	carlo.gaetano@gmail.com	Rosati, Jessica Diana/H-2867-2016; Martelli, Fabio/AAL-3788-2020; Cencioni, Chiara/I-8490-2018; Piaggio, Giulia/J-7214-2018; Valente, Sergio/K-2198-2016; Rosati, Jessica Diana/AAK-6084-2020; Mai, Antonello/AAC-2144-2019; Colussi, Claudia/H-8609-2019; Manni, Isabella/ABH-6460-2020; Gaetano, Carlo/P-9997-2019; Spallotta, Francesco/AAB-6261-2019; Farsetti, Antonella/I-8710-2018; Piaggio, Giulia/AAD-7336-2022	Rosati, Jessica Diana/0000-0002-4483-386X; Martelli, Fabio/0000-0002-8624-7738; Cencioni, Chiara/0000-0001-6284-539X; Piaggio, Giulia/0000-0003-2114-1892; Valente, Sergio/0000-0002-2241-607X; Rosati, Jessica Diana/0000-0002-4483-386X; Manni, Isabella/0000-0003-4823-0596; Gaetano, Carlo/0000-0002-5238-1832; Spallotta, Francesco/0000-0002-0466-6286; Farsetti, Antonella/0000-0002-8603-7925; Mai, Antonello/0000-0001-9176-2382; Colussi, Claudia/0000-0002-7727-8911	Italian Ministry of Education, University, and Research [PRIN2010TYCL9B_006, FIRB RBFR087JMZ_002]; LOEWE Center for Cell and Gene Therapy, Goethe University Frankfurt, Germany [III L 4-518/17.004]; Duchenne Parent Project, The Netherlands; AIRC [IG-13234]; CARIPLO Foundation [2009-2439]; Ministry of Health, Ricerca Corrente (RC) [4.3]	Italian Ministry of Education, University, and Research(Ministry of Education, Universities and Research (MIUR)); LOEWE Center for Cell and Gene Therapy, Goethe University Frankfurt, Germany; Duchenne Parent Project, The Netherlands(Netherlands Government); AIRC(Fondazione AIRC per la ricerca sul cancro); CARIPLO Foundation(Fondazione Cariplo); Ministry of Health, Ricerca Corrente (RC)	This work was supported by Italian Ministry of Education, University, and Research Grants PRIN2010TYCL9B_006 and FIRB RBFR087JMZ_002 (to A. F.). This work was also supported by the LOEWE Center for Cell and Gene Therapy, Goethe University Frankfurt, Germany (Funding Number III L 4-518/17.004 (2010) (to C. G. and F. S.), by the Duchenne Parent Project, The Netherlands (to C. C.), by grants from AIRC (IG-13234) and the CARIPLO Foundation (grant no. 2009-2439) (to G.P.), and by the Ministry of Health, Ricerca Corrente (RC) 4.3 (to the Istituto Dermopatico dell'Immacolata-IRCCS).	Bashmakov YK, 2011, MED HYPOTHESES, V77, P364, DOI 10.1016/j.mehy.2011.05.016; Blander G, 2009, J INVEST DERMATOL, V129, P41, DOI 10.1038/jid.2008.179; Broughton G, 2006, PLAST RECONSTR SURG, V117, p12S, DOI 10.1097/01.prs.0000225430.42531.c2; Colussi C, 2012, ARTERIOSCL THROM VAS, V32, P2435, DOI 10.1161/ATVBAHA.112.254011; Colussi C, 2008, P NATL ACAD SCI USA, V105, P19183, DOI 10.1073/pnas.0805514105; Dal Farra C, 2006, J COSMET SCI, V57, P187; Farci P, 2010, P NATL ACAD SCI USA, V107, P8766, DOI [10.1073/pnas.1003854107, 10.1073/pnas.1003833107]; Goeman F, 2012, MOL BIOL CELL, V23, P1467, DOI 10.1091/mbc.E12-01-0039; Illi B, 2008, CIRC RES, V102, P51, DOI 10.1161/CIRCRESAHA.107.157305; Illi B, 2009, PHARMACOL THERAPEUT, V123, P344, DOI 10.1016/j.pharmthera.2009.05.003; Isenberg JS, 2005, MICROSURG, V25, P442, DOI 10.1002/micr.20168; Khanna S, 2002, FREE RADICAL BIO MED, V33, P1089, DOI 10.1016/S0891-5849(02)00999-1; Luo JD, 2005, ACTA PHARMACOL SIN, V26, P259, DOI 10.1111/j.1745-7254.2005.00058.x; Mai A, 2005, J MED CHEM, V48, P3344, DOI 10.1021/jm049002a; Mai A, 2009, J MED CHEM, V52, P5496, DOI 10.1021/jm9008289; Marchese C, 2001, J INVEST DERMATOL, V116, P623, DOI 10.1046/j.0022-202x.2001.01280.x; Mattagajasingh I, 2007, P NATL ACAD SCI USA, V104, P14855, DOI 10.1073/pnas.0704329104; Nanni S, 2009, J CLIN INVEST, V119, P1093, DOI 10.1172/JCI35079; Nott A, 2008, NATURE, V455, P411, DOI 10.1038/nature07238; O'Connor EJF, 2012, J INVEST DERMATOL, V132, P1293, DOI 10.1038/jid.2011.432; Park SJ, 2012, CELL, V148, P421, DOI 10.1016/j.cell.2012.01.017; Rafehi H, 2011, INT WOUND J, V8, P12, DOI 10.1111/j.1742-481X.2010.00745.x; Schoop VM, 1999, J INVEST DERMATOL, V112, P343, DOI 10.1046/j.1523-1747.1999.00524.x; Shaw T, 2009, EMBO REP, V10, P881, DOI 10.1038/embor.2009.102; Soneja A, 2005, PHARMACOL REP, V57, P108; Spallotta F, 2010, STEM CELLS, V28, P431, DOI 10.1002/stem.300; Vaquero A, 2007, ONCOGENE, V26, P5505, DOI 10.1038/sj.onc.1210617; Watson P Marc D, 2009, Commun Integr Biol, V2, P11	28	59	61	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2013	288	16					11004	11012		10.1074/jbc.M112.441816	http://dx.doi.org/10.1074/jbc.M112.441816			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	130KW	23463510	Green Published, hybrid			2022-12-25	WOS:000317915500007
J	De Sibio, MT; Luvizotto, RAM; Olimpio, RMC; Correa, CR; Marino, J; de Oliveira, M; Conde, SJ; Ferreira, ALD; Padovani, CR; Nogueira, CR				De Sibio, Maria Teresa; Melo Luvizotto, Renata Azevedo; Castro Olimpio, Regiane Marques; Correa, Camila Renata; Marino, Juliana; de Oliveira, Miriane; Conde, Sandro Jose; dos Anjos Ferreira, Ana Lucia; Padovani, Carlos Roberto; Nogueira, Celia Regina			A Comparative Genotoxicity Study of a Supraphysiological Dose of Triiodothyronine (T-3) in Obese Rats Subjected to Either Calorie-Restricted Diet or Hyperthyroidism	PLOS ONE			English	Article							HIGH-FAT DIET; BODY-WEIGHT GAIN; OXIDATIVE STRESS; GENE-EXPRESSION; THYROID-HORMONE; LEPTIN CONCENTRATIONS; RADICAL GENERATION; CIRCULATING LEPTIN; BLOOD-PRESSURE; PLASMA LEPTIN	This study was designed to determine the genotoxicity of a supraphysiological dose of triiodothyronine (T-3) in both obese and calorie-restricted obese animals. Fifty male Wistar rats were randomly assigned to one of the two following groups: control (C; n = 10) and obese (OB; n = 40). The C group received standard food, whereas the OB group was fed a hypercaloric diet for 20 weeks. After this period, half of the OB animals (n = 20) were subjected to a 25%-calorie restriction of standard diet for 8 weeks forming thus a new group (OR), whereas the remaining OB animals were kept on the initial hypercaloric diet. During the following two weeks, 10 OR animals continued on the calorie restriction diet, whereas the remaining 10 rats of this group formed a new group (ORS) given a supraphysiological dose of T-3 (25 mu g/100 g body weight) along with the calorie restriction diet. Similarly, the remaining OB animals were divided into two groups, one that continued on the hypercaloric diet (OB, n = 10), and one that received the supraphysiological dose of T-3 (25 mu g/100 g body weight) along with the hypercaloric diet (OS, n = 10) for two weeks. The OB group showed weight gain, increased adiposity, insulin resistance, increased leptin levels and genotoxicity; T-3 administration in OS animals led to an increase in genotoxicity and oxidative stress when compared with the OB group. The OR group showed weight loss and normalized levels of adiposity, insulin resistance, serum leptin and genotoxicity, thus having features similar to those of the C group. On the other hand, the ORS group, compared to OR animals, showed higher genotoxicity. Our results indicate that regardless of diet, a supraphysiological dose of T-3 causes genotoxicity and potentiates oxidative stress.	[De Sibio, Maria Teresa; Melo Luvizotto, Renata Azevedo; Castro Olimpio, Regiane Marques; Marino, Juliana; de Oliveira, Miriane; Conde, Sandro Jose; dos Anjos Ferreira, Ana Lucia; Nogueira, Celia Regina] Univ Sao Paulo State UNESP, Botucatu Med Sch, Dept Internal Med, Botucatu, SP, Brazil; [Correa, Camila Renata] Univ Sao Paulo State UNESP, Botucatu Med Sch, Dept Pathol, Botucatu, SP, Brazil; [Padovani, Carlos Roberto] Univ Sao Paulo State UNESP, Biosci Inst, Dept Biostat, Botucatu, SP, Brazil	Universidade Estadual Paulista; Universidade Estadual Paulista; Universidade Estadual Paulista	De Sibio, MT (corresponding author), Univ Sao Paulo State UNESP, Botucatu Med Sch, Dept Internal Med, Botucatu, SP, Brazil.	mt_bio@yahoo.com.br	Correa, Camila/Q-2071-2019; Padovani, Carlos Roberto/A-3656-2013; Conde, Sandro J/E-6249-2013; De Sibio, Maria/AAM-4561-2020; Nogueira, Celia Regina/AAF-7440-2022; Nogueira, Celia Regina/AFK-0463-2022	Correa, Camila/0000-0002-6915-4230; Padovani, Carlos Roberto/0000-0002-7719-9682; Conde, Sandro J/0000-0003-1876-5418; Nogueira, Celia Regina/0000-0002-4014-0660; Nogueira, Celia Regina/0000-0002-4014-0660; Correa, Camila Renata/0000-0001-8493-5329	CAPES Coordenacao de Aperfeicoamento de Pessoal de Nivel; FAPESP Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2008/57310-3]	CAPES Coordenacao de Aperfeicoamento de Pessoal de Nivel(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPESP Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was supported by CAPES Coordenacao de Aperfeicoamento de Pessoal de Nivel and FAPESP Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (process no 2008/57310-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel ED, 2003, MOL ENDOCRINOL, V17, P1767, DOI 10.1210/me.2003-0109; Ahmed OM, 2012, INT J DEV NEUROSCI, V30, P517, DOI 10.1016/j.ijdevneu.2012.04.005; Ainslie DA, 2000, AM J CLIN NUTR, V71, P438; ASTRUP A, 1994, AM J CLIN NUTR, V59, P350, DOI 10.1093/ajcn/59.2.350; Barnes MJ, 2003, BRAIN RES BULL, V61, P511, DOI 10.1016/S0361-9230(03)00188-6; Bell-Anderson Kim S, 2004, Treat Endocrinol, V3, P11, DOI 10.2165/00024677-200403010-00002; Brown JL, 2002, ENDOCRINE, V19, P327, DOI 10.1385/ENDO:19:3:327; Claret M, 2004, OBES RES, V12, P1596, DOI 10.1038/oby.2004.199; Cowburn G, 1997, BRIT MED BULL, V53, P389, DOI 10.1093/oxfordjournals.bmb.a011619; Daly ME, 2006, DIABETIC MED, V23, P15, DOI 10.1111/j.1464-5491.2005.01760.x; Dimitriadis GD, 2001, EXP CLIN ENDOCR DIAB, V109, pS225, DOI 10.1055/s-2001-18584; Elliott JC, 2004, MOL BRAIN RES, V128, P150, DOI 10.1016/j.molbrainres.2004.06.010; Estadella D, 2004, NUTRITION, V20, P218, DOI 10.1016/j.nut.2003.10.008; FERNANDEZ V, 1985, ENDOCRINOLOGY, V117, P496, DOI 10.1210/endo-117-2-496; Fukuchi M, 2002, LIFE SCI, V71, P1059, DOI 10.1016/S0024-3205(02)01791-5; Gaiva MHG, 2001, BRIT J NUTR, V86, P371, DOI 10.1079/BJN2001392; Giannocco G, 2004, MOL CELL ENDOCRINOL, V226, P19, DOI 10.1016/j.mce.2004.07.007; Halliwell B, 1996, ANNU REV NUTR, V16, P33, DOI 10.1146/annurev.nu.16.070196.000341; HARRIS RBS, 1994, INT J OBESITY, V18, P632; Henning B, 2001, J AM COLL NUTR, V20, P97, DOI 10.1080/07315724.2001.10719021; Heydari AR, 2007, NUCLEIC ACIDS RES, V35, P7485, DOI 10.1093/nar/gkm860; Hudig F, 1997, J ENDOCRINOL, V152, P413, DOI 10.1677/joe.0.1520413; Johnstone AM, 2005, AM J CLIN NUTR, V82, P941, DOI 10.1093/ajcn/82.5.941; Kautzky-Willer A, 1999, EUR J CLIN INVEST, V29, P395, DOI 10.1046/j.1365-2362.1999.00470.x; Levin BE, 2002, AM J PHYSIOL-REG I, V283, pR941, DOI 10.1152/ajpregu.00245.2002; Levin BE, 2004, AM J PHYSIOL-REG I, V286, pR771, DOI 10.1152/ajpregu.00650.2003; Li L, 2009, EYE, V23, P1464, DOI 10.1038/eye.2008.281; Lopez-Torres M, 2002, FREE RADICAL BIO MED, V32, P882, DOI 10.1016/S0891-5849(02)00773-6; Luvizotto RAM, 2011, HORM METAB RES, V43, P452, DOI 10.1055/s-0031-1277187; Magsino CH, 2000, METABOLISM, V49, P799, DOI 10.1053/meta.2000.6263; Mattson MP, 2005, J NUTR BIOCHEM, V16, P129, DOI 10.1016/j.jnutbio.2004.12.007; Miyamae Y, 1998, Mutat Res, V415, P229, DOI 10.1016/S1383-5718(97)00192-7; Nascimento AF, 2011, LIFE SCI, V88, P1031, DOI 10.1016/j.lfs.2011.03.015; Nikolich-Zugich J, 2005, EXP GERONTOL, V40, P884, DOI 10.1016/j.exger.2005.06.007; O'Brien PE, 2002, AM J SURG, V184, p4S, DOI 10.1016/S0002-9610(02)01172-8; Oldham KM, 2002, JPEN-PARENTER ENTER, V26, P189, DOI 10.1177/0148607102026003189; Parks E J, 2001, Curr Atheroscler Rep, V3, P462, DOI 10.1007/s11883-001-0036-5; Pinkney JH, 1998, CLIN ENDOCRINOL, V49, P583, DOI 10.1046/j.1365-2265.1998.00573.x; Reinehr T, 2010, MOL CELL ENDOCRINOL, V316, P165, DOI 10.1016/j.mce.2009.06.005; Roberts CK, 2002, CIRCULATION, V106, P2530, DOI 10.1161/01.CIR.0000040584.91836.0D; Rotondi M, 2011, J CLIN ENDOCR METAB, V96, P344, DOI 10.1210/jc.2010-2515; Rybus-Kalinowska Barbara, 2008, Pol Arch Med Wewn, V118, P420; Sanchez-Suarez P, 2008, MUTAT RES-FUND MOL M, V640, P8, DOI 10.1016/j.mrfmmm.2007.11.008; Schrauwen P, 2000, BRIT J NUTR, V84, P417, DOI 10.1017/S0007114500001720; Setia S, 2007, CLIN CHIM ACTA, V376, P37, DOI 10.1016/j.cca.2006.07.007; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59; Thompson WG, 2005, OBES RES, V13, P1344, DOI 10.1038/oby.2005.163; TICE RR, 1991, ADV EXP MED BIOL, V283, P157; van Dam RM, 2002, DIABETES CARE, V25, P417, DOI 10.2337/diacare.25.3.417; Vasselli JR, 2005, OBES RES, V13, P693, DOI 10.1038/oby.2005.78; Venditti P, 2006, CELL MOL LIFE SCI, V63, P414, DOI 10.1007/s00018-005-5457-9; Vendrell J, 2004, OBES RES, V12, P962, DOI 10.1038/oby.2004.118; Videla LA, 2000, REDOX REP, V5, P265, DOI 10.1179/135100000101535807; Viguerie N, 2005, DIABETOLOGIA, V48, P123, DOI 10.1007/s00125-004-1618-x; Willett WC, 2001, J INTERN MED, V249, P395, DOI 10.1046/j.1365-2796.2001.00822.x; Wolfe BE, 2004, CLIN ENDOCRINOL, V61, P332, DOI 10.1111/j.1365-2265.2004.02101.x; Wynder EL, 1997, JNCI-J NATL CANCER I, V89, P766, DOI 10.1093/jnci/89.11.766; Zabrocka L, 2006, LIFE SCI, V79, P1114, DOI 10.1016/j.lfs.2006.03.009	59	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e56913	10.1371/journal.pone.0056913	http://dx.doi.org/10.1371/journal.pone.0056913			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23468891	Green Published, Green Submitted, gold			2022-12-25	WOS:000315524900043
J	Rieder, F; Siegmund, B; Bundschuh, DS; Lehr, HA; Endres, S; Eigler, A				Rieder, Florian; Siegmund, Britta; Bundschuh, Daniela S.; Lehr, Hans-Anton; Endres, Stefan; Eigler, Andreas			The Selective Phosphodiesterase 4 Inhibitor Roflumilast and Phosphodiesterase 3/4 Inhibitor Pumafentrine Reduce Clinical Score and TNF Expression in Experimental Colitis in Mice	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; INFLAMMATORY-BOWEL-DISEASE; OBSTRUCTIVE PULMONARY-DISEASE; SODIUM-INDUCED COLITIS; PDE4 INHIBITOR; ULCERATIVE-COLITIS; MURINE COLITIS; FACTOR-ALPHA; IN-VITRO; ROLIPRAM	Objective: The specific inhibition of phosphodiesterase (PDE) 4 and dual inhibition of PDE3 and PDE4 has been shown to decrease inflammation by suppression of pro-inflammatory cytokine synthesis. We examined the effect of roflumilast, a selective PDE4 inhibitor marketed for severe COPD, and the investigational compound pumafentrine, a dual PDE3/PDE4 inhibitor, in the preventive dextran sodium sulfate (DSS)-induced colitis model. Methods: The clinical score, colon length, histologic score and colon cytokine production from mice with DSS-induced colitis (3.5% DSS in drinking water for 11 days) receiving either roflumilast (1 or 5 mg/kg body weight/d p.o.) or pumafentrine (1.5 or 5 mg/kg/d p.o.) were determined and compared to vehicle treated control mice. In the pumafentrine-treated animals, splenocytes were analyzed for interferon-gamma (IFN gamma) production and CD69 expression. Results: Roflumilast treatment resulted in dose-dependent improvements of clinical score (weight loss, stool consistency and bleeding), colon length, and local tumor necrosis factor-alpha (TNF alpha) production in the colonic tissue. These findings, however, were not associated with an improvement of the histologic score. Administration of pumafentrine at 5 mg/kg/d alleviated the clinical score, the colon length shortening, and local TNF alpha production. In vitro stimulated splenocytes after in vivo treatment with pumafentrine showed a significantly lower state of activation and production of IFN gamma compared to no treatment in vivo. Conclusions: These series of experiments document the ameliorating effect of roflumilast and pumafentrine on the clinical score and TNF expression of experimental colitis in mice.	[Rieder, Florian; Siegmund, Britta; Endres, Stefan; Eigler, Andreas] Univ Munich, Div Clin Pharmacol, Munich, Germany; [Rieder, Florian; Siegmund, Britta; Endres, Stefan; Eigler, Andreas] Univ Munich, Gastroenterol Sect, Munich, Germany; [Rieder, Florian] Univ Regensburg, Dept Internal Med 1, D-93053 Regensburg, Germany; [Siegmund, Britta] Charite, Dept Med 1, D-13353 Berlin, Germany; [Bundschuh, Daniela S.] Takeda Pharmaceut Int GmbH, Zurich, Switzerland; [Lehr, Hans-Anton] CHU Vaudois, Inst Univ Pathol, Lausanne, Switzerland	University of Munich; University of Munich; University of Regensburg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Eigler, A (corresponding author), Univ Munich, Div Clin Pharmacol, Munich, Germany.	andreas.eigler@med.uni-muenchen.de	Siegmund, Britta/E-6929-2018	Siegmund, Britta/0000-0002-0055-958X	Takeda Pharmaceuticals International GmbH; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK083251] Funding Source: NIH RePORTER	Takeda Pharmaceuticals International GmbH; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was partly supported by Takeda Pharmaceuticals International GmbH (formerly Nycomed GmbH), the employer of Daniela S. Bundschuh. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banner KH, 2009, BRIT J PHARMACOL, V157, P892, DOI 10.1111/j.1476-5381.2009.00170.x; Banner KH, 2004, TRENDS PHARMACOL SCI, V25, P430, DOI 10.1016/j.tips.2004.06.008; Bielekova B, 2000, J IMMUNOL, V164, P1117, DOI 10.4049/jimmunol.164.2.1117; Bundschuh DS, 2001, J PHARMACOL EXP THER, V297, P280; Calverley PMA, 2009, LANCET, V374, P685, DOI 10.1016/S0140-6736(09)61255-1; COLIGAN JE, 1992, CURRENT PROTOCOLS IM; COOPER HS, 1993, LAB INVEST, V69, P238; Diaz-Granados N, 2000, AM J PATHOL, V156, P2169, DOI 10.1016/S0002-9440(10)65087-0; Dony E, 2008, EUR RESPIR J, V31, P599, DOI 10.1183/09031936.00002007; ELSON CO, 1995, GASTROENTEROLOGY, V109, P1344, DOI 10.1016/0016-5085(95)90599-5; Fabbri LM, 2009, LANCET, V374, P695, DOI 10.1016/S0140-6736(09)61252-6; Giembycz MA., 2005, P AM THORAC SOC, V2, P340; Grootendorst DC, 2007, THORAX, V62, P1081, DOI 10.1136/thx.2006.075937; Hartmann G, 2000, J PHARMACOL EXP THER, V292, P22; Hatzelmann A, 2001, J PHARMACOL EXP THER, V297, P267; Hatzelmann A, 2004, PULM PHARMACOL THER, V23, P235; Ichikawa H, 2008, INFLAMM BOWEL DIS, V14, P1483, DOI 10.1002/ibd.20524; Keane J, 2001, NEW ENGL J MED, V345, P1098, DOI 10.1056/NEJMoa011110; Kojouharoff G, 1997, CLIN EXP IMMUNOL, V107, P353, DOI 10.1111/j.1365-2249.1997.291-ce1184.x; Kumar RK, 2003, J PHARMACOL EXP THER, V307, P349, DOI 10.1124/jpet.103.053819; Loher F, 2003, J PHARMACOL EXP THER, V305, P549, DOI 10.1124/jpet.102.039529; MURCH SH, 1993, GUT, V34, P1705, DOI 10.1136/gut.34.12.1705; MURTHY SNS, 1993, DIGEST DIS SCI, V38, P1722, DOI 10.1007/BF01303184; Nyman U, 1997, CLIN EXP IMMUNOL, V108, P415, DOI 10.1046/j.1365-2249.1997.3931291.x; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Rabe KF, 2005, LANCET, V366, P563, DOI 10.1016/S0140-6736(05)67100-0; Rutgeerts P, 1999, GASTROENTEROLOGY, V117, P761, DOI 10.1016/S0016-5085(99)70332-X; Rutgeerts P, 2005, NEW ENGL J MED, V353, P2462, DOI 10.1056/NEJMoa050516; Sandborn WJ, 1999, INFLAMM BOWEL DIS, V5, P119, DOI 10.1097/00054725-199905000-00008; Schreiber S, 2007, GASTROENTEROLOGY, V132, P76, DOI 10.1053/j.gastro.2006.11.029; SEMMLER J, 1993, INT J IMMUNOPHARMACO, V15, P409, DOI 10.1016/0192-0561(93)90052-Z; Siegmund B, 2001, J PHARMACOL EXP THER, V296, P99; SINHA B, 1995, EUR J IMMUNOL, V25, P147, DOI 10.1002/eji.1830250125; SOMMER N, 1995, NAT MED, V1, P244, DOI 10.1038/nm0395-244; STURGESS I, 1990, BRIT J CLIN PHARMACO, V29, P369, DOI 10.1111/j.1365-2125.1990.tb03651.x; Tomoyose M, 1998, SCAND J GASTROENTERO, V33, P435; Torphy TJ, 1998, AM J RESP CRIT CARE, V157, P351, DOI 10.1164/ajrccm.157.2.9708012; Videla S, 2006, J PHARMACOL EXP THER, V316, P940, DOI 10.1124/jpet.105.090837; ZIEGLER SF, 1994, J IMMUNOL, V152, P1228; ZIEGLERHEITBROCK HWL, 1992, IMMUNOLOGY, V75, P264	40	16	18	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e56867	10.1371/journal.pone.0056867	http://dx.doi.org/10.1371/journal.pone.0056867			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23468885	gold, Green Published, Green Submitted			2022-12-25	WOS:000315524900041
J	Tency, I; Verstraelen, H; Saerens, B; Verhasselt, B; Vaneechoutte, M; Degomme, O; Verhelst, R; Temmerman, M				Tency, Inge; Verstraelen, Hans; Saerens, Bart; Verhasselt, Bruno; Vaneechoutte, Mario; Degomme, Olivier; Verhelst, Rita; Temmerman, Marleen			Elevated Soluble Triggering Receptor Expressed on Myeloid Cells (sTREM)-1 Levels in Maternal Serum during Term and Preterm Labor	PLOS ONE			English	Article							INTRAUTERINE INFECTION; INFLAMMATORY MARKERS; AMNIOTIC-FLUID; TREM-1; MEMBRANES; RISK; INTERLEUKIN-6; PARTURITION; PREGNANCY; DIAGNOSIS	Background: Infection and inflammation are important mechanisms leading to preterm birth. Soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) belongs to a family of cell surface receptors that seems to play an important role in fine-tuning the immune response. It has been demonstrated that sTREM-1 is involved in bacterial infection as well as in noninfectious inflammatory conditions. Few studies have investigated serum sTREM-1 expression during preterm labor. Therefore, the purpose of this study was to assess sTREM-1 concentrations in maternal serum during term and preterm labor. Methods: This case control study included 176 singleton pregnancies in the following groups: patients in (1) preterm labor, delivered before 34 weeks (PTB) (n = 52); (2) GA matched controls, not in labor, matched for gestational age (GA) with the PTB group (n = 52); (3) at term in labor (n = 40) and (4) at term not in labor (n = 32). sTREM-1 concentrations were determined by enzyme-linked immunoassay. Results: sTREM-1 was detected in all serum samples. Median sTREM-1 concentrations were significantly higher in women with PTB vs. GA matched controls (367 pg/ml, interquartile range (IQR) 304-483 vs. 273 pg/ml, IQR 208-334; P < 0.001) and in women at term in labor vs. at term not in labor (300 pg/ml, IQR 239-353 vs. 228 pg/ml, IQR 174-285; P < 0.001). Women with PTB had significantly higher levels of sTREM-1 compared to women at term in labor (P = 0.004). Multiple regression analysis, with groups recoded as three key covariates (labor, preterm and rupture of the membranes), showed significantly higher sTREM-1 concentrations for labor (+30%, P < 0.001) and preterm (+15%, P = 0.005) after adjusting for educational level, history of PTB and sample age. Conclusions: sTREM-1 concentrations in maternal serum were elevated during spontaneous term and preterm labor and sTREM-1 levels were significantly higher in preterm labor.	[Tency, Inge; Verstraelen, Hans; Temmerman, Marleen] Univ Ghent, Dept Obstet & Gynaecol, Fac Med & Hlth Sci, B-9000 Ghent, Belgium; [Saerens, Bart; Verhasselt, Bruno; Vaneechoutte, Mario] Univ Ghent, Dept Clin Chem Microbiol & Immunol, Fac Med & Hlth Sci, B-9000 Ghent, Belgium; [Degomme, Olivier; Verhelst, Rita; Temmerman, Marleen] Univ Ghent, Int Ctr Reprod Hlth, Dept Obstet & Gynecol, Fac Med & Hlth Sci, B-9000 Ghent, Belgium	Ghent University; Ghent University; Ghent University	Tency, I (corresponding author), Univ Ghent, Dept Obstet & Gynaecol, Fac Med & Hlth Sci, B-9000 Ghent, Belgium.	inge.tency@ugent.be	Verstraelen, Hans/A-5602-2008; Verstraelen, Hans/AAA-8694-2019; Vaneechoutte, Mario/A-6189-2009	Verstraelen, Hans/0000-0002-4070-1587; Vaneechoutte, Mario/0000-0002-4586-203X; Verhasselt, Bruno/0000-0002-4645-1144	Special Research fund of Ghent University	Special Research fund of Ghent University(Ghent University)	This research was supported by the Special Research fund of Ghent University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal V, 2012, SEMIN FETAL NEONAT M, V17, P12, DOI 10.1016/j.siny.2011.09.001; Bouchon A, 2001, NATURE, V410, P1103, DOI 10.1038/35074114; Cobo T, 2012, ACTA OBSTET GYNECOL; Cobo T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043677; Cobo T, 2012, ACTA OBSTET GYN SCAN, V91, P930, DOI 10.1111/j.1600-0412.2012.01427.x; Collins CE, 2009, ANN RHEUM DIS, V68, P1768, DOI 10.1136/ard.2008.089557; Colonna M, 2003, NAT REV IMMUNOL, V3, P445, DOI 10.1038/nri1106; DiGiulio DB, 2010, AM J REPROD IMMUNOL, V64, P38, DOI 10.1111/j.1600-0897.2010.00830.x; Ford JW, 2009, CURR OPIN IMMUNOL, V21, P38, DOI 10.1016/j.coi.2009.01.009; Friebe A, 2008, ARCH PATHOL LAB MED, V132, P1802, DOI 10.1043/1543-2165-132.11.1802; Gibot S, 2005, CRIT CARE MED, V33, P792, DOI 10.1097/01.CCM.0000159089.16462.4A; Gibot S, 2006, SEMIN RESP CRIT CARE, V27, P29, DOI 10.1055/s-2006-933671; Goldenberg RL, 2000, NEW ENGL J MED, V342, P1500, DOI 10.1056/NEJM200005183422007; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Goncalves LF, 2002, MENT RETARD DEV D R, V8, P3, DOI 10.1002/mrdd.10008; Gotsch F, 2009, J MATERN-FETAL NEO M, V22, P5, DOI 10.1080/14767050902860690; Jackman RP, 2011, CLIN VACCINE IMMUNOL, V18, P318, DOI 10.1128/CVI.00465-10; Jing JY, 2009, INTENS CARE MED, V35, P587, DOI 10.1007/s00134-008-1333-z; Klesney-Tait J, 2006, NAT IMMUNOL, V7, P1266, DOI 10.1038/ni1411; Knudsen LS, 2008, BIOMARKERS, V13, P59, DOI 10.1080/13547500701615017; Kramer MS, 2010, CYTOKINE, V49, P10, DOI 10.1016/j.cyto.2009.08.014; Kusanovic JP, 2010, J MATERN-FETAL NEO M, V23, P34, DOI 10.3109/14767050903009248; Lee SM, 2011, PLACENTA, V32, P516, DOI 10.1016/j.placenta.2011.03.012; Menon R, 2008, REPROD SCI, V15, P825, DOI 10.1177/1933719108320090; Norman Jane E, 2007, BMC Pregnancy Childbirth, V7 Suppl 1, pS7, DOI 10.1186/1471-2393-7-S1-S7; Park JJ, 2009, DIGEST DIS SCI, V54, P1525, DOI 10.1007/s10620-008-0514-5; Romero R, 2007, NUTR REV, V65, pS194, DOI 10.1301/nr.2007.dec.S194-S202; Romero R, 2007, SEMIN REPROD MED, V25, P21, DOI 10.1055/s-2006-956773; Seong HS, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.06.040; Sharif O, 2008, IMMUNOBIOLOGY, V213, P701, DOI 10.1016/j.imbio.2008.07.008; Tency I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049042; Tsiartas P, 2012, BJOG-INT J OBSTET GY, V119, P866, DOI 10.1111/j.1471-0528.2012.03328.x; Tworoger SS, 2006, CANCER EPIDEM BIOMAR, V15, P1578, DOI 10.1158/1055-9965.EPI-06-0629; Vogel I, 2007, J REPROD IMMUNOL, V75, P133, DOI 10.1016/j.jri.2007.02.008; Youssef RE, 2009, REPROD SCI, V16, P843, DOI 10.1177/1933719109336621; Yuan M, 2009, MOL HUM REPROD, V15, P713, DOI 10.1093/molehr/gap054	36	0	1	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e56050	10.1371/journal.pone.0056050	http://dx.doi.org/10.1371/journal.pone.0056050			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23468854	Green Submitted, Green Published, gold			2022-12-25	WOS:000315524900017
J	Wang, XF; Zhang, SZ; Su, L; Liu, X; Hao, YJ				Wang, Xiaofei; Zhang, Shizhong; Su, Ling; Liu, Xin; Hao, Yujin			A Genome-Wide Analysis of the LBD (LATERAL ORGAN BOUNDARIES Domain) Gene Family in Malus domestica with a Functional Characterization of MdLBD11	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; AUXIN-RESPONSE-FACTOR; ROOT-FORMATION; TRANSCRIPTION FACTORS; ARABIDOPSIS-THALIANA; ASYMMETRIC LEAVES1; REPRESS BREVIPEDICELLUS; AS2/LOB FAMILY; EXPRESSION; MEMBERS	The plant-specific LBD (LATERAL ORGAN BOUNDARIES domain) genes belong to a major family of transcription factor that encode a zinc finger-like domain. It has been shown that LBD genes play crucial roles in the growth and development of Arabidopsis and other plant species. However, no detailed information concerning this family is available for apple. In the present study, we analyzed the apple (Malus domestica) genome and identified 58 LBD genes. This gene family was tested for its phylogenetic relationships with homologous genes in the Arabidopsis genome, as well as its location in the genome, structure and expression. We also transformed one MdLBD gene into Arabidopsis to evaluate its function. Like Arabidopsis, apple LBD genes also have a conserved CX2CX6CX3C zinc finger-like domain in the N terminus and can be divided into two classes. The expression profile indicated that apple LBD genes exhibited a variety of expression patterns, suggesting that they have diverse functions. At the same time, the expression analysis implied that members of this apple gene family were responsive to hormones and stress and that they may participate in hormone-mediated plant organogenesis, which was demonstrated with the overexpression of the apple LBD gene MdLBD11, resulting in an abnormal phenotype. This phenotype included upward curling leaves, delayed flowering, downward-pointing flowers, siliques and other abnormal traits. Based on these data, we concluded that the MdLBD genes may play an important role in apple growth and development as in Arabidopsis and other species.	[Wang, Xiaofei; Zhang, Shizhong; Su, Ling; Liu, Xin; Hao, Yujin] Shandong Agr Univ, Natl Key Lab Crop Biol, Tai An, Shandong, Peoples R China; [Wang, Xiaofei; Zhang, Shizhong; Su, Ling; Liu, Xin; Hao, Yujin] Shandong Agr Univ, Natl Res Ctr Apple Engn & Technol, Tai An, Shandong, Peoples R China; [Wang, Xiaofei; Zhang, Shizhong; Su, Ling; Liu, Xin; Hao, Yujin] Shandong Agr Univ, Coll Hort Sci & Engn, Tai An, Shandong, Peoples R China	Shandong Agricultural University; Shandong Agricultural University; Shandong Agricultural University	Hao, YJ (corresponding author), Shandong Agr Univ, Natl Key Lab Crop Biol, Tai An, Shandong, Peoples R China.	haoyujin@sdau.edu.cn			National Public Benefit (Agricultural) Research Foundation of China [201203075-3]; Natural Science Foundation of China [30971969]; 948 project from Ministry of Agriculture of China [2011-G21]; Program for Changjiang Scholars and Innovative Research Team in University [IRT1155]	National Public Benefit (Agricultural) Research Foundation of China; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 948 project from Ministry of Agriculture of China; Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This work was supported by the National Public Benefit (Agricultural) Research Foundation of China (201203075-3), Natural Science Foundation of China (30971969), 948 project from Ministry of Agriculture of China (2011-G21) and Program for Changjiang Scholars and Innovative Research Team in University (IRT1155). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artimo P, 2012, NUCLEIC ACIDS RES, V40, pW597, DOI 10.1093/nar/gks400; Bai TH, 2012, MOL GENET GENOMICS, V287, P437, DOI 10.1007/s00438-012-0689-5; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Belles-Boix E, 2006, PLANT CELL, V18, P1900, DOI 10.1105/tpc.106.041988; Xu B, 2008, PLANT PHYSIOL, V146, P566, DOI 10.1104/pp.107.113787; Bortiri E, 2006, PLANT CELL, V18, P574, DOI 10.1105/tpc.105.039032; Bureau M, 2008, PLANT SIGNAL BEHAV, V3, P145, DOI 10.4161/psb.3.2.5080; Byrne ME, 2002, DEVELOPMENT, V129, P1957; Cannon Steven B., 2004, BMC Plant Biology, V4, P10, DOI 10.1186/1471-2229-4-10; Chalfun A, 2005, PLANT MOL BIOL, V57, P559, DOI 10.1007/s11103-005-0698-4; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Gomez MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018760; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fan MZ, 2012, CELL RES, V22, P1169, DOI 10.1038/cr.2012.63; Feng ZH, 2012, PLANTA, V236, P1227, DOI 10.1007/s00425-012-1673-3; Goh T, 2012, DEVELOPMENT, V139, P883, DOI 10.1242/dev.071928; Grennan AK, 2006, PLANT PHYSIOL, V141, P1164, DOI 10.1104/pp.104.900198; Guo An-Yuan, 2007, Yichuan, V29, P1023, DOI 10.1360/yc-007-1023; Guo MJ, 2008, PLANT CELL, V20, P48, DOI 10.1105/tpc.107.056127; Hay A, 2006, DEVELOPMENT, V133, P3955, DOI 10.1242/dev.02545; Husbands A, 2007, NUCLEIC ACIDS RES, V35, P6663, DOI 10.1093/nar/gkm775; Inukai Y, 2005, PLANT CELL, V17, P1387, DOI 10.1105/tpc.105.030981; Iwakawa H, 2007, PLANT J, V51, P173, DOI 10.1111/j.1365-313X.2007.03132.x; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; Jung S, 2008, NUCLEIC ACIDS RES, V36, pD1034, DOI 10.1093/nar/gkm803; Kessler S, 2004, CURR OPIN PLANT BIOL, V7, P65, DOI 10.1016/j.pbi.2003.11.002; Lee DK, 2009, DEVELOPMENT, V136, P2423, DOI 10.1242/dev.031971; Lee HW, 2013, PLANT J, V73, P212, DOI 10.1111/tpj.12013; Lee HW, 2009, PLANT PHYSIOL, V151, P1377, DOI 10.1104/pp.109.143685; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr201, 10.1093/nar/gkr931]; Li H, 2005, PLANT CELL, V17, P2157, DOI 10.1105/tpc.105.033449; Liu HJ, 2005, PLANT J, V43, P47, DOI 10.1111/j.1365-313X.2005.02434.x; Liu Ren-Hu, 2003, Yichuan, V25, P317; Majer C, 2011, TRENDS PLANT SCI, V16, P47, DOI 10.1016/j.tplants.2010.09.009; Mangeon A, 2011, J EXP BOT, V62, P221, DOI 10.1093/jxb/erq259; Matsumura Y, 2009, PLANT J, V58, P525, DOI 10.1111/j.1365-313X.2009.03797.x; Mount David W, 2007, CSH Protoc, V2007, DOI 10.1101/pdb.top17; Naito T, 2007, BIOSCI BIOTECH BIOCH, V71, P1269, DOI 10.1271/bbb.60681; Nakazawa M, 2003, PLANT J, V34, P741, DOI 10.1046/j.1365-313X.2003.01758.x; Okushima Y, 2005, PLANT CELL, V17, P444, DOI 10.1105/tpc.104.028316; Okushima Y, 2007, PLANT CELL, V19, P118, DOI 10.1105/tpc.106.047761; Phelps-Durr TL, 2005, PLANT CELL, V17, P2886, DOI 10.1105/tpc.105.035477; Qi YP, 2004, PLANTA, V219, P270, DOI 10.1007/s00425-004-1248-z; Rast MI, 2012, PLANT CELL, V24, P2917, DOI 10.1105/tpc.112.099978; Rubin G, 2009, PLANT CELL, V21, P3567, DOI 10.1105/tpc.109.067041; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Semiarti E, 2001, DEVELOPMENT, V128, P1771; Shuai B, 2002, PLANT PHYSIOL, V129, P747, DOI 10.1104/pp.010926; Soyano T, 2008, PLANT CELL, V20, P3359, DOI 10.1105/tpc.108.061796; Sun SB, 2012, MOL BIOL REP, V39, P4927, DOI 10.1007/s11033-011-1288-y; Sun SB, 2010, MOL BIOL REP, V37, P3973, DOI 10.1007/s11033-010-0056-8; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thatcher LF, 2012, PLANT PHYSIOL, V160, P407, DOI 10.1104/pp.112.199067; Theodoris G, 2003, P NATL ACAD SCI USA, V100, P6837, DOI 10.1073/pnas.1132113100; Velasco R, 2010, NAT GENET, V42, P833, DOI 10.1038/ng.654; Vollbrecht E, 2005, NATURE, V436, P1119, DOI 10.1038/nature03892; Wu Xiaoming, 2002, Sheng Wu Yi Xue Gong Cheng Xue Za Zhi, V19, P455; Xu L, 2003, DEVELOPMENT, V130, P4097, DOI 10.1242/dev.00622; Yang Y, 2006, MOL PHYLOGENET EVOL, V39, P248, DOI 10.1016/j.ympev.2005.09.016; Yao YX, 2007, PLANT PHYSIOL BIOCH, V45, P139, DOI 10.1016/j.plaphy.2007.01.010; Yordanov YS, 2010, PLANT CELL, V22, P3662, DOI 10.1105/tpc.110.078634; Zentella R, 2007, PLANT CELL, V19, P3037, DOI 10.1105/tpc.107.054999; Zhu QH, 2007, BIOINFORMATICS, V23, P1307, DOI 10.1093/bioinformatics/btm113	63	39	48	2	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57044	10.1371/journal.pone.0057044	http://dx.doi.org/10.1371/journal.pone.0057044			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23468909	gold, Green Published, Green Submitted			2022-12-25	WOS:000315524900050
J	Gaither, MR; Aeby, G; Vignon, M; Meguro, Y; Rigby, M; Runyon, C; Toonen, RJ; Wood, CL; Bowen, BW				Gaither, Michelle R.; Aeby, Greta; Vignon, Matthias; Meguro, Yu-ichiro; Rigby, Mark; Runyon, Christina; Toonen, Robert J.; Wood, Chelsea L.; Bowen, Brian W.			An Invasive Fish and the Time-Lagged Spread of Its Parasite across the Hawaiian Archipelago	PLOS ONE			English	Article							HAPLOTYPE RECONSTRUCTION; BIOLOGICAL INVASIONS; GENETIC DIVERSITY; ECONOMIC COSTS; GENOMIC DNA; CONSEQUENCES; HOST; MANAGEMENT; SERRANIDAE; PATHOGENS	Efforts to limit the impact of invasive species are frustrated by the cryptogenic status of a large proportion of those species. Half a century ago, the state of Hawai'i introduced the Bluestripe Snapper, Lutjanus kasmira, to O'ahu for fisheries enhancement. Today, this species shares an intestinal nematode parasite, Spirocamallanus istiblenni, with native Hawaiian fishes, raising the possibility that the introduced fish carried a parasite that has since spread to naive local hosts. Here, we employ a multidisciplinary approach, combining molecular, historical, and ecological data to confirm the alien status of S. istiblenni in Hawai'i. Using molecular sequence data we show that S. istiblenni from Hawai'i are genetically affiliated with source populations in French Polynesia, and not parasites at a geographically intermediate location in the Line Islands. S. istiblenni from Hawai'i are a genetic subset of the more diverse source populations, indicating a bottleneck at introduction. Ecological surveys indicate that the parasite has found suitable intermediate hosts in Hawai'i, which are required for the completion of its life cycle, and that the parasite is twice as prevalent in Hawaiian Bluestripe Snappers as in source populations. While the introduced snapper has spread across the entire 2600 km archipelago to Kure Atoll, the introduced parasite has spread only half that distance. However, the parasite faces no apparent impediments to invading the entire archipelago, with unknown implications for naive indigenous Hawaiian fishes and the protected Papahanaumokuakea Marine National Monument.	[Gaither, Michelle R.] Calif Acad Sci, San Francisco, CA 94118 USA; [Gaither, Michelle R.; Aeby, Greta; Runyon, Christina; Toonen, Robert J.; Bowen, Brian W.] Univ Hawaii Manoa, Hawaii Inst Marine Biol, Kaneohe, HI USA; [Vignon, Matthias] Univ Pau & Pays Adour, UMR Ecobiop 1224, UFR Sci & Tech Cote Basque, Anglet, France; [Vignon, Matthias] INRA, UMR Ecobiop 1224, St Pee Sur Nivelle, France; [Meguro, Yu-ichiro] Hokkaido Univ, Div Marine Biosci, Grad Sch Fisheries Sci, Hakodate, Hokkaido, Japan; [Rigby, Mark] Parsons, South Jordan, UT USA; [Rigby, Mark] Univ Calif Santa Barbara, Inst Marine Sci, Santa Barbara, CA 93106 USA; [Wood, Chelsea L.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Wood, Chelsea L.] Stanford Univ, Hopkins Marine Stn, Pacific Grove, CA 93950 USA	California Academy of Sciences; University of Hawaii System; University of Hawaii Manoa; Universite de Pau et des Pays de l'Adour; INRAE; Universite de Pau et des Pays de l'Adour; Hokkaido University; University of California System; University of California Santa Barbara; Stanford University; Stanford University	Gaither, MR (corresponding author), Calif Acad Sci, San Francisco, CA 94118 USA.	michellergaither@gmail.com	Vignon, Matthias/N-1122-2019; Toonen, Rob/V-6230-2019; Gaither, Michelle/J-3137-2015	Vignon, Matthias/0000-0001-9222-8966; Toonen, Rob/0000-0001-6339-4340; Gaither, Michelle/0000-0002-0371-5621; Meguro, Yu-ichiro/0000-0002-2811-9789	University of Hawai'i Sea Grant Program [UNIHI-SEAGRANT-JC-09-52]; Hawai'i Sea Grant [NA05OAR4171048]; National Science Foundation [OIA0554657, OCE-0453167, OCE-0929031]; NOAA National Centers for Coastal Ocean Science Coral Reef Ecosystem Studies Grant [NA07NOS4780188]; NOAA Coral Reef Conservation Program; Hawai'i Undersea Research Laboratory [NA05OAR4301108]; NOAA National Marine Sanctuaries Program MOA [2005-008/66882]	University of Hawai'i Sea Grant Program; Hawai'i Sea Grant; National Science Foundation(National Science Foundation (NSF)); NOAA National Centers for Coastal Ocean Science Coral Reef Ecosystem Studies Grant; NOAA Coral Reef Conservation Program(National Oceanic Atmospheric Admin (NOAA) - USA); Hawai'i Undersea Research Laboratory; NOAA National Marine Sanctuaries Program MOA	We thank Papahanaumokea kea Marine National Monument co-trustees NOAA Office of National Marine Sanctuaries, U. S. Fish and Wildlife Service (USFWS), and the State of Hawai'i. Randall Kosaki, Greg Concepcion, Matt Craig, Jonathan Dale, Toby Daly-Engel, Jeff Eble, Matt Iacchei, Stephen Karl, Carl Meyer, Mike Neumann, Yannis Papastamatiou, Luiz Rocha, Zoli Szabo, Daniel Wagner, Jill Zamzow, Joshua Reece, and the crew of the R. V. Hi'ialakai helped collect specimens. 'Aulani Wilhelm, Jo-Ann Leong, Hoku Johnson, Danielle Carter, Daniel Polhemus, Randall Kosaki, Ann Mooney, Elizabeth Keenen, and Kelly Gleason provided crucial logistic assistance to this project. We thank Mac Aveina for processing the fish from American Samoa and Shelley Jones and all the members of the ToBo lab and staff at HIMB for their assistance, support and feedback throughout this project. This is contribution #1538 from the Hawai'i Institute of Marine Biology, #8850 from the School of Ocean and Earth Science and Technology and UNIHI-SEAGRANT-JC-09-52 from the University of Hawai'i Sea Grant Program.; This study was supported by the Hawai'i Sea Grant No. NA05OAR4171048 (BWB), National Science Foundation (grants No. OIA0554657, OCE-0453167, OCE-0929031 to BWB), NOAA National Centers for Coastal Ocean Science Coral Reef Ecosystem Studies Grant NA07NOS4780188, NOAA Coral Reef Conservation Program and Hawai'i Undersea Research Laboratory Grant NA05OAR4301108, NOAA National Marine Sanctuaries Program MOA No. 2005-008/66882 (RJT). The views expressed herein are those of the authors and do not necessarily reflect the views of NSF, NOAA USFWS, the State of Hawai'i, or any of their sub-agencies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson R. C., 2000, Nematode parasites of vertebrates: their development and transmission., DOI 10.1079/9780851994215.0000; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bondad-Reantaso MG, 2005, VET PARASITOL, V132, P249, DOI 10.1016/j.vetpar.2005.07.005; Bush AO, 2000, J PARASITOL, V86, P212, DOI 10.2307/3284757; Carlton JT, 1996, ECOLOGY, V77, P1653, DOI 10.2307/2265767; Concepcion GT, 2010, MAR ECOL PROG SER, V401, P113, DOI 10.3354/meps08364; Cowie RH, 1998, BIODIVERS CONSERV, V7, P349, DOI 10.1023/A:1008881712635; Cox G. W., 1999, ALIEN SPECIES N AM H; Cribb TH, 2000, INT J PARASITOL, V30, P1445, DOI 10.1016/S0020-7519(00)00121-1; Dobson A, 2001, PHILOS T R SOC B, V356, P1001, DOI 10.1098/rstb.2001.0900; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Font William F., 2000, Bishop Museum Occasional Papers, V64, P53; Gaither MR, 2012, P ROY SOC B-BIOL SCI, V279, P3948, DOI 10.1098/rspb.2012.1481; Gaither MR, 2010, MOL ECOL, V19, P1107, DOI 10.1111/j.1365-294X.2010.04535.x; Godwin S, 2006, REDUCING POTENTIAL I; Grosholz E, 2002, TRENDS ECOL EVOL, V17, P22, DOI 10.1016/S0169-5347(01)02358-8; GUEGAN JF, 1993, PARASITOLOGY, V106, P91, DOI 10.1017/S0031182000074862; HOLMES JC, 1961, J PARASITOL, V47, P209, DOI 10.2307/3275291; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jarman SN, 2002, MAR BIOTECHNOL, V4, P347, DOI 10.1007/s10126-002-0029-6; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Meeker ND, 2007, BIOTECHNIQUES, V43, P610, DOI 10.2144/000112619; Meguid MA, 1996, J PARASITOL, V82, P118, DOI 10.2307/3284126; Menezes RC, 2006, MEM I OSWALDO CRUZ, V101, P683, DOI 10.1590/S0074-02762006000600018; Miura O, 2006, P NATL ACAD SCI USA, V103, P19818, DOI 10.1073/pnas.0609603103; Nadler SA, 2007, PARASITOLOGY, V134, P1421, DOI 10.1017/S0031182007002880; Nei M, 1987, MOL EVOLUTIONARY GEN; Perrings C, 2005, TRENDS ECOL EVOL, V20, P212, DOI 10.1016/j.tree.2005.02.011; Phillips BL, 2010, ECOLOGY, V91, P872, DOI 10.1890/09-0530.1; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; Pimentel D, 2000, BIOSCIENCE, V50, P53, DOI 10.1641/0006-3568(2000)050[0053:EAECON]2.3.CO;2; Prenter J, 2004, TRENDS ECOL EVOL, V19, P385, DOI 10.1016/j.tree.2004.05.002; RANDALL JE, 1987, B MAR SCI, V41, P490; Randall JE, 1998, ZOOL STUD, V37, P227; RANDALL JE, 1982, SEA FRONTIERS, V18, P144; READ CP, 1951, J PARASITOL, V37, P174, DOI 10.2307/3273449; Rigby MC, 2001, J PARASITOL, V87, P1210, DOI 10.1645/0022-3395(2001)087[1210:SROTDB]2.0.CO;2; Rigby MC, 1996, J PARASITOL, V82, P405, DOI 10.2307/3284076; Rigby MC, 1997, J HELMINTHOL SOC W, V64, P227; Rigby MC, 2013, HDB ZOOLOGY NATURAL; Roman J, 2007, TRENDS ECOL EVOL, V22, P454, DOI 10.1016/j.tree.2007.07.002; Schlaepfer MA, 2005, ECOL LETT, V8, P241, DOI 10.1111/j.1461-0248.2005.00730.x; Schumacher BD, 2005, BIOL INVASIONS, V7, P925, DOI 10.1007/s10530-004-2983-6; SEUTIN G, 1991, CAN J ZOOL, V69, P82, DOI 10.1139/z91-013; Simberloff D, 2005, J AGR ENVIRON ETHIC, V18, P595, DOI 10.1007/s10806-005-2851-0; Skillings Derek J., 2011, Journal of Marine Biology, V2011, P1, DOI 10.1155/2011/783030; Sokal R.R., 1995, BIOMETRY PRINCIPLES, Vthird; Stefani F, 2012, BIOL INVASIONS, V14, P1725, DOI 10.1007/s10530-012-0183-3; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tatem AJ, 2006, P NATL ACAD SCI USA, V103, P6242, DOI 10.1073/pnas.0508391103; Torchin ME, 2003, NATURE, V421, P628, DOI 10.1038/nature01346; Truett GE, 2000, BIOTECHNIQUES, V29, P52, DOI 10.2144/00291bm09; Vignon M, 2010, ENVIRON BIOL FISH, V87, P1, DOI 10.1007/s10641-009-9553-9; Vignon M, 2009, DIS AQUAT ORGAN, V85, P133, DOI 10.3354/dao02071; Vignon M, 2009, PARASITOL RES, V104, P775, DOI 10.1007/s00436-008-1254-3; Williamson M, 1996, ECOLOGY, V77, P1661, DOI 10.2307/2265769; Wu SG, 2009, VET PARASITOL, V164, P248, DOI 10.1016/j.vetpar.2009.04.030	60	27	30	0	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e56940	10.1371/journal.pone.0056940	http://dx.doi.org/10.1371/journal.pone.0056940			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23468894	Green Published, gold			2022-12-25	WOS:000315519000049
J	Geerling, JJ; Wang, YA; Havekes, LM; Romijn, JA; Rensen, PCN				Geerling, Janine J.; Wang, Yanan; Havekes, Louis M.; Romijn, Johannes A.; Rensen, Patrick C. N.			Acute Central Neuropeptide Y Administration Increases Food Intake but Does Not Affect Hepatic Very Low-Density Lipoprotein (Vldl) Production in Mice	PLOS ONE			English	Article							NERVOUS-SYSTEM; TRIGLYCERIDE SECRETION; PREPRONEUROPEPTIDE-Y; HYPOTHALAMIC CONTROL; SERUM TRIGLYCERIDE; ENERGY-METABOLISM; RECEPTOR GENE; POLYMORPHISM; EXPRESSION; ASSOCIATION	Objective: Central neuropeptide Y (NPY) administration stimulates food intake in rodents. In addition, acute modulation of central NPY signaling increases hepatic production of very low-density lipoprotein (VLDL)-triglyceride (TG) in rats. As hypertriglyceridemia is an important risk factor for atherosclerosis, for which well-established mouse models are available, we set out to validate the effect of NPY on hepatic VLDL-TG production in mice, to ultimately investigate whether NPY, by increasing VLDL production, contributes to the development of atherosclerosis. Research Design and Methods: Male C57Bl/6J mice received an intracerebroventricular (i.c.v.) cannula into the lateral (LV) or third (3V) ventricle of the brain. One week later, after a 4 h fast, the animals received an intravenous (i.v.) injection of Tran(35)S (100 mu Ci) followed by tyloxapol (500 mg/kg body weight; BW), enabling the study of hepatic VLDL-apoB and VLDL-TG production, respectively. Immediately after the i. v. injection of tyloxapol, the animals received either an i. c. v. injection of NPY (0.2 mg/kg BW in artificial cerebrospinal fluid; aCSF), synthetic Y-1 receptor antagonist GR231118 (0.5 mg/kg BW in aCSF) or vehicle (aCSF), or an i. v. injection of PYY3-36 (0.5 mg/kg BW in PBS) or vehicle (PBS). Results: Administration of NPY into both the LV and 3V increased food intake within one hour after injection (+164%, p<0.001 and +367%, p<0.001, respectively). NPY administration neither in the LV nor in the 3V affected hepatic VLDL-TG or VLDL-apoB production. Likewise, antagonizing central NPY signaling by either PYY3-36 or GR231118 administration did not affect hepatic VLDL production. Conclusion: In mice, as opposed to rats, acute central administration of NPY increases food intake without affecting hepatic VLDL production. These results are of great significance when extrapolating findings on the central regulation of hepatic VLDL production between species.	[Geerling, Janine J.; Wang, Yanan; Havekes, Louis M.; Rensen, Patrick C. N.] Leiden Univ, Dept Gen Internal Med Endocrinol & Metab Dis, Med Ctr, Leiden, Netherlands; [Havekes, Louis M.] Leiden Univ, Dept Cardiol, Med Ctr, Leiden, Netherlands; [Havekes, Louis M.] Netherlands Org Appl Sci Res Metab Hlth Res, Gaubius Lab, Leiden, Netherlands; [Romijn, Johannes A.] Univ Amsterdam, Acad Med Ctr, Dept Med, NL-1105 AZ Amsterdam, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Netherlands Organization Applied Science Research; University of Amsterdam; Academic Medical Center Amsterdam	Rensen, PCN (corresponding author), Leiden Univ, Dept Gen Internal Med Endocrinol & Metab Dis, Med Ctr, Leiden, Netherlands.	P.C.N.Rensen@lumc.nl	Rensen, Patrick C.N./D-7176-2018; Wang, Yanan/C-4143-2019	Rensen, Patrick C.N./0000-0002-8455-4988; Wang, Yanan/0000-0002-0327-0458	Netherlands Diabetes Foundation [DFN2007.00.010]; Netherlands Heart Foundation [2007B081]	Netherlands Diabetes Foundation; Netherlands Heart Foundation(Netherlands Heart Foundation)	This work was supported by research grants from the Netherlands Diabetes Foundation (DFN2007.00.010 to P.C.N.R.; http://www.diabetesfonds.nl) and the Netherlands Heart Foundation (2007B081 to P.C.N.R.). P.C.N. Rensen is an Established Investigator of the Netherlands Heart Foundation (2009T038 to P.C.N.R.; http://www.hartstichting.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AALTOSETALA K, 1992, J CLIN INVEST, V90, P1889, DOI 10.1172/JCI116066; Beck B, 2006, PHILOS T R SOC B, V361, P1159, DOI 10.1098/rstb.2006.1855; Blumenthal JB, 2002, CLIN GENET, V62, P196, DOI 10.1034/j.1399-0004.2002.620302.x; Broberger C, 1998, P NATL ACAD SCI USA, V95, P15043, DOI 10.1073/pnas.95.25.15043; Bruinstroop E, 2012, DIABETES, V61, P1043, DOI 10.2337/db11-1142; Burkhoff AM, 1998, MOL BRAIN RES, V53, P311, DOI 10.1016/S0169-328X(97)00302-1; Chambers Adam P, 2012, Handb Exp Pharmacol, P23, DOI 10.1007/978-3-642-24716-3_2; Christie MJ, 2000, CLIN EXP PHARMACOL P, V27, P520, DOI 10.1046/j.1440-1681.2000.03291.x; CHUA SC, 1991, MOL BRAIN RES, V9, P95, DOI 10.1016/0169-328X(91)90134-J; Dumont Y, 2006, EXP SUPPL, V95, P7; Dumont Y, 1998, J COMP NEUROL, V402, P372; Erkkila AT, 2002, MOL GENET METAB, V75, P260, DOI 10.1006/mgme.2002.3302; Garfield AS, 2009, TRENDS ENDOCRIN MET, V20, P203, DOI 10.1016/j.tem.2009.02.002; Horvath TL, 1997, BRAIN RES, V756, P283, DOI 10.1016/S0006-8993(97)00184-4; Huang PL, 2009, DIS MODEL MECH, V2, P231, DOI 10.1242/dmm.001180; Iyengar S, 1999, J PHARMACOL EXP THER, V289, P1031; Kalsbeek A, 2010, ANN NY ACAD SCI, V1212, P114, DOI 10.1111/j.1749-6632.2010.05800.x; Karvonen MK, 2000, J CLIN ENDOCR METAB, V85, P1455, DOI 10.1210/jc.85.4.1455; Koenner AC, 2009, PHYSIOL BEHAV, V97, P632, DOI 10.1016/j.physbeh.2009.03.027; Leibowitz SF, 2004, PEPTIDES, V25, P473, DOI 10.1016/j.peptides.2004.02.006; LEVINE AS, 1984, PEPTIDES, V5, P1025, DOI 10.1016/0196-9781(84)90165-7; Li XH, 1996, J LIPID RES, V37, P210; Lin S, 2004, NEUROPEPTIDES, V38, P189, DOI 10.1016/j.npep.2004.05.005; MORLEY JE, 1987, AM J PHYSIOL, V253, pR516, DOI 10.1152/ajpregu.1987.253.3.R516; Mullins DE, 2000, EUR J PHARMACOL, V395, P87, DOI 10.1016/S0014-2999(00)00255-7; Nguyen AD, 2011, CURR OPIN ENDOCRINOL, V18, P56, DOI 10.1097/MED.0b013e3283422f0a; Niswender K, 2010, DIABETES OBES METAB, V12, P267, DOI 10.1111/j.1463-1326.2009.01175.x; Pu SY, 1999, ENDOCRINOLOGY, V140, P933, DOI 10.1210/en.140.2.933; REDGRAVE TG, 1975, ANAL BIOCHEM, V65, P42, DOI 10.1016/0003-2697(75)90488-1; Simpson KA, 2009, ARQ BRAS ENDOCRINOL, V53, P120, DOI 10.1590/S0004-27302009000200002; Stafford JM, 2008, DIABETES, V57, P1482, DOI 10.2337/db07-1702; Takiguchi E, 2010, METABOLISM, V59, P1591, DOI 10.1016/j.metabol.2010.02.014; Talayero Beatriz G, 2011, Curr Cardiol Rep, V13, P544, DOI 10.1007/s11886-011-0220-3; van den Hoek AM, 2004, DIABETES, V53, P2529, DOI 10.2337/diabetes.53.10.2529; van den Hoek AM, 2008, DIABETES, V57, P2304, DOI 10.2337/db07-1658; Wallerstedt SM, 2004, J HYPERTENS, V22, P1277, DOI 10.1097/01.hjh.0000125415.50839.7b; Weinberg DH, 1996, J BIOL CHEM, V271, P16435, DOI 10.1074/jbc.271.28.16435	37	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e55217	10.1371/journal.pone.0055217	http://dx.doi.org/10.1371/journal.pone.0055217			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460782	Green Published, Green Submitted, gold			2022-12-25	WOS:000315519000005
J	Juraschek, SP; Kovell, LC; Miller, ER; Gelber, AC				Juraschek, Stephen P.; Kovell, Lara C.; Miller, Edgar R.; Gelber, Allan C.			Dose-Response Association of Uncontrolled Blood Pressure and Cardiovascular Disease Risk Factors with Hyperuricemia and Gout	PLOS ONE			English	Article							SERUM URIC-ACID; ATHEROSCLEROSIS RISK; INCIDENT HYPERTENSION; METABOLIC SYNDROME; NATIONAL-HEALTH; POPULATION; PREVALENCE; EPIDEMIOLOGY; PATHOGENESIS; CRITERIA	Background: First-line therapy of hypertension includes diuretics, known to exert a multiplicative increase on the risk of gout. Detailed insight into the underlying prevalence of hyperuricemia and gout in persons with uncontrolled blood pressure (BP) and common comorbidities is informative to practitioners initiating antihypertensive agents. We quantify the prevalence of hyperuricemia and gout in persons with uncontrolled BP and additional cardiovascular disease (CVD) risk factors. Methods and Findings: We performed a cross-sectional study of non-institutionalized US adults, 18 years and older, using the National Health and Nutrition Examination Surveys in 1988-1994 and 1999-2010. Hyperuricemia was defined as serum uric acid >6.0 mg/dL in women; >7.0 mg/dL in men. Gout was ascertained by self-report of physician-diagnosed gout. Uncontrolled BP was based on measured systolic BP >= 140 mmHg and diastolic BP >= 90 mmHg. Additional CVD risk factors included obesity, reduced glomerular filtration rate, and dyslipidemia. The prevalence of hyperuricemia was 6-8% among healthy US adults, 10-15% among adults with uncontrolled BP, 22-25% with uncontrolled BP and one additional CVD risk factor, and 34-37% with uncontrolled BP and two additional CVD risk factors. Similarly, the prevalence of gout was successively greater, at 1-2%, 4-5%, 6-8%, and 8-12%, respectively, across these same health status categories. In 2007-2010, those with uncontrolled BP and 2 additional CVD risk factors compared to those without CVD risk factors had prevalence ratios of 4.5 (95% CI 3.5-5.6) and 4.5 (95% CI: 3.1-6.3) for hyperuricemia and gout respectively (P < 0.01). Conclusions: Health care providers should be cognizant of the incrementally higher prevalence of hyperuricemia and gout among patients with uncontrolled BP and additional CVD risk factors. With one in three people affected by hyperuricemia among those with several CVD risk factors, physicians should consider their anti-hypertensive regimens carefully and potentially screen for hyperuricemia or gout.	[Juraschek, Stephen P.; Miller, Edgar R.; Gelber, Allan C.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA; [Juraschek, Stephen P.; Miller, Edgar R.; Gelber, Allan C.] Welch Ctr Prevent Epidemiol & Clin Res, Baltimore, MD USA; [Kovell, Lara C.; Miller, Edgar R.; Gelber, Allan C.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University	Gelber, AC (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA.	agelber@jhmi.edu		Kovell, Lara C/0000-0002-7919-2361; Juraschek, Stephen/0000-0003-4168-2696	National Institutes of Health/NIH Heart, Lung and Blood Institute [T32HL007024]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007024] Funding Source: NIH RePORTER	National Institutes of Health/NIH Heart, Lung and Blood Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	SPJ is supported by a National Institutes of Health/NIH Heart, Lung and Blood Institute T32HL007024 cardiovascular Epidemiology Training Grant. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; Anderson G, 2004, PUBLIC HEALTH REP, V119, P263, DOI 10.1016/j.phr.2004.04.005; Boner G, 1974, Adv Exp Med Biol, V41, P781; Campion E W, 1987, Am J Med, V82, P421, DOI 10.1016/0002-9343(87)90441-4; CDC, 2008, NAT AMB MED CAR SURV; Centers for Disease Control, 1999, NHANES 1999 2010 MAN; Centers for Disease Control, 1988, NHANES 3 REP REF MAN; Choi HK, 2005, ANN INTERN MED, V143, P499, DOI 10.7326/0003-4819-143-7-200510040-00009; Choi HK, 2007, ARTHRIT RHEUM-ARTHR, V57, P109, DOI 10.1002/art.22466; Cowie CC, 2010, DIABETES CARE, V33, P562, DOI 10.2337/dc09-1524; de Boer IH, 2011, JAMA-J AM MED ASSOC, V305, P2532, DOI 10.1001/jama.2011.861; DeMarco MAM, 2012, ARTHRITIS RHEUM-US, V64, P121, DOI 10.1002/art.33315; Egan BM, 2010, JAMA-J AM MED ASSOC, V303, P2043, DOI 10.1001/jama.2010.650; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Feig DI, 2008, NEW ENGL J MED, V359, P1811, DOI 10.1056/NEJMra0800885; Forman JP, 2007, J AM SOC NEPHROL, V18, P287, DOI 10.1681/ASN.2006080865; GREENE HL, 1978, J CLIN INVEST, V62, P321, DOI 10.1172/JCI109132; HERMAN JB, 1982, LANCET, V2, P240; HOCHBERG MC, 1995, ARTHRITIS RHEUM-US, V38, P628, DOI 10.1002/art.1780380508; Kim KY, 2003, CLIN THER, V25, P1593, DOI 10.1016/S0149-2918(03)80158-3; KLAG MJ, 1990, HYPERTENSION, V16, P700, DOI 10.1161/01.HYP.16.6.700; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Mazzali M, 2001, HYPERTENSION, V38, P1101, DOI 10.1161/hy1101.092839; McAdams MA, 2011, J RHEUMATOL, V38, P135, DOI 10.3899/jrheum.100418; McAdams-DeMarco MA, 2012, J CLIN HYPERTENS, V14, P675, DOI 10.1111/j.1751-7176.2012.00674.x; Mellen PB, 2006, HYPERTENSION, V48, P1037, DOI 10.1161/01.HYP.0000249768.26560.66; National Heart Lung and Blood Institute, 2002, 3 NAT HEART LUNG BLO; National Heart Lung and Blood Institute, 2004, 7 NAT HEART LUNG BLO; Neogi T, 2011, NEW ENGL J MED, V364, P443, DOI 10.1056/NEJMcp1001124; Perlstein TS, 2006, HYPERTENSION, V48, P1031, DOI 10.1161/01.HYP.0000248752.08807.4c; Pi-Sunyer FX, 1998, AM J CLIN NUTR, V68, P899; Puig JG, 2008, NUCLEOS NUCLEOT NUCL, V27, P620, DOI 10.1080/15257770802138582; REAVEN GM, 1988, DIABETES, V37, P1020, DOI 10.2337/diabetes.37.8.1020; Reyes AJ, 2003, CARDIOVASC DRUG THER, V17, P397, DOI 10.1023/B:CARD.0000015855.02485.e3; Rodriguez G, 2010, ANN RHEUM DIS, V69, P2090, DOI 10.1136/ard.2010.130013; Ryu S, 2012, AM J EPIDEMIOL, V175, P133, DOI 10.1093/aje/kwr291; Selvin E, 2007, AM J KIDNEY DIS, V50, P918, DOI 10.1053/j.ajkd.2007.08.020; Tsai J, 2012, ADDICT BEHAV, V37, P78, DOI 10.1016/j.addbeh.2011.09.002; WALLACE SL, 1977, ARTHRITIS RHEUM, V20, P895, DOI 10.1002/art.1780200320; World Health Organization, 1995, 854 WHO, V854; YANO K, 1977, J CHRON DIS, V30, P171, DOI 10.1016/0021-9681(77)90083-2	42	39	42	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e56546	10.1371/journal.pone.0056546	http://dx.doi.org/10.1371/journal.pone.0056546			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460805	Green Published, Green Submitted, gold			2022-12-25	WOS:000315519000028
J	Pu, H; Li, J; Li, DW; Han, CG; Yu, JL				Pu, Heng; Li, Jiang; Li, Dawei; Han, Chenggui; Yu, Jialin			Identification of an Internal RNA Element Essential for Replication and Translational Enhancement of Tobacco Necrosis Virus A(C)	PLOS ONE			English	Article							COMPLETE NUCLEOTIDE-SEQUENCE; CAP-INDEPENDENT TRANSLATION; TURNIP-CRINKLE-VIRUS; MESSENGER-RNA; COAT PROTEIN; SUBGENOMIC RNAS; GENOME STRUCTURE; BETA-GLUCURONIDASE; ETCH VIRUS; ENTRY SITE	Different regulatory elements function are involved in plant virus gene expression and replication by long-distance RNA-RNA interactions. A cap-independent functional element of the Barley yellow dwarf virus (BYDV) - like translational enhancer (BTE) is present in Tobacco necrosis virus A (TNV-A), a Necrovirus member in the Tombusviridae family. In this paper, an RNA stretch flanking the 5' proximal end of the TNV-A(C) coat protein (CP) gene was shown to be essential for viral replication in Chenopodium amaranticolor plants and tobacco cells. This internal sequence functioned in transient expression of beta-glucuronidase (GUS) when present at either the 5' or 3' sides of the GUS open reading frame. Serial deletion analyses revealed that nine nucleotides from nt 2609 to 2617 (-3 to +6 of the CP initiation site) within TNV-A(C) RNA are indispensable for viral replication in whole plants and tobacco cells. Fusion of this RNA element in mRNAs translated in tobacco cells resulted in a remarkable enhancement of luciferase expression from in vitro synthesised chimaeric RNAs or DNA expression vectors. Interestingly, the element also exhibited increased translational activity when fused downstream of the reporter genes, although the efficiency was lower than with upstream fusions. These results provide evidence that an internal RNA element in the genomic (g) RNA of TNV-A(C), ranging approximately from nt 2543 to 2617, plays a bifunctional role in viral replication and translation enhancement during infection, and that this element may use novel strategies differing from those previously reported for other viruses.	[Pu, Heng; Li, Jiang; Li, Dawei; Han, Chenggui; Yu, Jialin] China Agr Univ, Coll Biol Sci, State Key Labs Agrobiotechnol, Beijing 100094, Peoples R China	China Agricultural University	Yu, JL (corresponding author), China Agr Univ, Coll Biol Sci, State Key Labs Agrobiotechnol, Beijing 100094, Peoples R China.	yjl@cau.edu.cn	Li, Dawei/I-8751-2016	Li, Dawei/0000-0003-4133-1263	National Nature Science Foundation of China [30270063, 30325001]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Nature Science Foundation of China (30270063 and 30325001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbergenov RZ, 2004, NUCLEIC ACIDS RES, V32, P239, DOI 10.1093/nar/gkh176; BARLOW JJ, 1963, BIOCHEM BIOPH RES CO, V13, P61, DOI 10.1016/0006-291X(63)90163-3; BASSO J, 1994, J GEN VIROL, V75, P3157, DOI 10.1099/0022-1317-75-11-3157; Callaway A, 2001, ANNU REV PHYTOPATHOL, V39, P419, DOI 10.1146/annurev.phyto.39.1.419; Cao Y, 2002, ARCH VIROL, V147, P2431, DOI 10.1007/s00705-002-0896-1; Cao YH, 2006, PROG BIOCHEM BIOPHYS, V33, P127; CARRINGTON JC, 1989, VIROLOGY, V170, P219, DOI 10.1016/0042-6822(89)90369-3; CARRINGTON JC, 1990, J VIROL, V64, P1590, DOI 10.1128/JVI.64.4.1590-1597.1990; Choi IR, 2002, J BIOL CHEM, V277, P3760, DOI 10.1074/jbc.M109067200; CONDIT C, 1979, VIROLOGY, V97, P122, DOI 10.1016/0042-6822(79)90378-7; COUTTS RHA, 1991, J GEN VIROL, V72, P1521, DOI 10.1099/0022-1317-72-7-1521; DAY MJD, 1993, PLANT MOL BIOL, V23, P97, DOI 10.1007/BF00021423; Fabian MR, 2006, RNA, V12, P1304, DOI 10.1261/rna.69506; Fabian MR, 2004, J BIOL CHEM, V279, P28862, DOI 10.1074/jbc.M401272200; Fauquet C, 2005, VIRUS TAXONOMY CLASS, P359; GEIER GE, 1979, J BIOL CHEM, V254, P1408; GRIECO F, 1989, NUCLEIC ACIDS RES, V17, P6383, DOI 10.1093/nar/17.15.6383; Guo L, 2001, MOL CELL, V7, P1103, DOI 10.1016/S1097-2765(01)00252-0; HEARNE PQ, 1990, VIROLOGY, V177, P141, DOI 10.1016/0042-6822(90)90468-7; JEFFERSON RA, 1987, EMBO J, V6, P3901; Jiwan SD, 2011, VIROLOGY, V418, P1, DOI 10.1016/j.virol.2011.07.005; Karetnikov A, 2007, J GEN VIROL, V88, P286, DOI 10.1099/vir.0.82307-0; Kim KH, 1999, RNA, V5, P636, DOI 10.1017/S1355838299982006; Krizbai L, 2010, ARCH VIROL, V155, P999, DOI 10.1007/s00705-010-0660-x; LESNAW JA, 1970, P NATL ACAD SCI USA, V66, P140, DOI 10.1073/pnas.66.1.140; LEVIS C, 1993, VIRUS GENES, V7, P367, DOI 10.1007/BF01703392; Li J, 2008, CHINESE SCI BULL, V53, P1682, DOI 10.1007/s11434-008-0204-x; Lin HX, 2004, EMBO J, V23, P3365, DOI 10.1038/sj.emboj.7600336; Meulewaeter F, 2004, NUCLEIC ACIDS RES, V32, P1721, DOI 10.1093/nar/gkh338; MEULEWAETER F, 1990, VIROLOGY, V177, P699, DOI 10.1016/0042-6822(90)90536-Z; MEULEWAETER F, 1992, J VIROL, V66, P6419, DOI 10.1128/JVI.66.11.6419-6428.1992; Meulewaeter F, 1999, ENCY VIROLOGY, P901; Miao YS, 2007, NAT PROTOC, V2, P2348, DOI 10.1038/nprot.2007.360; Miller WA, 2006, ANNU REV PHYTOPATHOL, V44, P447, DOI 10.1146/annurev.phyto.44.070505.143353; Molnar A, 1997, J GEN VIROL, V78, P1235, DOI 10.1099/0022-1317-78-6-1235; Na H, 2006, VIROLOGY, V345, P305, DOI 10.1016/j.virol.2005.09.008; Niepel M, 1999, J VIROL, V73, P9080, DOI 10.1128/JVI.73.11.9080-9088.1999; Ohki Takehiro, 2005, Journal of General Plant Pathology, V71, P74, DOI 10.1007/s10327-004-0163-2; Qu F, 2003, J VIROL, V77, P511, DOI 10.1128/JVI.77.1.511-522.2003; Quaedvlieg NEM, 1998, PLANT MOL BIOL, V38, P861, DOI 10.1023/A:1006182623165; RUBINO L, 1995, ARCH VIROL, V140, P2027, DOI 10.1007/BF01322690; Sambrook J, 2001, MOL CLONING LAB MANU; Shen RZ, 2007, VIROLOGY, V358, P448, DOI 10.1016/j.virol.2006.08.054; Shen RZ, 2004, J VIROL, V78, P4655, DOI 10.1128/JVI.78.9.4655-4664.2004; Sit TL, 1998, SCIENCE, V281, P829, DOI 10.1126/science.281.5378.829; Szittya G, 2001, J VIROL, V75, P2411, DOI 10.1128/JVI.75.5.2411-2420.2001; Thomas CL, 2003, VIROLOGY, V306, P33, DOI 10.1016/S0042-6822(02)00018-1; Wang JL, 1999, VIROLOGY, V259, P234, DOI 10.1006/viro.1999.9781; Weiland JJ, 2007, PHYTOPATHOLOGY, V97, P1245, DOI 10.1094/PHYTO-97-10-1245; Wu BD, 1999, J VIROL, V73, P8982, DOI 10.1128/JVI.73.11.8982-8988.1999; Xi DeHui, 2007, Acta Phytopathologica Sinica, V37, P595; Xi DH, 2008, VIRUS GENES, V36, P259, DOI 10.1007/s11262-007-0185-x; Xu J, 2012, J GEN VIROL, V93, P2718, DOI 10.1099/vir.0.045641-0; Xu W, 2008, VIROLOGY, V371, P430, DOI 10.1016/j.virol.2007.09.035; Yuan XF, 2006, J GEN VIROL, V87, P3077, DOI 10.1099/vir.0.81928-0; Zeenko V, 2005, J BIOL CHEM, V280, P26813, DOI 10.1074/jbc.M503576200; Zhang GC, 1999, RNA, V5, P550, DOI 10.1017/S1355838299982080; Zhao YJ, 2000, MOL PLANT MICROBE IN, V13, P1015, DOI 10.1094/MPMI.2000.13.9.1015; Zhong X, 2005, CURR PROTOC MICROBIO	59	1	1	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57938	10.1371/journal.pone.0057938	http://dx.doi.org/10.1371/journal.pone.0057938			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460916	Green Submitted, Green Published, gold			2022-12-25	WOS:000315519000171
J	Shan, JC; Liu, CM; Chiu, MJ; Liu, CC; Chien, YL; Hwang, TJ; Lin, YT; Hsieh, MH; Jaw, FS; Hwu, HG				Shan, Jia-Chi; Liu, Chih-Min; Chiu, Ming-Jang; Liu, Chen-Chung; Chien, Yi-Ling; Hwang, Tzung-Jeng; Lin, Yi-Ting; Hsieh, Ming H.; Jaw, Fu-Shan; Hwu, Hai-Gwo			A Diagnostic Model Incorporating P50 Sensory Gating and Neuropsychological Tests for Schizophrenia	PLOS ONE			English	Article							BIPOLAR DISORDER; SUSTAINED ATTENTION; NEUROPHYSIOLOGICAL ENDOPHENOTYPES; UNAFFECTED SIBLINGS; DEFICITS; RELATIVES; METAANALYSIS; SUPPRESSION; PERFORMANCE; NORMALIZATION	Objectives: Endophenotypes in schizophrenia research is a contemporary approach to studying this heterogeneous mental illness, and several candidate neurophysiological markers (e.g. P50 sensory gating) and neuropsychological tests (e.g. Continuous Performance Test (CPT) and Wisconsin Card Sorting Test (WCST)) have been proposed. However, the clinical utility of a single marker appears to be limited. In the present study, we aimed to construct a diagnostic model incorporating P50 sensory gating with other neuropsychological tests in order to improve the clinical utility. Methods: We recruited clinically stable outpatients meeting DSM-IV criteria of schizophrenia and age-and gender-matched healthy controls. Participants underwent P50 sensory gating experimental sessions and batteries of neuropsychological tests, including CPT, WCST and Wechsler Adult Intelligence Scale Third Edition (WAIS-III). Results: A total of 106 schizophrenia patients and 74 healthy controls were enrolled. Compared with healthy controls, the patient group had significantly a larger S2 amplitude, and thus poorer P50 gating ratio (gating ratio = S2/S1). In addition, schizophrenia patients had a poorer performance on neuropsychological tests. We then developed a diagnostic model by using multivariable logistic regression analysis to differentiate patients from healthy controls. The final model included the following covariates: abnormal P50 gating (defined as P50 gating ratio >0.4), three subscales derived from the WAIS-III (Arithmetic, Block Design, and Performance IQ), sensitivity index from CPT and smoking status. This model had an adequate accuracy (concordant percentage = 90.4%; c-statistic = 0.904; Hosmer-Lemeshow Goodness-of-Fit Test, p = 0.64>0.05). Conclusion: To the best of our knowledge, this is the largest study to date using P50 sensory gating in subjects of Chinese ethnicity and the first to use P50 sensory gating along with other neuropsychological tests to develop a diagnostic model for schizophrenia. Further research to validate the predictive accuracy of this model by applying it on other samples is warranted.	[Shan, Jia-Chi] Cathay Gen Hosp, Dept Psychiat, Taipei, Taiwan; [Shan, Jia-Chi; Liu, Chih-Min; Liu, Chen-Chung; Chien, Yi-Ling; Hwang, Tzung-Jeng; Lin, Yi-Ting; Hsieh, Ming H.; Hwu, Hai-Gwo] Natl Taiwan Univ Hosp, Dept Psychiat, Taipei, Taiwan; [Liu, Chih-Min; Liu, Chen-Chung; Chien, Yi-Ling; Hwang, Tzung-Jeng; Hsieh, Ming H.; Hwu, Hai-Gwo] Natl Taiwan Univ, Coll Med, Dept Psychiat, Taipei 10764, Taiwan; [Liu, Chih-Min; Chiu, Ming-Jang; Liu, Chen-Chung; Hwang, Tzung-Jeng; Hsieh, Ming H.; Jaw, Fu-Shan; Hwu, Hai-Gwo] Natl Taiwan Univ, Neurobiol & Cognit Sci Ctr, Taipei 10764, Taiwan; [Chiu, Ming-Jang] Natl Taiwan Univ Hosp, Dept Neurol, Taipei, Taiwan; [Chiu, Ming-Jang] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan; [Hsieh, Ming H.; Jaw, Fu-Shan] Natl Taiwan Univ, Inst Biomed Engn, Taipei 10764, Taiwan; [Lin, Yi-Ting] Natl Taiwan Univ Hosp, Yun Lin Branch, Dept Psychiat, Yunlin, Taiwan	Cathay General Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital	Hsieh, MH (corresponding author), Natl Taiwan Univ Hosp, Dept Psychiat, Taipei, Taiwan.	mingh@ntuh.gov.tw	Hwang, TJ/K-4768-2019; H.Hsieh, Ming/B-2970-2010; Chiu, Ming-Jang/AAR-3940-2020	H.Hsieh, Ming/0000-0002-3585-7843; Chiu, Ming-Jang/0000-0002-4158-4423; HWU, HAI-GWO/0000-0002-2582-2807; Lin, Yi-Ting/0000-0003-3821-4744; Hwang, Tzung-Jeng/0000-0001-7894-9484; LIU, CHIH-MIN/0000-0001-7016-8990; Shan, Jia-Chi/0000-0002-2852-8224; LIU, CHEN-CHUNG/0000-0002-9290-110X; CHIEN, YI-LING/0000-0002-3477-3015	National Science Council, Taiwan [NSC-101-2314-B-002-137-, NSC-98-2314-B-002-047-MY3]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by the National Science Council, Taiwan (NSC-101-2314-B-002-137-, NSC-98-2314-B-002-047-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLER LE, 1982, BIOL PSYCHIAT, V17, P639; ADLER LE, 1992, BIOL PSYCHIAT, V32, P607, DOI 10.1016/0006-3223(92)90073-9; ADLER LE, 1993, AM J PSYCHIAT, V150, P1856; Ancin I, 2010, ACTA PSYCHIAT SCAND, V122, P235, DOI 10.1111/j.1600-0447.2009.01532.x; Andreasen N C, 1990, Mod Probl Pharmacopsychiatry, V24, P73; Andreasen NC, 2010, BIOL PSYCHIAT, V67, P255, DOI 10.1016/j.biopsych.2009.08.040; Bora E, 2009, J AFFECT DISORDERS, V113, P1, DOI 10.1016/j.jad.2008.06.009; Boutros N, 2008, SCHIZOPHR RES, V103, P336, DOI 10.1016/j.schres.2008.02.017; Boutros NN, 2004, PSYCHIAT RES, V126, P203, DOI 10.1016/j.psychres.2004.01.007; Braff David L, 2005, Dialogues Clin Neurosci, V7, P125; BRAFF DL, 1990, ARCH GEN PSYCHIAT, V47, P181; Brockhaus-Dumke A, 2008, BIOL PSYCHIAT, V64, P376, DOI 10.1016/j.biopsych.2008.02.006; Cabranes JA, 2012, EUR NEUROPSYCHOPHARM, V6, P6; Chang WP, 2011, PSYCHOPHYSIOLOGY, V48, P980, DOI 10.1111/j.1469-8986.2010.01168.x; Chen TF, 2009, HUM BRAIN MAPP, V30, P3826, DOI 10.1002/hbm.20810; Chen WJ, 1998, SCHIZOPHRENIA BULL, V24, P163, DOI 10.1093/oxfordjournals.schbul.a033308; Chen WJ, 1998, AM J PSYCHIAT, V155, P1214, DOI 10.1176/ajp.155.9.1214; Clementz BA, 1998, SCHIZOPHR RES, V30, P71, DOI 10.1016/S0920-9964(97)00122-9; Wilde OM, 2007, SCHIZOPHR RES, V97, P137, DOI 10.1016/j.schres.2007.04.028; de Wilde OM, 2007, SCHIZOPHRENIA BULL, V33, P1319, DOI 10.1093/schbul/sbm001; DELEON J, 1995, AM J PSYCHIAT, V152, P453; Dickinson D, 2007, ARCH GEN PSYCHIAT, V64, P532, DOI 10.1001/archpsyc.64.5.532; Doyle AE, 2009, PSYCHOL MED, V39, P1253, DOI 10.1017/S0033291708004832; Freedman R, 1997, P NATL ACAD SCI USA, V94, P587, DOI 10.1073/pnas.94.2.587; Gottesman II, 2003, AM J PSYCHIAT, V160, P636, DOI 10.1176/appi.ajp.160.4.636; Gur RE, 2007, SCHIZOPHRENIA BULL, V33, P49, DOI 10.1093/schbul/sbl055; Hashimoto T, 2008, PROG NEURO-PSYCHOPH, V32, P288, DOI 10.1016/j.pnpbp.2007.08.021; Heaton R.K., 1993, WISCONSIN CARD SORTI; Heinrichs RW, 1998, NEUROPSYCHOLOGY, V12, P426, DOI 10.1037/0894-4105.12.3.426; Holstein DH, 2012, PSYCHIAT RES; Johannesen JK, 2012, SCHIZOPHR B, V27, P27; Kalkstein S, 2010, CURR TOP BEHAV NEURO, V4, P373, DOI 10.1007/7854_2010_42; Light Gregory A, 2010, Curr Protoc Neurosci, VChapter 6, DOI 10.1002/0471142301.ns0625s52; Lijffijt M, 2009, J PSYCHOPHYSIOL, V23, P52, DOI 10.1027/0269-8803.23.2.52; Lin YT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034454; Liu SK, 2002, AM J PSYCHIAT, V159, P975, DOI 10.1176/appi.ajp.159.6.975; Sanchez-Morla EM, 2013, SCHIZOPHR RES, V143, P102, DOI 10.1016/j.schres.2012.10.017; NAGAMOTO HT, 1989, BIOL PSYCHIAT, V25, P549, DOI 10.1016/0006-3223(89)90215-1; Niznikiewicz MA, 2004, SCHIZOPHRENIA NEUROI, P293; Olincy A, 2005, AM J PSYCHIAT, V162, P43, DOI 10.1176/appi.ajp.162.1.43; Pardo PJ, 2006, SCHIZOPHR RES, V87, P297, DOI 10.1016/j.schres.2006.05.007; Patterson JV, 2008, PSYCHIAT RES, V158, P226, DOI 10.1016/j.psychres.2007.02.009; Pineda D, 1998, INT J NEUROSCI, V96, P177, DOI 10.3109/00207459808986466; Potter D, 2006, SCHIZOPHRENIA BULL, V32, P692, DOI 10.1093/schbul/sbj050; Price GW, 2006, BIOL PSYCHIAT, V60, P1, DOI 10.1016/j.biopsych.2005.09.010; Reichenberg Abraham, 2010, Dialogues Clin Neurosci, V12, P383; Riccio CA, 2001, ANN NY ACAD SCI, V931, P113; SEMLITSCH HV, 1986, PSYCHOPHYSIOLOGY, V23, P695, DOI 10.1111/j.1469-8986.1986.tb00696.x; Sevik AE, 2011, SCHIZOPHR RES, V130, P195, DOI 10.1016/j.schres.2011.04.018; Shan JC, 2010, SCHIZOPHR RES, V122, P270, DOI 10.1016/j.schres.2010.05.026; SIEGEL C, 1984, ARCH GEN PSYCHIAT, V41, P607; Su L, 2012, PSYCHIAT DANUB, V24, P44; Thaker GK, 2008, SCHIZOPHRENIA BULL, V34, P760, DOI 10.1093/schbul/sbn049; Thomas C, 2010, NEUROBIOL AGING, V31, P416, DOI 10.1016/j.neurobiolaging.2008.05.002; Tsuchiya E, 2005, BRAIN DEV-JPN, V27, P233, DOI 10.1016/j.braindev.2004.06.008; Turetsky BI, 2007, SCHIZOPHRENIA BULL, V33, P69, DOI 10.1093/schbul/sbl060; Uc EY, 2003, J NEUROL SCI, V212, P1, DOI 10.1016/S0022-510X(03)00082-0; WALDO MC, 1994, SCHIZOPHR RES, V12, P93, DOI 10.1016/0920-9964(94)90067-1; Weschler D., 2002, WAIS 3 CHINESE VERSI; Winterer G, 2010, CURR OPIN PSYCHIATR, V23, P112, DOI 10.1097/YCO.0b013e3283366643	60	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57197	10.1371/journal.pone.0057197	http://dx.doi.org/10.1371/journal.pone.0057197			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	098BN	23460831	Green Submitted, Green Published, gold			2022-12-25	WOS:000315519000075
J	Gary, T; Pichler, M; Belaj, K; Hafner, F; Gerger, A; Froehlich, H; Eller, P; Pilger, E; Brodmann, M				Gary, Thomas; Pichler, Martin; Belaj, Klara; Hafner, Franz; Gerger, Armin; Froehlich, Harald; Eller, Philipp; Pilger, Ernst; Brodmann, Marianne			Neutrophil-to-Lymphocyte Ratio and Its Association with Critical Limb Ischemia in PAOD Patients	PLOS ONE			English	Article							PERIPHERAL ARTERIAL-DISEASE; PREOPERATIVE NEUTROPHIL; LOWER-EXTREMITY; RESECTION	Background: The Neutrophil-to-Lymphocyte ratio (NLR) is an easy to perform test from the white blood cell count. An increase in NLR has been associated with vascular endpoints reflecting inflammation in atherosclerotic lesions. Atherosclerosis is a global threat and vascular endpoints, like myocardial infarction or critical limb ischemia (CLI), are a leading cause of death in industrialized countries. We therefore investigated NLR and its association with CLI and other vascular endpoints in peripheral arterial occlusive disease (PAOD) patients. Methods and Findings: We evaluated 2121 PAOD patients treated at our institution from 2005 to 2010. NLR was calculated and the cohort was divided into tertiles according to the NLR. An optimal cut-off value for the continuous NLR was calculated by applying a receiver operating curve analysis to discriminate between CLI and non-CLI. In our cohort occurrence of CLI significantly increased with an increase in NLR. As an optimal cut-off a NLR of 3.95 was identified. Two groups were categorized, one containing 1441 patients (NLR>3.95) and a second group with 680 patients (NLR. 3.95). CLI was more frequent in NLR. 3.95 patients (330(48.5%)) compared to NLR<3.95 patients (350(24.3%)) (p<0.001), as were prior myocardial infarction (48(7.0%) vs. 47(3.3%), p<0.001) and stroke (73(10.7) vs. 98(6.8%), p<0.001). Regarding other inflammatory parameters, C-reactive protein (median 5.6 mg/l (2.3-19.1) vs. median 3 mg/l (1.5-5.5)) and fibrinogen (median 412 mg/dl (345.5-507.5) vs. 344 mg/dl (308-403.5)) also significantly differed in the two patient groups (both p<0.001). A NLR>3.95 was associated with an OR of 2.5 (95% CI 2.3-2.7) for CLI even after adjustment for other vascular risk factors. Conclusions: An increased NLR is significantly associated with patients at high risk for CLI and other vascular endpoints. The NLR is an easy to perform test, which could be used to highlight patients at high risk for vascular endpoints.	[Gary, Thomas; Belaj, Klara; Hafner, Franz; Froehlich, Harald; Eller, Philipp; Pilger, Ernst; Brodmann, Marianne] Med Univ Graz, Dept Internal Med, Div Vasc Med, Graz, Austria; [Pichler, Martin; Gerger, Armin] Med Univ Graz, Div Oncol, Dept Internal Med, Graz, Austria	Medical University of Graz; Medical University of Graz	Gary, T (corresponding author), Med Univ Graz, Dept Internal Med, Div Vasc Med, Graz, Austria.	thomas.gary@medunigraz.at		Froehlich, Harald/0000-0003-4415-9809; Pichler, Martin/0000-0002-8701-9462				Aerden D, 2011, ANN VASC SURG, V25, P770, DOI 10.1016/j.avsg.2010.12.025; Bertele V, 1999, EUR J VASC ENDOVASC, V18, P401, DOI 10.1053/ejvs.1999.0934; Bertomeu V, 2008, EUR J VASC ENDOVASC, V36, P189, DOI 10.1016/j.ejvs.2008.02.004; Gary T, 2012, ATHEROSCLEROSIS, V225, P517, DOI 10.1016/j.atherosclerosis.2012.10.025; Gomez D, 2008, WORLD J SURG, V32, P1757, DOI 10.1007/s00268-008-9552-6; Halazun KJ, 2008, EJSO-EUR J SURG ONC, V34, P55, DOI 10.1016/j.ejso.2007.02.014; Hartaigh BO, 2012, ATHEROSCLEROSIS, V224, P161, DOI 10.1016/j.atherosclerosis.2012.04.012; Hirsch AT, 2006, J AM COLL CARDIOL, V47, P1239, DOI 10.1016/j.jacc.2005.10.009; Iso Y, 2010, ATHEROSCLEROSIS, V209, P167, DOI 10.1016/j.atherosclerosis.2009.08.028; Jabre P, 2011, CIRCULATION, V123, P2094, DOI 10.1161/CIRCULATIONAHA.110.990192; Mohri Y, 2010, WORLD J SURG, V34, P285, DOI 10.1007/s00268-009-0302-1; Norgren L, 2007, EUR J VASC ENDOVASC, V33, pS5, DOI 10.1016/j.ejvs.2006.09.024; Novo S., 2004, Current Drug Targets - Cardiovascular & Haematological Disorders, V4, P219, DOI 10.2174/1568006043335989; Powell RJ, 2010, J VASC SURG, V52, P1525, DOI 10.1016/j.jvs.2010.07.044; Spark JI, 2010, J VASC SURG, V52, P632, DOI 10.1016/j.jvs.2010.03.067; Stabile E, 2006, CIRCULATION, V113, P118, DOI 10.1161/CIRCULATIONAHA.105.576702; Tamhane UU, 2008, AM J CARDIOL, V102, P653, DOI 10.1016/j.amjcard.2008.05.006; Turak O, 2012, AM J CARDIOL	18	53	56	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56745	10.1371/journal.pone.0056745	http://dx.doi.org/10.1371/journal.pone.0056745			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457609	Green Submitted, gold, Green Published			2022-12-25	WOS:000315603700077
J	Niehorster, DC; Peli, E; Haun, A; Li, L				Niehorster, Diederick C.; Peli, Eli; Haun, Andrew; Li, Li			Influence of Hemianopic Visual Field Loss on Visual Motor Control	PLOS ONE			English	Article							LINE BISECTION; HOMONYMOUS HEMIANOPIA; DRIVING PERFORMANCE; STEERING CONTROL; ACTIVE CONTROL; NEGLECT; REHABILITATION; APHASIA; STRATEGIES; DISORDERS	Background: Homonymous hemianopia (HH) is an anisotropic visual impairment characterized by the binocular inability to see one side of the visual field. Patients with HH often misperceive visual space. Here we investigated how HH affects visual motor control. Methods and Findings: Seven patients with complete HH and no neglect or cognitive decline and seven gender-and age-matched controls viewed displays in which a target moved randomly along the horizontal or the vertical axis. They used a joystick to control the target movement to keep it at the center of the screen. We found that the mean deviation of the target position from the center of the screen along the horizontal axis was biased toward the blind side for five out of seven HH patients. More importantly, while the normal vision controls showed more precise control and larger response amplitudes when the target moved along the horizontal rather than the vertical axis, the control performance of the HH patients was not different between these two target motion experimental conditions. Conclusions: Compared with normal vision controls, HH affected patients' control performance when the target moved horizontally (i.e., along the axis of their visual impairment) rather than vertically. We conclude that hemianopia affects the use of visual information for online control of a moving target specific to the axis of visual impairment. The implications of the findings for driving in hemianopic patients are discussed.	[Niehorster, Diederick C.; Li, Li] Univ Hong Kong, Dept Psychol, Hong Kong, Hong Kong, Peoples R China; [Peli, Eli; Haun, Andrew] Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Schepens Eye Res Inst,Dept Ophthalmol, Boston, MA USA	University of Hong Kong; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Schepens Eye Research Institute	Niehorster, DC (corresponding author), Univ Hong Kong, Dept Psychol, Hong Kong, Hong Kong, Peoples R China.	dcniehorster@hku.hk; lili@hku.hk	Niehorster, Diederick C/E-9325-2010; Haun, Andrew/I-4956-2012	Niehorster, Diederick C/0000-0002-4672-8756; Haun, Andrew/0000-0001-9458-8957; Peli, Eli/0000-0002-1340-9257	Research Grants Council of Hong Kong [HKU 7478/08H]; NIH [EY12890]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR028122] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R24EY012890, R01EY012890] Funding Source: NIH RePORTER	Research Grants Council of Hong Kong(Hong Kong Research Grants Council); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by a grant from the Research Grants Council of Hong Kong (HKU 7478/08H) to L. Li, http://www.ugc.edu.hk, and a grant from the NIH (EY12890) to E. Peli, http://www.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen RW, 1981, JPL P 17 ANN C MAN C; Andersen GJ, 2006, VIS COGN, V13, P119, DOI 10.1080/13506280500405675; Barton JJS, 1998, BRAIN, V121, P1117, DOI 10.1093/brain/121.6.1117; Barton JJS, 1998, J NEUROL NEUROSUR PS, V64, P660, DOI 10.1136/jnnp.64.5.660; Beall AC, 1996, PERCEPTION, V25, P481, DOI 10.1068/p250481; Bowers AR, 2010, INVEST OPHTH VIS SCI, V51, P6605, DOI 10.1167/iovs.10-5310; Bowers AR, 2009, INVEST OPHTH VIS SCI, V50, P5137, DOI 10.1167/iovs.09-3799; Bowers AR, 2010, AM AC OPT M 2010; Casson EJ, 2000, CAN J OPHTHALMOL, V35, P192, DOI 10.1016/S0008-4182(00)80030-7; Croquelois A, 2011, CEREBROVASC DIS, V31, P392, DOI 10.1159/000323217; Doricchi F, 2005, BRAIN, V128, P1386, DOI 10.1093/brain/awh461; Elgin J, 2010, AM J OCCUP THER, V64, P268, DOI 10.5014/ajot.64.2.268; Ferber S, 1999, J NEUROL NEUROSUR PS, V67, P572, DOI 10.1136/jnnp.67.5.572; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Giorgi RG, 2009, OPTOMETRY VISION SCI, V86, P492, DOI 10.1097/OPX.0b013e31819f9e4d; Hildreth EC, 2000, J EXP PSYCHOL HUMAN, V26, P1106, DOI 10.1037//0096-1523.26.3.1106; Hillis AE, 2007, NEUROLOGY, V69, P200, DOI 10.1212/01.wnl.0000265600.69385.6f; International Council of Ophthalmology, 2006, VIS STAND VIS REQ DR; Jagacinski R.J., 2003, CONTROL THEORY HUMAN; Jex HR, 1974, AIAA LIF SCI SYST C; JONES RD, 1986, MED BIOL ENG COMPUT, V24, P536, DOI 10.1007/BF02443972; KERKHOFF G, 1992, RESTOR NEUROL NEUROS, V4, P245, DOI 10.3233/RNN-1992-4402; Kerkhoff G, 2009, NERVENARZT, V80, P1190, DOI 10.1007/s00115-009-2811-4; Kerkhoff G, 2008, CORTEX, V44, P200, DOI 10.1016/j.cortex.2006.07.002; Kerkhoff G, 2011, CORTEX, V47, P53, DOI 10.1016/j.cortex.2010.06.014; Kooijman A, 2004, VIS IMPAIR RES, V6, P1, DOI [10.1080/13882350390486965, DOI 10.1080/13882350390486965]; Krendel, 1959, J FRANKLIN I, V267, P381, DOI [10.1016/0016-0032(59)90091-2, DOI 10.1016/0016-0032(59)90091-2]; Kuhn C, 2010, NEUROPSYCHOLOGIA, V48, P3205, DOI 10.1016/j.neuropsychologia.2010.06.035; Li L, 2005, J NEUROPHYSIOL, V93, P2873, DOI 10.1152/jn.00200.2004; Li L, 2006, IEEE T SYST MAN CY A, V36, P1124, DOI 10.1109/TSMCA.2006.878951; Li L, 2010, J VISION, V10, DOI 10.1167/10.11.16; Li WO, 2009, J VISION, V9, DOI 10.1167/9.6.5; LYNN PA, 1979, MED BIOL ENG COMPUT, V17, P344, DOI 10.1007/BF02443821; LYNN PA, 1977, MED BIOL ENG COMPUT, V15, P184, DOI 10.1007/BF02442962; Mandel AJ, 2008, P 9 INT C LOW VIS NE; Mannan SK, 2010, J NEUROL, V257, P1812, DOI 10.1007/s00415-010-5615-3; McRuer D. T., 1965, AFFDLTR6515 WRIGHT P; MCRUER DT, 1977, HUM FACTORS, V19, P381, DOI 10.1177/001872087701900406; McRuer DT, 1974, AGARDAG188 GROUP AER; Michon J. A., 1985, HUMAN BEHAV TRAFFIC, P487; Miesner N., 2004, TOP GERIATR REHABIL, V20, P212, DOI DOI 10.1097/00013614-200407000-00009; Pambakian A, 2005, J NEURO-OPHTHALMOL, V25, P136; Peli E, 2000, OPTOMETRY VISION SCI, V77, P453, DOI 10.1097/00006324-200009000-00006; Peli E., 2002, DRIVING CONFIDENCE P; Peli E., 2008, ALBERT JOKOBIECS PRI, V4, P5369, DOI [10.1007/978-3-319-90495-5_245-1, DOI 10.1007/978-3-319-90495-5_245-1]; Racette L, 2005, OPTOMETRY VISION SCI, V82, P668, DOI 10.1097/01.opx.0000174719.25799.37; SCARPA M, 1987, CORTEX, V23, P331, DOI 10.1016/S0010-9452(87)80044-8; SCHENKENBERG T, 1980, NEUROLOGY, V30, P509, DOI 10.1212/WNL.30.5.509; Schofield TM, 2009, CURR OPIN NEUROL, V22, P36, DOI 10.1097/WCO.0b013e32831f1b2c; Schuett S, 2011, CORTEX, V47, P47, DOI 10.1016/j.cortex.2010.01.008; Silveira S, 2007, CLIN EXP OPHTHALMOL, V35, P612, DOI 10.1111/j.1442-9071.2007.01544.x; Stein AC, 1984, NASA AM RES CTR 20 A; STERZI R, 1993, J NEUROL NEUROSUR PS, V56, P308, DOI 10.1136/jnnp.56.3.308; STONE SP, 1993, AGE AGEING, V22, P46, DOI 10.1093/ageing/22.1.46; SZLYK JP, 1993, OPTOMETRY VISION SCI, V70, P1031, DOI 10.1097/00006324-199312000-00007; Tant MLM, 2002, NEUROPSYCHOL REHABIL, V12, P419, DOI 10.1080/09602010244000183; Trauzettel-Klosinski S, 1998, INVEST OPHTH VIS SCI, V39, P2177; Trauzettel-Klosinski S, 2008, ESSENT OPHTHALMOL, P301, DOI 10.1007/978-3-540-33679-2_17; Vallar G, 1997, PHILOS T ROY SOC B, V352, P1401, DOI 10.1098/rstb.1997.0126; Vanier M, 1990, NEUROPSYCHOLOGY, V4, P87, DOI 10.1037/0894-4105.4.2.87; Wood JM, 2009, INVEST OPHTH VIS SCI, V50, P577, DOI 10.1167/iovs.08-2506; Zhang X, 2006, NEUROLOGY, V66, P901, DOI 10.1212/01.wnl.0000203338.54323.22; ZIHL J, 1995, NEUROPSYCHOLOGIA, V33, P287, DOI 10.1016/0028-3932(94)00119-A; Zihl J, 2000, REHABILIATION VISUAL	64	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56615	10.1371/journal.pone.0056615	http://dx.doi.org/10.1371/journal.pone.0056615			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	099EQ	23457594	Green Published, gold			2022-12-25	WOS:000315603700066
J	Rosenbluth, KH; Martin, AJ; Mittermeyer, S; Eschermann, J; Dickinson, PJ; Bankiewicz, KS				Rosenbluth, Kathryn H.; Martin, Alastair J.; Mittermeyer, Stephan; Eschermann, Jan; Dickinson, Peter J.; Bankiewicz, Krystof S.			Rapid Inverse Planning for Pressure-Driven Drug Infusions in the Brain	PLOS ONE			English	Article							CONVECTION-ENHANCED DELIVERY; RECURRENT MALIGNANT GLIOMA; PRIMATE BRAIN; GENE-THERAPY; PARKINSON-DISEASE; NEUROTROPHIC FACTOR; PHASE-I; PLATFORM; TRIAL; ALGORITHM	Infusing drugs directly into the brain is advantageous to oral or intravenous delivery for large molecules or drugs requiring high local concentrations with low off-target exposure. However, surgeons manually planning the cannula position for drug delivery in the brain face a challenging three-dimensional visualization task. This study presents an intuitive inverse-planning technique to identify the optimal placement that maximizes coverage of the target structure while minimizing the potential for leakage outside the target. The technique was retrospectively validated using intraoperative magnetic resonance imaging of infusions into the striatum of non-human primates and into a tumor in a canine model and applied prospectively to upcoming human clinical trials.	[Rosenbluth, Kathryn H.; Bankiewicz, Krystof S.] Univ Calif San Francisco, Dept Neurosurg, San Francisco, CA 94143 USA; [Mittermeyer, Stephan; Eschermann, Jan] Brainlab, Feldkirchen, Bavaria, Germany; [Martin, Alastair J.] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA; [Dickinson, Peter J.] Univ Calif Davis, Dept Surg & Radiol Sci, Davis, CA 95616 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Davis	Rosenbluth, KH (corresponding author), Univ Calif San Francisco, Dept Neurosurg, San Francisco, CA 94143 USA.	Kate.Rosenbluth@ucsf.edu	Dickinson, Peter/GPT-0703-2022	Martin, Alastair/0000-0002-7963-4000	National Institutes of Health [PO1 CA118816]; NATIONAL CANCER INSTITUTE [P01CA118816] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health PO1 CA118816. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bankiewicz KS, 2006, MOL THER, V14, P564, DOI 10.1016/j.ymthe.2006.05.005; Bankiewicz KS, 2000, EXP NEUROL, V164, P2, DOI 10.1006/exnr.2000.7408; BOBO RH, 1994, P NATL ACAD SCI USA, V91, P2076, DOI 10.1073/pnas.91.6.2076; Daadi MM, 2006, NEUROREPORT, V17, P201, DOI 10.1097/01.wnr.0000198952.38563.05; Dickinson PJ, 2008, J NEUROSURG, V108, P989, DOI 10.3171/JNS/2008/108/5/0989; Eberling JL, 2008, NEUROLOGY, V70, P1980, DOI 10.1212/01.wnl.0000312381.29287.ff; Fiandaca MS, 2008, NEUROTHERAPEUTICS, V5, P123, DOI 10.1016/j.nurt.2007.10.064; Fiandaca MS, 2011, TOXINS, V3, P369, DOI 10.3390/toxins3040369; Krauze MT, 2007, NEURO-ONCOLOGY, V9, P393, DOI 10.1215/15228517-2007-019; Krauze MT, 2005, BRAIN RES PROTOC, V16, P20, DOI 10.1016/j.brainresprot.2005.08.003; Krauze MT, 2005, J NEUROSURG, V103, P923, DOI 10.3171/jns.2005.103.5.0923; Kunwar S, 2007, J CLIN ONCOL, V25, P837, DOI 10.1200/JCO.2006.08.1117; Lang AE, 2006, ANN NEUROL, V59, P459, DOI 10.1002/ana.20737; Lidar Z, 2004, J NEUROSURG, V100, P472, DOI 10.3171/jns.2004.100.3.0472; Lonser RR, 2002, J NEUROSURG, V97, P905, DOI 10.3171/jns.2002.97.4.0905; Marks WJ, 2009, PHASE 1 2 TRIAL ASSE; Morrison PF, 2007, J NEUROSURG, V107, P74, DOI 10.3171/JNS-07/07/0074; Noble CO, 2006, CANCER RES, V66, P2801, DOI 10.1158/0008-5472.CAN-05-3535; Ostertag D, 2012, NEURO-ONCOLOGY, V14, P145, DOI 10.1093/neuonc/nor199; Richardson RM, 2011, MOL THER, V19, P1048, DOI 10.1038/mt.2011.11; Richardson RM, 2011, STEREOT FUNCT NEUROS, V89, P141, DOI 10.1159/000323544; Rosenbluth KH, 2011, J NEUROSCI METH, V196, P118, DOI 10.1016/j.jneumeth.2010.12.022; Rosenbluth KH, 2012, NEUROIMAGE, V59, P2423, DOI 10.1016/j.neuroimage.2011.08.107; Saito R, 2005, EXP NEUROL, V196, P381, DOI 10.1016/j.expneurol.2005.08.016; Salegio EA, 2010, HUM GENE THER, V21, P1093, DOI 10.1089/hum.2010.040; Salegio EA, 2012, HUM GENE THER; SAMPSON JH, 2009, J NEUROSURG; Sampson JH, 2007, NEURO-ONCOLOGY, V9, P343, DOI 10.1215/15228517-2007-007; San Sebastian W, 2012, HUM GENE THER, V23, P210, DOI 10.1089/hum.2011.162; Smith Y, 2008, MOVEMENT DISORD, V23, pS534, DOI 10.1002/mds.22027; Su XM, 2009, HUM GENE THER, V20, P1627, DOI 10.1089/hum.2009.103; Tai CK, 2005, MOL THER, V12, P842, DOI 10.1016/j.ymthe.2005.03.017; Valles F, 2010, NEUROSURGERY, V67, P1377, DOI 10.1227/NEU.0b013e3181f53a5c; Villard Caroline, 2005, Computer Methods in Biomechanics and Biomedical Engineering, V8, P215, DOI 10.1080/10255840500289988; Yin D., 2009, NEUROIMAGE; Yin DL, 2010, J NEUROSURG, V113, P240, DOI 10.3171/2010.2.JNS091744; Yin DL, 2011, NEUROIMAGE, V54, pS196, DOI 10.1016/j.neuroimage.2009.08.069	37	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56397	10.1371/journal.pone.0056397	http://dx.doi.org/10.1371/journal.pone.0056397			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457563	Green Published, Green Submitted, gold			2022-12-25	WOS:000315603700050
J	Ruan, HL; Qin, HD; Shugart, YY; Bei, JX; Luo, FT; Zeng, YX; Jia, WH				Ruan, Hong-Lian; Qin, Hai-De; Shugart, Yin Yao; Bei, Jin-Xin; Luo, Fu-Tian; Zeng, Yi-Xin; Jia, Wei-Hua			Developing Genetic Epidemiological Models to Predict Risk for Nasopharyngeal Carcinoma in High-Risk Population of China	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; CANCER RISK; SUSCEPTIBILITY LOCUS; FAMILY-HISTORY; VARIANTS; POLYMORPHISMS; SCORE	To date, the only established model for assessing risk for nasopharyngeal carcinoma (NPC) relies on the sero-status of the Epstein-Barr virus (EBV). By contrast, the risk assessment models proposed here include environmental risk factors, family history of NPC, and information on genetic variants. The models were developed using epidemiological and genetic data from a large case-control study, which included 1,387 subjects with NPC and 1,459 controls of Cantonese origin. The predictive accuracy of the models were then assessed by calculating the area under the receiver-operating characteristic curves (AUC). To compare the discriminatory improvement of models with and without genetic information, we estimated the net reclassification improvement (NRI) and integrated discrimination index (IDI). Well-established environmental risk factors for NPC include consumption of salted fish and preserved vegetables and cigarette smoking (in pack years). The environmental model alone shows modest discriminatory ability (AUC = 0.68; 95% CI: 0.66, 0.70), which is only slightly increased by the addition of data on family history of NPC (AUC = 0.70; 95% CI: 0.68, 0.72). With the addition of data on genetic variants, however, our model's discriminatory ability rises to 0.74 (95% CI: 0.72, 0.76). The improvements in NRI and IDI also suggest the potential usefulness of considering genetic variants when screening for NPC in endemic areas. If these findings are confirmed in larger cohort and population-based case-control studies, use of the new models to analyse data from NPC-endemic areas could well lead to earlier detection of NPC.	[Ruan, Hong-Lian; Bei, Jin-Xin; Zeng, Yi-Xin; Jia, Wei-Hua] State Key Lab Oncol Southern China, Guangzhou, Guangdong, Peoples R China; [Ruan, Hong-Lian; Luo, Fu-Tian] Sun Yat Sen Univ, Sch Publ Hlth, Guangzhou 510275, Guangdong, Peoples R China; [Qin, Hai-De; Shugart, Yin Yao] NIMH, Unit Stat Genom, Div Intramural Res Program, NIH, Bethesda, MD 20892 USA	State Key Lab Oncology South China; Sun Yat Sen University; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Zeng, YX (corresponding author), State Key Lab Oncol Southern China, Guangzhou, Guangdong, Peoples R China.	zengyx@sysucc.org.cn; jiaweih@mail.sysu.edu.cn	Bei, Jin-Xin/AAO-1259-2020	YAO, YIN/0000-0003-3053-8429	National Natural Science Foundation of China Projects of International Cooperation and Exchanges [81220108022]; National High Technology Research and Development Program of China [2012AA02A206, 2012AA02A501]; State Basic Research Development Program of China [2011CB504303]; Ministry of Science and Technology of China [2011ZX11307]; National Science and Technology Major Project [2008ZX09312-002]; NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002929, ZIAMH002930] Funding Source: NIH RePORTER	National Natural Science Foundation of China Projects of International Cooperation and Exchanges; National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); State Basic Research Development Program of China(State Key Development Program for Basic Research of China); Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Science and Technology Major Project; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was funded by the National Natural Science Foundation of China Projects of International Cooperation and Exchanges (81220108022), the National High Technology Research and Development Program of China (2012AA02A206 and 2012AA02A501), the State Basic Research Development Program of China (2011CB504303), the Ministry of Science and Technology of China (2011ZX11307), and the National Science and Technology Major Project (2008ZX09312-002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, IARC SCI PUBL, VVIII, P1; Austin PC, 2004, J CLIN EPIDEMIOL, V57, P1138, DOI 10.1016/j.jclinepi.2004.04.003; Bach PB, 2003, JNCI-J NATL CANCER I, V95, P470, DOI 10.1093/jnci/95.6.470; Bei JX, 2010, NAT GENET, V42, P599, DOI 10.1038/ng.601; Cao SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019100; Chang ET, 2006, CANCER EPIDEM BIOMAR, V15, P1765, DOI 10.1158/1055-9965.EPI-06-0353; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Facio FM, 2010, GENET MED, V12, P370, DOI 10.1097/GIM.0b013e3181e15bd5; GAIL MH, 1989, J NATL CANCER I, V81, P1879, DOI 10.1093/jnci/81.24.1879; Gallicchio L, 2006, INT J CANCER, V119, P1125, DOI 10.1002/ijc.21946; Guttmacher AE, 2004, NEW ENGL J MED, V351, P2333, DOI 10.1056/NEJMsb042979; HENDERSON BE, 1976, NEW ENGL J MED, V295, P1101, DOI 10.1056/NEJM197611112952003; Hsu FC, 2008, CANCER GENET CYTOGEN, V183, P94, DOI 10.1016/j.cancergencyto.2008.02.008; Hsu FC, 2010, CANCER EPIDEM BIOMAR, V19, P1083, DOI 10.1158/1055-9965.EPI-09-1176; Jakobsdottir J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000337; Janssens ACJW, 2006, GENET MED, V8, P395, DOI 10.1097/01.gim.0000229689.18263.f4; Janssens ACJW, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d631; Jia WH, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-178; Jia WH, 2012, SEMIN CANCER BIOL, V22, P117, DOI 10.1016/j.semcancer.2012.01.009; Jia WH, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-446; Johansson M, 2012, INT J CANCER, V130, P129, DOI 10.1002/ijc.25986; Kathiresan S, 2008, NEW ENGL J MED, V358, P1240, DOI 10.1056/NEJMoa0706728; Kraft P, 2009, NEW ENGL J MED, V360, P1701, DOI 10.1056/NEJMp0810107; Lee AWM, 2005, INT J RADIAT ONCOL, V61, P1107, DOI 10.1016/j.ijrobp.2004.07.702; Lu CC, 2005, INT J CANCER, V115, P742, DOI 10.1002/ijc.20946; LU SJ, 1990, NATURE, V346, P470, DOI 10.1038/346470a0; Meigs JB, 2008, NEW ENGL J MED, V359, P2208, DOI 10.1056/NEJMoa0804742; Ng CC, 2009, J HUM GENET, V54, P392, DOI 10.1038/jhg.2009.49; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Paynter NP, 2010, JAMA-J AM MED ASSOC, V303, P631, DOI 10.1001/jama.2010.119; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Talmud PJ, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.b4838; Tse KP, 2009, AM J HUM GENET, V85, P194, DOI 10.1016/j.ajhg.2009.07.007; Vassy JL, 2012, BEST PRACT RES CL EN, V26, P189, DOI 10.1016/j.beem.2011.09.002; Wacholder S, 2010, NEW ENGL J MED, V362, P986, DOI 10.1056/NEJMoa0907727; Xu FH, 2012, JNCI-J NATL CANCER I, V104, P1396, DOI 10.1093/jnci/djs320; Zeng YX, 2002, SEMIN CANCER BIOL, V12, P443, DOI 10.1016/S1044579X02000871; Zheng SL, 2008, NEW ENGL J MED, V358, P910, DOI 10.1056/NEJMoa075819; Zheng SL, 2009, CLIN CANCER RES, V15, P1105, DOI 10.1158/1078-0432.CCR-08-1743; Zheng W, 2010, JNCI-J NATL CANCER I, V102, P972, DOI 10.1093/jnci/djq170	40	18	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56128	10.1371/journal.pone.0056128	http://dx.doi.org/10.1371/journal.pone.0056128			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457511	Green Submitted, Green Published, gold			2022-12-25	WOS:000315603700024
J	Sander, PR; Peer, M; Grandl, M; Bogdahn, U; Schmitz, G; Kalbitzer, HR				Sander, Paul Ramm; Peer, Markus; Grandl, Margot; Bogdahn, Ulrich; Schmitz, Gerd; Kalbitzer, Hans Robert			NMR Spectroscopy of Macrophages Loaded with Native, Oxidized or Enzymatically Degraded Lipoproteins	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; HIGH-THROUGHPUT QUANTIFICATION; H-1-NMR VISIBLE LIPIDS; SPECTROMETRY ESI-MS/MS; IN-VIVO; MOBILE LIPIDS; GENE-THERAPY; RAT-BRAIN; CHOLESTERYL ESTER; MODIFIED LDL	Oxidized and enzymatically modified low-density lipoproteins (oxLDL and eLDL) play a key role in early stages of atherogenesis. Their uptake by recruited macrophages leads to endolysosomal phospholipidosis or foam cell formation, respectively, each of which is preceded by highly differential lipid restructuring processes. We applied H-1-NMR spectroscopy (NMRS) to elucidate these structural rearrangements both in consequence of lipoprotein modifications and following phagocytosis. Being specifically sensitive to the mobile lipid subset, NMRS of oxLDL and eLDL revealed a partial and total immobilization of lipids, respectively. NMRS of intact macrophages showed a sixfold increase in mobile lipids in case of loading with eLDL but no significant changes for oxLDL or native LDL. This finding reflected the disparate lipid storage in lipid droplets and in multilamellar endolysosomal clusters when loaded with either eLDL or oxLDL, respectively. Moreover, a significant shift of the degree of saturation towards mainly polyunsaturated fatty acid chains was found for the mobile lipid pool in eLDL-loaded macrophages. Additional analyses of lipid extracts by NMRS and mass spectrometry (MS) reflected these changes in lipid content and in fatty acid composition only partially. In summary, in-cell NMRS represents a unique lipidomics tool to investigate structural changes within the mobile lipid pool following atherogenic triggers that can be not detected by the analysis of lipid extracts by MS or NMRS.	[Sander, Paul Ramm; Kalbitzer, Hans Robert] Univ Regensburg, Inst Biophys & Phys Biochem, D-93053 Regensburg, Germany; [Sander, Paul Ramm; Bogdahn, Ulrich; Kalbitzer, Hans Robert] CMRCB, Regensburg, Germany; [Sander, Paul Ramm; Bogdahn, Ulrich] Univ Regensburg, Dept Neurol, D-93053 Regensburg, Germany; [Peer, Markus; Grandl, Margot; Schmitz, Gerd] Univ Regensburg, Inst Clin Chem & Lab Med, D-93053 Regensburg, Germany	University of Regensburg; University of Regensburg; University of Regensburg	Kalbitzer, HR (corresponding author), Univ Regensburg, Inst Biophys & Phys Biochem, Univ Str 31, D-93053 Regensburg, Germany.	Hans-Robert.Kalbitzer@biologie.uni-regensburg.de		Kalbitzer, Hans Robert/0000-0002-6514-2355; Schmitz, Gerd/0000-0002-1325-1007	Fonds of the Chemical Industry (FCI); European Community's Seventh Framework Programme (FP7) [202272]; IP-Project LipidomicNet; BMBF network project "Systems Biology Consortium on Metabotypes (SysMBo)"	Fonds of the Chemical Industry (FCI)(Fonds der Chemischen Industrie); European Community's Seventh Framework Programme (FP7); IP-Project LipidomicNet; BMBF network project "Systems Biology Consortium on Metabotypes (SysMBo)"	This work was supported by the Fonds of the Chemical Industry (FCI) and by funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no 202272, IP-Project LipidomicNet and the BMBF network project "Systems Biology Consortium on Metabotypes (SysMBo)." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ala-Korpela M, 1998, J LIPID RES, V39, P1705; ALAKORPELA M, 1995, CHEM PHYS LETT, V242, P95, DOI 10.1016/0009-2614(95)00707-B; ALAKORPELA M, 1994, J LIPID RES, V35, P2292; Aranibar N, 2006, ANAL BIOCHEM, V355, P62, DOI 10.1016/j.ab.2006.04.014; BARENGHI L, 1990, FREE RADICAL RES COM, V8, P175, DOI 10.3109/10715769009087991; BEHAR KL, 1994, MAGNET RESON MED, V32, P294, DOI 10.1002/mrm.1910320304; BEHAR KL, 1991, MAGNET RESON MED, V17, P285, DOI 10.1002/mrm.1910170202; Boullier A, 2001, ANN NY ACAD SCI, V947, P214; CHAO FF, 1992, J BIOL CHEM, V267, P4992; Cooper WA, 2001, MAGNET RESON MED, V45, P1001, DOI 10.1002/mrm.1133; Delikatny EJ, 2011, NMR BIOMED, V24, P592, DOI 10.1002/nbm.1661; Grandl M, 2006, CYTOM PART A, V69A, P189, DOI 10.1002/cyto.a.20232; Griffin JL, 2003, CANCER RES, V63, P3195; Hakumaki JM, 1999, NAT MED, V5, P1323, DOI 10.1038/15279; Hakumaki JM, 2000, TRENDS BIOCHEM SCI, V25, P357, DOI 10.1016/S0968-0004(00)01614-5; Hevonoja T, 2000, BBA-MOL CELL BIOL L, V1488, P189, DOI 10.1016/S1388-1981(00)00123-2; Iorio E, 2003, BBA-MOL CELL BIOL L, V1634, P1, DOI 10.1016/j.bbalip.2003.07.001; Kapinsky M, 2001, ARTERIOSCL THROM VAS, V21, P1004, DOI 10.1161/01.ATV.21.6.1004; KAUPPINEN RA, 1993, NMR BIOMED, V6, P242, DOI 10.1002/nbm.1940060403; King N J, 1994, Immunomethods, V4, P188, DOI 10.1006/immu.1994.1019; Kumar V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018841; Le Moyec L, 2000, ANTICANCER RES, V20, P4513; Liebisch G, 1999, J LIPID RES, V40, P1539; Liebisch G, 2006, BBA-MOL CELL BIOL L, V1761, P121, DOI 10.1016/j.bbalip.2005.12.007; Liebisch G, 2004, BBA-MOL CELL BIOL L, V1686, P108, DOI 10.1016/j.bbalip.2004.09.003; Liimatainen T, 2009, NMR BIOMED, V22, P272, DOI 10.1002/nbm.1320; LINDGREN FT, 1975, LIPIDS, V10, P750, DOI 10.1007/BF02532316; LODGE JK, 1995, BBA-LIPID LIPID MET, V1256, P130, DOI 10.1016/0005-2760(94)00253-U; Loewenbruck KF, 2011, REJUV RES, V14, P371, DOI 10.1089/rej.2010.1102; Mallol R, 2012, ANAL BIOANAL CHEM, V402, P2407, DOI 10.1007/s00216-011-5705-9; Mlynarik V, 2008, J MAGN RESON, V194, P163, DOI 10.1016/j.jmr.2008.06.019; Orso E, 2011, CHEM PHYS LIPIDS, V164, P479, DOI 10.1016/j.chemphyslip.2011.06.001; OTVOS JD, 1992, CLIN CHEM, V38, P1632; Postle AD, 2012, CURR OPIN CLIN NUTR, V15, P127, DOI 10.1097/MCO.0b013e32834fb003; Quintero M, 2007, BBA-MOL CELL BIOL L, V1771, P31, DOI 10.1016/j.bbalip.2006.10.003; Ramm P, 2011, STEM CELLS DEV; Ramm P, 2009, STEM CELLS, V27, P420, DOI 10.1634/stemcells.2008-0816; Remy C, 1997, CANCER RES, V57, P407; Scherer M, 2010, J LIPID RES, V51, P2001, DOI 10.1194/jlr.D005322; Schmitz G, 2009, BBA-MOL CELL BIOL L, V1791, P524, DOI 10.1016/j.bbalip.2008.12.007; Soininen P, 2007, BIOCHEM BIOPH RES CO, V360, P290, DOI 10.1016/j.bbrc.2007.06.058; Soininen P, 2009, ANALYST, V134, P1781, DOI 10.1039/b910205a; Tkac I, 2009, MAGN RESON MED, V62, P868, DOI 10.1002/mrm.22086; Torzewski M, 1998, ARTERIOSCL THROM VAS, V18, P369, DOI 10.1161/01.ATV.18.3.369; Tukiainen T, 2008, BIOCHEM BIOPH RES CO, V375, P356, DOI 10.1016/j.bbrc.2008.08.007; Ulrich EL, 2008, NUCLEIC ACIDS RES, V36, pD402, DOI 10.1093/nar/gkm957; Wishart DS, 2009, NUCLEIC ACIDS RES, V37, pD603, DOI 10.1093/nar/gkn810; Zoula S, 2003, NMR BIOMED, V16, P199, DOI 10.1002/nbm.831	48	10	10	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56360	10.1371/journal.pone.0056360	http://dx.doi.org/10.1371/journal.pone.0056360			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457556	Green Published, Green Submitted, gold			2022-12-25	WOS:000315603700044
J	Sharma, S; Joshi, G; Dash, PK; Thomas, M; Athmaram, TN; Kumar, JS; Desai, A; Vasanthapuram, R; Patro, IK; Rao, PVL; Parida, M				Sharma, Shashi; Joshi, Gaurav; Dash, Paban K.; Thomas, Maria; Athmaram, Thimmasandra N.; Kumar, Jyoti S.; Desai, Anita; Vasanthapuram, Ravi; Patro, Ishan K.; Rao, Putcha V. L.; Parida, Manmohan			Molecular Epidemiology and Complete Genome Characterization of H1N1pdm Virus from India	PLOS ONE			English	Article							INFLUENZA-A H1N1; EMERGENCE	Background: Influenza A virus is one of world's major uncontrolled pathogen, causing seasonal epidemic as well as global pandemic. This was evidenced by recent emergence and continued prevalent 2009 swine origin pandemic H1N1 Influenza A virus, provoking first true pandemic in the past 40 years. In the course of its evolution, the virus acquired many mutations and multiple unidentified molecular determinants are likely responsible for the ability of the 2009 H1N1 virus to cause increased disease severity in humans. Availability of limited data on complete genome hampers the continuous monitoring of this type of events. Outbreaks with considerable morbidity and mortality have been reported from all parts of the country. Methods/Results: Considering a large number of clinical cases of infection complete genome based sequence characterization of Indian H1N1pdm virus and their phylogenetic analysis with respect to circulating global viruses was undertaken, to reveal the phylodynamic pattern of H1N1pdm virus in India from 2009-2011. The Clade VII was observed as a major circulating clade in phylogenetic analysis. Selection pressure analysis revealed 18 positively selected sites in major surface proteins of H1N1pdm virus. Conclusions: This study clearly revealed that clade VII has been identified as recent circulating clade in India as well globally. Few clade VII specific well identified markers undergone positive selection during virus evolution. Continuous monitoring of the H1N1pdm virus is warranted to track of the virus evolution and further transmission. This study will serve as a baseline data for future surveillance and also for development of suitable therapeutics.	[Sharma, Shashi; Joshi, Gaurav; Dash, Paban K.; Athmaram, Thimmasandra N.; Kumar, Jyoti S.; Rao, Putcha V. L.; Parida, Manmohan] DRDE, Div Virol, Gwalior, India; [Thomas, Maria; Desai, Anita; Vasanthapuram, Ravi] NIMHANS, Dept Neurovirol, Bangalore, Karnataka, India; [Patro, Ishan K.] Jiwaji Univ, Sch Studies Neurosci, Gwalior, India	Defence Research & Development Organisation (DRDO); Defence Research & Development Establishment (DRDE); National Institute of Mental Health & Neurosciences - India; Jiwaji University Gwalior	Parida, M (corresponding author), DRDE, Div Virol, Gwalior, India.	paridamm@rediffmail.com	Vasanthapuram, Ravi/AAD-5555-2019; Dash, Paban K/E-9935-2013; JOSHI, GAURAV/E-9634-2013	Dash, Paban K/0000-0003-4322-2044; Dash, Pramod/0000-0001-6746-1002; JOSHI, GAURAV/0000-0002-5028-4350	Defence Research and Development Establishment (DRDE), Gwalior an Institute under ministry of defence, Government of India	Defence Research and Development Establishment (DRDE), Gwalior an Institute under ministry of defence, Government of India	This work was funded by Defence Research and Development Establishment (DRDE), Gwalior an Institute under ministry of defence, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brookes SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009068; Broor S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029129; CDC, 2009, CDC PROT REAL TIM RT; Chakrabarti AK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007846; Chen GW, 2009, EMERG INFECT DIS, V15, P1897, DOI 10.3201/eid1512.090845; Choudhry A, 2012, INDIAN J MED RES, V135, P534; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Deem MW, 2009, PROTEIN ENG DES SEL, V22, P543, DOI 10.1093/protein/gzp027; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Hoskins JM, 1976, VIROLOGICAL PROCEDUR, P184; Li W, 2011, VIROL J, V8, P183; Nelson M., 2009, PLOS CURR, V1, DOI [DOI 10.1371/CURRENTS.RRN1126, 10.1371/currents.RRN1126]; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Ortiz JR, 2009, EMERG INFECT DIS, V15, P1271, DOI 10.3201/eid1508.081422; Pan CE, 2010, PLOS ONE, V5, pA31, DOI 10.1371/journal.pone.0009549; Potdar VA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009693; Rambaut A, 2008, NATURE, V453, P615, DOI 10.1038/nature06945; Rana Himanshu, 2012, J Assoc Physicians India, V60, P95; Rao SRJ, 2011, INDIAN J PATHOL MICR, V54, P323, DOI [10.4103/0377-4929.81588, 10.4103/0377-4929.81618]; Reid AH, 1999, P NATL ACAD SCI USA, V96, P1651, DOI 10.1073/pnas.96.4.1651; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Schrauwen EJA, 2011, EMERG INFECT DIS, V17, P200, DOI 10.3201/eid1702.101268; Sharma S, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-280; Vijaykrishna D, 2010, SCIENCE, V328, P1529, DOI 10.1126/science.1189132; World Health Organization, 2009, HUM INF PAND H1N1 20; York I, 2012, CURR TOP MICROBIOL I	28	11	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56364	10.1371/journal.pone.0056364	http://dx.doi.org/10.1371/journal.pone.0056364			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457559	gold, Green Published, Green Submitted			2022-12-25	WOS:000315603700047
J	Bissig, D; Goebel, D; Berkowitz, BA				Bissig, David; Goebel, Dennis; Berkowitz, Bruce A.			Diminished Vision in Healthy Aging Is Associated with Increased Retinal L-Type Voltage Gated Calcium Channel Ion Influx	PLOS ONE			English	Article							MANGANESE-ENHANCED MRI; HIPPOCAMPAL CA1 NEURONS; RESONANCE-IMAGING MEMRI; GANGLION-CELL LAYER; CONTRAST SENSITIVITY; RAT RETINA; EXPERIMENTAL RETINOPATHY; DEPENDENT CALCIUM; RODENT RETINA; CA2+ CURRENTS	Extensive evidence implicates an increase in hippocampal L-type voltage-gated calcium channel (L-VGCC) expression, and ion influx through these channels, in age-related cognitive declines. Here, we ask if this "calcium hypothesis" applies to the neuroretina: Is increased influx via L-VGCCs related to the well-documented but poorly-understood vision declines in healthy aging? In Long-Evans rats we find a significant age-related increase in ion flux through retinal L-VGCCs in vivo (manganese-enhanced MRI (MEMRI)) that are longitudinally linked with progressive vision declines (optokinetic tracking). Importantly, the degree of retinal Mn2+ uptake early in adulthood significantly predicted later visual contrast sensitivity declines. Furthermore, as in the aging hippocampus, retinal expression of a drug-insensitive L-VGCC isoform (alpha(1D)) increased - a pattern confirmed in vivo by an age-related decline in sensitivity to L-VGCC blockade. These data highlight mechanistic similarities between retinal and hippocampal aging, and raise the possibility of new treatment targets for minimizing vision loss during healthy aging.	[Bissig, David; Goebel, Dennis; Berkowitz, Bruce A.] Wayne State Univ, Dept Anat & Cell Biol, Detroit, MI 48202 USA; [Berkowitz, Bruce A.] Wayne State Univ, Dept Ophthalmol, Detroit, MI USA	Wayne State University; Wayne State University	Berkowitz, BA (corresponding author), Wayne State Univ, Dept Anat & Cell Biol, Detroit, MI 48202 USA.	baberko@med.wayne.edu		Bissig, David/0000-0001-9664-5433	National Institutes of Health (NIH) [EY018109]; Juvenile Diabetes Research Foundation [NIH AG034752]; Wayne State University School of Medicine MD/PhD program; Research to Prevent Blindness (Kresge Eye Institute); NATIONAL EYE INSTITUTE [R21EY018109] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F30AG034752] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Wayne State University School of Medicine MD/PhD program; Research to Prevent Blindness (Kresge Eye Institute)(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by National Institutes of Health (NIH) EY018109 (BAB), Juvenile Diabetes Research Foundation (BAB), NIH AG034752 (DB), Wayne State University School of Medicine MD/PhD program (DB), and an unrestricted grant from Research to Prevent Blindness (Kresge Eye Institute). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriaens E, 2005, TOXICOL IN VITRO, V19, P79, DOI 10.1016/j.tiv.2004.06.004; Alamouti B, 2003, BRIT J OPHTHALMOL, V87, P899, DOI 10.1136/bjo.87.7.899; BARRETT RJ, 1988, J PHARM PHARMACOL, V40, P408, DOI 10.1111/j.2042-7158.1988.tb06305.x; Berkowitz BA, 2007, INVEST OPHTH VIS SCI, V48, P4733, DOI 10.1167/iovs.06-1516; Berkowitz BA, 2007, INVEST OPHTH VIS SCI, V48, P3796, DOI 10.1167/iovs.06-1278; Berkowitz BA, 2006, INVEST OPHTH VIS SCI, V47, P2668, DOI 10.1167/iovs.05-1588; Berkowitz BA, 2011, MOL VIS, V17, P2516; Birch DG, 2002, ARCH OPHTHALMOL-CHIC, V120, P1045; Bissig D, 2011, NEUROIMAGE, V58, P749, DOI 10.1016/j.neuroimage.2011.06.062; Boehm AG, 2003, GRAEF ARCH CLIN EXP, V241, P34, DOI 10.1007/s00417-002-0592-6; BOSE S, 1995, OPHTHALMOLOGY, V102, P1236, DOI 10.1016/S0161-6420(95)30884-6; BRETON ME, 1994, INVEST OPHTH VIS SCI, V35, P295; CARLSON RO, 1994, J NEUROSCI, V14, P2272; Chang B, 2006, VISUAL NEUROSCI, V23, P11, DOI 10.1017/S095252380623102X; Charng J, 2011, INVEST OPHTH VIS SCI, V52, P8891, DOI 10.1167/iovs.11-7602; Chuang KH, 2009, MAGN RESON MED, V61, P1528, DOI 10.1002/mrm.21962; Chui TYP, 2012, J OPHTHALMOL, V2012, DOI 10.1155/2012/956705; Cross DJ, 2007, AM J NEURORADIOL, V28, P1865, DOI 10.3174/ajnr.A0693; Dittmer A, 2006, ELECTROPHORESIS, V27, P2844, DOI 10.1002/elps.200500785; Douglas RM, 2005, VISUAL NEUROSCI, V22, P677, DOI 10.1017/S0952523805225166; DRAPEAU P, 1984, J PHYSIOL-LONDON, V348, P493, DOI 10.1113/jphysiol.1984.sp015121; Eschenko O, 2010, MAGN RESON IMAGING, V28, P1165, DOI 10.1016/j.mri.2009.12.022; Feng LX, 2007, VISUAL NEUROSCI, V24, P799, DOI 10.1017/S0952523807070721; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; GLOSSMANN H, 1983, FEBS LETT, V160, P226, DOI 10.1016/0014-5793(83)80972-7; GONZALEZ GG, 1993, INVEST OPHTH VIS SCI, V34, P3329; Hariri S, 2009, OPT EXPRESS, V17, P24304, DOI 10.1364/OE.17.024304; Harman A, 2000, ANAT REC, V260, P124; Harman AM, 2003, GERONTOLOGY, V49, P350, DOI 10.1159/000073762; Hasegawa AE, 1997, ANESTH ANALG, V85, P633, DOI 10.1097/00000539-199709000-00026; HENKEL AW, 1994, ANAL BIOCHEM, V223, P329, DOI 10.1006/abio.1994.1595; Jackson SJ, 2011, BEHAV BRAIN RES, V216, P293, DOI 10.1016/j.bbr.2010.08.007; KAGEYAMA M, 1995, J OCUL PHARMACOL TH, V11, P553, DOI 10.1089/jop.1995.11.553; Kang S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2149; Karst H, 1997, SYNAPSE, V26, P155; KATZ ML, 1986, EXP EYE RES, V42, P293, DOI 10.1016/0014-4835(86)90022-9; KOCH KW, 1985, J BIOL CHEM, V260, P6788; Kolesnikov AV, 2010, J NEUROSCI, V30, P11222, DOI 10.1523/JNEUROSCI.4239-09.2010; Koschak A, 2001, J BIOL CHEM, V276, P22100, DOI 10.1074/jbc.M101469200; Koulen P, 1999, P NATL ACAD SCI USA, V96, P9909, DOI 10.1073/pnas.96.17.9909; LINDNER MD, 1991, BEHAV BRAIN RES, V45, P45, DOI 10.1016/S0166-4328(05)80179-2; Melena J, 2001, EXP EYE RES, V72, P393, DOI 10.1006/exer.2000.0968; Nachman-Clewner M, 1999, J COMP NEUROL, V415, P1, DOI 10.1002/(SICI)1096-9861(19991206)415:1<1::AID-CNE1>3.0.CO;2-G; Norris CM, 1998, J NEUROSCI, V18, P3171; OWSLEY C, 1983, VISION RES, V23, P689, DOI 10.1016/0042-6989(83)90210-9; Protti DA, 1998, J NEUROSCI, V18, P3715; Prusky GT, 2004, INVEST OPHTH VIS SCI, V45, P4611, DOI 10.1167/iovs.04-0541; Qu YX, 2011, PEDIATR RES, V69, P479, DOI 10.1203/PDR.0b013e318217a0df; Rubin GS, 1997, INVEST OPHTH VIS SCI, V38, P557; Schmitz Y, 1997, NEUROSCIENCE, V78, P1209, DOI 10.1016/S0306-4522(96)00678-1; Shah GM, 1995, ANAL BIOCHEM, V232, P251, DOI 10.1006/abio.1995.0016; Silva AC, 2004, NMR BIOMED, V17, P532, DOI 10.1002/nbm.945; SPEAR PD, 1993, VISION RES, V33, P2589, DOI 10.1016/0042-6989(93)90218-L; Srinivasan VJ, 2006, OPT LETT, V31, P2308, DOI 10.1364/OL.31.002308; Srinivasan VJ, 2006, INVEST OPHTH VIS SCI, V47, P5522, DOI 10.1167/iovs.06-0195; Tarabova B, 2007, EUR J PHARMACOL, V573, P39, DOI 10.1016/j.ejphar.2007.06.050; Thibault O, 1996, SCIENCE, V272, P1017, DOI 10.1126/science.272.5264.1017; Thibault O, 2001, J NEUROSCI, V21, P9744, DOI 10.1523/JNEUROSCI.21-24-09744.2001; Tofts PS, 2010, BRAIN RES BULL, V81, P333, DOI 10.1016/j.brainresbull.2009.06.002; Tombaugh GC, 2005, J NEUROSCI, V25, P2609, DOI 10.1523/JNEUROSCI.5023-04.2005; van Alphen B, 2009, INVEST OPHTH VIS SCI, V50, P2451, DOI 10.1167/iovs.08-2594; Veng LM, 2003, MOL BRAIN RES, V110, P193, DOI 10.1016/S0169-328X(02)00643-5; Veng LM, 2002, MOL BRAIN RES, V107, P120, DOI 10.1016/S0169-328X(02)00453-9; VINORES SA, 1990, J HISTOCHEM CYTOCHEM, V38, P1341, DOI 10.1177/38.9.2117624; Xu HP, 2002, NEUROSCI LETT, V329, P297, DOI 10.1016/S0304-3940(02)00688-2; Xu WF, 2001, J NEUROSCI, V21, P5944, DOI 10.1523/JNEUROSCI.21-16-05944.2001; YAU KW, 1994, INVEST OPHTH VIS SCI, V35, P9	67	20	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56340	10.1371/journal.pone.0056340	http://dx.doi.org/10.1371/journal.pone.0056340			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457553	Green Submitted, Green Published, gold			2022-12-25	WOS:000315602700069
J	de Bruyn, JR; Goiko, M; Mozaffari, M; Bator, D; Dauphinee, RL; Liao, YY; Flemming, RL; Bramble, MS; Hunter, GK; Goldberg, HA				de Bruyn, John R.; Goiko, Maria; Mozaffari, Maryam; Bator, Daniel; Dauphinee, Ron L.; Liao, Yinyin; Flemming, Roberta L.; Bramble, Michael S.; Hunter, Graeme K.; Goldberg, Harvey A.			Dynamic Light Scattering Study of Inhibition of Nucleation and Growth of Hydroxyapatite Crystals by Osteopontin	PLOS ONE			English	Article							BINDING-PROPERTIES; BONE SIALOPROTEIN; CALCIUM-PHOSPHATE; IN-VITRO; PHOSPHORYLATION; CRYSTALLIZATION; PROTEINS; CALCIFICATION; KINETICS	We study the effect of isoforms of osteopontin (OPN) on the nucleation and growth of crystals from a supersaturated solution of calcium and phosphate ions. Dynamic light scattering is used to monitor the size of the precipitating particles and to provide information about their concentration. At the ion concentrations studied, immediate precipitation was observed in control experiments with no osteopontin in the solution, and the size of the precipitating particles increased steadily with time. The precipitate was identified as hydroxyapatite by X-ray diffraction. Addition of native osteopontin (nOPN) extracted from rat bone caused a delay in the onset of precipitation and reduced the number of particles that formed, but the few particles that did form grew to a larger size than in the absence of the protein. Recombinant osteopontin (rOPN), which lacks phosphorylation, caused no delay in initial calcium phosphate precipitation but severely slowed crystal growth, suggesting that rOPN inhibits growth but not nucleation. rOPN treated with protein kinase CK2 to phosphorylate the molecule (p-rOPN) produced an effect similar to that of nOPN, but at higher protein concentrations and to a lesser extent. These results suggest that phosphorylations are critical to OPN's ability to inhibit nucleation, whereas the growth of the hydroxyapatite crystals is effectively controlled by the highly acidic OPN polypeptide. This work also demonstrates that dynamic light scattering can be a powerful tool for delineating the mechanism of protein modulation of mineral formation.	[de Bruyn, John R.; Goiko, Maria; Mozaffari, Maryam; Dauphinee, Ron L.] Univ Western Ontario, Dept Phys & Astron, London, ON, Canada; [Bator, Daniel; Hunter, Graeme K.] Univ Western Ontario, Dept Chem, London, ON, Canada; [Liao, Yinyin; Hunter, Graeme K.; Goldberg, Harvey A.] Univ Western Ontario, Sch Dent, London, ON, Canada; [Liao, Yinyin; Hunter, Graeme K.; Goldberg, Harvey A.] Univ Western Ontario, Dept Biochem, London, ON, Canada; [Flemming, Roberta L.; Bramble, Michael S.] Univ Western Ontario, Dept Earth Sci, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	de Bruyn, JR (corresponding author), Univ Western Ontario, Dept Phys & Astron, London, ON, Canada.	debruyn@uwo.ca	Goldberg, Harvey/B-5742-2015	Bramble, Michael/0000-0002-9440-4756	Canadian Institutes of Health Research; Natural Science and Engineering Research Council of Canada; Academic Development Fund of the University of Western Ontario	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Academic Development Fund of the University of Western Ontario	This research was supported by the Canadian Institutes of Health Research, the Natural Science and Engineering Research Council of Canada, and the Academic Development Fund of the University of Western Ontario. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addadi L, 2001, Z Kardiol, V90 Suppl 3, P92; Azzopardi PV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009330; Baht GS, 2010, BIOCHEM J, V428, P385, DOI 10.1042/BJ20091864; BERNE B. J., 1976, DYNAMIC LIGHT SCATTE; BOSKEY AL, 1993, BONE MINER, V22, P147, DOI 10.1016/S0169-6009(08)80225-5; BOSKEY AL, 1992, CLIN ORTHOP RELAT R, P244; BUTLER WT, 1995, ANN NY ACAD SCI, V760, P6, DOI 10.1111/j.1749-6632.1995.tb44615.x; CHEN Y, 1992, J BIOL CHEM, V267, P24871; De Yoreo JJ, 2004, SCIENCE, V306, P1301, DOI 10.1126/science.1100889; Fisher LW, 2001, BIOCHEM BIOPH RES CO, V280, P460, DOI 10.1006/bbrc.2000.4146; Flemming RL, 2007, CAN J EARTH SCI, V44, P1333, DOI 10.1139/e07-020; Frisken BJ, 2001, APPL OPTICS, V40, P4087, DOI 10.1364/AO.40.004087; George A, 2008, CHEM REV, V108, P4670, DOI 10.1021/cr0782729; Gericke A, 2005, CALCIFIED TISSUE INT, V77, P45, DOI 10.1007/s00223-004-1288-1; Giachelli C M, 2005, Orthod Craniofac Res, V8, P229, DOI 10.1111/j.1601-6343.2005.00345.x; Grohe B, 2007, J AM CHEM SOC, V129, P14946, DOI 10.1021/ja0745613; Grohe B, 2009, LANGMUIR, V25, P11635, DOI 10.1021/la901145d; Heiss A, 2003, J BIOL CHEM, V278, P13333, DOI 10.1074/jbc.M210868200; Hincke M.T., 2000, CHEM BIOL MINERALIZE, P13; Hoyer JR, 2001, KIDNEY INT, V60, P77, DOI 10.1046/j.1523-1755.2001.00772.x; Hunter GK, 1996, BIOCHEM J, V317, P59, DOI 10.1042/bj3170059; HUNTER GK, 1994, BIOCHEM J, V300, P723, DOI 10.1042/bj3000723; Kamiya N, 2011, B CHEM SOC JPN, V84, P344, DOI 10.1246/bcsj.20100228; Keykhosravani M, 2005, BIOCHEMISTRY-US, V44, P6990, DOI 10.1021/bi050109p; Li SY, 2012, CRYSTENGCOMM, V14, P8037, DOI 10.1039/c2ce26140e; Lowenstam HA, 1989, BIOMINERALIZATION; Mann S., 2001, BIOMINERALIZATION PR; NANCOLLAS GH, 1970, ARCH ORAL BIOL, V15, P731, DOI 10.1016/0003-9969(70)90037-3; O'Young J, 2011, J AM CHEM SOC, V133, P18406, DOI 10.1021/ja207628k; Onuma K, 2000, J PHYS CHEM B, V104, P10563, DOI 10.1021/jp002697g; Onuma K, 1998, CHEM MATER, V10, P3346, DOI 10.1021/cm980062c; Oyane A, 1999, J PHYS CHEM B, V103, P8230, DOI 10.1021/jp9910340; Pampena DA, 2004, BIOCHEM J, V378, P1083, DOI 10.1042/BJ20031150; PROVENCHER SW, 1982, COMPUT PHYS COMMUN, V27, P229, DOI 10.1016/0010-4655(82)90174-6; QI Z, 1990, J BIOL CHEM, V265, P7583; SHIRAGA H, 1992, P NATL ACAD SCI USA, V89, P426, DOI 10.1073/pnas.89.1.426; SINGH K, 1993, J BIOCHEM-TOKYO, V114, P702, DOI 10.1093/oxfordjournals.jbchem.a124240; TOMSON MB, 1978, SCIENCE, V200, P1059, DOI 10.1126/science.200.4345.1059; Wang LJ, 2008, J PHYS CHEM B, V112, P9151, DOI 10.1021/jp804282u; Xu R, 2000, PARTICLE CHARACTERIZ	40	35	36	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56764	10.1371/journal.pone.0056764	http://dx.doi.org/10.1371/journal.pone.0056764			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457612	Green Published, gold, Green Submitted			2022-12-25	WOS:000315602700092
J	Dugas, AF; Jalalpour, M; Gel, Y; Levin, S; Torcaso, F; Igusa, T; Rothman, RE				Dugas, Andrea Freyer; Jalalpour, Mehdi; Gel, Yulia; Levin, Scott; Torcaso, Fred; Igusa, Takeru; Rothman, Richard E.			Influenza Forecasting with Google Flu Trends	PLOS ONE			English	Article							TIME-SERIES ANALYSIS; SURVEILLANCE; TRANSMISSION; ASSOCIATION; PREDICTION; PNEUMONIA; EPIDEMICS; OUTBREAKS; DYNAMICS; SPREAD	Background: We developed a practical influenza forecast model based on real-time, geographically focused, and easy to access data, designed to provide individual medical centers with advanced warning of the expected number of influenza cases, thus allowing for sufficient time to implement interventions. Secondly, we evaluated the effects of incorporating a real-time influenza surveillance system, Google Flu Trends, and meteorological and temporal information on forecast accuracy. Methods: Forecast models designed to predict one week in advance were developed from weekly counts of confirmed influenza cases over seven seasons (2004-2011) divided into seven training and out-of-sample verification sets. Forecasting procedures using classical Box-Jenkins, generalized linear models (GLM), and generalized linear autoregressive moving average (GARMA) methods were employed to develop the final model and assess the relative contribution of external variables such as, Google Flu Trends, meteorological data, and temporal information. Results: A GARMA(3,0) forecast model with Negative Binomial distribution integrating Google Flu Trends information provided the most accurate influenza case predictions. The model, on the average, predicts weekly influenza cases during 7 out-of-sample outbreaks within 7 cases for 83% of estimates. Google Flu Trend data was the only source of external information to provide statistically significant forecast improvements over the base model in four of the seven out-of-sample verification sets. Overall, the p-value of adding this external information to the model is 0.0005. The other exogenous variables did not yield a statistically significant improvement in any of the verification sets. Conclusions: Integer-valued autoregression of influenza cases provides a strong base forecast model, which is enhanced by the addition of Google Flu Trends confirming the predictive capabilities of search query based syndromic surveillance. This accessible and flexible forecast model can be used by individual medical centers to provide advanced warning of future influenza cases.	[Dugas, Andrea Freyer; Levin, Scott; Rothman, Richard E.] Johns Hopkins Univ, Dept Emergency Med, Baltimore, MD 21218 USA; [Jalalpour, Mehdi; Gel, Yulia; Levin, Scott; Torcaso, Fred; Igusa, Takeru] Johns Hopkins Univ, Whiting Sch Engn, Baltimore, MD USA; [Gel, Yulia] Univ Waterloo, Waterloo, ON N2L 3G1, Canada	Johns Hopkins University; Johns Hopkins University; University of Waterloo	Dugas, AF (corresponding author), Johns Hopkins Univ, Dept Emergency Med, Baltimore, MD 21218 USA.	adugas1@jhmi.edu	Igusa, Takeru/A-3218-2010	Igusa, Takeru/0000-0002-3632-2867; Rothman, Richard/0000-0002-1017-9505	Department of Homeland Security (PACER: National Center for Study of Preparedness and Response) [2010-ST-061-PA0001]; National Science Foundation Systems Engineering and Design Program [NSF CMMI 0927207]; Natural Sciences and Engineering Research Council of Canada	Department of Homeland Security (PACER: National Center for Study of Preparedness and Response)(United States Department of Homeland Security (DHS)); National Science Foundation Systems Engineering and Design Program; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by the Department of Homeland Security (PACER: National Center for Study of Preparedness and Response [grant number: 2010-ST-061-PA0001]); the National Science Foundation Systems Engineering and Design Program [grant number: NSF CMMI 0927207]; and the Natural Sciences and Engineering Research Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman SA, 2002, METEOROLOGY UNDERSTA; Benjamin MA, 2003, J AM STAT ASSOC, V98, P214, DOI 10.1198/016214503388619238; Bernstein SL, 2009, ACAD EMERG MED, V16, P1, DOI 10.1111/j.1553-2712.2008.00295.x; Birrell PJ, 2011, P NATL ACAD SCI USA, V108, P18238, DOI 10.1073/pnas.1103002108; Boyle JR, 2011, MED J AUSTRALIA, V194, pS28; Buehler JW, 2009, BIOSECUR BIOTERROR, V7, P165, DOI 10.1089/bsp.2009.0013; Cook S, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0023610, 10.1371/journal.pone.0025407]; Dugas AF, 2012, CLIN INFECT DIS, V54, P463, DOI 10.1093/cid/cir883; Dukic V, 2012, J AM STAT ASSOC, V107, P1410, DOI 10.1080/01621459.2012.713876; Farias DR, 2010, DISASTER MED PUBLIC, V4, P207, DOI 10.1001/dmp.2010.29; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; Glaser CA, 2002, EMERG INFECT DIS, V8, P569, DOI 10.3201/eid0806.010370; Google, 2012, GOOGL FLU TRENDS; Hall IM, 2007, EPIDEMIOL INFECT, V135, P372, DOI 10.1017/S0950268806007084; Jalalpour M, 2012, GARMA TOOLKIT; Kedem B, 2005, REGRESSION MODELS TI, V488; Kim MJ, 2011, IIE T HEALTHCARE SYS, V1, P37; LONGINI IM, 1986, AM J EPIDEMIOL, V123, P383, DOI 10.1093/oxfordjournals.aje.a114253; Lowen AC, 2007, PLOS PATHOG, V3, P1470, DOI 10.1371/journal.ppat.0030151; McDonnell WM, 2012, AM J EMERG MED, V30, P275, DOI 10.1016/j.ajem.2010.11.027; Nishiura H, 2011, BIOMED ENG ONLINE, V10, DOI 10.1186/1475-925X-10-15; Ortiz JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018687; Osterholm MT, 2005, NEW ENGL J MED, V352, P1839, DOI 10.1056/NEJMp058068; Pines JM, 2006, ACAD EMERG MED, V13, P873, DOI [10.1197/j.aem.2006.03.568, 10.1111/j.1553-2712.2006.tb01741.x]; Pines JM, 2010, ACAD EMERG MED, V17, P276, DOI 10.1111/j.1553-2712.2009.00676.x; Pines JM, 2009, ACAD EMERG MED, V16, P617, DOI 10.1111/j.1553-2712.2009.00456.x; Quenel P, 1998, EUR J EPIDEMIOL, V14, P275, DOI 10.1023/A:1007467814485; Rebmann T, 2009, AM J INFECT CONTROL, V37, P271, DOI 10.1016/j.ajic.2008.12.002; Reeder Blaine, 2011, BMC Res Notes, V4, P187, DOI 10.1186/1756-0500-4-187; Schull MJ, 2004, ANN EMERG MED, V44, P61, DOI 10.1016/j.annemergmed.2003.12.008; Sloan C, 2011, CTS-CLIN TRANSL SCI, V4, P48, DOI 10.1111/j.1752-8062.2010.00257.x; Soebiyanto RP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009450; STROUP DF, 1988, STAT MED, V7, P1045, DOI 10.1002/sim.4780071006; Viboud C, 2003, AM J EPIDEMIOL, V158, P996, DOI 10.1093/aje/kwg239; Warden GL, 2006, ANN EMERG MED, V48, P115, DOI 10.1016/j.annemergmed.2006.06.015; WHO, 2009, INFL SEAS	36	186	199	2	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56176	10.1371/journal.pone.0056176	http://dx.doi.org/10.1371/journal.pone.0056176			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457520	Green Published, gold			2022-12-25	WOS:000315602700054
J	Dutta, S; Guin, S; Ghosh, S; Pazhani, GP; Rajendran, K; Bhattacharya, MK; Takeda, Y; Nair, GB; Ramamurthy, T				Dutta, Sanjucta; Guin, Sucharita; Ghosh, Santanu; Pazhani, Gururaja P.; Rajendran, Krishnan; Bhattacharya, Mihir K.; Takeda, Yoshifumi; Nair, G. Balakrish; Ramamurthy, Thandavarayan			Trends in the Prevalence of Diarrheagenic Escherichia coli among Hospitalized Diarrheal Patients in Kolkata, India	PLOS ONE			English	Article							DISEASE BURDEN; CHILDREN; IDENTIFICATION; INFECTION; EPIDEMIOLOGY; PATHOGENS; INFANTS	Background: To analyse the trends in the prevalence of different pathogroups of diarrheagenic Escherichia coli (DEC) among hospitalized acute diarrheal patients. Methodology/Principal Findings: From the active surveillance of diarrheal disease at the Infectious Diseases Hospital, Kolkata, 3826 stool specimens collected during 2008-2011 were screened for DEC and other enteric pathogens. PCR was used in the detection of enterotoxigenic, enteropathogenic and enteroaggregative E. coli and 10 major colonization factor antigens (CFs) of enterotoxigenic E. coli. The relationship between DEC infected patient's age group and clinical symptoms were also investigated. Multiplex PCR assay showed that the prevalence of EAEC was most common (5.7%) followed by ETEC (4.2%) and EPEC (1.8%). In diarrheal children >2 year of age, EAEC and EPEC were detected significantly (p = 0.000 and 0.007, respectively). In children >2 to 5 and >5 to 14 years, ETEC was significantly associated with diarrhea (p = 0.000 each). EAEC was significantly associated with diarrheal patients with age groups >14 to 30 and >30 to 50 years (p = 0.001, and p = 0.009, respectively). Clinical symptoms such as vomiting, abdominal pain, watery diarrhea, were recorded in patients infected with ETEC. Dehydration status was severe among patients infected by ST-ETEC (19%) and EPEC (15%). CS6 was frequently detected (37%) among ETEC. Conclusions/Significance: Hospital based surveillance reviled that specific pathogroups of DEC are important to certain age groups and among ETEC, CS6 was predominant.	[Dutta, Sanjucta; Ghosh, Santanu; Pazhani, Gururaja P.; Rajendran, Krishnan; Ramamurthy, Thandavarayan] Okayama Univ Infect Dis India, Div Bacteriol, Collaborat Res Ctr, Kolkata, W Bengal, India; [Guin, Sucharita; Bhattacharya, Mihir K.] Okayama Univ Infect Dis India, Clin Div, Inst Cholera & Enter Dis, Collaborat Res Ctr, Kolkata, W Bengal, India; [Takeda, Yoshifumi] Natl Inst Cholera & Enter Dis, Kolkata, W Bengal, India; [Nair, G. Balakrish] Translat Hlth Sci & Technol Inst, Gurgaon, Haryana, India	Okayama University; Okayama University; Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED); Department of Biotechnology (DBT) India; Translational Health Science & Technology Institute (THSTI)	Ramamurthy, T (corresponding author), Okayama Univ Infect Dis India, Div Bacteriol, Collaborat Res Ctr, Kolkata, W Bengal, India.	tramu@vsnl.net	KRISHNAN, RAJENDRAN/L-6274-2019	dutta, sanjucta/0000-0002-8850-9914; Pazhani, Gururaja Perumal/0000-0001-9500-006X	Japan Initiative for Global Research Network on Infectious Diseases, Ministry of Education, Culture, Sports, Science and Technology, Japan; Indian Council of Medical Research, New Delhi, India	Japan Initiative for Global Research Network on Infectious Diseases, Ministry of Education, Culture, Sports, Science and Technology, Japan; Indian Council of Medical Research, New Delhi, India(Indian Council of Medical Research (ICMR))	This work was supported in part by the Japan Initiative for Global Research Network on Infectious Diseases, Ministry of Education, Culture, Sports, Science and Technology, Japan and from intramural grants of the Indian Council of Medical Research, New Delhi, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERT MJ, 1995, J CLIN MICROBIOL, V33, P973, DOI 10.1128/JCM.33.4.973-977.1995; BAUDRY B, 1990, J INFECT DIS, V161, P1249, DOI 10.1093/infdis/161.6.1249; BINSZTEIN N, 1991, J CLIN MICROBIOL, V29, P1893, DOI 10.1128/JCM.29.9.1893-1898.1991; CASALINO M, 1988, T ROY SOC TROP MED H, V82, P637, DOI 10.1016/0035-9203(88)90542-1; Chen HD, 2005, FEMS MICROBIOL REV, V29, P83, DOI 10.1016/j.femsre.2004.07.002; Cho SH, 2006, J MICROBIOL, V44, P327; Clarke SC, 2001, DIAGN MICR INFEC DIS, V41, P93, DOI 10.1016/S0732-8893(01)00303-0; Dudley EG, 2006, MOL MICROBIOL, V61, P1267, DOI 10.1111/j.1365-2958.2006.05281.x; ECHEVERRIA P, 1983, DIAGN MICR INFEC DIS, V1, P193, DOI 10.1016/0732-8893(83)90018-4; ECHEVERRIA P, 1991, J INFECT DIS, V164, P550, DOI 10.1093/infdis/164.3.550; Estrada-Garcia T, 2009, J CLIN MICROBIOL, V47, P93, DOI 10.1128/JCM.01166-08; Faruque ASG, 1998, SCAND J INFECT DIS, V30, P393, DOI 10.1080/00365549850160701; Ghosal A, 2007, J CLIN MICROBIOL, V45, P3068, DOI 10.1128/JCM.00646-07; GIRON JA, 1991, SCIENCE, V254, P710, DOI 10.1126/science.1683004; Isidean SD, 2011, VACCINE, V29, P6167, DOI 10.1016/j.vaccine.2011.06.084; Jafari F, 2009, J INFECTION, V58, P21, DOI 10.1016/j.jinf.2008.10.013; Jenkins C, 2006, DIAGN MICR INFEC DIS, V55, P13, DOI 10.1016/j.diagmicrobio.2005.10.019; Kahali S, 2004, J CLIN MICROBIOL, V42, P4111, DOI 10.1128/JCM.42.9.4111-4120.2004; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Melo AR, 2005, SCAND J IMMUNOL, V61, P511, DOI 10.1111/j.1365-3083.2005.01626.x; Moyo SJ, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-92; Nair GB, 2010, GUT PATHOG, V2, DOI 10.1186/1757-4749-2-4; Nataro JP, 2006, CLIN INFECT DIS, V43, P402, DOI 10.1086/505867; Nguyen RN, 2006, EMERG INFECT DIS, V12, P597; Nguyen TV, 2005, J CLIN MICROBIOL, V43, P755, DOI 10.1128/JCM.43.2.755-760.2005; O'Ryan Miguel, 2005, Semin Pediatr Infect Dis, V16, P125, DOI 10.1053/j.spid.2005.12.008; Ochoa TJ, 2008, T ROY SOC TROP MED H, V102, P852, DOI 10.1016/j.trstmh.2008.03.017; Ochoa TJ, 2009, CLIN INFECT DIS, V49, P1694, DOI 10.1086/648069; Okeke I N, 2001, Lancet Infect Dis, V1, P304, DOI 10.1016/S1473-3099(01)00144-X; Panchalingam S, 2012, CLIN INFECT DIS, V55, pS294, DOI 10.1093/cid/cis754; Paniagua M, 1997, J CLIN MICROBIOL, V35, P1404, DOI 10.1128/JCM.35.6.1404-1410.1997; Qadri F, 2007, INFECT IMMUN, V75, P3961, DOI 10.1128/IAI.00459-07; Rao MR, 2003, J CLIN MICROBIOL, V41, P4862, DOI 10.1128/JCM.41.10.4862-4864.2003; Regua-Mangia AH, 2004, J INFECTION, V48, P161, DOI 10.1016/S0163-4453(03)00138-5; Sarantuya J, 2004, J CLIN MICROBIOL, V42, P133, DOI 10.1128/JCM.42.1.133-139.2004	35	36	40	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56068	10.1371/journal.pone.0056068	http://dx.doi.org/10.1371/journal.pone.0056068			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457500	Green Published, gold, Green Submitted			2022-12-25	WOS:000315602700039
J	Nurhonen, M; Cheng, AC; Auranen, K				Nurhonen, Markku; Cheng, Allen C.; Auranen, Kari			Pneumococcal Transmission and Disease In Silico: A Microsimulation Model of the Indirect Effects of Vaccination	PLOS ONE			English	Article							INFLUENZAE TYPE-B; STREPTOCOCCUS-PNEUMONIAE; CONJUGATE VACCINATION; SEROTYPE REPLACEMENT; NASOPHARYNGEAL CARRIAGE; CHILDREN YOUNGER; POPULATION; IMPACT; VACCINES; IMMUNITY	Background: The degree and time frame of indirect effects of vaccination (serotype replacement and herd immunity) are key determinants in assessing the net effectiveness of vaccination with pneumococcal conjugate vaccines (PCV) in control of pneumococcal disease. Using modelling, we aimed to quantify these effects and their dependence on coverage of vaccination and the vaccine's efficacy against susceptibility to pneumococcal carriage. Methods and Findings: We constructed an individual-based simulation model that explores the effects of large-scale PCV programmes and applied it in a developed country setting (Finland). A population structure with transmission of carriage taking place within relevant mixing groups (families, day care groups, schools and neighbourhoods) was considered in order to properly assess the dependency of herd immunity on coverage of vaccination and vaccine efficacy against carriage. Issues regarding potential serotype replacement were addressed by employing a novel competition structure between multiple pneumococcal serotypes. Model parameters were calibrated from pre-vaccination data about the age-specific carriage prevalence and serotype distribution. The model predicts that elimination of vaccine-type carriage and disease among those vaccinated and, due to a substantial herd effect, also among the general population takes place within 5-10 years since the onset of a PCV programme with high (90%) coverage of vaccination and moderate (50%) vaccine efficacy against acquisition of carriage. A near-complete replacement of vaccine-type carriage by non-vaccine-type carriage occurs within the same time frame. Conclusions: The changed patterns in pneumococcal carriage after PCV vaccination predicted by the model are unequivocal. The overall effect on disease incidence depends crucially on the magnitude of age-and serotype-specific case-to-carrier ratios of the remaining serotypes relative to those of the vaccine types. Thus the availability of reliable data on the incidence of both pneumococcal carriage and disease is essential in assessing the net effectiveness of PCV vaccination in a given epidemiological setting.	[Nurhonen, Markku; Auranen, Kari] Natl Inst Hlth & Welf, Dept Vaccinat & Immune Protect, Helsinki, Finland; [Cheng, Allen C.] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia; [Cheng, Allen C.] Alfred Hosp, Infect Dis Unit, Melbourne, Vic, Australia	Finland National Institute for Health & Welfare; Monash University; Florey Institute of Neuroscience & Mental Health	Nurhonen, M (corresponding author), Natl Inst Hlth & Welf, Dept Vaccinat & Immune Protect, Helsinki, Finland.	markku.nurhonen@thl.fi		Cheng, Allen/0000-0003-3152-116X	Bill and Melinda Gates Foundation through Grand Challenges in Global Health Initiative; Academy of Finland [138068]	Bill and Melinda Gates Foundation through Grand Challenges in Global Health Initiative; Academy of Finland(Academy of Finland)	This study is a part of the research of the PneumoCarr Consortium (www.pneumocarr.org) funded by a grant from the Bill and Melinda Gates Foundation through the Grand Challenges in Global Health Initiative. Additional funding was provided by grant 138068 from the Academy of Finland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auranen K, 2004, EPIDEMIOL INFECT, V132, P947, DOI 10.1017/S0950268804002493; Beutels P, 2007, VACCINE, V25, P1355, DOI 10.1016/j.vaccine.2006.10.034; Brueggemann AB, 2004, J INFECT DIS, V190, P1203, DOI 10.1086/423820; Calix JJ, 2010, J INFECT DIS, V202, P29, DOI 10.1086/653123; Choi YH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026190; Cobey S, 2012, SCIENCE, V335, P1376, DOI 10.1126/science.1215947; De Wals P, 2009, CLIN THER, V31, P2152, DOI 10.1016/j.clinthera.2009.10.014; Flasche S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001017; Garnett GP, 2011, LANCET, V378, P515, DOI 10.1016/S0140-6736(10)61505-X; Halloran ME., 2010, DESIGN ANAL VACCINE; Hanage WP, 2010, EPIDEMICS-NETH, V2, P80, DOI 10.1016/j.epidem.2010.03.005; Hanage WP, 2005, INFECT IMMUN, V73, P431, DOI 10.1128/IAI.73.1.431-435.2005; Hoti F, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-102; Iozzi F, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001021; Karlsson D, 2011, EPIDEMIOL INFECT, V139, P1351, DOI 10.1017/S0950268810002773; Leino T, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-173; Levine OS, 2010, CURR OPIN INFECT DIS, V23, P236, DOI 10.1097/QCO.0b013e328338c135; Lipsitch M, 1997, P NATL ACAD SCI USA, V94, P6571, DOI 10.1073/pnas.94.12.6571; Lipsitch M, 2007, J INFECT DIS, V196, P1221, DOI 10.1086/521831; Mbelle N, 1999, J INFECT DIS, V180, P1171, DOI 10.1086/315009; Melegaro A, 2007, AM J EPIDEMIOL, V166, P228, DOI 10.1093/aje/kwm076; Melegaro A, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-90; Miller E, 2011, LANCET INFECT DIS, V11, P760, DOI 10.1016/S1473-3099(11)70090-1; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Obaro SK, 1996, LANCET, V348, P271, DOI 10.1016/S0140-6736(05)65585-7; Palmu AA, 2002, 3 INT S PNEUM PNEUM; Park IH, 2008, J INFECT DIS, V198, P1818, DOI 10.1086/593339; Pavia M, 2009, PEDIATRICS, V123, pE1103, DOI 10.1542/peds.2008-3422; Pilishvili T, 2010, J INFECT DIS, V201, P32, DOI 10.1086/648593; Rinta-Kokko H, 2009, VACCINE, V27, P3831, DOI 10.1016/j.vaccine.2009.04.009; Sleeman KL, 2006, J INFECT DIS, V194, P682, DOI 10.1086/505710; Spijkerman J, 2011, EMERG INFECT DIS, V17, P584, DOI 10.3201/eid1704.101115; Syrjanen RK, 2001, J INFECT DIS, V184, P451, DOI 10.1086/322048; Talbird SE, 2010, VACCINE, V28, pG3, DOI 10.1016/j.vaccine.2010.06.013; Temime L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003244; Van Effelterre T, 2010, VACCINE, V28, P3650, DOI 10.1016/j.vaccine.2010.03.030; Vestrheim DF, 2010, CLIN VACCINE IMMUNOL, V17, P325, DOI 10.1128/CVI.00435-09; Wallinga J, 2010, P NATL ACAD SCI USA, V107, P923, DOI 10.1073/pnas.0908491107; Weinberger DM, 2011, LANCET, V378, P1962, DOI 10.1016/S0140-6736(10)62225-8; Weinberger DM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000476; Weiser JN, 2010, J MOL MED, V88, P97, DOI 10.1007/s00109-009-0557-x	41	36	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e56079	10.1371/journal.pone.0056079	http://dx.doi.org/10.1371/journal.pone.0056079			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23457504	Green Published, gold, Green Submitted			2022-12-25	WOS:000315153400199
J	Hofkens, W; Schelbergen, R; Storm, G; van den Berg, WB; van Lent, PL				Hofkens, Wouter; Schelbergen, Rik; Storm, Gert; van den Berg, Wim B.; van Lent, Peter L.			Liposomal Targeting of Prednisolone Phosphate to Synovial Lining Macrophages during Experimental Arthritis Inhibits M1 Activation but Does Not Favor M2 Differentiation	PLOS ONE			English	Article							IMMUNE-COMPLEX ARTHRITIS; NITRIC-OXIDE SYNTHASE; JOINT INFLAMMATION; HUMAN MONOCYTES; GLUCOCORTICOIDS INDUCE; CARTILAGE DESTRUCTION; RHEUMATOID-ARTHRITIS; CHONDROCYTE DEATH; II ARTHRITIS; CELLS	Background: To determine the effects of liposomal targeting of prednisolone phosphate (Lip-PLP) to synovial lining macrophages on M1 and M2 polarization in vitro and during experimental arthritis. Material and Methods: Experimental arthritis (antigen and immune complex induced) was elicited in mice and prednisolone containing liposomes were given systemically. Synovium was investigated using microarray analysis, RT-PCR and histology. Bone-marrow macrophages were stimulated towards M1 using LPS and IFN gamma before treatment by PLP-liposomes. M1 and M2 markers were determined using RT-PCR. Results: Microarray analysis of biopsies of inflamed synovium during antigen induced arthritis (AIA) showed an increased M1 signature characterized by upregulation of IL-1 beta, IL-6 and Fc gamma RI starting from day 1 and lasting up until day 7 after arthritis induction. The M2 signature remained low throughout the 7 day course of arthritis. Treatment of AIA with intravenously delivered Lip-PLP strongly suppressed joint swelling and synovial infiltration whereas colloidal gold containing liposomes exclusively targeted the macrophages within the inflamed synovial intima layer. In vitro studies showed that Lip-PLP phagocytosed by M1 macrophages resulted in a suppression of the M1 phenotype and induction of M2 markers (IL-10, TGF-beta, IL-1RII, CD163, CD206 and Ym1). In vivo, Lip-PLP treatment strongly suppressed M1 markers (TNF-alpha, IL-1 beta, IL-6, IL-12p40, iNOS, Fc gamma RI, Ciita and CD86) after local M1 activation of lining macrophages with LPS and IFN-gamma and during experimental AIA and immune complex arthritis (ICA). In contrast, M2 markers were not significantly upregulated in antigen-induced arthritis and down regulated in immune complex arthritis. Conclusion: This study clearly shows that systemic treatment with PLP-liposomes selectively targets synovial lining macrophages and inhibits M1 activation. In contrast to in vitro findings, PLP-liposomes do not cause a shift of synovial lining macrophages towards M2.	[Hofkens, Wouter; Schelbergen, Rik; van den Berg, Wim B.; van Lent, Peter L.] Radboud Univ Nijmegen, Med Ctr, Dept Rheumatol, NL-6525 ED Nijmegen, Netherlands; [Storm, Gert] Univ Utrecht, Dept Pharmaceut, Utrecht Inst Pharmaceut Sci, Utrecht, Netherlands	Radboud University Nijmegen; Utrecht University	van Lent, PL (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Rheumatol, NL-6525 ED Nijmegen, Netherlands.	p.vanlent@reuma.umcn.nl	van den Berg, W.B./H-8010-2014; Storm, Gerrit/O-8696-2016; van Lent, Peter/A-4269-2014; van Lent, Peter/A-4047-2014		Dutch Technology Foundation STW	Dutch Technology Foundation STW(Technologiestichting STW)	This study was supported by a research grant from the Dutch Technology Foundation STW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buechler C, 2000, J LEUKOCYTE BIOL, V67, P97, DOI 10.1002/jlb.67.1.97; Cai YP, 2009, J IMMUNOL, V182, P5393, DOI 10.4049/jimmunol.0803874; DIROSA M, 1986, AGENTS ACTIONS, V17, P284; Drexler SK, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2481; Edwards JP, 2006, J LEUKOCYTE BIOL, V80, P1298, DOI 10.1189/jlb.0406249; Ehrchen J, 2007, BLOOD, V109, P1265, DOI 10.1182/blood-2006-02-001115; Frankenberger M, 2005, INT IMMUNOPHARMACOL, V5, P289, DOI 10.1016/j.intimp.2004.09.033; Hardison SE, 2010, AM J PATHOL, V176, P774, DOI 10.2353/ajpath.2010.090634; Hofkens W, 2011, INT J PHARM; Hofkens W, 2011, J CONTROL RELEASE; JACOBS MJM, 1994, IMMUNOLOGY, V83, P390; Joosten LAB, 1999, INFLAMM RES, V48, P48, DOI 10.1007/s000110050396; Khanduja KL, 2011, MOL CELL BIOCHEM, V346, P31, DOI 10.1007/s11010-010-0588-1; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Kinne RW, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2333; KRUIJSEN MWM, 1981, AGENTS ACTIONS, V11, P640, DOI 10.1007/BF01978775; Metselaar JM, 2004, ANN RHEUM DIS, V63, P348, DOI 10.1136/ard.2003.009944; Metselaar JM, 2003, ARTHRITIS RHEUM-US, V48, P2059, DOI 10.1002/art.11140; Morris SM, 1998, AM J PHYSIOL-ENDOC M, V275, pE740, DOI 10.1152/ajpendo.1998.275.5.E740; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Nabbe KCAM, 2005, ARTHRITIS RES THER, V7, pR392, DOI 10.1186/ar1502; Pousset F, 2001, J NEUROCHEM, V76, P901, DOI 10.1046/j.1471-4159.2001.00103.x; Raes G, 2005, J IMMUNOL, V174, P6561, DOI 10.4049/jimmunol.174.11.6561; Sharif O, 2007, BMC IMMUNOL, V8, DOI 10.1186/1471-2172-8-1; Takahashi N, 2008, ARTHRITIS RHEUM-US, V58, P3471, DOI 10.1002/art.23956; van Lent P, 2003, AM J PATHOL, V163, P1839, DOI 10.1016/S0002-9440(10)63543-2; van Lent PL, 1995, SCAND J RHEUMATOL S, P83; van Lent PLEM, 1998, J RHEUMATOL, V25, P1135; van Lent PLEM, 2004, ARTHRITIS RHEUM, V50, P103, DOI 10.1002/art.11422; van Lent PLEM, 2002, OSTEOARTHR CARTILAGE, V10, P234, DOI 10.1053/joca.2001.0501; Van Lent PLEM, 1998, ANN RHEUM DIS, V57, P408, DOI 10.1136/ard.57.7.408; VANDENBERG WB, 1981, BRIT J EXP PATHOL, V62, P308; VANLENT PLEM, 1992, AM J PATHOL, V140, P1451; VanMeurs JBJ, 1997, RHEUMATOL INT, V16, P197, DOI 10.1007/BF01330296; Varga G, 2008, J LEUKOCYTE BIOL, V84, P644, DOI 10.1189/jlb.1107768; Welch JS, 2002, J BIOL CHEM, V277, P42821, DOI 10.1074/jbc.M205873200; Yeager MP, 2008, ANESTH ANALG, V107, P1726, DOI 10.1213/ane.0b013e3181875fb0	37	39	39	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e54016	10.1371/journal.pone.0054016	http://dx.doi.org/10.1371/journal.pone.0054016			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23468840	Green Submitted, gold, Green Published			2022-12-25	WOS:000315524900008
J	Ruiz-Alcaraz, AJ; Lipina, C; Petrie, JR; Murphy, MJ; Morris, AD; Sutherland, C; Cuthbertson, DJ				Ruiz-Alcaraz, Antonio J.; Lipina, Christopher; Petrie, John R.; Murphy, Michael J.; Morris, Andrew D.; Sutherland, Calum; Cuthbertson, Daniel J.			Obesity-Induced Insulin Resistance in Human Skeletal Muscle Is Characterised by Defective Activation of p42/p44 MAP Kinase	PLOS ONE			English	Article							IRS1; MECHANISMS	Insulin resistance (IR), an impaired cellular, tissue and whole body response to insulin, is a major pathophysiological defect of type 2 diabetes mellitus. Although IR is closely associated with obesity, the identity of the molecular defect(s) underlying obesity-induced IR in skeletal muscle remains controversial; reduced post-receptor signalling of the insulin receptor substrate 1 (IRS1) adaptor protein and downstream effectors such as protein kinase B (PKB) have previously been implicated. We examined expression and/or activation of a number of components of the insulin-signalling cascade in skeletal muscle of 22 healthy young men (with body mass index (BMI) range, 20-37 kg/m(2)). Whole body insulin sensitivity (M value) and body composition was determined by the hyperinsulinaemic (40 mU. min(-1).m(-2).), euglycaemic clamp and by dual energy X-ray absorptiometry (DEXA) respectively. Skeletal muscle (vastus lateralis) biopsies were taken before and after one hour of hyperinsulinaemia and the muscle insulin signalling proteins examined by western blot and immunoprecipitation assay. There was a strong inverse relationship between M-value and BMI. The most striking abnormality was significantly reduced insulin-induced activation of p42/44 MAP kinase, measured by specific assay, in the volunteers with poor insulin sensitivity. However, there was no relationship between individuals' BMI or M-value and protein expression/phosphorylation of IRS1, PKB, or p42/44 MAP kinase protein, under basal or hyperinsulinaemic conditions. In the few individuals with poor insulin sensitivity but preserved p42/44 MAP kinase activation, other signalling defects were evident. These findings implicate defective p42/44 MAP kinase signalling as a potential contributor to obesity-related IR in a non-diabetic population, although clearly multiple signalling defects underlie obesity associated IR.	[Ruiz-Alcaraz, Antonio J.] Univ Murcia, Sch Med, Dept Biochem & Mol Biol & Immunol B, Murcia, Spain; [Lipina, Christopher] Univ Dundee, Div Cell Signalling & Immunol, Dundee, Scotland; [Petrie, John R.] Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland; [Murphy, Michael J.; Morris, Andrew D.; Sutherland, Calum] Univ Dundee, Ninewells Hosp, Div Cardiovasc & Diabet Med, Dundee, Scotland; [Cuthbertson, Daniel J.] Aintree Univ Hosp NHS Fdn Trust, Ctr Clin Sci, Dept Obes & Endocrinol, Liverpool L9 7AL, Merseyside, England; [Cuthbertson, Daniel J.] Univ Liverpool, Inst Aging & Chron Dis, Dept Obes & Endocrinol, Liverpool L69 3BX, Merseyside, England	University of Murcia; University of Dundee; University of Glasgow; University of Dundee; Aintree University Hospitals NHS Foundation Trust; University of Liverpool; University of Liverpool	Cuthbertson, DJ (corresponding author), Aintree Univ Hosp NHS Fdn Trust, Ctr Clin Sci, Dept Obes & Endocrinol, Liverpool L9 7AL, Merseyside, England.	daniel.cuthbertson@liverpool.ac.uk	Murphy, Michael J/K-4008-2012; Ruiz-Alcaraz, Antonio José/Z-5867-2019	Murphy, Michael J/0000-0001-6735-125X; Ruiz-Alcaraz, Antonio José/0000-0001-6913-0610; Lipina, Christopher/0000-0001-7327-2857; Cuthbertson, Daniel/0000-0002-6128-0822; Sutherland, Calum/0000-0003-4398-7434	Diabetes UK [03/0002583]; CSO [CZB/4/125]; Diabetes UK [10/0004131] Funding Source: researchfish; Medical Research Council [G0801507] Funding Source: researchfish; MRC [G0801507] Funding Source: UKRI	Diabetes UK(Diabetes UK); CSO; Diabetes UK(Diabetes UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Diabetes UK Project Grant number (03/0002583) and CSO project grant number (CZB/4/125). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babraj JA, 2009, AM J PHYSIOL-ENDOC M, V296, pE1042, DOI 10.1152/ajpendo.90811.2008; Copps KD, 2010, CELL METAB, V11, P84, DOI 10.1016/j.cmet.2009.11.003; Corbould A, 2006, DIABETES, V55, P751, DOI 10.2337/diabetes.55.03.06.db05-0453; Cusi K, 2000, J CLIN INVEST, V105, P311, DOI 10.1172/JCI7535; Cuthbertson DJ, 2007, DIABETES, V56, P2078, DOI 10.2337/db06-1716; Cuthbertson DJ, 2006, AM J PHYSIOL-ENDOC M, V290, pE731, DOI 10.1152/ajpendo.00415.2005; DEFRONZO RA, 1979, AM J PHYSIOL, V237, pE214; DeFronzo RA, 2009, DIABETES CARE, V32, pS157, DOI 10.2337/dc09-S302; Friedrichsen M, 2010, DIABETOLOGIA, V53, P1998, DOI 10.1007/s00125-010-1795-8; George S, 2004, SCIENCE, V304, P1325, DOI 10.1126/science.1096706; GOODYEAR LJ, 1995, J CLIN INVEST, V95, P2195, DOI 10.1172/JCI117909; Jager J, 2011, DIABETOLOGIA, V54, P180, DOI 10.1007/s00125-010-1944-0; Krook A, 2000, DIABETES, V49, P284, DOI 10.2337/diabetes.49.2.284; Krook A, 1998, DIABETES, V47, P1281, DOI 10.2337/diabetes.47.8.1281; Langlais P, 2011, DIABETOLOGIA, V54, P2878, DOI 10.1007/s00125-011-2271-9; Marchesini G, 2001, DIABETES, V50, P1844, DOI 10.2337/diabetes.50.8.1844; Meyer MM, 2002, DIABETOLOGIA, V45, P813, DOI 10.1007/s00125-002-0830-9; Petersen KF, 2002, J ROY SOC MED, V95, P8; Rajkhowa M, 2009, BIOCHEM J, V418, P665, DOI 10.1042/BJ20082176; Ruiz-Alcaraz AJ, 2005, BIOCHEM J, V392, P345, DOI 10.1042/BJ20051194; Rung J, 2009, NAT GENET, V41, P1110, DOI 10.1038/ng.443; Samuel VT, 2010, LANCET, V375, P2267, DOI 10.1016/S0140-6736(10)60408-4; Schmitz-Peiffer C, 2000, CELL SIGNAL, V12, P583, DOI 10.1016/S0898-6568(00)00110-8; Shulman GI, 2000, J CLIN INVEST, V106, P171, DOI 10.1172/JCI10583; Tan K, 2007, DIABETES, V56, P714, DOI 10.2337/db06-0921; Tremblay F, 2001, J BIOL CHEM, V276, P38052; Woods Yvonne L., 2009, Endocrine Metabolic & Immune Disorders-Drug Targets, V9, P187	27	19	19	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e56928	10.1371/journal.pone.0056928	http://dx.doi.org/10.1371/journal.pone.0056928			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23468892	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000315524900044
J	Taylor, AC; Horvat-Gordon, M; Moore, A; Bartell, PA				Taylor, Alexander C.; Horvat-Gordon, Maria; Moore, Ashli; Bartell, Paul A.			The Effects of Melatonin on the Physical Properties of Bones and Egg Shells in the Laying Hen	PLOS ONE			English	Article							RECEPTOR SUBTYPES; ZINC; STRENGTH; EXPRESSION; STRONTIUM; CHICK; PINEALECTOMY; DEFICIENCY; VOLUME; RATS	Laying hens often experience unbalanced calcium utilization which can cause deficiencies in bone and egg mineralization. Because melatonin has been shown to affect bone mineralization in other animals, we examined whether treating hens with melatonin would affect eggshell thickness and improve skeletal performance, thereby reducing skeletal and egg shell defects. Birds were given a diet containing either low (30 mu g/kg), medium (300 mu g/kg), or high (3 mu g/kg) concentrations of melatonin, or control feed through approximately one laying cycle. We examined the weight, length, and strength of egg, femur, tibia, and keel. Hens treated with a high concentration of melatonin showed significant strengthening in their femur and tibia, as measured by maximum force sustained and breaking force, compared to controls. Egg weights from hens treated with melatonin were significantly greater than those from hens that were not treated with melatonin. Conversely, egg shell mass of hens treated with melatonin was significantly lower than those of hens not treated with melatonin. Our data suggest that melatonin may affect the allocation of calcium to bone at the expense of egg shell mineralization.	[Taylor, Alexander C.; Horvat-Gordon, Maria; Bartell, Paul A.] Penn State Univ, Dept Anim Sci, University Pk, PA 16802 USA; [Taylor, Alexander C.; Bartell, Paul A.] Penn State Univ, Intercoll Grad Degree Program Physiol, University Pk, PA 16802 USA; [Moore, Ashli] Univ Virginia, Dept Biol, Charlottesville, VA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Virginia	Bartell, PA (corresponding author), Penn State Univ, Dept Anim Sci, University Pk, PA 16802 USA.	pab43@psu.edu			USDA National Institute of Food and Agriculture [2010-65206-20779]	USDA National Institute of Food and Agriculture(United States Department of Agriculture (USDA))	This project was supported by Competitive Grant no. 2010-65206-20779 from the USDA National Institute of Food and Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baltaci AK, 2007, ACTA BIOL HUNG, V58, P335, DOI 10.1556/ABiol.58.2007.4.1; BRANDAONETO J, 1995, NUTR RES, V15, P335, DOI 10.1016/0271-5317(95)00003-8; Cardinali DP, 2003, J PINEAL RES, V34, P81, DOI 10.1034/j.1600-079X.2003.00028.x; Eberle J, 1999, J TRACE ELEM MED BIO, V13, P21, DOI 10.1016/S0946-672X(99)80019-4; ETCHES RJ, 1987, J NUTR, V117, P619, DOI 10.1093/jn/117.3.619; Everts V, 2005, J CELL PHYSL, V150, P221; Fagan AB, 2009, EUR SPINE J, V18, P1154, DOI 10.1007/s00586-009-0927-7; Fleming RH, 1998, RES VET SCI, V64, P63, DOI 10.1016/S0034-5288(98)90117-5; Geary GG, 1998, BRIT J PHARMACOL, V123, P1533, DOI 10.1038/sj.bjp.0701761; Greives TJ, 2012, BIOL LETTERS, V8, P330, DOI 10.1098/rsbl.2011.1100; Guard-Bouldin J, 2006, POULTRY SCI, V85, P129, DOI 10.1093/ps/85.1.129; Hosea HJ, 2004, EXP BIOL MED, V229, P303, DOI 10.1177/153537020422900404; JIANG ZG, 1995, BRAIN RES, V687, P125, DOI 10.1016/0006-8993(95)00478-9; Jones C, 2012, CHRONOBIOL INT, V29, P189, DOI 10.3109/07420528.2011.642912; Koyama H, 2002, J BONE MINER RES, V17, P1219, DOI 10.1359/jbmr.2002.17.7.1219; MACHIDA M, 1995, J BONE JOINT SURG BR, V77B, P134, DOI 10.1302/0301-620X.77B1.7822371; Miller SC, 1992, POULTRY SCI S, V23; Nakade O, 1999, J PINEAL RES, V27, P106, DOI 10.1111/j.1600-079X.1999.tb00603.x; Natesan AK, 2002, VISUAL NEUROSCI, V19, P265, DOI 10.1017/S0952523802192042; Noddegaard F, 1999, J PINEAL RES, V27, P129; Ozturk G, 2008, EXP AGING RES, V34, P453, DOI 10.1080/03610730802271922; Olszanska B, 2007, J PINEAL RES, V42, P310, DOI 10.1111/j.1600-079X.2007.00421.x; Ovesen J, 2001, BONE, V29, P565, DOI 10.1016/S8756-3282(01)00616-0; Park KH, 2011, J PINEAL RES, V51, P187, DOI 10.1111/j.1600-079X.2011.00875.x; Rada JAS, 2006, INVEST OPHTH VIS SCI, V47, P25, DOI 10.1167/iovs.05-0195; REPPERT SM, 1995, NEURON, V15, P1003, DOI 10.1016/0896-6273(95)90090-X; Sazanov AA, 2007, POULTRY SCI, V86, P202, DOI 10.1093/ps/86.1.202; Shahnazari M, 2007, CALCIFIED TISSUE INT, V80, P160, DOI 10.1007/s00223-006-0176-2; Shahnazari M, 2006, J BONE MINER RES, V21, P1696, DOI 10.1359/JBMR.060724; Sjoblom M, 2003, AM J PHYSIOL-GASTR L, V284, pG1034, DOI 10.1152/ajpgi.00500.2002; Sundaresan NR, 2009, VET RES COMMUN, V33, P49, DOI 10.1007/s11259-008-9071-9; Tournis S., 2007, Journal of Musculoskeletal & Neuronal Interactions, V7, P266; Whitehead CC, 2004, POULTRY SCI, V83, P193, DOI 10.1093/ps/83.2.193	33	14	16	3	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e55663	10.1371/journal.pone.0055663	http://dx.doi.org/10.1371/journal.pone.0055663			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23468846	Green Published, gold, Green Submitted			2022-12-25	WOS:000315524900012
J	Gronemeyer, T; Wiese, S; Ofman, R; Bunse, C; Pawlas, M; Hayen, H; Eisenacher, M; Stephan, C; Meyer, HE; Waterham, HR; Erdmann, R; Wanders, RJ; Warscheid, B				Gronemeyer, Thomas; Wiese, Sebastian; Ofman, Rob; Bunse, Christian; Pawlas, Magdalena; Hayen, Heiko; Eisenacher, Martin; Stephan, Christian; Meyer, Helmut E.; Waterham, Hans R.; Erdmann, Ralf; Wanders, Ronald J.; Warscheid, Bettina			The Proteome of Human Liver Peroxisomes: Identification of Five New Peroxisomal Constituents by a Label-Free Quantitative Proteomics Survey	PLOS ONE			English	Article							MOUSE KIDNEY PEROXISOMES; RAT-LIVER; MASS-SPECTROMETRY; SUBCELLULAR-LOCALIZATION; PROTEINS; BIOCHEMISTRY; MEMBRANE; DATABASE; ENZYMES; METABOLISM	The peroxisome is a key organelle of low abundance that fulfils various functions essential for human cell metabolism. Severe genetic diseases in humans are caused by defects in peroxisome biogenesis or deficiencies in the function of single peroxisomal proteins. To improve our knowledge of this important cellular structure, we studied for the first time human liver peroxisomes by quantitative proteomics. Peroxisomes were isolated by differential and Nycodenz density gradient centrifugation. A label-free quantitative study of 314 proteins across the density gradient was accomplished using high resolution mass spectrometry. By pairing statistical data evaluation, cDNA cloning and in vivo colocalization studies, we report the association of five new proteins with human liver peroxisomes. Among these, isochorismatase domain containing 1 protein points to the existence of a new metabolic pathway and hydroxysteroid dehydrogenase like 2 protein is likely involved in the transport or beta-oxidation of fatty acids in human peroxisomes. The detection of alcohol dehydrogenase 1A suggests the presence of an alternative alcohol-oxidizing system in hepatic peroxisomes. In addition, lactate dehydrogenase A and malate dehydrogenase 1 partially associate with human liver peroxisomes and enzyme activity profiles support the idea that NAD(+) becomes regenerated during fatty acid beta-oxidation by alternative shuttling processes in human peroxisomes involving lactate dehydrogenase and/or malate dehydrogenase. Taken together, our data represent a valuable resource for future studies of peroxisome biochemistry that will advance research of human peroxisomes in health and disease.	[Gronemeyer, Thomas] Univ Ulm, Dept Mol Genet & Cell Biol, D-89069 Ulm, Germany; [Wiese, Sebastian; Warscheid, Bettina] Univ Freiburg, Inst Biol 2, Fak Biol, Freiburg, Germany; [Wiese, Sebastian; Warscheid, Bettina] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, Freiburg, Germany; [Ofman, Rob; Waterham, Hans R.; Wanders, Ronald J.] Univ Amsterdam, Acad Med Ctr, Lab Genet Metab Dis, Dept Clin Chem & Pediat, NL-1105 AZ Amsterdam, Netherlands; [Bunse, Christian; Pawlas, Magdalena; Eisenacher, Martin; Stephan, Christian; Meyer, Helmut E.] Ruhr Univ Bochum, Med Proteom Ctr, Bochum, Germany; [Hayen, Heiko] Leibniz Inst Analyt Wissensch ISAS eV, Dortmund, Germany; [Erdmann, Ralf] Ruhr Univ Bochum, Abt Syst Biochem, Fak Med, Bochum, Germany	Ulm University; University of Freiburg; University of Freiburg; University of Amsterdam; Academic Medical Center Amsterdam; Ruhr University Bochum; Dortmund University of Technology; Leibniz Institut fur Analytische Wissenschaften (ISAS); Ruhr University Bochum	Warscheid, B (corresponding author), Univ Freiburg, Inst Biol 2, Fak Biol, Schanzlestr 1, Freiburg, Germany.	bettina.warscheid@biologie.uni-freiburg.de	Eisenacher, Martin/J-8044-2014	Eisenacher, Martin/0000-0003-2687-7444; Warscheid, Bettina/0000-0001-5096-1975	FP6 European Union Project "Peroxisome'' [LSHG-CT-2004-512018]; Deutsche Forschungsgemeinschaft; Excellence Initiative of the German Federal and State Governments [EXC 294]	FP6 European Union Project "Peroxisome''; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Excellence Initiative of the German Federal and State Governments	This research is supported by the FP6 European Union Project "Peroxisome'' (LSHG-CT-2004-512018) as well as by the Deutsche Forschungsgemeinschaft and the Excellence Initiative of the German Federal and State Governments (EXC 294 BIOSS Centre for Biological Signalling Studies). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen JS, 2006, EMBO REP, V7, P874, DOI 10.1038/sj.embor.7400780; Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166; Baird GS, 2000, P NATL ACAD SCI USA, V97, P11984, DOI 10.1073/pnas.97.22.11984; Baumgart E, 1996, J BIOL CHEM, V271, P3846; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; DECRAEMER D, 1995, HEPATOLOGY, V22, P744, DOI 10.1016/0270-9139(95)90292-9; Dunkley TPJ, 2004, MOL CELL PROTEOMICS, V3, P1128, DOI 10.1074/mcp.T400009-MCP200; Edqvist A, 2006, MOL THER, V14, P139, DOI 10.1016/j.ymthe.2005.12.018; Falcon-Perez JM, 2005, J CELL SCI, V118, P5243, DOI 10.1242/jcs.02633; Foster LJ, 2006, CELL, V125, P187, DOI 10.1016/j.cell.2006.03.022; HANDLER JA, 1990, J BIOL CHEM, V265, P1510; Islinger M, 2010, BBA-MOL CELL RES, V1803, P881, DOI 10.1016/j.bbamcr.2010.03.013; Islinger M, 2007, J BIOL CHEM, V282, P23055, DOI 10.1074/jbc.M610910200; Juillerat A, 2005, CHEMBIOCHEM, V6, P1263, DOI 10.1002/cbic.200400431; Kalish JE, 1996, EMBO J, V15, P3275, DOI 10.1002/j.1460-2075.1996.tb00692.x; KELLER GA, 1989, J CELL BIOL, V108, P1353, DOI 10.1083/jcb.108.4.1353; KETCHUM CH, 1988, CLIN BIOCHEM, V21, P231, DOI 10.1016/S0009-9120(88)80006-7; Kikuchi M, 2004, J BIOL CHEM, V279, P421, DOI 10.1074/jbc.M305623200; Kowalik D, 2009, J STEROID BIOCHEM, V117, P117, DOI 10.1016/j.jsbmb.2009.08.001; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; McClelland GB, 2003, BIOCHEM BIOPH RES CO, V304, P130, DOI 10.1016/S0006-291X(03)00550-3; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; Neuberger G, 2003, J MOL BIOL, V328, P581, DOI 10.1016/S0022-2836(03)00319-X; Ofman R, 2006, BIOCHEM J, V393, P537, DOI 10.1042/BJ20050893; Olsen JV, 2004, MOL CELL PROTEOMICS, V3, P608, DOI 10.1074/mcp.T400003-MCP200; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Popov VN, 1998, FEBS LETT, V440, P55, DOI 10.1016/S0014-5793(98)01422-7; Reidegeld KA, 2008, PROTEOMICS, V8, P1129, DOI 10.1002/pmic.200701073; SAKURABA H, 1995, J BIOL CHEM, V270, P37, DOI 10.1074/jbc.270.1.37; Schluter A, 2007, NUCLEIC ACIDS RES, V35, pD815, DOI 10.1093/nar/gkl935; Seuchter SA, 2004, METHOD INFORM MED, V43, P184; Skogsberg J, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000036; Stephan C, 2006, PROTEOMICS, V6, P5015, DOI 10.1002/pmic.200600294; VANROERMUND CWT, 1995, EMBO J, V14, P3480, DOI 10.1002/j.1460-2075.1995.tb07354.x; Visser WF, 2007, BIOCHEM J, V401, P365, DOI 10.1042/BJ20061352; Vizcaino JA, 2009, PROTEOMICS, V9, P4276, DOI 10.1002/pmic.200900402; WALSH CT, 1990, CHEM REV, V90, P1105, DOI 10.1021/cr00105a003; Wanders RJA, 2005, CLIN GENET, V67, P107, DOI 10.1111/j.1399-0004.2004.00329.x; WANDERS RJA, 1994, BBA-MOL BASIS DIS, V1227, P177, DOI 10.1016/0925-4439(94)90092-2; Wanders RJA, 2006, BBA-MOL CELL RES, V1763, P1707, DOI 10.1016/j.bbamcr.2006.08.010; Wanders RJA, 2006, ANNU REV BIOCHEM, V75, P295, DOI 10.1146/annurev.biochem.74.082803.133329; WIEMER EAC, 1992, J IMMUNOL METHODS, V151, P165, DOI 10.1016/0022-1759(92)90115-A; Wiese S, 2007, MOL CELL PROTEOMICS, V6, P2045, DOI 10.1074/mcp.M700169-MCP200; Wiese S, 2012, INT J MASS SPECTROM, V312, P30, DOI 10.1016/j.ijms.2011.09.005; Yan W, 2009, J PROTEOMICS, V72, P4, DOI 10.1016/j.jprot.2008.11.017; Yates JR, 2005, NAT REV MOL CELL BIO, V6, P702, DOI 10.1038/nrm1711	46	66	68	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57395	10.1371/journal.pone.0057395	http://dx.doi.org/10.1371/journal.pone.0057395			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460848	gold, Green Submitted, Green Published			2022-12-25	WOS:000315519000102
J	Ma, LJ; Murea, M; Snipes, JA; Marinelarena, A; Kruger, J; Hicks, PJ; Langberg, KA; Bostrom, MA; Cooke, JN; Suzuki, D; Babazono, T; Uzu, T; Tang, SCW; Mondal, AK; Sharma, NK; Kobes, S; Antinozzi, PA; Davis, M; Das, SK; Rasouli, N; Kern, PA; Shores, NJ; Rudel, LL; Bluuher, M; Stumvoll, M; Bowden, DW; Maeda, S; Parks, JS; Kovacs, P; Hanson, RL; Baier, LJ; Elbein, SC; Freedman, BI				Ma, Lijun; Murea, Mariana; Snipes, James A.; Marinelarena, Alejandra; Krueger, Jacqueline; Hicks, Pamela J.; Langberg, Kurt A.; Bostrom, Meredith A.; Cooke, Jessica N.; Suzuki, Daisuke; Babazono, Tetsuya; Uzu, Takashi; Tang, Sydney C. W.; Mondal, Ashis K.; Sharma, Neeraj K.; Kobes, Sayuko; Antinozzi, Peter A.; Davis, Matthew; Das, Swapan K.; Rasouli, Neda; Kern, Philip A.; Shores, Nathan J.; Rudel, Lawrence L.; Blueher, Matthias; Stumvoll, Michael; Bowden, Donald W.; Maeda, Shiro; Parks, John S.; Kovacs, Peter; Hanson, Robert L.; Baier, Leslie J.; Elbein, Steven C.; Freedman, Barry I.			An ACACB Variant Implicated in Diabetic Nephropathy Associates with Body Mass Index and Gene Expression in Obese Subjects	PLOS ONE			English	Article							FATTY-ACID OXIDATION; ADIPOSE-TISSUE; MICE LACKING; MUTANT MICE; POLYMORPHISMS; METABOLISM; KNOCKOUT; GLUCOSE; DIETARY; ACC2	Acetyl coenzyme A carboxylase B gene (ACACB) single nucleotide polymorphism (SNP) rs2268388 is reproducibly associated with type 2 diabetes (T2DM)-associated nephropathy (DN). ACACB knock-out mice are also protected from obesity. This study assessed relationships between rs2268388, body mass index (BMI) and gene expression in multiple populations, with and without T2DM. Among subjects without T2DM, rs2268388 DN risk allele (T) associated with higher BMI in Pima Indian children (n = 2021; p-additive = 0.029) and African Americans (AAs) (n = 177; p-additive = 0.05), with a trend in European Americans (EAs) (n = 512; p-additive = 0.09), but not Germans (n = 858; p-additive = 0.765). Association with BMI was seen in a meta-analysis including all non-T2DM subjects (n = 3568; p-additive = 0.02). Among subjects with T2DM, rs2268388 was not associated with BMI in Japanese (n = 2912) or EAs (n = 1149); however, the T allele associated with higher BMI in the subset with BMI >= 30 kg/m(2) (n = 568 EAs; p-additive = 0.049, n = 196 Japanese; p-additive = 0.049). Association with BMI was strengthened in a T2DM meta-analysis that included an additional 756 AAs (p-additive = 0.080) and 48 Hong Kong Chinese (p-additive = 0.81) with BMI >= 30 kg/m(2) (n = 1575; p-additive = 0.0033). The effect of rs2268388 on gene expression revealed that the T risk allele associated with higher ACACB messenger levels in adipose tissue (41 EAs and 20 AAs with BMI > 30 kg/m(2); p-additive = 0.018) and ACACB protein levels in the liver tissue (mixed model p-additive = 0.03, in 25 EA bariatric surgery patients with BMI > 30 kg/m(2) for 75 exams). The T allele also associated with higher hepatic triglyceride levels. These data support a role for ACACB in obesity and potential roles for altered lipid metabolism in susceptibility to DN.	[Ma, Lijun; Murea, Mariana; Snipes, James A.; Hicks, Pamela J.; Langberg, Kurt A.; Bostrom, Meredith A.; Cooke, Jessica N.; Mondal, Ashis K.; Sharma, Neeraj K.; Antinozzi, Peter A.; Davis, Matthew; Das, Swapan K.; Shores, Nathan J.; Rudel, Lawrence L.; Bowden, Donald W.; Parks, John S.; Elbein, Steven C.; Freedman, Barry I.] Wake Forest Sch Med, Winston Salem, NC USA; [Marinelarena, Alejandra; Kobes, Sayuko; Hanson, Robert L.; Baier, Leslie J.] NIDDKD, PECRB, Phoenix, AZ USA; [Krueger, Jacqueline; Blueher, Matthias; Stumvoll, Michael; Kovacs, Peter] Univ Leipzig, Interdisciplinary Ctr Clin Res, D-04109 Leipzig, Germany; [Suzuki, Daisuke] Tokai Univ, Div Nephrol & Metab, Dept Internal Med, Tokyo 151, Japan; [Babazono, Tetsuya] Tokyo Womens Med Univ, Ctr Diabet, Tokyo, Japan; [Uzu, Takashi] Shiga Univ Med Sci, Dept Med, Otsu, Shiga 52021, Japan; [Tang, Sydney C. W.] Univ Hong Kong, Dept Internal Med, Queen Mary Hosp, Hong Kong, Hong Kong, Peoples R China; [Rasouli, Neda] Univ Colorado, Dept Internal Med, Sch Med, Aurora, CO USA; [Kern, Philip A.] Univ Kentucky, Coll Med, Dept Internal Med, Lexington, KY USA; [Shores, Nathan J.] Tulane Univ Med Ctr Hosp & Clin, Abdominal Transplant Inst, New Orleans, LA USA; [Maeda, Shiro] RIKEN, Ctr Genom Med, Lab Endocrinol & Metab, Yokohama, Kanagawa, Japan	Wake Forest University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Leipzig University; Tokai University; Tokyo Women's Medical University; Shiga University of Medical Science; University of Hong Kong; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Kentucky; Tulane University; RIKEN	Ma, LJ (corresponding author), Wake Forest Sch Med, Winston Salem, NC USA.	lima@wakehealth.edu	Stumvoll, Michael/ABE-1121-2021; Tang, Sydney Chi Wai/C-4411-2009; Cooke Bailey, Jessica Nicole/AFQ-5925-2022; Koya, Daisuke/J-3257-2014; Bailey, Jessica Cooke/Q-5062-2019; Hanson, Robert L/O-3238-2015	Stumvoll, Michael/0000-0001-6225-8240; Tang, Sydney Chi Wai/0000-0002-6862-1941; Cooke Bailey, Jessica Nicole/0000-0002-4001-8702; Bailey, Jessica Cooke/0000-0002-4001-8702; Hanson, Robert L/0000-0002-4252-7068; Kovacs, Peter/0000-0002-0290-5423; Das, Swapan/0000-0002-2197-8855; Herold, Jacqueline/0000-0003-3059-0374; Rasouli, Neda/0000-0003-1269-3580	Wake Forest School of Medicine Translational Science Institute Synergy Grant [K99 DK081350]; National Institutes of Health [R01 DK071891, R01 HL67348, R01 DK53591, R01 DK039311]; Veterans Administration; NIDDK; Ministry of Education, Culture, Sports, Science and Technology, Japan; Boehringer Ingelheim Foundation;  [R0171349]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000117, UL1TR001998] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067348] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071349, R01DK039311, R01DK053591, R01DK071891, ZIADK069028, ZIADK069071, K99DK081350] Funding Source: NIH RePORTER	Wake Forest School of Medicine Translational Science Institute Synergy Grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Administration(US Department of Veterans Affairs); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Boehringer Ingelheim Foundation(Boehringer Ingelheim); ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by a Wake Forest School of Medicine Translational Science Institute Synergy Grant K99 DK081350, National Institutes of Health extramural grants R01 DK071891, R01 HL67348, R01 DK53591, R01 DK039311, and partially supported by R0171349, a Merit Grant from the Veterans Administration, and NIDDK intramural research program. The Japanese study was partly supported by a grant from the Ministry of Education, Culture, Sports, Science and Technology, Japan (S. M.). P. K. (Leipzig) was funded by Boehringer Ingelheim Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Elheiga L, 2003, P NATL ACAD SCI USA, V100, P10207, DOI 10.1073/pnas.1733877100; Abu-Elheiga L, 2001, SCIENCE, V291, P2613, DOI 10.1126/science.1056843; Abu-Elheiga L, 2012, J BIOL CHEM, V287, P12578, DOI 10.1074/jbc.M111.309559; Agarwal S, 2011, DIABETES CARE, V34, P1219, DOI 10.2337/dc11-0008; CARR TP, 1993, CLIN BIOCHEM, V26, P39, DOI 10.1016/0009-9120(93)90015-X; Das SK, 2011, J CLIN ENDOCR METAB, V96, pE1308, DOI 10.1210/jc.2011-0101; Das SK, 2010, J LIPID RES, V51, P2121, DOI 10.1194/jlr.M004275; Divers J, 2010, J CLIN ENDOCR METAB, V95, P5382, DOI 10.1210/jc.2010-0793; Elbein SC, 2007, DIABETOLOGIA, V50, P1621, DOI 10.1007/s00125-007-0717-x; Engelgau MM, 2004, ANN INTERN MED, V140, P945, DOI 10.7326/0003-4819-140-11-200406010-00035; FOLCH J, 1957, J BIOL CHEM, V226, P497; Hanson RL, 2012, COMMUNICATION; Hanson RL, 2007, DIABETES, V56, P3045, DOI 10.2337/db07-0462; Hoehn KL, 2010, CELL METAB, V11, P70, DOI 10.1016/j.cmet.2009.11.008; Ismail-Beigi F, 2010, LANCET, V376, P419, DOI 10.1016/S0140-6736(10)60576-4; Keech A, 2005, LANCET, V366, P1849, DOI 10.1016/S0140-6736(05)67667-2; Knowler WC, 2007, COMMUNICATION; Lenz LS, 2011, J BIOL CHEM, V286, P35578, DOI 10.1074/jbc.M111.226530; Ma LJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023860; Maeda S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000842; Oh WK, 2005, P NATL ACAD SCI USA, V102, P1384, DOI 10.1073/pnas.0409451102; Olson DP, 2010, P NATL ACAD SCI USA, V107, P7598, DOI 10.1073/pnas.0913492107; Park CW, 2006, DIABETES, V55, P885, DOI 10.2337/diabetes.55.04.06.db05-1329; Park CW, 2006, KIDNEY INT, V69, P1511, DOI 10.1038/sj.ki.5000209; Phillips CM, 2010, J LIPID RES, V51, P3500, DOI 10.1194/jlr.M008474; Riancho JA, 2011, MOL GENET METAB, V104, P670, DOI 10.1016/j.ymgme.2011.08.013; Rosario Rey F, 2006, Curr Diab Rep, V6, P455, DOI 10.1007/s11892-006-0079-7; Schreurs M, 2009, DIABETES OBES METAB, V11, P987, DOI 10.1111/j.1463-1326.2009.01078.x; Shores NJ, 2011, DIGEST DIS SCI, V56, P2145, DOI 10.1007/s10620-011-1602-5; Stouffer S. A., 1949, AM SOLDIER, V1; Taneja D, 2010, J LIPID RES, V51, P1464, DOI 10.1194/jlr.M002972; Tang SCW, 2010, NEPHROL DIAL TRANSPL, V25, P3931, DOI 10.1093/ndt/gfq303; Wakil SJ, 2009, J LIPID RES, V50, pS138, DOI 10.1194/jlr.R800079-JLR200; Wang ZW, 2005, DIABETES, V54, P2328, DOI 10.2337/diabetes.54.8.2328; Zhuang LN, 2011, J BIOL CHEM, V286, P28396, DOI 10.1074/jbc.M111.223206	35	10	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e56193	10.1371/journal.pone.0056193	http://dx.doi.org/10.1371/journal.pone.0056193			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460794	Green Published, gold, Green Submitted			2022-12-25	WOS:000315519000017
J	Rubin, JE; Costa, MO; Hill, JE; Kittrell, HE; Fernando, C; Huang, YY; O'Connor, B; Harding, JCS				Rubin, Joseph E.; Costa, Matheus O.; Hill, Janet E.; Kittrell, Heather E.; Fernando, Champika; Huang, Yanyun; O'Connor, Brendan; Harding, John C. S.			Reproduction of Mucohaemorrhagic Diarrhea and Colitis Indistinguishable from Swine Dysentery following Experimental Inoculation with "Brachyspira hampsonii" Strain 30446	PLOS ONE			English	Article							SELECTIVE MEDIUM; PIGS; DIFFERENTIATION; FECES	Background: Mucohaemorrhagic diarrhea caused by Brachyspira hyodysenteriae, swine dysentery, is a severe production limiting disease of swine. Recently, pigs in western Canada with clinical signs indistinguishable from swine dysentery were observed. Despite the presence of spirochetes on fecal smears, recognized Brachyspira spp. including B. hyodysenteriae could not be identified. A phylogenetically distinct Brachyspira, called "B. hampsonii" strain 30446, however was isolated. The purpose of this study was to experimentally reproduce mucohaemorrhagic colitis and characterize strain 30446 shedding following inoculation. Methods and Findings: Eighteen 13-week-old pigs were randomly assigned to inoculation (n = 12) or control (n = 6) groups in each of two trials. In trial 1, pigs were inoculated with a tissue homogenate collected from clinically affected field cases. In trial 2, pigs were inoculated with a pure broth culture of strain 30446. In both trials, mucohaemorrhagic diarrhea was significantly more common in inoculated pigs than controls, all of which remained healthy. In animals with mucohaemorrhagic diarrhea, significantly more spirochetes were observed on Gram stained fecal smears, and higher numbers of strain 30446 genome equivalents were detected by quantitative PCR (qPCR). Strain 30446 was cultured from colon and/or feces of all affected but no control animals at necropsy. Conclusions: "Brachyspira hampsonii" strain 30446 causes mucohaemorrhagic diarrhea in pigs following a 4-9 day incubation period. Fecal shedding was detectable by day 4 post inoculation, and rarely preceded the onset of mucoid or haemorrhagic diarrhea by more than 2 days. Culture and 30446-specific qPCR are reliable methods of detection of this organism in feces and tissues of diarrheic pigs. The emergence of a novel Brachyspira spp., such as "B. hampsonii", creates diagnostic challenges including higher risk of false negative diagnostic tests. We therefore recommend diagnostic laboratories routinely use Brachyspira culture, nox-based and species-specific PCR, and DNA sequencing to diagnose Brachyspira-associated colitis in pigs.	[Rubin, Joseph E.; Costa, Matheus O.; Hill, Janet E.; Fernando, Champika] Univ Saskatchewan, Western Coll Vet Med, Dept Vet Microbiol, Saskatoon, SK S7N 0W0, Canada; [Rubin, Joseph E.; Kittrell, Heather E.; Huang, Yanyun; Harding, John C. S.] Univ Saskatchewan, Western Coll Vet Med, Dept Large Anim Clin Sci, Saskatoon, SK S7N 0W0, Canada; [O'Connor, Brendan] Prairie Diagnost Serv Inc, Saskatoon, SK, Canada	University of Saskatchewan; University of Saskatchewan	Harding, JCS (corresponding author), Univ Saskatchewan, Western Coll Vet Med, Dept Large Anim Clin Sci, Saskatoon, SK S7N 0W0, Canada.	john.harding@usask.ca	Hill, Janet E./B-5001-2011; Rubin, Joseph E/B-3374-2009	Hill, Janet E./0000-0002-2187-6277; Rubin, Joseph E/0000-0002-2636-406X	Canadian Swine Health Board; University of Saskatchewan Industry Liaison Office, Western College of Veterinary Medicine Research Trust; Merck-Merial Veterinary Scholars Summer Research Program	Canadian Swine Health Board; University of Saskatchewan Industry Liaison Office, Western College of Veterinary Medicine Research Trust; Merck-Merial Veterinary Scholars Summer Research Program	This research was supported by grants from the Canadian Swine Health Board (www.swinehealth.ca) and by internal funding from the University of Saskatchewan Industry Liaison Office, Western College of Veterinary Medicine Research Trust (www.usask.ca). Salary support for HK was provided by the Merck-Merial Veterinary Scholars Summer Research Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atyeo RF, 1999, VET MICROBIOL, V67, P47, DOI 10.1016/S0378-1135(99)00030-9; Burrough E, 2012, VET MICROBIOL; Burrough ER, 2012, J VET DIAGN INVEST; Chander Y, 2012, J VET DIAGN INVEST, V24, P903, DOI 10.1177/1040638712456975; Duhamel Gerald E., 2001, Animal Health Research Reviews, V2, P3; Gebhart C.J., 2012, P IPVS KOR, VI, P48; Harding J, 2010, P ANN W CAN ASS SWIN, P65; Harding JCS, 2011, C PIJ S SWIN DYS AD, P27; Harding JCS, 2010, INT PIG VET SOC C JU, P740; Harding JCS, 2008, J VET DIAGN INVEST, V20, P274, DOI 10.1177/104063870802000303; Jacobson M, 2004, J MED MICROBIOL, V53, P273, DOI 10.1099/jmm.0.05323-0; JENKINSON SR, 1981, VET REC, V109, P384, DOI 10.1136/vr.109.17.384; Jensen TK, 2010, VET PATHOL, V47, P334, DOI 10.1177/0300985809359054; JONES GF, 1993, J CLIN MICROBIOL, V31, P2611, DOI 10.1128/JCM.31.10.2611-2615.1993; KINYON JM, 1977, INFECT IMMUN, V15, P638, DOI 10.1128/IAI.15.2.638-646.1977; Komarek V, 2009, VET MICROBIOL, V134, P311, DOI 10.1016/j.vetmic.2008.08.017; KUNKLE RA, 1988, J CLIN MICROBIOL, V26, P2357, DOI 10.1128/JCM.26.11.2357-2360.1988; NEEF NA, 1994, INFECT IMMUN, V62, P2395, DOI 10.1128/IAI.62.6.2395-2403.1994; Primus A., 2011, Evidence-based practice: how do we get there? American Association of Swine Veterinarians 42nd Annual Meeting Proceedings, 5-8 March, 2011, Phoenix, Arizona, USA, P109; Rasback T, 2007, MICROBIOL-SGM, V153, P4074, DOI 10.1099/mic.0.2007/008540-0; Rasback T, 2005, VET MICROBIOL, V109, P229, DOI 10.1016/j.vetmic.2005.05.009; Rasback T, 2007, ENVIRON MICROBIOL, V9, P983, DOI 10.1111/j.1462-2920.2006.01220.x; Rohde J, 2002, J CLIN MICROBIOL, V40, P2598, DOI 10.1128/JCM.40.7.2598-2600.2002; Song Y, 2009, VET MICROBIOL, V137, P129, DOI 10.1016/j.vetmic.2008.12.020; TAYLOR DJ, 1971, BRIT VET J, V127, pR58, DOI 10.1016/S0007-1935(17)37282-2; Trott DJ, 1996, INT J SYST BACTERIOL, V46, P206, DOI 10.1099/00207713-46-1-206; Whiting R. A., 1921, SWINE DYSENTERY, V257, P3; WILCOCK BP, 1979, VET PATHOL, V16, P450, DOI 10.1177/030098587901600409	28	57	59	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57146	10.1371/journal.pone.0057146	http://dx.doi.org/10.1371/journal.pone.0057146			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460829	Green Published, gold, Green Submitted			2022-12-25	WOS:000315519000067
J	Wavre-Shapton, ST; Tolmachova, T; da Silva, ML; Futter, CE; Seabra, MC				Wavre-Shapton, Silene T.; Tolmachova, Tanya; da Silva, Mafalda Lopes; Futter, Clare E.; Seabra, Miguel C.			Conditional Ablation of the Choroideremia Gene Causes Age-Related Changes in Mouse Retinal Pigment Epithelium	PLOS ONE			English	Article							MACULAR DEGENERATION; RAB GTPASES; MODELS; RPE; PHAGOSOMES; PROTEOME; DISEASE; CELLS	The retinal pigment epithelium (RPE) is a pigmented monolayer of cells lying between the photoreceptors and a layer of fenestrated capillaries, the choriocapillaris. Choroideremia (CHM) is an X-linked progressive degeneration of these three layers caused by the loss of function of Rab Escort protein-1 (REP1). REP1 is involved in the prenylation of Rab proteins, key regulators of membrane trafficking. To study the pathological consequences of chronic disruption of membrane traffic in the RPE we used a cell type-specific knock-out mouse model of the disease, where the Chm/Rep1 gene is deleted only in pigmented cells (Chm(Flox), Tyr-Cre+). Transmission electron microscopy (TEM) was used to quantitate the melanosome distribution in the RPE and immunofluorescent staining of rhodopsin was used to quantitate phagocytosed rod outer segments in retinal sections. The ultrastructure of the RPE and Bruch's membrane at different ages was characterised by TEM to analyse age-related changes occurring as a result of defects in membrane traffic pathways. Chm/Rep1 gene knockout in RPE cells resulted in reduced numbers of melanosomes in the apical processes and delayed phagosome degradation. In addition, the RPE accumulated pathological changes at 5-6 months of age similar to those observed in 2-year old controls. These included the intracellular accumulation of lipofuscin-containing deposits, disorganised basal infoldings and the extracellular accumulation of basal laminar and basal linear deposits. The phenotype of the Chm(Flox), Tyr-Cre+ mice suggests that loss of the Chm/Rep1 gene causes premature accumulation of features of aging in the RPE. Furthermore, the striking similarities between the present observations and some of the phenotypes reported in age-related macular degeneration (AMD) suggest that membrane traffic defects may contribute to the pathogenesis of AMD.	[Wavre-Shapton, Silene T.; Tolmachova, Tanya; da Silva, Mafalda Lopes; Seabra, Miguel C.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Mol Med Sect, London, England; [Wavre-Shapton, Silene T.; da Silva, Mafalda Lopes; Futter, Clare E.] UCL, UCL Inst Ophthalmol, London, England; [Seabra, Miguel C.] Univ Nova Lisboa, Fac Ciencias Med, CEDOC, P-1200 Lisbon, Portugal; [Seabra, Miguel C.] Inst Gulbenkian Ciencias, Oeiras, Portugal	Imperial College London; University of London; University College London; Universidade Nova de Lisboa; Instituto Gulbenkian de Ciencia	Futter, CE (corresponding author), UCL, UCL Inst Ophthalmol, London, England.	c.futter@ucl.ac.uk; m.seabra@imperial.ac.uk	Seabra, Miguel/AAC-3099-2019; Seabra, Miguel C/M-3280-2013	Seabra, Miguel C/0000-0002-6404-4892; Tolmachova, Tanya/0000-0002-8841-0797; Futter, Clare/0000-0001-5559-9389; Lopes da Silva, Mafalda/0000-0001-7651-8656	Medical Research Council; Wellcome trust; MRC [G0700778] Funding Source: UKRI; Medical Research Council [G0700778] Funding Source: researchfish; Fight for Sight [1936/38] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Fight for Sight	Funding came from the Medical Research Council (http://www.mrc.ac.uk) and the Wellcome trust (http://www.wellcome.ac.uk/). The authors also acknowledge contribution from Choroideremia Research Foundation Inc.(http://choroideremia.org/) and Tommy Salisbury fund (http://www.fightforsight.org.uk/tommysalisburyfund). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An E, 2006, J PROTEOME RES, V5, P2599, DOI 10.1021/pr060121j; Bonilha VL, 2008, OPHTHALMIC GENET, V29, P99, DOI 10.1080/13816810802206499; CREMERS FPM, 1994, J BIOL CHEM, V269, P2111; Delori FC, 2001, INVEST OPHTH VIS SCI, V42, P1855; Futter CE, 2004, MOL BIOL CELL, V15, P2264, DOI 10.1091/mbc.E03-10-0772; Gibbs D, 2004, J CELL SCI, V117, P6473, DOI 10.1242/jcs.01580; Gordiyenko NV, 2009, INVEST OPHTH VIS SCI, V51, P1143; Guymer RH, 2004, INVEST OPHTH VIS SCI, V45, P1660, DOI 10.1167/iovs.03-0913; Harrison RE, 2003, MOL CELL BIOL, V23, P6494, DOI 10.1128/MCB.23.18.6494-6506.2003; Knupp C, 2002, J STRUCT BIOL, V139, P181, DOI 10.1016/S1047-8477(02)00534-8; Knupp C, 2002, J STRUCT BIOL, V137, P31, DOI 10.1006/jsbi.2002.4449; MISHIMA H, 1978, A GRAEF ARCH KLIN EX, V209, P1, DOI 10.1007/BF00419157; MISHIMA H, 1981, EXP EYE RES, V33, P75, DOI 10.1016/S0014-4835(81)80083-8; Rakoczy PE, 2006, EXP EYE RES, V82, P741, DOI 10.1016/j.exer.2005.10.012; Rakoczy PE, 2002, AM J PATHOL, V161, P1515, DOI 10.1016/S0002-9440(10)64427-6; Reale E, 2001, MATRIX BIOL, V20, P37, DOI 10.1016/S0945-053X(00)00132-3; Roberts EA, 2006, J CELL BIOL, V174, P923, DOI 10.1083/jcb.200603026; Rogers LD, 2007, P NATL ACAD SCI USA, V104, P18520, DOI 10.1073/pnas.0705801104; Seabra MC, 2002, TRENDS MOL MED, V8, P23, DOI 10.1016/S1471-4914(01)02227-4; SEABRA MC, 1995, J BIOL CHEM, V270, P24420, DOI 10.1074/jbc.270.41.24420; Smith AC, 2007, J CELL BIOL, V176, P263, DOI 10.1083/jcb.200611056; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Strunnikova NV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008402; Swaroop A, 2009, ANNU REV GENOM HUM G, V10, P19, DOI 10.1146/annurev.genom.9.081307.164350; Tolmachova T, 2006, J CLIN INVEST, V116, P386, DOI 10.1172/JCI26617; Tolmachova T, 2010, INVEST OPHTH VIS SCI, V51, P4913, DOI 10.1167/iovs.09-4892; Vieira OV, 2003, MOL CELL BIOL, V23, P2501, DOI 10.1128/MCB.23.7.2501-2514.2003; Wang AL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004160	28	40	40	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57769	10.1371/journal.pone.0057769	http://dx.doi.org/10.1371/journal.pone.0057769			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460904	Green Published, gold, Green Submitted			2022-12-25	WOS:000315519000159
J	Chung, SD; Liu, SP; Lin, HC				Chung, Shiu-Dong; Liu, Shih-Ping; Lin, Herng-Ching			Association between Prostate Cancer and Urinary Calculi: A Population-Based Study	PLOS ONE			English	Article							UNITED-STATES; INSULIN-RESISTANCE; METABOLIC SYNDROME; KIDNEY-STONES; TIME-TRENDS; EPIDEMIOLOGY; RISK; NEPHROLITHIASIS; PREVALENCE; DATABASE	Background: Understanding the reasons underlying the emerging trend and the changing demographics of Asian prostate cancer (PC) has become an important field of study. This study set out to explore the possibility that urinary calculi (UC) and PC may share an association by conducting a case-control study on a population-based database in Taiwan. Methods: The cases of this study included 2,900 subjects >= 40 years-old who had received their first-time diagnosis of PC and 14,500 randomly selected controls without PC. Conditional logistic regressions were employed to explore the association between PC and having been previously diagnosed with UC. Results: We found that prior UC was found among 608 (21.0%) cases and 2,037 (14.1%) controls (p<0.001). Conditional logistic regression analysis revealed that compared to controls, the odds ratio (OR) of prior UC for cases was 1.63 (95% CI = 1.47-1.80). Furthermore, we found that cases were more likely to have been previously diagnosed with kidney calculus (OR = 1.71; 95% CI = 1.42-2.05), bladder calculus (OR = 2.06; 95% CI = 1.32-3.23), unspecified calculus (OR = 1.66; 95% CI = 1.37-2.00), and >= 2 locations of UC (OR = 1.73; 1.47-2.02) than controls. However, there was no significant relationship between PC and prior ureter calculus. We also found that of the patients with UC, there was no significant difference between PC and treatment method. Conclusions: This investigation detected an association between PC and prior UC. These results highlight a potential target population for PC screening.	[Chung, Shiu-Dong] Far Eastern Mem Hosp, Div Urol, Dept Surg, New Taipei City, Taiwan; [Chung, Shiu-Dong; Lin, Herng-Ching] Taipei Med Univ, Sch Hlth Care Adm, Taipei, Taiwan; [Liu, Shih-Ping] Natl Taiwan Univ Hosp, Dept Urol, Taipei, Taiwan; [Liu, Shih-Ping] Coll Med, Taipei, Taiwan	Far Eastern Memorial Hospital; Taipei Medical University; National Taiwan University; National Taiwan University Hospital	Lin, HC (corresponding author), Taipei Med Univ, Sch Hlth Care Adm, Taipei, Taiwan.	henry11111@tmu.edu.tw		LIU, SHIH-PING/0000-0002-8015-0695				Carruba G, 2007, J CELL BIOCHEM, V102, P899, DOI 10.1002/jcb.21529; Chen YC, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d637; Chen YC, 2011, SCIENTOMETRICS, V86, P365, DOI 10.1007/s11192-010-0289-2; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Cullen Jennifer, 2012, J Carcinog, V11, P7, DOI 10.4103/1477-3163.94025; Ferlay J, 2001, GLOBOSCAN 2000 CANC; Goldfarb DS, 2003, KIDNEY INT, V63, P1951, DOI 10.1046/j.1523-1755.2003.00942.x; GU FL, 1994, UROLOGY, V44, P688, DOI 10.1016/S0090-4295(94)80207-6; Iba A, 2010, BJU INT, V106, P1550, DOI 10.1111/j.1464-410X.2010.09216.x; Kang JH, 2010, ANN RHEUM DIS, V69, P1165, DOI 10.1136/ard.2009.116178; Long L O, 2007, Minerva Urol Nefrol, V59, P317; Lopez M, 2010, PEDIATR NEPHROL, V25, P49, DOI 10.1007/s00467-008-0960-5; MUIR CS, 1991, ACTA ONCOL, V30, P133, DOI 10.3109/02841869109092336; Pelucchi C, 2006, EUR J CANCER PREV, V15, P254, DOI 10.1097/01.cej.0000198897.40303.d4; Romeo GR, 2012, ARTERIOSCL THROM VAS, V32, P1771, DOI 10.1161/ATVBAHA.111.241869; Sakhaee K, 2002, KIDNEY INT, V62, P971, DOI 10.1046/j.1523-1755.2002.00508.x; Sakhaee K, 2008, CURR OPIN NEPHROL HY, V17, P304, DOI 10.1097/MNH.0b013e3282f8b34d; Santner SJ, 1998, J CLIN ENDOCR METAB, V83, P2104, DOI 10.1210/jc.83.6.2104; SEVERSON RK, 1989, CANCER RES, V49, P1857; Signorello LB, 1997, CANCER CAUSE CONTROL, V8, P632, DOI 10.1023/A:1018454632045; Sim HG, 2005, EUR J CANCER, V41, P834, DOI 10.1016/j.ejca.2004.12.033; Stamatelou KK, 2003, KIDNEY INT, V63, P1817, DOI 10.1046/j.1523-1755.2003.00917.x; YU H, 1991, INT J EPIDEMIOL, V20, P76, DOI 10.1093/ije/20.1.76	23	5	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57743	10.1371/journal.pone.0057743	http://dx.doi.org/10.1371/journal.pone.0057743			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451265	Green Submitted, gold, Green Published			2022-12-25	WOS:000316849500131
J	Yaniv, Y; Spurgeon, HA; Ziman, BD; Lakatta, EG				Yaniv, Yael; Spurgeon, Harold A.; Ziman, Bruce D.; Lakatta, Edward G.			Ca2+/Calmodulin-Dependent Protein Kinase II (CaMKII) Activity and Sinoatrial Nodal Pacemaker Cell Energetics	PLOS ONE			English	Article							CA2+ RELEASES; K+ CHANNELS; CALMODULIN; CALCIUM; CONTRACTION; PHOSPHORYLATION; RAT	Ca2+-activated basal adenylate cyclase (AC) in rabbit sinoatrial node cells (SANC) guarantees, via basal cAMP/PKA-calmodulin/CaMKII-dependent protein phosphorylation, the occurrence of rhythmic, sarcoplasmic-reticulum generated, sub-membrane Ca2+ releases that prompt rhythmic, spontaneous action potentials (APs). This high-throughput signaling consumes ATP. Aims: We have previously demonstrated that basal AC-cAMP/PKA signaling directly, and Ca2+ indirectly, regulate mitochondrial ATP production. While, clearly, Ca2+-calmodulin-CaMKII activity regulates ATP consumption, whether it has a role in the control of ATP production is unknown. Methods and Results: We superfused single, isolated rabbit SANC at 37 degrees C with physiological saline containing CaMKII inhibitors, (KN-93 or autocamtide-2 Related Inhibitory Peptide (AIP)), or a calmodulin inhibitor (W-7) and measured cytosolic Ca2+, flavoprotein fluorescence and spontaneous AP firing rate. We measured cAMP, ATP and O-2 consumption in cell suspensions. Graded reductions in basal CaMKII activity by KN-93 (0.5-3 mu mol/L) or AIP (2-10 mu mol/L) markedly slow the kinetics of intracellular Ca2+ cycling, decrease the spontaneous AP firing rate, decrease cAMP, and reduce O-2 consumption and flavoprotein fluorescence. In this context of graded reductions in ATP demand, however, ATP also becomes depleted, indicating reduced ATP production. Conclusions: CaMKII signaling, a crucial element of normal automaticity in rabbit SANC, is also involved in SANC bioenergetics.	[Yaniv, Yael; Spurgeon, Harold A.; Ziman, Bruce D.; Lakatta, Edward G.] NIA, Cardiovasc Sci Lab, Gerontol Res Ctr, Intramural Res Program,NIH, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Lakatta, EG (corresponding author), NIA, Cardiovasc Sci Lab, Gerontol Res Ctr, Intramural Res Program,NIH, Baltimore, MD 21224 USA.	LakattaE@mail.nih.gov	Yaniv, Yael/B-3311-2015; Lakatta, Edward G/AAL-1447-2020	Yaniv, Yael/0000-0002-5183-6284; Lakatta, Edward/0000-0002-4772-0035	Intramural Research Program of the National Institute on Aging, National Institutes of Health; NATIONAL INSTITUTE ON AGING [ZIAAG000874] Funding Source: NIH RePORTER	Intramural Research Program of the National Institute on Aging, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The work was supported entirely by the Intramural Research Program of the National Institute on Aging, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson ME, 2011, J MOL CELL CARDIOL; Boyett MR, 2000, CARDIOVASC RES, V47, P658, DOI 10.1016/S0008-6363(00)00135-8; Covian R, 2012, AM J PHYSL HEART CIR; Erickson JR, 2008, CELL, V133, P462, DOI 10.1016/j.cell.2008.02.048; Fedorov VV, 2007, HEART RHYTHM, V4, P619, DOI 10.1016/j.hrthm.2006.12.047; Fukuzaki K, 2008, J PHYSIOL-LONDON, V586, P2767, DOI 10.1113/jphysiol.2007.148932; Gao Z, 2011, CIRC-ARRHYTHMIA ELEC, V4, P379, DOI 10.1161/CIRCEP.110.961771; Ke YB, 2007, CIRC RES, V100, P1317, DOI 10.1161/01.RES.0000266742.51389.a4; Khan SZ, 2000, BIOCHEM PHARMACOL, V60, P1797, DOI 10.1016/S0006-2952(00)00505-0; Lakatta EG, 2010, CIRC RES, V106, P659, DOI 10.1161/CIRCRESAHA.109.206078; Ledoux J, 1999, J PHARMACOL EXP THER, V290, P1165; Lee DI, 2012, PHYSIOLOGY, V27, P248, DOI 10.1152/physiol.00011.2012; MacLennan DH, 2003, NAT REV MOL CELL BIO, V4, P566, DOI 10.1038/nrm1151; Maier LS, 2007, CARDIOVASC RES, V73, P631, DOI 10.1016/j.cardiores.2006.11.005; Mattick P, 2007, J PHYSIOL-LONDON, V582, P1195, DOI 10.1113/jphysiol.2007.133439; Rigg L, 2003, CARDIOVASC RES, V57, P497, DOI 10.1016/S0008-6363(02)00668-5; Saks V, 2008, INT J MOL SCI, V9, P751, DOI 10.3390/ijms9050751; Sham JSK, 1997, J PHYSIOL-LONDON, V500, P285, DOI 10.1113/jphysiol.1997.sp022020; Sirenko S, 2008, CIRCULATION, V118, pS346; SPURGEON HA, 1990, AM J PHYSIOL, V258, pH574, DOI 10.1152/ajpheart.1990.258.2.H574; Suzuki M, 2002, J CLIN INVEST, V109, P509, DOI 10.1172/JC1200214270; Vinogradova T., 2011, CIRCULATION, V124; Vinogradova TM, 2008, CIRC RES, V102, P761, DOI 10.1161/CIRCRESAHA.107.161679; Vinogradova TM, 2010, CIRC RES, V107, P767, DOI 10.1161/CIRCRESAHA.110.220517; Vinogradova TM, 2000, CIRC RES, V87, P760, DOI 10.1161/01.RES.87.9.760; Vinogradova TM, 2006, CIRC RES, V98, P505, DOI 10.1161/01.RES.0000204575.94040.d1; Wu YJ, 2009, P NATL ACAD SCI USA, V106, P5972, DOI 10.1073/pnas.0806422106; YAMADA EW, 1988, J BIOL CHEM, V263, P11498; Yaniv Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037582; Yaniv Y, 2011, J MOL CELL CARDIOL, V51, P740, DOI 10.1016/j.yjmcc.2011.07.018; Younes A, 2008, J BIOL CHEM, V283, P14461, DOI 10.1074/jbc.M707540200; Zhang R, 2005, NAT MED, V11, P409, DOI 10.1038/nm1215	32	25	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57079	10.1371/journal.pone.0057079	http://dx.doi.org/10.1371/journal.pone.0057079			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23459256	Green Published, gold, Green Submitted			2022-12-25	WOS:000316849500062
J	Murakami, K; Ichinohe, Y; Koike, M; Sasaoka, N; Iemura, S; Natsume, T; Kakizuka, A				Murakami, Katsuhiro; Ichinohe, Yuzuru; Koike, Masaaki; Sasaoka, Norio; Iemura, Shun-ichiro; Natsume, Tohru; Kakizuka, Akira			VCP Is an Integral Component of a Novel Feedback Mechanism that Controls Intracellular Localization of Catalase and H2O2 Levels	PLOS ONE			English	Article							P97/VALOSIN-CONTAINING PROTEIN VCP; AMINO-ACID-SEQUENCE; ATPASE ACTIVITY; PEROXISOMES; DISEASE; GENE	Catalase is a key antioxidant enzyme that catalyzes the decomposition of hydrogen peroxide (H2O2) to water and oxygen, and it appears to shuttle between the cytoplasm and peroxisome via unknown mechanisms. Valosin-containing protein (VCP) belongs to the AAA class of ATPases and is involved in diverse cellular functions, e.g. cell cycle and protein degradation, etc. Here we show that VCP and PEX19, a protein essential for peroxisome biogenesis, interact with each other. Knockdown of either VCP or PEX19 resulted in a predominantly cytoplasmic redistribution of catalase, and loss of VCP ATPase activity also increased its cytoplasmic redistribution. Moreover, VCP knockdown decreased intracellular ROS levels in normal and H2O2-treated cells, and an oxidation-resistant VCP impaired the ROS-induced cytoplasmic redistribution of catalase. These observations reveal a novel feedback mechanism, in which VCP can sense H2O2 levels, and regulates them by controlling the localization of catalase.	[Murakami, Katsuhiro; Ichinohe, Yuzuru; Koike, Masaaki; Sasaoka, Norio; Kakizuka, Akira] Kyoto Univ, Lab Funct Biol, Grad Sch Biostudies, Sakyo Ku, Kyoto, Japan; [Iemura, Shun-ichiro; Natsume, Tohru] Natl Inst Adv Ind Sci & Technol, Biol Informat Res Ctr JBIRC, Kohtoh Ku, Tokyo, Japan	Kyoto University; National Institute of Advanced Industrial Science & Technology (AIST)	Kakizuka, A (corresponding author), Kyoto Univ, Lab Funct Biol, Grad Sch Biostudies, Sakyo Ku, Kyoto, Japan.	kakizuka@lif.kyoto-u.ac.jp	Natsume, Tohru/M-7627-2018	Natsume, Tohru/0000-0002-1510-2582	Solution Oriented Research for Science and Technology (SORST) of Japan Science and Technology Agency (JST); Ministry of Education, Culture, Sports, Science, and Technology of Japan; Ministry of Health, Labour, and Welfare of Japan	Solution Oriented Research for Science and Technology (SORST) of Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported in part by research grants from Solution Oriented Research for Science and Technology (SORST) of Japan Science and Technology Agency (JST), the Ministry of Education, Culture, Sports, Science, and Technology of Japan, and the Ministry of Health, Labour, and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chou TF, 2011, P NATL ACAD SCI USA, V108, P4834, DOI 10.1073/pnas.1015312108; COHEN G, 1988, EUR J BIOCHEM, V176, P159; Funato Y, 2010, FREE RADICAL RES, V44, P379, DOI 10.3109/10715761003610745; HARTIG A, 1986, EUR J BIOCHEM, V160, P487, DOI 10.1111/j.1432-1033.1986.tb10065.x; Heiland I, 2005, FEBS J, V272, P2362, DOI 10.1111/j.1742-4658.2005.04690.x; Hirabayashi M, 2001, CELL DEATH DIFFER, V8, P977, DOI 10.1038/sj.cdd.4400907; Hu CT, 2011, CLIN EXP METASTAS, V28, P851, DOI 10.1007/s10585-011-9416-6; Johnson JO, 2010, NEURON, V68, P857, DOI 10.1016/j.neuron.2010.11.036; Kakizuka A, 2008, BIOCHEM SOC T, V36, P105, DOI 10.1042/BST0360105; Kobayashi T, 2002, J BIOL CHEM, V277, P47358, DOI 10.1074/jbc.M207783200; Koike M, 2010, J BIOL CHEM, V285, P21736, DOI 10.1074/jbc.M109.099283; Legakis JE, 2002, MOL BIOL CELL, V13, P4243, DOI 10.1091/mbc.E02-06-0322; Manno A, 2010, GENES CELLS, V15, P911, DOI 10.1111/j.1365-2443.2010.01428.x; Maynard EL, 2004, PROTEINS, V55, P856, DOI 10.1002/prot.20112; Mori-Konya C, 2009, GENES CELLS, V14, P483, DOI 10.1111/j.1365-2443.2009.01286.x; Natsume T, 2002, ANAL CHEM, V74, P4725, DOI 10.1021/ac020018n; Noguchi M, 2005, J BIOL CHEM, V280, P41332, DOI 10.1074/jbc.M509700200; Terlecky SR, 2006, BBA-MOL CELL RES, V1763, P1749, DOI 10.1016/j.bbamcr.2006.08.017; Togo SH, 2000, EUR J BIOCHEM, V267, P1307, DOI 10.1046/j.1432-1327.2000.01091.x; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Vurusaner B, 2012, FREE RADICAL BIO MED, V52, P7, DOI 10.1016/j.freeradbiomed.2011.09.035	21	18	19	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56012	10.1371/journal.pone.0056012	http://dx.doi.org/10.1371/journal.pone.0056012			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457492	Green Published, Green Submitted, gold			2022-12-25	WOS:000315602700032
J	Roellig, DM; Savage, MY; Fujita, AW; Barnabe, C; Tibayrenc, M; Steurer, FJ; Yabsley, MJ				Roellig, Dawn M.; Savage, Mason Y.; Fujita, A. Wendy; Barnabe, Christian; Tibayrenc, Michel; Steurer, Frank J.; Yabsley, Michael J.			Genetic Variation and Exchange in Trypanosoma cruzi Isolates from the United States	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; ST-CATHERINES ISLAND; CHAGAS-DISEASE; AUTOCHTHONOUS TRANSMISSION; AMERICAN TRYPANOSOMIASIS; PHYLOGENETIC LINEAGES; NUCLEOTIDE-SEQUENCES; BASIC MECHANISM; DIVERSITY; DNA	Trypanosoma cruzi, the causative agent of Chagas disease, is a multiclonal parasite with high levels of genetic diversity and broad host and geographic ranges. Molecular characterization of South American isolates of T. cruzi has demonstrated homologous recombination and nuclear hybridization, as well as the presence of 6 main genetic clusters or "discrete typing units'' (DTUs). Few studies have extensively investigated such exchange events and genetic diversity in North American isolates. In the current study, we genetically characterized over 50 US isolates from wildlife reservoirs (e.g., raccoons, opossums, armadillos, skunks), domestic dogs, humans, nonhuman primates, and reduviid vectors from nine states (TX, CA, OK, SC, FL, GA, MD, LA, TN) using a multilocus sequencing method. Single nucleotide polymorphisms were identified in sequences of the mismatch-repair class 2 (MSH2) and Tc52 genes. Typing based on the two genes often paralleled genotyping by classic methodologies using mini-exon and 18S and 24S alpha rRNA genes. Evidence for genetic exchange was obtained by comparing sequence phylogenies of nuclear and mitochondrial gene targets, dihydrofolate reductase-thymidylate synthase (DHFR-TS) and the cytochrome oxidase subunit II- NADH dehydrogenase subunit I region (COII-ND1), respectively. We observed genetic exchange in several US isolates as demonstrated by incongruent mitochondrial and nuclear genes phylogenies, which confirms a previous finding of a single genetic exchange event in a Florida isolate. The presence of SNPs and evidence of genetic exchange illustrates that strains from the US are genetically diverse, even though only two phylogenetic lineages have been identified in this region.	[Roellig, Dawn M.; Savage, Mason Y.; Fujita, A. Wendy; Yabsley, Michael J.] Univ Georgia, Coll Vet Med, Southeastern Cooperat Wildlife Dis Study, Athens, GA 30602 USA; [Roellig, Dawn M.] Univ Georgia, Coll Vet Med, Dept Infect Dis, Athens, GA USA; [Barnabe, Christian] Univ Montpellier I, MIVEGEC, IRD, CNRS 5290,IRD 224, La Paz, Bolivia; [Barnabe, Christian] Univ Montpellier 2, MIVEGEC, IRD, CNRS 5290,IRD 224, La Paz, Bolivia; [Tibayrenc, Michel] Univ Montpellier I, Ctr Natl Rech Sci, Inst Rech Dev, MIVEGEC,CNRS 5290,IRD 224,IRD Ctr, Montpellier, France; [Tibayrenc, Michel] Univ Montpellier 2, Univ Montpellier 1, Ctr Natl Rech Sci, MIVEGEC,CNRS 5290,IRD 224,Inst Rech Dev,IRD Ctr, Montpellier, France; [Steurer, Frank J.] Ctr Dis Control & Prevent, Atlanta, GA USA; [Yabsley, Michael J.] Univ Georgia, DB Warnell Sch Forestry & Nat Resources, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; Institut de Recherche pour le Developpement (IRD); Institut de Recherche pour le Developpement (IRD); Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Centers for Disease Control & Prevention - USA; University System of Georgia; University of Georgia	Roellig, DM (corresponding author), Univ Georgia, Coll Vet Med, Southeastern Cooperat Wildlife Dis Study, Athens, GA 30602 USA.	iyd4@cdc.gov	Barnabé, Christian/R-2904-2016; Tibayrenc, Michel/AAY-7494-2021; Savage, Mason/Q-1544-2019	Barnabé, Christian/0000-0003-1857-0741; Yabsley, Michael/0000-0003-2452-5015; Savage, Mason/0000-0001-8210-8207	National Institutes of Health, National Institute of Allergy and Infectious Diseases grant [R15 AI067304]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R15AI067304] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Allergy and Infectious Diseases grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the National Institutes of Health, National Institute of Allergy and Infectious Diseases grant R15 AI067304. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Augusto-Pinto L, 2003, GENETICS, V164, P117; Augusto-Pinto L, 2001, GENE, V272, P323, DOI 10.1016/S0378-1119(01)00549-2; Barnabe C, 2001, EXP PARASITOL, V99, P73, DOI 10.1006/expr.2001.4651; Barnabe C, 2012, INFECT GENET EVOL, V12, P1879, DOI 10.1016/j.meegid.2012.08.018; Barrera-Perez M., 2001, REV BIOMED, V12, P224; Barretto M.P., 1979, Revista do Instituto Adolfo Lutz, V39, P25; Bertoli M, 2006, PARASITOL RES, V99, P7, DOI 10.1007/s00436-005-0122-7; Bosseno MF, 2002, J CLIN MICROBIOL, V40, P627, DOI 10.1128/JCM.40.2.627-632.2002; Brisse S, 2001, INT J PARASITOL, V31, P1218, DOI 10.1016/S0020-7519(01)00238-7; Brisse S, 2000, INT J PARASITOL, V30, P35, DOI 10.1016/S0020-7519(99)00168-X; Brisse S, 2003, INFECT GENET EVOL, V2, P173, DOI 10.1016/S1567-1348(02)00097-7; Brown EL, 2010, VECTOR-BORNE ZOONOT, V10, P757, DOI 10.1089/vbz.2009.0009; Campos PC, 2011, MOL BIOCHEM PARASIT, V176, P8, DOI 10.1016/j.molbiopara.2010.11.001; CASTELLANI O, 1967, J PROTOZOOL, V14, P447, DOI 10.1111/j.1550-7408.1967.tb02024.x; CLARK CG, 1994, MOL BIOCHEM PARASIT, V66, P175, DOI 10.1016/0166-6851(94)90045-0; Ramirez JD, 2012, INFECT GENET EVOL, V12, P1743, DOI 10.1016/j.meegid.2012.06.018; Ramirez JD, 2012, MOL ECOL, V21, P4216, DOI 10.1111/j.1365-294X.2012.05699.x; Sanchez-Guillen MD, 2006, MEM I OSWALDO CRUZ, V101, P585, DOI 10.1590/S0074-02762006000600002; Dorn PL, 2007, EMERG INFECT DIS, V13, P605, DOI 10.3201/eid1304.061002; Eck R.V., 1966, ATLAS PROTEIN SEQUEN; Espinoza B, 1998, ACTA TROP, V70, P63, DOI 10.1016/S0001-706X(98)00005-9; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Ferreira RC, 2012, INFECT GENET EVOL, V12, P1064, DOI 10.1016/j.meegid.2012.03.010; Gaunt MW, 2003, NATURE, V421, P936, DOI 10.1038/nature01438; Hall CA, 2007, J PARASITOL, V93, P93, DOI 10.1645/GE-936R.1; Herrera C, 2007, INFECT GENET EVOL, V7, P535, DOI 10.1016/j.meegid.2006.12.003; Herwaldt BL, 2000, J INFECT DIS, V181, P395, DOI 10.1086/315212; Hoare CA, 1972, TRYPANOSOMES MAMMALS, P753; Iwagami M, 2007, PARASITOL RES, V102, P129, DOI 10.1007/s00436-007-0739-9; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Lisboa CV, 2007, EXP PARASITOL, V116, P150, DOI 10.1016/j.exppara.2006.12.005; Machado CA, 2001, P NATL ACAD SCI USA, V98, P7396, DOI 10.1073/pnas.121187198; Marcili A, 2009, INT J PARASITOL, V39, P615, DOI 10.1016/j.ijpara.2008.09.015; Mathieu-Daude F, 2007, PARASITOL RES, V101, P1355, DOI 10.1007/s00436-007-0651-3; Miles M.A., 1979, P117; MILES MA, 1978, NATURE, V272, P819, DOI 10.1038/272819a0; Minning TA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-139; O'Connor O, 2007, INFECT GENET EVOL, V7, P587, DOI 10.1016/j.meegid.2007.05.003; Ocana-Mayorga S, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000915; Ochs DE, 1996, AM J TROP MED HYG, V54, P526, DOI 10.4269/ajtmh.1996.54.526; Ouaissi A, 1995, IMMUNOL LETT, V48, P221, DOI 10.1016/0165-2478(95)02463-8; Ouaissi MA, 1995, EXP PARASITOL, V81, P453, DOI 10.1006/expr.1995.1138; Oury B, 2005, EXP PARASITOL, V111, P198, DOI 10.1016/j.exppara.2005.07.001; Pung OJ, 1998, J ZOO WILDLIFE MED, V29, P25; Roellig DM, 2008, EMERG INFECT DIS, V14, P1123, DOI 10.3201/eid1407.080175; Roellig DM, 2010, AM J TROP MED HYG, V83, P519, DOI 10.4269/ajtmh.2010.09-0663; RZHETSKY A, 1992, MOL BIOL EVOL, V9, P945; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SCHIFFLER RJ, 1984, JAMA-J AM MED ASSOC, V251, P2983, DOI 10.1001/jama.251.22.2983; Spotorno AE, 2008, INFECT GENET EVOL, V8, P898, DOI 10.1016/j.meegid.2008.08.006; Sturm NR, 2010, ACTA TROP, V115, P35, DOI 10.1016/j.actatropica.2009.08.018; Sturm NR, 2003, INT J PARASITOL, V33, P269, DOI 10.1016/S0020-7519(02)00264-3; Subileau M, 2009, EXP PARASITOL, V122, P328, DOI 10.1016/j.exppara.2009.04.008; Tibayrenc M, 2002, TRENDS PARASITOL, V18, P405, DOI 10.1016/S1471-4922(02)02357-7; Westenberger SJ, 2005, GENETICS, V171, P527, DOI 10.1534/genetics.104.038745; WOODY NC, 1955, JAMA-J AM MED ASSOC, V159, P676, DOI 10.1001/jama.1955.02960240042010a; Yeo M, 2005, INT J PARASITOL, V35, P225, DOI 10.1016/j.ijpara.2004.10.024; Yeo M, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001049; Zingales B, 2009, MEM I OSWALDO CRUZ, V104, P1051, DOI 10.1590/S0074-02762009000700021; Zingales B, 2012, INFECT GENET EVOL, V12, P240, DOI 10.1016/j.meegid.2011.12.009; Zumaya-Estrada FA, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-226	61	43	43	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56198	10.1371/journal.pone.0056198	http://dx.doi.org/10.1371/journal.pone.0056198			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457528	gold, Green Submitted, Green Published			2022-12-25	WOS:000315602700060
J	Ung, CY; Lam, SH; Zhang, X; Li, H; Zhang, LX; Li, BW; Gong, ZY				Ung, Choong Yong; Lam, Siew Hong; Zhang, Xun; Li, Hu; Zhang, Louxin; Li, Baowen; Gong, Zhiyuan			Inverted Expression Profiles of Sex-Biased Genes in Response to Toxicant Perturbations and Diseases	PLOS ONE			English	Article							ZEBRAFISH SPOTTED-MICROARRAY; X-CHROMOSOME INACTIVATION; DEPENDENT ASSOCIATION; BLOOD INSTITUTE; NATIONAL HEART; POLYMORPHISMS; SELECTION; WOMEN; AGE; MAINTENANCE	The influence of sex factor is widely recognized in various diseases, but its molecular basis, particularly how sex-biased genes, those with sexually dimorphic expression, behave in response to toxico-pathological changes is poorly understood. In this study, zebrafish toxicogenomic data and transcriptomic data from human pathological studies were analysed for the responses of male- and female-biased genes. Our analyses revealed obvious inverted expression profiles of sex-biased genes, where affected males tended to up-regulate genes of female-biased expression and down-regulate genes of male-biased expression, and vice versa in affected females, in a broad range of toxico-pathological conditions. Intriguingly, the extent of these inverted profiles correlated well to the susceptibility or severity of a given toxico-pathological state, suggesting that inverted expression profiles of sex-biased genes observed in this study can be used as important indicators to assess biological disorders.	[Ung, Choong Yong; Lam, Siew Hong; Gong, Zhiyuan] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Ung, Choong Yong] Univ Malaya, Inst Biol Sci, Bioinformat Programme, Kuala Lumpur, Malaysia; [Zhang, Xun; Zhang, Louxin; Li, Baowen; Gong, Zhiyuan] Natl Univ Singapore, Grad Sch Integrat Sci & Engn, Singapore 117548, Singapore; [Zhang, Xun; Li, Baowen] Natl Univ Singapore, Dept Phys, Singapore 117548, Singapore; [Zhang, Xun; Li, Baowen] Natl Univ Singapore, Ctr Computat Sci & Engn, Singapore 117548, Singapore; [Li, Hu] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; [Zhang, Louxin] Natl Univ Singapore, Dept Math, Singapore 117548, Singapore	National University of Singapore; Universiti Malaya; National University of Singapore; National University of Singapore; National University of Singapore; Boston University; National University of Singapore	Ung, CY (corresponding author), Natl Univ Singapore, Dept Biol Sci, Kent Ridge, Singapore 117548, Singapore.	zencyung@gmail.com; dbsgzy@nus.edu.sg	Zhang, Louxin/M-4865-2016; Gong, Zhiyuan/H-8794-2012; Li, Baowen/G-3003-2011; Lam, Siew Hong/H-8483-2012	Zhang, Louxin/0000-0003-0260-824X; Gong, Zhiyuan/0000-0002-9660-5260; Li, Baowen/0000-0002-8728-520X; 	Singapore National Research Foundation under its Environmental & Water Technologies Strategic Research Programme; Environment & Water Industry Programme Office (EWI) of the PUB [R-154-000-328-272]	Singapore National Research Foundation under its Environmental & Water Technologies Strategic Research Programme; Environment & Water Industry Programme Office (EWI) of the PUB	This work was supported by the Singapore National Research Foundation under its Environmental & Water Technologies Strategic Research Programme and administered by the Environment & Water Industry Programme Office (EWI) of the PUB, grant number R-154-000-328-272. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AF, 2001, NATURE, V411, P692, DOI 10.1038/35079590; Anderson GD, 2005, J WOMENS HEALTH, V14, P19, DOI 10.1089/jwh.2005.14.19; Barnes MG, 2009, ARTHRITIS RHEUM-US, V60, P2102, DOI 10.1002/art.24601; Berchtold NC, 2008, P NATL ACAD SCI USA, V105, P15605, DOI 10.1073/pnas.0806883105; Candolin U, 2008, TRENDS ECOL EVOL, V23, P446, DOI 10.1016/j.tree.2008.04.008; Chen WY, 2004, BIOCHEM BIOPH RES CO, V319, P866, DOI 10.1016/j.bbrc.2004.05.060; Chippindale AK, 2001, P NATL ACAD SCI USA, V98, P1671, DOI 10.1073/pnas.041378098; Colegrave N, 2002, NATURE, V420, P664, DOI 10.1038/nature01191; Connallon T, 2005, TRENDS GENET, V21, P495, DOI 10.1016/j.tig.2005.07.006; Dewing P, 2003, MOL BRAIN RES, V118, P82, DOI 10.1016/S0169-328X(03)00339-5; Ellegren H, 2007, NAT REV GENET, V8, P689, DOI 10.1038/nrg2167; Ellsworth DL, 2001, J MOL MED-JMM, V79, P390, DOI 10.1007/s001090100235; Galamb O, 2008, HELICOBACTER, V13, P112, DOI 10.1111/j.1523-5378.2008.00584.x; Giordano TJ, 2009, CLIN CANCER RES, V15, P668, DOI 10.1158/1078-0432.CCR-08-1067; HAMILTON WD, 1990, P NATL ACAD SCI USA, V87, P3566, DOI 10.1073/pnas.87.9.3566; HANSEN PS, 1994, CLIN GENET, V45, P78; Harris DJ, 2000, NEW ENGL J MED, V343, P475, DOI 10.1056/NEJM200008173430706; He HL, 2005, P NATL ACAD SCI USA, V102, P19075, DOI 10.1073/pnas.0509603102; Hong Y, 2007, CLIN CANCER RES, V13, P1107, DOI 10.1158/1078-0432.CCR-06-1633; Kaltz O, 2002, EVOLUTION, V56, P1743; Kim AM, 2010, NATURE, V465, P688, DOI 10.1038/465688a; Kim ESH, 2008, J AM COLL CARDIOL, V52, P672, DOI 10.1016/j.jacc.2008.05.025; Kwekel JC, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-675; Lam SH, 2006, PHYSIOL GENOMICS, V27, P351, DOI 10.1152/physiolgenomics.00201.2005; Lam Siew Hong, 2009, V546, P175, DOI 10.1007/978-1-60327-977-2_12; Lam Siew Hong, 2009, V546, P197, DOI 10.1007/978-1-60327-977-2_13; Lam SH, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000121; Lee JT, 2011, NAT REV MOL CELL BIO, V12, P815, DOI 10.1038/nrm3231; Lesnick TG, 2007, PLOS GENET, V3, P984, DOI 10.1371/journal.pgen.0030098; Leung KH, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-19; LIVELY CM, 1987, NATURE, V328, P519, DOI 10.1038/328519a0; Matanoski G, 2006, CANCER-AM CANCER SOC, V107, P1112, DOI 10.1002/cncr.22008; Morran LT, 2011, SCIENCE, V333, P216, DOI 10.1126/science.1206360; Ober C, 2008, NAT REV GENET, V9, P911, DOI 10.1038/nrg2415; Pennisi E, 2011, SCIENCE, V334, P1486, DOI 10.1126/science.334.6062.1486; Proud D, 2008, AM J RESP CRIT CARE, V178, P962, DOI 10.1164/rccm.200805-670OC; Richards SM, 2006, EXP EYE RES, V82, P13, DOI 10.1016/j.exer.2005.04.014; Rinn JL, 2004, DEV CELL, V6, P791, DOI 10.1016/j.devcel.2004.05.005; RISCH HA, 1993, AM J EPIDEMIOL, V138, P281, DOI 10.1093/oxfordjournals.aje.a116857; Schott E, 2007, J HEPATOL, V46, P372, DOI 10.1016/j.jhep.2006.09.011; Siller S, 2001, NATURE, V411, P689, DOI 10.1038/35079578; Stearns SC, 2010, P NATL ACAD SCI USA, V107, P1691, DOI 10.1073/pnas.0914475107; Ung CY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027819; Vandenbroeck K, 2003, ARTHRITIS RHEUM-US, V48, P2773, DOI 10.1002/art.11236; Vanni H, 2009, CHEST, V135, P1197, DOI 10.1378/chest.08-1024; Vawter MP, 2004, NEUROPSYCHOPHARMACOL, V29, P373, DOI 10.1038/sj.npp.1300337; Verma AS, 2006, J GASTROEN HEPATOL, V21, P1004, DOI 10.1111/j.1440-1746.2005.03948.x; Whitlock MC, 2009, EVOLUTION, V63, P569, DOI 10.1111/j.1558-5646.2008.00558.x; WILLIAMS GC, 1991, Q REV BIOL, V66, P1, DOI 10.1086/417048; Wooten GF, 2004, J NEUROL NEUROSUR PS, V75, P637, DOI 10.1136/jnnp.2003.020982; Wutz A, 2011, NAT REV GENET, V12, P542, DOI 10.1038/nrg3035; Yang X, 2006, GENOME RES, V16, P995, DOI 10.1101/gr.5217506; Zopf Y, 2008, EUR J CLIN PHARMACOL, V64, P999, DOI 10.1007/s00228-008-0494-6	53	4	4	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56668	10.1371/journal.pone.0056668	http://dx.doi.org/10.1371/journal.pone.0056668			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457601	gold, Green Submitted, Green Published			2022-12-25	WOS:000315602700090
J	Ramani, RG; Jacob, SG				Ramani, R. Geetha; Jacob, Shomona Gracia			Prediction of P53 Mutants (Multiple Sites) Transcriptional Activity Based on Structural (2D&3D) Properties	PLOS ONE			English	Article							AMINO-ACID-COMPOSITION; TUMOR-SUPPRESSOR GENE; CANCER RESCUE MUTANTS; PROTEIN; CLASSIFICATION; MUTATIONS; INFORMATION; PATTERNS; FEATURES; CRITERIA	Prediction of secondary site mutations that reinstate mutated p53 to normalcy has been the focus of intense research in the recent past owing to the fact that p53 mutants have been implicated in more than half of all human cancers and restoration of p53 causes tumor regression. However laboratory investigations are more often laborious and resource intensive but computational techniques could well surmount these drawbacks. In view of this, we formulated a novel approach utilizing computational techniques to predict the transcriptional activity of multiple site (one-site to five-site) p53 mutants. The optimal MCC obtained by the proposed approach on prediction of one-site, two-site, three-site, four-site and five-site mutants were 0.775,0.341,0.784,0.916 and 0.655 respectively, the highest reported thus far in literature. We have also demonstrated that 2D and 3D features generate higher prediction accuracy of p53 activity and our findings revealed the optimal results for prediction of p53 status, reported till date. We believe detection of the secondary site mutations that suppress tumor growth may facilitate better understanding of the relationship between p53 structure and function and further knowledge on the molecular mechanisms and biological activity of p53, a targeted source for cancer therapy. We expect that our prediction methods and reported results may provide useful insights on p53 functional mechanisms and generate more avenues for utilizing computational techniques in biological data analysis.	[Ramani, R. Geetha] Anna Univ, Coll Engn, Dept Informat Sci & Technol, Chennai 600025, Tamil Nadu, India; [Jacob, Shomona Gracia] Anna Univ, Fac Informat & Commun Engn, Chennai 600025, Tamil Nadu, India	Anna University; Anna University Chennai; Anna University; Anna University Chennai	Jacob, SG (corresponding author), Anna Univ, Fac Informat & Commun Engn, Chennai 600025, Tamil Nadu, India.	graciarun@gmail.com	r, geetharamani/AHH-4747-2022; Jacob, Shomona/GZB-1912-2022	r, geetharamani/0000-0003-2283-3428; 	All India Council for Technical Education (AICTE), India [8023/RID/RPS-56/2010-11, 200-62/FIN/04/05/1624]	All India Council for Technical Education (AICTE), India	This research work is a part of the All India Council for Technical Education (AICTE), India funded Research Promotion Scheme project titled "Efficient Classifier for clinical life data (Parkinson, Breast Cancer and P53 mutants) through feature relevance analysis and classification" with Reference No:8023/RID/RPS-56/2010-11, No:200-62/FIN/04/05/1624. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aires Rachel, 2009, TECHNICAL REPORT; [Anonymous], 2012, EUR J SCI RES, V78, P468; [Anonymous], 1999, CORRELATION BASED FE; Bai L, 2006, J CANC MOL, V2, P141; Baldi P, 2000, BIOINFORMATICS, V16, P412, DOI 10.1093/bioinformatics/16.5.412; Baroni TE, 2004, P NATL ACAD SCI USA, V101, P4930, DOI 10.1073/pnas.0401162101; Bazzan ALC, 2002, BIOINFORMATICS, V18, pS35, DOI 10.1093/bioinformatics/18.suppl_2.S35; Brachmann KR, 2005, [Global Suppressors of P53 Mutations, PCT No.: PCT/US03/0024], VUS2005/0065332, Patent No. 20050065332; Breiman Leo, RANDOM TREES; Chou K.-C., 2010, NAT SCI IRVINE, V2, P1090, DOI [10.4236/ns.2010.210136, DOI 10.4236/NS.2010.210136]; CHOU KC, 1995, CRIT REV BIOCHEM MOL, V30, P275, DOI 10.3109/10409239509083488; Chou KC, 2011, J THEOR BIOL, V273, P236, DOI 10.1016/j.jtbi.2010.12.024; CMP, CMP DATA MINING STAT; Danziger SA, 2006, IEEE ACM T COMPUT BI, V3, P114, DOI 10.1109/TCBB.2006.22; Danziger SA, 2007, BIOINFORMATICS, V23, pI104, DOI 10.1093/bioinformatics/btm166; Danziger SA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000498; Deng HT, 2011, LECT NOTES COMPUT SC, V6792, P293, DOI 10.1007/978-3-642-21738-8_38; Freund Y., 1999, Journal of Japanese Society for Artificial Intelligence, V14, P771; Freund Y., 1995, DECISION THEORETIC G; Friedman J., 1998, ADDITIVE LOGISTIC RE; Friedman N, 2000, J COMPUT BIOL, V7, P601, DOI 10.1089/106652700750050961; Gasco M, 2002, BREAST CANCER RES, V4, P70, DOI 10.1186/bcr426; Geisser S., 2017, PREDICTIVE INFERENCE; Gu Q, 2010, PROTEIN PEPTIDE LETT, V17, P559, DOI 10.2174/092986610791112693; Hainaut P, 1998, NUCLEIC ACIDS RES, V26, P205, DOI 10.1093/nar/26.1.205; Hainaut P, 2000, ADV CANCER RES, V77, P81; Harris CC, 1996, CARCINOGENESIS, V17, P1187, DOI 10.1093/carcin/17.6.1187; Harris CC, 1996, JNCI-J NATL CANCER I, V88, P1442, DOI 10.1093/jnci/88.20.1442; HARRIS CC, 1993, NEW ENGL J MED, V329, P1318, DOI 10.1056/NEJM199310283291807; Hayat M, 2011, J THEOR BIOL, V271, P10, DOI 10.1016/j.jtbi.2010.11.017; Heckerman D., 1995, TECHNICAL REPORT; HEIMDAL K, 1993, GENE CHROMOSOME CANC, V6, P92, DOI 10.1002/gcc.2870060205; Hock AK, 2011, EMBO J, V30, P4921, DOI 10.1038/emboj.2011.419; Huang T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016036; Huang T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022940; Huang T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011900; Huang T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010972; Iba W, 1992, P 9 INT C MACH LEARN, P233, DOI DOI 10.1016/B978-1-55860-247-2.50035-8; Jacob SG, 2012, P INT C ADV COMP COM, P997, DOI [10.1145/2345396.2345557, DOI 10.1145/2345396.2345557]; Jacob SG, 2011, P IEEE INT C COMP IN, P661; Jacob SG., 2011, INT J COMPUTERS APPL, V32, P46, DOI DOI 10.5120/3920-5521; Jacob Shomona Gracia, 2012, P INT C COMP APPL PO, DOI 10.73445/ISBN_0768; JAYNES ET, 1957, PHYS REV, V106, P620, DOI 10.1103/PhysRev.106.620; Jiang X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-89; Joerger AC, 2008, ANNU REV BIOCHEM, V77, P557, DOI 10.1146/annurev.biochem.77.060806.091238; Joshi RR, 2010, PROTEIN PEPTIDE LETT, V17, P1198; Kandaswamy KK, 2011, J THEOR BIOL, V270, P56, DOI 10.1016/j.jtbi.2010.10.037; Kato S, 2003, P NATL ACAD SCI USA, V100, P8424, DOI 10.1073/pnas.1431692100; KERN SE, 1991, SCIENCE, V252, P1708, DOI 10.1126/science.2047879; Kohavi R., 1995, IJCAI-95. Proceedings of the Fourteenth International Joint Conference on Artificial Intelligence, P1137; Kotsiantis SB, 2007, INFORMATICA, P31249; Le Gall J-F, 2005, RANDOM TREES APPL N; Luo R, 2002, J COMPUT CHEM, V23, P1244, DOI 10.1002/jcc.10120; Mathe E, 2006, HUM MUTAT, V0, P1; May P, 1999, ONCOGENE, V18, P7621, DOI 10.1038/sj.onc.1203285; Mitchell T.M, 2003, MACH LEARN; Mohabatkar H, 2010, PROTEIN PEPTIDE LETT, V17, P1207, DOI 10.2174/092986610792231564; Oliver JJ, 1994, LECT NOTES COMPUTER, V784, P231, DOI [DOI 10.1007/3-540-57868-4-61, 10.1007/3-540-57868-4-61]; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Petitjean A, 2007, HUM MUTAT, V28, P622, DOI 10.1002/humu.20495; PICARD RR, 1984, J AM STAT ASSOC, V79, P575, DOI 10.2307/2288403; Polikar R., 2006, IEEE Circuits and Systems Magazine, V6, P21, DOI 10.1109/MCAS.2006.1688199; Pourret O., 2008, BAYESIAN NETWORKS PR; Ray A, 2008, MACHINE LEARNING PRE; Schmitt CA, 2002, CANCER CELL, V1, P289, DOI 10.1016/S1535-6108(02)00047-8; Selvakuberan K, 2008, J INFORM COMPUTING S, V3, P083; Soussi T, 2000, HUM MUTAT, V15, P105, DOI 10.1002/(SICI)1098-1004(200001)15:1<105::AID-HUMU19>3.0.CO;2-G; UCI, MACH LEARN REP; Uebersax J, 2004, GENETIC COUNSELLING; Wang P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018476; Zakeri P, 2011, J THEOR BIOL, V269, P208, DOI 10.1016/j.jtbi.2010.10.026; Zhang T, 2004, ANN STAT, V32, P56; Zhou XB, 2007, J THEOR BIOL, V248, P546, DOI 10.1016/j.jtbi.2007.06.001	73	18	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e55401	10.1371/journal.pone.0055401	http://dx.doi.org/10.1371/journal.pone.0055401			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23468845	gold, Green Published, Green Submitted			2022-12-25	WOS:000315970300032
J	Labriola, JM; Pandhare, A; Jansen, M; Blanton, MP; Corringer, PJ; Baenziger, JE				Labriola, Jonathan M.; Pandhare, Akash; Jansen, Michaela; Blanton, Michael P.; Corringer, Pierre-Jean; Baenziger, John E.			Structural Sensitivity of a Prokaryotic Pentameric Ligand-gated Ion Channel to Its Membrane Environment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; CYS-LOOP RECEPTOR; X-RAY-STRUCTURE; TRANSMEMBRANE DOMAIN; ALLOSTERIC TRANSITIONS; LIPID-COMPOSITION; CHOLESTEROL; TORPEDO; DESENSITIZATION; MECHANISM	Although the activity of the nicotinic acetylcholine receptor (nAChR) is exquisitely sensitive to its membrane environment, the underlying mechanisms remain poorly defined. The homologous prokaryotic pentameric ligand-gated ion channel, Gloebacter ligand-gated ion channel (GLIC), represents an excellent model for probing the molecular basis of nAChR sensitivity because of its high structural homology, relative ease of expression, and amenability to crystallographic analysis. We show here that membrane-reconstituted GLIC exhibits structural and biophysical properties similar to those of the membrane-reconstituted nAChR, although GLIC is substantially more thermally stable. GLIC, however, does not possess the same exquisite lipid sensitivity. In particular, GLIC does not exhibit the same propensity to adopt an uncoupled conformation where agonist binding is uncoupled from channel gating. Structural comparisons provide insight into the chemical features that may predispose the nAChR to the formation of an uncoupled state.	[Labriola, Jonathan M.; Baenziger, John E.] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8M5, Canada; [Pandhare, Akash; Blanton, Michael P.] Texas Tech Univ, Hlth Sci Ctr, Sch Med, Dept Pharmacol & Neurosci, Lubbock, TX 79430 USA; [Pandhare, Akash; Jansen, Michaela; Blanton, Michael P.] Texas Tech Univ, Hlth Sci Ctr, Sch Med, Ctr Membrane Prot Res, Lubbock, TX 79430 USA; [Jansen, Michaela] Texas Tech Univ, Hlth Sci Ctr, Sch Med, Dept Cell Physiol & Mol Biophys, Lubbock, TX 79430 USA; [Corringer, Pierre-Jean] Inst Pasteur, CNRS, URA 2182, Grp Channel Receptors G5, F-75015 Paris, France	University of Ottawa; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Baenziger, JE (corresponding author), Univ Ottawa, Dept Biochem Microbiol & Immunol, 451 Smyth Rd, Ottawa, ON K1H 8M5, Canada.	John.Baenziger@uottawa.ca	Pandhare, Akash/M-1827-2016	Baenziger, John/0000-0002-2888-5328; Jansen, Michaela/0000-0003-1325-9700	Canadian Institute of Health Research; Natural Sciences and Engineering Research Council of Canada; Bourses d'Etudes pour la France from l'Ambassade de France au Canada; South Plains Foundation; Center for Membrane Protein Research, Texas Tech University Health Science Center; National Institutes of Health [NS059841]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R00NS059841, K99NS059841] Funding Source: NIH RePORTER	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Bourses d'Etudes pour la France from l'Ambassade de France au Canada; South Plains Foundation; Center for Membrane Protein Research, Texas Tech University Health Science Center; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the Canadian Institute of Health Research and the Natural Sciences and Engineering Research Council of Canada (to J. E. B.), by a Bourses d'Etudes pour la France (to J. E. B.) from l'Ambassade de France au Canada, by grants from the South Plains Foundation and the Center for Membrane Protein Research, Texas Tech University Health Science Center (to M. P. B. and M. J.), and by a grant from the National Institutes of Health Grant NS059841 (to M. J.).	Alexandrov AI, 2008, STRUCTURE, V16, P351, DOI 10.1016/j.str.2008.02.004; Baenziger JE, 1997, BIOCHEMISTRY-US, V36, P3617, DOI 10.1021/bi962845m; Baenziger JE, 2000, J BIOL CHEM, V275, P777, DOI 10.1074/jbc.275.2.777; BAENZIGER JE, 1995, J BIOL CHEM, V270, P29129, DOI 10.1074/jbc.270.49.29129; Baenziger JE, 2008, MOL PHARMACOL, V73, P880, DOI 10.1124/mol.107.039008; Baenziger John E, 2013, Biophys Rev, V5, P1, DOI 10.1007/s12551-012-0078-7; Baenziger JE, 2011, NEUROPHARMACOLOGY, V60, P116, DOI 10.1016/j.neuropharm.2010.08.007; Bocquet N, 2007, NATURE, V445, P116, DOI 10.1038/nature05371; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Brannigan G, 2008, P NATL ACAD SCI USA, V105, P14418, DOI 10.1073/pnas.0803029105; Carswell CL, 2008, J BACTERIOL, V190, P5650, DOI 10.1128/JB.00298-08; Changeux JPG, 2012, CURR OPIN ANESTHESIO, V25, P397, DOI 10.1097/ACO.0b013e32835561de; CRIADO M, 1982, BIOCHEMISTRY-US, V21, P3622, DOI 10.1021/bi00258a015; CRIADO M, 1984, J BIOL CHEM, V259, P9188; daCosta CJB, 2003, ACTA CRYSTALLOGR D, V59, P77, DOI 10.1107/S0907444902019236; daCosta CJB, 2011, BIOCHEM BIOPH RES CO, V407, P456, DOI 10.1016/j.bbrc.2011.03.026; daCosta CJB, 2009, J BIOL CHEM, V284, P33841, DOI 10.1074/jbc.M109.048280; daCosta CJB, 2009, J BIOL CHEM, V284, P17819, DOI 10.1074/jbc.M900030200; De Almeida RFM, 2006, MOL MEMBR BIOL, V23, P305, DOI 10.1080/09687860600703613; ELLENA JF, 1983, BIOCHEMISTRY-US, V22, P5523, DOI 10.1021/bi00293a012; FONG TM, 1986, BIOCHEMISTRY-US, V25, P830, DOI 10.1021/bi00352a015; Goyal R, 2011, J BIOL CHEM, V286, P34635, DOI 10.1074/jbc.M111.269647; Haeger S, 2010, NAT STRUCT MOL BIOL, V17, P90, DOI 10.1038/nsmb.1721; Hamouda AK, 2006, BIOCHEMISTRY-US, V45, P4327, DOI 10.1021/bi052281z; Hamouda AK, 2006, BIOCHEMISTRY-US, V45, P976, DOI 10.1021/bi051978h; HEIDMANN T, 1980, EUR J BIOCHEM, V110, P35, DOI 10.1111/j.1432-1033.1980.tb04839.x; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Hilf RJC, 2009, NATURE, V457, P115, DOI 10.1038/nature07461; JONES OT, 1988, BIOCHEMISTRY-US, V27, P2364, DOI 10.1021/bi00407a018; MARSH D, 1981, BIOCHIM BIOPHYS ACTA, V645, P97, DOI 10.1016/0005-2736(81)90516-2; METHOT N, 1995, BIOCHEMISTRY-US, V34, P15142, DOI 10.1021/bi00046a021; Methot N, 2001, J BIOL CHEM, V276, P23726, DOI 10.1074/jbc.M102101200; MORALES A, 1995, P NATL ACAD SCI USA, V92, P8468, DOI 10.1073/pnas.92.18.8468; Nury H, 2011, NATURE, V469, P428, DOI 10.1038/nature09647; Pandhare A, 2012, BIOCHEMISTRY-US, V51, P2425, DOI 10.1021/bi300101r; Rankin SE, 1997, BIOPHYS J, V73, P2446, DOI 10.1016/S0006-3495(97)78273-0; Reid SE, 1996, SPECTROCHIM ACTA A, V52, P1347, DOI 10.1016/0584-8539(96)01718-7; Ryan SE, 2002, J BIOL CHEM, V277, P10420, DOI 10.1074/jbc.M107412200; Ryan SE, 1996, J BIOL CHEM, V271, P24590, DOI 10.1074/jbc.271.40.24590; Sayeed WMH, 2009, BBA-BIOMEMBRANES, V1788, P1108, DOI 10.1016/j.bbamem.2009.01.010; Sine SM, 2006, NATURE, V440, P448, DOI 10.1038/nature04708; Sine SM, 2012, PHYSIOL REV, V92, P1189, DOI 10.1152/physrev.00015.2011; Taly A, 2009, NAT REV DRUG DISCOV, V8, P733, DOI 10.1038/nrd2927; Tasneem A, 2005, GENOME BIOL, V6; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Unwin N, 2012, J MOL BIOL, V422, P617, DOI 10.1016/j.jmb.2012.07.010; Velisetty P, 2012, J BIOL CHEM, V287, P36864, DOI 10.1074/jbc.M112.401067; Velisetty P, 2012, J BIOL CHEM, V287, P18467, DOI 10.1074/jbc.M112.348045; Wang H. L., 2011, J BIOL CHEM; Weng Y, 2010, ANESTH ANALG, V110, P59, DOI 10.1213/ANE.0b013e3181c4bc69; Xu YC, 2005, J AM CHEM SOC, V127, P1291, DOI 10.1021/ja044577i	51	30	30	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2013	288	16					11294	11303		10.1074/jbc.M113.458133	http://dx.doi.org/10.1074/jbc.M113.458133			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	130KW	23463505	Green Published, hybrid			2022-12-25	WOS:000317915500032
J	Song, ZC; Liu, C; Iwata, J; Gu, SP; Suzuki, A; Sun, C; He, W; Shu, R; Li, L; Chai, Y; Chen, YP				Song, Zhongchen; Liu, Chao; Iwata, Junichi; Gu, Shuping; Suzuki, Akiko; Sun, Cheng; He, Wei; Shu, Rong; Li, Lu; Chai, Yang; Chen, YiPing			Mice with Tak1 Deficiency in Neural Crest Lineage Exhibit Cleft Palate Associated with Abnormal Tongue Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PIERRE-ROBIN-SEQUENCE; SECONDARY PALATE; MUTANT MICE; NORMAL PALATOGENESIS; CELL-PROLIFERATION; BETA; DIFFERENTIATION; MORPHOGENESIS; MUTATIONS; GROWTH	Cleft palate represents one of the most common congenital birth defects in humans. TGF beta signaling, which is mediated by Smad-dependent and Smad-independent pathways, plays a crucial role in regulating craniofacial development and patterning, particularly in palate development. However, it remains largely unknown whether the Smad-independent pathway contributes to TGF beta signaling function during palatogenesis. In this study, we investigated the function of TGF beta activated kinase 1 (Tak1), a key regulator of Smad-independent TGF beta signaling in palate development. We show that Tak1 protein is expressed in both the epithelium and mesenchyme of the developing palatal shelves. Whereas deletion of Tak1 in the palatal epithelium or mesenchyme did not give rise to a cleft palate defect, inactivation of Tak1 in the neural crest lineage using the Wnt1-Cre transgenic allele resulted in failed palate elevation and subsequently the cleft palate formation. The failure in palate elevation in Wnt1-Cre; Tak1(F/F) mice results from a malformed tongue and micrognathia, resembling human Pierre Robin sequence cleft of the secondary palate. We found that the abnormal tongue development is associated with Fgf10 overexpression in the neural crest-derived tongue tissue. The failed palate elevation and cleft palate were recapitulated in an Fgf10-overexpressing mouse model. The repressive effect of the Tak1-mediated noncanonical TGF beta signaling on Fgf10 expression was further confirmed by inhibition of p38, a downstream kinase of Tak1, in the primary cell culture of developing tongue. Tak1 thus functions to regulate tongue development by controlling Fgf10 expression and could represent a candidate gene for mutation in human PRS clefting.	[Song, Zhongchen; Shu, Rong] Shanghai Jiao Tong Univ, Peoples Hosp 9, Shanghai Key Lab Stomatol, Dept Periodontol,Sch Med, Shanghai 200011, Peoples R China; [Song, Zhongchen; Liu, Chao; Gu, Shuping; Sun, Cheng; He, Wei; Li, Lu; Chen, YiPing] Tulane Univ, Dept Cell & Mol Biol, New Orleans, LA 70118 USA; [Iwata, Junichi; Suzuki, Akiko; Chai, Yang] Univ So Calif, Sch Dent, Ctr Craniofacial Mol Biol, Los Angeles, CA 90089 USA	Shanghai Jiao Tong University; Tulane University; University of Southern California	Chai, Y (corresponding author), Univ So Calif, Sch Dent, Ctr Craniofacial Mol Biol, Los Angeles, CA 90089 USA.	ychai@usc.edu; ychen@tulane.edu			National Institutes of Health [DE14044, DE12711, DE14078, DE17007]; Shanghai JiaoTong University; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE014044, R37DE012711, R01DE014078] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE012711, R01DE017007] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shanghai JiaoTong University; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants DE14044 (to Y.P. C.) and DE12711, DE14078, and DE17007 (to Y. C.).; Supported by a fellowship from Shanghai JiaoTong University.	Alappat SR, 2005, DEV BIOL, V277, P102, DOI 10.1016/j.ydbio.2004.09.010; Andl T, 2004, DEVELOPMENT, V131, P2257, DOI 10.1242/dev.01125; Barrow JR, 1999, DEVELOPMENT, V126, P5011; Benko S, 2009, NAT GENET, V41, P359, DOI 10.1038/ng.329; Bjork BC, 2010, HUM MOL GENET, V19, P774, DOI 10.1093/hmg/ddp543; Bush JO, 2012, DEVELOPMENT, V139, P231, DOI 10.1242/dev.067082; Casey LM, 2006, DEV DYNAM, V235, P1830, DOI 10.1002/dvdy.20821; Chai Y, 2006, DEV DYNAM, V235, P2353, DOI 10.1002/dvdy.20833; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; FERGUSON MWJ, 1988, DEVELOPMENT, V103, P41; FERGUSON MWJ, 1977, VIRCHOWS ARCH A, V375, P97, DOI 10.1007/BF00428098; FitzPatrick DR, 2003, HUM MOL GENET, V12, P2491, DOI 10.1093/hmg/ddg248; Gritli-Linde A, 2007, DEV BIOL, V301, P309, DOI 10.1016/j.ydbio.2006.07.042; He FL, 2010, DEV DYNAM, V239, P3235, DOI 10.1002/dvdy.22466; He FL, 2010, DEV BIOL, V347, P109, DOI 10.1016/j.ydbio.2010.08.014; Hilliard SA, 2005, J ANAT, V207, P655, DOI 10.1111/j.1469-7580.2005.00474.x; Hosokawa R, 2010, DEV BIOL, V341, P186, DOI 10.1016/j.ydbio.2010.02.030; Huang X, 2008, DEV DYNAM, V237, P3079, DOI 10.1002/dvdy.21714; Iwata J, 2006, J BIOL CHEM, V281, P4035, DOI 10.1074/jbc.M512283200; Iwata J, 2011, ORAL DIS, V17, P733, DOI 10.1111/j.1601-0825.2011.01806.x; Iwata J, 2012, J CLIN INVEST, V122, P873, DOI 10.1172/JCI61498; Iwata J, 2012, J BIOL CHEM, V287, P2353, DOI 10.1074/jbc.M111.280974; Iwata J, 2010, J BIOL CHEM, V285, P4975, DOI 10.1074/jbc.M109.035105; Jakobsen LP, 2007, J MED GENET, V44, P381, DOI 10.1136/jmg.2006.046177; Jiang RL, 1998, GENE DEV, V12, P1046, DOI 10.1101/gad.12.7.1046; Lan Y, 2004, DEVELOPMENT, V131, P3207, DOI 10.1242/dev.01175; Lan Y, 2007, GENESIS, V45, P618, DOI 10.1002/dvg.20334; Liu HH, 2006, P NATL ACAD SCI USA, V103, P11677, DOI 10.1073/pnas.0603089103; Liu W, 2005, DEVELOPMENT, V132, P1453, DOI 10.1242/dev.01676; Loeys BL, 2006, NEW ENGL J MED, V355, P788, DOI 10.1056/NEJMoa055695; Loeys BL, 2005, NAT GENET, V37, P275, DOI 10.1038/ng1511; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Matsumura K, 2011, BIOCHEM BIOPH RES CO, V404, P1076, DOI 10.1016/j.bbrc.2010.12.116; Mizuguchi T, 2004, NAT GENET, V36, P855, DOI 10.1038/ng1392; Moriguchi T, 1996, J BIOL CHEM, V271, P13675, DOI 10.1074/jbc.271.23.13675; Mulder KM, 2000, CYTOKINE GROWTH F R, V11, P23, DOI 10.1016/S1359-6101(99)00026-X; Murray SA, 2007, DEVELOPMENT, V134, P1789, DOI 10.1242/dev.02837; NODEN DM, 1983, DEV BIOL, V96, P144, DOI 10.1016/0012-1606(83)90318-4; Noden DM, 2006, DEV DYNAM, V235, P1194, DOI 10.1002/dvdy.20697; Parada C, 2012, J DENT RES, V91, P528, DOI 10.1177/0022034511434055; Rice R, 2004, J CLIN INVEST, V113, P1692, DOI 10.1172/JCI200420384; Robin P, 1994, Plast Reconstr Surg, V93, P1301; Shirakabe K, 1997, J BIOL CHEM, V272, P8141, DOI 10.1074/jbc.272.13.8141; Snyder-Warwick AK, 2010, P NATL ACAD SCI USA, V107, P2515, DOI 10.1073/pnas.0913985107; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; St Amand TR, 2000, DEV BIOL, V217, P323, DOI 10.1006/dbio.1999.9547; Xiong W, 2009, DEV BIOL, V330, P131, DOI 10.1016/j.ydbio.2009.03.021; Xu X, 2008, DEV CELL, V15, P322, DOI 10.1016/j.devcel.2008.06.004; YAMAGUCHI K, 1995, SCIENCE, V270, P2008, DOI 10.1126/science.270.5244.2008; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328; Zhang ZY, 2002, DEVELOPMENT, V129, P4135	51	39	40	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2013	288	15					10440	10450		10.1074/jbc.M112.432286	http://dx.doi.org/10.1074/jbc.M112.432286			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	125TU	23460641	hybrid, Green Published			2022-12-25	WOS:000317565000024
J	Annadurai, RS; Neethiraj, R; Jayakumar, V; Damodaran, AC; Rao, SN; Katta, MAVSK; Gopinathan, S; Sarma, SP; Senthilkumar, V; Niranjan, V; Gopinath, A; Mugasimangalam, RC				Annadurai, Ramasamy S.; Neethiraj, Ramprasad; Jayakumar, Vasanthan; Damodaran, Anand C.; Rao, Sudha Narayana; Katta, Mohan A. V. S. K.; Gopinathan, Sreeja; Sarma, Santosh Prasad; Senthilkumar, Vanitha; Niranjan, Vidya; Gopinath, Ashok; Mugasimangalam, Raja C.			De Novo Transcriptome Assembly (NGS) of Curcuma longa L. Rhizome Reveals Novel Transcripts Related to Anticancer and Antimalarial Terpenoids	PLOS ONE			English	Article							CELL-CYCLE; MULTIDRUG-RESISTANCE; FRUIT-DEVELOPMENT; ESSENTIAL OILS; APOPTOSIS; EXPRESSION; HYPERICIN; DISCOVERY; PATHWAYS; MARKERS	Herbal remedies are increasingly being recognised in recent years as alternative medicine for a number of diseases including cancer. Curcuma longa L., commonly known as turmeric is used as a culinary spice in India and in many Asian countries has been attributed to lower incidences of gastrointestinal cancers. Curcumin, a secondary metabolite isolated from the rhizomes of this plant has been shown to have significant anticancer properties, in addition to antimalarial and antioxidant effects. We sequenced the transcriptome of the rhizome of the 3 varieties of Curcuma longa L. using Illumina reversible dye terminator sequencing followed by de novo transcriptome assembly. Multiple databases were used to obtain a comprehensive annotation and the transcripts were functionally classified using GO, KOG and PlantCyc. Special emphasis was given for annotating the secondary metabolite pathways and terpenoid biosynthesis pathways. We report for the first time, the presence of transcripts related to biosynthetic pathways of several anti-cancer compounds like taxol, curcumin, and vinblastine in addition to anti-malarial compounds like artemisinin and acridone alkaloids, emphasizing turmeric's importance as a highly potent phytochemical. Our data not only provides molecular signatures for several terpenoids but also a comprehensive molecular resource for facilitating deeper insights into the transcriptome of C. longa.	[Annadurai, Ramasamy S.; Neethiraj, Ramprasad; Jayakumar, Vasanthan; Damodaran, Anand C.; Rao, Sudha Narayana; Katta, Mohan A. V. S. K.; Gopinathan, Sreeja; Sarma, Santosh Prasad; Senthilkumar, Vanitha; Niranjan, Vidya; Gopinath, Ashok; Mugasimangalam, Raja C.] Genotyp Technol Private Ltd, Res & Dev Unit, Bangalore, Karnataka, India		Mugasimangalam, RC (corresponding author), Genotyp Technol Private Ltd, Res & Dev Unit, Bangalore, Karnataka, India.	raja@genotypic.co.in	Niranjan, Vidya/AAF-5553-2019; Niranjan, Vidya/O-6464-2016	Niranjan, Vidya/0000-0001-9187-7753; Niranjan, Vidya/0000-0001-9187-7753; Jayakumar, Vasanthan/0000-0002-6067-4184	Genotypic Technology Research and Development Fund; Genotypic Technology Private Limited	Genotypic Technology Research and Development Fund; Genotypic Technology Private Limited	The funds for this study were provided by Genotypic Technology Research and Development Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The following authors have affiliations to Genotypic Technology Private Limited, the commercial funders of this research, and confirm that this affiliation does not in anyway alter the authors adherence of all PLOS ONE policies on sharing data and materials. 1. Ramasamy S Annadurai 2. Ramprasad Neethiraj 3. Vasanthan Jayakumar 4. Anand C Damodaran 5. Sudha Narayana Rao 6. Mohan AVSK Katta 7. Sreeja Gopinathan 8. Santosh Prasad Sarma 9. Vanitha Senthilkumar 10. Vidya Niranjan 11. Ashok Gopinath 12. Raja C Mugasimangalam The authors Ramasamy S Annadurai and Ashok Gopinath were working at Genotypic Technology Pvt Ltd when they carried out their work. Dr. Ramasamy S Annadurai and Dr. Ashok Gopinath's affiliations to ITC Limited and Sanofi Synthelabo India Limited respectively does not affect the project in any way. These companies were neither funders nor sponsors for this study.	Agostinis P, 2002, INT J BIOCHEM CELL B, V34, P221, DOI 10.1016/S1357-2725(01)00126-1; Ajaiyeoba EO, 2008, PHARM BIOL, V46, P279, DOI 10.1080/13880200701741138; Alappat L, 2010, NUTR REV, V68, P729, DOI 10.1111/j.1753-4887.2010.00341.x; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Barrero RA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-600; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Carnesecchi S, 2001, J PHARMACOL EXP THER, V298, P197; Chae L, 2012, CURR OPIN PLANT BIOL, V15, P177, DOI 10.1016/j.pbi.2012.01.006; Choudhuri T, 2005, J BIOL CHEM, V280, P20059, DOI 10.1074/jbc.M410670200; Cui L, 2007, ANTIMICROB AGENTS CH, V51, P488, DOI 10.1128/AAC.01238-06; Du HY, 2003, INT J ONCOL, V23, P1401; Elledge SJ, 1996, SCIENCE, V274, P1664, DOI 10.1126/science.274.5293.1664; Feng C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-19; Gajate C, 2005, J BIOL CHEM, V280, P11641, DOI 10.1074/jbc.M411781200; Ganta S, 2009, MOL PHARMACEUT, V6, P928, DOI 10.1021/mp800240j; Garg R, 2011, DNA RES, V18, P53, DOI 10.1093/dnares/dsq028; Gore MA, 2009, SCIENCE, V326, P1115, DOI 10.1126/science.1177837; Gupta SC, 2013, MOL NUTR FOOD RES, V57, P1510, DOI 10.1002/mnfr.201100741; Gupta SC, 2012, CLIN EXP PHARMACOL P, V39, P283, DOI 10.1111/j.1440-1681.2011.05648.x; Haddad M, 2011, PLANTA MED, V77, P672, DOI 10.1055/s-0030-1250549; Hamaguchi T, 2010, CNS NEUROSCI THER, V16, P285, DOI 10.1111/j.1755-5949.2010.00147.x; Honda S, 2006, J AGR FOOD CHEM, V54, P9055, DOI 10.1021/jf061788t; Iorizzo M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-389; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; Kashi Y, 2006, TRENDS GENET, V22, P253, DOI 10.1016/j.tig.2006.03.005; Kawase M, 2005, IN VIVO, V19, P705; Kelly JX, 2009, NATURE, V459, P270, DOI 10.1038/nature07937; Krazeisen A, 2001, MOL CELL ENDOCRINOL, V171, P151, DOI 10.1016/S0303-7207(00)00422-6; Kudapa H, 2012, MOL PLANT, V5, P1020, DOI 10.1093/mp/ssr111; La Rota M, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-23; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Lee B, 2012, BIOCHEM BIOPH RES CO, V421, P76, DOI 10.1016/j.bbrc.2012.03.114; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li Q, 2009, ONCOLOGY-BASEL, V77, P335, DOI 10.1159/000264627; Li S., 2011, PHARM CROPS, V2, P28, DOI [DOI 10.2174/2210290601102010028, 10.2174/2210290601102010028]; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lu HF, 2009, ONCOL REP, V22, P97, DOI 10.3892/or_00000411; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; Meshnick SR, 2002, INT J PARASITOL, V32, P1655, DOI 10.1016/S0020-7519(02)00194-7; Mohan R, 2000, J BIOL CHEM, V275, P10405, DOI 10.1074/jbc.275.14.10405; Mohandas K M, 1999, Indian J Gastroenterol, V18, P118; Nandakumar DN, 2006, ANTIMICROB AGENTS CH, V50, P1859, DOI 10.1128/AAC.50.5.1859-1860.2006; Negi PS, 1999, J AGR FOOD CHEM, V47, P4297, DOI 10.1021/jf990308d; Park MJ, 2002, INT J ONCOL, V21, P379; Peuhu E, 2010, ONCOGENE, V29, P898, DOI 10.1038/onc.2009.386; Quevillon E, 2005, NUCLEIC ACIDS RES, V33, pW116, DOI 10.1093/nar/gki442; Salminen A, 2008, CELL MOL LIFE SCI, V65, P2979, DOI 10.1007/s00018-008-8103-5; Schatz MC, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-4-243; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Shi CY, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-131; Shinojima N, 2007, AUTOPHAGY, V3, P635, DOI 10.4161/auto.4916; Shytle RD, 2009, CURR ALZHEIMER RES, V6, P564, DOI 10.2174/156720509790147115; Stevens JF, 2004, PHYTOCHEMISTRY, V65, P1317, DOI 10.1016/j.phytochem.2004.04.025; Subramaniyam S, 2011, PLANT CELL REP, V30, P2075, DOI 10.1007/s00299-011-1114-y; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; WANG YS, 1995, CELL GROWTH DIFFER, V6, P1071; Wang ZY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-726; Wei WL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-451; Wong MML, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-342; Xia ZH, 2011, PLANT MOL BIOL, V77, P299, DOI 10.1007/s11103-011-9811-z; Yow CMN, 2012, PHOTOCHEM PHOTOBIOL, V88, P626, DOI 10.1111/j.1751-1097.2012.01085.x; Yoysungnoen P, 2006, CLIN HEMORHEOL MICRO, V34, P109; Yu KQ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-10; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	65	58	61	1	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e56217	10.1371/journal.pone.0056217	http://dx.doi.org/10.1371/journal.pone.0056217			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23468859	Green Published, Green Submitted, gold			2022-12-25	WOS:000315524900021
J	Bertrand, A; Pasquier, A; Petiet, A; Wiggins, C; Kraska, A; Joseph-Mathurin, N; Aujard, F; Mestre-Frances, N; Dhenain, M				Bertrand, Anne; Pasquier, Adrien; Petiet, Alexandra; Wiggins, Christopher; Kraska, Audrey; Joseph-Mathurin, Nelly; Aujard, Fabienne; Mestre-Frances, Nadine; Dhenain, Marc			Micro-MRI Study of Cerebral Aging: Ex Vivo Detection of Hippocampal Subfield Reorganization, Microhemorrhages and Amyloid Plaques in Mouse Lemur Primates	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; APP/PS1 TRANSGENIC MICE; HIGH-RESOLUTION MRI; ALZHEIMERS-DISEASE; QUANTITATIVE-ANALYSIS; T2-WEIGHTED MRI; SENILE PLAQUES; BRAIN; AGE; MURINUS	Mouse lemurs are non-human primate models of cerebral aging and neurodegeneration. Much smaller than other primates, they recapitulate numerous features of human brain aging, including progressive cerebral atrophy and correlation between regional atrophy and cognitive impairments. Characterization of brain atrophy in mouse lemurs has been done by MRI measures of regional CSF volume and by MRI measures of regional atrophy. Here, we further characterize mouse lemur brain aging using ex vivo MR microscopy (31 mu m in-plane resolution). First, we performed a non-biased, direct volumetric quantification of dentate gyrus and extended Ammon's horn. We show that both dentate gyrus and Ammon's horn undergo an age-related reorganization leading to a growth of the dentate gyrus and an atrophy of the Ammon's horn, even in the absence of global hippocampal atrophy. Second, on these first MR microscopic images of the mouse lemur brain, we depicted cortical and hippocampal hypointense spots. We demonstrated that their incidence increases with aging and that they correspond either to amyloid deposits or to cerebral microhemorrhages.	[Bertrand, Anne; Pasquier, Adrien; Petiet, Alexandra; Kraska, Audrey; Joseph-Mathurin, Nelly; Dhenain, Marc] CNRS, URA2210, Fontenay Aux Roses, France; [Bertrand, Anne; Pasquier, Adrien; Petiet, Alexandra; Kraska, Audrey; Joseph-Mathurin, Nelly; Dhenain, Marc] CEA Commissariat Energie Atom & Energies Alternat, DSV, Inst Imagerie BioMed I2BM, MIRCen Mol Imaging Reseach CENter, Fontenay Aux Roses, France; [Bertrand, Anne; Petiet, Alexandra; Wiggins, Christopher; Dhenain, Marc] CEA Commissariat Energie Atom & Energies Alternat, Inst Imagerie BioMed I2BM, Neurospin, Gif Sur Yvette, France; [Aujard, Fabienne] CNRS, MNHN, UMR 7179, Unite Mixte Rech,Mecadev MECanismes ADaptatifs &, Brunoy, France; [Mestre-Frances, Nadine] Univ Montpellier 2, INSERM, U710, EPHE, Montpellier, France	Centre National de la Recherche Scientifique (CNRS); CEA; CEA; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Universite de Montpellier	Dhenain, M (corresponding author), CNRS, URA2210, Fontenay Aux Roses, France.	Marc.Dhenain@cea.fr	Bertrand, Anne/C-9882-2010; Mestre-Francés, Nadine/V-6289-2019; Dhenain, Marc/K-5630-2013	Bertrand, Anne/0000-0001-7683-507X; Mestre-Francés, Nadine/0000-0002-6856-3067; Dhenain, Marc/0000-0001-8804-4101; Joseph-Mathurin, Nelly/0000-0002-9735-5152	France-Alzheimer association; CNRS; National Foundation for Alzheimer's Disease and Related Disorders; NIH [R01-AG020197]; French Society of Radiology (SFR); French Society of NeuroRadiology (SFNR); French Ministry of Foreign Affairs (EGIDE funding); Philippe Fundation; NATIONAL INSTITUTE ON AGING [R01AG020197] Funding Source: NIH RePORTER	France-Alzheimer association; CNRS(Centre National de la Recherche Scientifique (CNRS)); National Foundation for Alzheimer's Disease and Related Disorders; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); French Society of Radiology (SFR); French Society of NeuroRadiology (SFNR); French Ministry of Foreign Affairs (EGIDE funding); Philippe Fundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the France-Alzheimer association, the Longevity program from the CNRS, the National Foundation for Alzheimer's Disease and Related Disorders, and the NIH (R01-AG020197). Anne Bertrand was funded by the French Society of Radiology (SFR), the French Society of NeuroRadiology (SFNR), the French Ministry of Foreign Affairs (EGIDE funding) and the Philippe Fundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benveniste H, 1999, P NATL ACAD SCI USA, V96, P14079, DOI 10.1073/pnas.96.24.14079; Bobinski M, 2000, NEUROSCIENCE, V95, P721; Bons N, 2006, GENES BRAIN BEHAV, V5, P120, DOI 10.1111/j.1601-183X.2005.00149.x; Bons N, 1998, BRAIN RES BULL, V46, P1; BONS N, 1992, NEUROBIOL AGING, V13, P99, DOI 10.1016/0197-4580(92)90016-Q; Carne RP, 2006, J CLIN NEUROSCI, V13, P60, DOI 10.1016/j.jocn.2005.02.013; Courchesne E, 2000, RADIOLOGY, V216, P672, DOI 10.1148/radiology.216.3.r00au37672; Cullen KM, 2005, J CEREBR BLOOD F MET, V25, P1656, DOI 10.1038/sj.jcbfm.9600155; DEKABAN AS, 1978, ANN NEUROL, V4, P345, DOI 10.1002/ana.410040410; Dhenain M, 2000, NEUROBIOL AGING, V21, P81, DOI 10.1016/S0197-4580(00)00098-1; Dhenain M, 1997, NEUROBIOL AGING, V18, P517, DOI 10.1016/S0197-4580(97)00105-X; Dhenain M, 2003, MAGNET RESON MED, V50, P984, DOI 10.1002/mrm.10612; Dhenain M, 2006, MAGN RESON MED, V55, P687, DOI 10.1002/mrm.20810; Dhenain M, 2001, DEV BIOL, V232, P458, DOI 10.1006/dbio.2001.0189; Dhenain M, 2002, NMR BIOMED, V15, P197, DOI 10.1002/nbm.760; Dhenain M, 1998, NEUROBIOL AGING, V19, P65, DOI 10.1016/S0197-4580(98)00005-0; DOUGLAS RJ, 1981, GERONTOLOGY, V27, P127, DOI 10.1159/000212460; Duyckaerts C, 2008, ACTA NEUROPATHOL, V115, P5, DOI 10.1007/s00401-007-0312-8; El Tayara NET, 2007, MAGN RESON MED, V58, P179, DOI 10.1002/mrm.21266; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; FOX MW, 1966, EXPERIENTIA, V22, P447, DOI 10.1007/BF01900975; FUKUTANI Y, 1995, NEUROSCI LETT, V200, P57, DOI 10.1016/0304-3940(95)12083-G; Giannakopoulos P, 1997, ACTA NEUROPATHOL, V94, P131, DOI 10.1007/s004010050684; Golomb J, 1996, NEUROLOGY, V47, P810, DOI 10.1212/WNL.47.3.810; Jack CR, 2004, MAGN RESON MED, V52, P1263, DOI 10.1002/mrm.20266; JACK CR, 1992, NEUROLOGY, V42, P183, DOI 10.1212/WNL.42.1.183; Kraska A, 2011, NEUROBIOL AGING, V32, P894, DOI 10.1016/j.neurobiolaging.2009.05.018; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Languille S, 2012, AGEING RES REV, V11, P150, DOI 10.1016/j.arr.2011.07.001; Lee SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025930; Lee SP, 2004, MAGN RESON MED, V52, P538, DOI 10.1002/mrm.20196; Lister JP, 2009, ARCH NEUROL-CHICAGO, V66, P829, DOI 10.1001/archneurol.2009.125; Luo F, 2010, J PHARMACOL EXP THER, V335, P580, DOI 10.1124/jpet.110.172932; Meadowcroft MD, 2009, J MAGN RESON IMAGING, V29, P997, DOI 10.1002/jmri.21731; Mueller SG, 2007, NEUROBIOL AGING, V28, P719, DOI 10.1016/j.neurobiolaging.2006.03.007; Mueller SG, 2010, HUM BRAIN MAPP, V31, P1339, DOI 10.1002/hbm.20934; Mueller SG, 2009, HIPPOCAMPUS, V19, P558, DOI 10.1002/hipo.20614; Niewenhuys R, 2007, HUMAN CENTRAL NERVOU; Palmer TD, 1997, MOL CELL NEUROSCI, V8, P389, DOI 10.1006/mcne.1996.0595; Perret M, 1997, J BIOL RHYTHM, V12, P136, DOI 10.1177/074873049701200205; Petersen RC, 2000, NEUROLOGY, V54, P581, DOI 10.1212/WNL.54.3.581; Petiet A, 2012, NEUROBIOL AGING, V33, P1533, DOI 10.1016/j.neurobiolaging.2011.03.009; Picq JL, 2012, NEUROBIOL AGING, V33, P1096, DOI 10.1016/j.neurobiolaging.2010.09.009; Pluta J, 2012, J ALZHEIMERS DIS, V31, P85, DOI 10.3233/JAD-2012-111931; Raz N, 1998, NEUROPSYCHOLOGY, V12, P95, DOI 10.1037/0894-4105.12.1.95; SCHELTENS P, 1992, J NEUROL NEUROSUR PS, V55, P967, DOI 10.1136/jnnp.55.10.967; Shamy JLT, 2006, NEUROBIOL AGING, V27, P1405, DOI 10.1016/j.neurobiolaging.2005.07.019; Sherwood CC, 2011, P NATL ACAD SCI USA, V108, P13029, DOI 10.1073/pnas.1016709108; Shing YL, 2011, FRONT AGING NEUROSCI, V3, DOI 10.3389/fnagi.2011.00002; Small SA, 1999, ANN NEUROL, V45, P466, DOI 10.1002/1531-8249(199904)45:4<466::AID-ANA8>3.0.CO;2-Q; Trouche SG, 2009, VACCINE, V27, P957, DOI 10.1016/j.vaccine.2008.12.012; Weisbecker V, 2012, BRAIN STRUCT FUNCT, V217, P677, DOI 10.1007/s00429-011-0366-1; West M, 1994, LANCET, V2, P769, DOI DOI 10.1016/S0140-6736(94)92338-8; Wisco JJ, 2008, NEUROBIOL AGING, V29, P1563, DOI 10.1016/j.neurobiolaging.2007.03.022	54	16	16	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e56593	10.1371/journal.pone.0056593	http://dx.doi.org/10.1371/journal.pone.0056593			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460806	Green Published, gold, Green Submitted			2022-12-25	WOS:000315519000029
J	Dayton, PK; Kim, S; Jarrell, SC; Oliver, JS; Hammerstrom, K; Fisher, JL; O'Connor, K; Barber, JS; Robilliard, G; Barry, J; Thurber, AR; Conlan, K				Dayton, Paul K.; Kim, Stacy; Jarrell, Shannon C.; Oliver, John S.; Hammerstrom, Kamille; Fisher, Jennifer L.; O'Connor, Kevin; Barber, Julie S.; Robilliard, Gordon; Barry, James; Thurber, Andrew R.; Conlan, Kathy			Recruitment, Growth and Mortality of an Antarctic Hexactinellid Sponge, Anoxycalyx joubini	PLOS ONE			English	Article							MCMURDO-SOUND; COMMUNITIES; PATTERNS; CLIMATE; PHYTOPLANKTON; PREDATORS; BIOLOGY; SEA	Polar ecosystems are sensitive to climate forcing, and we often lack baselines to evaluate changes. Here we report a nearly 50-year study in which a sudden shift in the population dynamics of an ecologically important, structure-forming hexactinellid sponge, Anoxycalyx joubini was observed. This is the largest Antarctic sponge, with individuals growing over two meters tall. In order to investigate life history characteristics of Antarctic marine invertebrates, artificial substrata were deployed at a number of sites in the southern portion of the Ross Sea between 1967 and 1975. Over a 22-year period, no growth or settlement was recorded for A. joubini on these substrata; however, in 2004 and 2010, A. joubini was observed to have settled and grown to large sizes on some but not all artificial substrata. This single settlement and growth event correlates with a region-wide shift in phytoplankton productivity driven by the calving of a massive iceberg. We also report almost complete mortality of large sponges followed over 40 years. Given our warming global climate, similar system-wide changes are expected in the future.	[Dayton, Paul K.; Jarrell, Shannon C.] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Kim, Stacy; Oliver, John S.; Hammerstrom, Kamille; O'Connor, Kevin] Moss Landing Marine Labs, Moss Landing, CA 95039 USA; [Fisher, Jennifer L.] Oregon State Univ, Hatfield Marine Sci Ctr, Newport, OR 97365 USA; [Barber, Julie S.] Swinomish Indian Tribal Community, La Conner, WA USA; [Robilliard, Gordon] Cardno Entrix, Gig Harbor, WA USA; [Barry, James] Monterey Bay Aquarium Res Inst, Moss Landing, CA USA; [Thurber, Andrew R.] Oregon State Univ, Coll Earth Ocean & Atmospher Sci, Corvallis, OR 97331 USA; [Conlan, Kathy] Canadian Museum Nat, Ottawa, ON K1P 6P4, Canada	University of California System; University of California San Diego; Scripps Institution of Oceanography; Moss Landing Marine Laboratories; Oregon State University; Monterey Bay Aquarium Research Institute; Oregon State University	Dayton, PK (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA.	pdayton@ucsd.edu	Barber, Julie/AAH-1823-2020; Barber, Julie S/V-7557-2017	Barber, Julie/0000-0002-5394-0747; Barber, Julie S/0000-0002-5394-0747	Division of Polar Programs, National Science Foundation [25264A-416451-440005]; Division Of Polar Programs [0842064] Funding Source: National Science Foundation; Office of Polar Programs (OPP) [1103428] Funding Source: National Science Foundation	Division of Polar Programs, National Science Foundation; Division Of Polar Programs(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Office of Polar Programs (OPP)(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This research was funded by the Division of Polar Programs, National Science Foundation, over the years. Grant number: 25264A-416451-440005. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNTZ WE, 1994, OCEANOGR MAR BIOL, V32, P241; Arrigo KR, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014160; BARRY JP, 1988, POLAR BIOL, V8, P367, DOI 10.1007/BF00442028; BARRY JP, 1988, POLAR BIOL, V8, P377, DOI 10.1007/BF00442029; BARTHEL D, 1992, OPHELIA, V36, P111, DOI 10.1080/00785326.1992.10430362; BARTHEL D, 1991, MAR ECOL PROG SER, V69, P303, DOI 10.3354/meps069303; Barthel D, 1994, SYNOPSES ANTARCTIC B, P9; Cerrano C, 2000, POLAR BIOL, V23, P441, DOI 10.1007/s003000050466; Conlan KE, 2010, MAR POLLUT BULL, V60, P419, DOI 10.1016/j.marpolbul.2009.10.009; Dayton P K, 1979, BIOLOGIE SPONGIARES, P271; DAYTON PK, 1986, POLAR BIOL, V6, P207, DOI 10.1007/BF00443397; DAYTON PK, 1969, SCIENCE, V163, P273, DOI 10.1126/science.163.3864.273; DAYTON PK, 1974, ECOL MONOGR, V44, P105, DOI 10.2307/1942321; DAYTON PK, 1977, SCIENCE, V197, P55, DOI 10.1126/science.197.4298.55; DAYTON PK, 1989, SCIENCE, V245, P1484, DOI 10.1126/science.245.4925.1484; Dinniman MS, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC004036; Fallon SJ, 2010, NUCL INSTRUM METH B, V268, P1241, DOI 10.1016/j.nimb.2009.10.143; Gili JM, 2006, DEEP-SEA RES PT II, V53, P1029, DOI 10.1016/j.dsr2.2005.10.021; Gutt J, 2003, POLAR BIOL, V26, P276, DOI 10.1007/s00300-002-0468-6; Gutt J, 2007, ANTARCT SCI, V19, P165, DOI 10.1017/S0954102007000247; Kahn AS, 2012, DEEP-SEA RES PT I, V70, P36, DOI 10.1016/j.dsr.2012.08.001; Leys SP, 2007, ADV MAR BIOL, V52, P1, DOI 10.1016/S0065-2881(06)52001-2; Lohrer AM, 2012, ECOSYSTEMS, P1; MARGALEF R, 1978, OCEANOL ACTA, V1, P493; McClintock JB, 2005, INTEGR COMP BIOL, V45, P359, DOI 10.1093/icb/45.2.359; Montes-Hugo M, 2009, SCIENCE, V323, P1470, DOI 10.1126/science.1164533; OLIVER JS, 1985, OPHELIA, V24, P155, DOI 10.1080/00785326.1985.10429725; OREJAS C, 2000, CONTRIB SCI, V1, P299; Reiswig H. G., 1990, NEW PERSPECTIVES SPO, P7; Seibel BA, 2003, BIOL BULL-US, V205, P93, DOI 10.2307/1543229; Suhr SB, 2008, MAR ECOL PROG SER, V371, P155, DOI 10.3354/meps07693; Teixido N, 2006, DEEP-SEA RES PT II, V53, P972, DOI 10.1016/j.dsr2.2006.02.008; Thorson G., 1966, Netherlands Journal of Sea Research, V3, P267, DOI 10.1016/0077-7579(66)90015-9; Thrush SF, 2011, MAR ECOL-EVOL PERSP, V32, P289, DOI 10.1111/j.1439-0485.2011.00462.x; Thurber AR, 2007, MAR ECOL PROG SER, V351, P77, DOI 10.3354/meps07122; Yahel G, 2006, AQUAT MICROB ECOL, V45, P181, DOI 10.3354/ame045181	36	52	52	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e56939	10.1371/journal.pone.0056939	http://dx.doi.org/10.1371/journal.pone.0056939			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460822	Green Published, Green Submitted, gold			2022-12-25	WOS:000315519000048
J	Han, GS; Yu, ZG; Anh, V; Krishnajith, APD; Tian, YC				Han, Guo Sheng; Yu, Zu Guo; Vo Anh; Krishnajith, Anaththa P. D.; Tian, Yu-Chu			An Ensemble Method for Predicting Subnuclear Localizations from Primary Protein Structures	PLOS ONE			English	Article							AMINO-ACID-COMPOSITION; RECURRENCE QUANTIFICATION ANALYSIS; GAUSSIAN KERNEL OPTIMIZATION; SUPPORT VECTOR MACHINES; SUBCELLULAR-LOCALIZATION; GENE ONTOLOGY; EUKARYOTIC PROTEINS; HOMOLOGY DETECTION; FOLD RECOGNITION; CLASSIFICATION	Background: Predicting protein subnuclear localization is a challenging problem. Some previous works based on non-sequence information including Gene Ontology annotations and kernel fusion have respective limitations. The aim of this work is twofold: one is to propose a novel individual feature extraction method; another is to develop an ensemble method to improve prediction performance using comprehensive information represented in the form of high dimensional feature vector obtained by 11 feature extraction methods. Methodology/Principal Findings: A novel two-stage multiclass support vector machine is proposed to predict protein subnuclear localizations. It only considers those feature extraction methods based on amino acid classifications and physicochemical properties. In order to speed up our system, an automatic search method for the kernel parameter is used. The prediction performance of our method is evaluated on four datasets: Lei dataset, multi-localization dataset, SNL9 dataset and a new independent dataset. The overall accuracy of prediction for 6 localizations on Lei dataset is 75.2% and that for 9 localizations on SNL9 dataset is 72.1% in the leave-one-out cross validation, 71.7% for the multi-localization dataset and 69.8% for the new independent dataset, respectively. Comparisons with those existing methods show that our method performs better for both single-localization and multi-localization proteins and achieves more balanced sensitivities and specificities on large-size and small-size subcellular localizations. The overall accuracy improvements are 4.0% and 4.7% for single-localization proteins and 6.5% for multi-localization proteins. The reliability and stability of our classification model are further confirmed by permutation analysis. Conclusions: It can be concluded that our method is effective and valuable for predicting protein subnuclear localizations. A web server has been designed to implement the proposed method. It is freely available at http://bioinformatics.awowshop.com/snlpred_page.php.	[Han, Guo Sheng; Yu, Zu Guo] Xiangtan Univ, Sch Math & Computat Sci, Xiangtan, Hunan, Peoples R China; [Yu, Zu Guo; Vo Anh] Queensland Univ Technol, Sch Math Sci, Brisbane, Qld 4001, Australia; [Krishnajith, Anaththa P. D.; Tian, Yu-Chu] Queensland Univ Technol, Sch Elect Engn & Comp Sci, Brisbane, Qld 4001, Australia	Xiangtan University; Queensland University of Technology (QUT); Queensland University of Technology (QUT)	Yu, ZG (corresponding author), Xiangtan Univ, Sch Math & Computat Sci, Xiangtan, Hunan, Peoples R China.	yuzuguo@yahoo.com.cn	Tian, Yu-Chu/I-9948-2012; peng, chen/HHS-8720-2022; Anh, Vo V/I-9590-2012; peng, chen/L-7111-2019	Tian, Yu-Chu/0000-0002-8709-5625; Anh, Vo V/0000-0003-2463-2099; 	Natural Science Foundation of China [11071282]; Chinese Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT) [IRT1179]; Research Foundation of Education Commission of Hunan Province of China [11A122]; Hunan Provincial Natural Science Foundation of China [10JJ7001]; Science and Technology Planning Project of Hunan Province of China [2011FJ2011]; Lotus Scholars Program of Hunan Province of China; Aid Program for Science and Technology Innovative Research Team in Higher Educational Institutions of Hunan Province of China; Australian Research Council [DP0559807]; Hunan Provincial Postgraduate Research and Innovation Project of China [CX2010B243]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT); Research Foundation of Education Commission of Hunan Province of China; Hunan Provincial Natural Science Foundation of China(Natural Science Foundation of Hunan Province); Science and Technology Planning Project of Hunan Province of China; Lotus Scholars Program of Hunan Province of China; Aid Program for Science and Technology Innovative Research Team in Higher Educational Institutions of Hunan Province of China; Australian Research Council(Australian Research Council); Hunan Provincial Postgraduate Research and Innovation Project of China	This project was supported by the Natural Science Foundation of China (grant 11071282), the Chinese Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT) (grant IRT1179), the Research Foundation of Education Commission of Hunan Province of China (grant 11A122), Hunan Provincial Natural Science Foundation of China (grant 10JJ7001), Science and Technology Planning Project of Hunan Province of China (grant 2011FJ2011), the Lotus Scholars Program of Hunan Province of China, the Aid Program for Science and Technology Innovative Research Team in Higher Educational Institutions of Hunan Province of China, and the Australian Research Council (grant DP0559807), and Hunan Provincial Postgraduate Research and Innovation Project of China (grant CX2010B243). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basu S, 1997, J MOL GRAPH MODEL, V15, P279, DOI 10.1016/S1093-3263(97)00106-X; Bhasin M, 2004, NUCLEIC ACIDS RES, V32, pW414, DOI 10.1093/nar/gkh350; Blum T, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-274; Bradley AP, 1997, PATTERN RECOGN, V30, P1145, DOI 10.1016/S0031-3203(96)00142-2; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Briesemeister S, 2010, BIOINFORMATICS, V26, P1232, DOI 10.1093/bioinformatics/btq115; Carmo-Fonseca M, 2002, CELL, V108, P513, DOI 10.1016/S0092-8674(02)00650-5; Cedano J, 1997, J MOL BIOL, V266, P594, DOI 10.1006/jmbi.1996.0804; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chang JM, 2008, PROTEINS, V72, P693, DOI 10.1002/prot.21944; Cherkassky V, 1997, IEEE Trans Neural Netw, V8, P1564, DOI 10.1109/TNN.1997.641482; Chou KC, 2000, BIOCHEM BIOPH RES CO, V278, P477, DOI 10.1006/bbrc.2000.3815; Chou KC, 2004, BIOCHEM BIOPH RES CO, V320, P1236, DOI 10.1016/j.bbrc.2004.06.073; Chou KC, 2002, J BIOL CHEM, V277, P45765, DOI 10.1074/jbc.M204161200; CHOU KC, 1988, BIOPHYS CHEM, V30, P3, DOI 10.1016/0301-4622(88)85002-6; CHOU KC, 1995, PROTEINS, V21, P319, DOI 10.1002/prot.340210406; Chou KC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009931; Dellaire G, 2003, NUCLEIC ACIDS RES, V31, P328, DOI 10.1093/nar/gkg018; DILL KA, 1985, BIOCHEMISTRY-US, V24, P1501, DOI 10.1021/bi00327a032; DUBCHAK I, 1995, P NATL ACAD SCI USA, V92, P8700, DOI 10.1073/pnas.92.19.8700; ECKMANN JP, 1987, EUROPHYS LETT, V4, P973, DOI 10.1209/0295-5075/4/9/004; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Feng Shi, 2008, Journal of Biomedical Science & Engineering, V1, P59, DOI 10.4236/jbise.2008.11009; Gardy JL, 2005, BIOINFORMATICS, V21, P617, DOI 10.1093/bioinformatics/bti057; Giuliani A, 2002, CHEM REV, V102, P1471, DOI 10.1021/cr0101499; Gubbi Jayavardhana, 2006, Genome Inform, V17, P259; Guda C, 2005, BIOINFORMATICS, V21, P3963, DOI 10.1093/bioinformatics/bti650; Guo J, 2006, BIOINFORMATICS, V22, P1784, DOI 10.1093/bioinformatics/btl180; Guo-Sheng Han, 2009, Proceedings of the 2009 Sixth International Conference on Fuzzy Systems and Knowledge Discovery (FSKD 2009), P42, DOI 10.1109/FSKD.2009.248; Han GS, 2011, CHINESE PHYS B, V20, DOI 10.1088/1674-1056/20/10/100504; Hancock R, 2004, BIOL CELL, V96, P595, DOI 10.1016/j.biolcel.2004.05.003; Hoglund A, 2006, BIOINFORMATICS, V22, P1158, DOI 10.1093/bioinformatics/btl002; Huang NE, 1998, P ROY SOC A-MATH PHY, V454, P903, DOI 10.1098/rspa.1998.0193; Huang T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010972; Huang WL, 2007, BIOSYSTEMS, V90, P573, DOI 10.1016/j.biosystems.2007.01.001; Kandaswamy A, 2004, COMPUT BIOL MED, V34, P523, DOI 10.1016/S0010-4825(03)00092-1; Kawashima S, 2000, NUCLEIC ACIDS RES, V28, P374, DOI 10.1093/nar/28.1.374; Lei ZD, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-291; Lei ZD, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-491; LEMPEL A, 1976, IEEE T INFORM THEORY, V22, P75, DOI 10.1109/TIT.1976.1055501; Li ZR, 2006, NUCLEIC ACIDS RES, V34, pW32, DOI 10.1093/nar/gkl305; Liu TG, 2010, AMINO ACIDS, V38, P721, DOI 10.1007/s00726-009-0276-1; MALLAT SG, 1989, IEEE T PATTERN ANAL, V11, P674, DOI 10.1109/34.192463; Marwan N, 2007, PHYS REP, V438, P237, DOI 10.1016/j.physrep.2006.11.001; Mei SY, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-44; Mei SY, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S1-S17; Mori K, 1996, WEAR, V195, P162, DOI 10.1016/0043-1648(95)06817-1; Mundra P, 2007, PATTERN RECOGN LETT, V28, P1610, DOI 10.1016/j.patrec.2007.04.001; Murphy LR, 2000, PROTEIN ENG, V13, P149, DOI 10.1093/protein/13.3.149; Murphy R F, 2000, Proc Int Conf Intell Syst Mol Biol, V8, P251; NAKASHIMA H, 1994, J MOL BIOL, V238, P54, DOI 10.1006/jmbi.1994.1267; Nguyen DV, 2002, BIOINFORMATICS, V18, P39, DOI 10.1093/bioinformatics/18.1.39; Nguyen MN, 2007, INT J DATA MIN BIOIN, V1, P248, DOI 10.1504/IJDMB.2007.011612; Nguyen MN, 2005, PROTEINS, V59, P30, DOI 10.1002/prot.20404; Otu HH, 2003, BIOINFORMATICS, V19, P2122, DOI 10.1093/bioinformatics/btg295; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Peng ZL, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-420; Phair RD, 2000, NATURE, V404, P604, DOI 10.1038/35007077; Pierleoni A, 2006, BIOINFORMATICS, V22, pE408, DOI 10.1093/bioinformatics/btl222; Platt JC, 2000, ADV NEUR IN, V12, P547; Riley E.B.M.A., 2005, TUTORIALS CONT NONLI; Rong-Quan Xiao, 2009, Journal of Biomedical Science & Engineering, V2, P51, DOI 10.4236/jbise.2009.21009; Sanchez-Flores A, 2008, PROTEINS, V70, P248, DOI 10.1002/prot.21506; Sarda D, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-152; Shen HB, 2005, BIOCHEM BIOPH RES CO, V337, P752, DOI 10.1016/j.bbrc.2005.09.117; Shen HB, 2007, PROTEIN ENG DES SEL, V20, P561, DOI 10.1093/protein/gzm057; Shen HB, 2009, ANAL BIOCHEM, V394, P269, DOI 10.1016/j.ab.2009.07.046; Shen JW, 2007, P NATL ACAD SCI USA, V104, P4337, DOI 10.1073/pnas.0607879104; Shi SP, 2011, BBA-MOL CELL RES, V1813, P424, DOI 10.1016/j.bbamcr.2011.01.011; Shin CJ, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-28; SILHAVY TJ, 1983, MICROBIOL REV, V47, P313, DOI 10.1128/MMBR.47.3.313-344.1983; Sutherland HGE, 2001, HUM MOL GENET, V10, P1995, DOI 10.1093/hmg/10.18.1995; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Tan YX, 2005, NUCLEIC ACIDS RES, V33, P56, DOI 10.1093/nar/gki144; Wang J, 2009, PATTERN RECOGN, V42, P1237, DOI 10.1016/j.patcog.2008.11.024; Wang JR, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-174; Webb-Robertson BJM, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-145; WEBBER CL, 1994, J APPL PHYSIOL, V76, P965, DOI 10.1152/jappl.1994.76.2.965; WOLD S, 1993, ANAL CHIM ACTA, V277, P239, DOI 10.1016/0003-2670(93)80437-P; Yang JY, 2008, BMC GENOMICS, V9, DOI [10.1186/1471-2164-9-S1-I1, 10.1186/1471-2164-9-S1-11]; Yang JY, 2011, PROTEINS, V79, P2053, DOI 10.1002/prot.23025; Yang JY, 2009, J THEOR BIOL, V257, P618, DOI 10.1016/j.jtbi.2008.12.027; Yang L, 2010, AMINO ACIDS, V38, P1497, DOI 10.1007/s00726-009-0362-4; Yang YC, 2008, J THEOR BIOL, V252, P145, DOI 10.1016/j.jtbi.2008.01.028; Yin JB, 2011, NEUROCOMPUTING, V74, P3816, DOI 10.1016/j.neucom.2011.07.017; Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249; Yu ZG, 2004, PHYSICA A, V337, P171, DOI 10.1016/j.physa.2004.01.057; Yu ZG, 2010, J GEOPHYS RES-SPACE, V115, DOI 10.1029/2009JA015206; Zeng YH, 2009, J THEOR BIOL, V259, P366, DOI 10.1016/j.jtbi.2009.03.028; Zheng XQ, 2009, AMINO ACIDS, V37, P427, DOI 10.1007/s00726-008-0172-0; Zhou Y, 2007, PHYS LETT A, V368, P314, DOI 10.1016/j.physleta.2007.04.012	92	43	45	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57225	10.1371/journal.pone.0057225	http://dx.doi.org/10.1371/journal.pone.0057225			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460833	Green Submitted, Green Published, gold			2022-12-25	WOS:000315519000081
J	Janos, DP; Scott, J; Aristizabal, C; Bowman, DMJS				Janos, David P.; Scott, John; Aristizabal, Catalina; Bowman, David M. J. S.			Arbuscular-Mycorrhizal Networks Inhibit Eucalyptus tetrodonta Seedlings in Rain Forest Soil Microcosms	PLOS ONE			English	Article							IRON CHLOROSIS PARADOX; INTERSPECIFIC TRANSFER; PLANTS; FUNGI; GROWTH; GLOMALIN; PHOSPHORUS; CARBON; TREES; ROOT	Eucalyptus tetrodonta, a co-dominant tree species of tropical, northern Australian savannas, does not invade adjacent monsoon rain forest unless the forest is burnt intensely. Such facilitation by fire of seedling establishment is known as the "ashbed effect." Because the ashbed effect might involve disruption of common mycorrhizal networks, we hypothesized that in the absence of fire, intact rain forest arbuscular mycorrhizal (AM) networks inhibit E. tetrodonta seedlings. Although arbuscular mycorrhizas predominate in the rain forest, common tree species of the northern Australian savannas (including adult E. tetrodonta) host ectomycorrhizas. To test our hypothesis, we grew E. tetrodonta and Ceiba pentandra (an AM-responsive species used to confirm treatments) separately in microcosms of ambient or methyl-bromide fumigated rain forest soil with or without severing potential mycorrhizal fungus connections to an AM nurse plant, Litsea glutinosa. As expected, C. pentandra formed mycorrhizas in all treatments but had the most root colonization and grew fastest in ambient soil. E. tetrodonta seedlings also formed AM in all treatments, but severing hyphae in fumigated soil produced the least colonization and the best growth. Three of ten E. tetrodonta seedlings in ambient soil with intact network hyphae died. Because foliar chlorosis was symptomatic of iron deficiency, after 130 days we began to fertilize half the E. tetrodonta seedlings in ambient soil with an iron solution. Iron fertilization completely remedied chlorosis and stimulated leaf growth. Our microcosm results suggest that in intact rain forest, common AM networks mediate belowground competition and AM fungi may exacerbate iron deficiency, thereby enhancing resistance to E. tetrodonta invasion. Common AM networks-previously unrecognized as contributors to the ashbed effect-probably help to maintain the rain forest-savanna boundary.	[Janos, David P.; Aristizabal, Catalina] Univ Miami, Dept Biol, Coral Gables, FL 33124 USA; [Scott, John] Charles Darwin Univ, Res Inst Environm & Livelihoods, Darwin, NT 0909, Australia; [Bowman, David M. J. S.] Univ Tasmania, Sch Plant Sci, Hobart, Tas, Australia	University of Miami; Charles Darwin University; University of Tasmania	Janos, DP (corresponding author), Univ Miami, Dept Biol, Coral Gables, FL 33124 USA.	davidjanos@miami.edu	Janos, David P/B-2264-2008; Bowman, David/A-2930-2011	Janos, David P/0000-0002-3877-0110; Bowman, David/0000-0001-8075-124X	Cooperative Research Centre (CRC) for Tropical Savannas; Parks and Wildlife Commission of the Northern Territory; University of Tasmania	Cooperative Research Centre (CRC) for Tropical Savannas; Parks and Wildlife Commission of the Northern Territory; University of Tasmania	The Cooperative Research Centre (CRC) for Tropical Savannas, and the Parks and Wildlife Commission of the Northern Territory funded this research. The University of Tasmania supported DPJ as a visiting scholar to prepare the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams F, 2006, AUST J BOT, V54, P271, DOI 10.1071/BT05028; Allen E. B., 1993, Mycorrhiza, V2, P147, DOI 10.1007/BF00210583; Allen EB, 2003, ECOL APPL, V13, P1701, DOI 10.1890/02-5309; ARNEBRANT K, 1993, NEW PHYTOL, V124, P231, DOI 10.1111/j.1469-8137.1993.tb03812.x; Ashton DH, 1996, J VEG SCI, V7, P487, DOI 10.2307/3236297; Bavaresco L, 1999, J PLANT NUTR, V22, P1589, DOI 10.1080/01904169909365739; Bever JD, 2010, TRENDS ECOL EVOL, V25, P468, DOI 10.1016/j.tree.2010.05.004; Booth MG, 2010, ECOLOGY, V91, P2294, DOI 10.1890/09-1139.1; Bowman D.M., 2000, AUSTR RAINFORESTS IS; Bowman D. M. J. S., 1995, Australian Forestry, V58, P46; Bowman DMJS, 2010, LANDSCAPE ECOL, V25, P1247, DOI 10.1007/s10980-010-9496-8; BOWMAN DMJS, 1992, AUST J BOT, V40, P89, DOI 10.1071/BT9920089; Brundrett MC, 1996, PLANT SOIL, V184, P173, DOI 10.1007/BF00029286; Cardoso IM, 2006, COMMUN SOIL SCI PLAN, V37, P1537, DOI 10.1080/00103620600710074; CHAMBERS DP, 1994, AUST J BOT, V42, P739, DOI 10.1071/BT9940739; CHIARIELLO N, 1982, SCIENCE, V217, P941, DOI 10.1126/science.217.4563.941; Collier FA, 2009, J ECOL, V97, P950, DOI 10.1111/j.1365-2745.2009.01544.x; Courty PE, 2010, SOIL BIOL BIOCHEM, V42, P679, DOI 10.1016/j.soilbio.2009.12.006; Egerton-Warburton LM, 2007, J EXP BOT, V58, P1473, DOI 10.1093/jxb/erm009; EISSENSTAT DM, 1990, FUNCT ECOL, V4, P95, DOI 10.2307/2389658; FLORENCE RG, 1962, ECOLOGY, V43, P670, DOI 10.2307/1933456; FRANCIS R, 1984, NATURE, V307, P53, DOI 10.1038/307053a0; Hoeksema JD, 2010, ECOL LETT, V13, P394, DOI 10.1111/j.1461-0248.2009.01430.x; Hopkins MS, 1996, J TROP ECOL, V12, P871, DOI 10.1017/S0266467400010130; Humphreys F.R., 1965, SOIL RES, V3, P81; Ilesa TM, 2010, AUST J BOT, V58, P133, DOI 10.1071/BT08124; Janos DP, 2008, J TROP ECOL, V24, P177, DOI 10.1017/S0266467408004860; Janos DP, 2008, SOIL BIOL BIOCHEM, V40, P728, DOI 10.1016/j.soilbio.2007.10.007; Janos DP, 2007, MYCORRHIZA, V17, P75, DOI 10.1007/s00572-006-0094-1; JANOS DP, 1980, BIOTROPICA, V12, P56, DOI 10.2307/2388157; Janos DP, 2001, PLANT SOIL, V233, P85, DOI 10.1023/A:1010329618152; Janouskova M, 2011, MYCORRHIZA, V21, P641, DOI 10.1007/s00572-011-0372-4; Knorr MA, 2003, MYCORRHIZA, V13, P205, DOI 10.1007/s00572-002-0218-1; KOIDE RT, 1989, NEW PHYTOL, V111, P35, DOI 10.1111/j.1469-8137.1989.tb04215.x; Kytoviita MM, 2003, ECOLOGY, V84, P898, DOI 10.1890/0012-9658(2003)084[0898:ATOMAI]2.0.CO;2; Launonen TM, 2004, PLANT SOIL, V267, P179, DOI 10.1007/s11104-005-4794-7; Leake JR, 2004, CAN J BOT, V82, P1016, DOI [10.1139/B04-060, 10.1139/b04-060]; Lekberg Y, 2010, FEMS MICROBIOL ECOL, V74, P336, DOI 10.1111/j.1574-6941.2010.00956.x; MCGONIGLE TP, 1990, NEW PHYTOL, V115, P495, DOI 10.1111/j.1469-8137.1990.tb00476.x; McGonigle TP, 2001, MYCORRHIZA, V10, P249, DOI 10.1007/s005720000080; McGuire KL, 2007, ECOLOGY, V88, P567, DOI 10.1890/05-1173; McMullan-Fisher SJM, 2011, AUST J BOT, V59, P70, DOI 10.1071/BT10059; MENGEL K, 1994, PLANT SOIL, V165, P275, DOI 10.1007/BF00008070; Moora M, 1998, CAN J BOT, V76, P613, DOI 10.1139/cjb-76-4-613; Morales F, 1998, J PLANT NUTR, V21, P815, DOI 10.1080/01904169809365444; NEWMAN EI, 1988, ADV ECOL RES, V18, P243, DOI 10.1016/S0065-2504(08)60182-8; Nunez MA, 2009, ECOLOGY, V90, P2352, DOI 10.1890/08-2139.1; Parsons RF, 2007, AUSTRALAS PLANT PATH, V36, P415, DOI 10.1071/AP07043; Preger AC, 2007, SOIL BIOL BIOCHEM, V39, P445, DOI 10.1016/j.soilbio.2006.08.014; REDDELL P, 1992, AUST J BOT, V40, P223, DOI 10.1071/BT9920223; Romheld V, 2000, J PLANT NUTR, V23, P1629, DOI 10.1080/01904160009382129; RUSSELLSMITH J, 1991, J VEG SCI, V2, P259, DOI 10.2307/3235959; Selosse MA, 2006, TRENDS ECOL EVOL, V21, P621, DOI 10.1016/j.tree.2006.07.003; Simard SW, 2004, CAN J BOT, V82, P1140, DOI [10.1139/b04-116, 10.1139/B04-116]; Simard SW, 1997, NATURE, V388, P579, DOI 10.1038/41557; STOCKER G C, 1969, Australian Forest Research, V4, P31; SZANISZLO PJ, 1981, MYCOLOGIA, V73, P1158, DOI 10.2307/3759685; Teste FP, 2010, J ECOL, V98, P429, DOI 10.1111/j.1365-2745.2009.01624.x; TREEBY MT, 1992, SOIL BIOL BIOCHEM, V24, P857, DOI 10.1016/0038-0717(92)90006-J; TURTON SM, 1992, AUST J ECOL, V17, P415, DOI 10.1111/j.1442-9993.1992.tb00824.x; VANKESSEL C, 1985, PLANT PHYSIOL, V79, P562, DOI 10.1104/pp.79.2.562; Wang MY, 2008, BIOL FERT SOILS, V45, P65, DOI 10.1007/s00374-008-0290-6; WARCUP JH, 1991, MYCOL RES, V95, P329, DOI 10.1016/S0953-7562(09)81243-4; Wilson BA, 1990, 49 CONS COMM NO TERR; Wilson GWT, 2006, FUNCT ECOL, V20, P427, DOI 10.1111/j.1365-2435.2006.01134.x; WOODS FW, 1964, ECOLOGY, V45, P886, DOI 10.2307/1934943; Wright SF, 1998, PLANT SOIL, V198, P97, DOI 10.1023/A:1004347701584	67	18	19	4	126	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57716	10.1371/journal.pone.0057716	http://dx.doi.org/10.1371/journal.pone.0057716			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460899	Green Submitted, gold, Green Published			2022-12-25	WOS:000315519000154
J	Noti, JD; Blachere, FM; McMillen, CM; Lindsley, WG; Kashon, ML; Slaughter, DR; Beezhold, DH				Noti, John D.; Blachere, Francoise M.; McMillen, Cynthia M.; Lindsley, William G.; Kashon, Michael L.; Slaughter, Denzil R.; Beezhold, Donald H.			High Humidity Leads to Loss of Infectious Influenza Virus from Simulated Coughs	PLOS ONE			English	Article							RELATIVE-HUMIDITY; TRANSMISSION; SURVIVAL; VENTILATION; DISPERSION; EXPOSURE; AEROSOL	Background: The role of relative humidity in the aerosol transmission of influenza was examined in a simulated examination room containing coughing and breathing manikins. Methods: Nebulized influenza was coughed into the examination room and Bioaerosol samplers collected size-fractionated aerosols (<1 mu M, 1-4 mu M, and >4 mu M aerodynamic diameters) adjacent to the breathing manikin's mouth and also at other locations within the room. At constant temperature, the RH was varied from 7-73% and infectivity was assessed by the viral plaque assay. Results: Total virus collected for 60 minutes retained 70.6-77.3% infectivity at relative humidity <= 23% but only 14.6-22.2% at relative humidity >= 43%. Analysis of the individual aerosol fractions showed a similar loss in infectivity among the fractions. Time interval analysis showed that most of the loss in infectivity within each aerosol fraction occurred 0-15 minutes after coughing. Thereafter, losses in infectivity continued up to 5 hours after coughing, however, the rate of decline at 45% relative humidity was not statistically different than that at 20% regardless of the aerosol fraction analyzed. Conclusion: At low relative humidity, influenza retains maximal infectivity and inactivation of the virus at higher relative humidity occurs rapidly after coughing. Although virus carried on aerosol particles,4 mM have the potential for remaining suspended in air currents longer and traveling further distances than those on larger particles, their rapid inactivation at high humidity tempers this concern. Maintaining indoor relative humidity >40% will significantly reduce the infectivity of aerosolized virus.	[Noti, John D.; Blachere, Francoise M.; McMillen, Cynthia M.; Lindsley, William G.; Kashon, Michael L.; Slaughter, Denzil R.; Beezhold, Donald H.] NIOSH, HELD, Ctr Dis Control & Prevent CDC, Morgantown, WV USA; [McMillen, Cynthia M.] W Virginia Univ, Sch Med, Dept Microbiol Immunol & Cell Biol, Morgantown, WV 26506 USA	Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH); West Virginia University	Noti, JD (corresponding author), NIOSH, HELD, Ctr Dis Control & Prevent CDC, Morgantown, WV USA.	ivr2@cdc.gov		McMillen, Cynthia/0000-0001-9211-7908; Lindsley, William/0000-0003-0720-5829; Beezhold, Donald/0000-0001-5543-5747	National Institute for Occupational Safety and Health; Centers for Disease Control and Prevention	National Institute for Occupational Safety and Health(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH)); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This work was supported by the National Institute for Occupational Safety and Health and the Centers for Disease Control and Prevention. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, ERGONOMICS THERMAL E, DOI DOI 10.1016/J.SOILDYN.2004.11.005; ASHRAE Standard, 2010, 55 ASHRAE; Bjorn E, 2002, INDOOR AIR, V12, P147, DOI 10.1034/j.1600-0668.2002.08126.x; Blachere FM, 2011, J VIROL METHODS, V176, P120, DOI 10.1016/j.jviromet.2011.05.030; Blachere FM, 2009, CLIN INFECT DIS, V48, P438, DOI 10.1086/596478; Brankston G, 2007, LANCET INFECT DIS, V7, P257, DOI 10.1016/S1473-3099(07)70029-4; Brown JD, 2009, VET MICROBIOL, V136, P20, DOI 10.1016/j.vetmic.2008.10.027; Fabian P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002691; Hanley BP, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-98; HARPER GJ, 1961, J HYG-CAMBRIDGE, V59, P479, DOI 10.1017/S0022172400039176; HEMMES JH, 1960, NATURE, V188, P430, DOI 10.1038/188430a0; HOOD AM, 1963, J HYG-CAMBRIDGE, V61, P331, DOI 10.1017/S0022172400039619; Huynh KN, 2008, CLIN INFECT DIS, V46, P93, DOI 10.1086/523000; ISO, 2007, 1697612007E ISOTS; Lindsley WG, 2006, J ENVIRON MONITOR, V8, P1136, DOI 10.1039/b609083d; Lindsley WG, 2012, J OCCUP ENVIRON HYG, V9, P681, DOI 10.1080/15459624.2012.725986; Lindsley WG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015100; Lindsley WG, 2010, CLIN INFECT DIS, V50, P693, DOI 10.1086/650457; Lowen AC, 2007, PLOS PATHOG, V3, P1470, DOI 10.1371/journal.ppat.0030151; Milton DK, 2010, APR 18 20 ATL GEORG; Noti JD, 2012, CLIN INFECT DIS, V54, P1569, DOI 10.1093/cid/cis237; Pantelic J, 2009, J R SOC INTERFACE, V6, pS715, DOI 10.1098/rsif.2009.0311.focus; Qian H, 2006, INDOOR AIR, V16, P111, DOI 10.1111/j.1600-0668.2005.00407.x; Qian H, 2010, INDOOR AIR, V20, P284, DOI 10.1111/j.1600-0668.2010.00653.x; SCHAFFER FL, 1976, ARCH VIROL, V51, P263, DOI 10.1007/BF01317930; Shaman J, 2011, AM J EPIDEMIOL, V173, P127, DOI 10.1093/aje/kwq347; Shaman J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000316; SHECHMEISTER IL, 1950, J INFECT DIS, V87, P128, DOI 10.1093/infdis/87.2.128; Stelzer-Braid S, 2009, J MED VIROL, V81, P1674, DOI 10.1002/jmv.21556; Tellier R, 2009, J R SOC INTERFACE, V6, pS783, DOI 10.1098/rsif.2009.0302.focus; Teunis PFM, 2010, EPIDEMICS-NETH, V2, P215, DOI 10.1016/j.epidem.2010.10.001; Weber TP, 2008, J INFECTION, V57, P361, DOI 10.1016/j.jinf.2008.08.013; Wein LM, 2009, RISK ANAL, V29, P949, DOI 10.1111/j.1539-6924.2009.01232.x; Yang W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021481	34	82	87	3	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57485	10.1371/journal.pone.0057485	http://dx.doi.org/10.1371/journal.pone.0057485			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460865	Green Submitted, Green Published, gold			2022-12-25	WOS:000315519000120
J	Simonato, M; Battisti, A; Kerdelhue, C; Burban, C; Lopez-Vaamonde, C; Pivotto, I; Salvato, P; Negrisolo, E				Simonato, Mauro; Battisti, Andrea; Kerdelhue, Carole; Burban, Christian; Lopez-Vaamonde, Carlos; Pivotto, Isabelle; Salvato, Paola; Negrisolo, Enrico			Host and Phenology Shifts in the Evolution of the Social Moth Genus Thaumetopoea	PLOS ONE			English	Article							PINE PROCESSIONARY MOTH; COMPLETE MITOCHONDRIAL GENOME; MULTIPLE SEQUENCE ALIGNMENT; PITYOCAMPA LEPIDOPTERA; PHYLOGENETIC ANALYSIS; TRANSFER-RNA; PLANT USE; DNA; BUTTERFLIES; INSECTA	The genus Thaumetopoea contains the processionary moths, a group of lepidopteran associated with forest trees, well known for the social behaviour of the larvae and for carrying urticating setae. The taxonomy of the genus is partly unresolved and a phylogenetic approach is lacking. The goal of this work is to produce a phylogeny for Thaumetopoea and to identify the main traits driving the evolution of this group. Eighteen mitochondrial and three nuclear genes were fully/partly sequenced. Markers were aligned and analysed singularly or in various combinations. Phylogenetic analyses were performed according to maximum likelihood and Bayesian inference methods. Trees obtained from largest data sets provided identical topologies that received strong statistical support. Three main clades were identified within Thaumetopoea and were further supported by several signatures located in the mitochondrial tRNAs and intergenic spacers. The reference topology was used to investigate the evolution of life history traits related to biogeography, host plant, ecology, and morphology. A multigenic approach allowed to produce a robust phylogenetic analysis of the genus Thaumetopoea, with the identification of three major clades linked to different ecological and life history traits. The first clade is associated with Angiosperm host plants and has a fast spring development of larvae on young foliage. The other clades have originated by one event of host plant shift to Gymnosperm Pinaceae, which implied a longer larval developmental time due to the lower nutritional quality of leaves. These clades showed different adaptations to such a constraint, the first with a switch of larval feeding to cold season (winter pine processionary moths), and the second with a retraction to high altitude and latitude and a development cycle extended over two years (summer pine processionary moths). Recent global warming is affecting all species and seems able to further shape the evolution of the group.	[Simonato, Mauro; Battisti, Andrea; Salvato, Paola] Univ Padua, DAFNAE Entomol, Padua, Italy; [Kerdelhue, Carole] INRA CIRAD IRD Montpellier Supagro, UMR CBGP, INRA, Montferrier Sur Lez, France; [Burban, Christian; Pivotto, Isabelle] Univ Bordeaux, INRA, BIOGECO UMR1202, INRA, Cestas, France; [Lopez-Vaamonde, Carlos] INRA, URZF UR033, Orleans, France; [Negrisolo, Enrico] Univ Padua, BCA Dept Comparat Biomed & Food Safety, Padua, Italy	University of Padua; CIRAD; INRAE; Institut Agro; Montpellier SupAgro; Institut de Recherche pour le Developpement (IRD); INRAE; UDICE-French Research Universities; Universite de Bordeaux; INRAE; University of Padua	Negrisolo, E (corresponding author), Univ Padua, BCA Dept Comparat Biomed & Food Safety, Padua, Italy.	enrico.negrisolo@unipd.it	Battisti, Andrea/F-6243-2015; Yakovlev, Roman/J-7243-2013; Vaamonde, Carlos Lopez/A-5548-2009; Kerdelhue, Carole/GVS-0309-2022; Negrisolo, Enrico/K-8124-2015	Battisti, Andrea/0000-0002-2497-3064; Vaamonde, Carlos Lopez/0000-0003-2278-2368; Negrisolo, Enrico/0000-0002-6244-805X; Kerdelhue, Carole/0000-0001-7667-902X	European Union [QLK5-CT-2002-00852]; University of Padova	European Union(European Commission); University of Padova	The work presented in this paper has started with a grant from the European Union (Promoth QLK5-CT-2002-00852, P.I. AB) and has been continued with several grants of the University of Padova to AB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2010, NUCLEIC ACIDS RES, V38, pW7, DOI 10.1093/nar/gkq291; Adachi J, 1996, J MOL EVOL, V42, P459; Agenjo R., 1941, Eos Madrid, V17, P69; Aimi A, 2008, AGR FOREST ENTOMOL, V10, P225, DOI 10.1111/j.1461-9563.2008.00378.x; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Barbaro L, 2011, BIOL CONTROL, V56, P107, DOI 10.1016/j.biocontrol.2010.10.009; Battisti A, 2005, ECOL APPL, V15, P2084, DOI 10.1890/04-1903; BATTISTI A, 1988, J APPL ENTOMOL, V105, P393, DOI 10.1111/j.1439-0418.1988.tb00202.x; Battisti A, 2011, ANNU REV ENTOMOL, V56, P203, DOI 10.1146/annurev-ento-120709-144844; BERNAYS E, 1988, ECOLOGY, V69, P886, DOI 10.2307/1941237; Bohm SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017857; Cameron SL, 2008, GENE, V408, P112, DOI 10.1016/j.gene.2007.10.023; Cannone JJ, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-2; Costa J., 2006, OTHER INSECT SOC; de Freina J., 1987, BOMBYCES SPHINGES WE, VI; de Freina J.J., 1982, Atalanta (Marktleuthen), V13, P309; DEMOLIN G, 1969, Annales des Sciences Forestieres (Paris), V26, P81; Doganlar Miktat, 2001, Turkiye Entomoloji Dergisi, V25, P19; Doganlar Miktat, 2005, Entomofauna, V26, P229; Dussourd David E., 1993, P92; EHRLICH PR, 1964, EVOLUTION, V18, P586, DOI 10.2307/2406212; FEARNLEY IM, 1987, BIOCHEMISTRY-US, V26, P8247, DOI 10.1021/bi00399a034; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Felsenstein J., 2004, INFERRING PHYLOGENIE, VVolume 2; Fenn JD, 2008, MOL PHYLOGENET EVOL, V49, P59, DOI 10.1016/j.ympev.2008.07.004; Fitzgerald Terrence D., 1993, P372; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; FURTH D G, 1979, Israel Journal of Entomology, V13, P1; Gaston KJ, 2003, STRUCTURE DYNAMICS G; Gilbert S. F., 2009, ECOLOGICAL DEV BIOL; Gowri-Shankar V., 2006, PHASE SOFTWARE PACKA; Groenen F, 2012, AGR FOREST ENTOMOL, V14, P147, DOI 10.1111/j.1461-9563.2011.00552.x; HALPERIN J, 1990, J APPL ENTOMOL, V110, P1, DOI 10.1111/j.1439-0418.1990.tb00088.x; JAENIKE J, 1990, ANNU REV ECOL SYST, V21, P243, DOI 10.1146/annurev.ecolsys.21.1.243; Janz N, 1998, EVOLUTION, V52, P486, DOI [10.2307/2411084, 10.1111/j.1558-5646.1998.tb01648.x]; Janz N, 2008, SPECIALIZATION, SPECIATION, AND RADIATION: THE EVOLUTIONARY BIOLOGY OF HERBIVOROUS INSECTS, P203; JONES DT, 1992, NATURE, V358, P86, DOI 10.1038/358086a0; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kerdelhue C, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-220; Kim I, 2005, GENE, V353, P155, DOI 10.1016/j.gene.2005.04.019; Kiriakoff S.G., 1970, GENERA INSECT, V219, P1; KRAMER P J, 1979, P811; Lavrov DV, 2000, MOL BIOL EVOL, V17, P813, DOI 10.1093/oxfordjournals.molbev.a026360; Liao F, 2010, INT J BIOL SCI, V6, P172; Lill JT, 2002, NATURE, V417, P170, DOI 10.1038/417170a; Lopez-Vaamonde C, 2003, EVOLUTION, V57, P1804, DOI 10.1111/j.0014-3820.2003.tb00588.x; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; MADDISON D. R., 2005, MACCLADE 4 ANAL PHYL; Mayr E., 1963, ANIMAL SPECIES EVOLU, P797; MILANI N, 1990, Redia, V73, P149; Mitchell A, 1997, MOL BIOL EVOL, V14, P381, DOI 10.1093/oxfordjournals.molbev.a025774; MITTER C, 1988, AM NAT, V132, P107, DOI 10.1086/284840; Negrisolo E, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-221; Nijhout HF, 2010, PHILOS T R SOC B, V365, P567, DOI 10.1098/rstb.2009.0249; Ohshima I, 2006, MOL PHYLOGENET EVOL, V38, P231, DOI 10.1016/j.ympev.2005.06.010; Paiva MR, 2011, J APPL ENTOMOL, V135, P195, DOI 10.1111/j.1439-0418.2010.01550.x; PATWARY MU, 1994, J SHELLFISH RES, V13, P547; Perez-Contreras T, 2003, ANN ZOOL FENN, V40, P505; PRICE PW, 1980, ANNU REV ECOL SYST, V11, P41, DOI 10.1146/annurev.es.11.110180.000353; Qiao CY, 2007, ANN BOT-LONDON, V100, P573, DOI 10.1093/aob/mcm134; Ratcliffe JM, 2008, NATURE, V455, P96, DOI 10.1038/nature07087; Ronnas C, 2010, ECOL ENTOMOL, V35, P436, DOI 10.1111/j.1365-2311.2010.01199.x; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rousselet J, 2010, J BIOGEOGR, V37, P1478, DOI 10.1111/j.1365-2699.2010.02289.x; Rubinoff D, 2005, SYST BIOL, V54, P952, DOI 10.1080/10635150500234674; Salvato P, 2002, MOL ECOL, V11, P2435, DOI 10.1046/j.1365-294X.2002.01631.x; Salvato P, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-331; Santos H, 2011, J EVOLUTION BIOL, V24, P1897, DOI 10.1111/j.1420-9101.2011.02318.x; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Silvestro D., 2011, ORG DIVERS EVOL, V12, P335, DOI [10.1007/sI3127-011-0056-0, DOI 10.1007/S13127-011-0056-0]; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Simon C, 2006, ANNU REV ECOL EVOL S, V37, P545, DOI 10.1146/annurev.ecolsys.37.091305.110018; Simonato M, 2007, MOL ECOL, V16, P2273, DOI 10.1111/j.1365-294X.2007.03302.x; SMITH AE, 1968, J MOL BIOL, V38, P241, DOI 10.1016/0022-2836(68)90409-9; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stastny M, 2006, ECOL ENTOMOL, V31, P481, DOI 10.1111/j.1365-2311.2006.00807.x; Strimmer K, 1997, P NATL ACAD SCI USA, V94, P6815, DOI 10.1073/pnas.94.13.6815; Strong D.R., 1984, INSECTS PLANTS COMMU; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Trought T., 1954, Entomologist's Record Bishop's Stortford, V66, P188; Wahlberg N, 2008, SYST BIOL, V57, P231, DOI 10.1080/10635150802033006; Wiltshire E.P., 1980, Journal of Oman Studies Special Report, P187; Winkler IS, 2008, SPECIALIZATION, SPECIATION, AND RADIATION: THE EVOLUTIONARY BIOLOGY OF HERBIVOROUS INSECTS, P240; WOLSTENHOLME DR, 1992, INT REV CYTOL, V141, P173, DOI 10.1016/S0074-7696(08)62066-5; Yang Z., 2006, COMPUTATIONAL MOL EV, DOI DOI 10.1093/ACPROF:OSO/9780198567028.001.0001; Zakharov EV, 2004, SYST BIOL, V53, P193, DOI 10.1080/10635150490423403; Zhang ZQ, 2011, ZOOTAXA, P7, DOI 10.11646/zootaxa.3148.1.3	91	23	23	0	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57192	10.1371/journal.pone.0057192	http://dx.doi.org/10.1371/journal.pone.0057192			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460830	Green Published, Green Submitted, gold			2022-12-25	WOS:000315519000074
J	Ukkola-Vuoti, L; Kanduri, C; Oikkonen, J; Buck, G; Blancher, C; Raijas, P; Karma, K; Lahdesmaki, H; Jarvela, I				Ukkola-Vuoti, Liisa; Kanduri, Chakravarthi; Oikkonen, Jaana; Buck, Gemma; Blancher, Christine; Raijas, Pirre; Karma, Kai; Lahdesmaki, Harri; Jarvela, Irma			Genome-Wide Copy Number Variation Analysis in Extended Families and Unrelated Individuals Characterized for Musical Aptitude and Creativity in Music	PLOS ONE			English	Article							PROTOCADHERIN-ALPHA FAMILY; PREFRONTAL CORTEX; GENE; ASSOCIATION; BINDING; DISORDER; MICRODELETION; SCHIZOPHRENIA; POLYMORPHISM; PERFORMANCE	Music perception and practice represent complex cognitive functions of the human brain. Recently, evidence for the molecular genetic background of music related phenotypes has been obtained. In order to further elucidate the molecular background of musical phenotypes we analyzed genome wide copy number variations (CNVs) in five extended pedigrees and in 172 unrelated subjects characterized for musical aptitude and creative functions in music. Musical aptitude was defined by combination of the scores of three music tests (COMB scores): auditory structuring ability, Seashores test for pitch and for time. Data on creativity in music (herein composing, improvising and/or arranging music) was surveyed using a web-based questionnaire. Several CNVRs containing genes that affect neurodevelopment, learning and memory were detected. A deletion at 5q31.1 covering the protocadherin-a gene cluster (Pcdha 1-9) was found co-segregating with low music test scores (COMB) in both sample sets. Pcdha is involved in neural migration, differentiation and synaptogenesis. Creativity in music was found to co-segregate with a duplication covering glucose mutarotase gene (GALM) at 2p22. GALM has influence on serotonin release and membrane trafficking of the human serotonin transporter. Interestingly, genes related to serotonergic systems have been shown to associate not only with psychiatric disorders but also with creativity and music perception. Both, Pcdha and GALM, are related to the serotonergic systems influencing cognitive and motor functions, important for music perception and practice. Finally, a 1.3 Mb duplication was identified in a subject with low COMB scores in the region previously linked with absolute pitch (AP) at 8q24. No differences in the CNV burden was detected among the high/low music test scores or creative/non-creative groups. In summary, CNVs and genes found in this study are related to cognitive functions. Our result suggests new candidate genes for music perception related traits and supports the previous results from AP study.	[Ukkola-Vuoti, Liisa; Kanduri, Chakravarthi; Oikkonen, Jaana; Jarvela, Irma] Univ Helsinki, Dept Med Genet, FIN-00014 Helsinki, Finland; [Kanduri, Chakravarthi; Lahdesmaki, Harri] Aalto Univ, Dept Informat & Comp Sci, Espoo, Finland; [Buck, Gemma; Blancher, Christine] Wellcome Trust Ctr Human Genet, Oxford, England; [Raijas, Pirre] Sibelius Acad, DocMus Dept, Helsinki, Finland; [Karma, Kai] Sibelius Acad, Dept Mus Educ, Helsinki, Finland	University of Helsinki; Aalto University; University of Oxford; Wellcome Centre for Human Genetics; University of the Arts Helsinki; University of the Arts Helsinki	Ukkola-Vuoti, L (corresponding author), Univ Helsinki, Dept Med Genet, FIN-00014 Helsinki, Finland.	liisa.ukkola@helsinki.fi	Kanduri, Chakravarthi/AAL-1021-2020; Ukkola-Vuoti, Liisa/E-6564-2016; Jarvela, Irma E/L-5836-2013	Kanduri, Chakravarthi/0000-0002-4783-9060; Ukkola-Vuoti, Liisa/0000-0002-0770-361X; Jarvela, Irma E/0000-0002-1770-6187; Buck, Gemma/0000-0001-5289-1050; Oikkonen, Jaana/0000-0002-1063-2736	Academy of Finland [13371]; Biocentrum Helsinki Foundation	Academy of Finland(Academy of Finland); Biocentrum Helsinki Foundation	The work was financially supported by the Academy of Finland (grant 13371) and the Biocentrum Helsinki Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott A, 2002, NATURE, V416, P12, DOI 10.1038/416012a; Almal SH, 2012, J HUM GENET, V57, P6, DOI 10.1038/jhg.2011.108; Antoniou AC, 2003, GENET EPIDEMIOL, V25, P190, DOI 10.1002/gepi.10261; Bachner-Melman R, 2005, PLOS GENET, V1, P394, DOI 10.1371/journal.pgen.0010042; Belsky J, 2009, MOL PSYCHIATR, V14, P746, DOI 10.1038/mp.2009.44; Bengtsson SL, 2007, J COGNITIVE NEUROSCI, V19, P830, DOI 10.1162/jocn.2007.19.5.830; Blood AJ, 2001, P NATL ACAD SCI USA, V98, P11818, DOI 10.1073/pnas.191355898; Blum K, 2010, MED HYPOTHESES, V74, P513, DOI 10.1016/j.mehy.2009.10.008; Craddock N, 2010, NATURE, V464, P713, DOI 10.1038/nature08979; Dauber A, 2011, AM J HUM GENET, V89, P751, DOI 10.1016/j.ajhg.2011.10.014; Dellinger AE, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq040; Djurovic S, 2009, PSYCHIAT RES, V168, P256, DOI 10.1016/j.psychres.2008.08.007; Drevets WC, 2007, NUCL MED BIOL, V34, P865, DOI 10.1016/j.nucmedbio.2007.06.008; ELBERT T, 1995, SCIENCE, V270, P305, DOI 10.1126/science.270.5234.305; Fukuda E, 2008, EUR J NEUROSCI, V28, P1362, DOI 10.1111/j.1460-9568.2008.06428.x; Girirajan S, 2011, ANNU REV GENET, V45, P203, DOI 10.1146/annurev-genet-102209-163544; Granota RY, 2007, EVOL HUM BEHAV, V28, P313, DOI 10.1016/j.evolhumbehav.2007.05.003; Grayton HM, 2012, PROG NEUROBIOL, V99, P81, DOI 10.1016/j.pneurobio.2012.07.005; Gu W, 2008, CYTOGENET GENOME RES, V123, P54, DOI 10.1159/000184692; Hannula-Jouppi K, 2005, PLOS GENET, V1, P467, DOI 10.1371/journal.pgen.0010050; Hasegawa S, 2008, MOL CELL NEUROSCI, V38, P66, DOI 10.1016/j.mcn.2008.01.016; Hauser MD, 2003, NAT NEUROSCI, V6, P663, DOI 10.1038/nn1080; Haworth CMA, 2009, J CHILD PSYCHOL PSYC, V50, P1318, DOI 10.1111/j.1469-7610.2009.02114.x; Itsara A, 2009, AM J HUM GENET, V84, P148, DOI 10.1016/j.ajhg.2008.12.014; Justus T, 2005, MUSIC PERCEPT, V23, P1, DOI 10.1525/mp.2005.23.1.1; Karlsson R, 2012, BIOL PSYCHIAT, V71, P922, DOI 10.1016/j.biopsych.2012.01.020; Karma K., 2007, PSYCHOMUSICOLOGY, V19, P79, DOI [10.1037/h0094033, DOI 10.1037/H0094033]; Kasowski M, 2010, SCIENCE, V328, P232, DOI 10.1126/science.1183621; Katori S, 2009, J NEUROSCI, V29, P9137, DOI 10.1523/JNEUROSCI.5478-08.2009; Keri S, 2009, PSYCHOL SCI, V20, P1070, DOI 10.1111/j.1467-9280.2009.02398.x; Knight S, 2009, GENET EPIDEMIOL, V33, pS99, DOI 10.1002/gepi.20480; Koelsch S, 2005, TRENDS COGN SCI, V9, P578, DOI 10.1016/j.tics.2005.10.001; Koelsch S, 2005, CURR OPIN NEUROBIOL, V15, P207, DOI 10.1016/j.conb.2005.03.005; Kousi M, 2012, J MED GENET, V49, P391, DOI 10.1136/jmedgenet-2012-100859; Kyaga S, 2011, BRIT J PSYCHIAT, V199, P373, DOI 10.1192/bjp.bp.110.085316; Li X, 2010, J GENET GENOMICS, V37, P779, DOI 10.1016/S1673-8527(09)60095-3; Limb CJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001679; Liu X, 2011, MOL PSYCHIATR, V16, P584, DOI 10.1038/mp.2011.1; Magri C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013422; Matsson H, 2011, BEHAV GENET, V41, P134, DOI 10.1007/s10519-010-9431-4; McDermott J, 2007, COGNITION, V104, P654, DOI 10.1016/j.cognition.2006.07.011; Menon V, 2005, NEUROIMAGE, V28, P175, DOI 10.1016/j.neuroimage.2005.05.053; Moghimi S, 2012, NEUROSCI LETT, V525, P7, DOI 10.1016/j.neulet.2012.07.009; Morley AP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031763; Noguchi Y, 2009, J BIOL CHEM, V284, P32002, DOI 10.1074/jbc.M109.046938; Norio R, 2003, HUM GENET, V112, P457, DOI 10.1007/s00439-002-0876-2; Park H, 2012, J MED GENET, V49, P747, DOI 10.1136/jmedgenet-2012-101209; Park JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031243; Pedrosa E, 2008, SCHIZOPHR RES, V102, P210, DOI 10.1016/j.schres.2008.04.013; Perani D, 2010, P NATL ACAD SCI USA, V107, P4758, DOI 10.1073/pnas.0909074107; Peretz I, 2005, ANNU REV PSYCHOL, V56, P89, DOI 10.1146/annurev.psych.56.091103.070225; Peretz I, 2007, AM J HUM GENET, V81, P582, DOI 10.1086/521337; Petrin AL, 2010, AM J MED GENET A, V152A, P3164, DOI 10.1002/ajmg.a.33749; Pinto D, 2011, NAT BIOTECHNOL, V29, P512, DOI 10.1038/nbt.1852; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; PORTER D, 1984, J EXP PSYCHOL ANIM B, V10, P138; Pulli K, 2008, J MED GENET, V45, P451, DOI 10.1136/jmg.2007.056366; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Reuter M, 2006, IDENTIFICATION 1 CAN; Sakai T, 2008, NEUROPATHOLOGY, V28, P143, DOI 10.1111/j.1440-1789.2007.00867.x; Salimpoor VN, 2011, NAT NEUROSCI, V14, P257, DOI 10.1038/nn.2726; Salyakina D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026049; Schlattl A, 2011, GENOME RES, V21, P2004, DOI 10.1101/gr.122614.111; Seashore CE., 1960, SEASHORE MEASURES MU; Shin OH, 2005, J BIOL CHEM, V280, P1641, DOI 10.1074/jbc.M407305200; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Sternberg RJ, 2006, INTERNATIONAL HANDBOOK OF CREATIVITY, P1; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Theusch E, 2009, AM J HUM GENET, V85, P112, DOI 10.1016/j.ajhg.2009.06.010; Trehub SE, 2001, ANN NY ACAD SCI, V930, P1; Ukkola LT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005534; Ukkola-Vuoti L, 2011, J HUM GENET, V56, P324, DOI 10.1038/jhg.2011.13; Watanabe S, 1999, BEHAV PROCESS, V47, P53, DOI 10.1016/S0376-6357(99)00049-2; Wong ST, 1999, NEURON, V23, P787, DOI 10.1016/S0896-6273(01)80036-2; Yeo RA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016339; Zentner M, 2008, EMOTION, V8, P494, DOI 10.1037/1528-3542.8.4.494; Zentner MR, 1996, NATURE, V383, P29, DOI 10.1038/383029a0; Zhang P, 2010, BIPOLAR DISORD, V12, P786, DOI 10.1111/j.1399-5618.2010.00883.x; Zollino M, 2012, NAT GENET, V44, P636, DOI 10.1038/ng.2257	79	52	54	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e56356	10.1371/journal.pone.0056356	http://dx.doi.org/10.1371/journal.pone.0056356			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460800	Green Published, Green Submitted, gold			2022-12-25	WOS:000315519000023
J	Ferreira, RM; Rybarczyk-Filho, JL; Dalmolin, RJS; Castro, MAA; Moreira, JCF; Brunnet, LG; de Almeida, RMC				Ferreira, Ricardo M.; Rybarczyk-Filho, Jose Luiz; Dalmolin, Rodrigo J. S.; Castro, Mauro A. A.; Moreira, Jose C. F.; Brunnet, Leonardo G.; de Almeida, Rita M. C.			Preferential Duplication of Intermodular Hub Genes: An Evolutionary Signature in Eukaryotes Genome Networks	PLOS ONE			English	Article							MODULARITY; PROTEINS; CONNECTIVITY; INTEGRATION; PLASTICITY; ORIGIN	Whole genome protein-protein association networks are not random and their topological properties stem from genome evolution mechanisms. In fact, more connected, but less clustered proteins are related to genes that, in general, present more paralogs as compared to other genes, indicating frequent previous gene duplication episodes. On the other hand, genes related to conserved biological functions present few or no paralogs and yield proteins that are highly connected and clustered. These general network characteristics must have an evolutionary explanation. Considering data from STRING database, we present here experimental evidence that, more than not being scale free, protein degree distributions of organisms present an increased probability for high degree nodes. Furthermore, based on this experimental evidence, we propose a simulation model for genome evolution, where genes in a network are either acquired de novo using a preferential attachment rule, or duplicated with a probability that linearly grows with gene degree and decreases with its clustering coefficient. For the first time a model yields results that simultaneously describe different topological distributions. Also, this model correctly predicts that, to produce protein-protein association networks with number of links and number of nodes in the observed range for Eukaryotes, it is necessary 90% of gene duplication and 10% of de novo gene acquisition. This scenario implies a universal mechanism for genome evolution.	[Ferreira, Ricardo M.; Rybarczyk-Filho, Jose Luiz; Castro, Mauro A. A.; Brunnet, Leonardo G.; de Almeida, Rita M. C.] Univ Fed Rio Grande do Sul, Inst Fis, Porto Alegre, RS, Brazil; [Castro, Mauro A. A.; de Almeida, Rita M. C.] Univ Fed Rio Grande do Sul, Natl Inst Sci & Technol Complex Syst, Porto Alegre, RS, Brazil; [Dalmolin, Rodrigo J. S.; Moreira, Jose C. F.] Univ Fed Rio Grande do Sul, Dept Bioquim, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul	de Almeida, RMC (corresponding author), Univ Fed Rio Grande do Sul, Inst Fis, Porto Alegre, RS, Brazil.	rita@if.ufrgs.br	Brunnet, Leonardo G/S-2397-2016; Filho, José Luiz Rybarczyk/ABC-6502-2020; Castro, Mauro A. A./A-5467-2008; Rybarczyk-Filho, José/F-8221-2012; de Almeida, Rita M. C./K-9239-2014; moreira, jose claudio/AAO-6400-2021; Dalmolin, Rodrigo J/L-3718-2013	Brunnet, Leonardo G/0000-0003-1156-3565; Filho, José Luiz Rybarczyk/0000-0002-0757-3608; Castro, Mauro A. A./0000-0003-4942-8131; de Almeida, Rita M. C./0000-0003-3897-1841; Dalmolin, Rodrigo J/0000-0002-1688-6155	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS); Centro de Fisica Computacional, Universidade Federal do Rio Grande do Sul	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS)(Fundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS)); Centro de Fisica Computacional, Universidade Federal do Rio Grande do Sul	This work has been partially funded by Brazilian agencies Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), and Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge fruitful discussions with Prof. Diego Bonnato, Centro de Biotecnologia, and support from the Centro de Fisica Computacional, Universidade Federal do Rio Grande do Sul.	Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Berg J, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-51; Castro MAA, 2008, NUCLEIC ACIDS RES, V36, P6269, DOI 10.1093/nar/gkn636; Colizza V, 2005, PHYSICA A, V352, P1, DOI 10.1016/j.physa.2004.12.030; Conant GC, 2008, NAT REV GENET, V9, P938, DOI 10.1038/nrg2482; Costa LD, 2007, ADV PHYS, V56, P167, DOI 10.1080/00018730601170527; Dalmolin RJS, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-22; Des Marais DL, 2008, NATURE, V454, P762, DOI 10.1038/nature07092; Evlampiev K, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-49; Fraser HB, 2005, NAT GENET, V37, P351, DOI 10.1038/ng1530; Han JDJ, 2004, NATURE, V430, P88, DOI 10.1038/nature02555; Innan H, 2010, NAT REV GENET, V11, P97, DOI 10.1038/nrg2689; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Khersonsky O, 2006, CURR OPIN CHEM BIOL, V10, P498, DOI 10.1016/j.cbpa.2006.08.011; Kim WK, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000232; Koonin EV, 2010, NAT REV GENET, V11, P487, DOI 10.1038/nrg2810; Koonin EV, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r7; Li L, 2006, MOL BIOL EVOL, V23, P2467, DOI 10.1093/molbev/msl121; Long M, 2003, NAT REV GENET, V4, P865, DOI 10.1038/nrg1204; McIntosh BE, 2010, ANNU REV PHYSIOL, V72, P625, DOI 10.1146/annurev-physiol-021909-135922; Mittal N, 2011, J MOL BIOL, V409, P466, DOI 10.1016/j.jmb.2011.03.064; Prachumwat A, 2006, MOL BIOL EVOL, V23, P30, DOI 10.1093/molbev/msi249; Rybarczyk JL, 2011, NUCLEIC ACIDS RES, V39, P3005, DOI 10.1093/nar/gkq1269; Schlitt T, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S6-S9; Soskine M, 2010, NAT REV GENET, V11, P572, DOI 10.1038/nrg2808; Stark C, 2011, NUCLEIC ACIDS RES, V39, pD698, DOI 10.1093/nar/gkq1116; Szklarczyk R, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-337; Takemoto K, 2007, MATH BIOSCI, V208, P454, DOI 10.1016/j.mbs.2006.11.002; Turner B, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq023; Vazquez A, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.056104; Vazquez Alexei, 2003, ComPlexUs, V1, P38, DOI 10.1159/000067642; von Mering C, 2005, NUCLEIC ACIDS RES, V33, pD433, DOI 10.1093/nar/gki005; von Mering C, 2007, NUCLEIC ACIDS RES, V35, pD358, DOI 10.1093/nar/gkl825; Wall DP, 2005, P NATL ACAD SCI USA, V102, P5483, DOI 10.1073/pnas.0501761102; Zhou Q, 2008, GENOME RES, V18, P1446, DOI 10.1101/gr.076588.108	37	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2013	8	2							e56579	10.1371/journal.pone.0056579	http://dx.doi.org/10.1371/journal.pone.0056579			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098PO	23468868	Green Published, gold			2022-12-25	WOS:000315561400011
J	Lowery, JW; LaVigne, AW; Kokabu, S; Rosen, V				Lowery, Jonathan W.; LaVigne, Anna W.; Kokabu, Shoichiro; Rosen, Vicki			Comparative Genomics Identifies the Mouse Bmp3 Promoter and an Upstream Evolutionary Conserved Region (ECR) in Mammals	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEIN-3; PULMONARY ARTERIAL-HYPERTENSION; FACTOR-BETA SUPERFAMILY; TGF-BETA; GENE-EXPRESSION; GROWTH-FACTOR; OSTEOBLAST DIFFERENTIATION; SIGNALING PATHWAYS; FRACTURE CALLUS; XENOPUS EMBRYOS	The Bone Morphogenetic Protein (BMP) pathway is a multi-member signaling cascade whose basic components are found in all animals. One member, BMP3, which arose more recently in evolution and is found only in deuterostomes, serves a unique role as an antagonist to both the canonical BMP and Activin pathways. However, the mechanisms that control BMP3 expression, and the cis-regulatory regions mediating this regulation, remain poorly defined. With this in mind, we sought to identify the Bmp3 promoter in mouse (M. musculus) through functional and comparative genomic analyses. We found that the minimal promoter required for expression in resides within 0.8 kb upstream of Bmp3 in a region that is highly conserved with rat (R. norvegicus). We also found that an upstream region abutting the minimal promoter acts as a repressor of the minimal promoter in HEK293T cells and osteoblasts. Strikingly, a portion of this region is conserved among all available eutherian mammal genomes (47/47), but not in any non-eutherian animal (0/136). We also identified multiple conserved transcription factor binding sites in the Bmp3 upstream ECR, suggesting that this region may preserve common cis-regulatory elements that govern Bmp3 expression across eutherian mammals. Since dysregulation of BMP signaling appears to play a role in human health and disease, our findings may have application in the development of novel therapeutics aimed at modulating BMP signaling in humans.	[Lowery, Jonathan W.; LaVigne, Anna W.; Kokabu, Shoichiro; Rosen, Vicki] Harvard Univ, Sch Dent Med, Dept Dev Biol, Boston, MA 02115 USA	Harvard University; Harvard School of Dental Medicine	Rosen, V (corresponding author), Harvard Univ, Sch Dent Med, Dept Dev Biol, 188 Longwood Ave, Boston, MA 02115 USA.	vicki_rosen@hsdm.harvard.edu		Kokabu, Shoichiro/0000-0002-6663-4327	American Recovery & Reinvestment Act Award; Harvard School of Dental Medicine Dean's Scholars Award; Harvard College Research Program Award	American Recovery & Reinvestment Act Award; Harvard School of Dental Medicine Dean's Scholars Award; Harvard College Research Program Award	This work was supported by: an American Recovery & Reinvestment Act Award (VR); the Harvard School of Dental Medicine Dean's Scholars Award (JWL and SK); and the Harvard College Research Program Award (AWL). The funders had no role in study design, data collection and analysis, decision to publish, or prparation of the manuscript.	Allendorph GP, 2006, P NATL ACAD SCI USA, V103, P7643, DOI 10.1073/pnas.0602558103; Bahamonde ME, 2001, J BONE JOINT SURG AM, V83A, pS56; Bonner C, 2011, J BIOL CHEM, V286, P25719, DOI 10.1074/jbc.M110.215525; Cadena SM, 2010, J APPL PHYSIOL, V109, P635, DOI 10.1152/japplphysiol.00866.2009; Chen GQ, 2012, INT J BIOL SCI, V8, P272, DOI 10.7150/ijbs.2929; Cho TJ, 2002, J BONE MINER RES, V17, P513, DOI 10.1359/jbmr.2002.17.3.513; Daluiski A, 2001, NAT GENET, V27, P84, DOI 10.1038/83810; Davies RJ, 2008, CHEST, V134, P1271, DOI 10.1378/chest.08-1341; Dwivedi PP, 2012, BMC BIOTECHNOL, V12, DOI 10.1186/1472-6750-12-45; Edwards JR, 2010, J BONE MINER RES, V25, P2419, DOI 10.1002/jbmr.139; Fajardo RJ, 2010, BONE, V46, P64, DOI 10.1016/j.bone.2009.09.018; Faucheux C, 1999, J CELL BIOCHEM, V73, P11, DOI 10.1002/(SICI)1097-4644(19990401)73:1<11::AID-JCB2>3.0.CO;2-4; Gamer LW, 2008, DEV DYNAM, V237, P1691, DOI 10.1002/dvdy.21561; Gamer LW, 2009, DEV DYNAM, V238, P2374, DOI 10.1002/dvdy.22048; Gamer LW, 2005, DEV BIOL, V285, P156, DOI 10.1016/j.ydbio.2005.06.012; Gil H, 2008, GROWTH HORM IGF RES, V18, P353, DOI 10.1016/j.ghir.2008.01.009; Goumans MJ, 2003, TRENDS CARDIOVAS MED, V13, P301, DOI 10.1016/S1050-1738(03)00142-7; Haque T, 2008, BONE, V42, P1144, DOI 10.1016/j.bone.2008.01.028; Hardy G, 2000, SADJ, V55, P136; Hino J, 2004, FRONT BIOSCI-LANDMRK, V9, P1520, DOI 10.2741/1355; Hino J, 2003, DEV BIOL, V260, P138, DOI 10.1016/S0012-1606(03)00223-9; Holstein TW, 2011, CURR TOP DEV BIOL, V97, P137, DOI 10.1016/B978-0-12-385975-4.00012-7; Inoue Y, 2008, CANCER SCI, V99, P2107, DOI 10.1111/j.1349-7006.2008.00925.x; Izumi N, 2006, AM J PHYSIOL-LUNG C, V290, pL120, DOI 10.1152/ajplung.00171.2005; Jaatinen R, 1996, J CLIN ENDOCR METAB, V81, P3877, DOI 10.1210/jc.81.11.3877; Jiang S, 2010, BIOCHEM BIOPH RES CO, V392, P124, DOI 10.1016/j.bbrc.2009.12.157; Johnson KJ, 2010, BIOL REPROD, V83, P774, DOI 10.1095/biolreprod.110.085175; Katoh Y, 2006, INT J MOL MED, V17, P951; Kemoun P, 2007, TISSUE CELL, V39, P257, DOI 10.1016/j.tice.2007.06.001; Kishigami S, 2005, CYTOKINE GROWTH F R, V16, P265, DOI 10.1016/j.cytogfr.2005.04.002; Kloen P, 2003, BONE, V33, P362, DOI 10.1016/S8756-3282(03)00191-1; Kohany O, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-474; Kokabu S, 2012, MOL ENDOCRINOL, V26, P87, DOI 10.1210/me.2011-1168; Koncarevic A, 2010, ENDOCRINOLOGY, V151, P4289, DOI 10.1210/en.2010-0134; Ku GM, 2012, MOL ENDOCRINOLOGY; Lapraz F, 2006, DEV BIOL, V300, P132, DOI 10.1016/j.ydbio.2006.08.048; Loots GG, 2004, NUCLEIC ACIDS RES, V32, pW217, DOI 10.1093/nar/gkh383; Lotinun S, 2010, BONE, V46, P1082, DOI 10.1016/j.bone.2010.01.370; Lowery JW, 2011, CRIT REV EUKAR GENE, V21, P177, DOI 10.1615/CritRevEukarGeneExpr.v21.i2.60; Lowery JW, 2010, CYTOKINE GROWTH F R, V21, P287, DOI 10.1016/j.cytogfr.2010.06.001; Luu HH, 2007, J ORTHOP RES, V25, P665, DOI 10.1002/jor.20359; Martinovic S, 2006, ARCH HISTOL CYTOL, V69, P23, DOI 10.1679/aohc.69.23; Murakami K, 2010, EXP BIOL MED, V235, P805, DOI 10.1258/ebm.2010.009383; Nacamuli RP, 2005, PLAST RECONSTR SURG, V116, P1353, DOI 10.1097/01.prs.0000182223.85978.34; Newfeld SJ, 1999, GENETICS, V152, P783; Nguyen TQ, 2008, PHARM RES-DORDR, V25, P2416, DOI 10.1007/s11095-008-9548-9; Nie XG, 2005, CHINESE MED J-PEKING, V118, P1710; Nie XG, 2005, ANAT EMBRYOL, V210, P125, DOI 10.1007/s00429-005-0009-5; Onyia JE, 2005, J CELL BIOCHEM, V95, P403, DOI 10.1002/jcb.20438; Ovcharenko I, 2004, GENOME RES, V14, P472, DOI 10.1101/gr.2129504; Ovcharenko I, 2004, NUCLEIC ACIDS RES, V32, pW280, DOI 10.1093/nar/gkh355; Owen Thomas A., 2008, V455, P3, DOI 10.1007/978-1-59745-104-8_1; PARTRIDGE NC, 1980, FEBS LETT, V115, P139, DOI 10.1016/0014-5793(80)80744-7; Qin L, 2003, J BIOL CHEM, V278, P19723, DOI 10.1074/jbc.M212226200; REDDI AH, 1989, CONNECT TISSUE RES, V20, P303, DOI 10.3109/03008208909023901; Reese MG, 2001, COMPUT CHEM, V26, P51, DOI 10.1016/S0097-8485(01)00099-7; Roider HG, 2007, BIOINFORMATICS, V23, P134, DOI 10.1093/bioinformatics/btl565; Stewart A, 2010, J CELL PHYSIOL, V223, P658, DOI 10.1002/jcp.22064; Takahashi H, 1996, DEV DYNAM, V207, P439, DOI 10.1002/(SICI)1097-0177(199612)207:4<439::AID-AJA8>3.0.CO;2-I; Takao M, 1996, BIOCHEM BIOPH RES CO, V219, P656, DOI 10.1006/bbrc.1996.0289; Tamura K, 2011, MOL BIOL EVOLUTION; Thomadakis G, 1999, EUR J ORAL SCI, V107, P368, DOI 10.1046/j.0909-8836.1999.eos107508.x; Thomas-Chollier M, 2011, NAT PROTOC, V6, P1860, DOI 10.1038/nprot.2011.409; URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893; Wordinger RJ, 2007, INVEST OPHTH VIS SCI, V48, P1191, DOI 10.1167/iovs.06-0296; WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241; Yamamoto M, 2009, J CELL BIOL, V184, P323, DOI 10.1083/jcb.200808044; Yamashiro T, 2003, J DENT RES, V82, P172, DOI 10.1177/154405910308200305; Yao SM, 2010, CONNECT TISSUE RES, V51, P59, DOI 10.3109/03008200903019703; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478; Zhao GQ, 2003, GENESIS, V35, P43, DOI 10.1002/gene.10167; Zheng L, 2005, EUR J ORAL SCI, V113, P318, DOI 10.1111/j.1600-0722.2005.00226.x; Zode GS, 2009, GLIA, V57, P755, DOI 10.1002/glia.20803; Zoricic S, 2003, J ANAT, V202, P269, DOI 10.1046/j.1469-7580.2003.00158.x	74	10	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e57840	10.1371/journal.pone.0057840	http://dx.doi.org/10.1371/journal.pone.0057840			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451274	Green Published, gold			2022-12-25	WOS:000316658800119
J	DeCicco-Skinner, KL; Nolan, SJ; Deshpande, MM; Trovato, EL; Dempsey, TA; Wiest, JS				DeCicco-Skinner, Kathleen L.; Nolan, Sabrina J.; Deshpande, Monika M.; Trovato, Erika L.; Dempsey, Taylor A.; Wiest, Jonathan S.			Altered Prostanoid Signaling Contributes to Increased Skin Tumorigenesis in Tpl2 Knockout Mice	PLOS ONE			English	Article							PROSTAGLANDIN RECEPTOR EP2; ACTIVATED PROTEIN-KINASE; NF-KAPPA-B; MOUSE SKIN; CYCLOOXYGENASE-2 EXPRESSION; TUMOR PROGRESSION; NF-KAPPA-B1 P105; KERATINOCYTE PROLIFERATION; CANCER-CHEMOTHERAPY; COT ONCOGENE	Squamous cell carcinoma is the second most common form of skin cancer with the incidence expected to double over the next 20 years. Inflammation is believed to be a critical component in skin cancer progression. Therefore, understanding genes involved in the regulation of inflammatory pathways is vital to the design of targeted therapies. Numerous studies show cyclooxygenases (COXs) play an essential role in inflammation-associated cancers. Tpl2 (MAP3K8) is a protein kinase in the MAP Kinase signal transduction cascade. Previous research using a two-stage skin carcinogenesis model revealed that Tpl2(-/-) mice have significantly higher tumor incidence and inflammatory response than wild-type (WT) controls. The current study investigates whether cyclooxygenase-2 (COX-2) and COX-2- regulated prostaglandins and prostaglandin receptors drive the highly tumorigenic state of Tpl2(-/-) mice by investigating the relationship between Tpl2 and COX-2. Keratinocytes from newborn WT or Tpl2(-/-) mice were treated with 12-O-tetradecanoylphorbol-13-acetate (TPA) for various times over 24 hours. Western analysis revealed significant differences in COX-2 and COX-2 dependent prostanoids and prostanoid receptors. Additionally, in vivo experiments confirmed that COX-2 and COX-2 downstream factors were elevated in TPA-treated Tpl2(-/-) skin, as well as in papillomas from Tpl2(-/-) mice. Use of the selective COX-2 inhibitor Celecoxib showed the increased tumorigenesis in the Tpl2(-/-) mice to primarily be mediated through COX-2. These experiments illustrate COX-2 induction in the absence of Tpl2 may be responsible for the increased tumorigenesis found in Tpl2(-/-) mice. Defining the relationship between Tpl2 and COX-2 may lead to new ways to downregulate COX-2 through the modulation of Tpl2.	[DeCicco-Skinner, Kathleen L.; Nolan, Sabrina J.; Trovato, Erika L.; Dempsey, Taylor A.] American Univ, Dept Biol, Washington, DC 20016 USA; [Deshpande, Monika M.; Trovato, Erika L.; Wiest, Jonathan S.] NCI, Lab Canc Biol & Genet, NIH, Bethesda, MD 20892 USA	American University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Wiest, JS (corresponding author), NCI, Lab Canc Biol & Genet, NIH, Bethesda, MD 20892 USA.	jwiest@mail.nih.gov		DeCicco-Skinner, Kathleen/0000-0002-0256-5609	Intramural Research Program of the National Cancer Institute, National Institutes of Health; National Cancer Institute [UA5CA152907]; NATIONAL CANCER INSTITUTE [ZIABC011108] Funding Source: NIH RePORTER	Intramural Research Program of the National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported in part by the Intramural Research Program of the National Cancer Institute, National Institutes of Health and by grant number UA5CA152907 from the National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Abramovitch R, 2004, CANCER RES, V64, P1338, DOI 10.1158/0008-5472.CAN-03-2089; AIZU E, 1990, EUR J PHARMACOL, V182, P19; An KP, 2002, PHOTOCHEM PHOTOBIOL, V76, P73, DOI 10.1562/0031-8655(2002)076<0073:CEIMAH>2.0.CO;2; Ansari KM, 2008, MOL CANCER RES, V6, P1003, DOI 10.1158/1541-7786.MCR-07-2144; Ansari KM, 2007, CARCINOGENESIS, V28, P2063, DOI 10.1093/carcin/bgm011; AOKI M, 1991, ONCOGENE, V6, P1515; Beinke S, 2003, MOL CELL BIOL, V23, P4739, DOI 10.1128/MCB.23.14.4739-4752.2003; Belich MP, 1999, NATURE, V397, P363, DOI 10.1038/16946; Brouxhon S, 2007, J INVEST DERMATOL, V127, P439, DOI 10.1038/sj.jid.5700547; Cao Y, 2002, J CELL PHYSIOL, V190, P279, DOI 10.1002/jcp.10068; Ceci JD, 1997, GENE DEV, V11, P688, DOI 10.1101/gad.11.6.688; Chiariello M, 2000, MOL CELL BIOL, V20, P1747, DOI 10.1128/MCB.20.5.1747-1758.2000; Chun KS, 2004, BIOCHEM PHARMACOL, V68, P1089, DOI 10.1016/j.bcp.2004.05.031; Chun KS, 2009, CARCINOGENESIS, V30, P1620, DOI 10.1093/carcin/bgp168; Clark AM, 2004, GENE CHROMOSOME CANC, V41, P99, DOI 10.1002/gcc.20069; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Dajani EZ, 2008, J PHYSIOL PHARMACOL, V59, P117; de Visser KE, 2006, NAT REV CANCER, V6, P24, DOI 10.1038/nrc1782; DeCicco-Skinner KL, 2011, ONCOGENE, V30, P389, DOI 10.1038/onc.2010.447; Dempke W, 2001, J CANCER RES CLIN, V127, P411, DOI 10.1007/s004320000225; Fischer Susan M., 2002, Journal of Environmental Pathology Toxicology and Oncology, V21, P183; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; FURSTENBERGER G, 1978, BIOCHEM BIOPH RES CO, V84, P1103, DOI 10.1016/0006-291X(78)91697-2; Ghosh N, 2010, PHARMACOL REP, V62, P233, DOI 10.1016/S1734-1140(10)70262-0; Greenhough A, 2009, CARCINOGENESIS, V30, P377, DOI 10.1093/carcin/bgp014; Hussain M, 2012, PHARMACOL RES, V66, P7, DOI 10.1016/j.phrs.2012.02.003; Johannessen CM, 2010, NATURE, V468, P968, DOI 10.1038/nature09627; Khavari TA, 2007, CELL CYCLE, V6, P2928, DOI 10.4161/cc.6.23.4998; Klein T, 2007, BBA-MOL CELL RES, V1773, P1605, DOI 10.1016/j.bbamcr.2007.09.001; Lang V, 2004, MOL CELL BIOL, V24, P5235, DOI 10.1128/MCB.24.12.5235-5248.2004; Lee JL, 2005, J INVEST DERMATOL, V125, P818, DOI 10.1111/j.0022-202X.2005.23829.x; Lichti U, 2008, NAT PROTOC, V3, P799, DOI 10.1038/nprot.2008.50; Maldve RE, 2000, J LIPID RES, V41, P873; MIYOSHI J, 1991, MOL CELL BIOL, V11, P4088, DOI 10.1128/MCB.11.8.4088; Mueller MM, 2006, EUR J CANCER, V42, P735, DOI 10.1016/j.ejca.2006.01.014; Muller-Decker K, 2007, MOL CARCINOGEN, V46, P705, DOI 10.1002/mc.20326; Muller-Decker K, 2002, P NATL ACAD SCI USA, V99, P12483, DOI 10.1073/pnas.192323799; Muller-Decker K, 1998, MOL CARCINOGEN, V23, P36, DOI 10.1002/(SICI)1098-2744(199809)23:1<36::AID-MC5>3.0.CO;2-F; PATRIOTIS C, 1994, P NATL ACAD SCI USA, V91, P9755, DOI 10.1073/pnas.91.21.9755; PATRIOTIS C, 1993, P NATL ACAD SCI USA, V90, P2251, DOI 10.1073/pnas.90.6.2251; PENTLAND AP, 1986, J CLIN INVEST, V77, P246, DOI 10.1172/JCI112283; Rundhaug Joyce E, 2010, Cancers (Basel), V2, P436, DOI 10.3390/cancers2020436; Salmeron A, 1996, EMBO J, V15, P817, DOI 10.1002/j.1460-2075.1996.tb00417.x; Sourvinos G, 1999, ONCOGENE, V18, P4968, DOI 10.1038/sj.onc.1202891; Sung YM, 2006, ONCOGENE, V25, P5507, DOI 10.1038/sj.onc.1209538; Sung YM, 2005, CANCER RES, V65, P9304, DOI 10.1158/0008-5472.CAN-05-1015; Tiano HF, 2002, CANCER RES, V62, P3395; Trifan OC, 2003, J CELL MOL MED, V7, P207, DOI 10.1111/j.1582-4934.2003.tb00222.x; Tsatsanis C, 2000, INT J MOL MED, V5, P583; Tsatsanis C, 1998, ONCOGENE, V17, P2609, DOI 10.1038/sj.onc.1202460; Tsatsanis C, 2008, P NATL ACAD SCI USA, V105, P2987, DOI 10.1073/pnas.0708381104; Vougioukalaki M, 2011, CANCER LETT, V304, P80, DOI 10.1016/j.canlet.2011.02.004; Xie J, 2008, ADV EXP MED BIOL, V624, P241, DOI 10.1007/978-0-387-77574-6_19	53	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56212	10.1371/journal.pone.0056212	http://dx.doi.org/10.1371/journal.pone.0056212			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457529	gold, Green Submitted, Green Published			2022-12-25	WOS:000315603700027
J	Flouty, OE; Oya, H; Kawasaki, H; Reddy, CG; Fredericks, DC; Gibson-Corley, KN; Jeffery, ND; Gillies, GT; Howard, MA				Flouty, Oliver E.; Oya, Hiroyuki; Kawasaki, Hiroto; Reddy, Chandan G.; Fredericks, Douglas C.; Gibson-Corley, Katherine N.; Jeffery, Nicholas D.; Gillies, George T.; Howard, Matthew A., III			Intracranial Somatosensory Responses with Direct Spinal Cord Stimulation in Anesthetized Sheep	PLOS ONE			English	Article							BACK SURGERY SYNDROME; BRAIN-STEM IMPLANT; ELECTRICAL-STIMULATION; NONHUMAN-PRIMATES; PAIN; EFFICACY; COLUMNS; FIBERS; DORSAL	The efficacy of spinal cord stimulators is dependent on the ability of the device to functionally activate targeted structures within the spinal cord, while avoiding activation of near-by non-targeted structures. In theory, these objectives can best be achieved by delivering electrical stimuli directly to the surface of the spinal cord. The current experiments were performed to study the influence of different stimulating electrode positions on patterns of spinal cord electrophysiological activation. A custom-designed spinal cord neurostimulator was used to investigate the effects of lead position and stimulus amplitude on cortical electrophysiological responses to spinal cord stimulation. Brain recordings were obtained from subdural grids placed in four adult sheep. We systematically varied the position of the stimulating lead relative to the spinal cord and the voltage delivered by the device at each position, and then examined how these variables influenced cortical responses. A clear relationship was observed between voltage and electrode position, and the magnitude of high gamma-band oscillations. Direct stimulation of the dorsal column contralateral to the grid required the lowest voltage to evoke brain responses to spinal cord stimulation. Given the lower voltage thresholds associated with direct stimulation of the dorsal column, and its possible impact on the therapeutic window, this intradural modality may have particular clinical advantages over standard epidural techniques now in routine use.	[Flouty, Oliver E.; Oya, Hiroyuki; Kawasaki, Hiroto; Reddy, Chandan G.; Howard, Matthew A., III] Univ Iowa Hosp & Clin, Dept Neurosurg, Iowa City, IA 52242 USA; [Fredericks, Douglas C.] Univ Iowa Hosp & Clin, Dept Orthopaed Surg, Iowa City, IA 52242 USA; [Gibson-Corley, Katherine N.] Univ Iowa Hosp & Clin, Dept Pathol, Iowa City, IA 52242 USA; [Jeffery, Nicholas D.] Iowa State Univ, Dept Vet Clin Sci, Ames, IA USA; [Gillies, George T.] Univ Virginia, Dept Mech & Aerosp Engn, Charlottesville, VA USA	University of Iowa; University of Iowa; University of Iowa; Iowa State University; University of Virginia	Howard, MA (corresponding author), Univ Iowa Hosp & Clin, Dept Neurosurg, Iowa City, IA 52242 USA.	matthew-howard@uiowa.edu	flouty, oliver/AAO-2469-2021; Oya, Hiroyuki/Q-2989-2018	Oya, Hiroyuki/0000-0002-1733-5478; Kawasaki, Hiroto/0000-0002-7688-9171; Reddy, Chandan/0000-0001-5053-8085; Gibson-Corley, Katherine/0000-0002-1846-1580; Jeffery, Nick/0000-0002-9812-1788; Howard, Matthew/0000-0003-3935-8889				Cameron T, 2004, J NEUROSURG, V100, P254, DOI 10.3171/spi.2004.100.3.0254; Feirabend HKP, 2002, BRAIN, V125, P1137, DOI 10.1093/brain/awf111; Flouty O, 2012, PHYSIOL MEAS, V33, P2003, DOI 10.1088/0967-3334/33/12/2003; Gabriel C, 2009, PHYS MED BIOL, V54, P4863, DOI 10.1088/0031-9155/54/16/002; Gibson-Corley KN, 2012, J INVEST SURG, V25, P366, DOI 10.3109/08941939.2012.677967; Hamilton L, 2009, BMC VET RES, V4, DOI 10.1186/1746-6148-4-47; Hamilton L, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-77; Holsheimer J, 2002, NEUROMODULATION, V5, P25, DOI 10.1046/j.1525-1403.2002._2005.x; Howard MA, 2011, J APPL PHYS, V110, DOI 10.1063/1.3626469; Kishima H, 2010, NEUROIMAGE, V49, P2564, DOI 10.1016/j.neuroimage.2009.10.054; Kumar K, 2007, PAIN, V132, P179, DOI 10.1016/j.pain.2007.07.028; Kumar K, 2009, J NEUROSURG-SPINE, V10, P564, DOI 10.3171/2009.2.SPINE0865; KUPERS RC, 1994, PAIN, V56, P211, DOI 10.1016/0304-3959(94)90096-5; LINTHICUM FH, 1991, AM J OTOL, V12, P245; Manrique M, 2000, ANN OTO RHINOL LARYN, V109, P163, DOI 10.1177/000348940010900210; Manrique M, 2008, ANN OTO RHINOL LARYN, V117, P212, DOI 10.1177/000348940811700309; MELZACK R, 1965, SCIENCE, V150, P971, DOI 10.1126/science.150.3699.971; Meyerson Bjorn A, 2006, J Pain Symptom Manage, V31, pS6, DOI 10.1016/j.jpainsymman.2005.12.009; Nourski KV, 2009, J NEUROSCI, V29, P15564, DOI 10.1523/JNEUROSCI.3065-09.2009; Otto SR, 2012, LARYNGOSCOPE, V122, P645, DOI 10.1002/lary.22491; Oya H., 2012, Journal of Medical Engineering & Technology, V36, P169, DOI 10.3109/03091902.2011.649884; SHEALY CN, 1967, ANESTH ANAL CURR RES, V46, P489; SMITH MC, 1984, BRAIN, V107, P671, DOI 10.1093/brain/107.3.671; Stancak A, 2008, EUR J PAIN, V12, P137, DOI 10.1016/j.ejpain.2007.03.003; SUTTON D, 1984, ARCH OTOLARYNGOL, V110, P164; THOMSON DJ, 1982, P IEEE, V70, P1055, DOI 10.1109/PROC.1982.12433; Turner JA, 2010, PAIN, V148, P14, DOI 10.1016/j.pain.2009.08.014; Ulink NCC, 1999, NEURMODULATION, V2, P33; Utz M, 2011, J APPL PHYS, V110; WALL PD, 1960, J NEUROPHYSIOL, V23, P197, DOI 10.1152/jn.1960.23.2.197; Wilson S., 2012, Journal of Medical Engineering & Technology, V36, P22, DOI 10.3109/03091902.2011.632061; Xu J, 1997, HEARING RES, V105, P1, DOI 10.1016/S0378-5955(96)00193-1	32	19	25	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56266	10.1371/journal.pone.0056266	http://dx.doi.org/10.1371/journal.pone.0056266			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457542	Green Published, Green Submitted, gold			2022-12-25	WOS:000315603700038
J	Radonjic, M; Wielinga, PY; Wopereis, S; Kelder, T; Goelela, VS; Verschuren, L; Toet, K; van Duyvenvoorde, W; van der Vat, BV; Stroeve, JHM; Cnubben, N; Kooistra, T; van Ommen, B; Kleemann, R				Radonjic, Marijana; Wielinga, Peter Y.; Wopereis, Suzan; Kelder, Thomas; Goelela, Varshna S.; Verschuren, Lars; Toet, Karin; van Duyvenvoorde, Wim; van der Vat, Bianca van der Werff; Stroeve, Johanna H. M.; Cnubben, Nicole; Kooistra, Teake; van Ommen, Ben; Kleemann, Robert			Differential Effects of Drug Interventions and Dietary Lifestyle in Developing Type 2 Diabetes and Complications: A Systems Biology Analysis in LDLr-/- Mice	PLOS ONE			English	Article							GLUCOSE-TOLERANCE; GLYCEMIC CONTROL; ATHEROSCLEROSIS; ROSIGLITAZONE; PROGRESSION; METFORMIN; MICROALBUMINURIA; INFLAMMATION; PREVENTION; REGRESSION	Excess caloric intake leads to metabolic overload and is associated with development of type 2 diabetes (T2DM). Current disease management concentrates on risk factors of the disease such as blood glucose, however with limited success. We hypothesize that normalizing blood glucose levels by itself is insufficient to reduce the development of T2DM and complications, and that removal of the metabolic overload with dietary interventions may be more efficacious. We explored the efficacy and systems effects of pharmaceutical interventions versus dietary lifestyle intervention (DLI) in developing T2DM and complications. To mimic the situation in humans, high fat diet (HFD)-fed LDLr-/- mice with already established disease phenotype were treated with ten different drugs mixed into HFD or subjected to DLI (switch to low-fat chow), for 7 weeks. Interventions were compared to untreated reference mice kept on HFD or chow only. Although most of the drugs improved HFD-induced hyperglycemia, drugs only partially affected other risk factors and also had limited effect on disease progression towards microalbuminuria, hepatosteatosis and atherosclerosis. By contrast, DLI normalized T2DM risk factors, fully reversed hepatosteatosis and microalbuminuria, and tended to attenuate atherogenesis. The comprehensive beneficial effect of DLI was reflected by normalized metabolite profiles in plasma and liver. Analysis of disease pathways in liver confirmed reversion of the metabolic distortions with DLI. This study demonstrates that the pathogenesis of T2DM towards complications is reversible with DLI and highlights the differential effects of current pharmacotherapies and their limitation to resolve the disease.	[Radonjic, Marijana; Wopereis, Suzan; Kelder, Thomas; Goelela, Varshna S.; Verschuren, Lars; van der Vat, Bianca van der Werff; Stroeve, Johanna H. M.; Cnubben, Nicole; van Ommen, Ben] TNO, NL-3700 AJ Zeist, Netherlands; [Wielinga, Peter Y.; Toet, Karin; van Duyvenvoorde, Wim; Kooistra, Teake; Kleemann, Robert] TNO, Leiden, Netherlands	Netherlands Organization Applied Science Research; Netherlands Organization Applied Science Research	Wielinga, PY (corresponding author), TNO, Leiden, Netherlands.	peter.wielinga@tno.nl						Abbas Aamer, 2012, Cardiovascular & Hematological Agents in Medicinal Chemistry, V10, P124; Ansquer JC, 2005, AM J KIDNEY DIS, V45, P485, DOI 10.1053/j.ajkd.2004.11.004; Balvers MGJ, 2012, METABOLOMICS, V8, P1130, DOI 10.1007/s11306-012-0421-9; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dluhy RG, 2008, NEW ENGL J MED, V358, P2630, DOI 10.1056/NEJMe0804182; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Dunkley AJ, 2012, DIABETES OBES METAB; Engin F, 2010, DIABETES OBES METAB, V12, P108, DOI 10.1111/j.1463-1326.2010.01282.x; Friedland SN, 2012, AM J MED, V125, P126, DOI 10.1016/j.amjmed.2011.08.025; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Gijbels MJJ, 1999, ATHEROSCLEROSIS, V143, P15, DOI 10.1016/S0021-9150(98)00263-9; Goldberg RB, 2009, DIABETES CARE, V32, P726, DOI 10.2337/dc08-0494; Grundy SM, 2009, NAT REV DRUG DISCOV, V8, P341, DOI 10.1038/nrd2894; Gupte AA, 2010, HEPATOLOGY, V52, P2001, DOI 10.1002/hep.23941; Hansson GK, 2011, NAT IMMUNOL, V12, P204, DOI 10.1038/ni.2001; Hotamisligil GS, 2008, INT J OBESITY, V32, pS52, DOI 10.1038/ijo.2008.238; Ismail-Beigi F, 2012, NEW ENGL J MED, V366, P1319, DOI 10.1056/NEJMcp1013127; Kahn SE, 2006, NEW ENGL J MED, V355, P2427, DOI 10.1056/NEJMoa066224; Katz A, 2000, J CLIN ENDOCR METAB, V85, P2402, DOI 10.1210/jc.85.7.2402; Kleemann R, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-125; Koek MM, 2011, METABOLOMICS, V7, P307, DOI 10.1007/s11306-010-0254-3; Kooistra T, 2006, ARTERIOSCL THROM VAS, V26, P2322, DOI 10.1161/01.ATV.0000238348.05028.14; Krentz AJ, 2005, DRUGS, V65, P385, DOI 10.2165/00003495-200565030-00005; Little PJ, 2011, PHARMACOL THERAPEUT, V131, P255, DOI 10.1016/j.pharmthera.2011.04.001; Nolan CJ, 2011, LANCET, V378, P169, DOI 10.1016/S0140-6736(11)60614-4; Peng DC, 2010, ATHEROSCLEROSIS, V208, P126, DOI 10.1016/j.atherosclerosis.2009.07.016; Peng D, 2009, ATHEROSCLEROSIS, V203, P59, DOI 10.1016/j.atherosclerosis.2008.05.058; Pistrosch F, 2005, DIABETES, V54, P2206, DOI 10.2337/diabetes.54.7.2206; Radonjic M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006646; Rayner KJ, 2011, J CLIN INVEST, V121, P2921, DOI 10.1172/JCI57275; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Remedi MS, 2008, PLOS MED, V5, P1473, DOI 10.1371/journal.pmed.0050206; Riedel AA, 2007, PHARMACOTHERAPY, V27, P1102, DOI 10.1592/phco.27.8.1102; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Terasaka N, 2003, FEBS LETT, V536, P6, DOI 10.1016/S0014-5793(02)03578-0; Terry T, 2012, CURR CARDIOL REP, V14, DOI 10.1007/s11886-011-0238-6; Tolman KG, 2011, EXPERT OPIN DRUG SAF, V10, P419, DOI 10.1517/14740338.2011.534982; Turnbull FM, 2009, DIABETOLOGIA, V52, P2288, DOI 10.1007/s00125-009-1470-0; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Verschuren L, 2009, J LIPID RES, V50, P301, DOI 10.1194/jlr.M800374-JLR200; Whiting DR, 2011, DIABETES RES CLIN PR, V94, P311, DOI 10.1016/j.diabres.2011.10.029; Wielinga PY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018432; Wierzbicki AS, 2006, INT J CLIN PRACT, V60, P442, DOI 10.1111/j.1368-5031.2006.00882.x; Wopereis S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004525; Yudkin JS, 2010, DIABETOLOGIA, V53, P2079, DOI 10.1007/s00125-010-1864-z; Yudkin JS, 2011, LANCET, V377, P1220, DOI 10.1016/S0140-6736(10)61112-9	46	19	20	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56122	10.1371/journal.pone.0056122	http://dx.doi.org/10.1371/journal.pone.0056122			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457508	Green Submitted, Green Published, gold			2022-12-25	WOS:000315603700022
J	Taki, H; Okochi, I; Okabe, K; Inoue, T; Goto, H; Matsumura, T; Makino, S				Taki, Hisatomo; Okochi, Isamu; Okabe, Kimiko; Inoue, Takenari; Goto, Hideaki; Matsumura, Takeshi; Makino, Shun'ichi			Succession Influences Wild Bees in a Temperate Forest Landscape: The Value of Early Successional Stages in Naturally Regenerated and Planted Forests	PLOS ONE			English	Article							FORAGING RANGE; POLLINATION; COMMUNITIES; ABUNDANCE; AREA; CONSERVATION; BIODIVERSITY; HYMENOPTERA; DIVERSITY; HABITATS	In many temperate terrestrial forest ecosystems, both natural human disturbances drive the reestablishment of forests. Succession in plant communities, in addition to reforestation following the creation of open sites through harvesting or natural disturbances, can affect forest faunal assemblages. Wild bees perform an important ecosystem function in human-altered and natural or seminatural ecosystems, as they are essential pollinators for both crops and wild flowering plants. To maintain high abundance and species richness for pollination services, it is important to conserve and create seminatural and natural land cover with optimal successional stages for wild bees. We examined the effects of forest succession on wild bees. In particular, we evaluated the importance of early successional stages for bees, which has been suspected but not previously demonstrated. A range of successional stages, between 1 and 178 years old, were examined in naturally regenerated and planted forests. In total 4465 wild bee individuals, representing 113 species, were captured. Results for total bees, solitary bees, and cleptoparasitic bees in both naturally regenerated and planted conifer forests indicated a higher abundance and species richness in the early successional stages. However, higher abundance and species richness of social bees in naturally regenerated forest were observed as the successional stages progressed, whereas the abundance of social bees in conifer planted forest showed a concave-shaped relationship when plotted. The results suggest that early successional stages of both naturally regenerated and conifer planted forest maintain a high abundance and species richness of solitary bees and their cleptoparasitic bees, although social bees respond differently in the early successional stages. This may imply that, in some cases, active forest stand management policies, such as the clear-cutting of planted forests for timber production, would create early successional habitats, leading to significant positive effects for bees in general.	[Taki, Hisatomo; Okabe, Kimiko] Forestry & Forest Prod Res Inst, Dept Forest Entomol, Tsukuba, Ibaraki 305, Japan; [Okochi, Isamu; Makino, Shun'ichi] Forestry & Forest Prod Res Inst, Tsukuba, Ibaraki 305, Japan; [Inoue, Takenari] Forestry & Forest Prod Res Inst, Hachioji, Tokyo, Japan; [Goto, Hideaki] Forestry & Forest Prod Res Inst, Kyushu Res Ctr, Kumamoto, Japan	Forestry & Forest Products Research Institute - Japan; Forestry & Forest Products Research Institute - Japan; Forestry & Forest Products Research Institute - Japan; Forestry & Forest Products Research Institute - Japan	Taki, H (corresponding author), Forestry & Forest Prod Res Inst, Dept Forest Entomol, Tsukuba, Ibaraki 305, Japan.	htaki@affrc.go.jp			Research Institute for Humanity and Nature; Global Environment Research Fund of the Ministry of the Environment, Japan [S-9]	Research Institute for Humanity and Nature; Global Environment Research Fund of the Ministry of the Environment, Japan	This study was funded as a project of the Research Institute for Humanity and Nature and was also supported in part by the Global Environment Research Fund (S-9) of the Ministry of the Environment, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BANASZAK J, 1992, AGR ECOSYST ENVIRON, V40, P179, DOI 10.1016/0167-8809(92)90091-O; Chan KMA, 2006, PLOS BIOL, V4, P2138, DOI 10.1371/journal.pbio.0040379; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; CORBET SA, 1991, BEE WORLD, V72, P47, DOI 10.1080/0005772X.1991.11099079; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; DYER FC, 1991, BEHAV ECOL SOCIOBIOL, V28, P227, DOI 10.1007/BF00175094; FAO, 2007, STAT WORLDS FOR 2007; Fontaine JB, 2009, FOREST ECOL MANAG, V257, P1496, DOI 10.1016/j.foreco.2008.12.030; Fujimori T, 2001, ECOLOGICAL SILVICULT; Garibaldi LA, 2011, ECOL LETT, V14, P1062, DOI 10.1111/j.1461-0248.2011.01669.x; Gathmann A, 2002, J ANIM ECOL, V71, P757, DOI 10.1046/j.1365-2656.2002.00641.x; Greenleaf SS, 2007, OECOLOGIA, V153, P589, DOI 10.1007/s00442-007-0752-9; GRIME JP, 1973, NATURE, V242, P344, DOI 10.1038/242344a0; Hirata A, 2011, FOREST ECOL MANAG, V262, P1280, DOI 10.1016/j.foreco.2011.06.025; Inoue Takenari, 2005, Japanese Journal of Entomology (New Series), V8, P43; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Klein AM, 2012, J APPL ECOL, V49, P723, DOI 10.1111/j.1365-2664.2012.02144.x; Klein AM, 2003, AM J BOT, V90, P153, DOI 10.3732/ajb.90.1.153; Knight ME, 2005, MOL ECOL, V14, P1811, DOI 10.1111/j.1365-294X.2005.02540.x; Krauss J, 2009, J APPL ECOL, V46, P194, DOI 10.1111/j.1365-2664.2008.01582.x; Kremen C, 2004, ECOL LETT, V7, P1109, DOI 10.1111/j.1461-0248.2004.00662.x; Makino S, 2006, ENVIRON MONIT ASSESS, V120, P477, DOI 10.1007/s10661-005-9074-8; Makino S, 2007, ECOL RES, V22, P372, DOI 10.1007/s11284-007-0359-y; Michener C.D., 2007, BEES WORLD, Vsecond; Mizoguchi Y, 2002, ECOL STU AN, V158, P11; Morandin LA, 2005, ECOL APPL, V15, P871, DOI 10.1890/03-5271; NAGY A, 1988, INT TRADE FOREST PRO; Oliver C.D., 1996, FOREST STAND DYNAMIC; Ollerton J, 2011, OIKOS, V120, P321, DOI 10.1111/j.1600-0706.2010.18644.x; OSBORNE JL, 1991, BEE WORLD, V72, P99, DOI 10.1080/0005772X.1991.11099088; Osborne JL, 1999, J APPL ECOL, V36, P519, DOI 10.1046/j.1365-2664.1999.00428.x; Osborne JL, 2008, J ANIM ECOL, V77, P406, DOI 10.1111/j.1365-2656.2007.01333.x; PICKETT STA, 1978, BIOL CONSERV, V13, P27, DOI 10.1016/0006-3207(78)90016-2; R Development Core Team, 2012, R LANG ENV STAT COMP; SAKAGAMI S F, 1977, Journal of the Faculty of Science Hokkaido University Series VI Zoology, V21, P92; Sasaki M, 1999, WONDERS JAPANESE HON; Sheffield C.S., 2008, CAN ENTOMOL, V140, P235, DOI 10.4039/n07-058; Slaa EJ, 2006, APIDOLOGIE, V37, P293, DOI 10.1051/apido:2006022; Spies Thomas A., 1999, P95, DOI 10.1017/CBO9780511613029.006; *STAT DEP, 2008, 82 STAT YB MIN AGR F; Steffan-Dewenter I, 2002, ECOLOGY, V83, P1421, DOI 10.1890/0012-9658(2002)083[1421:SDEOLC]2.0.CO;2; Steffan-Dewenter I, 2001, ECOGRAPHY, V24, P83, DOI 10.1034/j.1600-0587.2001.240110.x; Swanson ME, 2011, FRONT ECOL ENVIRON, V9, P117, DOI 10.1890/090157; Taki H, 2007, LANDSCAPE ECOL, V22, P1575, DOI 10.1007/s10980-007-9153-z; Taki H, 2011, SCI REP-UK, V1, DOI 10.1038/srep00132; Taki H, 2010, BASIC APPL ECOL, V11, P594, DOI 10.1016/j.baae.2010.08.004; Taki H, 2009, ANN APPL BIOL, V155, P121, DOI 10.1111/j.1744-7348.2009.00326.x; Winfree R, 2007, ECOL LETT, V10, P1105, DOI 10.1111/j.1461-0248.2007.01110.x; Winfree R, 2007, CONSERV BIOL, V21, P213, DOI 10.1111/j.1523-1739.2006.00574.x; Winfree R, 2011, ANNU REV ECOL EVOL S, V42, P1, DOI 10.1146/annurev-ecolsys-102710-145042; Winfree R, 2010, ANN NY ACAD SCI, V1195, P169, DOI 10.1111/j.1749-6632.2010.05449.x; Wolf S, 2008, APIDOLOGIE, V39, P419, DOI 10.1051/apido:2008020; Yamaura Y, 2012, BIODIVERS CONSERV, V21, P3107, DOI 10.1007/s10531-012-0357-4; Yamaura Y, 2012, BIODIVERS CONSERV, V21, P1365, DOI 10.1007/s10531-012-0244-z; Yamaura Y, 2009, BIOL CONSERV, V142, P2155, DOI 10.1016/j.biocon.2009.04.015; Yoshida T, 2000, REARING METHOD ECOLO; Zurbuchen A, 2010, BIOL CONSERV, V143, P669, DOI 10.1016/j.biocon.2009.12.003	57	51	55	3	102	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56678	10.1371/journal.pone.0056678	http://dx.doi.org/10.1371/journal.pone.0056678			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457602	gold, Green Published, Green Submitted			2022-12-25	WOS:000315603700071
J	Buc, E; Dubois, D; Sauvanet, P; Raisch, J; Delmas, J; Darfeuille-Michaud, A; Pezet, D; Bonnet, R				Buc, Emmanuel; Dubois, Damien; Sauvanet, Pierre; Raisch, Jennifer; Delmas, Julien; Darfeuille-Michaud, Arlette; Pezet, Denis; Bonnet, Richard			High Prevalence of Mucosa-Associated E-coli Producing Cyclomodulin and Genotoxin in Colon Cancer	PLOS ONE			English	Article							DISTENDING TOXIN CDT; CROHNS-DISEASE; CELL-CYCLE; PHYLOGENETIC DISTRIBUTION; COLORECTAL-CANCER; SHIGA TOXIN; IN-VITRO; DNA; EXPRESSION; PROMOTES	Some Escherichia coli strains produce toxins designated cyclomodulins (CMs) which interfere with the eukaryotic cell cycle of host cells, suggesting a possible link between these bacteria and cancers. There are relatively few data available concerning the colonization of colon tumors by cyclomodulin- and genotoxic-producing E. coli. We did a qualitative and phylogenetic analysis of mucosa-associated E. coli harboring cyclomodulin-encoding genes from 38 patients with colorectal cancer (CRC) and 31 with diverticulosis. The functionality of these genes was investigated on cell cultures and the genotoxic activity of strains devoid of known CM-encoding gene was investigated. Results showed a higher prevalence of B2 phylogroup E. coli harboring the colibatin-producing genes in biopsies of patients with CRC (55.3%) than in those of patients with diverticulosis (19.3%), (p<0.01). Likewise, a higher prevalence of B2 E. coli harboring the CNF1-encoding genes in biopsies of patients with CRC (39.5%) than in those of patients with diverticulosis (12.9%), (p = 0.01). Functional analysis revealed that the majority of these genes were functional. Analysis of the ability of E. coli to adhere to intestinal epithelial cells Int-407 indicated that highly adherent E. coli strains mostly belonged to A and D phylogroups, whatever the origin of the strains (CRC or diverticulosis), and that most E. coli strains belonging to B2 phylogroup displayed very low levels of adhesion. In addition, 27.6% (n = 21/76) E. coli strains devoid of known cyclomodulin-encoding genes induced DNA damage in vitro, as assessed by the comet assay. In contrast to cyclomodulin-producing E. coli, these strains mainly belonged to A or D E. coli phylogroups, and exhibited a non significant difference in the distribution of CRC and diverticulosis specimens (22% versus 32.5%, p = 0.91). In conclusion, cyclomodulin-producing E. coli belonging mostly to B2 phylogroup colonize the colonic mucosa of patients with CRC.	[Buc, Emmanuel; Dubois, Damien; Sauvanet, Pierre; Raisch, Jennifer; Delmas, Julien; Darfeuille-Michaud, Arlette; Pezet, Denis; Bonnet, Richard] Univ Clermont Ferrand 2, Univ Auvergne, INSERM, UMR 1071, Clermont Ferrand, France; [Buc, Emmanuel; Dubois, Damien; Sauvanet, Pierre; Raisch, Jennifer; Delmas, Julien; Darfeuille-Michaud, Arlette; Pezet, Denis; Bonnet, Richard] INRA, USC 2018, Clermont Ferrand, France; [Dubois, Damien; Delmas, Julien; Darfeuille-Michaud, Arlette; Bonnet, Richard] CHU Clermont Ferrand, Serv Bacteriol, Clermont Ferrand, France; [Buc, Emmanuel; Sauvanet, Pierre; Pezet, Denis] CHU Clermont Ferrand, Serv Chirurg Digest, Clermont Ferrand, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Clermont Auvergne (UCA); INRAE; CHU Clermont Ferrand; CHU Clermont Ferrand	Bonnet, R (corresponding author), Univ Clermont Ferrand 2, Univ Auvergne, INSERM, UMR 1071, Clermont Ferrand, France.	rbonnet@chu-clermontferrand.fr	Bonnet, Richard/C-8544-2015; Pezet, Denis/I-4423-2017	Pezet, Denis/0000-0001-9416-2876	Ministere Francais de l'Education Nationale, de la Recherche et de la Technologie, l'Institut national de la sante et de la recherche medicale (Inserm) [U1071]; l'Institut National de la Recherche Agronomique [USC-2018]; la Ligue contre le cancer	Ministere Francais de l'Education Nationale, de la Recherche et de la Technologie, l'Institut national de la sante et de la recherche medicale (Inserm); l'Institut National de la Recherche Agronomique; la Ligue contre le cancer(Ligue nationale contre le cancer)	This work was supported by the Ministere Francais de l'Education Nationale, de la Recherche et de la Technologie, l'Institut national de la sante et de la recherche medicale (Inserm U1071), l'Institut National de la Recherche Agronomique (USC-2018) and la Ligue contre le cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An Y, 2008, LUNG CANCER, V59, P164, DOI 10.1016/j.lungcan.2007.08.003; Arthur JC, 2012, SCIENCE, V338, P120, DOI 10.1126/science.1224820; Arthur JC, 2012, GASTROENTEROLOGY, V142, pS639; Barnich N, 2007, J CLIN INVEST, V117, P1566, DOI 10.1172/JCI30504; BARTHOLD SW, 1977, CANCER RES, V37, P4352; Bidet P, 2007, APPL ENVIRON MICROB, V73, P2373, DOI 10.1128/AEM.02341-06; Bielaszewska M, 2004, INFECT IMMUN, V72, P1812, DOI 10.1128/IAI.72.3.1812-1816.2004; BLEDAY R, 1993, DIS COLON RECTUM, V36, P844, DOI 10.1007/BF02047381; Boudeau J, 2001, MOL MICROBIOL, V39, P1272, DOI 10.1046/j.1365-2958.2001.02315.x; Bronowski C, 2008, MICROBIOL-SGM, V154, P571, DOI 10.1099/mic.0.2007/013086-0; Carvalho FA, 2009, J EXP MED, V206, P2179, DOI 10.1084/jem.20090741; Chassaing B, 2011, GASTROENTEROLOGY, V140, P1720, DOI 10.1053/j.gastro.2011.01.054; Clermont O, 2000, APPL ENVIRON MICROB, V66, P4555, DOI 10.1128/AEM.66.10.4555-4558.2000; Collins D, 2011, LANCET ONCOL, V12, P504, DOI 10.1016/S1470-2045(10)70186-8; Croxen MA, 2010, NAT REV MICROBIOL, V8, P26, DOI 10.1038/nrmicro2265; Cuevas-Ramos G, 2010, P NATL ACAD SCI USA, V107, P11537, DOI 10.1073/pnas.1001261107; De Rycke J, 1999, VET RES, V30, P221; De Rycke J, 2001, FEMS MICROBIOL LETT, V203, P141, DOI 10.1016/S0378-1097(01)00344-5; Dubois D, 2010, J CLIN MICROBIOL, V48, P2122, DOI 10.1128/JCM.02365-09; Duriez P, 2001, MICROBIOL-SGM, V147, P1671, DOI 10.1099/00221287-147-6-1671; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Escobar-Paramo P, 2004, MOL PHYLOGENET EVOL, V30, P243, DOI 10.1016/S1055-7903(03)00181-7; Escobar-Paramo P, 2004, MOL BIOL EVOL, V21, P1085, DOI 10.1093/molbev/msh118; Fiorentini C, 1998, EXP CELL RES, V242, P341, DOI 10.1006/excr.1998.4057; Fox JG, 2010, GUT, V59, P88, DOI 10.1136/gut.2009.183749; Ge ZM, 2008, CELL MICROBIOL, V10, P1599, DOI 10.1111/j.1462-5822.2008.01173.x; Ge ZM, 2007, CELL MICROBIOL, V9, P2070, DOI 10.1111/j.1462-5822.2007.00939.x; Gervaz P, 2002, SURGERY, V131, P190, DOI 10.1067/msy.2002.119816; Green GL, 2006, J APPL MICROBIOL, V100, P460, DOI 10.1111/j.1365-2672.2005.02783.x; Half E, 2009, ORPHANET J RARE DIS, V4, DOI 10.1186/1750-1172-4-22; HERZER PJ, 1990, J BACTERIOL, V172, P6175, DOI 10.1128/jb.172.11.6175-6181.1990; Hirata H, 2008, J UROLOGY, V179, P2020, DOI 10.1016/j.juro.2008.01.009; Hopkins AM, 2003, J CELL SCI, V116, P725, DOI 10.1242/jcs.00300; Jantscheff P, 2003, J CLIN ONCOL, V21, P3638, DOI 10.1200/JCO.2003.55.135; Johnson JR, 2008, J CLIN MICROBIOL, V46, P3906, DOI 10.1128/JCM.00949-08; Johnson TJ, 2010, VET MICROBIOL, V144, P100, DOI 10.1016/j.vetmic.2009.12.022; Jubelin G, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001128; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Karsa LV, 2010, BEST PRACT RES CL GA, V24, P381, DOI 10.1016/j.bpg.2010.06.004; Koessler T, 2008, GUT, V57, P1097, DOI 10.1136/gut.2007.137265; Kotlowski R, 2007, GUT, V56, P669, DOI 10.1136/gut.2006.099796; Kwak EL, 2007, CLIN COLORECTAL CANC, V6, P340, DOI 10.3816/CCC.2007.n.002; Lecuit M, 2004, NEW ENGL J MED, V350, P239, DOI 10.1056/NEJMoa031887; Lemonnier M, 2007, FEMS MICROBIOL REV, V31, P515, DOI 10.1111/j.1574-6976.2007.00078.x; Leser TD, 2009, ENVIRON MICROBIOL, V11, P2194, DOI 10.1111/j.1462-2920.2009.01941.x; Loukiadis E, 2008, J BACTERIOL, V190, P275, DOI 10.1128/JB.00844-07; Maddocks ODK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005517; Malorni W, 2006, FASEB J, V20, P606, DOI 10.1096/fj.05-4706hyp; Marches O, 2003, MOL MICROBIOL, V50, P1553, DOI 10.1046/j.1365-2958.2003.03821.x; Martin HM, 2004, GASTROENTEROLOGY, V127, P80, DOI 10.1053/j.gastro.2004.03.054; Nagamine CM, 2008, INFECT IMMUN, V76, P2758, DOI 10.1128/IAI.01604-07; Nagamine CM, 2008, INT J CANCER, V122, P832, DOI 10.1002/ijc.23175; Newman JV, 2001, J INFECT DIS, V184, P227, DOI 10.1086/321998; Nougayrede JP, 2006, SCIENCE, V313, P848, DOI 10.1126/science.1127059; Nougayrede JP, 2005, TRENDS MICROBIOL, V13, P103, DOI 10.1016/j.tim.2005.01.002; Orden JA, 2007, INT MICROBIOL, V10, P47, DOI 10.2436/20.1501.01.7; Orth D, 2007, DIAGN MICR INFEC DIS, V59, P235, DOI 10.1016/j.diagmicrobio.2007.04.013; Pandey M, 2003, J CLIN MICROBIOL, V41, P5277, DOI 10.1128/JCM.41.11.5277-5281.2003; Peres SY, 1997, MOL MICROBIOL, V24, P1095, DOI 10.1046/j.1365-2958.1997.4181785.x; Picard B, 1999, INFECT IMMUN, V67, P546, DOI 10.1128/IAI.67.2.546-553.1999; Poxton IR, 1997, CLIN INFECT DIS, V25, pS111, DOI 10.1086/516189; SCHAUER DB, 1995, J CLIN MICROBIOL, V33, P2064, DOI 10.1128/JCM.33.8.2064-2068.1995; Scholzel S, 2000, AM J PATHOL, V156, P595, DOI 10.1016/S0002-9440(10)64764-5; Sert V, 1999, ONCOGENE, V18, P6296, DOI 10.1038/sj.onc.1203007; Swidsinski A, 1998, GASTROENTEROLOGY, V115, P281, DOI 10.1016/S0016-5085(98)70194-5; Taieb F, 2006, CELL MICROBIOL, V8, P1910, DOI 10.1111/j.1462-5822.2006.00757.x; VERSALOVIC J, 1991, NUCLEIC ACIDS RES, V19, P6823, DOI 10.1093/nar/19.24.6823; Vogelmann R, 2007, CURR OPIN MICROBIOL, V10, P76, DOI 10.1016/j.mib.2006.12.004; WANG G, 1993, NUCLEIC ACIDS RES, V21, P5930, DOI 10.1093/nar/21.25.5930; Wood RD, 2001, SCIENCE, V291, P1284, DOI 10.1126/science.1056154; Wu SG, 2003, GASTROENTEROLOGY, V124, P392, DOI 10.1053/gast.2003.50047; Wu SG, 2009, NAT MED, V15, P1016, DOI 10.1038/nm.2015; Zhang LX, 2002, J CLIN MICROBIOL, V40, P3951, DOI 10.1128/JCM.40.11.3951-3955.2002	73	290	295	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56964	10.1371/journal.pone.0056964	http://dx.doi.org/10.1371/journal.pone.0056964			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457644	Green Published, gold			2022-12-25	WOS:000315602700103
J	Choi, YL; Sun, JM; Cho, J; Rampal, S; Han, J; Parasuraman, B; Guallar, E; Lee, G; Lee, J; Shim, YM				Choi, Yoon-La; Sun, Jong-Mu; Cho, Juhee; Rampal, Sanjay; Han, Joungho; Parasuraman, Bhash; Guallar, Eliseo; Lee, Genehee; Lee, Jeeyun; Shim, Young Mog			EGFR Mutation Testing in Patients with Advanced Non-Small Cell Lung Cancer: A Comprehensive Evaluation of Real-World Practice in an East Asian Tertiary Hospital	PLOS ONE			English	Article							FACTOR RECEPTOR MUTATIONS; PULMONARY ADENOCARCINOMA; GEFITINIB; CHEMOTHERAPY; GENE	Introduction: Guidelines for management of non-small cell lung cancer (NSCLC) strongly recommend EGFR mutation testing. These recommendations are particularly relevant in Asians that have higher EGFR mutation prevalence. This study aims to explore current testing practices, logistics of testing, types of EGFR mutation, and prevalence of EGFR mutations in patients with advanced NSCLC in a large comprehensive cancer center in Korea. Methods: Our retrospective cohort included 1,503 NSCLC patients aged >= 18 years, with stage IIIB/IV disease, who attended the Samsung Medical Center in Seoul, Korea, from January 2007 through July 2010. Trained oncology nurses reviewed and abstracted data from electronic medical records. Results: This cohort had a mean age (SD) of 59.6 (11.1) years, 62.7% were males, and 52.9% never-smokers. The most common NSCLC histological types were adenocarcinoma (70.5%) and squamous cell carcinoma (18.0%). Overall, 39.5% of patients were tested for EGFR mutations. The proportion of patients undergoing EGFR testing during January 2007 through July 2008, August 2008 through September 2009, and October 2009 through July 2010 were 23.3%, 38.3%, and 63.5%, respectively (P < 0.001). The median time elapsed between cancer diagnoses and receiving EGFR testing results was 21 days. EGFR testing was most frequently ordered by oncologists (57.7%), pulmonologists (31.9%), and thoracic surgeons (6.6%). EGFR testing was more commonly requested for women, younger patients, stage IV disease, non-smokers, and adenocarcinoma histology. Of 586 cases successfully tested for EGFR mutations, 209 (35.7%) were positive, including 118 cases with exon 19 deletions and 62 with L858R mutations. EGFR mutation positive patients were more likely to be female, never-smokers, never-drinkers and to have adenocarcinoma. Conclusions: In a large cancer center in Korea, the proportion of EGFR testing increased from 2007 through 2010. The high frequency of EGFR mutation positive cases warrants the need for generalized testing in Asian NSCLC patients.	[Choi, Yoon-La; Han, Joungho] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pathol, Seoul, South Korea; [Choi, Yoon-La; Cho, Juhee] Sungkyunkwan Univ, Dept Hlth Sci & Technol, Samsung Adv Inst Hlth Sci & Technol, Seoul, South Korea; [Sun, Jong-Mu; Lee, Jeeyun] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med,Div Hematol Oncol, Seoul, South Korea; [Cho, Juhee] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Behav & Soc, Baltimore, MD USA; [Cho, Juhee; Rampal, Sanjay; Guallar, Eliseo] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Rampal, Sanjay; Guallar, Eliseo] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Med, Baltimore, MD USA; [Rampal, Sanjay; Guallar, Eliseo] Johns Hopkins Bloomberg Sch Publ Hlth, Welch Ctr Prevent Epidemiol & Clin Res, Baltimore, MD USA; [Rampal, Sanjay] Univ Malaya, Julius Ctr, Dept Social & Prevent Med, Fac Med, Kuala Lumpur, Malaysia; [Parasuraman, Bhash] AstraZeneca, Wilmington, DE USA; [Lee, Genehee] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Nursing, Seoul, South Korea; [Lee, Genehee; Shim, Young Mog] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Thorac Surg, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Universiti Malaya; AstraZeneca; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Shim, YM (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Thorac Surg, Seoul, South Korea.	ymshim3482@gmail.com	Rampal, Sanjay/B-9691-2010; Lee, Jeeyun/I-7171-2015; Guallar, Eliseo/D-3807-2014; sun, jm/O-5938-2014; Cho, Juhee/ABD-2280-2021; Lee, Jee Yun/C-9646-2011	Rampal, Sanjay/0000-0002-0105-6407; Guallar, Eliseo/0000-0002-4471-9565; Lee, Genehee/0000-0002-6361-4822	AstraZeneca	AstraZeneca(AstraZeneca)	This study was funded in part by AstraZeneca. AstraZeneca provided guidance and support in the development of the research protocol, data analysis and interpretation of findings. No additional external funding was received for this study.	Dacic S, 2008, ADV ANAT PATHOL, V15, P241, DOI 10.1097/PAP.0b013e31817bf5a9; Gately K, 2012, J CLIN PATHOL, V65, P1, DOI 10.1136/jclinpath-2011-200275; Gupta R, 2009, MODERN PATHOL, V22, P128, DOI 10.1038/modpathol.2008.182; Inoue A, 2006, J CLIN ONCOL, V24, P3340, DOI 10.1200/JCO.2005.05.4692; Keedy VL, 2011, J CLIN ONCOL, V29, P2121, DOI 10.1200/JCO.2010.31.8923; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Leary AF, 2012, EUR J CANCER, V48, P61, DOI 10.1016/j.ejca.2011.09.022; Lynch JA, 2011, CANC EPIDEMIOL BIO S, V20, pB79; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Marchetti A, 2005, J CLIN ONCOL, V23, P857, DOI 10.1200/JCO.2005.08.043; Mitsudomi T, 2010, LANCET ONCOL, V11, P121, DOI 10.1016/S1470-2045(09)70364-X; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; National Comprehensive Cancer Network, 2011, NCCN CLIN PRACT GUID; Rosell R, 2009, NEW ENGL J MED, V361, P958, DOI 10.1056/NEJMoa0904554; Salto-Tellez M, 2011, J THORAC ONCOL, V6, P1663, DOI 10.1097/JTO.0b013e318227816a; Sharma SV, 2007, NAT REV CANCER, V7, P169, DOI 10.1038/nrc2088; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Sun PL, 2012, J THORAC ONCOL, V7, P323, DOI 10.1097/JTO.0b013e3182381515; Tanaka K, 2012, INTERNAL MED, V51, P659, DOI 10.2169/internalmedicine.51.6386	19	70	70	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e56011	10.1371/journal.pone.0056011	http://dx.doi.org/10.1371/journal.pone.0056011			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23468851	Green Published, gold, Green Submitted			2022-12-25	WOS:000315524900015
J	Chanvorachote, P; Chunhacha, P				Chanvorachote, Pithi; Chunhacha, Preedakorn			Caveolin-1 Regulates Endothelial Adhesion of Lung Cancer Cells via Reactive Oxygen Species-Dependent Mechanism	PLOS ONE			English	Article							PROSTATE-CANCER; CARCINOMA CELLS; ANOIKIS; METASTASIS; INHIBITION; GROWTH; DEGRADATION; EXPRESSION; STABILITY; APOPTOSIS	The knowledge regarding the role of caveolin-1 (Cav-1) protein on endothelium adhesion of cancer cells is unclear. The present study revealed that Cav-1 plays a negative regulatory role on cancer-endothelium interaction. Endogenous Cav-1 was shown to down-regulate during cell detachment and the level of such a protein was conversely associated with tumor-endothelial adhesion. Furthermore, the ectopic overexpression of Cav-1 attenuated the ability of the cancer cells to adhere to endothelium while shRNA-mediated Cav-1 knock-down exhibited the opposite effect. We found that cell detachment increased cellular hydrogen peroxide and hydroxyl radical generation and such reactive oxygen species (ROS) were responsible for the increasing interaction between cancer cells and endothelial cells through vascular endothelial cell adhesion molecule-1 (VCAM-1). Importantly, Cav-1 was shown to suppress hydrogen peroxide and hydroxyl radical formation by sustaining the level of activated Akt which was critical for the role of Cav-1 in attenuating the cell adhesion. Together, the present study revealed the novel role of Cav-1 and underlying mechanism on tumor adhesion which explain and highlight an important role of Cav-1 on lung cancer cell metastasis.	[Chunhacha, Preedakorn] Chulalongkorn Univ, Dept Physiol & Pharmacol, Fac Pharmaceut Sci, Bangkok, Thailand; Chulalongkorn Univ, Cell Based Drug & Hlth Prod Dev Res Unit, Bangkok, Thailand	Chulalongkorn University; Chulalongkorn University	Chunhacha, P (corresponding author), Chulalongkorn Univ, Dept Physiol & Pharmacol, Fac Pharmaceut Sci, Bangkok, Thailand.	Preedakorn.chun@gmail.com		Chunhacha, Preedakorn/0000-0002-5060-7113; chanvorachote, pithi/0000-0002-3103-3249	Thailand Research Fund; Ratchadaphiseksompot Endowment Fund, Chulalongkorn University	Thailand Research Fund(Thailand Research Fund (TRF)); Ratchadaphiseksompot Endowment Fund, Chulalongkorn University	This work is supported by grants from the Thailand Research Fund (P. Chanvorachote) and postdoctoral fellowship (Ratchadaphiseksompot Endowment Fund, Chulalongkorn University). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carnero A, 2008, CURR CANCER DRUG TAR, V8, P187, DOI 10.2174/156800908784293659; Chanvorachote P, 2009, J BIOL CHEM, V284, P28476, DOI 10.1074/jbc.M109.050864; Chen Q, 2012, CLIN CANCER RES, V18, P5520, DOI 10.1158/1078-0432.CCR-11-2904; Chunhacha P, 2012, AM J PHYSIOL-CELL PH, V302, pC1284, DOI 10.1152/ajpcell.00318.2011; Coll MAL, 2005, ONCOGENE, V24, P1727, DOI 10.1038/sj.onc.1208379; Dhanasekaran SM, 2001, NATURE, V412, P822, DOI 10.1038/35090585; Fiucci G, 2002, ONCOGENE, V21, P2365, DOI 10.1038/sj.onc.1205300; FRA AM, 1995, FEBS LETT, V375, P11, DOI 10.1016/0014-5793(95)95228-O; FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619; Frisch SM, 2001, CURR OPIN CELL BIOL, V13, P555, DOI 10.1016/S0955-0674(00)00251-9; GarciaCardena G, 1996, P NATL ACAD SCI USA, V93, P6448, DOI 10.1073/pnas.93.13.6448; Georgescu Maria-Magdalena, 2010, Genes Cancer, V1, P1170, DOI 10.1177/1947601911407325; Halim H, 2012, ANTICANCER RES, V32, P1649; Hampton MB, 1997, FEBS LETT, V414, P552, DOI 10.1016/S0014-5793(97)01068-5; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hileman EO, 2004, CANCER CHEMOTH PHARM, V53, P209, DOI 10.1007/s00280-003-0726-5; Ho CC, 2008, LUNG CANCER, V59, P105, DOI 10.1016/j.lungcan.2007.07.024; Kobayashi H, 2007, CURR MED CHEM, V14, P377, DOI 10.2174/092986707779941032; Kobayashi K, 2000, CANCER RES, V60, P3978; Lavie Y, 1998, J BIOL CHEM, V273, P32380, DOI 10.1074/jbc.273.49.32380; Li LK, 2003, MOL CELL BIOL, V23, P9389, DOI 10.1128/MCB.23.24.9389-9404.2003; Lloyd PG, 2011, AM J PHYSIOL-CELL PH, V300, pC232, DOI 10.1152/ajpcell.00483.2010; Luanpitpong S, 2010, J BIOL CHEM, V285, P38832, DOI 10.1074/jbc.M110.124958; Newham P, 1997, J BIOL CHEM, V272, P19429, DOI 10.1074/jbc.272.31.19429; Rungtabnapa P, 2011, AM J PHYSIOL-CELL PH, V300, pC235, DOI 10.1152/ajpcell.00249.2010; Sloan EK, 2004, ONCOGENE, V23, P7893, DOI 10.1038/sj.onc.1208062; Suchaoin W, 2012, ANTICANCER RES, V32, P483; Sunaga N, 2004, CANCER RES, V64, P4277, DOI 10.1158/0008-5472.CAN-03-3941; Suzuki K, 1999, BIOCHEM BIOPH RES CO, V257, P214, DOI 10.1006/bbrc.1999.0431; Tahir SA, 2001, CANCER RES, V61, P3882; TOZAWA K, 1995, CANCER RES, V55, P4162; Vazquez F, 2000, MOL CELL BIOL, V20, P5010, DOI 10.1128/MCB.20.14.5010-5018.2000; Williams TM, 2005, AM J PHYSIOL-CELL PH, V288, pC494, DOI 10.1152/ajpcell.00458.2004	33	28	29	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57466	10.1371/journal.pone.0057466	http://dx.doi.org/10.1371/journal.pone.0057466			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460862	Green Published, gold, Green Submitted			2022-12-25	WOS:000315519000117
J	Gotea, V; Petrykowska, HM; Elnitski, L				Gotea, Valer; Petrykowska, Hanna M.; Elnitski, Laura			Bidirectional Promoters as Important Drivers for the Emergence of Species-Specific Transcripts	PLOS ONE			English	Article							POSITIVE SELECTION; FACTOR-BINDING; ALU REPEATS; GENE; EVOLUTION; RNA; DNA; REGIONS; DUPLICATION; VARIABILITY	The diversification of gene functions has been largely attributed to the process of gene duplication. Novel examples of genes originating from previously untranscribed regions have been recently described without regard to a unifying functional mechanism for their emergence. Here we propose a model mechanism that could generate a large number of lineage-specific novel transcripts in vertebrates through the activation of bidirectional transcription from unidirectional promoters. We examined this model in silico using human transcriptomic and genomic data and identified evidence consistent with the emergence of more than 1,000 primate-specific transcripts. These are transcripts with low coding potential and virtually no functional annotation. They initiate at less than 1 kb upstream of an oppositely transcribed conserved protein coding gene, in agreement with the generally accepted definition of bidirectional promoters. We found that the genomic regions upstream of ancestral promoters, where the novel transcripts in our dataset reside, are characterized by preferential accumulation of transposable elements. This enhances the sequence diversity of regions located upstream of ancestral promoters, further highlighting their evolutionary importance for the emergence of transcriptional novelties. By applying a newly developed test for positive selection to transposable element-derived fragments in our set of novel transcripts, we found evidence of adaptive evolution in the human lineage in nearly 3% of the novel transcripts in our dataset. These findings indicate that at least some novel transcripts could become functionally relevant, and thus highlight the evolutionary importance of promoters, through their capacity for bidirectional transcription, for the emergence of novel genes.	[Gotea, Valer; Petrykowska, Hanna M.; Elnitski, Laura] NHGRI, DIR GTB Genom Funct Anal Sect, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Elnitski, L (corresponding author), NHGRI, DIR GTB Genom Funct Anal Sect, NIH, Bethesda, MD 20892 USA.	elnitski@mail.nih.gov	Elnitski, Laura/AAD-3595-2021	Elnitski, Laura/0000-0003-1065-019X; Gotea, Valer/0000-0001-7857-3309	Intramural program of the National Human Genome Research Institute, National Institutes of Health; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200323] Funding Source: NIH RePORTER	Intramural program of the National Human Genome Research Institute, National Institutes of Health; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by the Intramural program of the National Human Genome Research Institute, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi N, 2002, CELL, V109, P807, DOI 10.1016/S0092-8674(02)00758-4; Anno YN, 2011, NUCLEIC ACIDS RES, V39, P3116, DOI 10.1093/nar/gkq1301; Begun DJ, 2007, GENETICS, V176, P1131, DOI 10.1534/genetics.106.069245; Brawand D, 2011, NATURE, V478, P343, DOI 10.1038/nature10532; Cai J, 2008, GENETICS, V179, P487, DOI 10.1534/genetics.107.084491; Carvunis A.-R., 2012, NATURE; Conant GC, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-6-r50; Dogan RI, 2007, NUCLEIC ACIDS RES, V35, pW285, DOI 10.1093/nar/gkm407; FITCH WM, 1966, J MOL BIOL, V16, P17, DOI 10.1016/S0022-2836(66)80259-0; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Hanawalt PC, 2008, NAT REV MOL CELL BIO, V9, P958, DOI 10.1038/nrm2549; Howald C, 2012, GENOME RES, V22, P1698, DOI 10.1101/gr.134478.111; INGRAM VM, 1961, NATURE, V189, P704, DOI 10.1038/189704a0; JACOB F, 1977, SCIENCE, V196, P1161, DOI 10.1126/science.860134; Jacox E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012274; Johnson ME, 2001, NATURE, V413, P514, DOI 10.1038/35097067; Kaessmann H, 2010, GENOME RES, V20, P1313, DOI 10.1101/gr.101386.109; Kalitsis P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-498; Katzman S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000960; Knowles DG, 2009, GENOME RES, V19, P1752, DOI 10.1101/gr.095026.109; Kostka D, 2012, MOL BIOL EVOL, V29, P1047, DOI 10.1093/molbev/msr279; Levine MT, 2006, P NATL ACAD SCI USA, V103, P9935, DOI 10.1073/pnas.0509809103; Lin JM, 2007, GENOME RES, V17, P818, DOI 10.1101/gr.5623407; Liu BC, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-S1-S2; MAKALOWSKI W, 1994, TRENDS GENET, V10, P188, DOI 10.1016/0168-9525(94)90254-2; Muller HJ, 1918, GENETICS, V3, P422; Muller HJ, 1935, J HERED, V26, P469, DOI 10.1093/oxfordjournals.jhered.a104010; NEI M, 1969, NATURE, V221, P40, DOI 10.1038/221040a0; OHNO S., 1970, Evolution by gene duplication.; Orom UA, 2010, CELL, V143, P46, DOI 10.1016/j.cell.2010.09.001; Piontkivska H, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-189; Pohl AA, 2009, BIOINFORMATICS, V25, P2442, DOI 10.1093/bioinformatics/btp414; Pollard KS, 2006, PLOS GENET, V2, P1599, DOI 10.1371/journal.pgen.0020168; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Preker P, 2008, SCIENCE, V322, P1851, DOI 10.1126/science.1164096; Ratnakumar A, 2010, PHILOS T R SOC B, V365, P2571, DOI 10.1098/rstb.2010.0007; RUBIN CM, 1994, NUCLEIC ACIDS RES, V22, P5121, DOI 10.1093/nar/22.23.5121; Saxena A, 2011, BIOESSAYS, V33, P830, DOI 10.1002/bies.201100084; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; Shimada MK, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-122; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; SPOFFORD JB, 1969, AM NAT, V103, P407, DOI 10.1086/282611; Tan-Wong SM, 2012, SCIENCE, V338, P671, DOI 10.1126/science.1224350; Tang H, 1999, GENETICS, V153, P485; Toll-Riera M, 2009, MOL BIOL EVOL, V26, P603, DOI 10.1093/molbev/msn281; Trinklein ND, 2004, GENOME RES, V14, P62, DOI 10.1101/gr.1982804; van Bakel H, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000371; Witherspoon DJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-530; Woolfe A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r20; Xie HH, 2009, NUCLEIC ACIDS RES, V37, P4331, DOI 10.1093/nar/gkp393; Yang ZF, 2011, FEBS LETT, V585, P641, DOI 10.1016/j.febslet.2011.01.017; Yeo G, 2004, J COMPUT BIOL, V11, P377, DOI 10.1089/1066527041410418; Zhou Q, 2008, GENOME RES, V18, P1446, DOI 10.1101/gr.076588.108	54	19	19	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57323	10.1371/journal.pone.0057323	http://dx.doi.org/10.1371/journal.pone.0057323			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460838	Green Submitted, Green Published, gold			2022-12-25	WOS:000315519000092
J	Hall-Mendelin, S; Allcock, R; Kresoje, N; van den Hurk, AF; Warrilow, D				Hall-Mendelin, Sonja; Allcock, Richard; Kresoje, Nina; van den Hurk, Andrew F.; Warrilow, David			Detection of Arboviruses and Other Micro-Organisms in Experimentally Infected Mosquitoes Using Massively Parallel Sequencing	PLOS ONE			English	Article							AEDES-AEGYPTI; CYTOPLASMIC INCOMPATIBILITY; LARVAL DEVELOPMENT; FEEDING-BEHAVIOR; BLOCKS DENGUE; CULEX-PIPIENS; NATURAL FOOD; YELLOW-FEVER; WOLBACHIA; CHIKUNGUNYA	Human disease incidence attributed to arbovirus infection is increasing throughout the world, with effective control interventions limited by issues of sustainability, insecticide resistance and the lack of effective vaccines. Several promising control strategies are currently under development, such as the release of mosquitoes trans-infected with virus-blocking Wolbachia bacteria. Implementation of any control program is dependent on effective virus surveillance and a thorough understanding of virus-vector interactions. Massively parallel sequencing has enormous potential for providing comprehensive genomic information that can be used to assess many aspects of arbovirus ecology, as well as to evaluate novel control strategies. To demonstrate proof-of-principle, we analyzed Aedes aegypti or Aedes albopictus experimentally infected with dengue, yellow fever or chikungunya viruses. Random amplification was used to prepare sufficient template for sequencing on the Personal Genome Machine. Viral sequences were present in all infected mosquitoes. In addition, in most cases, we were also able to identify the mosquito species and mosquito micro-organisms, including the bacterial endosymbiont Wolbachia. Importantly, naturally occurring Wolbachia strains could be differentiated from strains that had been trans-infected into the mosquito. The method allowed us to assemble near full-length viral genomes and detect other micro-organisms without prior sequence knowledge, in a single reaction. This is a step toward the application of massively parallel sequencing as an arbovirus surveillance tool. It has the potential to provide insight into virus transmission dynamics, and has applicability to the post-release monitoring of Wolbachia in mosquito populations.	[Hall-Mendelin, Sonja; van den Hurk, Andrew F.; Warrilow, David] Queensland Hlth Forens & Sci Serv, Publ Hlth Virol Lab, Archerfield, Qld, Australia; [Allcock, Richard; Kresoje, Nina] Univ Western Australia, Sch Pathol & Lab Med, LotteryWest State Biomed Facil Genom, Perth, WA 6009, Australia; [Allcock, Richard] Royal Perth Hosp, Dept Clin Immunol, Pathwest Lab Med WA, Perth, WA 6001, Australia	Queensland Health; University of Western Australia; Royal Perth Hospital; University of Western Australia	Warrilow, D (corresponding author), Queensland Hlth Forens & Sci Serv, Publ Hlth Virol Lab, Archerfield, Qld, Australia.	David_Warrilow@health.qld.gov.au	van den Hurk, Andrew/X-9831-2019; van den Hurk, Andrew F/G-7992-2012	van den Hurk, Andrew/0000-0001-6262-831X; 	Queensland Health	Queensland Health	This project was internally funded by Queensland Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Barzon L, 2011, INT J MOL SCI, V12, P7861, DOI 10.3390/ijms12117861; Bishop-Lilly KA, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000878; Blagrove MSC, 2012, P NATL ACAD SCI USA, V109, P255, DOI 10.1073/pnas.1112021108; Boissiere Anne, 2012, PLoS Pathog, V8, pe1002742, DOI 10.1371/journal.ppat.1002742; BOUBLIK Y, 1994, VIROLOGY, V200, P752, DOI 10.1006/viro.1994.1239; Burt FJ, 2012, LANCET, V379, P662, DOI 10.1016/S0140-6736(11)60281-X; Carpi G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025604; Chouaia B, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-S1-S2; Chouaia B, 2010, APPL ENVIRON MICROB, V76, P7444, DOI 10.1128/AEM.01747-10; da Costa GL, 1998, J BASIC MICROB, V38, P343, DOI 10.1002/(SICI)1521-4028(199811)38:5/6&lt;343::AID-; Delwart EL, 2007, REV MED VIROL, V17, P115, DOI 10.1002/rmv.532; DeMaio J, 1996, AM J TROP MED HYG, V54, P219, DOI 10.4269/ajtmh.1996.54.219; Endersby NM, 2011, J MED ENTOMOL, V48, P999, DOI 10.1603/ME10264; Engelstadter J, 2009, HEREDITY, V103, P196, DOI 10.1038/hdy.2009.53; Gusmao DS, 2010, ACTA TROP, V115, P275, DOI 10.1016/j.actatropica.2010.04.011; Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460; Hinman EH, 1930, AM J HYG, V12, P238, DOI 10.1093/oxfordjournals.aje.a115265; Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356; Horsfall WR, 1955, MOSQUITOES THEIR BIO; HOWLAND L. J., 1930, BULL ENT RES [LONDON], V21, P431, DOI 10.1017/S0007485300024779; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Iturbe-Ormaetxe I, 2011, EMBO REP, V12, P508, DOI 10.1038/embor.2011.84; Jansen CC, 2009, AM J TROP MED HYG, V81, P849, DOI 10.4269/ajtmh.2009.09-0008; Jentes ES, 2011, LANCET INFECT DIS, V11, P622, DOI 10.1016/S1473-3099(11)70147-5; JONES JACK COLVARD, 1960, ANN ENT SOC AMER, V53, P459; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kittayapong P, 2002, AM J TROP MED HYG, V66, P108, DOI 10.4269/ajtmh.2002.66.108; Kobasa D, 2007, NATURE, V445, P319, DOI 10.1038/nature05495; Ma MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024758; MERRITT RW, 1990, J AM MOSQUITO CONTR, V6, P35; MERRITT RW, 1992, ANNU REV ENTOMOL, V37, P349, DOI 10.1146/annurev.en.37.010192.002025; Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042; Morrison AC, 2008, PLOS MED, V5, P362, DOI 10.1371/journal.pmed.0050068; Ng TFF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020579; ONEILL SL, 1995, J GEN VIROL, V76, P2067, DOI 10.1099/0022-1317-76-8-2067; Pidiyar VJ, 2004, AM J TROP MED HYG, V70, P597, DOI 10.4269/ajtmh.2004.70.597; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Pucat A. M., 1965, Quaestiones Entomologicae, V1, P41; Pumpuni CB, 1996, AM J TROP MED HYG, V54, P214, DOI 10.4269/ajtmh.1996.54.214; Radford AD, 2012, J GEN VIROL; Rakonjac J, 2011, CURR ISSUES MOL BIOL, V13, P51, DOI 10.21775/cimb.013.051; Ramirez JL, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001561; Rani A, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-96; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Terenius O, 2008, J MED ENTOMOL, V45, P172, DOI 10.1603/0022-2585(2008)45[172:SRGSFB]2.0.CO;2; THIERY I, 1991, APPL ENVIRON MICROB, V57, P1354, DOI 10.1128/AEM.57.5.1354-1359.1991; van den Hurk AF, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001892; van den Hurk AF, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/325659; Vazquez-Martinez MG, 2003, J AM MOSQUITO CONTR, V19, P155; Victoria JG, 2009, J VIROL, V83, P4642, DOI 10.1128/JVI.02301-08; Victoria JG, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000163; Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355; Wang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024767; Zhai YG, 2008, J GEN VIROL, V89, P195, DOI 10.1099/vir.0.83221-0; Zouache K, 2011, FEMS MICROBIOL ECOL, V75, P377, DOI 10.1111/j.1574-6941.2010.01012.x; Zouache K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006388	58	21	21	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e58026	10.1371/journal.pone.0058026	http://dx.doi.org/10.1371/journal.pone.0058026			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460918	gold, Green Submitted, Green Published			2022-12-25	WOS:000315519000173
J	Lang, SM; Bynoe, MOF; Karki, R; Tartell, MA; Means, RE				Lang, Sabine M.; Bynoe, Meisha O. F.; Karki, Roshan; Tartell, Michael A.; Means, Robert E.			Kaposi's Sarcoma-Associated Herpesvirus K3 and K5 Proteins Down Regulate Both DC-SIGN and DC-SIGNR	PLOS ONE			English	Article							HUMAN DENDRITIC CELLS; E3 UBIQUITIN LIGASES; PEPTIDE-LOADING COMPLEX; CLASS-I MOLECULES; WEST-NILE-VIRUS; ENDOTHELIAL-CELLS; GENE-EXPRESSION; DNA-SEQUENCES; MYCOBACTERIUM-TUBERCULOSIS; PRODUCTIVE INFECTION	Kaposi's sarcoma-associated herpesvirus (KSHV) is the etiological agent of multicentric Castleman's disease, primary effusion lymphoma and Kaposi's sarcoma. In this study, we show that like the C-type lectin DC-SIGN, the closely related DC-SIGNR can also enhance KSHV infection. Following infection, they are both targeted for down modulation and our data indicate that the KSHV MARCH-family ubiquitin ligase K5 is mediating this regulation and subsequent targeting for degradation of DC-SIGN and DC-SIGNR in the context of the virus. The closely related viral K3 protein, is also able to target these lectins in exogenous expressions studies, but only weakly during viral infection. In addition to requiring a functional RING-CH domain, several protein trafficking motifs in the C-terminal region of both K3 and K5 are important in regulation of DC-SIGN and DC-SIGNR. Further exploration of this modulation revealed that DC-SIGN is endocytosed from the cell surface in THP-1 monocytes, but degraded from an internal location with minimal endocytosis in HEK-293 cells. Pull-down data indicate that both K3 and K5 preferentially associate with immature forms of the lectins, mediating their ubiquitylation and degradation. Together, these data emphasize the molecular complexities of K3 and K5, while expanding the repertoire of targets of these two viral proteins.	[Lang, Sabine M.; Bynoe, Meisha O. F.; Karki, Roshan; Tartell, Michael A.; Means, Robert E.] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA	Yale University	Means, RE (corresponding author), Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA.	robert.means@yale.edu		Tartell, Michael/0000-0002-4518-4187	NIH/NCI [R01CA121925]; ASM Robert D. Watkins Graduate Research Fellowship; Howard Hughes Medical Institute Gilliam Fellowship; NATIONAL CANCER INSTITUTE [R01CA121925] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ASM Robert D. Watkins Graduate Research Fellowship; Howard Hughes Medical Institute Gilliam Fellowship(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding for these studies was received from NIH/NCI R01CA121925 (to REM), an ASM Robert D. Watkins Graduate Research Fellowship (to FB) and a Howard Hughes Medical Institute Gilliam Fellowship (to MB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIKEN C, 1994, CELL, V76, P853, DOI 10.1016/0092-8674(94)90360-3; Alvarez CP, 2002, J VIROL, V76, P6841, DOI 10.1128/JVI.76.13.6841-6844.2002; Bashirova AA, 2001, J EXP MED, V193, P671, DOI 10.1084/jem.193.6.671; Boname JM, 2005, EUR J IMMUNOL, V35, P171, DOI 10.1002/eji.200425459; Boname JM, 2004, IMMUNITY, V20, P305, DOI 10.1016/S1074-7613(04)00047-0; Brulois KF, 2012, J VIROL, V86, P9708, DOI 10.1128/JVI.01019-12; Cadwell K, 2005, SCIENCE, V309, P127, DOI 10.1126/science.1110340; Cadwell K, 2008, J VIROL, V82, P4184, DOI 10.1128/JVI.02264-07; CESARMAN E, 1995, NEW ENGL J MED, V332, P1186, DOI 10.1056/NEJM199505043321802; Chang HS, 2005, J VIROL, V79, P14371, DOI 10.1128/JVI.79.22.14371-14382.2005; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; Coscoy L, 2000, P NATL ACAD SCI USA, V97, P8051, DOI 10.1073/pnas.140129797; Coscoy L, 2001, J CELL BIOL, V155, P1265, DOI 10.1083/jcb.200111010; Coscoy L, 2001, J CLIN INVEST, V107, P1599, DOI 10.1172/JCI12432; Davis CW, 2006, J VIROL, V80, P1290, DOI 10.1128/JVI.80.3.1290-1301.2006; Dodd RB, 2004, J BIOL CHEM, V279, P53840, DOI 10.1074/jbc.M409662200; Engering A, 2002, J IMMUNOL, V168, P2118, DOI 10.4049/jimmunol.168.5.2118; Geijtenbeek TBH, 2003, APMIS, V111, P698, DOI 10.1034/j.1600-0463.2003.11107803.x; Geijtenbeek TBH, 2003, J EXP MED, V197, P7, DOI 10.1084/jem.20021229; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Geijtenbeek TBH, 2000, CELL, V100, P575, DOI 10.1016/S0092-8674(00)80693-5; Geijtenbeek TBH, 2000, NAT IMMUNOL, V1, P353, DOI 10.1038/79815; Geijtenbeek TBH, 2009, FUTURE MICROBIOL, V4, P879, DOI 10.2217/FMB.09.51; Granelli-Piperno A, 2005, J IMMUNOL, V175, P4265, DOI 10.4049/jimmunol.175.7.4265; Gringhuis SI, 2007, IMMUNITY, V26, P605, DOI 10.1016/j.immuni.2007.03.012; Gringhuis SI, 2010, NAT IMMUNOL, V11, P419, DOI 10.1038/ni.1858; Gringhuis SI, 2009, NAT IMMUNOL, V10, P1081, DOI 10.1038/ni.1778; Ishido S, 2000, IMMUNITY, V13, P365, DOI 10.1016/S1074-7613(00)00036-4; Ishido S, 2000, J VIROL, V74, P5300, DOI 10.1128/JVI.74.11.5300-5309.2000; Karki R, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001331; Kerur N, 2010, VIROLOGY, V406, P103, DOI 10.1016/j.virol.2010.07.012; Kong KF, 2008, J VIROL, V82, P7613, DOI 10.1128/JVI.00618-08; Li QL, 2007, J VIROL, V81, P2117, DOI 10.1128/JVI.01961-06; Lybarger L, 2003, IMMUNITY, V18, P121, DOI 10.1016/S1074-7613(02)00509-5; Mansouri M, 2008, J VIROL, V82, P9615, DOI 10.1128/JVI.02633-07; Mansouri M, 2006, BLOOD, V108, P1932, DOI 10.1182/blood-2005-11-4404; Mansouri M, 2009, J VIROL, V83, P9672, DOI 10.1128/JVI.00597-09; Means RE, 2002, EMBO J, V21, P1638, DOI 10.1093/emboj/21.7.1638; Means RE, 2007, J VIROL, V81, P6573, DOI 10.1128/JVI.02751-06; Navarro-Sanchez E, 2003, EMBO REP, V4, P723, DOI 10.1038/sj.embor.embor866; Ohmura-Hoshino M, 2006, J BIOCHEM, V140, P147, DOI 10.1093/jb/mvj160; Pardieu C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000843; Pohlmann S, 2001, J VIROL, V75, P4664, DOI 10.1128/JVI.75.10.4664-4672.2001; Pohlmann S, 2001, P NATL ACAD SCI USA, V98, P2670, DOI 10.1073/pnas.051631398; Puig-Kroger A, 2004, J BIOL CHEM, V279, P25680, DOI 10.1074/jbc.M311516200; Rappocciolo G, 2006, J IMMUNOL, V176, P1741, DOI 10.4049/jimmunol.176.3.1741; Rappocciolo G, 2008, J VIROL, V82, P4793, DOI 10.1128/JVI.01587-07; Rhodes DA, 2010, P NATL ACAD SCI USA, V107, P16240, DOI 10.1073/pnas.1003421107; Rimessi P, 2001, J VIROL, V75, P7161, DOI 10.1128/JVI.75.15.7161-7174.2001; Russo JJ, 1996, P NATL ACAD SCI USA, V93, P14862, DOI 10.1073/pnas.93.25.14862; Sanchez DJ, 2005, J CLIN INVEST, V115, P1369, DOI 10.1172/JCI200524041; Schneider-Schaulies J, 2008, ADV VIRUS RES, V71, P173, DOI 10.1016/S0065-3527(08)00004-3; Soilleux EJ, 2003, CLIN SCI, V104, P437, DOI 10.1042/CS20020092; Soilleux EJ, 2000, J IMMUNOL, V165, P2937, DOI 10.4049/jimmunol.165.6.2937; SOULIER J, 1995, BLOOD, V86, P1276, DOI 10.1182/blood.V86.4.1276.bloodjournal8641276; Sun R, 1999, J VIROL, V73, P2232, DOI 10.1128/JVI.73.3.2232-2242.1999; Tailleux L, 2003, J EXP MED, V197, P121, DOI 10.1084/jem.20021468; Tassaneetrithep B, 2003, J EXP MED, V197, P823, DOI 10.1084/jem.20021840; Vieira J, 2004, VIROLOGY, V325, P225, DOI 10.1016/j.virol.2004.03.049	59	14	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e58056	10.1371/journal.pone.0058056	http://dx.doi.org/10.1371/journal.pone.0058056			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460925	gold, Green Published, Green Submitted			2022-12-25	WOS:000315519000180
J	Melnychuk, MC; Banobi, JA; Hilborn, R				Melnychuk, Michael C.; Banobi, Jeannette A.; Hilborn, Ray			Effects of Management Tactics on Meeting Conservation Objectives for Western North American Groundfish Fisheries	PLOS ONE			English	Article							BERING-SEA; REFERENCE POINTS; CATCH SHARES; FISH STOCKS; COAST; SUSTAINABILITY; RISK; EXPLOITATION; UNCERTAINTY; INDICATORS	There is considerable variability in the status of fish populations around the world and a poor understanding of how specific management characteristics affect populations. Overfishing is a major problem in many fisheries, but in some regions the recent tendency has been to exploit stocks at levels below their maximum sustainable yield. In Western North American groundfish fisheries, the status of individual stocks and management systems among regions are highly variable. In this paper, we show the current status of groundfish stocks from Alaska, British Columbia, and the U. S. West Coast, and quantify the influence on stock status of six management tactics often hypothesized to affect groundfish. These tactics are: the use of harvest control rules with estimated biological reference points; seasonal closures; marine reserves; bycatch constraints; individual quotas (i.e., 'catch shares'); and gear type. Despite the high commercial value of many groundfish and consequent incentives for maintaining stocks at their most productive levels, most stocks were managed extremely conservatively, with current exploitation rates at only 40% of management targets and biomass 33% above target biomass on average. Catches rarely exceeded TACs but on occasion were far below TACs (mean catch: TAC ratio of 57%); approximately $150 million of potential landed value was foregone annually by underutilizing TACs. The use of individual quotas, marine reserves, and harvest control rules with estimated limit reference points had little overall effect on stock status. More valuable fisheries were maintained closer to management targets and were less variable over time than stocks with lower catches or ex-vessel prices. Together these results suggest there is no single effective management measure for meeting conservation objectives; if scientifically established quotas are set and enforced, a variety of means can be used to ensure that exploitation rates and biomass levels are near to or more conservative than management targets.	[Melnychuk, Michael C.; Banobi, Jeannette A.; Hilborn, Ray] Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Melnychuk, MC (corresponding author), Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA.	mmel@u.washington.edu	Hilborn, Ray W/D-6332-2013; Melnychuk, Michael/A-4680-2013	Melnychuk, Michael/0000-0002-6088-7657	CAMEO grant through National Science Foundation; National Oceanic and Atmospheric Administration [1041570]; Walton Family Foundation; Natural Sciences and Engineering Research Council of Canada [BPDF-424586-2012]; Directorate For Geosciences [1041570] Funding Source: National Science Foundation	CAMEO grant through National Science Foundation; National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA); Walton Family Foundation; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Funding for this study was provided by a CAMEO grant through National Science Foundation and National Oceanic and Atmospheric Administration (cameo.noaa.gov; grant number 1041570), by the Walton Family Foundation (www.waltonfamilyfoundation.org/), and by a Natural Sciences and Engineering Research Council of Canada fellowship (www.nserc-crsng.gc.ca; number BPDF-424586-2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adlerstein SA, 1998, J SEA RES, V39, P153, DOI 10.1016/S1385-1101(97)00055-5; Allison GW, 1998, ECOL APPL, V8, pS79, DOI 10.1890/1051-0761(1998)8[S79:MRANBN]2.0.CO;2; Beddington JR, 2007, SCIENCE, V316, P1713, DOI 10.1126/science.1137362; Branch TA, 2008, CAN J FISH AQUAT SCI, V65, P1435, DOI 10.1139/F08-065; Branch TA, 2006, B MAR SCI, V78, P669; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L, 2001, STAT SCI, V16, P199, DOI 10.1214/ss/1009213726; Brodziak J, 2002, N AM J FISH MANAGE, V22, P258, DOI 10.1577/1548-8675(2002)022<0258:ISOOHR>2.0.CO;2; Chuenpagdee R, 2003, FRONT ECOL ENVIRON, V1, P517; Cochrane K. L., 2002, FAO Fisheries Technical Paper; Costello C, 2008, SCIENCE, V321, P1678, DOI 10.1126/science.1159478; Crowder LB, 1998, FISHERIES, V23, P8, DOI 10.1577/1548-8446(1998)023&lt;0008:FBIFM&gt;2.0.CO;2; Cutler DR, 2007, ECOLOGY, V88, P2783, DOI 10.1890/07-0539.1; Davies TD, 2012, SCI REP-UK, V2, DOI 10.1038/srep00561; Degnbol P, 2006, MAR POLICY, V30, P534, DOI 10.1016/j.marpol.2005.07.002; Deroba JJ, 2008, FISH RES, V94, P210, DOI 10.1016/j.fishres.2008.01.003; DiCosimo J, 2010, ICES J MAR SCI, V67, P1861, DOI 10.1093/icesjms/fsq060; Essington TE, 2012, CONSERV LETT, V5, P186, DOI 10.1111/j.1755-263X.2012.00226.x; Essington TE, 2010, P NATL ACAD SCI USA, V107, P754, DOI 10.1073/pnas.0907252107; FAO, 2012, STAT WORLD FISH AQ; Fraser and Associates, 2008, LINK PRIM FISH PROD; Froese R, 2010, FISH FISH, V11, P194, DOI 10.1111/j.1467-2979.2009.00349.x; Fujita RM, 1998, ECOL APPL, V8, pS139, DOI 10.2307/2641372; Grafton RQ, 2006, CAN J FISH AQUAT SCI, V63, P699, DOI 10.1139/f05-247; Gutierrez NL, 2011, NATURE, V470, P386, DOI 10.1038/nature09689; Hiddink JG, 2006, CAN J FISH AQUAT SCI, V63, P721, DOI 10.1139/F05-266; Hilborn R, 2005, PHILOS T R SOC B, V360, P47, DOI 10.1098/rstb.2004.1569; Hilborn R, 2002, N AM J FISH MANAGE, V22, P365, DOI 10.1577/1548-8675(2002)022<0365:ERRPFW>2.0.CO;2; Hilborn R, 2007, FISH FISH, V8, P285, DOI 10.1111/j.1467-2979.2007.00263_2.x; Hilborn R, 2007, AMBIO, V36, P296, DOI 10.1579/0044-7447(2007)36[296:MTSBLF]2.0.CO;2; Hilborn R, 2012, CONSERV BIOL, V26, DOI 10.1111/j.1523-1739.2011.01800.x; Hilborn R, 2010, MAR POLICY, V34, P193, DOI 10.1016/j.marpol.2009.04.013; Ianelli J, 2005, B MAR SCI, V76, P321; Levin PS, 2006, CONSERV BIOL, V20, P1181, DOI 10.1111/j.1523-1739.2006.00400.x; LUDWIG D, 1993, SCIENCE, V260, P17, DOI 10.1126/science.260.5104.17; Mace PM, 2001, FISH FISH, V2, P2, DOI 10.1046/j.1467-2979.2001.00033.x; Mawani T, 2009, EVALUATION COMMERCIA; Melnychuk MC, 2012, FISH FISH, V13, P267, DOI 10.1111/j.1467-2979.2011.00429.x; Murawski SA, 2010, ICES J MAR SCI, V67, P1830, DOI 10.1093/icesjms/fsq125; Parker SJ, 2000, FISHERIES, V25, P22, DOI 10.1577/1548-8446(2000)025<0022:MOPR>2.0.CO;2; Parma AM, 2006, B MAR SCI, V78, P411; Pauly D, 2002, NATURE, V418, P689, DOI 10.1038/nature01017; Piet GJ, 2010, ICES J MAR SCI, V67, P559, DOI 10.1093/icesjms/fsp293; PORTER RB, 1974, AM ECON REV, V64, P200; R Core Team, 2021, R LANG ENV STAT COMP; Ralston S, 2002, N AM J FISH MANAGE, V22, P249, DOI 10.1577/1548-8675(2002)022<0249:WCGHP>2.0.CO;2; Restrepo VR, 1998, NMFSFSPO31 NAT OC AT; Ricard D, 2012, FISH FISH, V13, P380, DOI 10.1111/j.1467-2979.2011.00435.x; Rice JC, 2007, ICES J MAR SCI, V64, P718, DOI 10.1093/icesjms/fsm011; ROSENBERG AA, 1994, CAN J FISH AQUAT SCI, V51, P2715, DOI 10.1139/f94-271; Rosenberg AA, 2006, FRONT ECOL ENVIRON, V4, P303, DOI 10.1890/1540-9295(2006)4[303:RUFPAP]2.0.CO;2; Schaefer MB, 1954, SOME ASPECTS DYNAMIC; Sethi SA, 2010, P NATL ACAD SCI USA, V107, P12163, DOI 10.1073/pnas.1003236107; Sethi SA, 2012, CAN J FISH AQUAT SCI, V69, P487, DOI 10.1139/F2011-170; Sutinen JG, 1999, ICES J MAR SCI, V56, P1051, DOI 10.1006/jmsc.1999.0551; Turris B. R., 2000, FAO Fisheries Technical Paper, P254; Worm B, 2009, SCIENCE, V325, P578, DOI 10.1126/science.1173146; Yamanaka KL, 2010, MAR COAST FISH, V2, P28, DOI 10.1577/C08-036.1; Zuur Alain F., 2009, P1	59	27	27	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e56684	10.1371/journal.pone.0056684	http://dx.doi.org/10.1371/journal.pone.0056684			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460809	Green Published, Green Submitted, gold			2022-12-25	WOS:000315519000032
J	Qiu, EC; Wang, Y; Ma, L; Tian, LX; Liu, RZ; Dong, Z; Xu, X; Zou, ZT; Yu, SY				Qiu, Enchao; Wang, Yan; Ma, Lin; Tian, Lixia; Liu, Ruozhuo; Dong, Zhao; Xu, Xian; Zou, Zhitong; Yu, Shengyuan			Abnormal Brain Functional Connectivity of the Hypothalamus in Cluster Headaches	PLOS ONE			English	Article							REGIONAL HOMOGENEITY; ALZHEIMERS-DISEASE; PAIN; STIMULATION; CORTEX; RESPONSES; ACTIVATION; NETWORK	The aim of this study was to detect the abnormality of the brain functional connectivity of the hypothalamus during acute spontaneous cluster headache (CH) attacks ('in attack') and headache-free intervals ('out of attack') using resting-state functional magnetic resonance imaging (RS-fMRI) technique. The RS-fMRI data from twelve male CH patients during 'in attack' and 'out of attack' periods and twelve age- and sex-matched normal controls were analyzed by the region-of-interest-based functional connectivity method using SPM5 software. Abnormal brain functional connectivity of the hypothalamus is present in CH, which is located mainly in the pain system during the spontaneous CH attacks. It extends beyond the pain system during CH attack intervals.	[Qiu, Enchao; Liu, Ruozhuo; Dong, Zhao; Yu, Shengyuan] Chinese Peoples Liberat Army Gen Hosp, Dept Neurol, Beijing, Peoples R China; [Wang, Yan; Ma, Lin; Xu, Xian; Zou, Zhitong] Chinese Peoples Liberat Army Gen Hosp, Dept Radiol, Beijing, Peoples R China; [Qiu, Enchao] Chinese Peoples Liberat Army Gen Hosp, Affiliated Hosp 1, Dept Neurol, Beijing, Peoples R China; [Tian, Lixia] Beijing Jiaotong Univ, Sch Comp & Informat Technol, Dept Biomed Engn, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital; Beijing Jiaotong University	Yu, SY (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Neurol, Beijing, Peoples R China.	yusy1963@126.com	Ma, Lin/AAF-8728-2019; Qiu, Enchao/GXG-8556-2022		National Natural Science Foundation of China [30970417, 81171058]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China, Grant Nos. 30970417 and 81171058. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apkarian AV, 2005, EUR J PAIN, V9, P463, DOI 10.1016/j.ejpain.2004.11.001; Bahra A, 2002, NEUROLOGY, V58, P354, DOI 10.1212/WNL.58.3.354; Bingel U, 2007, PAIN, V131, P21, DOI 10.1016/j.pain.2006.12.005; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Biswal BB, 1997, NMR BIOMED, V10, P165, DOI 10.1002/(SICI)1099-1492(199706/08)10:4/5<165::AID-NBM454>3.0.CO;2-7; Chen LM, 2007, INT ANESTHESIOL CLIN, V45, P39, DOI 10.1097/AIA.0b013e31803419d3; DaSilva Alexandre F M, 2007, Curr Pain Headache Rep, V11, P131, DOI 10.1007/s11916-007-0010-1; Derbyshire SWG, 2002, NEUROIMAGE, V16, P158, DOI 10.1006/nimg.2002.1066; Diener HC, 1997, HEADACHE, V37, P622, DOI 10.1046/j.1526-4610.1997.3710622.x; Dodick DW, 2000, CEPHALALGIA, V20, P787, DOI 10.1046/j.1468-2982.2000.00118.x; Farooq K, 2008, BJA EDUC, V8, P138, DOI 10.1093/bjaceaccp/mkn025; Fattah QA, 2006, CEPHALALGIA, V26, P492, DOI 10.1111/j.1468-2982.2006.01052.x; FRISTON KJ, 1993, J CEREBR BLOOD F MET, V13, P5, DOI 10.1038/jcbfm.1993.4; Friston KJ, 1993, HUM BRAIN MAPP, V1, P69, DOI DOI 10.1002/HBM.460010108; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Hsieh JC, 1996, PAIN, V67, P59, DOI 10.1016/0304-3959(96)03066-7; International Headache Society, 2004, CEPHALALGIA S1, V24, pS1; Leone M, 2004, BRAIN, V127, P2259, DOI 10.1093/brain/awh245; Leone M, 2003, NEUROL SCI, V24, pS143; Liu Y, 2008, NEUROPSYCHOLOGIA, V46, P1648, DOI 10.1016/j.neuropsychologia.2008.01.027; Lowe MJ, 2000, NEUROIMAGE, V12, P582, DOI 10.1006/nimg.2000.0654; May A, 2006, J NEUROSCI, V26, P3589, DOI 10.1523/JNEUROSCI.4609-05.2006; May A, 1999, NAT MED, V5, P836, DOI 10.1038/10561; May A, 1998, LANCET, V352, P275, DOI 10.1016/S0140-6736(98)02470-2; May A, 2000, NEUROLOGY, V55, P1328, DOI 10.1212/WNL.55.9.1328; Morelli N, 2009, J HEADACHE PAIN, V10, P11, DOI 10.1007/s10194-008-0085-z; Morrison I, 2007, CEREB CORTEX, V17, P2214, DOI 10.1093/cercor/bhl129; Petrovic P, 2002, SCIENCE, V295, P1737, DOI 10.1126/science.1067176; Peyron R, 2000, NEUROPHYSIOL CLIN, V30, P263, DOI 10.1016/S0987-7053(00)00227-6; Ploner M, 2004, NERVENARZT, V75, P962, DOI 10.1007/s00115-004-1739-y; Qiu EC, 2012, CHINESE MED J-PEKING, V125, P705, DOI 10.3760/cma.j.issn.0366-6999.2012.04.027; Raij TT, 2005, P NATL ACAD SCI USA, V102, P2147, DOI 10.1073/pnas.0409542102; Rocca MA, 2010, CEPHALALGIA, V30, P1383, DOI 10.1177/0333102410365164; Seminowicz DA, 2006, PAIN, V120, P297, DOI 10.1016/j.pain.2005.11.008; Sprenger T, 2007, CEPHALALGIA, V27, P1033, DOI 10.1111/j.1468-2982.2007.01386.x; Sprenger T, 2004, NEUROLOGY, V62, P516, DOI 10.1212/WNL.62.3.516; Svensson P, 1997, J NEUROPHYSIOL, V78, P450, DOI 10.1152/jn.1997.78.1.450; Teepker M, 2012, HEADACHE, V52, P274, DOI 10.1111/j.1526-4610.2011.02000.x; Tian LX, 2006, NEUROSCI LETT, V400, P39, DOI 10.1016/j.neulet.2006.02.022; Tracey I, 2007, NEURON, V55, P377, DOI 10.1016/j.neuron.2007.07.012; Valet M, 2004, PAIN, V109, P399, DOI 10.1016/j.pain.2004.02.033; Vetrugno R, 2007, HEADACHE, V47, P1085, DOI 10.1111/j.1526-4610.2007.00864.x; Vogt BA, 2005, NAT REV NEUROSCI, V6, P533, DOI 10.1038/nrn1704; Wang K, 2007, HUM BRAIN MAPP, V28, P967, DOI 10.1002/hbm.20324; Wang L, 2006, NEUROIMAGE, V31, P496, DOI 10.1016/j.neuroimage.2005.12.033; Wang SJ, 2006, J NEUROL NEUROSUR PS, V77, P622, DOI 10.1136/jnnp.2005.081836; Zhou Y, 2007, NEUROSCI LETT, V417, P297, DOI 10.1016/j.neulet.2007.02.081	47	36	38	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57896	10.1371/journal.pone.0057896	http://dx.doi.org/10.1371/journal.pone.0057896			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460913	Green Published, Green Submitted, gold			2022-12-25	WOS:000315519000168
J	Vigneswara, V; Berry, M; Logan, A; Ahmed, Z				Vigneswara, Vasanthy; Berry, Martin; Logan, Ann; Ahmed, Zubair			Caspase-2 Is Upregulated after Sciatic Nerve Transection and Its Inhibition Protects Dorsal Root Ganglion Neurons from Apoptosis after Serum Withdrawal	PLOS ONE			English	Article							SATELLITE GLIAL-CELLS; PRIMARY SENSORY NEURONS; DNA-DAMAGE; PC12 CELLS; SYMPATHETIC NEURONS; DEATH; INJURY; REGENERATION; ELIMINATION; GROWTH	Sciatic nerve (SN) transection-induced apoptosis of dorsal root ganglion neurons (DRGN) is one factor determining the efficacy of peripheral axonal regeneration and the return of sensation. Here, we tested the hypothesis that caspase-2 (CASP2) orchestrates apoptosis of axotomised DRGN both in vivo and in vitro by disrupting the local neurotrophic supply to DRGN. We observed significantly elevated levels of cleaved CASP2 (C-CASP2), compared to cleaved caspase-3 (C-CASP3), within TUNEL+DRGN and DRG glia (satellite and Schwann cells) after SN transection. A serum withdrawal cell culture model, which induced 40% apoptotic death in DRGN and 60% in glia, was used to model DRGN loss after neurotrophic factor withdrawal. Elevated C-CASP2 and TUNEL were observed in both DRGN and DRG glia, with C-CASP2 localisation shifting from the cytosol to the nucleus, a required step for induction of direct CASP2-mediated apoptosis. Furthermore, siRNA-mediated downregulation of CASP2 protected 50% of DRGN from apoptosis after serum withdrawal, while downregulation of CASP3 had no effect on DRGN or DRG glia survival. We conclude that CASP2 orchestrates the death of SN-axotomised DRGN directly and also indirectly through loss of DRG glia and their local neurotrophic factor support. Accordingly, inhibiting CASP2 expression is a potential therapy for improving both the SN regeneration response and peripheral sensory recovery.	[Vigneswara, Vasanthy; Berry, Martin; Logan, Ann; Ahmed, Zubair] Univ Birmingham, Neurotrauma & Neurodegenerat Sect, Sch Clin & Expt Med, Birmingham, W Midlands, England; [Vigneswara, Vasanthy; Berry, Martin; Logan, Ann; Ahmed, Zubair] Neuregenix Ltd, Birmingham, W Midlands, England	University of Birmingham	Ahmed, Z (corresponding author), Univ Birmingham, Neurotrauma & Neurodegenerat Sect, Sch Clin & Expt Med, Birmingham, W Midlands, England.	z.ahmed.1@bham.ac.uk	Ahmed, Zubair/AAN-1869-2021	Logan, Ann/0000-0003-3215-5042	Neuregenix Ltd; Wellcome Trust; International Spinal Research Trust [STR103] Funding Source: researchfish	Neuregenix Ltd; Wellcome Trust(Wellcome TrustEuropean Commission); International Spinal Research Trust	This work was funded by grants from Neuregenix Ltd, a University-based not-for-profit company and by a Project Grant from the Wellcome Trust to ZA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was partly funded by grants from Neuregenix Ltd, with whom all authors have an affiliation to. Quark Pharmaceuticals Inc., Israel, provided the stable modified siCASP2 and Scr-siCASP2 used in this study. There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Ahmed Z, 2005, MOL CELL NEUROSCI, V28, P509, DOI 10.1016/j.mcn.2004.11.002; Ahmed Z, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.54; Ahmed Z, 2010, NEUROBIOL DIS, V39, P292, DOI 10.1016/j.nbd.2010.04.013; Ahmed Z, 2009, NEUROBIOL DIS, V36, P142, DOI 10.1016/j.nbd.2009.07.016; ALDSKOGIUS H, 1985, BRAIN RES REV, V10, P27, DOI 10.1016/0165-0173(85)90006-2; Arkhipova S S, 2010, Neurosci Behav Physiol, V40, P609, DOI 10.1007/s11055-010-9303-7; Cao XF, 2008, J BIOL CHEM, V283, P14490, DOI 10.1074/jbc.M801107200; Chauvier D, 2005, APOPTOSIS, V10, P1243, DOI 10.1007/s10495-005-1681-x; Chen F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006830; Colussi PA, 1998, J BIOL CHEM, V273, P24535, DOI 10.1074/jbc.273.38.24535; Gao ZH, 2005, J BIOL CHEM, V280, P38271, DOI 10.1074/jbc.M506488200; Gordon T, 2011, J NEUROSCI, V31, P5325, DOI 10.1523/JNEUROSCI.6156-10.2011; Guseva D, 2006, CELL MOL NEUROBIOL, V26, P1225, DOI 10.1007/s10571-006-9005-4; Hanani M, 2005, BRAIN RES REV, V48, P457, DOI 10.1016/j.brainresrev.2004.09.001; Hart AM, 2002, EXP BRAIN RES, V142, P308, DOI 10.1007/s00221-001-0929-0; Hart AM, 2008, NEUROL RES, V30, P999, DOI 10.1179/174313208X362479; Haviv R, 1998, J NEUROSCI RES, V52, P491, DOI 10.1002/(SICI)1097-4547(19980601)52:5<491::AID-JNR1>3.0.CO;2-7; Ho LH, 2008, ONCOGENE, V27, P3393, DOI 10.1038/sj.onc.1211005; JANCSO G, 1992, EXP PHYSIOL, V77, P405, DOI 10.1113/expphysiol.1992.sp003603; Janicke RU, 1998, J BIOL CHEM, V273, P9357, DOI 10.1074/jbc.273.16.9357; Kumar S, 2002, SCIENCE, V297, P1290, DOI 10.1126/science.1076118; Kumar S, 2009, NAT REV CANCER, V9, P897, DOI 10.1038/nrc2745; Lamkanfi M, 2002, CELL DEATH DIFFER, V9, P358, DOI 10.1038/sj.cdd.4400989; Lin CR, 2011, J NEUROSCI RES, V89, P689, DOI 10.1002/jnr.22589; Madro A, 2008, J PHYSIOL PHARMACOL, V59, P239; O'Reilly LA, 2002, CELL DEATH DIFFER, V9, P832, DOI 10.1038/sj.cdd.4401033; Pagliari LJ, 2005, P NATL ACAD SCI USA, V102, P17975, DOI 10.1073/pnas.0506712102; Pannese E, 2010, NEURON GLIA BIOL, V6, P3, DOI 10.1017/S1740925X10000037; Raginov I S, 2005, Neurosci Behav Physiol, V35, P17, DOI 10.1023/B:NEAB.0000049647.19397.30; Saito H, 2009, NEUROSCI LETT, V456, P30, DOI 10.1016/j.neulet.2009.03.075; Schaeffer V, 2010, GLIA, V58, P169, DOI 10.1002/glia.20910; Song XY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001707; Stefanis L, 1997, J NEUROCHEM, V69, P1425; Terenghi G, 2011, J HAND SURG-EUR VOL, V36E, P730, DOI 10.1177/1753193411422202; Tong JX, 1996, EXP NEUROL, V138, P45, DOI 10.1006/exnr.1996.0045; Tong JX, 1997, J NEUROCYTOL, V26, P771, DOI 10.1023/A:1018566431912; Troy CM, 1997, J NEUROSCI, V17, P1911; Troy CM, 2000, J NEUROSCI, V20, P1386; Tu S, 2006, NAT CELL BIOL, V8, P72, DOI 10.1038/ncb1340; Vakifahmetoglu H, 2008, CELL DEATH DIFFER, V15, P555, DOI 10.1038/sj.cdd.4402286; Vincent AM, 2004, ENDOCR REV, V25, P612, DOI 10.1210/er.2003-0019; WETMORE C, 1995, J COMP NEUROL, V353, P143, DOI 10.1002/cne.903530113; Wood MD, 2011, ANN ANAT, V193, P321, DOI 10.1016/j.aanat.2011.04.008; Zhivotovsky B, 2005, BIOCHEM BIOPH RES CO, V331, P859, DOI 10.1016/j.bbrc.2005.03.191	44	21	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57861	10.1371/journal.pone.0057861	http://dx.doi.org/10.1371/journal.pone.0057861			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451279	Green Published, gold, Green Submitted			2022-12-25	WOS:000316849500142
J	Ambroggio, X; Jiang, LB; Aebig, J; Obiakor, H; Lukszo, J; Narum, DL				Ambroggio, Xavier; Jiang, Lubin; Aebig, Joan; Obiakor, Harold; Lukszo, Jan; Narum, David L.			The Epitope of Monoclonal Antibodies Blocking Erythrocyte Invasion by Plasmodium falciparum Map to The Dimerization and Receptor Glycan Binding Sites of EBA-175	PLOS ONE			English	Article							SIALIC-ACID; ANTIGEN 175; MALARIA; PROTEIN; LIGAND; REGION; DOMAIN; PROTECTION; PATHWAYS; CRYSTAL	The malaria parasite, Plasmodium falciparum, and related parasites use a variety of proteins with Duffy-Binding Like (DBL) domains to bind glycoproteins on the surface of host cells. Among these proteins, the 175 kDa erythrocyte binding antigen, EBA-175, specifically binds to glycophorin A on the surface of human erythrocytes during the process of merozoite invasion. The domain responsible for glycophorin A binding was identified as region II (RII) which contains two DBL domains, F1 and F2. The crystal structure of this region revealed a dimer that is presumed to represent the glycophorin A binding conformation as sialic acid binding sites and large cavities are observed at the dimer interface. The dimer interface is largely composed of two loops from within each monomer, identified as the F1 and F2 beta-fingers that contact depressions in the opposing monomers in a similar manner. Previous studies have identified a panel of five monoclonal antibodies (mAbs) termed R215 to R218 and R256 that bind to RII and inhibit invasion of erythrocytes to varying extents. In this study, we predict the F2 beta-finger region as the conformational epitope for mAbs, R215, R217, and R256, and confirm binding for the most effective blocking mAb R217 and R215 to a synthetic peptide mimic of the F2 beta-finger. Localization of the epitope to the dimerization and glycan binding sites of EBA-175 RII and site-directed mutagenesis within the predicted epitope are consistent with R215 and R217 blocking erythrocyte invasion by Plasmodium falciparum by preventing formation of the EBA-175- glycophorin A complex.	[Ambroggio, Xavier] NIAID, Bioinformat & Computat Biosci Branch, Off Cyber Infrastruct & Computat Biol, NIH, Bethesda, MD 20892 USA; [Jiang, Lubin] Chinese Acad Sci, Inst Pasteur Shanghai, Shanghai, Peoples R China; [Aebig, Joan; Obiakor, Harold; Narum, David L.] NIAID, Lab Malaria Immunol & Vaccinol, NIH, Rockville, MD USA; [Lukszo, Jan] NIAID, Res Technol Branch, NIH, Rockville, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Narum, DL (corresponding author), NIAID, Lab Malaria Immunol & Vaccinol, NIH, Rockville, MD USA.	dnarum@niaid.nih.gov		Narum, David/0000-0003-3041-5402	Phase II NIAID Small Business Innovative Research Grant from NIAID [AI36758]; Intramural Research Program of the NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R43AI036758, R44AI036758] Funding Source: NIH RePORTER	Phase II NIAID Small Business Innovative Research Grant from NIAID; Intramural Research Program of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The project was supported by a Phase II NIAID Small Business Innovative Research Grant Number AI36758 supplement from NIAID and by the Intramural Research Program of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bublil EM, 2007, PROTEINS, V68, P294, DOI 10.1002/prot.21387; CAMUS D, 1985, SCIENCE, V230, P553, DOI 10.1126/science.3901257; Chootong P, 2010, INFECT IMMUN, V78, P1089, DOI 10.1128/IAI.01036-09; COHEN GH, 1988, J VIROL, V62, P1932, DOI 10.1128/JVI.62.6.1932-1940.1988; Cowman AF, 2006, CELL, V124, P755, DOI 10.1016/j.cell.2006.02.006; Duraisingh MT, 2003, P NATL ACAD SCI USA, V100, P4796, DOI 10.1073/pnas.0730883100; El Sahly HM, 2010, CLIN VACCINE IMMUNOL, V17, P1552, DOI 10.1128/CVI.00082-10; Grimberg BT, 2007, PLOS MED, V4, P1940, DOI 10.1371/journal.pmed.0040337; Jiang LB, 2011, P NATL ACAD SCI USA, V108, P7553, DOI 10.1073/pnas.1104050108; Jiang LB, 2009, MOL BIOCHEM PARASIT, V168, P49, DOI 10.1016/j.molbiopara.2009.06.006; King CL, 2008, P NATL ACAD SCI USA, V105, P8363, DOI 10.1073/pnas.0800371105; Li XR, 2012, MOL BIOCHEM PARASIT, V183, P23, DOI 10.1016/j.molbiopara.2012.01.002; Liang H, 1997, MOL BIOCHEM PARASIT, V84, P241, DOI 10.1016/S0166-6851(96)02791-0; Lin DH, 2012, J BIOL CHEM, V287, P36830, DOI 10.1074/jbc.M112.409276; Lopaticki S, 2011, INFECT IMMUN, V79, P1107, DOI 10.1128/IAI.01021-10; Maruyama K, 1999, PEPTIDES, V20, P881, DOI 10.1016/S0196-9781(99)00076-5; May AP, 1998, MOL CELL, V1, P719, DOI 10.1016/S1097-2765(00)80071-4; Mayer DCG, 2001, P NATL ACAD SCI USA, V98, P5222, DOI 10.1073/pnas.081075398; Mayrose I, 2007, NUCLEIC ACIDS RES, V35, P69, DOI 10.1093/nar/gkl975; McCarra MB, 2011, PEDIATR INFECT DIS J, V30, P1037, DOI 10.1097/INF.0b013e31822d1451; Michon P, 2000, INFECT IMMUN, V68, P3164, DOI 10.1128/IAI.68.6.3164-3171.2000; Miura K, 2008, VACCINE, V26, P193, DOI 10.1016/j.vaccine.2007.10.064; Narum DL, 2000, INFECT IMMUN, V68, P1964, DOI 10.1128/IAI.68.4.1964-1966.2000; Narum DL, 2002, MOL BIOCHEM PARASIT, V119, P159, DOI 10.1016/S0166-6851(01)00428-5; Narum DL, 2009, MOL DESIGN RECOMBINA; Ockenhouse CF, 2001, MOL BIOCHEM PARASIT, V113, P9, DOI 10.1016/S0166-6851(00)00375-3; Persson KEM, 2008, J CLIN INVEST, V118, P342, DOI 10.1172/JCI32138; Sim BKL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018393; Sim BKL, 2001, MOL MED, V7, P247, DOI 10.1007/BF03401844; SIM BKL, 1994, SCIENCE, V264, P1941, DOI 10.1126/science.8009226; Tham WH, 2012, TRENDS PARASITOL, V28, P23, DOI 10.1016/j.pt.2011.10.002; Thompson JK, 2001, MOL MICROBIOL, V41, P47, DOI 10.1046/j.1365-2958.2001.02484.x; Tolia NH, 2005, CELL, V122, P183, DOI 10.1016/j.cell.2005.05.033; VARGHESE JN, 1992, PROTEINS, V14, P327, DOI 10.1002/prot.340140302	35	19	19	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56326	10.1371/journal.pone.0056326	http://dx.doi.org/10.1371/journal.pone.0056326			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457550	Green Published, Green Submitted, gold			2022-12-25	WOS:000315603700040
J	Adame, MF; Kauffman, JB; Medina, I; Gamboa, JN; Torres, O; Caamal, JP; Reza, M; Herrera-Silveira, JA				Adame, Maria Fernanda; Kauffman, J. Boone; Medina, Israel; Gamboa, Julieta N.; Torres, Olmo; Caamal, Juan P.; Reza, Miriam; Herrera-Silveira, Jorge A.			Carbon Stocks of Tropical Coastal Wetlands within the Karstic Landscape of the Mexican Caribbean	PLOS ONE			English	Article							MANGROVE FORESTS; NUTRIENT DYNAMICS; BRAZILIAN AMAZON; ORGANIC-MATTER; SEA-LEVEL; SEDIMENTS; IGNITION; BIOMASS; FLORIDA; FIRE	Coastal wetlands can have exceptionally large carbon (C) stocks and their protection and restoration would constitute an effective mitigation strategy to climate change. Inclusion of coastal ecosystems in mitigation strategies requires quantification of carbon stocks in order to calculate emissions or sequestration through time. In this study, we quantified the ecosystem C stocks of coastal wetlands of the Sian Ka'an Biosphere Reserve (SKBR) in the Yucatan Peninsula, Mexico. We stratified the SKBR into different vegetation types (tall, medium and dwarf mangroves, and marshes), and examined relationships of environmental variables with C stocks. At nine sites within SKBR, we quantified ecosystem C stocks through measurement of above and belowground biomass, downed wood, and soil C. Additionally, we measured nitrogen (N) and phosphorus (P) from the soil and interstitial salinity. Tall mangroves had the highest C stocks (987 +/- 338 Mg ha(-1)) followed by medium mangroves (623 +/- 41 Mg ha(-1)), dwarf mangroves (381 +/- 52 Mg ha(-1)) and marshes (177 +/- 73 Mg ha(-1)). At all sites, soil C comprised the majority of the ecosystem C stocks (78-99%). Highest C stocks were measured in soils that were relatively low in salinity, high in P and low in N: P, suggesting that P limits C sequestration and accumulation potential. In this karstic area, coastal wetlands, especially mangroves, are important C stocks. At the landscape scale, the coastal wetlands of Sian Ka'an covering approximate to 172,176 ha may store 43.2 to 58.0 million Mg of C.	[Adame, Maria Fernanda; Medina, Israel; Gamboa, Julieta N.; Caamal, Juan P.; Herrera-Silveira, Jorge A.] Inst Politecn Nacl CINVESTAV IPN, Ctr Invest & Estudios Avanzados CINVESTAV, Merida, Mexico; [Adame, Maria Fernanda] Griffith Univ Brisbane, Australian Rivers Inst, Brisbane, Qld, Australia; [Kauffman, J. Boone] Oregon State Univ, Dept Fisheries & Wildlife, Corvallis, OR 97331 USA; [Kauffman, J. Boone] Ctr Int Forest Res, Bogor, Indonesia; [Torres, Olmo] Colectividad Razonatura AC, Mexico City, DF, Mexico; [Reza, Miriam] Amigos de Sian Kaan, Cancun, Mexico	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Griffith University; Oregon State University; CGIAR; Center for International Forestry Research (CIFOR)	Adame, MF (corresponding author), Inst Politecn Nacl CINVESTAV IPN, Ctr Invest & Estudios Avanzados CINVESTAV, Merida, Mexico.	f.adame@griffith.edu.au	Adame, Maria Fernanda/N-8463-2014	Adame, Maria Fernanda/0000-0001-9620-9252	US Agency for International Development (USAID/Mexico) through USFS; US Agency for International Development (USAID/Mexico) through Fondo Mexicano para la Conservacion	US Agency for International Development (USAID/Mexico) through USFS(United States Agency for International Development (USAID)); US Agency for International Development (USAID/Mexico) through Fondo Mexicano para la Conservacion(United States Agency for International Development (USAID))	Funding for the study was provided by the US Agency for International Development (USAID/Mexico) as part of a workshop on quantification of wetland carbon stocks, http://www.usaid.gov/, through USFS http://www.fs.fed.us/ and Fondo Mexicano para la Conservacion http://fmcn.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adame MF, 2013, BIOTROPICA, V45, P147, DOI 10.1111/btp.12000; Alongi DM, 2002, ENVIRON CONSERV, V29, P331, DOI 10.1017/S0376892902000231; [Anonymous], 1974, ANN REV ECOL SYST, DOI DOI 10.1146/ANNUREV.ES.05.110174.000351; [Anonymous], 2007, AR4 CLIM CHANG 2007; ASPILA KI, 1976, ANALYST, V101, P187, DOI 10.1039/an9760100187; Bauer-Gottwein P, 2011, HYDROGEOL J, V19, P507, DOI 10.1007/s10040-010-0699-5; Bedford BL, 1999, ECOLOGY, V80, P2151, DOI 10.1890/0012-9658(1999)080[2151:PINAAP]2.0.CO;2; BYERS SC, 1978, HYDROBIOLOGIA, V58, P43, DOI 10.1007/BF00018894; Chen RH, 1999, ESTUARIES, V22, P955, DOI 10.2307/1353075; Cintron G., 1984, MANGROVE ECOSYSTEM R, P91; Conabio, 2009, MANGLARES MEXICO EXT, P100; CONABIO National Commission on Biodiversity, NAT COMM BIOD; Coronado-Molina C., 2004, Wetlands Ecology and Management, V12, P157, DOI 10.1023/B:WETL.0000034071.17156.c0; DEAN WE, 1974, J SEDIMENT PETROL, V44, P242; DeBusk WF, 1998, SOIL SCI SOC AM J, V62, P1460, DOI 10.2136/sssaj1998.03615995006200050045x; Donato D.C., 2012, 86 CIFOR BOGOR; Donato DC, 2011, NAT GEOSCI, V4, P293, DOI [10.1038/ngeo1123, 10.1038/NGEO1123]; Duke NC, 2007, SCIENCE, V317, P41, DOI 10.1126/science.317.5834.41b; Ellison AM, 1996, BIOTROPICA, V28, P549, DOI 10.2307/2389096; FELLER IC, 1995, ECOL MONOGR, V65, P477, DOI 10.2307/2963499; Gilman EL, 2008, AQUAT BOT, V89, P237, DOI 10.1016/j.aquabot.2007.12.009; Giri C, 2011, GLOBAL ECOL BIOGEOGR, V20, P154, DOI 10.1111/j.1466-8238.2010.00584.x; Gondwe BRN, 2010, WETLANDS, V30, P1, DOI 10.1007/s13157-009-0016-z; Heiri O, 2001, J PALEOLIMNOL, V25, P101, DOI 10.1023/A:1008119611481; Hernandez-Terrones L, 2011, WATER AIR SOIL POLL, V218, P517, DOI 10.1007/s11270-010-0664-x; Herrera-Silveira JA, 2009, MAR POLLUT BULL, V59, P72, DOI 10.1016/j.marpolbul.2008.11.017; Hughes RF, 1999, ECOLOGY, V80, P1892; Hughes RF, 2000, ECOL APPL, V10, P515, DOI 10.1890/1051-0761(2000)010[0515:ESIODA]2.0.CO;2; INEGI, NAT I STAT GEOGR; International Energy Agency (IEA), 2011, CO2 EM FUEL COMB 201; Jaramillo VJ, 2003, ECOSYSTEMS, V6, P609, DOI 10.1007/s10021-002-0195-4; Kauffman JB, 2011, WETLANDS, V31, P343, DOI 10.1007/s13157-011-0148-9; KAUFFMAN JB, 1995, OECOLOGIA, V104, P397, DOI 10.1007/BF00341336; Kitayama K, 2002, J ECOL, V90, P37, DOI 10.1046/j.0022-0477.2001.00634.x; Komiyama A, 2005, J TROP ECOL, V21, P471, DOI 10.1017/S0266467405002476; Laffoley D., 2009, MANAGEMENT NATURAL C; Lopez-Medellin X, 2011, J VEG SCI, V22, P143, DOI 10.1111/j.1654-1103.2010.01232.x; Lovelock CE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021279; Mckee KL, 2007, GLOBAL ECOL BIOGEOGR, V16, P545, DOI 10.1111/j.1466-8238.2007.00317.x; Medina I, 2011, THESIS; MORAES JL, 1995, SOIL SCI SOC AM J, V59, P244, DOI 10.2136/sssaj1995.03615995005900010038x; Murdiyarso D, 2009, 48 CTR INT FOR RES; Murray MR, 2003, FOREST ECOL MANAG, V174, P265, DOI 10.1016/S0378-1127(02)00036-1; Nellemann C, 2009, BLUE CARBON RAPID RE; O'Brien RM, 2007, QUAL QUANT, V41, P673, DOI 10.1007/s11135-006-9018-6; Parsons T.R., 1984, MANUAL BIOL CHEM MET; POOL DJ, 1977, BIOTROPICA, V9, P195, DOI 10.2307/2387881; PRIMAVERA JH, 1995, HYDROBIOLOGIA, V295, P303, DOI 10.1007/BF00029137; Rejmankova E, 1996, INT REV GES HYDROBIO, V81, P223, DOI 10.1002/iroh.19960810208; Rejmankova E, 2001, PLANT SOIL, V236, P33, DOI 10.1023/A:1011953715153; Robertson A.I., 1992, TROPICAL MANGROVE EC; Rocha AV, 2010, J GEOPHYS RES, V115, P1; Ross Michael S., 2001, Wetlands Ecology and Management, V9, P27, DOI 10.1023/A:1008411103288; Santisteban JI, 2004, J PALEOLIMNOL, V32, P287, DOI 10.1023/B:JOPL.0000042999.30131.5b; Siikamaki J, 2012, P NATL ACAD SCI USA, V109, P14369, DOI 10.1073/pnas.1200519109; Smith SM, 2001, J ENVIRON QUAL, V30, P1998, DOI 10.2134/jeq2001.1998; Smith Thomas J. III, 2006, Wetlands Ecology and Management, V14, P409, DOI 10.1007/s11273-005-6243-z; SMN-CAN, NAT MET SYST NAT WAT; Spaulding M, 2010, WORLD ATLAS MANGROVE; URBAN NH, 1993, AQUAT BOT, V46, P203, DOI 10.1016/0304-3770(93)90002-E; Valiela I, 2001, BIOSCIENCE, V51, P807, DOI 10.1641/0006-3568(2001)051[0807:MFOOTW]2.0.CO;2; VANWAGNER CE, 1968, FOREST SCI, V14, P20; Wang XL, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0036663, 10.1371/journal.pone.0040711, 10.1371/journal.pone.0045939, 10.1371/journal.pone.0040084, 10.1371/journal.pone.0038932, 10.1371/journal.pone.0040857, 10.1371/journal.pone.0052707, 10.1371/journal.pone.0052082, 10.1371/journal.pone.0045036, 10.1371/journal.pone.0047429, 10.1371/journal.pone.0045380]; Zanne AE, 2009, GLOBAL WOOD DENSITY	65	182	191	7	192	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56569	10.1371/journal.pone.0056569	http://dx.doi.org/10.1371/journal.pone.0056569			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457583	Green Published, gold			2022-12-25	WOS:000315602700079
J	Huisman, CM; Zwart, JJ; Roos-Hesselink, JW; Duvekot, JJ; van Roosmalen, J				Huisman, Claartje M.; Zwart, Joost J.; Roos-Hesselink, Jolien W.; Duvekot, Johannes J.; van Roosmalen, Jos			Incidence and Predictors of Maternal Cardiovascular Mortality and Severe Morbidity in the Netherlands: A Prospective Cohort Study	PLOS ONE			English	Article							CONGENITAL HEART-DISEASE; PULMONARY-EDEMA; PERIPARTUM CARDIOMYOPATHY; MYOCARDIAL-INFARCTION; PROSTAGLANDIN ANALOG; CARDIAC-DISEASE; PREGNANCY; WOMEN; ASSOCIATION; MANAGEMENT	Objective: To assess incidence and possible risk factors of severe maternal morbidity and mortality from cardiovascular disease in the Netherlands. Design: A prospective population based cohort study. Setting: All 98 maternity units in the Netherlands. Population: All women delivering in the Netherlands between August 2004 and August 2006 (n = 371,021) Methods: Cases of severe maternal morbidity and mortality from cardiovascular disease were prospectively collected during a two-year period in the Netherlands. Women with cardiovascular complications during pregnancy or postpartum who were admitted to the ward, intensive care or coronary care unit were included. Cardiovascular morbidity was defined as cardiomyopathy, valvular disease, ischaemic heart disease, arrhythmias or aortic dissection. All women delivering in the same period served as a reference cohort. Main outcome measures: Incidence, case fatality rates and possible risk factors. Results: Incidence of severe maternal morbidity due to cardiovascular disease was 2.3 per 10,000 deliveries (84/358,874). Maternal mortality rate from cardiovascular disease was 3.0 per 100,000 deliveries (11/358,874). Case fatality rate in women with severe maternal morbidity due to cardiovascular disease was 13% (11/84). Case fatality rate was highest in aortic dissection (83%). Pre-existing acquired or congenital heart disease was identified in 34% of women. Thirty-one percent of women were of advanced maternal age (>35 years of age) and 5 percent above 40 years of age. Possible risk factors for cardiovascular morbidity were caesarean section (either resulting in or as a result of cardiovascular disease), multiple pregnancy, prior caesarean section, non-Western ethnicity and obesity. Conclusions: In the Netherlands cardiovascular disease is a rare cause of severe maternal morbidity with an incidence of 2.3 per 10,000 deliveries and a high case fatality rate of 13%. Cardiovascular complications develop mostly in women not known with cardiac disease pre-pregnancy.	[Huisman, Claartje M.] Bronovo Hosp, Dept Obstet & Gynaecol, The Hague, Netherlands; [Huisman, Claartje M.; Zwart, Joost J.; van Roosmalen, Jos] Leiden Univ, Dept Obstet, Med Ctr, Leiden, Netherlands; [Zwart, Joost J.] Deventer Hosp, Dept Obstet & Gynaecol, Deventer, Netherlands; [Roos-Hesselink, Jolien W.] Erasmus MC, Dept Cardiol, Rotterdam, Netherlands; [Duvekot, Johannes J.] Erasmus MC, Dept Obstet & Gynaecol, Rotterdam, Netherlands; [van Roosmalen, Jos] Vrije Univ Amsterdam, Dept Med Humanities, EMGO Inst Hlth & Care Res, Med Ctr, Amsterdam, Netherlands	Haaglanden Medical Center; Bronovo Hospital; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Deventer Hospital; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Vrije Universiteit Amsterdam	Huisman, CM (corresponding author), Bronovo Hosp, Dept Obstet & Gynaecol, The Hague, Netherlands.	c.m.a.huisman@gmail.com		Huisman, Claartje/0000-0003-0616-2847	Dutch Organisation for Health Research (ZonMw) [3610.0024]; Matty Brand Foundation	Dutch Organisation for Health Research (ZonMw)(Netherlands Organization for Health Research and Development); Matty Brand Foundation	The LEMMoN-study was supported by the Dutch Organisation for Health Research (ZonMw; grant 3610.0024) and the Matty Brand Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arafeh JMR, 2006, CRIT CARE NURS Q, V29, P32, DOI 10.1097/00002727-200601000-00004; Balci A, 2011, AM HEART J, V161, P269, DOI 10.1016/j.ahj.2010.10.024; Bax A, 1999, ACTA OBSTET GYN SCAN, V78, P915; Bedard E, 2008, BRIT MED BULL, V85, P151, DOI 10.1093/bmb/ldn005; BLICKSTEIN I, 1988, AM J OBSTET GYNECOL, V159, P332, DOI 10.1016/S0002-9378(88)80078-4; Bonneux L, 2008, Ned Tijdschr Geneeskd, V152, P2697; Brace V, 2004, BJOG-INT J OBSTET GY, V111, P481, DOI 10.1111/j.1471-0528.2004.00101.x; Chang Jeani, 2003, MMWR Surveill Summ, V52, P1; Chen YC, 2009, TAIWAN J OBSTET GYNE, V48, P181, DOI 10.1016/S1028-4559(09)60284-9; Chu SY, 2008, AM J OBSTET GYNECOL, V199, pE18, DOI [10.1016/j.ajog.2008.02.038, 10.1016/j.ajog.2007.12.020]; Curry R, 2009, CURR OPIN OBSTET GYN, V21, P508, DOI 10.1097/GCO.0b013e328332a762; Drenthen W, 2007, J AM COLL CARDIOL, V49, P2303, DOI 10.1016/j.jacc.2007.03.027; Dutch Society of Obstetricians and Gynaecologists (NVOG), 2011, NAT IVF RES; Farmacotherapeutisch Kompas, 2009, MED FARM VOORL UITG, P579; FLIERS E, 1991, BRIT MED J, V302, P416, DOI 10.1136/bmj.302.6773.416-a; Fornet I, 2006, Rev Esp Anestesiol Reanim, V53, P312; Gelson E, 2009, BJOG-INT J OBSTET GY, V116, P609, DOI 10.1111/j.1471-0528.2008.02082.x; Kwee A, 2007, EUR J OBSTET GYN R B, V132, P171, DOI 10.1016/j.ejogrb.2006.07.017; la Chapelle CF, 2012, BJOG-INT J OBSTET GY, V119, P86, DOI 10.1111/j.1471-0528.2011.03178.x; Lewis Ge, 2007, SAVING MOTHERS LIVES, P117; LVR, 2011, NETH PER REG; Ntusi NBA, 2009, INT J CARDIOL, V131, P168, DOI 10.1016/j.ijcard.2008.06.054; PALMER CM, 1990, ANESTH ANALG, V70, P36; Regitz-Zagrosek V, 2011, EUR HEART J, V32, P3147, DOI 10.1093/eurheartj/ehr218; Roos-Hesselink JW, 2012, EUR HEART J IN PRESS; Schutte JM, 2010, BJOG-INT J OBSTET GY, V117, P399, DOI 10.1111/j.1471-0528.2009.02382.x; Sliwa K, 2010, EUR J HEART FAIL, V12, P767, DOI 10.1093/eurjhf/hfq120; STOCK A, 1995, ACTA OBSTET GYN SCAN, V74, P156, DOI 10.3109/00016349509008927; ULMANN A, 1992, ACTA OBSTET GYN SCAN, V71, P278, DOI 10.3109/00016349209021052; Usta IM, 2008, AM J PERINAT, V25, P521, DOI 10.1055/s-0028-1085620; Waterstone M, 2001, BMJ-BRIT MED J, V322, P1089, DOI 10.1136/bmj.322.7294.1089; Wen SW, 2005, CAN MED ASSOC J, V173, P759, DOI 10.1503/cmaj.045156; Zwart JJ, 2008, BJOG-INT J OBSTET GY, V115, P842, DOI 10.1111/j.1471-0528.2008.01713.x	33	35	38	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56494	10.1371/journal.pone.0056494	http://dx.doi.org/10.1371/journal.pone.0056494			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457576	gold, Green Published, Green Submitted			2022-12-25	WOS:000315602700076
J	Moreira, S; Bishopp, A; Carvalho, H; Campilho, A				Moreira, Sofia; Bishopp, Anthony; Carvalho, Helena; Campilho, Ana			AHP6 Inhibits Cytokinin Signaling to Regulate the Orientation of Pericycle Cell Division during Lateral Root Initiation	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; FOUNDER CELLS; AUXIN; SHOOT; MERISTEM; DIFFERENTIATION; ORGANOGENESIS; SPECIFICATION; PATTERN; GROWTH	In Arabidopsis thaliana, lateral roots (LRs) initiate from anticlinal cell divisions of pericycle founder cells. The formation of LR primordia is regulated antagonistically by the phytohormones cytokinin and auxin. It has previously been shown that cytokinin has an inhibitory effect on the patterning events occurring during LR formation. However, the molecular players involved in cytokinin repression are still unknown. In a similar manner to protoxylem formation in Arabidopsis roots, in which AHP6 (ARABIDOPSIS HISTIDINE PHOSPHOTRANSFER PROTEIN 6) acts as a cytokinin inhibitor, we reveal that AHP6 also functions as a cytokinin repressor during early stages of LR development. We show that AHP6 is expressed at different developmental stages during LR formation and is required for the correct orientation of cell divisions at the onset of LR development. Moreover, we demonstrate that AHP6 influences the localization of the auxin efflux carrier PIN1, which is necessary for patterning the LR primordia. In summary, we show that the inhibition of cytokinin signaling through AHP6 is required to establish the correct pattern during LR initiation.	[Moreira, Sofia; Carvalho, Helena; Campilho, Ana] Univ Porto, Inst Mol & Cell Biol IBMC, P-4100 Oporto, Portugal; [Bishopp, Anthony] Univ Helsinki, Inst Biotechnol, Helsinki, Finland	Universidade do Porto; University of Helsinki	Campilho, A (corresponding author), Univ Porto, Inst Mol & Cell Biol IBMC, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	anacampilho@ibmc.up.pt	Carvalho, Helena G/E-9357-2012; Campilho, Ana/H-8790-2013; Campilho, Ana/U-8263-2019; Carvalho, Helena/M-6733-2019	Carvalho, Helena G/0000-0003-0651-7601; Campilho, Ana/0000-0002-3470-1943; Campilho, Ana/0000-0002-3470-1943; Carvalho, Helena/0000-0003-0651-7601; Moreira, Sofia/0000-0002-7530-4768; Bishopp, Anthony/0000-0003-2962-9542; Moreira, Sofia/0000-0002-2085-5001	'Programa Ciencia' (FCT); University of Helsinki; University of Porto	'Programa Ciencia' (FCT); University of Helsinki; University of Porto	AC was funded by 'Programa Ciencia' (FCT). AB was funded by University of Helsinki. HC was funded by University of Porto. No external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartrina I, 2011, PLANT CELL, V23, P69, DOI 10.1105/tpc.110.079079; Benkova E, 2003, CELL, V115, P591, DOI 10.1016/S0092-8674(03)00924-3; Bhalerao RP, 2002, PLANT J, V29, P325, DOI 10.1046/j.0960-7412.2001.01217.x; Bishopp A, 2011, CURR BIOL, V21, P917, DOI 10.1016/j.cub.2011.04.017; De Rybel B, 2010, CURR BIOL, V20, P1697, DOI 10.1016/j.cub.2010.09.007; De Smet I, 2010, P NATL ACAD SCI USA, V107, P2705, DOI 10.1073/pnas.0915001107; Dello Ioio R, 2008, SCIENCE, V322, P1380, DOI 10.1126/science.1164147; Dubrovsky JG, 2008, P NATL ACAD SCI USA, V105, P8790, DOI 10.1073/pnas.0712307105; Dubrovsky JG, 2012, PLANT CELL, V24, P4, DOI 10.1105/tpc.111.089698; Dubrovsky JG, 2011, NEW PHYTOL, V191, P970, DOI 10.1111/j.1469-8137.2011.03757.x; Hwang I, 2001, NATURE, V413, P383, DOI 10.1038/35096500; Laplaze L, 2007, PLANT CELL, V19, P3889, DOI 10.1105/tpc.107.055863; Mahonen AP, 2006, SCIENCE, V311, P94, DOI 10.1126/science.1118875; Malamy JE, 1997, DEVELOPMENT, V124, P33; Marhavy P, 2011, DEV CELL, V21, P796, DOI 10.1016/j.devcel.2011.08.014; Muller B, 2008, NATURE, V453, P1094, DOI 10.1038/nature06943; Peret B, 2009, TRENDS PLANT SCI, V14, P399, DOI 10.1016/j.tplants.2009.05.002; Riefler M, 2006, PLANT CELL, V18, P40, DOI 10.1105/tpc.105.037796; Sabatini S, 1999, CELL, V99, P463, DOI 10.1016/S0092-8674(00)81535-4; Swarup R, 2004, PLANT CELL, V16, P3069, DOI 10.1105/tpc.104.024737; ten Tusscher K, 2011, CURR OPIN GENET DEV, V21, P799, DOI 10.1016/j.gde.2011.09.008; Werner T, 2003, PLANT CELL, V15, P2532, DOI 10.1105/tpc.014928; Werner T, 2006, PLANT BIOLOGY, V8, P371, DOI 10.1055/s-2006-923928; Werner T, 2010, PLANT CELL, V22, P3905, DOI 10.1105/tpc.109.072694; Willemsen V, 1998, DEVELOPMENT, V125, P521; Zhao Z, 2010, NATURE, V465, P1089, DOI 10.1038/nature09126	26	40	41	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56370	10.1371/journal.pone.0056370	http://dx.doi.org/10.1371/journal.pone.0056370			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457561	gold, Green Submitted, Green Published			2022-12-25	WOS:000315602700071
J	Rui, T; Tang, QZ				Rui, Tao; Tang, Qizhu			IL-33 Attenuates Anoxia/Reoxygenation-Induced Cardiomyocyte Apoptosis by Inhibition of PKC beta/JNK Pathway	PLOS ONE			English	Article							INDUCED MYOCARDIAL APOPTOSIS; ISCHEMIA-REPERFUSION INJURY; CARDIAC MYOCYTE APOPTOSIS; ACTIVATED PROTEIN-KINASES; TUMOR-NECROSIS-FACTOR; NF-KAPPA-B; PROINFLAMMATORY PHENOTYPE; DIABETIC COMPLICATIONS; TNF-ALPHA; HEART	Background: Interleukin-33 (IL-33) is a new member of the IL-1 cytokine family. The objectives of present study are to assess whether IL-33 can protect cardiomyocytes from anoxia/reoxygenation (A/R)-induced injury and the mechanism involved in the protection. Methods: Cardiomyocytes derived from either wild type or JNK1(-/-) mice were challenged with an A/R with or without IL-33. Myocyte apoptosis was assessed by measuring caspase 3 activity, fragmented DNA and TUNEL staining. In addition, cardiomyocyte oxidative stress was assessed by measuring DHR123 oxidation; PKC beta II and JNK phosphorylation were assessed with Western blot. Results: Challenge of cardiomyocytes with an A/R resulted in cardiomyocyte oxidative stress, PKC beta II and JNK phosphorylation, and myocyte apoptosis. Treatment of the cardiomyocytes with IL-33 attenuated the A/R-induced myocyte oxidative stress, prevented PKC beta II and JNK phosphorylation and attenuated the A/R-induced myocyte apoptosis. The protective effect of the IL-33 did not show in cardiac myocytes with siRNA specific to PKC beta II or myocytes deficient in JNK1. Inhibition of PKC beta II prevented the A/R-induced JNK phosphorylation, but inhibition of JNK1 showed no effect on A/R-induced PKC beta II phosphorylation. Conclusions: Our results indicate that IL-33 prevents the A/R-induced myocyte apoptosis through inhibition of PKC beta/JNK pathway.	[Rui, Tao; Tang, Qizhu] Wuhan Univ, Div Cardiol, Dept Med, Renmin Hosp, Wuhan 430072, Hubei Province, Peoples R China; [Rui, Tao] Jiangsu Univ, Div Cardiol, Dept Med, Affiliated Peoples Hosp, Zhenjiang, Jiangsu, Peoples R China; [Rui, Tao] Lawson Hlth Res Inst, London, ON, Canada; [Rui, Tao] Univ Western Ontario, Dept Med, Schulich Sch Med & Dent, London, ON, Canada	Wuhan University; Jiangsu University; Western University (University of Western Ontario); Western University (University of Western Ontario)	Tang, QZ (corresponding author), Wuhan Univ, Div Cardiol, Dept Med, Renmin Hosp, Wuhan 430072, Hubei Province, Peoples R China.	qztang@whu.edu.cn	Rui, Tao/H-7044-2016		National Natural Science Foundation of China [81170210]; Heart and Stroke Foundation of Ontario [GIA 000212]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario)	This study was supported by the following grants: National Natural Science Foundation of China (81170210) and Heart and Stroke Foundation of Ontario (GIA 000212). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asbun J, 2006, J AM COLL CARDIOL, V47, P693, DOI 10.1016/j.jacc.2005.09.050; Baines CP, 2005, J MOL CELL CARDIOL, V38, P47, DOI 10.1016/j.yjmcc.2004.11.004; Crow MT, 2004, CIRC RES, V95, P957, DOI 10.1161/01.RES.0000148632.35500.d9; Dhingra S, 2009, CARDIOVASC RES, V82, P59, DOI 10.1093/cvr/cvp040; Geraldes P, 2010, CIRC RES, V106, P1319, DOI 10.1161/CIRCRESAHA.110.217117; Harja E, 2009, FASEB J, V23, P1081, DOI 10.1096/fj.08-120345; Kakkar R, 2008, NAT REV DRUG DISCOV, V7, P827, DOI 10.1038/nrd2660; Karin M, 1996, PHILOS T ROY SOC B, V351, P127, DOI 10.1098/rstb.1996.0008; Kleinbongard P, 2011, HEART FAIL REV, V16, P49, DOI 10.1007/s10741-010-9180-8; Kong L, 2008, AM J PHYSIOL-HEART C, V294, pH1862, DOI 10.1152/ajpheart.01346.2007; Koya D, 1998, DIABETES, V47, P859, DOI 10.2337/diabetes.47.6.859; Liew FY, 2010, NAT REV IMMUNOL, V10, P103, DOI 10.1038/nri2692; Liu J, 2004, MOL CELL BIOL, V24, P10844, DOI 10.1128/MCB.24.24.10844-10856.2004; Logue SE, 2005, J MOL CELL CARDIOL, V38, P21, DOI 10.1016/j.yjmcc.2004.11.009; Lopez-Bergami P, 2008, INT J BIOCHEM CELL B, V40, P1055, DOI 10.1016/j.biocel.2007.11.011; Michel MC, 2001, N-S ARCH PHARMACOL, V363, P245, DOI 10.1007/s002100000363; Murphy E, 2008, PHYSIOL REV, V88, P581, DOI 10.1152/physrev.00024.2007; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Rui T, 2005, FASEB J, V19, P1908, DOI 10.1096/fj.05-4028fje; Rui T, 2003, CARDIOVASC RES, V59, P901, DOI 10.1016/S0008-6363(03)00502-9; Rui T, 2001, AM J PHYSIOL-HEART C, V281, pH440, DOI 10.1152/ajpheart.2001.281.1.H440; Rui T, 2012, CARDIOVASC RES, V94, P370, DOI 10.1093/cvr/cvs015; Sanada S, 2007, J CLIN INVEST, V117, P1538, DOI 10.1172/JCI30634; Saraste A, 2000, CARDIOVASC RES, V45, P528, DOI 10.1016/S0008-6363(99)00384-3; Seki K, 2009, CIRC-HEART FAIL, V2, P684, DOI 10.1161/CIRCHEARTFAILURE.109.873240; Varfolomeev EE, 2004, CELL, V116, P491, DOI 10.1016/S0092-8674(04)00166-7; Xu H, 2011, AM J PHYSIOL-HEART C, V300, pH913, DOI 10.1152/ajpheart.00703.2010; Yan SF, 2006, J AM COLL CARDIOL, V48, pA47, DOI 10.1016/j.jacc.2006.05.063; Yang M, 2008, AM J PHYSIOL-HEART C, V294, pH994, DOI 10.1152/ajpheart.01044.2007; Yao YW, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0267-3; Yellon DM, 2007, NEW ENGL J MED, V357, P1121, DOI 10.1056/NEJMra071667	31	16	16	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56089	10.1371/journal.pone.0056089	http://dx.doi.org/10.1371/journal.pone.0056089			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457506	Green Published, Green Submitted, gold			2022-12-25	WOS:000315602700043
J	Tsakiri, EN; Sykiotis, GP; Papassideri, IS; Gorgoulis, VG; Bohmann, D; Trougakos, IP				Tsakiri, Eleni N.; Sykiotis, Gerasimos P.; Papassideri, Issidora S.; Gorgoulis, Vassilis G.; Bohmann, Dirk; Trougakos, Ioannis P.			Differential regulation of proteasome functionality in reproductive vs. somatic tissues of Drosophila during aging or oxidative stress	FASEB JOURNAL			English	Article						antioxidant response elements; gonads; Keap1; Nrf2	EMBRYONIC STEM-CELLS; DAMAGED PROTEINS; 20S PROTEASOME; 26S PROTEASOME; ANTIOXIDANT RESPONSE; HUMAN FIBROBLASTS; LIFE-SPAN; AGE; MELANOGASTER; LONGEVITY	Proteasome is central to proteostasis maintenance, as it degrades both normal and damaged proteins. Herein, we undertook a detailed analysis of proteasome regulation in the in vivo setting of Drosophila melanogaster. We report that a major hallmark of somatic tissues of aging flies is the gradual accumulation of ubiquitinated and carbonylated proteins; these effects correlated with a similar to 50% reduction of proteasome expression and catalytic activities. In contrast, gonads of aging flies were relatively free of proteome oxidative damage and maintained substantial proteasome expression levels and highly active proteasomes. Moreover, gonads of young flies were found to possess more abundant and more active proteasomes than somatic tissues. Exposure of flies to oxidants induced higher proteasome activities specifically in the gonads, which were, independently of age, more resistant than soma to oxidative challenge and, as analyses in reporter transgenic flies showed, retained functional antioxidant responses. Finally, inducible Nrf2 activation in transgenic flies promoted youthful proteasome expression levels in the aged soma, suggesting that age-dependent Nrf2 dysfunction is causative of decreasing somatic proteasome expression during aging. The higher investment in proteostasis maintenance in the gonads plausibly facilitates proteome stability across generations; it also provides evidence in support of the trade-off theories of aging.-Tsakiri, E. N., Sykiotis, G. P., Papassideri, I. S., Gorgoulis, V. G., Bohmann, D., Trougakos, I. P. Differential regulation of proteasome functionality in reproductive vs. somatic tissues of Drosophila during aging or oxidative stress.	[Tsakiri, Eleni N.; Papassideri, Issidora S.; Trougakos, Ioannis P.] Univ Athens, Fac Biol, Dept Cell Biol & Biophys, Athens 15784, Greece; [Sykiotis, Gerasimos P.] Univ Patras, Sch Med, Dept Internal Med, Div Endocrinol, GR-26110 Patras, Greece; [Gorgoulis, Vassilis G.] Univ Athens, Sch Med, Dept Histol & Embryol, GR-11527 Athens, Greece; [Bohmann, Dirk] Univ Rochester, Med Ctr, Dept Biomed Genet, Rochester, NY 14642 USA	National & Kapodistrian University of Athens; University of Patras; Athens Medical School; National & Kapodistrian University of Athens; University of Rochester	Trougakos, IP (corresponding author), Univ Athens, Fac Biol, Dept Cell Biol & Biophys, Athens 15784, Greece.	itrougakos@biol.uoa.gr	Sykiotis, Gerasimos P/E-7407-2017; Trougakos, Ioannis/R-6149-2018; Gorgoulis, Vassilis/AAD-3630-2019	Trougakos, Ioannis/0000-0002-6179-2772; Gorgoulis, Vassilis/0000-0001-9001-4112; Sykiotis, Gerasimos/0000-0002-9565-4941; Tsakiri, Eleni/0000-0002-3271-6316	European Union [REGPOT-CT-2011-284460]; NATIONAL INSTITUTE ON AGING [R01AG039753] Funding Source: NIH RePORTER	European Union(European Commission); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors thank Maria Figueiredo-Pereira (Hunter College, City University of New York, New York, NY, USA) for the Drosophila beta 5 proteasome subunit antibody; Eirini Komseli for immunostaining of paraffin-embedded flies; Triantafyllia Ntouroupi for technical support during the early phase of this project; and Marianna Antonelou for helpful suggestions. This work was supported by a European Union FP7 Capacities grant INsPiRE (REGPOT-CT-2011-284460) to I.P.T.	Aguilaniu H, 2003, SCIENCE, V299, P1751, DOI 10.1126/science.1080418; Aiken CT, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006924; Bader N, 2007, EXP GERONTOL, V42, P864, DOI 10.1016/j.exger.2007.03.010; Beedholm R, 2004, CELL STRESS CHAPERON, V9, P49, DOI 10.1379/1466-1268(2004)009<0049:MHSSSP>2.0.CO;2; Breusing N, 2008, BIOL CHEM, V389, P203, DOI 10.1515/BC.2008.029; Carnes BA, 2011, BIOGERONTOLOGY, V12, P367, DOI 10.1007/s10522-011-9338-3; Chatterjee N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034063; Chondrogianni N, 2003, J BIOL CHEM, V278, P28026, DOI 10.1074/jbc.M301048200; Chondrogianni N, 2000, EXP GERONTOL, V35, P721, DOI 10.1016/S0531-5565(00)00137-6; Cook C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005888; Edelmann MJ, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411002031; Erjavec N, 2008, P NATL ACAD SCI USA, V105, P18764, DOI 10.1073/pnas.0804550105; Erjavec N, 2007, P NATL ACAD SCI USA, V104, P10877, DOI 10.1073/pnas.0701634104; Ferguson M, 2005, BIOCHEM J, V390, P501, DOI 10.1042/BJ20042130; Fredriksson A, 2012, AGING CELL, V11, P634, DOI 10.1111/j.1474-9726.2012.00823.x; Friguet B, 2006, FEBS LETT, V580, P2910, DOI 10.1016/j.febslet.2006.03.028; Girardot F, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-69; Golden TR, 2002, AGING CELL, V1, P117, DOI 10.1046/j.1474-9728.2002.00015.x; Goudeau J, 2010, AGING CELL, V9, P991, DOI 10.1111/j.1474-9726.2010.00625.x; Grimberg KB, 2011, MOL CELL BIOL, V31, P897, DOI 10.1128/MCB.00799-10; Hansen TO, 2012, BIOGERONTOLOGY, V13, P429, DOI 10.1007/s10522-012-9387-2; Hernebring M, 2006, P NATL ACAD SCI USA, V103, P7700, DOI 10.1073/pnas.0510944103; Hubbard VM, 2012, BIOGERONTOLOGY, V13, P21, DOI 10.1007/s10522-011-9331-x; Imai J, 2003, EMBO J, V22, P3557, DOI 10.1093/emboj/cdg349; Jacobson J, 2010, AGING CELL, V9, P466, DOI 10.1111/j.1474-9726.2010.00573.x; Kim SK, 2007, J EXP BIOL, V210, P1607, DOI 10.1242/jeb.004887; Kirkwood TBL, 2000, NATURE, V408, P233, DOI 10.1038/35041682; Kucherenko M. M., 2010, J VIS EXP, V46; Kurapati R, 2000, J GERONTOL A-BIOL, V55, pB552, DOI 10.1093/gerona/55.11.B552; Navon A, 2009, J BIOL CHEM, V284, P33713, DOI 10.1074/jbc.R109.018481; Nickell S, 2009, P NATL ACAD SCI USA, V106, P11943, DOI 10.1073/pnas.0905081106; Petersen A., 2010, CURR GERONTOL GERIAT, DOI [10.1155/2010/, DOI 10.1155/2010]; Pickart CM, 2004, NAT REV MOL CELL BIO, V5, P177, DOI 10.1038/nrm1336; Pickering AM, 2012, PROG MOL BIOL TRANSL, V109, P227, DOI 10.1016/B978-0-12-397863-9.00006-7; Pickering AM, 2010, BIOCHEM J, V432, P585, DOI 10.1042/BJ20100878; Rattan SIS, 2008, BIOL CHEM, V389, P267, DOI 10.1515/BC.2008.030; Rattan SIS, 2006, FREE RADICAL RES, V40, P1230, DOI 10.1080/10715760600911303; Rattan SIS, 2012, BIOGERONTOLOGY, V13, P83, DOI 10.1007/s10522-011-9354-3; Reinheckel T, 1998, BIOCHEM J, V335, P637, DOI 10.1042/bj3350637; Shenvi SV, 2012, AGING CELL, V11, P297, DOI 10.1111/j.1474-9726.2011.00788.x; Simonsen A, 2008, AUTOPHAGY, V4, P176, DOI 10.4161/auto.5269; Sohal RS, 2012, FREE RADICAL BIO MED, V52, P539, DOI 10.1016/j.freeradbiomed.2011.10.445; Sykiotis GP, 2008, DEV CELL, V14, P76, DOI 10.1016/j.devcel.2007.12.002; Sykiotis GP, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3112re3; Szlanka T, 2003, J CELL SCI, V116, P1023, DOI 10.1242/jcs.00332; Tonoki A, 2009, MOL CELL BIOL, V29, P1095, DOI 10.1128/MCB.01227-08; Tower J, 2006, MECH AGEING DEV, V127, P705, DOI 10.1016/j.mad.2006.05.001; Trougakos IP, 1998, J STRUCT BIOL, V123, P97, DOI 10.1006/jsbi.1998.4999; Vernace VA, 2007, FASEB J, V21, P2672, DOI 10.1096/fj.06-6751com; Vijg J, 2008, NATURE, V454, P1065, DOI 10.1038/nature07216; Vilchez D, 2012, NATURE, V489, P263, DOI 10.1038/nature11315; Vilchez D, 2012, NATURE, V489, P304, DOI 10.1038/nature11468; Villeneuve NF, 2010, ANTIOXID REDOX SIGN, V13, P1699, DOI 10.1089/ars.2010.3211; Wensink M, 2013, BIOGERONTOLOGY, V14, P99, DOI 10.1007/s10522-012-9410-7	54	74	74	0	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2013	27	6					2407	2420		10.1096/fj.12-221408	http://dx.doi.org/10.1096/fj.12-221408			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	154II	23457214	Green Published, Bronze			2022-12-25	WOS:000319667600028
J	Streinzer, M; Brockmann, A; Nagaraja, N; Spaethe, J				Streinzer, Martin; Brockmann, Axel; Nagaraja, Narayanappa; Spaethe, Johannes			Sex and Caste-Specific Variation in Compound Eye Morphology of Five Honeybee Species	PLOS ONE			English	Article							APIS-MELLIFERA L; CERANA-JAPONICA RADOSZKOWSKI; DRONE FLIGHT; REPRODUCTIVE ISOLATION; MATING FLIGHTS; VISUAL ADAPTATIONS; CONGREGATION AREAS; TEMPORAL PERIOD; SPERM TRANSFER; BODY-SIZE	Ranging from dwarfs to giants, the species of honeybees show remarkable differences in body size that have placed evolutionary constrains on the size of sensory organs and the brain. Colonies comprise three adult phenotypes, drones and two female castes, the reproductive queen and sterile workers. The phenotypes differ with respect to tasks and thus selection pressures which additionally constrain the shape of sensory systems. In a first step to explore the variability and interaction between species size-limitations and sex and caste-specific selection pressures in sensory and neural structures in honeybees, we compared eye size, ommatidia number and distribution of facet lens diameters in drones, queens and workers of five species (Apis andreniformis, A. florea, A. dorsata, A. mellifera, A. cerana). In these species, male and female eyes show a consistent sex-specific organization with respect to eye size and regional specialization of facet diameters. Drones possess distinctly enlarged eyes with large dorsal facets. Aside from these general patterns, we found signs of unique adaptations in eyes of A. florea and A. dorsata drones. In both species, drone eyes are disproportionately enlarged. In A. dorsata the increased eye size results from enlarged facets, a likely adaptation to crepuscular mating flights. In contrast, the relative enlargement of A. florea drone eyes results from an increase in ommatidia number, suggesting strong selection for high spatial resolution. Comparison of eye morphology and published mating flight times indicates a correlation between overall light sensitivity and species-specific mating flight times. The correlation suggests an important role of ambient light intensities in the regulation of species-specific mating flight times and the evolution of the visual system. Our study further deepens insights into visual adaptations within the genus Apis and opens up future perspectives for research to better understand the timing mechanisms and sensory physiology of mating related signals.	[Streinzer, Martin; Spaethe, Johannes] Univ Wurzburg, Dept Behav Physiol & Sociobiol, Biozentrum, D-97070 Wurzburg, Germany; [Streinzer, Martin] Univ Vienna, Fac Life Sci, Dept Evolutionary Biol, Vienna, Austria; [Brockmann, Axel] Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bangalore, Karnataka, India; [Nagaraja, Narayanappa] Bangalore Univ, Acad Staff Coll, Univ Grants Commiss, Bangalore 560056, Karnataka, India	University of Wurzburg; University of Vienna; Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); Bangalore University	Streinzer, M (corresponding author), Univ Wurzburg, Dept Behav Physiol & Sociobiol, Biozentrum, D-97070 Wurzburg, Germany.	martin.streinzer@uni-wuerzburg.de	Spaethe, Johannes/B-8826-2014; Streinzer, Martin/AAE-2359-2019	Streinzer, Martin/0000-0002-6656-7224; Spaethe, Johannes/0000-0002-0734-2869	Austrian Academy of Sciences at the Department of Behavioral Physiology and Sociobiology, University of Wurzburg; Department of Evolutionary Biology, University of Vienna; German Research Foundation (DFG); University of Wurzburg	Austrian Academy of Sciences at the Department of Behavioral Physiology and Sociobiology, University of Wurzburg; Department of Evolutionary Biology, University of Vienna; German Research Foundation (DFG)(German Research Foundation (DFG)); University of Wurzburg	M.S. is recipient of a DOC-fellowship of the Austrian Academy of Sciences at the Department of Behavioral Physiology and Sociobiology, University of Wurzburg and the Department of Evolutionary Biology, University of Vienna. This publication was funded by the German Research Foundation (DFG) and the University of Wurzburg in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNOLD G, 1985, CELL TISSUE RES, V242, P593, DOI 10.1007/BF00225425; ARNOLD G, 1988, INT J INSECT MORPHOL, V17, P185, DOI 10.1016/0020-7322(88)90036-0; Berg S, 1997, APIDOLOGIE, V28, P449, DOI 10.1051/apido:19970611; Boucher M, 2009, ANIM BEHAV, V78, P247, DOI 10.1016/j.anbehav.2009.04.019; Brockmann A, 1998, NATURWISSENSCHAFTEN, V85, P283, DOI 10.1007/s001140050500; Brockmann A, 2001, NATURWISSENSCHAFTEN, V88, P78, DOI 10.1007/s001140000199; Brockmann A., 2003, INDIAN BEE J, V55, P131; Brockmann A, 2006, J CHEM ECOL, V32, P657, DOI 10.1007/s10886-005-9027-2; Buawangpang N, 2009, APIDOLOGIE, V40, P20, DOI 10.1051/apido:2008059; Burgett D. M., 2007, Natural History Bulletin of the Siam Society, V55, P99; Burgett DM, 2005, J APICULT RES, V44, P36, DOI 10.1080/00218839.2005.11101145; CANE JH, 1987, J KANSAS ENTOMOL SOC, V60, P145; Erickson E. H., 1990, Gleanings in Bee Culture, V118, P98; ESSLEN J, 1976, ZOOMORPHOLOGIE, V83, P227, DOI 10.1007/BF00993511; FUJIWARA S, 1994, APIDOLOGIE, V25, P331, DOI 10.1051/apido:19940309; Greiner B, 2006, J COMP NEUROL, V495, P255, DOI 10.1002/cne.20882; Greiner B, 2005, CELL TISSUE RES, V322, P313, DOI 10.1007/s00441-005-0034-y; Greiner B, 2004, CELL TISSUE RES, V316, P377, DOI 10.1007/s00441-004-0883-9; Gries M, 1996, J COMP PHYSIOL A, V179, P539, DOI 10.1007/BF00192319; Groh C, 2008, ARTHROPOD STRUCT DEV, V37, P459, DOI 10.1016/j.asd.2008.04.001; Haddad N, 2012, 5 EURB C HALL GERM; Hadisoesilo S, 1996, APIDOLOGIE, V27, P361, DOI 10.1051/apido:19960504; Hadisoesilo S, 2001, DRONE FLIGHT TIMES A; Hepburn HR, 2011, HONEYBEES OF ASIA, P133, DOI 10.1007/978-3-642-16422-4_7; Hepburn H.R., 1998, HONEYBEES AFRICA; Hepburn HR, 2005, APIDOLOGIE, V36, P359, DOI 10.1051/apido:2005023; Jordan LA, 2007, APIDOLOGIE, V38, P436, DOI 10.1051/apido:2007028; Kapustjanskij A, 2007, FUNCT ECOL, V21, P1130, DOI 10.1111/j.1365-2435.2007.01329.x; Kelber A, 2006, BEHAV ECOL, V17, P63, DOI 10.1093/beheco/arj001; KOENIGER G, 1989, INSECT SOC, V36, P129, DOI 10.1007/BF02225908; Koeniger G, 2000, APIDOLOGIE, V31, P301, DOI 10.1051/apido:2000124; Koeniger G, 2011, HONEYBEES OF ASIA, P159, DOI 10.1007/978-3-642-16422-4_8; Koeniger N, 1996, APIDOLOGIE, V27, P353, DOI 10.1051/apido:19960503; KOENIGER N, 1988, APIDOLOGIE, V19, P103, DOI 10.1051/apido:19880108; Koeniger N, 2000, APIDOLOGIE, V31, P313, DOI 10.1051/apido:2000125; KOENIGER N, 1994, APIDOLOGIE, V25, P249, DOI 10.1051/apido:19940211; KOENIGER N, 1989, APIDOLOGIE, V20, P413, DOI 10.1051/apido:19890506; Koeniger N, 2011, HONEYBEES OF ASIA, P23, DOI 10.1007/978-3-642-16422-4_2; Land MF, 1997, ANNU REV ENTOMOL, V42, P147, DOI 10.1146/annurev.ento.42.1.147; LENSKY Y, 1985, COMP BIOCHEM PHYS A, V81, P229, DOI 10.1016/0300-9629(85)90127-6; LOPER GM, 1987, APIDOLOGIE, V18, P163, DOI 10.1051/apido:19870206; LOPER GM, 1992, J KANSAS ENTOMOL SOC, V65, P223; MATHEW KP, 1990, BEE WORLD, V71, P61, DOI 10.1080/0005772X.1990.11099038; MENZEL JG, 1991, TISSUE CELL, V23, P525, DOI 10.1016/0040-8166(91)90010-Q; Michener C. D., 2000, The bees of the world; Nagaraja N, 2009, NATURE PRECEDINGS; Narendra A, 2011, P ROY SOC B-BIOL SCI, V278, P1141, DOI 10.1098/rspb.2010.1378; Narendra A, 2010, P ROY SOC B-BIOL SCI, V277, P1531, DOI 10.1098/rspb.2009.2324; Niven JE, 2008, J EXP BIOL, V211, P1792, DOI 10.1242/jeb.017574; Oldroyd BP, 2006, INSECT SOC, V53, P428, DOI 10.1007/s00040-005-0889-2; Otis GW, 2000, P 7 INT C TROP BEES, P137; PEITSCH D, 1992, J COMP PHYSIOL A, V170, P23, DOI 10.1007/BF00190398; PUNCHIHEWA RWK, 1990, APIDOLOGIE, V21, P201, DOI 10.1051/apido:19900305; Radloff SE, 2003, APIDOLOGIE, V34, P353, DOI 10.1051/apido:2003031; RIBI WA, 1989, ENTOMOL GEN, V14, P233; RINDERER TE, 1993, J APICULT RES, V32, P27, DOI 10.1080/00218839.1993.11101284; Ruttner F., 1972, Journal apic Res, V11, P141; Ruttner F., 2003, NATURGESCHICHTE HONI; Sasaki M., 1990, Advances in Invertebrate Reproduction, V5, P503; Seidl R., 1980, VERH ZOOL GESELL, P359; Somanathan H, 2008, J COMP PHYSIOL A, V194, P97, DOI 10.1007/s00359-007-0291-1; Somanathan H, 2009, J EXP BIOL, V212, P2448, DOI 10.1242/jeb.031484; Somanathan H, 2009, J COMP PHYSIOL A, V195, P571, DOI 10.1007/s00359-009-0432-9; Spaethe J, 2003, J EXP BIOL, V206, P3447, DOI 10.1242/jeb.00570; Spaethe J, 2007, NATURWISSENSCHAFTEN, V94, P733, DOI 10.1007/s00114-007-0251-1; STAVENGA DG, 1992, TRENDS NEUROSCI, V15, P213, DOI 10.1016/0166-2236(92)90038-A; TABER STEPHEN, 1964, ANN ENTOMOL SOC AMER, V57, P769; Tan NQ, 1999, APIDOLOGIE, V30, P339, DOI 10.1051/apido:19990410; Tan SJ, 2005, CURR BIOL, V15, pR540, DOI 10.1016/j.cub.2005.07.019; TYCHSEN PH, 1971, J INSECT PHYSIOL, V17, P2139, DOI 10.1016/0022-1910(71)90174-0; UNDERWOOD BA, 1990, APIDOLOGIE, V21, P501, DOI 10.1051/apido:19900602; VALLET AM, 1993, J COMP PHYSIOL A, V172, P183; VANPRAAGH JP, 1980, J COMP PHYSIOL, V136, P263, DOI 10.1007/BF00657542; VERMA L R, 1990, Journal of Insect Science, V3, P130; Wanner KW, 2007, P NATL ACAD SCI USA, V104, P14383, DOI 10.1073/pnas.0705459104; Warrant E, 1996, P ROY SOC B-BIOL SCI, V263, P1521, DOI 10.1098/rspb.1996.0222; Warrant E, 2011, ANNU REV ENTOMOL, V56, P239, DOI 10.1146/annurev-ento-120709-144852; Wcislo WT, 2009, BIOL REV, V84, P19, DOI 10.1111/j.1469-185X.2008.00059.x; Winston M.L., 1991, BIOL HONEY BEE; Wongsiri S, 1997, BEE WORLD, V78, P23, DOI 10.1080/0005772X.1997.11099328; Woyke J, 2005, J APICULT RES, V44, P130, DOI 10.1080/00218839.2005.11101165; Woyke J, 2001, APIDOLOGIE, V32, P407, DOI 10.1051/apido:2001140; Woyke J., 1975, Journal apic Res, V14, P153; YOSHIDA T, 1994, APIDOLOGIE, V25, P353, DOI 10.1051/apido:19940401	84	50	51	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57702	10.1371/journal.pone.0057702	http://dx.doi.org/10.1371/journal.pone.0057702			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460896	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000315519000151
J	Wong, J; Mehta, V; Voronova, A; Coutu, J; Ryan, T; Shelton, M; Skerjanc, IS				Wong, Jacob; Mehta, Virja; Voronova, Anastassia; Coutu, Josee; Ryan, Tammy; Shelton, Michael; Skerjanc, Ilona S.			beta-catenin Is Essential for Efficient In Vitro Premyogenic Mesoderm Formation but Can Be Partially Compensated by Retinoic Acid Signalling	PLOS ONE			English	Article							EMBRYONAL CARCINOMA-CELLS; SKELETAL MYOGENESIS; MUSCLE DEVELOPMENT; GENE-EXPRESSION; P19 CELLS; MOUSE EMBRYO; MYOD; SOMITES; FAMILY; EYA2	Previous studies have shown that P19 cells expressing a dominant negative beta-catenin mutant (beta-cat/EnR) cannot undergo myogenic differentiation in the presence or absence of muscle-inducing levels of retinoic acid ( RA). While RA could upregulate premyogenic mesoderm expression, including Pax3/7 and Meox1, only Pax3/7 and Gli2 could be upregulated by RA in the presence of beta-cat/EnR. However, the use of a dominant negative construct that cannot be compensated by other factors is limiting due to the possibility of negative chromatin remodelling overriding compensatory mechanisms. In this study, we set out to determine if beta-catenin function is essential for myogenesis with and without RA, by creating P19 cells with reduced beta-catenin transcriptional activity using an shRNA approach, termed P19[sh beta-cat] cells. The loss of beta-catenin resulted in a reduction of skeletal myogenesis in the absence of RA as early as premyogenic mesoderm, with the loss of Pax3/7, Eya2, Six1, Meox1, Gli2, Foxc1/2, and Sox7 transcript levels. Chromatin immunoprecipitation identified an association of beta-catenin with the promoter region of the Sox7 gene. Differentiation of P19[sh beta-cat] cells in the presence of RA resulted in the upregulation or lack of repression of all of the precursor genes, on day 5 and/or 9, with the exception of Foxc2. However, expression of Sox7, Gli2, the myogenic regulatory factors and terminal differentiation markers remained inhibited on day 9 and overall skeletal myogenesis was reduced. Thus, beta-catenin is essential for in vitro formation of premyogenic mesoderm, leading to skeletal myogenesis. RA can at least partially compensate for the loss of beta-catenin in the expression of many myogenic precursor genes, but not for myoblast gene expression or overall myogenesis.	[Wong, Jacob; Mehta, Virja; Voronova, Anastassia; Coutu, Josee; Ryan, Tammy; Shelton, Michael; Skerjanc, Ilona S.] Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada	University of Ottawa	Skerjanc, IS (corresponding author), Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada.	iskerjan@uottawa.ca	Skerjanc, Ilona/AAN-3318-2020; Voronova, Anastassia/GLR-8891-2022	Ryan, Tammy/0000-0002-0428-8932; Voronova, Anastassia/0000-0001-7504-1905	Canadian Institutes of Health Research [MOP-84458]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by an operating grant from the Canadian Institutes of Health Research (MOP-84458; http://www.cihr-irsc.gc.ca/e/193.html). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Madhoun AS, 2011, EMBO J, V30, P2477, DOI 10.1038/emboj.2011.153; Blomhoff R, 2006, J NEUROBIOL, V66, P606, DOI 10.1002/neu.20242; Brannon M, 1996, DEV BIOL, V180, P344, DOI 10.1006/dbio.1996.0306; Bryson-Richardson RJ, 2008, NAT REV GENET, V9, P632, DOI 10.1038/nrg2369; Buckingham M, 2009, CURR OPIN GENET DEV, V19, P444, DOI 10.1016/j.gde.2009.08.001; BUSKIN JN, 1989, MOL CELL BIOL, V9, P2627, DOI 10.1128/MCB.9.6.2627; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; EDWARDS MKS, 1983, MOL CELL BIOL, V3, P2280, DOI 10.1128/MCB.3.12.2280; FRANZ T, 1993, ANAT EMBRYOL, V187, P153; Galli LM, 2004, DEV BIOL, V269, P489, DOI 10.1016/j.ydbio.2004.01.041; Gianakopoulos PJ, 2011, J BIOL CHEM, V286, P2517, DOI 10.1074/jbc.M110.163709; Grifone R, 2007, DEV BIOL, V302, P602, DOI 10.1016/j.ydbio.2006.08.059; Heanue TA, 1999, GENE DEV, V13, P3231, DOI 10.1101/gad.13.24.3231; Ikeya M, 1998, DEVELOPMENT, V125, P4969; KEMLER R, 1993, TRENDS GENET, V9, P317, DOI 10.1016/0168-9525(93)90250-L; Kennedy KAM, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-67; Kim CH, 2008, MOL CELL BIOL, V28, P2941, DOI 10.1128/MCB.01682-07; Kume T, 2001, GENE DEV, V15, P2470, DOI 10.1101/gad.907301; Laclef C, 2003, DEVELOPMENT, V130, P2239, DOI 10.1242/dev.00440; Lagha M, 2009, DEV CELL, V17, P892, DOI 10.1016/j.devcel.2009.10.021; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mankoo BS, 2003, DEVELOPMENT, V130, P4655, DOI 10.1242/dev.00687; Matt N, 2005, DEVELOPMENT, V132, P4789, DOI 10.1242/dev.02031; MCBURNEY MW, 1993, INT J DEV BIOL, V37, P135; McDermott A, 2005, DEVELOPMENT, V132, P345, DOI 10.1242/dev.01537; MIURA N, 1993, FEBS LETT, V326, P171, DOI 10.1016/0014-5793(93)81785-X; MUNSTERBERG AE, 1995, GENE DEV, V9, P2911, DOI 10.1101/gad.9.23.2911; MURRE C, 1989, CELL, V56, P777, DOI 10.1016/0092-8674(89)90682-X; Oliver G, 1995, DEVELOPMENT, V121, P4045; Ovcharenko I, 2005, GENOME RES, V15, P184, DOI 10.1101/gr.3007205; Petropoulos H, 2004, J BIOL CHEM, V279, P23874, DOI 10.1074/jbc.M312612200; Petropoulos H, 2002, J BIOL CHEM, V277, P15393, DOI 10.1074/jbc.M112141200; Reijntjes S, 2007, INT J DEV BIOL, V51, P753, DOI 10.1387/ijdb.072332sr; Relaix F, 2005, NATURE, V435, P948, DOI 10.1038/nature03594; Ridgeway AG, 2001, J BIOL CHEM, V276, P19033, DOI 10.1074/jbc.M011491200; Ridgeway AG, 2000, J BIOL CHEM, V275, P32398, DOI 10.1074/jbc.M004349200; ROSSANT J, 1982, J EMBRYOL EXP MORPH, V70, P99; Ryan T, 2012, STEM CELL REV REP, V8, P482, DOI 10.1007/s12015-011-9284-0; SASAKI H, 1993, DEVELOPMENT, V118, P47; Savage J, 2010, DIFFERENTIATION, V79, P31, DOI 10.1016/j.diff.2009.08.008; Savage J, 2009, STEM CELLS, V27, P1231, DOI 10.1002/stem.57; Shi DL, 2002, DEV BIOL, V245, P124, DOI 10.1006/dbio.2002.0633; Skerjanc IS, 1999, TRENDS CARDIOVAS MED, V9, P139, DOI 10.1016/S1050-1738(99)00017-1; Tolkunova EN, 1998, MOL CELL BIOL, V18, P2804, DOI 10.1128/MCB.18.5.2804; VIDRICAIRE G, 1994, DEVELOPMENT, V120, P115; Voronova A, 2013, J BIOL CHEM, V288, P4389, DOI 10.1074/jbc.M112.400184; Voronova A, 2012, NUCLEIC ACIDS RES, V40, P3329, DOI 10.1093/nar/gkr1232; WEINTRAUB H, 1991, SCIENCE, V251, P761, DOI 10.1126/science.1846704; WILLIAMS BA, 1994, DEVELOPMENT, V120, P785; Wilm B, 2004, DEV BIOL, V271, P176, DOI 10.1016/j.ydbio.2004.03.034; Yu JY, 2002, P NATL ACAD SCI USA, V99, P6047, DOI 10.1073/pnas.092143499; Zhang C, 2005, DEV BIOL, V278, P526, DOI 10.1016/j.ydbio.2004.11.008	52	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57501	10.1371/journal.pone.0057501	http://dx.doi.org/10.1371/journal.pone.0057501			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460868	Green Submitted, Green Published, gold			2022-12-25	WOS:000315519000123
J	Wright, AJ; Maar, M; Mohn, C; Nabe-Nielsen, J; Siebert, U; Jensen, LF; Baagoe, HJ; Teilmann, J				Wright, Andrew J.; Maar, Marie; Mohn, Christian; Nabe-Nielsen, Jacob; Siebert, Ursula; Jensen, Lasse Fast; Baagoe, Hans J.; Teilmann, Jonas			Possible Causes of a Harbour Porpoise Mass Stranding in Danish Waters in 2005	PLOS ONE			English	Article							PHYSETER-MACROCEPHALUS STRANDINGS; PHOCOENA-PHOCOENA; NORTH-SEA; POSTMORTEM FINDINGS; WHALE STRANDINGS; GERMAN WATERS; CETACEANS; SONAR; COASTLINES; MORTALITY	An unprecedented 85 harbour porpoises stranded freshly dead along approximately 100 km of Danish coastline from 7-15 April, 2005. This total is considerably above the mean weekly stranding rate for the whole of Denmark, both for any time of year, 1.23 animals/week (ranging from 0 to 20 during 2003-2008, excluding April 2005), and specifically in April, 0.65 animals/week (0 to 4, same period). Bycatch was established as the cause of death for most of the individuals through typical indications of fisheries interactions, including net markings in the skin and around the flippers, and loss of tail flukes. Local fishermen confirmed unusually large porpoise bycatch in nets set for lumpfish (Cyclopterus lumpus) and the strandings were attributed to an early lumpfish season. However, lumpfish catches for 2005 were not unusual in terms of season onset, peak or total catch, when compared to 2003-2008. Consequently, human activity was combined with environmental factors and the variation in Danish fisheries landings (determined through a principal component analysis) in a two-part statistical model to assess the correlation of these factors with both the presence of fresh strandings and the numbers of strandings on the Danish west coast. The final statistical model (which was forward selected using Akaike information criterion; AIC) indicated that naval presence is correlated with higher rates of porpoise strandings, particularly in combination with certain fisheries, although it is not correlated with the actual presence of strandings. Military vessels from various countries were confirmed in the area from the 7th April, en route to the largest naval exercise in Danish waters to date (Loyal Mariner 2005, 11-28 April). Although sonar usage cannot be confirmed, it is likely that ships were testing various equipment prior to the main exercise. Thus naval activity cannot be ruled out as a possible contributing factor.	[Wright, Andrew J.; Maar, Marie; Mohn, Christian; Nabe-Nielsen, Jacob; Teilmann, Jonas] Aarhus Univ, Dept Biosci, Roskilde, Denmark; [Siebert, Ursula] Univ Vet Med, Inst Terr & Aquat Wildlife Res, Hannover, Busum, Germany; [Jensen, Lasse Fast] Fisheries & Maritime Museum, Esbjerg V, Denmark; [Baagoe, Hans J.] Univ Copenhagen, Zool Museum, Nat Hist Museum Denmark, DK-2100 Copenhagen, Denmark	Aarhus University; University of Veterinary Medicine Hannover, Foundation; University of Copenhagen	Wright, AJ (corresponding author), Aarhus Univ, Dept Biosci, Roskilde, Denmark.	marinebrit@gmail.com	Wright, Andrew/HDM-9615-2022; Teilmann, Jonas/J-7828-2013; Maar, Marie/C-5837-2008; Mohn, Christian/F-3468-2011; Nabe-Nielsen, Jacob/A-5891-2010	Teilmann, Jonas/0000-0002-4376-4700; Maar, Marie/0000-0001-8594-2993; Mohn, Christian/0000-0002-4331-1365; Nabe-Nielsen, Jacob/0000-0002-0716-9525; Wright, Andrew/0000-0002-8718-8143	Aarhus University; Danish research school SNAK; Carlsberg Foundation; SNAK Ph.D. school	Aarhus University; Danish research school SNAK; Carlsberg Foundation(Carlsberg Foundation); SNAK Ph.D. school	This work formed part of the lead author's PhD, which was funded by the Aarhus University (http://www.au.dk/), the Danish research school SNAK (http://www.snak.biology.sdu.dk/) and the Carlsberg Foundation (http://www.carlsbergfondet.dk/). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.; The work contained in this paper formed part of the lead author's Ph.D., which was funded by Aarhus University, the Carlsberg Foundation, and the SNAK Ph.D. school. Many thanks to Sidsel B. Meier (Danish Directorate of Fisheries) & Majbritt Aminde (Danish Meteorological Institute; DMI) for supplying raw data. Thanks also go to the Danish Nature Agency for their role in the strandings network, as well as all those who have collected strandings data and/or carcases on their behalf. Many thanks to Zhenwen Wan (DMI) for providing the DMI-BSHcmod model data. Thanks also to Jakob Tougaard (AU) for obtaining seismic survey information and Daniel Spelling Clausen for producing the map of strandings. Thanks are also due to David Hathaway (NASA), Klaus Vanselow (Kiel University) and Claudia Stolle (DTU), for assistance with locating appropriate data on solar cycles, solar activity and geomagnetic fields, as well as Peter H. Voss (GEUS) and Maureen Aspinwall (ISC) for their help locating earthquake information. Special thanks are due to Donald Hurlbert and James Di Loreto (Smithsonian Institution), and Juana Jacobsen and Kathe Mogelvang (AU) for helping to format the figures appropriately. Finally, thanks to Leslie Walsh and three anonymous reviewers for their helpful comments on earlier versions of this manuscript.	Baird Robin W., 1995, Reports of the International Whaling Commission Special Issue, V16, P159; BAKER JR, 1992, VET REC, V130, P554, DOI 10.1136/vr.130.25.554; Bouquegneau J. M., 1997, Bulletin de l'Institut Royal des Sciences Naturelles de Belgique Biologie, V67, P75; Breland K., 1966, ANIMAL BEHAV; Buscaino G, 2009, FISHERIES SCI, V75, P537, DOI 10.1007/s12562-009-0059-3; Chan AAYH, 2010, ANIM BEHAV, V80, P1075, DOI 10.1016/j.anbehav.2010.09.025; Chan AAYH, 2010, BIOL LETTERS, V6, P458, DOI 10.1098/rsbl.2009.1081; CLAUSEN B, 1988, Danish Review of Game Biology, V13, P1; Cox T. M., 2005, Journal of Cetacean Research and Management, V7, P177; Culik BM, 2001, MAR ECOL PROG SER, V211, P255, DOI 10.3354/meps211255; D'Amico Angela, 2009, Aquatic Mammals, V35, P452, DOI 10.1578/AM.35.4.2009.452; Dudok van Heel W. H., 1966, WHALES DOLPHINS PORP, P597; Dukas R, 2004, BRAIN BEHAV EVOLUT, V63, P197, DOI 10.1159/000076781; Evans D.L., 2001, JOINT INTERIM REPORT; Fernandez A, 2005, VET PATHOL, V42, P446, DOI 10.1354/vp.42-4-446; Filadelfo Ronald, 2009, Aquatic Mammals, V35, P445, DOI 10.1578/AM.35.4.2009.445; Filadelfo Ronald, 2009, Aquatic Mammals, V35, P435, DOI 10.1578/AM.35.4.2009.435; FRANSE R., 2005, EFFECTIVENESS ACOUST; Gonener S, 2009, TURK J FISH AQUAT SC, V9, P151, DOI 10.4194/trjfas.2009.0205; Haelters J., 2009, HARBOUR PORPOISE SO; Hamer DJ, 2010, SC62BC3 IWC; Harkonen T, 2008, VET REC, V162, P555, DOI 10.1136/vr.162.17.555; Hathaway DH, 2010, LIVING REV SOL PHYS, V7, DOI 10.12942/lrsp-2010-1; Hildebrand J, 2005, MARINE MAMMAL RESEARCH: CONSERVATION BEYOND CRISIS, P101; Hildebrand J. A, 2005, J CETACEAN RES MAN S, V7, P284; Hooker SK, 2012, P ROY SOC B-BIOL SCI, V279, P1041, DOI 10.1098/rspb.2011.2088; International Seismological Centre, 2010, ON LIN B INT SEIS CE; Jauniaux T., 1997, Bulletin de l'Institut Royal des Sciences Naturelles de Belgique Biologie, V67, P63; Jauniaux T, 2002, J COMP PATHOL, V126, P243, DOI 10.1053/jcpa.2001.0547; Jepson PD, 2003, NATURE, V425, P575, DOI 10.1038/425575a; Jepson PD, 2005, ENVIRON TOXICOL CHEM, V24, P238, DOI 10.1897/03-663.1; Jepson PD, 2000, VET REC, V146, P721, DOI 10.1136/vr.146.25.721; Jepson PD, 2009, INVESTIGATION COMMON; Jepson PD, 2006, POSTMORTEM RES FEASI; Johnston DW, 2005, MAR ECOL PROG SER, V295, P279, DOI 10.3354/meps295279; Joiris Claude R., 1997, Bulletin de l'Institut Royal des Sciences Naturelles de Belgique Biologie, V67, P69; Jolliffe I.T., 1986, PRINCIPAL COMPONENT, P487, DOI [DOI 10.1007/B98835, 10.1007/978-1-4757-1904-8_8]; KLINOWSKA M, 1988, J NAVIGATION, V41, P52, DOI 10.1017/S037346330000905X; Kuiken M, 1993, EUROPEAN CETACEAN SO, V17; Lambertsen Richard H., 1997, Bulletin de l'Institut Royal des Sciences Naturelles de Belgique Biologie, V67, P105; Maar M, 2011, ECOL MODEL, V222, P1696, DOI 10.1016/j.ecolmodel.2011.03.006; Marcogliese DJ, 2011, TRENDS PARASITOL, V27, P123, DOI 10.1016/j.pt.2010.11.002; Mazzariol S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019417; McCarthy E, 2011, MAR MAMMAL SCI, V27, pE206, DOI 10.1111/j.1748-7692.2010.00457.x; Mignucci-Giannoni AA, 2000, J MAR BIOL ASSOC UK, V80, P759, DOI 10.1017/S0025315499002702; Muller G, 2000, VET MICROBIOL, V75, P17, DOI 10.1016/S0378-1135(00)00209-1; Nieukirk SL, 2012, J ACOUST SOC AM, V131, P1102, DOI 10.1121/1.3672648; Norman SA, 2004, NOAA TECH MEMO NMFS; Nowacek DP, 2007, MAMMAL REV, V37, P81, DOI 10.1111/j.1365-2907.2007.00104.x; Nowacek DP, 2004, P ROY SOC B-BIOL SCI, V271, P227, DOI 10.1098/rspb.2003.2570; O'Brien RM, 2007, QUAL QUANT, V41, P673, DOI 10.1007/s11135-006-9018-6; Orphanides CD, 2009, 0914 US DEP COMM NE; Parsons ECM, 2008, MAR POLLUT BULL, V56, P1248, DOI 10.1016/j.marpolbul.2008.04.025; Peltier H, 2012, ECOL INDIC, V18, P278, DOI 10.1016/j.ecolind.2011.11.014; Purser J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017478; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Read AJ, 2006, CONSERV BIOL, V20, P163, DOI 10.1111/j.1523-1739.2006.00338.x; Ross A, 2004, NET EFFECT REV CETAC; Ross HM, 1996, P ROY SOC B-BIOL SCI, V263, P283, DOI 10.1098/rspb.1996.0043; SCANS-II, 2008, SMALL CET EUR ATL N; Siebert U, 2009, J APPL MICROBIOL, V106, P329, DOI 10.1111/j.1365-2672.2008.04006.x; Siebert U, 1999, MAR POLLUT BULL, V38, P285, DOI 10.1016/S0025-326X(98)00147-7; Siebert U, 2001, J COMP PATHOL, V124, P102, DOI 10.1053/jcpa.2000.0436; Siebert U, 2006, J SEA RES, V56, P65, DOI 10.1016/j.seares.2006.01.003; Siemers BM, 2011, P ROY SOC B-BIOL SCI, V278, P1646, DOI 10.1098/rspb.2010.2262; Southall Brandon L., 2007, Aquatic Mammals, V33, pI; Sveegaard S, 2012, MAR BIOL, V159, P1029, DOI 10.1007/s00227-012-1883-z; Sveegaard S, 2011, MAR MAMMAL SCI, V27, P230, DOI 10.1111/j.1748-7692.2010.00379.x; Swenshon M, 1998, J CLIN MICROBIOL, V36, P1902, DOI 10.1128/JCM.36.7.1902-1906.1998; Teilmann J, 2006, MAR MAMMAL SCI, V22, P240, DOI 10.1111/j.1748-7692.2006.00031.x; Todd S, 1996, CAN J ZOOL, V74, P1661, DOI 10.1139/z96-184; Tyack PL, 2006, J EXP BIOL, V209, P4238, DOI 10.1242/jeb.02505; Tyack PL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017009; Urick RJ., 1983, PRINCIPLES UNDERWATE, V3; Van Bressem MF, 2009, DIS AQUAT ORGAN, V86, P143, DOI 10.3354/dao02101; Vanselow KH, 2005, J SEA RES, V53, P319, DOI 10.1016/j.seares.2004.07.006; Vanselow Klaus Heinrich, 2009, Open Marine Biology Journal, V3, P89; Vinther Morten, 2004, Journal of Cetacean Research and Management, V6, P19; Weilgart LS, 2007, CAN J ZOOL, V85, P1091, DOI 10.1139/Z07-101; Weir Caroline R., 2000, European Research on Cetaceans, V14, P61; Wobeser G.A., 1994, INVESTIGATION MANAGE; Wood F.G., 1979, P129; Wright AJ, 2005, MAR MAMMAL SCI, V21, P145, DOI 10.1111/j.1748-7692.2005.tb01214.x; Wunschmann A, 2001, VET REC, V148, P715, DOI 10.1136/vr.148.23.715	84	19	19	0	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e55553	10.1371/journal.pone.0055553	http://dx.doi.org/10.1371/journal.pone.0055553			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460787	gold, Green Published, Green Submitted			2022-12-25	WOS:000315519000010
J	McCracken, JP; Schwartz, J; Diaz, A; Bruce, N; Smith, KR				McCracken, John P.; Schwartz, Joel; Diaz, Anaite; Bruce, Nigel; Smith, Kirk R.			Longitudinal Relationship between Personal CO and Personal PM2.5 among Women Cooking with Woodfired Cookstoves in Guatemala	PLOS ONE			English	Article							INDOOR AIR-POLLUTION; WOOD SMOKE EXPOSURE; PARTICULATE MATTER; CARBON-MONOXIDE; BIOMASS COMBUSTION; HIGHLAND GUATEMALA; STOVES; CHILDREN; INTERVENTION; REDUCTION	Household air pollution (HAP) due to solid fuel use is a major public health threat in low-income countries. Most health effects are thought to be related to exposure to the fine particulate matter (PM) component of HAP, but it is currently impractical to measure personal exposure to PM in large studies. Carbon monoxide (CO) has been shown in cross-sectional analyses to be a reliable surrogate for particles <2.5 mu m in diameter (PM2.5) in kitchens where wood-burning cookfires are a dominant source, but it is unknown whether a similar PM2.5-CO relationship exists for personal exposures longitudinally. We repeatedly measured (216 measures, 116 women) 24-hour personal PM2.5 (median [IQR] = 0.11 [0.05, 0.21] mg/m(3)) and CO (median [IQR] = 1.18 [0.50, 2.37] mg/m(3)) among women cooking over open woodfires or chimney woodstoves in Guatemala. Pollution measures were natural-log transformed for analyses. In linear mixed effects models with random subject intercepts, we found that personal CO explained 78% of between-subject variance in personal PM2.5. We did not see a difference in slope by stove type. This work provides evidence that in settings where there is a dominant source of biomass combustion, repeated measures of personal CO can be used as a reliable surrogate for an individual's PM2.5 exposure. This finding has important implications for the feasibility of reliably estimating long-term (months to years) PM2.5 exposure in large-scale epidemiological and intervention studies of HAP.	[McCracken, John P.; Schwartz, Joel] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA; [Diaz, Anaite] Univ Valle Guatemala, Ctr Hlth Studies, Guatemala City, Guatemala; [Bruce, Nigel] Univ Liverpool, Dept Publ Hlth & Policy, Liverpool L69 3BX, Merseyside, England; [Smith, Kirk R.] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA	Harvard University; Harvard T.H. Chan School of Public Health; Universidad del Valle de Guatemala; University of Liverpool; University of California System; University of California Berkeley	Smith, KR (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA.	krksmith@berkeley.edu			National Institutes of Health [R01ES010178, P01-ES09825, T-32 ES07069-25, ES-0002, ES015172]; World Health Organization; U.S. Environmental Protection Agency [R827353, R832416]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007069, R01ES010178, P30ES000002, P01ES009825, R01ES015172] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); World Health Organization(World Health Organization); U.S. Environmental Protection Agency(United States Environmental Protection Agency); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the National Institutes of Health (grants R01ES010178, P01-ES09825, T-32 ES07069-25, ES-0002, and ES015172), the World Health Organization, and the U.S. Environmental Protection Agency (grants R827353 and R832416). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balakrishnan K, 2011, GLOBAL HLTH ACTION, V4; Baumgartner J, 2011, INDOOR AIR, V21, P479, DOI 10.1111/j.1600-0668.2011.00730.x; Bruce N, 2004, J EXPO ANAL ENV EPID, V14, pS26, DOI 10.1038/sj.jea.7500355; Cynthia AA, 2008, INDOOR AIR, V18, P93, DOI 10.1111/j.1600-0668.2007.00509.x; Dionisio KL, 2012, ENVIRON SCI TECHNOL, V46, P3519, DOI 10.1021/es203047e; Ezzati M, 2000, ENVIRON HEALTH PERSP, V108, P833, DOI 10.2307/3434990; McCracken J, 2011, ENVIRON HEALTH PERSP, V119, P1562, DOI 10.1289/ehp.1002834; McCracken JP, 2007, ENVIRON HEALTH PERSP, V115, P996, DOI 10.1289/ehp.9888; Naeher LP, 2000, INDOOR AIR, V10, P200; Naeher LP, 2001, ENVIRON SCI TECHNOL, V35, P575, DOI 10.1021/es991225g; Northcross A, 2010, J ENVIRON MONITOR, V12, P873, DOI 10.1039/b916068j; Pope CA, 2011, ENVIRON HEALTH PERSP, V119, P1616, DOI 10.1289/ehp.1103639; Seinfeld J. H., 1998, ATMOSPHERIC CHEM PHY; Smith K, 2003, STRAD, V114, P279; Smith KR, 2011, LANCET, V378, P1717, DOI 10.1016/S0140-6736(11)60921-5; Smith KR, 2010, ENVIRON HEALTH PERSP, V118, P1643, DOI 10.1289/ehp.1002517; Smith KR, 2000, ANNU REV ENERG ENV, V25, P741, DOI 10.1146/annurev.energy.25.1.741; Smith KR., 1987, BIOFUELS AIR POLLUTI; Wallington TJ, 2008, METEOROL Z, V17, P109, DOI 10.1127/0941-2948/2008/0275; Zuk M, 2007, J EXPO SCI ENV EPID, V17, P224, DOI 10.1038/sj.jes.7500499	20	55	55	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2013	8	2							e55670	10.1371/journal.pone.0055670	http://dx.doi.org/10.1371/journal.pone.0055670			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098PO	23468847	gold, Green Published			2022-12-25	WOS:000315561400004
J	Eckler, AM; Wilder, C; Castanon, A; Ferris, VM; Lamere, RA; Perrin, BA; Pearlman, R; White, B; Byrd, C; Ludvik, N; Nichols, N; Poole-Sumrall, K; Sztul, E; Styers, ML				Eckler, Alan M.; Wilder, Caroline; Castanon, Antonio; Ferris, Veronica M.; Lamere, Rachael A.; Perrin, Benjamin A.; Pearlman, Ross; White, Blaise; Byrd, Clifton; Ludvik, Nicholas; Nichols, Nona; Poole-Sumrall, Kristen; Sztul, Elizabeth; Styers, Melanie L.			Haploinsufficiency of the Sec7 Guanine Nucleotide Exchange Factor Gea1 Impairs Septation in Fission Yeast	PLOS ONE			English	Article							ADP-RIBOSYLATION FACTOR; TRANS-GOLGI NETWORK; AFFECTS MEMBRANE TRAFFICKING; CELL-WALL INTEGRITY; BREFELDIN-A; SCHIZOSACCHAROMYCES-POMBE; ENDOPLASMIC-RETICULUM; ARF PROTEINS; DISTINCT PHENOTYPES; SYNTHASE SUBUNIT	Membrane trafficking is essential to eukaryotic life and is controlled by a complex network of proteins that regulate movement of proteins and lipids between organelles. The GBF1/GEA family of Guanine nucleotide Exchange Factors (GEFs) regulates trafficking between the endoplasmic reticulum and Golgi by catalyzing the exchange of GDP for GTP on ADP Ribosylation Factors (Arfs). Activated Arfs recruit coat protein complex 1 (COP-/I) to form vesicles that ferry cargo between these organelles. To further explore the function of the GBF1/GEA family, we have characterized a fission yeast mutant lacking one copy of the essential gene gea1 (gea1+/-), the Schizosaccharomyces pombe ortholog of GBF1. The haploinsufficient gea1+/- strain was shown to be sensitive to the GBF1 inhibitor brefeldin A (BFA) and was rescued from BFA sensitivity by gea1p overexpression. No overt defects in localization of arf1p or arf6p were observed in gea1+/- cells, but the fission yeast homolog of the COP-/I cargo sac1 was mislocalized, consistent with impaired COP-/I trafficking. Although Golgi morphology appeared normal, a slight increase in vacuolar size was observed in the gea1+/- mutant strain. Importantly, gea1+/- cells exhibited dramatic cytokinesis-/related defects, including disorganized contractile rings, an increased septation index, and alterations in septum morphology. Septation defects appear to result from altered secretion of enzymes required for septum dynamics, as decreased secretion of eng1p, a beta-/glucanase required for septum breakdown, was observed in gea1+/- cells, and overexpression of eng1p suppressed the increased septation phenotype. These observations implicate gea1 in regulation of septum breakdown and establish S. pombe as a model system to explore GBF1/GEA function in cytokinesis.	[Eckler, Alan M.; Wilder, Caroline; Castanon, Antonio; Ferris, Veronica M.; Lamere, Rachael A.; Perrin, Benjamin A.; Pearlman, Ross; White, Blaise; Byrd, Clifton; Ludvik, Nicholas; Nichols, Nona; Poole-Sumrall, Kristen; Styers, Melanie L.] Birmingham Southern Coll, Dept Biol, Birmingham, AL USA; [Sztul, Elizabeth] Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham	Styers, ML (corresponding author), Birmingham Southern Coll, Dept Biol, Birmingham, AL USA.	mstyers@bsc.edu						ACHSTETTER T, 1988, J BIOL CHEM, V263, P11711; Anders N, 2008, CELL MOL LIFE SCI, V65, P3433, DOI 10.1007/s00018-008-8227-7; ARIDOR M, 1995, J CELL BIOL, V131, P875, DOI 10.1083/jcb.131.4.875; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; BALCH WE, 1992, J BIOL CHEM, V267, P13053; Boal F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009898; Boman AL, 2000, MOL BIOL CELL, V11, P1241, DOI 10.1091/mbc.11.4.1241; BOMAN AL, 1995, TRENDS BIOCHEM SCI, V20, P147, DOI 10.1016/S0968-0004(00)88991-4; Bone N, 1998, CURR BIOL, V8, P135, DOI 10.1016/S0960-9822(98)00060-8; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Bonifacino JS, 2003, NAT REV MOL CELL BIO, V4, P409, DOI 10.1038/nrm1099; Bui QT, 2009, MOL GENET GENOMICS, V282, P329, DOI 10.1007/s00438-009-0473-3; Cavenagh MM, 1996, J BIOL CHEM, V271, P21767, DOI 10.1074/jbc.271.36.21767; Cherfils J, 2005, BIOCHEM SOC T, V33, P635, DOI 10.1042/BST0330635; Citterio C, 2008, P NATL ACAD SCI USA, V105, P2877, DOI 10.1073/pnas.0712224105; Claude A, 1999, J CELL BIOL, V146, P71, DOI 10.1083/jcb.146.1.71; Codlin S, 2008, TRAFFIC, V9, P936, DOI 10.1111/j.1600-0854.2008.00735.x; Cortes JCG, 2002, J CELL SCI, V115, P4081, DOI 10.1242/jcs.00085; Cortes JCG, 2007, MOL MICROBIOL, V65, P201, DOI 10.1111/j.1365-2958.2007.05784.x; Cox R, 2004, MOL BIOL CELL, V15, P1487, DOI 10.1091/mbc.E03-06-0443; Dekker N, 2004, MOL BIOL CELL, V15, P3903, DOI 10.1091/mbc.E04-04-0319; Dell'Angelica EC, 2000, J CELL BIOL, V149, P81, DOI 10.1083/jcb.149.1.81; DONALDSON JG, 1991, SCIENCE, V254, P1197, DOI 10.1126/science.1957170; Dumaresq-Doiron K, 2010, J CELL SCI, V123, P2273, DOI 10.1242/jcs.055798; Garcia-Mata R, 2003, MOL BIOL CELL, V14, P2250, DOI 10.1091/mbc.E02-11-0730; GOLDSTEIN JL, 1976, CURR TOP CELL REGUL, V11, P147; Gould KL, 1997, GENE DEV, V11, P2939, DOI 10.1101/gad.11.22.2939; Hirst J, 1998, BBA-MOL CELL RES, V1404, P173, DOI 10.1016/S0167-4889(98)00056-1; Holloway ZG, 2007, AM J PHYSIOL-CELL PH, V293, pC1753, DOI 10.1152/ajpcell.00253.2007; Ishizaki R, 2008, MOL BIOL CELL, V19, P2650, DOI 10.1091/mbc.E07-10-1067; Kawamoto K, 2002, TRAFFIC, V3, P483, DOI 10.1034/j.1600-0854.2002.30705.x; Kita A, 2004, MOL BIOL CELL, V15, P2920, DOI 10.1091/mbc.E03-09-0659; Kita A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016842; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; Kondo Y, 2012, CELL STRUCT FUNCT, V37, P141, DOI 10.1247/csf.12015; Krapp A, 2004, CURR BIOL, V14, pR722, DOI 10.1016/j.cub.2004.08.049; Krapp A, 2008, BIOCHEM SOC T, V36, P411, DOI 10.1042/BST0360411; Krawchuk MD, 1999, YEAST, V15, P1419, DOI 10.1002/(SICI)1097-0061(19990930)15:13<1419::AID-YEA466>3.0.CO;2-Q; KTISTAKIS NT, 1995, MOL BIOL CELL, V6, P135, DOI 10.1091/mbc.6.2.135; Le Goff X, 1999, CURR GENET, V35, P571, DOI 10.1007/s002940050455; Lee MCS, 2004, ANNU REV CELL DEV BI, V20, P87, DOI 10.1146/annurev.cellbio.20.010403.105307; Lefrancois P, 2007, TRAFFIC, V8, P1440, DOI 10.1111/j.1600-0854.2007.00623.x; Li YW, 2004, FASEB J, V18, P1834, DOI 10.1096/fj.04-2273com; Lippincott-Schwartz J, 2000, ANNU REV CELL DEV BI, V16, P557, DOI 10.1146/annurev.cellbio.16.1.557; Lippincott-Schwartz J, 1998, HISTOCHEM CELL BIOL, V109, P449, DOI 10.1007/s004180050247; Liu JH, 1999, GENETICS, V153, P1193; Ma Y, 2009, GENES CELLS, V14, P1015, DOI 10.1111/j.1365-2443.2009.01327.x; Manolea F, 2008, MOL BIOL CELL, V19, P523, DOI 10.1091/mbc.E07-04-0394; MARKS J, 1985, EUR J CELL BIOL, V39, P27; Martin-Cuadrado AB, 2003, J CELL SCI, V116, P1689, DOI 10.1242/jcs.00377; Martin-Cuadrado AB, 2005, MOL BIOL CELL, V16, P4867, DOI 10.1091/mbc.E04-12-1114; Matsuyama A, 2004, YEAST, V21, P1289, DOI 10.1002/yea.1181; Matsuyama A, 2006, NAT BIOTECHNOL, V24, P841, DOI 10.1038/nbt1222; Matsuyama A, 2009, METHODS MOL BIOL, V577, P11, DOI 10.1007/978-1-60761-232-2_2; Mayinger P, 2011, COLD SPRING HARB PER, V3, P1; McPherson PS, 2001, TRAFFIC, V2, P375, DOI 10.1034/j.1600-0854.2001.002006375.x; MITCHISON JM, 1985, J CELL SCI, V75, P357; MITCHISON JM, 1969, J CELL SCI, V5, P373; Miyatake M, 2007, GENETICS, V175, P1695, DOI 10.1534/genetics.107.070946; Morinaga N, 1999, J BIOL CHEM, V274, P17417, DOI 10.1074/jbc.274.25.17417; Morinaga N, 1996, P NATL ACAD SCI USA, V93, P12856, DOI 10.1073/pnas.93.23.12856; Morohashi Y, 2010, BIOCHEM J, V427, P401, DOI 10.1042/BJ20091681; Natter K, 2005, MOL CELL PROTEOMICS, V4, P662, DOI 10.1074/mcp.M400123-MCP200; Nelson NJ, 1955, METHOD ENZYMOL, V3, P85; Ooi CE, 1998, J CELL BIOL, V142, P391, DOI 10.1083/jcb.142.2.391; PAGANO RE, 1991, J CELL BIOL, V113, P1267, DOI 10.1083/jcb.113.6.1267; Park JS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006179; Peyroche A, 1999, MOL CELL, V3, P275, DOI 10.1016/S1097-2765(00)80455-4; Peyroche A, 1996, NATURE, V384, P479, DOI 10.1038/384479a0; Peyroche A, 2001, J CELL SCI, V114, P2241; Randazzo PA, 2004, CELL SIGNAL, V16, P401, DOI 10.1016/j.cellsig.2003.09.012; REGAZZI R, 1991, BIOCHEM J, V275, P639, DOI 10.1042/bj2750639; Reggiori F, 2002, EUKARYOT CELL, V1, P11, DOI 10.1128/EC.01.1.11-21.2002; Rohde HM, 2003, J BIOL CHEM, V278, P52689, DOI 10.1074/jbc.M307983200; Rothman JE, 1996, PROTEIN SCI, V5, P185; SABATINI DD, 1982, J CELL BIOL, V92, P1, DOI 10.1083/jcb.92.1.1; SANSEGUNDO P, 1993, J BACTERIOL, V175, P3823, DOI 10.1128/JB.175.12.3823-3837.1993; Santos B, 2005, EUKARYOT CELL, V4, P1639, DOI 10.1128/EC.4.10.1639-1645.2005; Santos B, 2003, EUKARYOT CELL, V2, P521, DOI 10.1128/EC.2.3.521-533.2003; Sata M, 1998, P NATL ACAD SCI USA, V95, P4204, DOI 10.1073/pnas.95.8.4204; Sawin KE, 1998, J CELL BIOL, V142, P457, DOI 10.1083/jcb.142.2.457; SERAFINI T, 1991, CELL, V67, P239, DOI 10.1016/0092-8674(91)90176-Y; Shima DT, 1999, CURR BIOL, V9, P821, DOI 10.1016/S0960-9822(99)80365-0; Shinotsuka C, 2002, BIOCHEM BIOPH RES CO, V294, P254, DOI 10.1016/S0006-291X(02)00456-4; Shinotsuka C, 2002, J BIOL CHEM, V277, P9468, DOI 10.1074/jbc.M112427200; Shuster CB, 2002, P NATL ACAD SCI USA, V99, P3633, DOI 10.1073/pnas.052342699; Sipiczki M, 2007, FEMS YEAST RES, V7, P761, DOI 10.1111/j.1567-1364.2007.00266.x; Skop AR, 2001, CURR BIOL, V11, P735, DOI 10.1016/S0960-9822(01)00231-7; SOMOGYI M, 1952, J BIOL CHEM, V195, P19; Spang A, 2001, MOL BIOL CELL, V12, P1035, DOI 10.1091/mbc.12.4.1035; Spang A, 2010, FEBS LETT, V584, P2646, DOI 10.1016/j.febslet.2010.04.005; STEARNS T, 1990, P NATL ACAD SCI USA, V87, P1238, DOI 10.1073/pnas.87.3.1238; Styers ML, 2008, AM J PHYSIOL-CELL PH, V294, pC1485, DOI 10.1152/ajpcell.00010.2008; Suda Y, 2011, YEAST GOLGI APPARATU; Szul T, 2007, J CELL SCI, V120, P3929, DOI 10.1242/jcs.010769; Szul Tomasz, 2011, Cell Logist, V1, P69; Tahirovic S, 2003, CURR GENET, V43, P71, DOI 10.1007/s00294-003-0380-9; TEAL SB, 1994, J BIOL CHEM, V269, P3135; Togawa A, 1999, J BIOL CHEM, V274, P12308, DOI 10.1074/jbc.274.18.12308; TRAUB LM, 1993, J CELL BIOL, V123, P561, DOI 10.1083/jcb.123.3.561; TURI TG, 1994, J BIOL CHEM, V269, P24229; van der Vaart A, 2010, MOL BIOL CELL, V21, P2270, DOI 10.1091/mbc.E09-04-0345; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; Wang HY, 2003, GENETICS, V164, P1323; Wang HY, 2002, MOL BIOL CELL, V13, P515, DOI 10.1091/mbc.01-11-0542; Wang SS, 2012, J CELL SCI, V125, P461, DOI 10.1242/jcs.092551; YOSHIDA T, 1994, J CELL SCI, V107, P1725; Zakrzewska E, 2003, GENETICS, V165, P985; Zeeh JC, 2006, J BIOL CHEM, V281, P11805, DOI 10.1074/jbc.M600149200; Zhang LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032135; Zhao XH, 2002, MOL BIOL CELL, V13, P119, DOI 10.1091/mbc.01-08-0420	111	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56807	10.1371/journal.pone.0056807	http://dx.doi.org/10.1371/journal.pone.0056807			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457617	Green Submitted, Green Published, gold			2022-12-25	WOS:000315603700082
J	Maruyama, EO; Yu, HMI; Jiang, M; Fu, J; Hsu, W				Maruyama, Eri Ohfuchi; Yu, H-M Ivy; Jiang, Ming; Fu, Jiang; Hsu, Wei			Gpr177 Deficiency Impairs Mammary Development and Prohibits Wnt-Induced Tumorigenesis	PLOS ONE			English	Article							CANCER STEM-CELLS; SIGNALING PATHWAY; MOUSE MODELS; BETA-CATENIN; TGF-BETA; EXPRESSION; PROTEINS; GLAND; GENE; TRAFFICKING	Aberrant regulation of the Wnt pathway, essential for various developmental processes, is tightly linked to human breast cancers. By hijacking this evolutionary conserved signaling pathway, cancer cells acquire sustaining proliferation ability, leading to modification of physiologic properties necessary for tumor initiation and progression. An enormous wealth of knowledge on the importance of Wnt signaling in breast development and cancer has been obtained, but the cell types responsible for production of this proliferative signal operating within normal and malignant tissues remains poorly understood. Here we report that Wnt production mediated by Gpr177 is essential for mammary morphogenesis. The loss of Gpr177 interferes with mammary stem cells, leading to deficiencies in cell proliferation and differentiation. Genetic analysis further demonstrates an indispensable role of Gpr177 in Wnt-induced tumorigenesis. The Gpr177-deficiency mice are resistant to malignant transformation. This study not only demonstrates the necessity of Wnt in mammary organogenesis but also provides a proof-of-principle for targeting of Gpr177 as a potential new treatment for human diseases with aberrant Wnt stimulation.	[Maruyama, Eri Ohfuchi; Yu, H-M Ivy; Jiang, Ming; Fu, Jiang; Hsu, Wei] Univ Rochester, Med Ctr, James P Wilmot Canc Ctr, Dept Biomed Genet,Ctr Oral Biol, Rochester, NY 14642 USA	University of Rochester	Hsu, W (corresponding author), Univ Rochester, Med Ctr, James P Wilmot Canc Ctr, Dept Biomed Genet,Ctr Oral Biol, Rochester, NY 14642 USA.	Wei_Hsu@urmc.rochester.edu	Hsu, Wei/ABG-6856-2021	Hsu, Wei/0000-0001-6738-6030; Maruyama, Eri/0000-0003-3797-2754	National Institutes of Health [CA106308]; USAMRMC Breast Cancer Research Program [W81XWH-07-1-0405]; NATIONAL CANCER INSTITUTE [R01CA106308] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE015654] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USAMRMC Breast Cancer Research Program(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work is supported by National Institutes of Health grant CA106308 and USAMRMC Breast Cancer Research Program grant W81XWH-07-1-0405 to W.H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Bai LX, 2010, GENE DEV, V24, P1882, DOI 10.1101/gad.1932810; Brennan KR, 2004, J MAMMARY GLAND BIOL, V9, P119, DOI 10.1023/B:JOMG.0000037157.94207.33; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; Ching W, 2006, CELL, V125, P432, DOI 10.1016/j.cell.2006.04.018; Chiu SY, 2008, PLOS BIOL, V6, P2801, DOI 10.1371/journal.pbio.0060310; Cho RW, 2008, STEM CELLS, V26, P364, DOI 10.1634/stemcells.2007-0440; Cicalese A, 2009, CELL, V138, P1083, DOI 10.1016/j.cell.2009.06.048; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Coudreuse D, 2007, DEVELOPMENT, V134, P3, DOI 10.1242/dev.02699; Fu J, 2012, J INVEST DERMATOL; Fu JA, 2011, DEV DYNAM, V240, P365, DOI 10.1002/dvdy.22541; Fu J, 2009, P NATL ACAD SCI USA, V106, P18598, DOI 10.1073/pnas.0904894106; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hatsell S, 2003, J MAMMARY GLAND BIOL, V8, P145, DOI 10.1023/A:1025944723047; Hausmann G, 2007, NAT REV MOL CELL BIO, V8, P331, DOI 10.1038/nrm2141; Howe LR, 2004, CANCER BIOL THER, V3, P36, DOI 10.4161/cbt.3.1.561; Hsu W, 2001, J CELL BIOL, V155, P1055, DOI 10.1083/jcb.200107066; Hsu W, 2010, DEV DYNAM, V239, P338, DOI 10.1002/dvdy.22044; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Hynes NE, 2009, CURR OPIN CELL BIOL, V21, P177, DOI 10.1016/j.ceb.2008.12.010; Jiang M, 2010, CELL DEATH DIFFER; Klaus A, 2008, NAT REV CANCER, V8, P387, DOI 10.1038/nrc2389; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Li Y, 2003, P NATL ACAD SCI USA, V100, P15853, DOI 10.1073/pnas.2136825100; Liu B, 2008, NEOPLASIA, V10, P1004, DOI 10.1593/neo.08548; Liu B, 2007, DEV BIOL, V301, P298, DOI 10.1016/j.ydbio.2006.10.018; Liu BY, 2004, P NATL ACAD SCI USA, V101, P4158, DOI 10.1073/pnas.0400699101; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Maruyama T., 2012, J BONE MINER RES; Maruyama T, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000727; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; McNeill H, 2010, NAT REV MOL CELL BIO, V11, P404, DOI 10.1038/nrm2902; Miraoui H, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3146re9; Pastrana E, 2011, CELL STEM CELL, V8, P486, DOI 10.1016/j.stem.2011.04.007; Port F, 2010, TRAFFIC, V11, P1265, DOI 10.1111/j.1600-0854.2010.01076.x; Roarty K, 2007, DEVELOPMENT, V134, P3929, DOI 10.1242/dev.008250; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Takada R, 2006, DEV CELL, V11, P791, DOI 10.1016/j.devcel.2006.10.003; Takahashi-Yanaga F, 2010, CLIN CANCER RES, V16, P3153, DOI 10.1158/1078-0432.CCR-09-2943; TSUKAMOTO AS, 1988, CELL, V55, P619, DOI 10.1016/0092-8674(88)90220-6; Vaillant F, 2008, CANCER RES, V68, P7711, DOI 10.1158/0008-5472.CAN-08-1949; van Amerongen R, 2006, TRENDS GENET, V22, P678, DOI 10.1016/j.tig.2006.10.001; Visvader JE, 2009, GENE DEV, V23, P2563, DOI 10.1101/gad.1849509; Wagner KU, 1997, NUCLEIC ACIDS RES, V25, P4323, DOI 10.1093/nar/25.21.4323; Willert K, 2003, NATURE; Witsch E, 2010, PHYSIOLOGY, V25, P85, DOI 10.1152/physiol.00045.2009; Yu HMI, 2005, P NATL ACAD SCI USA, V102, P8615, DOI 10.1073/pnas.0500124102; Yu HMI, 2005, DEVELOPMENT, V132, P1995, DOI 10.1242/dev.01786; Yu HMI, 2010, DEV DYNAM, V239, P2102, DOI 10.1002/dvdy.22336; Yu HMI, 2007, MECH DEVELOP, V124, P146, DOI 10.1016/j.mod.2006.10.002; Zeng YA, 2010, CELL STEM CELL, V6, P568, DOI 10.1016/j.stem.2010.03.020	53	16	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56644	10.1371/journal.pone.0056644	http://dx.doi.org/10.1371/journal.pone.0056644			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457599	Green Published, gold, Green Submitted			2022-12-25	WOS:000315603700070
J	Yan, SM; Tang, JJ; Huang, CY; Xi, SY; Huang, MY; Liang, JZ; Jiang, YX; Li, YH; Zhou, ZW; Ernberg, I; Wu, QL; Du, ZM				Yan, Shu-Mei; Tang, Jian-Jun; Huang, Chun-Yu; Xi, Shao-Yan; Huang, Ma-Yan; Liang, Jian-Zhong; Jiang, Yuan-Xue; Li, Yu-Hong; Zhou, Zhi-Wei; Ernberg, Ingemar; Wu, Qiu-Liang; Du, Zi-Ming			Reduced Expression of ZDHHC2 Is Associated with Lymph Node Metastasis and Poor Prognosis in Gastric Adenocarcinoma	PLOS ONE			English	Article							ANTIPROLIFERATIVE FACTOR; TUMOR-SUPPRESSOR; ALLELIC LOSS; INTERSTITIAL CYSTITIS; CANCER METASTASIS; SHORT ARM; PALMITOYLATION; IDENTIFICATION; CHROMOSOME-8; DELETION	Background: Zinc finger, DHHC-type containing 2 (ZDHHC2), originally named as reduced expression associated with metastasis protein (REAM), has been proposed as a putative tumor/metastasis suppressor gene and is often aberrantly decreased in human cancers. However ZDHHC2 expression pattern and its clinical significance have not yet been investigated in gastric adenocarcinoma. Methodology/Principal Findings: Quantitative Real-Time PCR (qRT-PCR) and immunostaining were performed to detect ZDHHC2 expression in gastric adenocarcinoma, and then the correlation between ZDHHC2 expression and clinicpathologic parameters, and patient survival was analyzed. Compared to the adjacent normal tissues, ZDHHC2 expression was significantly reduced in gastric tumor tissues as shown by qRT-PCR and immunostaining. Low expression of ZDHHC2 was observed in 44.7% (211/472) of gastric adenocarcinoma patients, and was associated significantly with lymph node metastasis (p<0.001) and histological grade (p<0.001). Multivariate Cox regression analysis indicated that ZDHHC2 expression had a significant, independent predictive value for survival of gastric cancer patients (HR = 0.627, p = 0.001). Conclusions/Significance: Our data suggest that reduced ZDHHC2 expression is associated with lymph node metastasis and independently predicts an unfavorable prognosis in gastric adenocarcinoma patients.	[Yan, Shu-Mei; Xi, Shao-Yan; Huang, Ma-Yan; Liang, Jian-Zhong; Wu, Qiu-Liang; Du, Zi-Ming] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Guangzhou 510275, Guangdong, Peoples R China; [Yan, Shu-Mei; Xi, Shao-Yan; Huang, Ma-Yan; Liang, Jian-Zhong; Wu, Qiu-Liang; Du, Zi-Ming] Sun Yat Sen Univ, Ctr Canc, Dept Pathol, Guangzhou 510275, Guangdong, Peoples R China; [Huang, Chun-Yu; Zhou, Zhi-Wei] Sun Yat Sen Univ, Ctr Canc, Dept Gastr & Pancreat Surg, Guangzhou 510275, Guangdong, Peoples R China; [Jiang, Yuan-Xue; Li, Yu-Hong] Sun Yat Sen Univ, Ctr Canc, Dept Med Oncol, Guangzhou 510275, Guangdong, Peoples R China; [Tang, Jian-Jun] Sun Yat Sen Univ, Ctr Canc, Dept Expt Res, Guangzhou 510275, Guangdong, Peoples R China; [Ernberg, Ingemar] Karolinska Inst, Dept Microbiolgy Tumor & Cell Biol, Stockholm, Sweden	State Key Lab Oncology South China; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Karolinska Institutet	Wu, QL (corresponding author), Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Guangzhou 510275, Guangdong, Peoples R China.	wuql@sysucc.org.cn; duzm@sysucc.org.cn			National Natural Science Foundation of China [81172565, 81202135]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 81172565 and No. 81202135). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anbazhagan R, 1998, AM J PATHOL, V152, P815; BOVA GS, 1993, CANCER RES, V53, P3869; Conrads TP, 2006, J BIOL CHEM, V281, P37836, DOI 10.1074/jbc.M604581200; Croxtall JD, 2010, DRUGS, V70, P2259, DOI 10.2165/11205900-000000000-00000; Du ZM, 2009, INT J CANCER, V125, P1832, DOI 10.1002/ijc.24531; EMI M, 1993, GENE CHROMOSOME CANC, V7, P152, DOI 10.1002/gcc.2870070307; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fernandez-Hernando C, 2006, J CELL BIOL, V174, P369, DOI 10.1083/jcb.200601051; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; FUJIWARA Y, 1994, GENE CHROMOSOME CANC, V10, P7, DOI 10.1002/gcc.2870100103; Fukata M, 2004, NEURON, V44, P987, DOI 10.1016/j.neuron.2004.12.005; Giannakis M, 2008, P NATL ACAD SCI USA, V105, P4358, DOI 10.1073/pnas.0800668105; Greaves J, 2011, TRENDS BIOCHEM SCI, V36, P245, DOI 10.1016/j.tibs.2011.01.003; Greaves J, 2010, J BIOL CHEM, V285, P24629, DOI 10.1074/jbc.M110.119289; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Jang BG, 2011, PATHOBIOLOGY, V78, P302, DOI 10.1159/000321703; Japanese Gastric Cancer Association, 1998, GASTRIC CANCER, V1, P10, DOI DOI 10.1007/S101209800016; Jia LX, 2011, J BIOL CHEM, V286, P13695, DOI 10.1074/jbc.M110.193763; Kanwal R, 2012, CLIN GENET, V81, P303, DOI 10.1111/j.1399-0004.2011.01809.x; Keay S, 2003, PHYSIOL GENOMICS, V14, P107, DOI 10.1152/physiolgenomics.00055.2003; KNOWLES MA, 1993, ONCOGENE, V8, P1357; Li YF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043555; Linder ME, 2004, J CELL SCI, V117, P521, DOI 10.1242/jcs.00989; Macdonald JS, 2001, NEW ENGL J MED, V345, P725, DOI 10.1056/NEJMoa010187; Mitchell DA, 2006, J LIPID RES, V47, P1118, DOI 10.1194/jlr.R600007-JLR200; Nault JC, 2011, SEMIN LIVER DIS, V31, P173, DOI 10.1055/s-0031-1276646; OHATA H, 1993, GENE CHROMOSOME CANC, V7, P85, DOI 10.1002/gcc.2870070204; Ohno Y, 2006, BBA-MOL CELL BIOL L, V1761, P474, DOI 10.1016/j.bbalip.2006.03.010; Oyama T, 2000, GENE CHROMOSOME CANC, V29, P9, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1001>3.0.CO;2-#; Sharma C, 2008, MOL BIOL CELL, V19, P3415, DOI 10.1091/mbc.E07-11-1164; Shibata MA, 1999, EMBO J, V18, P2692, DOI 10.1093/emboj/18.10.2692; Shmueli A, 2010, EMBO J, V29, P107, DOI 10.1038/emboj.2009.325; Singaraja RR, 2009, CIRC RES, V105, P138, DOI 10.1161/CIRCRESAHA.108.193011; Smotrys JE, 2004, ANNU REV BIOCHEM, V73, P559, DOI 10.1146/annurev.biochem.73.011303.073954; STANBRIDGE EJ, 1990, SCIENCE, V247, P12, DOI 10.1126/science.2403692; Talmadge JE, 2010, CANCER RES, V70, P5649, DOI 10.1158/0008-5472.CAN-10-1040; Tang BW, 1998, NAT MED, V4, P802, DOI 10.1038/nm0798-802; Tsutsumi R, 2009, MOL CELL BIOL, V29, P435, DOI 10.1128/MCB.01144-08; Wang W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024897; Yaremko ML, 1996, GENE CHROMOSOME CANC, V16, P189, DOI 10.1002/(SICI)1098-2264(199607)16:3<189::AID-GCC6>3.0.CO;2-V; Zagouri F, 2011, CANCER TREAT REV, V37, P599, DOI 10.1016/j.ctrv.2011.03.007; Zeidman R, 2011, MOL MEMBR BIOL, V28, P473, DOI 10.3109/09687688.2011.630682; Zhang CO, 2005, J UROLOGY, V174, P2382, DOI 10.1097/01.ju.0000180417.11976.99; Zhang J, 2008, MOL CELL PROTEOMICS, V7, P1378, DOI 10.1074/mcp.M800069-MCP200	44	28	28	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56366	10.1371/journal.pone.0056366	http://dx.doi.org/10.1371/journal.pone.0056366			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457560	Green Submitted, gold, Green Published			2022-12-25	WOS:000315603700048
J	Bronstein, I; Montgomery, P				Bronstein, Israel; Montgomery, Paul			Sleeping Patterns of Afghan Unaccompanied Asylum-Seeking Adolescents: A Large Observational Study	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; MENTAL-HEALTH-CARE; REFUGEE CHILDREN; CIRCADIAN PREFERENCE; IMAGERY REHEARSAL; EXPERIENCES; NIGHTMARES; VALIDITY; CULTURE; HABITS	Unaccompanied asylum-seeking children (UASC)have experienced multiple traumas and are a high-risk group for posttraumatic stress disorder (PTSD). The effects of trauma are known to be associated with sleep problems; indeed sleeping problems are core features of PTSD. However, there has been no systematic research examining the sleep of this high risk group of children. This study presents the first evidence on the sleeping patterns of Afghan UASC living in the UK. A total of 222 male Afghan children, aged 13-18, were interviewed using validated self-report questionnaires measuring sleeping patterns and PTSD. Overall, UASC patterns for bed time and rise time appear acculturated to the country of asylum. Mean UASC sleep onset latency scores were approximately 20 minutes greater compared with normative scores, which may be a reflection of UASC pre-migration and post-migration experiences. As expected, UASC who screened above the clinical cut-off for PTSD reported significantly greater sleep onset latency, increased nightmares, and less total sleep time compared to the non-PTSD group. The results may be of particular interest to clinicians given that, compared to screening for PTSD, screening for sleep problems may be a less culturally disputed form of initial assessment indicating distress in UASC. Similarly, the field of UASC and refugee child interventions is largely focused on trauma, yet sleep may provide a novel avenue for equally or more effective treatment.	[Bronstein, Israel; Montgomery, Paul] Univ Oxford, Ctr Evidence Based Intervent, Dept Social Policy & Intervent, Oxford, England; [Bronstein, Israel] Bar Ilan Univ, Louis & Gabi Weisfeld Sch Social Work, Ramat Gan, Israel	University of Oxford; Bar Ilan University	Bronstein, I (corresponding author), Univ Oxford, Ctr Evidence Based Intervent, Dept Social Policy & Intervent, Oxford, England.	raeli.bronstein@gmail.com		Bronstein, Israel/0000-0002-5136-1311; Montgomery, Paul/0000-0001-8008-1370	John Fell Fund (Oxford University Press)	John Fell Fund (Oxford University Press)	This research was supported by the John Fell Fund (Oxford University Press) - http://www.admin.ox.ac.uk/pras/jff/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abunimah A, 2010, CHILD CARE PRACTICE, V16, P129, DOI DOI 10.1080/13575270903482799; Bean T, 2006, J TRAUMA STRESS, V19, P241, DOI 10.1002/jts.20093; Bean T, 2004, REACTIONS ADOLESCENT, V45; Boland K, 2010, CHILDREN MOVE REPORT; Bronstein I, 2012, J TRAUMA STRESS, V25, P551, DOI 10.1002/jts.21740; Bronstein I, 2011, CLIN CHILD FAM PSYCH, V14, P44, DOI 10.1007/s10567-010-0081-0; Carskadon MA, 1991, SLEEP RES, V20, P175; Casement MD, 2012, CLIN PSYCHOL REV, V32, P566, DOI 10.1016/j.cpr.2012.06.002; Chase E, 2008, EMOTIONAL WELL BEING; Corkum P, 1998, J AM ACAD CHILD PSY, V37, P637, DOI 10.1097/00004583-199806000-00014; Ehntholt KA, 2006, J CHILD PSYCHOL PSYC, V47, P1197, DOI 10.1111/j.1469-7610.2006.01638.x; Fazel M, 2012, LANCET, V379, P266, DOI 10.1016/S0140-6736(11)60051-2; Field A, 2006, INTRO STAT METHODS S; Giannotti F, 2002, J SLEEP RES, V11, P191, DOI 10.1046/j.1365-2869.2002.00302.x; Gradisar M, 2011, SLEEP MED, V12, P110, DOI 10.1016/j.sleep.2010.11.008; Groark Claire, 2011, Clin Child Psychol Psychiatry, V16, P421, DOI 10.1177/1359104510370405; Harvey AG, 2003, CLIN PSYCHOL REV, V23, P377, DOI 10.1016/S0272-7358(03)00032-1; Home Office, 2010, HOM OFF STAT B, V15; Huemer Julia, 2009, Child Adolesc Psychiatry Ment Health, V3, P13, DOI 10.1186/1753-2000-3-13; Jenni OG, 2005, PEDIATRICS, V115, P204, DOI 10.1542/peds.2004-0815B; Jordans MJD, 2009, CHILD ADOL MENT H-UK, V14, P2, DOI 10.1111/j.1475-3588.2008.00515.x; KLEINMAN A, 1987, BRIT J PSYCHIAT, V151, P447, DOI 10.1192/bjp.151.4.447; Levy K. J., 1978, Journal of Statistical Computation and Simulation, V8, P49, DOI 10.1080/00949657808810247; Maneesriwongul W, 2004, J ADV NURS, V48, P175, DOI 10.1111/j.1365-2648.2004.03185.x; Montgomery E, 2001, EUR J PUBLIC HEALTH, V11, P18, DOI 10.1093/eurpub/11.1.18; Mougne C, 2010, TREES ONLY MOVE WIND; Murray KE, 2010, AM J ORTHOPSYCHIAT, V80, P576, DOI 10.1111/j.1939-0025.2010.01062.x; National Sleep Foundation, 2006, SUMM FIND 2006 SLEEP; Nickerson A, 2011, CLIN PSYCHOL REV, V31, P399, DOI 10.1016/j.cpr.2010.10.004; Owens JA, 2010, ARCH PEDIAT ADOL MED, V164, P608, DOI 10.1001/archpediatrics.2010.96; Owens Judith A, 2006, Behav Sleep Med, V4, P114, DOI 10.1207/s15402010bsm0402_4; Pilcher JJ, 1996, SLEEP, V19, P318, DOI 10.1093/sleep/19.4.318; Russo PM, 2007, J SLEEP RES, V16, P163, DOI 10.1111/j.1365-2869.2007.00584.x; Sadeh A, 2003, CHILD DEV, V74, P444, DOI 10.1111/1467-8624.7402008; Sadeh A, 1996, CHILD ADOL PSYCH CL, V5, P685, DOI 10.1016/S1056-4993(18)30356-0; Separated Children in Europe Programme, 2004, STAT GOOD PRACT; Soffer-Dudek N, 2010, PSYCHIATRY, V73, P264, DOI 10.1521/psyc.2010.73.3.264; Spoormaker VI, 2008, SLEEP MED REV, V12, P169, DOI 10.1016/j.smrv.2007.08.008; Spruyt K, 2011, SLEEP MED REV, V15, P19, DOI 10.1016/j.smrv.2010.07.005; St-Onge M, 2009, BEHAV SLEEP MED, V7, P81, DOI 10.1080/15402000902762360; Stanley K, 2001, COLD COMFORT YOUNG S; Thabet AAM, 2004, J CHILD PSYCHOL PSYC, V45, P533, DOI 10.1111/j.1469-7610.2004.00243.x; Thomas S, 2004, CHILD CARE HLTH DEV, V30, P113, DOI 10.1111/j.1365-2214.2003.00404.x; Van Ommeren M, 2003, BRIT J PSYCHIAT, V182, P376, DOI 10.1192/bjp.182.5.376; von Elm E, 2007, EPIDEMIOLOGY, V18, P800, DOI 10.1097/EDE.0b013e3181577654; Watters C, 2001, SOC SCI MED, V52, P1709, DOI 10.1016/S0277-9536(00)00284-7; Wolfson AR, 2003, SLEEP, V26, P213, DOI 10.1093/sleep/26.2.213; Wolfson AR, 1998, CHILD DEV, V69, P875, DOI 10.2307/1132351; Worthman CM, 2002, ADOLESCENT SLEEP PAT; Yang CK, 2005, PEDIATRICS, V115, P250, DOI 10.1542/peds.2004-0815G	50	14	14	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56156	10.1371/journal.pone.0056156	http://dx.doi.org/10.1371/journal.pone.0056156			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	099EJ	23457517	Green Published, Green Submitted, gold			2022-12-25	WOS:000315602700051
J	Oishi, T; Uezumi, A; Kanaji, A; Yamamoto, N; Yamaguchi, A; Yamada, H; Tsuchida, K				Oishi, Teruyo; Uezumi, Akiyoshi; Kanaji, Arihiko; Yamamoto, Naoki; Yamaguchi, Asami; Yamada, Harumoto; Tsuchida, Kunihiro			Osteogenic Differentiation Capacity of Human Skeletal Muscle-Derived Progenitor Cells	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; TOTAL HIP-ARTHROPLASTY; SPINAL-CORD INJURY; HETEROTOPIC OSSIFICATION; SATELLITE CELLS; BONE-FORMATION; ECTOPIC OSSIFICATION; IN-VITRO; IDENTIFICATION; INHIBITION	Heterotopic ossification (HO) is defined as the formation of ectopic bone in soft tissue outside the skeletal tissue. HO is thought to result from aberrant differentiation of osteogenic progenitors within skeletal muscle. However, the precise origin of HO is still unclear. Skeletal muscle contains two kinds of progenitor cells, myogenic progenitors and mesenchymal progenitors. Myogenic and mesenchymal progenitors in human skeletal muscle can be identified as CD56(+) and PDGFR alpha(+) cells, respectively. The purpose of this study was to investigate the osteogenic differentiation potential of human skeletal muscle-derived progenitors. Both CD56(+) cells and PDGFR alpha(+) cells showed comparable osteogenic differentiation potential in vitro. However, in an in vivo ectopic bone formation model, PDGFR alpha(+) cells formed bone-like tissue and showed successful engraftment, while CD56(+) cells did not form bone-like tissue and did not adapt to an osteogenic environment. Immunohistological analysis of human HO sample revealed that many PDGFR alpha(+) cells were localized in proximity to ectopic bone formed in skeletal muscle. MicroRNAs (miRNAs) are known to regulate many biological processes including osteogenic differentiation. We investigated the participation of miRNAs in the osteogenic differentiation of PDGFR alpha(+) cells by using microarray. We identified miRNAs that had not been known to be involved in osteogenesis but showed dramatic changes during osteogenic differentiation of PDGFR alpha(+) cells. Upregulation of miR-146b-5p and -424 and downregulation of miR-7 during osteogenic differentiation of PDGFR alpha(+) cells were confirmed by quantitative real-time RT-PCR. Inhibition of upregulated miRNAs, miR-146b-5p and -424, resulted in the suppression of osteocyte maturation, suggesting that these two miRNAs have the positive role in the osteogenesis of PDGFR alpha(+) cells. Our results suggest that PDGFR alpha(+) cells may be the major source of HO and that the newly identified miRNAs may regulate osteogenic differentiation process of PDGFR alpha(+) cells.	[Oishi, Teruyo; Yamaguchi, Asami; Yamada, Harumoto] Fujita Hlth Univ, Sch Med, Dept Orthopaed Surg, Toyoake, Aichi 47011, Japan; [Oishi, Teruyo; Uezumi, Akiyoshi; Tsuchida, Kunihiro] Fujita Hlth Univ, Div Therapies Intractable Dis, Inst Comprehens Med Sci, Toyoake, Aichi, Japan; [Kanaji, Arihiko] Keio Univ, Sch Med, Dept Orthopaed Surg, Tokyo, Japan; [Yamamoto, Naoki] Fujita Hlth Univ, Lab Mol Biol & Histochem, Joint Res Lab, Toyoake, Aichi, Japan	Fujita Health University; Fujita Health University; Keio University; Fujita Health University	Yamada, H (corresponding author), Fujita Hlth Univ, Sch Med, Dept Orthopaed Surg, Toyoake, Aichi 47011, Japan.	hayamada@fujita-hu.ac.jp	Tsuchida, Kunihiro/A-4501-2012; Yamamoto, Naoki/L-2603-2019; Uezumi, Akiyoshi/ABF-7359-2020	Tsuchida, Kunihiro/0000-0002-3983-5756; Uezumi, Akiyoshi/0000-0003-4294-0116	MEXT [23126527, S1001034]; NCNP [23-5]; Grants-in-Aid for Scientific Research [24590363] Funding Source: KAKEN	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NCNP; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas, MEXT (23126527); Intramural Research Grant (23-5) for Neurological and Psychiatric Disorders of NCNP; and MEXT-Supported Program for the Strategic Research Foundation at Private Universities (S1001034). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHRENGART L, 1991, CLIN ORTHOP RELAT R, P49; Akao Y, 2010, CANCER GENE THER, V17, P398, DOI 10.1038/cgt.2009.88; Banovac K, 2000, J Spinal Cord Med, V23, P40; Banovac K, 2001, SPINAL CORD, V39, P370, DOI 10.1038/sj.sc.3101166; BANOVAC K, 1993, PARAPLEGIA, V31, P660, DOI 10.1038/sc.1993.106; Banovac K, 1997, J Spinal Cord Med, V20, P60; Banovac Kresimir, 2004, J Spinal Cord Med, V27, P376; BROOKER AF, 1973, J BONE JOINT SURG AM, VA 55, P1629, DOI 10.2106/00004623-197355080-00006; Chang J, 2009, NAT MED, V15, P682, DOI 10.1038/nm.1954; Covas DT, 2008, EXP HEMATOL, V36, P642, DOI 10.1016/j.exphem.2007.12.015; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Dellavalle A, 2007, NAT CELL BIOL, V9, P255, DOI 10.1038/ncb1542; Eghbali-Fatourechi GZ, 2005, NEW ENGL J MED, V352, P1959, DOI 10.1056/NEJMoa044264; Eskildsen T, 2011, P NATL ACAD SCI USA, V108, P6139, DOI 10.1073/pnas.1016758108; Favier B, 2010, FASEB J, V24, P689, DOI 10.1096/fj.09-135194; FIDZIANSKA A, 1995, FOLIA NEUROPATHOL, V33, P125; Flannery SM, 2011, J BIOL CHEM, V286, P23688, DOI 10.1074/jbc.M111.248351; Hardy MP, 2004, J BIOL CHEM, V279, P27699, DOI 10.1074/jbc.M403068200; Hulsmans M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032794; ILLA I, 1992, ANN NEUROL, V31, P46, DOI 10.1002/ana.410310109; Inose H, 2009, P NATL ACAD SCI USA, V106, P20794, DOI 10.1073/pnas.0909311106; Itoh T, 2009, J BIOL CHEM, V284, P19272, DOI 10.1074/jbc.M109.014001; Jackson WM, 2009, J ORTHOP RES, V27, P1645, DOI 10.1002/jor.20924; Kan LX, 2009, STEM CELLS, V27, P150, DOI 10.1634/stemcells.2008-0576; Kaplan FS, 2007, J BONE JOINT SURG AM, V89A, P347, DOI 10.2106/JBJS.F.00472; Krum SA, 2010, NAT REV RHEUMATOL, V6, P607, DOI 10.1038/nrrheum.2010.133; Leblanc E, 2011, J BONE MINER RES, V26, P1166, DOI 10.1002/jbmr.311; Lecourt S, 2010, EXP CELL RES, V316, P2513, DOI 10.1016/j.yexcr.2010.04.020; Levy MM, 2001, BONE, V29, P317, DOI 10.1016/S8756-3282(01)00585-3; Li GH, 2011, J MOL CELL BIOL, V3, P369, DOI 10.1093/jmcb/mjr014; Li Z, 2008, P NATL ACAD SCI USA, V105, P13906, DOI 10.1073/pnas.0804438105; Lindstrom M, 2009, HISTOCHEM CELL BIOL, V132, P141, DOI 10.1007/s00418-009-0606-0; Mastrogiacomo M, 2005, J CELL PHYSIOL, V204, P594, DOI 10.1002/jcp.20325; Naraghi FF, 1996, ORTHOPEDICS, V19, P145; Nesti LJ, 2008, J BONE JOINT SURG AM, V90A, P2390, DOI 10.2106/JBJS.H.00049; Nilsson Olle S., 1999, Current Opinion in Rheumatology, V11, P127, DOI 10.1097/00002281-199903000-00008; O'Neill LA, 2011, NAT REV IMMUNOL, V11, P163, DOI 10.1038/nri2957; Otsuru S, 2008, STEM CELLS, V26, P223, DOI 10.1634/stemcells.2007-0515; Otsuru S, 2007, BIOCHEM BIOPH RES CO, V354, P453, DOI 10.1016/j.bbrc.2006.12.226; RITTER MA, 1977, J BONE JOINT SURG AM, V59, P345, DOI 10.2106/00004623-197759030-00009; SCHUBERT W, 1989, P NATL ACAD SCI USA, V86, P307, DOI 10.1073/pnas.86.1.307; Schulz TJ, 2011, P NATL ACAD SCI USA, V108, P143, DOI 10.1073/pnas.1010929108; Schwab KE, 2007, HUM REPROD, V22, P2903, DOI 10.1093/humrep/dem265; Shi S, 2003, J BONE MINER RES, V18, P696, DOI 10.1359/jbmr.2003.18.4.696; Starkey JD, 2011, J HISTOCHEM CYTOCHEM, V59, P33, DOI 10.1369/jhc.2010.956995; Suda RK, 2009, STEM CELLS, V27, P2209, DOI 10.1002/stem.150; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; THOMAS BJ, 1992, ORTHOP CLIN N AM, V23, P347; Uezumi A, 2011, J CELL SCI, V124, P3654, DOI 10.1242/jcs.086629; Uezumi A, 2010, NAT CELL BIOL, V12, P143, DOI 10.1038/ncb2014; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Wosczyna MN, 2012, J BONE MINER RES, V27, P1004, DOI 10.1002/jbmr.1562; Zannettino ACW, 2008, J CELL PHYSIOL, V214, P413, DOI 10.1002/jcp.21210	53	59	60	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56641	10.1371/journal.pone.0056641	http://dx.doi.org/10.1371/journal.pone.0056641			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457598	Green Published, gold, Green Submitted			2022-12-25	WOS:000315602700088
J	Preininger, B; Duda, G; Gerigk, H; Bruckner, J; Ellinghaus, A; Sass, FA; Perka, C; Schmidt-Bleek, K; Dienelt, A				Preininger, Bernd; Duda, Georg; Gerigk, Hinnerk; Bruckner, Jonas; Ellinghaus, Agnes; Sass, F. Andrea; Perka, Carsten; Schmidt-Bleek, Katharina; Dienelt, Anke			CD133: Enhancement of Bone Healing by Local Transplantation of Peripheral Blood Cells in a Biologically Delayed Rat Osteotomy Model	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; CORD BLOOD; GROWTH-FACTOR; IN-VITRO; ADULT; ANGIOGENESIS; FRACTURE; AGE; EXPRESSION; CALLUS	Sufficient angiogenesis is crucial during tissue regeneration and therefore also pivotal in bone defect healing. Recently, peripheral blood derived progenitor cells have been identified to have in addition to their angiogenic potential also osteogenic characteristics, leading to the hypothesis that bone regeneration could be stimulated by local administration of these cells. The aim of this study was to evaluate the angiogenic potential of locally administered progenitor cells to improve bone defect healing. Cells were separated from the peripheral blood of donor animals using the markers CD34 and CD133. Results of the in vitro experiments confirmed high angiogenic potential in the CD133(+) cell group. CD34(+) and CD133(+) cells were tested in an in vivo rat femoral defect model of delayed healing for their positive effect on the healing outcome. An increased callus formation and higher bone mineral density of callus tissue was found after the CD133(+) cell treatment compared to the group treated with CD34(+) cells and the control group without cells. Histological findings confirmed an increase in vessel formation and mineralization at day 42 in the osteotomy gap after CD133(+) cell transplantation. The higher angiogenic potential of CD133(+) cells from the in vitro experients therefore correlates with the in vivo data. This study demonstrates the suitability of angiogenic precursors to further bone healing and gives an indication that peripheral blood is a promising source for progenitor cells circumventing the problems associated with bone marrow extraction.	[Preininger, Bernd; Duda, Georg; Gerigk, Hinnerk; Bruckner, Jonas; Ellinghaus, Agnes; Sass, F. Andrea; Perka, Carsten; Schmidt-Bleek, Katharina; Dienelt, Anke] Charite, Julius Wolff Inst, D-13353 Berlin, Germany; [Preininger, Bernd; Duda, Georg; Gerigk, Hinnerk; Bruckner, Jonas; Ellinghaus, Agnes; Sass, F. Andrea; Perka, Carsten; Schmidt-Bleek, Katharina; Dienelt, Anke] Charite, Ctr Musculoskeletal Surg, D-13353 Berlin, Germany; [Preininger, Bernd; Perka, Carsten] Charite, Dept Orthopaed, Ctr Musculoskeletal Surg, D-13353 Berlin, Germany; [Duda, Georg; Dienelt, Anke] Charite, Berlin Brandenburg Ctr Regenerat Therapies, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Duda, G (corresponding author), Charite, Julius Wolff Inst, D-13353 Berlin, Germany.	georg.duda@charite.de	Sass, Andrea F/M-6962-2017; Schmidt-Bleek, Katharina/O-9816-2015; Perka, Carsten/ABG-6505-2021; Duda, Georg N/H-2085-2016	Sass, Andrea F/0000-0001-6098-3609; Duda, Georg N/0000-0001-7605-3908; Perka, Carsten/0000-0002-0993-581X	German Research Foundation [DFG SFB 760]; BMBF	German Research Foundation(German Research Foundation (DFG)); BMBF(Federal Ministry of Education & Research (BMBF))	This study was supported partially by the German Research Foundation (DFG SFB 760) and through the BMBF funded Berlin-Brandenburg Center for Regenerative Therapies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arinzeh TL, 2003, J BONE JOINT SURG AM, V85A, P1927, DOI 10.2106/00004623-200310000-00010; Bonanno G, 2004, TRANSFUSION, V44, P1087, DOI 10.1111/j.1537-2995.2004.03252.x; Bruder SP, 1998, J BONE JOINT SURG AM, V80A, P985, DOI 10.2106/00004623-199807000-00007; Carano RAD, 2003, DRUG DISCOV TODAY, V8, P980, DOI 10.1016/S1359-6446(03)02866-6; Chen C H, 1994, J Hematother, V3, P3, DOI 10.1089/scd.1.1994.3.3; CHOMCZYNSKI P, 1993, BIOTECHNIQUES, V15, P532; David V, 2006, AM J PHYSIOL-ENDOC M, V290, pE440, DOI 10.1152/ajpendo.00293.2004; Demir B, 2008, MATURITAS, V60, P253, DOI 10.1016/j.maturitas.2008.07.011; Dienelt A, 2011, STEM CELLS DEV, V20, P465, DOI 10.1089/scd.2010.0205; Eghbali-Fatourechi GZ, 2005, NEW ENGL J MED, V352, P1959, DOI 10.1056/NEJMoa044264; Elkhafif N, 2011, APMIS, V119, P66, DOI 10.1111/j.1600-0463.2010.02693.x; Fassbender M, 2011, EUR CELLS MATER, V22, P1; Finney MR, 2010, CYTOTHERAPY, V12, P67, DOI 10.3109/14653240903300658; George AL, 2011, J HEMATOL ONCOL, V4, DOI 10.1186/1756-8722-4-24; Giannicola G, 2010, J TISSUE ENG REGEN M, V4, P273, DOI 10.1002/term.238; GOSPODAROWICZ D, 1987, ENDOCR REV, V8, P95, DOI 10.1210/edrv-8-2-95; Hankenson KD, 2011, INJURY, V42, P556, DOI 10.1016/j.injury.2011.03.035; Hellberg C, 2010, RECENT RESULTS CANC, V180, P103, DOI 10.1007/978-3-540-78281-0_7; Kawachi Y, 1996, BRIT J HAEMATOL, V94, P413, DOI 10.1046/j.1365-2141.1996.d01-1807.x; Kinnaird T, 2004, CIRCULATION, V109, P1543, DOI 10.1161/01.CIR.0000124062.31102.57; Kolar P, TISSUE ENG B; Lienau J, 2009, J ORTHOP RES, V27, P1133, DOI 10.1002/jor.20870; Maes C, 2010, DEV CELL, V19, P329, DOI 10.1016/j.devcel.2010.07.010; Marie PJ, 2012, GENE, V498, P1, DOI 10.1016/j.gene.2012.01.086; Matsumoto T, 2006, AM J PATHOL, V169, P1440, DOI 10.2353/ajpath.2006.060064; Meyer RA, 2001, J ORTHOP RES, V19, P428, DOI 10.1016/S0736-0266(00)90034-2; Meyer RA, 2006, J ORTHOP RES, V24, P1933, DOI 10.1002/jor.20124; Morgan EF, 2009, BONE, V44, P335, DOI 10.1016/j.bone.2008.10.039; Murohara T, 2000, J CLIN INVEST, V105, P1527, DOI 10.1172/JCI8296; NASH TJ, 1994, BONE, V15, P203, DOI 10.1016/8756-3282(94)90709-9; OLAH AJ, 1977, STAIN TECHNOL, V52, P331, DOI 10.3109/10520297709116809; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pittenger Mark F., 2008, V449, P27, DOI 10.1007/978-1-60327-169-1_2; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Preininger B, 2012, EUR CELLS MATER, V23, P262, DOI 10.22203/eCM.v023a20; Schindeler A, 2009, DIFFERENTIATION, V77, P12, DOI 10.1016/j.diff.2008.09.007; Shah P, 2012, J ORAL IMPLANTOL; Sorrell JM, 2009, TISSUE ENG PT A, V15, P1751, DOI 10.1089/ten.tea.2008.0254; Strube P, 2008, J BIOMECH, V41, P2696, DOI 10.1016/j.jbiomech.2008.06.009; Strube P, 2008, BONE, V42, P758, DOI 10.1016/S0021-9290(08)70350-6; Strube P, 2009, BONE, V45, P1065, DOI 10.1016/j.bone.2009.08.005; Summers YJ, 2004, STEM CELLS, V22, P704, DOI 10.1634/stemcells.22-5-704; Tondreau T, 2005, STEM CELLS, V23, P1105, DOI 10.1634/stemcells.2004-0330; Weiss S, 2009, ARCH ORTHOP TRAUM SU, V129, P989, DOI 10.1007/s00402-008-0777-5; Yamada M, 2007, J SHOULDER ELB SURG, V16, P596, DOI 10.1016/j.jse.2007.01.006; Zeng Hui, 2003, Chin J Traumatol, V6, P229	46	10	10	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e52650	10.1371/journal.pone.0052650	http://dx.doi.org/10.1371/journal.pone.0052650			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457441	Green Published, gold, Green Submitted			2022-12-25	WOS:000315602700001
J	Watamura, SE; Devine, KA; Robertson, SS				Watamura, Sarah Enos; Devine, Katie A.; Robertson, Steven S.			The Dynamics of Attention during Free Looking	PLOS ONE			English	Article							BRAIN-COMPUTER INTERFACE; SPATIAL ATTENTION; TIME-COURSE; SELECTIVE ATTENTION; VISUAL-ATTENTION; SHIFTS; ALLOCATION; EXECUTION; LOCATION; GAIN	Simple methods to study attention dynamics in challenging research and practical applications are limited. We explored the utility of examining attention dynamics during free looking with steady-state visual evoked potentials (SSVEPs), which reflect the effects of attention on early sensory processing. This method can be used with participants who cannot follow verbal instructions and patients without voluntary motor control. In our healthy participants, there were robust fluctuations in the strength of SSVEPs driven by the fixated and non-fixated stimuli (rapidly changing pictures of faces) in the seconds leading up to the moment they chose to shift their gaze to the next stimulus sequence. Furthermore, the amplitude of SSVEPs driven by the fixated stimuli predicted subsequent recognition of individual stimuli. The results illustrate how information about the temporal course of attention during free looking can be obtained with simple methods based on the attentional modulation of SSVEPs.	[Watamura, Sarah Enos] Univ Denver, Dept Psychol, Denver, CO 80208 USA; [Devine, Katie A.] Univ Rochester, Med Ctr, Dept Radiat Oncol, Rochester, NY 14642 USA; [Robertson, Steven S.] Cornell Univ, Dept Human Dev, Ithaca, NY 14853 USA	University of Denver; University of Rochester; Cornell University	Robertson, SS (corresponding author), Cornell Univ, Dept Human Dev, Ithaca, NY 14853 USA.	ssr4@cornell.edu	Devine, Katie/K-1298-2019	Devine, Katie/0000-0002-1003-8905; Watamura, Sarah/0000-0001-7860-0290	National Institutes of Health (NIH) [R01-HD23814]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD023814] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by National Institutes of Health (NIH) grant R01-HD23814 to SSR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison BZ, 2008, CLIN NEUROPHYSIOL, V119, P399, DOI 10.1016/j.clinph.2007.09.121; Baldauf D, 2008, EXP BRAIN RES, V184, P411, DOI 10.1007/s00221-007-1114-x; Ballard DH, 1997, BEHAV BRAIN SCI, V20, P723, DOI 10.1017/S0140525X97001611; Belmonte M, 1998, COGNITIVE BRAIN RES, V6, P295, DOI 10.1016/S0926-6410(98)00007-X; Burkitt GR, 2000, CLIN NEUROPHYSIOL, V111, P246, DOI 10.1016/S1388-2457(99)00194-7; Cheng M, 2002, IEEE T BIO-MED ENG, V49, P1181, DOI 10.1109/TBME.2002.803536; Clark V.P., 1994, HUMAN BRAIN MAPPING, V2, P170, DOI [10.1002/hbm.460020306, DOI 10.1002/HBM.460020306]; Deubel H, 1996, VISION RES, V36, P1827, DOI 10.1016/0042-6989(95)00294-4; Di Russo F, 2002, CLIN NEUROPHYSIOL, V113, P1771, DOI 10.1016/S1388-2457(02)00262-6; Di Russo F, 2001, VISION RES, V41, P2435, DOI 10.1016/S0042-6989(01)00134-1; Di Russo F, 2007, HUM BRAIN MAPP, V28, P323, DOI 10.1002/hbm.20276; Ding J, 2006, CEREB CORTEX, V16, P1016, DOI 10.1093/cercor/bhj044; Fuchs S, 2008, NEUROIMAGE, V41, P1086, DOI 10.1016/j.neuroimage.2008.02.040; Gersch TM, 2004, VISION RES, V44, P1469, DOI 10.1016/j.visres.2003.12.014; Godijn R, 2003, J EXP PSYCHOL HUMAN, V29, P882, DOI 10.1037/0096-1523.29.5.882; HARVEY LO, 1972, AMER J OPT ARCH AM A, V49, P748; Henderson JM, 1999, PSYCHOL SCI, V10, P438, DOI 10.1111/1467-9280.00183; Hillyard SA, 1997, HUM BRAIN MAPP, V5, P287, DOI 10.1002/(SICI)1097-0193(1997)5:4<287::AID-HBM14>3.0.CO;2-B; HOFFMAN JE, 1995, PERCEPT PSYCHOPHYS, V57, P787, DOI 10.3758/BF03206794; Irwin DE, 1998, VIS COGN, V5, P127, DOI 10.1080/713756783; Kelly SP, 2005, IEEE T BIO-MED ENG, V52, P1588, DOI 10.1109/TBME.2005.851510; Kelly SP, 2005, IEEE T NEUR SYS REH, V13, P172, DOI 10.1109/TNSRE.2005.847369; Kim YJ, 2007, NAT NEUROSCI, V10, P117, DOI 10.1038/nn1821; KOWLER E, 1995, VISION RES, V35, P1897, DOI 10.1016/0042-6989(94)00279-U; Malinowski P, 2007, NEUROSCI LETT, V414, P65, DOI 10.1016/j.neulet.2006.12.001; Middendorf M, 2000, IEEE T REHABIL ENG, V8, P211, DOI 10.1109/86.847819; Morgan ST, 1996, P NATL ACAD SCI USA, V93, P4770, DOI 10.1073/pnas.93.10.4770; Muller MM, 2006, P NATL ACAD SCI USA, V103, P14250, DOI 10.1073/pnas.0606668103; Muller MM, 2008, CEREB CORTEX, V18, P1892, DOI 10.1093/cercor/bhm215; Muller MM, 2008, BIOL PSYCHOL, V77, P292, DOI 10.1016/j.biopsycho.2007.11.003; Muller-Putz GR, 2008, IEEE T BIO-MED ENG, V55, P361, DOI 10.1109/TBME.2007.897815; Muller MM, 1997, BRAIN TOPOGR, V9, P163, DOI 10.1007/BF01190385; Muller MM, 2000, CLIN NEUROPHYSIOL, V111, P1544, DOI 10.1016/S1388-2457(00)00371-0; Muller MM, 1998, NAT NEUROSCI, V1, P631, DOI 10.1038/2865; Pastor MA, 2003, J NEUROSCI, V23, P11621; Regan D., 1989, HUMAN BRAIN ELECTROP; Robertson SS, 2012, P NATL ACAD SCI USA, V109, P11460, DOI 10.1073/pnas.1203482109; Silberstein Richard B., 1995, P272; Skoczenski AM, 1999, INVEST OPHTH VIS SCI, V40, P2411; TallonBaudry C, 1996, J NEUROSCI, V16, P4240; Vialatte FB, 2010, PROG NEUROBIOL, V90, P418, DOI 10.1016/j.pneurobio.2009.11.005; Wickens Thomas D., 2002, ELEMENTARY SIGNAL DE; Wu ZH, 2007, BRAIN TOPOGR, V20, P97, DOI 10.1007/s10548-007-0035-0	43	1	1	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56428	10.1371/journal.pone.0056428	http://dx.doi.org/10.1371/journal.pone.0056428			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	099EJ	23457567	gold, Green Submitted, Green Published			2022-12-25	WOS:000315602700072
J	Wongtrakoongate, P; Jones, M; Gokhale, PJ; Andrews, PW				Wongtrakoongate, Patompon; Jones, Mark; Gokhale, Paul J.; Andrews, Peter W.			STELLA Facilitates Differentiation of Germ Cell and Endodermal Lineages of Human Embryonic Stem Cells	PLOS ONE			English	Article							EXPRESSION PATTERNS; DNA DEMETHYLATION; CARCINOMA; LINES; SPECIFICATION; PLURIPOTENCY; ADAPTATION; DERIVATION; DEAMINASE; REVEALS	Stella is a developmentally regulated gene highly expressed in mouse embryonic stem (ES) cells and in primordial germ cells (PGCs). In human, the gene encoding the STELLA homologue lies on chromosome 12p, which is frequently amplified in long-term cultured human ES cells. However, the role played by STELLA in human ES cells has not been reported. In the present study, we show that during retinoic acid (RA)-induced differentiation of human ES cells, expression of STELLA follows that of VASA, a marker of germline differentiation. By contrast, human embryonal carcinoma cells express STELLA at a higher level compared with both karyotypically normal and abnormal human ES cell lines. We found that over-expression of STELLA does not interfere with maintenance of the stem cell state of human ES cells, but following retinoic acid induction it leads to up-regulation of germline- and endodermal-associated genes, whereas neural markers PAX6 and NEUROD1 are down-regulated. Further, STELLA over-expression facilitates the differentiation of human ES cells into BE12-positive cells, in which the expression of germline- and endodermal-associated genes is enriched, and suppresses differentiation of the neural lineage. Taken together, this finding suggests a role for STELLA in facilitating germline and endodermal differentiation of human ES cells.	[Wongtrakoongate, Patompon; Jones, Mark; Gokhale, Paul J.; Andrews, Peter W.] Univ Sheffield, Dept Biomed Sci, Ctr Stem Cell Biol, Sheffield S10 2TN, S Yorkshire, England	University of Sheffield	Wongtrakoongate, P (corresponding author), NIDDKD, Mol Biol Lab, NIH, Bethesda, MD 20892 USA.	p.wongtrakoongate@gmail.com; p.w.andrews@sheffield.ac.uk	Wongtrakoongate, Patompon/M-2021-2019	Andrews, Peter/0000-0001-7215-4410; Wongtrakoongate, Patompon/0000-0001-6070-1843; Gokhale, Paul/0000-0001-7225-4403	Thai government; Royal Thai Government; Medical Research Council	Thai government; Royal Thai Government; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	PW is a PhD student supported by the Thai government. This work was supported by the Royal Thai Government. PWA is supported by a grant from the Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; Alagaratnam S, 2013, STEM CELLS DEV, V22, P1136, DOI 10.1089/scd.2012.0369; Amps K, 2011, NAT BIOTECHNOL, V29, P1132, DOI 10.1038/nbt.2051; Aravind L, 2000, TRENDS BIOCHEM SCI, V25, P112, DOI 10.1016/S0968-0004(99)01537-6; Baker DEC, 2007, NAT BIOTECHNOL, V25, P207, DOI 10.1038/nbt1285; Bhutani N, 2010, NATURE, V463, P1042, DOI 10.1038/nature08752; Bortvin Alex, 2004, BMC Developmental Biology, V4; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Bucay N, 2009, STEM CELLS, V27, P68, DOI 10.1634/stemcells.2007-1018; de Jong J, 2008, J PATHOL, V215, P21, DOI 10.1002/path.2332; de Jong J, 2008, GENE CHROMOSOME CANC, V47, P185, DOI 10.1002/gcc.20520; Draper JS, 2002, J ANAT, V200, P249, DOI 10.1046/j.1469-7580.2002.00030.x; Hajkova P, 2002, MECH DEVELOP, V117, P15, DOI 10.1016/S0925-4773(02)00181-8; Harrison NJ, 2009, STEM CELLS, V27, P1057, DOI 10.1002/stem.41; Hayashi K, 2008, CELL STEM CELL, V3, P391, DOI 10.1016/j.stem.2008.07.027; Hayashi K, 2009, DEVELOPMENT, V136, P3549, DOI 10.1242/dev.037747; Josephson R, 2007, STEM CELLS, V25, P437, DOI 10.1634/stemcells.2006-0236; Kee K, 2009, NATURE, V462, P222, DOI 10.1038/nature08562; Lagarkova MA, 2006, CELL CYCLE, V5, P416, DOI 10.4161/cc.5.4.2440; Liew CG, 2007, STEM CELLS, V25, P1521, DOI 10.1634/stemcells.2006-0634; McIntyre A, 2007, BRIT J CANCER, V97, P1707, DOI 10.1038/sj.bjc.6604079; Morgan HD, 2004, J BIOL CHEM, V279, P52353, DOI 10.1074/jbc.M407695200; Nakamura T, 2007, NAT CELL BIOL, V9, P64, DOI 10.1038/ncb1519; Nettersheim D, 2011, INT J ANDROL, V34, pE189, DOI 10.1111/j.1365-2605.2011.01172.x; Oosterhuis JW, 2005, NAT REV CANCER, V5, P210, DOI 10.1038/nrc1568; Payer B, 2003, CURR BIOL, V13, P2110, DOI 10.1016/j.cub.2003.11.026; Qu XB, 2008, DEV GROWTH DIFFER, V50, P585, DOI 10.1111/j.1440-169X.2008.01056.x; Rai K, 2008, CELL, V135, P1201, DOI 10.1016/j.cell.2008.11.042; Saitou M, 2002, NATURE, V418, P293, DOI 10.1038/nature00927; Sato M, 2002, MECH DEVELOP, V113, P91, DOI 10.1016/S0925-4773(02)00002-3; Seguin CA, 2008, CELL STEM CELL, V3, P182, DOI 10.1016/j.stem.2008.06.018; Skotheim RI, 2005, CANCER RES, V65, P5588, DOI 10.1158/0008-5472.CAN-05-0153; Sperger JM, 2003, P NATL ACAD SCI USA, V100, P13350, DOI 10.1073/pnas.2235735100; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tonge PD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010901; Wei W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004013; Wright A, 2011, INT J ANDROL, V34, pE175, DOI 10.1111/j.1365-2605.2011.01185.x; Wu J, 2002, ZYGOTE, V10, P333, DOI 10.1017/S0967199402004070	39	41	46	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56893	10.1371/journal.pone.0056893	http://dx.doi.org/10.1371/journal.pone.0056893			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457636	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000315602700101
J	Yang, CC; Sun, WC; Wang, WY; Huang, CH; Lu, FS; Tseng, SM; Chen, CW				Yang, Chien-Chin; Sun, We-Chi; Wang, Wan-Yu; Huang, Chi-Hung; Lu, Fang-Shy; Tseng, Shu-Min; Chen, Carton W.			Mutational Analysis of the Terminal Protein Tpg of Streptomyces Chromosomes: Identification of the Deoxynucleotidylation Site	PLOS ONE			English	Article							IN-VITRO DEOXYNUCLEOTIDYLATION; ADENOVIRUS DNA-REPLICATION; AMINO-ACID-SEQUENCE; LINEAR PLASMID; ESCHERICHIA-COLI; GENOME SEQUENCE; PHAGE-PHI-29; TELOMERES; REPLICON; LIVIDANS	The linear chromosomes and linear plasmids of Streptomyces are capped by terminal proteins (TPs) covalently bound to the 59 ends of the DNA. The TPs serve as primers for DNA synthesis that patches in the single-stranded gaps at the telomeres resulting from the bi-directional replication ('end patching'). Typical Streptomyces TPs, designated Tpgs, are conserved in sequence and size (about 185 amino acids), and contain a predicted helix-turn-helix domain and a functional nuclear localization signal. The Tpg-encoding gene (tpg) is often accompanied by an upstream gene tap that encodes an essential telomere-associating protein. Five lone tpg variants (not accompanied by tap) from various Streptomyces species were tested, and three were found to be pseudogenes. The lone tpg variant on the SLP2 plasmid, although functional, still requires the presence of tap on the chromosome for end patching. Using a combination of in vitro deoxynucleotidylation, physical localization, and genetic analysis, we identified the threonine at position 114 (T114) in Tpg of Streptomyces lividans chromosome as the deoxynucleotidylated site. Interestingly, T114 could be substituted by a serine without destroying the priming activity of Tpg in vitro and in vivo. Such T114S substitution is seen in and a number of pseudogenes as well as functional Tpgs. T114 lies in a predicted coil flanked by two short helixes in a highly hydrophilic region. The location and structural arrangement of the deoxynucleotidylated site in Tpg is similar to those in the TPs of phage circle divide 29 and adenoviruses. However, these TPs are distinct in their sequences and sizes, indicating that they have evolved independently during evolution. Using naturally occurring and artificially created tpg variants, we further identified several amino acid residues in the N-terminus and the helix-turn-helix domain that were important for functionality.	[Yang, Chien-Chin; Sun, We-Chi; Wang, Wan-Yu; Lu, Fang-Shy; Tseng, Shu-Min] Chung Yuan Christian Univ, Dept Chem, Chungli 32023, Taiwan; [Huang, Chi-Hung] Natl Taipei Univ Technol, Inst Biotechnol, Taipei, Taiwan; [Chen, Carton W.] Natl Yang Ming Univ, Dept Life Sci, Inst Genome Sci, Taipei 112, Taiwan	Chung Yuan Christian University; National Taipei University of Technology; National Yang Ming Chiao Tung University	Yang, CC (corresponding author), Chung Yuan Christian Univ, Dept Chem, Chungli 32023, Taiwan.	ccyang@cycu.edu.tw; cwchen@ym.edu.tw	Chen, Carton W/GVS-7763-2022	Chen, Carton W/0000-0001-8891-1623	Ministry of Education, ROC; Chung-Yuan Christian University; National Science Council, ROC [NSC98-2311-B-010-004-MY3, NSC99-2811-B-010-027]	Ministry of Education, ROC; Chung-Yuan Christian University; National Science Council, ROC(Ministry of Science and Technology, Taiwan)	CWC is the recipient of a National Professorship from the Ministry of Education, ROC. This study was funded by research funds from Chung-Yuan Christian University, research grants from National Science Council, ROC. (NSC98-2311-B-010-004-MY3; NSC99-2811-B-010-027) and a grant (Aim for the Top University Plan) from Ministry of Education, ROC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ausubel FM, 1994, CURRENT PROTOCOLS MO; Bao K, 2003, GENE DEV, V17, P774, DOI 10.1101/gad.1060303; Bao K, 2001, GENE DEV, V15, P1518, DOI 10.1101/gad.896201; BIERMAN M, 1992, GENE, V116, P43, DOI 10.1016/0378-1119(92)90627-2; Billy E, 1999, J BIOL CHEM, V274, P34955, DOI 10.1074/jbc.274.49.34955; Chaconas George, 2005, P525; Chen Carton W., 2007, V7, P33, DOI 10.1007/7171_2007_090; Choulet F, 2006, MOL BIOL EVOL, V23, P2361, DOI 10.1093/molbev/msl108; Coligan JE, 1995, CURRENT PROTOCOLS PR; de Jong RN, 1999, GENE, V236, P1, DOI 10.1016/S0378-1119(99)00249-8; DODD IB, 1990, NUCLEIC ACIDS RES, V18, P5019, DOI 10.1093/nar/18.17.5019; GARCIA P, 1986, J VIROL, V58, P31; GARMENDIA C, 1988, NUCLEIC ACIDS RES, V16, P5727, DOI 10.1093/nar/16.13.5727; GARMENDIA C, 1990, GENE, V88, P73, DOI 10.1016/0378-1119(90)90061-U; Garnier J, 1996, METHOD ENZYMOL, V266, P540; HERMOSO JM, 1985, NUCLEIC ACIDS RES, V13, P7715, DOI 10.1093/nar/13.21.7715; Hsu CC, 2010, J BACTERIOL, V192, P307, DOI 10.1128/JB.01192-09; Huang CH, 2003, MOL MICROBIOL, V47, P1563, DOI 10.1046/j.1365-2958.2003.03403.x; Huang CH, 2007, MOL MICROBIOL, V63, P1710, DOI 10.1111/j.1365-2958.2007.05616.x; Ikeda H, 2003, NAT BIOTECHNOL, V21, P526, DOI 10.1038/nbt820; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; Kinashi H, 1998, BIOSCI BIOTECH BIOCH, V62, P1892, DOI 10.1271/bbb.62.1892; Kirby R, 2011, STREPTOMYCES: MOLECULAR BIOLOGY AND BIOTECHNOLOGY, P5; Kolkenbrock S, 2010, FEMS MICROBIOL LETT, V304, P169, DOI 10.1111/j.1574-6968.2010.01900.x; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lai C-h, 2010, THESIS NATL YANG MIN; Lin Y-L, 1998, THESIS NATL YANG MIN; Liu H, 2003, CURR TOP MICROBIOL, V272, P131; Ohnishi Y, 2008, J BACTERIOL, V190, P4050, DOI 10.1128/JB.00204-08; PARGELLIS CA, 1988, J BIOL CHEM, V263, P7678; Qin ZJ, 2002, MOL MICROBIOL, V45, P785, DOI 10.1046/j.1365-2958.2002.03051.x; Qin ZJ, 1998, MOL MICROBIOL, V28, P893, DOI 10.1046/j.1365-2958.1998.00838.x; Redenbach M, 1996, MOL MICROBIOL, V21, P77, DOI 10.1046/j.1365-2958.1996.6191336.x; REDENBACH M, 1993, MOL GEN GENET, V241, P255, DOI 10.1007/BF00284676; Salas M, 1991, ANNU REV BIOCHEM, V60, P37; SHIFFMAN D, 1992, P NATL ACAD SCI USA, V89, P6129, DOI 10.1073/pnas.89.13.6129; SMART JE, 1982, J BIOL CHEM, V257, P13499; Spatz K, 2002, FEMS MICROBIOL LETT, V213, P87, DOI 10.1111/j.1574-6968.2002.tb11290.x; Suzuki H, 2008, BIOSCI BIOTECH BIOCH, V72, P2973, DOI 10.1271/bbb.80454; Tsai HH, 2011, NUCL ACIDS RES; Tsai HH, 2011, NUCLEIC ACIDS RES, V39, P2165, DOI 10.1093/nar/gkq1204; Tsai HH, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1170; Westermeier J, 1990, ELECTROPHORESIS PRAC; Yang CC, 2002, MOL MICROBIOL, V43, P297, DOI 10.1046/j.1365-2958.2002.02760.x; Yang CC, 2006, APPL ENVIRON MICROB, V72, P7959, DOI 10.1128/AEM.01857-06; Zhang R, 2006, APPL ENVIRON MICROB, V72, P5728, DOI 10.1128/AEM.00707-06	46	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56322	10.1371/journal.pone.0056322	http://dx.doi.org/10.1371/journal.pone.0056322			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457549	Green Published, Green Submitted, gold			2022-12-25	WOS:000315602700068
J	Tilan, JU; Everhart, LM; Abe, K; Kuo-Bonde, L; Chalothorn, D; Kitlinska, J; Burnett, MS; Epstein, SE; Faber, JE; Zukowska, Z				Tilan, Jason U.; Everhart, Lindsay M.; Abe, Ken; Kuo-Bonde, Lydia; Chalothorn, Dan; Kitlinska, Joanna; Burnett, Mary Susan; Epstein, Stephen E.; Faber, James E.; Zukowska, Zofia			Platelet neuropeptide Y is critical for ischemic revascularization in mice	FASEB JOURNAL			English	Article						angiogenesis; NPY	ENDOTHELIAL GROWTH-FACTOR; SMOOTH-MUSCLE-CELLS; IMMUNOREACTIVE-NEUROPEPTIDE; DIFFERENTIAL RELEASE; INDUCED ANGIOGENESIS; HINDLIMB ISCHEMIA; RABBIT HINDLIMB; ALPHA-GRANULES; MOUSE STRAINS; NITRIC-OXIDE	We previously reported that the sympathetic neurotransmitter neuropeptide Y (NPY) is potently angiogenic, primarily through its Y2 receptor, and that endogenous NPY is crucial for capillary angiogenesis in rodent hindlimb ischemia. Here we sought to identify the source of NPY responsible for revascularization and its mechanisms of action. At d 3, NPY-/- mice demonstrated delayed recovery of blood flow and limb function, consistent with impaired collateral conductance, while ischemic capillary angiogenesis was reduced (similar to 70%) at d 14. This biphasic temporal response was confirmed by 2 peaks of NPY activation in rats: a transient early increase in neuronally derived plasma NPY and increase in platelet NPY during late-phase recovery. Compared to NPY-null platelets, collagen-activated NPY-rich platelets were more mitogenic (similar to 2-fold vs. similar to 1.6-fold increase) for human microvascular endothelial cells, and Y2/Y5 receptor antagonists ablated this difference in proliferation. In NPY+/+ mice, ischemic angiogenesis was prevented by platelet depletion and then restored by transfusion of platelets from NPY+/+ mice, but not NPY-/- mice. In thrombocytopenic NPY-/- mice, transfusion of wild-type platelets fully restored ischemia-induced angiogenesis. These findings suggest that neuronally derived NPY accelerates the early response to femoral artery ligation by promoting collateral conductance, while platelet-derived NPY is critical for sustained capillary angiogenesis.-Tilan, J. U., Everhart, L. M., Abe, K., Kuo-Bonde, L., Chalothorn, D., Kitlinska, J., Burnett, M. S., Epstein, S. E., Faber, J. E., Zukowska, Z. Platelet neuropeptide Y is critical for ischemic revascularization in mice.	[Tilan, Jason U.; Everhart, Lindsay M.; Abe, Ken; Kuo-Bonde, Lydia; Kitlinska, Joanna; Zukowska, Zofia] Georgetown Univ, Dept Physiol & Biophys, Sch Nursing & Hlth Studies, Washington, DC 20057 USA; [Tilan, Jason U.] Georgetown Univ, Dept Nursing, Sch Nursing & Hlth Studies, Washington, DC 20057 USA; [Kitlinska, Joanna] Georgetown Univ, Dept Biochem & Mol & Cellular Biol, Washington, DC 20057 USA; [Chalothorn, Dan; Faber, James E.] Univ N Carolina, Dept Physiol, Chapel Hill, NC USA; [Burnett, Mary Susan; Epstein, Stephen E.] MedStar Hlth Res Inst, Cardiovasc Res Inst, Washington, DC USA; [Zukowska, Zofia] Univ Minnesota, Sch Med, Dept Integrat Biol & Physiol, Minneapolis, MN 55455 USA	Georgetown University; Georgetown University; Georgetown University; University of North Carolina; University of North Carolina Chapel Hill; MedStar Health Research Institute; University of Minnesota System; University of Minnesota Twin Cities	Tilan, JU (corresponding author), Georgetown Univ, Dept Nursing, Sch Nursing & Hlth Studies, 3700 Reservoir Rd NW,St Marys Hall 427E, Washington, DC 20057 USA.	jut@georgetown.edu			U.S. National Institutes of Health (NIH) [HL067357, HL055310, CA123211]; NATIONAL CANCER INSTITUTE [R01CA123211] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL055310, R01HL067357, R01HL055310] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by U.S. National Institutes of Health (NIH) grants HL067357 and HL055310 to Z.Z. and, in part, CA123211 to J.K. The authors thank Anton Wellstein, Thomas G. Sherman, and Allan V. Kalueff for their insightful comments and editing. The authors declare no conflicts of interest.	Amano H, 2005, CIRC RES, V97, P337, DOI 10.1161/01.RES.0000179534.17668.f8; Andre P, 2011, BLOOD, V118, P5000, DOI 10.1182/blood-2011-06-360743; Brenes RA, 2012, J VASC SURG, V56, P1669, DOI 10.1016/j.jvs.2012.04.067; BRUNNER G, 1993, BLOOD, V81, P631; Carmeliet P, 2005, NATURE, V436, P193, DOI 10.1038/nature03875; Chalothorn D, 2005, AM J PHYSIOL-HEART C, V289, pH947, DOI 10.1152/ajpheart.00952.2004; Chalothorn D, 2007, PHYSIOL GENOMICS, V30, P179, DOI 10.1152/physiolgenomics.00047.2007; Cruze CA, 2007, PEPTIDES, V28, P269, DOI 10.1016/j.peptides.2006.09.026; Ekstrand AJ, 2003, P NATL ACAD SCI USA, V100, P6033, DOI 10.1073/pnas.1135965100; Epstein SE, 2004, CIRCULATION, V109, P2826, DOI 10.1161/01.CIR.0000132468.82942.F5; ERICSSON A, 1987, P NATL ACAD SCI USA, V84, P5585, DOI 10.1073/pnas.84.16.5585; Ferreira R, 2010, J BIOL CHEM, V285, P41921, DOI 10.1074/jbc.M110.164020; Hancock V., 1993, BRIT J HAEMATOL, V85, P694; HARRISON P, 1993, BLOOD REV, V7, P52, DOI 10.1016/0268-960X(93)90024-X; Hershey JC, 2001, CARDIOVASC RES, V49, P618, DOI 10.1016/S0008-6363(00)00232-7; Herzog H, 2003, EUR J PHARMACOL, V480, P21, DOI 10.1016/j.ejphar.2003.08.089; Hoefer IE, 2005, ATHEROSCLEROSIS, V181, P285, DOI 10.1016/j.atherosclerosis.2005.01.047; Holler J, 2008, J IMMUNOL, V181, P6906, DOI 10.4049/jimmunol.181.10.6906; Hu ZW, 1999, J PHARMACOL EXP THER, V290, P28; Iba O, 2002, CIRCULATION, V106, P2019, DOI 10.1161/01.CIR.0000031332.45480.79; IRUELAARISPE ML, 1991, P NATL ACAD SCI USA, V88, P5026, DOI 10.1073/pnas.88.11.5026; Italiano JE, 2008, BLOOD, V111, P1227, DOI 10.1182/blood-2007-09-113837; Kinnaird T, 2004, CIRCULATION, V109, P1543, DOI 10.1161/01.CIR.0000124062.31102.57; Kitlinska J, 2005, CANCER RES, V65, P1719, DOI 10.1158/0008-5472.CAN-04-2192; Kitlinska J, 2002, PEPTIDES, V23, P71, DOI 10.1016/S0196-9781(01)00581-2; Klement GL, 2009, BLOOD, V113, P2835, DOI 10.1182/blood-2008-06-159541; Kondoh K, 2004, CARDIOVASC RES, V61, P132, DOI 10.1016/j.cardiores.2003.10.003; Kuo LE, 2007, NAT MED, V13, P803, DOI 10.1038/nm1611; KUTER DJ, 1995, BLOOD, V85, P2720, DOI 10.1182/blood.V85.10.2720.bloodjournal85102720; Lee EW, 2003, J CLIN INVEST, V111, P1853, DOI 10.1172/JCI200316929; Li LJ, 2011, J CARDIOVASC TRANSL, V4, P351, DOI 10.1007/s12265-011-9271-5; Li LJ, 2003, ARTERIOSCL THROM VAS, V23, P1204, DOI 10.1161/01.ATV.0000071349.30914.25; Lu C, 2010, ONCOGENE, V29, P5630, DOI 10.1038/onc.2010.301; Lu CY, 2011, J BIOL CHEM, V286, P27494, DOI 10.1074/jbc.M111.224089; LUNDBERG JM, 1986, NEUROSCI LETT, V63, P96, DOI 10.1016/0304-3940(86)90020-0; Ma L, 2005, P NATL ACAD SCI USA, V102, P216, DOI 10.1073/pnas.0406682102; MAIONE TE, 1990, SCIENCE, V247, P77, DOI 10.1126/science.1688470; Mohle R, 1997, P NATL ACAD SCI USA, V94, P663, DOI 10.1073/pnas.94.2.663; Movafagh S, 2006, FASEB J, V20, P1924, DOI 10.1096/fj.05-4770fje; Murakami M, 2011, J CLIN INVEST, V121, P2668, DOI 10.1172/JCI44762; MYERS AK, 1993, REGUL PEPTIDES, V47, P239, DOI 10.1016/0167-0115(93)90391-K; MYERS AK, 1988, BIOCHEM BIOPH RES CO, V155, P118, DOI 10.1016/S0006-291X(88)81057-X; Pinedo HM, 1998, LANCET, V352, P1775, DOI 10.1016/S0140-6736(98)05095-8; Pintucci G, 2002, THROMB HAEMOSTASIS, V88, P834, DOI 10.1055/s-0037-1613311; Pons J, 2003, CAN J PHYSIOL PHARM, V81, P177, DOI 10.1139/Y02-166; Potente M, 2011, CELL, V146, P873, DOI 10.1016/j.cell.2011.08.039; Robich MP, 2010, J MOL CELL CARDIOL, V49, P1022, DOI 10.1016/j.yjmcc.2010.08.022; Rutherford RB, 1997, J VASC SURG, V26, P517, DOI 10.1016/S0741-5214(97)70045-4; SCHAPER W, 2004, ARTERIOGENESIS; Schaper W, 2009, BASIC RES CARDIOL, V104, P5, DOI 10.1007/s00395-008-0760-x; Scholz D, 2000, VIRCHOWS ARCH, V436, P257, DOI 10.1007/s004280050039; SCHWARZ H, 1994, J NEUROIMMUNOL, V51, P53, DOI 10.1016/0165-5728(94)90128-7; Sehgal S, 2007, J THROMB HAEMOST, V5, P2009, DOI 10.1111/j.1538-7836.2007.02698.x; Sirois MG, 1997, CIRCULATION, V96, P1291, DOI 10.1161/01.CIR.96.4.1291; Stabile E, 2003, CIRCULATION, V108, P205, DOI 10.1161/01.CIR.0000079225.50817.71; Tan YH, 2007, CARDIOVASC RES, V73, P823, DOI 10.1016/j.cardiores.2006.12.015; Tirziu D, 2005, CIRCULATION, V112, P2501, DOI 10.1161/CIRCULATIONAHA.105.542829; Torres-Vazquez J, 2004, DEV CELL, V7, P117, DOI 10.1016/j.devcel.2004.06.008; Tritsaris K, 2007, P NATL ACAD SCI USA, V104, P15364, DOI 10.1073/pnas.0707302104; Troidl K, 2010, J CARDIOVASC PHARM, V55, P153, DOI 10.1097/FJC.0b013e3181c9556f; Vecchione C, 2002, CIRCULATION, V105, P1700, DOI 10.1161/01.CIR.0000012750.08480.55; WAHLESTEDT C, 1990, AM J PHYSIOL, V258, pR736, DOI 10.1152/ajpregu.1990.258.3.R736; Wartiovaara U, 1998, THROMB HAEMOSTASIS, V80, P171, DOI 10.1055/s-0037-1615158; Westfall TC, 2004, HANDB EXP PHARM, V162, P137; Yamaguchi J, 2003, CIRCULATION, V107, P1322, DOI 10.1161/01.CIR.0000055313.77510.22; Zukowska-Grojec Z, 1998, CIRC RES, V83, P187, DOI 10.1161/01.RES.83.2.187; ZUKOWSKAGROJEC Z, 1988, SYNAPSE, V2, P293, DOI 10.1002/syn.890020319	67	15	16	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	JUN	2013	27	6					2244	2255		10.1096/fj.12-213546	http://dx.doi.org/10.1096/fj.12-213546			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	154II	23457218	Green Published			2022-12-25	WOS:000319667600015
J	Liu, CR; Weng, HB; Chen, LX; Yang, SM; Wang, H; Debnath, G; Guo, XH; Wu, LC; Mohandas, N; An, XL				Liu, Congrong; Weng, Haibao; Chen, Lixiang; Yang, Shaomin; Wang, Hua; Debnath, Gargi; Guo, Xinhua; Wu, Liancheng; Mohandas, Narla; An, Xiuli			Impaired Intestinal Calcium Absorption in Protein 4.1R-deficient Mice Due to Altered Expression of Plasma Membrane Calcium ATPase 1b (PMCA1b)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+ PUMP; FUNCTIONAL-CHARACTERIZATION; GENE FAMILY; 4.1R; CELLS; BINDING; ISOFORMS; COMPLEX; PHOSPHORYLATION; CYTOSKELETON	Protein 4.1R was first identified in the erythrocyte membrane skeleton. It is now known that the protein is expressed in a variety of epithelial cell lines and in the epithelia of many tissues, including the small intestine. However, the physiological function of 4.1R in the epithelial cells of the small intestine has not so far been explored. Here, we show that 4.1R knock-out mice exhibited a significantly impaired small intestinal calcium absorption that resulted in secondary hyperparathyroidism as evidenced by increased serum 1,25-(OH)(2)-vitamin D-3 and parathyroid hormone levels, decreased serum calcium levels, hyperplasia of the parathyroid, and demineralization of the bones. 4.1R is located on the basolateral membrane of enterocytes, where it co-localizes with PMCA1b (plasma membrane calcium ATPase 1b). Expression of PMCA1b in enterocytes was decreased in 4.1(-/-) mice. 4.1R directly associated with PMCA1b, and the association involved the membrane-binding domain of 4.1R and the second intracellular loop and C terminus of PMCA1b. Our findings have enabled us to define a functional role for 4.1R in small intestinal calcium absorption through regulation of membrane expression of PMCA1b.	[Liu, Congrong; Weng, Haibao; Chen, Lixiang; Yang, Shaomin; Wang, Hua; Debnath, Gargi; Guo, Xinhua; Wu, Liancheng; Mohandas, Narla; An, Xiuli] New York Blood Ctr, Red Cell Physiol Lab, New York, NY 10065 USA; [Liu, Congrong; Yang, Shaomin; Wang, Hua] Peking Univ, Hlth Sci Ctr, Dept Pathol, Beijing 100191, Peoples R China; [Weng, Haibao; Chen, Lixiang; An, Xiuli] Zhengzhou Univ, Dept Bioengn, Zhengzhou 450051, Peoples R China	New York Blood Center; Peking University; Zhengzhou University	An, XL (corresponding author), Red Cell Physiol Lab, 310 East 67th St, New York, NY 10065 USA.	xan@nybloodcenter.org			National Institutes of Health [DK26263, DK32094]; Beijing Municipal Natural Science Foundation of China [7082055]; Natural Science Foundation of China [81171905]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK026263, P01DK032094, R01DK026263] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Beijing Municipal Natural Science Foundation of China; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK26263 and DK32094. This work was also supported by Grant 7082055 from Beijing Municipal Natural Science Foundation of China and Grant 81171905 from the Natural Science Foundation of China.	An XL, 2001, J BIOL CHEM, V276, P35778, DOI 10.1074/jbc.M101364200; An XL, 1996, J BIOL CHEM, V271, P33187, DOI 10.1074/jbc.271.52.33187; Armesilla AL, 2004, J BIOL CHEM, V279, P31318, DOI 10.1074/jbc.M307557200; BRODIN P, 1992, EUR J BIOCHEM, V204, P939, DOI 10.1111/j.1432-1033.1992.tb16715.x; BRONNER F, 1986, AM J PHYSIOL, V250, pG561, DOI 10.1152/ajpgi.1986.250.5.G561; CHRISTAKOS S, 1989, ENDOCR REV, V10, P3, DOI 10.1210/edrv-10-1-3; CONBOY JG, 1988, P NATL ACAD SCI USA, V85, P9062, DOI 10.1073/pnas.85.23.9062; Dean WL, 1997, J BIOL CHEM, V272, P15113, DOI 10.1074/jbc.272.24.15113; DeCarcer G, 1995, BIOCHEM J, V312, P871, DOI 10.1042/bj3120871; Di Leva F, 2008, ARCH BIOCHEM BIOPHYS, V476, P65, DOI 10.1016/j.abb.2008.02.026; Elshorst B, 1999, BIOCHEMISTRY-US, V38, P12320, DOI 10.1021/bi9908235; FREEMAN TC, 1995, AM J PHYSIOL-GASTR L, V269, pG126, DOI 10.1152/ajpgi.1995.269.1.G126; Gascard P, 1998, BLOOD, V92, P4404, DOI 10.1182/blood.V92.11.4404.423k50_4404_4414; GIANGRANDE A, 1992, NEPHROL DIAL TRANSPL, V7, P412; Gimm JA, 2002, BIOCHEMISTRY-US, V41, P7275, DOI 10.1021/bi0256330; Hoenderop JGJ, 2005, PHYSIOL REV, V85, P373, DOI 10.1152/physrev.00003.2004; Kang QZ, 2009, BLOOD, V113, P6128, DOI 10.1182/blood-2008-10-182329; Kang QZ, 2009, J CELL SCI, V122, P1091, DOI 10.1242/jcs.039644; Krauss SW, 1997, J CELL BIOL, V137, P275, DOI 10.1083/jcb.137.2.275; Krauss SW, 1997, P NATL ACAD SCI USA, V94, P7297, DOI 10.1073/pnas.94.14.7297; Mattagajasingh SN, 2000, J BIOL CHEM, V275, P30573, DOI 10.1074/jbc.M004578200; Parra M, 1998, GENOMICS, V49, P298, DOI 10.1006/geno.1998.5265; Parra MK, 2003, BLOOD, V101, P4164, DOI 10.1182/blood-2002-06-1796; Peng JB, 2000, BIOCHEM BIOPH RES CO, V278, P326, DOI 10.1006/bbrc.2000.3716; Peng JB, 1999, J BIOL CHEM, V274, P22739, DOI 10.1074/jbc.274.32.22739; Ramez M, 2003, KIDNEY INT, V63, P1321, DOI 10.1046/j.1523-1755.2003.00870.x; Salomao M, 2008, P NATL ACAD SCI USA, V105, P8026, DOI 10.1073/pnas.0803225105; Shi ZT, 1999, J CLIN INVEST, V103, P331, DOI 10.1172/JCI3858; Stagg MA, 2008, CIRC RES, V103, P855, DOI 10.1161/CIRCRESAHA.108.176461; Strehler EE, 2001, PHYSIOL REV, V81, P21, DOI 10.1152/physrev.2001.81.1.21; TCHERNIA G, 1981, J CLIN INVEST, V68, P454, DOI 10.1172/JCI110275; Van Cromphaut SJ, 2001, P NATL ACAD SCI USA, V98, P13324, DOI 10.1073/pnas.231474698; Yang SM, 2011, MOL CELL BIOL, V31, P2276, DOI 10.1128/MCB.01105-10; Yang SM, 2009, BBA-BIOMEMBRANES, V1788, P1458, DOI 10.1016/j.bbamem.2009.03.022; Zhuang LY, 2002, LAB INVEST, V82, P1755, DOI 10.1097/01.LAB.0000043910.41414.E7	35	23	25	5	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2013	288	16					11407	11415		10.1074/jbc.M112.436659	http://dx.doi.org/10.1074/jbc.M112.436659			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	130KW	23460639	Green Published, hybrid			2022-12-25	WOS:000317915500043
J	Kong, XP; Lv, W; Zhang, D; Jiang, SS; Zhang, SZ; Li, DQ				Kong, Xiangpei; Lv, Wei; Zhang, Dan; Jiang, Shanshan; Zhang, Shizhong; Li, Dequan			Genome-Wide Identification and Analysis of Expression Profiles of Maize Mitogen-Activated Protein Kinase Kinase Kinase	PLOS ONE			English	Article							MAP KINASE; CELL-DEATH; OSMOTIC-STRESS; SALT STRESS; GENE FAMILY; ARABIDOPSIS-THALIANA; SIGNALING PATHWAYS; DEFENSE RESPONSES; INNATE IMMUNITY; LOW-TEMPERATURE	Mitogen-activated protein kinase (MAPK) cascades are highly conserved signal transduction model in animals, yeast and plants. Plant MAPK cascades have been implicated in development and stress responses. Although MAPKKKs have been investigated in several plant species including Arabidopsis and rice, no systematic analysis has been conducted in maize. In this study, we performed a bioinformatics analysis of the entire maize genome and identified 74 MAPKKK genes. Phylogenetic analyses of MAPKKKs from maize, rice and Arabidopsis have classified them into three subgroups, which included Raf, ZIK and MEKK. Evolutionary relationships within subfamilies were also supported by exon-intron organizations and the conserved protein motifs. Further expression analysis of the MAPKKKs in microarray databases revealed that MAPKKKs were involved in important signaling pathways in maize different organs and developmental stages. Our genomics analysis of maize MAPKKK genes provides important information for evolutionary and functional characterization of this family in maize.	[Kong, Xiangpei; Lv, Wei; Zhang, Dan; Jiang, Shanshan; Li, Dequan] Shandong Agr Univ, Coll Life Sci, Shandong Key Lab Crop Biol, State Key Lab Crop Biol, Tai An, Shandong, Peoples R China; [Zhang, Shizhong] Shandong Agr Univ, Coll Hort Sci & Engn, Shandong Key Lab Crop Biol, State Key Lab Crop Biol, Tai An, Shandong, Peoples R China	Shandong Agricultural University; Shandong Agricultural University	Li, DQ (corresponding author), Shandong Agr Univ, Coll Life Sci, Shandong Key Lab Crop Biol, State Key Lab Crop Biol, Tai An, Shandong, Peoples R China.	dqli@sdau.edu.cn			Nation Natural Science Foundation of China [31071337, 31271633]	Nation Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Grants from the Nation Natural Science Foundation of China [Grant numbers 31071337, 31271633]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; Beck M, 2011, NEW PHYTOL, V189, P1069, DOI 10.1111/j.1469-8137.2010.03565.x; Beck M, 2010, PLANT CELL, V22, P755, DOI 10.1105/tpc.109.071746; Berberich T, 1999, MOL GEN GENET, V262, P534, DOI 10.1007/s004380051115; Bethke G, 2009, P NATL ACAD SCI USA, V106, DOI 10.1073/pnas.0810206106; Chen LH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046744; Colcombet J, 2008, BIOCHEM J, V413, P217, DOI 10.1042/BJ20080625; Fiil BK, 2009, CURR OPIN PLANT BIOL, V12, P615, DOI 10.1016/j.pbi.2009.07.017; Gao L, 2008, PLANT MOL BIOL, V67, P125, DOI 10.1007/s11103-008-9306-8; Gao MH, 2008, CELL RES, V18, P1190, DOI 10.1038/cr.2008.300; Hamel LP, 2006, TRENDS PLANT SCI, V11, P192, DOI 10.1016/j.tplants.2006.02.007; Hashimoto M, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-103; Huang YF, 2000, PLANT PHYSIOL, V122, P1301, DOI 10.1104/pp.122.4.1301; Ichimura K, 2002, TRENDS PLANT SCI, V7, P301, DOI 10.1016/S1360-1385(02)02302-6; Ichimura K, 2000, PLANT J, V24, P655, DOI 10.1046/j.1365-313x.2000.00913.x; Ichimura K, 2006, J BIOL CHEM, V281, P36969, DOI 10.1074/jbc.M605319200; Jammes F, 2009, P NATL ACAD SCI USA, V106, P20520, DOI 10.1073/pnas.0907205106; Jin HL, 2002, DEV CELL, V3, P291, DOI 10.1016/S1534-5807(02)00205-8; Kiegerl S, 2000, PLANT CELL, V12, P2247, DOI 10.1105/tpc.12.11.2247; Kong FL, 2012, GENE, V499, P108, DOI 10.1016/j.gene.2012.01.048; Kong Q, 2012, PLANT CELL, V24, P2225, DOI 10.1105/tpc.112.097253; Kong XP, 2011, PLANT CELL REP, V30, P2097, DOI 10.1007/s00299-011-1116-9; Kong XP, 2011, PLANT CELL ENVIRON, V34, P1291, DOI 10.1111/j.1365-3040.2011.02329.x; Kumar K, 2011, PLANT SIGNAL BEHAV, V6, P316, DOI 10.4161/psb.6.3.13063; Lampard GR, 2009, PLANT CELL, V21, P3506, DOI 10.1105/tpc.109.070110; Lee JS, 2008, PLANT SIGNAL BEHAV, V3, P1037, DOI 10.4161/psb.3.12.6848; Lin F, 2009, J EXP BOT, V60, P3221, DOI 10.1093/jxb/erp157; Liu YK, 2012, MOL BIOL REP, V39, P2957, DOI 10.1007/s11033-011-1057-y; Melech-Bonfil S, 2010, PLANT J, V64, P379, DOI 10.1111/j.1365-313X.2010.04333.x; Meszaros T, 2006, PLANT J, V48, P485, DOI 10.1111/j.1365-313X.2006.02888.x; Munnik T, 2001, FEBS LETT, V498, P172, DOI 10.1016/S0014-5793(01)02492-9; Murakami-Kojima M, 2002, PLANT CELL PHYSIOL, V43, P675, DOI 10.1093/pcp/pcf084; Nakagami H, 2005, TRENDS PLANT SCI, V10, P339, DOI 10.1016/j.tplants.2005.05.009; Ning J, 2011, PLANT CELL, V23, P4334, DOI 10.1105/tpc.111.093419; Ning J, 2010, PLANT PHYSIOL, V152, P876, DOI 10.1104/pp.109.149856; Pan JW, 2012, PLANTA, V235, P661, DOI 10.1007/s00425-011-1510-0; Pitzschke A, 2009, MOL PLANT, V2, P120, DOI 10.1093/mp/ssn079; Popescu SC, 2009, GENE DEV, V23, P80, DOI 10.1101/gad.1740009; Rao KP, 2010, DNA RES, V17, P139, DOI 10.1093/dnares/dsq011; Ren DT, 2002, J BIOL CHEM, V277, P559, DOI 10.1074/jbc.M109495200; Rodriguez MCS, 2010, ANNU REV PLANT BIOL, V61, P621, DOI 10.1146/annurev-arplant-042809-112252; Sasabe M, 2006, GENE DEV, V20, P1004, DOI 10.1101/gad.1408106; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Song D, 2006, PLANT BIOLOGY, V8, P587, DOI 10.1055/s-2006-924149; Soyano T, 2003, GENE DEV, V17, P1055, DOI 10.1101/gad.1071103; Takahashi Y, 2010, PLANT CELL PHYSIOL, V51, P1766, DOI 10.1093/pcp/pcq135; Teige M, 2004, MOL CELL, V15, P141, DOI 10.1016/j.molcel.2004.06.023; Wang Y, 2008, PLANT BIOLOGY, V10, P548, DOI 10.1111/j.1438-8677.2008.00072.x; Wu T, 2011, MOL BIOL REP, V38, P3967, DOI 10.1007/s11033-010-0514-3; Xing Y, 2008, PLANT J, V54, P440, DOI 10.1111/j.1365-313X.2008.03433.x; Xu J, 2008, J BIOL CHEM, V283, P26996, DOI 10.1074/jbc.M801392200; Yoo SD, 2008, NATURE, V451, P789, DOI 10.1038/nature06543; Zeng QN, 2011, PLANT J, V67, P895, DOI 10.1111/j.1365-313X.2011.04642.x; Zhang LA, 2011, FEBS J, V278, P1367, DOI 10.1111/j.1742-4658.2011.08056.x; Zhang MY, 2012, J PLANT PHYSIOL, V169, P1501, DOI 10.1016/j.jplph.2012.06.008; Zhang ZB, 2012, CELL HOST MICROBE, V11, P253, DOI 10.1016/j.chom.2012.01.015; Zhou Y, 2012, PLANT PHYSIOL BIOCH, V58, P174, DOI 10.1016/j.plaphy.2012.06.020	57	47	57	6	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57714	10.1371/journal.pone.0057714	http://dx.doi.org/10.1371/journal.pone.0057714			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460898	Green Submitted, gold, Green Published			2022-12-25	WOS:000315519000153
J	Lin, Y; Berger, U; Grimm, V; Huth, F; Weiner, J				Lin, Yue; Berger, Uta; Grimm, Volker; Huth, Franka; Weiner, Jacob			Plant Interactions Alter the Predictions of Metabolic Scaling Theory	PLOS ONE			English	Article							GENERAL QUANTITATIVE THEORY; DENSITY RELATIONSHIP; SIZE SYMMETRY; MASS-DENSITY; TREE GROWTH; COMPETITION; ALLOMETRY; PROTOCOL; MODELS	Metabolic scaling theory (MST) is an attempt to link physiological processes of individual organisms with macroecology. It predicts a power law relationship with an exponent of -4/3 between mean individual biomass and density during density-dependent mortality (self-thinning). Empirical tests have produced variable results, and the validity of MST is intensely debated. MST focuses on organisms' internal physiological mechanisms but we hypothesize that ecological interactions can be more important in determining plant mass-density relationships induced by density. We employ an individual-based model of plant stand development that includes three elements: a model of individual plant growth based on MST, different modes of local competition (size-symmetric vs. -asymmetric), and different resource levels. Our model is consistent with the observed variation in the slopes of self-thinning trajectories. Slopes were significantly shallower than -4/3 if competition was size-symmetric. We conclude that when the size of survivors is influenced by strong ecological interactions, these can override predictions of MST, whereas when surviving plants are less affected by interactions, individual-level metabolic processes can scale up to the population level. MST, like thermodynamics or biomechanics, sets limits within which organisms can live and function, but there may be stronger limits determined by ecological interactions. In such cases MST will not be predictive.	[Lin, Yue; Berger, Uta] Tech Univ Dresden, Inst Forest Growth & Comp Sci, Tharandt, Germany; [Lin, Yue; Grimm, Volker] UFZ Helmholtz Ctr Environm Res, Dept Ecol Modelling, Leipzig, Germany; [Grimm, Volker] Univ Potsdam, Inst Biochem & Biol, Potsdam, Germany; [Huth, Franka] Tech Univ Dresden, Inst Silviculture & Forest Protect, Tharandt, Germany; [Weiner, Jacob] Univ Copenhagen, Dept Plant & Environm Sci, Frederiksberg, Denmark	Technische Universitat Dresden; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); University of Potsdam; Technische Universitat Dresden; University of Copenhagen	Lin, Y (corresponding author), Tech Univ Dresden, Inst Forest Growth & Comp Sci, Tharandt, Germany.	yue.lin.tud@gmail.com	Weiner, Jacob/E-1839-2011	Weiner, Jacob/0000-0002-0736-7943; Lin, Yue/0000-0002-0346-6493	Helmholtz Impulse and Networking Fund through Helmholtz Interdisciplinary Graduate School for Environmental Research (HIGRADE)	Helmholtz Impulse and Networking Fund through Helmholtz Interdisciplinary Graduate School for Environmental Research (HIGRADE)	This work is supported by Helmholtz Impulse and Networking Fund through Helmholtz Interdisciplinary Graduate School for Environmental Research (HIGRADE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen AP, 2008, FUNCT ECOL, V22, P197, DOI 10.1111/j.1365-2435.2007.01376.x; Armas C, 2004, ECOLOGY, V85, P2682, DOI 10.1890/03-0650; Berger U, 2008, PERSPECT PLANT ECOL, V9, P121, DOI 10.1016/j.ppees.2007.11.002; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Chu CJ, 2010, ANN BOT-LONDON, V106, P647, DOI 10.1093/aob/mcq145; Coomes DA, 2007, J ECOL, V95, P1084, DOI 10.1111/j.1365-2745.2007.01280.x; Coomes DA, 2011, J ECOL, V99, P748, DOI 10.1111/j.1365-2745.2011.01811.x; Dai XF, 2009, BIOL LETTERS, V5, P571, DOI 10.1098/rsbl.2009.0228; Deng JM, 2006, J ECOL, V94, P953, DOI 10.1111/j.1365-2745.2006.01141.x; Enquist BJ, 2002, TREE PHYSIOL, V22, P1045, DOI 10.1093/treephys/22.15-16.1045; Enquist BJ, 2001, NATURE, V410, P655, DOI 10.1038/35070500; Enquist BJ, 1998, NATURE, V395, P163, DOI 10.1038/25977; Enquist BJ, 2009, P NATL ACAD SCI USA, V106, P7046, DOI 10.1073/pnas.0812303106; Grimm V, 2006, ECOL MODEL, V198, P115, DOI 10.1016/j.ecolmodel.2006.04.023; Grimm V, 2010, ECOL MODEL, V221, P2760, DOI 10.1016/j.ecolmodel.2010.08.019; Hou C, 2008, SCIENCE, V322, P736, DOI 10.1126/science.1162302; Kooijman S.A.L.M., 2010, DYNAMIC ENERGY BUDGE; Lambers H., 2008, PLANT PHYSL ECOLOGY, P134; Li HT, 2006, J INTEGR PLANT BIOL, V48, P268, DOI 10.1111/j.1744-7909.2006.00222.x; Lin Y, 2012, J ECOL, V100, P1482, DOI 10.1111/j.1365-2745.2012.02019.x; Martin BT, 2012, METHODS ECOL EVOL, V3, P445, DOI 10.1111/j.2041-210X.2011.00168.x; Martin BT, AM NAT IN PRESS; Morris EC, 2003, ECOL RES, V18, P287, DOI 10.1046/j.1440-1703.2003.00555.x; Ruger N, 2012, FUNCT ECOL, V26, P759, DOI 10.1111/j.1365-2435.2012.01981.x; Schwinning S, 1998, OECOLOGIA, V113, P447, DOI 10.1007/s004420050397; Stoll P, 2002, P ROY SOC B-BIOL SCI, V269, P2191, DOI 10.1098/rspb.2002.2137; Weiner J, 1997, OIKOS, V79, P85, DOI 10.2307/3546093; WEINER J, 1992, ECOLOGY, V73, P648, DOI 10.2307/1940771; Weiner J, 2001, AM NAT, V158, P438, DOI 10.1086/321988; West GB, 2001, NATURE, V413, P628, DOI 10.1038/35098076; West GB, 1999, SCIENCE, V284, P1677, DOI 10.1126/science.284.5420.1677; WESTOBY M, 1984, ADV ECOL RES, V14, P167, DOI 10.1016/S0065-2504(08)60171-3; Wilensky U, 1999, NETLOGO; Zhang WP, 2011, ECOL RES, V26, P819, DOI 10.1007/s11284-011-0843-2	34	25	25	0	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57612	10.1371/journal.pone.0057612	http://dx.doi.org/10.1371/journal.pone.0057612			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460884	gold, Green Published			2022-12-25	WOS:000315519000139
J	Mettke-Hofmann, C; Winkler, H; Hamel, PB; Greenberg, R				Mettke-Hofmann, Claudia; Winkler, Hans; Hamel, Paul B.; Greenberg, Russell			Migratory New World Blackbirds (Icterids) Are More Neophobic than Closely Related Resident Icterids	PLOS ONE			English	Article							ECOLOGICAL PLASTICITY; NOVELTY RESPONSES; EXPERIENCE; ASSEMBLAGE; SONG; INFORMATION; EXPLORATION; PHYLOGENIES; BEHAVIOR; RAT	Environments undergo short-term and long-term changes due to natural or human-induced events. Animals differ in their ability to cope with such changes which can be related to their ecology. Changes in the environment often elicit avoidance reactions (neophobia) which protect animals from dangerous situations but can also inhibit exploration and familiarization with novel situations and thus, learning about new resources. Studies investigating the relationship between a species' ecology and its neophobia have so far been restricted to comparing only a few species and mainly in captivity. The current study investigated neophobia reactions to experimentally-induced changes in the natural environment of six closely-related blackbird species (Icteridae), including two species represented by two distinct populations. For analyses, neophobic reactions (difference in number of birds feeding and time spent feeding with and without novel objects) were related to several measures of ecological plasticity and the migratory strategy (resident or migratory) of the population. Phylogenetic relationships were incorporated into the analysis. The degree of neophobia was related to migratory strategy with migrants expressing much higher neophobia (fewer birds feeding and for a shorter time with objects present) than residents. Furthermore, neophobia showed a relationship to diet breadth with fewer individuals of diet generalists than specialists returning when objects were present supporting the dangerous niche hypothesis. Residents may have evolved lower neophobia as costs of missing out on opportunities may be higher for residents than migrants as the former are restricted to a smaller area. Lower neophobia allows them approaching changes in the environment (e. g. novel objects) quickly, thereby securing access to resources. Additionally, residents have a greater familiarity with similar situations in the area than migrants and the latter may, therefore, initially stay behind resident species.	[Mettke-Hofmann, Claudia] Liverpool John Moores Univ, Sch Nat Sci & Psychol, Liverpool L3 5UX, Merseyside, England; [Mettke-Hofmann, Claudia; Greenberg, Russell] Smithsonian Inst, Natl Zool Pk, Smithsonian Migratory Bird Ctr, Washington, DC 20008 USA; [Winkler, Hans] Univ Vet Med, Dept Integrat Biol & Evolut, Konrad Lorenz Inst Ethol, Vienna, Austria; [Hamel, Paul B.] US Forest Serv, Southern Hardwood Lab, Stoneville, MS USA	Liverpool John Moores University; Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; University of Veterinary Medicine Vienna; United States Department of Agriculture (USDA); United States Forest Service	Mettke-Hofmann, C (corresponding author), Liverpool John Moores Univ, Sch Nat Sci & Psychol, Liverpool L3 5UX, Merseyside, England.	C.C.Mettke-Hofmann@ljmu.ac.uk			Max Kade Foundation; Max Planck Institute for Ornithology, Andechs, Germany; German Ethological Society; Society for Tropical Ornithology, Germany; Point Reyes Bird Observatory, CA; USDA Forest Service, Center for Bottomland Hardwoods, MS	Max Kade Foundation; Max Planck Institute for Ornithology, Andechs, Germany; German Ethological Society; Society for Tropical Ornithology, Germany; Point Reyes Bird Observatory, CA; USDA Forest Service, Center for Bottomland Hardwoods, MS	The study was supported by a grant from the Max Kade Foundation. Assistants, travel and material were supported by the Max Planck Institute for Ornithology, Andechs, Germany, the German Ethological Society, and the Society for Tropical Ornithology, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Point Reyes Bird Observatory, CA, and the USDA Forest Service, Center for Bottomland Hardwoods, MS, for providing housing and support, the National Park Service Point Reyes National Seashore, CA, Yazoo NWR, Leroy Percy SP, Delta Research and Experimental Center, (all MS), and all cooperating farmers for permitting experiments on their land and Gerhard Hofmann for his assistance with the experiments.	Avery Michael L., 1995, Birds of North America, V200, P1; BARNETT SA, 1958, BRIT J PSYCHOL, V49, P195, DOI 10.1111/j.2044-8295.1958.tb00657.x; Beedy Edward C., 1999, Birds of North America, V423, P1; Boogert NJ, 2006, ANIM BEHAV, V72, P1229, DOI 10.1016/j.anbehav.2006.02.021; Conti LH, 2004, BEHAV GENET, V34, P93, DOI 10.1023/B:BEGE.0000009479.02183.1f; Dobson A. J, 2002, INTRO GEN LINEAR MOD; Echeverria AI, 2006, CAN J ZOOL, V84, P974, DOI 10.1139/Z06-089; Echeverria AI, 2008, ETHOLOGY, V114, P616, DOI 10.1111/j.1439-0310.2008.01512.x; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; GAVIN TA, 1991, AUK, V108, P602, DOI 10.2307/4088101; GREENBERG R, 1992, ETHOLOGY, V91, P17; GREENBERG R, 1990, ANIM BEHAV, V39, P375, DOI 10.1016/S0003-3472(05)80884-X; Greenberg R, 2001, CURR ORNITHOL, V16, P119; Greenberg R, 1999, CONSERV BIOL, V13, P553, DOI 10.1046/j.1523-1739.1999.97478.x; GREENBERG R, 1989, CAN J ZOOL, V67, P1194, DOI 10.1139/z89-172; GREENBERG R, 1983, AM NAT, V122, P444, DOI 10.1086/284148; Greenberg Russell, 2003, P175; Gros-Louis J, 2003, BEHAV ECOL SOCIOBIOL, V53, P163, DOI 10.1007/s00265-002-0560-5; GRUNBERGER S, 1993, J ORNITHOL, V134, P352, DOI 10.1007/BF01640433; HEINRICH B, 1988, CONDOR, V90, P950, DOI 10.2307/1368859; Hocking RR, 1977, STAT METHODS DIGITAL, P39; Jaramillo A., 1999, NEW WORLD BLACKBIRDS; Johnson KP, 1999, AUK, V116, P759, DOI 10.2307/4089336; Lecuelle S, 2011, APPL ANIM BEHAV SCI, V135, P78, DOI 10.1016/j.applanim.2011.08.007; Lowther Peter E., 1993, Birds of North America, V47, P1; Marples NM, 2007, BEHAV ECOL, V18, P803, DOI 10.1093/beheco/arm053; Martin LB, 2005, BEHAV ECOL, V16, P702, DOI 10.1093/beheco/ari044; Martin Stephen G., 2002, Birds of North America, V616, P1; Martins EP, 1997, AM NAT, V149, P646, DOI 10.1086/286013; Mettke-Hofmann C, 2005, BEHAVIOUR, V142, P1357, DOI 10.1163/156853905774539427; Mettke-Hofmann C, 2005, BEHAV ECOL, V16, P247, DOI 10.1093/beheco/arh159; Mettke-Hofmann C, 2002, ETHOLOGY, V108, P249, DOI 10.1046/j.1439-0310.2002.00773.x; Monkkonen M, 1997, CAN J ZOOL, V75, P2077, DOI 10.1139/z97-842; Moussus JP, 2011, OIKOS, V120, P991, DOI 10.1111/j.1600-0706.2010.18955.x; Niven D., 2004, AM BIRDS, V58, P10; Peer Brain D., 1997, Birds of North America, V271, P1; RANA B D, 1989, Pavo, V27, P35; Ray J, 2005, DEV PSYCHOBIOL, V47, P136, DOI 10.1002/dev.20080; Renken WJ, 2008, APPL ANIM BEHAV SCI, V109, P128, DOI 10.1016/j.applanim.2007.03.014; Rockwell C, 2012, BEHAV ECOL, V23, P676, DOI 10.1093/beheco/ars015; Rohlf FJ, 2001, EVOLUTION, V55, P2143; Shirihai H., 1996, BIRDS ISRAEL, P503; Sol D, 2000, OIKOS, V90, P599, DOI 10.1034/j.1600-0706.2000.900317.x; Sol D, 2005, P ROY SOC B-BIOL SCI, V272, P1433, DOI 10.1098/rspb.2005.3099; Starck JM, 1996, J ZOOL, V238, P53, DOI 10.1111/j.1469-7998.1996.tb05379.x; Tebbich S, 2012, ETHOLOGY, V118, P135, DOI 10.1111/j.1439-0310.2011.02001.x; Thomas RJ, 2010, BEHAV ECOL, V21, P669, DOI 10.1093/beheco/arq037; Valone TJ, 2002, PHILOS T R SOC B, V357, P1549, DOI 10.1098/rstb.2002.1064; van Oers K, 2004, P ROY SOC B-BIOL SCI, V271, P65, DOI 10.1098/rspb.2003.2518; Voelkl B, 2006, ANIM BEHAV, V72, P365, DOI 10.1016/j.anbehav.2005.10.013; Webster SJ, 2000, WILSON BULL, V112, P424, DOI 10.1676/0043-5643(2000)112[0424:NBTLAB]2.0.CO;2; Webster SJ, 2001, ANIM BEHAV, V62, P23, DOI 10.1006/anbe.2000.1725; Yasukawa Ken, 1995, Birds of North America, V184, P1	53	23	23	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57565	10.1371/journal.pone.0057565	http://dx.doi.org/10.1371/journal.pone.0057565			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460875	Green Published, gold, Green Submitted			2022-12-25	WOS:000315519000130
J	Habbout, A; Guenancia, C; Lorin, J; Rigal, E; Fassot, C; Rochette, L; Vergely, C				Habbout, Ahmed; Guenancia, Charles; Lorin, Julie; Rigal, Eve; Fassot, Celine; Rochette, Luc; Vergely, Catherine			Postnatal Overfeeding Causes Early Shifts in Gene Expression in the Heart and Long-Term Alterations in Cardiometabolic and Oxidative Parameters	PLOS ONE			English	Article							IMMUNOCYTOCHEMICAL LOCALIZATION; LEPTIN RECEPTOR; PEPTIDE APELIN; NEUROPEPTIDE-Y; BLOOD-PRESSURE; INSULIN; OBESITY; ADIPOSITY; LACTATION; ADULTHOOD	Background: Postnatal overfeeding (OF) in rodents induces a permanent moderate increase in body weight in adulthood. However, the repercussions of postnatal OF on cardiac gene expression, cardiac metabolism and nitro-oxidative stress are less well known. Methodology/Principal Findings: Immediately after birth, litters of C57BL/6 mice were either maintained at 10 (normal-fed group, NF), or reduced to 3 in order to induce OF. At weaning, mice of both groups received a standard diet. The cardiac gene expression profile was determined at weaning and cardiac metabolism and oxidative stress were assessed at 7 months. The cardiac expression of several genes, including members of the extracellular matrix and apelin pathway, was modified in juvenile OF mice. In adult mice, OF led to an increase in body weight (+30%) and to significant increases in plasma cholesterol, insulin and leptin levels. Myocardial oxidative stress, SOD and catalase activity and mRNA expression were increased in OF mice. In vivo, diastolic and systolic blood pressures were significantly higher and LV shortening and ejection fraction were decreased in OF mice. Ex vivo, after 30 min of ischemia, hearts isolated from OF mice showed lower functional recovery and larger infarct size (31% vs. 54%, p<0.05). Increases in collagen deposition and expression/activity of matrix-metalloproteinase-2 were observed in adult OF mouse hearts. Moreover, an increase in the expression of SOCS-3 and a decrease in STAT-3 phosphorylation were observed in ventricular tissues from OF mice. Conclusions/Significance: Our study emphasizes that over-nutrition during the immediate postnatal period in mice leads to early changes in cardiac gene expression, which may permanently modify the heart's structural organization and metabolism and could contribute to a greater susceptibility to myocardial ischemia-reperfusion injury.	[Habbout, Ahmed; Guenancia, Charles; Lorin, Julie; Rigal, Eve; Rochette, Luc; Vergely, Catherine] Univ Burgundy, Fac Med, LPPCM, INSERM,UMR866, Dijon, France; [Habbout, Ahmed; Guenancia, Charles; Lorin, Julie; Rigal, Eve; Rochette, Luc; Vergely, Catherine] Univ Burgundy, Fac Pharm, LPPCM, INSERM,UMR866, Dijon, France; [Fassot, Celine] INSERM, Biol Neurovasc & Mitochondriale Integree UMR1083, Angers, France	Institut Agro; AgroSup Dijon; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; Institut Agro; AgroSup Dijon; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers	Vergely, C (corresponding author), Univ Burgundy, Fac Med, LPPCM, INSERM,UMR866, Dijon, France.	cvergely@u-bourgogne.fr	Vergely, Catherine/L-9534-2015; Guenancia, Charles/M-5558-2013; Fassot, Celine/K-1494-2015	Vergely, Catherine/0000-0003-4009-776X; Guenancia, Charles/0000-0002-3554-7714; Rochette, Luc/0000-0001-9973-8803	French Ministry of Research; Institut National de la Sante et de la Recherche Medicale (INSERM); Regional Council of Burgundy	French Ministry of Research(Ministry of Research, FranceEuropean Commission); Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Regional Council of Burgundy(Region Bourgogne-Franche-Comte)	This work was supported by grants from the French Ministry of Research, from the Institut National de la Sante et de la Recherche Medicale (INSERM) and from the Regional Council of Burgundy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Y, 2007, AM J PHYSIOL-HEART C, V292, pH2387, DOI 10.1152/ajpheart.00579.2006; Aebi H, 1984, Methods Enzymol, V105, P121; Alcazar MAA, 2012, ENDOCRINOLOGY, V153, P1397, DOI 10.1210/en.2011-1670; Balonan LC, 2000, PEDIATR RES, V48, P668, DOI 10.1203/00006450-200011000-00019; Berry MF, 2004, CIRCULATION, V110, pII187, DOI 10.1161/01.CIR.0000138382.57325.5c; Boengler K, 2008, PHARMACOL THERAPEUT, V120, P172, DOI 10.1016/j.pharmthera.2008.08.002; Boullu-Ciocca S, 2005, DIABETES, V54, P197, DOI 10.2337/diabetes.54.1.197; Castan-Laurell I, 2011, ENDOCRINE, V40, P1, DOI 10.1007/s12020-011-9507-9; Dalloz F, 1999, FREE RADICAL BIO MED, V26, P785, DOI 10.1016/S0891-5849(98)00259-7; Davidowa H, 2007, NEUROREPORT, V18, P521, DOI 10.1097/WNR.0b013e32805dfb93; Cunha ACDR, 2009, J NUTR BIOCHEM, V20, P435, DOI 10.1016/j.jnutbio.2008.05.002; Ecarnot-Laubriet Aline, 2003, Heart Dis, V5, P308, DOI 10.1097/01.hdx.0000089836.03515.a9; Fuglesteg BN, 2008, BASIC RES CARDIOL, V103, P444, DOI 10.1007/s00395-008-0728-x; Gualillo O, 2007, TRENDS CARDIOVAS MED, V17, P275, DOI 10.1016/j.tcm.2007.09.005; Habbout A, 2012, BIOCHIMIE, V94, P117, DOI 10.1016/j.biochi.2011.09.023; Hattori R, 2001, J MOL CELL CARDIOL, V33, P1929, DOI 10.1006/jmcc.2001.1456; Hwang DM, 1997, CIRCULATION, V96, P4146; Kappeler L, 2009, ENDOCRINOLOGY, V150, P314, DOI 10.1210/en.2008-0981; Kelly RF, 2010, BASIC RES CARDIOL, V105, P763, DOI 10.1007/s00395-010-0125-0; Kleinz MJ, 2005, REGUL PEPTIDES, V126, P233, DOI 10.1016/j.regpep.2004.10.019; Kleinz MJ, 2004, REGUL PEPTIDES, V118, P119, DOI 10.1016/j.regpep.2003.11.002; Laight DW, 1999, EUR J PHARMACOL, V377, P89, DOI 10.1016/S0014-2999(99)00407-0; Lopez M, 2005, DIABETOLOGIA, V48, P140, DOI 10.1007/s00125-004-1596-z; Lorgis L, 2010, ATHEROSCLEROSIS, V213, P616, DOI 10.1016/j.atherosclerosis.2010.09.018; Oudot A, 2006, FREE RADICAL BIO MED, V40, P2214, DOI 10.1016/j.freeradbiomed.2006.02.020; Perego L, 2005, J CLIN ENDOCR METAB, V90, P4087, DOI 10.1210/jc.2004-1963; Pereira RO, 2006, REGUL PEPTIDES, V136, P117, DOI 10.1016/j.regpep.2006.05.002; Plagemann A, 1999, BRAIN RES, V836, P146, DOI 10.1016/S0006-8993(99)01662-5; Rajia S, 2010, J NEUROENDOCRINOL, V22, P905, DOI 10.1111/j.1365-2826.2010.02005.x; Schulze PC, 2003, EUR J HEART FAIL, V5, P33, DOI 10.1016/S1388-9842(02)00177-0; Scott IC, 2007, DEV CELL, V12, P403, DOI 10.1016/j.devcel.2007.01.012; Suleman N, 2008, CARDIOVASC RES, V79, P127, DOI 10.1093/cvr/cvn067; Tatemoto K, 2001, REGUL PEPTIDES, V99, P87, DOI 10.1016/S0167-0115(01)00236-1; Velkoska E, 2005, AM J PHYSIOL-ENDOC M, V288, pE1236, DOI 10.1152/ajpendo.00505.2004; Vergely C, 2001, FREE RADICAL RES, V35, P475, DOI 10.1080/10715760100301491; Vincent HK, 1999, INT J OBESITY, V23, P67, DOI 10.1038/sj.ijo.0800761	36	32	34	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2013	8	2							e56981	10.1371/journal.pone.0056981	http://dx.doi.org/10.1371/journal.pone.0056981			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098PO	23468899	Green Published, gold			2022-12-25	WOS:000315561400019
J	Manzano, D				Manzano, Daniel			Quantum Transport in Networks and Photosynthetic Complexes at the Steady State	PLOS ONE			English	Article							COHERENCE	Recently, several works have analysed the efficiency of photosynthetic complexes in a transient scenario and how that efficiency is affected by environmental noise. Here, following a quantum master equation approach, we study the energy and excitation transport in fully connected networks both in general and in the particular case of the Fenna-Matthew-Olson complex. The analysis is carried out for the steady state of the system where the excitation energy is constantly "flowing" through the system. Steady state transport scenarios are particularly relevant if the evolution of the quantum system is not conditioned on the arrival of individual excitations. By adding dephasing to the system, we analyse the possibility of noise-enhancement of the quantum transport.	[Manzano, Daniel] Univ Granada, Inst Carlos Fis Teor & Computac 1, Granada, Spain; [Manzano, Daniel] Univ Innsbruck, Inst Theoret Phys, A-6020 Innsbruck, Austria	University of Granada; University of Innsbruck	Manzano, D (corresponding author), Univ Granada, Inst Carlos Fis Teor & Computac 1, Granada, Spain.	daniel.manzano@uibk.ac.at	Manzano, Daniel/F-5823-2013	Manzano, Daniel/0000-0001-9241-5884	Austrian Science Fund (FWF) [F04011, F04012]; Spanish MEC-FEDER [FIS2009-08451]; Campus de Excelencia Internacional; Junta de Andalucia (Spain) [FQM-165]	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Spanish MEC-FEDER(Spanish Government); Campus de Excelencia Internacional; Junta de Andalucia (Spain)(Junta de Andalucia)	The research was funded by the Austrian Science Fund (FWF): F04011 and F04012 and by Spanish MEC-FEDER, project FIS2009-08451, together with the Campus de Excelencia Internacional and the Junta de Andalucia, project FQM-165 (Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs T, 2006, BIOPHYS J, V91; Asadian A, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.012109; Blankenship RE, 2011, SCIENCE, V332, P805, DOI 10.1126/science.1200165; Breuer F. P. Heinz-Peter, 2002, THEORY OPEN QUANTUM; Brumer P, 2012, P NATL ACAD SCI USA, V109, P19575, DOI 10.1073/pnas.1211209109; Cao JS, 1997, J CHEM PHYS, V107, P3204, DOI 10.1063/1.474670; Caruso F, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3223548; Caruso F, 2010, PHYS REV A, V81, DOI 10.1103/PhysRevA.81.062346; Chin AW, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/6/065002; Collini E, 2010, NATURE, V463, P644, DOI 10.1038/nature08811; Engel GS, 2007, NATURE, V446, P782, DOI 10.1038/nature05678; Jacobs K, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.040106; Linden N, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.130401; Mancal L, 2010, NJP, V12; Manzano D, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.061118; Mohseni M, 2008, J CHEM PHYS, V129, DOI 10.1063/1.3002335; Olaya-Castro A, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.085115; Panitchayangkoon G, 2010, P NATL ACAD SCI USA, V107, P12766, DOI 10.1073/pnas.1005484107; Plenio S, 2008, J NEW PHYS, V10; Rebentrost P, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/3/033003; Rivas A, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/11/113032; Scholak T, 2011, J PHYS B-AT MOL OPT, V44, DOI 10.1088/0953-4075/44/18/184012; Scholak T, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.021912; Tiersch M, 2012, PHILOS T R SOC A, V370, P3771, DOI 10.1098/rsta.2011.0202; Wu JL, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/10/105012	25	39	40	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2013	8	2							e57041	10.1371/journal.pone.0057041	http://dx.doi.org/10.1371/journal.pone.0057041			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098PO	23468907	Green Published, Green Submitted, gold			2022-12-25	WOS:000315561400023
J	Seabloom, EW; Borer, ET; Lacroix, C; Mitchell, CE; Power, AG				Seabloom, Eric W.; Borer, Elizabeth T.; Lacroix, Christelle; Mitchell, Charles E.; Power, Alison G.			Richness and Composition of Niche-Assembled Viral Pathogen Communities	PLOS ONE			English	Article							BARLEY-YELLOW-DWARF; WEST-NILE-VIRUS; INFECTIOUS-DISEASE; SPECIES-DIVERSITY; PLANT-DISEASE; HEPATITIS-C; T-CELL; HOST; COMPETITION; CALIFORNIA	The pathogen and parasite community that inhabits every free-living organism can control host vital rates including lifespan and reproductive output. To date, however, there have been few experiments examining pathogen community assembly replicated at large-enough spatial scales to inform our understanding of pathogen dynamics in natural systems. Pathogen community assembly may be driven by neutral stochastic colonization and extinction events or by niche differentiation that constrains pathogen distributions to particular environmental conditions, hosts, or vectors. Here, we present results from a regionally-replicated experiment investigating the community of barley and cereal yellow dwarf viruses (B/CYDV's) in over 5000 experimentally planted individuals of six grass species along a 700 km latitudinal gradient along the Pacific coast of North America (USA) in response to experimentally manipulated nitrogen and phosphorus supplies. The composition of the virus community varied predictably among hosts and across nutrient-addition treatments, indicating niche differentiation among virus species. There were some concordant responses among the viral species. For example, the prevalence of most viral species increased consistently with perennial grass cover, leading to a 60% increase in the richness of the viral community within individual hosts (i.e., coinfection) in perennial-dominated plots. Furthermore, infection rates of the six host species in the field were highly correlated with vector preferences assessed in laboratory trials. Our results reveal the importance of niche differentiation in structuring virus assemblages. Virus species distributions reflected a combination of local host community composition, host species-specific vector preferences, and virus responses to host nutrition. In addition, our results suggest that heterogeneity among host species in their capacity to attract vectors or support pathogens between growing seasons can lead to positive covariation among virus species.	[Seabloom, Eric W.; Borer, Elizabeth T.; Lacroix, Christelle] Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA; [Mitchell, Charles E.] Univ N Carolina, Dept Biol, Chapel Hill, NC USA; [Power, Alison G.] Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY USA	University of Minnesota System; University of Minnesota Twin Cities; University of North Carolina; University of North Carolina Chapel Hill; Cornell University	Seabloom, EW (corresponding author), Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA.	seabloom@umn.edu	Mitchell, Charles E/I-3709-2014; Lacroix, Christelle/G-9569-2011	Mitchell, Charles E/0000-0002-1633-1993; Lacroix, Christelle/0000-0001-8808-4752; Seabloom, Eric/0000-0001-6780-9259; Borer, Elizabeth/0000-0003-2259-5853	National Science Foundation (NSF) as part of the joint NSF-National Institutes of Health Ecology of Infectious Disease program [EF-0525666, DEB-1015805, EF-05-25641, DEB-10-15909, EF-0525669, DEB-1015903]	National Science Foundation (NSF) as part of the joint NSF-National Institutes of Health Ecology of Infectious Disease program(National Science Foundation (NSF))	Support for this project was provided, in part, by National Science Foundation (NSF) grants EF-0525666 and DEB-1015805 to E. T. Borer and E. W. Seabloom, EF-05-25641 and DEB-10-15909 to C. E. Mitchell, and EF-0525669 and DEB-1015903 to A. G. Power as part of the joint NSF-National Institutes of Health Ecology of Infectious Disease program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrios G. N., 1978, PLANT PATHOLOGY; Ahlquist P, 2003, J VIROL, V77, P8181, DOI 10.1128/JVI.77.15.8181-8186.2003; Al-Naimi FA, 2005, OECOLOGIA, V143, P449, DOI 10.1007/s00442-004-1814-x; Allan BF, 2009, OECOLOGIA, V158, P699, DOI 10.1007/s00442-008-1169-9; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; [Anonymous], 2010, R LANG ENV STAT COMP; Beck MA, 2000, J INFECT DIS, V182, pS93, DOI 10.1086/315918; Bentwich Z, 1999, IMMUNOL TODAY, V20, P485, DOI 10.1016/S0167-5699(99)01499-1; Borer ET, 2007, P NATL ACAD SCI USA, V104, P5473, DOI 10.1073/pnas.0608573104; Borer ET, 2010, ECOL LETT, V13, P810, DOI 10.1111/j.1461-0248.2010.01475.x; Borer ET, 2009, ECOL APPL, V19, P1187, DOI 10.1890/08-1205.1; Borer ET, 2009, P NATL ACAD SCI USA, V106, P503, DOI 10.1073/pnas.0808778106; Borer ET, 2011, ECOHEALTH; BURDON JJ, 1982, ANNU REV PHYTOPATHOL, V20, P143, DOI 10.1146/annurev.py.20.090182.001043; Carlsson-Graner U, 2006, EVOL ECOL RES, V8, P659; Chase JM, 2007, P NATL ACAD SCI USA, V104, P17430, DOI 10.1073/pnas.0704350104; Clasen JL, 2007, FRESHWATER BIOL, V52, P112, DOI 10.1111/j.1365-2427.2006.01677.x; COLHOUN J, 1973, ANNU REV PHYTOPATHOL, V11, P343, DOI 10.1146/annurev.py.11.090173.002015; Crawley MJ., 2007, R BOOK; Cronin JP, 2010, ECOL LETT, V13, P1221, DOI 10.1111/j.1461-0248.2010.01513.x; Cumming GS, 2006, ECOHEALTH, V3, P163, DOI 10.1007/s10393-006-0028-6; D'Arcy C. J., 1995, BARLEY YELLOW DWARF, P9; Dobson A, 2008, P NATL ACAD SCI USA, V105, P11482, DOI 10.1073/pnas.0803232105; Dobson A, 2006, PLOS MED, V3, P714, DOI 10.1371/journal.pmed.0030231; Dodds P, 2009, FUNCT PLANT BIOL, V36, P395, DOI 10.1071/FP08320; Dove ADM, 2006, TRENDS PARASITOL, V22, P568, DOI 10.1016/j.pt.2006.09.008; Ezenwa VO, 2006, P ROY SOC B-BIOL SCI, V273, P109, DOI 10.1098/rspb.2005.3284; Fereres A, 2009, VIRUS RES, V141, P158, DOI 10.1016/j.virusres.2008.10.020; FLOR HH, 1955, PHYTOPATHOLOGY, V45, P680; Gaidet N, 2012, P ROY SOC B-BIOL SCI, V279, P1131, DOI 10.1098/rspb.2011.1417; Garcia-Arenal F, 2003, INT MICROBIOL, V6, P225, DOI 10.1007/s10123-003-0142-z; Gilbert GS, 2007, P NATL ACAD SCI USA, V104, P4979, DOI 10.1073/pnas.0607968104; Halbert Susan, 1995, P217; Hall GS, 2010, PLANT PATHOL, V59, P1152, DOI 10.1111/j.1365-3059.2010.02351.x; Harpole WS, 2007, NATURE, V446, P791, DOI 10.1038/nature05684; Harpole WS, 2006, ECOL LETT, V9, P15, DOI 10.1111/j.1461-0248.2005.00836.x; Harvell CD, 2002, SCIENCE, V296, P2158, DOI 10.1126/science.1063699; Hillebrand H, 2007, P NATL ACAD SCI USA, V104, P10904, DOI 10.1073/pnas.0701918104; Hood ME, 2003, AM NAT, V162, P122, DOI 10.1086/375539; IRWIN ME, 1990, ANNU REV PHYTOPATHOL, V28, P393, DOI 10.1146/annurev.py.28.090190.002141; Jolles AE, 2008, ECOLOGY, V89, P2239, DOI 10.1890/07-0995.1; Jones LR, 1924, AM J BOT, V11, P601, DOI 10.2307/2435541; Kamal SM, 2001, J INFECT DIS, V184, P972, DOI 10.1086/323352; Kamal SM, 2001, GASTROENTEROLOGY, V121, P646, DOI 10.1053/gast.2001.27024; Keesing F, 2006, ECOL LETT, V9, P485, DOI 10.1111/j.1461-0248.2006.00885.x; Khoruts A, 2010, J CLIN GASTROENTEROL, V44, P354, DOI 10.1097/MCG.0b013e3181c87e02; Kniskern JM, 2006, ECOLOGY, V87, P675, DOI 10.1890/05-1327; Kosova K, 2008, CZECH J GENET PLANT, V44, P1, DOI 10.17221/6/2008-CJGPB; LAL RB, 1994, CLIN DIAGN LAB IMMUN, V1, P5, DOI 10.1128/CDLI.1.1.5-10.1994; Laneri K, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000898; Legendre P, 1999, ECOL MONOGR, V69, P1, DOI 10.1890/0012-9615(1999)069[0001:DBRATM]2.0.CO;2; Lello J, 2004, NATURE, V428, P840, DOI 10.1038/nature02490; Lindenfors P, 2007, GLOBAL ECOL BIOGEOGR, V16, P496, DOI 10.1111/j.1466-8238.2006.00301.x; LoGiudice K, 2003, P NATL ACAD SCI USA, V100, P567, DOI 10.1073/pnas.0233733100; Lyimo IN, 2009, TRENDS PARASITOL, V25, P189, DOI 10.1016/j.pt.2009.01.005; Malmstrom CM, 2005, OECOLOGIA, V145, P153, DOI 10.1007/s00442-005-0099-z; Malmstrom CM, 2005, NEW PHYTOL, V168, P217, DOI 10.1111/j.1469-8137.2005.01479.x; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:fmmtcd]2.0.co;2; Miller WA, 1997, ANNU REV PHYTOPATHOL, V35, P167, DOI 10.1146/annurev.phyto.35.1.167; Minakawa N, 2006, AM J TROP MED HYG, V75, P448, DOI 10.4269/ajtmh.2006.75.448; Mitchell CE, 2002, ECOLOGY, V83, P1713, DOI 10.1890/0012-9658(2002)083[1713:EOGPSD]2.0.CO;2; Nelson KE, 2010, SCIENCE, V328, P994, DOI 10.1126/science.1183605; Pope K, 2005, ECOL APPL, V15, P1223, DOI 10.1890/04-0934; POULIN R, 1995, ECOL MONOGR, V65, P283, DOI 10.2307/2937061; Power A.G., 2003, IMPORTANCE SPECIES P, P330; Power AG, 2004, AM NAT, V164, pS79, DOI 10.1086/424610; Power AG, 1996, ECOLOGY, V77, P1004, DOI 10.2307/2265571; Rizzo DM, 2003, FRONT ECOL ENVIRON, V1, P197, DOI 10.1890/1540-9295(2003)001[0197:SODECA]2.0.CO;2; ROCHOW WF, 1970, SCIENCE, V167, P875, DOI 10.1126/science.167.3919.875; Rockstrom J, 2009, NATURE, V461, P472, DOI 10.1038/461472a; Sacristan S, 2008, MOL PLANT PATHOL, V9, P369, DOI 10.1111/J.1364-3703.2007.00460.X; Scholz M, 2009, THEOR APPL GENET, V119, P837, DOI 10.1007/s00122-009-1093-3; Seabloom EW, 2006, ECOL APPL, V16, P1338, DOI 10.1890/1051-0761(2006)016[1338:HIPIAI]2.0.CO;2; Seabloom EW, 2010, ECOLOGY, V91, P721, DOI 10.1890/08-2170.1; Seabloom EW, 2009, J ECOL, V97, P1264, DOI 10.1111/j.1365-2745.2009.01550.x; Seabloom EW, 2009, AM NAT, V173, pE79, DOI 10.1086/596529; SERVICE MW, 1991, REV SAUDE PUBL, V25, P165, DOI 10.1590/S0034-89101991000300002; Smith VH, 2005, FRONT ECOL ENVIRON, V3, P268; SOTA T, 1989, MED VET ENTOMOL, V3, P337, DOI 10.1111/j.1365-2915.1989.tb00240.x; Springer YP, 2007, OECOLOGIA, V151, P10, DOI 10.1007/s00442-006-0566-1; STRONG DR, 1975, P NATL ACAD SCI USA, V72, P2116, DOI 10.1073/pnas.72.6.2116; Taylor LH, 2001, PHILOS T R SOC B, V356, P983, DOI 10.1098/rstb.2001.0888; Thrall PH, 2003, PLANT PATHOL, V52, P350, DOI 10.1046/j.1365-3059.2003.00863.x; Tilman D, 2001, SCIENCE, V292, P281, DOI 10.1126/science.1057544; Tirado SMC, 2003, VIRAL IMMUNOL, V16, P69, DOI 10.1089/088282403763635465; Tompkins DM, 2003, ECOL LETT, V6, P189, DOI 10.1046/j.1461-0248.2003.00417.x; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; WEN F, 1991, J GEN VIROL, V72, P791, DOI 10.1099/0022-1317-72-4-791; Yoshida-Takashima Y, 2012, APPL ENVIRON MICROB, V78, P1311, DOI 10.1128/AEM.06491-11; Zhang ZY, 2009, J GENET GENOMICS, V36, P567, DOI 10.1016/S1673-8527(08)60148-4	91	24	25	1	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2013	8	2							e55675	10.1371/journal.pone.0055675	http://dx.doi.org/10.1371/journal.pone.0055675			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098PO	23468848	Green Published, Green Submitted, gold			2022-12-25	WOS:000315561400005
J	Alexandrescu, AT				Alexandrescu, Andrei T.			Amide Proton Solvent Protection in Amylin Fibrils Probed by Quenched Hydrogen Exchange NMR	PLOS ONE			English	Article							ISLET-AMYLOID-POLYPEPTIDE; GENE-RELATED PEPTIDE; ALPHA-HELIX; PROTEIN; FOLD; CONFORMATION; MECHANISM; MUTATION; MODEL; DEATH	Amylin is an endocrine hormone that accumulates in amyloid plaques in patients with advanced type 2 diabetes. The amyloid plaques have been implicated in the destruction of pancreatic beta-cells, which synthesize amylin and insulin. To better characterize the secondary structure of amylin in amyloid fibrils we assigned the NMR spectrum of the unfolded state in 95% DMSO and used a quenched hydrogen-deuterium exchange technique to look at amide proton solvent protection in the fibrils. In this technique, partially exchanged fibrils are dissolved in 95% DMSO and information about amide proton occupancy in the fibrils is determined from DMSO-denatured monomers. Hydrogen exchange lifetimes at pH 7.6 and 37 degrees C vary between similar to 5 h for the unstructured N-terminus to 600 h for amide protons in the two beta-strands that form intermolecular hydrogen bonds between amylin monomers along the length of the fibril. Based on the protection data we conclude that residues A8-H18 and I26-Y37 comprise the two beta-strands in amylin fibrils. There is variation in protection within the beta-strands, particularly for strand beta 1 where only residues F15-H18 are strongly protected. Differences in protection appear to be due to restrictions on backbone dynamics imposed by the packing of two-layers of C2-symmetry-related beta-hairpins in the protofilament structure, with strand beta 1 positioned on the surface and beta 2 in the interior.	Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT 06269 USA	University of Connecticut	Alexandrescu, AT (corresponding author), Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT 06269 USA.	andrei@uconn.edu			American Diabetes Association Basic Science Award [1-10-BS-04]	American Diabetes Association Basic Science Award(American Diabetes Association)	Funding provided by American Diabetes Association Basic Science Award 1-10-BS-04. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedini A, 2005, BIOCHEMISTRY-US, V44, P16284, DOI 10.1021/bi051432v; Abedini A, 2007, J AM CHEM SOC, V129, P11300, DOI 10.1021/ja072157y; Alexandrescu A T, 2001, Pac Symp Biocomput, P67; ALEXANDRESCU AT, 2008, PROTEIN MISFOLDING; Anguiano M, 2002, BIOCHEMISTRY-US, V41, P11338, DOI 10.1021/bi020314u; Bahar I, 1997, FOLD DES, V2, P173, DOI 10.1016/S1359-0278(97)00024-2; BAI YW, 1993, PROTEINS, V17, P75, DOI 10.1002/prot.340170110; BAI YW, 1995, SCIENCE, V269, P192, DOI 10.1126/science.7618079; Bedrood S, 2012, J BIOL CHEM, V287, P5235, DOI 10.1074/jbc.M111.327817; Brender JR, 2008, BIOCHEMISTRY-US, V47, P12680, DOI 10.1021/bi801427c; Carulla N, 2005, NATURE, V436, P554, DOI 10.1038/nature03986; COOPER GJS, 1994, ENDOCR REV, V15, P163, DOI 10.1210/er.15.2.163; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Damo SM, 2010, J BIOL CHEM, V285, P32303, DOI 10.1074/jbc.M110.114504; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Engel MFM, 2009, CHEM PHYS LIPIDS, V160, P1, DOI 10.1016/j.chemphyslip.2009.03.008; Englander SW, 1997, PROTEIN SCI, V6, P1101, DOI 10.1002/pro.5560060517; Guardino KM, 2009, INT J MOL SCI, V10, P2412, DOI 10.3390/ijms10052412; Haataja L, 2008, ENDOCR REV, V29, P303, DOI 10.1210/er.2007-0037; Hoshino M, 2002, NAT STRUCT BIOL, V9, P332, DOI 10.1038/nsb792; IDF Diabetes Atlas, 2011, IDF DIAB ATL; Jaravine VA, 2000, PROTEIN SCI, V9, P290; Jha S, 2011, J BIOL CHEM, V286, P22894, DOI 10.1074/jbc.M110.215814; Kajava AV, 2005, J MOL BIOL, V348, P247, DOI 10.1016/j.jmb.2005.02.029; Lin YS, 2009, J PHYS CHEM B, V113, P592, DOI 10.1021/jp807528q; Luca S, 2007, BIOCHEMISTRY-US, V46, P13505, DOI 10.1021/bi701427q; Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102; Meng FL, 2008, BIOCHEMISTRY-US, V47, P6016, DOI 10.1021/bi702518m; Morgan GJ, 2008, J MOL BIOL, V375, P487, DOI 10.1016/j.jmb.2007.10.033; Moriarty DF, 1999, BIOCHEMISTRY-US, V38, P1811, DOI 10.1021/bi981658g; Newgard CB, 2010, NAT MED, V16, P388, DOI 10.1038/nm0410-388; Olofsson A, 2007, BIOCHEM J, V404, P63, DOI 10.1042/BJ20061561; Padrick SB, 2001, J MOL BIOL, V308, P783, DOI 10.1006/jmbi.2001.4608; Patil SM, 2009, J BIOL CHEM, V284, P11982, DOI 10.1074/jbc.M809085200; Rhodes CJ, 2005, SCIENCE, V307, P380, DOI 10.1126/science.1104345; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Vilar M, 2008, P NATL ACAD SCI USA, V105, P8637, DOI 10.1073/pnas.0712179105; Wang L, 2011, J AM CHEM SOC, V133, P16062, DOI 10.1021/ja204035k; Watson E, 2007, BIOCHEMISTRY-US, V46, P9484, DOI 10.1021/bi700532j; WESTERMARK P, 1986, BIOCHEM BIOPH RES CO, V140, P827, DOI 10.1016/0006-291X(86)90708-4; Westermark P, 2011, PHYSIOL REV, V91, P795, DOI 10.1152/physrev.00042.2009; Wilkins DK, 1999, BIOCHEMISTRY-US, V38, P16424, DOI 10.1021/bi991765q; Wilson LM, 2007, J MOL BIOL, V366, P1639, DOI 10.1016/j.jmb.2006.12.040; Yang LW, 2006, NUCLEIC ACIDS RES, V34, pW24, DOI 10.1093/nar/gkl084; ZHANG YZ, 1995, PROTEIN SCI, V4, P804	45	28	28	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56467	10.1371/journal.pone.0056467	http://dx.doi.org/10.1371/journal.pone.0056467			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457571	Green Submitted, Green Published, gold			2022-12-25	WOS:000315603700056
J	Chitrampalam, P; Inderbitzin, P; Maruthachalam, K; Wu, BM; Subbarao, KV				Chitrampalam, Periasamy; Inderbitzin, Patrik; Maruthachalam, Karunakaran; Wu, Bo-Ming; Subbarao, Krishna V.			The Sclerotinia sclerotiorum Mating Type Locus (MAT) Contains a 3.6-kb Region That Is Inverted in Every Meiotic Generation	PLOS ONE			English	Article							ASCOSPORE DIMORPHISM; DROSOPHILA INVERSION; NEUROSPORA-CRASSA; GENE; RECOGNITION; LETTUCE; FUNGUS; COMPATIBILITY; STRATEGIES; EVOLUTION	Sclerotinia sclerotiorum is a fungal plant pathogen and the causal agent of lettuce drop, an economically important disease of California lettuce. The structure of the S. sclerotiorum mating type locus MAT has previously been reported and consists of two idiomorphs that are fused end-to-end as in other homothallics. We investigated the diversity of S. sclerotiorum MAT using a total of 283 isolates from multiple hosts and locations, and identified a novel MAT allele that differed by a 3.6-kb inversion and was designated Inv+, as opposed to the previously known S. sclerotiorum MAT that lacked the inversion and was Inv-. The inversion affected three of the four MAT genes: MAT1-2-1 and MAT1-2-4 were inverted and MAT1-1-1 was truncated at the 3'-end. Expression of MAT genes differed between Inv+ and Inv-isolates. In Inv+ isolates, only one of the three MAT1-2-1 transcript variants of Inv- isolates was detected, and the alpha1 domain of Inv+ MAT1-1-1 transcripts was truncated. Both Inv- and Inv+ isolates were self-fertile, and the inversion segregated in a 1:1 ratio regardless of whether the parent was Inv- or Inv+. This suggested the involvement of a highly regulated process in maintaining equal proportions of Inv- and Inv+, likely associated with the sexual state. The MAT inversion region, defined as the 3.6-kb MAT inversion in Inv+ isolates and the homologous region of Inv- isolates, was flanked by a 250-bp inverted repeat on either side. The 250-bp inverted repeat was a partial MAT1-1-1 that through mediation of loop formation and crossing over, may be involved in the inversion process. Inv+ isolates were widespread, and in California and Nebraska constituted half of the isolates examined. We speculate that a similar inversion region may be involved in mating type switching in the filamentous ascomycetes Chromocrea spinulosa, Sclerotinia trifoliorum and in certain Ceratocystis species.	[Chitrampalam, Periasamy; Inderbitzin, Patrik; Maruthachalam, Karunakaran; Wu, Bo-Ming; Subbarao, Krishna V.] Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA	University of California System; University of California Davis	Subbarao, KV (corresponding author), Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA.	kvsubbarao@ucdavis.edu	Subbarao, Krishna/X-3870-2019	Subbarao, Krishna/0000-0002-2075-1835	California Leafy Greens Board [2011-05, 2011-06]	California Leafy Greens Board	Financial support for this research was provided by the California Leafy Greens Board (www.caleafygreens.ca.gov/), contracts 2011-05 and 2011-06. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS PB, 1979, PHYTOPATHOLOGY, V69, P896, DOI 10.1094/Phyto-69-896; Amselem J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002230; Andrew M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029943; Arnaise S, 1997, MOL GEN GENET, V256, P169, DOI 10.1007/PL00008611; Betley JN, 2002, CURR BIOL, V12, P1756, DOI 10.1016/S0960-9822(02)01220-4; Bidard F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021476; BISTIS GN, 1981, MYCOLOGIA, V73, P959, DOI 10.2307/3759806; Bobrowicz P, 2002, MOL MICROBIOL, V45, P795, DOI 10.1046/j.1365-2958.2002.03052.x; BOLAND GJ, 1994, CAN J PLANT PATHOL, V16, P93, DOI 10.1080/07060669409500766; Bolton MD, 2006, MOL PLANT PATHOL, V7, P1, DOI 10.1111/J.1364-3703.2005.00316.X; Bourdot GW, 2001, BIOCONTROL SCI TECHN, V11, P119, DOI 10.1080/09583150020029808; Codron D, 1974, ANN SCI NATURELLES B, P12; Debuchy R, 1999, FUNGAL GENET BIOL, V27, P218, DOI 10.1006/fgbi.1999.1142; Debuchy R, 2010, CELLULAR AND MOLECULAR BIOLOGY OF FILAMENTOUS FUNGI, P501; DRAYTON FL, 1952, MYCOLOGIA, V44, P119, DOI 10.1080/00275514.1952.12024177; Drummond A.J., 2010, GENEIOUS V4 8 5; Ekins M, 2006, MYCOL RES, V110, P1193, DOI 10.1016/j.mycres.2006.07.014; Faretra F, 1996, MYCOL RES, V100, P620, DOI 10.1016/S0953-7562(96)80018-9; Flores M, 2007, P NATL ACAD SCI USA, V104, P6099, DOI 10.1073/pnas.0701631104; FORD EJ, 1995, MYCOL RES, V99, P241, DOI 10.1016/S0953-7562(09)80893-9; Garza E, 2011, WORLD J MICROB BIOT, V27, P449, DOI 10.1007/s11274-010-0451-2; GLASS NL, 1988, SCIENCE, V241, P570, DOI 10.1126/science.2840740; Glass NL, 2003, EUKARYOT CELL, V2, P1, DOI 10.1128/EC.2.1.1-8.2003; Guillen Y, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-53; Haber JE, 2012, GENETICS, V191, P33, DOI 10.1534/genetics.111.134577; Harrington TC, 1997, CURR GENET, V32, P52, DOI 10.1007/s002940050247; HERSKOWITZ I, 1989, NATURE, V342, P749, DOI 10.1038/342749a0; Hoang ML, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001228; HolstJensen A, 1997, MYCOLOGIA, V89, P885, DOI 10.2307/3761109; Hurles ME, 2006, GENOMIC DISORDERS: THE GENOMIC BASIS OF DISEASE, P341, DOI 10.1007/978-1-59745-039-3_24; Inderbitzin P, 2005, P NATL ACAD SCI USA, V102, P11390, DOI 10.1073/pnas.0501918102; Inderbitzin P, 2006, CAN J BOT, V84, P1304, DOI 10.1139/B06-067; Keszthelyi A, 2007, ANTON LEEUW INT J G, V91, P373, DOI 10.1007/s10482-006-9123-5; Klix V, 2010, EUKARYOT CELL, V9, P894, DOI 10.1128/EC.00019-10; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LESLIE JF, 1986, PHYTOPATHOLOGY, V76, P1142; Leubner-Metzger G, 1997, MOL GEN GENET, V256, P661, DOI 10.1007/s004380050614; Lu SW, 2011, FUNGAL GENET BIOL, V48, P714, DOI 10.1016/j.fgb.2011.04.006; Malvarez G, 2007, PHYTOPATHOLOGY, V97, P470, DOI 10.1094/PHYTO-97-4-0470; Martin T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015199; MATHIESON MJ, 1952, ANN BOT-LONDON, V16, P449, DOI 10.1093/oxfordjournals.aob.a083327; METZENBERG RL, 1990, BIOESSAYS, V12, P53, DOI 10.1002/bies.950120202; PERKINS DD, 1987, GENETICS, V115, P215; Poggeler S, 2006, MOL GENET GENOMICS, V275, P492, DOI 10.1007/s00438-006-0107-y; Puig M, 2004, P NATL ACAD SCI USA, V101, P9013, DOI 10.1073/pnas.0403090101; PURDY LH, 1979, PHYTOPATHOLOGY, V69, P875, DOI 10.1094/Phyto-69-875; Raju NB, 2009, J BIOSCIENCES, V34, P139, DOI 10.1007/s12038-009-0015-5; RAJU NB, 1980, EUR J CELL BIOL, V23, P208; Raju NB, 2000, FUNGAL GENET BIOL, V30, P213, DOI 10.1006/fgbi.2000.1217; Sambrook J., 2001, MOL CLONING; Samuels GJ, 1996, MYCOLOGIA, V88, P302, DOI 10.2307/3760935; Schafer MR, 2006, MYCOLOGIA, V98, P593, DOI 10.3852/mycologia.98.4.593; Selden RF, 1989, SHORT PROTOCOLS MOL, P75; Shiu PKT, 2000, CURR OPIN MICROBIOL, V3, P183, DOI 10.1016/S1369-5274(00)00073-4; SIMON M, 1980, SCIENCE, V209, P1370, DOI 10.1126/science.6251543; Subbarao KV, 1998, PLANT DIS, V82, P1068, DOI 10.1094/PDIS.1998.82.10.1068; Swofford DL, 2001, PAUP PHYLOGENETIC AN; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Turgeon B. Gillian, 2007, P93; TURGEON BG, 1993, FUNGAL HOLOMORPH : MITOTIC, MEIOTIC AND PLEOMORPHIC SPECIATION IN FUNGAL SYSTEMATICS, P199; Turgeon G, 2000, FUNGAL GENET BIOL, V31, P1, DOI 10.1006/fgbi.2000.1227; UHM JY, 1983, PHYTOPATHOLOGY, V73, P565, DOI 10.1094/Phyto-73-565; UHM JY, 1983, PHYTOPATHOLOGY, V73, P569, DOI 10.1094/Phyto-73-569; Witthuhn RC, 2000, CURR GENET, V38, P48, DOI 10.1007/s002940000131; Woudenberg JHC, 2012, MOL PLANT PATHOL, V13, P350, DOI 10.1111/j.1364-3703.2011.00751.x; Wu BM, 2007, MYCOLOGIA, V99, P33, DOI 10.3852/mycologia.99.1.33; Wu BM, 2006, PHYTOPATHOLOGY, V96, P1322, DOI 10.1094/PHYTO-96-1322; YODER OC, 1986, PHYTOPATHOLOGY, V76, P383, DOI 10.1094/Phyto-76-383; Yun SH, 1999, P NATL ACAD SCI USA, V96, P5592, DOI 10.1073/pnas.96.10.5592; Yun SH, 2000, FUNGAL GENET BIOL, V31, P7, DOI 10.1006/fgbi.2000.1226; ZICKLER D, 1995, GENETICS, V140, P493	71	40	47	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56895	10.1371/journal.pone.0056895	http://dx.doi.org/10.1371/journal.pone.0056895			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457637	Green Submitted, Green Published, gold			2022-12-25	WOS:000315603700095
J	Dambach, M; Irnov, I; Winkler, WC				Dambach, Michael; Irnov, Irnov; Winkler, Wade C.			Association of RNAs with Bacillus subtilis Hfq	PLOS ONE			English	Article							ESCHERICHIA-COLI HFQ; BINDING RNAS; PROTEIN; REVEALS; IDENTIFICATION; BACTERIA; GENE; RIBOSWITCHES; REPRESSION; EXPRESSION	The prevalence and characteristics of small regulatory RNAs (sRNAs) have not been well characterized for Bacillus subtilis, an important model system for Gram-positive bacteria. However, B. subtilis was recently found to synthesize many candidate sRNAs during stationary phase. In the current study, we performed deep sequencing on Hfq-associated RNAs and found that a small subset of sRNAs associates with Hfq, an enigmatic RNA-binding protein that stabilizes sRNAs in Gram-negatives, but whose role is largely unknown in Gram-positive bacteria. We also found that Hfq associated with antisense RNAs, antitoxin transcripts, and many mRNA leaders. Several new candidate sRNAs and mRNA leader regions were also discovered by this analysis. Additionally, mRNA fragments overlapping with start or stop codons associated with Hfq, while, in contrast, relatively few full-length mRNAs were recovered. Deletion of hfq reduced the intracellular abundance of several representative sRNAs, suggesting that B. subtilis Hfq-sRNA interactions may be functionally significant in vivo. In general, we anticipate this catalog of Hfq-associated RNAs to serve as a resource in the functional characterization of Hfq in B. subtilis.	[Dambach, Michael; Irnov, Irnov] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Winkler, Wade C.] Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University System of Maryland; University of Maryland College Park	Winkler, WC (corresponding author), Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA.	wwinkler@umd.edu		Irnov, Irnov/0000-0001-8631-4075	University of Texas Southwestern Medical Center Endowed Scholars Program; National Institutes of Health (NIH) [R01GM081882]; NIH T32 [GM008203]; Sara and Frank McKnight; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081882] Funding Source: NIH RePORTER	University of Texas Southwestern Medical Center Endowed Scholars Program; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH T32(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sara and Frank McKnight; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was funded in part by the University of Texas Southwestern Medical Center Endowed Scholars Program and National Institutes of Health (NIH) R01GM081882. MD was supported by the NIH T32 training grant GM008203. II was supported by the Sara and Frank McKnight graduate fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansong C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004809; Arnaud M, 2004, APPL ENVIRON MICROB, V70, P6887, DOI 10.1128/AEM.70.11.6887-6891.2004; Attia AS, 2008, INFECT IMMUN, V76, P2520, DOI 10.1128/IAI.01652-07; Barrick JE, 2004, P NATL ACAD SCI USA, V101, P6421, DOI 10.1073/pnas.0308014101; Barrick Jeffrey E., 2009, V540, P1, DOI 10.1007/978-1-59745-558-9_1; Bohn C, 2010, NUCLEIC ACIDS RES, V38, P6620, DOI 10.1093/nar/gkq462; Bouvier M, 2008, MOL CELL, V32, P827, DOI 10.1016/j.molcel.2008.10.027; Brennan RG, 2007, CURR OPIN MICROBIOL, V10, P125, DOI 10.1016/j.mib.2007.03.015; Chao YJ, 2012, EMBO J, V31, P4005, DOI 10.1038/emboj.2012.229; Chao YJ, 2010, CURR OPIN MICROBIOL, V13, P24, DOI 10.1016/j.mib.2010.01.001; Christiansen JK, 2006, RNA, V12, P1383, DOI 10.1261/rna.49706; Christiansen JK, 2004, J BACTERIOL, V186, P3355, DOI 10.1128/JB.186.11.3355-3362.2004; Dambach MD, 2009, CURR OPIN MICROBIOL, V12, P161, DOI 10.1016/j.mib.2009.01.012; Durand S, 2012, PLOS GENET, V8; Eiamphungporn W, 2009, J BACTERIOL, V191, P1101, DOI 10.1128/JB.01530-08; Fender A, 2010, GENE DEV, V24, P2621, DOI 10.1101/gad.591310; Fozo EM, 2010, NUCLEIC ACIDS RES, V38, P3743, DOI 10.1093/nar/gkq054; Fozo EM, 2008, MICROBIOL MOL BIOL R, V72, P579, DOI 10.1128/MMBR.00025-08; Gaballa A, 2008, P NATL ACAD SCI USA, V105, P11927, DOI 10.1073/pnas.0711752105; Gardner PP, 2009, NUCLEIC ACIDS RES, V37, pD136, DOI 10.1093/nar/gkn766; Geisinger E, 2006, MOL MICROBIOL, V61, P1038, DOI 10.1111/j.1365-2958.2006.05292.x; Geissmann T, 2009, NUCLEIC ACIDS RES, V37, P7239, DOI 10.1093/nar/gkp668; Gottesman S, 2010, COLD SPRING HARB PER; Heidrich N, 2007, NUCLEIC ACIDS RES, V35, P4331, DOI 10.1093/nar/gkm439; Heidrich N, 2006, MOL MICROBIOL, V62, P520, DOI 10.1111/j.1365-2958.2006.05384.x; Hopkins JF, 2011, NUCLEIC ACIDS RES, V39, P5193, DOI 10.1093/nar/gkr062; Huttenhofer A, 2006, COLD SPRING HARB SYM, V71, P135, DOI 10.1101/sqb.2006.71.007; Hwang W, 2011, NUCLEIC ACIDS RES, V39, P5131, DOI 10.1093/nar/gkr075; Irnov AK, 2006, COLD SH Q B, V71, P239, DOI 10.1101/sqb.2006.71.021; Irnov I, 2010, NUCLEIC ACIDS RES, V38, P6637, DOI 10.1093/nar/gkq454; Jahn N, 2012, MOL MICROBIOL, V83, P579, DOI 10.1111/j.1365-2958.2011.07952.x; Jarmer H, 2002, FEMS MICROBIOL LETT, V206, P197, DOI 10.1016/S0378-1097(01)00525-0; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Link TM, 2009, P NATL ACAD SCI USA, V106, P19286, DOI 10.1073/pnas.0908744106; Lorenz C, 2010, NUCLEIC ACIDS RES, V38, P3794, DOI 10.1093/nar/gkq032; Maki K, 2010, MOL MICROBIOL, V76, P782, DOI 10.1111/j.1365-2958.2010.07141.x; Mandal M, 2003, CELL, V113, P577, DOI 10.1016/S0092-8674(03)00391-X; MANTSALA P, 1992, J BACTERIOL, V174, P1883; Marchais A, 2011, RNA BIOL, V8, P358, DOI 10.4161/rna.8.3.14998; MELIN L, 1987, J BACTERIOL, V169, P3232, DOI 10.1128/jb.169.7.3232-3236.1987; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; NAKANO MM, 1991, J BACTERIOL, V173, P5487, DOI 10.1128/jb.173.17.5487-5493.1991; Nicolas P, 2012, SCIENCE, V335, P1103, DOI 10.1126/science.1206848; Nielsen JS, 2010, NUCLEIC ACIDS RES, V38, P907, DOI 10.1093/nar/gkp1081; Olsen AS, 2010, J MOL BIOL, V404, P173, DOI 10.1016/j.jmb.2010.09.038; Papenfort K, 2010, CELL HOST MICROBE, V8, P116, DOI 10.1016/j.chom.2010.06.008; Pfeiffer V, 2009, NAT STRUCT MOL BIOL, V16, P840, DOI 10.1038/nsmb.1631; Preis H, 2009, J BACTERIOL, V191, P5446, DOI 10.1128/JB.00602-09; Ramesh A, 2011, J MOL BIOL, V407, P556, DOI 10.1016/j.jmb.2011.01.049; Ramesh A, 2010, RNA BIOL, V7, P77, DOI 10.4161/rna.7.1.10490; Rasmussen S, 2009, MOL MICROBIOL, V73, P1043, DOI 10.1111/j.1365-2958.2009.06830.x; Romby P, 2010, CELL MOL LIFE SCI, V67, P217, DOI 10.1007/s00018-009-0162-8; Saito S, 2009, GENE, V428, P2, DOI 10.1016/j.gene.2008.09.024; Schilling D, 2009, J BACTERIOL, V191, P5553, DOI 10.1128/JB.00490-09; Schmalisch M, 2010, J BACTERIOL, V192, P5402, DOI 10.1128/JB.00534-10; Sharma CM, 2009, CURR OPIN MICROBIOL, V12, P536, DOI 10.1016/j.mib.2009.07.006; Silvaggi JM, 2005, J BACTERIOL, V188, P532; Sittka A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000163; Sittka A, 2007, MOL MICROBIOL, V63, P193, DOI 10.1111/j.1365-2958.2006.05489.x; Sittka A, 2009, RNA BIOL, V6, P266, DOI 10.4161/rna.6.3.8332; Smaidone GT, 2012, J BACTERIOL, V194, P2586, DOI 10.1128/JB.05567-11; Someya T, 2012, NUCLEIC ACIDS RES, V40, P1856, DOI 10.1093/nar/gkr892; Sonnleitner E, 2008, MICROBIOL-SGM, V154, P3175, DOI 10.1099/mic.0.2008/019703-0; Soper T, 2010, P NATL ACAD SCI USA, V107, P9602, DOI 10.1073/pnas.1004435107; Storz G, 2011, MOL CELL, V43, P880, DOI 10.1016/j.molcel.2011.08.022; Sun XG, 2002, NUCLEIC ACIDS RES, V30, P3662, DOI 10.1093/nar/gkf508; Toledo-Arana A, 2009, NATURE, V459, P950, DOI 10.1038/nature08080; Turnbough CL, 2008, MICROBIOL MOL BIOL R, V72, P266, DOI 10.1128/MMBR.00001-08; Valentin-Hansen P, 2004, MOL MICROBIOL, V51, P1525, DOI 10.1111/j.1365-2958.2003.03935.x; Vecerek B, 2008, NUCLEIC ACIDS RES, V36, P133, DOI 10.1093/nar/gkm985; Vogel J, 2011, NAT REV MICROBIOL, V9, P578, DOI 10.1038/nrmicro2615; Waters LS, 2009, CELL, V136, P615, DOI 10.1016/j.cell.2009.01.043; Winkler WC, 2007, BACILLUS CELLULAR MO, P167; Zhang AX, 2003, MOL MICROBIOL, V50, P1111, DOI 10.1046/j.1365-2958.2003.03734.x	74	50	52	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e55156	10.1371/journal.pone.0055156	http://dx.doi.org/10.1371/journal.pone.0055156			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457461	Green Published, Green Submitted, gold			2022-12-25	WOS:000315603700009
J	Rae, M; Grace, C; Hogg, K; Wilson, LM; McHaffie, SL; Ramaswamy, S; MacCallum, J; Connolly, F; McNeilly, AS; Duncan, C				Rae, Mick; Grace, Cathal; Hogg, Kirsten; Wilson, Lisa Marie; McHaffie, Sophie L.; Ramaswamy, Seshadri; MacCallum, Janis; Connolly, Fiona; McNeilly, Alan S.; Duncan, Colin			The Pancreas Is Altered by In Utero Androgen Exposure: Implications for Clinical Conditions Such as Polycystic Ovary Syndrome (PCOS)	PLOS ONE			English	Article							BETA-CELL FUNCTION; PRENATAL TESTOSTERONE EXCESS; GROWTH-FACTOR-II; INSULIN SENSITIVITY; FEMALE SHEEP; MATERNAL UNDERNUTRITION; NEUROENDOCRINE FUNCTION; METABOLIC DYSFUNCTION; GLUCOSE-HOMEOSTASIS; ISLET DEVELOPMENT	Using an ovine model of polycystic ovary syndrome (PCOS), (pregnant ewes injected with testosterone propionate (TP) (100 mg twice weekly) from day (d)62 to d102 of d147 gestation (maternal injection - MI-TP)), we previously reported female offspring with normal glucose tolerance but hyperinsulinemia. We therefore examined insulin signalling and pancreatic morphology in these offspring using quantitative (Q) RT-PCR and western blotting. In addition the fetal pancreatic responses to MI-TP, and androgenic and estrogenic contributions to such responses (direct fetal injection (FI) of TP (20 mg) or diethylstilbestrol (DES) (20 mg) at d62 and d82 gestation) were assessed at d90 gestation. Fetal plasma was assayed for insulin, testosterone and estradiol, pancreatic tissue was cultured, and expression of key beta-cell developmental genes was assessed by QRT-PCR. In female d62MI-TP offspring insulin signalling was unaltered but there was a pancreatic phenotype with increased numbers of beta-cells (P<0.05). The fetal pancreas expressed androgen receptors in islets and genes involved in beta-cell development and function (PDX1, IGF1R, INSR and INS) were up-regulated in female fetuses after d62MI-TP treatment (P<0.05-0.01). In addition the d62MI-TP pancreas showed increased insulin secretion under euglycaemic conditions (P<0.05) in vitro. The same effects were not seen in the male fetal pancreas or when MI-TP was started at d30, before the male programming window. As d62MI-TP increased both fetal plasma testosterone (P<0.05) and estradiol concentrations (P<0.05) we assessed the relative contribution of androgens and estrogens. FI-TP (commencing d62) (not FIDES treatment) caused elevated basal insulin secretion in vitro and the genes altered by d62MI-TP treatment were similarly altered by FI-TP but not FI-DES. In conclusion, androgen over-exposure alters fetal pancreatic development and beta-cell numbers in offspring. These data suggest that that there may be a primary pancreatic phenotype in models of PCOS, and that there may be a distinct male and female pancreas.	[Rae, Mick; Grace, Cathal; Wilson, Lisa Marie; Ramaswamy, Seshadri; MacCallum, Janis] Edinburgh Napier Univ, Sch Life Sport & Social Sci, Edinburgh, Midlothian, Scotland; [Hogg, Kirsten; McHaffie, Sophie L.; Connolly, Fiona; McNeilly, Alan S.; Duncan, Colin] Univ Edinburgh, Queens Med Res Inst, MRC Ctr Reprod Hlth, Edinburgh, Midlothian, Scotland	Edinburgh Napier University; University of Edinburgh	Rae, M (corresponding author), Edinburgh Napier Univ, Sch Life Sport & Social Sci, Edinburgh, Midlothian, Scotland.	m.rae@napier.ac.uk		McHaffie, Sophie/0000-0002-9088-2646	Medical Research Council (MRC) [G0500717]; MRC project grant [G0901807]; University of Edinburgh; SFC; MRC [G1100355, G1002033, G0901807, G0500717] Funding Source: UKRI; Medical Research Council [G0901807, G0500717, G1002033, G1100355] Funding Source: researchfish	Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC project grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Edinburgh; SFC; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by Medical Research Council (MRC) project grant (G0500717) to CD and ASM and MRC project grant (G0901807) to CD, MTR and ASM. KH has a University of Edinburgh CMVM studentship. CD is supported by a Scottish Senior Clinical Fellowship from the SFC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott DH, 2010, AM J PHYSIOL-ENDOC M, V299, pE741, DOI 10.1152/ajpendo.00058.2010; Abbott DH, 2005, HUM REPROD UPDATE, V11, P357, DOI 10.1093/humupd/dmi013; Alonso-Magdalena P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002069; Arslanian SA, 2001, J CLIN ENDOCR METAB, V86, P66, DOI 10.1210/jc.86.1.66; ATTAL J, 1969, ENDOCRINOLOGY, V85, P280, DOI 10.1210/endo-85-2-280; Babu DA, 2007, MOL GENET METAB, V92, P43, DOI 10.1016/j.ymgme.2007.06.008; BARNES RB, 1994, J CLIN ENDOCR METAB, V79, P1328, DOI 10.1210/jcem.79.5.7962325; Barry JA, 2010, J OBSTET GYNAECOL, V30, P444, DOI 10.3109/01443615.2010.485254; Birch RA, 2003, ENDOCRINOLOGY, V144, P1426, DOI 10.1210/en.2002-220965; Breant B, 2006, HORM RES, V65, P98, DOI 10.1159/000091513; Cao WH, 2010, AM J PHYSIOL-ENDOC M, V298, pE372, DOI 10.1152/ajpendo.00677.2009; Carter JD, 2009, BIOL PROCED ONLINE, V11, P3, DOI 10.1007/s12575-009-9021-0; Ciampelli M, 1997, HUM REPROD, V12, P1897, DOI 10.1093/humrep/12.9.1897; Colilla S, 2001, J CLIN ENDOCR METAB, V86, P2027, DOI 10.1210/jc.86.5.2027; de Miguel-Santos L, 2010, J MOL ENDOCRINOL, V44, P25, DOI 10.1677/JME-09-0045; Demissie M, 2008, AM J PHYSIOL-ENDOC M, V295, pE262, DOI 10.1152/ajpendo.90208.2008; Dickinson RE, 2008, ENDOCRINOLOGY, V149, P5024, DOI 10.1210/en.2008-0204; Dumesic DA, 2007, REV ENDOCR METAB DIS, V8, P127, DOI 10.1007/s11154-007-9046-0; Dunaif A, 1997, ENDOCR REV, V18, P774, DOI 10.1210/er.18.6.774; EHRMANN DA, 1995, J CLIN INVEST, V96, P520, DOI 10.1172/JCI118064; Eisner JR, 2000, J CLIN ENDOCR METAB, V85, P1206, DOI 10.1210/jc.85.3.1206; Ford SP, 2009, AM J PHYSIOL-REG I, V297, pR835, DOI 10.1152/ajpregu.00072.2009; FRANKS S, 1995, NEW ENGL J MED, V333, P853, DOI 10.1056/NEJM199509283331307; Fujimoto K, 2009, DIABETES OBES METAB, V11, P30, DOI 10.1111/j.1463-1326.2009.01121.x; Gatford KL, 2008, ENDOCRINOLOGY, V149, P5118, DOI 10.1210/en.2008-0233; Goodarzi MO, 2005, J CLIN ENDOCR METAB, V90, P310, DOI 10.1210/jc.2004-1006; Green AS, 2011, AM J PHYSIOL-ENDOC M, V300, pE817, DOI 10.1152/ajpendo.00572.2010; Hogg K, 2012, ENDOCRINOLOGY, V153, P450, DOI 10.1210/en.2011-1607; Hogg K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024877; HOLTE J, 1995, J CLIN ENDOCR METAB, V80, P2586, DOI 10.1210/jc.80.9.2586; Husted SM, 2008, DOMEST ANIM ENDOCRIN, V34, P419, DOI 10.1016/j.domaniend.2007.12.002; Li R, 2008, MAR GEOD, V31, P1, DOI 10.1080/01490410701860856; MCNATTY KP, 1976, J ENDOCRINOL, V71, P77, DOI 10.1677/joe.0.0710077; Melloul D, 2004, ANN NY ACAD SCI, V1014, P28, DOI 10.1196/annals.1294.003; Messer C, 2012, ENDOCR PRACT, V1, P1; Morimoto S, 2005, J ENDOCRINOL, V187, P217, DOI 10.1677/joe.1.06357; Morimoto S, 2001, ENDOCRINOLOGY, V142, P1442, DOI 10.1210/en.142.4.1442; Nadal A, 2009, MOL CELL ENDOCRINOL, V304, P63, DOI 10.1016/j.mce.2009.02.016; Padmanabhan V, 2006, MOL CELL ENDOCRINOL, V246, P165, DOI 10.1016/j.mce.2005.11.016; Padmanabhan V, 2010, ENDOCRINOLOGY, V151, P595, DOI 10.1210/en.2009-1015; Palomar-Morales M, 2010, PANCREAS, V39, P193, DOI 10.1097/MPA.0b013e3181c156d9; Petrik J, 1999, ENDOCRINOLOGY, V140, P4861, DOI 10.1210/en.140.10.4861; Petrik J, 1999, ENDOCRINOLOGY, V140, P2353, DOI 10.1210/en.140.5.2353; Quirke LD, 2001, BIOL REPROD, V65, P216, DOI 10.1095/biolreprod65.1.216; Rae MT, 2002, REPRODUCTION, V124, P33, DOI 10.1530/rep.0.1240033; Rajkhowa M, 2009, BIOCHEM J, V418, P665, DOI 10.1042/BJ20082176; Recabarren SE, 2005, AM J PHYSIOL-ENDOC M, V289, pE801, DOI 10.1152/ajpendo.00107.2005; Ren ZH, 2010, CELL BIOL INT, V34, P523, DOI 10.1042/CBI20090390; Roberts EK, 2008, BIOL REPROD, V79, P43, DOI 10.1095/biolreprod.107.067074; Robles-Diaz G, 2001, ISRAEL MED ASSOC J, V3, P364; Roland AV, 2010, J ENDOCRINOL, V207, P213, DOI 10.1677/JOE-10-0217; Savabieasfahani M, 2005, BIOL REPROD, V72, P221, DOI 10.1095/biolreprod.104.031070; Steckler T, 2007, ENDOCRINOLOGY, V148, P3532, DOI 10.1210/en.2007-0339	53	39	43	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56263	10.1371/journal.pone.0056263	http://dx.doi.org/10.1371/journal.pone.0056263			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457541	Green Submitted, Green Published, gold			2022-12-25	WOS:000315603700037
J	Varadarajan, S; Tanaka, K; Smalley, JL; Bampton, ETW; Pellecchia, M; Dinsdale, D; Willars, GB; Cohen, GM				Varadarajan, Shankar; Tanaka, Kayoko; Smalley, Joshua L.; Bampton, Edward T. W.; Pellecchia, Maurizio; Dinsdale, David; Willars, Gary B.; Cohen, Gerald M.			Endoplasmic Reticulum Membrane Reorganization Is Regulated by Ionic Homeostasis	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; SPINDLE POLE BODY; 2-AMINOETHOXYDIPHENYL BORATE; CA2+ ENTRY; CALMODULIN ANTAGONISTS; STRESS-RESPONSE; SMALL MOLECULES; CALCIUM-UPTAKE; CELLS; BCL-2	Recently we described a new, evolutionarily conserved cellular stress response characterized by a reversible reorganization of endoplasmic reticulum (ER) membranes that is distinct from canonical ER stress and the unfolded protein response (UPR). Apogossypol, a putative broad spectrum BCL-2 family antagonist, was the prototype compound used to induce this ER membrane reorganization. Following microarray analysis of cells treated with apogossypol, we used connectivity mapping to identify a wide range of structurally diverse chemicals from different pharmacological classes and established their ability to induce ER membrane reorganization. Such structural diversity suggests that the mechanisms initiating ER membrane reorganization are also diverse and a major objective of the present study was to identify potentially common features of these mechanisms. In order to explore this, we used hierarchical clustering of transcription profiles for a number of chemicals that induce membrane reorganization and discovered two distinct clusters. One cluster contained chemicals with known effects on Ca2+ homeostasis. Support for this was provided by the findings that ER membrane reorganization was induced by agents that either deplete ER Ca2+ (thapsigargin) or cause an alteration in cellular Ca2+ handling (calmodulin antagonists). Furthermore, overexpression of the ER luminal Ca2+ sensor, STIM1, also evoked ER membrane reorganization. Although perturbation of Ca2+ homeostasis was clearly one mechanism by which some agents induced ER membrane reorganization, influx of extracellular Na+ but not Ca2+ was required for ER membrane reorganization induced by apogossypol and the related BCL-2 family antagonist, TW37, in both human and yeast cells. Not only is this novel, non-canonical ER stress response evolutionary conserved but so also are aspects of the mechanism of formation of ER membrane aggregates. Thus perturbation of ionic homeostasis is important in the regulation of ER membrane reorganization.	[Varadarajan, Shankar; Smalley, Joshua L.; Bampton, Edward T. W.; Dinsdale, David; Cohen, Gerald M.] Univ Leicester, MRC Toxicol Unit, Leicester, Leics, England; [Tanaka, Kayoko; Cohen, Gerald M.] Univ Leicester, Dept Biochem, Leicester LE1 7RH, Leics, England; [Willars, Gary B.] Univ Leicester, Dept Cell Physiol & Pharmacol, Leicester LE1 9HN, Leics, England; [Pellecchia, Maurizio] Sanford Burnham Inst, La Jolla, CA USA	University of Leicester; University of Leicester; University of Leicester; Sanford Burnham Prebys Medical Discovery Institute	Cohen, GM (corresponding author), Univ Leicester, MRC Toxicol Unit, Leicester, Leics, England.	gmc2@le.ac.uk	Pellecchia, Maurizio/Y-7072-2018; Smalley, Joshua L./ABF-8150-2020	Smalley, Joshua/0000-0002-7437-6655; VARADARAJAN, SHANKAR/0000-0002-8827-6567; Tanaka, Kayoko/0000-0002-2905-3603; Smalley, Joshua/0000-0002-5642-3948	Medical Research Council	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The study was supported by the Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfa C, 1993, EXPT FISSION YEAST L; Barata H, 1999, MOL CELL BIOCHEM, V195, P227, DOI 10.1023/A:1006953126740; Bartolommei G, 2006, J BIOL CHEM, V281, P9547, DOI 10.1074/jbc.M510550200; Becattini B, 2004, CHEM BIOL, V11, P389, DOI 10.1016/j.chembiol.2004.02.020; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Berridge MJ, 2002, CELL CALCIUM, V32, P235, DOI 10.1016/S0143416002001823; Bilmen JG, 2002, BIOCHEM J, V366, P255, DOI 10.1042/bj20020431; Bootman MD, 2002, FASEB J, V16, DOI 10.1096/fj.02-0037rev; Borgese N, 2006, CURR OPIN CELL BIOL, V18, P358, DOI 10.1016/j.ceb.2006.06.008; Choi SY, 2001, BRIT J PHARMACOL, V132, P411, DOI 10.1038/sj.bjp.0703840; Dellis O, 2006, SCIENCE, V313, P229, DOI 10.1126/science.1125203; Distelhorst CW, 2004, ONCOGENE, V23, P2875, DOI 10.1038/sj.onc.1207519; ELENO N, 1987, AGENTS ACTIONS, V22, P189, DOI 10.1007/BF02009045; Funaya C, 2012, CURR BIOL, V22, P562, DOI 10.1016/j.cub.2012.02.042; Garty H, 1997, PHYSIOL REV, V77, P359, DOI 10.1152/physrev.1997.77.2.359; Gees M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003962; Godoy C, 1996, YEAST, V12, P983, DOI 10.1002/(SICI)1097-0061(199608)12:10<983::AID-YEA2>3.0.CO;2-D; Gonzalez Y, 2009, J CELL SCI, V122, P2464, DOI 10.1242/jcs.049999; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Gwack Y, 2007, J BIOL CHEM, V282, P16232, DOI 10.1074/jbc.M609630200; Hewavitharana T, 2008, J BIOL CHEM, V283, P26252, DOI 10.1074/jbc.M802239200; Hogan PG, 2010, ANNU REV IMMUNOL, V28, P491, DOI 10.1146/annurev.immunol.021908.132550; Hu HZ, 2004, J BIOL CHEM, V279, P35741, DOI 10.1074/jbc.M404164200; ITOH H, 1984, J BIOCHEM-TOKYO, V96, P1721, DOI 10.1093/oxfordjournals.jbchem.a135004; Khan SZ, 2000, BIOCHEM PHARMACOL, V60, P1797, DOI 10.1016/S0006-2952(00)00505-0; KLEYMAN TR, 1988, J MEMBRANE BIOL, V105, P1, DOI 10.1007/BF01871102; Kucherenko Y, 2012, CELL PHYSIOL BIOCHEM, V30, P407, DOI 10.1159/000339034; Kuum M, 2012, J CELL SCI, V125, P625, DOI 10.1242/jcs.090126; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; MARTINEZ F, 1993, COMP BIOCHEM PHYS C, V104, P165, DOI 10.1016/0742-8413(93)90129-9; Maruyama T, 1997, J BIOCHEM-TOKYO, V122, P498; Miwa S, 2000, CARDIOVASC DRUG REV, V18, P61; Peppiatt CM, 2004, BIOCHEM J, V381, P929, DOI 10.1042/BJ20040097; Pinton P, 2006, CELL DEATH DIFFER, V13, P1409, DOI 10.1038/sj.cdd.4401960; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rong Y, 2008, ANNU REV PHYSIOL, V70, P73, DOI 10.1146/annurev.physiol.70.021507.105852; Sammels E, 2010, CELL CALCIUM, V47, P297, DOI 10.1016/j.ceca.2010.02.001; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Scorrano L, 2003, SCIENCE, V300, P135, DOI 10.1126/science.1081208; Shore GC, 2011, CURR OPIN CELL BIOL, V23, P143, DOI 10.1016/j.ceb.2010.11.003; Shuttleworth TJ, 2009, CELL CALCIUM, V45, P602, DOI 10.1016/j.ceca.2009.02.001; Smyth JT, 2012, CURR BIOL, V22, P1487, DOI 10.1016/j.cub.2012.05.057; Snapp EL, 2003, J CELL BIOL, V163, P257, DOI 10.1083/jcb.200306020; Sprocati T, 2006, J CELL SCI, V119, P3249, DOI 10.1242/jcs.03058; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; TAKEI K, 1994, NEURON, V12, P327, DOI 10.1016/0896-6273(94)90275-5; Treiman M, 1998, TRENDS PHARMACOL SCI, V19, P131, DOI 10.1016/S0165-6147(98)01184-5; VANDONSELAAR M, 1994, NAT STRUCT BIOL, V1, P795, DOI 10.1038/nsb1194-795; Varadarajan S, 2012, CELL DEATH DIFFER, V19, P1896, DOI 10.1038/cdd.2012.108; Voeltz GK, 2006, CELL, V124, P573, DOI 10.1016/j.cell.2005.11.047; Vogler M, 2009, CELL DEATH DIFFER, V16, P360, DOI 10.1038/cdd.2008.137; Wang GP, 2006, J MED CHEM, V49, P6139, DOI 10.1021/jm060460o; WILCOX RA, 1993, MOL PHARMACOL, V44, P810; Xu SZ, 2005, BRIT J PHARMACOL, V145, P405, DOI 10.1038/sj.bjp.0706197	56	21	21	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56603	10.1371/journal.pone.0056603	http://dx.doi.org/10.1371/journal.pone.0056603			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457590	Green Published, Green Submitted, gold			2022-12-25	WOS:000315603700064
J	Faeh, D; Braun, J; Rufibach, K; Puhan, MA; Marques-Vidal, P; Bopp, M				Faeh, David; Braun, Julia; Rufibach, Kaspar; Puhan, Milo A.; Marques-Vidal, Pedro; Bopp, Matthias		SNC	Population Specific and Up to Date Cardiovascular Risk Charts Can Be Efficiently Obtained with Record Linkage of Routine and Observational Data	PLOS ONE			English	Article							EUROPEAN GUIDELINES; SCORE; MORTALITY; DISEASE; PREVENTION	Background: Only few countries have cohorts enabling specific and up-to-date cardiovascular disease (CVD) risk estimation. Individual risk assessment based on study samples that differ too much from the target population could jeopardize the benefit of risk charts in general practice. Our aim was to provide up-to-date and valid CVD risk estimation for a Swiss population using a novel record linkage approach. Methods: Anonymous record linkage was used to follow-up (for mortality, until 2008) 9,853 men and women aged 25-74 years who participated in the Swiss MONICA (MONItoring of trends and determinants in CVD) study of 1983-92. The linkage success was 97.8%, loss to follow-up 1990-2000 was 4.7%. Based on the ESC SCORE methodology (Weibull regression), we used age, sex, blood pressure, smoking, and cholesterol to generate three models. We compared the 1) original SCORE model with a 2) recalibrated and a 3) new model using the Brier score (BS) and cross-validation. Results: Based on the cross-validated BS, the new model (BS = 14107 x 10(-6)) was somewhat more appropriate for risk estimation than the original (BS = 14190 x 10(-6)) and the recalibrated (BS = 14172 x 10(-6)) model. Particularly at younger age, derived absolute risks were consistently lower than those from the original and the recalibrated model which was mainly due to a smaller impact of total cholesterol. Conclusion: Using record linkage of observational and routine data is an efficient procedure to obtain valid and up-to-date CVD risk estimates for a specific population.	[Faeh, David; Braun, Julia; Rufibach, Kaspar; Bopp, Matthias] Univ Zurich, Inst Social & Prevent Med, CH-8006 Zurich, Switzerland; [Puhan, Milo A.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Marques-Vidal, Pedro] Univ Lausanne Hosp, Inst Social & Prevent Med IUMSP, Lausanne, Switzerland	University of Zurich; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Bopp, M (corresponding author), Univ Zurich, Inst Social & Prevent Med, CH-8006 Zurich, Switzerland.	bopp@ifspm.uzh.ch	Puhan, Milo/ABE-6298-2020; Rufibach, Kaspar/F-1163-2010; Marques-Vidal, Pedro M/C-9449-2009	Puhan, Milo/0000-0003-4721-1879; Rufibach, Kaspar/0000-0002-2634-1167; Marques-Vidal, Pedro M/0000-0002-4548-8500; Bopp, Matthias/0000-0003-0766-3723	Swiss National Science Foundation [3347CO-108806, 33CS30-134273, 32473B-125710]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by the Swiss National Science Foundation (grants 3347CO-108806, 33CS30-134273, 32473B-125710). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bopp M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030795; Bopp M, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-562; Bopp M, 2009, INT J EPIDEMIOL, V38, P379, DOI 10.1093/ije/dyn042; Conroy RM, 2003, EUR HEART J, V24, P987, DOI 10.1016/S0195-668X(03)00114-3; Cook NR, 2007, CIRCULATION, V115, P928, DOI 10.1161/CIRCULATIONAHA.106.672402; Faeh D, 2009, J EPIDEMIOL COMMUN H, V63, P639, DOI 10.1136/jech.2008.081042; Faeh D, 2011, EUR J CARDIOVASC PRE; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Gaspoz JM, 2009, SUIVI FACTEURS RISQU; Gneiting T, 2007, J AM STAT ASSOC, V102, P359, DOI 10.1198/016214506000001437; Graham I, 2007, EUR J CARDIOV PREV R, V14, pS1, DOI 10.1097/01.hjr.0000277983.23934.c9; Hartz I, 2005, EUR HEART J, V26, P2673, DOI 10.1093/eurheartj/ehi556; Marques-Vidal P, 2008, EUR J CARDIOV PREV R, V15, P402, DOI 10.1097/HJR.0b013e3282fb040f; Menotti A, 2000, HEART, V84, P238, DOI 10.1136/heart.84.3.238; OECD, 2011, HLTH GLANC EUR 2010; Panagiotakos Demosthenes B, 2007, Hellenic J Cardiol, V48, P55; Sans S, 2007, REV ESP CARDIOL, V60, P476, DOI 10.1016/S1885-5857(07)60188-1; Steiger VS, 2009, SWISS MED WKLY, V139, P453, DOI smw-12607; Steyerberg E., 2009, CLIN PREDICTION MODE; Tunstall-Pedoe H., 2003, MONICA MONOGRAPH MUL; Wietlisbach V, 1997, PREV MED, V26, P523, DOI 10.1006/pmed.1997.0167; WIETLISBACH V, 1987, SOZ PRAVENTIV MED, V32, P52	22	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56149	10.1371/journal.pone.0056149	http://dx.doi.org/10.1371/journal.pone.0056149			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457516	Green Published, gold			2022-12-25	WOS:000315602700050
J	Kuhlmann, L; Foster, BL; Liley, DTJ				Kuhlmann, Levin; Foster, Brett L.; Liley, David T. J.			Modulation of Functional EEG Networks by the NMDA Antagonist Nitrous Oxide	PLOS ONE			English	Article							PROPOFOL ANESTHESIA; GENERAL-ANESTHESIA; CONNECTIVITY; MECHANISMS; GENUINE; STATES; INDEX; SLOW	Parietal networks are hypothesised to play a central role in the cortical information synthesis that supports conscious experience and behavior. Significant reductions in parietal level functional connectivity have been shown to occur during general anesthesia with propofol and a range of other GABAergic general anesthetic agents. Using two analysis approaches (1) a graph theoretic analysis based on surrogate-corrected zero-lag correlations of scalp EEG, and (2) a global coherence analysis based on the EEG cross-spectrum, we reveal that sedation with the NMDA receptor antagonist nitrous oxide (N2O), an agent that has quite different electroencephalographic effects compared to the inductive general anesthetics, also causes significant alterations in parietal level functional networks, as well as changes in full brain and frontal level networks. A total of 20 subjects underwent N2O inhalation at either 20%, 40% or 60% peak N2O/O-2 gas concentration levels. N2O-induced reductions in parietal network level functional connectivity (on the order of 50%) were exclusively detected by utilising a surface Laplacian derivation, suggesting that superficial, smaller spatial scale, cortical networks were most affected. In contrast reductions in frontal network functional connectivity were optimally discriminated using a common-reference derivation (reductions on the order of 10%), indicating that the NMDA antagonist N2O induces spatially coherent and widespread perturbations in frontal activity. Our findings not only give important weight to the idea of agent invariant final network changes underlying drug-induced reductions in consciousness, but also provide significant impetus for the application and development of multiscale functional analyses to systematically characterise the network level cortical effects of NMDA receptor related hypofunction. Future work at the source space level will be needed to verify the consistency between cortical network changes seen at the source level and those presented here at the EEG sensor space level.	[Kuhlmann, Levin; Liley, David T. J.] Swinburne Univ Technol, Brain & Psychol Sci Res Ctr, Hawthorn, Vic 3122, Australia; [Foster, Brett L.] Stanford Univ, Dept Neurol & Neurol Sci, Sch Med, Stanford, CA 94305 USA	Swinburne University of Technology; Stanford University	Liley, DTJ (corresponding author), Swinburne Univ Technol, Brain & Psychol Sci Res Ctr, Hawthorn, Vic 3122, Australia.	dliley@swin.edu.au	Kuhlmann, Levin/N-7418-2015; Kuhlmann, Levin/P-8769-2019	Kuhlmann, Levin/0000-0002-5108-6348; Kuhlmann, Levin/0000-0002-5108-6348	Swinburne University of Technology	Swinburne University of Technology	This work was supported by Swinburne University of Technology intramural funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkire MT, 2008, SCIENCE, V322, P876, DOI 10.1126/science.1149213; ALKIRE MT, 1995, ANESTHESIOLOGY, V82, P393, DOI 10.1097/00000542-199502000-00010; Barrett AB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029072; Bokil H, 2010, J NEUROSCI METH, V192; Boveroux P, 2010, ANESTHESIOLOGY, V113, P1038, DOI 10.1097/ALN.0b013e3181f697f5; Brown EN, 2011, ANNU REV NEUROSCI, V34, P601, DOI 10.1146/annurev-neuro-060909-153200; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Campagna JA, 2003, NEW ENGL J MED, V348, P2110, DOI 10.1056/NEJMra021261; Cimenser A, 2011, P NATL ACAD SCI USA, V108, P8832, DOI 10.1073/pnas.1017041108; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Deng S, 2012, IEEE T BIOMED ENG; Deshpande G, 2010, BRAIN RES, V1318, P110, DOI 10.1016/j.brainres.2009.12.075; FEIN G, 1988, ELECTROEN CLIN NEURO, V69, P581, DOI 10.1016/0013-4694(88)90171-X; FIELD LM, 1993, BRIT J ANAESTH, V70, P154, DOI 10.1093/bja/70.2.154; Fitzgibbon S., 2012, IEEE T BIOMED ENG; Foster BL, 2013, CLIN NEUROPHYSIOL, V124, P417, DOI 10.1016/j.clinph.2012.08.007; Foster BL, 2011, ANESTH ANALG, V113, P758, DOI 10.1213/ANE.0b013e318227b688; FRANKS NP, 1994, NATURE, V367, P607, DOI 10.1038/367607a0; Gorunescu F, 2011, INTEL SYST REF LIBR, P1, DOI 10.1007/978-3-642-19721-5; Greicius MD, 2008, HUM BRAIN MAPP, V29, P839, DOI 10.1002/hbm.20537; Hahn CG, 2006, NAT MED, V12, P824, DOI 10.1038/nm1418; HORNBEIN TF, 1982, ANESTH ANALG, V61, P553; Hudetz A, 2010, SUPPRESSING THE MIND: ANESTHETIC MODULATION OF MEMORY AND CONSCIOUSNESS, P1, DOI 10.1007/978-1-60761-462-3_1; Jain A. K., 1989, FUNDAMENTALS DIGITAL; Jelles B, 2008, CLIN NEUROPHYSIOL, V119, P837, DOI 10.1016/j.clinph.2007.12.002; Jevtovic-Todorovic V, 1998, NAT MED, V4, P460, DOI 10.1038/nm0498-460; John ER, 2001, CONSCIOUS COGN, V10, P165, DOI 10.1006/ccog.2001.0507; KATOH T, 1993, ANESTH ANALG, V77, P1012; Ku SW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025155; Lagerlund TD, 2005, ELECTROENCEPHALOGRAP, P829; Langsjo JW, 2012, J NEUROSCI, V32, P4935, DOI 10.1523/JNEUROSCI.4962-11.2012; Lee U, 2011, ANESTHESIOLOGY, V114, P872, DOI 10.1097/ALN.0b013e31821102c9; Messner M, 2003, ANESTH ANALG, V97, P488, DOI 10.1213/01.ANE.0000072741.78244.C0; Mitra P., 2007, OBSERVED BRAIN DYNAM; Muller M, 2008, EPL-EUROPHYS LETT, V84, DOI 10.1209/0295-5075/84/10009; Murphy M, 2011, SLEEP, V34, P283, DOI 10.1093/sleep/34.3.283; Murrough JW, 2010, NAT MED, V16, P1384, DOI 10.1038/nm1210-1384; Nolte G, 2004, CLIN NEUROPHYSIOL, V115, P2292, DOI 10.1016/j.clinph.2004.04.029; Nunez PL, 2005, ELECT FIELDS BRAIN N, DOI 10.1093/acprof:oso/9780195050387.001.0001; Percival Donald B., 1993, SPECTRAL ANAL PHYS A; Perouansky M, 2010, MILLERS ANESTHESIA, P515; Rampil IJ, 1998, ANESTHESIOLOGY, V89, P671, DOI 10.1097/00000542-199809000-00017; Reinstrup P, 2008, BRIT J ANAESTH, V100, P66, DOI 10.1093/bja/aem334; Rudolph U, 2004, NAT REV NEUROSCI, V5, P709, DOI 10.1038/nrn1496; Rummel C, 2010, J NEUROSCI METH, V191, P94, DOI 10.1016/j.jneumeth.2010.05.022; Sanders RD, 2012, ANESTHESIOLOGY, V116, P946, DOI 10.1097/ALN.0b013e318249d0a7; Schoffelen JM, 2009, HUM BRAIN MAPP, V30, P1857, DOI 10.1002/hbm.20745; Schreiber T, 2000, PHYSICA D, V142, P346, DOI 10.1016/S0167-2789(00)00043-9; Schroter M, 2012, J NEUROSCI, V32; Stephan KE, 2006, BIOL PSYCHIAT, V59, P929, DOI 10.1016/j.biopsych.2005.10.005; Tandonnet C, 2005, CLIN NEUROPHYSIOL, V116, P18, DOI 10.1016/j.clinph.2004.07.021; TINKER JH, 1977, ANESTHESIOLOGY, V46, P252, DOI 10.1097/00000542-197704000-00005; YAMAMURA T, 1981, ANESTH ANALG, V60, P283; Zhou X.H., 2002, STAT METHODS DIAGNOS, DOI 10.1002/9780470317082	54	21	22	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56434	10.1371/journal.pone.0056434	http://dx.doi.org/10.1371/journal.pone.0056434			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457568	Green Submitted, Green Published, gold			2022-12-25	WOS:000315602700073
J	van der Aa, NE; Benders, MJNL; Vincken, KL; Groenendaal, F; de Vries, LS				van der Aa, Niek E.; Benders, Manon J. N. L.; Vincken, Koen L.; Groenendaal, Floris; de Vries, Linda S.			The Course of Apparent Diffusion Coefficient Values following Perinatal Arterial Ischemic Stroke	PLOS ONE			English	Article							NEONATAL CEREBRAL INFARCTION; MAGNETIC-RESONANCE; HYPOXIA-ISCHEMIA; BRAIN-INJURY; TENSOR MRI; TRANSIENT; EVOLUTION; LESIONS; TIME; INSIGHTS	Background: Diffusion weighted MR imaging (DWI) plays an important role in the diagnosis of perinatal arterial ischemic stroke (PAIS) during the acute phase. Its derived apparent diffusion coefficient (ADC) can be used to quantify the diffusion restriction. Aim of the current study was to identify the changes in ADC values in the acute phase following PAIS. Methods: A cohort of 36 infants with a confirmed PAIS who were examined once during the first ten days of life was studied. ADC values in the core of the ischemic tissue (iADC) were determined and correlated with postnatal age. ADC ratios (rADC) were calculated by dividing the iADC value by the ADC value of the corresponding area in the contralateral 'healthy' hemisphere. Results: Infants were scanned between days two and ten. A non-linear increase in iADC and rADC values was observed over time and large middle cerebral artery strokes resulted in lower iADC and rADC values. Normalisation of rADC values was observed after day seven. rADC values were lower when compared to previously published rADC values of infants with hypoxic ischemic encephalopathy, suggesting more severe injury. Conclusions: Following PAIS, DWI showed decreased ADC values with a non-linear increase during the first week, and pseudonormalization after day 7, which limits the use of DWI to assess PAIS to the first week. Compared to previous studies, ADC values were lower when compared to infants with hypoxic ischemic encephalopathy, most likely due to more severe injury.	[van der Aa, Niek E.; Benders, Manon J. N. L.; Groenendaal, Floris; de Vries, Linda S.] Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Dept Neonatol, Utrecht, Netherlands; [Vincken, Koen L.] Univ Med Ctr, Image Sci Inst, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; Utrecht University; Utrecht University Medical Center	de Vries, LS (corresponding author), Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Dept Neonatol, Utrecht, Netherlands.	l.s.devries@umcutrecht.nl	Vincken, Koen/AAP-3558-2021; de Vries, Linda S/AAB-6454-2021; Groenendaal, Floris/P-6872-2019	Groenendaal, Floris/0000-0002-9284-1637	Wilhelmina Childrens' Hospital Research fund; Dutch Phelps Foundation	Wilhelmina Childrens' Hospital Research fund; Dutch Phelps Foundation	NE van der Aa was supported by grants of the Wilhelmina Childrens' Hospital Research fund and of the Dutch Phelps Foundation (www.phelps-stichting.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderliesten T, 2011, RADIOLOGY, V261, P235, DOI 10.1148/radiol.11110213; Amiel-Tison C, 1986, NEUROLOGICAL ASSESSM; An HY, 2011, STROKE, V42, P1276, DOI 10.1161/STROKEAHA.110.610501; Bednarek N, 2012, NEUROLOGY, V78, P1420, DOI 10.1212/WNL.0b013e318253d589; Berman JI, 2005, NEUROIMAGE, V27, P862, DOI 10.1016/j.neuroimage.2005.05.018; Chabrier S, 2011, THROMB RES, V127, P13, DOI 10.1016/j.thromres.2010.10.003; CLAEYS V, 1983, HELV PAEDIATR ACTA, V38, P439; COWAN EM, 1994, NEUROPEDIATRICS, V25, P172, DOI 10.1055/s-2008-1073018; Cowan F, 2005, ARCH DIS CHILD-FETAL, V90, P252, DOI 10.1136/adc.2004.055558; De Vries LS, 2005, NEUROPEDIATRICS, V36, P12, DOI 10.1055/s-2005-837544; Dudink J, 2009, AM J NEURORADIOL, V30, P998, DOI 10.3174/ajnr.A1480; Gadian DG, 2000, J CHILD NEUROL, V15, P279, DOI 10.1177/088307380001500502; Govaert P, 2008, NEUROIMAGE, V39, P1850, DOI 10.1016/j.neuroimage.2007.10.056; Griffiths R., 1976, ABILITIES BABIES STU; Groenendaal F, 2006, SEMIN PERINATOL, V30, P146, DOI 10.1053/j.semperi.2006.04.005; Gunn AJ, 2008, CURR OPIN OBSTET GYN, V20, P175, DOI 10.1097/GCO.0b013e3282f4ef9e; Haku T, 2006, BRAIN RES, V1100, P136, DOI 10.1016/j.brainres.2006.05.018; HASEGAWA Y, 1994, NEUROLOGY, V44, P1484, DOI 10.1212/WNL.44.8.1484; Thierry AGM, 2006, EUR RADIOL, V16, P1651, DOI 10.1007/s00330-006-0175-8; Husson B, 2010, PEDIATRICS, V126, pE912, DOI 10.1542/peds.2009-3611; Kirton A, 2007, STROKE, V38, P974, DOI 10.1161/01.STR.0000258101.67119.72; Kirton A, 2011, PEDIATRICS, V128, pE1402, DOI 10.1542/peds.2011-1148; Kuker W, 2004, CHILD NERV SYST, V20, P742, DOI 10.1007/s00381-004-0988-1; Li FH, 2000, STROKE, V31, P946, DOI 10.1161/01.STR.31.4.946; Liu YR, 2007, STROKE, V38, P138, DOI 10.1161/01.STR.0000252127.07428.9c; Mader I, 2002, STROKE, V33, P1142, DOI 10.1161/hs0402.105883; McKinstry RC, 2002, NEUROLOGY, V59, P824, DOI 10.1212/WNL.59.6.824; Mercuri E, 2004, PEDIATRICS, V113, P95, DOI 10.1542/peds.113.1.95; Nelson KB, 2004, LANCET NEUROL, V3, P150, DOI 10.1016/S1474-4422(04)00679-9; Neumann-Haefelin T, 2000, STROKE, V31, P1965, DOI 10.1161/01.STR.31.8.1965; Ramaswamy V, 2004, NEUROLOGY, V62, P2088, DOI 10.1212/01.WNL.0000129909.77753.C4; REITH W, 1995, NEUROLOGY, V45, P172, DOI 10.1212/WNL.45.1.172; Robertson RL, 1999, AM J NEURORADIOL, V20, P1658; Rumpel H, 1997, PEDIATR RES, V42, P54, DOI 10.1203/00006450-199707000-00009; Rutherford M, 2004, PEDIATRICS, V114, P1004, DOI 10.1542/peds.2004-0222; Rutherford M, 2010, LANCET NEUROL, V9, P39, DOI 10.1016/S1474-4422(09)70295-9; Schlaug G, 1999, NEUROLOGY, V53, P1528, DOI 10.1212/WNL.53.7.1528; Schulzke S, 2005, J PERINAT MED, V33, P170, DOI 10.1515/JPM.2005.032; Touwen B. C. L, 1979, EXAMINATION CHILD MI; Winbeck K, 2004, STROKE, V35, P1095, DOI 10.1161/01.STR.0000125720.02983.fe; Winter JD, 2007, PEDIATR NEUROL, V37, P255, DOI 10.1016/j.pediatrneurol.2007.06.005; Wintermark P, 2012, TRANSL STROKE RES, V3, P255, DOI 10.1007/s12975-011-0122-0; Wu YW, 2005, SEMIN NEUROL, V25, P424, DOI 10.1055/s-2005-923536	43	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56784	10.1371/journal.pone.0056784	http://dx.doi.org/10.1371/journal.pone.0056784			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457613	Green Published, gold, Green Submitted			2022-12-25	WOS:000315602700093
J	Patil, AGG; Sang, PB; Govindan, A; Varshney, U				Patil, Aravind Goud G.; Sang, Pau Biak; Govindan, Ashwin; Varshney, Umesh			Mycobacterium tuberculosis MutT1 (Rv2985) and ADPRase (Rv1700) Proteins Constitute a Two-stage Mechanism of 8-Oxo-dGTP and 8-Oxo-GTP Detoxification and Adenosine to Cytidine Mutation Avoidance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUDIX HYDROLASE; MUTAGENIC SUBSTRATE; ESCHERICHIA-COLI; OXIDATIVE STRESS; HYDROLYZES; STRAINS; FORMS; MICE; MTH1	Approximately one third of the world population is infected with Mycobacterium tuberculosis, the causative agent of tuberculosis. A better understanding of the pathogen biology is crucial to develop new tools/strategies to tackle its spread and treatment. In the host macrophages, the pathogen is exposed to reactive oxygen species, known to damage dGTP and GTP to 8-oxo-dGTP and 8-oxo-GTP, respectively. Incorporation of the damaged nucleotides in nucleic acids is detrimental to organisms. MutT proteins, belonging to a class of Nudix hydrolases, hydrolyze 8-oxo-G nucleoside triphosphates/diphosphates to the corresponding nucleoside monophosphates and sanitize the nucleotide pool. Mycobacteria possess several MutT proteins. However, a functional homolog of Escherichia coli MutT has not been identified. Here, we characterized MtuMutT1 and Rv1700 proteins of M. tuberculosis. Unlike other MutT proteins, MtuMutT1 converts 8-oxo-dGTP to 8-oxo-dGDP, and 8-oxo-GTP to 8-oxo-GDP. Rv1700 then converts them to the corresponding nucleoside monophosphates. This observation suggests the presence of a two-stage mechanism of 8-oxo-dGTP/8-oxo-GTP detoxification in mycobacteria. MtuMutT1 converts 8-oxo-dGTP to 8-oxo-dGDP with a K-m of similar to 50 mu M and V-max of similar to 0.9 pmol/min per ng of protein, and Rv1700 converts 8-oxo-dGDP to 8-oxo-dGMP with a K-m of similar to 9.5 mu M and V-max of similar to 0.04 pmol/min per ng of protein. Together, MtuMutT1 and Rv1700 offer maximal rescue to E. coli for its MutT deficiency by decreasing A to C mutations (a hallmark of MutT deficiency). We suggest that the concerted action of MtuMutT1 and Rv1700 plays a crucial role in survival of bacteria against oxidative stress.	[Patil, Aravind Goud G.; Sang, Pau Biak; Govindan, Ashwin; Varshney, Umesh] Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India; [Varshney, Umesh] Jawaharlal Nehru Ctr Adv Sci Res, Bangalore 560064, Karnataka, India	Indian Institute of Science (IISC) - Bangalore; Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR)	Varshney, U (corresponding author), Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India.	varshney@mcbl.iisc.ernet.in	Sang, Pau Biak/AAK-7980-2021; Govindan, Ashwin/M-5897-2014; Sang, Pau Biak/ABB-3621-2021; Varshney, Umesh/Q-6914-2019	Sang, Pau Biak/0000-0001-7261-5117; Govindan, Ashwin/0000-0003-1759-707X; Sang, Pau Biak/0000-0001-7261-5117; 	Department of Biotechnology, New Delhi; Council of Scientific and Industrial Research, New Delhi	Department of Biotechnology, New Delhi(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research, New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by grants from the Department of Biotechnology, New Delhi, and the Council of Scientific and Industrial Research, New Delhi.	AKIYAMA M, 1989, P NATL ACAD SCI USA, V86, P3949, DOI 10.1073/pnas.86.11.3949; Arif SM, 2012, ACTA CRYSTALLOGR F, V68, P1214, DOI 10.1107/S1744309112035804; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; CUPPLES CG, 1989, P NATL ACAD SCI USA, V86, P5345, DOI 10.1073/pnas.86.14.5345; David SS, 2007, NATURE, V447, P941, DOI 10.1038/nature05978; Dos Vultos T, 2006, J BACTERIOL, V188, P3159, DOI 10.1128/JB.188.8.3159-3161.2006; Dye C, 1999, JAMA-J AM MED ASSOC, V282, P677, DOI 10.1001/jama.282.7.677; Egashira A, 2001, Tanpakushitsu Kakusan Koso, V46, P1162; Ehrt S, 2009, CELL MICROBIOL, V11, P1170, DOI 10.1111/j.1462-5822.2009.01335.x; Foti JJ, 2012, SCIENCE, V336, P315, DOI 10.1126/science.1219192; FRAGA CG, 1990, P NATL ACAD SCI USA, V87, P4533, DOI 10.1073/pnas.87.12.4533; Gonzalez-Juarrero M, 2011, TUBERCULOSIS, V91, P86, DOI 10.1016/j.tube.2010.08.007; Jain R, 2007, DNA REPAIR, V6, P1774, DOI 10.1016/j.dnarep.2007.06.009; Kang LW, 2003, STRUCTURE, V11, P1015, DOI 10.1016/S0969-2126(03)00154-0; Kurthkoti K, 2010, MICROBIOL-SGM, V156, P88, DOI 10.1099/mic.0.033621-0; MAKI H, 1992, NATURE, V355, P273, DOI 10.1038/355273a0; McLennan AG, 2006, CELL MOL LIFE SCI, V63, P123, DOI 10.1007/s00018-005-5386-7; Mishima M, 2004, J BIOL CHEM, V279, P33806, DOI 10.1074/jbc.M402393200; Moreland NJ, 2009, BIOCHEMISTRY-US, V48, P699, DOI 10.1021/bi8009554; Nakamura T, 2010, J BIOL CHEM, V285, P444, DOI 10.1074/jbc.M109.066373; Rao AR, 2001, EMBO J, V20, P2977, DOI 10.1093/emboj/20.11.2977; Sakamoto K, 2007, CANCER RES, V67, P6599, DOI 10.1158/0008-5472.CAN-06-4802; SAKUMI K, 1993, J BIOL CHEM, V268, P23524; Sang PB, 2013, J BACTERIOL, V195, P1552, DOI 10.1128/JB.02102-12; Takagi Y, 2012, J BIOL CHEM, V287, P21541, DOI 10.1074/jbc.M112.363010; Tsuzuki T, 2001, MUTAT RES-FUND MOL M, V477, P71, DOI 10.1016/S0027-5107(01)00108-7; Tsuzuki T, 2007, CANCER SCI, V98, P465, DOI 10.1111/j.1349-7006.2007.00409.x; Velayati AA, 2009, CHEST, V136, P420, DOI 10.1378/chest.08-2427; Xu P, 2003, J BIOL CHEM, V278, P48422, DOI 10.1074/jbc.M307888200	31	26	28	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2013	288	16					11252	11262		10.1074/jbc.M112.442566	http://dx.doi.org/10.1074/jbc.M112.442566			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	130KW	23463507	hybrid, Green Published			2022-12-25	WOS:000317915500028
J	Smulski, CR; Beyrath, J; Decossas, M; Chekkat, N; Wolff, P; Estieu-Gionnet, K; Guichard, G; Speiser, D; Schneider, P; Fournel, S				Smulski, Cristian R.; Beyrath, Julien; Decossas, Marion; Chekkat, Neila; Wolff, Philippe; Estieu-Gionnet, Karine; Guichard, Gilles; Speiser, Daniel; Schneider, Pascal; Fournel, Sylvie			Cysteine-rich Domain 1 of CD40 Mediates Receptor Self-assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGAND; REQUIREMENT; DIMERIZATION; HOMODIMERS; PROTEIN	The activation of CD40 on B cells, macrophages, and dendritic cells by its ligand CD154 (CD40L) is essential for the development of humoral and cellular immune responses. CD40L and other TNF superfamily ligands are noncovalent homotrimers, but the form under which CD40 exists in the absence of ligand remains to be elucidated. Here, we show that both cell surface-expressed and soluble CD40 self-assemble, most probably as noncovalent dimers. The cysteine-rich domain 1 (CRD1) of CD40 participated to dimerization and was also required for efficient receptor expression. Modelization of a CD40 dimer allowed the identification of lysine 29 in CRD1, whose mutation decreased CD40 self-interaction without affecting expression or response to ligand. When expressed alone, recombinant CD40-CRD1 bound CD40 with a K-D of 0.6 mu M. This molecule triggered expression of maturation markers on human dendritic cells and potentiated CD40L activity. These results suggest that CD40 self-assembly modulates signaling, possibly by maintaining the receptor in a quiescent state.	[Smulski, Cristian R.; Beyrath, Julien; Decossas, Marion; Chekkat, Neila; Fournel, Sylvie] CNRS, UPR 9021, Inst Biol Mol & Cellulaire Immunol & Chim Therape, F-67084 Strasbourg, France; [Wolff, Philippe] Inst Biol Mol & Cellulaire, F-67084 Strasbourg, France; [Estieu-Gionnet, Karine; Guichard, Gilles] Univ Bordeaux 1, Inst Europeen Chim & Biol CBMN, CNRS, UMR 5248, F-33607 Pessac, France; [Speiser, Daniel] Univ Lausanne, Dept Oncol, CH-1011 Lausanne, Switzerland; [Speiser, Daniel] Univ Lausanne, Ludwig Ctr Canc Res, CH-1011 Lausanne, Switzerland; [Smulski, Cristian R.; Schneider, Pascal] Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite de Bordeaux; University of Lausanne; University of Lausanne; University of Lausanne	Smulski, CR (corresponding author), Univ Lausanne, Dept Biochem, Boveresses 155, CH-1066 Epalinges, Switzerland.	cristianroberto.smulski@unil.ch; s.fournel@unistra.fr	GUICHARD, Gilles/I-3858-2016; Speiser, Daniel E./F-2173-2013; Fournel, Sylvie/C-1195-2014	GUICHARD, Gilles/0000-0002-2584-7502; Fournel, Sylvie/0000-0003-3583-6548; Schneider, Pascal/0000-0003-0677-9409; decossas, marion/0000-0003-0810-4309; Smulski, Cristian/0000-0003-4186-8116	Centre National de la Recherche Scientifique; Swiss National Science Foundation; Agence Nationale Recherche [ANR-08-PCVI-0034-01]; Agence Nationale de la Recherche; University of Strasbourg; French Ministere de la Recherche	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Agence Nationale Recherche(French National Research Agency (ANR)); Agence Nationale de la Recherche(French National Research Agency (ANR)); University of Strasbourg; French Ministere de la Recherche(Ministry of Research, France)	This work was supported by the Centre National de la Recherche Scientifique (to S. F. and G. G.), the Swiss National Science Foundation (to P. S.), and the Agence Nationale Recherche Grant ANR-08-PCVI-0034-01) (to G. G.).; Recipient of grants from the Agence Nationale de la Recherche and the University of Strasbourg. To whom correspondence may be sent at the present address: Dept. of Biochemistry, University of Lausanne, Boveresses 155, CH-1066 Epalinges, Switzerland. Tel.: 41-216925743; Fax: 41-216925705; E-mail: cristianroberto.smulski@unil.ch.; Recipient of a grant from the French Ministere de la Recherche.	An HJ, 2011, J BIOL CHEM, V286, P11226, DOI 10.1074/jbc.M110.208215; Banning C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009344; Bodmer JL, 2002, TRENDS BIOCHEM SCI, V27, P19, DOI 10.1016/S0968-0004(01)01995-8; Cardoso LS, 2007, MICROB CELL FACT, V6, DOI 10.1186/1475-2859-6-1; Chan FKM, 2000, SCIENCE, V288, P2351, DOI 10.1126/science.288.5475.2351; Clancy L, 2005, P NATL ACAD SCI USA, V102, P18099, DOI 10.1073/pnas.0507329102; Compaan DM, 2005, J BIOL CHEM, V280, P39553, DOI 10.1074/jbc.M507629200; Deng GM, 2005, NAT MED, V11, P1066, DOI 10.1038/nm1304; Girouard J, 2005, MOL IMMUNOL, V42, P773, DOI 10.1016/j.molimm.2004.07.048; Haswell LE, 2001, EUR J IMMUNOL, V31, P3094, DOI 10.1002/1521-4141(2001010)31:10<3094::AID-IMMU3094>3.0.CO;2-F; HELDIN CH, 1995, CELL, V80, P213, DOI 10.1016/0092-8674(95)90404-2; Holler N, 2003, MOL CELL BIOL, V23, P1428, DOI 10.1128/MCB.23.4.1428-1440.2003; Naismith JH, 1996, STRUCTURE, V4, P1251, DOI 10.1016/S0969-2126(96)00134-7; NAISMITH JH, 1995, J BIOL CHEM, V270, P13303, DOI 10.1074/jbc.270.22.13303; Pullen SS, 1999, BIOCHEMISTRY-US, V38, P10168, DOI 10.1021/bi9909905; Pullen SS, 1998, BIOCHEMISTRY-US, V37, P11836, DOI 10.1021/bi981067q; Reyes-Moreno C, 2004, J BIOL CHEM, V279, P7799, DOI 10.1074/jbc.M313168200; Reyes-Moreno C, 2007, J BIOL CHEM, V282, P19473, DOI 10.1074/jbc.M701076200; RichaletSecordel PM, 1997, ANAL BIOCHEM, V249, P165, DOI 10.1006/abio.1997.2183; Siegel RM, 2000, SCIENCE, V288, P2354, DOI 10.1126/science.288.5475.2354; Smulski C, 2006, FASEB J, V20, P1396, DOI 10.1096/fj.05-5699com; Tetsch L, 2009, AMINO ACIDS, V37, P467, DOI 10.1007/s00726-009-0235-x; van Kooten C, 2000, J LEUKOCYTE BIOL, V67, P2, DOI 10.1002/jlb.67.1.2; Wu YL, 2003, INT J CANCER, V105, P724, DOI 10.1002/ijc.11138; Zhan CY, 2011, STRUCTURE, V19, P162, DOI 10.1016/j.str.2010.12.004	25	23	24	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2013	288	15					10914	10922		10.1074/jbc.M112.427583	http://dx.doi.org/10.1074/jbc.M112.427583			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	125TU	23463508	Green Published, Green Accepted, hybrid			2022-12-25	WOS:000317565000068
J	Frieboes, HB; Wu, M; Lowengrub, J; Decuzzi, P; Cristini, V				Frieboes, Hermann B.; Wu, Min; Lowengrub, John; Decuzzi, Paolo; Cristini, Vittorio			A Computational Model for Predicting Nanoparticle Accumulation in Tumor Vasculature	PLOS ONE			English	Article							INDUCED ANGIOGENESIS; SOLID TUMORS; MACROMOLECULAR THERAPEUTICS; TUMORITROPIC ACCUMULATION; NONLINEAR SIMULATION; COMPUTER-SIMULATION; GROWTH; DELIVERY; DRUG; STRATEGIES	Vascular targeting of malignant tissues with systemically injected nanoparticles (NPs) holds promise in molecular imaging and anti-angiogenic therapies. Here, a computational model is presented to predict the development of tumor neovasculature over time and the specific, vascular accumulation of blood-borne NPs. A multidimensional tumor-growth model is integrated with a mesoscale formulation for the NP adhesion to blood vessel walls. The fraction of injected NPs depositing within the diseased vasculature and their spatial distribution is computed as a function of tumor stage, from 0 to day 24 post-tumor inception. As the malignant mass grows in size, average blood flow and shear rates increase within the tumor neovasculature, reaching values comparable with those measured in healthy, pre-existing vessels already at 10 days. The NP vascular affinity, interpreted as the likelihood for a blood-borne NP to firmly adhere to the vessel walls, is a fundamental parameter in this analysis and depends on NP size and ligand density, and vascular receptor expression. For high vascular affinities, NPs tend to accumulate mostly at the inlet tumor vessels leaving the inner and outer vasculature depleted of NPs. For low vascular affinities, NPs distribute quite uniformly intra-tumorally but exhibit low accumulation doses. It is shown that an optimal vascular affinity can be identified providing the proper balance between accumulation dose and uniform spatial distribution of the NPs. This balance depends on the stage of tumor development (vascularity and endothelial receptor expression) and the NP properties (size, ligand density and ligand-receptor molecular affinity). Also, it is demonstrated that for insufficiently developed vascular networks, NPs are transported preferentially through the healthy, pre-existing vessels, thus bypassing the tumor mass. The computational tool described here can effectively select an optimal NP formulation presenting high accumulation doses and uniform spatial intra-tumor distributions as a function of the development stage of the malignancy.	[Frieboes, Hermann B.] Univ Louisville, Dept Bioengn, Louisville, KY 40292 USA; [Frieboes, Hermann B.] Univ Louisville, James Graham Brown Canc Ctr, Louisville, KY 40292 USA; [Frieboes, Hermann B.; Cristini, Vittorio] Univ New Mexico, Dept Pathol, Albuquerque, NM 87131 USA; [Wu, Min; Lowengrub, John] Univ Calif Irvine, Dept Math, Irvine, CA 92717 USA; [Decuzzi, Paolo] Methodist Hosp, Res Inst, Dept Translat Imaging, Houston, TX 77030 USA; [Decuzzi, Paolo] Methodist Hosp, Res Inst, Dept Nanomed, Houston, TX 77030 USA; [Cristini, Vittorio] Univ New Mexico, Dept Chem Engn, Albuquerque, NM 87131 USA	University of Louisville; University of Louisville; University of New Mexico; University of California System; University of California Irvine; The Methodist Hospital System; The Methodist Hospital - Houston; The Methodist Hospital System; The Methodist Hospital - Houston; University of New Mexico	Frieboes, HB (corresponding author), Univ Louisville, Dept Bioengn, Louisville, KY 40292 USA.	hbfrie01@louisville.edu	Cristini, Vittorio/N-3540-2013; Decuzzi, Paolo/F-1899-2016	Decuzzi, Paolo/0000-0001-6050-4188; Cristini, Vittorio/0000-0002-7909-4278; Wu, Min/0000-0003-4728-6475	National Institutes of Health/National Cancer Institute (NIH/NCI) Physical Sciences - Oncology Center (PS-OC) Young Investigator Trans-Network, Methodist [U54CA143837]; University of Southern California (USC) PS-OC Centers [U54CA143907]; National Science Foundation (NSF), Division of Mathematical Sciences; NIH [P50GM76516]; Center of Excellence in Systems Biology at the University of California, Irvine.; NIH/NCI PS-OC [U54CA143837]; National Institutes of Health Integrative Cancer Biology Program (NIH-ICBP) [U54CA151668]; Cullen Trust for Health Care; NIH-ICBP [U54CA149196]; NSF [DMS-0818104]; NATIONAL CANCER INSTITUTE [U54CA151668, U54CA149196, U54CA143837, U54CA143907] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM076516] Funding Source: NIH RePORTER	National Institutes of Health/National Cancer Institute (NIH/NCI) Physical Sciences - Oncology Center (PS-OC) Young Investigator Trans-Network, Methodist; University of Southern California (USC) PS-OC Centers; National Science Foundation (NSF), Division of Mathematical Sciences(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center of Excellence in Systems Biology at the University of California, Irvine.; NIH/NCI PS-OC(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Integrative Cancer Biology Program (NIH-ICBP); Cullen Trust for Health Care; NIH-ICBP; NSF(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health/National Cancer Institute (NIH/NCI) Physical Sciences - Oncology Center (PS-OC) Young Investigator Trans-Network Award to HF as a part of the Methodist (U54CA143837) and University of Southern California (USC) (U54CA143907) PS-OC Centers. JL acknowledges funding by the National Science Foundation (NSF), Division of Mathematical Sciences, and NIH grant P50GM76516 for a Center of Excellence in Systems Biology at the University of California, Irvine. PD acknowledges funding by NIH/NCI PS-OC grant U54CA143837 and National Institutes of Health Integrative Cancer Biology Program (NIH-ICBP) grant U54CA151668. VC acknowledges funding by the Cullen Trust for Health Care, NIH/NCI PS-OC grant U54CA143837, NIH-ICBP grant U54CA149196, and NSF grant DMS-0818104. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen TM, 2004, SCIENCE, V303, P1818, DOI 10.1126/science.1095833; Anderson ARA, 1998, B MATH BIOL, V60, P857, DOI 10.1006/bulm.1998.0042; AUERBACH R, 1991, INT J RADIAT BIOL, V60, P1, DOI 10.1080/09553009114551401; Boso DP, 2011, INT J NANOMED, V6, P1517, DOI 10.2147/IJN.S20283; Caputo KE, 2005, BIOPHYS J, V89, P187, DOI 10.1529/biophysj.104.054171; Cristini V, 2003, J MATH BIOL, V46, P191, DOI 10.1007/s00285-002-0174-6; Decuzzi P, 2006, BIOMATERIALS, V27, P5307, DOI 10.1016/j.biomaterials.2006.05.024; Decuzzi P, 2009, PHARM RES-DORD, V26, P235, DOI 10.1007/s11095-008-9697-x; Drummond DC, 1999, PHARMACOL REV, V51, P691; Ferrari M, 2005, NAT REV CANCER, V5, P161, DOI 10.1038/nrc1566; Frieboes HB, 2006, CANCER RES, V66, P1597, DOI 10.1158/0008-5472.CAN-05-3166; Frieboes HB, 2007, NEUROIMAGE, V37, pS59, DOI 10.1016/j.neuroimage.2007.03.008; Frieboes HB, 2011, CANCER RES, V71, P298, DOI 10.1158/0008-5472.CAN-10-2676; Frieboes HB, 2010, J THEOR BIOL, V264, P1254, DOI 10.1016/j.jtbi.2010.02.036; Frieboes HB, 2009, CANCER RES, V69, P4484, DOI 10.1158/0008-5472.CAN-08-3740; Gompertz B, 1825, PHILOS T ROY SOC LON, V31, P513, DOI [10.1098/rstl.1825.0026, DOI 10.1098/RSTL.1825.0026]; Jain RK, 2010, NAT REV CLIN ONCOL, V7, P653, DOI 10.1038/nrclinonc.2010.139; JAIN RK, 1990, CANCER RES, V50, pS814; Jain RK, 2001, J CONTROL RELEASE, V74, P7, DOI 10.1016/S0168-3659(01)00306-6; Jain RK, 2011, NAT MED, V7, P987; LAIRD AK, 1964, BRIT J CANCER, V18, P490, DOI 10.1038/bjc.1964.55; Lee SY, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/49/495101; Macklin P, 2009, J MATH BIOL, V58, P765, DOI 10.1007/s00285-008-0216-9; Maeda H, 2000, J CONTROL RELEASE, V65, P271, DOI 10.1016/S0168-3659(99)00248-5; MATSUMURA Y, 1986, CANCER RES, V46, P6387; McDougall SR, 2002, B MATH BIOL, V64, P673, DOI 10.1006/bulm.2002.0293; McDougall SR, 2006, J THEOR BIOL, V241, P564, DOI 10.1016/j.jtbi.2005.12.022; Peer D, 2007, NAT NANOTECHNOL, V2, P751, DOI 10.1038/nnano.2007.387; Pham K, 2011, J R SOC INTERFACE, V8, P16, DOI 10.1098/rsif.2010.0194; PRIES AR, 1992, AM J PHYSIOL, V263, pH1770, DOI 10.1152/ajpheart.1992.263.6.H1770; Pries AR, 1998, AM J PHYSIOL-HEART C, V275, pH349; Sergeeva A, 2006, ADV DRUG DELIVER REV, V58, P1622, DOI 10.1016/j.addr.2006.09.018; Sinek JP, 2009, J MATH BIOL, V58, P485, DOI 10.1007/s00285-008-0214-y; Smith BR, 2008, NANO LETT, V8, P2599, DOI 10.1021/nl080141f; Torchilin VP, 2005, NAT REV DRUG DISCOV, V4, P145, DOI 10.1038/nrd1632; van de Ven AL, 2012, AIP ADV, V2, DOI 10.1063/1.3699060; van de Ven AL, 2012, J CONTROL RELEASE, V158, P148, DOI 10.1016/j.jconrel.2011.10.021; Winsor CP, 1932, P NATL ACAD SCI USA, V18, P1, DOI 10.1073/pnas.18.1.1; Winter PM, 2003, CANCER RES, V63, P5838; Wu M, 2013, J THEOR BIOL, V320, P131, DOI 10.1016/j.jtbi.2012.11.031	40	80	82	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e56876	10.1371/journal.pone.0056876	http://dx.doi.org/10.1371/journal.pone.0056876			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23468887	Green Published, gold			2022-12-25	WOS:000315524900042
J	Altenburg, TM; de Kroon, MLA; Renders, CM; HiraSing, R; Chinapaw, MJM				Altenburg, Teatske M.; de Kroon, Marlou L. A.; Renders, Carry M.; HiraSing, Remy; Chinapaw, Mai J. M.			TV Time but Not Computer Time Is Associated with Cardiometabolic Risk in Dutch Young Adults	PLOS ONE			English	Article							METABOLIC SYNDROME; SEDENTARY BEHAVIOR; PHYSICAL-ACTIVITY; CARDIOVASCULAR-DISEASE; HEALTH OUTCOMES; INACTIVITY PHYSIOLOGY; MEAL INTAKE; MORTALITY; ADOLESCENTS; EXERCISE	Background: TV time and total sedentary time have been positively related to biomarkers of cardiometabolic risk in adults. We aim to examine the association of TV time and computer time separately with cardiometabolic biomarkers in young adults. Additionally, the mediating role of waist circumference (WC) is studied. Methods and Findings: Data of 634 Dutch young adults (18-28 years; 39% male) were used. Cardiometabolic biomarkers included indicators of overweight, blood pressure, blood levels of fasting plasma insulin, cholesterol, glucose, triglycerides and a clustered cardiometabolic risk score. Linear regression analyses were used to assess the cross-sectional association of self-reported TV and computer time with cardiometabolic biomarkers, adjusting for demographic and lifestyle factors. Mediation by WC was checked using the product-of-coefficient method. TV time was significantly associated with triglycerides (B = 0.004; CI = [0.001;0.05]) and insulin (B = 0.10; CI = [0.01;0.20]). Computer time was not significantly associated with any of the cardiometabolic biomarkers. We found no evidence for WC to mediate the association of TV time or computer time with cardiometabolic biomarkers. Conclusions: We found a significantly positive association of TV time with cardiometabolic biomarkers. In addition, we found no evidence for WC as a mediator of this association. Our findings suggest a need to distinguish between TV time and computer time within future guidelines for screen time.	[Altenburg, Teatske M.; de Kroon, Marlou L. A.; HiraSing, Remy; Chinapaw, Mai J. M.] Vrije Univ Amsterdam, Med Ctr, EMGO Inst Hlth & Care Res, Dept Publ & Occupat Hlth, Amsterdam, Netherlands; [Renders, Carry M.] Vrije Univ Amsterdam, EMGO Inst Hlth & Care Res, Dept Hlth Sci, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	Altenburg, TM (corresponding author), Vrije Univ Amsterdam, Med Ctr, EMGO Inst Hlth & Care Res, Dept Publ & Occupat Hlth, Amsterdam, Netherlands.	t.altenburg@vumc.nl	Paw, Mai Chin A/N-1665-2019; de Kroon, Marlou MLA/M-4040-2014; Altenburg, Teatske/S-2059-2016	Paw, Mai Chin A/0000-0001-6259-2441; de Kroon, Marlou/0000-0003-1730-4994; Altenburg, Teatske/0000-0002-8764-5631; Renders, Carry/0000-0001-6688-1312	Health Research and Development Council of the Netherlands (ZonMw) [2100.0092]	Health Research and Development Council of the Netherlands (ZonMw)(Netherlands Organization for Health Research and Development)	The Terneuzen Birth Cohort was funded by the Health Research and Development Council of the Netherlands (ZonMw Grants no.2100.0092). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Bellisle F, 2004, APPETITE, V43, P175, DOI 10.1016/j.appet.2004.04.004; Bey L, 2003, J PHYSIOL-LONDON, V551, P673, DOI 10.1113/jphysiol.2003.045591; Blass EM, 2006, PHYSIOL BEHAV, V88, P597, DOI 10.1016/j.physbeh.2006.05.035; Carson V, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-274; de Jong E, 2011, INT J OBES LOND; de Kroon MLA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013966; Dunstan DW, 2005, DIABETOLOGIA, V48, P2254, DOI 10.1007/s00125-005-1963-4; Edwardson CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034916; Ekelund U, 2009, DIABETES CARE, V32, P1081, DOI 10.2337/dc08-1895; Franks PW, 2004, DIABETES CARE, V27, P1187, DOI 10.2337/diacare.27.5.1187; Grontved A, 2011, JAMA-J AM MED ASSOC, V305, P2448, DOI 10.1001/jama.2011.812; Hamilton MT, 2008, CURR CARDIOVASC RISK, V2, P292, DOI 10.1007/s12170-008-0054-8; Hamilton MT, 2004, EXERC SPORT SCI REV, V32, P161; Healy GN, 2011, EUR HEART J, V32, P590, DOI 10.1093/eurheartj/ehq451; Hetherington MM, 2006, PHYSIOL BEHAV, V88, P498, DOI 10.1016/j.physbeh.2006.04.025; Hu FB, 2003, JAMA-J AM MED ASSOC, V289, P1785, DOI 10.1001/jama.289.14.1785; Lakka HM, 2002, JAMA-J AM MED ASSOC, V288, P2709, DOI 10.1001/jama.288.21.2709; Lanningham-Foster L, 2009, J PEDIATR-US, V154, P819, DOI 10.1016/j.jpeds.2009.01.009; MacKinnon DP, 2007, ANNU REV PSYCHOL, V58, P593, DOI 10.1146/annurev.psych.58.110405.085542; Malik S, 2004, CIRCULATION, V110, P1245, DOI 10.1161/01.CIR.0000140677.20606.0E; Owen N, 2010, EXERC SPORT SCI REV, V38, P105, DOI 10.1097/JES.0b013e3181e373a2; Pate RR, 2008, EXERC SPORT SCI REV, V36, P173, DOI 10.1097/JES.0b013e3181877d1a; Pearson N, 2011, AM J PREV MED, V41, P178, DOI 10.1016/j.amepre.2011.05.002; Pereira SMP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031132; Proper KI, 2011, AM J PREV MED, V40, P174, DOI 10.1016/j.amepre.2010.10.015; Stamatakis E, 2012, OBESITY, V20, P229, DOI 10.1038/oby.2011.209; Stephens BR, 2011, METABOLISM, V60, P941, DOI 10.1016/j.metabol.2010.08.014; Sugiyama T, 2008, ANN BEHAV MED, V35, P245, DOI 10.1007/s12160-008-9017-z; Thorp AA, 2011, AM J PREV MED, V41, P207, DOI 10.1016/j.amepre.2011.05.004; Wendel-Vos GCW, 2003, J CLIN EPIDEMIOL, V56, P1163, DOI 10.1016/S0895-4356(03)00220-8; Wijndaele K, 2009, EUR J CLIN NUTR, V63, P421, DOI 10.1038/sj.ejcn.1602944; Williams DM, 2008, AM J LIFESTYLE MED, V2, P250, DOI 10.1177/1559827608314104	33	21	22	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57749	10.1371/journal.pone.0057749	http://dx.doi.org/10.1371/journal.pone.0057749			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460900	gold, Green Published, Green Submitted			2022-12-25	WOS:000315519000155
J	Basu, S; Yoffe, P; Hills, N; Lustig, RH				Basu, Sanjay; Yoffe, Paula; Hills, Nancy; Lustig, Robert H.			The Relationship of Sugar to Population-Level Diabetes Prevalence: An Econometric Analysis of Repeated Cross-Sectional Data	PLOS ONE			English	Article							METABOLIC SYNDROME; INSULIN-RESISTANCE; LIFE-STYLE; FRUCTOSE; OBESITY; PATHOGENESIS; EPIDEMIC; GLUCOSE; RISK; BAD	While experimental and observational studies suggest that sugar intake is associated with the development of type 2 diabetes, independent of its role in obesity, it is unclear whether alterations in sugar intake can account for differences in diabetes prevalence among overall populations. Using econometric models of repeated cross-sectional data on diabetes and nutritional components of food from 175 countries, we found that every 150 kcal/person/day increase in sugar availability (about one can of soda/day) was associated with increased diabetes prevalence by 1.1% (p<0.001) after testing for potential selection biases and controlling for other food types (including fibers, meats, fruits, oils, cereals), total calories, overweight and obesity, period-effects, and several socioeconomic variables such as aging, urbanization and income. No other food types yielded significant individual associations with diabetes prevalence after controlling for obesity and other confounders. The impact of sugar on diabetes was independent of sedentary behavior and alcohol use, and the effect was modified but not confounded by obesity or overweight. Duration and degree of sugar exposure correlated significantly with diabetes prevalence in a dose-dependent manner, while declines in sugar exposure correlated with significant subsequent declines in diabetes rates independently of other socioeconomic, dietary and obesity prevalence changes. Differences in sugar availability statistically explain variations in diabetes prevalence rates at a population level that are not explained by physical activity, overweight or obesity.	[Basu, Sanjay] Stanford Univ, Dept Med, Stanford Prevent Res Ctr, Palo Alto, CA 94304 USA; [Yoffe, Paula] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Hills, Nancy] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Lustig, Robert H.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA USA; [Lustig, Robert H.] Univ Calif San Francisco, Philip R Lee Inst Hlth Policy Studies, San Francisco, CA 94143 USA	Stanford University; University of California System; University of California Berkeley; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Basu, S (corresponding author), Stanford Univ, Dept Med, Stanford Prevent Res Ctr, Palo Alto, CA 94304 USA.	basus@stanford.edu	Lustig, Robert/O-9380-2019	Lustig, Robert/0000-0001-6983-2639				Abbasi F, 2004, DIABETES, V53, P585, DOI 10.2337/diabetes.53.3.585; Bray GA, 2007, AM J CLIN NUTR, V86, P895, DOI 10.1093/ajcn/86.4.895; Bremer AA, 2012, PEDIATRICS, V129, P557, DOI 10.1542/peds.2011-2912; Bremer AA, 2011, CTS-CLIN TRANSL SCI, V4, P243, DOI 10.1111/j.1752-8062.2011.00298.x; Cecchini M, 2010, LANCET, V376, P1775, DOI 10.1016/S0140-6736(10)61514-0; CHAN JM, 1994, DIABETES CARE, V17, P961, DOI 10.2337/diacare.17.9.961; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; DILLS WL, 1993, AM J CLIN NUTR, V58, P779, DOI 10.1093/ajcn/58.5.779S; Elobeld A, 2006, J AGR ECON, V57, P23, DOI 10.1111/j.1477-9552.2006.00030.x; FAOSTAT, 2011, FAOSTAT; Goran MI, 2012, HIGH FRUCTOSE CORN S; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Gustavsson J., 2011, Global food losses and food waste: extent, causes and prevention; Hall KD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007940; Hallal PC, 2012, LANCET, V380, P247, DOI 10.1016/S0140-6736(12)60646-1; Hardin J., 2003, GEN ESTIMATING EQUAT; HAUSMAN JA, 1978, ECONOMETRICA, V46, P1251, DOI 10.2307/1913827; Heckman J, 2004, REV ECON STAT, V86, P30, DOI 10.1162/003465304323023660; Hu FB, 2011, DIABETES CARE, V34, P1249, DOI 10.2337/dc11-0442; Hummasti S, 2010, CIRC RES, V107, P579, DOI 10.1161/CIRCRESAHA.110.225698; International Diabetes Federation, 2011, IDF DIAB ATL; Johnson RK, 2009, CIRCULATION, V120, P1011, DOI 10.1161/CIRCULATIONAHA.109.192627; Johnson RJ, 2007, AM J CLIN NUTR, V86, P899; Lee DC, 2012, AM J EPIDEMIOL, V176, P43, DOI 10.1093/aje/kwr471; Lim JS, 2010, NAT REV GASTRO HEPAT, V7, P251, DOI 10.1038/nrgastro.2010.41; Lustig RH, 2012, NATURE, V482, P27, DOI 10.1038/482027a; Malik VS, 2012, CURR DIABETES REP, V12, P195, DOI 10.1007/s11892-012-0259-6; Muth MK, 2011, USDA TECHNICAL B, V1927; Nagai Y, 2009, CELL METAB, V9, P252, DOI 10.1016/j.cmet.2009.01.011; Popkin BM, 1999, WORLD DEV, V27, P1905, DOI 10.1016/S0305-750X(99)00094-7; Ramachandran A, 2010, LANCET, V375, P408, DOI 10.1016/S0140-6736(09)60937-5; Santos CXC, 2009, ANTIOXID REDOX SIGN, V11, P2409, DOI 10.1089/ARS.2009.2625; Schalkwijk CG, 2004, DIABETES-METAB RES, V20, P369, DOI 10.1002/dmrr.488; Siegel KR, 2012, DIABETES RES CLIN PR, V96, P76, DOI 10.1016/j.diabres.2011.11.014; Sung KC, 2011, J CLIN ENDOCR METAB, V96, P1093, DOI 10.1210/jc.2010-2190; Sung KCC, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-108; Teff KL, 2009, J CLIN ENDOCR METAB, V94, P1562, DOI 10.1210/jc.2008-2192; Viljoen A, 2011, MED CLIN N AM, V95, P615, DOI 10.1016/j.mcna.2011.02.003; Voulgari C, 2011, J AM COLL CARDIOL, V58, P1343, DOI 10.1016/j.jacc.2011.04.047; World Bank, 2022, WORLD DEV IND; World Health Organization, 2012, WHO GLOB INF; World Health Organization, 2012, GLOB HLTH OBS DAT RE; World Health Organization (WHO), 2012, GLOB DAT BOD MASS IN; Yoon KH, 2006, LANCET, V368, P1681, DOI 10.1016/S0140-6736(06)69703-1	44	214	216	1	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57873	10.1371/journal.pone.0057873	http://dx.doi.org/10.1371/journal.pone.0057873			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	098BN	23460912	Green Published, gold			2022-12-25	WOS:000315519000167
J	Lombardi, MG; Negroni, MP; Pelegrina, LT; Castro, ME; Fiszman, GL; Azar, ME; Morgado, CC; Sales, ME				Gabriela Lombardi, Maria; Pia Negroni, Maria; Tatiana Pelegrina, Laura; Ester Castro, Maria; Fiszman, Gabriel L.; Eugenia Azar, Maria; Cresta Morgado, Carlos; Elena Sales, Maria			Autoantibodies against Muscarinic Receptors in Breast Cancer: Their Role in Tumor Angiogenesis	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; CELLS PROLIFERATION; MCF-7 CELLS; ACTIVATION; PRINCIPLE; VEGF	The presence of autoantibodies in cancer has become relevant in recent years. We demonstrated that autoantibodies purified from the sera of breast cancer patients activate muscarinic acetylcholine receptors in tumor cells. Immunoglobulin G (IgG) from breast cancer patients in T1N0Mx stage (tumor size <= 2 cm, without lymph node metastasis) mimics the action of the muscarinic agonist carbachol stimulating MCF-7 cell proliferation, migration and invasion. Angiogenesis is a central step in tumor progression because it promotes tumor invasion and metastatic spread. Vascular endothelial growth factor-A (VEGF-A) is the main angiogenic mediator, and its levels have been correlated with poor prognosis in cancer. The aim of the present work was to investigate the effect of T1N0Mx-IgG on the expression of VEGF-A, and the in vivo neovascular response triggered by MCF-7 cells, via muscarinic receptor activation. We demonstrated that T1N0Mx-IgG (10(-8) M) and carbachol (10(-9) M) increased the constitutive expression of VEGF-A in tumor cells, effect that was reverted by the muscarinic antagonist atropine. We also observed that T1N0Mx-IgG and carbachol enhanced the neovascular response produced by MCF-7 cells in the skin of NUDE mice. The action of IgG or carbachol was reduced in the presence of atropine. In conclusion, T1N0Mx-IgG and carbachol may promote VEGF-A production and neovascularization induced by breast tumor cells via muscarinic receptors activation. These effects may be accelerating breast tumor progression.	[Gabriela Lombardi, Maria; Tatiana Pelegrina, Laura; Ester Castro, Maria; Elena Sales, Maria] UBA Buenos Aires, CONICET, Ctr Estudios Farmacol & Bot CEFYBO, Lab Inmunofarmacol Tumoral, Buenos Aires, DF, Argentina; [Pia Negroni, Maria] Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01605 USA; [Fiszman, Gabriel L.; Eugenia Azar, Maria; Cresta Morgado, Carlos] UBA, Inst Oncol AH Roffo, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Massachusetts System; University of Massachusetts Worcester; University of Buenos Aires	Sales, ME (corresponding author), UBA Buenos Aires, CONICET, Ctr Estudios Farmacol & Bot CEFYBO, Lab Inmunofarmacol Tumoral, Buenos Aires, DF, Argentina.	malegazpio@yahoo.com.ar			University of Buenos Aires [UBACYT MO064]; National Agency for Scientific and Technology Promotion [ANPCyT PICT 2006-485]	University of Buenos Aires(University of Buenos Aires); National Agency for Scientific and Technology Promotion	This work was supported by grants from University of Buenos Aires (UBACYT MO064) and from the National Agency for Scientific and Technology Promotion (ANPCyT PICT 2006-485). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chapman C, 2007, ANN ONCOL, V18, P868, DOI 10.1093/annonc/mdm007; CHEN TR, 1977, EXP CELL RES, V104, P255, DOI 10.1016/0014-4827(77)90089-1; Davel Lilia E., 2004, Angiogenesis, V7, P45, DOI 10.1023/B:AGEN.0000037329.45326.a8; Dvorak HF, 2002, J CLIN ONCOL, V20, P4368, DOI 10.1200/JCO.2002.10.088; Eglen RM, 2005, PROGR MED CHEM, V43, P105, DOI 10.1016/S0079-6468(05)43004-0; Espanol AJ, 2004, INT J MOL MED, V13, P311; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Fiszman G, 2006, INT IMMUNOPHARMACOL, V6, P1323, DOI 10.1016/j.intimp.2006.04.007; Fiszman GL, 2007, CANCER BIOL THER, V6, P1106, DOI 10.4161/cbt.6.7.4330; Fiszman Gabriel L., 2008, Current Immunology Reviews, V4, P176, DOI 10.2174/157339508785160732; Folkman J, 2007, NAT REV DRUG DISCOV, V6, P273, DOI 10.1038/nrd2115; Hawinkels LJAC, 2008, EUR J CANCER, V44, P1904, DOI 10.1016/j.ejca.2008.06.031; Hicklin DJ, 2005, J CLIN ONCOL, V23, P1011, DOI 10.1200/JCO.2005.06.081; John Anitha, 2001, Pathology and Oncology Research, V7, P14; Kasukabe T, 2005, BREAST CANCER RES, V7, pR1097, DOI 10.1186/bcr1344; Madrid FF, 2005, AUTOIMMUN REV, V4, P230, DOI 10.1016/j.autrev.2004.11.004; Madrid MF, 2005, CANCER LETT, V230, P187, DOI 10.1016/j.canlet.2004.12.017; Monte M, 1997, EUR J CANCER, V33, P676, DOI 10.1016/S0959-8049(96)00506-0; Pelegrina LT, 2012, J CLIN IMMU IN PRESS; Negroni MP, 2010, J CLIN IMMUNOL, V30, P474, DOI 10.1007/s10875-010-9370-0; Rimmaudo LE, 2005, BIOCHEM BIOPH RES CO, V334, P1359, DOI 10.1016/j.bbrc.2005.07.031; Shah N, 2009, AM J PHYSIOL-CELL PH, V296, pC221, DOI 10.1152/ajpcell.00514.2008; Urtreger AJ, 1997, INT J ONCOL, V11, P489	24	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57572	10.1371/journal.pone.0057572	http://dx.doi.org/10.1371/journal.pone.0057572			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460876	Green Published, gold, Green Submitted			2022-12-25	WOS:000315519000131
J	Song, F; Fan, CD; Wang, XJ; Goodrich, DW				Song, Fei; Fan, Chuandong; Wang, Xinjiang; Goodrich, David W.			The Thoc1 Encoded Ribonucleoprotein Is a Substrate for the NEDD4-1 E3 Ubiquitin Protein Ligase	PLOS ONE			English	Article							RNA-POLYMERASE-II; MESSENGER-RNA; EXPORT MACHINERY; NUCLEAR EXPORT; COMPLEX; TRANSCRIPTION; GENE; TREX; RECRUITMENT; BIOGENESIS	Ribonucleoprotein (RNP) complexes form around nascent RNA during transcription to facilitate proper transcriptional elongation, RNA processing, and nuclear export. RNPs are highly heterogeneous, and different types of RNPs tend to package functionally related transcripts. These observations have inspired the hypothesis that RNP mediated mechanisms help specify coordinated gene expression. This hypothesis is supported by the observation that mutations in RNP components can cause defects in specific developmental pathways. How RNP biogenesis itself is regulated, however, is not well understood. The evolutionarily conserved THO RNP complex functions early during transcription to package nascent transcripts and facilitate subsequent RNP biogenesis. THO deficiency compromises transcriptional elongation as well as RNP mediated events like 3' end formation nuclear export for some transcripts. Using molecularly manipulated cells and in vitro reconstituted biochemical reactions, we demonstrate that the essential THO protein component encoded by the Thoc1 gene is poly-ubiquitinated by the NEDD4-1 E3 ubiquitin ligase. Poly-ubiquitinated pThoc1 is degraded by the proteasome. These results indicate THO activity is regulated by the ubiquitin-proteasome pathway, and that this regulation is evolutionarily conserved between yeast and mammals. Manipulation of NEDD4-1 levels has modest effects on Thoc1 protein levels under steady state conditions, but destabilization of Thoc1 protein upon treatment with a transcriptional elongation inhibitor is dependent on NEDD4-1. This suggests NEDD4-1 functions in conjunction with other post-translational mechanisms to regulate Thoc1 protein and THO activity.	[Song, Fei; Fan, Chuandong; Wang, Xinjiang; Goodrich, David W.] Roswell Pk Canc Inst, Dept Pharmacol & Therapeut, Buffalo, NY 14263 USA	Roswell Park Cancer Institute	Goodrich, DW (corresponding author), Roswell Pk Canc Inst, Dept Pharmacol & Therapeut, Buffalo, NY 14263 USA.	david.goodrich@roswellpark.org			NIH [R01 CA125665]; NATIONAL CANCER INSTITUTE [R01CA125665, P30CA016056] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The work was supported by a grant from the NIH (R01 CA125665 to D.W.G.), http://www.nih.gov/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albuquerque CP, 2008, MOL CELL PROTEOMICS, V7, P1389, DOI 10.1074/mcp.M700468-MCP200; Cao XR, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1160940; Chang MP, 1999, MOL CELL BIOL, V19, P1056; Cheng H, 2006, CELL, V127, P1389, DOI 10.1016/j.cell.2006.10.044; Cooper TA, 2009, CELL, V136, P777, DOI 10.1016/j.cell.2009.02.011; Dominguez-Sanchez MS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002386; Dufu K, 2010, GENE DEV, V24, P2043, DOI 10.1101/gad.1898610; DURFEE T, 1994, J CELL BIOL, V127, P609, DOI 10.1083/jcb.127.3.609; Gasparri F, 2004, FEBS LETT, V574, P13, DOI 10.1016/j.febslet.2004.07.074; Glisovic T, 2008, FEBS LETT, V582, P1977, DOI 10.1016/j.febslet.2008.03.004; Gwizdek C, 2005, J BIOL CHEM, V280, P13401, DOI 10.1074/jbc.C500040200; Gwizdek C, 2006, P NATL ACAD SCI USA, V103, P16376, DOI 10.1073/pnas.0607941103; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Huertas P, 2003, MOL CELL, V12, P711, DOI 10.1016/j.molcel.2003.08.010; Huertas P, 2006, MOL CELL BIOL, V26, P7451, DOI 10.1128/MCB.00684-06; Jimeno S, 2002, EMBO J, V21, P3526, DOI 10.1093/emboj/cdf335; Kasanov J, 2001, CHEM BIOL, V8, P231, DOI 10.1016/S1074-5521(01)00005-9; Keene JD, 2007, NAT REV GENET, V8, P533, DOI 10.1038/nrg2111; Li YL, 2007, CANCER RES, V67, P6657, DOI 10.1158/0008-5472.CAN-06-3234; Li YP, 2005, MOL CELL BIOL, V25, P4023, DOI 10.1128/MCB.25.10.4023-4033.2005; Luna R, 2008, CHROMOSOMA, V117, P319, DOI 10.1007/s00412-008-0158-4; Mancini A, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-1; Moore MJ, 2005, SCIENCE, V309, P1514, DOI 10.1126/science.1111443; Saguez C, 2008, MOL CELL, V31, P91, DOI 10.1016/j.molcel.2008.04.030; Schneiter R, 1999, MOL CELL BIOL, V19, P3415; Strasser K, 2002, NATURE, V417, P304, DOI 10.1038/nature746; Voynov V, 2006, P NATL ACAD SCI USA, V103, P14423, DOI 10.1073/pnas.0606546103; Wang XJ, 2008, BIOCHEM J, V414, P221, DOI 10.1042/BJ20080674; Wang XJ, 2007, CELL, V128, P129, DOI 10.1016/j.cell.2006.11.039; Wellinger RE, 2006, MOL CELL BIOL, V26, P3327, DOI 10.1128/MCB.26.8.3327-3334.2006; Zenklusen D, 2002, MOL CELL BIOL, V22, P8241, DOI 10.1128/MCB.22.23.8241-8253.2002	32	3	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57995	10.1371/journal.pone.0057995	http://dx.doi.org/10.1371/journal.pone.0057995			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460917	Green Published, gold, Green Submitted			2022-12-25	WOS:000315519000172
J	Tang, SW; Lv, XZ; Zhang, Y; Wu, SS; Yang, ZR; Xia, YY; Tu, DH; Deng, PY; Ma, Y; Chen, DF; Zhan, SY				Tang, Shaowen; Lv, Xiaozhen; Zhang, Yuan; Wu, Shanshan; Yang, Zhirong; Xia, Yinyin; Tu, Dehua; Deng, Peiyuan; Ma, Yu; Chen, Dafang; Zhan, Siyan			Cytochrome P450 2E1 Gene Polymorphisms/Haplotypes and Anti-Tuberculosis Drug-Induced Hepatitis in a Chinese Cohort	PLOS ONE			English	Article							INDUCED HEPATOTOXICITY; CYP2E1; LIVER; NAT2; SUSCEPTIBILITY; PYRAZINAMIDE; METABOLITES; GENOTYPE; ENZYMES	Objective: The pathogenic mechanism of anti-tuberculosis (anti-TB) drug-induced hepatitis is associated with drug metabolizing enzymes. No tagging single-nucleotide polymorphisms (tSNPs) of cytochrome P450 2E1(CYP2E1) in the risk of anti-TB drug-induced hepatitis have been reported. The present study was aimed at exploring the role of tSNPs in CYP2E1 gene in a population-based anti-TB treatment cohort. Methods and Design: A nested case-control study was designed. Each hepatitis case was 14 matched with controls by age, gender, treatment history, disease severity and drug dosage. The tSNPs were selected by using Haploview 4.2 based on the HapMap database of Han Chinese in Beijing, and detected by using TaqMan allelic discrimination technology. Results: Eighty-nine anti-TB drug-induced hepatitis cases and 356 controls were included in this study. 6 tSNPs (rs2031920, rs2070672, rs915908, rs8192775, rs2515641, rs2515644) were genotyped and minor allele frequencies of these tSNPs were 21.9%, 23.0%, 19.1%, 23.6%, 20.8% and 44.4% in the cases and 20.9%, 22.7%, 18.9%, 23.2%, 18.2% and 43.2% in the controls, respectively. No significant difference was observed in genotypes or allele frequencies of the 6 tSNPs between case group and control group, and neither of haplotypes in block 1 nor in block 2 was significantly associated with the development of hepatitis. Conclusion: Based on the Chinese anti-TB treatment cohort, we did not find a statistically significant association between genetic polymorphisms of CYP2E1 and the risk of anti-TB drug-induced hepatitis. None of the haplotypes showed a significant association with the development of hepatitis in Chinese TB population.	[Tang, Shaowen; Lv, Xiaozhen; Zhang, Yuan; Wu, Shanshan; Yang, Zhirong; Chen, Dafang; Zhan, Siyan] Peking Univ, Dept Epidemiol & Biostat, Sch Publ Hlth, Hlth Sci Ctr, Beijing 100871, Peoples R China; [Tang, Shaowen] Nanjing Med Univ, Dept Epidemiol & Biostat, Sch Publ Hlth, Nanjing, Jiangsu, Peoples R China; [Xia, Yinyin] Chinese Ctr Dis Control & Prevent, Ctr TB Control & Prevent, Beijing, Peoples R China; [Tu, Dehua] Beijing Inst TB Control, Dept TB Treatment, Beijing, Peoples R China; [Deng, Peiyuan] State Food & Drug Adm, Ctr Drug Reassessment, Beijing, Peoples R China; [Ma, Yu] Beijing TB & Thorac Tumor Res Inst, Dept TB Treatment, Beijing, Peoples R China	Peking University; Nanjing Medical University; Chinese Center for Disease Control & Prevention	Zhan, SY (corresponding author), Peking Univ, Dept Epidemiol & Biostat, Sch Publ Hlth, Hlth Sci Ctr, Beijing 100871, Peoples R China.	siyan-zhan@bjmu.edu.cn		Tang, Shaowen/0000-0001-5879-8594; Zhang, Yuan/0000-0002-4174-0641	National Natural Science Foundation of China [81072387]; Beijing Natural Science Foundation [7111006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This study is funded by National Natural Science Foundation of China (NO. 81072387) and Beijing Natural Science Foundation (NO. 7111006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An HR, 2012, CLIN EXP PHARMACOL P, V39, P535, DOI 10.1111/j.1440-1681.2012.05713.x; [Anonymous], 2003, AM J RESP CRIT CARE, V167, P603; BENICHOU C, 1990, J HEPATOL, V11, P272; Bose PD, 2011, J GASTROEN HEPATOL, V26, P312, DOI 10.1111/j.1440-1746.2010.06355.x; Burman WJ, 2001, AM J RESP CRIT CARE, V164, P1112, DOI 10.1164/ajrccm.164.7.2109052; Cho HJ, 2007, TUBERCULOSIS, V87, P551, DOI 10.1016/j.tube.2007.05.012; Das Roy P, 2008, PHARMACOGENOMICS, V9, P311, DOI 10.2217/14622416.9.3.311; Teixeira RLD, 2011, MEM I OSWALDO CRUZ, V106, P716, DOI 10.1590/S0074-02762011000600011; De Rosa HJ, 2007, BIOPHARM DRUG DISPOS, V28, P291, DOI 10.1002/bdd.557; Devarbhavi Harshad, 2011, Trop Gastroenterol, V32, P167; Guo Mingruo, 2009, P1; HAYASHI S, 1991, J BIOCHEM-TOKYO, V110, P559, DOI 10.1093/oxfordjournals.jbchem.a123619; Huang XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040883; Huang YS, 2007, J HEPATOL, V47, P128, DOI 10.1016/j.jhep.2007.02.009; Huang YS, 2003, HEPATOLOGY, V37, P924, DOI 10.1053/jhep.2003.50144; Huang YS, 2002, HEPATOLOGY, V35, P883, DOI 10.1053/jhep.2002.32102; Ingelman-Sundberg M, 2007, PHARMACOL THERAPEUT, V116, P496, DOI 10.1016/j.pharmthera.2007.09.004; Jana S, 2007, CURR PROTEIN PEPT SC, V8, P619, DOI 10.2174/138920307783018668; Kim SH, 2009, PHARMACOGENOMICS, V10, P1767, DOI 10.2217/PGS.09.100; Knowles SR, 2000, LANCET, V356, P1587, DOI 10.1016/S0140-6736(00)03137-8; Lee SW, 2010, INT J TUBERC LUNG D, V14, P622; Lv XZ, 2012, ANN HEPATOL, V11, P700, DOI 10.1016/S1665-2681(19)31446-2; MITCHELL JR, 1976, ANN INTERN MED, V84, P181, DOI 10.7326/0003-4819-84-2-181; Mohri T, 2010, BIOCHEM PHARMACOL, V79, P1045, DOI 10.1016/j.bcp.2009.11.015; Naisbitt DJ, 2001, CURR OPIN ALLERGY CL, V1, P317; NELSON SD, 1976, SCIENCE, V193, P901, DOI 10.1126/science.7838; Ormerod P, 1998, THORAX, V53, P536; Pennell WT, 2011, TECHNICAL CHALLENGES OF MULTIPOLLUTANT AIR QUALITY MANAGEMENT, P1, DOI 10.1007/978-94-007-0304-9_1; Roy B, 2006, J GASTROEN HEPATOL, V21, P784, DOI 10.1111/j.1440-1746.2006.04197.x; Saukkonen JJ, 2006, AM J RESP CRIT CARE, V174, P935, DOI 10.1164/rccm.200510-1666ST; Sotsuka T, 2011, IN VIVO, V25, P803; Teuber M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-81; Tostmann A, 2008, J GASTROEN HEPATOL, V23, P192, DOI 10.1111/j.1440-1746.2007.05207.x; TSUTSUMI M, 1994, GASTROENTEROLOGY, V107, P1430, DOI 10.1016/0016-5085(94)90546-0; Vieira I, 1996, EUR J BIOCHEM, V238, P476, DOI 10.1111/j.1432-1033.1996.0476z.x; Wang T, 2010, J INT MED RES, V38, P977, DOI 10.1177/147323001003800324; World Health Organization, 2005, USE WHO UMC SYST STA; Xia YY, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-267; Yamada S, 2009, PHARMACOGENOMICS, V10, P1433, DOI [10.2217/pgs.09.66, 10.2217/PGS.09.66]; Yee D, 2003, AM J RESP CRIT CARE, V167, P1472, DOI 10.1164/rccm.200206-626OC; Yew WW, 2006, RESPIROLOGY, V11, P699, DOI 10.1111/j.1440-1843.2006.00941.x	41	18	21	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57526	10.1371/journal.pone.0057526	http://dx.doi.org/10.1371/journal.pone.0057526			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460870	Green Published, Green Submitted, gold			2022-12-25	WOS:000315519000125
J	Wang, YJ; Yang, YT; Hui, L; Tie, C; Li, F; Xu, ZQD; Wang, CY				Wang, Yongjun; Yang, Yutao; Hui, Li; Tie, Changle; Li, Feng; Xu, Zhi-Qing David; Wang, Chuanyue			A Neuropeptide Y Variant (rs16139) Associated with Major Depressive Disorder in Replicate Samples from Chinese Han Population	PLOS ONE			English	Article							RESTRAINT STRESS; NPY; POLYMORPHISM; BEHAVIOR; ANXIETY; WOMEN; RISK; TWIN	Objective: This study aimed to investigate the single nucleotide polymorphisms (SNPs) of neuropeptide Y (NPY) and major depressive disorder (MDD) in Chinese Han population. Design: Prospective and randomized studies were carried out. Patients: A total of 700 patients (324 male and 376 female; mean age = 406 +/- 14.9 years) with depression who met the diagnostic criteria of Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) and 673 healthy controls (313 male and 360 female; mean age = 41.9 +/- 17.2 years) were used to investigate the relationship between SNPs of NPY and the pathogenesis of MDD. A total of 417 patients (195 male and 202 female; mean age = 36 +/- 14.2 years) diagnosed with MDD and 314 healthy controls (153 male and 161 female; mean age = 37.9 +/- 14.2 years) from Chinese Han population were used to verify the relationship between SNPs of NPY and the pathogenesis of MDD. Intervention and outcome: Ligase detection reactions were performed to detect the SNP sites of NPY. A series of statistical methods was carried out to investigate the correlation between the NPY gene SNP and MDD. Results: Statistical analysis showed a significant correlation between the SNP sites rs16139 in NPY and the morbidity of depression. Patients with MDD have a lower frequency of A-allele in rs16139 in replicate samples from Chinese Han population. However, the frequency varied between male and female patients. Conclusion: The gene polymorphism loci rs16139 was closely related to MDD in Chinese Han population.	[Wang, Yongjun; Wang, Chuanyue] Capital Med Univ, Beijing Anding Hosp, Beijing, Peoples R China; [Yang, Yutao; Hui, Li; Tie, Changle; Li, Feng; Xu, Zhi-Qing David] Capital Med Univ, Beijing Key Lab Brain Major Disorders, Beijing, Peoples R China; [Wang, Yongjun] Tianjin Anding Hosp, Tianjin, Peoples R China	Capital Medical University; Capital Medical University	Xu, ZQD (corresponding author), Capital Med Univ, Beijing Key Lab Brain Major Disorders, Beijing, Peoples R China.	zhiqingx@ccmu.edu.cn; chuanyuewang2012@163.com	Wang, Chuan-Yue/C-9369-2015; Xu, Zhi-Qing David/H-9757-2013	Wang, Chuan-Yue/0000-0001-6549-3713; Xu, Zhi-Qing David/0000-0002-0387-7559	Beijing Municipal Natural Science Foundation of China [7091002]; National Science and Technology Support Program of China [2007BAI17B05]	Beijing Municipal Natural Science Foundation of China; National Science and Technology Support Program of China	This work was funded by the Beijing Municipal Natural Science Foundation of China (7091002), and the National Science and Technology Support Program of China (2007BAI17B05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews G, 2005, BRIT J PSYCHIAT, V187, P495, DOI 10.1192/bjp.187.6.495; Barlow DH, 2005, CENGAGE LEARNING; Bosker FJ, 2011, MOL PSYCHIATR, V16, P516, DOI 10.1038/mp.2010.38; Cizza G, 2008, BIOL PSYCHIAT, V64, P907, DOI 10.1016/j.biopsych.2008.05.035; Ding B, 2002, J CLIN PHARM THER, V27, P211, DOI 10.1046/j.1365-2710.2002.00409.x; Domschke K, 2010, EUR NEUROPSYCHOPHARM, V20, P301, DOI 10.1016/j.euroneuro.2009.09.006; Heilig M, 2004, NEUROPEPTIDES, V38, P213, DOI 10.1016/j.npep.2004.05.002; Heilig M, 2004, J PSYCHIATR RES, V38, P113, DOI 10.1016/S0022-3956(03)00101-8; Hou CL, 2006, BRAIN RES, V1095, P154, DOI 10.1016/j.brainres.2006.04.026; Karl T, 2010, NEUROPEPTIDES, V44, P233, DOI 10.1016/j.npep.2009.12.008; Kendler KS, 1999, ARCH GEN PSYCHIAT, V56, P39, DOI 10.1001/archpsyc.56.1.39; Lohoff FW, 2010, CURR PSYCHIAT REP, V12, P539, DOI 10.1007/s11920-010-0150-6; Madaan V, 2009, DRUG NEWS PERSPECT, V22, P319, DOI 10.1358/dnp.2009.22.6.1395255; Mickey BJ, 2011, ARCH GEN PSYCHIAT, V68, P158, DOI 10.1001/archgenpsychiatry.2010.197; Morales-Medina JC, 2010, BRAIN RES, V1314, P194, DOI 10.1016/j.brainres.2009.09.077; Moreno FA, 2010, EUR NEUROPSYCHOPHARM, V20, P18, DOI 10.1016/j.euroneuro.2009.10.003; Rhee SH, 2002, PSYCHOL BULL, V128, P490, DOI 10.1037//0033-2909.128.3.490; Sjoholm LK, 2009, J AFFECT DISORDERS, V118, P124, DOI 10.1016/j.jad.2009.02.009; Sommer WH, 2010, HUM MUTAT, V31, pE1594, DOI 10.1002/humu.21299; Southwick SM, 2005, ANNU REV CLIN PSYCHO, V1, P255, DOI 10.1146/annurev.clinpsy.1.102803.143948; Thorsell A, 2000, P NATL ACAD SCI USA, V97, P12852, DOI 10.1073/pnas.220232997; Thorsell A, 1998, REGUL PEPTIDES, V75-6, P247, DOI 10.1016/S0167-0115(98)00075-5; Weizman Shira, 2012, Neuropsychopharmacol Hung, V14, P87; Witt SH, 2011, PSYCHONEUROENDOCRINO, V36, P1010, DOI 10.1016/j.psyneuen.2010.12.015	24	10	10	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57042	10.1371/journal.pone.0057042	http://dx.doi.org/10.1371/journal.pone.0057042			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23468908	Green Submitted, Green Published, gold			2022-12-25	WOS:000315519000055
J	Rodriguez-Barreiro, R; Abendroth, C; Vilanova, C; Moya, A; Porcar, M				Rodriguez-Barreiro, Raul; Abendroth, Christian; Vilanova, Cristina; Moya, Andres; Porcar, Manuel			Towards a Microbial Thermoelectric Cell	PLOS ONE			English	Article							WASTE HEAT; FUEL-CELLS; ELECTRICITY; POWER	Microbial growth is an exothermic process. Biotechnological industries produce large amounts of heat, usually considered an undesirable by-product. In this work, we report the construction and characterization of the first microbial thermoelectric cell (MTC), in which the metabolic heat produced by a thermally insulated microbial culture is partially converted into electricity through a thermoelectric device optimized for low DT values. A temperature of 41 degrees C and net electric voltage of around 250-600 mV was achieved with 1.7 L baker's yeast culture. This is the first time microbial metabolic energy has been converted into electricity with an ad hoc thermoelectric device. These results might contribute towards developing a novel strategy to harvest excess heat in the biotechnology industry, in processes such as ethanol fermentation, auto thermal aerobic digestion (ATAD) or bioremediation, which could be coupled with MTCs in a single unit to produce electricity as a valuable by-product of the primary biotechnological product. Additionally, we propose that small portable MTCs could be conceived and inoculated with suitable thermophilic of hyperthermophilic starter cultures and used for powering small electric devices.	[Rodriguez-Barreiro, Raul; Abendroth, Christian; Vilanova, Cristina; Moya, Andres; Porcar, Manuel] Univ Valencia, Cavanilles Inst Biodivers & Evolut Biol, Valencia, Spain; [Moya, Andres] CSISP, Unidad Mixta Invest Genom & Salud, Valencia, Spain; [Porcar, Manuel] Univ Valencia, Fundacio Gen, Valencia, Spain	University of Valencia; University of Valencia	Porcar, M (corresponding author), Univ Valencia, Cavanilles Inst Biodivers & Evolut Biol, Valencia, Spain.	manuel.porcar@uv.es	Abendroth, Christian/E-2851-2015; Moya, Andrés/A-8190-2008; Porcar, Manuel/D-2503-2010; Abendroth, Christian/GLN-7432-2022	Moya, Andrés/0000-0002-2867-1119; Porcar, Manuel/0000-0002-7916-9479; Abendroth, Christian/0000-0002-3940-9124	Conselleria d'Educacio, Generalitat Valenciana, Spain [Prometeo/2009/092]	Conselleria d'Educacio, Generalitat Valenciana, Spain(Center for Forestry Research & Experimentation (CIEF))	Financial support was provided by grant Prometeo/2009/092 (Conselleria d'Educacio, Generalitat Valenciana, Spain) to AM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell LE, 2008, SCIENCE, V321, P1457, DOI 10.1126/science.1158899; Cheng SA, 2009, ENVIRON SCI TECHNOL, V43, P3953, DOI 10.1021/es803531g; Dauer LT, 2011, J NUCL MED, V52, P1423, DOI 10.2967/jnumed.111.091413; Delas J, 2009, NEW BIOTECHNOL, V26, P300, DOI 10.1016/j.nbt.2009.09.005; Ducommun R, 2010, YEAST, V27, P139, DOI 10.1002/yea.1738; Gross M, 2011, CURR BIOL, V21, pR379, DOI 10.1016/j.cub.2011.05.003; Gunawardena A, 2008, INT J MOL SCI, V9, P1893, DOI 10.3390/ijms9101893; Kim D, 2009, BIORESOURCE TECHNOL, V100, P4527, DOI 10.1016/j.biortech.2009.04.017; Larjola J, 1995, INT J PROD ECON, V41, P227, DOI 10.1016/0925-5273(94)00098-0; Lehmann J, 2007, NATURE, V447, P143, DOI 10.1038/447143a; Lineykin S, 2007, IEEE T IND APPL, V43, P505, DOI 10.1109/TIA.2006.889813; Liu H, 2005, ENVIRON SCI TECHNOL, V39, P4317, DOI 10.1021/es050244p; Logan BE, 2010, APPL MICROBIOL BIOT, V85, P1665, DOI 10.1007/s00253-009-2378-9; Rozendal RA, 2006, INT J HYDROGEN ENERG, V31, P1632, DOI 10.1016/j.ijhydene.2005.12.006; Saidur R, 2012, RENEW SUST ENERG REV, V16, P5649, DOI 10.1016/j.rser.2012.05.018; Song CS, 2002, CATAL TODAY, V77, P17, DOI 10.1016/S0920-5861(02)00231-6; Turker M, 2004, THERMOCHIM ACTA, V419, P73, DOI 10.1016/j.tca.2004.01.036; Ugwuanyi JO, 2008, J APPL MICROBIOL, V104, P79, DOI 10.1111/j.1365-2672.2007.03557.x; von Stockar U, 1997, J BIOTECHNOL, V59, P25, DOI 10.1016/S0168-1656(97)00167-3	19	4	4	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2013	8	2							e56358	10.1371/journal.pone.0056358	http://dx.doi.org/10.1371/journal.pone.0056358			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098PO	23468862	Green Published, Green Submitted, gold			2022-12-25	WOS:000315561400008
J	Jasinska, M; Siucinska, E; Jasek, E; Litwin, JA; Pyza, E; Kossut, M				Jasinska, Malgorzata; Siucinska, Ewa; Jasek, Ewa; Litwin, Jan A.; Pyza, Elzbieta; Kossut, Malgorzata			Fear Learning Increases the Number of Polyribosomes Associated with Excitatory and Inhibitory Synapses in the Barrel Cortex	PLOS ONE			English	Article							PROTEIN-SYNTHESIS; SOMATOSENSORY CORTEX; INDUCED ENHANCEMENT; DENDRITIC SPINES; NMDA RECEPTORS; MESSENGER-RNA; PLASTICITY; SYNAPTOGENESIS; TRANSLATION; EXPRESSION	Associative fear learning, resulting from whisker stimulation paired with application of a mild electric shock to the tail in a classical conditioning paradigm, changes the motor behavior of mice and modifies the cortical functional representation of sensory receptors involved in the conditioning. It also induces the formation of new inhibitory synapses on double-synapse spines of the cognate barrel hollows. We studied density and distribution of polyribosomes, the putative structural markers of enhanced synaptic activation, following conditioning. By analyzing serial sections of the barrel cortex by electron microscopy and stereology, we found that the density of polyribosomes was significantly increased in dendrites of the barrel activated during conditioning. The results revealed fear learning-induced increase in the density of polyribosomes associated with both excitatory and inhibitory synapses located on dendritic spines (in both single- and double-synapse spines) and only with the inhibitory synapses located on dendritic shafts. This effect was accompanied by a significant increase in the postsynaptic density area of the excitatory synapses on single-synapse spines and of the inhibitory synapses on double-synapse spines containing polyribosomes. The present results show that associative fear learning not only induces inhibitory synaptogenesis, as demonstrated in the previous studies, but also stimulates local protein synthesis and produces modifications of the synapses that indicate their potentiation.	[Jasinska, Malgorzata; Jasek, Ewa; Litwin, Jan A.] Jagiellonian Univ, Coll Med, Dept Histol, Krakow, Poland; [Siucinska, Ewa; Kossut, Malgorzata] M Nencki Inst Expt Biol, Dept Mol & Cellular Neurobiol, PL-02093 Warsaw, Poland; [Pyza, Elzbieta] Jagiellonian Univ, Inst Zool, Dept Cell Biol & Imaging, PL-30060 Krakow, Poland; [Kossut, Malgorzata] Warsaw Sch Social Psychol, Warsaw, Poland	Jagiellonian University; Collegium Medicum Jagiellonian University; Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences; Jagiellonian University; SWPS University of Social Sciences & Humanities	Kossut, M (corresponding author), M Nencki Inst Expt Biol, Dept Mol & Cellular Neurobiol, PL-02093 Warsaw, Poland.	kossut@nencki.gov.pl	Jasek-Gajda, Ewa/ACT-6284-2022; Siucinska, Ewa/W-7969-2018	Jasek-Gajda, Ewa/0000-0002-2030-0356; Siucinska, Ewa/0000-0002-4541-2864; Kossut, Malgorzata/0000-0001-7808-1101; Jasinska, Malgorzata/0000-0002-8102-6039	Polish Ministry of Science and Higher Education [IP2010 014970]	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	The study was supported by Iuventus Plus grant IP2010 014970 from the Polish Ministry of Science and Higher Education to MJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAILEY CH, 1988, P NATL ACAD SCI USA, V85, P9356, DOI 10.1073/pnas.85.23.9356; Bekisz M, 2010, EUR J NEUROSCI, V32, P1715, DOI 10.1111/j.1460-9568.2010.07453.x; BLACK JE, 1990, P NATL ACAD SCI USA, V87, P5568, DOI 10.1073/pnas.87.14.5568; Bourne JN, 2007, HIPPOCAMPUS, V17, P1, DOI 10.1002/hipo.20238; Bourne J, 2011, RACE CLASS, V52, P1, DOI 10.1177/0306396810392114; Brosh I, 2009, LEARN MEMORY, V16, P413, DOI 10.1101/lm.1430809; Cajigas IJ, 2012, NEURON, V74, P453, DOI 10.1016/j.neuron.2012.02.036; Cybulska-Klosowicz A, 2009, BEHAV BRAIN RES, V204, P102, DOI 10.1016/j.bbr.2009.05.024; Dictenberg JB, 2008, DEV CELL, V14, P926, DOI 10.1016/j.devcel.2008.04.003; Fiala JC, 2001, J AM MED INFORM ASSN, V8, P1; Froemke RC, 2007, NATURE, V450, P425, DOI 10.1038/nature06289; Galindo-Leon EE, 2009, NEURON, V62, P705, DOI 10.1016/j.neuron.2009.05.001; Ganeshina O, 2004, NEUROSCIENCE, V125, P615, DOI 10.1016/j.neuroscience.2004.02.025; Ganeshina O, 2004, J COMP NEUROL, V468, P86, DOI 10.1002/cne.10950; Gierdalski M, 2001, CEREB CORTEX, V11, P806, DOI 10.1093/cercor/11.9.806; Gray NW, 2006, PLOS BIOL, V4, P2065, DOI 10.1371/journal.pbio.0040370; Holtmaat A, 2008, BEHAV BRAIN RES, V192, P20, DOI 10.1016/j.bbr.2008.04.005; HUNTER A, 1993, BRAIN RES, V605, P251, DOI 10.1016/0006-8993(93)91747-G; Jasinska M, 2006, ACTA NEUROBIOL EXP, V66, P99; Jasinska M, 2010, J NEUROSCI, V30, P1176, DOI 10.1523/JNEUROSCI.2970-09.2010; Jones MS, 1997, BRAIN RES, V768, P167, DOI 10.1016/S0006-8993(97)00639-2; Kleim JA, 1996, J NEUROSCI, V16, P4529; Knafo S, 2004, HIPPOCAMPUS, V14, P819, DOI 10.1002/hipo.10219; Knott GW, 2002, NEURON, V34, P265, DOI 10.1016/S0896-6273(02)00663-3; Lee CC, 2005, J BIOL CHEM, V280, P18543, DOI 10.1074/jbc.M414112200; Li Z, 2003, NAT REV MOL CELL BIO, V4, P833, DOI 10.1038/nrm1242; Lushnikova I, 2011, NEUROPHARMACOLOGY, V60, P757, DOI 10.1016/j.neuropharm.2010.12.014; Majewska AK, 2006, J NEUROSCI, V26, P3021, DOI 10.1523/JNEUROSCI.4454-05.2006; Martin KC, 2006, J NEUROSCI, V26, P7131, DOI 10.1523/JNEUROSCI.1801-06.2006; Miller KD, 2001, CURR OPIN NEUROBIOL, V11, P488, DOI 10.1016/S0959-4388(00)00239-7; Ostroff LE, 2002, NEURON, V35, P535, DOI 10.1016/S0896-6273(02)00785-7; Ostroff LE, 2010, P NATL ACAD SCI USA, V107, P9418, DOI 10.1073/pnas.0913384107; Racca C, 2010, FRONT NEURAL CIRCUIT, V4, DOI 10.3389/neuro.04.005.2010; Saar D, 2012, J NEUROPHYSIOL, V107, P1222, DOI 10.1152/jn.00356.2011; Scheetz AJ, 2000, NAT NEUROSCI, V3, P211, DOI 10.1038/72915; Siucinska E, 1996, CEREB CORTEX, V6, P506, DOI 10.1093/cercor/6.3.506; Siucinska E, 1999, BRAIN RES, V843, P62, DOI 10.1016/S0006-8993(99)01881-8; Skibinska A, 2005, BRAIN RES, V1065, P26, DOI 10.1016/j.brainres.2005.10.021; Skibinska A, 2001, NEUROREPORT, V12, P2907, DOI 10.1097/00001756-200109170-00030; Steward O, 2003, NEURON, V40, P347, DOI 10.1016/S0896-6273(03)00635-4; Steward O, 2001, ANNU REV NEUROSCI, V24, P299, DOI 10.1146/annurev.neuro.24.1.299; STEWARD O, 1986, J NEUROSCI, V6, P3079; STEWARD O, 1982, J NEUROSCI, V2, P284; Sun QQ, 2006, J NEUROSCI, V26, P1219, DOI 10.1523/JNEUROSCI.4727-04.2006; Takumi Y, 1999, NAT NEUROSCI, V2, P618, DOI 10.1038/10172; Todd PK, 2003, P NATL ACAD SCI USA, V100, P14374, DOI 10.1073/pnas.2336265100; Tokarski K, 2007, EUR J NEUROSCI, V26, P134, DOI 10.1111/j.1460-9568.2007.05629.x; Wells DG, 2000, CURR OPIN NEUROBIOL, V10, P132, DOI 10.1016/S0959-4388(99)00050-1; Witcher MR, 2010, GLIA, V58, P572, DOI 10.1002/glia.20946; WOOLSEY TA, 1970, BRAIN RES, V17, P205, DOI 10.1016/0006-8993(70)90079-X; Xu TH, 2009, NATURE, V462, P915, DOI 10.1038/nature08389; Yu HB, 2011, P NATL ACAD SCI USA, V108, P21235, DOI 10.1073/pnas.1108270109	52	13	13	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e54301	10.1371/journal.pone.0054301	http://dx.doi.org/10.1371/journal.pone.0054301			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	099EJ	23457448	Green Published, gold, Green Submitted			2022-12-25	WOS:000315602700005
J	Singh, A; Ramnath, RD; Foster, RR; Wylie, EC; Friden, V; Dasgupta, I; Haraldsson, B; Welsh, GI; Mathieson, PW; Satchell, SC				Singh, Anurag; Ramnath, Raina D.; Foster, Rebecca R.; Wylie, Emma C.; Friden, Vincent; Dasgupta, Ishita; Haraldsson, Borje; Welsh, Gavin I.; Mathieson, Peter W.; Satchell, Simon C.			Reactive Oxygen Species Modulate the Barrier Function of the Human Glomerular Endothelial Glycocalyx	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; HEPARAN-SULFATE; HYDROGEN-PEROXIDE; OXIDATIVE STRESS; CELL GLYCOCALYX; IN-VITRO; PERMEABILITY; PROTEINURIA; KIDNEY; GLYCOSAMINOGLYCANS	Reactive oxygen species (ROS) play a key role in the pathogenesis of proteinuria in glomerular diseases like diabetic nephropathy. Glomerular endothelial cell (GEnC) glycocalyx covers the luminal aspect of the glomerular capillary wall and makes an important contribution to the glomerular barrier. ROS are known to depolymerise glycosaminoglycan (GAG) chains of proteoglycans, which are crucial for the barrier function of GEnC glycocalyx. The aim of this study is to investigate the direct effects of ROS on the structure and function of GEnC glycocalyx using conditionally immortalised human GEnC. ROS were generated by exogenous hydrogen peroxide. Biosynthesis and cleavage of GAG chains was analyzed by radiolabelling (S 35 and 3 H-glucosamine). GAG chains were quantified on GEnC surface and in the cell supernatant using liquid chromatography and immunofluorescence techniques. Barrier properties were estimated by measuring transendothelial passage of albumin. ROS caused a significant loss of WGA lectin and heparan sulphate staining from the surface of GEnC. This lead to an increase in trans-endothelial albumin passage. The latter could be inhibited by catalase and superoxide dismutase. The effect of ROS on GEnC was not mediated via the GAG biosynthetic pathway. Quantification of radiolabelled GAG fractions in the supernatant confirmed that ROS directly caused shedding of HS GAG. This finding is clinically relevant and suggests a mechanism by which ROS may cause proteinuria in clinical conditions associated with high oxidative stress.	[Singh, Anurag; Ramnath, Raina D.; Foster, Rebecca R.; Wylie, Emma C.; Dasgupta, Ishita; Welsh, Gavin I.; Mathieson, Peter W.; Satchell, Simon C.] Southmead Hosp, Acad Renal Unit, Bristol, Avon, England; [Singh, Anurag] Chilliwack Gen Hosp, Fraser Hlth Author Chilliwack, Div Med, Chilliwack, BC, Canada; [Friden, Vincent; Haraldsson, Borje] Gothenburg Univ, Sahlgrenska Acad, Inst Med, Renal Unit, Gothenburg, Sweden	Southmead Hospital; University of Gothenburg	Singh, A (corresponding author), Southmead Hosp, Acad Renal Unit, Bristol, Avon, England.	anuragsing@hotmail.com	Haraldsson, Borje/B-3871-2010; Ramnath, Raina/AAO-1180-2020; Foster, Rebecca/GSM-6886-2022; Foster, Becky/ABC-4433-2020	Haraldsson, Borje/0000-0002-7536-973X; Foster, Rebecca/0000-0002-9645-1476; Ramnath, Raina/0000-0001-8472-5081; Welsh, Gavin Iain/0000-0002-2148-6658	Kidney Research UK [TF22/2004]; Academy of Medical Sciences/Wellcome Trust UK; Diabetes UK [10/0004003]; MRC [G0800200] Funding Source: UKRI; British Heart Foundation [FS/10/017/28249] Funding Source: researchfish; Medical Research Council [G0800200] Funding Source: researchfish	Kidney Research UK(Kidney Research UK (KRUK)); Academy of Medical Sciences/Wellcome Trust UK; Diabetes UK(Diabetes UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	A. Singh is the recipient of a research training fellowship from Kidney Research UK (Grant TF22/2004) and an Academy of Medical Sciences/Wellcome Trust UK starter grant for clinical lecturers. The work was also supported by Diabetes UK (Grant 10/0004003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI T, 1993, BIOCHEM J, V289, P523, DOI 10.1042/bj2890523; Amann K, 2006, J AM SOC NEPHROL, V17, P2112, DOI 10.1681/ASN.2006030204; Andersson M, 2007, AM J PHYSIOL-RENAL, V292, pF1802, DOI 10.1152/ajprenal.00152.2006; BECKER M, 1994, AM J PHYSIOL, V267, pH925, DOI 10.1152/ajpheart.1994.267.3.H925; BRENNER BM, 1977, KIDNEY INT, V12, P229, DOI 10.1038/ki.1977.107; de Vega JMA, 2002, CRIT CARE MED, V30, P1782, DOI 10.1097/00003246-200208000-00018; Deen WM, 2001, AM J PHYSIOL-RENAL, V281, pF579; Edge ASB, 2000, DIABETOLOGIA, V43, P1056, DOI 10.1007/s001250051489; Foley RN, 1998, AM J KIDNEY DIS, V32, pS112, DOI 10.1053/ajkd.1998.v32.pm9820470; Forbes JM, 2008, DIABETES, V57, P1446, DOI 10.2337/db08-0057; Franco M, 2011, AM J MED, V124, P95, DOI 10.1016/j.amjmed.2010.08.015; Gerstein HC, 2001, JAMA-J AM MED ASSOC, V286, P421, DOI 10.1001/jama.286.4.421; GRANGER DN, 1986, ACTA PHYSIOL SCAND, V126, P47; Halliwell B, 2000, FEBS LETT, V486, P10, DOI 10.1016/S0014-5793(00)02197-9; Haraldsson B, 2008, PHYSIOL REV, V88, P451, DOI 10.1152/physrev.00055.2006; Harrison D, 2003, AM J CARDIOL, V91, p7A; Harrison DG, 2003, J RENIN-ANGIO-ALDO S, V4, P51, DOI 10.3317/jraas.2003.014; Henry CBS, 2000, AM J PHYSIOL-HEART C, V279, pH2815, DOI 10.1152/ajpheart.2000.279.6.H2815; Hjalmarsson C, 2004, MICROVASC RES, V67, P9, DOI 10.1016/j.mvr.2003.10.001; Jeansson M, 2006, AM J PHYSIOL-RENAL, V290, pF111, DOI 10.1152/ajprenal.00173.2005; Kevil CG, 1998, FREE RADICAL BIO MED, V24, P1015, DOI 10.1016/S0891-5849(97)00433-4; MOSELEY R, 1995, BBA-GEN SUBJECTS, V1244, P245, DOI 10.1016/0304-4165(95)00010-9; Moseley R, 1997, BBA-MOL BASIS DIS, V1362, P221, DOI 10.1016/S0925-4439(97)00083-5; Mulivor AW, 2004, AM J PHYSIOL-HEART C, V286, pH1672, DOI 10.1152/ajpheart.00832.2003; Raats CJI, 1997, J BIOL CHEM, V272, P26734, DOI 10.1074/jbc.272.42.26734; Reitsma S, 2007, PFLUG ARCH EUR J PHY, V454, P345, DOI 10.1007/s00424-007-0212-8; Rops ALWMM, 2004, KIDNEY INT, V65, P768, DOI 10.1111/j.1523-1755.2004.00451.x; Satchell SC, 2008, DIABETOLOGIA, V51, P714, DOI 10.1007/s00125-008-0961-8; Satchell SC, 2006, KIDNEY INT, V69, P1633, DOI 10.1038/sj.ki.5000277; Satchell SC, 2009, AM J PHYSIOL-RENAL, V296, pF947, DOI 10.1152/ajprenal.90601.2008; SHASBY DM, 1985, BLOOD, V65, P605; SiflingerBirnboim A, 1996, AM J PHYSIOL-LUNG C, V270, pL973, DOI 10.1152/ajplung.1996.270.6.L973; Singh A, 2007, J AM SOC NEPHROL, V18, P2885, DOI 10.1681/ASN.2007010119; Stan RV, 2007, J AM SOC NEPHROL, V18, P2432, DOI 10.1681/ASN.2007060687; Stehouwer CDA, 2006, J AM SOC NEPHROL, V17, P2106, DOI 10.1681/ASN.2005121288; TAY M, 1990, BIOCHEM INT, V20, P767; Witting PK, 2007, CELL PHYSIOL BIOCHEM, V20, P255, DOI 10.1159/000107512; YOSHIOKA T, 1991, J AM SOC NEPHROL, V2, P902; Ysebaert DK, 2000, NEPHROL DIAL TRANSPL, V15, P1562, DOI 10.1093/ndt/15.10.1562	39	101	111	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e55852	10.1371/journal.pone.0055852	http://dx.doi.org/10.1371/journal.pone.0055852			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457483	Green Submitted, Green Published, gold			2022-12-25	WOS:000315602700024
J	Wargo, MJ				Wargo, Matthew J.			Choline Catabolism to Glycine Betaine Contributes to Pseudomonas aeruginosa Survival during Murine Lung Infection	PLOS ONE			English	Article							PHOSPHOLIPASE-C; CYSTIC-FIBROSIS; LISTERIA-MONOCYTOGENES; VIRULENCE FACTORS; ESCHERICHIA-COLI; 3 TRANSPORTERS; IN-VIVO; CARNITINE; IDENTIFICATION; GROWTH	Pseudomonas aeruginosa can acquire and metabolize a variety of molecules including choline, an abundant host-derived molecule. In P. aeruginosa, choline is oxidized to glycine betaine which can be used as an osmoprotectant, a sole source of carbon and nitrogen, and as an inducer of the virulence factor, hemolytic phospholipase C (PlcH) via the transcriptional regulator GbdR. The primary objective was to determine the contribution of choline conversion to glycine betaine to P. aeruginosa survival during mouse lung infection. A secondary objective was to gain insight into the relative contributions of the different roles of glycine betaine to P. aeruginosa survival during infection. Using a model of acute murine pneumonia, we determined that deletion of the choline oxidase system (encoded by betBA) decreased P. aeruginosa survival in the mouse lung. Deletion of the glycine betaine demethylase genes (gbcA-B), required for glycine betaine catabolism, did not impact P. aeruginosa survival in the lung. Thus, the defect of the betBA mutant was not due to a requirement for glycine betaine catabolism or dependence on a downstream metabolite. Deletion of betBA decreased the abundance of plcH transcript during infection, which suggested a role for PlcH in the betBA survival defect. To test the contribution of plcH to the betBA mutant phenotype a betBAplcHR double deletion mutant was generated. The betBA and betBAplcHR double mutant had a small but significant survival defect compared to the plcHR single mutant, suggesting that regulation of plcH expression is not the only role for glycine betaine during infection. The conclusion was that choline acquisition and its oxidation to glycine betaine contribute to P. aeruginosa survival in the mouse lung. While defective plcH induction can explain a portion of the betBA mutant phenotype, the exact mechanisms driving the betBA mutant survival defect remain unknown.	[Wargo, Matthew J.] Univ Vermont, Coll Med, Dept Microbiol & Mol Genet, Burlington, VT 05405 USA; [Wargo, Matthew J.] Univ Vermont, Coll Med, Vermont Lung Ctr, Burlington, VT USA	University of Vermont; University of Vermont	Wargo, MJ (corresponding author), Univ Vermont, Coll Med, Dept Microbiol & Mol Genet, Burlington, VT 05405 USA.	mwargo@uvm.edu		Wargo, Matthew/0000-0001-5659-749X	National Center for Research Resources [5P20RR021905-07]; National Institute of General Medical Sciences from the National Institutes of Health [8 P20 GM103496-07]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021905] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103496] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences from the National Institutes of Health(General Electric); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was supported by grants from the National Center for Research Resources (5P20RR021905-07) and the National Institute of General Medical Sciences (8 P20 GM103496-07) from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelidis AS, 2003, APPL ENVIRON MICROB, V69, P1013, DOI 10.1128/AEM.69.2.1013-1022.2003; BERKA RM, 1982, J BACTERIOL, V152, P239; BODY DR, 1971, LIPIDS, V6, P625, DOI 10.1007/BF02531518; Boncompagni E, 1999, APPL ENVIRON MICROB, V65, P2072; Boulette ML, 2009, J BACTERIOL, V191, P6329, DOI 10.1128/JB.00817-09; BREMER J, 1983, PHYSIOL REV, V63, P1420, DOI 10.1152/physrev.1983.63.4.1420; Brown SA, 2008, NAT REV MICROBIOL, V6, P657, DOI 10.1038/nrmicro1955; Cattoir V, 2012, MBIO, V3, DOI 10.1128/mBio.00410-12; Chastre J, 2002, AM J RESP CRIT CARE, V165, P867, DOI 10.1164/ajrccm.165.7.2105078; Chen C, 2008, J BACTERIOL, V190, P2717, DOI 10.1128/JB.01585-07; Chen CL, 2010, MOL MICROBIOL, V75, P29, DOI 10.1111/j.1365-2958.2009.06962.x; CSONKA LN, 1991, ANNU REV MICROBIOL, V45, P569, DOI 10.1146/annurev.mi.45.100191.003033; CSONKA LN, 1989, MICROBIOL REV, V53, P121, DOI 10.1128/MMBR.53.1.121-147.1989; Diab F, 2006, MICROBIOL-SGM, V152, P1395, DOI 10.1099/mic.0.28652-0; DOMENECH CE, 1991, FEMS MICROBIOL LETT, V82, P131, DOI 10.1111/j.1574-6968.1991.tb04853.x; Feinbaum RL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002813; Fischbach MA, 2009, SCIENCE, V325, P1089, DOI 10.1126/science.1176667; Fitzsimmons LF, 2012, J BACTERIOL, V194, P4718, DOI 10.1128/JB.00596-12; Fitzsimmons LF, 2011, APPL ENVIRON MICROB, V77, P4383, DOI 10.1128/AEM.00504-11; GARBER ED, 1960, ANN NY ACAD SCI, V88, P1187, DOI 10.1111/j.1749-6632.1960.tb20108.x; Gibson RL, 2003, AM J RESP CRIT CARE, V168, P918, DOI 10.1164/rccm.200304-505SO; GILLJAM H, 1988, CLIN CHIM ACTA, V176, P29, DOI 10.1016/0009-8981(88)90171-4; GRAY GL, 1981, J BACTERIOL, V147, P675, DOI 10.1128/JB.147.2.675-678.1981; GUTIERREZ JA, 1995, J BACTERIOL, V177, P390, DOI 10.1128/jb.177.2.390-400.1995; Kang PJ, 1997, MOL MICROBIOL, V24, P1249; Kim SH, 2008, INFECT IMMUN, V76, P4152, DOI 10.1128/IAI.01637-07; KORTSTEE GJ, 1970, ARCH MIKROBIOL, V71, P235, DOI 10.1007/BF00410157; KUNIN CM, 1992, J INFECT DIS, V166, P1311, DOI 10.1093/infdis/166.6.1311; Lanotte P, 2003, PEDIATR PULM, V36, P405, DOI 10.1002/ppul.10380; LINDSTED.G, 1967, BIOCHEMISTRY-US, V6, P1262, DOI 10.1021/bi00857a006; LISA TA, 1994, CURR MICROBIOL, V29, P193, DOI 10.1007/BF01570153; Mahajan-Miklos S, 2000, MOL MICROBIOL, V37, P981, DOI 10.1046/j.1365-2958.2000.02056.x; Malek AA, 2011, J BACTERIOL, V193, P3033, DOI 10.1128/JB.00160-11; Massimelli MJ, 2011, MICROBIOL RES, V166, P380, DOI 10.1016/j.micres.2010.07.004; Massimelli MJ, 2005, CURR MICROBIOL, V50, P251, DOI 10.1007/s00284-004-4499-9; Mathias S, 1998, BIOCHEM J, V335, P465, DOI 10.1042/bj3350465; MEYERS DJ, 1992, TOXICON, V30, P161, DOI 10.1016/0041-0101(92)90469-L; OSTROFF RM, 1989, INFECT IMMUN, V57, P1369, DOI 10.1128/IAI.57.5.1369-1373.1989; Price CTD, 2008, J BACTERIOL, V190, P3955, DOI 10.1128/JB.01476-07; RAHME LG, 1995, SCIENCE, V268, P1899, DOI 10.1126/science.7604262; Rahme LG, 1997, P NATL ACAD SCI USA, V94, P13245, DOI 10.1073/pnas.94.24.13245; Rahme LG, 2000, P NATL ACAD SCI USA, V97, P8815, DOI 10.1073/pnas.97.16.8815; Rebouche CJ, 1998, ANNU REV NUTR, V18, P39, DOI 10.1146/annurev.nutr.18.1.39; Sage AE, 1997, MOL MICROBIOL, V23, P43, DOI 10.1046/j.1365-2958.1997.1681542.x; Salunkhe P, 2005, J BACTERIOL, V187, P4908, DOI 10.1128/JB.187.14.4908-4920.2005; Shanks RMQ, 2006, APPL ENVIRON MICROB, V72, P5027, DOI 10.1128/AEM.00682-06; Sleator RD, 2003, J APPL MICROBIOL, V95, P839, DOI 10.1046/j.1365-2672.2003.02056.x; Slow S, 2009, PHYSIOL RES, V58, P403, DOI 10.33549/physiolres.931569; Son MS, 2007, INFECT IMMUN, V75, P5313, DOI 10.1128/IAI.01807-06; Vasil ML, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000420; VASIL ML, 1991, ANTIBIOT CHEMOTHER, V44, P34; Velasco-Garcia R, 2006, ARCH MICROBIOL, V185, P14, DOI 10.1007/s00203-005-0054-8; WANNER C, 1986, AM J NEPHROL, V6, P206, DOI 10.1159/000167119; Wargo MJ, 2008, J BACTERIOL, V190, P2690, DOI 10.1128/JB.01393-07; Wargo MJ, 2011, AM J RESP CRIT CARE, V184, P345, DOI 10.1164/rccm.201103-0374OC; Wargo MJ, 2009, MICROBIOL-SGM, V155, P2411, DOI 10.1099/mic.0.028787-0; Wargo MJ, 2009, INFECT IMMUN, V77, P1103, DOI 10.1128/IAI.01008-08; Wieland CW, 2002, INFECT IMMUN, V70, P1352, DOI 10.1128/IAI.70.3.1352-1358.2002; Winsor GL, 2011, NUCLEIC ACIDS RES, V39, pD596, DOI 10.1093/nar/gkq869; Zaldivar-Machorro VJ, 2011, BIOCHIMIE, V93, P286, DOI 10.1016/j.biochi.2010.09.022	60	32	34	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56850	10.1371/journal.pone.0056850	http://dx.doi.org/10.1371/journal.pone.0056850			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457628	Green Published, gold, Green Submitted			2022-12-25	WOS:000315602700099
J	Zhou, WW; Liang, QM; Xu, Y; Gurr, GM; Bao, YY; Zhou, XP; Zhang, CX; Cheng, J; Zhu, ZR				Zhou, Wen-Wu; Liang, Qing-Mei; Xu, Yi; Gurr, Geoff M.; Bao, Yan-Yuan; Zhou, Xue-Ping; Zhang, Chuan-Xi; Cheng, Jiaan; Zhu, Zeng-Rong			Genomic Insights into the Glutathione S-Transferase Gene Family of Two Rice Planthoppers, Nilaparvata lugens (Stal) and Sogatella furcifera (Horvath) (Hemiptera: Delphacidae)	PLOS ONE			English	Article							BROWN PLANTHOPPER; INSECTICIDE-RESISTANCE; EXPRESSION PROFILES; PHLOEM SAP; HETEROLOGOUS EXPRESSION; DETOXIFICATION ENZYMES; CHEMICAL-COMPOSITION; SUPERGENE FAMILY; RNA INTERFERENCE; IDENTIFICATION	Background: Glutathione S-transferase (GST) genes control crucial traits for the metabolism of various toxins encountered by insects in host plants and the wider environment, including insecticides. The planthoppers Nilaparvata lugens and Sogatella furcifera are serious specialist pests of rice throughout eastern Asia. Their capacity to rapidly adapt to resistant rice varieties and to develop resistance to various insecticides has led to severe outbreaks over the last decade. Methodology/Principal Findings: Using the genome sequence of N. lugens, we identified for the first time the complete GST gene family of a delphacid insect whilst nine GST gene orthologs were identified from the closely related species S. furcifera. Nilaparvata lugens has 11 GST genes belonging to six cytosolic subclasses and a microsomal class, many fewer than seen in other insects with known genomes. Sigma is the largest GST subclass, and the intron-exon pattern deviates significantly from that of other species. Higher GST gene expression in the N. lugens adult migratory form reflects the higher risk of this life stage in encountering the toxins of non-host plants. After exposure to a sub-lethal dose of four insecticides, chlorpyrifos, imidacloprid, buprofezin or beta-cypermethrin, more GST genes were upregulated in S. furcifera than in N. lugens. RNA interference targeting two N. lugens GST genes, NlGSTe1 and NlGSTm2, significantly increased the sensitivity of fourth instar nymphs to chlorpyrifos but not to beta-cypermethrin. Conclusions/Significance: This study provides the first elucidation of the nature of the GST gene family in a delphacid species, offering new insights into the evolution of metabolic enzyme genes in insects. Further, the use of RNA interference to identify the GST genes induced by insecticides illustrates likely mechanisms for the tolerance of these insects.	[Zhou, Wen-Wu; Liang, Qing-Mei; Gurr, Geoff M.; Bao, Yan-Yuan; Zhang, Chuan-Xi; Cheng, Jiaan; Zhu, Zeng-Rong] Zhejiang Univ, Minist Agr, Key Lab Agr Entomol, State Key Lab Rice Biol, Hangzhou 310003, Zhejiang, Peoples R China; [Zhou, Wen-Wu; Liang, Qing-Mei; Gurr, Geoff M.; Bao, Yan-Yuan; Zhang, Chuan-Xi; Cheng, Jiaan; Zhu, Zeng-Rong] Zhejiang Univ, Inst Insect Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Xu, Yi; Zhou, Xue-Ping] Zhejiang Univ, Inst Biotechnol, Hangzhou 310003, Zhejiang, Peoples R China; [Gurr, Geoff M.] Charles Sturt Univ, EH Graham Ctr Agr Innovat, Orange, NSW, Australia	Ministry of Agriculture & Rural Affairs; Zhejiang University; Zhejiang University; Zhejiang University; Charles Sturt University	Zhu, ZR (corresponding author), Zhejiang Univ, Minist Agr, Key Lab Agr Entomol, State Key Lab Rice Biol, Hangzhou 310003, Zhejiang, Peoples R China.	zrzhu@zju.edu.cn	GURR, GEOFFREY M/F-3519-2011; Zhang, Chuan-Xi/K-7978-2019	Zhang, Chuan-Xi/0000-0002-7784-1188; Gurr, Geoff/0000-0001-5008-7966; Zhou, Wenwu/0000-0002-0727-8086	973 Programme [2010CB126200]; National Key Technology R&D Program of the Ministry of Science and Technology of China [2012BAD19B01]; National Natural Science Foundation of China [30971908]	973 Programme(National Basic Research Program of China); National Key Technology R&D Program of the Ministry of Science and Technology of China(National Key Technology R&D Program); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financially supported by the 973 Programme (2010CB126200) and National Key Technology R&D Program (2012BAD19B01) of the Ministry of Science and Technology of China and the National Natural Science Foundation of China (30971908). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Asano K, 2011, P NATL ACAD SCI USA, V108, P11034, DOI 10.1073/pnas.1019490108; Bass C, 2012, INSECT SCI, V19, P1, DOI 10.1111/j.1744-7917.2011.01440.x; Catindig J. L., 2009, PLANTHOPPERS NEW THR, P191; Chen J, 2010, INSECT MOL BIOL, V19, P777, DOI 10.1111/j.1365-2583.2010.01038.x; Cheng J., 2009, PLANTHOPPERS NEW THR, P157; Despres L, 2007, TRENDS ECOL EVOL, V22, P298, DOI 10.1016/j.tree.2007.02.010; Ding J.-H., 1981, J NANJING AGR COLL, V3, P78; Ding YC, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-35; Enayati AA, 2005, INSECT MOL BIOL, V14, P3, DOI 10.1111/j.1365-2583.2004.00529.x; Fedorov A, 2003, GENOME RES, V13, P2236, DOI 10.1101/gr.1029803; Feng QL, 2001, J INSECT PHYSIOL, V47, P1, DOI 10.1016/S0022-1910(00)00093-7; Friedman R, 2011, MOL PHYLOGENET EVOL, V61, P924, DOI 10.1016/j.ympev.2011.08.027; FUKUMORITA T, 1982, PLANT CELL PHYSIOL, V23, P273; HAYASHI H, 1990, PLANT CELL PHYSIOL, V31, P247; HAYASHI H, 1985, PLANT CELL PHYSIOL, V26, P325; Hayes JD, 1995, CRIT REV BIOCHEM MOL, V30, P445, DOI 10.3109/10409239509083491; Hemingway J, 2000, ANNU REV ENTOMOL, V45, P371, DOI 10.1146/annurev.ento.45.1.371; Hemingway J, 1999, INT J PEST MANAGE, V45, P215, DOI 10.1080/096708799227824; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; KAWABE S, 1980, PLANT CELL PHYSIOL, V21, P1319, DOI 10.1093/oxfordjournals.pcp.a076130; Kenmore P. E., 1991, INDONESIAS INTEGRATE; Ketterman AJ, 2011, DRUG METAB REV, V43, P253, DOI 10.3109/03602532.2011.552911; Kim HS, 2010, NUCLEIC ACIDS RES, V38, pD437, DOI 10.1093/nar/gkp807; Li J, 2011, PEST MANAG SCI, V67, P852, DOI 10.1002/ps.2124; Li XC, 2007, ANNU REV ENTOMOL, V52, P231, DOI 10.1146/annurev.ento.51.110104.151104; Li XW, 2009, INSECT BIOCHEM MOLEC, V39, P745, DOI 10.1016/j.ibmb.2009.08.010; Liu SH, 2010, INSECT BIOCHEM MOLEC, V40, P666, DOI 10.1016/j.ibmb.2010.06.007; Liu ZW, 2006, PEST MANAG SCI, V62, P279, DOI 10.1002/ps.1169; Lougarre A, 1999, INSECT MOL BIOL, V8, P141, DOI 10.1046/j.1365-2583.1999.810141.x; Lumjuan N, 2011, INSECT BIOCHEM MOLEC, V41, P203, DOI 10.1016/j.ibmb.2010.12.005; Meng JY, 2009, J INSECT PHYSIOL, V55, P588, DOI 10.1016/j.jinsphys.2009.03.003; Morgenstern R, 2005, METHOD ENZYMOL, V401, P136, DOI 10.1016/S0076-6879(05)01008-6; NAGATA T, 1979, APPL ENTOMOL ZOOL, V14, P264, DOI 10.1303/aez.14.264; Nair PMG, 2011, AQUAT TOXICOL, V101, P550, DOI 10.1016/j.aquatox.2010.12.006; Nardini L, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-113; Noda H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-117; Oakeshott JG, 2010, INSECT MOL BIOL, V19, P147, DOI 10.1111/j.1365-2583.2009.00961.x; Ortelli F, 2003, BIOCHEM J, V373, P957, DOI 10.1042/BJ20030169; Otuka A, 2005, POPUL ECOL, V47, P143, DOI 10.1007/s10144-005-0216-1; PANNABECKER T, 1995, ANNU REV ENTOMOL, V40, P493, DOI 10.1146/annurev.en.40.010195.002425; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Qin GH, 2011, PEST MANAG SCI, V67, P697, DOI 10.1002/ps.2110; Ramsey JS, 2010, INSECT MOL BIOL, V19, P155, DOI 10.1111/j.1365-2583.2009.00973.x; Ranson H, 2002, SCIENCE, V298, P179, DOI 10.1126/science.1076781; Reddy BPN, 2011, PARASITOL RES, V109, P1165, DOI 10.1007/s00436-011-2364-x; Sezer M, 1998, HEREDITY, V80, P499, DOI 10.1046/j.1365-2540.1998.00316.x; Singh M, 2000, GENE, V247, P167, DOI 10.1016/S0378-1119(00)00102-5; Singh SP, 2001, EUR J BIOCHEM, V268, P2912, DOI 10.1046/j.1432-1327.2001.02179.x; Skopelitou K, 2012, FUNCT INTEGR GENOMIC, V12, P157, DOI 10.1007/s10142-011-0248-x; Strode C, 2008, INSECT BIOCHEM MOLEC, V38, P113, DOI 10.1016/j.ibmb.2007.09.007; Tang J, 2010, PEST MANAG SCI, V66, P121, DOI 10.1002/ps.1836; Toba G, 2000, GENE, V253, P179, DOI 10.1016/S0378-1119(00)00246-8; Vit P, 2008, ARCH LATINOAM NUTR, V58, P411; Vontas JG, 2001, BIOCHEM J, V357, P65, DOI 10.1042/0264-6021:3570065; Vontas JG, 2002, BIOCHEM J, V362, P329, DOI 10.1042/bj3620329; Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260; Wongtrakul J, 2010, J MED ENTOMOL, V47, P162, DOI 10.1603/ME09132; Xu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036238; Xue JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014233; Yamamoto K, 2009, PESTIC BIOCHEM PHYS, V94, P30, DOI 10.1016/j.pestbp.2009.02.008; Yang ZF, 2005, ARCH INSECT BIOCHEM, V59, P59, DOI 10.1002/arch.20055; Yang ZH, 1998, J MOL EVOL, V46, P409, DOI 10.1007/PL00006320; Yao HW, 2002, INSECT SCI, V9, P9; Yu QY, 2008, INSECT BIOCHEM MOLEC, V38, P1158, DOI 10.1016/j.ibmb.2008.08.002; Zha WJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020504; Zhou GH, 2008, CHINESE SCI BULL, V53, P3677, DOI 10.1007/s11434-008-0467-2; Zhou WW, 2012, PEST MANAG SCI, V68, P1296, DOI 10.1002/ps.3297; Zou FM, 2011, MOL BIOL REP, V38, P639, DOI 10.1007/s11033-010-0150-y; Zou S, 2000, P NATL ACAD SCI USA, V97, P13726, DOI 10.1073/pnas.260496697	70	85	89	0	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56604	10.1371/journal.pone.0056604	http://dx.doi.org/10.1371/journal.pone.0056604			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457591	Green Published, gold			2022-12-25	WOS:000315602700085
J	Bocian, C; Urbanowitz, AK; Owens, RT; Iozzo, RV; Gotte, M; Seidler, DG				Bocian, Carla; Urbanowitz, Ann-Kathrin; Owens, Rick T.; Iozzo, Renato V.; Goette, Martin; Seidler, Daniela G.			Decorin Potentiates Interferon-gamma Activity in a Model of Allergic Inflammation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONTACT HYPERSENSITIVITY RESPONSE; DELAYED-TYPE HYPERSENSITIVITY; ENDOTHELIAL-GROWTH-FACTOR; TOLL-LIKE RECEPTOR; IFN-GAMMA; INDUCIBLE PROTEIN-10; T-CELLS; SKIN INFLAMMATION; MURINE MODEL; MAST-CELLS	The proteoglycan decorin modulates leukocyte recruitment during delayed-type hypersensitivity responses. Decorin-deficient (Dcn(-/-)) mice show reduced edema formation during the first 24 h with a concurrent attenuated recruitment of CD8(+) leukocytes in the inflamed Dcn(-/-) ears. The aim of this study was to elucidate the molecular pathways affected by the loss of decorin. In vivo, reduced numbers of CD8(+) cells in Dcn(-/-) ears correlated with a reduced interferon-gamma (Ifn-gamma) and CXCL-10 expression. In vitro, Dcn(-/-) lymphocytes displayed an increased adhesion to brain microvascular (bEnd.3) endothelial cells. Decorin treatment of bEnd.3 increased Icam1 and down-regulated Vcam1 expression after TNF-alpha stimulation. However, Dcn(-/-) and wild-type lymphocytes produced IFN-gamma after activation with CD3 epsilon. Upon incubation with decorin, endothelial cells and fibroblasts responded differently to IFN-gamma and TNF-alpha; CCL2 in bEnd.3 cells was more prominently up-regulated by TNF-alpha compared with IFN-gamma. Notably, both factors were more potent in the presence of decorin. Compared with TNF-alpha, IFN-gamma treatment induced significantly more CXCL-10, and both factors increased synthesis of CXCL-10 in the presence of decorin. The response to IFN-gamma was similar in Dcn(-/-) and wild-type fibroblasts, an additional source of CXCL-10. However, addition of decorin yielded significantly more CXCL-10. Notably, decorin increased the stability of IFN-gamma in vitro and potentiated IFN-gamma-induced activation of STAT-1. Furthermore, only dermatan sulfate influenced IFN-gamma signaling by significantly increasing CXCL-10 expression in contrast to decorin protein core alone. Our data demonstrate that decorin modulates delayed-type hypersensitivity responses by augmenting the induction of downstream effector cytokines of IFN-gamma and TNF-alpha, thereby influencing the recruitment of CD8(+) lymphocytes into the inflamed tissue.	[Bocian, Carla; Urbanowitz, Ann-Kathrin; Seidler, Daniela G.] Univ Munster, Inst Physiol Chem & Pathobiochem, D-48149 Munster, Germany; [Bocian, Carla; Urbanowitz, Ann-Kathrin; Goette, Martin] Munster Univ Hosp, Dept Gynecol & Obstet, D-48149 Munster, Germany; [Owens, Rick T.] LifeCell Corp, Branchburg, NJ 08876 USA; [Iozzo, Renato V.] Thomas Jefferson Univ, Kimmel Canc Ctr, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA; [Iozzo, Renato V.] Thomas Jefferson Univ, Kimmel Canc Ctr, Canc Cell Biol & Signaling Program, Philadelphia, PA 19107 USA	University of Munster; University of Munster; Jefferson University; Jefferson University	Seidler, DG (corresponding author), Univ Munster, UKM, Inst Physiol Chem & Pathobiochem, Waldeyerstr 15, D-48149 Munster, Germany.	dgseidle@uni-muenster.de	Iozzo, Renato/AAS-1980-2020; Gotte, M/Z-5878-2019; Götte, Martin/G-2254-2018	Gotte, M/0000-0003-2360-2496; Götte, Martin/0000-0003-2360-2496; Iozzo, Renato/0000-0002-5908-5112	Innovative Medizinische Forschung of the Medical Faculty Munster Grant [I-SE 12 08 11]; Deutsche Forschungsgemeinschaft Grant [SE1431/3-1]; International Research Training Group "Molecular and Cellular GlycoSciences" Grant [GRK 1549]; NATIONAL CANCER INSTITUTE [R01CA039481] Funding Source: NIH RePORTER	Innovative Medizinische Forschung of the Medical Faculty Munster Grant; Deutsche Forschungsgemeinschaft Grant(German Research Foundation (DFG)); International Research Training Group "Molecular and Cellular GlycoSciences" Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Innovative Medizinische Forschung of the Medical Faculty Munster Grant I-SE 12 08 11, Deutsche Forschungsgemeinschaft Grant SE1431/3-1 (to D. G. S. and M. G.), and International Research Training Group "Molecular and Cellular GlycoSciences" Grant GRK 1549 (to A. K. U.).	Ahlfors EE, 2010, SCAND J IMMUNOL, V72, P8, DOI 10.1111/j.1365-3083.2010.02402.x; Anthoni M, 2008, BRIT J DERMATOL, V159, P546, DOI 10.1111/j.1365-2133.2008.08696.x; Babelova A, 2009, J BIOL CHEM, V284, P24035, DOI 10.1074/jbc.M109.014266; Brooks B, 2000, J IMMUNOL, V164, P573, DOI 10.4049/jimmunol.164.2.573; Buraschi Simone, 2010, J Biol Chem, V285, P42075, DOI 10.1074/jbc.M110.172841; Cabello-Verrugio C, 2012, J BIOL CHEM, V287, P6773, DOI 10.1074/jbc.M111.312488; Comalada M, 2003, J IMMUNOL, V170, P4450, DOI 10.4049/jimmunol.170.9.4450; Danielson KG, 1997, J CELL BIOL, V136, P729, DOI 10.1083/jcb.136.3.729; Dufour JH, 2002, J IMMUNOL, V168, P3195, DOI 10.4049/jimmunol.168.7.3195; Edovitsky E, 2006, BLOOD, V107, P3609, DOI 10.1182/blood-2005-08-3301; Engeman T, 2004, J LEUKOCYTE BIOL, V76, P941, DOI 10.1189/jlb.0304193; Ferdous Z, 2010, J BIOMED MATER RES A, V93A, P419, DOI 10.1002/jbm.a.32545; Fernandez-Botran R, 1999, CYTOKINE, V11, P313, DOI 10.1006/cyto.1998.0438; Flacher V, 2008, IMMUNOLOGY, V123, P339, DOI 10.1111/j.1365-2567.2007.02785.x; Floer M, 2010, AM J PATHOL, V176, P146, DOI 10.2353/ajpath.2010.080639; GOKA AKJ, 1987, J IMMUNOASSAY, V8, P29, DOI 10.1080/01971528708063053; Goldoni S, 2009, J CELL BIOL, V185, P743, DOI 10.1083/jcb.200901129; Gotte M, 2003, FASEB J, V17, P575, DOI 10.1096/fj.02-0739rev; GOTTE M, 1995, EUR J CELL BIOL, V66, P226; Grabbe S, 1998, IMMUNOL TODAY, V19, P37, DOI 10.1016/S0167-5699(97)01186-9; Hope JC, 2000, EUR J IMMUNOL, V30, P197, DOI 10.1002/1521-4141(200001)30:1<197::AID-IMMU197>3.3.CO;2-0; Huckel M, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1869; Itakura A, 2006, INT ARCH ALLERGY IMM, V140, P8, DOI 10.1159/000092705; Jin HL, 2009, J ALLERGY CLIN IMMUN, V123, P875, DOI 10.1016/j.jaci.2009.02.007; Jungmann O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050809; Kaplan DH, 2012, NAT REV IMMUNOL, V12, P114, DOI 10.1038/nri3150; Kish DD, 2011, J IMMUNOL, V186, P2117, DOI 10.4049/jimmunol.1002337; Ku HO, 2009, TOXICOL LETT, V190, P231, DOI 10.1016/j.toxlet.2009.07.022; Kusumoto M, 2007, J INTERF CYTOK RES, V27, P901, DOI 10.1089/jir.2006.0064; Lee S, 2009, J BIOL CHEM, V284, P23662, DOI 10.1074/jbc.M109.026229; Lehtimaki S, 2010, J INVEST DERMATOL, V130, P2743, DOI 10.1038/jid.2010.208; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marchica CL, 2011, AM J PHYSIOL-LUNG C, V300, pL863, DOI 10.1152/ajplung.00300.2009; Martin SF, 2008, J EXP MED, V205, P2151, DOI 10.1084/jem.20070509; Masouleh BK, 2009, J IMMUNOL, V182, P4985, DOI 10.4049/jimmunol.0800574; Merline R, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001868; MONTESANO R, 1990, CELL, V62, P435, DOI 10.1016/0092-8674(90)90009-4; Nakae S, 2003, INT IMMUNOL, V15, P251, DOI 10.1093/intimm/dxg028; Neill T, 2012, J BIOL CHEM, V287, P5492, DOI 10.1074/jbc.M111.283499; Norman MU, 2008, AM J PATHOL, V172, P1638, DOI 10.2353/ajpath.2008.070559; Penc SF, 1999, J CLIN INVEST, V103, P1329, DOI 10.1172/JCI4742; PORTOLES P, 1989, J IMMUNOL, V142, P4169; Ramamurthy P, 1996, J BIOL CHEM, V271, P19578, DOI 10.1074/jbc.271.32.19578; Reeves EP, 2010, J IMMUNOL, V184, P1642, DOI 10.4049/jimmunol.0902605; Ruehland C, 2007, FEBS J, V274, P4246, DOI 10.1111/j.1742-4658.2007.05951.x; Salek-Ardakani S, 2000, BLOOD, V96, P1879, DOI 10.1182/blood.V96.5.1879.h8001879_1879_1888; Schaefer L, 2002, AM J PATHOL, V160, P1181, DOI 10.1016/S0002-9440(10)64937-1; Schaefer L, 2005, J CLIN INVEST, V115, P2223, DOI 10.1172/JCI23755; Schaefer L, 2012, CURR OPIN GENET DEV, V22, P56, DOI 10.1016/j.gde.2011.12.002; Seidler DG, 2008, IUBMB LIFE, V60, P729, DOI 10.1002/iub.115; Seidler DG, 2006, J MOL MED, V84, P583, DOI 10.1007/s00109-006-0046-4; Seidler DG, 2011, J IMMUNOL, V187, P6108, DOI 10.4049/jimmunol.1100373; Seidler DG, 2005, BIOCHEM BIOPH RES CO, V332, P1162, DOI 10.1016/j.bbrc.2005.04.175; Shetty S, 2011, J IMMUNOL, V186, P4147, DOI 10.4049/jimmunol.1002961; Shibata M, 2005, J DERMATOL, V32, P523, DOI 10.1111/j.1346-8138.2005.tb00794.x; Tamassia N, 2007, EUR J IMMUNOL, V37, P2627, DOI 10.1002/eji.200737340; TAUB DD, 1993, J EXP MED, V177, P1809, DOI 10.1084/jem.177.6.1809; THOMSON JA, 1993, IMMUNOLOGY, V78, P185; Tufvesson E, 2002, FEBS LETT, V530, P124, DOI 10.1016/S0014-5793(02)03439-7; Wang BH, 2000, J IMMUNOL, V165, P6783, DOI 10.4049/jimmunol.165.12.6783; Wang BH, 2002, J IMMUNOL, V168, P3303, DOI 10.4049/jimmunol.168.7.3303; Wang LC, 2005, NAT IMMUNOL, V6, P902, DOI 10.1038/ni1233; Wang LC, 2002, J CLIN INVEST, V110, P127, DOI 10.1172/JCI200214996; Xu H, 1997, J IMMUNOL, V158, P4721; Yin Y, 2011, EUR J PHARMACOL, V651, P205, DOI 10.1016/j.ejphar.2010.10.068; Yuan C, 2012, J BIOL CHEM, V287, P17006, DOI 10.1074/jbc.M112.341198; Zamfir AD, 2009, PROTEOMICS, V9, P3435, DOI 10.1002/pmic.200800440	67	23	23	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2013	288	18					12699	12711		10.1074/jbc.M112.419366	http://dx.doi.org/10.1074/jbc.M112.419366			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	139AZ	23460644	Green Published, hybrid			2022-12-25	WOS:000318555100027
J	Granberg, F; Vicente-Rubiano, M; Rubio-Guerri, C; Karlsson, OE; Kukielka, D; Belak, S; Sanchez-Vizcaino, JM				Granberg, Fredrik; Vicente-Rubiano, Marina; Rubio-Guerri, Consuelo; Karlsson, Oskar E.; Kukielka, Deborah; Belak, Sandor; Manuel Sanchez-Vizcaino, Jose			Metagenomic Detection of Viral Pathogens in Spanish Honeybees: Co- Infection by Aphid Lethal Paralysis, Israel Acute Paralysis and Lake Sinai Viruses	PLOS ONE			English	Article							DEFORMED WING VIRUS; 1ST DETECTION; BEE VIRUSES; SHORT COMMUNICATION.; PREVALENCE; IAPV; APIARIES; KASHMIR; PUPAE	The situation in Europe concerning honeybees has in recent years become increasingly aggravated with steady decline in populations and/or catastrophic winter losses. This has largely been attributed to the occurrence of a variety of known and "unknown", emerging novel diseases. Previous studies have demonstrated that colonies often can harbour more than one pathogen, making identification of etiological agents with classical methods difficult. By employing an unbiased metagenomic approach, which allows the detection of both unexpected and previously unknown infectious agents, the detection of three viruses, Aphid Lethal Paralysis Virus (ALPV), Israel Acute Paralysis Virus (IAPV), and Lake Sinai Virus (LSV), in honeybees from Spain is reported in this article. The existence of a subgroup of ALPV with the ability to infect bees was only recently reported and this is the first identification of such a strain in Europe. Similarly, LSV appear to be a still unclassified group of viruses with unclear impact on colony health and these viruses have not previously been identified outside of the United States. Furthermore, our study also reveals that these bees carried a plant virus, Turnip Ringspot Virus (TuRSV), potentially serving as important vector organisms. Taken together, these results demonstrate the new possibilities opened up by high-throughput sequencing and metagenomic analysis to study emerging new diseases in domestic and wild animal populations, including honeybees.	[Granberg, Fredrik; Karlsson, Oskar E.; Belak, Sandor] Swedish Univ Agr Sci SLU, Dept Biomed Sci & Vet Publ Hlth BVF, Uppsala, Sweden; [Granberg, Fredrik; Karlsson, Oskar E.; Belak, Sandor] OIE Collaborating Ctr Biotechnol Based Diag Infec, Uppsala, Sweden; [Vicente-Rubiano, Marina; Rubio-Guerri, Consuelo; Kukielka, Deborah; Manuel Sanchez-Vizcaino, Jose] Univ Complutense Madrid, Fac Vet, Dept Anim Hlth, Madrid, Spain; [Karlsson, Oskar E.] SLU, Dept Anim Breeding & Genet HGEN, SLU Global Bioinformat Ctr, Uppsala, Sweden; [Belak, Sandor] Natl Vet Inst SVA, VIP, Dept Virol Immunobiol & Parasitol, Uppsala, Sweden	Swedish University of Agricultural Sciences; Complutense University of Madrid; Swedish University of Agricultural Sciences; National Veterinary Institute SVA	Granberg, F (corresponding author), Swedish Univ Agr Sci SLU, Dept Biomed Sci & Vet Publ Hlth BVF, Uppsala, Sweden.	fredrik.granberg@slu.se	Sánchez-Vizcaíno, José Manuel/G-6299-2015; Kukielka, Deborah/L-4667-2014; Belak, Sandor/AAP-4759-2021; Granberg, Fredrik/AAH-6330-2021	Sánchez-Vizcaíno, José Manuel/0000-0002-1502-8968; Kukielka, Deborah/0000-0002-3114-7377; Granberg, Fredrik/0000-0001-5497-9611; Karlsson Lindsjo, Oskar/0000-0003-1068-981X	Swedish University of Agricultural Sciences (SLU); Ministry of Education, Culture and Sports of Spain; EU-project AniBioThreat [Home/2009/ISEC/AG/191]; Prevention of and Fight against Crime Programme of the European Union, European Commission - Directorate General Home Affairs	Swedish University of Agricultural Sciences (SLU); Ministry of Education, Culture and Sports of Spain; EU-project AniBioThreat; Prevention of and Fight against Crime Programme of the European Union, European Commission - Directorate General Home Affairs	This work was mainly supported by the Award of Excellence (Excellensbidrag), provided to SB by the Swedish University of Agricultural Sciences (SLU), and an FPU grant from the Ministry of Education, Culture and Sports of Spain, which supported MVR and CRG. Special recognition is given to the Ministry of Education of Spain for the FPU grant of Consuelo Rubio-Guerri and Marina Vicente-Rubiano. The work was also partly supported by/executed in the framework of the EU-project AniBioThreat (Grant Agreement: Home/2009/ISEC/AG/191) with the financial support from the Prevention of and Fight against Crime Programme of the European Union, European Commission - Directorate General Home Affairs. This publication reflects the views only of the authors, and the European Commission cannot be held responsible for any use, which may be made of the information contained therein. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allander T, 2005, P NATL ACAD SCI USA, V102, P12891, DOI 10.1073/pnas.0504666102; Allen M, 1996, BEE WORLD, V77, P141, DOI 10.1080/0005772X.1996.11099306; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ANDERSON DL, 1988, J GEN VIROL, V69, P1617, DOI 10.1099/0022-1317-69-7-1617; ANDERSON DL, 1991, AM BEE J, V131, P767; BAILEY L, 1983, ANN APPL BIOL, V103, P13, DOI 10.1111/j.1744-7348.1983.tb02735.x; BALL BV, 1988, ANN APPL BIOL, V113, P237, DOI 10.1111/j.1744-7348.1988.tb03300.x; Berenyi O, 2006, APPL ENVIRON MICROB, V72, P2414, DOI 10.1128/AEM.72.4.2414-2420.2006; Blanchard P, 2008, J INVERTEBR PATHOL, V99, P348, DOI 10.1016/j.jip.2008.07.006; Blomstrom AL, 2009, VIRUS RES, V146, P125, DOI 10.1016/j.virusres.2009.09.006; Blomstrom AL, 2010, J CLIN MICROBIOL, V48, P4392, DOI 10.1128/JCM.01040-10; Blomstrom AL, 2010, VIRUS RES, V152, P59, DOI 10.1016/j.virusres.2010.06.004; Brodsgaard CJ, 2000, APIDOLOGIE, V31, P543, DOI 10.1051/apido:2000145; Bromenshenk JJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013181; Chen YP, 2007, ADV VIRUS RES, V70, P33, DOI 10.1016/S0065-3527(07)70002-7; Chen YP, 2004, J INVERTEBR PATHOL, V87, P84, DOI 10.1016/j.jip.2004.07.005; Cheval J, 2011, J CLIN MICROBIOL, V49, P3268, DOI 10.1128/JCM.00850-11; Chevreux B, 2004, GENOME RES, V14, P1147, DOI 10.1101/gr.1917404; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; DALL DJ, 1985, ANN APPL BIOL, V106, P461, DOI 10.1111/j.1744-7348.1985.tb03136.x; de Miranda JR, 2010, J INVERTEBR PATHOL, V103, pS30, DOI 10.1016/j.jip.2009.06.014; Di Prisco G, 2011, VIRUSES-BASEL, V3, P2425, DOI 10.3390/v3122425; Ellis JD, 2005, BEE WORLD, V86, P88, DOI 10.1080/0005772X.2005.11417323; Engel P, 2012, P NATL ACAD SCI USA, V109, P11002, DOI 10.1073/pnas.1202970109; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Forgach P, 2008, J INVERTEBR PATHOL, V98, P235, DOI 10.1016/j.jip.2007.11.002; Gallai N, 2009, ECOL ECON, V68, P810, DOI 10.1016/j.ecolecon.2008.06.014; Garrido-Bailon E, 2010, SPAN J AGRIC RES, V8, P658, DOI 10.5424/sjar/2010083-1262; Genersch E, 2010, VET RES, V41, DOI 10.1051/vetres/2010027; Hunter W, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001160; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Kukielka D, 2010, SPAN J AGRIC RES, V8, P308, DOI 10.5424/sjar/2010082-1218; Kukielka D, 2008, J VIROL METHODS, V147, P275, DOI 10.1016/j.jviromet.2007.09.008; Kukielka D, 2009, J VIROL METHODS, V161, P240, DOI 10.1016/j.jviromet.2009.06.014; Lipkin WI, 2010, MICROBIOL MOL BIOL R, V74, P363, DOI 10.1128/MMBR.00007-10; MORAN NA, 2012, PLOS ONE, V7; Nakamura S, 2011, EXP BIOL MED, V236, P968, DOI 10.1258/ebm.2011.010378; [NRC] National Research Council, 2006, STAT POLL N AM; Palacios G, 2008, J VIROL, V82, P6209, DOI 10.1128/JVI.00251-08; Reynaldi FJ, 2011, REV ARGENT MICROBIOL, V43, P84, DOI 10.1590/S0325-75412011000200003; Ribiere M, 2002, APIDOLOGIE, V33, P339, DOI 10.1051/apido:2002020; Rozen S, 2000, Methods Mol Biol, V132, P365; Runckel C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020656; Sato E, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-110; Segundo E., 2003, Plant Disease, V87, P103, DOI 10.1094/PDIS.2003.87.1.103; Singh R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014357; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tang P, 2010, FUTURE MICROBIOL, V5, P177, DOI [10.2217/fmb.09.120, 10.2217/FMB.09.120]; Tatusova TA, 1999, FEMS MICROBIOL LETT, V174, P247, DOI 10.1016/S0378-1097(99)00149-4; Tentcheva D, 2004, APPL ENVIRON MICROB, V70, P7185, DOI 10.1128/AEM.70.12.7185-7191.2004; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; van Munster M, 2002, J GEN VIROL, V83, P3131, DOI 10.1099/0022-1317-83-12-3131; Vanengelsdorp D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004071; Ward L, 2007, APIDOLOGIE, V38, P181, DOI 10.1051/apido:2006072; Weiss RA, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-124	55	75	81	1	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57459	10.1371/journal.pone.0057459	http://dx.doi.org/10.1371/journal.pone.0057459			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460860	gold, Green Accepted, Green Published			2022-12-25	WOS:000315519000114
J	Joppa, LN; Williams, R				Joppa, Lucas N.; Williams, Rich			Modeling the Building Blocks of Biodiversity	PLOS ONE			English	Article							NETWORK STRUCTURE; FOOD WEBS; NESTEDNESS; ARCHITECTURE; LINKAGE; RULES	Background: Networks of single interaction types, such as plant-pollinator mutualisms, are biodiversity's "building blocks". Yet, the structure of mutualistic and antagonistic networks differs, leaving no unified modeling framework across biodiversity's component pieces. Methods/Principal Findings: We use a one-dimensional "niche model" to predict antagonistic and mutualistic species interactions, finding that accuracy decreases with the size of the network. We show that properties of the modeled network structure closely approximate empirical properties even where individual interactions are poorly predicted. Further, some aspects of the structure of the niche space were consistently different between network classes. Conclusions/Significance: These novel results reveal fundamental differences between the ability to predict ecologically important features of the overall structure of a network and the ability to predict pair-wise species interactions.	[Joppa, Lucas N.] Microsoft Res, Computat Ecol & Environm Sci, Cambridge, England; [Williams, Rich] Quid Com, San Francisco, CA USA	Microsoft; QUID INC.	Joppa, LN (corresponding author), Microsoft Res, Computat Ecol & Environm Sci, Cambridge, England.	lujoppa@microsoft.com	Williams, Richard J/B-8344-2011	Williams, Richard J/0000-0001-8847-3213				Allesina S, 2008, SCIENCE, V320, P658, DOI 10.1126/science.1156269; Almeida-Neto M, 2008, OIKOS, V117, P1227, DOI 10.1111/j.0030-1299.2008.16644.x; Bascompte J, 2007, ANNU REV ECOL EVOL S, V38, P567, DOI 10.1146/annurev.ecolsys.38.091206.095818; Belgrano A, 2005, AQUATIC FOOD WEBS EC; Brose U, 2005, ECOL LETT, V8, P1317, DOI 10.1111/j.1461-0248.2005.00838.x; Campbell C, 2011, P NATL ACAD SCI USA, V108, P197, DOI 10.1073/pnas.1008204108; Cohen J.E., 1990, COMMUNITY FOOD WEBS; Dunne JA, 2002, ECOL LETT, V5, P558, DOI 10.1046/j.1461-0248.2002.00354.x; Fontaine C, 2011, ECOL LETT, V14, P1170, DOI 10.1111/j.1461-0248.2011.01688.x; Grant V., 1965, FLOWER POLLINATION P; Guimaraes PR, 2007, CURR BIOL, V17, P1797, DOI 10.1016/j.cub.2007.09.059; Jabot F, 2012, P NATL ACAD SCI USA, V109, P4521, DOI 10.1073/pnas.1107004109; Joppa LN, 2011, METHODS ECOL EVOL, V2, P541, DOI 10.1111/j.2041-210X.2011.00101.x; Joppa LN, 2010, EVOL ECOL RES, V12, P35; Joppa LN, 2009, ECOL LETT, V12, P961, DOI 10.1111/j.1461-0248.2009.01341.x; Kearns CA, 1998, ANNU REV ECOL SYST, V29, P83, DOI 10.1146/annurev.ecolsys.29.1.83; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Lafferty KD, 2008, ECOL LETT, V11, P533, DOI 10.1111/j.1461-0248.2008.01174.x; Martinez ND, 2006, SFI S SCI C, P163; May RM, 2006, TRENDS ECOL EVOL, V21, P394, DOI 10.1016/j.tree.2006.03.013; Mitchell CE, 2003, NATURE, V421, P625, DOI 10.1038/nature01317; Montoya JM, 2006, NATURE, V442, P259, DOI 10.1038/nature04927; PAINE RT, 1980, J ANIM ECOL, V49, P667; PASCUAL M, 2006, ECOLOGICAL NETWORKS; Petanidou T, 2008, ECOL LETT, V11, P564, DOI 10.1111/j.1461-0248.2008.01170.x; Petchey OL, 2008, P NATL ACAD SCI USA, V105, P4191, DOI 10.1073/pnas.0710672105; PIMM SL, 1982, FOOD WEBS; Pires MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027280; Ruiter de PC, 2006, THEORETICAL ECOLOGY; Saavedra S, 2009, NATURE, V457, P463, DOI 10.1038/nature07532; Santamaria L, 2007, PLOS BIOL, V5, P354, DOI 10.1371/journal.pbio.0050031; Srinivasan UT, 2007, ECOLOGY, V88, P671, DOI 10.1890/06-0971; Thebault E, 2010, SCIENCE, V329, P853, DOI 10.1126/science.1188321; Torchin ME, 2003, NATURE, V421, P628, DOI 10.1038/nature01346; Ulrich W, 2009, OIKOS, V118, P3, DOI 10.1111/j.1600-0706.2008.17053.x; Williams RJ, 2008, J ANIM ECOL, V77, P512, DOI 10.1111/j.1365-2656.2008.01362.x; Williams RJ, 2011, ECOLOGY, V92, P1849, DOI 10.1890/11-0200.1; Williams RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012092; Williams RJ, 2010, THEOR ECOL-NETH, V3, P45, DOI 10.1007/s12080-009-0052-6; Williams RJ, 2000, NATURE, V404, P180, DOI 10.1038/35004572	40	9	9	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e56277	10.1371/journal.pone.0056277	http://dx.doi.org/10.1371/journal.pone.0056277			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460797	Green Published, gold, Green Submitted			2022-12-25	WOS:000315519000020
J	Kong, Y; Xu, XY; Zhu, L				Kong, Yun; Xu, Xiangyang; Zhu, Liang			Cyanobactericidal Effect of Streptomyces sp HJC-D1 on Microcystis auruginosa	PLOS ONE			English	Article							2-METHYL ACETOACETATE EMA; CHLORELLA-VULGARIS; ANTIOXIDANT ENZYMES; OXIDATIVE DAMAGE; GENE-EXPRESSION; GREEN-ALGAE; AERUGINOSA; INHIBITION; STRESS; MECHANISM	An isolated strain Streptomyces sp. HJC-D1 was applied to inhibit the growth of cyanobacterium Microcystis aeruginosa FACHB-905. The effect of Streptomyces sp. HJC-D1 culture broth on the cell integrity and physiological characteristics of M. aeruginosa FACHB-905 was investigated using the ow cytometry (FCM), enzyme activity and transmission electron microscopy (TEM) methods. Results showed that the growth of M. aeruginosa FACHB-905 was significantly inhibited, and the percentage of live cells depended on the culture broth concentration and exposure time. The activities of antioxidant enzymes including superoxide dismutase (SOD), peroxidase (POD) and catalase (CAT) increased with exposure concentration and exposure time, and the significant increase of reactive oxygen species (ROS) led to the disruption of the subcellular structure of M. aeruginosa FACHB-905, and caused the increase of malondialdehyde (MDA). Furthermore, TEM observation suggested the presence of three stages (cell breakage, organelle release and cell death) for the cyanobactericidal process of Streptomyces sp. HJC-D1. Therefore, Streptomyces sp. HJC-D1 not only affected antioxidant enzyme activities and ROS level, but also destroyed the subcellular structure of M. aeruginosa FACHB-905, demonstrating excellent cyanobactericidal properties.	[Kong, Yun; Xu, Xiangyang; Zhu, Liang] Zhejiang Univ, Dept Environm Engn, Hangzhou 310003, Zhejiang, Peoples R China; [Xu, Xiangyang] ZJU UWA Joint Ctr Integrated Water Management & P, Hangzhou, Zhejiang, Peoples R China	Zhejiang University	Zhu, L (corresponding author), Zhejiang Univ, Dept Environm Engn, Hangzhou 310003, Zhejiang, Peoples R China.	felix79cn@zju.edu.cn	Kong, Yun/M-5848-2014		National Key Technology RD Program [2006BAJ08B01/2012BAJ25B07]; Department of Education of Zhejiang Province [Y200909172]	National Key Technology RD Program(National Key Technology R&D Program); Department of Education of Zhejiang Province	This work was supported by the National Key Technology R&D Program (No. 2006BAJ08B01/2012BAJ25B07), and Research Projects of the Department of Education of Zhejiang Province (No. Y200909172). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Public Health Association (APHA), 1998, AM PHYS ED REV, V20th; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Bonekamp NA, 2009, BIOFACTORS, V35, P346, DOI 10.1002/biof.48; Chang DW, 2011, J HAZARD MATER, V185, P1214, DOI 10.1016/j.jhazmat.2010.10.033; Choi HJ, 2005, BIOL CONTROL, V33, P335, DOI 10.1016/j.biocontrol.2005.03.007; Daly RI, 2007, ENVIRON SCI TECHNOL, V41, P4447, DOI 10.1021/es070318s; Dogru MK, 2008, J APPL TOXICOL, V28, P140, DOI 10.1002/jat.1259; Henderson RK, 2008, WATER RES, V42, P3435, DOI 10.1016/j.watres.2007.10.032; Hong HC, 2009, ARCH ENVIRON CON TOX, V56, P638, DOI 10.1007/s00244-008-9216-4; Hong Y, 2008, ECOTOX ENVIRON SAFE, V71, P527, DOI 10.1016/j.ecoenv.2007.10.010; Hong Y, 2008, J PLANT PHYSIOL, V165, P1264, DOI 10.1016/j.jplph.2007.10.007; Hong Y, 2009, AQUAT TOXICOL, V91, P262, DOI 10.1016/j.aquatox.2008.11.014; Hua XH, 2009, BIOTECHNOL LETT, V31, P1531, DOI 10.1007/s10529-009-0051-0; Huang HL, 2008, INT BIODETER BIODEGR, V61, P331, DOI 10.1016/j.ibiod.2007.06.014; Jia Y, 2010, J HAZARD MATER, V183, P176, DOI 10.1016/j.jhazmat.2010.07.009; Kim MJ, 2008, J APPL PHYCOL, V20, P1069, DOI 10.1007/s10811-008-9312-x; Liu ZQ, 2011, WATER RES, V45, P6489, DOI 10.1016/j.watres.2011.09.043; Lovejoy C, 1998, APPL ENVIRON MICROB, V64, P2806; MYKLESTAD SM, 1995, SCI TOTAL ENVIRON, V165, P155, DOI 10.1016/0048-9697(95)04549-G; Prado R, 2012, ECOTOXICOLOGY, V21, P409, DOI 10.1007/s10646-011-0801-3; Qian HF, 2008, AQUAT TOXICOL, V88, P301, DOI 10.1016/j.aquatox.2008.05.009; Qian HF, 2008, ENVIRON TOXICOL CHEM, V27, P182, DOI 10.1897/07-163.1; Qian HF, 2012, ENVIRON TOXICOL, V27, P229, DOI 10.1002/tox.20636; Qian HF, 2009, ECOTOXICOLOGY, V18, P537, DOI 10.1007/s10646-009-0311-8; Qian HF, 2009, CHEMOSPHERE, V75, P368, DOI 10.1016/j.chemosphere.2008.12.040; Qin BQ, 2006, CHINESE SCI BULL, V51, P2401, DOI 10.1007/s11434-006-2096-y; Qu JH, 2010, CRIT REV ENV SCI TEC, V40, P519, DOI 10.1080/10643380802451953; Rioboo C, 2009, AQUAT TOXICOL, V94, P229, DOI 10.1016/j.aquatox.2009.07.009; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; Shao JH, 2011, AQUAT TOXICOL, V104, P48, DOI 10.1016/j.aquatox.2011.03.014; Shao JH, 2009, CHEMOSPHERE, V75, P924, DOI 10.1016/j.chemosphere.2009.01.021; Shi SY, 2006, BIOL CONTROL, V39, P345, DOI 10.1016/j.biocontrol.2006.06.011; Tang XQ, 2012, WATER AIR SOIL POLL, V223, P723, DOI 10.1007/s11270-011-0897-3; Trenzado C, 2006, AQUACULTURE, V254, P758, DOI 10.1016/j.aquaculture.2005.11.020; Wang J, 2011, CHEMOSPHERE, V85, P977, DOI 10.1016/j.chemosphere.2011.06.076; Xiao X, 2010, CHEMOSPHERE, V81, P1118, DOI 10.1016/j.chemosphere.2010.09.001; Yang CY, 2011, PESTIC BIOCHEM PHYS, V100, P93, DOI 10.1016/j.pestbp.2011.02.014; Zhang H, 2011, LIMNOLOGICA, V41, P70, DOI 10.1016/j.limno.2010.08.001	38	49	49	4	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57654	10.1371/journal.pone.0057654	http://dx.doi.org/10.1371/journal.pone.0057654			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460891	Green Published, Green Submitted, gold			2022-12-25	WOS:000315519000146
J	Ma, ZM; Liu, Y; Xu, Y; Huang, Y; Xu, M; Zhu, XL; Zhang, HJ; Xu, BH; Huang, F; Yang, Z; Li, XY; Wang, WQ; Bi, YF				Ma, Zhimin; Liu, Yu; Xu, Yu; Huang, Yun; Xu, Min; Zhu, Xiaolin; Zhang, Huijie; Xu, Baihui; Huang, Fei; Yang, Zhi; Li, Xiaoying; Wang, Weiqing; Bi, Yufang			Impaired Lung Function Is Associated with Increased Carotid Intima-Media Thickness in Middle-Aged and Elderly Chinese	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; ATHEROSCLEROSIS RISK; CARDIOVASCULAR-DISEASE; PULMONARY-FUNCTION; METABOLIC SYNDROME; INFLAMMATION; MORTALITY; HYPOXIA; MARKERS; DECLINE	Background: Impairment of lung function was reported to be associated with cardiovascular disease (CVD). The aim of the present study is to evaluate the relationship between lung function and carotid intima-media thickness (cIMT) in participants without chronic pulmonary disease. Methodology and Principal Findings: A total of 6,423 participants aged 40 years and above were recruited from Jiading District, Shanghai, China. Lung function, evaluated by forced vital capacity (FVC) and forced expiratory volume in one second (FEV1) was measured with standard spirometry. CIMT was measured with high-resolution ultrasonography by trained physicians. Mean values of FVC (% pred) and FEV1 (% pred) in participants with elevated cIMT were significantly lower than in those without (0.92 +/- 0.20 vs. 0.99 +/- 0.19, 0.83 +/- 0.24 vs. 0.90 +/- 0.22; both p-values < 0.0001). The levels of cIMT in the lowest quartile of FVC (% pred) and FEV1 (% pred) were markedly higher than in the second, third and fourth quartile, respectively (p < 0.0001 for all). The lowest quartile of FVC (% pred) and FEV1 (% pred) was associated with increased odds of elevated cIMT, with the fully adjusted odds ratio of 1.34 and 1.41 ( 95% confidence interval (CI) 1.09-1.65, p = 0.006, 95% CI 1.15-1.72, p = 0.0008), respectively. Conclusions and Significance: Impaired lung function is associated with elevated cIMT in middle-aged and elderly Chinese. These findings suggest the need to screen impairment of lung function in people without respiratory disease for the presence of subclinical atherosclerosis in CVD prevention.	[Ma, Zhimin; Liu, Yu; Xu, Yu; Xu, Min; Zhu, Xiaolin; Zhang, Huijie; Xu, Baihui; Huang, Fei; Yang, Zhi; Li, Xiaoying; Wang, Weiqing; Bi, Yufang] Shanghai Jiao Tong Univ, Key Lab Endocrine & Metab Dis, Minist Hlth, Rui Jin Hosp,Sch Med,E Inst Shanghai Univ, Shanghai 200030, Peoples R China; [Ma, Zhimin; Liu, Yu; Xu, Yu; Huang, Yun; Xu, Min; Zhang, Huijie; Xu, Baihui; Huang, Fei; Yang, Zhi; Li, Xiaoying; Wang, Weiqing; Bi, Yufang] Shanghai Jiao Tong Univ, Shanghai Clin Ctr Endocrine & Metab Dis, Shanghai Inst Endocrine & Metab Dis, Dept Endocrinol & Metab,Rui Jin Hosp,Sch Med, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Bi, YF (corresponding author), Shanghai Jiao Tong Univ, Key Lab Endocrine & Metab Dis, Minist Hlth, Rui Jin Hosp,Sch Med,E Inst Shanghai Univ, Shanghai 200030, Peoples R China.	byf10784@rjh.com.cn	Zhu, Xiaolin/GLV-1533-2022; Zhang, Hui/HHN-8494-2022; zhang, hui/GXH-6098-2022	Zhu, Xiaolin/0000-0002-3221-595X; Li, Xiaoying/0000-0002-9383-5757	Key Laboratory for Endocrine and Metabolic Diseases of Ministry of Health [1994DP131044]; Sector Funds of Ministry of Health [201002002]; National Key New Drug Creation and Manufacturing Program of Ministry of Science and Technology [2012ZX09303006-001]; National Natural Science Foundation of China [81222008, 81100564, 30911120493, 81130016]; New One Hundred Person Project of the Shanghai Jiao-Tong University School of Medicine	Key Laboratory for Endocrine and Metabolic Diseases of Ministry of Health; Sector Funds of Ministry of Health; National Key New Drug Creation and Manufacturing Program of Ministry of Science and Technology; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); New One Hundred Person Project of the Shanghai Jiao-Tong University School of Medicine	This study was supported by the grants from the Key Laboratory for Endocrine and Metabolic Diseases of Ministry of Health (1994DP131044), the Sector Funds of Ministry of Health (201002002), the National Key New Drug Creation and Manufacturing Program of Ministry of Science and Technology (2012ZX09303006-001), the National Natural Science Foundation of China (number 81222008, number 81100564, number 30911120493 and number 81130016) and New One Hundred Person Project of the Shanghai Jiao-Tong University School of Medicine 2011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atabek ME, 2008, J PEDIATR ENDOCR MET, V21, P603; Cao JJ, 2007, CIRCULATION, V116, P32, DOI 10.1161/CIRCULATIONAHA.106.645606; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Engstrom G, 2003, J INTERN MED, V253, P574, DOI 10.1046/j.1365-2796.2003.01138.x; Engstrom G, 2002, CIRCULATION, V106, P2555, DOI 10.1161/01.CIR.0000037220.00065.0D; Engstrom G, 2001, ATHEROSCLEROSIS, V155, P237, DOI 10.1016/S0021-9150(00)00557-8; GAINER JL, 1987, ATHEROSCLEROSIS, V68, P263, DOI 10.1016/0021-9150(87)90206-1; Georgiopoulou VV, 2011, AM J MED, V124, P334, DOI 10.1016/j.amjmed.2010.12.006; Guazzi M, 2002, AM J CARDIOL, V89, P191, DOI 10.1016/S0002-9149(01)02199-3; Hozawa A, 2006, CHEST, V130, P1642, DOI 10.1378/chest.130.6.1642; Huang Y, 2010, J CLIN ENDOCR METAB, V95, P5122, DOI 10.1210/jc.2010-0544; Jiang R, 2008, AM J EPIDEMIOL, V168, P602, DOI 10.1093/aje/kwn174; Johnston AK, 2008, THORAX, V63, P599, DOI 10.1136/thx.2007.088112; Kwon CH, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-38; Leone N, 2009, AM J RESP CRIT CARE, V179, P509, DOI 10.1164/rccm.200807-1195OC; Li M, 2012, J CLIN ENDOCR METAB, V97, P2033, DOI 10.1210/jc.2011-3010; Lin WY, 2006, OBESITY, V14, P1654, DOI 10.1038/oby.2006.190; Ochs-Balcom HM, 2006, CHEST, V129, P853, DOI 10.1378/chest.129.4.853; Park HY, 2010, RESP MED, V104, P1326, DOI 10.1016/j.rmed.2010.02.024; Pathan SS, 2011, EUR J NEUROL, V18, P888, DOI 10.1111/j.1468-1331.2010.03340.x; Schroeder EB, 2003, AM J EPIDEMIOL, V158, P1171, DOI 10.1093/aje/kwg276; Schroeder EB, 2005, ATHEROSCLEROSIS, V180, P367, DOI 10.1016/j.atherosclerosis.2004.12.012; Simanonok JP, 1996, MED HYPOTHESES, V46, P155, DOI 10.1016/S0306-9877(96)90017-1; Sin DD, 2005, CHEST, V127, P1952, DOI 10.1378/chest.127.6.1952; Wannamethee SG, 2010, DIABETES CARE, V33, P1990, DOI 10.2337/dc10-0324	25	6	6	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e53153	10.1371/journal.pone.0053153	http://dx.doi.org/10.1371/journal.pone.0053153			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457443	Green Submitted, Green Published, gold			2022-12-25	WOS:000315603700003
J	Peng, YY; Shi, KK; Wang, LT; Lu, JL; Li, HW; Pan, SY; Ma, CY				Peng, Yanyan; Shi, Kaikai; Wang, Lintao; Lu, Jianlei; Li, Hongwei; Pan, Shiyang; Ma, Changyan			Characterization of Osterix Protein Stability and Physiological Role in Osteoblast Differentiation	PLOS ONE			English	Article							BONE-FORMATION; PROTEASOME SYSTEM; TRANSCRIPTION; UBIQUITIN; DEGRADATION; INHIBITORS; PATHWAY	Osterix (Osx/SP7) is a C2H2 zinc finger-containing transcription factor of the SP gene family. Osx knockout mice indicate that the gene plays an essential role in osteoblast differentiation and bone formation. However, the mechanisms involved in the regulation of Osx are still poorly understood. Here, we report a novel post-translational mechanism for the regulation of Osx in mammalian cells. We found that the stability of endogenous and exogenous Osx reduced after cycloheximide treatment. In cells treated with the proteasome inhibitors MG-132 or lactacystin, both endogenous and exogenous Osx protein expression increased in a time-dependent manner. Co-immunoprecipitation (Co-IP) assays showed that both endogenous and exogenous Osx were ubiquitinated. Six lysine residues of Osx were identified as candidate ubiquitination sites by construction of point mutant plasmids and luciferase reporter assays. Furthermore, we confirmed that K58 and K230 are the ubiquitination sites of Osx by Co-IP assays and protein stability assays. Moreover, the Osx K58R and K230R mutations promoted the expression of osteoblast differentiation markers (alkaline phosphatase, collagen I and osteocalcin) and enhanced osteogenic differentiation in C2C12 cells. Taken together, our data indicate that Osx is an unstable protein, and that the ubiquitin-proteasome pathway is involved in the regulation of Osx and thereby regulates osteoblast differentiation.	[Peng, Yanyan; Shi, Kaikai; Lu, Jianlei; Ma, Changyan] Nanjing Med Univ, Dept Dev Genet, Nanjing, Jiangsu, Peoples R China; [Wang, Lintao] Nanjing Med Univ, Dept Biochem & Mol Biol, Nanjing, Jiangsu, Peoples R China; [Li, Hongwei] Nanjing Med Univ, Dept Oral & Maxillofacial Surg, Affiliated Hosp Stomatol, Nanjing, Jiangsu, Peoples R China; [Pan, Shiyang] Nanjing Med Univ, Dept Lab Med, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China; [Pan, Shiyang] Natl Key Clin Dept Lab Med, Nanjing, Jiangsu, Peoples R China; [Ma, Changyan] Nanjing Med Univ, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Ma, CY (corresponding author), Nanjing Med Univ, Dept Dev Genet, Nanjing, Jiangsu, Peoples R China.	cyma@njmu.edu.cn	Peng, Yanyan/I-1515-2019	Peng, Yanyan/0000-0002-1176-4837	National Natural Science Foundation of China [81071525]; Key Laboratory for Laboratory Medicine of Jiangsu Province of China [XK201114]; Priority Academic Program Development of Jiangsu Higher Education Institutions; Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Laboratory for Laboratory Medicine of Jiangsu Province of China; Priority Academic Program Development of Jiangsu Higher Education Institutions; Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry(Scientific Research Foundation for the Returned Overseas Chinese Scholars)	This work was supported by grants from the National Natural Science Foundation of China (81071525); Key Laboratory for Laboratory Medicine of Jiangsu Province of China (No. XK201114); A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions; The Project Sponsored by the Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek WY, 2010, BONE, V46, P920, DOI 10.1016/j.bone.2009.12.007; Baek WY, 2009, J BONE MINER RES, V24, P1055, DOI [10.1359/JBMR.081248, 10.1359/jbmr.081248]; Cai QL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012636; Ciechanover A, 2005, NAT REV MOL CELL BIO, V6, P79, DOI 10.1038/nrm1552; Ciechanover A, 2005, PROTEIN DEGRADATION: UBIQUITIN AND THE CHEMISTRY OF LIFE, VOL 1, pXIII; Craiu A, 1997, J BIOL CHEM, V272, P13437, DOI 10.1074/jbc.272.20.13437; Garrett IR, 2003, J CLIN INVEST, V111, P1771, DOI 10.1172/JCI200316198; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Heino TJ, 2008, CURR STEM CELL RES T, V3, P131, DOI 10.2174/157488808784223032; Hobler SC, 1999, AM J PHYSIOL-REG I, V276, pR468, DOI 10.1152/ajpregu.1999.276.2.R468; KATAGIRI T, 1994, J CELL BIOL, V127, P1755, DOI 10.1083/jcb.127.6.1755; Katagiri T, 2002, ORAL DIS, V8, P147, DOI 10.1034/j.1601-0825.2002.01829.x; Kawamura N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001058; Kim MY, 2012, EXP DIABETES RES, DOI 10.1155/2012/716425; Lee MH, 2003, BIOCHEM BIOPH RES CO, V309, P689, DOI 10.1016/j.bbrc.2003.08.058; Matsubara T, 2008, J BIOL CHEM, V283, P29119, DOI 10.1074/jbc.M801774200; Mayer R.J., 2008, PROTEIN DEGRADATION; Mayer RJ, 2006, PROTEIN DEGRADATION; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; Sasaki A, 2002, J BIOL CHEM, V277, P22541, DOI 10.1074/jbc.M109728200; Shi Y, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.002089; Sorokin AV, 2009, BIOCHEMISTRY-MOSCOW+, V74, P1411, DOI 10.1134/S000629790913001X; Varshavsky A, 2005, TRENDS BIOCHEM SCI, V30, P283, DOI 10.1016/j.tibs.2005.04.005; Voutsadakis IA, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-67; Weissman AM, 2001, NAT REV MOL CELL BIO, V2, P169, DOI 10.1038/35056563; Zhang C, 2010, J ORTHOP SURG RES, V5, DOI 10.1186/1749-799X-5-37; Zhao X, 2012, J PHYSIOL BIOCHEM, V68, P129, DOI 10.1007/s13105-011-0126-y; Zhou X, 2010, P NATL ACAD SCI USA, V107, P12919, DOI 10.1073/pnas.0912855107	29	33	35	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56451	10.1371/journal.pone.0056451	http://dx.doi.org/10.1371/journal.pone.0056451			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457570	gold, Green Submitted, Green Published			2022-12-25	WOS:000315603700055
J	Xing, B; Bachstetter, AD; Van Eldik, LJ				Xing, Bin; Bachstetter, Adam D.; Van Eldik, Linda J.			Deficiency in p38 beta MAPK Fails to Inhibit Cytokine Production or Protect Neurons against Inflammatory Insult in In Vitro and In Vivo Mouse Models	PLOS ONE			English	Article							MICROGLIAL P38-ALPHA MAPK; DELAYED INDUCTION; CARBON-MONOXIDE; UP-REGULATION; BRAIN; ASTROCYTES; CYTOPROTECTION; CELLS	The p38 MAPK pathway plays a key role in regulating the production of proinflammatory cytokines, such as TNF alpha and IL-1 beta, in peripheral inflammatory disorders. There are four major isoforms of p38 MAPK (p38 alpha, beta, delta, gamma), with p38 alpha and p38 beta the targets of most p38 MAPK inhibitor drugs. Our previous studies demonstrated that the p38 alpha MAPK isoform is an important contributor to stressor-induced proinflammatory cytokine up-regulation and neurotoxicity in the brain. However, the potential role of the p38 beta MAPK isoform in CNS proinflammatory cytokine overproduction and neurotoxicity is poorly understood. In the current studies, we used primary microglia from wild type (WT) and p38 beta knockout (KO) mice in co-culture with WT neurons, and measured proinflammatory cytokines and neuron death after LPS insult. We also measured neuroinflammatory responses in vivo in WT and p38 beta KO mice after administration of LPS by intraperitoneal or intracerebroventricular injection. WT and p38 beta KO microglia/neuron co-cultures showed similar levels of TNF alpha and IL-1 beta production in response to LPS treatment, and no differences in LPS-induced neurotoxicity. The in vitro results were confirmed in vivo, where levels of TNF alpha and IL-1 beta in the CNS were not significantly different between WT or p38 beta KO mice after LPS insult. Our results suggest that, similar to peripheral inflammation, p38 alpha is critical but p38 beta MAPK is dispensable in the brain in regards to proinflammatory cytokine production and neurotoxicity induced by LPS inflammatory insult.	[Xing, Bin; Bachstetter, Adam D.; Van Eldik, Linda J.] Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40536 USA; [Van Eldik, Linda J.] Univ Kentucky, Dept Anat & Neurobiol, Coll Med, Lexington, KY 40536 USA	University of Kentucky; University of Kentucky	Van Eldik, LJ (corresponding author), Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40536 USA.	linda.vaneldik@uky.edu		Bachstetter, Adam/0000-0003-4646-6757	Alzheimer's Association [ZEN-09-134506];  [NIH R01 NS064247];  [NIH F32 AG037280]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064247] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F32AG037280] Funding Source: NIH RePORTER	Alzheimer's Association(Alzheimer's Association); ; ; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	NIH R01 NS064247; NIH F32 AG037280; Alzheimer's Association ZEN-09-134506. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachstetter AD, 2010, AGING DIS, V1, P199; Bachstetter AD, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-79; Beardmore VA, 2005, MOL CELL BIOL, V25, P10454, DOI 10.1128/MCB.25.23.10454-10464.2005; Che YZ, 2001, MOL BRAIN RES, V94, P157, DOI 10.1016/S0169-328X(01)00233-9; Cuadrado A, 2010, BIOCHEM J, V429, P403, DOI 10.1042/BJ20100323; David S, 2011, NAT REV NEUROSCI, V12, P388, DOI 10.1038/nrn3053; Fitzsimmons BL, 2010, NEUROREPORT, V21, P313, DOI 10.1097/WNR.0b013e32833774bf; Guo YL, 2001, J CELL BIOCHEM, V82, P556, DOI 10.1002/jcb.1180; Kaminska B, 2009, ANAT REC, V292, P1902, DOI 10.1002/ar.21047; Kim C, 2008, NAT IMMUNOL, V9, P1019, DOI 10.1038/ni.1640; Kim HP, 2005, J IMMUNOL, V175, P2622, DOI 10.4049/jimmunol.175.4.2622; Kim SW, 2004, BRAIN RES, V1007, P188, DOI 10.1016/j.brainres.2004.02.009; Lee SH, 2000, J NEUROSCI RES, V60, P623, DOI 10.1002/(SICI)1097-4547(20000601)60:5<623::AID-JNR7>3.0.CO;2-4; Loy B, 2011, J NEUROSCI, V31, P12059, DOI 10.1523/JNEUROSCI.0448-11.2011; Munoz L, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-21; O'Keefe SJ, 2007, J BIOL CHEM, V282, P34663, DOI 10.1074/jbc.M704236200; Petrova TV, 1999, P NATL ACAD SCI USA, V96, P4668, DOI 10.1073/pnas.96.8.4668; Piao CS, 2003, BRAIN RES, V976, P120, DOI 10.1016/S0006-8993(03)02579-4; Piao CS, 2002, MOL BRAIN RES, V107, P137, DOI 10.1016/S0169-328X(02)00456-4; Risco A., 2012, J SIGNAL TRANSDUCT, V2012, DOI DOI 10.1155/2012/520289; Saklatvala J, 2004, CURR OPIN PHARMACOL, V4, P372, DOI 10.1016/j.coph.2004.03.009; Schallner N, 2011, EUR J PHARMACOL, V670, P58, DOI 10.1016/j.ejphar.2011.08.028; Shin JH, 2011, NEUROSCI LETT, V501, P132, DOI 10.1016/j.neulet.2011.06.061; Wyss-Coray T, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006346; Xie Z, 2004, GLIA, V45, P170, DOI 10.1002/glia.10314; Xing B, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-84	26	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56852	10.1371/journal.pone.0056852	http://dx.doi.org/10.1371/journal.pone.0056852			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457629	Green Submitted, Green Published, gold			2022-12-25	WOS:000315603700089
J	Chen, B; Yi, B; Mao, R; Liu, HT; Wang, JH; Sharma, A; Peiper, S; Leonard, WJ; She, JX				Chen, Bo; Yi, Bing; Mao, Rui; Liu, Haitao; Wang, Jinhua; Sharma, Ashok; Peiper, Stephen; Leonard, Warren J.; She, Jin-Xiong			Enhanced T Cell Lymphoma in NOD.Stat5b Transgenic Mice Is Caused by Hyperactivation of Stat5b in CD8(+) Thymocytes	PLOS ONE			English	Article							CONSTITUTIVE ACTIVATION; UP-REGULATION; JANUS KINASE; DNA-BINDING; EXPRESSION; CANCER; PATHWAY; EXPANSION; LEUKEMIA; RECEPTOR	Activation of signal transducers and activators of transcription (STAT) proteins may be critical to their oncogenic functions as demonstrated by the development of B-cell lymphoma/leukemia in transgenic (TG) mice overexpressing a constitutively activated form of Stat5b. However, low incidence of CD8(+) T cell lymphoma was observed in B6 transgenic mice overexpressing a wild-type Stat5b (B6.Stat5b(Tg)) despite of undetectable Stat5b phosphorylation and the rate of lymphomagenesis was markedly enhanced by immunization or the introduction of TCR transgenes [1]. Here, we report that the wild-type Stat5b transgene leads to the acceleration and high incidence (74%) of CD8(+) T cell lymphoblastic lymphomas in the non-obese-diabetic (NOD) background. In contrast to the B6.Stat5b(Tg) mice, Stat5b in transgenic NOD (NOD.Stat5b(Tg)) mice is selectively and progressively phosphorylated in CD8(+) thymocytes. Stat5 phosphorylation also leads to up-regulation of many genes putatively relevant to tumorigenesis. Treatment of NOD.Stat5b(Tg) mice with cancer chemopreventive agents Apigenin and Xanthohumol efficiently blocked lymphomagenesis through reduction of Stat5 phosphorylation and genes up-regulated in the NOD.Stat5b(Tg) mice. These results suggest that NOD genetic background is critical to the Stat5b-mediated lymphomagenesis through regulation of Stat5 hyperactivation. NOD.Stat5b(Tg) mouse is an excellent model for studying the molecular mechanisms underlying lymphomagenesis and testing novel chemoprevention strategies.	[Chen, Bo; Yi, Bing; Mao, Rui; Liu, Haitao; Wang, Jinhua; Sharma, Ashok; She, Jin-Xiong] Georgia Regents Univ, Med Coll Georgia, Ctr Biotechnol & Genom Med, Augusta, GA USA; [Chen, Bo; Wang, Jinhua; She, Jin-Xiong] Nanjing Univ Technol, Sinoamer Inst Translat Med, Nanjing, Jiangsu, Peoples R China; [Wang, Jinhua] Jiangsu Canc Hosp, Nanjing, Jiangsu, Peoples R China; [Peiper, Stephen] Jefferson Univ, Dept Pathol, Philadelphia, PA USA; [Leonard, Warren J.] NHLBI, NIH, Bethesda, MD 20892 USA	University System of Georgia; Augusta University; Nanjing Tech University; Nanjing Medical University; Jefferson University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	She, JX (corresponding author), Georgia Regents Univ, Med Coll Georgia, Ctr Biotechnol & Genom Med, Augusta, GA USA.	jshe@georgiahealth.edu	Leonard, Warren/AAA-1397-2022; chen, bo/G-4522-2014	Sharma, Ashok/0000-0001-9597-4374	Georgia Health Sciences University; National Natural Science Foundation of China [81272244]; GRA endowment; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL005402] Funding Source: NIH RePORTER	Georgia Health Sciences University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); GRA endowment; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by funds from the Georgia Health Sciences University and National Natural Science Foundation of China(81272244). J.X.S. is a Georgia Research Alliance (GRA) Eminent Scholar and supported by a GRA endowment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahsberg J, 2010, J BIOL CHEM, V285, P36275, DOI 10.1074/jbc.M110.155531; Aifantis I, 2008, NAT REV IMMUNOL, V8, P380, DOI 10.1038/nri2304; Bessette K, 2008, BLOOD, V111, P344, DOI 10.1182/blood-2007-04-084707; Bunting KD, 2007, FRONT BIOSCI-LANDMRK, V12, P2807, DOI 10.2741/2274; Burchill MA, 2003, J IMMUNOL, V171, P5853, DOI 10.4049/jimmunol.171.11.5853; Carron C, 2000, BLOOD, V95, P3891; Chen E, 2012, IMMUNITY, V36, P529, DOI 10.1016/j.immuni.2012.03.017; Davoodi-Semiromi A, 2004, J BIOL CHEM, V279, P11553, DOI 10.1074/jbc.M312110200; Davoodi-Semiromi A, 2007, BIOCHEM BIOPH RES CO, V356, P655, DOI 10.1016/j.bbrc.2007.03.028; dos Santos NR, 2007, BLOOD, V109, P3972, DOI 10.1182/blood-2006-09-048801; Ermakova O, 2011, EMBO MOL MED, V3, P50, DOI 10.1002/emmm.201000112; Fantin VR, 2008, CANCER RES, V68, P3785, DOI 10.1158/0008-5472.CAN-07-6091; Gerhauser C, 2002, MOL CANCER THER, V1, P959; HATHCOCK KS, 1994, J EXP MED, V180, P631, DOI 10.1084/jem.180.2.631; IHLE JN, 1995, TRENDS GENET, V11, P69, DOI 10.1016/S0168-9525(00)89000-9; Jin YL, 2012, BIOCHEM BIOPH RES CO, V424, P669, DOI 10.1016/j.bbrc.2012.06.162; Joliot V, 2006, ONCOGENE, V25, P4573, DOI 10.1038/sj.onc.1209480; Kelly J, 2003, J IMMUNOL, V170, P210, DOI 10.4049/jimmunol.170.1.210; Kelly JA, 2003, J EXP MED, V198, P79, DOI 10.1084/jem.20021548; Kerr KF, 2009, BIOINFORMATICS, V25, P2035, DOI 10.1093/bioinformatics/btp363; Klinger MB, 2005, ONCOGENE, V24, P2695, DOI 10.1038/sj.onc.1208334; Laloraya M, 2006, DIABETES, V55, P734, DOI 10.2337/diabetes.55.03.06.db05-1059; Lebigot I, 2003, BLOOD, V102, P4555, DOI 10.1182/blood-2003-06-2077; Litherland SA, 2005, J IMMUNOL, V175, P4561, DOI 10.4049/jimmunol.175.7.4561; Liu Yongbo, 2012, J Exp Ther Oncol, V10, P1; Moriggl R, 1999, IMMUNITY, V10, P249, DOI 10.1016/S1074-7613(00)80025-4; Nikitakis NG, 2004, CURR CANCER DRUG TAR, V4, P637, DOI 10.2174/1568009043332736; O'Shea JJ, 2012, IMMUNITY, V36, P542, DOI 10.1016/j.immuni.2012.03.014; Peck AR, 2011, J CLIN ONCOL, V29, P2448, DOI 10.1200/JCO.2010.30.3552; Pecquet C, 2010, BLOOD, V115, P1037, DOI 10.1182/blood-2008-10-183558; PRATT JA, 1988, J CLIN EPIDEMIOL, V41, P367, DOI 10.1016/0895-4356(88)90144-8; Rouet V, 2010, P NATL ACAD SCI USA, V107, P15199, DOI 10.1073/pnas.0911651107; Ruela-de-Sousa RR, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2009.18; Schwaller J, 2000, MOL CELL, V6, P693, DOI 10.1016/S1097-2765(00)00067-8; Serwold T, 2010, P NATL ACAD SCI USA, V107, P18939, DOI 10.1073/pnas.1013230107; Sexl V, 2000, BLOOD, V96, P2277, DOI 10.1182/blood.V96.6.2277; SHUAI K, 1994, CELL, V76, P821, DOI 10.1016/0092-8674(94)90357-3; Shukla S, 2010, PHARM RES-DORDR, V27, P962, DOI 10.1007/s11095-010-0089-7; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Sordella R, 2004, SCIENCE, V305, P1163, DOI 10.1126/science.1101637; Tan AHM, 2010, J IMMUNOL, V184, P1849, DOI 10.4049/jimmunol.0901509; Tang JZ, 2010, ENDOCRINOLOGY, V151, P43, DOI 10.1210/en.2009-0651; Tweardy D, 2011, J CLIN ONCOL, V29, P2443, DOI 10.1200/JCO.2010.34.2014; Wang N, 2006, AM J RESP CELL MOL, V35, P206, DOI 10.1165/rcmb.2005-0294OC; Wang Y, 2007, BLOOD, V109, P2147, DOI 10.1182/blood-2006-08-040022; Yang JB, 2008, CELL RES, V18, P443, DOI 10.1038/cr.2008.41; Yao ZJ, 2006, P NATL ACAD SCI USA, V103, P1000, DOI 10.1073/pnas.0507350103; Yu CL, 1997, J IMMUNOL, V159, P5206; Zawistowski M, 2010, AM J HUM GENET, V87, P604, DOI 10.1016/j.ajhg.2010.10.012	49	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56600	10.1371/journal.pone.0056600	http://dx.doi.org/10.1371/journal.pone.0056600			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457589	Green Published, Green Submitted, gold			2022-12-25	WOS:000315602700084
J	Huveldt, D; Lewis-Tuffin, LJ; Carlson, BL; Schroeder, MA; Rodriguez, F; Giannini, C; Galanis, E; Sarkaria, JN; Anastasiadis, PZ				Huveldt, Deborah; Lewis-Tuffin, Laura J.; Carlson, Brett L.; Schroeder, Mark A.; Rodriguez, Fausto; Giannini, Caterina; Galanis, Evanthia; Sarkaria, Jann N.; Anastasiadis, Panos Z.			Targeting Src Family Kinases Inhibits Bevacizumab-Induced Glioma Cell Invasion	PLOS ONE			English	Article							FACTOR-KAPPA-B; P120 CATENIN; DASATINIB BMS-354825; TUMOR ANGIOGENESIS; MALIGNANT GLIOMAS; TYROSINE KINASES; PROSTATE-CANCER; XENOGRAFT MODEL; RHO-GTPASES; IN-VIVO	Anti-VEGF antibody therapy with bevacizumab provides significant clinical benefit in patients with recurrent glioblastoma multiforme (GBM). Unfortunately, progression on bevacizumab therapy is often associated with a diffuse disease recurrence pattern, which limits subsequent therapeutic options. Therefore, there is an urgent need to understand bevacizumab's influence on glioma biology and block it's actions towards cell invasion. To explore the mechanism(s) of GBM cell invasion we have examined a panel of serially transplanted human GBM lines grown either in short-term culture, as xenografts in mouse flank, or injected orthotopically in mouse brain. Using an orthotopic xenograft model that exhibits increased invasiveness upon bevacizumab treatment, we also tested the effect of dasatinib, a broad spectrum SFK inhibitor, on bevacizumab-induced invasion. We show that 1) activation of Src family kinases (SFKs) is common in GBM, 2) the relative invasiveness of 17 serially transplanted GBM xenografts correlates strongly with p120 catenin phosphorylation at Y228, a Src kinase site, and 3) SFK activation assessed immunohistochemically in orthotopic xenografts, as well as the phosphorylation of downstream substrates occurs specifically at the invasive tumor edge. Further, we show that SFK signaling is markedly elevated at the invasive tumor front upon bevacizumab administration, and that dasatinib treatment effectively blocked the increased invasion induced by bevacizumab. Our data are consistent with the hypothesis that the increased invasiveness associated with anti-VEGF therapy is due to increased SFK signaling, and support testing the combination of dasatinib with bevacizumab in the clinic.	[Huveldt, Deborah; Lewis-Tuffin, Laura J.; Anastasiadis, Panos Z.] Mayo Clin, Dept Canc Biol, Jacksonville, FL 32224 USA; [Rodriguez, Fausto; Giannini, Caterina] Mayo Clin, Dept Pathol, Rochester, MN USA; [Galanis, Evanthia] Mayo Clin, Dept Oncol, Rochester, MN USA; [Carlson, Brett L.; Schroeder, Mark A.; Sarkaria, Jann N.] Mayo Clin, Dept Radiat Oncol, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Anastasiadis, PZ (corresponding author), Mayo Clin, Dept Canc Biol, Jacksonville, FL 32224 USA.	panos@mayo.edu	Ramos, Joe W./L-6189-2013; Giannini, Caterina/AAB-7551-2022	Ramos, Joe W./0000-0002-9708-2115; 	National Institutes of Health [R01 CA100467, R01 NS069753, P50 CA108961]; NATIONAL CANCER INSTITUTE [P50CA108961, R01CA100467, R01CA154348] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS069753] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The work was supported by National Institutes of Health R01 CA100467, R01 NS069753, and a career development project P50 CA108961 (PZA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali SA, 2008, J NEUROSURG, V109, P268, DOI 10.3171/JNS/2008/109/8/0268; Anastasiadis PZ, 2001, CURR OPIN CELL BIOL, V13, P604, DOI 10.1016/S0955-0674(00)00258-1; Angers-Loustau A, 2004, MOL CANCER RES, V2, P595; Bible KC, 1999, ANAL BIOCHEM, V267, P217, DOI 10.1006/abio.1998.2980; Bokstein F, 2008, CANCER-AM CANCER SOC, V112, P2267, DOI 10.1002/cncr.23401; Brunton VG, 2004, BBA-MOL CELL RES, V1692, P121, DOI 10.1016/j.bbamcr.2004.04.010; Carlson Brett L, 2011, Curr Protoc Pharmacol, VChapter 14, DOI 10.1002/0471141755.ph1416s52; Christopher LJ, 2008, DRUG METAB DISPOS, V36, P1357, DOI 10.1124/dmd.107.018267; Cloughesy TF, 2008, J CLIN ONCOL, V26, DOI 10.1200/jco.2008.26.15_suppl.2010b; Coluccia AML, 2006, CANCER RES, V66, P2279, DOI 10.1158/0008-5472.CAN-05-2057; de Groot JF, 2010, NEURO-ONCOLOGY, V12, P233, DOI 10.1093/neuonc/nop027; Ding Q, 2003, J BIOL CHEM, V278, P39882, DOI 10.1074/jbc.M304685200; Du JY, 2009, NAT BIOTECHNOL, V27, P77, DOI 10.1038/nbt.1513; Ebos JML, 2009, CANCER CELL, V15, P232, DOI 10.1016/j.ccr.2009.01.021; Fong TAT, 1999, CANCER RES, V59, P99; Frame MC, 2004, J CELL SCI, V117, P989, DOI 10.1242/jcs.01111; Garrett TA, 2007, EXP CELL RES, V313, P3285, DOI 10.1016/j.yexcr.2007.05.027; Giannini C, 2005, NEURO-ONCOLOGY, V7, P164, DOI 10.1215/S1152851704000821; Golas JM, 2005, CANCER RES, V65, P5358, DOI 10.1158/0008-5472.CAN-04-2484; Goldbrunner RH, 2004, NEUROSURGERY, V55, P426, DOI 10.1227/01.NEU.0000129551.64651.74; Hall A, 2005, BIOCHEM SOC T, V33, P891, DOI 10.1042/BST0330891; Jallal H, 2007, CANCER RES, V67, P1580, DOI 10.1158/0008-5472.CAN-06-2027; Johnson FM, 2005, CLIN CANCER RES, V11, P6924, DOI 10.1158/1078-0432.CCR-05-0757; Keunen O, 2011, P NATL ACAD SCI USA, V108, P3749, DOI 10.1073/pnas.1014480108; Kiyokawa E, 1998, GENE DEV, V12, P3331, DOI 10.1101/gad.12.21.3331; Kleber S, 2008, CANCER CELL, V13, P235, DOI 10.1016/j.ccr.2008.02.003; Kunkel P, 2001, CANCER RES, V61, P6624; Laird AD, 2000, CANCER RES, V60, P4152; Lewis-Tuffin LJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013665; Li LM, 2003, MOL CELL BIOL, V23, P2883, DOI 10.1128/MCB.23.8.2883-2892.2003; Li Q, 2008, BIOCHEM J, V411, P531, DOI 10.1042/BJ20071534; Lluis JM, 2007, CANCER RES, V67, P7368, DOI 10.1158/0008-5472.CAN-07-0515; Lombardo LJ, 2004, J MED CHEM, V47, P6658, DOI 10.1021/jm049486a; Lu KV, 2012, CANCER CELL, V22, P21, DOI 10.1016/j.ccr.2012.05.037; Lu KV, 2009, CANCER RES, V69, P6889, DOI 10.1158/0008-5472.CAN-09-0347; Lund CV, 2006, J NEURO-ONCOL, V78, P19, DOI 10.1007/s11060-005-9068-y; Mariner DJ, 2001, J BIOL CHEM, V276, P28006, DOI 10.1074/jbc.M102443200; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Morton JP, 2010, GASTROENTEROLOGY, V139, P292, DOI 10.1053/j.gastro.2010.03.034; MUKHOPADHYAY D, 1995, NATURE, V375, P577, DOI 10.1038/375577a0; Nam S, 2005, CANCER RES, V65, P9185, DOI 10.1158/0008-5472.CAN-05-1731; Narayana A, 2012, J NEUROSURG, V116, P341, DOI 10.3171/2011.9.JNS11656; Norden AD, 2008, NEUROLOGY, V70, P779, DOI 10.1212/01.wnl.0000304121.57857.38; Noren NK, 2000, J CELL BIOL, V150, P567, DOI 10.1083/jcb.150.3.567; Paez-Ribes M, 2009, CANCER CELL, V15, P220, DOI 10.1016/j.ccr.2009.01.027; Park CM, 2006, CANCER RES, V66, P8511, DOI 10.1158/0008-5472.CAN-05-4340; Park SI, 2008, CANCER RES, V68, P3323, DOI 10.1158/0008-5472.CAN-07-2997; Parsons SJ, 2004, ONCOGENE, V23, P7906, DOI 10.1038/sj.onc.1208160; Plate KH, 2012, ACTA NEUROPATHOL, V124, P763, DOI 10.1007/s00401-012-1066-5; Playford MP, 2004, ONCOGENE, V23, P7928, DOI 10.1038/sj.onc.1208080; Rubenstein JL, 2000, NEOPLASIA, V2, P306, DOI 10.1038/sj.neo.7900102; Salhia B, 2005, CANCER RES, V65, P8792, DOI 10.1158/0008-5472.CAN-05-0160; Sarkaria JN, 2007, MOL CANCER THER, V6, P1167, DOI 10.1158/1535-7163.MCT-06-0691; Sarkaria JN, 2006, CLIN CANCER RES, V12, P2264, DOI 10.1158/1078-0432.CCR-05-2510; Serrels A, 2006, MOL CANCER THER, V5, P3014, DOI 10.1158/1535-7163.MCT-06-0382; Shor AC, 2007, CANCER RES, V67, P2800, DOI 10.1158/0008-5472.CAN-06-3469; Soto E, 2008, J CELL BIOL, V183, P737, DOI 10.1083/jcb.200805113; Theurillat JP, 1999, AM J PATHOL, V154, P581, DOI 10.1016/S0002-9440(10)65303-5; Tran NL, 2006, CANCER RES, V66, P9535, DOI 10.1158/0008-5472.CAN-06-0418; Vredenburgh JJ, 2007, J CLIN ONCOL, V25, P4722, DOI 10.1200/JCO.2007.12.2440; Vredenburgh JJ, 2007, CLIN CANCER RES, V13, P1253, DOI 10.1158/1078-0432.CCR-06-2309; Vultur A, 2008, MOL CANCER THER, V7, P1185, DOI 10.1158/1535-7163.MCT-08-0126; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Wick A, 2011, ANN NEUROL, V69, P586, DOI 10.1002/ana.22336; Yanagisawa M, 2006, J CELL BIOL, V174, P1087, DOI 10.1083/jcb.200605022; Yang L, 2008, CLIN CANCER RES, V14, P3993, DOI 10.1158/1078-0432.CCR-07-4152; Yeatman TJ, 2004, NAT REV CANCER, V4, P470, DOI 10.1038/nrc1366; Zagzag D, 2000, PEDIATR NEUROSURG, V33, P49, DOI 10.1159/000028975	68	62	66	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56505	10.1371/journal.pone.0056505	http://dx.doi.org/10.1371/journal.pone.0056505			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457577	Green Published, gold, Green Submitted			2022-12-25	WOS:000315602700077
J	Wang, C; Jiang, K; Gao, DM; Kang, XN; Sun, C; Zhang, QL; Li, Y; Sun, L; Zhang, S; Guo, K; Liu, YK				Wang, Cun; Jiang, Kai; Gao, Dongmei; Kang, Xiaonan; Sun, Chun; Zhang, Qinle; Li, Yan; Sun, Lu; Zhang, Shu; Guo, Kun; Liu, Yinkun			Clusterin Protects Hepatocellular Carcinoma Cells from Endoplasmic Reticulum Stress Induced Apoptosis through GRP78	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; CUSTIRSEN OGX-011; RESISTANCE; EXPRESSION; OVEREXPRESSION; METASTASIS; COMBINATION; SORAFENIB; INHIBITOR; SURVIVAL	Clusterin (CLU) is a stress-activated chaperone, which plays an important role in cancer development and progression through promoting cell survival. However, the exact mechanism of how CLU exerts its cell protective role under ER stress condition is still unclear. Therefore, in order to explore the molecular mechanisms by which CLU inhibited ER stress-induced apoptosis, HCC cell lines were treated with tunicamycin (TN), an ER stress inducer. We found that the expressions of both CLU and GRP78 were increased after TN treatment. Knockdown of CLU expression in SMMC7721 and HCCLM3 cells inhibited GRP78 expression after TN treatment and enhanced ER stress-induced apoptosis, whereas over-expression of CLU in HepG2 cells increased GRP78 expression after TN induction and abolished the effect of TN on cell apoptosis. Furthermore, knockdown of GRP78 expression in CLU-HepG2 cells abrogated the protective role of CLU under ER stress condition. Co-immunoprecipitation (co-IP) and confocal microscopy experiments confirmed the direct interaction between CLU and GRP78 under ER stress condition. The effect of CLU knockdown on GRP78 expression and cell apoptosis in HCC tumors were further determined in orthotopic xenograft tumor model. Knockdown of CLU expression in HCCLM3 cells inhibited GRP78 expression in tumor tissues, accompanied with increased number of apoptotic cancer cells. Moreover, the correlation between CLU and GRP78 expression was further determined in clinical HCC specimens. Taken together, these findings reveal that CLU protects HCC cells from ER stress induced apoptosis at least partially through interacting with GRP78.	[Wang, Cun; Gao, Dongmei; Sun, Chun; Li, Yan; Zhang, Shu; Guo, Kun; Liu, Yinkun] Fudan Univ, Liver Canc Inst, Zhongshan Hosp, Key Lab Carcinogenesis & Canc Invas,Minist Educ, Shanghai 200433, Peoples R China; [Wang, Cun; Jiang, Kai; Kang, Xiaonan; Sun, Chun; Zhang, Qinle; Sun, Lu; Liu, Yinkun] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China	Fudan University; Fudan University	Guo, K (corresponding author), Fudan Univ, Liver Canc Inst, Zhongshan Hosp, Key Lab Carcinogenesis & Canc Invas,Minist Educ, Shanghai 200433, Peoples R China.	jacky.guo.joan@gmail.com; liu.yinkun@zs-hospital.sh.cn			China National Key Projects for Infectious Diseases [2012ZX10002-012, 2012ZX10002-009]; National Basic Research Program of China (973 Program) [2011CB910604]; China National Natural Science Foundation [81001057]	China National Key Projects for Infectious Diseases; National Basic Research Program of China (973 Program)(National Basic Research Program of China); China National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This work was financially supported by China National Key Projects for Infectious Diseases (2012ZX10002-012 and 2012ZX10002-009), National Basic Research Program of China (973 Program: 2011CB910604), and China National Natural Science Foundation (81001057). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammar H, 2008, J BIOL CHEM, V283, P12851, DOI 10.1074/jbc.M800403200; Chang YJ, 2011, ANN SURG ONCOL, V18, P2395, DOI 10.1245/s10434-011-1597-3; Chen KF, 2010, J HEPATOL, V52, P88, DOI 10.1016/j.jhep.2009.10.011; Chiou JF, 2010, ANN SURG ONCOL, V17, P603, DOI 10.1245/s10434-009-0718-8; Gan L, 2010, ONCOL REP, V23, P1037, DOI 10.3892/or_00000730; Hung CS, 2012, ANN SURG ONCOL, V19, P2744, DOI 10.1245/s10434-011-2188-z; July LV, 2002, PROSTATE, V50, P179, DOI 10.1002/pros.10047; Kang YK, 2004, HUM PATHOL, V35, P1340, DOI 10.1016/j.humpath.2004.07.021; Kususda Y, 2012, BRIT J CANCER, V106, P1945, DOI 10.1038/bjc.2012.209; Lamoureux F, 2011, CANCER RES, V71, P5838, DOI 10.1158/0008-5472.CAN-11-0994; Laskin JJ, 2012, J THORAC ONCOL, V7, P579, DOI 10.1097/JTO.0b013e31823f459c; Lau SH, 2006, ONCOGENE, V25, P1242, DOI 10.1038/sj.onc.1209141; Liu T, 2009, EUR J CANCER, V45, P1846, DOI 10.1016/j.ejca.2009.03.002; Lu Q, 2012, ONCOGENESIS, V1, DOI 10.1038/oncsis.2012.30; Luk JM, 2006, PROTEOMICS, V6, P1049, DOI 10.1002/pmic.200500306; Malhi H, 2011, J HEPATOL, V54, P795, DOI 10.1016/j.jhep.2010.11.005; Nizard P, 2007, TRAFFIC, V8, P554, DOI 10.1111/j.1600-0854.2007.00549.x; Park DC, 2008, NEOPLASIA, V10, P964, DOI 10.1593/neo.08604; Redondo M, 2009, ADV CANCER RES, V105, P21, DOI 10.1016/S0065-230X(09)05002-7; Saad F, 2011, CLIN CANCER RES, V17, P5765, DOI 10.1158/1078-0432.CCR-11-0859; Sallman DA, 2007, MOL CANCER THER, V6, P2938, DOI 10.1158/1535-7163.MCT-07-0345; Shuda M, 2003, J HEPATOL, V38, P605, DOI 10.1016/S0168-8278(03)00029-1; Su RJ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-20; Sun Q, 2012, MOL BIOL REP, V39, P6753, DOI 10.1007/s11033-012-1500-8; Tian J, 1999, BRIT J CANCER, V81, P814, DOI 10.1038/sj.bjc.6690769; Wang C, 2012, INT J BIOCHEM CELL B, V44, P2308, DOI 10.1016/j.biocel.2012.09.012; Wang C, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-166; Wei L, 2009, INT J CANCER, V125, P791, DOI 10.1002/ijc.24316; Xie D, 2005, WORLD J GASTROENTERO, V11, P3285, DOI 10.3748/wjg.v11.i21.3285; Yom CK, 2009, ANTICANCER RES, V29, P3909; Zhang HL, 2005, NAT CELL BIOL, V7, P909, DOI 10.1038/ncb1291; Zhang J, 2006, CLIN EXP METASTAS, V23, P401, DOI 10.1007/s10585-006-9051-9; Zoubeidi A, 2012, INT J BIOCHEM CELL B, V44, P1646, DOI 10.1016/j.biocel.2012.04.010; Zoubeidi A, 2010, CLIN CANCER RES, V16, P1088, DOI 10.1158/1078-0432.CCR-09-2917; Zoubeidi A, 2010, MOL CANCER RES, V8, P119, DOI 10.1158/1541-7786.MCR-09-0277	35	38	44	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e55981	10.1371/journal.pone.0055981	http://dx.doi.org/10.1371/journal.pone.0055981			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457489	Green Submitted, Green Published, gold			2022-12-25	WOS:000315602700029
J	Yoshioka, S; Tsukamoto, Y; Hijiya, N; Nakada, C; Uchida, T; Matsuura, K; Takeuchi, I; Seto, M; Kawano, K; Moriyama, M				Yoshioka, Shunichi; Tsukamoto, Yoshiyuki; Hijiya, Naoki; Nakada, Chisato; Uchida, Tomohisa; Matsuura, Keiko; Takeuchi, Ichiro; Seto, Masao; Kawano, Kenji; Moriyama, Masatsugu			Genomic Profiling of Oral Squamous Cell Carcinoma by Array-Based Comparative Genomic Hybridization	PLOS ONE			English	Article							DNA COPY-NUMBER; ELECTIVE NECK DISSECTION; LYMPH-NODE INVOLVEMENT; TUMOR THICKNESS; GENE-EXPRESSION; BREAST-CANCER; METASTASIS FORMATION; SUPRAOMOHYOID NECK; PROSTATE-CANCER; HEAD	We designed a study to investigate genetic relationships between primary tumors of oral squamous cell carcinoma (OSCC) and their lymph node metastases, and to identify genomic copy number aberrations (CNAs) related to lymph node metastasis. For this purpose, we collected a total of 42 tumor samples from 25 patients and analyzed their genomic profiles by array-based comparative genomic hybridization. We then compared the genetic profiles of metastatic primary tumors (MPTs) with their paired lymph node metastases (LNMs), and also those of LNMs with non-metastatic primary tumors (NMPTs). Firstly, we found that although there were some distinctive differences in the patterns of genomic profiles between MPTs and their paired LNMs, the paired samples shared similar genomic aberration patterns in each case. Unsupervised hierarchical clustering analysis grouped together 12 of the 15 MPT-LNM pairs. Furthermore, similarity scores between paired samples were significantly higher than those between non-paired samples. These results suggested that MPTs and their paired LNMs are composed predominantly of genetically clonal tumor cells, while minor populations with different CNAs may also exist in metastatic OSCCs. Secondly, to identify CNAs related to lymph node metastasis, we compared CNAs between grouped samples of MPTs and LNMs, but were unable to find any CNAs that were more common in LNMs. Finally, we hypothesized that subpopulations carrying metastasis-related CNAs might be present in both the MPT and LNM. Accordingly, we compared CNAs between NMPTs and LNMs, and found that gains of 7p, 8q and 17q were more common in the latter than in the former, suggesting that these CNAs may be involved in lymph node metastasis of OSCC. In conclusion, our data suggest that in OSCCs showing metastasis, the primary and metastatic tumors share similar genomic profiles, and that cells in the primary tumor may tend to metastasize after acquiring metastasis-associated CNAs.	[Yoshioka, Shunichi; Tsukamoto, Yoshiyuki; Hijiya, Naoki; Nakada, Chisato; Uchida, Tomohisa; Matsuura, Keiko; Moriyama, Masatsugu] Oita Univ, Dept Mol Pathol, Fac Med, Oita 87011, Japan; [Yoshioka, Shunichi; Kawano, Kenji] Oita Univ, Dept Dent & Oral Maxillofacial Surg, Fac Med, Oita 87011, Japan; [Takeuchi, Ichiro] Nagoya Inst Technol, Dept Comp Sci Sci & Engn Simulat, Nagoya, Aichi, Japan; [Seto, Masao] Aichi Canc Ctr, Res Inst, Div Mol Med, Nagoya, Aichi 464, Japan	Oita University; Oita University; Nagoya Institute of Technology; Aichi Cancer Center	Tsukamoto, Y (corresponding author), Oita Univ, Dept Mol Pathol, Fac Med, Oita 87011, Japan.	tuka@oita-u.ac.jp			Ministry of Education, Science, Sports and Culture of Japan;  [20592205]; Grants-in-Aid for Scientific Research [24591952] Funding Source: KAKEN	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported in part by the Ministry of Education, Science, Sports and Culture of Japan, and a Grant-in-Aid for Scientific Research (C), No. 20592205. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asakage T, 1998, CANCER, V82, P1443, DOI 10.1002/(SICI)1097-0142(19980415)82:8<1443::AID-CNCR2>3.0.CO;2-A; Bernards R, 2002, NATURE, V418, P823, DOI 10.1038/418823a; Bockmuhl U, 2002, GENE CHROMOSOME CANC, V33, P29, DOI 10.1002/gcc.1209.abs; Cai HY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036944; Capote A, 2007, HEAD NECK-J SCI SPEC, V29, P3, DOI 10.1002/hed.20482; Chen YJ, 2004, J PATHOL, V204, P326, DOI 10.1002/path.1640; Childs G, 2012, NAT CELL BIOL, V14, P337, DOI 10.1038/ncb2477; Chung CH, 2004, CANCER CELL, V5, P489, DOI 10.1016/S1535-6108(04)00112-6; Clark JR, 2006, OTOLARYNG HEAD NECK, V135, P748, DOI 10.1016/j.otohns.2006.05.751; Davies JJ, 2005, CHROMOSOME RES, V13, P237, DOI 10.1007/s10577-005-2168-x; Dias FL, 2001, OTOLARYNG HEAD NECK, V125, P23, DOI 10.1067/mhn.2001.116188; Dias FL, 2006, OTOLARYNG HEAD NECK, V134, P460, DOI 10.1016/j.otohns.2005.09.025; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fradet A, 2011, CANCER RES, V71, P5728, DOI 10.1158/0008-5472.CAN-11-1431; Freier K, 2010, GENE CHROMOSOME CANC, V49, P9, DOI 10.1002/gcc.20714; Galliher-Beckley AJ, 2008, CARCINOGENESIS, V29, P244, DOI 10.1093/carcin/bgm245; Garnis C, 2004, ONCOGENE, V23, P2582, DOI 10.1038/sj.onc.1207367; Garnis C, 2003, CANCER RES, V63, P8582; Garnis C, 2004, GENE CHROMOSOME CANC, V39, P93, DOI 10.1002/gcc.10294; Hao SP, 2002, ORAL ONCOL, V38, P309, DOI 10.1016/S1368-8375(01)00061-6; Harada K, 1998, CANCER RES, V58, P4694; Harada T, 2002, CANCER RES, V62, P835; Helliwell TR, 2001, J PATHOL, V194, P289, DOI 10.1002/1096-9896(200107)194:3<289::AID-PATH912>3.0.CO;2-L; Heng HHQ, 2010, J CELL BIOCHEM, V109, P1072, DOI 10.1002/jcb.22497; Heng HHQ, 2009, J CELL PHYSIOL, V220, P538, DOI 10.1002/jcp.21799; Hu GH, 2009, CLIN CANCER RES, V15, P5615, DOI 10.1158/1078-0432.CCR-09-0049; Huang SH, 2009, CANCER-AM CANCER SOC, V115, P1489, DOI 10.1002/cncr.24161; Jones A S, 1994, Eur J Cancer B Oral Oncol, V30B, P8, DOI 10.1016/0964-1955(94)90044-2; KALNINS IK, 1977, AM J SURG, V134, P450, DOI 10.1016/0002-9610(77)90376-2; Keski-Santti H, 2006, ORAL ONCOL, V42, P96, DOI 10.1016/j.oraloncology.2005.06.018; Kujawski M, 1999, GENE CHROMOSOME CANC, V26, P253, DOI 10.1002/(SICI)1098-2264(199911)26:3<253::AID-GCC10>3.0.CO;2-A; Leemans CR, 2011, NAT REV CANCER, V11, P9, DOI 10.1038/nrc2982; Liu CJ, 2008, J PATHOL, V214, P489, DOI 10.1002/path.2306; Liu CJ, 2006, MOL CARCINOGEN, V45, P721, DOI 10.1002/mc.20213; Liu WN, 2009, NAT MED, V15, P559, DOI 10.1038/nm.1944; Mayland MK, 2005, LARYNGOSCOPE, V115, P629, DOI 10.1097/01.mlg.0000161338.54515.b1; Merlo LMF, 2006, NAT REV CANCER, V6, P924, DOI 10.1038/nrc2013; MOORE C, 1986, CANCER-AM CANCER SOC, V58, P158, DOI 10.1002/1097-0142(19860701)58:1<158::AID-CNCR2820580127>3.0.CO;2-B; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Noutomi Y, 2006, J PATHOL, V210, P67, DOI 10.1002/path.2015; O-charoenrat P, 2003, ORAL ONCOL, V39, P386, DOI 10.1016/S1368-8375(02)00142-2; Pathare SM, 2011, ONCOL LETT, V2, P445, DOI 10.3892/ol.2011.271; Patmore HS, 2004, BRIT J CANCER, V90, P1976, DOI 10.1038/sj.bjc.6601756; Pentenero M, 2005, HEAD NECK-J SCI SPEC, V27, P1080, DOI 10.1002/hed.20275; Pollack JR, 1999, NAT GENET, V23, P41, DOI 10.1038/12640; Polyak K, 2008, CLIN CANCER RES, V14, P339, DOI 10.1158/1078-0432.CCR-07-2188; Ried T, 1999, GENE CHROMOSOME CANC, V25, P195, DOI 10.1002/(SICI)1098-2264(199907)25:3<195::AID-GCC1>3.0.CO;2-8; Sugahara K, 2011, INT J ONCOL, V39, P761, DOI 10.3892/ijo.2011.1094; Torres L, 2007, BREAST CANCER RES TR, V102, P143, DOI 10.1007/s10549-006-9317-6; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Weigelt B, 2005, NAT REV CANCER, V5, P591, DOI 10.1038/nrc1670; Wreesmann VB, 2004, HEAD NECK-J SCI SPEC, V26, P10, DOI 10.1002/hed.10344; Wu Z, 2009, NEOPLASIA, V11, P66, DOI 10.1593/neo.81048; Xu C, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-143; Yang WH, 2012, NAT CELL BIOL, V14, P366, DOI 10.1038/ncb2455; Yu SB, 2006, AM J SURG, V191, P94, DOI 10.1016/j.amjsurg.2005.10.008	56	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56165	10.1371/journal.pone.0056165	http://dx.doi.org/10.1371/journal.pone.0056165			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457519	gold, Green Submitted, Green Published			2022-12-25	WOS:000315602700053
J	Bovijn, C; Desmet, AS; Uyttendaele, I; Van Acker, T; Tavernier, J; Peelman, F				Bovijn, Celia; Desmet, Anne-Sophie; Uyttendaele, Isabel; Van Acker, Tim; Tavernier, Jan; Peelman, Frank			Identification of Binding Sites for Myeloid Differentiation Primary Response Gene 88 (MyD88) and Toll-like Receptor 4 in MyD88 Adapter-like (Mal)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; MULTIPLE SEQUENCE ALIGNMENT; BRUTONS TYROSINE KINASE; SIGNAL-TRANSDUCTION; TIR-DOMAIN; CRYSTAL-STRUCTURE; INTERFERON-BETA; INTERACTION TRAP; STRUCTURAL BASIS; MAPPIT ANALYSIS	Upon activation, Toll-like receptor 4 (TLR4) binds adapter proteins, including MyD88 (myeloid differentiation primary response gene 88) and Mal (MyD88 adapter-like) for its signal transduction. TLR4 and the adapter proteins each contain a Toll/Il-1 receptor domain (TIR domain). In this study we used random mutagenesis and the mammalian two-hybrid method MAPPIT (mammalian protein-protein interaction trap) to identify mutations in Mal that disrupt its interaction with TLR4 and/or MyD88. Our study shows that four potential binding sites and the AB-loop in the Mal TIR domain all contribute to formation of the TLR4-Mal-MyD88 complex. Mutations in the symmetrical back-to-back Mal homodimer interface affect Mal homodimerization and interaction with MyD88 and TLR4. Our data suggest that Mal dimerization may lead to formation of potential binding platforms on the top and the side of the Mal dimer that bind MyD88 or TLR4. Mutations that affect the interaction of Mal with MyD88 also affect NF-kappa B activation induced by Mal overexpression. In MAPPIT, co-expression of the MyD88 TIR domain enhances Mal dimerization and Mal binding to TLR4. Similarly, co-expression of Mal and the MyD88 TIR domain strongly promotes dimerization of the TLR4 intracellular domain in MAPPIT. The different types of TIR-TIR interactions in the TLR4-Mal-MyD88 complex thus show cooperative binding in MAPPIT. We present plausible models for the TIR-TIR interactions in the TLR4-Mal-MyD88 complex.	[Peelman, Frank] Univ Ghent VIB, Dept Med Prot Res, B-9000 Ghent, Belgium; [Peelman, Frank] Univ Ghent, B-9000 Ghent, Belgium	Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University	Peelman, F (corresponding author), Univ Ghent VIB, Dept Med Prot Res, Baertsoenkaai 3, B-9000 Ghent, Belgium.	frank.peelman@vib-ugent.be	Tavernier, Jan/AAG-3636-2019		Ugent BOF Grant [01Z03306]; Group-ID Multidisciplinary Research Partnership of Ghent University; FWO "krediet aan navorsers" Grant [1.5.256.08N]; FWO-V of the Fund for Scientific Research-Flanders (FWO); grant "doctoraatsbeurs voor strategisch basisonderzoek" of the agency for innovation by Science and Technology (IWT)	Ugent BOF Grant; Group-ID Multidisciplinary Research Partnership of Ghent University; FWO "krediet aan navorsers" Grant; FWO-V of the Fund for Scientific Research-Flanders (FWO)(FWO); grant "doctoraatsbeurs voor strategisch basisonderzoek" of the agency for innovation by Science and Technology (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT))	This work was supported by Ugent BOF Grant 01Z03306, the Group-ID Multidisciplinary Research Partnership of Ghent University, and by FWO "krediet aan navorsers" Grant 1.5.256.08N.; Recipient of grant FWO-V of the Fund for Scientific Research-Flanders (FWO).; Recipient of a grant "doctoraatsbeurs voor strategisch basisonderzoek" of the agency for innovation by Science and Technology (IWT).	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bovijn C, 2012, J BIOL CHEM, V287, P4088, DOI 10.1074/jbc.M111.282350; Cole LE, 2010, J LEUKOCYTE BIOL, V87, P275, DOI 10.1189/jlb.0909619; Dunne A, 2010, J BIOL CHEM, V285, P18276, DOI 10.1074/jbc.M109.098137; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; Eyckerman S, 2001, NAT CELL BIOL, V3, P1114, DOI 10.1038/ncb1201-1114; Eyckerman Sven, 2002, Sci STKE, V2002, ppl18; Fitzgerald KA, 2001, NATURE, V413, P78, DOI 10.1038/35092578; Fitzgerald KA, 2003, J EXP MED, V198, P1043, DOI 10.1084/jem.20031023; Funami K, 2008, J BIOL CHEM, V283, P18283, DOI 10.1074/jbc.M801013200; Gay NJ, 2007, ANNU REV BIOCHEM, V76, P141, DOI 10.1146/annurev.biochem.76.060305.151318; GAY NJ, 1991, NATURE, V351, P355, DOI 10.1038/351355b0; George J, 2010, J IMMUNOL, V184, P3025, DOI 10.4049/jimmunol.0901156; Gray P, 2006, J BIOL CHEM, V281, P10489, DOI 10.1074/jbc.M508892200; Hennessy EJ, 2010, NAT REV DRUG DISCOV, V9, P293, DOI 10.1038/nrd3203; Horng T, 2002, NATURE, V420, P329, DOI 10.1038/nature01180; Horng T, 2001, NAT IMMUNOL, V2, P835, DOI 10.1038/ni0901-835; Jefferies CA, 2003, J BIOL CHEM, V278, P26258, DOI 10.1074/jbc.M301484200; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kagan JC, 2006, CELL, V125, P943, DOI 10.1016/j.cell.2006.03.047; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kenny EF, 2009, J IMMUNOL, V183, P3642, DOI 10.4049/jimmunol.0901140; Khan JA, 2004, J BIOL CHEM, V279, P31664, DOI 10.1074/jbc.M403434200; Khor CC, 2007, NAT GENET, V39, P523, DOI 10.1038/ng1976; Lemmens I, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng075; Lin SC, 2010, NATURE, V465, P885, DOI 10.1038/nature09121; Lin ZJ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0034202, 10.1371/journal.pone.0040262]; Mansell A, 2004, J BIOL CHEM, V279, P37227, DOI 10.1074/jbc.C400289200; Miggin SM, 2007, P NATL ACAD SCI USA, V104, P3372, DOI 10.1073/pnas.0608100104; Miguel RN, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000788; Motshwene PG, 2009, J BIOL CHEM, V284, P25404, DOI 10.1074/jbc.M109.022392; Nagpal K, 2009, J BIOL CHEM, V284, P25742, DOI 10.1074/jbc.M109.014886; Nyman T, 2008, J BIOL CHEM, V283, P11861, DOI 10.1074/jbc.C800001200; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Ohnishi H, 2009, P NATL ACAD SCI USA, V106, P10260, DOI 10.1073/pnas.0812956106; Oshiumi H, 2003, J BIOL CHEM, V278, P49751, DOI 10.1074/jbc.M305820200; Oshiumi H, 2003, NAT IMMUNOL, V4, P161, DOI 10.1038/ni886; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Piao W, 2008, J BIOL CHEM, V283, P3109, DOI 10.1074/jbc.M707400200; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Siednienko J, 2010, EUR J IMMUNOL, V40, P3150, DOI 10.1002/eji.201040547; Tao X, 2002, BIOCHEM BIOPH RES CO, V299, P216, DOI 10.1016/S0006-291X(02)02581-0; Ulrichts P, 2008, IMMUNOL LETT, V116, P141, DOI 10.1016/j.imlet.2007.11.026; Ulrichts P, 2007, FEBS LETT, V581, P629, DOI 10.1016/j.febslet.2007.01.026; Ulrichts P, 2010, J CELL SCI, V123, P256, DOI 10.1242/jcs.056002; Ulrichts Peter, 2009, V517, P133, DOI 10.1007/978-1-59745-541-1_9; Uyttendaele I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044143; Valkov E, 2011, P NATL ACAD SCI USA, V108, P14879, DOI 10.1073/pnas.1104780108; Ve T, 2012, CURR DRUG TARGETS, V13, P1360, DOI 10.2174/138945012803530260; Verstak B, 2009, J BIOL CHEM, V284, P24192, DOI 10.1074/jbc.M109.023044; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Xu YW, 2000, NATURE, V408, P111, DOI 10.1038/35040600; Yan JP, 2010, J VIROL, V84, P76, DOI 10.1128/JVI.01647-09; Ye H, 2002, NATURE, V418, P443, DOI 10.1038/nature00888	55	34	34	1	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2013	288	17					12054	12066		10.1074/jbc.M112.415810	http://dx.doi.org/10.1074/jbc.M112.415810			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	133RP	23460645	hybrid, Green Published			2022-12-25	WOS:000318157600039
J	Shah, NR; AlBitar-Nehme, S; Kim, E; Marr, N; Novikov, A; Caroff, M; Fernandez, RC				Shah, Nita R.; AlBitar-Nehme, Sami; Kim, Emma; Marr, Nico; Novikov, Alexey; Caroff, Martine; Fernandez, Rachel C.			Minor Modifications to the Phosphate Groups and the C3 ' Acyl Chain Length of Lipid A in Two Bordetella pertussis Strains, BP338 and 18-323, Independently Affect Toll-like Receptor 4 Protein Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-ACETYLGLUCOSAMINE ACYLTRANSFERASES; GRAM-NEGATIVE BACTERIA; RANGE CLONING VECTOR; ESCHERICHIA-COLI; STRUCTURAL BASIS; LIPOPOLYSACCHARIDES; 4-AMINO-4-DEOXY-L-ARABINOSE; MICROEXTRACTION; PATHOGENESIS; DEACETYLASE	Lipopolysaccharides (LPS) of Bordetella pertussis are important modulators of the immune system. Interaction of the lipid A region of LPS with the Toll-like receptor 4 (TLR4) complex causes dimerization of TLR4 and activation of downstream nuclear factor kappa B (NF kappa B), which can lead to inflammation. We have previously shown that two strains of B. pertussis, BP338 (a Tohama I-derivative) and 18-323, display two differences in lipid A structure. 1) BP338 can modify the 1- and 4'-phosphates by the addition of glucosamine (GlcN), whereas 18-323 cannot, and 2) the C3' acyl chain in BP338 is 14 carbons long, but only 10 or 12 carbons long in 18-323. In addition, BP338 lipid A can activate TLR4 to a greater extent than 18-323 lipid A. Here we set out to determine the genetic reasons for the differences in these lipid A structures and the contribution of each structural difference to the ability of lipid A to activate TLR4. We show that three genes of the lipid A GlcN modification (Lgm) locus, lgmA, lgmB, and lgmC (previously locus tags BP0399-BP0397), are required for GlcN modification and a single amino acid difference in LpxA is responsible for the difference in C3' acyl chain length. Furthermore, by introducing lipid A-modifying genes into 18-323 to generate isogenic strains with varying penta-acyl lipid A structures, we determined that both modifications increase TLR4 activation, although the GlcN modification plays a dominant role. These results shed light on how TLR4 may interact with penta-acyl lipid A species.	[Shah, Nita R.; Kim, Emma; Marr, Nico; Fernandez, Rachel C.] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z3, Canada; [AlBitar-Nehme, Sami; Novikov, Alexey; Caroff, Martine] Univ Paris 11, IGM, Ctr Natl Rech Sci, Equipe Struct & Activites Endotoxines,UMR 8621, F-91405 Orsay, France	University of British Columbia; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Fernandez, RC (corresponding author), Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z3, Canada.	rachelf@mail.ubc.ca	Marr, Nico/T-7741-2019; Caroff, Martine/N-4293-2019; Nehme, Sami Al Bitar/AAH-9585-2019	Marr, Nico/0000-0002-1927-7072; AL BITAR NEHME, SAMI/0000-0002-6472-5380; CAROFF, Martine/0000-0002-7329-5247	Canadian Institutes of Health Research [MOP-102706]; CNRS; Natural Sciences and Engineering Research Council of Canada	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); CNRS(Centre National de la Recherche Scientifique (CNRS)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was funded by an operating grant from the Canadian Institutes of Health Research (Grant MOP-102706) and a Programme International de Collaboration Scientifique (Franco-Canadien) grant from the CNRS to fund exchanges between the two countries.; The recipient of a Natural Sciences and Engineering Research Council of Canada scholarship.	Breazeale SD, 2005, J BIOL CHEM, V280, P14154, DOI 10.1074/jbc.M414265200; Caroff M, 2003, CARBOHYD RES, V338, P2431, DOI 10.1016/j.carres.2003.07.010; Caroff M, 2000, FEBS LETT, V477, P8, DOI 10.1016/S0014-5793(00)01720-8; Caroff M., 2012, Patent, Patent No. [WO 2004/062690 A1, 2004062690]; Coats SR, 2011, INFECT IMMUN, V79, P203, DOI 10.1128/IAI.00937-10; El Hamidi A, 2005, J LIPID RES, V46, P1773, DOI 10.1194/jlr.D500014-JLR200; FURSTE JP, 1986, GENE, V48, P119, DOI 10.1016/0378-1119(86)90358-6; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Imagawa T, 2008, BIOCHEM BIOPH RES CO, V367, P535, DOI 10.1016/j.bbrc.2007.12.144; Inatsuka CS, 2010, INFECT IMMUN, V78, P2901, DOI 10.1128/IAI.00188-10; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; KOVACH ME, 1994, BIOTECHNIQUES, V16, P800; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Llewellyn AC, 2012, MOL MICROBIOL, V86, P611, DOI 10.1111/mmi.12004; Marr N, 2008, J BACTERIOL, V190, P4281, DOI 10.1128/JB.01875-07; Marr N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020585; Marr N, 2010, J INFECT DIS, V202, P1897, DOI 10.1086/657409; Marr N, 2010, INFECT IMMUN, V78, P2060, DOI 10.1128/IAI.01346-09; Ohto U, 2007, SCIENCE, V316, P1632, DOI 10.1126/science.1139111; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Park J, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-545; Parkhill J, 2003, NAT GENET, V35, P32, DOI 10.1038/ng1227; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; Raetz CRH, 2009, J LIPID RES, V50, pS103, DOI 10.1194/jlr.R800060-JLR200; Sambrook J., 1989, MOL CLONING LAB MANU, p[153, 510]; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; STAINER DW, 1970, J GEN MICROBIOL, V63, P211, DOI 10.1099/00221287-63-2-211; Sweet CR, 2002, J BIOL CHEM, V277, P18281, DOI 10.1074/jbc.M201057200; Therisod H, 2001, ANAL CHEM, V73, P3804, DOI 10.1021/ac010313s; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tirsoaga A, 2007, J LIPID RES, V48, P2419, DOI 10.1194/jlr.M700193-JLR200; Tirsoaga A, 2007, APPL ENVIRON MICROB, V73, P1803, DOI 10.1128/AEM.02452-06; Trent MS, 2006, J ENDOTOXIN RES, V12, P205, DOI 10.1179/096805106X118825; Trent MS, 2001, J BIOL CHEM, V276, P43122, DOI 10.1074/jbc.M106961200; TSAI CM, 1982, ANAL BIOCHEM, V119, P115, DOI 10.1016/0003-2697(82)90673-X; Weingart CL, 1999, INFECT IMMUN, V67, P4264, DOI 10.1128/IAI.67.8.4264-4267.1999; WEISS AA, 1983, INFECT IMMUN, V42, P33, DOI 10.1128/IAI.42.1.33-41.1983; Williams AH, 2007, P NATL ACAD SCI USA, V104, P13543, DOI 10.1073/pnas.0705833104; Wyckoff TJO, 1998, J BIOL CHEM, V273, P32369, DOI 10.1074/jbc.273.49.32369	40	33	33	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2013	288	17					11751	11760		10.1074/jbc.M112.434365	http://dx.doi.org/10.1074/jbc.M112.434365			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	133RP	23467413	Green Published, hybrid			2022-12-25	WOS:000318157600012
J	Hu, WT; Shelnutt, M; Wilson, A; Yarab, N; Kelly, C; Grossman, M; Libon, DJ; Khan, J; Lah, JJ; Levey, AI; Glass, J				Hu, William T.; Shelnutt, Matthew; Wilson, Ashley; Yarab, Nicole; Kelly, Crystal; Grossman, Murray; Libon, David J.; Khan, Jaffar; Lah, James J.; Levey, Allan I.; Glass, Jonathan			Behavior Matters-Cognitive Predictors of Survival in Amyotrophic Lateral Sclerosis	PLOS ONE			English	Article							FRONTOTEMPORAL LOBAR DEGENERATION; PHILADELPHIA BRIEF ASSESSMENT; FRONTAL ASSESSMENT BATTERY; DIAGNOSTIC-CRITERIA; ALZHEIMERS-DISEASE; EXECUTIVE FUNCTION; DEMENTIA; ALS; IMPAIRMENT; DYSFUNCTION	Background: It is difficult to longitudinally characterize cognitive impairment in amyotrophic lateral sclerosis (ALS) due to motor deficits, and existing instruments aren't comparable with assessments in other dementias. Methods: The ALS Brief Cognitive Assessment (ALS-BCA) was validated in 70 subjects (37 with ALS) who also underwent detailed neuropsychological analysis. Cognitive predictors for poor survival were then analyzed in a longitudinal cohort of 171 ALS patients. Results: The ALS-BCA was highly sensitive (90%) and specific (85%) for ALS-dementia (ALS-D). ALS-D patients had shorter overall survival, primarily due to the poor survival among ALS-D patients with disinhibited or apathetic behaviors after adjusting for demographic variables, ALS site of onset, medications, and supportive measures. ALS-D without behavioral changes was not a predictor of poor survival. Conclusion: ALS-D can present with or without prominent behavioral changes. Cognitive screening in ALS patients should focus on behavioral changes for prognosis, while non-behavioral cognitive impairments may impact quality of life without impacting survival.	[Hu, William T.; Shelnutt, Matthew; Wilson, Ashley; Yarab, Nicole; Kelly, Crystal; Khan, Jaffar; Lah, James J.; Levey, Allan I.; Glass, Jonathan] Emory Univ, Sch Med, Dept Neurol, Atlanta, GA 30322 USA; [Hu, William T.; Lah, James J.; Levey, Allan I.; Glass, Jonathan] Emory Univ, Sch Med, Ctr Neurodegenerat Dis, Atlanta, GA USA; [Hu, William T.; Shelnutt, Matthew; Lah, James J.; Levey, Allan I.; Glass, Jonathan] Emory Univ, Sch Med, Alzheimers Dis Res Ctr, Atlanta, GA USA; [Grossman, Murray] Univ Penn, Dept Neurol, Philadelphia, PA 19104 USA; [Libon, David J.] Drexel Univ, Dept Neurol, Philadelphia, PA 19104 USA	Emory University; Emory University; Emory University; University of Pennsylvania; Drexel University	Hu, WT (corresponding author), Emory Univ, Sch Med, Dept Neurol, Atlanta, GA 30322 USA.	william.hu@emory.edu	Levey, Allan/F-2104-2011	Levey, Allan/0000-0002-3153-502X; Hu, William/0000-0003-4862-6777	Viretta Brady Discovery Fund at Emory University School of Medicine; NIH [AG025688]; NATIONAL INSTITUTE ON AGING [P50AG025688] Funding Source: NIH RePORTER	Viretta Brady Discovery Fund at Emory University School of Medicine; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by the Viretta Brady Discovery Fund at Emory University School of Medicine, and NIH AG025688. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adenzato M, 2010, NEUROPSYCHOLOGIA, V48, P2, DOI 10.1016/j.neuropsychologia.2009.08.001; Ahn SW, 2011, CAN J NEUROL SCI, V38, P242, DOI 10.1017/S0317167100011409; Armitage SG, 1946, PSYCHOL MONOGR, V60, P1; Benedict R., 1997, BRIEF VISUOSPATIAL M; Benton A.L., 1994, CONTRIBUTIONS NEUROP; Brooks BR, 2000, AMYOTROPH LATERAL SC, V1, P293, DOI 10.1080/146608200300079536; Cavallo M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025948; Cedarbaum JM, 1999, J NEUROL SCI, V169, P13, DOI 10.1016/S0022-510X(99)00210-5; Elamin M, 2011, NEUROLOGY, V76, P1263, DOI 10.1212/WNL.0b013e318214359f; Eslinger PJ, 2007, J NEUROL NEUROSUR PS, V78, P457, DOI 10.1136/jnnp.2006.098228; Fernandez-Duque D, 2010, J CLIN EXP NEUROPSYC, V32, P289, DOI 10.1080/13803390903002191; Geser F, 2008, ARCH NEUROL-CHICAGO, V65, P636, DOI 10.1001/archneur.65.5.636; Goodglass H., 1983, ASSESSMENT APHASIA R, V2; Gordon PH, 2007, AMYOTROPH LATERAL SC, V8, P362, DOI 10.1080/17482960701500817; Gordon PH, 2010, AMYOTROPH LATERAL SC, V11, P312, DOI 10.3109/17482961003622585; Grossman M, 2008, NEUROLOGY, V70, P2036, DOI 10.1212/01.wnl.0000303816.25065.bc; Hu WT, 2009, ARCH NEUROL-CHICAGO, V66, P1359, DOI 10.1001/archneurol.2009.253; Josephs KA, 2006, NEUROLOGY, V66, P41, DOI 10.1212/01.wnl.0000191307.69661.c3; Kertesz A, 1997, CAN J NEUROL SCI, V24, P29, DOI 10.1017/S0317167100021053; Kertesz A, 2000, J INT NEUROPSYCH SOC, V6, P460, DOI 10.1017/S1355617700644041; Libon DJ, 2007, DEMENT GERIATR COGN, V24, P441, DOI 10.1159/000110577; Libon DJ, 2011, CLIN NEUROPSYCHOL, V25, P1314, DOI 10.1080/13854046.2011.631585; Lillo P, 2011, AMYOTROPH LATERAL SC, V12, P45, DOI 10.3109/17482968.2010.520718; Lough S, 2001, NEUROCASE, V7, P123, DOI 10.1076/neur.7.2.123.16266; Mackenzie IRA, 2009, ACTA NEUROPATHOL, V117, P15, DOI 10.1007/s00401-008-0460-5; Mathuranath PS, 2000, NEUROLOGY, V55, P1613, DOI 10.1212/01.wnl.0000434309.85312.19; McKhann GM, 2001, ARCH NEUROL-CHICAGO, V58, P1803, DOI 10.1001/archneur.58.11.1803; MORRIS JC, 1989, NEUROLOGY, V39, P1159, DOI 10.1212/wnl.43.12.2457; Morris JC, 2006, ALZ DIS ASSOC DIS, V20, P210, DOI 10.1097/01.wad.0000213865.09806.92; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; National Collaborative Group for the Revision of the Wechsler Adult Intelligence Scale, 1983, MANUAL WECHSLER ADUL, V03, P362; Neary D, 1998, NEUROLOGY, V51, P1546, DOI 10.1212/WNL.51.6.1546; Neumann M, 2009, ACTA NEUROPATHOL, V117, P137, DOI 10.1007/s00401-008-0477-9; Olney RK, 2005, NEUROLOGY, V65, P1774, DOI 10.1212/01.wnl.0000188759.87240.8b; Oskarsson B, 2010, AMYOTROPH LATERAL SC, V11, P244, DOI 10.3109/17482960903059588; Rascovsky K, 2007, ALZ DIS ASSOC DIS, V21, pS14, DOI 10.1097/WAD.0b013e31815c3445; Rascovsky K, 2011, BRAIN, V134, P2456, DOI 10.1093/brain/awr179; Ricker, 1994, Assessment, V1, P47, DOI 10.1177/1073191194001001007; Rippon GA, 2006, ARCH NEUROL-CHICAGO, V63, P345, DOI 10.1001/archneur.63.3.345; Rusina R, 2010, EUR J NEUROL, V17, P23, DOI 10.1111/j.1468-1331.2009.02717.x; Snowden J, 2007, ACTA NEUROPATHOL, V114, P31, DOI 10.1007/s00401-007-0236-3; Spreen O, 1990, COMPENDIUM NEUROPSYC; Strong MJ, 2009, AMYOTROPH LATERAL SC, V10, P131, DOI 10.1080/17482960802654364; Strong MJ, 1999, NEUROLOGY, V53, P1665, DOI 10.1212/WNL.53.8.1665; Wechsler D, 1973, MANUAL WECHSLER MEMO; Woolley SC, 2010, AMYOTROPH LATERAL SC, V11, P303, DOI 10.3109/17482961003727954	46	56	59	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57584	10.1371/journal.pone.0057584	http://dx.doi.org/10.1371/journal.pone.0057584			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460879	Green Published, gold			2022-12-25	WOS:000315519000134
J	Quintens, R; Singh, S; Lemaire, K; De Bock, K; Granvik, M; Schraenen, A; Vroegrijk, IOCM; Costa, V; Van Noten, P; Lambrechts, D; Lehnert, S; Van Lommel, L; Thorrez, L; De Faudeur, G; Romijn, JA; Shelton, JM; Scorrano, L; Lijnen, HR; Voshol, PJ; Carmeliet, P; Mammen, PPA; Schuit, F				Quintens, Roel; Singh, Sarvjeet; Lemaire, Katleen; De Bock, Katrien; Granvik, Mikaela; Schraenen, Anica; Vroegrijk, Irene Olga Cornelia Maria; Costa, Veronica; Van Noten, Pieter; Lambrechts, Dennis; Lehnert, Stefan; Van Lommel, Leentje; Thorrez, Lieven; De Faudeur, Geoffroy; Romijn, Johannes Anthonius; Shelton, John Michael; Scorrano, Luca; Lijnen, Henri Roger; Voshol, Peter Jacobus; Carmeliet, Peter; Mammen, Pradeep Puthenveetil Abraham; Schuit, Frans			Mice Deficient in the Respiratory Chain Gene Cox6a2 Are Protected against High-Fat Diet-Induced Obesity and Insulin Resistance	PLOS ONE			English	Article							CYTOCHROME-C-OXIDASE; MITOCHONDRIAL OXIDATIVE-PHOSPHORYLATION; TISSUE-SPECIFIC REGULATION; SKELETAL-MUSCLE; UNCOUPLING PROTEIN-2; ENERGY-METABOLISM; NUCLEAR RECEPTOR; ADIPOSE-TISSUE; UP-REGULATION; BOVINE HEART	Oxidative phosphorylation in mitochondria is responsible for 90% of ATP synthesis in most cells. This essential housekeeping function is mediated by nuclear and mitochondrial genes encoding subunits of complex I to V of the respiratory chain. Although complex IV is the best studied of these complexes, the exact function of the striated muscle-specific subunit COX6A2 is still poorly understood. In this study, we show that Cox6a2-deficient mice are protected against high-fat diet-induced obesity, insulin resistance and glucose intolerance. This phenotype results from elevated energy expenditure and a skeletal muscle fiber type switch towards more oxidative fibers. At the molecular level we observe increased formation of reactive oxygen species, constitutive activation of AMP-activated protein kinase, and enhanced expression of uncoupling proteins. Our data indicate that COX6A2 is a regulator of respiratory uncoupling in muscle and we demonstrate that a novel and direct link exists between muscle respiratory chain activity and diet-induced obesity/insulin resistance.	[Quintens, Roel; Lemaire, Katleen; Granvik, Mikaela; Schraenen, Anica; Lehnert, Stefan; Van Lommel, Leentje; Thorrez, Lieven; De Faudeur, Geoffroy; Schuit, Frans] Katholieke Univ Leuven, Gene Express Unit, Dept Mol & Cellular Med, Louvain, Belgium; [Singh, Sarvjeet; Shelton, John Michael; Mammen, Pradeep Puthenveetil Abraham] Univ Texas SW Med Ctr Dallas, Div Cardiol, Dept Internal Med, Dallas, TX 75390 USA; [De Bock, Katrien; Carmeliet, Peter] Katholieke Univ Leuven, Vesalius Res Ctr, Louvain, Belgium; [De Bock, Katrien; Carmeliet, Peter] Catholic Univ Louvain VIB, Vesalius Res Ctr, B-3000 Louvain, Belgium; [Vroegrijk, Irene Olga Cornelia Maria; Romijn, Johannes Anthonius; Voshol, Peter Jacobus] Leiden Univ, Dept Endocrinol & Metab Dis, Med Ctr, Leiden, Netherlands; [Costa, Veronica; Scorrano, Luca] Univ Geneva, Dept Cell Physiol & Metab, Geneva, Switzerland; [Van Noten, Pieter] Katholieke Univ Leuven, Phys Act & Hlth Lab, Biomed Kinesiol Dept, Louvain, Belgium; [Lambrechts, Dennis] Katholieke Univ Leuven, Dept Met & Mat Engn, Louvain, Belgium; [Lijnen, Henri Roger] Katholieke Univ Leuven, Ctr Mol & Vasc Biol, Louvain, Belgium	KU Leuven; University of Texas System; University of Texas Southwestern Medical Center Dallas; KU Leuven; Flanders Institute for Biotechnology (VIB); Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Geneva; KU Leuven; KU Leuven; KU Leuven	Schuit, F (corresponding author), Katholieke Univ Leuven, Gene Express Unit, Dept Mol & Cellular Med, Louvain, Belgium.	Frans.Schuit@med.kuleuven.be	Carmeliet, Peter/AAQ-5140-2020; Scorrano, Luca/A-6652-2008; Scorrano, Luca/K-3967-2019; Thorrez, Lieven/A-2583-2011; De Bock, Katrien/L-2273-2013; singh, sarvjeet/F-1569-2015; Lijnen, Roger/AAA-4085-2020; Quintens, Roel/G-5339-2017	Carmeliet, Peter/0000-0001-7961-1821; Scorrano, Luca/0000-0002-8515-8928; Scorrano, Luca/0000-0002-8515-8928; Thorrez, Lieven/0000-0002-5896-6823; De Bock, Katrien/0000-0001-8232-4663; Quintens, Roel/0000-0002-4359-3403; Lambrechts, Dennis/0000-0002-2373-2795	KU Leuven [GOA 2008/16]; Flanders Fund for Scientific Research (FWO) [G.0733-09, G.0672-12]; National Institutes of Health (USA) [HL-076440]; MRC [G0600717, MC_UU_12012/5] Funding Source: UKRI; Medical Research Council [MC_UU_12012/5/B, MC_UU_12012/5, G0600717B, G0600717] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL102478, K08HL076440] Funding Source: NIH RePORTER	KU Leuven(KU Leuven); Flanders Fund for Scientific Research (FWO)(FWO); National Institutes of Health (USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was financially supported by grants of the KU Leuven (GOA 2008/16 to FS), the Flanders Fund for Scientific Research (FWO grants G.0733-09 and G.0672-12 to FS) and the National Institutes of Health (USA, HL-076440 to PM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTHONY G, 1993, P NATL ACAD SCI USA, V90, P1652, DOI 10.1073/pnas.90.5.1652; ANTHONY G, 1990, FEBS LETT, V277, P97, DOI 10.1016/0014-5793(90)80817-3; Arsenijevic D, 2000, NAT GENET, V26, P435, DOI 10.1038/82565; Azzu V, 2010, TRENDS BIOCHEM SCI, V35, P298, DOI 10.1016/j.tibs.2009.11.001; Bal NC, 2012, NAT MED; Boily G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001759; Bonnard C, 2008, J CLIN INVEST, V118, P789, DOI 10.1172/JCI32601; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Brand MD, 2005, CELL METAB, V2, P85, DOI 10.1016/j.cmet.2005.06.002; Chemello F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016807; Chen W, 2010, P NATL ACAD SCI USA, V107, P10196, DOI 10.1073/pnas.1005626107; Chida D, 2008, DIABETOLOGIA, V51, P1698, DOI 10.1007/s00125-008-1075-z; Choi CS, 2007, J CLIN INVEST, V117, P1995, DOI 10.1172/JCI13579; Clapham JC, 2000, NATURE, V406, P415, DOI 10.1038/35019082; Crawford D, 2000, INT J OBESITY, V24, P1107, DOI 10.1038/sj.ijo.0801374; Diaz F, 2005, HUM MOL GENET, V14, P2737, DOI 10.1093/hmg/ddi307; Echtay KS, 2002, NATURE, V415, P96, DOI 10.1038/415096a; Feige JN, 2008, CELL METAB, V8, P347, DOI 10.1016/j.cmet.2008.08.017; Fornuskova D, 2010, BIOCHEM J, V428, P363, DOI 10.1042/BJ20091714; Frank V, 1996, FEBS LETT, V382, P121, DOI 10.1016/0014-5793(96)00096-8; Fritah A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032520; Gomez-Cabrera MC, 2008, FREE RADICAL BIO MED, V44, P126, DOI 10.1016/j.freeradbiomed.2007.02.001; Gong DW, 2000, J BIOL CHEM, V275, P16251, DOI 10.1074/jbc.M910177199; Handschin C, 2007, J CLIN INVEST, V117, P3463, DOI 10.1172/JCI31785; Handschin C, 2007, J BIOL CHEM, V282, P30014, DOI 10.1074/jbc.M704817200; Hoeks J, 2012, TRENDS ENDOCRIN MET, V23, P444, DOI 10.1016/j.tem.2012.05.007; Hoeks J, 2010, DIABETES, V59, P2117, DOI 10.2337/db10-0519; Horvath TL, 2003, INT J OBESITY, V27, P433, DOI 10.1038/sj.ijo.0802257; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; Irrcher I, 2009, AM J PHYSIOL-CELL PH, V296, pC116, DOI 10.1152/ajpcell.00267.2007; Ivarsson R, 2005, DIABETES, V54, P2132, DOI 10.2337/diabetes.54.7.2132; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Jheng HF, 2012, MOL CELL BIOL, V32, P309, DOI 10.1128/MCB.05603-11; KADENBACH B, 1995, BBA-MOL BASIS DIS, V1271, P103, DOI 10.1016/0925-4439(95)00016-W; KADENBACH B, 1990, BIOCHIM BIOPHYS ACTA, V1015, P368, DOI 10.1016/0005-2728(90)90042-3; Kim JA, 2008, CIRC RES, V102, P401, DOI 10.1161/CIRCRESAHA.107.165472; Klaus S, 2011, GENES NUTR; Kopecky J, 1995, J CLIN INVEST, V96, P2914, DOI 10.1172/JCI118363; Korshunov SS, 1997, FEBS LETT, V416, P15, DOI 10.1016/S0014-5793(97)01159-9; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lee CH, 2006, P NATL ACAD SCI USA, V103, P3444, DOI 10.1073/pnas.0511253103; Lee FYJ, 1999, HEPATOLOGY, V29, P677, DOI 10.1002/hep.510290320; Li B, 2000, NAT MED, V6, P1115, DOI 10.1038/80450; Lijnen HR, 2006, DIABETES, V55, P2698, DOI 10.2337/db06-0526; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Loh K, 2009, CELL METAB, V10, P260, DOI 10.1016/j.cmet.2009.08.009; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Nakai Y, 2008, BIOSCI BIOTECH BIOCH, V72, P139, DOI 10.1271/bbb.70508; Neschen S, 2008, PHYSIOL GENOMICS, V33, P333, DOI 10.1152/physiolgenomics.00226.2007; Netea MG, 2006, NAT MED, V12, P650, DOI 10.1038/nm1415; OGILVIE RW, 1990, STAIN TECHNOL, V65, P231, DOI 10.3109/10520299009105613; Papa S, 1997, BIOSCIENCE REP, V17, P23, DOI 10.1023/A:1027331116866; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Pearen MA, 2012, MOL ENDOCRINOL, V26, P372, DOI 10.1210/me.2011-1274; Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889; Polak P, 2008, CELL METAB, V8, P399, DOI 10.1016/j.cmet.2008.09.003; Pospisilik JA, 2007, CELL, V131, P476, DOI 10.1016/j.cell.2007.08.047; Radford NB, 2002, AM J PHYSIOL-HEART C, V282, pH726, DOI 10.1152/ajpheart.00308.2001; Ristow M, 2010, EXP GERONTOL, V45, P410, DOI 10.1016/j.exger.2010.03.014; Ristow M, 2009, P NATL ACAD SCI USA, V106, P8665, DOI 10.1073/pnas.0903485106; ROHDICH F, 1993, BIOCHEMISTRY-US, V32, P8499, DOI 10.1021/bi00084a015; Rufini A, 2012, GENE DEV, V26, P2009, DOI 10.1101/gad.197640.112; Sadler NC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047996; Seale P, 2011, J CLIN INVEST, V121, P96, DOI 10.1172/JCI44271; Sokolovic M, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-361; Sparks LM, 2005, DIABETES, V54, P1926, DOI 10.2337/diabetes.54.7.1926; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Surwit RS, 1998, P NATL ACAD SCI USA, V95, P4061, DOI 10.1073/pnas.95.7.4061; TAANMAN JW, 1993, BIOCHIM BIOPHYS ACTA, V1225, P95, DOI 10.1016/0925-4439(93)90128-N; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; Vernochet C, 2012, CELL METAB, V16, P765, DOI 10.1016/j.cmet.2012.10.016; Vidal-Puig AJ, 2000, J BIOL CHEM, V275, P16258, DOI 10.1074/jbc.M910179199; Wamil M, 2011, DIABETES, V60, P1158, DOI 10.2337/db10-0830; Wang YX, 2004, PLOS BIOL, V2, P1532, DOI 10.1371/journal.pbio.0020294; Wredenberg A, 2006, BIOCHEM BIOPH RES CO, V350, P202, DOI 10.1016/j.bbrc.2006.09.029; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Zanetti M, 2005, METH MOLEC MED, V108, P65	79	41	44	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e56719	10.1371/journal.pone.0056719	http://dx.doi.org/10.1371/journal.pone.0056719			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460811	Green Published, gold, Green Submitted			2022-12-25	WOS:000315519000034
J	Tan, SC; Yao, XH; Gao, HW; Shi, GY; Yue, X				Tan, Sai-Chun; Yao, Xiaohong; Gao, Hui-Wang; Shi, Guang-Yu; Yue, Xu			Variability in the Correlation between Asian Dust Storms and Chlorophyll a Concentration from the North to Equatorial Pacific	PLOS ONE			English	Article							EXPORT PRODUCTION; DISSOLVED IRON; CLIMATE-CHANGE; TRANSPORT; AEROSOLS; IMPACTS; MODEL; SEA	A long-term record of Asian dust storms showed seven high-occurrence-frequency centers in China. The intrusion of Asian dust into the downwind seas, including the China seas, the Sea of Japan, the subarctic North Pacific, the North Pacific subtropical gyre, and the western and eastern Equatorial Pacific, has been shown to add nutrients to ocean ecosystems and enhance their biological activities. To explore the relationship between the transported dust from various sources to the six seas and oceanic biological activities with different nutrient conditions, the correlation between monthly chlorophyll a concentration in each sea and monthly dust storm occurrence frequencies reaching the sea during 1997-2007 was examined in this study. No correlations were observed between dust and chlorophyll a concentration in the <50 m China seas because atmospheric deposition is commonly believed to exert less impact on coastal seas. Significant correlations existed between dust sources and many sea areas, suggesting a link between dust and chlorophyll a concentration in those seas. However, the correlation coefficients were highly variable. In general, the correlation coefficients (0.54-0.63) for the Sea of Japan were highest, except for that between the subarctic Pacific and the Taklimakan Desert, where it was as high as 0.7. For the >50 m China seas and the North Pacific subtropical gyre, the correlation coefficients were in the range 0.32-0.57. The correlation coefficients for the western and eastern Equatorial Pacific were relatively low (<0.36). These correlation coefficients were further interpreted in terms of the geographical distributions of dust sources, the transport pathways, the dust deposition, the nutrient conditions of oceans, and the probability of dust storms reaching the seas.	[Tan, Sai-Chun; Shi, Guang-Yu] Chinese Acad Sci, Inst Atmospher Phys, State Key Lab Numer Modeling Atmospher Sci & Geop, Beijing, Peoples R China; [Yao, Xiaohong; Gao, Hui-Wang] Ocean Univ China, Minist Educ China, Key Lab Marine Environm & Ecol, Qingdao, Peoples R China; [Yue, Xu] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA	Chinese Academy of Sciences; Institute of Atmospheric Physics, CAS; Ministry of Education, China; Ocean University of China; Harvard University	Tan, SC (corresponding author), Chinese Acad Sci, Inst Atmospher Phys, State Key Lab Numer Modeling Atmospher Sci & Geop, Beijing, Peoples R China.	sctan@mail.iap.ac.cn; hwgao@ouc.edu.cn	Yue, Xu/ABD-9066-2021; Tan, Saichun/D-1984-2015	Tan, Saichun/0000-0003-3089-3439; Yue, Xu/0000-0002-8861-8192	National Natural Science Foundation of China [41005080, 40976063, 41130104]; Ministry of Science and Technology of China [2010DFA22770, 2010DFA91350]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work was supported by the National Natural Science Foundation of China (Grants No. 41005080, 40976063 and 41130104) and the Ministry of Science and Technology of China (Grant nos. 2010DFA22770 and 2010DFA91350). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker AR, 2010, MAR CHEM, V120, P4, DOI 10.1016/j.marchem.2008.09.003; Bishop JKB, 2002, SCIENCE, V298, P817, DOI 10.1126/science.1074961; Boyd PW, 2010, MAR CHEM, V120, P128, DOI 10.1016/j.marchem.2009.01.008; Calil PHR, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006704; Chan CK, 2008, ATMOS ENVIRON, V42, P1, DOI 10.1016/j.atmosenv.2007.09.003; Coale KH, 1996, NATURE, V379, P621, DOI 10.1038/379621a0; Draxler RR, 2010, HYSPLIT HYBRID SINGL; Duce RA, 2008, SCIENCE, V320, P893, DOI 10.1126/science.1150369; Furutani H, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL041367; Han YX, 2011, ATMOS ENVIRON, V45, P4291, DOI 10.1016/j.atmosenv.2011.04.078; Jickells TD, 2005, SCIENCE, V308, P67, DOI 10.1126/science.1105959; Jo CO, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL027395; Kai Z, 2007, ATMOS ENVIRON, V41, P9136, DOI 10.1016/j.atmosenv.2007.08.007; Liu XH, 2007, THEOR APPL CLIMATOL, V88, P71, DOI 10.1007/s00704-006-0231-y; Longhurst A, 1995, PROG OCEANOGR, V36, P77, DOI 10.1016/0079-6611(95)00015-1; Matsuki A, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD003266; Mikami M, 2006, GLOBAL PLANET CHANGE, V52, P142, DOI 10.1016/j.gloplacha.2006.03.001; Nohara D, 2006, J HYDROMETEOROL, V7, P1076, DOI 10.1175/JHM531.1; Paytan A, 2009, P NATL ACAD SCI USA, V106, P4601, DOI 10.1073/pnas.0811486106; Qian ZA, 2006, CHINESE J GEOPHYS-CH, V49, P83; Shi JH, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD013238; Takata H, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL031794; Tan SC, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2010JG001456; Tang YH, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD003806; Uematsu M, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016645; Wang BD, 2003, ESTUAR COAST SHELF S, V58, P127, DOI 10.1016/S0272-7714(03)00067-2; Wu JF, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001924; Yuan W, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025174; Yue X, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2008JD010995; Zhang XY, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL018206; Zhao TL, 2006, J CLIMATE, V19, P88, DOI 10.1175/JCLI3605.1	31	45	48	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57656	10.1371/journal.pone.0057656	http://dx.doi.org/10.1371/journal.pone.0057656			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460892	Green Published, gold, Green Submitted			2022-12-25	WOS:000315519000147
J	van der Werf, CS; Hsiao, NH; Conroy, S; Paredes, J; Ribeiro, AS; Sribudiani, Y; Seruca, R; Hofstra, RMW; Westers, H; van IJzendoorn, SCD				van der Werf, Christine S.; Hsiao, Nai-Hua; Conroy, Siobhan; Paredes, Joana; Ribeiro, Ana S.; Sribudiani, Yunia; Seruca, Raquel; Hofstra, Robert M. W.; Westers, Helga; van IJzendoorn, Sven C. D.			CLMP Is Essential for Intestinal Development, but Does Not Play a Key Role in Cellular Processes Involved in Intestinal Epithelial Development	PLOS ONE			English	Article							TIGHT JUNCTION PROTEIN; ADHERENS JUNCTIONS; FAMILY; EXPRESSION; CELLS	Loss-of-function mutations in CLMP have been found in patients with Congenital Short Bowel Syndrome (CSBS), suggesting that its encoded protein plays a major role in intestinal development. CLMP is a membrane protein that co-localizes with tight junction proteins, but its function is largely unknown. We expressed wild-type (WT)-CLMP and a mutant-CLMP (associated with CSBS) in human intestinal epithelial T84 cells that, as we show here, do not produce endogenous CLMP. We investigated the effects of WT-CLMP and mutant-CLMP proteins on key cellular processes that are important for intestinal epithelial development, including migration, proliferation, viability and transepithelial resistance. Our data showed that expression of WT-CLMP or mutant-CLMP does not affect any of these processes. Moreover, our aggregation assays in CHO cells show that CLMP does not act as a strong adhesion molecule. Thus, our data suggest that, in the in vitro model systems we used, the key processes involved in intestinal epithelial development appear to be unaffected by WT-CLMP or mutant-CLMP. Further research is needed to determine the role of CLMP in the development of the intestine.	[van der Werf, Christine S.; Conroy, Siobhan; Sribudiani, Yunia; Hofstra, Robert M. W.; Westers, Helga] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands; [Hsiao, Nai-Hua; van IJzendoorn, Sven C. D.] Univ Groningen, Univ Med Ctr Groningen, Dept Cell Biol, Groningen, Netherlands; [Paredes, Joana; Ribeiro, Ana S.; Seruca, Raquel] Univ Porto, Canc Genet Grp, Inst Mol Pathol & Immunol, P-4100 Oporto, Portugal; [Sribudiani, Yunia; Hofstra, Robert M. W.] Erasmus Univ, Dept Clin Genet, Erasmus Med Ctr, Rotterdam, Netherlands	University of Groningen; University of Groningen; Universidade do Porto; Erasmus University Rotterdam; Erasmus MC	Hofstra, RMW (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands.	r.hofstra@erasmus.nl	Paredes, Joana/F-8224-2011; Ribeiro, Ana/J-7334-2013; Sribudiani, Yunia/I-2972-2019; seruca, raquel/F-8187-2011	Paredes, Joana/0000-0002-1076-1343; Ribeiro, Ana/0000-0002-9698-9233; Sribudiani, Yunia/0000-0003-1985-3292; Seruca, Raquel/0000-0002-8851-4166; Hofstra, Robert/0000-0001-7498-3829	Junior Scientific Masterclass (University of Groningen); J.K. de Cockstichting	Junior Scientific Masterclass (University of Groningen); J.K. de Cockstichting	This study was financially supported by the Junior Scientific Masterclass (University of Groningen) and the J.K. de Cockstichting. The funders had no role in study desing, data collection and analysis, decision to publish, or preparation of the manuscript.	Balda MS, 2000, EMBO J, V19, P2024, DOI 10.1093/emboj/19.9.2024; Bazzoni G, 2003, CURR OPIN CELL BIOL, V15, P525, DOI 10.1016/S0955-0674(03)00104-2; Boterberg T, 2001, Methods Mol Med, V58, P33, DOI 10.1385/1-59259-137-X:033; Clark E, 2005, GASTROENTEROLOGY, V128, P1258, DOI 10.1053/j.gastro.2005.01.046; Dukes JD, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-43; Eguchi J, 2005, BIOCHEM J, V387, P343, DOI 10.1042/BJ20041709; Juuti-Uusitalo K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022967; Matter K, 2003, NAT REV MOL CELL BIO, V4, P225, DOI 10.1038/nrm1055; Naydenov NG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034320; Perez-Moreno M, 2003, CELL, V112, P535, DOI 10.1016/S0092-8674(03)00108-9; Raschperger E, 2004, J BIOL CHEM, V279, P796, DOI 10.1074/jbc.M308249200; Sze KL, 2008, BIOCHEM J, V410, P575, DOI 10.1042/BJ20070901; Sze KL, 2008, J CELL PHYSIOL, V214, P334, DOI 10.1002/jcp.21201; Van Der Werf CS, 2012, GASTROENTEROLOGY, V142, P453, DOI 10.1053/j.gastro.2011.11.038; Young P, 2003, EMBO J, V22, P5723, DOI 10.1093/emboj/cdg560	15	9	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e54649	10.1371/journal.pone.0054649	http://dx.doi.org/10.1371/journal.pone.0054649			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460781	Green Published, Green Submitted, gold			2022-12-25	WOS:000315519000004
J	Christians, JK; de Zwaan, DR; Fung, SHY				Christians, Julian Kenneth; de Zwaan, Devin Rhys; Fung, Sunny Ho Yeung			Pregnancy Associated Plasma Protein A2 (PAPP-A2) Affects Bone Size and Shape and Contributes to Natural Variation in Postnatal Growth in Mice	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCUS; FACTOR-BINDING-PROTEIN; MANDIBLE SHAPE; EXPRESSION; GENE; POLYMORPHISM; PROTEOLYSIS; RODENTIA; PAPPA2; LIFE	Pregnancy associated plasma protein A2 (PAPP-A2) is a protease of insulin-like growth factor binding protein 5 and is receiving increasing attention for its roles in pregnancy and postnatal growth. The goals of the present study were to characterize the effects of PAPP-A2 deletion on bone size and shape in mice at 10 weeks of age, and to determine whether Pappa2 is the gene responsible for a previously-identified quantitative trait locus (QTL) contributing to natural variation in postnatal growth in mice. Mice homozygous for constitutive PAPP-A2 deletion were lighter than wild-type littermates, and had smaller mandible dimensions and shorter skull, humerus, femur, tibia, pelvic girdle, and tail bone. Furthermore, PAPP-A2 deletion reduced mandible dimensions and the lengths of the skull, femur, pelvic girdle, and tail bone more than would be expected due to the effect on body mass. In addition to its effects on bone size, PAPP-A2 deficiency also altered the shape of the mandible and pelvic girdle, as assessed by geometric morphometrics. Mice homozygous for the PAPP-A2 deletion had less deep mandibles, and pelvic girdles with a more feminine shape. Using a quantitative complementation test, we confirmed that Pappa2 is responsible for the effects of the previously-identified QTL, demonstrating that natural variation in the Pappa2 gene contributes to variation in postnatal growth in mice. If similar functional variation in the Pappa2 gene exists in other species, effects of this variation on the shape of the pelvic girdle might explain the previously-reported associations between Pappa2 SNPs and developmental dysplasia of the hip in humans, and birthing in cattle.	[Christians, Julian Kenneth; de Zwaan, Devin Rhys; Fung, Sunny Ho Yeung] Simon Fraser Univ, Burnaby, BC V5A 1S6, Canada	Simon Fraser University	Christians, JK (corresponding author), Simon Fraser Univ, Burnaby, BC V5A 1S6, Canada.	julian_christians@sfu.ca	Christians, J.K./AAL-2547-2020; de Zwaan, Devin R/L-4628-2016	Christians, J.K./0000-0003-1797-0591; de Zwaan, Devin R/0000-0001-5418-0754	Natural Sciences and Engineering Research Council (NSERC) [326791-11]; Simon Fraser University; Simon Fraser University President's Research Grant; NSERC	Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Simon Fraser University; Simon Fraser University President's Research Grant; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This study was funded by a Natural Sciences and Engineering Research Council (NSERC) operating grant (326791-11), start-up funds from Simon Fraser University and a Simon Fraser University President's Research Grant to JKC and by a NSERC undergraduate student research award (USRA) to DRDZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez A, 2011, BIOL J LINN SOC, V102, P828, DOI 10.1111/j.1095-8312.2011.01622.x; Bunn RC, 2003, TRENDS ENDOCRIN MET, V14, P176, DOI 10.1016/S1043-2760(03)00049-3; Chen BK, 2003, J CLIN ENDOCR METAB, V88, P4465, DOI 10.1210/jc.2003-030193; Cheverud JM, 2010, J LIPID RES, V51, P907, DOI 10.1194/jlr.M900128; Christians JK, 2005, CURR BIOL, V15, pR19, DOI 10.1016/j.cub.2004.12.013; Christians JK, 2004, MAMM GENOME, V15, P482, DOI 10.1007/s00335-004-3046-0; Christians JK, 2003, MAMM GENOME, V14, P175, DOI 10.1007/s00335-002-3041-2; Christians JK, 2007, MAMM GENOME, V18, P240, DOI 10.1007/s00335-007-9018-4; Christians JK, 2006, GENETICS, V173, P1547, DOI 10.1534/genetics.106.057513; Christians JK, 2010, PRENATAL DIAG, V30, P815, DOI 10.1002/pd.2583; Conover CA, 2008, AM J PHYSIOL-ENDOC M, V294, pE10, DOI 10.1152/ajpendo.00648.2007; Conover CA, 2007, AGING CELL, V6, P727, DOI 10.1111/j.1474-9726.2007.00328.x; Conover CA, 2011, ENDOCRINOLOGY, V152, P2837, DOI 10.1210/en.2011-0036; Govoni KE, 2005, PEDIATR NEPHROL, V20, P261, DOI 10.1007/s00467-004-1658-y; Jia JY, 2012, OSTEOARTHR CARTILAGE, V20, P60, DOI 10.1016/j.joca.2011.10.004; Kaski JC, 2006, EUR HEART J, V27, P1637, DOI 10.1093/eurheartj/ehl118; Klingenberg CP, 2011, MOL ECOL RESOUR, V11, P353, DOI 10.1111/j.1755-0998.2010.02924.x; Klingenberg CP, 2010, NAT REV GENET, V11, P623, DOI 10.1038/nrg2829; Luna-Nevarez P, 2011, J ANIM SCI, V89, P926, DOI 10.2527/jas.2010-3483; Luna-Nevarez P, 2012, REV MEX CIENC PECU, V3, P185; Monteiro LR, 2003, J ZOOL, V261, P47, DOI 10.1017/S0952836903003893; Overgaard MT, 2001, J BIOL CHEM, V276, P21849, DOI 10.1074/jbc.M102191200; Renaud S, 2003, J BIOGEOGR, V30, P1617, DOI 10.1046/j.1365-2699.2003.00932.x; Schutz H, 2009, J MORPHOL, V270, P834, DOI 10.1002/jmor.10723; Tanner SJ, 2008, J BONE MINER RES, V23, P655, DOI 10.1359/JBMR.071210; Wagner PK, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-90; Wang J, 2009, J ENDOCRINOL, V202, P337, DOI 10.1677/JOE-09-0136; Wickramasinghe S, 2011, J DAIRY SCI, V94, P1552, DOI 10.3168/jds.2010-3237; Yalcin B, 2004, NAT GENET, V36, P1197, DOI 10.1038/ng1450; Yan XL, 2010, J CLIN ENDOCR METAB, V95, P1412, DOI 10.1210/jc.2009-2277	30	38	39	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56260	10.1371/journal.pone.0056260	http://dx.doi.org/10.1371/journal.pone.0056260			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457539	Green Submitted, Green Published, gold			2022-12-25	WOS:000315603700035
J	Parravicini, F; Natalello, A; Papaleo, E; De Gioia, L; Doglia, SM; Lotti, M; Brocca, S				Parravicini, Federica; Natalello, Antonino; Papaleo, Elena; De Gioia, Luca; Doglia, Silvia Maria; Lotti, Marina; Brocca, Stefania			Reciprocal Influence of Protein Domains in the Cold-Adapted Acyl Aminoacyl Peptidase from Sporosarcina psychrophila	PLOS ONE			English	Article							AEROPYRUM-PERNIX K1; TRANSFORM INFRARED-SPECTROSCOPY; PROLYL OLIGOPEPTIDASE; ACYLPEPTIDE HYDROLASE; ACYLAMINOACYL PEPTIDASE; STRUCTURE PREDICTION; SECONDARY STRUCTURE; CRYSTAL-STRUCTURE; BETA-PROPELLERS; SERVER	Acyl aminoacyl peptidases are two-domain proteins composed by a C-terminal catalytic alpha/beta-hydrolase domain and by an N-terminal beta-propeller domain connected through a structural element that is at the N-terminus in sequence but participates in the 3D structure of the C-domain. We investigated about the structural and functional interplay between the two domains and the bridge structure (in this case a single helix named alpha 1-helix) in the cold-adapted enzyme from Sporosarcina psychrophila (SpAAP) using both protein variants in which entire domains were deleted and proteins carrying substitutions in the alpha 1-helix. We found that in this enzyme the inter-domain connection dramatically affects the stability of both the whole enzyme and the beta-propeller. The alpha 1-helix is required for the stability of the intact protein, as in other enzymes of the same family; however in this psychrophilic enzyme only, it destabilizes the isolated beta-propeller. A single charged residue (E10) in the alpha 1-helix plays a major role for the stability of the whole structure. Overall, a strict interaction of the SpAAP domains seems to be mandatory for the preservation of their reciprocal structural integrity and may witness their co-evolution.	[Parravicini, Federica; Natalello, Antonino; Papaleo, Elena; De Gioia, Luca; Doglia, Silvia Maria; Lotti, Marina; Brocca, Stefania] Univ Milano Bicocca, Dept Biotechnol & Biosci, Milan, Italy	University of Milano-Bicocca	Lotti, M (corresponding author), Univ Milano Bicocca, Dept Biotechnol & Biosci, Milan, Italy.	marina.lotti@unimib.it; stefania.brocca@unimib.it	Papaleo, Elena/M-6629-2014; Natalello, Antonino/B-9659-2012; Brocca, Stefania/AAE-1299-2021; Lotti, Marina/AAU-1630-2020; De Gioia, Luca/K-6439-2016	Papaleo, Elena/0000-0002-7376-5894; Natalello, Antonino/0000-0002-1489-272X; Lotti, Marina/0000-0001-5419-7572; , Elena/0000-0003-2296-898X; BROCCA, STEFANIA/0000-0001-7256-4436	University of Milano-Bicocca (Fondo di Ateneo); CASPUR (Consorzio Interuniversitario per le Applicazioni di Supercalcolo per Universita e Ricerca) Standard HPC Grant	University of Milano-Bicocca (Fondo di Ateneo); CASPUR (Consorzio Interuniversitario per le Applicazioni di Supercalcolo per Universita e Ricerca) Standard HPC Grant	This work was partly supported by grants of the University of Milano-Bicocca (Fondo di Ateneo) to SB, ML, LDG, SMD. This research was also supported by CASPUR (Consorzio Interuniversitario per le Applicazioni di Supercalcolo per Universita e Ricerca) Standard HPC Grant 2011 and 2012 to EP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcolombri U, 2011, J MOL BIOL, V411, P837, DOI 10.1016/j.jmb.2011.06.037; Barth A, 2007, BBA-BIOENERGETICS, V1767, P1073, DOI 10.1016/j.bbabio.2007.06.004; Bartlam M, 2004, STRUCTURE, V12, P1481, DOI 10.1016/j.str.2004.05.019; Brunialti EAS, 2011, BIOCHIMIE, V93, P1543, DOI 10.1016/j.biochi.2011.05.010; Eisenberg D, 1997, METHOD ENZYMOL, V277, P396, DOI 10.1016/S0076-6879(97)77022-8; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Fulop V, 1999, CURR OPIN STRUC BIOL, V9, P715, DOI 10.1016/S0959-440X(99)00035-4; Fulop V, 1998, CELL, V94, P161, DOI 10.1016/S0092-8674(00)81416-6; Gogliettino M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037921; Harmat V, 2011, J BIOL CHEM, V286, P1987, DOI 10.1074/jbc.M110.169862; Ishikawa K, 1998, J BIOL CHEM, V273, P17726, DOI 10.1074/jbc.273.28.17726; Juhasz T, 2005, J MOL BIOL, V346, P907, DOI 10.1016/j.jmb.2004.12.014; Kaushik S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026251; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kurowski MA, 2003, NUCLEIC ACIDS RES, V31, P3305, DOI 10.1093/nar/gkg557; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li M, 2010, J BIOL CHEM, V285, P21487, DOI 10.1074/jbc.M109.092692; Liu C, 2011, PROTEIN CELL, V2, P497, DOI 10.1007/s13238-011-1057-7; Matsumura I, 2005, BIOMOL ENG, V22, P73, DOI 10.1016/j.bioeng.2004.10.004; Natalello A, 2005, BIOCHEM J, V385, P511, DOI 10.1042/BJ20041296; Natalello A, 2008, J MOL BIOL, V381, P1349, DOI 10.1016/j.jmb.2008.06.063; Natalello A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018789; OLLIS DL, 1992, PROTEIN ENG, V5, P197, DOI 10.1093/protein/5.3.197; Palmieri G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025888; Papaleo E, 2012, J MOL GRAPH IN PRESS; Papaleo E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035686; Perrier J, 2005, BIOCHIMIE, V87, P673, DOI 10.1016/j.biochi.2005.04.002; POLGAR L, 1992, FEBS LETT, V311, P281, DOI 10.1016/0014-5793(92)81120-B; RAWLINGS ND, 1991, BIOCHEM J, V279, P907, DOI 10.1042/bj2790907; Sambrook J., 1989, MOL CLONING LAB MANU, V2; SCALONI A, 1992, J LAB CLIN MED, V120, P546; Seshadri S, 1999, METHOD ENZYMOL, V309, P559; SHARMA KK, 1993, EUR J BIOCHEM, V216, P631, DOI 10.1111/j.1432-1033.1993.tb18183.x; Shimizu K, 2004, BIOCHEM BIOPH RES CO, V324, P140, DOI 10.1016/j.bbrc.2004.08.231; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; SUSI H, 1986, METHOD ENZYMOL, V130, P290; Szeltner Z, 2004, J MOL BIOL, V340, P627, DOI 10.1016/j.jmb.2004.05.011; Szeltner Z, 2008, CURR PROTEIN PEPT SC, V9, P96; Szeltner Z, 2009, BBA-PROTEINS PROTEOM, V1794, P1204, DOI 10.1016/j.bbapap.2009.03.004; Van Elzen R, 2011, CNS NEUROL DISORD-DR, V10, P297, DOI 10.2174/187152711794653814; Wang QY, 2006, J BIOL CHEM, V281, P18618, DOI 10.1074/jbc.M601015200; Willard L, 2003, NUCLEIC ACIDS RES, V31, P3316, DOI 10.1093/nar/gkg565; Yang GY, 2009, BBA-PROTEINS PROTEOM, V1794, P94, DOI 10.1016/j.bbapap.2008.09.007; Zhang HF, 2005, ACTA BIOCH BIOPH SIN, V37, P613, DOI 10.1111/j.1745-7270.2005.00085.x; Zhang ZM, 2008, BBA-PROTEINS PROTEOM, V1784, P1176, DOI 10.1016/j.bbapap.2008.05.011	49	11	11	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56254	10.1371/journal.pone.0056254	http://dx.doi.org/10.1371/journal.pone.0056254			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457536	gold, Green Published, Green Submitted			2022-12-25	WOS:000315603700033
J	Czapla, L; Grosner, MA; Swigon, D; Olson, WK				Czapla, Luke; Grosner, Michael A.; Swigon, David; Olson, Wilma K.			Interplay of Protein and DNA Structure Revealed in Simulations of the lac Operon	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; LENGTH DEPENDENCE; LOOP FORMATION; MONTE-CARLO; REPRESSOR; HU; CONFORMATION; FLEXIBILITY; SEQUENCE; BINDING	The E. coli Lac repressor is the classic textbook example of a protein that attaches to widely spaced sites along a genome and forces the intervening DNA into a loop. The short loops implicated in the regulation of the lac operon suggest the involvement of factors other than DNA and repressor in gene control. The molecular simulations presented here examine two likely structural contributions to the in-vivo looping of bacterial DNA: the distortions of the double helix introduced upon association of the highly abundant, nonspecific nucleoid protein HU and the large-scale deformations of the repressor detected in low-resolution experiments. The computations take account of the three-dimensional arrangements of nucleotides and amino acids found in crystal structures of DNA with the two proteins, the natural rest state and deformational properties of protein-free DNA, and the constraints on looping imposed by the conformation of the repressor and the orientation of bound DNA. The predicted looping propensities capture the complex, chain-length-dependent variation in repression efficacy extracted from gene expression studies and in vitro experiments and reveal unexpected chain-length-dependent variations in the uptake of HU, the deformation of repressor, and the folding of DNA. Both the opening of repressor and the presence of HU, at levels approximating those found in vivo, enhance the probability of loop formation. HU affects the global organization of the repressor and the opening of repressor influences the levels of HU binding to DNA. The length of the loop determines whether the DNA adopts antiparallel or parallel orientations on the repressor, whether the repressor is opened or closed, and how many HU molecules bind to the loop. The collective behavior of proteins and DNA is greater than the sum of the parts and hints of ways in which multiple proteins may coordinate the packaging and processing of genetic information.	[Czapla, Luke; Grosner, Michael A.; Olson, Wilma K.] Rutgers State Univ, Dept Chem & Chem Biol, Piscataway, NJ 08855 USA; [Olson, Wilma K.] Rutgers State Univ, BioMaPS Inst Quantitat Biol, Piscataway, NJ USA; [Swigon, David] Univ Pittsburgh, Dept Math, Pittsburgh, PA 15260 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Olson, WK (corresponding author), Rutgers State Univ, Dept Chem & Chem Biol, Piscataway, NJ 08855 USA.	wilma.olson@rutgers.edu			National Institutes of Health [2 R01 GM034809 25]; Human Frontiers in Science Program [RGP0051/2009]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034809] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontiers in Science Program(Human Frontier Science Program); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding came from the National Institutes of Health 2 R01 GM034809 25 URL: grants.nih.gov/, Human Frontiers in Science Program RGP0051/2009, URL: www.hfsp.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aki T, 1997, EMBO J, V16, P3666, DOI 10.1093/emboj/16.12.3666; ALEXANDR.Z, 1969, J CHEM PHYS, V51, P561, DOI 10.1063/1.1672034; Azam TA, 1999, J BACTERIOL, V181, P6361, DOI 10.1128/JB.181.20.6361-6370.1999; Balaeff A, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.031919; Balaeff A, 2004, STRUCTURE, V12, P123, DOI 10.1016/j.str.2003.12.004; Becker NA, 2005, J MOL BIOL, V349, P716, DOI 10.1016/j.jmb.2005.04.035; Becker NA, 2007, NUCLEIC ACIDS RES, V35, P3988, DOI 10.1093/nar/gkm419; Bell CE, 2000, NAT STRUCT BIOL, V7, P209; Berger M, 2010, EMBO REP, V11, P59, DOI 10.1038/embor.2009.232; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; BOLSHOY A, 1991, P NATL ACAD SCI USA, V88, P2312, DOI 10.1073/pnas.88.6.2312; Bond LM, 2010, NUCLEIC ACIDS RES, V38, P8072, DOI 10.1093/nar/gkq755; Clauvelin N, 2013, VIBRATIONAL MO UNPUB; Clauvelin N, 2012, J CHEM THEORY COMPUT, V8, P1092, DOI 10.1021/ct200657e; Coleman BD, 2003, J CHEM PHYS, V118, P7127, DOI 10.1063/1.1559690; Cordeiro TN, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002380; Czapla L, 2008, J MOL BIOL, V382, P353, DOI 10.1016/j.jmb.2008.05.088; Czapla L, 2006, J CHEM THEORY COMPUT, V2, P685, DOI 10.1021/ct060025+; Czapla L, 2011, J MOL BIOL, V409, P278, DOI 10.1016/j.jmb.2011.03.050; DIEKMANN S, 1989, J MOL BIOL, V205, P787, DOI 10.1016/0022-2836(89)90324-0; Edelman LM, 2003, BIOPHYS J, V84, P1131, DOI 10.1016/S0006-3495(03)74929-7; ELHASSAN MA, 1995, J MOL BIOL, V251, P648, DOI 10.1006/jmbi.1995.0462; FINZI L, 1995, SCIENCE, V267, P378, DOI 10.1126/science.7824935; FRIEDMAN AM, 1995, SCIENCE, V268, P1721, DOI 10.1126/science.7792597; Geanacopoulos M, 2001, NAT STRUCT BIOL, V8, P432, DOI 10.1038/87595; GILBERT W, 1966, P NATL ACAD SCI USA, V56, P1891, DOI 10.1073/pnas.56.6.1891; Goyal S, 2007, BIOPHYS J, V93, P4342, DOI 10.1529/biophysj.107.112268; Haeusler AR, 2012, NUCLEIC ACIDS RES, V40, P4432, DOI 10.1093/nar/gks019; Han L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005621; Heath PJ, 1996, J MOL BIOL, V260, P718, DOI 10.1006/jmbi.1996.0432; Hirsh AD, 2011, BIOPHYS J, V101, P718, DOI 10.1016/j.bpj.2011.06.040; HODGESGARCIA Y, 1989, J BIOL CHEM, V264, P14621; HOROWITZ DS, 1984, J MOL BIOL, V173, P75, DOI 10.1016/0022-2836(84)90404-2; JACOBSON H, 1950, J CHEM PHYS, V18, P1600, DOI 10.1063/1.1747547; La Penna G, 2010, BIOPHYS J, V98, P2964, DOI 10.1016/j.bpj.2010.03.024; Lewis M, 1996, SCIENCE, V271, P1247, DOI 10.1126/science.271.5253.1247; Lillian TD, 2008, BIOPHYS J, V95, P5832, DOI 10.1529/biophysj.108.142471; Lu XJ, 2008, NAT PROTOC, V3, P1213, DOI 10.1038/nprot.2008.104; Lu XJ, 2003, NUCLEIC ACIDS RES, V31, P5108, DOI 10.1093/nar/gkg680; Mehta RA, 1999, J MOL BIOL, V294, P67, DOI 10.1006/jmbi.1999.3244; Muller J, 1996, J MOL BIOL, V257, P21, DOI 10.1006/jmbi.1996.0143; Olson WK, 1998, P NATL ACAD SCI USA, V95, P11163, DOI 10.1073/pnas.95.19.11163; Olson WK, 2012, BIOCH SOC T IN PRESS; PAULL TT, 1993, GENE DEV, V7, P1521, DOI 10.1101/gad.7.8.1521; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Press W. H., 1992, NUMERICAL RECIPES C, P288; Romanuka J, 2009, J MOL BIOL, V390, P478, DOI 10.1016/j.jmb.2009.05.022; Ruben GC, 1997, MICROSC RES TECHNIQ, V36, P400, DOI 10.1002/(SICI)1097-0029(19970301)36:5<400::AID-JEMT10>3.0.CO;2-W; SADLER JR, 1965, J MOL BIOL, V12, P305, DOI 10.1016/S0022-2836(65)80255-8; Sagi D, 2004, J MOL BIOL, V341, P419, DOI 10.1016/j.jmb.2004.06.023; Saiz L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000355; Semsey S, 2005, TRENDS BIOCHEM SCI, V30, P334, DOI 10.1016/j.tibs.2005.04.009; Skoko D, 2006, J MOL BIOL, V364, P777, DOI 10.1016/j.jmb.2006.09.043; Spronk CAEM, 1999, STRUCT FOLD DES, V7, P1483, DOI 10.1016/S0969-2126(00)88339-2; Stella S, 2010, GENE DEV, V24, P814, DOI 10.1101/gad.1900610; Stenberg KAE, 2009, PROTEINS, V75, P748, DOI 10.1002/prot.22284; Sundararaj S, 2004, NUCLEIC ACIDS RES, V32, pD293, DOI 10.1093/nar/gkh108; Swigon D, 2006, P NATL ACAD SCI USA, V103, P9879, DOI 10.1073/pnas.0603557103; Swigon D, 2008, INT J NONLIN MECH, V43, P1082, DOI 10.1016/j.ijnonlinmec.2008.07.003; Swinger KK, 2007, J MOL BIOL, V365, P1005, DOI 10.1016/j.jmb.2006.10.024; Swinger KK, 2003, EMBO J, V22, P3749, DOI 10.1093/emboj/cdg351; Swinger KK, 2004, CURR OPIN STRUC BIOL, V14, P28, DOI 10.1016/j.sbi.2003.12.003; Taraban M, 2008, J MOL BIOL, V376, P466, DOI 10.1016/j.jmb.2007.11.067; Towles KB, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/2/025001; Vanzi F, 2006, NUCLEIC ACIDS RES, V34, P3409, DOI 10.1093/nar/gkl393; Villa E, 2005, P NATL ACAD SCI USA, V102, P6783, DOI 10.1073/pnas.0409387102; Virnik K, 2003, J MOL BIOL, V334, P53, DOI 10.1016/j.jmb.2003.09.030; Vreede J, 2012, BIOPHYS J, V103, P89, DOI 10.1016/j.bpj.2012.05.040; Wang WQ, 2011, SCIENCE, V333, P1445, DOI 10.1126/science.1204697; Wong OK, 2008, PLOS BIOL, V6, P2028, DOI 10.1371/journal.pbio.0060232; Zhang Y, 2006, BIOPHYS J, V90, P1903, DOI 10.1529/biophysj.105.070490; Zhang YL, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000136; ZHURKIN VB, 1979, NUCLEIC ACIDS RES, V6, P1081, DOI 10.1093/nar/6.3.1081	73	21	21	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56548	10.1371/journal.pone.0056548	http://dx.doi.org/10.1371/journal.pone.0056548			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457581	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000315602700078
J	Onuma, Y; Tateno, H; Tsuji, S; Hirabayashi, J; Ito, Y; Asashima, M				Onuma, Yasuko; Tateno, Hiroaki; Tsuji, Shingo; Hirabayashi, Jun; Ito, Yuzuru; Asashima, Makoto			A Lectin-Based Glycomic Approach to Identify Characteristic Features of Xenopus Embryogenesis	PLOS ONE			English	Article							CELL-CELL ADHESION; MICROARRAY; INVOLVEMENT; BLASTULA; STRATEGY	Cell surface glycans show dynamic changes during cell differentiation. Several glycans are useful biomarkers of tumors, stem cells, and embryogenesis. Glycomic studies have been performed using liquid chromatography and mass spectrometry, which are powerful tools for glycan structural analysis but are difficult to use for small sample sizes. Recently, a lectin microarray system was developed for profiling cell surface glycome changes to terminal carbohydrate chains and branch types, using sample sizes of a few micrograms. In this study, we used the lectin microarray system for the first time to investigate stage-specific glycomes in Xenopus laevis embryos. Unsupervised cluster analysis of lectin microarray data indicated that glycan profiles changed sequentially during development. Nine lectin probes showed significantly different signals between early and the late-stage embryos: 4 showed higher signals in the early stages, and 5 exhibited higher signals in the late stages. The gene expression profiles of relevant glycosyltransferase genes support the lectin microarray data. Therefore, we have shown that lectin microarray is an effective tool for high-throughput glycan analysis in Xenopus embryogenesis, allowing glycan profiling of early embryos and small biopsy specimens.	[Onuma, Yasuko; Tateno, Hiroaki; Hirabayashi, Jun; Ito, Yuzuru; Asashima, Makoto] Natl Inst Adv Ind Sci & Technol, Res Ctr Stem Cell Engn, Tsukuba, Ibaraki, Japan; [Tsuji, Shingo] Univ Tokyo, Res Ctr Adv Sci & Technol, Genome Sci Div, Tokyo, Japan	National Institute of Advanced Industrial Science & Technology (AIST); University of Tokyo	Ito, Y (corresponding author), Natl Inst Adv Ind Sci & Technol, Res Ctr Stem Cell Engn, Tsukuba Cent 4, Tsukuba, Ibaraki, Japan.	yuzu-itou@aist.go.jp	Tateno, Hiroaki/M-2706-2018; Hirabayashi, Jun/M-3998-2018; Onuma, Yasuko/L-7083-2018; Ito, Yuzuru/M-1085-2018; Asashima, Makoto/O-8389-2018	Tateno, Hiroaki/0000-0003-3006-1659; Hirabayashi, Jun/0000-0002-8571-359X; Onuma, Yasuko/0000-0002-9330-194X; Ito, Yuzuru/0000-0001-7923-865X; Asashima, Makoto/0000-0002-0012-026X	JSPS KAKENHI Grant [23770267]	JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Number 23770267 (http://www.jsps.go.jp/english/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bowes JB, 2008, NUCLEIC ACIDS RES, V36, pD761, DOI 10.1093/nar/gkm826; Fakhro KA, 2011, P NATL ACAD SCI USA, V108, P2915, DOI 10.1073/pnas.1019645108; Kuno A, 2005, NAT METHODS, V2, P851, DOI 10.1038/NMETH803; Narimatsu H, 2004, GLYCOCONJUGATE J, V21, P17, DOI 10.1023/B:GLYC.0000043742.99482.01; Narimatsu H, 2010, FEBS J, V277, P95, DOI 10.1111/j.1742-4658.2009.07430.x; Nieuwkoop PD., 1956, DEVELOPMENT, DOI [DOI 10.1242/DEV.200356, 10.1242/dev.200356]; NOMURA K, 1995, BIOCHEM J, V306, P821, DOI 10.1042/bj3060821; Nomura KH, 1998, DEV GENES EVOL, V208, P9, DOI 10.1007/s004270050148; Sive Hazel L., 2000, EARLY DEV XENOPUS LA; Tateno H, 2011, J BIOL CHEM, V286, P20345, DOI 10.1074/jbc.M111.231274; Tateno H, 2010, METHOD ENZYMOL, V478, P181, DOI 10.1016/S0076-6879(10)78008-3; Ten Hagen KG, 2003, GLYCOBIOLOGY, V13, p1R, DOI 10.1093/glycob/cwg007; Tsuboi S, 2012, TRENDS MOL MED, V18, P224, DOI 10.1016/j.molmed.2012.02.001; Yeo CY, 2001, MOL CELL, V7, P949, DOI 10.1016/S1097-2765(01)00249-0	14	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56581	10.1371/journal.pone.0056581	http://dx.doi.org/10.1371/journal.pone.0056581			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457585	Green Published, Green Submitted, gold			2022-12-25	WOS:000315602700081
J	Shao, DC; Liu, J; Ni, J; Wang, Z; Shen, Y; Zhou, L; Huang, Y; Wang, J; Xue, H; Zhang, W; Lu, LM				Shao, Decui; Liu, Jia; Ni, Jun; Wang, Zhen; Shen, Yang; Zhou, Li; Huang, Yu; Wang, Jun; Xue, Hong; Zhang, Wei; Lu, Limin			Suppression of XBP1S Mediates High Glucose-Induced Oxidative Stress and Extracellular Matrix Synthesis in Renal Mesangial Cell and Kidney of Diabetic Rats	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; NADPH OXIDASE; ANGIOTENSIN-II; ER STRESS; MESENCHYMAL TRANSITION; NAD(P)H OXIDASE; NEPHROPATHY; PATHWAY; XBP-1; PROLIFERATION	Recent evidences suggest that endoplasmic reticulum (ER) stress was involved in multi pathological conditions, including diabetic nephropathy (DN). X-box binding protein 1(XBP1), as a key mediator of ER stress, has been proved having the capability of preventing oxidative stress. In this study, we investigated the effects of spliced XBP1 (XBP1S), the dominant active form of XBP1, on high glucose (HG)-induced reactive oxygen species (ROS) production and extracellular matrix (ECM) synthesis in cultured renal mesangial cells (MCs) and renal cortex of STZ-induced diabetic rats. Real time PCR and Western blot were used to evaluate the mRNA and protein levels respectively. Transfection of recombinant adenovirus vector carrying XBP1S gene (Ad-XBP1S) was used to upregulate XBP1S expression. XBP1S siRNA was used to knockdown XBP1S expression. ROS level was detected by dihydroethidium (DHE) fluorescent probe assay. The results showed that HG treatment significantly reduced XBP1S protein and mRNA level in the cultured MCs while no obvious change was observed in unspliced XBP1 (XBP1U). In the mean time, the ROS production, collagen IV and fibronectin expressions were increased. Diphenylene-chloride iodonium (DPI), a NADPH oxidase inhibtor, prevented HG-induced increases in ROS as well as collagen IV and fibronectin expressions. Transfection of Ad-XBP1S reversed HG-induced ROS production and ECM expressions. Knockdown intrinsic XBP1S expression induced increases in ROS production and ECM expressions. Supplementation of supreoxide reversed the inhibitory effect of Ad-XBP1S transfection on ECM synthesis. P47phox was increased in HG-treated MCs. Ad-XBP1S transfection reversed HG-induced p47phox increase while XBP1S knockdown upregulated p47phox expression. In the renal cortex of diabetic rats, the expression of XBP1S was reduced while p47phox, collagen IV and fibronectin expression were elevated. These results suggested that XBP1S pathway of ER stress was involved in HG-induced oxidative stress and ECM synthesis. A downstream target of XBP1S in regulating ROS formation might be NADPH oxidase.	[Shao, Decui; Liu, Jia; Ni, Jun; Wang, Zhen; Shen, Yang; Zhou, Li; Xue, Hong; Zhang, Wei; Lu, Limin] Fudan Univ, Dept Physiol & Pathophysiol, Shanghai Med Coll, Shanghai 200433, Peoples R China; [Wang, Jun] Fudan Univ, Dept Integrat Med, Shanghai Med Coll, Shanghai 200433, Peoples R China; [Huang, Yu] Chinese Univ Hong Kong, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China; [Huang, Yu] Chinese Univ Hong Kong, Inst Vasc Med, Hong Kong, Hong Kong, Peoples R China	Fudan University; Fudan University; Chinese University of Hong Kong; Chinese University of Hong Kong	Lu, LM (corresponding author), Fudan Univ, Dept Physiol & Pathophysiol, Shanghai Med Coll, Shanghai 200433, Peoples R China.	lulimin@shmu.edu.cn	Huang, Yu/K-2866-2017	Huang, Yu/0000-0002-1277-6784; SHEN, YANG/0000-0002-2448-8405	Natural Science Foundation of China [81070577, 81170636, 8110053]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was financially supported by the Natural Science Foundation of China (No. 81070577, 81170636) to LL and (No. 81100531) to ZW (http://www.nsfc.gov.cn/Portal0/default152.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Alvear D, 2007, MOL CELL, V27, P53, DOI 10.1016/j.molcel.2007.06.011; ADLER S, 1994, J AM SOC NEPHROL, V5, P1165; Asaba K, 2005, KIDNEY INT, V67, P1890, DOI 10.1111/j.1523-1755.2005.00287.x; Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161; Chandy A, 2008, SAUDI J KIDNEY DIS T, V19, P924; Chen JC, 2012, MOL CELL BIOL, V32, P981, DOI 10.1128/MCB.06410-11; Cnop M, 2012, TRENDS MOL MED, V18, P59, DOI 10.1016/j.molmed.2011.07.010; El Nahas AM, 2003, KIDNEY INT, V64, P1553, DOI 10.1046/j.1523-1755.2003.00255.x; Forbes JM, 2008, DIABETES, V57, P1446, DOI 10.2337/db08-0057; Geoffroy K, 2005, FEBS LETT, V579, P1249, DOI 10.1016/j.febslet.2004.12.094; Hummasti S, 2010, CIRC RES, V107, P579, DOI 10.1161/CIRCRESAHA.110.225698; Jaimes EA, 2010, AM J PHYSIOL-RENAL, V298, pF125, DOI 10.1152/ajprenal.00248.2009; Jeong SI, 2012, FOOD CHEM TOXICOL, V50, P1045, DOI 10.1016/j.fct.2011.11.028; Kashihara N, 2010, CURR MED CHEM, V17, P4256, DOI 10.2174/092986710793348581; Lee AH, 2005, EMBO J, V24, P4368, DOI 10.1038/sj.emboj.7600903; Lee HB, 2003, J AM SOC NEPHROL, V14, pS241, DOI 10.1097/01.ASN.0000077410.66390.0F; Lee J, 2011, NAT MED, V17, P1251, DOI 10.1038/nm.2449; Lee JY, 2011, AM J PHYSIOL-RENAL, V300, pF1214, DOI 10.1152/ajprenal.00710.2010; Li XJ, 2010, J BIOL CHEM, V285, P35169, DOI 10.1074/jbc.M110.164475; Lindenmeyer MT, 2008, J AM SOC NEPHROL, V19, P2225, DOI 10.1681/ASN.2007121313; Liu GC, 2012, DIABETOLOGIA; Liu Y, 2009, CELL DEATH DIFFER, V16, P847, DOI 10.1038/cdd.2009.14; Nam SM, 2009, DIABETES RES CLIN PR, V83, P176, DOI 10.1016/j.diabres.2008.10.007; Reimold AM, 2000, GENE DEV, V14, P152; Ritz E, 1999, AM J KIDNEY DIS, V34, P795, DOI 10.1016/S0272-6386(99)70035-1; Rutkowski DT, 2006, PLOS BIOL, V4, P2024, DOI 10.1371/journal.pbio.0040374; Satoh M, 2005, AM J PHYSIOL-RENAL, V288, pF1144, DOI 10.1152/ajprenal.00221.2004; Shinya S, 2011, NUCLEIC ACIDS RES, V39, P5245, DOI 10.1093/nar/gkr132; Sims-Robinson C, 2012, DIABETOLOGIA, V55, P2276, DOI 10.1007/s00125-012-2573-6; Stegbauer J, 2011, BRIT J PHARMACOL, V163, P974, DOI 10.1111/j.1476-5381.2011.01295.x; Susztak K, 2006, DIABETES, V55, P225, DOI 10.2337/diabetes.55.01.06.db05-0894; Titan SM, 2011, CLIN NEPHROL, V76, P273, DOI 10.5414/CN107013; Tojo A, 2007, EXPERT OPIN THER TAR, V11, P1011, DOI 10.1517/14728222.11.8.1011; Xia L, 2006, AM J PHYSIOL-RENAL, V290, pF345, DOI 10.1152/ajprenal.00119.2005; Xue H, 2012, REGUL PEPTIDES, V177, P12, DOI 10.1016/j.regpep.2012.04.002; Yoshida H, 2006, J CELL BIOL, V172, P565, DOI 10.1083/jcb.200508145; Yu HY, 2005, MED CHEM, V1, P461, DOI 10.2174/1573406054864052; Zhang JY, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-25; Zhang LY, 2012, INT J BIOCHEM CELL B, V44, P629, DOI 10.1016/j.biocel.2012.01.001; Zhong YM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038616; Zhou YJ, 2011, NAT MED, V17, P356, DOI 10.1038/nm.2293	41	26	30	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56124	10.1371/journal.pone.0056124	http://dx.doi.org/10.1371/journal.pone.0056124			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457509	Green Submitted, Green Accepted, Green Published, gold			2022-12-25	WOS:000315602700045
J	Syfert, MM; Smith, MJ; Coomes, DA				Syfert, Mindy M.; Smith, Matthew J.; Coomes, David A.			The Effects of Sampling Bias and Model Complexity on the Predictive Performance of MaxEnt Species Distribution Models	PLOS ONE			English	Article							PSEUDO-ABSENCES; TREE FERNS; CLIMATE; CONSERVATION; SIZE; EVAPOTRANSPIRATION; INFORMATION; PATTERNS; IMPACTS; ERRORS	Species distribution models (SDMs) trained on presence-only data are frequently used in ecological research and conservation planning. However, users of SDM software are faced with a variety of options, and it is not always obvious how selecting one option over another will affect model performance. Working with MaxEnt software and with tree fern presence data from New Zealand, we assessed whether (a) choosing to correct for geographical sampling bias and (b) using complex environmental response curves have strong effects on goodness of fit. SDMs were trained on tree fern data, obtained from an online biodiversity data portal, with two sources that differed in size and geographical sampling bias: a small, widely-distributed set of herbarium specimens and a large, spatially clustered set of ecological survey records. We attempted to correct for geographical sampling bias by incorporating sampling bias grids in the SDMs, created from all georeferenced vascular plants in the datasets, and explored model complexity issues by fitting a wide variety of environmental response curves (known as "feature types" in MaxEnt). In each case, goodness of fit was assessed by comparing predicted range maps with tree fern presences and absences using an independent national dataset to validate the SDMs. We found that correcting for geographical sampling bias led to major improvements in goodness of fit, but did not entirely resolve the problem: predictions made with clustered ecological data were inferior to those made with the herbarium dataset, even after sampling bias correction. We also found that the choice of feature type had negligible effects on predictive performance, indicating that simple feature types may be sufficient once sampling bias is accounted for. Our study emphasizes the importance of reducing geographical sampling bias, where possible, in datasets used to train SDMs, and the effectiveness and essentialness of sampling bias correction within MaxEnt.	[Syfert, Mindy M.; Coomes, David A.] Univ Cambridge, Dept Plant Sci, Forest Ecol & Conservat Grp, Cambridge, England; [Syfert, Mindy M.; Smith, Matthew J.] Microsoft Res, Sci Computat Lab, Computat Ecol & Environm Sci Grp, Cambridge, England	University of Cambridge; Microsoft	Syfert, MM (corresponding author), Univ Cambridge, Dept Plant Sci, Forest Ecol & Conservat Grp, Cambridge, England.	mmsyfert@gmail.com; matthew.smith@microsoft.com; dac18@cam.ac.uk		Coomes, David/0000-0002-8261-2582; Smith, Matthew/0000-0002-5401-1763	Microsoft Research through its PhD Scholarship Programme	Microsoft Research through its PhD Scholarship Programme(Microsoft)	This work was supported by Microsoft Research through its PhD Scholarship Programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; Araujo MB, 2007, GLOBAL ECOL BIOGEOGR, V16, P743, DOI 10.1111/j.1466-8238.2007.00359.x; Barbet-Massin M, 2012, METHODS ECOL EVOL, V3, P327, DOI 10.1111/j.2041-210X.2011.00172.x; Brummitt Neil, 2008, Endangered Species Research, V6, P127, DOI 10.3354/esr00135; Bystriakova N, 2008, ECOLOGY BIOGEOGRAPHY; Chefaoui RM, 2008, ECOL MODEL, V210, P478, DOI 10.1016/j.ecolmodel.2007.08.010; Coomes DA, 2002, FOREST ECOL MANAG, V164, P89, DOI 10.1016/S0378-1127(01)00592-8; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Elith J, 2010, METHODS ECOL EVOL, V1, P330, DOI 10.1111/j.2041-210X.2010.00036.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Elith J, 2009, ECOGRAPHY, V32, P66, DOI 10.1111/j.1600-0587.2008.05505.x; Engler R, 2004, J APPL ECOL, V41, P263, DOI 10.1111/j.0021-8901.2004.00881.x; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; FRANK DA, 1994, J BIOGEOGR, V21, P401, DOI 10.2307/2845758; Franklin J, 2009, MAPPING SPECIES DIST; Graham CH, 2004, TRENDS ECOL EVOL, V19, P497, DOI 10.1016/j.tree.2004.07.006; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Hanspach J, 2011, GLOBAL ECOL BIOGEOGR, V20, P779, DOI 10.1111/j.1466-8238.2011.00649.x; Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hortal J, 2008, OIKOS, V117, P847, DOI 10.1111/j.0030-1299.2008.16434.x; Kadmon R, 2004, ECOL APPL, V14, P401, DOI 10.1890/02-5364; Korall P, 2007, AM J BOT, V94, P873, DOI 10.3732/ajb.94.5.873; Korall P, 2006, MOL PHYLOGENET EVOL, V39, P830, DOI 10.1016/j.ympev.2006.01.001; Lehmann A, 2002, BIODIVERS CONSERV, V11, P2217, DOI 10.1023/A:1021398729516; Lutolf M, 2006, J APPL ECOL, V43, P802, DOI 10.1111/j.1365-2664.2006.01191.x; Mateo RG, 2010, DIVERS DISTRIB, V16, P84, DOI 10.1111/j.1472-4642.2009.00617.x; Newbold T, 2010, PROG PHYS GEOG, V34, P3, DOI 10.1177/0309133309355630; Newbold T, 2009, BIODIVERS CONSERV, V18, P3629, DOI 10.1007/s10531-009-9668-5; Payton IJ, 2004, NZ CARBON MONITORING; Pearce J, 2000, ECOL MODEL, V133, P225, DOI 10.1016/S0304-3800(00)00322-7; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Phillips SJ, 2010, ECOLOGY, V91, P2476, DOI 10.1890/09-0760.1; Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1; Reddy S, 2003, J BIOGEOGR, V30, P1719, DOI 10.1046/j.1365-2699.2003.00946.x; Richardson SJ, 2009, FOREST ECOL MANAG, V258, P2456, DOI 10.1016/j.foreco.2009.08.022; Rivers MC, 2011, BIOL CONSERV, V144, P2541, DOI 10.1016/j.biocon.2011.07.014; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Stephenson NL, 1998, J BIOGEOGR, V25, P855, DOI 10.1046/j.1365-2699.1998.00233.x; Stephenson NL, 2000, 0062 US GEOL SURV; Stokland JN, 2011, ECOL MODEL, V222, P1800, DOI 10.1016/j.ecolmodel.2011.02.025; Thuiller W, 2004, ECOGRAPHY, V27, P165, DOI 10.1111/j.0906-7590.2004.03673.x; Thuiller W, 2008, PERSPECT PLANT ECOL, V9, P137, DOI 10.1016/j.ppees.2007.09.004; Trabucco A., 2010, GLOBAL HIGH RESOLUTI; Trabucco A, 2009, CGIAR CONSORT SPATIA; VanDerWal J, 2009, ECOL MODEL, V220, P589, DOI 10.1016/j.ecolmodel.2008.11.010; Warren DL, 2011, ECOL APPL, V21, P335, DOI 10.1890/10-1171.1; Williams JN, 2009, DIVERS DISTRIB, V15, P565, DOI 10.1111/j.1472-4642.2009.00567.x; Wiser SK, 2001, NEW ZEAL J ECOL, V25, P1; Wiser SK, 2011, APPL VEG SCI, V14, P506, DOI 10.1111/j.1654-109X.2011.01146.x; Wisz MS, 2008, DIVERS DISTRIB, V14, P763, DOI 10.1111/j.1472-4642.2008.00482.x; Wisz Mary S., 2009, BMC Ecology, V9, P8, DOI 10.1186/1472-6785-9-8; WOODWARD FI, 1987, VEGETATIO, V69, P189, DOI 10.1007/BF00038700; Yackulic CB, 2012, METHODS ECOLOGY EVOL; Yates CJ, 2010, DIVERS DISTRIB, V16, P187, DOI 10.1111/j.1472-4642.2009.00623.x; Zaniewski AE, 2002, ECOL MODEL, V157, P261, DOI 10.1016/S0304-3800(02)00199-0; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x	60	373	383	15	268	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e55158	10.1371/journal.pone.0055158	http://dx.doi.org/10.1371/journal.pone.0055158			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457462	Green Submitted, Green Published, gold			2022-12-25	WOS:000315602700014
J	Taylor, KM; Meyers, E; Phipps, M; Kishnani, PS; Cheng, SH; Scheule, RK; Moreland, RJ				Taylor, Kristin M.; Meyers, Elizabeth; Phipps, Michael; Kishnani, Priya S.; Cheng, Seng H.; Scheule, Ronald K.; Moreland, Rodney J.			Dysregulation of Multiple Facets of Glycogen Metabolism in a Murine Model of Pompe Disease	PLOS ONE			English	Article							SKELETAL-MUSCLE; SUPPRESSION; MICE; AUTOPHAGY; THERAPY; ENZYME	Pompe disease, also known as glycogen storage disease (GSD) type II, is caused by deficiency of lysosomal acid alpha-glucosidase (GAA). The resulting glycogen accumulation causes a spectrum of disease severity ranging from a rapidly progressive course that is typically fatal by 1 to 2 years of age to a slower progressive course that causes significant morbidity and early mortality in children and adults. The aim of this study is to better understand the biochemical consequences of glycogen accumulation in the Pompe mouse. We evaluated glycogen metabolism in heart, triceps, quadriceps, and liver from wild type and several strains of GAA(-/-) mice. Unexpectedly, we observed that lysosomal glycogen storage correlated with a robust increase in factors that normally promote glycogen biosynthesis. The GAA(-/-) mouse strains were found to have elevated glycogen synthase (GS), glycogenin, hexokinase, and glucose-6-phosphate (G-6-P, the allosteric activator of GS). Treating GAA(-/-) mice with recombinant human GAA (rhGAA) led to a dramatic reduction in the levels of glycogen, GS, glycogenin, and G-6-P. Lysosomal glycogen storage also correlated with a dysregulation of phosphorylase, which normally breaks down cytoplasmic glycogen. Analysis of phosphorylase activity confirmed a previous report that, although phosphorylase protein levels are identical in muscle lysates from wild type and GAA(-/-) mice, phosphorylase activity is suppressed in the GAA(-/-) mice in the absence of AMP. This reduction in phosphorylase activity likely exacerbates lysosomal glycogen accumulation. If the dysregulation in glycogen metabolism observed in the mouse model of Pompe disease also occurs in Pompe patients, it may contribute to the observed broad spectrum of disease severity.	[Taylor, Kristin M.; Meyers, Elizabeth; Phipps, Michael; Cheng, Seng H.; Scheule, Ronald K.; Moreland, Rodney J.] Genzyme Corp, Framingham, MA 01701 USA; [Kishnani, Priya S.] Duke Univ, Dept Pediat, Div Med Genet, Durham, NC 27706 USA	Sanofi-Aventis; Genzyme Corporation; Duke University	Moreland, RJ (corresponding author), Genzyme Corp, Framingham, MA 01701 USA.	Rod.Moreland@genzyme.com	Cheng, Seng H/AAC-6564-2022		Genzyme; Duke University Medical Center; Sanofi Company	Genzyme(Sanofi-AventisGenzyme Corporation); Duke University Medical Center; Sanofi Company	No current external funding sources for this study. Support for these studies was provided by Genzyme, a Sanofi Company, through the employment of Kristin M. Taylor, Elizabeth Meyers, Michael Phipps, Seng H. Cheng, Ronald K. Scheule, and Rodney J. Moreland. Support for Priya S. Kishnani was provided by Duke University Medical Center. The funders had no role in study design, data collection and analysis, or preparation of the manuscript.; Kristin M. Taylor, Elizabeth Meyers, Michael Phipps, Seng H. Cheng, Ronald K. Scheule, and Rodney J. Moreland are all employees of Genzyme, a Sanofi Company, who funded this study. The described studies were part of the drug development program at Genzyme Corporation. There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	[Anonymous], [No title captured]; Ashe KM, 2010, MOL GENET METAB, V100, P309, DOI 10.1016/j.ymgme.2010.05.001; Douillard-Guilloux G, 2010, HUM MOL GENET, V19, P684, DOI 10.1093/hmg/ddp535; Douillard-Guilloux G, 2008, HUM MOL GENET, V17, P3876, DOI 10.1093/hmg/ddn290; Fukuda T, 2006, ANN NEUROL, V59, P700, DOI 10.1002/ana.20807; Fukuda T, 2006, MOL THER, V14, P831, DOI 10.1016/j.ymthe.2006.08.009; Hurley TD, 2005, J BIOL CHEM, V280, P23892, DOI 10.1074/jbc.M502344200; Kroos MA, 2007, NEUROLOGY, V68, P110, DOI 10.1212/01.wnl.0000252798.25690.76; Moreland RJ, 2005, J BIOL CHEM, V280, P6780, DOI 10.1074/jbc.M404008200; Niederwanger A, 2005, J CHROMATOGR B, V820, P143, DOI 10.1016/j.jchromb.2005.02.019; Orth M, 2003, NEUROMUSCULAR DISORD, V13, P49, DOI 10.1016/S0960-8966(02)00186-4; Pende M, 2004, MOL CELL BIOL, V24, P3112, DOI 10.1128/MCB.24.8.3112-3124.2004; Raben N, 1998, J BIOL CHEM, V273, P19086, DOI 10.1074/jbc.273.30.19086; Raben N, 2010, AUTOPHAGY, V6, P1078, DOI 10.4161/auto.6.8.13378; Schliselfeld LH, 2002, BIOCHEM BIOPH RES CO, V290, P874, DOI 10.1006/bbrc.2001.6292	15	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56181	10.1371/journal.pone.0056181	http://dx.doi.org/10.1371/journal.pone.0056181			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457523	Green Submitted, gold, Green Published			2022-12-25	WOS:000315602700057
J	Maxwell, BA; Suo, ZC				Maxwell, Brian A.; Suo, Zucai			Single-molecule Investigation of Substrate Binding Kinetics and Protein Conformational Dynamics of a B-family Replicative DNA Polymerase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIV-1 REVERSE-TRANSCRIPTASE; I KLENOW FRAGMENT; CRYSTAL-STRUCTURE; SULFOLOBUS-SOLFATARICUS; FINGERS SUBDOMAIN; NUCLEOTIDE INCORPORATION; FIDELITY; MECHANISM; FLUORESCENCE; EXONUCLEASE	Replicative DNA polymerases use a complex, multistep mechanism for efficient and accurate DNA replication as uncovered by intense kinetic and structural studies. Recently, single-molecule fluorescence spectroscopy has provided new insights into real time conformational dynamics utilized by DNA polymerases during substrate binding and nucleotide incorporation. We have used single-molecule Forster resonance energy transfer techniques to investigate the kinetics and conformational dynamics of Sulfolobus solfataricus DNA polymerase B1 (PolB1) during DNA and nucleotide binding. Our experiments demonstrate that this replicative polymerase can bind to DNA in at least three conformations, corresponding to an open and closed conformation of the finger domain as well as a conformation with the DNA substrate bound to the exonuclease active site of PolB1. Additionally, our results show that PolB1 can transition between these conformations without dissociating from a primer-template DNA substrate. Furthermore, we show that the closed conformation is promoted by a matched incoming dNTP but not by a mismatched dNTP and that mismatches at the primer-template terminus lead to an increase in the binding of the DNA to the exonuclease site. Our analysis has also revealed new details of the biphasic dissociation kinetics of the polymerase-DNA binary complex. Notably, comparison of the results obtained in this study with PolB1 with those from similar single-molecule studies with an A-family DNA polymerase suggests mechanistic differences between these polymerases. In summary, our findings provide novel mechanistic insights into protein conformational dynamics and substrate binding kinetics of a high fidelity B-family DNA polymerase.	Ohio State Univ, Biophys Program, Columbus, OH 43210 USA; [Suo, Zucai] Ohio State Univ, Dept Chem & Biochem, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Suo, ZC (corresponding author), Ohio State Univ, Dept Chem & Biochem, 484 W 12th Ave, Columbus, OH 43210 USA.	suo.3@osu.edu		Maxwell, Brian/0000-0002-0177-3991	National Science Foundation [MCB-0960961]; Div Of Molecular and Cellular Bioscience [0960961] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by National Science Foundation Grant MCB-0960961 (to Z.S.).	Allen WJ, 2008, PROTEIN SCI, V17, P401, DOI 10.1110/ps.073309208; BEESE LS, 1993, SCIENCE, V260, P352, DOI 10.1126/science.8469987; Berezhna SY, 2012, J AM CHEM SOC, V134, P11261, DOI 10.1021/ja3038273; Brown JA, 2009, BIOCHEMISTRY-US, V48, P7502, DOI 10.1021/bi9005336; CAPSON TL, 1992, BIOCHEMISTRY-US, V31, P10984, DOI 10.1021/bi00160a007; CARVER TE, 1994, P NATL ACAD SCI USA, V91, P10670, DOI 10.1073/pnas.91.22.10670; Choi JY, 2011, J BIOL CHEM, V286, P31180, DOI 10.1074/jbc.M111.258038; Christian TD, 2009, P NATL ACAD SCI USA, V106, P21109, DOI 10.1073/pnas.0908640106; DONLIN MJ, 1991, BIOCHEMISTRY-US, V30, P538, DOI 10.1021/bi00216a031; Doublie S, 1999, STRUCTURE, V7, pR31, DOI 10.1016/S0969-2126(99)80017-3; EGER BT, 1991, BIOCHEMISTRY-US, V30, P1441, DOI 10.1021/bi00219a039; Franklin MC, 2001, CELL, V105, P657, DOI 10.1016/S0092-8674(01)00367-1; FREEMONT PS, 1988, P NATL ACAD SCI USA, V85, P8924, DOI 10.1073/pnas.85.23.8924; Hashimoto H, 2001, J MOL BIOL, V306, P469, DOI 10.1006/jmbi.2000.4403; Heyduk T, 1996, METHOD ENZYMOL, V274, P492; Hopfner KP, 1999, P NATL ACAD SCI USA, V96, P3600, DOI 10.1073/pnas.96.7.3600; Johnson AA, 2001, J BIOL CHEM, V276, P38097; Joyce CM, 2008, BIOCHEMISTRY-US, V47, P6103, DOI 10.1021/bi7021848; Joyce CM, 2004, BIOCHEMISTRY-US, V43, P14317, DOI 10.1021/bi048422z; Kornberg A., 1980, DNA REPLICATION, P101; KUCHTA RD, 1987, BIOCHEMISTRY-US, V26, P8410, DOI 10.1021/bi00399a057; KUCHTA RD, 1988, BIOCHEMISTRY-US, V27, P6716, DOI 10.1021/bi00418a012; Li Y, 1998, EMBO J, V17, P7514, DOI 10.1093/emboj/17.24.7514; Luo G, 2007, P NATL ACAD SCI USA, V104, P12610, DOI 10.1073/pnas.0700920104; Markiewicz RP, 2012, NUCLEIC ACIDS RES, V40, P7975, DOI 10.1093/nar/gks523; Maxwell BA, 2012, J BIOL CHEM, V287, P13040, DOI 10.1074/jbc.M112.345835; Ortiz TP, 2005, J PHYS CHEM B, V109, P16127, DOI 10.1021/jp051778f; PATEL SS, 1991, BIOCHEMISTRY-US, V30, P511, DOI 10.1021/bi00216a029; Purohit V, 2003, BIOCHEMISTRY-US, V42, P10200, DOI 10.1021/bi0341206; RITTINGER K, 1995, P NATL ACAD SCI USA, V92, P8046, DOI 10.1073/pnas.92.17.8046; Rodriguez AC, 2000, J MOL BIOL, V299, P447, DOI 10.1006/jmbi.2000.3728; Rothwell PJ, 2007, J BIOL CHEM, V282, P28884, DOI 10.1074/jbc.M704824200; Rothwell PJ, 2005, MOL CELL, V19, P345, DOI 10.1016/j.molcel.2005.06.032; Santoso Y, 2010, P NATL ACAD SCI USA, V107, P715, DOI 10.1073/pnas.0910909107; Savino C, 2004, STRUCTURE, V12, P2001, DOI 10.1016/j.str.2004.09.007; Selvin P. R., 2008, SINGLE MOL TECHNIQUE, P3; Shamoo Y, 1999, CELL, V99, P155, DOI 10.1016/S0092-8674(00)81647-5; Wang J, 1997, CELL, V89, P1087, DOI 10.1016/S0092-8674(00)80296-2; Wohrl BM, 1999, J MOL BIOL, V292, P333, DOI 10.1006/jmbi.1999.3057; WONG I, 1991, BIOCHEMISTRY-US, V30, P526, DOI 10.1021/bi00216a030; Wong JH, 2008, J MOL BIOL, V379, P317, DOI 10.1016/j.jmb.2008.03.038; Xu CL, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000225; Zhang H, 2006, BIOCHEMISTRY-US, V45, P2211, DOI 10.1021/bi052099y; Zhang LK, 2009, BIOCHEMISTRY-US, V48, P7492, DOI 10.1021/bi900532w; Zhao YX, 1999, STRUCTURE, V7, P1189, DOI 10.1016/S0969-2126(00)80053-2	45	21	21	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2013	288	16					11590	11600		10.1074/jbc.M113.459982	http://dx.doi.org/10.1074/jbc.M113.459982			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	130KW	23463511	hybrid, Green Published			2022-12-25	WOS:000317915500064
J	Batista, MD; Tincati, C; Milush, JM; Ho, EL; Ndhlovu, LC; York, VA; Kallas, EG; Kalil, J; Keating, SM; Norris, PJ; Chang, D; Unemori, P; Leslie, KS; Maurer, T; Liao, W; Nixon, DF				Batista, Mariana D.; Tincati, Camilla; Milush, Jeffrey M.; Ho, Emily L.; Ndhlovu, Lishomwa C.; York, Vanessa A.; Kallas, Esper G.; Kalil, Jorge; Keating, Sheila M.; Norris, Philip J.; Chang, David; Unemori, Patrick; Leslie, Kieron S.; Maurer, Toby; Liao, Wilson; Nixon, Douglas F.			CD57 Expression and Cytokine Production by T Cells in Lesional and Unaffected Skin from Patients with Psoriasis	PLOS ONE			English	Article							HUMAN KERATINOCYTES; ATOPIC-DERMATITIS; GENE-EXPRESSION; IL-22; DIFFERENTIATION; LYMPHOCYTES; IMMUNOPATHOGENESIS; ACTIVATION; IMMUNITY; SUBSET	Background: The immunopathogenic mechanisms leading to psoriasis remain unresolved. CD57 is a marker of replicative inability and immunosenescence on CD8+ T cells and the proportion of CD57 expressing CD8+ T cells is increased in a number of inflammatory conditions. Methodology: We examined the expression of CD57 on T cells in the skin of patients affected with psoriasis, comparing lesional and unaffected skin. We also assessed functionality of the T cells by evaluating the secretion of several inflammatory cytokines (IL-17A, IFN-gamma, IL-2, IL-33, TNF-alpha, IL-21, IL-22, and IL-27), from cell-sorted purified CD4+ and CD8+ T cells isolated from lesional and unaffected skin biopsies of psoriasis patients. Principal Findings: We observed that the frequency of CD57+CD4+ and CD57+CD8+ T cells was significantly higher in unaffected skin of psoriasis patients compared to lesional skin. Sorted CD4+ T cells from psoriatic lesional skin produced higher levels of IL-17A, IL-22, and IFN-gamma compared to unaffected skin, while sorted CD8+ T cells from lesional skin produced higher levels of IL-17, IL-22, IFN-gamma, TNF-alpha, and IL-2 compared to unaffected skin. Conclusions/Significance: These findings suggest that T cells in unaffected skin from psoriasis patients exhibit a phenotype compatible with replicative inability. As they have a lower replicative capacity, CD57+ T cells are less frequent in lesional tissue due to the high cellular turnover.	[Batista, Mariana D.; Tincati, Camilla; Milush, Jeffrey M.; Ho, Emily L.; Ndhlovu, Lishomwa C.; York, Vanessa A.; Nixon, Douglas F.] Univ Calif San Francisco, Dept Med, Div Expt Med, San Francisco, CA 94143 USA; [Batista, Mariana D.; Kallas, Esper G.; Kalil, Jorge] Univ Sao Paulo, Sch Med, Div Clin Immunol & Allergy, Sao Paulo, Brazil; [Kallas, Esper G.; Kalil, Jorge] Univ Sao Paulo, Inst Invest Imunol, Sao Paulo, Brazil; [Keating, Sheila M.; Norris, Philip J.] Blood Syst Res Inst, San Francisco, CA USA; [Keating, Sheila M.; Norris, Philip J.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA USA; [Norris, Philip J.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Chang, David] Calif Pacific Med Ctr, San Francisco, CA USA; [Unemori, Patrick; Leslie, Kieron S.; Maurer, Toby; Liao, Wilson] Univ Calif San Francisco, Dept Dermatol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; Universidade de Sao Paulo; Universidade de Sao Paulo; Vitalant; Vitalant Research Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; California Pacific Medical Center; University of California System; University of California San Francisco	Batista, MD (corresponding author), Univ Calif San Francisco, Dept Med, Div Expt Med, San Francisco, CA 94143 USA.	maridiasbatista@gmail.com	n, l/AAX-3992-2020; Ho, Emily Lin/AAR-4815-2021; KALIL, JORGE/C-8029-2012; Nixon, Douglas/AAU-5734-2020; TINCATI, CAMILLA/K-4501-2018	KALIL, JORGE/0000-0001-8415-4274; Nixon, Douglas/0000-0002-2801-1786; Ndhlovu, Lishomwa/0000-0001-5427-4187; TINCATI, CAMILLA/0000-0002-3083-2962; Keating, Sheila/0000-0002-8324-3694; Kallas, Esper/0000-0003-2026-6925; Milush, Jeffrey M./0000-0002-0773-6411	National Institutes of Health [AI64520, 5T32HL007185]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [04/15856-9/Kallas, 2010/05845-0/Kallas]; Peter and Shelagh Godsoe Family Foundation; UCSF REAC [37710/521717]; American Academy of Neurology Clinical Research Training Fellowship; National Institute of Musculoskeletal and Skin Diseases [5K08AR057763]; International AIDS Society; U.S. National Institutes of Health; UW Institute of Translational Health Sciences; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007185] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI064520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR057763] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Peter and Shelagh Godsoe Family Foundation; UCSF REAC; American Academy of Neurology Clinical Research Training Fellowship; National Institute of Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); International AIDS Society; U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UW Institute of Translational Health Sciences; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported in part by the National Institutes of Health (grants AI64520), Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (04/15856-9/Kallas and 2010/05845-0/Kallas and Nixon), and the Peter and Shelagh Godsoe Family Foundation. DN was supported in part by UCSF REAC grant no. 37710/521717. ELH was a recipient of the American Academy of Neurology Clinical Research Training Fellowship. JMM was supported in part by the National Institutes of Health (grant 5T32HL007185). WL was supported in part by grants from the National Institute of Musculoskeletal and Skin Diseases (5K08AR057763) and the International AIDS Society in collaboration with the NIH-funded Centers for AIDS Research, U.S. National Institutes of Health, and the UW Institute of Translational Health Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai K, 1998, CLIN EXP IMMUNOL, V111, P345; Boniface K, 2005, J IMMUNOL, V174, P3695, DOI 10.4049/jimmunol.174.6.3695; Brenchley JM, 2003, BLOOD, V101, P2711, DOI 10.1182/blood-2002-07-2103; Cameron AL, 2002, ARCH DERMATOL RES, V294, P363, DOI 10.1007/s00403-002-0349-4; Caruso R, 2009, NAT MED, V15, P1013, DOI 10.1038/nm.1995; Chattopadhyay PK, 2009, J LEUKOCYTE BIOL, V85, P88, DOI 10.1189/jlb.0208107; Clark RA, 2011, J INVEST DERMATOL, V131, P283, DOI 10.1038/jid.2010.374; Clark RA, 2010, J INVEST DERMATOL, V130, P362, DOI 10.1038/jid.2009.247; Di Cesare A, 2009, J INVEST DERMATOL, V129, P1339, DOI 10.1038/jid.2009.59; Evans TG, 1999, AIDS, V13, P1139, DOI 10.1097/00002030-199906180-00019; Focosi D, 2010, J LEUKOCYTE BIOL, V87, P107, DOI 10.1189/jlb.0809566; Gudjonsson JE, 2009, J INVEST DERMATOL, V129, P2795, DOI 10.1038/jid.2009.173; Iking-Konert C, 2009, CLIN EXP RHEUMATOL, V27, pS19; Le Priol Y, 2006, J IMMUNOL, V177, P5145, DOI 10.4049/jimmunol.177.8.5145; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Lowes MA, 2008, J INVEST DERMATOL, V128, P1207, DOI 10.1038/sj.jid.5701213; Mak RKH, 2009, ACTAS DERMO-SIFILOGR, V100, P2, DOI 10.1016/S0001-7310(09)73372-1; Nestle FO, 2009, NEW ENGL J MED, V361, P496, DOI 10.1056/NEJMra0804595; Nograles KE, 2008, BRIT J DERMATOL, V159, P1092, DOI 10.1111/j.1365-2133.2008.08769.x; Nograles KE, 2009, J ALLERGY CLIN IMMUN, V123, P1244, DOI 10.1016/j.jaci.2009.03.041; Ortega C, 2009, J LEUKOCYTE BIOL, V86, P435, DOI [10.1189/jlb.0109046, 10.1189/JLB.0109046]; Palmer BE, 2005, J IMMUNOL, V175, P8415, DOI 10.4049/jimmunol.175.12.8415; Plant D, 2006, EXP DERMATOL, V15, P900, DOI 10.1111/j.1600-0625.2006.00486.x; Res PCM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014108; Sabat R, 2007, EXP DERMATOL, V16, P779, DOI 10.1111/j.1600-0625.2007.00629.x; Shibata S, J INVEST DERMATOL, V130, P1034; Simpson RJ, 2008, BRAIN BEHAV IMMUN, V22, P544, DOI 10.1016/j.bbi.2007.11.002; Stritesky GL, 2008, J IMMUNOL, V181, P5948, DOI 10.4049/jimmunol.181.9.5948; Suarez-Farinas M, 2011, J ALLERGY CLIN IMMUN, V127, P954, DOI 10.1016/j.jaci.2010.12.1124; Suarez-Farinas M, 2011, J INVEST DERMATOL, V131, P391, DOI 10.1038/jid.2010.280; Tarazona R, 2000, MECH AGEING DEV, V121, P77; Teunissen MBM, 1998, J INVEST DERMATOL, V111, P645, DOI 10.1046/j.1523-1747.1998.00347.x; Theoharides TC, P NATL ACAD SCI US, V107, P4448; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Wolk K, 2006, EUR J IMMUNOL, V36, P1309, DOI 10.1002/eji.200535503; Zenewicz LA, 2011, INT IMMUNOL, V23, P159, DOI 10.1093/intimm/dxr001; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505	37	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e52144	10.1371/journal.pone.0052144	http://dx.doi.org/10.1371/journal.pone.0052144			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23468834	Green Published, gold, Green Submitted			2022-12-25	WOS:000315524900002
J	Tsai, VWW; Macia, L; Johnen, H; Kuffner, T; Manadhar, R; Jorgensen, SB; Lee-Ng, KKM; Zhang, HP; Wu, LY; Marquis, CP; Jiang, LL; Husaini, Y; Lin, S; Herzog, H; Brown, DA; Sainsbury, A; Breit, SN				Tsai, Vicky Wang-Wei; Macia, Laurence; Johnen, Heiko; Kuffner, Tamara; Manadhar, Rakesh; Jorgensen, Sebastian Beck; Lee-Ng, Ka Ki Michelle; Zhang, Hong Ping; Wu, Liyun; Marquis, Christopher Peter; Jiang, Lele; Husaini, Yasmin; Lin, Shu; Herzog, Herbert; Brown, David A.; Sainsbury, Amanda; Breit, Samuel N.			TGF-b Superfamily Cytokine MIC-1/GDF15 Is a Physiological Appetite and Body Weight Regulator	PLOS ONE			English	Article							MACROPHAGE INHIBITORY CYTOKINE-1; GROWTH-DIFFERENTIATION FACTOR-15; BONE MORPHOGENETIC PROTEIN-7; FACTOR-BETA SUPERFAMILY; DIET-INDUCED OBESITY; BROWN ADIPOGENESIS; SERUM; MIC-1; INDIVIDUALS; DIAGNOSIS	The TGF-b superfamily cytokine MIC-1/GDF15 circulates in all humans and when overproduced in cancer leads to anorexia/cachexia, by direct action on brain feeding centres. In these studies we have examined the role of physiologically relevant levels of MIC-1/GDF15 in the regulation of appetite, body weight and basal metabolic rate. MIC-1/GDF15 gene knockout mice (MIC-1(-/-)) weighed more and had increased adiposity, which was associated with increased spontaneous food intake. Female MIC-1(-/-) mice exhibited some additional alterations in reduced basal energy expenditure and physical activity, possibly owing to the associated decrease in total lean mass. Further, infusion of human recombinant MIC-1/GDF15 sufficient to raise serum levels in MIC-1(-/-) mice to within the normal human range reduced body weight and food intake. Taken together, our findings suggest that MIC-1/GDF15 is involved in the physiological regulation of appetite and energy storage.	[Tsai, Vicky Wang-Wei; Johnen, Heiko; Kuffner, Tamara; Manadhar, Rakesh; Lee-Ng, Ka Ki Michelle; Zhang, Hong Ping; Wu, Liyun; Jiang, Lele; Husaini, Yasmin; Brown, David A.; Breit, Samuel N.] St Vincents Hosp, St Vincents Ctr Appl Med Res, Sydney, NSW 2010, Australia; [Tsai, Vicky Wang-Wei; Johnen, Heiko; Kuffner, Tamara; Manadhar, Rakesh; Lee-Ng, Ka Ki Michelle; Zhang, Hong Ping; Wu, Liyun; Jiang, Lele; Husaini, Yasmin; Brown, David A.; Breit, Samuel N.] Univ New S Wales, Sydney, NSW, Australia; [Macia, Laurence; Lin, Shu; Herzog, Herbert; Sainsbury, Amanda] Garvan Inst Med Res, Neurosci Program, Sydney, NSW, Australia; [Jorgensen, Sebastian Beck] Novo Nordisk AS, Diabet Res Unit, Malov, Denmark; [Marquis, Christopher Peter] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia	St Vincents Hospital Sydney; University of New South Wales Sydney; Garvan Institute of Medical Research; Novo Nordisk; University of New South Wales Sydney	Breit, SN (corresponding author), St Vincents Hosp, St Vincents Ctr Appl Med Res, Sydney, NSW 2010, Australia.	s.breit@amr.org.au	Macia, laurence/D-5983-2016; Herzog, Herbert/B-8294-2008; Salis, Amanda/A-3187-2011; Marquis, Christopher P/E-3847-2013	Macia, laurence/0000-0003-0835-851X; Salis, Amanda/0000-0001-9176-1574; Marquis, Christopher P/0000-0003-1656-7215; , Herbert/0000-0002-1713-1029; Brown, David/0000-0003-1382-9419; Jiang, Lele/0000-0002-1326-5871; lin, shu/0000-0002-4239-2028	National Health and Medical Research Council of Australia (NHMRC); NHMRC	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by grants from the National Health and Medical Research Council of Australia (NHMRC). AS, DAB and HH are all recipients of NHMRC Career Development Awards or Fellowships. The funders had no role in study design, date collection and analysis, decision to publish, or preparation of the manuscript.	Bauskin AR, 2005, CANCER RES, V65, P2330, DOI 10.1158/0008-5472.CAN-04-3827; Bauskin AR, 2006, CANCER RES, V66, P4983, DOI 10.1158/0008-5472.CAN-05-4067; Bjursell M, 2008, AM J PHYSIOL-ENDOC M, V294, pE251, DOI 10.1152/ajpendo.00401.2007; Bootcov MR, 1997, P NATL ACAD SCI USA, V94, P11514, DOI 10.1073/pnas.94.21.11514; Breit SN, 2011, NEPHROL DIAL TRANSPL; Brown DA, 2006, CLIN CANCER RES, V12, P89, DOI 10.1158/1078-0432.CCR-05-1331; Brown DA, 2003, CLIN CANCER RES, V9, P2642; Brown DA, 2002, BIOTECHNIQUES, V33, P118, DOI 10.2144/02331rr03; Brown WJ, 2005, OBES RES, V13, P1431, DOI 10.1038/oby.2005.173; Carstensen M, 2010, EUR J ENDOCRINOL, V162, P913, DOI 10.1530/EJE-09-1066; Cegla J, 2010, CURR OPIN CLIN NUTR, V13, P588, DOI 10.1097/MCO.0b013e32833b64a3; Cho I, 2012, NATURE, V488, P621, DOI 10.1038/nature11400; Coll AP, 2007, CELL, V129, P251, DOI 10.1016/j.cell.2007.04.001; Dani C, 2012, INT J OBES LOND; de Caestecker M, 2004, CYTOKINE GROWTH F R, V15, P1, DOI 10.1016/j.cytogfr.2003.10.004; Fairlie WD, 1999, J LEUKOCYTE BIOL, V65, P2, DOI 10.1002/jlb.65.1.2; FERRANNINI E, 1988, METABOLISM, V37, P287, DOI 10.1016/0026-0495(88)90110-2; Fournier B, 2012, MOL CELL BIOL, V32, P2871, DOI 10.1128/MCB.06575-11; FRAYN KN, 1983, J APPL PHYSIOL, V55, P628, DOI 10.1152/jappl.1983.55.2.628; Gao Q, 2007, ANNU REV NEUROSCI, V30, P367, DOI 10.1146/annurev.neuro.30.051606.094324; Hatori M, 2012, CELL METAB, V15, P848, DOI 10.1016/j.cmet.2012.04.019; Hill JO, 2003, SCIENCE, V299, P853, DOI 10.1126/science.1079857; Huang HY, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.002691; Johnen H, 2007, NAT MED, V13, P1333, DOI 10.1038/nm1677; Kempf T, 2007, J AM COLL CARDIOL, V50, P1054, DOI 10.1016/j.jacc.2007.04.091; Koopmann J, 2004, CLIN CANCER RES, V10, P2386, DOI 10.1158/1078-0432.CCR-03-0165; Lenth RV, 2007, J ANIM SCI, V85, pE24, DOI 10.2527/jas.2006-449; Lind L, 2009, EUR HEART J, V30, P2346, DOI 10.1093/eurheartj/ehp261; Luo X, 2012, DIABETES, V61, P124, DOI 10.2337/db11-0998; Macia L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034868; Magee TR, 2006, J GENE MED, V8, P1171, DOI 10.1002/jgm.946; Moore AG, 2000, J CLIN ENDOCR METAB, V85, P4781, DOI 10.1210/jc.85.12.4781; Reisz-Porszasz S, 2003, AM J PHYSIOL-ENDOC M, V285, pE876, DOI 10.1152/ajpendo.00107.2003; Shen JJ, 2009, MOL ENDOCRINOL, V23, P113, DOI 10.1210/me.2007-0322; Sun FY, 2009, BIOCHEM GENET, V47, P789, DOI 10.1007/s10528-009-9277-8; Suzuki K, 2011, J OBES, V2011, DOI 10.1155/2011/528401; Tang QQ, 2004, P NATL ACAD SCI USA, V101, P9607, DOI 10.1073/pnas.0403100101; Toth MJ, 2001, CURR OPIN CLIN NUTR, V4, P391, DOI 10.1097/00075197-200109000-00009; Townsend KL, 2012, FASEB J, V26, P2187, DOI 10.1096/fj.11-199067; Tseng YH, 2008, NATURE, V454, P1000, DOI 10.1038/nature07221; Welsh JB, 2003, P NATL ACAD SCI USA, V100, P3410, DOI 10.1073/pnas.0530278100; Zac-Varghese S, 2010, DISCOV MED, V10, P543	42	109	123	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e55174	10.1371/journal.pone.0055174	http://dx.doi.org/10.1371/journal.pone.0055174			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23468844	Green Submitted, Green Published, gold			2022-12-25	WOS:000315524900011
J	Fragaszy, DM; Liu, Q; Wright, BW; Allen, A; Brown, CW; Visalberghi, E				Fragaszy, Dorothy M.; Liu, Qing; Wright, Barth W.; Allen, Angellica; Brown, Callie Welch; Visalberghi, Elisabetta			Wild Bearded Capuchin Monkeys (Sapajus libidinosus) Strategically Place Nuts in a Stable Position during Nut-Cracking	PLOS ONE			English	Article							TOOL USE	Humans can use hand tools smoothly and effectively in varying circumstances; in other words, skillfully. A few other species of primates crack encased foods using hammer tools and anvils. Are they skilled? Positioning the food on the anvil so that it does not fall off when struck is a component of skilled cracking. We discovered that bearded capuchin monkeys deliberately place palm nuts in a relatively stable position on the anvil before striking them. In the first experiment, we marked the meridians of palm nuts where they stopped when rolled on a flat surface ("Stop meridian"). We videotaped monkeys as they cracked these nuts on an anvil. In playback we coded the position of the Stop meridian prior to each strike. Monkeys typically knocked the nuts on the anvil a few times before releasing them in a pit. They positioned the nuts so that the Stop meridian was within 30 degrees of vertical with respect to gravity more often than expected, and the nuts rarely moved after the monkeys released them. In the second experiment, 14 blindfolded people (7 men) asked to position marked nuts on an anvil as if to crack them reliably placed them with the Stop meridian in the same position as the monkeys did. In the third experiment, two people judged that palm nuts are most bilaterally symmetric along a meridian on, or close to, the Stop meridian. Thus the monkeys reliably placed the more symmetrical side of the nuts against the side of the pit, and the nuts reliably remained stationary when released. Monkeys apparently used information gained from knocking the nut to achieve this position. Thus, monkeys place the nuts skillfully, strategically managing the fit between the variable nuts and pits in the anvil, and skilled placement depends upon information generated by manual action.	[Fragaszy, Dorothy M.; Liu, Qing; Allen, Angellica; Brown, Callie Welch] Univ Georgia, Dept Psychol, Athens, GA 30602 USA; [Wright, Barth W.] Kansas City Univ Med & Biosci, Dept Anat, Kansas City, MO USA; [Visalberghi, Elisabetta] CNR, Unit Cognit Primatol, Inst Sci & Technol Cognit, Rome, Italy	University System of Georgia; University of Georgia; Kansas City University of Medicine & Biosciences; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze e Tecnologie della Cognizione (ISTC-CNR)	Fragaszy, DM (corresponding author), Univ Georgia, Dept Psychol, Athens, GA 30602 USA.	doree@uga.edu	Liu, Qing/C-5620-2014; , Doree/HCI-4354-2022	Visalberghi, Elisabetta/0000-0001-7407-5468	National Geographic Society; LSB Leakey Foundation; University of Georgia	National Geographic Society(National Geographic Society); LSB Leakey Foundation; University of Georgia	This study was funded by the National Geographic Society, The LSB Leakey Foundation, and The University of Georgia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett TM, 2007, DEV PSYCHOL, V43, P352, DOI 10.1037/0012-1649.43.2.352; Bernstein N.A., 1996, RES ECOL PS; Bril B, 2010, J EXP PSYCHOL HUMAN, V36, P825, DOI 10.1037/a0018171; Carello C, 2005, MOVING IMAGE THEORY, P79; Chemero A, 2009, BRADFORD BOOKS, P1; ELLIOTT JM, 1984, DEV MED CHILD NEUROL, V26, P283, DOI 10.1111/j.1469-8749.1984.tb04445.x; Fobes J.L., 1982, P245; Fragaszy D, 2010, ANIM BEHAV, V79, P321, DOI 10.1016/j.anbehav.2009.11.004; Fragaszy D. M., 2004, COMPLETE CAPUCHIN; FRAGASZY DM, 1991, J COMP PSYCHOL, V105, P387, DOI 10.1037/0735-7036.105.4.387; Fragaszy Dorothy M, 2005, Behav Cogn Neurosci Rev, V4, P282, DOI 10.1177/1534582306286573; Fragaszy DM, 2010, ANIM BEHAV, V80, P205, DOI 10.1016/j.anbehav.2010.04.018; Hoffmann JN, 2004, ANAT REC PART A, V281A, P1138, DOI 10.1002/ar.a.20119; Humle T., 2010, PRIMATES PERSPECTIVE, P637; Jones L.A., 2006, HUMAN HAND FUNCTION; KAAS JH, 1993, ANN ANAT, V175, P509, DOI 10.1016/S0940-9602(11)80212-8; Khanna S.M., 1978, P23; Klatzky RL, 2005, INFANT BEHAV DEV, V28, P240, DOI 10.1016/j.infbeh.2005.05.002; LEDERMAN SJ, 1987, COGNITIVE PSYCHOL, V19, P342, DOI 10.1016/0010-0285(87)90008-9; Liu Q, 2011, THESIS U GEORGIA; Liu Q, 2011, ANIM BEHAV, V81, P297, DOI 10.1016/j.anbehav.2010.10.021; McCarty ME, 2001, INFANCY, V2, P233, DOI 10.1207/S15327078IN0202_8; Ottoni EB, 2008, EVOL ANTHROPOL, V17, P171, DOI 10.1002/evan.20185; Richardson M. J., 2008, HDB COGNITIVE SCI EM, P161, DOI [DOI 10.1016/B978-0-08-046616-3.00009-8, 10.1016/B978-0-08-046616-3.00009-8]; Sirianni G, 2010, PROCESSAMENTO CIBO P; Spagnoletti N, 2011, J HUM EVOL, V61, P97, DOI 10.1016/j.jhevol.2011.02.010; TALBOT WH, 1968, J NEUROPHYSIOL, V31, P301, DOI 10.1152/jn.1968.31.2.301; Turvey MT, 1996, AM PSYCHOL, V51, P1134, DOI 10.1037/0003-066X.51.11.1134; Visalberghi E, 2008, AM J PRIMATOL, V70, P884, DOI 10.1002/ajp.20578; Visalberghi E, 2012, COMP COGNITION, P529; Visalberghi E, 2009, CURR BIOL, V19, P213, DOI 10.1016/j.cub.2008.11.064	31	29	30	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e56182	10.1371/journal.pone.0056182	http://dx.doi.org/10.1371/journal.pone.0056182			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460793	Green Published, gold			2022-12-25	WOS:000315519000016
J	Ibarrola-Jurado, N; Bullo, M; Guasch-Ferre, M; Ros, E; Martinez-Gonzalez, MA; Corella, D; Fiol, M; Warnberg, J; Estruch, R; Roman, P; Aros, F; Vinyoles, E; Serra-Majem, L; Pinto, X; Covas, MI; Basora, J; Salas-Salvado, J				Ibarrola-Jurado, Nuria; Bullo, Monica; Guasch-Ferre, Marta; Ros, Emilio; Martinez-Gonzalez, Miguel A.; Corella, Dolores; Fiol, Miquel; Waernberg, Julia; Estruch, Ramon; Roman, Pilar; Aros, Fernando; Vinyoles, Ernest; Serra-Majem, Lluis; Pinto, Xavier; Covas, Maria-Isabel; Basora, Josep; Salas-Salvado, Jordi		PREDIMED Study Investigators	Cross-Sectional Assessment of Nut Consumption and Obesity, Metabolic Syndrome and Other Cardiometabolic Risk Factors: The PREDIMED Study	PLOS ONE			English	Article							BODY-WEIGHT; MEDITERRANEAN DIET; COMPONENTS; COHORT; MARKERS	Introduction: Prospective studies have consistently suggested that nut consumption is inversely related to fatal and non-fatal coronary heart disease. Limited data are available on the epidemiological associations between nut intake and cardiometabolic risk factors. Objective: To evaluate associations between frequency of nut consumption and prevalence of cardiometabolic risk factors [obesity, metabolic syndrome (MetS), type-2 diabetes, hypertension, and dyslipidemia] in a Mediterranean population at high cardiovascular risk. Materials and Methods: Cross-sectional study of 7,210 men and women (mean age, 67 y) recruited into the PREDIMED study. MetS was defined by the harmonized ATPIII and IDF criteria. Diabetes and hypertension were assessed by clinical diagnosis and dyslipidemia (high triglycerides, low HDL-cholesterol, and hypercholesterolemia) by lipid analyses. Nut consumption was assessed using a validated food frequency questionnaire and categorized as <1, 1-3, and >3 servings/wk. Control of confounding was done with multivariate logistic regression. Results: Compared to participants consuming <1 serving/wk of nuts, those consuming >3 servings/wk had lower adjusted odds ratios (OR) for obesity (0.61, 95% confidence interval 0.54 to 0.68; P-trend <0.001), MetS (0.74, 0.65 to 0.85; P-trend<0.001), and diabetes (0.87, 0.78 to 0.99; P-trend = 0.043). Higher nut consumption was also associated with lower risk of the abdominal obesity MetS criterion (OR 0.68, 0.60 to 0.79; P-trend<0.001). No significant associations were observed for the MetS components high blood pressure, dyslipidemia, or elevated fasting glucose. Conclusions: Nut consumption was inversely associated with the prevalence of general obesity, central obesity, MetS, and diabetes in subjects at high cardiovascular risk.	[Ibarrola-Jurado, Nuria; Bullo, Monica; Guasch-Ferre, Marta; Basora, Josep; Salas-Salvado, Jordi] Univ Rovira & Virgili, Human Nutr Unit, Hosp Univ St Joan Reus, IISPV, E-43201 Reus, Spain; [Ibarrola-Jurado, Nuria; Bullo, Monica; Guasch-Ferre, Marta; Ros, Emilio; Corella, Dolores; Fiol, Miquel; Estruch, Ramon; Roman, Pilar; Covas, Maria-Isabel; Basora, Josep; Salas-Salvado, Jordi] Inst Salud Carlos III, CIBER Fisiopatol Obesidad & Nutr CIBERobn, Madrid, Spain; [Ros, Emilio] Hosp Clin Barcelona, Lipid Clin, Endocrinol & Nutr Serv, Inst Invest Biomed August Pi Sunyer IDIBAPS, Barcelona, Spain; [Martinez-Gonzalez, Miguel A.] Univ Navarra, Dept Prevent Med & Publ Hlth, Med Sch Clin, E-31080 Pamplona, Spain; [Corella, Dolores] Univ Valencia, Dept Prevent Med & Publ Hlth, Valencia, Spain; [Fiol, Miquel] Univ Inst Hlth Sci Invest, Palma de Mallorca, Spain; [Waernberg, Julia] Univ Malaga, Dept Prevent Med, E-29071 Malaga, Spain; [Estruch, Ramon] Hosp Clin Barcelona, Dept Internal Med, Inst Invest Biomed August Pi Sunyer IDIBAPS, Barcelona, Spain; [Roman, Pilar] Mercedes Navarro Hlth Ctr, Dept Family Med, Primary Care Div Sevilla, Seville, Spain; [Aros, Fernando] Hosp Txangorritxu, Clin Trial Unit, Vitoria, Spain; [Vinyoles, Ernest] Univ Barcelona, La Mina Primary Care Ctr, IDIAP Jordi Gol, Barcelona, Spain; [Serra-Majem, Lluis] Univ Las Palmas Gran Canaria, Dept Clin Sci, Las Palmas Gran Canaria, Spain; [Pinto, Xavier] Bellvitge Hosp, Internal Med Serv, Lhospitalet De Llobregat, Spain; [Covas, Maria-Isabel] Hosp del Mar, Cardiovasc Risk & Nutr Res Grp, IMIM Inst Recerca, Barcelona, Spain	Universitat Rovira i Virgili; Institut d'Investigacio Sanitaria Pere Virgili (IISPV); CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Navarra; University of Valencia; Universidad de Malaga; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Universidad de Las Palmas de Gran Canaria; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar	Salas-Salvado, J (corresponding author), Univ Rovira & Virgili, Human Nutr Unit, Hosp Univ St Joan Reus, IISPV, C St Llorenc 21, E-43201 Reus, Spain.	jordi.salas@urv.cat	Bulló, Mònica/F-2925-2016; IBIS, ATENCION PRIMARIA/I-3524-2016; Guasch-Ferre, Marta/H-6680-2019; Pintó, Xavier/AGI-4297-2022; Serra-Majem, Lluis/I-6708-2019; Salas-Salvado, Jordi/C-7229-2017; Estruch, Ramon/AAZ-3723-2020; Fiol, Miguel/F-6793-2016; Martinez-Gonzalez, Miguel A./AAE-7669-2019; Warnberg, Julia/G-1390-2011; Vinyoles, Ernest/GRX-4615-2022; Lapetra, Jose/F-2552-2015; Babio, Nancy/AAN-2715-2020; Toledo, Estefania/H-6211-2014; Lamuela-Raventos, Rosa M/F-3986-2016	Bulló, Mònica/0000-0002-0218-7046; Guasch-Ferre, Marta/0000-0001-8525-1404; Pintó, Xavier/0000-0002-2216-2444; Serra-Majem, Lluis/0000-0002-9658-9061; Salas-Salvado, Jordi/0000-0003-2700-7459; Fiol, Miguel/0000-0002-5370-1391; Warnberg, Julia/0000-0002-8408-316X; Babio, Nancy/0000-0003-3527-5277; Fernandez-Ballart, Joan D./0000-0002-1320-6484; Toledo, Estefania/0000-0002-6263-4434; Basora, Josep/0000-0003-0278-1149; Martinez-Gonzalez, Miguel A./0000-0002-3917-9808; Ros, Emilio/0000-0002-2573-1294; Sorli, Jose V/0000-0002-0130-2006; Lamuela-Raventos, Rosa M/0000-0002-1287-4560; Vinyoles, Ernest/0000-0002-8725-9431	Spanish Ministry of Health (ISCIII) [PI1001407]; Thematic Network [G03/140, RD06/0045]; FEDER (Fondo Europeo de Desarrollo Regional); Centre Catala de la Nutricio de l'Institut d'Estudis Catalans	Spanish Ministry of Health (ISCIII)(Instituto de Salud Carlos IIISpanish Government); Thematic Network; FEDER (Fondo Europeo de Desarrollo Regional)(European Commission); Centre Catala de la Nutricio de l'Institut d'Estudis Catalans	This study was funded, in part, by the Spanish Ministry of Health (ISCIII), PI1001407, Thematic Network G03/140, RD06/0045, FEDER (Fondo Europeo de Desarrollo Regional), and the Centre Catala de la Nutricio de l'Institut d'Estudis Catalans. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abete I, 2011, NUTR METAB CARDIOVAS, V21, pB1, DOI 10.1016/j.numecd.2011.05.001; Grundy Scott M, 2005, Crit Pathw Cardiol, V4, P198; Martinez-Gonzalez MA, 2012, INT J EPIDEMIOL, V41, P377, DOI 10.1093/ije/dyq250; Bes-Rastrollo M, 2007, OBESITY, V15, P107, DOI 10.1038/oby.2007.507; Bes-Rastrollo M, 2009, AM J CLIN NUTR, V89, P1913, DOI 10.3945/ajcn.2008.27276; Blomhoff R, 2006, BRIT J NUTR, V96, pS52, DOI 10.1017/BJN20061864; Casas-Agustench P, 2011, NUTR METAB CARDIOVAS, V21, P518, DOI 10.1016/j.numecd.2009.11.010; Casas-Agustench P, 2011, NUTR METAB CARDIOVAS, V21, pS21, DOI 10.1016/j.numecd.2011.01.009; Casas-Agustench P, 2011, NUTR METAB CARDIOVAS, V21, P126, DOI 10.1016/j.numecd.2009.08.005; Casas-Agustench P, 2009, CLIN NUTR, V28, P39, DOI 10.1016/j.clnu.2008.10.008; Casas-Agustench P, 2010, ASIA PAC J CLIN NUTR, V19, P124; Chen CYO, 2008, ASIA PAC J CLIN NUTR, V17, P329; Djousse L, 2009, CLIN NUTR, V28, P10, DOI 10.1016/j.clnu.2008.08.005; Estruch R, 2006, ANN INTERN MED, V145, P1, DOI 10.7326/0003-4819-145-1-200607040-00004; Fernandez-Ballarth JD, 2010, BRIT J NUTR, V103, P1808, DOI 10.1017/S0007114509993837; Fernandez-Montero A, 2012, PUBLIC HEALTH NUTR, V23, P1; Garcia-Lorda P, 2003, EUR J CLIN NUTR, V57, pS8, DOI 10.1038/sj.ejcn.1601802; Grundy SM, 2008, ARTERIOSCL THROM VAS, V28, P629, DOI 10.1161/ATVBAHA.107.151092; Jenkins DJA, 2011, DIABETES CARE, V34, P1706, DOI 10.2337/dc11-0338; Jiang R, 2002, JAMA-J AM MED ASSOC, V288, P2554, DOI 10.1001/jama.288.20.2554; Kastorini CM, 2011, J AM COLL CARDIOL, V57, P1299, DOI 10.1016/j.jacc.2010.09.073; Kendall CWC, 2010, BRIT J NUTR, V104, P465, DOI 10.1017/S0007114510001546; King JG, 2008, J NUTR, V138, p1736S, DOI 10.1093/jn/138.9.1736S; Lopez-Uriarte P, 2010, CLIN NUTR, V29, P373, DOI 10.1016/j.clnu.2009.12.008; Lopez-Uriarte P, 2009, NUTR REV, V67, P497, DOI 10.1111/j.1753-4887.2009.00223.x; Martinez-Gonzalez MA, 2011, NUTR METAB CARDIOVAS, V21, pS40, DOI 10.1016/j.numecd.2010.11.005; Martinez-Lapiscina EH, 2010, NUTR METAB CARDIOVAS, V20, P359, DOI 10.1016/j.numecd.2009.04.013; Mattes RD, 2010, ASIA PAC J CLIN NUTR, V19, P137; Mukuddem-Petersen J, 2007, BRIT J NUTR, V97, P1144, DOI 10.1017/S0007114507682944; O'Neil CE, 2011, J AM COLL NUTR, V30, P502, DOI 10.1080/07315724.2011.10719996; Parker ED, 2003, JAMA-J AM MED ASSOC, V290, P38, DOI 10.1001/jama.290.1.38; Ros E, 2006, BRIT J NUTR, V96, pS29, DOI 10.1017/BJN20061861; Ros E, 2010, CURR ATHEROSCLER REP, V12, P397, DOI 10.1007/s11883-010-0132-5; Sabate J, 2010, ARCH INTERN MED, V170, P821, DOI 10.1001/archinternmed.2010.79; Salas-Salvado J, 2011, NUTR METAB CARDIOVAS, V21, pB32, DOI 10.1016/j.numecd.2011.03.009; Salas-Salvado J, 2008, ARCH INTERN MED, V168, P2449, DOI 10.1001/archinte.168.22.2449; Salas-Salvado J, 2006, BRIT J NUTR, V96, pS45, DOI 10.1017/BJN20061863; Sanchez-Tainta A, 2008, EUR J CARDIOV PREV R, V15, P589, DOI 10.1097/HJR.0b013e328308ba61; Segura R, 2006, BRIT J NUTR, V96, pS36, DOI 10.1017/BJN20061862; Sokka T, 2008, CLIN EXP RHEUMATOL, V26, pS35, DOI 10.1161/CIRCULATIONAHA.109.192644; US Food and Drug Administration. Center for Food Safety and Applied Nutrition, QUAL HLTH CLAIMS SUB; Villegas R, 2008, AM J CLIN NUTR, V87, P162, DOI 10.1093/ajcn/87.1.162; Wang X, 2012, NUTR J, V11, DOI 10.1186/1475-2891-11-20	43	84	85	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57367	10.1371/journal.pone.0057367	http://dx.doi.org/10.1371/journal.pone.0057367			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460844	Green Published, gold			2022-12-25	WOS:000315519000098
J	Ling, JL; Pan, HZ; Gao, QQ; Xiong, LP; Zhou, YF; Zhang, DB; Gao, S; Liu, XF				Ling, Jielu; Pan, Haizhu; Gao, Qingqing; Xiong, Liping; Zhou, Yefei; Zhang, Debao; Gao, Song; Liu, Xiufan			Aerobactin Synthesis Genes iucA and iucC Contribute to the Pathogenicity of Avian Pathogenic Escherichia coli O2 Strain E058	PLOS ONE			English	Article							IRON UPTAKE SYSTEM; VIRULENCE FACTORS; INVASIVE STRAINS; PLASMID COLV-K30; TRANSPORT GENES; OPERON; IDENTIFICATION; CHROMOSOME; EXPRESSION; RESISTANCE	Aerobactin genes are known to be present in virulent strains and absent from avirulent strains, but contributions of iucC and iucA, which are involved in aerobactin synthesis, to the pathogenicity of avian pathogenic Escherichia coli (APEC) have not been clarified. In this study, effects of double mutants (iucA/iutA or iucC/iutA) compared to those of single mutants (iucA, iucC or iutA) of aerobactin genes on the virulence of APEC strain E058 were examined both in vitro (aerobactin production, ingestion into HD-11 cells, survival in chicken serum) and in vivo (competitive growth against parental strain, colonization and persistence). In competitive co-infection assays, compared to the E058 parental strain, the E058 Delta iucA mutant was significantly reduced in the liver, kidney, spleen (all P<0.01), heart and lung (both P<0.001). The E058 Delta iutA mutant also was significantly reduced in the liver, lung, kidney (all P<0.01), heart and spleen (both P<0.001). The E058 Delta iucC mutant was significantly attenuated in the heart and kidney (both P<0.05) and showed a remarkable reduction in the liver, spleen and lung (P<0.01); meanwhile, both E058 Delta iucA Delta iutA and E058 Delta iucC Delta iutA double mutants were sharply reduced as well (P<0.001). In colonization and persistence assays, compared with E058, recovered colonies of E058 Delta iucA were significantly reduced from the lung, liver, spleen and kidney (P<0.01) and significantly reduced in the heart (P<0.001). E058 Delta iutA was significantly reduced from the heart, lung, liver, spleen and kidney (P<0.01). E058 Delta iucC, E058 Delta iucA Delta iutA and E058 Delta iucC Delta iutA were significantly decreased in all organs tested (P<0.001). These results suggest that iutA, iucA and iucC play important roles in the pathogenicity of APEC E058.	[Ling, Jielu; Pan, Haizhu; Gao, Qingqing; Xiong, Liping; Zhou, Yefei; Zhang, Debao; Gao, Song; Liu, Xiufan] Yangzhou Univ, Coll Vet Med, Minist Agr, Anim Infect Dis Lab, Yangzhou, Jiangsu, Peoples R China	Ministry of Agriculture & Rural Affairs; Yangzhou University	Gao, S (corresponding author), Yangzhou Univ, Coll Vet Med, Minist Agr, Anim Infect Dis Lab, Yangzhou, Jiangsu, Peoples R China.	gsong@yzu.edu.cn			National Natural Science Foundation of China [30972196, 30771604, 30471281]; National Program for High Technology Research and Development in China [2003 AA222141]; program for Changjiang Scholars and Innovative Research Team in University [PCSIRT0978]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Program for High Technology Research and Development in China; program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported by the National Natural Science Foundation of China Grant 30972196, 30771604 and 30471281, and National Program for High Technology Research and Development in China Grant 2003 AA222141 to Song Gao. This study was also supported by the program for Changjiang Scholars and Innovative Research Team in University (PCSIRT0978) and a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; BINDEREIF A, 1985, J BACTERIOL, V161, P727, DOI 10.1128/JB.161.2.727-735.1985; BINDEREIF A, 1983, J BACTERIOL, V153, P1111, DOI 10.1128/JB.153.2.1111-1113.1983; BULLEN JJ, 1981, REV INFECT DIS, V3, P1127; CARBONETTI NH, 1984, INFECT IMMUN, V46, P7, DOI 10.1128/IAI.46.1.7-12.1984; COLONNA B, 1985, J BACTERIOL, V162, P307, DOI 10.1128/JB.162.1.307-316.1985; DELORENZO V, 1986, J BACTERIOL, V167, P350, DOI 10.1128/jb.167.1.350-355.1986; DELORENZO V, 1986, J BACTERIOL, V165, P570, DOI 10.1128/jb.165.2.570-578.1986; DERVARTANIAN M, 1988, INFECT IMMUN, V56, P413, DOI 10.1128/IAI.56.2.413-418.1988; DHO M, 1984, AVIAN DIS, V28, P1016, DOI 10.2307/1590278; Dozois CM, 2003, P NATL ACAD SCI USA, V100, P247, DOI 10.1073/pnas.232686799; Escolar L, 2000, J BIOL CHEM, V275, P24709, DOI 10.1074/jbc.M002839200; FINKELSTEIN RA, 1983, REV INFECT DIS, V5, pS759; Forman S, 2007, MICROBIOL-SGM, V153, P2332, DOI 10.1099/mic.0.2006/004275-0; Gao Song, 1999, Acta Veterinaria et Zootechnica Sinica, V30, P164; GIBSON F, 1969, BIOCHIM BIOPHYS ACTA, V192, P175, DOI 10.1016/0304-4165(69)90353-5; GRIFFITHS E, 1985, INFECT IMMUN, V49, P67, DOI 10.1128/IAI.49.1.67-71.1985; GROSS R, 1984, MOL GEN GENET, V196, P74, DOI 10.1007/BF00334095; Johnson TJ, 2006, J BACTERIOL, V188, P745, DOI 10.1128/JB.188.2.745-758.2006; Kariyawasam S, 2006, INFECT IMMUN, V74, P744, DOI 10.1128/IAI.74.1.744-749.2006; Knobl T, 2001, VET MICROBIOL, V83, P71, DOI 10.1016/S0378-1135(01)00403-5; KONOPKA K, 1982, BIOCHEMISTRY-US, V21, P6503, DOI 10.1021/bi00268a028; LAFONT JP, 1987, INFECT IMMUN, V55, P193, DOI 10.1128/IAI.55.1.193-197.1987; LAWLOR KM, 1984, J BACTERIOL, V160, P266, DOI 10.1128/JB.160.1.266-272.1984; Li G, 2008, MICROBIOL-SGM, V154, P1082, DOI 10.1099/mic.0.2007/015784-0; Li GW, 2005, INFECT IMMUN, V73, P2818, DOI 10.1128/IAI.73.5.2818-2827.2005; MCDOUGALL S, 1984, J BACTERIOL, V159, P300, DOI 10.1128/JB.159.1.300-305.1984; Ngeleka M, 2002, AVIAN DIS, V46, P143, DOI 10.1637/0005-2086(2002)046[0143:POAECA]2.0.CO;2; Sabri M, 2006, MICROBIOL-SGM, V152, P745, DOI 10.1099/mic.0.28682-0; Sabri M, 2008, INFECT IMMUN, V76, P601, DOI 10.1128/IAI.00789-07; Skyberg JA, 2006, INFECT IMMUN, V74, P6287, DOI 10.1128/IAI.00363-06; Skyberg JA, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-24; Tivendale KA, 2004, INFECT IMMUN, V72, P6554, DOI 10.1128/IAI.72.11.6554-6560.2004; Torres AG, 2001, INFECT IMMUN, V69, P6179, DOI 10.1128/IAI.69.10.6179-6185.2001; Valdebenito M, 2006, INT J MED MICROBIOL, V296, P513, DOI 10.1016/j.ijmm.2006.06.003; VALVANO MA, 1984, INFECT IMMUN, V46, P159, DOI 10.1128/IAI.46.1.159-167.1984; Van LP, 1996, BIOCHEM J, V313, P39; VIDOTTO MC, 1990, AVIAN DIS, V34, P531, DOI 10.2307/1591241; WARNER PJ, 1981, INFECT IMMUN, V33, P540, DOI 10.1128/IAI.33.2.540-545.1981; Watson RJ, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-177; WEINBERG ED, 1984, PHYSIOL REV, V64, P65, DOI 10.1152/physrev.1984.64.1.65; WILLIAMS PH, 1979, INFECT IMMUN, V26, P925, DOI 10.1128/IAI.26.3.925-932.1979; Xiong LP, 2012, VET MICROBIOL, V159, P420, DOI 10.1016/j.vetmic.2012.04.024; Zaleski A, 2000, INFECT IMMUN, V68, P5261, DOI 10.1128/IAI.68.9.5261-5268.2000; Zhao LX, 2009, MICROBIOL-SGM, V155, P1634, DOI 10.1099/mic.0.024869-0	45	24	26	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57794	10.1371/journal.pone.0057794	http://dx.doi.org/10.1371/journal.pone.0057794			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460907	gold, Green Submitted, Green Published			2022-12-25	WOS:000315519000162
J	Manunza, A; Zidi, A; Yeghoyan, S; Balteanu, VA; Carsai, TC; Scherbakov, O; Ramirez, O; Eghbalsaied, S; Castello, A; Mercade, A; Amills, M				Manunza, Arianna; Zidi, Ali; Yeghoyan, Seryozha; Balteanu, Valentin Adrian; Carsai, Teodora Crina; Scherbakov, Oleg; Ramirez, Oscar; Eghbalsaied, Shahin; Castello, Anna; Mercade, Anna; Amills, Marcel			A High Throughput Genotyping Approach Reveals Distinctive Autosomal Genetic Signatures for European and Near Eastern Wild Boar	PLOS ONE			English	Article							PIG BREEDS; DOMESTIC PIG; DIVERSITY; MITOCHONDRIAL; POPULATION; DNA; ORIGIN; MULTIPLE; NUMBER	The lack of a Near Eastern genetic signature in modern European porcine breeds indicates that, although domestic pigs from the Fertile Crescent entered Europe during the Neolithic, they were completely replaced by their European counterparts in a short window of time. Whilst the absence of such genetic signature has been convincingly demonstrated at the mitochondrial level, variation at the autosomal genomes of European and Near Eastern Sus scrofa has not been compared yet. Herewith, we have explored the genetic relationships among 43 wild boar from Europe (N = 21), Near East (N = 19) and Korea (N = 3), and 40 Iberian (N = 16), Canarian (N = 4) and Mangalitza (N = 20) pigs by using a high throughput SNP genotyping platform. After data filtering, 37,167 autosomal SNPs were used to perform population genetics analyses. A multidimensional scaling plot based on genome-wide identity-by-state pairwise distances inferred with PLINK showed that Near Eastern and European wild boar populations are genetically differentiated. Maximum likelihood trees built with TreeMix supported this conclusion i.e. an early population split between Near Eastern and European Sus scrofa was observed. Moreover, analysis of the data with Structure evidenced that the sampled Iberian, Canarian and Mangalitza pigs did not carry any autosomal signature compatible with a Near Eastern ancestry, a finding that agrees well with previous mitochondrial studies.	[Manunza, Arianna; Zidi, Ali; Castello, Anna; Amills, Marcel] Univ Autonoma Barcelona, Dept Anim Genet, Ctr Res Agr Genom, CSIC,IRTA,UB, Bellaterra, Spain; [Yeghoyan, Seryozha; Scherbakov, Oleg] Armenian State Agr Univ, Yerevan, Armenia; [Balteanu, Valentin Adrian; Carsai, Teodora Crina] Univ Agr Sci & Vet Med Cluj Napoca, Fac Anim Husb & Biotechnol, Dept Biotechnol, Reg Lab Anim Genotyping, Cluj Napoca, Cluj County, Romania; [Ramirez, Oscar] Univ Pompeu Fabra, Inst Biol Evolut, CSIC, CEXS,PRBB, Barcelona, Spain; [Eghbalsaied, Shahin] Islamic Azad Univ, Dept Anim Sci, Khorasgan Isfahan Branch, Esfahan, Iran; [Mercade, Anna; Amills, Marcel] Univ Autonoma Barcelona, Dept Ciencia Anim & Aliments, Bellaterra, Spain	Autonomous University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); Centre de Recerca en Agrigenomica (CRAG); IRTA; University of Barcelona; Armenian National Agrarian University; University of Agricultural Sciences & Veterinary Medicine Cluj Napoca; Consejo Superior de Investigaciones Cientificas (CSIC); Pompeu Fabra University; Islamic Azad University; Autonomous University of Barcelona	Amills, M (corresponding author), Univ Autonoma Barcelona, Dept Anim Genet, Ctr Res Agr Genom, CSIC,IRTA,UB, Bellaterra, Spain.	Marcel.Amills@uab.cat	Amills, Marcel/D-4908-2019; Eghbalsaied, Shahin/AAC-8686-2019; Farré, Anna Castelló/K-9637-2015; Amills, Marcel/C-7156-2008; Ramirez, Oscar/E-7293-2012; Zidi, Ali/Q-6806-2016	Amills, Marcel/0000-0002-8999-0770; Eghbalsaied, Shahin/0000-0002-9030-8679; Farré, Anna Castelló/0000-0001-8497-6251; Ramirez, Oscar/0000-0001-5164-6790; Zidi, Ali/0000-0002-2314-4336; Mercade, Anna/0000-0002-4714-3565	Ministerio de Ciencia e Innovacion [AGL2010-22208-C02-02, CSD 2007-00036]	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	This work has been funded by grants AGL2010-22208-C02-02 (Ministerio de Ciencia e Innovacion) and CSD 2007-00036 (Ministerio de Ciencia e Innovacion, Consolider Ingenio 2010 Program). A. Zidi received a contractual grant under the framework of CSD 2007-00036. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Alexandri P, 2012, J BIOGEOGR, V39, P713, DOI 10.1111/j.1365-2699.2011.02636.x; Alves E, 2009, ANIMAL, V3, P1216, DOI 10.1017/S1751731109004819; Amills M, 2010, ENCY LIFE SCI, P1, DOI [10.1002/9780470015902.a0022884, DOI 10.1002/9780470015902.A0022884]; Bruford MW, 2005, WORLD POULTR SCI ASS; Burgos-Paz W, 2013, ANIM GENET, V44, P130, DOI 10.1111/j.1365-2052.2012.02374.x; Capote JF, 1982, CERDO NEGRO CANARIO; Ciobanu DC, 2001, GENET SEL EVOL, V33, P417, DOI 10.1051/gse:2001125; Clop A, 2004, GENET SEL EVOL, V36, P97, DOI 10.1051/gse:2003053; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fabuel E, 2004, HEREDITY, V93, P104, DOI 10.1038/sj.hdy.6800488; Fang MY, 2006, P R SOC B, V273, P1803, DOI 10.1098/rspb.2006.3514; Fernandez AI, 2011, ANIM GENET, V42, P86, DOI 10.1111/j.1365-2052.2010.02068.x; Georgescu SE, 2012, INT J MOL SCI, V13, P8467, DOI 10.3390/ijms13078467; Giuffra E, 2000, GENETICS, V154, P1785; Goedbloed DJ, 2013, MOL ECOL, V22, P856, DOI 10.1111/j.1365-294X.2012.05670.x; Groenen MAM, 2012, NATURE, V491, P393, DOI 10.1038/nature11622; Ji YQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026416; Kijas JMH, 2001, J MOL EVOL, V52, P302, DOI 10.1007/s002390010158; Kim TH, 2005, J ANIM SCI, V83, P2255; Larson G, 2005, SCIENCE, V307, P1618, DOI 10.1126/science.1106927; Larson G, 2007, P NATL ACAD SCI USA, V104, P15276, DOI 10.1073/pnas.0703411104; Laval G, 2000, GENET SEL EVOL, V32, P187, DOI 10.1051/gse:2000113; Li SJ, 2004, J ANIM SCI, V82, P368; Martinez AM, 2000, ANIM GENET, V31, P295, DOI 10.1046/j.1365-2052.2000.00645.x; Pickrell JK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002967; Pritchard JK, 2000, GENETICS, V155, P945; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ramirez O, 2009, MOL BIOL EVOL, V26, P2061, DOI 10.1093/molbev/msp118; Ramos AM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006524; SanCristobal M, 2006, ANIM GENET, V37, P189, DOI 10.1111/j.1365-2052.2005.01385.x; Scandura M, 2008, MOL ECOL, V17, P1745, DOI 10.1111/j.1365-294X.2008.03703.x; Scandura M, 2011, HEREDITY, V106, P1012, DOI 10.1038/hdy.2010.155; van Asch B, 2012, ANIM GENET, V43, P35, DOI 10.1111/j.1365-2052.2011.02222.x; Vila C, 2005, TRENDS GENET, V21, P214, DOI 10.1016/j.tig.2005.02.004; Waples RS, 2006, MOL ECOL, V15, P1419, DOI 10.1111/j.1365-294X.2006.02890.x; White S, 2011, ENVIRON HIST-US, V16, P94, DOI 10.1093/envhis/emq143; Zhang CY, 2011, CURR GENOMICS, V12, P138, DOI 10.2174/138920211795564386	40	24	24	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e55891	10.1371/journal.pone.0055891	http://dx.doi.org/10.1371/journal.pone.0055891			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460788	Green Published, Green Submitted, gold			2022-12-25	WOS:000315519000011
J	Shen, CC; Hu, YW; Hu, LY; Hung, MH; Su, TP; Huang, MW; Tsai, CF; Ou, SM; Yen, SH; Tzeng, CH; Chiou, TJ; Chen, TJ; Liu, CJ				Shen, Cheng-Che; Hu, Yu-Wen; Hu, Li-Yu; Hung, Man-Hsin; Su, Tung-Ping; Huang, Min-Wei; Tsai, Chia-Fen; Ou, Shuo-Ming; Yen, Sang-Hue; Tzeng, Cheng-Hwai; Chiou, Tzeon-Jye; Chen, Tzeng-Ji; Liu, Chia-Jen			The Risk of Cancer in Patients with Generalized Anxiety Disorder: A Nationwide Population-Based Study	PLOS ONE			English	Article							QUALITY-OF-LIFE; BREAST-CANCER; TUBERCULOSIS PATIENTS; GENDER-DIFFERENCES; PROSTATE-CANCER; UNITED-STATES; LUNG-CANCER; STRESS; DEPRESSION; COMORBIDITY	Objective: To evaluate the risk of cancer among patients with generalized anxiety disorder (GAD) in a nationwide population-based dataset. Methods: We recruited newly-diagnosed GAD patients aged 20 years or older without antecedent cancer from the Taiwan National Health Insurance Research database between 2000-2010. Standardized incidence ratios (SIRs) of cancers were calculated in GAD patients, and the subgroup of GAD patients diagnosed by psychiatric specialists. Results: A total of 559 cancers developed among 19,793 GAD patients with a follow-up of 89,485 person-years (median follow-up of 4.34 years), leading to a significantly increased SIR of 1.14 [95% confidence interval (CI) 1.05-1.24]. Male GAD patients had a significantly increased SIR overall (1.30, 95% CI 1.15-1.46) and for lung and prostate cancer (1.77, 95% CI 1.33-2.30 and 2.17, 95% CI 1.56-2.93, respectively). Patients over 80 years of age also had a significantly increased SIR (1.56, 95% CI 1.25-1.92), especially in males. However, psychiatrist-diagnosed GAD patients did not show increased cancer risk relative to the general population, perhaps due to having fewer physical comorbidities than non-psychiatrist-diagnosed GAD patients. Conclusion: This study found that overall cancer risk is elevated among patients with GAD. The risk of lung and prostate cancer also increased in male patients with GAD. This increased cancer risk may be due to physical comorbidities and surveillance bias. Further prospective study is necessary to confirm these findings.	[Shen, Cheng-Che; Huang, Min-Wei] Taichung Vet Gen Hosp, Dept Psychiat, Chiayi Branch, Chiayi, Taiwan; [Hu, Yu-Wen; Su, Tung-Ping; Tsai, Chia-Fen; Yen, Sang-Hue; Tzeng, Cheng-Hwai; Chiou, Tzeon-Jye; Liu, Chia-Jen] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Hu, Yu-Wen; Yen, Sang-Hue] Taipei Vet Gen Hosp, Ctr Canc, Taipei, Taiwan; [Hu, Yu-Wen; Liu, Chia-Jen] Natl Yang Ming Univ, Inst Publ Hlth, Taipei 112, Taiwan; [Hu, Li-Yu] Yuli Vet Hosp, Dept Psychiat, Hualien, Taiwan; [Hung, Man-Hsin; Tzeng, Cheng-Hwai; Chiou, Tzeon-Jye; Liu, Chia-Jen] Taipei Vet Gen Hosp, Div Hematol & Oncol, Dept Med, Taipei, Taiwan; [Su, Tung-Ping; Tsai, Chia-Fen] Taipei Vet Gen Hosp, Dept Psychiat, Taipei, Taiwan; [Ou, Shuo-Ming] Taipei Vet Gen Hosp, Div Nephrol, Dept Med, Taipei, Taiwan; [Yen, Sang-Hue] Natl Yang Ming Univ, Dept Biomed Imaging & Radiol Sci, Taipei 112, Taiwan; [Chen, Tzeng-Ji] Taipei Vet Gen Hosp, Dept Family Med, Taipei, Taiwan; [Liu, Chia-Jen] Natl Yang Ming Univ Hosp, Dept Internal Med, Yilan, Taiwan	Taichung Veterans General Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Taipei Veterans General Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital	Liu, CJ (corresponding author), Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan.	chiajenliu@gmail.com	Chen, TJ/AAH-8430-2021	Shen, Cheng-Che/0000-0003-1587-5590; Hu, Yu-Wen/0000-0002-7983-415X				Antoni MH, 2006, NAT REV CANCER, V6, P240, DOI 10.1038/nrc1820; Aro AR, 2005, PSYCHOL MED, V35, P1515, DOI 10.1017/S0033291705005313; Biesalski HK, 1998, CA-CANCER J CLIN, V48, P167, DOI 10.3322/canjclin.48.3.167; Brenner DR, 2012, AM J EPIDEMIOL, V176, P573, DOI 10.1093/aje/kws151; BRESLOW N, 1977, INT J CANCER, V20, P680, DOI 10.1002/ijc.2910200506; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Carter RM, 2001, DEPRESS ANXIETY, V13, P78, DOI 10.1002/da.1020; Chen YH, 2011, J AFFECT DISORDERS, V131, P200, DOI 10.1016/j.jad.2010.12.006; Chida Y, 2008, NAT CLIN PRACT ONCOL, V5, P466, DOI 10.1038/ncponc1134; Cougle JR, 2010, NICOTINE TOB RES, V12, P355, DOI 10.1093/ntr/ntq006; Farrell M, 2001, BRIT J PSYCHIAT, V179, P432, DOI 10.1192/bjp.179.5.432; Feng JY, 2012, CLIN MICROBIOL INFEC, V18, pE331, DOI 10.1111/j.1469-0691.2012.03931.x; Friedenreich CM, 2010, EUR J CANCER, V46, P2593, DOI 10.1016/j.ejca.2010.07.028; Goldacre MJ, 2007, SOC PSYCH PSYCH EPID, V42, P683, DOI 10.1007/s00127-007-0211-2; Gonzalez AV, 2011, THORAX, V66, P38, DOI 10.1136/thx.2010.141978; Gross AL, 2010, CANCER CAUSE CONTROL, V21, P191, DOI 10.1007/s10552-009-9449-1; Gudmundsson G, 2006, RESP MED, V100, P87, DOI 10.1016/j.rmed.2005.04.003; Hamer M, 2009, J PSYCHOSOM RES, V66, P255, DOI 10.1016/j.jpsychores.2008.11.002; Hankey BF, 1999, JNCI-J NATL CANCER I, V91, P1017, DOI 10.1093/jnci/91.12.1017; Haut ER, 2011, JAMA-J AM MED ASSOC, V305, P2462, DOI 10.1001/jama.2011.822; Hidalgo RB, 2012, HAND CLINIC, V106, P343, DOI 10.1016/B978-0-444-52002-9.00019-X; Hornstein Cecilia, 2004, Vertex, V15 Suppl 1, P21; Hsueh PR, 2006, J INFECTION, V52, P77, DOI 10.1016/j.jinf.2005.08.008; Jaeckle KA, 1996, PARANEOPLASTIC NEURO, P361; Kao CH, 2012, J CLIN PSYCHIAT, V73, P1264, DOI [10.4088/JCP.11m07333, 10.4088/JCP.12lr07984a]; KARNO M, 1988, ARCH GEN PSYCHIAT, V45, P1094, DOI 10.1001/archpsyc.1988.01800360042006; Kayano H, 2012, CIRC J, V76, P1670, DOI 10.1253/circj.CJ-11-1085; Kayser MS, 2010, AM J PSYCHIAT, V167, P1039, DOI 10.1176/appi.ajp.2010.09101547; KESSLER RC, 1994, ARCH GEN PSYCHIAT, V51, P8; Kruk J, 2004, CANCER DETECT PREV, V28, P399, DOI 10.1016/j.cdp.2004.07.009; Liang JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036370; Lichtermann D, 2001, ARCH GEN PSYCHIAT, V58, P573, DOI 10.1001/archpsyc.58.6.573; Lillberg K, 2003, AM J EPIDEMIOL, V157, P415, DOI 10.1093/aje/kwg002; Lin HP, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-55; Lykouras L, 2011, Psychiatriki, V22, P307; Martin RM, 2010, CANCER CAUSE CONTROL, V21, P463, DOI 10.1007/s10552-009-9477-x; MASSION AO, 1993, AM J PSYCHIAT, V150, P600; Moussas Georgios, 2008, Ann Gen Psychiatry, V7, P7, DOI 10.1186/1744-859X-7-7; Nielsen NR, 2006, NAT CLIN PRACT ONCOL, V3, P612, DOI 10.1038/ncponc0652; Ou SM, 2013, NEUROEPIDEMIOLOGY, V40, P42, DOI 10.1159/000341411; Reiche EMV, 2006, INT REV PSYCHIATR, V17, P515, DOI 10.1080/02646830500382102; Reiche EMV, 2004, LANCET ONCOL, V5, P617, DOI 10.1016/S1470-2045(04)01597-9; Rovira J, 2012, COMMUNITY MENT HLT J, V48, P372, DOI 10.1007/s10597-012-9503-4; Sabourin Brigitte C., 2011, Cognitive Behaviour Therapy, V40, P206, DOI 10.1080/16506073.2011.573572; Schraub S, 2009, REV EPIDEMIOL SANTE, V57, P113, DOI 10.1016/j.respe.2008.12.012; Schwarz S, 2007, MED KLIN, V102, P967, DOI 10.1007/s00063-007-1128-y; Sephton S, 2003, BRAIN BEHAV IMMUN, V17, P321, DOI 10.1016/S0889-1591(03)00078-3; Shikata K, 2012, CANC SCI; Sood AK, 2006, CLIN CANCER RES, V12, P369, DOI 10.1158/1078-0432.CCR-05-1698; Tseng CH, 2012, EXP DIABETES RES, DOI 10.1155/2012/101802; Wittchen HU, 2000, INT CLIN PSYCHOPHARM, V15, P319, DOI 10.1097/00004850-200015060-00002; Wittchen HU, 2002, DEPRESS ANXIETY, V16, P162, DOI 10.1002/da.10065; Yang EV, 2003, BRAIN BEHAV IMMUN, V17, pS37	53	16	16	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57399	10.1371/journal.pone.0057399	http://dx.doi.org/10.1371/journal.pone.0057399			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	098BN	23460851	Green Submitted, Green Published, gold			2022-12-25	WOS:000315519000105
J	Sanchez, S; Dupret, V; Tafforeau, P; Trinajstic, KM; Ryll, B; Gouttenoire, PJ; Wretman, L; Zylberberg, L; Peyrin, F; Ahlberg, PE				Sanchez, Sophie; Dupret, Vincent; Tafforeau, Paul; Trinajstic, Katherine M.; Ryll, Bettina; Gouttenoire, Pierre-Jean; Wretman, Lovisa; Zylberberg, Louise; Peyrin, Francoise; Ahlberg, Per E.			3D Microstructural Architecture of Muscle Attachments in Extant and Fossil Vertebrates Revealed by Synchrotron Microtomography	PLOS ONE			English	Article							LIGAMENT INSERTION; JAWED VERTEBRATES; WESTERN-AUSTRALIA; PHASE TOMOGRAPHY; TENDON ENTHESES; BONE; EVOLUTION; HISTOLOGY; PALEOHISTOLOGY; TETRAPODS	Background: Firm attachments binding muscles to skeleton are crucial mechanical components of the vertebrate body. These attachments (entheses) are complex three-dimensional structures, containing distinctive arrangements of cells and fibre systems embedded in the bone, which can be modified during ontogeny. Until recently it has only been possible to obtain 2D surface and thin section images of entheses, leaving their 3D histology largely unstudied except by extrapolation from 2D data. Entheses are frequently preserved in fossil bones, but sectioning is inappropriate for rare or unique fossil material. Methodology/Principal Findings: Here we present the first non-destructive 3D investigation, by propagation phase contrast synchrotron microtomography (PPC-SR mu CT), of enthesis histology in extant and fossil vertebrates. We are able to identify entheses in the humerus of the salamander Desmognathus from the organization of bone-cell lacunae and extrinsic fibres. Statistical analysis of the lacunae differentiates types of attachments, and the orientation of the fibres, reflect the approximate alignment of the muscle. Similar histological structures, including ontogenetically related pattern changes, are perfectly preserved in two 380 million year old fossil vertebrates, the placoderm Compagopiscis croucheri and the sarcopterygian fish Eusthenopteron foordi. Conclusions/Significance: We are able to determine the position of entheses in fossil vertebrates, the approximate orientation of the attached muscles, and aspects of their ontogenetic histories, from PPC-SRmCT data. Sub-micron microtomography thus provides a powerful tool for studying the structure, development, evolution and palaeobiology of muscle attachments.	[Sanchez, Sophie; Tafforeau, Paul; Gouttenoire, Pierre-Jean; Peyrin, Francoise] European Synchrotron Radiat Facil, F-38043 Grenoble, France; [Sanchez, Sophie; Dupret, Vincent; Ryll, Bettina; Wretman, Lovisa; Ahlberg, Per E.] Uppsala Univ, Dept Organismal Biol, Uppsala, Sweden; [Trinajstic, Katherine M.] Curtin Univ Technol, Dept Chem, Perth, WA, Australia; [Trinajstic, Katherine M.] Western Australian Museum, Dept Earth & Planetary Sci, Perth, WA 6000, Australia; [Zylberberg, Louise] Univ Paris 06, UMR 7193, CNRS, Inst Sci Terre Paris, Paris, France; [Gouttenoire, Pierre-Jean; Peyrin, Francoise] Univ Lyon, INSERM, CNRS, UMR 5220,U1044, Lyon, France	European Synchrotron Radiation Facility (ESRF); Uppsala University; Curtin University; Western Australian Museum; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National des Sciences Appliquees de Lyon - INSA Lyon	Ahlberg, PE (corresponding author), Uppsala Univ, Dept Organismal Biol, Uppsala, Sweden.	per.ahlberg@ebc.uu.se	Peyrin, Francoise/G-2823-2013; Ahlberg, Per/E-8086-2013; Sanchez, Sophie/AAE-1168-2022; Dupret, Vincent/L-2306-2015	Peyrin, Francoise/0000-0002-1988-3435; Sanchez, Sophie/0000-0002-3611-6836; Tafforeau, Paul/0000-0002-5962-1683; Ahlberg, Per/0000-0001-9054-2900; Dupret, Vincent/0000-0002-6859-1041; Trinajstic, Kate/0000-0002-6519-6396	European Synchrotron Radiation Facility (ESRF) in Grenoble, France [EC203, EC519]; ESRF; ERC [233111]; Wallenberg Scholarship from Knut och Alice Wallenbergs Stiftelse; Uppsala University; ARC QEII Fellowship;  [DP110101127]	European Synchrotron Radiation Facility (ESRF) in Grenoble, France; ESRF; ERC(European Research Council (ERC)European Commission); Wallenberg Scholarship from Knut och Alice Wallenbergs Stiftelse; Uppsala University; ARC QEII Fellowship(Australian Research Council); 	All scans were performed at the European Synchrotron Radiation Facility (ESRF) in Grenoble	Ahlberg PE, 1998, NATURE, V395, P792, DOI 10.1038/27421; ANDREWS S M, 1970, Transactions of the Royal Society of Edinburgh, V68, P207; Benjamin M, 2006, J ANAT, V208, P471, DOI 10.1111/j.1469-7580.2006.00540.x; Benjamin M, 2002, COMP BIOCHEM PHYS A, V133, P931, DOI 10.1016/S1095-6433(02)00138-1; Boyde A., 1972, BIOCH PHYSL BONE, V1, P259; Bromage TG, 2003, SCI TECHNOLOGY ED MI, P742; Bruce RC, 2002, HERPETOLOGICA, V58, P181, DOI 10.1655/0018-0831(2002)058[0181:SAOVIA]2.0.CO;2; Carr RK, 2009, J MORPHOL, V270, P775, DOI 10.1002/jmor.10719; Cloetens P, 1999, APPL PHYS LETT, V75, P2912, DOI 10.1063/1.125225; COOPER RR, 1970, J BONE JOINT SURG AM, VA 52, P1; De Ricqles AJ, 2003, J VERTEBR PALEONTOL, V23, P373, DOI 10.1671/0272-4634(2003)023[0373:OOCSTA]2.0.CO;2; Diogo R, 2009, J ANAT, V214, P694, DOI 10.1111/j.1469-7580.2009.01067.x; Doschak M. R., 2005, Journal of Musculoskeletal & Neuronal Interactions, V5, P35; Gabe M., 1968, TECHNIQUES HISTOLOGI; GARDINER BG, 1994, ZOOL J LINN SOC-LOND, V112, P443, DOI 10.1006/zjls.1994.1053; Goodwin MB, 2004, PALEOBIOLOGY, V30, P253, DOI 10.1666/0094-8373(2004)030<0253:CHOPOM>2.0.CO;2; Graham A, 1996, MOL CELL NEUROSCI, V8, P76, DOI 10.1006/mcne.1996.0046; Hems T, 2000, ANAT EMBRYOL, V202, P201, DOI 10.1007/s004290000107; Hieronymus TL, 2006, J MORPHOL, V267, P954, DOI 10.1002/jmor.10450; HUGHES DR, 1994, ANAT EMBRYOL, V190, P163; Jarvik E., 1980, BASIC STRUCTURE EVOL; Johanson Z, 2003, J VERTEBR PALEONTOL, V23, P735, DOI 10.1671/2; JONES SJ, 1974, CELL TISSUE RES, V148, P83; Kawamoto T, 1992, Kokubyo Gakkai Zasshi, V59, P351; Langer M, 2008, MED PHYS, V35, P4556, DOI 10.1118/1.2975224; Long JA, 2010, ANNU REV EARTH PL SC, V38, P255, DOI 10.1146/annurev-earth-040809-152416; Matsuoka T, 2005, NATURE, V436, P347, DOI 10.1038/nature03837; MATYAS JR, 1990, J ORTHOP RES, V8, P412, DOI 10.1002/jor.1100080313; Millot J., 1958, ANATOMIE LATIMERIA C; MOTTA PJ, 1995, J MORPHOL, V226, P309, DOI 10.1002/jmor.1052260307; Organ CL, 2011, J EVOLUTION BIOL, V24, P372, DOI 10.1111/j.1420-9101.2010.02176.x; Paganin D, 2002, J MICROSC-OXFORD, V206, P33, DOI 10.1046/j.1365-2818.2002.01010.x; Renous S, 1986, ANATOMIE PHYSL COMP, P225; Sanchez S, 2008, BIOL LETTERS, V4, P411, DOI 10.1098/rsbl.2008.0159; Sanchez S, 2012, MICROSC MICROANAL, V18, P1095, DOI 10.1017/S1431927612001079; Soda Y, 2003, ACTA ORTHOP SCAND, V74, P322, DOI 10.1080/00016470310014256; Staszyk C, 2001, EUR J MORPHOL, V39, P319, DOI 10.1076/ejom.39.5.319.7382; Suzuki D, 2002, ANN ANAT, V184, P363, DOI 10.1016/S0940-9602(02)80057-7; Tafforeau P, 2008, J HUM EVOL, V54, P272, DOI 10.1016/j.jhevol.2007.09.018; Walthall JC, 2006, ANAT REC PART A, V288A, P46, DOI 10.1002/ar.a.20279; Wilga CD, 2000, BIOL J LINN SOC, V71, P165; Witzmann Florian, 2009, Palaeodiversity, P233	42	52	54	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2013	8	2							e56992	10.1371/journal.pone.0056992	http://dx.doi.org/10.1371/journal.pone.0056992			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098PO	23468901	Green Published, gold			2022-12-25	WOS:000315561400020
J	Szasz, AM; Li, QY; Eklund, AC; Sztupinszki, Z; Rowan, A; Tokes, AM; Szekely, B; Kiss, A; Szendroi, M; Gyorffy, B; Szallasi, Z; Swanton, C; Kulka, J				Szasz, Attila Marcell; Li, Qiyuan; Eklund, Aron C.; Sztupinszki, Zsofia; Rowan, Andrew; Tokes, Anna-Maria; Szekely, Borbala; Kiss, Andras; Szendroi, Miklos; Gyorffy, Balazs; Szallasi, Zoltan; Swanton, Charles; Kulka, Janina			The CIN4 Chromosomal Instability qPCR Classifier Defines Tumor Aneuploidy and Stratifies Outcome in Grade 2 Breast Cancer	PLOS ONE			English	Article							GENE-EXPRESSION; HISTOLOGIC GRADE; GENOMIC GRADE; SURVIVAL; PROGNOSIS; SIGNATURE; DIAGNOSIS; SUBTYPES; LEVEL; INDEX	Purpose: Quantifying chromosomal instability (CIN) has both prognostic and predictive clinical utility in breast cancer. In order to establish a robust and clinically applicable gene expression-based measure of CIN, we assessed the ability of four qPCR quantified genes selected from the 70-gene Chromosomal Instability (CIN70) expression signature to stratify outcome in patients with grade 2 breast cancer. Methods: AURKA, FOXM1, TOP2A and TPX2 (CIN4), were selected from the CIN70 signature due to their high level of correlation with histological grade and mean CIN70 signature expression in silico. We assessed the ability of CIN4 to stratify outcome in an independent cohort of patients diagnosed between 1999 and 2002. 185 formalin-fixed, paraffin-embedded (FFPE) samples were included in the qPCR measurement of CIN4 expression. In parallel, ploidy status of tumors was assessed by flow cytometry. We investigated whether the categorical CIN4 score derived from the CIN4 signature was correlated with recurrence-free survival (RFS) and ploidy status in this cohort. Results: We observed a significant association of tumor proliferation, defined by Ki67 and mitotic index (MI), with both CIN4 expression and aneuploidy. The CIN4 score stratified grade 2 carcinomas into good and poor prognostic cohorts (mean RFS: 83.8+/-4.9 and 69.4+/-8.2 months, respectively, p = 0.016) and its predictive power was confirmed by multivariate analysis outperforming MI and Ki67 expression. Conclusions: The first clinically applicable qPCR derived measure of tumor aneuploidy from FFPE tissue, stratifies grade 2 tumors into good and poor prognosis groups.	[Szasz, Attila Marcell; Tokes, Anna-Maria; Szekely, Borbala; Kiss, Andras; Kulka, Janina] Semmelweis Univ, Dept Pathol 2, H-1085 Budapest, Hungary; [Li, Qiyuan; Eklund, Aron C.; Szallasi, Zoltan] Tech Univ Denmark, Dept Syst Biol, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark; [Sztupinszki, Zsofia; Gyorffy, Balazs] Semmelweis Univ, Dept Pediat 1, Hungarian Acad Sci, Res Lab Pediat & Nephrol, H-1085 Budapest, Hungary; [Rowan, Andrew; Swanton, Charles] Canc Res UK, London Res Inst, Translat Canc Therapeut Lab, London, England; [Tokes, Anna-Maria] Semmelweis Univ, Hungarian Acad Sci, MTA SE Tumour Progress Res Grp, Dept Pathol 2, H-1085 Budapest, Hungary; [Szendroi, Miklos] Semmelweis Univ, Dept Orthopaed, H-1085 Budapest, Hungary; [Szallasi, Zoltan] Harvard Univ, Sch Med, Informat Program, Childrens Hosp Boston, Boston, MA USA; [Swanton, Charles] UCL, Inst Canc, London, England; [Kulka, Janina] Buda MAV Hosp, Dept Pathol, Budapest, Hungary	Semmelweis University; Technical University of Denmark; Hungarian Academy of Sciences; Semmelweis University; Cancer Research UK; Hungarian Academy of Sciences; Semmelweis University; Semmelweis University; Harvard University; Boston Children's Hospital; Harvard Medical School; University of London; University College London	Szallasi, Z (corresponding author), Tech Univ Denmark, Dept Syst Biol, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark.	zszallasi@chip.org; Charles.Swanton@cancer.org.uk; kj@korb2.sote.hu	Kiss, András/K-5649-2017; Kulka, Janina/K-5703-2017; Gyorffy, Balazs/AAA-9135-2021; Tokes, Anna-Maria/S-5713-2017	Kiss, András/0000-0002-7453-3163; Kulka, Janina/0000-0003-1530-6646; Gyorffy, Balazs/0000-0002-5772-3766; Sztupinszki, Zsofia/0000-0002-8691-4086; Szallasi, Zoltan/0000-0001-5395-7509; Swanton, Charles/0000-0002-4299-3018; Eklund, Aron Charles/0000-0003-0861-1001; Tokes, Anna-Maria/0000-0002-9581-7536; Szasz, Attila Marcell/0000-0003-2739-4196; Kulka, Janina/0000-0001-8884-8337	Legacy of Szollos Andras Peterne; Egeszsegugyi Tudomanyos Tanacs [(ETT)-029/2009, ETT-088/2009]; Tarsadalmi Megujulas Operativ Program [(TaMOP)-4.2.1.B-09/1/KMR2010-0001, TaMOP-4.2.2/B-10/1-2010-0013]; Medical Research Council [G0701935] Funding Source: researchfish; MRC [G0701935] Funding Source: UKRI	Legacy of Szollos Andras Peterne; Egeszsegugyi Tudomanyos Tanacs; Tarsadalmi Megujulas Operativ Program; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Legacy of Szollos Andras Peterne, Egeszsegugyi Tudomanyos Tanacs (ETT)-029/2009, ETT-088/2009, Tarsadalmi Megujulas Operativ Program(TaMOP)-4.2.1.B-09/1/KMR2010-0001 and the TaMOP-4.2.2/B-10/1-2010-0013 grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakhoum SF, 2011, CLIN CANCER RES, V17, P7704, DOI 10.1158/1078-0432.CCR-11-2049; Birkbak NJ, 2011, CANCER RES, V71, P3447, DOI 10.1158/0008-5472.CAN-10-3667; Carter SL, 2006, NAT GENET, V38, P1043, DOI 10.1038/ng1861; Chassevent A, 2001, CLIN CANCER RES, V7, P909; Colleoni M, 2004, ANN ONCOL, V15, P1633, DOI 10.1093/annonc/mdh434; Dalton LW, 2000, MODERN PATHOL, V13, P730, DOI 10.1038/modpathol.3880126; Eisenberg E, 2003, TRENDS GENET, V19, P362, DOI 10.1016/S0168-9525(03)00140-9; Ellsworth RE, 2008, BREAST CANCER RES TR, V107, P259, DOI 10.1007/s10549-007-9547-2; Fiegler H, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1030; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Habermann JK, 2009, INT J CANCER, V124, P1552, DOI 10.1002/ijc.24017; Heselmeyer-Haddad K, 2002, CANCER RES, V62, P2365; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Ivshina AV, 2006, CANCER RES, V66, P10292, DOI 10.1158/0008-5472.CAN-05-4414; Lee AJX, 2011, CANCER RES, V71, P1858, DOI 10.1158/0008-5472.CAN-10-3604; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Li QY, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-474; Loi S, 2007, J CLIN ONCOL, V25, P1239, DOI 10.1200/JCO.2006.07.1522; Ma XJ, 2008, CLIN CANCER RES, V14, P2601, DOI 10.1158/1078-0432.CCR-07-5026; McClelland SE, 2009, CELL CYCLE, V8, P3262, DOI 10.4161/cc.8.20.9690; Nakamura H, 2003, CLIN CANCER RES, V9, P2294; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Reis-Filho JS, 2008, HISTOPATHOLOGY, V52, P108, DOI 10.1111/j.1365-2559.2007.02889.x; Roylance R, 2011, CANCER EPIDEM BIOMAR, V20, P2183, DOI 10.1158/1055-9965.EPI-11-0343; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; Swanton C, 2009, P NATL ACAD SCI USA, V106, P8671, DOI 10.1073/pnas.0811835106; Szabo A, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-8-r59; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Toussaint J, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-424; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967	31	24	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2013	8	2							e56707	10.1371/journal.pone.0056707	http://dx.doi.org/10.1371/journal.pone.0056707			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098PO	23468873	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000315561400014
J	Errami, Y; Brim, H; Oumouna-Benachour, K; Oumouna, M; Naura, AS; Kim, H; Ju, JH; Davis, CJ; Kim, JG; Ashktorab, H; Fallon, K; Xu, M; Zhang, JH; Del Valle, L; Boulares, AH				Errami, Youssef; Brim, Hassan; Oumouna-Benachour, Karine; Oumouna, Mustapha; Naura, Amarjit S.; Kim, Hogyoung; Ju, Jihang; Davis, Christian J.; Kim, Jong G.; Ashktorab, Hassan; Fallon, Kenneth; Xu, Ming; Zhang, Jianhua; Del Valle, Luis; Boulares, A. Hamid			ICAD Deficiency in Human Colon Cancer and Predisposition to Colon Tumorigenesis: Linkage to Apoptosis Resistance and Genomic Instability	PLOS ONE			English	Article							DNA-FRAGMENTATION FACTOR; POLY(ADP-RIBOSE) POLYMERASE PARP; CASPASE-ACTIVATED DNASE; TNF-ALPHA; TUMOR-SUPPRESSOR; EPITHELIAL-CELLS; FACTOR DFF45; EXPRESSION; ENDONUCLEASE; BUTYRATE	We previously showed that DNA fragmentation factor, which comprises a caspase-3-activated DNase (CAD) and its inhibitor (ICAD), may influence the rate of cell death by generating PARP-1-activating DNA breaks. Here we tested the hypothesis that ICAD-deficient colon epithelial cells exhibiting resistance to death stimuli may accumulate additional genetic modifications, leading to a tumorigenic phenotype. We show that ICAD deficiency may be associated with colon malignancy in humans. Indeed, an examination of ICAD expression using immunohistochemistry in an array of both colon cancer and normal tissues revealed that ICAD expression levels were severely compromised in the cancerous tissues. Upon DNA damage caused by a low dose of irradiation, ICAD cells acquire a tumorigenic phenotype. Colon epithelial cells derived from ICAD mice showed a significant resistance to death induced by the colon carcinogen dimethylhydrazine in vitro and in mice. Such resistance was associated with a decrease in PARP-1 activation. In an animal model of dimethylhydrazine-induced colon tumorigenesis, ICAD(-/-) mice developed significantly higher numbers of tumors with markedly larger sizes than the wild-type counterparts. Interestingly, the phenotype of the ICAD(-/-) mice was not associated with a significant increase in the precancerous aberrant crypt foci suggesting a potential link to tumor progression rather than initiation. More importantly, ICAD deficiency was associated with severe genomic instability as assessed by array comparative genomic hybridization. Such genomic instability consisted most prominently of amplifications but with sizable deletions as compared to the wild-type counterparts affecting several cancer-related genes including RAF-1, GSN, LMO3, and Fzd6 independently of p53. Altogether, our results present a viable case for the involvement of ICAD deficiency in colon carcinogenesis and show that apoptosis and genomic instability may comprise the means by which such deficiency may contribute to the process of increasing susceptibility to carcinogen-induced tumorigenesis.	[Errami, Youssef; Oumouna-Benachour, Karine; Oumouna, Mustapha; Naura, Amarjit S.; Kim, Hogyoung; Ju, Jihang; Davis, Christian J.; Kim, Jong G.; Del Valle, Luis; Boulares, A. Hamid] Louisiana State Univ, Stanley Scott Canc Ctr, Hlth Sci Ctr, New Orleans, LA USA; [Brim, Hassan; Ashktorab, Hassan] Howard Univ, Dept Pathol, Washington, DC 20059 USA; [Brim, Hassan; Ashktorab, Hassan] Howard Univ, Ctr Canc, Washington, DC 20059 USA; [Fallon, Kenneth; Zhang, Jianhua] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Xu, Ming] Univ Chicago, Dept Anesthesia & Crit Care, Chicago, IL 60637 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Howard University; Howard University; University of Alabama System; University of Alabama Birmingham; University of Chicago	Boulares, AH (corresponding author), Louisiana State Univ, Stanley Scott Canc Ctr, Hlth Sci Ctr, New Orleans, LA USA.	hboulr@lsuhsc.edu	Del Valle, Luis/J-4085-2015; Ashktorab, hassan/AAJ-2908-2020	Del Valle, Luis/0000-0003-3894-9206; Zhang, Jianhua/0000-0002-2128-9574; Errami, Youssef/0000-0002-0432-4331; mustapha, oumouna/0000-0001-9228-1185	American Cancer Society [RSG-116608]; National Institutes of Health [HL072889]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL072889] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in part, by grant RSG-116608 from the American Cancer Society (http://www.cancer.org/) and grant HL072889 from the National Institutes of Health (http://www.nhlbi.nih.gov/) to AHB. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel F, 2004, INT J ONCOL, V25, P1297; Abel F, 2002, BRIT J CANCER, V86, P596, DOI 10.1038/sj.bjc.6600111; An JH, 2011, BIOCHEM BIOPH RES CO, V412, P44, DOI 10.1016/j.bbrc.2011.07.034; Boulares AH, 2002, CANCER RES, V62, P4439; Boulares AH, 2002, BIOCHEM BIOPH RES CO, V290, P796, DOI 10.1006/bbrc.2001.6280; Boulares AH, 2001, J BIOL CHEM, V276, P38185; Boulares AH, 1999, J BIOL CHEM, V274, P22932, DOI 10.1074/jbc.274.33.22932; Brustmann H, 2007, PATHOL RES PRACT, V203, P65, DOI 10.1016/j.prp.2006.12.003; Brustmann H, 2006, PATHOL RES PRACT, V202, P713, DOI 10.1016/j.prp.2006.06.003; COHEN GM, 1994, J IMMUNOL, V153, P507; de Leon MP, 2001, DIGEST LIVER DIS, V33, P372; Enari M, 1998, NATURE, V391, P43, DOI 10.1038/34112; Fearon ER, 2011, ANNU REV PATHOL-MECH, V6, P479, DOI 10.1146/annurev-pathol-011110-130235; Fransen K, 2004, CARCINOGENESIS, V25, P527, DOI 10.1093/carcin/bgh049; Giardina C, 1999, BBA-MOL CELL RES, V1448, P425, DOI 10.1016/S0167-4889(98)00156-6; Golan T, 2004, J BIOL CHEM, V279, P14879, DOI 10.1074/jbc.M306421200; Guda K, 2004, ONCOGENE, V23, P3813, DOI 10.1038/sj.onc.1207489; Ha HC, 1999, P NATL ACAD SCI USA, V96, P13978, DOI 10.1073/pnas.96.24.13978; Hao XP, 2000, CANCER RES, V60, P18; He Y, 2011, ONCOGENE, V30, P1032, DOI 10.1038/onc.2010.477; Hyzd'alova M, 2008, CYTOKINE, V44, P33, DOI 10.1016/j.cyto.2008.06.003; Katoh M, 2006, INT J ONCOL, V29, P163; Konishi S, 2002, CANCER-AM CANCER SOC, V95, P2473, DOI 10.1002/cncr.10987; Koon HB, 2007, EXPERT OPIN THER TAR, V11, P955, DOI 10.1517/14728222.11.7.955; Kwong LN, 2009, ADV EXP MED BIOL, V656, P85, DOI 10.1007/978-1-4419-1145-2_8; Larsen S, 2010, BIOCHEM BIOPH RES CO, V392, P252, DOI 10.1016/j.bbrc.2009.12.010; Liu XS, 1999, J BIOL CHEM, V274, P13836, DOI 10.1074/jbc.274.20.13836; Liu XS, 1998, P NATL ACAD SCI USA, V95, P8461, DOI 10.1073/pnas.95.15.8461; Liu XS, 1997, CELL, V89, P175, DOI 10.1016/S0092-8674(00)80197-X; Migliorini D, 2011, J CLIN INVEST, V121, P1329, DOI 10.1172/JCI45784; Nagata S, 2000, EXP CELL RES, V256, P12, DOI 10.1006/excr.2000.4834; Nagata S, 2003, CELL DEATH DIFFER, V10, P108, DOI 10.1038/sj.cdd.4401161; Nambiar PR, 2003, INT J ONCOL, V22, P145; Naura AS, 2009, EUR RESPIR J, V33, P252, DOI 10.1183/09031936.00089008; NEAMATI N, 1995, J IMMUNOL, V154, P3788; Neta G, 2011, CARCINOGENESIS, V32, P1231, DOI 10.1093/carcin/bgr100; Nhan TQ, 2005, ARTERIOSCL THROM VAS, V25, P895, DOI 10.1161/01.ATV.0000159519.07181.33; Oumouna-Benachour K, 2007, MOL CARCINOGEN, V46, P993, DOI 10.1002/mc.20351; Pajak B, 2007, J PHYSIOL PHARMACOL, V58, P163; Pajak B, 2005, J Physiol Pharmacol, V56 Suppl 3, P101; Pieper AA, 1999, TRENDS PHARMACOL SCI, V20, P171, DOI 10.1016/S0165-6147(99)01292-4; Reiterer G, 2010, CELL CYCLE, V9, P3297, DOI 10.4161/cc.9.16.12631; Sakahira H, 1999, CURR BIOL, V9, P543, DOI 10.1016/S0960-9822(99)80240-1; Scaglia N, 2008, INT J ONCOL, V33, P839, DOI 10.3892/ijo_00000072; Sordet O, 2002, BLOOD, V100, P4446, DOI 10.1182/blood-2002-06-1778; Terzic J, 2010, GASTROENTEROLOGY, V138, P2101, DOI 10.1053/j.gastro.2010.01.058; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Widlak P, 2000, ACTA BIOCHIM POL, V47, P1037; Yakovlev AG, 2001, MOL MED, V7, P205, DOI 10.1007/BF03401955; Yan B, 2006, ONCOGENE, V25, P5370, DOI 10.1038/sj.onc.1209535; Yan B, 2006, P NATL ACAD SCI USA, V103, P1504, DOI 10.1073/pnas.0507779103; Yan B, 2006, BRIT J CANCER, V95, P1696, DOI 10.1038/sj.bjc.6603484; Zhang JH, 1999, J BIOL CHEM, V274, P37450, DOI 10.1074/jbc.274.52.37450; Zhang JH, 2000, BIOCHEM BIOPH RES CO, V274, P225, DOI 10.1006/bbrc.2000.3122	54	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e57871	10.1371/journal.pone.0057871	http://dx.doi.org/10.1371/journal.pone.0057871			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451280	Green Published, gold, Green Submitted			2022-12-25	WOS:000316658800120
J	March, C; Cano, V; Moranta, D; Llobet, E; Perez-Gutierrez, C; Tomas, JM; Suarez, T; Garmendia, J; Bengoechea, JA				March, Catalina; Cano, Victoria; Moranta, David; Llobet, Enrique; Perez-Gutierrez, Camino; Tomas, Juan M.; Suarez, Teresa; Garmendia, Junkal; Bengoechea, Jose A.			Role of Bacterial Surface Structures on the Interaction of Klebsiella pneumoniae with Phagocytes	PLOS ONE			English	Article							ANTIMICROBIAL PEPTIDE RESISTANCE; O SIDE-CHAIN; DICTYOSTELIUM-DISCOIDEUM; CAPSULAR POLYSACCHARIDE; CORE LIPOPOLYSACCHARIDE; ALVEOLAR MACROPHAGES; HOST MODEL; OUTER-CORE; LIPID-A; VIRULENCE	Phagocytosis is a key process of the immune system. The human pathogen Klebsiella pneumoniae is a well known example of a pathogen highly resistant to phagocytosis. A wealth of evidence demonstrates that the capsule polysaccharide (CPS) plays a crucial role in resistance to phagocytosis. The amoeba Dictyostelium discoideum shares with mammalian macrophages the ability to phagocytose and kill bacteria. The fact that K. pneumoniae is ubiquitous in nature and, therefore, should avoid predation by amoebae, poses the question whether K. pneumoniae employs similar means to counteract amoebae and mammalian phagocytes. Here we developed an assay to evaluate K. pneumoniae-D. discoideum interaction. The richness of the growth medium affected the threshold at which the cps mutant was permissive for Dictyostelium and only at lower nutrient concentrations the cps mutant was susceptible to predation by amoebae. Given the critical role of bacterial surface elements on host-pathogen interactions, we explored the possible contribution of the lipopolysaccharide (LPS) and outer membrane proteins (OMPs) to combat phagoyctosis by D. discoideum. We uncover that, in addition to the CPS, the LPS O-polysaccharide and the first core sugar participate in Klebsiella resistance to predation by D. discoideum. K. pneumoniae LPS lipid A decorations are also necessary to avoid predation by amoebae although PagP-dependent palmitoylation plays a more important role than the lipid A modification with aminoarabinose. Mutants lacking OMPs OmpA or OmpK36 were also permissive for D. discoideium growth. Except the LPS O-polysaccharide mutants, all mutants were more susceptible to phagocytosis by mouse alveolar macrophages. Finally, we found a correlation between virulence, using the pneumonia mouse model, and resistance to phagocytosis. Altogether, this work reveals novel K. pneumoniae determinants involved in resistance to phagocytosis and supports the notion that Dictyostelium amoebae might be useful as host model to measure K. pneumoniae virulence and not only phagocytosis.	[March, Catalina; Cano, Victoria; Moranta, David; Llobet, Enrique; Perez-Gutierrez, Camino; Garmendia, Junkal; Bengoechea, Jose A.] Fundacio Invest Sanitaria Illes Balears FISIB, Lab Microbial Pathogenesis, Bunyola, Spain; [March, Catalina; Cano, Victoria; Moranta, David; Llobet, Enrique; Perez-Gutierrez, Camino; Garmendia, Junkal; Bengoechea, Jose A.] Ctr Invest Biomed Red Enfermedades Resp CibeRes, Program Host Pathogen Interact, Bunyola, Spain; [Tomas, Juan M.] Univ Barcelona, Fac Biol, Dept Microbiol, Barcelona, Spain; [Suarez, Teresa] Ctr Invest Biol CSIC, Dept Med Celular & Mol, Madrid, Spain; [Garmendia, Junkal] CSIC Univ Publ Navarra Gobierno Navarra, Inst Agrobiotecnol, Mutilva, Spain; [Bengoechea, Jose A.] CSIC, Madrid, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERES; University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-GN-UPNA - Instituto de Agrobiotecnologia (IDAB); Universidad Publica de Navarra; Consejo Superior de Investigaciones Cientificas (CSIC)	Bengoechea, JA (corresponding author), Fundacio Invest Sanitaria Illes Balears FISIB, Lab Microbial Pathogenesis, Bunyola, Spain.	bengoechea@caubet-cimera.es	Cano, Victoria/GRO-4093-2022; Tomas, Juan M/L-1398-2015; Cano García, Victoria/E-1861-2017; Garmendia, Juncal/G-4360-2011; Suarez, Teresa/M-9126-2016; Mesquida, David Moranta/H-4958-2012	Tomas, Juan M/0000-0002-3575-7113; Cano García, Victoria/0000-0002-2537-4063; Garmendia, Juncal/0000-0002-7440-2737; Suarez, Teresa/0000-0002-4553-3818; Mesquida, David Moranta/0000-0001-9528-4920; Bengoechea, Jose/0000-0002-9677-8751	Ministerio de Economia y Competitividad (Spain); Generalitat de Catalunya (Centre de Referencia en Biotecnologia); Biomedicine Program [SAF2009-07885]; SEPAR (Sociedad Espanola de Neumologia) [068/2011]; Govern Illes Balears [46/2011]; European Regional Development Fund	Ministerio de Economia y Competitividad (Spain); Generalitat de Catalunya (Centre de Referencia en Biotecnologia)(Generalitat de Catalunya); Biomedicine Program; SEPAR (Sociedad Espanola de Neumologia); Govern Illes Balears; European Regional Development Fund(European Commission)	Part of this work was supported by Ministerio de Economia y Competitividad (Spain) and from Generalitat de Catalunya (Centre de Referencia en Biotecnologia) grants to J.M.T.; by grants from Biomedicine Program (SAF2009-07885; Ministerio de Economia y Competitividad) and SEPAR (Sociedad Espanola de Neumologia, project reference 068/2011) to J.A.B. The laboratory of Microbial Pathogenesis is supported by a grant to Competitive groups (project reference 46/2011) from Govern Illes Balears (co-funded by European Regional Development Fund). CIBERES is an initiative from Instituto de Salud Carlos III. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez D, 2000, INFECT IMMUN, V68, P953, DOI 10.1128/IAI.68.2.953-955.2000; APPLEYARD RK, 1954, GENETICS, V39, P440; BAGLEY ST, 1985, INFECT CONT HOSP EP, V6, P52, DOI 10.1017/S0195941700062603; Benghezal M, 2006, CELL MICROBIOL, V8, P139, DOI 10.1111/j.1462-5822.2005.00607.x; Bozzaro S, 2008, INT REV CEL MOL BIO, V271, P253, DOI 10.1016/S1937-6448(08)01206-9; BrougHolub E, 1997, INFECT IMMUN, V65, P1139, DOI 10.1128/IAI.65.4.1139-1146.1997; CAMPRUBI S, 1993, FEMS MICROBIOL LETT, V111, P9; Cardelli J, 2001, TRAFFIC, V2, P311, DOI 10.1034/j.1600-0854.2001.002005311.x; Cheung DOY, 2000, INFECT IMMUN, V68, P4585, DOI 10.1128/IAI.68.8.4585-4592.2000; Choi KH, 2005, NAT METHODS, V2, P443, DOI 10.1038/NMETH765; Cortes G, 2002, INFECT IMMUN, V70, P2583, DOI 10.1128/IAI.70.5.2583-2590.2002; Cosson P, 2008, CURR OPIN MICROBIOL, V11, P271, DOI 10.1016/j.mib.2008.05.005; de Astorza B, 2004, INFECT IMMUN, V72, P1767, DOI 10.1128/IAI.72.3.1767-1774.2004; Dennis JJ, 1998, APPL ENVIRON MICROB, V64, P2710; Eichinger L, 2005, NATURE, V435, P43, DOI 10.1038/nature03481; Evrard B, 2010, INFECT IMMUN, V78, P210, DOI 10.1128/IAI.00864-09; Fischer M, 2004, FEBS LETT, V577, P227, DOI 10.1016/j.febslet.2004.09.084; Fresno S, 2006, MICROBIOL-SGM, V152, P1807, DOI 10.1099/mic.0.28611-0; Froquet R, 2007, APPL ENVIRON MICROB, V73, P5657, DOI 10.1128/AEM.00908-07; Froquet R, 2009, NAT PROTOC, V4, P25, DOI 10.1038/nprot.2008.212; Gunn JS, 2000, INFECT IMMUN, V68, P6139, DOI 10.1128/IAI.68.11.6139-6146.2000; Gunn JS, 1998, MOL MICROBIOL, V27, P1171, DOI 10.1046/j.1365-2958.1998.00757.x; Guo L, 1998, CELL, V95, P189, DOI 10.1016/S0092-8674(00)81750-X; Hansen DS, 1999, J CLIN MICROBIOL, V37, P56, DOI 10.1128/JCM.37.1.56-62.1999; Hernandez-Alles S, 1999, MICROBIOL-UK, V145, P673, DOI 10.1099/13500872-145-3-673; Hilbi H, 2007, ENVIRON MICROBIOL, V9, P563, DOI 10.1111/j.1462-2920.2007.01238.x; Hsieh PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033155; Izquierdo L, 2003, J BACTERIOL, V185, P7213, DOI 10.1128/JB.185.24.7213-7221.2003; KABHA K, 1995, INFECT IMMUN, V63, P847, DOI 10.1128/IAI.63.3.847-852.1995; Lawlor MS, 2005, MOL MICROBIOL, V58, P1054, DOI 10.1111/j.1365-2958.2005.04918.x; Lee H, 2004, J BACTERIOL, V186, P4124, DOI 10.1128/JB.186.13.4124-4133.2004; Lelong E, 2011, CELL MICROBIOL, V13, P246, DOI 10.1111/j.1462-5822.2010.01532.x; Lin J, 2002, MICROBES INFECT, V4, P325, DOI 10.1016/S1286-4579(02)01545-9; Lin JC, 2004, MICROBES INFECT, V6, P1191, DOI 10.1016/j.micinf.2004.06.003; Link AJ, 1997, J BACTERIOL, V179, P6228, DOI 10.1128/jb.179.20.6228-6237.1997; Llobet E, 2008, MICROBIOL-SGM, V154, P3877, DOI 10.1099/mic.0.2008/022301-0; Llobet E, 2011, INFECT IMMUN, V79, P3718, DOI 10.1128/IAI.05226-11; Llobet E, 2009, ANTIMICROB AGENTS CH, V53, P298, DOI 10.1128/AAC.00657-08; Lugo JZ, 2007, SHOCK, V27, P186, DOI 10.1097/01.shk.0000238058.23837.21; March C, 2011, J BIOL CHEM, V286, P9956, DOI 10.1074/jbc.M110.181008; Marolda Cristina L., 2006, V347, P237; Marti-Lliteras P, 2009, INFECT IMMUN; Moranta D, 2010, INFECT IMMUN, V78, P1135, DOI 10.1128/IAI.00940-09; NASSIF X, 1989, INFECT IMMUN, V57, P546, DOI 10.1128/IAI.57.2.546-552.1989; Nizet V, 2006, CURR ISSUES MOL BIOL, V8, P11; Nordmann P, 2009, LANCET INFECT DIS, V9, P228, DOI 10.1016/S1473-3099(09)70054-4; Pan YJ, 2011, INFECT IMMUN, V79, P997, DOI 10.1128/IAI.00906-10; Perez-Gutierrez C, 2010, INFECT IMMUN, V78, P2768, DOI 10.1128/IAI.01417-09; Pukatzki S, 2006, P NATL ACAD SCI USA, V103, P1528, DOI 10.1073/pnas.0510322103; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; Ravanel K, 2001, EUR J CELL BIOL, V80, P754, DOI 10.1078/0171-9335-00215; Regue M, 2005, J BACTERIOL, V187, P4198, DOI 10.1128/JB.187.12.4198-4206.2005; Regue M, 2001, J BACTERIOL, V183, P3564, DOI 10.1128/JB.183.12.3564-3573.2001; Regueiro V, 2006, MICROBIOL-SGM, V152, P555, DOI 10.1099/mic.0.28285-0; Robey M, 2001, INFECT IMMUN, V69, P4276, DOI 10.1128/IAI.69.7.4276-4286.2001; Sahly H, 1997, CLIN DIAGN LAB IMMUN, V4, P393, DOI 10.1128/CDLI.4.4.393-399.1997; Shankar-Sinha S, 2004, INFECT IMMUN, V72, P1423, DOI 10.1128/IAI.72.3.1423-1430.2004; Skurnik M, 1999, MOL MICROBIOL, V31, P1443, DOI 10.1046/j.1365-2958.1999.01285.x; Smith SGJ, 2007, FEMS MICROBIOL LETT, V273, P1, DOI 10.1111/j.1574-6968.2007.00778.x; Struve C, 2004, ENVIRON MICROBIOL, V6, P584, DOI 10.1111/j.1462-2920.2004.00590.x; SUSSMAN R, 1967, BIOCHEM BIOPH RES CO, V29, P53, DOI 10.1016/0006-291X(67)90539-6; Valdivia RH, 1996, MOL MICROBIOL, V22, P367, DOI 10.1046/j.1365-2958.1996.00120.x; Valdivia RH, 1997, SCIENCE, V277, P2007, DOI 10.1126/science.277.5334.2007	63	85	87	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56847	10.1371/journal.pone.0056847	http://dx.doi.org/10.1371/journal.pone.0056847			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457627	Green Published, Green Submitted, gold			2022-12-25	WOS:000315603700088
J	Song, XC; Sturgis, EM; Liu, J; Jin, L; Wang, ZQ; Zhang, CY; Wei, QY; Li, GJ				Song, Xicheng; Sturgis, Erich M.; Liu, Jun; Jin, Lei; Wang, Zhongqiu; Zhang, Caiyun; Wei, Qingyi; Li, Guojun			MicroRNA Variants Increase the Risk of HPV-Associated Squamous Cell Carcinoma of the Oropharynx in Never Smokers	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS TYPE-16; NECK-CANCER; ORAL-CANCER; EXPRESSION PROFILES; ANIMAL DEVELOPMENT; GENETIC-VARIANTS; UNITED-STATES; HEAD; PROGNOSIS; TRENDS	Background: Both microRNAs and human papillomavirus (HPV) infection play an important role in the development and progression of oral squamous cell carcinoma (OSCC). In addition, microRNAs affect all facets of the immune/inflammation responses to infection, which may control HPV clearance. We thus hypothesized that microRNA polymorphisms modify the association between HPV16 seropositivity and OSCC risk. Methods: Four single-nucleotide polymorphisms in microRNAs were genotyped and HPV16 serology was determined in 325 cases and 335 matched controls. Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated using univariate and multivariable logistic regression models. Results: Overall, each polymorphism had no significant main effect on OSCC risk. Compared with the risk among individuals with both miR146 rs2910164 GG genotype and HPV16 seronegativity, risk of OSCC was increased among those with CG or CC genotype and HPV16 seronegativity (OR, 1.2; 95% CI, 0.9-1.8), GG genotype and HPV16 seropositivity (OR, 3.0; 95% CI, 1.8-5.0), and CG or CC genotype and HPV16 seropositivity (OR, 4.7; 95% CI, 2.3-9.4). Similar results were found for miR149 rs2292832, miR196 rs11614913, and miR499 rs3746444. Analyses stratified by tumor sites and smoking status showed that each polymorphism significantly increased the risk of HPV16-associated squamous cell carcinoma of the oropharynx (SCCOP), and such effect modification was particularly prominent in never smokers. Conclusions: Our results indicate that microRNA polymorphisms modify the risk of OSCC associated with HPV16 seropositivity, particularly in patients with SCCOP and never smokers. Larger studies are needed to verify our findings.	[Song, Xicheng; Sturgis, Erich M.; Liu, Jun; Jin, Lei; Wang, Zhongqiu; Li, Guojun] Univ Texas MD Anderson Canc Ctr, Dept Head & Neck Surg, Houston, TX 77030 USA; [Song, Xicheng] Qingdao Univ, Yuhuangding Hosp, Dept Otorhinolaryngol & Head & Neck Surg, Yantai, Peoples R China; [Sturgis, Erich M.; Wei, Qingyi; Li, Guojun] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Liu, Jun] Sichuan Univ, Dept Otolaryngol Head & Neck Surg, West China Hosp, Chengdu 610064, Peoples R China; [Jin, Lei] Southern Med Univ, Sch Med, Jinling Hosp, Dept Stomatol, Nanjing, Jiangsu, Peoples R China; [Wang, Zhongqiu] Tongji Univ, East Hosp, Sch Med, Dept Radiol, Shanghai 200092, Peoples R China; [Zhang, Caiyun] Second Mil Med Univ, Changhai Hosp, Dept Otorhinolaryngol Head & Neck Surg, Shanghai, Peoples R China	University of Texas System; UTMD Anderson Cancer Center; Qingdao University; University of Texas System; UTMD Anderson Cancer Center; Sichuan University; Southern Medical University - China; Tongji University; Naval Medical University	Li, GJ (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Head & Neck Surg, Houston, TX 77030 USA.	gli@mdanderson.org			National Institute of Environmental Health Sciences [R01 ES-11740]; National Institutes of Health (NIH) [P-30 CA 16672]; NIH [CA 135679, CA133099]; NATIONAL CANCER INSTITUTE [R03CA135679, K07CA133099, P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES011740] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the National Institute of Environmental Health Sciences Grant R01 ES-11740 (to Q. W.); National Institutes of Health (NIH) Grant P-30 CA 16672 (to the University of Texas M. D. Anderson Cancer Center); and NIH grants CA 135679 (to G. L.) and CA133099 (to G. L.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Bloomston M, 2007, JAMA-J AM MED ASSOC, V297, P1901, DOI 10.1001/jama.297.17.1901; Carvalho AL, 2005, INT J CANCER, V114, P806, DOI 10.1002/ijc.20740; Chang SS, 2008, INT J CANCER, V123, P2791, DOI 10.1002/ijc.23831; Chaturvedi AK, 2008, J CLIN ONCOL, V26, P612, DOI 10.1200/JCO.2007.14.1713; Chen XM, 2010, CANCER RES, V70, P7199, DOI 10.1158/0008-5472.CAN-09-4733; Christensen BC, 2010, CLIN CANCER RES, V16, P3713, DOI 10.1158/1078-0432.CCR-10-0657; Dahlstrom KR, 2003, CLIN CANCER RES, V9, P2620; Ernster JA, 2007, LARYNGOSCOPE, V117, P2115, DOI 10.1097/MLG.0b013e31813e5fbb; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fakhry C, 2006, J CLIN ONCOL, V24, P2606, DOI 10.1200/JCO.2006.06.1291; Gillison ML, 2007, HEAD NECK-J SCI SPEC, V29, P779, DOI 10.1002/hed.20573; Gillison ML, 2000, JNCI-J NATL CANCER I, V92, P709, DOI 10.1093/jnci/92.9.709; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Guo Y, 2012, ONCOL REP, V27, P1097, DOI 10.3892/or.2011.1571; Hebert C, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-5; Henson BJ, 2009, GENE CHROMOSOME CANC, V48, P569, DOI 10.1002/gcc.20666; Herrero R, 2003, JNCI-J NATL CANCER I, V95, P1772, DOI [10.1093/jnci/djg/107, 10.1093/jnci/djg107]; Hu ZB, 2008, J CLIN INVEST, V118, P2600, DOI 10.1172/JCI34934; Hu ZB, 2009, HUM MUTAT, V30, P79, DOI 10.1002/humu.20837; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Jazdzewski K, 2008, P NATL ACAD SCI USA, V105, P7269, DOI 10.1073/pnas.0802682105; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; KIRNBAUER R, 1994, JNCI-J NATL CANCER I, V86, P494, DOI 10.1093/jnci/86.7.494; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Kozaki KI, 2008, CANCER RES, V68, P2094, DOI 10.1158/0008-5472.CAN-07-5194; Lindsay MA, 2008, TRENDS IMMUNOL, V29, P343, DOI 10.1016/j.coph.2009.05.003; Liu XQ, 2009, COMP FUNCT GENOM, DOI 10.1155/2009/837514; Liu ZS, 2010, CANCER-AM CANCER SOC, V116, P4753, DOI 10.1002/cncr.25323; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Osada H, 2007, CARCINOGENESIS, V28, P2, DOI 10.1093/carcin/bgl185; Pedersen I, 2008, CYTOKINE, V43, P391, DOI 10.1016/j.cyto.2008.07.016; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Sonkoly E, 2008, SEMIN CANCER BIOL, V18, P131, DOI 10.1016/j.semcancer.2008.01.005; Sonkoly E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000610; Stefani G, 2008, NAT REV MOL CELL BIO, V9, P219, DOI 10.1038/nrm2347; Sturgis EM, 2007, CANCER-AM CANCER SOC, V110, P1429, DOI 10.1002/cncr.22963; Tran N, 2007, BIOCHEM BIOPH RES CO, V358, P12, DOI 10.1016/j.bbrc.2007.03.201; VOKES EE, 1993, NEW ENGL J MED, V328, P184, DOI 10.1056/NEJM199301213280306; Wong TS, 2008, CLIN CANCER RES, V14, P2588, DOI 10.1158/1078-0432.CCR-07-0666; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025	42	24	24	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56622	10.1371/journal.pone.0056622	http://dx.doi.org/10.1371/journal.pone.0056622			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457596	Green Submitted, gold, Green Published			2022-12-25	WOS:000315603700069
J	Bejugam, PR; Kuppili, RR; Singh, N; Gadewal, N; Chaganti, LK; Sastry, GM; Bose, K				Bejugam, Pruthvi Raj; Kuppili, Raja R.; Singh, Nitu; Gadewal, Nikhil; Chaganti, Lalith K.; Sastry, G. Madhavi; Bose, Kakoli			Allosteric Regulation of Serine Protease HtrA2 through Novel Non-Canonical Substrate Binding Pocket	PLOS ONE			English	Article							PROMOTES CELL-DEATH; PDZ DOMAINS; FUNCTIONAL-ANALYSIS; ACCURATE DOCKING; GLIDE; SPECIFICITY; ACTIVATION; INHIBITOR; APOPTOSIS; PROTEINS	HtrA2, a trimeric proapoptotic serine protease is involved in several diseases including cancer and neurodegenerative disorders. Its unique ability to mediate apoptosis via multiple pathways makes it an important therapeutic target. In HtrA2, C-terminal PDZ domain upon substrate binding regulates its functions through coordinated conformational changes the mechanism of which is yet to be elucidated. Although allostery has been found in some of its homologs, it has not been characterized in HtrA2 so far. Here, with an in silico and biochemical approach we have shown that allostery does regulate HtrA2 activity. Our studies identified a novel non-canonical selective binding pocket in HtrA2 which initiates signal propagation to the distal active site through a complex allosteric mechanism. This non-classical binding pocket is unique among HtrA family proteins and thus unfolds a novel mechanism of regulation of HtrA2 activity and hence apoptosis.	[Bejugam, Pruthvi Raj; Kuppili, Raja R.; Singh, Nitu; Gadewal, Nikhil; Chaganti, Lalith K.; Bose, Kakoli] Tata Mem Hosp, ACTREC, Kharghar, Navi Mumbai, India; [Sastry, G. Madhavi] Schrodinger, Hyderabad, Andhra Pradesh, India	Tata Memorial Centre (TMC); Advance Centre for Treatment, Research & Education in Cancer (ACTREC); Tata Memorial Hospital	Bose, K (corresponding author), Tata Mem Hosp, ACTREC, Kharghar, Navi Mumbai, India.	kbose@actrec.gov.in	Bejugam, Pruthvi raj/AAU-1244-2020; Gadewal, Nikhil/ABA-2942-2020	Bejugam, Pruthvi raj/0000-0002-0802-9153; Gadewal, Nikhil/0000-0003-3552-0703	Department of Biotechnology (DBT), Govt. of India	Department of Biotechnology (DBT), Govt. of India(Department of Biotechnology (DBT) India)	The project was funded by a grant provided by Department of Biotechnology (DBT), Govt. of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Beuming T, 2009, PROTEIN SCI, V18, P1609, DOI 10.1002/pro.177; Bowers K.J., 2006, P ACM IEEE C SUP SC0, DOI 10.1109/SC.2006.54; Christopoulos A, 2004, BIOCHEM SOC T, V32, P873, DOI 10.1042/BST0320873; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Feng W, 2002, J BIOL CHEM, V277, P41140, DOI 10.1074/jbc.M207206200; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o; Halgren TA, 2004, J MED CHEM, V47, P1750, DOI 10.1021/jm030644s; Halgren T, 2007, CHEM BIOL DRUG DES, V69, P146, DOI 10.1111/j.1747-0285.2007.00483.x; HUMPHREYS DD, 1994, J PHYS CHEM-US, V98, P6885, DOI 10.1021/j100078a035; Hung AY, 2002, J BIOL CHEM, V277, P5699, DOI 10.1074/jbc.R100065200; Ibrahim Azza Mostafa, 2012, Lab Hematol, V18, P1, DOI 10.1532/LH96.09013; Jelen F, 2003, ACTA BIOCHIM POL, V50, P985; Johnson F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007100; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kooistra J, 2009, J ALZHEIMERS DIS, V17, P281, DOI 10.3233/JAD-2009-1037; KRAUT J, 1977, ANNU REV BIOCHEM, V46, P331, DOI 10.1146/annurev.bi.46.070177.001555; Li WY, 2002, NAT STRUCT BIOL, V9, P436, DOI 10.1038/nsb795; Lin CB, 2011, J APPL PHYS, V110, DOI 10.1063/1.3606513; Ma BY, 2011, STRUCTURE, V19, P907, DOI 10.1016/j.str.2011.06.002; Ma SC, 2007, SCI CHINA SER C, V50, P412, DOI 10.1007/s11427-007-0037-x; Martins LM, 2002, J BIOL CHEM, V277, P439, DOI 10.1074/jbc.M109784200; Martins LM, 2003, J BIOL CHEM, V278, P49417, DOI 10.1074/jbc.M308659200; MARTYNA GJ, 1994, J CHEM PHYS, V101, P4177, DOI 10.1063/1.467468; May LT, 2007, ANNU REV PHARMACOL, V47, P1, DOI 10.1146/annurev.pharmtox.47.120505.105159; MAZAT JP, 1976, BIOCHEMISTRY-US, V15, P4053, DOI 10.1021/bi00663a021; Merdanovic M, 2010, NAT STRUCT MOL BIOL, V17, P837, DOI 10.1038/nsmb.1839; Nagata M, 2011, BRIT J CANCER, V105, P1322, DOI 10.1038/bjc.2011.387; Nallamsetty S, 2004, PROTEIN EXPRES PURIF, V38, P108, DOI 10.1016/j.pep.2004.08.016; Nam MK, 2006, EXP MOL MED, V38, P36, DOI 10.1038/emm.2006.5; Navakanit Ruxapon, 2007, Journal of the Medical Association of Thailand, V90, P2416; Runyon ST, 2007, PROTEIN SCI, V16, P2454, DOI 10.1110/ps.073049407; Savopoulos JW, 2000, PROTEIN EXPRES PURIF, V19, P227, DOI 10.1006/prep.2000.1240; Sherman W, 2006, J MED CHEM, V49, P534, DOI 10.1021/jm050540c; Singh N, 2011, ARCH BIOCHEM BIOPHYS, V516, P85, DOI 10.1016/j.abb.2011.10.007; Sohn J, 2010, J BIOL CHEM, V285, P34039, DOI 10.1074/jbc.M110.135541; Sohn J, 2009, MOL CELL, V33, P64, DOI 10.1016/j.molcel.2008.12.017; Sugiyama H, 1998, LEUKEMIA LYMPHOMA, V30, P55, DOI 10.3109/10428199809050929; Suzuki Y, 2004, CELL DEATH DIFFER, V11, P208, DOI 10.1038/sj.cdd.4401343; Trencia A, 2004, J BIOL CHEM, V279, P46566, DOI 10.1074/jbc.M406317200; TWINING SS, 1984, ANAL BIOCHEM, V143, P30, DOI 10.1016/0003-2697(84)90553-0; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Verhagen AM, 2002, J BIOL CHEM, V277, P445, DOI 10.1074/jbc.M109891200; Zeng J, 1999, PROTEIN ENG, V12, P457, DOI 10.1093/protein/12.6.457	46	29	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e55416	10.1371/journal.pone.0055416	http://dx.doi.org/10.1371/journal.pone.0055416			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457469	Green Published, gold, Green Submitted			2022-12-25	WOS:000315602700017
J	Fields, J; Cisneros, IE; Borgmann, K; Ghorpade, A				Fields, Jerel; Cisneros, Irma E.; Borgmann, Kathleen; Ghorpade, Anuja			Extracellular Regulated Kinase 1/2 Signaling Is a Critical Regulator of Interleukin-1 beta-Mediated Astrocyte Tissue Inhibitor of Metalloproteinase-1 Expression	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; MATRIX-METALLOPROTEINASE; DOWN-REGULATION; TUMOR-GROWTH; TGF-BETA; TIMP-1; BRAIN; GENE; PHOSPHORYLATION; CONTRIBUTES	Astrocytes are essential for proper central nervous system (CNS) function and are intricately involved in neuroinflammation. Despite evidence that immune-activated astrocytes contribute to many CNS pathologies, little is known about the inflammatory pathways controlling gene expression. Our laboratory identified altered levels of tissue inhibitor of metalloproteinase (TIMP)-1 in brain lysates from human immunodeficiency virus (HIV)-1 infected patients, compared to age-matched controls, and interleukin (IL)-1 beta as a key regulator of astrocyte TIMP-1. Additionally, CCAAT enhancer binding protein (C/EBP)beta levels are elevated in brain specimens from HIV-1 patients and the transcription factor contributes to astrocyte TIMP-1 expression. In this report we sought to identify key signaling pathways necessary for IL-1 beta-mediated astrocyte TIMP-1 expression and their interaction with C/EBP beta. Primary human astrocytes were cultured and treated with mitogen activated protein kinase-selective small molecule inhibitors, and IL-1 beta. TIMP-1 and C/EBP beta mRNA and protein expression were evaluated at 12 and 24 h post-treatment, respectively. TIMP-1 promoter-driven luciferase plasmids were used to evaluate TIMP-1 promoter activity in inhibitor-treated astrocytes. These data show that extracellular regulated kinase (ERK) 1/2-selective inhibitors block IL-1 beta-induced astrocyte TIMP-1 expression, but did not decrease C/EBP beta expression in parallel. The p38 kinase (p38K) inhibitors partially blocked both IL-1 beta-induced astrocyte TIMP-1 expression and C/EBP beta expression. The ERK1/2-selective inhibitor abrogated IL-1 beta-mediated increases in TIMP-1 promoter activity. Our data demonstrate that ERK1/2 activation is critical for IL-1 beta-mediated astrocyte TIMP-1 expression. ERK1/2-selective inhibition may elicit a compensatory response in the form of enhanced IL-1 beta-mediated astrocyte C/EBP beta expression, or, alternatively, ERK1/2 signaling may function to moderate IL-1 beta-mediated astrocyte C/EBP beta expression. Furthermore, p38K activation contributes to IL-1 beta-induced astrocyte TIMP-1 and C/EBP beta expression. These data suggest that ERK1/2 signals downstream of C/EBP beta to facilitate IL-1 beta-induced astrocyte TIMP-1 expression. Astrocyte ERK1/2 and p38K signaling may serve as therapeutic targets for manipulating CNS TIMP-1 and C/EBP beta levels, respectively.	[Fields, Jerel; Cisneros, Irma E.; Borgmann, Kathleen; Ghorpade, Anuja] Univ N Texas, Hlth Sci Ctr, Dept Cell Biol & Anat, Ft Worth, TX USA	University of North Texas System; University of North Texas Health Science Center	Ghorpade, A (corresponding author), Univ N Texas, Hlth Sci Ctr, Dept Cell Biol & Anat, Ft Worth, TX USA.	anuja.ghorpade@unthsc.edu	Borgmann, Kathleen/ABU-3329-2022	Borgmann, Kathleen/0000-0003-0897-390X	National Institute of Neurological Disorders and Stroke (NINDS) [2R01NS048837]; National Institute on Aging (NIA) [T32 AG020494, 1F31NS072006-01A1]; National Institutes of Health from the Eunice Kennedy Shriver National Institute of Child Health & Human Development [5R24HD0008836]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048837, F31NS072006] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG020494] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institutes of Health from the Eunice Kennedy Shriver National Institute of Child Health & Human Development; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by 2R01NS048837 from National Institute of Neurological Disorders and Stroke (NINDS) to A. Ghorpade; a fellowship from National Institute on Aging (NIA) T32 AG020494 and 1F31NS072006-01A1 to J. Fields. The authors appreciate the assistance of the Laboratory of Developmental Biology for providing them with human brain tissues; also supported by National Institutes of Health award number 5R24HD0008836 from the Eunice Kennedy Shriver National Institute of Child Health & Human Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araque A, 1999, CAN J PHYSIOL PHARM, V77, P699, DOI 10.1139/cjpp-77-9-699; ARTHUR FE, 1987, DEV BRAIN RES, V36, P155, DOI 10.1016/0165-3806(87)90075-7; Aschner M, 1998, TOXICOL LETT, V103, P283, DOI 10.1016/S0378-4274(98)00324-5; Ashutosh, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.54; Barter MJ, 2010, MATRIX BIOL, V29, P602, DOI 10.1016/j.matbio.2010.05.002; Bloomston M, 2002, J SURG RES, V102, P39, DOI 10.1006/jsre.2001.6318; BLUMBERG BM, 1994, VIRUS RES, V32, P253, DOI 10.1016/0168-1702(94)90044-2; Boisse L, 2008, NEUROL CLIN, V26, P799, DOI 10.1016/j.ncl.2008.04.002; Bugno M, 1999, FEBS LETT, V448, P9, DOI 10.1016/S0014-5793(99)00323-3; Chen XM, 2002, KIDNEY INT, V61, P1377, DOI 10.1046/j.1523-1755.2002.00283.x; Ferrari CC, 2006, NEUROBIOL DIS, V24, P183, DOI 10.1016/j.nbd.2006.06.013; Clark IM, 1997, BIOCHEM J, V324, P611, DOI 10.1042/bj3240611; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Dhar A, 2006, J NEUROSCI RES, V83, P1271, DOI 10.1002/jnr.20787; Dou H, 2006, GLIA; Ferrari CC, 2004, AM J PATHOL, V165, P1827, DOI 10.1016/S0002-9440(10)63438-4; Fields J, 2011, J NEUROCHEM, V118, P93, DOI 10.1111/j.1471-4159.2011.07203.x; Friday BB, 2008, CLIN CANCER RES, V14, P342, DOI 10.1158/1078-0432.CCR-07-4790; Fu ZY, 2011, BIOMED PHARMACOTHER, V65, P163, DOI 10.1016/j.biopha.2011.02.004; Gardner J, 2003, J NEUROSCI RES, V74, P801, DOI 10.1002/jnr.10835; Gardner J, 2006, J NEUROSCI RES, V83, P1281, DOI 10.1002/jnr.20823; Hall MC, 2003, J BIOL CHEM, V278, P10304, DOI 10.1074/jbc.M212334200; Hornebeck W, 2003, PATHOL BIOL, V51, P569, DOI 10.1016/j.patbio.2003.09.003; Hsieh HL, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-88; Ikenaka Y, 2003, INT J CANCER, V105, P340, DOI 10.1002/ijc.11094; Itoh Y, 1998, J BIOL CHEM, V273, P24360, DOI 10.1074/jbc.273.38.24360; Jaworski DM, 2000, GLIA, V30, P199, DOI 10.1002/(SICI)1098-1136(200004)30:2<199::AID-GLIA9>3.0.CO;2-#; Kaul M, 2001, NATURE, V410, P988, DOI 10.1038/35073667; Kettlun AM, 2003, LIFE SCI, V72, P2863, DOI 10.1016/S0024-3205(03)00146-2; Lambert E, 2003, BIOCHEM J, V372, P767, DOI 10.1042/BJ20030187; Li FX, 2009, ENDOCRINOLOGY, V150, P3903, DOI 10.1210/en.2008-1141; Li RY, 2011, J NEUROCHEM, V118, P354, DOI 10.1111/j.1471-4159.2011.07317.x; Lorenzl S, 2002, EXP NEUROL, V178, P13, DOI 10.1006/exnr.2002.8019; Magnoni S, 2007, GENE THER, V14, P621, DOI 10.1038/sj.gt.3302894; MANTHORPE M, 1986, DEV BRAIN RES, V25, P191, DOI 10.1016/0165-3806(86)90208-7; Neary JT, 2004, NEUROCHEM RES, V29, P2037, DOI 10.1007/s11064-004-6876-y; Ould-yahoui A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008289; Pagenstecher A, 1998, AM J PATHOL, V152, P729; Rivera S, 1997, J NEUROSCI, V17, P4223; Rossi JL, 2011, J NEUROSCI RES, V89, P852, DOI 10.1002/jnr.22600; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shen F, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000066; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Sofroniew MV, 2005, NEUROSCIENTIST, V11, P400, DOI 10.1177/1073858405278321; Stetler-Stevenson WG, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.127re6; Suryadevara R, 2003, GLIA, V44, P47, DOI 10.1002/glia.10266; Tong L, 2004, CELL SIGNAL, V16, P1123, DOI 10.1016/j.cellsig.2004.03.003; Wilczynska KM, 2006, J BIOL CHEM, V281, P34955, DOI 10.1074/jbc.M604616200; Young DA, 2005, FEBS J, V272, P1912, DOI 10.1111/j.1742-4658.2005.04622.x	50	20	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56891	10.1371/journal.pone.0056891	http://dx.doi.org/10.1371/journal.pone.0056891			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457635	gold, Green Published, Green Submitted			2022-12-25	WOS:000315602700100
J	Park, SJ; Kim, YH; Lee, Y; Kim, KM; Kim, HS; Lee, SR; Kim, SU; Kim, SH; Kim, JS; Jeong, KJ; Lee, KM; Huh, JW; Chang, KT				Park, Sang-Je; Kim, Young-Hyun; Lee, Youngjeon; Kim, Kyoung-Min; Kim, Heui-Soo; Lee, Sang-Rae; Kim, Sun-Uk; Kim, Sang-Hyun; Kim, Ji-Su; Jeong, Kang-Jin; Lee, Kyoung-Min; Huh, Jae-Won; Chang, Kyu-Tae			Selection of Appropriate Reference Genes for RT-qPCR Analysis in a Streptozotocin-Induced Alzheimer's Disease Model of Cynomolgus Monkeys (Macaca fascicularis)	PLOS ONE			English	Article							NONHUMAN PRIMATE MODEL; INTERNAL REFERENCE GENES; GROWTH-FACTOR EXPRESSION; RHESUS MACAQUE; BRAIN; INSULIN; PCR	Reverse transcription quantitative real-time polymerase chain reaction (RT-qPCR) has been widely used to quantify relative gene expression because of the specificity, sensitivity, and accuracy of this technique. In order to obtain reliable gene expression data from RT-qPCR experiments, it is important to utilize optimal reference genes for the normalization of target gene expression under varied experimental conditions. Previously, we developed and validated a novel icv-STZ cynomolgus monkey model for Alzheimer's disease (AD) research. However, in order to enhance the reliability of this disease model, appropriate reference genes must be selected to allow meaningful analysis of the gene expression levels in the icv-STZ cynomolgus monkey brain. In this study, we assessed the expression stability of 9 candidate reference genes in 2 matched-pair brain samples (5 regions) of control cynomolgus monkeys and those who had received intracerebroventricular injection of streptozotocin (icv-STZ). Three well-known analytical programs geNorm, NormFinder, and BestKeeper were used to choose the suitable reference genes from the total sample group, control group, and icv-STZ group. Combination analysis of the 3 different programs clearly indicated that the ideal reference genes are RPS19 and YWHAZ in the total sample group, GAPDH and RPS19 in the control group, and ACTB and GAPDH in the icv-STZ group. Additionally, we validated the normalization accuracy of the most appropriate reference genes (RPS19 and YWHAZ) by comparison with the least stable gene (TBP) using quantification of the APP and MAPT genes in the total sample group. To the best of our knowledge, this research is the first study to identify and validate the appropriate reference genes in cynomolgus monkey brains. These findings provide useful information for future studies involving the expression of target genes in the cynomolgus monkey.	[Park, Sang-Je; Kim, Young-Hyun; Lee, Youngjeon; Kim, Kyoung-Min; Lee, Sang-Rae; Kim, Sun-Uk; Kim, Sang-Hyun; Kim, Ji-Su; Jeong, Kang-Jin; Huh, Jae-Won; Chang, Kyu-Tae] Korea Res Inst Biosci & Biotechnol, Natl Primate Res Ctr, Ochang, Chungbuk, South Korea; [Park, Sang-Je; Kim, Heui-Soo] Pusan Natl Univ, Dept Biol Sci, Coll Nat Sci, Pusan, South Korea; [Kim, Young-Hyun; Kim, Kyoung-Min; Huh, Jae-Won; Chang, Kyu-Tae] Univ Sci & Technol, Natl Primate Res Ctr, Korea Res Inst Biosci & Biotechnol, Chungbuk, South Korea; [Lee, Youngjeon] Inje Univ, Dept Rehabil Sci, Interdisciplinary PhD Program, Grad Sch, Gimhae, Gyeongnam, South Korea; [Lee, Kyoung-Min] Seoul Natl Univ Hosp, Dept Neurol, Seoul 110744, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB); Pusan National University; Korea Research Institute of Bioscience & Biotechnology (KRIBB); Inje University; Seoul National University (SNU); Seoul National University Hospital	Huh, JW (corresponding author), Korea Res Inst Biosci & Biotechnol, Natl Primate Res Ctr, Ochang, Chungbuk, South Korea.	huhjw@kribb.re.kr; changkt@kribb.re.kr	Kim, Heui-Soo/ABF-3773-2021	Kim, Heui-Soo/0000-0002-5226-6594; Lee, Sang-Rae/0000-0001-8400-5973; Lee, Youngjeon/0000-0002-5387-3441	KRIBB Research Initiative Program [KGM4241231]	KRIBB Research Initiative Program	This research was supported by a grant from the KRIBB Research Initiative Program (KGM4241231). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn K, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-78; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chang Z, 2010, ANAL BIOCHEM, V406, P214, DOI 10.1016/j.ab.2010.07.021; Everaert BR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023793; Ferguson BS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015208; Grunblatt E, 2007, J NEUROCHEM, V101, P757, DOI 10.1111/j.1471-4159.2006.04368.x; Heo JH, 2011, J ALZHEIMERS DIS, V25, P517, DOI 10.3233/JAD-2011-102079; Huh JW, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-163; Kriks S, 2011, NATURE, V480, P547, DOI 10.1038/nature10648; Lester-Coll N, 2006, J ALZHEIMERS DIS, V9, P13; Li WD, 2010, METAB BRAIN DIS, V25, P277, DOI 10.1007/s11011-010-9207-9; Ma YL, 2012, J CEREBR BLOOD F MET, V32, P633, DOI 10.1038/jcbfm.2011.166; Mafra V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031263; Marum L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035113; McBride JL, 2011, MOL THER, V19, P2152, DOI 10.1038/mt.2011.219; Mistur R, 2009, J CLIN NEUROL, V5, P153, DOI 10.3988/jcn.2009.5.4.153; Miura C, 2012, GENE IN PRESS; Noriega NC, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-47; Noriega NC, 2009, METHODS, V49, P42, DOI 10.1016/j.ymeth.2009.05.008; Park SJ, 2012, MOL BIOTECH IN PRESS; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Rivera EJ, 2005, J ALZHEIMERS DIS, V8, P247; Rozen S, 2000, Methods Mol Biol, V132, P365; Saigusa S, 2012, J CANC RES IN PRESS; Shen B, 2011, EXP THER MED, V2, P1151, DOI 10.3892/etm.2011.331; Steen E, 2005, J ALZHEIMERS DIS, V7, P63, DOI 10.3233/jad-2005-7107; Tachaudomdach C, 2012, EXP THER MED, V3, P713, DOI 10.3892/etm.2012.473; Uchida A, 2012, BRAIN, V135, P833, DOI 10.1093/brain/awr348; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Yperman J, 2004, J HEART VALVE DIS, V13, P848; Yuasa K, 2012, FEBS LETT, V586, P3464, DOI 10.1016/j.febslet.2012.07.074	32	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56034	10.1371/journal.pone.0056034	http://dx.doi.org/10.1371/journal.pone.0056034			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457495	Green Submitted, Green Published, gold			2022-12-25	WOS:000315602700035
J	Wang, BF; Wen, X; Qin, XH; Wang, ZF; Tan, Y; Shen, YQ; Xi, Z				Wang, Baifan; Wen, Xin; Qin, Xiaohong; Wang, Zhifang; Tan, Ying; Shen, Yuequan; Xi, Zhen			Quantitative Structural Insight into Human Variegate Porphyria Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; PROTOPORPHYRINOGEN OXIDASE; ENZYMATIC DEFECT; SOUTH-AFRICAN; GROUND-STATE; FORCE-FIELD; PORPHOBILINOGEN; IDENTIFICATION; CONFORMATIONS; MUTATION	Defects in the human protoporphyrinogen oxidase (hPPO) gene, resulting in similar to 50% decreased activity of hPPO, is responsible for the dominantly inherited disorder variegate porphyria (VP). To understand the molecular mechanism of VP, we employed the site-directed mutagenesis, biochemical assays, structural biology, and molecular dynamics simulation studies to investigate VP-causing hPPO mutants. We report here the crystal structures of R59Q and R59G mutants in complex with acifluorfen at a resolution of 2.6 and 2.8 angstrom. The r.m.s.d. of the C alpha atoms of the active site structure of R59G and R59Q with respect to the wild-type was 0.20 and 0.15 angstrom, respectively. However, these highly similar static crystal structures of mutants with the wild-type could not quantitatively explain the observed large differences in their enzymatic activity. To understand how the hPPO mutations affect their catalytic activities, we combined molecular dynamics simulation and statistical analysis to quantitatively understand the molecular mechanism of VP-causing mutants. We have found that the probability of the privileged conformations of hPPO can be correlated very well with the k(cat)/K-m of PPO (correlation coefficient, R-2 > 0.9), and the catalytic activity of 44 clinically reported VP-causing mutants can be accurately predicted. These results indicated that the VP-causing mutation affect the catalytic activity of hPPO by affecting the ability of hPPO to sample the privileged conformations. The current work, together with our previous crystal structure study on the wild-type hPPO, provided the quantitative structural insight into human variegate porphyria disease.	[Wang, Baifan; Wen, Xin; Wang, Zhifang; Tan, Ying; Xi, Zhen] Nankai Univ, Coll Chem, Dept Biol Chem, State Key Lab Elemento Organ Chem, Tianjin 300071, Peoples R China; [Qin, Xiaohong; Shen, Yuequan] Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China	Nankai University; Nankai University	Xi, Z (corresponding author), Nankai Univ, Coll Chem, Dept Biol Chem, State Key Lab Elemento Organ Chem, 94 Weijin Rd, Tianjin 300071, Peoples R China.	zhenxi@nankai.edu.cn	TAN, YING/AAT-4671-2020; Wang, Baifan/J-3491-2014	TAN, YING/0000-0003-2957-0165; Wang, Baifan/0000-0003-0887-5795	Ministry of Science and Technology of the People's Republic of China [2010CB126102, 2011BAE06B05]; National Natural Science Foundation of China [20932005, 21172122]	Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Ministry of Science and Technology of the People's Republic of China Grants 2010CB126102 and 2011BAE06B05 and National Natural Science Foundation of China Grants 20932005 and 21172122.	Akhtar M., 1991, BIOSYNTHESIS TETRAPY, P67; Arnould S, 1998, P NATL ACAD SCI USA, V95, P10553, DOI 10.1073/pnas.95.18.10553; Bonnin A, 2009, J INHERIT METAB DIS, V32, pS59, DOI 10.1007/s10545-009-1059-2; BRENNER DA, 1980, NEW ENGL J MED, V302, P765, DOI 10.1056/NEJM198004033021401; Bruice TC, 1999, ACCOUNTS CHEM RES, V32, P127, DOI 10.1021/ar960131y; Bruice TC, 2000, BIOCHEMISTRY-US, V39, P6267, DOI 10.1021/bi0003689; Bruice TC, 2006, CHEM REV, V106, P3119, DOI 10.1021/cr050283j; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Corrigall AV, 2001, MOL GENET METAB, V73, P91, DOI 10.1006/mgme.2001.3163; Corrigall AV, 2000, MOL GENET METAB, V69, P323, DOI 10.1006/mgme.2000.2975; Dailey H. A., 1990, BIOSYNTHESIS HEME CH, P287; Dailey TA, 1996, PROTEIN SCI, V5, P98; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DEYBACH JC, 1981, HUM GENET, V58, P425, DOI 10.1007/BF00282829; Di Pierro E, 2009, CELL MOL BIOL, V55, P79, DOI 10.1170/T856; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Elder GH, 1997, LANCET, V349, P1613, DOI 10.1016/S0140-6736(96)09070-8; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fraaije MW, 2000, TRENDS BIOCHEM SCI, V25, P126, DOI 10.1016/S0968-0004(99)01533-9; Frisch M., 2016, GAUSSIAN 16 REVISION; HAWORTH P, 1988, PLANT PHYSIOL, V86, P672, DOI 10.1104/pp.86.3.672; Hur S, 2003, P NATL ACAD SCI USA, V100, P12015, DOI 10.1073/pnas.1534873100; JONES C, 1979, J CHEM SOC CHEM COMM, P96, DOI 10.1039/c39790000096; JONES C, 1984, J CHEM SOC PERK T 1, P2625, DOI 10.1039/p19840002625; Kauppinen R, 2005, LANCET, V365, P241; Kirsch RE, 1998, SEMIN LIVER DIS, V18, P33, DOI 10.1055/s-2007-1007138; Kiss G, 2010, PROTEIN SCI, V19, P1760, DOI 10.1002/pro.462; Koch M, 2004, EMBO J, V23, P1720, DOI 10.1038/sj.emboj.7600189; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lau EY, 1998, J AM CHEM SOC, V120, P12387, DOI 10.1021/ja9827447; Lee MC, 2004, PROTEINS, V55, P620, DOI 10.1002/prot.10470; Lightstone FC, 1996, J AM CHEM SOC, V118, P2595, DOI 10.1021/ja952589l; Luo J, 2001, J AM CHEM SOC, V123, P11952, DOI 10.1021/ja0109747; Maneli MH, 2003, BBA-PROTEINS PROTEOM, V1650, P10, DOI 10.1016/S1570-9639(03)00186-9; MATRINGE M, 1992, J BIOL CHEM, V267, P4646; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Meissner PN, 2012, SAMJ S AFR MED J, V102, P422, DOI 10.7196/SAMJ.5710; Meissner PN, 1996, NAT GENET, V13, P95, DOI 10.1038/ng0596-95; MEISSNER PN, 1986, EUR J CLIN INVEST, V16, P257, DOI 10.1111/j.1365-2362.1986.tb01339.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; POST CB, 1994, PURE APPL CHEM, V66, P83, DOI 10.1351/pac199466010083; POULSON R, 1975, J BIOL CHEM, V250, P1269; Puy H, 2010, LANCET, V375, P924, DOI 10.1016/S0140-6736(09)61925-5; Qin XH, 2011, FASEB J, V25, P653, DOI 10.1096/fj.10-170811; Qin XH, 2010, J STRUCT BIOL, V170, P76, DOI 10.1016/j.jsb.2009.11.012; Rossetti MV, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-54; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Schneider-Yin X, 2009, SWISS MED WKLY, V139, P198, DOI smw-12496; SEEMAN JI, 1983, CHEM REV, V83, P83, DOI 10.1021/cr00054a001; Shepherd M, 2005, ANAL BIOCHEM, V344, P115, DOI 10.1016/j.ab.2005.06.012; Sun L, 2009, AMINO ACIDS, V37, P523, DOI 10.1007/s00726-009-0256-5; Warnich L, 1996, HUM MOL GENET, V5, P981, DOI 10.1093/hmg/5.7.981	53	27	29	0	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2013	288	17					11731	11740		10.1074/jbc.M113.459768	http://dx.doi.org/10.1074/jbc.M113.459768			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	133RP	23467411	Green Published, hybrid			2022-12-25	WOS:000318157600010
J	Calabrese, F; Kipar, A; Lunardi, F; Balestro, E; Perissinotto, E; Rossi, E; Nannini, N; Marulli, G; Stewart, JP; Rea, F				Calabrese, Fiorella; Kipar, Anja; Lunardi, Francesca; Balestro, Elisabetta; Perissinotto, Egle; Rossi, Emanuela; Nannini, Nazarena; Marulli, Giuseppe; Stewart, James P.; Rea, Federico			Herpes Virus Infection Is Associated with Vascular Remodeling and Pulmonary Hypertension in Idiopathic Pulmonary Fibrosis	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; MEMBRANE-PROTEIN 1; LUNG FIBROSIS; DNA; CELLS; PREVALENCE; ACTIVATION; APOPTOSIS; SURVIVAL; EBV	Background: Pulmonary hypertension (PH) represents an important complication of idiopathic pulmonary fibrosis (IPF) with a negative impact on patient survival. Herpes viruses are thought to play an etiological role in the development and/or progression of IPF. The influence of viruses on PH associated with IPF is unknown. We aimed to investigate the influence of viruses in IPF patients focusing on aspects related to PH. A laboratory mouse model of gamma-herpesvirus (MHV-68) induced pulmonary fibrosis was also assessed. Methods: Lung tissue samples from 55 IPF patients and 41 controls were studied by molecular analysis to detect various viral genomes. Viral molecular data obtained were correlated with mean pulmonary arterial pressure (mPAP) and arterial remodelling. Different clinical and morphological variables were studied by univariate and multivariate analyses at time of transplant and in the early post-transplant period. The same lung tissue analyses were performed in MHV-68 infected mice. Results: A higher frequency of virus positive cases was found in IPF patients than in controls (p=0.0003) and only herpes virus genomes were detected. Viral cases showed higher mPAP (p=0.01), poorer performance in the six minute walking test (6MWT; p=0.002) and higher frequency of primary graft (PGD) dysfunction after lung transplant (p = 0.02). Increased arterial thickening, particularly of the intimal layer (p=0.002 and p=0.004) and higher TGF-beta expression (p=0.002) were demonstrated in viral cases. The remodelled vessels showed increased vessel cell proliferation (Ki-67 positive cells) in the proximity to metaplastic epithelial cells and macrophages. Viral infection was associated with higher mPAP (p=0.03), poorer performance in the 6MWT (p=0.008) and PGD (p = 0.02) after adjusting for other covariates/intermediate factors. In MHV-68 infected mice, morphological features were similar to those of patients. Conclusion: Herpesviral infections may contribute to the development of PH in IPF patients.	[Calabrese, Fiorella; Lunardi, Francesca; Balestro, Elisabetta; Perissinotto, Egle; Rossi, Emanuela; Nannini, Nazarena; Marulli, Giuseppe; Rea, Federico] Univ Padua, Dept Cardiac Thorac & Vasc Sci, Padua, Italy; [Kipar, Anja; Stewart, James P.] Univ Liverpool, Dept Infect Biol, Liverpool L69 3BX, Merseyside, England; [Kipar, Anja; Stewart, James P.] Univ Liverpool, Sch Vet Sci, Liverpool L69 3BX, Merseyside, England; [Kipar, Anja] Univ Helsinki, Dept Vet Basic Sci, Fac Vet Med, Helsinki, Finland	University of Padua; University of Liverpool; University of Liverpool; University of Helsinki	Calabrese, F (corresponding author), Univ Padua, Dept Cardiac Thorac & Vasc Sci, Padua, Italy.	fiorella.calabrese@unipd.it	Kipar, Anja/L-7214-2014	Kipar, Anja/0000-0001-7289-3459; MARULLI, GIUSEPPE/0000-0001-6570-615X; Lunardi, Francesca/0000-0001-5792-4683; Balestro, Elisabetta/0000-0003-1373-8197; Stewart, James/0000-0002-8928-2037	Italian Ministry of Instruction, University and Research [prot. 60A07-0959/11]	Italian Ministry of Instruction, University and Research(Ministry of Education, Universities and Research (MIUR))	This study was supported by the Italian Ministry of Instruction, University and Research (prot. 60A07-0959/11). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Thoracic Society, 2002, Am J Respir Crit Care Med, V165, P277; Arase Y, 2008, WORLD J GASTROENTERO, V14, P5880, DOI 10.3748/wjg.14.5880; Calabrese F, 2008, THORAX, V63, P795, DOI 10.1136/thx.2007.088583; Calabrese F, 2000, J CLIN PATHOL, V53, P382, DOI 10.1136/jcp.53.5.382; Calabrese F, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-14; Calabrese F, 2008, PEDIATR PULM, V43, P690, DOI 10.1002/ppul.20841; Chomczynski P, 2006, NAT PROTOC, V1, P581, DOI 10.1038/nprot.2006.83; Christie JD, 2005, J HEART LUNG TRANSPL, V24, P1454, DOI 10.1016/j.healun.2004.11.049; Cool CD, 2003, NEW ENGL J MED, V349, P1113, DOI 10.1056/NEJMoa035115; Cooper LT, 2009, NEW ENGL J MED, V360, P1526, DOI 10.1056/NEJMra0800028; Delgado JF, 2005, EUR J HEART FAIL, V7, P1011, DOI 10.1016/j.ejheart.2004.10.021; Ebina M, 2004, AM J RESP CRIT CARE, V169, P1203, DOI 10.1164/rccm.200308-1111OC; EGAN J, 1994, LANCET, V343, P481, DOI 10.1016/S0140-6736(94)92726-X; Egan JJ, 2011, PULM MED, V2011, DOI 10.1155/2011/240805; EGAN JJ, 1995, THORAX, V50, P1234, DOI 10.1136/thx.50.12.1234; ERCOLANI L, 1988, J BIOL CHEM, V263, P15335; Farkas L, 2011, AM J RESP CELL MOL, V45, P1, DOI 10.1165/rcmb.2010-0365TR; Farkas L, 2009, J CLIN INVEST, V119, P1298, DOI 10.1172/JCI36136; Hansson GK, 2006, ANNU REV PATHOL-MECH, V1, P297, DOI 10.1146/annurev.pathol.1.110304.100100; Kelly BG, 2002, AM J RESP CRIT CARE, V166, P510, DOI 10.1164/rccm.2103058; King TE, 2011, LANCET, V378, P1949, DOI 10.1016/S0140-6736(11)60052-4; Kuwano K, 1997, EUR RESPIR J, V10, P1445, DOI 10.1183/09031936.97.10071445; KWOK S, 1989, NATURE, V339, P237, DOI 10.1038/339237a0; Lettieri CJ, 2006, CHEST, V129, P746, DOI 10.1378/chest.129.3.746; Leuchte HH, 2004, AM J RESP CRIT CARE, V170, P360, DOI 10.1164/rccm.200308-1142OC; Lok SS, 2002, EUR RESPIR J, V20, P1228, DOI 10.1183/09031936.02.00272902; Lunardi F, 2011, CLIN KIDNEY J, V4, P49, DOI 10.1093/ndtplus/sfq197; LUNG ML, 1985, LANCET, V1, P889; Malizia AP, 2008, AM J PHYSIOL-LUNG C, V295, pL451, DOI 10.1152/ajplung.00376.2007; Malizia AP, 2009, EXP CELL RES, V315, P1819, DOI 10.1016/j.yexcr.2009.04.001; Malizia AP, 2009, MOL IMMUNOL, V46, P1905, DOI 10.1016/j.molimm.2009.01.002; McMillan TR, 2008, AM J RESP CRIT CARE, V177, P771, DOI 10.1164/rccm.200708-1184OC; Mihira H, 2012, J BIOCHEM, V151, P145, DOI 10.1093/jb/mvr121; Mora AL, 2005, AM J PHYSIOL-LUNG C, V289, pL711, DOI 10.1152/ajplung.00007.2005; Mora AL, 2007, AM J RESP CRIT CARE, V175, P1139, DOI 10.1164/rccm.200610-1426OC; Mora AL, 2006, AM J RESP CELL MOL, V35, P466, DOI 10.1165/rcmb.2006-0121OC; Nadrous HF, 2005, CHEST, V128, p616S, DOI 10.1378/chest.128.6_suppl.616S-a; Nathan SD, 2007, AM J RESP CRIT CARE, V175, P875, DOI 10.1164/rccm.200608-1153CC; Patel NM, 2007, CHEST, V132, P998, DOI 10.1378/chest.06-3087; Payne CM, 2001, J VIROL, V75, P10467, DOI 10.1128/JVI.75.21.10467-10471.2001; Pozharskaya V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007559; Pulkkinen V, 2012, ANN MED, V44, P178, DOI 10.3109/07853890.2010.532151; Pulkkinen V, 2010, FASEB J, V24, P1167, DOI 10.1096/fj.09-138545; Raghu G, 2006, AM J RESP CRIT CARE, V174, P810, DOI 10.1164/rccm.200602-163OC; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; Selman M, 2001, ANN INTERN MED, V134, P136, DOI 10.7326/0003-4819-134-2-200101160-00015; Sides MD, 2011, AM J RESP CELL MOL, V44, P852, DOI 10.1165/rcmb.2009-0232OC; Stewart JP, 1999, AM J RESP CRIT CARE, V159, P1336, DOI 10.1164/ajrccm.159.4.9807077; Stewart S, 2007, J HEART LUNG TRANSPL, V26, P1229, DOI 10.1016/j.healun.2007.10.017; Suarez AL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000152; Tang YW, 2003, J CLIN MICROBIOL, V41, P2633, DOI 10.1128/JCM.41.6.2633-2640.2003; Tsukamoto K, 2000, THORAX, V55, P958, DOI 10.1136/thorax.55.11.958; Vannella KM, 2010, AM J RESP CRIT CARE, V181, P465, DOI 10.1164/rccm.200905-0798OC; Whelan TPM, 2005, J HEART LUNG TRANSPL, V24, P1269, DOI 10.1016/j.healun.2004.10.014; Williams KJ, 2007, VET PATHOL, V44, P849, DOI 10.1354/vp.44-6-849; Zamo A, 2005, SARCOIDOSIS VASC DIF, V22, P123; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690; Zisman DA, 2007, CHEST, V132, P773, DOI 10.1378/chest.07-0116	58	37	39	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e55715	10.1371/journal.pone.0055715	http://dx.doi.org/10.1371/journal.pone.0055715			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23468849	Green Submitted, gold, Green Accepted, Green Published			2022-12-25	WOS:000315524900013
J	Hao, GY; Du, Y; Zhou, XJ; Guo, JF; Sun, XK; Mohan, C; Oz, OK				Hao, Guiyang; Du, Yong; Zhou, Xin J.; Guo, Jianfei; Sun, Xiankai; Mohan, Chandra; Oez, Orhan K.			Serial Non-Invasive Assessment of Antibody Induced Nephritis in Mice Using Positron Emission Tomography	PLOS ONE			English	Article							GA-67 SCINTIGRAPHY; F-18-FDG PET; FDG-PET; LUPUS; KIDNEY; TOOL	Mouse models of experimental anti-glomerular basement membrane (anti-GBM) nephritis provide an analytical tool for studying spontaneous lupus nephritis. The potential of Positron Emission Tomography (PET) was evaluated using 2-deoxy-2-[F-18]fluoro-d-glucose (FDG) as a probe to monitor the progression of anti-GBM induced nephritis in a mouse model. The imaging results were compared to conventional measures of renal function and pathological changes. Serum and urinary vascular cell adhesion molecule-1 (VCAM-1) levels were used as measures of endothelial cell activation and inflammation. Following a challenge with anti-glomerular antibodies, mice exhibited peak changes in serum creatinine, proteinuria, and glomerulonephritis score at 14 days post-challenge (p.c.). In contrast, VCAM levels peaked at day 7 p.c. On dynamic PET images (0-60 min) of day 7, kidneys of the anti-GBM nephritis mice demonstrated a unique pattern of FDG uptake. Compared to the time activity curve (TAC) prior to challenge, a rightward shift was observed after the challenge. By day 10 p.c., kidney FDG uptake was lower than baseline and remained so until the study ended at 21 days p.c. During this time frame measures of renal dysfunction remained high but VCAM-1 levels declined. These changes were accompanied by an increase in kidney volume as measured by Computed Tomography (CT) and intra-abdominal fluid collection. Our results suggest that FDG-PET-CT can be used as a non-invasive imaging tool to longitudinally monitor the progression of renal disease activity in antibody mediated nephritis and the magnitude of renal FDG retention correlates better with early markers of renal inflammation than renal dysfunction.	[Hao, Guiyang; Guo, Jianfei; Sun, Xiankai; Oez, Orhan K.] Univ Texas SW Med Ctr Dallas, Dept Radiol, Dallas, TX 75390 USA; [Du, Yong; Mohan, Chandra] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; [Zhou, Xin J.] Univ Texas SW Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA; [Sun, Xiankai] Univ Texas SW Med Ctr Dallas, Adv Imaging Res Ctr, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Sun, XK (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Radiol, Dallas, TX 75390 USA.	xiankai.sun@utsouthwestern.edu; chandra.mohan@utsouthwestern.edu; orhan.oz@utsouthwestern.edu	Hao, Guiyang/D-5312-2011; Mohan, Chandra/GPX-8233-2022; DU, YONG/B-9964-2011; Oz, Orhan/GVT-7264-2022	Hao, Guiyang/0000-0001-6695-5123; DU, YONG/0000-0003-1687-9024	National Institutes of Health [R01 DK092163, R01 DK081872]; Cain Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081872, R01DK092163] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cain Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health (R01 DK092163 and R01 DK081872) and the Cain Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aten J, 2000, J AM SOC NEPHROL, V11, P1426, DOI 10.1681/ASN.V1181426; BAKIR AA, 1985, AM J MED, V79, P175, DOI 10.1016/0002-9343(85)90007-5; Bleeker-Rovers CP, 2003, AM J KIDNEY DIS, V41, DOI 10.1016/S0272-6386(03)00368-8; Davidson A, 2010, NAT REV RHEUMATOL, V6, P13, DOI 10.1038/nrrheum.2009.240; Du Y, 2008, ARCH IMMUNOL THER EX, V56, P31, DOI 10.1007/s00005-008-0007-4; Du Y, 2011, SYSTEMIC LUPUS ERYTHEMATOSUS, 5TH EDITION, P453; Du Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043941; Fu YY, 2007, CLIN IMMUNOL, V124, P109, DOI 10.1016/j.clim.2007.05.007; Karadeli E, 2010, RHEUMATOL INT, V30, P1177, DOI 10.1007/s00296-009-1124-z; Kobayashi M, 2010, NUCL MED COMMUN, V31, P141, DOI 10.1097/MNM.0b013e328333bcf5; Kosuda S, 1997, Ann Nucl Med, V11, P213; Lin WY, 2000, EUR J NUCL MED, V27, P1626, DOI 10.1007/s002590000350; Lin WY, 1998, J NUCL MED, V39, P2137; Love C, 2005, RADIOGRAPHICS, V25, P1357, DOI 10.1148/rg.255045122; Meller J, 2007, J NUCL MED, V48, P35; Minamimoto R, 2007, ANN NUCL MED, V21, P217, DOI 10.1007/s12149-007-0012-4; MUNK ZM, 1979, CLIN EXP IMMUNOL, V36, P244; O'Keefe DS, 1998, BBA-GENE STRUCT EXPR, V1443, P113; OZBEK SS, 1995, J CLIN ULTRASOUND, V23, P17, DOI 10.1002/jcu.1870230104; Panopalis P, 2008, ARTHRIT RHEUM-ARTHR, V59, P1788, DOI 10.1002/art.24063; Peters AM, 2000, RHEUMATOLOGY, V39, P463, DOI 10.1093/rheumatology/39.5.463; Reuter S, 2010, J NUCL MED, V51, P1644, DOI 10.2967/jnumed.110.078550; Serkova NJ, 2010, RADIOLOGY, V255, P517, DOI 10.1148/radiol.09091134; STANLEY JH, 1984, AM J ROENTGENOL, V142, P1165, DOI 10.2214/ajr.142.6.1165; WILSON CB, 1973, KIDNEY INT, V3, P74, DOI 10.1038/ki.1973.14; Wu TF, 2007, ARTHRITIS RHEUM-US, V56, P949, DOI 10.1002/art.22556; WUTHRICH RP, 1992, KIDNEY INT, V42, P903, DOI 10.1038/ki.1992.367; Xie C, 2004, J IMMUNOL, V172, P5047, DOI 10.4049/jimmunol.172.8.5047	28	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57418	10.1371/journal.pone.0057418	http://dx.doi.org/10.1371/journal.pone.0057418			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460853	Green Submitted, gold, Green Published			2022-12-25	WOS:000315519000107
J	Link, A; Balaguer, F; Shen, Y; Lozano, JJ; Leung, HCE; Boland, CR; Goel, A				Link, Alexander; Balaguer, Francesc; Shen, Yan; Lozano, Juan Jose; Leung, Hon-Chiu E.; Boland, C. Richard; Goel, Ajay			Curcumin Modulates DNA Methylation in Colorectal Cancer Cells	PLOS ONE			English	Article							CHROMOSOMAL INSTABILITY; CPG-ISLAND; METHYLTRANSFERASE INHIBITORS; PROSTATE-CANCER; IN-VITRO; HYPERMETHYLATION; DIETARY; CHEMOPREVENTION; TUMORIGENESIS; DEMETHYLATION	Aim: Recent evidence suggests that several dietary polyphenols may exert their chemopreventive effect through epigenetic modifications. Curcumin is one of the most widely studied dietary chemopreventive agents for colon cancer prevention, however, its effects on epigenetic alterations, particularly DNA methylation, remain unclear. Using systematic genome-wide approaches, we aimed to elucidate the effect of curcumin on DNA methylation alterations in colorectal cancer cells. Materials and Methods: To evaluate the effect of curcumin on DNA methylation, three CRC cell lines, HCT116, HT29 and RKO, were treated with curcumin. 5-aza-2'-deoxycytidine (5-aza-CdR) and trichostatin A treated cells were used as positive and negative controls for DNA methylation changes, respectively. Methylation status of LINE-1 repeat elements, DNA promoter methylation microarrays and gene expression arrays were used to assess global methylation and gene expression changes. Validation was performed using independent microarrays, quantitative bisulfite pyrosequencing, and qPCR. Results: As expected, genome-wide methylation microarrays revealed significant DNA hypomethylation in 5-aza-CdR-treated cells (mean beta-values of 0.12), however, non-significant changes in mean beta-values were observed in curcumin-treated cells. In comparison to mock-treated cells, curcumin-induced DNA methylation alterations occurred in a time-dependent manner. In contrast to the generalized, non-specific global hypomethylation observed with 5-aza-CdR, curcumin treatment resulted in methylation changes at selected, partially-methylated loci, instead of fully-methylated CpG sites. DNA methylation alterations were supported by corresponding changes in gene expression at both up- and down-regulated genes in various CRC cell lines. Conclusions: Our data provide previously unrecognized evidence for curcumin-mediated DNA methylation alterations as a potential mechanism of colon cancer chemoprevention. In contrast to non-specific global hypomethylation induced by 5-aza-CdR, curcumin-induced methylation changes occurred only in a subset of partially-methylated genes, which provides additional mechanistic insights into the potent chemopreventive effect of this dietary nutraceutical.	[Link, Alexander; Balaguer, Francesc; Shen, Yan; Boland, C. Richard; Goel, Ajay] Baylor Univ, Med Ctr, Div Gastroenterol, Gastrointestinal Canc Res Lab, Dallas, TX USA; [Link, Alexander] Otto Von Guericke Univ, Dept Gastroenterol Hepatol & Infect Dis, Magdeburg, Germany; [Balaguer, Francesc; Lozano, Juan Jose] Univ Barcelona, Dept Gastroenterol, Hosp Clin,IDIBAPS, Ctr Invest Biomed Red Enfermedades Hepat & Digest, Barcelona, Spain; [Leung, Hon-Chiu E.] Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA	Baylor University; Baylor University Medical Center; Otto von Guericke University; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Baylor College of Medicine	Goel, A (corresponding author), Baylor Univ, Med Ctr, Div Gastroenterol, Gastrointestinal Canc Res Lab, Dallas, TX USA.	ajay.goel@baylorhealth.edu	BALAGUER, FRANCESC/G-2389-2016; Balaguer, Francesc/GPX-7801-2022	Link, Alexander/0000-0002-9514-4562; Lozano, Juan Jose/0000-0001-7613-3908; Balaguer, Francesc/0000-0002-0206-0539; Goel, Ajay/0000-0003-1396-6341	National Cancer Institute, National Institutes of Health [R01 CA72851, CA129286]; Baylor Research Institute; NATIONAL CANCER INSTITUTE [R01CA129286, R01CA072851] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Baylor Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The present work was supported by grants R01 CA72851 and CA129286 from the National Cancer Institute, National Institutes of Health, and funds from the Baylor Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balaguer F, 2010, CANCER RES, V70, P6609, DOI 10.1158/0008-5472.CAN-10-0622; Balasubramanyam K, 2004, J BIOL CHEM, V279, P51163, DOI 10.1074/jbc.M409024200; Chuang JC, 2005, MOL CANCER THER, V4, P1515, DOI 10.1158/1535-7163.MCT-05-0172; Costello JF, 2009, NAT BIOTECHNOL, V27, P1130, DOI 10.1038/nbt1209-1130; Davis CD, 2002, J NUTR, V132, P292, DOI 10.1093/jn/132.2.292; DOLL R, 1981, JNCI-J NATL CANCER I, V66, P1191, DOI 10.1093/jnci/66.6.1192; Eads CA, 2002, CANCER RES, V62, P1296; Fang MZ, 2005, CLIN CANCER RES, V11, P7033, DOI 10.1158/1078-0432.CCR-05-0406; Fang MZ, 2003, CANCER RES, V63, P7563; Feinberg AP, 2008, JAMA-J AM MED ASSOC, V299, P1345, DOI 10.1001/jama.299.11.1345; Feinberg AP, 2006, NAT REV GENET, V7, P21, DOI 10.1038/nrg1748; Figueiredo JC, 2009, CANCER EPIDEM BIOMAR, V18, P1041, DOI 10.1158/1055-9965.EPI-08-0926; Gaudet F, 2003, SCIENCE, V300, P489, DOI 10.1126/science.1083558; Ghoshal K, 2005, MOL CELL BIOL, V25, P4727, DOI 10.1128/MCB.25.11.4727-4741.2005; Goel A, 2008, MOL NUTR FOOD RES, V52, P1010, DOI 10.1002/mnfr.200700354; Goel A, 2008, BIOCHEM PHARMACOL, V75, P787, DOI 10.1016/j.bcp.2007.08.016; Goel A, 2007, GASTROENTEROLOGY, V132, P127, DOI 10.1053/j.gastro.2006.09.018; Gunderson Kevin L., 2009, V529, P197, DOI 10.1007/978-1-59745-538-1_13; Hamm CA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008340; Issa JPJ, 2007, CLIN CANCER RES, V13, P1634, DOI 10.1158/1078-0432.CCR-06-2076; Issa JPJ, 1996, CANCER RES, V56, P3655; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Jha AK, 2010, FOLIA BIOL-PRAGUE, V56, P195; Karpf AR, 2005, CANCER RES, V65, P8635, DOI 10.1158/0008-5472.CAN-05-1961; Kristensen LS, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn113; Kuck D, 2010, BIOORGAN MED CHEM, V18, P822, DOI 10.1016/j.bmc.2009.11.050; Laird PW, 2003, NAT REV CANCER, V3, P253, DOI 10.1038/nrc1045; Link A, 2010, BIOCHEM PHARMACOL, V80, P1771, DOI 10.1016/j.bcp.2010.06.036; Link A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008146; Liu ZF, 2009, BIOORG MED CHEM LETT, V19, P706, DOI 10.1016/j.bmcl.2008.12.041; Majid S, 2010, CANCER-AM CANCER SOC, V116, P66, DOI 10.1002/cncr.24662; Morimoto T, 2008, J CLIN INVEST, V118, P868, DOI 10.1172/JCI33160; Nagasaka T, 2008, INT J CANCER, V122, P2429, DOI 10.1002/ijc.23398; Patel K, 2010, NUCLEIC ACIDS RES, V38, P4313, DOI 10.1093/nar/gkq187; Peto J, 2001, NATURE, V411, P390, DOI 10.1038/35077256; Prasanna P, 1995, CLIN CANCER RES, V1, P865; Rabbani SA, 2008, NEOPLASIA, V10, P266, DOI 10.1593/neo.07947; Rodriguez J, 2006, CANCER RES, V66, P8462, DOI 10.1158/0008-5472.CAN-06-0293; Schermelleh L, 2005, NAT METHODS, V2, P751, DOI 10.1038/NMETH794; Shen Y, 2012, CANCER BIOL THER, V13, P542, DOI 10.4161/cbt.19604; Shukeir N, 2006, CANCER RES, V66, P9202, DOI 10.1158/0008-5472.CAN-06-1954; Sporn MB, 2002, NAT REV CANCER, V2, P537, DOI 10.1038/nrc844; Stresemann C, 2006, CANCER RES, V66, P2794, DOI 10.1158/0008-5472.CAN-05-2821; Suzuki K, 2006, CANCER CELL, V9, P199, DOI 10.1016/j.ccr.2006.02.016; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Wong JJL, 2007, GUT, V56, P140, DOI 10.1136/gut.2005.088799; Yagi K, 2010, CLIN CANCER RES, V16, P21, DOI 10.1158/1078-0432.CCR-09-2006; Yoo CB, 2006, NAT REV DRUG DISCOV, V5, P37, DOI 10.1038/nrd1930	48	110	116	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57709	10.1371/journal.pone.0057709	http://dx.doi.org/10.1371/journal.pone.0057709			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460897	Green Submitted, Green Published, gold			2022-12-25	WOS:000315519000152
J	Sun, Y; Xu, CC; Li, J; Guan, XY; Gao, L; Ma, LX; Li, RX; Peng, YW; Zhu, GP				Sun, Yan; Xu, Chong-Chong; Li, Jin; Guan, Xi-Yin; Gao, Lu; Ma, Li-Xiang; Li, Rui-Xi; Peng, Yu-Wen; Zhu, Guo-Pei			Transplantation of Oligodendrocyte Precursor Cells Improves Locomotion Deficits in Rats with Spinal Cord Irradiation Injury	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; CENTRAL-NERVOUS-SYSTEM; RADIATION MYELOPATHY; SCHWANN-CELLS; IN-VITRO; NEUROTROPHIC FACTOR; NEURONAL SURVIVAL; GENE-EXPRESSION; INDUCED DAMAGE; WHITE-MATTER	Demyelination contributes to the functional impairment of irradiation injured spinal cord. One potential therapeutic strategy involves replacing the myelin-forming cells. Here, we asked whether transplantation of Olig2(+)-GFP(+)-oligodendrocyte precursor cells (OPCs), which are derived from Olig2-GFP-mouse embryonic stem cells (mESCs), could enhance remyelination and functional recovery after spinal cord irradiation injury. We differentiated Olig2-GFP-mESCs into purified Olig2(+)-GFP(+)-OPCs and transplanted them into the rats' cervical 4-5 dorsal spinal cord level at 4 months after irradiation injury. Eight weeks after transplantation, the Olig2(+)-GFP(+)-OPCs survived and integrated into the injured spinal cord. Immunofluorescence analysis showed that the grafted Olig2(+)-GFP(+)-OPCs primarily differentiated into adenomatous polyposis coli (APC(+)) oligodendrocytes (54.6+/-10.5%). The staining with luxol fast blue, hematoxylin & eosin (LFB/H&E) and electron microscopy demonstrated that the engrafted Olig2(+)-GFP(+)-OPCs attenuated the demyelination resulted from the irradiation. More importantly, the recovery of forelimb locomotor function was enhanced in animals receiving grafts of Olig2(+)-GFP(+)-OPCs. We concluded that OPC transplantation is a feasible therapy to repair the irradiated lesions in the central nervous system (CNS).	[Sun, Yan; Xu, Chong-Chong; Gao, Lu; Ma, Li-Xiang; Li, Rui-Xi; Peng, Yu-Wen] Fudan Univ, Shanghai Med Coll, Dept Anat Histol & Embryol, Shanghai 200433, Peoples R China; [Li, Jin] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China; [Guan, Xi-Yin; Zhu, Guo-Pei] Fudan Univ, Shanghai Canc Hosp, Dept Radiat Oncol, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University	Peng, YW (corresponding author), Fudan Univ, Shanghai Med Coll, Dept Anat Histol & Embryol, Shanghai 200433, Peoples R China.	ywpeng@fudan.edu.cn; antica@gmail.com		ma, lixiang/0000-0001-9399-155X	National Natural Science Foundation of China [30770637, 30901615, 81201029]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported the by the National Natural Science Foundation of China (No. 30770637, 30901615 and 81201029). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson S, 2003, INT J RADIAT ONCOL, V57, P1093, DOI 10.1016/S0360-3016(03)00735-1; AvellanaAdalid V, 1996, J NEUROSCI RES, V45, P558, DOI 10.1002/(SICI)1097-4547(19960901)45:5<558::AID-JNR6>3.0.CO;2-B; BAIN G, 1995, DEV BIOL, V168, P342, DOI 10.1006/dbio.1995.1085; Bijl HP, 2003, INT J RADIAT ONCOL, V57, P274, DOI [10.1016/S0360-3016(03)00529-7, 10.1016/s0360-3016(03)00529-7]; Billon N, 2002, J CELL SCI, V115, P3657, DOI 10.1242/jcs.00049; Bruce CC, 2010, HORM BEHAV, V57, P56, DOI 10.1016/j.yhbeh.2009.06.004; Brustle O, 1999, SCIENCE, V285, P754, DOI 10.1126/science.285.5428.754; Cao Q, J NEUROSCI, V30, P2989; Cao QL, 2010, J NEUROSCI, V30, P2989, DOI 10.1523/JNEUROSCI.3174-09.2010; Cao QL, 2005, EXP NEUROL, V191, pS3, DOI 10.1016/j.expneurol.2004.08.026; Chari DM, 2006, EXP NEUROL, V198, P145, DOI 10.1016/j.expneurol.2005.11.023; Chari DM, 2003, J NEUROSCI RES, V73, P787, DOI 10.1002/jnr.10700; Cummings BJ, 2005, P NATL ACAD SCI USA, V102, P14069, DOI 10.1073/pnas.0507063102; Dai XD, 2003, J NEUROSCI, V23, P5846; DELATTRE JY, 1988, BRAIN, V111, P1319, DOI 10.1093/brain/111.6.1319; Du YZ, 2002, J NEUROSCI RES, V68, P647, DOI 10.1002/jnr.10245; Du ZW, 2006, MOL CELL NEUROSCI, V33, P371, DOI 10.1016/j.mcn.2006.08.007; Evans M, 2011, NAT REV MOL CELL BIO, V12, P680, DOI 10.1038/nrm3190; Fowler JF, 2000, RADIOTHER ONCOL, V55, P295, DOI 10.1016/S0167-8140(99)00133-4; Franklin RJM, 1996, EXP NEUROL, V137, P263, DOI 10.1006/exnr.1996.0025; Franklin RJM, 2008, NAT REV NEUROSCI, V9, P839, DOI 10.1038/nrn2480; Franklin RJM, 2008, J NEUROL, V255, P19, DOI 10.1007/s00415-008-1004-6; Goldberg JL, 2000, ANNU REV NEUROSCI, V23, P579, DOI 10.1146/annurev.neuro.23.1.579; Hofstetter CP, 2005, NAT NEUROSCI, V8, P346, DOI 10.1038/nn1405; Hopewell JW, 1999, FRONT RADIAT THER ON, V33, P265; Iwashita Y, 2000, EXP NEUROL, V164, P292, DOI 10.1006/exnr.2000.7440; Jadasz JJ, 2012, CELL TISSUE RES; Jeffery ND, 1999, EUR J NEUROSCI, V11, P1508, DOI 10.1046/j.1460-9568.1999.00564.x; Karimi-Abdolrezaee S, 2004, EUR J NEUROSCI, V19, P577, DOI 10.1111/j.0953-816X.2004.03164.x; Keirstead HS, 2005, J NEUROSCI, V25, P4694, DOI 10.1523/JNEUROSCI.0311-05.2005; Lankford KL, 2008, GLIA, V56, P1664, DOI 10.1002/glia.20718; Li YQ, 1996, CANCER RES, V56, P5417; Maier IC, 2006, PHILOS T R SOC B, V361, P1611, DOI 10.1098/rstb.2006.1890; Mitsui T, 2005, J NEUROSCI, V25, P9624, DOI 10.1523/JNEUROSCI.2175-05.2005; Monje ML, 2002, NAT MED, V8, P955, DOI 10.1038/nm749; Mothe AJ, 2008, EXP NEUROL, V213, P176, DOI 10.1016/j.expneurol.2008.05.024; Nave KA, 2008, ANNU REV NEUROSCI, V31, P535, DOI 10.1146/annurev.neuro.30.051606.094309; Okabe S, 1996, MECH DEVELOP, V59, P89, DOI 10.1016/0925-4773(96)00572-2; Okada S, 2001, NEUROPATHOLOGY, V21, P247, DOI 10.1046/j.1440-1789.2001.00408.x; Rezvani M, 2001, RADIAT RES, V156, P408, DOI 10.1667/0033-7587(2001)156[0408:MORMBT]2.0.CO;2; SCHULTHEISS TE, 1986, INT J RADIAT ONCOL, V12, P1765, DOI 10.1016/0360-3016(86)90317-2; SCHULTHEISS TE, 1992, BRIT J RADIOL, V65, P737, DOI 10.1259/0007-1285-65-777-737; SCHULTHEISS TE, 1995, INT J RADIAT ONCOL, V31, P1093, DOI 10.1016/0360-3016(94)00655-5; Sharp J, 2010, STEM CELLS, V28, P152, DOI 10.1002/stem.245; Talbott JF, 2006, GLIA, V54, P147, DOI 10.1002/glia.20369; Trapp BD, 2008, ANNU REV NEUROSCI, V31, P247, DOI 10.1146/annurev.neuro.30.051606.094313; USHIO Y, 1977, NEUROLOGY, V27, P422, DOI 10.1212/WNL.27.5.422; Wilkins A, 2003, J NEUROSCI, V23, P4967, DOI 10.1523/jneurosci.23-12-04967.2003; Wong CS, 2004, MOL INTERV, V4, P273, DOI 10.1124/mi.4.5.7; Zhang SC, 1998, J NEUROCYTOL, V27, P475, DOI 10.1023/A:1006953023845; Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129; Zhou Q, 2001, NEURON, V31, P791, DOI 10.1016/S0896-6273(01)00414-7	52	44	47	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57534	10.1371/journal.pone.0057534	http://dx.doi.org/10.1371/journal.pone.0057534			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460872	gold, Green Submitted, Green Published			2022-12-25	WOS:000315519000127
J	Tsai, TH; Wong, AMK; Hsu, CL; Tseng, KC				Tsai, Tsai-Hsuan; Wong, Alice May-Kuen; Hsu, Chien-Lung; Tseng, Kevin C.			Research on a Community-based Platform for Promoting Health and Physical Fitness in the Elderly Community	PLOS ONE			English	Article							OLDER-ADULTS; FRAILTY; TESTS	This study aims to assess the acceptability of a fitness testing platform (iFit) for installation in an assisted living community with the aim of promoting fitness and slowing the onset of frailty. The iFit platform develops a means of testing Bureau of Health Promotion mandated health assessment items for the elderly (including flexibility tests, grip strength tests, balance tests, and reaction time tests) and integrates wireless remote sensors in a game-like environment to capture and store subject response data, thus providing individuals in elderly care contexts with a greater awareness of their own physical condition. In this study, we specifically evaluated the users' intention of using the iFit using a technology acceptance model (TAM). A total of 101 elderly subjects (27 males and 74 females) were recruited. A survey was conducted to measure technology acceptance, to verify that the platform could be used as intended to promote fitness among the elderly. Results indicate that perceived usefulness, perceived ease of use and usage attitude positively impact behavioral intention to use the platform. The iFit platform can offer user-friendly solutions for a community-based fitness care and monitoring of elderly subjects. In summary, iFit was determined by three key drivers and discussed as follows: risk factors among the frail elderly, mechanism for slowing the advance frailty, and technology acceptance and support for promoting physical fitness.	[Tsai, Tsai-Hsuan; Tseng, Kevin C.] Chang Gung Univ, Res Ctr Ind Innovat Senior Citizens, Tao Yuan, Taiwan; [Wong, Alice May-Kuen] Chang Gung Med Fdn, Dept Phys Med & Rehabil, Tao Yuan, Taiwan; [Hsu, Chien-Lung] Chang Gung Univ, Hlth Aging Res Ctr, Tao Yuan, Taiwan	Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University	Tseng, KC (corresponding author), Chang Gung Univ, Res Ctr Ind Innovat Senior Citizens, Tao Yuan, Taiwan.	ktseng@pddlab.org	Wong, Alice M. K./ABI-1000-2020	Wong, Alice M. K./0000-0003-3586-1292	National Science Council, Taiwan, ROC [NSC 100-2410-H-182-023-MY2, NSC100-2321-B-182A-003-]; Chang Gung University [UARPD3B0081]	National Science Council, Taiwan, ROC(Ministry of Science and Technology, Taiwan); Chang Gung University	This work was supported in part by the National Science Council, Taiwan, ROC under Contracts NSC 100-2410-H-182-023-MY2, NSC100-2321-B-182A-003- and the Chang Gung University under Contract UARPD3B0081. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggar C, 2011, ARCH GERONTOL GERIAT, V53, pE138, DOI 10.1016/j.archger.2010.07.010; Asparouhov T, 2009, STRUCT EQU MODELING, V16, P397, DOI 10.1080/10705510903008204; Bagozzi R.P., 1988, J ACAD MARKET SCI, V16, P74, DOI [10.1007/BF02723327, DOI 10.1007/BF02723327]; Bartlett MS, 1951, B J PSYCHOL-STAT SEC, V4, P1, DOI 10.1111/j.2044-8317.1951.tb00299.x; BENTLER PM, 1980, PSYCHOL BULL, V88, P588, DOI 10.1037/0033-2909.107.2.238; Black J.T, 1992, MULTIVARIATE DATA AN; [Bureau of Health Promotion Department of Health], 2006, GUID HLTH FITN MAK P, P1; Campbell AJ, 1997, AGE AGEING, V26, P315, DOI 10.1093/ageing/26.4.315; Chan M, 2009, MATURITAS, V64, P90, DOI 10.1016/j.maturitas.2009.07.014; Chen CY, 2010, ARCH GERONTOL GERIAT, V50, pS43, DOI 10.1016/S0167-4943(10)70012-1; Chen ML, 2011, AFR J BUS MANAGE, V5, P7099; DAVIS FD, 1989, MIS QUART, V13, P319, DOI 10.2307/249008; de Vries NM, 2010, AGEING RES IN PRESS; Department of Health, 2007, HLTH STAT TAIW 2007; Espinoza S, 2005, CLEV CLIN J MED, V72, P1105, DOI 10.3949/ccjm.72.12.1105; Faber MJ, 2006, ARCH PHYS MED REHAB, V87, P885, DOI 10.1016/j.apmr.2006.04.005; Ferrucci L, 2003, CRIT REV ONCOL HEMAT, V46, P127, DOI 10.1016/S1040-8428(02)00177-4; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Fulop T, 2010, BIOGERONTOLOGY, V11, P547, DOI 10.1007/s10522-010-9287-2; Gobbens RJ, 2010, NURS OUTLOOK, V58, P76, DOI 10.1016/j.outlook.2009.09.005; Goodman J, 2003, AGE OLD QUESTION NAI; Hayduk L. A., 1987, STRUCTURAL EQUATION; Hilgenkamp TIM, 2010, RES DEV DISABIL, V31, P1027, DOI 10.1016/j.ridd.2010.04.012; Hirpara KM, 2008, INJURY EXTRA, V39, P86; Holzinger A, 2011, UNIVERSAL ACCESS INF, V10, P245, DOI 10.1007/s10209-010-0212-x; [HsinChu City Government HsinChu], 2010, HLTH IOH CIT; Hubbard RE, 2010, BIOGERONTOLOGY, V11, P635, DOI 10.1007/s10522-010-9292-5; Jarvenpaa SL, 1999, J COMPUTER MEDIATED, V5, P0; Jones DM, 2004, J AM GERIATR SOC, V52, P1929, DOI 10.1111/j.1532-5415.2004.52521.x; JORESKOG KG, 1969, PSYCHOMETRIKA, V34, P183, DOI 10.1007/BF02289343; Klein BEK, 2005, ARCH GERONTOL GERIAT, V41, P141, DOI 10.1016/j.archger.2005.01.002; Levers MJ, 2006, J ADV NURS, V56, P282, DOI 10.1111/j.1365-2648.2006.04021.x; Lin CC, 2009, EPIDEMIOLOGIC STUDY; Marks A, 2009, COMPLETE GUIDE GAME, P343; Mitchell AJ, 2009, J PSYCHIATR RES, V43, P411, DOI 10.1016/j.jpsychires.2008.04.014; Puts MTE, 2009, J AGING STUD, V23, P258, DOI 10.1016/j.jaging.2008.03.002; Rockwood K, 2005, CAN MED ASSOC J, V173, P489, DOI 10.1503/cmaj.050051; Shih CH, 2010, RES DEV DISABIL, V31, P281, DOI 10.1016/j.ridd.2009.09.013; Sparks Dorothy, 2009, Inform Prim Care, V17, P55; Theng YL, 2010, IFIP ADV INF COMM TE, V332, P152; Walsh K, 2011, AGEING INT, V36, P102, DOI 10.1007/s12126-010-9075-y; Wong AMK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040591; Xynos K, 2010, DIGIT INVEST, V6, P104, DOI 10.1016/j.diin.2010.02.004	44	12	12	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57452	10.1371/journal.pone.0057452	http://dx.doi.org/10.1371/journal.pone.0057452			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	098BN	23460859	gold, Green Published, Green Submitted			2022-12-25	WOS:000315519000113
J	Kattoor, J; Gizewski, ER; Kotsis, V; Benson, S; Gramsch, C; Theysohn, N; Maderwald, S; Forsting, M; Schedlowski, M; Elsenbruch, S				Kattoor, Joswin; Gizewski, Elke R.; Kotsis, Vassilios; Benson, Sven; Gramsch, Carolin; Theysohn, Nina; Maderwald, Stefan; Forsting, Michael; Schedlowski, Manfred; Elsenbruch, Sigrid			Fear Conditioning in an Abdominal Pain Model: Neural Responses during Associative Learning and Extinction in Healthy Subjects	PLOS ONE			English	Article							IRRITABLE-BOWEL-SYNDROME; AMYGDALA ACTIVATION; MUSCULAR RESPONSES; BRAIN ACTIVATION; VISCERAL STIMULI; REINSTATEMENT; MECHANISMS; EXPOSURE; CORTEX; HYPERSENSITIVITY	Fear conditioning is relevant for elucidating the pathophysiology of anxiety, but may also be useful in the context of chronic pain syndromes which often overlap with anxiety. Thus far, no fear conditioning studies have employed aversive visceral stimuli from the lower gastrointestinal tract. Therefore, we implemented a fear conditioning paradigm to analyze the conditioned response to rectal pain stimuli using fMRI during associative learning, extinction and reinstatement. In N = 21 healthy humans, visual conditioned stimuli (CS+) were paired with painful rectal distensions as unconditioned stimuli (US), while different visual stimuli (CS-) were presented without US. During extinction, all CSs were presented without US, whereas during reinstatement, a single, unpaired US was presented. In region-of-interest analyses, conditioned anticipatory neural activation was assessed along with perceived CS-US contingency and CS unpleasantness. Fear conditioning resulted in significant contingency awareness and valence change, i.e., learned unpleasantness of a previously neutral stimulus. This was paralleled by anticipatory activation of the anterior cingulate cortex, the somatosensory cortex and precuneus (all during early acquisition) and the amygdala (late acquisition) in response to the CS+. During extinction, anticipatory activation of the dorsolateral prefrontal cortex to the CS- was observed. In the reinstatement phase, a tendency for parahippocampal activation was found. Fear conditioning with rectal pain stimuli is feasible and leads to learned unpleasantness of previously neutral stimuli. Within the brain, conditioned anticipatory activations are seen in core areas of the central fear network including the amygdala and the anterior cingulate cortex. During extinction, conditioned responses quickly disappear, and learning of new predictive cue properties is paralleled by prefrontal activation. A tendency for parahippocampal activation during reinstatement could indicate a reactivation of the old memory trace. Together, these findings contribute to our understanding of aversive visceral learning and memory processes relevant to the pathophysiology of chronic abdominal pain.	[Kattoor, Joswin; Kotsis, Vassilios; Benson, Sven; Schedlowski, Manfred; Elsenbruch, Sigrid] Univ Duisburg Essen, Univ Hosp Essen, Inst Med Psychol & Behav Immunobiol, Essen, Germany; [Gizewski, Elke R.] Med Univ Innsbruck, Clin Neuroradiol, A-6020 Innsbruck, Austria; [Gramsch, Carolin; Theysohn, Nina; Forsting, Michael] Univ Duisburg Essen, Univ Hosp Essen, Inst Diagnost & Intervent Radiol & Neuroradiol, Essen, Germany; [Maderwald, Stefan] Univ Duisburg Essen, Erwin L Hahn Inst Resonance Imaging, Essen, Germany	University of Duisburg Essen; Medical University of Innsbruck; University of Duisburg Essen; University of Duisburg Essen	Elsenbruch, S (corresponding author), Univ Duisburg Essen, Univ Hosp Essen, Inst Med Psychol & Behav Immunobiol, Essen, Germany.	sigrid.elsenbruch@uk-essen.de	Benson, Sven/O-7201-2019; Maderwald, Stefan/B-4241-2011; Benson, Sven/I-1981-2014; Forsting, Michael/C-6925-2013	Benson, Sven/0000-0002-4487-4258; Benson, Sven/0000-0002-4487-4258; Elsenbruch, Sigrid/0000-0002-6528-2665; KOTSIS, VASILIOS/0000-0002-3755-8097; Gizewski, Elke Ruth/0000-0001-6859-8377	German Research Foundation [DFG EL 236/9-1]	German Research Foundation(German Research Foundation (DFG))	This work was funded by the German Research Foundation (DFG EL 236/9-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaro E, 2006, BRAIN COGNITION, V60, P220, DOI 10.1016/j.bandc.2005.11.009; Benson S, 2012, EUR J PAIN, V16, P349, DOI 10.1002/j.1532-2149.2011.00027.x; Berman SM, 2008, J NEUROSCI, V28, P349, DOI 10.1523/JNEUROSCI.2500-07.2008; Bishop SJ, 2007, TRENDS COGN SCI, V11, P307, DOI 10.1016/j.tics.2007.05.008; Bouton ME, 2004, LEARN MEMORY, V11, P485, DOI 10.1101/lm.78804; Buchel C, 1998, NEURON, V20, P947, DOI 10.1016/S0896-6273(00)80476-6; Coen SJ, 2011, GASTROENTEROLOGY, V141, P909, DOI 10.1053/j.gastro.2011.06.008; Craske MG, 2011, BEHAV RES THER, V49, P413, DOI 10.1016/j.brat.2011.04.001; Davis KD, 2005, J NEUROSCI, V25, P8402, DOI 10.1523/JNEUROSCI.2315-05.2005; De Peuter S, 2011, EUR J PAIN, V15, P889, DOI 10.1016/j.ejpain.2011.03.002; Dunsmoor JE, 2008, NEUROIMAGE, V40, P811, DOI 10.1016/j.neuroimage.2007.11.042; Dunsmoor JE, 2007, BEHAV NEUROSCI, V121, P635, DOI 10.1037/0735-7044.121.4.635; Ehrlich I, 2009, NEURON, V62, P757, DOI 10.1016/j.neuron.2009.05.026; Elsenbruch S, 2012, PAIN, V153, P382, DOI 10.1016/j.pain.2011.10.036; Elsenbruch S, 2011, BRAIN BEHAV IMMUN, V25, P386, DOI 10.1016/j.bbi.2010.11.010; Elsenbruch S, 2010, GASTROENTEROLOGY, V139, P1310, DOI 10.1053/j.gastro.2010.06.054; Fiddick L, 2011, NEUROSCI BIOBEHAV R, V35, P1007, DOI 10.1016/j.neubiorev.2010.09.014; Flor H, 2002, PAIN, V95, P111, DOI 10.1016/S0304-3959(01)00385-2; Giovanello KS, 2009, HIPPOCAMPUS, V19, P111, DOI 10.1002/hipo.20491; Hermans D, 2005, BEHAV RES THER, V43, P533, DOI 10.1016/j.brat.2004.03.013; Hermans D, 2006, BIOL PSYCHIAT, V60, P361, DOI 10.1016/j.biopsych.2005.10.006; Herrmann-Lingen C., 2005, HADS D HOSP ANXIETY; Hubbard CS, 2011, J NEUROSCI, V31, P12491, DOI 10.1523/JNEUROSCI.1860-11.2011; Klinger R, 2010, PAIN, V150, P66, DOI 10.1016/j.pain.2010.03.036; Klosterhalfen S, 2000, PSYCHOSOM MED, V62, P671, DOI 10.1097/00006842-200009000-00011; LaBar KS, 2005, BEHAV NEUROSCI, V119, P677, DOI 10.1037/0735-7044.119.3.677; LaBar KS, 1998, NEURON, V20, P937, DOI 10.1016/S0896-6273(00)80475-4; Labus JS, 2009, NEUROIMAGE, V47, P952, DOI 10.1016/j.neuroimage.2009.05.078; Lembo T, 1999, AM J GASTROENTEROL, V94, P1320, DOI 10.1111/j.1572-0241.1999.01009.x; Lissek S, 2010, AM J PSYCHIAT, V167, P47, DOI 10.1176/appi.ajp.2009.09030410; Lissek S, 2009, BEHAV RES THER, V47, P111, DOI 10.1016/j.brat.2008.10.017; Ljotsson B, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-110; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Milad MR, 2012, ANNU REV PSYCHOL, V63, P129, DOI 10.1146/annurev.psych.121208.131631; Nees F, 2010, PSYCHOSOM MED, V72, P412, DOI 10.1097/PSY.0b013e3181d2bbef; Norberg MM, 2008, BIOL PSYCHIAT, V63, P1118, DOI 10.1016/j.biopsych.2008.01.012; North CS, 2007, WORLD J GASTROENTERO, V13, P2020, DOI 10.3748/wjg.v13.i14.2020; Nozu T, 2006, J GASTROENTEROL, V41, P217, DOI 10.1007/s00535-005-1748-z; Phelps EA, 2004, NEURON, V43, P897, DOI 10.1016/j.neuron.2004.08.042; Price DD, 2000, SCIENCE, V288, P1769, DOI 10.1126/science.288.5472.1769; Quirk GJ, 2010, J NEUROSCI, V30, P14993, DOI 10.1523/JNEUROSCI.4268-10.2010; Rosenberger C, 2009, NEUROGASTROENT MOTIL, V21, P740, DOI 10.1111/j.1365-2982.2009.01295.x; Schmajuk NA, 2007, BEHAV BRAIN RES, V177, P242, DOI 10.1016/j.bbr.2006.11.026; Schneider C, 2004, PAIN, V112, P239, DOI 10.1016/j.pain.2004.08.025; Sehlmeyer C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005865; Shackman AJ, 2011, NAT REV NEUROSCI, V12, P154, DOI 10.1038/nrn2994; Stockhorst U, 2007, WORLD J GASTROENTERO, V13, P3430, DOI 10.3748/wjg.v13.i25.3430; Straube T, 2007, NEUROIMAGE, V34, P462, DOI 10.1016/j.neuroimage.2006.08.021; Tabbert K, 2005, INT J PSYCHOPHYSIOL, V57, P15, DOI 10.1016/j.ijpsycho.2005.01.007; Tyler K, 2007, NEUROGASTROENT MOTIL, V19, P761, DOI 10.1111/j.1365-2982.2007.00955.x; Van Damme S, 2006, J PAIN, V7, P346, DOI 10.1016/j.jpain.2005.12.006; Vogt BA, 2005, NAT REV NEUROSCI, V6, P533, DOI 10.1038/nrn1704; Vouimba RM, 2011, NEUROPSYCHOPHARMACOL, V36, P2276, DOI 10.1038/npp.2011.115; Wang Z, 2011, PAIN, V152, P2746, DOI 10.1016/j.pain.2011.08.022; Worthen SF, 2011, EUR J NEUROSCI, V33, P946, DOI 10.1111/j.1460-9568.2010.07575.x; Yaguez L, 2005, GASTROENTEROLOGY, V128, P1819, DOI 10.1053/j.gastro.2005.02.068	56	66	67	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2013	8	2							e51149	10.1371/journal.pone.0051149	http://dx.doi.org/10.1371/journal.pone.0051149			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098PO	23468832	gold, Green Submitted, Green Published			2022-12-25	WOS:000315561400002
J	Huber, RM; Rajski, M; Sivasankaran, B; Moncayo, G; Hemmings, BA; Merlo, A				Huber, Roland M.; Rajski, Michal; Sivasankaran, Balasubramanian; Moncayo, Gerald; Hemmings, Brian A.; Merlo, Adrian			Deltex-1 Activates Mitotic Signaling and Proliferation and Increases the Clonogenic and Invasive Potential of U373 and LN18 Glioblastoma Cells and Correlates with Patient Survival	PLOS ONE			English	Article							HUMAN GLIOMAS; GENE-EXPRESSION; DOWN-REGULATION; NOTCH RECEPTOR; BRAIN-TUMORS; STEM-CELLS; PATHWAY; CANCER; DIFFERENTIATION; REGULATOR	Glioblastoma (GBM) is a highly malignant primary tumor of the central nervous system originating in glial cells. GBM results in more years of life lost than any other cancer type. Low levels of Notch receptor expression correlates with prolonged survival in various high grade gliomas independent of other markers. Different downstream pathways of Notch receptors have been identified. We tested if the Notch/Deltex pathway, which is distinct from the canonical, CSL-mediated pathway, has a role in GBM. We show that the alternative or non-canonical Notch pathway functioning through Deltex1 (DTX1) mediates key features of glioblastoma cell aggressiveness. For example, DTX1 activates the RTK/PI3K/PKB and the MAPK/ERK mitotic pathways and induces anti-apoptotic Mcl-1. The clonogenic and growth potential of established glioma cells correlated with DTX1 levels. Microarray gene expression analysis further identified a DTX1-specific, MAML1-independent transcriptional program - including microRNA-21- which is functionally linked to the changes in tumor cell aggressiveness. Over-expression of DTX1 increased cell migration and invasion correlating to ERK activation, miR-21 levels and endogenous Notch levels. In contrast to high and intermediate expressors, patients with low DTX1 levels have a more favorable prognosis. The alternative Notch pathway via DTX1 appears to be an oncogenic factor in glioblastoma and these findings offer new potential therapeutic targets.	[Huber, Roland M.; Sivasankaran, Balasubramanian; Merlo, Adrian] Univ Basel, Dept Biomed, Basel, Switzerland; [Huber, Roland M.; Moncayo, Gerald; Hemmings, Brian A.] Friedrich Miescher Inst Biomed Res, Mech Canc Program, Basel, Switzerland; [Rajski, Michal] Univ Zurich, Inst Physiol, Zurich, Switzerland	University of Basel; Friedrich Miescher Institute for Biomedical Research; University of Zurich	Huber, RM (corresponding author), Fred Hutchinson Canc Res Ctr, Human Biol Div, 1124 Columbia St, Seattle, WA 98104 USA.	rhuber@fhcrc.org	Sivasankaran, Balasubramanian/D-1527-2015	Sivasankaran, Balasubramanian/0000-0001-6207-5516	Oncosuisse grant [OCS-01613-12-2004]	Oncosuisse grant	This study was supported by Oncosuisse grant #OCS-01613-12-2004 (www.swisscancer.ch). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias AM, 2002, CURR OPIN GENET DEV, V12, P524, DOI 10.1016/S0959-437X(02)00336-2; Boulay JL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000576; Brennan K, 2002, BIOESSAYS, V24, P405, DOI 10.1002/bies.10089; Burnet NG, 2005, BRIT J CANCER, V92, P241, DOI 10.1038/sj.bjc.6602321; Cui XY, 2004, J BIOL CHEM, V279, P25858, DOI 10.1074/jbc.M313505200; Dotto GP, 2009, NAT REV CANCER, V9, P587, DOI 10.1038/nrc2675; Eiraku M, 2005, NAT NEUROSCI, V8, P873, DOI 10.1038/nn1492; Fan X, 2010, STEM CELLS, V28, P5, DOI 10.1002/stem.254; Gabriely G, 2008, MOL CELL BIOL, V28, P5369, DOI 10.1128/MCB.00479-08; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gilbert CA, 2010, CANCER RES, V70, P6870, DOI 10.1158/0008-5472.CAN-10-1378; Grzmil M, 2010, BBA-PROTEINS PROTEOM, V1804, P476, DOI 10.1016/j.bbapap.2009.10.018; Holland EC, 2000, NAT GENET, V25, P55, DOI 10.1038/75596; Hsiao HW, 2009, IMMUNITY, V31, P72, DOI 10.1016/j.immuni.2009.04.017; Hu QD, 2004, ANN ACAD MED SINGAP, V33, P581; Hu QD, 2003, CELL, V115, P163, DOI 10.1016/S0092-8674(03)00810-9; Huang TH, 2009, J BIOL CHEM, V284, P18515, DOI 10.1074/jbc.M109.006676; HUETTNER C, 1995, AM J PATHOL, V146, P317; Ishii N, 1999, BRAIN PATHOL, V9, P469, DOI 10.1111/j.1750-3639.1999.tb00536.x; Joy AM, 2003, J CELL SCI, V116, P4409, DOI 10.1242/jcs.00712; Korur S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007443; Lakka SS, 2002, ONCOGENE, V21, P5601, DOI 10.1038/sj.onc.1205646; Lino M, 2009, CURR OPIN CELL BIOL, V21, P311, DOI 10.1016/j.ceb.2008.12.009; Liu WH, 2005, MOL CELL BIOL, V25, P1367, DOI 10.1128/MCB.25.4.1367-1378.2005; MATSUNO K, 1995, DEVELOPMENT, V121, P2633; Miele L, 2006, CURR MOL MED, V6, P905, DOI 10.2174/156652406779010830; Mitsuuchi Y, 1999, ONCOGENE, V18, P4891, DOI 10.1038/sj.onc.1203080; Mukherjee A, 2005, NAT CELL BIOL, V7, P1191, DOI 10.1038/ncb1327; Oishi K, 2004, DEV BIOL, V276, P172, DOI 10.1016/j.ydbio.2004.08.039; Oliver TG, 2003, P NATL ACAD SCI USA, V100, P7331, DOI 10.1073/pnas.0832317100; Ordentlich P, 1998, MOL CELL BIOL, V18, P2230, DOI 10.1128/MCB.18.4.2230; Papagiannakopoulos T, 2008, CANCER RES, V68, P8164, DOI 10.1158/0008-5472.CAN-08-1305; Patterson KI, 2009, BIOCHEM J, V418, P475, DOI 10.1042/BJ20082234; Purow BW, 2005, CANCER RES, V65, P2353, DOI 10.1158/0008-5472.CAN-04-1890; Ramain P, 2001, CURR BIOL, V11, P1729, DOI 10.1016/S0960-9822(01)00562-0; Rangarajan A, 2003, NAT REV CANCER, V3, P952, DOI 10.1038/nrc1235; Sanai N, 2005, NEW ENGL J MED, V353, P811, DOI 10.1056/NEJMra043666; Selcuklu SD, 2009, BIOCHEM SOC T, V37, P918, DOI 10.1042/BST0370918; Sivasankaran B, 2009, CANCER RES, V69, P458, DOI 10.1158/0008-5472.CAN-08-2610; Stockhausen MT, 2010, NEURO-ONCOLOGY, V12, P199, DOI 10.1093/neuonc/nop022; Strippoli R, 2008, DIS MODEL MECH, V1, P264, DOI 10.1242/dmm.001321; Stupp R, 2005, ONKOLOGIE, V28, P315, DOI 10.1159/000085575; Sun P, 2009, STEM CELLS, V27, P1473, DOI 10.1002/stem.89; Suzuki K, 2005, BIOORGAN MED CHEM, V13, P4014, DOI 10.1016/j.bmc.2005.03.053; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Wang JL, 2010, STEM CELLS, V28, P17, DOI 10.1002/stem.261; Wettenhall JM, 2004, BIOINFORMATICS, V20, P3705, DOI 10.1093/bioinformatics/bth449; Yamamoto N, 2001, J BIOL CHEM, V276, P45031, DOI 10.1074/jbc.M105245200; Yoo AS, 2005, SCIENCE, V310, P1330, DOI 10.1126/science.1119481; Zamecnik J, 2005, ACTA NEUROPATHOL, V110, P435, DOI 10.1007/s00401-005-1078-5; Zhang BB, 2009, INT J CANCER, V125, P585, DOI 10.1002/ijc.24314; Zhang P, 2010, ONCOGENE, V29, P2916, DOI 10.1038/onc.2010.62; Zhang X, 2011, CANC SCI; Zhu TS, 2011, CANCER RES, V71, P6061, DOI 10.1158/0008-5472.CAN-10-4269; Zohrabian VM, 2009, ANTICANCER RES, V29, P119	56	32	32	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57793	10.1371/journal.pone.0057793	http://dx.doi.org/10.1371/journal.pone.0057793			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451269	Green Published, Green Submitted, gold			2022-12-25	WOS:000316849500134
J	Sehgal, P; Chaturvedi, P; Kumaran, RI; Kumar, S; Parnaik, VK				Sehgal, Poonam; Chaturvedi, Pankaj; Kumaran, R. Ileng; Kumar, Satish; Parnaik, Veena K.			Lamin A/C Haploinsufficiency Modulates the Differentiation Potential of Mouse Embryonic Stem Cells	PLOS ONE			English	Article							SKELETAL-MUSCLE DIFFERENTIATION; A-TYPE LAMINS; NUCLEAR LAMINS; TRANSCRIPTION FACTORS; VISCERAL ENDODERM; DILATED CARDIOMYOPATHY; DEFINITIVE ENDODERM; ALPHA-FETOPROTEIN; EXPRESSION; GENE	Background: Lamins are structural proteins that are the major determinants of nuclear architecture and play important roles in various nuclear functions including gene regulation and cell differentiation. Mutations in the human lamin A gene cause a spectrum of genetic diseases that affect specific tissues. Most available mouse models for laminopathies recapitulate disease symptoms for muscle diseases and progerias. However, loss of human lamin A/C also has highly deleterious effects on fetal development. Hence it is important to understand the impact of lamin A/C expression levels on embryonic differentiation pathways. Methodology and Principal Findings: We have investigated the differentiation potential of mouse embryonic stem cells containing reduced levels of lamin A/C by detailed lineage analysis of embryoid bodies derived from these cells by in vitro culture. We initially carried out a targeted disruption of one allele of the mouse lamin A/C gene (Lmna). Undifferentiated wild-type and Lmna(+/-) embryonic stem cells showed similar expression of pluripotency markers and cell cycle profiles. Upon spontaneous differentiation into embryoid bodies, markers for visceral endoderm such as alpha-fetoprotein were highly upregulated in haploinsufficient cells. However, neuronal markers such as beta-III tubulin and nestin were downregulated. Furthermore, we observed a reduction in the commitment of Lmna(+/-) cells into the myogenic lineage, but no discernible effects on cardiac, adipocyte or osteocyte lineages. In the next series of experiments, we derived embryonic stem cell clones expressing lamin A/C short hairpin RNA and examined their differentiation potential. These cells expressed pluripotency markers and, upon differentiation, the expression of lineage-specific markers was altered as observed with Lmna(+/-) embryonic stem cells. Conclusions: We have observed significant effects on embryonic stem cell differentiation to visceral endoderm, neuronal and myogenic lineages upon depletion of lamin A/C. Hence our results implicate lamin A/C level as an important determinant of lineage-specific differentiation during embryonic development.	[Sehgal, Poonam; Chaturvedi, Pankaj; Kumaran, R. Ileng; Kumar, Satish; Parnaik, Veena K.] CSIR Ctr Cellular & Mol Biol, Hyderabad, Andhra Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Parnaik, VK (corresponding author), CSIR Ctr Cellular & Mol Biol, Hyderabad, Andhra Pradesh, India.	veenap@ccmb.res.in	Sehgal, Poonam/AAA-7935-2021; Chaturvedi, Pankaj/ABC-4658-2020	Sehgal, Poonam/0000-0003-3704-6283; Chaturvedi, Pankaj/0000-0001-7596-2165	JC Bose national fellowship from the Department of Science and Technology, India; Council of Scientific and Industrial Research, India; Department of Science and Technology; Council of Scientific and Industrial Research	JC Bose national fellowship from the Department of Science and Technology, India; Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India); Department of Science and Technology(Department of Science & Technology (India)); Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India)	VKP is a recipient of the JC Bose national fellowship from the Department of Science and Technology, India. PS and RIK were supported by pre-doctoral fellowships from the Council of Scientific and Industrial Research, India. PC was supported by a research fellowship from the Department of Science and Technology. Financial support from the Department of Science and Technology and Council of Scientific and Industrial Research for this work is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Andres V, 2009, J CELL BIOL, V187, P945, DOI 10.1083/jcb.200904124; ANG SL, 1993, DEVELOPMENT, V119, P1301; BEDDINGTON RSP, 1989, DEVELOPMENT, V105, P733; Bonne G, 1999, NAT GENET, V21, P285, DOI 10.1038/6799; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Broers JLV, 2006, PHYSIOL REV, V86, P967, DOI 10.1152/physrev.00047.2005; Bylund M, 2003, NAT NEUROSCI, V6, P1162, DOI 10.1038/nn1131; Capell BC, 2006, NAT REV GENET, V7, P940, DOI 10.1038/nrg1906; Charron F, 1999, SEMIN CELL DEV BIOL, V10, P85, DOI 10.1006/scdb.1998.0281; Coffinier C, 1999, DEVELOPMENT, V126, P4785; Constantinescu D, 2006, STEM CELLS, V24, P474, DOI 10.1634/stemcells.2006-erratum.2; COUCOUVANIS E, 1995, CELL, V83, P279, DOI 10.1016/0092-8674(95)90169-8; Crispino JD, 2001, GENE DEV, V15, P839, DOI 10.1101/gad.875201; Cupesi M, 2010, J MOL CELL CARDIOL, V48, P1290, DOI 10.1016/j.yjmcc.2009.10.024; Dechat T, 2008, GENE DEV, V22, P832, DOI 10.1101/gad.1652708; DOETSCHMAN TC, 1985, J EMBRYOL EXP MORPH, V87, P27; Dufort D, 1998, DEVELOPMENT, V125, P3015; Duque G, 2011, BONE, V49, P412, DOI 10.1016/j.bone.2011.04.023; DZIADEK M, 1978, J EMBRYOL EXP MORPH, V43, P289; Favreau C, 2004, MOL CELL BIOL, V24, P1481, DOI 10.1128/MCB.24.4.1481-1492.2004; Foster HA, 2007, CHROMOSOME RES, V15, P163, DOI 10.1007/s10577-006-1088-8; Frock RL, 2006, GENE DEV, V20, P486, DOI 10.1101/gad.1364906; Hall VJ, 2005, MOL REPROD DEV, V72, P471, DOI 10.1002/mrd.20381; HERRMANN BG, 1994, TRENDS GENET, V10, P280, DOI 10.1016/0168-9525(90)90011-T; Jahn D, 2012, NUCLEUS-AUSTIN, V3, P463, DOI 10.4161/nucl.21676; Jung HJ, 2012, P NATL ACAD SCI USA, V109, pE423, DOI 10.1073/pnas.1111780109; Kan LX, 2004, DEV BIOL, V269, P580, DOI 10.1016/j.ydbio.2004.02.005; Kennedy KAM, 2010, J BIOL CHEM, V285, P17974, DOI 10.1074/jbc.M109.084616; Kim WK, 2008, ENDOCR J, V55, P827, DOI 10.1507/endocrj.K08E-115; Koutsourakis M, 1999, DEVELOPMENT, V126, P723; Kubo A, 2004, DEVELOPMENT, V131, P1651, DOI 10.1242/dev.01044; Kumaran RI, 2002, J CELL BIOL, V159, P783, DOI 10.1083/jcb.200204149; LASSAR AB, 1994, CURR OPIN CELL BIOL, V6, P788, DOI 10.1016/0955-0674(94)90046-9; Lazarevich NL, 2000, BIOCHEMISTRY-MOSCOW+, V65, P117; Li HW, 2009, BMC NEUROSCI, V10, DOI [10.1186/1471-2202-10-122, 10.1186/1471-2105-10-418]; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Mariappan I, 2005, MOL BIOL CELL, V16, P1948, DOI 10.1091/mbc.E04-02-0154; Markiewicz E, 2005, J CELL SCI, V118, P409, DOI 10.1242/jcs.01630; MARTIN GR, 1977, DEV BIOL, V61, P230, DOI 10.1016/0012-1606(77)90294-9; Meshorer E, 2006, NAT REV MOL CELL BIO, V7, P540, DOI 10.1038/nrm1938; Metzger JM, 1996, CIRC RES, V78, P547, DOI 10.1161/01.RES.78.4.547; Muchir A, 2003, EXP CELL RES, V291, P352, DOI 10.1016/j.yexcr.2003.07.002; Muralikrishna B, 2012, MOL CELL BIOCHEM, V365, P323, DOI 10.1007/s11010-012-1272-4; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Nikolova V, 2004, J CLIN INVEST, V113, P357, DOI 10.1172/JCI200419448; Niwa H, 2010, DEV GROWTH DIFFER, V52, P275, DOI 10.1111/j.1440-169X.2009.01166.x; Parnaik VK, 2008, INT REV CEL MOL BIO, V266, P157, DOI 10.1016/S1937-6448(07)66004-3; Parnaik VK, 2006, J BIOSCIENCES, V31, P405, DOI 10.1007/BF02704113; Parnaik VK, 2011, J BIOSCIENCES, V36, P471, DOI 10.1007/s12038-011-9085-2; Pekovic V, 2008, J ANAT, V213, P5, DOI 10.1111/j.1469-7580.2008.00928.x; Perrien DS, 2006, J CLIN ENDOCR METAB, V91, P1848, DOI 10.1210/jc.2005-2423; ROBER RA, 1989, DEVELOPMENT, V105, P365; ROGERS MB, 1991, DEVELOPMENT, V113, P815; Rossant J, 2007, REPROD FERT DEVELOP, V19, P111, DOI 10.1071/RD06125; RUDNICKI MA, 1995, BIOESSAYS, V17, P203, DOI 10.1002/bies.950170306; SCHATTEN G, 1985, P NATL ACAD SCI USA, V82, P4727, DOI 10.1073/pnas.82.14.4727; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; Solter D, 2006, NAT REV GENET, V7, P319, DOI 10.1038/nrg1827; SOUDAIS C, 1995, DEVELOPMENT, V121, P3877; Spann TP, 2002, J CELL BIOL, V156, P603, DOI 10.1083/jcb.200112047; STEWART C, 1987, CELL, V51, P383, DOI 10.1016/0092-8674(87)90634-9; Stewart CL, 2007, EXP CELL RES, V313, P2144, DOI 10.1016/j.yexcr.2007.03.026; Sullivan T, 1999, J CELL BIOL, V147, P913, DOI 10.1083/jcb.147.5.913; Thomas PQ, 1998, DEVELOPMENT, V125, P85; Tong J, 2011, MECH AGEING DEV, V132, P552, DOI 10.1016/j.mad.2011.09.004; Vlcek S, 2007, CURR OPIN CELL BIOL, V19, P298, DOI 10.1016/j.ceb.2007.04.001; WINNIER G, 1995, GENE DEV, V9, P2105, DOI 10.1101/gad.9.17.2105; Wolf CM, 2008, J MOL CELL CARDIOL, V44, P293, DOI 10.1016/j.yjmcc.2007.11.008; Worman HJ, 2007, EXP CELL RES, V313, P2121, DOI 10.1016/j.yexcr.2007.03.028; Young SG, 2012, J BIOL CHEM, V287, P16103, DOI 10.1074/jbc.R112.354407; Zhou Q, 2000, NEURON, V25, P331, DOI 10.1016/S0896-6273(00)80898-3	71	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57891	10.1371/journal.pone.0057891	http://dx.doi.org/10.1371/journal.pone.0057891			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451281	Green Submitted, gold, Green Published, Green Accepted			2022-12-25	WOS:000316849500143
J	Shekarabi, M; Lafreniere, RG; Gaudet, R; Laganiere, J; Marcinkiewicz, MM; Dion, PA; Rouleau, GA				Shekarabi, Masoud; Lafreniere, Ron G.; Gaudet, Rebecca; Laganiere, Janet; Marcinkiewicz, Martin M.; Dion, Patrick A.; Rouleau, Guy A.			Comparative Analysis of the Expression Profile of Wnk1 and Wnk1/Hsn2 Splice Variants in Developing and Adult Mouse Tissues	PLOS ONE			English	Article							CL-COTRANSPORTER; BLOOD-PRESSURE; KINASE; GENE; MUTATIONS; HYPERTENSION; POTASSIUM; EPITHELIA; ISOFORMS; PATHWAY	The With No lysine (K) family of serine/threonine kinase (WNK) defines a small family of kinases with significant roles in ion homeostasis. WNK1 has been shown to have different isoforms due to what seems to be largely tissue specific splicing. Here, we used two distinct in situ hybridization riboprobes on developing and adult mouse tissues to make a comparative analysis of Wnk1 and its sensory associated splice isoform, Wnk1/Hsn2. The hybridization signals in developing mouse tissues, which were prepared at embryonic day e10.5 and e12.5, revealed a homogenous expression profile with both probes. At e15.5 and in the newborn mouse, the two probes revealed different expression profiles with prominent signals in nervous system tissues and also other tissues such as kidney, thymus and testis. In adult mouse tissues, the two expression profiles appeared even more restricted to the nervous tissues, kidney, thymus and testis, with no detectable signal in the other tissues. Throughout the nervous system, sensory tissues, as well as in Cornu Ammonis 1 (CA1), CA2 and CA3 areas of the hippocampus, were strongly labeled with both probes. Hybridization signals were also strongly detected in Schwann and supporting satellite cells. Our results show that the expression profiles of Wnk1 isoforms change during the development, and that the expression of the Wnk1 splice variant containing the Hsn2 exon is prominent during developing and in adult mouse tissues, suggesting its important role in the development and maintenance of the nervous system.	[Shekarabi, Masoud; Lafreniere, Ron G.; Gaudet, Rebecca; Laganiere, Janet; Dion, Patrick A.; Rouleau, Guy A.] Univ Montreal, CRCHUM, Univ Montreal CENUM, Ctr Excellence Neurosci, Montreal, PQ, Canada; [Marcinkiewicz, Martin M.] Cytochem Inc, Montreal, PQ, Canada; [Dion, Patrick A.; Rouleau, Guy A.] Univ Montreal, Dept Pathol & Cellular Biol, Montreal, PQ, Canada; [Rouleau, Guy A.] Univ Montreal, CHU St Justine Res Ctr, Montreal, PQ, Canada; [Rouleau, Guy A.] Univ Montreal, Dept Paediat & Biochem, Montreal, PQ, Canada; [Rouleau, Guy A.] Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Universite de Montreal; Universite de Montreal	Rouleau, GA (corresponding author), Univ Montreal, CRCHUM, Univ Montreal CENUM, Ctr Excellence Neurosci, Montreal, PQ, Canada.	guy.rouleau@umontreal.ca			Canadian Institutes of Health Research [IG1-78904]; Fondation de Jumelle Coude	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fondation de Jumelle Coude	This work was supported by a research grant (IG1-78904) from the Canadian Institutes of Health Research to GAR and the Fondation de Jumelle Coude. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergaya S, 2012, CURR OPIN NEPHROL HY, V21, P39, DOI 10.1097/MNH.0b013e32834d2fde; Choate KA, 2003, P NATL ACAD SCI USA, V100, P663, DOI 10.1073/pnas.242728499; Delaloy C, 2003, MOL CELL BIOL, V23, P9208, DOI 10.1128/MCB.23.24.9208-9221.2003; Delaloy C, 2006, AM J PATHOL, V169, P105, DOI 10.2353/ajpath.2006.051290; Glover M, 2009, J AM SOC NEPHROL, V20, P1314, DOI 10.1681/ASN.2008050542; Holden S, 2004, GENE, V335, P109, DOI 10.1016/j.gene.2004.03.009; Hoorn EJ, 2011, J AM SOC NEPHROL, V22, P605, DOI 10.1681/ASN.2010080827; Kahle KT, 2005, P NATL ACAD SCI USA, V102, P16783, DOI 10.1073/pnas.0508307102; Kahle KT, 2004, P NATL ACAD SCI USA, V101, P2064, DOI 10.1073/pnas.0308434100; Lafreniere RG, 2010, NAT MED, V16, P1157, DOI 10.1038/nm.2216; McCormick JA, 2011, PHYSIOL REV, V91, P177, DOI 10.1152/physrev.00017.2010; O'Reilly M, 2003, J AM SOC NEPHROL, V14, P2447, DOI 10.1097/01.ASN.0000089830.97681.3B; O'Reilly M, 2006, J AM SOC NEPHROL, V17, P2402, DOI 10.1681/ASN.2005111197; Pearson MM, 2001, NEUROSCIENCE, V103, P481, DOI 10.1016/S0306-4522(00)00567-4; Rinehart J, 2009, CELL, V138, P525, DOI 10.1016/j.cell.2009.05.031; Shekarabi M, 2008, J CLIN INVEST, V118, P2496, DOI 10.1172/JCI34088; Thastrup JO, 2011, BIOCH J; Verissimo F, 2001, ONCOGENE, V20, P5562, DOI 10.1038/sj.onc.1204726; Vidal-Petiot E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037751; Wilson FH, 2001, SCIENCE, V293, P1107, DOI 10.1126/science.1062844; Xie J, 2009, AM J PATHOL, V175, P1315, DOI 10.2353/ajpath.2009.090094	21	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57807	10.1371/journal.pone.0057807	http://dx.doi.org/10.1371/journal.pone.0057807			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451271	gold, Green Submitted, Green Published			2022-12-25	WOS:000316849500136
J	van der Marel, K; Homberg, JR; Otte, WM; Dijkhuizen, RM				van der Marel, Kajo; Homberg, Judith R.; Otte, Willem M.; Dijkhuizen, Rick M.			Functional and Structural Neural Network Characterization of Serotonin Transporter Knockout Rats	PLOS ONE			English	Article							GRAPH-THEORETICAL ANALYSIS; GENETIC-VARIATION; DOPAMINE TRANSPORTER; CORPUS-CALLOSUM; COCAINE REWARD; BRAIN; ISOFLURANE; CONNECTIVITY; 5-HTTLPR; ANXIETY	Brain serotonin homeostasis is crucially maintained by the serotonin transporter (5-HTT), and its down-regulation has been linked to increased vulnerability for anxiety- and depression-related behavior. Studies in 5-HTT knockout (5-HTT-/-) rodents have associated inherited reduced functional expression of 5-HTT with increased sensitivity to adverse as well as rewarding environmental stimuli, and in particular cocaine hyperresponsivity. 5-HTT down-regulation may affect normal neuronal wiring of implicated corticolimbic cerebral structures. To further our understanding of its contribution to potential alterations in basal functional and structural properties of neural network configurations, we applied resting-state functional MRI (fMRI), pharmacological MRI of cocaine-induced activation, and diffusion tensor imaging (DTI) in 5-HTT-/- rats and wildtype controls (5-HTT+/+). We found that baseline functional connectivity values and cocaine-induced neural activity within the corticolimbic network was not significantly altered in 5-HTT-/- versus 5-HTT+/+ rats. Similarly, DTI revealed mostly intact white matter structural integrity, except for a reduced fractional anisotropy in the genu of the corpus callosum of 5-HTT-/- rats. At the macroscopic level, analyses of complex graphs constructed from either functional connectivity values or structural DTI-based tractography results revealed that key properties of brain network organization were essentially similar between 5-HTT+/+ and 5-HTT-/- rats. The individual tests for differences between 5-HTT+/+ and 5-HTT-/- rats were capable of detecting significant effects ranging from 5.8% (fractional anisotropy) to 26.1% (pharmacological MRI) and 29.3% (functional connectivity). Tentatively, lower fractional anisotropy in the genu of the corpus callosum could indicate a reduced capacity for information integration across hemispheres in 5-HTT-/- rats. Overall, the comparison of 5-HTT-/- and wild-type rats suggests mostly limited effects of 5-HTT genotype on MRI-based measures of brain morphology and function.	[van der Marel, Kajo; Otte, Willem M.; Dijkhuizen, Rick M.] Univ Med Ctr Utrecht, Image Sci Inst, Biomed MR Imaging & Spect Grp, Utrecht, Netherlands; [Homberg, Judith R.] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Dept Cognit Neurosci,Ctr Neurosci, NL-6525 ED Nijmegen, Netherlands; [Otte, Willem M.] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Pediat Neurol, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Radboud University Nijmegen; Utrecht University; Utrecht University Medical Center	van der Marel, K (corresponding author), Univ Med Ctr Utrecht, Image Sci Inst, Biomed MR Imaging & Spect Grp, Utrecht, Netherlands.	kajo@isi.uu.nl	Otte, Willem M./J-6140-2019; Homberg, Judith R/D-2473-2010; Homberg, J.R./N-4172-2019; Otte, Willem M/I-1228-2013	Otte, Willem M./0000-0003-1511-6834; Otte, Willem M/0000-0003-1511-6834; Dijkhuizen, Rick/0000-0002-4623-4078; van der Marel, Kajo/0000-0003-1099-9498	Netherlands Brain Foundation [15F07(2).20]; Utrecht University's High Potential program	Netherlands Brain Foundation; Utrecht University's High Potential program	This work has been financially supported by a grant of the Netherlands Brain Foundation (15F07(2).20) (JRH), and Utrecht University's High Potential program (RMD). The grant providers had no further role in the design of the study, in the collection, analysis and interpretation of data, in the writing of the report, and in the decision to submit the paper for publication.	Altamura C, 2007, CEREB CORTEX, V17, P1394, DOI 10.1093/cercor/bhl051; Ansorge MS, 2004, SCIENCE, V306, P879, DOI 10.1126/science.1101678; Avants BB, 2011, NEUROIMAGE, V54, P2033, DOI 10.1016/j.neuroimage.2010.09.025; Bassett DS, 2006, NEUROSCIENTIST, V12, P512, DOI 10.1177/1073858406293182; Bearer EL, 2007, NEUROIMAGE, V37, pS37, DOI 10.1016/j.neuroimage.2007.04.053; Bearer EL, 2009, NEUROIMAGE, V46, P1091, DOI 10.1016/j.neuroimage.2009.03.026; Bengel D, 1998, MOL PHARMACOL, V53, P649, DOI 10.1124/mol.53.4.649; Bockhorst KH, 2008, J NEUROSCI RES, V86, P1520, DOI 10.1002/jnr.21607; Bullmore ET, 2012, NAT REV NEUROSCI, V13, P336, DOI 10.1038/nrn3214; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Byas-Smith MG, 2004, SYNAPSE, V53, P68, DOI 10.1002/syn.20037; Canli T, 2005, P NATL ACAD SCI USA, V102, P12224, DOI 10.1073/pnas.0503880102; Canli T, 2007, NAT NEUROSCI, V10, P1103, DOI 10.1038/nn1964; Canli T, 2006, P NATL ACAD SCI USA, V103, P16033, DOI 10.1073/pnas.0601674103; CAPECCHI MR, 1989, SCIENCE, V244, P1288, DOI 10.1126/science.2660260; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Cools R, 2008, TRENDS COGN SCI, V12, P31, DOI 10.1016/j.tics.2007.10.011; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Csardi N., 2006, INT J COMP SYST, V1695, P1; Damoiseaux JS, 2009, BRAIN STRUCT FUNCT, V213, P525, DOI 10.1007/s00429-009-0208-6; Donders ART, 2006, J CLIN EPIDEMIOL, V59, P1087, DOI 10.1016/j.jclinepi.2006.01.014; Du CW, 2009, EUR J NEUROSCI, V30, P1565, DOI 10.1111/j.1460-9568.2009.06931.x; Enoch MA, 2011, MOL PSYCHIATR, V16, P1139, DOI 10.1038/mp.2010.94; Esaki T, 2005, P NATL ACAD SCI USA, V102, P5582, DOI 10.1073/pnas.0501509102; Gerra G, 2007, AM J MED GENET B, V144B, P52, DOI 10.1002/ajmg.b.30388; Gokturk C, 2008, ARCH WOMEN MENT HLTH, V11, P347, DOI 10.1007/s00737-008-0033-6; Hall FS, 2009, NEUROSCIENCE, V162, P870, DOI 10.1016/j.neuroscience.2009.05.058; Hariri AR, 2002, SCIENCE, V297, P400, DOI 10.1126/science.1071829; Hariri AR, 2006, TRENDS COGN SCI, V10, P182, DOI 10.1016/j.tics.2006.02.011; Hariri AR, 2002, NEUROIMAGE, V17, P317, DOI 10.1006/nimg.2002.1179; Heidbreder CA, 2003, NEUROSCI BIOBEHAV R, V27, P555, DOI 10.1016/j.neubiorev.2003.09.003; Heinz A, 2005, NAT NEUROSCI, V8, P20, DOI 10.1038/nn1366; Holmes A, 2003, NEUROPSYCHOPHARMACOL, V28, P2077, DOI 10.1038/sj.npp.1300266; Holmes A, 2003, GENES BRAIN BEHAV, V2, P365, DOI 10.1046/j.1601-1848.2003.00050.x; Homberg JR, 2008, PSYCHOPHARMACOLOGY, V200, P367, DOI 10.1007/s00213-008-1212-x; Homberg JR, 2012, NEUROSCI BIOBEHAV R, V36, P218, DOI 10.1016/j.neubiorev.2011.06.001; Homberg JR, 2011, BIOL PSYCHIAT, V69, P513, DOI 10.1016/j.biopsych.2010.09.024; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Kalueff AV, 2010, NEUROSCI BIOBEHAV R, V34, P373, DOI 10.1016/j.neubiorev.2009.08.003; Kalueff AV, 2007, TRENDS PHARMACOL SCI, V28, P122, DOI 10.1016/j.tips.2007.01.002; Kim MJ, 2009, J NEUROSCI, V29, P11614, DOI 10.1523/JNEUROSCI.2335-09.2009; Koob GF, 2009, PHARMACOPSYCHIATRY, V42, pS32, DOI 10.1055/s-0029-1216356; Lee TW, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-33; Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527; Lira A, 2003, BIOL PSYCHIAT, V54, P960, DOI 10.1016/S0006-3223(03)00696-6; Lowe AS, 2008, NMR BIOMED, V21, P859, DOI 10.1002/nbm.1272; Mandeville JB, 2004, MAGNET RESON MED, V52, P1272, DOI 10.1002/mrm.20278; Margoob Mushtaq A, 2011, Indian J Psychiatry, V53, P289, DOI 10.4103/0019-5545.91901; MARTIN DC, 1990, NEUROCHEM RES, V15, P969, DOI 10.1007/BF00965741; Masamoto K, 2007, CEREB CORTEX, V17, P942, DOI 10.1093/cercor/bhl005; Moeller FG, 2005, NEUROPSYCHOPHARMACOL, V30, P610, DOI 10.1038/sj.npp.1300617; Munafo MR, 2008, BIOL PSYCHIAT, V63, P852, DOI 10.1016/j.biopsych.2007.08.016; Nietzer SL, 2011, BEHAV BRAIN RES, V220, P42, DOI 10.1016/j.bbr.2011.01.011; Nonkes LJP, 2013, ADDICT BIOL, V18, P434, DOI 10.1111/j.1369-1600.2011.00351.x; Nonkes LJP, 2011, BEHAV PHARMACOL, V22, P723, DOI 10.1097/FBP.0b013e32834d6260; Olivier JDA, 2008, NEUROSCIENCE, V152, P573, DOI 10.1016/j.neuroscience.2007.12.032; Olivier JDA, 2010, EXPT MODELS SEROTONI, P170, DOI [10.1017/CBO9780511729935, DOI 10.1017/CBO9780511729935]; Olsson A, 2007, SOC COGN AFFECT NEUR, V2, P3, DOI 10.1093/scan/nsm005; Onnela JP, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.065103; Pacheco J, 2009, J NEUROSCI, V29, P6229, DOI 10.1523/JNEUROSCI.0896-09.2009; Pang RD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023869; Pautler RG, 1998, MAGNET RESON MED, V40, P740, DOI 10.1002/mrm.1910400515; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Pendse GV, 2010, J MAGN RESON IMAGING, V31, P1445, DOI 10.1002/jmri.22180; Pezawas L, 2005, NAT NEUROSCI, V8, P828, DOI 10.1038/nn1463; Pinheiro JC, 2012, NLME LINEAR NONLINEA, P1; Plummer M., 2003, JAGS PROGRAM ANAL BA, DOI DOI 10.1.1.13.3406; Ponten SC, 2009, EXP NEUROL, V217, P197, DOI 10.1016/j.expneurol.2009.02.001; Rao HY, 2007, BIOL PSYCHIAT, V62, P600, DOI 10.1016/j.biopsych.2006.11.028; Reyes-Haro D, 2003, J NEUROSCI RES, V74, P97, DOI 10.1002/jnr.10724; RITZ MC, 1990, LIFE SCI, V46, P635, DOI 10.1016/0024-3205(90)90132-B; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Silva AC, 2004, NMR BIOMED, V17, P532, DOI 10.1002/nbm.945; Simpson KL, 2011, P NATL ACAD SCI USA, V108, P18465, DOI 10.1073/pnas.1109353108; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smits BMG, 2006, PHARMACOGENET GENOM, V16, P159; Sora I, 2001, P NATL ACAD SCI USA, V98, P5300, DOI 10.1073/pnas.091039298; Sora I, 1998, P NATL ACAD SCI USA, V95, P7699, DOI 10.1073/pnas.95.13.7699; Sorensen AG, 2007, P INT SOC MAG RESON, V15, P3720, DOI [DOI 10.1128/MCB.25.11.4371, DOI 10.1038/SJ.IJ0.0803354]; Stam CJ, 2009, BRAIN, V132, P213, DOI 10.1093/brain/awn262; Stam Cornelis J, 2007, Nonlinear Biomed Phys, V1, P3, DOI 10.1186/1753-4631-1-3; Tong C, 2010, NATURE, V467, P211, DOI 10.1038/nature09368; Tsukada H, 1999, BRAIN RES, V849, P85, DOI 10.1016/S0006-8993(99)02018-1; Tuch DS, 2002, MAGNET RESON MED, V48, P577, DOI 10.1002/mrm.10268; Upton AL, 2002, NEUROSCIENCE, V111, P597, DOI 10.1016/S0306-4522(01)00602-9; Uylings HBM, 2003, BEHAV BRAIN RES, V146, P3, DOI 10.1016/j.bbr.2003.09.028; Viviani R, 2010, BIOL PSYCHIAT, V67, P317, DOI 10.1016/j.biopsych.2009.08.035; Ward B. D., 2000, SIMULTANEOUS INFEREN, DOI https://afni.nimh.nih.gov/pub/dist/doc/manuals/AlphaSim.pdf; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Weissenbacher A, 2009, NEUROIMAGE, V47, P1408, DOI 10.1016/j.neuroimage.2009.05.005; Wellman CL, 2007, J NEUROSCI, V27, P684, DOI 10.1523/JNEUROSCI.4595-06.2007; Whittington RA, 2006, ANESTH ANALG, V103, P92, DOI 10.1213/01.ane.0000221488.48352.61; Zhang JY, 2005, NEUROIMAGE, V26, P1042, DOI 10.1016/j.neuroimage.2005.03.009	94	12	12	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57780	10.1371/journal.pone.0057780	http://dx.doi.org/10.1371/journal.pone.0057780			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451267	Green Submitted, Green Published, gold			2022-12-25	WOS:000316849500132
J	Gandhapudi, SK; Chilton, PM; Mitchell, TC				Gandhapudi, Siva K.; Chilton, Paula M.; Mitchell, Thomas C.			TRIF Is Required for TLR4 Mediated Adjuvant Effects on T Cell Clonal Expansion	PLOS ONE			English	Article							MONOPHOSPHORYL-LIPID-A; TOLL-LIKE RECEPTORS; CUTTING EDGE; LIPOPOLYSACCHARIDE; CD4; EXPRESSION; AGONISTS; IDENTIFICATION; COSTIMULATION; ACCUMULATION	Toll like receptor 4 (TLR4) is an important pattern recognition receptor with the ability to drive potent innate immune responses and also to modulate adaptive immune responses needed for long term protection. Activation of TLR4 by its ligands is mediated by engagement of the adapter proteins MyD88 (myeloid differentiation factor 88) and TRIF (Toll-interleukin 1 receptor domain-containing adapter inducing interferon-beta). Previously, we showed that TRIF, but not MyD88, plays an important role in allowing TLR4 agonists to adjuvant early T cell responses. In this study, we investigated the T cell priming events that are regulated specifically by the TRIF signaling branch of TLR4. We found that TRIF deficiency prevented the TLR4 agonist lipid A from enhancing T cell proliferation and survival in an adoptive transfer model of T cell priming. TRIF deficient DC showed defective maturation as evidenced by their failure to upregulate co-stimulatory molecules in response to lipid A stimulation. Importantly, TRIF alone caused CD86 and CD40 upregulation on splenic DC, but both TRIF and MyD88 were required for CD80 upregulation. The impairment of T cell adjuvant effects and defective DC maturation in TRIF (lps/lps) mice after TLR4 stimulation was mainly due to loss of type I IFN production, indicating that type I interferons are central to TLR4's adjuvant effects. These results are useful for the continued development of TLR4 based vaccine adjuvants that avoid inflammatory risks while retaining beneficial immune response.	[Gandhapudi, Siva K.; Chilton, Paula M.; Mitchell, Thomas C.] Univ Louisville, Sch Med, Inst Cellular Therapeut, Louisville, KY 40292 USA; [Mitchell, Thomas C.] Univ Louisville, Sch Med, Dept Microbiol & Immunol, Louisville, KY 40292 USA	University of Louisville; University of Louisville	Mitchell, TC (corresponding author), Univ Louisville, Sch Med, Inst Cellular Therapeut, Louisville, KY 40292 USA.	tom.mitchell@louisville.edu	Mitchell, Thomas C/B-4193-2013	Chilton, Paula/0000-0002-8749-0975	National Institute of Health [RO1-AI071047]; Barnstable Brown research foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI071047] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Barnstable Brown research foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded in part by National Institute of Health grant awarded to Thomas C Mitchell (grant RO1-AI071047) and the Barnstable Brown research foundation. The funders had no role in study desing, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahonen CL, 2004, J EXP MED, V199, P775, DOI 10.1084/jem.20031591; Alderson MR, 2006, J ENDOTOXIN RES, V12, P313, DOI 10.1179/096805106X118753; Asselin-Paturel C, 2003, J IMMUNOL, V171, P6466, DOI 10.4049/jimmunol.171.12.6466; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Casella CR, 2008, CELL MOL LIFE SCI, V65, P3231, DOI 10.1007/s00018-008-8228-6; Cekic C, 2009, J BIOL CHEM, V284, P31982, DOI 10.1074/jbc.M109.046383; Chang ZL, 2010, INFLAMM RES, V59, P791, DOI 10.1007/s00011-010-0208-2; Curtsinger JM, 2005, J IMMUNOL, V174, P4465, DOI 10.4049/jimmunol.174.8.4465; Dufour JH, 2002, J IMMUNOL, V168, P3195, DOI 10.4049/jimmunol.168.7.3195; Durand V, 2004, IMMUNOL CELL BIOL, V82, P596, DOI 10.1111/j.0818-9641.2004.01285.x; Edwards AD, 2003, EUR J IMMUNOL, V33, P827, DOI 10.1002/eji.200323797; Eri R, 2008, INFLAMM BOWEL DIS, V14, P458, DOI 10.1002/ibd.20344; Fang WF, 2007, AM J PHYSIOL-LUNG C, V293, pL336, DOI 10.1152/ajplung.00011.2007; Fitzgerald KA, 2003, J EXP MED, V198, P1043, DOI 10.1084/jem.20031023; Foulds KE, 2002, J IMMUNOL, V168, P1528, DOI 10.4049/jimmunol.168.4.1528; Fox CB, 2010, SUBCELL BIOCHEM, V53, P303, DOI 10.1007/978-90-481-9078-2_14; Garcon N, 2007, EXPERT REV VACCINES, V6, P723, DOI 10.1586/14760584.6.5.723; Garcon N, 2011, EXPERT REV VACCINES, V10, P471, DOI [10.1586/erv.11.29, 10.1586/ERV.11.29]; Gelman AE, 2004, J IMMUNOL, V172, P6065, DOI 10.4049/jimmunol.172.10.6065; Gonzalez-Navajas JM, 2012, NAT REV IMMUNOL, V12, P125, DOI 10.1038/nri3133; Havenar-Daughton C, 2006, J IMMUNOL, V176, P3315, DOI 10.4049/jimmunol.176.6.3315; Hoebe K, 2003, NAT IMMUNOL, V4, P1223, DOI 10.1038/ni1010; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Holt PG, 2008, NAT REV IMMUNOL, V8, P142, DOI 10.1038/nri2236; HOU S, 1994, NATURE, V369, P652, DOI 10.1038/369652a0; HWANG SY, 1995, P NATL ACAD SCI USA, V92, P11284, DOI 10.1073/pnas.92.24.11284; Johnson DA, 2008, CURR TOP MED CHEM, V8, P64, DOI 10.2174/156802608783378882; Kadowaki N, 2001, J EXP MED, V194, P863, DOI 10.1084/jem.194.6.863; Kaisho T, 2002, BBA-MOL CELL RES, V1589, P1, DOI 10.1016/S0167-4889(01)00182-3; Kamath AT, 2000, J IMMUNOL, V165, P6762, DOI 10.4049/jimmunol.165.12.6762; Liu ML, 2011, CYTOKINE GROWTH F R, V22, P121, DOI 10.1016/j.cytogfr.2011.06.001; Longhi MP, 2009, J EXP MED, V206, P1589, DOI 10.1084/jem.20090247; MacKenzie SA, 2010, MOL IMMUNOL, V47, P1450, DOI 10.1016/j.molimm.2010.02.009; Marrack P, 1999, J EXP MED, V189, P521, DOI 10.1084/jem.189.3.521; Mata-Haro V, 2007, SCIENCE, V316, P1628, DOI 10.1126/science.1138963; Maxwell JR, 2002, J IMMUNOL, V168, P4372, DOI 10.4049/jimmunol.168.9.4372; McAleer JP, 2008, CRIT REV IMMUNOL, V28, P281; McAleer JP, 2007, J IMMUNOL, V179, P6524, DOI 10.4049/jimmunol.179.10.6524; McAleer JP, 2009, J IMMUNOL, V182, P5322, DOI 10.4049/jimmunol.0803616; Mitchell TC, 2002, ANN NY ACAD SCI, V975, P114, DOI 10.1111/j.1749-6632.2002.tb05946.x; Nolan A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006600; Ohashi K, 2000, J IMMUNOL, V164, P558, DOI 10.4049/jimmunol.164.2.558; Palsson-McDermott EM, 2004, IMMUNOLOGY, V113, P153, DOI 10.1111/j.1365-2567.2004.01976.x; Pasare C, 2004, IMMUNITY, V21, P733, DOI 10.1016/j.immuni.2004.10.006; Saibil SD, 2007, J IMMUNOL, V178, P2932, DOI 10.4049/jimmunol.178.5.2932; Sathe P, 2008, MUCOSAL IMMUNOL, V1, P425, DOI 10.1038/mi.2008.56; Sengupta S, 2005, IMMUNOBIOLOGY, V210, P647, DOI 10.1016/j.imbio.2005.06.003; Sheehan KCF, 2006, J INTERF CYTOK RES, V26, P804, DOI 10.1089/jir.2006.26.804; Shen H, 2008, J IMMUNOL, V181, P1849, DOI 10.4049/jimmunol.181.3.1849; Thompson BS, 2005, EUR J IMMUNOL, V35, P3196, DOI 10.1002/eji.200526132; Thompson BS, 2004, J IMMUNOL METHODS, V295, P79, DOI 10.1016/j.jim.2004.09.008; Ulrich J T, 1995, Pharm Biotechnol, V6, P495; VELLA AT, 1995, IMMUNITY, V2, P261, DOI 10.1016/1074-7613(95)90050-0; Weighardt H, 2004, EUR J IMMUNOL, V34, P558, DOI 10.1002/eji.200324714; Yamamoto M, 2009, ADV EXP MED BIOL, V667, P59, DOI 10.1007/978-1-4419-1603-7_6; Yang D, 2012, J EXP MED, V209, P157, DOI 10.1084/jem.20101354; Yoneyama H, 2002, J EXP MED, V195, P1257, DOI 10.1084/jem.20011983	59	33	34	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56855	10.1371/journal.pone.0056855	http://dx.doi.org/10.1371/journal.pone.0056855			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457630	gold, Green Published, Green Submitted			2022-12-25	WOS:000315603700090
J	Schneider, K; Nwizu, C; Kaplan, R; Anderson, J; Wilson, DP; Emery, S; Cooper, DA; Boyd, MA				Schneider, Karen; Nwizu, Chidi; Kaplan, Richard; Anderson, Jonathan; Wilson, David P.; Emery, Sean; Cooper, David A.; Boyd, Mark A.			The Potential Cost and Benefits of Raltegravir in Simplified Second-Line Therapy among HIV Infected Patients in Nigeria and South Africa	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; SAFETY; RESISTANCE; REGIMENS; EFFICACY; TENOFOVIR/EMTRICITABINE; TOLERABILITY; MORTALITY; OUTCOMES; FAILURE	Background: There is an urgent need to improve the evidence base for provision of second-line antiretroviral therapy (ART) following first-line virological failure. This is particularly the case in Sub-Saharan Africa where 70% of all people living with HIV/AIDS (PHA) reside. The aim of this study was to simulate the potential risks and benefits of treatment simplification in second-line therapy compared to the current standard of care (SOC) in a lower-middle income and an upper-middle income country in Sub-Saharan Africa. Methods: We developed a microsimulation model to compare outcomes associated with reducing treatment discontinuations between current SOC for second-line therapy in South Africa and Nigeria and an alternative regimen: ritonavir-boosted lopinavir (LPV/r) combined with raltegravir (RAL). We used published studies and collaborating sites to estimate efficacy, adverse effect and cost. Model outcomes were reported as incremental cost effectiveness ratios (ICERs) in 2011 USD per quality adjusted life year ($/QALY) gained. Results: Reducing treatment discontinuations with LPV/r+RAL resulted in an additional 0.4 discounted QALYs and increased the undiscounted life expectancy by 0.8 years per person compared to the current SOC. The average incremental cost was $6,525 per treated patient in Nigeria and $4,409 per treated patient in South Africa. The cost-effectiveness ratios were $16,302/QALY gained and $11,085/QALY gained for Nigeria and South Africa, respectively. Our results were sensitive to the probability of ART discontinuation and the unit cost for RAL. Conclusions: The combination of raltegravir and ritonavir-boosted lopinavir was projected to be cost-effective in South Africa. However, at its current price, it is unlikely to be cost-effective in Nigeria.	[Schneider, Karen; Anderson, Jonathan; Wilson, David P.; Emery, Sean; Cooper, David A.; Boyd, Mark A.] Univ New S Wales, Kirby Inst Infect & Immun Soc, Sydney, NSW, Australia; [Nwizu, Chidi] Univ Maryland, Sch Med, Dept Med, Inst Human Virol, Baltimore, MD 21201 USA; [Kaplan, Richard] Desmond Tutu HIV Fdn, Cape Town, South Africa; [Cooper, David A.] St Vincents Hosp, Ctr Appl Med Res SVH AMR, Sydney, NSW 2010, Australia; [Boyd, Mark A.] St Vincents Hosp, Sydney, NSW 2010, Australia	University of New South Wales Sydney; Kirby Institute; University System of Maryland; University of Maryland Baltimore; St Vincents Hospital Sydney; St Vincents Hospital Sydney	Schneider, K (corresponding author), Univ New S Wales, Kirby Inst Infect & Immun Soc, Sydney, NSW, Australia.	KSchneider@kirby.unsw.edu.au; DWilson@kirby.unsw.edu.au; MBoyd@kirby.unsw.edu.au	Emery, Sean/J-3825-2017; Wilson, David P/G-4614-2013; Emery, Sean/O-9122-2019	Emery, Sean/0000-0001-6072-8309; Emery, Sean/0000-0001-6072-8309; Kaplan, Richard/0000-0003-1565-4704; Anderson, Jonathan/0000-0002-7316-428X; Boyd, Mark/0000-0002-6848-3307	Australian Research Council; University of New South Wales; Australian Government, Department of Health and Ageing	Australian Research Council(Australian Research Council); University of New South Wales; Australian Government, Department of Health and Ageing(Australian GovernmentDepartment of Health & Ageing)	The authors acknowledge funding from the Australian Research Council and the University of New South Wales. The Kirby Institute is funded by the Australian Government, Department of Health and Ageing. The views expressed in this publication do not necessarily represent the position of the Australian Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajose O, 2012, AIDS, V26, P929, DOI 10.1097/QAD.0b013e328351f5b2; Braithwaite RS, 2008, MED CARE, V46, P349, DOI 10.1097/MLR.0b013e31815c31a7; Cahn P, 2008, WHO EXPERT CONSULTAT; Chimbete C, 2009, 16 C RETR OPP INF 8; CLEARY S, 2004, COST EFFECTIVENESS A; Cleary Susan M, 2006, Cost Eff Resour Alloc, V4, P20, DOI 10.1186/1478-7547-4-20; CRITCHFIELD GC, 1986, MED DECIS MAKING, V6, P85, DOI 10.1177/0272989X8600600205; Ekwueme DU, 2003, AM J PREV MED, V25, P112, DOI 10.1016/S0749-3797(03)00115-6; Farnham PG, 1996, PUBLIC HEALTH REP, V111, P44; Freedberg KA, 1998, JAMA-J AM MED ASSOC, V279, P130, DOI 10.1001/jama.279.2.130; Hosseinipour MC, 2010, HIV MED, V11, P510, DOI 10.1111/j.1468-1293.2010.00825.x; Hosseinipour MC, 2009, AIDS, V23, P1127, DOI 10.1097/QAD.0b013e32832ac34e; Keiser O, 2008, PLOS MED, V5, P1102, DOI 10.1371/journal.pmed.0050148; Kumarasamy N, 2003, AIDS, V17, P2267, DOI 10.1097/00002030-200310170-00019; Ledergerber B, 2004, LANCET, V364, P51, DOI 10.1016/S0140-6736(04)16589-6; Lennox JL, 2010, JAIDS-J ACQ IMM DEF, V55, P39, DOI 10.1097/QAI.0b013e3181da1287; Manosuthi W, 2010, AIDS RES HUM RETROV, V26, P609, DOI 10.1089/aid.2009.0107; Medicins Sans Frontieres, 2011, UNT WEB ANT PRIC RED; Mellors JW, 1997, ANN INTERN MED, V126, P946, DOI 10.7326/0003-4819-126-12-199706150-00003; Mocroft A, 2007, LANCET, V370, P407, DOI 10.1016/S0140-6736(07)60948-9; Mocroft A, 2003, LANCET, V362, P22, DOI 10.1016/S0140-6736(03)13802-0; Mrus JM, 2003, MED DECIS MAKING, V23, P414, DOI 10.1177/0272989X03256884; Reynes J, 2011, HIV CLIN TRIALS, V12, P255, DOI 10.1310/hct1205-255; Rockstroh JK, 2011, CLIN INFECT DIS, V53, P807, DOI 10.1093/cid/cir510; Schackman BR, 2002, MED DECIS MAKING, V22, P27, DOI 10.1177/02729890222062892; Schackman BR, 2007, CLIN INFECT DIS, V45, P1062, DOI 10.1086/521933; Steigbigel RT, 2010, CLIN INFECT DIS, V50, P605, DOI 10.1086/650002; Taiwo B, 2011, AIDS, V25, P2113, DOI 10.1097/QAD.0b013e32834bbaa9; Tengs TO, 2002, MED DECIS MAKING, V22, P475, DOI 10.1177/0272989X02238300; Tsevat J, 1999, ANN INTERN MED, V131, P194, DOI 10.7326/0003-4819-131-3-199908030-00006; UNAIDS, 2011, GLOB HIV AIDS RESP E; van Wyk J, 2012, 6 IAS C HIV PATH TRE	32	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e54435	10.1371/journal.pone.0054435	http://dx.doi.org/10.1371/journal.pone.0054435			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457450	gold, Green Published, Green Submitted			2022-12-25	WOS:000315603700005
J	Unuma, K; Aki, T; Funakoshi, T; Yoshida, K; Uemura, K				Unuma, Kana; Aki, Toshihiko; Funakoshi, Takeshi; Yoshida, Ken-ichi; Uemura, Koichi			Cobalt Protoporphyrin Accelerates TFEB Activation and Lysosome Reformation during LPS-Induced Septic Insults in the Rat Heart	PLOS ONE			English	Article							CARDIAC MITOCHONDRIAL BIOGENESIS; HEME OXYGENASE-1 GENE; RESPIRATORY FACTOR-I; TOLL-LIKE RECEPTOR; NF-KAPPA-B; INFLAMMATORY RESPONSE; CELL-DEATH; AUTOPHAGY; MONOXIDE; MICE	Lipopolysaccharide (LPS)-induced myocardial dysfunction is caused, at least in part, by mitochondrial dysfunction. Mitochondrial dysfunction and the oxidative damage associated with it are scavenged through various cellular defense systems such as autophagy to prevent harmful effects. Our recent study has demonstrated that cobalt protoporphyrin IX (CoPPIX), a potent inducer of heme oxygenase-1 (HO-1), ameliorates septic liver injuries by enhancing mitochondrial autophagy in rats. In our current study, we show that CoPPIX (5 mg/kg s.c.) not only accelerates the autophagic response but also promotes lysosome reformation in the rat heart treated with LPS (15 mg/kg i.p.). Lysosomal membrane-associated protein-2 (LAMP2), which is essential to the maintenance of lysosomal functions in the heart, is depleted transiently but restored rapidly during LPS administration in the rat. Activation of transcription factor EB (TFEB), a master regulator of lysosomal biogenesis and autophagy, was also observed, indicating a hyper consumption and subsequent reformation of the lysosome to meet the increased demand for autophagosome cleaning. CoPPIX was found to promote these processes and tended to restore the LPS-induced suppression of cardiac performances whilst chloroquine (CQ; 20 mg/kg i.p.), an inhibitor of lysosomes and autophagic protein degradation, abrogates these beneficial effects. The cardioprotective effect of CoPPIX against LPS toxicity was also observed via decreased levels of cardiac releasing enzymes in the plasma. Taken together, our current data indicate that lysosome reformation mediated by TFEB may be involved in cardioprotection against LPS-induced septic insults, and serve as a novel mechanism by which CoPPIX protects the heart against oxidative stress.	[Unuma, Kana; Aki, Toshihiko; Funakoshi, Takeshi; Uemura, Koichi] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Sect Forens Med, Tokyo, Japan; [Yoshida, Ken-ichi] Univ Tokyo, Dept Forens Med, Grad Sch Med, Tokyo, Japan; [Yoshida, Ken-ichi] Univ Tokyo, Fac Med, Tokyo 113, Japan	Tokyo Medical & Dental University (TMDU); University of Tokyo; University of Tokyo	Aki, T (corresponding author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Sect Forens Med, Tokyo, Japan.	aki.legm@tmd.ac.jp			Japan Society for the Promotion of Science [24790639, 22590629, 30586425]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by Grant-in Aid from the Japan Society for the Promotion of Science (Grant 24790639 to K. Unuma, Grant 22590629 to TA and Grant 30586425 to K. Uemura). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrades M, 2011, J SURG RES, V167, pE307, DOI 10.1016/j.jss.2009.08.005; Avlas O, 2011, ANTIOXID REDOX SIGN, V15, P1895, DOI 10.1089/ars.2010.3728; Boyd JH, 2006, CARDIOVASC RES, V72, P384, DOI 10.1016/j.cardiores.2006.09.011; Carchman EH, 2011, HEPATOLOGY, V53, P2053, DOI 10.1002/hep.24324; Chen B, 2009, AM J PATHOL, V175, P422, DOI 10.2353/ajpath.2009.081033; Cuervo AM, 1996, SCIENCE, V273, P501, DOI 10.1126/science.273.5274.501; Dare AJ, 2009, FREE RADICAL BIO MED, V47, P1517, DOI 10.1016/j.freeradbiomed.2009.08.019; Dehay B, 2010, J NEUROSCI, V30, P12535, DOI 10.1523/JNEUROSCI.1920-10.2010; Fortunato F, 2009, GASTROENTEROLOGY, V137, P350, DOI 10.1053/j.gastro.2009.04.003; GALBRAITH RA, 1989, P NATL ACAD SCI USA, V86, P7653, DOI 10.1073/pnas.86.19.7653; Gottlieb RA, 2010, AM J PHYSIOL-CELL PH, V299, pC203, DOI 10.1152/ajpcell.00097.2010; Hickson-Bick DLM, 2008, J MOL CELL CARDIOL, V44, P411, DOI 10.1016/j.yjmcc.2007.10.013; Hsieh CH, 2011, ANN SURG, V253, P1190, DOI 10.1097/SLA.0b013e318214b67e; Lancel S, 2009, J PHARMACOL EXP THER, V329, P641, DOI 10.1124/jpet.108.148049; Lee SJ, 2011, AM J RESP CELL MOL, V45, P867, DOI 10.1165/rcmb.2010-0352OC; Lin WJ, 2005, SHOCK, V24, P206, DOI 10.1097/01.shk.0000180074.69143.77; Ma X., 2012, CIRCULATION; Ma X, 2012, AUTOPHAGY, V8, P3, DOI DOI 10.4161/AUT0.18658; Minutoli L, 2008, EUR J PHARMACOL, V589, P272, DOI 10.1016/j.ejphar.2008.04.005; Nishino I, 2000, NATURE, V406, P906, DOI 10.1038/35022604; O'Brien PJ, 2008, TOXICOLOGY, V245, P206, DOI 10.1016/j.tox.2007.12.006; Palmieri M, 2011, HUM MOL GENET, V20, P3852, DOI 10.1093/hmg/ddr306; Pena-Llopis S, 2011, EMBO J, V30, P3242, DOI 10.1038/emboj.2011.257; Piantadosi CA, 2008, CIRC RES, V103, P1232, DOI 10.1161/01.RES.0000338597.71702.ad; Ruivo R, 2009, BBA-MOL CELL RES, V1793, P636, DOI 10.1016/j.bbamcr.2008.12.008; Ryter SW, 2006, PHYSIOL REV, V86, P583, DOI 10.1152/physrev.00011.2005; Sardiello M, 2009, SCIENCE, V325, P473, DOI 10.1126/science.1174447; Sarkar S, 2007, J BIOL CHEM, V282, P5641, DOI 10.1074/jbc.M609532200; Schmidt R, 2004, J HEPATOL, V41, P706, DOI 10.1016/j.jhep.2004.07.004; Sehmidt R, 2007, ANN SURG, V245, P931, DOI 10.1097/01.sla.0000256891.45790.4d; Settembre C, 2012, EMBO J, V31, P1095, DOI 10.1038/emboj.2012.32; Settembre C, 2011, SCIENCE, V332, P1429, DOI 10.1126/science.1204592; Shan Y, 2000, ARCH BIOCHEM BIOPHYS, V380, P219, DOI 10.1006/abbi.2000.1921; Shan Y, 2006, FASEB J, V20, P2651, DOI 10.1096/fj.06-6346fje; SMITH TJ, 1987, PHARMACOLOGY, V34, P9, DOI 10.1159/000138242; Srigley JR, 2009, MODERN PATHOL, V22, pS2, DOI 10.1038/modpathol.2009.70; Suliman HB, 2010, J CELL SCI, V123, P2565, DOI 10.1242/jcs.064089; Suliman HB, 2007, J CELL SCI, V120, P299, DOI 10.1242/jcs.03318; Tanaka Y, 2000, NATURE, V406, P902, DOI 10.1038/35022595; Unuma K, 2012, HEPATOL RES, DOI 10.1111/j.1872-034X.2012.01049.x; Yu L, 2010, NATURE, V465, P942, DOI 10.1038/nature09076; Yuan H, 2009, AM J PHYSIOL-HEART C, V296, pH470, DOI 10.1152/ajpheart.01051.2008; Zuckerbraun BS, 2007, FASEB J, V21, P1099, DOI 10.1096/fj.06-6644com	43	33	36	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56526	10.1371/journal.pone.0056526	http://dx.doi.org/10.1371/journal.pone.0056526			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457579	Green Published, Green Submitted, gold			2022-12-25	WOS:000315603700060
J	Zeman, A; Obst, O; Brooks, KR; Rich, AN				Zeman, Astrid; Obst, Oliver; Brooks, Kevin R.; Rich, Anina N.			The Muller-Lyer Illusion in a Computational Model of Biological Object Recognition	PLOS ONE			English	Article							RECEPTIVE-FIELDS; LENGTH	Studying illusions provides insight into the way the brain processes information. The Muller-Lyer Illusion (MLI) is a classical geometrical illusion of size, in which perceived line length is decreased by arrowheads and increased by arrowtails. Many theories have been put forward to explain the MLI, such as misapplied size constancy scaling, the statistics of image-source relationships and the filtering properties of signal processing in primary visual areas. Artificial models of the ventral visual processing stream allow us to isolate factors hypothesised to cause the illusion and test how these affect classification performance. We trained a feed-forward feature hierarchical model, HMAX, to perform a dual category line length judgment task (short versus long) with over 90% accuracy. We then tested the system in its ability to judge relative line lengths for images in a control set versus images that induce the MLI in humans. Results from the computational model show an overall illusory effect similar to that experienced by human subjects. No natural images were used for training, implying that misapplied size constancy and image-source statistics are not necessary factors for generating the illusion. A post-hoc analysis of response weights within a representative trained network ruled out the possibility that the illusion is caused by a reliance on information at low spatial frequencies. Our results suggest that the MLI can be produced using only feed-forward, neurophysiological connections.	[Zeman, Astrid; Brooks, Kevin R.; Rich, Anina N.] Macquarie Univ, Dept Cognit Sci, Macquarie Pk, NSW, Australia; [Zeman, Astrid; Brooks, Kevin R.; Rich, Anina N.] Macquarie Univ, ARC Ctr Excellence Cognit & Disorders CCD, Macquarie Pk, NSW, Australia; [Zeman, Astrid; Obst, Oliver] CSIRO, ICT Ctr, Marsfield, NSW, Australia; [Brooks, Kevin R.] Macquarie Univ, Dept Psychol, Macquarie Pk, NSW, Australia	Macquarie University; Macquarie University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Macquarie University	Zeman, A (corresponding author), Macquarie Univ, Dept Cognit Sci, Macquarie Pk, NSW, Australia.	astrid.zeman@mq.edu.au	Zeman, Astrid/AAC-4079-2019; Obst, Oliver/A-5296-2008	Obst, Oliver/0000-0002-8284-2062; Rich, Anina/0000-0002-5702-6450; Zeman, Astrid/0000-0003-3341-0025; Brooks, Kevin/0000-0003-1424-4092	Australian Research Council [DP0984494]; Menzies Foundation; CSIRO Top-Up Scholarship by the Australian Federal Government; Australian Postgraduate Award (APA) by the Australian Federal Government; Australian Research Council Centre of Excellence for Cognition and its Disorders [CE110001021]	Australian Research Council(Australian Research Council); Menzies Foundation; CSIRO Top-Up Scholarship by the Australian Federal Government; Australian Postgraduate Award (APA) by the Australian Federal Government; Australian Research Council Centre of Excellence for Cognition and its Disorders(Australian Research Council)	Anina N. Rich is supported by the Australian Research Council (DP0984494) and the Menzies Foundation. Astrid Zeman is supported by a CSIRO Top-Up Scholarship and the Australian Postgraduate Award (APA) provided by the Australian Federal Government. Astrid Zeman, Kevin Brooks and Anina Rich are supported by the Australian Research Council Centre of Excellence for Cognition and its Disorders (CE110001021) http://www.ccd.edu.au. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertulis A., 2001, BIOMEDICINE, V1, P3, DOI DOI 10.1068/P270183; BRIGELL M, 1979, PERCEPTION, V8, P187, DOI 10.1068/p080187; CARRASCO M, 1986, PERCEPTION, V15, P553, DOI 10.1068/p150553; COREN S, 1970, Q J EXP PSYCHOL, V22, P274, DOI 10.1080/00335557043000212; COREN S, 1984, PERCEPT PSYCHOPHYS, V35, P313, DOI 10.3758/BF03206334; Corney D, 2007, PLOS COMPUT BIOL, V3, P1790, DOI 10.1371/journal.pcbi.0030180; Cun YL, 1989, IEEE COMMUNICATIONS, V27, P41; DEWAR RE, 1967, CAN J PSYCHOLOGY, V21, P504, DOI 10.1037/h0083002; FELLOWS BJ, 1967, Q J EXP PSYCHOL, V19, P208, DOI 10.1080/14640746708400094; FUKUSHIMA K, 1980, BIOL CYBERN, V36, P193, DOI 10.1007/BF00344251; Ginsburg A, 1978, THESIS AEROSPACE MED; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; GREGORY RL, 1963, NATURE, V199, P678, DOI 10.1038/199678a0; Howe CQ, 2005, P NATL ACAD SCI USA, V102, P1234, DOI 10.1073/pnas.0409314102; HUBEL DH, 1959, J PHYSIOL-LONDON, V148, P574, DOI 10.1113/jphysiol.1959.sp006308; LeCun Y, 1995, HDB BRAIN THEORY NEU, V3361, DOI DOI 10.1109/IJCNN.2004.1381049; Muller-Lyer F. C., 1896, Z PSYCHOL, V9, P1; Muller-Lyer F. C., 1896, Z PSYCHOL PHYSIOL SI, V10, P421; Muller-Lyer FC., 1889, ARCHIV F R ANATOMIE, V2, P263; Mutch J, 2008, INT J COMPUT VISION, V80, P45, DOI 10.1007/s11263-007-0118-0; Ogawa T., 1999, 6 INT C NEUR INF PRO, V2, P550; Predebon J, 1997, J PREDEBON, V27, P183; RESTLE F, 1977, PERCEPT PSYCHOPHYS, V21, P489, DOI 10.3758/BF03198729; Serre T, 2004, 2004017 AI MIT CSAIL; Serre T., 2005, P 2005 IEEE COMP SOC, P886, DOI 10.1109/CVPR.2005.254; Serre T, 2007, P NATL ACAD SCI USA, V104, P6424, DOI 10.1073/pnas.0700622104; Serre T, 2010, COMMUN ACM, V53, P54, DOI 10.1145/1831407.1831425; Weidner R, 2010, CEREB CORTEX, V20, P1586, DOI 10.1093/cercor/bhp217; Weidner R, 2007, CEREB CORTEX, V17, P878, DOI 10.1093/cercor/bhk042	29	7	7	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56126	10.1371/journal.pone.0056126	http://dx.doi.org/10.1371/journal.pone.0056126			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457510	Green Submitted, gold, Green Published			2022-12-25	WOS:000315603700023
J	Ruebner, M; Strissel, PL; Ekici, AB; Stiegler, E; Dammer, U; Goecke, TW; Faschingbauer, F; Fahlbusch, FB; Beckmann, MW; Strick, R				Ruebner, Matthias; Strissel, Pamela L.; Ekici, Arif B.; Stiegler, Elisabeth; Dammer, Ulf; Goecke, Tamme W.; Faschingbauer, Florian; Fahlbusch, Fabian B.; Beckmann, Matthias W.; Strick, Reiner			Reduced Syncytin-1 Expression Levels in Placental Syndromes Correlates with Epigenetic Hypermethylation of the ERVW-1 Promoter Region	PLOS ONE			English	Article							TROPHOBLAST CELL-FUSION; ELEVATED LIVER-ENZYMES; W ENV GLYCOPROTEIN; DNA METHYLATION; TRANSCRIPTIONAL ACTIVITY; CPG METHYLATION; HELLP-SYNDROME; BEWO CELLS; HERV-W; HISTONE METHYLATION	Terminal differentiation of villous cytotrophoblasts (CT) ends in formation of the multinucleated syncytiotrophoblast representing the fetal-maternal interface. Aberrations during this cell-fusion process are associated with Intrauterine Growth Restriction (IUGR), Preeclampsia (PE) and High Elevated Liver and Low Platelets (HELLP) Syndrome. Syncytin-1, the envelope gene of the human Endogenous Retrovirus ERVW-1, is one of the most important genes involved in cell-fusion and showed decreased gene expression during these pathological pregnancies. The aim of this study was to determine the methylation pattern of the entire promoter of ERVW-1 and to correlate these findings with the expression profile of Syncytin-1 in the placental syndromes. 14 isolated villous cytotrophoblasts from control (n = 3), IUGR (n = 3), PE (n = 3), PE/IUGR (n = 3) and HELLP/IUGR (n = 2) placentae were used to determine the mean methylation level (ML) for the ERVW-1 promoter region. ML rose significantly from 29% in control CTs to 49% in IUGR, 53% in PE, 47% in PE/IUGR and 64% in HELLP/IUGR indicating an epigenetic down-regulation of Syncytin-1 by promoter hypermethylation. DNA demethylation of the trophoblast like cell lines BeWo, JEG-3 and JAR with 5-AZA-2'desoxycytidine (AZA) showed an increased Syncytin-1 expression and fusion ability in all cell lines. Promoter activity of the 5'LTR could be inhibited by hypermethylation 42-fold using a luciferase based reporter-gene assay. Finally overexpression of the methyltransferases DNMT3a and LSH could be responsible for a decreased Syncytin-1 expression by promoter hypermethylation of ERVW-1. Our study linked decreased Syncytin-1 expression to an epigenetic hypermethylation of the entire promoter of ERVW-1. Based on our findings we are predicting a broad aberrant epigenetic DNA-methylation pattern in pathological placentae affecting placentogenesis, but also the development of the fetus and the mother during pregnancy.	[Ruebner, Matthias; Strissel, Pamela L.; Stiegler, Elisabeth; Dammer, Ulf; Goecke, Tamme W.; Faschingbauer, Florian; Beckmann, Matthias W.; Strick, Reiner] Univ Clin Erlangen, Dept Obstet & Gynaecol, Mol Med Lab, Erlangen, Germany; [Ekici, Arif B.] Univ Clin Erlangen, Inst Human Genet, Erlangen, Germany; [Fahlbusch, Fabian B.] Univ Clin Erlangen, Dept Paediat & Adolescent Med, Erlangen, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Erlangen Nuremberg	Ruebner, M (corresponding author), Univ Clin Erlangen, Dept Obstet & Gynaecol, Mol Med Lab, Erlangen, Germany.	Matthias.Ruebner@uk-erlangen.de	Ekici, Arif B/C-3971-2013	Ekici, Arif B/0000-0001-6099-7066; Fahlbusch, Fabian/0000-0001-5480-0204	'Deutsche Forschungsgemeinschaft' (DFG) [STR 923/1-1, STR 923/3-1]	'Deutsche Forschungsgemeinschaft' (DFG)(German Research Foundation (DFG))	This work was supported by grants of the 'Deutsche Forschungsgemeinschaft' (DFG) to STR 923/1-1 and STR 923/3-1 (http://www.dfg.de/index.jsp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bannert N, 2004, P NATL ACAD SCI USA, V101, P14572, DOI 10.1073/pnas.0404838101; BERTAKIS KD, 1986, WESTERN J MED, V144, P81; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Biswas S, 2008, J OBSTET GYNAECOL RE, V34, P487, DOI 10.1111/j.1447-0756.2008.00719.x; Blaise S, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-19; Blond JL, 2000, J VIROL, V74, P3321, DOI 10.1128/JVI.74.7.3321-3329.2000; Bogdanovic O, 2009, CHROMOSOMA, V118, P549, DOI 10.1007/s00412-009-0221-9; Cetin I, 2004, PLACENTA, V25, P753, DOI 10.1016/j.placenta.2004.02.004; Chang CW, 2005, MOL CELL BIOL, V25, P8401, DOI 10.1128/MCB.25.19.8401-8414.2005; Cheng XD, 2005, ANNU REV BIOPH BIOM, V34, P267, DOI 10.1146/annurev.biophys.34.040204.144452; Cheng YH, 2004, BIOL REPROD, V70, P694, DOI 10.1095/biolreprod.103.023473; Curradi M, 2002, MOL CELL BIOL, V22, P3157, DOI 10.1128/MCB.22.9.3157-3173.2002; de Parseval N, 2005, CYTOGENET GENOME RES, V110, P318, DOI 10.1159/000084964; Dekker GA, 1998, AM J OBSTET GYNECOL, V179, P1359, DOI 10.1016/S0002-9378(98)70160-7; DULEY L, 1992, BRIT J OBSTET GYNAEC, V99, P547, DOI 10.1111/j.1471-0528.1992.tb13818.x; Frendo JL, 2003, MOL CELL BIOL, V23, P3566, DOI 10.1128/MCB.23.10.3566-3574.2003; Frendo JL, 2003, J CELL SCI, V116, P3413, DOI 10.1242/jcs.00648; Gao Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033503; GETZOWA S, 1950, J OBSTET GYN BRIT EM, V57, P388; Gimenez J, 2009, DNA RES, V16, P195, DOI 10.1093/dnares/dsp011; Guilbert LJ, 2007, PLACENTA, V28, P348, DOI 10.1016/j.placenta.2006.04.011; Howard JH, 2009, CANCER BIOL THER, V8, P94, DOI 10.4161/cbt.8.1.7469; Huang JQ, 2004, NUCLEIC ACIDS RES, V32, P5019, DOI 10.1093/nar/gkh821; Huppertz B, 2006, AM J OBSTET GYNECOL, V195, P29, DOI 10.1016/j.ajog.2005.07.039; Kim TH, 2004, MOL CELLS, V18, P87; Kitazawa R, 2007, MOL ENDOCRINOL, V21, P148, DOI 10.1210/me.2006-0205; Kjeldbjerg AL, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-266; KLIMAN HJ, 1986, ENDOCRINOLOGY, V118, P1567, DOI 10.1210/endo-118-4-1567; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Klose RJ, 2005, MOL CELL, V19, P667, DOI 10.1016/j.molcel.2005.07.021; Knerr I, 2003, AM J OBSTET GYNECOL, V189, P583, DOI 10.1067/S0002-9378(03)00538-6; Kudo Y, 2003, BBA-MOL BASIS DIS, V1638, P63, DOI 10.1016/S0925-4439(03)00043-7; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Langbein M, 2008, MOL REPROD DEV, V75, P175, DOI 10.1002/mrd.20729; Larsen JM, 2009, CANCER LETT, V280, P44, DOI 10.1016/j.canlet.2009.02.008; Larsson LI, 2007, HUM PATHOL, V38, P726, DOI 10.1016/j.humpath.2006.10.018; Lavie L, 2005, J VIROL, V79, P876, DOI 10.1128/JVI.79.2.876-883.2005; Lower R, 1996, P NATL ACAD SCI USA, V93, P5177, DOI 10.1073/pnas.93.11.5177; LYDEN TW, 1993, PLACENTA, V14, P177, DOI 10.1016/S0143-4004(05)80259-0; Macaulay EC, 2011, MAMM GENOME, V22, P722, DOI 10.1007/s00335-011-9355-1; Malassine A, 2005, PLACENTA, V26, P556, DOI 10.1016/j.placenta.2004.09.002; Matouskova M, 2006, EXP CELL RES, V312, P1011, DOI 10.1016/j.yexcr.2005.12.010; MOMPARLER RL, 1985, PHARMACOL THERAPEUT, V30, P287, DOI 10.1016/0163-7258(85)90053-1; Nan XS, 1997, CELL, V88, P471, DOI 10.1016/S0092-8674(00)81887-5; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Newby D, 2007, PLACENTA, V28, P350, DOI 10.1016/j.placenta.2006.04.012; Novakovic B, 2010, J BIOL CHEM, V285, P9583, DOI 10.1074/jbc.M109.064956; Parsons BL, 2003, P NATL ACAD SCI USA, V100, P14601, DOI 10.1073/pnas.2637169100; POLLACK RN, 1992, CLIN OBSTET GYNECOL, V35, P99, DOI 10.1097/00003081-199203000-00015; Potgens AJG, 2002, PLACENTA, V23, pS107, DOI 10.1053/plac.2002.0772; Prudhomme S, 2004, J VIROL, V78, P12157, DOI 10.1128/JVI.78.22.12157-12168.2004; Rahnama F, 2006, ENDOCRINOLOGY, V147, P5275, DOI 10.1210/en.2006-0288; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Reiss D, 2007, NUCLEIC ACIDS RES, V35, P4743, DOI 10.1093/nar/gkm455; Ruebner M, 2012, J CELL BIOCHEM, V113, P2383, DOI 10.1002/jcb.24110; Ruebner M, 2010, J MOL MED, V88, P1143, DOI 10.1007/s00109-010-0656-8; Saphier CJ, 1998, SEMIN PERINATOL, V22, P118, DOI 10.1016/S0146-0005(98)80044-X; Sibai BM, 2005, OBSTET GYNECOL, V105, P402, DOI 10.1097/01.AOG.0000152351.13671.99; Smiraglia DJ, 2002, ONCOGENE, V21, P3909, DOI 10.1038/sj.onc.1205488; Strick R, 2007, J MOL MED, V85, P23, DOI 10.1007/s00109-006-0104-y; Sun Y, 2010, LEUKEMIA RES, V34, P1195, DOI 10.1016/j.leukres.2010.03.016; Surani MA, 2001, NATURE, V414, P122, DOI 10.1038/35102186; Tallarek AC, 2012, GEBURTSH FRAUENHEILK, V72, P27; Tao YG, 2011, P NATL ACAD SCI USA, V108, P5626, DOI 10.1073/pnas.1017000108; Tao YG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009163; Trejbalova K, 2011, NUCLEIC ACIDS RES, V39, P8728, DOI 10.1093/nar/gkr562; Vargas A, 2009, J MOL BIOL, V392, P301, DOI 10.1016/j.jmb.2009.07.025; Villesen Palle, 2004, Retrovirology, V1, P32, DOI 10.1186/1742-4690-1-32; Wich C, 2009, GYNECOL OBSTET INVES, V68, P9, DOI 10.1159/000209396; Wilson ML, 2003, OBSTET GYNECOL SURV, V58, P39, DOI 10.1097/00006254-200301000-00022; Yamashita Y, 2003, INT J CANCER, V103, P572, DOI 10.1002/ijc.10699; Yan QS, 2003, EMBO J, V22, P5154, DOI 10.1093/emboj/cdg493; Yildirim O, 2011, CELL, V147, P1498, DOI 10.1016/j.cell.2011.11.054; Yu CC, 2002, J BIOL CHEM, V277, P50062, DOI 10.1074/jbc.M209316200; Zhu HM, 2006, EMBO J, V25, P335, DOI 10.1038/sj.emboj.7600925; Zou XQ, 2012, NUCLEIC ACIDS RES, V40, P2747, DOI 10.1093/nar/gkr1057	76	59	63	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56145	10.1371/journal.pone.0056145	http://dx.doi.org/10.1371/journal.pone.0056145			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457515	gold, Green Published, Green Submitted			2022-12-25	WOS:000315602700049
J	Wang, LH; Cao, HL; Lu, N; Liu, LP; Wang, BM; Hu, TH; Israel, DA; Peek, RM; Polk, DB; Yan, F				Wang, Lihong; Cao, Hailong; Lu, Ning; Liu, Liping; Wang, Bangmao; Hu, Tianhui; Israel, Dawn A.; Peek, Richard M., Jr.; Polk, D. Brent; Yan, Fang			Berberine Inhibits Proliferation and Down-Regulates Epidermal Growth Factor Receptor through Activation of Cbl in Colon Tumor Cells	PLOS ONE			English	Article							CANCER-CELLS; COLORECTAL-CANCER; GENOTOXIC STRESS; EGF RECEPTOR; APOPTOSIS; PATHWAYS; MECHANISM; ADENOMAS; ARREST; DEATH	Berberine, an isoquinoline alkaloid, is an active component of Ranunculaceae and Papaveraceae plant families. Berberine has been found to suppress growth of several tumor cell lines in vitro through the cell-type-dependent mechanism. Expression and activation of epidermal growth factor receptor (EGFR) is increased in colonic precancerous lesions and tumours, thus EGFR is considered a tumour promoter. The aim of this study was to investigate the effects and mechanisms of berberine on regulation of EGFR activity and proliferation in colonic tumor cell lines and in vivo. We reported that berberine significantly inhibited basal level and EGF-stimulated EGFR activation and proliferation in the immorto Min mouse colonic epithelial (IMCE) cells carrying the APC(min) mutation and human colonic carcinoma cell line, HT-29 cells. Berberine acted to inhibit proliferation through inducing G1/S and G2/M cell cycle arrest, which correlated with regulation of the checkpoint protein expression. In this study, we also showed that berberine stimulated ubiquitin ligase Cbl activation and Cbl's interaction with EGFR, and EGFR ubiquitinylation and down-regulation in these two cell lines in the presence or absence of EGF treatment. Knock-down Cbl expression blocked the effects of berberine on down-regulation of EGFR and inhibition of proliferation. Furthermore, berberine suppressed tumor growth in the HT-29 cell xenograft model. Cell proliferation and EGFR expression level was decreased by berberine treatment in this xenograft model and in colon epithelial cells of APC(min/+) mice. Taken together, these data indicate that berberine enhances Cbl activity, resulting in downregulation of EGFR expression and inhibition of proliferation in colon tumor cells.	[Wang, Lihong; Hu, Tianhui] Xiamen Univ, Coll Med, Ctr Canc, Xiamen, Peoples R China; [Wang, Lihong; Cao, Hailong; Lu, Ning; Liu, Liping; Yan, Fang] Vanderbilt Univ, Med Ctr, Div Gastroenterol Hepatol & Nutr, Dept Pediat, Nashville, TN 37235 USA; [Cao, Hailong; Wang, Bangmao] Tianjin Med Univ, Gen Hosp, Dept Med, Tianjin, Peoples R China; [Lu, Ning; Yan, Fang] Tianjin Med Univ, Canc Inst & Hosp, Dept Breast Canc Med Oncol, Key Lab Breast Canc Prevent & Therapy, Tianjin, Peoples R China; [Israel, Dawn A.; Peek, Richard M., Jr.] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN USA; [Peek, Richard M., Jr.] Vanderbilt Univ, Med Ctr, Dept Canc Biol, Nashville, TN USA; [Polk, D. Brent] Univ So Calif, Dept Pediat, Los Angeles, CA 90089 USA; [Polk, D. Brent] Univ So Calif, Dept Biochem & Mol Biol, Los Angeles, CA USA; [Polk, D. Brent] Childrens Hosp Los Angeles, Saban Res Inst, Los Angeles, CA 90027 USA	Xiamen University; Vanderbilt University; Tianjin Medical University; Tianjin Medical University; Vanderbilt University; Vanderbilt University; University of Southern California; University of Southern California; Children's Hospital Los Angeles	Yan, F (corresponding author), Vanderbilt Univ, Med Ctr, Div Gastroenterol Hepatol & Nutr, Dept Pediat, Nashville, TN 37235 USA.	fang.yan@vanderbilt.edu	liu, li/HGC-0900-2022		National Institutes of Health [R01DK081134, R01DK56008]; National Nature Science Foundation of China [81070283, 30971524, 81172284]; NIH grant [P30DK058404]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056008, P30DK058404, R01DK081134] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health grants R01DK081134 (F.Y.), R01DK56008 (D.B.P.), National Nature Science Foundation of China grants 81070283 (B.W.), 30971524 and 81172284 (T.H.), core services performed through Vanderbilt University Medical Center's Digestive Disease Research Center supported by NIH grant P30DK058404. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alferez D, 2008, MOL CANCER THER, V7, P590, DOI 10.1158/1535-7163.MCT-07-0433; Bucci M, 2000, BRIT J PHARMACOL, V131, P13, DOI 10.1038/sj.bjp.0703549; Budanov AV, 2008, CELL, V134, P451, DOI 10.1016/j.cell.2008.06.028; Cohen G, 2006, CANCER RES, V66, P5656, DOI 10.1158/0008-5472.CAN-05-0308; de Melker AA, 2004, J CELL SCI, V117, P5001, DOI 10.1242/jcs.01354; De Renzis S, 2002, NAT CELL BIOL, V4, P124, DOI 10.1038/ncb744; Dikic I, 2003, CURR OPIN CELL BIOL, V15, P128, DOI 10.1016/S0955-0674(03)00004-8; Fayolle C, 2006, CELL CYCLE, V5, P1859, DOI 10.4161/cc.5.16.3119; Goel GA, 2011, AM J GASTROENTEROL, V106, P719, DOI 10.1038/ajg.2011.51; Goldstein NS, 2001, CANCER, V92, P1331, DOI 10.1002/1097-0142(20010901)92:5<1331::AID-CNCR1455>3.0.CO;2-M; Gu LL, 2011, J INFECT DIS, V203, P1602, DOI 10.1093/infdis/jir147; Hogel H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027112; Jauhiainen A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033208; Liebermann Dan A., 2011, Critical Reviews in Oncogenesis, V16, P129; Malynn BA, 2000, GENE DEV, V14, P1390; Mantena SK, 2006, CARCINOGENESIS, V27, P2018, DOI 10.1093/carcin/bgl043; Meyerhardt JA, 2005, NEW ENGL J MED, V352, P476, DOI 10.1056/NEJMra040958; Mosesson Y, 2003, J BIOL CHEM, V278, P21323, DOI 10.1074/jbc.C300096200; Murthy KNC, 2012, EUR J PHARMACOL, V688, P14, DOI 10.1016/j.ejphar.2012.05.004; Oksvold MP, 2003, ONCOGENE, V22, P8509, DOI 10.1038/sj.onc.1207117; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Roberts RB, 2002, P NATL ACAD SCI USA, V99, P1521, DOI 10.1073/pnas.032678499; Sun YY, 2009, ANTI-CANCER DRUG, V20, P757, DOI 10.1097/CAD.0b013e328330d95b; Tang J, 2009, J ETHNOPHARMACOL, V126, P5, DOI 10.1016/j.jep.2009.08.009; Tillhon M, 2012, BIOCHEM PHARMACOL, V84, P1260, DOI 10.1016/j.bcp.2012.07.018; Vairapandi M, 2002, J CELL PHYSIOL, V192, P327, DOI 10.1002/jcp.10140; Walther A, 2009, NAT REV CANCER, V9, P489, DOI 10.1038/nrc2645; Wang LH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036418; Wang N, 2010, J CELL BIOCHEM, V111, P1426, DOI 10.1002/jcb.22869; Wheeler DL, 2010, NAT REV CLIN ONCOL, V7, P493, DOI 10.1038/nrclinonc.2010.97; WHITEHEAD RH, 1994, EPITHELIAL CELL BIOL, V3, P119; Yamaoka T, 2008, P NATL ACAD SCI USA, V105, P11772, DOI 10.1073/pnas.0801463105; Yan F, 2011, J CLIN INVEST, V121, P2242, DOI 10.1172/JCI44031; Zhang XL, 2010, CANCER RES, V70, P9895, DOI 10.1158/0008-5472.CAN-10-1546	35	50	58	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56666	10.1371/journal.pone.0056666	http://dx.doi.org/10.1371/journal.pone.0056666			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457600	Green Submitted, Green Published, gold			2022-12-25	WOS:000315602700089
J	Womble, JN; Gende, SM				Womble, Jamie N.; Gende, Scott M.			Post-Breeding Season Migrations of a Top Predator, the Harbor Seal (Phoca vitulina richardii), from a Marine Protected Area in Alaska	PLOS ONE			English	Article							BAY NATIONAL-PARK; GLACIER BAY; SITE FIDELITY; BYCATCH MORTALITY; CONSERVATION; PATTERNS; TELEMETRY; POPULATION; FISHERIES; DESIGN	Marine protected areas (MPAs) are increasingly being used as a conservation tool for highly mobile marine vertebrates and the focus is typically on protecting breeding areas where individuals are aggregated seasonally. Yet movements during the non-breeding season can overlap with threats that may be equally as important to population dynamics. Thus understanding habitat use and movements of species during the non-breeding periods is critical for conservation. Glacier Bay National Park, Alaska, is one of the largest marine mammal protected areas in the world and has the only enforceable protection measures for reducing disturbance to harbor seals in the United States. Yet harbor seals have declined by up to 11.5%/year from 1992 to 2009. We used satellite-linked transmitters that were attached to 37 female harbor seals to quantify the post-breeding season migrations of seals and the amount of time that seals spent inside vs. outside of the MPA of Glacier Bay. Harbor seals traveled extensively beyond the boundaries of the MPA of Glacier Bay during the post-breeding season, encompassing an area (25,325 km(2)) significantly larger than that used by seals during the breeding season (8,125 km(2)). These movements included the longest migration yet recorded for a harbor seal (3,411 km) and extended use (up to 23 days) of pelagic areas by some seals. Although the collective utilization distribution of harbor seals during the post-breeding season was quite expansive, there was a substantial degree of individual variability in the percentage of days that seals spent in the MPA. Nevertheless, harbor seals demonstrated a high degree of inter-annual site fidelity (93%) to Glacier Bay the following breeding season. Our results highlight the importance of understanding the threats that seals may interact with outside of the boundaries of the MPA of Glacier Bay for understanding population dynamics of seals in Glacier Bay.	[Womble, Jamie N.] Oregon State Univ, Hatfield Marine Sci Ctr, Marine Mammal Inst, Dept Fisheries & Wildlife, Newport, OR 97365 USA; [Womble, Jamie N.; Gende, Scott M.] Natl Pk Serv, Glacier Bay Field Stn, Juneau, AK USA	Oregon State University; United States Department of the Interior	Womble, JN (corresponding author), Oregon State Univ, Hatfield Marine Sci Ctr, Marine Mammal Inst, Dept Fisheries & Wildlife, Newport, OR 97365 USA.	Jamie_Womble@nps.gov		Womble, Jamie/0000-0002-6635-1490	National Park Service (NPS)-Natural Resource Preservation Program [35747]; Glacier Bay National Park Preserve; NPS Coastal Cluster Program; Alaska Fisheries Science Center-National Marine Mammal Laboratory-Polar Ecosystem Program; Alaska Department of Fish Game; Alaska Sealife Center; United States Fish & Wildlife Service; Horace M. Albright-Conrad L. Wirth Fellowship through the National Park Foundation; Oregon State University (OSU) Hatfield Marine Science Center Mamie Markham Research Fellowship; OSU Marine Mammal Institute; OSU Pinniped Ecology Applied Research Laboratory; OSU Department of Fisheries & Wildlife Munson Wildlife Fellowship; NPS NRAC Professional Development Grants	National Park Service (NPS)-Natural Resource Preservation Program; Glacier Bay National Park Preserve; NPS Coastal Cluster Program; Alaska Fisheries Science Center-National Marine Mammal Laboratory-Polar Ecosystem Program; Alaska Department of Fish Game; Alaska Sealife Center; United States Fish & Wildlife Service; Horace M. Albright-Conrad L. Wirth Fellowship through the National Park Foundation; Oregon State University (OSU) Hatfield Marine Science Center Mamie Markham Research Fellowship; OSU Marine Mammal Institute; OSU Pinniped Ecology Applied Research Laboratory; OSU Department of Fisheries & Wildlife Munson Wildlife Fellowship; NPS NRAC Professional Development Grants	Funding and logistical support was provided by the National Park Service (NPS)-Natural Resource Preservation Program (Project# 35747), Glacier Bay National Park & Preserve, the NPS Coastal Cluster Program, the Alaska Fisheries Science Center-National Marine Mammal Laboratory-Polar Ecosystem Program, the Alaska Department of Fish & Game, the Alaska Sealife Center, and the United States Fish & Wildlife Service. JNW was supported by a Horace M. Albright-Conrad L. Wirth Fellowship through the National Park Foundation, the Oregon State University (OSU) Hatfield Marine Science Center Mamie Markham Research Fellowship, the OSU Marine Mammal Institute, the OSU Pinniped Ecology Applied Research Laboratory, the OSU Department of Fisheries & Wildlife Munson Wildlife Fellowship, and NPS NRAC Professional Development Grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen BM, 2012, AFSC234 NOAA NMFS US; Arimitsu ML, 2008, FISH OCEANOGR, V17, P137, DOI 10.1111/j.1365-2419.2008.00470.x; Ballard G, 2012, BIOL CONSERV, V156, P72, DOI 10.1016/j.biocon.2011.11.017; Barlow Jay, 1994, Reports of the International Whaling Commission Special Issue, V15, P405; Berry KJ, 2001, SPRINGER SERIES STAT; Bjorge A, 2002, ICES J MAR SCI, V59, P29, DOI 10.1006/jmsc.2001.1137; Bjorge A, 2002, MAR MAMMAL SCI, V18, P963, DOI 10.1111/j.1748-7692.2002.tb01085.x; Blundell GM, 2008, MAR MAMMAL SCI, V24, P577, DOI 10.1111/j.1748-7692.2008.00194.x; Blundell GM, 2011, MAR ECOL PROG SER, V429, P277, DOI 10.3354/meps09073; Bodkin J. L., 2007, P 4 GLAC BAY SCI S O, P133; Bolnick DI, 2003, AM NAT, V161, P1, DOI 10.1086/343878; Botsford LW, 2003, ECOL APPL, V13, pS25; CALAMBOKIDIS J, 1987, CAN J ZOOL, V65, P1391, DOI 10.1139/z87-219; Campbell RA, 2008, BIOL LETTERS, V4, P139, DOI 10.1098/rsbl.2007.0487; Catton T, 1995, LAND REBORN LAND REB; Cooper WS, 1937, GEOGR REV, V27, P37, DOI 10.2307/209660; Daniel RG, 2003, MAR MAMMAL SCI, V19, P128, DOI 10.1111/j.1748-7692.2003.tb01097.x; De Laguna F., 1972, SMITHSONIAN CONTRIBU, V7; Douglas DC, 2012, METHODS ECOL EVOL, V3, P999, DOI 10.1111/j.2041-210X.2012.00245.x; Emmons G.T., 1991, TLINGIT INDIANS; Etherington LL, 2007, ESTUAR COAST, V30, P927, DOI 10.1007/BF02841386; FAITH DP, 1987, VEGETATIO, V69, P57, DOI 10.1007/BF00038687; Field WO, 1947, GEOGR REV, V37, P369, DOI 10.2307/211127; Game ET, 2009, TRENDS ECOL EVOL, V24, P360, DOI 10.1016/j.tree.2009.01.011; Gerber LR, 2011, CONSERV LETT, V4, P417, DOI 10.1111/j.1755-263X.2011.00197.x; Gerber LR, 2004, BIOL CONSERV, V120, P121, DOI 10.1016/j.biocon.2004.01.029; Gerber LR, 2003, ECOL APPL, V13, pS47; Gerrodette T, 2011, MAR MAMMAL SCI, V27, pE101, DOI 10.1111/j.1748-7692.2010.00449.x; Getz WM, 2004, ECOGRAPHY, V27, P489, DOI 10.1111/j.0906-7590.2004.03835.x; Goodman SJ, 1998, MOL BIOL EVOL, V15, P104, DOI 10.1093/oxfordjournals.molbev.a025907; Gormley AM, 2012, J APPL ECOL, V49, P474, DOI 10.1111/j.1365-2664.2012.02121.x; HALL DK, 1995, PHYS GEOGR, V16, P27, DOI 10.1080/02723646.1995.10642541; Hamer D. J., 2011, Endangered Species Research, V14, P203, DOI 10.3354/esr00353; Harkonen T, 2001, CAN J ZOOL, V79, P2115, DOI 10.1139/cjz-79-12-2115; Hendrix AN, 2012, CAN J FISH AQUAT SCI, V69, P1783, DOI [10.1139/F2012-101, 10.1139/f2012-101]; Hill DF, 2009, ESTUAR COAST SHELF S, V82, P95, DOI 10.1016/j.ecss.2008.12.019; Hooker Sascha K., 2011, Endangered Species Research, V13, P203, DOI 10.3354/esr00322; Hooker SK, 2004, BIOSCIENCE, V54, P27, DOI 10.1641/0006-3568(2004)054[0027:MRAATF]2.0.CO;2; Hooker SK, 2002, BIOL CONSERV, V104, P51, DOI 10.1016/S0006-3207(01)00153-7; Hooker SK, 1999, CONSERV BIOL, V13, P592, DOI 10.1046/j.1523-1739.1999.98099.x; Horning M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030173; Howell Evan A., 2008, Endangered Species Research, V5, P267, DOI 10.3354/esr00096; Hoyt E., 2011, MARINE PROTECTED ARE; Hueffer K, 2011, J WILDLIFE DIS, V47, P984, DOI 10.7589/0090-3558-47.4.984; Hyrenbach KD, 2006, FISH OCEANOGR, V15, P95, DOI 10.1111/j.1365-2419.2005.00350.x; Hyrenbach KD, 2000, AQUAT CONSERV, V10, P437, DOI 10.1002/1099-0755(200011/12)10:6<437::AID-AQC425>3.3.CO;2-H; Jansen JK, 2010, J WILDLIFE MANAGE, V74, P1186, DOI 10.2193/2008-192; Johnson DS, 2008, ECOLOGY, V89, P1208, DOI 10.1890/07-1032.1; Kenow KP, 2002, WATERBIRDS, V25, P449, DOI 10.1675/1524-4695(2002)025[0449:UOSTTI]2.0.CO;2; Kenyon K. W, 1969, N AM FAUNA; Kernohan Brian J., 2001, P125, DOI 10.1016/B978-012497781-5/50006-2; Kie JG, 2010, PHILOS T R SOC B, V365, P2221, DOI 10.1098/rstb.2010.0093; Leslie HM, 2005, CONSERV BIOL, V19, P1701, DOI 10.1111/j.1523-1739.2005.00268.x; Lowry LF, 2001, MAR MAMMAL SCI, V17, P835, DOI 10.1111/j.1748-7692.2001.tb01301.x; Lowther AD, 2011, MAR ECOL PROG SER, V443, P249, DOI 10.3354/meps09392; Lubchenco J, 2003, ECOL APPL, V13, pS3; LUNN NJ, 1991, J MAMMAL, V72, P202, DOI 10.2307/1381999; Mackovjack J, 2010, NAVIGATING TROUBLED; Martin TG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000751; Mathews EA, 2006, MAR MAMMAL SCI, V22, P167, DOI 10.1111/j.1748-7692.2006.00011.x; Mathews EA, 1996, MAR MAMMAL SCI, V12, P483, DOI 10.1111/j.1748-7692.1996.tb00603.x; Mathews EA, 2011, MAR MAMMAL SCI, V27, P852, DOI 10.1111/j.1748-7692.2010.00455.x; Matkin CO, 1980, MMX78107 US MAR MAMM; Maxwell SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019905; McCune B., 2006, PC ORD MULTIVARIATE; MIELKE PW, 1976, COMMUN STAT A-THEOR, V5, P1409, DOI 10.1080/03610927608827451; National Research Council, 2001, MAR PROT AR TOOLS SU; Notarbartolo-Di-Sciara G, 2008, AQUAT CONSERV, V18, P367, DOI 10.1002/aqc.855; Peckham SH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001041; Peterson SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039046; Pomeroy PP, 2000, ETHOLOGY, V106, P899, DOI 10.1046/j.1439-0310.2000.00610.x; Read AJ, 2006, CONSERV BIOL, V20, P163, DOI 10.1111/j.1523-1739.2006.00338.x; Robards MD, 2003, ECOLOGY SELECTED MAR; Roberts CM, 2003, ECOL APPL, V13, pS215; Rojas-Bracho L, 1999, MAR MAMMAL SCI, V15, P974, DOI 10.1111/j.1748-7692.1999.tb00873.x; Sala E, 2002, SCIENCE, V298, P1991, DOI 10.1126/science.1075284; Sharples RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037216; Shillinger GL, 2008, PLOS BIOL, V6, P1408, DOI 10.1371/journal.pbio.0060171; Small RJ, 2005, MAR MAMMAL SCI, V21, P671, DOI 10.1111/j.1748-7692.2005.tb01259.x; Small RJ, 2003, MAR MAMMAL SCI, V19, P344, DOI 10.1111/j.1748-7692.2003.tb01113.x; Thompson PM, 1998, CAN J ZOOL, V76, P1044, DOI 10.1139/cjz-76-6-1044; THOMPSON PM, 1989, J ZOOL, V217, P281, DOI 10.1111/j.1469-7998.1989.tb02488.x; Westlake RL, 2002, J MAMMAL, V83, P1111, DOI 10.1644/1545-1542(2002)083<1111:MSAPOG>2.0.CO;2; Wolfe RJ, 2009, 339 AL DEP FISH GAM; Womble JN, 2010, MAR MAMMAL SCI, V26, P686, DOI 10.1111/j.1748-7692.2009.00360.x; Womble JN, 2009, J BIOGEOGR, V36, P439, DOI 10.1111/j.1365-2699.2007.01873.x; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423; YOCHEM PK, 1987, MAR MAMMAL SCI, V3, P323, DOI 10.1111/j.1748-7692.1987.tb00319.x; Yorio P, 2009, CONSERV LETT, V2, P171, DOI 10.1111/j.1755-263X.2009.00062.x; Young C., 2009, THESIS SAN JOSE STAT; Zydelis R, 2011, P ROY SOC B-BIOL SCI, V278, P3191, DOI 10.1098/rspb.2011.0330	91	31	31	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e55386	10.1371/journal.pone.0055386	http://dx.doi.org/10.1371/journal.pone.0055386			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457468	Green Submitted, gold, Green Published			2022-12-25	WOS:000315602700016
J	Wei-LaPierre, L; Gong, GH; Gerstner, BJ; Ducreux, S; Yule, DI; Pouvreau, S; Wang, XH; Sheu, SS; Cheng, HP; Dirksen, RT; Wang, W				Wei-LaPierre, Lan; Gong, Guohua; Gerstner, Brent J.; Ducreux, Sylvie; Yule, David I.; Pouvreau, Sandrine; Wang, Xianhua; Sheu, Shey-Shing; Cheng, Heping; Dirksen, Robert T.; Wang, Wang			Respective Contribution of Mitochondrial Superoxide and pH to Mitochondria-targeted Circularly Permuted Yellow Fluorescent Protein (mt-cpYFP) Flash Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERMEABILITY TRANSITION; RELEASE; PROBE	Superoxide flashes are transient bursts of superoxide production within the mitochondrial matrix that are detected using the superoxide-sensitive biosensor, mitochondria-targeted circularly permuted YFP (mt-cpYFP). However, due to the pH sensitivity of mt-cpYFP, flashes were suggested to reflect transient events of mitochondrial alkalinization. Here, we simultaneously monitored flashes with mt-cpYFP and mitochondrial pH with carboxy-SNARF-1. In intact cardiac myocytes and purified skeletal muscle mitochondria, robust mt-cpYFP flashes were accompanied by only a modest increase in SNARF-1 ratio (corresponding to a pH increase of <0.1), indicating that matrix alkalinization is minimal during an mt-cpYFP flash. Individual flashes were also accompanied by stepwise increases of MitoSOX signal and decreases of NADH autofluorescence, supporting the superoxide origin of mt-cpYFP flashes. Transient matrix alkalinization induced by NH4Cl only minimally influenced flash frequency and failed to alter flash amplitude. How-ever, matrix acidification modulated superoxide flash frequency in a bimodal manner. Low concentrations of nigericin (< 100 nM) that resulted in a mild dissipation of the mitochondrial pH gradient increased flash frequency, whereas a maximal concentration of nigericin (5 mu M) collapsed the pH gradient and abolished flash activity. These results indicate that mt-cpYFP flash events reflect a burst in electron transport chain-dependent superoxide production that is coincident with a modest increase in matrix pH. Furthermore, flash activity depends strongly on a combination of mitochondrial oxidation and pH gradient.	[Wei-LaPierre, Lan; Gerstner, Brent J.; Yule, David I.; Dirksen, Robert T.] Univ Rochester, Med Ctr, Dept Physiol & Pharmacol, Rochester, NY 14642 USA; [Gong, Guohua; Wang, Wang] Univ Washington, Dept Anesthesiol & Pain Med, Mitochondria & Metab Ctr, Seattle, WA 98109 USA; [Ducreux, Sylvie; Pouvreau, Sandrine] Univ Lyon 1, CNRS, UMR 5123, F-69622 Villeurbanne, France; [Wang, Xianhua; Cheng, Heping] Peking Univ, State Key Lab Biomembrane & Membrane Biotechnol, Inst Mol Med, Peking Tsinghua Ctr Life Sci, Beijing 100871, Peoples R China; [Sheu, Shey-Shing] Thomas Jefferson Univ, Ctr Translat Med, Dept Med, Jefferson Med Coll, Philadelphia, PA 19107 USA	University of Rochester; University of Washington; University of Washington Seattle; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Peking University; Jefferson University	Dirksen, RT (corresponding author), Univ Rochester, Med Ctr, Dept Physiol & Pharmacol, 601 Elmwood Ave, Rochester, NY 14642 USA.	Robert_Dirksen@URMC.rochester.edu; wangwang@u.washington.edu	DUCREUX, SYLVIE/D-6257-2013; wang, wang/GWQ-7272-2022; Pouvreau, Sandrine/AFV-8178-2022; Heping, Cheng/AAE-2680-2019; cheng, heping/A-7299-2011; Sheu, Shey-Shing/Y-4009-2019	DUCREUX, SYLVIE/0000-0003-3207-9537; Heping, Cheng/0000-0002-9604-6702; Sheu, Shey-Shing/0000-0003-3838-3601; Wang, Wang/0000-0001-9093-412X	National Institutes of Health [AR44657, HL114760, HL093671]; American Heart Association; Universite Lyon 1; CNRS; Academia Dei Lincea Fund; National Basic Research Program of China [2013CB531201, 2011CB809102]; National Science Foundation of China [31221002, 31130067]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL110349, R01HL093671, R01HL114760] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R29AR044657, R01AR044657] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Universite Lyon 1; CNRS(Centre National de la Recherche Scientifique (CNRS)); Academia Dei Lincea Fund; National Basic Research Program of China(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AR44657 (to R. T. D.), HL114760 (to W. W.), and HL093671 (to S. S. S.). This work was also supported by a Scientist Development Grant from the American Heart Association (to W. W.) and grants from the Universite Lyon 1 and the CNRS (to S. P.), the Academia Dei Lincea Fund (to L. W. L.), and National Basic Research Program of China 2013CB531201 and 2011CB809102 and the National Science Foundation of China 31221002, 31130067 (to H. C).	Aon MA, 2003, J BIOL CHEM, V278, P44735, DOI 10.1074/jbc.M302673200; Azarias G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028505; Buckman JF, 2001, J NEUROSCI, V21, P5054, DOI 10.1523/JNEUROSCI.21-14-05054.2001; Duchen MR, 1998, J CELL BIOL, V142, P975, DOI 10.1083/jcb.142.4.975; Fang HQ, 2011, CELL RES, V21, P1295, DOI 10.1038/cr.2011.81; Hou TT, 2013, J BIOL CHEM, V288, P4602, DOI [10.1074/jbc.M112.398297, 10.1074/jbc.M113.527770]; Hou Y, 2012, STEM CELLS, V30, P2535, DOI 10.1002/stem.1213; Huang ZL, 2011, FREE RADICAL BIO MED, V51, P1937, DOI 10.1016/j.freeradbiomed.2011.08.024; Huser J, 1998, BIOPHYS J, V74, P2129, DOI 10.1016/S0006-3495(98)77920-2; Jacquemond V, 1997, BIOPHYS J, V73, P920, DOI 10.1016/S0006-3495(97)78124-4; Lambert AJ, 2010, AGING CELL, V9, P78, DOI 10.1111/j.1474-9726.2009.00538.x; Lambert AJ, 2004, BIOCHEM J, V382, P511, DOI 10.1042/BJ20040485; Life Technologies Corp, 2013, MOL PROB HDB; Ma Q, 2011, J BIOL CHEM, V286, P27573, DOI 10.1074/jbc.M111.241794; Miwa S, 2003, BIOCHEM SOC T, V31, P1300; Poburko D, 2011, J BIOL CHEM, V286, P11672, DOI 10.1074/jbc.M110.159962; Pouvreau S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013035; Quatresous E, 2012, J GEN PHYSIOL, V140, P567, DOI 10.1085/jgp.201210863; Robinson KM, 2006, P NATL ACAD SCI USA, V103, P15038, DOI 10.1073/pnas.0601945103; Santo-Domingo J, 2012, J GEN PHYSIOL, V139, P415, DOI 10.1085/jgp.201110767; Santo-Domingo J, 2011, J GEN PHYSIOL, V138, p16A; Schwarzlander M, 2012, TRENDS CELL BIOL, V22, P503, DOI 10.1016/j.tcb.2012.07.007; Schwarzlander M, 2012, PLANT CELL, V24, P1188, DOI 10.1105/tpc.112.096438; Schwarzlander M, 2011, BIOCHEM J, V437, P381, DOI 10.1042/BJ20110883; Selivanov VA, 2008, J BIOL CHEM, V283, P29292, DOI 10.1074/jbc.M801019200; Skolnick RL, 1998, AM J PHYSIOL-HEART C, V275, pH1788, DOI 10.1152/ajpheart.1998.275.5.H1788; Wang W, 2008, CELL, V134, P279, DOI 10.1016/j.cell.2008.06.017; Wang XH, 2012, J MOL CELL CARDIOL, V52, P940, DOI 10.1016/j.yjmcc.2012.02.007; Wei L, 2012, J GEN PHYSIOL, V139, P425, DOI 10.1085/jgp.201210790; Wei L, 2011, FASEB J, V25, P3068, DOI 10.1096/fj.11-187252; Zorov DB, 2000, J EXP MED, V192, P1001, DOI 10.1084/jem.192.7.1001	31	59	62	0	43	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2013	288	15					10567	10577		10.1074/jbc.M113.455709	http://dx.doi.org/10.1074/jbc.M113.455709			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	125TU	23457298	hybrid, Green Published			2022-12-25	WOS:000317565000036
J	Shames, DS; Carbon, J; Walter, K; Jubb, AM; Kozlowski, C; Januario, T; AnDo; Fu, L; Xiao, YY; Raja, R; Jiang, B; Malekafzali, A; Stern, H; Settleman, J; Wilson, TR; Hampton, GM; Yauch, RL; Pirzkall, A; Amler, LC				Shames, David S.; Carbon, Juliet; Walter, Kim; Jubb, Adrian M.; Kozlowski, Cleopatra; Januario, Tom; AnDo; Fu, Ling; Xiao, Yuanyuan; Raja, Rajiv; Jiang, Brittany; Malekafzali, Ashi; Stern, Howard; Settleman, Jeff; Wilson, Timothy R.; Hampton, Garret M.; Yauch, Robert L.; Pirzkall, Andrea; Amler, Lukas C.			High Heregulin Expression Is Associated with Activated HER3 and May Define an Actionable Biomarker in Patients with Squamous Cell Carcinomas of the Head and Neck	PLOS ONE			English	Article							LUNG-CANCER; BIOLOGY; ERBB3; RECURRENT; RECEPTOR	Purpose: Tumors with oncogenic dependencies on the HER family of receptor tyrosine kinases (RTKs) often respond well to targeted inhibition. Our previous work suggested that many cell lines derived from squamous cell carcinomas of the head and neck (SCCHNs) depend on autocrine signaling driven by HER2/3 dimerization and high-level co-expression of HRG. Additionally, results from a Phase I trial of MEHD7495A, a dual-action antibody that blocks ligand binding to EGFR and HER3, suggest that high-level HRG expression was associated with clinical response in SCCHN patients. Here we explore the hypothesis that high-level HRG expression defines a subpopulation of SCCHNs with activated HER3. Experimental Design: qRT-PCR expression profiling was performed on >750 tumors of diverse origin, including >150 therapy-naive, primary, and recurrent SCCHNs. Activated HER3, defined by immunoprecipitation of phospho-HER3, was compared to HRG expression in SCCHN samples. Paracrine versus autocrine expression was evaluated using RNA-in situ hybridization. Results: SCCHN tumors express the highest levels of HRG compared to a diverse collection of other tumor types. We show that high HRG expression is associated with activated HER3, whereas low HRG expression is associated with low HER3 activation in SCCHN tumors. Furthermore, HRG expression is higher in recurrent SCCHN compared to patient-matched therapy naive specimens. Conclusions: HRG expression levels define a biologically distinct subset of SCCHN patients. We propose that high-level expression of HRG is associated with constitutive activation of HER3 in SCCHN and thus defines an actionable biomarker for interventions targeting HER3.	[Shames, David S.; Carbon, Juliet; Walter, Kim; Januario, Tom; AnDo; Fu, Ling; Raja, Rajiv; Jiang, Brittany; Malekafzali, Ashi; Wilson, Timothy R.; Hampton, Garret M.; Yauch, Robert L.; Amler, Lukas C.] Genentech Inc, Oncol Biomarker Dev, San Francisco, CA 94080 USA; [Jubb, Adrian M.; Stern, Howard] Genentech Inc, Res Pathol, San Francisco, CA 94080 USA; [Pirzkall, Andrea] Genentech Inc, Early Clin Dev, San Francisco, CA 94080 USA; [Xiao, Yuanyuan] Genentech Inc, Biostat, San Francisco, CA 94080 USA; [Kozlowski, Cleopatra] Genentech Inc, Safety Assessment Pathol, San Francisco, CA 94080 USA; [Settleman, Jeff] Genentech Inc, Mol Diagnost & Canc Cell Biol, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Shames, DS (corresponding author), Genentech Inc, Oncol Biomarker Dev, San Francisco, CA 94080 USA.	shames.david@gene.com; Amler.Lukas@gene.com			Genentech	Genentech(Roche HoldingGenentech)	This study was funded by Genentech (www.gene.com). All authors are employees of Genentech and Genentech played a role in study design, data collection and analysis, decision to publish and preparation of the manuscript.	Agrawal N, 2011, SCIENCE, V333, P1154, DOI 10.1126/science.1206923; Baselga J, 2009, NAT REV CANCER, V9, P463, DOI 10.1038/nrc2656; Benaglia T, 2009, J STAT SOFTW, V32, P1; Bonner JA, 2006, NEW ENGL J MED, V354, P567, DOI 10.1056/NEJMoa053422; Cervantes-Ruiperez A, 2012, ASCO M, V30, P2568; Cohen EEW, 2009, LANCET ONCOL, V10, P247, DOI 10.1016/S1470-2045(09)70002-6; del Campo JM, 2011, BRIT J CANCER, V105, P618, DOI 10.1038/bjc.2011.237; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; HOLMES WE, 1992, SCIENCE, V256, P1205, DOI 10.1126/science.256.5060.1205; Kalyankrishna S, 2006, J CLIN ONCOL, V24, P2666, DOI 10.1200/JCO.2005.04.8306; Leemans CR, 2011, NAT REV CANCER, V11, P9, DOI 10.1038/nrc2982; LEFEBVRE JL, 2005, ANN ONCOL S, V16, P7; Morgan S, 2009, EXP CELL RES, V315, P572, DOI 10.1016/j.yexcr.2008.08.009; Schaefer G, 2011, CANCER CELL, V20, P472, DOI 10.1016/j.ccr.2011.09.003; SLIWKOWSKI MX, 1994, J BIOL CHEM, V269, P14661; Stewart JSW, 2009, J CLIN ONCOL, V27, P1864, DOI 10.1200/JCO.2008.17.0530; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Walter K, 2012, CLIN CANCER RES, V18, P2360, DOI 10.1158/1078-0432.CCR-11-2635-T; Wilson TR, 2011, CANCER CELL, V20, P158, DOI 10.1016/j.ccr.2011.07.011	20	59	69	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e56765	10.1371/journal.pone.0056765	http://dx.doi.org/10.1371/journal.pone.0056765			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23468880	gold, Green Published, Green Submitted			2022-12-25	WOS:000315524900037
J	O'Haire, ME; McKenzie, SJ; Beck, AM; Slaughter, V				O'Haire, Marguerite E.; McKenzie, Samantha J.; Beck, Alan M.; Slaughter, Virginia			Social Behaviors Increase in Children with Autism in the Presence of Animals Compared to Toys	PLOS ONE			English	Article							SPECTRUM DISORDER; COMMUNICATION QUESTIONNAIRE; YOUNG-CHILDREN; HUMAN HEALTH; TEACHERS; STUDENTS; THERAPY; FRIENDSHIP; EFFICACY; SKILLS	Background: Previous research has demonstrated the capacity of animal presence to stimulate social interaction among humans. The purpose of this study was to examine the interactions of children with autism spectrum disorder (ASD) with an adult and their typically-developing peers in the presence of animals (two guinea pigs) compared to toys. Methods: Ninety-nine children from 15 classrooms in 4 schools met the inclusion criteria and participated in groups of three (1 child with ASD and 2 typically-developing peers). Each group was video-recorded during three 10-minute, free-play sessions with toys and three 10-minute, free-play sessions with two guinea pigs. Two blinded observers coded the behavior of children with ASD and their peers. To account for the nested study design, data were analyzed using hierarchical generalized linear modeling. Results: Participants with ASD demonstrated more social approach behaviors (including talking, looking at faces, and making tactile contact) and received more social approaches from their peers in the presence of animals compared to toys. They also displayed more prosocial behaviors and positive affect (i.e., smiling and laughing) as well as less self-focused behaviors and negative affect (i.e., frowning, crying, and whining) in the presence of animals compared to toys. Conclusions: These results suggest that the presence of an animal can significantly increase positive social behaviors among children with ASD.	[O'Haire, Marguerite E.; Slaughter, Virginia] Univ Queensland, Sch Psychol, Brisbane, Qld, Australia; [McKenzie, Samantha J.] Univ Queensland, Sch Populat Hlth, Herston, Qld, Australia; [Beck, Alan M.] Purdue Univ, Ctr Human Anim Bond, Coll Vet Med, W Lafayette, IN 47907 USA	University of Queensland; University of Queensland; Purdue University System; Purdue University; Purdue University West Lafayette Campus	O'Haire, ME (corresponding author), Univ Queensland, Sch Psychol, Brisbane, Qld, Australia.	maggie.ohaire@gmail.com	Slaughter, Virginia/I-6370-2015; McKenzie, Samantha/A-2516-2010	Slaughter, Virginia/0000-0001-9315-1497; McKenzie, Samantha/0000-0003-1328-4527	Thomas Meloy Foundation; Eunice Kennedy Shriver National Institute of Child Health & Human Development [R03HD070683]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R03HD070683] Funding Source: NIH RePORTER	Thomas Meloy Foundation; Eunice Kennedy Shriver National Institute of Child Health & Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was supported by funding from the Thomas Meloy Foundation and Grant Number R03HD070683 from the Eunice Kennedy Shriver National Institute of Child Health & Human Development. The content is solely the responsibility of the authors and does not necessarily represent the official views of the Eunice Kennedy Shriver National Institute of Child Health & Human Development or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Atkins DC, 2007, J FAM PSYCHOL, V21, P726, DOI 10.1037/0893-3200.21.4.726; Berument SK, 1999, BRIT J PSYCHIAT, V175, P444, DOI 10.1192/bjp.175.5.444; Burrows KE, 2008, QUAL HEALTH RES, V18, P1642, DOI 10.1177/1049732308327088; Cappadocia MC, 2012, J AUTISM DEV DISORD, V42, P266, DOI 10.1007/s10803-011-1241-x; Chandler S, 2007, J AM ACAD CHILD PSY, V46, P1324, DOI 10.1097/chi.0b013e31812f7d8d; Clifford S, 2010, RES AUTISM SPECT DIS, V4, P509, DOI 10.1016/j.rasd.2009.11.008; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd ed., DOI DOI 10.4324/9780203771587; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Esposito L, 2011, CHILD DEV PERSPECT, V5, P205, DOI 10.1111/j.1750-8606.2011.00175.x; Fine AH, 2010, HANDBOOK ON ANIMAL-ASSISTED THERAPY: THEORETICAL FOUNDATIONS AND GUIDELINES FOR PRACTICE, 3RD EDITION, P1; FLEISS JL, 1973, EDUC PSYCHOL MEAS, V33, P613, DOI 10.1177/001316447303300309; Friedmann E, 2009, VET CLIN N AM-SMALL, V39, P293, DOI 10.1016/j.cvsm.2008.10.015; Goin-Kochel RP, 2008, FOCUS AUTISM DEV DIS, V23, P148, DOI 10.1177/1088357608316270; Grandgeorge M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041739; Gresham F. M., 1990, SOCIAL SKILLS RATING; HUNT SJ, 1992, J SOC PSYCHOL, V132, P245, DOI 10.1080/00224545.1992.9922976; IBM Corp, 2011, IBM SPSS STAT WIND V; Jennett HK, 2003, J AUTISM DEV DISORD, V33, P583, DOI 10.1023/B:JADD.0000005996.19417.57; Kogan MD, 2009, PEDIATRICS, V124, P1395, DOI 10.1542/peds.2009-1522; Koning C, 2001, AUTISM, V5, P23, DOI 10.1177/1362361301005001003; Krskova L, 2010, SOC ANIM, V18, P139, DOI 10.1163/156853010X491999; Kruger KA, 2010, HANDBOOK ON ANIMAL-ASSISTED THERAPY: THEORETICAL FOUNDATIONS AND GUIDELINES FOR PRACTICE, 3RD EDITION, P33, DOI 10.1016/B978-0-12-381453-1.10003-0; Lockwood R., 1983, NEW PERSPECTIVES OUR, P64; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; MacDonald R, 2007, RES DEV DISABIL, V28, P266, DOI 10.1016/j.ridd.2006.01.004; Macintosh K, 2006, J AUTISM DEV DISORD, V36, P1065, DOI 10.1007/s10803-006-0139-5; Marino L, 2012, ANTHROZOOS, V25, pS139, DOI 10.2752/175303712X13353430377219; Martin F, 2002, WESTERN J NURS RES, V24, P657, DOI 10.1177/019394502320555403; Martin P., 1993, MEASURING BEHAV INTR; Matson JL, 2011, RES AUTISM SPECT DIS, V5, P418, DOI 10.1016/j.rasd.2010.06.004; Mazurek MO, 2010, J AUTISM DEV DISORD, V40, P1512, DOI 10.1007/s10803-010-1014-y; McConnell SR, 2002, J AUTISM DEV DISORD, V32, P351, DOI 10.1023/A:1020537805154; Mcduffie AS, 2012, AUTISM, V16, P398, DOI 10.1177/1362361309360983; McGee GG, 1997, J AUTISM DEV DISORD, V27, P353, DOI 10.1023/A:1025849220209; McNicholas J, 2000, BRIT J PSYCHOL, V91, P61, DOI 10.1348/000712600161673; Melson G. F., 2009, WHY WILD THINGS ARE; Melson GF, 2006, HDB ANIMAL ASSISTED, P207; Norris M, 2010, AUTISM, V14, P263, DOI 10.1177/1362361309348071; O'Haire M, 2010, J VET BEHAV, V5, P226, DOI 10.1016/j.jveb.2010.02.002; O'Haire ME, 2013, J AUTISM DEV DISORD, V43, P1606, DOI 10.1007/s10803-012-1707-5; Pasco G, 2008, J AUTISM DEV DISORD, V38, P1807, DOI 10.1007/s10803-008-0569-3; PORESKY RH, 1990, PSYCHOL REP, V67, P51, DOI 10.2466/PR0.67.5.51-54; Raudenbush S. W., 2002, HIERARCHICAL LINEAR, V1; REDEFER LA, 1989, J AUTISM DEV DISORD, V19, P461, DOI 10.1007/BF02212943; Remington A, 2012, AUTISM, V16, P59, DOI 10.1177/1362361311409257; Robertson K, 2003, J AUTISM DEV DISORD, V33, P123, DOI 10.1023/A:1022979108096; Rowley E, 2012, RES AUTISM SPECT DIS, V6, P1126, DOI 10.1016/j.rasd.2012.03.004; Ruble LA, 2011, FOCUS AUTISM DEV DIS, V26, P67, DOI 10.1177/1088357610397345; Rutter M., 2003, SOCIAL COMMUNICATION; Sams MJ, 2006, AM J OCCUP THER, V60, P268, DOI 10.5014/ajot.60.3.268; Schafer JL, 2002, PSYCHOL METHODS, V7, P147, DOI 10.1037//1082-989X.7.2.147; Silva K, 2011, J ALTERN COMPLEM MED, V17, P655, DOI 10.1089/acm.2010.0436; Snijders T.A.B., 2012, MULTILEVEL ANAL INTR, V2nd; Thompson KL, 2003, AUST PSYCHOL, V38, P175, DOI 10.1080/00050060310001707187; Viau R, 2010, PSYCHONEUROENDOCRINO, V35, P1187, DOI 10.1016/j.psyneuen.2010.02.004; Wells DL, 2009, J SOC ISSUES, V65, P523, DOI 10.1111/j.1540-4560.2009.01612.x; Wells M, 2001, ANTHROZOOS, V14, P161, DOI 10.2752/089279301786999472; White SW, 2009, J AUTISM DEV DISORD, V39, P1006, DOI 10.1007/s10803-009-0713-8; White SW, 2009, CLIN PSYCHOL REV, V29, P216, DOI 10.1016/j.cpr.2009.01.003; Witwer AN, 2007, J INTELLECT DEV DIS, V32, P179, DOI 10.1080/13668250701604776	62	75	75	5	110	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57010	10.1371/journal.pone.0057010	http://dx.doi.org/10.1371/journal.pone.0057010			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	098BN	23468902	Green Published, gold, Green Submitted			2022-12-25	WOS:000315519000054
J	Rong, JJ; Wang, QH; Liu, KJ; Tan, LW; Ran, X; Zhang, SX; Li, QY; Han, YL				Rong, Jingjing; Wang, Qinghua; Liu, Kaijun; Tan, Liwen; Ran, Xu; Zhang, Shaoxiang; Li, Qiyu; Han, Yaling			A New Atlas Localization Approach for Subthalamic Nucleus Utilizing Chinese Visible Human Head Datasets	PLOS ONE			English	Article							DEEP BRAIN-STIMULATION; BASAL GANGLIA; VALIDATION; ELECTRODES; DISEASE; TARGET	Objective: To study the possibility of Chinese visible human (CVH) head datasets as brain atlas for locating the subthalamic nucleus (STN) before deep brain stimulation (DBS) surgery. Methods: Optimal head axial and coronal 3.0T, T2-weighted magnetic resonance images (MRI) of 30 patients were obtained. Cross-sectional head images of four CVH head datasets were chosen to establish an average CVH model. All MRI sequences were registered to the CVH model via fiducials in X-, Y-, and Z-direction, respectively, within the same stereotactic space. The correlations between red nucleus (RN) and fiducials, the accuracy of MRI-to-CVH registration, and the coordinate value differences of RN gravity center between MRI and CVH were tested. Results: The mean gravity center coordinate values and ranges of STN in CVH were measured; The X coordinate value of RN positively correlates with the most anterior point of putamen(PU-A), the lateral edges of putamens (PU-L), and width of the third ventricle, negatively correlated with the patients' age; The minimal mean errors were when no fiducials were used when locating RN between the MRI and the CVH average model; There were no significant differences of RN in X- and Y-direction between MRI sequences and CVH. Conclusion: CVH head datasets can be used as brain atlas for Chinese STN localization. Moreover, average coordinate values of the gravity center and the ranges of STN in CVH can be considered as references for locating STN.	[Rong, Jingjing; Liu, Kaijun; Tan, Liwen; Zhang, Shaoxiang; Li, Qiyu] Third Mil Med Univ, Chongqing Inst Comp Med, Dept Anat, Coll Basic Med Sci, Chongqing, Peoples R China; [Wang, Qinghua] Third Mil Med Univ, Dept Neurol, Daping Hosp, Chongqing, Peoples R China; [Wang, Qinghua] Third Mil Med Univ, Ctr Clin Neurosci, Daping Hosp, Chongqing, Peoples R China; [Ran, Xu] Chongqing Commun Coll, Network Informat Ctr, Training Dept, Chongqing, Peoples R China; [Han, Yaling] Shenyang Mil Gen Hosp, Dept Cardiol, Shenyang, Peoples R China	Army Medical University; Army Medical University; Army Medical University	Li, QY (corresponding author), Third Mil Med Univ, Chongqing Inst Comp Med, Dept Anat, Coll Basic Med Sci, Chongqing, Peoples R China.	liqiyu_99@163.com; hanyaling@263.net	Wang, Qinghua/GVT-3252-2022		National Natural Science Foundation of China [30872659, 30870696]; Major Program of the National Natural Science Foundation of China [61190122]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Program of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Nos. 30872659 and 30870696). This work was also supported by the Major Program of the National Natural Science Foundation of China (No. 61190122). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of this manuscript.	Acar F, 2007, STEREOT FUNCT NEUROS, V85, P287, DOI 10.1159/000107361; Bardinet E, 2009, J NEUROSURG, V110, P208, DOI 10.3171/2008.3.17469; Brunenberg EJL, 2011, J NEUROSURG, V115, P971, DOI 10.3171/2011.6.JNS101571; Castro FJS, 2006, IEEE T MED IMAGING, V25, P1440, DOI 10.1109/TMI.2006.882129; Coenen VA, 2008, ACTA NEUROCHIR, V150, P1163, DOI 10.1007/s00701-008-0136-x; Daniluk S, 2010, ACTA NEUROCHIR, V152, P201, DOI 10.1007/s00701-009-0514-z; Dormont D, 2004, AM J NEURORADIOL, V25, P1516; Duay V, 2008, LECT NOTES COMPUT SC, V5242, P980, DOI 10.1007/978-3-540-85990-1_118; Guehl D, 2007, J NEUROSURG, V106, P101, DOI 10.3171/jns.2007.106.1.101; Lemaire JJ, 2007, INT J COMPUT ASS RAD, V2, P75, DOI 10.1007/s11548-007-0124-2; Mai J.K., 1997, ATLAS HUMAN BRAIN; McClelland S, 2005, NEUROSURG FOCUS, V19, P1, DOI DOI 10.3171/; PARENT A, 1995, BRAIN RES REV, V20, P128, DOI 10.1016/0165-0173(94)00008-D; Patel NK, 2008, STEREOT FUNCT NEUROS, V86, P153, DOI 10.1159/000120427; Richter EO, 2004, J NEUROSURG, V100, P541, DOI 10.3171/jns.2004.100.3.0541; Saint-Cyr JA, 2002, J NEUROSURG, V97, P1152, DOI 10.3171/jns.2002.97.5.1152; Schaltenbrand G., 1977, ATLAS STEREOTAXY HUM; Schlaier J, 2005, ACTA NEUROCHIR, V147, P1175, DOI 10.1007/s00701-005-0606-3; Standring S, 2008, GRAYS ANATOMY; Tang YC, 2010, NEUROIMAGE, V51, P33, DOI 10.1016/j.neuroimage.2010.01.111; Videen TO, 2008, J NEUROSCI METH, V168, P275, DOI 10.1016/j.jneumeth.2007.10.007; Vitek JL, 2010, MOVEMENT DISORD, V25, P1530, DOI 10.1002/mds.23151; Yelnik J, 2003, J NEUROSURG, V99, P89, DOI 10.3171/jns.2003.99.1.0089; Yelnik J, 2007, NEUROIMAGE, V34, P618, DOI 10.1016/j.neuroimage.2006.09.026; Zaidel A, 2009, MOVEMENT DISORD, V24, P1785, DOI 10.1002/mds.22674; Zhang SX, 2006, CLIN ANAT, V19, P204, DOI 10.1002/ca.20273; Zhu XL, 2002, ACTA NEUROCHIR, V144, P959, DOI 10.1007/s00701-002-0982-x	27	3	6	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57264	10.1371/journal.pone.0057264	http://dx.doi.org/10.1371/journal.pone.0057264			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460836	Green Published, Green Submitted, gold			2022-12-25	WOS:000315519000086
J	Rossi, PG; Benevolo, M; Vocaturo, A; Caraceni, D; Ciccocioppo, L; Frega, A; Terrenato, I; Zappacosta, R; French, D; Rosini, S				Rossi, Paolo Giorgi; Benevolo, Maria; Vocaturo, Amina; Caraceni, Donatella; Ciccocioppo, Lucia; Frega, Antonio; Terrenato, Irene; Zappacosta, Roberta; French, Deborah; Rosini, Sandra			Prognostic Value of HPV E6/E7 mRNA Assay in Women with Negative Colposcopy or CIN1 Histology Result: A Follow-Up Study	PLOS ONE			English	Article							CERVICAL INTRAEPITHELIAL NEOPLASIA; HUMAN-PAPILLOMAVIRUS INFECTION; CLINICAL-PERFORMANCE; GRADE 3; CANCER; DNA; CYTOLOGY; RISK; PROOFER; TRIAGE	Pap test, and especially HPV DNA test, identify a large group of women who do not have any clinically relevant lesions, i.e., CIN2+ (Cervical Intraepithelial Neoplasia grade 2 or worse), but who are at greater risk of getting lesions in the future. The follow up of these women needs new biomarkers with prognostic value. The objective of this study is to evaluate the prognostic value of E6/E7 mRNA over-expression assay (PreTect HPV-Proofer, Norchip) for 5 HR-HPV types (16, 18, 31, 33, and 45) for progression to CIN2+ after a negative colposcopy. This prospective study, conducted at four Italian centres, enrolled 673 women with either a negative colposcopy or a negative or CIN1 histology. The clinical end-point was histological confirmation of CIN2+. Women were classified at baseline according to mRNA results and managed according to local colposcopy protocols. At least one conclusive follow-up test was obtained for 347 women (25 months average lapse since recruitment, range 5-74). Only seven CIN2+ were detected during follow up, three among the 82 women positive for mRNA at baseline, two among the 250 negative (Fisher exact test, p = 0.02), and two among the 12 with an invalid test. Absolute CIN2+ risk was 6.7/1,000 person/years in the whole cohort. The absolute CIN2+ risk was 18.4/1,000 person/years and 3.6/1,000 person/years in mRNA-positive and mRNA-negative women, respectively. In conclusion, E6/E7 mRNA overexpression appears to be a good candidate as a prognostic biomarker to manage HR-HPV DNA-positive women with negative colposcopy or histology, particularly in order to decrease follow-up intensity in those who are negative.	[Rossi, Paolo Giorgi] Agcy Publ Hlth Lazio Sanita, Rome, Italy; [Rossi, Paolo Giorgi] AUSL Reggio Emilia, Epidemiol Unit, Reggio Emilia, Italy; [Benevolo, Maria; Vocaturo, Amina] Regina Elena Inst Canc Res, Dept Pathol, Rome, Italy; [Caraceni, Donatella; Ciccocioppo, Lucia] F Renzetti Hosp, Cytopathol Unit, Chieti, Italy; [Frega, Antonio] Univ Roma La Sapienza, Dept Gynecol, Fac Med 2, St Andrea Hosp, Rome, Italy; [Terrenato, Irene] Regina Elena Inst Canc Res, Dept Epidemiol, Rome, Italy; [Zappacosta, Roberta; Rosini, Sandra] Univ G DAnnunzio, Oncol & Neurosci Dept, Cytopathol Sect, Pescara, Italy; [French, Deborah] Univ Roma La Sapienza, Clin & Mol Med Dept, Fac Med 2, St Andrea Hosp, Rome, Italy	IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; Sapienza University Rome; Azienda Ospedaliera Sant'Andrea; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; G d'Annunzio University of Chieti-Pescara; Sapienza University Rome; Azienda Ospedaliera Sant'Andrea	Benevolo, M (corresponding author), Regina Elena Inst Canc Res, Dept Pathol, Rome, Italy.	benevolo@ifo.it	Rossi, Paolo Giorgi/K-6367-2016; Terrenato, Irene/B-1308-2017; Benevolo, Maria/J-8491-2018	Rossi, Paolo Giorgi/0000-0001-9703-2460; Terrenato, Irene/0000-0002-0187-9323; Benevolo, Maria/0000-0003-1994-0935	Italian Ministry of Health through grant "Progetto finalizzato Screening'' of the Agenzia Sanitaria Abruzzo; Italian Ministry of Health through "Programma Integrato Oncologia''	Italian Ministry of Health through grant "Progetto finalizzato Screening'' of the Agenzia Sanitaria Abruzzo; Italian Ministry of Health through "Programma Integrato Oncologia''	This study was partially supported by the Italian Ministry of Health, through a grant "Progetto finalizzato Screening'' of the Agenzia Sanitaria Abruzzo, and through the "Programma Integrato Oncologia''. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anttila A, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1804; Arbyn M, 2008, EUROPEAN GUIDELINES; Arbyn M, 2013, INT J CANCER, V132, P101, DOI 10.1002/ijc.27636; Benevolo M, 2011, J CLIN MICROBIOL, V49, P2643, DOI 10.1128/JCM.02570-10; Benevolo M, 2011, CANCER CAUSE CONTROL, V22, P869, DOI 10.1007/s10552-011-9757-0; Bulkmans NWJ, 2007, LANCET, V370, P1764, DOI 10.1016/S0140-6736(07)61450-0; Carozzi F, 2008, LANCET ONCOL, V9, P937, DOI 10.1016/S1470-2045(08)70208-0; Castle PE, 2007, CLIN CANCER RES, V13, P2599, DOI 10.1158/1078-0432.CCR-06-2881; Castle PE, 2012, AM J CLIN PATHOL, V138, P241, DOI 10.1309/AJCPNTK6G2PXWHOO; Castle PE, 2011, OBSTET GYNECOL, V118, P1222, DOI 10.1097/AOG.0b013e318237caf4; Castle PE, 2010, LANCET ONCOL, V11, P214, DOI 10.1016/S1470-2045(09)70385-7; Castle PE, 2009, INT J CANCER, V125, P1649, DOI 10.1002/ijc.24525; Cuschieri K, 2008, CANCER EPIDEM BIOMAR, V17, P2536, DOI 10.1158/1055-9965.EPI-08-0306; Cuzick J, 2006, VACCINE, V24, P90, DOI 10.1016/j.vaccine.2006.05.122; Dillner J, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1754; Dockter J, 2009, J CLIN VIROL, V45, pS55, DOI 10.1016/S1386-6532(09)70009-5; Doeberitz MV, 2002, EUR J CANCER, V38, P2229, DOI 10.1016/S0959-8049(02)00462-8; Dona MG, 2012, GYNECOL ONCOL, V126, P198, DOI 10.1016/j.ygyno.2012.05.004; Halfon P, 2010, J CLIN VIROL, V47, P177, DOI 10.1016/j.jcv.2009.11.011; International Agency for Research on Cancer (IARC), 2005, IARC HDB CANC PREV, V10, P45; Kitchener HC, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI 10.3310/hta13510; Kitchener HC, 2009, LANCET ONCOL, V10, P672, DOI 10.1016/S1470-2045(09)70156-1; Kjaer SK, 2010, JNCI-J NATL CANCER I, V102, P1478, DOI 10.1093/jnci/djq356; Klaes R, 2001, INT J CANCER, V92, P276, DOI 10.1002/ijc.1174; Koliopoulos G, 2012, ACTA OBSTET GYN SCAN, V91, P794, DOI 10.1111/j.1600-0412.2012.01414.x; Lie AK, 2008, EXPERT REV MOL DIAGN, V8, P405, DOI 10.1586/14737159.8.4.405; Lie AK, 2005, GYNECOL ONCOL, V97, P908, DOI 10.1016/j.ygyno.2005.02.026; Massad LS, 2009, J LOW GENIT TRACT DI, V13, P137, DOI 10.1097/LGT.0b013e31819308d4; Mitchell MF, 1998, OBSTET GYNECOL, V91, P626, DOI 10.1016/S0029-7844(98)00006-4; Molden T, 2005, INT J CANCER, V114, P973, DOI 10.1002/ijc.20839; Moyer VA., 2012, ANN INTERN MED; Naucler P, 2007, NEW ENGL J MED, V357, P1589, DOI 10.1056/NEJMoa073204; Pretorius RG, 2011, J LOW GENIT TRACT DI, V15, P180, DOI 10.1097/LGT.0b013e3181fb4547; Ratnam S, 2010, J CLIN MICROBIOL, V48, P2779, DOI 10.1128/JCM.00382-10; Rijkaart DC, 2012, J CLIN MICROBIOL, V50, P2390, DOI 10.1128/JCM.06587-11; Ronco G., 2012, EPIDEMIOL PREV, V36, P1; Ronco G, 2008, J NATL CANCER I, V100, P492, DOI 10.1093/jnci/djn065; Ronco G, 2010, EPIDEMIOL PREV, V34, P35; Ronco G, 2010, LANCET ONCOL, V11, P249, DOI 10.1016/S1470-2045(09)70360-2; Rosini S, 2007, INT J IMMUNOPATH PH, V20, P341, DOI 10.1177/039463200702000214; Rossi PG, 2009, BMC PUBLIC HEALTH, V9, DOI [10.1186/1471-2458-9-71, 10.1186/1471-2407-9-69]; Solomon D, 2002, JAMA-J AM MED ASSOC, V287, P2114, DOI 10.1001/jama.287.16.2114; Sorbye SW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026022; Sorbye SW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012724; Stoler MH, 2011, INT J CANCER, V128, P1354, DOI 10.1002/ijc.25470; Szarewski A, 2008, CANCER EPIDEM BIOMAR, V17, P3033, DOI 10.1158/1055-9965.EPI-08-0508; Szarewski A, 2012, J CLIN MICROBIOL, V50, P1867, DOI 10.1128/JCM.00181-12; The NHS Information Centre, 2010, PUBL HLTH IND POP ST; Zuchna C, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.05.033	49	16	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57600	10.1371/journal.pone.0057600	http://dx.doi.org/10.1371/journal.pone.0057600			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460880	gold, Green Submitted, Green Published			2022-12-25	WOS:000315519000135
J	Soloviev, M; Esteves, MP; Amiri, F; Crompton, MR; Rider, CC				Soloviev, Mikhail; Esteves, Michelle P.; Amiri, Fakhria; Crompton, Mark R.; Rider, Christopher C.			Elevated Transcription of the Gene QSOX1 Encoding Quiescin Q6 Sulfhydryl Oxidase 1 in Breast Cancer	PLOS ONE			English	Article							HUMAN URINARY PROTEOME; CANDIDATE GENES; EXPRESSION; IDENTIFICATION; THIOREDOXIN; PROGRESSION; FAMILY; CELLS; MICROARRAY; ESTROGEN	The q arm of chromosome 1 is frequently amplified at the gene level in breast cancer. Since the significance of this is unclear we investigated whether 1q genes are overexpressed in this disease. The cDNA levels of 1q-located genes were analysed in a search for overexpressed genes. 26 genes mapping to the 1q arm show highly significant (P <= 0.01) overexpression of transcripts in breast cancer compared to normal breast tissue. Amongst those showing the highest levels of overexpression in both expressed sequence tag (EST) and serial analysis of gene expression (SAGE) databases was enzyme quiescin Q6 sulfhydryl oxidase 1 (QSOX1). We investigated QSOX1 cDNA derived from T47D breast carcinoma cells by RT-PCR and 3'-RACE PCR and identified a novel extended form of QSOX1 transcript, containing a long 3'UTR, nearly double the size of the previously reported QSOX1 cDNA, and confirmed its 3' end nucleotide sequence using RACE-PCR. We also used quantitative real-time PCR to analyse a panel of cDNAs derived from 50 clinically-graded normal and malignant breast tissue samples for the expression of QSOX1 mRNAs. QSOX1 transcription was elevated in an increasing proportion in the grade 2 and grade 3 tumours (graded according to the Nottingham prognostic index), with 10 of the 15 grade 3 tumours (67%) examined exceeding the normal range. There was a significant correlation between relative transcript level and clinical grade (P <= 0.01) for all qPCR primer sets tested. QSOX1 mRNA levels, based on SAGE expression data, did not correlate with either Estrogen Receptor (ER) or Epidermal Growth Factor Receptor 2 (ErbB-2 or HER2/neu) expression. Our data indicate that QSOX1 is a potential new prognostic marker which may prove of use in the staging of breast tumours and the stratification of breast cancer patients.	[Soloviev, Mikhail; Esteves, Michelle P.; Amiri, Fakhria; Crompton, Mark R.; Rider, Christopher C.] Royal Holloway Univ London, Sch Biol Sci, Ctr Biomed Sci, London, England	University of London; Royal Holloway University London	Soloviev, M (corresponding author), Royal Holloway Univ London, Sch Biol Sci, Ctr Biomed Sci, London, England.	mikhail.soloviev@rhul.ac.uk		Soloviev, Mikhail/0000-0002-3235-1134				Adachi J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-r80; ALLRED DC, 1992, HUM PATHOL, V23, P974, DOI 10.1016/0046-8177(92)90257-4; Andreassi C, 2009, TRENDS CELL BIOL, V19, P465, DOI 10.1016/j.tcb.2009.06.001; Antwi K, 2009, J PROTEOME RES, V8, P4722, DOI 10.1021/pr900414f; Castagna A, 2005, J PROTEOME RES, V4, P1917, DOI 10.1021/pr050153r; Chang XZ, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1789; Coppock DL, 1998, GENOMICS, V54, P460, DOI 10.1006/geno.1998.5605; de Andrade CR, 2011, IN VITRO CELL DEV-AN, V47, P716, DOI 10.1007/s11626-011-9461-0; Fabre-Lafay S, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-73; Fridlyand J, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-96; GALEA MH, 1992, BREAST CANCER RES TR, V22, P207, DOI 10.1007/BF01840834; Grzybowska EA, 2001, BIOCHEM BIOPH RES CO, V288, P291, DOI 10.1006/bbrc.2001.5738; Gumireddy K, 2007, P NATL ACAD SCI USA, V104, P6696, DOI 10.1073/pnas.0701145104; He J, 2007, CANCER BIOL THER, V6, P76, DOI 10.4161/cbt.6.1.3551; Heckler EJ, 2008, BBA-MOL CELL RES, V1783, P567, DOI 10.1016/j.bbamcr.2007.10.002; Heckler EJ, 2008, BIOCHEMISTRY-US, V47, P4955, DOI 10.1021/bi702522q; Hill JJ, 2011, J PROTEOME RES, V10, P2479, DOI 10.1021/pr101267k; Hyman E, 1962, CANCER RES, V62, P6240; Inoue A, 2002, J MOL ENDOCRINOL, V29, P175, DOI 10.1677/jme.0.0290175; Katchman BA, 2011, MOL CANCER RES, V9, P1621, DOI 10.1158/1541-7786.MCR-11-0018; Kodali VK, 2010, BIOCHEMISTRY-US, V49, P2075, DOI 10.1021/bi902222s; Kulasingam V, 2007, MOL CELL PROTEOMICS, V6, P1997, DOI 10.1074/mcp.M600465-MCP200; Kung HN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002229; Leth-Larsen R, 2012, MOL MED, V18, P1109, DOI 10.2119/molmed.2012.00091; Li ZG, 2008, CLIN EXP METASTAS, V25, P389, DOI 10.1007/s10585-007-9117-3; Lopez de Silanes I, 2007, CELL ONCOL, V29, P1; Lucci A, 2009, BREAST CANCER RES TR, V117, P61, DOI 10.1007/s10549-008-0135-x; Mairet-Coello G, 2004, J COMP NEUROL, V473, P334, DOI 10.1002/cne.20126; Moggs JG, 2005, J MOL ENDOCRINOL, V34, P535, DOI 10.1677/jme.1.01677; Morel C, 2007, EXP CELL RES, V313, P3971, DOI 10.1016/j.yexcr.2007.09.003; Nessling M, 2005, CANCER RES, V65, P439; Orsetti B, 2006, BRIT J CANCER, V95, P1439, DOI 10.1038/sj.bjc.6603433; Porter S, 2004, CLIN CANCER RES, V10, P2429, DOI 10.1158/1078-0432.CCR-0398-3; Radom J, 2006, BBA-GENE STRUCT EXPR, V1759, P225, DOI 10.1016/j.bbaexp.2006.04.008; Raje S, 2003, BIOCHEMISTRY-US, V42, P4560, DOI 10.1021/bi030003z; Salh B, 2002, INT J CANCER, V98, P148, DOI 10.1002/ijc.10147; Song H, 2009, ONCOGENE, V28, P3307, DOI 10.1038/onc.2009.181; Stange DE, 2006, CLIN CANCER RES, V12, P345, DOI 10.1158/1078-0432.CCR-05-1633; Thorpe C, 2002, ARCH BIOCHEM BIOPHYS, V405, P1, DOI 10.1016/S0003-9861(02)00337-5; Tirkkonen M, 1998, GENE CHROMOSOME CANC, V21, P177, DOI 10.1002/(SICI)1098-2264(199803)21:3<177::AID-GCC1>3.3.CO;2-C; Tury A, 2004, J ENDOCRINOL, V183, P353, DOI 10.1677/joe.1.05842; Witkiewicz AK, 2009, CANCER BIOL THER, V8, P1071, DOI 10.4161/cbt.8.11.8874; Witkiewicz AK, 2009, AM J PATHOL, V174, P2023, DOI 10.2353/ajpath.2009.080873; Wittke I, 2003, CANCER RES, V63, P7742; Zheng WY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040935; Zheng WY, 2011, J BIOCHEM, V149, P293, DOI 10.1093/jb/mvq143	46	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57327	10.1371/journal.pone.0057327	http://dx.doi.org/10.1371/journal.pone.0057327			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460839	Green Published, gold, Green Submitted			2022-12-25	WOS:000315519000093
J	Sunami, Y; Araki, M; Hironaka, Y; Morishita, S; Kobayashi, M; Liew, EL; Edahiro, Y; Tsutsui, M; Ohsaka, A; Komatsu, N				Sunami, Yoshitaka; Araki, Marito; Hironaka, Yumi; Morishita, Soji; Kobayashi, Masaki; Liew, Ei Leen; Edahiro, Yoko; Tsutsui, Miyuki; Ohsaka, Akimichi; Komatsu, Norio			Inhibition of the NAD-Dependent Protein Deacetylase SIRT2 Induces Granulocytic Differentiation in Human Leukemia Cells	PLOS ONE			English	Article							ACUTE PROMYELOCYTIC LEUKEMIA; TRANS-RETINOIC ACID; ACUTE MYELOID-LEUKEMIA; HISTONE DEACETYLASE; DOWN-REGULATION; TUMOR-SUPPRESSOR; DNA-DAMAGE; CANCER; TUMORIGENESIS; ONCOPROTEIN	Sirtuins, NAD-dependent protein deacetylases, play important roles in cellular functions such as metabolism and differentiation. Whether sirtuins function in tumorigenesis is still controversial, but sirtuins are aberrantly expressed in tumors, which may keep cancerous cells undifferentiated. Therefore, we investigated whether the inhibition of sirtuin family proteins induces cellular differentiation in leukemic cells. The sirtuin inhibitors tenovin-6 and BML-266 induce granulocytic differentiation in the acute promyelocytic leukemia (APL) cell line NB4. This differentiation is likely caused by an inhibition of SIRT2 deacetylase activity, judging from the accumulation of acetylated alpha-tubulin, a major SIRT2 substrate. Unlike the clinically used differentiation inducer all-trans retinoic acid, tenovin-6 shows limited effects on promyelocytic leukemia-retinoic acid receptor alpha (PML-RAR-alpha) stability and promyelocytic leukemia nuclear body formation in NB4 cells, suggesting that tenovin-6 does not directly target PML-RAR-alpha activity. In agreement with this, tenovin-6 induces cellular differentiation in the non-APL cell line HL-60, where PML-RAR-alpha does not exist. Knocking down SIRT2 by shRNA induces granulocytic differentiation in NB4 cells, which demonstrates that the inhibition of SIRT2 activity is sufficient to induce cell differentiation in NB4 cells. The overexpression of SIRT2 in NB4 cells decreases the level of granulocytic differentiation induced by tenovin-6, which indicates that tenovin-6 induces granulocytic differentiation by inhibiting SIRT2 activity. Taken together, our data suggest that targeting SIRT2 is a viable strategy to induce leukemic cell differentiation.	[Sunami, Yoshitaka; Hironaka, Yumi; Kobayashi, Masaki; Liew, Ei Leen; Edahiro, Yoko; Tsutsui, Miyuki; Komatsu, Norio] Juntendo Univ, Sch Med, Dept Hematol, Tokyo 113, Japan; [Araki, Marito; Morishita, Soji; Ohsaka, Akimichi] Juntendo Univ, Sch Med, Dept Transfus Med & Stem Cell Regulat, Tokyo 113, Japan; [Kobayashi, Masaki] Sysmex Corp, Cent Res Labs, Hyogo, Japan; [Liew, Ei Leen] Otsuka Pharmaceut Co Ltd, Fujii Mem Res Inst, Shiga, Japan	Juntendo University; Juntendo University; Sysmex Corporation; Otsuka Pharmaceutical	Komatsu, N (corresponding author), Juntendo Univ, Sch Med, Dept Hematol, Tokyo 113, Japan.	komatsun@juntendo.ac.jp	Araki, Marito/T-4283-2019	Araki, Marito/0000-0002-3502-5000	JSPS KAKENHI [23800055, 23118528]; Japan Leukemia Research Fund; Grants-in-Aid for Scientific Research [25118725] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Leukemia Research Fund(Japan Leukemia Research Fund (JLRF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was funded in part by JSPS KAKENHI grants #23800055 (MA) and #23118528 (NK) and a grant from the Japan Leukemia Research Fund (NK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ablain J, 2011, BLOOD, V117, P5795, DOI 10.1182/blood-2011-02-329367; Amin HM, 2001, BRIT J HAEMATOL, V115, P287, DOI 10.1046/j.1365-2141.2001.03123.x; Andersen JL, 2011, MOL CELL, V43, P834, DOI 10.1016/j.molcel.2011.07.028; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Bosch-Presegue Laia, 2011, Genes Cancer, V2, P648, DOI 10.1177/1947601911417862; COLLINS SJ, 1987, BLOOD, V70, P1233; Cote S, 2002, BLOOD, V100, P2586, DOI 10.1182/blood-2002-02-0614; Dan L, 2012, HAEMATOL-HEMATOL J, V97, P551, DOI 10.3324/haematol.2011.055236; DANIEL MT, 1993, BLOOD, V82, P1858; de The H, 2010, NAT REV CANCER, V10, P775, DOI 10.1038/nrc2943; Dellaire G, 2004, BIOESSAYS, V26, P963, DOI 10.1002/bies.20089; Derouazi M, 2004, BIOTECHNOL BIOENG, V87, P537, DOI 10.1002/bit.20161; DYCK JA, 1994, CELL, V76, P333, DOI 10.1016/0092-8674(94)90340-9; Firestein R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002020; Grimwade D, 2002, LEUKEMIA, V16, P1959, DOI 10.1038/sj.leu.2402721; Harris MN, 2004, BLOOD, V104, P1314, DOI 10.1182/blood-2004-01-0046; He LZ, 2001, J CLIN INVEST, V108, P1321, DOI 10.1172/JCI200111537; Heltweg B, 2006, CANCER RES, V66, P4368, DOI 10.1158/0008-5472.CAN-05-3617; Hiratsuka M, 2003, BIOCHEM BIOPH RES CO, V309, P558, DOI 10.1016/j.bbrc.2003.08.029; Houtkooper RH, 2012, NAT REV MOL CELL BIO, V13, P225, DOI 10.1038/nrm3293; Inoue T, 2007, CELL CYCLE, V6, P1011, DOI 10.4161/cc.6.9.4219; Isakson P, 2010, BLOOD, V116, P2324, DOI 10.1182/blood-2010-01-261040; Kim HS, 2011, CANCER CELL, V20, P487, DOI 10.1016/j.ccr.2011.09.004; Kitamura K, 1997, LEUKEMIA, V11, P1950, DOI 10.1038/sj.leu.2400837; Kiviranta PH, 2006, J MED CHEM, V49, P7907, DOI 10.1021/jm060566j; Kosugi H, 2001, JPN J CANCER RES, V92, P529, DOI 10.1111/j.1349-7006.2001.tb01126.x; Lain S, 2008, CANCER CELL, V13, P454, DOI 10.1016/j.ccr.2008.03.004; LANOTTE M, 1991, BLOOD, V77, P1080; Li L, 2012, CANCER CELL, V21, P266, DOI 10.1016/j.ccr.2011.12.020; Li YZ, 2011, GENES CELLS, V16, P34, DOI 10.1111/j.1365-2443.2010.01460.x; Liu T, 2009, CANCER RES, V69, P1702, DOI 10.1158/0008-5472.CAN-08-3365; Matsushita N, 2005, GENES CELLS, V10, P321, DOI 10.1111/j.1365-2443.2005.00836.x; Minucci S, 2001, ONCOGENE, V20, P3110, DOI 10.1038/sj.onc.1204336; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Myatt SS, 2011, ANTIOXID REDOX SIGN, V14, P675, DOI 10.1089/ars.2010.3383; Nakagawa T, 2011, J CELL SCI, V124, P833, DOI 10.1242/jcs.081067; NEWBURGER PE, 1979, J CELL BIOL, V82, P315, DOI 10.1083/jcb.82.2.315; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; Obsilova V, 2008, PHYSIOL RES, V57, pS11, DOI 10.33549/physiolres.931598; Rajendran R, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/368276; Sanz MA, 2009, BLOOD, V113, P1875, DOI 10.1182/blood-2008-04-150250; Saunders LR, 2007, ONCOGENE, V26, P5489, DOI 10.1038/sj.onc.1210616; Schenk T, 2012, NAT MED, V18, P605, DOI 10.1038/nm.2661; Sebastian C, 2012, CELL, V151, P1185, DOI 10.1016/j.cell.2012.10.047; Skokowa J, 2009, NAT MED, V15, P151, DOI 10.1038/nm.1913; Van Meter M, 2011, CELL CYCLE, V10, P3153, DOI 10.4161/cc.10.18.17435; Wang RH, 2008, CANCER CELL, V14, P312, DOI 10.1016/j.ccr.2008.09.001; Wang Z, 2013, ONCOGENE, V32, P589, DOI 10.1038/onc.2012.83; Warrell RP, 1998, JNCI-J NATL CANCER I, V90, P1621, DOI 10.1093/jnci/90.21.1621; Witt O, 2009, CANCER LETT, V277, P8, DOI 10.1016/j.canlet.2008.08.016; Yoo CB, 2006, NAT REV DRUG DISCOV, V5, P37, DOI 10.1038/nrd1930; Yoshida H, 1996, CANCER RES, V56, P2945; Yuan HF, 2012, BLOOD, V119, P1904, DOI 10.1182/blood-2011-06-361691; Zhao Y, 2010, NAT CELL BIOL, V12, P665, DOI 10.1038/ncb2069	54	28	29	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57633	10.1371/journal.pone.0057633	http://dx.doi.org/10.1371/journal.pone.0057633			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460888	gold, Green Submitted, Green Published			2022-12-25	WOS:000315519000143
J	Lai, YH; Xu, M; Zhang, ZZ; Liu, Y				Lai, Yanhao; Xu, Meng; Zhang, Zunzhen; Liu, Yuan			Instability of CTG Repeats Is Governed by the Position of a DNA Base Lesion through Base Excision Repair	PLOS ONE			English	Article							FLAP ENDONUCLEASE-1; GENETIC INSTABILITY; MYOTONIC-DYSTROPHY; CAG REPEATS; IN-VITRO; EXPANSION; DAMAGE; MECHANISMS; DELETION; BROMATE	Trinucleotide repeat (TNR) expansions and deletions are associated with human neurodegeneration and cancer. However, their underlying mechanisms remain to be elucidated. Recent studies have demonstrated that CAG repeat expansions can be initiated by oxidative DNA base damage and fulfilled by base excision repair (BER), suggesting active roles for oxidative DNA damage and BER in TNR instability. Here, we provide the first evidence that oxidative DNA damage can induce CTG repeat deletions along with limited expansions in human cells. Biochemical characterization of BER in the context of (CTG)(20) repeats further revealed that repeat instability correlated with the position of a base lesion in the repeat tract. A lesion located at the 5'-end of CTG repeats resulted in expansion, whereas a lesion located either in the middle or the 3'-end of the repeats led to deletions only. The positioning effects appeared to be determined by the formation of hairpins at various locations on the template and the damaged strands that were bypassed by DNA polymerase beta and processed by flap endonuclease 1 with different efficiency. Our study indicates that the position of a DNA base lesion governs whether TNR is expanded or deleted through BER.	[Lai, Yanhao; Xu, Meng; Liu, Yuan] Florida Int Univ, Dept Chem & Biochem, Miami, FL 33199 USA; [Lai, Yanhao; Zhang, Zunzhen] Sichuan Univ, Dept Environm & Occupat Hlth, West China Sch Publ Hlth, Chengdu 610064, Peoples R China	State University System of Florida; Florida International University; Sichuan University	Liu, Y (corresponding author), Florida Int Univ, Dept Chem & Biochem, Miami, FL 33199 USA.	yualiu@fiu.edu	Lai, Yanhao/AAD-3392-2019		NIH [ES017476]; National Natural Science Foundation of China [81172632]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R00ES017476] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by NIH grant ES017476 to Y.L.(http://www.nih.gov/) and partially was supported by the grant No. 81172632 from the National Natural Science Foundation of China to Z.Z.(http://www.nsfc.gov.cn/Portal0/default166.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biade S, 1998, J BIOL CHEM, V273, P898, DOI 10.1074/jbc.273.2.898; Bogdanov MB, 2001, J NEUROCHEM, V79, P1246, DOI 10.1046/j.1471-4159.2001.00689.x; Braithwaite EK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012229; Castel AL, 2010, NAT REV MOL CELL BIO, V11, P165, DOI 10.1038/nrm2854; Entezam A, 2010, HUM MUTAT, V31, P611, DOI 10.1002/humu.21237; Freudenreich CH, 1998, SCIENCE, V279, P853, DOI 10.1126/science.279.5352.853; Gomes-Pereira M, 2004, NUCLEIC ACIDS RES, V32, P2865, DOI 10.1093/nar/gkh612; Goula AV, 2012, BIOCHEMISTRY-US, V51, P3919, DOI 10.1021/bi300410d; Goula AV, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000749; Hashem VI, 2002, MUTAT RES-FUND MOL M, V508, P107, DOI 10.1016/S0027-5107(02)00190-2; Jackson AL, 2000, MUTAT RES-FUND MOL M, V447, P187, DOI 10.1016/S0027-5107(99)00206-7; Jakupciak JP, 2000, IUBMB LIFE, V50, P355, DOI 10.1080/152165400300089358; Jarem DA, 2011, DNA REPAIR, V10, P887, DOI 10.1016/j.dnarep.2011.06.003; Jarem DA, 2009, BIOCHEMISTRY-US, V48, P6655, DOI 10.1021/bi9007403; KANG S, 1995, NAT GENET, V10, P213, DOI 10.1038/ng0695-213; KANG SM, 1995, J BIOL CHEM, V270, P27014, DOI 10.1074/jbc.270.45.27014; Kawanishi S, 2006, TOXICOLOGY, V221, P172, DOI 10.1016/j.tox.2006.01.002; Kovtun IV, 2007, NATURE, V447, P447, DOI 10.1038/nature05778; Lahue RS, 2003, FRONT BIOSCI-LANDMRK, V8, pS653, DOI 10.2741/1107; Liu Y, 2005, J BIOL CHEM, V280, P3665, DOI 10.1074/jbc.M412922200; Liu Y, 2003, J BIOL CHEM, V278, P13728, DOI 10.1074/jbc.M212061200; Liu Y, 2012, TRENDS BIOCHEM SCI, V37, P162, DOI 10.1016/j.tibs.2011.12.002; Liu Y, 2009, J BIOL CHEM, V284, P28352, DOI 10.1074/jbc.M109.050286; McMurray CT, 1999, P NATL ACAD SCI USA, V96, P1823, DOI 10.1073/pnas.96.5.1823; McMurray CT, 2010, NAT REV GENET, V11, P786, DOI 10.1038/nrg2828; Messer J, 2006, FREE RADICAL BIO MED, V40, P1981, DOI 10.1016/j.freeradbiomed.2006.01.028; Mirkin SM, 2007, NATURE, V447, P932, DOI 10.1038/nature05977; Nakamori M, 2011, HUM MOL GENET, V20, P580, DOI 10.1093/hmg/ddq501; Nelson KA, 2002, AM J EPIDEMIOL, V155, P883, DOI 10.1093/aje/155.10.883; Oussatcheva E.A., 2001, J MOL BIOL, V279, P1101; Owen BAL, 2005, NAT STRUCT MOL BIOL, V12, P663, DOI 10.1038/nsmb965; Panigrahi GB, 2010, P NATL ACAD SCI USA, V107, P12593, DOI 10.1073/pnas.0909087107; Paull TT, 1998, MOL CELL, V1, P969, DOI 10.1016/S1097-2765(00)80097-0; Pearson CE, 2005, NAT REV GENET, V6, P729, DOI 10.1038/nrg1689; Pelletier R, 2005, NUCLEIC ACIDS RES, V33, P5667, DOI 10.1093/nar/gki880; Pineiro E, 2003, NUCLEIC ACIDS RES, V31, P6733, DOI 10.1093/nar/gkg898; Pluciennik A, 2002, J BIOL CHEM, V277, P34074, DOI 10.1074/jbc.M202127200; Savouret C, 2003, EMBO J, V22, P2264, DOI 10.1093/emboj/cdg202; Schildkraut JM, 2007, CANCER EPIDEM BIOMAR, V16, P473, DOI 10.1158/1055-9965.EPI-06-0868; Vallur AC, 2010, J BIOL CHEM, V285, P28514, DOI 10.1074/jbc.M110.132738; Volle CB, 2012, BIOCHEMISTRY-US, V51, P52, DOI 10.1021/bi201552s; Wells RD, 2005, NUCLEIC ACIDS RES, V33, P3785, DOI 10.1093/nar/gki697; Wells RD, 1996, J BIOL CHEM, V271, P2875, DOI 10.1074/jbc.271.6.2875; Wilson SH, 2010, CELL MOL LIFE SCI, V67, P3633, DOI 10.1007/s00018-010-0489-1; Xu Meng, 2013, Nucleic Acids Res, V41, P1684, DOI 10.1093/nar/gks1306	45	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2013	8	2							e56960	10.1371/journal.pone.0056960	http://dx.doi.org/10.1371/journal.pone.0056960			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098PO	23468897	Green Published, gold			2022-12-25	WOS:000315561400018
J	Prokosch, V; Schallenberg, M; Thanos, S				Prokosch, Verena; Schallenberg, Maurice; Thanos, Solon			Crystallins Are Regulated Biomarkers for Monitoring Topical Therapy of Glaucomatous Optic Neuropathy	PLOS ONE			English	Article							ALPHA-B-CRYSTALLIN; RETINAL GANGLION-CELLS; HEAT-SHOCK PROTEINS; ELEVATED INTRAOCULAR-PRESSURE; BETA-ADRENOCEPTOR ANTAGONISTS; OPEN-ANGLE GLAUCOMA; 2-DIMENSIONAL ELECTROPHORESIS; STRESS PROTEINS; RAT MODEL; BETA(1)-ADRENOCEPTOR ANTAGONIST	Optic nerve atrophy caused by abnormal intraocular pressure (IOP) remains the most common cause of irreversible loss of vision worldwide. The aim of this study was to determine whether topically applied IOP-lowering eye drugs affect retinal ganglion cells (RGCs) and retinal metabolism in a rat model of optic neuropathy. IOP was elevated through cauterization of episcleral veins, and then lowered either by the daily topical application of timolol, timolol/travoprost, timolol/dorzolamide, or timolol/brimonidine, or surgically with sectorial iridectomy. RGCs were retrogradely labeled 4 days prior to enucleation, and counted. Two-dimensional polyacrylamide gel electrophoresis (2D-PAGE), matrix-assisted laser desorption ionization mass spectrometry, Western blotting, and immunohistochemistry allowed the identification of IOP-dependent proteomic changes. Genomic changes were scrutinized using microarrays and qRT-PCR. The significant increase in IOP induced by episcleral vein cauterization that persisted until 8 weeks of follow-up in control animals (p<0.05) was effectively lowered by the eye drops (p<0.05). As anticipated, the number of RGCs decreased significantly following 8 weeks of elevated IOP (p<0.05), while treatment with combination compounds markedly improved RGC survival (p<0.05). 2D-PAGE and Western blot analyses revealed an IOP-dependent expression of crystallin cry-bb2. Microarray and qRT-PCR analyses verified the results at the mRNA level. IHC demonstrated that crystallins were expressed mainly in the ganglion cell layer. The data suggest that IOP and either topically applied antiglaucomatous drugs influence crystallin expression within the retina. Neuronal crystallins are thus suitable biomarkers for monitoring the progression of neuropathy and evaluating any neuroprotective effects.	[Prokosch, Verena; Schallenberg, Maurice; Thanos, Solon] Univ Munster, Sch Med, Inst Expt Ophthalmol, D-48149 Munster, Germany; [Thanos, Solon] Interdisciplinary Ctr Clin Res, Munster, Germany	University of Munster	Thanos, S (corresponding author), Univ Munster, Sch Med, Inst Expt Ophthalmol, Albert Schweitzer Campus 1, D-48149 Munster, Germany.	solon@uni-muenster.de			Deutsche Forschungsgemeinschaft (DFG) [Th386 18-1]; IZKF [Tha3/002/09]; Medical Faculty of the University of Munster	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); IZKF; Medical Faculty of the University of Munster	The work was supported by the Deutsche Forschungsgemeinschaft (DFG, grant Th386 18-1 to S. T.), the IZKF (grant Tha3/002/09 to S. T.), and the Medical Faculty of the University of Munster. The funders have no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andley UP, 1996, J BIOL CHEM, V271, P31973, DOI 10.1074/jbc.271.50.31973; Berman Elaine R., 1994, P533; Caprioli J, 1996, INVEST OPHTH VIS SCI, V37, P2376; Chauhan BC, 2002, INVEST OPHTH VIS SCI, V43, P2969; Chidlow G, 2000, BRIT J PHARMACOL, V130, P759, DOI 10.1038/sj.bjp.0703369; CLAYTON RM, 1979, NATURE, V282, P628, DOI 10.1038/282628a0; COCKBURN DM, 1983, AM J OPTOM PHYS OPT, V60, P705; Davis TL, 1999, J OCUL PHARMACOL TH, V15, P323, DOI 10.1089/jop.1999.15.323; Donello JE, 2001, J PHARMACOL EXP THER, V296, P216; Dreyer EB, 1996, ARCH OPHTHALMOL-CHIC, V114, P299, DOI 10.1001/archopht.1996.01100130295012; Furuyoshi N, 2000, OPHTHALMOLOGICA, V214, P24, DOI 10.1159/000027470; GARCIAVALENZUELA E, 1995, EXP EYE RES, V61, P33, DOI 10.1016/S0014-4835(95)80056-5; Graw J, 1997, BIOL CHEM, V378, P1331; Grus FH, 2010, KLIN MONATSBL AUGENH, V227, P114, DOI 10.1055/s-0029-1245150; HEAD MW, 1993, AM J PATHOL, V143, P1743; Hitchings R A, 1995, Curr Opin Ophthalmol, V6, P67; Hoyng PFJ, 2000, DRUGS, V59, P411, DOI 10.2165/00003495-200059030-00003; IWAKI T, 1992, AM J PATHOL, V140, P345; Joachim SC, 2007, CURR EYE RES, V32, P501, DOI 10.1080/02713680701375183; Kumar PA, 2005, ARCH BIOCHEM BIOPHYS, V444, P77, DOI 10.1016/j.abb.2005.09.021; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lai RK, 2002, VISUAL NEUROSCI, V19, P175, DOI 10.1017/S0952523802191152; Levkovitch-Verbin H, 2002, INVEST OPHTH VIS SCI, V43, P402; Liedtke T, 2007, MOL CELL PROTEOMICS, V6, P895, DOI 10.1074/mcp.M600245-MCP200; Liu SQ, 2007, CELL MOL IMMUNOL, V4, P65; Martinez A, 2009, J OCUL PHARMACOL TH, V25, P239, DOI 10.1089/jop.2008.0114; Melena J, 1999, EUR J PHARMACOL, V378, P317, DOI 10.1016/S0014-2999(99)00459-8; Mittag TW, 2000, INVEST OPHTH VIS SCI, V41, P3451; MOORE CG, 1995, CURR EYE RES, V14, P711, DOI 10.3109/02713689508998499; Nakanishi Y, 2006, EXP EYE RES, V83, P1108, DOI 10.1016/j.exer.2006.05.018; Naskar R, 2002, INVEST OPHTH VIS SCI, V43, P2962; Naskar R, 2006, MOL VIS, V12, P1199; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; Osborne NN, 1999, BRIT J OPHTHALMOL, V83, P980, DOI 10.1136/bjo.83.8.980; Park HY, 2008, J OCUL PHARMACOL TH, V24, P563, DOI 10.1089/jop.2008.0039; Piri N, 2007, BRAIN RES, V1141, P1, DOI 10.1016/j.brainres.2006.11.095; Quigley HA, 2000, INVEST OPHTH VIS SCI, V41, P3460; Quigley HA, 1996, BRIT J OPHTHALMOL, V80, P389, DOI 10.1136/bjo.80.5.389; QUIGLEY HA, 1995, INVEST OPHTH VIS SCI, V36, P774; RENKAWEK K, 1992, ACTA NEUROPATHOL, V83, P324, DOI 10.1007/BF00296796; Sakaguchi H, 2003, EXP EYE RES, V76, P131, DOI 10.1016/S0014-4835(02)00249-X; Salvador-Silva M, 2001, J NEUROSCI RES, V66, P59, DOI 10.1002/jnr.1197; Sax C M, 1994, Adv Enzymol Relat Areas Mol Biol, V69, P155; Saylor M, 2009, ARCH OPHTHALMOL-CHIC, V127, P402, DOI 10.1001/archophthalmol.2009.9; Schwartz M, 2000, INVEST OPHTH VIS SCI, V41, P349; Stone EM, 1997, SCIENCE, V275, P668, DOI 10.1126/science.275.5300.668; Tezel G, 2004, BRAIN RES BULL, V62, P473, DOI 10.1016/S0361-9230(03)00074-1; Tezel G, 1998, INVEST OPHTH VIS SCI, V39, P2277; Thanos S, 1997, EXP BRAIN RES, V114, P483, DOI 10.1007/PL00005657; Vazquez-Chona F, 2004, INVEST OPHTH VIS SCI, V45, P2737, DOI 10.1167/iovs.03-1047; Wang YD, 2007, CURR EYE RES, V32, P891, DOI 10.1080/02713680701593702; Wood JPM, 2003, EXP EYE RES, V76, P505, DOI 10.1016/S0014-4835(02)00335-4; Yoshimura N, 2003, INVEST OPHTH VIS SCI, V44, P2211, DOI 10.1167/iovs.02-0704; YOUNG DB, 1990, ANTON LEEUW INT J G, V58, P203, DOI 10.1007/BF00548934; YOUNG RA, 1989, CELL, V59, P5, DOI 10.1016/0092-8674(89)90861-1; ZIMMERMAN TJ, 1993, J OCUL PHARMACOL, V9, P373, DOI 10.1089/jop.1993.9.373	56	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2013	8	2							e49730	10.1371/journal.pone.0049730	http://dx.doi.org/10.1371/journal.pone.0049730			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098PO	23468831	Green Published, Green Submitted, gold			2022-12-25	WOS:000315561400001
J	Eberhardt, RY; Bartholdson, SJ; Punta, M; Bateman, A				Eberhardt, Ruth Y.; Bartholdson, S. Josefin; Punta, Marco; Bateman, Alex			The SHOCT Domain: A Widespread Domain Under-Represented in Model Organisms	PLOS ONE			English	Article							PLECKSTRIN HOMOLOGY DOMAINS; ANAEROTRUNCUS-COLIHOMINIS; SPFH DOMAIN; PROTEINS; PREDICTION; SEQUENCE; KINASES; ORIGIN	We have identified a new protein domain, which we have named the SHOCT domain (Short C-terminal domain). This domain is widespread in bacteria with over a thousand examples. But we found it is missing from the most commonly studied model organisms, despite being present in closely related species. It's predominantly C-terminal location, co-occurrence with numerous other domains and short size is reminiscent of the Gram-positive anchor motif, however it is present in a much wider range of species. We suggest several hypotheses about the function of SHOCT, including oligomerisation and nucleic acid binding. Our initial experiments do not support its role as an oligomerisation domain.	[Eberhardt, Ruth Y.; Punta, Marco; Bateman, Alex] European Bioinformat Inst, Hinxton, England; [Eberhardt, Ruth Y.; Bartholdson, S. Josefin; Punta, Marco; Bateman, Alex] Wellcome Trust Sanger Inst, Hinxton, England	European Molecular Biology Laboratory (EMBL); Wellcome Trust Sanger Institute	Eberhardt, RY (corresponding author), European Bioinformat Inst, Wellcome Trust Genome Campus, Hinxton, England.	re3@sanger.ac.uk	Punta, Marco/ABH-4698-2020; Bateman, Alex/H-2861-2019	Punta, Marco/0000-0002-0050-0676; Bateman, Alex/0000-0002-6982-4660; Bartholdson Scott, Sara Josefin/0000-0003-3380-4446; Eberhardt, Ruth/0000-0001-6152-1369	Wellcome Trust [WT098051]	Wellcome Trust(Wellcome Trust)	This work was supported by the Wellcome Trust, grant number WT098051 (http://www.wellcome.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen MD, 2006, J BIOL CHEM, V281, P25502, DOI 10.1074/jbc.M601173200; Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Bork P, 1996, CURR OPIN STRUC BIOL, V6, P366, DOI 10.1016/S0959-440X(96)80057-1; Browman DT, 2007, TRENDS CELL BIOL, V17, P394, DOI 10.1016/j.tcb.2007.06.005; Burkhard P, 2001, TRENDS CELL BIOL, V11, P82, DOI 10.1016/S0962-8924(00)01898-5; Bushell KM, 2008, GENOME RES, V18, P622, DOI 10.1101/gr.7187808; Clayton GM, 2004, CELL, V119, P615, DOI 10.1016/j.cell.2004.10.030; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Crosnier C, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-76; Durocher Y, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e9; Frick DN, 2001, ANNU REV BIOCHEM, V70, P39, DOI 10.1146/annurev.biochem.70.1.39; Grishin NV, 2000, J MOL BIOL, V299, P1165, DOI 10.1006/jmbi.2000.3841; Hedges SB, 2002, NAT REV GENET, V3, P838, DOI 10.1038/nrg929; Johnson LS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-431; Kall L, 2007, NUCLEIC ACIDS RES, V35, pW429, DOI 10.1093/nar/gkm256; Kovacs-Bogdan E, 2010, BBA-MOL CELL RES, V1803, P740, DOI 10.1016/j.bbamcr.2010.01.015; Krishna SS, 2004, CELL CYCLE, V3, P1046; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; Langhorst MF, 2005, CELL MOL LIFE SCI, V62, P2228, DOI 10.1007/s00018-005-5166-4; Lau SKP, 2006, J CLIN PATHOL, V59, P748, DOI 10.1136/jcp.2005.031773; Lawson PA, 2004, INT J SYST EVOL MICR, V54, P413, DOI 10.1099/ijs.0.02653-0; Lupas AN, 2005, ADV PROTEIN CHEM, V70, P37, DOI 10.1016/S0065-3233(04)70003-0; Macias MJ, 1996, NATURE, V382, P646, DOI 10.1038/382646a0; Marcotte EM, 1999, SCIENCE, V285, P751, DOI 10.1126/science.285.5428.751; Minor DL, 2000, CELL, V102, P657, DOI 10.1016/S0092-8674(00)00088-X; Musset B, 2010, CHANNELS, V4, P260, DOI 10.4161/chan.4.4.12789; Niegowski D, 2007, CELL MOL LIFE SCI, V64, P2564, DOI 10.1007/s00018-007-7174-z; Petrey D, 2003, METHOD ENZYMOL, V374, P492, DOI 10.1016/S0076-6879(03)74021-X; Petrey D, 2009, P NATL ACAD SCI USA, V106, P17377, DOI 10.1073/pnas.0907971106; QIAN XQ, 1993, NATURE, V365, P277, DOI 10.1038/365277a0; Rackham OJL, 2010, J MOL BIOL, V403, P480, DOI 10.1016/j.jmb.2010.08.032; Rebecchi MJ, 1998, ANNU REV BIOPH BIOM, V27, P503, DOI 10.1146/annurev.biophys.27.1.503; Ryazanov AG, 1999, CURR BIOL, V9, pR43, DOI 10.1016/S0960-9822(99)80006-2; Schumacher MA, 2001, NATURE, V410, P1120, DOI 10.1038/35074145; Snyers L, 1998, J BIOL CHEM, V273, P17221, DOI 10.1074/jbc.273.27.17221; Tanaka H, 2009, SCIENCE, V323, P384, DOI 10.1126/science.1164975; Tavernarakis N, 1999, TRENDS BIOCHEM SCI, V24, P425, DOI 10.1016/S0968-0004(99)01467-X; Ton-That H, 1999, P NATL ACAD SCI USA, V96, P12424, DOI 10.1073/pnas.96.22.12424; Tropp BE, 1997, BBA-LIPID LIPID MET, V1348, P192, DOI 10.1016/S0005-2760(97)00100-8; Verma A, 2003, INFECT IMMUN, V71, P5772, DOI 10.1128/IAI.71.10.5772-5784.2003; Witte G, 2008, MOL CELL, V30, P167, DOI 10.1016/j.molcel.2008.02.020; Xu D, 2012, PROTEINS, V80, P1715, DOI 10.1002/prot.24065; Xu Q, 2010, J MOL BIOL, V396, P31, DOI 10.1016/j.jmb.2009.11.006; Yeats C, 2002, TRENDS BIOCHEM SCI, V27, P438, DOI 10.1016/S0968-0004(02)02164-3	45	3	3	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57848	10.1371/journal.pone.0057848	http://dx.doi.org/10.1371/journal.pone.0057848			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451277	Green Published, Green Submitted, gold			2022-12-25	WOS:000316849500140
J	Follet, H; Farlay, D; Bala, Y; Viguet-Carrin, S; Gineyts, E; Burt-Pichat, B; Wegrzyn, J; Delmas, P; Boivin, G; Chapurlat, R				Follet, Helene; Farlay, Delphine; Bala, Yohann; Viguet-Carrin, Stephanie; Gineyts, Evelyne; Burt-Pichat, Brigitte; Wegrzyn, Julien; Delmas, Pierre; Boivin, Georges; Chapurlat, Roland			Determinants of Microdamage in Elderly Human Vertebral Trabecular Bone	PLOS ONE			English	Article							COLLAGEN CROSS-LINKS; HUMAN CORTICAL BONE; CANCELLOUS BONE; NONENZYMATIC GLYCATION; MECHANICAL-PROPERTIES; ORGANIC MATRIX; DIFFUSE DAMAGE; FRACTURE; ACCUMULATION; MINERALIZATION	Previous studies have shown that microdamage accumulates in bone as a result of physiological loading and occurs naturally in human trabecular bone. The purpose of this study was to determine the factors associated with pre-existing microdamage in human vertebral trabecular bone, namely age, architecture, hardness, mineral and organic matrix. Trabecular bone cores were collected from human L2 vertebrae (n = 53) from donors 54-95 years of age (22 men and 30 women, 1 unknown) and previous cited parameters were evaluated. Collagen cross-link content (PYD, DPD, PEN and % of collagen) was measured on surrounding trabecular bone. We found that determinants of microdamage were mostly the age of donors, architecture, mineral characteristics and mature enzymatic cross-links. Moreover, linear microcracks were mostly associated with the bone matrix characteristics whereas diffuse damage was associated with architecture. We conclude that linear and diffuse types of microdamage seemed to have different determinants, with age being critical for both types.	[Follet, Helene; Farlay, Delphine; Bala, Yohann; Viguet-Carrin, Stephanie; Gineyts, Evelyne; Burt-Pichat, Brigitte; Wegrzyn, Julien; Delmas, Pierre; Boivin, Georges; Chapurlat, Roland] INSERM, UMR 1033, F-69008 Lyon, France; [Follet, Helene; Farlay, Delphine; Bala, Yohann; Viguet-Carrin, Stephanie; Gineyts, Evelyne; Burt-Pichat, Brigitte; Wegrzyn, Julien; Delmas, Pierre; Boivin, Georges; Chapurlat, Roland] Univ Lyon, UMR 1033, Lyon, France; [Wegrzyn, Julien] Hop Edouard Herriot, Dept Chirurg Orthoped, Lyon, France	Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Lyon	Follet, H (corresponding author), INSERM, UMR 1033, F-69008 Lyon, France.	Helene.Follet@inserm.fr	Follet, Hélène/E-5536-2010; FARLAY, Delphine/AGF-1234-2022; CHAPURLAT, ROLAND/AAU-1165-2021	Follet, Hélène/0000-0002-3290-2899; FARLAY, Delphine/0000-0001-6487-0337; Gineyts, Evelyne/0000-0003-3868-5810	Eli Lilly	Eli Lilly(Eli Lilly)	This study was supported in part by an unrestricted educational grant from Eli Lilly to INSERM. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported in part by an unrestricted educational grant from Eli Lilly to INSERM. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Allen MR., 2007, BONEKEY OSTEOVISION, V4, P49; Arlot ME, 2008, J BONE MINER RES, V23, P1613, DOI 10.1359/JBMR.080517; Augat P, 2006, AGE AGEING, V35, P27, DOI 10.1093/ageing/afl081; Bala Y, 2011, J MECH BEHAV BIOMED, V4, P1473, DOI 10.1016/j.jmbbm.2011.05.017; Bala Y, 2012, J BONE MINER RES, V27, P825, DOI 10.1002/jbmr.1501; Bala Y, 2010, BONE, V46, P1204, DOI 10.1016/j.bone.2009.11.032; Boivin G, 2008, BONE, V43, P532, DOI 10.1016/j.bone.2008.05.024; Boivin G, 2002, CALCIFIED TISSUE INT, V70, P503, DOI 10.1007/s00223-001-2048-0; Burr D. B., 2002, Journal of Musculoskeletal & Neuronal Interactions, V2, P201; Burr DB, 1998, J BIOMECH, V31, P337, DOI 10.1016/S0021-9290(98)00016-5; Burr DB, 1997, J BONE MINER RES, V12, P6, DOI 10.1359/jbmr.1997.12.1.6; Burt-Pichat B, 2011, J BONE MINER METAB, V29, P756, DOI 10.1007/s00774-011-0291-7; Donahue Seth W., 2006, Critical Reviews in Biomedical Engineering, V34, P215, DOI 10.1615/CritRevBiomedEng.v34.i3.20; Durchschlag E, 2006, J BONE MINER RES, V21, P1581, DOI 10.1359/JBMR.060701; Fantner GE, 2004, BONE, V35, P1013, DOI 10.1016/j.bone.2004.05.027; Fantner GE, 2006, COMPOS SCI TECHNOL, V66, P1205, DOI 10.1016/j.compscitech.2005.10.005; Farlay D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028736; Farlay D, 2010, J BONE MINER METAB, V28, P433, DOI 10.1007/s00774-009-0146-7; Fazzalari NL, 1998, BONE, V23, P373, DOI 10.1016/S8756-3282(98)00111-2; Fazzalari NL, 1998, BONE, V22, P381, DOI 10.1016/S8756-3282(97)00298-6; Fazzalari NL, 2002, BONE, V31, P697, DOI 10.1016/S8756-3282(02)00906-7; Follet H, 2011, J ORTHOP RES, V29, P481, DOI 10.1002/jor.21275; Hernandez CJ, 2005, BONE, V37, P825, DOI 10.1016/j.bone.2005.07.019; Karim L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035047; Kuliwaba JS, 2009, BONE, V44, pS151, DOI 10.1016/j.bone.2009.01.331; LANDIS WJ, 1995, BONE, V16, P533, DOI 10.1016/8756-3282(95)00076-P; Lee TC, 2003, J ANAT, V203, P161, DOI 10.1046/j.1469-7580.2003.00211.x; Luo Q, 2010, J BIOMECH, V43, P2356, DOI 10.1016/j.jbiomech.2010.04.026; MARTIN RB, 1982, J BIOMECH, V15, P137, DOI 10.1016/S0021-9290(82)80001-8; MONGIORGI R, 1983, BIOMATERIALS, V4, P192, DOI 10.1016/0142-9612(83)90009-1; Mori S, 1997, BONE, V21, P521, DOI 10.1016/S8756-3282(97)00200-7; Najafi AR, 2007, J BIOMECH, V40, P2788, DOI 10.1016/j.jbiomech.2007.01.017; Norman TL, 1997, BONE, V20, P375, DOI 10.1016/S8756-3282(97)00004-5; Paschalis EP, 2001, J BONE MINER RES, V16, P1821, DOI 10.1359/jbmr.2001.16.10.1821; Paschalis EP, 1996, CALCIFIED TISSUE INT, V59, P480, DOI 10.1007/BF00369214; Peterlik H, 2006, NAT MATER, V5, P52, DOI 10.1038/nmat1545; Saito M, 2008, OSTEOPOROSIS INT, V19, P1343, DOI 10.1007/s00198-008-0585-3; Schaffler MB, 1995, BONE, V17, P521, DOI 10.1016/8756-3282(95)00370-3; Shi XT, 2010, BONE, V46, P1260, DOI 10.1016/j.bone.2010.02.005; Soicher MA, 2011, BONE, V48, P663, DOI 10.1016/j.bone.2010.11.009; Tang SY, 2007, BONE, V40, P1144, DOI 10.1016/j.bone.2006.12.056; Tang SY, 2010, BONE, V46, P148, DOI 10.1016/j.bone.2009.09.003; Taylor D, 2007, NAT MATER, V6, P263, DOI 10.1038/nmat1866; Vashishth D, 2000, BONE, V26, P147, DOI 10.1016/S8756-3282(99)00253-7; Vashishth D, 1997, J BIOMECH, V30, P763, DOI 10.1016/S0021-9290(97)00029-8; Viguet-Carrin S, 2009, J CHROMATOGR B, V877, P1, DOI 10.1016/j.jchromb.2008.10.043; Viguet-Carrin S, 2006, BONE, V39, P1073, DOI 10.1016/j.bone.2006.05.013; Viguet-Carrin S, 2010, BONE, V46, P342, DOI 10.1016/j.bone.2009.10.001; Wang X, 2002, BONE, V31, P1, DOI 10.1016/S8756-3282(01)00697-4; Wang X, 2008, J BIOMECH, V41, P2654, DOI 10.1016/j.jbiomech.2008.06.011; Wang X, 2008, J BIOMED MATER RES B, V85B, P68, DOI 10.1002/jbm.b.30918; Wasserman Nicholas, 2005, European Journal of Morphology, V42, P43, DOI 10.1080/09243860500095471; Wenzel TE, 1996, BONE, V19, P89, DOI 10.1016/8756-3282(96)88871-5; Yeni YN, 2006, CLIN ORTHOP RELAT R, P101, DOI 10.1097/01.blo.0000200239.29931.56; Yeni YN, 2003, ANN BIOMED ENG, V31, P726, DOI 10.1114/1.1569264; Yerramshetty JS, 2008, BONE, V42, P476, DOI 10.1016/j.bone.2007.12.001	56	16	20	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e55232	10.1371/journal.pone.0055232	http://dx.doi.org/10.1371/journal.pone.0055232			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457465	Green Published, gold, Green Submitted			2022-12-25	WOS:000315603700011
J	Soong, RS; Trieu, J; Lee, SY; He, LM; Tsai, YC; Wu, TC; Hung, CF				Soong, Ruey-Shyang; Trieu, Janson; Lee, Sung Yong; He, Liangmei; Tsai, Ya-Chea; Wu, T. -C.; Hung, Chien-Fu			Xenogeneic Human p53 DNA Vaccination by Electroporation Breaks Immune Tolerance to Control Murine Tumors Expressing Mouse p53	PLOS ONE			English	Article							CYTOTOXIC T-LYMPHOCYTES; CANCER-IMMUNOTHERAPY; CELLS; ANTIGEN	The pivotal role of p53 as a tumor suppressor protein is illustrated by the fact that this protein is found mutated in more than 50% of human cancers. In most cases, mutations in p53 greatly increase the otherwise short half-life of this protein in normal tissue and cause it to accumulate in the cytoplasm of tumors. The overexpression of mutated p53 in tumor cells makes p53 a potentially desirable target for the development of cancer immunotherapy. However, p53 protein represents an endogenous tumor-associated antigen (TAA). Immunization against a self-antigen is challenging because an antigen-specific immune response likely generates only low affinity antigen-specific CD8(+) T-cells. This represents a bottleneck of tumor immunotherapy when targeting endogenous TAAs expressed by tumors. The objective of the current study is to develop a safe cancer immunotherapy using a naked DNA vaccine. The vaccine employs a xenogeneic p53 gene to break immune tolerance resulting in a potent therapeutic antitumor effect against tumors expressing mutated p53. Our study assessed the therapeutic antitumor effect after immunization with DNA encoding human p53 (hp53) or mouse p53 (mp53). Mice immunized with xenogeneic full length hp53 DNA plasmid intramuscularly followed by electroporation were protected against challenge with murine colon cancer MC38 while those immunized with mp53 DNA were not. In a therapeutic model, established MC38 tumors were also well controlled by treatment with hp53 DNA therapy in tumor bearing mice compared to mp53 DNA. Mice vaccinated with hp53 DNA plasmid also exhibited an increase in mp53-specific CD8(+) T-cell precursors compared to vaccination with mp53 DNA. Antibody depletion experiments also demonstrated that CD8(+) T-cells play crucial roles in the antitumor effects. This study showed intramuscular vaccination with xenogeneic p53 DNA vaccine followed by electroporation is capable of inducing potent antitumor effects against tumors expressing mutated p53 through CD8(+) T cells.	[Soong, Ruey-Shyang; Lee, Sung Yong; He, Liangmei; Tsai, Ya-Chea; Wu, T. -C.; Hung, Chien-Fu] Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21205 USA; [Wu, T. -C.; Hung, Chien-Fu] Johns Hopkins Med Inst, Baltimore, MD 21205 USA; [Soong, Ruey-Shyang] Chang Gung Mem Hosp Keelung, Dept Gen Surg, Keelung, Taiwan; [Soong, Ruey-Shyang] Chang Gung Univ, Coll Med, Tao Yuan, Taiwan; [Trieu, Janson] Johns Hopkins Univ, Baltimore, MD USA; [Lee, Sung Yong] Korea Univ, Dept Internal Med, Med Ctr, Seoul, South Korea	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Chang Gung Memorial Hospital; Chang Gung University; Johns Hopkins University; Korea University; Korea University Medicine (KU Medicine)	Hung, CF (corresponding author), Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21205 USA.	chung2@jhmi.edu		LEE, SUNG YONG/0000-0002-8693-5792	United States National Institutes of Health (NIH)/NCI cervical cancer SPORE grant [P50CA098252]; Chang Gung Memorial Hospital at Keelung, Taiwan [CMRPG2B0381]; NATIONAL CANCER INSTITUTE [P50CA098252] Funding Source: NIH RePORTER	United States National Institutes of Health (NIH)/NCI cervical cancer SPORE grant; Chang Gung Memorial Hospital at Keelung, Taiwan; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by United States National Institutes of Health (NIH)/NCI cervical cancer SPORE grant P50CA098252 and CMRPG2B0381 from Chang Gung Memorial Hospital at Keelung, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adotevi O, 2010, BLOOD, V115, P3025, DOI 10.1182/blood-2009-11-253641; Bergman PJ, 2006, VACCINE, V24, P4582, DOI 10.1016/j.vaccine.2005.08.027; Best SR, 2009, VACCINE, V27, P5450, DOI 10.1016/j.vaccine.2009.07.005; Brown CJ, 2009, NAT REV CANCER, V9, P862, DOI 10.1038/nrc2763; Chang CL, 2007, GENE THER, V14, P1189, DOI 10.1038/sj.gt.3302974; Cheng WF, 2001, J CLIN INVEST, V108, P669, DOI 10.1172/JCI200112346; Cheok CF, 2011, NAT REV CLIN ONCOL, V8, P25, DOI 10.1038/nrclinonc.2010.174; Dahl AM, 1996, J IMMUNOL, V157, P239; Fong L, 2001, J IMMUNOL, V167, P7150, DOI 10.4049/jimmunol.167.12.7150; FOX BA, 1990, J BIOL RESP MODIF, V9, P499; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Hung CF, 2007, GENE THER, V14, P921, DOI 10.1038/sj.gt.3302913; Hung CF, 2001, CANCER RES, V61, P3698; Kang TH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035141; Lane DP, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001222; Luxembourg A, 2006, VACCINE, V24, P4490, DOI 10.1016/j.vaccine.2005.08.014; Redmond WL, 2005, IMMUNITY, V22, P275, DOI 10.1016/j.immuni.2005.01.010; Ruan ZH, 2009, J IMMUNOTHER, V32, P486, DOI 10.1097/CJI.0b013e3181a1d134; Ryan MH, 2001, CANCER IMMUNOL IMMUN, V49, P603, DOI 10.1007/s002620000156; Tu CF, 2007, VACCINE, V25, P719, DOI 10.1016/j.vaccine.2006.08.009; Turner MJ, 2008, J EXP MED, V205, P1859, DOI 10.1084/jem.20072390; Vierboom MPM, 2000, CANCER RES, V60, P5508; Walker LSK, 2002, NAT REV IMMUNOL, V2, P11, DOI 10.1038/nri701	23	22	22	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56912	10.1371/journal.pone.0056912	http://dx.doi.org/10.1371/journal.pone.0056912			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457640	Green Submitted, gold, Green Published			2022-12-25	WOS:000315603700098
J	Cheng, CW; Su, JL; Lin, CW; Su, CW; Shih, CH; Yang, SF; Chien, MH				Cheng, Chao-Wen; Su, Jen-Liang; Lin, Chiao-Wen; Su, Chun-Wen; Shih, Chun-Han; Yang, Shun-Fa; Chien, Ming-Hsien			Effects of NFKB1 and NFKBIA Gene Polymorphisms on Hepatocellular Carcinoma Susceptibility and Clinicopathological Features	PLOS ONE			English	Article							NF-KAPPA-B; FUNCTIONAL INSERTION/DELETION POLYMORPHISM; HEPATITIS-B; PROMOTER POLYMORPHISMS; INCREASES SUSCEPTIBILITY; CONSTITUTIVE ACTIVATION; ALPHA POLYMORPHISM; GASTRIC-CANCER; BREAST CANCERS; RISK	Background: Constitutive activation of nuclear factor (NF)-kappa B is frequently observed in hepatocellular carcinoma (HCC). The current study examined associations of polymorphisms within promoter regions of NFKB1 encoding NF-kappa B1 and NFKBIA encoding IkB alpha with the susceptibility of developing HCC and clinicopathological characteristics of the tumors. Methodology and Principal Findings: Genetic polymorphisms of NFKB1 and NFKBIA were analyzed by a real-time polymerase chain reaction (PCR) in 135 HCC patients and 520 healthy controls. The genotypic frequency of the NFKB1-94 Ins polymorphism in HCC patients was significantly higher than that of the controls (adjusted odds ratio (AOR) = 2.23; 95% confidence interval (CI) 1.32 similar to 3.77). No statistical significance was observed for the distribution frequency of the NFKBIA - 2519 C/T, -826 C/T, or -881 A/G genotype and haplotype polymorphisms between HCC patients and controls. Furthermore, female HCC patients carrying the NFKB1 -94 Ins polymorphism were associated with lower clinical stages and smaller tumor sizes. Conclusions: Our results indicate that the NFKB1 -94 Ins promoter polymorphism increased the risk of HCC, and may be applied as a predictive factor for the clinical stage and tumor size in female HCC patients.	[Cheng, Chao-Wen; Chien, Ming-Hsien] Taipei Med Univ, Grad Inst Clin Med, Coll Med, Taipei, Taiwan; [Su, Jen-Liang] China Med Univ, Grad Inst Canc Biol, Coll Med, Taichung, Taiwan; [Su, Jen-Liang] China Med Univ Hosp, Ctr Mol Med, Taichung, Taiwan; [Su, Jen-Liang] Asia Univ, Dept Biotechnol, Taichung, Taiwan; [Su, Jen-Liang] Natl Taiwan Univ, Coll Med, Grad Inst Toxicol, Taipei 10764, Taiwan; [Lin, Chiao-Wen] Chung Shan Med Univ, Inst Oral Sci, Taichung, Taiwan; [Su, Chun-Wen; Yang, Shun-Fa] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Shih, Chun-Han] Taipei Med Univ, Wan Fang Hosp, Dept Trauma & Emergency Surg, Taipei, Taiwan; [Yang, Shun-Fa] Chung Shan Med Univ Hosp, Dept Med Res, Taichung, Taiwan; [Chien, Ming-Hsien] Taipei Med Univ, Wan Fan Hosp, Taipei, Taiwan	Taipei Medical University; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Asia University Taiwan; National Taiwan University; Chung Shan Medical University; Chung Shan Medical University; Taipei Medical University; Taipei Municipal WanFang Hospital; Chung Shan Medical University; Chung Shan Medical University Hospital; Taipei Medical University	Yang, SF (corresponding author), Chung Shan Med Univ, Inst Med, Taichung, Taiwan.	ysf@csmu.edu.tw; mhchien1976@gmail.com	Yang, Shun-Fa/AAN-1519-2020	Yang, Shun-Fa/0000-0002-0365-7927	Taipei Medical University-Wan Fang Hospital [101swf03]	Taipei Medical University-Wan Fang Hospital	This study was supported by a grant from Taipei Medical University-Wan Fang Hospital (grant no. 101swf03 to Drs. Chien and Yang). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah A, 2003, GENES IMMUN, V4, P450, DOI 10.1038/sj.gene.6364001; Aggarwal BB, 2004, CANCER CELL, V6, P203, DOI 10.1016/j.ccr.2004.09.003; Akkiz H, 2009, CANCER EPIDEMIOL, V33, P261, DOI 10.1016/j.canep.2009.06.001; Arbuthnot P, 2000, J GASTROEN HEPATOL, V15, P357, DOI 10.1046/j.1440-1746.2000.02069.x; Baumgarten SC, 2012, MOL ENDOCRINOL, V26, P360, DOI 10.1210/me.2011-1302; Chang CC, 2009, CLIN CHEM LAB MED, V47, P412, DOI 10.1515/CCLM.2009.092; Chen DS, 2007, HEPATOL RES, V37, pS101, DOI 10.1111/j.1872-034X.2007.00170.x; Chen F, 1999, CLIN CHEM, V45, P7; Chien MH, 2011, J SURG ONCOL, V104, P299, DOI 10.1002/jso.21929; Curran JE, 2002, CANCER LETT, V188, P103, DOI 10.1016/S0304-3835(02)00460-3; Drent M, 2001, SARCOIDOSIS VASC DIF, V18, P50; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Farazi PA, 2006, NAT REV CANCER, V6, P674, DOI 10.1038/nrc1934; Firpi Roberto J, 2006, Hematology Am Soc Hematol Educ Program, P375; Gilmore Thomas D, 2003, Cancer Treat Res, V115, P241; He YC, 2009, CARCINOGENESIS, V30, P1916, DOI 10.1093/carcin/bgp226; Karban AS, 2004, HUM MOL GENET, V13, P35, DOI 10.1093/hmg/ddh008; Kato N, 2000, HEPATOLOGY, V32, P405, DOI 10.1053/jhep.2000.9198; Li RN, 2010, J CLIN IMMUNOL, V30, P676, DOI 10.1007/s10875-010-9439-9; Lin CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035078; Lin SC, 2006, CANCER LETT, V243, P47, DOI 10.1016/j.canlet.2005.11.019; Liu P, 2002, J HEPATOL, V37, P63, DOI 10.1016/S0168-8278(02)00064-8; Lo SS, 2009, SURGERY, V145, P280, DOI 10.1016/j.surg.2008.11.001; Naugler WE, 2007, SCIENCE, V317, P121, DOI 10.1126/science.1140485; Pacifico F, 2006, BIOCHEM PHARMACOL, V72, P1142, DOI 10.1016/j.bcp.2006.07.032; Qiao L, 2006, HUM GENE THER, V17, P280, DOI 10.1089/hum.2006.17.280; Tai DI, 2000, CANCER, V89, P2274, DOI 10.1002/1097-0142(20001201)89:11<2274::AID-CNCR16>3.0.CO;2-2; Venook AP, 2010, ONCOLOGIST, V15, P5, DOI 10.1634/theoncologist.2010-S4-05; Viatour P, 2005, TRENDS BIOCHEM SCI, V30, P43, DOI 10.1016/j.tibs.2004.11.009; Wang SY, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-15; Xu HW, 2012, J PATHOL, V228, P216, DOI 10.1002/path.4009; Yano Y, 2006, LIVER INT, V26, P789, DOI 10.1111/j.1478-3231.2006.01310.x; Yokoo H, 2011, HEPATOL RES, V41, P240, DOI 10.1111/j.1872-034X.2010.00758.x; Yu MW, 2003, HEPATOLOGY, V38, P1393, DOI 10.1016/j.hep.2003.09.041; Zhang P, 2009, CANCER GENET CYTOGEN, V191, P73, DOI 10.1016/j.cancergencyto.2009.01.017; Zhou B, 2010, ANN ONCOL, V21, P506, DOI 10.1093/annonc/mdp507; Zhou B, 2009, CANCER LETT, V275, P72, DOI 10.1016/j.canlet.2008.10.002; Zhou YM, 2005, INT J BIOCHEM CELL B, V37, P1130, DOI 10.1016/j.biocel.2004.09.006; Zou YF, 2011, CANCER INVEST, V29, P78, DOI 10.3109/07357907.2010.535054	40	30	31	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56130	10.1371/journal.pone.0056130	http://dx.doi.org/10.1371/journal.pone.0056130			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457512	Green Published, Green Submitted, gold			2022-12-25	WOS:000315602700046
J	Chiplunkar, AR; Lung, TK; Alhashem, Y; Koppenhaver, BA; Salloum, FN; Kukreja, RC; Haar, JL; Lloyd, JA				Chiplunkar, Aditi R.; Lung, Tina K.; Alhashem, Yousef; Koppenhaver, Benjamin A.; Salloum, Fadi N.; Kukreja, Rakesh C.; Haar, Jack L.; Lloyd, Joyce A.			Kruppel-Like Factor 2 Is Required for Normal Mouse Cardiac Development	PLOS ONE			English	Article							UDP-GLUCOSE DEHYDROGENASE; CONGENITAL HEART-DEFECTS; HOLT-ORAM-SYNDROME; GENE-EXPRESSION; VALVE FORMATION; PRIMITIVE ERYTHROPOIESIS; TRANSCRIPTION FACTORS; ENDOCARDIAL CUSHION; CELLS; TRANSFORMATION	Kruppel-like factor 2 (KLF2) is expressed in endothelial cells in the developing heart, particularly in areas of high shear stress, such as the atrioventricular (AV) canal. KLF2 ablation leads to myocardial thinning, high output cardiac failure and death by mouse embryonic day 14.5 (E14.5) in a mixed genetic background. This work identifies an earlier and more fundamental role for KLF2 in mouse cardiac development in FVB/N mice. FVB/N KLF2-/- embryos die earlier, by E11.5. E9.5 FVB/N KLF2-/- hearts have multiple, disorganized cell layers lining the AV cushions, the primordia of the AV valves, rather than the normal single layer. By E10.5, traditional and endothelial-specific FVB/N KLF2-/- AV cushions are hypocellular, suggesting that the cells accumulating at the AV canal have a defect in endothelial to mesenchymal transformation (EMT). E10.5 FVB/N KLF2-/- hearts have reduced glycosaminoglycans in the cardiac jelly, correlating with the reduced EMT. However, the number of mesenchymal cells migrating from FVB/N KLF2-/- AV explants into a collagen matrix is reduced considerably compared to wild-type, suggesting that the EMT defect is not due solely to abnormal cardiac jelly. Echocardiography of E10.5 FVB/N KLF2-/- embryos indicates that they have abnormal heart function compared to wild-type. E10.5 C57BL/6 KLF2-/- hearts have largely normal AV cushions. However, E10.5 FVB/N and C57BL/6 KLF2-/- embryos have a delay in the formation of the atrial septum that is not observed in a defined mixed background. KLF2 ablation results in reduced Sox9, UDP-glucose dehydrogenase (Ugdh), Gata4 and Tbx5 mRNA in FVB/N AV canals. KLF2 binds to the Gata4, Tbx5 and Ugdh promoters in chromatin immunoprecipitation assays, indicating that KLF2 could directly regulate these genes. In conclusion, KLF2-/- heart phenotypes are genetic background-dependent. KLF2 plays a role in EMT through its regulation of important cardiovascular genes.	[Chiplunkar, Aditi R.; Lung, Tina K.; Alhashem, Yousef; Koppenhaver, Benjamin A.; Lloyd, Joyce A.] Virginia Commonwealth Univ, Dept Human & Mol Genet, Richmond, VA 23284 USA; [Salloum, Fadi N.; Kukreja, Rakesh C.] Virginia Commonwealth Univ, Dept Internal Med, Richmond, VA USA; [Haar, Jack L.] Virginia Commonwealth Univ, Dept Anat & Neurobiol, Richmond, VA USA; [Lloyd, Joyce A.] Virginia Commonwealth Univ, Massey Canc Ctr, Richmond, VA USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University	Lloyd, JA (corresponding author), Virginia Commonwealth Univ, Dept Human & Mol Genet, Richmond, VA 23284 USA.	jlloyd@vcu.edu	Salloum, Fadi N/C-2391-2008	Salloum, Fadi N/0000-0002-8947-9315; Khandekar, Aditi/0000-0001-5362-1335; Alhashem, Yousef N./0000-0003-4435-3003	National Institutes of Health [NIH R01 DK074694]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074694] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM090084] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health (NIH R01 DK074694). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama H, 2004, P NATL ACAD SCI USA, V101, P6502, DOI 10.1073/pnas.0401711101; Alhashem YN, 2011, J BIOL CHEM, V286, P24819, DOI 10.1074/jbc.M111.247536; Sophie A, 2007, MECH DEVELOP, V124, P551, DOI 10.1016/j.mod.2007.05.004; Atkins GB, 2008, CIRC RES, V103, P690, DOI 10.1161/CIRCRESAHA.108.184663; Basson CT, 1997, NAT GENET, V15, P30, DOI 10.1038/ng0197-30; Basu P, 2007, BLOOD, V110, P3417, DOI 10.1182/blood-2006-11-057307; BERNANKE DH, 1982, DEV BIOL, V91, P235, DOI 10.1016/0012-1606(82)90030-6; Bieker JJ, 2001, J BIOL CHEM, V276, P34355, DOI 10.1074/jbc.R100043200; Bruneau BG, 2001, CELL, V106, P709, DOI 10.1016/S0092-8674(01)00493-7; Camenisch TD, 2000, J CLIN INVEST, V106, P349, DOI 10.1172/JCI10272; Clarkin CE, 2011, J CELL PHYSIOL, V226, P749, DOI 10.1002/jcp.22393; Corrigan N, 2010, REPROD SCI, V17, P147, DOI 10.1177/1933719109348923; Dekker RJ, 2005, AM J PATHOL, V167, P609, DOI 10.1016/S0002-9440(10)63002-7; Desgrosellier JS, 2005, DEV BIOL, V280, P201, DOI 10.1016/j.ydbio.2004.12.037; Garg V, 2003, NATURE, V424, P443, DOI 10.1038/nature01827; Griffin CT, 2008, DEVELOPMENT, V135, P493, DOI 10.1242/dev.010090; High FA, 2008, NAT REV GENET, V9, P49, DOI 10.1038/nrg2279; Huddleson JP, 2004, BIOL CHEM, V385, P723, DOI 10.1515/BC.2004.088; Hyde AS, 2012, J BIOL CHEM, V287, P32708, DOI 10.1074/jbc.M112.395202; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Joziasse IC, 2008, BASIC RES CARDIOL, V103, P216, DOI 10.1007/s00395-008-0713-4; Kaczynski J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-206; KRUG EL, 1985, DEV BIOL, V112, P414, DOI 10.1016/0012-1606(85)90414-2; Kuo CT, 1997, GENE DEV, V11, P2996, DOI 10.1101/gad.11.22.2996; Lee JS, 2006, DEV CELL, V11, P845, DOI 10.1016/j.devcel.2006.09.006; Lim J, 2012, DEVELOPMENT, V139, P3471, DOI 10.1242/dev.071209; Lin ZY, 2010, ARTERIOSCL THROM VAS, V30, P1952, DOI 10.1161/ATVBAHA.110.211474; Lincoln J, 2007, DEV BIOL, V305, P120, DOI 10.1016/j.ydbio.2007.02.002; Lingrel JB, 2012, CIRC RES, V110, P1294, DOI 10.1161/CIRCRESAHA.112.267310; Maitra M, 2009, DEV BIOL, V326, P368, DOI 10.1016/j.ydbio.2008.11.004; McConnell BB, 2010, PHYSIOL REV, V90, P1337, DOI 10.1152/physrev.00058.2009; Nakajima Y, 2000, ANAT RECORD, V258, P119, DOI 10.1002/(SICI)1097-0185(20000201)258:2<119::AID-AR1>3.0.CO;2-U; Olson EN, 2006, SCIENCE, V313, P1922, DOI 10.1126/science.1132292; Parmar KM, 2006, J CLIN INVEST, V116, P49, DOI 10.1172/JCI24787; Person AD, 2005, INT REV CYTOL, V243, P287, DOI 10.1016/S0074-7696(05)43005-3; Pierpont ME, 2007, CIRCULATION, V115, P3015, DOI 10.1161/CIRCULATIONAHA.106.183056; Redmond LC, 2008, DEV DYNAM, V237, P436, DOI 10.1002/dvdy.21426; Rivera-Feliciano J, 2006, DEVELOPMENT, V133, P3607, DOI 10.1242/dev.02519; Sakata Y, 2006, J MOL CELL CARDIOL, V40, P267, DOI 10.1016/j.yjmcc.2005.09.006; Smith KA, 2009, CIRCULATION, V119, P3062, DOI 10.1161/CIRCULATIONAHA.108.843714; Snyder M, 2010, J BIOL CHEM, V285, P23639, DOI 10.1074/jbc.M110.101063; Timmerman LA, 2004, GENE DEV, V18, P99, DOI 10.1101/gad.276304; Vermot J, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000246; Walsh EC, 2001, SCIENCE, V293, P1670, DOI 10.1126/science.293.5535.1670; Wang JK, 2005, DEV BIOL, V286, P299, DOI 10.1016/j.ydbio.2005.07.035; Wani MA, 1998, TRANSGENIC RES, V7, P229, DOI 10.1023/A:1008809809843; Wood HB, 1997, BLOOD, V90, P2300	47	32	32	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e54891	10.1371/journal.pone.0054891	http://dx.doi.org/10.1371/journal.pone.0054891			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457456	Green Published, gold, Green Submitted			2022-12-25	WOS:000315602700010
J	Dijkstra, JK; Lindenberg, S; Zijlstra, L; Bouma, E; Veenstra, R				Dijkstra, Jan Kornelis; Lindenberg, Siegwart; Zijlstra, Lieuwe; Bouma, Esther; Veenstra, Rene			The Secret Ingredient for Social Success of Young Males: A Functional Polymorphism in the 5HT(2A) Serotonin Receptor Gene	PLOS ONE			English	Article							POPULARITY; ENVIRONMENT; ENHANCEMENT; AGGRESSION; DOMINANCE; BREAKING	In adolescence, being socially successful depends to a large extent on being popular with peers. Even though some youths have what it takes to be popular, they are not, whereas others seem to have a secret ingredient that just makes the difference. In this study the G-allele of a functional polymorphism in the promotor region of the 5HT(2A) serotonin receptor gene (-G1438A) was identified as a secret ingredient for popularity among peers. These findings build on and extend previous work by Burt (2008, 2009). Tackling limitations from previous research, the role of the 5HT(2A) serotonin receptor gene was examined in adolescent males (N = 285; average age 13) using a unique sample of the TRAILS study. Carrying the G-allele enhanced the relation between aggression and popularity, particularly for those boys who have many female friends. This seems to be an "enhancer" effect of the G-allele whereby popularity relevant characteristics are made more noticeable. There is no "popularity gene", as the G-allele by itself had no effect on popularity.	[Dijkstra, Jan Kornelis; Lindenberg, Siegwart; Zijlstra, Lieuwe; Veenstra, Rene] Univ Groningen, Dept Sociol, Groningen, Netherlands; [Dijkstra, Jan Kornelis; Lindenberg, Siegwart; Veenstra, Rene] Univ Groningen, Interuniv Ctr Social Sci Theory & Methodol ICS, Groningen, Netherlands; [Lindenberg, Siegwart] Tilburg Univ, Tilburg Sch Social & Behav Sci, NL-5000 LE Tilburg, Netherlands; [Lindenberg, Siegwart] Tilburg Univ, TIBER, NL-5000 LE Tilburg, Netherlands; [Bouma, Esther] Univ Groningen, Fac Math & Nat Sci, Groningen, Netherlands	University of Groningen; University of Groningen; Tilburg University; Tilburg University; University of Groningen	Dijkstra, JK (corresponding author), Univ Groningen, Dept Sociol, Groningen, Netherlands.	jan.dijkstra@rug.nl	Dijkstra, Jan/E-9338-2013; Veenstra, René/G-6696-2011; Lindenberg, Siegwart/E-2932-2013	Veenstra, René/0000-0001-6686-6307; Lindenberg, Siegwart/0000-0003-0053-3651; bouma, esther/0000-0003-2993-7086; Zijlstra, Lieuwe/0000-0002-3977-3890	Netherlands Organization for Scientific Research NWO (Medical Research Council program) [GB-MW 940-38-011, 100-001-004, 60-60600-97-118, 261-98-710, GB-MaGW 480-01-006, GB-MaGW 480-07-001, GB-MaGW 452-04-314, GB-MaGW 452-06-004, 175.010.2003.005, 481-08-013]; Dutch Ministry of Justice (WODC); European Science Foundation (EuroSTRESS project) [FP-006]; Biobanking and Biomolecular Resources Research Infrastructure BBMRI-NL [CP 32]; Netherlands Organisation for Scientific Research (NWO) Vernieuwingsimpuls (VENI) Project [451-10-012]	Netherlands Organization for Scientific Research NWO (Medical Research Council program)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)Netherlands Organization for Scientific Research (NWO)); Dutch Ministry of Justice (WODC); European Science Foundation (EuroSTRESS project); Biobanking and Biomolecular Resources Research Infrastructure BBMRI-NL; Netherlands Organisation for Scientific Research (NWO) Vernieuwingsimpuls (VENI) Project	This research is part of the TRacking Adolescents' Individual Lives Survey (TRAILS). Participating centers of TRAILS include various departments of the University Medical Center and University of Groningen, the Erasmus University Medical Center Rotterdam, the University of Utrecht, the Radboud Medical Center Nijmegen, and the Parnassia Bavo group, all in the Netherlands. TRAILS has been financially supported by various grants from the Netherlands Organization for Scientific Research NWO (Medical Research Council program grant GB-MW 940-38-011; ZonMW Brainpower grant 100-001-004; ZonMw Risk Behavior and Dependence grants 60-60600-97-118; ZonMw Culture and Health grant 261-98-710; Social Sciences Council medium-sized investment grants GB-MaGW 480-01-006 and GB-MaGW 480-07-001; Social Sciences Council project grants GB-MaGW 452-04-314 and GB-MaGW 452-06-004; NWO large-sized investment grant 175.010.2003.005; NWO Longitudinal Survey and Panel Funding 481-08-013), the Dutch Ministry of Justice (WODC), the European Science Foundation (EuroSTRESS project FP-006), Biobanking and Biomolecular Resources Research Infrastructure BBMRI-NL (CP 32), and the participating universities. The authors are grateful to all adolescents, their parents and teachers who participated in this research and to everyone who worked on this project and made it possible (www.trails.nl). Part of this research was funded by the Netherlands Organisation for Scientific Research (NWO) Vernieuwingsimpuls (VENI) Project number 451-10-012 awarded to JKD (2010)(www.nwo.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achenbach T. M., 1991, MANUAL YSR 1991 PROF; Aiken L.S., 1991, MULTIPLE REGRESSION; Back MD, 2010, J PERS SOC PSYCHOL, V98, P132, DOI 10.1037/a0016338; Burt A, 2009, J PERS SOC PSYCHOL, V96, P783, DOI 10.1037/a0013702; Burt SA, 2008, PSYCHOL SCI, V19, P112, DOI 10.1111/j.1467-9280.2008.02055.x; Cillessen AHN, 2005, CURR DIR PSYCHOL SCI, V14, P102, DOI 10.1111/j.0963-7214.2005.00343.x; Cillessen AHN, 2004, CHILD DEV, V75, P147, DOI 10.1111/j.1467-8624.2004.00660.x; de Winter AF, 2005, EUR J EPIDEMIOL, V20, P173, DOI 10.1007/s10654-004-4948-6; Dijkstra JK, 2010, J EARLY ADOLESCENCE, V30, P773, DOI 10.1177/0272431609350926; Dijkstra JK, 2009, J RES ADOLESCENCE, V19, P401, DOI 10.1111/j.1532-7795.2009.00594.x; Ellis BJ, 2011, DEV PSYCHOPATHOL, V23, P7, DOI 10.1017/S0954579410000611; Huisman M, 2008, INT J EPIDEMIOL, V37, P1227, DOI 10.1093/ije/dym273; Keizer K, 2008, SCIENCE, V322, P1681, DOI 10.1126/science.1161405; Knutson B, 1998, AM J PSYCHIAT, V155, P373, DOI 10.1176/ajp.155.3.373; Lindenberg S. M., 2012, ENV PSYCHOL INTRO, P119; Paulhus DL, 1998, J PERS SOC PSYCHOL, V74, P1197, DOI 10.1037/0022-3514.74.5.1197; RALEIGH MJ, 1991, BRAIN RES, V559, P181, DOI 10.1016/0006-8993(91)90001-C; Tse WS, 2002, PSYCHOPHARMACOLOGY, V161, P324, DOI 10.1007/s00213-002-1049-7; Vaillancourt T, 2006, AGGRESSIVE BEHAV, V32, P396, DOI 10.1002/ab.20138	19	12	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e54821	10.1371/journal.pone.0054821	http://dx.doi.org/10.1371/journal.pone.0054821			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457454	Green Submitted, gold, Green Published			2022-12-25	WOS:000315602700008
J	Giubellino, A; Sourbier, C; Lee, MJ; Scroggins, B; Bullova, P; Landau, M; Ying, WW; Neckers, L; Trepel, JB; Pacak, K				Giubellino, Alessio; Sourbier, Carole; Lee, Min-Jung; Scroggins, Brad; Bullova, Petra; Landau, Michael; Ying, Weiwen; Neckers, Len; Trepel, Jane B.; Pacak, Karel			Targeting Heat Shock Protein 90 for the Treatment of Malignant Pheochromocytoma	PLOS ONE			English	Article							MOLECULAR CHAPERONE; HSP90 INHIBITORS; SIGNALING PATHWAYS; TUMOR-SUPPRESSOR; CANCER-THERAPY; GROWTH-FACTOR; PHASE-I; COMPLEX; PARAGANGLIOMAS; EXPRESSION	Metastatic pheochromocytoma represents one of the major clinical challenges in the field of neuroendocrine oncology. Recent molecular characterization of pheochromocytoma suggests new treatment options with targeted therapies. In this study we investigated the 90 kDa heat shock protein (Hsp90) as a potential therapeutic target for advanced pheochromocytoma. Both the first generation, natural product Hsp90 inhibitor 17-allylamino-17-demethoxygeldanamycin (17-AAG, tanespimycin), and the second-generation synthetic Hsp90 inhibitor STA-9090 (ganetespib) demonstrated potent inhibition of proliferation and migration of pheochromocytoma cell lines and induced degradation of key Hsp90 clients. Furthermore, ganetespib induced dose-dependent cytotoxicity in primary pheochromocytoma cells. Using metastatic models of pheochromocytoma, we demonstrate the efficacy of 17-AAG and ganetespib in reducing metastatic burden and increasing survival. Levels of Hsp70 in plasma from the xenograft studies served as a proximal biomarker of drug treatment. Our study suggests that targeting Hsp90 may benefit patients with advanced pheochromocytoma.	[Giubellino, Alessio; Bullova, Petra; Pacak, Karel] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Program Reprod & Adult Endocrinol, NIH, Bethesda, MD USA; [Sourbier, Carole; Scroggins, Brad; Neckers, Len] NCI, Urol Oncol Branch, NIH, Bethesda, MD 20892 USA; [Lee, Min-Jung; Landau, Michael; Trepel, Jane B.] NCI, Med Oncol Branch, NIH, Bethesda, MD 20892 USA; [Ying, Weiwen] Synta Pharmaceut, Lexington, MA USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Giubellino, A (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Program Reprod & Adult Endocrinol, NIH, Bethesda, MD USA.	giubella@mail.nih.gov; karel@mail.nih.gov	Bullova, Petra/ABG-5262-2020; Giubellino, Alessio/H-3432-2019	Bullova, Petra/0000-0002-5411-2185; Giubellino, Alessio/0000-0002-5352-0662	Eunice Kennedy Shriver National Institute of Child Health and Human Development; Center for Cancer Research, National Cancer Institute of the National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008735] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [ZICSC006743, ZIASC010074] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Center for Cancer Research, National Cancer Institute of the National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by intramural research funding of the Eunice Kennedy Shriver National Institute of Child Health and Human Development and the Center for Cancer Research, National Cancer Institute of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerji U, 2009, CLIN CANCER RES, V15, P9, DOI 10.1158/1078-0432.CCR-08-0132; Basso AD, 2002, J BIOL CHEM, V277, P39858, DOI 10.1074/jbc.M206322200; Benn DE, 2003, ONCOGENE, V22, P1358, DOI 10.1038/sj.onc.1206300; Bishop SC, 2007, CURR CANCER DRUG TAR, V7, P369, DOI 10.2174/156800907780809778; Boltze C, 2003, J CLIN ENDOCR METAB, V88, P4280, DOI 10.1210/jc.2002-021299; Brieger J, 2005, ORL-J OTO-RHIN-LARYN, V67, P119, DOI 10.1159/000085171; Buffet A, 2012, HORM METAB RES, V44, P359, DOI 10.1055/s-0032-1304594; Cascon A, 2012, ENDOCR PATHOL, V23, P15, DOI 10.1007/s12022-012-9195-x; DeZwaan DC, 2008, CELL CYCLE, V7, P1006, DOI 10.4161/cc.7.8.5723; Druce MR, 2009, HORM METAB RES, V41, P697, DOI 10.1055/s-0029-1220687; Engelman JA, 2008, CURR OPIN GENET DEV, V18, P73, DOI 10.1016/j.gde.2008.01.004; Favier J, 2005, HORM RES, V63, P171, DOI 10.1159/000084685; Favier J, 2002, AM J PATHOL, V161, P1235, DOI 10.1016/S0002-9440(10)64400-8; Favier J, 2012, ENDOCR PATHOL, V23, P34, DOI 10.1007/s12022-011-9189-0; Gimenez-Roqueplo AP, 2012, HORM METAB RES, V44, P328, DOI 10.1055/s-0031-1301302; Giubellino A, 2012, CANCER LETT, V316, P46, DOI 10.1016/j.canlet.2011.10.019; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Grogan RH, 2011, CANCER CONTROL, V18, P104, DOI 10.1177/107327481101800205; Isaacs JS, 2002, J BIOL CHEM, V277, P29936, DOI 10.1074/jbc.M204733200; Jhaveri K, 2012, BBA-MOL CELL RES, V1823, P742, DOI 10.1016/j.bbamcr.2011.10.008; Jimenez C, 2009, J CLIN ENDOCR METAB, V94, P386, DOI 10.1210/jc.2008-1972; Jyung RW, 2000, LARYNGOSCOPE, V110, P161, DOI 10.1097/00005537-200001000-00029; Kaelin WG, 2008, NAT REV CANCER, V8, P865, DOI 10.1038/nrc2502; Kim YS, 2009, CURR TOP MED CHEM, V9, P1479, DOI 10.2174/156802609789895728; Korpershoek E, 2012, ENDOCR PATHOL, V23, P43, DOI 10.1007/s12022-012-9194-y; Lai EW, 2007, CELL CYCLE, V6, P1946, DOI 10.4161/cc.6.15.4521; Lenders JWM, 2005, LANCET, V366, P665, DOI 10.1016/S0140-6736(05)67139-5; Lopez-Jimenez E, 2010, MOL ENDOCRINOL, V24, P2382, DOI 10.1210/me.2010-0256; Martiniova L, 2009, CLIN EXP METASTAS, V26, P239, DOI 10.1007/s10585-009-9236-0; Modi S, 2007, J CLIN ONCOL, V25, P5410, DOI 10.1200/JCO.2007.11.7960; Neckers L, 2012, CLIN CANCER RES, V18, P64, DOI 10.1158/1078-0432.CCR-11-1000; Neckers L, 2009, NAT STRUCT MOL BIOL, V16, P235, DOI 10.1038/nsmb0309-235; Neckers L, 2009, TRENDS BIOCHEM SCI, V34, P223, DOI 10.1016/j.tibs.2009.01.006; Nolting S, 2012, ENDOCR PATHOL, V23, P21, DOI 10.1007/s12022-012-9199-6; Pacak K, 2011, Endocr Regul, V45, P65; Powers JF, 2000, CELL TISSUE RES, V302, P309, DOI 10.1007/s004410000290; Proia DA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018552; Rajan A, 2011, CLIN CANCER RES, V17, P6831, DOI 10.1158/1078-0432.CCR-11-0821; Rooijens PPGM, 2004, ENDOCR PATHOL, V15, P39, DOI 10.1385/EP:15:1:39; Schlisio S, 2008, GENE DEV, V22, P884, DOI 10.1101/gad.1648608; SCHULTE TW, 1995, J BIOL CHEM, V270, P24585, DOI 10.1074/jbc.270.41.24585; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Taldone T, 2009, BIOORGAN MED CHEM, V17, P2225, DOI 10.1016/j.bmc.2008.10.087; Tischler AS, 2004, HISTOL HISTOPATHOL, V19, P883, DOI 10.14670/HH-19.883; Trepel J, 2010, NAT REV CANCER, V10, P537, DOI 10.1038/nrc2887; Wang YS, 2010, CURR OPIN INVEST DR, V11, P1466; Weber A, 2012, HORM CANC; Xu WP, 2007, CLIN CANCER RES, V13, P1625, DOI 10.1158/1078-0432.CCR-06-2966; Ying WW, 2012, MOL CANCER THER, V11, P475, DOI 10.1158/1535-7163.MCT-11-0755; Zhang H, 2006, MOL CANCER THER, V5, P1256, DOI 10.1158/1535-7163.MCT-05-0537; Zou JY, 1998, CELL, V94, P471, DOI 10.1016/S0092-8674(00)81588-3	51	21	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56083	10.1371/journal.pone.0056083	http://dx.doi.org/10.1371/journal.pone.0056083			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457505	Green Submitted, gold, Green Published			2022-12-25	WOS:000315602700042
J	Mandel, K; Seidl, D; Rades, D; Lehnert, H; Gieseler, F; Hass, R; Ungefroren, H				Mandel, Katharina; Seidl, Daniel; Rades, Dirk; Lehnert, Hendrik; Gieseler, Frank; Hass, Ralf; Ungefroren, Hendrik			Characterization of Spontaneous and TGF-beta-Induced Cell Motility of Primary Human Normal and Neoplastic Mammary Cells In Vitro Using Novel Real-Time Technology	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; PANCREATIC DUCTAL ADENOCARCINOMA; MESENCHYMAL STEM-CELLS; CANCER TISSUE-EXTRACTS; BREAST-CANCER; EPITHELIAL-CELLS; PLASMINOGEN-ACTIVATOR; DIFFERENTIAL ROLES; UMBILICAL-CORD; TUMOR-CELLS	The clinical complications derived from metastatic disease are responsible for the majority of all breast cancer related deaths. Since cell migration and invasion are a prerequisite for metastasis their assessment in patient cancer cells in vitro may have prognostic value for the tumor's metastatic capacity. We employed real-time cell analysis (RTCA) on the xCELLigence DP system to determine in vitro motility of patient-derived primary human breast cancer epithelial cells (HBCEC). Initially, the RTCA assay was validated using established human breast cancer cell lines with either an invasive (MDA-MB-231, MDA-MB-435s) or a non-invasive phenotype (MCF-7, MDA-MB-468), and primary NSCLC cells (Tu459). Previous standard assays of cell migration/invasion revealed that only MDA-MB-231, -435s, and Tu459 cells exhibited spontaneous and TGF-beta 1-stimulated migration and invasion through a Matrigel barrier. In the present study, the TGF-beta 1-stimulated activities could be blocked by SB431542, a potent kinase inhibitor of the TGF-beta type I receptor ALK5. Application of the RTCA assay to patient-derived tumor cells showed that 4/4 primary HBCEC and primary NSCLC cells, but not normal human mammary epithelial cells (HMEC), displayed high spontaneous migratory and invasive activity which correlated with higher MMP-2 expression and uPA protein levels in HBCEC compared to HMEC. Upon treatment with TGF-beta 1, HBCEC exhibited morphologic and gene regulatory alterations indicative of epithelial-to-mesenchymal transition. However, exclusively the invasive but not the migratory activity of HBCEC was further enhanced by TGF-beta 1. This indicates the requirement for molecular, e.g. integrin interactions with Matrigel components in HBCEC in order to become responsive to pro-invasive TGF-beta effects. Together, these results show for the first time that tumorigenic HBCEC but not normal HMEC possess a strong basal migratory as well as a basal and TGF-beta 1-inducible invasive potential. These findings qualify the RTCA assay as an in vitro migration/invasion testing system for patient-specific primary breast cancer cells.	[Mandel, Katharina; Hass, Ralf] Med Univ, Dept Gynecol & Obstet, Gynecol Res Unit, Biochem & Tumor Biol Lab, Hannover, Germany; [Seidl, Daniel; Lehnert, Hendrik; Gieseler, Frank; Ungefroren, Hendrik] Univ Hosp Schleswig Holstein UKSH, Dept Med 1, Lubeck, Germany; [Seidl, Daniel; Rades, Dirk] Univ Hosp Schleswig Holstein UKSH, Dept Radiat Oncol, Lubeck, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Schleswig Holstein University Hospital	Ungefroren, H (corresponding author), Univ Hosp Schleswig Holstein UKSH, Dept Med 1, Campus Lubeck, Lubeck, Germany.	hendrik.ungefroren@uksh.de	Gieseler, Frank/L-4668-2013; Hass, Ralf/F-3197-2012; Gieseler, Frank/E-8386-2012	Hass, Ralf/0000-0002-2481-7547; Gieseler, Frank/0000-0001-6409-3822	Niedersachsische Krebshilfe	Niedersachsische Krebshilfe	This work was sponsored in part by the Niedersachsische Krebshilfe (awarded to Ralf Hass). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander S, 2012, TRENDS MOL MED, V18, P13, DOI 10.1016/j.molmed.2011.11.003; Bartsch JE, 2003, J SURG RES, V110, P383, DOI 10.1016/S0022-4804(03)00007-6; Bartscht T, 2012, CANCER CHEMOTH PHARM, V70, P221, DOI 10.1007/s00280-012-1904-0; Bertram C, 2009, MECH AGEING DEV, V130, P657, DOI 10.1016/j.mad.2009.08.001; Brabek J, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-22; Calorini L, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-24; Chaturvedi S, 2011, MECH AGEING DEV, V132, P213, DOI 10.1016/j.mad.2011.04.002; Drabsch Y, 2011, J MAMMARY GLAND BIOL, V16, P97, DOI 10.1007/s10911-011-9217-1; Figueira RCS, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-20; Friedl P, 2011, CELL, V147, P992, DOI 10.1016/j.cell.2011.11.016; Gieseler F, 2007, Hamostaseologie, V27, P273; Guillot E, 2011, BREAST J, V17, P129, DOI 10.1111/j.1524-4741.2010.01045.x; Harbeck N, 2002, J CLIN ONCOL, V20, P1000, DOI 10.1200/JCO.20.4.1000; Hass R, 2012, CELL COMMUN SIGNAL, V10, DOI 10.1186/1478-811X-10-26; Hass R, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-12; Hass R, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-127; Hess KR, 2006, CANCER, V106, P1624, DOI 10.1002/cncr.21778; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Jezierska A, 2009, MED SCI MONITOR, V15, pRA32; Keese CR, 2002, BIOTECHNIQUES, V33, P842, DOI 10.2144/02334rr01; Klein CA, 2008, SCIENCE, V321, P1785, DOI 10.1126/science.1164853; Lavrentieva A, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-18; Limame R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046536; Lv ZD, 2013, ONCOL REP, V29, P219, DOI 10.3892/or.2012.2111; Majore I, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-6; McSherry EA, 2007, CELL MOL LIFE SCI, V64, P3201, DOI 10.1007/s00018-007-7388-0; Porter PL, 2009, SALUD PUBLICA MEXICO, V51, pS141, DOI 10.1590/s0036-36342009000800003; Radisky ES, 2010, J MAMMARY GLAND BIOL, V15, P201, DOI 10.1007/s10911-010-9177-x; Schmitt M, 2006, METH MOLEC MED, V120, P245; Schniewind B, 2007, ONCOGENE, V26, P4850, DOI 10.1038/sj.onc.1210272; Sweep CGJ, 1998, BRIT J CANCER, V78, P1434, DOI 10.1038/bjc.1998.704; Taylor MA, 2010, J MAMMARY GLAND BIOL, V15, P169, DOI 10.1007/s10911-010-9181-1; Ungefroren H, 1996, J BIOL CHEM, V271, P15787, DOI 10.1074/jbc.271.26.15787; Ungefroren H, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-18; Ungefroren H, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-67; Ungefroren H, 2011, INT J ONCOL, V38, P797, DOI 10.3892/ijo.2011.897; Wang SJ, 2004, EXP CELL RES, V300, P180, DOI 10.1016/j.yexcr.2004.06.030; Wiercinska E, 2011, BREAST CANCER RES TR, V128, P657, DOI 10.1007/s10549-010-1147-x	38	33	34	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56591	10.1371/journal.pone.0056591	http://dx.doi.org/10.1371/journal.pone.0056591			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457587	Green Published, Green Submitted, gold			2022-12-25	WOS:000315602700083
J	Roth, M; Zhong, J; Zumkeller, C; S'ng, CT; Goulet, S; Tamm, M				Roth, Michael; Zhong, Jun; Zumkeller, Celine; S'ng, Chong Teck; Goulet, Stephanie; Tamm, Michael			The Role of IgE-Receptors in IgE-Dependent Airway Smooth Muscle Cell Remodelling	PLOS ONE			English	Article							HOUSE-DUST MITE; EXTRACELLULAR-MATRIX PROTEINS; COLLAGEN EXPRESSION; ALLERGIC-ASTHMA; MURINE MODEL; MAST-CELLS; FIBRONECTIN; LUNG; PROLIFERATION; SENSITIZATION	Background: In allergic asthma, IgE increases airway remodelling but the mechanism is incompletely understood. Airway remodelling consists of two independent events increased cell numbers and enhanced extracellular matrix deposition, and the mechanism by which IgE up-regulates cell proliferation and extracellular matrix deposition by human airway smooth muscle cells in asthma is unclear. Objective: Characterise the role of the two IgE receptors and associated signalling cascades in airway smooth muscle cell remodelling. Methods: Primary human airway smooth muscle cells (8 asthmatics, 8 non-asthmatics) were stimulated with human purified antibody-activated IgE. Proliferation was determined by direct cell counts. Total collagen deposition was determined by Sircol; collagen species deposition by ELISA. IgE receptors were silenced by siRNA and mitogen activated protein kinase (MAPK) signalling was blocked by chemical inhibitors. Results: IgE dose-dependently increased extracellular matrix and collagen deposition by airway smooth muscle cells as well as their proliferation. Specifically in cells of asthma patients IgE increased the deposition of collagen-type-I, -III, -VII and fibronectin, but did not affect the deposition of collagens type-IV. IgE stimulated collagen type-I and type-VII deposition through IgE receptor-I and Erk1/2 MAPK. Proliferation and deposition of collagens type-III and fibronectin involved both IgE receptors as well as Erk1/2 and p38 MAPK. Pre-incubation (30 minutes) with Omalizumab prevented all remodelling effects completely. We observed no changes in gelatinase activity or their inhibitors. Conclusion & Clincal Relevance: Our study provides the molecular biological mechanism by which IgE increases airway remodelling in asthma through increased airway smooth muscle cell proliferation and deposition of pro-inflammatory collagens and fibronectin. Blocking IgE action prevents several aspects of airway smooth muscle cell remodelling. Our findings may explain the recently described reduction of airway wall thickness in severe asthma patients treated with humanised anti-IgE antibodies.	[Roth, Michael; Zhong, Jun; Zumkeller, Celine; S'ng, Chong Teck; Goulet, Stephanie] Univ Basel, Dept Biomed, Basel, Switzerland; [Roth, Michael; Tamm, Michael] Univ Basel Hosp, Dept Internal Med, CH-4031 Basel, Switzerland	University of Basel; University of Basel	Roth, M (corresponding author), Univ Basel, Dept Biomed, Basel, Switzerland.	michael.roth@usb.ch	Roth, Michael/H-8657-2019	Roth, Michael/0000-0002-8139-2821	Swiss National Foundation [310030_130740]; Novartis	Swiss National Foundation(Swiss National Science Foundation (SNSF)); Novartis(Novartis)	Michael Roth received a research grant from the Swiss National Foundation (310030_130740). Michael Tamm received an unrestricted research grant from Novartis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkhouri H, 2011, ALLERGY, V66, P1231, DOI 10.1111/j.1398-9995.2011.02616.x; Belleau Joseph T, 2005, Clin Mol Allergy, V3, P6, DOI 10.1186/1476-7961-3-6; Blacquiere MJ, 2010, INT ARCH ALLERGY IMM, V153, P173, DOI 10.1159/000312635; Bonacci JV, 2006, BRIT J PHARMACOL, V149, P365, DOI 10.1038/sj.bjp.0706881; Brellier F, FEBS LETT, V585, P913; Burgess JK, 2009, PULM PHARMACOL THER, V22, P379, DOI 10.1016/j.pupt.2008.12.007; Camara J, 2010, FIBROGENESIS TISSUE, V3, DOI 10.1186/1755-1536-3-2; Chakir J, 2003, J ALLERGY CLIN IMMUN, V111, P1293, DOI 10.1067/mai.2003.1557; Che J, 2007, MOL PHARMACOL, V72, P1626, DOI 10.1124/mol.107.038760; Chen JC, 2011, J BIOL CHEM, V286, P26667, DOI 10.1074/jbc.M110.193987; Chuang GS, 2004, CLIN EXP DERMATOL, V29, P304, DOI 10.1111/j.1365-2230.2004.01495.x; Dekkers BGJ, 2012, BRIT J PHARMACOL, V166, P359, DOI 10.1111/j.1476-5381.2011.01773.x; Demoule A, 2006, INTENS CARE MED, V32, P413, DOI 10.1007/s00134-005-0043-z; Dunsmore SE, 1996, AM J PHYSIOL-LUNG C, V270, pL3, DOI 10.1152/ajplung.1996.270.1.L3; Evans MJ, 2010, AM J PHYSIOL-LUNG C, V298, pL543, DOI 10.1152/ajplung.00337.2009; Fedorov IA, 2005, THORAX, V60, P389, DOI 10.1136/thx.2004.030262; Galli SJ, 2012, NAT MED, V18, P693, DOI 10.1038/nm.2755; Girodet PO, 2011, PHARMACOL THERAPEUT, V130, P325, DOI 10.1016/j.pharmthera.2011.02.001; Goulet S, 2007, J CELL PHYSIOL, V210, P167, DOI 10.1002/jcp.20836; Grainge CL, 2011, NEW ENGL J MED, V364, P2006, DOI 10.1056/NEJMoa1014350; Grunstein MM, 2001, AM J PHYSIOL-LUNG C, V280, pL229, DOI 10.1152/ajplung.2001.280.2.L229; Hoshino M, 2012, RESPIRATION, V83, P520, DOI 10.1159/000334701; Johnson PRA, 2000, AM J RESP CRIT CARE, V162, P2145, DOI 10.1164/ajrccm.162.6.9909111; Johnson PRA, 2006, AM J RESP CRIT CARE, V173, P32, DOI 10.1164/rccm.200406-703OC; Johnson PRA, 2004, J ALLERGY CLIN IMMUN, V113, P690, DOI 10.1016/j.jaci.2003.12.312; Johnson PRA, 2001, AM J RESP CRIT CARE, V164, P474, DOI 10.1164/ajrccm.164.3.2010109; Joks R, 2011, RECENT PATENTS INFLA, V5, P221, DOI 10.2174/187221311797264919; Kang JY, 2010, J ASTHMA, V47, P374, DOI 10.3109/02770901003801972; Kicic A, 2010, AM J RESP CRIT CARE, V181, P889, DOI 10.1164/rccm.200907-1071OC; Kim SJ, 2009, J ASTHMA, V46, P884, DOI 10.3109/02770900903089998; Kohan M, 2011, J ALLERGY CLIN IMMUN, V127, P439, DOI 10.1016/j.jaci.2010.10.021; Koziol-White CJ, 2011, EXPERT REV RESP MED, V5, P767, DOI [10.1586/ERS.11.77, 10.1586/ers.11.77]; Larsen M, 2006, J CELL SCI, V119, P3376, DOI 10.1242/jcs.03079; McParland BE, 2004, J APPL PHYSIOL, V97, P556, DOI 10.1152/japplphysiol.00982.2003; Mor A, 2010, INFLAMMATION, V33, P119, DOI 10.1007/s10753-009-9165-8; Nam YH, 2012, J INVEST ALLERG CLIN, V22, P20; Nelea V, 2008, PROTEIN J, V27, P223, DOI 10.1007/s10930-008-9128-1; Nihlberg K, 2010, THORAX, V65, P670, DOI 10.1136/thx.2009.129320; Post S, 2012, THORAX, V67, P488, DOI 10.1136/thoraxjnl-2011-200606; Rabe KF, 2011, ALLERGY, V66, P1142, DOI 10.1111/j.1398-9995.2011.02617.x; Redhu NS, 2012, PULM PHARM IN PRESS; Riccio AM, 2012, INT J IMMUNOPATH PH, V25, P475, DOI 10.1177/039463201202500217; Royce SG, 2009, ANN ALLERG ASTHMA IM, V102, P238, DOI 10.1016/S1081-1206(10)60087-7; Schuliga M, 2011, AM J RESP CELL MOL, V44, P831, DOI 10.1165/rcmb.2009-0469OC; Soucy PA, 2011, ACTA BIOMATER, V7, P96, DOI 10.1016/j.actbio.2010.07.021; Yick CY, 2012, ALLERGY, V67, P552, DOI 10.1111/j.1398-9995.2011.02773.x	46	45	51	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56015	10.1371/journal.pone.0056015	http://dx.doi.org/10.1371/journal.pone.0056015			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457493	Green Published, gold, Green Submitted			2022-12-25	WOS:000315602700033
J	Gonzalez-Flores, A; Aguilar-Quesada, R; Siles, E; Pozo, S; Rodriguez-Lara, MI; Lopez-Jimenez, L; Lopez-Rodriguez, M; Peralta-Leal, A; Villar, D; Martin-Oliva, D; del Peso, L; Berra, E; Oliver, FJ				Gonzalez-Flores, A.; Aguilar-Quesada, R.; Siles, E.; Pozo, S.; Rodriguez-Lara, M. I.; Lopez-Jimenez, L.; Lopez-Rodriguez, M.; Peralta-Leal, A.; Villar, D.; Martin-Oliva, D.; del Peso, L.; Berra, E.; Oliver, F. J.			Interaction between PARP-1 and HIF-2 alpha in the hypoxic response	ONCOGENE			English	Article						hypoxia; PARP-1; HIF-2	RENAL-CELL CARCINOMA; INDUCIBLE FACTOR-I; TRANSCRIPTIONAL ACTIVITY; EMBRYONIC-DEVELOPMENT; PROLYL HYDROXYLATION; HIF-ALPHA; HIF-1-ALPHA; PROMOTES; GENE; POLY(ADP-RIBOSE)	Hypoxia-inducible factors (HIFs) mediate the transcriptional adaptation of hypoxic cells. The extensive transcriptional programm regulated by HIFs involves the induction of genes controlling angiogenesis, cellular metabolism, cell growth, metastasis, apoptosis, extracellular matrix remodeling and others. HIF is a heterodimer of HIF-alpha and HIF-beta subunits. In addition to HIF-1 alpha, HIF-2 alpha has evolved as an isoform that contributes differently to the hypoxic adaptation by performing non-redundant functions. Poly (ADPribose) polymerase-1 (PARP-1) is a nuclear protein involved in the control of DNA repair and gene transcription by modulating chromatin structure and acting as part of gene-specific enhancer/promoter-binding complexes. Previous results have shown that PARP-1 regulates HIF-1 activity. In this study, we focused on the cross-talk between HIF-2 alpha and PARP-1. By using different approaches to suppress PARP-1, we show that HIF-2 alpha mRNA expression, protein levels and HIF-2-dependent gene expression, such as ANGPTL4 and erythropoietin (EPO), are regulated by PARP-1. This regulation occurs at both the transcriptional and post-trancriptional level. We also show a complex formation between HIF-2 alpha with PARP-1. This complex is sensitive to PARP inhibition and seems to protect against the von Hippel-Lindau-dependent HIF-2 alpha degradation. Finally, we show that parp-1(-/-) mice display a significant reduction in the circulating hypoxia-induced EPO levels, number of red cells and hemoglobin concentration. Altogether, these results reveal a complex functional interaction between PARP-1 and the HIF system and suggest that PARP-1 is involved in the fine tuning of the HIF-mediated hypoxic response in vivo.	[Gonzalez-Flores, A.; Aguilar-Quesada, R.; Rodriguez-Lara, M. I.; Lopez-Jimenez, L.; Lopez-Rodriguez, M.; Peralta-Leal, A.; Oliver, F. J.] CSIC, Inst Parasitol & Biomed Lopez Neyra, Granada 18100, Spain; [Siles, E.] Univ Jaen, Dept Expt Biol, Jaen, Spain; [Pozo, S.; Berra, E.] CIC bioGUNE, Derio 48160, Spain; [Villar, D.; del Peso, L.] Autonomous Univ Madrid, Fac Med, CSIC, Inst Biomed Res Alberto Sols, E-28049 Madrid, Spain; [Martin-Oliva, D.] Univ Granada, Fac Sci, Dept Cellular Biol, Granada, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Parasitologia y Biomedicina Lopez-Neyra (IPBLN); Universidad de Jaen; CIC bioGUNE; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); University of Granada	Berra, E (corresponding author), CIC bioGUNE, Parque Tecnol Bizkaia Ed 801A, Derio 48160, Spain.	eberra@cicbiogune.es; joliver@ipb.csic.es	Lara, María Isabel Rodríguez/A-1961-2017; Oliver, Javier/S-1725-2018; Peralta Leal, Andreína Cecilia/AAE-8342-2022; Martín-Oliva, David/L-8472-2014; cancer, biogune/H-7276-2012; Villar, Diego/K-8595-2017; Berra, Edurne/F-9692-2011; del Peso, Luis/K-9391-2014	Lara, María Isabel Rodríguez/0000-0002-2270-0070; Oliver, Javier/0000-0001-8468-1998; Peralta Leal, Andreína Cecilia/0000-0001-7120-9870; Martín-Oliva, David/0000-0002-8095-5442; Villar, Diego/0000-0002-8614-6232; Berra, Edurne/0000-0002-3820-5744; del Peso, Luis/0000-0003-4014-5688; Siles Rivas, Eva/0000-0003-4192-7008; Aguilar-Quesada, Rocio/0000-0003-3125-6634	Ministerio de Ciencia e Innovacion [SAF2006-01094, SAF2009-13281-C02-01]; Fundacion La Caixa [BM06-219-0]; Junta de Andalucia [P07-CTS-0239]; Ministerio de Educacion y Ciencia [SAF2007-64597, SAF-2010-20067]; BIZKAIA XEDE Program from the Bizkaia County	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Fundacion La Caixa(La Caixa Foundation); Junta de Andalucia(Junta de Andalucia); Ministerio de Educacion y Ciencia(Spanish Government); BIZKAIA XEDE Program from the Bizkaia County	We thank Dr Francoise Dantzer, CNRS, Strasbourg (France), for providing the pEGFP-PARP-1 construct. This work was supported by Ministerio de Ciencia e Innovacion (SAF2006-01094 and SAF2009-13281-C02-01), Fundacion La Caixa (BM06-219-0) and Junta de Andalucia (P07-CTS-0239) to FJO; Ministerio de Educacion y Ciencia (SAF2007-64597 and SAF-2010-20067) and the BIZKAIA XEDE Program from the Bizkaia County to EB.	Aguilar-Quesada R, 2007, CURR MED CHEM, V14, P1179, DOI 10.2174/092986707780597998; Aprelikova O, 2006, CANCER RES, V66, P5641, DOI 10.1158/0008-5472.CAN-05-3345; Benizri E, 2008, CELL MOL LIFE SCI, V65, P1133, DOI 10.1007/s00018-008-7472-0; Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Carmeliet P, 1998, NATURE, V394, P485, DOI 10.1038/28867; Covello KL, 2006, GENE DEV, V20, P557, DOI 10.1101/gad.1399906; deMurcia JM, 1997, P NATL ACAD SCI USA, V94, P7303, DOI 10.1073/pnas.94.14.7303; Elser M, 2008, MOL CANCER RES, V6, P282, DOI 10.1158/1541-7786.MCR-07-0377; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Flamme I, 1998, AM J PATHOL, V153, P25, DOI 10.1016/S0002-9440(10)65541-1; Gordan JD, 2007, CANCER CELL, V11, P335, DOI 10.1016/j.ccr.2007.02.006; Hochachka PW, 1996, P NATL ACAD SCI USA, V93, P9493, DOI 10.1073/pnas.93.18.9493; Holmquist-Mengelbier L, 2006, CANCER CELL, V10, P413, DOI 10.1016/j.ccr.2006.08.026; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kondo K, 2003, PLOS BIOL, V1, P439, DOI 10.1371/journal.pbio.0000083; Kondo K, 2002, CANCER CELL, V1, P237, DOI 10.1016/S1535-6108(02)00043-0; Koshiji M, 2004, EMBO J, V23, P1949, DOI 10.1038/sj.emboj.7600196; Kraus WL, 2003, CELL, V113, P677, DOI 10.1016/S0092-8674(03)00433-1; Lando D, 2002, GENE DEV, V16, P1466, DOI 10.1101/gad.991402; Loboda A, 2012, VASC PHARMACOL, V56, P245, DOI 10.1016/j.vph.2012.02.006; Maranchie JK, 2002, CANCER CELL, V1, P247, DOI 10.1016/S1535-6108(02)00044-2; Martinez-Romero R, 2012, J APPL PHYSIOL, V112, P816, DOI 10.1152/japplphysiol.00898.2011; Mastrogiannaki M, 2009, J CLIN INVEST, V119, P1159, DOI 10.1172/JCI38499; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Peng J, 2000, P NATL ACAD SCI USA, V97, P8386, DOI 10.1073/pnas.140087397; Pescador N, 2005, BIOCHEM J, V390, P189, DOI 10.1042/BJ20042121; PUGH CW, 1991, P NATL ACAD SCI USA, V88, P10553, DOI 10.1073/pnas.88.23.10553; Rankin EB, 2007, J CLIN INVEST, V117, P1068, DOI 10.1172/JCI30117; Raval RR, 2005, MOL CELL BIOL, V25, P5675, DOI 10.1128/MCB.25.13.5675-5686.2005; Rosenberger C, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000017223.49823.2A; Ryan HE, 1998, EMBO J, V17, P3005, DOI 10.1093/emboj/17.11.3005; Schodel J, 2011, BLOOD, V117, pE207, DOI 10.1182/blood-2010-10-314427; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Tian H, 1997, GENE DEV, V11, P72, DOI 10.1101/gad.11.1.72; Tian H, 1998, GENE DEV, V12, P3320, DOI 10.1101/gad.12.21.3320; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Yoon D, 2011, AM J PHYSIOL-CELL PH, V300, pC1215, DOI 10.1152/ajpcell.00044.2011	41	38	39	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 13	2014	33	7					891	898		10.1038/onc.2013.9	http://dx.doi.org/10.1038/onc.2013.9			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AB2MN	23455322				2022-12-25	WOS:000331626900010
J	van Putten, M; Hulsker, M; Young, C; Nadarajah, VD; Heemskerk, H; van der Weerd, L; 't Hoen, PAC; van Ommen, GJB; Aartsma-Rus, AM				van Putten, Maaike; Hulsker, Margriet; Young, Courtney; Nadarajah, Vishna D.; Heemskerk, Hans; van der Weerd, Louise; 't Hoen, Peter A. C.; van Ommen, Gert-Jan B.; Aartsma-Rus, Annemieke M.			Low dystrophin levels increase survival and improve muscle pathology and function in dystrophin/utrophin double-knockout mice	FASEB JOURNAL			English	Article						Duchenne muscular dystrophy; Becker muscular dystrophy; biomarkers; cardiomyopathy; mouse models	DUCHENNE MUSCULAR-DYSTROPHY; FULL-LENGTH; GENE-THERAPY; MDX MOUSE; DEFICIENT MICE; UTROPHIN; SKELETAL; EXPRESSION; RESCUE; MODEL	Duchenne muscular dystrophy (DMD) is a severe muscle-wasting disorder caused by the lack of functional dystrophin. There is no cure, but several clinical trials aimed to restore the synthesis of functional dystrophin are underway. The dystrophin levels needed for improvement of muscle pathology, function, and overall vitality are not known. Here, we describe the mdx/utrn(-/-)/Xist(Delta hs) mouse model, which expresses a range of low dystrophin levels, depending on the degree of skewing of X inactivation in a utrophin-negative background. Mdx/utrn(-/-) mice develop severe muscle weakness, kyphosis, respiratory and heart failure, and premature death closely resembling DMD pathology. We show that at dystrophin levels < 4%, survival and motor function in these animals are greatly improved. In mice expressing >4% dystrophin, histopathology is ameliorated, as well. These findings suggest that the dystrophin levels needed to benefit vitality and functioning of patients with DMD might be lower than those needed for full protection against muscle damage.	[van Putten, Maaike; Hulsker, Margriet; Young, Courtney; Nadarajah, Vishna D.; Heemskerk, Hans; van der Weerd, Louise; 't Hoen, Peter A. C.; van Ommen, Gert-Jan B.; Aartsma-Rus, Annemieke M.] Leiden Univ, Med Ctr, Dept Human Genet, NL-2300 RC Leiden, Netherlands; [van der Weerd, Louise] Leiden Univ, Med Ctr, Dept Radiol, NL-2300 RC Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Aartsma-Rus, AM (corresponding author), Leiden Univ, Med Ctr, Dept Human Genet, POB 9600, NL-2300 RC Leiden, Netherlands.	a.m.rus@lumc.nl	Hoen, Peter A 't/D-3950-2018; van der Weerd, Louise/B-5421-2014	Hoen, Peter A 't/0000-0003-4450-3112; van der Weerd, Louise/0000-0002-5997-2125; V Nadarajah, Vishna Devi/0000-0002-7126-7189; van Putten, Maaike/0000-0002-0683-8897; Aartsma-Rus, Annemieke/0000-0003-1565-654X	Sixth Framework Programme [LSHM-CT-2006-036825]; Dutch Organization for Scientific Research (NWO/ZonMW) [43200002]; Dutch Duchenne Parent Project	Sixth Framework Programme(European Commission); Dutch Organization for Scientific Research (NWO/ZonMW)(Netherlands Organization for Scientific Research (NWO)Netherlands Organization for Health Research and Development); Dutch Duchenne Parent Project	The authors thank Prof. Neil Brockdorff and Dr. Tatyana Nesterova (Medical Research Council Clinical Sciences Center, London, UK; current affiliation: Department of Biochemistry, University of Oxford, Oxford, UK) for providing the Xist<SUP>Delta hs</SUP> embryos and help with genotyping the mice, respectively, and Prof. Kay Davies (Department of Physiology, Anatomy, and Genetics, University of Oxford, Oxford, UK) for providing the mdx/utrn<SUP>-/-</SUP> mouse. The authors are grateful to Maarten van Iterson and Jelle Goeman for their help with statistical analyses. This work was supported by the Sixth Framework Programme-funded TREAT-NMD network of excellence (LSHM-CT-2006-036825), the Dutch Organization for Scientific Research (NWO/ZonMW, grant 43200002), and the Dutch Duchenne Parent Project and used the infrastructure of the Center for Biomedical Genetics (Utrecht, The Netherlands) and the Center for Medical Systems Biology (Leiden, The Netherlands). The authors declare no conflicts of interest.	Bowles DE, 2012, MOL THER, V20, P443, DOI 10.1038/mt.2011.237; Cirak S, 2011, LANCET, V378, P595, DOI 10.1016/S0140-6736(11)60756-3; Crisp A, 2011, HUM MOL GENET, V20, P413, DOI 10.1093/hmg/ddq477; DANKO I, 1992, PEDIATR RES, V32, P128, DOI 10.1203/00006450-199207000-00025; Deconinck AE, 1997, CELL, V90, P717, DOI 10.1016/S0092-8674(00)80532-2; Goemans NM, 2011, NEW ENGL J MED, V364, P1513, DOI 10.1056/NEJMoa1011367; Goyenvalle A, 2012, HUM MOL GENET, V21, P2559, DOI 10.1093/hmg/dds082; Goyenvalle A, 2010, MOL THER, V18, P198, DOI 10.1038/mt.2009.248; Grady RM, 1997, CELL, V90, P729, DOI 10.1016/S0092-8674(00)80533-4; Hauser MA, 1997, NEUROMUSCULAR DISORD, V7, P277, DOI 10.1016/S0960-8966(97)00052-7; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; KARPATI G, 1990, J NEUROPATH EXP NEUR, V49, P96, DOI 10.1097/00005072-199003000-00002; Kawano R, 2008, MOL THER, V16, P825, DOI 10.1038/mt.2008.23; Kohler M, 2009, J NEUROL NEUROSUR PS, V80, P320, DOI 10.1136/jnnp.2007.141721; Li DJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015286; Malik V, 2010, ANN NEUROL, V67, P771, DOI 10.1002/ana.22024; Muntoni F, 2003, LANCET NEUROL, V2, P731, DOI 10.1016/S1474-4422(03)00585-4; Nadarajah VD, 2011, NEUROMUSCULAR DISORD, V21, P569, DOI 10.1016/j.nmd.2011.05.011; Neri M, 2007, NEUROMUSCULAR DISORD, V17, P913, DOI 10.1016/j.nmd.2007.07.005; Newall AET, 2001, HUM MOL GENET, V10, P581, DOI 10.1093/hmg/10.6.581; PHELPS SF, 1995, HUM MOL GENET, V4, P1251, DOI 10.1093/hmg/4.8.1251; Rafael JA, 1999, MUSCLE NERVE, V22, P517, DOI 10.1002/(SICI)1097-4598(199904)22:4<517::AID-MUS14>3.0.CO;2-6; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Saito T, 2009, BRAIN DEV-JPN, V31, P612, DOI 10.1016/j.braindev.2008.09.008; SICINSKI P, 1989, SCIENCE, V244, P1578, DOI 10.1126/science.2662404; Skuk D, 2006, J NEUROPATH EXP NEUR, V65, P371, DOI 10.1097/01.jnen.0000218443.45782.81; STEDMAN HH, 1991, NATURE, V352, P536, DOI 10.1038/352536a0; 't Hoen PAC, 2008, J BIOL CHEM, V283, P5899, DOI 10.1074/jbc.M709410200; van der Geest RJ, 1999, J MAGN RESON IMAGING, V10, P602, DOI 10.1002/(SICI)1522-2586(199911)10:5<602::AID-JMRI3>3.0.CO;2-C; van Putten M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031937; van Putten M, 2012, NEUROMUSCULAR DISORD, V22, P406, DOI 10.1016/j.nmd.2011.10.011; van Putten M, 2010, NEUROMUSCULAR DISORD, V20, P273, DOI 10.1016/j.nmd.2010.02.004; Verhaart IEC, 2012, NEUROMUSCULAR DISORD, V22, P418, DOI 10.1016/j.nmd.2011.10.025; WELLS DJ, 1995, HUM MOL GENET, V4, P1245, DOI 10.1093/hmg/4.8.1245	34	69	76	0	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2013	27	6					2484	2495		10.1096/fj.12-224170	http://dx.doi.org/10.1096/fj.12-224170			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	154II	23460734	Green Published			2022-12-25	WOS:000319667600036
J	Novellasdemunt, L; Tato, I; Navarro-Sabate, A; Ruiz-Meana, M; Mendez-Lucas, A; Perales, JC; Garcia-Dorado, D; Ventura, F; Bartrons, R; Rosa, JL				Novellasdemunt, Laura; Tato, Irantzu; Navarro-Sabate, Aurea; Ruiz-Meana, Marisol; Mendez-Lucas, Andres; Carlos Perales, Jose; Garcia-Dorado, David; Ventura, Francesc; Bartrons, Ramon; Luis Rosa, Jose			Akt-dependent Activation of the Heart 6-Phosphofructo-2-kinase/Fructose-2,6-bisphosphatase (PFKFB2) Isoenzyme by Amino Acids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE B; GLUCOSE-METABOLISM; FRUCTOSE 2,6-BISPHOSPHATE; CANCER CELLS; GLYCOLYSIS; INSULIN; 6-PHOSPHOFRUCTO-2-KINASE; PHOSPHORYLATION; PATHWAYS; HYPOXIA	Reciprocal regulation of metabolism and signaling allows cells to modulate their activity in accordance with their metabolic resources. Thus, amino acids could activate signal transduction pathways that control cell metabolism. To test this hypothesis, we analyzed the effect of amino acids on fructose-2,6-bisphosphate (Fru-2,6-P-2) metabolism. We demonstrate that amino acids increase Fru-2,6-P-2 concentration in HeLa and in MCF7 human cells. In conjunction with this, 6-phosphofructo-2-kinase activity, glucose uptake, and lactate concentration were increased. These data correlate with the specific phosphorylation of heart 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase (PFKFB2) isoenzyme at Ser-483. This activation was mediated by the PI3K and p38 signaling pathways. Furthermore, Akt inactivation blocked PFKFB2 phosphorylation and Fru-2,6-P-2 production, thereby suggesting that the above signaling pathways converge at Akt kinase. In accordance with these results, kinase assays showed that amino acid-activated Akt phosphorylated PFKFB2 at Ser-483 and that knockdown experiments confirmed that the increase in Fru-2,6-P-2 concentration induced by amino acids was due to PFKFB2. In addition, similar effects on Fru-2,6-P-2 metabolism were observed in freshly isolated rat cardiomyocytes treated with amino acids, which indicates that these effects are not restricted to human cancer cells. In these cardiomyocytes, the glucose consumption and the production of lactate and ATP suggest an increase of glycolytic flux. Taken together, these results demonstrate that amino acids stimulate Fru-2,6-P-2 synthesis by Akt-dependent PFKFB2 phos-phorylation and activation and show how signaling and metabolism are inextricably linked.	[Novellasdemunt, Laura; Tato, Irantzu; Navarro-Sabate, Aurea; Mendez-Lucas, Andres; Carlos Perales, Jose; Ventura, Francesc; Bartrons, Ramon; Luis Rosa, Jose] Univ Barcelona, Dept Ciencies Fisiol 2, Inst Invest Biomed Bellvitge IDIBELL, Barcelona 08907, Spain; [Ruiz-Meana, Marisol; Garcia-Dorado, David] Univ Autonoma Barcelona, Lab Expt Cardiol, Vall dHebron Univ Hosp & Res Inst, Barcelona 08035, Spain	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron	Bartrons, R (corresponding author), Univ Barcelona, Dept Ciencies Fisiol 2, Campus Bellvitge, Barcelona 08907, Spain.	rbartrons@ub.edu; joseluisrosa@ub.edu	Ventura, Francesc/K-9700-2014; Navarro-Sabaté, Aurea/K-6329-2018; PERALES, JOSE C/J-7457-2017; Ventura, Francesc/ABG-2285-2020; Lucas, Andres Mendez/AAG-7488-2020; Rosa, Jose Luis/K-6685-2014; PERALES, JOSE C./AAC-3156-2019; PERALES, JOSE C. C/D-5586-2012	Ventura, Francesc/0000-0001-9673-9405; Navarro-Sabaté, Aurea/0000-0002-8286-9732; PERALES, JOSE C/0000-0001-7363-2226; Ventura, Francesc/0000-0001-9673-9405; Lucas, Andres Mendez/0000-0002-0725-4375; Rosa, Jose Luis/0000-0002-6161-5688; PERALES, JOSE C./0000-0001-7363-2226; PERALES, JOSE C. C/0000-0001-7363-2226; Novellasdemunt Vilaseca, Laura/0000-0003-1590-9842; Bartrons, Ramon/0000-0001-9349-5847	Spanish Ministerio de Ciencia e Innovacion (MICINN) [BFU2011-22498, BFU2009-07380]; Instituto de Salud Carlos III (ISCIII), Spain [RD06/0020]	Spanish Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Instituto de Salud Carlos III (ISCIII), Spain(Instituto de Salud Carlos III)	This research was supported by Spanish Ministerio de Ciencia e Innovacion (MICINN) Grants BFU2011-22498 and BFU2009-07380 and by Instituto de Salud Carlos III (ISCIII) Grant RETIC, RD06/0020, Spain.	ASHCROFT SJ, 1972, BIOCHEM J, V126, P525, DOI 10.1042/bj1260525; Atlante A, 2003, J NEUROCHEM, V86, P591, DOI 10.1046/j.1471-4159.2003.01863.x; Atsumi T, 2002, CANCER RES, V62, P5881; Bando H, 2005, CLIN CANCER RES, V11, P5784, DOI 10.1158/1078-0432.CCR-05-0149; Bartrons R, 2007, J BIOENERG BIOMEMBR, V39, P223, DOI 10.1007/S10863-007-9080-3; Casas-Terradellas E, 2008, BBA-MOL CELL RES, V1783, P2241, DOI 10.1016/j.bbamcr.2008.08.011; Cubillos-Rojas Monica, 2012, Methods Mol Biol, V869, P205, DOI 10.1007/978-1-61779-821-4_17; Cubillos-Rojas M, 2010, ELECTROPHORESIS, V31, P1318, DOI 10.1002/elps.200900657; Dann SG, 2007, TRENDS MOL MED, V13, P252, DOI 10.1016/j.molmed.2007.04.002; DeFeo-Jones D, 2005, MOL CANCER THER, V4, P271; Deprez J, 1997, J BIOL CHEM, V272, P17269, DOI 10.1074/jbc.272.28.17269; Donthi RV, 2004, J BIOL CHEM, V279, P48085, DOI 10.1074/jbc.M405510200; Garcia-Martinez JM, 2008, BIOCHEM J, V416, P375, DOI 10.1042/BJ20081668; Gutmann I., 1974, METHOD ENZYMAT AN, P1461; Hagiwara A, 2012, CELL METAB, V15, P725, DOI 10.1016/j.cmet.2012.03.015; Hue L, 2002, J MOL CELL CARDIOL, V34, P1091, DOI 10.1006/jmcc.2002.2063; HUGHES SD, 1993, J BIOL CHEM, V268, P15205; Jackson SP, 2005, NAT MED, V11, P507, DOI 10.1038/nm1232; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Li YZ, 2004, J BIOL CHEM, V279, P970, DOI 10.1074/jbc.M309927200; Marsin AS, 2000, CURR BIOL, V10, P1247, DOI 10.1016/S0960-9822(00)00742-9; Marsin AS, 2002, J BIOL CHEM, V277, P30778, DOI 10.1074/jbc.M205213200; Moon JS, 2011, BIOCHEM J, V433, P225, DOI 10.1042/BJ20101104; Mouton V, 2010, BIOCHEM J, V431, P267, DOI 10.1042/BJ20101089; Novellasdemunt L, 2012, BIOCHEM J, V442, P345, DOI 10.1042/BJ20111418; Okar DO, 2001, TRENDS BIOCHEM SCI, V26, P30, DOI 10.1016/S0968-0004(00)01699-6; Rider MH, 2004, BIOCHEM J, V381, P561, DOI 10.1042/BJ20040752; Ros S, 2012, CANCER DISCOV, V2, P328, DOI 10.1158/2159-8290.CD-11-0234; Rubio MP, 2003, EMBO J, V22, P3514, DOI 10.1093/emboj/cdg363; Ruckle T, 2004, J MED CHEM, V47, P6921, DOI 10.1021/jm031112e; Ryu JM, 2011, J BIOL CHEM, V286, P23667, DOI 10.1074/jbc.M110.216283; Tato I, 2011, J BIOL CHEM, V286, P6128, DOI 10.1074/jbc.M110.166991; Tudzarova S, 2011, P NATL ACAD SCI USA, V108, P5278, DOI 10.1073/pnas.1102247108; VANSCHAFTINGEN E, 1987, ADV ENZYMOL RAMB, V59, P315; VANSCHAFTINGEN E, 1982, EUR J BIOCHEM, V129, P191; Vertii A, 2006, J BIOL CHEM, V281, P26966, DOI 10.1074/jbc.M602134200; Wang QW, 2008, AM J PHYSIOL-HEART C, V294, pH2889, DOI 10.1152/ajpheart.91501.2007; Wellen KE, 2012, NAT REV MOL CELL BIO, V13, P270, DOI 10.1038/nrm3305; Yalcin A, 2009, J BIOL CHEM, V284, P24223, DOI 10.1074/jbc.M109.016816; Yalcin A, 2009, EXP MOL PATHOL, V86, P174, DOI 10.1016/j.yexmp.2009.01.003; Yamamoto N., 2011, CURR PROTOC PHARM, V12, P12141	41	51	52	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2013	288	15					10640	10651		10.1074/jbc.M113.455998	http://dx.doi.org/10.1074/jbc.M113.455998			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	125TU	23457334	Green Published, hybrid			2022-12-25	WOS:000317565000042
J	Chen, CCV; Ku, MC; Jayaseema, DM; Lai, JS; Hueng, DY; Chang, C				Chen, Chiao-Chi V.; Ku, Min-Chi; Jayaseema, D. M.; Lai, Jiann-Shiun; Hueng, Dueng-Yuan; Chang, Chen			Simple SPION Incubation as an Efficient Intracellular Labeling Method for Tracking Neural Progenitor Cells Using MRI	PLOS ONE			English	Article							IRON-OXIDE NANOPARTICLES; STEM-CELLS; TRANSFERRIN RECEPTOR; TRANSFECTION AGENT; CONTRAST AGENTS; IN-VIVO; FERUMOXIDES; TRANSPLANTATION; METABOLISM	Cellular magnetic resonance imaging (MRI) has been well-established for tracking neural progenitor cells (NPC). Superparamagnetic iron oxide nanoparticles (SPIONs) approved for clinical application are the most common agents used for labeling. Conventionally, transfection agents (TAs) were added with SPIONs to facilitate cell labeling because SPIONs in the native unmodified form were deemed inefficient for intracellular labeling. However, compelling evidence also shows that simple SPION incubation is not invariably ineffective. The labeling efficiency can be improved by prolonged incubation and elevated iron doses. The goal of the present study was to establish simple SPION incubation as an efficient intracellular labeling method. To this end, NPCs derived from the neonatal subventricular zone were incubated with SPIONs (FeridexH) and then evaluated in vitro with regard to the labeling efficiency and biological functions. The results showed that, following 48 hours of incubation at 75 mu g/ml, nearly all NPCs exhibited visible SPION intake. Evidence from light microscopy, electron microscopy, chemical analysis, and magnetic resonance imaging confirmed the effectiveness of the labeling. Additionally, biological assays showed that the labeled NPCs exhibited unaffected viability, oxidative stress, apoptosis and differentiation. In the demonstrated in vivo cellular MRI experiment, the hypointensities representing the SPION labeled NPCs remained observable throughout the entire tracking period. The findings indicate that simple SPION incubation without the addition of TAs is an efficient intracellular magnetic labeling method. This simple approach may be considered as an alternative approach to the mainstream labeling method that involves the use of TAs.	[Chen, Chiao-Chi V.; Ku, Min-Chi; Jayaseema, D. M.; Chang, Chen] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Chen, Chiao-Chi V.; Ku, Min-Chi; Jayaseema, D. M.; Chang, Chen] Acad Sinica, Funct & Micromagnet Resonance Imaging Ctr, Taipei 115, Taiwan; [Lai, Jiann-Shiun] Dev Ctr Biotechnol, New Taipei, Taiwan; [Hueng, Dueng-Yuan] Triserv Gen Hosp, Dept Neurol Surg, Taipei, Taiwan; [Hueng, Dueng-Yuan] Natl Def Med Ctr, Dept Biochem, Taipei 10764, Taiwan	Academia Sinica - Taiwan; Academia Sinica - Taiwan; Tri-Service General Hospital; National Defense Medical Center	Hueng, DY (corresponding author), Triserv Gen Hosp, Dept Neurol Surg, Taipei, Taiwan.	hondy2195@yahoo.com.tw; bmcchen@ibms.sinica.edu.tw	Hueng, Dueng-Yuan/AAM-7807-2021; Chang, Chen/B-5079-2009	Hueng, Dueng-Yuan/0000-0001-7868-3161; Ku, Min-Chi/0000-0003-0963-2461	National Research Program for Genomic Medicine, National Science Council, Taiwan [NSC100-3112-B-001-009]	National Research Program for Genomic Medicine, National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	The work was supported by funding from National Research Program for Genomic Medicine, National Science Council, Taiwan, NSC100-3112-B-001-009. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Montet K, 2005, MOL IMAGING, V4, P165; Andreas K, 2012, BIOMATERIALS, V33, P4515, DOI 10.1016/j.biomaterials.2012.02.064; Arbab AS, 2003, RADIOLOGY, V229, P838, DOI 10.1148/radiol.2293021215; Arbab AS, 2005, NMR BIOMED, V18, P383, DOI 10.1002/nbm.970; Arbab AS, 2003, TRANSPLANTATION, V76, P1123, DOI 10.1097/01.TP.0000089237.39220.83; Arbab AS, 2004, BLOOD, V104, P1217, DOI 10.1182/blood-2004-02-0655; Berman SMC, 2011, METHODS MOL BIOL, V711, P435, DOI 10.1007/978-1-61737-992-5_22; Bulte JWM, 2004, NMR BIOMED, V17, P484, DOI 10.1002/nbm.924; Dokka S, 2000, PHARMACEUT RES, V17, P521, DOI 10.1023/A:1007504613351; Dunning MD, 2004, J NEUROSCI, V24, P9799, DOI 10.1523/JNEUROSCI.3126-04.2004; Emerit J, 2001, BIOMED PHARMACOTHER, V55, P333, DOI 10.1016/S0753-3322(01)00068-3; Ferrari Daniela, 2010, Curr Protoc Stem Cell Biol, VChapter 2, DOI 10.1002/9780470151808.sc02d06s15; Frank JA, 2003, RADIOLOGY, V228, P480, DOI 10.1148/radiol.2281020638; Hunter AC, 2006, ADV DRUG DELIVER REV, V58, P1523, DOI 10.1016/j.addr.2006.09.008; Jing Y, 2008, FASEB J, V22, P4239, DOI 10.1096/fj.07-105544; Kalish H, 2003, MAGN RESON MED, V50, P275, DOI 10.1002/mrm.10556; Kohno RI, 2006, BRAIN RES, V1093, P54, DOI 10.1016/j.brainres.2006.03.093; Kunzmann A, 2011, TOXICOL APPL PHARM, V253, P81, DOI 10.1016/j.taap.2011.03.011; Miyoshi S, 2005, MOL IMAGING BIOL, V7, P286, DOI 10.1007/s11307-005-0008-1; Neri M, 2008, STEM CELLS, V26, P505, DOI 10.1634/stemcells.2007-0251; Pawelczyk E, 2006, NMR BIOMED, V19, P581, DOI 10.1002/nbm.1038; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Schafer R, 2007, RADIOLOGY, V244, P514, DOI 10.1148/radiol.2442060599; Singh N, 2010, NANO REV EXP, V1, DOI 10.3402/nano.v1i0.5358; Sipe JC, 1999, MAGN RESON IMAGING, V17, P1521, DOI 10.1016/S0730-725X(99)00085-5; Suzuki Y, 2007, MAGN RESON MED, V57, P1173, DOI 10.1002/mrm.21219; Weinstein JS, 2010, J CEREBR BLOOD F MET, V30, P15, DOI 10.1038/jcbfm.2009.192	27	33	33	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e56125	10.1371/journal.pone.0056125	http://dx.doi.org/10.1371/journal.pone.0056125			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23468856	gold, Green Published, Green Submitted			2022-12-25	WOS:000315524900018
J	Huang, JG; Bergeron, Y; Berninger, F; Zhai, LH; Tardif, JC; Denneler, B				Huang, Jian-Guo; Bergeron, Yves; Berninger, Frank; Zhai, Lihong; Tardif, Jacques C.; Denneler, Bernhard			Impact of Future Climate on Radial Growth of Four Major Boreal Tree Species in the Eastern Canadian Boreal Forest	PLOS ONE			English	Article							PREDICT OPTIMAL-GROWTH; JACK PINE POPULATIONS; LATITUDINAL GRADIENT; STATISTICAL-MODEL; WESTERN QUEBEC; COUPLED MODEL; PICEA-MARIANA; RESPONSES; NORTH; DENDROCLIMATOLOGY	Immediate phenotypic variation and the lagged effect of evolutionary adaptation to climate change appear to be two key processes in tree responses to climate warming. This study examines these components in two types of growth models for predicting the 2010-2099 diameter growth change of four major boreal species Betula papyrifera, Pinus banksiana, Picea mariana, and Populus tremuloides along a broad latitudinal gradient in eastern Canada under future climate projections. Climate-growth response models for 34 stands over nine latitudes were calibrated and cross-validated. An adaptive response model (A-model), in which the climate-growth relationship varies over time, and a fixed response model (F-model), in which the relationship is constant over time, were constructed to predict future growth. For the former, we examined how future growth of stands in northern latitudes could be forecasted using growth-climate equations derived from stands currently growing in southern latitudes assuming that current climate in southern locations provide an analogue for future conditions in the north. For the latter, we tested if future growth of stands would be maximally predicted using the growthclimate equation obtained from the given local stand assuming a lagged response to climate due to genetic constraints. Both models predicted a large growth increase in northern stands due to more benign temperatures, whereas there was a minimal growth change in southern stands due to potentially warm-temperature induced drought-stress. The A-model demonstrates a changing environment whereas the F-model highlights a constant growth response to future warming. As time elapses we can predict a gradual transition between a response to climate associated with the current conditions (F-model) to a more adapted response to future climate (A-model). Our modeling approach provides a template to predict tree growth response to climate warming at mid-high latitudes of the Northern Hemisphere.	[Huang, Jian-Guo; Bergeron, Yves; Denneler, Bernhard] Univ Quebec Abitibi Temiscamingue, Chaire Ind CRSNG UQAT UQAM Amenagement Forestier, Rouyn Noranda, PQ, Canada; [Berninger, Frank; Zhai, Lihong] Univ Quebec, Dept Sci Biol, Montreal, PQ H3C 3P8, Canada; [Tardif, Jacques C.] Univ Winnipeg, C FIR, Winnipeg, MB R3B 2E9, Canada	University of Quebec; University of Quebec Montreal; University Quebec Abitibi-Temiscamingue; University of Quebec; University of Quebec Montreal; University of Winnipeg	Huang, JG (corresponding author), Purdue Univ, Dept Forestry & Nat Resources, W Lafayette, IN 47907 USA.	huang500@purdue.edu	Berninger, Frank/A-8891-2010	Berninger, Frank/0000-0001-7718-1661	Natural Science and Engineering Research Council of Canada; Ouranos Consortium; Canada Research Chair programs	Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ouranos Consortium; Canada Research Chair programs(Canada Research Chairs)	This project was financially supported by the Natural Science and Engineering Research Council of Canada, Ouranos Consortium, and Canada Research Chair programs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken SN, 2008, EVOL APPL, V1, P95, DOI 10.1111/j.1752-4571.2007.00013.x; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Andalo C, 2005, FOREST ECOL MANAG, V205, P169, DOI 10.1016/j.foreco.2004.10.045; [Anonymous], 1979, PHYSL WOODY PLANTS; BELSLEY D. A, 1980, REGRESSION DIAGNOSTI; Berninger F, 1997, FUNCT ECOL, V11, P146, DOI 10.1046/j.1365-2435.1997.00067.x; Chhin S, 2008, FOREST ECOL MANAG, V256, P1692, DOI 10.1016/j.foreco.2008.02.046; Collins M, 2001, CLIM DYNAM, V17, P61, DOI 10.1007/s003820000094; Cook E.R., 2013, METHODS DENDROCHRONO; COOK ER, 1994, INT J CLIMATOL, V14, P379, DOI 10.1002/joc.3370140404; Drobyshev I, 2010, ECOSYSTEMS, V13, P556, DOI 10.1007/s10021-010-9340-7; Eggers J, 2008, GLOBAL CHANGE BIOL, V14, P2288, DOI 10.1111/j.1365-2486.2008.01653.x; Flato GM, 2000, CLIM DYNAM, V16, P451, DOI 10.1007/s003820050339; Fritts H. C., 1976, TREE RINGS CLIMATE; Futuyma DJ, 1979, EVOLUTIONARY BIOL; Gauthier S, 2000, J VEG SCI, V11, P781, DOI 10.2307/3236548; GAUTHIER S, 1992, CAN J FOREST RES, V22, P1958, DOI 10.1139/x92-255; Girardin MP, 2008, ECOL MODEL, V213, P209, DOI 10.1016/j.ecolmodel.2007.12.010; Girardin MP, 2009, J APPL METEOROL CLIM, V48, P517, DOI 10.1175/2008JAMC1996.1; Goldblum D, 2005, CAN J FOREST RES, V35, P2709, DOI 10.1139/X05-185; Hofgaard A, 1999, CAN J FOREST RES, V29, P1333, DOI 10.1139/cjfr-29-9-1333; Holmes R.L., 1999, DENDROCHRONOLOGICAL; Huang JG, 2008, CAN J FOREST RES, V38, P2535, DOI 10.1139/X08-080; Huang JG, 2007, CRIT REV PLANT SCI, V26, P265, DOI 10.1080/07352680701626978; Huang JG, 2011, AM J BOT, V98, P792, DOI 10.3732/ajb.1000074; Huang JG, 2010, GLOBAL CHANGE BIOL, V16, P711, DOI 10.1111/j.1365-2486.2009.01990.x; Hutchinson M.F., 2004, ANUSPLIN VERSION 4 3; Kochy M, 2001, J ECOL, V89, P807, DOI 10.1046/j.0022-0477.2001.00600.x; Korner C, 2010, SCIENCE, V327, P1461, DOI 10.1126/science.1186473; Kurz WA, 2008, NATURE, V452, P987, DOI 10.1038/nature06777; Lapointe-Garant MP, 2010, GLOBAL CHANGE BIOL, V16, P2039, DOI 10.1111/j.1365-2486.2009.02048.x; Laroque CP, 2003, FOREST ECOL MANAG, V183, P313, DOI 10.1016/S0378-1127(03)00110-5; Lawler JJ, 2006, CONDOR, V108, P47, DOI 10.1650/0010-5422(2006)108[0047:AVATIM]2.0.CO;2; Ledig FT, 2010, AM J BOT, V97, P970, DOI 10.3732/ajb.0900329; Ma ZH, 2012, P NATL ACAD SCI USA, V109, P2423, DOI 10.1073/pnas.1111576109; MATYAS C, 1994, TREE PHYSIOL, V14, P797, DOI 10.1093/treephys/14.7-8-9.797; Morin X, 2009, GLOBAL CHANGE BIOL, V15, P961, DOI 10.1111/j.1365-2486.2008.01735.x; Peng CH, 2011, NAT CLIM CHANGE, V1, P467, DOI 10.1038/NCLIMATE1293; Petit RJ, 2003, SCIENCE, V300, P1563, DOI 10.1126/science.1083264; Ramirez-Villegas J., 2010, DOWNSCALING GLOBAL C; Rathgeber C, 2000, GLOBAL PLANET CHANGE, V26, P405, DOI 10.1016/S0921-8181(00)00053-9; Rehfeldt G. E., 2003, Eurasian Journal of Forest Research, V6-2, P83; Rehfeldt GE, 1999, ECOL MONOGR, V69, P375, DOI 10.1890/0012-9615(1999)069[0375:GRTCIP]2.0.CO;2; Rehfeldt GE, 2002, GLOBAL CHANGE BIOL, V8, P912, DOI 10.1046/j.1365-2486.2002.00516.x; Reich PB, 2008, ECOL LETT, V11, P588, DOI 10.1111/j.1461-0248.2008.01172.x; Roeckner E., 1996, 218 M PLANCK I MET; RUNNING SW, 1988, ECOL MODEL, V42, P125, DOI 10.1016/0304-3800(88)90112-3; Savolainen O, 2007, ANNU REV ECOL EVOL S, V38, P595, DOI 10.1146/annurev.ecolsys.38.091206.095646; Savva Y, 2007, FOREST ECOL MANAG, V242, P636, DOI 10.1016/j.foreco.2007.01.073; Sheridan SC, 2002, INT J CLIMATOL, V22, P51, DOI 10.1002/joc.709; Stadt KJ, 2007, ANN FOREST SCI, V64, P477, DOI 10.1051/forest:2007025; Thomson AM, 2008, CAN J FOREST RES, V38, P157, DOI 10.1139/X07-122; Thomson AM, 2009, CAN J FOREST RES, V39, P143, DOI 10.1139/X08-167; WIGLEY TML, 1984, J CLIM APPL METEOROL, V23, P201, DOI 10.1175/1520-0450(1984)023<0201:OTAVOC>2.0.CO;2; Zhai LH, 2012, AM J BOT, V99, P827, DOI 10.3732/ajb.1100235	55	37	40	2	106	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e56758	10.1371/journal.pone.0056758	http://dx.doi.org/10.1371/journal.pone.0056758			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23468879	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000315524900036
J	Peng, YF; Shi, YH; Ding, ZB; Zhou, J; Qiu, SJ; Hui, B; Gu, CY; Yang, H; Liu, WR; Fan, J				Peng, Yuan-Fei; Shi, Ying-Hong; Ding, Zhen-Bin; Zhou, Jian; Qiu, Shuang-Jian; Hui, Bo; Gu, Cheng-Yu; Yang, Hua; Liu, Wei-Ren; Fan, Jia			Alpha-Fetoprotein Promoter-Driven Cre/LoxP-Switched RNA Interference for Hepatocellular Carcinoma Tissue-Specific Target Therapy	PLOS ONE			English	Article							IN-VIVO SELECTION; GENE-THERAPY; METASTATIC CHARACTERISTICS; CELL-LINE; ADENOVIRUS; SIRNA; ESTABLISHMENT; THERAPEUTICS; CHALLENGES; APOPTOSIS	Backgroud: RNA interference (RNAi) has recently emerged as a potential treatment modality for hepatocellular carcinoma (HCC) therapy, but the lack of cellular targets and sustained efficacy limits its application. The purpose of this study is to develop an HCC tissue-specific RNAi system and investigate its possibility for HCC treatment. Methods: Two different HCC-specific RNAi systems in which therapeutic miRNA or shRNA against target gene (Beclin 1) was directly or indirectly driven by alpha-fetoprotein promoter (AFP-miRNA and AFP-Cre/LoxP-shRNA) were constructed. Human HCC cell lines (HepG2, Hep3B and HCCLM3) and non-HCC cell lines (L-02, Hela and SW1116) were infected with the systems. The effectiveness and tissue-specificity of the systems were examined by Q-PCR and western blot analysis. The efficacy of the systems was further tested in mouse model of HCC by intravenous or intratumoral administration. The feasibility of the system for HCC treatment was evaluated by applying the system as adjuvant therapy to enhance sorafenib treatment. An AFP-Cre/LoxP-shRNA system targeting Atg5 gene (AFP-Cre/LoxP-shRNA-Atg5) was constructed and its efficacy in sensitizing HCC cells (MHCC97L/PLC) to sorafenib treatment was examined by apoptosis assay in vitro and tumorigenesis assay in vivo. Results: The AFP-miRNA system could silence target gene (Beclin 1) but required a high titer which was lethal to target cells. The AFP-Cre/LoxP-shRNA system could efficiently knockdown target gene while maintain high HCC specificity. Intratumoral injection of the AFP-Cre/LoxP-shRNA system could efficiently silence target gene (Beclin 1) in vivo while intravenous administration could not. The AFP-Cre/LoxP-shRNA system target Atg5 gene could significantly sensitize MHCC97L/PLC cells to sorafenib-induced apoptosis in vitro and tumor growth suppression in vivo. Conclusions: An efficient HCC tissue-specific RNAi system (AFP-Cre/LoxP-shRNA) was successfully established. The system provides a usable tool for HCC-specific RNAi therapy, which may serve as a new treatment modality for HCC.	[Peng, Yuan-Fei; Shi, Ying-Hong; Ding, Zhen-Bin; Zhou, Jian; Qiu, Shuang-Jian; Hui, Bo; Gu, Cheng-Yu; Yang, Hua; Liu, Wei-Ren; Fan, Jia] Fudan Univ, Zhongshan Hosp, Liver Canc Inst, Dept Liver Surg, Shanghai 200433, Peoples R China; [Peng, Yuan-Fei; Shi, Ying-Hong; Ding, Zhen-Bin; Zhou, Jian; Qiu, Shuang-Jian; Hui, Bo; Gu, Cheng-Yu; Yang, Hua; Liu, Wei-Ren; Fan, Jia] Minist Educ Res, Key Lab Carcinogenesis & Canc Invas, Shanghai, Peoples R China; [Fan, Jia] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China	Fudan University; Fudan University	Fan, J (corresponding author), Fudan Univ, Zhongshan Hosp, Liver Canc Inst, Dept Liver Surg, Shanghai 200433, Peoples R China.	fan.jia@zs-hosptal.sh.cn	Shi, Ying-Hong/B-7063-2017; Fan, Jia/C-6689-2017	Zhou, Jian/0000-0002-7650-7540	National Natural Science Foundation of China [81030038, 81001060, 81272389]; National Key Sci-Tech Project [2012ZX10002011-002]; China Postdoctoral Science Foundation [20100470639, 201104240]; Shanghai Postdoctoral Science Foundation [11R21410300]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Sci-Tech Project; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Shanghai Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by the grants from National Natural Science Foundation of China (81030038, 81001060, 81272389), National Key Sci-Tech Project (2012ZX10002011-002), China Postdoctoral Science Foundation (20100470639, 201104240), and Shanghai Postdoctoral Science Foundation (11R21410300). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bora RS, 2012, MOL MED REP, V6, P9, DOI 10.3892/mmr.2012.871; Chen SH, 2011, EUR J CLIN INVEST, V41, P221, DOI 10.1111/j.1365-2362.2010.02400.x; Davis ME, 2010, NATURE, V464, P1067, DOI 10.1038/nature08956; Ding ZB, 2008, CANCER RES, V68, P9167, DOI 10.1158/0008-5472.CAN-08-1573; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; Gilmore Ian R., 2006, Current Drug Delivery, V3, P147, DOI 10.2174/156720106776359159; Hirano T, 2001, GENE THER, V8, P80, DOI 10.1038/sj.gt.3301355; IDO A, 1995, CANCER RES, V55, P3105; Johnson PJ, 1999, J GASTROEN HEPATOL, V14, pS32, DOI 10.1046/j.1440-1746.1999.01873.x; Kanai F, 1997, CANCER RES, V57, P461; Kaneko S, 2001, MOL BIOTECHNOL, V19, P323, DOI 10.1385/MB:19:3:323; Li Y, 2004, J CANCER RES CLIN, V130, P460, DOI 10.1007/s00432-004-0564-9; Li Y, 2003, J CANCER RES CLIN, V129, P43, DOI 10.1007/s00432-002-0396-4; Li Y, 2001, WORLD J GASTROENTERO, V7, P630; Li Y, 2012, NAT REV GASTRO HEPAT, V9, P32, DOI 10.1038/nrgastro.2011.196; Mao CY, 2009, HEPATOB PANCREAT DIS, V8, P282; Marquardt JU, 2012, J HEPATOL, V56, P267, DOI 10.1016/j.jhep.2011.07.007; Pecot CV, 2011, NAT REV CANCER, V11, P59, DOI 10.1038/nrc2966; Peng YF, 2008, ONCOL REP, V19, P73; Petrocca F, 2011, J CLIN ONCOL, V29, P747, DOI 10.1200/JCO.2009.27.6287; Sakuma T, 2012, BIOCHEM J, V443, P603, DOI 10.1042/BJ20120146; Shi YH, 2011, AUTOPHAGY, V7, P1159, DOI 10.4161/auto.7.10.16818; Takahashi M, 2002, MOL THER, V5, P627, DOI 10.1006/mthe.2002.0589; Xu CR, 2011, RECENT PAT ANTI-CANC, V6, P106, DOI 10.2174/157489211793980097; Yang PL, 2002, P NATL ACAD SCI USA, V99, P13825, DOI 10.1073/pnas.202398599; Zhang G, 2004, GENE THER, V11, P675, DOI 10.1038/sj.gt.3302210	26	18	18	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e53072	10.1371/journal.pone.0053072	http://dx.doi.org/10.1371/journal.pone.0053072			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23468839	gold, Green Published, Green Submitted			2022-12-25	WOS:000315524900007
J	Honsell, G; Bonifacio, A; De Bortoli, M; Penna, A; Battocchi, C; Ciminiello, P; Dell'Aversano, C; Fattorusso, E; Sosa, S; Yasumoto, T; Tubaro, A				Honsell, Giorgio; Bonifacio, Alois; De Bortoli, Marco; Penna, Antonella; Battocchi, Cecilia; Ciminiello, Patrizia; Dell'Aversano, Carmela; Fattorusso, Ernesto; Sosa, Silvio; Yasumoto, Takeshi; Tubaro, Aurelia			New Insights on Cytological and Metabolic Features of Ostreopsis cf. ovata Fukuyo (Dinophyceae): A Multidisciplinary Approach	PLOS ONE			English	Article							RAMAN-SPECTROSCOPY; BENTHIC DINOFLAGELLATE; OVATOXIN-A; PUTATIVE PALYTOXIN; PROROCENTRUM-LIMA; TOXIN PRODUCTION; NUTRIENT STATUS; FINE-STRUCTURE; LC-MS; TEMPERATURE	The harmful dinoflagellate Ostreopsis cf. ovata has been causing toxic events along the Mediterranean coasts and other temperate and tropical areas, with increasing frequency during the last decade. Despite many studies, important biological features of this species are still poorly known. An integrated study, using different microscopy and molecular techniques, Raman microspectroscopy and high resolution liquid chromatography-mass spectrometry (HR LC-MS), was undertaken to elucidate cytological aspects, and identify main metabolites including toxins. The species was genetically identified as O. cf. ovata, Atlantic-Mediterranean clade. The ultrastructural results show unique features of the mucilage network abundantly produced by this species to colonize benthic substrates, with a new role of trichocysts, never described before. The amorphous polysaccharidic component of mucilage appears to derive from pusule fibrous material and mucocysts. In all stages of growth, the cells show an abundant production of lipids. Different developmental stages of chloroplasts are found in the peripheral cytoplasm and in the centre of cell. In vivo Raman microspectroscopy confirms the presence of the carotenoid peridinin in O. cf. ovata, and detects in several specimen the abundant presence of unsaturated lipids structurally related to docosahexaenoic acid. The HR LC-MS analysis reveals that ovatoxin-a is the predominant toxin, together with decreasing amounts of ovatoxin-b, -d/e, -c and putative palytoxin. Toxins concentration on a per cell basis increases from exponential to senescent phase. The results suggest that benthic blooms of this species are probably related to features such as the ability to create a unique mucilaginous sheath covering the sea bottom, associated with the production of potent toxins as palytoxin-like compounds. In this way, O. cf. ovata may be able to rapidly colonize benthic substrates outcompeting other species.	[Honsell, Giorgio] Univ Udine, Dept Agr & Environm Sci, I-33100 Udine, Italy; [Bonifacio, Alois] Univ Trieste, Dept Engn & Architecture, Trieste, Italy; [De Bortoli, Marco; Sosa, Silvio; Tubaro, Aurelia] Univ Trieste, Dept Life Sci, Trieste, Italy; [Penna, Antonella; Battocchi, Cecilia] Univ Urbino, Dept Biomol Sci, Lab Environm Biol, Pesaro, Italy; [Ciminiello, Patrizia; Dell'Aversano, Carmela; Fattorusso, Ernesto] Univ Naples Federico II, Dept Nat Prod Chem, Naples, Italy; [Yasumoto, Takeshi] Tama Lab, Japan Food Res Labs, Tokyo, Japan	University of Udine; University of Trieste; University of Trieste; University of Urbino; University of Naples Federico II	Tubaro, A (corresponding author), Univ Trieste, Dept Life Sci, Trieste, Italy.	tubaro@units.it	Bonifacio, Alois/C-6311-2008; Tubaro, Aurelia/AAB-2601-2022; Dell'Aversano, Carmela/H-1803-2013; Honsell, Giorgio/B-2946-2009	Bonifacio, Alois/0000-0002-2251-7786; Dell'Aversano, Carmela/0000-0001-8337-3029; Honsell, Giorgio/0000-0003-3425-5952; SOSA, SILVIO/0000-0002-2909-6603	Italian Ministry of Education, University and Research [PRIN 2007FXSCL2_005]; Regione Autonoma Friuli-Venezia Giulia, Direzione Risorse Rurali, Agroalimentari e Forestali	Italian Ministry of Education, University and Research(Ministry of Education, Universities and Research (MIUR)); Regione Autonoma Friuli-Venezia Giulia, Direzione Risorse Rurali, Agroalimentari e Forestali	The work was supported by the Italian Ministry of Education, University and Research (www.miur.it; PRIN 2007FXSCL2_005) and by Regione Autonoma Friuli-Venezia Giulia, Direzione Risorse Rurali, Agroalimentari e Forestali (www.regione.fvg.it/rafvg/cms/RAFVG/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas A, 2011, CHEMOMETR INTELL LAB, V107, P174, DOI 10.1016/j.chemolab.2011.03.004; Accoroni S, 2011, MAR POLLUT BULL, V62, P2512, DOI 10.1016/j.marpolbul.2011.08.003; ALLDREDGE AL, 1993, DEEP-SEA RES PT I, V40, P1131, DOI 10.1016/0967-0637(93)90129-Q; Alldredge AL, 1998, J PLANKTON RES, V20, P393, DOI 10.1093/plankt/20.3.393; Almeida MR, 2010, ANAL BIOANAL CHEM, V397, P2693, DOI 10.1007/s00216-010-3566-2; [Anonymous], 2010, R LANG ENV STAT COMP; Barone R., 2007, Harmful Algae News, V33, P1; Barone Rossella, 2006, Naturalista Siciliano, V30, P401; Beattie JR, 2004, LIPIDS, V39, P407, DOI 10.1007/s11745-004-1245-z; Beleites C., 2012, HYPERSPEC PACKAGE HA; BESADA EG, 1982, B MAR SCI, V32, P723; Blossom HE, 2012, HARMFUL ALGAE, V17, P40, DOI 10.1016/j.hal.2012.02.010; BOUCK GB, 1966, PROTOPLASMA, V61, P205, DOI 10.1007/BF01247920; Cachon J, 1974, ANN STATION BIOL BES, V9, P177; Ciminiello P, 2008, J AM SOC MASS SPECTR, V19, P111, DOI 10.1016/j.jasms.2007.11.001; Ciminiello P, 2006, ANAL CHEM, V78, P6153, DOI 10.1021/ac060250j; Ciminiello P, 2012, CHEM RES TOXICOL, V25, P1243, DOI 10.1021/tx300085e; Ciminiello P, 2012, J AM SOC MASS SPECTR, V23, P952, DOI 10.1007/s13361-012-0345-7; Ciminiello P, 2012, J AM CHEM SOC, V134, P1869, DOI 10.1021/ja210784u; Ciminiello P, 2011, TOXICON, V57, P376, DOI 10.1016/j.toxicon.2010.11.002; Ciminiello P, 2010, RAPID COMMUN MASS SP, V24, P2735, DOI 10.1002/rcm.4696; Claquin P, 2008, AQUAT MICROB ECOL, V51, P1, DOI 10.3354/ame01187; De Gelder J, 2007, J RAMAN SPECTROSC, V38, P1133, DOI 10.1002/jrs.1734; Dietzek B, 2010, CHEM PHYS, V373, P129, DOI 10.1016/j.chemphys.2010.02.028; DURAND M, 1986, BIOL CELL, V56, P171; DURAND M, 1985, PHYCOLOGIA, V24, P217, DOI 10.2216/i0031-8884-24-2-217.1; Durando P., 2007, EUROSURVEILLANCE, V12, P1, DOI DOI 10.2807/ESW.12.23.03212-EN; Fraga S, 2008, J PHYCOL, V44, P1060, DOI 10.1111/j.1529-8817.2008.00555.x; FRITZ L, 1985, J PHYCOL, V21, P662, DOI 10.1111/j.0022-3646.1985.00662.x; Fuentes-Grunewald C, 2009, J IND MICROBIOL BIOT, V36, P1215, DOI 10.1007/s10295-009-0602-3; Gallitelli M, 2005, JAMA-J AM MED ASSOC, V293, P2599, DOI 10.1001/jama.293.21.2599-c; Gedaria AI, 2007, TOXICON, V50, P518, DOI 10.1016/j.toxicon.2007.04.021; Graneli E, 2011, HARMFUL ALGAE, V10, P165, DOI 10.1016/j.hal.2010.09.002; GREENSPAN P, 1985, J CELL BIOL, V100, P965, DOI 10.1083/jcb.100.3.965; Guerrini F, 2010, TOXICON, V55, P211, DOI 10.1016/j.toxicon.2009.07.019; Guillard R.R.L., 1975, CULTURE MARINE INVER, P29, DOI [10.1007/978-1-4615-8714-9_3, DOI 10.1007/978-1-4615-8714-9_3]; HARRINGT.GW, 1968, BIOCHIM BIOPHYS ACTA, V164, P137, DOI 10.1016/0005-2760(68)90083-0; Heraud P, 2006, J CHEMOMETR, V20, P193, DOI 10.1002/cem.990; Heraud P, 2007, FEMS MICROBIOL LETT, V275, P24, DOI 10.1111/j.1574-6968.2007.00861.x; Honsell G, 2004, BOT MAR, V47, P152, DOI 10.1515/BOT.2004.016; Honsell G, 1992, G BOT, V126, P749; Honsell G, 2011, ENVIRON SCI TECHNOL, V45, P7051, DOI 10.1021/es201373e; Huang YY, 2010, BIOTECHNOL BIOENG, V105, P889, DOI 10.1002/bit.22617; Kaczor A, 2011, ANALYST, V136, P1109, DOI 10.1039/c0an00553c; Kim E., 2008, CHLOROPLAST INTERACT, P1; Kwok ACM, 2005, PLANT CELL PHYSIOL, V46, P1973, DOI 10.1093/pcp/pci213; LARSEN J, 1988, PHYCOLOGIA, V27, P366, DOI 10.2216/i0031-8884-27-3-366.1; Lemee R, 2012, CRYPTOGAMIE ALGOL, V33, P137, DOI 10.7872/crya.v33.iss2.2011.137; LIVOLANT F, 1982, BIOL CELL, V43, P201; MacKenzie L, 2002, HARMFUL ALGAE, V1, P295, DOI 10.1016/S1568-9883(02)00006-9; Mangialajo L, 2011, TOXICON, V57, P408, DOI 10.1016/j.toxicon.2010.11.019; Mayo D. W., 2004, COURSE NOTES INTERPR; MESSER G, 1972, Phycologia, V11, P291, DOI 10.2216/i0031-8884-11-3-291.1; Miyagishima S, 2011, PLANT PHYSIOL, V155, P1533, DOI 10.1104/pp.110.170688; MOORE RE, 1981, J AM CHEM SOC, V103, P2491, DOI 10.1021/ja00399a093; Murphy DJ, 2012, PROTOPLASMA, V249, P541, DOI 10.1007/s00709-011-0329-7; Murphy DJ, 2001, PROG LIPID RES, V40, P325, DOI 10.1016/S0163-7827(01)00013-3; Navarro JM, 2006, HARMFUL ALGAE, V5, P762, DOI 10.1016/j.hal.2006.04.001; Parker B. C., 1966, PHYCOLOGIA, V6, P37, DOI DOI 10.2216/I0031-8884-6-1-37.1; Parsons ML, 2012, HARMFUL ALGAE, V14, P107, DOI 10.1016/j.hal.2011.10.017; Penna A, 2005, J PHYCOL, V41, P212, DOI 10.1111/j.1529-8817.2005.04011.x; Penna A, 2008, EUR J PHYCOL, V43, P163, DOI 10.1080/09670260701783730; Penna A, 2010, J BIOGEOGR, V37, P830, DOI 10.1111/j.1365-2699.2009.02265.x; Perini F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017699; Pezzolesi L, 2012, WATER RES, V46, P82, DOI 10.1016/j.watres.2011.10.029; Pfannkuchen M, 2012, ENVIRON SCI TECHNOL, V46, P5574, DOI 10.1021/es300189h; Pickett-Heaps JD, 2006, KINGDOM PROTISTA DAZ; Pistocchi R, 2011, TOXICON, V57, P421, DOI 10.1016/j.toxicon.2010.09.013; Pompei M, 2003, HARMFUL ALGAE, V2, P301, DOI 10.1016/S1568-9883(03)00059-3; Privitera D, 2012, HARMFUL ALGAE, V18, P16, DOI 10.1016/j.hal.2012.03.009; Quintarelli G, 1964, HISTOCHEM CELL BIOL, V4, P86; Reynolds CS, 2007, HYDROBIOLOGIA, V578, P37, DOI 10.1007/s10750-006-0431-6; Reynolds CS, 2006, ECOL BIODIVERS CONS, P1, DOI 10.2277/ 0521605199; Rhodes L, 2011, TOXICON, V57, P400, DOI 10.1016/j.toxicon.2010.05.010; Robert B, 1999, ADV PHOTOSYNTH, V8, P189; Robert B, 2009, PHOTOSYNTH RES, V101, P147, DOI 10.1007/s11120-009-9440-4; Rossi R, 2010, TOXICON, V56, P1381, DOI 10.1016/j.toxicon.2010.08.003; Sansoni G., 2003, BIOL AMBIENT, V17, P17, DOI DOI 10.1021/AC060250J; SCHMITTER RE, 1971, J CELL SCI, V9, P147; SCHMITTER RE, 1981, J CELL SCI, V51, P15; Schnepf E, 1999, GRANA, V38, P81, DOI 10.1080/00173139908559217; Schultz ZD, 2011, AUST J CHEM, V64, P611, DOI 10.1071/CH11019; Shears NT, 2010, ECOL LETT, V13, P1149, DOI 10.1111/j.1461-0248.2010.01512.x; Shears NT, 2009, HARMFUL ALGAE, V8, P916, DOI 10.1016/j.hal.2009.05.003; Simonini R, 2011, MAR ENVIRON RES, V72, P230, DOI 10.1016/j.marenvres.2011.08.009; Smith E, 2005, MODERN RAMAN SPECTROSCOPY: A PRACTICAL APPROACH, P1; Socrates G., 2004, INFRARED RAMAN CHARA; Throndsen J., 1978, PHYTOPLANKTON MANUAL, P69; Tischendorf G, 2007, EUR J PHYCOL, V42, P243, DOI 10.1080/09670260701437642; Totti C, 2010, HARMFUL ALGAE, V9, P233, DOI 10.1016/j.hal.2009.10.006; Tubaro A, 2011, TOXICON, V57, P478, DOI 10.1016/j.toxicon.2011.01.005; Turrell G., 1996, RAMAN MICROSCOPY DEV; UEMURA D, 1985, TETRAHEDRON, V41, P1007, DOI 10.1016/S0040-4020(01)96468-3; Urban PL, 2011, ANAL CHEM, V83, P1843, DOI 10.1021/ac102702m; Usup G, 2008, PHYCOLOGIA, V47, P105, DOI 10.2216/07-55.1; Utermohl H., 1958, MITT INT VER THEOR, V9, P1, DOI DOI 10.1080/05384680.1958.11904091; Vanucci S, 2012, HARMFUL ALGAE, V15, P78, DOI 10.1016/j.hal.2011.12.003; Vidyarathna NK, 2012, AQUAT MICROB ECOL, V65, P261, DOI 10.3354/ame01555; Wang ZT, 2009, EUKARYOT CELL, V8, P1856, DOI 10.1128/EC.00272-09; Wood BR, 2005, ANAL CHEM, V77, P4955, DOI 10.1021/ac050281z; Wu HW, 2011, P NATL ACAD SCI USA, V108, P3809, DOI 10.1073/pnas.1009043108; Zhang J, 2009, THESIS RUTGERS U NEW; ZHOU J, 1993, PHYCOLOGIA, V32, P444, DOI 10.2216/i0031-8884-32-6-444.1; ZHOU J, 1994, J PHYCOL, V30, P39, DOI 10.1111/j.0022-3646.1994.00039.x	104	53	56	0	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57291	10.1371/journal.pone.0057291	http://dx.doi.org/10.1371/journal.pone.0057291			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460837	Green Submitted, Green Published, gold			2022-12-25	WOS:000315519000088
J	Kavcic, A; Cokl, A; Laumann, RA; Blassioli-Moraes, MC; Borges, M				Kavcic, Andreja; Cokl, Andrej; Laumann, Raul A.; Blassioli-Moraes, Maria Carolina; Borges, Miguel			Tremulatory and Abdomen Vibration Signals Enable Communication through Air in the Stink Bug Euschistus heros	PLOS ONE			English	Article							NEZARA-VIRIDULA HETEROPTERA; SUBSTRATE-BORNE SIGNALS; FUNCTIONAL-PROPERTIES; MATE LOCATION; HOST PLANTS; TRICHOBOTHRIA; PENTATOMIDAE; TRANSMISSION; BEHAVIOR	Communication by substrate-borne mechanical signals is widespread among animals but remains one of their least understood communication channels. Past studies of vibrational communication in insects have been oriented predominantly to communication during mating, showing that species-and sex-specific vibrational signals enable recognition and localization of potential mates on continuous solid substrates. No special attention has been paid to vibrational signals with less obvious specificity as well as to the possibility of vibrational communication across substrates that are not in physical contact. We aimed to reinvestigate emission of the aforementioned vibrational signals transmitted through a plant in the stink bug Euschistus heros (Pentatomidae: Pentatominae) and to check whether individuals are able to communicate across adjecent, physically separated substrates. We used laser vibrometry for registration of substrateborne vibrational signals on a bean plant. Using two bean plants separated for 3 to 7 cm between two most adjacent leaves, we investigated the possibility of transmission of these signals through air. Our study showed that males and females of E. heros communicate using tremulatory, percussion and buzzing signals in addition to the previously described signals produced by vibrations of the abdomen. Contrary to the latter, the first three signal types did not differ between sexes or between pentatomid species. Experiments with two physically separated plants showed significant searching behaviour and localization of vibrational signals of an E. heros male or a female, in response to abdominal vibration produced signals of a pair duetting on the neighbouring plant, in comparison to control where no animals were on the neighbouring plant. We also confirmed that transmission through air causes amplitude and frequency decay of vibrational signals, which suggests high-amplitude, low-frequency tremulatory signals of these stink bugs their most plausible way of communication across discontinuous substrates.	[Kavcic, Andreja; Cokl, Andrej] Natl Inst Biol, Dept Entomol, Ljubljana, Slovenia; [Laumann, Raul A.; Blassioli-Moraes, Maria Carolina; Borges, Miguel] Embrapa Genet Resources & Biotechnol, Brasilia, DF, Brazil	National Institute of Biology - Slovenia; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)	Kavcic, A (corresponding author), Natl Inst Biol, Dept Entomol, Ljubljana, Slovenia.	andreja.kavcic@nib.si	Laumann, Raul/C-4026-2013; Blassioli-Moraes, Maria carolina/C-6072-2013; laumann, raul/AAC-4416-2019; Kavčič, Andreja/AAC-5694-2022; Borges, Miguel/C-6937-2013; Borges, Miguel/K-9918-2019	Laumann, Raul/0000-0003-3531-2613; Blassioli-Moraes, Maria carolina/0000-0001-7569-9985; laumann, raul/0000-0003-3531-2613; Borges, Miguel/0000-0003-3364-9677	Brazilian Council for Scientific and Technological Development (CNPq); Distrito Federal Research Foundation (FAP-DF); Brazilian Corporation of Agricultural Research (EMBRAPA); Slovenian National Research Agency [1000-10-310036, P1-0255-105, BI-BR/10-12-003]	Brazilian Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Distrito Federal Research Foundation (FAP-DF)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brazilian Corporation of Agricultural Research (EMBRAPA); Slovenian National Research Agency(Slovenian Research Agency - Slovenia)	This work received financial support from the Brazilian Council for Scientific and Technological Development (CNPq), Distrito Federal Research Foundation (FAP-DF), Brazilian Corporation of Agricultural Research (EMBRAPA) and the Slovenian National Research Agency (PhD Fellowship 1000-10-310036, Research Program P1-0255-105 and Project BI-BR/10-12-003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldrich Jeffrey R., 1995, P318; ALDRICH JR, 1987, J EXP ZOOL, V244, P171, DOI 10.1002/jez.1402440121; Amon T, 1999, SCOPOLIA S1, V1, P133; Barth FG, 1999, PHILOS T R SOC B, V354, P183, DOI 10.1098/rstb.1999.0370; Bennet-Clark HC, 1998, PHILOS T ROY SOC B, V353, P407, DOI 10.1098/rstb.1998.0219; BORGES M, 1987, ENTOMOL EXP APPL, V44, P205, DOI 10.1007/BF00369180; Borges M, 2006, EMBRAPA RESURSOS GEN, V182; BRENNAN BM, 1977, ENVIRON ENTOMOL, V6, P169, DOI 10.1093/ee/6.1.169; Broughton W. B., 1963, ACOUSTIC BEHAVIOUR A, P3; Cocroft RB, 2005, BIOSCIENCE, V55, P323, DOI 10.1641/0006-3568(2005)055[0323:TBEOIV]2.0.CO;2; Cokl A, 2005, J EXP BIOL, V208, P1481, DOI 10.1242/jeb.01557; Cokl A, 2003, ANNU REV ENTOMOL, V48, P29, DOI 10.1146/annurev.ento.48.091801.112605; COKL A, 1983, J COMP PHYSIOL, V150, P261; Cokl A, 1999, ANIM BEHAV, V58, P1277, DOI 10.1006/anbe.1999.1272; Cokl AJ, 2006, PHYSIOL ENTOMOL, V31, P371, DOI 10.1111/j.1365-3032.2006.00530.x; Cokl A, 2008, J INSECT PHYSIOL, V54, P1113, DOI 10.1016/j.jinsphys.2008.06.004; Cokl A, 2011, CENT EUR J BIOL, V6, P431, DOI 10.2478/s11535-011-0015-y; Cokl A, 2009, CENT EUR J BIOL, V4, P585, DOI 10.2478/s11535-009-0043-z; Costa Maria L. M., 1998, Anais da Sociedade Entomologica do Brasil, V27, P559, DOI 10.1590/S0301-80591998000400008; de Groot M, 2011, BEHAV ECOL, V22, P1209, DOI 10.1093/beheco/arr115; de Groot M, 2011, CENT EUR J BIOL, V6, P756, DOI 10.2478/s11535-011-0056-2; de Groot M, 2010, J EXP BIOL, V213, P3213, DOI 10.1242/jeb.044024; De Luca PA, 1998, BEHAVIOUR, V135, P777, DOI 10.1163/156853998792640422; DRASLAR K, 1973, J COMP PHYSIOL, V84, P175, DOI 10.1007/BF00697605; Eriksson A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019692; Hill P.S., 2008, VIBRATIONAL COMMUNIC, DOI DOI 10.4159/9780674273825; Markl H., 1983, P332; McBrien HL, 1999, PHEROMONES OF NON-LEPIDOPTERAN INSECTS ASSOCIATED WITH AGRICULTURAL PLANTS, P277; Moraes MCB, 2005, PHYSIOL ENTOMOL, V30, P175, DOI 10.1111/j.1365-3032.2005.00446.x; OTA D, 1991, J INSECT BEHAV, V4, P441, DOI 10.1007/BF01049329; Polajnar J, 2012, J R SOC INTERFACE, V9, P1898, DOI 10.1098/rsif.2011.0770; Romer H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013325; STADDON BW, 1994, J NAT HIST, V28, P353, DOI 10.1080/00222939400770141; Zunic A, 2008, ANN ENTOMOL SOC AM, V101, P1169, DOI 10.1603/0013-8746-101.6.1169; Zunic A, 2011, J INSECT BEHAV, V24, P468, DOI 10.1007/s10905-011-9272-x	35	18	17	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e56503	10.1371/journal.pone.0056503	http://dx.doi.org/10.1371/journal.pone.0056503			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460803	Green Submitted, Green Published, gold			2022-12-25	WOS:000315519000026
J	Rodrigues, RJ; Antony, J; Krishnamurthy, S; Shet, A; De Costa, A				Rodrigues, Rashmi J.; Antony, Jimmy; Krishnamurthy, Shubha; Shet, Anita; De Costa, Ayesha			'What Do I Know? Should I Participate?' Considerations on Participation in HIV Related Research among HIV Infected Adults in Bangalore, South India	PLOS ONE			English	Article							CLINICAL-TRIALS; INFORMED-CONSENT; VACCINE TRIALS; WILLINGNESS	Background: India has the highest number of HIV infected persons in the world after South Africa. Much HIV related behavioral, clinical and laboratory based research is ongoing in India. Yet little is known on Indian HIV patients' knowledge of research, their processes of decision making and motives for participation. We aimed to explore these areas among HIV infected individuals to understand their reasons for participating in research. Methodology/Principal Findings: This is a cross sectional survey among 173 HIV infected adults at a tertiary level hospital in Bangalore, India, done between October 2010 and January 2011. A pre-tested questionnaire was administered to the participants by trained research assistants to assess their knowledge regarding research, willingness to participate, decision making and determinants of participation. Participants were presented with five hypothetical HIV research studies. Each study had a different level of intervention and time commitment. Of respondents, 103(60%), said that research meant 'to discover something new' and 138(80%) were willing to participate in research. A third of the respondents were unaware of their right to refuse participation. Willingness to participate in research varied with level of intervention. It was the lowest for the hypothetical study involving sensitive questions followed by the hypothetical drug trial; and was the highest for the hypothetical cross sectional questionnaire based study (p<0.0015). Individual health benefits and altruism were the primary motives for participation in research and indicate the presence of therapeutic misconception. Women were less likely to make autonomous decisions for participation in interventional studies. Conclusions/Significance: Despite a majority willing to participate, over a third of respondents did not have any knowledge of research or the voluntary nature of participation. This has ethical implications. Researchers need to focus on enabling potential research participants understand the concepts of research, promote autonomous decisions, especially by women and restrict therapeutic misconception.	[Rodrigues, Rashmi J.; Shet, Anita; De Costa, Ayesha] Karolinska Inst, Div Global Hlth, Stockholm, Sweden; [Rodrigues, Rashmi J.; Antony, Jimmy; Krishnamurthy, Shubha; Shet, Anita] St Johns Natl Acad Hlth Sci, Bangalore, Karnataka, India	Karolinska Institutet; St. John's National Academy of Health Sciences	Rodrigues, RJ (corresponding author), Karolinska Inst, Div Global Hlth, Stockholm, Sweden.	rashmijr@gmail.com	Rodrigues, Rashmi J/H-1901-2012	Rodrigues, Rashmi J/0000-0002-0656-0178; Shet, Anita/0000-0002-7204-8164; De Costa, Ayesha/0000-0003-1869-5990	European Commission	European Commission(European CommissionEuropean Commission Joint Research Centre)	European Commission's Seventh Framework Program Grant for the HIVIND project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeyemi OF, 2009, AIDS PATIENT CARE ST, V23, P859, DOI 10.1089/apc.2009.0008; Annas GJ, 2009, NEW ENGL J MED, V360, P2050, DOI 10.1056/NEJMp0901474; Appelbaum Paul S, 2004, IRB, V26, P1, DOI 10.2307/3564231; Ballantyne A, 2007, HARVARD HLTH POLICY, V8, P29; BARRY M, 1988, NEW ENGL J MED, V319, P1083, DOI 10.1056/NEJM198810203191609; de la Gorgendiere L, 2005, HUM ORGAN, V64, P166, DOI 10.17730/humo.64.2.qywa96br4laj9k18; Ding EL, 2007, ARCH INTERN MED, V167, P905, DOI 10.1001/archinte.167.9.905; Edwards SJL, 2005, BIOETHICS, V19, P112, DOI 10.1111/j.1467-8519.2005.00429.x; Faden R, 1998, AM J PUBLIC HEALTH, V88, P548, DOI 10.2105/AJPH.88.4.548; Gifford AL, 2002, NEW ENGL J MED, V346, P1373, DOI 10.1056/NEJMsa011565; Gitanjali B, 2003, J Postgrad Med, V49, P109; Gucciardi E, 2010, J AMBUL CARE MANAG, V33, P272, DOI 10.1097/JAC.0b013e3181e62d3c; Hill Z, 2008, J MED ETHICS, V34, P48, DOI 10.1136/jme.2006.019059; Indian Council of Medical Research (ICMR), 2006, ETH GUID BIOM RES HU; Jayant K, 2005, TALKING SEXUALITY CO; Jejeebhoy SJ, 2001, POPUL DEV REV, V27, P687, DOI 10.1111/j.1728-4457.2001.00687.x; Karim QA, 1998, AM J PUBLIC HEALTH, V88, P637, DOI 10.2105/AJPH.88.4.637; Khalil Susan S, 2007, BMC Med Ethics, V8, P9, DOI 10.1186/1472-6939-8-9; Krishnan Suneeta, 2007, Indian J Med Ethics, V4, P121; Mason S, 2003, BRIT MED J, V326, P1244, DOI 10.1136/bmj.326.7401.1244; Muthuswamy V, 2005, INDIAN J MED RES, V121, P601; Mystakidou K, 2009, SAHARA J-J SOC ASP H, V6, P46, DOI 10.1080/17290376.2009.9724930; NACO, 2008, ETH GUID OP RES HIV; NACO, 2012, ANN REPORT; Nyamathi AM, 2007, AIDS BEHAV, V11, P619, DOI 10.1007/s10461-006-9173-8; Paradis C, 2010, J MED ETHICS, V36, P580, DOI 10.1136/jme.2009.032904; Pranati, 2010, Perspect Clin Res, V1, P124, DOI 10.4103/2229-3485.71769; Riessman CK, 2005, HEALTH-LONDON, V9, P473, DOI 10.1177/1363459305056414; Sastry J, 2004, BMC MED, V2, DOI 10.1186/1741-7015-2-28; Shah JY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010730; Shavers VL, 2000, J NATL MED ASSOC, V92, P563; Steward WT, 2008, SOC SCI MED, V67, P1225, DOI 10.1016/j.socscimed.2008.05.032; Suhadev M, 2009, AIDS RES HUM RETROV, V25, P217, DOI 10.1089/aid.2007.0312; Sumathipala A, 2010, BMC MED ETHICS, V11, DOI 10.1186/1472-6939-11-7; Tharawan K, 2001, J ACQ IMMUN DEF SYND, V28, P180; van Herk H, 2004, J CROSS CULT PSYCHOL, V35, P346, DOI 10.1177/0022022104264126; Wazaify M, 2009, BMC MED ETHICS, V10, DOI 10.1186/1472-6939-10-7; Wendler D, 2008, ARCH INTERN MED, V168, P1294, DOI 10.1001/archinte.168.12.1294; Yousuf RM, 2009, SINGAP MED J, V48, P559; Zukelwa N, 2009, CONCEPTIONS RES ATTI, P122	40	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e53054	10.1371/journal.pone.0053054	http://dx.doi.org/10.1371/journal.pone.0053054			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	098BN	23460780	Green Published, gold, Green Submitted			2022-12-25	WOS:000315519000003
J	Shabaneh, TB; Downey, SL; Goddard, AL; Screen, M; Lucas, MM; Eastman, A; Kisselev, AF				Shabaneh, Tamer B.; Downey, Sondra L.; Goddard, Ayrton L.; Screen, Michael; Lucas, Marcella M.; Eastman, Alan; Kisselev, Alexei F.			Molecular Basis of Differential Sensitivity of Myeloma Cells to Clinically Relevant Bolus Treatment with Bortezomib	PLOS ONE			English	Article							PHASE-I TRIAL; ACTIVE PROTEASOME INHIBITOR; OVERCOMES DRUG-RESISTANCE; ADVANCED SOLID TUMORS; MULTIPLE-MYELOMA; PS-341; APOPTOSIS; MICROENVIRONMENT; ESTABLISHMENT; SPECIFICITY	The proteasome inhibitor bortezomib (Velcade) is prescribed for the treatment of multiple myeloma. Clinically achievable concentrations of bortezomib cause less than 85% inhibition of the chymotrypsin-like activity of the proteasome, but little attention has been paid as to whether in vitro studies are representative of this level of inhibition. Patients receive bortezomib as an intravenous or subcutaneous bolus injection, resulting in maximum proteasome inhibition within one hour followed by a gradual recovery of activity. In contrast, most in vitro studies use continuous treatment so that activity never recovers. Replacing continuous treatment with 1 h-pulse treatment increases differences in sensitivity in a panel of 7 multiple myeloma cell lines from 5.3-fold to 18-fold, and reveals that the more sensitive cell lines undergo apoptosis at faster rates. Clinically achievable inhibition of active sites was sufficient to induce cytotoxicity only in one cell line. At concentrations of bortezomib that produced similar inhibition of peptidase activities a different extent of inhibition of protein degradation was observed, providing an explanation for the differential sensitivity. The amount of protein degraded per number of active proteasomes correlated with sensitivity to bortezomib. Thus, (i) in vitro studies of proteasome inhibitors should be conducted at pharmacologically achievable concentrations and duration of treatment; (ii) a similar level of inhibition of active sites results in a different extent of inhibition of protein breakdown in different cell lines, and hence a difference in sensitivity.	[Shabaneh, Tamer B.; Downey, Sondra L.; Goddard, Ayrton L.; Screen, Michael; Lucas, Marcella M.; Eastman, Alan; Kisselev, Alexei F.] Geisel Sch Med Dartmouth, Norris Cotton Canc Ctr, Lebanon, NH USA; [Shabaneh, Tamer B.; Downey, Sondra L.; Goddard, Ayrton L.; Screen, Michael; Lucas, Marcella M.; Eastman, Alan; Kisselev, Alexei F.] Geisel Sch Med Dartmouth, Dept Pharmacol & Toxicol, Lebanon, NH USA; [Goddard, Ayrton L.; Screen, Michael; Lucas, Marcella M.] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England	Dartmouth College; Norris Cotton Cancer Center; Dartmouth College; University of Bath	Kisselev, AF (corresponding author), Geisel Sch Med Dartmouth, Norris Cotton Canc Ctr, Lebanon, NH USA.	Alexei.F.Kisselev@Dartmouth.edu		Downey, Sondra/0000-0003-4203-3583	NCI [R01CA124634]; Multiple Myeloma Research Foundation; NATIONAL CANCER INSTITUTE [R01CA124634] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Multiple Myeloma Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	These studies were supported by grant R01CA124634 from the NCI, by the American Recovery and Reinvestment Act supplement to this grant, and by a grant from the Multiple Myeloma Research Foundation (http://www.themmrf.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Adams J, 1999, CANCER RES, V59, P2615; Aghajanian C, 2002, CLIN CANCER RES, V8, P2505; Altun M, 2005, CANCER RES, V65, P7896, DOI 10.1158/0008-5472.CAN-05-0506; Berkers CR, 2005, NAT METHODS, V2, P357, DOI 10.1038/nmeth759; Bianchi G, 2009, BLOOD, V113, P3040, DOI 10.1182/blood-2008-08-172734; Britton M, 2009, CHEM BIOL, V16, P1278, DOI 10.1016/j.chembiol.2009.11.015; Cenci S., 2012, J LEUKOC BIOL; Chauhan D, 2005, CANCER CELL, V8, P407, DOI 10.1016/j.ccr.2005.10.013; Demo SD, 2007, CANCER RES, V67, P6383, DOI 10.1158/0008-5472.CAN-06-4086; Edwards CM, 2009, AM J HEMATOL, V84, P268, DOI 10.1002/ajh.21374; Fuertes G, 2003, INT J BIOCHEM CELL B, V35, P651, DOI 10.1016/S1357-2725(02)00382-5; Greenstein S, 2003, EXP HEMATOL, V31, P271, DOI 10.1016/S0301-472X(03)00023-7; Groll M, 2000, J AM CHEM SOC, V122, P1237, DOI 10.1021/ja993588m; Gu JL, 2012, BIOCHEM BIOPH RES CO, V420, P644, DOI 10.1016/j.bbrc.2012.03.056; Hamilton AL, 2005, J CLIN ONCOL, V23, P6107, DOI 10.1200/JCO.2005.01.136; Hao M, 2011, LEUKEMIA LYMPHOMA, V52, P1787, DOI 10.3109/10428194.2011.576791; Hazlehurst LA, 2003, ONCOGENE, V22, P7396, DOI 10.1038/sj.onc.1206943; Hideshima T, 2001, CANCER RES, V61, P3071; Kisselev AF, 2006, J BIOL CHEM, V281, P8582, DOI 10.1074/jbc.M509043200; Kupperman E, 2010, CANCER RES, V70, P1970, DOI 10.1158/0008-5472.CAN-09-2766; McMillin DW, 2010, NAT MED, V16, P483, DOI 10.1038/nm.2112; Meiners S, 2003, J BIOL CHEM, V278, P21517, DOI 10.1074/jbc.M301032200; Meister S, 2007, CANCER RES, V67, P1783, DOI 10.1158/0008-5472.CAN-06-2258; Mirabella AC, 2011, CHEM BIOL, V18, P608, DOI 10.1016/j.chembiol.2011.02.015; Moreau P, 2011, LANCET ONCOL, V12, P431, DOI 10.1016/S1470-2045(11)70081-X; NAMBA M, 1989, IN VITRO CELL DEV B, V25, P723; Obeng EA, 2006, BLOOD, V107, P4907, DOI 10.1182/blood-2005-08-3531; Orlowski RZ, 2002, J CLIN ONCOL, V20, P4420, DOI 10.1200/JCO.2002.01.133; Otsuki T, 1998, INT J ONCOL, V12, P545; Papandreou CN, 2004, J CLIN ONCOL, V22, P2108, DOI 10.1200/JCO.2004.02.106; Piva R, 2008, BLOOD, V111, P2765, DOI 10.1182/blood-2007-07-100651; Reece DE, 2011, CANCER CHEMOTH PHARM, V67, P57, DOI 10.1007/s00280-010-1283-3; Richardson PG, 2009, J CLIN ONCOL, V27, P3518, DOI 10.1200/JCO.2008.18.3087; Richardson PG, 2005, NEW ENGL J MED, V352, P2487, DOI 10.1056/NEJMoa043445; Screen M, 2010, J BIOL CHEM, V285, P40125, DOI 10.1074/jbc.M110.160606; Suraweera A, 2012, MOL CELL, V48, P242, DOI 10.1016/j.molcel.2012.08.003; Venkatakrishnan K, 2009, CLIN THER, V31, P2444, DOI 10.1016/j.clinthera.2009.11.012; Zhou HJ, 2009, J MED CHEM, V52, P3028, DOI 10.1021/jm801329v	38	38	38	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e56132	10.1371/journal.pone.0056132	http://dx.doi.org/10.1371/journal.pone.0056132			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460792	Green Submitted, Green Published, gold			2022-12-25	WOS:000315519000015
J	Shigdar, S; Qian, C; Lv, L; Pu, CW; Li, Y; Li, LH; Marappan, M; Lin, J; Wang, LF; Duan, W				Shigdar, Sarah; Qian, Christine; Lv, Li; Pu, Chunwen; Li, Yong; Li, Lianhong; Marappan, Manju; Lin, Jia; Wang, Lifen; Duan, Wei			The Use of Sensitive Chemical Antibodies for Diagnosis: Detection of Low Levels of Epcam in Breast Cancer	PLOS ONE			English	Article							EP-CAM; EXPRESSION; HYBRIDIZATION; MOLECULE; APTAMERS; ENRICHMENT; THERAPY	EpCAM is expressed at low levels in a variety of normal human epithelial tissues, but is overexpressed in 70-90% of carcinomas. From a clinico-pathological point of view, this has both prognostic and therapeutic significance. EpCAM was first suggested as a therapeutic target for the treatment of epithelial cancers in the 1990s. However, following several immunotherapy trials, the results have been mixed. It has been suggested that this is due, at least in part, to an unknown level of EpCAM expression in the tumors being targeted. Thus, selection of patients who would benefit from EpCAM immunotherapy by determining EpCAM status in the tumor biopsies is currently undergoing vigorous evaluation. However, current EpCAM antibodies are not robust enough to be able to detect EpCAM expression in all pathological tissues. Here we report a newly developed EpCAM RNA aptamer, also known as a chemical antibody, which is not only specific but also more sensitive than current antibodies for the detection of EpCAM in formalin-fixed paraffin-embedded primary breast cancers. This new aptamer, together with our previously described aptamer, showed no non-specific staining or cross-reactivity with tissues that do not express EpCAM. They were able to reliably detect target proteins in breast cancer xenograft where an anti-EpCAM antibody (323/A3) showed limited or no reactivity. Our results demonstrated a more robust detection of EpCAM using RNA aptamers over antibodies in clinical samples with chromogenic staining. This shows the potential of aptamers in the future of histopathological diagnosis and as a tool to guide targeted immunotherapy.	[Shigdar, Sarah; Qian, Christine; Marappan, Manju; Lin, Jia; Duan, Wei] Deakin Univ, Sch Med, Waurn Ponds, Vic, Australia; [Lv, Li; Wang, Lifen] Dalian Med Univ, Affiliated Hosp 2, Dalian, Peoples R China; [Pu, Chunwen] Dalian Sixth Peoples Hosp, Dalian, Peoples R China; [Li, Yong] Univ New S Wales, St George Hosp, Canc Care Ctr, Kensington, NSW 2033, Australia; [Li, Yong] Univ New S Wales, Fac Med, St George Clin Sch, Kensington, NSW 2033, Australia; [Li, Lianhong] Dalian Med Univ, Dept Pathol & Forens Sci, Dalian, Peoples R China; [Qian, Christine] St John God Pathol, Dept Histopathol, Geelong, Vic, Australia	Deakin University; Dalian Medical University; St George Hospital; University of New South Wales Sydney; University of New South Wales Sydney; Dalian Medical University; St John of God Health Care	Wang, LF (corresponding author), Dalian Med Univ, Affiliated Hosp 2, Dalian, Peoples R China.	wduan@deakin.edu.au; lifen_w@163.com	Shigdar, Sarah/AFR-0438-2022; Duan, Wei/A-5181-2015	Duan, Wei/0000-0001-5782-9184; Li, Yong/0000-0002-8910-9787; Shigdar, Sarah/0000-0001-8084-8447	Royal College of Pathologists of Australasia; National Health & Medical Research Council, Australia (NH MRC); Australia-India Strategic Research Fund; Victorian Cancer Agency	Royal College of Pathologists of Australasia; National Health & Medical Research Council, Australia (NH MRC)(National Health and Medical Research Council (NHMRC) of Australia); Australia-India Strategic Research Fund(Australian GovernmentDepartment of Industry, Innovation and Science); Victorian Cancer Agency	This work was supported by grants from the Royal College of Pathologists of Australasia, National Health & Medical Research Council, Australia (NH & MRC); Australia-India Strategic Research Fund and Victorian Cancer Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antolovic D, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-35; Arora R, 2011, CYTOJOURNAL, V8, DOI 10.4103/1742-6413.83233; Arteaga CL, 2012, NAT REV CLIN ONCOL, V9, P16, DOI 10.1038/nrclinonc.2011.177; Baird GS, 2010, AM J CLIN PATHOL, V134, P529, DOI 10.1309/AJCPFU4CG2WGJJKS; Bhatt AN, 2010, INDIAN J MED RES, V132, P129; Blazar M, 2001, MOL CELL BIOL, V21, P2570, DOI 10.1128/MCB.21.7.2570-2580.2001; Bordeaux J, 2010, BIOTECHNIQUES, V48, P197, DOI 10.2144/000113382; Cimino A, 2010, BREAST CANCER RES TR, V123, P701, DOI 10.1007/s10549-009-0671-z; Das M, 2009, EXPERT OPIN DRUG DEL, V6, P285, DOI 10.1517/17425240902780166; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Farokhzad OC, 2004, CANCER RES, V64, P7668, DOI 10.1158/0008-5472.CAN-04-2550; Fritschy JM, 2008, EUR J NEUROSCI, V28, P2365, DOI 10.1111/j.1460-9568.2008.06552.x; Gires O, 2010, J CLIN ONCOL, V28, pE239, DOI 10.1200/JCO.2009.26.8540; Gown AM, 2008, MODERN PATHOL, V21, pS8, DOI 10.1038/modpathol.2008.34; Gupta S, 2011, APPL IMMUNOHISTO M M, V19, P273, DOI 10.1097/PAI.0b013e3182008c29; Heine M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036258; Hough CD, 2000, CANCER RES, V60, P6281; Idikio HA, 2010, INT J CLIN EXP PATHO, V3, P169; Kataria S, 2011, IJPBA, V2, P1346; Keefe AD, 2010, NAT REV DRUG DISCOV, V9, P537, DOI 10.1038/nrd3141; Lassalle H. P., 2012, CURR DRUG METAB; Lindblom A, 2000, BMJ-BRIT MED J, V320, P424, DOI 10.1136/bmj.320.7232.424; Patriarca C, 2012, CANCER TREAT REV, V38, P68, DOI 10.1016/j.ctrv.2011.04.002; Prang N, 2005, BRIT J CANCER, V92, P342, DOI 10.1038/sj.bjc.6602310; Rayburn ER, 2008, DRUG DISCOV TODAY, V13, P513, DOI 10.1016/j.drudis.2008.03.014; Rhodes A, 2000, J CLIN PATHOL, V53, P292, DOI 10.1136/jcp.53.4.292; Rodriguez-Canales J, 2011, BIOESSAYS, V33, P490, DOI 10.1002/bies.201100017; Sankpal NV, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3070; Schmidt M, 2008, CLIN CANCER RES, V14, P5849, DOI 10.1158/1078-0432.CCR-08-0669; Sharma S, 2009, INDIAN J MED PAEDIAT, V30, P1, DOI 10.4103/0971-5851.56328; Shigdar S, 2011, BRIT J HAEMATOL, V155, P3, DOI 10.1111/j.1365-2141.2011.08807.x; Shigdar S, 2011, CANCER SCI, V102, P991, DOI 10.1111/j.1349-7006.2011.01897.x; SINGH L, 1984, NUCLEIC ACIDS RES, V12, P5627, DOI 10.1093/nar/12.14.5627; Songun I, 2005, BRIT J CANCER, V92, P1767, DOI 10.1038/sj.bjc.6602519; Spizzo G, 2011, J CLIN PATHOL, V64, P415, DOI 10.1136/jcp.2011.090274; Stoltenburg R, 2007, BIOMOL ENG, V24, P381, DOI 10.1016/j.bioeng.2007.06.001; Stone Marvin J, 2003, Proc (Bayl Univ Med Cent), V16, P30; Thurber GM, 2011, MOL IMAGING BIOL, V13, P623, DOI 10.1007/s11307-010-0397-7; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; van der Gun BTF, 2010, CARCINOGENESIS, V31, P1913, DOI 10.1093/carcin/bgq187; vanGijlswijk RPM, 1996, J HISTOCHEM CYTOCHEM, V44, P389, DOI 10.1177/44.4.8601698; WAHL GM, 1979, P NATL ACAD SCI USA, V76, P3683, DOI 10.1073/pnas.76.8.3683; Winter MJ, 2003, AM J PATHOL, V163, P2139, DOI 10.1016/S0002-9440(10)63570-5; Yeong SS, 2006, J BIOL CHEM, V281, P30768, DOI 10.1074/jbc.M511278200; Zeng ZH, 2010, MODERN PATHOL, V23, P1553, DOI 10.1038/modpathol.2010.151	45	36	38	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57613	10.1371/journal.pone.0057613	http://dx.doi.org/10.1371/journal.pone.0057613			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460885	Green Submitted, Green Published, gold			2022-12-25	WOS:000315519000140
J	Dorfer, C; Kuhn, P; Baumann, F; He, JS; Scholten, T				Doerfer, Corina; Kuehn, Peter; Baumann, Frank; He, Jin-Sheng; Scholten, Thomas			Soil Organic Carbon Pools and Stocks in Permafrost-Affected Soils on the Tibetan Plateau	PLOS ONE			English	Article							DENSITY FRACTIONS; TEMPERATURE-DEPENDENCE; MATTER DECOMPOSITION; NMR-SPECTROSCOPY; CLIMATIC-CHANGE; ALPINE MEADOW; TUNDRA SOILS; FOREST SOILS; STORAGE; DEGRADATION	The Tibetan Plateau reacts particularly sensitively to possible effects of climate change. Approximately two thirds of the total area is affected by permafrost. To get a better understanding of the role of permafrost on soil organic carbon pools and stocks, investigations were carried out including both discontinuous (site Huashixia, HUA) and continuous permafrost (site Wudaoliang, WUD). Three organic carbon fractions were isolated using density separation combined with ultrasonic dispersion: the light fractions (<1.6 g cm(-3)) of free particulate organic matter (FPOM) and occluded particulate organic matter (OPOM), plus a heavy fraction (>1.6 g cm(-3)) of mineral associated organic matter (MOM). The fractions were analyzed for C, N, and their portion of organic C. FPOM contained an average SOC content of 252 g kg(-1). Higher SOC contents (320 g kg(-1)) were found in OPOM while MOM had the lowest SOC contents (29 g kg(-1)). Due to their lower density the easily decomposable fractions FPOM and OPOM contribute 27% (HUA) and 22% (WUD) to the total SOC stocks. In HUA mean SOC stocks (0-30 cm depth) account for 10.4 kg m(-2), compared to 3.4 kg m(-2) in WUD. 53% of the SOC is stored in the upper 10 cm in WUD, in HUA only 39%. Highest POM values of 36% occurred in profiles with high soil moisture content. SOC stocks, soil moisture and active layer thickness correlated strongly in discontinuous permafrost while no correlation between SOC stocks and active layer thickness and only a weak relation between soil moisture and SOC stocks could be found in continuous permafrost. Consequently, permafrost-affected soils in discontinuous permafrost environments are susceptible to soil moisture changes due to alterations in quantity and seasonal distribution of precipitation, increasing temperature and therefore evaporation.	[Doerfer, Corina; Kuehn, Peter; Baumann, Frank; Scholten, Thomas] Univ Tubingen, Dept Geosci Phys Geog & Soil Sci, Tubingen, Germany; [He, Jin-Sheng] Peking Univ, Coll Urban & Environm Sci, Dept Ecol, Beijing 100871, Peoples R China	Eberhard Karls University of Tubingen; Peking University	Dorfer, C (corresponding author), Univ Tubingen, Dept Geosci Phys Geog & Soil Sci, Tubingen, Germany.	corina.doerfer@uni-tuebingen.de	Scholten, Thomas/E-4024-2012; Kühn, Peter/A-9146-2009; He, Jin-Sheng/A-4053-2009	Scholten, Thomas/0000-0002-4875-2602; Kühn, Peter/0000-0002-4417-5633; He, Jin-Sheng/0000-0001-5081-3569	Federal Ministry of Education and Research (BMBF) [03G0810A]; German Academic Exchange Service (DAAD); National Natural Science Foundation of China [31025005, 31021001]	Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Federal Ministry of Education and Research (BMBF, 03G0810A, http://www.bmbf.de/en), the German Academic Exchange Service (DAAD, http://www.daad.de) and the National Natural Science Foundation of China (31025005 and 31021001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumann F, 2009, GLOBAL CHANGE BIOL, V15, P3001, DOI 10.1111/j.1365-2486.2009.01953.x; Bockheim JG, 2003, SOIL SCI SOC AM J, V67, P948, DOI 10.2136/sssaj2003.0948; Callesen I, 2003, GLOBAL CHANGE BIOL, V9, P358, DOI 10.1046/j.1365-2486.2003.00587.x; Callesen I, 2007, BOREAL ENVIRON RES, V12, P681; Cheng GD, 2007, J GEOPHYS RES-EARTH, V112, DOI 10.1029/2006JF000631; Christensen B.T., 1992, ADV SOIL SCI, V20, P1, DOI [10.1007/978-1-4612-2930-8_1, DOI 10.1007/978-1-4612-2930-8_1]; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; Du Zheng, 2000, MOUNTAIN GEOECOLOGY; Geng Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034968; Geng Y, 2012, GLOBAL ECOL BIOGEOGR, V21, P416, DOI 10.1111/j.1466-8238.2011.00692.x; GOLCHIN A, 1994, AUST J SOIL RES, V32, P285, DOI 10.1071/SR9940285; GOLCHIN A, 1995, AUST J SOIL RES, V33, P59, DOI 10.1071/SR9950059; Grosse G., 2011, EOS T AM GEOPHYS UN, V92, P73, DOI [10.1002/ppp.689.Rowland, DOI 10.1029/2011EO090001, 10.1029/2011EO090001]; Grunewald G, 2006, ORG GEOCHEM, V37, P1573, DOI 10.1016/j.orggeochem.2006.05.002; Gundelwein A, 2007, EUR J SOIL SCI, V58, P1164, DOI 10.1111/j.1365-2389.2007.00908.x; IUSS Working Group WRB, 2007, WORLD SOIL RESOURCES; Jin HJ, 2000, GLOBAL PLANET CHANGE, V26, P387, DOI 10.1016/S0921-8181(00)00051-5; Jin HJ, 2006, SCI CHINA SER D, V49, P1170, DOI 10.1007/s11430-006-2003-z; Jobbagy EG, 2000, ECOL APPL, V10, P423, DOI 10.1890/1051-0761(2000)010[0423:TVDOSO]2.0.CO;2; John B, 2005, GEODERMA, V128, P63, DOI 10.1016/j.geoderma.2004.12.013; Kadono A, 2008, SOIL BIOL BIOCHEM, V40, P947, DOI 10.1016/j.soilbio.2007.11.015; Kaiser K, 2008, CATENA, V73, P300, DOI 10.1016/j.catena.2007.12.001; Kang SC, 2010, ENVIRON RES LETT, V5, DOI 10.1088/1748-9326/5/1/015101; Kato T, 2004, AGR FOREST METEOROL, V124, P121, DOI 10.1016/j.agrformet.2003.12.008; Kirschbaum MUF, 2006, SOIL BIOL BIOCHEM, V38, P2510, DOI 10.1016/j.soilbio.2006.01.030; KIRSCHBAUM MUF, 1995, SOIL BIOL BIOCHEM, V27, P753, DOI 10.1016/0038-0717(94)00242-S; Kolbl A, 2004, J PLANT NUTR SOIL SC, V167, P45, DOI 10.1002/jpln.200321185; Luo TX, 2002, ECOL APPL, V12, P980, DOI 10.1890/1051-0761(2002)012[0980:EBAPON]2.0.CO;2; Nan ZT, 2005, SCI CHINA SER D, V48, P797, DOI 10.1360/03yd0258; Ni J, 2002, J ARID ENVIRON, V50, P205, DOI 10.1006/jare.2001.0902; Ohtsuka T., 2008, POLAR SCI, V2, P277, DOI [10.1016/j.polar.2008.08.003, DOI 10.1016/J.POLAR.2008.08.003]; POST WM, 1982, NATURE, V298, P156, DOI 10.1038/298156a0; Roscoe R, 2000, EUR J SOIL SCI, V51, P445, DOI 10.1046/j.1365-2389.2000.00321.x; Saito M, 2009, GLOBAL CHANGE BIOL, V15, P221, DOI 10.1111/j.1365-2486.2008.01713.x; Schuur EAG, 2008, BIOSCIENCE, V58, P701, DOI 10.1641/B580807; Six J, 1999, SOIL BIOL BIOCHEM, V31, P1193, DOI 10.1016/S0038-0717(99)00023-1; Tarnocai C, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003327; Torn MS, 1997, NATURE, V389, P170, DOI 10.1038/38260; Trumbore S, 2006, GLOBAL CHANGE BIOL, V12, P141, DOI 10.1111/j.1365-2486.2006.01067.x; Uhlirova E, 2007, SOIL BIOL BIOCHEM, V39, P1978, DOI 10.1016/j.soilbio.2007.02.018; von Lutzow M, 2007, SOIL BIOL BIOCHEM, V39, P2183, DOI 10.1016/j.soilbio.2007.03.007; Wagner D., 2009, SOIL BIOL, P219; Wagner D, 2009, CAN J MICROBIOL, V55, P73, DOI 10.1139/W08-121; WANG BL, 1995, QUATERNARY SCI REV, V14, P255, DOI 10.1016/0277-3791(95)00006-B; Wang GX, 2008, HYDROL PROCESS, V22, P3310, DOI 10.1002/hyp.6913; Wang GX, 2008, GEODERMA, V143, P143, DOI 10.1016/j.geoderma.2007.10.023; Wang GX, 2007, CATENA, V70, P506, DOI 10.1016/j.catena.2007.01.001; Wang GX, 2006, MT RES DEV, V26, P153, DOI 10.1659/0276-4741(2006)26[153:LCCAII]2.0.CO;2; Wang GX, 2002, SCI TOTAL ENVIRON, V291, P207, DOI 10.1016/S0048-9697(01)01100-7; Wang W, 2009, SCI CHINA SER D, V52, P660, DOI 10.1007/s11430-009-0056-5; Weischet W., 2000, REGIONALE KLIMATOL 2; Yang MX, 2010, EARTH-SCI REV, V103, P31, DOI 10.1016/j.earscirev.2010.07.002; Yang MX, 2004, COLD REG SCI TECHNOL, V39, P47, DOI 10.1016/j.coldregions.2004.01.002; Yang Y.H., 2010, BIOGEOSCI DISCUSS, V7, P1, DOI [10.5194/bgd-7-1-2010, DOI 10.5194/BGD-7-1-2010]; Yang YH, 2008, GLOBAL CHANGE BIOL, V14, P1592, DOI 10.1111/j.1365-2486.2008.01591.x; Zhang TJ, 2005, PHYS GEOGR, V26, P279, DOI 10.2747/0272-3646.26.4.279; Zhang YQ, 2007, SCI CHINA SER D, V50, P113, DOI 10.1007/s11430-007-2032-2; Zhao L, 2000, CHINESE SCI BULL, V45, P2181, DOI 10.1007/BF02886326; Zhou HK, 2005, JAPANESE J GRASSLAND, V51, P191	59	51	53	19	169	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2013	8	2							e57024	10.1371/journal.pone.0057024	http://dx.doi.org/10.1371/journal.pone.0057024			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098PO	23468904	Green Published, Green Submitted, gold			2022-12-25	WOS:000315561400022
J	Hsu, YH; Li, HH; Sung, JM; Chen, WT; Hou, YC; Chang, MS				Hsu, Yu-Hsiang; Li, Hsing-Hui; Sung, Junne-Ming; Chen, Wei-Ting; Hou, Ya-Chin; Chang, Ming-Shi			Interleukin-19 Mediates Tissue Damage in Murine Ischemic Acute Kidney Injury	PLOS ONE			English	Article							RENAL EPITHELIAL-CELLS; INDUCED APOPTOSIS; TNF-ALPHA; ISCHEMIA/REPERFUSION INJURY; MESANGIAL CELLS; HIGH GLUCOSE; ACTIVATION; IL-19; FAILURE; CYTOKINES	Inflammation and renal tubular injury are major features of acute kidney injury (AKI). Many cytokines and chemokines are released from injured tubular cells and acts as proinflammatory mediators. However, the role of IL-19 in the pathogenesis of AKI is not defined yet. In bilateral renal ischemia/reperfusion injury (IRI)-induced and HgCl2-induced AKI animal models, real-time quantitative (RTQ)-PCR showed that the kidneys, livers, and lungs of AKI mice expressed significantly higher IL-19 and its receptors than did sham control mice. Immunohistochemical staining showed that IL-19 and its receptors were strongly stained in the kidney, liver, and lung tissue of AKI mice. In vitro, IL-19 upregulated MCP-1, TGF-beta 1, and IL-19, and induced mitochondria-dependent apoptosis in murine renal tubular epithelial M-1 cells. IL-19 upregulated TNF-alpha and IL-10 in cultured HepG2 cells, and it increased IL-1 beta and TNF-alpha expression in cultured A549 cells. In vivo, after renal IRI or a nephrotoxic dose of HgCl2 treatment, IL-20R1-deficient mice (the deficiency blocks IL-19 signaling) showed lower levels of blood urea nitrogen (BUN) in serum and less tubular damage than did wild-type mice. Therefore, we conclude that IL-19 mediates kidney, liver, and lung tissue damage in murine AKI and that blocking IL-19 signaling may provide a potent therapeutic strategy for treating AKI.	[Hsu, Yu-Hsiang; Chen, Wei-Ting; Chang, Ming-Shi] Natl Cheng Kung Univ, Coll Med, Dept Biochem & Mol Biol, Tainan 70101, Taiwan; [Li, Hsing-Hui] Natl Museum Marine Biol & Aquarium, Dept Planning & Res, Pingtung, Taiwan; [Sung, Junne-Ming] Natl Cheng Kung Univ, Coll Med, Dept Internal Med, Tainan 70101, Taiwan; [Hou, Ya-Chin; Chang, Ming-Shi] Natl Cheng Kung Univ, Coll Med, Inst Basic Med Sci, Tainan 70101, Taiwan	National Cheng Kung University; National Museum of Marine Biology & Aquarium; National Cheng Kung University; National Cheng Kung University	Chang, MS (corresponding author), Natl Cheng Kung Univ, Coll Med, Dept Biochem & Mol Biol, Tainan 70101, Taiwan.	mschang@mail.ncku.edu.tw		Sung, Junne-Ming/0000-0003-1916-7815				Akcay A, 2009, MEDIAT INFLAMM, V2009, DOI 10.1155/2009/137072; Amiri F, 2002, KIDNEY INT, V61, P1605, DOI 10.1046/j.1523-1755.2002.00311.x; Azuma YT, 2010, INFLAMM BOWEL DIS, V16, P1017, DOI 10.1002/ibd.21151; Coca SG, 2009, AM J KIDNEY DIS, V53, P961, DOI 10.1053/j.ajkd.2008.11.034; Dai CS, 2003, J BIOL CHEM, V278, P12537, DOI 10.1074/jbc.M300777200; Deng JP, 2004, AM J RESP CRIT CARE, V169, P749, DOI 10.1164/rccm.200303-372OC; Deng JP, 2001, KIDNEY INT, V60, P2118, DOI 10.1046/j.1523-1755.2001.00043.x; Devarajan P, 2006, J AM SOC NEPHROL, V17, P1503, DOI 10.1681/ASN.2006010017; Dumoutier L, 2001, J IMMUNOL, V167, P3545, DOI 10.4049/jimmunol.167.7.3545; Franke TF, 1997, CELL, V88, P435, DOI 10.1016/S0092-8674(00)81883-8; Gabunia K, 2011, AM J PHYSIOL-CELL PH, V300, pC896, DOI 10.1152/ajpcell.00439.2010; Gallagher G, 2000, GENES IMMUN, V1, P442, DOI 10.1038/sj.gene.6363714; Golab F, 2009, KIDNEY INT, V75, P783, DOI 10.1038/ki.2008.683; HAY ED, 1995, AM J KIDNEY DIS, V26, P678, DOI 10.1016/0272-6386(95)90610-X; Hoke TS, 2007, J AM SOC NEPHROL, V18, P155, DOI 10.1681/ASN.2006050494; Hsing CH, 2008, SHOCK, V29, P7, DOI 10.1097/shk.0b013e318067de40; Hsing CH, 2006, ANN THORAC SURG, V81, P2196, DOI 10.1016/j.athoracsur.2006.01.092; Hsu YH, 2012, RHEUMATOLOGY, V51, P434, DOI 10.1093/rheumatology/ker127; Hsu YH, 2011, J EXP MED, V208, P1849, DOI 10.1084/jem.20102234; Jiang J, 2004, TOXICOL SCI, V80, P170, DOI 10.1093/toxsci/kfh143; Jordan WJ, 2005, EUR J IMMUNOL, V35, P1576, DOI 10.1002/eji.200425317; Kelly KJ, 2003, J AM SOC NEPHROL, V14, P1549, DOI 10.1097/01.ASN.0000064946.94590.46; Kim YK, 2005, J APPL TOXICOL, V25, P374, DOI 10.1002/jat.1081; Kramer AA, 1999, KIDNEY INT, V55, P2362, DOI 10.1046/j.1523-1755.1999.00460.x; Kunduzova OR, 2002, FASEB J, V16, P1129, DOI 10.1096/fj.01-1008fje; Lee DW, 2011, CLIN NEPHROL, V76, P165, DOI 10.5414/CN106921; Li HH, 2008, GENES IMMUN, V9, P395, DOI 10.1038/gene.2008.28; Li HH, 2005, BRIT J DERMATOL, V153, P591, DOI 10.1111/j.1365-2133.2005.06665.x; Liao SC, 2004, J IMMUNOL, V173, P6712, DOI 10.4049/jimmunol.173.11.6712; Liao YC, 2002, J IMMUNOL, V169, P4288, DOI 10.4049/jimmunol.169.8.4288; Nguyen HT, 2006, NEPHRON EXP NEPHROL, V102, P49, DOI 10.1159/000088401; Okusa MD, 2002, NEPHRON, V90, P133, DOI 10.1159/000049032; Pecoits R, 2005, PEDIATR NEPHROL, V20, P714, DOI 10.1007/s00467-005-1891-z; Pestka S, 2004, ANNU REV IMMUNOL, V22, P929, DOI 10.1146/annurev.immunol.22.012703.104622; Rabb H, 2003, KIDNEY INT, V63, P600, DOI 10.1046/j.1523-1755.2003.00753.x; Rana A, 2001, APOPTOSIS, V6, P83, DOI 10.1023/A:1009680229931; Saperstein S, 2009, J INTERF CYTOK RES, V29, P273, DOI 10.1089/jir.2008.0076; Serteser M, 2002, J SURG RES, V107, P234, DOI 10.1006/jsre.2002.6513; Wang XD, 2002, DIABETES, V51, P3505, DOI 10.2337/diabetes.51.12.3505; Wei CC, 2008, BIOCHEM BIOPH RES CO, V374, P448, DOI 10.1016/j.bbrc.2008.07.039; Wong VY, 2001, EUR J PHARMACOL, V433, P135, DOI 10.1016/S0014-2999(01)01517-5; Yadav N, 2012, INDIAN J MED RES, V136, P211; Zhuang SG, 2007, AM J PHYSIOL-RENAL, V292, pF440, DOI 10.1152/ajprenal.00170.2006	43	24	30	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2013	8	2							e56028	10.1371/journal.pone.0056028	http://dx.doi.org/10.1371/journal.pone.0056028			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098PO	23468852	Green Published, Green Submitted, gold			2022-12-25	WOS:000315561400006
J	Hong, SB; Zalesky, A; Cocchi, L; Fornito, A; Choi, EJ; Kim, HH; Suh, JE; Kim, CD; Kim, JW; Yi, SH				Hong, Soon-Beom; Zalesky, Andrew; Cocchi, Luca; Fornito, Alex; Choi, Eun-Jung; Kim, Ho-Hyun; Suh, Jeong-Eun; Kim, Chang-Dai; Kim, Jae-Won; Yi, Soon-Hyung			Decreased Functional Brain Connectivity in Adolescents with Internet Addiction	PLOS ONE			English	Article							GRAPH-THEORETICAL ANALYSIS; SPONTANEOUS FLUCTUATIONS; PREFRONTAL CORTEX; BASAL GANGLIA; NETWORKS; SCHIZOPHRENIA; FMRI; DISORDER; DURATION; TOOLBOX	Background: Internet addiction has become increasingly recognized as a mental disorder, though its neurobiological basis is unknown. This study used functional neuroimaging to investigate whole-brain functional connectivity in adolescents diagnosed with internet addiction. Based on neurobiological changes seen in other addiction related disorders, it was predicted that connectivity disruptions in adolescents with internet addiction would be most prominent in cortico-striatal circuitry. Methods: Participants were 12 adolescents diagnosed with internet addiction and 11 healthy comparison subjects. Resting-state functional magnetic resonance images were acquired, and group differences in brain functional connectivity were analyzed using the network-based statistic. We also analyzed network topology, testing for between-group differences in key graph-based network measures. Results: Adolescents with internet addiction showed reduced functional connectivity spanning a distributed network. The majority of impaired connections involved cortico-subcortical circuits (similar to 24% with prefrontal and similar to 27% with parietal cortex). Bilateral putamen was the most extensively involved subcortical brain region. No between-group difference was observed in network topological measures, including the clustering coefficient, characteristic path length, or the small-worldness ratio. Conclusions: Internet addiction is associated with a widespread and significant decrease of functional connectivity in cortico-striatal circuits, in the absence of global changes in brain functional network topology.	[Hong, Soon-Beom; Zalesky, Andrew; Fornito, Alex] Univ Melbourne & Melbourne Hlth, Dept Psychiat, Melbourne Neuropsychiat Ctr, Parkville, Vic, Australia; [Hong, Soon-Beom] Florey Inst Neurosci & Mental Hlth, Parkville, Vic, Australia; [Hong, Soon-Beom; Kim, Jae-Won] Seoul Natl Univ, Coll Med, Dept Psychiat, Div Child & Adolescent Psychiat, Seoul, South Korea; [Cocchi, Luca] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia; [Fornito, Alex] Univ Melbourne, Ctr Neural Engn, Parkville, Vic 3052, Australia; [Fornito, Alex] Univ Melbourne, NICTA Victorian Res Lab, Parkville, Vic 3052, Australia; [Choi, Eun-Jung; Yi, Soon-Hyung] Seoul Natl Univ, Dept Child Dev & Family Studies, Coll Human Ecol, Seoul, South Korea; [Kim, Ho-Hyun] Seoul Natl Univ, Coll Educ, Interdisciplinary Program Early Childhood Educ Ma, Seoul, South Korea; [Suh, Jeong-Eun] Seoul Natl Univ, Ctr Campus Life & Culture, Seoul, South Korea; [Kim, Chang-Dai] Seoul Natl Univ, Dept Educ Educ Counseling Major, Coll Educ, Seoul, South Korea	University of Melbourne; Florey Institute of Neuroscience & Mental Health; Seoul National University (SNU); University of Queensland; University of Melbourne; University of Melbourne; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Yi, SH (corresponding author), Seoul Natl Univ, Dept Child Dev & Family Studies, Coll Human Ecol, Seoul, South Korea.	ysh@snu.ac.kr	Cocchi, Luca/G-7611-2011; Alex, Fornito/N-8214-2013; Cocchi, Luca/AAC-3337-2019	Cocchi, Luca/0000-0003-3651-2676; Alex, Fornito/0000-0001-9134-480X; Cocchi, Luca/0000-0003-3651-2676; ZALESKY, ANDREW/0000-0003-2298-9908	Seoul National University Brain Fusion Program Research Fund; National Research Foundation of Korea grant (Global Internship Program); Korean government; National Health and Medical Research Council CJ Martin Fellowship [454797]	Seoul National University Brain Fusion Program Research Fund; National Research Foundation of Korea grant (Global Internship Program); Korean government(Korean Government); National Health and Medical Research Council CJ Martin Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the Seoul National University Brain Fusion Program Research Fund. SBH was supported by a National Research Foundation of Korea grant (Global Internship Program) funded by the Korean government. AF was supported by a National Health and Medical Research Council CJ Martin Fellowship (ID: 454797). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JS, 2011, CEREB CORTEX, V21, P1134, DOI 10.1093/cercor/bhq190; Bassett DS, 2011, TRENDS COGN SCI, V15, P200, DOI 10.1016/j.tics.2011.03.006; Bassett DS, 2009, CURR OPIN NEUROL, V22, P340, DOI 10.1097/WCO.0b013e32832d93dd; Block JJ, 2008, AM J PSYCHIAT, V165, P306, DOI 10.1176/appi.ajp.2007.07101556; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Choi JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045938; Christakis DA, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-61; Clarke AR, 2008, INT J PSYCHOPHYSIOL, V67, P35, DOI 10.1016/j.ijpsycho.2007.10.001; Cocchi L, 2012, J NEUROSCI, V32, P17753, DOI 10.1523/JNEUROSCI.3272-12.2012; Cole DM, 2012, CEREB CORTEX; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; De Havas JA, 2012, NEUROIMAGE, V59, P1745, DOI 10.1016/j.neuroimage.2011.08.026; Di X, 2012, BRAIN CONNECT, V2, P225, DOI 10.1089/brain.2011.0050; Dong GH, 2011, J PSYCHIATR RES, V45, P1525, DOI 10.1016/j.jpsychires.2011.06.017; Duan XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032532; Fletcher P, 1999, NEUROIMAGE, V9, P337, DOI 10.1006/nimg.1998.0411; Flisher C, 2010, J PAEDIATR CHILD H, V46, P557, DOI 10.1111/j.1440-1754.2010.01879.x; Fornito A, 2012, NEUROIMAGE, V62, P2296, DOI 10.1016/j.neuroimage.2011.12.090; Fornito Alex, 2012, Front Psychiatry, V3, P32, DOI 10.3389/fpsyt.2012.00032; Fornito A, 2011, BIOL PSYCHIAT, V70, P64, DOI 10.1016/j.biopsych.2011.02.019; Fornito A, 2011, J NEUROSCI, V31, P3261, DOI 10.1523/JNEUROSCI.4858-10.2011; Fornito A, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00022; Fornito A, 2010, CURR OPIN PSYCHIATR, V23, P239, DOI 10.1097/YCO.0b013e328337d78d; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Fox MD, 2006, P NATL ACAD SCI USA, V103, P10046, DOI 10.1073/pnas.0604187103; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Glahn DC, 2010, P NATL ACAD SCI USA, V107, P1223, DOI 10.1073/pnas.0909969107; Goldstein RZ, 2011, NAT REV NEUROSCI, V12, P652, DOI 10.1038/nrn3119; Goldstein RZ, 2009, TRENDS COGN SCI, V13, P372, DOI 10.1016/j.tics.2009.06.004; Gong GL, 2011, NEUROSCIENTIST, V17, P575, DOI 10.1177/1073858410386492; Gordon EM, 2011, CEREB CORTEX; Guye M, 2010, MAGN RESON MATER PHY, V23, P409, DOI 10.1007/s10334-010-0205-z; Han DH, 2012, J PSYCHIATR RES, V46, P507, DOI 10.1016/j.jpsychires.2012.01.004; Han DH, 2010, CYBERPSYCH BEH SOC N, V13, P655, DOI 10.1089/cyber.2009.0327; Han DH, 2011, COMPR PSYCHIAT, V52, P88, DOI 10.1016/j.comppsych.2010.04.004; He Y, 2010, CURR OPIN NEUROL, V23, P341, DOI 10.1097/WCO.0b013e32833aa567; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; Hou HF, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/854524; JENKINS IH, 1994, J NEUROSCI, V14, P3775; Jueptner M, 1997, J NEUROPHYSIOL, V77, P1325, DOI 10.1152/jn.1997.77.3.1325; Kaufman J, 1997, J AM ACAD CHILD PSY, V36, P980, DOI 10.1097/00004583-199707000-00021; Kelly C, 2011, BIOL PSYCHIAT, V69, P684, DOI 10.1016/j.biopsych.2010.11.022; Killgore WDS, 2012, NEUROREPORT, V23, P741, DOI 10.1097/WNR.0b013e3283565056; Kim SH, 2011, NEUROREPORT, V22, P407, DOI 10.1097/WNR.0b013e328346e16e; Kim YS, 2004, YONSEI MED J, V45, P81, DOI 10.3349/ymj.2004.45.1.81; Ko CH, 2012, EUR PSYCHIAT, V27, P1, DOI 10.1016/j.eurpsy.2010.04.011; Ko CH, 2009, J PSYCHIATR RES, V43, P739, DOI 10.1016/j.jpsychires.2008.09.012; Lehericy S, 2006, CEREB CORTEX, V16, P149, DOI 10.1093/cercor/bhi089; Lin FC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030253; Liu J, 2010, CHINESE MED J-PEKING, V123, P1904, DOI 10.3760/cma.j.issn.0366-6999.2010.14.014; Lynall ME, 2010, J NEUROSCI, V30, P9477, DOI 10.1523/JNEUROSCI.0333-10.2010; Ma LS, 2011, NEUROIMAGE, V58, P226, DOI 10.1016/j.neuroimage.2011.06.014; Martinez K, 2012, HUM BRAIN MAPP; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Naqvi NH, 2010, BRAIN STRUCT FUNCT, V214, P435, DOI 10.1007/s00429-010-0268-7; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Pettigrew JD, 1998, P ROY SOC B-BIOL SCI, V265, P2141, DOI 10.1098/rspb.1998.0551; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Ralchle ME, 2007, NEUROIMAGE, V37, P1083, DOI 10.1016/j.neuroimage.2007.02.041; Rieckmann A, 2011, J NEUROSCI, V31, P14284, DOI 10.1523/JNEUROSCI.3114-11.2011; ROLAND PE, 1982, J NEUROPHYSIOL, V48, P467, DOI 10.1152/jn.1982.48.2.467; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Shaw M, 2008, CNS DRUGS, V22, P353, DOI 10.2165/00023210-200822050-00001; Shehzad Z, 2009, CEREB CORTEX, V19, P2209, DOI 10.1093/cercor/bhn256; SHIBASAKI H, 1993, BRAIN, V116, P1387, DOI 10.1093/brain/116.6.1387; Smith SM, 2012, P NATL ACAD SCI USA, V109, P3131, DOI 10.1073/pnas.1121329109; Spencer KM, 2003, J NEUROSCI, V23, P7407; Sutherland MT, 2012, NEUROIMAGE, V62, P2281, DOI 10.1016/j.neuroimage.2012.01.117; Tomasi D, 2012, CRIT REV BIOCHEM MOL; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Volkow ND, 2003, J CLIN INVEST, V111, P1444, DOI 10.1172/JCI200318533; Wang JH, 2009, HUM BRAIN MAPP, V30, P1511, DOI 10.1002/hbm.20623; Whitfield-Gabrieli S, 2009, P NATL ACAD SCI USA, V106, P1279, DOI 10.1073/pnas.0809141106; Widyanto L, 2004, CYBERPSYCHOL BEHAV, V7, P443, DOI 10.1089/cpb.2004.7.443; Wig GS, 2011, ANN NY ACAD SCI, V1224, P126, DOI 10.1111/j.1749-6632.2010.05947.x; Wilke M, 2008, NEUROIMAGE, V41, P903, DOI 10.1016/j.neuroimage.2008.02.056; Xia MR, 2011, BRAIN CONNECT, V1, P349, DOI 10.1089/brain.2011.0062; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Yuan Kai, 2011, Commun Integr Biol, V4, P637; Yuan K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020708; Yuan K, 2010, NEUROSCI LETT, V482, P101, DOI 10.1016/j.neulet.2010.07.005; Yuan K, 2010, NEUROSCI LETT, V477, P37, DOI 10.1016/j.neulet.2010.04.032; Zalesky A, 2012, NEUROIMAGE, V60, P1055, DOI 10.1016/j.neuroimage.2012.01.068; Zalesky A, 2010, NEUROIMAGE, V53, P1197, DOI 10.1016/j.neuroimage.2010.06.041; Zalesky A, 2010, NEUROIMAGE, V50, P970, DOI 10.1016/j.neuroimage.2009.12.027; Zhou Y, 2011, EUR J RADIOL, V79, P92, DOI 10.1016/j.ejrad.2009.10.025; Zhou Y, 2007, SCHIZOPHR RES, V97, P194, DOI 10.1016/j.schres.2007.05.029	88	103	108	0	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57831	10.1371/journal.pone.0057831	http://dx.doi.org/10.1371/journal.pone.0057831			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	115ZB	23451272	gold, Green Published			2022-12-25	WOS:000316849500137
J	Zanet, DL; Saberi, S; Oliveira, L; Sattha, B; Gadawski, I; Cote, HCF				Zanet, DeAnna L.; Saberi, Sara; Oliveira, Laura; Sattha, Beheroze; Gadawski, Izabella; Cote, Helene C. F.			Blood and Dried Blood Spot Telomere Length Measurement by qPCR: Assay Considerations	PLOS ONE			English	Article							HEMATOLOGICAL PARAMETERS; SAMPLE COLLECTION; QUANTITATIVE PCR; VENOUS-BLOOD; DNA; CAPILLARY; STABILITY; DISEASE; QUALITY; STORAGE	Measurement of telomere length is crucial for the study of telomere maintenance and its role in molecular pathophysiology of diseases and in aging. Several methods are used to measure telomere length, the choice of which usually depends on the type and size of sample to be assayed, as well as cost and throughput considerations. The goal of this study was to investigate the factors that may influence the reliability of qPCR-based relative telomere length measurements in whole blood. Day to day intra-individual variability, types of blood anticoagulant, sample storage conditions, processing and site of blood draw were investigated. Two qPCR-based methods to measure telomere length (monoplex vs. multiplex) were also investigated and showed a strong correlation between them. Freezing and thawing of the blood and storage of the blood at 4 degrees C for up to 4 days did not affect telomere length values. Telomere lengths in dried blood spots were significantly higher than both whole blood and peripheral mononuclear blood cells, and were highly correlated with both. We found that telomere length measurements were significantly higher in dried blood spots collected directly from fingertip prick compared to dried blood spots prepared with anticoagulated whole blood collected from the finger, and non-blotted whole blood taken from both finger and arm venipuncture. This suggests that DNA from cells blotted on paper is not equivalent to that collected from venipuncture whole blood, and caution should be taken when comparing between blood sample types.	[Zanet, DeAnna L.; Saberi, Sara; Oliveira, Laura; Sattha, Beheroze; Gadawski, Izabella; Cote, Helene C. F.] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada	University of British Columbia	Cote, HCF (corresponding author), Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada.	helene.cote@ubc.ca	Cote, Helene/K-7896-2012		CIHR [HET-85515, YSH-80511]; CFI-New Opportunity [10427]	CIHR(Canadian Institutes of Health Research (CIHR)); CFI-New Opportunity	This research was supported in part by a CIHR emerging team grant in HIV therapy and aging (to HCFC), (#HET-85515). HCFC was partially supported by a CIHR New Investigator award (YSH-80511) and a CFI-New Opportunity (#10427). http://www.cihr-irsc.gc.ca/e/193.html https://www2.innovation.ca/pls/fci/fcienrep.base. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aubert G, 2008, PHYSIOL REV, V88, P557, DOI 10.1152/physrev.00026.2007; Aubert G, 2012, MUTAT RES-FUND MOL M, V730, P59, DOI 10.1016/j.mrfmmm.2011.04.003; Aviv A., 2011, NUCL ACIDS RES, V39; Baerlocher GM, 2006, NAT PROTOC, V1, P2365, DOI 10.1038/nprot.2006.263; BLACKBURN EH, 1991, NATURE, V350, P569, DOI 10.1038/350569a0; Blasco MA, 2005, NAT REV GENET, V6, P611, DOI 10.1038/nrg1656; Cawthon RM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn1027; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; DAAE LNW, 1988, SCAND J CLIN LAB INV, V48, P723, DOI 10.3109/00365518809085796; DAAE LNW, 1991, SCAND J CLIN LAB INV, V51, P651, DOI 10.3109/00365519109104576; Farzaneh-Far R, 2008, ARTERIOSCL THROM VAS, V28, P1379, DOI 10.1161/ATVBAHA.108.167049; Fazili Z, 2012, CLIN CHIM ACTA, V413, P966, DOI 10.1016/j.cca.2012.02.003; Gadalla SM, 2010, AGING-US, V2, P867, DOI 10.18632/aging.100235; Halfon P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033000; Halsall A, 2008, INT J EPIDEMIOL, V37, P7, DOI 10.1093/ije/dym278; Holland NT, 2005, TOXICOL APPL PHARM, V206, P261, DOI 10.1016/j.taap.2004.10.024; Holland NT, 2003, MUTAT RES-REV MUTAT, V543, P217, DOI 10.1016/S1383-5742(02)00090-X; Imam T, 2012, JAIDS-J ACQ IMM DEF, V60, P495, DOI 10.1097/QAI.0b013e31825aa89c; Kayiran SM, 2003, CLIN LAB HAEMATOL, V25, P9, DOI 10.1046/j.1365-2257.2003.00484.x; Kimura M, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr235; Kume K, 2012, EUR J NEUROL, V19, P905, DOI 10.1111/j.1468-1331.2011.03655.x; Lauzon W, 2000, CYTOMETRY, V42, P159, DOI 10.1002/1097-0320(20000615)42:3<159::AID-CYTO1>3.0.CO;2-9; Lee J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035567; Mas S, 2007, BASIC CLIN PHARMACOL, V101, P132, DOI 10.1111/j.1742-7843.2007.00089.x; Mirabello L, 2010, CANCER CAUSE CONTROL, V21, P77, DOI 10.1007/s10552-009-9436-6; Neidle S, 2003, CURR OPIN STRUC BIOL, V13, P275, DOI 10.1016/S0959-440X(03)00072-1; Oeseburg H, 2010, PFLUG ARCH EUR J PHY, V459, P259, DOI 10.1007/s00424-009-0728-1; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Schalk E, 2007, VOX SANG, V93, P348, DOI 10.1111/j.1423-0410.2007.00978.x; Visvikis S, 1998, CLIN CHEM LAB MED, V36, P551, DOI 10.1515/CCLM.1998.094; Xu Y, 2011, CHEM SOC REV, V40, P2719, DOI 10.1039/c0cs00134a; Yang ZW, 2001, CLIN LAB HAEMATOL, V23, P155, DOI 10.1046/j.1365-2257.2001.00388.x	32	53	55	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57787	10.1371/journal.pone.0057787	http://dx.doi.org/10.1371/journal.pone.0057787			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451268	Green Published, Green Submitted, gold			2022-12-25	WOS:000316849500133
J	Faucher, CP; Hilker, M; de Bruyne, M				Faucher, Cecile P.; Hilker, Monika; de Bruyne, Marien			Interactions of Carbon Dioxide and Food Odours in Drosophila: Olfactory Hedonics and Sensory Neuron Properties	PLOS ONE			English	Article							AVOIDANCE-BEHAVIOR; RECEPTOR NEURONS; SEX-PHEROMONE; FLORAL CO2; RESPONSES; MELANOGASTER; ATTRACTION; MODULATION; CHEMICALS; SENSILLA	Behavioural responses of animals to volatiles in their environment are generally dependent on context. Most natural odours are mixtures of components that can each induce different behaviours when presented on their own. We have investigated how a complex of two olfactory stimuli is evaluated by Drosophila flies in a free-flying two-trap choice assay and how these stimuli are encoded in olfactory receptor neurons. We first observed that volatiles from apple cider vinegar attracted flies while carbon dioxide (CO2) was avoided, confirming their inherent positive and negative values. In contradiction with previous results obtained from walking flies in a four-field olfactometer, in the present assay the addition of CO2 to vinegar increased rather than decreased the attractiveness of vinegar. This effect was female-specific even though males and females responded similarly to CO2 and vinegar on their own. To test whether the female-specific behavioural response to the mixture correlated with a sexual dimorphism at the peripheral level we recorded from olfactory receptor neurons stimulated with vinegar, CO2 and their combination. Responses to vinegar were obtained from three neuron classes, two of them housed with the CO2-responsive neuron in ab1 sensilla. Sensitivity of these neurons to both CO2 and vinegar per se did not differ between males and females and responses from female neurons did not change when CO2 and vinegar were presented simultaneously. We also found that CO2-sensitive neurons are particularly well adapted to respond rapidly to small concentration changes irrespective of background CO2 levels. The ability to encode temporal properties of stimulations differs considerably between CO2- and vinegar-sensitive neurons. These properties may have important implications for in-flight navigation when rapid responses to fragmented odour plumes are crucial to locate odour sources. However, the flies' sex-specific response to the CO2-vinegar combination and the context-dependent hedonics most likely originate from central rather than peripheral processing.	[Faucher, Cecile P.; de Bruyne, Marien] Free Univ Berlin, Inst Biol Neurobiol, Berlin, Germany; [Hilker, Monika] Free Univ Berlin, Inst Biol Appl Zool, Berlin, Germany	Free University of Berlin; Free University of Berlin	de Bruyne, M (corresponding author), Monash Univ, Sch Biol Sci, Clayton, Vic, Australia.	Marien.DeBruijne@monash.au	Faucher, Cecile P/E-6908-2010		German Research Foundation DFG Graduiertenkolleg [837]	German Research Foundation DFG Graduiertenkolleg(German Research Foundation (DFG))	Funding was provided by the German Research Foundation (www.dfg.de) DFG Graduiertenkolleg 837. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becher PG, 2010, J CHEM ECOL, V36, P599, DOI 10.1007/s10886-010-9794-2; BELL WJ, 1990, ANNU REV ENTOMOL, V35, P447, DOI 10.1146/annurev.en.35.010190.002311; Bhandawat V, 2010, J EXP BIOL, V213, P3625, DOI 10.1242/jeb.040402; Bodin A, 2008, J INSECT PHYSIOL, V54, P1343, DOI 10.1016/j.jinsphys.2008.07.004; Bodin A, 2009, J EXP BIOL, V212, P2386, DOI 10.1242/jeb.030668; Bruce TJA, 2011, PHYTOCHEMISTRY, V72, P1605, DOI 10.1016/j.phytochem.2011.04.011; Budick SA, 2006, J EXP BIOL, V209, P3001, DOI 10.1242/jeb.02305; Cachero S, 2010, CURR BIOL, V20, P1589, DOI 10.1016/j.cub.2010.07.045; de Bruyne M, 1999, J NEUROSCI, V19, P4520; de Bruyne M, 2001, NEURON, V30, P537, DOI 10.1016/S0896-6273(01)00289-6; Dekker T, 2005, J EXP BIOL, V208, P2963, DOI 10.1242/jeb.01736; DETHIER VG, 1960, J ECON ENTOMOL, V53, P134, DOI 10.1093/jee/53.1.134; Devaud JM, 2003, BEHAV PROCESS, V64, P177, DOI 10.1016/S0376-6357(03)00134-7; Duistermars BJ, 2009, CURR BIOL, V19, P1301, DOI 10.1016/j.cub.2009.06.022; Faucher C, 2006, J EXP BIOL, V209, P2739, DOI 10.1242/jeb.02297; Fischler W, 2007, NATURE, V448, P1054, DOI 10.1038/nature06101; Furukawa S, 2004, ADV EXP MED BIOL, V542, P251; Goyret J, 2008, P NATL ACAD SCI USA, V105, P4565, DOI 10.1073/pnas.0708629105; GRANT AJ, 1995, J COMP PHYSIOL A, V177, P389, DOI 10.1007/BF00187475; Guerenstein PG, 2008, ANNU REV ENTOMOL, V53, P161, DOI 10.1146/annurev.ento.53.103106.093402; HOFFMANN AA, 1985, AUST J ZOOL, V33, P451, DOI 10.1071/ZO9850451; Jones WD, 2007, NATURE, V445, P86, DOI 10.1038/nature05466; Krishnan P, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-62; Kwon JY, 2007, P NATL ACAD SCI USA, V104, P3574, DOI 10.1073/pnas.0700079104; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Lebreton S, 2012, J INSECT PHYSIOL, V58, P125, DOI 10.1016/j.jinsphys.2011.10.009; Nagel KI, 2011, NAT NEUROSCI, V14, P208, DOI 10.1038/nn.2725; Nikonov AA, 2002, J CHEM ECOL, V28, P1075, DOI 10.1023/A:1015274104626; Ochieng SA, 2002, J COMP PHYSIOL A, V188, P325, DOI 10.1007/s00359-002-0308-8; Park SK, 2002, J NEUROBIOL, V51, P248, DOI 10.1002/neu.10057; Partridge L, 2005, MECH AGEING DEV, V126, P938, DOI 10.1016/j.mad.2005.03.023; Poon PC, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000356; Riffell JA, 2012, CURR OPIN NEUROBIOL, V22, P236, DOI 10.1016/j.conb.2012.02.013; Root CM, 2011, CELL, V145, P133, DOI 10.1016/j.cell.2011.02.008; Ruebenbauer A, 2008, CURR BIOL, V18, P1438, DOI 10.1016/j.cub.2008.08.062; Ruta V, 2010, NATURE, V468, P686, DOI 10.1038/nature09554; Sachse S, 2007, NEURON, V56, P838, DOI 10.1016/j.neuron.2007.10.035; Schroeder R, 2008, BIOSCIENCE, V58, P308, DOI 10.1641/B580406; Scott K, 2001, CELL, V104, P661, DOI 10.1016/S0092-8674(02)02052-4; Semmelhack JL, 2009, NATURE, V459, P218, DOI 10.1038/nature07983; SPIETH HT, 1974, ANNU REV ENTOMOL, V19, P385, DOI 10.1146/annurev.en.19.010174.002125; STANGE G, 1995, OECOLOGIA, V102, P341, DOI 10.1007/BF00329801; Stange G., 1996, Advances in Bioclimatology, V4, P223; Steck K, 2012, SCI REP-UK, V2, DOI 10.1038/srep00361; Su CY, 2011, P NATL ACAD SCI USA, V108, P5075, DOI 10.1073/pnas.1100369108; Suh GSB, 2007, CURR BIOL, V17, P905, DOI 10.1016/j.cub.2007.04.046; Suh GSB, 2004, NATURE, V431, P854, DOI 10.1038/nature02980; Syed Z, 2007, CHEM SENSES, V32, P727, DOI 10.1093/chemse/bjm040; Tanaka NK, 2012, J COMP NEUROL, V520, P4067, DOI 10.1002/cne.23142; Thom C, 2004, J CHEM ECOL, V30, P1285, DOI 10.1023/B:JOEC.0000030298.77377.7d; Tinette S, 2004, GENES BRAIN BEHAV, V3, P39, DOI 10.1046/j.1601-183x.2003.0046.x; TULLY T, 1985, J COMP PHYSIOL A, V157, P263, DOI 10.1007/BF01350033; Turner SL, 2009, NATURE, V461, P277, DOI 10.1038/nature08295; Vosshall LB, 2011, CHEM SENSES, V36, P497, DOI 10.1093/chemse/bjr022; WILLIS ER, 1952, J EXP ZOOL, V121, P149, DOI 10.1002/jez.1401210107; Wilson RI, 2006, ANNU REV NEUROSCI, V29, P163, DOI 10.1146/annurev.neuro.29.051605.112950; Zhu JW, 2003, J CHEM ECOL, V29, P899, DOI 10.1023/A:1022931816351; Zollner GE, 2004, PHYSIOL ENTOMOL, V29, P381, DOI 10.1111/j.0307-6962.2004.00399.x	58	37	38	0	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56361	10.1371/journal.pone.0056361	http://dx.doi.org/10.1371/journal.pone.0056361			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457557	Green Published, gold, Green Submitted			2022-12-25	WOS:000315603700045
J	Pyrgos, V; Seitz, AE; Steiner, CA; Prevots, DR; Williamson, PR				Pyrgos, Vasilios; Seitz, Amy E.; Steiner, Claudia A.; Prevots, D. Rebecca; Williamson, Peter R.			Epidemiology of Cryptococcal Meningitis in the US: 1997-2009	PLOS ONE			English	Article							CLINICAL-PRACTICE GUIDELINES; INFECTIOUS-DISEASES SOCIETY; ACTIVE SURVEILLANCE; NEOFORMANS; UPDATE; MANAGEMENT; MYCOSES; GATTII; HAART; ERA	Cryptococcal meningitis (CM) causes significant morbidity and mortality globally; however, recent national trends have not been described. Incidence and trends for CM-associated hospitalizations in 18 states were estimated using the Agency for Healthcare and Research Quality (AHRQ) State Inpatient Databases (SID) datasets for 1997 through 2009. We identified 30,840 hospitalizations coded for CM, of which 21.6% were among HIV-uninfected patients. CM in-hospital mortality was significant (12.4% for women and 10.8% for men) with a total of 3,440 deaths over the study period. Co-morbidities of CM coded at increased frequency in HIV-uninfected CM hospitalized populations included hydrocephalus and acute/chronic renal failure as well as possible predispositions including transplantation, combined T and B cell defects, Cushing's syndrome, liver disease and hypogammaglobulinemia. Median hospitalization costs were significant for CM and higher for HIV-uninfected patients (16,803.01 vs. 15,708.07; p<0.0001). Cryptococcal meningitis remains a disease with significant morbidity and mortality in the U.S. and the relative burden among persons without HIV infection is increasing.	[Pyrgos, Vasilios; Seitz, Amy E.; Prevots, D. Rebecca; Williamson, Peter R.] NIAID, Lab Clin Infect Dis, NIH, Bethesda, MD 20892 USA; [Steiner, Claudia A.] Agcy Healthcare Res & Qual, Ctr Delivery Org & Markets, Healthcare Cost & Utilizat Project, Rockville, MD USA; [Williamson, Peter R.] Univ Chicago, Dept Med, Chicago Coll Med, Infect Dis Sect, Chicago, IL 60637 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Agency for Healthcare Research & Quality; University of Chicago	Williamson, PR (corresponding author), NIAID, Lab Clin Infect Dis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	williamsonpr@mail.nih.gov		Prevots, D Rebecca/0000-0003-0339-9873	Intramural Research Program of the National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001124] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the Intramural Research Program of the National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional outside funding was obtained.	Adjemian J, 2012, AM J RESP CRIT CARE, V185, P881, DOI 10.1164/rccm.201111-2016OC; Baddley JW, 2008, EUR J CLIN MICROBIOL, V27, P937, DOI 10.1007/s10096-008-0529-z; Battal B, 2011, BRIT J RADIOL, V84, P758, DOI 10.1259/bjr/66206791; Baumgardner DJ, 2004, WILD ENVIRON MED, V15, P250, DOI 10.1580/1080-6032(2004)015[0250:SOPBNW]2.0.CO;2; Bonnet F, 2005, SCAND J INFECT DIS, V37, P482, DOI 10.1080/00365540510035328; Bratton EW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043582; Byrnes EJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005851; Chang DC, 2008, INFECT CONT HOSP EP, V29, P25, DOI 10.1086/524324; Chayakulkeeree M, 2006, INFECT DIS CLIN N AM, V20, P507, DOI 10.1016/j.idc.2006.07.001; Chen S, 2000, CLIN INFECT DIS, V31, P499, DOI 10.1086/313992; Chetchotisakd P, 2004, HIV MED, V5, P140, DOI 10.1111/j.1468-1293.2004.00201.x; Chu JH, 2006, CLIN INFECT DIS, V42, P822, DOI 10.1086/500405; De Pauw B, 2008, CLIN INFECT DIS, V46, P1813, DOI 10.1086/588660; Dromer F, 2004, AIDS, V18, P555, DOI 10.1097/00002030-200402200-00024; EMMONS CW, 1955, AM J HYG, V62, P227, DOI 10.1093/oxfordjournals.aje.a119775; Fisher ES, 2009, NEW ENGL J MED, V360, P849, DOI 10.1056/NEJMp0809794; Hajjeh RA, 1999, J INFECT DIS, V179, P449, DOI 10.1086/314606; Harris JR, 2011, CLIN INFECT DIS, V53, P1188, DOI 10.1093/cid/cir723; Hoang LMN, 2004, J MED MICROBIOL, V53, P935, DOI 10.1099/jmm.0.05427-0; Jiang H J, 2001, Jt Comm J Qual Improv, V27, P200; Joshi NS, 2010, PEDIATR INFECT DIS J, V29, pE91, DOI 10.1097/INF.0b013e3181fbc83d; Kaufman L, 1978, CRYPTOCOCCOSIS AWAKE, P176; Lindenauer PK, 2012, JAMA-J AM MED ASSOC, V307, P1405, DOI 10.1001/jama.2012.384; LITTMAN ML, 1968, MYCOPATH MYCOL APPL, V35, P329, DOI 10.1007/BF02050749; Lui G, 2006, QJM-INT J MED, V99, P143, DOI 10.1093/qjmed/hcl014; MANGHAM D, 1983, ARCH INTERN MED, V143, P728, DOI 10.1001/archinte.143.4.728; Mirza SA, 2003, CLIN INFECT DIS, V36, P789, DOI 10.1086/368091; MUKHERJEE J, 1993, P NATL ACAD SCI USA, V90, P3636, DOI 10.1073/pnas.90.8.3636; Pappas PG, 2009, CLIN INFECT DIS, V48, P503, DOI 10.1086/596757; Pappas PG, 2001, CLIN INFECT DIS, V33, P690, DOI 10.1086/322597; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; Park MK, 1999, CLIN INFECT DIS, V28, P629, DOI 10.1086/515161; Perfect JR, 2010, CLIN INFECT DIS, V50, P291, DOI 10.1086/649858; Rentz AM, 1998, CLIN INFECT DIS, V27, P781, DOI 10.1086/514955; Sickbert-Bennett EE, 2010, AM J EPIDEMIOL, V172, P1299, DOI 10.1093/aje/kwq285; Singh N, 2004, MEDICINE, V83, P188, DOI 10.1097/01.md.0000126760.45299.69; Subramaniam KS, 2010, J IMMUNOL, V184, P5755, DOI 10.4049/jimmunol.0901638; TRUELSEN K, 1992, INFECT IMMUN, V60, P3937, DOI 10.1128/IAI.60.9.3937-3939.1992; Walsh TJ, 1999, NEW ENGL J MED, V340, P764, DOI 10.1056/NEJM199903113401004; WYKE RJ, 1980, GUT, V21, P643, DOI 10.1136/gut.21.8.643; Zonios DI, 2007, MEDICINE, V86, P78, DOI 10.1097/md.0b013e31803b52f5	41	188	198	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56269	10.1371/journal.pone.0056269	http://dx.doi.org/10.1371/journal.pone.0056269			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457543	gold, Green Published, Green Submitted			2022-12-25	WOS:000315603700039
J	Maldonado, M; Kapphahn, RJ; Terluk, MR; Heuss, ND; Yuan, C; Gregerson, DS; Ferrington, DA				Maldonado, Marcela; Kapphahn, Rebecca J.; Terluk, Marcia R.; Heuss, Neal D.; Yuan, Ching; Gregerson, Dale S.; Ferrington, Deborah A.			Immunoproteasome Deficiency Modifies the Alternative Pathway of NF kappa B Signaling	PLOS ONE			English	Article							IN-VIVO; PROTEASOME; SUBUNIT; LMP2; ACTIVATION; MICE; CELLS; EXPRESSION; CROSSTALK; MUTATION	Immunoproteasome is a protease abundant in immune cells and also present, albeit at lower concentrations, in cells outside the immune system. Recent evidence supports a novel role for the immunoproteasome in the cellular stress response potentially through regulation of NF kappa B signaling, which is the primary response to multiple stressors. The current study tests whether the Classical or Alternative Pathways are regulated by immunoproteasome following chronic TNF alpha exposure in cultured retinal pigment epithelial cells isolated from wild-type mice and mice deficient in one (LMP2, L2) or two (LMP7 and MECL-1, L7M1) immunoproteasome subunits. Assays were performed to assess the expression of NF kappa B responsive genes, the content and activity of NF kappa B transcription factors (p65, p50, p52, cRel, RelB), and expression and content of regulatory proteins (I kappa B alpha, A20, RPS3). Major findings include distinct differences in expression of NF kappa B responsive genes in both KO cells. The mechanism responsible for the altered gene expression could not be established for L7M1 since no major differences in NF kappa B transcription factor content or activation were observed. However, L2 cells exhibited substantially higher content and diminished activation of NF kappa B transcription factors associated with the Alternative Pathway and delayed termination of the Classical Pathway. These results provide strong experimental evidence supporting a role for immunoproteasome in modulating NF kappa B signaling.	[Maldonado, Marcela; Kapphahn, Rebecca J.; Terluk, Marcia R.; Heuss, Neal D.; Yuan, Ching; Gregerson, Dale S.; Ferrington, Deborah A.] Univ Minnesota, Dept Ophthalmol & Visual Neurosci, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Ferrington, DA (corresponding author), Univ Minnesota, Dept Ophthalmol & Visual Neurosci, Minneapolis, MN 55455 USA.	ferri013@umn.edu		Ferrington, Deborah/0000-0003-2561-7464; Gregerson, Dale/0000-0001-5769-796X	National Institutes of Health (NIH) [EY013623, AG032391, EY016376, EY019552, P30-EY11374]; NIH T32 Training Grant [AG029796]; Research to Prevent Blindness, Inc., New York, NY; Minnesota Medical Foundation, Minnesota Lions and Lioness Clubs; NATIONAL EYE INSTITUTE [P30EY011374, R01EY013623, R01EY016376, R01EY021996, R21EY019552] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG029796, R21AG032391] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH T32 Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness, Inc., New York, NY(Research to Prevent Blindness (RPB)); Minnesota Medical Foundation, Minnesota Lions and Lioness Clubs; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by grants from the National Institutes of Health (NIH) (EY013623, AG032391 to DAF, EY016376 to DSG, EY019552 to CY, and P30-EY11374 Core Grant for Vision Research). MM was supported by an NIH T32 Training Grant AG029796. Additional support was through an unrestricted grant to the Department of Ophthalmology and Visual Neurosciences at the University of Minnesota from Research to Prevent Blindness, Inc., New York, NY; the Minnesota Medical Foundation, Minnesota Lions and Lioness Clubs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arima K, 2011, P NATL ACAD SCI USA, V108, P14914, DOI 10.1073/pnas.1106015108; Atkinson S, 2012, STEM CELLS; Basak S, 2008, CYTOKINE GROWTH F R, V19, P187, DOI 10.1016/j.cytogfr.2008.04.005; Basler M, 2006, J IMMUNOL, V176, P6665, DOI 10.4049/jimmunol.176.11.6665; Basler M, 2012, J IMMUNOL, V189, P1868, DOI 10.4049/jimmunol.1103592; Basler M, 2011, J IMMUNOL, V187, P5548, DOI 10.4049/jimmunol.1101064; Cai ZP, 2008, FASEB J, V22, P4248, DOI 10.1096/fj.08-105940; De M, 2003, J BIOL CHEM, V278, P6153, DOI 10.1074/jbc.M209292200; Ding QX, 2006, ANTIOXID REDOX SIGN, V8, P130, DOI 10.1089/ars.2006.8.130; Ebstein F, 2012, CELL MOL LIFE SCI, V69, P2543, DOI 10.1007/s00018-012-0938-0; Ethen CM, 2007, FEBS LETT, V581, P885, DOI 10.1016/j.febslet.2007.01.061; FEHLING HJ, 1994, SCIENCE, V265, P1234, DOI 10.1126/science.8066463; Ferrington DA, 2005, FASEB J, V19, P664, DOI 10.1096/fj.04-2578fje; Ferrington DA, 2008, J NEUROCHEM, V106, P158, DOI 10.1111/j.1471-4159.2008.05345.x; Ferrington DA, 2006, EXP EYE RES, V83, P638, DOI 10.1016/j.exer.2006.03.003; Ferrington DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054347; Ferrington DA, 2012, PROG MOL BIOL TRANSL, V109, P75, DOI 10.1016/B978-0-12-397863-9.00003-1; Fusco AJ, 2008, J BIOL CHEM, V283, P12324, DOI 10.1074/jbc.M707898200; Gavilan MP, 2009, J NEUROCHEM, V108, P260, DOI 10.1111/j.1471-4159.2008.05762.x; Gregerson DS, 2007, INVEST OPHTH VIS SCI, V48, P4654, DOI 10.1167/iovs.07-0286; Gregerson DS, 2006, INVEST OPHTH VIS SCI, V47, P5385, DOI 10.1167/iovs.06-0636; Griffin TA, 1998, J EXP MED, V187, P97, DOI 10.1084/jem.187.1.97; Groettrup M, 1997, P NATL ACAD SCI USA, V94, P8970, DOI 10.1073/pnas.94.17.8970; Hayashi T, 2000, J BIOL CHEM, V275, P5238, DOI 10.1074/jbc.275.7.5238; Hayashi T, 1999, MOL CELL BIOL, V19, P8646; Hayden MS, 2012, GENE DEV, V26, P203, DOI 10.1101/gad.183434.111; Heink S, 2005, P NATL ACAD SCI USA, V102, P9241, DOI 10.1073/pnas.0501711102; Hensley SE, 2010, J IMMUNOL, V184, P4115, DOI 10.4049/jimmunol.0903003; Heyninck K, 2005, TRENDS BIOCHEM SCI, V30, P1, DOI 10.1016/j.tibs.2004.11.001; Huber EM, 2012, CELL, V148, P727, DOI 10.1016/j.cell.2011.12.030; Hussong SA, 2011, INVEST OPHTH VIS SCI, V52, P714, DOI 10.1167/iovs.10-6032; Hussong SA, 2010, J NEUROCHEM, V113, P1481, DOI 10.1111/j.1471-4159.2010.06688.x; Jang ER, 2012, MOL BIOSYST, V8, P2295, DOI 10.1039/c2mb25125f; Kanazawa N, 2012, J DERMATOL SCI, V66, P183, DOI 10.1016/j.jdermsci.2012.01.004; Kessler BM, 2000, NAT MED, V6, P1064, DOI 10.1038/80346; Kincaid EZ, 2012, NAT IMMUNOL, V13, P129, DOI 10.1038/ni.2203; Kitamura A, 2011, J CLIN INVEST, V121, P4150, DOI 10.1172/JCI58414; Klare N, 2007, J MOL BIOL, V373, P1, DOI 10.1016/j.jmb.2007.07.038; Li J, 2011, J CLIN INVEST, V121, P3689, DOI 10.1172/JCI45709; Louie JL, 2002, EXP EYE RES, V75, P271, DOI 10.1006/exer.2002.2022; Malek R, 2007, PHARMACOL REP, V59, P25; Mishto M, 2006, NEUROBIOL AGING, V27, P54, DOI 10.1016/j.neurobiolaging.2004.12.004; NAUMANN M, 1994, EMBO J, V13, P4597, DOI 10.1002/j.1460-2075.1994.tb06781.x; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Pickering AM, 2012, ARCH BIOCHEM BIOPHYS, V523, P181, DOI 10.1016/j.abb.2012.04.018; Reis J, 2011, CELL BIOCHEM BIOPHYS, V60, P77, DOI 10.1007/s12013-011-9182-8; Runnels HA, 2000, NAT MED, V6, P1064, DOI 10.1038/80349; Saeki Y, 2012, METHODS MOL BIOL, V832, P315, DOI 10.1007/978-1-61779-474-2_22; Seifert U, 2010, CELL, V142, P613, DOI 10.1016/j.cell.2010.07.036; Siggers T, 2012, NAT IMMUNOL, V13, P95, DOI 10.1038/ni.2151; Smale ST, 2011, NAT IMMUNOL, V12, P689, DOI 10.1038/ni.2070; VANKAER L, 1994, IMMUNITY, V1, P533, DOI 10.1016/1074-7613(94)90043-4; Wan FY, 2007, CELL, V131, P927, DOI 10.1016/j.cell.2007.10.009; Zu LY, 2010, J MOL CELL CARDIOL, V49, P5, DOI 10.1016/j.yjmcc.2010.02.007	54	23	24	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56187	10.1371/journal.pone.0056187	http://dx.doi.org/10.1371/journal.pone.0056187			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457524	Green Published, gold, Green Submitted			2022-12-25	WOS:000315602700058
J	DiPatrizio, NV; Joslin, A; Jung, KM; Piomelli, D				DiPatrizio, Nicholas V.; Joslin, Alexandra; Jung, Kwang-Mook; Piomelli, Daniele			Endocannabinoid signaling in the gut mediates preference for dietary unsaturated fats	FASEB JOURNAL			English	Article						2-arachidonoyl-sn-glycerol; anandamide; taste; lipids	CANNABINOID CB1 RECEPTORS; LINOLEIC-ACID; CORN-OIL; CARDIOMETABOLIC RISK; OROSENSORY DETECTION; ENERGY-BALANCE; ADIPOSE-TISSUE; NEURAL-CONTROL; FEMALE RATS; OBESITY	Dietary fat exerts a potent stimulatory effect on feeding. This effect is mediated, at least in part, by a cephalic mechanism that involves recruitment of the vagus nerve and subsequent activation of endocannabinoid signaling in the gut. Here, we used a sham-feeding protocol in rats to identify fatty-acid constituents of dietary fat that might be responsible for triggering small-intestinal endocannabinoid signaling. Sham feeding rats with a corn oil emulsion increased endocannabinoid levels in jejunum, relative to animals that received either mineral oil (which contains no fatty acids) or no oil. Sham-feeding emulsions containing oleic acid (18:1) or linoleic acid (18:2) caused, on average, a nearly 2-fold accumulation of jejunal endocannabinoids, whereas emulsions containing stearic acid (18:0) or linolenic acid (18:3) had no such effect. In a 2-bottle-choice sham-feeding test, rats displayed strong preference for emulsions containing 18:2, which was blocked by pretreatment with the peripherally restricted CB1 cannabinoid receptor antagonists, AM6546 and URB447. Our results suggest that oral exposure to the monoenoic and dienoic fatty acid component of dietary fat selectively initiates endocannabinoid mobilization in the gut, and that this local signaling event is essential for fat preference.	[DiPatrizio, Nicholas V.; Joslin, Alexandra; Jung, Kwang-Mook; Piomelli, Daniele] Univ Calif Irvine, Sch Med, Dept Anat & Neurobiol, Irvine, CA 92697 USA; [Piomelli, Daniele] Univ Calif Irvine, Sch Med, Dept Pharmacol, Irvine, CA 92697 USA; [Piomelli, Daniele] Univ Calif Irvine, Sch Med, Dept Biol Chem, Irvine, CA 92697 USA; [Piomelli, Daniele] Ist Italiano Tecnol, Unit Drug Discovery & Dev, Genoa, Italy	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; Istituto Italiano di Tecnologia - IIT	Piomelli, D (corresponding author), Univ Calif Irvine, Sch Med, Gillespie Neurosci Res Facil 3103, Irvine, CA 92697 USA.	piomelli@uci.edu	DiPatrizio, NIcholas/AAV-1865-2021; Jung, Kwang-Mook/F-1035-2018	DiPatrizio, NIcholas/0000-0001-8423-0695; Jung, Kwang-Mook/0000-0003-4096-6953	U.S. National Institutes of Health [DK073955]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073955] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Joe Gancayco, Conor Murray, Paul Coh, David Grigoryan, James Lim, and Dr. Miki Igarashi for help with experiments. This work was supported by U.S. National Institutes of Health grant DK073955 (to D.P.).	Alvheim AR, 2012, OBESITY, V20, P1984, DOI 10.1038/oby.2012.38; Astarita G, 2009, J CHROMATOGR B, V877, P2755, DOI 10.1016/j.jchromb.2009.01.008; Bluher M, 2006, DIABETES, V55, P3053, DOI 10.2337/db06-0812; Cartoni C, 2010, J NEUROSCI, V30, P8376, DOI 10.1523/JNEUROSCI.0496-10.2010; Cote M, 2007, INT J OBESITY, V31, P692, DOI 10.1038/sj.ijo.0803539; DAYTON S, 1966, J LIPID RES, V7, P103; DiPatrizio NV, 2008, AM J PHYSIOL-REG I, V295, pR1409, DOI 10.1152/ajpregu.90484.2008; DiPatrizio NV, 2008, J NEUROSCI, V28, P9702, DOI 10.1523/JNEUROSCI.1171-08.2008; DiPatrizio NV, 2012, TRENDS NEUROSCI, V35, P403, DOI 10.1016/j.tins.2012.04.006; DiPatrizio NV, 2011, P NATL ACAD SCI USA, V108, P12904, DOI 10.1073/pnas.1104675108; Engeli S, 2005, DIABETES, V54, P2838, DOI 10.2337/diabetes.54.10.2838; Gaillard D, 2008, FASEB J, V22, P1458, DOI 10.1096/fj.07-8415com; Giuffrida A, 2000, ANAL BIOCHEM, V280, P87, DOI 10.1006/abio.2000.4509; Greenberg D, 1996, PSYCHOSOM MED, V58, P559, DOI 10.1097/00006842-199611000-00004; Grill HJ, 2006, OBESITY, V14, P216, DOI 10.1038/oby.2006.312; HAMILTON RB, 1984, J COMP NEUROL, V222, P560, DOI 10.1002/cne.902220408; HAMOSH M, 1977, LAB INVEST, V37, P603; HAMOSH M, 1990, NUTRITION, V6, P421; HAMOSH M, 1973, J CLIN INVEST, V52, P88, DOI 10.1172/JCI107177; Izzo AA, 2009, BRIT J PHARMACOL, V158, P451, DOI 10.1111/j.1476-5381.2009.00183.x; Jarbe TUC, 2005, BEHAV PHARMACOL, V16, P373; Kawai T, 2003, AM J PHYSIOL-REG I, V285, pR447, DOI 10.1152/ajpregu.00729.2002; Kelley AE, 2004, NEUROSCI BIOBEHAV R, V27, P765, DOI 10.1016/j.neubiorev.2003.11.015; Laugerette F, 2005, J CLIN INVEST, V115, P3177, DOI 10.1172/JCI25299; Liang NC, 2006, AM J PHYSIOL-REG I, V291, pR1236, DOI 10.1152/ajpregu.00226.2006; Liu P, 2011, J NEUROSCI, V31, P8634, DOI 10.1523/JNEUROSCI.6273-10.2011; LoVerme J, 2009, BIOORG MED CHEM LETT, V19, P639, DOI 10.1016/j.bmcl.2008.12.059; Mahler SV, 2007, NEUROPSYCHOPHARMACOL, V32, P2267, DOI 10.1038/sj.npp.1301376; Martin C, 2011, PHYSIOL BEHAV, V105, P36, DOI 10.1016/j.physbeh.2011.02.029; Matias I, 2007, TRENDS ENDOCRIN MET, V18, P27, DOI 10.1016/j.tem.2006.11.006; Matias I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042399; MINDELL S, 1990, PHYSIOL BEHAV, V48, P283, DOI 10.1016/0031-9384(90)90314-T; Moreau R. A., 2011, Vegetable oils in food technology: composition, properties and uses, P273; Piomelli D, 2003, NAT REV NEUROSCI, V4, P873, DOI 10.1038/nrn1247; Pittman D, 2007, BRAIN RES, V1151, P74, DOI 10.1016/j.brainres.2007.03.027; Saitou K, 2009, PHYSIOL BEHAV, V96, P142, DOI 10.1016/j.physbeh.2008.09.014; Sclafani A, 2007, AM J PHYSIOL-REG I, V293, pR1823, DOI 10.1152/ajpregu.00211.2007; Smith G P, 2001, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0806ds04; SMITH GP, 1991, BRAIN RES BULL, V27, P379, DOI 10.1016/0361-9230(91)90128-7; Smith KS, 2011, P NATL ACAD SCI USA, V108, pE255, DOI 10.1073/pnas.1101920108; Stratford JM, 2006, PHYSIOL BEHAV, V89, P311, DOI 10.1016/j.physbeh.2006.06.009; Sykaras AG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042373; Tam J, 2010, J CLIN INVEST, V120, P2953, DOI 10.1172/JCI42551; Treesukosol Y, 2010, AM J PHYSIOL-REG I, V299, pR1050, DOI 10.1152/ajpregu.00763.2009; Wu Q, 2012, NATURE, V483, P594, DOI 10.1038/nature10899; Yoneda T, 2007, PHYSIOL BEHAV, V91, P304, DOI 10.1016/j.physbeh.2007.03.006; Yoneda T, 2009, PHYSIOL BEHAV, V96, P735, DOI 10.1016/j.physbeh.2009.01.010; Yoshida R, 2010, P NATL ACAD SCI USA, V107, P935, DOI 10.1073/pnas.0912048107; Yu WZ, 1999, PHARMACOL BIOCHEM BE, V64, P573, DOI 10.1016/S0091-3057(99)00124-0	49	54	54	1	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	JUN	2013	27	6					2513	2520		10.1096/fj.13-227587	http://dx.doi.org/10.1096/fj.13-227587			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	154II	23463697	Green Published, Green Submitted			2022-12-25	WOS:000319667600039
J	Aley, PK; Singh, N; Brailoiu, GC; Brailoiu, E; Churchill, GC				Aley, Parvinder K.; Singh, Nisha; Brailoiu, G. Cristina; Brailoiu, Eugen; Churchill, Grant C.			Nicotinic Acid Adenine Dinucleotide Phosphate (NAADP) Is a Second Messenger in Muscarinic Receptor-induced Contraction of Guinea Pig Trachea	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AIRWAY SMOOTH-MUSCLE; ADP-RIBOSYL CYCLASE; INDUCED CA2+ RELEASE; MOBILIZES CALCIUM; SENSITIVE CA2+; TRIGGER ZONE; CD38; STORES; ENZYME; CADPR	Nicotinic acid adenine dinucleotide phosphate (NAADP) is increasingly being demonstrated to be involved in calcium signaling in many cell types and species. Although it has been shown to play a role in smooth muscle cell contraction in several tissues, nothing is known about its possible role in tracheal smooth muscle, a muscle type that is clinically relevant to asthma. To determine whether NAADP functions as a second messenger in tracheal smooth muscle contraction, we used the criteria set out by Sutherland for a molecule to be designated a second messenger. We report that NAADP satisfies all five criteria as follows. First, the NAADP antagonist Ned-19 inhibited contractions in tracheal rings and calcium increases in isolated smooth muscle cells induced by the muscarinic agonist carbachol. Second, NAADP increased cytosolic calcium in isolated cells when microinjected and was blocked by Ned-19. Third, tracheal homogenates could synthesize NAADP by base exchange from exogenous NADP and nicotinic acid and metabolize exogenous NAADP to nicotinic acid adenine dinucleotide by a 2'-phosphatase. Fourth, carbachol induced a rapid and transient increase in endogenous NAADP levels. Fifth, tracheal homogenates contained NAADP-binding sites of high affinity. Taken together, these data demonstrate that NAADP functions as a second messenger in tracheal smooth muscle, and therefore, steps in the NAADP signaling pathway might provide possible new drug targets.	[Aley, Parvinder K.; Singh, Nisha; Churchill, Grant C.] Univ Oxford, Dept Pharmacol, Oxford OX1 3QT, England; [Brailoiu, G. Cristina] Thomas Jefferson Univ, Jefferson Sch Pharm, Dept Pharmaceut Sci, Philadelphia, PA 19107 USA; [Brailoiu, Eugen] Temple Univ, Sch Med, Dept Pharmacol, Philadelphia, PA 19140 USA	University of Oxford; Jefferson University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Churchill, GC (corresponding author), Univ Oxford, Dept Pharmacol, Mansfield Rd, Oxford OX1 3QT, England.	grant.churchill@pharm.ox.ac.uk	Singh, Nisha/M-3780-2015	Singh, Nisha/0000-0002-1312-688X; Aley, Parvinder/0000-0002-0749-8329	Asthma UK Grant [09/037]; BBSRC [BB/G008523/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G008523/1] Funding Source: researchfish; Asthma UK [09/037] Funding Source: researchfish	Asthma UK Grant; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Asthma UK	This work was supported by Asthma UK Grant 09/037.	Aarhus R, 1995, J BIOL CHEM, V270, P30327, DOI 10.1074/jbc.270.51.30327; Alejandro EU, 2010, ENDOCRINOLOGY, V151, P502, DOI 10.1210/en.2009-0678; Aley PK, 2010, J PHARMACOL EXP THER, V333, P726, DOI 10.1124/jpet.110.165837; AXELSON JT, 1981, ANAL BIOCHEM, V116, P357, DOI 10.1016/0003-2697(81)90371-7; Barcelo-Torns M, 2011, FEBS LETT, V585, P2300, DOI 10.1016/j.febslet.2011.05.062; Berg I, 2000, J CELL BIOL, V150, P581, DOI 10.1083/jcb.150.3.581; Berridge G, 2002, BIOCHEM J, V365, P295, DOI 10.1042/BJ20020180; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; BERRIDGE MJ, 1988, FASEB J, V2, P3074, DOI 10.1096/fasebj.2.15.2847949; Billington CK, 2012, BRIT J PHARMACOL, V166, P401, DOI 10.1111/j.1476-5381.2011.01719.x; Billington RA, 2004, BIOCHEM J, V378, P275, DOI 10.1042/BJ20031284; Boittin FX, 2002, CIRC RES, V91, P1168, DOI 10.1161/01.RES.0000047507.22487.85; Brailoiu E, 2009, J CELL BIOL, V186, P201, DOI 10.1083/jcb.200904073; Brailoiu GC, 2011, J BIOL CHEM, V286, P29166, DOI 10.1074/jbc.M110.217463; Calcraft PJ, 2009, NATURE, V459, P596, DOI 10.1038/nature08030; Campos-Bedolla P, 2005, J ETHNOPHARMACOL, V97, P267, DOI 10.1016/j.jep.2004.11.005; Cancela JM, 1999, NATURE, V398, P74, DOI 10.1038/18032; Chen H, 2003, J APPL PHYSIOL, V95, P864, DOI 10.1152/japplphysiol.00140.2003; Chini EN, 2002, BIOCHEM J, V362, P125, DOI 10.1042/0264-6021:3620125; Churchill GC, 2000, J BIOL CHEM, V275, P38687, DOI 10.1074/jbc.M005827200; Churchill GC, 2003, CURR BIOL, V13, P125, DOI 10.1016/S0960-9822(03)00002-2; Churchill GC, 2001, EMBO J, V20, P2666, DOI 10.1093/emboj/20.11.2666; Churchill GC, 2002, CELL, V111, P703, DOI 10.1016/S0092-8674(02)01082-6; CLAPPER DL, 1987, J BIOL CHEM, V262, P9561; Cosker F, 2010, J BIOL CHEM, V285, P38251, DOI 10.1074/jbc.M110.125864; Coxon CH, 2012, BIOCHEM J, V441, P435, DOI 10.1042/BJ20111175; Deshpande DA, 2005, AM J PHYSIOL-LUNG C, V288, pL773, DOI 10.1152/ajplung.00217.2004; Deshpande DA, 2010, NAT MED, V16, P1299, DOI 10.1038/nm.2237; Dickey Deborah M., 1998, Cell Biochemistry and Biophysics, V28, P63, DOI 10.1007/BF02738310; Dickinson GD, 2003, BIOCHEM J, V375, P805, DOI 10.1042/BJ20030672; Eglen RM, 1996, PHARMACOL REV, V48, P531; Esposito B, 2011, BLOOD, V117, P4968, DOI 10.1182/blood-2010-02-266338; Evans AM, 2010, ADV EXP MED BIOL, V661, P57, DOI 10.1007/978-1-60761-500-2_4; Evans AM, 2005, PHARMACOL THERAPEUT, V107, P286, DOI 10.1016/j.pharmthera.2005.03.003; Franco L, 2001, AM J PHYSIOL-LUNG C, V280, pL98; GALIONE A, 1991, SCIENCE, V253, P1143, DOI 10.1126/science.1909457; Galione A, 2011, SCI CHINA LIFE SCI, V54, P725, DOI 10.1007/s11427-011-4207-5; Gasser A, 2006, J BIOL CHEM, V281, P16906, DOI 10.1074/jbc.M601347200; Genazzani AA, 1996, BIOCHEM J, V315, P721, DOI 10.1042/bj3150721; GERTHOFFER WT, 1991, AM J PHYSIOL, V261, pL15, DOI 10.1152/ajplung.1991.261.2.L15; Graeff R, 2006, J BIOL CHEM, V281, P28951, DOI 10.1074/jbc.M604370200; Guse AH, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.144re10; Hakonarson H, 1998, AM J RESP CRIT CARE, V158, pS115, DOI 10.1164/ajrccm.158.supplement_2.13tac700; Iizuka K, 1998, J PHYSIOL-LONDON, V511, P915, DOI 10.1111/j.1469-7793.1998.915bg.x; Irvine RF, 2001, NAT REV MOL CELL BIO, V2, P327, DOI 10.1038/35073015; Ito S, 2002, AM J RESP CELL MOL, V26, P491, DOI 10.1165/ajrcmb.26.4.4701; Jude Joseph A, 2008, Proc Am Thorac Soc, V5, P15, DOI 10.1513/pats.200704-047VS; Kinnear NP, 2008, CELL CALCIUM, V44, P190, DOI 10.1016/j.ceca.2007.11.003; Kinnear NP, 2004, J BIOL CHEM, V279, P54319, DOI 10.1074/jbc.M406132200; Lee H C, 2000, Sci STKE, V2000, ppe1, DOI 10.1126/stke.2000.40.pe1; LEE HC, 1991, CELL REGUL, V2, P203, DOI 10.1091/mbc.2.3.203; LEE HC, 1995, J BIOL CHEM, V270, P2152, DOI 10.1074/jbc.270.5.2152; Lee HC, 1997, J BIOL CHEM, V272, P20378, DOI 10.1074/jbc.272.33.20378; LEE HC, 1989, J BIOL CHEM, V264, P1608; Lee HC, 2005, J BIOL CHEM, V280, P33693, DOI 10.1074/jbc.R500012200; Lee HC, 2011, SCI CHINA LIFE SCI, V54, P699, DOI 10.1007/s11427-011-4197-3; Lewis AM, 2012, BIOCHEM BIOPH RES CO, V427, P326, DOI 10.1016/j.bbrc.2012.09.054; Lin-Moshier Y, 2012, J BIOL CHEM, V287, P2296, DOI 10.1074/jbc.M111.305813; Macgregor A, 2007, J BIOL CHEM, V282, P15302, DOI 10.1074/jbc.M611167200; Masgrau R, 2003, CURR BIOL, V13, P247, DOI 10.1016/S0960-9822(03)00041-1; Naylor E, 2009, NAT CHEM BIOL, V5, P220, DOI 10.1038/nchembio.150; Palade P, 2007, AM J PHYSIOL-CELL PH, V292, pC4, DOI 10.1152/ajpcell.00390.2006; Pandey V, 2009, BIOCHEM J, V422, P503, DOI 10.1042/BJ20090194; Parkesh R, 2008, CELL CALCIUM, V43, P531, DOI 10.1016/j.ceca.2007.08.006; Patel S, 2004, BIOL CELL, V96, P19, DOI 10.1016/j.biolcel.2003.12.001; Pitt SJ, 2010, J BIOL CHEM, V285, P35039, DOI 10.1074/jbc.M110.156927; Prakash YS, 1998, AM J PHYSIOL-CELL PH, V274, pC1653, DOI 10.1152/ajpcell.1998.274.6.C1653; Prakash YS, 2000, CELL CALCIUM, V27, P153, DOI 10.1054/ceca.1999.0106; ROBERTSON DN, 1988, AM REV RESPIR DIS, V137, P1317, DOI 10.1164/ajrccm/137.6.1317; Robison G.A., 1971, CYCLIC AMP, DOI [10.1146/annurev.bi.37.070168.001053, DOI 10.1146/ANNUREV.BI.37.070168.001053]; ROFFEL AF, 1990, BRIT J PHARMACOL, V99, P293, DOI 10.1111/j.1476-5381.1990.tb14697.x; Rosen D, 2009, J BIOL CHEM, V284, P34930, DOI 10.1074/jbc.M109.016519; Sanderson Michael J, 2008, Proc Am Thorac Soc, V5, P23, DOI 10.1513/pats.200704-050VS; Santella L, 2000, J BIOL CHEM, V275, P8301, DOI 10.1074/jbc.275.12.8301; Schmid F, 2012, J BIOL CHEM, V287, P32525, DOI 10.1074/jbc.M112.362715; Schultz C, 2003, BIOORGAN MED CHEM, V11, P885, DOI 10.1016/S0968-0896(02)00552-7; SHIEH CC, 1991, J PHARMACOL EXP THER, V256, P141; Siddiqui S, 2013, PULM PHARMACOL THER, V26, P132, DOI 10.1016/j.pupt.2012.08.008; Soares S, 2007, AM J PHYSIOL-CELL PH, V292, pC227, DOI 10.1152/ajpcell.00638.2005; Song EK, 2012, CELL REP, V2, P1607, DOI 10.1016/j.celrep.2012.10.018; SUTHERLAND EW, 1968, CIRCULATION, V37, P279, DOI 10.1161/01.CIR.37.2.279; Sweeney M, 2002, J APPL PHYSIOL, V92, P1594, DOI 10.1152/japplphysiol.00722.2001; Tao FC, 1999, AM J RESP CRIT CARE, V160, P446, DOI 10.1164/ajrccm.160.2.9811098; Thai TL, 2009, AM J PHYSIOL-RENAL, V297, pF510, DOI 10.1152/ajprenal.00116.2009; VANROSSUM JM, 1963, ARCH INT PHARMACOD T, V143, P240; Vasudevan SR, 2010, J BIOL CHEM, V285, P18262, DOI 10.1074/jbc.M109.087858; Walseth TF, 2012, J BIOL CHEM, V287, P2308, DOI 10.1074/jbc.M111.306563; White RA, 2003, FASEB J, V17, P482, DOI 10.1096/fj.02-0622fje; Yamasaki M, 2005, CURR BIOL, V15, P874, DOI 10.1016/j.cub.2005.04.033; Zong XG, 2009, PFLUG ARCH EUR J PHY, V458, P891, DOI 10.1007/s00424-009-0690-y	91	11	11	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2013	288	16					10986	10993		10.1074/jbc.M113.458620	http://dx.doi.org/10.1074/jbc.M113.458620			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	130KW	23467410	hybrid, Green Published			2022-12-25	WOS:000317915500005
J	Lei, L; Cao, X; Yang, F; Shi, DJ; Tang, YQ; Zheng, J; Wang, KW				Lei, Lei; Cao, Xu; Yang, Fan; Shi, Di-Jing; Tang, Yi-Quan; Zheng, Jie; Wang, Kewei			A TRPV4 Channel C-terminal Folding Recognition Domain Critical for Trafficking and Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR POTENTIAL VANILLOID-4; NONSELECTIVE CATION CHANNEL; ION CHANNELS; PORE TURRET; VR-OAC; ACTIVATION; SENSITIVITY; STIMULI; DISRUPTION; KINASE	The Ca2+-permeable transient receptor potential vanilloid subtype 4 (TRPV4) channel mediates crucial physiological functions, such as calcium signaling, temperature sensing, and maintaining cell volume and energy homeostasis. Noticeably, most disease-causing genetic mutations are concentrated in the cytoplasmic domains. In the present study, we focused on the role of the TRPV4 C terminus in modulating protein folding, trafficking, and activity. By examining a series of C-terminal deletions, we identified a 20-amino acid distal region covering residues 838-857 that is critical for channel folding, maturation, and trafficking. Surface biotinylation, confocal imaging, and fluorescence-based calcium influx assay demonstrated that mutant proteins missing this region were trapped in the endoplasmic reticulum and unglycosylated, leading to accelerated degradation and loss of channel activity. Rosetta de novo structural modeling indicated that residues 838-857 assume a defined conformation, with Gly(849) and Pro(851) located at critical positions. Patch clamp recordings confirmed that lowering the temperature from 37 to 30 degrees C rescued channel activity of folding-defective mutants. Moreover, biochemical tests demonstrated that, in addition to participating in C-C interaction, the C terminus also interacts with the N terminus. Taken together, our findings indicate that the C-terminal region of TRPV4 is critical for channel protein folding and maturation, and the short distal segment plays an essential role in this process. Therefore, selectively disrupting the folding-sensitive region may present therapeutic potential for treating overactive TRPV4-mediated diseases, such as pain and skeletal dysplasias.	[Lei, Lei; Cao, Xu; Shi, Di-Jing; Tang, Yi-Quan; Wang, Kewei] Peking Univ, Hlth Sci Ctr, Dept Neurobiol, Neurosci Res Inst, Beijing 100191, Peoples R China; [Yang, Fan; Zheng, Jie] Univ Calif Davis, Sch Med, Dept Physiol & Membrane Biol, Davis, CA 95616 USA; [Wang, Kewei] Peking Univ, Sch Pharmaceut Sci, Dept Mol & Cellular Pharmacol, State Key Lab Nat & Biomimet Drugs, Beijing 100191, Peoples R China; [Wang, Kewei] Peking Univ, PKU IDG McGovern Inst Brain Res, Beijing 100871, Peoples R China	Peking University; University of California System; University of California Davis; Peking University; Peking University	Zheng, J (corresponding author), Univ Calif Davis, Sch Med, Dept Physiol & Membrane Biol, Davis, CA 95616 USA.	jzheng@ucdavis.edu; wangkw@bjmu.edu.cn	Yang, Fan/GYU-4249-2022; Cao, Xu/G-6209-2015; Yang, Fan/AAA-6904-2022; Zhu, Ren-Yuan/V-8966-2019; Yang, Fan/J-4562-2015; Yang, Fan/C-6586-2012	Cao, Xu/0000-0003-1796-2735; Yang, Fan/0000-0002-0520-5254; Zhu, Ren-Yuan/0000-0003-3091-7461; Yang, Fan/0000-0002-9406-7710; Yang, Fan/0000-0002-9406-7710; Tang, Yiquan/0000-0002-6639-8897	National Institutes of Health [R01NS072377]; National Science Foundation of China [30970919, 81221002]; Ministry of Education of China [B07001]; Ministry of Science and Technology of China [2013CB531300]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS072377] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China); Ministry of Science and Technology of China(Ministry of Science and Technology, China); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01NS072377 (to J. Z.). This work was also supported by National Science Foundation of China Research Grants 30970919 and 81221002 (to K. W. W.); Ministry of Education of China, 111 Project China, Grant B07001; and Ministry of Science and Technology of China Grant 2013CB531300 (to K. W. W.).	Alessandri-Haber N, 2005, PAIN, V118, P70, DOI 10.1016/j.pain.2005.07.016; Alessandri-Haber N, 2008, J NEUROSCI, V28, P1046, DOI 10.1523/JNEUROSCI.4497-07.2008; Alvarez DF, 2006, CIRC RES, V99, P988, DOI 10.1161/01.RES.0000247065.11756.19; Andreucci E, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-37; Arniges M, 2006, J BIOL CHEM, V281, P1580, DOI 10.1074/jbc.M511456200; Becker D, 2008, MOL MEMBR BIOL, V25, P139, DOI 10.1080/09687680701635237; Benowitz LI, 1997, TRENDS NEUROSCI, V20, P84, DOI 10.1016/S0166-2236(96)10072-2; Blackshaw LA, 2010, GUT, V59, P126, DOI 10.1136/gut.2009.179523; Brierley SM, 2008, GASTROENTEROLOGY, V134, P2059, DOI 10.1053/j.gastro.2008.01.074; Casas S, 2008, DIABETOLOGIA, V51, P2252, DOI 10.1007/s00125-008-1111-z; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Cui YY, 2012, J GEN PHYSIOL, V139, P273, DOI 10.1085/jgp.201110724; de Groot T, 2011, J BIOL CHEM, V286, P32132, DOI 10.1074/jbc.M111.226878; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Erler I, 2006, J BIOL CHEM, V281, P38396, DOI 10.1074/jbc.M607756200; Everaerts W, 2010, PROG BIOPHYS MOL BIO, V103, P2, DOI 10.1016/j.pbiomolbio.2009.10.002; Gao X, 2003, J BIOL CHEM, V278, P27129, DOI 10.1074/jbc.M302517200; Garcia-Elias A, 2008, J BIOL CHEM, V283, P31284, DOI 10.1074/jbc.C800184200; Guler AD, 2002, J NEUROSCI, V22, P6408; Harley CA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032654; Hellwig N, 2005, J CELL SCI, V118, P917, DOI 10.1242/jcs.01675; Hille B., 2001, ION CHANNELS EXCITAB, P131; Hu HZ, 2009, P NATL ACAD SCI USA, V106, P1626, DOI 10.1073/pnas.0812209106; Hu HZ, 2004, J BIOL CHEM, V279, P35741, DOI 10.1074/jbc.M404164200; Kotttgen M, 2008, J CELL BIOL, V182, P437, DOI 10.1083/jcb.200805124; Krakow D, 2009, AM J HUM GENET, V84, P307, DOI 10.1016/j.ajhg.2009.01.021; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; Liedtke W, 2003, P NATL ACAD SCI USA, V100, P14531, DOI 10.1073/pnas.2235619100; Loukin S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019533; Mendoza SA, 2010, AM J PHYSIOL-HEART C, V298, pH466, DOI 10.1152/ajpheart.00854.2009; Montell C, 2001, Sci STKE, V2001, pre1, DOI 10.1126/stke.2001.90.re1; Montell Craig, 2005, Sci STKE, V2005, pre3, DOI 10.1126/stke.2722005re3; Nickel W, 2008, ANNU REV CELL DEV BI, V24, P287, DOI 10.1146/annurev.cellbio.24.110707.175320; Nilius B, 2004, AM J PHYSIOL-CELL PH, V286, pC195, DOI 10.1152/ajpcell.00365.2003; Ramadass R, 2007, ARCH BIOCHEM BIOPHYS, V463, P27, DOI 10.1016/j.abb.2007.01.036; Rohl CA, 2004, METHOD ENZYMOL, V383, P66; Saito S, 2006, PHYSIOL GENOMICS, V27, P219, DOI 10.1152/physiolgenomics.00322.2005; Shigematsu H, 2010, J BIOL CHEM, V285, P11210, DOI 10.1074/jbc.M109.090712; Simons KT, 1997, J MOL BIOL, V268, P209, DOI 10.1006/jmbi.1997.0959; Strotmann R, 2000, NAT CELL BIOL, V2, P695, DOI 10.1038/35036318; Strotmann R, 2003, J BIOL CHEM, V278, P26541, DOI 10.1074/jbc.M302590200; Strotmann R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010580; Suzuki M, 2003, J BIOL CHEM, V278, P51448, DOI 10.1074/jbc.M308212200; Suzuki M, 2003, J BIOL CHEM, V278, P22664, DOI 10.1074/jbc.M302561200; Thorneloe KS, 2008, J PHARMACOL EXP THER, V326, P432, DOI 10.1124/jpet.108.139295; Tsuruda PR, 2006, NEURON, V51, P201, DOI 10.1016/j.neuron.2006.06.023; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Vriens J, 2004, P NATL ACAD SCI USA, V101, P396, DOI 10.1073/pnas.0303329101; Wang XD, 2008, TRAFFIC, V9, P1878, DOI 10.1111/j.1600-0854.2008.00806.x; Wang Y, 2007, J BIOL CHEM, V282, P36561, DOI 10.1074/jbc.M703903200; Watanabe H, 2003, NATURE, V424, P434, DOI 10.1038/nature01807; Watanabe H, 2002, J BIOL CHEM, V277, P13569, DOI 10.1074/jbc.M200062200; Yang F, 2010, P NATL ACAD SCI USA, V107, P7083, DOI 10.1073/pnas.1000357107; Ye L, 2012, CELL, V151, P96, DOI 10.1016/j.cell.2012.08.034; Yin J, 2008, CIRC RES, V102, P966, DOI 10.1161/CIRCRESAHA.107.168724; Zheng J, 2013, COMPR PHYSIOL, V3, P221, DOI 10.1002/cphy.c120001	56	30	30	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2013	288	15					10427	10439		10.1074/jbc.M113.457291	http://dx.doi.org/10.1074/jbc.M113.457291			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	125TU	23457335	Green Published, hybrid			2022-12-25	WOS:000317565000023
J	Cao, XC; Zhang, WR; Cao, WF; Liu, BW; Zhang, F; Zhao, HM; Meng, R; Zhang, L; Niu, RF; Hao, XS; Zhang, B				Cao, Xu-Chen; Zhang, Wei-Ran; Cao, Wen-Feng; Liu, Bo-Wen; Zhang, Fei; Zhao, Hong-Meng; Meng, Ran; Zhang, Lin; Niu, Rui-Fang; Hao, Xi-Shan; Zhang, Bin			Aquaporin3 Is Required for FGF-2-Induced Migration of Human Breast Cancers	PLOS ONE			English	Article							FIBROBLAST GROWTH FACTOR-2; CELL-MIGRATION; WATER CHANNELS; MOLECULAR-MECHANISMS; EXPRESSION; RECEPTOR; METASTASIS; PATHWAY; PLAYERS; ROLES	Purpose: The aquaporin (AQP) family consists of a number of small integral membrane proteins that transport water and glycerol. AQPs are critical for trans-epithelial fluid transport. Recent reports demonstrated that AQPs, particularly AQP1 and AQP5, are expressed in high grade tumor cells of a variety of tissue origins, and that AQPs are involved in cell migration and metastasis. Based on this background, we examined whether AQP3, another important member of the AQP family, could facilitate cell migration in human breast cancers. Methods: Potential role of AQP3 was examined using two representative breast cancer cell lines (MDA-MB-231 and Bcap-37). Briefly, AQP3 expression was inhibited with a lentivirus construct that stably expressed shRNA against the AQP3 mRNA. AQP3 expression inhibition was verified with Western blot. Cell migration was examined using a wound scratch assay in the presence of fibroblast growth factor-2 (FGF-2). In additional experiments, AQP3 was inhibited by CuSO4. Fibroblast growth factor receptor (FGFR) kinase inhibitor PD173074, PI3K inhibitor LY294002, and MEK1/2 inhibitor PD98059 were used to dissect the molecular mechanism of FGF-2 induced AQP3 expression. Results: FGF-2 treatment increased AQP3 expression and induced cell migration in a dose dependent manner. Silencing AQP3 expression by a lentiviral shRNA inhibited FGF-2 induced cell migration. CuSO4, a water transport inhibitor selective for AQP3, also suppressed FGF-2-induced cell migration. The FGFR kinase inhibitor PD173074, significantly inhibited FGF-2-induced AQP3 expression and cell migration. The PI3K inhibitor LY294002 and MEK1/2 inhibitor PD98059 inhibited, but not fully blocked, FGF-2-induced AQP3 expression and cell migration. Conclusions: AQP3 is required for FGF-2-induced cell migration in cultured human breast cancer cells. Our findings also suggest the importance of FGFR-PI3K and FGFR-ERK signaling in FGF-2-induced AQP3 expression. In summary, our findings suggest a novel function of AQP3 in cell migration and metastasis of breast cancers.	[Cao, Xu-Chen; Zhang, Wei-Ran; Liu, Bo-Wen; Zhao, Hong-Meng; Meng, Ran; Hao, Xi-Shan; Zhang, Bin] Canc Inst & Hosp, Natl Key Lab Breast Canc Prevent & Treatment, Tianjin, Peoples R China; [Cao, Xu-Chen; Zhang, Wei-Ran; Liu, Bo-Wen; Zhao, Hong-Meng; Meng, Ran; Hao, Xi-Shan; Zhang, Bin] Canc Inst & Hosp, Dept Breast Canc Surg, Tianjin, Peoples R China; [Cao, Wen-Feng] Canc Inst & Hosp, Dept Pathol, Tianjin, Peoples R China; [Zhang, Fei; Zhang, Lin; Niu, Rui-Fang] Tianjin Med Univ, Tianjin Key Lab Canc Prevent & Treatment, Tianjin, Peoples R China	Tianjin Medical University	Zhang, B (corresponding author), Canc Inst & Hosp, Natl Key Lab Breast Canc Prevent & Treatment, Tianjin, Peoples R China.	eeflying@163.com	Niu, Ruifang/AAJ-8017-2020	Niu, Ruifang/0000-0002-1905-7408; Zhang, Fei/0000-0001-7434-7339	National Natural Science Foundation of China [81001186]; Tianjin Municipal Natural Science Foundation [10JCYBJC14100, 11JCZDJC28000]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tianjin Municipal Natural Science Foundation(Natural Science Foundation of Tianjin)	This work was supported by the National Natural Science Foundation of China (Grant no. 81001186) and the Tianjin Municipal Natural Science Foundation (Grant no. 10JCYBJC14100, 11JCZDJC28000). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agre P, 2003, FEBS LETT, V555, P72, DOI 10.1016/S0014-5793(03)01083-4; Bikfalvi A, 1997, ENDOCR REV, V18, P26, DOI 10.1210/er.18.1.26; Cavallaro U, 1998, FASEB J, V12, P1027, DOI 10.1096/fasebj.12.11.1027; Ding T, 2010, J CLIN NEUROSCI, V17, P1359, DOI 10.1016/j.jocn.2010.02.014; Hu J, 2006, FASEB J, V20, P1892, DOI 10.1096/fj.06-5930fje; Itoh T, 2005, BIOCHEM BIOPH RES CO, V330, P832, DOI 10.1016/j.bbrc.2005.03.046; Ji C, 2008, CANCER CHEMOTH PHARM, V62, P857, DOI 10.1007/s00280-007-0674-6; Jung HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028492; Kasimir-Bauer S, 2009, MOL MED REP, V2, P645, DOI 10.3892/mmr_00000151; Khurana A, 2011, CANCER RES, V71, P2152, DOI 10.1158/0008-5472.CAN-10-3059; Li HP, 2005, BIOL CELL, V97, P823, DOI 10.1042/BC20040091; Liu JF, 2002, BIOCHEM BIOPH RES CO, V293, P1174, DOI 10.1016/S0006-291X(02)00350-9; Mazal PR, 2005, MODERN PATHOL, V18, P535, DOI 10.1038/modpathol.3800320; McIntosh I, 2000, CELL STRUCT FUNCT, V25, P85, DOI 10.1247/csf.25.85; Moon C, 2003, ONCOGENE, V22, P6699, DOI 10.1038/sj.onc.1206762; Okada-Ban M, 2000, INT J BIOCHEM CELL B, V32, P263, DOI 10.1016/S1357-2725(99)00133-8; Ornitz DM, 2000, BIOESSAYS, V22, P108, DOI 10.1002/(SICI)1521-1878(200002)22:2<108::AID-BIES2>3.0.CO;2-M; Otterbach F, 2010, BREAST CANCER RES TR, V120, P67, DOI 10.1007/s10549-009-0370-9; Papadopoulos MC, 2008, PFLUG ARCH EUR J PHY, V456, P693, DOI 10.1007/s00424-007-0357-5; Procino G, 2008, SEMIN NEPHROL, V28, P297, DOI 10.1016/j.semnephrol.2008.03.007; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Shi ZH, 2012, J SURG ONCOL, V106, P267, DOI 10.1002/jso.22155; Suyama K, 2002, CANCER CELL, V2, P301, DOI 10.1016/S1535-6108(02)00150-2; Tan G, 2008, J INT MED RES, V36, P777, DOI 10.1177/147323000803600420; Verkman AS, 2008, J MOL MED, V86, P523, DOI 10.1007/s00109-008-0303-9; Verkman AS, 2005, J CELL SCI, V118, P3225, DOI 10.1242/jcs.02519; Vicente-Manzanares M, 2005, J CELL SCI, V118, DOI 10.1242/jcs.02662; Zhang ZQ, 2010, J PATHOL, V221, P210, DOI 10.1002/path.2702	28	53	55	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e56735	10.1371/journal.pone.0056735	http://dx.doi.org/10.1371/journal.pone.0056735			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23468877	gold, Green Published, Green Submitted			2022-12-25	WOS:000315524900034
J	Bishop, L; Bailes, F; Dean, RT				Bishop, Laura; Bailes, Freya; Dean, Roger T.			Musical Expertise and the Ability to Imagine Loudness	PLOS ONE			English	Article							AUDITORY IMAGERY; WORKING-MEMORY; PITCH; PERFORMANCE; PERCEPTION; EMOTION; COMMUNICATION; INTENSITY; MUSICIANS; TIME	Most perceived parameters of sound (e. g. pitch, duration, timbre) can also be imagined in the absence of sound. These parameters are imagined more veridically by expert musicians than non-experts. Evidence for whether loudness is imagined, however, is conflicting. In music, the question of whether loudness is imagined is particularly relevant due to its role as a principal parameter of performance expression. This study addressed the hypothesis that the veridicality of imagined loudness improves with increasing musical expertise. Experts, novices and non-musicians imagined short passages of well-known classical music under two counterbalanced conditions: 1) while adjusting a slider to indicate imagined loudness of the music and 2) while tapping out the rhythm to indicate imagined timing. Subtests assessed music listening abilities and working memory span to determine whether these factors, also hypothesised to improve with increasing musical expertise, could account for imagery task performance. Similarity between each participant's imagined and listening loudness profiles and reference recording intensity profiles was assessed using time series analysis and dynamic time warping. The results suggest a widespread ability to imagine the loudness of familiar music. The veridicality of imagined loudness tended to be greatest for the expert musicians, supporting the predicted relationship between musical expertise and musical imagery ability.	[Bishop, Laura; Bailes, Freya; Dean, Roger T.] Univ Western Sydney, MARCS Inst, Penrith, NSW 1797, Australia; [Bailes, Freya] Univ Hull, Mus Dept, Kingston Upon Hull HU6 7RX, N Humberside, England	Western Sydney University; University of Hull	Bishop, L (corresponding author), Univ Western Sydney, MARCS Inst, Penrith, NSW 1797, Australia.	L.Bishop@uws.edu.au		Dean, Roger Thornton/0000-0002-8859-8902; Bishop, Laura/0000-0002-0656-3969; Bailes, Freya/0000-0003-2723-3579	University of Western Sydney International Postgraduate Research Scholarship	University of Western Sydney International Postgraduate Research Scholarship	This research was funded by a University of Western Sydney International Postgraduate Research Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleman A, 2000, NEUROPSYCHOLOGIA, V38, P1664, DOI 10.1016/S0028-3932(00)00079-8; Aleman A., 2004, COGNITIVE PROCESSING, V5, P228, DOI [DOI 10.1007/S10339-004-0034-Y, 10.1007/s10339-004-0034-y]; Baddeley AD, 2000, J EXP PSYCHOL GEN, V129, P126, DOI 10.1037//0096-3445.129.1.126; Bailes F, 2012, FRONTIERS PERCEPTION, P3; Bailes F, 2004, 8 INT C MUS PERC COG; Bailes F, 2007, EMPIR MUSICOL REV, V2, P21, DOI 10.18061/1811/24476; Besson M, 2007, RESTOR NEUROL NEUROS, V25, P399; Bigand E, 2006, COGNITION, V100, P100, DOI 10.1016/j.cognition.2005.11.007; Bishop L, MUSICAL IMA IN PRESS; Brodsky W, 2003, PERCEPT PSYCHOPHYS, V65, P602, DOI 10.3758/BF03194586; Chaffin R., 2006, ADV COGN PSYCHOL, V2, P113, DOI [10.2478/vl0053-008-0050-z, DOI 10.2478/V10053-008-0050-Z]; Chaffin R, 2010, PSYCHOL MUSIC, V38, P3, DOI 10.1177/0305735608100377; CHASE WG, 1973, COGNITIVE PSYCHOL, V4, P55, DOI 10.1016/0010-0285(73)90004-2; Clark T, 2011, IMAGINE MUSIC CONTEX; Conway ARA, 2005, PSYCHON B REV, V12, P769, DOI 10.3758/BF03196772; Dean RT, 2010, EMPIR MUSICOL REV, V5, P152, DOI 10.18061/1811/48550; Dean RT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018591; Dean RT, 2010, ORGAN SOUND, V15, P147, DOI 10.1017/S1355771810000142; Drake C, 2000, MUSIC PERCEPT, V18, P1; Dyson BJ, 2010, ATTEN PERCEPT PSYCHO, V72, P1676, DOI 10.3758/APP.72.6.1676; Ericsson KA, 1996, ANNU REV PSYCHOL, V47, P273, DOI 10.1146/annurev.psych.47.1.273; Franklin MS, 2008, PSYCHOL MUSIC, V36, P353, DOI 10.1177/0305735607086044; GERINGER JM, 1995, J RES MUSIC EDUC, V43, P22, DOI 10.2307/3345789; Gingras B, 2011, PERCEPTION, V40, P1206, DOI 10.1068/p6891; Giovagnoli AR, 2011, PERCEPT MOTOR SKILL, V113, P563, DOI 10.2466/04.11.22.23.PMS.113.5.563-569; Gordon E. E., 1979, PSYCHOL MUSIC, V7, P42, DOI [10.1177/030573567971005, DOI 10.1177/030573567971005]; GOWER JC, 1975, PSYCHOMETRIKA, V40, P33, DOI 10.1007/BF02291478; Grahn JA, 2007, J COGNITIVE NEUROSCI, V19, P893, DOI 10.1162/jocn.2007.19.5.893; Halpern AR, 2012, ANN NY ACAD SCI, V1252, P200, DOI 10.1111/j.1749-6632.2011.06442.x; Halpern AR, 2004, NEUROPSYCHOLOGIA, V42, P1281, DOI 10.1016/j.neuropsychologia.2003.12.017; HALPERN AR, 1988, J EXP PSYCHOL LEARN, V14, P434, DOI 10.1037/0278-7393.14.3.434; HALPERN AR, 1982, AM J PSYCHOL, V95, P31, DOI 10.2307/1422658; Helmbold N., 2005, J INDIVID DIFFER, V26, P74, DOI [10.1027/1614-0001.26.2.74, DOI 10.1027/1614-0001.26.2.74]; Highben Z, 2004, B COUN RES MUSIC ED, P58; Hill NM, 2006, CAMBRIDGE HANDBOOK OF EXPERTISE AND EXPERT PERFORMANCE, P653; Hubbard TL, 2010, PSYCHOL BULL, V136, P302, DOI 10.1037/a0018436; Huron D., 1991, PSYCHOL MUSIC, V19, P33, DOI 10.1177/0305735691191003; Ilie G, 2006, MUSIC PERCEPT, V23, P319, DOI 10.1525/mp.2006.23.4.319; INTONSPETERSON MJ, 1980, MEM COGNITION, V8, P385, DOI 10.3758/BF03211134; Janata P, 2006, PERCEPT PSYCHOPHYS, V68, P829, DOI 10.3758/BF03193705; Juslin P.N., 2003, PSYCHOL MUSIC, V31, P273, DOI [10.1177/03057356030313003, DOI 10.1177/03057356030313003]; Juslin PN, 2003, PSYCHOL BULL, V129, P770, DOI 10.1037/0033-2909.129.5.770; Kamenetsky S.B., 1997, PSYCHOL MUSIC, V25, P149, DOI 10.1177/ 0305735697252005.; Keller PE, 2010, J EXP PSYCHOL HUMAN, V36, P508, DOI 10.1037/a0017604; Knecht M.G., 2003, MUSIC EDUC RES, V5, P227; Kosslyn S. M., 1980, IMAGE MIND; LEVITIN DJ, 1994, PERCEPT PSYCHOPHYS, V56, P414, DOI 10.3758/BF03206733; Levitin DJ, 1996, PERCEPT PSYCHOPHYS, V58, P927, DOI 10.3758/BF03205494; Livingstone S, 2009, INT S PERF SCI AUCKL, P445; Lucas BJ, 2010, MUSIC PERCEPT, V27, P399, DOI 10.1525/mp.2010.27.5.399; Madison G, 2000, J NEW MUSIC RES, V29, P335, DOI 10.1080/09298210008565466; MCADAMS S, 1995, PSYCHOL RES-PSYCH FO, V58, P177, DOI 10.1007/BF00419633; Neuhoff JG, 1999, J EXP PSYCHOL HUMAN, V25, P1050, DOI 10.1037/0096-1523.25.4.1050; Ollen J, 2009, SOC MUS PERC COGN C; Ollen J.E., 2006, THESIS OHIO STATE U; Olsen KN, 2010, PERCEPTION, V39, P695, DOI 10.1068/p6592; Palmer C, 1997, ANNU REV PSYCHOL, V48, P115, DOI 10.1146/annurev.psych.48.1.115; Palmer C, 2003, PSYCHOL REV, V110, P683, DOI 10.1037/0033-295X.110.4.683; Pecenka N, 2009, ANN NY ACAD SCI, V1169, P282, DOI 10.1111/j.1749-6632.2009.04785.x; Penel A, 2004, PERCEPT PSYCHOPHYS, V66, P545, DOI 10.3758/BF03194900; PITT MA, 1992, J EXP PSYCHOL HUMAN, V18, P728, DOI 10.1037/0096-1523.18.3.728; PYLYSHYN ZW, 1981, PSYCHOL REV, V88, P16, DOI 10.1037/0033-295X.88.1.16; Quinn GP, 2003, EXPT DESIGN DATA ANA; Rammsayer T, 2006, MUSIC PERCEPT, V24, P37, DOI 10.1525/mp.2006.24.1.37; Repp B. H., 1997, MUSIC SCI, V1, P257, DOI DOI 10.1177/102986499700100206; Repp BH, 1999, MUSIC PERCEPT, V16, P409; Rosenberg HS, 1990, IMAGERY CURRENT PERS, P55; Schubert E, 2004, MUSIC PERCEPT, V21, P561, DOI 10.1525/mp.2004.21.4.561; SHIFFRIN RM, 1977, PSYCHOL REV, V84, P127, DOI 10.1037/0033-295X.84.2.127; Sloboda JA, 2001, MUSIC PERCEPT, V19, P87, DOI 10.1525/mp.2001.19.1.87; Sloboda JA, 2000, TRENDS COGN SCI, V4, P397, DOI 10.1016/S1364-6613(00)01531-X; Snyder J, 2001, MUSIC PERCEPT, V18, P455, DOI 10.1525/mp.2001.18.4.455; Snyder JS, 2006, MUSIC PERCEPT, V24, P135, DOI 10.1525/mp.2006.24.2.135; Strait DL, 2010, HEARING RES, V261, P22, DOI 10.1016/j.heares.2009.12.021; Tervaniemi M, 2005, EXP BRAIN RES, V161, P1, DOI 10.1007/s00221-004-2044-5; Thompson WL, 2008, MEM COGNITION, V36, P1024, DOI 10.3758/MC.36.5.1024; TURNER ML, 1989, J MEM LANG, V28, P127, DOI 10.1016/0749-596X(89)90040-5; WEBER RJ, 1986, MUSIC PERCEPT, V3, P411; Williamson A, 2002, COGNITIVE PSYCHOL, V44, P1, DOI 10.1006/cogp.2001.0759; Wollner C, 2007, RES STUD MUSIC EDUC, V29, P39; Wu JH, 2011, PSYCHOPHYSIOLOGY, V48, P415, DOI 10.1111/j.1469-8986.2010.01070.x; Zatorre RJ, 2005, NEURON, V47, P9, DOI 10.1016/j.neuron.2005.06.013	82	16	16	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e56052	10.1371/journal.pone.0056052	http://dx.doi.org/10.1371/journal.pone.0056052			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	098BN	23460791	Green Published, gold			2022-12-25	WOS:000315519000014
J	Fassbinder-Orth, CA; Barak, VA; Brown, CR				Fassbinder-Orth, Carol A.; Barak, Virginia A.; Brown, Charles R.			Immune Responses of a Native and an Invasive Bird to Buggy Creek Virus (Togaviridae: Alphavirus) and Its Arthropod Vector, the Swallow Bug (Oeciacus vicarius)	PLOS ONE			English	Article							WEST NILE VIRUS; ANTIBODY-RESPONSE; HOUSE SPARROWS; PASSER-DOMESTICUS; ANOPHELES-GAMBIAE; SALIVARY PROTEINS; MIGRATORY BIRDS; CLIFF SWALLOWS; UNITED-STATES; AEDES-AEGYPTI	Invasive species often display different patterns of parasite burden and virulence compared to their native counterparts. These differences may be the result of variability in host-parasite co-evolutionary relationships, the occurrence of novel host-parasite encounters, or possibly innate differences in physiological responses to infection between invasive and native hosts. Here we examine the adaptive, humoral immune responses of a resistant, native bird and a susceptible, invasive bird to an arbovirus (Buggy Creek virus; Togaviridae: Alphavirus) and its ectoparasitic arthropod vector (the swallow bug; Oeciacus vicarius). Swallow bugs parasitize the native, colonially nesting cliff swallow (Petrochelidon pyrrhonota) and the introduced house sparrow (Passer domesticus) that occupies nests in cliff swallow colonies. We measured levels of BCRV-specific and swallow bug-specific IgY levels before nesting (prior to swallow bug exposure) and after nesting (after swallow bug exposure) in house sparrows and cliff swallows in western Nebraska. Levels of BCRV-specific IgY increased significantly following nesting in the house sparrow but not in the cliff swallow. Additionally, house sparrows displayed consistently higher levels of swallow bug-specific antibodies both before and after nesting compared to cliff swallows. The higher levels of BCRV and swallow bug specific antibodies detected in house sparrows may be reflective of significant differences in both antiviral and anti-ectoparasite immune responses that exist between these two avian species. To our knowledge, this is the first study to compare the macro-and microparasite-specific immune responses of an invasive and a native avian host exposed to the same parasites.	[Fassbinder-Orth, Carol A.; Barak, Virginia A.] Creighton Univ, Dept Biol, Omaha, NE 68178 USA; [Brown, Charles R.] Univ Tulsa, Dept Biol Sci, Tulsa, OK 74104 USA	Creighton University; University of Tulsa	Fassbinder-Orth, CA (corresponding author), Creighton Univ, Dept Biol, Omaha, NE 68178 USA.	carolfassbinder-orth@creighton.edu			Creighton College of Arts and Sciences Faculty Summer Research Fellowship; Creighton College of Arts and Sciences Undergraduate Summer Research Scholarship; National Science Foundation [DEB-1019423]	Creighton College of Arts and Sciences Faculty Summer Research Fellowship; Creighton College of Arts and Sciences Undergraduate Summer Research Scholarship; National Science Foundation(National Science Foundation (NSF))	This work was funded by Creighton College of Arts and Sciences Faculty Summer Research Fellowship to CFO and Creighton College of Arts and Sciences Undergraduate Summer Research Scholarship to VAB (www.creighton.edu), and National Science Foundation grant DEB-1019423 to CRB (www.nsf.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson TR., 2006, BIOL UBIQUITOUS HOUS; Belkaid Y, 1998, J EXP MED, V188, P1941, DOI 10.1084/jem.188.10.1941; Boppana VD, 2009, PARASITE IMMUNOL, V31, P287, DOI 10.1111/j.1365-3024.2009.01096.x; Brown C. R., 1996, COLONIALITY CLIFF SW; Brown C.R., 2011, ORNITHOL MONOGR, V71, P1, DOI [DOI 10.1525/0M.2011.71.1.1, 10.1525/om.2011.71.1.1.1, DOI 10.1525/OM.2011.71.1.1.1]; Brown CR, 2012, VECTOR-BORNE ZOONOT, V12, P34, DOI 10.1089/vbz.2011.0677; Brown CR, 2010, J MED ENTOMOL, V47, P436, DOI 10.1603/ME09288; Brown CR, 2010, VECTOR-BORNE ZOONOT, V10, P355, DOI 10.1089/vbz.2009.0031; Brown CR, 2009, ECOLOGY, V90, P3168, DOI 10.1890/08-1731.1; BROWN CR, 1986, ECOLOGY, V67, P1206, DOI 10.2307/1938676; Brown CR, 2004, ECOLOGY, V85, P1619, DOI 10.1890/03-0206; Brown CR, 2001, P ROY SOC B-BIOL SCI, V268, P1833, DOI 10.1098/rspb.2001.1749; CALISHER CH, 1994, CLIN MICROBIOL REV, V7, P89, DOI 10.1128/CMR.7.1.89-116.1994; CALISHER CH, 1980, AM J TROP MED HYG, V29, P1428, DOI 10.4269/ajtmh.1980.29.1428; Callaway RM, 2004, FRONT ECOL ENVIRON, V2, P436, DOI 10.2307/3868432; Dusek RJ, 2009, AM J TROP MED HYG, V81, P1151, DOI 10.4269/ajtmh.2009.09-0106; Fitze PS, 2004, J ANIM ECOL, V73, P216, DOI 10.1111/j.0021-8790.2004.00799.x; HAMILTON WD, 1982, SCIENCE, V218, P384, DOI 10.1126/science.7123238; HAYES RO, 1977, J MED ENTOMOL, V14, P257, DOI 10.1093/jmedent/14.3.257; HOPLA CE, 1993, J MED ENTOMOL, V30, P267, DOI 10.1093/jmedent/30.1.267; Hostomska J, 2008, VECTOR-BORNE ZOONOT, V8, P443, DOI 10.1089/vbz.2007.0214; Huber SK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008605; Kelly DW, 2009, ECOLOGY, V90, P2047, DOI 10.1890/08-1085.1; King MO, 2011, AUK, V128, P340, DOI 10.1525/auk.2011.10253; Lee KA, 2005, OECOLOGIA, V145, P244, DOI 10.1007/s00442-005-0113-5; Lee KA, 2004, TRENDS ECOL EVOL, V19, P523, DOI 10.1016/j.tree.2004.07.012; Lee KA, 2006, OECOLOGIA, V150, P383, DOI 10.1007/s00442-006-0537-6; LOWTHER PE, 1992, BIRDS N AM; Machain-Williams C, 2012, PARASITE IMMUNOL, V34, P15, DOI 10.1111/j.1365-3024.2011.01339.x; Marzal A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021905; Medzhitov R, 2012, SCIENCE, V335, P936, DOI 10.1126/science.1214935; MOLLER AP, 1993, J ANIM ECOL, V62, P309, DOI 10.2307/5362; Moore AT, 2007, J MED ENTOMOL, V44, P42, DOI 10.1603/0022-2585(2007)44[42:ECOBCV]2.0.CO;2; Moseman EA, 2012, IMMUNITY, V36, P415, DOI 10.1016/j.immuni.2012.01.013; O'Brien VA, 2012, J WILDLIFE DIS, V48, P138, DOI 10.7589/0090-3558-48.1.138; O'Brien VA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025521; O'Brien VA, 2011, P ROY SOC B-BIOL SCI, V278, P239, DOI 10.1098/rspb.2010.1098; O'Brien VA, 2010, AM J TROP MED HYG, V82, P937, DOI 10.4269/ajtmh.2010.09-0515; O'Brien VA, 2010, J WILDLIFE DIS, V46, P23, DOI 10.7589/0090-3558-46.1.23; Orlandi-Pradines E, 2007, MICROBES INFECT, V9, P1454, DOI 10.1016/j.micinf.2007.07.012; Peng ZK, 2004, J ALLERGY CLIN IMMUN, V114, P1189, DOI 10.1016/j.jaci.2004.08.014; Pfeffer M, 2006, APPL ENVIRON MICROB, V72, P6886, DOI 10.1128/AEM.00868-06; Powers AM, 2001, J VIROL, V75, P10118, DOI 10.1128/JVI.75.21.10118-10131.2001; Proctor H, 2000, TRENDS ECOL EVOL, V15, P358, DOI 10.1016/S0169-5347(00)01924-8; Ramamoorthi N, 2005, NATURE, V436, P573, DOI 10.1038/nature03812; Reisen WK, 2010, AM J TROP MED HYG, V83, P808, DOI 10.4269/ajtmh.2010.10-0200; Reisen WK, 2003, J MED ENTOMOL, V40, P968, DOI 10.1603/0022-2585-40.6.968; Restif O, 2004, AM NAT, V164, pE90, DOI 10.1086/423713; Rizzo C, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-206; Robbins C.S., 1973, Ornithological Monographs, VNo. 14, P3; Sanders ML, 1998, AM J TROP MED HYG, V59, P279, DOI 10.4269/ajtmh.1998.59.279; Schneider BS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001171; Schneider BS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011704; Schwarz A, 2009, INT J PARASITOL, V39, P1021, DOI 10.1016/j.ijpara.2009.01.010; Tsujimoto H, 2010, PARASITE IMMUNOL, V32, P275, DOI 10.1111/j.1365-3024.2009.01186.x; Wikel SK, 1999, INT J PARASITOL, V29, P851, DOI 10.1016/S0020-7519(99)00042-9; Wilkinson L, 1999, SYSTAT; Zeidner NS, 1999, PARASITE IMMUNOL, V21, P35, DOI 10.1046/j.1365-3024.1999.00199.x; [No title captured]	59	18	21	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e58045	10.1371/journal.pone.0058045	http://dx.doi.org/10.1371/journal.pone.0058045			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460922	Green Submitted, gold, Green Published			2022-12-25	WOS:000315519000177
J	Liu, JG; Folberth, C; Yang, H; Rockstrom, J; Abbaspour, K; Zehnder, AJB				Liu, Junguo; Folberth, Christian; Yang, Hong; Rockstrom, Johan; Abbaspour, Karim; Zehnder, Alexander J. B.			A Global and Spatially Explicit Assessment of Climate Change Impacts on Crop Production and Consumptive Water Use	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; FOOD SECURITY; HIGH-RESOLUTION; SRES EMISSIONS; WHEAT YIELD; EPIC MODEL; AGRICULTURE; ADAPTATION; MAIZE; AVAILABILITY	Food security and water scarcity have become two major concerns for future human's sustainable development, particularly in the context of climate change. Here we present a comprehensive assessment of climate change impacts on the production and water use of major cereal crops on a global scale with a spatial resolution of 30 arc-minutes for the 2030s (short term) and the 2090s (long term), respectively. Our findings show that impact uncertainties are higher on larger spatial scales (e.g., global and continental) but lower on smaller spatial scales (e.g., national and grid cell). Such patterns allow decision makers and investors to take adaptive measures without being puzzled by a highly uncertain future at the global level. Short-term gains in crop production from climate change are projected for many regions, particularly in African countries, but the gains will mostly vanish and turn to losses in the long run. Irrigation dependence in crop production is projected to increase in general. However, several water poor regions will rely less heavily on irrigation, conducive to alleviating regional water scarcity. The heterogeneity of spatial patterns and the non-linearity of temporal changes of the impacts call for site-specific adaptive measures with perspectives of reducing short-and long-term risks of future food and water security.	[Liu, Junguo] Beijing Forestry Univ, Sch Nat Conservat, Beijing, Peoples R China; [Liu, Junguo] Int Inst Appl Syst Anal, Ecosyst Serv & Management Program, A-2361 Laxenburg, Austria; [Folberth, Christian; Yang, Hong; Abbaspour, Karim] Swiss Fed Inst Aquat Sci & Technol, SIAM, Dubendorf, Switzerland; [Rockstrom, Johan] Stockholm Environm Inst, Stockholm, Sweden; [Zehnder, Alexander J. B.] Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore; [Zehnder, Alexander J. B.] Alberta Water Res Inst, Edmonton, AB, Canada	Beijing Forestry University; International Institute for Applied Systems Analysis (IIASA); Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); Stockholm Environment Institute; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Liu, JG (corresponding author), Beijing Forestry Univ, Sch Nat Conservat, Beijing, Peoples R China.	junguo.liu@gmail.com	Liu, Junguo/B-3021-2012; Yang, Hong/AAA-5152-2020	Liu, Junguo/0000-0002-5745-6311; Folberth, Christian/0000-0002-6738-5238; Rockstrom, Johan/0000-0001-8988-2983	National Natural Science Foundation of China [91025009]; Projects of International Cooperation and Exchanges NSFC [41161140353]; New Century Excellent Talents in University [NCET-09-0222]; Special Fund for Forestry Scientific Research in the Public Interest [201204204]; International S&T Cooperation Program from the Ministry of Science and Technology of China [2012DFA91530]; Fundamental Research Funds for the Central Universities [HJ2010-1]; Swiss National Science Foundation [K-21K0_122479]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Projects of International Cooperation and Exchanges NSFC; New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Special Fund for Forestry Scientific Research in the Public Interest; International S&T Cooperation Program from the Ministry of Science and Technology of China; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study was supported by the National Natural Science Foundation of China (91025009) and Projects of International Cooperation and Exchanges NSFC (41161140353), New Century Excellent Talents in University (NCET-09-0222), the Special Fund for Forestry Scientific Research in the Public Interest (No. 201204204), International S&T Cooperation Program from the Ministry of Science and Technology of China (2012DFA91530), Fundamental Research Funds for the Central Universities (HJ2010-1), and the Swiss National Science Foundation (K-21K0_122479). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adejuwon JO, 2006, CLIM RES, V32, P229, DOI 10.3354/cr032229; Aggarwal PK, 2008, INDIAN J AGR SCI, V78, P911; Arnell NW, 2004, GLOBAL ENVIRON CHANG, V14, P31, DOI 10.1016/j.gloenvcha.2003.10.006; Babel MS, 2011, CLIM RES, V46, P137, DOI 10.3354/cr00978; Bernardos JN, 2001, AGR SYST, V69, P215, DOI 10.1016/S0308-521X(01)00027-0; Bondeau A, 2007, GLOBAL CHANGE BIOL, V13, P679, DOI 10.1111/j.1365-2486.2006.01305.x; Brown ME, 2008, SCIENCE, V319, P580, DOI 10.1126/science.1154102; Chavas DR, 2009, AGR FOREST METEOROL, V149, P1118, DOI 10.1016/j.agrformet.2009.02.001; Deryng D, 2011, GLOBAL BIOGEOCHEM CY, V25, DOI 10.1029/2009GB003765; Easterling WE, 1996, CLIMATE RES, V6, P263, DOI 10.3354/cr006263; Faramarzi M, 2013, J HYDROL, V480, P85, DOI 10.1016/j.jhydrol.2012.12.016; Fedoroff NV, 2010, SCIENCE, V327, P833, DOI 10.1126/science.1186834; Flato GM, 2001, GEOPHYS RES LETT, V28, P195, DOI 10.1029/2000GL012121; Folberth C, 2012, ECOL MODEL, V235, P8, DOI 10.1016/j.ecolmodel.2012.03.035; Folberth C, 2012, AGR ECOSYST ENVIRON, V151, P21, DOI 10.1016/j.agee.2012.01.026; Gaiser T, 2011, AGR FOREST METEOROL, V151, P1120, DOI 10.1016/j.agrformet.2011.03.015; Gassman PW, 2005, HIST DEV APPL EPIC A; Gedney N, 2006, NATURE, V439, P835, DOI 10.1038/nature04504; Ghosh S, 2007, WATER RESOUR RES, V43, DOI 10.1029/2006WR005351; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Gordon HB, 1997, MON WEATHER REV, V125, P875, DOI 10.1175/1520-0493(1997)125<0875:TCCITC>2.0.CO;2; GWSP Digital Water Atlas, 2008, MAP 7 WAT STRESS V1; Hargreaves G. H., 1985, Applied Engineering in Agriculture, V1, P96; Heijmans MMPD, 2001, GLOBAL CHANGE BIOL, V7, P817, DOI 10.1046/j.1354-1013.2001.00440.x; Intergovernmental Panel on Climate Change { IPCC, 2007, GENEBRA SUICA; IPCC, 2001, CLIMATE CHANGE 2001, DOI DOI 10.1017/CBO9781107415379; Liu J, 2007, IRRIGATION SCI, V26, P21, DOI 10.1007/s00271-007-0069-9; Liu JG, 2007, AGR SYST, V94, P478, DOI 10.1016/j.agsy.2006.11.019; Liu JG, 2010, J HYDROL, V384, P187, DOI 10.1016/j.jhydrol.2009.11.024; Liu JG, 2009, WATER RESOUR RES, V45, DOI 10.1029/2007WR006051; Liu J, 2009, ENVIRON MODELL SOFTW, V24, P655, DOI 10.1016/j.envsoft.2008.10.008; Liu JG, 2008, GLOBAL PLANET CHANGE, V64, P222, DOI 10.1016/j.gloplacha.2008.09.007; Liu JG, 2009, ENVIRON MODELL SOFTW, V24, P411, DOI 10.1016/j.envsoft.2008.08.004; Lobell DB, 2008, SCIENCE, V319, P607, DOI 10.1126/science.1152339; Milly PCD, 2008, SCIENCE, V319, P573, DOI 10.1126/science.1151915; MITCHELL JFB, 1998, 2 HADL CTR; Mitchell T. D., 2004, TYNDALL CTR CLIMATE, V55, P25; Mitchell TD, 2005, INT J CLIMATOL, V25, P693, DOI 10.1002/joc.1181; Muller C, 2011, P NATL ACAD SCI USA, V108, P4313, DOI 10.1073/pnas.1015078108; Nakicenovic N., 2000, SPECIAL REPORT EMISS; PARRY M, 1999, GLOBAL ENVIRON CHANG, V9, pS51, DOI DOI 10.1016/S0959-3780(99)00018-7; Parry ML, 2004, GLOBAL ENVIRON CHANG, V14, P53, DOI 10.1016/j.gloenvcha.2003.10.008; Pierson ST, 2001, J ENVIRON QUAL, V30, P1790, DOI 10.2134/jeq2001.3051790x; Portmann F., 2008, GLOBAL DATA SET MONT; Priya S, 2001, ECOL MODEL, V136, P113, DOI 10.1016/S0304-3800(00)00364-1; Ramankutty N, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB002952; Reilly J, 2000, CLIMATIC CHANGE, V45, P253, DOI 10.1023/A:1005669807945; Rinaldi M, 2001, AGR WATER MANAGE, V49, P185, DOI 10.1016/S0378-3774(00)00148-7; Rosegrant MW, 2003, SCIENCE, V302, P1917, DOI 10.1126/science.1092958; ROSENZWEIG C, 1994, NATURE, V367, P133, DOI 10.1038/367133a0; Schmidhuber J, 2007, P NATL ACAD SCI USA, V104, P19703, DOI 10.1073/pnas.0701976104; Siebert S, 2010, J HYDROL, V384, P198, DOI 10.1016/j.jhydrol.2009.07.031; Tao F, 2008, AGR FOREST METEOROL, V148, P94, DOI 10.1016/j.agrformet.2007.09.012; Thornton PK, 2010, AGR SYST, V103, P73, DOI 10.1016/j.agsy.2009.09.003; Valmir da Silva R, HYDROLOGICAL PROCESS, V25, P2715; van der Velde M, 2012, CLIMATIC CHANGE, V113, P751, DOI 10.1007/s10584-011-0368-2; Vorosmarty CJ, 2000, SCIENCE, V289, P284, DOI 10.1126/science.289.5477.284; Washington WM, 2000, CLIM DYNAM, V16, P755, DOI 10.1007/s003820000079; WILLIAMS JR, 1989, T ASAE, V32, P497; Xiong W, 2009, GLOBAL ENVIRON CHANG, V19, P34, DOI 10.1016/j.gloenvcha.2008.10.006; Zwart SJ, 2010, AGR WATER MANAGE, V97, P1617, DOI 10.1016/j.agwat.2010.05.018; Zwart SJ, 2004, AGR WATER MANAGE, V69, P115, DOI 10.1016/j.agwat.2004.04.007	62	65	69	4	126	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57750	10.1371/journal.pone.0057750	http://dx.doi.org/10.1371/journal.pone.0057750			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460901	Green Accepted, gold, Green Submitted, Green Published			2022-12-25	WOS:000315519000156
J	Turroni, S; Tolomeo, M; Mamone, G; Picariello, G; Giacomini, E; Brigidi, P; Roberti, M; Grimaudo, S; Pipitone, RM; Di Cristina, A; Recanatini, M				Turroni, Silvia; Tolomeo, Manlio; Mamone, Gianfranco; Picariello, Gianluca; Giacomini, Elisa; Brigidi, Patrizia; Roberti, Marinella; Grimaudo, Stefania; Pipitone, Rosaria Maria; Di Cristina, Antonietta; Recanatini, Maurizio			A Natural-Like Synthetic Small Molecule Impairs Bcr-Abl Signaling Cascades and Induces Megakaryocyte Differentiation in Erythroleukemia Cells	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; ERYTHROID-DIFFERENTIATION; TYROSINE KINASE; MYC; THERAPY; OVEREXPRESSION; RESISTANCE; INDUCTION; APOPTOSIS; BIOLOGY	Over the past years, we synthesized a series of new molecules that are hybrids of spirocyclic ketones as complexity-bearing cores with bi- and ter-phenyls as privileged fragments. Some of these newly-shaped small molecules showed antiproliferative, pro-apoptotic and differentiating activity in leukemia cell lines. In the present study, to investigate more in depth the mechanisms of action of these molecules, the protein expression profiles of K562 cells treated with or without the compounds IND_S1, MEL_T1, IND_S7 and MEL_S3 were analyzed using two-dimensional gel electrophoresis coupled with mass spectrometry. Proteome comparisons revealed several differentially expressed proteins, mainly related to cellular metabolism, chaperone activity, cytoskeletal organization and RNA biogenesis. The major results were validated by Western blot and qPCR. To attempt integrating findings into a cellular signaling context, proteomic data were explored using MetaCore. Network analysis highlighted relevant relationships between the identified proteins and additional potential effectors. Notably, qPCR validation of central hubs showed that the compound MEL_S3 induced high mRNA levels of the transcriptional factors EGR1 and HNF4-alpha; the latter to our knowledge is reported here for the first time to be present in K562 cells. Consistently with the known EGR1 involvement in the regulation of differentiation along megakaryocyte lineage, MEL_S3-treated leukemia cells showed a marked expression of glycoprotein IIb/IIIa (CD41) and glycoprotein Ib (CD42), two important cell markers in megakaryocytic differentiation, together with morphological aspects of megakaryoblasts and megakaryocytes.	[Turroni, Silvia; Giacomini, Elisa; Brigidi, Patrizia; Roberti, Marinella; Recanatini, Maurizio] Univ Bologna, Dept Pharm & Biotechnol, Bologna, Italy; [Tolomeo, Manlio; Grimaudo, Stefania; Pipitone, Rosaria Maria; Di Cristina, Antonietta] Univ Palermo, Interdept Ctr Res Clin Oncol, Palermo, Italy; [Tolomeo, Manlio; Grimaudo, Stefania; Pipitone, Rosaria Maria; Di Cristina, Antonietta] Univ Palermo, Dept Infect Dis, Palermo, Italy; [Mamone, Gianfranco; Picariello, Gianluca] CNR, Inst Food Sci, Avellino, Italy	University of Bologna; University of Palermo; University of Palermo; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze dell' Alimentazione (ISA-CNR)	Roberti, M (corresponding author), Univ Bologna, Dept Pharm & Biotechnol, Bologna, Italy.	marinella.roberti@unibo.it	Mamone, Gianfranco/AAX-8690-2020; Recanatini, Maurizio/AAU-3319-2021; Turroni, Silvia/J-7195-2016; Roberti, Marinella/R-1996-2016; Recanatini, Maurizio/GXH-1338-2022	Mamone, Gianfranco/0000-0002-0394-7617; Recanatini, Maurizio/0000-0002-0039-0518; Turroni, Silvia/0000-0003-2345-9482; Tolomeo, Manlio/0000-0002-7974-2319; PICARIELLO, Gianluca/0000-0003-1290-1239; PIPITONE, Rosaria Maria/0000-0002-6721-3962; Brigidi, Patrizia/0000-0001-8375-6150; Grimaudo, Stefania/0000-0003-3225-4112	MIUR, Italy	MIUR, Italy(Ministry of Education, Universities and Research (MIUR))	This work was supported by a PRIN2009 Project Grant from MIUR, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An X, 2010, LEUKEMIA RES, V34, P1255, DOI 10.1016/j.leukres.2010.04.016; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Bantscheff M, 2011, BIOORG MED CHEM; Branford S, 2011, CURR OPIN HEMATOL, V18, P111, DOI 10.1097/MOH.0b013e32834399ef; BREITMAN TR, 1980, P NATL ACAD SCI-BIOL, V77, P2936, DOI 10.1073/pnas.77.5.2936; Buchi F, 2011, LEUKEMIA RES, V35, P921, DOI 10.1016/j.leukres.2011.01.033; Caraux G, 2005, BIOINFORMATICS, V21, P1280, DOI 10.1093/bioinformatics/bti141; Cheng EHY, 2003, SCIENCE, V301, P513, DOI 10.1126/science.1083995; CHENG T, 1994, J BIOL CHEM, V269, P30848; Cornelison A Megan, 2011, Clin Lymphoma Myeloma Leuk, V11 Suppl 1, pS101, DOI 10.1016/j.clml.2011.02.009; Deininger MWN, 2000, BLOOD, V96, P3343, DOI 10.1182/blood.V96.10.3343; Druker BJ, 1996, NAT MED, V2, P561, DOI 10.1038/nm0596-561; Du QF, 2010, MED ONCOL, V27, P673, DOI 10.1007/s12032-009-9267-z; Eiring AM, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-99; Felsher DW, 2000, P NATL ACAD SCI USA, V97, P10544, DOI 10.1073/pnas.190327097; Galluzzi L, 2006, ONCOGENE, V25, P4812, DOI 10.1038/sj.onc.1209598; Garrido C, 2001, BIOCHEM BIOPH RES CO, V286, P433, DOI 10.1006/bbrc.2001.5427; Gartel AL, 2001, P NATL ACAD SCI USA, V98, P4510, DOI 10.1073/pnas.081074898; Gobom J, 1999, J MASS SPECTROM, V34, P105, DOI 10.1002/(SICI)1096-9888(199902)34:2<105::AID-JMS768>3.0.CO;2-4; Goehe RW, 2010, J CLIN INVEST, V120, P3923, DOI 10.1172/JCI43552; GORG A, 1988, ELECTROPHORESIS, V9, P531, DOI 10.1002/elps.1150090913; Hong Y, 1996, BLOOD, V87, P123, DOI 10.1182/blood.V87.1.123.bloodjournal871123; Hwang-Verslues WW, 2008, MOL ENDOCRINOL, V22, P78, DOI 10.1210/me.2007-0298; Iervolino A, 2002, MOL CELL BIOL, V22, P2255, DOI 10.1128/MCB.22.7.2255-2266.2002; Jin S, 2007, J CELL SCI, V120, P379, DOI 10.1242/jcs.03349; KANZ L, 1987, KLIN WOCHENSCHR, V65, P297, DOI 10.1007/BF01745383; Khalil AA, 2011, BBA-REV CANCER, V1816, P89, DOI 10.1016/j.bbcan.2011.05.001; Koppenol WH, 2011, NAT REV CANCER, V11, P325, DOI 10.1038/nrc3038; Leps J, 2003, MULTIVARIATE ANAL EC; LONG MW, 1990, J CLIN INVEST, V85, P1072, DOI 10.1172/JCI114538; Mazzoni C, 2009, YEAST, V26, P31, DOI 10.1002/yea.1647; Meunier B, 2007, J PROTEOME RES, V6, P358, DOI 10.1021/pr060343h; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; Munoz-Alonso MJ, 2012, J CELL PHYSIOL, V227, P2069, DOI 10.1002/jcp.22935; Nowak D, 2009, BLOOD, V113, P3655, DOI 10.1182/blood-2009-01-198911; Osti F, 1997, HAEMATOLOGICA, V82, P395; Perrotti D, 2007, CLIN CANCER RES, V13, P1638, DOI 10.1158/1078-0432.CCR-06-2320; Perrotti D, 2011, LEUKEMIA LYMPHOMA, V52, P30, DOI 10.3109/10428194.2010.546914; Pizzirani D, 2007, TETRAHEDRON LETT, V48, P7120, DOI 10.1016/j.tetlet.2007.07.214; Pizzirani D, 2009, J MED CHEM, V52, P6936, DOI 10.1021/jm900907s; Pocaly M, 2007, LEUKEMIA, V21, P93, DOI 10.1038/sj.leu.2404463; Quintas-Cardama A, 2009, BLOOD, V113, P1619, DOI 10.1182/blood-2008-03-144790; Romanov V, 2011, APOPTOSIS, V16, P1217, DOI 10.1007/s10495-011-0646-5; Schmitt E, 2007, J LEUKOCYTE BIOL, V81, P15, DOI 10.1189/jlb.0306167; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Sreedhar AS, 2004, PHARMACOL THERAPEUT, V101, P227, DOI 10.1016/j.pharmthera.2003.11.004; Tolomeo M, 2009, ANTI-CANCER AGENT ME, V9, P853, DOI 10.2174/187152009789124637; Turroni S, 2010, WORLD J GASTROENTERO, V16, P30, DOI 10.3748/wjg.v16.i1.30; Valledor AF, 1998, J LEUKOCYTE BIOL, V63, P405, DOI 10.1002/jlb.63.4.405; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Walz C, 2006, CRIT REV ONCOL HEMAT, V57, P145, DOI 10.1016/j.critrevonc.2005.06.007; Wei Q, 2006, FRONT BIOSCI-LANDMRK, V11, P977, DOI 10.2741/1854; Wierzba K, 2011, CURR OPIN CHEM BIOL, V15, P57, DOI 10.1016/j.cbpa.2010.10.009	54	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57650	10.1371/journal.pone.0057650	http://dx.doi.org/10.1371/journal.pone.0057650			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460890	Green Published, gold, Green Submitted			2022-12-25	WOS:000315519000145
J	Willemink, MJ; Borstlap, J; Takx, RAP; Schilham, AMR; Leiner, T; Budde, RPJ; de Jong, PA				Willemink, Martin J.; Borstlap, Jaap; Takx, Richard A. P.; Schilham, Arnold M. R.; Leiner, Tim; Budde, Ricardo P. J.; de Jong, Pim A.			The Effects of Computed Tomography with Iterative Reconstruction on Solid Pulmonary Nodule Volume Quantification	PLOS ONE			English	Article							DOSE CT; CHEST; VARIABILITY; PERFORMANCE; ALGORITHM; GROWTH	Background: The objectives of this study were to evaluate the influence of iterative reconstruction (IR) on pulmonary nodule volumetry with chest computed tomography (CT). Methods: Twenty patients (12 women and 8 men, mean age 61.9, range 32-87) underwent evaluation of pulmonary nodules with a 64-slice CT-scanner. Data were reconstructed using filtered back projection (FBP) and IR (Philips Healthcare, iDose(4)-levels 2, 4 and 6) at similar radiation dose. Volumetric nodule measurements were performed with semi-automatic software on thin slice reconstructions. Only solid pulmonary nodules were measured, no additional selection criteria were used for the nature of nodules. For intra-observer and inter-observer variability, measurements were performed once by one observer and twice by another observer. Algorithms were compared using the concordance correlation-coefficient (p(c)) and Friedman-test, and post-hoc analysis with the Wilcoxon-signed ranks-test with Bonferroni-correction (significance-level p<0.017). Results: Seventy-eight nodules were present including 56 small nodules (volume<200 mm(3), diameter<8 mm) and 22 large nodules (volume >= 200 mm(3), diameter >= 8 mm). No significant differences in measured pulmonary nodule volumes between FBP, iDose 4 -levels 2, 4 and 6 were found in both small nodules and large nodules. FBP and iDose 4 -levels 2, 4 and 6 were correlated with p(c)-values of 0.98 or higher for both small and large nodules. P-c-values of intra-observer and inter-observer variability were 0.98 or higher. Conclusions: Measurements of solid pulmonary nodule volume measured with standard-FBP were comparable with IR, regardless of the IR-level and no significant differences between measured volumes of both small and large solid nodules were found.	[Willemink, Martin J.; Borstlap, Jaap; Takx, Richard A. P.; Schilham, Arnold M. R.; Leiner, Tim; Budde, Ricardo P. J.; de Jong, Pim A.] Univ Utrecht, Med Ctr, Utrecht, Netherlands; [Budde, Ricardo P. J.] Gelre Hosp, Dept Radiol, Apeldoorn, Netherlands	Utrecht University; Gelre Hospitals	Willemink, MJ (corresponding author), Univ Utrecht, Med Ctr, Utrecht, Netherlands.	m.willemink@umcutrecht.nl	de Jong, Pim A/G-7220-2014; Willemink, Martin/GRX-4798-2022; Takx, Richard/T-2852-2019; Willemink, Martin/M-3650-2013; Budde, Ricardo/E-4252-2015	de Jong, Pim A/0000-0003-4840-6854; Willemink, Martin/0000-0002-6991-6557; Takx, Richard/0000-0003-2252-3040; Willemink, Martin/0000-0002-6991-6557; 				Ahn MI, 2010, RADIOLOGY, V254, P949, DOI 10.1148/radiol.09090031; Beister M, 2012, PHYS MEDICA, V28, P94, DOI 10.1016/j.ejmp.2012.01.003; de Hoop B, 2009, EUR RADIOL, V19, P800, DOI 10.1007/s00330-008-1229-x; Deak PD, 2010, RADIOLOGY, V257, P158, DOI 10.1148/radiol.10100047; Funama Y, 2011, J COMPUT ASSIST TOMO, V35, P480, DOI 10.1097/RCT.0b013e31821fee94; Gervaise A, 2012, EUR RADIOL, V22, P295, DOI 10.1007/s00330-011-2271-7; Gietema HA, 2006, RADIOLOGY, V241, P251, DOI 10.1148/radiol.2411050860; Habets J, 2012, INT J CARDIOVAS IMAG, V28, P1567, DOI 10.1007/s10554-011-9954-7; Hansell DM, 2008, RADIOLOGY, V246, P697, DOI 10.1148/radiol.2462070712; Hein PA, 2009, ROFO-FORTSCHR RONTG, V181, P24, DOI 10.1055/s-2008-1027874; Hein PA, 2010, J DIGIT IMAGING, V23, P8, DOI 10.1007/s10278-008-9157-5; Hu XH, 2011, CLIN RADIOL, V66, P1023, DOI 10.1016/j.crad.2011.04.008; LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051; MacMahon H, 2005, RADIOLOGY, V237, P395, DOI 10.1148/radiol.2372041887; McBride GB, 2005, HAM2005062 NIWA; Noel PB, 2011, AM J ROENTGENOL, V197, P1404, DOI 10.2214/AJR.11.6907; Ost D, 2003, NEW ENGL J MED, V348, P2535, DOI 10.1056/NEJMcp012290; Pontana F, 2011, EUR RADIOL, V21, P636, DOI 10.1007/s00330-010-1991-4; Prakash P, 2010, RADIOLOGY, V256, P261, DOI 10.1148/radiol.10091487; Prakash P, 2010, J COMPUT ASSIST TOMO, V34, P40, DOI 10.1097/RCT.0b013e3181b26c67; Revel MP, 2004, RADIOLOGY, V231, P459, DOI 10.1148/radiol.2312030241; Scibelli A, 2011, IDOSE ITERATIVE RECO; Singh S, 2011, RADIOLOGY, V259, P565, DOI 10.1148/radiol.11101450; Utsunomiya D, 2012, EUR RADIOL, V22, P1287, DOI 10.1007/s00330-011-2361-6; Willemink MJ, 2013, EUR RADIOL, V23, P1623, DOI 10.1007/s00330-012-2765-y; Willemink MJ, 2013, EUR RADIOL, V23, P1632, DOI 10.1007/s00330-012-2764-z; Willemink MJ, 2012, AM J ROENTGENOL, V199, P1241, DOI 10.2214/AJR.12.8727; Wormanns D, 2004, EUR RADIOL, V14, P86, DOI 10.1007/s00330-003-2132-0; Xu DM, 2009, RADIOLOGY, V250, P264, DOI 10.1148/radiol.2493070847; Yanagawa M, 2012, EUR J RADIOL, V81, P2877, DOI 10.1016/j.ejrad.2011.09.011; Yanagawa M, 2010, ACAD RADIOL, V17, P1259, DOI 10.1016/j.acra.2010.05.014; Yankelevitz DF, 2000, RADIOLOGY, V217, P251, DOI 10.1148/radiology.217.1.r00oc33251	32	30	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e58053	10.1371/journal.pone.0058053	http://dx.doi.org/10.1371/journal.pone.0058053			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460924	Green Published, gold, Green Submitted			2022-12-25	WOS:000315519000179
J	Cruz, SM; Hooten, M; Huyvaert, KP; Proano, CB; Anderson, DJ; Afanasyev, V; Wikelski, M				Cruz, Sebastian M.; Hooten, Mevin; Huyvaert, Kathryn P.; Proano, Carolina B.; Anderson, David J.; Afanasyev, Vsevolod; Wikelski, Martin			At-Sea Behavior Varies with Lunar Phase in a Nocturnal Pelagic Seabird, the Swallow-Tailed Gull	PLOS ONE			English	Article							VERTICAL MIGRATION; FORAGING ACTIVITY; ACTIVITY PATTERN; CYCLES; MOONLIGHT; PREDATION; AVOIDANCE; ALBATROSS; NIGHT; LIGHT	Strong and predictable environmental variability can reward flexible behaviors among animals. We used long-term records of activity data that cover several lunar cycles to investigate whether behavior at-sea of swallow-tailed gulls Creagrus furcatus, a nocturnal pelagic seabird, varied with lunar phase in the Galapagos Islands. A Bayesian hierarchical model showed that nighttime at-sea activity of 37 breeding swallow-tailed gulls was clearly associated with changes in moon phase. Proportion of nighttime spent on water was highest during darker periods of the lunar cycle, coinciding with the cycle of the diel vertical migration (DVM) that brings prey to the sea surface at night. Our data show that at-sea behavior of a tropical seabird can vary with environmental changes, including lunar phase.	[Cruz, Sebastian M.; Proano, Carolina B.; Wikelski, Martin] Max Planck Inst Ornithol, Dept Migrat & Immunoecol, Radolfzell am Bodensee, Baden Wurttembe, Germany; [Hooten, Mevin] US Geol Survey, Colorado Cooperat Fish & Wildlife Res Unit, Ft Collins, CO USA; [Hooten, Mevin; Huyvaert, Kathryn P.] Colorado State Univ, Dept Fish Wildlife & Conservat Biol, Ft Collins, CO 80523 USA; [Anderson, David J.] Wake Forest Univ, Dept Biol, Winston Salem, NC 27109 USA; [Afanasyev, Vsevolod] British Antarctic Survey, Nat Environm Res Council, Cambridge, England; [Wikelski, Martin] Univ Konstanz, Constance, Baden Wurttembe, Germany	Max Planck Society; United States Department of the Interior; United States Geological Survey; Colorado State University; Wake Forest University; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; University of Konstanz	Cruz, SM (corresponding author), Max Planck Inst Ornithol, Dept Migrat & Immunoecol, Radolfzell am Bodensee, Baden Wurttembe, Germany.	cruz.seb@gmail.com	Callahan, Charles D/L-1641-2013; Huyvaert, Kathryn P/A-2710-2009	Huyvaert, Kathryn P/0000-0003-3302-030X	Max Planck Society; National Science Foundation [DEB 0842199]; NERC [bas010011] Funding Source: UKRI; Natural Environment Research Council [bas010011] Funding Source: researchfish	Max Planck Society(Max Planck SocietyFoundation CELLEX); National Science Foundation(National Science Foundation (NSF)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work had the support from the Max Planck Society (http://www.orn.mpg.de/) and National Science Foundation (http://www.nsf.gov/) Grant No. DEB 0842199. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awkerman JA, 2005, MAR ECOL PROG SER, V291, P289, DOI 10.3354/meps291289; Ballance L. T., 1999, P INT ORN C, P2057; Ballance LT, 2006, PROG OCEANOGR, V69, P360, DOI 10.1016/j.pocean.2006.03.013; Ballance Lisa T., 2007, Marine Ornithology, V35, P127; BRINTON E, 1967, LIMNOL OCEANOGR, V12, P451, DOI 10.4319/lo.1967.12.3.0451; Castro P., 2009, MARINE BIOL; Croxall JP, 2005, SCIENCE, V307, P249, DOI 10.1126/science.1106042; Cubaynes S, 2011, BIOL LETTERS, V7, P303, DOI 10.1098/rsbl.2010.0778; Dall SRX, 2005, TRENDS ECOL EVOL, V20, P187, DOI 10.1016/j.tree.2005.01.010; DALY M, 1992, ANIM BEHAV, V44, P1, DOI 10.1016/S0003-3472(05)80748-1; deBruyn AMH, 2001, MAR ECOL PROG SER, V214, P307, DOI 10.3354/meps214307; Fernandez P, 2000, CONDOR, V102, P577, DOI 10.1650/0010-5422(2000)102[0577:NADFAO]2.0.CO;2; Fernandez-Duque E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012572; FINGERMAN M, 1957, AM NAT, V91, P167, DOI 10.1086/281976; Fraser NHC, 1997, FUNCT ECOL, V11, P385, DOI 10.1046/j.1365-2435.1997.00098.x; Garamszegi LZ, 2002, P ROY SOC B-BIOL SCI, V269, P961, DOI 10.1098/rspb.2002.1967; Gelman A., 2003, BAYESIAN DATA ANAL; GLIWICZ MZ, 1986, NATURE, V320, P746, DOI 10.1038/320746a0; GLIWICZ ZM, 1986, ECOLOGY, V67, P883, DOI 10.2307/1939811; HAILMAN JACK P., 1964, WILSON BULL, V76, P347; Hall MI, 2007, J ZOOL, V271, P437, DOI 10.1111/j.1469-7998.2006.00227.x; Harris MP., 1977, P65; HARRIS MP, 1970, AUK, V87, P215, DOI 10.2307/4083917; Horning M, 1999, P ROY SOC B-BIOL SCI, V266, P1127, DOI 10.1098/rspb.1999.0753; Irons DB, 1998, ECOLOGY, V79, P647, DOI 10.2307/176960; Jetz W, 2003, OIKOS, V103, P627, DOI 10.1034/j.1600-0706.2003.12856.x; Lang AB, 2006, OECOLOGIA, V146, P659, DOI 10.1007/s00442-005-0131-3; Longhurst AR, 1987, ECOLOGY TROPICAL OCE; Lowry M, 2007, FISH RES, V88, P15, DOI 10.1016/j.fishres.2007.07.011; LUECKE C, 1993, T AM FISH SOC, V122, P112, DOI 10.1577/1548-8659(1993)122<0112:EOMADO>2.3.CO;2; Meyer CFJ, 2004, J TROP ECOL, V20, P397, DOI 10.1017/S0266467404001373; Naylor E, 2001, EARTH MOON PLANETS, V85-6, P291, DOI 10.1023/A:1017088504226; Phalan B, 2007, MAR ECOL PROG SER, V340, P271, DOI 10.3354/meps340271; Pinet P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027663; Regular PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026763; Schreiber Elizabeth, 2002, BIOL MARINE BIRDS, DOI 10.1201/9781420036305; SNOW BK, 1968, CONDOR, V70, P252, DOI 10.2307/1366698; Tessmar-Raible K, 2011, BIOESSAYS, V33, P165, DOI 10.1002/bies.201000096; TRILLMICH F, 1981, OECOLOGIA, V48, P85, DOI 10.1007/BF00346992; van Gils Jan, 1999, Wader Study Group Bulletin, V89, P36; Weimerskirch H, 1997, MAR ECOL PROG SER, V151, P245, DOI 10.3354/meps151245; Weimerskirch H, 2007, DEEP-SEA RES PT II, V54, P211, DOI 10.1016/j.dsr2.2006.11.013; Wikelski M, 2006, J ORNITHOL, V147, P107, DOI 10.1007/s10336-005-0018-4; Yamamoto T, 2008, ANIM BEHAV, V76, P1647, DOI 10.1016/j.anbehav.2008.07.019; Zuyev G, 2002, B MAR SCI, V71, P1091	45	17	17	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2013	8	2							e56889	10.1371/journal.pone.0056889	http://dx.doi.org/10.1371/journal.pone.0056889			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098PO	23468889	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000315561400016
J	Hamano, T; Kawakami, N; Li, XJ; Sundquist, K				Hamano, Tsuyoshi; Kawakami, Naomi; Li, Xinjun; Sundquist, Kristina			Neighbourhood Environment and Stroke: A Follow-Up Study in Sweden	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; FAST-FOOD; HEALTH; RISK; DEPRIVATION; WOMEN; CONSUMPTION; MULTILEVEL; PEOPLE; COHORT	Background: In recent years, research on the association between physical environments and cardiovascular disease outcomes has gained momentum with growing attention being paid to Geographic Information Systems (GIS). This nationwide study is the first to examine the effect of neighbourhood physical environments on individual-level stroke, using GIS-based measures of neighbourhood availability of potentially health-damaging (fast food restaurants and pubs/bars) and health-promoting (physical activity and healthcare) resources. Methods: The study population comprised a nationwide sample of 2,115,974 men and 2,193,700 women aged 35-80 years who were followed between 1 December 2005 and 31 December 2007 in Sweden. Totally 42,270 first-ever strokes (both morbidity and mortality) were identified. Multilevel logistic regression models were used to estimate the association between neighbourhood availability of four different resources (fast food restaurants, pubs/bars, physical activity and healthcare) and individual-level stroke. Principal Findings: There were significant associations between neighbourhood availability of the four types of neighbourhood resources and individual-level stroke. The significant odds ratios varied between 1.06 and 1.12 for men and 1.07 and 1.24 for women. After adjustment for age, income, and neighbourhood-level deprivation, the increased odds remained statistically significant for neighbourhood availability of fast food restaurants in both men and women. Conclusions: Specific neighbourhood availability of resources were associated with individual-level stroke but most of these associations were explained by individual-level sociodemographic factors and neighbourhood-level deprivation.	[Hamano, Tsuyoshi] Shimane Univ, Org Promot Project Res, Ctr Community Based Hlth Res & Educ, Izumo, Shimane, Japan; [Hamano, Tsuyoshi] Shimane Univ, Sch Med, Dept Environm & Prevent Med, Izumo, Shimane, Japan; [Kawakami, Naomi] Waseda Univ, Waseda Inst Sport Sci, Tokorozawa, Saitama, Japan; [Li, Xinjun; Sundquist, Kristina] Lund Univ, Ctr Primary Hlth Care Res, Malmo, Sweden; [Sundquist, Kristina] Stanford Univ, Stanford Sch Med, SPRC, Stanford, CA 94305 USA	Shimane University; Shimane University; Waseda University; Lund University; Stanford University	Hamano, T (corresponding author), Shimane Univ, Org Promot Project Res, Ctr Community Based Hlth Res & Educ, Izumo, Shimane, Japan.	thamano@med.shimane-u.ac.jp		Hamano, Tsuyoshi/0000-0002-6755-9138; Li, Xinjun/0000-0002-5559-4657	ALF; Swedish Research Council	ALF; Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by ALF funding awarded to Kristina Sundquist and by grants from the Swedish Research Council (awarded to Kristina Sundquist). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AG HEALTHC RES QU, NAT HEALTHC DISP REP; Babisch W, 1999, ARCH ENVIRON HEALTH, V54, P210, DOI 10.1080/00039899909602261; Callas PW, 1998, AM J IND MED, V33, P33; Chuang YC, 2005, J EPIDEMIOL COMMUN H, V59, P568, DOI 10.1136/jech.2004.029041; Clark CJ, 2011, STROKE, V42, P1212, DOI 10.1161/STROKEAHA.110.609164; ESRI, 2006, ARCGIS ARCINFO 9 2 S; Gilthorpe MS, 1995, J EPIDEMIOL COMMUN H, V49, pS45, DOI 10.1136/jech.49.Suppl_2.S45; Hiscock R, 2008, HEALTH SERV RES, V43, P2183, DOI 10.1111/j.1475-6773.2008.00877.x; Kawachi I., 2003, NEIGHBORHOODS HLTH; Kawakami N, 2011, J EPIDEMIOL COMMUN H, V65, P866, DOI 10.1136/jech.2010.117580; Miller KA, 2007, NEW ENGL J MED, V356, P447, DOI 10.1056/NEJMoa054409; Morgenstern LB, 2009, ANN NEUROL, V66, P165, DOI 10.1002/ana.21726; Pollack CE, 2005, INT J EPIDEMIOL, V34, P772, DOI 10.1093/ije/dyi026; RASBASH J, 2000, USERS GUIDE MLWIN VE; Rosenheck R, 2008, OBES REV, V9, P535, DOI 10.1111/j.1467-789X.2008.00477.x; Roux AVD, 2010, ANN NY ACAD SCI, V1186, P125, DOI 10.1111/j.1749-6632.2009.05333.x; Rushton G, 2003, ANNU REV PUBL HEALTH, V24, P43, DOI 10.1146/annurev.publhealth.24.012902.140843; Schmidt M, 2005, ARCH PEDIAT ADOL MED, V159, P626, DOI 10.1001/archpedi.159.7.626; Sundquist J, 2006, SOC SCI MED, V62, P954, DOI 10.1016/j.socscimed.2005.06.049; Sundquist K, 2006, SOC SCI MED, V62, P2061, DOI 10.1016/j.socscimed.2005.08.051; Sundquist K, 2004, J EPIDEMIOL COMMUN H, V58, P71, DOI 10.1136/jech.58.1.71; Sundquist K, 2004, AM J EPIDEMIOL, V159, P655, DOI 10.1093/aje/kwh096; Winkleby M, 2007, AM J PREV MED, V32, P97, DOI 10.1016/j.amepre.2006.10.002; World Health Organization, 1992, INT STAT CLASS DIS R	24	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56680	10.1371/journal.pone.0056680	http://dx.doi.org/10.1371/journal.pone.0056680			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	099EQ	23457603	Green Published, Green Submitted, gold			2022-12-25	WOS:000315603700072
J	Xu, B; Xu, WJ; Yang, FY; Li, JJ; Yang, YJ; Tang, XH; Mu, YL; Zhou, JP; Huang, ZX				Xu, Bo; Xu, Weijiang; Yang, Fuya; Li, Junjun; Yang, Yunjuan; Tang, Xianghua; Mu, Yuelin; Zhou, Junpei; Huang, Zunxi			Metagenomic Analysis of the Pygmy Loris Fecal Microbiome Reveals Unique Functional Capacity Related to Metabolism of Aromatic Compounds	PLOS ONE			English	Article							GENE-CENTRIC METAGENOMICS; HUMAN GUT MICROBIOTA; INTESTINAL MICROBIOTA; BACTERIAL DIVERSITY; COMMUNITY; BENZOATE; WILD; OBESITY; DEGRADATION; POPULATIONS	The animal gastrointestinal tract contains a complex community of microbes, whose composition ultimately reflects the co-evolution of microorganisms with their animal host. An analysis of 78,619 pyrosequencing reads generated from pygmy loris fecal DNA extracts was performed to help better understand the microbial diversity and functional capacity of the pygmy loris gut microbiome. The taxonomic analysis of the metagenomic reads indicated that pygmy loris fecal microbiomes were dominated by Bacteroidetes and Proteobacteria phyla. The hierarchical clustering of several gastrointestinal metagenomes demonstrated the similarities of the microbial community structures of pygmy loris and mouse gut systems despite their differences in functional capacity. The comparative analysis of function classification revealed that the metagenome of the pygmy loris was characterized by an overrepresentation of those sequences involved in aromatic compound metabolism compared with humans and other animals. The key enzymes related to the benzoate degradation pathway were identified based on the Kyoto Encyclopedia of Genes and Genomes pathway assignment. These results would contribute to the limited body of primate metagenome studies and provide a framework for comparative metagenomic analysis between human and non-human primates, as well as a comparative understanding of the evolution of humans and their microbiome. However, future studies on the metagenome sequencing of pygmy loris and other prosimians regarding the effects of age, genetics, and environment on the composition and activity of the metagenomes are required.	[Xu, Bo; Xu, Weijiang; Yang, Fuya; Li, Junjun; Yang, Yunjuan; Tang, Xianghua; Mu, Yuelin; Zhou, Junpei; Huang, Zunxi] Yunnan Normal Univ, Sch Life Sci, Kunming, Peoples R China; [Xu, Bo; Xu, Weijiang; Li, Junjun; Yang, Yunjuan; Tang, Xianghua; Mu, Yuelin; Zhou, Junpei; Huang, Zunxi] Minist Educ, Engn Res Ctr Sustainable Dev & Utilizat Biomass E, Kunming, Peoples R China; [Xu, Bo; Xu, Weijiang; Li, Junjun; Yang, Yunjuan; Tang, Xianghua; Mu, Yuelin; Zhou, Junpei; Huang, Zunxi] Key Lab Yunnan Biomass Energy & Biotechnol Enviro, Kunming, Peoples R China; [Xu, Bo; Xu, Weijiang; Yang, Fuya; Li, Junjun; Yang, Yunjuan; Tang, Xianghua; Mu, Yuelin; Zhou, Junpei; Huang, Zunxi] Yunnan Normal Univ, Key Lab Enzyme Engn, Kunming, Peoples R China	Yunnan Normal University; Yunnan Normal University	Huang, ZX (corresponding author), Yunnan Normal Univ, Sch Life Sci, Kunming, Peoples R China.	huangzunxi@163.com			National Natural Science Foundation of China [30960165, 31160229]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financially supported by the National Natural Science Foundation of China (30960165 and 31160229). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abnous K, 2009, J NUTR, V139, P2024, DOI 10.3945/jn.109.109470; Andersson AF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002836; Valderrama JA, 2012, J BIOL CHEM, V287, P10494, DOI 10.1074/jbc.M111.309005; BOTTA GA, 1994, CLIN INFECT DIS, V18, pS260, DOI 10.1093/clinids/18.Supplement_4.S260; Breitbart M, 2003, J BACTERIOL, V185, P6220, DOI 10.1128/JB.185.20.6220-6223.2003; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Chandler DP, 1997, MOL ECOL, V6, P475, DOI 10.1046/j.1365-294X.1997.00205.x; Collado MC, 2007, APPL ENVIRON MICROB, V73, P7767, DOI 10.1128/AEM.01477-07; Davies TJ, 2008, P ROY SOC B-BIOL SCI, V275, P1695, DOI 10.1098/rspb.2008.0284; de Macario EC, 2009, INT J MED MICROBIOL, V299, P99, DOI 10.1016/j.ijmm.2008.06.011; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Flint HJ, 2008, ANN NY ACAD SCI, V1125, P280, DOI 10.1196/annals.1419.022; Frey JC, 2006, APPL ENVIRON MICROB, V72, P3788, DOI 10.1128/AEM.72.5.3788-3792.2006; GIBSON DT, 1968, SCIENCE, V161, P1093, DOI 10.1126/science.161.3846.1093; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Gorski A, 2005, CELL MOL LIFE SCI, V62, P511, DOI 10.1007/s00018-004-4403-6; Griswold KE, 1999, CURR MICROBIOL, V39, P187, DOI 10.1007/s002849900443; Hackstein J. H. P., 2010, ENDOSYMBIOTIC METHAN; HARAYAMA S, 1991, J BACTERIOL, V173, P7540, DOI 10.1128/jb.173.23.7540-7548.1991; Harvey AJ, 2000, PROTEINS, V41, P257, DOI 10.1002/1097-0134(20001101)41:2<257::AID-PROT100>3.0.CO;2-C; HOBSON PN, 1982, CRC CR REV MICROBIOL, V9, P165, DOI 10.3109/10408418209104490; Hugenholtz P, 2008, NATURE, V455, P481, DOI 10.1038/455481a; KIM MK, 1991, FEMS MICROBIOL LETT, V83, P199, DOI 10.1016/0378-1097(91)90354-D; Kisidayova S, 2009, AM J PRIMATOL, V71, P548, DOI 10.1002/ajp.20687; KOTTURI G, 1991, APPL MICROBIOL BIOT, V34, P539, DOI 10.1007/BF00180585; Kurokawa K, 2007, DNA RES, V14, P169, DOI 10.1093/dnares/dsm018; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Lamendella R, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-103; Lee HC, 2006, RES MICROBIOL, V157, P876, DOI 10.1016/j.resmic.2006.07.004; Lee RC, 2003, J BIOL CHEM, V278, P5377, DOI 10.1074/jbc.M210627200; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Li F, 2009, J NUTR, V139, P1685, DOI 10.3945/jn.109.108191; Lubbs DC, 2009, J ANIM PHYSIOL AN N, V93, P113, DOI 10.1111/j.1439-0396.2007.00788.x; Markowitz VM, 2008, NUCLEIC ACIDS RES, V36, pD534, DOI 10.1093/nar/gkm869; MARQUES S, 1993, MOL MICROBIOL, V9, P923, DOI 10.1111/j.1365-2958.1993.tb01222.x; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; McKenna P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040020; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Oboirien B.O., 2005, BIOTECHNOLOGY, V4, P56, DOI DOI 10.3923/biotech.2005.56.61; Ochman H, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000546; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Ott SJ, 2008, SCAND J GASTROENTERO, V43, P831, DOI 10.1080/00365520801935434; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Pandey PK, 2012, J BIOSCIENCES, V37, P221, DOI 10.1007/s12038-012-9197-3; Pryde SE, 2002, FEMS MICROBIOL LETT, V217, P133, DOI 10.1111/j.1574-6968.2002.tb11467.x; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Qu A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002945; Ratajszczak R, 1998, FOLIA PRIMATOL, V69, P171, DOI 10.1159/000052710; Round JL, 2010, P NATL ACAD SCI USA, V107, P12204, DOI 10.1073/pnas.0909122107; Rousseeuw P.J., 1990, FINDING GROUPS DATA; SAHASRABUDHE SR, 1985, BIOCHEM INT, V10, P525; Salonen A, 2010, J MICROBIOL METH, V81, P127, DOI 10.1016/j.mimet.2010.02.007; Scanlan PD, 2008, ISME J, V2, P1183, DOI 10.1038/ismej.2008.76; SIEBER R, 1995, INT DAIRY J, V5, P227, DOI 10.1016/0958-6946(94)00005-A; Swanson KS, 2011, ISME J, V5, P639, DOI 10.1038/ismej.2010.162; Szekely BA, 2010, AM J PRIMATOL, V72, P566, DOI 10.1002/ajp.20809; Tajima K, 2001, APPL ENVIRON MICROB, V67, P2766, DOI 10.1128/AEM.67.6.2766-2774.2001; Ten Hove RJ, 2009, J EUKARYOT MICROBIOL, V56, P388, DOI 10.1111/j.1550-7408.2009.00393.x; Tun HM, 2012, J MICROBIOL METH, V88, P369, DOI 10.1016/j.mimet.2012.01.001; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Uenishi G, 2007, AM J PRIMATOL, V69, P367, DOI 10.1002/ajp.20351; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wei B, 2002, INFECT IMMUN, V70, P6567, DOI 10.1128/IAI.70.12.6567-6575.2002; Weinbauer MG, 2004, FEMS MICROBIOL REV, V28, P127, DOI 10.1016/j.femsre.2003.08.001; Xu B, 2010, AM J PRIMATOL, V72, P699, DOI 10.1002/ajp.20826; Yildirim S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013963; Zhang HS, 2009, P NATL ACAD SCI USA, V106, P2365, DOI 10.1073/pnas.0812600106	71	35	40	0	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56565	10.1371/journal.pone.0056565	http://dx.doi.org/10.1371/journal.pone.0056565			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457582	Green Published, gold, Green Submitted			2022-12-25	WOS:000315603700062
J	Jiang, J; Qi, YX; Zhang, P; Gu, WT; Yan, ZQ; Shen, BR; Yao, QP; Kong, H; Chien, S; Jiang, ZL				Jiang, Jun; Qi, Ying-Xin; Zhang, Ping; Gu, Wen-Tian; Yan, Zhi-Qiang; Shen, Bao-Rong; Yao, Qing-Ping; Kong, Han; Chien, Shu; Jiang, Zong-Lai			Involvement of Rab28 in NF-kappa B Nuclear Transport in Endothelial Cells	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; ANGIOTENSIN-II; VASCULAR ENDOTHELIUM; MOLECULAR-MECHANISM; SHEAR-STRESS; GTPASES; HYPERTENSION; ACTIVATION; FLOW; INHIBITION	Our previous proteomic analysis revealed the expression of Rab28 in arteries of rats. However, the function of Rab28 in mammalian cells, and its role in vessels are still unknown. Coarctation of abdominal aorta above left kidney artery in rat was used as hypertensive animal model. FX-4000 cyclic strain loading system was used to mimic the mechanical condition on vascular cells during hypertension in vitro. Immunofluorescence and co-immunoprecipitation (Co-IP) were used to identify distribution and interaction of Rab28 and nuclear factor kappa B (NF-kappa B). Rab28 expression was significantly increased in carotid arteries of hypertensive rats. High cyclic strain induced Rab28 expression of endothelial cells (ECs) through a paracrine control of vascular smooth muscles cells (VSMCs), which at least partly via angiotensin II (Ang II). Rab28 knockdown decreased proliferation of ECs, while increased apoptosis and migration. Immunofluorescence revealed that Ang II stimulated the co-translocation of Rab28 and NF-kappa B from cytoplasm into nucleus. Knockdown of Rab28 attenuated NF-kappa B activation. Co-IP of NF-kappa B p65 and Rab28 indicated their interaction. Our results revealed that Rab28, as a novel regulator of NF-kappa B nuclear transport, might participate in the disturbance of EC homeostasis.	[Jiang, Jun; Qi, Ying-Xin; Zhang, Ping; Gu, Wen-Tian; Yan, Zhi-Qiang; Shen, Bao-Rong; Yao, Qing-Ping; Kong, Han; Chien, Shu; Jiang, Zong-Lai] Shanghai Jiao Tong Univ, Inst Mechanobiol & Med Engn, Sch Life Sci & Biotechnol, Shanghai 200030, Peoples R China; [Chien, Shu] Univ Calif San Diego, Inst Engn Med, La Jolla, CA 92093 USA; [Chien, Shu] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Chien, Shu] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	Shanghai Jiao Tong University; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Jiang, ZL (corresponding author), Shanghai Jiao Tong Univ, Inst Mechanobiol & Med Engn, Sch Life Sci & Biotechnol, Shanghai 200030, Peoples R China.	zljiang@sjtu.edu.cn			National Natural Science Foundation of China [31170892, 11232010, 1172178]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (Nos. 31170892, 11232010 and 1172178, www.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bader M, 2010, ANNU REV PHARMACOL, V50, P439, DOI 10.1146/annurev.pharmtox.010909.105610; Balcells M, 2010, CIRCULATION, V121, P2192, DOI 10.1161/CIRCULATIONAHA.109.877282; Bayliss R, 2000, TRAFFIC, V1, P448, DOI 10.1034/j.1600-0854.2000.010602.x; Blann AD, 2005, THROMB HAEMOSTASIS, V93, P228, DOI 10.1160/TH04-09-0578; Brauers A, 1996, EUR J BIOCHEM, V237, P833, DOI 10.1111/j.1432-1033.1996.0833p.x; Chiu JJ, 2011, PHYSIOL REV, V91, P327, DOI 10.1152/physrev.00047.2009; Chiu JJ, 2003, BLOOD, V101, P2667, DOI 10.1182/blood-2002-08-2560; Cines DB, 1998, BLOOD, V91, P3527; Cummins PM, 2007, AM J PHYSIOL-HEART C, V292, pH28, DOI 10.1152/ajpheart.00304.2006; Farkas L, 2009, J CLIN INVEST, V119, P1298, DOI 10.1172/JCI36136; Fukuda M, 2008, MOL CELL PROTEOMICS, V7, P1031, DOI 10.1074/mcp.M700569-MCP200; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Humphrey JD, 2008, HYPERTENSION, V52, P195, DOI 10.1161/HYPERTENSIONAHA.107.103440; Hutagalung AH, 2011, PHYSIOL REV, V91, P119, DOI 10.1152/physrev.00059.2009; Kanno E, 2010, TRAFFIC, V11, P491, DOI 10.1111/j.1600-0854.2010.01038.x; Lee SH, 2008, FEBS LETT, V582, P4107, DOI 10.1016/j.febslet.2008.11.008; Lemarie CA, 2003, CIRC RES, V93, P207, DOI 10.1161/01.RES.0000086942.13523.88; Li Q, 1997, Hypertens Res, V20, P217, DOI 10.1291/hypres.20.217; Liu G, 2010, HYPERTENS RES, V33, P1250, DOI 10.1038/hr.2010.187; Lowe AR, 2010, NATURE, V467, P600, DOI 10.1038/nature09285; Lumb JH, 2011, J CELL SCI, V124, P3771, DOI 10.1242/jcs.079178; Ono Y, 1999, HYPERTENSION, V34, P609, DOI 10.1161/01.HYP.34.4.609; Pemberton LF, 2005, TRAFFIC, V6, P187, DOI 10.1111/j.1600-0854.2005.00270.x; Pfeffer S, 2004, NAT REV MOL CELL BIO, V5, P886, DOI 10.1038/nrm1500; Qi YX, 2011, P NATL ACAD SCI USA, V108, P1908, DOI 10.1073/pnas.1019219108; Ruiz-Ortega M, 2000, CIRC RES, V86, P1266, DOI 10.1161/01.RES.86.12.1266; SAFAR ME, 1981, CIRCULATION, V63, P393, DOI 10.1161/01.CIR.63.2.393; Schwartz SL, 2007, J CELL SCI, V120, P3905, DOI 10.1242/jcs.015909; Seabra MC, 2004, CURR OPIN CELL BIOL, V16, P451, DOI 10.1016/j.ceb.2004.06.014; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Stewart M, 2007, NAT REV MOL CELL BIO, V8, P195, DOI 10.1038/nrm2114; Strambio-De-Castillia C, 2010, NAT REV MOL CELL BIO, V11, P490, DOI 10.1038/nrm2928; Terry LJ, 2007, SCIENCE, V318, P1412, DOI 10.1126/science.1142204; Williams B, 1998, J HYPERTENS, V16, P1921, DOI 10.1097/00004872-199816121-00011; Yung YC, 2009, P NATL ACAD SCI USA, V106, P15279, DOI 10.1073/pnas.0905891106; Zhang LP, 2005, CIRC RES, V97, P975, DOI 10.1161/01.RES.0000190589.52286.41	36	7	12	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56076	10.1371/journal.pone.0056076	http://dx.doi.org/10.1371/journal.pone.0056076			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457503	Green Published, gold, Green Submitted			2022-12-25	WOS:000315602700041
J	Ma, DL; Zhong, HJ; Fu, WC; Chan, DSH; Kwan, HY; Fong, WF; Chung, LH; Wong, CY; Leung, CH				Ma, Dik-Lung; Zhong, Hai-Jing; Fu, Wai-Chung; Chan, Daniel Shiu-Hin; Kwan, Hiu-Yee; Fong, Wang-Fun; Chung, Lai-Hon; Wong, Chun-Yuen; Leung, Chung-Hang			Phosphorescent Imaging of Living Cells Using a Cyclometalated Iridium(III) Complex	PLOS ONE			English	Article							LIGHT-EMITTING DEVICES; ELECTROCHEMICAL PROPERTIES; PLATINUM(II) COMPLEXES; METAL-COMPLEXES; IN-VIVO; EFFICIENT; PROBES; MICROSCOPY; EMISSION; PHOTOPHYSICS	A cell permeable cyclometalated iridium(III) complex has been developed as a phosphorescent probe for cell imaging. The iridium(III) solvato complex [Ir(phq)(2)(H2O](2))] preferentially stains the cytoplasm of both live and dead cells with a bright luminescence.	[Ma, Dik-Lung; Fu, Wai-Chung; Chan, Daniel Shiu-Hin] Hong Kong Baptist Univ, Dept Chem, Kowloon Tong, Hong Kong, Peoples R China; [Zhong, Hai-Jing; Leung, Chung-Hang] Univ Macau, Inst Chinese Med Sci, State Key Lab Qual Res Chinese Med, Taipa, Peoples R China; [Kwan, Hiu-Yee; Fong, Wang-Fun] Hong Kong Baptist Univ, Sch Chinese Med, Ctr Canc & Inflammat Res, Kowloon, Hong Kong, Peoples R China; [Chung, Lai-Hon; Wong, Chun-Yuen] City Univ Hong Kong, Dept Biol & Chem, Kowloon, Hong Kong, Peoples R China	Hong Kong Baptist University; University of Macau; Hong Kong Baptist University; City University of Hong Kong	Ma, DL (corresponding author), Hong Kong Baptist Univ, Dept Chem, Kowloon Tong, Hong Kong, Peoples R China.	edmondma@hkbu.edu.hk	Wong, Chun-Yuen/H-2272-2011; Fu, Wai Chung/HGC-1135-2022; Fu, Wai-Chung/C-4487-2013	Wong, Chun-Yuen/0000-0003-4780-480X; Fu, Wai Chung/0000-0002-7181-0057; Fu, Wai-Chung/0000-0002-7181-0057; Ma, Dik-Lung/0000-0002-9515-340X; Zhong, Hai-Jing/0000-0002-1247-3150; KWAN, Hiu Yee/0000-0002-6088-7323; Chung, Lai-Hon/0000-0002-0482-1362	Hong Kong Baptist University [FRG2/11-12/009]; Environment and Conservation Fund (ECF) [3/2010]; Centre for Cancer and Inflammation Research, School of Chinese Medicine (CCIR-SCM, HKBU); Health and Medical Research Fund [HMRF/11101212]; Research Grants Council [HKBU/201811]; University of Macau [SRG013-ICMS12-LCH, MYRG091(Y1-L2)-ICMS12-LCH, MYRG121(Y1-L2)-ICMS12-LCH]	Hong Kong Baptist University; Environment and Conservation Fund (ECF); Centre for Cancer and Inflammation Research, School of Chinese Medicine (CCIR-SCM, HKBU); Health and Medical Research Fund; Research Grants Council(Hong Kong Research Grants Council); University of Macau	This work is supported by Hong Kong Baptist University (FRG2/11-12/009), Environment and Conservation Fund (ECF Project 3/2010), Centre for Cancer and Inflammation Research, School of Chinese Medicine (CCIR-SCM, HKBU), the Health and Medical Research Fund (HMRF/11101212), the Research Grants Council (HKBU/201811) and the University of Macau (SRG013-ICMS12-LCH, MYRG091(Y1-L2)-ICMS12-LCH and MYRG121(Y1-L2)-ICMS12-LCH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amoroso AJ, 2007, CHEM COMMUN, P3066, DOI 10.1039/b706657k; Baggaley E, 2012, COORDIN CHEM REV, V256, P1762, DOI 10.1016/j.ccr.2012.03.018; Baldo MA, 1999, APPL PHYS LETT, V75, P4, DOI 10.1063/1.124258; Baldo MA, 2000, NATURE, V403, P750, DOI 10.1038/35001541; Ballas SK, 2004, MICROCIRCULATION, V11, P209, DOI 10.1080/10739680490279410; Beeby A, 2003, J MATER CHEM, V13, P80, DOI 10.1039/b207502d; Botchway SW, 2008, P NATL ACAD SCI USA, V105, P16071, DOI 10.1073/pnas.0804071105; Chen FC, 2002, APPL PHYS LETT, V80, P2308, DOI 10.1063/1.1462862; Coppo P, 2004, CHEM COMMUN, P1774, DOI 10.1039/b406851c; Evans CL, 2005, P NATL ACAD SCI USA, V102, P16807, DOI 10.1073/pnas.0508282102; Fernandez-Moreira V, 2010, CHEM COMMUN, V46, P186, DOI 10.1039/b917757d; Finkenzeller WJ, 2007, INORG CHEM, V46, P5076, DOI 10.1021/ic0622860; Gill MR, 2012, CHEM SOC REV, V41, P3179, DOI 10.1039/c2cs15299a; Grushin VV, 2001, CHEM COMMUN, P1494, DOI 10.1039/b103490c; Guerchais V, 2011, COORDIN CHEM REV, V255, P2448, DOI 10.1016/j.ccr.2011.04.006; Hanson K, 2010, INORG CHEM, V49, P6077, DOI 10.1021/ic100633w; Ho ML, 2006, ORG BIOMOL CHEM, V4, P98, DOI 10.1039/b511943j; HORNE MK, 1981, AM J MED, V70, P288, DOI 10.1016/0002-9343(81)90764-6; Huisken J, 2004, SCIENCE, V305, P1007, DOI 10.1126/science.1100035; Ikai M, 2001, APPL PHYS LETT, V79, P156, DOI 10.1063/1.1385182; Kim JI, 2005, J AM CHEM SOC, V127, P1614, DOI 10.1021/ja043721x; Koo CK, 2010, CHEM-EUR J, V16, P3942, DOI 10.1002/chem.200902919; Kuil J, 2011, CHEMBIOCHEM, V12, P1896, DOI 10.1002/cbic.201100271; Kwon TH, 2009, ADV FUNCT MATER, V19, P711, DOI 10.1002/adfm.200801231; Lau JSY, 2009, INORG CHEM, V48, P708, DOI 10.1021/ic801818x; Lau MK, 2004, J ORGANOMET CHEM, V689, P2401, DOI 10.1016/j.jorganchem.2004.04.033; Lee PK, 2011, DALTON T, V40, P2180, DOI 10.1039/c0dt00501k; Lee PK, 2011, INORG CHEM, V50, P8570, DOI 10.1021/ic201153d; Li CY, 2011, J AM CHEM SOC, V133, P11231, DOI 10.1021/ja202344c; Liu HW, 2010, ORGANOMETALLICS, V29, P3474, DOI 10.1021/om100597g; Liu JL, 2011, J AM CHEM SOC, V133, P15276, DOI 10.1021/ja205907y; Lo KKW, 2007, CHEM-EUR J, V13, P7110, DOI 10.1002/chem.200700530; Lo KKW, 2006, COORDIN CHEM REV, V250, P1724, DOI 10.1016/j.ccr.2006.01.010; Lo KKW, 2012, DALTON T, V41, P6021, DOI 10.1039/c2dt11892k; Lo KKW, 2006, CHEM-EUR J, V12, P1500, DOI 10.1002/chem.200500885; Lo KKW, 2005, COORDIN CHEM REV, V249, P1434, DOI 10.1016/j.ccr.2004.10.004; Louie MW, 2009, ORGANOMETALLICS, V28, P4297, DOI 10.1021/om900311s; Lowry MS, 2004, J AM CHEM SOC, V126, P14129, DOI 10.1021/ja047156+; Ma DL, 2008, ANGEW CHEM INT EDIT, V47, P3735, DOI 10.1002/anie.200705319; Man BYW, 2011, CHEM SCI, V2, P917, DOI 10.1039/c0sc00636j; Martin RM, 2005, CYTOM PART A, V67A, P45, DOI 10.1002/cyto.a.20172; McDaniel ND, 2008, J AM CHEM SOC, V130, P210, DOI 10.1021/ja074478f; Murphy L, 2010, CHEM COMMUN, V46, P8743, DOI 10.1039/c0cc03705b; Nazeeruddin MK, 2003, J AM CHEM SOC, V125, P8790, DOI 10.1021/ja021413y; Neugebauer U, 2008, CHEM COMMUN, P5307, DOI 10.1039/b810403d; Ntziachristos V, 2003, EUR RADIOL, V13, P195, DOI 10.1007/s00330-002-1524-x; O'Connor NA, 2009, CHEM COMMUN, P2640, DOI 10.1039/b900290a; Pfeifer GP, 2005, MUTAT RES-FUND MOL M, V571, P19, DOI 10.1016/j.mrfmmm.2004.06.057; Puckett CA, 2007, J AM CHEM SOC, V129, P46, DOI 10.1021/ja0677564; Rausch AF, 2009, J PHYS CHEM A, V113, P5927, DOI 10.1021/jp902261c; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Sandee AJ, 2004, J AM CHEM SOC, V126, P7041, DOI 10.1021/ja039445o; Schaferling M, 2012, ANGEW CHEM INT EDIT, V51, P3532, DOI 10.1002/anie.201105459; Slinker JD, 2004, J AM CHEM SOC, V126, P2763, DOI 10.1021/ja0345221; Stephens DJ, 2003, SCIENCE, V300, P82, DOI 10.1126/science.1082160; Steunenberg P, 2012, INORG CHEM, V51, P2105, DOI 10.1021/ic201860s; Tamayo AB, 2003, J AM CHEM SOC, V125, P7377, DOI 10.1021/ja034537z; Tan WJ, 2011, CHEM-ASIAN J, V6, P1263, DOI 10.1002/asia.201000820; Tian XH, 2011, CHEMBIOCHEM, V12, P548, DOI 10.1002/cbic.201000743; Tsuboyama A, 2004, DALTON T, P1115, DOI 10.1039/b404101c; Ulbricht C, 2009, ADV MATER, V21, P4418, DOI 10.1002/adma.200803537; Wu C, 2010, J AM CHEM SOC, V132, P3133, DOI 10.1021/ja9097725; Wu HZ, 2011, DALTON T, V40, P1969, DOI 10.1039/c0dt01366h; Wu P, 2009, CHEM-EUR J, V15, P3652, DOI 10.1002/chem.200802707; Wu YQ, 2011, INORG CHEM, V50, P7412, DOI 10.1021/ic102082k; Xiong LQ, 2010, INORG CHEM, V49, P6402, DOI 10.1021/ic902266x; Yam VWW, 2011, CHEM COMMUN, V47, P11579, DOI 10.1039/c1cc13767k; Yang TS, 2011, J MATER CHEM, V21, P5360, DOI 10.1039/c0jm04235h; Yang Y.Z.Q, 2012, CHEM REV, DOI org/10.1021/cr2004103; You Y, 2011, J AM CHEM SOC, V133, P18328, DOI 10.1021/ja207163r; You Y, 2011, J AM CHEM SOC, V133, P11488, DOI 10.1021/ja204997c; Yu MX, 2008, CHEM COMMUN, P2115, DOI 10.1039/b800939b; Yu MX, 2009, ANAL CHEM, V81, P930, DOI 10.1021/ac802072d; Zhang KY, 2010, INORG CHEM, V49, P2530, DOI 10.1021/ic902465b; Zhang R, 2012, BIOCONJUGATE CHEM, V23, P725, DOI 10.1021/bc200506w; Zhang SJ, 2010, CANCER RES, V70, P4490, DOI 10.1158/0008-5472.CAN-09-3948; Zhao Q, 2011, CHEM SOC REV, V40, P2508, DOI 10.1039/c0cs00114g; Zhao QA, 2010, CHEM SOC REV, V39, P3007, DOI 10.1039/b915340c; Zhao Q, 2010, ORGANOMETALLICS, V29, P1085, DOI 10.1021/om900691r	79	28	28	0	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e55751	10.1371/journal.pone.0055751	http://dx.doi.org/10.1371/journal.pone.0055751			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457478	Green Published, gold, Green Submitted			2022-12-25	WOS:000315602700021
J	Wang, ZY; Wang, DM; Han, SW; Wang, N; Mo, FZ; Loo, TY; Shen, JG; Huang, H; Chen, JP				Wang, Zhiyu; Wang, Dongmei; Han, Shouwei; Wang, Neng; Mo, Feizhi; Loo, Tjing Yung; Shen, Jiangang; Huang, Hui; Chen, Jianping			Bioactivity-Guided Identification and Cell Signaling Technology to Delineate the Lactate Dehydrogenase A Inhibition Effects of Spatholobus suberectus on Breast Cancer	PLOS ONE			English	Article							GLYCOLYSIS; (-)-EPIGALLOCATECHIN; METABOLISM; ACTIVATION; EXPRESSION; FLAVONOIDS; CARCINOMA; ESTROGEN; STRATEGY; HSP90	Aerobic glycolysis is an important feature of cancer cells. In recent years, lactate dehydrogenase A (LDH-A) is emerging as a novel therapeutic target for cancer treatment. Seeking LDH-A inhibitors from natural resources has been paid much attention for drug discovery. Spatholobus suberectus (SS) is a common herbal medicine used in China for treating blood-stasis related diseases such as cancer. This study aims to explore the potential medicinal application of SS for LDH-A inhibition on breast cancer and to determine its bioactive compounds. We found that SS manifested apoptosis-inducing, cell cycle arresting and anti-LDH-A activities in both estrogen-dependent human MCF-7 cells and estrogen-independent MDA-MB-231 cell. Oral herbal extracts (1 g/kg/d) administration attenuated tumor growth and LDH-A expression in both breast cancer xenografts. Bioactivity-guided fractionation finally identified epigallocatechin as a key compound in SS inhibiting LDH-A activity. Further studies revealed that LDH-A plays a critical role in mediating the apoptosis-induction effects of epigallocatechin. The inhibited LDH-A activities by epigallocatechin is attributed to disassociation of Hsp90 from HIF-1 alpha and subsequent accelerated HIF-1 alpha proteasome degradation. In vivo study also demonstrated that epigallocatechin could significantly inhibit breast cancer growth, HIF-1 alpha/LDH-A expression and trigger apoptosis without bringing toxic effects. The preclinical study thus suggests that the potential medicinal application of SS for inhibiting cancer LDH-A activity and the possibility to consider epigallocatechin as a lead compound to develop LDH-A inhibitors. Future studies of SS for chemoprevention or chemosensitization against breast cancer are thus warranted.	[Wang, Zhiyu; Wang, Neng; Mo, Feizhi; Loo, Tjing Yung; Shen, Jiangang; Chen, Jianping] Univ Hong Kong, Sch Chinese Med, Pokfulam, Hong Kong, Peoples R China; [Wang, Dongmei] Sun Yat Sen Univ, Sch Pharmaceut Sci, Guangzhou 510275, Guangdong, Peoples R China; [Han, Shouwei] Univ Guangzhou Tradit Chinese Med, Clin Med Collage 2, Guangdong Prov Hosp Chinese Med, Guangzhou, Guangdong, Peoples R China; [Huang, Hui] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Guangzhou 510275, Guangdong, Peoples R China	University of Hong Kong; Sun Yat Sen University; Guangzhou University of Chinese Medicine; Sun Yat Sen University	Chen, JP (corresponding author), Univ Hong Kong, Sch Chinese Med, Pokfulam, Hong Kong, Peoples R China.	jpjpchen@yahoo.com	wang, zhiyu/K-5255-2016	wang, zhiyu/0000-0002-5299-8410	Hong Kong Innovation and Technology Support Programme ITF funding [ITS/073/11FP]; National Natural Science Foundation of China [81170647]; Projects of International Cooperation program, Guangdong Province [2012B050300014]	Hong Kong Innovation and Technology Support Programme ITF funding; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Projects of International Cooperation program, Guangdong Province	The work was supported by the Hong Kong Innovation and Technology Support Programme ITF funding (ITS/073/11FP), National Natural Science Foundation of China (81170647) and Projects of International Cooperation program, Guangdong Province 2012B050300014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRENTANI MM, 1983, CANCER DETECT PREV, V6, P241; BURKE RE, 1978, CANCER RES, V38, P2773; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Chen Dong-hui, 2004, Zhongguo Zhong Yao Za Zhi, V29, P352; Cheng XL, 2011, J CHROMATOGR A, V1218, P5774, DOI 10.1016/j.chroma.2011.06.091; Clark AS, 2002, MOL CANCER THER, V1, P707; Fantin VR, 2006, CANCER CELL, V9, P425, DOI 10.1016/j.ccr.2006.04.023; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Gatenby RA, 2007, INT J BIOCHEM CELL B, V39, P1358, DOI 10.1016/j.biocel.2007.03.021; Gordan JD, 2007, CANCER CELL, V12, P108, DOI 10.1016/j.ccr.2007.07.006; Granchi C, 2010, CURR MED CHEM, V17, P672, DOI 10.2174/092986710790416263; Gu LW, 2003, J AGR FOOD CHEM, V51, P7513, DOI 10.1021/jf034815d; Guo WM, 2009, NUTR CANCER, V61, P807, DOI 10.1080/01635580903285098; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hirschhaeuser F, 2011, CANCER RES, V71, P6921, DOI 10.1158/0008-5472.CAN-11-1457; Isaacs JS, 2002, J BIOL CHEM, V277, P29936, DOI 10.1074/jbc.M204733200; Kolev Y, 2008, ANN SURG ONCOL, V15, P2336, DOI 10.1245/s10434-008-9955-5; Kushima Y, 2009, BIOL PHARM BULL, V32, P899, DOI 10.1248/bpb.32.899; Kuzuhara T, 2008, CANCER LETT, V261, P12, DOI 10.1016/j.canlet.2007.10.037; Liu YV, 2007, CELL CYCLE, V6, P656, DOI 10.4161/cc.6.6.3981; Lu HS, 2002, J BIOL CHEM, V277, P23111, DOI 10.1074/jbc.M202487200; Minet E, 1999, FEBS LETT, V460, P251, DOI 10.1016/S0014-5793(99)01359-9; Ocana A, 2011, NAT REV CLIN ONCOL, V8, P200, DOI 10.1038/nrclinonc.2010.194; Pelicano H, 2006, ONCOGENE, V25, P4633, DOI 10.1038/sj.onc.1209597; Semenza GL, 2010, CURR OPIN GENET DEV, V20, P51, DOI 10.1016/j.gde.2009.10.009; Shi HS, 2010, CANCER SCI, V101, P1447, DOI 10.1111/j.1349-7006.2010.01562.x; TAKAHASHI Y, 1995, INTERNAL MED, V34, P326, DOI 10.2169/internalmedicine.34.326; Vander Heiden MG, 2011, NAT REV DRUG DISCOV, V10, P671, DOI 10.1038/nrd3504; Vergote D, 2002, BREAST CANCER RES TR, V76, P195, DOI 10.1023/A:1020833410523; Wang Z, 2012, EVID-BASED COMPL ALT, V2012; Wang ZY, 2012, BREAST CANCER RES TR, V131, P791, DOI 10.1007/s10549-011-1466-6; Wang ZY, 2011, J ETHNOPHARMACOL, V133, P751, DOI 10.1016/j.jep.2010.11.004; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Xie H, 2009, MOL CANCER THER, V8, P626, DOI 10.1158/1535-7163.MCT-08-1049; Yang CS, 2009, NAT REV CANCER, V9, P429, DOI 10.1038/nrc2641; Yoon JS, 2004, ARCH PHARM RES, V27, P589, DOI 10.1007/BF02980154; 杨德明, 2003, [中医杂志, Journal of Traditional Chinese Medicine], V44, P730	37	52	54	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56631	10.1371/journal.pone.0056631	http://dx.doi.org/10.1371/journal.pone.0056631			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457597	Green Submitted, Green Published, gold			2022-12-25	WOS:000315602700087
J	Durham, AL; McLaren, A; Hayes, BP; Caramori, G; Clayton, CL; Barnes, PJ; Chung, KF; Adcock, IM				Durham, Andrew L.; McLaren, Alistair; Hayes, Brian P.; Caramori, Gaetano; Clayton, Chris L.; Barnes, Peter J.; Chung, K. Fan; Adcock, Ian M.			Regulation of Wnt4 in chronic obstructive pulmonary disease	FASEB JOURNAL			English	Article						inflammation; proliferation; epithelial cells	OXIDATIVE STRESS; HISTONE DEACETYLASE; BETA-CATENIN; GENE-EXPRESSION; COPD; INFLAMMATION; MOUSE; LUNG; ACTIVATION; INHIBITOR	Chronic obstructive pulmonary disease (COPD) is associated with persistent inflammation and oxidative stress in susceptible individuals. Using microarray analysis of bronchial biopsy samples from patients with COPD and controls, we identified Wnt4 as being up-regulated in COPD. Analysis of bronchial biopsy samples showed a very strong correlation between Wnt4 and IL8 gene expression, suggesting that Wnt4 plays a role in chronic lung inflammation. In vitro, Wnt4 induced proliferation and inflammation in human epithelial cells (BEAS-2B) and normal primary human bronchial epithelial cells in a concentration-dependent manner. This effect was enhanced in the presence of interleukin-1 beta (IL-1 beta) as a result of activation of the p38 and c-Jun NH2-terminal kinase mitogen-activated protein kinase pathways. Hydrogen peroxide, but not proinflammatory stimuli, up-regulated Wnt4 expression in epithelial cells. In monocytic THP-1 and primary airway smooth muscle cells, Wnt4 induced inflammation and enhanced the inflammatory response to lipopolysaccharide and IL-1 beta but did not induce proliferation. In addition, these other cell types did not have enhanced Wnt4 expression in response to hydrogen peroxide. Our results indicate that airway epithelial activation, due to oxidative stress, may lead to Wnt4 induction. Wnt4, in turn, acts through the noncanonical pathway to activate epithelial cell remodeling and IL8 gene expression, leading to neutrophil infiltration and inflammation.-Durham, A. L., McLaren, A., Hayes, B. P., Caramori, G., Clayton, C. L., Barnes, P. J., Chung, K. F., Adcock, I. M. Regulation of Wnt4 in chronic obstructive pulmonary disease.	[Durham, Andrew L.; Barnes, Peter J.; Chung, K. Fan; Adcock, Ian M.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Airway Dis Sect, London, England; [McLaren, Alistair; Clayton, Chris L.] GlaxoSmithKline Res, Core Discovery Technol Grp, Resp Ctr Excellence Drug Discovery, Stevenage, Herts, England; [Hayes, Brian P.] GlaxoSmithKline Res, Allergy & Inflammat Grp, Resp Ctr Excellence Drug Discovery, Stevenage, Herts, England; [Caramori, Gaetano] Univ Ferrara, Sect Resp Dis, Ctr Studio Malattie Infiammatorie Cron Vie Aeree, Dept Med Sci, I-44100 Ferrara, Italy	Imperial College London; GlaxoSmithKline; GlaxoSmithKline; University of Ferrara	Durham, AL (corresponding author), Natl Heart & Lung Inst, Airways Dis Sect, Dovehouse St, London SW3 6LY, England.	a.durham@imperial.ac.uk	Chung, Kian Fan/B-1872-2012; Caramori, Gaetano/AAS-8611-2020; Adcock, Ian/L-3217-2019; Chung, Kian Fan/I-8456-2019	Chung, Kian Fan/0000-0001-7101-1426; Caramori, Gaetano/0000-0002-9807-327X; Chung, Kian Fan/0000-0001-7101-1426; Adcock, Ian/0000-0003-2101-8843; Barnes, Peter/0000-0002-5122-4018; Durham, Andrew/0000-0003-2372-4688	Medical Research Council; Wellcome Trust; GlaxoSmithKline; Medical Research Council [G0801056B] Funding Source: researchfish; National Institute for Health Research [NF-SI-0509-10080, NF-SI-0611-10148] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); GlaxoSmithKline(GlaxoSmithKline); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	The in vivo mouse model work was performed by Colin J. Clarke and Cornelis H. C. Wiegman. This work was funded by the Medical Research Council and Wellcome Trust and by an unrestricted research grant from GlaxoSmithKline.	Baarsma HA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025450; Barnes PJ, 2011, AM J RESP CRIT CARE, V184, P866, DOI 10.1164/rccm.201108-1436ED; Barnes PJ, 2009, LANCET, V373, P1905, DOI 10.1016/S0140-6736(09)60326-3; Barnes PJ, 2000, CHEST, V117, P10; Barnes PJ, 2006, CHEST, V129, P151, DOI 10.1378/chest.129.1.151; Bernard P, 2008, BIOL CELL, V100, P167, DOI 10.1042/BC20070072; Bowler Russell P, 2004, COPD, V1, P255, DOI 10.1081/COPD-200027031; Chang J, 2007, J BIOL CHEM, V282, P30938, DOI 10.1074/jbc.M702391200; Chung KF, 2008, EUR RESPIR J, V31, P1334, DOI 10.1183/09031936.00018908; CHURCH DF, 1985, ENVIRON HEALTH PERSP, V64, P111, DOI 10.2307/3430003; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Cohen ED, 2009, J CLIN INVEST, V119, P2538, DOI 10.1172/JCI38079; CUENDA A, 1995, FEBS LETT, V364, P229, DOI 10.1016/0014-5793(95)00357-F; de Boer WI, 2006, AM J CLIN PATHOL, V125, P184, DOI 10.1039/W1AXKGT7UA37X257; Deng XM, 2000, P NATL ACAD SCI USA, V97, P1578, DOI 10.1073/pnas.97.4.1578; Ezzie ME, 2012, THORAX, V67, P122, DOI 10.1136/thoraxjnl-2011-200089; Fearon ER, 2011, ANNU REV PATHOL-MECH, V6, P479, DOI 10.1146/annurev-pathol-011110-130235; GAVIN BJ, 1990, GENE DEV, V4, P2319, DOI 10.1101/gad.4.12b.2319; Groves AM, 2012, AM J RESP CELL MOL, V47, P776, DOI 10.1165/rcmb.2011-0433OC; Gueders MM, 2006, EUR J PHARMACOL, V533, P133, DOI 10.1016/j.ejphar.2005.12.082; Heinonen KM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019279; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Huang B, 2009, MOL CELL BIOL, V29, P1375, DOI 10.1128/MCB.01365-08; Ito K, 2005, NEW ENGL J MED, V352, P1967, DOI 10.1056/NEJMoa041892; Ito K, 2004, BIOCHEM BIOPH RES CO, V315, P240, DOI 10.1016/j.bbrc.2004.01.046; Ito K, 2001, FASEB J, V15, pA473; Jourdan M, 2007, BRIT J HAEMATOL, V138, P160, DOI 10.1111/j.1365-2141.2007.06629.x; Kim D, 2007, ONCOGENE, V26, P4571, DOI 10.1038/sj.onc.1210230; Kim W, 2013, BIOCHEM J, V450, P9, DOI 10.1042/BJ20121284; KIRKHAM P, 2006, PHARMACOL THERAPEUT, V111, P776; Konigshoff M, 2010, AM J RESP CELL MOL, V42, P21, DOI 10.1165/rcmb.2008-0485TR; Kuraishy A, 2011, IMMUNITY, V35, P467, DOI 10.1016/j.immuni.2011.09.006; Lapperre TS, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-85; Lara E, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-170; Lee G, 2010, GASTROENTEROLOGY, V139, P869, DOI 10.1053/j.gastro.2010.05.037; Li Y, 2012, REPROD SCI, V19, P1232, DOI 10.1177/1933719112447126; Liu CF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010382; Llinas L, 2011, PULM PHARMACOL THER, V24, P32, DOI 10.1016/j.pupt.2010.10.010; Luppi F, 2007, AM J RESP CRIT CARE, V175, P527, DOI 10.1164/rccm.200612-1821ED; Lyons JP, 2004, EXP CELL RES, V298, P369, DOI 10.1016/j.yexcr.2004.04.036; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Macedo P, 2009, CLIN EXP ALLERGY, V39, P1668, DOI 10.1111/j.1365-2222.2009.03319.x; Mandel H, 2008, AM J HUM GENET, V82, P39, DOI 10.1016/j.ajhg.2007.08.005; Masckauchan T. Nestor H., 2005, Angiogenesis, V8, P43, DOI 10.1007/s10456-005-5612-9; Morello S, 2006, J IMMUNOL, V177, P7173, DOI 10.4049/jimmunol.177.10.7173; Nicodeme E, 2010, NATURE, V468, P1119, DOI 10.1038/nature09589; NUSSE R, 1982, CELL, V31, P99, DOI 10.1016/0092-8674(82)90409-3; Osafune K, 2006, DEVELOPMENT, V133, P151, DOI 10.1242/dev.02174; Perry MM, 2011, AM J RESP CELL MOL, V45, P746, DOI 10.1165/rcmb.2010-0304OC; Polakis P, 2000, GENE DEV, V14, P1837; Polakis P, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008052; Postma Dirkje S, 2006, Proc Am Thorac Soc, V3, P434, DOI 10.1513/pats.200601-006AW; Qiu WM, 2011, BIOCHEM BIOPH RES CO, V413, P98, DOI 10.1016/j.bbrc.2011.08.061; Rahman I, 2006, EUR RESPIR J, V28, P219, DOI 10.1183/09031936.06.00053805; Rangasamy T, 2004, J CLIN INVEST, V114, P1248, DOI 10.1172/JCI200421146; Renda T, 2008, EUR RESPIR J, V31, P62, DOI 10.1183/09031936.00036707; Russell REK, 2002, AM J RESP CELL MOL, V26, P602, DOI 10.1165/ajrcmb.26.5.4685; Soriano JB, 2008, EUR RESPIR J, V32, P1426, DOI 10.1183/09031936.00138108; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Tilley AE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022798; Triantaphyllopoulos K, 2011, AM J PHYSIOL-LUNG C, V300, pL691, DOI 10.1152/ajplung.00252.2010; Ushijima H, 2012, BIOCHEM BIOPH RES CO, V423, P679, DOI 10.1016/j.bbrc.2012.06.013; Voynow JA, 2009, AM J RESP CELL MOL, V41, P107, DOI 10.1165/rcmb.2008-0381OC; Wang R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014793; Williams AS, 2007, J PHARMACOL EXP THER, V322, P351, DOI 10.1124/jpet.107.121624; Zeskind Julie E, 2008, Proc Am Thorac Soc, V5, P834, DOI 10.1513/pats.200807-074TH	66	27	27	0	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2013	27	6					2367	2381		10.1096/fj.12-217083	http://dx.doi.org/10.1096/fj.12-217083			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	154II	23463699	Green Published, Green Submitted			2022-12-25	WOS:000319667600025
J	Dowell, KG; Simons, AK; Wang, ZZ; Yun, K; Hibbs, MA				Dowell, Karen G.; Simons, Allen K.; Wang, Zack Z.; Yun, Kyuson; Hibbs, Matthew A.			Cell-Type-Specific Predictive Network Yields Novel Insights into Mouse Embryonic Stem Cell Self-Renewal and Cell Fate	PLOS ONE			English	Article							GENE-FUNCTION PREDICTION; SIGNALING PATHWAYS; SYSTEMS BIOLOGY; PLURIPOTENCY; EXPRESSION; NORMALIZATION; INTEGRATION; GENOME; GBX2	Self-renewal, the ability of a stem cell to divide repeatedly while maintaining an undifferentiated state, is a defining characteristic of all stem cells. Here, we clarify the molecular foundations of mouse embryonic stem cell (mESC) self-renewal by applying a proven Bayesian network machine learning approach to integrate high-throughput data for protein function discovery. By focusing on a single stem-cell system, at a specific developmental stage, within the context of well-defined biological processes known to be active in that cell type, we produce a consensus predictive network that reflects biological reality more closely than those made by prior efforts using more generalized, context-independent methods. In addition, we show how machine learning efforts may be misled if the tissue specific role of mammalian proteins is not defined in the training set and circumscribed in the evidential data. For this study, we assembled an extensive compendium of mESC data: similar to 2.2 million data points, collected from 60 different studies, under 992 conditions. We then integrated these data into a consensus mESC functional relationship network focused on biological processes associated with embryonic stem cell self-renewal and cell fate determination. Computational evaluations, literature validation, and analyses of predicted functional linkages show that our results are highly accurate and biologically relevant. Our mESC network predicts many novel players involved in self-renewal and serves as the foundation for future pluripotent stem cell studies. This network can be used by stem cell researchers (at http://StemSight.org) to explore hypotheses about gene function in the context of self-renewal and to prioritize genes of interest for experimental validation.	[Dowell, Karen G.; Simons, Allen K.; Yun, Kyuson; Hibbs, Matthew A.] Jackson Lab, Bar Harbor, ME 04609 USA; [Dowell, Karen G.; Wang, Zack Z.; Yun, Kyuson; Hibbs, Matthew A.] Univ Maine, Grad Sch Biomed Sci & Engn, Orono, ME USA; [Wang, Zack Z.] Johns Hopkins Univ, Baltimore, MD USA; [Hibbs, Matthew A.] Trinity Univ, Dept Comp Sci, San Antonio, TX USA	Jackson Laboratory; University of Maine System; University of Maine Orono; Johns Hopkins University; Trinity University	Hibbs, MA (corresponding author), Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.	mhibbs@trinity.edu			Jackson Laboratory; Pharmaceutical Researchers and Manufacturers of America (PhRMA) Foundation; University of Maine Graduate School of Biomedical Sciences; National Science Foundation [0221625]; National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin (NIH/NIAMS) [R21 AR069981-01]; NIH [P50 GM076468-06]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM076468] Funding Source: NIH RePORTER	Jackson Laboratory; Pharmaceutical Researchers and Manufacturers of America (PhRMA) Foundation; University of Maine Graduate School of Biomedical Sciences; National Science Foundation(National Science Foundation (NSF)); National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin (NIH/NIAMS); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was partially funded by The Jackson Laboratory. KGD is supported by a Pharmaceutical Researchers and Manufacturers of America (PhRMA) Foundation Fellowship in Informatics, and has received funding from the University of Maine Graduate School of Biomedical Sciences and the National Science Foundation Integrated Graduate Education and Research Traineeship (IGERT) program grant 0221625 to conduct this work. MAH is an Ellison Medical Foundation New Scholar in Aging; he is partially supported by National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin (NIH/NIAMS) grant R21 AR069981-01 (Hibbs, Ackert-Bicknell), and NIH Grant P50 GM076468-06 (Churchill). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts B, 2002, MOL BIOL CELL; Allison DB, 2006, NAT REV GENET, V7, P55, DOI 10.1038/nrg1749; Berardini TZ, 2010, NUCLEIC ACIDS RES, V38, pD331, DOI 10.1093/nar/gkp1018; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Bult CJ, 2010, NUCLEIC ACIDS RES, V38, pD586, DOI 10.1093/nar/gkp880; Canham MA, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000379; Chapman G, 1997, GENOMICS, V46, P223, DOI 10.1006/geno.1997.4969; CHARNIAK E, 1991, AI MAG, V12, P50; Chen X, 2008, COLD SH Q B, V73, P203, DOI 10.1101/sqb.2008.73.026; Chikina MD, 2012, BIOINFORMATICS, V28, P607, DOI 10.1093/bioinformatics/bts009; Darwiche A, 2009, MODELING AND REASONING WITH BAYESIAN NETWORKS, P1, DOI 10.1017/CBO9780511811357; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Druzdzel MJ, 1999, SIXTEENTH NATIONAL CONFERENCE ON ARTIFICIAL INTELLIGENCE (AAAI-99)/ELEVENTH INNOVATIVE APPLICATIONS OF ARTIFICIAL INTELLIGENCE (IAAI-99), P902; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Gillis J, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002444; Guan YF, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-s1-s3; Guan YF, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000165; Hampton T, 2011, JAMA-J AM MED ASSOC, V306, P1968, DOI 10.1001/jama.2011.1625; Hibbs MA, 2010, PRINCIPLES PRACTICES, V3; Hibbs MA, 2007, BIOINFORMATICS, V23, P2692, DOI 10.1093/bioinformatics/btm403; Hibbs MA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000322; Hill DP, 2009, MOL REPROD DEV; Hirai H, 2011, BIOCHEM J, V438, P11, DOI 10.1042/BJ20102152; Horvath S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000117; Huttenhower C, 2008, BIOINFORMATICS, V24, P1559, DOI 10.1093/bioinformatics/btn237; Huttenhower C, 2006, BIOINFORMATICS, V22, P2890, DOI 10.1093/bioinformatics/btl492; Huttenhower C, 2009, BIOINFORMATICS, V25, P2404, DOI 10.1093/bioinformatics/btp397; Huttenhower C, 2009, GENOME RES, V19, P1093, DOI 10.1101/gr.082214.108; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Jones A, 2010, PROTEIN CELL, V1, P1056, DOI 10.1007/s13238-010-0142-7; Joshi Trupti, 2008, V439, P369, DOI 10.1007/978-1-59745-188-8_25; Kanehisa M, 2002, NOVART FDN SYMP, V247, P91; Katoh M, 2008, CURR DRUG TARGETS, V9, P565, DOI 10.2174/138945008784911750; Katoh M, 2007, CLIN CANCER RES, V13, P4042, DOI 10.1158/1078-0432.CCR-06-2316; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kim WK, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-s1-s5; Kitano H, 2002, NATURE, V420, P206, DOI 10.1038/nature01254; Lanza R., 2006, ESSENTIALS STEM CELL; Li B, 2009, DEVELOPMENT, V136, P3267, DOI 10.1242/dev.036954; MacArthur BD, 2008, COLD SH Q B, V73, P211, DOI 10.1101/sqb.2008.73.061; MacArthur BD, 2009, NAT REV MOL CELL BIO, V10, P672, DOI 10.1038/nrm2766; Markowetz F, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S6-S5; Meehan TF, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-6; Miki T, 2011, STEM CELL REV; Mostafavi S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-s1-s4; Myers CL, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-187; Myers CL, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-13-r114; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Niwa H, 2009, NATURE, V460, P118, DOI 10.1038/nature08113; Obozinski G, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-s1-s6; Ohi Y, 2011, NAT CELL BIOL, V13, P541, DOI 10.1038/ncb2239; Okita Keisuke, 2006, Curr Stem Cell Res Ther, V1, P103, DOI 10.2174/157488806775269061; Pena-Castillo L, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-s1-s2; Quackenbush J, 2002, NAT GENET, V32, P496, DOI 10.1038/ng1032; Quackenbush J, 2007, J EXP BIOL, V210, P1507, DOI 10.1242/jeb.004432; Russell S, 2009, ARTIFICAL INTELLIGEN; Ryu JM, 2011, J BIOL CHEM, V286, P23667, DOI 10.1074/jbc.M110.216283; Sato A, 2010, EMBO J, V29, P41, DOI 10.1038/emboj.2009.322; Sealfon RSG, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-443; Shannon C. E., 1993, CE SHANNON COLLECTED; Shigekawa M, 2011, BIOCHEM BIOPH RES CO, V406, P614, DOI 10.1016/j.bbrc.2011.02.105; Steck H, 2002, DIRICHLET PRIOR BAYE; Tasan M, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-s1-s8; Troyanskaya O, 2001, BIOINFORMATICS, V17, P520, DOI 10.1093/bioinformatics/17.6.520; Troyanskaya OG, 2003, P NATL ACAD SCI USA, V100, P8348, DOI 10.1073/pnas.0832373100; Wang J, 2009, SCIENCE, V325, P435, DOI 10.1126/science.1173288; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Yamanaka S, 2008, CELL TISSUE RES, V331, P5, DOI 10.1007/s00441-007-0520-5; Yoshida Y, 2010, CIRCULATION, V122, P80, DOI 10.1161/CIRCULATIONAHA.109.881433	70	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e56810	10.1371/journal.pone.0056810	http://dx.doi.org/10.1371/journal.pone.0056810			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23468881	Green Published, Green Submitted, gold			2022-12-25	WOS:000315524900038
J	Ren, YF; Li, GL; Xue, YF; Zhang, XJ; Song, YJ; Lv, L; Wu, JM; Fang, YX; Wang, YQ; Shi, KQ; Chen, YP; Tang, KF				Ren, Yong-Feng; Li, Guiling; Xue, Yong-Feng; Zhang, Xue-Jiao; Song, Yi-Jiang; Lv, Lu; Wu, Jianmin; Fang, Yu-Xiao; Wang, Yu-Qun; Shi, Ke-Qing; Chen, Yong-ping; Tang, Kai-Fu			Decreased Dicer Expression Enhances SRP-Mediated Protein Targeting	PLOS ONE			English	Article							SIGNAL RECOGNITION PARTICLE; VIRUS-LIKE PARTICLES; 7SL RNA; ENDOPLASMIC-RETICULUM; UP-REGULATION; CELLS; HIV-1; MECHANISM; TRANSPORT; APOBEC3G	We have shown that Dicer processes 7SL RNA into different fragments ranging from similar to 20 to more than 200 nucleotides. Here we addressed the molecular functions of these 7SL RNA fragments and found that some of them functioned as dominant-negative regulators of the full-length 7SL RNA, interfering with signal recognition particle (SRP) complex formation. Transfection of these 7SL RNA fragments inhibited the expression of cell surface glycoproteins, the targeting of a reporter protein to the endoplasmic reticulum, and the secretion of secreted alkaline phosphatase. These results suggest that some Dicer-processed 7SL RNA fragments interfered with SRP-mediated protein targeting. Moreover, we showed that Dicer knockdown enhanced SRP-mediated protein targeting and that transfection of a mixture of the 7SL RNA fragments partially restored this effect. Our data indicate that Dicer can fine-tune the efficiency of SRP-mediated protein targeting via processing a proportion of 7SL RNA into fragments of different lengths.	[Ren, Yong-Feng; Li, Guiling; Xue, Yong-Feng; Zhang, Xue-Jiao; Song, Yi-Jiang; Lv, Lu; Wu, Jianmin; Fang, Yu-Xiao; Tang, Kai-Fu] Wenzhou Med Coll, Inst Genom Med, Wenzhou, Zhejiang, Peoples R China; [Wang, Yu-Qun; Shi, Ke-Qing; Chen, Yong-ping] Wenzhou Med Coll, Liver Res Ctr, Dept Infect & Liver Dis, Wenzhou, Zhejiang, Peoples R China	Wenzhou Medical University; Wenzhou Medical University	Tang, KF (corresponding author), Wenzhou Med Coll, Inst Genom Med, Wenzhou, Zhejiang, Peoples R China.	tangkaifu@hotmail.com	Shi, KeQing/A-3411-2009; Shi, Keqing/GZK-5146-2022	Shi, KeQing/0000-0002-5070-3834; Shi, Keqing/0000-0002-5070-3834; Tang, Kai-Fu/0000-0002-2657-4163; Tang, Kai-Fu/0000-0002-6892-1207; Wu, Jianmin/0000-0002-8223-1667	National Natural Science Foundation of China [30971612, 81171967, 31271383, 30700708]; Zhejiang Provincial Natural Science Foundation [R2110503, Y2101210]; Wenzhou Science and Technology Foundation [Y20100202, Y20100203]; Chongqing Medical Science Foundation [09-1-17]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation(Natural Science Foundation of Zhejiang Province); Wenzhou Science and Technology Foundation; Chongqing Medical Science Foundation	This work was supported by National Natural Science Foundation of China (30971612, 81171967, 31271383 and 30700708 to KFT); Zhejiang Provincial Natural Science Foundation (R2110503 to KFT, Y2101210 to JW); Wenzhou Science and Technology Foundation (Y20100202 to KFT, Y20100203 to JW) and the key project of Chongqing Medical Science Foundation (09-1-17 to KFT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bach D, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-54; BISHOP JM, 1970, VIROLOGY, V42, P927, DOI 10.1016/0042-6822(70)90341-7; BOVIA F, 1995, MOL BIOL CELL, V6, P471, DOI 10.1091/mbc.6.4.471; Carmell MA, 2004, NAT STRUCT MOL BIOL, V11, P214, DOI 10.1038/nsmb729; Egea PF, 2005, CURR OPIN STRUC BIOL, V15, P213, DOI 10.1016/j.sbi.2005.03.007; Halic M, 2005, CURR OPIN STRUC BIOL, V15, P116, DOI 10.1016/j.sbi.2005.01.013; Keene SE, 2010, J VIROL, V84, P9070, DOI 10.1128/JVI.00714-10; Lakkaraju AKK, 2007, EXP CELL RES, V313, P834, DOI 10.1016/j.yexcr.2006.12.003; LOWE ME, 1992, J CELL BIOL, V116, P799, DOI 10.1083/jcb.116.3.799; Misra S, 2005, J BIOL CHEM, V280, P29364, DOI 10.1074/jbc.M504162200; Onafuwa-Nuga AA, 2006, RNA, V12, P542, DOI 10.1261/rna.2306306; PRICE SR, 1995, J MOL BIOL, V249, P398, DOI 10.1006/jmbi.1995.0305; Ren YF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040705; Saraogi I, 2011, TRAFFIC, V12, P535, DOI 10.1111/j.1600-0854.2011.01171.x; Schwartz TU, 2007, ADV EXP MED BIOL, V607, P52; Shao SC, 2011, ANNU REV CELL DEV BI, V27, P25, DOI 10.1146/annurev-cellbio-092910-154125; Tang KF, 2008, J CELL BIOL, V182, P233, DOI 10.1083/jcb.200801169; Tang KF, 2007, BBA-GEN SUBJECTS, V1770, P820, DOI 10.1016/j.bbagen.2007.01.004; Tang KF, 2010, BBA-GEN SUBJECTS, V1800, P380, DOI 10.1016/j.bbagen.2009.11.009; Tijsterman M, 2004, CELL, V117, P1, DOI 10.1016/S0092-8674(04)00293-4; Wang T, 2008, J MOL BIOL, V375, P1098, DOI 10.1016/j.jmb.2007.11.017; Wang T, 2007, J VIROL, V81, P13112, DOI 10.1128/JVI.00892-07	22	10	10	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e56950	10.1371/journal.pone.0056950	http://dx.doi.org/10.1371/journal.pone.0056950			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23468895	gold, Green Published, Green Submitted			2022-12-25	WOS:000315524900045
J	Deaner, RO; Lowen, A; Cobley, S				Deaner, Robert O.; Lowen, Aaron; Cobley, Stephen			Born at the Wrong Time: Selection Bias in the NHL Draft	PLOS ONE			English	Article							RELATIVE AGE; BIRTH DATES; TEAM SPORTS; LEAGUE; SOCCER; HOCKEY; SUCCESS; DISCRIMINATION; PERFORMANCE; MATURITY	Relative age effects (RAEs) occur when those who are relatively older for their age group are more likely to succeed. RAEs occur reliably in some educational and athletic contexts, yet the causal mechanisms remain unclear. Here we provide the first direct test of one mechanism, selection bias, which can be defined as evaluators granting fewer opportunities to relatively younger individuals than is warranted by their latent ability. Because RAEs are well-established in hockey, we analyzed National Hockey League (NHL) drafts from 1980 to 2006. Compared to those born in the first quarter (i.e., January-March), those born in the third and fourth quarters were drafted more than 40 slots later than their productivity warranted, and they were roughly twice as likely to reach career benchmarks, such as 400 games played or 200 points scored. This selection bias in drafting did not decrease over time, apparently continues to occur, and reduces the playing opportunities of relatively younger players. This bias is remarkable because it is exhibited by professional decision makers evaluating adults in a context where RAEs have been widely publicized. Thus, selection bias based on relative age may be pervasive.	[Deaner, Robert O.] Grand Valley State Univ, Dept Psychol, Allendale, MI 49401 USA; [Lowen, Aaron] Grand Valley State Univ, Dept Econ, Grand Rapids, MI USA; [Cobley, Stephen] Univ Sydney, Fac Hlth Sci, Sydney, NSW 2006, Australia	Grand Valley State University; Grand Valley State University; University of Sydney	Deaner, RO (corresponding author), Grand Valley State Univ, Dept Psychol, Allendale, MI 49401 USA.	deanerr@gvsu.edu	Cobley, Stephen P/I-5686-2017	Cobley, Stephen P/0000-0001-6099-392X; Lowen, Aaron/0000-0002-1769-9693	Grand Valley State University	Grand Valley State University	Grand Valley State University supported this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adonna V, 2010, J QUANT ANAL SPORT, V6, P1, DOI [10.2202/1559-0410.1227, DOI 10.2202/1559-0410.1227]; [Anonymous], 2012, NAT HOCK LE IN PRESS; Ashworth J, 2007, J SPORT ECON, V8, P355, DOI 10.1177/1527002506287695; Baker J, 2007, BRIT J SPORT MED, V41, P515, DOI 10.1136/bjsm.2006.033977; Barnsley R. H., 1985, CANADIAN ASS HLTH PH, V51, P23, DOI [10.1177/1012690210371560, DOI 10.1177/1012690210371560]; BARNSLEY RH, 1988, CAN J BEHAV SCI, V20, P167, DOI 10.1037/h0079927; Bedard K, 2006, Q J ECON, V121, P1437, DOI 10.1093/qje/121.4.1437; Black SE, 2011, REV ECON STAT, V93, P455, DOI 10.1162/REST_a_00081; Burger JD, 2009, J SPORT ECON, V10, P485, DOI 10.1177/1527002509332350; Camerer CF, 1999, J ECON BEHAV ORGAN, V39, P59, DOI 10.1016/S0167-2681(99)00026-8; Cobley S, 2009, SPORTS MED, V39, P235, DOI 10.2165/00007256-200939030-00005; Crawford C, 2007, ARE YOU BORN MATTERS; Delorme N, 2010, EUR J SPORT SCI, V10, P91, DOI 10.1080/17461390903271584; Dhuey E, 2008, ECON EDUC REV, V27, P173, DOI 10.1016/j.econedurev.2006.08.005; Duckworth AL, 2011, SOC PSYCHOL PERS SCI, V2, P174, DOI 10.1177/1948550610385872; Elder TE, 2010, J HEALTH ECON, V29, P641, DOI 10.1016/j.jhealeco.2010.06.003; Elder TE, 2009, J HUM RESOUR, V44, P641; Fischler S, 1999, CRACKED ICE INSIDERS; Ford PR, 2011, RES Q EXERCISE SPORT, V82, P570, DOI 10.1080/02701367.2011.10599790; Gibbs BG, 2012, INT REV SOCIOL SPORT, V47, P644, DOI 10.1177/1012690211414343; Gladwell Malcolm, 2008, OUTLIERS; Grondin S., 1984, APPRENT SOCIAL, V16, P169, DOI DOI 10.1234/12345678; Hendricks W, 2003, J LABOR ECON, V21, P857, DOI 10.1086/377025; Joyce G., 2007, FUTURE GREATS HEARTB; Jurges H, 2011, GER ECON REV, V12, P371, DOI 10.1111/j.1468-0475.2011.00533.x; Koz D, 2012, SCAND J MED SCI SPOR, V22, pE64, DOI 10.1111/j.1600-0838.2011.01408.x; Malloy S, 2011, ART SCOUTING HOCKEY; Massey C., 2010, LOSERS CURSE OVERCON; Meylan C, 2010, INT J SPORTS SCI COA, V5, P571, DOI 10.1260/1747-9541.5.4.571; Mitchell H, 2011, J SPORT ECON, V12, P36, DOI 10.1177/1527002510365051; Muhlenweg AM, 2010, J HUM RESOUR, V45, P407; Musch J, 2001, DEV REV, V21, P147, DOI 10.1006/drev.2000.0516; National Hockey League, 2005, COLL BARG AGR NAT HO; Nolan JE, 2010, INT REV SOCIOL SPORT, V45, P507, DOI 10.1177/1012690210371560; Pedace R, 2008, J SPORT ECON, V9, P115, DOI 10.1177/1527002507301422; Pellizzari M, 2012, J POPUL ECON, V25, P697, DOI 10.1007/s00148-011-0379-3; Petersen AM, 2011, P NATL ACAD SCI USA, V108, P18, DOI 10.1073/pnas.1016733108; STAW BM, 1995, ADMIN SCI QUART, V40, P474, DOI 10.2307/2393794; Thompson AH, 2004, EDUC RES-UK, V46, P313, DOI 10.1080/0013188042000277368; Till K, 2010, SCAND J MED SCI SPOR, V20, P320, DOI 10.1111/j.1600-0838.2009.00884.x; Vaeyens R, 2005, J SPORT SCI, V23, P747, DOI 10.1080/02640410400022052; Wattie N, 2007, INT J SPORT PSYCHOL, V38, P178	42	55	55	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57753	10.1371/journal.pone.0057753	http://dx.doi.org/10.1371/journal.pone.0057753			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	098BN	23460902	gold, Green Published			2022-12-25	WOS:000315519000157
J	Hsu, PH; Wei, KC; Huang, CY; Wen, CJ; Yen, TC; Liu, CL; Lin, YT; Chen, JC; Shen, CR; Liu, HL				Hsu, Po-Hung; Wei, Kuo-Chen; Huang, Chiung-Yin; Wen, Chih-Jen; Yen, Tzu-Chen; Liu, Chao-Lin; Lin, Ya-Tin; Chen, Jin-Chung; Shen, Chia-Rui; Liu, Hao-Li			Noninvasive and Targeted Gene Delivery into the Brain Using Microbubble-Facilitated Focused Ultrasound	PLOS ONE			English	Article							ADENOASSOCIATED VIRUS VECTORS; CENTRAL-NERVOUS-SYSTEM; TRANSGENE EXPRESSION; AAV SEROTYPES; PARKINSONS-DISEASE; BARRIER DISRUPTION; VIRAL VECTORS; MOUSE-BRAIN; IN-VITRO; PHASE-I	Recombinant adeno-associated viral (rAAV) vectors are potentially powerful tools for gene therapy of CNS diseases, but their penetration into brain parenchyma is severely limited by the blood-brain barrier (BBB) and current delivery relies on invasive stereotactic injection. Here we evaluate the local, targeted delivery of rAAV vectors into the brains of mice by noninvasive, reversible, microbubble-facilitated focused ultrasound (FUS), resulting in BBB opening that can be monitored and controlled by magnetic resonance imaging (MRI). Using this method, we found that IV-administered AAV2-GFP (green fluorescence protein) with a low viral vector titer (1x10(9) vg/g) can successfully penetrate the BBB-opened brain regions to express GFP. We show that MRI monitoring of BBB-opening could serve as an indicator of the scale and distribution of AAV transduction. Transduction peaked at 3 weeks and neurons and astrocytes were affected. This novel, noninvasive delivery approach could significantly broaden the application of AAV-viral-vector-based genes for treatment of CNS diseases.	[Hsu, Po-Hung; Liu, Hao-Li] Chang Gung Univ, Dept Elect Engn, Tao Yuan, Taiwan; [Wei, Kuo-Chen; Huang, Chiung-Yin] Chang Gung Univ, Dept Neurosurg, Tao Yuan, Taiwan; [Wei, Kuo-Chen; Huang, Chiung-Yin; Wen, Chih-Jen; Yen, Tzu-Chen] Mem Hosp, Tao Yuan, Taiwan; [Wen, Chih-Jen; Yen, Tzu-Chen] Chang Gung Univ, Mol Imaging Ctr, Tao Yuan, Taiwan; [Yen, Tzu-Chen] Chang Gung Univ, Dept Nucl Med, Tao Yuan, Taiwan; [Liu, Chao-Lin] Min Chi Univ Technol, Dept Chem Engn, Taipei, Taiwan; [Lin, Ya-Tin; Chen, Jin-Chung] Chang Gung Univ, Grad Inst Biomed Sci, Tao Yuan, Taiwan; [Shen, Chia-Rui] Chang Gung Univ, Dept Med Biotechnol & Lab Sci, Coll Med, Tao Yuan, Taiwan	Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Chang Gung University; Chang Gung University	Shen, CR (corresponding author), Chang Gung Univ, Dept Med Biotechnol & Lab Sci, Coll Med, Tao Yuan, Taiwan.	crshen@mail.cgu.edu.tw; haoliliu@mail.cgu.edu.tw	Lin, Ya-Tin/AAM-2733-2021	Lin, Ya-Tin/0000-0001-7910-1223; Shen, Chia-Rui/0000-0002-8386-3965; Wei, Kuochen/0000-0003-3505-2196; Chen, Jin-Chung/0000-0003-2996-5781; Hsu, Pohung/0000-0002-2941-4712	National Science Council (Taiwan) [NSC-100-2321-B-182-010]	National Science Council (Taiwan)(Ministry of Science and Technology, Taiwan)	This study was supported by National Science Council (Taiwan) Grants NSC-100-2321-B-182-010. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alisky JM, 2000, NEUROREPORT, V11, P2669, DOI 10.1097/00001756-200008210-00013; [Anonymous], HUM GENE THER; Bankiewicz KS, 2000, EXP NEUROL, V164, P2, DOI 10.1006/exnr.2000.7408; Bennett J, 1999, P NATL ACAD SCI USA, V96, P9920, DOI 10.1073/pnas.96.17.9920; Burger C, 2004, MOL THER, V10, P302, DOI 10.1016/j.ymthe.2004.05.024; Carty N, J NEUROSCI METHODS, V194, P144; Carty N, 2010, J NEUROSCI METH, V194, P144, DOI 10.1016/j.jneumeth.2010.10.010; Chen H, 1999, J NEUROSCI RES, V55, P504, DOI 10.1002/(SICI)1097-4547(19990215)55:4<504::AID-JNR10>3.0.CO;2-0; Chen H, 1998, GENE THER, V5, P50, DOI 10.1038/sj.gt.3300547; Chen PY, 2010, NEURO-ONCOLOGY, V12, P1050, DOI 10.1093/neuonc/noq054; Christine CW, 2009, NEUROLOGY, V73, P1662, DOI 10.1212/WNL.0b013e3181c29356; Davidson BL, 2000, P NATL ACAD SCI USA, V97, P3428, DOI 10.1073/pnas.050581197; DORAN SE, 1995, NEUROSURGERY, V36, P965, DOI 10.1227/00006123-199505000-00012; Duque S, 2009, MOL THER, V17, P1187, DOI 10.1038/mt.2009.71; Favre D, 2001, MOL THER, V4, P559, DOI 10.1006/mthe.2001.0494; Fu HY, 2003, MOL THER, V8, P911, DOI 10.1016/j.ymthe.2003.08.021; Gray SJ, 2011, MOL THER, V19, P1058, DOI 10.1038/mt.2011.72; Howard DB, 2008, VIROLOGY, V372, P24, DOI 10.1016/j.virol.2007.10.007; Hu CH, 2010, J GENE MED, V12, P766, DOI 10.1002/jgm.1496; Huang Q, 2012, EXP NEUROL, V233, P350, DOI 10.1016/j.expneurol.2011.10.027; Hynynen K, 2005, NEUROIMAGE, V24, P12, DOI 10.1016/j.neuroimage.2004.06.046; Hynynen K, 2001, RADIOLOGY, V220, P640, DOI 10.1148/radiol.2202001804; Hynynen K, 2006, J NEUROSURG, V105, P445, DOI 10.3171/jns.2006.105.3.445; KAPLITT MG, 1994, NAT GENET, V8, P148, DOI 10.1038/ng1094-148; Kaplitt MG, 2007, LANCET, V369, P2097, DOI 10.1016/S0140-6736(07)60982-9; Kinoshita M, 2006, BIOCHEM BIOPH RES CO, V340, P1085, DOI 10.1016/j.bbrc.2005.12.112; Kinoshita M, 2006, P NATL ACAD SCI USA, V103, P11719, DOI 10.1073/pnas.0604318103; Klein RL, 2008, EUR J NEUROSCI, V27, P1615, DOI 10.1111/j.1460-9568.2008.06161.x; Lawlor PA, 2009, MOL THER, V17, P1692, DOI 10.1038/mt.2009.170; LeWitt PA, 2011, LANCET NEUROL, V10, P309, DOI 10.1016/S1474-4422(11)70039-4; Liu HL, 2008, ULTRASOUND MED BIOL, V34, P598, DOI 10.1016/j.ultrasmedbio.2008.01.011; Liu HL, 2010, P NATL ACAD SCI USA, V107, P15205, DOI 10.1073/pnas.1003388107; Liu HL, 2010, RADIOLOGY, V255, P415, DOI 10.1148/radiol.10090699; Mandel RJ, 2010, CURR OPIN MOL THER, V12, P240; McCown TJ, 1996, BRAIN RES, V713, P99, DOI 10.1016/0006-8993(95)01488-8; McDannold N, 2010, NEUROSURGERY, V66, P323, DOI 10.1227/01.NEU.0000360379.95800.2F; McPhee SWJ, 2006, J GENE MED, V8, P577, DOI 10.1002/jgm.885; Meijer DH, 2009, CANCER GENE THER, V16, P664, DOI 10.1038/cgt.2009.8; Mingozzi F, 2011, NAT REV GENET, V12, P341, DOI 10.1038/nrg2988; Ponnazhagan S, 1997, GENE, V190, P203, DOI 10.1016/S0378-1119(96)00576-8; Properzi F, 2008, EUR J NEUROSCI, V27, P593, DOI 10.1111/j.1460-9568.2008.06042.x; Rapoport SI, 1976, BLOOD BRAIN BARRIER; Royo NC, 2008, BRAIN RES, V1190, P15, DOI 10.1016/j.brainres.2007.11.015; Ryals RC, 2011, MOL VIS, V17, P1090; Sarra GM, 2002, VISION RES, V42, P541, DOI 10.1016/S0042-6989(01)00230-9; Sheikov N, 2004, ULTRASOUND MED BIOL, V30, P979, DOI 10.1016/j.ultrasmedbio.2004.04.010; Shevtsova Z, 2005, EXP PHYSIOL, V90, P53, DOI 10.1113/expphysiol.2004.028159; Summerford C, 1998, J VIROL, V72, P1438, DOI 10.1128/JVI.72.2.1438-1445.1998; Toromanoff A, 2008, MOL THER, V16, P1291, DOI 10.1038/mt.2008.87; Treat LH, 2007, INT J CANCER, V121, P901, DOI 10.1002/ijc.22732; Worgall S, 2008, HUM GENE THER, V19, P463, DOI 10.1089/hum.2008.022; Wu CJ, 2012, HUM GENE THER; Wu ZJ, 2006, MOL THER, V14, P316, DOI 10.1016/j.ymthe.2006.05.009; Xing X, 1998, GENE THER, V5, P1538, DOI 10.1038/sj.gt.3300771; Yang CJ, 2009, HUM GENE THER, V20, P1597, DOI 10.1089/hum.2008.092	55	94	100	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57682	10.1371/journal.pone.0057682	http://dx.doi.org/10.1371/journal.pone.0057682			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460893	Green Submitted, gold, Green Published			2022-12-25	WOS:000315519000148
J	Stevens, SG; Brown, CM				Stevens, Stewart G.; Brown, Chris M.			In Silico Estimation of Translation Efficiency in Human Cell Lines: Potential Evidence for Widespread Translational Control	PLOS ONE			English	Article							MESSENGER-RNA; TRANSCRIPTOME; REVEALS; QUANTIFICATION; NORMALIZATION; PROTEOME; DETERMINANTS; DYNAMICS; GENES; SILAC	Recently large scale transcriptome and proteome datasets for human cells have become available. A striking finding from these studies is that the level of an mRNA typically predicts no more than 40% of the abundance of protein. This correlation represents the overall figure for all genes. We present here a bioinformatic analysis of translation efficiency - the rate at which mRNA is translated into protein. We have analysed those human datasets that include genome wide mRNA and protein levels determined in the same study. The analysis comprises five distinct human cell lines that together provide comparable data for 8,170 genes. For each gene we have used levels of mRNA and protein combined with protein stability data from the HeLa cell line to estimate translation efficiency. This was possible for 3,990 genes in one or more cell lines and 1,807 genes in all five cell lines. Interestingly, our analysis and modelling shows that for many genes this estimated translation efficiency has considerable consistency between cell lines. Some deviations from this consistency likely result from the regulation of protein degradation. Others are likely due to known translational control mechanisms. These findings suggest it will be possible to build improved models for the interpretation of mRNA expression data. The results we present here provide a view of translation efficiency for many genes. We provide an online resource allowing the exploration of translation efficiency in genes of interest within different cell lines (http://bioanalysis.otago.ac.nz/TranslationEfficiency).	[Stevens, Stewart G.; Brown, Chris M.] Univ Otago, Dunedin, New Zealand	University of Otago	Brown, CM (corresponding author), Univ Otago, Dunedin, New Zealand.	chris.brown@otago.ac.nz		Brown, Chris M/0000-0003-0079-7067	Human Frontier Science Foundation Research Grant [RGP0031 2009]; University of Otago	Human Frontier Science Foundation Research Grant; University of Otago	Partially funded by a Human Frontier Science Foundation Research Grant[RGP0031 2009 to Ian Macara, Anne Spang and C. M. B.]; University of Otago Research Grant to C. M. B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amman F, 2012, INT J MOL SCI, V13, P16223, DOI 10.3390/ijms131216223; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Araujo PR, 2012, COMP FUNCT GENOM, DOI 10.1155/2012/475731; Bermano G, 2001, FEBS LETT, V497, P77, DOI 10.1016/S0014-5793(01)02438-3; Cambridge SB, 2011, J PROTEOME RES, V10, P5275, DOI 10.1021/pr101183k; Chepelev NL, 2011, FREE RADICAL BIO MED, V50, P645, DOI 10.1016/j.freeradbiomed.2010.12.023; Dressaire C, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000606; Geiger T, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014050; Ghazalpour A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001393; Gingold H, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.14; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; HARGROVE JL, 1989, FASEB J, V3, P2360, DOI 10.1096/fasebj.3.12.2676679; Hinkson IV, 2011, TRENDS CELL BIOL, V21, P293, DOI 10.1016/j.tcb.2011.02.002; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010972; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Jacobs GH, 2009, NUCLEIC ACIDS RES, V37, pD72, DOI 10.1093/nar/gkn763; Kleffmann T, 2007, PLANT PHYSIOL, V143, P912, DOI 10.1104/pp.106.090738; Law GL, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-13-r111; Lundberg E, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.106; Mahlab S, 2012, RNA; Meyuhas O, 2000, EUR J BIOCHEM, V267, P6321, DOI 10.1046/j.1432-1327.2000.01719.x; Moore MJ, 2009, CELL, V136, P688, DOI 10.1016/j.cell.2009.02.001; Nagaraj N, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.81; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Schwanhausser B, 2009, PROTEOMICS, V9, P205, DOI 10.1002/pmic.200800275; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Song XF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027836; Stevens SG, 2011, RNA BIOL, V8, P792, DOI 10.4161/rna.8.5.16037; Sury MD, 2010, MOL CELL PROTEOMICS, V9, P2173, DOI 10.1074/mcp.M110.000323; Szostak E, 2012, BRIEF FUNCT GENOMICS; Tebaldi T, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-220; Thellin O, 2009, BIOTECHNOL ADV, V27, P323, DOI 10.1016/j.biotechadv.2009.01.010; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tuller T, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-11-r110; Tuller T, 2010, CELL, V141, P344, DOI 10.1016/j.cell.2010.03.031; Tunbridge EM, 2011, BIOL PSYCHIAT, V69, P173, DOI 10.1016/j.biopsych.2010.05.023; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Vogel C, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.59; Waldman YY, 2010, NUCLEIC ACIDS RES, V38, P2964, DOI 10.1093/nar/gkq009; Walther DM, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.004523; Wilkins MR, 1999, METH MOL B, V112, P531	46	14	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57625	10.1371/journal.pone.0057625	http://dx.doi.org/10.1371/journal.pone.0057625			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460887	Green Published, Green Submitted, gold			2022-12-25	WOS:000315519000142
J	Geissler, C; Nadrowski, K; Kuhn, P; Baruffol, M; Bruelheide, H; Schmid, B; Scholten, T				Geissler, Christian; Nadrowski, Karin; Kuehn, Peter; Baruffol, Martin; Bruelheide, Helge; Schmid, Bernhard; Scholten, Thomas			Kinetic Energy of Throughfall in Subtropical Forests of SE China - Effects of Tree Canopy Structure, Functional Traits, and Biodiversity	PLOS ONE			English	Article							DROP-SIZE DISTRIBUTION; SOIL-EROSION; SPLASH DETACHMENT; RAINFALL; INTERCEPTION; DIVERSITY; TRANSFORMATION; ECOLOGY; IMPACT; VOLUME	Throughfall kinetic energy (TKE) plays an important role in soil erosion in forests. We studied TKE as a function of biodiversity, functional diversity as well as structural stand variables in a secondary subtropical broad-leaved forest in the Gutianshan National Nature Reserve (GNNR) in south-east China, a biodiversity hotspot in the northern hemisphere with more than 250 woody species present. Using a mixed model approach we could identify significant effects of all these variables on TKE: TKE increased with rarefied tree species richness and decreased with increasing proportion of needle-leaved species and increasing leaf area index (LAI). Furthermore, for average rainfall amounts TKE was decreasing with tree canopy height whereas for high rainfall amounts this was not the case. The spatial pattern of throughfall was stable across several rain events. The temporal variation of TKE decreased with rainfall intensity and increased with tree diversity. Our results show that more diverse forest stands over the season have to cope with higher cumulative raindrop energy than less diverse stands. However, the kinetic energy (KE) of one single raindrop is less predictable in diverse stands since the variability in KE is higher. This paper is the first to contribute to the understanding of the ecosystem function of soil erosion prevention in diverse subtropical forests.	[Geissler, Christian; Kuehn, Peter; Scholten, Thomas] Univ Tubingen, Inst Geog, Tubingen, Germany; [Nadrowski, Karin] Univ Leipzig, D-04109 Leipzig, Germany; [Baruffol, Martin; Schmid, Bernhard] Univ Zurich, Inst Evolutionary Biol & Environm Studies, Zurich, Switzerland; [Bruelheide, Helge] Univ Halle Wittenberg, Inst Biol Geobot, D-06108 Halle, Germany; [Bruelheide, Helge] Univ Halle Wittenberg, Bot Garden, D-06108 Halle, Germany	Eberhard Karls University of Tubingen; Leipzig University; University of Zurich; Martin Luther University Halle Wittenberg; Martin Luther University Halle Wittenberg	Geissler, C (corresponding author), Univ Tubingen, Inst Geog, Tubingen, Germany.	christian.geissler@uni-tuebingen.de	Schmid, Bernhard/C-8625-2009; Baruffol, Martin/A-2406-2014; Kühn, Peter/A-9146-2009; Bruelheide, Helge/G-3907-2013; Scholten, Thomas/E-4024-2012	Schmid, Bernhard/0000-0002-8430-3214; Baruffol, Martin/0000-0001-9358-5885; Kühn, Peter/0000-0002-4417-5633; Bruelheide, Helge/0000-0003-3135-0356; Scholten, Thomas/0000-0002-4875-2602; Nadrowski, Karin/0000-0001-5358-5469	German Research Foundation [DFG FOR 891/1]; National Science Foundation of China (NSFC) [30710103907, 309300005]; DFG; NSFC; Sino-German Centre for Research Promotion in Beijing [GZ 524, 592, 698, 699]	German Research Foundation(German Research Foundation (DFG)); National Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); DFG(German Research Foundation (DFG)); NSFC(National Natural Science Foundation of China (NSFC)); Sino-German Centre for Research Promotion in Beijing	The funding by the German Research Foundation (DFG FOR 891/1) and by the National Science Foundation of China (NSFC 30710103907 and 309300005), as well as various travel grants to prepare the project financed by DFG, NSFC and the Sino-German Centre for Research Promotion in Beijing (GZ 524, 592, 698 and 699) are highly acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDHOUS P, 1993, SCIENCE, V259, P1390, DOI 10.1126/science.259.5100.1390; ARMSTRONG CL, 1988, T ASAE, V31, P1400; Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; Bates D, 2012, LME4 LINEAR MIXED EF; Both S, 2011, J VEG SCI, V22, P1120, DOI 10.1111/j.1654-1103.2011.01324.x; BRANDT J, 1988, J BIOGEOGR, V15, P41, DOI 10.2307/2845044; BROOKS SM, 1994, GEOGR ANN A, V76, P143, DOI 10.2307/521033; Bruelheide H, 2011, ECOL MONOGR, V81, P25, DOI 10.1890/09-2172.1; Chen JM, 1997, J GEOPHYS RES-ATMOS, V102, P29429, DOI 10.1029/97JD01107; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Crockford RH, 2000, HYDROL PROCESS, V14, P2903, DOI [10.1002/1099-1085(200011/12)14:16/17<2903::AID-HYP126>3.0.CO;2-6, 10.1002/1099-1085(200011/12)14:16/17&lt;2903::AID-HYP126&gt;3.0.CO;2-6]; Frasson RPD, 2011, AGR FOREST METEOROL, V151, P1244, DOI 10.1016/j.agrformet.2011.05.001; Geissler C, 2012, CATENA, V91, P85, DOI 10.1016/j.catena.2010.10.009; Geissler C, 2012, AGR FOREST METEOROL, V156, P31, DOI 10.1016/j.agrformet.2011.12.005; Geissler C, 2010, J EARTH SCI-CHINA, V21, P897, DOI 10.1007/s12583-010-0132-y; Gomez JA, 2001, AGR WATER MANAGE, V49, P65, DOI 10.1016/S0378-3774(00)00116-5; HALL RL, 1993, J GEOPHYS RES-ATMOS, V98, P18465, DOI 10.1029/93JD01498; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Hu Z, 2008, FRONT BIOL CHINA, V3, P45, DOI DOI 10.1007/S11515-008-0011-4; HURLBERT SH, 1971, ECOLOGY, V52, P577, DOI 10.2307/1934145; IUSS Working Group WRB, 2006, WORLD REF BAS SOIL R, V103; Korner C, 2002, MOUNTAIN BIODIVERSITY: A GLOBAL ASSESSMENT, P3; KWAAD FJPM, 1977, EARTH SURF PROC LAND, V2, P161, DOI 10.1002/esp.3290020208; Lal R, 1998, SOIL TILL RES, V48, P103, DOI 10.1016/S0167-1987(98)00109-3; Laliberte E, 2010, ECOLOGY, V91, P299, DOI 10.1890/08-2244.1; Levia DF, 2006, PROG PHYS GEOG, V30, P605, DOI 10.1177/0309133306071145; Loescher HW, 2002, J TROP ECOL, V18, P397, DOI 10.1017/S0266467402002274; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Marks R, 1998, STUDIES ENV HIST; Molnar P, 2004, ANNU REV EARTH PL SC, V32, P67, DOI 10.1146/annurev.earth.32.091003.143456; Montgomery DR, 2007, P NATL ACAD SCI USA, V104, P13268, DOI 10.1073/pnas.0611508104; Morgan R.P.C., 2005, EROSION HAZARD ASS; MOSLEY MP, 1982, EARTH SURF PROC LAND, V7, P103, DOI 10.1002/esp.3290070204; Murakami S, 2006, J HYDROL, V319, P72, DOI 10.1016/j.jhydrol.2005.07.002; Nadrowski K, 2010, CURR OPIN ENV SUST, V2, P75, DOI 10.1016/j.cosust.2010.02.003; NAEEM S, 1994, NATURE, V368, P734, DOI 10.1038/368734a0; Nanko K, 2008, CATENA, V72, P348, DOI 10.1016/j.catena.2007.07.002; Nanko K, 2004, J FOREST RES-JPN, V9, P157, DOI 10.1007/s10310-003-0067-6; Nanko K, 2006, J HYDROL, V329, P422, DOI 10.1016/j.jhydrol.2006.02.036; Nanko K, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL033010; Pimentel D, 1998, ECOSYSTEMS, V1, P416, DOI 10.1007/s100219900035; R Core Team, 2016, R FDN STAT COMP; Scherer-Lorenzen M, 2010, FUNCTIONAL SIGNIFICA; Scholten T, 2011, J PLANT NUTR SOIL SC, V174, P596, DOI 10.1002/jpln.201000349; Smith J R, 1914, Science, V39, P858, DOI 10.1126/science.39.1015.858; VIS M, 1986, EARTH SURF PROC LAND, V11, P591, DOI 10.1002/esp.3290110603; Wakiyama Y, 2010, EARTH SURF PROC LAND, V35, P993, DOI 10.1002/esp.1844; Wang K, 2005, PEDOSPHERE, V15, P620; Wiersum K. F., 1985, Soil erosion and conservation, P79; Zuur Alain F., 2009, P1	51	30	31	2	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e49618	10.1371/journal.pone.0049618	http://dx.doi.org/10.1371/journal.pone.0049618			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457440	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000315603700002
J	Stockel, J; Elvitigala, TR; Liberton, M; Pakrasi, HB				Stoeckel, Jana; Elvitigala, Thanura R.; Liberton, Michelle; Pakrasi, Himadri B.			Carbon Availability Affects Diurnally Controlled Processes and Cell Morphology of Cyanothece 51142	PLOS ONE			English	Article							GENE-EXPRESSION; N-2 FIXATION; AMINO-ACIDS; ANABAENA SP; WILD-TYPE; CYANOBACTERIUM; CO2; LIMITATION; GROWTH; TRICHODESMIUM	Cyanobacteria are oxygenic photoautotrophs notable for their ability to utilize atmospheric CO2 as the major source of carbon. The prospect of using cyanobacteria to convert solar energy and high concentrations of CO2 efficiently into biomass and renewable energy sources has sparked substantial interest in using flue gas from coal-burning power plants as a source of inorganic carbon. However, in order to guide further advances in this area, a better understanding of the metabolic changes that occur under conditions of high CO2 is needed. To determine the effect of high CO2 on cell physiology and growth, we analyzed the global transcriptional changes in the unicellular diazotrophic cyanobacterium Cyanothece 51142 grown in 8% CO2-enriched air. We found a concerted response of genes related to photosynthesis, carbon metabolism, respiration, nitrogen fixation, ribosome biosynthesis, and the synthesis of nucleotides and structural cell wall polysaccharides. The overall response to 8% CO2 in Cyanothece 51142 involves different strategies, to compensate for the high C/N ratio during both phases of the diurnal cycle. Our analyses show that high CO2 conditions trigger the production of carbon-rich compounds and stimulate processes such as respiration and nitrogen fixation. In addition, we observed that high levels of CO2 affect fundamental cellular processes such as cell growth and dramatically alter the intracellular morphology. This study provides novel insights on how diurnal and developmental rhythms are integrated to facilitate adaptation to high CO2 in Cyanothece 51142.	[Stoeckel, Jana; Elvitigala, Thanura R.; Liberton, Michelle; Pakrasi, Himadri B.] Washington Univ, Dept Biol, St Louis, MO 63130 USA	Washington University (WUSTL)	Pakrasi, HB (corresponding author), Washington Univ, Dept Biol, Campus Box 1137, St Louis, MO 63130 USA.	pakrasi@wustl.edu			Office of Science (BER), U.S. Department of Energy; Consortium for Clean Coal Utilization at Washington University; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-SC 0001035]	Office of Science (BER), U.S. Department of Energy(United States Department of Energy (DOE)); Consortium for Clean Coal Utilization at Washington University; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE))	This research was supported by funding from the Office of Science (BER), U.S. Department of Energy and from the Consortium for Clean Coal Utilization at Washington University. Electron microscopy imaging was performed as part of the Photosynthetic Antenna Research Center, an Energy Frontier Research Center funded by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences under Award Number DE-SC 0001035. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth EA, 2006, PLANT PHYSIOL, V142, P135, DOI 10.1104/pp.106.086256; Badger MR, 2003, J EXP BOT, V54, P609, DOI 10.1093/jxb/erg076; Bandyopadhyay A, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1139; Battchikova N, 2011, BBA-BIOENERGETICS, V1807, P935, DOI 10.1016/j.bbabio.2010.10.017; Battchikova N, 2010, J PROTEOME RES, V9, P5896, DOI 10.1021/pr100651w; Carr NG, 1988, NITROGEN RESERVES DY; Ducat DC, 2011, TRENDS BIOTECHNOL, V29, P95, DOI 10.1016/j.tibtech.2010.12.003; Eisenhut M, 2007, PLANT PHYSIOL, V144, P1946, DOI 10.1104/pp.107.103341; Eisenhut M, 2008, PLANT PHYSIOL, V148, P2109, DOI 10.1104/pp.108.129403; FLYNN KJ, 1990, ARCH MICROBIOL, V153, P574, DOI 10.1007/BF00245267; Fu FX, 2008, LIMNOL OCEANOGR, V53, P2472, DOI 10.4319/lo.2008.53.6.2472; Lopez CVG, 2009, BIORESOURCE TECHNOL, V100, P5904, DOI 10.1016/j.biortech.2009.04.070; Hacham Y, 2002, PLANT PHYSIOL, V128, P454, DOI 10.1104/pp.010819; Hutchins DA, 2007, LIMNOL OCEANOGR, V52, P1293, DOI 10.4319/lo.2007.52.4.1293; KALLAS T, 1983, J BACTERIOL, V155, P427, DOI 10.1128/JB.155.1.427-431.1983; Karradt A, 2008, J BIOL CHEM, V283, P32394, DOI 10.1074/jbc.M805823200; Kranz SA, 2010, PLANT PHYSIOL, V154, P334, DOI 10.1104/pp.110.159145; Kranz SA, 2009, LIMNOL OCEANOGR, V54, P548, DOI 10.4319/lo.2009.54.2.0548; LANG NJ, 1987, J BACTERIOL, V169, P920, DOI 10.1128/jb.169.2.920-923.1987; Leakey ADB, 2009, P NATL ACAD SCI USA, V106, P3597, DOI 10.1073/pnas.0810955106; Levitan O, 2007, GLOBAL CHANGE BIOL, V13, P531, DOI 10.1111/j.1365-2486.2006.01314.x; Liberton M, 2011, PLANT PHYSIOL, V155, P1656, DOI 10.1104/pp.110.165332; Long BM, 2001, APPL ENVIRON MICROB, V67, P278, DOI 10.1128/AEM.67.1.278-283.2001; Paul MJ, 2003, J EXP BOT, V54, P539, DOI 10.1093/jxb/erg052; Pereira S, 2009, FEMS MICROBIOL REV, V33, P917, DOI 10.1111/j.1574-6976.2009.00183.x; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Raetz CRH, 2009, J LIPID RES, V50, pS103, DOI 10.1194/jlr.R800060-JLR200; REDDY KJ, 1993, J BACTERIOL, V175, P1284, DOI 10.1128/JB.175.5.1284-1292.1993; SCHRADER M, 1981, FEMS MICROBIOL LETT, V11, P37; SEBER GAF, 1984, MULTIVARIATE OBSERVA; SINGH S, 1993, J BASIC MICROB, V33, P41, DOI 10.1002/jobm.3620330109; Smith PMC, 2002, PLANT PHYSIOL, V128, P793, DOI 10.1104/pp.010912; Stoeckel J, 2008, P NATL ACAD SCI USA, V105, P6156, DOI 10.1073/pnas.0711068105; Stockel J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016680; Summerfield TC, 2011, MICROBIOL-SGM, V157, P301, DOI 10.1099/mic.0.041053-0; Tapia MI, 1996, PLANTA, V198, P526, DOI 10.1007/BF00262638; Typas A, 2010, CELL, V143, P1097, DOI 10.1016/j.cell.2010.11.038; VERMAAS WFJ, 2001, PHOTOSYNTHESIS RESP, P1; Wang H, 2004, J BIOL CHEM, V279, P1468, DOI 10.1074/jbc.M309106200; Welsh EA, 2008, P NATL ACAD SCI USA, V105, P15094, DOI 10.1073/pnas.0805418105; Woodger FJ, 2003, PLANT PHYSIOL, V133, P2069, DOI 10.1104/pp.103.029728; Worrell E, 2001, ANNU REV ENERG ENV, V26, P303, DOI 10.1146/annurev.energy.26.1.303; Ziegler K, 2001, FEMS MICROBIOL LETT, V196, P13, DOI 10.1111/j.1574-6968.2001.tb10533.x	43	13	13	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56887	10.1371/journal.pone.0056887	http://dx.doi.org/10.1371/journal.pone.0056887			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457634	gold, Green Published, Green Submitted			2022-12-25	WOS:000315603700094
J	Turner, A; Li, LC; Pilli, T; Qian, LX; Wiley, EL; Setty, S; Christov, K; Ganesh, L; Maker, AV; Li, PF; Kanteti, P; Gupta, TKD; Prabhakar, BS				Turner, Andrea; Li, Liang-Cheng; Pilli, Tania; Qian, Lixia; Wiley, Elizabeth Louise; Setty, Suman; Christov, Konstantin; Ganesh, Lakshmy; Maker, Ajay V.; Li, Peifeng; Kanteti, Prasad; Gupta, Tapas K. Das; Prabhakar, Bellur S.			MADD Knock-Down Enhances Doxorubicin and TRAIL Induced Apoptosis in Breast Cancer Cells	PLOS ONE			English	Article							MADD/DENN SPLICE VARIANT; CYTOTOXIC LIGAND TRAIL; DEATH RECEPTORS 4; IG20 GENE; DENN-SV; CASPASE-8; EXPRESSION; RESISTANCE; ACTIVATION; FADD	The Map kinase Activating Death Domain containing protein (MADD) isoform of the IG20 gene is over-expressed in different types of cancer tissues and cell lines and it functions as a negative regulator of apoptosis. Therefore, we speculated that MADD might be over-expressed in human breast cancer tissues and that MADD knock-down might synergize with chemotherapeutic or TRAIL-induced apoptosis of breast cancer cells. Analyses of breast tissue microarrays revealed overexpression of MADD in ductal and invasive carcinomas relative to benign tissues. MADD knockdown resulted in enhanced spontaneous apoptosis in human breast cancer cell lines. Moreover, MADD knockdown followed by treatment with TRAIL or doxorubicin resulted in increased cell death compared to either treatment alone. Enhanced cell death was found to be secondary to increased caspase-8 activation. These data indicate that strategies to decrease MADD expression or function in breast cancer may be utilized to increase tumor cell sensitivity to TRAIL and doxorubicin induced apoptosis.	[Turner, Andrea; Li, Liang-Cheng; Pilli, Tania; Qian, Lixia; Ganesh, Lakshmy; Maker, Ajay V.; Li, Peifeng; Kanteti, Prasad; Prabhakar, Bellur S.] Univ Illinois, Coll Med, Dept Microbiol & Immunol, Chicago, IL 60612 USA; [Wiley, Elizabeth Louise; Setty, Suman] Univ Illinois, Coll Med, Dept Pathol, Chicago, IL 60612 USA; [Christov, Konstantin; Gupta, Tapas K. Das] Univ Illinois, Coll Med, Dept Surg Oncol, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Prabhakar, BS (corresponding author), Univ Illinois, Coll Med, Dept Microbiol & Immunol, Chicago, IL 60612 USA.	bprabhak@uic.edu	Li, Peifeng/AHE-6906-2022; Li, Peifeng/ABD-5663-2021	Li, Peifeng/0000-0002-0969-9407; Das Gupta, Tapas K./0000-0001-6437-6320	National Institutes of Health, Bethesda, Maryland [RO1 CA107506]; Elsa U. Pardee Foundation; NATIONAL CANCER INSTITUTE [R01CA107506] Funding Source: NIH RePORTER	National Institutes of Health, Bethesda, Maryland(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Elsa U. Pardee Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by the grant RO1 CA107506 to B.S.P. from the National Institutes of Health, Bethesda, Maryland, and by a grant from Elsa U. Pardee Foundation to L-C.L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Zoubi AM, 2001, J BIOL CHEM, V276, P47202, DOI 10.1074/jbc.M104835200; Bodmer JL, 2000, NAT CELL BIOL, V2, P241, DOI 10.1038/35008667; Chinnaiyan AM, 2000, P NATL ACAD SCI USA, V97, P1754, DOI 10.1073/pnas.030545097; Chinnaiyan AM, 1996, J BIOL CHEM, V271, P4961; Efimova E, 2003, CANCER RES, V63, P8768; Efimova EV, 2004, ONCOGENE, V23, P1076, DOI 10.1038/sj.onc.1207210; El-Deiry WS, 1998, SEMIN CANCER BIOL, V8, P345, DOI 10.1006/scbi.1998.0097; Geisler S, 2001, CANCER RES, V61, P2505; Guseva NV, 2008, BREAST CANCER RES TR, V107, P349, DOI 10.1007/s10549-007-9563-2; Keane MM, 1999, CANCER RES, V59, P734; Kim KH, 2000, CLIN CANCER RES, V6, P335; Kischkel FC, 2000, IMMUNITY, V12, P611, DOI 10.1016/S1074-7613(00)80212-5; Li LC, 2011, AM J OBSTET GYNECOL, V205; Li LC, 2008, CANCER RES, V68, P7352, DOI 10.1158/0008-5472.CAN-07-6311; Li PF, 2010, J BIOL CHEM, V285, P22713, DOI 10.1074/jbc.M110.105692; Li S, 2007, MOL CANCER THER, V6, P1031, DOI 10.1158/1535-7163.MCT-06-0643; Li XQ, 2005, BREAST CANCER RES, V7, pR589, DOI 10.1186/bcr1259; Liang K, 2006, MOL PHARMACOL, V70, P1045, DOI 10.1124/mol.106.023333; Lim KM, 2002, MOL CARCINOGEN, V35, P110, DOI 10.1002/mc.10082; Lin TY, 2002, ONCOGENE, V21, P8020, DOI 10.1038/sj.onc.1205926; MacFarlane M, 1997, J BIOL CHEM, V272, P25417, DOI 10.1074/jbc.272.41.25417; Mulherkar N, 2006, ONCOGENE, V25, P6252, DOI 10.1038/sj.onc.1209650; Mulherkar N, 2007, J BIOL CHEM, V282, P11715, DOI 10.1074/jbc.M701085200; Navarro R, 2006, ANN NY ACAD SCI, V1090, P408, DOI 10.1196/annals.1378.044; Pan GH, 1997, SCIENCE, V276, P111, DOI 10.1126/science.276.5309.111; Prabhakar BS, 2008, CLIN CANCER RES, V14, P347, DOI 10.1158/1078-0432.CCR-07-0493; Ramaswamy M, 2004, ONCOGENE, V23, P6083, DOI 10.1038/sj.onc.1207804; Song JJ, 2007, J BIOL CHEM, V282, P319, DOI 10.1074/jbc.M608065200; Sprick MR, 2000, IMMUNITY, V12, P599, DOI 10.1016/S1074-7613(00)80211-3; Subramanian M, 2009, J CLIN ENDOCR METAB, V94, P1467, DOI 10.1210/jc.2008-2378; Ta HQ, 2008, CANCER RES, V68, P8796, DOI 10.1158/0008-5472.CAN-08-2426; Tari AM, 2001, J CHEMOTHERAPY, V13, P334, DOI 10.1179/joc.2001.13.3.334; Thome M, 1997, NATURE, V386, P517, DOI 10.1038/386517a0; Wu XX, 2007, CANCER SCI, V98, P1969, DOI 10.1111/j.1349-7006.2007.00632.x; Zhang YQ, 2008, MOL CANCER RES, V6, P1861, DOI 10.1158/1541-7786.MCR-08-0313; Zhao YB, 2008, ACTA BIOCH BIOPH SIN, V40, P304, DOI 10.1111/j.1745-7270.2008.00402.x	36	20	26	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56817	10.1371/journal.pone.0056817	http://dx.doi.org/10.1371/journal.pone.0056817			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457619	Green Submitted, Green Published, gold			2022-12-25	WOS:000315603700083
J	Choi, JK; He, XM				Choi, Jung Kyu; He, Xiaoming			In Vitro Maturation of Cumulus-Oocyte Complexes for Efficient Isolation of Oocytes from Outbred Deer Mice	PLOS ONE			English	Article							DEVELOPMENTAL COMPETENCE; EMBRYO DEVELOPMENT; FERTILIZATION; SUPEROVULATION; PERFORMANCE; CULTURE; INVITRO; SPERM	In Background: The outbred (as with humans) deer mice have been a useful animal model of research on human behavior and biology including that of the reproductive system. One of the major challenges in using this species is that the yield of oocyte isolation via superovulation is dismal according to the literature to date less than similar to 5 oocytes per animal can be obtained so far. Objective: The goal of this study is to improve the yield of oocyte isolation from outbred deer mice close to that of most laboratory mice by in vitro maturation (IVM) of cumulus-oocyte complexes (COCs). Methods: Oocytes were isolated by both superovulation and IVM. For the latter, COCs were obtained by follicular puncture of antral follicles in both the surface and inner cortical layers of ovaries. Immature oocytes in the COCs were then cultured in vitro under optimized conditions to obtain metaphase II (MII) oocytes. Quality of the oocytes from IVM and superovulation was tested by in vitro fertilization (IVF) and embryo development. Results: Less than similar to 5 oocytes per animal could be isolated by superovulation only. However, we successfully obtained 20.3 +/- 2.9 oocytes per animal by IVM (16.0 +/- 2.5) and superovulation (4.3 +/- 1.3) in this study. Moreover, IVF and embryo development studies suggest that IVM oocytes have even better quality than that from superovulation The latter never developed to beyond 2-cell stage as usual while 9% of the former developed to 4-cells. Significance: We have successfully established the protocol for isolating oocytes from deer mice with high yield by IVM. Moreover, this is the first ever success to develop in vitro fertilized deer mice oocytes beyond the 2-cell stage in vitro. Therefore, this study is of significance to the use of deer mice for reproductive biology research.	[Choi, Jung Kyu; He, Xiaoming] Ohio State Univ, Dept Biomed Engn, Columbus, OH 43210 USA; [Choi, Jung Kyu; He, Xiaoming] Ohio State Univ, Davis Heart & Lung Res Inst, Columbus, OH 43210 USA; [He, Xiaoming] Ohio State Univ, James Comprehens Canc Ctr, Columbus, OH 43210 USA	Ohio State University; Ohio State University; James Cancer Hospital & Solove Research Institute; Ohio State University	He, XM (corresponding author), Ohio State Univ, Dept Biomed Engn, Columbus, OH 43210 USA.	He.429@osu.edu	He, Xiaoming/C-5499-2008	He, Xiaoming/0000-0003-0125-6086	National Institutes of Health [R01EB012108]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB012108] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by National Institutes of Health (Grant#:R01EB012108). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeydeera LR, 1998, BIOL REPROD, V58, P1316, DOI 10.1095/biolreprod58.5.1316; Ali AA, 2003, THERIOGENOLOGY, V59, P939, DOI 10.1016/S0093-691X(02)01125-1; Anckaert E, 2013, HUM REPROD UPDATE, V19, P52, DOI 10.1093/humupd/dms042; ANDERIESZ C, 1995, HUM REPROD, V10, P2377; Breen KM, 2006, FRONT NEUROENDOCRIN, V27, P233, DOI 10.1016/j.yfrne.2006.03.335; Byers SL, 2006, THERIOGENOLOGY, V65, P1716, DOI 10.1016/j.theriogenology.2005.09.016; Chappell MA, 2003, J EXP BIOL, V206, P1221, DOI 10.1242/jeb.00255; Combelles CMH, 2003, BIOL REPROD, V68, P812, DOI 10.1095/biolreprod.102.008656; deMatos DG, 1997, BIOL REPROD, V57, P1420, DOI 10.1095/biolreprod57.6.1420; Dewey MJ, 2001, GENESIS, V29, P105, DOI 10.1002/gene.1011; Duselis Amanda R, 2007, J Vis Exp, P185, DOI 10.3791/185; Eppig JJ, 1998, THERIOGENOLOGY, V49, P415, DOI 10.1016/S0093-691X(97)00413-5; Fisher HS, 2010, NATURE, V463, P801, DOI 10.1038/nature08736; FUKUDA Y, 1979, J EXP ZOOL, V207, P481, DOI 10.1002/jez.1402070316; Holzer H, 2007, FERTIL STERIL, V88, P62, DOI 10.1016/j.fertnstert.2006.11.087; Joyner Charlotte P., 1998, ILAR J, V39, P322; KLEIN MS, 1981, J EXP ZOOL, V218, P183, DOI 10.1002/jez.1402180211; Lee ST, 2006, FERTIL STERIL, V86, P1164, DOI 10.1016/j.fertnstert.2006.01.059; Lee ST, 2006, MOL REPROD DEV, V73, P1022, DOI 10.1002/mrd.20500; Lee ST, 2005, FERTIL STERIL, V83, P1264, DOI 10.1016/j.fertnstert.2004.09.039; Marchesi DE, 2012, SEMIN REPROD MED, V30, P323, DOI 10.1055/s-0032-1320013; MARSTON JH, 1966, J EMBRYOL EXP MORPH, V15, P169; Martin-Coello J, 2008, THERIOGENOLOGY, V70, P1004, DOI 10.1016/j.theriogenology.2008.06.002; Mott R, 2007, NAT GENET, V39, P1054, DOI 10.1038/ng0907-1054; Niu Y, 2009, J ZOOL, V278, P42, DOI 10.1111/j.1469-7998.2008.00546.x; SCHMIDT PM, 1989, GAMETE RES, V23, P11, DOI 10.1002/mrd.1120230103; Shorter KR, 2012, GENET RES INT, V2012, DOI 10.1155/2012/179159; Spearow JL, 1999, BIOL REPROD, V61, P851, DOI 10.1095/biolreprod61.4.851; Takagi M, 1998, THERIOGENOLOGY, V50, P307, DOI 10.1016/S0093-691X(98)00139-3; Tropea A, 2004, ANN NY ACAD SCI, V1034, P211, DOI 10.1196/annals.1335.023; Veres M, 2012, THERIOGENOLOGY, V77, P311, DOI 10.1016/j.theriogenology.2011.07.044; Vergara GJ, 1997, THERIOGENOLOGY, V47, P1245, DOI 10.1016/S0093-691X(97)00104-0; Wade CM, 2002, NATURE, V420, P574, DOI 10.1038/nature01252; Yuan Y, 2012, METHODS MOL BIOL, V825, P183, DOI 10.1007/978-1-61779-436-0_14; ZHANG X, 1991, MOL REPROD DEV, V28, P292, DOI 10.1002/mrd.1080280312	35	15	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56158	10.1371/journal.pone.0056158	http://dx.doi.org/10.1371/journal.pone.0056158			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457518	Green Published, gold, Green Submitted			2022-12-25	WOS:000315602700052
J	Dogac, E; Kandemir, I; Taskin, V				Dogac, Ersin; Kandemir, Irfan; Taskin, Vatan			The Genetic Polymorphisms and Colonization Process of Olive Fly Populations in Turkey	PLOS ONE			English	Article							BACTROCERA-CUCURBITAE DIPTERA; PEST FRUIT-FLY; MICROSATELLITE MARKERS; DACUS-OLEAE; ALLOZYME VARIATION; MELON FLY; TEPHRITIDAE; DNA; LOCI; FLOW	The olive fruit fly, Bactrocera oleae, is the most important pest of olives in olive growing regions worldwide, especially in the Mediterranean basin and North America. Despite the economic importance of the olive fly, the colonization route of this species is unclear. We used nuclear microsatellite markers and mitochondrial DNA to provide information about the population structure and invasion route of olive fly populations in Turkey, as representative of the Eastern Mediterranean region. Adult fly samples were collected from 38 sublocations covering all olive growing regions in Turkey. The simple sequence variability data revealed a significant genetic variability in olive fly populations and a certain degree of differentiation between Mediterranean and Aegean populations. Mediterranean populations harbor higher levels of microsatellite variation than Aegean populations, which points to the eastern part of the Mediterranean as the putative source of invasion. mtDNA results suggest olive flies from the western part of Turkey are closely related to Italo-Aegean flies of the Mediterranean basin and the olive fly populations have invaded the northern part of the Mediterranean basin through western Turkey. In addition, finding specific American haplotypes in high frequencies might indicate that Turkey is the possible source of American olive fly populations. In order to more precisely characterize the population structure and invasion routes of this organism, more DNA-based sequence analysis should be carried out worldwide.	[Dogac, Ersin; Taskin, Vatan] Mugla Sitki Kocman Univ, Dept Biol, Fac Sci, Mugla, Turkey; [Kandemir, Irfan] Ankara Univ, Dept Biol, Fac Sci, TR-06100 Ankara, Turkey	Mugla Sitki Kocman University; Ankara University	Taskin, V (corresponding author), Mugla Sitki Kocman Univ, Dept Biol, Fac Sci, Mugla, Turkey.	tvatan@mu.edu.tr	kandemir, irfan/L-3944-2019	DOGAC, ERSIN/0000-0003-4426-2187; kandemir, irfan/0000-0002-2888-1044	Scientific and Technological Research Council of Turkey (TUBITAK-TBAG) [110T190]; Mugla Sitki Kocman University Scientific Research Funds [MUBAP- 2010/26, 2012/46]; Scientific and Technological Research Council of Turkey	Scientific and Technological Research Council of Turkey (TUBITAK-TBAG)(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); Mugla Sitki Kocman University Scientific Research Funds(Mugla Sitki Kocman University); Scientific and Technological Research Council of Turkey(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK))	This study was financially supported by The Scientific and Technological Research Council of Turkey (TUBITAK-TBAG), project number 110T190, and Mugla Sitki Kocman University Scientific Research Funds (MUBAP- 2010/26 and 2012/46). ED was financially supported by a fellowship from The Scientific and Technological Research Council of Turkey. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamson WG, 1997, MONOGRAPHS POPULATIO, V29; Aketarawong N, 2007, MOL ECOL, V16, P3522, DOI 10.1111/j.1365-294X.2007.03409.x; Augustinos AA, 2005, GENETICA, V125, P231, DOI 10.1007/s10709-005-8692-y; Augustinos AA, 2002, MOL ECOL NOTES, V2, P278, DOI 10.1046/j.1471-8286.2002.00222.x; Augustinos AA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-618; Baker GC., 2002, T ROY SOC TROP MED H, V96, P21; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Basoglu I.M., 2009, THESIS CUKUROVA U AD; Belkhir K, 1996, 5000 CNRS UMR; BENDER W, 1983, J MOL BIOL, V168, P17, DOI 10.1016/S0022-2836(83)80320-9; Bonizzoni M, 2001, MOL ECOL, V10, P2515, DOI 10.1046/j.0962-1083.2001.01376.x; BRUFORD MW, 1993, CURR OPIN GENET DEV, V3, P939, DOI 10.1016/0959-437X(93)90017-J; Burrack HJ, 2008, J ECON ENTOMOL, V101, P750, DOI 10.1603/0022-0493(2008)101[750:OFFDTO]2.0.CO;2; Bush GL, 1979, RES GENETIC STRUCTUR, P11; Cameron EC, 2010, B ENTOMOL RES, V100, P197, DOI 10.1017/S0007485309990150; Cornuet JM, 1996, GENETICS, V144, P2001; Downie DA, 2001, EVOLUTION, V55, P1345, DOI 10.1111/j.0014-3820.2001.tb00657.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Falush D, 2003, GENETICS, V164, P1567; Fletcher B.S., 1989, FRUIT FLIES THEIR B, P195; FLETCHER BS, 1989, FRUIT FLIES THEIR B, V3, P209; Gilchrist AS, 2010, HEREDITY, V105, P165, DOI 10.1038/hdy.2009.163; GILLESPIE JH, 1974, GENETICS, V76, P837; Goudet J, 2002, FSTAT PROGRAM ESTIMA, DOI DOI 10.1093/OXFORDJOURNALS.JHERED.A111627; Gumusay B, 1990, ACTA HORTIC, V286, P359; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hu J, 2008, GENETICA, V134, P319, DOI 10.1007/s10709-007-9239-1; Iannotta N., 1999, Acta Horticulturae, P545; Jarne P, 1996, TRENDS ECOL EVOL, V11, P424, DOI 10.1016/0169-5347(96)10049-5; Langella O, 2002, POPULATIONS 1 2 29 P; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; LOUKAS M, 1985, ANN ENTOMOL SOC AM, V78, P159, DOI 10.1093/aesa/78.2.159; Loukas M, 1989, ELECTROPHORETIC STUD, P69; Lumaret R, 2004, HEREDITY, V92, P343, DOI 10.1038/sj.hdy.6800430; MANTEL N, 1967, CANCER RES, V27, P209; Meixner MD, 2002, MOL ECOL, V11, P891, DOI 10.1046/j.1365-294X.2002.01488.x; Montiel Bueno A, 2002, BULLETIN, V25, P1; Nardi F, 2005, MOL ECOL, V14, P2729, DOI 10.1111/j.1365-294X.2005.02610.x; Nardi F, 2003, INSECT MOL BIOL, V12, P605, DOI 10.1046/j.1365-2583.2003.00445.x; Nardi F, 2010, MOL PHYLOGENET EVOL, V57, P678, DOI 10.1016/j.ympev.2010.08.008; Nardi F., 2011, TEAM NEWS LETT, V10, P3; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; Nei M., 1987, MOL EVOLUTIONARY GEN; NEUENSCHWANDER P, 1985, Z ANGEW ENTOMOL, V100, P174; Ochando MD, 2000, J APPL ENTOMOL, V124, P177, DOI 10.1046/j.1439-0418.2000.00460.x; Oybak G, 2005, THESIS MUGLA SITKI K; Ozdogan M, 2007, TURKIYEDE NEOLITIK D; Polzin T, 2003, OPER RES LETT, V31, P12, DOI 10.1016/S0167-6377(02)00185-2; Pritchard JK, 2000, GENETICS, V155, P945; Rice R. E., 2003, California Agriculture, V57, P122, DOI 10.3733/ca.v057n04p122; Rice RE, 2000, U CALIFORNIA PLANT P, V10, P2; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Roderick GK, 2003, NAT REV GENET, V4, P889, DOI 10.1038/nrg1201; Segura MD, 2008, J APPL ENTOMOL, V132, P706, DOI 10.1111/j.1439-0418.2008.01366.x; Shi W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037083; SLATKIN M, 1985, EVOLUTION, V39, P53, DOI 10.2307/2408516; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TSAKAS S, 1975, GENETICS, V79, P675; TSAKAS SC, 1980, ENTOMOL EXP APPL, V28, P268, DOI 10.1007/BF00366313; van Asch B, 2012, GENETICA, V140, P181, DOI 10.1007/s10709-012-9669-2; Wan XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025238; WAPLES RS, 1987, EVOLUTION, V41, P385, DOI 10.1111/j.1558-5646.1987.tb05805.x; Wu Y, 2011, J ECON ENTOMOL, V104, P1065, DOI 10.1603/EC10395; Yeh F.C., 1999, MICROSOFT WINDOWS BA; YONG HS, 1992, COMP BIOCHEM PHYS B, V102, P367, DOI 10.1016/0305-0491(92)90136-F; Zohary D., 2000, Domestication of plants in the Old World: the origin and spread of cultivated plants in West Asia, Europe and the Nile Valley; ZOUROS E, 1969, GENET RES, V14, P249, DOI 10.1017/S0016672300002081; Zygouridis NE, 2009, HEREDITY, V102, P402, DOI 10.1038/hdy.2008.125	68	18	19	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56067	10.1371/journal.pone.0056067	http://dx.doi.org/10.1371/journal.pone.0056067			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457499	gold, Green Published, Green Submitted			2022-12-25	WOS:000315602700038
J	Nakagawa, S; Sugiura, M; Akitsuki, Y; Hosseini, SMH; Kotozaki, Y; Miyauchi, CM; Yomogida, Y; Yokoyama, R; Takeuchi, H; Kawashima, R				Nakagawa, Seishu; Sugiura, Motoaki; Akitsuki, Yuko; Hosseini, S. M. Hadi; Kotozaki, Yuka; Miyauchi, Carlos Makoto; Yomogida, Yukihito; Yokoyama, Ryoichi; Takeuchi, Hikaru; Kawashima, Ryuta			Compensatory Effort Parallels Midbrain Deactivation during Mental Fatigue: An fMRI Study	PLOS ONE			English	Article							DOPAMINERGIC MIDBRAIN; INVOLVEMENT; QUESTIONNAIRE; ACTIVATION; ATTENTION; WORKLOAD; EXERCISE	Fatigue reflects the functioning of our physiological negative feedback system, which prevents us from overworking. When fatigued, however, we often try to suppress this system in an effort to compensate for the resulting deterioration in performance. Previous studies have suggested that the effect of fatigue on neurovascular demand may be influenced by this compensatory effort. The primary goal of the present study was to isolate the effect of compensatory effort on neurovascular demand. Healthy male volunteers participated in a series of visual and auditory divided attention tasks that steadily increased fatigue levels for 2 hours. Functional magnetic resonance imaging scans were performed during the first and last quarter of the study (Pre and Post sessions, respectively). Tasks with low and high attentional load (Low and High conditions, respectively) were administrated in alternating blocks. We assumed that compensatory effort would be greater under the High-attentional-load condition compared with the Low-load condition. The difference was assessed during the two sessions. The effect of compensatory effort on neurovascular demand was evaluated by examining the interaction between load (High vs. Low) and time (Pre vs. Post). Significant fatigue-induced deactivation (i.e., Pre>Post) was observed in the frontal, temporal, occipital, and parietal cortices, in the cerebellum, and in the midbrain in both the High and Low conditions. The interaction was significantly greater in the High than in the Low condition in the midbrain. Neither significant fatigue-induced activation (i.e., Pre<Post), nor its interaction with factor Load, was identified. The observed midbrain deactivation ([PreH - PostH]>[PreE- PostE]) may reflect suppression of the negative feedback system that normally triggers recuperative rest to maintain homeostasis.	[Nakagawa, Seishu; Sugiura, Motoaki; Hosseini, S. M. Hadi; Miyauchi, Carlos Makoto; Yomogida, Yukihito; Yokoyama, Ryoichi; Kawashima, Ryuta] Tohoku Univ, IDAC, Dept Funct Brain Imaging, Sendai, Miyagi 980, Japan; [Sugiura, Motoaki] Tohoku Univ, Int Res Inst Disaster Sci, Sendai, Miyagi 980, Japan; [Akitsuki, Yuko; Kotozaki, Yuka; Takeuchi, Hikaru; Kawashima, Ryuta] Tohoku Univ, IDAC, Smart Ageing Ctr, Sendai, Miyagi 980, Japan; [Hosseini, S. M. Hadi] Stanford Univ, Dept Psychiat & Behav Sci, Ctr Interdisciplinary Brain Sci Res, Sch Med, Stanford, CA 94305 USA; [Yomogida, Yukihito] Japan Soc Promot Sci, Tokyo, Japan	Tohoku University; Tohoku University; Tohoku University; Stanford University; Japan Society for the Promotion of Science	Nakagawa, S (corresponding author), Tohoku Univ, IDAC, Dept Funct Brain Imaging, Sendai, Miyagi 980, Japan.	seishu@idac.tohoku.ac.jp	Kotozaki, Yuka/ABA-2922-2020; Hosseini, Hadi/AAF-7095-2020; Kotozaki, Yuka/ABA-2267-2020; Takeuchi, Hikaru/D-1057-2011	Kotozaki, Yuka/0000-0002-4659-1200; Takeuchi, Hikaru/0000-0002-8022-9694; Yomogida, Yukihito/0000-0001-5026-4440; Hosseini, Hadi/0000-0001-5186-7008	JSPS	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by JSPS (there are no particular numbers). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amann M, 2008, J PHYSIOL-LONDON, V586, P161, DOI 10.1113/jphysiol.2007.141838; Amann M, 2011, MED SCI SPORT EXER, V43, P2039, DOI 10.1249/MSS.0b013e31821f59ab; Aratake Y, 2007, J OCCUP HEALTH, V49, P453, DOI 10.1539/joh.49.453; Ashburner J, 2008, SPM5 MANUAL; Barnden LR, 2011, NMR BIOMED, V24, P1302, DOI 10.1002/nbm.1692; Beurskens AJHM, 2000, OCCUP ENVIRON MED, V57, P353, DOI 10.1136/oem.57.5.353; Blouet C, 2010, BEHAV BRAIN RES, V209, P1, DOI 10.1016/j.bbr.2009.12.024; Boehler CN, 2011, J NEUROSCI, V31, P4955, DOI 10.1523/JNEUROSCI.4845-10.2011; Boksem MAS, 2008, BRAIN RES REV, V59, P125, DOI 10.1016/j.brainresrev.2008.07.001; BRUNO RL, 1995, ANN NY ACAD SCI, V753, P257, DOI 10.1111/j.1749-6632.1995.tb27552.x; Chaudhuri A, 2000, J NEUROL SCI, V179, P34, DOI 10.1016/S0022-510X(00)00411-1; Chaudhuri A, 2004, LANCET, V363, P978, DOI 10.1016/S0140-6736(04)15794-2; Cook DB, 2007, NEUROIMAGE, V36, P108, DOI 10.1016/j.neuroimage.2007.02.033; Dorland WAN, 2007, DORLANDS ILLUSTRATED, Vxxxi, P695; Gao Q, 2008, FEBS LETT, V582, P132, DOI 10.1016/j.febslet.2007.11.063; Hockey GRJ, 1997, BIOL PSYCHOL, V45, P73; Hommel JD, 2006, NEURON, V51, P801, DOI 10.1016/j.neuron.2006.08.023; Honda M, 1998, BRAIN, V121, P2159, DOI 10.1093/brain/121.11.2159; Klaassen EB, 2012, NEUROPHARMACOLOGY, P160; Kondo N, 2010, J EPIDEMIOL COMMUN H, V64, P649, DOI 10.1136/jech.2009.090787; Krebs RM, 2012, CEREB CORTEX, V22, P607, DOI 10.1093/cercor/bhr134; LEMOAL M, 1991, PHYSIOL REV, V71, P155, DOI 10.1152/physrev.1991.71.1.155; Lim J, 2010, NEUROIMAGE, V49, P3426, DOI 10.1016/j.neuroimage.2009.11.020; McHaffie JG, 2005, TRENDS NEUROSCI, V28, P401, DOI 10.1016/j.tins.2005.06.006; McKiernan KA, 2003, J COGNITIVE NEUROSCI, V15, P394, DOI 10.1162/089892903321593117; Meeusen R, 2006, SPORTS MED, V36, P881, DOI 10.2165/00007256-200636100-00006; Mulert C, 2008, NEUROIMAGE, V42, P158, DOI 10.1016/j.neuroimage.2008.04.236; Naidich T., 2009, DUVERNOYS ATLAS BRAI; Napadow V, 2006, NEUROIMAGE, V32, P1113, DOI 10.1016/j.neuroimage.2006.05.050; Nater UM, 2008, J CLIN ENDOCR METAB, V93, P703, DOI 10.1210/jc.2007-1747; Rahman S, 2001, J NEUROCHEM, V77, P1248, DOI 10.1046/j.1471-4159.2001.00326.x; Roberts ADL, 2004, BRIT J PSYCHIAT, V184, P136, DOI 10.1192/bjp.184.2.136; Sarter M, 2001, BRAIN RES REV, V35, P146, DOI 10.1016/S0165-0173(01)00044-3; Sarter M, 2006, BRAIN RES REV, V51, P145, DOI 10.1016/j.brainresrev.2005.11.002; Suda M, 2009, BRAIN RES, V1252, P152, DOI 10.1016/j.brainres.2008.11.077; Tajima S, 2010, NEUROL RES INT, V2010, DOI 10.1155/2010/671421; Tanaka M, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-9; Tolentino NJ, 2011, ALCOHOL CLIN EXP RES, V35, P1034, DOI 10.1111/j.1530-0277.2011.01435.x; Ungerleider LG, 2002, NEUROBIOL LEARN MEM, V78, P553, DOI 10.1006/nlme.2002.4091; van der Linden D, 2003, ACTA PSYCHOL, V113, P45, DOI 10.1016/S0001-6918(02)00150-6; VERCOULEN JHMM, 1994, J PSYCHOSOM RES, V38, P383, DOI 10.1016/0022-3999(94)90099-X	41	26	28	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56606	10.1371/journal.pone.0056606	http://dx.doi.org/10.1371/journal.pone.0056606			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457592	Green Published, gold, Green Submitted			2022-12-25	WOS:000315602700086
J	van den Heuvel, DMA; Hellemons, AJCGM; Pasterkamp, RJ				van den Heuvel, Dianne M. A.; Hellemons, Anita J. C. G. M.; Pasterkamp, R. Jeroen			Spatiotemporal Expression of Repulsive Guidance Molecules (RGMs) and Their Receptor Neogenin in the Mouse Brain	PLOS ONE			English	Article							SPINAL-CORD-INJURY; MORPHOGENETIC PROTEIN CORECEPTOR; EMBRYONIC VERTEBRATE FOREBRAIN; CENTRAL-NERVOUS-SYSTEM; NEURAL-TUBE CLOSURE; AXON GUIDANCE; HEPCIDIN EXPRESSION; GROWTH CONE; NEURONAL DIFFERENTIATION; COLORECTAL-CANCER	Neogenin has been implicated in a variety of developmental processes such as neurogenesis, neuronal differentiation, apoptosis, migration and axon guidance. Binding of repulsive guidance molecules (RGMs) to Neogenin inhibits axon outgrowth of different neuronal populations. This effect requires Neogenin to interact with co-receptors of the uncoordinated locomotion-5 (Unc5) family to activate downstream Rho signaling. Although previous studies have reported RGM, Neogenin, and/or Unc5 expression, a systematic comparison of RGM and Neogenin expression in the developing nervous system is lacking, especially at later developmental stages. Furthermore, information on RGM and Neogenin expression at the protein level is limited. To fill this void and to gain further insight into the role of RGM-Neogenin signaling during mouse neural development, we studied the expression of RGMa, RGMb, Neogenin and Unc5A-D using in situ hybridization, immunohistochemistry and RGMa section binding. Expression patterns in the primary olfactory system, cortex, hippocampus, habenula, and cerebellum were studied in more detail. Characteristic cell layer-specific expression patterns were detected for RGMa, RGMb, Neogenin and Unc5A-D. Furthermore, strong expression of RGMa, RGMb and Neogenin protein was found on several major axon tracts such as the primary olfactory projections, anterior commissure and fasciculus retroflexus. These data not only hint at a role for RGM-Neogenin signaling during the development of different neuronal systems, but also suggest that Neogenin partners with different Unc5 family members in different systems. Overall, the results presented here will serve as a framework for further dissection of the role of RGM-Neogenin signaling during neural development.	[van den Heuvel, Dianne M. A.; Hellemons, Anita J. C. G. M.; Pasterkamp, R. Jeroen] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Neurosci & Pharmacol, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center	Pasterkamp, RJ (corresponding author), Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Neurosci & Pharmacol, Utrecht, Netherlands.	r.j.pasterkamp@umcutrecht.nl		Pasterkamp, Jeroen/0000-0003-1631-6440	Human Frontier Science Program Organization; Hersenstichting; Netherlands Organization for Health Research and Development (VIDI)	Human Frontier Science Program Organization(Human Frontier Science Program); Hersenstichting; Netherlands Organization for Health Research and Development (VIDI)	This work was funded by the Human Frontier Science Program Organization (Career Development Award), Hersenstichting, and The Netherlands Organization for Health Research and Development (VIDI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman SL, 1997, NATURE, V386, P838, DOI 10.1038/386838a0; Alcantara S, 2000, DEVELOPMENT, V127, P1359; Amaral David G., 1995, P443; Andrusiak MG, 2011, MOL CELL BIOL, V31, P238, DOI 10.1128/MCB.00378-10; Babitt JL, 2006, NAT GENET, V38, P531, DOI 10.1038/ng1777; Babitt JL, 2005, J BIOL CHEM, V280, P29820, DOI 10.1074/jbc.M503511200; Bianco IH, 2009, PHILOS T R SOC B, V364, P1005, DOI 10.1098/rstb.2008.0213; Bradford D, 2010, J COMP NEUROL, V518, P3237, DOI 10.1002/cne.22397; Brinks H, 2004, J NEUROSCI, V24, P3862, DOI 10.1523/JNEUROSCI.5296-03.2004; Chedotal A, 2010, TRENDS NEUROSCI, V33, P163, DOI 10.1016/j.tins.2010.01.004; Cho J, 2009, MOL NEUROBIOL, V39, P1, DOI 10.1007/s12035-008-8047-7; Conrad S, 2007, J BIOL CHEM, V282, P16423, DOI 10.1074/jbc.M610901200; Conrad S, 2010, MOL CELL NEUROSCI, V43, P222, DOI 10.1016/j.mcn.2009.11.003; Corradini E, 2009, CYTOKINE GROWTH F R, V20, P389, DOI 10.1016/j.cytogfr.2009.10.008; De Vries M, 2008, J NEUROCHEM, V106, P1483, DOI 10.1111/j.1471-4159.2008.05485.x; Endo M, 2009, J NEUROSCI, V29, P6649, DOI 10.1523/JNEUROSCI.0927-09.2009; Engelkamp D, 2002, MECH DEVELOP, V118, P191, DOI 10.1016/S0925-4773(02)00248-4; Fenstermaker AG, 2010, J NEUROSCI, V30, P16053, DOI 10.1523/JNEUROSCI.4508-10.2010; Fitzgerald DP, 2006, NEUROSCIENCE, V142, P703, DOI 10.1016/j.neuroscience.2006.06.041; Fitzgerald DP, 2007, GENE EXPR PATTERNS, V7, P784, DOI 10.1016/j.modgep.2007.05.004; Fitzgerald DP, 2006, DEV DYNAM, V235, P1720, DOI 10.1002/dvdy.20744; Gad JM, 1997, DEV BIOL, V192, P258, DOI 10.1006/dbio.1997.8756; Gessert S, 2008, BIOL CELL, V100, P659, DOI 10.1042/BC20080023; GRIMA B, 1985, P NATL ACAD SCI USA, V82, P617, DOI 10.1073/pnas.82.2.617; Gruber C, 2007, NEUROSCI LETT, V427, P165, DOI 10.1016/j.neulet.2007.09.016; Guijarro P, 2006, MOL CELL NEUROSCI, V33, P389, DOI 10.1016/j.mcn.2006.08.010; Gupta A, 2002, NAT REV GENET, V3, P342, DOI 10.1038/nrg799; Hagihara M, 2011, J BIOL CHEM, V286, P5157, DOI 10.1074/jbc.M110.180919; Halbrooks Peter J, 2007, J Mol Signal, V2, P4, DOI 10.1186/1750-2187-2-4; Hata K, 2006, J CELL BIOL, V173, P47, DOI 10.1083/jcb.200508143; Hata K, 2009, J CELL BIOL, V184, P737, DOI 10.1083/jcb.200807029; Jorge EC, 2012, DEV DYNAM, V241, P1886, DOI 10.1002/dvdy.23889; Kang JS, 2004, J CELL BIOL, V167, P493, DOI 10.1083/jcb.200405039; Kanomata K, 2009, GENES CELLS, V14, P695, DOI 10.1111/j.1365-2443.2009.01302.x; Kee N, 2008, J NEUROSCI, V28, P12643, DOI 10.1523/JNEUROSCI.4265-08.2008; Key B, 2012, CELL ADHES MIGR, V6, P85, DOI 10.4161/cam.20167; Kim D, 2011, J NEUROSCI, V31, P2167, DOI 10.1523/JNEUROSCI.5254-10.2011; Koeberle PD, 2010, NEUROSCIENCE, V169, P495, DOI 10.1016/j.neuroscience.2010.04.079; Kolk SM, 2009, J NEUROSCI, V29, P12542, DOI 10.1523/JNEUROSCI.2521-09.2009; Kuns-Hashimoto R, 2008, AM J PHYSIOL-CELL PH, V294, pC994, DOI 10.1152/ajpcell.00563.2007; Kuramoto T, 2004, MOL BRAIN RES, V122, P103, DOI 10.1016/j.molbrainres.2003.12.003; Lah GJ, 2012, DEV NEUROBIOL, V72, P1458, DOI 10.1002/dneu.22010; Lah GJ, 2012, MOL CELL BIOL, V32, P968, DOI 10.1128/MCB.06128-11; Lee DH, 2010, BLOOD, V115, P3136, DOI 10.1182/blood-2009-11-251199; Lejmi E, 2008, P NATL ACAD SCI USA, V105, P12491, DOI 10.1073/pnas.0804008105; Leonardo ED, 1997, NATURE, V386, P833, DOI 10.1038/386833a0; Li J, 2012, J CELL BIOCHEM, V113, P2523, DOI 10.1002/jcb.24128; Liu XX, 2009, BIOCHEM BIOPH RES CO, V382, P795, DOI 10.1016/j.bbrc.2009.03.115; Lu XW, 2004, NATURE, V432, P179, DOI 10.1038/nature03080; Manitt C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011463; MARTINEZ S, 1989, EUR J NEUROSCI, V1, P549, DOI 10.1111/j.1460-9568.1989.tb00362.x; Matsunaga E, 2004, NAT CELL BIOL, V6, P749, DOI 10.1038/ncb1157; Matsunaga E, 2004, DEV GROWTH DIFFER, V46, P481; Matsunaga E, 2006, J NEUROSCI, V26, P6082, DOI 10.1523/JNEUROSCI.4556-05.2006; Mawdsley DJ, 2004, DEV BIOL, V269, P302, DOI 10.1016/j.ydbio.2004.02.001; Metzger M, 2007, J NEUROCHEM, V103, P2665, DOI 10.1111/j.1471-4159.2007.04994.x; Mirakaj V, 2011, P NATL ACAD SCI USA, V108, P6555, DOI 10.1073/pnas.1015605108; Monnier PP, 2002, NATURE, V419, P392, DOI 10.1038/nature01041; Mori K, 2011, ANNU REV NEUROSCI, V34, P467, DOI 10.1146/annurev-neuro-112210-112917; Muramatsu R, 2010, BRAIN, V133, P60, DOI 10.1093/brain/awp266; Murase S, 2002, J NEUROSCI, V22, P3568; Niederkofler V, 2004, J NEUROSCI, V24, P808, DOI 10.1523/JNEUROSCI.4610-03.2004; Okamura Y, 2011, NEUROSCI RES, V71, P63, DOI 10.1016/j.neures.2011.05.012; Oldekamp J, 2004, GENE EXPR PATTERNS, V4, P283, DOI 10.1016/j.modgep.2003.11.008; Park KW, 2004, P NATL ACAD SCI USA, V101, P16210, DOI 10.1073/pnas.0405984101; Pasterkamp RJ, 1998, J NEUROSCI, V18, P9962; PHILLIPSON OT, 1982, EXP BRAIN RES, V45, P89; Przyborski SA, 1998, DEVELOPMENT, V125, P41; Rajagopalan S, 2004, NAT CELL BIOL, V6, P756, DOI 10.1038/ncb1156; Reed SE, 2006, J VIROL METHODS, V138, P85, DOI 10.1016/j.jviromet.2006.07.024; Samad TA, 2005, J BIOL CHEM, V280, P14122, DOI 10.1074/jbc.M410034200; Samad TA, 2004, J NEUROSCI, V24, P2027, DOI 10.1523/JNEUROSCI.4115-03.2004; Schmidtmer J, 2004, GENE EXPR PATTERNS, V4, P105, DOI 10.1016/S1567-133X(03)00144-3; Schnichels S, 2012, GRAEF ARCH CLIN EXP, V250, P39, DOI 10.1007/s00417-011-1791-9; Schnichels S, 2011, J NEUROSCI RES, V89, P490, DOI 10.1002/jnr.22584; Schwab JM, 2005, EUR J NEUROSCI, V21, P1569, DOI 10.1111/j.1460-9568.2005.03962.x; Severyn CJ, 2009, BIOCHEM J, V422, P393, DOI 10.1042/BJ20090978; Shin GJ, 2008, J MOL HISTOL, V39, P105, DOI 10.1007/s10735-007-9138-x; Srinivasan K, 2003, DEV CELL, V4, P371, DOI 10.1016/S1534-5807(03)00054-6; STAHL B, 1990, NEURON, V5, P735, DOI 10.1016/0896-6273(90)90227-7; Takemoto M, 2011, CEREB CORTEX, V21, P1925, DOI 10.1093/cercor/bhq265; Tassew NG, 2008, MOL CELL NEUROSCI, V37, P761, DOI 10.1016/j.mcn.2008.01.002; VIELMETTER J, 1994, J CELL BIOL, V127, P2009, DOI 10.1083/jcb.127.6.2009; Wilson NH, 2006, DEV BIOL, V296, P485, DOI 10.1016/j.ydbio.2006.06.018; Wingate RJT, 1999, DEVELOPMENT, V126, P4395; Xia Y, 2007, J BIOL CHEM, V282, P18129, DOI 10.1074/jbc.M701679200; Xia Y, 2010, J AM SOC NEPHROL, V21, P666, DOI 10.1681/ASN.2009050511; Yamashita T, 2007, CURR OPIN NEUROBIOL, V17, P29, DOI 10.1016/j.conb.2006.12.001; Yoshida J, 2008, BIOCHEM BIOPH RES CO, V372, P725, DOI 10.1016/j.bbrc.2008.05.124; Zhang AS, 2009, J BIOL CHEM, V284, P22580, DOI 10.1074/jbc.M109.027318; Zhang AS, 2005, J BIOL CHEM, V280, P33885, DOI 10.1074/jbc.M506207200; Zhong Y, 2004, CEREB CORTEX, V14, P1144, DOI 10.1093/cercor/bhh074; Zhou Z, 2010, DEV CELL, V19, P90, DOI 10.1016/j.devcel.2010.06.016	93	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e55828	10.1371/journal.pone.0055828	http://dx.doi.org/10.1371/journal.pone.0055828			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457482	Green Submitted, Green Published, gold			2022-12-25	WOS:000315602700023
J	McMahan, RH; Wang, XXX; Cheng, LL; Krisko, T; Smith, M; El Kasmi, K; Pruzanski, M; Adorini, L; Golden-Mason, L; Levi, M; Rosen, HR				McMahan, Rachel H.; Wang, Xiaoxin X.; Cheng, Lin Ling; Krisko, Tibor; Smith, Maxwell; El Kasmi, Karim; Pruzanski, Mark; Adorini, Luciano; Golden-Mason, Lucy; Levi, Moshe; Rosen, Hugo R.			Bile Acid Receptor Activation Modulates Hepatic Monocyte Activity and Improves Nonalcoholic Fatty Liver Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FARNESOID X RECEPTOR; INDUCED INSULIN-RESISTANCE; KUPFFER CELLS; ALTERNATIVE ACTIVATION; DENDRITIC CELLS; SCORING SYSTEM; STEATOHEPATITIS; TGR5; MACROPHAGES; MICE	Nonalcoholic fatty liver disease (NAFLD) affects a large proportion of the American population. The spectrum of disease ranges from bland steatosis without inflammation to nonalcoholic steatohepatitis and cirrhosis. Bile acids are critical regulators of hepatic lipid and glucose metabolism and signal through two major receptor pathways: farnesoid X receptor (FXR), a member of the nuclear hormone receptor superfamily, and TGR5, a G protein-coupled bile acid receptor (GPBAR1). Both FXR and TGR5 demonstrate pleiotropic functions, including immune modulation. To evaluate the effects of these pathways in NAFLD, we treated obese db/db mice with a dual FXR/TGR5 agonist (INT-767) for 6 weeks. Treatment with the agonist significantly improved the histological features of nonalcoholic steatohepatitis. Furthermore, treatment increased the proportion of intrahepatic monocytes with the anti-inflammatory Ly6C(low) phenotype and increased intrahepatic expression of genes expressed by alternatively activated macrophages, including CD206, Retnla, and Clec7a. In vitro treatment of monocytes with INT-767 led to decreased Ly6C expression and increased IL-10 production through a cAMP-dependent pathway. Our data indicate that FXR/TGR5 activation coordinates the immune phenotype of monocytes and macrophages, both in vitro and in vivo, identifying potential targeting strategies for treatment of NAFLD.	[McMahan, Rachel H.; Cheng, Lin Ling; Golden-Mason, Lucy; Rosen, Hugo R.] Univ Colorado Denver, Div Gastroenterol, Dept Med, Aurora, CO 80045 USA; [Wang, Xiaoxin X.; Levi, Moshe] Univ Colorado Denver, Dept Med, Div Nephrol & Hypertens, Aurora, CO 80045 USA; [El Kasmi, Karim] Univ Colorado Denver, Dept Pediat, Div Gastroenterol Hepatol & Nutr, Aurora, CO 80045 USA; [Krisko, Tibor] Brigham & Womens Hosp, Div Gastroenterol Hepatol & Endoscopy, Boston, MA 02115 USA; [Smith, Maxwell] Mayo Clin Arizona, Dept Lab Med & Pathol, Scottsdale, AZ 85259 USA; [Pruzanski, Mark] Intercept Pharmaceut, New York, NY 10013 USA; [Adorini, Luciano] Intercept Pharmaceut, I-06073 Perugia, Italy; [Golden-Mason, Lucy; Rosen, Hugo R.] Natl Jewish Hosp, Integrated Program Immunol, Denver, CO 80206 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Harvard University; Brigham & Women's Hospital; Mayo Clinic; Mayo Clinic Phoenix; Intercept Pharmaceuticals; Intercept Pharmaceuticals; National Jewish Health	Rosen, HR (corresponding author), Univ Colorado, Dept Med, Div Gastroenterol, Anschutz Med Campus,B-158,12631 E 17th Ave, Aurora, CO 80045 USA.	hugo.rosen@ucdenver.edu	Adorini, Luciano/AAE-5149-2020; Krisko, Tibor/AAG-7595-2020	Krisko, Tibor/0000-0002-9414-5846; Golden-Mason, Lucy/0000-0003-3347-4192; Golden-Mason, Lucy/0000-0002-2087-4405; Levi, Moshe/0000-0002-6225-946X	National Institutes of Health [U19 AI 1066328]; Veterans Affairs Merit Review grants; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K24AI083742, F31AI010663] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK048520, K01DK096025, R01DK098336] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001954] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit Review grants(US Department of Veterans Affairs); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grant U19 AI 1066328 (to H. R. R.). This work was also supported by Veterans Affairs Merit Review grants (to H. R. R.).	Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; Baffy G, 2009, J HEPATOL, V51, P212, DOI 10.1016/j.jhep.2009.03.008; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Bosschaerts T, 2008, J IMMUNOL, V180, P6168, DOI 10.4049/jimmunol.180.9.6168; Cintra DE, 2008, J HEPATOL, V48, P628, DOI 10.1016/j.jhep.2007.12.017; Clementi AH, 2009, BBA-MOL BASIS DIS, V1792, P1062, DOI 10.1016/j.bbadis.2009.08.007; Deng ZB, 2009, HEPATOLOGY, V50, P1412, DOI 10.1002/hep.23148; Dominguez PM, 2010, IMMUNOL REV, V234, P90, DOI 10.1111/j.0105-2896.2009.00876.x; Fiorucci S, 2009, TRENDS PHARMACOL SCI, V30, P570, DOI 10.1016/j.tips.2009.08.001; Foey AD, 2004, IMMUNOLOGY, V112, P44, DOI 10.1111/j.1365-2567.2004.01852.x; Gadaleta RM, 2011, GUT, V60, P463, DOI 10.1136/gut.2010.212159; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Guebre-Xabier M, 2000, HEPATOLOGY, V31, P633, DOI 10.1002/hep.510310313; Harrison SA, 2008, GUT, V57, P1441, DOI 10.1136/gut.2007.146019; Huang H, 2008, J GASTROEN HEPATOL, V23, pS50, DOI 10.1111/j.1440-1746.2007.05284.x; Huang W, 2010, DIABETES, V59, P347, DOI 10.2337/db09-0016; Ilkovitch D, 2009, CANCER RES, V69, P5514, DOI 10.1158/0008-5472.CAN-08-4625; Kawamata Y, 2003, J BIOL CHEM, V278, P9435, DOI 10.1074/jbc.M209706200; Keitel V, 2008, BIOCHEM BIOPH RES CO, V372, P78, DOI 10.1016/j.bbrc.2008.04.171; Keitel V, 2009, HEPATOLOGY, V50, P861, DOI 10.1002/hep.23032; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kong B, 2009, J PHARMACOL EXP THER, V328, P116, DOI 10.1124/jpet.108.144600; Lefebvre P, 2009, PHYSIOL REV, V89, P147, DOI 10.1152/physrev.00010.2008; Li ZP, 2003, HEPATOLOGY, V37, P343, DOI 10.1053/jhep.2003.50048; Lin HZ, 2000, NAT MED, V6, P998, DOI 10.1038/79697; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Maher JJ, 2008, HEPATOLOGY, V48, P670, DOI 10.1002/hep.22399; Maruyama T, 2002, BIOCHEM BIOPH RES CO, V298, P714, DOI 10.1016/S0006-291X(02)02550-0; Musso G, 2010, ANNU REV MED, V61, P375, DOI 10.1146/annurev.med.60.101107.134820; Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885; Neuschwander-Tetri BA, 2010, HEPATOLOGY, V52, P774, DOI 10.1002/hep.23719; Odegaard JI, 2008, CELL METAB, V7, P496, DOI 10.1016/j.cmet.2008.04.003; Odegaard JI, 2011, ANNU REV PATHOL-MECH, V6, P275, DOI 10.1146/annurev-pathol-011110-130138; Peng YF, 2009, J IMMUNOL, V182, P2777, DOI 10.4049/jimmunol.0803172; Pols TWH, 2011, CELL METAB, V14, P747, DOI 10.1016/j.cmet.2011.11.006; Puri P, 2009, HEPATOLOGY, V50, P1827, DOI 10.1002/hep.23229; Rizzo G, 2010, MOL PHARMACOL, V78, P617, DOI 10.1124/mol.110.064501; Sahai A, 2004, AM J PHYSIOL-GASTR L, V287, pG1035, DOI 10.1152/ajpgi.00199.2004; Sheth SG, 1997, ANN INTERN MED, V126, P137, DOI 10.7326/0003-4819-126-2-199701150-00008; Swirski FK, 2007, J CLIN INVEST, V117, P195, DOI 10.1172/JCI29950; Thomas C, 2008, NAT REV DRUG DISCOV, V7, P678, DOI 10.1038/nrd2619; Thomas C, 2009, CELL METAB, V10, P167, DOI 10.1016/j.cmet.2009.08.001; Vavassori P, 2009, J IMMUNOL, V183, P6251, DOI 10.4049/jimmunol.0803978; Wang XXX, 2010, DIABETES, V59, P2916, DOI 10.2337/db10-0019; Wang YD, 2008, HEPATOLOGY, V48, P1632, DOI 10.1002/hep.22519; Wang YD, 2011, HEPATOLOGY, V54, P1421, DOI 10.1002/hep.24525	49	154	162	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2013	288	17					11761	11770		10.1074/jbc.M112.446575	http://dx.doi.org/10.1074/jbc.M112.446575			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	133RP	23460643	hybrid, Green Published			2022-12-25	WOS:000318157600013
J	Aurass, P; Schlegel, M; Metwally, O; Harding, CR; Schroeder, GN; Frankel, G; Flieger, A				Aurass, Philipp; Schlegel, Maren; Metwally, Omar; Harding, Clare R.; Schroeder, Gunnar N.; Frankel, Gad; Flieger, Antje			The Legionella pneumophila Dot/Icm-secreted Effector PlcC/CegC1 Together with PlcA and PlcB Promotes Virulence and Belongs to a Novel Zinc Metallophospholipase C Family Present in Bacteria and Fungi	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYDROLYZING PHOSPHOLIPASE-C; PERFRINGENS ALPHA-TOXIN; II PROTEIN SECRETION; TO-CELL SPREAD; PSEUDOMONAS-AERUGINOSA; LISTERIA-MONOCYTOGENES; INTRACELLULAR INFECTION; CLOSTRIDIUM-PERFRINGENS; CRYSTAL-STRUCTURE; BACILLUS-CEREUS	Legionella pneumophila is a water-borne bacterium that causes pneumonia in humans. PlcA and PlcB are two previously defined L. pneumophila proteins with homology to the phosphatidylcholine-specific phospholipase C (PC-PLC) of Pseudomonas fluorescens. Additionally, we found that Lpg0012 shows similarity to PLCs and has been shown to be a Dot/Icm-injected effector, CegC1, which is designated here as PlcC. It remained unclear, however, whether these L. pneumophila proteins exhibit PLC activity. PlcC expressed in Escherichia coli hydrolyzed a broad phospholipid spectrum, including PC, phosphatidylglycerol (PG), and phosphatidyl inositol. The addition of Zn2+ ions activated, whereas EDTA inhibited, PlcC-derived PLC activity. Protein homology search revealed that the three Legionella enzymes and P. fluorescens PC-PLC share conserved domains also present in uncharacterized fungal proteins. Fifteen conserved amino acids were essential for enzyme activity as identified via PlcC mutagenesis. Analysis of defined L. pneumophila knock-out mutants indicated Lsp-dependent export of PG-hydrolyzing PLC activity. PlcA and PlcB exhibited PG-specific activity and contain a predicted Sec signal sequence. In line with the reported requirement of host cell contact for Dot/Icm-dependent effector translocation, PlcC showed cell-associated PC-specific PLC activity after bacterial growth in broth. A PLC triple mutant, but not single or double mutants, exhibited reduced host killing in a Galleria mellonella infection model, highlighting the importance of the three PLCs in pathogenesis. In summary, we describe here a novel Zn2+-dependent PLC family present in Legionella, Pseudomonas, and fungi with broad substrate preference and function in virulence.	[Aurass, Philipp; Schlegel, Maren; Metwally, Omar; Flieger, Antje] Robert Koch Inst, Div Bacterial Infect, D-38855 Wernigerode, Germany; [Harding, Clare R.; Schroeder, Gunnar N.; Frankel, Gad] Univ London Imperial Coll Sci Technol & Med, MRC Ctr Mol Bacteriol & Infect, Div Cell & Mol Biol, London SW7 2AZ, England	Robert Koch Institute; Imperial College London	Flieger, A (corresponding author), Robert Koch Inst, Div Bacterial Infect, Burgstr 37, D-38855 Wernigerode, Germany.	fliegera@rki.de	Schroeder, Gunnar Neels/AAJ-2591-2020	Schroeder, Gunnar Neels/0000-0002-0412-7741; Flieger, Antje/0000-0003-3819-2979	Robert Koch Institute, Germany; German Research Foundation (DFG) [DFG FL 359/6-1]; MRC [G1001729, MR/J006874/1] Funding Source: UKRI; Medical Research Council [G1001729] Funding Source: researchfish	Robert Koch Institute, Germany; German Research Foundation (DFG)(German Research Foundation (DFG)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the special research fund of the Robert Koch Institute, Germany, and by Grant DFG FL 359/6-1 from the German Research Foundation (DFG).	Altman E, 2008, J BACTERIOL, V190, P1985, DOI 10.1128/JB.01493-07; Aragon V, 2000, INFECT IMMUN, V68, P1855, DOI 10.1128/IAI.68.4.1855-1863.2000; Aragon V, 2002, MICROBIOL-SGM, V148, P2223, DOI 10.1099/00221287-148-7-2223; Aurass P, 2009, APPL ENVIRON MICROB, V75, P4506, DOI 10.1128/AEM.00187-09; BAINE WB, 1985, J GEN MICROBIOL, V131, P1383; BAINE WB, 1988, J GEN MICROBIOL, V134, P489; Banerji S, 2005, INFECT IMMUN, V73, P2899, DOI 10.1128/IAI.73.5.2899-2909.2005; Banerji S, 2008, INT J MED MICROBIOL, V298, P169, DOI 10.1016/j.ijmm.2007.11.004; Barker AP, 2004, MOL MICROBIOL, V53, P1089, DOI 10.1111/j.1365-2958.2004.04189.x; Benfield AP, 2007, ARCH BIOCHEM BIOPHYS, V460, P41, DOI 10.1016/j.abb.2007.01.023; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Broich M, 2006, J BACTERIOL, V188, P1218, DOI 10.1128/JB.188.4.1218-1226.2006; Bruggemann H, 2006, CELL MICROBIOL, V8, P1228, DOI 10.1111/j.1462-5822.2006.00703.x; CAMILLI A, 1993, MOL MICROBIOL, V8, P143, DOI 10.1111/j.1365-2958.1993.tb01211.x; Cianciotto NP, 2009, FUTURE MICROBIOL, V4, P797, DOI 10.2217/FMB.09.53; CIANCIOTTO NP, 1992, P NATL ACAD SCI USA, V89, P5188, DOI 10.1073/pnas.89.11.5188; Costas MJ, 2010, MOL MICROBIOL, V78, P1556, DOI 10.1111/j.1365-2958.2010.07425.x; de Felipe KS, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000117; DebRoy S, 2006, P NATL ACAD SCI USA, V103, P19146, DOI 10.1073/pnas.0608279103; DebRoy S, 2006, INFECT IMMUN, V74, P5152, DOI 10.1128/IAI.00484-06; DIAZLAVIADA I, 1990, EMBO J, V9, P3907, DOI 10.1002/j.1460-2075.1990.tb07611.x; EDELSTEIN PH, 1981, J CLIN MICROBIOL, V14, P298, DOI 10.1128/JCM.14.3.298-303.1981; Faucher SP, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00060; Felts RL, 2006, J BIOL CHEM, V281, P30289, DOI 10.1074/jbc.M606391200; Finck-Barbancon V, 1998, J BACTERIOL, V180, P6224; FinckBarbancon V, 1997, MOL MICROBIOL, V25, P547, DOI 10.1046/j.1365-2958.1997.4891851.x; Flieger A, 2000, J BACTERIOL, V182, P1321, DOI 10.1128/JB.182.5.1321-1327.2000; Flieger A, 2004, INFECT IMMUN, V72, P2648, DOI 10.1128/IAI.72.5.2648-2658.2004; Flieger A, 2002, INFECT IMMUN, V70, P6094, DOI 10.1128/IAI.70.11.6094-6106.2002; Flieger A, 2000, ENZYME MICROB TECH, V26, P451, DOI 10.1016/S0141-0229(99)00190-8; Franco IS, 2009, CELL MICROBIOL, V11, P1435, DOI 10.1111/j.1462-5822.2009.01351.x; FUJII Y, 1989, BRIT J PHARMACOL, V97, P119, DOI 10.1111/j.1476-5381.1989.tb11931.x; GEOFFROY C, 1991, INFECT IMMUN, V59, P2382, DOI 10.1128/IAI.59.7.2382-2388.1991; Hales LM, 1999, J BACTERIOL, V181, P4879, DOI 10.1128/JB.181.16.4879-4889.1999; HANSEN S, 1993, J MOL BIOL, V231, P870, DOI 10.1006/jmbi.1993.1333; Harding CR, 2012, INFECT IMMUN, V80, P2780, DOI 10.1128/IAI.00510-12; Hauser AR, 1998, MOL MICROBIOL, V27, P807, DOI 10.1046/j.1365-2958.1998.00727.x; Heidtman M, 2009, CELL MICROBIOL, V11, P230, DOI 10.1111/j.1462-5822.2008.01249.x; HOUGH E, 1989, NATURE, V338, P357, DOI 10.1038/338357a0; Hovel-Miner G, 2009, J BACTERIOL, V191, P2461, DOI 10.1128/JB.01578-08; Huang L, 2011, CELL MICROBIOL, V13, P227, DOI 10.1111/j.1462-5822.2010.01531.x; Hubber A, 2010, ANNU REV CELL DEV BI, V26, P261, DOI 10.1146/annurev-cellbio-100109-104034; Isberg RR, 2009, NAT REV MICROBIOL, V7, P12, DOI 10.1038/nrmicro1967; JEPRAS RI, 1985, J HYG-CAMBRIDGE, V95, P29, DOI 10.1017/S0022172400062252; Kirby JE, 1998, MOL MICROBIOL, V27, P323, DOI 10.1046/j.1365-2958.1998.00680.x; KRUG EL, 1984, ARCH BIOCHEM BIOPHYS, V231, P400, DOI 10.1016/0003-9861(84)90403-X; Kubiak RJ, 2001, BIOCHEMISTRY-US, V40, P5422, DOI 10.1021/bi002371y; Lang C, 2012, J BIOL CHEM, V287, P23464, DOI 10.1074/jbc.M112.346387; Lang C, 2011, EUR J CELL BIOL, V90, P903, DOI 10.1016/j.ejcb.2010.12.003; LEVINE L, 1987, PROSTAGLANDINS, V34, P633, DOI 10.1016/0090-6980(87)90288-7; Liles MR, 1999, MOL MICROBIOL, V31, P959, DOI 10.1046/j.1365-2958.1999.01239.x; MARQUIS H, 1995, INFECT IMMUN, V63, P4531, DOI 10.1128/IAI.63.11.4531-4534.1995; McCoy-Simandle K, 2011, INFECT IMMUN, V79, P1984, DOI 10.1128/IAI.01077-10; Merzbacher M, 2004, EUR J BIOCHEM, V271, P367, DOI 10.1046/j.1432-1033.2003.03935.x; MEYERS DJ, 1990, INFECT IMMUN, V58, P659, DOI 10.1128/IAI.58.3.659-666.1990; MEZNA M, 1994, BIOCHEM J, V301, P503, DOI 10.1042/bj3010503; MOFFAT JF, 1992, INFECT IMMUN, V60, P296, DOI 10.1128/IAI.60.1.296-301.1992; Moser J, 1997, J MOL BIOL, V273, P269, DOI 10.1006/jmbi.1997.1290; Naylor CE, 1998, NAT STRUCT BIOL, V5, P738, DOI 10.1038/1447; Ochsner UA, 2002, P NATL ACAD SCI USA, V99, P8312, DOI 10.1073/pnas.082238299; PARKINSON EK, 1987, CARCINOGENESIS, V8, P857, DOI 10.1093/carcin/8.6.857; Phillips RM, 2003, J BIOL CHEM, V278, P41326, DOI 10.1074/jbc.M302472200; Plekhanov AY, 1999, ANAL BIOCHEM, V271, P186, DOI 10.1006/abio.1999.4127; Preuss I, 2001, EUR J BIOCHEM, V268, P5081, DOI 10.1046/j.0014-2956.2001.02440.x; Raynaud C, 2002, MOL MICROBIOL, V45, P203, DOI 10.1046/j.1365-2958.2002.03009.x; RECHNITZER C, 1992, J GEN MICROBIOL, V138, P1671, DOI 10.1099/00221287-138-8-1671; Reilly TJ, 1996, J BIOL CHEM, V271, P10973, DOI 10.1074/jbc.271.18.10973; Rossier O, 2005, INFECT IMMUN, V73, P2020, DOI 10.1128/IAI.73.4.2020-2032.2005; Rossier O, 2004, INFECT IMMUN, V72, P310, DOI 10.1128/IAI.72.1.310-321.2004; Rossier O, 2001, INFECT IMMUN, V69, P2092, DOI 10.1128/IAI.69.4.2092-2098.2001; Rossignol G, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-189; Roy CR, 1998, MOL MICROBIOL, V28, P663, DOI 10.1046/j.1365-2958.1998.00841.x; SADOSKY AB, 1993, INFECT IMMUN, V61, P5361, DOI 10.1128/IAI.61.12.5361-5373.1993; Sakurai J, 2004, J BIOCHEM, V136, P569, DOI 10.1093/jb/mvh161; Salacha R, 2010, ENVIRON MICROBIOL, V12, P1498, DOI 10.1111/j.1462-2920.2010.02174.x; Saliba AM, 2005, CELL MICROBIOL, V7, P1811, DOI 10.1111/j.1462-5822.2005.00635.x; Sato H, 2003, EMBO J, V22, P2959, DOI 10.1093/emboj/cdg290; Sato H, 2004, MOL MICROBIOL, V53, P1279, DOI 10.1111/j.1365-2958.2004.04194.x; Schmiel DH, 1999, MICROBES INFECT, V1, P1103, DOI 10.1016/S1286-4579(99)00205-1; Segal G, 1998, P NATL ACAD SCI USA, V95, P1669, DOI 10.1073/pnas.95.4.1669; Shohdy N, 2005, P NATL ACAD SCI USA, V102, P4866, DOI 10.1073/pnas.0501315102; Sitkiewicz I, 2007, TRENDS MICROBIOL, V15, P63, DOI 10.1016/j.tim.2006.12.003; SMITH GA, 1995, INFECT IMMUN, V63, P4231, DOI 10.1128/IAI.63.11.4231-4237.1995; Songer JG, 1997, TRENDS MICROBIOL, V5, P156, DOI 10.1016/S0966-842X(97)01005-6; Srinivas M, 2008, J BIOSCIENCES, V33, P221, DOI 10.1007/s12038-008-0039-2; Stonehouse MJ, 2002, MOL MICROBIOL, V46, P661, DOI 10.1046/j.1365-2958.2002.03194.x; TITBALL RW, 1993, MICROBIOL REV, V57, P347, DOI 10.1128/MMBR.57.2.347-366.1993; VanRheenen SM, 2006, INFECT IMMUN, V74, P3597, DOI 10.1128/IAI.02060-05; VAZQUEZBOLAND JA, 1992, INFECT IMMUN, V60, P219, DOI 10.1128/IAI.60.1.219-230.1992; Vogel JP, 1998, SCIENCE, V279, P873, DOI 10.1126/science.279.5352.873; Voulhoux R, 2001, EMBO J, V20, P6735, DOI 10.1093/emboj/20.23.6735; Weissenmayer BA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017570; WELLS MA, 1973, BIOCHEMISTRY-US, V12, P1080, DOI 10.1021/bi00730a010; WIATER LA, 1994, MOL MICROBIOL, V11, P641; Zavaleta-Pastor M, 2010, P NATL ACAD SCI USA, V107, P302, DOI 10.1073/pnas.0912930107; Zhu WH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017638	96	31	32	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2013	288	16					11080	11092		10.1074/jbc.M112.426049	http://dx.doi.org/10.1074/jbc.M112.426049			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	130KW	23457299	hybrid, Green Published			2022-12-25	WOS:000317915500014
J	Oshima, A; Matsuzawa, T; Nishikawa, K; Fujiyoshi, Y				Oshima, Atsunori; Matsuzawa, Tomohiro; Nishikawa, Kouki; Fujiyoshi, Yoshinori			Oligomeric Structure and Functional Characterization of Caenorhabditis elegans Innexin-6 Gap Junction Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MECHANOSENSITIVE ION-CHANNEL; LOW RESISTANCE JUNCTIONS; MEMBRANE CHANNEL; 3-DIMENSIONAL STRUCTURE; INTERCELLULAR CHANNELS; PROJECTION STRUCTURE; ANGSTROM RESOLUTION; CRAYFISH; MOLECULES; FAMILY	Innexin is the molecular component of invertebrate gap junctions. Here we successfully expressed and purified Caenorhabditis elegans innexin-6 (INX-6) gap junction channels and characterized the molecular dimensions and channel permeability using electron microscopy (EM) and microinjection of fluorescent dye tracers, respectively. Negative staining and thin-section EM of isolated INX-6 gap junction membranes revealed a loosely packed hexagonal lattice and a greater cross-sectional width than that of connexin26 and connexin43 (Cx43)-GFP. In gel filtration analysis, the elution profile of purified INX-6 channels in dodecyl maltoside solution exhibited a peak at similar to 400 kDa that was shifted to similar to 800 kDa in octyl glucose neopentyl glycol. We also obtained the class averages of purified INX-6 channels from these peak fractions by single particle analysis. The class average from the similar to 800-kDa fraction showed features of the junction form with a longitudinal height of 220 angstrom, a channel diameter of 110 angstrom in the absence of detergent micelles, and an extracellular gap space of 60 angstrom, whereas the class averages from the similar to 400-kDa fraction showed diameters of up to 140 angstrom in the presence of detergent micelles. These findings indicate that the purified INX-6 channels are predominantly hemichannels in dodecyl maltoside and docked junction channels in octyl glucose neopentyl glycol. Dye transfer experiments revealed that the INX-6-GFP-His channels are permeable to 3- and 10-kDa tracers, whereas no significant amounts of these tracers passed through the Cx43-GFP channels. Based on these findings, INX-6 channels have a larger overall structure and greater permeability than connexin channels.	[Oshima, Atsunori; Nishikawa, Kouki; Fujiyoshi, Yoshinori] Nagoya Univ, Cellular & Struct Physiol Inst CeSPI, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Oshima, Atsunori; Fujiyoshi, Yoshinori] Nagoya Univ, Dept Basic Med Sci, Grad Sch Pharmaceut Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Matsuzawa, Tomohiro] Kyoto Univ, Dept Biophys, Grad Sch Sci, Sakyo Ku, Kyoto 6068502, Japan	Nagoya University; Nagoya University; Kyoto University	Oshima, A (corresponding author), Nagoya Univ, Cellular & Struct Physiol Inst CeSPI, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648601, Japan.	atsu@cespi.nagoya-u.ac.jp	Oshima, Atsunori/F-8346-2010; Fujiyoshi, Yoshinori/E-5989-2012	Fujiyoshi, Yoshinori/0000-0002-8070-1493; Oshima, Atsunori/0000-0003-1174-1368	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; Japan New Energy and Industrial Technology Development Organization (NEDO)	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan New Energy and Industrial Technology Development Organization (NEDO)(New Energy and Industrial Technology Development Organization (NEDO))	This work was supported by grants-in-aid for scientific research (S) (to Y. F.), the Platform for Drug Design, Discovery and Development (to A. O.) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan, and the Japan New Energy and Industrial Technology Development Organization (NEDO) (to Y. F.).	Altun ZF, 2009, DEV DYNAM, V238, P1936, DOI 10.1002/dvdy.22025; Ambrosi C, 2010, J BIOL CHEM, V285, P24420, DOI 10.1074/jbc.M110.115444; BAKER TS, 1983, J CELL BIOL, V96, P204, DOI 10.1083/jcb.96.1.204; Bennett MVL, 2004, NEURON, V41, P495, DOI 10.1016/S0896-6273(04)00043-1; BERDAN RC, 1988, CELL TISSUE RES, V251, P257, DOI 10.1007/BF00215833; BOSCH E, 1989, J COMP NEUROL, V285, P399, DOI 10.1002/cne.902850307; Bukauskas FF, 1997, J PHYSIOL-LONDON, V499, P701, DOI 10.1113/jphysiol.1997.sp021962; BUKAUSKAS FF, 1995, PFLUG ARCH EUR J PHY, V429, P870, DOI 10.1007/BF00374812; Chang G, 1998, SCIENCE, V282, P2220, DOI 10.1126/science.282.5397.2220; Chekeni FB, 2010, NATURE, V467, P863, DOI 10.1038/nature09413; Cheng A, 2003, CELL COMMUN ADHES, V10, P187, DOI 10.1080/714040425; Dbouk HA, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-4; DePriest A, 2011, BIOPHYS J, V101, P2408, DOI 10.1016/j.bpj.2011.10.004; FLAGGNEWTON J, 1979, J MEMBRANE BIOL, V50, P65, DOI 10.1007/BF01868788; FURSHPAN EJ, 1959, J PHYSIOL-LONDON, V145, P289, DOI 10.1113/jphysiol.1959.sp006143; GIAUME C, 1987, J PHYSIOL-LONDON, V386, P91, DOI 10.1113/jphysiol.1987.sp016524; Gilula N. B., 1978, INTERCELLULAR JUNCTI, P1; Hand GM, 2002, J MOL BIOL, V315, P587, DOI 10.1006/jmbi.2001.5262; Harris AL, 2001, Q REV BIOPHYS, V34, P325, DOI 10.1017/S0033583501003705; HERTZBERG EL, 1984, J BIOL CHEM, V259, P9936; HIROKAWA N, 1982, CELL, V30, P395, DOI 10.1016/0092-8674(82)90237-9; Kanaporis G, 2011, AM J PHYSIOL-CELL PH, V300, pC600, DOI 10.1152/ajpcell.00316.2010; Kandarian B, 2012, DEV GENES EVOL, V222, P29, DOI 10.1007/s00427-011-0387-z; KISTLER J, 1993, J STRUCT BIOL, V110, P28, DOI 10.1006/jsbi.1993.1002; Kumar NM, 1996, CELL, V84, P381, DOI 10.1016/S0092-8674(00)81282-9; LAMPE PD, 1991, J STRUCT BIOL, V107, P281, DOI 10.1016/1047-8477(91)90053-Y; Li SL, 2003, MOL BIOL CELL, V14, P2630, DOI 10.1091/mbc.E02-11-0716; LOEWENSTEIN WR, 1981, PHYSIOL REV, V61, P829, DOI 10.1152/physrev.1981.61.4.829; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Maeda S, 2009, NATURE, V458, P597, DOI 10.1038/nature07869; MAKOWSKI L, 1977, J CELL BIOL, V74, P629, DOI 10.1083/jcb.74.2.629; Neijssen J, 2005, NATURE, V434, P83, DOI 10.1038/nature03290; Ohta Y, 2011, J STRUCT BIOL, V175, P49, DOI 10.1016/j.jsb.2011.04.002; Oshima A, 2003, J BIOL CHEM, V278, P1807, DOI 10.1074/jbc.M207713200; Oshima A, 2007, P NATL ACAD SCI USA, V104, P10034, DOI 10.1073/pnas.0703704104; Oshima A, 2011, J MOL BIOL, V405, P724, DOI 10.1016/j.jmb.2010.10.032; Panchin Y, 2000, CURR BIOL, V10, pR473, DOI 10.1016/S0960-9822(00)00576-5; PERACCHIA C, 1973, J CELL BIOL, V57, P66, DOI 10.1083/jcb.57.1.66; PERACCHIA C, 1973, J CELL BIOL, V57, P54, DOI 10.1083/jcb.57.1.54; Phelan P, 1998, NATURE, V391, P181, DOI 10.1038/34426; Phelan P, 1998, TRENDS GENET, V14, P348, DOI 10.1016/S0168-9525(98)01547-9; Phelan P, 2001, BIOESSAYS, V23, P388, DOI 10.1002/bies.1057; Phelan P, 1996, J NEUROSCI, V16, P1101; Phelan P, 2005, BBA-BIOMEMBRANES, V1711, P225, DOI 10.1016/j.bbamem.2004.10.004; Saint N, 1998, J BIOL CHEM, V273, P14667, DOI 10.1074/jbc.273.24.14667; SCHWARZMANN G, 1981, SCIENCE, V213, P551, DOI 10.1126/science.7244653; SIMPSON I, 1977, SCIENCE, V195, P294, DOI 10.1126/science.831276; Starich TA, 1996, J CELL BIOL, V134, P537, DOI 10.1083/jcb.134.2.537; STARICH TA, 1993, GENETICS, V133, P527; STAUFFER KA, 1995, J BIOL CHEM, V270, P6768; STAUFFER KA, 1991, J CELL BIOL, V115, P141, DOI 10.1083/jcb.115.1.141; Suchyna TM, 1999, BIOPHYS J, V77, P2968, DOI 10.1016/S0006-3495(99)77129-8; Unger VM, 1999, SCIENCE, V283, P1176, DOI 10.1126/science.283.5405.1176; Unger VM, 1997, NAT STRUCT BIOL, V4, P39, DOI 10.1038/nsb0197-39; UNWIN PNT, 1984, NATURE, V307, P609, DOI 10.1038/307609a0; VEENSTRA RD, 1995, CIRC RES, V77, P1156, DOI 10.1161/01.RES.77.6.1156; Whitten SJ, 2007, DEV BIOL, V301, P432, DOI 10.1016/j.ydbio.2006.08.038; Woehrle T, 2010, J LEUKOCYTE BIOL, V88, P1181, DOI 10.1189/jlb.0410211; YEAGER M, 1992, J MOL BIOL, V223, P929, DOI 10.1016/0022-2836(92)90253-G; Yeager M, 1998, J STRUCT BIOL, V121, P231, DOI 10.1006/jsbi.1998.3972; Yeh E, 2009, J NEUROSCI, V29, P5207, DOI 10.1523/JNEUROSCI.0637-09.2009; ZAMPIGHI G, 1988, J CELL BIOL, V106, P1667, DOI 10.1083/jcb.106.5.1667; ZAMPIGHI G, 1978, TISSUE CELL, V10, P413, DOI 10.1016/S0040-8166(16)30337-8; ZAMPIGHI G, 1979, J MOL BIOL, V135, P451, DOI 10.1016/0022-2836(79)90446-7	64	24	25	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2013	288	15					10513	10521		10.1074/jbc.M112.428383	http://dx.doi.org/10.1074/jbc.M112.428383			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	125TU	23460640	hybrid, Green Published			2022-12-25	WOS:000317565000031
J	Stiver, KA; Wolff, SH; Alonzo, SH				Stiver, Kelly A.; Wolff, Stephen H.; Alonzo, Suzanne H.			Sharing of Potential Nest Sites by Etheostoma olmstedi Males Suggests Mutual Tolerance in an Alloparental Species	PLOS ONE			English	Article							ECOLOGICAL CONSTRAINTS; PIMEPHALES-PROMELAS; FATHEAD MINNOW; COALITION-FORMATION; TESSELLATED DARTER; KIN SELECTION; NEOLAMPROLOGUS-PULCHER; GENETIC RELATEDNESS; PRISONERS-DILEMMA; ALLOPATERNAL CARE	When reproductive competitors tolerate or cooperate with one another, they may gain particular benefits, such as collectively guarding resources or attracting mates. Shared resources may be those essential to reproduction, such as a breeding site or nest. Using the tessellated darter, a species where males but not females compete over potential nest sites, we examined site use and sharing under controlled conditions of differing competitor density. Sharing was observed even when competitor density was low and individuals could have each occupied a potential nest site without same-sex sharing. Males were more likely to share a nest site with one other when the difference in size between them was larger rather than smaller. There was no evidence that female sharing was dependent on their relative size. Fish were generally more likely to use and share larger sites, in accordance with the greater relative surface area they offered. We discuss how one or both sharing males may potentially benefit, and how male sharing of potential nest sites could relate to female mating preferences. Tessellated darter males are known to provide alloparental care for eggs but this occurs without any social contact between the alloparent and the genetic father of the young. Thus, the suggestion that they may also share sites and maintain social contact with reproductive competitors highlights the importance of increased focus on the potential complexity of reproductive systems.	[Stiver, Kelly A.] So Connecticut State Univ, Dept Psychol, New Haven, CT 06515 USA; [Stiver, Kelly A.; Alonzo, Suzanne H.] Yale Univ, Sch Med, Dept Ecol & Evolut Biol, New Haven, CT USA; [Wolff, Stephen H.] Rice Univ, Dept Econ, Houston, TX USA	Connecticut State University System; Southern Connecticut State University; Yale University; Rice University	Stiver, KA (corresponding author), So Connecticut State Univ, Dept Psychol, New Haven, CT 06515 USA.	stiverk1@southernct.edu		Stiver, Kelly/0000-0002-0650-8281	Yale University; National Science Foundation [IOB-0450807]; Natural Sciences and Engineering Research Council of Canada (NSERC)	Yale University; National Science Foundation(National Science Foundation (NSF)); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	Funding support was courtesy of Yale University, a grant from the National Science Foundation (IOB-0450807) to S. H. A., and a Natural Sciences and Engineering Research Council of Canada (NSERC) Postdoctoral Fellowship to K. A. S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awata S, 2005, BEHAV ECOL SOCIOBIOL, V58, P506, DOI 10.1007/s00265-005-0934-6; Backwell PRY, 2004, NATURE, V430, P417, DOI 10.1038/430417a; Balshine Sigal, 2008, P437; Bergmuller R, 2007, BEHAV PROCESS, V76, P61, DOI 10.1016/j.beproc.2007.07.001; Bergmuller R, 2005, P ROY SOC B-BIOL SCI, V272, P325, DOI 10.1098/rspb.2004.2960; Bessert ML, 2007, J HERED, V98, P716, DOI 10.1093/jhered/esm092; BROWN JL, 1978, ANNU REV ECOL SYST, V9, P123, DOI 10.1146/annurev.es.09.110178.001011; Buston PM, 2007, BEHAV PROCESS, V76, P152, DOI 10.1016/j.beproc.2007.01.020; Clutton-Brock T, 2009, NATURE, V462, P51, DOI 10.1038/nature08366; CONNOR RC, 1995, TRENDS ECOL EVOL, V10, P84, DOI 10.1016/S0169-5347(00)88988-0; Connor R, 2007, BEHAV PROCESS, V76, P109, DOI 10.1016/j.beproc.2007.01.014; CONSTANTZ GD, 1985, ENVIRON BIOL FISH, V14, P175, DOI 10.1007/BF00000824; Constantz GD, 1979, P ACAD NAT SCI PHILI, V313, P131; Detto T, 2010, AM NAT, V175, pE119, DOI 10.1086/651588; DeWoody JA, 2000, COPEIA, P740; Dierkes P, 2008, BEHAV ECOL SOCIOBIOL, V62, P1581, DOI 10.1007/s00265-008-0587-3; Dierkes P, 2005, ECOL LETT, V8, P968, DOI 10.1111/j.1461-0248.2005.00801.x; Dugatkin LA, 1998, P ROY SOC B-BIOL SCI, V265, P2121, DOI 10.1098/rspb.1998.0548; Duval EH, 2007, AM NAT, V169, P423, DOI 10.1086/512137; EMLEN ST, 1982, AM NAT, V119, P29, DOI 10.1086/283888; FAHY WILLIAM E., 1954, JOUR ELISHA MITCHELL SCI SOC, V70, P139; GALE WF, 1985, T AM FISH SOC, V114, P220, DOI 10.1577/1548-8659(1985)114<220:FASFOC>2.0.CO;2; HARCOURT AH, 1992, POLIT LIFE SCI, V11, P251, DOI 10.1017/S0730938400015252; Harcourt AH., 1992, COALITIONS ALLIANCES; Hatchwell BJ, 2000, ANIM BEHAV, V59, P1079, DOI 10.1006/anbe.2000.1394; Heg D, 2008, ENVIRON BIOL FISH, V83, P191, DOI 10.1007/s10641-007-9317-3; Heg D, 2004, P ROY SOC B-BIOL SCI, V271, P2367, DOI 10.1098/rspb.2004.2855; Heg D, 2011, BEHAV ECOL, V22, P82, DOI 10.1093/beheco/arq170; Hoglund J, 1999, P ROY SOC B-BIOL SCI, V266, P813; Hoglund J, 2003, ANN ZOOL FENN, V40, P249; Hoglund J., 1995, LEKS, DOI DOI 10.1515/9781400864157; Jadwiszczak P., 2009, RUNDOM PRO 3 14 SOFT; Johnstone RA, 2000, P ROY SOC B-BIOL SCI, V267, P17, DOI 10.1098/rspb.2000.0960; Koenig W.D., 1981, P261; Kokko H, 1996, P ROY SOC B-BIOL SCI, V263, P919, DOI 10.1098/rspb.1996.0136; MCDONALD DB, 1994, SCIENCE, V266, P1030, DOI 10.1126/science.7973654; Mesterton-Gibbons M, 2007, BEHAV ECOL, V18, P277, DOI 10.1093/beheco/arl084; NOE R, 1990, ANIM BEHAV, V39, P78, DOI 10.1016/S0003-3472(05)80728-6; Olson LE, 2009, BEHAV ECOL, V20, P624, DOI 10.1093/beheco/arp040; PACKER C, 1982, NATURE, V296, P740, DOI 10.1038/296740a0; PACKER C, 1991, NATURE, V351, P562, DOI 10.1038/351562a0; Page L.M., 1983, HDB DARTERS; Petrie M, 1999, NATURE, V401, P155, DOI 10.1038/43651; POPE TR, 1990, BEHAV ECOL SOCIOBIOL, V27, P439, DOI 10.1007/BF00164071; RADABAUGH DC, 1989, J FISH BIOL, V34, P679, DOI 10.1111/j.1095-8649.1989.tb03349.x; Riehl C, 2011, P ROY SOC B-BIOL SCI, V278, P1728, DOI 10.1098/rspb.2010.1752; SARGENT RC, 1988, BEHAV ECOL SOCIOBIOL, V23, P33, DOI 10.1007/BF00303055; Schoepf I, 2012, J ANIM ECOL, V81, P649, DOI 10.1111/j.1365-2656.2011.01939.x; Shorey L, 2000, NATURE, V408, P352, DOI 10.1038/35042562; Silk JB, 2003, SCIENCE, V302, P1231, DOI 10.1126/science.1088580; Stiver KA, 2008, BEHAV ECOL, V19, P816, DOI 10.1093/beheco/arn031; Stiver KA, 2009, J FISH BIOL, V74, P1129, DOI 10.1111/j.1095-8649.2009.02173.x; Stiver KA, 2005, P ROY SOC B-BIOL SCI, V272, P1593, DOI 10.1098/rspb.2005.3123; Stiver KA, 2012, BEHAV ECOL SOCIOBIOL, V66, P855, DOI 10.1007/s00265-012-1334-3; Stiver KA, 2011, BEHAV ECOL, V22, P206, DOI 10.1093/beheco/arq186; Stiver KA, 2010, CURR ZOOL, V56, P1; TABORSKY M, 1987, BEHAVIOUR, V102, P82, DOI 10.1163/156853986X00063; TABORSKY M, 1994, ADV STUD BEHAV, V23, P1, DOI 10.1016/S0065-3454(08)60351-4; Taborsky M, 2008, ALTERNATIVE REPRODUCTIVE TACTICS: AN INTEGRATIVE APPROACH, P251, DOI 10.1017/CBO9780511542602.011; UNGER LM, 1983, BEHAV ECOL SOCIOBIOL, V13, P125, DOI 10.1007/BF00293802; UNGER LM, 1988, BEHAV ECOL SOCIOBIOL, V23, P27, DOI 10.1007/BF00303054; Vehrencamp SL, 2000, BEHAV ECOL, V11, P334, DOI 10.1093/beheco/11.3.334; WARNER RR, 1985, MAR BIOL, V87, P89, DOI 10.1007/BF00397010; WISENDEN BD, 1995, J CHEM ECOL, V21, P1469, DOI 10.1007/BF02035146; Wong MYL, 2007, P ROY SOC B-BIOL SCI, V274, P1093, DOI 10.1098/rspb.2006.0284; Woolfenden G.E., 1984, FLORIDA SCRUB JAY DE	66	6	6	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e56041	10.1371/journal.pone.0056041	http://dx.doi.org/10.1371/journal.pone.0056041			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23468853	Green Submitted, Green Published, gold			2022-12-25	WOS:000315524900016
J	Majumder, P; Banerjee, A; Shandilya, J; Senapati, P; Chatterjee, S; Kundu, TK; Dasgupta, D				Majumder, Parijat; Banerjee, Amrita; Shandilya, Jayasha; Senapati, Parijat; Chatterjee, Snehajyoti; Kundu, Tapas K.; Dasgupta, Dipak			Minor Groove Binder Distamycin Remodels Chromatin but Inhibits Transcription	PLOS ONE			English	Article							RNA-POLYMERASE-II; IN-VITRO; SYNTHETIC ANALOGS; DNA-BINDING; NUCLEOSOMAL BARRIER; HISTONE OCTAMER; NETROPSIN; SPECIFICITY; DISPLACEMENT; ASSOCIATION	The condensed structure of chromatin limits access of cellular machinery towards template DNA. This in turn represses essential processes like transcription, replication, repair and recombination. The repression is alleviated by a variety of energy dependent processes, collectively known as "chromatin remodeling''. In a eukaryotic cell, a fine balance between condensed and de-condensed states of chromatin helps to maintain an optimum level of gene expression. DNA binding small molecules have the potential to perturb such equilibrium. We present herein the study of an oligopeptide antibiotic distamycin, which binds to the minor groove of B-DNA. Chromatin mobility assays and circular dichroism spectroscopy have been employed to study the effect of distamycin on chromatosomes, isolated from the liver of Sprague-Dawley rats. Our results show that distamycin is capable of remodeling both chromatosomes and reconstituted nucleosomes, and the remodeling takes place in an ATP-independent manner. Binding of distamycin to the linker and nucleosomal DNA culminates in eviction of the linker histone and the formation of a population of off-centered nucleosomes. This hints at a possible corkscrew type motion of the DNA with respect to the histone octamer. Our results indicate that distamycin in spite of remodeling chromatin, inhibits transcription from both DNA and chromatin templates. Therefore, the DNA that is made accessible due to remodeling is either structurally incompetent for transcription, or bound distamycin poses a roadblock for the transcription machinery to advance.	[Majumder, Parijat; Banerjee, Amrita; Dasgupta, Dipak] Saha Inst Nucl Phys, Div Biophys, Kolkata, W Bengal, India; [Shandilya, Jayasha; Senapati, Parijat; Chatterjee, Snehajyoti; Kundu, Tapas K.] Indian Inst Sci, Jawaharlal Nehru Ctr Adv Sci Res, Transcript & Dis Lab, Mol Biol & Genet Unit, Bangalore 560012, Karnataka, India	Saha Institute of Nuclear Physics; Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR); Indian Institute of Science (IISC) - Bangalore	Dasgupta, D (corresponding author), Saha Inst Nucl Phys, Div Biophys, Kolkata, W Bengal, India.	dipak.dasgupta@saha.ac.in	Chatterjee, Snehajyoti/AAV-3919-2021; Senapati, Parijat/C-6300-2009	Chatterjee, Snehajyoti/0000-0002-4873-9416; Senapati, Parijat/0000-0002-7324-1230; Shandilya, Jayasha/0000-0001-9911-8065; Kundu, Tapas/0000-0001-7790-214X	intramural grant MMDDA, of the Department of Atomic Energy, India	intramural grant MMDDA, of the Department of Atomic Energy, India	This work was funded by the intramural grant MMDDA, of the Department of Atomic Energy, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asagi M, 2010, BIOPHYS CHEM, V149, P34, DOI 10.1016/j.bpc.2010.03.014; B RS, 2009, CHEM BIOL, V16, P203, DOI 10.1016/j.chembiol.2008.12.006; Baron RM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010656; Bednar J, 1998, P NATL ACAD SCI USA, V95, P14173, DOI 10.1073/pnas.95.24.14173; BELLORINI M, 1995, NUCLEIC ACIDS RES, V23, P1657, DOI 10.1093/nar/23.10.1657; Blossey R, 2011, FEBS J, V278, P3619, DOI 10.1111/j.1742-4658.2011.08283.x; Brown PM, 1996, J MOL BIOL, V262, P671, DOI 10.1006/jmbi.1996.0544; Broyles SS, 2004, J VIROL, V78, P2137, DOI 10.1128/JVI.78.4.2137-2141.2004; Cairns BR, 2009, NATURE, V461, P193, DOI 10.1038/nature08450; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; DASGUPTA D, 1990, BIOPOLYMERS, V30, P223, DOI 10.1002/bip.360300124; DASGUPTA D, 1987, BIOCHEMISTRY-US, V26, P6381, DOI 10.1021/bi00394a011; DASGUPTA D, 1986, BIOCHEM BIOPH RES CO, V140, P626, DOI 10.1016/0006-291X(86)90777-1; DATTAGUPTA N, 1980, BIOCHEMISTRY-US, V19, P5998, DOI 10.1021/bi00567a009; Fasman G D, 1978, Methods Cell Biol, V18, P327; Fasman G.D., 1996, CIRCULAR DICHROISM C; FENG HP, 1993, BIOCHEMISTRY-US, V32, P7824, DOI 10.1021/bi00081a030; FISH EL, 1988, BIOCHEMISTRY-US, V27, P6026, DOI 10.1021/bi00416a030; Flaus A, 2001, CURR OPIN GENET DEV, V11, P148, DOI 10.1016/S0959-437X(00)00172-6; GARTENBERG MR, 1992, P NATL ACAD SCI USA, V89, P11461, DOI 10.1073/pnas.89.23.11461; Gottesfeld JM, 2002, J MOL BIOL, V321, P249, DOI 10.1016/S0022-2836(02)00598-3; Horn PJ, 2002, SCIENCE, V297, P1824, DOI 10.1126/science.1074200; Hubner MR, 2010, ANNU REV BIOPHYS, V39, P471, DOI 10.1146/annurev.biophys.093008.131348; IZBAN MG, 1992, J BIOL CHEM, V267, P13647; Joshi RS, 2010, EMBO J, V29, P740, DOI 10.1038/emboj.2009.391; KAS E, 1989, J MOL BIOL, V210, P587, DOI 10.1016/0022-2836(89)90134-4; Kireeva ML, 2002, MOL CELL, V9, P541, DOI 10.1016/S1097-2765(02)00472-0; KIROV N, 1992, EMBO J, V11, P1941, DOI 10.1002/j.1460-2075.1992.tb05247.x; KOPKA ML, 1985, P NATL ACAD SCI USA, V82, P1376, DOI 10.1073/pnas.82.5.1376; Kulaeva OI, 2010, P NATL ACAD SCI USA, V107, P11325, DOI 10.1073/pnas.1001148107; Kundu TK, 2000, MOL CELL, V6, P551, DOI 10.1016/S1097-2765(00)00054-X; KUPPER HA, 1973, EUR J BIOCHEM, V38, P581, DOI 10.1111/j.1432-1033.1973.tb03093.x; Lah J, 2000, BIOCHEMISTRY-US, V39, P9317, DOI 10.1021/bi000748u; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; LOW CML, 1986, NUCLEIC ACIDS RES, V14, P6785, DOI 10.1093/nar/14.17.6785; LUCK G, 1977, NUCLEIC ACIDS RES, V4, P2655, DOI 10.1093/nar/4.8.2655; Luger K, 2005, CURR OPIN STRUC BIOL, V15, P188, DOI 10.1016/j.sbi.2005.03.006; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Majumder P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026486; Mir MA, 2003, BIOORGAN MED CHEM, V11, P2791, DOI 10.1016/S0968-0896(03)00211-6; Mir MA, 2001, BIOCHEMISTRY-US, V40, P11578, DOI 10.1021/bi010731r; Nelson SM, 2007, MUTAT RES-FUND MOL M, V623, P24, DOI 10.1016/j.mrfmmm.2007.03.012; Park YJ, 2005, J BIOL CHEM, V280, P1817, DOI 10.1074/jbc.M411347200; PARRACK P, 1987, FEBS LETT, V212, P297, DOI 10.1016/0014-5793(87)81364-9; PAZIN MJ, 1994, SCIENCE, V266, P2007, DOI 10.1126/science.7801129; PENNINGS S, 1994, P NATL ACAD SCI USA, V91, P10275, DOI 10.1073/pnas.91.22.10275; Peterson CL, 2008, CSH PROTOC; Portugal J, 2001, METHOD ENZYMOL, V340, P503; PUSCHENDORF B, 1974, EUR J BIOCHEM, V49, P531, DOI 10.1111/j.1432-1033.1974.tb03857.x; RAO KE, 1988, BIOCHEMISTRY-US, V27, P3018, DOI 10.1021/bi00408a053; Reinberg D, 2006, J BIOL CHEM, V281, P23297, DOI 10.1074/jbc.R600007200; Robinson PJJ, 2006, CURR OPIN STRUC BIOL, V16, P336, DOI 10.1016/j.sbi.2006.05.007; Roca J, TRANSCRIPTION, V2, P82; Schalch T, 2005, NATURE, V436, P138, DOI 10.1038/nature03686; SIMPSON RT, 1978, BIOCHEMISTRY-US, V17, P5524, DOI 10.1021/bi00618a030; STRANEY DC, 1987, BIOCHEMISTRY-US, V26, P1987, DOI 10.1021/bi00381a031; STUDITSKY VM, 1995, CELL, V83, P19, DOI 10.1016/0092-8674(95)90230-9; Studitsky VM, 1997, SCIENCE, V278, P1960, DOI 10.1126/science.278.5345.1960; STUDITSKY VM, 1994, CELL, V76, P371, DOI 10.1016/0092-8674(94)90343-3; Taylor A, 1997, MOL CELL BIOCHEM, V169, P61, DOI 10.1023/A:1006898812618; Todd RC, 2010, CHEM BIOL, V17, P1334, DOI 10.1016/j.chembiol.2010.10.018; Todd RC, 2009, METALLOMICS, V1, P280, DOI 10.1039/b907567d; VANDYKE MW, 1982, P NATL ACAD SCI-BIOL, V79, P5470; Workman JL, 2006, GENE DEV, V20, P2009, DOI 10.1101/gad.1435706; WORKMAN JL, 1992, SCIENCE, V258, P1780, DOI 10.1126/science.1465613; Wu B, 2008, CHEM BIOL, V15, P1023, DOI 10.1016/j.chembiol.2008.08.010; Zimmer C, 1975, Prog Nucleic Acid Res Mol Biol, V15, P285, DOI 10.1016/S0079-6603(08)60122-1	67	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57693	10.1371/journal.pone.0057693	http://dx.doi.org/10.1371/journal.pone.0057693			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460895	gold, Green Published, Green Submitted			2022-12-25	WOS:000315519000150
J	Tripathi, AM; Tyagi, A; Kumar, A; Singh, A; Singh, S; Chaudhary, LB; Roy, S				Tripathi, Abhinandan Mani; Tyagi, Antariksh; Kumar, Anoop; Singh, Akanksha; Singh, Shivani; Chaudhary, Lal Babu; Roy, Sribash			The Internal Transcribed Spacer (ITS) Region and trnhH-psbA Are Suitable Candidate Loci for DNA Barcoding of Tropical Tree Species of India	PLOS ONE			English	Article							LAND PLANTS; BIOLOGICAL IDENTIFICATIONS; SEDGES CAREX; RBCL; L.; RESOLUTION; PROSPECTS; MARKERS; GENUS; COX1	Background: DNA barcoding as a tool for species identification has been successful in animals and other organisms, including certain groups of plants. The exploration of this new tool for species identification, particularly in tree species, is very scanty from biodiversity-rich countries like India. rbcL and matK are standard barcode loci while ITS, and trnH-psbA are considered as supplementary loci for plants. Methodology and Principal Findings: Plant barcode loci, namely, rbcL, matK, ITS, trnH-psbA, and the recently proposed ITS2, were tested for their efficacy as barcode loci using 300 accessions of tropical tree species. We tested these loci for PCR, sequencing success, and species discrimination ability using three methods. rbcL was the best locus as far as PCR and sequencing success rate were concerned, but not for the species discrimination ability of tropical tree species. ITS and trnH-psbA were the second best loci in PCR and sequencing success, respectively. The species discrimination ability of ITS ranged from 24.4 percent to 74.3 percent and that of trnH-psbA was 25.6 percent to 67.7 percent, depending upon the data set and the method used. matK provided the least PCR success, followed by ITS2 (59.0%). Species resolution by ITS2 and rbcL ranged from 9.0 percent to 48.7 percent and 13.2 percent to 43.6 percent, respectively. Further, we observed that the NCBI nucleotide database is poorly represented by the sequences of barcode loci studied here for tree species. Conclusion: Although a conservative approach of a success rate of 60-70 percent by both ITS and trnH-psbA may not be considered as highly successful but would certainly help in large-scale biodiversity inventorization, particularly for tropical tree species, considering the standard success rate of plant DNA barcode program reported so far. The recommended matK and rbcL primers combination may not work in tropical tree species as barcode markers.	[Tripathi, Abhinandan Mani; Tyagi, Antariksh; Singh, Akanksha; Singh, Shivani; Roy, Sribash] Natl Bot Res Inst, CSIR, Genet & Mol Biol Div, Lucknow 226001, Uttar Pradesh, India; [Kumar, Anoop; Chaudhary, Lal Babu] Natl Bot Res Inst, CSIR, Plant Divers Systemat & Herbarium Div, Lucknow 226001, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Botanical Research Institute (NBRI); Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Botanical Research Institute (NBRI)	Roy, S (corresponding author), Natl Bot Res Inst, CSIR, Genet & Mol Biol Div, Lucknow 226001, Uttar Pradesh, India.	sribashroy@nbri.res.in	Tripathi, Abhinandan/ABF-2608-2020; Tyagi, Antariksh/F-4367-2015	Tyagi, Antariksh/0000-0002-4662-077X	Department of Science and Technology, Government of India, New Delhi; CSIR, New Delhi; UGC, New Delhi	Department of Science and Technology, Government of India, New Delhi(Department of Science & Technology (India)); CSIR, New Delhi(Council of Scientific & Industrial Research (CSIR) - India); UGC, New Delhi(University Grants Commission, India)	The authors are thankful to the Director, CSIR-National Botanical Research Institute, Lucknow for facilities. The Department of Science and Technology, Government of India, New Delhi is duly acknowledged for partly sponsoring the work. The authors also acknowledge CSIR, New Delhi for fellowship provided to AT and AS and UGC, New Delhi, for AMT and SS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez I, 2003, MOL PHYLOGENET EVOL, V29, P417, DOI 10.1016/S1055-7903(03)00208-2; Arca M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034089; Austerlitz F, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S14-S10; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0812297106, 10.1073/pnas.0905845106]; Ball SL, 2005, J N AM BENTHOL SOC, V24, P508, DOI 10.1899/04-142.1; Blaxter M, 2005, PHILOS T R SOC B, V360, P1935, DOI 10.1098/rstb.2005.1725; Borek K, 2009, DNA BARCODING QUERCU; Campbell CS, 2005, MOL PHYLOGENET EVOL, V35, P165, DOI 10.1016/j.ympev.2004.11.010; Chase MW, 2007, TAXON, V56, P295, DOI 10.1002/tax.562004; Chase MW, 2005, PHILOS T R SOC B, V360, P1889, DOI 10.1098/rstb.2005.1720; Chen SL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008613, 10.1371/journal.pone.0015633]; Coley PD, 1996, ANNU REV ECOL SYST, V27, P305, DOI 10.1146/annurev.ecolsys.27.1.305; Condit R, 2002, SCIENCE, V295, P666, DOI 10.1126/science.1066854; de Groot GA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016371; de Vere N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037945; DeSaille R, 2007, BIOESSAYS, V29, P1289, DOI 10.1002/bies.20667; Devey DS, 2009, TAXON, V58, P7, DOI 10.1002/tax.581003; Ebihara A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015136; Edwards D, 2008, TAXON, V57, P1317, DOI 10.1002/tax.574021; Evans KM, 2007, PROTIST, V158, P349, DOI 10.1016/j.protis.2007.04.001; Fazekas AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002802; Gao T, 2010, J ETHNOPHARMACOL; Gao T, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-324; GENTRY AH, 1988, P NATL ACAD SCI USA, V85, P156, DOI 10.1073/pnas.85.1.156; Gonzalez MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007483; Gu J, 2011, J SYST EVOL, V49, P213, DOI 10.1111/j.1759-6831.2011.00136.x; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hollingsworth ML, 2009, MOL ECOL RESOUR, V9, P439, DOI 10.1111/j.1755-0998.2008.02439.x; Hollingsworth PM, 2011, P NATL ACAD SCI USA, V108, P19451, DOI 10.1073/pnas.1116812108; Hollingsworth PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019254; Hubbell SP, 2008, P NATL ACAD SCI USA, V105, P11498, DOI 10.1073/pnas.0801915105; Jobes DV, 1997, PLANT MOL BIOL REP, V15, P326, DOI 10.1023/A:1007462330699; Kelly LJ, 2010, TAXON, V59, P251, DOI 10.1002/tax.591023; Kiebala M, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0013102, 10.1371/journal.pone.0011875]; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Lahaye R, 2008, P NATL ACAD SCI USA, V105, P2923, DOI 10.1073/pnas.0709936105; Le Clerc-Blain J, 2010, MOL ECOL RESOUR, V10, P69, DOI 10.1111/j.1755-0998.2009.02725.x; Li DZ, 2011, P NATL ACAD SCI USA, V108, P19641, DOI 10.1073/pnas.1104551108; Liu J, 2011, MOL ECOL RESOUR, V11, P89, DOI 10.1111/j.1755-0998.2010.02907.x; Luo K, 2010, SCI CHINA LIFE SCI, V53, P701, DOI 10.1007/s11427-010-4009-1; Maia VH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029877; Moritz C, 2004, PLOS BIOL, V2, P1529, DOI 10.1371/journal.pbio.0020354; Mort ME, 2010, TAXON, V59, P581, DOI 10.1002/tax.592022; Mower JP, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-135; Muellner AN, 2011, MOL ECOL RESOUR, V11, P450, DOI 10.1111/j.1755-0998.2011.02984.x; Newmaster SG, 2006, CAN J BOT, V84, P335, DOI 10.1139/B06-047; Newmaster SG, 2008, MOL ECOL RESOUR, V8, P480, DOI 10.1111/j.1471-8286.2007.02002.x; Newmaster SG, 2009, MOL ECOL RESOUR, V9, P172, DOI 10.1111/j.1755-0998.2009.02642.x; Pang X, PLANT BIOL SUTTG; Pang XH, 2011, CLADISTICS, V27, P165, DOI 10.1111/j.1096-0031.2010.00328.x; Pang XH, 2010, PLANTA MED, V76, P1784, DOI 10.1055/s-0030-1249806; Piredda R, 2011, MOL ECOL RESOUR, V11, P72, DOI 10.1111/j.1755-0998.2010.02900.x; Ragupathy S, 2009, MOL ECOL RESOUR, V9, P164, DOI 10.1111/j.1755-0998.2009.02641.x; Rao RR, 1994, BIODIVERSITY INDIA F; Robba L, 2006, AM J BOT, V93, P1101, DOI 10.3732/ajb.93.8.1101; Roy S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013674; Sass C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001154; Seifert KA, 2007, P NATL ACAD SCI USA, V104, P3901, DOI 10.1073/pnas.0611691104; Singh Hemant Kumar, 2012, BMC Res Notes, V5, P42, DOI 10.1186/1756-0500-5-42; Smith MA, 2006, P NATL ACAD SCI USA, V103, P3657, DOI 10.1073/pnas.0511318103; Smith SA, 2008, SCIENCE, V322, P86, DOI 10.1126/science.1163197; Spooner DM, 2009, AM J BOT, V96, P1177, DOI 10.3732/ajb.0800246; Starr JR, 2009, MOL ECOL RESOUR, V9, P151, DOI 10.1111/j.1755-0998.2009.02640.x; Sun XQ, PLOS ONE, V7; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; ter Steege H, 2006, NATURE, V443, P444, DOI 10.1038/nature05134; Tuomisto H, 2003, SCIENCE, V299, P241, DOI 10.1126/science.1078037; Van De Wiel CCM, 2009, MOL ECOL RESOUR, V9, P1086, DOI 10.1111/j.1755-0998.2009.02547.x; van Velzen R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030490; Wang WQ, 2010, BMC PLANT BIOL, V10, DOI [10.1186/1471-2229-10-205, 10.1186/1471-2229-10-14]; Wang YiHong, 2009, Acta Horticulturae Sinica, V36, P1651; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Waugh J, 2007, BIOESSAYS, V29, P188, DOI 10.1002/bies.20529	75	60	72	0	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57934	10.1371/journal.pone.0057934	http://dx.doi.org/10.1371/journal.pone.0057934			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460915	gold, Green Submitted, Green Published			2022-12-25	WOS:000315519000170
J	Stahl, JS; Thumser, ZC				Stahl, John S.; Thumser, Zachary C.			4-Aminopyridine Does Not Enhance Flocculus Function in Tottering, a Mouse Model of Vestibulocerebellar Dysfunction and Ataxia	PLOS ONE			English	Article							CEREBELLAR PURKINJE-CELLS; VESTIBULO-OCULAR REFLEX; DOWNBEAT NYSTAGMUS; EYE-MOVEMENTS; MULTIPLE-SCLEROSIS; ZONAL ORGANIZATION; POTASSIUM CHANNELS; SMOOTH-PURSUIT; QUICK PHASE; GUINEA-PIGS	The potassium channel antagonist 4-aminopyridine (4-AP) improves a variety of motor abnormalities associated with disorders of the cerebellum. The most rigorous quantitative data relate to 4-AP's ability to improve eye movement deficits in humans referable to dysfunction of the cerebellar flocculus. Largely based on work in the ataxic mouse mutant tottering (which carries a mutation of the Cacna1a gene of the P/Q voltage-activated calcium channel), 4-AP is hypothesized to function by enhancing excitability or rhythmicity of floccular Purkinje cells. We tested this hypothesis by determining whether systemic or intrafloccular administration of 4-AP would ameliorate the eye movement deficits in tottering that are attributable to flocculus dysfunction, including the reductions in amplitude of the yaw-axis vestibulo-ocular reflex (VOR) and vision-enhanced vestibulo-ocular reflex (VVOR), and the optokinetic reflex (OKR) about yaw and roll axes. Because tottering's deficits increase with age, both young and elderly mutants were tested to detect any age-dependent 4-AP effects. 4-AP failed to improve VOR, VVOR, and OKR gains during sinusoidal stimuli, although it may have reduced the tendency of the mutants' responses to VOR and VVOR to decline over the course of a one-hour recording session. For constant-velocity optokinetic stimuli, 4-AP generated some enhancement of yaw OKR and upward-directed roll OKR, but the effects were also seen in normal C57BL/6 controls, and thus do not represent a specific reversal of the electrophysiological consequences of the tottering mutation. Data support a possible extra-floccular locus for the effects of 4-AP on habituation and roll OKR. Unilateral intrafloccular 4-AP injections did not affect ocular motility, except to generate mild eye elevations, consistent with reduced floccular output. Because 4-AP did not produce the effects expected if it normalized outputs of floccular Purkinje cells, there is a need for further studies to elucidate the drug's mechanism of action on cerebellar motor dysfunction.	[Stahl, John S.; Thumser, Zachary C.] Louis Stokes Cleveland Dept Vet Affairs Med Ctr, Div Neurol, Cleveland, OH USA; [Stahl, John S.] Case Western Reserve Univ, Dept Neurol, Cleveland, OH 44106 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; Case Western Reserve University	Stahl, JS (corresponding author), Louis Stokes Cleveland Dept Vet Affairs Med Ctr, Div Neurol, Cleveland, OH USA.	jss6@case.edu			Department of Veterans Affairs (Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development) [1 I01 BX000278-01]; NATIONAL EYE INSTITUTE [P30EY011373] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000278] Funding Source: NIH RePORTER	Department of Veterans Affairs (Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development)(US Department of Veterans Affairs); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by the Department of Veterans Affairs (Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development, application #1 I01 BX000278-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvina K, 2010, J NEUROSCI, V30, P7258, DOI 10.1523/JNEUROSCI.3582-09.2010; Alvina K, 2010, J NEUROSCI, V30, P7249, DOI 10.1523/JNEUROSCI.6341-09.2010; Balaban CD, 2000, NEUROSCIENCE, V99, P669, DOI 10.1016/S0306-4522(00)00232-3; Bense S, 2006, NEUROREPORT, V17, P599, DOI 10.1097/00001756-200604240-00009; BEVER CT, 1994, NEUROLOGY, V44, P1054, DOI 10.1212/WNL.44.6.1054; Campbell DB, 1999, EXP NEUROL, V160, P268, DOI 10.1006/exnr.1999.7171; Capacio BR, 1996, BIOMED CHROMATOGR, V10, P111, DOI 10.1002/(SICI)1099-0801(199605)10:3<111::AID-BMC569>3.0.CO;2-E; Capacio BR, 1997, DRUG CHEM TOXICOL, V20, P151, DOI 10.3109/01480549709003876; Chen G, 2009, J NEUROPHYSIOL, V101, P234, DOI 10.1152/jn.90829.2008; Coetzee WA, 1999, ANN NY ACAD SCI, V868, P233, DOI 10.1111/j.1749-6632.1999.tb11293.x; Curthoys IS, 2002, EXP BRAIN RES, V143, P397, DOI 10.1007/s00221-002-1022-z; Etzion Y, 2001, EXP BRAIN RES, V139, P419, DOI 10.1007/s002210100788; Etzion Y, 1998, EXP BRAIN RES, V122, P283, DOI 10.1007/s002210050516; FURMAN JM, 1981, BRAIN RES, V206, P490, DOI 10.1016/0006-8993(81)90553-9; Glasauer S, 2005, ANN NY ACAD SCI, V1039, P528, DOI 10.1196/annals.1325.060; Glasauer S, 2011, ANN NY ACAD SCI, V1233, P162, DOI 10.1111/j.1749-6632.2011.06149.x; Glasauer S, 2009, CEREBELLUM, V8, P385, DOI 10.1007/s12311-009-0109-5; GODAUX E, 1984, J PHYSIOL-LONDON, V346, P155, DOI 10.1113/jphysiol.1984.sp015013; Goossens HHLM, 2004, EUR J NEUROSCI, V19, P687, DOI 10.1111/j.0953-816X.2003.03173.x; HALMAGYI GM, 1983, ARCH NEUROL-CHICAGO, V40, P777; HASSUL M, 1976, BRAIN RES, V118, P339, DOI 10.1016/0006-8993(76)90722-8; Hoebeek FE, 2005, NEURON, V45, P953, DOI 10.1016/j.neuron.2005.02.012; Hourez R, 2011, J NEUROSCI, V31, P11795, DOI 10.1523/JNEUROSCI.0905-11.2011; ISAACS KR, 1995, BRAIN RES BULL, V36, P309, DOI 10.1016/0361-9230(94)00207-H; ISAACS KR, 1992, DEV NEUROSCI-BASEL, V14, P386, DOI 10.1159/000111687; ITO M, 1977, J PHYSIOL-LONDON, V265, P833, DOI 10.1113/jphysiol.1977.sp011747; Kalla R, 2006, NEUROLOGY, V66, P281, DOI 10.1212/01.wnl.0000194242.28018.d9; Kalla R, 2004, NEUROLOGY, V62, P1228, DOI 10.1212/01.WNL.0000118287.68294.E5; Kalla R, 2007, BRAIN, V130, P2441, DOI 10.1093/brain/awm172; Kalla R, 2011, J NEURO-OPHTHALMOL, V31, P320, DOI 10.1097/WNO.0b013e3182258086; Kim CH, 2012, J PHYSIOL-LONDON, V590, P273, DOI 10.1113/jphysiol.2011.221846; LANGER T, 1985, J COMP NEUROL, V235, P26, DOI 10.1002/cne.902350103; Leigh R. J., 2006, NEUROLOGY EYE MOVEME; LEMEIGNAN M, 1984, BRAIN RES, V304, P166, DOI 10.1016/0006-8993(84)90875-8; Luthman J, 2011, CEREBELLUM, V10, P667, DOI 10.1007/s12311-011-0295-9; Marti S, 2002, ANN NEUROL, V52, P712, DOI 10.1002/ana.10370; Marti S, 2008, EXP BRAIN RES, V188, P613, DOI 10.1007/s00221-008-1396-7; Martina M, 2003, J NEUROSCI, V23, P5698; MOLGO J, 1985, EUR J MED CHEM, V20, P149; NAGAO S, 1989, EXP BRAIN RES, V77, P531; NICHOLSON C, 1985, BRAIN RES, V333, P325, DOI 10.1016/0006-8993(85)91586-0; Oommen BS, 2008, BRAIN RES, V1193, P57, DOI 10.1016/j.brainres.2007.11.053; Potter PJ, 1998, SPINAL CORD, V36, P147, DOI 10.1038/sj.sc.3100559; Quartel A, 2010, CURR MED RES OPIN, V26, P1363, DOI 10.1185/03007991003745209; RUDY B, 1988, NEUROSCIENCE, V25, P729, DOI 10.1016/0306-4522(88)90033-4; Sacco T, 2002, J PHYSIOL-LONDON, V543, P505, DOI 10.1113/jphysiol.2002.022525; Sander T, 2011, J NEUROL, V258, P618, DOI 10.1007/s00415-010-5806-y; Sanders DB, 1998, ANN NY ACAD SCI, V841, P811, DOI 10.1111/j.1749-6632.1998.tb11022.x; SATO Y, 1990, J NEUROPHYSIOL, V64, P551, DOI 10.1152/jn.1990.64.2.551; Schonewille M, 2006, J COMP NEUROL, V497, P670, DOI 10.1002/cne.21036; Sedehizadeh S, 2012, CLIN NEUROPHARMACOL, V35, P191, DOI 10.1097/WNF.0b013e31825a68c5; SERAFIN M, 1990, EXP BRAIN RES, V82, P187, DOI 10.1007/BF00230850; Shin M, 2011, J NEUROSCI, V31, P10776, DOI 10.1523/JNEUROSCI.0768-11.2011; Stahl JS, 2012, J VESTIBUL RES-EQUIL, V22, P221, DOI 10.3233/VES-120463; Stahl JS, 2008, PROG BRAIN RES, V171, P503, DOI 10.1016/S0079-6123(08)00672-9; Stahl JS, 2000, J NEUROSCI METH, V99, P101, DOI 10.1016/S0165-0270(00)00218-1; Stahl JS, 2006, J NEUROPHYSIOL, V95, P1588, DOI 10.1152/jn.00318.2005; Stahl JS, 2004, J NEUROPHYSIOL, V91, P2066, DOI 10.1152/jn.01068.2003; Stahl JS, 2002, ANN NY ACAD SCI, V956, P64, DOI 10.1111/j.1749-6632.2002.tb02809.x; STAHL JS, 1995, J NEUROPHYSIOL, V73, P1396, DOI 10.1152/jn.1995.73.4.1396; Stahl JS, 2012, CHALLENGE NYSTAGMUS, P59; Stahl JS, 2010, SOC NEUR ABSTR, V36; Stahl JS., 2008, EYE RETINA VISUAL SY, V2008, P872; STONE LS, 1990, J NEUROPHYSIOL, V63, P1241, DOI 10.1152/jn.1990.63.5.1241; Strupp M, 2011, NEUROLOGY, V77, P269, DOI 10.1212/WNL.0b013e318225ab07; Strupp M, 2003, NEUROLOGY, V61, P165, DOI 10.1212/01.WNL.0000078893.41040.56; Strupp M, 2006, CURR OPIN NEUROL, V19, P33, DOI 10.1097/01.wco.0000196156.00481.e1; Strupp M, 2007, NEUROTHERAPEUTICS, V4, P267, DOI 10.1016/j.nurt.2007.01.014; Strupp Michael, 2009, Ther Adv Neurol Disord, V2, P223, DOI 10.1177/1756285609103120; VANDERSTEEN J, 1994, J NEUROPHYSIOL, V72, P31, DOI 10.1152/jn.1994.72.1.31; VANDIEMEN HAM, 1993, CLIN NEUROPHARMACOL, V16, P195, DOI 10.1097/00002826-199306000-00002; VANNEERVEN J, 1991, PROG BRAIN RES, V88, P485; Vollmer T, 2009, CLIN THER, V31, P2215, DOI 10.1016/j.clinthera.2009.10.007; Walter JT, 2006, NAT NEUROSCI, V9, P389, DOI 10.1038/nn1648; WEBER RB, 1972, VISION RES, V12, P467, DOI 10.1016/0042-6989(72)90090-9; Weisz CJC, 2005, J NEUROSCI, V25, P4141, DOI 10.1523/JNEUROSCI.0098-05.2005; Womack MD, 2009, NEUROSCIENCE, V162, P989, DOI 10.1016/j.neuroscience.2009.05.016; ZEE DS, 1981, J NEUROPHYSIOL, V46, P878, DOI 10.1152/jn.1981.46.4.878	78	6	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57895	10.1371/journal.pone.0057895	http://dx.doi.org/10.1371/journal.pone.0057895			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451282	Green Published, gold, Green Submitted			2022-12-25	WOS:000316849500144
J	Arriazu, R; Duran, E; Pozuelo, JM; Santamaria, L				Arriazu, Riansares; Duran, Esther; Pozuelo, Jose M.; Santamaria, Luis			Expression of Lysophosphatidic Acid Receptor 1 and Relation with Cell Proliferation, Apoptosis, and Angiogenesis on Preneoplastic Changes Induced by Cadmium Chloride in the Rat Ventral Prostate	PLOS ONE			English	Article							LPA RECEPTORS; ZINC-CHLORIDE; CANCER; CARCINOGENESIS; P53; CHEMOPREVENTION; IDENTIFICATION; EFFICACY	Background: Lysophosphatidic acid (LPA) is a phospholipid growth factor involved in cell proliferation, differentiation, migration, inflammation, angiogenesis, wound healing, cancer invasion, and survival. This study was directed to evaluate the immunoexpression of LPA-1, cell proliferation, apoptosis, and angiogenesis markers in preneoplastic lesions induced with cadmium chloride in rat prostate. Methods: The following parameters were calculated in ventral prostate of normal rats and rats that received Cd in drinking water during 24 months: percentages of cells immunoreactive to LPA-1 (LILPA1), PCNA (LIPCNA), MCM7 (LIMCM7), ubiquitin (LIUBI), apoptotic cells (LIAPO), and p53 (LIp53); volume fraction of Bcl-2 (V(F)Bcl-2); and length of microvessels per unit of volume (LVMV/mm3). Data were analyzed using Student's t-test and Pearson correlation test. Results: The LILPA1 in dysplastic lesions and normal epithelium of Cd-treated rats was significantly higher than those in the control group. Markers of proliferation were significantly increased in dysplastic lesions, whereas some apoptotic markers were significantly decreased. No significant differences between groups were found in V(F)Bcl-2. Dysplastic lesions showed a significant increase of LIp53. The length of microvessels per unit of volume was elevated in dysplastic acini. Statistically significant correlations were found only between LILPA1 and LIUBI. Conclusions: Our results suggest that LPA-1 might be implicated in dysplastic lesions induced by cadmium chloride development. More studies are needed to confirm its potential contribution to the disease.	[Arriazu, Riansares; Duran, Esther] CEU San Pablo Univ, Histol Lab, Inst Appl Mol Med, Dept Basic Med Sci,Sch Med, Madrid, Spain; [Pozuelo, Jose M.] CEU San Pablo Univ, Inst Appl Mol Med, Sch Med, Dept Basic Med Sci,Cell Biol Lab, Madrid, Spain; [Santamaria, Luis] Autonomous Univ Madrid, Dept Morphol, Sch Med, E-28049 Madrid, Spain	San Pablo CEU University; San Pablo CEU University; Autonomous University of Madrid	Arriazu, R (corresponding author), CEU San Pablo Univ, Histol Lab, Inst Appl Mol Med, Dept Basic Med Sci,Sch Med, Madrid, Spain.	arriazun@ceu.es	Arriazu, Riánsares/J-6764-2012	Arriazu, Riánsares/0000-0001-6253-9552; Santamaria Solis, Luis/0000-0001-6560-2502	San Pablo-CEU University; Santander Bank [USP-BS-PPC04/2011]	San Pablo-CEU University; Santander Bank	This study was supported in part by a financial grant from San Pablo-CEU University and Santander Bank (USP-BS-PPC04/2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aimola P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033647; Arakawa A, 1997, PROSTATE CANCER P D, V1, P32, DOI 10.1038/sj.pcan.4500204; Aronson KJ, 1996, AM J EPIDEMIOL, V143, P363; Arriazu R, 2005, HORMONAL CARCINOGENESIS IV, P522, DOI 10.1007/0-387-23761-5_58; Arriazu R, 2005, PROSTATE, V63, P347, DOI 10.1002/pros.20192; Arriazu R, 2006, J HISTOCHEM CYTOCHEM, V54, P981, DOI 10.1369/jhc.5A6733.2006; Arunkumar A, 2006, BIOL PHARM BULL, V29, P375, DOI 10.1248/bpb.29.375; Bonkhoff H, 1998, PATHOLOGE, V19, P33, DOI 10.1007/s002920050252; BOSARI S, 1992, VIRCHOWS ARCH A, V421, P291, DOI 10.1007/BF01660975; Bosland MC, 1999, EUR UROL, V35, P459, DOI 10.1159/000019879; Chen M, 2007, AM J PHYSIOL-CELL PH, V292, pC1927, DOI 10.1152/ajpcell.00400.2006; Chen SU, 2008, ENDOCRINOLOGY, V149, P5888, DOI 10.1210/en.2008-0314; Choi JW, 2010, ANNU REV PHARMACOL, V50, P157, DOI 10.1146/annurev.pharmtox.010909.105753; Delves GH, 2007, SEMIN THROMB HEMOST, V33, P75, DOI 10.1055/s-2006-958465; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Guo R, 2006, ENDOCRINOLOGY, V147, P4883, DOI 10.1210/en.2005-1635; Ishino H, 2011, DOMEST ANIM ENDOCRIN, V41, P207, DOI 10.1016/j.domaniend.2011.07.002; Knillova Jana, 2003, Biomedical Papers (Olomouc), V147, P3; KOLONEL L, 1977, LANCET, V2, P566; Kong DJ, 2007, CANCER RES, V67, P3310, DOI 10.1158/0008-5472.CAN-06-4277; Kwon J, 2004, AM J PATHOL, V165, P1367, DOI 10.1016/S0002-9440(10)63394-9; LAUWERYS RR, 1994, CLIN CHEM, V40, P1391; Lin CE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041096; Lundequist A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018192; Luo JH, 2011, WORLD J CLIN ONCOL, V2, P120, DOI 10.5306/wjco.v2.i2.120; Marshall J R, 2001, IARC Sci Publ, V154, P191; Martens-Uzunova ES, 2012, ONCOGENE, V31, P978, DOI 10.1038/onc.2011.304; Martin JJ, 2001, PROSTATE, V46, P11; Morrissey C, 2002, J ANDROL, V23, P341; Murph MM, 2008, BBA-MOL CELL BIOL L, V1781, P547, DOI 10.1016/j.bbalip.2008.04.007; Nicholson B, 2003, HISTOL HISTOPATHOL, V18, P275, DOI 10.14670/HH-18.275; OBRIEN TS, 1995, BRIT J UROL, V76, P675, DOI 10.1111/j.1464-410X.1995.tb00755.x; Ota T, 2011, MODERN PATHOL, V24, P277, DOI 10.1038/modpathol.2010.202; Pollard M, 2001, CANCER LETT, V173, P127, DOI 10.1016/S0304-3835(01)00673-5; Reisman D, 2012, BIOCHEM RES INT, V2012, DOI 10.1155/2012/808934; RITTMASTER RS, 1995, ENDOCRINOLOGY, V136, P741, DOI 10.1210/en.136.2.741; Santamaria L, 2008, OPEN PROSTATE CANC J, V2, P46; SILVESTRINI R, 1993, J NATL CANCER I, V85, P965, DOI 10.1093/jnci/85.12.965; STERIO DC, 1984, J MICROSC-OXFORD, V134, P127, DOI 10.1111/j.1365-2818.1984.tb02501.x; Sumida H, 2010, BLOOD, V116, P5060, DOI 10.1182/blood-2010-03-272443; Tang DG, 1998, CANCER RES, V58, P3466; Waalkes MP, 2003, MUTAT RES-FUND MOL M, V533, P107, DOI 10.1016/j.mrfmmm.2003.07.011; Waalkes MP, 2000, J INORG BIOCHEM, V79, P241, DOI 10.1016/S0162-0134(00)00009-X; WAALKES MP, 1989, CANCER RES, V49, P4282; Yamashita H, 2010, J ONCOL, V2010, DOI 10.1155/2010/107075; Yanagida K, 2011, J BIOCHEM, V150, P223, DOI 10.1093/jb/mvr087; Yanagida K, 2009, J BIOL CHEM, V284, P17731, DOI 10.1074/jbc.M808506200; Zeng Y, 2009, PROSTATE, V69, P283, DOI 10.1002/pros.20879; Zhu GB, 2011, ONCOL LETT, V2, P1213, DOI 10.3892/ol.2011.410	49	12	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e57742	10.1371/journal.pone.0057742	http://dx.doi.org/10.1371/journal.pone.0057742			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451264	gold, Green Submitted, Green Published			2022-12-25	WOS:000316658800116
J	Pang, JB; Rhodes, DH; Pini, M; Akasheh, RT; Castellanos, KJ; Cabay, RJ; Cooper, D; Perretti, M; Fantuzzi, G				Pang, Jingbo; Rhodes, Davina H.; Pini, Maria; Akasheh, Rand T.; Castellanos, Karla J.; Cabay, Robert J.; Cooper, Dianne; Perretti, Mauro; Fantuzzi, Giamila			Increased Adiposity, Dysregulated Glucose Metabolism and Systemic Inflammation in Galectin-3 KO Mice	PLOS ONE			English	Article							GALECTIN-3/AGE-RECEPTOR-3 KNOCKOUT MICE; RECEPTOR-MEDIATED MECHANISMS; INDUCED GLOMERULAR INJURY; DIET-INDUCED OBESITY; INSULIN SENSITIVITY; AGE-RECEPTOR; FATTY LIVER; LIPOXIDATION; ACTIVATION; EXPRESSION	Obesity and type 2 diabetes are associated with increased production of Galectin-3 (Gal-3), a protein that modulates inflammation and clearance of glucose adducts. We used Lean and Diet-induced Obese (DIO) WT and Gal-3 KO mice to investigate the role of Gal-3 in modulation of adiposity, glucose metabolism and inflammation. Deficiency of Gal-3 lead to age-dependent development of excess adiposity and systemic inflammation, as indicated by elevated production of acute-phase proteins, number of circulating pro-inflammatory Ly6C(high) monocytes and development of neutrophilia, microcytic anemia and thrombocytosis in 20-week-old Lean and DIO male Gal-3 KO mice. This was associated with impaired fasting glucose, heightened response to a glucose tolerance test and reduced adipose tissue expression of adiponectin, Gal-12, ATGL and PPAR gamma, in the presence of maintained insulin sensitivity and hepatic expression of gluconeogenic enzymes in 20-week- old Gal-3 KO mice compared to their diet-matched WT controls. Expression of PGC-1 alpha and FGF-21 in the liver of Lean Gal-3 KO mice was comparable to that observed in DIO animals. Impaired fasting glucose and altered responsiveness to a glucose load preceded development of excess adiposity and systemic inflammation, as demonstrated in 12-week-old Gal-3 KO mice. Finally, a role for the microflora in mediating the fasting hyperglycemia, but not the excessive response to a glucose load, of 12-week-old Gal-3 KO mice was demonstrated by administration of antibiotics. In conclusion, Gal-3 is an important modulator of glucose metabolism, adiposity and inflammation.	[Pang, Jingbo; Rhodes, Davina H.; Pini, Maria; Akasheh, Rand T.; Castellanos, Karla J.; Fantuzzi, Giamila] Univ Illinois, Dept Kinesiol & Nutr, Chicago, IL 60680 USA; [Cabay, Robert J.] Univ Illinois, Dept Pathol, Chicago, IL USA; [Cooper, Dianne; Perretti, Mauro] Queen Mary Univ London, William Harvey Res Inst, Barts & London Sch Med, London, England	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of London; Queen Mary University London	Fantuzzi, G (corresponding author), Univ Illinois, Dept Kinesiol & Nutr, Chicago, IL 60680 USA.	giamila@uic.edu	Akasheh, Rand/AAY-2606-2020; Cabay, Robert J./AAP-9570-2021; Fantuzzi, Giamila/A-1758-2009; Castellanos, Karla/D-1164-2018; Pini, Maria/AAC-2530-2021; Pini, Maria/T-6292-2018; Pini, Maria/O-8620-2019	Cabay, Robert J./0000-0001-8473-296X; Fantuzzi, Giamila/0000-0001-5334-0082; Castellanos, Karla/0000-0002-8723-6475; Pini, Maria/0000-0002-9995-5370; Pini, Maria/0000-0002-9995-5370; Pang, Jingbo/0000-0001-8325-8434	NIH [DK083328]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083328] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	G.F. is supported by NIH grant DK083328. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barroso E, 2011, ENDOCRINOLOGY, V152, P1848, DOI 10.1210/en.2010-1468; Bechmann LP, 2012, J HEPATOL, V56, P952, DOI 10.1016/j.jhep.2011.08.025; Bonetto A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022538; Caricilli AM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001212; Chakrabarti P, 2011, CURR DIABETES REV, V7, P270, DOI 10.2174/157339911796397866; Darrow AL, 2011, PHYSIOL GENOMICS, V43, P1144, DOI 10.1152/physiolgenomics.00035.2011; de Boer RA, 2011, J INTERN MED; de Boer RA, 2011, ANN MED, V43, P60, DOI 10.3109/07853890.2010.538080; de Boer RA, 2009, EUR J HEART FAIL, V11, P811, DOI 10.1093/eurjhf/hfp097; Estall JL, 2009, P NATL ACAD SCI USA, V106, P22510, DOI 10.1073/pnas.0912533106; Fantuzzi G, 2005, J ALLERGY CLIN IMMUN, V115, P911, DOI 10.1016/j.jaci.2005.02.023; Ferraz LC, 2008, EUR J IMMUNOL, V38, P2762, DOI 10.1002/eji.200737986; Fisher FM, 2010, DIABETES, V59, P2781, DOI 10.2337/db10-0193; Ge X, 2011, J BIOL CHEM, V286, P34533, DOI 10.1074/jbc.M111.248591; Haffner SM, 2007, AM J MED, V120, P10, DOI 10.1016/j.amjmed.2007.06.006; Iacobini C, 2005, AM J PHYSIOL-RENAL, V289, pF611, DOI 10.1152/ajprenal.00435.2004; Iacobini C, 2004, FASEB J, V18, P1773, DOI 10.1096/fj.04-2031fje; Iacobini C, 2011, J HEPATOL, V54, P975, DOI 10.1016/j.jhep.2010.09.020; Iacobini C, 2009, J PATHOL, V218, P360, DOI 10.1002/path.2536; Iacobini C, 2009, ARTERIOSCL THROM VAS, V29, P831, DOI 10.1161/ATVBAHA.109.186791; Kiwaki K, 2007, OBESITY, V15, P32, DOI 10.1038/oby.2007.526; Levy JC, 1998, DIABETES CARE, V21, P2191, DOI 10.2337/diacare.21.12.2191; Li PP, 2010, J BIOL CHEM, V285, P15333, DOI 10.1074/jbc.M110.100263; Li Y, 2008, J IMMUNOL, V181, P2781, DOI 10.4049/jimmunol.181.4.2781; MacKinnon AC, 2008, J IMMUNOL, V180, P2650, DOI 10.4049/jimmunol.180.4.2650; Nomoto K, 2006, J PATHOL, V210, P469, DOI 10.1002/path.2065; Nomoto K, 2012, SCI WORLD J, P1, DOI 10.1100/2012/959824; Norling LV, 2009, J ENDOCRINOL, V201, P169, DOI 10.1677/JOE-08-0512; Patsouris D, 2008, CELL METAB, V8, P301, DOI 10.1016/j.cmet.2008.08.015; Pini M, 2012, J LEUKOCYTE BIOL, V91, P957, DOI 10.1189/jlb.1211627; Pini M, 2011, CYTOKINE, V56, P708, DOI 10.1016/j.cyto.2011.09.015; Pugliese G, 2001, FASEB J, V15, P2471, DOI 10.1096/fj.01-0006com; Ramnanan CJ, 2011, DIABETES OBES METAB, V13, P118, DOI 10.1111/j.1463-1326.2011.01454.x; Rhodes DH, 2012, OBESITY IN PRESS; Rossmeisl M, 2003, DIABETES, V52, P1958, DOI 10.2337/diabetes.52.8.1958; Sachithanandan N, 2010, HEPATOLOGY, V52, P1632, DOI 10.1002/hep.23861; Sano H, 2003, J CLIN INVEST, V112, P389, DOI 10.1172/JCI200317592; Savino B, 2012, BLOOD, V119, P5250, DOI 10.1182/blood-2011-10-388082; Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552; VLASSARA H, 1995, MOL MED, V1, P634, DOI 10.1007/BF03401604; Weigert J, 2010, J CLIN ENDOCR METAB, V95, P1404, DOI 10.1210/jc.2009-1619; Yang RY, 2004, J BIOL CHEM, V279, P29761, DOI 10.1074/jbc.M401303200	42	73	75	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e57915	10.1371/journal.pone.0057915	http://dx.doi.org/10.1371/journal.pone.0057915			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451284	Green Published, Green Submitted, gold			2022-12-25	WOS:000316658800121
J	Cuturi, LF; MacNeilage, PR				Cuturi, Luigi F.; MacNeilage, Paul R.			Systematic Biases in Human Heading Estimation	PLOS ONE			English	Article							PSYCHOMETRIC FUNCTION; PERIPHERAL-VISION; OPTIC FLOW; 3-D SOUND; PERCEPTION; ORIENTATION; MOTION; AREA; DISCRIMINATION; DIRECTION	Heading estimation is vital to everyday navigation and locomotion. Despite extensive behavioral and physiological research on both visual and vestibular heading estimation over more than two decades, the accuracy of heading estimation has not yet been systematically evaluated. Therefore human visual and vestibular heading estimation was assessed in the horizontal plane using a motion platform and stereo visual display. Heading angle was overestimated during forward movements and underestimated during backward movements in response to both visual and vestibular stimuli, indicating an overall multimodal bias toward lateral directions. Lateral biases are consistent with the overrepresentation of lateral preferred directions observed in neural populations that carry visual and vestibular heading information, including MSTd and otolith afferent populations. Due to this overrepresentation, population vector decoding yields patterns of bias remarkably similar to those observed behaviorally. Lateral biases are inconsistent with standard Bayesian accounts which predict that estimates should be biased toward the most common straight forward heading direction. Nevertheless, lateral biases may be functionally relevant. They effectively constitute a perceptual scale expansion around straight ahead which could allow for more precise estimation and provide a high gain feedback signal to facilitate maintenance of straight-forward heading during everyday navigation and locomotion.	[Cuturi, Luigi F.; MacNeilage, Paul R.] Univ Hosp Munich, German Ctr Vertigo & Balance Disorders, Munich, Germany; [Cuturi, Luigi F.] Univ Munich, Grad Sch Syst Neurosci, Munich, Germany	University of Munich; University of Munich	MacNeilage, PR (corresponding author), Univ Hosp Munich, German Ctr Vertigo & Balance Disorders, Munich, Germany.	p.macneilage@gmail.com	Cuturi, Luigi/N-1581-2016	Cuturi, Luigi/0000-0001-8144-3740	German Federal Ministry of Education and Research [01 EO 0901]	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	The work was supported by a grant from the German Federal Ministry of Education and Research under the Grant code 01 EO 0901. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	APPELLE S, 1972, PSYCHOL BULL, V78, P266, DOI 10.1037/h0033117; Arthur JC, 2008, ACTA PSYCHOL, V129, P72, DOI 10.1016/j.actpsy.2008.04.008; Bardy BG, 1999, PERCEPT PSYCHOPHYS, V61, P1356, DOI 10.3758/BF03206186; Bremmer F, 2002, EUR J NEUROSCI, V16, P1569, DOI 10.1046/j.1460-9568.2002.02206.x; Britten KH, 1998, NAT NEUROSCI, V1, P59, DOI 10.1038/259; Butler JS, 2010, J VISION, V10, DOI 10.1167/10.11.23; Chen AH, 2011, J NEUROSCI, V31, P11617, DOI 10.1523/JNEUROSCI.1266-11.2011; CROWELL JA, 1993, PERCEPT PSYCHOPHYS, V53, P325, DOI 10.3758/BF03205187; Cuturi LF, 2011, SOC NEUR M; DAvossa G, 1996, VISION RES, V36, P2915, DOI 10.1016/0042-6989(96)00010-7; De Vrijer M, 2008, J NEUROPHYSIOL, V99, P915, DOI 10.1152/jn.00921.2007; De Vrijer M, 2009, J VISION, V9, DOI 10.1167/9.2.9; Dokka K, 2011, J VISION, V11, DOI 10.1167/11.13.2; Duffy CJ, 1998, J NEUROPHYSIOL, V80, P1816, DOI 10.1152/jn.1998.80.4.1816; Durgin FH, 2011, ATTEN PERCEPT PSYCHO, V73, P1856, DOI 10.3758/s13414-011-0143-5; Durgin FH, 2011, J VISION, V11, DOI 10.1167/11.8.13; Feldman NH, 2009, PSYCHOL REV, V116, P752, DOI 10.1037/a0017196; FERNANDEZ C, 1976, J NEUROPHYSIOL, V39, P970, DOI 10.1152/jn.1976.39.5.970; Fetsch CR, 2009, J NEUROSCI, V29, P15601, DOI 10.1523/JNEUROSCI.2574-09.2009; Fetsch CR, 2011, NAT NEUROSCI; Fischer BJ, 2011, NAT NEUROSCI, V14, P1061, DOI 10.1038/nn.2872; GEORGOPOULOS AP, 1986, SCIENCE, V233, P1416, DOI 10.1126/science.3749885; Gibson JJ, 1950, PERCEPTION VISUAL WO; Girshick AR, 2011, NAT NEUROSCI, V14, P926, DOI 10.1038/nn.2831; Gu Y, 2007, NAT NEUROSCI, V10, P1038, DOI 10.1038/nn1935; Gu Y, 2010, NEURON, V66, P596, DOI 10.1016/j.neuron.2010.04.026; Jewell G, 2000, NEUROPSYCHOLOGIA, V38, P93, DOI 10.1016/S0028-3932(99)00045-7; Karnath HO, 2006, BRAIN, V129, P293, DOI 10.1093/brain/awh698; Klatzky RL, 2003, EXP BRAIN RES, V149, P48, DOI 10.1007/s00221-002-1334-z; KOENDERINK JJ, 1987, BIOL CYBERN, V56, P247, DOI 10.1007/BF00365219; Lappe M, 1996, J NEUROSCI, V16, P6265; Li L, 2002, OPTOMETRY VISION SCI, V79, P581, DOI 10.1097/00006324-200209000-00009; Loomis JM, 2002, J EXP PSYCHOL LEARN, V28, P335, DOI 10.1037//0278-7393.28.2.335; MacNeilage PR, 2007, EXP BRAIN RES, V179, P263, DOI 10.1007/s00221-006-0792-0; MacNeilage PR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040264; MacNeilage PR, 2010, J NEUROSCI, V30, P9084, DOI 10.1523/JNEUROSCI.1304-10.2010; MacNeilage PR, 2008, J NEUROPHYSIOL, V100, P2981, DOI 10.1152/jn.90677.2008; Sanger TD, 1996, J NEUROPHYSIOL, V76, P2790, DOI 10.1152/jn.1996.76.4.2790; Telford L, 1996, PERCEPT PSYCHOPHYS, V58, P283, DOI 10.3758/BF03211881; TELFORD L, 1995, EXP BRAIN RES, V104, P502; WARREN WH, 1988, J EXP PSYCHOL HUMAN, V14, P646, DOI 10.1037/0096-1523.14.4.646; WARREN WH, 1992, PERCEPT PSYCHOPHYS, V51, P443, DOI 10.3758/BF03211640; Weiss Y, 2002, NAT NEUROSCI, V5, P598, DOI 10.1038/nn858; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1314, DOI 10.3758/BF03194545; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1293, DOI 10.3758/BF03194544	45	40	40	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56862	10.1371/journal.pone.0056862	http://dx.doi.org/10.1371/journal.pone.0056862			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457631	gold, Green Submitted, Green Published			2022-12-25	WOS:000315603700091
J	Gdalevitch, M; Kasaai, B; Alam, N; Dohin, B; Lauzier, D; Hamdy, RC				Gdalevitch, Marie; Kasaai, Bahar; Alam, Norine; Dohin, Bruno; Lauzier, Dominique; Hamdy, Reggie C.			The Effect of Heparan Sulfate Application on Bone Formation during Distraction Osteogenesis	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; MORPHOGENETIC PROTEIN; CELL-SURFACE; MOUSE MODEL; PROTEOGLYCANS; BMP; DIFFERENTIATION; EXPRESSION; LOCALIZATION; REGENERATION	Bone morphogenetic proteins (BMPs) are recognized for their ability to induce bone formation in vivo and in vitro. Their osteogenic and osteoinductive properties are tightly regulated by the secretion of specific BMP antagonists, which have been shown to physically bind and sometimes be blocked by the extracellular proteoglycan heparan sulphate side chains (from hereon referred to as HS). The purpose of this study was to investigate if local application of 5 mu g of HS proteoglycan to a bone regenerate site in a mouse model of distraction osteogenesis (DO) can accelerate bone healing and affect the expression of key members of the BMP signaling pathway. DO was performed on the right tibia of 115 adult male wild-type mice. At mid-distraction (day 11), half the group was injected locally with 5 mu g of HS, while the other half was injected with saline. The mice were sacrificed at 2 time-points: mid-consolidation (34 days) and full consolidation (51 days). The distracted tibial zone was then collected for analysis by mu CT, radiology, biomechanical testing, immunohistochemistry, and histology. While mu CT data showed no statistically significant difference in bone formation, the results of biomechanical testing in stiffness and ultimate force were significantly lower in the HS-injected bones at 51 days, compared to controls. Immunohistochemistry results also suggested a decrease in expression of several key members of the BMP signaling pathway at 34 days. Furthermore, wound dehiscence and infection rates were significantly elevated in the HS group compared to the controls, which resulted in a higher rate of euthanasia in the treatment group. Our findings demonstrate that exogenous application of 5 mu g of HS in the distracted gap of a murine model had a negative impact on bone and wound healing.	[Gdalevitch, Marie; Kasaai, Bahar; Alam, Norine; Lauzier, Dominique; Hamdy, Reggie C.] Shriners Hosp Children, Div Orthoped, Montreal, PQ, Canada; [Dohin, Bruno] Univ St Etienne, Hop Femme Mere Enfant, Dept Pediat Orthoped Surg, Bron, France	McGill University; CHU Lyon; Universite Jean Monnet	Gdalevitch, M (corresponding author), Shriners Hosp Children, Div Orthoped, Montreal, PQ, Canada.	marie.gdalevitch@mail.mcgill.ca	dohin, bruno/AAS-2974-2021		Shriners of Canada [8700]	Shriners of Canada	This study was funded by Shriners of Canada under operating grant 8700. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation o the manuscript.	Alam N, 2009, CLIN ORTHOP RELAT R, V467, P3190, DOI 10.1007/s11999-009-1065-6; Borza DB, 1998, J BIOL CHEM, V273, P5493, DOI 10.1074/jbc.273.10.5493; Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890; Chen GQ, 2012, INT J BIOL SCI, V8, P272, DOI 10.7150/ijbs.2929; Colburn NT, 2009, ARTHRITIS RHEUM-US, V60, P1694, DOI 10.1002/art.24520; Coombe DR, 2005, CELL MOL LIFE SCI, V62, P410, DOI 10.1007/s00018-004-4293-7; Devescovi Valentina, 2008, Chir Organi Mov, V92, P161, DOI 10.1007/s12306-008-0064-1; Eckert R, 2003, FEBS LETT, V541, P121, DOI 10.1016/S0014-5793(03)00322-3; Economides A, 2000, MODIFIED NOGGIN POLY; Esko JD, 2001, J CLIN INVEST, V108, P169, DOI 10.1172/JCI200113530; Fisher MC, 2006, MATRIX BIOL, V25, P27, DOI 10.1016/j.matbio.2005.07.008; Gallagher JT, 2001, J CLIN INVEST, V108, P357, DOI 10.1172/JCI13713; Giannoudis PV, 2007, OSTEOPOROSIS INT, V18, P1565, DOI 10.1007/s00198-007-0441-x; Groeneveld EHJ, 2000, EUR J ENDOCRINOL, V142, P9, DOI 10.1530/eje.0.1420009; Haidar ZS, 2010, GROWTH FACTORS, V28, P44, DOI 10.3109/08977190903367788; Hamdy RC, 2003, BONE, V33, P248, DOI 10.1016/S8756-3282(03)00154-6; Hamdy RC, 1997, ANN CHIR, V51, P875; Haque T, 2007, HISTOL HISTOPATHOL, V22, P119, DOI 10.14670/HH-22.119; Haque T, 2006, J HISTOCHEM CYTOCHEM, V54, P407, DOI 10.1369/jhc.5A6738.2005; Haque T, 2008, BONE, V42, P1144, DOI 10.1016/j.bone.2008.01.028; Harwood Paul J, 2005, Expert Opin Drug Saf, V4, P75, DOI 10.1517/14740338.4.1.75; Hu J, 2007, J ORTHOP RES, V25, P241, DOI 10.1002/jor.20288; Hu J, 2002, INT J ORAL MAX SURG, V31, P185, DOI 10.1054/ijom.2001.0193; ILIZAROV GA, 1990, CLIN ORTHOP RELAT R, P8; Irie A, 2003, BIOCHEM BIOPH RES CO, V308, P858, DOI 10.1016/S0006-291X(03)01500-6; Isefuku S, 2000, BONE, V27, P661, DOI 10.1016/S8756-3282(00)00385-9; Jackson R, 2006, J ORTHOPAEDIC RES, V24; Jasuja R, 2004, J BIOL CHEM, V279, P51289, DOI 10.1074/jbc.M408129200; Jiao XY, 2007, J BIOL CHEM, V282, P1080, DOI 10.1074/jbc.M513414200; Kanzaki S, 2008, J CELLULAR PHYSL, V216; Kasaai B, 2012, J HISTOCHEM CYTOCHEM, V60, P219, DOI 10.1369/0022155411432010; Khan SA, 2008, AM J PHYSIOL-CELL PH, V294, pC1387, DOI 10.1152/ajpcell.00346.2007; KJELLEN L, 1991, ANNU REV BIOCHEM, V60, P443, DOI 10.1146/annurev.bi.60.070191.002303; Krawczyk A, 2007, BONE, V40, P781, DOI 10.1016/j.bone.2006.10.002; Mandu-Hrit M, 2006, GROWTH FACTORS, V24, P172, DOI 10.1080/08977190600621362; Ohkawara B, 2002, CURR BIOL, V12, P205, DOI 10.1016/S0960-9822(01)00684-4; Okamoto M, 2006, J BONE MINER RES, V21, P1022, DOI 10.1359/JBMR.060411; OLWIN BB, 1992, J CELL BIOL, V118, P631, DOI 10.1083/jcb.118.3.631; Paine-Saunders S, 2002, J BIOL CHEM, V277, P2089, DOI 10.1074/jbc.M109151200; Rengachary S, 2002, NEUROSURG FOCUS, V13, P1; Ricard-Blum S, 2004, J BIOL CHEM, V279, P2927, DOI 10.1074/jbc.M309868200; Rider CC, 2010, BIOCHEM J, V429, P1, DOI 10.1042/BJ20100305; Sailhan F, 2011, OSTEOPOROSIS INT, V22, P2011, DOI 10.1007/s00198-011-1613-2; SCHLESSINGER J, 1995, CELL, V83, P357, DOI 10.1016/0092-8674(95)90112-4; Takada T, 2003, J BIOL CHEM, V278, P43229, DOI 10.1074/jbc.M300937200; Tavakoli K, 1999, BRIT J PLAST SURG, V52, P434, DOI 10.1054/bjps.1999.3157; Troulis MJ, 2003, J ORAL MAXIL SURG, V61, P1144, DOI 10.1016/S0278-2391(03)00672-4; Tsuji K, 2006, NAT GENET, V38, P1424, DOI 10.1038/ng1916; Woodruff MA, 2007, J MOL HISTOL, V38, P425, DOI 10.1007/s10735-007-9137-y; YAYON A, 1991, CELL, V64, P841, DOI 10.1016/0092-8674(91)90512-W; Yeung HY, 2001, CLIN ORTHOP RELAT R, P219	51	16	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56790	10.1371/journal.pone.0056790	http://dx.doi.org/10.1371/journal.pone.0056790			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457615	Green Published, gold, Green Submitted			2022-12-25	WOS:000315603700081
J	MacInnis, RJ; Severi, G; Baglietto, L; Dowty, JG; Jenkins, MA; Southey, MC; Hopper, JL; Giles, GG				MacInnis, Robert J.; Severi, Gianluca; Baglietto, Laura; Dowty, James G.; Jenkins, Mark A.; Southey, Melissa C.; Hopper, John L.; Giles, Graham G.			Population-Based Estimate of Prostate Cancer Risk for Carriers of the HOXB13 Missense Mutation G84E	PLOS ONE			English	Article							FAMILY; PENETRANCE	The HOXB13 missense mutation G84E (rs138213197) is associated with increased risk of prostate cancer, but the current estimate of increased risk has a wide confidence interval (width of 95% confidence interval (CI) >200-fold) so the point estimate of 20-fold increased risk could be misleading. Population-based family studies can be more informative for estimating risks for rare variants, therefore, we screened for mutations in an Australian population-based series of early-onset prostate cancer cases (probands). We found that 19 of 1,384 (1.4%) probands carried the missense mutation, and of these, six (32%) had a family history of prostate cancer. We tested the 22 relatives of carriers diagnosed from 1998 to 2008 for whom we had a DNA sample, and found seven more carriers and one obligate carrier. The age-specific incidence for carriers was estimated to be, on average, 16.4 (95% CI 2.5-107.2) times that for the population over the time frame when the relatives were at risk prior to baseline. We then estimated the age and birth year-specific cumulative risk of prostate cancer (penetrance) for carriers. For example, the penetrance for an unaffected male carrier born in 1950 was 19% (95% CI 5-46%) at age 60 years, 44% (95% CI 18-74%) at age 70 years and 60% (95% CI 30-85%) at age 80 years. Our study has provided a population-based estimate of the average risk of prostate cancer for HOXB13 missense mutation G84E carriers that can be used to guide clinical practice and research. This study has also shown that the majority of hereditary prostate cancers due to the HOXB13 missense mutation are 'sporadic' in the sense that unselected cases with the missense mutation do not typically report having a family history of prostate cancer.	[MacInnis, Robert J.; Severi, Gianluca; Baglietto, Laura; Hopper, John L.; Giles, Graham G.] Canc Council Victoria, Canc Epidemiol Ctr, Carlton, Vic, Australia; [MacInnis, Robert J.; Severi, Gianluca; Baglietto, Laura; Dowty, James G.; Jenkins, Mark A.; Giles, Graham G.] Univ Melbourne, Ctr Mol Environm Genet & Analyt Epidemiol, Sch Populat Hlth, Melbourne, Vic 3010, Australia; [Southey, Melissa C.] Univ Melbourne, Genet Epidemiol Lab, Dept Pathol, Melbourne, Vic 3010, Australia	Cancer Council Victoria; University of Melbourne; University of Melbourne	Hopper, JL (corresponding author), Canc Council Victoria, Canc Epidemiol Ctr, Carlton, Vic, Australia.	j.hopper@unimelb.edu.au	Severi, Gianluca/H-3774-2018; Baglietto, Laura/AAB-9051-2019; Severi, Gianluca/Q-1824-2019; Jenkins, Mark/P-7803-2015	Severi, Gianluca/0000-0001-7157-419X; Severi, Gianluca/0000-0001-7157-419X; Jenkins, Mark/0000-0002-8964-6160; Dowty, James/0000-0003-2383-0886; Baglietto, Laura/0000-0002-8193-7529; MacInnis, Robert/0000-0002-1627-5047; Giles, Graham/0000-0003-4946-9099; Southey, Melissa/0000-0002-6313-9005	Cancer Council Victoria; Tattersall's charitable programme; Whitten Foundation; PricewaterhouseCoopers Australia charitable programme; National Health and Medical Research Council	Cancer Council Victoria(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); Tattersall's charitable programme; Whitten Foundation; PricewaterhouseCoopers Australia charitable programme; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	The work was supported largely by infrastructure and core funding provided by Cancer Council Victoria. Additional support was provided by Tattersall's charitable programme, The Whitten Foundation, PricewaterhouseCoopers Australia charitable programme and by grants from the National Health and Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbari MR, 2012, J NATL CANC I; Australian Institute of Health and Welfare (AIHW), 2011, ACIM AUSTR CANC INC; Breyer JP, 2012, CANC EPIDEMIOL BIOMA; Byrnes GB, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2099; Cui JS, 2000, CANCER EPIDEM BIOMAR, V9, P805; Etzioni R, 1998, AM J EPIDEMIOL, V148, P775; Ewing CM, 2012, NEW ENGL J MED, V366, P141, DOI 10.1056/NEJMoa1110000; Gong G, 2010, GENET EPIDEMIOL, V34, P373, DOI 10.1002/gepi.20493; Hopper JL, 2005, LANCET, V366, P1397, DOI 10.1016/S0140-6736(05)67570-8; Karlsson R, 2012, EUR UROL; LANGE K, 1988, GENET EPIDEMIOL, V5, P471, DOI 10.1002/gepi.1370050611; Lange K, 1997, GENETICS, V147, P1423; MacInnis RJ, 2010, GENET EPIDEMIOL, V34, P42, DOI 10.1002/gepi.20433; ROYSTON P, 1991, STATA TECH B, V3, P7	14	25	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e54727	10.1371/journal.pone.0054727	http://dx.doi.org/10.1371/journal.pone.0054727			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457453	Green Published, gold, Green Submitted			2022-12-25	WOS:000315603700007
J	Phillips, AN; Cambiano, V; Nakagawa, F; Brown, AE; Lampe, F; Rodger, A; Miners, A; Elford, J; Hart, G; Johnson, AM; Lundgren, J; Delpech, VC				Phillips, Andrew N.; Cambiano, Valentina; Nakagawa, Fumiyo; Brown, Alison E.; Lampe, Fiona; Rodger, Alison; Miners, Alec; Elford, Jonathan; Hart, Graham; Johnson, Anne M.; Lundgren, Jens; Delpech, Valerie C.			Increased HIV Incidence in Men Who Have Sex with Men Despite High Levels of ART-Induced Viral Suppression: Analysis of an Extensively Documented Epidemic	PLOS ONE			English	Article							RISK BEHAVIOR; ANTIRETROVIRAL THERAPY; GAY MEN; COMMUNITY SAMPLES; HOMOSEXUAL-MEN; INFECTION; TRANSMISSION; PREVENTION; LONDON; SPREAD	Background: There is interest in expanding ART to prevent HIV transmission, but in the group with the highest levels of ART use, men-who-have-sex-with-men (MSM), numbers of new infections diagnosed each year have not decreased as ARTcoverage has increased for reasons which remain unclear. Methods: We analysed data on the HIV-epidemic in MSM in the UK from a range of sources using an individual-based simulation model. Model runs using parameter sets found to result in good model fit were used to infer changes in HIV-incidence and risk behaviour. Results: HIV-incidence has increased (estimated mean incidence 0.30/100 person-years 1990-1997, 0.45/100 py 1998-2010), associated with a modest (26%) rise in condomless sex. We also explored counter-factual scenarios: had ART not been introduced, but the rise in condomless sex had still occurred, then incidence 2006-2010 was 68% higher; a policy of ART initiation in all diagnosed with HIV from 2001 resulted in 32% lower incidence; had levels of HIV testing been higher (68% tested/year instead of 25%) incidence was 25% lower; a combination of higher testing and ART at diagnosis resulted in 62% lower incidence; cessation of all condom use in 2000 resulted in a 424% increase in incidence. In 2010, we estimate that undiagnosed men, the majority in primary infection, accounted for 82% of new infections. Conclusion: A rise in HIV-incidence has occurred in MSM in the UK despite an only modest increase in levels of condomless sex and high coverage of ART. ART has almost certainly exerted a limiting effect on incidence. Much higher rates of HIV testing combined with initiation of ART at diagnosis would be likely to lead to substantial reductions in HIV incidence. Increased condom use should be promoted to avoid the erosion of the benefits of ART and to prevent other serious sexually transmitted infections.	[Phillips, Andrew N.; Cambiano, Valentina; Nakagawa, Fumiyo; Lampe, Fiona; Rodger, Alison; Hart, Graham; Johnson, Anne M.] UCL, Res Dept Infect & Populat Hlth, London, England; [Brown, Alison E.; Delpech, Valerie C.] Hlth Protect Agcy, London, England; [Miners, Alec] London Sch Hyg & Trop Med, London WC1, England; [Elford, Jonathan] City Univ London, London EC1V 0HB, England; [Lundgren, Jens] Univ Copenhagen Hosp, Rigshosp, DK-2100 Copenhagen, Denmark; [Lundgren, Jens] Univ Copenhagen, Copenhagen, Denmark	University of London; University College London; Health Protection Agency; University of London; London School of Hygiene & Tropical Medicine; City University London; Rigshospitalet; University of Copenhagen; University of Copenhagen	Phillips, AN (corresponding author), UCL, Res Dept Infect & Populat Hlth, London, England.	andrew.phillips@ucl.ac.uk	Lampe, Fiona/I-5826-2019; Phillips, Andrew N/B-4427-2008; Lundgren, Jens/AAE-6876-2019	Lampe, Fiona/0000-0001-6851-5471; Phillips, Andrew N/0000-0003-2384-4807; Lundgren, Jens/0000-0001-8901-7850; delpech, valerie/0000-0002-9952-8109; Johnson, Anne/0000-0003-1330-7100; Nakagawa, Fumiyo/0000-0002-6646-8744; Hart, Graham/0000-0001-9676-6577	National Institute for Health Research (NIHR) under its Programme Grants for Applied Research funding scheme [RP-PG-0608-10142]; National Institute for Health Research [NF-SI-0611-10255, RP-PG-0608-10142] Funding Source: researchfish	National Institute for Health Research (NIHR) under its Programme Grants for Applied Research funding scheme(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	This paper presents independent research commissioned by the National Institute for Health Research (NIHR) under its Programme Grants for Applied Research funding scheme (RP-PG-0608-10142). The views expressed in this paper are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babiker AG, 2012, CLIN TRIALS, V9, P144; Bansi L, 2010, HIV MED, V11, P432, DOI 10.1111/j.1468-1293.2009.00809.x; Bezemer D, 2008, AIDS, V22, P1071, DOI 10.1097/QAD.0b013e3282fd167c; Blower SM, 2000, SCIENCE, V287, P650, DOI 10.1126/science.287.5453.650; Brenner BG, 2007, J INFECT DIS, V195, P951, DOI 10.1086/512088; Cambiano V, 2011, CURR OPIN INFECT DIS, V24, P19, DOI 10.1097/QCO.0b013e3283422c8c; CARNE CA, 1987, LANCET, V1, P656; Charlebois ED, 2011, CLIN INFECT DIS, V52, P1046, DOI 10.1093/cid/cir085; Clements MS, 2004, JAIDS-J ACQ IMM DEF, V35, P401, DOI 10.1097/00126334-200404010-00010; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Das M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011068; Department of Health and Human Services, PAN ANT GUID AD AD G; Dodds JP, 2004, SEX TRANSM INFECT, V80, P236, DOI 10.1136/sti.2003.007286; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; Elford J, 2004, SEX TRANSM INFECT, V80, P451, DOI 10.1136/sti.2004.010785; Elford J, 2002, AIDS, V16, P1537, DOI 10.1097/00002030-200207260-00011; Fisher M, 2007, AIDS, V21, P2309, DOI 10.1097/QAD.0b013e3282ef9fed; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Hart GJ, 2010, CURR OPIN INFECT DIS, V23, P39, DOI 10.1097/QCO.0b013e328334feb1; Health Protection Agency, HIV AIDS SURV; Hickson FCI, 1996, AIDS, V10, P771, DOI 10.1097/00002030-199606001-00012; Koopman JS, 1997, J ACQ IMMUN DEF SYND, V14, P249, DOI 10.1097/00042560-199703010-00009; Lampe FC, 2007, ARCH INTERN MED, V167, P692, DOI 10.1001/archinte.167.7.692; Lewis F, 2008, PLOS MED, V5, P392, DOI 10.1371/journal.pmed.0050050; Mercer CH, 2004, AIDS, V18, P1453, DOI 10.1097/01.aids.0000131331.36386.de; Miller WC, 2010, CURR OPIN HIV AIDS, V5, P277, DOI 10.1097/COH.0b013e32833a0d3a; Montaner JSG, 2006, LANCET, V368, P531, DOI 10.1016/S0140-6736(06)69162-9; Montaner JSG, 2010, LANCET, V376, P532, DOI 10.1016/S0140-6736(10)60936-1; Murray JM, 2011, SEX HEALTH, V8, P304, DOI 10.1071/SH10114; Ndawinz JDA, 2011, AIDS, V25, P1905, DOI 10.1097/QAD.0b013e32834af619; Pao D, 2005, AIDS, V19, P85, DOI 10.1097/00002030-200501030-00010; Phillips AN, 2008, LANCET, V371, P1443, DOI 10.1016/S0140-6736(08)60624-8; Phillips AN, 2007, HIV MED, V8, P536, DOI 10.1111/j.1468-1293.2007.00507.x; Phillips AN, 2011, AIDS, V25, P843, DOI 10.1097/QAD.0b013e328344037a; Powers KA, 2011, LANCET, V378, P256, DOI 10.1016/S0140-6736(11)60842-8; Presanis AM, 2010, AIDS, V24, P2849, DOI 10.1097/QAD.0b013e32834021ed; Rodger A, 2012, 19 C RETR OPP INF SE; Sudarshi D, 2007, SEX TRANSM INFECT, V84, P14, DOI 10.1136/sti.2007.026963; THOMPSON JLP, 1993, AM J PUBLIC HEALTH, V83, P1409, DOI 10.2105/AJPH.83.10.1409; Thompson MA, 2012, JAMA-J AM MED ASSOC, V308, P387, DOI 10.1001/jama.2012.7961; Torrone EA, 2011, JAIDS-J ACQ IMM DEF, V58, P328, DOI 10.1097/QAI.0b013e31822e1075; van Griensven F, 2009, CURR OPIN HIV AIDS, V4, P300, DOI 10.1097/COH.0b013e32832c3bb3; Vemazza P., 2008, B MED SUISSES, V89, P5; Williamson LM, 2008, AIDS, V22, P1063, DOI 10.1097/QAD.0b013e3282f8af9b; Williamson LM, 2006, JAIDS-J ACQ IMM DEF, V42, P238, DOI 10.1097/01.qai.0000214816.03411.c9; Yerly S, 2001, AIDS, V15, P2287, DOI 10.1097/00002030-200111230-00010	46	154	155	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e55312	10.1371/journal.pone.0055312	http://dx.doi.org/10.1371/journal.pone.0055312			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457467	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000315603700012
J	Verschuren, JJW; Trompet, S; Deelen, J; Stott, DJ; Sattar, N; Buckley, BM; Ford, I; Heijmans, BT; Guchelaar, HJ; Houwing-Duistermaat, JJ; Slagboom, PE; Jukema, JW				Verschuren, Jeffrey J. W.; Trompet, Stella; Deelen, Joris; Stott, David J.; Sattar, Naveed; Buckley, Brendan M.; Ford, Ian; Heijmans, Bastiaan T.; Guchelaar, Henk-Jan; Houwing-Duistermaat, Jeanine J.; Slagboom, P. Eline; Jukema, J. Wouter			Non-Homologous End-Joining Pathway Associated with Occurrence of Myocardial Infarction: Gene Set Analysis of Genome-Wide Association Study Data	PLOS ONE			English	Article							STRAND BREAK REPAIR; OXIDATIVE DNA-DAMAGE; CARDIOVASCULAR-DISEASE; CIGARETTE-SMOKING; CELL SENESCENCE; MRE11 COMPLEX; RISK; ATHEROSCLEROSIS; TELOMERASE; SUSCEPTIBILITY	Purpose: DNA repair deficiencies have been postulated to play a role in the development and progression of cardiovascular disease (CVD). The hypothesis is that DNA damage accumulating with age may induce cell death, which promotes formation of unstable plaques. Defects in DNA repair mechanisms may therefore increase the risk of CVD events. We examined whether the joints effect of common genetic variants in 5 DNA repair pathways may influence the risk of CVD events. Methods: The PLINK set-based test was used to examine the association to myocardial infarction (MI) of the DNA repair pathway in GWAS data of 866 subjects of the GENetic DEterminants of Restenosis (GENDER) study and 5,244 subjects of the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER) study. We included the main DNA repair pathways (base excision repair, nucleotide excision repair, mismatch repair, homologous recombination and non-homologous end-joining (NHEJ)) in the analysis. Results: The NHEJ pathway was associated with the occurrence of MI in both GENDER (P = 0.0083) and PROSPER (P = 0.014). This association was mainly driven by genetic variation in the MRE11A gene (P-GENDER = 0.0001 and P-PROSPER = 0.002). The homologous recombination pathway was associated with MI in GENDER only (P = 0.011), for the other pathways no associations were observed. Conclusion: This is the first study analyzing the joint effect of common genetic variation in DNA repair pathways and the risk of CVD events, demonstrating an association between the NHEJ pathway and MI in 2 different cohorts.	[Verschuren, Jeffrey J. W.; Trompet, Stella; Jukema, J. Wouter] Leiden Univ, Dept Cardiol, Med Ctr, Leiden, Netherlands; [Trompet, Stella] Leiden Univ, Dept Geriatr & Gerontol, Med Ctr, Leiden, Netherlands; [Deelen, Joris; Heijmans, Bastiaan T.; Slagboom, P. Eline] Leiden Univ, Med Ctr, Leiden, Netherlands; [Stott, David J.] Univ Glasgow, Acad Sect Geriatr Med, Glasgow, Lanark, Scotland; [Stott, David J.; Sattar, Naveed] Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland; [Buckley, Brendan M.] Cork Univ Hosp, Dept Pharmacol & Therapeut, Cork, Ireland; [Ford, Ian] Univ Glasgow, Robertson Ctr Biostat, Glasgow, Lanark, Scotland; [Guchelaar, Henk-Jan] Leiden Univ, Dept Clin Pharm & Toxicol, Med Ctr, Leiden, Netherlands; [Houwing-Duistermaat, Jeanine J.] Leiden Univ, Dept Med Stat & Bioinformat, Med Ctr, Leiden, Netherlands; [Deelen, Joris; Heijmans, Bastiaan T.; Slagboom, P. Eline] Leiden Univ, Netherlands Consortium Hlth Ageing, Med Ctr, Leiden, Netherlands; [Jukema, J. Wouter] Durrer Ctr Cardiogenet Res, Amsterdam, Netherlands; [Jukema, J. Wouter] Interuniv Cardiol Inst ICIN, Utrecht, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Glasgow; University of Glasgow; University College Cork; University of Glasgow; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Jukema, JW (corresponding author), Leiden Univ, Dept Cardiol, Med Ctr, Leiden, Netherlands.	j.w.jukema@lumc.nl	Ford, Ian/ABE-6145-2020; Houwing-Duistermaat, Jeanne/V-9048-2018; Jukema, J. Wouter/ABD-6503-2021; Slagboom, P. Eline/R-4790-2016; guchelaar, henk-jan/AAP-1381-2021; Deelen, Joris/H-3201-2019	Jukema, J. Wouter/0000-0002-3246-8359; Slagboom, P. Eline/0000-0002-2875-4723; Deelen, Joris/0000-0003-4483-3701; Houwing-Duistermaat, Jeanine/0000-0002-4505-7137; Guchelaar, Henk-Jan/0000-0002-7085-1383	Interuniversity Cardiology Institute of the Netherlands (ICIN); European Community Framework FP7 Programme [HEALTH-F2-2009-223004]; Center for Medical Systems Biology (CMSB); center of excellence approved by the Netherlands Genomics Initiative/Netherlands Organisation for Scientific Research (NWO); Netherlands Consortium for Healthy Ageing (NCHA)	Interuniversity Cardiology Institute of the Netherlands (ICIN); European Community Framework FP7 Programme; Center for Medical Systems Biology (CMSB); center of excellence approved by the Netherlands Genomics Initiative/Netherlands Organisation for Scientific Research (NWO); Netherlands Consortium for Healthy Ageing (NCHA)	This work was funded by grants from the Interuniversity Cardiology Institute of the Netherlands (ICIN) http://www.icin.nl/, the European Community Framework FP7 Programme under grant agreement [no HEALTH-F2-2009-223004], the Center for Medical Systems Biology (CMSB) [http://www.cmsb.nl], a center of excellence approved by the Netherlands Genomics Initiative/Netherlands Organisation for Scientific Research (NWO), and the Netherlands Consortium for Healthy Ageing (NCHA) [http://www.healthy-ageing.nl]. JWJ is an established clinical investigator of the Netherlands Heart Foundation (2001D032) [http://www.hartstichting.nl/]. The funders had no role in study design, data collection and analysis, decision to publish or the preparation of the manuscript.	Agema WRP, 2004, EUR HEART J, V25, P1163, DOI 10.1016/j.ehj.2004.05.006; Allen-Brady K, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-99; Andreassi MG, 2003, MUTAT RES-REV MUTAT, V543, P67, DOI 10.1016/S1383-5742(02)00089-3; Arcidiacono B, 2012, EXP DIABETES RES, DOI 10.1155/2012/789174; Bauriedel G, 1999, CARDIOVASC RES, V41, P480, DOI 10.1016/S0008-6363(98)00318-6; Bazo Ana Paula, 2011, Cardiovasc Pathol, V20, pe9, DOI 10.1016/j.carpath.2009.12.004; Borde V, 2007, CHROMOSOME RES, V15, P551, DOI 10.1007/s10577-007-1147-9; Borde V, 2009, INT J BIOCHEM CELL B, V41, P1249, DOI 10.1016/j.biocel.2008.12.013; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Choudhury A, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-69; CORRALDEBRINSKI M, 1991, JAMA-J AM MED ASSOC, V266, P1812, DOI 10.1001/jama.266.13.1812; Deelen J, 2013, AGE, V35, P235, DOI 10.1007/s11357-011-9340-3; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Durand E, 2004, CIRCULATION, V109, P2503, DOI 10.1161/01.CIR.0000130172.62481.90; Durik M, 2012, CIRCULATION, V126, P468, DOI 10.1161/CIRCULATIONAHA.112.104380; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI20042162S, 10.1172/JCI21625]; Gizard F, 2011, ARTERIOSCL THROM VAS, V31, P245, DOI 10.1161/ATVBAHA.110.219808; Gui Hongsheng, 2011, BMC Res Notes, V4, P386, DOI 10.1186/1756-0500-4-386; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Knudsen S, 1999, BIOINFORMATICS, V15, P356, DOI 10.1093/bioinformatics/15.5.356; Lamarche BJ, 2010, FEBS LETT, V584, P3682, DOI 10.1016/j.febslet.2010.07.029; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Liu SC, 2005, CARDIOVASC PATHOL, V14, P232, DOI 10.1016/j.carpath.2005.05.006; Loizidou MA, 2009, BREAST CANCER RES TR, V115, P623, DOI 10.1007/s10549-008-0084-4; Macintyre G, 2010, BIOINFORMATICS, V26, pi524, DOI 10.1093/bioinformatics/btq378; Mahabir S, 2007, J EPIDEMIOL COMMUN H, V61, P737, DOI 10.1136/jech.2006.048934; Mahmoudi M, 2006, CARDIOVASC RES, V71, P259, DOI 10.1016/j.cardiores.2006.03.002; Matthews C, 2006, CIRC RES, V99, P156, DOI 10.1161/01.RES.0000233315.38086.bc; Mercer JR, 2010, CIRC RES, V107, P1021, DOI 10.1161/CIRCRESAHA.110.218966; Minamino T, 2007, CIRC RES, V100, P15, DOI 10.1161/01.RES.0000256837.40544.4a; Mirzoeva OK, 2003, MOL CANCER RES, V1, P207; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Ockene IS, 1997, CIRCULATION, V96, P3243, DOI 10.1161/01.CIR.96.9.3243; Ozturk S, 2011, HISTOL HISTOPATHOL, V26, P505, DOI 10.14670/HH-26.505; Park YB, 2011, STRUCTURE, V19, P1591, DOI 10.1016/j.str.2011.09.010; Perez-Rivero G, 2006, CIRCULATION, V114, P309, DOI 10.1161/CIRCULATIONAHA.105.611111; Poch E, 2004, FASEB J, V18, P418, DOI 10.1096/fj.03-0710fje; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ragnauth CD, 2010, CIRCULATION, V121, P2200, DOI 10.1161/CIRCULATIONAHA.109.902056; Rossi ML, 2004, CIRCULATION, V110, P1767, DOI 10.1161/01.CIR.0000142865.04816.89; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; Sampietro ML, 2011, HUM MOL GENET, V20, P4748, DOI 10.1093/hmg/ddr389; Satoh M, 2008, ATHEROSCLEROSIS, V198, P347, DOI 10.1016/j.atherosclerosis.2007.09.040; Schunkert H, 2011, NAT GENET, V43, P333, DOI [10.1038/ng.784, 10.1161/CIRCGENETICS.111.960443]; Shepherd J, 2002, LANCET, V360, P1623, DOI 10.1016/S0140-6736(02)11600-X; Shepherd J, 1999, AM J CARDIOL, V84, P1192, DOI 10.1016/S0002-9149(99)00533-0; Shimada MK, 2009, NUCLEIC ACIDS RES, V37, pD810, DOI 10.1093/nar/gkn798; Shyu HY, 2012, J ATHEROSCLER THROMB, V19, P316, DOI 10.5551/jat.10967; Stewart GS, 1999, CELL, V99, P577, DOI 10.1016/S0092-8674(00)81547-0; Thorne D, 2009, MUTAT RES-GEN TOX EN, V673, P3, DOI 10.1016/j.mrgentox.2008.11.008; Torkamani A, 2008, GENOMICS, V92, P265, DOI 10.1016/j.ygeno.2008.07.011; Trompet S, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-131; Voghel G, 2010, MECH AGEING DEV, V131, P354, DOI 10.1016/j.mad.2010.04.004; Wang K, 2010, NAT REV GENET, V11, P843, DOI 10.1038/nrg2884; Waters LS, 2009, MICROBIOL MOL BIOL R, V73, P134, DOI 10.1128/MMBR.00034-08; Williams GJ, 2010, DNA REPAIR, V9, P1299, DOI 10.1016/j.dnarep.2010.10.001; Xie XH, 2007, P NATL ACAD SCI USA, V104, P7145, DOI 10.1073/pnas.0701811104; Zeller T, 2012, CLIN CHEM, V58, P92, DOI 10.1373/clinchem.2011.170431	58	13	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56262	10.1371/journal.pone.0056262	http://dx.doi.org/10.1371/journal.pone.0056262			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457540	Green Published, gold, Green Accepted			2022-12-25	WOS:000315603700036
J	Zhang, WL; Yang, WP; Wang, MC; Wang, W; Zeng, GP; Chen, ZW; Cai, YL				Zhang, Wenlong; Yang, Wenpeng; Wang, Mingchun; Wang, Wei; Zeng, Guiping; Chen, Zhiwei; Cai, Yilin			Increasing Lysine Content of Waxy Maize through Introgression of Opaque-2 and Opaque-16 Genes Using Molecular Assisted and Biochemical Development	PLOS ONE			English	Article							RESISTANCE; SELECTION; MUTANT; DNA	The low lysine content of waxy maize cannot meet the nutritional requirements of humans, livestock, or poultry. In the present study, the high-lysine genes o2 and o16 were backcrossed into wx lines using the maize high-lysine inbreds TAIXI19 (o2o2) and QCL3021 (o16o16) as donors and the waxy maize inbred line QCL5019 (wxwx) as a receptor. In the triple-cross F-1, backcross, and inbred generations, the SSR markers phi027 and phi112 within the wx and o2 genes and the SSR marker umc1121 linked to the o16 gene were used for foreground selection. Background selection of the whole-genome SSR markers was performed for the selected individuals. The grain lysine content was determined using the dye-binding lysine method. The waxiness of the grain was determined with the I-2-KI staining and dual-wavelength spectrophotometric analysis. The BC2F2 generation included 7 plants of genotype wxwxo2o2O16_, 19 plants of genotype wxwxo16o16O2_, and 3 plants of genotype wxwxo2o2o16o16. In these seeds, the average amylopectin content was 96.67%, 96.87%, and 96.62%, respectively, which is similar to that of QCL5019. The average lysine content was 0.555%, 0.380%, and 0.616%, respectively, representing increases of 75.1%, 19.9%, 94.3%, respectively, over QCL5019. The average genetic background recovery rate of the BC2F3 families was 95.3%, 94.3%, 94.2%, respectively. Among these 3 wxwxo2o2O16O16 families, 4 wxwxo2o2O16o16 families, and 3 wxwxo2o2o16o16 families, the longest imported parent donor fragment was 113.35 cM and the shortest fragment was 11.75 cM. No significant differences in lysine content were found between the BC2F4 seeds and the BC2F3 seeds in these 10 families. This allowed us to increase the lysine content of waxy corn and produce seeds with excellent nutritional characteristics suitable for human consumption, animal feed, and food processing. This may be of significance in the breeding of high-quality corn and in improvement of the nutrition of humans, livestock, and poultry.	[Zhang, Wenlong; Yang, Wenpeng; Wang, Mingchun; Wang, Wei; Chen, Zhiwei] Guizhou Acad Agr Sci, Guizhou Inst Upland Food Crops, Guiyang, Guizhou, Peoples R China; [Zhang, Wenlong; Chen, Zhiwei; Cai, Yilin] Southwest Univ, Coll Agron & Biotechnol, Chongqing, Peoples R China; [Zhang, Wenlong] Guizhou Agr Comm, Guizhou Gen Seed Stn, Guiyang, Guizhou, Peoples R China; [Yang, Wenpeng] Guizhou Acad Agr Sci, Guizhou Key Lab Agr Biotechnol, Guiyang, Guizhou, Peoples R China; [Zeng, Guiping] Guizhou Univ, Coll Agr, Guiyang 550003, Guizhou, Peoples R China	Guizhou Academy of Agricultural Sciences; Southwest University - China; Guizhou Academy of Agricultural Sciences; Guizhou University	Yang, WP (corresponding author), Guizhou Acad Agr Sci, Guizhou Inst Upland Food Crops, Guiyang, Guizhou, Peoples R China.	ywpmaize@126.com			National Natural Science Foundation of China [30560079, 31160307]; National Basic Research Program of China [2006CB708206]; Special Foundation of Guizhou Academy of Agricultural Sciences [052]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Special Foundation of Guizhou Academy of Agricultural Sciences	This work was supported by the National Natural Science Foundation of China (No.30560079 and No.31160307; http://www.nsfc.gov.cn/Portal0/default166.htm), the National Basic Research Program of China (No.2006CB708206; http://www.most.gov.cn/eng/index.htm) and the Special Foundation of Guizhou Academy of Agricultural Sciences (No.052, 2010; http://www.gzaas.org.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergman CJ, 2000, RICE GENETICS S, V4, P22; BRIGGS RW, 1965, NATURE, V207, P890, DOI 10.1038/207890a0; Collins GN, 1909, BUREAU PLANT IND B, V161, P1; Fang MingJing, 2005, Acta Agronomica Sinica, V31, P1359; He Guang-Ming, 2004, Acta Genetica Sinica, V31, P836; He ZF, 1981, PROG BIOCHEM BIOPHYS, V1, P70; He ZF, 1985, QUALITY CEREALS OILS; Hittalmani S, 2000, THEOR APPL GENET, V100, P1121, DOI 10.1007/s001220051395; HOSPITAL F, 1992, GENETICS, V132, P1199; KLOSGEN RB, 1986, MOL GEN GENET, V203, P237, DOI 10.1007/BF00333960; KULESHOV N. N., 1954, Ann. Mo. Bot. Gdn., V41, P271, DOI 10.2307/2394586; LAUGHNAN JR, 1953, GENETICS, V38, P485; Li X. Y., 1993, Acta Agronomica Sinica, V19, P460; Li XH, 2003, J MAIZE SCI, P14; Liu Jian, 2005, Journal of Maize Sciences, V13, P60; [柳李旺 Liu Liwang], 2003, [分子植物育种, Molecular Plant Breeding], V1, P48; Liu Z, 2003, J ANHUI TECHNICAL TE, V17, P32; Mason-Gamer RJ, 1998, MOL BIOL EVOL, V15, P1658, DOI 10.1093/oxfordjournals.molbev.a025893; McClintock B., 1963, Year Book of the Carnegie Institution of Washington 1962-1963, V62, P486; McClintock B., 1964, Yearbook of the Carnegie Institution of Washington 1963-64, P592; Meng ZD, 2001, J MAIZE SCI, V9, P14; Ming R, 1997, THEOR APPL GENET, V95, P271, DOI 10.1007/s001220050559; NELSON OE, 1962, BIOCHEM BIOPH RES CO, V9, P297, DOI 10.1016/0006-291X(62)90043-8; Neuffer MG, 1997, MUTANTS MAIZE; Sanchez AC, 2000, CROP SCI, V40, P792, DOI 10.2135/cropsci2000.403792x; Schneider KA, 1997, CROP SCI, V37, P51, DOI 10.2135/cropsci1997.0011183X003700010008x; Sprague G. F., 1943, JOUR AMER SOC AGRON, V35, P817; Sun Z, 1998, J BEIJING AGR COLL, V13, P1; [田清震 Tian Qingzhen], 2004, [玉米科学, Maize Science], V12, P108; Weatherwax P, 1922, GENETICS, V7, P568; WESSLER S, 1990, P NATL ACAD SCI USA, V87, P8731, DOI 10.1073/pnas.87.22.8731; [夏军红 Xia Junhong], 2002, [作物学报, Acta Agronomica Sinica], V28, P339; Xia Tao, 1997, Acta Agronomica Sinica, V23, P753; Yang W, 2004, PLANT MOL BIOL REP, V22, P361, DOI 10.1007/BF02772679; Yang WP, 2008, HEREDITAS, V145, P225, DOI 10.1111/j.1601-5223.2008.02056.x; Yang WP, 2005, MOL BREEDING, V15, P257, DOI 10.1007/s11032-004-5947-8; Yang WP, 2005, THESIS HUAZHONG AGR; Yang Yin-fu, 2009, ACTA BOTANICA BOREALI-OCCIDENTALIA SINICA, V29, P2213; [杨子贤 Yang Zixian], 2004, [分子植物育种, Molecular Plant Breeding], V2, P473; Zeng MQ, 1987, CROP BREED RESOURCE, V3, P8; Zhai FL, 1991, BREEDING CROP QUALIT; Zhang JianHua, 2006, Southwest China Journal of Agricultural Sciences, V19, P543; Zhang Wenfang, 2010, J BUILDING STRUCTURE, V21, P36; [张增艳 Zhang Zengyan], 2002, [中国农业科学, Scientia Agricultura Sinica], V35, P789	44	12	14	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56227	10.1371/journal.pone.0056227	http://dx.doi.org/10.1371/journal.pone.0056227			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457531	Green Published, Green Submitted, gold			2022-12-25	WOS:000315603700029
J	Albright, R; Mason, B				Albright, Rebecca; Mason, Benjamin			Projected Near-Future Levels of Temperature and pCO(2) Reduce Coral Fertilization Success	PLOS ONE			English	Article							OCEAN ACIDIFICATION; CLIMATE-CHANGE; ELEVATED-TEMPERATURE; SPERM LIMITATION; RECRUITMENT; SETTLEMENT; SURVIVORSHIP; MOTILITY; DECLINE; IMPACT	Increases in atmospheric carbon dioxide (pCO(2)) are projected to contribute to a 1.1-6.4 degrees C rise in global average surface temperatures and a 0.14-0.35 reduction in the average pH of the global surface ocean by 2100. If realized, these changes are expected to have negative consequences for reef-building corals including increased frequency and severity of coral bleaching and reduced rates of calcification and reef accretion. Much less is known regarding the independent and combined effects of temperature and pCO(2) on critical early life history processes such as fertilization. Here we show that increases in temperature (+3 degrees C) and pCO(2) (+400 mu atm) projected for this century negatively impact fertilization success of a common Indo-Pacific coral species, Acropora tenuis. While maximum fertilization did not differ among treatments, the sperm concentration required to obtain 50% of maximum fertilization increased 6- to 8- fold with the addition of a single factor (temperature or CO2) and nearly 50- fold when both factors interact. Our results indicate that near-future changes in temperature and pCO(2) narrow the range of sperm concentrations that are capable of yielding high fertilization success in A. tenuis. Increased sperm limitation, in conjunction with adult population decline, may have severe consequences for coral reproductive success. Impaired sexual reproduction will further challenge corals by inhibiting population recovery and adaptation potential.	[Albright, Rebecca; Mason, Benjamin] Australian Inst Marine Sci, Townsville, Qld 4810, Australia	Australian Institute of Marine Science	Albright, R (corresponding author), Australian Inst Marine Sci, PMB 3, Townsville, Qld 4810, Australia.	r.albright@aims.gov.au		Albright, Rebecca/0000-0003-3409-8766	Australian Research Council fellowship; Australian Institute of Marine Science	Australian Research Council fellowship(Australian Research Council); Australian Institute of Marine Science	This project was supported by an Australian Research Council fellowship awarded to RA and by the Australian Institute of Marine Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albright R., 2011, J MAR BIOL, V2011, P1, DOI [10.1155/2011/473615, DOI 10.1155/2011/473615]; Albright R, 2011, GLOBAL CHANGE BIOL, V17, P2478, DOI 10.1111/j.1365-2486.2011.02404.x; Albright R, 2010, P NATL ACAD SCI USA, V107, P20400, DOI 10.1073/pnas.1007273107; Andersson A. J., 2011, OCEAN ACIDIFICATION, P122; Anlauf H, 2011, J EXP MAR BIOL ECOL, V397, P13, DOI 10.1016/j.jembe.2010.11.009; Baker AC, 2008, ESTUAR COAST SHELF S, V80, P435, DOI 10.1016/j.ecss.2008.09.003; Bassim KM, 2003, MAR BIOL, V142, P241, DOI 10.1007/S00227-002-0953-z; Byrne M, 2011, OCEANOGR MAR BIOL, V49, P1; Byrne M, 2010, MAR BIOL, V157, P2061, DOI 10.1007/s00227-010-1474-9; Byrne M, 2010, MAR ENVIRON RES, V69, P234, DOI 10.1016/j.marenvres.2009.10.014; Byrne M, 2009, P ROY SOC B-BIOL SCI, V276, P1883, DOI 10.1098/rspb.2008.1935; Cohen AL, 2009, GEOCHEM GEOPHY GEOSY, V10, DOI 10.1029/2009GC002411; Dickson A. G., 2007, PICES SPECIAL PUBLIC, DOI DOI 10.1159/000331784; Doropoulos C, 2012, ECOL LETT, V15, P338, DOI 10.1111/j.1461-0248.2012.01743.x; Edmunds PJ, 2007, MAR ECOL PROG SER, V341, P1, DOI 10.3354/meps341001; Gattuso J-P, 2011, OCEAN ACIDIFICATION; Harrison P.L., 1990, P133; Harrison PL, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P59, DOI 10.1007/978-94-007-0114-4_6; Havenhand JN, 2009, BIOGEOSCIENCES, V6, P3009, DOI 10.5194/bg-6-3009-2009; Havenhand JN, 2008, CURR BIOL, V18, pR651, DOI 10.1016/j.cub.2008.06.015; Heyward AJ, 2010, CORAL REEFS, V29, P631, DOI 10.1007/s00338-009-0578-5; HEYWARD AJ, 1986, MAR BIOL, V90, P191, DOI 10.1007/BF00569127; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hughes TP, 2012, CURR BIOL, V22, P736, DOI 10.1016/j.cub.2012.02.068; Hughes TP, 2000, ECOLOGY, V81, P2250, DOI 10.1890/0012-9658(2000)081[2250:RFLHAL]2.0.CO;2; LEVITAN DR, 1995, TRENDS ECOL EVOL, V10, P228, DOI 10.1016/S0169-5347(00)89071-0; Marshall DJ, 2006, MAR POLLUT BULL, V52, P734, DOI 10.1016/j.marpolbul.2006.05.005; Medina-Rosas P, 2012, INV REP DEV; Morita M, 2010, ZYGOTE, V18, P103, DOI 10.1017/S0967199409990177; Nakamura M, 2012, AQUAT BIOL, V15, P299, DOI 10.3354/ab00436; Nakamura M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014521; Negri AP, 2007, CORAL REEFS, V26, P759, DOI 10.1007/s00338-007-0258-2; Nozawa Y, 2007, MAR BIOL, V152, P1181, DOI 10.1007/s00227-007-0765-2; OLIVER J, 1992, BIOL BULL, V183, P409, DOI 10.2307/1542017; Omori M, 2001, LIMNOL OCEANOGR, V46, P704, DOI 10.4319/lo.2001.46.3.0704; Pandolfi JM, 2011, SCIENCE, V333, P418, DOI 10.1126/science.1204794; Parker LM, 2010, MAR BIOL, V157, P2435, DOI 10.1007/s00227-010-1508-3; Randall CJ, 2009, BIOL BULL-US, V217, P269, DOI 10.1086/BBLv217n3p269; Reuter KE, 2011, GLOBAL CHANGE BIOL, V17, P163, DOI 10.1111/j.1365-2486.2010.02216.x; Ritson-Williams Raphael, 2009, Smithsonian Contributions to the Marine Sciences, P437; Ross PM, 2011, WATER-SUI, V3, P1005, DOI 10.3390/w3041005; Silverman J, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036282; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; van Vuuren DP, 2011, CLIMATIC CHANGE, V109, P95, DOI [10.1007/s10584-011-0157-y, 10.1007/s10584-011-0152-3]; Willis BL, 1997, CORAL REEFS, V16, pS53, DOI 10.1007/s003380050242	45	65	66	0	115	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56468	10.1371/journal.pone.0056468	http://dx.doi.org/10.1371/journal.pone.0056468			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457572	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000315602700074
J	Chen, FF; Bai, J; Li, W; Mei, PJ; Liu, H; Li, LL; Pan, ZQ; Wu, YP; Zheng, JN				Chen, Feifei; Bai, Jin; Li, Wang; Mei, Pengjin; Liu, Hui; Li, Linlin; Pan, Zhenqiang; Wu, Yongping; Zheng, Junnian			RUNX3 Suppresses Migration, Invasion and Angiogenesis of Human Renal Cell Carcinoma	PLOS ONE			English	Article							TRANSFORMING-GROWTH-FACTOR; MATRIX METALLOPROTEINASES; EXPRESSION; GENE; METHYLATION	RUNX3 (runt-related transcription factor-3) is a known tumor suppressor gene which exhibits potent antitumor activity in several carcinomas. However, little is known about the role of RUNX3 in human renal cell carcinoma (RCC). To investigate the clinical relevance of RUNX3 in RCC patients, immunohistochemistry was performed to detect the clinical relevance of RUNX3 in 75 RCC tissues and paired non-cancerous tissues by using tissue microarray (TMA). We also investigated the role of RUNX3 in RCC cell migration, invasion and angiogenesis. The RUNX3 expression was decreased dramatically in human RCC tissue. The RUNX3 expression was significantly correlated with tumor size (P<0.001), depth of invasion (P<0.001), and of TNM stage (P<0.001). Restoration of RUNX3 significantly decreased renal carcinoma cell migration and invasion capacity compared with controls. In addition, we found that overexpression of RUNX3 reduced the proliferation and tube formation of human umbilical vascular endothelial cells (HUVECs). Gelatin zymography and Western blot showed that RUNX3 expression suppressed matrix metalloproteinase-9 (MMP-9) protein level and enzyme activity. Western blot and ELISA showed that RUNX3 restoration inhibited the expression and secretion of vascular endothelial growth factor (VEGF). Taken together, our studies indicate that decreased expression of RUNX3 in human RCC tissue is significantly correlated with RCC progression. Restoration of RUNX3 expression significantly inhibits RCC cells migration, invasion and angiogenesis. These findings provide new insights into the significance of RUNX3 in migration, invasion and angiogenesis of RCC.	[Chen, Feifei; Bai, Jin; Mei, Pengjin; Pan, Zhenqiang; Zheng, Junnian] Xuzhou Med Coll, Jiangsu Key Lab Biol Canc Therapy, Xuzhou, Jiangsu, Peoples R China; [Li, Wang; Mei, Pengjin; Liu, Hui; Li, Linlin; Zheng, Junnian] Xuzhou Med Coll, Affiliated Hosp, Xuzhou, Jiangsu, Peoples R China; [Liu, Hui; Li, Linlin; Wu, Yongping] Xuzhou Med Coll, Sch Pathol, Xuzhou, Jiangsu, Peoples R China; [Pan, Zhenqiang] Mt Sinai Sch Med, Dept Oncol Sci, New York, NY USA	Xuzhou Medical University; Xuzhou Medical University; Xuzhou Medical University; Icahn School of Medicine at Mount Sinai	Wu, YP (corresponding author), Xuzhou Med Coll, Sch Pathol, Xuzhou, Jiangsu, Peoples R China.	WYP@xzmc.edu.cn; jnzheng@xzmc.edu.cn	Liu, Hui/AAJ-4339-2020	Liu, Hui/0000-0002-7669-9386	National Natural Science Foundation of China [81201636]; Science and Technology Department of Jiangsu province [BK2012139]; China Postdoctoral Science Foundation [2012M511323]; Natural Science Foundation for colleges and universities in Jiangsu Province [10KJB320023]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Department of Jiangsu province; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Natural Science Foundation for colleges and universities in Jiangsu Province	This project is supported by grants from the National Natural Science Foundation of China (No. 81201636), the Science and Technology Department of Jiangsu province (No. BK2012139), China Postdoctoral Science Foundation (No. 2012M511323) and Natural Science Foundation for colleges and universities in Jiangsu Province (No. 10KJB320023). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlquist T, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-94; Bae SC, 2004, ONCOGENE, V23, P4336, DOI 10.1038/sj.onc.1207286; BAE SC, 1995, GENE, V159, P245, DOI 10.1016/0378-1119(95)00060-J; Cao Y, 2012, CANCER RES, V72, P3912, DOI 10.1158/0008-5472.CAN-11-4058; Cohen HT, 2005, NEW ENGL J MED, V353, P2477, DOI 10.1056/NEJMra043172; Connolly EC, 2012, INT J BIOL SCI, V8, P964, DOI 10.7150/ijbs.4564; Degue S, 2012, J WOMENS HLTH LARCHM; Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9; Hsu PI, 2009, ANN SURG ONCOL, V16, P1686, DOI 10.1245/s10434-009-0428-2; Kim TY, 2004, LAB INVEST, V84, P479, DOI 10.1038/labinvest.3700060; Lau QC, 2006, CANCER RES, V66, P6512, DOI 10.1158/0008-5472.CAN-06-0369; Li QL, 2002, CELL, V109, P113, DOI 10.1016/S0092-8674(02)00690-6; Lund AH, 2002, CANCER CELL, V1, P213, DOI 10.1016/S1535-6108(02)00049-1; Martin MD, 2007, CANCER METAST REV, V26, P717, DOI 10.1007/s10555-007-9089-4; Mei PJ, 2011, J CANCER RES CLIN, V137, P1823, DOI 10.1007/s00432-011-1063-4; OGAWA E, 1993, P NATL ACAD SCI USA, V90, P6859, DOI 10.1073/pnas.90.14.6859; Peng ZH, 2006, CLIN CANCER RES, V12, P6386, DOI 10.1158/1078-0432.CCR-05-2359; Pennison M, 2007, CURR OPIN ONCOL, V19, P579, DOI 10.1097/CCO.0b013e3282f0ad0e; ROBERTS AB, 1985, P NATL ACAD SCI USA, V82, P119, DOI 10.1073/pnas.82.1.119; Rundhaug JE, 2005, J CELL MOL MED, V9, P267, DOI 10.1111/j.1582-4934.2005.tb00355.x; Sakakura C, 2005, CLIN CANCER RES, V11, P6479, DOI 10.1158/1078-0432.CCR-05-0729; Stephenson CP, 2012, AUST NZ J PSYCHIAT; Subramaniam MM, 2009, BBA-REV CANCER, V1796, P315, DOI 10.1016/j.bbcan.2009.07.004; Volpe A, 2010, WORLD J UROL, V28, P319, DOI 10.1007/s00345-010-0540-8; Zhang ZZ, 2011, CANCER-AM CANCER SOC, V117, P2719, DOI 10.1002/cncr.25838; Zisman A, 2002, J CLIN ONCOL, V20, P4559, DOI 10.1200/JCO.2002.05.111	26	36	38	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56241	10.1371/journal.pone.0056241	http://dx.doi.org/10.1371/journal.pone.0056241			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457532	Green Published, Green Submitted, gold			2022-12-25	WOS:000315602700061
J	Collins, HF; Biedendieck, R; Leech, HK; Gray, M; Escalante-Semerena, JC; McLean, KJ; Munro, AW; Rigby, SEJ; Warren, MJ; Lawrence, AD				Collins, Hannah F.; Biedendieck, Rebekka; Leech, Helen K.; Gray, Michael; Escalante-Semerena, Jorge C.; McLean, Kirsty J.; Munro, Andrew W.; Rigby, Stephen E. J.; Warren, Martin J.; Lawrence, Andrew D.			Bacillus megaterium Has Both a Functional BluB Protein Required for DMB Synthesis and a Related Flavoprotein That Forms a Stable Radical Species	PLOS ONE			English	Article							LOWER LIGAND; COBALAMIN VITAMIN-B-12; BIOSYNTHESIS; IDENTIFICATION; 5,6-DIMETHYLBENZIMIDAZOLE; FLAVIN; DIMETHYLBENZIMIDAZOLE; PURIFICATION; COFACTORS; SEQUENCE	Despite the extensive study of the biosynthesis of the complex molecule B-12 (cobalamin), the mechanism by which the lower ligand 5,6-dimethylbenzimidazole (DMB) is formed has remained something of a mystery. However, recent work has identified and characterized a DMB-synthase (BluB) responsible for the oxygen-dependent, single enzyme conversion of FMN to DMB. In this work, we have identified BluB homologs from the aerobic purple, nonsulfur, photosynthetic bacterium Rhodobacter capsulatus and the aerobic soil bacterium Bacillus megaterium and have demonstrated DMB synthesis by the use of a novel complementation assay in which a B-12 deficient strain, substituted with the precursor cobinamide is recovered either by the addition of DMB or by the recombinant expression of a bluB gene. The DMB-synthetic activity of the purified recombinant BluB enzymes was further confirmed in vitro by providing the enzyme with FMNH2 and oxygen and observing the formation of DMB by HPLC. The formation of a 4a-peroxyflavin intermediate, the first step in the oxygen dependent mechanism of DMB biosynthesis, is reported here and is the first intermediate in the enzyme catalysed reaction to be demonstrated experimentally to date. The identification and characterization of an FMN-binding protein found on the cobl operon of B. megaterium, CbiY, is also detailed, revealing an FMN-containing enzyme which is able to stabilize a blue flavin semiquinone upon reduction with a 1-electron donor.	[Collins, Hannah F.; Leech, Helen K.; Warren, Martin J.; Lawrence, Andrew D.] Univ Kent, Sch Biosci, Canterbury, Kent, England; [Biedendieck, Rebekka] Tech Univ Carolo Wilhelmina Braunschweig, Inst Microbiol, D-38106 Braunschweig, Germany; [Gray, Michael; Escalante-Semerena, Jorge C.] Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA; [McLean, Kirsty J.; Munro, Andrew W.; Rigby, Stephen E. J.] Univ Manchester, Manchester Interdisciplinary Bioctr, Manchester, Lancs, England	University of Kent; Braunschweig University of Technology; University of Wisconsin System; University of Wisconsin Madison; University of Manchester	Warren, MJ (corresponding author), Univ Kent, Sch Biosci, Canterbury, Kent, England.	m.j.warren@kent.ac.uk; a.lawrence-219@kent.ac.uk	McLean, Kirsty J/GXI-2853-2022; Collins, Hannah/GSD-5229-2022; Munro, Andrew/G-5639-2019	Munro, Andrew/0000-0002-4642-180X; Warren, Martin/0000-0002-6028-6456; McLean, Kirsty/0000-0002-7193-5044; Biedendieck, Rebekka/0000-0002-3567-6196; Gray, Michael/0000-0002-7112-4188	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/G014361/1]; BBSRC [BB/G014361/1, BB/E002889/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G014361/1, BB/E002889/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a grant from the Biotechnology and Biological Sciences Research Council (BBSRC) - BB/G014361/1 to MJW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson PJ, 2008, J BACTERIOL, V190, P1160, DOI 10.1128/JB.01386-07; BALCH WE, 1976, APPL ENVIRON MICROB, V32, P781, DOI 10.1128/AEM.32.6.781-791.1976; Banerjee R., 1999, CHEM BIOCH B 12; Campbell GRO, 2006, P NATL ACAD SCI USA, V103, P4634, DOI 10.1073/pnas.0509384103; Daff SN, 1997, BIOCHEMISTRY-US, V36, P13816, DOI 10.1021/bi971085s; Dutton P L, 1978, Methods Enzymol, V54, P411; Ealick SE, 2007, NATURE, V446, P387, DOI 10.1038/446387a; Fan CG, 2008, J BIOL CHEM, V283, P11322, DOI 10.1074/jbc.M800287200; Gray MJ, 2007, P NATL ACAD SCI USA, V104, P2921, DOI 10.1073/pnas.0609270104; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; HOLLRIEGL V, 1982, ARCH MICROBIOL, V132, P155, DOI 10.1007/BF00508722; Kay CWM, 2005, MAGN RESON CHEM, V43, pS96, DOI 10.1002/mrc.1667; Kurreck H, 1988, ELECT NUCL DOUBLE RE, P308; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lawrence AD, 2008, J BIOL CHEM, V283, P10813, DOI 10.1074/jbc.M710431200; Maggio-Hall LA, 2003, ORG LETT, V5, P2211, DOI 10.1021/ol034530m; MASSEY V, 1966, BIOCHEMISTRY-US, V5, P3181, DOI 10.1021/bi00874a016; MAYHEW SG, 1969, J BIOL CHEM, V244, P794; McGoldrick HM, 2005, J BIOL CHEM, V280, P1086, DOI 10.1074/jbc.M411884200; Minot GR, 1926, J AMER MED ASSOC, V87, P470, DOI 10.1001/jama.1926.02680070016005; Munro AW, 2001, BIOCHEMISTRY-US, V40, P1956, DOI 10.1021/bi001718u; Noble MA, 1999, BIOCHEMISTRY-US, V38, P16413, DOI 10.1021/bi992150w; OTOOLE GA, 1994, J BIOL CHEM, V269, P26503; Palmer G., 1971, FLAVINS FLAVOPROTEIN, P123; POLLICH M, 1995, J BACTERIOL, V177, P4481, DOI 10.1128/jb.177.15.4481-4487.1995; Raleigh EA, 1989, CURRENT PROTOCOLS MO, P1; Raux E, 1998, BIOCHEM J, V335, P159, DOI 10.1042/bj3350159; Raux E, 2000, CELL MOL LIFE SCI, V57, P1880, DOI 10.1007/PL00000670; Raux E, 1999, BIOORG CHEM, V27, P100, DOI 10.1006/bioo.1998.1125; Renz P., 1999, Chemistry and biochemistry of B12., P557; RENZ P, 1972, FEBS LETT, V22, P124, DOI 10.1016/0014-5793(72)80236-9; ROOF DM, 1992, J BACTERIOL, V174, P6634, DOI 10.1128/JB.174.20.6634-6643.1992; Sambrook J, 2001, MOL CLONING LAB MANU; Sancho J, 2006, CELL MOL LIFE SCI, V63, P855, DOI 10.1007/s00018-005-5514-4; Schleicher E, 2010, APPL MAGN RESON, V37, P339, DOI 10.1007/s00723-009-0101-8; Schweiger A, 2001, PRINCIPLES PULSE ELE, P360; Taga ME, 2007, NATURE, V446, P449, DOI 10.1038/nature05611; TANG LB, 1990, GENE, V96, P89, DOI 10.1016/0378-1119(90)90345-R; VOGEL HJ, 1956, J BIOL CHEM, V218, P97; Wang XL, 2011, J AM CHEM SOC, V133, P4079, DOI 10.1021/ja1106207; Warren MJ, 2002, NAT PROD REP, V19, P390, DOI 10.1039/B108967F; Wolthers KR, 2003, BIOCHEMISTRY-US, V42, P3911, DOI 10.1021/bi027290b	42	15	15	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e55708	10.1371/journal.pone.0055708	http://dx.doi.org/10.1371/journal.pone.0055708			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457476	Green Published, gold, Green Submitted			2022-12-25	WOS:000315602700020
J	Khan, R; Khan, AQ; Lateef, A; Rehman, MU; Tahir, M; Ali, F; Hamiza, OO; Sultana, S				Khan, Rehan; Khan, Abdul Quaiyoom; Lateef, Abdul; Rehman, Muneeb U.; Tahir, Mir; Ali, Farrah; Hamiza, Oday O.; Sultana, Sarwat			Glycyrrhizic Acid Suppresses the Development of Precancerous Lesions via Regulating the Hyperproliferation, Inflammation, Angiogenesis and Apoptosis in the Colon of Wistar Rats	PLOS ONE			English	Article							ABERRANT CRYPT FOCI; MUCIN-DEPLETED FOCI; K-RAS MUTATIONS; CHRONIC HEPATITIS-C; NF-KAPPA-B; MAST-CELLS; PRENEOPLASTIC LESIONS; PROMYELOTIC LEUKEMIA; OXIDATIVE STRESS; CANCER	Background: Colon carcinogenesis is a multistep process and it emanates from a series of molecular and histopathological alterations. Glycyrrhizic acid (GA) is a natural and major pentacyclic triterpenoid glycoside of licorice roots extracts. It has several pharmacological and biological properties such as anti-inflammatory, anti-viral, and anti-cancer. In the present study, we investigated the chemopreventive potential of GA against 1,2-dimethyhydrazine (DMH)-induced precancerous lesions i.e., aberrant crypt foci (ACF) and mucin depleted foci (MDF), and its role in regulating the hyperproliferation, inflammation, angiogenesis and apoptosis in the colon of Wistar rats. Methods: Animals were divided into 5 groups. In group III, IV and V, GA was administered at the dose of 15 mg/kg b. wt. orally while in group II, III and IV, DMH was administered subcutaneously in the groin at the dose of 20 mg/kg b. wt once a week for first 5 weeks and animals were euthanized after 9 weeks. Results: GA supplementation suppressed the development of precancerous lesions and it also reduced the infiltration of mast cells, suppressed the immunostaining of Ki-67, NF-kB-p65, COX-2, iNOS and VEGF while enhanced the immunostaining of p53, connexin-43, caspase-9 and cleaved caspase-3. GA treatment significantly attenuated the level of TNF-alpha and it also reduced the depletion of the mucous layer as well as attenuated the shifting of sialomucin to sulphomucin. Conclusion: Our findings suggest that GA has strong chemopreventive potential against DMH-induced colon carcinogenesis but further studies are warranted to elucidate the precise mechanism of action of GA.	[Khan, Rehan; Khan, Abdul Quaiyoom; Lateef, Abdul; Rehman, Muneeb U.; Tahir, Mir; Ali, Farrah; Hamiza, Oday O.; Sultana, Sarwat] Jamia Hamdard, Sect Mol Carcinogenesis & Chemoprevent, Dept Med Elementol & Toxicol, New Delhi, India	Jamia Hamdard University	Sultana, S (corresponding author), Jamia Hamdard, Sect Mol Carcinogenesis & Chemoprevent, Dept Med Elementol & Toxicol, New Delhi, India.	sarwat786@rediffmail.com	TAHIR, MIR/AAO-4255-2020; Lateef, Abdul/D-9074-2013; Khan, Rehan/AAR-4803-2020	TAHIR, MIR/0000-0002-7294-3660; Lateef, Abdul/0000-0001-7924-1381; Khan, Rehan/0000-0001-8724-5788; Khan, Rehan/0000-0002-2406-1129; U Rehman, Muneeb/0000-0002-9995-6576	Indian Council of Medical Research, New Delhi, India	Indian Council of Medical Research, New Delhi, India(Indian Council of Medical Research (ICMR))	This work was supported by Indian Council of Medical Research, New Delhi, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGARWAL R, 1991, NUTR CANCER, V15, P187, DOI 10.1080/01635589109514126; Andoh A, 2006, ONCOL REP, V16, P103; Arase Y, 1997, CANCER, V79, P1494, DOI 10.1002/(SICI)1097-0142(19970415)79:8<1494::AID-CNCR8>3.0.CO;2-B; BIRD RP, 1987, CANCER LETT, V37, P147, DOI 10.1016/0304-3835(87)90157-1; BIRD RP, 1995, CANCER LETT, V93, P55, DOI 10.1016/0304-3835(95)03788-X; Caderni G, 2003, CANCER RES, V63, P2388; Cherng JM, 2011, RADIAT RES, V176, P177, DOI 10.1667/RR2510.1; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Curreli F, 2005, J CLIN INVEST, V115, P642, DOI 10.1172/JCI200523334; DAVIS EA, 1991, MOL CELL ENDOCRINOL, V78, P1, DOI 10.1016/0303-7207(91)90179-V; Dimitriadou V, 1997, ANTICANCER RES, V17, P1541; Femia AP, 2008, INT J CANCER, V122, P117, DOI 10.1002/ijc.23065; Femia AP, 2007, INT J CANCER, V120, P2301, DOI 10.1002/ijc.22145; Femia AP, 2007, CANCER RES, V67, P445, DOI 10.1158/0008-5472.CAN-06-3861; Femia AP, 2012, INT J CANCER, V131, P529, DOI 10.1002/ijc.26406; Femia AP, 2009, INT J CANCER, V125, P541, DOI 10.1002/ijc.24417; Femia AP, 2008, CANCER PREV RES, V1, P562, DOI 10.1158/1940-6207.CAPR-08-0125; Femia AP, 2005, INT J CANCER, V116, P9, DOI 10.1002/ijc.20981; FILIPE MI, 1974, CANCER-AM CANCER SOC, V34, P282, DOI 10.1002/1097-0142(197408)34:2<282::AID-CNCR2820340211>3.0.CO;2-W; FILIPE MI, 1975, BRIT J CANCER, V32, P60, DOI 10.1038/bjc.1975.134; Galli SJ, 2005, NAT IMMUNOL, V6, P135, DOI 10.1038/ni1158; Gounaris E, 2007, P NATL ACAD SCI USA, V104, P19977, DOI 10.1073/pnas.0704620104; He SH, 2004, WORLD J GASTROENTERO, V10, P309; Hibasami H, 2006, INT J MOL MED, V17, P215; Hibasami H, 2005, INT J MOL MED, V16, P233; Hirayama C., 1983, ASIAN MED J, V26, P423, DOI DOI 10.1093/JNCI/53.5.1515; Janne PA, 2000, NEW ENGL J MED, V342, P1960, DOI 10.1056/NEJM200006293422606; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; JEN J, 1994, CANCER RES, V54, P5523; Jin SK, 2001, J CELL SCI, V114, P4139; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Khan R, 2012, TOXICOL APPL PHARM, V258, P315, DOI 10.1016/j.taap.2011.11.013; Khan R, 2011, CHEM-BIOL INTERACT, V192, P193, DOI 10.1016/j.cbi.2011.03.009; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Mollica L, 2007, CHEM BIOL, V14, P431, DOI 10.1016/j.chembiol.2007.03.007; Mori H, 2005, CHEM-BIOL INTERACT, V155, P1, DOI 10.1016/j.cbi.2005.04.005; Nakai Y, 2007, CANCER RES, V67, P1378, DOI 10.1158/0008-5472.CAN-06-1336; Nucci MR, 1997, HUM PATHOL, V28, P1396, DOI 10.1016/S0046-8177(97)90230-6; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Okamura N, 2003, BIOL PHARM BULL, V26, P658, DOI 10.1248/bpb.26.658; Orlowski RZ, 2002, TRENDS MOL MED, V8, P385, DOI 10.1016/S1471-4914(02)02375-4; Paulsen JE, 2005, CANCER RES, V65, P121; Paulsen JE, 2001, CANCER RES, V61, P5010; POMPEI R, 1979, NATURE, V281, P689, DOI 10.1038/281689a0; PRETLOW TP, 1991, CANCER RES, V51, P1564; PRETLOW TP, 1993, J NATL CANCER I, V85, P2004, DOI 10.1093/jnci/85.24.2004; PRETLOW TP, 1994, INT J CANCER, V56, P599, DOI 10.1002/ijc.2910560422; RAO BNN, 1994, J BIOL CHEM, V269, P19663; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Robbe C, 2004, BIOCHEM J, V384, P307, DOI 10.1042/BJ20040605; RONCUCCI L, 1991, HUM PATHOL, V22, P287, DOI 10.1016/0046-8177(91)90163-J; Saez JC, 2003, PHYSIOL REV, V83, P1359, DOI 10.1152/physrev.00007.2003; Sakai E, 2012, CANCER SCI, V103, P144, DOI 10.1111/j.1349-7006.2011.02125.x; SANDFORTH F, 1988, EUR J CLIN INVEST, V18, P655, DOI 10.1111/j.1365-2362.1988.tb01283.x; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Shiota G, 1999, CARCINOGENESIS, V20, P59, DOI 10.1093/carcin/20.1.59; Sirnes S, 2012, INT J CANCER, V131, P570, DOI 10.1002/ijc.26392; Siu IM, 1997, AM J PATHOL, V150, P1805; Soucek L, 2007, NAT MED, V13, P1211, DOI 10.1038/nm1649; SPECIAN RD, 1991, AM J PHYSIOL, V260, pC183, DOI 10.1152/ajpcell.1991.260.2.C183; STOPERA SA, 1992, CARCINOGENESIS, V13, P1863, DOI 10.1093/carcin/13.10.1863; STOPERA SA, 1992, CARCINOGENESIS, V13, P573, DOI 10.1093/carcin/13.4.573; STOPERA SA, 1992, CARCINOGENESIS, V13, P2081, DOI 10.1093/carcin/13.11.2081; Takeda S, 1996, J PHARM PHARMACOL, V48, P902, DOI 10.1111/j.2042-7158.1996.tb05998.x; Theoharides TC, 2004, TRENDS IMMUNOL, V25, P235, DOI 10.1016/j.it.2004.02.013; Thirugnanam S, 2008, ONCOL REP, V20, P1387, DOI 10.3892/or_00000157; Van Rossum TGJ, 1999, J GASTROEN HEPATOL, V14, P1093, DOI 10.1046/j.1440-1746.1999.02008.x; VIVONA AA, 1993, CARCINOGENESIS, V14, P1777, DOI 10.1093/carcin/14.9.1777; Wargovich MJ, 2000, CARCINOGENESIS, V21, P1149, DOI 10.1093/carcin/21.6.1149; WARGOVICH MJ, 1983, JNCI-J NATL CANCER I, V71, P125; Wedemeyer J, 2005, LAB INVEST, V85, P388, DOI 10.1038/labinvest.3700232; YASUKAWA K, 1988, YAKUGAKU ZASSHI, V108, P794, DOI 10.1248/yakushi1947.108.8_794; Zhang MZ, 2009, J CLIN INVEST, V119, P876, DOI 10.1172/JCI37398	73	86	93	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56020	10.1371/journal.pone.0056020	http://dx.doi.org/10.1371/journal.pone.0056020			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457494	Green Published, Green Submitted, gold			2022-12-25	WOS:000315602700034
J	Stetz, J; Hunt, K; Kendall, KC; Wasser, SK				Stetz, Jeff; Hunt, Kathleen; Kendall, Katherine C.; Wasser, Samuel K.			Effects of Exposure, Diet, and Thermoregulation on Fecal Glucocorticoid Measures in Wild Bears	PLOS ONE			English	Article							STRESS; EXCRETION; ALBERTA	We examined fecal glucocorticoid (fGC) measures of nutrition and thermoregulatory demands on wild bears in Glacier National Park, Montana, and assessed how these measures changed in samples left in the field. Both ambient temperature and exposure can impact thermoregulation and sample degradation. Bear diets vary markedly with season, affecting body condition and thus fGC. We collected fecal samples during September and October, 2001, when ambient temperatures ranged from 30 degrees C to -5 degrees C. We collected half of each sample immediately and left the other half in its original location for 1-28 days. We used generalized linear models (GLM) to first predict fGC concentrations in fresh samples based on proxies of nutrition, ambient temperature, thermal exposure, and precipitation. These same covariates were then used to predict degradation-based differences in fGC concentrations between the paired sample halves. Variation in fGC was predicted by diet, Julian date, aspect, and the interaction between Julian date and aspect in both fresh and exposed samples. Cumulative precipitation was also a significant predictor of fGC concentrations in the exposed samples, independent of time, indicating that precipitation contributes to sample degradation but not enough to mask effects of other environmental factors on fGC concentrations. Differences between sample halves were only predicted by cumulative precipitation and exposure time; cumulative precipitation decreased, whereas exposure time increased, fGC concentrations in the exposed sample halves. Results indicate that fGC can provide reliable indices of nutrition and thermoregulatory demands in bears and that sample degradation impacts on these relations are minimal and can be virtually eliminated by controlling for cumulative precipitation over the estimated exposure times.	[Stetz, Jeff] Sinopah Wildlife Res Associates, Missoula, MT USA; [Hunt, Kathleen; Wasser, Samuel K.] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Kendall, Katherine C.] US Geol Survey, Northern Rocky Mt Sci Ctr, West Glacier, MT USA	University of Washington; University of Washington Seattle; United States Department of the Interior; United States Geological Survey	Stetz, J (corresponding author), Sinopah Wildlife Res Associates, Missoula, MT USA.	jeff.stetz@gmail.com	Wasser, Samuel K/I-5542-2015		JBS; University of Washington Center for Conservation Biology; University of Montana	JBS; University of Washington Center for Conservation Biology; University of Montana	Field work for this study was primarily funded by JBS, but there were no potential financial gains to any author via this work. The USGS provided office space, IT support, and a field vehicle. All laboratory analyses were supported by the University of Washington Center for Conservation Biology. Additional lab support was provided by the University of Montana. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayres KL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036842; Burnham KP, 2002, MULTIMODEL INFERENCE; Correa-Calderon A, 2004, INT J BIOMETEOROL, V48, P142, DOI 10.1007/s00484-003-0194-y; Foley CAH, 2001, CONSERV BIOL, V15, P1134, DOI 10.1046/j.1523-1739.2001.0150041134.x; Gobush KS, 2008, CONSERV BIOL, V22, P1590, DOI 10.1111/j.1523-1739.2008.01035.x; GOLDIN BR, 1981, CANCER RES, V41, P3771; GOLDIN BR, 1982, NEW ENGL J MED, V307, P1542, DOI 10.1056/NEJM198212163072502; Hayward LS, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00199.1; Hunt KE, 2003, PHYSIOL BIOCHEM ZOOL, V76, P918, DOI 10.1086/380209; Kitaysky AS, 2005, HORM BEHAV, V47, P606, DOI 10.1016/j.yhbeh.2005.01.005; MATTSON DJ, 1991, CAN J ZOOL, V69, P1619, DOI 10.1139/z91-226; MCLELLAN BN, 1995, CAN J ZOOL, V73, P704, DOI 10.1139/z95-082; Millspaugh JJ, 2001, WILDLIFE SOC B, V29, P899; PRITCHARD GT, 1990, CAN J ZOOL, V68, P1645, DOI 10.1139/z90-244; Stage AR, 2007, FOREST SCI, V53, P486; von der Ohe CG, 2004, PHYSIOL BIOCHEM ZOOL, V77, P313, DOI 10.1086/378139; Washburn BE, 2002, GEN COMP ENDOCR, V127, P217, DOI 10.1016/S0016-6480(02)00056-4; Wasser SK, 2011, FRONT ECOL ENVIRON, V9, P546, DOI 10.1890/100071; WASSER SK, 1988, BIOL REPROD, V39, P862, DOI 10.1095/biolreprod39.4.862; Wasser SK, 1997, CONSERV BIOL, V11, P1019, DOI 10.1046/j.1523-1739.1997.96240.x; Wasser SK, 2004, CAN J ZOOL, V82, P475, DOI 10.1139/Z04-020; Wasser SK, 2000, GEN COMP ENDOCR, V120, P260, DOI 10.1006/gcen.2000.7557; Wasser SK, 1996, BIOL REPROD, V55, P393, DOI 10.1095/biolreprod55.2.393; WASSER SK, 1993, J REPROD FERTIL, V97, P569, DOI 10.1530/jrf.0.0970569; WERNER R, 1985, J COMP PHYSIOL B, V155, P219, DOI 10.1007/BF00685216; Wingfield J.C., 2001, HANDBK PHYSL, P211, DOI [10.1002/cphy.cp070411, DOI 10.1002/CPHY.CP070411]	26	27	27	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e55967	10.1371/journal.pone.0055967	http://dx.doi.org/10.1371/journal.pone.0055967			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457488	Green Submitted, Green Published, gold			2022-12-25	WOS:000315602700028
J	Franceschini, M; Rampello, A; Agosti, M; Massucci, M; Bovolenta, F; Sale, P				Franceschini, Marco; Rampello, Anais; Agosti, Maurizio; Massucci, Maurizio; Bovolenta, Federica; Sale, Patrizio			Walking Performance: Correlation between Energy Cost of Walking and Walking Participation. New Statistical Approach Concerning Outcome Measurement	PLOS ONE			English	Article							COMMUNITY AMBULATION; STROKE PATIENTS; LEVEL WALKING; OLDER-ADULTS; GAIT; REHABILITATION; POPULATION; PARAMETERS; MOBILITY; INJURY	Walking ability, though important for quality of life and participation in social and economic activities, can be adversely affected by neurological disorders, such as Spinal Cord Injury, Stroke, Multiple Sclerosis or Traumatic Brain Injury. The aim of this study is to evaluate if the energy cost of walking (CW), in a mixed group of chronic patients with neurological diseases almost 6 months after discharge from rehabilitation wards, can predict the walking performance and any walking restriction on community activities, as indicated by Walking Handicap Scale categories (WHS). One hundred and seven subjects were included in the study, 31 suffering from Stroke, 26 from Spinal Cord Injury and 50 from Multiple Sclerosis. The multivariable binary logistical regression analysis has produced a statistical model with good characteristics of fit and good predictability. This model generated a cut-off value of. 40, which enabled us to classify correctly the cases with a percentage of 85.0%. Our research reveal that, in our subjects, CW is the only predictor of the walking performance of in the community, to be compared with the score of WHS. We have been also identifying a cut-off value of CW cost, which makes a distinction between those who can walk in the community and those who cannot do it. In particular, these values could be used to predict the ability to walk in the community when discharged from the rehabilitation units, and to adjust the rehabilitative treatment to improve the performance.	[Franceschini, Marco; Sale, Patrizio] IRCCS San Raffale, Dept NeuroRehabilitat, Rome, Italy; [Rampello, Anais; Agosti, Maurizio] Univ Hosp, Dept Rehabil, Parma, Italy; [Massucci, Maurizio] Hosp Passignano, Rehabil Unit, Perugia, Italy; [Bovolenta, Federica] Med Rehabil NOCSAE Hosp AUSL Modena, Modena, Italy	University of Parma; University Hospital of Parma	Sale, P (corresponding author), IRCCS San Raffale, Dept NeuroRehabilitat, Rome, Italy.	patrizio.sale@gmail.com	Sale, Patrizio/J-3276-2019; Sale, Patrizio/K-8757-2016	Sale, Patrizio/0000-0002-4850-3673; Sale, Patrizio/0000-0002-4850-3673; Agosti, Maurizio/0000-0003-2365-3488; Franceschini, Marco/0000-0002-2131-1583				BAMBER D, 1975, J MATH PSYCHOL, V12, P387, DOI 10.1016/0022-2496(75)90001-2; Barbeau H, 2001, CURR OPIN NEUROL, V14, P735, DOI 10.1097/00019052-200112000-00009; Bernardi M, 1999, J ELECTROMYOGR KINES, V9, P149, DOI 10.1016/S1050-6411(98)00046-7; Blessey R L, 1976, Phys Ther, V56, P1019; Bregman DJJ, 2010, PROSTHET ORTHOT INT, V34, P293, DOI 10.3109/03093646.2010.495969; Corrigan R, 2008, DISABIL REHABIL, V30, P1079, DOI 10.1080/09638280701623158; Cunha IT, 2002, AM J PHYS MED REHAB, V81, P848, DOI 10.1097/00002060-200211000-00008; Delextrat A, 2011, HUM MOVEMENT SCI, V30, P115, DOI 10.1016/j.humov.2010.10.004; Duffy CM, 1997, DEV MED CHILD NEUROL, V39, P234; Eriksson JS, 2012, EUR J APPL PHYSIOL, V112, P345, DOI 10.1007/s00421-011-1985-1; Finlayson ML, 2010, PHYS MED REH CLIN N, V21, P357, DOI 10.1016/j.pmr.2009.12.003; Franceschini M, 2003, CLIN REHABIL, V17, P368, DOI 10.1191/0269215503cr622oa; Ijzerman MJ, 2002, ARCH PHYS MED REHAB, V83, P1777, DOI 10.1053/apmr.2002.35655; Kelly JO, 2003, ARCH PHYS MED REHAB, V84, P1780, DOI 10.1016/S0003-9993(03)00376-9; Lapointe R, 2001, SPINAL CORD, V39, P327, DOI 10.1038/sj.sc.3101167; Lord SE, 2004, ARCH PHYS MED REHAB, V85, P234, DOI 10.1016/j.apmr.2003.05.002; Maclean N, 2000, SOC SCI MED, V50, P495; Mayo NE, 2002, ARCH PHYS MED REHAB, V83, P1035, DOI 10.1053/apmr.2002.33984; Mudge S, 2009, ARCH PHYS MED REHAB, V90, P296, DOI 10.1016/j.apmr.2008.07.025; Pang MYC, 2007, PHYS THER, V87, P282, DOI 10.2522/ptj.20060142; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; PERRY J, 1995, STROKE, V26, P982, DOI 10.1161/01.STR.26.6.982; Peyrot N, 2009, J APPL PHYSIOL, V106, P1763, DOI 10.1152/japplphysiol.91240.2008; Rosdahl H, 2010, EUR J APPL PHYSIOL, V109, P159, DOI 10.1007/s00421-009-1326-9; SCHAFER H, 1989, STAT MED, V8, P1381, DOI 10.1002/sim.4780081110; Shumway-Cook A, 2002, PHYS THER, V82, P670, DOI 10.1093/ptj/82.7.670; Snook EM, 2009, NEUROREHAB NEURAL RE, V23, P108, DOI 10.1177/1545968308320641; van de Port IG, 2008, J REHABIL MED, V40, P23, DOI 10.2340/16501977-0114; van Hedel HJA, 2010, RESTOR NEUROL NEUROS, V28, P123, DOI 10.3233/RNN-2010-0508; WATERS R L, 1983, Journal of Orthopaedic Research, V1, P73, DOI 10.1002/jor.1100010110; WATERS RL, 1994, ARCH PHYS MED REHAB, V75, P756; Wevers L, 2009, STROKE, V40, P2450, DOI 10.1161/STROKEAHA.108.541946; World Health Organization/Regional Office for Europe. Vienna Declaration on Nutrition and Noncommunicable Diseases in the Context of Health, 2013, EUR MIN C NUTR NONC, P5, DOI [10.1136/bmj.f4417, DOI 10.1136/BMJ.F4417]; YOUDEN W. J., 1950, CANCER, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3; Zamparo P., 1995, Scandinavian Journal of Medicine and Science in Sports, V5, P348; Zamparo P, 1998, SCAND J MED SCI SPOR, V8, P222; ZWEIG MH, 1993, CLIN CHEM, V39, P561	37	42	42	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e56669	10.1371/journal.pone.0056669	http://dx.doi.org/10.1371/journal.pone.0056669			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23468871	Green Published, Green Submitted, gold			2022-12-25	WOS:000315524900030
J	Stella, EJ; Franceschelli, JJ; Tasselli, SE; Morbidoni, HR				Stella, Emma J.; Franceschelli, Jorgelina J.; Tasselli, Sabrina E.; Morbidoni, Hector R.			Analysis of Novel Mycobacteriophages Indicates the Existence of Different Strategies for Phage Inheritance in Mycobacteria	PLOS ONE			English	Article							COMPARATIVE GENOMIC ANALYSIS; DRUG-RESISTANT TUBERCULOSIS; LINEAR PLASMID-PROPHAGE; BOVIS BCG; DNA; DETERMINANTS; CONSTRUCTION; ACQUISITION; MUTAGENESIS; VIRULENCE	Mycobacteriophages have been essential in the development of mycobacterial genetics through their use in the construction of tools for genetic manipulation. Due to the simplicity of their isolation and variety of exploitable molecular features, we searched for and isolated 18 novel mycobacteriophages from environmental samples collected from several geographic locations. Characterization of these phages did not differ from most of the previously described ones in the predominant physical features (virion size in the 100-400 nm, genome size in the 50-70 kbp, morphological features compatible with those corresponding to the Siphoviridae family), however novel characteristics for propagation were noticed. Although all the mycobacteriophages propagated at 30 degrees C, eight of them failed to propagate at 37 degrees C. Since some of our phages yielded pinpoint plaques, we improved plaque detection by including sub-inhibitory concentrations of isoniazid or ampicillin-sulbactam in the culture medium. Thus, searches for novel mycobacteriophages at low temperature and in the presence of these drugs would allow for the isolation of novel members that would otherwise not be detected. Importantly, while eight phages lysogenized Mycobacterium smegmatis, four of them were also capable of lysogenizing Mycobacterium tuberculosis. Analysis of the complete genome sequence obtained for twelve mycobacteriophages (the remaining six rendered partial genomic sequences) allowed for the identification of a new singleton. Surprisingly, sequence analysis revealed the presence of parA or parA/parB genes in 7/18 phages including four that behaved as temperate in M. tuberculosis. In summary, we report here the isolation and preliminary characterization of mycobacteriophages that bring new information to the field.	[Stella, Emma J.; Franceschelli, Jorgelina J.; Tasselli, Sabrina E.; Morbidoni, Hector R.] Univ Nacl Rosario, Fac Ciencias Med, Catedra Microbiol, RA-2000 Rosario, Argentina	National University of Rosario	Morbidoni, HR (corresponding author), Univ Nacl Rosario, Fac Ciencias Med, Catedra Microbiol, RA-2000 Rosario, Argentina.	morbiatny@yahoo.com			National Agency for Science and Technology Promotion (ANPCyT), Argentina [PICT 02337]; Bill and Melinda Gates Foundation [OPP1045751]	National Agency for Science and Technology Promotion (ANPCyT), Argentina(ANPCyT); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This work was supported by grants (PICT 02337) from the National Agency for Science and Technology Promotion (ANPCyT), Argentina, and the Bill and Melinda Gates Foundation (662 Grnad Challenges Explorations Grant OPP1045751). HRM is a career member of Consejo de Investigaciones de la Universidad Nacional de Rosario (CIUNR), EJS and JJF are Fellows of Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET), Argentina. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bardarov S, 2002, MICROBIOL-SGM, V148, P3007, DOI 10.1099/00221287-148-10-3007; Bardarov S, 1997, P NATL ACAD SCI USA, V94, P10961, DOI 10.1073/pnas.94.20.10961; Bignell C, 2001, J BIOTECHNOL, V91, P1, DOI 10.1016/S0168-1656(01)00293-0; Bourhy P, 2005, J BACTERIOL, V187, P3931, DOI 10.1128/JB.187.12.3931-3940.2005; Braunstein M, 2002, METHOD ENZYMOL, V358, P67; Brussow H, 2004, MICROBIOL MOL BIOL R, V68, P560, DOI 10.1128/MMBR.68.3.560-602.2004; Casart Y, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-51; Casjens Sherwood R., 2009, V502, P91, DOI 10.1007/978-1-60327-565-1_7; Casjens SR, 2004, J BACTERIOL, V186, P1818, DOI 10.1128/JB.186.6.1818-1832.2004; Cresawn SG, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-395; ENGEL HWB, 1978, ANN INST PASTEUR MIC, VA129, P75; Fullner KJ, 1997, MOL MICROBIOL, V26, P755, DOI 10.1046/j.1365-2958.1997.6111984.x; Gao LY, 2003, INFECT IMMUN, V71, P922, DOI 10.1128/IAI.71.2.922-929.2003; Gerdes K, 2000, MOL MICROBIOL, V37, P455, DOI 10.1046/j.1365-2958.2000.01975.x; Glickman MS, 2000, MOL CELL, V5, P717, DOI 10.1016/S1097-2765(00)80250-6; Grigoriev PS, 2001, MOL MICROBIOL, V42, P355, DOI 10.1046/j.1365-2958.2001.02632.x; GUILHOT C, 1994, J BACTERIOL, V176, P535, DOI 10.1128/JB.176.2.535-539.1994; Hatfull GF, 2008, RES MICROBIOL, V159, P332, DOI 10.1016/j.resmic.2008.04.008; Hatfull GF, 2006, PLOS GENET, V2, P835, DOI 10.1371/journal.pgen.0020092; Hatfull GF, 2012, ADV VIRUS RES, V82, P179, DOI 10.1016/B978-0-12-394621-8.00015-7; Hatfull GF, 2012, J VIROL, V86, P2382, DOI 10.1128/JVI.06870-11; Hatfull GF, 2010, ANNU REV MICROBIOL, V64, P331, DOI 10.1146/annurev.micro.112408.134233; Hatfull GF, 2010, J MOL BIOL, V397, P119, DOI 10.1016/j.jmb.2010.01.011; Hsu T, 2003, P NATL ACAD SCI USA, V100, P12420, DOI 10.1073/pnas.1635213100; Huff J, 2010, GENE, V468, P8, DOI 10.1016/j.gene.2010.07.012; Jacobs-Sera D, 2012, VIROLOGY; JONES WD, 1982, AM REV RESPIR DIS, V125, P640; JONES WD, 1988, TUBERCLE, V69, P43, DOI 10.1016/0041-3879(88)90039-6; Lee S, 2004, FEMS MICROBIOL LETT, V241, P271, DOI 10.1016/j.femsle.2004.10.032; Leonard TA, 2005, PHILOS T R SOC B, V360, P523, DOI 10.1098/rstb.2004.1608; Los JM, 2008, APPL ENVIRON MICROB, V74, P5113, DOI 10.1128/AEM.00306-08; LUDTKE DN, 1989, J MOL BIOL, V209, P393, DOI 10.1016/0022-2836(89)90005-3; Morris P, 2008, J BACTERIOL, V190, P2172, DOI 10.1128/JB.01657-07; MOTALLEBIVESHAREH M, 1990, MOL MICROBIOL, V4, P1455, DOI 10.1111/j.1365-2958.1990.tb02056.x; Parish T, 2001, TUBERCULOSIS, V81, P359, DOI 10.1054/tube.2001.0312; Payne K, 2009, MOL MICROBIOL, V73, P367, DOI 10.1111/j.1365-2958.2009.06775.x; Payne KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034052; Pedulla ML, 2003, CELL, V113, P171, DOI 10.1016/S0092-8674(03)00233-2; Pham TT, 2007, MICROBIOL-SGM, V153, P2711, DOI 10.1099/mic.0.2007/008904-0; Pope WH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016329; Raviglione MC, 2008, NEW ENGL J MED, V359, P636, DOI 10.1056/NEJMe0804906; Raviglione MC, 2007, NEW ENGL J MED, V356, P656, DOI 10.1056/NEJMp068273; Raviglione MC, 2006, INT J TUBERC LUNG D, V10, P238; Ravin NV, 2011, PLASMID, V65, P102, DOI 10.1016/j.plasmid.2010.12.004; Rybniker J, 2006, J MED MICROBIOL, V55, P37, DOI 10.1099/jmm.0.46238-0; Saint Girons I, 2000, J BACTERIOL, V182, P5700, DOI 10.1128/JB.182.20.5700-5705.2000; Sambandamurthy VK, 2002, NAT MED, V8, P1171, DOI 10.1038/nm765; Sampson T, 2009, MICROBIOL-SGM, V155, P2962, DOI 10.1099/mic.0.030486-0; SARKIS GJ, 1995, MOL MICROBIOL, V15, P1055, DOI 10.1111/j.1365-2958.1995.tb02281.x; Schumacher MA, 2007, CURR OPIN STRUC BIOL, V17, P103, DOI 10.1016/j.sbi.2006.11.005; Smartt AE, 2011, ANAL BIOANAL CHEM, V400, P991, DOI 10.1007/s00216-010-4561-3; van Kessel Julia C., 2008, V435, P203, DOI 10.1007/978-1-59745-232-8_15; van Kessel JC, 2008, NAT REV MICROBIOL, V6, P851, DOI 10.1038/nrmicro2014; van Kessel JC, 2008, MOL MICROBIOL, V67, P1094, DOI 10.1111/j.1365-2958.2008.06109.x; van Kessel JC, 2007, NAT METHODS, V4, P147, DOI 10.1038/nmeth996; Vilcheze C, 2000, J BACTERIOL, V182, P4059, DOI 10.1128/JB.182.14.4059-4067.2000; Vilcheze C, 2006, NAT MED, V12, P1027, DOI 10.1038/nm1466; Zumla A, 2012, J INFECT DIS, V205, pS228, DOI 10.1093/infdis/jir858	58	19	19	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e56384	10.1371/journal.pone.0056384	http://dx.doi.org/10.1371/journal.pone.0056384			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23468864	gold, Green Published, Green Submitted			2022-12-25	WOS:000315524900024
J	Villacorta-Atienza, JA; Makarov, VA				Antonio Villacorta-Atienza, Jose; Makarov, Valeri A.			Wave-Processing of Long-Scale Information by Neuronal Chains	PLOS ONE			English	Article							FIELD POTENTIALS; BRAIN; PROPAGATION; OSCILLATIONS; COLLISIONS; SOLITONS	Investigation of mechanisms of information handling in neural assemblies involved in computational and cognitive tasks is a challenging problem. Synergetic cooperation of neurons in time domain, through synchronization of firing of multiple spatially distant neurons, has been widely spread as the main paradigm. Complementary, the brain may also employ information coding and processing in spatial dimension. Then, the result of computation depends also on the spatial distribution of long-scale information. The latter bi-dimensional alternative is notably less explored in the literature. Here, we propose and theoretically illustrate a concept of spatiotemporal representation and processing of long-scale information in laminar neural structures. We argue that relevant information may be hidden in self-sustained traveling waves of neuronal activity and then their nonlinear interaction yields efficient wave- processing of spatiotemporal information. Using as a testbed a chain of FitzHugh-Nagumo neurons, we show that the wave-processing can be achieved by incorporating into the single-neuron dynamics an additional voltage-gated membrane current. This local mechanism provides a chain of such neurons with new emergent network properties. In particular, nonlinear waves as a carrier of long-scale information exhibit a variety of functionally different regimes of interaction: from complete or asymmetric annihilation to transparent crossing. Thus neuronal chains can work as computational units performing different operations over spatiotemporal information. Exploiting complexity resonance these composite units can discard stimuli of too high or too low frequencies, while selectively compress those in the natural frequency range. We also show how neuronal chains can contextually interpret raw wave information. The same stimulus can be processed differently or identically according to the context set by a periodic wave train injected at the opposite end of the chain.	[Antonio Villacorta-Atienza, Jose; Makarov, Valeri A.] Univ Complutense, Fac Ciencias Matemat, Dept Appl Math, E-28040 Madrid, Spain	Complutense University of Madrid	Makarov, VA (corresponding author), Univ Complutense, Fac Ciencias Matemat, Dept Appl Math, E-28040 Madrid, Spain.	vmakarov@mat.ucm.es	Makarov, Valeri/AAF-4790-2019; Makarov, Valeri A/L-5031-2014; Villacorta-Atienza, José/L-1621-2017	Makarov, Valeri/0000-0001-8789-7532; Makarov, Valeri A/0000-0001-8789-7532; Villacorta-Atienza, José/0000-0002-9220-1226	Spanish Ministry of Science and Innovation [FIS2010-20054]; Russian Ministry of Education and Science [14.B37.21.1237]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Russian Ministry of Education and Science(Ministry of Education and Science, Russian Federation)	This work has been supported by the Spanish Ministry of Science and Innovation (project FIS2010-20054) and by the Russian Ministry of Education and Science (contract14.B37.21.1237). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcon G, 1997, BRAIN, V120, P2259, DOI 10.1093/brain/120.12.2259; Villacorta-Atienza JA, 2010, BIOL CYBERN, V103, P285, DOI 10.1007/s00422-010-0398-2; Argentina M, 2000, J THEOR BIOL, V205, P47, DOI 10.1006/jtbi.2000.2044; Aslanidi OV, 1999, J BIOL PHYS, V25, P149, DOI 10.1023/A:1005119218136; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Dahlem MA, 1997, EXP BRAIN RES, V115, P319, DOI 10.1007/PL00005700; Ermakova EA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004454; Fernandez-Ruiz A, 2012, J NEUROSCI, V32, P5165, DOI 10.1523/JNEUROSCI.4499-11.2012; Fuster J M, 2003, CORTEX MIND UNIFYING; Gollo LL, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000402; Grun S, 2010, SPR SER COMPUT NEURO, V7, P1, DOI 10.1007/978-1-4419-5675-0; Hasselmo ME, 1999, TRENDS COGN SCI, V3, P351, DOI 10.1016/S1364-6613(99)01365-0; Hausser M, 2000, SCIENCE, V290, P739, DOI 10.1126/science.290.5492.739; Koch Christof, 1999, P1; KOSEK J, 1995, PHYS REV LETT, V74, P2134, DOI 10.1103/PhysRevLett.74.2134; Kwaku KF, 1996, CIRC RES, V79, P957, DOI 10.1161/01.RES.79.5.957; Llinas R, 1998, PHILOS T ROY SOC B, V353, P1841, DOI 10.1098/rstb.1998.0336; Lu Y, 2011, NEURAL COMPUT, V23, P1248, DOI 10.1162/NECO_a_00111; Makarov V.A., 2011, RECURRENT NEURAL NET; Makarov VA, 2001, INT J BIFURCAT CHAOS, V11, P109, DOI 10.1142/S0218127401001931; Makarov VA, 2010, J COMPUT NEUROSCI, V29, P445, DOI 10.1007/s10827-009-0206-y; Makarov Valeri A, 2010, Comput Intell Neurosci, P340541, DOI 10.1155/2010/340541; Makarova J, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00077; Makarova J, 2010, J NEUROPHYSIOL, V103, P2446, DOI 10.1152/jn.01045.2009; Murray J. D., 2002, MATH BIOL, V2; NEKORKIN VI, 1995, PHYS REV LETT, V74, P4819, DOI 10.1103/PhysRevLett.74.4819; Northoff G, 2006, NEUROIMAGE, V31, P440, DOI 10.1016/j.neuroimage.2005.12.002; Nunez PL, 2006, CLIN NEUROPHYSIOL, V117, P2424, DOI 10.1016/j.clinph.2006.06.754; Pulvermuller F, 2005, NAT REV NEUROSCI, V6, P576, DOI 10.1038/nrn1706; Rieke F., 1999, SPIKES EXPLORING NEU; ROTERMUND HH, 1991, PHYS REV LETT, V66, P3083, DOI 10.1103/PhysRevLett.66.3083; Royer AS, 2007, VISUAL NEUROSCI, V24, P619, DOI 10.1017/S0952523807070617; SantiagoRosanne M, 1997, J COLLOID INTERF SCI, V191, P65, DOI 10.1006/jcis.1997.4956; SINGER W, 1995, ANNU REV NEUROSCI, V18, P555, DOI 10.1146/annurev.ne.18.030195.003011; Steuer R, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.061911; Tsyganov MA, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.031901; Tsyganov MA, 2004, PHYSICA D, V197, P18, DOI 10.1016/j.phsyd.2004.06.004; TUCKWELL HC, 1981, INT J NEUROSCI, V12, P95, DOI 10.3109/00207458108985794; TUCKWELL HC, 1979, SCIENCE, V205, P493, DOI 10.1126/science.205.4405.493; VanRullen R, 2005, TRENDS NEUROSCI, V28, P1, DOI 10.1016/j.tins.2004.10.010; Wu JY, 2008, NEUROSCIENTIST, V14, P487, DOI 10.1177/1073858408317066; Wu JY, 1999, J NEUROSCI, V19, P5005; Wu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038402; Zochowski MR, 2005, J NEUROPHYSIOL, V94, P2667, DOI 10.1152/jn.00328.2005	44	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57440	10.1371/journal.pone.0057440	http://dx.doi.org/10.1371/journal.pone.0057440			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460856	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000315519000110
J	Caldwell, N; Srebotnjak, T; Wang, T; Hsia, R				Caldwell, Nolan; Srebotnjak, Tanja; Wang, Tiffany; Hsia, Renee			"How Much Will I get Charged for This?" Patient Charges for Top Ten Diagnoses in the Emergency Department	PLOS ONE			English	Article							HEALTH-CARE; VISITS	Objectives: We examined the charges, their variability, and respective payer group for diagnosis and treatment of the ten most common outpatient conditions presenting to the Emergency department (ED). Methods: We conducted a cross-sectional study of the 2006-2008 Medical Expenditure Panel Survey. Analysis was limited to outpatient visits with non-elderly, adult (years 18-64) patients with a single discharge diagnosis. Results: We studied 8,303 ED encounters, representing 76.6 million visits. Median charges ranged from $740 (95% CI $651-$817) for an upper respiratory infection to $3437 (95% CI $2917-$3877) for a kidney stone. The median charge for all ten outpatient conditions in the ED was $1233 (95% CI $1199-$1268), with a high degree of charge variability. All diagnoses had an interquartile range (IQR) greater than $800 with 60% of IQRs greater than $1550. Conclusion: Emergency department charges for common conditions are expensive with high charge variability. Greater acute care charge transparency will at least allow patients and providers to be aware of the emergency department charges patients may face in the current health care system.	[Caldwell, Nolan] Stanford Univ, Dept Emergency Med, Stanford, CA 94305 USA; [Srebotnjak, Tanja] Inst Ecol, San Mateo, CA USA; [Wang, Tiffany] Univ Minnesota, Sch Med, St Paul, MN USA; [Hsia, Renee] Univ Calif San Francisco, Dept Emergency Med, San Francisco, CA 94143 USA	Stanford University; University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California San Francisco	Hsia, R (corresponding author), Univ Calif San Francisco, Dept Emergency Med, San Francisco, CA 94143 USA.	Renee.hsia@emergency.ucsf.edu			National Institutes of Health (NIH)/National Center for Research Resources (NCRR) University of California San Francisco-Clinical and Translational Science Institute (UCSF-CTSI) [UL1 RR024131 01]; Robert Wood Johnson Foundation Physician Faculty Scholars; UCSF Center for Healthcare Value; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024131] Funding Source: NIH RePORTER	National Institutes of Health (NIH)/National Center for Research Resources (NCRR) University of California San Francisco-Clinical and Translational Science Institute (UCSF-CTSI); Robert Wood Johnson Foundation Physician Faculty Scholars; UCSF Center for Healthcare Value; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This project is funded by National Institutes of Health (NIH)/National Center for Research Resources (NCRR) University of California San Francisco-Clinical and Translational Science Institute (UCSF-CTSI) Grant Number UL1 RR024131 01 (RYH), the Robert Wood Johnson Foundation Physician Faculty Scholars (RYH), and a grant from the UCSF Center for Healthcare Value (RYH). No other authors have funding sources to disclose. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACS, 2011, MED MONTHL HOUS COST; AHRQ, 2011, EM ROOM SERV MEAN ME; Alderman L, 2010, NY TIMES; Allan GM, 2008, INT J TECHNOL ASSESS, V24, P158, DOI 10.1017/S0266462308080227; Cohen S, 1999, 5 AHRQ; Cunningham P. J., 2008, FALLING AM ACCESS ME, V19; Emerman E, 2010, WATSON WYATT IDENTIF; GAO, 2003, HOSP PREP MOST URB H, P1; Himmelstein DU, 2009, AM J MED, V122, P741, DOI 10.1016/j.amjmed.2009.04.012; Hsia RY, 2008, ANN EMERG MED, V51, P265, DOI 10.1016/j.annemergmed.2007.08.009; Hsu J, 2004, MED CARE, V42, P290, DOI 10.1097/01.mlr.0000114917.50457.52; Innes G, 2000, CJEM, V2, P95; Lagnado L, 2004, WALL STREET J; Machlin S, 2010, 24 AHRQ; Massachusetts Division of Health Care Finance and Policy, 2011, MASS HLTH CAR COST T; McCarron S, 2011, LATEST HEALTHCARE TR; National Center for Health Statistics, 2006, HLTH US 2006 CHARTB; Porter ME, 2004, HARVARD BUS REV, V82, P64; Reinhardt UE, 2006, HEALTH AFFAIR, V25, P57, DOI 10.1377/hlthaff.25.1.57; Richmond R, 2011, WALL STREET J; Robinson JC, 2008, HEALTH AFFAIR, V27, P1353, DOI 10.1377/hlthaff.27.5.1353; Sinaiko AD, 2011, NEW ENGL J MED, V364, P891, DOI 10.1056/NEJMp1100041; Stagnitti MN, 2008, DESIGN METHODS FIELD; Tang N, 2010, JAMA-J AM MED ASSOC, V304, P664, DOI 10.1001/jama.2010.1112; Truffer CJ, 2010, HEALTH AFFAIR, V29, P522, DOI 10.1377/hlthaff.2009.1074; Waldman P, 2010, WHY BABY COSTS LESS; Wielawski I, 2000, HEALTH AFFAIR, V19, P180, DOI 10.1377/hlthaff.19.5.180	27	79	79	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e55491	10.1371/journal.pone.0055491	http://dx.doi.org/10.1371/journal.pone.0055491			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	098BN	23460786	gold, Green Published, Green Submitted			2022-12-25	WOS:000315519000009
J	Vetrovsky, T; Baldrian, P				Vetrovsky, Tomas; Baldrian, Petr			The Variability of the 16S rRNA Gene in Bacterial Genomes and Its Consequences for Bacterial Community Analyses	PLOS ONE			English	Article							OPERON COPY NUMBER; MICROBIAL COMMUNITIES; MOLECULAR MARKERS; DISTINCT TYPES; DIVERSITY; PROTEIN	16S ribosomal RNA currently represents the most important target of study in bacterial ecology. Its use for the description of bacterial diversity is, however, limited by the presence of variable copy numbers in bacterial genomes and sequence variation within closely related taxa or within a genome. Here we use the information from sequenced bacterial genomes to explore the variability of 16S rRNA sequences and copy numbers at various taxonomic levels and apply it to estimate bacterial genome and DNA abundances. In total, 7,081 16S rRNA sequences were in silico extracted from 1,690 available bacterial genomes (1-15 per genome). While there are several phyla containing low 16S rRNA copy numbers, in certain taxa, e. g., the Firmicutes and Gammaproteobacteria, the variation is large. Genome sizes are more conserved at all tested taxonomic levels than 16S rRNA copy numbers. Only a minority of bacterial genomes harbors identical 16S rRNA gene copies, and sequence diversity increases with increasing copy numbers. While certain taxa harbor dissimilar 16S rRNA genes, others contain sequences common to multiple species. Sequence identity clusters (often termed operational taxonomic units) thus provide an imperfect representation of bacterial taxa of a certain phylogenetic rank. We have demonstrated that the information on 16S rRNA copy numbers and genome sizes of genome-sequenced bacteria may be used as an estimate for the closest related taxon in an environmental dataset to calculate alternative estimates of the relative abundance of individual bacterial taxa in environmental samples. Using an example from forest soil, this procedure would increase the abundance estimates of Acidobacteria and decrease these of Firmicutes. Using the currently available information, alternative estimates of bacterial community composition may be obtained in this way if the variation of 16S rRNA copy numbers among bacteria is considered.	[Vetrovsky, Tomas; Baldrian, Petr] Acad Sci Czech Republ, Inst Microbiol, Lab Environm Microbiol, Prague, Czech Republic	Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences	Baldrian, P (corresponding author), Acad Sci Czech Republ, Inst Microbiol, Lab Environm Microbiol, Prague, Czech Republic.	baldrian@biomed.cas.cz	Vetrovsky, Tomas/R-5817-2017; Baldrian, Petr/A-9170-2009	Baldrian, Petr/0000-0002-8983-2721	Ministry of Education, Youth and Sports of the Czech Republic [LD12048, LD12050]; research concept of the Institute of Microbiology of the Academy of Sciences of the Czech Republic [RVO61388971]	Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); research concept of the Institute of Microbiology of the Academy of Sciences of the Czech Republic	This work was supported by the Ministry of Education, Youth and Sports of the Czech Republic (LD12048, LD12050) and by the research concept of the Institute of Microbiology of the Academy of Sciences of the Czech Republic (RVO61388971). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acinas SG, 2004, J BACTERIOL, V186, P2629, DOI 10.1128/JB.186.9.2629-2635.2004; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amend AS, 2010, MOL ECOL, V19, P5555, DOI 10.1111/j.1365-294X.2010.04898.x; Baldrian P, 2013, FUNGAL ECOL, V6, P1, DOI 10.1016/j.funeco.2012.10.002; Baldrian P, 2012, ISME J, V6, P248, DOI 10.1038/ismej.2011.95; Bresler V, 2003, MAR BIOL, V143, P17, DOI 10.1007/s00227-003-1055-2; Candela M, 2004, LETT APPL MICROBIOL, V38, P229, DOI 10.1111/j.1472-765X.2003.01475.x; Case RJ, 2007, APPL ENVIRON MICROB, V73, P278, DOI 10.1128/AEM.01177-06; Dahllof I, 2000, APPL ENVIRON MICROB, V66, P3376, DOI 10.1128/AEM.66.8.3376-3380.2000; Daubin V, 2003, SCIENCE, V301, P829, DOI 10.1126/science.1086568; Dowd SE, 2008, BMC MICROBIOL, V8, DOI [10.1186/1471-2180-8-125, 10.1186/1471-2180-8-43]; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Eichorst SA, 2007, APPL ENVIRON MICROB, V73, P2708, DOI 10.1128/AEM.02140-06; FARRELLY V, 1995, APPL ENVIRON MICROB, V61, P2798, DOI 10.1128/AEM.61.7.2798-2801.1995; FOX GE, 1992, INT J SYST BACTERIOL, V42, P166, DOI 10.1099/00207713-42-1-166; Hashimoto JQ, 2003, J BACTERIOL, V185, P966, DOI 10.1128/JB.185.3.966-972.2003; Head IM, 1998, MICROB ECOL, V35, P1, DOI 10.1007/s002489900056; Hugenholtz P, 1998, J BACTERIOL, V180, P4765, DOI 10.1128/JB.180.18.4765-4774.1998; Klappenbach JA, 2000, APPL ENVIRON MICROB, V66, P1328, DOI 10.1128/AEM.66.4.1328-1333.2000; Klappenbach JA, 2001, NUCLEIC ACIDS RES, V29, P181, DOI 10.1093/nar/29.1.181; Konstantinidis KT, 2006, APPL ENVIRON MICROB, V72, P7286, DOI 10.1128/AEM.01398-06; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Lee CM, 2008, FEMS MICROBIOL LETT, V287, P136, DOI 10.1111/j.1574-6968.2008.01305.x; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Ohtani N, 2010, J BACTERIOL, V192, P5499, DOI 10.1128/JB.00662-10; Pei AY, 2010, APPL ENVIRON MICROB, V76, P3886, DOI 10.1128/AEM.02953-09; Reeder J, 2010, NAT METHODS, V7, P668, DOI 10.1038/nmeth0910-668b; Roux S, 2011, FEMS MICROBIOL ECOL, V78, P617, DOI 10.1111/j.1574-6941.2011.01190.x; Santos SR, 2004, ENVIRON MICROBIOL, V6, P754, DOI 10.1111/j.1462-2920.2004.00617.x; Schellenberg J, 2011, METHODS MOL BIOL, V733, P143, DOI 10.1007/978-1-61779-089-8_10; STACKEBRANDT E, 1994, INT J SYST BACTERIOL, V44, P846, DOI 10.1099/00207713-44-4-846; Sukenik A, 2012, ISME J, V6, P670, DOI 10.1038/ismej.2011.128; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; von Mering C, 2007, SCIENCE, V315, P1126, DOI 10.1126/science.1133420; Vos M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030600; Wang Y, 1997, J BACTERIOL, V179, P3270, DOI 10.1128/jb.179.10.3270-3276.1997; Yap WH, 1999, J BACTERIOL, V181, P5201, DOI 10.1128/JB.181.17.5201-5209.1999	37	604	652	14	192	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57923	10.1371/journal.pone.0057923	http://dx.doi.org/10.1371/journal.pone.0057923			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460914	Green Submitted, Green Published, gold			2022-12-25	WOS:000315519000169
J	Zhang, CH; Awasthi, N; Schwarz, MA; Hinz, S; Schwarz, RE				Zhang, Changhua; Awasthi, Niranjan; Schwarz, Margaret A.; Hinz, Stefan; Schwarz, Roderich E.			Superior Antitumor Activity of Nanoparticle Albumin-Bound Paclitaxel in Experimental Gastric Cancer	PLOS ONE			English	Article							PHASE-III TRIAL; 1ST-LINE THERAPY; NAB-PACLITAXEL; BOLUS 5-FLUOROURACIL; PLUS; OXALIPLATIN; COMBINATION; STATHMIN; CAPECITABINE; FLUOROURACIL	Gastric cancer is the second common cause of cancer related death worldwide and lacks highly effective treatment for advanced disease. Nab-paclitaxel is a novel microtubule-inhibitory cytotoxic agent that has not been tested in gastric cancer as of yet. In this study, human gastric cancer cell lines AGS, NCI-N87 and SNU16 were studied. Nab-paclitaxel inhibited cell proliferation with an IC50 of 5 nM in SNU16, 23 nM in AGS and 49 nM in NCI-N87 cells after 72-hour treatment, which was lower than that of oxaliplatin (1.05 mu M to 1.51 mu M) and epirubicin (0.12 mu M to 0.25 mu M). Nab-paclitaxel treatment increased expression of the mitotic-spindle associated phospho-stathmin irrespective of the baseline total or phosphorylated stathmin level, and induced mitotic cell death as confirmed through increased expression of cleaved-PARP and caspase-3. After a two-week nab-paclitaxel, oxaliplatin or epirubicin treatment, the average in vivo local tumor growth inhibition rate was 77, 17.2 and 21.4 percent, respectively (p = 0.002). Effects of therapy on tumoral proliferative and apoptotic indices corresponded with tumor growth inhibition data, while expression of phospho-stathmin also increased in tissues. There was an increase in median animal survival after nab-paclitaxel treatment (93 days) compared to controls (31 days, p = 0.0007), oxaliplatin (40 days, p = 0.0007) or to docetaxel therapy (81 days, p = 0.0416). The strong antitumor activity of nab-paclitaxel in experimental gastric cancer supports such microtubule-inhibitory strategy for clinical application. Nab-paclitaxel benefits were observed independent from phosphorylated stathmin expression at baseline, putting into question the consideration of nab-paclitaxel use in gastric cancer based on this putative biomarker.	[Zhang, Changhua; Awasthi, Niranjan; Hinz, Stefan; Schwarz, Roderich E.] Univ Texas SW Med Ctr Dallas, Dept Surg, Div Surg Oncol, Dallas, TX 75390 USA; [Zhang, Changhua; Awasthi, Niranjan; Hinz, Stefan; Schwarz, Roderich E.] Univ Texas SW Med Ctr Dallas, Hamon Ctr Therapeut Oncol Res, Simmons Comprehens Canc Ctr, Dallas, TX 75390 USA; [Zhang, Changhua] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Gastrointestinopancreat Surg, Guangzhou 510275, Guangdong, Peoples R China; [Schwarz, Margaret A.] Univ Texas SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Sun Yat Sen University; University of Texas System; University of Texas Southwestern Medical Center Dallas	Schwarz, RE (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Surg, Div Surg Oncol, Dallas, TX 75390 USA.	Roderich.Schwarz@utsouthwestern.edu		Hinz, Stefan/0000-0003-3184-2983				Al-Batran SE, 2008, J CLIN ONCOL, V26, P1435, DOI 10.1200/JCO.2007.13.9378; Andersen SSL, 1997, NATURE, V389, P640, DOI 10.1038/39382; [Anonymous], J GASTRIC CANC, V12, P3; Awasthi N, 2012, MOL CANCER THER, V11, P2644, DOI 10.1158/1535-7163.MCT-12-0447; Awasthi N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038477; Awasthi N, 2009, LAB INVEST, V89, P38, DOI 10.1038/labinvest.2008.106; Belletti B, 2011, EXPERT OPIN THER TAR, V15, P1249, DOI 10.1517/14728222.2011.620951; Boku N, 2009, LANCET ONCOL, V10, P1063, DOI 10.1016/S1470-2045(09)70259-1; Choi YH, 2012, CANC CHEMOTHER PHARM; Coleman RL, 2011, GYNECOL ONCOL, V122, P111, DOI 10.1016/j.ygyno.2011.03.036; Crown J, 2004, ONCOLOGIST, V9, P24, DOI 10.1634/theoncologist.9-suppl_2-24; De Vita F, 2005, BRIT J CANCER, V92, P1644, DOI 10.1038/sj.bjc.6602573; De Vita F, 2012, EXPERT OPIN THER TAR, V16, pS29, DOI 10.1517/14728222.2011.652616; Elsadek B, 2012, J CONTROL RELEASE, V157, P4, DOI 10.1016/j.jconrel.2011.09.069; Gradishar WJ, 2006, EXPERT OPIN PHARMACO, V7, P1041, DOI 10.1517/14656566.7.8.1041; Gradishar WJ, 2005, J CLIN ONCOL, V23, P7794, DOI 10.1200/JCO.2005.04.937; Gradishar WJ, 2012, CLIN BREAST CANC; Hofheinz RD, 2009, INT J RADIAT ONCOL, V73, P142, DOI 10.1016/j.ijrobp.2008.04.033; Hou HL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035665; Huang HC, 2009, CANCER CELL, V16, P347, DOI 10.1016/j.ccr.2009.08.020; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jeon TY, 2010, BRIT J CANCER, V102, P710, DOI 10.1038/sj.bjc.6605537; Kang W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033919; Kobunai T, 2011, ANTICANCER RES, V31, P3691; Kottschade LA, 2011, CANCER-AM CANCER SOC, V117, P1704, DOI 10.1002/cncr.25659; Li XD, 2011, WORLD J GASTROENTERO, V17, P1082, DOI 10.3748/wjg.v17.i8.1082; Mansilla S, 2006, CELL CYCLE, V5, P53, DOI 10.4161/cc.5.1.2267; Matsubara J, 2008, JPN J CLIN ONCOL, V38, P540, DOI 10.1093/jjco/hyn062; Matsubara J, 2011, ONCOLOGY-BASEL, V81, P291, DOI 10.1159/000334462; Mistry SJ, 2007, MOL CANCER RES, V5, P773, DOI 10.1158/1541-7786.MCR-06-0290; Ohtsu A, 2011, J CLIN ONCOL, V29, P3968, DOI 10.1200/JCO.2011.36.2236; PYRHONEN S, 1995, BRIT J CANCER, V71, P587, DOI 10.1038/bjc.1995.114; Rao S, 2010, ANN ONCOL, V21, P2213, DOI 10.1093/annonc/mdq247; Risinger AL, 2009, CANCER TREAT REV, V35, P255, DOI 10.1016/j.ctrv.2008.11.001; ROWINSKY EK, 1990, JNCI-J NATL CANCER I, V82, P1247, DOI 10.1093/jnci/82.15.1247; Schwarz RE, 2002, ANN SURG ONCOL, V9, P394, DOI 10.1007/BF02573875; Schwarz RE, 2007, ANN SURG ONCOL, V14, P317, DOI 10.1245/s10434-006-9218-2; Socinski MA, 2012, J CLIN ONCOL, V30, P2055, DOI 10.1200/JCO.2011.39.5848; Stanton RA, 2011, MED RES REV, V31, P443, DOI 10.1002/med.20242; Vakifahmetoglu H, 2008, CELL DEATH DIFFER, V15, P1153, DOI 10.1038/cdd.2008.47; Volk LD, 2011, NEOPLASIA, V13, P327, DOI 10.1593/neo.101490; Von Hoff DD, 2011, J CLIN ONCOL, V29, P4548, DOI 10.1200/JCO.2011.36.5742; Wacheck V, 2001, J MOL MED-JMM, V79, P587, DOI 10.1007/s001090100251; Wosnitzer MS, 2011, J UROLOGY, V186, P2094, DOI 10.1016/j.juro.2011.06.051; Zhang C, 2012, J SURG RES; Zhang CH, 2007, ANN SURG ONCOL, V14, P1312, DOI 10.1245/s10434-006-9190-x; Zhao PX, 2012, CHEMMEDCHEM, V7, P952, DOI 10.1002/cmdc.201200052; Zhou QA, 2011, INT J ONCOL, V38, P721, DOI 10.3892/ijo.2011.902	48	20	21	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e58037	10.1371/journal.pone.0058037	http://dx.doi.org/10.1371/journal.pone.0058037			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460921	Green Published, Green Submitted, gold			2022-12-25	WOS:000315519000176
J	Nkenfou, CN; Nana, CT; Payne, VK				Nkenfou, Celine Nguefeu; Nana, Christelle Tafou; Payne, Vincent Khan			Intestinal Parasitic Infections in HIV Infected and Non-Infected Patients in a Low HIV Prevalence Region, West-Cameroon	PLOS ONE			English	Article								The magnitude of intestinal parasitic infection in acquired immunodeficiency syndrome patients requires careful consideration in the developing world where poor nutrition is associated with poor hygiene and several tropical diseases. However, there have been very few studies addressing this issue in Cameroon. This study was conducted to determine the prevalence of intestinal parasitosis in HIV/AIDS patients in Dschang -Cameroon. Stool and blood specimens from HIV/AIDS patients and control group were screened respectively for intestinal parasites and for HIV antibodies. Intestinal parasites were identified using direct microscopy, formalin-ether concentration and Ziehl Neelsen methods. Out of 396 participants recruited among patients consulting at hospital, 42 (10.6%) were HIV positive, thirty of them treatment naive. The overall prevalence of intestinal parasites was 14.64%. Out of 42 HIV/AIDS patients, 59.5% (25/42) were infected with intestinal parasites, while only 9.32% (33/354) of the HIV negative patients were infected with intestinal parasites. The parasites detected in our study population included Crystosporidium parvum (2.53%), Entamoeba histolytica (7.52%), Entamoeba coli (4.04%), Giardia lamblia (0.25%), Trichuris trichura (0.25%), Strongyloides stercoralis (0.25%) and Taenia spp. (0.25%). In the HIV infected group, Crystosporidium parvum (19.04%), Entamoeba histolytica (19.04%), Entamoeba coli (21.42%), Giardia lamblia (2.38%), Strongyloides stercoralis (0.25%) and Taenia spp. (0.25%) were found. Crystosporidium parvum was found to be significantly higher in HIV/AIDS patients than in controls (P<0.05). Multivariate analysis showed that the HIV status and the quality of water were the major risk factors for intestinal parasitosis. Routine examinations of stool samples for parasites would significantly benefit the HIV patients by contributing in reducing morbidity and improving the efficiency of antiretroviral treatment. Even after the introduction of free anti-retroviral drugs, opportunistic intestinal infections are still a threat. HIV patients should be screened routinely for intestinal parasites and treated for their overall well being.	[Nkenfou, Celine Nguefeu] Chantal Biya Int Reference Ctr Res HIV AIDS Preve, Lab Syst Biol, Yaounde, Cameroon; [Nkenfou, Celine Nguefeu] Univ Yaounde I, Higher Teacher Training Coll, Dept Biol Sci, Yaounde, Cameroon; [Nana, Christelle Tafou; Payne, Vincent Khan] Univ Dschang, Dept Anim Biol, Fac Sci, Dschang, Cameroon	University of Yaounde I	Nkenfou, CN (corresponding author), Chantal Biya Int Reference Ctr Res HIV AIDS Preve, Lab Syst Biol, Yaounde, Cameroon.	nkenfou@yahoo.com			"Chantal Biya'' International Reference Centre for Research on HIV/AIDS Prevention and Management (CBIRC); University of Dschang	"Chantal Biya'' International Reference Centre for Research on HIV/AIDS Prevention and Management (CBIRC); University of Dschang	The "Chantal Biya'' International Reference Centre for Research on HIV/AIDS Prevention and Management (CBIRC) and University of Dschang provided funding to support this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamu H, 2009, ETHIOP J HEALTH DEV, V23, P133; Alyoune M, 1991, MED MAGHREB, V25, P5; Babatunde SK, 2010, ANN AFR MED, V9, P123, DOI 10.4103/1596-3519.68356; Barbot L., 2001, Annales Pharmaceutiques Francaises, V59, P305; Collins CH, 1989, MICROBIOLOGICAL METH, P93; Corbett EL, 2002, LANCET, V359, P2177, DOI 10.1016/S0140-6736(02)09095-5; Da Silva CV, 2005, SCAND J INFECT DIS, V37, P211, DOI 10.1080/00365540410020875; Ekejindu IM, 2010, WORLD J MED SCI, V5, P71; Fincham JE, 2003, ACTA TROP, V86, P315, DOI 10.1016/S0001-706X(03)00063-9; Garcia L. S., 2001, DIAGNOSTIC MED PARAS, P723; HENRIKSEN SA, 1981, ACTA VET SCAND, V22, P594; Ilboudo D., 1997, Medecine d'Afrique Noire, V44, P69; Konate A, 2005, Bull Soc Pathol Exot, V98, P33; Lehman LG, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-S1-P48; OMS, 1987, INT MAL TROP INF VIH; ONUSIDA, 2005, POINT SIDA; Oumar AA, 2008, DOUVAIN MED, V127, P12; Sarfati C, 2006, AM J TROP MED HYG, V74, P162, DOI 10.4269/ajtmh.2006.74.162; Tian Li-Guang, 2012, Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi, V24, P168; Tian LG, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-36; Veas F, 1991, CAHIERS SANTE, V1, P189; Wiwanitkit V, 2001, BMC Gastroenterol, V1, P3, DOI 10.1186/1471-230X-1-3; Wumba R, 2007, Med Trop (Mars), V67, P145	23	45	48	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57914	10.1371/journal.pone.0057914	http://dx.doi.org/10.1371/journal.pone.0057914			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451283	gold, Green Submitted, Green Published			2022-12-25	WOS:000316849500145
J	Nguyen, DB; Do, NT; Shiraishi, RW; Le, YN; Tran, QH; Nguyen, HH; Medland, N; Nguyen, LT; Struminger, BB				Duc Bui Nguyen; Nhan Thi Do; Shiraishi, Ray W.; Yen Ngoc Le; Quang Hong Tran; Hai Huu Nguyen; Medland, Nicholas; Long Thanh Nguyen; Struminger, Bruce Baird			Outcomes of Antiretroviral Therapy in Vietnam: Results from a National Evaluation	PLOS ONE			English	Article							INJECTION-DRUG USERS; FOLLOW-UP; TREATMENT PROGRAM; PATIENTS LOST; SCALE-UP; MULTIPLE IMPUTATION; MISSING VALUES; SOUTH-AFRICA; RISK-FACTORS; HIV	Objectives: Vietnam has significantly scaled up its national antiretroviral therapy (ART) program since 2005. With the aim of improving Vietnam's national ART program, we conducted an outcome evaluation of the first five years of the program in this concentrated HIV epidemic where the majority of persons enrolled in HIV care and treatment services are people who inject drugs (PWID). The results of this evaluation may have relevance for other national ART programs with significant PWID populations. Design: Retrospective cohort analysis of patients at 30 clinics randomly selected with probability proportional to size among 120 clinics with at least 50 patients on ART. Methods: Charts of patients whose ART initiation was at least 6 months prior to the study date were abstracted. Depending on clinic size, either all charts or a random sample of 300 charts were selected. Analyses were limited to treatment-naive patients. Multiple imputations were used for missing data. Results: Of 7,587 patient charts sampled, 6,875 were those of treatment-naive patients (74.4% male, 95% confidence interval [CI]: 72.4-76.5, median age 30, interquartile range [IQR]: 26-34, 62.0% reported a history of intravenous drug use, CI: 58.6-65.3). Median baseline CD4 cell count was 78 cells/mm 3 (IQR: 30-162) and 30.4% (CI: 25.8-35.1) of patients were at WHO stage IV. The majority of patients started d4T/3TC/NVP (74.3%) or d4T/3TC/EFV (18.6%). Retention rates after 6, 12, 24, and 36 months were 88.4% (CI: 86.8-89.9), 84.0% (CI: 81.8-86.0), 78.8% (CI: 75.7-81.6), and 74.6% (CI: 69.6-79.0). Median CD4 cell count gains after 6, 12, 24, and 36 months were 94 (IQR: 45-153), 142 (IQR: 78-217), 213 (IQR: 120-329), and 254 (IQR: 135-391) cells/mm(3). Patients who were PWID showed significantly poorer retention. Conclusions: The study showed good retention and immunological response to ART among a predominantly PWID group of patients despite advanced HIV infections at baseline.	[Duc Bui Nguyen; Yen Ngoc Le; Medland, Nicholas; Struminger, Bruce Baird] US Ctr Dis Control & Prevent, Hanoi, Vietnam; [Nhan Thi Do; Hai Huu Nguyen; Long Thanh Nguyen] Vietnam Adm HIV AIDS Control, Minist Hlth, Hanoi, Vietnam; [Shiraishi, Ray W.] Ctr Dis Control & Prevent, Div Global HIV AIDS, Ctr Global Hlth, Atlanta, GA USA; [Quang Hong Tran] Hanoi Sch Publ Hlth, Hanoi, Vietnam	Centers for Disease Control & Prevention - USA; Hanoi University of Public Health	Nguyen, DB (corresponding author), US Ctr Dis Control & Prevent, Hanoi, Vietnam.	vif8@cdc.gov		Medland, Nicholas Andrew/0000-0003-0403-8930; Shiraishi, Ray/0000-0001-7640-0666	Emory AIDS International Training and Research Program [NIH/FIC D43 TW01042]; United States's President's Emergency Plan for AIDS Relief (PEPFAR) through the U.S. Centers for Disease Control and Prevention [1U2GPS000747]; FOGARTY INTERNATIONAL CENTER [D43TW001042] Funding Source: NIH RePORTER	Emory AIDS International Training and Research Program; United States's President's Emergency Plan for AIDS Relief (PEPFAR) through the U.S. Centers for Disease Control and Prevention; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This evaluation was supported by the United States's President's Emergency Plan for AIDS Relief (PEPFAR) through the U.S. Centers for Disease Control and Prevention under the terms of 1U2GPS000747. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank the data collection and entry team, as well as the clinic staff whose generous assistance made this survey possible. We would also like to thank the staff from the provincial Departments of Health and AIDS Control Centers where we collected data. We thank Dr. Mitchell Wolfe and Mr. Raymond Ransom from U.S. CDC for their contributions to the protocol development, and we thank Dr. Michelle McConnell, Dr. Anh Van Ho and Patrick Nadol from CDC Vietnam office for their valuable contributions to the study and the manuscript. We thank Dr. Stefan Wiktor and Dr. Andrew Baughman of CDC's Division of Global HIV/AIDS, and Timothy Dondero of CDC's National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention for their scientific reviews. We thank Dr. Michael Iademarco from U.S. CDC for his review of the manuscript. The team also acknowledges general support from the VAAC and U.S. CDC Vietnam office. Dr. Duc Bui Nguyen received training support from the Emory AIDS International Training and Research Program (NIH/FIC D43 TW01042).	Auld AF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018453; Boulle A, 2010, AIDS, V24, P563, DOI 10.1097/QAD.0b013e328333bfb7; Brinkhof MWG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005790; Chasombat S, 2009, JAIDS-J ACQ IMM DEF, V50, P506, DOI 10.1097/QAI.0b013e3181967602; Dalal RP, 2008, JAIDS-J ACQ IMM DEF, V47, P101, DOI 10.1097/QAI.0b013e31815b833a; Dronda F, 2004, AIDS, V18, P2210, DOI 10.1097/00002030-200411050-00018; Etard JF, 2006, AIDS, V20, P1181, DOI 10.1097/01.aids.0000226959.87471.01; Geng EH, 2010, JAIDS-J ACQ IMM DEF, V53, P405, DOI 10.1097/QAI.0b013e3181b843f0; Grigoryan A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004445; Lowrance DW, 2009, JAIDS-J ACQ IMM DEF, V52, P49, DOI 10.1097/QAI.0b013e3181b03316; Malta M, 2009, JAIDS-J ACQ IMM DEF, V52, P629, DOI 10.1097/QAI.0b013e3181b31b8a; May M, 2010, LANCET, V376, P449, DOI 10.1016/S0140-6736(10)60666-6; Ministry of Health, 2009, NAT GUID DIAGN TREAT; Ministry of Health, 2008, HIV SENT SURV; Moh R, 2007, AIDS, V21, P2483, DOI 10.1097/QAD.0b013e3282f09876; Mojumdar K, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-416; Moore RD, 2004, JAIDS-J ACQ IMM DEF, V35, P46, DOI 10.1097/00126334-200401010-00006; Morris John D, 2007, AIDS Res Ther, V4, P12, DOI 10.1186/1742-6405-4-12; Muga R, 2007, AIDS, V21, P2521, DOI 10.1097/QAD.0b013e3282f1c933; National Committee for Aids Drugs Control and Prostitution Prevention UNAIDS, 2012, VIET NAM AIDS RESP P; Nguyen Duc, 2011, 10 INT C AIDS AS PAC; Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298; Royston P, 2005, STATA J, V5, P188, DOI 10.1177/1536867X0500500204; Royston P, 2005, STATA J, V5, P527, DOI 10.1177/1536867X0500500404; Royston P, 2004, STATA J, V4, P227, DOI 10.1177/1536867X0400400301; Royston P, 2009, STATA J, V9, P252, DOI 10.1177/1536867X0900900205; Rubin DB, 2004, MULTIPLE IMPUTATION; Severe P, 2005, NEW ENGL J MED, V353, P2325, DOI 10.1056/NEJMoa051908; Solomon SS, 2008, INDIAN J MED RES, V127, P447; Solomon SS, 2008, JAIDS-J ACQ IMM DEF, V49, P327, DOI 10.1097/QAI.0b013e3181831e85; Stringer JSA, 2006, JAMA-J AM MED ASSOC, V296, P782, DOI 10.1001/jama.296.7.782; Vietnam Administration of HIV/AIDS Control, 2012, VIETN HIV AIDS EST P; White IR, 2009, STAT MED, V28, P1982, DOI 10.1002/sim.3618; Wolfe D, 2010, LANCET, V376, P355, DOI 10.1016/S0140-6736(10)60832-X; Wood E, 2008, HIV MED, V9, P503, DOI 10.1111/j.1468-1293.2008.00582.x; Yu JKL, 2007, B WORLD HEALTH ORGAN, V85, P550, DOI 10.2471/BLT.06.037739; Zachariah R, 2006, AIDS, V20, P2355, DOI 10.1097/QAD.0b013e32801086b0; Zhang FJ, 2009, ANN INTERN MED, V151, P241, DOI 10.7326/0003-4819-151-4-200908180-00006	38	57	57	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e55750	10.1371/journal.pone.0055750	http://dx.doi.org/10.1371/journal.pone.0055750			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457477	Green Published, Green Submitted, gold			2022-12-25	WOS:000315603700017
J	Kristensen, SL; Ahlehoff, O; Lindhardsen, J; Erichsen, R; Jensen, GV; Torp-Pedersen, C; Nielsen, OH; Gislason, GH; Hansen, PR				Kristensen, Soren Lund; Ahlehoff, Ole; Lindhardsen, Jesper; Erichsen, Rune; Jensen, Gunnar Vagn; Torp-Pedersen, Christian; Nielsen, Ole Haagen; Gislason, Gunnar Hilmar; Hansen, Peter Riis			Disease Activity in Inflammatory Bowel Disease Is Associated with Increased Risk of Myocardial Infarction, Stroke and Cardiovascular Death - A Danish Nationwide Cohort Study	PLOS ONE			English	Article							VENOUS THROMBOEMBOLISM; RHEUMATOID-ARTHRITIS; ATRIAL-FIBRILLATION; ULCERATIVE-COLITIS; ISCHEMIC-STROKE; CROHNS-DISEASE; MORTALITY; ATHEROSCLEROSIS; MECHANISMS; THROMBOSIS	Purpose: Chronic inflammatory diseases have been linked to increased risk of atherothrombotic events, but the risk associated with inflammatory bowel disease (IBD) is unclear. We therefore examined the risk of myocardial infarction (MI), stroke, and cardiovascular death in patients with IBD. Methods: In a nationwide Danish population-based setting, a cohort of patients with incident IBD between 1996 and 2009 were identified in national registers. Hospitalizations with IBD as primary diagnosis, initiation of biological treatment and dispensed prescriptions of corticosteroids were all used as surrogate markers for disease activity, with flares classified as the first 120 days after diagnosis of IBD, and 120 days after a new corticosteroid prescription, biological treatment or IBD hospitalization, respectively. Continued corticosteroid prescriptions or IBD hospitalizations were defined as persistent activity, and periods free of such events were defined as remissions. Poisson regression was used to examine risk of MI, stroke, and cardiovascular death using a matched population-based comparison cohort as reference Results: We identified 20,795 IBD patients with a mean age of 40.3 years that were matched according to age and sex with 199,978 controls. During the study period, there were 365 patients with MI, 454 with stroke, and 778 with cardiovascular death. Patients with IBD had an overall increased risk of MI (rate ratio [RR] 1.17 [95% confidence interval 1.05-1.31]), stroke (RR 1.15 [1.04-1.27], and cardiovascular death (RR 1.35 [1.25-1.45]). During flares and persistent IBD activity the RRs of MI increased to 1.49 (1.16-1.93) and 2.05 (1.58-2.65), the RRs of stroke to 1.53 (1.22-1.92) and 1.55 (1.18-2.04) and for cardiovascular death 2.32 (2.01-2.68) and 2.50 (2.14-2.92). In remission periods, the risk of MI, stroke and cardiovascular death was similar to controls. Conclusion: Inflammatory bowel disease is associated with increased risk of MI, stroke, and cardiovascular death during periods with active disease.	[Kristensen, Soren Lund; Ahlehoff, Ole; Lindhardsen, Jesper; Torp-Pedersen, Christian; Gislason, Gunnar Hilmar; Hansen, Peter Riis] Univ Copenhagen, Dept Cardiol, Gentofte Hosp, Hellerup, Denmark; [Kristensen, Soren Lund; Ahlehoff, Ole; Jensen, Gunnar Vagn] Univ Copenhagen, Dept Cardiol, Hosp Roskilde, Roskilde, Denmark; [Erichsen, Rune] Aarhus Univ Hosp, Dept Clin Epidemiol, Aarhus, Denmark; [Nielsen, Ole Haagen] Univ Copenhagen, Herlev Hosp, Dept Gastroenterol, DK-2730 Herlev, Denmark	University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; Aarhus University; University of Copenhagen; Herlev & Gentofte Hospital	Kristensen, SL (corresponding author), Univ Copenhagen, Dept Cardiol, Gentofte Hosp, Hellerup, Denmark.	slk@heart.dk	Hansen, Peter Riis/AAR-7659-2020; Gislason, Gunnar/B-7561-2009; Torp-Pedersen, Christian/E-5931-2013; Nielsen, Ole Haagen/AAK-2482-2021; Kristensen, Søren Lund/J-5267-2019	Gislason, Gunnar/0000-0002-0548-402X; Nielsen, Ole Haagen/0000-0003-4612-8635; Kristensen, Søren Lund/0000-0002-9759-7397; Erichsen, Rune/0000-0001-9398-9185; Hansen, Peter Riis/0000-0002-9056-535X	Department of Cardiology, Copenhagen University Hospital Gentofte, Denmark [DK-2900]; Department of Cardiology, Copenhagen University Roskilde, Denmark [DK-4000]	Department of Cardiology, Copenhagen University Hospital Gentofte, Denmark; Department of Cardiology, Copenhagen University Roskilde, Denmark	The study was supported by Department of Cardiology, Copenhagen University Hospital Gentofte, DK-2900, and Department of Cardiology, Copenhagen University Roskilde, DK-4000, Denmark. SL Kristensen has received donations from the foundations of Eva and Henry Frankel and Snedkermester Sophus Jacobsen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ageno W, 2008, THROMB HAEMOSTASIS, V100, P181, DOI 10.1160/TH08-06-0360; Ahlehoff O, 2011, J INTERN MED, V270, P147, DOI 10.1111/j.1365-2796.2010.02310.x; Ahlehoff O, 2012, EUR HEART J, V33, P2054, DOI 10.1093/eurheartj/ehr285; Andersohn F, 2010, INFLAMM BOWEL DIS, V16, P1387, DOI 10.1002/ibd.21187; Baumgart DC, 2007, LANCET, V369, P1627, DOI 10.1016/S0140-6736(07)60750-8; Bernstein CN, 2008, CLIN GASTROENTEROL H, V6, P41, DOI 10.1016/j.cgh.2007.09.016; Dagli N, 2010, ANGIOLOGY, V61, P198, DOI 10.1177/0003319709333869; Dorn SD, 2007, AM J GASTROENTEROL, V102, P662, DOI 10.1111/j.1572-0241.2006.01018.x; Fonager K, 1996, SCAND J GASTROENTERO, V31, P154, DOI 10.3109/00365529609031980; Gaist D, 1997, DAN MED BULL, V44, P445; Gandhi S, 2012, AM J MED; Grainge MJ, 2010, LANCET, V375, P657, DOI 10.1016/S0140-6736(09)61963-2; Gresele P, 2010, THROMB HAEMOSTASIS, V103, P56, DOI 10.1160/TH09-08-0562; Ha C, 2009, AM J GASTROENTEROL, V104, P1445, DOI 10.1038/ajg.2009.81; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Irving PM, 2005, CLIN GASTROENTEROL H, V3, P617, DOI 10.1016/S1542-3565(05)00154-0; Kappelman MD, 2011, GUT, V60, P937, DOI 10.1136/gut.2010.228585; Kaptoge S, 2010, LANCET, V375, P132, DOI 10.1016/S0140-6736(09)61717-7; Kildemoes HW, 2011, SCAND J PUBLIC HEALT, V39, P38, DOI 10.1177/1403494810394717; Krarup LH, 2007, NEUROEPIDEMIOLOGY, V28, P150, DOI 10.1159/000102143; Libby P, 2009, J AM COLL CARDIOL, V54, P2129, DOI 10.1016/j.jacc.2009.09.009; Liuzzo G, 2001, Rays, V26, P221; Loftus EV, 2004, GASTROENTEROLOGY, V126, P1504, DOI 10.1053/j.gastro.2004.01.063; Madsen M, 2003, J CLIN EPIDEMIOL, V56, P124, DOI 10.1016/S0895-4356(02)00591-7; Meune C, 2009, RHEUMATOLOGY, V48, P1309, DOI 10.1093/rheumatology/kep252; Olesen Jonas Bjerring, 2011, BMJ, V342, pd124, DOI 10.1136/bmj.d124; Osterman MT, 2011, CLIN GASTROENTEROL H, V9, P875, DOI 10.1016/j.cgh.2011.06.032; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Roifman I, 2009, CLIN GASTROENTEROL H, V7, P175, DOI 10.1016/j.cgh.2008.10.021; Rungoe C, 2012, GUT; Schneeweiss S, 2006, PHARMACOEPIDEM DR S, V15, P291, DOI 10.1002/pds.1200; Solomon DH, 2010, ANN RHEUM DIS, V69, P1920, DOI 10.1136/ard.2009.122226; Strober W, 2011, GASTROENTEROLOGY, V140, P1756, DOI 10.1053/j.gastro.2011.02.016; Svenungsson E, 2001, CIRCULATION, V104, P1887, DOI 10.1161/hc4101.097518; van Leuven SI, 2007, J LIPID RES, V48, P2640, DOI 10.1194/jlr.M700176-JLR200; Vind I, 2006, AM J GASTROENTEROL, V101, P1274, DOI 10.1111/j.1572-0241.2006.00552.x; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Walker BR, 2007, EUR J ENDOCRINOL, V157, P545, DOI 10.1530/EJE-07-0455; Yarur AJ, 2011, AM J GASTROENTEROL, V106, P741, DOI 10.1038/ajg.2011.63; Zitomersky NL, 2011, INFLAMM BOWEL DIS, V17, P458, DOI 10.1002/ibd.21334	40	134	140	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56944	10.1371/journal.pone.0056944	http://dx.doi.org/10.1371/journal.pone.0056944			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457642	Green Published, Green Submitted, gold			2022-12-25	WOS:000315603700100
J	Pielstrom, S; Roces, F				Pielstroem, Steffen; Roces, Flavio			Sequential Soil Transport and Its Influence on the Spatial Organisation of Collective Digging in Leaf-Cutting Ants	PLOS ONE			English	Article							ATTA-VOLLENWEIDERI FOREL; INTERNAL STRUCTURE; NEST VENTILATION; INSECT SOCIETIES; 1893 HYM; HYMENOPTERA; FORMICIDAE; TERMITES; PATTERNS; DISTANCE	The Chaco leaf-cutting ant Atta vollenweideri (Forel) inhabits large and deep subterranean nests composed of a large number of fungus and refuse chambers. The ants dispose of the excavated soil by forming small pellets that are carried to the surface. For ants in general, the organisation of underground soil transport during nest building remains completely unknown. In the laboratory, we investigated how soil pellets are formed and transported, and whether their occurrence influences the spatial organisation of collective digging. Similar to leaf transport, we discovered size matching between soil pellet mass and carrier mass. Workers observed while digging excavated pellets at a rate of 26 per hour. Each excavator deposited its pellets in an individual cluster, independently of the preferred deposition sites of other excavators. Soil pellets were transported sequentially over 2 m, and the transport involved up to 12 workers belonging to three functionally distinct groups: excavators, several short-distance carriers that dropped the collected pellets after a few centimetres, and long-distance, last carriers that reached the final deposition site. When initiating a new excavation, the proportion of long-distance carriers increased from 18% to 45% within the first five hours, and remained unchanged over more than 20 hours. Accumulated, freshly-excavated pellets significantly influenced the workers' decision where to start digging in a choice experiment. Thus, pellets temporarily accumulated as a result of their sequential transport provide cues that spatially organise collective nest excavation.	[Pielstroem, Steffen; Roces, Flavio] Univ Wurzburg, Bioctr, D-97070 Wurzburg, Germany	University of Wurzburg	Pielstrom, S (corresponding author), Univ Wurzburg, Bioctr, D-97070 Wurzburg, Germany.	steffen.pielstroem@gmx.com	Pielström, Steffen/C-6878-2013	Roces, Flavio/0000-0001-9258-3079	German Excellence Initiative to the Graduate School of Life Sciences, University of Wurzburg; German Research Foundation (DFG) [SFB 554/TP E1]	German Excellence Initiative to the Graduate School of Life Sciences, University of Wurzburg; German Research Foundation (DFG)(German Research Foundation (DFG))	This research was supported by a grant of the German Excellence Initiative to the Graduate School of Life Sciences, University of Wurzburg, and by funds from the German Research Foundation (DFG, grant SFB 554/TP E1). The publication costs were covered by the Library of the University of Wurzburg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson C, 2000, INSECT SOC, V47, P198, DOI 10.1007/PL00001702; Anderson C, 2002, INSECT SOC, V49, P171, DOI 10.1007/s00040-002-8298-7; Autuori M., 1942, ARQ INST BIOL [SAO PAULO], V13, P137; BLUM MS, 1966, ANN ENTOMOL SOC AM, V59, P774, DOI 10.1093/aesa/59.4.774; BUCHER E H, 1967, Acta Zoologica Lilloana, V23, P83; Cosarinsky MI, 2007, GEODERMA, V141, P224, DOI 10.1016/j.geoderma.2007.06.006; Cosarinsky MI, 2012, J INSECT BEHAV, V25, P222, DOI 10.1007/s10905-011-9290-8; DELYE G, 1971, INSECT SOC, V18, P15, DOI 10.1007/BF02223160; Delye G., 1957, Insectes Sociaux Paris, V4, P77, DOI 10.1007/BF02224144; EMERSON ALFRED E., 1938, ECOL MONOGR, V8, P247, DOI 10.2307/1943251; FOWLER HG, 1979, ECOL ENTOMOL, V4, P239, DOI 10.1111/j.1365-2311.1979.tb00581.x; FREEDMAN DA, 1981, ANN STAT, V9, P1218, DOI 10.1214/aos/1176345638; Frohle K, 2009, THESIS JULIUS MAXIMI; Frohle K., 2009, INSECT NEST HUMAN AR, P95; Gordon DM, 1996, NATURE, V380, P121, DOI 10.1038/380121a0; Grasse P. P., 1959, Insectes Sociaux Paris, V6, P41, DOI 10.1007/BF02223791; Hansell M, 2005, OXF ANIMAL BIOL SER; Hingston R.W.G., 1929, INSTINCT INTELLIGENC; HUBBELL SP, 1980, BIOTROPICA, V12, P210, DOI 10.2307/2387973; JARVIS JUM, 1971, J ZOOL, V163, P451; JEANNE RL, 1986, BEHAV ECOL SOCIOBIOL, V19, P333, DOI 10.1007/BF00295706; JEANNE RL, 1986, MONIT ZOOL ITAL, V20, P119; JONKMAN JCM, 1980, Z ANGEW ENTOMOL, V89, P158; JONKMAN JCM, 1980, Z ANGEW ENTOMOL, V89, P217; JONKMAN JCM, 1978, Z ANGEW ENTOMOL, V86, P25; JONKMAN JCM, 1976, Z ANGEW ENTOMOL, V81, P140; Kleineidam C, 2000, INSECT SOC, V47, P241, DOI 10.1007/PL00001710; Kleineidam C, 2001, NATURWISSENSCHAFTEN, V88, P301, DOI 10.1007/s001140100235; Lee SH, 2008, BEHAV PROCESS, V78, P397, DOI 10.1016/j.beproc.2008.02.009; LIGHTON JRB, 1987, PHYSIOL ZOOL, V60, P524, DOI 10.1086/physzool.60.5.30156127; Pielstrom S, 2012, ANIM BEHAV, V84, P743, DOI 10.1016/j.anbehav.2012.07.008; Roces F, 2009, CONTEMP TOP ENTOMOL, P261; Roschard J, 2003, J TROP ECOL, V19, P647, DOI 10.1017/S0266467403006047; Roschard J, 2003, INSECT SOC, V50, P237, DOI 10.1007/s00040-003-0663-7; Roschard J, 2002, OECOLOGIA, V131, P319, DOI 10.1007/s00442-002-0882-z; Roschard Jacqueline, 2011, Psyche (Cambridge), V2011, P1, DOI 10.1155/2011/643127; SLEEMAN JR, 1972, PEDOBIOLOGIA, V12, P347; Sosa B, 2010, J VEG SCI, V21, P597, DOI 10.1111/j.1654-1103.2010.01170.x; SPANGLER HAYWARD G., 1966, J KANS ENTOMOL SOC, V39, P739; Sudd J. H., 1969, Zeitschrift fuer Tierpsychologie, V26, P257; Theraulaz G, 1999, ARTIF LIFE, V5, P97, DOI 10.1162/106454699568700; Weber N. A., 1972, GARDENING ANTS ATTIN; WILSON EDWARD O., 1958, PSYCHE, V65, P41, DOI 10.1155/1958/57483	43	24	24	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e57040	10.1371/journal.pone.0057040	http://dx.doi.org/10.1371/journal.pone.0057040			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457648	gold, Green Published, Green Submitted			2022-12-25	WOS:000315603700102
J	Saleem, M; Prince, SM; Rigby, SEJ; Imran, M; Patel, H; Chan, H; Sanders, H; Maiden, MCJ; Feavers, IM; Derrick, JP				Saleem, Muhammad; Prince, Stephen M.; Rigby, Stephen E. J.; Imran, Muhammad; Patel, Hema; Chan, Hannah; Sanders, Holly; Maiden, Martin C. J.; Feavers, Ian M.; Derrick, Jeremy P.			Use of a Molecular Decoy to Segregate Transport from Antigenicity in the FrpB Iron Transporter from Neisseria meningitidis	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEIN; FERRIC ENTEROBACTIN; STRUCTURAL BASIS; CLUSTAL-W; TONB; EVOLUTION; BINDING; FETA; FEPA; CRYSTALLOGRAPHY	FrpB is an outer membrane transporter from Neisseria meningitidis, the causative agent of meningococcal meningitis. It is a member of the TonB-dependent transporter (TBDT) family and is responsible for iron uptake into the periplasm. FrpB is subject to a high degree of antigenic variation, principally through a region of hypervariable sequence exposed at the cell surface. From the crystal structures of two FrpB antigenic variants, we identify a bound ferric ion within the structure which induces structural changes on binding which are consistent with it being the transported substrate. Binding experiments, followed by elemental analysis, verified that FrpB binds Fe3+ with high affinity. EPR spectra of the bound Fe3+ ion confirmed that its chemical environment was consistent with that observed in the crystal structure. Fe3+ binding was reduced or abolished on mutation of the Fe3+-chelating residues. FrpB orthologs were identified in other Gram-negative bacteria which showed absolute conservation of the coordinating residues, suggesting the existence of a specific TBDT sub-family dedicated to the transport of Fe3+. The region of antigenic hypervariability lies in a separate, external sub-domain, whose structure is conserved in both the F3-3 and F5-1 variants, despite their sequence divergence. We conclude that the antigenic sub-domain has arisen separately as a result of immune selection pressure to distract the immune response from the primary transport function. This would enable FrpB to function as a transporter independently of antibody binding, by using the antigenic sub-domain as a 'molecular decoy' to distract immune surveillance.	[Saleem, Muhammad; Imran, Muhammad; Derrick, Jeremy P.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [Prince, Stephen M.; Rigby, Stephen E. J.] Univ Manchester, Manchester Inst Biotechnol, Manchester, Lancs, England; [Patel, Hema; Chan, Hannah; Sanders, Holly; Feavers, Ian M.] Hlth Protect Agcy, Natl Inst Biol Stand & Control, Potters Bar, Herts, England; [Maiden, Martin C. J.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England	University of Manchester; University of Manchester; Health Protection Agency; National Institute for Biological Standards & Control; University of Oxford	Derrick, JP (corresponding author), Univ Manchester, Fac Life Sci, Michael Smith Bldg,Oxford Rd, Manchester, Lancs, England.	Jeremy.Derrick@manchester.ac.uk	Maiden, Martin C J/C-5055-2014; Saleem, Muhammad/W-4014-2017; Maiden, Martin/N-6805-2019	Maiden, Martin C J/0000-0001-6321-5138; Saleem, Muhammad/0000-0002-0994-9701; Maiden, Martin/0000-0001-6321-5138; Prince, Stephen/0000-0003-0929-0254; Derrick, Jeremy/0000-0002-4350-5354	Wellcome Trust; Biotechnology and Biological Sciences Research Council [BB/E013007/1] Funding Source: researchfish; BBSRC [BB/E013007/1] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The work was supported with a Translation Award from the Wellcome Trust. Martin Maiden is a Wellcome Trust Senior Research Fellow. The funders had no role in study design, data collection and analysis, or preparation of the manuscript.	Alexeev D, 2003, NAT STRUCT BIOL, V10, P297, DOI 10.1038/nsb903; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Beernink PT, 2009, MICROBIOL-SGM, V155, P2873, DOI 10.1099/mic.0.029876-0; BEUCHER M, 1995, J BACTERIOL, V177, P2041, DOI 10.1128/jb.177.8.2041-2049.1995; Brehony C, 2007, FEMS MICROBIOL REV, V31, P15, DOI 10.1111/j.1574-6976.2006.00056.x; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Bruns CM, 1997, NAT STRUCT BIOL, V4, P919, DOI 10.1038/nsb1197-919; Buchanan SK, 1999, NAT STRUCT BIOL, V6, P56; Buchanan SK, 2007, EMBO J, V26, P2594, DOI 10.1038/sj.emboj.7601693; Buckee CO, 2010, P ROY SOC B-BIOL SCI, V277, P1635, DOI 10.1098/rspb.2009.2033; Buckee CO, 2008, P NATL ACAD SCI USA, V105, P15082, DOI 10.1073/pnas.0712019105; Callaghan MJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000020; Carson SDB, 1999, J BACTERIOL, V181, P2895, DOI 10.1128/JB.181.9.2895-2901.1999; Chimento DP, 2005, PROTEINS, V59, P240, DOI 10.1002/prot.20416; Cobessi D, 2010, PROTEINS, V78, P286, DOI 10.1002/prot.22539; Cowtan KD, 1999, PROG BIOPHYS MOL BIO, V72, P245, DOI 10.1016/S0079-6107(99)00008-5; Devanathan S, 2007, MOL MICROBIOL, V65, P441, DOI 10.1111/j.1365-2958.2007.05808.x; DYER DW, 1988, INFECT IMMUN, V56, P977, DOI 10.1128/IAI.56.4.977-983.1988; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fanucci GE, 2003, BIOCHEMISTRY-US, V42, P13106, DOI 10.1021/bi035439t; Fanucci GE, 2003, P NATL ACAD SCI USA, V100, P11382, DOI 10.1073/pnas.1932486100; Feavers IM, 2009, VACCINE, V27, pB42, DOI 10.1016/j.vaccine.2009.05.001; Ferguson AD, 2002, SCIENCE, V295, P1715, DOI 10.1126/science.1067313; Guo ML, 2003, J BIOL CHEM, V278, P2490, DOI 10.1074/jbc.M208776200; Gupta S, 2001, TRENDS MICROBIOL, V9, P181, DOI 10.1016/S0966-842X(01)01986-2; Gupta S, 1996, NAT MED, V2, P437, DOI 10.1038/nm0496-437; Hollander A, 2011, INFECT IMMUN, V79, P4764, DOI 10.1128/IAI.05806-11; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kortekaas J, 2007, VACCINE, V25, P72, DOI 10.1016/j.vaccine.2006.07.016; Krewulak KD, 2008, BBA-BIOMEMBRANES, V1778, P1781, DOI 10.1016/j.bbamem.2007.07.026; Krieg S, 2009, P NATL ACAD SCI USA, V106, P1045, DOI 10.1073/pnas.0809406106; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Laskowski R. A., 1993, J APPL CRYSTALLOGR, V24, P946; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; Ma L, 2007, J BIOL CHEM, V282, P397, DOI 10.1074/jbc.M605333200; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McLuskey K, 2001, BIOCHEMISTRY-US, V40, P8783, DOI 10.1021/bi010309a; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Noinaj N, 2012, NATURE, V483, P53, DOI 10.1038/nature10823; Noinaj N, 2010, ANNU REV MICROBIOL, V64, P43, DOI 10.1146/annurev.micro.112408.134247; Pawelek PD, 2006, SCIENCE, V312, P1399, DOI 10.1126/science.1128057; Perkins-Balding D, 2004, MICROBIOL MOL BIOL R, V68, P154, DOI 10.1128/MMBR.68.1.154-171.2004; PETTERSSON A, 1995, INFECT IMMUN, V63, P4181, DOI 10.1128/IAI.63.10.4181-4184.1995; PETTERSSON A, 1990, INFECT IMMUN, V58, P3036, DOI 10.1128/IAI.58.9.3036-3041.1990; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; Saleem M, 2012, ACTA CRYSTALLOGR F, V68, P231, DOI 10.1107/S1744309111056028; Schauer K, 2008, TRENDS BIOCHEM SCI, V33, P330, DOI 10.1016/j.tibs.2008.04.012; Schulz GE, 2002, BBA-BIOMEMBRANES, V1565, P308, DOI 10.1016/S0005-2736(02)00577-1; Schwarzenbacher R, 2004, ACTA CRYSTALLOGR D, V60, P1229, DOI 10.1107/S0907444904010145; Shultis DD, 2006, SCIENCE, V312, P1396, DOI 10.1126/science.1127694; Smallwood CR, 2009, MOL MICROBIOL, V72, P1171, DOI 10.1111/j.1365-2958.2009.06715.x; SPARTALIAN K, 1975, J CHEM PHYS, V62, P3538, DOI 10.1063/1.430998; Stein N, 2008, J APPL CRYSTALLOGR, V41, P641, DOI 10.1107/S0021889808006985; Thompson EAL, 2003, MICROBIOL-SGM, V149, P1849, DOI 10.1099/mic.0.26131-0; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Zhu HZ, 2003, BIOCHEM J, V376, P35, DOI 10.1042/BJ20031283; Zollinger WD, 2011, EXPERT REV VACCINES, V10, P559, DOI [10.1586/erv.11.41, 10.1586/ERV.11.41]	62	22	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56746	10.1371/journal.pone.0056746	http://dx.doi.org/10.1371/journal.pone.0056746			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457610	gold, Green Published, Green Submitted			2022-12-25	WOS:000315603700078
J	Malde, K; Furmanek, T				Malde, Ketil; Furmanek, Tomasz			Increasing Sequence Search Sensitivity with Transitive Alignments	PLOS ONE			English	Article							DATABASE; PROTEIN; TOOL	Sequence alignment is an important bioinformatics tool for identifying homology, but searching against the full set of available sequences is likely to result in many hits to poorly annotated sequences providing very little information. Consequently, we often want alignments against a specific subset of sequences: for instance, we are looking for sequences from a particular species, sequences that have known 3d-structures, sequences that have a reliable (curated) function annotation, and so on. Although such subset databases are readily available, they only represent a small fraction of all sequences. Thus, the likelihood of finding close homologs for query sequences is smaller, and the alignments will in general have lower scores. This makes it difficult to distinguish hits to homologous sequences from random hits to unrelated sequences. Here, we propose a method that addresses this problem by first aligning query sequences against a large database representing the corpus of known sequences, and then constructing indirect (or transitive) alignments by combining the results with alignments from the large database against the desired target database. We compare the results to direct pairwise alignments, and show that our method gives us higher sensitivity alignments against the target database.	[Malde, Ketil; Furmanek, Tomasz] Inst Marine Res, N-5024 Bergen, Norway	Institute of Marine Research - Norway	Malde, K (corresponding author), Inst Marine Res, POB 1870, N-5024 Bergen, Norway.	ketil.malde@imr.no	M, Ketil/AAH-5604-2020		Norwegian Department of Fisheries and Coastal Affairs	Norwegian Department of Fisheries and Coastal Affairs	This study was funded by the Norwegian Department of Fisheries and Coastal Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Biegert A, 2009, P NATL ACAD SCI USA, V106, P3770, DOI 10.1073/pnas.0810767106; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Demattei MV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023693; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Grundy WN, 1998, J COMPUT BIOL, V5, P479, DOI 10.1089/cmb.1998.5.479; Ma B, 2002, BIOINFORMATICS, V18, P440, DOI 10.1093/bioinformatics/18.3.440; Malde K, 2008, BIOINFORMATICS, V24, P897, DOI 10.1093/bioinformatics/btn052; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; O'Donovan Claire, 2002, Brief Bioinform, V3, P275; Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025; Rost B, 1999, PROTEIN ENG, V12, P85, DOI 10.1093/protein/12.2.85; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Selden Paul A, 2010, Nat Commun, V1, P50, DOI 10.1038/ncomms1049; Stanke M, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s11; Suzek BE, 2007, BIOINFORMATICS, V23, P1282, DOI 10.1093/bioinformatics/btm098; Wang L, 1994, J Comput Biol, V1, P337, DOI 10.1089/cmb.1994.1.337	20	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e54422	10.1371/journal.pone.0054422	http://dx.doi.org/10.1371/journal.pone.0054422			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457449	gold, Green Published, Green Submitted			2022-12-25	WOS:000315602700006
J	DeWitt, J; Ochoa, V; Urschitz, J; Elston, M; Moisyadi, S; Nishi, R				DeWitt, J.; Ochoa, V.; Urschitz, J.; Elston, M.; Moisyadi, S.; Nishi, R.			Constitutively active TrkB confers an aggressive transformed phenotype to a neural crest-derived cell line	ONCOGENE			English	Article						neuroblastoma; neural crest; transformation; TrkB; MYCN	NEUROTROPHIC FACTOR ACTIVATION; PROTECTS NEUROBLASTOMA-CELLS; C-MET; UP-REGULATION; EXPRESSION; RECEPTOR; MYC; BDNF; OVEREXPRESSION; PROTOONCOGENE	Neuroblastoma arises from sympathoadrenal progenitors of the neural crest and expression of the neurotrophin receptor TrkB and its ligand, brain-derived neurotrophic factor (BDNF), is correlated with poor prognosis. Although activated TrkB signaling promotes a more aggressive phenotype in established neuroblastoma cell lines, whether TrkB signaling is sufficient to transform neural crest-derived cells has not been investigated. To address the role of TrkB signaling in malignant transformation, we removed two immunoglobulin-like domains from the extracellular domain of the full-length rat TrkB receptor to create a Delta IgTrkB that is constitutively active. In the pheochromocytoma-derived cell line PC12, Delta IgTrkB promotes differentiation by stimulating process outgrowth; however, in the rat neural crest-derived cell line NCM-1, Delta IgTrkB signaling produces a markedly transformed phenotype characterized by increased proliferation, anchorage-independent cell growth, anoikis resistance and matrix invasion. Furthermore, expression of Delta IgTrkB leads to the upregulation of many transcripts encoding cancer-associated genes including cyclind1, twist1 and hgf, as well as downregulation of tumor suppressors such as pten and rb1. In addition, Delta IgTrkB NCM-1 cells show a 21-fold increase in mRNA for MYCN, the most common genetic marker for a poor prognosis in neuroblastoma. When injected into NOD SCID mice, control GFP NCM-1 cells fail to grow whereas Delta IgTrkB NCM-1 cells form rapidly growing and invasive tumors necessitating euthanasia of all mice by 15 days post injection. In summary, these results indicate that activated TrkB signaling is sufficient to promote the formation of a highly malignant phenotype in neural crest-derived cells.	[DeWitt, J.; Ochoa, V.; Nishi, R.] Univ Vermont, Dept Anat & Neurobiol, Burlington, VT 05405 USA; [DeWitt, J.; Ochoa, V.; Nishi, R.] Univ Vermont, Neurosci Grad Program, Burlington, VT 05405 USA; [Urschitz, J.; Elston, M.; Moisyadi, S.] Univ Hawaii, John A Burns Sch Med, Depat Anat Biochem & Physiol, Honolulu, HI USA; [Moisyadi, S.] Manoa BioSci, Honolulu, HI USA	University of Vermont; University of Vermont; University of Hawaii System; University of Hawaii System; University of Hawaii Manoa	Nishi, R (corresponding author), Univ Vermont, Dept Anat & Neurobiol, HSRF 406,149 Beaumont Ave, Burlington, VT 05405 USA.	Rae.Nishi@med.uvm.edu			Alex's Lemonade Foundation [R21NS25788, P30RR032135, P30GM103498, 5P20RR024206, R01GM083158-01A1]; NATIONAL CENTER FOR RESEARCH RESOURCES [P30RR032135, P20RR024206] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103457, R01GM083158, P30GM103498] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS076969] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [U54MD007584] Funding Source: NIH RePORTER	Alex's Lemonade Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	We would like to thank Felix Eckenstein, Andy McKenzie and Nourine Ahmed for technical assistance. We also thank Alan Howe for helpful comments on our manuscript and for assistance with the 'donut' assay. Portions of this work were performed in the DNA Analysis Facility at the Vermont Cancer Center and the Neuroscience COBRE Molecular Cellular Core at the University of Vermont. This work was funded by Alex's Lemonade Foundation (RN); R21NS25788 (RN); P30RR032135 (COBRE); P30GM103498 (COBRE); 5P20RR024206 (SM); and R01GM083158-01A1 (SM).	Arevalo JC, 2000, MOL CELL BIOL, V20, P5908, DOI 10.1128/MCB.20.16.5908-5916.2000; Brodeur GM, 2009, CLIN CANCER RES, V15, P3244, DOI 10.1158/1078-0432.CCR-08-1815; Brodeur GM, 1997, J NEURO-ONCOL, V31, P49, DOI 10.1023/A:1005729329526; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; Chiarugi P, 2008, BIOCHEM PHARMACOL, V76, P1352, DOI 10.1016/j.bcp.2008.07.023; Cimmino F, 2009, ONCOGENE, V28, P2015, DOI 10.1038/onc.2009.70; De Bernardi B, 2005, CANCER LETT, V228, P283, DOI 10.1016/j.canlet.2005.01.053; De Bernardi B, 2001, J CLIN ONCOL, V19, P183, DOI 10.1200/JCO.2001.19.1.183; Douma S, 2004, NATURE, V430, P1034, DOI 10.1038/nature02765; Eggert A, 2002, CANCER RES, V62, P1802; Feldman JP, 2009, J APPL QUANT METHODS, V4, P455, DOI DOI 10.1111/J.2042-3306.2010.TB05629.X; FURUKAWA T, 1995, AM J PATHOL, V147, P889; GLASS DJ, 1991, CELL, V66, P405, DOI 10.1016/0092-8674(91)90629-D; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Hecht M, 2005, CARCINOGENESIS, V26, P2105, DOI 10.1093/carcin/bgi192; Ho R, 2002, CANCER RES, V62, P6462; Huang YT, 2010, INT J ONCOL, V36, P1469, DOI 10.3892/ijo_00000633; Jaboin J, 2002, CANCER RES, V62, P6756; Jian Z, 1996, CELL SIGNAL, V8, P365, DOI 10.1016/0898-6568(96)00069-1; KAPLAN DR, 1991, NATURE, V350, P158, DOI 10.1038/350158a0; Kim CJ, 1999, AM J PATHOL, V155, P1661, DOI 10.1016/S0002-9440(10)65481-8; KLEIN R, 1991, CELL, V66, P395, DOI 10.1016/0092-8674(91)90628-C; Kupferman ME, 2010, ONCOGENE, V29, P2047, DOI 10.1038/onc.2009.486; Lengyel E, 2005, INT J CANCER, V113, P678, DOI 10.1002/ijc.20598; Li CW, 2012, CANCER RES, V72, P1290, DOI 10.1158/0008-5472.CAN-11-3123; LIU C, 1992, ONCOGENE, V7, P181; LO LC, 1991, DEV BIOL, V145, P139, DOI 10.1016/0012-1606(91)90220-W; LUGO TG, 1989, MOL CELL BIOL, V9, P1263, DOI 10.1128/MCB.9.3.1263; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; MARTINZANCA D, 1986, NATURE, V319, P743, DOI 10.1038/319743a0; MATSUMOTO K, 1995, CANCER RES, V55, P1798; McKenzie AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026552; Miller FD, 2001, CELL MOL LIFE SCI, V58, P1045, DOI 10.1007/PL00000919; Minturn JE, 2011, CANCER CHEMOTH PHARM, V68, P1057, DOI 10.1007/s00280-011-1581-4; Molenaar JJ, 2012, GENE CHROMOSOME CANC, V51, P10, DOI 10.1002/gcc.20926; NAKAGAWARA A, 1994, MOL CELL BIOL, V14, P759, DOI 10.1128/MCB.14.1.759; Nakagawara A, 1998, Hum Cell, V11, P115; Nakamura K, 2006, CANCER RES, V66, P4249, DOI 10.1158/0008-5472.CAN-05-2789; Plantaz D, 1996, CANCER, V78, P311, DOI 10.1002/(SICI)1097-0142(19960715)78:2<311::AID-CNCR19>3.3.CO;2-O; Ramirez R, 2000, CLIN ENDOCRINOL, V53, P635, DOI 10.1046/j.1365-2265.2000.01124.x; RAMSAY GM, 1990, P NATL ACAD SCI USA, V87, P2102, DOI 10.1073/pnas.87.6.2102; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; Reiff T, 2010, J NEUROSCI, V30, P905, DOI 10.1523/JNEUROSCI.5368-09.2010; Scala S, 1996, CANCER RES, V56, P3737; Schramm A, 2005, CANCER LETT, V228, P143, DOI 10.1016/j.canlet.2005.02.051; Schulte JH, 2013, ONCOGENE, V32, P1059, DOI 10.1038/onc.2012.106; SCHWAB M, 1984, P NATL ACAD SCI-BIOL, V81, P4940, DOI 10.1073/pnas.81.15.4940; Screaton RA, 1997, J CELL BIOL, V137, P939, DOI 10.1083/jcb.137.4.939; SEEGER RC, 1985, NEW ENGL J MED, V313, P1111, DOI 10.1056/NEJM198510313131802; Singh RK, 2007, BIOORG MED CHEM LETT, V17, P5846, DOI 10.1016/j.bmcl.2007.08.032; Straub JA, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-10; Tacconelli A, 2004, CANCER CELL, V6, P347, DOI 10.1016/j.ccr.2004.09.011; Thullberg M, 2008, CELL CYCLE, V7, P984, DOI 10.4161/cc.7.8.5674; Tokunou M, 2001, AM J PATHOL, V158, P1451, DOI 10.1016/S0002-9440(10)64096-5; Urschitz J, 2010, P NATL ACAD SCI USA, V107, P8117, DOI 10.1073/pnas.1003674107; Valsesia-Wittmann S, 2004, CANCER CELL, V6, P625, DOI 10.1016/j.ccr.2004.09.033; Weiss WA, 1997, EMBO J, V16, P2985, DOI 10.1093/emboj/16.11.2985; Yu YJ, 2010, APMIS, V118, P188, DOI 10.1111/j.1600-0463.2009.02577.x; Zhang SY, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-43	59	12	12	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 20	2014	33	8					977	985		10.1038/onc.2013.39	http://dx.doi.org/10.1038/onc.2013.39			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AB6XO	23455321	Green Accepted			2022-12-25	WOS:000331933200005
J	Perez-Hernandez, D; Gutierrez-Vazquez, C; Jorge, I; Lopez-Martin, S; Ursa, A; Sanchez-Madrid, F; Vazquez, J; Yanez-Mo, M				Perez-Hernandez, Daniel; Gutierrez-Vazquez, Cristina; Jorge, Inmaculada; Lopez-Martin, Soraya; Ursa, Angeles; Sanchez-Madrid, Francisco; Vazquez, Jesus; Yanez-Mo, Maria			The Intracellular Interactome of Tetraspanin-enriched Microdomains Reveals Their Function as Sorting Machineries toward Exosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRAP MASS-SPECTROMETRY; QUANTITATIVE PROTEOMICS; PEPTIDE IDENTIFICATION; STATISTICAL-MODEL; MESSENGER-RNAS; CELL-MIGRATION; PROTEINS; CD81; ASSOCIATION; EWI-2	Extracellular vesicles are emerging as a potent mechanism of intercellular communication because they can systemically exchange genetic and protein material between cells. Tetraspanin molecules are commonly used as protein markers of extracellular vesicles, although their role in the unexplored mechanisms of cargo selection into exosomes has not been addressed. For that purpose, we have characterized the intracellular tetraspanin-enriched microdomain (TEM) interactome by high throughput mass spectrometry, in both human lymphoblasts and their derived exosomes, revealing a clear pattern of interaction networks. Proteins interacting with TEM receptors cytoplasmic regions presented a considerable degree of overlap, although some highly specific CD81 tetraspanin ligands, such as Rac GTPase, were detected. Quantitative proteomics showed that TEM ligands account for a great proportion of the exosome proteome and that a selective repertoire of CD81-associated molecules, including Rac, is not correctly routed to exosomes in cells from CD81-deficient animals. Our data provide evidence that insertion into TEM may be necessary for protein inclusion into the exosome structure.	[Perez-Hernandez, Daniel; Vazquez, Jesus] Univ Autonoma Madrid, CSIC, Ctr Biol Mol Severo Ochoa, Lab Prot Chem & Prote, E-28049 Madrid, Spain; [Perez-Hernandez, Daniel; Gutierrez-Vazquez, Cristina; Jorge, Inmaculada; Sanchez-Madrid, Francisco; Vazquez, Jesus] Ctr Nacl Invest Cardiovasc, Dept Vasc Biol & Inflammat, E-28029 Madrid, Spain; [Lopez-Martin, Soraya; Yanez-Mo, Maria] Hosp Santa Cristina, Unidad Invest, E-28006 Madrid, Spain; [Ursa, Angeles; Sanchez-Madrid, Francisco] Inst Invest Sanitaria Princesa IIS IP, Hosp Princesa, Serv Inmunol, E-28006 Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Centro Nacional de Investigaciones Cardiovasculares (CNIC)	Vazquez, J (corresponding author), Univ Autonoma Madrid, CSIC, Ctr Biol Mol Severo Ochoa, Lab Prot Chem & Prote, E-28049 Madrid, Spain.	jvazquez@cnic.es; myanez.hlpr@salud.madrid.org	YÃÃez-MÃ, Maria/AAI-4544-2020; Sanchez-Madrid, Francisco/M-7889-2016; Vazquez, Jesus/B-7697-2015; Yáñez-Mó, María/K-8577-2014	YÃÃez-MÃ, Maria/0000-0001-7484-2866; Sanchez-Madrid, Francisco/0000-0001-5303-0762; Vazquez, Jesus/0000-0003-1461-5092; Yáñez-Mó, María/0000-0001-7484-2866; Perez Hernandez, Daniel/0000-0003-0266-9050; Gutierrez-Vazquez, Cristina/0000-0002-3846-4631; Jorge, Inmaculada/0000-0001-8645-9477; Perez Hernandez, Daniel/0000-0003-4721-1203	Instituto de Salud Carlos III [PI080794, PI11/01645]; Ministerio de Ciencia e Innovacion (MCINN) [ERC-2011-AdG 294340-GEN-TRIS, SAF2011-25834]; Comunidad de Madrid (CAM) [INDISNET S2011/BMD-2332]; MCINN [BIO2009-07990]; CAM [BIO/0194/2006]; Fondo de Investigaciones Sanitarias (MCINN) [RECAVA RD06/0014]	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Ministerio de Ciencia e Innovacion (MCINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Comunidad de Madrid (CAM)(Comunidad de Madrid); MCINN(European Commission); CAM; Fondo de Investigaciones Sanitarias (MCINN)	This work was supported by Grants PI080794 and PI11/01645 from the Instituto de Salud Carlos III (to M. Y.-M.); Grants ERC-2011-AdG 294340-GEN-TRIS, and SAF2011-25834 from the Ministerio de Ciencia e Innovacion (MCINN) and INDISNET S2011/BMD-2332 from the Comunidad de Madrid (CAM) (to F. S. M); Grants BIO2009-07990 from the MCINN and BIO/0194/2006 from the CAM(to J. V.); and Grant RECAVA RD06/0014 from the Fondo de Investigaciones Sanitarias (MCINN) (to J. V. and F. S. M.).	Abache T, 2007, J CELL BIOCHEM, V102, P650, DOI 10.1002/jcb.21318; Baietti MF, 2012, NAT CELL BIOL, V14, P677, DOI 10.1038/ncb2502; Balaj L, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1180; Barreiro O, 2005, BLOOD, V105, P2852, DOI 10.1182/blood-2004-09-3606; Barreiro O, 2002, J CELL BIOL, V157, P1233, DOI 10.1083/jcb.200112126; BASSELL GJ, 1994, J CELL BIOL, V126, P863, DOI 10.1083/jcb.126.4.863; Berditchevski F, 1997, J BIOL CHEM, V272, P2595, DOI 10.1074/jbc.272.5.2595; Berditchevski F, 2007, TRAFFIC, V8, P89, DOI 10.1111/j.1600-0854.2006.00515.x; Bonzon-Kulichenko E, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.003335; CARPEN O, 1992, J CELL BIOL, V118, P1223, DOI 10.1083/jcb.118.5.1223; Chairoungdua A, 2010, J CELL BIOL, V190, P1079, DOI 10.1083/jcb.201002049; Charrin S, 2003, BIOCHEM J, V373, P409, DOI 10.1042/BJ20030343; Charrin S, 2009, BIOCHEM J, V420, P133, DOI 10.1042/BJ20082422; Chicurel ME, 1998, NATURE, V392, P730, DOI 10.1038/33719; Clark KL, 2004, J BIOL CHEM, V279, P19401, DOI 10.1074/jbc.M312626200; de Hoog CL, 2004, CELL, V117, P649, DOI 10.1016/S0092-8674(04)00456-8; Escola JM, 1998, J BIOL CHEM, V273, P20121, DOI 10.1074/jbc.273.32.20121; Gordon-Alonso M, 2012, J IMMUNOL, V189, P689, DOI 10.4049/jimmunol.1103708; Gorrini C, 2005, P NATL ACAD SCI USA, V102, P9200, DOI 10.1073/pnas.0409513102; Humphries JD, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000396; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; Jorge I, 2007, J MASS SPECTROM, V42, P1391, DOI 10.1002/jms.1314; Jorge I, 2009, MOL CELL PROTEOMICS, V8, P1130, DOI 10.1074/mcp.M800260-MCP200; Kalra H, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001450; Kanters E, 2008, J BIOL CHEM, V283, P31830, DOI 10.1074/jbc.M804888200; Latysheva N, 2006, MOL CELL BIOL, V26, P7707, DOI 10.1128/MCB.00849-06; Le Naour F, 2006, PROTEOMICS, V6, P6447, DOI 10.1002/pmic.200600282; Liu L, 2007, J BIOL CHEM, V282, P31631, DOI 10.1074/jbc.M701165200; Lopez-Ferrer D, 2004, ANAL CHEM, V76, P6853, DOI 10.1021/ac049305c; Maecker HT, 1997, J EXP MED, V185, P1505, DOI 10.1084/jem.185.8.1505; Martinez-Bartolome S, 2008, MOL CELL PROTEOMICS, V7, P1135, DOI 10.1074/mcp.M700239-MCP200; Mazzocca A, 2008, GASTROENTEROLOGY, V135, P244, DOI 10.1053/j.gastro.2008.03.024; Mittelbrunn M, 2012, NAT REV MOL CELL BIO, V13, P328, DOI 10.1038/nrm3335; Mittelbrunn M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1285; Miyado K, 2008, P NATL ACAD SCI USA, V105, P12921, DOI 10.1073/pnas.0710608105; Miyazaki T, 1997, EMBO J, V16, P4217, DOI 10.1093/emboj/16.14.4217; Navarro P, 2009, J PROTEOME RES, V8, P1792, DOI 10.1021/pr800362h; Nazarenko I, 2010, CANCER RES, V70, P1668, DOI 10.1158/0008-5472.CAN-09-2470; Pegtel DM, 2010, P NATL ACAD SCI USA, V107, P6328, DOI 10.1073/pnas.0914843107; Ramos-Fernandez A, 2007, MOL CELL PROTEOMICS, V6, P1274, DOI 10.1074/mcp.T600029-MCP200; Rubinstein E, 2006, DEV BIOL, V290, P351, DOI 10.1016/j.ydbio.2005.11.031; Sala-Valdes M, 2006, J BIOL CHEM, V281, P19665, DOI 10.1074/jbc.M602116200; Sanvito F, 1999, J CELL BIOL, V144, P823, DOI 10.1083/jcb.144.5.823; Schiller HB, 2011, EMBO REP, V12, P259, DOI 10.1038/embor.2011.5; Serrador JM, 1997, J CELL BIOL, V138, P1409, DOI 10.1083/jcb.138.6.1409; Simons M, 2009, CURR OPIN CELL BIOL, V21, P575, DOI 10.1016/j.ceb.2009.03.007; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Stipp CS, 2003, TRENDS BIOCHEM SCI, V28, P106, DOI 10.1016/S0968-0004(02)00014-2; Stipp CS, 2001, J BIOL CHEM, V276, P40545, DOI 10.1074/jbc.M107338200; Tejera E, 2013, MOL BIOL CELL, V24, P261, DOI 10.1091/mbc.E12-09-0642; Thery C, 2001, J IMMUNOL, V166, P7309, DOI 10.4049/jimmunol.166.12.7309; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Tsitsikov EN, 1997, P NATL ACAD SCI USA, V94, P10844, DOI 10.1073/pnas.94.20.10844; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; van Niel G, 2011, DEV CELL, V21, P708, DOI 10.1016/j.devcel.2011.08.019; Yanez-Mo M, 2011, CELL MOL LIFE SCI, V68, P3323, DOI 10.1007/s00018-011-0746-y; Yanez-Mo M, 2009, TRENDS CELL BIOL, V19, P434, DOI 10.1016/j.tcb.2009.06.004; Zhang XA, 2001, J BIOL CHEM, V276, P25005, DOI 10.1074/jbc.M102156200; Zoller M, 2009, NAT REV CANCER, V9, P40, DOI 10.1038/nrc2543	59	294	307	2	41	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2013	288	17					11649	11661		10.1074/jbc.M112.445304	http://dx.doi.org/10.1074/jbc.M112.445304			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	133RP	23463506	hybrid, Green Published			2022-12-25	WOS:000318157600004
J	Farrer, RG; Farrer, JR; DeVries, GH				Farrer, Robert G.; Farrer, Jason R.; DeVries, George H.			Platelet-derived Growth Factor-BB Activates Calcium/Calmodulin-dependent and -independent Mechanisms That Mediate Akt Phosphorylation in the Neurofibromin-deficient Human Schwann Cell Line ST88-14	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NERVE SHEATH TUMORS; PROTEIN-KINASE-B; TYPE-1 NEUROFIBROMATOSIS; SURVIVAL; RAS; EXPRESSION; HYPERACTIVATION; PROLIFERATION; APOPTOSIS; P21(RAS)	Neurofibromatosis type 1-derived Schwann cells isolated from malignant peripheral nerve sheath tumors (MPNSTs) overexpress PDGF receptor-beta and generate an aberrant intracellular calcium increase in response to PDGF-BB. Using the human MPNST Schwann cell line ST88-14, we demonstrate that, in addition to a transient phosphorylation of Akt, PDGF-BB stimulation produces an atypical sustained phosphorylation of Akt that is dependent on calcium and calmodulin (CaM). The sustained Akt phosphorylation did not occur in PDGF-BB-stimulated normal human Schwann cells or ST88-14 cells stimulated with stem cell factor, whose receptor is also overexpressed in ST88-14 cells. The sustained Akt phosphorylation induced by PDGF-BB was inhibited by pretreatment of the cells with either the intracellular calcium chelator 1,2-bis(2-aminophenoxy)ethane-N,N, N',N'-tetraacetic acid tetrakis(acetoxymethyl) ester (BAPTA-AM) or the CaM antagonist W7, whereas the transient portion was not inhibited. Akt also co-immunoprecipitated with CaM in a PDGF-BB-dependent manner, suggesting that direct interaction between Akt and CaM is involved in the sustained phosphorylation of Akt. Furthermore, we provide evidence that anti-apoptotic effects of PDGF-BB on serum-deprived ST88-14 cells can be inhibited by W7, implicating the PDGF-BB-induced activation of calcium/CaM in promoting cell survival, presumably through sustained Akt activation. We conclude that the activation of the calcium/CaM/Akt pathway resulting from stimulation of overexpressed PDGF receptor-beta may contribute to the survival and tumorigenicity of MPNST cells.	[Farrer, Robert G.; Farrer, Jason R.] Vet Affairs Edward Hines Jr Hosp, Res Serv, Hines, IL 60141 USA; [DeVries, George H.] Hunter Holmes McGuire Vet Adm Med Ctr, Res Serv, Richmond, VA 23249 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Edward Hines Jr. VA Hospital; Hunter Holmes McGuire Veterinary Affairs Medical Center	Farrer, RG (corresponding author), Vet Affairs Edward Hines Jr Hosp, Res Serv 151, Bldg 1,Rm D4001,5000 5th Ave, Hines, IL 60141 USA.	robert.farrer@va.gov			Department of Veterans Affairs, Illinois Neurofibromatosis, Inc.; United States Army Medical Research and Materiel Command [DAMD17-98-8607]	Department of Veterans Affairs, Illinois Neurofibromatosis, Inc.(US Department of Veterans Affairs); United States Army Medical Research and Materiel Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC))	This work was supported by the Department of Veterans Affairs, Illinois Neurofibromatosis, Inc., and United States Army Medical Research and Materiel Command Contract Grant DAMD17-98-8607.	Badache A, 1998, ONCOGENE, V17, P795, DOI 10.1038/sj.onc.1201978; Badache A, 1998, J CELL PHYSIOL, V177, P334, DOI 10.1002/(SICI)1097-4652(199811)177:2<334::AID-JCP15>3.0.CO;2-9; BASU TN, 1992, NATURE, V356, P713, DOI 10.1038/356713a0; Carroll SL, 2005, J NEUROPATH EXP NEUR, V64, P1; Casella CTB, 1996, GLIA, V17, P327, DOI 10.1002/(SICI)1098-1136(199608)17:4<327::AID-GLIA7>3.0.CO;2-W; Cho H, 2001, J BIOL CHEM, V276, P38349, DOI 10.1074/jbc.C100462200; Coticchia CM, 2009, BREAST CANCER RES TR, V115, P545, DOI 10.1007/s10549-008-0097-z; Dang I, 2005, J NEUROSCI RES, V79, P318, DOI 10.1002/jnr.20334; Deb TB, 2004, J BIOL CHEM, V279, P38903, DOI 10.1074/jbc.M405314200; DECLUE JE, 1992, CELL, V69, P265, DOI 10.1016/0092-8674(92)90407-4; DeClue JE, 2000, J CLIN INVEST, V105, P1233, DOI 10.1172/JCI7610; Dong B, 2007, J BIOL CHEM, V282, P25131, DOI 10.1074/jbc.M702123200; Donovan S, 2002, CANCER CELL, V2, P507, DOI 10.1016/S1535-6108(02)00214-3; Franke TF, 2008, ONCOGENE, V27, P6473, DOI 10.1038/onc.2008.313; Gao TY, 2005, MOL CELL, V18, P13, DOI 10.1016/j.molcel.2005.03.008; Gonzalez E, 2009, CELL CYCLE, V8, P2502, DOI 10.4161/cc.8.16.9335; Hollander MC, 2011, ONCOGENE, V30, P1812, DOI 10.1038/onc.2010.556; Ingram DA, 2001, J EXP MED, V194, P57, DOI 10.1084/jem.194.1.57; Joyal JL, 1997, J BIOL CHEM, V272, P28183, DOI 10.1074/jbc.272.45.28183; Koseoglu S, 2007, CANCER BIOL THER, V6, P755, DOI 10.4161/cbt.6.5.3995; Liu XS, 2006, J BIOL CHEM, V281, P31380, DOI 10.1074/jbc.M606603200; Maiuri T, 2010, J BIOL CHEM, V285, P15038, DOI 10.1074/jbc.M110.121434; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; THOMAS SL, 2009, HDB NEUROCHEMISTRY M, P107; Yano S, 1998, NATURE, V396, P584, DOI 10.1038/25147; Yue YZ, 2004, J BIOL CHEM, V279, P12883, DOI 10.1074/jbc.M312308200; Zhang YY, 1998, J EXP MED, V187, P1893, DOI 10.1084/jem.187.11.1893	27	7	7	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2013	288	16					11066	11073		10.1074/jbc.M112.442244	http://dx.doi.org/10.1074/jbc.M112.442244			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	130KW	23457304	Green Published, hybrid			2022-12-25	WOS:000317915500012
J	Watanabe, N; Mii, S; Asai, N; Asai, M; Niimi, K; Ushida, K; Kato, T; Enomoto, A; Ishii, H; Takahashi, M; Murakumo, Y				Watanabe, Naoki; Mii, Shinji; Asai, Naoya; Asai, Masato; Niimi, Kaoru; Ushida, Kaori; Kato, Takuya; Enomoto, Atsushi; Ishii, Hideshi; Takahashi, Masahide; Murakumo, Yoshiki			The REV7 Subunit of DNA Polymerase zeta Is Essential for Primordial Germ Cell Maintenance in the Mouse	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR ELK-1; BINDING PROTEIN TIAR; EMBRYONIC STEM-CELLS; MICE LACKING; CATALYTIC SUBUNIT; REPAIR; COMPLEX; SPECIFICATION; MAD2L2; DISRUPTION	REV7 (also known as MAD2L2 and MAD2B) is involved in DNA repair, cell cycle regulation, gene expression, and carcinogenesis. In vitro studies show that REV7 interacts with several proteins and regulates their function. It has been reported that human REV7 is highly expressed in the adult testis by Northern blot analysis. However, the significance of REV7 in mammalian development has not been elucidated. Here, we present analyses of REV7-deficient (Rev7(-/-)) mice to clarify the significance of Rev7 in mouse development. In WT mice (Rev7(-/-)), Rev7 expression was ubiquitously observed in the embryo and confined to germ cells in the testes after birth. Rev7(-/-) mice exhibited growth retardation and a partial embryonic lethal phenotype. Mice that survived to adulthood were infertile in both sexes and showed germ cell aplasia in the testes and ovaries. Analyses of Rev7(-/-) embryos revealed that primordial germ cells (PGCs) were present at embryonic day 8.5 (E8.5). However, progressive loss of PGCs was observed during migration, and PGCs were absent in the genital ridges at E13.5. An increase of apoptotic cells was detected not only among PGCs but also in the forebrain of the Rev7(-/-) embryo, whereas cell proliferation was unaffected. Moreover, DNA damage accumulation and increased levels of histone methylation were detected in Rev7(-/-) embryos, and expression of Oct4 and Nanog was deregulated by REV7 deficiency at E8.5. These findings indicate that Rev7 is essential for PGC maintenance by prevention of apoptotic cell death in the mouse.	[Watanabe, Naoki; Mii, Shinji; Asai, Masato; Niimi, Kaoru; Ushida, Kaori; Kato, Takuya; Enomoto, Atsushi; Takahashi, Masahide; Murakumo, Yoshiki] Nagoya Univ, Grad Sch Med, Ctr Neurol Dis & Canc, Dept Pathol,Showa Ku, Nagoya, Aichi 4668550, Japan; [Niimi, Kaoru] Nagoya Univ, Grad Sch Med, Ctr Neurol Dis & Canc, Dept Obstet & Gynecol,Showa Ku, Nagoya, Aichi 4668550, Japan; [Asai, Naoya; Takahashi, Masahide] Nagoya Univ, Grad Sch Med, Ctr Neurol Dis & Canc, Div Mol Pathol,Showa Ku, Nagoya, Aichi 4668550, Japan; [Ishii, Hideshi] Osaka Univ, Grad Sch Med, Dept Surg Gastroenterol, Suita, Osaka 5650871, Japan; [Murakumo, Yoshiki] Kitasato Univ, Sch Med, Dept Pathol, Minami Ku, Sagamihara, Kanagawa 2520374, Japan	Nagoya University; Nagoya University; Nagoya University; Osaka University; Kitasato University	Murakumo, Y (corresponding author), Kitasato Univ, Sch Med, Dept Pathol, Minami Ku, 1-15-1 Kitasato, Sagamihara, Kanagawa 2520374, Japan.	murakumo@med.kitasato-u.ac.jp	Takahashi, Masahide/AAN-4770-2020; Mii, Shinji/I-7480-2014; asai, masato/I-7294-2014; Ishii, Hideshi/AAV-5317-2020; TAKAHASHI, Masahide/I-7244-2014; NIIMI, Kaoru/I-7509-2014; ASAI, Naoya/I-7377-2014; Enomoto, Atsushi/I-7272-2014	Takahashi, Masahide/0000-0002-2803-2683; Mii, Shinji/0000-0001-8266-3235; Enomoto, Atsushi/0000-0002-9206-6116	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; MEXT of Japan	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-aid for Global Center of Excellence (GCOE) Research and for Scientific Research (A) commissioned by the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan (to M. T.), and by Grants-in-aid for Scientific Research (C) commissioned by MEXT of Japan (to Y. M.).	Anderson R, 1999, DEVELOPMENT, V126, P1655; Beck ARP, 1998, P NATL ACAD SCI USA, V95, P2331, DOI 10.1073/pnas.95.5.2331; Bemark M, 2000, CURR BIOL, V10, P1213, DOI 10.1016/S0960-9822(00)00724-7; Burcham PC, 1999, MUTAT RES-GEN TOX EN, V443, P11, DOI 10.1016/S1383-5742(99)00008-3; Cahill DP, 1999, GENOMICS, V58, P181, DOI 10.1006/geno.1999.5831; Cesari F, 2004, MOL CELL BIOL, V24, P294, DOI 10.1128/MCB.24.1.294-305.2004; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chen J, 2001, GENE DEV, V15, P1765, DOI 10.1101/gad.898701; Chen TJ, 2012, MOL BIOL REP, V39, P1855, DOI 10.1007/s11033-011-0928-6; Dobles M, 2000, CELL, V101, P635, DOI 10.1016/S0092-8674(00)80875-2; Esposito G, 2000, CURR BIOL, V10, P1221, DOI 10.1016/S0960-9822(00)00726-0; Ewen KA, 2010, MOL CELL ENDOCRINOL, V323, P76, DOI 10.1016/j.mce.2009.12.013; Ferlin A, 2006, REPROD TOXICOL, V22, P133, DOI 10.1016/j.reprotox.2006.04.016; Garcia-Higuera I, 2008, NAT CELL BIOL, V10, P802, DOI 10.1038/ncb1742; Guo CX, 2009, CELL MOL LIFE SCI, V66, P2363, DOI 10.1007/s00018-009-0024-4; Hara K, 2010, J BIOL CHEM, V285, P12299, DOI 10.1074/jbc.M109.092403; Hong CF, 2009, J BIOL CHEM, V284, P19613, DOI 10.1074/jbc.M109.005017; Hsia KT, 2003, DEVELOPMENT, V130, P369, DOI 10.1242/dev.00221; Iwai H, 2007, CELL, V130, P611, DOI 10.1016/j.cell.2007.06.043; Jaroudi S, 2007, MUTAT RES-REV MUTAT, V635, P53, DOI 10.1016/j.mrrev.2006.09.002; Kehler J, 2004, EMBO REP, V5, P1078, DOI 10.1038/sj.embor.7400279; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; Kurimoto K, 2008, GENE DEV, V22, P1617, DOI 10.1101/gad.1649908; Li L, 2007, MOL CELL BIOCHEM, V304, P297, DOI 10.1007/s11010-007-9512-8; Li M, 2007, MOL CELL BIOL, V27, P3481, DOI 10.1128/MCB.02088-06; Masuda Y, 2003, J BIOL CHEM, V278, P12356, DOI 10.1074/jbc.M211765200; Matsui Y, 2010, J ANDROL, V31, P61, DOI 10.2164/jandrol.109.008094; Matsunami H, 1995, DEV BIOL, V172, P466, DOI 10.1006/dbio.1995.8029; Matzuk MM, 2002, NAT CELL BIOL, V4, pS41; Mazan-Mamczarz K, 2006, MOL CELL BIOL, V26, P2716, DOI 10.1128/MCB.26.7.2716-2727.2006; McNally K, 2008, DNA REPAIR, V7, P597, DOI 10.1016/j.dnarep.2007.12.013; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Murakumo Y, 2000, J BIOL CHEM, V275, P4391, DOI 10.1074/jbc.275.6.4391; Murakumo Y, 2001, J BIOL CHEM, V276, P35644, DOI 10.1074/jbc.M102051200; Nakane H, 2008, DNA REPAIR, V7, P1938, DOI 10.1016/j.dnarep.2008.08.003; Nelson JR, 1996, SCIENCE, V272, P1646, DOI 10.1126/science.272.5268.1646; Ng JMY, 2002, MOL CELL BIOL, V22, P1233, DOI 10.1128/MCB.22.4.1233-1245.2002; Ohinata Y, 2005, NATURE, V436, P207, DOI 10.1038/nature03813; Okada T, 2005, MOL CELL BIOL, V25, P6103, DOI 10.1128/MCB.25.14.6103-6111.2005; Ombelet W, 2008, HUM REPROD UPDATE, V14, P605, DOI 10.1093/humupd/dmn042; Pfleger CM, 2001, GENE DEV, V15, P1759, DOI 10.1101/gad.897901; Rimkus C, 2007, INT J CANCER, V120, P207, DOI 10.1002/ijc.22155; Runyan C, 2006, DEVELOPMENT, V133, P4861, DOI 10.1242/dev.02688; Saga Y, 2008, CURR OPIN GENET DEV, V18, P337, DOI 10.1016/j.gde.2008.06.003; Saitou M, 2010, REPRODUCTION, V139, P931, DOI 10.1530/REP-10-0043; Saitou M, 2009, CURR OPIN GENET DEV, V19, P386, DOI 10.1016/j.gde.2009.06.003; Schmahl J, 2000, DEVELOPMENT, V127, P65; SCHOLER HR, 1990, EMBO J, V9, P2185, DOI 10.1002/j.1460-2075.1990.tb07388.x; Seki Y, 2005, DEV BIOL, V278, P440, DOI 10.1016/j.ydbio.2004.11.025; Seki Y, 2007, DEVELOPMENT, V134, P2627, DOI 10.1242/dev.005611; Sharma S, 2012, NUCLEIC ACIDS RES, V40, P682, DOI 10.1093/nar/gkr769; Sun JH, 2009, MECH DEVELOP, V126, P173, DOI 10.1016/j.mod.2008.11.004; Tsuda M, 2003, SCIENCE, V301, P1239, DOI 10.1126/science.1085222; Van Sloun PPH, 2002, MOL CELL BIOL, V22, P2159, DOI 10.1128/MCB.22.7.2159-2169.2002; Vinson RK, 2002, MUTAT RES-FUND MOL M, V509, P79, DOI 10.1016/S0027-5107(02)00223-3; Waters LS, 2009, MICROBIOL MOL BIOL R, V73, P134, DOI 10.1128/MMBR.00034-08; Weterman MAJ, 2001, P NATL ACAD SCI USA, V98, P13808, DOI 10.1073/pnas.241304198; WILKINSON DG, 1993, METHOD ENZYMOL, V225, P361; WINK DA, 1991, SCIENCE, V254, P1001, DOI 10.1126/science.1948068; Wittschieben J, 2000, CURR BIOL, V10, P1217, DOI 10.1016/S0960-9822(00)00725-9; Yamaji M, 2008, NAT GENET, V40, P1016, DOI 10.1038/ng.186; Yeom YI, 1996, DEVELOPMENT, V122, P881; Youngren KK, 2005, NATURE, V435, P360, DOI 10.1038/nature03595; Zhang L, 2007, MOL CELL BIOL, V27, P2861, DOI 10.1128/MCB.02276-06	64	38	39	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2013	288	15					10459	10471		10.1074/jbc.M112.421966	http://dx.doi.org/10.1074/jbc.M112.421966			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	125TU	23463509	Green Published, hybrid			2022-12-25	WOS:000317565000026
J	Bains, I; Yates, AJ; Callard, RE				Bains, Iren; Yates, Andrew J.; Callard, Robin E.			Heterogeneity in Thymic Emigrants: Implications for Thymectomy and Immunosenescence	PLOS ONE			English	Article							CD4(+) T-CELLS; EXCISION CIRCLE CONTENT; IMMUNE FUNCTION; AGED MICE; DEFECTS; ANTIGEN; LIFE; POOL; PROLIFERATION; COMPARTMENT	The development of mature, antigen-inexperienced (naive) T cells begins in the thymus and continues after export into the periphery. Post-thymic maturation of naive T cells, in humans, coincides with the progressive loss of markers such as protein tyrosine kinase 7 (PTK7) and platelet endothelial cell adhesion molecule-1 (CD31). As a consequence, subpopulations of naive T cells can be recognised raising questions about the processes that give rise to the loss of these markers and their exact relationship to recent thymic emigrants (RTE). Here, we combine a mathematical survival analysis approach and data from healthy and thymectomised humans to understand the apparent persistence of populations of 'veteran' PTK7(+)T cells in thymectomised individuals. We show that a model of heterogeneity in rates of maturation, possibly linked to natural variation in TCR signalling thresholds or affinity for self-antigens, can explain the data. This model of maturation predicts that the average post-thymic age of PTK7(+)T cells will increase linearly with the age of the host suggesting that, despite the immature phenotype, PTK7(+) cells do not necessarily represent a population of RTE. Further, the model predicts an accelerated increase in the average post-thymic age of residual PTK7(+) T cells following thymectomy and may also explain in part the prematurely aged phenotype of the naive T cell pool in individuals thymectomised early in life.	[Bains, Iren] Natl Inst Med Res, London NW7 1AA, England; [Bains, Iren; Yates, Andrew J.] Albert Einstein Coll Med, Dept Syst & Computat Biol, Bronx, NY 10467 USA; [Bains, Iren; Callard, Robin E.] UCL Inst Child Hlth, Immunobiol Unit, London, England; [Bains, Iren; Callard, Robin E.] UCL, Ctr Math & Phys Life Sci & Expt Biol CoMPLEX, London, England; [Yates, Andrew J.] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA	MRC National Institute for Medical Research; Yeshiva University; Albert Einstein College of Medicine; University of London; University College London; University of London; University College London; Yeshiva University; Albert Einstein College of Medicine	Bains, I (corresponding author), Natl Inst Med Res, Mill Hill, London NW7 1AA, England.	ibains@nimr.mrc.ac.uk			NIH [R01 AI093870-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093870] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the NIH (R01 AI093870-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azevedo RI, 2009, BLOOD, V113, P2999, DOI 10.1182/blood-2008-07-166223; Bains I, 2009, J IMMUNOL, V183, P4329, DOI 10.4049/jimmunol.0900743; Bains I, 2009, BLOOD, V113, P5480, DOI 10.1182/blood-2008-10-184184; Berzins SP, 1998, J EXP MED, V187, P1839, DOI 10.1084/jem.187.11.1839; Boursalian TE, 2004, NAT IMMUNOL, V5, P418, DOI 10.1038/ni1049; CALLARD RE, 1978, EUR J IMMUNOL, V8, P552, DOI 10.1002/eji.1830080803; Cho JH, 2010, IMMUNITY, V32, P214, DOI 10.1016/j.immuni.2009.11.014; Chu YW, 2004, BLOOD, V104, P1110, DOI 10.1182/blood-2003-10-3635; Clise-Dwyer K, 2007, J IMMUNOL, V178, P1321, DOI 10.4049/jimmunol.178.3.1321; COOK JM, 1987, CELL IMMUNOL, V109, P89, DOI 10.1016/0008-8749(87)90294-2; Douek DC, 1998, NATURE, V396, P690, DOI 10.1038/25374; Feinerman O, 2008, SCIENCE, V321, P1081, DOI 10.1126/science.1158013; Goronzy JJ, 2007, EXP GERONTOL, V42, P400, DOI 10.1016/j.exger.2006.11.016; Grubeck-Loebenstein B, 2002, ADV IMMUNOL, V80, P243, DOI 10.1016/S0065-2776(02)80017-7; Haines CJ, 2009, J EXP MED, V206, P275, DOI 10.1084/jem.20080996; Haynes L, 2005, J EXP MED, V201, P845, DOI 10.1084/jem.20041933; Hazenberg MD, 2003, NAT IMMUNOL, V4, P97, DOI 10.1038/ni0203-97; Hazenberg MD, 2000, NAT MED, V6, P1036, DOI 10.1038/79549; HOSSEINZADEH H, 1993, J IMMUNOL, V150, P1670; Huenecke S, 2008, EUR J HAEMATOL, V80, P532, DOI 10.1111/j.1600-0609.2008.01052.x; HULSTAERT F, 1994, CLIN IMMUNOL IMMUNOP, V70, P152, DOI 10.1006/clin.1994.1023; Jenkins MK, 2010, ANNU REV IMMUNOL, V28, P275, DOI 10.1146/annurev-immunol-030409-101253; Jones SC, 2008, J IMMUNOL, V180, P4465, DOI 10.4049/jimmunol.180.7.4465; Kilpatrick RD, 2008, J IMMUNOL, V180, P1499, DOI 10.4049/jimmunol.180.3.1499; Kimmig S, 2002, J EXP MED, V195, P789, DOI 10.1084/jem.20011756; Kohler S, 2005, EUR J IMMUNOL, V35, P1987, DOI 10.1002/eji.200526181; Linton PJ, 1996, J EXP MED, V184, P1891, DOI 10.1084/jem.184.5.1891; Macallan DC, 2004, J EXP MED, V200, P255, DOI 10.1084/jem.20040341; Mancebo E, 2008, CLIN EXP IMMUNOL, V154, P375, DOI 10.1111/j.1365-2249.2008.03771.x; Naylor K, 2005, J IMMUNOL, V174, P7446, DOI 10.4049/jimmunol.174.11.7446; Opiela SJ, 2009, BLOOD, V113, P5635, DOI 10.1182/blood-2008-08-173658; Palmer MJ, 2011, IMMUNOL CELL BIOL, V89, P581, DOI 10.1038/icb.2011.5; PHAIR J, 1978, J LAB CLIN MED, V92, P822; Prelog M, 2008, VACCINE, V26, P595, DOI 10.1016/j.vaccine.2007.11.074; Prelog M, 2009, CLIN IMMUNOL, V130, P123, DOI 10.1016/j.clim.2008.08.023; Sauce D, 2009, J CLIN INVEST, V119, P3070, DOI 10.1172/JCI39269; Shigemura N, 2006, SURG ENDOSC, V20, P1614, DOI 10.1007/s00464-005-0614-7; STEINMANN GG, 1985, SCAND J IMMUNOL, V22, P563, DOI 10.1111/j.1365-3083.1985.tb01916.x; Surh CD, 2000, J EXP MED, V192, pF9, DOI 10.1084/jem.192.4.F9; Terszowski G, 2006, SCIENCE, V312, P284, DOI 10.1126/science.1123497; Tsukamoto H, 2009, P NATL ACAD SCI USA, V106, P18333, DOI 10.1073/pnas.0910139106; Vrisekoop N, 2008, P NATL ACAD SCI USA, V105, P6115, DOI 10.1073/pnas.0709713105; Zamoyska R, 2003, IMMUNOL REV, V191, P107, DOI 10.1034/j.1600-065X.2003.00015.x; Zlamy M, 2009, REJUV RES, V12, P249, DOI 10.1089/rej.2009.0864	44	10	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e49554	10.1371/journal.pone.0049554	http://dx.doi.org/10.1371/journal.pone.0049554			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23468830	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000315519000001
J	Edelmann, MN; Demers, CH; Auger, AP				Edelmann, Michelle N.; Demers, Catherine H.; Auger, Anthony P.			Maternal Touch Moderates Sex Differences in Juvenile Social Play Behavior	PLOS ONE			English	Article							TACTILE STIMULATION; PREPUBESCENT RATS; EXPRESSION; GENES; CARE; NORMALIZATION; TESTOSTERONE; ORGANIZATION; RECEPTORS; TISSUE	Additional somatosensory contact of preterm human infants improves a variety of developmental assessment scores, but less is known about its lasting consequences. In rodents, maternal contact may influence the programming of juvenile social play behavior. Therefore, we used a paradigm where we can control the levels of somatosensory contact associated with maternal care. We find that additional somatosensory contact of offspring can have lasting consequences on juvenile social play behavior in a sex-dependent manner. Specifically, additional somatosensory stimuli reduced male social play behavior, but did not change female play behavior. We then examined if this additional infant contact altered some neurobiological substrates associated with play within the juvenile amygdala. Control males had lower levels of 5HT2a receptor mRNA levels contrasted to females; however, similar to its sex-dependent effect on juvenile social play, males that received additional somatosensory contact had higher serotonin 5HT2a receptor mRNA levels than control males. No difference was found in females. As serotonin signaling typically opposes juvenile play behavior, these data suggest that maternal touch can program lasting differences in juvenile social play and 5HT2a receptors mRNA levels within the juvenile amygdala.	[Edelmann, Michelle N.; Auger, Anthony P.] Univ Wisconsin, Neurosci Training Program, Madison, WI 53706 USA; [Demers, Catherine H.; Auger, Anthony P.] Univ Wisconsin, Dept Psychol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Auger, AP (corresponding author), Univ Wisconsin, Neurosci Training Program, Madison, WI 53706 USA.	apauger@wisc.edu			National Institute of Mental Health grant [R01-MH072956]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH072956] Funding Source: NIH RePORTER	National Institute of Mental Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by National Institute of Mental Health grant R01-MH072956 to APA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardiel EL, 2010, PAED CHILD HEALT-CAN, V15, P153, DOI 10.1093/pch/15.3.153; Auger AP, 2009, J NEUROENDOCRINOL, V21, P519, DOI 10.1111/j.1365-2826.2009.01871.x; BEATTY WW, 1984, PHARMACOL BIOCHEM BE, V20, P747, DOI 10.1016/0091-3057(84)90194-1; BEATTY WW, 1981, PHYSIOL BEHAV, V26, P241, DOI 10.1016/0031-9384(81)90017-2; BIRKE LIA, 1987, DEV PSYCHOBIOL, V20, P85, DOI 10.1002/dev.420200111; BLACKBURN JR, 1992, PROG NEUROBIOL, V39, P247, DOI 10.1016/0301-0082(92)90018-A; Bonefeld BE, 2008, SYNAPSE, V62, P302, DOI 10.1002/syn.20496; CASLER L, 1965, GENET PSYCHOL MONOGR, V71, P137; Casto JM, 2003, PHYSIOL BEHAV, V79, P633, DOI 10.1016/S0031-9384(03)00120-3; de Kok JB, 2005, LAB INVEST, V85, P154, DOI 10.1038/labinvest.3700208; EVONIUK GE, 1979, COMMUN PSYCHOPHARMAC, V3, P363; Fairbanks LA, 2001, NEUROPSYCHOPHARMACOL, V24, P370, DOI 10.1016/S0893-133X(00)00211-6; FIELD TM, 1986, PEDIATRICS, V77, P654; Filby AL, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-10; GERALL HD, 1967, ANIM BEHAV, V15, P54, DOI 10.1016/S0003-3472(67)80010-1; Higley JD, 1997, ANN NY ACAD SCI, V836, P39, DOI 10.1111/j.1749-6632.1997.tb52354.x; Homberg JR, 2007, PSYCHOPHARMACOLOGY, V195, P175, DOI 10.1007/s00213-007-0895-8; HUMPHREYS AP, 1981, ANIM BEHAV, V29, P259, DOI 10.1016/S0003-3472(81)80173-X; LE MM, 1991, PHYSIOL REV, V71, P155; Liu D, 1997, SCIENCE, V277, P1659, DOI 10.1126/science.277.5332.1659; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MEANEY MJ, 1981, HORM BEHAV, V15, P197, DOI 10.1016/0018-506X(81)90028-3; MEANEY MJ, 1986, BRAIN RES, V398, P324, DOI 10.1016/0006-8993(86)91492-7; MOORE CL, 1979, J COMP PHYSIOL PSYCH, V93, P677, DOI 10.1037/h0077599; MOORE CL, 1992, DEV PSYCHOBIOL, V25, P165, DOI 10.1002/dev.420250303; MOORE CL, 1984, DEV PSYCHOBIOL, V17, P347, DOI 10.1002/dev.420170403; NIESINK RJM, 1989, NEUROPHARMACOLOGY, V28, P411, DOI 10.1016/0028-3908(89)90038-5; Olesen KM, 2005, ENDOCRINOLOGY, V146, P3705, DOI 10.1210/en.2005-0498; OLIOFF M, 1978, PHYSIOL BEHAV, V20, P113, DOI 10.1016/0031-9384(78)90060-4; PANKSEPP J, 1984, NEUROSCI BIOBEHAV R, V8, P465, DOI 10.1016/0149-7634(84)90005-8; Parent CI, 2008, DEV PSYCHOBIOL, V50, P767, DOI 10.1002/dev.20342; SALAMONE JD, 1994, BEHAV BRAIN RES, V65, P221, DOI 10.1016/0166-4328(94)90108-2; SPEAR LP, 1983, DEV PSYCHOBIOL, V16, P83, DOI 10.1002/dev.420160203; TAYLOR GT, 1980, J COMP PHYSIOL PSYCH, V94, P953, DOI 10.1037/h0077816; THOR DH, 1986, BEHAV NEUROSCI, V100, P275, DOI 10.1037/0735-7044.100.2.275; TONJES R, 1987, EXP CLIN ENDOCRINOL, V90, P257; Vanderschuren LJMJ, 1997, NEUROSCI BIOBEHAV R, V21, P309, DOI 10.1016/S0149-7634(96)00020-6; Veenema AH, 2009, PSYCHONEUROENDOCRINO, V34, P463, DOI 10.1016/j.psyneuen.2008.10.017	38	21	21	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57396	10.1371/journal.pone.0057396	http://dx.doi.org/10.1371/journal.pone.0057396			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460849	Green Published, gold, Green Submitted			2022-12-25	WOS:000315519000103
J	James, MM; Laeyendecker, O; Sun, J; Hoover, DR; Mullis, CE; Cousins, MM; Coates, T; Moore, RD; Kelen, GD; Fowler, MG; Kumwenda, JJ; Mofenson, LM; Kumwenda, NI; Taha, TE; Eshleman, SH				James, Maria M.; Laeyendecker, Oliver; Sun, Jin; Hoover, Donald R.; Mullis, Caroline E.; Cousins, Matthew M.; Coates, Thomas; Moore, Richard D.; Kelen, Gabor D.; Fowler, Mary Glenn; Kumwenda, Johnstone J.; Mofenson, Lynne M.; Kumwenda, Newton I.; Taha, Taha E.; Eshleman, Susan H.			Antibody Maturation and Viral Diversification in HIV-Infected Women	PLOS ONE			English	Article							RESOLUTION MELTING ASSAY; ENZYME-IMMUNOASSAY; DRUG-RESISTANCE; SUBTYPE-C; DIVERSITY; MUTATIONS; SEX	Introduction: The Post-exposure Prophylaxis in Infants (PEPI)-Malawi trial evaluated infant antiretroviral regimens for prevention of post-natal HIV transmission. A multi-assay algorithm (MAA) that includes the BED capture immunoassay, an avidity assay, CD4 cell count, and viral load was used to identify women who were vs. were not recently infected at the time of enrollment (MAA recent, N = 73; MAA non-recent, N = 2,488); a subset of the women in the MAA non-recent group known to have been HIV infected for at least 2 years before enrollment (known non-recent, N = 54). Antibody maturation and viral diversification were examined in these women. Methods: Samples collected at enrollment (N = 2,561) and 12-24 months later (N = 1,306) were available for serologic analysis using the BED and avidity assays. A subset of those samples was used for analysis of viral diversity, which was performed using a high resolution melting (HRM) diversity assay. Viral diversity analysis was performed using all available samples from women in the MAA recent group (61 enrollment samples, 38 follow-up samples) and the known non-recent group (43 enrollment samples, 22 follow-up samples). Diversity data from PEPI-Malawi were also compared to similar data from 169 adults in the United States (US) with known recent infection (N = 102) and known non-recent infection (N = 67). Results: In PEPI-Malawi, results from the BED and avidity assays increased over time in the MAA recent group, but did not change significantly in the MAA non- recent group. At enrollment, HIV diversity was lower in the MAA recent group than in the known non- recent group. HRM diversity assay results from women in PEPI-Malawi were similar to those from adults in the US with known duration of HIV infection. Conclusions: Antibody maturation and HIV diversification patterns in African women provide additional support for use of the MAA to identify populations with recent HIV infection.	[James, Maria M.; Cousins, Matthew M.; Fowler, Mary Glenn; Eshleman, Susan H.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Laeyendecker, Oliver] NIAID, Immunoregulat Lab, NIH, Bethesda, MD 20892 USA; [Laeyendecker, Oliver; Mullis, Caroline E.; Moore, Richard D.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Sun, Jin; Kumwenda, Newton I.; Taha, Taha E.] Johns Hopkins Univ, Dept Epidemiol, Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Hoover, Donald R.] Rutgers State Univ, Dept Stat & Biostat, Piscataway, NJ USA; [Hoover, Donald R.] Rutgers State Univ, Inst Hlth Hlth Care Policy & Aging Res, Piscataway, NJ USA; [Coates, Thomas] Univ Calif Los Angeles, Program Global Hlth, Los Angeles, CA USA; [Kelen, Gabor D.] Johns Hopkins Univ, Sch Med, Dept Emergency Med, Baltimore, MD USA; [Kumwenda, Johnstone J.] Univ Malawi, Dept Med, Coll Med, Blantyre, Malawi; [Mofenson, Lynne M.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Pediat Adolescent & Maternal AIDS Branch, NIH, Rockville, MD USA	Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Rutgers State University New Brunswick; Rutgers State University New Brunswick; University of California System; University of California Los Angeles; Johns Hopkins University; University of Malawi; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Eshleman, SH (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA.	seshlem@jhmi.edu	Laeyendecker, Oliver B/B-9331-2009; Kumwenda, Newton/ADL-6890-2022; Mofenson, Lynne/P-9631-2019	Mofenson, Lynne/0000-0002-2818-9808; Cousins, Matthew/0000-0003-0067-9087; Taha, Taha/0000-0001-9814-4894; Laeyendecker, Oliver/0000-0002-6429-4760; Kelen, Gabor/0000-0002-3236-8286; Kumwenda, Newton/0000-0003-2622-4339	International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) Group, American Recovery and Reinvestment Act (ARRA) award [3U01AI068632-05S3]; National Institute of Allergy and Infectious Diseases (NIAID); National Institute on Drug Abuse (NIDA); National Institute of Mental Health (NIMH); Office of AIDS Research, of the National Institutes of Health (NIH), Dept. of Health and Human Services (DHHS) [U01AI068613, UM1AI068613]; Centers for Disease Control and Prevention [U50/CCU022061]; International Maternal Pediatric and Adolescent AIDS Clinical Trials (IMPAACT) Group [U01-AI068632]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI068613, UM1AI068613, R01AI095068, ZIAAI000361, U01AI068632] Funding Source: NIH RePORTER	International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) Group, American Recovery and Reinvestment Act (ARRA) award; National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute on Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Office of AIDS Research, of the National Institutes of Health (NIH), Dept. of Health and Human Services (DHHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); International Maternal Pediatric and Adolescent AIDS Clinical Trials (IMPAACT) Group; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funders for this work are as follows: (1) International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) Group, American Recovery and Reinvestment Act (ARRA) award (Cooperative Agreement 3U01AI068632-05S3); (2) The HIV Prevention Trials Network (HPTN) sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), the National Institute on Drug Abuse (NIDA), the National Institute of Mental Health (NIMH), and the Office of AIDS Research, of the National Institutes of Health (NIH), Dept. of Health and Human Services (DHHS) (U01AI068613, UM1AI068613); (3) The Centers for Disease Control and Prevention (Cooperative Agreement U50/CCU022061); and (4) The International Maternal Pediatric and Adolescent AIDS Clinical Trials (IMPAACT) Group (U01-AI068632). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Church JD, 2007, AIDS RES HUM RETROV, V23, P764, DOI 10.1089/aid.2006.0272; Coates T, 2013, 20 C RETR OPP INF AT; Cousins MM, 2012, J CLIN MICROBIOL, V50, P3054, DOI 10.1128/JCM.01460-12; Cousins MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027211; Dobbs T, 2004, J CLIN MICROBIOL, V42, P2623, DOI 10.1128/JCM.42.6.2623-2628.2004; Eshleman SH, 2007, AIDS, V21, P1165, DOI 10.1097/QAD.0b013e32810fd72e; Eshleman SH, 2013, J INFECT DIS, V207, P223, DOI 10.1093/infdis/jis658; Guy R, 2009, LANCET INFECT DIS, V9, P747, DOI 10.1016/S1473-3099(09)70300-7; James MM, 2012, PEDIATR INFECT DIS J, V31, pE222, DOI 10.1097/INF.0b013e3182678c3f; James MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018642; Karita E, 2007, AIDS, V21, P403, DOI 10.1097/QAD.0b013e32801481b7; Kouyos RD, 2011, CLIN INFECT DIS, V52, P532, DOI 10.1093/cid/ciq164; Kumwenda NI, 2008, NEW ENGL J MED, V359, P119, DOI 10.1056/NEJMoa0801941; Laeyendecker O, 2013, 20 C RETR OPP INF AT; Laeyendecker O, 2008, JAIDS-J ACQ IMM DEF, V48, P211, DOI 10.1097/QAI.0b013e3181743980; Laeyendecker O, 2012, AIDS RES HUM RETROV, V28, P816, DOI [10.1089/aid.2011.0258, 10.1089/AID.2011.0258]; Laeyendecker O, 2013, J INFECT DIS, V207, P232, DOI 10.1093/infdis/jis659; Lihana RW, 2012, AIDS REV, V14, P83; Long EM, 2000, NAT MED, V6, P71; Masciotra S., 2010, 17 C RETR OPP INF 20; Murphy G, 2008, EURO SURVEILL, V13; Petch LA, 2005, AIDS RES HUM RETROV, V21, P799, DOI 10.1089/aid.2005.21.799; Ray SC, 2000, NAT MED, V6, P23, DOI 10.1038/71487; Taha TE, 2011, AIDS, V25, P1357, DOI 10.1097/QAD.0b013e3283489d45; Towler WI, 2010, AIDS RES HUM RETROV, V26, P913, DOI 10.1089/aid.2009.0259; *UNAIDS, 2005, UNAIDS REF GROUP EST; Wheeler WH, 2010, AIDS, V24, P1203, DOI 10.1097/QAD.0b013e3283388742; Wilson E, 2011, 18 C RETR OPP INF BO	28	11	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57350	10.1371/journal.pone.0057350	http://dx.doi.org/10.1371/journal.pone.0057350			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460842	Green Published, Green Submitted, gold			2022-12-25	WOS:000315519000096
J	Kerlin, DH; Gatton, ML				Kerlin, Douglas H.; Gatton, Michelle L.			Preferential Invasion by Plasmodium Merozoites and the Self-Regulation of Parasite Burden	PLOS ONE			English	Article							ACUTE MALARIA INFECTIONS; RED-BLOOD-CELLS; HUMAN RETICULOCYTES; ANEMIA; VIVAX; FALCIPARUM; ERYTHROCYTES; DYNAMICS; SUSCEPTIBILITY; SELECTIVITY	The preferential invasion of particular red blood cell (RBC) age classes may offer a mechanism by which certain species of Plasmodia regulate their population growth. Asexual reproduction of the parasite within RBCs exponentially increases the number of circulating parasites; limiting this explosion in parasite density may be key to providing sufficient time for the parasite to reproduce, and for the host to develop a specific immune response. It is critical that the role of preferential invasion in infection is properly understood to model the within-host dynamics of different Plasmodia species. We develop a simulation model to show that limiting the range of RBC age classes available for invasion is a credible mechanism for restricting parasite density, one which is equally as important as the maximum parasite replication rate and the duration of the erythrocytic cycle. Different species of Plasmodia that regularly infect humans exhibit different preferences for RBC invasion, with all species except P. falciparum appearing to exhibit a combination of characteristics which are able to self-regulate parasite density.	[Kerlin, Douglas H.; Gatton, Michelle L.] Queensland Inst Med Res, Malaria Drug Resistance & Chemotherapy Lab, Brisbane, Qld 4006, Australia	QIMR Berghofer Medical Research Institute	Gatton, ML (corresponding author), Queensland Inst Med Res, Malaria Drug Resistance & Chemotherapy Lab, Brisbane, Qld 4006, Australia.	Michelle.Gatton@qimr.edu.au	Borrmann, Steffen/G-1838-2013; Gatton, Michelle/H-3139-2019	Borrmann, Steffen/0000-0001-9189-4393; Gatton, Michelle/0000-0003-1188-609X; Kerlin, Douglas/0000-0001-5898-1559	NHMRC grant [613648]; NHMRC CDA; Research and Policy for Infectious Disease Dynamics (RAPIDD) program of the Science and Technology Directorate, Department of Homeland Security; Fogarty International Center, National Institutes of Health	NHMRC grant(National Health and Medical Research Council (NHMRC) of Australia); NHMRC CDA(National Health and Medical Research Council (NHMRC) of Australia); Research and Policy for Infectious Disease Dynamics (RAPIDD) program of the Science and Technology Directorate, Department of Homeland Security; Fogarty International Center, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported by NHMRC grant #613648. MLG is supported by NHMRC CDA and the Research and Policy for Infectious Disease Dynamics (RAPIDD) program of the Science and Technology Directorate, Department of Homeland Security, and the Fogarty International Center, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDALLA S, 1980, BRIT J HAEMATOL, V46, P171, DOI 10.1111/j.1365-2141.1980.tb05956.x; ABDALLA SH, 1990, BLOOD CELLS, V16, P401; Antia R, 2008, P ROY SOC B-BIOL SCI, V275, P1449, DOI 10.1098/rspb.2008.0198; BELAIR J, 1995, MATH BIOSCI, V128, P317, DOI 10.1016/0025-5564(94)00078-E; BERLIN NI, 1964, JAMA-J AM MED ASSOC, V188, P375; Boyle MJ, 2010, P NATL ACAD SCI USA, V107, P14378, DOI 10.1073/pnas.1009198107; Chang KH, 2004, BLOOD, V103, P3727, DOI 10.1182/blood-2003-08-2887; Collins WE, 2003, AM J TROP MED HYG, V68, P410, DOI 10.4269/ajtmh.2003.68.410; Cowman AF, 2006, CELL, V124, P755, DOI 10.1016/j.cell.2006.02.006; Cromer D, 2006, INT J PARASITOL, V36, P1389, DOI 10.1016/j.ijpara.2006.07.009; Cromer D, 2009, J THEOR BIOL, V257, P533, DOI 10.1016/j.jtbi.2008.12.019; Deans AM, 2006, AM J TROP MED HYG, V74, P554, DOI 10.4269/ajtmh.2006.74.554; Galinski MR, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-S1-S9; Galinski MR, 1996, PARASITOL TODAY, V12, P20, DOI 10.1016/0169-4758(96)80641-7; Garnham PCC, 1966, MALARIA PARASITES OT; Gotelli NJ, 2001, PRIMER ECOLOGY; Haydon DT, 2003, P ROY SOC B-BIOL SCI, V270, P289, DOI 10.1098/rspb.2002.2203; Hegner R, 1938, AM J HYG, V27, P690, DOI 10.1093/oxfordjournals.aje.a118422; Iyer J, 2007, MOL MICROBIOL, V65, P231, DOI 10.1111/j.1365-2958.2007.05791.x; Jakeman GN, 1999, PARASITOLOGY, V119, P127, DOI 10.1017/S0031182099004564; McQueen Philip G, 2010, Biophys Rev, V2, P111; MONS B, 1990, BLOOD CELLS, V16, P299; Pacheco MA, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-299; PASVOL G, 1980, BRIT J HAEMATOL, V45, P285, DOI 10.1111/j.1365-2141.1980.tb07148.x; Price RN, 2007, AM J TROP MED HYG, V77, P79, DOI 10.4269/ajtmh.2007.77.79; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rodriguez LE, 2002, VACCINE, V20, P1331, DOI 10.1016/S0264-410X(01)00472-8; ROTH RL, 1979, EXP PARASITOL, V47, P169, DOI 10.1016/0014-4894(79)90070-5; Russell B, 2011, BLOOD, V118, pE74, DOI 10.1182/blood-2011-04-348748; Sherwood L., 1997, HUMAN PHYSL CELLS SY; Silva JC, 2011, PARASITOLOGY, V138, P1737, DOI 10.1017/S0031182010001575; Simpson JA, 1999, T ROY SOC TROP MED H, V93, P165, DOI 10.1016/S0035-9203(99)90295-X; Tian LP, 1998, ACTA OBSTET GYN SCAN, V77, P717, DOI 10.1034/j.1600-0412.1998.770704.x; White NJ, 2009, MANSONS TROPICAL DIS; William T, 2011, EMERG INFECT DIS, V17, P1248, DOI 10.3201/eid1707.101017; World Health Organization, 2008, WORLD MAL REP	36	26	27	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57434	10.1371/journal.pone.0057434	http://dx.doi.org/10.1371/journal.pone.0057434			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460855	Green Published, Green Submitted, gold			2022-12-25	WOS:000315519000109
J	Liu, Y; Huo, NX; Dong, LL; Wang, Y; Zhang, SX; Young, HA; Feng, XX; Gu, YQ				Liu, Yue; Huo, Naxin; Dong, Lingli; Wang, Yi; Zhang, Shuixian; Young, Hugh A.; Feng, Xiaoxiao; Gu, Yong Qiang			Complete Chloroplast Genome Sequences of Mongolia Medicine Artemisia frigida and Phylogenetic Relationships with Other Plants	PLOS ONE			English	Article							ANCIENT EVOLUTIONARY SPLIT; PLASTID GENOME; DNA INVERSION; MOLECULAR PHYLOGENY; HORDEUM-VULGARE; MAJOR CLADES; ASTERACEAE; GENE; MICROSATELLITES; REPEAT	Background: Artemisia frigida Willd. is an important Mongolian traditional medicinal plant with pharmacological functions of stanch and detumescence. However, there is little sequence and genomic information available for Artemisia frigida, which makes phylogenetic identification, evolutionary studies, and genetic improvement of its value very difficult. We report the complete chloroplast genome sequence of Artemisia frigida based on 454 pyrosequencing. Methodology/Principal Findings: The complete chloroplast genome of Artemisia frigida is 151,076 bp including a large single copy (LSC) region of 82,740 bp, a small single copy (SSC) region of 18,394 bp and a pair of inverted repeats (IRs) of 24,971 bp. The genome contains 114 unique genes and 18 duplicated genes. The chloroplast genome of Artemisia frigida contains a small 3.4 kb inversion within a large 23 kb inversion in the LSC region, a unique feature in Asteraceae. The gene order in the SSC region of Artemisia frigida is inverted compared with the other 6 Asteraceae species with the chloroplast genomes sequenced. This inversion is likely caused by an intramolecular recombination event only occurred in Artemisia frigida. The existence of rich SSR loci in the Artemisia frigida chloroplast genome provides a rare opportunity to study population genetics of this Mongolian medicinal plant. Phylogenetic analysis demonstrates a sister relationship between Artemisia frigida and four other species in Asteraceae, including Ageratina adenophora, Helianthus annuus, Guizotia abyssinica and Lactuca sativa, based on 61 protein-coding sequences. Furthermore, Artemisia frigida was placed in the tribe Anthemideae in the subfamily Asteroideae (Asteraceae) based on ndhF and trnL-F sequence comparisons. Conclusion: The chloroplast genome sequence of Artemisia frigida was assembled and analyzed in this study, representing the first plastid genome sequenced in the Anthemideae tribe. This complete chloroplast genome sequence will be useful for molecular ecology and molecular phylogeny studies within Artemisia species and also within the Asteraceae family.	[Liu, Yue; Zhang, Shuixian; Feng, Xiaoxiao] Minzu Univ China, Coll Life & Environm Sci, Beijing, Peoples R China; [Liu, Yue] China Acad Tradit Chinese Med, Inst Chinese Mat Med, Beijing, Peoples R China; [Liu, Yue; Huo, Naxin; Dong, Lingli; Wang, Yi; Young, Hugh A.; Gu, Yong Qiang] ARS, Western Reg Res Ctr, USDA, Albany, CA USA; [Liu, Yue] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; [Zhang, Shuixian; Feng, Xiaoxiao] Minzu Univ China, Grad Sch, Beijing, Peoples R China	Minzu University of China; China Academy of Chinese Medical Sciences; Institute of Chinese Materia Medica, CACMS; United States Department of Agriculture (USDA); University of California System; University of California Davis; Minzu University of China	Liu, Y (corresponding author), Minzu Univ China, Coll Life & Environm Sci, Beijing, Peoples R China.	yueliu@caas.net.cn; yong.gu@ars.usda.gov		Wang, Yi/0000-0002-4706-8171	National Science Foundation of China [30801554, 81110108011]; China Postdoctoral Science Foundation [20110490556]; 111 Project [B08044]; 985 Project of Minzu University of China [MUC98504-14, MUC98507-08]; 211 Project of Minzu University of China	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); 111 Project(Ministry of Education, China - 111 Project); 985 Project of Minzu University of China; 211 Project of Minzu University of China	This work was supported by National Science Foundation of China (30801554 and 81110108011), China Postdoctoral Science Foundation (20110490556), 111 Project (B08044), 985 Project of Minzu University of China (MUC98504-14 and MUC98507-08), and 211 Project of Minzu University of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bremer K., 1994, ASTERACEAE CLADISTIC; Bryan GJ, 1999, THEOR APPL GENET, V99, P859, DOI 10.1007/s001220051306; Cai ZQ, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-77; Catalan P, 1997, MOL PHYLOGENET EVOL, V8, P150, DOI 10.1006/mpev.1997.0416; Chumley TW, 2006, MOL BIOL EVOL, V23, P2175, DOI 10.1093/molbev/msl089; Cronn R, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn502; Cui J, 2006, J MINZU U CHINA NATU, V15, P149; Daniell H, 2006, THEOR APPL GENET, V112, P1503, DOI 10.1007/s00122-006-0254-x; De Cosa B, 2001, NAT BIOTECHNOL, V19, P71, DOI 10.1038/83559; Dempewolf H, 2010, MOL ECOL RESOUR, V10, P1048, DOI 10.1111/j.1755-0998.2010.02859.x; Denda T, 1999, PLANT SYST EVOL, V217, P299, DOI 10.1007/BF00984372; Doorduin L, 2011, DNA RES, V18, P93, DOI 10.1093/dnares/dsr002; Doyle JJ, 1996, MOL PHYLOGENET EVOL, V5, P429, DOI 10.1006/mpev.1996.0038; DOYLE JJ, 1992, P NATL ACAD SCI USA, V89, P7722, DOI 10.1073/pnas.89.16.7722; Dufourmantel N, 2004, PLANT MOL BIOL, V55, P479, DOI 10.1007/s11103-004-0192-4; Ebert D, 2009, MOL ECOL RESOUR, V9, P673, DOI 10.1111/j.1755-0998.2008.02319.x; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Fernandez IA, 2001, MOL PHYLOGENET EVOL, V20, P41, DOI 10.1006/mpev.2001.0954; Flannery ML, 2006, THEOR APPL GENET, V113, P1221, DOI 10.1007/s00122-006-0377-0; Frank DA, 2010, ECOLOGY, V91, P3201, DOI 10.1890/09-1831.1; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; Garcia S, 2004, GENOME, V47, P1004, DOI 10.1139/G04-061; Garcia S, 2011, AM J BOT, V98, P638, DOI 10.3732/ajb.1000386; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Goremykin VV, 2003, MOL BIOL EVOL, V20, P1499, DOI 10.1093/molbev/msg159; Hagemann R, 2004, SEXUAL INHERITANCE P; Hansen DR, 2007, MOL PHYLOGENET EVOL, V45, P547, DOI 10.1016/j.ympev.2007.06.004; Hiiesalu I, 2012, MOL ECOL, V21, P2004, DOI 10.1111/j.1365-294X.2011.05390.x; HIRATSUKA J, 1989, MOL GEN GENET, V217, P185, DOI 10.1007/BF02464880; Jakobsson M, 2007, THEOR APPL GENET, V114, P223, DOI 10.1007/s00122-006-0425-9; JANSEN RK, 1987, P NATL ACAD SCI USA, V84, P5818, DOI 10.1073/pnas.84.16.5818; Jansen RK, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-32; Kajita T, 1998, MOL PHYLOGENET EVOL, V10, P202, DOI 10.1006/mpev.1998.0516; Kim KJ, 2005, MOL BIOL EVOL, V22, P1783, DOI 10.1093/molbev/msi174; KIM KJ, 1995, P NATL ACAD SCI USA, V92, P10379, DOI 10.1073/pnas.92.22.10379; Kumar S, 2004, PLANT MOL BIOL, V56, P203, DOI 10.1007/s11103-004-2907-y; Kumar S, 2004, PLANT PHYSIOL, V136, P2843, DOI 10.1104/pp.104.045187; Kumar S, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-131; Kurtz S, 1999, BIOINFORMATICS, V15, P426, DOI 10.1093/bioinformatics/15.5.426; Lee JH, 2009, BIOL PHARM BULL, V32, P1912, DOI 10.1248/bpb.32.1912; Liu Y., 2008, STUD TRACE ELEM HLTH, V25, P55; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Moore MJ, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-17; NECKERMANN K, 1994, GENE, V146, P177, DOI 10.1016/0378-1119(94)90290-9; Nie XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036869; Nock CJ, 2011, PLANT BIOTECHNOL J, V9, P328, DOI 10.1111/j.1467-7652.2010.00558.x; OGIHARA Y, 1988, P NATL ACAD SCI USA, V85, P8573, DOI 10.1073/pnas.85.22.8573; Palmer J. D, 1991, PLASTID CHROMOSOMES; PALMER JD, 1988, ANN MO BOT GARD, V75, P1180, DOI 10.2307/2399279; PALMER JD, 1987, P NATL ACAD SCI USA, V84, P769, DOI 10.1073/pnas.84.3.769; Panero JL, 2008, MOL PHYLOGENET EVOL, V47, P757, DOI 10.1016/j.ympev.2008.02.011; [朴香兰 PIAO Xiang-lan], 2009, [时珍国医国药, Lishizhen Medicine and Materia Medica Research], V20, P1848; Provan J, 1997, GENOME, V40, P104, DOI 10.1139/g97-014; Provan J, 1999, MOL ECOL, V8, P505, DOI 10.1046/j.1365-294X.1999.00545.x; Provan J, 2000, MOL ECOL, V9, P2183, DOI 10.1046/j.1365-294X.2000.105316.x; Provan J, 2001, TRENDS ECOL EVOL, V16, P142, DOI 10.1016/S0169-5347(00)02097-8; Provan J, 1996, P ROY SOC B-BIOL SCI, V263, P1275, DOI 10.1098/rspb.1996.0187; Quesada-Vargas T, 2005, PLANT PHYSIOL, V138, P1746, DOI 10.1104/pp.105.063040; RAUBESON LA, 1992, SCIENCE, V255, P1697, DOI 10.1126/science.255.5052.1697; Riggins CW, 2012, MOL PHYLOGENET EVOL, V64, P471, DOI 10.1016/j.ympev.2012.05.003; Ruiz ON, 2003, PLANT PHYSIOL, V132, P1344, DOI 10.1104/pp.103.020958; Saski C, 2007, THEOR APPL GENET, V115, P571, DOI [10.1007/s00122-007-0567-4, 10.1007/s00122-007-0595-0]; Schulze-Menz G.K., 1964, ENGLERS SYLLABUS PFL; SCOTLAND RW, 1995, AM J BOT, V82, P266, DOI 10.2307/2445533; SHINOZAKI K, 1986, EMBO J, V5, P2043, DOI 10.1002/j.1460-2075.1986.tb04464.x; Soininen EM, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-16; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tangphatsornruang S, 2010, DNA RES, V17, P11, DOI 10.1093/dnares/dsp025; Tangphatsornruang S, 2011, GENE, V475, P104, DOI 10.1016/j.gene.2011.01.002; Terry RG, 1997, AM J BOT, V84, P664, DOI 10.2307/2445903; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; Tian YH, 2000, CHINESE NATL MED PRO; Timme RE, 2007, AM J BOT, V94, P302, DOI 10.3732/ajb.94.3.302; Tkach NV, 2008, EVOLUTION, V62, P184, DOI 10.1111/j.1558-5646.2007.00270.x; Wan Tao, 2011, ACTA BOTANICA BOREALI-OCCIDENTALIA SINICA, V31, P456; Wang QH, 2010, J ASIAN NAT PROD RES, V12, P950, DOI 10.1080/10286020.2010.510469; Wang WQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024670; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Yang M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012762; Young HA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023980; Zhang TW, 2011, PLANT METHODS, V7, DOI 10.1186/1746-4811-7-38; Zhang W, 2008, LI SHIZHEN MED MATER, V19, P2952	85	18	23	7	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57533	10.1371/journal.pone.0057533	http://dx.doi.org/10.1371/journal.pone.0057533			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460871	Green Published, gold, Green Submitted			2022-12-25	WOS:000315519000126
J	Pathai, S; Lawn, SD; Shiels, PG; Weiss, HA; Cook, C; Wood, R; Gilbert, CE				Pathai, Sophia; Lawn, Stephen D.; Shiels, Paul G.; Weiss, Helen A.; Cook, Colin; Wood, Robin; Gilbert, Clare E.			Corneal Endothelial Cells Provide Evidence of Accelerated Cellular Senescence Associated with HIV Infection: A Case-Control Study	PLOS ONE			English	Article							AGE-RELATED COMORBIDITIES; ANTIRETROVIRAL TREATMENT; PROLIFERATIVE CAPACITY; DIABETES-MELLITUS; EXPRESSION; DENSITY; INFLAMMATION; POPULATION; P16(INK4A); MORTALITY	Background: Cellular senescence may be a key factor in HIV-related premature biological aging. We assessed features of the corneal endothelium that are known to be associated with biological aging, and cellular senescence markers in HIV-infected adults. Methods: Case-control study of 242 HIV-infected adults and 249 matched controls. Using specular microscopy, the corneal endothelium was assessed for features of aging (low endothelial cell density [ECD], high variation in cell size, and low hexagonality index). Data were analysed by multivariable regression. CDKN2A expression (a cell senescence mediator) was measured in peripheral blood leukocytes and 8-hydroxy-2'-deoxyguanosine (8-OHDG; an oxidative DNA damage marker) levels were measured in plasma. Results: The median age of both groups was 40 years. Among HIV-infected adults, 88% were receiving antiretroviral therapy (ART); their median CD4 count was 468 cells/mu L. HIV infection was associated with increased odds of variation in cell size (OR = 1.67; 95% CI: 1.00-2.78, p = 0.04). Among HIV-infected participants, low ECD was independently associated with current CD4 count <200 cells/mu L (OR = 2.77; 95%CI: 1.12-6.81, p = 0.03). In participants on ART with undetectable viral load, CDKN2A expression and 8-OHDG levels were higher in those with accelerated aging, as reflected by lower ECD. Conclusions: The corneal endothelium shows features consistent with HIV-related accelerated senescence, especially among those with poor immune recovery.	[Pathai, Sophia; Gilbert, Clare E.] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Int Ctr Eye Hlth, Dept Clin Res, London WC1, England; [Pathai, Sophia; Lawn, Stephen D.; Wood, Robin] Univ Cape Town, Fac Hlth Sci, Desmond Tutu HIV Ctr, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa; [Lawn, Stephen D.] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Clin Res, London WC1, England; [Shiels, Paul G.] Univ Glasgow, Coll Med Vet & Life Sci, Inst Canc Sci, Glasgow, Lanark, Scotland; [Weiss, Helen A.] London Sch Hyg & Trop Med, Trop Epidemiol Grp, Fac Epidemiol & Populat Hlth, MRC, London WC1, England; [Cook, Colin] Univ Cape Town, Groote Schuur Hosp, Fac Hlth Sci, Dept Ophthalmol, ZA-7925 Cape Town, South Africa	University of London; London School of Hygiene & Tropical Medicine; University of Cape Town; University of London; London School of Hygiene & Tropical Medicine; University of Glasgow; University of London; London School of Hygiene & Tropical Medicine; University of Cape Town	Pathai, S (corresponding author), London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Int Ctr Eye Hlth, Dept Clin Res, London WC1, England.	Sophia.pathai@lshtm.ac.uk	weiss, helen/ABC-7823-2021; Pathai, Sophia/GLU-7811-2022	weiss, helen/0000-0003-3547-7936; Pathai, Sophia/0000-0002-2835-4666; Shiels, Paul/0000-0002-7577-9843	Wellcome Trust [090354/Z/09/Z]; Wellcome Trust, London [088590]; International Epidemiologic Database to Evaluate Aids [5U01AI069924-02]; Cost-Effectiveness of Preventing AIDS Complications 5 [R01AI058736-02]; Medical Research Council [MR/K012126/1] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Wellcome Trust, London(Wellcome Trust); International Epidemiologic Database to Evaluate Aids; Cost-Effectiveness of Preventing AIDS Complications 5; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by a Wellcome Trust grant awarded to SP (Grant number: 090354/Z/09/Z). SDL is funded by the Wellcome Trust, London (Grant # 088590). RW is supported by International Epidemiologic Database to Evaluate Aids (Grant no: 5U01AI069924-02) and Cost-Effectiveness of Preventing AIDS Complications 5 (R01AI058736-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amann J, 2003, AM J OPHTHALMOL, V135, P584, DOI 10.1016/S0002-9394(02)02237-7; BERGMANSON JPG, 1992, CORNEA, V11, P133, DOI 10.1097/00003226-199203000-00007; Bourne WM, 2004, EXP EYE RES, V78, P561, DOI 10.1016/j.exer.2003.08.002; Bourne WM, 1997, INVEST OPHTH VIS SCI, V38, P779; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Campisi J, 2011, CURR OPIN GENET DEV, V21, P107, DOI 10.1016/j.gde.2010.10.005; Capeau J, 2011, CLIN INFECT DIS, V53, P1127, DOI 10.1093/cid/cir628; Carrero JJ, 2008, J INTERN MED, V263, P302, DOI 10.1111/j.1365-2796.2007.01890.x; CHENG H, 1985, ARCH OPHTHALMOL-CHIC, V103, P1478; Deeks SG, 2011, ANNU REV MED, V62, P141, DOI 10.1146/annurev-med-042909-093756; Deeks Steven G, 2009, Top HIV Med, V17, P118; Deeks SG, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a3172; Fisher M, 2012, CURR OPIN INFECT DIS, V25, P1, DOI 10.1097/QCO.0b013e32834f14fa; Guaraldi G, 2011, CLIN INFECT DIS, V53, P1120, DOI 10.1093/cid/cir627; Higuchi A, 2011, FREE RADICAL BIO MED, V51, P2210, DOI 10.1016/j.freeradbiomed.2011.09.025; Joyce NC, 2012, EXP EYE RES, V95, P16, DOI 10.1016/j.exer.2011.08.014; Joyce NC, 2009, INVEST OPHTH VIS SCI, V50, P2116, DOI 10.1167/iovs.08-3007; Koppelstaetter C, 2008, AGING CELL, V7, P491, DOI 10.1111/j.1474-9726.2008.00398.x; LAING RA, 1976, EXP EYE RES, V22, P587, DOI 10.1016/0014-4835(76)90003-8; Larsson LI, 1996, ARCH OPHTHALMOL-CHIC, V114, P9, DOI 10.1001/archopht.1996.01100130007001; Lawn SD, 2005, AIDS, V19, P2141, DOI 10.1097/01.aids.0000194802.89540.e1; Lawn SD, 2006, AIDS, V20, P1605, DOI 10.1097/01.aids.0000238406.93249.cd; Lee JS, 2006, EYE, V20, P315, DOI 10.1038/sj.eye.6701868; Liu Y, 2009, AGING CELL, V8, P439, DOI 10.1111/j.1474-9726.2009.00489.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lohse N, 2007, ANN INTERN MED, V146, P87, DOI 10.7326/0003-4819-146-2-200701160-00003; Martin J, 2010, ANN INTERN MED, V153, P477, DOI 10.7326/0003-4819-153-7-201010050-00013; McCarey BE, 2008, CORNEA, V27, P1, DOI 10.1097/ICO.0b013e31815892da; McGlynn LM, 2009, AGING CELL, V8, P45, DOI 10.1111/j.1474-9726.2008.00447.x; Newton R, 2001, INT J CANCER, V92, P622, DOI 10.1002/1097-0215(20010601)92:5&lt;622::AID-IJC1256&gt;3.0.CO;2-K; Ohguro N, 1999, AM J OPHTHALMOL, V128, P234, DOI 10.1016/S0002-9394(99)00086-0; Otiti-Sengeri J, 2008, CURR OPIN HIV AIDS, V3, P432, DOI 10.1097/COH.0b013e328302cc3d; PATHAI S, 2012, J ACQ IMMUN DEF SYND, V62, P43; Pathai S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051405; Pathai S, 2011, TROP MED INT HEALTH, V16, P356, DOI 10.1111/j.1365-3156.2010.02712.x; Pathanapitoon K, 2011, AIDS, V25, P81, DOI 10.1097/QAD.0b013e328340fe91; Phillips AN, 2008, AIDS, V22, P2409, DOI 10.1097/QAD.0b013e3283174636; Rasmussen LD, 2011, AIDS, V25, P1637, DOI 10.1097/QAD.0b013e3283493fb0; Sanchis-Gimeno JA, 2005, HISTOL HISTOPATHOL, V20, P423, DOI 10.14670/HH-20.423; SCHULTZ RO, 1984, AM J OPHTHALMOL, V98, P401, DOI 10.1016/0002-9394(84)90120-X; Sheerin AN, 2012, AGING CELL, V11, P234, DOI 10.1111/j.1474-9726.2011.00776.x; Song ZH, 2008, MOL VIS, V14, P161; Tsygankov D, 2009, P NATL ACAD SCI USA, V106, P16562, DOI 10.1073/pnas.0904405106; Waddell K, 2010, INT J CANCER, V127, P427, DOI 10.1002/ijc.25040; Wang Y, 2012, MOL VIS, V18, P803; WILSON RS, 1982, BRIT J OPHTHALMOL, V66, P513, DOI 10.1136/bjo.66.8.513; Xiao X, 2009, MOL VIS, V15, P747; YEE RW, 1985, CURR EYE RES, V4, P671, DOI 10.3109/02713688509017661; Zhu C, 2004, INVEST OPHTH VIS SCI, V45, P1743, DOI 10.1167/iovs.03-0814	49	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57422	10.1371/journal.pone.0057422	http://dx.doi.org/10.1371/journal.pone.0057422			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460854	Green Accepted, Green Submitted, gold, Green Published			2022-12-25	WOS:000315519000108
J	McFarland, R; Roebuck, H; Yan, Y; Majolo, B; Li, W; Guo, K				McFarland, Richard; Roebuck, Hettie; Yan, Yin; Majolo, Bonaventura; Li, Wu; Guo, Kun			Social Interactions through the Eyes of Macaques and Humans	PLOS ONE			English	Article							GAZE; MONKEYS; PATTERNS; VIEW; COMPETITION; ATTENTION; MOVEMENTS; IMAGES; FACES	Group-living primates frequently interact with each other to maintain social bonds as well as to compete for valuable resources. Observing such social interactions between group members provides individuals with essential information (e.g. on the fighting ability or altruistic attitude of group companions) to guide their social tactics and choice of social partners. This process requires individuals to selectively attend to the most informative content within a social scene. It is unclear how non-human primates allocate attention to social interactions in different contexts, and whether they share similar patterns of social attention to humans. Here we compared the gaze behaviour of rhesus macaques and humans when free-viewing the same set of naturalistic images. The images contained positive or negative social interactions between two conspecifics of different phylogenetic distance from the observer; i.e. affiliation or aggression exchanged by two humans, rhesus macaques, Barbary macaques, baboons or lions. Monkeys directed a variable amount of gaze at the two conspecific individuals in the images according to their roles in the interaction (i.e. giver or receiver of affiliation/aggression). Their gaze distribution to non-conspecific individuals was systematically varied according to the viewed species and the nature of interactions, suggesting a contribution of both prior experience and innate bias in guiding social attention. Furthermore, the monkeys' gaze behavior was qualitatively similar to that of humans, especially when viewing negative interactions. Detailed analysis revealed that both species directed more gaze at the face than the body region when inspecting individuals, and attended more to the body region in negative than in positive social interactions. Our study suggests that monkeys and humans share a similar pattern of role-sensitive, species- and context-dependent social attention, implying a homologous cognitive mechanism of social attention between rhesus macaques and humans.	[McFarland, Richard; Roebuck, Hettie; Majolo, Bonaventura; Guo, Kun] Lincoln Univ, Sch Psychol, Lincoln, England; [McFarland, Richard] Univ Witwatersrand, Sch Physiol, ZA-2050 Johannesburg, South Africa; [Yan, Yin; Li, Wu] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China	University of Lincoln; University of Witwatersrand; Beijing Normal University	Majolo, B (corresponding author), Lincoln Univ, Sch Psychol, Lincoln, England.	bmajolo@lincoln.ac.uk; liwu@bnu.edu.cn; kguo@lincoln.ac.uk	Li, Wu/G-9415-2011; Li, Wu/AHA-4320-2022	Li, Wu/0000-0002-2175-4579; McFarland, Richard/0000-0001-8245-9269; Majolo, Bonaventura/0000-0002-0235-3040; Roebuck, Hettie/0000-0002-5053-7274; Yan, Yin/0000-0001-5594-3020; Guo, Kun/0000-0001-6765-1957	National Basic Research Program of China Grant [2011CBA00405]; National Natural Science Foundation of China Grant [30970983, 31125014, 30930031]; Open Research Fund of the State Key Laboratory of Cognitive Neuroscience and Learning, China; Leverhulme Trust Grant [RF/2/RFG/2009/0152]	National Basic Research Program of China Grant(National Basic Research Program of China); National Natural Science Foundation of China Grant(National Natural Science Foundation of China (NSFC)); Open Research Fund of the State Key Laboratory of Cognitive Neuroscience and Learning, China; Leverhulme Trust Grant(Leverhulme Trust)	This work was supported by National Basic Research Program of China Grant 2011CBA00405; National Natural Science Foundation of China Grant 30970983, 31125014 and 30930031; Open Research Fund of the State Key Laboratory of Cognitive Neuroscience and Learning, China; the Leverhulme Trust Grant No. RF/2/RFG/2009/0152. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berg DJ, 2009, J VISION, V9, DOI 10.1167/9.5.19; Birmingham E, 2008, Q J EXP PSYCHOL, V61, P986, DOI 10.1080/17470210701410375; Birmingham E, 2008, VIS COGN, V16, P341, DOI 10.1080/13506280701434532; Cheney D., 1990, MONKEYS SEE WORLD IN, DOI [10.7208/chicago/9780226218526.001.0001, DOI 10.7208/CHICAGO/9780226218526.001.0001]; Colmenares F, 2002, BEHAVIOUR, V139, P1525, DOI 10.1163/15685390260514753; Dahl CD, 2009, CURR BIOL, V19, P509, DOI 10.1016/j.cub.2009.01.061; de Waal F.B.M., 2005, ANIMAL SOCIAL COMPLE; Deaner RO, 2005, CURR BIOL, V15, P543, DOI 10.1016/j.cub.2005.01.044; DUNBAR RIM, 1991, FOLIA PRIMATOL, V57, P121, DOI 10.1159/000156574; Foulsham T, 2010, COGNITION, V117, P319, DOI 10.1016/j.cognition.2010.09.003; Fraser ON, 2008, P NATL ACAD SCI USA, V105, P8557, DOI 10.1073/pnas.0804141105; Ghazanfar AA, 2006, COGNITION, V101, P515, DOI 10.1016/j.cognition.2005.12.007; Guo K, 1998, NEUROREPORT, V9, P3543, DOI 10.1097/00001756-199810260-00038; Guo K, 2003, EXP BRAIN RES, V150, P363, DOI 10.1007/s00221-003-1429-1; Guo K, 2007, EXP BRAIN RES, V181, P673, DOI 10.1007/s00221-007-1038-5; Guo K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042585; Guo K, 2010, PERCEPTION, V39, P533, DOI 10.1068/p6517; Guo K, 2009, ANIM COGN, V12, P409, DOI 10.1007/s10071-008-0199-3; Hamlin JK, 2007, NATURE, V450, P557, DOI 10.1038/nature06288; Henderson JM, 2003, TRENDS COGN SCI, V7, P498, DOI 10.1016/j.tics.2003.09.006; Hoffman M.L., 2000, EMPATHY MORAL DEV IM, DOI DOI 10.1017/CBO9780511805851; Isaacowitz DM, 2006, CURR DIR PSYCHOL SCI, V15, P68, DOI 10.1111/j.0963-7214.2006.00409.x; Kano F, 2009, P R SOC B, V276, P1949, DOI 10.1098/rspb.2008.1811; KEATING CF, 1982, PERCEPTION, V11, P211, DOI 10.1068/p110211; Machado CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026598; Majolo B, 2012, ANIM BEHAV, V83, P763, DOI 10.1016/j.anbehav.2011.12.026; Maner JK, 2008, PERS SOC PSYCHOL B, V34, P488, DOI 10.1177/0146167207311910; McFarland R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026893; McGregor PK, 2005, ANIMAL COMMUNICATION; Mosher CP, 2011, BEHAV NEUROSCI, V125, P639, DOI 10.1037/a0024264; Nahm FKD, 1997, J COGNITIVE NEUROSCI, V9, P611, DOI 10.1162/jocn.1997.9.5.611; PARKER GA, 1974, J THEOR BIOL, V47, P223, DOI 10.1016/0022-5193(74)90111-8; Pinheiro J, 2001, MIXED EFFECTS MODELS; Preston SD, 2002, BEHAV BRAIN SCI, V25, P1, DOI 10.1017/S0140525X02000018; Rutte C, 2006, TRENDS ECOL EVOL, V21, P16, DOI 10.1016/j.tree.2005.10.014; Schaller GB, 1996, SERENGETI LION STUDY; Schino G, 2001, ANIM BEHAV, V62, P265, DOI 10.1006/anbe.2001.1750; Shepherd SV, 2010, CURR BIOL, V20, P649, DOI 10.1016/j.cub.2010.02.032; VAN HOOF J. A. R. A. M., 1967, P7	39	23	23	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56437	10.1371/journal.pone.0056437	http://dx.doi.org/10.1371/journal.pone.0056437			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	099EQ	23457569	Green Published, Green Accepted, gold			2022-12-25	WOS:000315603700054
J	Sanciangco, JC; Carpenter, KE; Etnoyer, PJ; Moretzsohn, F				Sanciangco, Jonnell C.; Carpenter, Kent E.; Etnoyer, Peter J.; Moretzsohn, Fabio			Habitat Availability and Heterogeneity and the Indo-Pacific Warm Pool as Predictors of Marine Species Richness in the Tropical Indo-Pacific	PLOS ONE			English	Article							WEST PACIFIC; LATITUDINAL GRADIENTS; FISH BIODIVERSITY; CORAL-REEFS; DIVERSITY; PATTERNS; BIOGEOGRAPHY; SPECIATION; ORIGINS; MODEL	Range overlap patterns were observed in a dataset of 10,446 expert-derived marine species distribution maps, including 8,295 coastal fishes, 1,212 invertebrates (crustaceans and molluscs), 820 reef-building corals, 50 seagrasses, and 69 mangroves. Distributions of tropical Indo-Pacific shore fishes revealed a concentration of species richness in the northern apex and central region of the Coral Triangle epicenter of marine biodiversity. This pattern was supported by distributions of invertebrates and habitat-forming primary producers. Habitat availability, heterogeneity, and sea surface temperatures were highly correlated with species richness across spatial grains ranging from 23,000 to 5,100,000 km(2) with and without correction for autocorrelation. The consistent retention of habitat variables in our predictive models supports the area of refuge hypothesis which posits reduced extinction rates in the Coral Triangle. This does not preclude support for a center of origin hypothesis that suggests increased speciation in the region may contribute to species richness. In addition, consistent retention of sea surface temperatures in models suggests that available kinetic energy may also be an important factor in shaping patterns of marine species richness. Kinetic energy may hasten rates of both extinction and speciation. The position of the Indo-Pacific Warm Pool to the east of the Coral Triangle in central Oceania and a pattern of increasing species richness from this region into the central and northern parts of the Coral Triangle suggests peripheral speciation with enhanced survival in the cooler parts of the Coral Triangle that also have highly concentrated available habitat. These results indicate that conservation of habitat availability and heterogeneity is important to reduce extinction of marine species and that changes in sea surface temperatures may influence the evolutionary potential of the region.	[Sanciangco, Jonnell C.; Carpenter, Kent E.] Int Union Conservat Nat, Marine Biodivers Unit Global Marine Species Asses, Global Species Programme, Gland, Switzerland; [Sanciangco, Jonnell C.; Carpenter, Kent E.] Old Dominion Univ, Dept Biol Sci, Norfolk, VA 23529 USA; [Etnoyer, Peter J.] NOAA, Ctr Coastal Environm Hlth & Biomol Res, Charleston, SC USA; [Moretzsohn, Fabio] Texas A&M Univ, Harte Res Inst Gulf Mexico Studies, Corpus Christi, TX USA	Old Dominion University; National Oceanic Atmospheric Admin (NOAA) - USA; Texas A&M University System	Sanciangco, JC (corresponding author), Int Union Conservat Nat, Marine Biodivers Unit Global Marine Species Asses, Global Species Programme, Gland, Switzerland.	jsanc005@odu.edu	Moretzsohn, Fabio/B-8142-2012	Etnoyer, Peter/0000-0002-9932-3066; Sanciangco, Jonnell Cueto/0000-0001-8268-3180	New Hampshire Charitable Foundation; Thomas W. Haas Foundation	New Hampshire Charitable Foundation; Thomas W. Haas Foundation	This research was generously supported by core funding from the Tom Haas and the New Hampshire Charitable Foundation, and the Thomas W. Haas Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abram NJ, 2009, QUATERNARY SCI REV, V28, P2794, DOI 10.1016/j.quascirev.2009.07.006; Allen G. R., 2007, AQUAT CONSERV, V17, P1; Allen GR, 2003, ZOOL STUD, V42, P1; Amante C., 2008, NGDC24 NOAA NESDIS; Anderson DR, 2002, J WILDLIFE MANAGE, V66, P912, DOI 10.2307/3803155; [Anonymous], 1997, WORLD MANGROVE ATLAS; Badgley C, 2000, J BIOGEOGR, V27, P1437, DOI 10.1046/j.1365-2699.2000.00498.x; Barber PH, 2006, EVOLUTION, V60, P1825; Barber PH, 2005, MOL PHYLOGENET EVOL, V35, P235, DOI 10.1016/j.ympev.2004.10.004; Behrenfeld MJ, 1997, LIMNOL OCEANOGR, V42, P1, DOI 10.4319/lo.1997.42.1.0001; Bellwood David R., 2002, P5, DOI 10.1016/B978-012615185-5/50003-7; Bellwood DR, 2009, J BIOGEOGR, V36, P569, DOI 10.1111/j.1365-2699.2008.02029.x; Bellwood DR, 2005, ECOL LETT, V8, P643, DOI 10.1111/j.1461-0248.2005.00763.x; Bellwood DR, 2001, SCIENCE, V292, P1532, DOI 10.1126/science.1058635; Benzie JAH, 1997, EVOLUTION, V51, P768, DOI 10.1111/j.1558-5646.1997.tb03660.x; BEST MB, 1989, NETH J SEA RES, V23, P107, DOI 10.1016/0077-7579(89)90005-7; Bini LM, 2004, J BIOGEOGR, V31, P1819, DOI 10.1111/j.1365-2699.2004.01126.x; Bivand R., 2009, SPDEP SPATIAL DEPEND; Briggs J, 1974, MARINE ZOOGEOGRAPHY, DOI 10.2307/1442613; Briggs J.C., 1995, GLOBAL BIOGEOGRAPHY; Briggs JC, 1999, EVOLUTION, V53, P326, DOI 10.1111/j.1558-5646.1999.tb03769.x; Briggs JC, 2003, J BIOGEOGR, V30, P1, DOI 10.1046/j.1365-2699.2003.00810.x; BRIGGS JC, 1992, GLOBAL ECOL BIOGEOGR, V2, P149, DOI 10.2307/2997803; Briggs JC, 2000, J BIOGEOGR, V27, P1183, DOI 10.1046/j.1365-2699.2000.00459.x; Briggs JC, 2007, J BIOGEOGR, V34, P193, DOI 10.1111/j.1365-2699.2006.01632.x; Briggs JC, 2012, J BIOGEOGR, V39, P12, DOI 10.1111/j.1365-2699.2011.02613.x; CARPENTER K.E, 1998, LIVING MARINE RESOUR, V1, P1; Carpenter KE, 2005, ENVIRON BIOL FISH, V72, P467, DOI 10.1007/s10641-004-3154-4; Carpenter KE, 2008, SCIENCE, V321, P560, DOI 10.1126/science.1159196; Carpenter Kent E., 2011, Journal of Marine Biology, V2011, P1; Cleary DFR, 2006, BIODIVERS CONSERV, V15, P3653, DOI 10.1007/s10531-004-4692-y; Cleary DFR, 2005, ESTUAR COAST SHELF S, V65, P557, DOI 10.1016/j.ecss.2005.06.025; Colwell RK, 2009, EVOL ECOL RES, V11, P355; Connolly SR, 2003, ECOLOGY, V84, P2178, DOI 10.1890/02-0254; Cowman PF, 2011, J EVOLUTION BIOL, V24, P2543, DOI 10.1111/j.1420-9101.2011.02391.x; Crandall ED, 2012, MOL BIOL EVOL, V29, P707, DOI 10.1093/molbev/msr227; Currie DJ, 2008, ECOL MONOGR, V78, P3, DOI 10.1890/06-1302.1; CURRIE DJ, 1991, AM NAT, V137, P27, DOI 10.1086/285144; de Garidel-Thoron T, 2005, NATURE, V433, P294, DOI 10.1038/nature03189; Diniz JAF, 2004, OECOLOGIA, V140, P633, DOI 10.1007/s00442-004-1577-4; Dorenbosch M, 2005, MAR ECOL PROG SER, V302, P63, DOI 10.3354/meps302063; Dormann CF, 2007, ECOGRAPHY, V30, P609, DOI 10.1111/j.2007.0906-7590.05171.x; Ekman S., 1953, ZOOGEOGRAPHY SEA; Eschmeyer WN, 2010, ZOOTAXA, P19; Eschmeyer WN, 2012, CATALOG FISHES; Etnoyer PJ, 2001, THESIS DUKE U DURHAM; Field R, 2009, J BIOGEOGR, V36, P132, DOI 10.1111/j.1365-2699.2008.01963.x; Fraser RH, 1996, AM NAT, V148, P138, DOI 10.1086/285915; Fukami H, 2004, NATURE, V427, P832, DOI 10.1038/nature02339; Green E. E. P., 2003, WORLD ATLAS SEAGRASS; Halas D, 2009, J BIOGEOGR, V36, P1847, DOI 10.1111/j.1365-2699.2009.02103.x; Hall R, 2002, J ASIAN EARTH SCI, V20, P353, DOI 10.1016/S1367-9120(01)00069-4; Hawkins BA, 2003, ECOLOGY, V84, P1608, DOI 10.1890/0012-9658(2003)084[1608:PAHAPO]2.0.CO;2; Hawkins BA, 2012, J BIOGEOGR, V39, P998, DOI 10.1111/j.1365-2699.2012.02716.x; Hawkins BA, 2012, J BIOGEOGR, V39, P1, DOI 10.1111/j.1365-2699.2011.02637.x; Herre A. H., 1953, RES REPORT; Hoeksema BW, 2012, RAFFLES B ZOOL, V60, P183; Hoeksema BW, 2007, BIOGEOGRAPHY TIME PL, P416; Holloway JD, 1998, BIOGEOGRAPHY GEOLOGI, P419; Jetz W, 2009, P ROY SOC B-BIOL SCI, V276, P269, DOI 10.1098/rspb.2008.1005; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; JOKIEL P, 1992, J BIOGEOGR, V19, P449, DOI 10.2307/2845572; Kerswell AP, 2006, ECOLOGY, V87, P2479, DOI 10.1890/0012-9658(2006)87[2479:GBPOBM]2.0.CO;2; Kuhn I, 2012, J BIOGEOGR, V39, P995, DOI 10.1111/j.1365-2699.2012.02707.x; LADD HS, 1960, AM J SCI, V258, P137; Lomolino MV, 2006, BIOGEOGRAPHY; Malay MCD, 2010, EVOLUTION, V64, P634, DOI 10.1111/j.1558-5646.2009.00848.x; McClain CR, 2007, GLOBAL ECOL BIOGEOGR, V16, P257, DOI 10.1111/j.1466-8238.2007.00286.x; MCCOY ED, 1976, SYST ZOOL, V25, P201, DOI 10.2307/2412488; McGarigal K., 1995, SPATIAL PATTERN ANAL; McManus J. W., 1985, P 5 INT COR REEF C T, P133; Mora C, 2012, ECOGRAPHY, V35, P89, DOI 10.1111/j.1600-0587.2011.06874.x; MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.2307/2332142; Moretzsohn F, 2004, 30 JOHN D CT MAC FDN; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; Nanola CL, 2011, ENVIRON BIOL FISH, V90, P405, DOI 10.1007/s10641-010-9750-6; Nathan SA, 2009, PALAEOGEOGR PALAEOCL, V274, P140, DOI 10.1016/j.palaeo.2009.01.007; Nichols G., 2009, SEDIMENTOLOGY STRATI, P163; Nogues-Bravo D, 2006, GLOBAL ECOL BIOGEOGR, V15, P452, DOI 10.1111/j.1566-822x.2006.00240.x; Palumbi SR, 1996, J EXP MAR BIOL ECOL, V203, P75, DOI 10.1016/0022-0981(96)02571-3; PAULAY G, 1990, PALEOBIOLOGY, V16, P415, DOI 10.1017/S0094837300010162; Peterson M. S., 2000, Wetlands Ecology and Management, V8, P209, DOI 10.1023/A:1008452805584; PIANKA ER, 1966, AM NAT, V100, P33, DOI 10.1086/282398; Polidoro BA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010095; Potts D. C., 1985, PROC 5 INT CORAL REE, V4, P127; Randall JE, 1998, ZOOL STUD, V37, P227; Read CI, 2006, MOL PHYLOGENET EVOL, V38, P808, DOI 10.1016/j.ympev.2005.08.001; Reaka ML, 2008, P NATL ACAD SCI USA, V105, P11474, DOI 10.1073/pnas.0802594105; Reaka ML, 2008, P 11 INT COR REEF C, V2, P1384; Renema W, 2008, SCIENCE, V321, P654, DOI 10.1126/science.1155674; Ricklefs Robert E., 1993, P350; Robertson DR, 2008, DIVERS DISTRIB, V14, P891, DOI 10.1111/j.1472-4642.2008.00519.x; Rocha LA, 2008, J FISH BIOL, V72, P1101, DOI 10.1111/j.1095-8649.2007.01770.x; ROHDE K, 1992, OIKOS, V65, P514, DOI 10.2307/3545569; Rosen B. R., 1988, GEOLOGICAL SOC SPECI, V37, P275; ROSEN BR, 1988, HELGOLANDER MEERESUN, V42, P269, DOI 10.1007/BF02366046; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Roy K, 1998, P NATL ACAD SCI USA, V95, P3699, DOI 10.1073/pnas.95.7.3699; Santini F, 2002, J BIOGEOGR, V29, P189, DOI 10.1046/j.1365-2699.2002.00669.x; Shannon C.E., 1963, MATH THEORY COMMUNIC; Short FT, 2011, BIOL CONSERV, V144, P1961, DOI 10.1016/j.biocon.2011.04.010; Smith TM, 1998, J CLIMATE, V11, P3320, DOI 10.1175/1520-0442(1998)011<3320:AHRGSS>2.0.CO;2; SOLURI EA, 1990, INT HYDROGR REV, V67, P27; Spalding M. D., 2001, WORLD ATLAS CORAL RE; Spalding MD, 2007, BIOSCIENCE, V57, P573, DOI 10.1641/B570707; STEHLI FG, 1971, SYST ZOOL, V20, P115, DOI 10.2307/2412052; Tews J, 2004, J BIOGEOGR, V31, P79, DOI 10.1046/j.0305-0270.2003.00994.x; Tittensor DP, 2010, NATURE, V466, P1098, DOI 10.1038/nature09329; Vermeij GJ, 2001, MARINE COMMUNITY ECOLOGY, P39; Veron J.E.N., 2009, Galaxea - Tokyo, V11, P91; Wallace Carden C., 1997, P365; Whittaker RJ, 2001, J BIOGEOGR, V28, P453, DOI 10.1046/j.1365-2699.2001.00563.x; Willette DA, 2011, J FISH BIOL, V79, P2087, DOI 10.1111/j.1095-8649.2011.03133.x; Williams ST, 2004, EVOLUTION, V58, P2227; Williams ST, 2008, EVOLUTION, V62, P1618, DOI 10.1111/j.1558-5646.2008.00399.x; Wilson Moyra E. J., 1998, P165; Woodland David J., 1990, Indo-Pacific Fishes, V19, P1; WOODLAND DJ, 1983, B MAR SCI, V33, P713; YAN XH, 1992, SCIENCE, V258, P1643, DOI 10.1126/science.258.5088.1643	119	69	75	0	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56245	10.1371/journal.pone.0056245	http://dx.doi.org/10.1371/journal.pone.0056245			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457533	gold, Green Submitted, Green Published			2022-12-25	WOS:000315603700030
J	Marlow, MA; Mattos, MD; Makowiecky, ME; Eger, I; Rossetto, AL; Grisard, EC; Steindel, M				Marlow, Mariel Asbury; Mattos, Marise da Silva; Makowiecky, Maria Ernestina; Eger, Iriane; Rossetto, Andre Luiz; Grisard, Edmundo Carlos; Steindel, Mario			Divergent Profile of Emerging Cutaneous Leishmaniasis in Subtropical Brazil: New Endemic Areas in the Southern Frontier	PLOS ONE			English	Article							SPECIES INFECTING PATIENTS; VIANNIA BRAZILIENSIS; TEGUMENTARY LEISHMANIASIS; SANTA-CATARINA; STATE; EPIDEMIOLOGY; VECTORS; DISEASE; DIPTERA; REGION	Background: Although known to be highly endemic in the Amazon regions of Brazil, the presence of cutaneous leishmaniasis (CL) in the subtropical southern part of the country has largely been ignored. This study was conducted to demonstrate CL is emerging in the Brazilian state of Santa Catarina, as well as to characterize the epidemiological profile and Leishmania species involved. Methodology/Principal Findings: For this cross-sectional study, data from all CL cases from Santa Catarina, Brazil, reported to the Brazilian National Notifiable Diseases Information System from 2001 to 2009 were investigated. Amplification of the kDNA minicircle conserved region followed by restriction fragment length polymorphism (PCR-RFLP) was conducted to screen for Leishmania species present in patient biopsy. Overall, 542 CL cases were reported, with majority resulting from autochthonous transmission (n = 401, 73.99%) and occurring in urban zones (n = 422, 77.86%). Age, gender, zone of residence, origin of case, clinical form and case outcome were found to differ significantly by region. Imported cases were over seven times more likely to relapse (95% CI 2.56-21.09). Mapping of cases revealed new endemic areas in northeastern Santa Catarina with two species present. With the exception of three L. (Leishmania) amazonensis cases (1.20%), majority of PCR positive samples were found to be L. (Viannia) braziliensis (n = 248, 98.80%). Conclusions/Significance: CL is now endemic in the state of Santa Catarina, Brazil, with case profiles varying significantly by region. L. (V.) braziliensis has been identified as the predominant species in the region.	[Marlow, Mariel Asbury; Grisard, Edmundo Carlos; Steindel, Mario] Univ Fed Santa Catarina, Dept Microbiol Immunol & Parasitol, Florianopolis, SC, Brazil; [Mattos, Marise da Silva] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Rio De Janeiro, Brazil; [Makowiecky, Maria Ernestina] Secretaria Estadual Saude Santa Catarina, Dept Zoonoses, Diretoria Vigilancia Epidemiol, Florianopolis, SC, Brazil; [Eger, Iriane; Rossetto, Andre Luiz] Univ Vale Itajai, Ctr Hlth Sci, Itajai, Brazil	Universidade Federal de Santa Catarina (UFSC); Universidade Federal do Rio de Janeiro; Universidade do Vale do Itajai	Steindel, M (corresponding author), Univ Fed Santa Catarina, Dept Microbiol Immunol & Parasitol, Florianopolis, SC, Brazil.	mario.steindel@ufsc.br	Grisard, Edmundo C/A-7338-2015; Steindel, Mario/N-2040-2018; Steindel, Mario/H-2945-2015; Rossetto, André/U-1756-2019	Grisard, Edmundo C/0000-0001-8916-8296; Steindel, Mario/0000-0002-2768-7469; Steindel, Mario/0000-0002-2768-7469; 	CAPES; FAPESC; PPSUS; CNPq; CAPES scholarship (Brazilian Government Agency)	CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPESC(Fundacao de Amparo a Pesquisa e Inovacoo Estado de Santa Catarina (FAPESC)); PPSUS; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES scholarship (Brazilian Government Agency)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The authors would like to express their gratitude to the funding agencies, CAPES, FAPESC, PPSUS and CNPq. M.A.M. is recipient of a CAPES scholarship (Brazilian Government Agency). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], SANT CAT EST; Ashford RW, 2000, INT J PARASITOL, V30, P1269, DOI 10.1016/S0020-7519(00)00136-3; Banuls AL, 2007, ADV PARASIT, V64, P1, DOI 10.1016/S0065-308X(06)64001-3; Barreto ML, 2011, LANCET, V377, P1877, DOI 10.1016/S0140-6736(11)60202-X; Campbell-Lendrum D, 2001, MEM I OSWALDO CRUZ, V96, P159, DOI 10.1590/S0074-02762001000200004; Carvalho MDR, 2006, ACTA TROP, V98, P277, DOI 10.1016/j.actatropica.2006.06.001; Dantas-Torres F, 2007, VET PARASITOL, V149, P139, DOI 10.1016/j.vetpar.2007.07.007; Guerra JAD, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000980; Dengue in Brazil, DENG BRAZ CURR SIT A; Falqueto A, 2003, MEM I OSWALDO CRUZ, V98, P1003, DOI 10.1590/S0074-02762003000800004; Grisard EC, 2000, ACTA TROP, V74, P89, DOI 10.1016/S0001-706X(99)00054-6; IBGE - Instituto Brasileiro de Geografia e Estatistica (Brazilian Institute of Geography and Statistics), 2010, DEM CENS SANT CAT; Lainson Ralph, 2010, Revista Pan-Amazonica de Saude, V1, P13; Lima Filho JHC, 1998, ARQ CATARINENSES MED, V27, P25; Marcondes CB, 2009, T ROY SOC TROP MED H, V103, P1093, DOI 10.1016/j.trstmh.2008.12.006; Marcondes CB, 2005, REV SOC BRAS MED TRO, V38, P353, DOI 10.1590/S0037-86822005000400016; Ministerio Da Saude, 2007, MAN SURV AM CUT LEIS; Ministerio Da Saude, 2007, EP SIT MAL BRAZ YEAR; Mitropoulos P, 2010, J AM ACAD DERMATOL, V63, P309, DOI 10.1016/j.jaad.2009.06.088; Monteiro WM, 2009, REV SOC BRAS MED TRO, V42, P509, DOI 10.1590/S0037-86822009000500007; Murray HW, 2005, LANCET, V366, P1561, DOI 10.1016/S0140-6736(05)67629-5; Oliveira CCG, 2004, ACTA TROP, V90, P155, DOI 10.1016/j.actatropica.2003.11.011; Passos VMA, 1999, ACTA TROP, V72, P251, DOI 10.1016/S0001-706X(98)00100-4; Peterson AT, 2003, INT J PARASITOL, V33, P919, DOI 10.1016/S0020-7519(03)00094-8; Pires Menezes ML, 2000, REV ELECT GEOGRAFIA, V69; Pocai E. A., 1998, Ciencia Rural, V28, P501, DOI 10.1590/S0103-84781998000300025; Razera F, 2005, REV AMRIGS PORTO ALE, V49, P165; Reithinger R, 1999, AM J TROP MED HYG, V61, P530, DOI 10.4269/ajtmh.1999.61.530; Reithinger R, 2007, LANCET INFECT DIS, V7, P581, DOI 10.1016/S1473-3099(07)70209-8; Ribeiro de Oliveira AT, 2011, INTERNAL MIGRATION P; Sambrook J., 1989, MOL CLONING LAB MANU, DOI [10.1016/0092-8674(90)90210-6, DOI 10.1016/0092-8674(90)90210-6]; Sharma Umakant, 2008, Journal of Vector Borne Diseases, V45, P255; Silveira FT, 2004, MEM I OSWALDO CRUZ, V99, P239, DOI 10.1590/S0074-02762004000300001; Souza GD, 2009, MEM I OSWALDO CRUZ, V104, P1181, DOI 10.1590/S0074-02762009000800017; Tarso Sao P. de, 1990, Revista da Sociedade Brasileira de Medicina Tropical, V23, P201, DOI 10.1590/S0037-86821990000400003; Volf P, 2007, TRENDS PARASITOL, V23, P91, DOI 10.1016/j.pt.2006.12.010; Volpini AC, 2004, ACTA TROP, V90, P31, DOI 10.1016/j.actatropica.2003.10.008; YOSHIDA ELA, 1990, MEM I OSWALDO CRUZ, V85, P133, DOI 10.1590/S0074-02761990000100026	38	20	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56177	10.1371/journal.pone.0056177	http://dx.doi.org/10.1371/journal.pone.0056177			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457521	Green Submitted, Green Published, gold			2022-12-25	WOS:000315602700055
J	Mortamais, M; Reynes, C; Brickman, AM; Provenzano, FA; Muraskin, J; Portet, F; Berr, C; Touchon, J; Bonafe, A; le Bars, E; Maller, JJ; Meslin, C; Sabatier, R; Ritchie, K; Artero, S				Mortamais, Marion; Reynes, Christelle; Brickman, Adam M.; Provenzano, Frank A.; Muraskin, Jordan; Portet, Florence; Berr, Claudine; Touchon, Jacques; Bonafe, Alain; le Bars, Emmanuelle; Maller, Jerome J.; Meslin, Chantal; Sabatier, Robert; Ritchie, Karen; Artero, Sylvaine			Spatial Distribution of Cerebral White Matter Lesions Predicts Progression to Mild Cognitive Impairment and Dementia	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; HYPERINTENSITIES; DEPRESSION; LEUKOARAIOSIS; PREVALENCE; DECLINE; MCI; AD	Context: White matter lesions (WML) increase the risk of dementia. The relevance of WML location is less clear. We sought to determine whether a particular WML profile, based on the density and location of lesions, could be associated with an increased risk of mild cognitive impairment (MCI) or dementia over the following 7 years. Methods: In 426 healthy subjects from a cohort of community-dwelling people aged 65 years and over (ESPRIT Project), standardized cognitive and neurological evaluations were repeated after 2, 4 and 7 years. Patterns of WML were computed with a supervised data mining approach (decision trees) using the regional WML volumes (frontal, parietal, temporal, and occipital regions) and the total WML volume estimated at baseline. Cox proportional hazard models were then constructed to study the association between WML patterns and risk of MCI/dementia. Results: Total WML volume and percentage of WML in the temporal region proved to be the best predictors of progression to MCI and dementia. Specifically, severe total WML load with a high proportion of lesions in the temporal region was significantly associated with the risk of developing MCI or dementia. Conclusions: Above a certain threshold of damage, a pattern of WML clustering in the temporal region identifies individuals at increased risk of MCI or dementia. As this WML pattern is observed before the onset of clinical symptoms, it may facilitate the detection of patients at risk of MCI/dementia.	[Mortamais, Marion; Portet, Florence; Berr, Claudine; Touchon, Jacques; Ritchie, Karen; Artero, Sylvaine] La Colombiere Hosp, INSERM, U1061, Montpellier, France; [Mortamais, Marion; Reynes, Christelle; Berr, Claudine; Touchon, Jacques; Bonafe, Alain; le Bars, Emmanuelle; Sabatier, Robert; Ritchie, Karen; Artero, Sylvaine] Univ Montpellier I, Montpellier, France; [Reynes, Christelle; Sabatier, Robert] Fac Pharm Montpellier, EA 2415, Montpellier, France; [Brickman, Adam M.; Provenzano, Frank A.; Muraskin, Jordan] Columbia Univ, Coll Phys & Surg, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY USA; [Portet, Florence] CHU Nimes, Ctr Ruffi, CHU Caremeau, Unite Transversale Troubles Neurol Sujet Age, Nimes, France; [Portet, Florence] CHU Montpellier, La Colombiere Hosp, Univ Dept Adult Psychiat, Montpellier Univ Hosp, Montpellier, France; [Bonafe, Alain; le Bars, Emmanuelle] CHRU Montpellier, Montpellier, France; [Maller, Jerome J.] Alfred & Monash Univ Cent Clin Sch, Monash Alfred Psychiat Res Ctr, Melbourne, Vic, Australia; [Meslin, Chantal] Australian Natl Univ, Mental Hlth Res Ctr, Canberra, ACT, Australia; [Ritchie, Karen] Univ London Imperial Coll Sci Technol & Med, Fac Med, London, England	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; CHU de Montpellier; Universite de Montpellier; Universite de Montpellier; Columbia University; Universite de Montpellier; CHU de Nimes; Universite de Montpellier; CHU de Montpellier; Universite de Montpellier; CHU de Montpellier; Monash University; Australian National University; Imperial College London	Artero, S (corresponding author), La Colombiere Hosp, INSERM, U1061, Montpellier, France.	sylvaine.artero@inserm.fr	Maller, Jerome J/H-4963-2014; Artero, Sylvaine/AAE-6059-2020; Ritchie, Karen/G-3571-2013; berr, Claudine/D-5238-2014	Maller, Jerome J/0000-0003-4685-1508; Ritchie, Karen/0000-0002-0688-8982; berr, Claudine/0000-0001-5254-7655; Artero, Sylvaine/0000-0002-1671-226X; Muraskin, Jordan/0000-0002-9913-4193; Sabatier, Robert/0000-0001-8685-6579; Mortamais, Marion/0000-0003-3983-9826; BONAFE, ALAIN/0000-0002-9187-1375	regional government of Languedoc-Roussillon; Agence Nationale de la Recherche (ANR); Novartis; France Alzheimer; NATIONAL INSTITUTE ON AGING [R01AG034189] Funding Source: NIH RePORTER	regional government of Languedoc-Roussillon(Region Occitanie); Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Novartis(Novartis); France Alzheimer; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The ESPRIT Project is financed by the regional government of Languedoc-Roussillon (http://www.laregion.fr), the Agence Nationale de la Recherche (ANR: http://www.agence-nationale-recherche.fr) and an unconditional grant from Novartis (http://www.novartis.fr). This study is also supported by France Alzheimer (http://www.francealzheimer.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Admiraal-Behloul F., 2004, P INT SOC MAGN RES, P138; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Artero S, 2004, J NEUROL NEUROSUR PS, V75, P1304, DOI 10.1136/jnnp.2003.023713; Artero S, 2006, DEMENT GERIATR COGN, V22, P465, DOI 10.1159/000096287; Benton A, 1965, MANUEL APPL TEST RET; Bozzali M, 2002, J NEUROL NEUROSUR PS, V72, P742, DOI 10.1136/jnnp.72.6.742; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Breiman L., 1984, CLASSIFICATION REGRE, P368, DOI DOI 10.1201/9781315139470-8; Brickman AM, 2011, PSYCHIAT RES-NEUROIM, V193, P101, DOI 10.1016/j.pscychresns.2011.03.007; Chen YF, 2006, DEMENT GERIATR COGN, V22, P177, DOI 10.1159/000094785; Chua TC, 2008, CURR OPIN NEUROL, V21, P83, DOI 10.1097/WCO.0b013e3282f4594b; de Leeuw FE, 2000, J NEUROL, V247, P291, DOI 10.1007/s004150050586; Debette S, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c3666; DeCarli C, 2005, STROKE, V36, P50, DOI 10.1161/01.STR.0000150668.58689.f2; Dubois B., 2001, NEUROLOGIE PSYCHIAT, V1, P40; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; Gao JL, 2011, J ALZHEIMERS DIS, V26, P47, DOI 10.3233/JAD-2011-101788; Gootjes L, 2004, DEMENT GERIATR COGN, V18, P180, DOI 10.1159/000079199; Greenwald BS, 2001, J AM GERIATR SOC, V49, P1218, DOI 10.1046/j.1532-5415.2001.49240.x; Gurol ME, 2006, NEUROLOGY, V66, P23, DOI 10.1212/01.wnl.0000191403.95453.6a; Herrmann LL, 2008, J NEUROL NEUROSUR PS, V79, P619, DOI 10.1136/jnnp.2007.124651; Holland CM, 2008, STROKE, V39, P1127, DOI 10.1161/STROKEAHA.107.497438; ISAACS B, 1973, BRIT J PSYCHIAT, V123, P467, DOI 10.1192/bjp.123.4.467; Lamarca R, 1998, J GERONTOL A-BIOL, V53, pM337, DOI 10.1093/gerona/53A.5.M337; Maller JJ, 2007, HIPPOCAMPUS, V17, P1023, DOI 10.1002/hipo.20339; Medina D, 2006, NEUROBIOL AGING, V27, P663, DOI 10.1016/j.neurobiolaging.2005.03.026; Pantoni L, 1997, STROKE, V28, P652, DOI 10.1161/01.STR.28.3.652; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Ritchie K, 2004, BRIT J PSYCHIAT, V184, P147, DOI 10.1192/bjp.184.2.147; Ritchie K, 2012, J AFFECT DISORDERS, V141, P294, DOI 10.1016/j.jad.2012.03.035; Rorden C, 2000, BEHAV NEUROL, V12, P191, DOI 10.1155/2000/421719; Ross ED, 2005, COGN BEHAV NEUROL, V18, P89, DOI 10.1097/01.wnn.0000151859.19031.e8; Schmidt R, 2005, ANN NEUROL, V58, P610, DOI 10.1002/ana.20630; Smith EE, 2011, NEUROLOGY, V76, P1492, DOI 10.1212/WNL.0b013e318217e7c8; Takahashi S, 2002, NEUROSCI LETT, V332, P45, DOI 10.1016/S0304-3940(02)00914-X; Winblad B, 2004, J INTERN MED, V256, P240, DOI 10.1111/j.1365-2796.2004.01380.x; Xie S, 2006, NEUROLOGY, V66, P1845, DOI 10.1212/01.wnl.0000219625.77625.aa; Yoshita M, 2006, NEUROLOGY, V67, P2192, DOI 10.1212/01.wnl.0000249119.95747.1f	39	27	27	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56972	10.1371/journal.pone.0056972	http://dx.doi.org/10.1371/journal.pone.0056972			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	099EJ	23457645	Green Published, gold			2022-12-25	WOS:000315602700104
J	Alvarez-Dominguez, JR; Amosova, O; Fresco, JR				Alvarez-Dominguez, Juan R.; Amosova, Olga; Fresco, Jacques R.			Self-catalytic DNA Depurination Underlies Human beta-Globin Gene Mutations at Codon 6 That Cause Anemias and Thalassemias	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTROPHORETICALLY SILENT VARIANT; SITE-SPECIFIC DEPURINATION; BASE EXCISION-REPAIR; SICKLE-CELL MUTATION; CHAIN VARIANT; HEMOGLOBIN-VARIANTS; ORIGIN; DATABASE; HAPLOTYPES; RESISTANCE	The human beta-globin gene contains an 18-nucleotide coding strand sequence centered at codon 6 and capable of forming a stem-loop structure that can self-catalyze depurination of the 5' G residue of that codon. The resultant apurinic lesion is subject to error-prone repair, consistent with the occurrence about this codon of mutations responsible for 6 anemias and beta-thalassemias and additional substitutions without clinical consequences. The 4-residue loop of this stem-loop-forming sequence shows the highest incidence of mutation across the gene. The loop and first stem base pair-forming residues appeared early in the mammalian clade. The other stem-forming segments evolved more recently among primates, thereby conferring self-depurination capacity at codon 6. These observations indicate a conserved molecular mechanism leading to beta-globin variants underlying phenotypic diversity and disease.	[Alvarez-Dominguez, Juan R.; Amosova, Olga; Fresco, Jacques R.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	Princeton University	Alvarez-Dominguez, JR (corresponding author), MIT, Whitehead Inst Biomed Res, Cambridge, MA 02139 USA.	juan.alvarez@mit.edu; olga.amosova@gmail.com; jrfresco@princeton.edu			Higgins Trust	Higgins Trust	This work was supported in part by a grant from the Higgins Trust.	Agarwal S, 1999, HEMOGLOBIN, V23, P263, DOI 10.3109/03630269909005707; Alanazi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025876; Allison AC, 2002, BIOCHEM MOL BIOL EDU, V30, P279, DOI 10.1002/bmb.2002.494030050108; Allison AC, 2009, CURR OPIN IMMUNOL, V21, P499, DOI 10.1016/j.coi.2009.04.001; Amosova O, 2006, P NATL ACAD SCI USA, V103, P4392, DOI 10.1073/pnas.0508499103; Amosova O, 2011, J BIOL CHEM, V286, P36316, DOI 10.1074/jbc.M111.272047; Amosova O, 2011, J BIOL CHEM, V286, P36322, DOI 10.1074/jbc.M111.272112; Bergman AC, 2009, HEMOGLOBIN, V33, P137, DOI 10.1080/03630260902861956; Bisse E, 2003, CLIN CHEM, V49, P137, DOI 10.1373/49.1.137; Bisse E, 2006, J CHROMATOGR A, V1115, P118, DOI 10.1016/j.chroma.2006.02.082; Blanchette M, 2004, GENOME RES, V14, P708, DOI 10.1101/gr.1933104; Cai Y., 1982, CHINESE HEMATOL J, V3, P263; CHEBLOUNE Y, 1988, P NATL ACAD SCI USA, V85, P4431, DOI 10.1073/pnas.85.12.4431; Chotivanich K, 2002, BLOOD, V100, P1172, DOI 10.1182/blood.V100.4.1172.h81602001172_1172_1176; Doss CGP, 2009, NEW BIOTECHNOL, V25, P214, DOI 10.1016/j.nbt.2009.01.004; Fresco JR, 2011, EVOLUTIONARY BIOLOGY: CONCEPTS, BIODIVERSITY, MACROEVOLUTION AND GENOME EVOLUTION, P3, DOI 10.1007/978-3-642-20763-1_1; FRESCO JR, 1960, P NATL ACAD SCI USA, V46, P311, DOI 10.1073/pnas.46.3.311; Harano K, 1995, HEMOGLOBIN, V19, P397, DOI 10.3109/03630269509005831; Hardison RC, 2002, HUM MUTAT, V19, P225, DOI 10.1002/humu.10044; Hedrick PW, 2011, HEREDITY, V107, P283, DOI 10.1038/hdy.2011.16; Ivaldi G., 2009, CLIN BIOCHEM, V42, P1851; Joly P, 2011, HEMOGLOBIN, V35, P147, DOI 10.3109/03630269.2010.550795; JURICIC D, 1983, HEMOGLOBIN, V7, P271, DOI 10.3109/03630268309048657; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; KOLLIA P, 1989, HEMOGLOBIN, V13, P597, DOI 10.3109/03630268908993110; Korolev VG, 2005, RUSS J GENET+, V41, P1063, DOI 10.1007/s11177-005-0201-y; Krawczak M, 2000, HUM MUTAT, V15, P45, DOI 10.1002/(SICI)1098-1004(200001)15:1<45::AID-HUMU10>3.0.CO;2-T; KULOZIK AE, 1986, AM J HUM GENET, V39, P239; KUNKEL TA, 1984, P NATL ACAD SCI-BIOL, V81, P1494, DOI 10.1073/pnas.81.5.1494; Kyrri A, 2001, HEMOGLOBIN, V25, P421, DOI 10.1081/HEM-100107880; Lacerra G, 2002, HEMOGLOBIN, V26, P59, DOI 10.1081/HEM-120002941; LANGDOWN JV, 1994, HEMOGLOBIN, V18, P333, DOI 10.3109/03630269408996199; LAPOUMEROULIE C, 1992, HUM GENET, V89, P333; LENARUSSO D, 1989, HEMOGLOBIN, V13, P743, DOI 10.3109/03630268908998848; MOOPENN WF, 1983, HEMOGLOBIN, V7, P91, DOI 10.3109/03630268309038405; ORKIN SH, 1981, J BIOL CHEM, V256, P9782; PAGNIER J, 1984, P NATL ACAD SCI-BIOL, V81, P1771, DOI 10.1073/pnas.81.6.1771; Perea FJ, 1999, HEMOGLOBIN, V23, P231, DOI 10.3109/03630269909005703; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; PURRELLO R, 1993, J AM CHEM SOC, V115, P760, DOI 10.1021/ja00055a056; Sanguansermsri P., 2003, HAEMATOLOGICA, V88, pECR35; SCHROEDER WA, 1989, HEMOGLOBIN, V13, P325, DOI 10.3109/03630268909003397; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Simonelli V, 2005, NUCLEIC ACIDS RES, V33, P4404, DOI 10.1093/nar/gki749; SUGIYAMA H, 1994, CHEM RES TOXICOL, V7, P673, DOI 10.1021/tx00041a013; TOPAL MD, 1976, NATURE, V263, P285, DOI 10.1038/263285a0; TUCHINDA S, 1965, BRIT MED J, V1, P1583, DOI 10.1136/bmj.1.5450.1583; Vichinsky Elliott, 2007, Hematology Am Soc Hematol Educ Program, P79; WAILOO K, 1991, B HIST MED, V65, P185; WILSON CID, 1984, FEBS LETT, V176, P331, DOI 10.1016/0014-5793(84)81190-4; Zhao X, 2010, J BIOINF COMPUT BIOL, V8, P101, DOI 10.1142/S021972001000518X	51	9	10	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2013	288	16					11581	11589		10.1074/jbc.M113.454744	http://dx.doi.org/10.1074/jbc.M113.454744			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	130KW	23457306	Green Published, hybrid			2022-12-25	WOS:000317915500063
J	Boyd, CA; Drumheller, SK; Gates, TA				Boyd, Clint A.; Drumheller, Stephanie K.; Gates, Terry A.			Crocodyliform Feeding Traces on Juvenile Ornithischian Dinosaurs from the Upper Cretaceous (Campanian) Kaiparowits Formation, Utah	PLOS ONE			English	Article							TOOTH MARKS; CROCODILE; BONE; ONTOGENY; BEHAVIOR	Crocodyliforms serve as important taphonomic agents, accumulating and modifying vertebrate remains. Previous discussions of Mesozoic crocodyliform feeding in terrestrial and riverine ecosystems have often focused on larger taxa and their interactions with equally large dinosaurian prey. However, recent evidence suggests that the impact of smaller crocodyliforms on their environments should not be discounted. Here we present direct evidence of feeding by a small crocodyliform on juvenile specimens of a 'hypsilophodontid' dinosaur from the Upper Cretaceous (Campanian) Kaiparowits Formation of southern Utah. Diagnostic crocodyliform bite marks present on a left scapula and a right femur, as well as a partial probable crocodyliform tooth crown (ovoid in cross-section) preserved within a puncture on the right femur, comprise the bulk of the feeding evidence. Computed tomography scans of the femoral puncture reveal impact damage to the surrounding bone and that the distal tip of the embedded tooth was missing prior to the biting event. This is only the second reported incidence of a fossil crocodyliform tooth being found embedded directly into prey bone. These bite marks provide insight into the trophic interactions of the ecosystem preserved in the Kaiparowits Formation. The high diversity of crocodyliforms within this formation may have led to accentuated niche partitioning, which seems to have included juvenile dinosaurian prey.	[Boyd, Clint A.] S Dakota Sch Mines & Technol, Dept Geol & Geol Engn, Rapid City, SD USA; [Drumheller, Stephanie K.] Univ Iowa, Dept Geosci, Iowa City, IA USA; [Drumheller, Stephanie K.] Univ Tennessee, Dept Earth & Planetary Sci, Knoxville, TN USA; [Gates, Terry A.] N Carolina State Univ, Dept Biol, Raleigh, NC 27695 USA; [Gates, Terry A.] Nat Hist Museum Utah, Salt Lake City, UT USA	South Dakota School Mines & Technology; University of Iowa; University of Tennessee System; University of Tennessee Knoxville; University of North Carolina; North Carolina State University	Boyd, CA (corresponding author), S Dakota Sch Mines & Technol, Dept Geol & Geol Engn, Rapid City, SD USA.	clintboyd@stratfit.org		Gates, Terry/0000-0001-6850-7455; Drumheller, Stephanie/0000-0001-9714-7153	Geological Society of America; Max and Lorraine Littlefield Geoscience fund; University of Iowa Department of Geoscience; Division Of Earth Sciences [0948842] Funding Source: National Science Foundation	Geological Society of America; Max and Lorraine Littlefield Geoscience fund; University of Iowa Department of Geoscience; Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This study was funded in part by a Geological Society of America Graduate Student Research Grant (http://www.geosociety.org/grants/gradgrants.htm) to CAB. SKD received funding from the Max and Lorraine Littlefield Geoscience fund and the University of Iowa Department of Geoscience. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	ANDERSON JF, 1985, J ZOOL, V207, P53, DOI 10.1111/j.1469-7998.1985.tb04915.x; Bader KS, 2009, PALAIOS, V24, P140, DOI 10.2110/palo.2008.p08-058r; Binford L.R., 1981, BONES ANCIENT MEN MO; Blumenschine RJ, 1996, J ARCHAEOL SCI, V23, P493, DOI 10.1006/jasc.1996.0047; Boyd CA, 2009, J VERTEBR PALEONTOL, V29, P758, DOI 10.1671/039.029.0328; Brochu CA, 2003, PALAIOS, V18, P475, DOI 10.1669/0883-1351(2003)018<0475:LFATTA>2.0.CO;2; Brochu CA, 1996, J VERTEBR PALEONTOL, V16, P49, DOI 10.1080/02724634.1996.10011283; Brochu CA, 1997, PALAIOS, V18, P80; Brochu CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009333; Byers S., 2004, INTRO FORENSIC ANTHR, P254, DOI 10.4324/9781315642031; Carpenter Kenneth, 2000, Gaia (Lisboa), V15, P135; Chure Daniel J., 2000, Gaia (Lisboa), V15, P227; Cisneros Juan Carlos, 2005, Revista Brasileira de Paleontologia, V8, P239; D'Amore DC, 2009, PALEOBIOLOGY, V35, P525, DOI 10.1666/0094-8373-35.4.525; Davidson I., 1990, Tempus, V2, P197; DEBROIN F, 1966, CR ACAD SCI D NAT, V262, P2326; DRUMHELLER S. K., 2007, MICROSC MICROANAL, V13, p510CD; Drumheller-Horton SK, 2012, ACTUALISTIC PHYLOGEN; Eaton J.G., 1999, UTAH GEOLOGICAL SURV, V99-1, P345; Erickson GM, 1996, J VERTEBR PALEONTOL, V16, P175, DOI 10.1080/02724634.1996.10011297; Erickson GM, 2003, J ZOOL, V260, P317, DOI 10.1017/S0952836903003819; Erickson GM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031781; Farlow J.O., 1991, Modern Geology, V16, P161; Farlow JO, 2002, HIST BIOL, V16, P21, DOI DOI 10.1080/0891296031000154687; FIORILLO AR, 1991, PALAEOGEOGR PALAEOCL, V88, P157, DOI 10.1016/0031-0182(91)90062-V; Forrest R, 2003, P GEOLOGIST ASSOC, V114, P363, DOI 10.1016/S0016-7878(03)80037-8; Fowler Denver W., 2006, BULLETIN OF THE NEW MEXICO MUSEUM OF NATURAL HISTORY AND SCIENCE, P127; Franzen Jens Lorenz, 1993, Kaupia Darmstaedter Beitraege zur Naturgeschichte, V3, P113; Frey Eberhard, 2010, Palaeobiodiversity and Palaeoenvironments, V90, P65, DOI 10.1007/s12549-009-0021-5; Fuentes E. J., 2003, STUDIA GEOLOGICA SAL, V39, P11; Gates TA, 2010, PALAEOGEOGR PALAEOCL, V291, P371, DOI 10.1016/j.palaeo.2010.03.008; GEBO DL, 1984, AM J PHYS ANTHROPOL, V65, P31, DOI 10.1002/ajpa.1330650106; Haglund W., 1997, FORENSIC TAPHONOMY P, P405; Hiiemae Karen M., 2000, P411, DOI 10.1016/B978-012632590-4/50014-9; Horner J.R, 1993, COMPLETE T REX; Hu YM, 2005, NATURE, V433, P149, DOI 10.1038/nature03102; Hutchison JH, 2009, ADV W INTERIOR LATE, V1, P27; Hyslop DB, 2004, GEOLOGICAL SOC AM AB, V36, P381; Irmis RB, TOP GRAND STAIRCASE; Jacobsen A.R., 2001, P58; Lehman TM, 2010, J VERTEBR PALEONTOL, V30, P1709, DOI 10.1080/02724634.2010.520782; Longrich NR, 2010, PALAEONTOLOGY, V53, P703, DOI 10.1111/j.1475-4983.2010.00957.x; Mayr G, 2009, WATERBIRDS, V32, P468, DOI 10.1675/063.032.0315; MCILHENNY EA, 1935, ALLIGATORS LIFE HIST; Mead JI, 2006, STUD NEOTROP FAUNA E, V41, P1, DOI 10.1080/01650520500309917; Mikulas Radek, 2006, Ichnos, V13, P113, DOI 10.1080/10420940600850729; Milan J., 2010, NEW MEXICO MUSEUM NA, V51, P195; Njau JK, 2012, J HUM EVOL, V63, P408, DOI 10.1016/j.jhevol.2011.05.008; Njau JK, 2006, J HUM EVOL, V50, P142, DOI 10.1016/j.jhevol.2005.08.008; Noto CR, 2012, PALAIOS, V27, P105, DOI 10.2110/palo.2011.p11-052r; Platt SG, 2006, HERPETOL J, V16, P281; Rivera-Sylva HE, 2009, CARNETS GEOLOGIE LET, V2; Roberts EM, 2005, CRETACEOUS RES, V26, P307, DOI 10.1016/j.cretres.2005.01.002; Roberts EM, 2007, SEDIMENT GEOL, V197, P207, DOI 10.1016/j.sedgeo.2006.10.001; Schwimmer DR, 2010, GEOLOGICAL SOC AM AB, V42, P104; Schwimmer DR., 2002, KING CROCODYLIANS PA; Sereno PC, 2001, SCIENCE, V294, P1516, DOI 10.1126/science.1066521; Steadman DW, 2006, J FORENSIC SCI, V51, P11, DOI 10.1111/j.1556-4029.2005.00001.x; Subalusky AL, 2009, BIOL CONSERV, V142, P1507, DOI 10.1016/j.biocon.2009.02.019; Titus A.L., 2008, GEOLOGICAL SOC AM AB, V40, P58; Varricchio DJ, 2007, P ROY SOC B-BIOL SCI, V274, P1361, DOI 10.1098/rspb.2006.0443; von Nopsca F., 1902, Z DTSCH GEOLOGISCHEN, V54, P34; WEIGELT J, 1927, RECENT VERTEBRATE CA; Wiersma J, 2004, J VERTEBR PALEONTOL, V24, p129A; Xing LD, 2012, LETHAIA, V45, P500, DOI 10.1111/j.1502-3931.2012.00310.x	65	30	30	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57605	10.1371/journal.pone.0057605	http://dx.doi.org/10.1371/journal.pone.0057605			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460882	Green Published, gold, Green Submitted			2022-12-25	WOS:000315519000137
J	Coskun, D; Britto, DT; Jean, YK; Kabir, I; Tolay, I; Torun, AA; Kronzucker, HJ				Coskun, Devrim; Britto, Dev T.; Jean, Yuel-Kai; Kabir, Imtiaz; Tolay, Inci; Torun, Ayfer A.; Kronzucker, Herbert J.			K+ Efflux and Retention in Response to NaCl Stress Do Not Predict Salt Tolerance in Contrasting Genotypes of Rice (Oryza sativa L.)	PLOS ONE			English	Article							HORDEUM-VULGARE L.; NITROGEN-SOURCE INCREASES; POTASSIUM-TRANSPORT; BARLEY ROOTS; COMPARTMENTAL ANALYSIS; SALINITY RESISTANCE; ION CONCENTRATIONS; SODIUM-TRANSPORT; PLASMA-MEMBRANE; EXCISED BARLEY	Sudden elevations in external sodium chloride (NaCl) accelerate potassium (K+) efflux across the plasma membrane of plant root cells. It has been proposed that the extent of this acceleration can predict salt tolerance among contrasting cultivars. However, this proposal has not been considered in the context of plant nutritional history, nor has it been explored in rice (Oryza sativa L.), which stands among the world's most important and salt-sensitive crop species. Using efflux analysis with 42 K, coupled with growth and tissue K+ analyses, we examined the short-and long-term effects of NaCl exposure to plant performance within a nutritional matrix that significantly altered tissue-K+ set points in three rice cultivars that differ in salt tolerance: IR29 (sensitive), IR72 (moderate), and Pokkali (tolerant). We show that total short-term K+ release from roots in response to NaCl stress is small (no more than 26% over 45 min) in rice. Despite strong varietal differences, the extent of efflux is shown to be a poor predictor of plant performance on long-term NaCl stress. In fact, no measure of K+ status was found to correlate with plant performance among cultivars either in the presence or absence of NaCl stress. By contrast, shoot Na+ accumulation showed the strongest correlation (a negative one) with biomass, under long-term salinity. Pharmacological evidence suggests that NaCl-induced K+ efflux is a result of membrane disintegrity, possibly as result of osmotic shock, and not due to ion-channel mediation. Taken together, we conclude that, in rice, K+ status (including efflux) is a poor predictor of salt tolerance and overall plant performance and, instead, shoot Na+ accumulation is the key factor in performance decline on NaCl stress.	[Coskun, Devrim; Britto, Dev T.; Jean, Yuel-Kai; Kabir, Imtiaz; Kronzucker, Herbert J.] Univ Toronto, Dept Biol Sci, Toronto, ON, Canada; [Tolay, Inci] Akdeniz Univ, Dept Agr, TR-07058 Antalya, Turkey; [Torun, Ayfer A.] Cukurova Univ, Dept Soil Sci & Plant Nutr, Adana, Turkey	University of Toronto; Akdeniz University; Cukurova University	Kronzucker, HJ (corresponding author), Univ Toronto, Dept Biol Sci, Toronto, ON, Canada.	herbertk@utsc.utoronto.ca	Kronzucker, Herbert J./HCH-4019-2022; Coskun, Devrim/E-4604-2010; Tolay, Inci/C-7582-2016; Coskun, Devrim/J-7084-2019; Alkan Torun, Ayfer/J-7235-2018	Coskun, Devrim/0000-0001-9598-2227; Kronzucker, Herbert/0000-0002-9358-0029	University of Toronto; Natural Sciences and Engineering Research Council of Canada (NSERC); Canada Research Chair (CRC) program; Canadian Foundation for Innovation (CFI)	University of Toronto(University of Toronto); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chair (CRC) program(Canada Research ChairsAustralian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Canadian Foundation for Innovation (CFI)(Canada Foundation for Innovation)	Funding for this work was provided by the University of Toronto, the Natural Sciences and Engineering Research Council of Canada (NSERC), the Canada Research Chair (CRC) program, and the Canadian Foundation for Innovation (CFI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achilea O, 2002, ACTA HORTIC, P43, DOI 10.17660/ActaHortic.2002.573.4; Anil VS, 2005, PHYSIOL PLANTARUM, V124, P451, DOI 10.1111/j.1399-3054.2005.00529.x; Balkos KD, 2010, PLANT CELL ENVIRON, V33, P23, DOI 10.1111/j.1365-3040.2009.02046.x; Bartholomew RP, 1929, SOIL SCI, V27, P189, DOI 10.1097/00010694-192903000-00002; BEHL R, 1982, J EXP BOT, V33, P584, DOI 10.1093/jxb/33.4.584; Botella MA, 1997, J PLANT NUTR, V20, P793, DOI 10.1080/01904169709365295; BOURGEAISCHAILLOU P, 1992, J EXP BOT, V43, P1225, DOI 10.1093/jxb/43.9.1225; Britto DT, 2008, PHYSIOL PLANTARUM, V133, P637, DOI 10.1111/j.1399-3054.2008.01067.x; Britto DT, 2010, NEW PHYTOL, V186, P373, DOI 10.1111/j.1469-8137.2009.03169.x; Cakmak I, 2005, J PLANT NUTR SOIL SC, V168, P521, DOI 10.1002/jpln.200420485; CHAPIN FS, 1980, ANNU REV ECOL SYST, V11, P233, DOI 10.1146/annurev.es.11.110180.001313; Chen Z, 2005, PLANT CELL ENVIRON, V28, P1230, DOI 10.1111/j.1365-3040.2005.01364.x; Chen ZG, 2008, CROP SCI, V48, P1382, DOI 10.2135/cropsci2007.10.0557; Chen ZH, 2007, FUNCT PLANT BIOL, V34, P150, DOI 10.1071/FP06237; Coskun D, 2012, J EXP BOT, V63, P151, DOI 10.1093/jxb/err267; CRAMER GR, 1985, PLANT PHYSIOL, V79, P207, DOI 10.1104/pp.79.1.207; Cuin TA, 2008, J EXP BOT, V59, P2697, DOI 10.1093/jxb/ern128; Davenport RJ, 2000, PLANT PHYSIOL, V122, P823, DOI 10.1104/pp.122.3.823; EPSTEIN E, 1963, P NATL ACAD SCI USA, V49, P684, DOI 10.1073/pnas.49.5.684; Faiyue B, 2012, PLANT CELL ENVIRON, V35, P1099, DOI 10.1111/j.1365-3040.2011.02475.x; Flowers TJ, 1999, SCI HORTIC-AMSTERDAM, V78, P1; Frechilla S, 2001, PLANT GROWTH REGUL, V35, P171, DOI 10.1023/A:1014487908495; Garcia A, 1997, PLANT CELL ENVIRON, V20, P1167, DOI 10.1046/j.1365-3040.1997.d01-146.x; GARYBOBO CM, 1970, NATURE, V228, P1101, DOI 10.1038/2281101a0; Grattan SR, 1999, SCI HORTIC-AMSTERDAM, V78, P127, DOI 10.1016/S0304-4238(98)00192-7; HAJIBAGHERI MA, 1988, J EXP BOT, V39, P279, DOI 10.1093/jxb/39.3.279; Hepler PK, 2005, PLANT CELL, V17, P2142, DOI 10.1105/tpc.105.032508; Hoagland DR, 1933, SOIL SCI, V36, P1; Ismail AM, 2007, PLANT MOL BIOL, V65, P547, DOI 10.1007/s11103-007-9215-2; Kinraide TB, 1999, J EXP BOT, V50, P1495, DOI 10.1093/jexbot/50.338.1495; KOCHIAN LV, 1985, PLANT PHYSIOL, V79, P771, DOI 10.1104/pp.79.3.771; Krishnamurthy P, 2011, J EXP BOT, V62, P4215, DOI 10.1093/jxb/err135; Krol E, 2000, ANN BOT-LONDON, V86, P449, DOI 10.1006/anbo.2000.1226; Kronzucker HJ, 2006, PLANT CELL ENVIRON, V29, P2228, DOI 10.1111/j.1365-3040.2006.01597.x; Kronzucker HJ, 2011, NEW PHYTOL, V189, P54, DOI 10.1111/j.1469-8137.2010.03540.x; Kronzucker HJ, 2003, PLANTA, V217, P540, DOI 10.1007/s00425-003-1032-5; KRONZUCKER HJ, 1995, PLANT PHYSIOL, V109, P481, DOI 10.1104/pp.109.2.481; Lee KS, 2003, PLANTA, V216, P1043, DOI 10.1007/s00425-002-0958-3; LEE RB, 1986, J EXP BOT, V37, P1753, DOI 10.1093/jxb/37.12.1753; LEWIS OAM, 1989, NEW PHYTOL, V111, P155, DOI 10.1111/j.1469-8137.1989.tb00676.x; Lopez MV, 1996, PLANT SCI, V114, P19, DOI 10.1016/0168-9452(95)04300-4; Maathuis FJM, 1999, ANN BOT-LONDON, V84, P123, DOI 10.1006/anbo.1999.0912; MEMON AR, 1985, J EXP BOT, V36, P1860, DOI 10.1093/jxb/36.12.1860; Munns R, 2002, PLANT CELL ENVIRON, V25, P239, DOI 10.1046/j.0016-8025.2001.00808.x; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; NASSERY H, 1979, NEW PHYTOL, V83, P23, DOI 10.1111/j.1469-8137.1979.tb00722.x; NASSERY H, 1975, NEW PHYTOL, V75, P63, DOI 10.1111/j.1469-8137.1975.tb01371.x; POOLE RJ, 1971, PLANT PHYSIOL, V47, P731, DOI 10.1104/pp.47.6.731; RAINS DW, 1967, PLANT PHYSIOL, V42, P319, DOI 10.1104/pp.42.3.319; RENGEL Z, 1992, PLANT CELL ENVIRON, V15, P625, DOI 10.1111/j.1365-3040.1992.tb01004.x; Roberts SK, 1997, J EXP BOT, V48, P431, DOI 10.1093/jxb/48.Special_Issue.431; Roberts SK, 1995, PLANT J, V8, P811, DOI 10.1046/j.1365-313X.1995.8060811.x; Schulze LM, 2012, J EXP BOT, V63, P2479, DOI 10.1093/jxb/err419; Shabala S, 2008, PHYSIOL PLANTARUM, V133, P651, DOI 10.1111/j.1399-3054.2007.01008.x; Shabala S, 2007, FEBS LETT, V581, P1993, DOI 10.1016/j.febslet.2007.04.032; Shabala S, 2006, PLANT PHYSIOL, V141, P1653, DOI 10.1104/pp.106.082388; Shannon MC, 1998, CROP SCI, V38, P394, DOI 10.2135/cropsci1998.0011183X003800020021x; SIDDIQI MY, 1991, J EXP BOT, V42, P1455, DOI 10.1093/jxb/42.11.1455; Smethurst CF, 2008, FUNCT PLANT BIOL, V35, P640, DOI 10.1071/FP08030; SPEER M, 1994, PLANT CELL ENVIRON, V17, P1223, DOI 10.1111/j.1365-3040.1994.tb02020.x; SPEER M, 1994, PLANT CELL ENVIRON, V17, P1215, DOI 10.1111/j.1365-3040.1994.tb02019.x; Szczerba MW, 2009, J PLANT PHYSIOL, V166, P447, DOI 10.1016/j.jplph.2008.12.009; Tyerman SD, 1997, J EXP BOT, V48, P459, DOI 10.1093/jxb/48.Special_Issue.459; Walker DJ, 1996, P NATL ACAD SCI USA, V93, P10510, DOI 10.1073/pnas.93.19.10510; White PJ, 2000, NEW PHYTOL, V147, P241, DOI 10.1046/j.1469-8137.2000.00704.x; YEO AR, 1987, J EXP BOT, V38, P1141, DOI 10.1093/jxb/38.7.1141; YEO AR, 1982, PHYSIOL PLANTARUM, V56, P343, DOI 10.1111/j.1399-3054.1982.tb00350.x; YEO AR, 1990, THEOR APPL GENET, V79, P377, DOI 10.1007/BF01186082; YEO AR, 1983, PHYSIOL PLANTARUM, V59, P189, DOI 10.1111/j.1399-3054.1983.tb00756.x; Zhang JL, 2010, PLANT SOIL, V326, P45, DOI 10.1007/s11104-009-0076-0; Zhu JK, 2001, TRENDS PLANT SCI, V6, P66, DOI 10.1016/S1360-1385(00)01838-0	72	38	40	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57767	10.1371/journal.pone.0057767	http://dx.doi.org/10.1371/journal.pone.0057767			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460903	gold, Green Published, Green Submitted			2022-12-25	WOS:000315519000158
J	Hosseini, A; Espona-Fiedler, M; Soto-Cerrato, V; Quesada, R; Perez-Tomas, R; Guallar, V				Hosseini, Ali; Espona-Fiedler, Margarita; Soto-Cerrato, Vanessa; Quesada, Roberto; Perez-Tomas, Ricardo; Guallar, Victor			Molecular Interactions of Prodiginines with the BH3 Domain of Anti-Apoptotic Bcl-2 Family Members	PLOS ONE			English	Article							MELANOMA-CELLS; MCL-1; PROTEIN; INHIBITORS; GX15-070; EXPLORATION; RESISTANCE; BCL-X(L); INSIGHTS; DOCKING	Prodigiosin and obatoclax, members of the prodiginines family, are small molecules with anti-cancer properties that are currently under preclinical and clinical trials. The molecular target(s) of these agents, however, is an open question. Combining experimental and computational techniques we find that prodigiosin binds to the BH3 domain in some BCL-2 protein families, which play an important role in the apoptotic programmed cell death. In particular, our results indicate a large affinity of prodigiosin for MCL-1, an anti-apoptotic member of the BCL-2 family. In melanoma cells, we demonstrate that prodigiosin activates the mitochondrial apoptotic pathway by disrupting MCL-1/BAK complexes. Computer simulations with the PELE software allow the description of the induced fit process, obtaining a detailed atomic view of the molecular interactions. These results provide new data to understand the mechanism of action of these molecules, and assist in the development of more specific inhibitors of anti-apoptotic BCL-2 proteins.	[Hosseini, Ali; Guallar, Victor] Joint BSC IRB Res Program Computat Biol, Barcelona, Spain; [Espona-Fiedler, Margarita; Soto-Cerrato, Vanessa; Perez-Tomas, Ricardo] Univ Barcelona, Canc Cell Biol Res Grp, Dept Pathol & Expt Therapeut, Barcelona, Spain; [Quesada, Roberto] Univ Burgos, Dept Chem, Burgos, Spain; [Guallar, Victor] Inst Catalana Recerca & Estudis Avancats, Barcelona, Spain	University of Barcelona; Universidad de Burgos; ICREA	Guallar, V (corresponding author), Joint BSC IRB Res Program Computat Biol, Barcelona, Spain.	victor.guallar@bsc.es	Espona-Fiedler, Margarita/AAL-9280-2021; quesada, roberto/GSM-7910-2022; quesada, roberto/C-6965-2008; Soto-Cerrato, Vanessa/AAB-4392-2020; Guallar, Victor/B-1579-2013; quesada, roberto/AAX-8833-2021	quesada, roberto/0000-0003-2764-7157; quesada, roberto/0000-0003-2764-7157; Soto-Cerrato, Vanessa/0000-0001-5835-3595; Guallar, Victor/0000-0002-4580-1114; Espona-Fiedler, Margarita/0000-0001-7639-2299; Perez-Tomas, Ricardo/0000-0003-3226-1240	Spanish government; European Union [FIS-PI10/00338]; ERC-2009-Adg 25027-PELE European project; ICREA Funding Source: Custom	Spanish government(Spanish GovernmentEuropean Commission); European Union(European Commission); ERC-2009-Adg 25027-PELE European project; ICREA(ICREA)	This work was supported by a research grant from the Spanish government and the European Union (FIS-PI10/00338) and from the ERC-2009-Adg 25027-PELE European project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acoca S, 2011, PROTEINS, V79, P2624, DOI 10.1002/prot.23083; [Anonymous], 2011, PROT PREP WIZ EP VER; [Anonymous], 2010, GLID; [Anonymous], 2011, SITEMAP; Bernardo PH, 2010, J MED CHEM, V53, P2314, DOI 10.1021/jm901469p; Boersma MD, 2012, J AM CHEM SOC, V134, P315, DOI 10.1021/ja207148m; Borrelli KW, 2010, J COMPUT CHEM, V31, P1224, DOI 10.1002/jcc.21409; Borrelli KW, 2005, J CHEM THEORY COMPUT, V1, P1304, DOI 10.1021/ct0501811; Certo M, 2006, CANCER CELL, V9, P351, DOI 10.1016/j.ccr.2006.03.027; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Chonghaile TN, 2008, ONCOGENE, V27, pS149, DOI 10.1038/onc.2009.52; Cossins BP, 2012, J CHEM THEORY COMPUT, V8, P959, DOI 10.1021/ct200675g; Czabotar PE, 2007, P NATL ACAD SCI USA, V104, P6217, DOI 10.1073/pnas.0701297104; Day CL, 2005, J BIOL CHEM, V280, P4738, DOI 10.1074/jbc.M411434200; de Grenu BD, 2011, CHEM-EUR J, V17, P14074, DOI 10.1002/chem.201101547; Dong L, 2011, ONCOGENE, V30, P3716, DOI 10.1038/onc.2011.87; Espona-Fiedler M, 2012, BIOCHEM PHARMACOL, V83, P489, DOI 10.1016/j.bcp.2011.11.027; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o; Gandhi L, 2011, J CLIN ONCOL, V29, P909, DOI 10.1200/JCO.2010.31.6208; Ho TF, 2009, TOXICOL APPL PHARM, V235, P253, DOI 10.1016/j.taap.2008.12.009; Hsieh HY, 2012, BRIT J PHARMACOL, V166, P2095, DOI 10.1111/j.1476-5381.2012.01921.x; Kazi A, 2011, J BIOL CHEM, V286, P9382, DOI 10.1074/jbc.M110.203638; Konopleva M, 2008, CANCER RES, V68, P3413, DOI 10.1158/0008-5472.CAN-07-1919; Ku B, 2011, CELL RES, V21, P627, DOI 10.1038/cr.2010.149; Lee EF, 2007, CELL DEATH DIFFER, V14, P1711, DOI 10.1038/sj.cdd.4402178; Li J, 2008, CANCER CHEMOTH PHARM, V61, P525, DOI 10.1007/s00280-007-0499-3; Lu CH, 2012, TOXICOL LETT, V212, P83, DOI 10.1016/j.toxlet.2012.05.002; Martin AP, 2009, MOL PHARMACOL, V76, P327, DOI 10.1124/mol.109.056309; Maurer U, 2006, MOL CELL, V21, P749, DOI 10.1016/j.molcel.2006.02.009; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nguyen M, 2007, P NATL ACAD SCI USA, V104, P19512, DOI 10.1073/pnas.0709443104; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Parikh SA, 2010, CL LYMPH MYELOM LEUK, V10, P285, DOI 10.3816/CLML.2010.n.059; Perez-Tomas R, 2010, CURR MED CHEM, V17, P2222, DOI 10.2174/092986710791331103; Rahmani M, 2012, BLOOD, V119, P6089, DOI 10.1182/blood-2011-09-378141; Smits C, 2008, STRUCTURE, V16, P818, DOI 10.1016/j.str.2008.02.009; Soto-Cerrato V, 2004, BIOCHEM PHARMACOL, V68, P1345, DOI 10.1016/j.bcp.2004.05.056; Soto-Cerrato V, 2007, MOL CANCER THER, V6, P362, DOI 10.1158/1535-7163.MCT-06-0266; Trudel S, 2007, BLOOD, V109, P5430, DOI 10.1182/blood-2006-10-047951; van Delft MF, 2006, CANCER CELL, V10, P389, DOI 10.1016/j.ccr.2006.08.027; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Zhai D, 2006, CELL DEATH DIFFER, V13, P1419, DOI 10.1038/sj.cdd.4401937	44	36	37	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57562	10.1371/journal.pone.0057562	http://dx.doi.org/10.1371/journal.pone.0057562			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460874	Green Published, Green Submitted, gold			2022-12-25	WOS:000315519000129
J	Jobbings, CE; Sandig, H; Whittingham-Dowd, JK; Roberts, IS; Bulfone-Paus, S				Jobbings, Catherine E.; Sandig, Hilary; Whittingham-Dowd, Jayde K.; Roberts, Ian S.; Bulfone-Paus, Silvia			Listeria monocytogenes Alters Mast Cell Phenotype, Mediator and Osteopontin Secretion in a Listeriolysin-Dependent Manner	PLOS ONE			English	Article							RECEPTOR TYROSINE KINASE; C-KIT; PHOSPHATIDYLINOSITOL 3-KINASE; ALPHA-2-BETA-1 INTEGRIN; INTRACELLULAR GROWTH; HOST-DEFENSE; MICE LACKING; E-CADHERIN; GM-CSF; RESPONSES	Whilst mast cells participate in the immune defence against the intracellular bacterium Listeria monocytogenes, there is conflicting evidence regarding the ability of L. monocytogenes to infect mast cells. It is known that the pore-forming toxin listeriolysin (LLO) is important for mast cell activation, degranulation and the release of pro-inflammatory cytokines. Mast cells, however, are a potential source of a wide range of cytokines, chemokines and other mediators including osteopontin, which contributes to the clearing of L. monocytogenes infections in vivo, although its source is unknown. We therefore aimed to resolve the controversy of mast cell infection by L. monocytogenes and investigated the extent of mediator release in response to the bacterium. In this paper we show that the infection of bone marrow-derived mast cells by L. monocytogenes is inefficient and LLO-independent. LLO, however, is required for calcium-independent mast cell degranulation as well as for the transient and selective downregulation of cell surface CD117 (c-kit) on mast cells. We demonstrate that in addition to the key pro-inflammatory cytokines TNF-alpha and IL-6, mast cells release a wide range of other mediators in response to L. monocytogenes. Osteopontin, IL-2, IL-4, IL-13 and granulocyte macrophage colony-stimulating factor (GM-CSF), and chemokines including CCL2, CCL3, CCL4 and CCL5 are released in a MyD88-dependent manner. The wide range of mediators released by mast cells in response to L. monocytogenes may play an important role in the recruitment and activation of a variety of immune cells in vivo. The cocktail of mediators, however, is unlikely to skew the immune response to a particular effector response. We propose that mast cells provide a hitherto unreported source of osteopontin, and may provide an important role in co-ordinating the immune response during Listeria infection.	[Jobbings, Catherine E.; Sandig, Hilary; Whittingham-Dowd, Jayde K.; Bulfone-Paus, Silvia] Univ Manchester, Fac Human & Med Sci, Manchester, Lancs, England; [Roberts, Ian S.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [Bulfone-Paus, Silvia] Res Ctr Borstel, Borstel, Germany	University of Manchester; University of Manchester; Forschungszentrum Borstel	Bulfone-Paus, S (corresponding author), Univ Manchester, Fac Human & Med Sci, Manchester, Lancs, England.	Silvia.bulfone-paus@manchester.ac.uk		Whittingham-Dowd, Jayde/0000-0002-7939-6081	MRC [G0601205] Funding Source: UKRI; Medical Research Council [G0601205] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Abel B, 2005, J IMMUNOL, V175, P6006, DOI 10.4049/jimmunol.175.9.6006; Abraham SN, 2010, NAT REV IMMUNOL, V10, P440, DOI 10.1038/nri2782; Allen SJ, 2007, ANNU REV IMMUNOL, V25, P787, DOI 10.1146/annurev.immunol.24.021605.090529; Ashkar S, 2000, SCIENCE, V287, P860, DOI 10.1126/science.287.5454.860; Ashman LK, 1999, INT J BIOCHEM CELL B, V31, P1037, DOI 10.1016/S1357-2725(99)00076-X; BISCHOFF SC, 1992, J EXP MED, V175, P237, DOI 10.1084/jem.175.1.237; CHEERS C, 1978, INFECT IMMUN, V19, P755, DOI 10.1128/IAI.19.3.755-762.1978; Cruz AC, 2004, J BIOL CHEM, V279, P5612, DOI 10.1074/jbc.M312323200; Dietrich N, 2010, P NATL ACAD SCI USA, V107, P8748, DOI 10.1073/pnas.0912551107; Dorner BG, 2002, P NATL ACAD SCI USA, V99, P6181, DOI 10.1073/pnas.092141999; Drube S, 2010, BLOOD, V115, P3899, DOI 10.1182/blood-2009-10-247411; Edelson BT, 2006, BLOOD, V107, P143, DOI 10.1182/blood-2005-06-2218; Edelson BT, 2004, BLOOD, V103, P2214, DOI 10.1182/blood-2003-08-2978; Fuchs TM, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00023; GAILLARD JL, 1987, INFECT IMMUN, V55, P2822, DOI 10.1128/IAI.55.11.2822-2829.1987; Gekara NO, 2008, CELL MICROBIOL, V10, P225, DOI 10.1111/j.1462-5822.2007.01033.x; Gekara NO, 2007, CELL MICROBIOL, V9, P2008, DOI 10.1111/j.1462-5822.2007.00932.x; Gekara NO, 2009, J INFECT DIS, V199, P124, DOI 10.1086/595562; Gommerman JL, 1997, J BIOL CHEM, V272, P30519, DOI 10.1074/jbc.272.48.30519; Greter M, 2012, IMMUNITY, V36, P1031, DOI 10.1016/j.immuni.2012.03.027; Hamon M, 2006, NAT REV MICROBIOL, V4, P423, DOI 10.1038/nrmicro1413; Heo Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020912; KOPF M, 1994, NATURE, V368, P339, DOI 10.1038/368339a0; Kurihara T, 1997, J EXP MED, V186, P1757, DOI 10.1084/jem.186.10.1757; Lecuit M, 1999, EMBO J, V18, P3956, DOI 10.1093/emboj/18.14.3956; Lopez-Castejon G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035936; Lundequist A, 2011, CELL MOL LIFE SCI, V68, P965, DOI 10.1007/s00018-010-0587-0; MALAVIYA R, 1994, J IMMUNOL, V152, P1907; Marshall JS, 2004, NAT REV IMMUNOL, V4, P787, DOI 10.1038/nri1460; Mccall-Culbreath KD, 2008, BLOOD, V111, P3562, DOI 10.1182/blood-2007-08-107664; McCall-Culbreath KD, 2011, J INNATE IMMUN, V3, P459, DOI 10.1159/000324832; Metcalfe DD, 1997, PHYSIOL REV, V77, P1033, DOI 10.1152/physrev.1997.77.4.1033; Mirmonsef P, 1999, J IMMUNOL, V163, P2530; Moussion C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003331; Nagasaka A, 2008, EUR J IMMUNOL, V38, P489, DOI 10.1002/eji.200737057; Oboki Keisuke, 2010, Allergology International, V59, P143, DOI 10.2332/allergolint.10-RAI-0186; Park JM, 2004, J EXP MED, V200, P1647, DOI 10.1084/jem.20041215; PATARCA R, 1989, J EXP MED, V170, P145, DOI 10.1084/jem.170.1.145; PORTNOY DA, 1988, J EXP MED, V167, P1459, DOI 10.1084/jem.167.4.1459; Repp H, 2002, CELL MICROBIOL, V4, P483, DOI 10.1046/j.1462-5822.2002.00207.x; ROGERS HW, 1994, J IMMUNOL, V153, P2093; ROTHE J, 1993, NATURE, V364, P798, DOI 10.1038/364798a0; Sandig H, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00185; Stelekati E, 2009, IMMUNITY, V31, P665, DOI 10.1016/j.immuni.2009.08.022; Tegoshi T, 2000, LAB INVEST, V80, P1571, DOI 10.1038/labinvest.3780167; Unanue ER, 1997, IMMUNOL REV, V158, P11, DOI 10.1111/j.1600-065X.1997.tb00988.x; Wang KX, 2008, CYTOKINE GROWTH F R, V19, P333, DOI 10.1016/j.cytogfr.2008.08.001; Westcott MM, 2007, CELL MICROBIOL, V9, P1397, DOI 10.1111/j.1462-5822.2006.00880.x; Wilson BS, 2000, J CELL BIOL, V149, P1131, DOI 10.1083/jcb.149.5.1131; Wollert T, 2007, CELL, V129, P891, DOI 10.1016/j.cell.2007.03.049; Yamamoto K, 2005, CLIN EXP IMMUNOL, V142, P268, DOI 10.1111/j.1365-2249.2005.02922.x; YEE NS, 1994, J BIOL CHEM, V269, P31991; Zhan YF, 1998, BLOOD, V91, P863, DOI 10.1182/blood.V91.3.863.863_863_869; Zhong MX, 2004, INFECT IMMUN, V72, P1057, DOI 10.1128/IAI.72.2.1057-1064.2004	54	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57102	10.1371/journal.pone.0057102	http://dx.doi.org/10.1371/journal.pone.0057102			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460827	Green Published, gold, Green Submitted			2022-12-25	WOS:000315519000063
J	Sakabe, T; Tsuchiya, H; Kanki, K; Azumi, J; Gonda, K; Mizuta, Y; Yamada, D; Wada, H; Shomori, K; Nagano, H; Shiota, G				Sakabe, Tomohiko; Tsuchiya, Hiroyuki; Kanki, Keita; Azumi, Junya; Gonda, Kazue; Mizuta, Yusuke; Yamada, Daisaku; Wada, Hiroshi; Shomori, Kohei; Nagano, Hiroaki; Shiota, Goshi			Identification of the Genes Chemosensitizing Hepatocellular Carcinoma Cells to Interferon-alpha/5-Fluorouracil and Their Clinical Significance	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; ACTIVATED PROTEIN-KINASE; 5-FLUOROURACIL INDUCES APOPTOSIS; SUBCUTANEOUS INTERFERON-ALPHA; COMBINATION THERAPY; INTRAARTERIAL 5-FLUOROURACIL; UP-REGULATION; EXPRESSION; RECEPTOR; PATHWAY	The incidence of advanced hepatocellular carcinoma (HCC) is increasing worldwide, and its prognosis is extremely poor. Interferon-alpha (IFN-alpha)/5-fluorouracil (5-FU) therapy is reportedly effective in some HCC patients. In the present study, to improve HCC prognosis, we identified the genes that are sensitizing to these agents. The screening strategy was dependent on the concentration of ribozymes that rendered HepG2 cells resistant to 5-FU by the repeated transfection of ribozymes into the cells. After 10 cycles of transfection, which was initiated by 5,902,875 sequences of a ribozyme library, three genes including protein kinase, adenosine monophosphate (AMP)-activated, gamma 2 non-catalytic subunit (PRKAG2); transforming growth factor-beta receptor II (TGFBR2); and exostosin 1 (EXT1) were identified as 5-FU-sensitizing genes. Adenovirus-mediated transfer of TGFBR2 and EXT1 enhanced IFN-alpha/5-FU-induced cytotoxicity as well as 5-FU, although the overexpression of these genes in the absence of IFN-alpha/5-FU did not induce cell death. This effect was also observed in a tumor xenograft model. The mechanisms of TGFBR2 and EXT1 include activation of the TGF-beta signal and induction of endoplasmic reticulum stress, resulting in apoptosis. In HCC patients treated with IFN-alpha/5-FU therapy, the PRKAG2 mRNA level in HCC tissues was positively correlated with survival period, suggesting that PRKAG2 enhances the effect of IFN-alpha/5-FU and serves as a prognostic marker for IFN-alpha/5-FU therapy. In conclusion, we identified three genes that chemosensitize the effects of 5-FU and IFN-alpha/5-FU on HCC cells and demonstrated that PRKAG2 mRNA can serve as a prognostic marker for IFN-alpha/5-FU therapy.	[Sakabe, Tomohiko; Kanki, Keita; Azumi, Junya; Gonda, Kazue; Mizuta, Yusuke; Shiota, Goshi] Tottori Univ, Div Mol & Genet Med, Grad Sch Med, Dept Genet Med & Regenerat Therapeut, Yonago, Tottori, Japan; [Tsuchiya, Hiroyuki] Kyoto Pharmaceut Univ, Dept Biophys Chem, Kyoto 607, Japan; [Yamada, Daisaku; Wada, Hiroshi; Nagano, Hiroaki] Osaka Univ, Grad Sch Med, Dept Surg, Suita, Osaka, Japan; [Shomori, Kohei] Tottori Univ, Fac Med, Dept Pathol & Microbiol, Yonago, Tottori 683, Japan	Tottori University; Kyoto Pharmaceutical University; Osaka University; Tottori University	Shiota, G (corresponding author), Tottori Univ, Div Mol & Genet Med, Grad Sch Med, Dept Genet Med & Regenerat Therapeut, Yonago, Tottori, Japan.	gshiota@med.tottori-u.ac.jp			Japan Society for the Promotion of Science; Special Coordination Funds for Promoting Science and Technology from the Ministry of Education, Culture, Sports, Science, and Technology of Japan	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Special Coordination Funds for Promoting Science and Technology from the Ministry of Education, Culture, Sports, Science, and Technology of Japan	This work was supported by a Grant-in-Aid for JSPS Fellows from the Japan Society for the Promotion of Science and by Special Coordination Funds for Promoting Science and Technology from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balzarini P, 2012, LAB INVEST, V92, P1297, DOI 10.1038/labinvest.2012.94; Beger C, 2001, P NATL ACAD SCI USA, V98, P130, DOI 10.1073/pnas.98.1.130; Buenemann CL, 2001, CARCINOGENESIS, V22, P447, DOI 10.1093/carcin/22.3.447; Cheng AL, 2009, LANCET ONCOL, V10, P25, DOI 10.1016/S1470-2045(08)70285-7; Damdinsuren B, 2007, HEPATOL RES, V37, P77, DOI 10.1111/j.1872-034X.2007.00007.x; Eguchi H, 2000, CLIN CANCER RES, V6, P2881; Hagiwara S, 2011, J GASTROENTEROL, V46, P212, DOI 10.1007/s00535-010-0294-5; Hwang JT, 2005, BIOCHEM BIOPH RES CO, V332, P433, DOI 10.1016/j.bbrc.2005.04.143; Ishii K, 2008, HEPATOLOGY, V48, P597, DOI 10.1002/hep.22362; Kondo M, 2005, CLIN CANCER RES, V11, P1277; Lee CW, 2012, CANCER RES, V72, P4394, DOI 10.1158/0008-5472.CAN-12-0429; Lee YY, 2010, BIOCHEM BIOPH RES CO, V397, P735, DOI 10.1016/j.bbrc.2010.06.022; Li HQ, 2009, J IMMUNOL, V182, P240, DOI 10.4049/jimmunol.182.1.240; Liao JH, 2001, CELL RES, V11, P89, DOI 10.1038/sj.cr.7290072; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Malo A, 2010, AM J PHYSIOL-GASTR L, V299, pG877, DOI 10.1152/ajpgi.00423.2009; Mamiya T, 2010, LAB INVEST, V90, P1339, DOI 10.1038/labinvest.2010.105; McCormick C, 1998, NAT GENET, V19, P158, DOI 10.1038/514; MILLER AB, 1981, CANCER, V47, P207, DOI 10.1002/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6; Mitsuyasu RT, 2009, NAT MED, V15, P285, DOI 10.1038/nm.1932; Morris SM, 2012, HEPATOLOGY, V55, P121, DOI 10.1002/hep.24653; Musch A, 2005, DIGESTION, V71, P78, DOI 10.1159/000084523; Nakamura M, 2007, J HEPATOL, V46, P77, DOI 10.1016/j.jhep.2006.07.032; Noda T, 2009, BRIT J CANCER, V100, P1647, DOI 10.1038/sj.bjc.6605064; Obi S, 2006, CANCER-AM CANCER SOC, V106, P1990, DOI 10.1002/cncr.21832; Okoshi R, 2008, J BIOL CHEM, V283, P3979, DOI 10.1074/jbc.M705232200; Ota H, 2005, BRIT J CANCER, V93, P557, DOI 10.1038/sj.bjc.6602742; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Patt YZ, 2003, J CLIN ONCOL, V21, P421, DOI 10.1200/JCO.2003.10.103; Perlman R, 2001, NAT CELL BIOL, V3, P708, DOI 10.1038/35087019; Presto J, 2008, P NATL ACAD SCI USA, V105, P4751, DOI 10.1073/pnas.0705807105; Ray S, 2003, J GASTROEN HEPATOL, V18, P393, DOI 10.1046/j.1440-1746.2003.02985.x; Raynal S, 1997, INT J CANCER, V72, P356, DOI 10.1002/(SICI)1097-0215(19970717)72:2<356::AID-IJC26>3.3.CO;2-J; Rojas A, 2009, BBA-MOL CELL RES, V1793, P1165, DOI 10.1016/j.bbamcr.2009.02.001; Ropero S, 2004, HUM MOL GENET, V13, P2753, DOI 10.1093/hmg/ddh298; Sakon M, 2002, CANCER, V94, P435, DOI 10.1002/cncr.10246; Sun CK, 2011, NEOPLASIA, V13, P735, DOI 10.1593/neo.11664; Teramoto T, 1998, BIOCHEM BIOPH RES CO, V251, P56, DOI 10.1006/bbrc.1998.9411; Tobin SW, 2001, CELL GROWTH DIFFER, V12, P109; Uka K, 2007, J GASTROENTEROL, V42, P845, DOI 10.1007/s00535-007-2099-8; Umemura T, 2009, J GASTROENTEROL, V44, P102, DOI 10.1007/s00535-008-2251-0; van Zijl F, 2009, FUTURE ONCOL, V5, P1169, DOI [10.2217/fon.09.91, 10.2217/FON.09.91]; Verfaillie Tom, 2010, Int J Cell Biol, V2010, P930509, DOI 10.1155/2010/930509; Wada H, 2007, ONCOL REP, V18, P801; Wang W, 2009, ACTA PHYSIOL, V196, P55, DOI 10.1111/j.1748-1716.2009.01980.x; Watanabe Y, 2008, BIOCHEM BIOPH RES CO, V366, P840, DOI 10.1016/j.bbrc.2007.12.028; William WN, 2012, ANN ONCOL, V23, P78, DOI 10.1093/annonc/mdr036; World Health Organisation, 1979, HDB REP RES CANC TRE; Yau T, 2009, CANCER-AM CANCER SOC, V115, P428, DOI 10.1002/cncr.24029; Yie Q, 2002, HEPATOLOGY, V36, P592, DOI 10.1053/jhep.2002.35441; Yin HP, 2011, CANCER LETT, V306, P34, DOI 10.1016/j.canlet.2011.02.017; Yu L, 2002, EMBO J, V21, P3749, DOI 10.1093/emboj/cdf366; Zhu B, 2010, PROSTATE, V70, P17, DOI 10.1002/pros.21033	53	13	14	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56197	10.1371/journal.pone.0056197	http://dx.doi.org/10.1371/journal.pone.0056197			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457527	Green Published, Green Submitted, gold			2022-12-25	WOS:000315603700026
J	Soto-Liebe, K; Lopez-Cortes, XA; Fuentes-Valdes, JJ; Stucken, K; Gonzalez-Nilo, F; Vasquez, M				Soto-Liebe, Katia; Lopez-Cortes, Xaviera A.; Jose Fuentes-Valdes, Juan; Stucken, Karina; Gonzalez-Nilo, Fernando; Vasquez, Monica			In Silico Analysis of Putative Paralytic Shellfish Poisoning Toxins Export Proteins in Cyanobacteria	PLOS ONE			English	Article							FRESH-WATER CYANOBACTERIUM; SAXITOXIN; STRAINS; NITROGEN; SODIUM; GROWTH; IDENTIFICATION; OPTIMIZATION; HOMOLOGY	Paralytic shellfish poisoning toxins (PSTs) are a family of more than 30 natural alkaloids synthesized by dinoflagellates and cyanobacteria whose toxicity in animals is mediated by voltage-gated Na+ channel blocking. The export of PST analogues may be through SxtF and SxtM, two putative MATE (multidrug and toxic compound extrusion) family transporters encoded in PSTs biosynthetic gene cluster (sxt). sxtM is present in every sxt cluster analyzed; however, sxtF is only present in the Cylindrospermopsis-Raphidiopsis clade. These transporters are energetically coupled with an electrochemical gradient of proton (H+) or sodium (Na+) ions across membranes. Because the functional role of PSTs remains unknown and methods for genetic manipulation in PST-producing organisms have not yet been developed, protein structure analyses will allow us to understand their function. By analyzing the sxt cluster of eight PST-producing cyanobacteria, we found no correlation between the presence of sxtF or sxtM and a specific PSTs profile. Phylogenetic analyses of SxtF/M showed a high conservation of SxtF in the Cylindrospermopsis-Raphidiopsis clade, suggesting conserved substrate affinity. Two domains involved in Na+ and drug recognition from NorM proteins (MATE family) of Vibrio parahaemolyticus and V. cholerae are present in SxtF/M. The Na+ recognition domain was conserved in both SxtF/M, indicating that Na+ can maintain the role as a cation anti-transporter. Consensus motifs for toxin binding differed between SxtF and SxtM implying differential substrate binding. Through protein modeling and docking analysis, we found that there is no marked affinity between the recognition domain and a specific PST analogue. This agrees with our previous results of PST export in R. brookii D9, where we observed that the response to Na+ incubation was similar to different analogues. These results reassert the hypothesis regarding the involvement of Na+ in toxin export, as well as the motifs L(398)XGLQD(403) (SxtM) and L(390)VGLRD(395) (SxtF) in toxin recognition.	[Soto-Liebe, Katia; Jose Fuentes-Valdes, Juan; Vasquez, Monica] Pontificia Univ Catolica Chile, Santiago, Chile; [Lopez-Cortes, Xaviera A.] Univ Talca, Nanobiotechnol Div, Fraunhofer Chile Res Fdn, Ctr Syst Biotechnol, Talca, Chile; [Stucken, Karina] Univ Dusseldorf, Inst Mol Evolut Heinrich Heine, D-40225 Dusseldorf, Germany; [Gonzalez-Nilo, Fernando] Univ Andres Bello, Ctr Bioinformat & Integrat Biol, Santiago, Chile	Pontificia Universidad Catolica de Chile; Universidad de Talca; Heinrich Heine University Dusseldorf; Universidad Andres Bello	Vasquez, M (corresponding author), Pontificia Univ Catolica Chile, Alameda 340, Santiago, Chile.	mvasquez@bio.puc.cl	González Nilo, Fernando Danilo/M-5368-2017; lopez, xaviera/R-1027-2019; González-Nilo, Fernando/M-5671-2016; Stucken, Karina/AAI-8343-2021	González Nilo, Fernando Danilo/0000-0001-6857-3575; González-Nilo, Fernando/0000-0001-6857-3575; Stucken, Karina/0000-0002-2783-4342; lopez cortes, xaviera/0000-0002-7514-8777	Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT) [1050433, 1080075]	Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	The first author KSL is a Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT) PhD fellow. This work was financed and supported by Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT) Grant 1050433 and 1080075. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; ALLEN MB, 1955, PLANT PHYSIOL, V30, P366, DOI 10.1104/pp.30.4.366; ANDZELM J, 1992, J CHEM PHYS, V96, P1280, DOI 10.1063/1.462165; APTE SK, 1986, EUR J BIOCHEM, V154, P395, DOI 10.1111/j.1432-1033.1986.tb09411.x; Bernard C, 2003, ENVIRON TOXICOL, V18, P176, DOI 10.1002/tox.10112; Carmichael WW, 1997, APPL ENVIRON MICROB, V63, P3104, DOI 10.1128/AEM.63.8.3104-3110.1997; Castro D, 2004, TOXICON, V44, P483, DOI 10.1016/j.toxicon.2004.06.005; Cembella AD, 2003, PHYCOLOGIA, V42, P420, DOI 10.2216/i0031-8884-42-4-420.1; Christiansen G, 2008, MOL BIOL EVOL, V25, P1695, DOI 10.1093/molbev/msn120; Cusick KD, 2012, ENVIRON SCI TECHNOL, V46, P2959, DOI 10.1021/es204027m; Dauber-Osguthorpe P, 1998, PROTEINS, V4, P31; Frisch M.J., 2009, GAUSSIAN 09 LINUX VE; Gugger M, 2005, APPL ENVIRON MICROB, V71, P1097, DOI 10.1128/AEM.71.2.1097-1100.2005; He XA, 2010, NATURE, V467, P991, DOI 10.1038/nature09408; Jiang YG, 2012, APPL ENVIRON MICROB, V78, P2256, DOI 10.1128/AEM.07321-11; Kellmann R, 2008, APPL ENVIRON MICROB, V74, P4044, DOI 10.1128/AEM.00353-08; KRATZ WA, 1955, AM J BOT, V42, P282, DOI 10.2307/2438564; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; Livshits VA, 2003, RES MICROBIOL, V154, P123, DOI 10.1016/S0923-2508(03)00036-6; Llewellyn LE, 2006, NAT PROD REP, V23, P200, DOI 10.1039/b501296c; Llewellyn LE, 2001, ENVIRON SCI TECHNOL, V35, P1445, DOI 10.1021/es001575z; MAHMOOD NA, 1986, TOXICON, V24, P175, DOI 10.1016/0041-0101(86)90120-0; Mihali TK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014657; Mihali Troco K, 2009, BMC Biochem, V10, P8, DOI 10.1186/1471-2091-10-8; Moustafa A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005758; Murray SA, 2011, MOL BIOL EVOL, V28, P1173, DOI 10.1093/molbev/msq295; NARAHASHI T, 1967, SCIENCE, V157, P1441, DOI 10.1126/science.157.3795.1441; Neilan BA, 2008, ADV EXP MED BIOL, V619, P417; Nielsen DL, 2003, AUST J BOT, V51, P655, DOI 10.1071/BT02115; Onodera Hideyuki, 1997, Natural Toxins, V5, P146; Paerl HW, 2012, WATER RES, V46, P1349, DOI 10.1016/j.watres.2011.08.002; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sanner MF, 1999, J MOL GRAPH MODEL, V17, P57; Singh AK, 2006, ANTIMICROB AGENTS CH, V50, P3717, DOI 10.1128/AAC.00460-06; Soto-Liebe K, 2012, TOXICON, V60, P1324, DOI 10.1016/j.toxicon.2012.09.001; Soto-Liebe K, 2010, TOXICON, V56, P1350, DOI 10.1016/j.toxicon.2010.07.022; Stucken K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009235; Su Z, 2004, J PHARMACOL EXP THER, V308, P324, DOI 10.1124/jpet.103.056564; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tikhonov DB, 2005, BIOPHYS J, V88, P184, DOI 10.1529/biophysj.104.048173; Truhlar DG, 2007, J COMPUT CHEM, V28, P73, DOI 10.1002/jcc.20529; Vanommeslaeghe K, 2010, J COMPUT CHEM, V31, P671, DOI 10.1002/jcc.21367; Vitousek PM, 2002, AMBIO, V31, P97, DOI 10.1639/0044-7447(2002)031[0097:NAN]2.0.CO;2; Wang JX, 2003, J GEN PHYSIOL, V121, P583, DOI 10.1085/jgp.200308812; Wilson K, 1990, CURRENT PROTOCOLS MO, P241	48	10	10	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e55664	10.1371/journal.pone.0055664	http://dx.doi.org/10.1371/journal.pone.0055664			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457475	Green Published, gold			2022-12-25	WOS:000315603700016
J	Halder, S; Hammer, EM; Kleih, SC; Bogdan, M; Rosenstiel, W; Birbaumer, N; Kubler, A				Halder, Sebastian; Hammer, Eva Maria; Kleih, Sonja Claudia; Bogdan, Martin; Rosenstiel, Wolfgang; Birbaumer, Niels; Kuebler, Andrea			Prediction of Auditory and Visual P300 Brain-Computer Interface Aptitude	PLOS ONE			English	Article							SPELLING SYSTEM; POTENTIALS; PARADIGM; ERP; COMMUNICATION; PERFORMANCE; COMPONENT; ERROR; P3A	Objective: Brain-computer interfaces (BCIs) provide a non-muscular communication channel for patients with late-stage motoneuron disease (e.g., amyotrophic lateral sclerosis (ALS)) or otherwise motor impaired people and are also used for motor rehabilitation in chronic stroke. Differences in the ability to use a BCI vary from person to person and from session to session. A reliable predictor of aptitude would allow for the selection of suitable BCI paradigms. For this reason, we investigated whether P300 BCI aptitude could be predicted from a short experiment with a standard auditory oddball. Methods: Forty healthy participants performed an electroencephalography (EEG) based visual and auditory P300-BCI spelling task in a single session. In addition, prior to each session an auditory oddball was presented. Features extracted from the auditory oddball were analyzed with respect to predictive power for BCI aptitude. Results: Correlation between auditory oddball response and P300 BCI accuracy revealed a strong relationship between accuracy and N2 amplitude and the amplitude of a late ERP component between 400 and 600 ms. Interestingly, the P3 amplitude of the auditory oddball response was not correlated with accuracy. Conclusions: Event-related potentials recorded during a standard auditory oddball session moderately predict aptitude in an audiory and highly in a visual P300 BCI. The predictor will allow for faster paradigm selection. Significance: Our method will reduce strain on patients because unsuccessful training may be avoided, provided the results can be generalized to the patient population.	[Halder, Sebastian; Hammer, Eva Maria; Kleih, Sonja Claudia; Kuebler, Andrea] Univ Wurzburg, Inst Psychol, D-97070 Wurzburg, Germany; [Halder, Sebastian; Birbaumer, Niels; Kuebler, Andrea] Univ Tubingen, Inst Med Psychol & Behav Neurobiol, Tubingen, Germany; [Halder, Sebastian; Bogdan, Martin; Rosenstiel, Wolfgang] Univ Tubingen, Wilhelm Schickard Inst Comp Sci, Tubingen, Germany; [Birbaumer, Niels] Ist Ricovero & Cura Carattere Sci, Osped San Camillo, Venice, Italy; [Bogdan, Martin] Univ Leipzig, D-04109 Leipzig, Germany	University of Wurzburg; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Leipzig University	Halder, S (corresponding author), Univ Wurzburg, Inst Psychol, D-97070 Wurzburg, Germany.	sebastian.halder@uni-wuerzburg.de	Halder, Sebastian/J-6144-2019; Halder, Sebastian/G-3745-2012; Kleih-Dahms, Sonja/AAA-6650-2022	Halder, Sebastian/0000-0003-1017-3696; Kubler, Andrea/0000-0003-4876-0415; Birbaumer, Niels/0000-0002-6786-5127	Deutsche Forschungsgemeinschaft (DFG) [KU 1453/3-1, BI 195/58-1]; European ICT Programme [FP7-224631, SFB 550/B5, SFB 550/C6]; BMBF (Bundesministerium fur Bildung und Forschung) Bernstein Center for Neurocomputation [01GQ0831]; European Research Council Grant [ERC 227632-BCCI]; European Community's, Seventh Framework Programme FP7, BackHome project [288566]; German Reasearch Foundation (DFG); University of Wurzburg	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); European ICT Programme; BMBF (Bundesministerium fur Bildung und Forschung) Bernstein Center for Neurocomputation(Federal Ministry of Education & Research (BMBF)); European Research Council Grant(European Research Council (ERC)); European Community's, Seventh Framework Programme FP7, BackHome project; German Reasearch Foundation (DFG)(German Research Foundation (DFG)); University of Wurzburg	Funded by Deutsche Forschungsgemeinschaft (DFG) KU 1453/3-1 and BI 195/58-1. This work is supported by the European ICT Programme Project FP7-224631, SFB 550/B5 and C6, BMBF (Bundesministerium fur Bildung und Forschung) Bernstein Center for Neurocomputation (Nr 01GQ0831) and the European Research Council Grant (ERC 227632-BCCI). The research leading to these results has also received funding from the European Community's, Seventh Framework Programme FP7/2007-2013, BackHome project grant agreement number 288566. This publication was funded by the German Reasearch Foundation (DFG) and the University of Wurzburg in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1991, J CLIN NEUROPHYSIOL, V8, P200, DOI 10.1097/00004691-199104000-00007; Averbuch-Heller L, 1998, ANN NEUROL, V44, P641, DOI 10.1002/ana.410440410; Birbaumer N, 2006, CLIN NEUROPHYSIOL, V117, P479, DOI 10.1016/j.clinph.2005.11.002; Birbaumer N, 2008, CURR OPIN NEUROL, V21, P634, DOI 10.1097/WCO.0b013e328315ee2d; Blankertz B, 2010, NEUROIMAGE, V51, P1303, DOI 10.1016/j.neuroimage.2010.03.022; Brunner P, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/5/056013; Cichocki A, 2005, CLIN NEUROPHYSIOL, V116, P729, DOI 10.1016/j.clinph.2004.09.017; Comerchero MD, 1999, CLIN NEUROPHYSIOL, V110, P24, DOI 10.1016/S0168-5597(98)00033-1; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; FARWELL LA, 1988, ELECTROEN CLIN NEURO, V70, P510, DOI 10.1016/0013-4694(88)90149-6; Fazel-Rezai R, 2007, P ANN INT IEEE EMBS, P2516, DOI 10.1109/IEMBS.2007.4352840; Folstein JR, 2008, PSYCHOPHYSIOLOGY, V45, P152, DOI 10.1111/j.1469-8986.2007.00602.x; Furdea A, 2009, PSYCHOPHYSIOLOGY, V46, P617, DOI 10.1111/j.1469-8986.2008.00783.x; Halder S, 2011, NEUROIMAGE, V55, P1779, DOI 10.1016/j.neuroimage.2011.01.021; Halder S, 2010, CLIN NEUROPHYSIOL, V121, P516, DOI 10.1016/j.clinph.2009.11.087; Halder Sebastian, 2007, Comput Intell Neurosci, P82069, DOI 10.1155/2007/82069; Hammer EM, 2012, BIOL PSYCHOL, V89, P80, DOI 10.1016/j.biopsycho.2011.09.006; Hill N, 2004, ADV NEURAL INFORM PR, V17; Hohne J, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00099; Hoffmann U, 2008, J NEUROSCI METH, V167, P115, DOI 10.1016/j.jneumeth.2007.03.005; Iturrate I, 2009, IEEE INT C ROB AUT; JACOBS L, 1981, NEUROLOGY, V31, P1282, DOI 10.1212/WNL.31.10.1282; Kathner I, 2013, CLIN NEUROPHYSIOL, V124, P327, DOI 10.1016/j.clinph.2012.08.006; Katayama J, 1999, CLIN NEUROPHYSIOL, V110, P463, DOI 10.1016/S1388-2457(98)00035-2; Kaufmann T, 2011, P 5 INT BRAIN COMP I, P136; Kaufmann T, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00072; Kaufmann T, 2012, INT J PSYCHOPHYSIOL, V83, P336, DOI 10.1016/j.ijpsycho.2011.11.018; Kleih SC, 2010, CLIN NEUROPHYSIOL, V121, P1023, DOI 10.1016/j.clinph.2010.01.034; Klobassa DS, 2009, CLIN NEUROPHYSIOL, V120, P1252, DOI 10.1016/j.clinph.2009.04.019; Kotchoubey B, 2003, NEUROSCI RES, V45, P369, DOI 10.1016/S0168-0102(02)00250-X; Kotchoubey B, 2001, NEUROSCI LETT, V301, P37, DOI 10.1016/S0304-3940(01)01600-7; Kotchoubey B, 2000, EXP AGING RES, V26, P15, DOI 10.1080/036107300243669; Krusienski DJ, 2008, J NEUROSCI METH, V167, P15, DOI 10.1016/j.jneumeth.2007.07.017; Krusienski DJ, 2006, J NEURAL ENG, V3, P299, DOI 10.1088/1741-2560/3/4/007; Kubler A, 2005, PROG BRAIN RES, V150, P513, DOI 10.1016/S0079-6123(05)50035-9; Kubler A, 2004, J PSYCHOPHYSIOL, V18, P121, DOI 10.1027/0269-8803.18.23.121; Kubler A, 2008, CLIN NEUROPHYSIOL, V119, P2658, DOI 10.1016/j.clinph.2008.06.019; Kubler A, 2009, ANN NY ACAD SCI, V1157, P90, DOI 10.1111/j.1749-6632.2008.04122.x; LANG T, 1991, IEEE T CIRCUITS SYST, V38, P499, DOI 10.1109/31.76486; Loveless N E, 1974, Biol Psychol, V1, P303, DOI 10.1016/0301-0511(74)90005-2; MCCALLUM WC, 1981, ELECTROEN CLIN NEURO, V51, P123, DOI 10.1016/0013-4694(81)90001-8; Munssinger JI, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00182; Mugler EM, 2010, IEEE T NEUR SYS REH, V18, P599, DOI 10.1109/TNSRE.2010.2068059; Naatanen R, 1986, Electroencephalogr Clin Neurophysiol Suppl, V38, P169; Naatanen R, 1983, ADV PSYCHOL, P119, DOI DOI 10.1016/S0166-4115(08)62036-1; Neshige Ryuji, 2006, Suppl Clin Neurophysiol, V59, P35; Neumann N, 2003, J NEUROL NEUROSUR PS, V74, P1117, DOI 10.1136/jnnp.74.8.1117; Nijboer F, 2008, J NEUROSCI METH, V167, P43, DOI 10.1016/j.jneumeth.2007.02.009; Nykopp T., 2001, THESIS HELSINKI U TE; Pfurtscheller G, 2000, NEUROSCI LETT, V292, P211, DOI 10.1016/S0304-3940(00)01471-3; Pichiorri F, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/2/025020; Pierce J.R., 1980, INTRO INFORM THEORY; Polich J, 1996, INT J PSYCHOPHYSIOL, V23, P55, DOI 10.1016/0167-8760(96)00028-1; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; RITTER W, 1979, SCIENCE, V203, P1358, DOI 10.1126/science.424760; Robles L., 2007, SENSES COMPREHENSIVE, P413; Schalk G, 2004, IEEE T BIO-MED ENG, V51, P1034, DOI 10.1109/TBME.2004.827072; Schlogl A, 2007, BRAIN COMPUTER INTER, P373; Schreuder M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009813; Schroger E, 1998, NEUROREPORT, V9, P3355, DOI 10.1097/00001756-199810260-00003; Sellers EW, 2006, CLIN NEUROPHYSIOL, V117, P538, DOI 10.1016/j.clinph.2005.06.027; Silvoni S, 2009, FRONT NEUROSCI-SWITZ, V3, DOI 10.3389/neuro.20.001.2009; Smith E, 2005, BMJ-BRIT MED J, V330, P406, DOI 10.1136/bmj.330.7488.406; SPEARMAN C, 1987, AM J PSYCHOL, V100, P441, DOI 10.2307/1422689; Spencer KM, 2001, PSYCHOPHYSIOLOGY, V38, P343, DOI 10.1111/1469-8986.3820343; Spuler M, 2012, CLIN NEUROPHYSIOL, V123, P1328, DOI 10.1016/j.clinph.2011.11.082; SQUIRES NK, 1977, J EXP PSYCHOL HUMAN, V3, P299, DOI 10.1037/0096-1523.3.2.299; Townsend G, 2010, CLIN NEUROPHYSIOL, V121, P1109, DOI 10.1016/j.clinph.2010.01.030; Treder MS, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/6/066003; Vieregge P, 1999, COGNITIVE BRAIN RES, V8, P27, DOI 10.1016/S0926-6410(99)00004-X; Zickler C, 2011, CLIN EEG NEUROSCI, V42, P236, DOI 10.1177/155005941104200409	71	44	45	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e53513	10.1371/journal.pone.0053513	http://dx.doi.org/10.1371/journal.pone.0053513			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	099EJ	23457444	Green Published, gold			2022-12-25	WOS:000315602700003
J	Isomura, N; Iwao, K; Fukami, H				Isomura, Naoko; Iwao, Kenji; Fukami, Hironobu			Possible Natural Hybridization of Two Morphologically Distinct Species of Acropora (Cnidaria, Scleractinia) in the Pacific: Fertilization and Larval Survival Rates	PLOS ONE			English	Article							MONTASTRAEA-ANNULARIS COMPLEX; CORAL GENUS ACROPORA; REPRODUCTIVE ISOLATION; RETICULATE EVOLUTION; BOUNDARIES; SETTLEMENT; MECHANISMS	Natural hybridization of corals in the Indo-Pacific has been considered rather rare. However, field studies have observed many corals with intermediate interspecific or unusual morphologies. Given that the existence of F1 hybrids with intermediate interspecific morphologies has been proven in the Caribbean, hybrids may also inhabit the Indo-Pacific and occur more frequently than expected. In this study, we focused on two morphologically different species, Acropora florida and A. intermedia, and performed crossing experiments at Akajima Island, Japan. Results showed that these species could hybridize in both directions via eggs and sperm, but that fertilization rates significantly differed according to which species provided eggs. These results are similar to those reported from the Caribbean. Although all embryos developed normally to the planular larval stage, the developmental processes of some hybrid embryos were delayed by approximately 1 h compared with conspecific embryos, suggesting that fertilization occurred 1 h later in interspecific crosses than in intraspecific crosses. More successful hybridization could occur under conditions with low numbers of conspecific colonies. Additionally, a comparison of survival rates between hybrid and intraspecific larvae revealed that intra- and interspecific larvae produced from eggs of A. florida survived for significantly longer than those produced from eggs of A. intermedia. Considering these data, under specific conditions, hybrids can be expected to be produced and survive in nature in the Pacific. Furthermore, we identified one colony with intermediate morphology between A. florida and A. intermedia in the field. This colony was fertilized only by eggs of A. florida, with high fertilization rates, suggesting that this colony would be a hybrid of these two species and might be backcrossed.	[Isomura, Naoko] Okinawa Natl Coll Technol, Dept Bioresources Engn, Nago City, Okinawa, Japan; [Iwao, Kenji] Akajima Marine Sci Lab, Zamamison, Okinawa, Japan; [Fukami, Hironobu] Miyazaki Univ, Fac Agr, Dept Marine Biol & Environm Sci, Miyazaki 88921, Japan	University of Miyazaki	Fukami, H (corresponding author), Miyazaki Univ, Fac Agr, Dept Marine Biol & Environm Sci, Miyazaki 88921, Japan.	hirofukami@cc.miyazaki-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [22370033, 20121002]; Grants-in-Aid for Scientific Research [20121002] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grant-in-Aid for Scientific Research (B) (Grant No. 22370033) to HF and Grant-in-Aid for Scientific Research on Innovative Areas "Coral reef science for symbiosis and coexistence of human and ecosystem under combined stresses'' (Grant No. 20121002) of the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan to NI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold ML, 2009, INT J MOL SCI, V10, P3836, DOI 10.3390/ijms10093836; BABCOCK RC, 1986, MAR BIOL, V90, P379, DOI 10.1007/BF00428562; Cruz P, 1997, J EXP MAR BIOL ECOL, V212, P95, DOI 10.1016/S0022-0981(96)02742-6; Fogarty ND, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030486; Fujioka Y., 2002, GALAXEA JCRS, V4, P53, DOI DOI 10.3755/JCRS.2002.53; Fujioka Y., 1999, GALAXEA JCRS, V1, P41, DOI DOI 10.3755/jcrs.1999.41; Fukami H, 2004, EVOLUTION, V58, P324, DOI 10.1111/j.0014-3820.2004.tb01648.x; Fukami H, 2003, MAR BIOL, V142, P679, DOI 10.1007/s00227-002-1001-8; Gardner JPA, 1997, ADV MAR BIOL, V31, P1, DOI 10.1016/S0065-2881(08)60221-7; HARRISON PL, 1984, SCIENCE, V223, P1186, DOI 10.1126/science.223.4641.1186; Hatta M, 1999, MOL BIOL EVOL, V16, P1607, DOI 10.1093/oxfordjournals.molbev.a026073; HAYASHIBARA T, 1993, MAR ECOL PROG SER, V101, P253, DOI 10.3354/meps101253; Isomura N, 2001, CORAL REEFS, V20, P309, DOI 10.1007/s003380100180; Isomura N, 2013, MAR BIOL RES, V9, P181, DOI 10.1080/17451000.2012.707321; Kenyon JC, 1997, EVOLUTION, V51, P756, DOI 10.1111/j.1558-5646.1997.tb03659.x; Knowlton N, 1997, MAR BIOL, V127, P705, DOI 10.1007/s002270050061; Levitan DR, 2004, EVOLUTION, V58, P308, DOI 10.1111/j.0014-3820.2004.tb01647.x; Lopez JV, 1999, BIOL BULL-US, V196, P80, DOI 10.2307/1543170; Medina M, 1999, MAR BIOTECHNOL, V1, P89, DOI 10.1007/PL00011756; Miller DJ, 2003, MOL ECOL, V12, P805, DOI 10.1046/j.1365-294X.2003.01808.x; Miller K, 1997, BIOL BULL, V192, P98, DOI 10.2307/1542579; Morita M, 2006, J EXP BIOL, V209, P4574, DOI 10.1242/jeb.02500; Nishihira M., 1995, HERMATYPIC CORALS JA; Nishikawa A, 2003, MAR ECOL PROG SER, V256, P87, DOI 10.3354/meps256087; Nozawa Y, 2008, MAR BIOL, V155, P347, DOI 10.1007/s00227-008-1034-8; Okubo N, 2007, ZOOL SCI, V24, P1169, DOI 10.2108/zsj.24.1169; Richards ZT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003240; Rieseberg LH, 1997, ANNU REV ECOL SYST, V28, P359, DOI 10.1146/annurev.ecolsys.28.1.359; Scheer G., 1983, Zoologica (Stuttgart), P1; Sessa EB, 2012, MOL PHYLOGENET EVOL, V64, P563, DOI 10.1016/j.ympev.2012.05.009; Suzuki G, 2011, MAR ECOL PROG SER, V421, P131, DOI 10.3354/meps08896; Szmant AM, 1997, MAR BIOL, V129, P561, DOI 10.1007/s002270050197; Taniguchi H., 2012, Midoriishi, V23, P20; Taniguchi H, 2004, MIDORIISHI, P16; Taniguchi H, 1999, GALAXEA JCRS, V1, P59; Van Oppen MJH, 2000, MOL ECOL, V9, P1363, DOI 10.1046/j.1365-294x.2000.01010.x; Veron J, 1984, AUST I MAR SCI MONOG, V6, P485; Veron J. E., 2000, CORALS WORLD, V1-3; VERON JEN, 1995, CORALS SPACE TIME BI; Vollmer SV, 2002, SCIENCE, V296, P2023, DOI 10.1126/science.1069524; Wallace C.C., 1999, STAGHORN CORALS WORL, DOI 10.1071/9780643101388; WALLACE CC, 1994, ANNU REV ECOL SYST, V25, P237, DOI 10.1146/annurev.es.25.110194.001321; Wei NV, 2012, ZOOL STUD, V51, P85; Willis BL, 2006, ANNU REV ECOL EVOL S, V37, P489, DOI 10.1146/annurev.ecolsys.37.091305.110136; Willis BL, 1997, CORAL REEFS, V16, pS53, DOI 10.1007/s003380050242; Wolstenholme JK, 2004, MAR BIOL, V144, P567, DOI 10.1007/s00227-003-1209-2; Yamazato K, 1999, GALAXEA JCRS, V1999, P83, DOI DOI 10.3755/JCRS.1999.83	47	25	27	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56701	10.1371/journal.pone.0056701	http://dx.doi.org/10.1371/journal.pone.0056701			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457605	Green Published, Green Submitted, gold			2022-12-25	WOS:000315602700091
J	Yang, SZ; Cui, HC; Xie, N; Icyuz, M; Banerjee, S; Antony, VB; Abraham, E; Thannickal, VJ; Liu, G				Yang, Shanzhong; Cui, Huachun; Xie, Na; Icyuz, Mert; Banerjee, Sami; Antony, Veena B.; Abraham, Edward; Thannickal, Victor J.; Liu, Gang			miR-145 regulates myofibroblast differentiation and lung fibrosis	FASEB JOURNAL			English	Article						smooth muscle actin alpha; KLF4; contraction	GROWTH-FACTOR-BETA; EPIGENETIC REGULATION; PULMONARY-FIBROSIS; MICRORNAS; FIBROBLASTS; ACTIVATION; PRINCIPLES; TGF-BETA-1; MIR-29; TARGET	The expression of smooth muscle actin-alpha (SMA-alpha) by fibroblasts defines phenotypic transition to myofibroblasts and is a primary contributor to contractile force generation by these differentiated cells. Although the regulation of SMA-alpha expression has been the focus of many studies, there is presently only limited information concerning miRNA regulation of lung myofibroblast differentiation and the involvement of these miRNAs in pulmonary fibrosis. To determine the role of miR-145 in regulating lung myofibroblast differentiation and pulmonary fibrosis. Wild-type and miR-145(-/-) mice were studied. Lung fibrosis models and cell culture systems were employed. miR-145 mimics or inhibitors were transfected into pulmonary fibroblasts. Fibrogenic and contractile activities of lung fibroblasts were determined. We found that miR-145 expression is upregulated in TGF-beta 1-reated lung fibroblasts. miR-145 expression is also increased in the lungs of patients with idiopathic pulmonary fibrosis as compared to in normal human lungs. Overexpression of miR-145 in lung fibroblasts increased SMA-alpha expression, enhanced contractility, and promoted formation of focal and fibrillar adhesions. In contrast, miR-145 deficiency diminished TGF-beta 1 induced SMA-alpha expression. miR-145 did not affect the activity of TGF-beta 1, but promoted the activation of latent TGF-beta 1. miR-145 targets KLF4, a known negative regulator of SMA-alpha expression. Finally, we found that miR-145(-/-) mice are protected from bleomycin-induced pulmonary fibrosis. miR-145 plays an important role in the differentiation of lung myofibroblasts. miR-145 deficiency is protective against bleomycin-induced lung fibrosis, suggesting that miR-145 may be a potential target in the development of novel therapies to treat pathological fibrotic disorders.-Yang, S., Cui, H., Xie, N., Icyuz, M., Banerjee, S., Antony, V. B., Abraham, E., Thannickal, V. J., Liu, G. miR-145 regulates myofibroblast differentiation and lung fibrosis.	[Yang, Shanzhong; Cui, Huachun; Xie, Na; Icyuz, Mert; Banerjee, Sami; Antony, Veena B.; Thannickal, Victor J.; Liu, Gang] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Abraham, Edward] Wake Forest Sch Med, Winston Salem, NC USA	University of Alabama System; University of Alabama Birmingham; Wake Forest University	Liu, G (corresponding author), Univ Alabama Birmingham, Dept Med, 901 19th St So,BMR 2 233, Birmingham, AL 35294 USA.	gliu@uab.edu	Icyuz, Mert/J-6598-2013	Icyuz, Mert/0000-0003-1681-0115; Liu, Gang/0000-0003-2615-131X; , Gang/0000-0002-6999-7633	U.S. National Institutes of Health (NIH) [HL105473, HL097218, HL076206, HL067967, HL10781]; American Heart Association [10SDG4210009]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076206, R01HL105473, R01HL067967, R21HL097218] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by U.S. National Institutes of Health (NIH) grants HL105473 (to G. L.), HL097218 (to G. L.), HL076206 (to G. L.), HL067967 (to V.J.T.), and HL10781 (to V.J.T.) and by American Heart Association award 10SDG4210009 (to G. L.). Author contributions: conception and design, V.J.T. and G.L.; execution and interpretation, S.Y., N.X., H.C., S.B., E.A., V.J.T., and G.L.; drafting the manuscript, S.Y., N.X., H.C., M.I., V.B.A., E.A., V.J.T, and G.L.	ABE M, 1994, ANAL BIOCHEM, V216, P276, DOI 10.1006/abio.1994.1042; Ambros V, 2001, CELL, V107, P823, DOI 10.1016/S0092-8674(01)00616-X; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Caruso P, 2012, CIRC RES, V111, P290, DOI 10.1161/CIRCRESAHA.112.267591; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Croce CM, 2005, CELL, V122, P6, DOI 10.1016/j.cell.2005.06.036; Cushing L, 2011, AM J RESP CELL MOL, V45, P287, DOI 10.1165/rcmb.2010-0323OC; Cutroneo KR, 2007, J CELL PHYSIOL, V211, P585, DOI 10.1002/jcp.20972; Davis-Dusenbery BN, 2011, J BIOL CHEM, V286, P28097, DOI 10.1074/jbc.M111.236950; Engels BM, 2006, ONCOGENE, V25, P6163, DOI 10.1038/sj.onc.1209909; Hardie WD, 2009, AM J PATHOL, V175, P3, DOI 10.2353/ajpath.2009.081170; Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112; Hinz Boris, 2012, Proc Am Thorac Soc, V9, P137, DOI 10.1513/pats.201202-017AW; Hinz B, 2012, AM J PATHOL, V180, P1340, DOI 10.1016/j.ajpath.2012.02.004; Hu B, 2007, AM J RESP CELL MOL, V36, P78, DOI 10.1165/rcmb.2006-0043OC; Hu B, 2010, AM J PATHOL, V177, P21, DOI 10.2353/ajpath.2010.090999; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Konigshoff M, 2009, J CLIN INVEST, V119, P772, DOI 10.1172/JCI33950; Latronico MVG, 2009, NAT REV CARDIOL, V6, P418, DOI 10.1038/nrcardio.2009.56; Lee Chun Geun, 2006, Proc Am Thorac Soc, V3, P476; Liao XD, 2010, J MOL CELL CARDIOL, V49, P334, DOI 10.1016/j.yjmcc.2010.04.008; Liu G, 2008, FASEB J, V22, P2285, DOI 10.1096/fj.07-101816; Liu G, 2010, J EXP MED, V207, P1589, DOI 10.1084/jem.20100035; Liu Y, 2005, J BIOL CHEM, V280, P9719, DOI 10.1074/jbc.M412862200; Liu Y, 2003, J BIOL CHEM, V278, P48004, DOI 10.1074/jbc.M301902200; Mishra PK, 2009, J CELL MOL MED, V13, P778, DOI 10.1111/j.1582-4934.2009.00744.x; Pandey AK, 2009, CELL PHYSIOL BIOCHEM, V23, P221, DOI 10.1159/000218169; Pandit KV, 2010, AM J RESP CRIT CARE, V182, P220, DOI 10.1164/rccm.200911-1698OC; Pottier N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006718; Sachdeva M, 2010, CANCER RES, V70, P378, DOI 10.1158/0008-5472.CAN-09-2021; Sanders YY, 2011, AM J RESP CELL MOL, V45, P16, DOI 10.1165/rcmb.2010-0154OC; Thum T, 2008, CARDIOVASC RES, V79, P562, DOI 10.1093/cvr/cvn137; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Wipff PJ, 2007, J CELL BIOL, V179, P1311, DOI 10.1083/jcb.200704042; Wynn TA, 2011, J EXP MED, V208, P1339, DOI 10.1084/jem.20110551; Xiao J, 2012, MOL THER, V20, P1251, DOI 10.1038/mt.2012.36; Xin M, 2009, GENE DEV, V23, P2166, DOI 10.1101/gad.1842409; Xu N, 2009, CELL, V137, P647, DOI 10.1016/j.cell.2009.02.038; Yang SZ, 2012, AM J PATHOL, V180, P484, DOI 10.1016/j.ajpath.2011.10.005; Zeng Y, 2006, ONCOGENE, V25, P6156, DOI 10.1038/sj.onc.1209908; Zhou Y, 2004, AM J PATHOL, V165, P659, DOI 10.1016/S0002-9440(10)63330-5	44	114	121	0	33	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2013	27	6					2382	2391		10.1096/fj.12-219493	http://dx.doi.org/10.1096/fj.12-219493			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	154II	23457217	Green Published			2022-12-25	WOS:000319667600026
J	Wibral, M; Pampu, N; Priesemann, V; Siebenhuhner, F; Seiwert, H; Lindner, M; Lizier, JT; Vicente, R				Wibral, Michael; Pampu, Nicolae; Priesemann, Viola; Siebenhuehner, Felix; Seiwert, Hannes; Lindner, Michael; Lizier, Joseph T.; Vicente, Raul			Measuring Information-Transfer Delays	PLOS ONE			English	Article							CAUSALITY	In complex networks such as gene networks, traffic systems or brain circuits it is important to understand how long it takes for the different parts of the network to effectively influence one another. In the brain, for example, axonal delays between brain areas can amount to several tens of milliseconds, adding an intrinsic component to any timing-based processing of information. Inferring neural interaction delays is thus needed to interpret the information transfer revealed by any analysis of directed interactions across brain structures. However, a robust estimation of interaction delays from neural activity faces several challenges if modeling assumptions on interaction mechanisms are wrong or cannot be made. Here, we propose a robust estimator for neuronal interaction delays rooted in an information-theoretic framework, which allows a model-free exploration of interactions. In particular, we extend transfer entropy to account for delayed source-target interactions, while crucially retaining the conditioning on the embedded target state at the immediately previous time step. We prove that this particular extension is indeed guaranteed to identify interaction delays between two coupled systems and is the only relevant option in keeping with Wiener's principle of causality. We demonstrate the performance of our approach in detecting interaction delays on finite data by numerical simulations of stochastic and deterministic processes, as well as on local field potential recordings. We also show the ability of the extended transfer entropy to detect the presence of multiple delays, as well as feedback loops. While evaluated on neuroscience data, we expect the estimator to be useful in other fields dealing with network dynamics.	[Wibral, Michael; Siebenhuehner, Felix; Seiwert, Hannes; Vicente, Raul] Goethe Univ Frankfurt, MEG Unit, Brain Imaging Ctr, D-60054 Frankfurt, Germany; [Pampu, Nicolae] Ctr Cognit & Neural Studies Coneural, Cluj Napoca, Romania; [Priesemann, Viola; Vicente, Raul] Goethe Univ Frankfurt, FIAS, D-60054 Frankfurt, Germany; [Siebenhuehner, Felix] Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA; [Lindner, Michael] Univ Bonn, Ctr Econ & Neurosci, Bonn, Germany; [Lizier, Joseph T.] Max Planck Inst Math Sci, Leipzig, Germany; [Lizier, Joseph T.] CSIRO Informat & Commun Technol Ctr, Marsfield, NSW, Australia; [Vicente, Raul] Max Planck Inst Brain Res, Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt; University of California System; University of California Santa Barbara; University of Bonn; Max Planck Society; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Max Planck Society	Wibral, M (corresponding author), Goethe Univ Frankfurt, MEG Unit, Brain Imaging Ctr, D-60054 Frankfurt, Germany.	wibral@em.uni-frankfurt.de	Siebenhühner, Felix/A-4788-2019; Lizier, Joseph/B-8093-2008; Vicente, Raul/E-1566-2011; Priesemann, Viola/R-3042-2017; Siebenhühner, Felix/V-2935-2019; Wibral, Michael/H-5255-2019	Siebenhühner, Felix/0000-0002-2621-9145; Lizier, Joseph/0000-0002-9910-8972; Vicente, Raul/0000-0002-2497-0007; Priesemann, Viola/0000-0001-8905-5873; Siebenhühner, Felix/0000-0002-2621-9145; Wibral, Michael/0000-0001-8010-5862	LOEWE Grant "Neuronale Koordination Forschungsschwerpunkt Frankfurt(NeFF)"; Max Planck Society; Max Planck Institute for Mathematics in the Sciences	LOEWE Grant "Neuronale Koordination Forschungsschwerpunkt Frankfurt(NeFF)"; Max Planck Society(Max Planck Society); Max Planck Institute for Mathematics in the Sciences(Max Planck Society)	MW, RV, and VP received financial support from LOEWE Grant "Neuronale Koordination Forschungsschwerpunkt Frankfurt(NeFF)." VP received financial support from the Max Planck Society. MW thanks the Max Planck Institute for Mathematics in the Sciences for funding a visit which contributed to this work. JL thanks the LOEWE Grant "Neuronale Koordination Forschungsschwerpunkt Frankfurt(NeFF)" for funding a visit which contributed to this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amblard PO, 2011, J COMPUT NEUROSCI, V30, P7, DOI 10.1007/s10827-010-0231-x; Ay N, 2008, ADV COMPLEX SYST, V11, P17, DOI 10.1142/S0219525908001465; Barnett L, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.238701; Besserve M, 2010, J COMPUT NEUROSCI, V29, P547, DOI 10.1007/s10827-010-0236-5; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Buehlmann A, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000934; Chavez M, 2003, J NEUROSCI METH, V124, P113, DOI 10.1016/S0165-0270(02)00367-9; Chicharro D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032466; Csorgo M., 1998, LIMIT THEOREMS CHANG; Faes L, 2006, MED BIOL ENG COMPUT, V44, P383, DOI 10.1007/s11517-006-0043-3; Faes L, 2012, COMPUT BIOL MED, V42, P290, DOI 10.1016/j.compbiomed.2011.02.007; Faes L, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.051112; Felts PA, 1997, J NEUROSCI, V17, P7267; Freiwald WA, 1999, J NEUROSCI METH, V94, P105, DOI 10.1016/S0165-0270(99)00129-6; Garofalo M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006482; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Gomez-Herrero G., 2010, ARXIV10080539; Gourevitch B, 2007, J NEUROPHYSIOL, V97, P2533, DOI 10.1152/jn.01106.2006; Hadjipapas A, 2005, CLIN NEUROPHYSIOL, V116, P1300, DOI 10.1016/j.clinph.2005.01.014; Hahs DW, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.128701; Ito SY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027431; Kantz H., 2003, NONLINEAR TIME SERIE; Kozachenko L, 1987, PROBL INFORM TRANSM, V23, P95; Kraskov A, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066138; Leistritz L, 2006, BIOMED TECH, V51, P64, DOI 10.1515/BMT.2006.012; Lindner M, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-119; Lizier J., 2012, 252012 M PLANCK I MA; Lizier JT, 2010, EUR PHYS J B, V73, P605, DOI 10.1140/epjb/e2010-00034-5; Lizier JT, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.026110; Lizier JT, 2012, INFORM SCIENCES, V208, P39, DOI 10.1016/j.ins.2012.04.016; Lizier JT, 2011, J COMPUT NEUROSCI, V30, P85, DOI 10.1007/s10827-010-0271-2; Lizier JT, 2010, CHAOS, V20, DOI 10.1063/1.3486801; LIZIER JT, 2012, JIDT INFORM THEORETI; Ludtke N, 2010, MAGN RESON IMAGING, V28, P1113, DOI 10.1016/j.mri.2010.03.028; MARIMONT RB, 1979, J I MATH APPL, V24, P59; Neymotin SA, 2011, J COMPUT NEUROSCI, V30, P69, DOI 10.1007/s10827-010-0253-4; Nichols JM, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.046217; Nolte G, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.234101; Overbey LA, 2009, J SOUND VIB, V322, P438, DOI 10.1016/j.jsv.2008.11.025; Palus M, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.046211; Pearl J., 2000, CAUSALITY MODELS REA, DOI DOI 10.1017/CBO9780511803161; Pecora L, 1996, BUILDING BRIDGE NATU, P49; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Pompe B, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.051122; Ragwitz M, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.056201; ROSENBERG AF, 1990, J NEUROPHYSIOL, V63, P1033, DOI 10.1152/jn.1990.63.5.1033; Sabesan S, 2009, IEEE T NEUR SYS REH, V17, P244, DOI 10.1109/TNSRE.2009.2023291; Schreiber T, 2000, PHYS REV LETT, V85, P461, DOI 10.1103/PhysRevLett.85.461; Soriano MC, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.134101; Staniek M, 2009, BIOMED TECH, V54, P323, DOI 10.1515/BMT.2009.040; Sun LM, 2012, J NEUROSCI, V32, P9563, DOI 10.1523/JNEUROSCI.1073-12.2012; Takens F, 1981, LECT NOTES MATH, P366, DOI [10.1007/BFb0091924, DOI 10.1007/BFB0091924]; Terry JR, 2003, BIOL CYBERN, V88, P129, DOI 10.1007/s00422-002-0368-4; Turi G, 2012, NEUROIMAGE, V59, P2607, DOI 10.1016/j.neuroimage.2011.08.078; Vakorin VA, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00096; Vakorin VA, 2010, NEUROIMAGE, V49, P1593, DOI 10.1016/j.neuroimage.2009.08.027; Vakorin VA, 2009, J NEUROSCI METH, V184, P152, DOI 10.1016/j.jneumeth.2009.07.014; VANDERLO.H, 1972, BRAIN RES, V48, P355, DOI 10.1016/0006-8993(72)90189-8; Victor J, 2005, PHYS REV E, V72; Voss HU, 2000, PHYS REV E, V61, P5115, DOI 10.1103/PhysRevE.61.5115; Whitford TJ, 2012, SCHIZOPHRENIA BULL, V38, P486, DOI 10.1093/schbul/sbq105; Wibral M, 2008, INT J PSYCHOPHYSIOL, V67, P200, DOI 10.1016/j.ijpsycho.2007.06.009; Wibral M, 2011, PROG BIOPHYS MOL BIO, V105, P80, DOI 10.1016/j.pbiomolbio.2010.11.006	64	163	164	2	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e55809	10.1371/journal.pone.0055809	http://dx.doi.org/10.1371/journal.pone.0055809			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23468850	Green Submitted, gold, Green Published			2022-12-25	WOS:000315524900014
J	Kashani-Sabet, M; Sagebiel, RW; Joensuu, H; Miller, JR				Kashani-Sabet, Mohammed; Sagebiel, Richard W.; Joensuu, Heikki; Miller, James R., III			A Patient-Centered Methodology That Improves the Accuracy of Prognostic Predictions in Cancer	PLOS ONE			English	Article							PRIMARY CUTANEOUS MELANOMA; AMERICAN JOINT COMMITTEE; DOSE INTERFERON-ALPHA-2B; CARDIOVASCULAR RISK; BREAST-CANCER; ROC CURVE; RECLASSIFICATION; MARKER; STATISTICS; VALIDATION	Individualized approaches to prognosis are crucial to effective management of cancer patients. We developed a methodology to assign individualized 5-year disease-specific death probabilities to 1,222 patients with melanoma and to 1,225 patients with breast cancer. For each cancer, three risk subgroups were identified by stratifying patients according to initial stage, and prediction probabilities were generated based on the factors most closely related to 5-year disease-specific death. Separate subgroup probabilities were merged to form a single composite index, and its predictive efficacy was assessed by several measures, including the area (AUC) under its receiver operating characteristic (ROC) curve. The patient-centered methodology achieved an AUC of 0.867 in the prediction of 5-year disease-specific death, compared with 0.787 using the AJCC staging classification alone. When applied to breast cancer patients, it achieved an AUC of 0.907, compared with 0.802 using the AJCC staging classification alone. A prognostic algorithm produced from a randomly selected training subsample of 800 melanoma patients preserved 92.5% of its prognostic efficacy (as measured by AUC) when the same algorithm was applied to a validation subsample containing the remaining patients. Finally, the tailored prognostic approach enhanced the identification of high-risk candidates for adjuvant therapy in melanoma. These results describe a novel patient-centered prognostic methodology with improved predictive efficacy when compared with AJCC stage alone in two distinct malignancies drawn from two separate populations.	[Kashani-Sabet, Mohammed; Sagebiel, Richard W.; Miller, James R., III] Calif Pacific Med Ctr & Res Inst, Ctr Melanoma Res & Treatment, San Francisco, CA USA; [Joensuu, Heikki] Univ Helsinki, Mol Canc Biol Program, Helsinki, Finland	California Pacific Medical Center; California Pacific Medical Center Research Institute; University of Helsinki	Kashani-Sabet, M (corresponding author), Calif Pacific Med Ctr & Res Inst, Ctr Melanoma Res & Treatment, San Francisco, CA USA.	kashani@cpmcri.org		Joensuu, Heikki/0000-0003-0281-2507	United States Public Health Service [CA114337, CA122947]; NATIONAL CANCER INSTITUTE [R01CA122947, R01CA114337] Funding Source: NIH RePORTER	United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by United States Public Health Service Grants CA114337 and CA122947 (to M. K. S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso SR, 2007, CANCER RES, V67, P3450, DOI 10.1158/0008-5472.CAN-06-3481; Balch CM, 2009, J CLIN ONCOL, V27, P6199, DOI 10.1200/JCO.2009.23.4799; Balch CM, 2001, J CLIN ONCOL, V19, P3622, DOI 10.1200/JCO.2001.19.16.3622; Balch CM, 2001, J CLIN ONCOL, V19, P3635, DOI 10.1200/JCO.2001.19.16.3635; Cochran AJ, 2000, HUM PATHOL, V31, P327, DOI 10.1016/S0046-8177(00)80246-4; Conway C, 2009, CLIN CANCER RES, V15, P6939, DOI 10.1158/1078-0432.CCR-09-1631; Cook NR, 2006, ANN INTERN MED, V145, P21, DOI 10.7326/0003-4819-145-1-200607040-00128; Cook NR, 2009, ANN INTERN MED, V150, P795, DOI 10.7326/0003-4819-150-11-200906020-00007; JOENSUU H, 1995, J CLIN ONCOL, V13, P62, DOI 10.1200/JCO.1995.13.1.62; Kashani-Sabet M, 2004, J CLIN ONCOL, V22, P617, DOI 10.1200/JCO.2004.06.047; Kashani-Sabet M, 2002, J CLIN ONCOL, V20, P1826, DOI 10.1200/JCO.2002.07.082; Kashani-Sabet M, 2001, ARCH DERMATOL, V137, P1169; Kashani-Sabet M, 2009, CLIN CANCER RES, V15, P6987, DOI 10.1158/1078-0432.CCR-09-1777; Kashani-Sabet M, 2009, P NATL ACAD SCI USA, V106, P6268, DOI 10.1073/pnas.0901185106; Kirkwood JM, 2000, J CLIN ONCOL, V18, P2444, DOI 10.1200/JCO.2000.18.12.2444; Kirkwood JM, 1996, J CLIN ONCOL, V14, P7, DOI 10.1200/JCO.1996.14.1.7; Kirkwood JM, 2001, J CLIN ONCOL, V19, P2370, DOI 10.1200/JCO.2001.19.9.2370; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pepe MS, 2008, STAT MED, V27, P173, DOI 10.1002/sim.2991; Rangel J, 2006, J CLIN ONCOL, V24, P4565, DOI 10.1200/JCO.2006.07.3833; Rothberg BEG, 2009, J CLIN ONCOL, V27, P5772, DOI 10.1200/JCO.2009.22.8239; Soong SJ, 2010, ANN SURG ONCOL, V17, P2006, DOI 10.1245/s10434-010-1050-z; Tice JA, 2008, ANN INTERN MED, V148, P337, DOI 10.7326/0003-4819-148-5-200803040-00004; Ware JH, 2006, NEW ENGL J MED, V355, P2615, DOI 10.1056/NEJMp068249; Zettersten E, 2003, SURG CLIN N AM, V83, P61, DOI 10.1016/S0039-6109(02)00094-4	25	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e56435	10.1371/journal.pone.0056435	http://dx.doi.org/10.1371/journal.pone.0056435			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460802	Green Published, gold, Green Submitted			2022-12-25	WOS:000315519000025
J	Yu, Q; Shen, XH; Li, Y; Li, RJ; Li, J; Luo, YY; Liu, SF; Deng, MY; Pei, MF; Zhang, GS				Yu, Qian; Shen, Xiao-hui; Li, Ying; Li, Rui-juan; Li, Ji; Luo, Yun-ya; Liu, Su-fang; Deng, Ming-yang; Pei, Min-fei; Zhang, Guang-sen			An Intron Mutation in the ACVRL1 May Be Associated with a Transcriptional Regulation Defect in a Chinese Family with Hereditary Hemorrhagic Telangiectasia	PLOS ONE			English	Article							ENDOTHELIAL-CELLS; GENETIC-HETEROGENEITY; JUVENILE POLYPOSIS; KINASE GENE; ENDOGLIN; LOCUS; EXPRESSION; TYPE-2; MAPS; PHENOTYPES	Purpose: To identify a novel pathogenic gene mutation present in a Chinese family with hereditary hemorrhagic telangiectasia (HHT) and to determine if an intron mutation may influence the transcriptional activity of the ACVRL1 gene. Methods: HHT family members were ascertained following the presentation of proband and involved subjects. All family members (n = 5) and 113 healthy individuals were genotyped for the variant in intron 6 c.772+27G>C of ACVRL1 gene. The genomic structure of ACVRL1 in affected HHT patients and healthy individuals was determined by long range PCR and sequencing. The expression of ACVRL1 mRNA and protein in patients with HHT was evaluated using real-time polymerase chain reaction and immunoblot analysis. Luciferase activity assay and electrophoretic mobility shift assay (EMSA) were performed to uncover the mechanism of intron-related transcriptional regulation. Results: Only one novel mutation in intron 6 (c.772+27G>C) of ACVRL1 gene, no other mutation, abnormal splice, gross genomic deletion or rearrangement was found in this HHT2 family. Compared with healthy individuals, ACVRL1 mRNA and protein were significantly decreased in affected HHT2 individuals. Luciferase activity assay demonstrated that the transcriptional activity of the mutated ACVRL1 was significantly lower than that of the wild-type of intron 6; EMSA results showed that intron 6 c.772+27G>C mutation was able to inhibit the binding of transcriptional factor Sp1. Conclusions: A novel intron mutation in ACVRL1 gene is associated with familial HHT2. The mechanisms may be involved in the down-regulation of ACVRL1 gene transcription.	[Yu, Qian; Shen, Xiao-hui; Li, Ying; Li, Rui-juan; Li, Ji; Luo, Yun-ya; Liu, Su-fang; Deng, Ming-yang; Pei, Min-fei; Zhang, Guang-sen] Cent S Univ, Xiang Ya Hosp 2, Inst Mol Hematol, Div Hematol, Changsha, Hunan, Peoples R China	Central South University	Zhang, GS (corresponding author), Cent S Univ, Xiang Ya Hosp 2, Inst Mol Hematol, Div Hematol, Changsha, Hunan, Peoples R China.	zgsllzy@163.com			Ministry of Health [2008-02031]; Scientific Research Program for Public Interests from The Health Ministry of China [201202017]; Health Ministry of China	Ministry of Health; Scientific Research Program for Public Interests from The Health Ministry of China; Health Ministry of China	This study was supported in part by public welfare and special-purpose fund (No: 2008-02031) from Ministry of Health; Scientific Research Program for Public Interests from The Health Ministry of China (No: 201202017), and Clinical Research Program from Health Ministry of China (key project 2011-2014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdalla SA, 2000, HUM MOL GENET, V9, P1227, DOI 10.1093/hmg/9.8.1227; Abdalla SA, 2003, J MED GENET, V40, P494, DOI 10.1136/jmg.40.7.494; Abdalla SA, 2005, HUM MUTAT, V25, DOI 10.1002/humu.9312; Berg J, 2003, J MED GENET, V40, P585, DOI 10.1136/jmg.40.8.585; Berg JN, 1997, AM J HUM GENET, V61, P60, DOI 10.1086/513903; Berg JN, 1996, J MED GENET, V33, P256, DOI 10.1136/jmg.33.3.256; Cole SG, 2005, J MED GENET, V42, P577, DOI 10.1136/jmg.2004.028712; Cunnion KM, 2003, INFECT IMMUN, V71, P1321, DOI 10.1128/IAI.71.3.1321-1327.2003; Cymerman U, 2003, HUM MUTAT, V21, P482, DOI 10.1002/humu.10203; Fernandez-L A, 2005, CARDIOVASC RES, V68, P235, DOI 10.1016/j.cardiores.2005.06.009; Gallione CJ, 2006, J MED GENET, V43, P793, DOI 10.1136/jmg.2006.041517; Gallione CJ, 2004, LANCET, V363, P852, DOI 10.1016/S0140-6736(04)15732-2; Garrido-Martin EM, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-51; HAMANN L, 1994, MOL CELL BIOL, V14, P5786, DOI 10.1128/MCB.14.9.5786; HENKEL G, 1994, P NATL ACAD SCI USA, V91, P7737, DOI 10.1073/pnas.91.16.7737; HEUTINK P, 1994, J MED GENET, V31, P933, DOI 10.1136/jmg.31.12.933; Jiang LL, 2004, AM J PHYSIOL-GASTR L, V286, P922; Jo EK, 2001, J IMMUNOL, V167, P4038, DOI 10.4049/jimmunol.167.7.4038; JOHNSON DW, 1995, GENOME RES, V5, P21, DOI 10.1101/gr.5.1.21; Kuehl HKA, 2005, HUM MUTAT, V25, DOI 10.1002/humu.9311; LASTRES P, 1992, EUR J IMMUNOL, V22, P393, DOI 10.1002/eji.1830220216; Letteboer TGW, 2005, HUM GENET, V116, P8, DOI 10.1007/s00439-004-1196-5; MCALLISTER KA, 1994, NAT GENET, V8, P345, DOI 10.1038/ng1294-345; MCALLISTER KA, 1994, J MED GENET, V31, P927, DOI 10.1136/jmg.31.12.927; McDonald J, 2009, J MOL DIAGN, V11, P569, DOI 10.2353/jmoldx.2009.080148; MCDONALD MT, 1994, NAT GENET, V6, P197, DOI 10.1038/ng0294-197; Olivieri C, 2007, J HUM GENET, V52, P820, DOI 10.1007/s10038-007-0187-5; PORTEOUS MEM, 1994, J MED GENET, V31, P925, DOI 10.1136/jmg.31.12.925; Pyatt RE, 2006, J MOL DIAGN, V8, P84, DOI 10.2353/jmoldx.2006.050072; ROTHENEDER H, 1991, NUCLEIC ACIDS RES, V19, P6805, DOI 10.1093/nar/19.24.6805; SAFFER JD, 1991, MOL CELL BIOL, V11, P2189, DOI 10.1128/MCB.11.4.2189; Sanz-Rodriguez F, 2004, CLIN CHEM, V50, P2003, DOI 10.1373/clinchem.2004.035287; Schulte Claudia, 2005, Hum Mutat, V25, P595, DOI 10.1002/humu.9345; Shovlin CL, 2000, AM J MED GENET, V91, P66, DOI 10.1002/(SICI)1096-8628(20000306)91:1<66::AID-AJMG12>3.0.CO;2-P; ten Dijke P, 2004, TRENDS BIOCHEM SCI, V29, P265, DOI 10.1016/j.tibs.2004.03.008; WAKABAYASHIITO N, 1994, J BIOL CHEM, V269, P29831; Yan K, 2008, GASTROINTEST ENDOSC, V18, P415; Zhang GS, 2004, CHINESE MED J-PEKING, V117, P808	38	11	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e58031	10.1371/journal.pone.0058031	http://dx.doi.org/10.1371/journal.pone.0058031			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460919	Green Submitted, Green Published, gold			2022-12-25	WOS:000315519000174
J	Wisnowski, JL; Bluml, S; Paquette, L; Zelinski, E; Nelson, MD; Painter, MJ; Damasio, H; Gilles, F; Panigrahy, A				Wisnowski, Jessica L.; Blueml, Stefan; Paquette, Lisa; Zelinski, Elizabeth; Nelson, Marvin D., Jr.; Painter, Michael J.; Damasio, Hanna; Gilles, Floyd; Panigrahy, Ashok			Altered Glutamatergic Metabolism Associated with Punctate White Matter Lesions in Preterm Infants	PLOS ONE			English	Article							PERIVENTRICULAR LEUKOMALACIA; MITOCHONDRIAL GLUTAMINASE; N-ACETYLASPARTATE; MR SPECTROSCOPY; AMINO-ACIDS; HUMAN BRAIN; RESONANCE; INJURY; EXPRESSION; ISCHEMIA	Preterm infants (similar to 10% of all births) are at high-risk for long-term neurodevelopmental disabilities, most often resulting from white matter injury sustained during the neonatal period. Glutamate excitotoxicity is hypothesized to be a key mechanism in the pathogenesis of white matter injury; however, there has been no in vivo demonstration of glutamate excitotoxicity in preterm infants. Using magnetic resonance spectroscopy (MRS), we tested the hypothesis that glutamate and glutamine, i.e., markers of glutamatergic metabolism, are altered in association with punctate white matter lesions and "diffuse excessive high signal intensity" (DEHSI), the predominant patterns of preterm white matter injury. We reviewed all clinically-indicated MRS studies conducted on preterm infants at a single institution during a six-year period and determined the absolute concentration of glutamate, glutamine, and four other key metabolites in the parietal white matter in 108 of those infants after two investigators independently evaluated the studies for punctate white matter lesions and DEHSI. Punctate white matter lesions were associated with a 29% increase in glutamine concentration (p = 0.002). In contrast, there were no differences in glutamatergic metabolism in association with DEHSI. Severe DEHSI, however, was associated with increased lactate concentration (p = 0.001), a marker of tissue acidosis. Findings from this study support glutamate excitotoxicity in the pathogenesis of punctate white matter lesions, but not necessarily in DEHSI, and suggest that MRS provides a useful biomarker for determining the pathogenesis of white matter injury in preterm infants during a period when neuroprotective agents may be especially effective.	[Wisnowski, Jessica L.; Blueml, Stefan; Nelson, Marvin D., Jr.; Panigrahy, Ashok] Childrens Hosp Los Angeles, Dept Radiol, Los Angeles, CA 90027 USA; [Wisnowski, Jessica L.; Damasio, Hanna] Univ So Calif, Brain & Creat Inst, Los Angeles, CA USA; [Paquette, Lisa] Childrens Hosp Los Angeles, Div Neonatol, Dept Pediat, Los Angeles, CA 90027 USA; [Zelinski, Elizabeth] Univ So Calif, Davis Sch Gerontol, Los Angeles, CA USA; [Painter, Michael J.] UPMC, Childrens Hosp Pittsburgh, Div Neurol, Dept Pediat, Pittsburgh, PA USA; [Gilles, Floyd] Childrens Hosp Los Angeles, Dept Pathol & Lab Med, Neuropathol Sect, Los Angeles, CA 90027 USA; [Panigrahy, Ashok] UPMC, Childrens Hosp Pittsburgh, Dept Radiol, Pittsburgh, PA USA	Children's Hospital Los Angeles; University of Southern California; Children's Hospital Los Angeles; University of Southern California; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Children's Hospital Los Angeles; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Panigrahy, A (corresponding author), Childrens Hosp Los Angeles, Dept Radiol, Los Angeles, CA 90027 USA.	panigrahya@upmc.edu		Bluml, Stefan/0000-0003-2124-797X	National Institutes of Health [K23NS063371, P50NS01962]; Rudi Schulte Foundation; USC-CHLA CTSI [1UL1RR031986]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR031986] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K23NS063371] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rudi Schulte Foundation; USC-CHLA CTSI; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by: National Institutes of Health [K23NS063371 to AP, P50NS01962 to JLW and HD]; and the Rudi Schulte Foundation to SB; and USC-CHLA CTSI grant 1UL1RR031986 to AP, JLW, and LP. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Back SA, 2007, STROKE, V38, P724, DOI 10.1161/01.STR.0000254729.27386.05; Back SA, 2007, J CEREBR BLOOD F MET, V27, P334, DOI 10.1038/sj.jcbfm.9600344; BANKER BQ, 1962, ARCH NEUROL-CHICAGO, V7, P386, DOI 10.1001/archneur.1962.04210050022004; Barkovich AJ, 2006, AM J NEURORADIOL, V27, P533; Bates TE, 1996, NEUROREPORT, V7, P1397, DOI 10.1097/00001756-199605310-00014; Beck S, 2010, B WORLD HEALTH ORGAN, V88, P31, DOI 10.2471/BLT.08.062554; Billiards SS, 2008, BRAIN PATHOL, V18, P153, DOI 10.1111/j.1750-3639.2007.00107.x; Bluml S, 2013, CEREB CORTEX, V23, P2944, DOI 10.1093/cercor/bhs283; Bluml S, 2001, MAGNET RESON MED, V45, P981, DOI 10.1002/mrm.1131; Braissant O, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-9; Chen J, 2012, PLOS ONE, V7; CHOI DW, 1988, J NEUROSCI, V8, P185; Clark JB, 1998, DEV NEUROSCI-BASEL, V20, P271, DOI 10.1159/000017321; Cornette LG, 2002, ARCH DIS CHILD-FETAL, V86, P171, DOI 10.1136/fn.86.3.F171; Daikhin Y, 2000, J NUTR, V130, p1026S, DOI 10.1093/jn/130.4.1026S; Desilva TM, 2008, J COMP NEUROL, V508, P238, DOI 10.1002/cne.21667; DOBBING J, 1973, ARCH DIS CHILD, V48, P757, DOI 10.1136/adc.48.10.757; ERNST T, 1993, J MAGN RESON SER B, V102, P1, DOI 10.1006/jmrb.1993.1055; Follett PL, 2004, J NEUROSCI, V24, P4412, DOI 10.1523/JNEUROSCI.0477-04.2004; GILLES FH, 1969, J NEUROL NEUROSUR PS, V32, P404, DOI 10.1136/jnnp.32.5.404; Hagberg H, 2002, MENT RETARD DEV D R, V8, P30, DOI 10.1002/mrdd.10007; Haynes RL, 2008, PEDIATR RES, V63, P656, DOI 10.1203/PDR.0b013e31816c825c; Kidokoro H, 2011, AM J NEURORADIOL, V32, P2005, DOI 10.3174/ajnr.A2703; Kreis R, 2004, NMR BIOMED, V17, P361, DOI 10.1002/nbm.891; Kreis R, 2002, MAGNET RESON MED, V48, P949, DOI 10.1002/mrm.10304; Lei HX, 2009, J CEREBR BLOOD F MET, V29, P811, DOI 10.1038/jcbfm.2009.8; Lentner C, 1981, GEIGY SCI TABLES, p[220, 222, 223]; LIPTON SA, 1994, NEW ENGL J MED, V330, P613; Maalouf EF, 1999, J PEDIATR-US, V135, P351, DOI 10.1016/S0022-3476(99)70133-2; Manning SM, 2008, J NEUROSCI, V28, P6670, DOI 10.1523/JNEUROSCI.1702-08.2008; Matsumae M, 2001, MECH AGEING DEV, V122, P1281, DOI 10.1016/S0047-6374(01)00265-2; McKenna MC, 2007, J NEUROSCI RES, V85, P3347, DOI 10.1002/jnr.21444; MELDRUM B, 1990, TRENDS PHARMACOL SCI, V11, P379, DOI 10.1016/0165-6147(90)90184-A; Miller SP, 2005, J PEDIATR-US, V147, P609, DOI 10.1016/j.jpeds.2005.06.033; Miller SP, 2009, TRENDS NEUROSCI, V32, P496, DOI 10.1016/j.tins.2009.05.010; Newcomb R, 1997, J BIOL CHEM, V272, P11276; Newcomb R, 1998, BRAIN RES, V813, P103, DOI 10.1016/S0006-8993(98)01006-3; Panigrahy Ashok, 2007, Top Magn Reson Imaging, V18, P3, DOI 10.1097/RMR.0b013e318093e6c7; Panigrahy A, 2010, PEDIATR RADIOL, V40, P3, DOI 10.1007/s00247-009-1450-z; PATEL TB, 1979, BIOCHEM J, V184, P539, DOI 10.1042/bj1840539; Richards DA, 2003, PHARMACOL RES, V48, P101, DOI 10.1016/S1043-6618(03)00081-1; Riddle A, 2011, ANN NEUROL, V70, P493, DOI 10.1002/ana.22501; Robertson NJ, 2000, J CEREBR BLOOD F MET, V20, P1446, DOI 10.1097/00004647-200010000-00006; Rossi DJ, 2007, NAT NEUROSCI, V10, P1377, DOI 10.1038/nn2004; Rutherford MA, 2010, NEURORADIOLOGY, V52, P505, DOI 10.1007/s00234-010-0700-y; Saigal S, 2008, LANCET, V371, P261, DOI 10.1016/S0140-6736(08)60136-1; Salter MG, 2005, NATURE, V438, P1167, DOI 10.1038/nature04301; Sanchez-Gomez MV, 2003, J NEUROSCI, V23, P9519; Skiold B, 2012, J PEDIATR-US, V160, P559, DOI 10.1016/j.jpeds.2011.09.053; SMART JL, 1973, J NUTR, V103, P1327, DOI 10.1093/jn/103.9.1327; Sulyok E, 2001, BIOL NEONATE, V79, P67, DOI 10.1159/000047068; TORP R, 1991, NEUROSCIENCE, V41, P433, DOI 10.1016/0306-4522(91)90339-P; URENJAK J, 1992, J NEUROCHEM, V59, P55, DOI 10.1111/j.1471-4159.1992.tb08875.x; URENJAK J, 1993, J NEUROSCI, V13, P981, DOI 10.1523/jneurosci.13-03-00981.1993; Volpe J.J., 2008, NEUROLOGY NEWBORN; Volpe JJ, 2011, INT J DEV NEUROSCI, V29, P423, DOI 10.1016/j.ijdevneu.2011.02.012; Woodward LJ, 2006, NEW ENGL J MED, V355, P685, DOI 10.1056/NEJMoa053792; Xu DA, 2011, J MAGN RESON IMAGING, V33, P306, DOI 10.1002/jmri.22460	58	25	28	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2013	8	2							e56880	10.1371/journal.pone.0056880	http://dx.doi.org/10.1371/journal.pone.0056880			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098PO	23468888	Green Published, gold, Green Submitted			2022-12-25	WOS:000315561400015
J	Bhaduri, B; Wickland, D; Wang, R; Chan, V; Bashir, R; Popescu, G				Bhaduri, Basanta; Wickland, David; Wang, Ru; Chan, Vincent; Bashir, Rashid; Popescu, Gabriel			Cardiomyocyte Imaging Using Real-Time Spatial Light Interference Microscopy (SLIM)	PLOS ONE			English	Article							QUANTITATIVE PHASE; CELL; CONTRAST; SUBWAVELENGTH; TOMOGRAPHY	Spatial light interference microscopy (SLIM) is a highly sensitive quantitative phase imaging method, which is capable of unprecedented structure studies in biology and beyond. In addition to the pi/2 shift introduced in phase contrast between the scattered and unscattered light from the sample, 4 phase shifts are generated in SLIM, by increments of pi/2 using a reflective liquid crystal phase modulator (LCPM). As 4 phase shifted images are required to produce a quantitative phase image, the switching speed of the LCPM and the acquisition rate of the camera limit the acquisition rate and, thus, SLIM's applicability to highly dynamic samples. In this paper we present a fast SLIM setup which can image at a maximum rate of 50 frames per second and provide in real-time quantitative phase images at 50/4 = 12.5 frames per second. We use a fast LCPM for phase shifting and a fast scientific-grade complementary metal oxide semiconductor (sCMOS) camera (Andor) for imaging. We present the dispersion relation, i.e. decay rate vs. spatial mode, associated with dynamic beating cardiomyocyte cells from the quantitative phase images obtained with the real-time SLIM system.	[Bhaduri, Basanta; Wickland, David; Wang, Ru; Bashir, Rashid; Popescu, Gabriel] Univ Illinois, Dept Elect & Comp Engn, Urbana, IL USA; [Chan, Vincent; Bashir, Rashid; Popescu, Gabriel] Univ Illinois, Dept Bioengn, Urbana, IL USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Popescu, G (corresponding author), Univ Illinois, Dept Elect & Comp Engn, Urbana, IL USA.	gpopescu@illinois.edu		Bhaduri, Basanta/0000-0001-9737-0996	National Science Foundation [CBET 08-46660 CAREER, CBET-1040462 MRI, CBET-0939511 EBICS]	National Science Foundation(National Science Foundation (NSF))	This research was supported by the National Science Foundation (grants CBET 08-46660 CAREER, CBET-1040462 MRI, CBET-0939511 EBICS). For more information, visit http://light.ece.uiuc.edu/. BB acknowledges useful discussions with Mustafa Mir. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barty A, 1998, OPT LETT, V23, P817, DOI 10.1364/OL.23.000817; Charriere F, 2006, OPT LETT, V31, P178, DOI 10.1364/OL.31.000178; Choi W, 2007, NAT METHODS, V4, P717, DOI 10.1038/NMETH1078; Ding HF, 2011, OPT LETT, V36, P2281, DOI 10.1364/OL.36.002281; Ding HF, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.238102; Dubois F, 1999, APPL OPTICS, V38, P7085, DOI 10.1364/AO.38.007085; Dunn GA, 1998, CELL BIOL LAB HDB; Fowler B, 2010, PROC SPIE, V7536, DOI 10.1117/12.846975; GABOR D, 1948, NATURE, V161, P777, DOI 10.1038/161777a0; Ikeda T, 2005, OPT LETT, V30, P1165, DOI 10.1364/OL.30.001165; Maass Alexander H, 2007, Methods Mol Biol, V366, P321; Mann CJ, 2005, OPT EXPRESS, V13, P8693, DOI 10.1364/OPEX.13.008693; Marquet P, 2005, OPT LETT, V30, P468, DOI 10.1364/OL.30.000468; Mir M, 2012, PROG OPTICS, V57, P133, DOI 10.1016/B978-0-44-459422-8.00003-5; Mir M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039816; Mir M, 2011, BIOMED OPT EXPRESS, V2, P3259, DOI 10.1364/BOE.2.003259; Mir M, 2011, P NATL ACAD SCI USA, V108, P13124, DOI 10.1073/pnas.1100506108; Mir M, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3369965; Park Y, 2010, P NATL ACAD SCI USA, V107, P6731, DOI 10.1073/pnas.0909533107; Pham H, 2012, OPT LETT, V37, P3438, DOI 10.1364/OL.37.003438; Popescu G, 2006, OPT LETT, V31, P775, DOI 10.1364/OL.31.000775; Popescu G, 2004, OPT LETT, V29, P2503, DOI 10.1364/OL.29.002503; Popescu G., 2011, QUANTITATIVE PHASE I, P385; Popescu G, 2008, AM J PHYSIOL-CELL PH, V295, pC538, DOI 10.1152/ajpcell.00121.2008; Popescu G, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.218101; Saurabh S, 2012, OPT EXPRESS, V20, P7338, DOI 10.1364/OE.20.007338; Shaked NT, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3420179; Sridharan S, 2011, BIOMED OPT EXPRESS, V2, P2815, DOI 10.1364/BOE.2.002815; Wang R, 2011, OPT EXPRESS, V19, P20571, DOI 10.1364/OE.19.020571; Wang R, 2011, J PHYS-CONDENS MAT, V23, DOI 10.1088/0953-8984/23/37/374107; Wang Z, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3656732; Wang Z, 2011, OPT EXPRESS, V19, P19907, DOI 10.1364/OE.19.019907; Wang Z, 2011, OPT LETT, V36, P1215, DOI 10.1364/OL.36.001215; Wang Z, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3549204; Wang Z, 2011, OPT EXPRESS, V19, P1016, DOI 10.1364/OE.19.001016; Yang CH, 2001, OPT LETT, V26, P1271, DOI 10.1364/OL.26.001271; Zernike F, 1942, PHYSICA, V9, P686, DOI 10.1016/S0031-8914(42)80035-X	37	18	19	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56930	10.1371/journal.pone.0056930	http://dx.doi.org/10.1371/journal.pone.0056930			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457641	gold, Green Submitted, Green Published			2022-12-25	WOS:000315603700099
J	Junemann, AGM; Stopa, P; Michalke, B; Chaudhri, A; Reulbach, U; Huchzermeyer, C; Schlotzer-Schrehardt, U; Kruse, FE; Zrenner, E; Rejdak, R				Juenemann, Anselm G. M.; Stopa, Piotr; Michalke, Bernhard; Chaudhri, Anwar; Reulbach, Udo; Huchzermeyer, Cord; Schloetzer-Schrehardt, Ursula; Kruse, Friedrich E.; Zrenner, Eberhart; Rejdak, Robert			Levels of Aqueous Humor Trace Elements in Patients with Non-Exsudative Age-related Macular Degeneration: A Case-control Study	PLOS ONE			English	Article							RETINAL-PIGMENT EPITHELIUM; CADMIUM ACCUMULATION; GENE-EXPRESSION; PC12 CELLS; ZINC; COBALT; TOXICITY; HYPOXIA; PROTEIN; METALLOTHIONEIN	Trace elements might play a role in the complex multifactorial pathogenesis of age-related macular degeneration (AMD). The aim of this study was to measure alterations of trace elements levels in aqueous humor of patients with non-exsudative (dry) AMD. For this pilot study, aqueous humor samples were collected from patients undergoing cataract surgery. 12 patients with dry AMD (age 77.9 +/- 6.62, female 8, male 4) and 11 patients without AMD (age 66.6 +/- 16.7, female 7, male 4) were included. Aqueous levels of cadmium, cobalt, copper, iron, manganese, selenium, and zinc were measured by use of Flow-Injection-Inductively-Coupled-Plasma-Mass-Spectrometry (FI-ICP-MS), quality controlled with certified standards. Patients with AMD had significantly higher aqueous humor levels of cadmium (median: 0.70 mu mol/L, IQR: 0.40-0.84 vs. 0.06 mu mol/L; IQR: 0.01-.018; p = 0.002), cobalt (median: 3.1 mu mol/L, IQR: 2.62-3.15 vs. 1.17 mu mol/L; IQR: 0.95-1.27; p<0.001), iron (median: 311 mu mol/L, IQR: 289-329 vs. 129 mu mol/L; IQR: 111-145; p<0.001) and zinc (median: 23.1 mu mol/L, IQR: 12.9-32.6 vs. 5.1 mu mol/L; IQR: 4.4-9.4; p = 0.020) when compared with patients without AMD. Copper levels were significantly reduced in patients with AMD (median: 16.2 mu mol/L, IQR: 11.4-31.3 vs. 49.9 mu mol/L; IQR: 32.0-. 142.0; p = 0.022) when compared to those without. No significant differences were observed in aqueous humor levels of manganese and selenium between patients with and without AMD. After an adjustment for multiple testing, cadmium, cobalt, copper and iron remained a significant factor in GLM models (adjusted for age and gender of the patients) for AMD. Alterations of trace element levels support the hypothesis that cadmium, cobalt, iron, and copper are involved in the pathogenesis of AMD.	[Juenemann, Anselm G. M.; Huchzermeyer, Cord; Schloetzer-Schrehardt, Ursula; Kruse, Friedrich E.] Univ Hosp Erlangen, Dept Ophthalmol, Erlangen, Germany; [Stopa, Piotr; Rejdak, Robert] Med Univ Lublin, Dept Gen Ophthalmol, Lublin, Poland; [Michalke, Bernhard] Helmholtz Zentrum Munchen, Inst Ecol Chem, Neuherberg, Germany; [Chaudhri, Anwar] Univ Erlangen Nurnberg, D-91054 Erlangen, Germany; [Reulbach, Udo] Trinity Coll Dublin, Dept Publ Hlth & Primary Care, Dublin, Ireland; [Zrenner, Eberhart] Ctr Ophthalmol, Tubingen, Germany; [Rejdak, Robert] Polish Acad Sci, Med Res Ctr, Dept Expt Pharmacol, Warsaw, Poland	University of Erlangen Nuremberg; Medical University of Lublin; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Erlangen Nuremberg; Trinity College Dublin; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Polish Academy of Sciences	Junemann, AGM (corresponding author), Univ Hosp Erlangen, Dept Ophthalmol, Erlangen, Germany.	anselm.juenemann@uk-erlangen.de	Jünemann, Anselm Gerhard Maria/GPK-8482-2022; Reulbach, Udo/F-4239-2012; Schmuki, Patrik/B-9720-2008	Reulbach, Udo/0000-0002-9527-157X; Rejdak, Robert/0000-0003-3321-2723				Erie JC, 2007, AM J OPHTHALMOL, V144, P414, DOI 10.1016/j.ajo.2007.05.020; Erie JC, 2009, AM J OPHTHALMOL, V147, P276, DOI 10.1016/j.ajo.2008.08.014; Erie JC, 2005, AM J OPHTHALMOL, V139, P888, DOI 10.1016/j.ajo.2004.12.007; Hahn P, 2003, ARCH OPHTHALMOL-CHIC, V121, P1099, DOI 10.1001/archopht.121.8.1099; Karovic O, 2007, BIOCHEM PHARMACOL, V73, P694, DOI 10.1016/j.bcp.2006.11.008; Klein R, 2008, OPHTHALMOLOGY, V115, P1460, DOI 10.1016/j.ophtha.2008.01.026; Kowalski M, 2010, MED SCI MONITOR, V16, pCR190; Lengyel I, 2007, EXP EYE RES, V84, P772, DOI 10.1016/j.exer.2006.12.015; Montezuma Sandra R, 2007, Semin Ophthalmol, V22, P229, DOI 10.1080/08820530701745140; Moulis JM, 2010, BIOMETALS, V23, P877, DOI 10.1007/s10534-010-9336-y; Nicolas MG, 1996, EXP EYE RES, V62, P399, DOI 10.1006/exer.1996.0045; Olbryt M, 2006, GENE EXPRESSION, V13, P191, DOI 10.3727/000000006783991818; Ortega R, 2009, TOXICOL LETT, V188, P26, DOI 10.1016/j.toxlet.2009.02.024; Rousselet E, 2008, PROTEOMICS, V8, P2244, DOI 10.1002/pmic.200701067; Sabolic I, 2010, BIOMETALS, V23, P897, DOI 10.1007/s10534-010-9351-z; Terman A, 2006, CHEM-BIOL INTERACT, V163, P29, DOI 10.1016/j.cbi.2006.04.013; Ugarte M, 2001, PROG NEUROBIOL, V64, P219, DOI 10.1016/S0301-0082(00)00057-5; Wenger RH, 2002, FASEB J, V16, DOI 10.1096/fj.01-0944rev; Wills NK, 2008, EXP EYE RES, V87, P80, DOI 10.1016/j.exer.2008.04.013; Wills NK, 2008, EXP EYE RES, V86, P41, DOI 10.1016/j.exer.2007.09.005; Yuan Y, 2003, J BIOL CHEM, V278, P15911, DOI 10.1074/jbc.M300463200; Zou WG, 2002, J NEUROSCI RES, V67, P837, DOI 10.1002/jnr.10168; Zou WG, 2001, J NEUROSCI RES, V64, P646, DOI 10.1002/jnr.1118; 2001, ARCH OPHTHALMOL, V119, P1417	24	43	44	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56734	10.1371/journal.pone.0056734	http://dx.doi.org/10.1371/journal.pone.0056734			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457607	gold, Green Published, Green Submitted			2022-12-25	WOS:000315603700075
J	Moul, C; Dobson-Stone, C; Brennan, J; Hawes, D; Dadds, M				Moul, Caroline; Dobson-Stone, Carol; Brennan, John; Hawes, David; Dadds, Mark			An Exploration of the Serotonin System in Antisocial Boys with High Levels of Callous-Unemotional Traits	PLOS ONE			English	Article							WHOLE-BLOOD SEROTONIN; TRYPTOPHAN HYDROXYLASE-2 GENE; MESSENGER-RNA EXPRESSION; 1B RECEPTOR GENE; CONDUCT PROBLEMS; CANDIDATE GENES; MONOAMINE METABOLITES; PSYCHOPATHIC TRAITS; AGGRESSIVE-BEHAVIOR; CEREBROSPINAL-FLUID	Background: The serotonin system is thought to play a role in the aetiology of antisocial and aggressive behaviour in both adults and children however previous findings have been inconsistent. Recently, research has suggested that the function of the serotonin system may be specifically altered in a sub-set of antisocial populations - those with psychopathic (callous-unemotional) personality traits. We explored the relationships between callous-unemotional traits and functional polymorphisms of selected serotonin-system genes, and tested the association between callous-unemotional traits and serum serotonin levels independently of antisocial and aggressive behaviour. Method: Participants were boys with antisocial behaviour problems aged 3-16 years referred to University of New South Wales Child Behaviour Research Clinics. Participants volunteered either a blood or saliva sample from which levels of serum serotonin (N = 66) and/or serotonin-system single nucleotide polymorphisms (N = 157) were assayed. Results: Functional single nucleotide polymorphisms from the serotonin 1b receptor gene (HTR1B) and 2a receptor gene (HTR2A) were found to be associated with callous-unemotional traits. Serum serotonin level was a significant predictor of callous-unemotional traits; levels were significantly lower in boys with high callous-unemotional traits than in boys with low callous-unemotional traits. Conclusion: Results provide support to the emerging literature that argues for a genetically-driven system-wide alteration in serotonin function in the aetiology of callous-unemotional traits. The findings should be interpreted as preliminary and future research that aims to replicate and further investigate these results is required.	[Moul, Caroline; Brennan, John; Dadds, Mark] Univ New S Wales, Sch Psychol, Sydney, NSW, Australia; [Dobson-Stone, Carol] Neurosci Res Australia, Sydney, NSW, Australia; [Dobson-Stone, Carol] Univ New S Wales, Sch Med Sci, Sydney, NSW, Australia; [Brennan, John] Sydney Childrens Hosp, Sydney, NSW, Australia; [Hawes, David] Univ Sydney, Sch Psychol, Sydney, NSW 2006, Australia	University of New South Wales Sydney; Neuroscience Research Australia; University of New South Wales Sydney; University of Sydney; University of Sydney	Moul, C (corresponding author), Univ New S Wales, Sch Psychol, Sydney, NSW, Australia.	cmoul@psy.unsw.edu.au	Hawes, David/AAE-6800-2021	Dadds, Mark/0000-0002-2900-1715; Dobson-Stone, Carol/0000-0002-2211-0257; Moul, Caroline/0000-0003-2632-1067; Hawes, David/0000-0003-3260-1225	Australian Research Council [DP120102296, LP100200150]	Australian Research Council(Australian Research Council)	Prof. Dadds is supported by grants from the Australian Research Council (DP120102296 and LP100200150) (http://www.arc.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert PR, 2012, PHILOS T R SOC B, V367, P2402, DOI 10.1098/rstb.2011.0376; [Anonymous], 2001, INFORM PAPER CENSUS; [Anonymous], 2006, BIOL AGGRESSION, DOI DOI 10.1093/ACPROF:OSO/9780195168761.003.0004; Association AP, 1994, DIAGN STAT MAN MENT, V4th; Attenburrow MJ, 2003, PSYCHOPHARMACOLOGY, V169, P104, DOI 10.1007/s00213-003-1479-x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Birbaumer N, 2005, ARCH GEN PSYCHIAT, V62, P799, DOI 10.1001/archpsyc.62.7.799; Brown SM, 2005, MOL PSYCHIATR, V10, P884, DOI 10.1038/sj.mp.4001716; Burt SA, 2008, AGGRESSIVE BEHAV, V34, P437, DOI 10.1002/ab.20251; CASTELLANOS FX, 1994, PSYCHIAT RES, V52, P305, DOI 10.1016/0165-1781(94)90076-0; Chen DY, 2012, J AFFECT DISORDERS, V138, P27, DOI 10.1016/j.jad.2011.04.018; Chen GL, 2008, HUM GENET, V122, P645, DOI 10.1007/s00439-007-0443-y; Clark M S, 2001, Psychopharmacol Bull, V35, P170; Clarke HF, 2005, J NEUROSCI, V25, P532, DOI 10.1523/JNEUROSCI.3690-04.2005; Conner TS, 2010, AM J MED GENET B, V153B, P67, DOI 10.1002/ajmg.b.30955; COOK EH, 1995, PSYCHIAT RES, V57, P13, DOI 10.1016/0165-1781(95)02596-O; Arias JMC, 2011, PSYCHIAT GENET, V21, P115, DOI 10.1097/YPG.0b013e3283437175; Dadds MR, 2008, J AM ACAD CHILD PSY, V47, P455, DOI 10.1097/CHI.0b013e31816407f1; Dadds MR, 2009, J CHILD PSYCHOL PSYC, V50, P599, DOI 10.1111/j.1469-7610.2008.02058.x; Dadds MR, 2005, J CONSULT CLIN PSYCH, V73, P400, DOI 10.1037/0022-006X.73.3.400; Davidson RJ, 2000, SCIENCE, V289, P591, DOI 10.1126/science.289.5479.591; Divers J, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-28; Drago A, 2010, EUR J CLIN PHARMACOL, V66, P5, DOI 10.1007/s00228-009-0724-6; Duan J, 2003, MOL PSYCHIATR, V8, P901, DOI 10.1038/sj.mp.4001403; Enoch MA, 2011, MOL PSYCHIATR, V16, P1139, DOI 10.1038/mp.2010.94; EPSTEIN NB, 1983, J MARITAL FAM THER, V9, P171, DOI 10.1111/j.1752-0606.1983.tb01497.x; Fowler T, 2009, PSYCHIAT GENET, V19, P312, DOI 10.1097/YPG.0b013e3283328df4; Frick PJ, 2003, J ABNORM CHILD PSYCH, V31, P457, DOI 10.1023/A:1023899703866; Frick PJ, 2005, J ABNORM CHILD PSYCH, V33, P471, DOI 10.1007/s10648-005-5728-9; Frick PJ., 2001, ANTISOCIAL PROCESS S; Frick PJ, 2010, PROPOSAL DSM 5 CHILD; Gao J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036721; Gao XP, 2005, CHINESE J CLIN REHAB, V9, P221; Gaysina D, 2006, ANN GEN PSYCHIATR, V5, pS213; Giegling I, 2006, J AFFECT DISORDERS, V96, P75, DOI 10.1016/j.jad.2006.05.016; Glenn AL, 2008, PSYCHIAT CLIN N AM, V31, P463, DOI 10.1016/j.psc.2008.03.004; Glenn AL, 2011, NEUROSCI BIOBEHAV R, V35, P612, DOI 10.1016/j.neubiorev.2010.07.005; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Gutknecht L, 2007, INT J NEUROPSYCHOPH, V10, P309, DOI 10.1017/S1461145706007437; Halperin JM, 2006, J AM ACAD CHILD PSY, V45, P833, DOI 10.1097/01.chi.0000220855.79144.ae; Halperin JM, 2003, PSYCHIAT RES, V119, P205, DOI 10.1016/S0165-1781(03)00136-7; Harmer CJ, 2003, NEUROPSYCHOPHARMACOL, V28, P148, DOI 10.1038/sj.npp.1300004; Heiser P, 2007, J NEURAL TRANSM, V114, P513, DOI 10.1007/s00702-006-0584-5; Hicks BM, 2010, PERSONAL DISORD, V1, P38, DOI 10.1037/a0018135; Holland D., 1997, DIAGNOSTIC INTERVIEW; Hughes CW, 1996, PSYCHIAT RES, V65, P79, DOI 10.1016/S0165-1781(96)02932-0; Jensen KP, 2009, MOL PSYCHIATR, V14, P381, DOI 10.1038/mp.2008.15; Jones AP, 2009, AM J PSYCHIAT, V166, P95, DOI 10.1176/appi.ajp.2008.07071050; Jonsson EG, 1997, EUR ARCH PSY CLIN N, V247, P297, DOI 10.1007/BF02922258; Keselman HJ, 1999, PSYCHOL METHODS, V4, P58, DOI 10.1037/1082-989X.4.1.58; Koglin U, 2012, KINDH ENTWICKL, V21, P141, DOI 10.1026/0942-5403/a000080; Krischer MK, 2008, INT J LAW PSYCHIAT, V31, P253, DOI 10.1016/j.ijlp.2008.04.008; Lim JE, 2007, MOL PSYCHIATR, V12, P491, DOI 10.1038/sj.mp.4001923; Lovibond SH, 1995, MANUAL DEPRESSION AN, V2nd; Lynam DR, 2007, J ABNORM PSYCHOL, V116, P155, DOI 10.1037/0021-843X.116.1.155; Ma DQ, 2010, AM J MED GENET B, V153B, P477, DOI 10.1002/ajmg.b.31003; Marsh AA, 2008, AM J PSYCHIAT, V165, P712, DOI 10.1176/appi.ajp.2007.07071145; Mossner R, 2006, INT J NEUROPSYCHOPH, V9, P437, DOI 10.1017/S1461145705005997; Moffitt TE, 1998, BIOL PSYCHIAT, V43, P446, DOI 10.1016/S0006-3223(97)00340-5; Moffitt TE, 2003, CAUSES OF CONDUCT DISORDER AND JUVENILE DELINQUENCY, P49; Moore TM, 2002, AGGRESSIVE BEHAV, V28, P299, DOI 10.1002/ab.90027; MOSS HB, 1990, BIOL PSYCHIAT, V28, P325, DOI 10.1016/0006-3223(90)90660-T; Moul C, 2012, PSYCHOL REV; MULLER J, 2003, BIOL PSYCHIAT, V171, P54; Newman JP, 2010, BIOL PSYCHIAT, V67, P66, DOI 10.1016/j.biopsych.2009.07.035; OKEANE V, 1992, BRIT J PSYCHIAT, V160, P643, DOI 10.1192/bjp.160.5.643; Pasalich DS, 2012, J CHILD PSYCHOL PSYC; PATRICK CJ, 1994, PSYCHOPHYSIOLOGY, V31, P319, DOI 10.1111/j.1469-8986.1994.tb02440.x; Pine DS, 1997, ARCH GEN PSYCHIAT, V54, P839; Rey JM, 1997, ARCH GEN PSYCHIAT, V54, P817; Rowe R, 2010, J CHILD PSYCHOL PSYC, V51, P688, DOI 10.1111/j.1469-7610.2009.02199.x; Sadeh N, 2010, J ABNORM PSYCHOL, V119, P604, DOI 10.1037/a0019709; Scheuch K, 2007, BIOL PSYCHIAT, V62, P1288, DOI 10.1016/j.biopsych.2007.01.015; Scott S, 2001, BRIT MED J, V323, P191, DOI 10.1136/bmj.323.7306.191; STOFF DM, 1992, PSYCHIAT RES, V43, P263, DOI 10.1016/0165-1781(92)90059-C; Szabo M, 2010, J ADOLESCENCE, V33, P1, DOI 10.1016/j.adolescence.2009.05.014; Turecki G, 1999, AM J PSYCHIAT, V156, P1456; Unis AS, 1997, BIOL PSYCHIAT, V42, P553, DOI 10.1016/S0006-3223(96)00465-9; van Goozen SHM, 1999, EUR NEUROPSYCHOPHARM, V9, P141, DOI 10.1016/S0924-977X(98)00019-4; Viding E, 2005, J CHILD PSYCHOL PSYC, V46, P592, DOI 10.1111/j.1469-7610.2004.00393.x; Viding E, 2008, DEVELOPMENTAL SCI, V11, P17, DOI 10.1111/j.1467-7687.2007.00648.x; VIRKKUNEN M, 1995, J PSYCHIATR NEUROSCI, V20, P271; WALLER G, 1990, BRIT J PSYCHIAT, V156, P546, DOI 10.1192/bjp.156.4.546; Walrath CM, 2004, J PSYCHOEDUC ASSESS, V22, P209, DOI 10.1177/073428290402200302; Walstab J, 2008, PHARMACOGENET GENOM, V18, P793, DOI 10.1097/FPC.0b013e3283050117; Weiss LA, 2005, AM J HUM GENET, V76, P33, DOI 10.1086/426697; Willemsen J, 2012, INT J OFFENDER THER, V56, P505, DOI 10.1177/0306624X11407443; YAN D, 1993, LIFE SCI, V52, P745, DOI 10.1016/0024-3205(93)90237-W; Zill P, 2007, J PSYCHIATR RES, V41, P168, DOI 10.1016/j.jpsychires.2005.05.004; Zouk H, 2007, AM J MED GENET B, V144B, P996, DOI 10.1002/ajmg.b.30521	90	32	32	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56619	10.1371/journal.pone.0056619	http://dx.doi.org/10.1371/journal.pone.0056619			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	099EQ	23457595	Green Submitted, Green Published, gold			2022-12-25	WOS:000315603700067
J	Buniello, A; Hardisty-Hughes, RE; Pass, JC; Bober, E; Smith, RJ; Steel, KP				Buniello, Annalisa; Hardisty-Hughes, Rachel E.; Pass, Johanna C.; Bober, Eva; Smith, Richard J.; Steel, Karen P.			Headbobber: A Combined Morphogenetic and Cochleosaccular Mouse Model to Study 10qter Deletions in Human Deafness	PLOS ONE			English	Article							ACETYLGALACTOSAMINE 4-SULFATE 6-O-SULFOTRANSFERASE; SEMICIRCULAR CANAL FORMATION; SENSORY ORGAN DEVELOPMENT; MURINE INNER-EAR; PROTEIN EXPRESSION; NERVOUS-SYSTEM; MICE LACKING; GENE FAMILY; LONG ARM; C-KIT	The recessive mouse mutant headbobber (hb) displays the characteristic behavioural traits associated with vestibular defects including headbobbing, circling and deafness. This mutation was caused by the insertion of a transgene into distal chromosome 7 affecting expression of native genes. We show that the inner ear of hb/hb mutants lacks semicircular canals and cristae, and the saccule and utricle are fused together in a single utriculosaccular sac. Moreover, we detect severe abnormalities of the cochlear sensory hair cells, the stria vascularis looks severely disorganised, Reissner's membrane is collapsed and no endocochlear potential is detected. Myo7a and Kcnj10 expression analysis show a lack of the melanocyte-like intermediate cells in hb/hb stria vascularis, which can explain the absence of endocochlear potential. We use Trp2 as a marker of melanoblasts migrating from the neural crest at E12.5 and show that they do not interdigitate into the developing strial epithelium, associated with abnormal persistence of the basal lamina in the hb/hb cochlea. We perform array CGH, deep sequencing as well as an extensive expression analysis of candidate genes in the headbobber region of hb/hb and littermate controls, and conclude that the headbobber phenotype is caused by: 1) effect of a 648 kb deletion on distal Chr7, resulting in the loss of three protein coding genes (Gpr26, Cpmx2 and Chst15) with expression in the inner ear but unknown function; and 2) indirect, long range effect of the deletion on the expression of neighboring genes on Chr7, associated with downregulation of Hmx3, Hmx2 and Nkx1.2 homeobox transcription factors. Interestingly, deletions of the orthologous region in humans, affecting the same genes, have been reported in nineteen patients with common features including sensorineural hearing loss and vestibular problems. Therefore, we propose that headbobber is a useful model to gain insight into the mechanisms underlying deafness in human 10qter deletion syndrome.	[Buniello, Annalisa; Pass, Johanna C.; Steel, Karen P.] Wellcome Trust Sanger Inst, Hinxton, Cambs, England; [Buniello, Annalisa; Pass, Johanna C.; Steel, Karen P.] Kings Coll London, Wolfson Ctr Age Related Dis, London WC2R 2LS, England; [Hardisty-Hughes, Rachel E.; Smith, Richard J.; Steel, Karen P.] MRC Inst Hearing Res, Nottingham, England; [Bober, Eva] Max Planck Inst Heart & Lung Res, Bad Nauheim, Germany	Wellcome Trust Sanger Institute; University of London; King's College London; Max Planck Society	Steel, KP (corresponding author), Wellcome Trust Sanger Inst, Hinxton, Cambs, England.	karen.steel@kcl.ac.uk		Smith, Richard/0000-0003-1201-6731; Buniello, Annalisa/0000-0002-4623-8642	Wellcome Trust Sanger Institute Hinxton UK [098051]; Medical Research Council (MRC) (UK); Telethon Foundation; Medical Research Council [MC_qA137918, G0300212] Funding Source: researchfish; MRC [MC_qA137918, G0300212] Funding Source: UKRI	Wellcome Trust Sanger Institute Hinxton UK; Medical Research Council (MRC) (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Telethon Foundation(Fondazione Telethon); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Wellcome Trust Sanger Institute Hinxton UK (grant no098051) (http://www.wellcome.ac.uk/), Medical Research Council (MRC) (UK) (http://www.mrc.ac.uk/index.htm), and Telethon Foundation (http://www.telethon.it/en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abello G, 2010, DEV BIOL, V339, P166, DOI 10.1016/j.ydbio.2009.12.027; BERNSTEIN A, 1990, CIBA F SYMP, V148, P158; Brown SDM, 2008, NAT REV GENET, V9, P277, DOI 10.1038/nrg2309; Bryant J, 2002, BRIT MED BULL, V63, P39, DOI 10.1093/bmb/63.1.39; Buniello A, 2004, GENOMICS, V83, P812, DOI 10.1016/j.ygeno.2003.10.011; CABLE J, 1993, PIGM CELL RES, V6, P215, DOI 10.1111/j.1600-0749.1993.tb00605.x; CABLE J, 1994, PIGM CELL RES, V7, P17, DOI 10.1111/j.1600-0749.1994.tb00015.x; CABLE J, 1992, HEARING RES, V64, P6, DOI 10.1016/0378-5955(92)90164-I; CABLE J, 1995, MECH DEVELOP, V50, P139, DOI 10.1016/0925-4773(94)00331-G; Cable J, 1998, HEARING RES, V123, P125, DOI 10.1016/S0378-5955(98)00107-5; Cantos R, 2000, P NATL ACAD SCI USA, V97, P11707, DOI 10.1073/pnas.97.22.11707; Cecconi F, 2004, DEVELOPMENT, V131, P2125, DOI 10.1242/dev.01082; Chang WI, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000050; Chatterjee S, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-68; Chen P, 1999, DEVELOPMENT, V126, P1581; Diez-Roux G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000582; Ebmeyer J, 2010, OTOL NEUROTOL, V31, P42, DOI 10.1097/MAO.0b013e3181b4e3e3; Fekete DM, 1999, TRENDS NEUROSCI, V22, P263, DOI 10.1016/S0166-2236(98)01366-6; Gavalas A, 1998, DEVELOPMENT, V125, P1123; GIBSON F, 1995, NATURE, V374, P62, DOI 10.1038/374062a0; Hadrys T, 1998, DEVELOPMENT, V125, P33; Hardisty R, 1997, THESIS U NOTTINGHAM; Hardisty RE, 1998, BRIT J AUDIOL, V32, P118; Hardisty RE, 1999, BRIT J AUDIOL, V33, P82; HARVEY D, 1992, HEARING RES, V61, P137, DOI 10.1016/0378-5955(92)90044-N; Huang MQ, 2008, DEV DYNAM, V237, P3305, DOI 10.1002/dvdy.21735; Hunter-Duvar, 1978, ACTA OTO-LARYNGOL, V351, P1; Irving M, 2003, AM J MED GENET A, V123A, P153, DOI 10.1002/ajmg.a.20220; Jones PG, 2007, BBA-GEN SUBJECTS, V1770, P890, DOI 10.1016/j.bbagen.2007.01.013; Keane TM, 2011, NATURE, V477, P289, DOI 10.1038/nature10413; Kiernan AE, 2005, NATURE, V434, P1031, DOI 10.1038/nature03487; Kiernan AE, 2006, BRAIN RES, V1091, P270, DOI 10.1016/j.brainres.2006.02.037; Koo SK, 2009, DEV BIOL, V333, P14, DOI 10.1016/j.ydbio.2009.06.016; Lee DK, 2000, BBA-GENE STRUCT EXPR, V1490, P311, DOI 10.1016/S0167-4781(99)00241-9; LEWANDOWSKI RC, 1978, HUM GENET, V42, P339, DOI 10.1007/BF00291317; Lewis MA, 2009, NAT GENET, V41, P614, DOI 10.1038/ng.369; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Macfarlane WM, 1999, J BIOL CHEM, V274, P1011, DOI 10.1074/jbc.274.2.1011; McKenna DJ, 2010, J VIROL, V84, P10644, DOI 10.1128/JVI.00703-10; Miller ND, 2009, AM J MED GENET A, V149A, P669, DOI 10.1002/ajmg.a.32705; Molino M, 1997, J BIOL CHEM, V272, P4043, DOI 10.1074/jbc.272.7.4043; Morsli H, 1999, DEVELOPMENT, V126, P2335; Morsli H, 1998, J NEUROSCI, V18, P3327; Ohtake-Niimi S, 2010, J BIOL CHEM, V285, P20793, DOI 10.1074/jbc.M109.084749; Ozaki H, 2004, DEVELOPMENT, V131, P551, DOI 10.1242/dev.00943; Petersen B, 1998, AM J MED GENET, V77, P60, DOI 10.1002/(SICI)1096-8628(19980428)77:1<60::AID-AJMG13>3.3.CO;2-Z; Purushothaman A, 2007, J BIOL CHEM, V282, P19442, DOI 10.1074/jbc.M700630200; Rhodes CR, 2003, J NEUROCYTOL, V32, P1143, DOI 10.1023/B:NEUR.0000021908.98337.91; RinkwitzBrandt S, 1996, HEARING RES, V99, P129, DOI 10.1016/S0378-5955(96)00093-7; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rodgers KD, 2001, HEARING RES, V158, P39, DOI 10.1016/S0378-5955(01)00283-0; Sajan SA, 2011, HUM MOL GENET, V20, P1262, DOI 10.1093/hmg/ddq567; Salgueiro AM, 2006, INT J DEV BIOL, V50, P705, DOI 10.1387/ijdb.062168as; Salminen M, 2000, DEVELOPMENT, V127, P13; Schonberger J, 2005, NAT GENET, V37, P418, DOI 10.1038/ng1527; SCHUBERT FR, 1995, MECH DEVELOP, V51, P99, DOI 10.1016/0925-4773(95)00358-8; Simeone A, 1998, EMBO J, V17, P6790, DOI 10.1093/emboj/17.23.6790; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Somma G, 2012, JARO-J ASSOC RES OTO, V13, P335, DOI 10.1007/s10162-012-0316-5; Spicer SS, 1998, HEARING RES, V118, P1, DOI 10.1016/S0378-5955(98)00006-9; STEEL KP, 1987, HEARING RES, V27, P11, DOI 10.1016/0378-5955(87)90022-0; Steel KP, 1999, TRENDS GENET, V15, P207, DOI 10.1016/S0168-9525(99)01753-9; STEEL KP, 1983, ARCH OTOLARYNGOL, V109, P22; STEEL KP, 1989, DEVELOPMENT, V107, P453; Steel KP, 1995, ANNU REV GENET, V29, P675; STEEL KP, 1992, DEVELOPMENT, V115, P1111; Steel KP, 1991, ANN NY ACAD SCI, V630, P68; Tekin M, 2001, LANCET, V358, P1082, DOI 10.1016/S0140-6736(01)06186-4; Theisen A, 2008, NATURE ED, V1, P1; Torres MA, 1996, DEVELOPMENT, V122, P3381; Trowe MO, 2008, DEVELOPMENT, V135, P1725, DOI 10.1242/dev.014043; Turner N, 2010, NAT REV CANCER, V10, P116, DOI 10.1038/nrc2780; Wang WD, 2005, EXP CELL RES, V306, P373, DOI 10.1016/j.yexcr.2005.03.016; Wang WD, 2004, DEV CELL, V7, P439, DOI 10.1016/j.devcel.2004.06.016; Wang WD, 2001, DEVELOPMENT, V128, P5017; Wang WD, 2000, MECH DEVELOP, V99, P123, DOI 10.1016/S0925-4773(00)00488-3; Wang WD, 1998, DEVELOPMENT, V125, P621; Wangemann P, 2004, BMC MED, V2, DOI 10.1186/1741-7015-2-30; Wei J, 2000, HUM MUTAT, V15, P387, DOI 10.1002/(SICI)1098-1004(200004)15:4<387::AID-HUMU26>3.0.CO;2-T; Wingender E, 1997, NUCLEIC ACIDS RES, V25, P265, DOI 10.1093/nar/25.1.265; WULFSBERG EA, 1989, AM J MED GENET, V32, P364, DOI 10.1002/ajmg.1320320319; Xin XN, 1998, DNA CELL BIOL, V17, P897, DOI 10.1089/dna.1998.17.897; Zhang LL, 2011, NEUROSCIENCE, V196, P203, DOI 10.1016/j.neuroscience.2011.08.069; Zheng JL, 1997, J NEUROSCI, V17, P8270; Zheng WM, 2003, DEVELOPMENT, V130, P3989, DOI 10.1242/dev.00628; Zou D, 2006, DEV BIOL, V298, P430, DOI 10.1016/j.ydbio.2006.06.049	86	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56274	10.1371/journal.pone.0056274	http://dx.doi.org/10.1371/journal.pone.0056274			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457544	Green Submitted, Green Published, gold			2022-12-25	WOS:000315602700063
J	Valenzuela, SM; Alkhamici, H; Brown, LJ; Almond, OC; Goodchild, SC; Carne, S; Curmi, PMG; Holt, SA; Cornell, BA				Valenzuela, Stella M.; Alkhamici, Heba; Brown, Louise J.; Almond, Oscar C.; Goodchild, Sophia C.; Carne, Sonia; Curmi, Paul M. G.; Holt, Stephen A.; Cornell, Bruce A.			Regulation of the Membrane Insertion and Conductance Activity of the Metamorphic Chloride Intracellular Channel Protein CLIC1 by Cholesterol	PLOS ONE			English	Article							STAPHYLOCOCCAL ALPHA-HEMOLYSIN; HEPTAMERIC TRANSMEMBRANE PORE; DEPENDENT CYTOLYSINS; CRYSTAL-STRUCTURE; LIPID-BILAYERS; SOLUBLE FORM; ION CHANNELS; NCC27; FLUORESCENCE; DOMAIN	The Chloride Intracellular ion channel protein CLIC1 has the ability to spontaneously insert into lipid membranes from a soluble, globular state. The precise mechanism of how this occurs and what regulates this insertion is still largely unknown, although factors such as pH and redox environment are known contributors. In the current study, we demonstrate that the presence and concentration of cholesterol in the membrane regulates the spontaneous insertion of CLIC1 into the membrane as well as its ion channel activity. The study employed pressure versus area change measurements of Langmuir lipid monolayer films; and impedance spectroscopy measurements using tethered bilayer membranes to monitor membrane conductance during and following the addition of CLIC1 protein. The observed cholesterol dependent behaviour of CLIC1 is highly reminiscent of the cholesterol-dependent-cytolysin family of bacterial pore-forming proteins, suggesting common regulatory mechanisms for spontaneous protein insertion into the membrane bilayer.	[Valenzuela, Stella M.; Alkhamici, Heba; Almond, Oscar C.; Carne, Sonia] Univ Technol Sydney, Sch Med & Mol Biosci, Sydney, NSW 2007, Australia; [Brown, Louise J.; Goodchild, Sophia C.] Macquarie Univ, Dept Chem & Biomol Sci, Sydney, NSW 2109, Australia; [Carne, Sonia; Cornell, Bruce A.] Surgical Diagnost Pty Ltd, Sydney, NSW, Australia; [Curmi, Paul M. G.] Univ New S Wales, Sch Phys, Sydney, NSW, Australia; [Curmi, Paul M. G.] St Vincents Hosp, Ctr Appl Med Res, Sydney, NSW 2010, Australia; [Holt, Stephen A.] Australian Nucl Sci & Technol Org, Bragg Inst, Sydney, NSW, Australia	University of Technology Sydney; Macquarie University; University of New South Wales Sydney; St Vincents Hospital Sydney; Australian Nuclear Science & Technology Organisation	Valenzuela, SM (corresponding author), Univ Technol Sydney, Sch Med & Mol Biosci, Sydney, NSW 2007, Australia.	Stella.Valenzuela@uts.edu.au	Valenzuela, Stella/R-6387-2019; Goodchild, Sophia/AAB-1465-2021; Curmi, Paul/G-7185-2011; Holt, Stephen A/E-4662-2011	Valenzuela, Stella/0000-0001-5934-6047; Curmi, Paul/0000-0001-5762-7638; Holt, Stephen A/0000-0003-3189-8047; Brown, Louise/0000-0001-8592-2431; Goodchild, Sophia/0000-0002-5091-7576; cornell, bruce/0000-0003-4166-3241	Australian Research Council [LP0990084]; Australian Institute of Nuclear Science and Engineering (AINSE Award) [ALNGRA12018]	Australian Research Council(Australian Research Council); Australian Institute of Nuclear Science and Engineering (AINSE Award)	The authors thank the following organisations for financial support of this research: the Australian Research Council (grant LP0990084 to S.M.V. and B.A.C.) and the Australian Institute of Nuclear Science and Engineering (AINSE Award ALNGRA12018 to S.M.V., S.A.H., L.J.B.). ARC website URL: http://www.arc.gov. au/; AINSE website URL: http://www.ainse.edu.au/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts B., 2010, ESSENTIAL CELL BIOL; Barrett PJ, 2012, SCIENCE, V336, P1168, DOI 10.1126/science.1219988; Berryman M, 2004, J BIOL CHEM, V279, P34794, DOI 10.1074/jbc.M402835200; BHAKDI S, 1991, MICROBIOL REV, V55, P733, DOI 10.1128/MMBR.55.4.733-751.1991; Cornell BA, 1997, NATURE, V387, P580, DOI 10.1038/42432; Cromer BA, 2007, J MOL BIOL, V374, P719, DOI 10.1016/j.jmb.2007.09.041; Epand RF, 2002, BIOCHEM J, V367, P849, DOI 10.1042/BJ20020986; Epand RF, 2002, BIOCHEM BIOPH RES CO, V298, P744, DOI 10.1016/S0006-291X(02)02544-5; Giddings KS, 2003, P NATL ACAD SCI USA, V100, P11315, DOI 10.1073/pnas.2033520100; Gilbert RJC, 1999, CELL, V97, P647, DOI 10.1016/S0092-8674(00)80775-8; Gilbert RJC, 2010, ADV EXP MED BIOL, V677, P56; Goodchild SC, 2011, BIOCHEMISTRY-US, V50, P10887, DOI 10.1021/bi2012564; Goodchild SC, 2010, BIOCHEMISTRY-US, V49, P5278, DOI 10.1021/bi100111c; Goodchild SC, 2009, EUR BIOPHYS J BIOPHY, V39, P129, DOI 10.1007/s00249-009-0450-0; GOUAUX JE, 1994, P NATL ACAD SCI USA, V91, P12828, DOI 10.1073/pnas.91.26.12828; Harrop SJ, 2001, J BIOL CHEM, V276, P44993, DOI 10.1074/jbc.M107804200; Ishitsuka Y, 2010, ANAL CHEM, V82, P9694, DOI 10.1021/ac101714u; Littler DR, 2008, PROTEINS, V71, P364, DOI 10.1002/prot.21704; Littler DR, 2005, FEBS J, V272, P4996, DOI 10.1111/j.1742-4658.2005.04909.x; Littler DR, 2004, J BIOL CHEM, V279, P9298, DOI 10.1074/jbc.M308444200; Murzin AG, 2008, SCIENCE, V320, P1725, DOI 10.1126/science.1158868; Posokhov YO, 2008, BIOCHEMISTRY-US, V47, P5078, DOI 10.1021/bi702223c; Rescher U, 2004, J CELL SCI, V117, P2631, DOI 10.1242/jcs.01245; Reshetnyak YK, 2007, BIOPHYS J, V93, P2363, DOI 10.1529/biophysj.107.109967; Senes A, 2004, CURR OPIN STRUC BIOL, V14, P465, DOI 10.1016/j.sbi.2004.07.007; Singh H, 2007, FEBS J, V274, P6306, DOI 10.1111/j.1742-4658.2007.06145.x; Singh H, 2006, BIOPHYS J, V90, P1628, DOI 10.1529/biophysj.105.072678; Singh H, 2007, MOL MEMBR BIOL, V24, P41, DOI 10.1080/09687860600927907; Song LZ, 1996, SCIENCE, V274, P1859, DOI 10.1126/science.274.5294.1859; Stoychev SH, 2009, BIOCHEMISTRY-US, V48, P8413, DOI 10.1021/bi9010607; Tulk BM, 2002, AM J PHYSIOL-CELL PH, V282, pC1103, DOI 10.1152/ajpcell.00402.2001; Tweten RK, 2005, INFECT IMMUN, V73, P6199, DOI 10.1128/IAI.73.10.6199-6209.2005; Valenzuela S, 1996, J LEUKOCYTE BIOL, P106; Valenzuela SM, 2000, J PHYSIOL-LONDON, V529, P541, DOI 10.1111/j.1469-7793.2000.00541.x; Vijayvargia R, 2004, BIOCHEM BIOPH RES CO, V324, P1130, DOI 10.1016/j.bbrc.2004.09.164; Vockenroth IK, 2008, LANGMUIR, V24, P496, DOI 10.1021/la7030279; Warton K, 2002, J BIOL CHEM, V277, P26003, DOI 10.1074/jbc.M203666200	37	28	28	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56948	10.1371/journal.pone.0056948	http://dx.doi.org/10.1371/journal.pone.0056948			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457643	gold, Green Published, Green Submitted			2022-12-25	WOS:000315602700102
J	Mikelis, CM; Palmby, TR; Simaan, M; Li, WL; Szabo, R; Lyons, R; Martin, D; Yagi, H; Fukuhara, S; Chikumi, H; Galisteo, R; Mukouyama, YS; Bugge, TH; Gutkind, JS				Mikelis, Constantinos M.; Palmby, Todd R.; Simaan, May; Li, Wenling; Szabo, Roman; Lyons, Ruth; Martin, Daniel; Yagi, Hiroshi; Fukuhara, Shigetomo; Chikumi, Hiroki; Galisteo, Rebeca; Mukouyama, Yoh-suke; Bugge, Thomas H.; Gutkind, J. Silvio			PDZ-RhoGEF and LARG Are Essential for Embryonic Development and Provide a Link between Thrombin and LPA Receptors and Rho Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCHANGE FACTOR; LEUKEMIA-ASSOCIATED RHO; HETEROTRIMERIC G-PROTEINS; VASCULAR SMOOTH-MUSCLE; GTPASES; GROWTH; G-ALPHA(13); MIGRATION; CROSSTALK; PLEXIN-B1	G protein-coupled receptors (GPCRs) linked to both members of the G alpha(12) family of heterotrimeric G proteins alpha subunits, G alpha(12) and G alpha(13), regulate the activation of Rho GTPases, thereby contributing to many key biological processes. Multiple Rho GEFs have been proposed to link G alpha(12/13) GPCRs to Rho activation, including PDZ-RhoGEF (PRG), leukemia-associated Rho GEF (LARG), p115-RhoGEF (p115), lymphoid blast crisis (Lbc), and Dbl. PRG, LARG, and p115 share the presence of a regulator of G protein signaling homology (RGS) domain. There is limited information on the biological roles of this RGS-containing family of RhoGEFs in vivo. p115-deficient mice are viable with some defects in the immune system and gastrointestinal motor dysfunctions, whereas in an initial study we showed that mice deficient for Larg are viable and resistant to salt-induced hypertension. Here, we generated knock-out mice for Prg and observed that these mice do not display any overt phenotype. However, deficiency in Prg and Larg leads to complex developmental defects and early embryonic lethality. Signaling from G alpha(11/q)-linked GPCRs to Rho was not impaired in mouse embryonic fibroblasts defective in all three RGS-containing RhoGEFs. However, a combined lack of Prg, Larg, and p115 expression	[Mikelis, Constantinos M.; Palmby, Todd R.; Simaan, May; Szabo, Roman; Lyons, Ruth; Martin, Daniel; Yagi, Hiroshi; Fukuhara, Shigetomo; Chikumi, Hiroki; Galisteo, Rebeca; Bugge, Thomas H.; Gutkind, J. Silvio] NIDCR, Oral & Pharyngeal Canc Branch, Bethesda, MD 20892 USA; [Li, Wenling; Mukouyama, Yoh-suke] NHLBI, Lab Stem Cell & Neurovasc Biol, Genet & Dev Biol Ctr, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Gutkind, JS (corresponding author), NIDCR, NIH, 30 Convent Dr,Bldg 30,Rm 211, Bethesda, MD 20892 USA.	sg39v@nih.gov	Mikelis, Constantinos/AGF-9423-2022; Gutkind, J. Silvio/J-1201-2016	Gutkind, J. Silvio/0000-0002-5150-4482; Mukouyama, Yoh-suke/0000-0002-9084-4922; Martin Izquierdo, Daniel/0000-0002-8880-9087	National Institutes of Health Grant [Z01DE00551]; Intramural Research Program of the NIDCR, National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL005702] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000551, ZIADE000699] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [22113009, 22390040] Funding Source: KAKEN	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research Program of the NIDCR, National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported, in whole or in part, by National Institutes of Health Grant Z01DE00551 and the Intramural Research Program of the NIDCR, National Institutes of Health.	Aittaleb M, 2010, MOL PHARMACOL, V77, P111, DOI 10.1124/mol.109.061234; Basile JR, 2004, CANCER RES, V64, P5212, DOI 10.1158/0008-5472.CAN-04-0126; Booden MA, 2002, MOL CELL BIOL, V22, P4053, DOI 10.1128/MCB.22.12.4053-4061.2002; BUGGE TH, 1995, GENE DEV, V9, P794, DOI 10.1101/gad.9.7.794; Chikumi H, 2004, ONCOGENE, V23, P233, DOI 10.1038/sj.onc.1207012; Chikumi H, 2002, J BIOL CHEM, V277, P12463, DOI 10.1074/jbc.M108504200; COSO OA, 1995, CELL, V81, P1137, DOI 10.1016/S0092-8674(05)80018-2; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; Diviani D, 2001, J BIOL CHEM, V276, P44247, DOI 10.1074/jbc.M106629200; Dorsam RT, 2007, NAT REV CANCER, V7, P79, DOI 10.1038/nrc2069; Fukuhara S, 2001, ONCOGENE, V20, P1661, DOI 10.1038/sj.onc.1204182; Fukuhara S, 2000, FEBS LETT, V485, P183, DOI 10.1016/S0014-5793(00)02224-9; Fukuhara S, 1999, J BIOL CHEM, V274, P5868, DOI 10.1074/jbc.274.9.5868; Girkontaite I, 2001, NAT IMMUNOL, V2, P855, DOI 10.1038/ni0901-855; Gu JL, 2002, P NATL ACAD SCI USA, V99, P9352, DOI 10.1073/pnas.102291599; Hart MJ, 1998, SCIENCE, V280, P2112, DOI 10.1126/science.280.5372.2112; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Iden S, 2008, NAT REV MOL CELL BIO, V9, P846, DOI 10.1038/nrm2521; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Jin SH, 2000, BIOCHEM BIOPH RES CO, V277, P718, DOI 10.1006/bbrc.2000.3744; Kelly P, 2007, BIOCHEMISTRY-US, V46, P6677, DOI 10.1021/bi700235f; Kuner R, 2002, EUR J NEUROSCI, V16, P2333, DOI 10.1046/j.1460-9568.2002.02402.x; Meiri D, 2009, MOL CELL BIOL, V29, P5963, DOI 10.1128/MCB.01268-08; Nishimura T, 2012, CELL, V149, P1084, DOI 10.1016/j.cell.2012.04.021; Nourry Claire, 2003, Sci STKE, V2003, pRE7; Offermanns S, 1997, SCIENCE, V275, P533, DOI 10.1126/science.275.5299.533; Ohtsu H, 2005, ARTERIOSCL THROM VAS, V25, P1831, DOI 10.1161/01.ATV.0000175749.41799.9b; Oinuma I, 2003, J BIOL CHEM, V278, P25671, DOI 10.1074/jbc.M303047200; Panizzi JR, 2007, DEVELOPMENT, V134, P921, DOI 10.1242/dev.02776; Perrot V, 2002, J BIOL CHEM, V277, P43115, DOI 10.1074/jbc.M206005200; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Siehler S, 2009, BRIT J PHARMACOL, V158, P41, DOI 10.1111/j.1476-5381.2009.00121.x; Swiercz JM, 2009, MOL CELL BIOL, V29, P6321, DOI 10.1128/MCB.00103-09; Swiercz JM, 2002, NEURON, V35, P51, DOI 10.1016/S0896-6273(02)00750-X; Szabo R, 2007, ONCOGENE, V26, P1546, DOI 10.1038/sj.onc.1209966; Taya S, 2001, J CELL BIOL, V155, P809, DOI 10.1083/jcb.200106139; Vanni C, 2007, CELL CYCLE, V6, P2058, DOI 10.4161/cc.6.16.4574; Wirth A, 2008, NAT MED, V14, P64, DOI 10.1038/nm1666; Worzfeld T, 2008, TRENDS PHARMACOL SCI, V29, P582, DOI 10.1016/j.tips.2008.08.002; Yagi H, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002221; Yamada T, 2005, J BIOL CHEM, V280, P19358, DOI 10.1074/jbc.M414561200; Ying ZK, 2006, MOL PHARMACOL, V69, P932, DOI 10.1124/mol.105.017830	43	42	44	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2013	288	17					12232	12243		10.1074/jbc.M112.428599	http://dx.doi.org/10.1074/jbc.M112.428599			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	133RP	23467409	Green Published, hybrid			2022-12-25	WOS:000318157600055
J	Cebotaru, L; Woodward, O; Cebotaru, V; Guggino, WB				Cebotaru, Liudmila; Woodward, Owen; Cebotaru, Valeriu; Guggino, William B.			Transcomplementation by a Truncation Mutant of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Enhances Delta F508 Processing through a Biomolecular Interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHLORIDE CHANNELS; GENE-TRANSFER; EXPRESSION; IDENTIFICATION; PROTEIN; VECTOR; DOMAIN; TRAFFICKING; SEROTYPE-2; TRANSPORT	We previously showed that a truncation mutant of CFTR missing the first four transmembrane segments of TMD1, Delta 264 CFTR, binds to key elements in the ER quality control mechanism to increase the amounts of the mature C band of both wt and Delta F508 CFTR through transcomplementation. Here, we created a new construct, Delta 27-264 CFTR. Even though Delta 27-264 CFTR is rapidly degraded in the proteasome, steady state protein can be detected by Western blot. Delta 27-264 CFTR can also increase the amounts of the mature C band of both wt and Delta F508 CFTR through transcomplementation. Electrophysiology experiments show that Delta 27-264 CFTR can restore chloride channel currents. Further experiments with the conduction mutant S341A show conclusively that currents are indeed generated by rescued channel function of Delta F508 CFTR. Immunoprecipitation studies show that Delta 27-264 binds to Delta F508-CFTR, suggesting a bimolecular interaction. Thus the adeno-associated viral vector, rAAV-Delta 27-264 CFTR, is a highly promising CF gene therapy vector, because it increases the amount of mature band C protein both from wt and Delta F508 CFTR, and rescues channel activity of Delta F508 CFTR.	[Cebotaru, Liudmila] Johns Hopkins Univ, Dept Ophthalmol, Baltimore, MD 21205 USA; [Cebotaru, Liudmila; Woodward, Owen; Guggino, William B.] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA; [Cebotaru, Valeriu] Johns Hopkins Univ, Dept Med, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Guggino, WB (corresponding author), Johns Hopkins Univ, Sch Med, Dept Physiol, Wood Basic Sci Bldg 214A,725 N Wolfe St, Baltimore, MD 21205 USA.	wguggino@jhmi.edu		Woodward, Owen M./0000-0001-9514-2180	National Institutes of Health [NIH P01 HL51811]; Cystic Fibrosis Foundation [GUGGINO5X0]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL051811] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in whole or in part by National Institutes of Health Grant NIH P01 HL51811 and Cystic Fibrosis Foundation Grant GUGGINO5X0.	Accurso FJ, 2010, NEW ENGL J MED, V363, P1991, DOI 10.1056/NEJMoa0909825; Atwell S, 2010, PROTEIN ENG DES SEL, V23, P375, DOI 10.1093/protein/gzq004; Bebok Z, 2005, J PHYSIOL-LONDON, V569, P601, DOI 10.1113/jphysiol.2005.096669; CARROLL TP, 1995, J BIOL CHEM, V270, P11941, DOI 10.1074/jbc.270.20.11941; Cebotaru L, 2008, J BIOL CHEM, V283, P21926, DOI 10.1074/jbc.M709156200; Cheng J, 2002, J BIOL CHEM, V277, P3520, DOI 10.1074/jbc.M110177200; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; Clancy JP, 2012, THORAX, V67, P12, DOI 10.1136/thoraxjnl-2011-200393; Cohen-Cymberknoh M, 2011, AM J RESP CRIT CARE, V183, P1463, DOI 10.1164/rccm.201009-1478CI; COLLINS FS, 1990, HOSP PRACT, V25, P47; Cormet-Boyaka E, 2002, P NATL ACAD SCI USA, V99, P12477, DOI 10.1073/pnas.192203899; Cormet-Boyaka E, 2009, FASEB J, V23, P3743, DOI 10.1096/fj.08-127878; Devidas S, 1998, J BIOL CHEM, V273, P29373, DOI 10.1074/jbc.273.45.29373; Fischer AC, 2007, MOL THER, V15, P756, DOI 10.1038/sj.mt.6300059; Flotte T, 1996, HUM GENE THER, V7, P1145, DOI 10.1089/hum.1996.7.9-1145; FLOTTE TR, 1993, J BIOL CHEM, V268, P3781; FULLER CM, 1992, AM J PHYSIOL, V263, pC267, DOI 10.1152/ajpcell.1992.263.2.C267; Gao GP, 2005, CURR GENE THER, V5, P285, DOI 10.2174/1566523054065057; Gruenert D C, 2004, J Cyst Fibros, V3 Suppl 2, P191, DOI 10.1016/j.jcf.2004.05.040; Hoelen H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015458; Illek B, 2008, CELL PHYSIOL BIOCHEM, V22, P57, DOI 10.1159/000149783; Kirk KL, 2000, CELL MOL LIFE SCI, V57, P623, DOI 10.1007/PL00000724; Ma TH, 2002, J CLIN INVEST, V110, P1651, DOI 10.1172/JCI200216112; McCarty NA, 2001, AM J PHYSIOL-LUNG C, V281, pL852, DOI 10.1152/ajplung.2001.281.4.L852; McCarty NA, 2000, J EXP BIOL, V203, P1947; Mickle JE, 2000, MED CLIN N AM, V84, P597, DOI 10.1016/S0025-7125(05)70243-1; Moss RB, 2004, CHEST, V125, P509, DOI 10.1378/chest.125.2.509; Moyer BD, 1998, J BIOL CHEM, V273, P21759, DOI 10.1074/jbc.273.34.21759; Mueller C, 2008, J GENE MED, V10, P51, DOI 10.1002/jgm.1119; RIORDAN JR, 1989, SCIENCE, V245, P1066; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; Schwiebert EM, 1998, P NATL ACAD SCI USA, V95, P2674, DOI 10.1073/pnas.95.5.2674; SCHWIEBERT EM, 1995, CELL, V81, P1063, DOI 10.1016/S0092-8674(05)80011-X; Sirninger J, 2004, HUM GENE THER, V15, P832, DOI 10.1089/1043034041839262; Sun F, 2008, FASEB J, V22, P3255, DOI 10.1096/fj.07-105338; Van Goor F, 2006, AM J PHYSIOL-LUNG C, V290, pL1117, DOI 10.1152/ajplung.00169.2005; Van Goor F, 2011, P NATL ACAD SCI USA, V108, P18843, DOI 10.1073/pnas.1105787108; Wang SS, 1998, FEBS LETT, V427, P103, DOI 10.1016/S0014-5793(98)00402-5; Xu LF, 2001, HUM GENE THER, V12, P563, DOI 10.1089/104303401300042500; ZEITLIN PL, 1991, AM J RESP CELL MOL, V4, P313, DOI 10.1165/ajrcmb/4.4.313; Zolotukhin S, 2002, METHODS, V28, P158, DOI 10.1016/S1046-2023(02)00220-7	41	11	11	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2013	288	15					10505	10512		10.1074/jbc.M112.420489	http://dx.doi.org/10.1074/jbc.M112.420489			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	125TU	23463513	Green Published, hybrid			2022-12-25	WOS:000317565000030
J	Kapoor, A; Iqbal, M; Petropoulos, S; Ho, HL; Gibb, W; Matthews, SG				Kapoor, Amita; Iqbal, Majid; Petropoulos, Sophie; Ho, Hay Lam; Gibb, William; Matthews, Stephen G.			Effects of Sertraline and Fluoxetine on P-Glycoprotein at Barrier Sites: In Vivo and In Vitro Approaches	PLOS ONE			English	Article							MULTIDRUG-RESISTANCE; BLOOD-BRAIN; SUBSTRATE RECOGNITION; DIFFERENT EPITOPES; MOUSE PLACENTA; CANCER; TRANSPORTERS; EXPRESSION; MICE; MRP1	Background and Purpose: Retention of substances from systemic circulation in the brain and testes are limited due to high levels of P-glycoprotein (P-gp) in the luminal membranes of brain and testes capillary endothelial cells. From a clinical perspective, P-gp rapidly extrudes lipophilic therapeutic agents, which then fail to reach efficacious levels. Recent studies have demonstrated that acute administration of selective serotonin reuptake inhibitors (SSRI) can affect P-gp function, in vitro and in vivo. However, little is known concerning the time-course of these effects or the effects of different SSRI in vivo. Experimental Approach: The P-gp substrate, tritiated digoxin ([H-3] digoxin), was co-administered with fluoxetine or sertraline to determine if either compound increased drug accumulation within the brains and testes of mice due to inhibition of P-gp activity. We undertook parallel studies in endothelial cells derived from brain microvessels to determine the dose-response and time-course of effects. Key Results: In vitro, sertraline resulted in rapid and potent inhibition of P-gp function in brain endothelial cells, as determined by cellular calcein accumulation. In vivo, a biphasic effect was demonstrated. Brain accumulation of [H-3] digoxin was increased 5 minutes after treatment with sertraline, but by 60 minutes after sertraline treatment, brain accumulation of digoxin was reduced compared to control. By 240 minutes after sertraline treatment brain digoxin accumulation was elevated compared to control. A similar pattern of results was obtained in the testes. There was no significant effect of fluoxetine on P-gp function, in vitro or in vivo. Conclusions and Implications: Acute sertraline administration can modulate P-gp activity in the blood-brain barrier and blood-testes barrier. This clearly has implications for the ability of therapeutic agents that are P-gp substrates, to enter the brain when co-administered with SSRI.	[Kapoor, Amita] Univ Wisconsin, Wisconsin Natl Primate Res Ctr, Madison, WI 53706 USA; [Iqbal, Majid; Petropoulos, Sophie; Ho, Hay Lam; Matthews, Stephen G.] Univ Toronto, Fac Med, Dept Phys, Toronto, ON, Canada; [Iqbal, Majid; Petropoulos, Sophie; Ho, Hay Lam; Matthews, Stephen G.] Univ Toronto, Fac Med, Dept Obstet & Gynecol, Toronto, ON, Canada; [Iqbal, Majid; Petropoulos, Sophie; Ho, Hay Lam; Matthews, Stephen G.] Univ Toronto, Fac Med, Dept Med, Toronto, ON, Canada; [Gibb, William] Univ Ottawa, Dept Obstet & Gynecol Cellular & Mol Med, Ottawa, ON, Canada	University of Wisconsin System; University of Wisconsin Madison; University of Toronto; University of Toronto; University of Toronto; University of Ottawa	Kapoor, A (corresponding author), Univ Wisconsin, Wisconsin Natl Primate Res Ctr, Madison, WI 53706 USA.	akapoor@wisc.edu	Petropoulos, Sophie/D-6861-2016; Petropoulos, Sophie/M-3090-2017; Matthews, Stephen G/N-7555-2018; Matthews, Stephen/R-5147-2019	Petropoulos, Sophie/0000-0003-2293-8238; Matthews, Stephen G/0000-0002-9654-9940; Matthews, Stephen/0000-0002-9654-9940	Canadian Institutes for Health Research [452740]	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	This study was funded by the Canadian Institutes for Health Research 452740 to WG and SGM and Doctoral Research Award to MI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argov M, 2009, CANCER LETT, V274, P118, DOI 10.1016/j.canlet.2008.09.005; Bansal T, 2009, J PHARM PHARM SCI, V12, P46, DOI 10.18433/J3RC77; Bart J, 2004, EUR J CANCER, V40, P2064, DOI 10.1016/j.ejca.2004.05.010; Bhuiyan M, 2012, REPROD SCI, V19, P407, DOI 10.1177/1933719111424438; Carlson RW, 2006, CANCER INVEST, V24, P677, DOI 10.1080/07357900600981349; CORDONCARDO C, 1989, P NATL ACAD SCI USA, V86, P695, DOI 10.1073/pnas.86.2.695; CORDONCARDO C, 1990, J HISTOCHEM CYTOCHEM, V38, P1277, DOI 10.1177/38.9.1974900; Endres CJ, 2006, EUR J PHARM SCI, V27, P501, DOI 10.1016/j.ejps.2005.11.002; GROS P, 1986, NATURE, V323, P728, DOI 10.1038/323728a0; Iqbal M, 2011, ENDOCRINOLOGY, V152, P1067, DOI 10.1210/en.2010-1227; Kalabis GM, 2007, PLACENTA, V28, P1073, DOI 10.1016/j.placenta.2007.03.010; Lhomme C, 2008, J CLIN ONCOL, V26, P2674, DOI 10.1200/JCO.2007.14.9807; Loscher W, 2005, PROG NEUROBIOL, V76, P22, DOI 10.1016/j.pneurobio.2005.04.006; Luna-Tortos C, 2010, NEUROPHARMACOLOGY, V58, P1019, DOI 10.1016/j.neuropharm.2010.01.007; Mayer U, 1997, J CLIN INVEST, V100, P2430, DOI 10.1172/JCI119784; Peer D, 2004, CANCER RES, V64, P7562, DOI 10.1158/0008-5472.CAN-03-4046; Petropoulos S, 2010, PLACENTA, V31, P803, DOI 10.1016/j.placenta.2010.06.014; Petropoulos S, 2007, REPROD SCI, V14, P321, DOI 10.1177/1933719107303856; SCHINKEL AH, 1995, J CLIN INVEST, V96, P1698, DOI 10.1172/JCI118214; Seelig A, 2000, INT J CLIN PHARM TH, V38, P111; Seelig A, 1998, EUR J BIOCHEM, V251, P252, DOI 10.1046/j.1432-1327.1998.2510252.x; Solbach TF, 2006, TRENDS CARDIOVAS MED, V16, P7, DOI 10.1016/j.tcm.2005.10.001; Sun M, 2006, PLACENTA, V27, P602, DOI 10.1016/j.placenta.2005.05.007; THIEBAUT F, 1989, J HISTOCHEM CYTOCHEM, V37, P159, DOI 10.1177/37.2.2463300; TSUJI A, 1992, LIFE SCI, V51, P1427, DOI 10.1016/0024-3205(92)90537-Y; Uhr M, 2003, BIOL PSYCHIAT, V54, P840, DOI 10.1016/S0006-3223(03)00074-X; Uhr M, 2003, J PSYCHIAT RES, V37, P179, DOI 10.1016/S0022-3956(03)00022-0; VANDERVALK P, 1990, ANN ONCOL, V1, P56; Weiss J, 2003, J PHARMACOL EXP THER, V305, P197, DOI 10.1124/jpet.102.046532; Westholm DE, 2008, CURR TOP DEV BIOL, V80, P135, DOI 10.1016/S0070-2153(07)80004-4	30	29	31	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e56525	10.1371/journal.pone.0056525	http://dx.doi.org/10.1371/journal.pone.0056525			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23468867	Green Published, gold, Green Submitted			2022-12-25	WOS:000315524900028
J	Lama, D; Modi, V; Sankararamakrishnan, R				Lama, Dilraj; Modi, Vivek; Sankararamakrishnan, Ramasubbu			Behavior of Solvent-Exposed Hydrophobic Groove in the Anti-Apoptotic Bcl-X-L Protein: Clues for Its Ability to Bind Diverse BH3 Ligands from MD Simulations	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; EWALD BOUNDARY-CONDITIONS; CYTOCHROME-C RELEASE; PARTICLE MESH EWALD; INDUCED CELL-DEATH; FAMILY-MEMBERS; STRUCTURAL PLASTICITY; CANCER CELLS; ARTIFICIAL PERIODICITY; BCL-X(L) INHIBITORS	Bcl-X-L is a member of Bcl-2 family of proteins involved in the regulation of intrinsic pathway of apoptosis. Its overexpression in many human cancers makes it an important target for anti-cancer drugs. Bcl-X-L interacts with the BH3 domain of several pro-apoptotic Bcl-2 partners. This helical bundle protein has a pronounced hydrophobic groove which acts as a binding region for the BH3 domains. Eight independent molecular dynamics simulations of the apo/'holo forms of Bcl-X-L were carried out to investigate the behavior of solvent-exposed hydrophobic groove. The simulations used either a twin-range cut-off or particle mesh Ewald (PME) scheme to treat long-range interactions. Destabilization of the BH3 domain-containing helix H2 was observed in all four twin-range cut-off simulations. Most of the other major helices remained stable. The unwinding of H2 can be related to the ability of Bcl-X-L to bind diverse BH3 ligands. The loss of helical character can also be linked to the formation of homo-or hetero-dimers in Bcl-2 proteins. Several experimental studies have suggested that exposure of BH3 domain is a crucial event before they form dimers. Thus unwinding of H2 seems to be functionally very important. The four PME simulations, however, revealed a stable helix H2. It is possible that the H2 unfolding might occur in PME simulations at longer time scales. Hydrophobic residues in the hydrophobic groove are involved in stable interactions among themselves. The solvent accessible surface areas of bulky hydrophobic residues in the groove are significantly buried by the loop LB connecting the helix H2 and subsequent helix. These observations help to understand how the hydrophobic patch in Bcl-X-L remains stable in the solvent-exposed state. We suggest that both the destabilization of helix H2 and the conformational heterogeneity of loop LB are important factors for binding of diverse ligands in the hydrophobic groove of Bcl-X-L.	[Lama, Dilraj; Modi, Vivek; Sankararamakrishnan, Ramasubbu] Indian Inst Technol, Dept Biol Sci & Bioengn, Kanpur 208016, Uttar Pradesh, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Kanpur	Sankararamakrishnan, R (corresponding author), Indian Inst Technol, Dept Biol Sci & Bioengn, Kanpur 208016, Uttar Pradesh, India.	rsankar@iitk.ac.in	Lama, Dilraj/ABG-9950-2020	Sankararamakrishnan, Ramasubbu/0000-0002-8527-5614; Modi, Vivek/0000-0002-9742-0559; Lama, Dilraj/0000-0001-8603-9368	IIT-Kanpur	IIT-Kanpur	RS is a USV Chair Professor of IIT-Kanpur. VM thanks IIT-Kanpur for a fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramovitz A, 2012, BIOCHEMISTRY-US, V51, P715, DOI 10.1021/bi201211v; Almerico AM, 2010, EUR J MED CHEM, V45, P4774, DOI 10.1016/j.ejmech.2010.07.042; Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Barelier S, 2010, J MED CHEM, V53, P2577, DOI 10.1021/jm100009z; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berendsen HJC, 1981, INTERMOLECULAR FORCE, P331, DOI [DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658-1_21]; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Billen LP, 2008, PLOS BIOL, V6, P1268, DOI 10.1371/journal.pbio.0060147; Bodur C, 2012, CURR MED CHEM, V19, P1804, DOI 10.2174/092986712800099839; Certo M, 2006, CANCER CELL, V9, P351, DOI 10.1016/j.ccr.2006.03.027; CHEATHAM TE, 1995, J AM CHEM SOC, V117, P4193, DOI 10.1021/ja00119a045; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Chipuk JE, 2010, MOL CELL, V37, P299, DOI 10.1016/j.molcel.2010.01.025; Cordomi A, 2007, J COMPUT CHEM, V28, P1017, DOI 10.1002/jcc.20579; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Daura X, 1998, J COMPUT CHEM, V19, P535, DOI 10.1002/(SICI)1096-987X(19980415)19:5<535::AID-JCC6>3.0.CO;2-N; Day CL, 2005, J BIOL CHEM, V280, P4738, DOI 10.1074/jbc.M411434200; Delaney CL, 2001, J NEUROPATH EXP NEUR, V60, P147, DOI 10.1093/jnen/60.2.147; Dewson G, 2012, CELL DEATH DIFFER, V19, P661, DOI 10.1038/cdd.2011.138; Dewson G, 2008, MOL CELL, V30, P369, DOI 10.1016/j.molcel.2008.04.005; Diaz JL, 1997, J BIOL CHEM, V272, P11350; Eisenmesser EZ, 2005, NATURE, V438, P117, DOI 10.1038/nature04105; Ernst JT, 2003, ANGEW CHEM INT EDIT, V42, P535, DOI 10.1002/anie.200390154; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Eswar N, 2000, PROTEIN ENG, V13, P227, DOI 10.1093/protein/13.4.227; Webb Benjamin, 2016, Curr Protoc Bioinformatics, V54, DOI [10.1002/0471140864.ps0209s50, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/cpbi.3]; Ezzoukhry Z, 2011, MOL PHARMACOL, V79, P997, DOI 10.1124/mol.110.070565; Finucane DM, 1999, J BIOL CHEM, V274, P2225, DOI 10.1074/jbc.274.4.2225; Florova P, 2010, J CHEM THEORY COMPUT, V6, P3569, DOI 10.1021/ct1003687; Friess H, 1998, ANN SURG, V228, P780, DOI 10.1097/00000658-199812000-00009; Furse KE, 2009, J CHEM THEORY COMPUT, V5, P1959, DOI 10.1021/ct9001416; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hinds MG, 2003, EMBO J, V22, P1497, DOI 10.1093/emboj/cdg144; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hunenberger PH, 1999, BIOPHYS CHEM, V78, P69, DOI 10.1016/S0301-4622(99)00007-1; Issack BB, 2012, PROTEINS, V80, P1847, DOI 10.1002/prot.24082; Karthik S, 2011, PROTEINS, V79, P1830, DOI 10.1002/prot.23008; Kazi A, 2011, J BIOL CHEM, V286, P9382, DOI 10.1074/jbc.M110.203638; Kim R, 2005, BIOCHEM BIOPH RES CO, V333, P336, DOI 10.1016/j.bbrc.2005.04.161; Lama D, 2008, PROTEINS, V73, P492, DOI 10.1002/prot.22075; Lama D, 2011, J COMPUT AID MOL DES, V25, P413, DOI 10.1007/s10822-011-9428-y; Lama D, 2010, BIOCHEMISTRY-US, V49, P2574, DOI 10.1021/bi100029k; Lebedeva I, 2000, CANCER RES, V60, P6052; Leber B, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001572; Lee EF, 2011, CHEMBIOCHEM, V12, P2025, DOI 10.1002/cbic.201100314; Lee EF, 2009, J BIOL CHEM, V284, P30508, DOI 10.1074/jbc.M109.040725; Leech SH, 2000, INT J CANCER, V86, P570, DOI 10.1002/(SICI)1097-0215(20000515)86:4<570::AID-IJC20>3.0.CO;2-T; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Lins RD, 2006, J CHEM THEORY COMPUT, V2, P246, DOI 10.1021/ct0501699; Liu XQ, 2003, IMMUNITY, V19, P341, DOI 10.1016/S1074-7613(03)00234-6; Lopez H, 2010, J BIOL CHEM, V285, P15016, DOI 10.1074/jbc.M109.086231; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Manion MK, 2004, J BIOL CHEM, V279, P2159, DOI 10.1074/jbc.M306021200; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Modi V, 2013, J BIOMOL STRUCT DYN, V31, P65, DOI 10.1080/07391102.2012.691363; Monticelli L, 2004, THEOR CHEM ACC, V112, P145, DOI 10.1007/s00214-004-0565-4; Monticelli L, 2006, J PHYS-CONDENS MAT, V18, pS329, DOI 10.1088/0953-8984/18/14/S15; MORTON A, 1995, BIOCHEMISTRY-US, V34, P8576, DOI 10.1021/bi00027a007; Mukherjee P, 2010, J CHEM INF MODEL, V50, P906, DOI 10.1021/ci1000373; Nettles KW, 2007, EMBO REP, V8, P563, DOI 10.1038/sj.embor.7400963; Petros AM, 2000, PROTEIN SCI, V9, P2528, DOI 10.1017/S096183680000331X; Petros AM, 2004, BBA-MOL CELL RES, V1644, P83, DOI 10.1016/j.bbamcr.2003.08.012; Petros AM, 2001, P NATL ACAD SCI USA, V98, P3012, DOI 10.1073/pnas.041619798; Pinto M, 2011, J CHEM INF MODEL, V51, P1249, DOI 10.1021/ci100501d; Prakash P, 2010, J COMPUT CHEM, V31, P266, DOI 10.1002/jcc.21313; Sattler M, 1997, SCIENCE, V275, P983, DOI 10.1126/science.275.5302.983; Schulz R, 2009, J CHEM THEORY COMPUT, V5, P2798, DOI 10.1021/ct900292r; Shangary S, 2002, BIOCHEMISTRY-US, V41, P9485, DOI 10.1021/bi025605h; SHIMIZU S, 1995, NATURE, V374, P811, DOI 10.1038/374811a0; Silva DA, 2011, PROTEINS, V79, P2097, DOI 10.1002/prot.23030; Simoes-Wust AP, 2000, INT J CANCER, V87, P582, DOI 10.1002/1097-0215(20000815)87:4<582::AID-IJC19>3.0.CO;2-P; Simonen M, 1997, EUR J BIOCHEM, V249, P85, DOI 10.1111/j.1432-1033.1997.t01-1-00085.x; Simonian PL, 1997, BLOOD, V90, P1208, DOI 10.1182/blood.V90.3.1208.1208_1208_1216; Smits C, 2008, STRUCTURE, V16, P818, DOI 10.1016/j.str.2008.02.009; Tieleman DP, 2002, BIOPHYS J, V83, P2393, DOI 10.1016/S0006-3495(02)75253-3; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; van Gunsteren W.F., 1996, BIOMOLECULAR SIMULAT, P1; Venken T, 2012, PROTEINS, V80, P1633, DOI 10.1002/prot.24057; Villarreal MA, 2005, J BIOMOL STRUCT DYN, V23, P135, DOI 10.1080/07391102.2005.10507054; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; Weber W, 2000, J PHYS CHEM B, V104, P3668, DOI 10.1021/jp9937757; Yang CY, 2011, ACS MED CHEM LETT, V2, P280, DOI 10.1021/ml100276b; Yap JL, 2012, ORG BIOMOL CHEM, V10, P2928, DOI 10.1039/c2ob07125h; Zhu HB, 2005, MOL CANCER THER, V4, P451	85	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e54397	10.1371/journal.pone.0054397	http://dx.doi.org/10.1371/journal.pone.0054397			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23468841	Green Submitted, Green Published, gold			2022-12-25	WOS:000315524900009
J	Braga, RF; Korasaki, V; Andresen, E; Louzada, J				Braga, Rodrigo F.; Korasaki, Vanesca; Andresen, Ellen; Louzada, Julio			Dung Beetle Community and Functions along a Habitat-Disturbance Gradient in the Amazon: A Rapid Assessment of Ecological Functions Associated to Biodiversity	PLOS ONE			English	Article							SECONDARY SEED DISPERSAL; ECOSYSTEM FUNCTION; RAIN-FOREST; CONSERVATION BIOLOGY; SCARABAEIDAE; FRAGMENTATION; COLEOPTERA; DIVERSITY; LAND; INTENSIFICATION	Although there is increasing interest in the effects of habitat disturbance on community attributes and the potential consequences for ecosystem functioning, objective approaches linking biodiversity loss to functional loss are uncommon. The objectives of this study were to implement simultaneous assessment of community attributes (richness, abundance and biomass, each calculated for total-beetle assemblages as well as small-and large-beetle assemblages) and three ecological functions of dung beetles (dung removal, soil perturbation and secondary seed dispersal), to compare the effects of habitat disturbance on both sets of response variables, and their relations. We studied dung beetle community attributes and functions in five land-use systems representing a disturbance gradient in the Brazilian Amazon: primary forest, secondary forest, agroforestry, agriculture and pasture. All response variables were affected negatively by the intensification of habitat disturbance regimes, but community attributes and ecological functions did not follow the same pattern of decline. A hierarchical partitioning analysis showed that, although all community attributes had a significant effect on the three ecological functions (except the abundance of small beetles on all three ecological functions and the biomass of small beetles on secondary dispersal of large seed mimics), species richness and abundance of large beetles were the community attributes with the highest explanatory value. Our results show the importance of measuring ecological function empirically instead of deducing it from community metrics.	[Braga, Rodrigo F.; Korasaki, Vanesca; Louzada, Julio] Univ Fed Lavras, Dept Biol, Setor Ecol & Conservacao, Lavras, MG, Brazil; [Andresen, Ellen] Univ Nacl Autonoma Mexico, Ctr Invest Ecosistemas, Morelia, Michoacan, Mexico	Universidade Federal de Lavras; Universidad Nacional Autonoma de Mexico	Braga, RF (corresponding author), Univ Fed Lavras, Dept Biol, Setor Ecol & Conservacao, Campus Univ, Lavras, MG, Brazil.	rodrigo.fagundes@yahoo.com.br	Andresen, Ellen/AFM-7145-2022; Louzada, Julio/F-1265-2010	Andresen, Ellen/0000-0001-8957-4454; Louzada, Julio/0000-0002-1481-3112; Korasaki, Vanesca/0000-0001-6239-2976	Global Environmental Facility (GEF); CAPES [5081-11-4]	Global Environmental Facility (GEF); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The authors thank Conservation and Sustainable Management of Below-Ground Biodiversity (CSM-BGBD), coordinated by the Tropical Soil Biology and Fertility Institute of CIAT (TSBF-CIAT) with funding from the Global Environmental Facility (GEF) and implemented by the United Nations Environmental Program (UNEP), which is coordinated in Brazil by Dr. F.M.S. Moreira, Universidade Federal de Lavras (UFLA). RFB thanks CAPES for the scholarship granted (process 5081-11-4), and VK thanks Capes for the scholarship granted. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida S, 2011, BIOTROPICA, V43, P704, DOI 10.1111/j.1744-7429.2011.00751.x; Altieri MA, 1993, BIODIVERSITY PEST MA; Amezquita S, 2010, ENVIRON ENTOMOL, V39, P328, DOI 10.1603/EN09182; Andresen E, 1999, BIOTROPICA, V31, P145, DOI 10.1111/j.1744-7429.1999.tb00125.x; Andresen E, 2002, ECOL ENTOMOL, V27, P257, DOI 10.1046/j.1365-2311.2002.00408.x; Andresen E, 2004, OECOLOGIA, V139, P45, DOI 10.1007/s00442-003-1480-4; Andresen E, 2003, ECOGRAPHY, V26, P87, DOI 10.1034/j.1600-0587.2003.03362.x; Andresen E, 2001, J TROP ECOL, V17, P61, DOI 10.1017/S0266467401001043; Andresen Ellen, 2005, P331, DOI 10.1079/9780851998060.0331; Anduaga S, 2004, ENVIRON ENTOMOL, V33, P1306, DOI 10.1603/0046-225X-33.5.1306; Bang HS, 2005, APPL SOIL ECOL, V29, P165, DOI 10.1016/j.apsoil.2004.11.001; Barragan F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017976; BERGSTROM RC, 1976, P HELM SOC WASH, V43, P171; Braga RF, 2012, ECOSYSTEMS, V15, P1173, DOI 10.1007/s10021-012-9576-5; CHEVAN A, 1991, AM STAT, V45, P90, DOI 10.2307/2684366; Coelho MR, 2005, CONSERVATION SUSTAIN; Colwell RK, 2013, ESTIMATES STAT ESTIM; Crawley M. J, 2002, STAT COMPUTING INTRO; Culot L, 2011, BIOTROPICA, V43, P84, DOI 10.1111/j.1744-7429.2010.00655.x; Dangles O, 2012, ECOLOGY, V93, P2615, DOI 10.1890/12-0510.1; Diaz S, 2006, PLOS BIOL, V4, P1300, DOI 10.1371/journal.pbio.0040277; Escobar F, 2008, J APPL ECOL, V45, P1584, DOI 10.1111/j.1365-2664.2008.01551.x; Feer F, 2005, CONSERV BIOL, V19, P1103, DOI 10.1111/j.1523-1739.2005.00087.x; Feer F, 1999, J TROP ECOL, V15, P129, DOI 10.1017/S0266467499000711; Fidalgo ECC, 2005, CONSERVATION SUSTAIN; Gardner TA, 2008, J APPL ECOL, V45, P883, DOI 10.1111/j.1365-2664.2008.01454.x; Gardner TA, 2008, ECOL LETT, V11, P139, DOI 10.1111/j.1461-0248.2007.01133.x; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Halffer G, 1982, NESTING BEHAV DUNG B; Hanski I., 1991, P305; Hassan R., 2005, ECOSYSTEMS HUMAN WEL, V1, P297, DOI DOI 10.1021/JF020083Y; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Horgan FG, 2005, FOREST ECOL MANAG, V216, P117, DOI 10.1016/j.foreco.2005.05.049; Jacobs CT, 2010, J INSECT CONSERV, V14, P389, DOI 10.1007/s10841-010-9270-x; Koike S, 2012, ACTA OECOL, V41, P74, DOI 10.1016/j.actao.2012.04.009; Korasaki V, 2012, INSECT SCI, V00, P1; Larsen TH, 2005, ECOL LETT, V8, P538, DOI 10.1111/j.1461-0248.2005.00749.x; Larsen TH, 2005, BIOTROPICA, V37, P322, DOI 10.1111/j.1744-7429.2005.00042.x; Lawson CR, 2012, BIOTROPICA, V44, P271, DOI 10.1111/j.1744-7429.2012.00871.x; Lewis OT, 2009, BASIC APPL ECOL, V10, P97, DOI 10.1016/j.baae.2008.08.010; Losey JE, 2006, BIOSCIENCE, V56, P311, DOI 10.1641/0006-3568(2006)56[311:TEVOES]2.0.CO;2; Louzada J, 2010, LANDSCAPE ECOL, V25, P631, DOI 10.1007/s10980-010-9448-3; Mac Nally R, 2000, BIODIVERS CONSERV, V9, P655, DOI 10.1023/A:1008985925162; Mac Nally R, 2002, BIODIVERS CONSERV, V11, P1397, DOI 10.1023/A:1016250716679; MCKINNEY GT, 1975, J APPL ECOL, V12, P831; Nichols E, 2008, BIOL CONSERV, V141, P1461, DOI 10.1016/j.biocon.2008.04.011; Nichols E, 2007, BIOL CONSERV, V137, P1, DOI 10.1016/j.biocon.2007.01.023; R Core Team, 2016, R FDN STAT COMP; SAMWAYS MJ, 1995, INSECT CONSERVATION; Santos-Heredia C, 2011, INTEGR ZOOL, V6, P399, DOI 10.1111/j.1749-4877.2011.00261.x; Santos-Heredia C, 2010, J TROP ECOL, V26, P355, DOI 10.1017/S0266467410000192; Schupp EW, 2010, NEW PHYTOL, V188, P333, DOI 10.1111/j.1469-8137.2010.03402.x; Simelane TS, 2010, AFR J ECOL, V48, P490, DOI 10.1111/j.1365-2028.2009.01138.x; Slade EM, 2007, J ANIM ECOL, V76, P1094, DOI 10.1111/j.1365-2656.2007.01296.x; Slade EM, 2011, BIOL CONSERV, V144, P166, DOI 10.1016/j.biocon.2010.08.011; Spector S, 2006, COLEOPTS BULL, V60, P71, DOI 10.1649/0010-065X(2006)60[71:SDBCSS]2.0.CO;2; Tilman D, 1999, SCIENCE, V286, P1099, DOI 10.1126/science.286.5442.1099; Tscharntke T, 2005, ECOL LETT, V8, P857, DOI 10.1111/j.1461-0248.2005.00782.x; Vulinec K, 2002, BIOTROPICA, V34, P297, DOI 10.1111/j.1744-7429.2002.tb00541.x; Yamada Daigo, 2007, Grassland Science, V53, P121, DOI 10.1111/j.1744-697X.2007.00082.x	60	143	146	2	123	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57786	10.1371/journal.pone.0057786	http://dx.doi.org/10.1371/journal.pone.0057786			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460906	Green Submitted, Green Accepted, gold, Green Published			2022-12-25	WOS:000315519000161
J	Del Coso, J; Fernandez, D; Abian-Vicen, J; Salinero, JJ; Gonzalez-Millan, C; Areces, F; Ruiz, D; Gallo, C; Calleja-Gonzalez, J; Perez-Gonzalez, B				Del Coso, Juan; Fernandez, David; Abian-Vicen, Javier; Jose Salinero, Juan; Gonzalez-Millan, Cristina; Areces, Francisco; Ruiz, Diana; Gallo, Cesar; Calleja-Gonzalez, Julio; Perez-Gonzalez, Benito			Running Pace Decrease during a Marathon Is Positively Related to Blood Markers of Muscle Damage	PLOS ONE			English	Article							PROLONGED STRENUOUS EXERCISE; HEAT ILLNESS; TEMPERATURE; HYDRATION; DEHYDRATION; PERFORMANCE; GLYCOGEN; FATIGUE; THERMOREGULATION; RUNNERS	Background: Completing a marathon is one of the most challenging sports activities, yet the source of running fatigue during this event is not completely understood. The aim of this investigation was to determine the cause(s) of running fatigue during a marathon in warm weather. Methodology/Principal Findings: We recruited 40 amateur runners (34 men and 6 women) for the study. Before the race, body core temperature, body mass, leg muscle power output during a countermovement jump, and blood samples were obtained. During the marathon (27 degrees C; 27% relative humidity) running fatigue was measured as the pace reduction from the first 5-km to the end of the race. Within 3 min after the marathon, the same pre-exercise variables were obtained. Results: Marathoners reduced their running pace from 3.5 +/- 0.4 m/s after 5-km to 2.9 +/- 0.6 m/s at the end of the race (P<0.05), although the running fatigue experienced by the marathoners was uneven. Marathoners with greater running fatigue (> 15% pace reduction) had elevated post-race myoglobin (1318 +/- 1411 v 623 +/- 391 mu g L-1; P<0.05), lactate dehydrogenase (687 +/- 151 v 583 +/- 117 U L-1; P<0.05), and creatine kinase (564 +/- 469 v 363 +/- 158 U L-1; P = 0.07) in comparison with marathoners that preserved their running pace reasonably well throughout the race. However, they did not differ in their body mass change (-3.1 +/- 1.0 v -3.0 +/- 1.0%; P = 0.60) or post-race body temperature (38.7 +/- 0.7 v 38.9 +/- 0.9 degrees C; P = 0.35). Conclusions/Significance: Running pace decline during a marathon was positively related with muscle breakdown blood markers. To elucidate if muscle damage during a marathon is related to mechanistic or metabolic factors requires further investigation.	[Del Coso, Juan; Abian-Vicen, Javier; Jose Salinero, Juan; Gonzalez-Millan, Cristina; Areces, Francisco; Ruiz, Diana; Gallo, Cesar; Perez-Gonzalez, Benito] Camilo Jose Cela Univ, Sports Sci Inst, Exercise Physiol Lab, Madrid, Spain; [Fernandez, David] Univ Complutense, Fac Med, E-28040 Madrid, Spain; [Calleja-Gonzalez, Julio] Univ Basque Country, Fac Sport Sci, Lab Anal Sport Performance, Sport & Phys Educ Dept, Vitoria, Spain	Camilo Jose Cela University; Complutense University of Madrid; University of Basque Country	Del Coso, J (corresponding author), Camilo Jose Cela Univ, Sports Sci Inst, Exercise Physiol Lab, Madrid, Spain.	jdelcoso@ucjc.edu	Abián-Vicén, Javier/I-8509-2012; MARTÍN, JUAN JOSÉ JJ SALINERO/I-4212-2012; Salinero, Juan J./GLT-1243-2022; Areces, Francisco/ABH-3023-2020; Pérez-González, Benito/AAF-7128-2021; Del Coso, Juan/AAC-7117-2020; GALLO, CESAR/O-4823-2019; Calleja-Gonzalez, Julio/AAX-3058-2021	Abián-Vicén, Javier/0000-0001-9635-3289; MARTÍN, JUAN JOSÉ JJ SALINERO/0000-0003-4153-5100; Salinero, Juan J./0000-0003-4153-5100; Areces, Francisco/0000-0003-2996-4156; Pérez-González, Benito/0000-0002-6191-2885; Del Coso, Juan/0000-0002-5785-984X; GALLO, CESAR/0000-0001-8676-4658; Fernandez-de-Velasco, David/0000-0003-0889-8145; calleja-gonzalez, julio/0000-0003-2575-7168; CALLEJA GONZALEZ, JULIO MARIA/0000-0003-4878-0176; Gonzalez-Millan, Cristina/0000-0002-3371-9420				Armstrong LE, 2007, MED SCI SPORT EXER, V39, P556, DOI 10.1249/MSS.0b013e31802fa199; Beis LY, 2012, CLIN J SPORT MED, V22, P254, DOI 10.1097/JSM.0b013e31824a55d7; Blake JB, 1903, BOSTON MED SURG J, V148, P41; CALLOW M, 1986, EUR J APPL PHYSIOL O, V55, P654, DOI 10.1007/BF00423212; Casa DJ, 2010, J ATHL TRAINING, V45, P147, DOI 10.4085/1062-6050-45.2.147; Cheuvront SN, 2002, MED SCI SPORT EXER, V34, P1344, DOI 10.1097/00005768-200208000-00017; Cheuvront SN, 2001, SPORTS MED, V31, P743, DOI 10.2165/00007256-200131100-00004; Coso JD, 2012, APPL PHYSL IN PRESS; Coso S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039558; Coyle EF, 2007, SPORTS MED, V37, P306, DOI 10.2165/00007256-200737040-00009; COYLE EF, 1986, J APPL PHYSIOL, V61, P165, DOI 10.1152/jappl.1986.61.1.165; Ely MR, 2008, MED SCI SPORT EXER, V40, P1675, DOI 10.1249/MSS.0b013e3181788da9; Finch CF, 2008, J SCI MED SPORT, V11, P48, DOI 10.1016/j.jsams.2007.08.008; Gonzalez-Alonso J, 1999, J APPL PHYSIOL, V86, P1032, DOI 10.1152/jappl.1999.86.3.1032; Gonzalez-Alonso J, 2008, J PHYSIOL-LONDON, V586, P45, DOI 10.1113/jphysiol.2007.142158; Gonzalez-Alonso J, 2007, SPORTS MED, V37, P371, DOI 10.2165/00007256-200737040-00025; Gosztyla AE, 2006, J STRENGTH COND RES, V20, P882, DOI 10.1519/R-19275.1; Goulet EDB, 2011, BRIT J SPORT MED, V45, P1149, DOI 10.1136/bjsm.2010.077966; HIKIDA RS, 1983, J NEUROL SCI, V59, P185, DOI 10.1016/0022-510X(83)90037-0; Kratz A, 2002, AM J CLIN PATHOL, V118, P856, DOI 10.1092/BTWQ5YMYVQ67QK9L; Laursen PB, 2006, BRIT J SPORT MED, V40, P320, DOI 10.1136/bjsm.2005.022426; Maughan R J, 1985, Br J Sports Med, V19, P192; MAUGHAN RJ, 1985, INT J SPORTS MED, V6, P15, DOI 10.1055/s-2008-1025806; Maughan RJ, 2007, SPORTS MED, V37, P396, DOI 10.2165/00007256-200737040-00032; MCCARTHY DA, 1988, SPORTS MED, V6, P333, DOI 10.2165/00007256-198806060-00002; Meludu S C, 2005, Niger J Physiol Sci, V20, P43; Millet GY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017059; Mora-Rodriguez R, 2010, EUR J APPL PHYSIOL, V109, P973, DOI 10.1007/s00421-010-1436-4; Noakes TD, 2007, J SPORT SCI, V25, P781, DOI 10.1080/02640410600875036; NOAKES TD, 1991, MED SCI SPORT EXER, V23, P443; Noakes TD, 2007, SPORTS MED, V37, P463, DOI 10.2165/00007256-200737040-00050; Nybo L, 2003, MED SCI SPORT EXER, V35, P589, DOI 10.1249/01.MSS.0000058433.85789.66; Passe D, 2007, INT J SPORT NUTR EXE, V17, P284, DOI 10.1123/ijsnem.17.3.284; Pfeiffer B, 2012, MED SCI SPORT EXER, V44, P344, DOI 10.1249/MSS.0b013e31822dc809; PUGH LGC, 1967, J APPL PHYSIOL, V23, P347, DOI 10.1152/jappl.1967.23.3.347; Rapoport BI, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000960; Rust CA, 2012, J STRENGTH COND RES, V26, P1505, DOI 10.1519/JSC.0b013e318231a7b5; Salinero JJ, 2012, ANN C SPAN OL COMM, P3; Sawka MN, 2007, MED SCI SPORT EXER, V39, P377, DOI 10.1249/mss.0b013e31802ca597; SCHIFF HB, 1978, Q J MED, V47, P463; SHERMAN WM, 1983, J APPL PHYSIOL, V55, P1219, DOI 10.1152/jappl.1983.55.4.1219; Shirreffs SM, 2000, J SPORT MED PHYS FIT, V40, P80; Smith JE, 2004, BRIT J SPORT MED, V38, P292, DOI 10.1136/bjsm.2002.002873; Tee JC, 2007, SPORTS MED, V37, P827, DOI 10.2165/00007256-200737100-00001; Vihma T, 2010, INT J BIOMETEOROL, V54, P297, DOI 10.1007/s00484-009-0280-x; Wyndham C H, 1969, S Afr Med J, V43, P893	46	66	68	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57602	10.1371/journal.pone.0057602	http://dx.doi.org/10.1371/journal.pone.0057602			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460881	Green Published, gold, Green Submitted			2022-12-25	WOS:000315519000136
J	Geller, R; Andino, R; Frydman, J				Geller, Ron; Andino, Raul; Frydman, Judith			Hsp90 Inhibitors Exhibit Resistance-Free Antiviral Activity against Respiratory Syncytial Virus	PLOS ONE			English	Article							AIRWAY EPITHELIAL-CELLS; SHOCK-PROTEIN 90; GENE NETWORKS; REPLICATION; PREVENTION; EVOLUTION; INFECTION	Respiratory syncytial virus (RSV) is a major cause of respiratory illness in young children, leading to significant morbidity and mortality worldwide. Despite its medical importance, no vaccine or effective therapeutic interventions are currently available. Therefore, there is a pressing need to identify novel antiviral drugs to combat RSV infections. Hsp90, a cellular protein-folding factor, has been shown to play an important role in the replication of numerous viruses. We here demonstrate that RSV requires Hsp90 for replication. Mechanistic studies reveal that inhibition of Hsp90 during RSV infection leads to the degradation of a viral protein similar in size to the RSV L protein, the viral RNA-dependent RNA polymerase, implicating it as an Hsp90 client protein. Accordingly, Hsp90 inhibitors exhibit antiviral activity against laboratory and clinical isolates of RSV in both immortalized as well as primary differentiated airway epithelial cells. Interestingly, we find a high barrier to the emergence of drug resistance to Hsp90 inhibitors, as extensive growth of RSV under conditions of Hsp90 inhibition did not yield mutants with reduced sensitivity to these drugs. Our results suggest that Hsp90 inhibitors may present attractive antiviral therapeutics for treatment of RSV infections and highlight the potential of chaperone inhibitors as antivirals exhibiting high barriers to development of drug resistance.	[Geller, Ron; Frydman, Judith] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Andino, Raul] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA	Stanford University; University of California System; University of California San Francisco	Frydman, J (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	jfrydman@stanford.edu	Geller, Ron/D-2919-2017	Geller, Ron/0000-0002-7612-4611; , judith/0000-0003-2302-6943	NIH [GM56433, AI91575]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI091575] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM056433, R01GM056433] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The study was supported by NIH grants GM56433 to JF and AI91575 to JF and RA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blanco JCG, 2010, HUM VACCINES, V6, P482, DOI 10.4161/hv.6.6.11562; Brasier AR, 2004, J VIROL, V78, P11461, DOI 10.1128/JVI.78.21.11461-11476.2004; Chase G, 2008, VIROLOGY, V377, P431, DOI 10.1016/j.virol.2008.04.040; Collins PL, 2007, FIELDS VIROLOGY, P1497; Connor JH, 2007, VIROLOGY, V362, P109, DOI 10.1016/j.virol.2006.12.026; Duffy S, 2008, NAT REV GENET, V9, P267, DOI 10.1038/nrg2323; Echtenkamp FJ, 2012, BBA-MOL CELL RES, V1823, P668, DOI 10.1016/j.bbamcr.2011.08.011; Empey KM, 2010, CLIN INFECT DIS, V50, P1258, DOI 10.1086/651603; Geller R, 2007, GENE DEV, V21, P195, DOI 10.1101/gad.1505307; Geller R, 2012, BBA-MOL CELL RES, V1823, P698, DOI 10.1016/j.bbamcr.2011.11.007; Graham BS, 2011, IMMUNOL REV, V239, P149, DOI 10.1111/j.1600-065X.2010.00972.x; Jhaveri K, 2012, BBA-MOL CELL RES, V1823, P742, DOI 10.1016/j.bbamcr.2011.10.008; Lauring AS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001005; Li J, 2012, BBA-MOL CELL RES, V1823, P624, DOI 10.1016/j.bbamcr.2011.09.003; Lundin A, 2010, ANTIVIR RES, V88, P317, DOI 10.1016/j.antiviral.2010.10.004; Lyles D. S., 2007, FIELDS VIROLOGY, V1, P1364; Miller S, 2008, NAT REV MICROBIOL, V6, P363, DOI 10.1038/nrmicro1890; Murata Y, 2007, ANTIVIR THER, V12, P659; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Nijhuis M., 2009, V189, P299, DOI 10.1007/978-3-540-79086-0_11; Pashtan I, 2008, CELL CYCLE, V7, P2936, DOI 10.4161/cc.7.18.6701; Radhakrishnan A, 2010, MOL CELL PROTEOMICS, V9, P1829, DOI 10.1074/mcp.M110.001651; Sanjuan R, 2010, J VIROL, V84, P9733, DOI 10.1128/JVI.00694-10; Taguwa S, 2008, J VIROL, V82, P2631, DOI 10.1128/JVI.02153-07; Taguwa S, 2009, J VIROL, V83, P10427, DOI 10.1128/JVI.01035-09; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Theodoraki MA, 2012, BBA-MOL CELL RES, V1823, P683, DOI 10.1016/j.bbamcr.2011.08.006; Tian B, 2002, J VIROL, V76, P6800, DOI 10.1128/JVI.76.13.6800-6814.2002; Trepel J, 2010, NAT REV CANCER, V10, P537, DOI 10.1038/nrc2887; Whitesell L, 2012, BBA-MOL CELL RES, V1823, P756, DOI 10.1016/j.bbamcr.2011.12.006; Wright M, 2011, PEDIATR PULM, V46, P324, DOI 10.1002/ppul.21377; Xiao A, 2010, ARCH VIROL, V155, P1021, DOI 10.1007/s00705-010-0691-3; Zhang LQ, 2002, J VIROL, V76, P5654, DOI 10.1128/JVI.76.11.5654-5666.2002; Zhang YH, 2001, J VIROL, V75, P9044, DOI 10.1128/JVI.75.19.9044-9058.2001; zur Wiesch PA, 2011, LANCET INFECT DIS, V11, P236, DOI 10.1016/S1473-3099(10)70264-4	35	45	46	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e56762	10.1371/journal.pone.0056762	http://dx.doi.org/10.1371/journal.pone.0056762			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460813	Green Submitted, Green Published, gold			2022-12-25	WOS:000315519000036
J	Hadad, I; Veithen, A; Springael, JY; Sotiropoulou, PA; Da Costa, AM; Miot, F; Naeije, R; De Deken, X; Mc Entee, K				Hadad, Ielham; Veithen, Alex; Springael, Jean-Yves; Sotiropoulou, Panagiota A.; Da Costa, Agnes Mendes; Miot, Francoise; Naeije, Robert; De Deken, Xavier; Mc Entee, Kathleen			Stroma Cell-Derived Factor-1 alpha Signaling Enhances Calcium Transients and Beating Frequency in Rat Neonatal Cardiomyocytes	PLOS ONE			English	Article							MYOCARDIAL-INFARCTION; CARDIAC-HYPERTROPHY; CA2+ TRANSIENTS; CXCR4; HEART; EXPRESSION; MYOCYTES; THERAPY	Stroma cell-derived factor-1 alpha (SDF-1 alpha) is a cardioprotective chemokine, acting through its G-protein coupled receptor CXCR4. In experimental acute myocardial infarction, administration of SDF-1 alpha induces an early improvement of systolic function which is difficult to explain solely by an anti-apoptotic and angiogenic effect. We wondered whether SDF-1 alpha signaling might have direct effects on calcium transients and beating frequency. Primary rat neonatal cardiomyocytes were culture-expanded and characterized by immunofluorescence staining. Calcium sparks were studied by fluorescence microscopy after calcium loading with the Fluo-4 acetoxymethyl ester sensor. The cardiomyocyte enriched cellular suspension expressed troponin I and CXCR4 but was vimentin negative. Addition of SDF-1 alpha in the medium increased cytoplasmic calcium release. The calcium response was completely abolished by using a neutralizing anti-CXCR4 antibody and partially suppressed and delayed by preincubation with an inositol triphosphate receptor (IP3R) blocker, but not with a ryanodine receptor (RyR) antagonist. Calcium fluxes induced by caffeine, a RyR agonist, were decreased by an IP3R blocker. Treatment with forskolin or SDF-1 alpha increased cardiomyocyte beating frequency and their effects were additive. In vivo, treatment with SDF-1 alpha increased left ventricular dP/dtmax. These results suggest that in rat neonatal cardiomyocytes, the SDF-1 alpha/CXCR4 signaling increases calcium transients in an IP3-gated fashion leading to a positive chronotropic and inotropic effect.	[Hadad, Ielham; Da Costa, Agnes Mendes; Naeije, Robert; Mc Entee, Kathleen] Univ Libre Brussels, Dept Physiopathol, Fac Med, Brussels, Belgium; [Springael, Jean-Yves; Sotiropoulou, Panagiota A.; Miot, Francoise; De Deken, Xavier] Univ Libre Brussels, Inst Rech Interdisciplinaire Biol Humaine & Mol, Fac Med, Brussels, Belgium; [Veithen, Alex] Chemcom SA, Brussels, Belgium	Universite Libre de Bruxelles; Universite Libre de Bruxelles	Hadad, I (corresponding author), Univ Libre Brussels, Dept Physiopathol, Fac Med, Brussels, Belgium.	ielham.hadad@ulb.ac.be		Mc Entee, Kathleen/0000-0003-3521-9232	Foundation for Cardiac Surgery, Brussels, Belgium	Foundation for Cardiac Surgery, Brussels, Belgium	This work was supported by the Foundation for Cardiac Surgery, Brussels, Belgium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Askari AT, 2003, LANCET, V362, P697, DOI 10.1016/S0140-6736(03)14232-8; Balsam LB, 2004, NATURE, V428, P668, DOI 10.1038/nature02460; Bers DM, 2008, ANNU REV PHYSIOL, V70, P23, DOI 10.1146/annurev.physiol.70.113006.100455; Chlopcikova Sarka, 2001, Biomedical Papers (Olomouc), V145, P49; GO LO, 1995, J CLIN INVEST, V95, P888, DOI 10.1172/JCI117739; HARARY I, 1973, ARCH BIOCHEM BIOPHYS, V156, P563, DOI 10.1016/0003-9861(73)90306-8; Harzheim D, 2009, P NATL ACAD SCI USA, V106, P11406, DOI 10.1073/pnas.0905485106; Hasenfuss G, 2011, EUR HEART J, V32, P1838, DOI 10.1093/eurheartj/ehr026; Heineke J, 2006, NAT REV MOL CELL BIO, V7, P589, DOI 10.1038/nrm1983; Janowski E, 2010, AM J PHYSIOL-HEART C, V298, pH1939, DOI 10.1152/ajpheart.00607.2009; Kanki S, 2011, CIRC-HEART FAIL, V4, P509, DOI 10.1161/CIRCHEARTFAILURE.110.960302; LaRocca TJ, 2010, J CARDIOVASC PHARM, V56, P548, DOI 10.1097/FJC.0b013e3181f713fe; Lee BC, 2009, EUR J HEART FAIL, V11, P238, DOI 10.1093/eurjhf/hfn035; Leszek P, 2007, EUR J HEART FAIL, V9, P579, DOI 10.1016/j.ejheart.2007.01.011; Maier LS, 2002, J MOL CELL CARDIOL, V34, P919, DOI 10.1006/jmcc.2002.2038; Mathieu M, 2009, J THORAC CARDIOV SUR, V138, P646, DOI 10.1016/j.jtcvs.2008.12.031; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; Passier R, 2008, NATURE, V453, P322, DOI 10.1038/nature07040; Pillarisetti K, 2001, INFLAMMATION, V25, P293, DOI 10.1023/A:1012808525370; Pyo RT, 2006, J MOL CELL CARDIOL, V41, P834, DOI 10.1016/j.yjmcc.2006.08.008; Rubin JB, 2009, SEMIN CANCER BIOL, V19, P116, DOI 10.1016/j.semcancer.2008.10.001; Saxena A, 2008, CIRCULATION, V117, P2224, DOI 10.1161/CIRCULATIONAHA.107.694992; Seki S, 2003, CARDIOVASC RES, V58, P535, DOI 10.1016/S0008-6363(03)00255-4; Tan WF, 2006, J BIOL CHEM, V281, P39542, DOI 10.1074/jbc.M609062200; Teicher BA, 2010, CLIN CANCER RES, V16, P2927, DOI 10.1158/1078-0432.CCR-09-2329; Winship IR, 2007, J NEUROSCI, V27, P6268, DOI 10.1523/JNEUROSCI.4801-06.2007; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	27	15	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e56007	10.1371/journal.pone.0056007	http://dx.doi.org/10.1371/journal.pone.0056007			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460790	Green Published, Green Submitted, gold			2022-12-25	WOS:000315519000013
J	Hobson-Peters, J; Yam, AWY; Lu, JWF; Setoh, YX; May, FJ; Kurucz, N; Walsh, S; Prow, NA; Davis, SS; Weir, R; Melville, L; Hunt, N; Webb, RI; Blitvich, BJ; Whelan, P; Hall, RA				Hobson-Peters, Jody; Yam, Alice Wei Yee; Lu, Jennifer Wei Fei; Setoh, Yin Xiang; May, Fiona J.; Kurucz, Nina; Walsh, Susan; Prow, Natalie A.; Davis, Steven S.; Weir, Richard; Melville, Lorna; Hunt, Neville; Webb, Richard I.; Blitvich, Bradley J.; Whelan, Peter; Hall, Roy A.			A New Insect-Specific Flavivirus from Northern Australia Suppresses Replication of West Nile Virus and Murray Valley Encephalitis Virus in Co-infected Mosquito Cells	PLOS ONE			English	Article							CULEX FLAVIVIRUS; MONOCLONAL-ANTIBODIES; JAPANESE ENCEPHALITIS; GENETIC-CHARACTERIZATION; ENVELOPE PROTEIN; SEQUENCE; AEDES; INTERFERENCE; TRANSMISSION; STRAIN	Recent reports of a novel group of flaviviruses that replicate only in mosquitoes and appear to spread through insect populations via vertical transmission have emerged from around the globe. To date, there is no information on the presence or prevalence of these insect-specific flaviviruses (ISFs) in Australian mosquito species. To assess whether such viruses occur locally, we used reverse transcription-polymerase chain reaction (RT-PCR) and flavivirus universal primers that are specific to the NS5 gene to detect these viruses in mosquito pools collected from the Northern Territory. Of 94 pools of mosquitoes, 13 were RT-PCR positive, and of these, 6 flavivirus isolates were obtained by inoculation of mosquito cell culture. Sequence analysis of the NS5 gene revealed that these isolates are genetically and phylogenetically similar to ISFs reported from other parts of the world. The entire coding region of one isolate (designated 56) was sequenced and shown to have approximately 63.7% nucleotide identity and 66.6% amino acid identity with its closest known relative (Nakiwogo virus) indicating that the prototype Australian ISF represents a new species. All isolates were obtained from Coquillettidia xanthogaster mosquitoes. The new virus is tentatively named Palm Creek virus (PCV) after its place of isolation. We also demonstrated that prior infection of cultured mosquito cells with PCV suppressed subsequent replication of the medically significant West Nile and Murray Valley encephalitis viruses by 10-43 fold (1 to 1.63 log) at 48 hr post-infection, suggesting that superinfection exclusion can occur between ISFs and vertebrate-infecting flaviviruses despite their high level of genetic diversity. We also generated several monoclonal antibodies (mAbs) that are specific to the NS1 protein of PCV, and these represent the first ISF-specific mAbs reported to date.	[Hobson-Peters, Jody; Yam, Alice Wei Yee; Lu, Jennifer Wei Fei; Setoh, Yin Xiang; Prow, Natalie A.; Hall, Roy A.] Univ Queensland, Australian Infect Dis Res Ctr, Sch Chem & Mol Biosci, St Lucia, Qld, Australia; [May, Fiona J.] Univ Queensland, Australian Ctr Ecogen, Lucia, Qld, Australia; [Kurucz, Nina; Whelan, Peter] Northern Terr Dept Hlth, Ctr Dis Control, Hlth Protect Div, Darwin, NT, Australia; [Walsh, Susan; Davis, Steven S.; Weir, Richard; Melville, Lorna; Hunt, Neville] Dept Primary Ind & Fisheries, Berrimah Vet Labs, Darwin, NT, Australia; [Webb, Richard I.] Univ Queensland, Ctr Microscopy & Microanal, St Lucia, Qld, Australia; [Blitvich, Bradley J.] Iowa State Univ, Dept Vet Microbiol & Preventat Med, Coll Vet Med, Ames, IA USA	University of Queensland; University of Queensland; University of Queensland; Iowa State University	Hall, RA (corresponding author), Univ Queensland, Australian Infect Dis Res Ctr, Sch Chem & Mol Biosci, St Lucia, Qld, Australia.	roy.hall@uq.edu.au	Lu, Jennifer WF/O-8473-2015; Blitvich, Brad/P-3168-2019; Setoh, Yin Xiang/K-4503-2012	Lu, Jennifer WF/0000-0002-1777-4788; Setoh, Yin Xiang/0000-0002-1683-3555; Prow, Natalie/0000-0001-7312-8767; May, Fiona/0000-0003-1306-0179	Australian Research Council [DP120103994]	Australian Research Council(Australian Research Council)	Funding for this study was provided by the Australian Research Council (DP120103994). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS SC, 1995, VIROLOGY, V206, P49, DOI 10.1016/S0042-6822(95)80018-2; Blitvich BJ, 2009, J MED ENTOMOL, V46, P934, DOI 10.1603/033.046.0428; Bolling BG, 2011, AM J TROP MED HYG, V85, P169, DOI 10.4269/ajtmh.2011.10-0474; Bolling BG, 2012, VIROLOGY, V427, P90, DOI 10.1016/j.virol.2012.02.016; Brackney DE, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000856; Broom AK, 1998, PATHOLOGY, V30, P286, DOI 10.1080/00313029800169456; Calzolari M, 2012, J GEN VIROL, V93, P1215, DOI 10.1099/vir.0.040485-0; CAMMISAPARKS H, 1992, VIROLOGY, V189, P511, DOI 10.1016/0042-6822(92)90575-A; Chang GJJ, 2000, J VIROL, V74, P4244, DOI 10.1128/JVI.74.9.4244-4252.2000; Clark DC, 2007, J GEN VIROL, V88, P1175, DOI 10.1099/vir.0.82609-0; Cook S, 2006, J GEN VIROL, V87, P735, DOI 10.1099/vir.0.81475-0; Cook S, 2012, J GEN VIROL, V93, P223, DOI 10.1099/vir.0.036525-0; Cook S, 2009, J GEN VIROL, V90, P2669, DOI 10.1099/vir.0.014183-0; Crabtree MB, 2009, ARCH VIROL, V154, P857, DOI 10.1007/s00705-009-0373-1; Crabtree MB, 2003, ARCH VIROL, V148, P1095, DOI 10.1007/s00705-003-0019-7; Davis BS, 2001, J VIROL, V75, P4040, DOI 10.1128/JVI.75.9.4040-4047.2001; DITTMAR D, 1982, J GEN VIROL, V59, P273, DOI 10.1099/0022-1317-59-2-273; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Flamand M, 1999, J VIROL, V73, P6104, DOI 10.1128/JVI.73.7.6104-6110.1999; Frost MJ, 2012, EMERG INFECT DIS, V18, P792, DOI 10.3201/eid1805.111720; GENTRY MK, 1982, AM J TROP MED HYG, V31, P548, DOI 10.4269/ajtmh.1982.31.548; GORMAN B. M., 1975, Aust. J. Med. Technol., V6, P65; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; HALL RA, 1988, IMMUNOL CELL BIOL, V66, P51, DOI 10.1038/icb.1988.6; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Harbach RE, 1998, SYST ENTOMOL, V23, P327, DOI 10.1046/j.1365-3113.1998.00072.x; Hobson-Peters J, 2008, J GEN VIROL, V89, P3063, DOI 10.1099/vir.0.2008/003731-0; Hoshino K, 2007, VIROLOGY, V359, P405, DOI 10.1016/j.virol.2006.09.039; Hoshino K, 2009, VIROLOGY, V391, P119, DOI 10.1016/j.virol.2009.06.025; Huhtamo E, 2009, J VIROL, V83, P9532, DOI 10.1128/JVI.00529-09; Junglen S, 2009, J VIROL, V83, P4462, DOI 10.1128/JVI.00014-09; Kent RJ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000671; KOZAK M, 1987, J MOL BIOL, V196, P947, DOI 10.1016/0022-2836(87)90418-9; Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998; Lanciotti RS, 1999, SCIENCE, V286, P2333, DOI 10.1126/science.286.5448.2333; Lee YM, 2005, J VIROL, V79, P3231, DOI 10.1128/JVI.79.6.3231-3242.2005; Lindenbach BD, 2007, FIELDS VIROLOGY, V1, P1101, DOI DOI 10.1016/0038-092X(88)90131-4; LOBIGS M, 1988, VIROLOGY, V165, P245, DOI 10.1016/0042-6822(88)90678-2; Lutomiah Joel J.L., 2007, Journal of Insect Science (Tucson), V7, P1, DOI 10.1673/031.007.5501; Mackenzie JS, 2004, NAT MED, V10, pS98, DOI 10.1038/nm1144; MACKENZIE JS, 1994, ARCH VIROL, V136, P447, DOI 10.1007/BF01321074; May FJ, 2006, J GEN VIROL, V87, P329, DOI 10.1099/vir.0.81252-0; Newman CM, 2011, VECTOR-BORNE ZOONOT, V11, P1099, DOI 10.1089/vbz.2010.0144; Parreira R, 2012, VIRUS RES, V167, P152, DOI 10.1016/j.virusres.2012.04.010; Pepin KM, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-28; RANDOLPH VB, 1988, J GEN VIROL, V69, P2189, DOI 10.1099/0022-1317-69-9-2189; RANDOLPH VB, 1990, J GEN VIROL, V71, P1845, DOI 10.1099/0022-1317-71-8-1845; Ritchie SA, 1997, AM J TROP MED HYG, V56, P80, DOI 10.4269/ajtmh.1997.56.80; Rohe D.L., 1979, Bulletin of the Society of Vector Ecologists, V4, P24; Saiyasombat R, 2011, J MED ENTOMOL, V48, P1031, DOI 10.1603/ME11043; Scott JC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000848; STOLLAR V, 1975, VIROLOGY, V64, P367, DOI 10.1016/0042-6822(75)90113-0; Tyler S, 2011, AM J TROP MED HYG, V85, P162, DOI 10.4269/ajtmh.2011.10-0469; Whelan P. L., 1993, ARBOVIRUS RES AUST, V6, P270; Zou G, 2009, J VIROL, V83, P11765, DOI 10.1128/JVI.01205-09	55	143	145	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e56534	10.1371/journal.pone.0056534	http://dx.doi.org/10.1371/journal.pone.0056534			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460804	gold, Green Published, Green Submitted			2022-12-25	WOS:000315519000027
J	Krueger, M; Hartig, W; Reichenbach, A; Bechmann, I; Michalski, D				Krueger, Martin; Haertig, Wolfgang; Reichenbach, Andreas; Bechmann, Ingo; Michalski, Dominik			Blood-Brain Barrier Breakdown after Embolic Stroke in Rats Occurs without Ultrastructural Evidence for Disrupting Tight Junctions	PLOS ONE			English	Article							FOCAL CEREBRAL-ISCHEMIA; NEURODEGENERATIVE DISORDERS; HEMORRHAGIC TRANSFORMATION; CLAUDIN-5 EXPRESSION; SYNAPTIC VESICLES; ENDOTHELIAL-CELLS; ARTERY OCCLUSION; L-GLUTAMATE; PERMEABILITY; PERICYTES	The term blood-brain barrier (BBB) relates to the ability of cerebral vessels to hold back hydrophilic and large molecules from entering the brain, thereby crucially contributing to brain homeostasis. In fact, experimental opening of endothelial tight junctions causes a breakdown of the BBB evidenced as for instance by albumin leakage. This and similar observations led to the conclusion that BBB breakdown is predominantly mediated by damage to tight junction complexes, but evidentiary ultrastructural data are rare. Since functional deficits of the BBB contribute to an increased risk of hemorrhagic transformation and brain edema after stroke, which both critically impact on the clinical outcome, we studied the mechanism of BBB breakdown using an embolic model of focal cerebral ischemia in Wistar rats to closely mimic the essential human pathophysiology. Ischemia-induced BBB breakdown was detected using intravenous injection of FITC-albumin and tight junctions in areas of FITC-albumin extravasation were subsequently studied using fluorescence and electron microscopy. Against our expectation, 25 hours after ischemia induction the morphology of tight junction complexes (identified ultrastructurally and using antibodies against the transcellular proteins occludin and claudin-5) appeared to be regularly maintained in regions where FITC-albumin massively leaked into the neuropil. Furthermore, occludin signals along pan-laminin-labeled vessels in the affected hemisphere equaled the non-affected contralateral side (ratio: 0.966 vs. 0.963; P = 0.500). Additional ultrastructural analyses at 5 and 25 h after ischemia induction clearly indicated FITC-albumin extravasation around vessels with intact tight junctions, while the endothelium exhibited enhanced transendothelial vesicle trafficking and signs of degeneration. Thus, BBB breakdown and leakage of FITC-albumin cannot be correlated with staining patterns for common tight junction proteins alone. Understanding the mechanisms causing functional endothelial alterations and endothelial damage is likely to provide novel protective targets in stroke.	[Krueger, Martin; Bechmann, Ingo] Univ Leipzig, Inst Anat, D-04109 Leipzig, Germany; [Haertig, Wolfgang; Reichenbach, Andreas] Univ Leipzig, Paul Flechsig Inst Brain Res, D-04109 Leipzig, Germany; [Michalski, Dominik] Univ Leipzig, Dept Neurol, D-04109 Leipzig, Germany	Leipzig University; Leipzig University; Leipzig University	Krueger, M (corresponding author), Univ Leipzig, Inst Anat, D-04109 Leipzig, Germany.	martin.krueger@medizin.uni-leipzig.de; dominik.michalski@medizin.uni-leipzig.de	Reichenbach, Andreas/B-2510-2017		Department of Neurology, University of Leipzig; DFG [FOR1336]	Department of Neurology, University of Leipzig; DFG(German Research Foundation (DFG))	Funding was provided for initial experiments by Prof. Dietmar Schneider and Dr. Carsten Hobohm (Department of Neurology, University of Leipzig) and then by the DFG (FOR1336) to Prof. Ingo Bechmann. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armulik A, 2010, NATURE, V468, P557, DOI 10.1038/nature09522; ARTHUR FE, 1987, DEV BRAIN RES, V36, P155, DOI 10.1016/0165-3806(87)90075-7; Bauer AT, 2010, J CEREBR BLOOD F MET, V30, P837, DOI 10.1038/jcbfm.2009.248; Bechmann I, 2007, TRENDS IMMUNOL, V28, P5, DOI 10.1016/j.it.2006.11.007; Belayev L, 1996, BRAIN RES, V739, P88, DOI 10.1016/S0006-8993(96)00815-3; Bell RD, 2012, NATURE, V485, P512, DOI 10.1038/nature11087; Bell RD, 2010, NEURON, V68, P409, DOI 10.1016/j.neuron.2010.09.043; Braeuninger Stefan, 2009, Exp Transl Stroke Med, V1, P8, DOI 10.1186/2040-7378-1-8; Chen B, 2009, STROKE, V40, pE666, DOI 10.1161/STROKEAHA.109.551341; Daneman R, 2010, NATURE, V468, P562, DOI 10.1038/nature09513; del Zoppo GJ, 2010, J INTERN MED, V267, P156, DOI 10.1111/j.1365-2796.2009.02199.x; Dente CJ, 2001, J SURG RES, V97, P85, DOI 10.1006/jsre.2001.6117; Diener HC, 2008, STROKE, V39, P1751, DOI 10.1161/STROKEAHA.107.503334; DIETRICH WD, 1987, ACTA NEUROPATHOL, V72, P326, DOI 10.1007/BF00687263; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; Donnan GA, 2008, LANCET, V371, P1612, DOI 10.1016/S0140-6736(08)60694-7; Durukan A, 2007, PHARMACOL BIOCHEM BE, V87, P179, DOI 10.1016/j.pbb.2007.04.015; Ehrlich P, 1885, FARBENANALYTISCHE ST; Endres M, 2008, CEREBROVASC DIS, V25, P268, DOI 10.1159/000118039; Endres Matthias, 2009, Handb Clin Neurol, V92, P31, DOI 10.1016/S0072-9752(08)01902-7; Engelhardt B, 2011, J CEREBR BLOOD F MET, V31, P1969, DOI 10.1038/jcbfm.2011.98; Fischer S, 2000, AM J PHYSIOL-CELL PH, V279, pC935, DOI 10.1152/ajpcell.2000.279.4.C935; Fisher M, 2009, STROKE, V40, P2244, DOI 10.1161/STROKEAHA.108.541128; Hamm S, 2004, CELL TISSUE RES, V315, P157, DOI 10.1007/s00441-003-0825-y; Hang Y, 2012, J MOL NEUROSCI, V46, P236, DOI 10.1007/s12031-011-9584-5; Hawkins BT, 2005, PHARMACOL REV, V57, P173, DOI 10.1124/pr.57.2.4; Hom J, 2011, AM J NEURORADIOL, V32, P41, DOI 10.3174/ajnr.A2244; ITO U, 1980, STROKE, V11, P606, DOI 10.1161/01.STR.11.6.606; Ito U, 2011, J CEREBR BLOOD F MET, V31, P328, DOI 10.1038/jcbfm.2010.97; JANZER RC, 1987, NATURE, V325, P253, DOI 10.1038/325253a0; Jiang J, 2007, EUR J PHARMACOL, V561, P54, DOI 10.1016/j.ejphar.2006.12.028; Jiao HX, 2011, J MOL NEUROSCI, V44, P130, DOI 10.1007/s12031-011-9496-4; Lewandowsky M., 1909, KLIN MED, V40, P480; Liebner S, 2000, ACTA NEUROPATHOL, V100, P323, DOI 10.1007/s004010000180; Liu J, 2012, J NEUROSCI, V32, P3044, DOI 10.1523/JNEUROSCI.6409-11.2012; Liu WL, 2008, J NEUROCHEM, V107, P1196, DOI 10.1111/j.1471-4159.2008.05664.x; Mark KS, 2002, AM J PHYSIOL-HEART C, V282, pH1485, DOI 10.1152/ajpheart.00645.2001; Matsuzaki M, 2010, NEUROPEDIATRICS, V41, P72, DOI 10.1055/s-0030-1261886; McCaffrey G, 2009, J NEUROCHEM, V110, P58, DOI 10.1111/j.1471-4159.2009.06113.x; Meairs S, 2006, CEREBROVASC DIS, V22, P75, DOI 10.1159/000093098; MENZIES SA, 1992, NEUROSURGERY, V31, P100, DOI 10.1227/00006123-199207000-00014; Mergenthaler P, 2004, METAB BRAIN DIS, V19, P151, DOI 10.1023/B:MEBR.0000043966.46964.e6; Michalski D, 2010, BRAIN RES, V1359, P186, DOI 10.1016/j.brainres.2010.08.045; Nagaraja TN, 2008, MICROCIRCULATION, V15, P1, DOI 10.1080/10739680701409811; Osada T, 2011, J CEREBR BLOOD F MET, V31, P1972, DOI 10.1038/jcbfm.2011.99; Piontek J, 2008, FASEB J, V22, P146, DOI 10.1096/fj.07-8319com; Qin ZY, 2007, STROKE, V38, P1362, DOI 10.1161/01.STR.0000259660.62865.eb; REESE TS, 1967, J CELL BIOL, V34, P207, DOI 10.1083/jcb.34.1.207; Roseth S, 1998, BIOCHEM PHARMACOL, V56, P1243, DOI 10.1016/S0006-2952(98)00200-7; ROSETH S, 1995, J NEUROCHEM, V65, P96; Sandoval KE, 2008, NEUROBIOL DIS, V32, P200, DOI 10.1016/j.nbd.2008.08.005; Seiffert E, 2004, J NEUROSCI, V24, P7829, DOI 10.1523/JNEUROSCI.1751-04.2004; Sixt M, 2001, J CELL BIOL, V153, P933, DOI 10.1083/jcb.153.5.933; Spirig R, 2008, MOL IMMUNOL, V45, P4084, DOI 10.1016/j.molimm.2008.07.024; STEWART PA, 1981, DEV BIOL, V84, P183, DOI 10.1016/0012-1606(81)90382-1; Strbian D, 2008, NEUROSCIENCE, V153, P175, DOI 10.1016/j.neuroscience.2008.02.012; Tarawneh R, 2010, CLIN GERIATR MED, V26, P125, DOI 10.1016/j.cger.2009.12.003; Wang GM, 2009, BRAIN RES, V1294, P183, DOI 10.1016/j.brainres.2009.07.070; Wang Y, 2012, P NATL ACAD SCI USA, V109, P4892, DOI 10.1073/pnas.1112129109; Winkler EA, 2011, NAT NEUROSCI, V14, P1398, DOI 10.1038/nn.2946; Wolburg H, 2002, VASC PHARMACOL, V38, P323, DOI 10.1016/S1537-1891(02)00200-8; Yang Y, 2007, J CEREBR BLOOD F MET, V27, P697, DOI 10.1038/sj.jcbfm.9600375; Young AR, 2007, J NEUROCHEM, V103, P1302, DOI 10.1111/j.1471-4159.2007.04866.x; Zhang RL, 1997, BRAIN RES, V766, P83, DOI 10.1016/S0006-8993(97)00580-5; Zhao YJ, 2010, NEUROL RES, V32, P748, DOI 10.1179/016164109X12445616596562; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003	67	123	127	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2013	8	2							e56419	10.1371/journal.pone.0056419	http://dx.doi.org/10.1371/journal.pone.0056419			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098PO	23468865	Green Submitted, gold, Green Published			2022-12-25	WOS:000315561400010
J	Rackham, CL; Jones, PM; King, AJF				Rackham, Chloe L.; Jones, Peter M.; King, Aileen J. F.			Maintenance of Islet Morphology Is Beneficial for Transplantation Outcome in Diabetic Mice	PLOS ONE			English	Article							MOUSE PANCREATIC-ISLETS; STEM-CELLS PREVENT; EXTRACELLULAR-MATRIX; INSULIN-SECRETION; GRAFT FUNCTION; ISOLATED RAT; BETA-CELLS; SHORT-TERM; REVASCULARIZATION; MASS	We have previously shown that co-transplantation of islets and Mesenchymal Stem Cells (MSCs) improves islet graft function and revascularisation, which was associated with the maintenance of normal islet morphology. The aim of the current study was to determine whether maintaining islet morphology in the absence of additional islet-helper cells would improve transplantation outcome in diabetic mice. Islets were isolated from C57BL/6 mice. Recipient streptozotocin-diabetic C57BL/6 mice were transplanted with a minimal mass of 150 islets as a single pellet or islets that were either manually dispersed or dispersed within a matrigel plug beneath the kidney capsule. Blood glucose concentrations were monitored for one month. Islet graft morphology and vascularisation were analysed by histology. Islets dispersed either alone or within matrigel plugs maintained near normal morphology, in contrast to pelleted islets, where individual islets fused to form large endocrine aggregates. The vascularisation of manually dispersed islets and islets dispersed within matrigel plugs was increased relative to respective control pelleted islet grafts. After one month 1/6 mice transplanted with pelleted islets cured compared to 5/6 mice transplanted with manually dispersed islets. The curative capacity of islets dispersed in matrigel was also better than that of pelleted islets (5/8 islet-matrigel implanted mice vs. 1/7 mice transplanted with pelleted islets cured by one month). Therefore, this study demonstrates that the maintenance of islet morphology is associated with improved graft function and revascularisation in diabetic mice.	[Rackham, Chloe L.; Jones, Peter M.; King, Aileen J. F.] Kings Coll London, Div Diabet & Nutr Sci, Sch Med, Diabet Res Grp, London WC2R 2LS, England	University of London; King's College London	Rackham, CL (corresponding author), Kings Coll London, Div Diabet & Nutr Sci, Sch Med, Diabet Res Grp, London WC2R 2LS, England.	chloe.rackham@kcl.ac.uk	King, Aileen/I-5935-2013; Rackham, Chloe/AAW-3941-2020	King, Aileen/0000-0001-5759-7985; Rackham, Chloe/0000-0003-4314-6109; Jones, Peter/0000-0003-1201-2335	Biotechnology and Biological Sciences Research Council; Novo Nordisk UK Research Foundation; Diabetes UK [06/0003387, 11/0004290]	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Novo Nordisk UK Research Foundation; Diabetes UK(Diabetes UK)	This work was supported by grants from the Biotechnology and Biological Sciences Research Council (CR), Novo Nordisk UK Research Foundation (A. K) and Diabetes UK (AK, PJ; 06/0003387; 11/0004290) for funding this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berman DM, 2010, DIABETES, V59, P2558, DOI 10.2337/db10-0136; Biarnes M, 2002, DIABETES, V51, P66, DOI 10.2337/diabetes.51.1.66; BOSCO D, 1989, EXP CELL RES, V184, P72, DOI 10.1016/0014-4827(89)90365-0; Brissova M, 2006, DIABETES, V55, P2974, DOI 10.2337/db06-0690; Carlsson PO, 2011, UPSALA J MED SCI, V116, P1, DOI 10.3109/03009734.2010.548609; Carlsson PO, 1998, DIABETES, V47, P1027, DOI 10.2337/diabetes.47.7.1027; Carvell MJ, 2007, CELL PHYSIOL BIOCHEM, V20, P617, DOI 10.1159/000107545; Christoffersson G, 2010, DIABETES, V59, P2569, DOI 10.2337/db10-0205; Davalli AM, 1996, DIABETES, V45, P1161, DOI 10.2337/diabetes.45.9.1161; Ding YC, 2009, DIABETES, V58, P1797, DOI 10.2337/db09-0317; DIONNE KE, 1993, DIABETES, V42, P12, DOI 10.2337/diabetes.42.1.12; Emamaullee JA, 2007, DIABETES, V56, P1289, DOI 10.2337/db06-1653; Figliuzzi M, 2009, TRANSPL P, V41, P1797, DOI 10.1016/j.transproceed.2008.11.015; Frisch SM, 2001, CURR OPIN CELL BIOL, V13, P555, DOI 10.1016/S0955-0674(00)00251-9; Gibly RF, 2011, DIABETOLOGIA, V54, P2494, DOI 10.1007/s00125-011-2243-0; Hammar E, 2004, DIABETES, V53, P2034, DOI 10.2337/diabetes.53.8.2034; Hauge-Evans AC, 2009, DIABETES, V58, P403, DOI 10.2337/db08-0792; Hughes CS, 2010, PROTEOMICS, V10, P1886, DOI 10.1002/pmic.200900758; Ito T, 2010, TRANSPLANTATION, V89, P1438, DOI 10.1097/TP.0b013e3181db09c4; Jalili RB, 2011, J CELL PHYSIOL, V226, P1813, DOI 10.1002/jcp.22515; Johansson M, 2009, ENDOCRINOLOGY, V150, P1646, DOI 10.1210/en.2008-1318; Kaido T, 2006, DIABETES, V55, P2723, DOI 10.2337/db06-0120; Kampf C, 2006, CELL TRANSPLANT, V15, P205, DOI 10.3727/000000006783982124; Kerby A, 2012, CYTOTHERAPY IN PRESS; King A, 2005, DIABETOLOGIA, V48, P2074, DOI 10.1007/s00125-005-1922-0; Lai Y, 2005, TRANSPLANTATION, V79, P1530, DOI 10.1097/01.TP.0000163506.40189.65; Lau J, 2009, TRANSPLANTATION, V87, P322, DOI 10.1097/TP.0b013e3181943b3d; Longoni B, 2010, DIABETES TECHNOL THE, V12, P435, DOI 10.1089/dia.2009.0154; Lund T, 2010, J SURG RES, V160, P145, DOI 10.1016/j.jss.2008.11.009; Mattsson G, 2002, DIABETES, V51, P1362, DOI 10.2337/diabetes.51.5.1362; Mattsson G, 2003, TRANSPLANTATION, V75, P736, DOI 10.1097/01.TP.0000052592.92966.FE; MENGER MD, 1992, EUR SURG RES, V24, P89, DOI 10.1159/000129193; Miao G, 2006, AM J TRANSPLANT, V6, P2636, DOI 10.1111/j.1600-6143.2006.01541.x; Morini S, 2007, J ANAT, V210, P565, DOI 10.1111/j.1469-7580.2007.00717.x; Nagata N, 2001, CELL TRANSPLANT, V10, P447; O'Sullivan ES, 2010, DIABETOLOGIA, V53, P937, DOI 10.1007/s00125-009-1653-8; Olsson R, 2005, DIABETOLOGIA, V48, P469, DOI 10.1007/s00125-004-1650-x; Perfetti R, 1996, PANCREAS, V13, P47, DOI 10.1097/00006676-199607000-00006; Pinkse GGM, 2006, DIABETES, V55, P312, DOI 10.2337/diabetes.55.02.06.db04-0195; Rackham CL, 2011, DIABETOLOGIA, V54, P1127, DOI 10.1007/s00125-011-2053-4; Rackham CL, 2012, CYTOTHERAPY IN PRESS; Salvay DM, 2008, TRANSPLANTATION, V85, P1456, DOI 10.1097/TP.0b013e31816fc0ea; Shapiro AMJ, 2011, CURR OPIN ORGAN TRAN, V16, P627, DOI 10.1097/MOT.0b013e32834cfb84; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; Solari MG, 2009, J AUTOIMMUN, V32, P116, DOI 10.1016/j.jaut.2009.01.003; Sordi V, 2010, STEM CELLS, V28, P140, DOI 10.1002/stem.259; SWARM RL, 1963, J NATL CANCER I, V31, P953; Thomas FT, 1999, SURGERY, V126, P299, DOI 10.1067/msy.1999.99164; VANDEIJNEN JHM, 1992, CELL TISSUE RES, V267, P139, DOI 10.1007/BF00318700; Zhao Y, 2010, TRANSPL P, V42, P4638, DOI 10.1016/j.transproceed.2010.09.154	50	20	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57844	10.1371/journal.pone.0057844	http://dx.doi.org/10.1371/journal.pone.0057844			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451276	Green Submitted, gold, Green Published			2022-12-25	WOS:000316849500139
J	Fogarty, MJ; Smallcombe, KL; Yanagawa, Y; Obata, K; Bellingham, MC; Noakes, PG				Fogarty, Matthew J.; Smallcombe, Karen L.; Yanagawa, Yuchio; Obata, Kunihiko; Bellingham, Mark C.; Noakes, Peter G.			Genetic Deficiency of GABA Differentially Regulates Respiratory and Non-Respiratory Motor Neuron Development	PLOS ONE			English	Article							GAMMA-AMINOBUTYRIC-ACID; PROGRAMMED CELL-DEATH; VESICULAR ACETYLCHOLINE TRANSPORTER; EMBRYO SPINAL-CORD; MOTONEURON SURVIVAL; NEUROMUSCULAR ACTIVITY; SYNAPTIC TRANSMISSION; STEREOLOGICAL METHODS; MICE LACKING; RAT-BRAIN	Central nervous system GABAergic and glycinergic synaptic activity switches from postsynaptic excitation to inhibition during the stage when motor neuron numbers are being reduced, and when synaptic connections are being established onto and by motor neurons. In mice this occurs between embryonic (E) day 13 and birth (postnatal day 0). Our previous work on mice lacking glycinergic transmission suggested that altered motor neuron activity levels correspondingly regulated motor neuron survival and muscle innervation for all respiratory and non respiratory motor neuron pools, during this period of development [1]. To determine if GABAergic transmission plays a similar role, we quantified motor neuron number and the extent of muscle innervation in four distinct regions of the brain stem and spinal cord; hypoglossal, phrenic, brachial and lumbar motor pools, in mice lacking the enzyme GAD67. These mice display a 90% drop in CNS GABA levels ( [2]; this study). For respiratory-based motor neurons (hypoglossal and phrenic motor pools), we have observed significant drops in motor neuron number (17% decline for hypoglossal and 23% decline for phrenic) and muscle innervations (55% decrease). By contrast for non-respiratory motor neurons of the brachial lateral motor column, we have observed an increase in motor neuron number (43% increase) and muscle innervations (99% increase); however for more caudally located motor neurons within the lumbar lateral motor column, we observed no change in either neuron number or muscle innervation. These results show in mice lacking physiological levels of GABA, there are distinct regional changes in motor neuron number and muscle innervation, which appear to be linked to their physiological function and to their rostral-caudal position within the developing spinal cord. Our results also suggest that for more caudal (lumbar) regions of the spinal cord, the effect of GABA is less influential on motor neuron development compared to that of glycine.	[Fogarty, Matthew J.; Smallcombe, Karen L.; Bellingham, Mark C.; Noakes, Peter G.] Univ Queensland, Sch Biomed Sci, Brisbane, Qld, Australia; [Noakes, Peter G.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia; [Yanagawa, Yuchio] Gunma Univ, Grad Sch Med, Maebashi, Gunma 371, Japan; [Yanagawa, Yuchio] CREST, Japan Sci & Technol Agcy, Tokyo, Japan; [Obata, Kunihiko] RIKEN Brain Sci Inst, Obata Res Unit, Saitama, Japan	University of Queensland; University of Queensland; Gunma University; Japan Science & Technology Agency (JST); RIKEN	Noakes, PG (corresponding author), Univ Queensland, Sch Biomed Sci, Brisbane, Qld, Australia.	p.noakes@uq.edu.au	Noakes, Peter/X-9825-2019; Bellingham, Mark/G-1697-2011	Noakes, Peter/0000-0001-9821-8478; Bellingham, Mark/0000-0001-9189-4430	NHMRC [568680]; MNDRI project grant; University of Queensland; Australian Government; MEXT, Japan; Takeda Science Foundation; ARC LIEF grant [LE100100074]	NHMRC(National Health and Medical Research Council (NHMRC) of Australia); MNDRI project grant; University of Queensland(University of Queensland); Australian Government(Australian GovernmentCGIAR); MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); ARC LIEF grant(Australian Research Council)	The work was funded by project grant 568680 from NHMRC to PGN and MCB, and by a MNDRI project grant to PGN. KLS was supported by postgraduate scholarship from the University of Queensland, and MJF was supported by and APA Scholarship from the Australian Government. YY was supported by a Grant-in aid for scientific research on innovative areas "Mesoscopic Neurocircuitry" and scientific research (B) from MEXT, Japan and Takeda Science Foundation. An ARC LIEF grant LE100100074 funded the stereology system. The authors declare no financial or commercial ties to the production or interpretation of this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allain AE, 2004, BRAIN RES, V1000, P134, DOI 10.1016/j.brainres.2003.11.071; Allain AE, 2006, J COMP NEUROL, V496, P832, DOI 10.1002/cne.20967; Arvidsson U, 1997, J COMP NEUROL, V378, P454; Asada H, 1997, P NATL ACAD SCI USA, V94, P6496, DOI 10.1073/pnas.94.12.6496; Bacskai T, 2012, BRAIN STRUCT FUNCT; Ballion B, 2002, DEV BRAIN RES, V137, P81, DOI 10.1016/S0165-3806(02)00414-5; Banks GB, 2001, J COMP NEUROL, V429, P156, DOI 10.1002/1096-9861(20000101)429:1<156::AID-CNE12>3.0.CO;2-3; Banks GB, 2005, J NEUROSCI, V25, P1249, DOI 10.1523/JNEUROSCI.1786-04.2005; Banks GB, 2003, DEV BIOL, V257, P71, DOI 10.1016/S0012-1606(03)00056-3; Banks GB, 2002, INT J DEV BIOL, V46, P551; Behar TN, 1996, J NEUROSCI, V16, P1808; Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; Bhumbra GS, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00008; Boyce RW, 2010, TOXICOL PATHOL, V38, P1011, DOI 10.1177/0192623310385140; Buss RR, 2006, ANNU REV NEUROSCI, V29, P1, DOI 10.1146/annurev.neuro.29.051605.112800; CLARKE PGH, 1995, METHOD CELL BIOL, V46, P277; DAHM LM, 1991, J NEUROSCI, V11, P238; DAHM LM, 1988, DEV BIOL, V130, P621, DOI 10.1016/0012-1606(88)90357-0; DING R, 1983, J NEUROCYTOL, V12, P887, DOI 10.1007/BF01153341; Drummond GB, 2009, J PHYSIOL-LONDON, V587, P713, DOI 10.1113/jphysiol.2008.167387; Dumoulin A, 2010, FRONT MOL NEUROSCI, V2, DOI 10.3389/neuro.02.028.2009; Duveau V, 2011, EUR J NEUROSCI, V34, P362, DOI 10.1111/j.1460-9568.2011.07782.x; Feng GP, 1998, SCIENCE, V282, P1321, DOI 10.1126/science.282.5392.1321; Ferraro E, 2012, J CACHEXIA SARCOPENI, V3, P13, DOI 10.1007/s13539-011-0041-7; Fortin G, 1999, NAT NEUROSCI, V2, P873, DOI 10.1038/13172; Fritschy JM, 2008, TRENDS NEUROSCI, V31, P257, DOI 10.1016/j.tins.2008.02.006; Gao BX, 2001, J NEUROPHYSIOL, V86, P492, DOI 10.1152/jn.2001.86.1.492; Gilmor ML, 1996, J NEUROSCI, V16, P2179; Glover JC, 2000, PHYSIOL REV, V80, P615, DOI 10.1152/physrev.2000.80.2.615; Gould TW, 2006, J NEUROSCI, V26, P8774, DOI 10.1523/JNEUROSCI.2315-06.2006; GUNDERSEN HJG, 1988, APMIS, V96, P379, DOI 10.1111/j.1699-0463.1988.tb05320.x; GUNDERSEN HJG, 1988, APMIS, V96, P857, DOI 10.1111/j.1699-0463.1988.tb00954.x; HALL ZW, 1993, CELL, V72, P99, DOI 10.1016/S0092-8674(05)80031-5; Hanson MG, 2003, J NEUROSCI, V23, P587, DOI 10.1523/JNEUROSCI.23-02-00587.2003; KIRSCH J, 1993, BRAIN RES, V621, P301, DOI 10.1016/0006-8993(93)90120-C; Kneussel M, 2000, P NATL ACAD SCI USA, V97, P8594, DOI 10.1073/pnas.97.15.8594; Kneussel M, 1999, J NEUROSCI, V19, P9289, DOI 10.1523/jneurosci.19-21-09289.1999; KOPRIWA BM, 1984, J HISTOCHEM CYTOCHEM, V32, P552, DOI 10.1177/32.5.6201530; LANCEJONES C, 1982, DEV BRAIN RES, V4, P473, DOI 10.1016/0165-3806(82)90192-4; LANDMESSER L, 1990, NEURON, V4, P655, DOI 10.1016/0896-6273(90)90193-J; LANDMESSER L, 1978, FED PROC, V37, P2016; LANDMESSER L, 1992, J NEUROBIOL, V23, P1131, DOI 10.1002/neu.480230906; Landmesser LT, 1998, CURR BIOL, V8, pR564, DOI 10.1016/S0960-9822(07)00362-4; Lin WC, 2001, NATURE, V410, P1057, DOI 10.1038/35074025; Lorenzo LE, 2006, EUR J NEUROSCI, V23, P3161, DOI 10.1111/j.1460-9568.2006.04863.x; Mantilla CB, 2008, J APPL PHYSIOL, V104, P1818, DOI 10.1152/japplphysiol.01192.2007; Maric HM, 2011, J BIOL CHEM, V286, P42105, DOI 10.1074/jbc.M111.303412; MCLENNAN IS, 1982, DEV BIOL, V92, P263, DOI 10.1016/0012-1606(82)90171-3; Moody WJ, 2005, PHYSIOL REV, V85, P883, DOI 10.1152/physrev.00017.2004; NARAYANAN CH, 1971, BEHAVIOUR, V40, P100, DOI 10.1163/156853971X00357; Nishimaru H, 2000, BRAIN RES BULL, V53, P661, DOI 10.1016/S0361-9230(00)00399-3; Nishimaru H, 1996, J PHYSIOL-LONDON, V497, P131, DOI 10.1113/jphysiol.1996.sp021755; NOAKES PG, 1993, DEV BIOL, V155, P275, DOI 10.1006/dbio.1993.1025; Noakes PG, 1999, J COMP NEUROL, V410, P531; Obata K, 2008, BIOCHEM BIOPH RES CO, V370, P429, DOI 10.1016/j.bbrc.2008.03.110; Oppenheim RW, 2008, DEV NEUROBIOL, V68, P972, DOI 10.1002/dneu.20636; Oppenheim RW, 2003, MOL CELL NEUROSCI, V22, P331, DOI 10.1016/S1044-7431(02)00020-9; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.ne.14.030191.002321; OPPENHEIM RW, 1982, NATURE, V295, P57, DOI 10.1038/295057a0; OPPENHEIM RW, 1989, DEVELOPMENT, V107, P331; OPPENHEIM RW, 1986, DEV BIOL, V114, P426, DOI 10.1016/0012-1606(86)90207-1; Oppenheim RW, 1997, J COMP NEUROL, V381, P353, DOI 10.1002/(SICI)1096-9861(19970512)381:3<353::AID-CNE7>3.0.CO;2-1; Oppenheim RW, 2000, J NEUROSCI, V20, P6117, DOI 10.1523/JNEUROSCI.20-16-06117.2000; OPPENHEIM RW, 1989, TRENDS NEUROSCI, V12, P252, DOI 10.1016/0166-2236(89)90021-0; Owens DF, 2002, NAT REV NEUROSCI, V3, P715, DOI 10.1038/nrn919; PITTMAN R, 1979, J COMP NEUROL, V187, P425, DOI 10.1002/cne.901870210; PITTMAN RH, 1978, NATURE, V271, P364, DOI 10.1038/271364a0; Porcher C, 2011, J BIOL CHEM, V286, P21667, DOI 10.1074/jbc.M110.201582; Rasband W.S., 1997, IMAGE J; Rekling JC, 2000, PHYSIOL REV, V80, P767, DOI 10.1152/physrev.2000.80.2.767; Ren J, 2003, J NEUROPHYSIOL, V89, P1187, DOI 10.1152/jn.00539.2002; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; Rozzo A, 2002, EUR J NEUROSCI, V15, P1747, DOI 10.1046/j.1460-9568.2002.02013.x; Sands SA, 2003, BRAIN RES, V972, P197, DOI 10.1016/S0006-8993(03)02534-4; Sibilla S, 2009, PROG NEUROBIOL, V89, P46, DOI 10.1016/j.pneurobio.2009.06.001; Singer JH, 2000, BRAIN RES BULL, V53, P553, DOI 10.1016/S0361-9230(00)00389-0; Tamamaki N, 2003, J COMP NEUROL, V467, P60, DOI 10.1002/cne.10905; TANG JC, 1993, J NEUROSCI, V13, P3095; Tsunekawa N, 2005, EUR J NEUROSCI, V21, P173, DOI 10.1111/j.1460-9568.2004.03860.x; Velez-Fort M, 2012, NEUROSCIENTIST, V18, P237, DOI 10.1177/1073858411403317; Waagepetersen HS, 1999, J NEUROCHEM, V73, P1335, DOI 10.1046/j.1471-4159.1999.0731335.x; Waterhouse EG, 2012, J NEUROSCI, V32, P14318, DOI 10.1523/JNEUROSCI.0709-12.2012; Watson C, 2009, SPINAL CORD: A CHRISTOPHER AND DANA REEVE FOUNDATION TEXT AND ATLAS, P1; Watson C, 2009, CHEMOARCHITECTURE AL; WEST MJ, 1993, NEUROBIOL AGING, V14, P275, DOI 10.1016/0197-4580(93)90112-O; West MJ, 1999, TRENDS NEUROSCI, V22, P51, DOI 10.1016/S0166-2236(98)01362-9; WOLFF JR, 1978, NATURE, V274, P72, DOI 10.1038/274072a0; Young SZ, 2012, J NEUROSCI, V32, P13630, DOI 10.1523/JNEUROSCI.2864-12.2012; Yvert B, 2004, J NEUROPHYSIOL, V91, P2101, DOI 10.1152/jn.01095.2003	89	19	20	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56257	10.1371/journal.pone.0056257	http://dx.doi.org/10.1371/journal.pone.0056257			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457538	gold, Green Submitted, Green Published			2022-12-25	WOS:000315603700034
J	Platzer, A				Platzer, Alexander			Visualization of SNPs with t-SNE	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; GENETIC-VARIATION; VALIDATION	Background: Single Nucleotide Polymorphisms (SNPs) are one of the largest sources of new data in biology. In most papers, SNPs between individuals are visualized with Principal Component Analysis (PCA), an older method for this purpose. Principal Findings: We compare PCA, an aging method for this purpose, with a newer method, t-Distributed Stochastic Neighbor Embedding (t-SNE) for the visualization of large SNP datasets. We also propose a set of key figures for evaluating these visualizations; in all of these t-SNE performs better. Significance: To transform data PCA remains a reasonably good method, but for visualization it should be replaced by a method from the subfield of dimension reduction. To evaluate the performance of visualization, we propose key figures of cross-validation with machine learning methods, as well as indices of cluster validity.	Gregor Mendel Inst, Vienna, Austria	Austrian Academy of Sciences; Vienna Biocenter (VBC); Gregor Mendel Institute of Molecular Plant Biology (GMI)	Platzer, A (corresponding author), Gregor Mendel Inst, Vienna, Austria.	alexander.platzer@gmi.oeaw.ac.at		Platzer, Alexander/0000-0002-2318-8806	Austrian Academy of Science	Austrian Academy of Science	Funding was provided by the Austrian Academy of Science (http://www.oeaw.ac.at/english/home.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman M, 2009, CLUSTERABILITY THEOR; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; [Anonymous], J STAT SOFTWARE; Asuncion A., 2010, UCI MACHINE LEARNING; Belkin M, 2002, ADV NEUR IN, V14, P585; Bellman R., 1961, ADAPTIVE CONTROL PRO; Brown P. F., 1992, Computational Linguistics, V18, P31; Christopher D, 2009, INTRO INFORM RETRIEV; Dunn J. C., 1973, Journal of Cybernetics, V3, P32, DOI 10.1080/01969727308546046; Frank E, 2004, BIOINFORMATICS, V20, P2479, DOI 10.1093/bioinformatics/bth261; Frank E, 1998, GENERATING ACCURATE; Globerson A, 2003, Journal of Machine Learning Research, V3, P1307, DOI 10.1162/153244303322753689; Halkidi M, 2001, J INTELL INF SYST, V17, P107, DOI 10.1023/A:1012801612483; Horton MW, 2012, NAT GENET, V44, P212, DOI 10.1038/ng.1042; Huang XH, 2012, NATURE, V490, P497, DOI 10.1038/nature11532; Hurtado MA, 2012, COMP BIOCH PHYSL B; Jarzynska G, 2011, ENVIRON INT, V37, P882, DOI 10.1016/j.envint.2011.02.017; Khalilia M, 2011, BMC MED INFORM DECIS, V11, DOI 10.1186/1472-6947-11-51; Laurens van der Maaten EP, 2009, DIMENSIONALITY REDUC; Lin W.J., 2012, BRIEF BIOINFORM; Lu HP, 2008, IEEE T NEURAL NETWOR, V19, P18, DOI 10.1109/TNN.2007.901277; Nothnagel M, 2010, HUM MOL GENET, V19, P2927, DOI 10.1093/hmg/ddq198; Pau G, 2010, ITALY COMPUTATIONAL; Pearson K, 1901, PHILOS MAG, V2, P559, DOI 10.1080/14786440109462720; Quinlan J.R., 1993, C4 5 PROGRAMS MACHIN; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Roweis ST, 2000, SCIENCE, V290, P2323, DOI 10.1126/science.290.5500.2323; Rumelhart G.E., 1986, PARALLEL DISTRIBUTED, P318, DOI DOI 10.1016/B978-1-4832-1446-7.50035-2; SAMMON JW, 1969, IEEE T COMPUT, VC 18, P401, DOI 10.1109/T-C.1969.222678; Sharbel TF, 2000, MOL ECOL, V9, P2109, DOI 10.1046/j.1365-294X.2000.01122.x; Sun ZF, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-84; Swingley WD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038108; Tenenbaum JB, 2000, SCIENCE, V290, P2319, DOI 10.1126/science.290.5500.2319; Tibshirani R, 2001, J ROY STAT SOC B, V63, P411, DOI 10.1111/1467-9868.00293; TORGERSON WS, 1952, PSYCHOMETRIKA, V17, P401; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Weigel D, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-107; Xie B, 2010, LECT NOTES COMPUT SC, V6443, P338, DOI 10.1007/978-3-642-17537-4_42; Yu ZZ, 2012, NEPHROL DIAL TRANSPL, V27, P4437, DOI 10.1093/ndt/gfs075; Zhang H, 2005, INT J PATTERN RECOGN, V19, P183, DOI 10.1142/S0218001405003983; Zhou H, 2012, J ZHEJIANG UNIV-SC B, V13, P438, DOI 10.1631/jzus.B1200003	41	46	46	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56883	10.1371/journal.pone.0056883	http://dx.doi.org/10.1371/journal.pone.0056883			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457633	Green Published, Green Submitted, gold			2022-12-25	WOS:000315603700093
J	Smith, BT; Klicka, J				Smith, Brian Tilston; Klicka, John			Examining the Role of Effective Population Size on Mitochondrial and Multilocus Divergence Time Discordance in a Songbird	PLOS ONE			English	Article							SPECIES TREES; MUTATION-RATE; GENE TREES; DNA; EVOLUTION; ISLAND; SUBSTITUTION; DIVERSITY; INFERENCE; SUPPORT	Estimates of speciation times are subject to a number of potential errors. One source of bias is that effective population size (N-e) has been shown to influence substitution rates. This issue is of particular interest for phylogeographic studies because population sizes can vary dramatically among genetically structured populations across species' ranges. In this study, we used multilocus data to examine temporal phylogeographic patterns in a widespread North American songbird, the Northern Cardinal (Cardinalis cardinalis). Species tree estimation indicated that the phylogeographic structure of C. cardinalis was comprised of four well-supported mainland lineages with large population sizes (large N-e) and two island lineages comprised of much smaller populations (small N-e). We inferred speciation times from mtDNA and multilocus data and found there was discordance between events that represented island-mainland divergences, whereas both estimates were similar for divergences among mainland lineages. We performed coalescent simulations and found that the difference in speciation times could be attributed to stochasticity for a recently diverged island lineage. However, the magnitude of the change between speciation times estimated from mtDNA and multilocus data of an older island lineage was substantially greater than predicted by coalescent simulations. For this divergence, we found the discordance in time estimates was due to a substantial increase in the mtDNA substitution rate in the small island population. These findings indicate that in phylogeographic studies the relative tempo of evolution between mtDNA and nuclear DNA can become highly discordant in small populations.	[Smith, Brian Tilston] Univ Nevada, Sch Life Sci, Las Vegas, NV 89154 USA; [Smith, Brian Tilston; Klicka, John] Univ Nevada, Marjorie Barrick Museum Nat Hist, Las Vegas, NV 89154 USA	Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; Nevada System of Higher Education (NSHE); University of Nevada Las Vegas	Smith, BT (corresponding author), Louisiana State Univ, Museum Nat Sci, Baton Rouge, LA 70803 USA.	briantilstonsmith@gmail.com			UNLV International Studies Scholarship; UNLV GPSA grant; AMNH Chapman Grant	UNLV International Studies Scholarship; UNLV GPSA grant; AMNH Chapman Grant	This work was partially funded by a UNLV International Studies Scholarship, a UNLV GPSA grant, and an AMNH Chapman Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avise JC, 1998, P ROY SOC B-BIOL SCI, V265, P1707, DOI 10.1098/rspb.1998.0492; Axelsson E, 2004, MOL BIOL EVOL, V21, P1538, DOI 10.1093/molbev/msh157; Bromham L, 2005, MOL BIOL EVOL, V22, P1393, DOI 10.1093/molbev/msi133; Bryson RW, 2010, EVOLUTION, V64, P2315, DOI 10.1111/j.1558-5646.2010.01014.x; Cabanne GS, 2013, J ORNITHOL, V154, P371, DOI 10.1007/s10336-012-0901-8; Carling MD, 2008, GENETICS, V178, P363, DOI 10.1534/genetics.107.076422; Creevey CJ, 2003, BIOINFORMATICS, V19, P1726, DOI 10.1093/bioinformatics/btg225; Degnan JH, 2009, TRENDS ECOL EVOL, V24, P332, DOI 10.1016/j.tree.2009.01.009; DESALLE R, 1988, EVOLUTION, V42, P1076, DOI 10.1111/j.1558-5646.1988.tb02525.x; Dmitriev DA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000113; EASTEAL S, 1994, MOL BIOL EVOL, V11, P643; Edwards SV, 2000, EVOLUTION, V54, P1839; Halkin SL, 1999, BIRDS N AM ONLINE; Heads M, 2011, SYST BIOL, V60, P204, DOI 10.1093/sysbio/syq075; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; Heslewood MM, 1998, ELECTROPHORESIS, V19, P142, DOI 10.1002/elps.1150190203; Hey J, 2007, P NATL ACAD SCI USA, V104, P2785, DOI 10.1073/pnas.0611164104; Ho SYW, 2005, MOL BIOL EVOL, V22, P1561, DOI 10.1093/molbev/msi145; Johnson KP, 2001, MOL BIOL EVOL, V18, P874, DOI 10.1093/oxfordjournals.molbev.a003869; Kimball RT, 2009, MOL PHYLOGENET EVOL, V50, P654, DOI 10.1016/j.ympev.2008.11.018; KIMURA M, 1962, GENETICS, V47, P713; Klicka J, 2007, MOL PHYLOGENET EVOL, V45, P1014, DOI 10.1016/j.ympev.2007.07.006; Ksepka DT, 2009, CLADISTICS, V25, P173, DOI 10.1111/j.1096-0031.2009.00250.x; Liu L, 2007, SYST BIOL, V56, P504, DOI 10.1080/10635150701429982; Lovette IJ, 2004, AUK, V121, P1, DOI 10.1642/0004-8038(2004)121[0001:MDAMSF]2.0.CO;2; Maddison WP, 2009, MESQUITE MODULAR SYS; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; MCCLOY C, 1988, MAR MICROPALEONTOL, V13, P193, DOI 10.1016/0377-8398(88)90003-5; McCormack JE, 2011, EVOLUTION, V65, P184, DOI 10.1111/j.1558-5646.2010.01097.x; Nylander J., 2004, MRMODELTEST V 2 3; OHTA T, 1972, J MOL EVOL, V1, P305, DOI 10.1007/BF01653959; Peters JL, 2012, MOL ECOL, V21, P3562, DOI 10.1111/j.1365-294X.2012.05612.x; Peterson GI, 2009, MOL BIOL EVOL, V26, P2595, DOI 10.1093/molbev/msp175; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Primmer CR, 2002, MOL ECOL, V11, P603, DOI 10.1046/j.0962-1083.2001.01452.x; Rannala B, 2003, GENETICS, V164, P1645; Reid N, 2012, SYST BIOL, V61, P44, DOI 10.1093/sysbio/syr094; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; SLADE RW, 1993, MOL ECOL, V2, P359, DOI 10.1111/j.1365-294X.1993.tb00029.x; Smith BT, 2013, MOL ECOL, V22, P483, DOI 10.1111/mec.12118; Smith BT, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-136; Smith BT, 2010, ECOGRAPHY, V33, P333, DOI 10.1111/j.1600-0587.2009.06335.x; Spaw R.H., 1978, GULF COAST ASS GEOLO, V28, P601, DOI [10.1306/2fa1add9aa-0dfe-11d7-8641000102c1865d, DOI 10.1306/2FA1ADD9AA-0DFE-11D7-8641000102C1865D]; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Swofford D.L., 2002, PAUP V 4 0B10 PHYLOG; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Woolfit M, 2005, P ROY SOC B-BIOL SCI, V272, P2277, DOI 10.1098/rspb.2005.3217; Woolfit M, 2003, MOL BIOL EVOL, V20, P1545, DOI 10.1093/molbev/msg167; Woolfit M, 2009, BIOL LETTERS, V5, P417, DOI 10.1098/rsbl.2009.0155; Wright SD, 2009, EVOLUTION, V63, P2275, DOI 10.1111/j.1558-5646.2009.00717.x; Zink RM, 2008, MOL ECOL, V17, P2107, DOI 10.1111/j.1365-294X.2008.03737.x	51	33	34	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e55161	10.1371/journal.pone.0055161	http://dx.doi.org/10.1371/journal.pone.0055161			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457463	gold, Green Published, Green Submitted			2022-12-25	WOS:000315603700010
J	Liu, DS; Loh, KH; Lam, SS; White, KA; Ting, AY				Liu, Daniel S.; Loh, Ken H.; Lam, Stephanie S.; White, Katharine A.; Ting, Alice Y.			Imaging Trans-Cellular Neurexin-Neuroligin Interactions by Enzymatic Probe Ligation	PLOS ONE			English	Article							ACTIVITY-DEPENDENT REGULATION; PROTEIN-PROTEIN INTERACTIONS; LIVING CELLS; MONOVALENT STREPTAVIDIN; SYNAPSE DEVELOPMENT; NEURONS; SITE; BIOTINYLATION; LIGASE; CYCLOADDITION	Neurexin and neuroligin are transmembrane adhesion proteins that play an important role in organizing the neuronal synaptic cleft. Our lab previously reported a method for imaging the trans-synaptic binding of neurexin and neuroligin called BLINC (Biotin Labeling of INtercellular Contacts). In BLINC, biotin ligase (BirA) is fused to one protein while its 15-amino acid acceptor peptide substrate (AP) is fused to the binding partner. When the two fusion proteins interact across cellular junctions, BirA catalyzes the site-specific biotinylation of AP, which can be read out by staining with streptavidin-fluorophore conjugates. Here, we report that BLINC in neurons cannot be reproduced using the reporter constructs and labeling protocol previously described. We uncover the technical reasons for the lack of reproducibilty and then re-design the BLINC reporters and labeling protocol to achieve neurexin-neuroligin BLINC imaging in neuron cultures. In addition, we introduce a new method, based on lipoic acid ligase instead of biotin ligase, to image trans-cellular neurexin-neuroligin interactions in human embryonic kidney cells and in neuron cultures. This method, called ID-PRIME for Interaction-Dependent PRobe Incorporation Mediated by Enzymes, is more robust than BLINC due to higher surface expression of lipoic acid ligase fusion constructs, gives stronger and more localized labeling, and is more versatile than BLINC in terms of signal readout. ID-PRIME expands the toolkit of methods available to study trans-cellular protein-protein interactions in living systems.	[Liu, Daniel S.; Loh, Ken H.; Lam, Stephanie S.; White, Katharine A.; Ting, Alice Y.] MIT, Dept Chem, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Ting, AY (corresponding author), MIT, Dept Chem, Cambridge, MA 02139 USA.	ating@mit.edu	White, Katharine A./X-9101-2019; White, Katharine/G-8700-2013	White, Katharine A./0000-0002-5831-1886; Ting, Alice/0000-0002-8277-5226	National Institutes of Health [DP1 OD003961]; NATIONAL CANCER INSTITUTE [P30CA014051] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003961] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding for this work was provided by the National Institutes of Health (DP1 OD003961). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arac D, 2007, NEURON, V56, P992, DOI 10.1016/j.neuron.2007.12.002; Baruah H, 2008, ANGEW CHEM INT EDIT, V47, P7018, DOI 10.1002/anie.200802088; Beckett D, 1999, PROTEIN SCI, V8, P921, DOI 10.1110/ps.8.4.921; Bot N, 2011, J BIOL CHEM, V286, P2762, DOI 10.1074/jbc.M110.142521; Chan TR, 2004, ORG LETT, V6, P2853, DOI 10.1021/ol0493094; Chih B, 2006, NEURON, V51, P171, DOI 10.1016/j.neuron.2006.06.005; Craig AM, 2007, CURR OPIN NEUROBIOL, V17, P43, DOI 10.1016/j.conb.2007.01.011; Dalby B, 2004, METHODS, V33, P95, DOI 10.1016/j.ymeth.2003.11.023; Fairless R, 2008, J NEUROSCI, V28, P12969, DOI 10.1523/JNEUROSCI.5294-07.2008; Feinberg EH, 2008, NEURON, V57, P353, DOI 10.1016/j.neuron.2007.11.030; Fernandez-Suarez M, 2008, J AM CHEM SOC, V130, P9251, DOI 10.1021/ja801445p; Fu Y, 2010, P NATL ACAD SCI USA, V107, P22699, DOI 10.1073/pnas.1011233108; Graf ER, 2004, CELL, V119, P1013, DOI 10.1016/j.cell.2004.11.035; Graf ER, 2006, J NEUROSCI, V26, P4256, DOI 10.1523/JNEUROSCI.1253-05.2006; Howarth M, 2006, NAT METHODS, V3, P267, DOI 10.1038/NMETH861; Howarth M, 2008, NAT PROTOC, V3, P534, DOI 10.1038/nprot.2008.20; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Kerppola TK, 2006, NAT REV MOL CELL BIO, V7, P449, DOI 10.1038/nrm1929; Koehnke J, 2010, NEURON, V67, P61, DOI 10.1016/j.neuron.2010.06.001; Kwon K, 2000, PROTEIN SCI, V9, P1530, DOI 10.1110/ps.9.8.1530; Liu DS, 2012, J AM CHEM SOC, V134, P792, DOI 10.1021/ja209325n; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Peixoto RT, 2012, NEURON, V76, P396, DOI 10.1016/j.neuron.2012.07.006; Puthenveetil S, 2009, J AM CHEM SOC, V131, P16430, DOI 10.1021/ja904596f; Rathbone MP, 1999, PROG NEUROBIOL, V59, P663, DOI 10.1016/S0301-0082(99)00017-9; Saura CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019430; Siddiqui TJ, 2010, J NEUROSCI, V30, P7495, DOI 10.1523/JNEUROSCI.0470-10.2010; Slavoff SA, 2011, J AM CHEM SOC, V133, P19769, DOI 10.1021/ja206435e; Suzuki K, 2012, NEURON, V76, P410, DOI 10.1016/j.neuron.2012.10.003; Tanaka H, 2012, CELL REPORTS, V2, P101, DOI 10.1016/j.celrep.2012.06.009; Taniguchi H, 2007, J NEUROSCI, V27, P2815, DOI 10.1523/JNEUROSCI.0032-07.2007; Thyagarajan A, 2010, CELL, V143, P456, DOI 10.1016/j.cell.2010.09.025; Uttamapinant C, 2012, ANGEW CHEM INT EDIT, V51, P5852, DOI 10.1002/anie.201108181; Uttamapinant C, 2010, P NATL ACAD SCI USA, V107, P10914, DOI 10.1073/pnas.0914067107; Wheeler DG, 2001, J BIOL CHEM, V276, P31978, DOI 10.1074/jbc.M103667200; White KA, 2012, THESIS MIT CAMBRIDGE; Yamagata M, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00018; Yao JZ, 2012, J AM CHEM SOC, V134, P3720, DOI 10.1021/ja208090p	38	34	35	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e52823	10.1371/journal.pone.0052823	http://dx.doi.org/10.1371/journal.pone.0052823			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457442	Green Published, gold, Green Submitted			2022-12-25	WOS:000315602700002
J	Seppala, EH; Reuser, AJJ; Lohi, H				Seppala, Eija H.; Reuser, Arnold J. J.; Lohi, Hannes			A Nonsense Mutation in the Acid alpha-Glucosidase Gene Causes Pompe Disease in Finnish and Swedish Lapphunds	PLOS ONE			English	Article							GLYCOGEN-STORAGE-DISEASE; ITALIAN PATIENTS; MODEL	Pompe disease is a recessively inherited and often fatal disorder caused by the deficiency of acid alpha-glucosidase, an enzyme encoded by the GAA gene and needed to break down glycogen in lysosomes. This glycogen storage disease type II has been reported also in Swedish Lapphund dogs. Here we describe the genetic defect in canine Pompe disease and show that three related breeds from Scandinavia carry the same mutation. The affected dogs are homozygous for the GAA c.2237G>A mutation leading to a premature stop codon at amino acid position 746. The corresponding mutation has previously been reported in humans and causes infantile Pompe disease in combination with a second fully deleterious mutation. The affected dogs from both the Finnish as well as the Swedish breed mimic infantile-onset Pompe disease genetically, but also clinico-pathologically. Therefore this canine model provides a valuable tool for preclinical studies aimed at the development of gene therapy in Pompe disease.	[Seppala, Eija H.; Lohi, Hannes] Univ Helsinki, Res Programs Unit, Helsinki, Finland; [Seppala, Eija H.; Lohi, Hannes] Univ Helsinki, Dept Vet Biosci, Helsinki, Finland; [Seppala, Eija H.; Lohi, Hannes] Univ Helsinki, Dept Med Genet, Helsinki, Finland; [Seppala, Eija H.; Lohi, Hannes] Folkhalsan Inst Genet, Helsinki, Finland; [Reuser, Arnold J. J.] Erasmus MC, Ctr Lysosomal & Metab Dis, Dept Clin Genet, Rotterdam, Netherlands; [Reuser, Arnold J. J.] Erasmus MC, Ctr Lysosomal & Metab Dis, Dept Paediat, Rotterdam, Netherlands	University of Helsinki; University of Helsinki; University of Helsinki; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Lohi, H (corresponding author), Univ Helsinki, Res Programs Unit, Helsinki, Finland.	hannes.lohi@helsinki.fi	Lohi, Hannes/F-4596-2011	Lohi, Hannes/0000-0003-1087-5532	Academy of Finland; Sigrid Juselius Foundation; Jane and Aatos Erkko Foundation	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Jane and Aatos Erkko Foundation	This study was funded by the Academy of Finland, the Sigrid Juselius Foundation and The Jane and Aatos Erkko Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bali DS, 2011, MUSCLE NERVE, V43, P665, DOI 10.1002/mus.21933; Beesley C E, 1998, Hum Mutat, V11, P413, DOI 10.1002/(SICI)1098-1004(1998)11:5<413::AID-HUMU16>3.0.CO;2-I; Chiara A, 2008, NEUROLOGY, V70, P617, DOI 10.1212/01.wnl.0000299892.81127.8e; Dennis JA, 2000, MAMM GENOME, V11, P206, DOI 10.1007/s003350010038; Hirschhorn R, 2001, METABOLIC MOL BASES, P3389; HUDGSON P, 1968, BRAIN, V91, P435, DOI 10.1093/brain/91.3.435; Jackson T, 2003, FINNISH LAPPHUND COM, P9; Kishnani PS, 2007, NEUROLOGY, V68, P99, DOI 10.1212/01.wnl.0000251268.41188.04; Kishnani PS, 2012, AM J MED GENET C, V160C, P1, DOI [10.1002/ajmc.31324, 10.1002/ajmg.c.31324]; Kroos M, 2012, AM J MED GENET C, V160C, P59, DOI [10.1002/ajmg.c.31318, 10.1002/ajmc.31318]; MANKTELOW BW, 1975, J COMP PATHOL, V85, P139, DOI 10.1016/0021-9975(75)90092-4; MATSUI T, 1983, VET PATHOL, V20, P312, DOI 10.1177/030098588302000307; Montalvo ALE, 2006, HUM MUTAT, V27, P999, DOI 10.1002/humu.20374; MOSTAFA IE, 1970, ACTA VET SCAND, V11, P197; OSULLIVAN BM, 1981, AUST VET J, V57, P227, DOI 10.1111/j.1751-0813.1981.tb02666.x; Pittis M G, 2008, Hum Mutat, V29, pE27, DOI 10.1002/humu.20753; Pittis MG, 2003, AM J MED GENET A, V121A, P225, DOI 10.1002/ajmg.a.20164; Pompe JC, 1932, NED TIJDSCHR GENEESK, V76, P304; SANDSTROM B, 1969, ACTA NEUROPATHOL, V14, P194, DOI 10.1007/BF00685299; van der Ploeg AT, 2010, NEW ENGL J MED, V362, P1396, DOI 10.1056/NEJMoa0909859; WALVOORT HC, 1984, AM J MED GENET, V19, P589, DOI 10.1002/ajmg.1320190323; WALVOORT HC, 1985, J INHERIT METAB DIS, V8, P38, DOI 10.1007/BF01805484; WALVOORT HC, 1984, J AM ANIM HOSP ASSOC, V20, P279; WALVOORT HC, 1985, VET QUART, V7, P187, DOI 10.1080/01652176.1985.9693981; WALVOORT HC, 1982, BIOCHIM BIOPHYS ACTA, V715, P63, DOI 10.1016/0304-4165(82)90050-2; WALVOORT HC, 1981, BERL MUNCH TIERARZTL, V94, P39	26	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56825	10.1371/journal.pone.0056825	http://dx.doi.org/10.1371/journal.pone.0056825			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457621	Green Published, Green Submitted, gold			2022-12-25	WOS:000315602700097
J	Ling, LS; Voskas, D; Woodgett, JR				Ling, L. S.; Voskas, D.; Woodgett, J. R.			Activation of PDK-1 maintains mouse embryonic stem cell self-renewal in a PKB-dependent manner	ONCOGENE			English	Article						PDK-1; GSK-3; embryonic stem cell; pluripotency	PROTEIN-KINASE-B; BETA-CATENIN; PHOSPHATIDYLINOSITOL 3-KINASES; INSULIN; PLURIPOTENCY; PHOSPHORYLATION; INHIBITION; GROWTH; AKT; PROLIFERATION	The phosphatidylinositol 30 kinase (PI3K) pathway is involved in many cellular processes including cell proliferation, survival and glucose transport, and is implicated in various disease states, such as cancer and diabetes. Although there have been numerous studies dissecting the role of PI3K signaling in different cell types and disease models, the mechanism by which PI3K signaling regulates embryonic stem (ES) cell fate remains unclear. It is believed that in addition to proliferation and tumorigenesis, PI3K activity may also be important for ES cell self-renewal. Paling et al. reported that the inhibition of PI3K led to a reduction in the ability of leukemia inhibitory factor to maintain self-renewal, causing cells to differentiate. Studies in our lab have revealed that ES cells completely lacking glycogen synthase kinase-3 (GSK-3) remain undifferentiated compared with wild-type ES cells. GSK-3 is negatively regulated by PI3K, suggesting that PI3K may have a vital role in maintaining pluripotency in ES cells through GSK-3. By using a modified Flp recombinase system, we expressed activated alleles of 3-phosphoinositide-dependent protein kinase-1 and protein kinase B to create stable, isogenic ES cell lines to further study the role of the PI3K signaling pathway in stem cell fate determination. In vitro characterization of the transgenic cell lines revealed a strong tendency toward the maintenance of pluripotency, and this phenotype was found to be independent of canonical Wnt signal transduction. In summary, PI3K signaling is sufficient to maintain the self-renewal and survival of stem cells. As this pathway is frequently mutationally activated in cancers, its effect on suppressing differentiation may contribute to its oncogenicity.	[Ling, L. S.; Woodgett, J. R.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Ling, L. S.; Voskas, D.; Woodgett, J. R.] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Woodgett, JR (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, 600 Univ Ave,Room 982, Toronto, ON M5G 1X5, Canada.	woodgett@lunenfeld.ca	Woodgett, Jim/F-1087-2010	Woodgett, Jim/0000-0003-3731-5797	NSERC Canada Graduate Scholarship; Heart and Stroke Foundation of Canada Fellowship; CIHR [FRN 12858]	NSERC Canada Graduate Scholarship(Natural Sciences and Engineering Research Council of Canada (NSERC)); Heart and Stroke Foundation of Canada Fellowship(Heart & Stroke Foundation of Canada); CIHR(Canadian Institutes of Health Research (CIHR))	We thank Brad Doble for generously sharing reagents and protocols, Malgosia Kownacka for providing feeder cells, Mike Parsons and Elizabeth Rubie for technical expertise and advice, and Eric Ho and Satish Patel for troubleshooting and helpful discussions. LSL was supported by a NSERC Canada Graduate Scholarship and DV was supported by a Heart and Stroke Foundation of Canada Fellowship. These studies were funded by a CIHR operating grant (FRN 12858).	Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Armstrong L, 2006, HUM MOL GENET, V15, P1894, DOI 10.1093/hmg/ddl112; Bader AG, 2005, NAT REV CANCER, V5, P921, DOI 10.1038/nrc1753; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Desbois-Mouthon C, 2001, ONCOGENE, V20, P252, DOI 10.1038/sj.onc.1204064; Ding VW, 2000, J BIOL CHEM, V275, P32475, DOI 10.1074/jbc.M005342200; Doble BW, 2007, DEV CELL, V12, P957, DOI 10.1016/j.devcel.2007.04.001; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Gu DY, 2007, FEBS LETT, V581, P382, DOI 10.1016/j.febslet.2006.12.043; Hawkins PT, 2006, BIOCHEM SOC T, V34, P647, DOI 10.1042/BST0340647; He XC, 2004, NAT GENET, V36, P1117, DOI 10.1038/ng1430; Huang H, 2008, CURR OPIN CELL BIOL, V20, P119, DOI 10.1016/j.ceb.2008.01.009; Ishibe S, 2006, MOL CELL BIOL, V26, P9232, DOI 10.1128/MCB.01312-06; Jirmanova L, 2002, ONCOGENE, V21, P5515, DOI 10.1038/sj.onc.1205728; Kingham E, 2009, J CELL SCI, V122, P2311, DOI 10.1242/jcs.046557; Kobielak K, 2007, P NATL ACAD SCI USA, V104, P10063, DOI 10.1073/pnas.0703004104; Lianguzova MS, 2007, CELL BIOL INT, V31, P330, DOI 10.1016/j.cellbi.2007.01.019; Lin YJ, 2012, MOL CELL, V48, P627, DOI 10.1016/j.molcel.2012.08.030; Logie L, 2007, DIABETES, V56, P2218, DOI 10.2337/db07-0343; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Maes C, 2010, EMBO J, V29, P424, DOI 10.1038/emboj.2009.361; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; McManus EJ, 2005, EMBO J, V24, P1571, DOI 10.1038/sj.emboj.7600633; Mora A, 2004, SEMIN CELL DEV BIOL, V15, P161, DOI 10.1016/j.semcdb.2003.12.022; Murakami M, 2004, MOL CELL BIOL, V24, P6710, DOI 10.1128/mcb.24.15.6710-6718.2004; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Ng SW, 2009, J BIOL CHEM, V284, P24767, DOI 10.1074/jbc.M109.011692; Niwa H, 2009, NATURE, V460, P118, DOI 10.1038/nature08113; Orlando L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030234; Paling NRD, 2004, J BIOL CHEM, V279, P48063, DOI 10.1074/jbc.M406467200; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Scheid MP, 2001, NAT REV MOL CELL BIO, V2, P760, DOI 10.1038/35096067; Scheid MP, 2005, MOL CELL BIOL, V25, P2347, DOI 10.1128/MCB.25.6.2347-2363.2005; Storm MP, 2009, STEM CELLS, V27, P764, DOI 10.1002/stem.3; Sun H, 1999, P NATL ACAD SCI USA, V96, P6199, DOI 10.1073/pnas.96.11.6199; Takahashi K, 2005, BIOCHEM SOC T, V33, P1522, DOI 10.1042/BST0331522; Watanabe S, 2006, ONCOGENE, V25, P2697, DOI 10.1038/sj.onc.1209307; Wu G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004926; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Zhao JJ, 2005, P NATL ACAD SCI USA, V102, P18443, DOI 10.1073/pnas.0508988102	40	13	13	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 21	2013	32	47					5397	5408		10.1038/onc.2013.44	http://dx.doi.org/10.1038/onc.2013.44			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	254PM	23455320	Green Published, hybrid			2022-12-25	WOS:000327177600003
J	Edwards, M; Beaugrand, G; Helaouet, P; Alheit, J; Coombs, S				Edwards, Martin; Beaugrand, Gregory; Helaouet, Pierre; Alheit, Juergen; Coombs, Stephen			Marine Ecosystem Response to the Atlantic Multidecadal Oscillation	PLOS ONE			English	Article							NORTH-ATLANTIC; LONG-TERM; SUBPOLAR GYRE; REGIME SHIFT; CLIMATE; SEA; OCEAN; FLUCTUATIONS; BIODIVERSITY; VARIABILITY	Against the backdrop of warming of the Northern Hemisphere it has recently been acknowledged that North Atlantic temperature changes undergo considerable variability over multidecadal periods. The leading component of natural low-frequency temperature variability has been termed the Atlantic Multidecadal Oscillation (AMO). Presently, correlative studies on the biological impact of the AMO on marine ecosystems over the duration of a whole AMO cycle (similar to 60 years) is largely unknown due to the rarity of continuously sustained biological observations at the same time period. To test whether there is multidecadal cyclic behaviour in biological time-series in the North Atlantic we used one of the world's longest continuously sustained marine biological time-series in oceanic waters, long-term fisheries data and historical records over the last century and beyond. Our findings suggest that the AMO is far from a trivial presence against the backdrop of continued temperature warming in the North Atlantic and accounts for the second most important macro-trend in North Atlantic plankton records; responsible for habitat switching (abrupt ecosystem/regime shifts) over multidecadal scales and influences the fortunes of various fisheries over many centuries.	[Edwards, Martin; Helaouet, Pierre] Sir Alister Hardy Fdn Ocean Sci, The Laboratory, Plymouth, Devon, England; [Edwards, Martin] Univ Plymouth, Inst Marine, Plymouth PL4 8AA, Devon, England; [Beaugrand, Gregory] Univ Sci & Technol Lille 1, Stn Marine, CNRS, LOG,UMR 8187, Wimereux, France; [Alheit, Juergen] Univ Rostock, Balt Sea Res Inst, Warnemunde, Germany; [Coombs, Stephen] Marine Biol Assoc UK, The Laboratory, Plymouth, Devon, England	University of Plymouth; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Universite de Lille - ISITE; Universite de Lille; Leibniz Institut fur Ostseeforschung Warnemunde; University of Rostock; Marine Biological Association United Kingdom	Edwards, M (corresponding author), Sir Alister Hardy Fdn Ocean Sci, The Laboratory, Citadel Hill, Plymouth, Devon, England.	maed@sahfos.ac.uk		BEAUGRAND, GREGORY/0000-0002-0712-5223; Helaouet, Pierre/0000-0001-6102-7379	Canada (Department of Fisheries and Oceans); United Kingdom (Department for Environment, Food and Rural Affairs and National Environmental Research Council); USA (National Science Foundation); UK DEFRA; UK NERC; German Federal Ministry for Education and Research through the ECODRIVE project; EU through the FACTS project; Norway (Institute of Marine Research); Division Of Ocean Sciences [1154661] Funding Source: National Science Foundation	Canada (Department of Fisheries and Oceans); United Kingdom (Department for Environment, Food and Rural Affairs and National Environmental Research Council); USA (National Science Foundation)(National Science Foundation (NSF)); UK DEFRA(Department for Environment, Food & Rural Affairs (DEFRA)); UK NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); German Federal Ministry for Education and Research through the ECODRIVE project; EU through the FACTS project; Norway (Institute of Marine Research); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	A funding consortium made up of governmental agencies from Canada (Department of Fisheries and Oceans), Norway (Institute of Marine Research), the United Kingdom (Department for Environment, Food and Rural Affairs and National Environmental Research Council) and the USA (National Science Foundation) financially supports the CPR survey. Main support for this work was provided by UK DEFRA and UK NERC. J.A. received funding from the German Federal Ministry for Education and Research through the ECODRIVE project and from the EU through the FACTS project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alheit J, 1997, FISH OCEANOGR, V6, P130, DOI 10.1046/j.1365-2419.1997.00035.x; Beare D, 2004, GLOBAL CHANGE BIOL, V10, P1209, DOI 10.1111/j.1529-8817.2003.00790.x; Beaugrand G, 2000, MAR ECOL PROG SER, V204, P299, DOI 10.3354/meps204299; Beaugrand G, 2002, SCIENCE, V296, P1692, DOI 10.1126/science.1071329; Beaugrand G, 2008, ECOL LETT, V11, P1157, DOI 10.1111/j.1461-0248.2008.01218.x; Cannaby H, 2009, ICES J MAR SCI, V66, P1480, DOI 10.1093/icesjms/fsp062; Coombs Steve, 2011, Marine Biological Association of the United Kingdom Occasional Publication, V24, P1; Cushing D.H., 1976, Advances mar Biol, V14, P1; Dragesund O, 1997, SARSIA, V82, P97, DOI 10.1080/00364827.1997.10413643; Drinkwater KF, 2006, PROG OCEANOGR, V68, P134, DOI 10.1016/j.pocean.2006.02.011; Edwards M, 2002, MAR ECOL PROG SER, V239, P1, DOI 10.3354/meps239001; Edwards M, 2001, ICES J MAR SCI, V58, P39, DOI 10.1006/jmsc.2000.0987; Edwards M, 2010, TRENDS ECOL EVOL, V25, P602, DOI 10.1016/j.tree.2010.07.007; Enfield DB, 2001, GEOPHYS RES LETT, V28, P2077, DOI 10.1029/2000GL012745; Fischer H, 2005, CLIM DYNAM, V25, P65, DOI 10.1007/s00382-005-0011-x; Gray ST, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019932; Hatun H, 2009, PROG OCEANOGR, V80, P149, DOI 10.1016/j.pocean.2009.03.001; Hatun H, 2009, CAN J FISH AQUAT SCI, V66, P759, DOI 10.1139/F09-037; Keenlyside NS, 2008, NATURE, V453, P84, DOI 10.1038/nature06921; Knight JR, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026242; Reid PC, 2001, FISH RES, V50, P163, DOI 10.1016/S0165-7836(00)00249-6; Reid PC, 2003, PROG OCEANOGR, V58, P117, DOI 10.1016/j.pocean.2003.08.002; Reid PC, 2001, SENCK MARIT, V31, P107, DOI 10.1007/BF03043021; RUSSELL FS, 1971, NATURE, V234, P468, DOI 10.1038/234468a0; SOUTHWARD AJ, 1988, J MAR BIOL ASSOC UK, V68, P423, DOI 10.1017/S0025315400043320; Stenseth NC, 2002, SCIENCE, V297, P1292, DOI 10.1126/science.1071281; Ting MF, 2009, J CLIMATE, V22, P1469, DOI 10.1175/2008JCLI2561.1; Toresen R, 2000, FISH FISH, V1, P231, DOI 10.1111/j.1467-2979.2000.00022.x; WOODRUFF SD, 1987, B AM METEOROL SOC, V68, P1239, DOI 10.1175/1520-0477(1987)068<1239:ACOADS>2.0.CO;2; Zhang XD, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035607	30	90	90	0	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57212	10.1371/journal.pone.0057212	http://dx.doi.org/10.1371/journal.pone.0057212			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460832	Green Published, gold, Green Submitted			2022-12-25	WOS:000315519000076
J	Fernandez, E; Toledo, JR; Mendez, L; Gonzalez, N; Parra, F; Martin-Alonso, JM; Limonta, M; Sanchez, K; Cabrales, A; Estrada, MP; Rodriguez-Mallon, A; Farnos, O				Fernandez, Erlinda; Toledo, Jorge R.; Mendez, Lidice; Gonzalez, Nemecio; Parra, Francisco; Martin-Alonso, Jose M.; Limonta, Miladys; Sanchez, Kosara; Cabrales, Ania; Estrada, Mario P.; Rodriguez-Mallon, Alina; Farnos, Omar			Conformational and Thermal Stability Improvements for the Large-Scale Production of Yeast-Derived Rabbit Hemorrhagic Disease Virus-Like Particles as Multipurpose Vaccine	PLOS ONE			English	Article							CLASSICAL SWINE-FEVER; B SURFACE-ANTIGEN; PICHIA-PASTORIS; IMMUNOGENIC PROPERTIES; PROTECTS RABBITS; RHDV; VP60; IMMUNIZATION; CALICIVIRUS; EXPRESSION	Recombinant virus-like particles (VLP) antigenically similar to rabbit hemorrhagic disease virus (RHDV) were recently expressed at high levels inside Pichia pastoris cells. Based on the potential of RHDV VLP as platform for diverse vaccination purposes we undertook the design, development and scale-up of a production process. Conformational and stability issues were addressed to improve process control and optimization. Analyses on the structure, morphology and antigenicity of these multimers were carried out at different pH values during cell disruption and purification by size-exclusion chromatography. Process steps and environmental stresses in which aggregation or conformational instability can be detected were included. These analyses revealed higher stability and recoveries of properly assembled high-purity capsids at acidic and neutral pH in phosphate buffer. The use of stabilizers during long-term storage in solution showed that sucrose, sorbitol, trehalose and glycerol acted as useful aggregation-reducing agents. The VLP emulsified in an oil-based adjuvant were subjected to accelerated thermal stress treatments. None to slight variations were detected in the stability of formulations and in the structure of recovered capsids. A comprehensive analysis on scale-up strategies was accomplished and a nine steps large-scale production process was established. VLP produced after chromatographic separation protected rabbits against a lethal challenge. The minimum protective dose was identified. Stabilized particles were ultimately assayed as carriers of a foreign viral epitope from another pathogen affecting a larger animal species. For that purpose, a linear protective B-cell epitope from Classical Swine Fever Virus (CSFV) E2 envelope protein was chemically coupled to RHDV VLP. Conjugates were able to present the E2 peptide fragment for immune recognition and significantly enhanced the peptide-specific antibody response in vaccinated pigs. Overall these results allowed establishing improved conditions regarding conformational stability and recovery of these multimers for their production at large-scale and potential use on different animal species or humans.	[Fernandez, Erlinda; Mendez, Lidice; Estrada, Mario P.; Rodriguez-Mallon, Alina; Farnos, Omar] Ctr Genet Engn & Biotechnol, Div Anim Biotechnol, Havana, Cuba; [Toledo, Jorge R.] Univ Concepcion, Dept Physiopathol, Fac Biol Sci, Concepcion, Chile; [Gonzalez, Nemecio] Ctr Genet Engn & Biotechnol Camaguey, Dev Technol Dept, Camaguey, Cuba; [Parra, Francisco; Martin-Alonso, Jose M.] Univ Oviedo, Dept Biochem & Mol Biol, Inst Univ Biotecnol Asturias, Oviedo, Spain; [Limonta, Miladys] Ctr Genet Engn & Biotechnol, Technol Dev Div, Havana, Cuba; [Sanchez, Kosara] Ctr Genet Engn & Biotechnol, Div Dev Formulat, Havana, Cuba; [Cabrales, Ania] Ctr Genet Engn & Biotechnol, Peptide Synth Dept, Havana, Cuba	Centro de Ingenieria Genetica y Biotecnologia; Universidad de Concepcion; University of Oviedo; Centro de Ingenieria Genetica y Biotecnologia; Centro de Ingenieria Genetica y Biotecnologia; Centro de Ingenieria Genetica y Biotecnologia	Farnos, O (corresponding author), Ctr Genet Engn & Biotechnol, Div Anim Biotechnol, Havana, Cuba.	omar.farnos@yahoo.com	Rodriguez Mallon, Alina/GVU-0924-2022; Parra, Francisco/D-5401-2009	Parra, Francisco/0000-0002-1885-9521; Toledo, Jorge R./0000-0002-9879-7710; Farnos, Omar/0000-0003-1295-8323	Center for Genetic Engineering and Biotechnology (Ministry of Science, Technology and Environment of Cuba); Instituto Universitario de Biotecnologia de Asturias from the University of Oviedo, Spain	Center for Genetic Engineering and Biotechnology (Ministry of Science, Technology and Environment of Cuba); Instituto Universitario de Biotecnologia de Asturias from the University of Oviedo, Spain	This work was supported by research projects on Animal Health from the Center for Genetic Engineering and Biotechnology (Ministry of Science, Technology and Environment of Cuba) and the Instituto Universitario de Biotecnologia de Asturias from the University of Oviedo, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrantes J, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-12; Acosta-Rivero N, 2004, BIOCHEM BIOPH RES CO, V325, P68, DOI 10.1016/j.bbrc.2004.10.012; Acosta-Rivero N, 2004, BIOCHEM BIOPH RES CO, V323, P926, DOI 10.1016/j.bbrc.2004.08.189; Acosta-Rivero N, 2001, BIOCHEM BIOPH RES CO, V287, P122, DOI 10.1006/bbrc.2001.5561; Alvarez-Lajonchere L, 2009, J VIRAL HEPATITIS, V16, P156, DOI 10.1111/j.1365-2893.2008.01058.x; Ausar SF, 2006, J BIOL CHEM, V281, P19478, DOI 10.1074/jbc.M603313200; Barcena J, 2000, J VIROL, V74, P1114, DOI 10.1128/JVI.74.3.1114-1123.2000; Barrera M, 2010, VET IMMUNOL IMMUNOP, V133, P25, DOI 10.1016/j.vetimm.2009.06.015; Bertagnoli S, 1996, VACCINE, V14, P506, DOI 10.1016/0264-410X(95)00232-P; Bertagnoli S, 1996, J VIROL, V70, P5061, DOI 10.1128/JVI.70.8.5061-5066.1996; BOGA JA, 1994, J GEN VIROL, V75, P2409, DOI 10.1099/0022-1317-75-9-2409; Boga JA, 1997, J GEN VIROL, V78, P2315, DOI 10.1099/0022-1317-78-9-2315; Brun A, 2011, VIRUS RES, V157, P1, DOI 10.1016/j.virusres.2011.02.006; Canales M, 1997, VACCINE, V15, P414, DOI 10.1016/S0264-410X(96)00192-2; CAPUCCI L, 1995, VIRUS RES, V37, P221, DOI 10.1016/0168-1702(95)00033-M; Castanon S, 1999, J VIROL, V73, P4452; Chackerian B, 2007, EXPERT REV VACCINES, V6, P381, DOI 10.1586/14760584.6.3.381; Chang CY, 2012, VIRUS RES, V163, P190, DOI 10.1016/j.virusres.2011.09.019; Estevez ZC, 2007, BIOLOGICALS, V35, P115, DOI 10.1016/j.biologicals.2006.06.001; Cooke BD, 2002, REV SCI TECH OIE, V21, P347, DOI 10.20506/rst.21.2.1337; Crisci E, 2012, VACCINE, V30, P2427, DOI 10.1016/j.vaccine.2012.01.069; Crisci E, 2009, VIROLOGY, V387, P303, DOI 10.1016/j.virol.2009.02.045; de Arce HD, 2005, VIRUS RES, V112, P123, DOI 10.1016/j.virusres.2005.03.018; de la Fuente Jose, 2007, Animal Health Research Reviews, V8, P23, DOI 10.1017/S1466252307001193; Dong XN, 2007, VACCINE, V25, P205, DOI 10.1016/j.vaccine.2006.07.033; Dong XN, 2006, VACCINE, V24, P426, DOI 10.1016/j.vaccine.2005.08.002; Evans RK, 2004, J PHARM SCI-US, V93, P2458, DOI 10.1002/jps.20157; Farnos O, 2007, ARCH VIROL, V152, P1215, DOI 10.1007/s00705-006-0926-5; Farnos O, 2005, J BIOTECHNOL, V117, P215, DOI 10.1016/j.jbiotec.2005.01.013; Farnos O, 2009, ANTIVIR RES, V81, P25, DOI 10.1016/j.antiviral.2008.08.007; Fernandez E, 2011, VET IMMUNOL IMMUNOP, V142, P179, DOI 10.1016/j.vetimm.2011.05.007; Fernandez-Fernandez MR, 2001, VIROLOGY, V280, P283, DOI 10.1006/viro.2000.0762; Ferreira PG, 2006, RES VET SCI, V80, P218, DOI 10.1016/j.rvsc.2005.05.007; FIELDS GB, 1990, INT J PEPT PROT RES, V35, P161, DOI 10.1111/j.1399-3011.1990.tb00939.x; Fischer L, 1997, VACCINE, V15, P90, DOI 10.1016/S0264-410X(96)00102-8; Forrester NL, 2006, VIROLOGY, V344, P277, DOI 10.1016/j.virol.2005.10.006; Gil F, 2006, PLANT BIOTECHNOL J, V4, P135, DOI 10.1111/j.1467-7652.2005.00172.x; Gonzalez N, 2011, P INT C BIOT HAV 201; Gould EA, 2012, MOL ECOL, V21, P1042, DOI 10.1111/j.1365-294X.2012.05462.x; Hardy E, 2000, J BIOTECHNOL, V77, P157, DOI 10.1016/S0168-1656(99)00201-1; Jiang G, 2006, J PHARM SCI-US, V95, P80, DOI 10.1002/jps.20484; Kissmann J, 2008, J PHARM SCI-US, V97, P4208, DOI 10.1002/jps.21315; Krell T, 2005, BIOTECHNOL APPL BIOC, V41, P241, DOI 10.1042/BA20040113; LAURENT S, 1994, J VIROL, V68, P6794, DOI 10.1128/JVI.68.10.6794-6798.1994; LEE JC, 1981, J BIOL CHEM, V256, P7193; Lewis JD, 1997, J COLLOID INTERF SCI, V196, P170, DOI 10.1006/jcis.1997.5187; Li GX, 2012, VET MICROBIOL, V156, P200, DOI 10.1016/j.vetmic.2011.10.012; Liu FX, 2012, RES VET SCI, V93, P553, DOI 10.1016/j.rvsc.2011.10.018; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maa YF, 1997, BIOTECHNOL BIOENG, V54, P503, DOI 10.1002/(SICI)1097-0290(19970620)54:6<503::AID-BIT1>3.0.CO;2-N; Maddux NR, 2011, J PHARM SCI-US, V100, P4171, DOI 10.1002/jps.22618; Marin MS, 1995, VIRUS RES, V39, P119, DOI 10.1016/0168-1702(95)00074-7; McIntosh MT, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-96; Moennig V, 2000, VET MICROBIOL, V73, P93, DOI 10.1016/S0378-1135(00)00137-1; Monso M, 2011, J PEPT SCI, V17, P24, DOI 10.1002/psc.1292; PARRA F, 1993, VIRUS RES, V27, P219, DOI 10.1016/0168-1702(93)90034-K; PARRA F, 1990, J VIROL, V64, P4013, DOI 10.1128/JVI.64.8.4013-4015.1990; Peacey M, 2008, VACCINE, V26, P5334, DOI 10.1016/j.vaccine.2008.07.074; Peacey M, 2007, BIOTECHNOL BIOENG, V98, P968, DOI 10.1002/bit.21518; Peek LJ, 2007, J PHARM SCI-US, V96, P547, DOI 10.1002/jps.20762; Peek LJ, 2006, VACCINE, V24, P5839, DOI 10.1016/j.vaccine.2006.04.067; Perez-Filgueira DM, 2007, VIROLOGY, V364, P422, DOI 10.1016/j.virol.2007.03.016; Perez-Perez D, 2010, VET PARASITOL, V167, P321, DOI 10.1016/j.vetpar.2009.09.034; Rohde J, 2011, VACCINE, V29, P9256, DOI 10.1016/j.vaccine.2011.09.121; Roldao A, 2010, EXPERT REV VACCINES, V9, P1149, DOI [10.1586/erv.10.115, 10.1586/ERV.10.115]; Ruvoen-Clouet N, 2000, J VIROL, V74, P11950, DOI 10.1128/JVI.74.24.11950-11954.2000; Salnikova MS, 2008, J PHARM SCI-US, V97, P4194, DOI 10.1002/jps.21300; Smith JS, 1996, BIOCHEMISTRY-US, V35, P7292, DOI 10.1021/bi960341i; Suarez M, 2011, P INT C BIOT HAV 201; Tarradas J, 2011, VACCINE, V29, P4422, DOI 10.1016/j.vaccine.2011.03.095; Tleugabulova D, 1998, J CHROMATOGR B, V716, P209, DOI 10.1016/S0378-4347(98)00297-7; Toledo JR, 2008, J BIOTECHNOL, V133, P370, DOI 10.1016/j.jbiotec.2007.09.014; Toledo JR, 2010, VACCINE, V28, P7907, DOI 10.1016/j.vaccine.2010.09.073; Valdes I, 2007, MOL BIOTECHNOL, V35, P23, DOI 10.1385/MB:35:1:23; Vargas M, 2010, BMC VET RES, V6, DOI 10.1186/1746-6148-6-43; Yildiz I, 2011, CURR OPIN BIOTECH, V22, P901, DOI 10.1016/j.copbio.2011.04.020; Zheng T, 2011, VET MICROBIOL, V153, P387, DOI 10.1016/j.vetmic.2011.05.049; Zhou B, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-378	78	14	14	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e56417	10.1371/journal.pone.0056417	http://dx.doi.org/10.1371/journal.pone.0056417			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460801	Green Published, Green Submitted, gold			2022-12-25	WOS:000315519000024
J	Leptidis, S; el Azzouzi, H; Lok, SI; de Weger, R; Olieslagers, S; Kisters, N; Silva, GJ; Heymans, S; Cuppen, E; Berezikov, E; De Windt, LJ; Martins, PD				Leptidis, Stefanos; el Azzouzi, Hamid; Lok, Sjoukje I.; de Weger, Roel; Olieslagers, Serv; Kisters, Natasja; Silva, Gustavo J.; Heymans, Stephane; Cuppen, Edwin; Berezikov, Eugene; De Windt, Leon J.; Martins, Paula da Costa			A Deep Sequencing Approach to Uncover the miRNOME in the Human Heart	PLOS ONE			English	Article							SMALL RNAS; CARDIAC-HYPERTROPHY; MICRORNA EXPRESSION; IDENTIFICATION; DISCOVERY; MIR-145; REVEALS; TARGETS; MIRNAS; CELLS	MicroRNAs (miRNAs) are a class of non-coding RNAs of similar to 22 nucleotides in length, and constitute a novel class of gene regulators by imperfect base-pairing to the 3'UTR of protein encoding messenger RNAs. Growing evidence indicates that miRNAs are implicated in several pathological processes in myocardial disease. The past years, we have witnessed several profiling attempts using high-density oligonucleotide array-based approaches to identify the complete miRNA content (miRNOME) in the healthy and diseased mammalian heart. These efforts have demonstrated that the failing heart displays differential expression of several dozens of miRNAs. While the total number of experimentally validated human miRNAs is roughly two thousand, the number of expressed miRNAs in the human myocardium remains elusive. Our objective was to perform an unbiased assay to identify the miRNOME of the human heart, both under physiological and pathophysiological conditions. We used deep sequencing and bioinformatics to annotate and quantify microRNA expression in healthy and diseased human heart (heart failure secondary to hypertrophic or dilated cardiomyopathy). Our results indicate that the human heart expresses >800 miRNAs, the majority of which not being annotated nor described so far and some of which being unique to primate species. Furthermore, >250 miRNAs show differential and etiology-dependent expression in human dilated cardiomyopathy (DCM) or hypertrophic cardiomyopathy (HCM). The human cardiac miRNOME still possesses a large number of miRNAs that remain virtually unexplored. The current study provides a starting point for a more comprehensive understanding of the role of miRNAs in regulating human heart disease.	[Leptidis, Stefanos; el Azzouzi, Hamid; Olieslagers, Serv; Kisters, Natasja; Silva, Gustavo J.; Heymans, Stephane; De Windt, Leon J.; Martins, Paula da Costa] Maastricht Univ, Fac Hlth Med & Life Sci, CARIM Sch Cardiovasc Dis, Dept Cardiol, Maastricht, Netherlands; [Lok, Sjoukje I.; de Weger, Roel] Univ Med Ctr Utrecht, Dept Pathol, Utrecht, Netherlands; [Cuppen, Edwin; Berezikov, Eugene] Royal Netherlands Acad Sci, Hubrecht Inst, Utrecht, Netherlands	Maastricht University; Utrecht University; Utrecht University Medical Center; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW)	Martins, PD (corresponding author), Maastricht Univ, Fac Hlth Med & Life Sci, CARIM Sch Cardiovasc Dis, Dept Cardiol, Maastricht, Netherlands.	p.dacostamartins@maastrichtuniversity.nl	Cuppen, Edwin/H-2389-2016; Leptidis, Stefanos/D-1455-2016; Berezikov, Eugene/D-3363-2013; de Windt, Leon/AAO-6395-2020; da Silva, Gustavo J Justo/H-5222-2011; Cuppen, Edwin/F-5696-2011	Cuppen, Edwin/0000-0002-0400-9542; Leptidis, Stefanos/0000-0003-0172-4193; Berezikov, Eugene/0000-0002-1145-2884; de Windt, Leon/0000-0002-7793-2856; da Silva, Gustavo J Justo/0000-0002-1651-7966; Cuppen, Edwin/0000-0002-0400-9542; Heymans, Stephane/0000-0001-9477-7803; el Azzouzi, Hamid/0000-0003-1242-9691	Netherlands Organization for Health Research and Development [917-863-72]; Netherlands Heart Foundation [NHS2007B167, NHS2010B261]; Foundation Leducq Transatlantic Network of Excellence program [08-CVD-03]; Foundation Leducq	Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development); Netherlands Heart Foundation(Netherlands Heart Foundation); Foundation Leducq Transatlantic Network of Excellence program(Leducq Foundation); Foundation Leducq(Leducq Foundation)	L.D.W. was supported by a VIDI award 917-863-72 from the Netherlands Organization for Health Research and Development, the Netherlands Heart Foundation program grant NHS2007B167, and by the Foundation Leducq Transatlantic Network of Excellence program 08-CVD-03. P.D.C.M. was supported by a Career Development Award from Foundation Leducq and by the Netherlands Heart Foundation program grant NHS2010B261. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Aravin A, 2005, FEBS LETT, V579, P5830, DOI 10.1016/j.febslet.2005.08.009; Bar M, 2008, STEM CELLS, V26, P2496, DOI 10.1634/stemcells.2008-0356; Barringhaus KG, 2009, CIRCULATION, V119, P2217, DOI 10.1161/CIRCULATIONAHA.107.715839; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Berezikov E, 2005, CELL, V120, P21, DOI 10.1016/j.cell.2004.12.031; Berezikov E, 2007, MOL CELL, V28, P328, DOI 10.1016/j.molcel.2007.09.028; Berezikov E, 2006, NAT GENET, V38, P1375, DOI 10.1038/ng1914; Bonauer A, 2009, SCIENCE, V324, P1710, DOI 10.1126/science.1174381; Callis TE, 2009, J CLIN INVEST, V119, P2772, DOI 10.1172/JCI36154; Care A, 2007, NAT MED, V13, P613, DOI 10.1038/nm1582; Caruso P, 2012, CIRC RES, V111, P290, DOI 10.1161/CIRCRESAHA.112.267591; Cheng AM, 2005, NUCLEIC ACIDS RES, V33, P1290, DOI 10.1093/nar/gki200; Cheng YH, 2007, AM J PATHOL, V170, P1831, DOI 10.2353/ajpath.2007.061170; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; de Wit E, 2009, GENOME RES, V19, P2064, DOI 10.1101/gr.093781.109; Dorn GW, 2011, TRANSL RES, V157, P226, DOI 10.1016/j.trsl.2010.12.013; Elia L, 2009, CIRCULATION, V120, P2377, DOI 10.1161/CIRCULATIONAHA.109.879429; Fiedler J, 2011, CIRCULATION, V124, P720, DOI 10.1161/CIRCULATIONAHA.111.039008; Gilad S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003148; Glazov EA, 2008, GENOME RES, V18, P957, DOI 10.1101/gr.074740.107; Gommans WM, 2012, METHODS MOL BIOL, V786, P167, DOI 10.1007/978-1-61779-292-2_10; Hata A, 2012, ANN REV PHYSL; Hwang HW, 2006, BRIT J CANCER, V94, P776, DOI 10.1038/sj.bjc.6603023; Ikeda S, 2007, PHYSIOL GENOMICS, V31, P367, DOI 10.1152/physiolgenomics.00144.2007; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Krichevsky AM, 2003, RNA, V9, P1274, DOI 10.1261/rna.5980303; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lee JH, 2011, CIRC RES, V109, P1332, DOI 10.1161/CIRCRESAHA.111.249433; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Liu CG, 2004, P NATL ACAD SCI USA, V101, P9740, DOI 10.1073/pnas.0403293101; Lu C, 2005, SCIENCE, V309, P1567, DOI 10.1126/science.1114112; Martins PAD, 2010, NAT CELL BIOL, V12, P1220, DOI 10.1038/ncb2126; Matkovich SJ, 2010, CIRC RES, V106, P1459, DOI 10.1161/CIRCRESAHA.110.217513; Matkovich SJ, 2010, CIRC RES, V106, P166, DOI 10.1161/CIRCRESAHA.109.202176; Mayorga ME, 2012, J CELL MOL MED, V16, P1106, DOI 10.1111/j.1582-4934.2011.01385.x; Meiri E, 2010, NUCLEIC ACIDS RES, V38, P6234, DOI 10.1093/nar/gkq376; Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508; Moxon S, 2008, GENOME RES, V18, P1602, DOI 10.1101/gr.080127.108; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Ryu S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016403; Sayed D, 2007, CIRC RES, V100, P416, DOI 10.1161/01.RES.0000257913.42552.23; Shieh JTC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019481; Small EM, 2010, CIRCULATION, V121, P1022, DOI 10.1161/CIRCULATIONAHA.109.889048; Steffen P, 2006, BIOINFORMATICS, V22, P500, DOI 10.1093/bioinformatics/btk010; Tatsuguchi M, 2007, J MOL CELL CARDIOL, V42, P1137, DOI 10.1016/j.yjmcc.2007.04.004; Thum T, 2007, CIRCULATION, V116, P258, DOI 10.1161/CIRCULATIONAHA.107.687947; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333; van Empel VPM, 2012, CURR HYPERTENS REP, V14, P498, DOI 10.1007/s11906-012-0310-7; van Loosdregt J, 2006, CIRCULATION, V114, P1599, DOI 10.1161/CIRCULATIONAHA.105.597526; van Rooij E, 2008, P NATL ACAD SCI USA, V105, P13027, DOI 10.1073/pnas.0805038105; van Rooij E, 2007, SCIENCE, V316, P575, DOI 10.1126/science.1139089; van Rooij E, 2006, P NATL ACAD SCI USA, V103, P18255, DOI 10.1073/pnas.0608791103; Wang JX, 2011, NAT MED, V17, P71, DOI 10.1038/nm.2282; Zhang Z, 1998, J COMPUT BIOL, V5, P197, DOI 10.1089/cmb.1998.5.197	57	73	75	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57800	10.1371/journal.pone.0057800	http://dx.doi.org/10.1371/journal.pone.0057800			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460909	Green Published, Green Submitted, gold			2022-12-25	WOS:000315519000164
J	Munn, AJ; Dunne, C; Muller, DWH; Clauss, M				Munn, Adam J.; Dunne, Craig; Mueller, Dennis W. H.; Clauss, Marcus			Energy In-Equivalence in Australian Marsupials: Evidence for Disruption of the Continent's Mammal Assemblage, or Are Rules Meant to Be Broken?	PLOS ONE			English	Article							BASAL METABOLIC-RATE; BODY-SIZE; POPULATION-DENSITY; ABUNDANCE; ANIMALS; BIODIVERSITY; EXTINCTION; ALLOMETRY; VARIABLES; ECOLOGY	The energy equivalence rule (EER) is a macroecological hypothesis that posits that total population energy use (PEU) should be independent of species body mass, because population densities and energy metabolisms scale with body mass in a directly inverse manner. However, evidence supporting the EER is equivocal, and the use of basal metabolic rate (BMR) in such studies has been questioned; ecologically-relevant indices like field metabolic rate (FMR) are probably more appropriate. In this regard, Australian marsupials present a novel test for the EER because, unlike eutherians, marsupial BMRs and FMRs scale differently with body mass. Based on either FMR or BMR, Australian marsupial PEU did not obey an EER, and scaled positively with body mass based on ordinary least squares (OLS) regressions. Importantly, the scaling of marsupial population density with body mass had a slope of -0.37, significantly shallower than the expected slope of -0.75, and not directly inverse of body-mass scaling exponents for BMR (0.72) or FMR (0.62). The findings suggest that the EER may not be a causal, universal rule, or that for reasons not yet clear, it is not operating for Australia's unique native fauna.	[Munn, Adam J.; Dunne, Craig] Univ Wollongong, Sch Biol Sci, Inst Conservat Biol & Environm Management, Wollongong, NSW, Australia; [Mueller, Dennis W. H.; Clauss, Marcus] Univ Zurich, Clin Zoo Anim Exot Pets & Wildlife, Vetsuisse Fac, Zurich, Switzerland	University of Wollongong; University of Zurich	Munn, AJ (corresponding author), Univ Wollongong, Sch Biol Sci, Inst Conservat Biol & Environm Management, Wollongong, NSW, Australia.	amunn@uow.edu.au	Clauss, Marcus/GRR-7996-2022; Clauss, Marcus/M-8702-2019; Clauss, Marcus/A-4710-2008	Clauss, Marcus/0000-0003-3841-6207; Clauss, Marcus/0000-0003-3841-6207; Clauss, Marcus/0000-0003-3841-6207				Ackerman JL, 2004, OECOLOGIA, V139, P568, DOI 10.1007/s00442-004-1536-0; Allen AP, 2002, SCIENCE, V297, P1545, DOI 10.1126/science.1072380; Anderson KJ, 2005, ECOL LETT, V8, P310, DOI 10.1111/j.1461-0248.2005.00723.x; Blackburn TM, 1997, J ANIM ECOL, V66, P233, DOI 10.2307/6025; Brown JH, 2003, P NATL ACAD SCI USA, V100, P1467, DOI 10.1073/pnas.0630310100; Capellini I, 2010, ECOLOGY, V91, P2783, DOI 10.1890/09-0817.1; Carbone C, 2009, INT J ECOLOGY, V2009; Carbone C, 2007, AM NAT, V170, P479, DOI 10.1086/519858; Cardillo M, 2001, CONSERV BIOL, V15, P1435, DOI 10.1046/j.1523-1739.2001.00286.x; COTGREAVE P, 1993, TRENDS ECOL EVOL, V8, P244, DOI 10.1016/0169-5347(93)90199-Y; DAMUTH J, 1987, BIOL J LINN SOC, V31, P193, DOI 10.1111/j.1095-8312.1987.tb01990.x; Damuth J, 1981, NATURE, V290; Dawson TJ, 2012, AUSTRAL NAT HIST SER, P1; Ernest SKM, 2003, ECOL LETT, V6, P990, DOI 10.1046/j.1461-0248.2003.00526.x; Gaston K. J., 2000, PATTERNS PROCESS MAC; Geiser F, 2009, NATURWISSENSCHAFTEN, V96, P1235, DOI 10.1007/s00114-009-0583-0; Happold D.C.D., 2008, MAMMALS AUSTR, P589; Isaac NJB, 2011, BIOL LETTERS, V7, P615, DOI 10.1098/rsbl.2011.0128; Isaac NJB, 2010, ECOL LETT, V13, P728, DOI 10.1111/j.1461-0248.2010.01461.x; JOHNSON C, 2006, AUSTR MAMMAL EXTINCT; Johnson CN, 2009, AUSTRAL ECOL, V34, P35, DOI 10.1111/j.1442-9993.2008.01878.x; Johnson CN, 1999, OIKOS, V85, P565, DOI 10.2307/3546706; Letnic M, 2012, BIOL REV, V87, P390, DOI 10.1111/j.1469-185X.2011.00203.x; Letnic M, 2009, P ROY SOC B-BIOL SCI, V276, P3249, DOI 10.1098/rspb.2009.0574; Lovegrove BG, 2000, AM NAT, V156, P201, DOI 10.1086/303383; MARQUET PA, 1995, J ANIM ECOL, V64, P325, DOI 10.2307/5894; Mcnab BK, 2008, COMP BIOCHEM PHYS A, V151, P5, DOI 10.1016/j.cbpa.2008.05.008; NEE S, 1991, NATURE, V351, P312, DOI 10.1038/351312a0; Newsome AE, 2001, RANGELAND J, V23, P71, DOI 10.1071/RJ01015; Ozgul A, 2009, SCIENCE, V325, P464, DOI 10.1126/science.1173668; Russo SE, 2003, AM NAT, V161, P267, DOI 10.1086/345938; WESTOBY M, 1995, J ECOL, V83, P531, DOI 10.2307/2261605; White CR, 2005, J EXP BIOL, V208, P1611, DOI 10.1242/jeb.01501; White CR, 2004, PHYSIOL BIOCHEM ZOOL, V77, P929, DOI 10.1086/425186; White CR, 2012, P ROY SOC B-BIOL SCI, V279, P3616, DOI 10.1098/rspb.2012.0884; White CR, 2011, COMP BIOCHEM PHYS A, V158, P346, DOI 10.1016/j.cbpa.2010.10.004; White EP, 2007, TRENDS ECOL EVOL, V22, P323, DOI 10.1016/j.tree.2007.03.007; Withers PC, 2006, PHYSIOL BIOCHEM ZOOL, V79, P437, DOI 10.1086/501063	38	8	8	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57449	10.1371/journal.pone.0057449	http://dx.doi.org/10.1371/journal.pone.0057449			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460858	Green Accepted, gold, Green Published			2022-12-25	WOS:000315519000112
J	Tiwari, A; Hadley, JA; Hendricks, GL; Elkin, RG; Cooper, T; Ramachandran, R				Tiwari, Anupama; Hadley, Jill A.; Hendricks, Gilbert L., III; Elkin, Robert G.; Cooper, Timothy; Ramachandran, Ramesh			Characterization of Ascites-Derived Ovarian Tumor Cells from Spontaneously Occurring Ovarian Tumors of the Chicken: Evidence for E-Cadherin Upregulation	PLOS ONE			English	Article							SURFACE EPITHELIAL-CELLS; ANTI-MULLERIAN HORMONE; IN-VITRO MODEL; GENE-EXPRESSION; CANCER CELLS; TRANSCRIPTION FACTOR; ADHESION MOLECULES; SKELETAL-MUSCLE; LAYING HENS; ADENOCARCINOMAS	Ovarian cancer, a highly metastatic disease, is the fifth leading cause of cancer-related deaths in women. Chickens are widely used as a model for human ovarian cancer as they spontaneously develop epithelial ovarian tumors similar to humans. The cellular and molecular biology of chicken ovarian cancer (COVCAR) cells, however, have not been studied. Our objectives were to culture COVCAR cells and to characterize their invasiveness and expression of genes and proteins associated with ovarian cancer. COVCAR cell lines (n = 13) were successfully maintained in culture for up to19 passages, cryopreserved and found to be viable upon thawing and replating. E-cadherin, cytokeratin and alpha-smooth muscle actin were localized in COVCAR cells by immunostaining. COVCAR cells were found to be invasive in extracellular matrix and exhibited anchorage-independent growth forming colonies, acini and tube-like structures in soft agar. Using RT-PCR, COVCAR cells were found to express E-cadherin, N-cadherin, cytokeratin, vimentin, mesothelin, EpCAM, steroidogenic enzymes/proteins, inhibin subunits-alpha, beta A, beta B, anti-mullerian hormone, estrogen receptor [ER]-alpha, ER-beta, progesterone receptor, androgen receptor, and activin receptors. Quantitative PCR analysis revealed greater N-cadherin, vimentin, and VEGF mRNA levels and lesser cytokeratin mRNA levels in COVCAR cells as compared with normal ovarian surface epithelial (NOSE) cells, which was suggestive of epithelial-mesenchymal transformation. Western blotting analyses revealed significantly greater E-cadherin levels in COVCAR cell lines compared with NOSE cells. Furthermore, cancerous ovaries and COVCAR cell lines expressed higher levels of an E-cadherin cleavage product when compared to normal ovaries and NOSE cells, respectively. Cancerous ovaries were found to express significantly higher ovalbumin levels whereas COVCAR cell lines did not express ovalbumin thus suggesting that the latter did not originate from oviduct. Taken together, COVCAR cell lines are likely to improve our understanding of the cellular and molecular biology of ovarian tumors and its metastasis.	[Tiwari, Anupama; Hadley, Jill A.; Hendricks, Gilbert L., III; Elkin, Robert G.; Ramachandran, Ramesh] Penn State Univ, Ctr Reprod Biol & Hlth, Dept Anim Sci, University Pk, PA 16802 USA; [Cooper, Timothy] Penn State Hershey Med Ctr, Penn State Coll Med, Dept Comparat Med, Hershey, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Ramachandran, R (corresponding author), Penn State Univ, Ctr Reprod Biol & Hlth, Dept Anim Sci, University Pk, PA 16802 USA.	RameshR@psu.edu			College of Agricultural Sciences, Pennsylvania State University	College of Agricultural Sciences, Pennsylvania State University	The authors acknowledge funding support from the College of Agricultural Sciences, Pennsylvania State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed N, 2007, J CELL PHYSIOL, V213, P581, DOI 10.1002/jcp.21240; Aigner K, 2007, ONCOGENE, V26, P6979, DOI 10.1038/sj.onc.1210508; Ansenberger K, 2010, GYNECOL ONCOL, V117, P341, DOI 10.1016/j.ygyno.2010.01.021; Ansenberger K, 2009, GYNECOL ONCOL, V113, P362, DOI 10.1016/j.ygyno.2009.02.011; AUERSPERG N, 1994, LAB INVEST, V71, P510; Auersperg N, 2001, ENDOCR REV, V22, P255, DOI 10.1210/er.22.2.255; Auersperg N, 2011, INT J GYNECOL PATHOL, V30, P12, DOI 10.1097/PGP.0b013e3181f45f3e; Barnes MN, 2002, GYNECOL ONCOL, V87, P57, DOI 10.1006/gyno.2002.6806; Barua A, 2009, INT J GYNECOL CANCER, V19, P531, DOI 10.1111/IGC.0b013e3181a41613; Bosquet JG, 2011, GYNECOL ONCOL, V120, P256, DOI 10.1016/j.ygyno.2010.10.030; CAMPBELL JG, 1951, BRIT J CANCER, V5, P69, DOI 10.1038/bjc.1951.7; Choi JW, 2011, ONCOL LETT, V2, P1047, DOI 10.3892/ol.2011.391; David JM, 2012, CANCER RES, V72, P2917, DOI 10.1158/0008-5472.CAN-11-3498; Eger A, 2005, ONCOGENE, V24, P2375, DOI 10.1038/sj.onc.1208429; Fishman DA, 1997, CANCER-AM CANCER SOC, V80, P1457, DOI 10.1002/(SICI)1097-0142(19971015)80:8<1457::AID-CNCR13>3.0.CO;2-4; FREDRICKSON TN, 1987, ENVIRON HEALTH PERSP, V73, P35, DOI 10.2307/3430596; GALLIN WJ, 1983, P NATL ACAD SCI-BIOL, V80, P1038, DOI 10.1073/pnas.80.4.1038; Giles JR, 2006, EXP BIOL MED, V231, P1718, DOI 10.1177/153537020623101108; Giles JR, 2004, GYNECOL ONCOL, V95, P530, DOI 10.1016/j.ygyno.2004.07.061; Goodman MT, 2003, CANCER, V97, P2615, DOI 10.1002/cncr.11339; Graves LE, 2004, CANCER RES, V64, P7045, DOI 10.1158/0008-5472.CAN-04-1800; Hakim AA, 2009, CANCER PREV RES, V2, P114, DOI 10.1158/1940-6207.CAPR-08-0065; Heinzelmann-Schwarz VA, 2004, CLIN CANCER RES, V10, P4427, DOI 10.1158/1078-0432.CCR-04-0073; HOFFMAN AG, 1993, INT J CANCER, V54, P828, DOI 10.1002/ijc.2910540518; Hurt EM, 2008, MOL CELL BIOCHEM, V318, P89, DOI 10.1007/s11010-008-9860-z; Ito I, 2000, BRIT J CANCER, V82, P1415, DOI 10.1054/bjoc.1999.1127; Jackson E, 2007, GYNECOL ONCOL, V104, P192, DOI 10.1016/j.ygyno.2006.07.024; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Johnson PA, 2008, BIOL REPROD, V78, P13, DOI 10.1095/biolreprod.107.061879; Johnson PA, 2009, REPRODUCTION, V137, P857, DOI 10.1530/REP-08-0406; KANEMOTO T, 1991, INVAS METAST, V11, P84; KARLAN BY, 1995, AM J OBSTET GYNECOL, V173, P97, DOI 10.1016/0002-9378(95)90176-0; Klar M, 2009, INT J GYNECOL CANCER, V19, P489, DOI 10.1111/IGC.0b013e3181a40561; Krzysik-Walker SM, 2008, ENDOCRINOLOGY, V149, P1543, DOI 10.1210/en.2007-1301; Krzysik-Walker SM, 2011, COMP BIOCHEM PHYS A, V159, P413, DOI 10.1016/j.cbpa.2011.04.007; Lau KM, 1999, P NATL ACAD SCI USA, V96, P5722, DOI 10.1073/pnas.96.10.5722; Lim W, 2012, EXP BIOL MED, V237, P150, DOI 10.1258/ebm.2011.011250; LINGEMAN CH, 1974, JNCI-J NATL CANCER I, V53, P1603; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Meunier L, 2010, TRANSL ONCOL, V3, P230, DOI 10.1593/tlo.10103; Millimagg D, 2009, INT J ONCOL, V35, P1423, DOI 10.3892/ijo_00000460; Murdoch WJ, 2005, EXP BIOL MED, V230, P429, DOI 10.1177/15353702-0323006-11; OLSON TA, 1994, CANCER RES, V54, P276; Reddy P, 2005, MOL ENDOCRINOL, V19, P2564, DOI 10.1210/me.2004-0342; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; Romero I, 2012, ENDOCRINOLOGY, V153, P1593, DOI 10.1210/en.2011-2123; Shepherd TG, 2006, NAT PROTOC, V1, P2643, DOI 10.1038/nprot.2006.328; SHIRAYOSHI Y, 1986, EMBO J, V5, P2485, DOI 10.1002/j.1460-2075.1986.tb04525.x; Theriault BL, 2007, CARCINOGENESIS, V28, P1153, DOI 10.1093/carcin/bgm015; Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006; Tingulstad S, 2003, OBSTET GYNECOL, V101, P885, DOI 10.1016/S0029-7844(03)00123-6; Trevino Lindsey S., 2010, Hormones & Cancer, V1, P177, DOI 10.1007/s12672-010-0024-8; Urick ME, 2008, GYNECOL ONCOL, V110, P418, DOI 10.1016/j.ygyno.2008.05.018; Urick ME, 2009, GYNECOL ONCOL, V112, P166, DOI 10.1016/j.ygyno.2008.09.032; VEATCH AL, 1994, INT J CANCER, V58, P393, DOI 10.1002/ijc.2910580315; Vergara D, 2010, CANCER LETT, V291, P59, DOI 10.1016/j.canlet.2009.09.017; Wright JW, 2011, HUM REPROD, V26, P1408, DOI 10.1093/humrep/der057	57	13	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57582	10.1371/journal.pone.0057582	http://dx.doi.org/10.1371/journal.pone.0057582			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460878	Green Submitted, gold, Green Published			2022-12-25	WOS:000315519000133
J	Ullrich, S; Bremer, P; Neumann-Grutzeck, C; Otto, H; Ruther, C; von Seydewitz, CU; Meyer, GP; Ahmadi-Simab, K; Rother, J; Hogan, B; Schwenk, W; Fischbach, R; Caselitz, J; Puttfarcken, J; Huggett, S; Tiedeken, P; Pober, J; Kirkiles-Smith, NC; Hagenmuller, F				Ullrich, Sebastian; Bremer, Phillip; Neumann-Grutzeck, Christine; Otto, Helge; Ruether, Christoph; von Seydewitz, Cay Uwe; Meyer, Gerd Peter; Ahmadi-Simab, Keihan; Roether, Joachim; Hogan, Barbara; Schwenk, Wolfgang; Fischbach, Roman; Caselitz, Joerg; Puttfarcken, Jochen; Huggett, Susanne; Tiedeken, Petra; Pober, Jordan; Kirkiles-Smith, Nancy C.; Hagenmueller, Friedrich			Symptoms and Clinical Course of EHEC O104 Infection in Hospitalized Patients: A Prospective Single Center Study	PLOS ONE			English	Article							HEMOLYTIC-UREMIC SYNDROME; THROMBOTIC THROMBOCYTOPENIC PURPURA; ESCHERICHIA-COLI; NEUROLOGICAL INVOLVEMENT; ANTIBIOTIC-TREATMENT; OUTBREAK; VEROTOXIN; RISK; HUS; ASSOCIATION	Objectives: Shiga-toxin producing O157:H7 Entero Haemorrhagic E. coli (STEC/EHEC) is one of the most common causes of Haemolytic Uraemic Syndrome (HUS) related to infectious haemorrhagic colitis. Nearly all recommendations on clinical management of EHEC infections refer to this strain. The 2011 outbreak in Northern Europe was the first to be caused by the serotype O104:H4. This EHEC strain was found to carry genetic features of Entero Aggregative E. coli (EAEC) and extended spectrum beta lactamase (ESBL). We report symptoms and complications in patients at one of the most affected centres of the 2011 EHEC O104 outbreak in Northern Germany. Methods: The courses of patients admitted to our hospital due to bloody diarrhoea with suspected EHEC O104 infection were recorded prospectively. These data include the patients' histories, clinical findings, and complications. Results: EHEC O104 infection was confirmed in 61 patients (female = 37; mean age: 44+/-2 years). The frequency of HUS was 59% (36/61) in our cohort. An enteric colonisation with co-pathogens was found in 57%. Thirty-one (51%) patients were treated with plasma-separation/plasmapheresis, 16 (26%) with haemodialysis, and 7 (11%) with Eculizumab. Patients receiving antibiotic treatment (n = 37; 61%) experienced no apparent change in their clinical course. Twenty-six (43%) patients suffered from neurological symptoms. One 83-year-old patient died due to comorbidities after HUS was successfully treated. Conclusions: EHEC O104: H4 infections differ markedly from earlier reports on O157: H7 induced enterocolitis in regard to epidemiology, symptomatology, and frequency of complications. We recommend a standard of practice for clinical monitoring and support the renaming of EHEC O104: H4 syndrome as "EAHEC disease".	[Ullrich, Sebastian; Bremer, Phillip; Neumann-Grutzeck, Christine; Otto, Helge; Ruether, Christoph; Hagenmueller, Friedrich] Asklepios Klin Altona, Dept Med Gastroenterol 1, Hamburg, Germany; [von Seydewitz, Cay Uwe] Asklepios Klin Altona, Dept Med Oncol & Haematol 2, Hamburg, Germany; [Meyer, Gerd Peter] Asklepios Klin Altona, Dept Med Cardiol Angiol & Pulmonol Intens Care 3, Hamburg, Germany; [Ahmadi-Simab, Keihan] Asklepios Klin Altona, Dept Med Rheumatol Immunol & Nephrol 4, Hamburg, Germany; [Roether, Joachim] Asklepios Klin Altona, Dept Neurol, Hamburg, Germany; [Hogan, Barbara] Asklepios Klin Altona, Emergency Dept, Hamburg, Germany; [Schwenk, Wolfgang] Asklepios Klin Altona, Dept Surg Gen & Visceral Surg 1, Hamburg, Germany; [Fischbach, Roman] Asklepios Klin Altona, Dept Radiol Neuroradiol & Nucl Med, Hamburg, Germany; [Caselitz, Joerg] Asklepios Klin Altona, Dept Pathol, Hamburg, Germany; [Puttfarcken, Jochen; Huggett, Susanne] Lab Gesell mbh, MEDILYS, Hamburg, Germany; [Tiedeken, Petra] Dialysezentrum Hamburg West, Hamburg, Germany; [Pober, Jordan] Yale Univ, Sch Med, Dept Immunobiol Pathol & Dermatol, New Haven, CT USA; [Kirkiles-Smith, Nancy C.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT USA	Asklepios Klinik Altona; Asklepios Klinik Altona; Asklepios Klinik Altona; Asklepios Klinik Altona; Asklepios Klinik Altona; Asklepios Klinik Altona; Asklepios Klinik Altona; Asklepios Klinik Altona; Asklepios Klinik Altona; Yale University; Yale University	Ullrich, S (corresponding author), Asklepios Klin Altona, Dept Med Gastroenterol 1, Hamburg, Germany.	mi.ullrich@asklepios.com	Schwenk, Wolfgamg/AAB-8515-2021; Bremer, Phillip/AAE-7842-2020	Fischbach, Roman/0000-0002-2125-6748				Ake JA, 2005, PEDIATRICS, V115, pE673, DOI 10.1542/peds.2004-2236; Aurass P, 2011, ENVIRON MICROBIOL, V13, P3139, DOI 10.1111/j.1462-2920.2011.02604.x; Bae WK, 2006, YONSEI MED J, V47, P437, DOI 10.3349/ymj.2006.47.3.437; Bettelheim KA, 1999, J DIARRHOEAL DIS RES, V17, P34; Bielaszewska M, 2012, ANTIMICROB AGENTS CH, V56, P3277, DOI 10.1128/AAC.06315-11; Bielaszewska M, 2011, LANCET INFECT DIS, V11, P671, DOI 10.1016/S1473-3099(11)70165-7; Bitzan M, 2010, SEMIN THROMB HEMOST, V36, P594, DOI 10.1055/s-0030-1262881; Bitzan M, 2009, KIDNEY INT, V75, pS62, DOI 10.1038/ki.2008.624; Brzuszkiewicz E, 2011, ARCH MICROBIOL, V193, P883, DOI 10.1007/s00203-011-0725-6; Chattaway MA, 2011, J INFECT DEV COUNTR, V5, P425, DOI 10.3855/jidc.2166; CIMOLAI N, 1992, PEDIATRICS, V90, P616; Deutsche Gesellschaft fur Infektiologie, 2011, EHEC ANT; Deutsche Gesellschaft fur Nephrologie, 2011, THER APH BEI EHEC AS; Dolgikh T. I., 2010, Klinicheskaya Laboratornaya Diagnostika, P52; Ducker C, 2011, DEUT MED WOCHENSCHR, V136, P1770, DOI 10.1055/s-0031-1286099; European Food Safety Authority, 2011, TRAC SEEDS PART FEN; Frank C, 2011, NEW ENGL J MED, V365, P1771, DOI 10.1056/NEJMoa1106483; GALLO GE, 1995, PEDIATR NEPHROL, V9, P117, DOI 10.1007/BF00858990; GASSER C, 1955, Schweiz Med Wochenschr, V85, P905; HAHN JS, 1989, J CHILD NEUROL, V4, P108, DOI 10.1177/088307388900400206; HUGHES DA, 1991, SCOT MED J, V36, P9, DOI 10.1177/003693309103600105; Iizuka S, 2005, JPN J INFECT DIS, V58, P329; Karpac CA, 2008, BRIT J HAEMATOL, V141, P696, DOI 10.1111/j.1365-2141.2008.07116.x; Lapeyraque AL, 2011, NEW ENGL J MED, V364, P2561, DOI 10.1056/NEJMc1100859; McGannon CM, 2010, ANTIMICROB AGENTS CH, V54, P3790, DOI 10.1128/AAC.01783-09; Mellmann A, 2008, EMERG INFECT DIS, V14, P1287, DOI 10.3201/eid1408.071082; Michael M, 2009, AM J KIDNEY DIS, V53, P259, DOI 10.1053/j.ajkd.2008.07.038; Michino H, 1999, AM J EPIDEMIOL, V150, P787, DOI 10.1093/oxfordjournals.aje.a010082; Nathanson S, 2010, CLIN J AM SOC NEPHRO, V5, P1218, DOI 10.2215/CJN.08921209; Nayar Deepa M, 2006, J Infect, V52, pe103, DOI 10.1016/j.jinf.2005.07.029; Nitschke M, 2012, JAMA-J AM MED ASSOC, V307, P1046, DOI 10.1001/jama.2012.264; Ochoa TJ, 2007, ANTIMICROB AGENTS CH, V51, P2837, DOI 10.1128/AAC.01397-06; Panos GZ, 2006, ALIMENT PHARM THER, V24, P731, DOI 10.1111/j.1365-2036.2006.03036.x; Pennington H, 2010, LANCET, V376, P1428, DOI 10.1016/S0140-6736(10)60963-4; PROULX F, 1992, J PEDIATR-US, V121, P299, DOI 10.1016/S0022-3476(05)81209-0; Robert Koch Institut, 2011, ABSCHL DARST BEW EP; Robert Koch-Institut, 2011, PRAV ENT EINZ WERN; Safdar N, 2002, JAMA-J AM MED ASSOC, V288, P996, DOI 10.1001/jama.288.8.996; SHETH KJ, 1986, ANN NEUROL, V19, P90, DOI 10.1002/ana.410190120; Steinborn M, 2004, PEDIATR RADIOL, V34, P805, DOI 10.1007/s00247-004-1289-2; Tarr PI, 2005, LANCET, V365, P1073, DOI 10.1016/S0140-6736(05)71144-2; TAYLOR CM, 1986, BRIT MED J, V292, P1513, DOI 10.1136/bmj.292.6534.1513; Wong CS, 2000, NEW ENGL J MED, V342, P1930, DOI 10.1056/NEJM200006293422601; Yoh M, 1999, CAN J MICROBIOL, V45, P732, DOI 10.1139/cjm-45-9-732	44	18	19	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e55278	10.1371/journal.pone.0055278	http://dx.doi.org/10.1371/journal.pone.0055278			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460784	Green Published, gold, Green Submitted			2022-12-25	WOS:000315519000007
J	Patel, N; Itakura, T; Gonzalez, JM; Schwartz, SG; Fini, ME				Patel, Nitin; Itakura, Tatsuo; Gonzalez, Jose M., Jr.; Schwartz, Stephen G.; Fini, M. Elizabeth			GPR158, an Orphan Member of G Protein-Coupled Receptor Family C: Glucocorticoid-Stimulated Expression and Novel Nuclear Role	PLOS ONE			English	Article							TRABECULAR MESHWORK CELLS; INTRAVITREAL TRIAMCINOLONE ACETONIDE; INTRAOCULAR-PRESSURE; OUTFLOW PATHWAY; TIGHT JUNCTIONS; AQUEOUS OUTFLOW; MOLECULAR-BASIS; FLUID-FLOW; LOCALIZATION; PERMEABILITY	Members of the large G protein-coupled receptor (GPCR) clan are implicated in many physiological and disease processes, making them important therapeutic drug targets. In the present study, we follow up on results of a pilot study suggesting a functional relationship between glucocorticoid (GC)-induced ocular hypertension and GPR158, one of three orphan members of the GPCR Family C. GC treatment increases levels of GPR158 mRNA and protein through transcriptional mechanisms, in cultured trabecular meshwork (TBM) cells derived from the eye's aqueous outflow pathway. Like treatment with GCs, transient overexpression of GPR158 stimulates cell proliferation, while siRNA knockdown of endogenous GPR158 has the opposite effect. Both endogenous and overexpressed GPR158 show an unusual subcellular localization pattern, being found almost entirely in the nucleus. However, when cells are treated with inhibitors of clathrin-mediated endocytosis, GPR158 is shifted to the plasma membrane. Mutation of a bipartite nuclear localization signal (NLS) in the 8th helix also shifts GPR158 out of the nucleus, but in this case the protein is found in vesicles localized in the cytoplasm. These results suggest that newly synthesized GPR158 first traffics to the plasma membrane, where it rapidly undergoes endocytosis and translocation to the nucleus. Significantly, mutation of the NLS abrogates GPR158-mediated enhancement of cell proliferation, indicating a functional requirement for nuclear localization. GPR158 overexpression upregulates levels of the cell cycle regulator cyclin D1, but mutation of the NLS reverses this. Overexpression of GPR158 enhances the barrier function of a TBM cell monolayer, which is associated with an increase in the levels of tight junction proteins ZO-1 and occludin, similar to reported studies on GC treatment. Regulated paracellular permeability controls aqueous outflow facility in vivo. Since GCs stimulate GPR158 expression, the result is consistent with a role for elevation of GPR158 expression in GC-induced ocular hypertension.	[Patel, Nitin; Itakura, Tatsuo; Fini, M. Elizabeth] Univ So Calif, Keck Sch Med, Inst Med Genet, Los Angeles, CA 90033 USA; [Gonzalez, Jose M., Jr.] Doheny Eye Inst, Los Angeles, CA 90033 USA; [Schwartz, Stephen G.] Univ Miami, Miller Sch Med, Bascom Palmer Eye Inst, Miami, FL 33136 USA	University of Southern California; Doheny Eye Institute; Bascom Palmer Eye Institute; University of Miami	Patel, N (corresponding author), Univ So Calif, Keck Sch Med, Inst Med Genet, Los Angeles, CA 90033 USA.	nitinpat@usc.edu			National Institutes of Health [R01-EY09828, P30-0EY03040]; foundation Research to Prevent Blindness, New York, NY; NATIONAL EYE INSTITUTE [R01EY009828, P30EY003040] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); foundation Research to Prevent Blindness, New York, NY; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health Grants [R01-EY09828] to MEF and [P30-0EY03040] to Doheny Eye Institute. The foundation Research to Prevent Blindness, New York, NY, also provided support for conducting this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal P, 2010, CELL CYCLE, V9, P4908, DOI 10.4161/cc.9.24.14199; Alvarado JA, 2005, BRIT J OPHTHALMOL, V89, P1500, DOI 10.1136/bjo.2005.081307; Alvarado JA, 1998, INVEST OPHTH VIS SCI, V39, P1813; ANDERSON JM, 1995, AM J PHYSIOL-GASTR L, V269, pG467, DOI 10.1152/ajpgi.1995.269.4.G467; Bakunowicz-Lazarczyk A., 2001, Journal of Submicroscopic Cytology and Pathology, V33, P17; BALDA MS, 1993, AM J PHYSIOL, V264, pC918, DOI 10.1152/ajpcell.1993.264.4.C918; Beaulieu JM, 2005, CELL, V123, P755, DOI 10.1016/j.cell.2005.11.010; Beaumont V, 1998, J BIOL CHEM, V273, P33174, DOI 10.1074/jbc.273.50.33174; Binet V, 2007, J BIOL CHEM, V282, P12154, DOI 10.1074/jbc.M611071200; Bjarndottir TK, 2005, GENE, V362, P70, DOI 10.1016/j.gene.2005.07.029; Boivin B, 2008, J RECEPT SIG TRANSD, V28, P15, DOI [10.1080/10799890801941889, 10.1080/10799890801941889 ]; Brameier M, 2007, BIOINFORMATICS, V23, P1159, DOI 10.1093/bioinformatics/btm066; Buchan DWA, 2010, NUCLEIC ACIDS RES, V38, pW563, DOI 10.1093/nar/gkq427; CHAN GCK, 1991, J BIOL CHEM, V266, P22634; CLARK AF, 1994, INVEST OPHTH VIS SCI, V35, P281; Cole MD, 2006, CURR TOP MICROBIOL, V302, P33; DEJANA E, 1995, FASEB J, V9, P910, DOI 10.1096/fasebj.9.10.7615160; Fay JF, 2005, BIOCHEMISTRY-US, V44, P8757, DOI 10.1021/bi0472651; Filla MS, 2002, INVEST OPHTH VIS SCI, V43, P151; Fini ME, 2011, INVEST OPHTHALMOL VI, V52; Fuchshofer R, 2012, CELL TISSUE RES, V347, P279, DOI 10.1007/s00441-011-1274-7; Goetzl EJ, 2007, FASEB J, V21, P638, DOI 10.1096/fj.06-6624hyp; Gould DB, 2004, INT J DEV BIOL, V48, P1015, DOI 10.1387/ijdb.041865dg; Jans DA, 2000, BIOESSAYS, V22, P532, DOI 10.1002/(SICI)1521-1878(200006)22:6<532::AID-BIES6>3.0.CO;2-O; Jeon JW, 2003, YONSEI MED J, V44, P299, DOI 10.3349/ymj.2003.44.2.299; Kniazeff J, 2011, PHARMACOL THERAPEUT, V130, P9, DOI 10.1016/j.pharmthera.2011.01.006; KOLAKOWSKI LF, 1994, RECEPTOR CHANNEL, V2, P1; Lee DK, 2004, J BIOL CHEM, V279, P7901, DOI 10.1074/jbc.M306377200; Li AF, 2004, MOL VIS, V10, P750; Lundstrom K, 2005, IDRUGS, V8, P909; Marina-Garcia N, 2009, J IMMUNOL, V182, P4321, DOI 10.4049/jimmunol.0802197; Mathew D, 2005, SCIENCE, V310, P1344, DOI 10.1126/science.1117051; Menaa F, 2011, MOLECULES, V16, P5402, DOI 10.3390/molecules16075402; Miyamoto-Sato E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009289; Nguyen TD, 1998, J BIOL CHEM, V273, P6341, DOI 10.1074/jbc.273.11.6341; Orlandi C, 2012, J CELL BIOL, V197, P711, DOI 10.1083/jcb.201202123; Peachey NS, 2012, AM J HUM GENET, V90, P331, DOI 10.1016/j.ajhg.2011.12.006; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Quentien MH, 2006, J NEUROENDOCRINOL, V18, P633, DOI 10.1111/j.1365-2826.2006.01461.x; Rao PV, 2001, INVEST OPHTH VIS SCI, V42, P1029; Rebhan M, 1997, TRENDS GENET, V13, P163, DOI 10.1016/S0168-9525(97)01103-7; Reis LM, 2011, CURR OPIN OPHTHALMOL, V22, P314, DOI 10.1097/ICU.0b013e328349412b; Rhee DJ, 2006, BRIT J OPHTHALMOL, V90, P999, DOI 10.1136/bjo.2006.090340; Shepard AR, 2001, INVEST OPHTH VIS SCI, V42, P3173; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Smithen LM, 2004, AM J OPHTHALMOL, V138, P740, DOI 10.1016/j.ajo.2004.06.067; Sorkin A, 2002, NAT REV MOL CELL BIO, V3, P600, DOI 10.1038/nrm883; Strungaru MH, 2001, INVEST OPHTH VIS SCI, V52, P7625; Takeda S, 2002, FEBS LETT, V520, P97, DOI 10.1016/S0014-5793(02)02775-8; Thathiah A, 2009, SCIENCE, V323, P946, DOI 10.1126/science.1160649; Underwood JL, 1999, AM J PHYSIOL-CELL PH, V277, pC330, DOI 10.1152/ajpcell.1999.277.2.C330; Wang N, 2001, NAT MED, V7, P304, DOI 10.1038/85446; Wellendorph P, 2009, BRIT J PHARMACOL, V156, P869, DOI 10.1111/j.1476-5381.2008.00078.x; Yang K, 1996, BIOCHEMISTRY-US, V35, P14040, DOI 10.1021/bi962113u	54	26	27	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57843	10.1371/journal.pone.0057843	http://dx.doi.org/10.1371/journal.pone.0057843			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451275	Green Submitted, gold, Green Published			2022-12-25	WOS:000316849500138
J	Bodenhausen, N; Horton, MW; Bergelson, J				Bodenhausen, Natacha; Horton, Matthew W.; Bergelson, Joy			Bacterial Communities Associated with the Leaves and the Roots of Arabidopsis thaliana	PLOS ONE			English	Article							PYROSEQUENCING REVEALS; MICROBIAL COMMUNITIES; RIBOSOMAL-RNA; SOIL TYPE; DIVERSITY; PLANT; RHIZOSPHERE; ENDOPHYTES; COLONIZATION; VARIABILITY	Diverse communities of bacteria inhabit plant leaves and roots and those bacteria play a crucial role for plant health and growth. Arabidopsis thaliana is an important model to study plant pathogen interactions, but little is known about its associated bacterial community under natural conditions. We used 454 pyrosequencing to characterize the bacterial communities associated with the roots and the leaves of wild A. thaliana collected at 4 sites; we further compared communities on the outside of the plants with communities in the endophytic compartments. We found that the most heavily sequenced bacteria in A. thaliana associated community are related to culturable species. Proteobacteria, Actinobacteria, and Bacteroidetes are the most abundant phyla in both leaf and root samples. At the genus level, sequences of Massilia and Flavobacterium are prevalent in both samples. Organ (leaf vs root) and habitat (epiphytes vs endophytes) structure the community. In the roots, richness is higher in the epiphytic communities compared to the endophytic compartment (P = 0.024), while the reverse is true for the leaves (P = 0.032). Interestingly, leaf and root endophytic compartments do not differ in richness, diversity and evenness, while they differ in community composition (P = 0.001). The results show that although the communities associated with leaves and roots share many bacterial species, the associated communities differ in structure.	[Bodenhausen, Natacha; Horton, Matthew W.; Bergelson, Joy] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA	University of Chicago	Bergelson, J (corresponding author), Univ Chicago, Dept Ecol & Evolut, 940 E 57th St, Chicago, IL 60637 USA.	jbergels@uchicago.edu	Bodenhausen, Natacha/Y-6203-2019	Horton, Matthew/0000-0002-7537-0730; Bodenhausen, Natacha/0000-0001-9680-1176; Bergelson, Joy/0000-0001-7893-7387	National Science Foundation, NSF, entitled Microbial Observatories: Forces shaping microbial communities in the phyllosphere of Arabidopsis thaliana [MCB 0603515]; National Institute of Health, NIH, entitled Evolutionary genetics of R gene loci in Arabidopsis [GM057994]; Swiss National Science Foundation through the postdoc mobility fellowship; Swiss National Science Foundation through the Marie Heim-Vogtlin fellowship; National Science Foundation through a predoctoral fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057994] Funding Source: NIH RePORTER	National Science Foundation, NSF, entitled Microbial Observatories: Forces shaping microbial communities in the phyllosphere of Arabidopsis thaliana(National Science Foundation (NSF)); National Institute of Health, NIH, entitled Evolutionary genetics of R gene loci in Arabidopsis(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation through the postdoc mobility fellowship; Swiss National Science Foundation through the Marie Heim-Vogtlin fellowship; National Science Foundation through a predoctoral fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by two grants to JB: National Science Foundation, NSF, MCB 0603515 entitled Microbial Observatories: Forces shaping microbial communities in the phyllosphere of Arabidopsis thaliana and National Institute of Health, NIH, GM057994 entitled Evolutionary genetics of R gene loci in Arabidopsis. NB acknowledges funding from the Swiss National Science Foundation through the postdoc mobility and Marie Heim-Vogtlin fellowships. MWH acknowledges funding from the National Science Foundation through a predoctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Badri DV, 2009, CURR OPIN BIOTECH, V20, P642, DOI 10.1016/j.copbio.2009.09.014; Beattie GA, 1999, PHYTOPATHOLOGY, V89, P353, DOI 10.1094/PHYTO.1999.89.5.353; Becker R, 2008, FEMS MICROBIOL ECOL, V66, P411, DOI 10.1111/j.1574-6941.2008.00562.x; Berg G, 2005, FEMS MICROBIOL ECOL, V51, P215, DOI 10.1016/j.femsec.2004.08.006; Berg G, 2009, FEMS MICROBIOL ECOL, V68, P1, DOI 10.1111/j.1574-6941.2009.00654.x; Berry KJ, 2003, PSYCHOL REP, V92, P1141; Bulgarelli D, 2012, NATURE, V488, P91, DOI 10.1038/nature11336; Chelius MK, 2001, MICROB ECOL, V41, P252, DOI 10.1007/s002480000087; CHESSON PL, 1981, AM NAT, V117, P923, DOI 10.1086/283778; Chi F, 2005, APPL ENVIRON MICROB, V71, P7271, DOI 10.1128/AEM.71.11.7271-7278.2005; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Crosby LD, 2003, BIOTECHNIQUES, V34, P790, DOI 10.2144/03344rr01; Czajkowski R, 2010, PHYTOPATHOLOGY, V100, P134, DOI 10.1094/PHYTO-100-2-0134; Delmotte N, 2009, P NATL ACAD SCI USA, V106, P16428, DOI 10.1073/pnas.0905240106; ERCOLANI GL, 1991, MICROBIAL ECOL, V21, P35, DOI 10.1007/BF02539143; Garbeva P, 2004, ANNU REV PHYTOPATHOL, V42, P243, DOI 10.1146/annurev.phyto.42.012604.135455; Gottel NR, 2011, APPL ENVIRON MICROB, V77, P5934, DOI 10.1128/AEM.05255-11; Hardoim PR, 2008, TRENDS MICROBIOL, V16, P463, DOI 10.1016/j.tim.2008.07.008; Hunter PJ, 2010, APPL ENVIRON MICROB, V76, P8117, DOI 10.1128/AEM.01321-10; HUTCHINSON GE, 1961, AM NAT, V95, P137, DOI 10.1086/282171; Innerebner G, 2011, APPL ENVIRON MICROB, V77, P3202, DOI 10.1128/AEM.00133-11; Jost L, 2007, ECOLOGY, V88, P2427, DOI 10.1890/06-1736.1; Knief C, 2010, ISME J, V4, P719, DOI 10.1038/ismej.2010.9; Kniskern JM, 2007, MOL PLANT MICROBE IN, V20, P1512, DOI 10.1094/MPMI-20-12-1512; Lee ZMP, 2009, NUCLEIC ACIDS RES, V37, pD489, DOI 10.1093/nar/gkn689; Legendre P, 2005, J AGR BIOL ENVIR ST, V10, P226, DOI 10.1198/108571105X46642; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; Lindow SE, 2002, CURR OPIN BIOTECH, V13, P238, DOI 10.1016/S0958-1669(02)00313-0; Lindow SE, 2003, APPL ENVIRON MICROB, V69, P1875, DOI 10.1128/AEM.69.4.1875-1883.2003; Lopez-Velasco G, 2011, J APPL MICROBIOL, V110, P1203, DOI 10.1111/j.1365-2672.2011.04969.x; Lundberg DS, 2012, NATURE, V488, P86, DOI 10.1038/nature11237; Manter DK, 2010, MICROB ECOL, V60, P157, DOI 10.1007/s00248-010-9658-x; Marschner P, 2001, SOIL BIOL BIOCHEM, V33, P1437, DOI 10.1016/S0038-0717(01)00052-9; Micallef SA, 2009, J EXP BOT, V60, P1729, DOI 10.1093/jxb/erp053; Nunan N, 2005, APPL ENVIRON MICROB, V71, P6784, DOI 10.1128/AEM.71.11.6784-6792.2005; Oksanen J., 2011, VEGAN COMMUNITY ECOL; Qvit-Raz N, 2008, GENETICS, V178, P1615, DOI 10.1534/genetics.107.082164; Rasche F, 2006, CAN J MICROBIOL, V52, P1036, DOI 10.1139/W06-059; Rastogi G, 2012, ISME J, V6, P1812, DOI 10.1038/ismej.2012.32; Redford AJ, 2010, ENVIRON MICROBIOL, V12, P2885, DOI 10.1111/j.1462-2920.2010.02258.x; Redford AJ, 2009, MICROB ECOL, V58, P189, DOI 10.1007/s00248-009-9495-y; Reisberg EE, 2012, ANTON LEEUW INT J G, V101, P551, DOI 10.1007/s10482-011-9669-8; Rosenblueth M, 2006, MOL PLANT MICROBE IN, V19, P827, DOI 10.1094/MPMI-19-0827; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; SHELDON AL, 1969, ECOLOGY, V50, P466, DOI 10.2307/1933900; Sun L, 2008, MICROB ECOL, V55, P415, DOI 10.1007/s00248-007-9287-1; Takeuchi M, 2001, INT J SYST EVOL MICR, V51, P1405, DOI 10.1099/00207713-51-4-1405; Timms-Wilson T. M., 2006, Microbial ecology of aerial plant surfaces, P21, DOI 10.1079/9781845930615.0021; Uroz S, 2010, ENV MICROBIOL REP, V2, P281, DOI 10.1111/j.1758-2229.2009.00117.x; van Overbeek L, 2008, FEMS MICROBIOL ECOL, V64, P283, DOI 10.1111/j.1574-6941.2008.00469.x; Weinert N, 2009, APPL ENVIRON MICROB, V75, P3859, DOI 10.1128/AEM.00414-09; WHITTAKER R H, 1972, Taxon, V21, P213, DOI 10.2307/1218190; Yang CH, 2001, P NATL ACAD SCI USA, V98, P3889, DOI 10.1073/pnas.051633898	55	423	446	17	336	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56329	10.1371/journal.pone.0056329	http://dx.doi.org/10.1371/journal.pone.0056329			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457551	gold, Green Published, Green Submitted			2022-12-25	WOS:000315603700041
J	Chen, L; Lu, J; Zhang, J; Feng, KR; Zheng, MY; Cai, YD				Chen, Lei; Lu, Jing; Zhang, Jian; Feng, Kai-Rui; Zheng, Ming-Yue; Cai, Yu-Dong			Predicting Chemical Toxicity Effects Based on Chemical-Chemical Interactions	PLOS ONE			English	Article							PROTEIN STRUCTURAL CLASSES; AMINO-ACID-COMPOSITION; INTERACTION NETWORK; LUNG-CANCER; CARCINOGENICITY; LOCATIONS; BIOMARKER; MACHINE; DISEASE; SMOKERS	Toxicity is a major contributor to high attrition rates of new chemical entities in drug discoveries. In this study, an order-classifier was built to predict a series of toxic effects based on data concerning chemical-chemical interactions under the assumption that interactive compounds are more likely to share similar toxicity profiles. According to their interaction confidence scores, the order from the most likely toxicity to the least was obtained for each compound. Ten test groups, each of them containing one training dataset and one test dataset, were constructed from a benchmark dataset consisting of 17,233 compounds. By a Jackknife test on each of these test groups, the 1st order prediction accuracies of the training dataset and the test dataset were all approximately 79.50%, substantially higher than the rate of 25.43% achieved by random guesses. Encouraged by the promising results, we expect that our method will become a useful tool in screening out drugs with high toxicity.	[Cai, Yu-Dong] Shanghai Univ, Inst Syst Biol, Shanghai, Peoples R China; [Chen, Lei] Shanghai Maritime Univ, Coll Informat Engn, Shanghai, Peoples R China; [Lu, Jing; Zheng, Ming-Yue] Shanghai Inst Mat Med, Drug Discovery & Design Ctr, Shanghai, Peoples R China; [Zhang, Jian] Shanghai Jiao Tong Univ, Dept Ophthalmol, Shanghai Peoples Hosp 1, Shanghai 200030, Peoples R China; [Feng, Kai-Rui] Simcyp Ltd, Blades Enterprise Ctr, Sheffield, S Yorkshire, England	Shanghai University; Shanghai Maritime University; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Shanghai Jiao Tong University; Simcyp	Zheng, MY (corresponding author), Shanghai Inst Mat Med, Drug Discovery & Design Ctr, Shanghai, Peoples R China.	myzheng@mail.shcnc.ac.cn; cai_yud@yahoo.com.cn	Chen, Lei/A-2275-2011; Zheng, Mingyue/AAJ-8027-2020; Zheng, Mingyue/B-4860-2010; Zheng, Mingyue/HHZ-4062-2022; Zheng, Mingyue/Z-3582-2019	Chen, Lei/0000-0003-3068-1583; Zheng, Mingyue/0000-0002-3323-3092; Zheng, Mingyue/0000-0002-3323-3092; Zheng, Mingyue/0000-0002-3323-3092; cai, yudong/0000-0001-5664-7979	National Basic Research Program of China [2011CB510102, 2011CB510101]; National Natural Science Foundation of China [61202021, 81001399]; National ST Major Project [2012ZX09301-001-002]; Hi-TECH Research and Development Program of China [2012AA020308]; Innovation Program of Shanghai Municipal Education Commission [12YZ120, 12ZZ087]; Shanghai Educational Development Foundation [12CG55]; Science and Technology Program of Shanghai Maritime University [20120105]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National ST Major Project; Hi-TECH Research and Development Program of China(National High Technology Research and Development Program of China); Innovation Program of Shanghai Municipal Education Commission(Innovation Program of Shanghai Municipal Education Commission); Shanghai Educational Development Foundation; Science and Technology Program of Shanghai Maritime University	This work was supported by National Basic Research Program of China (2011CB510102, 2011CB510101), National Natural Science Foundation of China (61202021, 81001399), National S&T Major Project (2012ZX09301-001-002), Hi-TECH Research and Development Program of China (2012AA020308), Innovation Program of Shanghai Municipal Education Commission (12YZ120, 12ZZ087), Shanghai Educational Development Foundation (12CG55), and Science and Technology Program of Shanghai Maritime University (No. 20120105). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], ACC TOX DAT 2011 4; Arcos JC, 1995, MULTIFACTOR INTERACT, P1; Benigni R, 2008, MUTAT RES-REV MUTAT, V659, P248, DOI 10.1016/j.mrrev.2008.05.003; Benigni R, 2011, CHEM REV, V111, P2507, DOI 10.1021/cr100222q; Bogdanov P, 2010, IEEE ACM T COMPUT BI, V7, P208, DOI 10.1109/TCBB.2009.81; Cai YD, 2010, MOL DIVERS, V14, P551, DOI 10.1007/s11030-009-9182-4; Chen L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035254; Chen L, 2012, PROTEIN PEPTIDE LETT, V19, P99, DOI 10.2174/092986612798472857; Church TR, 2009, CANCER EPIDEM BIOMAR, V18, P260, DOI 10.1158/1055-9965.EPI-08-0718; Crammer K., 2001, J MACHINE LEARNING R, V2, P265; Dietterich T. G., 1995, Journal of Artificial Intelligence Research, V2, P263; Du PF, 2011, EXPERT REV PROTEOMIC, V8, P391, DOI [10.1586/EPR.11.20, 10.1586/epr.11.20]; DUBACH UC, 1991, NEW ENGL J MED, V324, P155, DOI 10.1056/NEJM199101173240304; Esmaeili M, 2010, J THEOR BIOL, V263, P203, DOI 10.1016/j.jtbi.2009.11.016; Gao P, 2012, PROTEIN PEPTIDE LETT, V19, P910, DOI 10.2174/092986612802084528; Georgiou DN, 2009, J THEOR BIOL, V257, P17, DOI 10.1016/j.jtbi.2008.11.003; Hu L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017668; Hu LL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014556; Ivanciuc O, 2008, CURR TOP MED CHEM, V8, P1691, DOI 10.2174/156802608786786589; Jin LX, 2003, COMPUT BIOL CHEM, V27, P373, DOI 10.1016/S1476-9271(02)00087-7; Kourmpetis YAI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009293; Kuhn M, 2008, NUCLEIC ACIDS RES, V36, pD684, DOI 10.1093/nar/gkm795; Kuhn M, 2010, NUCLEIC ACIDS RES, V38, pD552, DOI 10.1093/nar/gkp937; Li BQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039308; Ng KL, 2010, COMPUT BIOL MED, V40, P300, DOI 10.1016/j.compbiomed.2010.01.001; Patlewicz GY, 2002, CONTACT DERMATITIS, V47, P219, DOI 10.1034/j.1600-0536.2002.470406.x; Plaimas K, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-67; Ravetti MG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003111; Shao XJ, 2009, J THEOR BIOL, V258, P289, DOI 10.1016/j.jtbi.2009.01.024; Sharan R, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100129; Sun XD, 2006, AMINO ACIDS, V30, P469, DOI 10.1007/s00726-005-0239-0; Wang Wei-bin, 2011, Chinese Medical Sciences Journal, V26, P168; Wang Y, 2012, J CHEM INF MODEL, V52, P1994, DOI 10.1021/ci300266p; Woo Y. T., 2003, QUANTITATIVE STRUCTU, P41; Yuan JM, 2009, CANCER RES, V69, P2990, DOI 10.1158/0008-5472.CAN-08-4330; Zeng YH, 2009, J THEOR BIOL, V259, P366, DOI 10.1016/j.jtbi.2009.03.028; Zheng MY, 2006, BIOINFORMATICS, V22, P2099, DOI 10.1093/bioinformatics/btl352	37	22	22	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56517	10.1371/journal.pone.0056517	http://dx.doi.org/10.1371/journal.pone.0056517			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457578	Green Published, gold, Green Submitted			2022-12-25	WOS:000315603700059
J	Hsu, MF; Yu, TF; Chou, CC; Fu, HY; Yang, CS; Wang, AHJ				Hsu, Min-Feng; Yu, Tsung-Fu; Chou, Chia-Cheng; Fu, Hsu-Yuan; Yang, Chii-Shen; Wang, Andrew H. J.			Using Haloarcula marismortui Bacteriorhodopsin as a Fusion Tag for Enhancing and Visible Expression of Integral Membrane Proteins in Escherichia coli	PLOS ONE			English	Article							UNDECAPRENYL PYROPHOSPHATE PHOSPHATASE; GENOME SEQUENCE; CARNITINE TRANSPORTER; ANGSTROM RESOLUTION; NMR STRUCTURE; OVEREXPRESSION; PURIFICATION; ARCHAEON; TEMPERATURE; MECHANISM	Membrane proteins are key targets for pharmacological intervention because of their vital functions. Structural and functional studies of membrane proteins have been severely hampered because of the difficulties in producing sufficient quantities of properly folded and biologically active proteins. Here we generate a high-level expression system of integral membrane proteins in Escherichia coli by using a mutated bacteriorhodopsin (BR) from Haloarcula marismortui (HmBRI/D94N) as a fusion partner. A purification strategy was designed by incorporating a His-tag on the target membrane protein for affinity purification and an appropriate protease cleavage site to generate the final products. The fusion system can be used to detect the intended target membrane proteins during overexpression and purification either with the naked eye or by directly monitoring their characteristic optical absorption. In this study, we applied this approach to produce two functional integral membrane proteins, undecaprenyl pyrophosphate phosphatase and carnitine/butyrobetaine antiporter with significant yield enhancement. This technology could facilitate the development of a high-throughput strategy to screen for conditions that improve the yield of correctly folded target membrane proteins. Other robust BRs can also be incorporated in this system.	[Hsu, Min-Feng; Yu, Tsung-Fu; Chou, Chia-Cheng; Wang, Andrew H. J.] Acad Sinica, Inst Biol Chem, Taipei, Taiwan; [Hsu, Min-Feng; Chou, Chia-Cheng; Wang, Andrew H. J.] Acad Sinica, Core Facil Prot Struct Anal, Taipei 115, Taiwan; [Yu, Tsung-Fu] Natl Tsing Hua Univ, Inst Bioinformat & Struct Biol, Hsinchu, Taiwan; [Fu, Hsu-Yuan; Yang, Chii-Shen] Natl Taiwan Univ, Dept Biochem Sci & Technol, Taipei 10764, Taiwan; [Wang, Andrew H. J.] Natl Taiwan Univ, Inst Biochem Sci, Taipei, Taiwan	Academia Sinica - Taiwan; Academia Sinica - Taiwan; National Tsing Hua University; National Taiwan University; National Taiwan University	Yang, CS (corresponding author), Natl Taiwan Univ, Dept Biochem Sci & Technol, Taipei 10764, Taiwan.	chiishen@ntu.edu.tw; ahjwang@gate.sinica.edu.tw	Hsiao, Wei-Hung/B-9931-2013	YANG, CHII-SHEN/0000-0002-2792-6247; Fu, Hsu-Yuan/0000-0002-5327-2208	National Science Council [NSC100-2325-B-001-029]	National Science Council(Ministry of Science and Technology, Taiwan)	This work was supported in part by grants from National Science Council NSC100-2325-B-001-029 to AHJW for core facilities for protein structural analysis at Academia Sinica, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Baliga NS, 2004, GENOME RES, V14, P2221, DOI 10.1101/gr.2700304; Belrhali H, 1999, STRUCTURE, V7, P909, DOI 10.1016/S0969-2126(99)80118-X; Bolhuis H, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-169; BRAIMAN MS, 1987, J BIOL CHEM, V262, P9271; Chun E, 2012, STRUCTURE, V20, P967, DOI 10.1016/j.str.2012.04.010; Daggett V, 2009, CURR OPIN STRUC BIOL, V19, P1, DOI 10.1016/j.sbi.2009.01.006; Douglas SM, 2007, P NATL ACAD SCI USA, V104, P6644, DOI 10.1073/pnas.0700930104; Drew D, 2006, NAT METHODS, V3, P303, DOI 10.1038/nmeth0406-303; Drew DE, 2001, FEBS LETT, V507, P220, DOI 10.1016/S0014-5793(01)02980-5; DUNN RJ, 1987, J BIOL CHEM, V262, P9246; El Ghachi M, 2004, J BIOL CHEM, V279, P30106, DOI 10.1074/jbc.M401701200; Esposito D, 2006, CURR OPIN BIOTECH, V17, P353, DOI 10.1016/j.copbio.2006.06.003; Falb M, 2005, GENOME RES, V15, P1336, DOI 10.1101/gr.3952905; Falb M, 2008, EXTREMOPHILES, V12, P177, DOI 10.1007/s00792-008-0138-x; Finn RD, 2005, BIOTECHNIQUES, V38, P387, DOI 10.2144/05383ST01; Fu HY, 2010, J BACTERIOL, V192, P5866, DOI 10.1128/JB.00642-10; Jung H, 2002, J BIOL CHEM, V277, P39251, DOI 10.1074/jbc.M206319200; Kapust RB, 2001, PROTEIN ENG, V14, P993, DOI 10.1093/protein/14.12.993; Katzen F, 2009, TRENDS BIOTECHNOL, V27, P455, DOI 10.1016/j.tibtech.2009.05.005; Lu T, 1998, J CHEM SOC FARADAY T, V94, P79, DOI 10.1039/a701858d; Luecke H, 1999, SCIENCE, V286, P255, DOI 10.1126/science.286.5438.255; Lundstrom K, 2004, CURR OPIN DRUG DISC, V7, P342; Manley DM, 2000, BIOCHEMISTRY-US, V39, P12303, DOI 10.1021/bi000703t; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; MOGI T, 1988, P NATL ACAD SCI USA, V85, P4148, DOI 10.1073/pnas.85.12.4148; Neophytou I, 2007, APPL MICROBIOL BIOT, V77, P375, DOI 10.1007/s00253-007-1174-7; Ng WV, 2000, P NATL ACAD SCI USA, V97, P12176, DOI 10.1073/pnas.190337797; OTTO H, 1989, P NATL ACAD SCI USA, V86, P9228, DOI 10.1073/pnas.86.23.9228; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PebayPeyroula E, 1997, SCIENCE, V277, P1676, DOI 10.1126/science.277.5332.1676; Roosild TP, 2005, SCIENCE, V307, P1317, DOI 10.1126/science.1106392; Schmies G, 2000, FEBS LETT, V466, P67, DOI 10.1016/S0014-5793(99)01760-3; Shih YP, 2002, PROTEIN SCI, V11, P1714, DOI 10.1110/ps.0205202; Tang L, 2010, NAT STRUCT MOL BIOL, V17, P492, DOI 10.1038/nsmb.1788; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Touze T, 2008, J BIOL CHEM, V283, P16573, DOI 10.1074/jbc.M800394200; Vinothkumar KR, 2006, J BIOL CHEM, V281, P4795, DOI 10.1074/jbc.M508993200; Wagner S, 2006, TRENDS BIOTECHNOL, V24, P364, DOI 10.1016/j.tibtech.2006.06.008; White SH, 2009, NATURE, V459, P344, DOI [10.1038/nature08142, 10.1038/nature]; Yokoyama Y, 2002, J BIOCHEM, V131, P785, DOI 10.1093/oxfordjournals.jbchem.a003166; Yokoyama Y, 2007, J BIOCHEM, V142, P325, DOI 10.1093/jb/mvm135	41	32	34	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56363	10.1371/journal.pone.0056363	http://dx.doi.org/10.1371/journal.pone.0056363			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457558	gold, Green Published, Green Submitted			2022-12-25	WOS:000315603700046
J	Ledeganck, KJ; Boulet, GA; Bogers, JJ; Verpooten, GA; De Winter, BY				Ledeganck, Kristien J.; Boulet, Gaelle A.; Bogers, Johannes J.; Verpooten, Gert A.; De Winter, Benedicte Y.			The TRPM6/EGF Pathway Is Downregulated in a Rat Model of Cisplatin Nephrotoxicity	PLOS ONE			English	Article							SECONDARY HYPOCALCEMIA; INDUCED HYPOMAGNESEMIA; MAGNESIUM DEPLETION; EXPRESSION; CETUXIMAB; CHANNELS; CA2+	Cisplatin-induced hypomagnesemia is described in humans and rats, but the underlying mechanisms are still unclear. Recent studies have shown that epidermal growth factor (EGF) stimulates Mg2+ re-absorption in the distal convoluted tubule via the Mg2+ channel TRPM6. This study investigates the role of TRPM Mg2+ channels, claudines, and EGF in the Mg2+ homeostasis in a rat model of cisplatin-induced nephrotoxicity. Wistar rats were given 2.5 mg/kg cisplatin per week for 3 weeks and were euthanized 4 or 9 weeks after the first administration. The cisplatin treatment significantly increased the fractional excretion of Mg2+. Real-time RT-PCR and/or Western blots were performed to assess the renal expression TRPM6, TRPM7, claudin-16, claudin-19, EGF, EGF receptor (EGFR) and EGFR-pathway components. The renal mRNA expression of TRPM6 and EGF showed a significant decrease after cisplatin treatment, while the TRPM7, claudin-16 and EGFR expressions remained stable. The claudin-19 mRNA expression was significantly upregulated after cisplatin treatment. Western blotting confirmed the mRNA expression data for the claudins, but an showed upregulation of EGFR only at week 9. The role of the EGFR pathway, involving Pi3-AKT-Rac1, in cisplatin-induced nephropathy, could not be substantiated in further detail. This study shows that cisplatin treatment results in EGF and TRPM6 downregulation in the rat kidney, causing renal Mg2+ loss. Our results are in line with the hypothesis that EGF influences the renal expression or activation of TRPM6 and plays a significant role in Mg2+ loss in medication-induced nephropathy.	[Ledeganck, Kristien J.; Verpooten, Gert A.; De Winter, Benedicte Y.] Univ Antwerp, Lab Expt Med & Pediat, B-2020 Antwerp, Belgium; [Boulet, Gaelle A.; Bogers, Johannes J.] Univ Antwerp, Appl Mol Biol Res Grp, B-2020 Antwerp, Belgium; [Verpooten, Gert A.] Univ Antwerp Hosp, Dept Nephrol Hypertens, Edegem, Belgium	University of Antwerp; University of Antwerp; University of Antwerp	De Winter, BY (corresponding author), Univ Antwerp, Lab Expt Med & Pediat, B-2020 Antwerp, Belgium.	benedicte.dewinter@ua.ac.be	Ledeganck, Kristien/AAY-1428-2020; De Winter, Benedicte Y/G-2616-2011; Bogers, John-Paul/E-2596-2017	Ledeganck, Kristien/0000-0003-4377-7648; De Winter, Benedicte Y/0000-0003-0327-6304; Bogers, John-Paul/0000-0001-9107-132X	University of Antwerp	University of Antwerp	This study was supported by a research grant for KJL from the University of Antwerp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bussieres L, 1990, Magnes Res, V3, P179; Cahalan MD, 2009, IMMUNOL REV, V231, P59, DOI 10.1111/j.1600-065X.2009.00816.x; Cao YF, 2010, CHEMOTHERAPY, V56, P459, DOI 10.1159/000321011; Choi Dae Eun, 2009, Korean Journal of Internal Medicine, V24, P238, DOI 10.3904/kjim.2009.24.3.238; Chubanov V, 2007, J BIOL CHEM, V282, P7656, DOI 10.1074/jbc.M611117200; Dimke H, 2010, J AM SOC NEPHROL, V21, P1309, DOI 10.1681/ASN.2009111153; Duymelinck C, 1998, KIDNEY INT, V54, P804, DOI 10.1046/j.1523-1755.1998.00050.x; Fakih MG, 2006, CLIN COLORECTAL CANC, V6, P152, DOI 10.3816/CCC.2006.n.033; Gamba G, 2009, AM J PHYSIOL-RENAL, V297, pF838, DOI 10.1152/ajprenal.00159.2009; Groenestege WMT, 2007, J CLIN INVEST, V117, P2260, DOI 10.1172/JCI31680; Hodgkinson E, 2006, CLIN ONCOL-UK, V18, P710, DOI 10.1016/j.clon.2006.06.011; Hoenderop JGJ, 2005, J AM SOC NEPHROL, V16, P15, DOI 10.1681/ASN.2004070523; Hou JH, 2010, CURR OPIN NEPHROL HY, V19, P483, DOI 10.1097/MNH.0b013e32833b7125; Ikari A, 2007, ARCH PHARM, V377, P333; Konrad M, 2004, AM J PHYSIOL-RENAL, V286, pF599, DOI 10.1152/ajprenal.00312.2003; Lajer H, 2005, CANCER CHEMOTH PHARM, V56, P535, DOI 10.1007/s00280-005-1010-7; LAM M, 1986, AM J KIDNEY DIS, V8, P164, DOI 10.1016/S0272-6386(86)80020-8; Ledeganck KJ, 2011, AM J PHYSIOL-RENAL, V301, pF486, DOI 10.1152/ajprenal.00116.2011; Li M, 2006, J GEN PHYSIOL, V127, P525, DOI 10.1085/jgp.200609502; MAVICHAK V, 1985, KIDNEY INT, V28, P914, DOI 10.1038/ki.1985.217; Meier M, 2008, CELL PHYSIOL BIOCHEM, V21, P279, DOI 10.1159/000129386; Nadler MJS, 2001, NATURE, V411, P590, DOI 10.1038/35079092; Nijenhuis T, 2004, J AM SOC NEPHROL, V15, P549, DOI 10.1097/01.ASN.0000113318.56023.B6; Perez-Rojas JM, 2009, FREE RADICAL RES, V43, P1122, DOI 10.1080/10715760903214447; Runyan CE, 2004, J BIOL CHEM, V279, P2632, DOI 10.1074/jbc.M310412200; SAFIRSTEIN R, 1989, KIDNEY INT, V36, P810, DOI 10.1038/ki.1989.266; Schlingmann KP, 2002, NAT GENET, V31, P166, DOI 10.1038/ng889; Seo JY, 2009, AM J NEPHROL, V30, P481, DOI 10.1159/000242477; Shimamura H, 2003, J AM SOC NEPHROL, V14, P1427, DOI 10.1097/01.ASN.0000066140.99610.32; Tejpar S, 2007, LANCET ONCOL, V8, P387, DOI 10.1016/S1470-2045(07)70108-0; Thebault S, 2009, J AM SOC NEPHROL, V20, P78, DOI 10.1681/ASN.2008030327; Touyz RM, 2008, AM J PHYSIOL-HEART C, V294, pH1103, DOI 10.1152/ajpheart.00903.2007; van Angelen AA, 2012, NEPHROL DIAL TRANSPL; Voets T, 2004, J BIOL CHEM, V279, P19, DOI 10.1074/jbc.M311201200; Wang ZF, 2003, J AM SOC NEPHROL, V14, P3147, DOI 10.1097/01.ASN.0000098681.56240.1A	35	40	43	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e57016	10.1371/journal.pone.0057016	http://dx.doi.org/10.1371/journal.pone.0057016			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457647	Green Submitted, Green Published, gold			2022-12-25	WOS:000315603700101
J	Maestro, B; Galan, B; Alfonso, C; Rivas, G; Prieto, MA; Sanz, JM				Maestro, Beatriz; Galan, Beatriz; Alfonso, Carlos; Rivas, German; Prieto, Maria A.; Sanz, Jesus M.			A New Family of Intrinsically Disordered Proteins: Structural Characterization of the Major Phasin PhaF from Pseudomonas putida KT2440	PLOS ONE			English	Article							POLYHYDROXYALKANOIC ACID GRANULES; SECONDARY STRUCTURE PREDICTION; CIRCULAR-DICHROISM; RALSTONIA-EUTROPHA; BACILLUS-MEGATERIUM; LEUCINE-ZIPPER; HEAT-CAPACITY; COILED COILS; BACTERIAL; IDENTIFICATION	Phasins are intracellular polyhydroxyalkanoat4e ( PHA)-associated proteins involved in the stabilization of these bacterial carbon storage granules. Despite its importance in PHA metabolism and regulation, only few reports have focused so far on the structure of these proteins. In this work we have investigated the structure and stability of the PhaF phasin from Pseudomonas putida KT2440, a protein that is involved in PHA granule stabilization and distribution to daughter cells upon cell division. A structural, three-dimensional model of the protein was built from homology modeling procedures and consensus secondary structure predictions. The model predicts that PhaF is an elongated protein, with a long, amphipathic N-terminal helix with PHA binding capacity, followed by a short leucine zipper involved in protein oligomerization and a superhelical C-terminal domain wrapped around the chromosomal DNA. Hydrodynamic, spectroscopical and thermodynamic experiments validated the model and confirmed both that free PhaF is a tetramer in solution and that most part of the protein is intrinsically disordered in the absence of its ligands. The results lay a molecular basis for the explanation of the biological role of PhaF and, along with an exhaustive analysis of phasin sequence databases, suggest that intrinsic disorder and oligomerization through coiled-coils may be a widespread mechanism among these proteins.	[Maestro, Beatriz; Sanz, Jesus M.] Univ Miguel Hernandez, Inst Biol Mol & Celular, Elche, Spain; [Galan, Beatriz; Alfonso, Carlos; Rivas, German; Prieto, Maria A.] CSIC, Ctr Invest Biol, Madrid, Spain	Universidad Miguel Hernandez de Elche; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)	Sanz, JM (corresponding author), Univ Miguel Hernandez, Inst Biol Mol & Celular, Elche, Spain.	jmsanz@umh.es	Rivas, German/AAG-7458-2022; Alfonso, Carlos/K-1316-2014; Sanz, Jesus M/B-2244-2008; Maestro, Beatriz/F-3857-2016; Rivas, German/AFL-7528-2022; Prieto, María Auxiliadora/I-8092-2015	Rivas, German/0000-0003-3450-7478; Alfonso, Carlos/0000-0001-7165-4800; Sanz, Jesus M/0000-0002-4421-9376; Maestro, Beatriz/0000-0001-5317-650X; Rivas, German/0000-0003-3450-7478; Galan, Beatriz/0000-0002-2596-6034; Prieto Jimenez, M. Auxiliadora/0000-0002-8038-1223	Spanish Ministry of Economy and Competitiveness [BFU2010-17824, BIO2010-21049, BIO2007-67304-C02]; Valencian Government, Spain [FPA/2010/055]	Spanish Ministry of Economy and Competitiveness(Spanish Government); Valencian Government, Spain	This work was supported by grants BFU2010-17824, BIO2010-21049, BIO2007-67304-C02 (Spanish Ministry of Economy and Competitiveness, http://www.mineco.gob.es/portal/site/mineco?lang_choosen=en) and FPA/2010/055 (Valencian Government, Spain, http://www.gva.es/en/inicio/presentacion). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backmann J, 1998, J MOL BIOL, V284, P817, DOI 10.1006/jmbi.1998.2216; Buck M, 1998, Q REV BIOPHYS, V31, P297, DOI 10.1017/S003358359800345X; Cheng JL, 2005, DATA MIN KNOWL DISC, V11, P213, DOI 10.1007/s10618-005-0001-y; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Delorenzi M, 2002, BIOINFORMATICS, V18, P617, DOI 10.1093/bioinformatics/18.4.617; DESMET MJ, 1983, J BACTERIOL, V154, P870, DOI 10.1128/JB.154.2.870-878.1983; Dunker AK, 2002, ADV PROTEIN CHEM, V62, P25; Dunker AK, 2002, BIOCHEMISTRY-US, V41, P6573, DOI 10.1021/bi012159+; Durr E, 1999, BIOCHEMISTRY-US, V38, P870, DOI 10.1021/bi981891e; Fairman R, 1996, BIOCHEMISTRY-US, V35, P2824, DOI 10.1021/bi952784c; FENG SB, 1994, SCIENCE, V266, P1241, DOI 10.1126/science.7526465; FINDLAY RH, 1983, APPL ENVIRON MICROB, V45, P71, DOI 10.1128/AEM.45.1.71-78.1983; FREIRE E, 1990, ANNU REV BIOPHYS BIO, V19, P159; Galan B, 2011, MOL MICROBIOL, V79, P402, DOI 10.1111/j.1365-2958.2010.07450.x; Gao X, 2011, CURR OPIN BIOTECH, V22, P768, DOI 10.1016/j.copbio.2011.06.005; Garcia B, 1999, J BIOL CHEM, V274, P29228, DOI 10.1074/jbc.274.41.29228; GREENE RF, 1974, J BIOL CHEM, V249, P5388; Guermeur Y, 1999, BIOINFORMATICS, V15, P413, DOI 10.1093/bioinformatics/15.5.413; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Jendrossek D, 2009, J BACTERIOL, V191, P3195, DOI 10.1128/JB.01723-08; Johnson WC, 1999, PROTEINS, V35, P307, DOI 10.1002/(SICI)1097-0134(19990515)35:3<307::AID-PROT4>3.0.CO;2-3; Kuchta K, 2007, BIOMACROMOLECULES, V8, P657, DOI 10.1021/bm060912e; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Lewitzky M, 2004, J BIOL CHEM, V279, P28724, DOI 10.1074/jbc.M402745200; Linding R, 2003, STRUCTURE, V11, P1453, DOI 10.1016/j.str.2003.10.002; Luengo JM, 2003, CURR OPIN MICROBIOL, V6, P251, DOI 10.1016/S1369-5274(03)00040-7; LUMRY R, 1954, J PHYS CHEM-US, V58, P110, DOI 10.1021/j150512a005; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Madison LL, 1999, MICROBIOL MOL BIOL R, V63, P21, DOI 10.1128/MMBR.63.1.21-53.1999; Maehara A, 1999, J BACTERIOL, V181, P2914, DOI 10.1128/JB.181.9.2914-2921.1999; Mayer F, 1996, J GEN APPL MICROBIOL, V42, P445, DOI 10.2323/jgam.42.445; McCool GJ, 1999, J BACTERIOL, V181, P585, DOI 10.1128/JB.181.2.585-592.1999; MEDVEDKIN VN, 1995, PROTEIN ENG, V8, P63, DOI 10.1093/protein/8.1.63; Minton A.P., 1994, MODERN ANAL ULTRACEN, P81; Moldes C, 2004, APPL ENVIRON MICROB, V70, P3205, DOI 10.1128/AEM.70.6.3205-3212.2004; Moldes C, 2006, APPL MICROBIOL BIOT, V72, P88, DOI 10.1007/s00253-005-0257-6; MYERS JK, 1995, PROTEIN SCI, V4, P2138, DOI 10.1002/pro.5560041020; Peng ZL, 2012, MOL BIOSYST, V8, P1886, DOI 10.1039/c2mb25102g; Phelan P, 2002, BIOCHEMISTRY-US, V41, P2998, DOI 10.1021/bi011920c; PIEPERFURST U, 1994, J BACTERIOL, V176, P4328, DOI 10.1128/jb.176.14.4328-4337.1994; Prieto M, 2007, PSEUDOMONAS MODEL SY, P397, DOI [10.1007/978-1-4020-6097-7_14, DOI 10.1007/978-1-4020-6097-7_14]; Prieto MA, 1999, J BACTERIOL, V181, P858, DOI 10.1128/JB.181.3.858-868.1999; PRIVALOV PL, 1989, J MOL BIOL, V205, P737, DOI 10.1016/0022-2836(89)90318-5; PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006; Qi Q, 2000, APPL MICROBIOL BIOT, V54, P37, DOI 10.1007/s002530000357; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; SANCHEZRUIZ JM, 1988, BIOCHEMISTRY-US, V27, P1648, DOI 10.1021/bi00405a039; Sandoval A, 2007, ENVIRON MICROBIOL, V9, P737, DOI 10.1111/j.1462-2920.2006.01196.x; SCHEMBRI MA, 1995, FEMS MICROBIOL LETT, V133, P277, DOI 10.1016/0378-1097(95)00374-E; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; SREERAMA N, 1994, BIOCHEMISTRY-US, V33, P10022, DOI 10.1021/bi00199a028; Steinbuchel A, 1998, TRENDS BIOTECHNOL, V16, P419, DOI 10.1016/S0167-7799(98)01194-9; STEINBUCHEL A, 1995, CAN J MICROBIOL, V41, P94, DOI 10.1139/m95-175; SWINT L, 1993, PROTEIN SCI, V2, P2037, DOI 10.1002/pro.5560021205; Uversky VN, 2011, INT J BIOCHEM CELL B, V43, P1090, DOI 10.1016/j.biocel.2011.04.001; van Holde KE, 1986, PHYSICAL BIOCH, P3; VENTURI V, 1995, GENE, V155, P83, DOI 10.1016/0378-1119(94)00868-S; Wang ZH, 2008, LAB CHIP, V8, P1957, DOI 10.1039/b807762b; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; WIECZOREK R, 1995, J BACTERIOL, V177, P2425, DOI 10.1128/jb.177.9.2425-2435.1995; Williams S.F., 2002, BIOPOLYMERS POLYESTE, V4, P91; WOODY RW, 1995, METHOD ENZYMOL, V246, P34; Xue B, 2010, BBA-PROTEINS PROTEOM, V1804, P996, DOI 10.1016/j.bbapap.2010.01.011; York GM, 2002, J BACTERIOL, V184, P59, DOI 10.1128/JB.184.1.59-66.2002; York GM, 2001, J BACTERIOL, V183, P4217, DOI 10.1128/JB.183.14.4217-4226.2001; Zinn M, 2001, ADV DRUG DELIVER REV, V53, P5, DOI 10.1016/S0169-409X(01)00218-6	68	40	42	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56904	10.1371/journal.pone.0056904	http://dx.doi.org/10.1371/journal.pone.0056904			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457638	Green Published, Green Submitted, gold			2022-12-25	WOS:000315603700096
J	Goto, R; Okamoto, T; Ishikawa, H; Hamamura, Y; Kato, M				Goto, Ryutaro; Okamoto, Tomoko; Ishikawa, Hiroshi; Hamamura, Yoichi; Kato, Makoto			Molecular Phylogeny of Echiuran Worms (Phylum: Annelida) Reveals Evolutionary Pattern of Feeding Mode and Sexual Dimorphism	PLOS ONE			English	Article							SEQUENCE ALIGNMENT; CLASSIFICATION; SEAVIEW	The Echiura, or spoon worms, are a group of marine worms, most of which live in burrows in soft sediments. This annelid-like animal group was once considered as a separate phylum because of the absence of segmentation, although recent molecular analyses have placed it within the annelids. In this study, we elucidate the interfamily relationships of echiuran worms and their evolutionary pattern of feeding mode and sexual dimorphism, by performing molecular phylogenetic analyses using four genes (18S, 28S, H3, and COI) of representatives of all extant echiuran families. Our results suggest that Echiura is monophyletic and comprises two unexpected groups: [Echiuridae+Urechidae+Thalassematidae] and [Bonelliidae+Ikedidae]. This grouping agrees with the presence/absence of marked sexual dimorphism involving dwarf males and the paired/non-paired configuration of the gonoducts (genital sacs). Furthermore, the data supports the sister group relationship of Echiuridae and Urechidae. These two families share the character of having anal chaetae rings around the posterior trunk as a synapomorphy. The analyses also suggest that deposit feeding is a basal feeding mode in echiurans and that filter feeding originated once in the common ancestor of Urechidae. Overall, our results contradict the currently accepted order-level classification, especially in that Echiuroinea is polyphyletic, and provide novel insights into the evolution of echiuran worms.	[Goto, Ryutaro] Univ Tokyo, Dept Marine Ecosyst Dynam, Atmosphere & Ocean Res Inst, Kashiwa, Chiba, Japan; [Goto, Ryutaro; Okamoto, Tomoko; Kato, Makoto] Kyoto Univ, Grad Sch Human & Environm Studies, Kyoto, Japan	University of Tokyo; Kyoto University	Goto, R (corresponding author), Univ Tokyo, Dept Marine Ecosyst Dynam, Atmosphere & Ocean Res Inst, Kashiwa, Chiba, Japan.	gotoryutaro@gmail.com	Okamoto, Tomoko/L-8550-2013	Okamoto, Tomoko/0000-0001-8135-481X	Japan Society for the Promotion of Science Grant; Japan Society for the Promotion of Science Research Fellowships for Young Scientists Grant	Japan Society for the Promotion of Science Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Society for the Promotion of Science Research Fellowships for Young Scientists Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was funded by a Japan Society for the Promotion of Science Grant to MK and a Japan Society for the Promotion of Science Research Fellowships for Young Scientists Grant to RG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biseswar R, 2010, ZOOTAXA, P21; Biseswar R, 2009, ZOOTAXA, P17, DOI 10.11646/zootaxa.2222.1.2; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edmonds S.J., 2000, POLYCHAETES ALLIES A, P353; Fisher Walter Kenrick, 1946, PROC U S NATION MUS, V96, P215; Galtier N, 1996, COMPUT APPL BIOSCI, V12, P543; Gislen T., 1940, Lunds Universitets Arsskrift, V36, P1; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Jobb G, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-18; Lehrke J, 2012, THESIS RHEINISCHEN F; McHugh D, 1997, P NATL ACAD SCI USA, V94, P8006, DOI 10.1073/pnas.94.15.8006; Nishikawa T, 2002, ZOOL SCI, V19, P1175, DOI 10.2108/zsj.19.1175; Pietsch TW, 2005, ICHTHYOL RES, V52, P207, DOI 10.1007/s10228-005-0286-2; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rouse GW, 2004, SCIENCE, V305, P668, DOI 10.1126/science.1098650; Rouse GW, 2001, POLYCHAETES, P42, DOI DOI 10.1111/J.1439-0469.2004.00263.X; Ruppert EE, 2004, INVERTEBRATE ZOOLOGY; SAXENA R, 1983, J ZOOL, V199, P149; Sokolov EP, 2000, J MOLLUS STUD, V66, P573, DOI 10.1093/mollus/66.4.573; Stephen A. C., 1972, PHYLA SIPUNCULA ECHI; Struck TH, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-57; Struck TH, 2011, NATURE, V471, P95, DOI 10.1038/nature09864; Tanabe AS, 2011, MOL ECOL RESOUR, V11, P914, DOI 10.1111/j.1755-0998.2011.03021.x; Yusa Y, 2012, P ROY SOC B-BIOL SCI, V279, P959, DOI 10.1098/rspb.2011.1554	24	22	24	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56809	10.1371/journal.pone.0056809	http://dx.doi.org/10.1371/journal.pone.0056809			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457618	Green Submitted, Green Published, gold			2022-12-25	WOS:000315602700095
J	Jaussent, I; Empana, JP; Ancelin, ML; Besset, A; Helmer, C; Tzourio, C; Ritchie, K; Bouyer, J; Dauvilliers, Y				Jaussent, Isabelle; Empana, Jean-Philippe; Ancelin, Marie-Laure; Besset, Alain; Helmer, Catherine; Tzourio, Christophe; Ritchie, Karen; Bouyer, Jean; Dauvilliers, Yves			Insomnia, Daytime Sleepiness and Cardio-Cerebrovascular Diseases in the Elderly: A 6-Year Prospective Study	PLOS ONE			English	Article							OLDER-ADULTS; MYOCARDIAL-INFARCTION; HEART-DISEASE; RISK-FACTOR; 3 CITY; HEALTH; POPULATION; MORTALITY; COMPLAINTS; STROKE	Objective: To examine 1) the associations between history of cardio-cerebrovascular diseases (CVD) and insomnia complaints and excessive daytime sleepiness (EDS), and 2) the relationships between sleep complaints and future CVD in persons over 65. Methods: CVD was assessed at baseline and during two, four, and six-year follow-up in 5494 non-demented subjects. Self-reported insomnia complaints (poor sleep quality, difficulty in initiating sleep, difficulty in maintening sleep, and early morning awakening), EDS and sleep medication use were evaluated at baseline. Logistic regression models and Cox proportional hazard models, with delayed entry and age of participants as the time scale, were adjusted for socio-demographic, lifestyle and clinical variables. Results: At baseline, 748 participants had a past-history of CVD. A past-history of CVD was associated with EDS (OR = 1.28 95%CI = [1.05-1.57]) and the number of insomnia complaints (OR = 1.26 95%CI = [1.03-1.55] for 1-2 insomnia complaints; OR = 1.32 95%CI = [1.03-1.71] for >= 3 complaints). In longitudinal analyses, neither the four components of insomnia nor the number of insomnia complaints were significantly associated with first or recurrent CVD events (n = 391 events). EDS was independently associated with future CVD events even after adjusting for prescribed sleep medication and past-history of CVD (HR = 1.35 95%CI = [1.06-1.71]). Conclusion: Our results suggest that the relationships between sleep complaints and CVD could be complex. Insomnia complaints are more likely a consequence of CVD, whereas EDS appears to be a determinant of CVD independently of past-history of CVD. EDS screening may thus constitute a means of detecting persons at high risk of CVD.	[Jaussent, Isabelle; Ancelin, Marie-Laure; Besset, Alain; Ritchie, Karen; Dauvilliers, Yves] INSERM, U1061, Montpellier, France; [Jaussent, Isabelle; Ancelin, Marie-Laure; Besset, Alain; Ritchie, Karen; Dauvilliers, Yves] Univ Montpellier I, Montpellier, France; [Empana, Jean-Philippe] Univ Paris 05, Paris Cardiovasc Res Ctr PARCC, Sorbonne Paris Cite, UMR S970, Paris, France; [Helmer, Catherine; Tzourio, Christophe] INSERM, U897, Bordeaux, France; [Helmer, Catherine; Tzourio, Christophe] Univ Bordeaux 2, ISPED, F-33076 Bordeaux, France; [Ritchie, Karen] Univ London Imperial Coll Sci Technol & Med, Fac Med, London, England; [Bouyer, Jean] CESP Ctr Res Epidemiol & Populat Hlth, INSERM, Reprod & Child Dev U1018, Villejuif, France; [Bouyer, Jean] Univ Paris Sud, UMR S1018, Villejuif, France; [Dauvilliers, Yves] Hop Gui de Chauliac, CHU Montpellier, Serv Neurol, Unite Troubles Sommeil, Montpellier, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; Imperial College London; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Universite de Montpellier; CHU de Montpellier	Dauvilliers, Y (corresponding author), INSERM, U1061, Montpellier, France.	ydauvilliers@yahoo.fr	Ancelin, Marie-Laure/L-1198-2019; HELMER, Catherine/I-6581-2015; bouyer, jean/G-2717-2013; Tzourio, christophe/B-4015-2009; HELMER, Catherine/AAG-5126-2021; Ancelin, Marie-Laure/F-3079-2013; Tzourio, christophe/L-6344-2019; Empana, Jean-Philippe/AAF-6923-2021; Ritchie, Karen/G-3571-2013	Ancelin, Marie-Laure/0000-0002-1149-4320; HELMER, Catherine/0000-0002-5169-7421; bouyer, jean/0000-0003-4861-0783; Tzourio, christophe/0000-0002-6517-2984; Ancelin, Marie-Laure/0000-0002-1149-4320; Tzourio, christophe/0000-0002-6517-2984; Empana, Jean-Philippe/0000-0002-1469-7772; Ritchie, Karen/0000-0002-0688-8982; Jaussent, Isabelle/0000-0002-8205-7590; Dauvilliers, yves/0000-0003-0683-6506	Fondation pour la Recherche Medicale; Caisse Nationale Maladie des Travailleurs Salaries; Direction Generale de la Sante; MGEN; Institut de la Longevite; Agence Francaise de Securite Sanitaire des Produits de Sante; Regional Governments of Aquitaine; Bourgogne and Languedoc-Roussillon; Fondation de France; Eisai; Agence Nationale de la Recherche (ANR) [07-LVIE-004, 06-PNRA-005]; Fondation Plan Alzheimer; Fondation de Recherche sur l'Hypertension Arterielle; ABBOTT company; French National Research Agency (ANR); UCB pharma; Cephalon; Jazz; Novartis; Bioprojet; Ministry of Research-Inserm Programme "Cohorts and collection of biological material"	Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Caisse Nationale Maladie des Travailleurs Salaries; Direction Generale de la Sante(General Electric); MGEN; Institut de la Longevite; Agence Francaise de Securite Sanitaire des Produits de Sante; Regional Governments of Aquitaine; Bourgogne and Languedoc-Roussillon(Region Occitanie); Fondation de France(Fondation de France); Eisai(Eisai Co Ltd); Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Fondation Plan Alzheimer; Fondation de Recherche sur l'Hypertension Arterielle; ABBOTT company; French National Research Agency (ANR)(French National Research Agency (ANR)); UCB pharma(UCB Pharma SA); Cephalon; Jazz(Jazz Pharmaceuticals); Novartis(Novartis); Bioprojet; Ministry of Research-Inserm Programme "Cohorts and collection of biological material"	The 3C Study is conducted under a partnership agreement between Inserm, the Victor Segalen-Bordeaux II University and Sanofi-Synthelabo and was supported by the Fondation pour la Recherche Medicale, the Caisse Nationale Maladie des Travailleurs Salaries, Direction Generale de la Sante, MGEN, Institut de la Longevite, Agence Francaise de Securite Sanitaire des Produits de Sante, the Regional Governments of Aquitaine, Bourgogne and Languedoc-Roussillon and, the Fondation de France, the Ministry of Research-Inserm Programme "Cohorts and collection of biological material". The Lille Genopole received a grant from Eisai. Part of this project is financed by two grants from the Agence Nationale de la Recherche (ANR) (projects 07-LVIE-004 and 06-PNRA-005). Isabelle Jaussent, Dr. Jean Bouyer, Dr. Marie-Laure Ancelin, Dr. Catherine Helmer and Dr. Alain Besset report no disclosures. Dr. Jean-Philippe Empana has received consultancy honoraria from Lundbeck and speaker honoraria from Pfizer. Dr. Karen Ritchie serves on scientific advisory boards for the Biomedical Research Centre, King's College London, and MRC Strategic Steering Committee (Longitudinal Health and Aging Research Unit); and serves on the editorial advisory boards of the International Journal of Geriatric Psychiatry, Dementia, International Psychogeriatrics, Journal of Clinical and Experimental Gerontology, Psychogeriatrics, Neuronale, Neurologie-Psychiatrie-Geriatrie, and Gerontology. Dr. Christophe Tzourio has received fees from the Fondation Plan Alzheimer, the Fondation de Recherche sur l'Hypertension Arterielle, and the ABBOTT company for participating in scientific committees. He has also received investigator-initiated research funding from the French National Research Agency (ANR) and the Fondation Plan Alzheimer for the 3C study. He serves on the editorial advisory board of Neuroepidemiology, Journal of Hypertension, and Journal of Alzheimer's disease. Pr. Yves Dauvilliers has received funds for speaking and board engagements with UCB pharma, Cephalon, Jazz, Novartis, and Bioprojet. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Isabelle Jaussent, Dr. Jean Bouyer, Dr. Marie-Laure Ancelin, Dr. Catherine Helmer and Dr. Alain Besset report no disclosures. Dr. Jean-Philippe Empana has received consultancy honoraria from Lundbeck and speaker honoraria from Pfizer. Dr. Karen Ritchie serves on scientific advisory boards for the Biomedical Research Centre, King's College London, and MRC Strategic Steering Committee (Longitudinal Health and Aging Research Unit); and serves on the editorial advisory boards of the International Journal of Geriatric Psychiatry, Dementia, International Psychogeriatrics, Journal of Clinical and Experimental Gerontology, Psychogeriatrics, Neuronale, Neurologie-Psychiatrie-Geriatrie, and Gerontology. Dr. Christophe Tzourio has received fees from the Fondation Plan Alzheimer, the Fondation de Recherche sur l'Hypertension Arterielle, and the ABBOTT company for participating in scientific committees. He has also received investigator-initiated research funding from the French National Research Agency (ANR) and the Fondation Plan Alzheimer for the 3C study. He serves on the editorial advisory board of Neuroepidemiology, Journal of Hypertension, and Journal of Alzheimer's disease. Pr. Yves Dauvilliers has received funds for speaking and board engagements with UCB pharma, Cephalon, Jazz, Novartis, and Bioprojet. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Alperovitch A, 2003, NEUROEPIDEMIOLOGY, V22, P316, DOI 10.1159/000072920; Blachier M, 2012, ANN NEUROL, V71, P661, DOI 10.1002/ana.22656; Boden-Albala B, 2012, CIRC-CARDIOVASC QUAL, V5, P500, DOI 10.1161/CIRCOUTCOMES.111.963801; Divani AA, 2011, STROKE, V42, P1821, DOI 10.1161/STROKEAHA.110.607630; Empana JP, 2007, STROKE, V38, P893, DOI 10.1161/01.STR.0000257983.62530.75; Empana JP, 2009, STROKE, V40, P1219, DOI 10.1161/STROKEAHA.108.530824; FOLEY DJ, 1995, SLEEP, V18, P425, DOI 10.1093/sleep/18.6.425; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gooneratne NS, 2011, SLEEP, V34, P435, DOI 10.1093/sleep/34.4.435; Gottlieb DJ, 2010, CIRCULATION, V122, P352, DOI 10.1161/CIRCULATIONAHA.109.901801; Jaussent I, 2011, AM J GERIAT PSYCHIAT, V19, P88, DOI 10.1097/JGP.0b013e3181e049b6; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Laugsand LE, 2011, CIRCULATION, V124, P2073, DOI 10.1161/CIRCULATIONAHA.111.025858; Marin JM, 2005, LANCET, V365, P1046, DOI 10.1016/S0140-6736(05)71141-7; Mendis S., 2011, GLOB ATL CARD DIS PR; Newman AB, 2000, J AM GERIATR SOC, V48, P115, DOI 10.1111/j.1532-5415.2000.tb03901.x; Ohayon MM, 2004, SLEEP, V27, P1255, DOI 10.1093/sleep/27.7.1255; Pack AI, 2006, ANN NEUROL, V59, P893, DOI 10.1002/ana.20863; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Schwartz S, 1999, J PSYCHOSOM RES, V47, P313, DOI 10.1016/S0022-3999(99)00029-X; Schwartz SW, 1998, ANN EPIDEMIOL, V8, P384, DOI 10.1016/S1047-2797(97)00238-X; Tsuno N, 2007, J SLEEP RES, V16, P364, DOI 10.1111/j.1365-2869.2007.00606.x; Vitiello MV, 1997, J GERONTOL A-BIOL, V52, pM189, DOI 10.1093/gerona/52A.4.M189; Whitney CW, 1998, SLEEP, V21, P27, DOI 10.1093/sleep/21.1.27; WHO, 2001, WHO INT CLASS FUNCT; Young T, 2002, ARCH INTERN MED, V162, P893, DOI 10.1001/archinte.162.8.893	26	33	33	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56048	10.1371/journal.pone.0056048	http://dx.doi.org/10.1371/journal.pone.0056048			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	099EJ	23457496	Green Published, gold, Green Submitted			2022-12-25	WOS:000315602700036
J	Rommer, A; Steinmetz, B; Herbst, F; Hackl, H; Heffeter, P; Heilos, D; Filipits, M; Steinleitner, K; Hemmati, S; Herbacek, I; Schwarzinger, I; Hartl, K; Rondou, P; Glimm, H; Karakaya, K; Kramer, A; Berger, W; Wieser, R				Rommer, Anna; Steinmetz, Birgit; Herbst, Friederike; Hackl, Hubert; Heffeter, Petra; Heilos, Daniela; Filipits, Martin; Steinleitner, Katarina; Hemmati, Shayda; Herbacek, Irene; Schwarzinger, Ilse; Hartl, Katharina; Rondou, Pieter; Glimm, Hanno; Karakaya, Kadin; Kraemer, Alwin; Berger, Walter; Wieser, Rotraud			EVI1 Inhibits Apoptosis Induced by Antileukemic Drugs via Upregulation of CDKN1A/p21/WAF in Human Myeloid Cells	PLOS ONE			English	Article							ACUTE MYELOGENOUS LEUKEMIA; JUVENILE MYELOMONOCYTIC LEUKEMIA; HEMATOPOIETIC-CELLS; GENE-EXPRESSION; DOWN-REGULATION; SELF-RENEWAL; PROGNOSTIC-SIGNIFICANCE; DIFFERENTIATION; P21; ONCOGENE	Overexpression of ecotropic viral integration site 1 (EVI1) is associated with aggressive disease in acute myeloid leukemia (AML). Despite of its clinical importance, little is known about the mechanism through which EVI1 confers resistance to antileukemic drugs. Here, we show that a human myeloid cell line constitutively overexpressing EVI1 after infection with a retroviral vector (U937_EVI1) was partially resistant to etoposide and daunorubicin as compared to empty vector infected control cells (U937_vec). Similarly, inducible expression of EVI1 in HL-60 cells decreased their sensitivity to daunorubicin. Gene expression microarray analyses of U937_EVI1 and U937_vec cells cultured in the absence or presence of etoposide showed that 77 and 419 genes were regulated by EVI1 and etoposide, respectively. Notably, mRNA levels of 26 of these genes were altered by both stimuli, indicating that EVI1 regulated genes were strongly enriched among etoposide regulated genes and vice versa. One of the genes that were induced by both EVI1 and etoposide was CDKN1A/p21/WAF, which in addition to its function as a cell cycle regulator plays an important role in conferring chemotherapy resistance in various tumor types. Indeed, overexpression of CDKN1A in U937 cells mimicked the phenotype of EVI1 overexpression, similarly conferring partial resistance to antileukemic drugs.	[Rommer, Anna; Steinmetz, Birgit; Heilos, Daniela; Steinleitner, Katarina; Hartl, Katharina; Wieser, Rotraud] Med Univ Vienna, Dept Med 1, Vienna, Austria; [Rommer, Anna; Steinmetz, Birgit; Heffeter, Petra; Heilos, Daniela; Filipits, Martin; Steinleitner, Katarina; Hartl, Katharina; Berger, Walter; Wieser, Rotraud] Med Univ Vienna, Ctr Comprehens Canc, Vienna, Austria; [Herbst, Friederike; Hemmati, Shayda; Glimm, Hanno] Natl Ctr Tumor Dis, Dept Translat Oncol, Heidelberg, Germany; [Herbst, Friederike; Hemmati, Shayda; Glimm, Hanno] German Canc Res Ctr, Heidelberg, Germany; [Hackl, Hubert] Med Univ Innsbruck, Div Bioinformat, A-6020 Innsbruck, Austria; [Heffeter, Petra; Filipits, Martin; Herbacek, Irene; Berger, Walter] Med Univ Vienna, Dept Med 1, Inst Canc Res, Vienna, Austria; [Heffeter, Petra; Filipits, Martin; Herbacek, Irene; Berger, Walter] Med Univ Vienna, Res Platform Translat Canc Therapy Res, Vienna, Austria; [Schwarzinger, Ilse] Med Univ Vienna, Dept Lab Med, Vienna, Austria; [Rondou, Pieter] Ghent Univ Hosp, Ctr Med Genet Ghent, Ghent, Belgium; [Karakaya, Kadin; Kraemer, Alwin] German Canc Res Ctr, Clin Cooperat Unit Mol Haematol Oncol, Heidelberg, Germany	Medical University of Vienna; Medical University of Vienna; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Medical University of Innsbruck; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Ghent University; Ghent University Hospital; Helmholtz Association; German Cancer Research Center (DKFZ)	Wieser, R (corresponding author), Med Univ Vienna, Dept Med 1, Vienna, Austria.	rotraud.wieser@meduniwien.ac.at	Hackl, Hubert/B-3168-2018	Hackl, Hubert/0000-0003-4055-3841; Wieser, Rotraud/0000-0003-4384-6658; Filipits, Martin/0000-0003-2847-4534; Heffeter, Petra/0000-0001-6401-8646; Lupinek, Daniela/0000-0001-5749-9701; Berger, Walter/0000-0003-0014-1658	Austrian Science Foundation (FWF) [P20920, P19795, P21401]; Deutsche Forschungsgemeinschaft [SFB873]; Austrian Science Fund (FWF) [P 21401, P 20920] Funding Source: researchfish	Austrian Science Foundation (FWF)(Austrian Science Fund (FWF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was funded by the Austrian Science Foundation (FWF), grants no. P20920, P19795, and P21401 to RW (http://www.fwf.ac.at/) and Deutsche Forschungsgemeinschaft, grant SFB873 to FH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Ahmed W, 2004, CELL CYCLE, V3, P1305, DOI 10.4161/cc.3.10.1161; Bacher U, 2006, BLOOD, V107, P3847, DOI 10.1182/blood-2005-08-3522; Balgobind BV, 2010, LEUKEMIA, V24, P942, DOI 10.1038/leu.2010.47; Bard-Chapeau EA, 2012, P NATL ACAD SCI USA, V109, P2168, DOI 10.1073/pnas.1119229109; Bastin-Coyette L, 2011, BIOCHEM PHARMACOL, V81, P586, DOI 10.1016/j.bcp.2010.12.009; Braun F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023577; Buonamici S, 2005, J BIOL CHEM, V280, P428, DOI 10.1074/jbc.M410836200; CANMAN CE, 1995, GENE DEV, V9, P600, DOI 10.1101/gad.9.5.600; COLLINS SJ, 1977, NATURE, V270, P347, DOI 10.1038/270347a0; Daghistani M, 2010, BLOOD, V116, P6014, DOI 10.1182/blood-2010-01-264234; Dasmahapatra G, 2007, CLIN CANCER RES, V13, P4280, DOI 10.1158/1078-0432.CCR-07-0835; FICHELSON S, 1992, LEUKEMIA, V6, P93; Follenzi A, 2000, NAT GENET, V25, P217, DOI 10.1038/76095; Forster K, 2008, ANN HEMATOL, V87, P183, DOI 10.1007/s00277-007-0400-9; Gerhardt TM, 1997, BRIT J HAEMATOL, V99, P882, DOI 10.1046/j.1365-2141.1997.4983304.x; Grimwade D, 2010, BLOOD, V116, P354, DOI 10.1182/blood-2009-11-254441; Groschel S, 2010, J CLIN ONCOL, V28, P2101, DOI 10.1200/JCO.2009.26.0646; Haas K, 2008, GENE CHROMOSOME CANC, V47, P288, DOI 10.1002/gcc.20532; Hamaguchi H, 1997, BRIT J HAEMATOL, V98, P399, DOI 10.1046/j.1365-2141.1997.2143029.x; Ichihara E, 2011, BIOCHEM BIOPH RES CO, V416, P239, DOI 10.1016/j.bbrc.2011.10.061; Karakaya K, 2012, CELL CYCLE, V11, P3492, DOI 10.4161/cc.21801; Kataoka K, 2011, J EXP MED, V208, P2402, DOI 10.1084/jem.20110447; Konrad TA, 2009, J LEUKOCYTE BIOL, V86, P813, DOI 10.1189/jlb.0109042; Koster R, 2010, J CLIN INVEST, V120, P3594, DOI 10.1172/JCI41939; Kurokawa M, 2000, EMBO J, V19, P2958, DOI 10.1093/emboj/19.12.2958; Laricchia-Robbio L, 2008, BLOOD CELL MOL DIS, V40, P141, DOI 10.1016/j.bcmd.2007.07.012; Lazzarini R, 2008, CLIN CANCER RES, V14, P5099, DOI 10.1158/1078-0432.CCR-08-0255; Li Q, 2011, BLOOD, V117, P2022, DOI 10.1182/blood-2010-04-280750; Liu Y, 2006, ONCOGENE, V25, P3565, DOI 10.1038/sj.onc.1209403; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lugthart S, 2008, BLOOD, V111, P4329, DOI 10.1182/blood-2007-10-119230; Lugthart S, 2010, J CLIN ONCOL, V28, P3890, DOI 10.1200/JCO.2010.29.2771; Manfred S, 2007, NAT METHODS, V4, P1051, DOI 10.1038/nmeth1103; Martelli AM, 2010, ONCOTARGET, V1, P89, DOI 10.18632/oncotarget.114; Min YH, 2003, LEUKEMIA, V17, P995, DOI 10.1038/sj.leu.2402874; MORISHITA K, 1992, P NATL ACAD SCI USA, V89, P3937, DOI 10.1073/pnas.89.9.3937; Nanjundan M, 2007, CANCER RES, V67, P3074, DOI 10.1158/0008-5472.CAN-06-2366; Pardee TS, 2011, EXP HEMATOL, V39, P473, DOI 10.1016/j.exphem.2011.01.009; Patel JB, 2011, ONCOGENE, V30, P1290, DOI 10.1038/onc.2010.510; Poppe B, 2006, GENE CHROMOSOME CANC, V45, P349, DOI 10.1002/gcc.20295; Privitera E, 1997, LEUKEMIA, V11, P2045, DOI 10.1038/sj.leu.2400865; Saito Y, 2011, LEUKEMIA, V25, P921, DOI 10.1038/leu.2011.36; Santamaria CM, 2009, LEUKEMIA RES, V33, P1706, DOI 10.1016/j.leukres.2009.04.024; Santamaria CM, 2009, BLOOD, V114, P148, DOI 10.1182/blood-2008-11-187724; Shimizu S, 2002, BIOCHEM BIOPH RES CO, V292, P609, DOI 10.1006/bbrc.2002.6693; Steinleitner K, 2012, ANTICANCER RES, V32, P4883; Steinman RA, 2000, MOL MED, V6, P736, DOI 10.1007/BF03402190; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; SUNDSTROM C, 1976, INT J CANCER, V17, P565, DOI 10.1002/ijc.2910170504; Sykes SM, 2011, CELL, V146, P697, DOI 10.1016/j.cell.2011.07.032; Tamburini J, 2007, BLOOD, V110, P1025, DOI 10.1182/blood-2006-12-061283; Tang JJ, 2006, MOL CELL BIOCHEM, V291, P139, DOI 10.1007/s11010-006-9206-7; Taschner S, 2007, BLOOD, V109, P971, DOI 10.1182/blood-2006-04-020552.7; Tsuchiya N, 2011, CANCER RES, V71, P4628, DOI 10.1158/0008-5472.CAN-10-2475; Valk PJM, 2004, NEW ENGL J MED, V350, P1617, DOI 10.1056/NEJMoa040465; van Doorn-Khosrovani SBV, 2003, BLOOD, V101, P837, DOI 10.1182/blood-2002-05-1459; Vazquez I, 2011, HAEMATOL-HEMATOL J, V96, P1448, DOI 10.3324/haematol.2011.040535; Viale A, 2009, NATURE, V457, P51, DOI 10.1038/nature07618; Vinatzer U, 2003, GENE CHROMOSOME CANC, V36, P80, DOI 10.1002/gcc.10144; Wang ZL, 2000, DIFFERENTIATION, V66, P1, DOI 10.1046/j.1432-0436.2000.066001001.x; Wieser R, 2007, GENE, V396, P346, DOI 10.1016/j.gene.2007.04.012; Wieser R, 2012, CELL CYCLE, V11, P3915, DOI 10.4161/cc.22392; Wolf S, 2013, ONCOGENE, V32, P3028, DOI 10.1038/onc.2012.329; Wu JR, 2010, J BIOPHARM STAT, V20, P954, DOI 10.1080/10543401003618983; Yamakawa N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030706; Yoshimi A, 2011, BLOOD, V117, P3617, DOI 10.1182/blood-2009-12-261602; Zhang W, 1995, CLIN CANCER RES, V1, P1051	68	20	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56308	10.1371/journal.pone.0056308	http://dx.doi.org/10.1371/journal.pone.0056308			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457546	Green Published, Green Submitted, gold			2022-12-25	WOS:000315602700065
J	Dolan, D; Nelson, G; Zupanic, A; Smith, G; Shanley, D				Dolan, David; Nelson, Glyn; Zupanic, Anze; Smith, Graham; Shanley, Daryl			Systems Modelling of NHEJ Reveals the Importance of Redox Regulation of Ku70/80 in the Dynamics of DNA Damage Foci	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; DOUBLE-STRAND BREAKS; CELL-CYCLE ARREST; COMPLEX; REPAIR; ATM; END; ELECTROSTATICS; PDB2PQR; BINDING	The presence of DNA double-stranded breaks in a mammalian cell typically activates the Non-Homologous End Joining (NHEJ) pathway to repair the damage and signal to downstream systems that govern cellular decisions such as apoptosis or senescence. The signalling system also stimulates effects such as the generation of reactive oxygen species (ROS) which in turn feed back into the damage response. Although the overall process of NHEJ is well documented, we know little of the dynamics and how the system operates as a whole. We have developed a computational model which includes DNA Protein Kinase (DNA-PK) dependent NHEJ (D-NHEJ) and back-up NHEJ mechanisms (B-NHEJ) and use it to explain the dynamic response to damage induced by different levels of gamma irradiation in human fibroblasts. Our work suggests that the observed shift from fast to slow repair of DNA damage foci at higher levels of damage cannot be explained solely by inherent stochasticity in the NHEJ system. Instead, our model highlights the importance of Ku oxidation which leads to increased Ku dissociation rates from DNA damage foci and shifts repair in favour of the less efficient B-NHEJ system.	[Dolan, David; Nelson, Glyn; Zupanic, Anze; Smith, Graham; Shanley, Daryl] Newcastle Univ, Inst Ageing & Hlth, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Newcastle University - UK	Shanley, D (corresponding author), Newcastle Univ, Inst Ageing & Hlth, Campus Ageing & Vital, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	daryl.shanley@ncl.ac.uk	Zupanic, Anze/B-9396-2008; nelson, glyn/A-6346-2009	Zupanic, Anze/0000-0003-3303-9086; nelson, glyn/0000-0002-1895-4772; Shanley, Daryl/0000-0003-3096-6386	Biotechnology and Biological Sciences Research Council, BBSRC	Biotechnology and Biological Sciences Research Council, BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council, BBSRC (www.bbsrc.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed EA, 2009, MUTAT RES-FUND MOL M, V683, P84; Amsel AD, 2008, P NATL ACAD SCI USA, V105, P5117, DOI 10.1073/pnas.0706700105; Anderson CW, 1996, CURR TOP MICROBIOL, V217, P91; Andrews BJ, 2006, J BIOL CHEM, V281, P13596, DOI 10.1074/jbc.M512787200; Bachman JA, 2011, NAT METHODS, V8, P130, DOI 10.1038/nmeth0211-130; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bennett SM, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-86; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Brenkman AB, 2010, FASEB J, V24, P4271, DOI 10.1096/fj.10-158717; Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.C100466200; Cann KL, 2007, BIOCHEM CELL BIOL, V85, P663, DOI 10.1139/O07-135; Covo S, 2009, NUCLEIC ACIDS RES, V37, P6737, DOI 10.1093/nar/gkp703; Cross JV, 2006, ANTIOXID REDOX SIGN, V8, P1819, DOI 10.1089/ars.2006.8.1819; DeFazio LG, 2002, EMBO J, V21, P3192, DOI 10.1093/emboj/cdf299; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Downs JA, 2004, NAT REV MOL CELL BIO, V5, P367, DOI 10.1038/nrm1367; Drager A, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-39; Falck J, 2005, NATURE, V434, P605, DOI 10.1038/nature03442; Fumagalli M, 2012, NAT CELL BIOL, V14, P355, DOI 10.1038/ncb2466; Funahashi Akira, 2003, Biosilico, V1, P159, DOI 10.1016/S1478-5382(03)02370-9; Gillespie CS, 2006, BIOINFORMATICS, V22, P628, DOI 10.1093/bioinformatics/btk042; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Grawunder U, 1997, NATURE, V388, P492, DOI 10.1038/41358; Gross A, 2008, TRENDS BIOCHEM SCI, V33, P514, DOI 10.1016/j.tibs.2008.08.005; Guirouilh-Barbat J, 2004, MOL CELL, V14, P611, DOI 10.1016/j.molcel.2004.05.008; Hammarsten O, 1998, P NATL ACAD SCI USA, V95, P525, DOI 10.1073/pnas.95.2.525; Iliakis G, 2009, RADIOTHER ONCOL, V92, P310, DOI 10.1016/j.radonc.2009.06.024; Kamata H, 1999, CELL SIGNAL, V11, P1, DOI 10.1016/S0898-6568(98)00037-0; Karran P, 2000, CURR OPIN GENET DEV, V10, P144, DOI 10.1016/S0959-437X(00)00069-1; Kim JR, 2000, ANAL BIOCHEM, V283, P214, DOI 10.1006/abio.2000.4623; Lieber MR, 2003, NAT REV MOL CELL BIO, V4, P712, DOI 10.1038/nrm1202; Mari PO, 2006, P NATL ACAD SCI USA, V103, P18597, DOI 10.1073/pnas.0609061103; Mason KA, 2012, AM J CLIN ONCOL-CANC, DOI [10.1097/COC.1090-b1013e3182467dce, DOI 10.1097/C0C.1090-B1013E3182467DCE]; Meek K, 2004, IMMUNOL REV, V200, P132, DOI 10.1111/j.0105-2896.2004.00162.x; Nelson G, 2002, J CELL SCI, V115, P1137; Nelson G, 2012, AGING CELL, V11, P345, DOI 10.1111/j.1474-9726.2012.00795.x; Nelson G, 2009, CELL CYCLE, V8, P3379, DOI 10.4161/cc.8.20.9857; Nielsen JE, 2001, PROTEINS, V43, P403, DOI 10.1002/prot.1053; Paddock MN, 2011, DNA REPAIR, V10, P338, DOI 10.1016/j.dnarep.2010.12.005; Passos JF, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.5; Perkins TJ, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.83; Peters GH, 1998, BIOCHEMISTRY-US, V37, P5383, DOI 10.1021/bi971187i; Poole LB, 2008, CURR OPIN CHEM BIOL, V12, P18, DOI 10.1016/j.cbpa.2008.01.021; Rothkamm K, 2003, MOL CELL BIOL, V23, P5706, DOI 10.1128/MCB.23.16.5706-5715.2003; Shahrezaei V, 2008, CURR OPIN BIOTECH, V19, P369, DOI 10.1016/j.copbio.2008.06.011; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Singh SK, 2011, INT J RADIAT ONCOL, V79, P540, DOI 10.1016/j.ijrobp.2010.08.018; Smith GCM, 1999, GENE DEV, V13, P916, DOI 10.1101/gad.13.8.916; Spagnolo L, 2012, NUCL ACIDS RES; Stiff T, 2004, CANCER RES, V64, P2390, DOI 10.1158/0008-5472.CAN-03-3207; Suzuki K, 2009, MUTAT RES-FUND MOL M, V683, P29; Symington LS, 2011, ANN REV GENETICS, V45; Tapia PC, 2006, MED HYPOTHESES, V66, P332, DOI 10.1016/j.mehy.2005.08.032; Valko M, 2004, MOL CELL BIOCHEM, V266, P37, DOI 10.1023/B:MCBI.0000049134.69131.89; van den Bosch M, 2003, EMBO REP, V4, P844, DOI 10.1038/sj.embor.embor925; Walker JR, 2001, NATURE, V412, P607, DOI 10.1038/35088000; Wang ML, 2006, NUCLEIC ACIDS RES, V34, P6170, DOI 10.1093/nar/gkl840; Wu XJ, 2005, MUTAT RES-FUND MOL M, V579, P115, DOI 10.1016/j.mrfmmm.2005.02.026; Xiao D, 2005, ONCOGENE, V24, P6256, DOI 10.1038/sj.onc.1208759	60	16	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55190	10.1371/journal.pone.0055190	http://dx.doi.org/10.1371/journal.pone.0055190			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23457464	Green Published, gold, Green Submitted			2022-12-25	WOS:000315153400066
J	Yu, JH; Peng, Y; Wu, LC; Xie, ZL; Deng, YC; Hughes, T; He, S; Mo, XK; Chiu, M; Wang, QE; He, XM; Liu, SJ; Grever, MR; Chan, KK; Liu, ZF				Yu, Jianhua; Peng, Yong; Wu, Lai-Chu; Xie, Zhiliang; Deng, Youcai; Hughes, Tiffany; He, Shun; Mo, XiaoKui; Chiu, Ming; Wang, Qi-En; He, Xiaoming; Liu, Shujun; Grever, Michael R.; Chan, Kenneth K.; Liu, Zhongfa			Curcumin Down-Regulates DNA Methyltransferase 1 and Plays an Anti-Leukemic Role in Acute Myeloid Leukemia	PLOS ONE			English	Article							CANCER-THERAPY; METHYLATION; TRANSCRIPTION; INHIBITORS; ACETYLTRANSFERASE; HYPOMETHYLATION; DECITABINE; DELIVERY; TARGET; GENES	Bioactive components from dietary supplements such as curcumin may represent attractive agents for cancer prevention or treatment. DNA methylation plays a critical role in acute myeloid leukemia (AML) development, and presents an excellent target for treatment of this disease. However, it remains largely unknown how curcumin, a component of the popular Indian spice turmeric, plays a role in DNA hypomethylation to reactivate silenced tumor suppressor genes and to present a potential treatment option for AML. Here we show that curcumin down-regulates DNMT1 expression in AML cell lines, both in vitro and in vivo, and in primary AML cells ex vivo. Mechanistically, curcumin reduced the expression of positive regulators of DNMT1, p65 and Sp1, which correlated with a reduction in binding of these transcription factors to the DNMT1 promoter in AML cell lines. This curcumin-mediated down-regulation of DNMT1 expression was concomitant with p15(INK4B) tumor suppressor gene reactivation, hypomethylation of the p15(INK4B) promoter, G1 cell cycle arrest, and induction of tumor cell apoptosis in vitro. In mice implanted with the human AML MV4-11 cell line, administration of curcumin resulted in remarkable suppression of AML tumor growth. Collectively, our data indicate that curcumin shows promise as a potential treatment for AML, and our findings provide a basis for future studies to test the clinical efficacy of curcumin - whether used as a single agent or as an adjuvant - for AML treatment.	[Yu, Jianhua; Grever, Michael R.] Ohio State Univ, Coll Med, Dept Internal Med, Div Hematol, Columbus, OH 43210 USA; [Yu, Jianhua; Peng, Yong; Wu, Lai-Chu; Deng, Youcai; Hughes, Tiffany; He, Shun; Wang, Qi-En; He, Xiaoming; Grever, Michael R.; Chan, Kenneth K.; Liu, Zhongfa] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Wu, Lai-Chu] Ohio State Univ, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA; [Xie, Zhiliang; Chiu, Ming; Chan, Kenneth K.; Liu, Zhongfa] Ohio State Univ, Coll Pharm, Div Pharmaceut, Columbus, OH 43210 USA; [Deng, Youcai] Third Mil Med Univ, Coll Pharm, Chongqing, Peoples R China; [Mo, XiaoKui] Ohio State Univ, Ctr Biostat, Columbus, OH 43210 USA; [He, Xiaoming] Ohio State Univ, Dept Biomed Engn, Columbus, OH 43210 USA; [Liu, Shujun] Univ Minnesota, Hormel Inst, Austin, MN 55912 USA	University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Army Medical University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of Minnesota System	Yu, JH (corresponding author), Ohio State Univ, Coll Med, Dept Internal Med, Div Hematol, Columbus, OH 43210 USA.	Jianhua.yu@osumc.edu; liu.550@osu.edu	Wu, Lai-Chu/E-4328-2011; Liu, Zhongfa/G-8549-2013; He, Xiaoming/C-5499-2008; Deng, Youcai/GZK-9548-2022; He, Shun/K-7448-2014	Wu, Lai-Chu/0000-0002-1348-269X; He, Xiaoming/0000-0003-0125-6086; Deng, Youcai/0000-0001-5488-8576; Ye, Xiaojian/0000-0003-2402-5782; He, Dannong/0000-0003-4921-1063; Li, Kai/0000-0001-5436-4836; Wang, Meiyan/0000-0002-2118-6647	U.S. National Institutes of Health (NIH) [CA155521, CA135478]; Experimental Therapeutic Program seed grant; Biomedical Mass Spectrometric Laboratory at The Ohio State University; American Cancer Society [IRG-67-003-47]; National Blood Foundation Scientific Research Grant; NATIONAL CANCER INSTITUTE [R01CA151248, R01CA155521, P30CA016058, R21CA135478] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000090] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Experimental Therapeutic Program seed grant; Biomedical Mass Spectrometric Laboratory at The Ohio State University; American Cancer Society(American Cancer Society); National Blood Foundation Scientific Research Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported in part by the U.S. National Institutes of Health (NIH) grants CA155521 (to JY) and CA135478 (to ZL), the Experimental Therapeutic Program seed grant (to ZL), and the Biomedical Mass Spectrometric Laboratory (KKC and ZL) at The Ohio State University. It was also supported in part by Grant # IRG-67-003-47 from the American Cancer Society and by a National Blood Foundation Scientific Research Grant (both to JY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balasubramanyam K, 2004, J BIOL CHEM, V279, P51163, DOI 10.1074/jbc.M409024200; Baylin Stephen B, 2005, Nat Clin Pract Oncol, V2 Suppl 1, pS4, DOI 10.1038/ncponc0354; Blum William, 2005, Clin Adv Hematol Oncol, V3, P855; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Chim CS, 2006, LEUKEMIA LYMPHOMA, V47, P815, DOI 10.1080/10428190500513827; Christiansen DH, 2003, LEUKEMIA, V17, P1813, DOI 10.1038/sj.leu.2403054; de Vos D, 2005, ANN HEMATOL, V84, P3, DOI 10.1007/s00277-005-0008-x; Dhillon N, 2008, CLIN CANCER RES, V14, P4491, DOI 10.1158/1078-0432.CCR-08-0024; Fu SQ, 2010, CANCER-AM CANCER SOC, V116, P4670, DOI 10.1002/cncr.25414; Grovdal M, 2007, CLIN CANCER RES, V13, P7107, DOI 10.1158/1078-0432.CCR-07-1193; Issa JPJ, 2007, CLIN CANCER RES, V13, P1634, DOI 10.1158/1078-0432.CCR-06-2076; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Lee BH, 2005, J BIOL CHEM, V280, P40749, DOI 10.1074/jbc.M505593200; Li Xin-gang, 2005, Zhonghua Xue Ye Xue Za Zhi, V26, P551; Liu SJ, 2008, BLOOD, V111, P2364, DOI 10.1182/blood-2007-08-110171; Liu Z, 2009, ANAL BIOCH; Liu ZF, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1156; Liu ZF, 2012, CANCER CHEMOTH PHARM, V69, P679, DOI 10.1007/s00280-011-1749-y; Liu ZF, 2009, BIOORG MED CHEM LETT, V19, P706, DOI 10.1016/j.bmcl.2008.12.041; Lyko F, 2005, JNCI-J NATL CANCER I, V97, P1498, DOI 10.1093/jnci/dji311; Maheshwari RK, 2006, LIFE SCI, V78, P2081, DOI 10.1016/j.lfs.2005.12.007; Melisi D, 2007, EXPERT OPIN THER TAR, V11, P133, DOI 10.1517/14728222.11.2.133; Menon VP, 2007, ADV EXP MED BIOL, V595, P105; Moiseeva EP, 2007, MOL CANCER THER, V6, P3071, DOI 10.1158/1535-7163.MCT-07-0117; Morimoto T, 2008, J CLIN INVEST, V118, P868, DOI 10.1172/JCI33160; Plass C, 2008, SEMIN ONCOL, V35, P378, DOI 10.1053/j.seminoncol.2008.04.008; Pouton CW, 2000, EUR J PHARM SCI, V11, pS93, DOI 10.1016/S0928-0987(00)00167-6; Reuter S, 2011, GENES NUTR, V6, P93, DOI 10.1007/s12263-011-0222-1; Shishodia S, 2007, CURR PROB CANCER, V31, P243, DOI 10.1016/j.currproblcancer.2007.04.001; Shishodia S, 2007, ADV EXP MED BIOL, V595, P127; Siedlecki P, 2006, J MED CHEM, V49, P678, DOI 10.1021/jm050844z; Singh Sarvjeet, 2006, Anti-Cancer Agents in Medicinal Chemistry, V6, P259, DOI 10.2174/187152006776930918; Stresemann C, 2006, CANCER RES, V66, P2794, DOI 10.1158/0008-5472.CAN-05-2821; vanIersel MLPS, 1996, CHEM-BIOL INTERACT, V102, P117, DOI 10.1016/S0009-2797(96)03739-8; Yoo CB, 2006, NAT REV DRUG DISCOV, V5, P37, DOI 10.1038/nrd1930; Yoo CB, 2007, CANCER RES, V67, P6400, DOI 10.1158/0008-5472.CAN-07-0251	36	104	111	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e55934	10.1371/journal.pone.0055934	http://dx.doi.org/10.1371/journal.pone.0055934			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23483914	Green Submitted, gold, Green Published			2022-12-25	WOS:000315970300068
J	Wu, CL; Zhang, ZF; Lu, Z; Liao, M; Zhang, YJ; Xie, YL; Guo, XF; Yu, XX; Yang, XB; Gao, Y; Tan, AH; Mo, ZN				Wu, Chunlei; Zhang, Zhifu; Lu, Zheng; Liao, Ming; Zhang, Youjie; Xie, Yuanliang; Guo, Xuefeng; Yu, Xiaoxiang; Yang, Xiaobo; Gao, Yong; Tan, Aihua; Mo, Zengnan			Prevalence of and Risk Factors for Asymptomatic Inammatory (NIH-IV) Prostatitis in Chinese Men	PLOS ONE			English	Article							FANGCHENGGANG AREA; HEALTH; SYMPTOMS; POPULATION; ASSOCIATION; PAIN	Background: While many investigators have studied symptomatic prostatitis, little research has been done with regard to asymptomatic (NIH-IV) prostatitis. Purpose: To describe the prevalence of and risk factors for NIH-IV prostatitis among a large male population. Methods: The study population was comprised of 1,868 men at the second phase recruitment of a population-based cohort in China. Asymptomatic and symptomatic men were defined by the National Institutes of Health Chronic Prostatitis (CP) Symptom Index. Meanwhile, EPS specimens and their leukocyte count were collected. Lifestyle and demographic characteristics were obtained through a questionnaire. Results: Prevalence of NIH-IV prostatitis was 21.1% among 1,868 asymptomatic men aged 19-78 years and increased with age. After adjusteing for potential confounding variables (age, smoking habits, alcohol drinking habits, education, physical activity, hypertension, dyslipidemia, obesity and diabetes), age remained a significant factor for NIH-IV prostatitis (OR = 1.35; 95% CI = 1.06-1.71; P = 0.01) and the risk of NIH-IV prostatitis was significantly higher in smokers >= 15 pack/years than nonsmokers (OR = 1.33; 95% CI = 1.01-1.75; P = 0.03). In addition, compared with non-drinkers, the OR of NIH-IV prostatitis in drinkers >= 1 drinks/week was 1.35 (95% CI = 1.03, 1.77, p = 0.02) after adjusting for the other variables above. In addition, having less than a college education may be a risk factor for NIH-IV prostatitis, although a statistically significant difference did not exist in our data (OR = 1.22; 95% CI = 0.97-1.52; P = 0.08). Conclusions: Our findings suggest that NIH-IV prostatitis is prevalent in China. Age, smoking, drinking and lower education levels were associated with an increased risk of NIH-IV prostatitis. The prevalence of NIH-IV prostatitis should be taken into account when estimating the total prevalence of CP in future studies.	[Wu, Chunlei; Zhang, Zhifu; Lu, Zheng; Liao, Ming; Zhang, Youjie; Xie, Yuanliang; Mo, Zengnan] Guangxi Med Univ, Affiliated Hosp 1, Inst Urol & Nephrol, Nanning, Guangxi Zhuang, Peoples R China; [Zhang, Zhifu; Lu, Zheng; Liao, Ming; Zhang, Youjie; Xie, Yuanliang; Guo, Xuefeng; Yu, Xiaoxiang; Gao, Yong; Tan, Aihua] Guangxi Med Univ, Ctr Genom & Personalized Med, Nanning, Guangxi Zhuang, Peoples R China; [Yang, Xiaobo] Guangxi Med Univ, Sch Publ Hlth, Dept Occupat Hlth & Environm Hlth, Nanning, Guangxi Zhuang, Peoples R China; [Yu, Xiaoxiang] 303rd Hosp Chinese Peoples Liberat Army, Dept Urol, Nanning, Guangxi Zhuang, Peoples R China	Guangxi Medical University; Guangxi Medical University; Guangxi Medical University	Mo, ZN (corresponding author), Guangxi Med Univ, Affiliated Hosp 1, Inst Urol & Nephrol, Nanning, Guangxi Zhuang, Peoples R China.	zengnanmo@hotmail.com	Zhang, Youjie/F-7346-2016; Sun, Yuelian/AFF-2622-2022; Olsen, Jørn/F-8801-2015; Yang, Xiaobo/G-3854-2016	Zhang, Youjie/0000-0002-6035-8536; Sun, Yuelian/0000-0002-6905-0503; Olsen, Jørn/0000-0001-7462-5140; mo, zengnan/0000-0002-3047-3138; Miller, Jessica/0000-0002-1806-1894	National Natural Science Foundation of China [30945204]; Provincial Department of Finance, Guangxi Zhuang Autonomous Region, China [2009GJCJ150]; Provincial Department of Education, Guangxi Zhuang Autonomous Region, China [2009GJCJ150]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Provincial Department of Finance, Guangxi Zhuang Autonomous Region, China; Provincial Department of Education, Guangxi Zhuang Autonomous Region, China	The work described in this article is supported by grants from the National Natural Science Foundation of China (grant number 30945204) and the Provincial Departments of Finance and Education, Guangxi Zhuang Autonomous Region, China (grant number 2009GJCJ150). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anonymous, 2007, Zhonghua Xinxueguanbing Zazhi, V35, P390; Bozeman CB, 2002, J UROLOGY, V167, P1723, DOI 10.1016/S0022-5347(05)65186-5; Carver BS, 2003, J UROLOGY, V169, P589, DOI 10.1016/S0022-5347(05)63959-6; Chen Chunming, 2004, Biomed Environ Sci, V17 Suppl, P1; De Nunzio C, 2011, EUR UROL, V60, P106, DOI 10.1016/j.eururo.2011.03.055; Ejike CECC, 2008, INT J UROL, V15, P340, DOI 10.1111/j.1442-2042.2008.02003.x; Ferris JA, 2010, BJU INT, V105, P373, DOI 10.1111/j.1464-410X.2009.08708.x; Gavin JR, 1999, DIABETES CARE, V22, pS5; Korrovits P, 2008, UROLOGY, V71, P1010, DOI 10.1016/j.urology.2007.12.082; Krieger JN, 1999, JAMA-J AM MED ASSOC, V282, P236, DOI 10.1001/jama.282.3.236; Ku JH, 2005, INT J ANDROL, V28, P317, DOI 10.1111/j.1365-2605.2005.00560.x; Kunishima Y, 2006, INT J UROL, V13, P1286, DOI 10.1111/j.1442-2042.2004.01556.x; Li GZ, 2011, INT UROL NEPHROL, V43, P295, DOI 10.1007/s11255-010-9825-5; Liang CZ, 2009, J UROLOGY, V182, P558, DOI 10.1016/j.juro.2009.04.011; Litwin MS, 1999, J UROLOGY, V162, P369, DOI 10.1016/S0022-5347(05)68562-X; MEARES EM, 1991, MED CLIN N AM, V75, P405, DOI 10.1016/S0025-7125(16)30462-X; Mehik A, 2000, BJU INT, V86, P443, DOI 10.1046/j.1464-410X.2000.00836.x; Mi H, 2012, UROLOGY, V79, P403, DOI 10.1016/j.urology.2011.09.032; Muller CH, 2001, J UROLOGY, V166, P2518, DOI 10.1016/S0022-5347(05)65627-3; Nickel JC, 2003, J UROLOGY, V170, P818, DOI 10.1097/01.ju.0000082252.49374.e9; Nickel JC, 2001, J UROLOGY, V165, P842, DOI 10.1016/S0022-5347(05)66541-X; Pontari MA, 2007, J UROLOGY, V177, P2050, DOI 10.1016/j.juro.2007.01.128; Sharma RK, 2001, J ANDROL, V22, P575; Shimomura Tatsuya, 2003, Kansenshogaku Zasshi, V77, P611; Simardi LH, 2004, UROLOGY, V64, P1098, DOI 10.1016/j.urology.2004.08.060; Stancik I, 2004, EUR UROL, V46, P760, DOI 10.1016/j.eururo.2004.08.003; Tripp DA, 2009, BJU INT, V103, P1080, DOI 10.1111/j.1464-410X.2008.08157.x; Wu CL, 2011, J ANDROL, V33, P59, DOI 10.2164/jandrol.110.012542	28	24	36	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2013	8	8							e71298	10.1371/journal.pone.0071298	http://dx.doi.org/10.1371/journal.pone.0071298			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201BN	23967188	Green Submitted, Green Published, gold			2022-12-25	WOS:000323115800048
J	Zhang, XP; Wang, H; Duvernay, MT; Zhu, S; Wu, GY				Zhang, Xiaoping; Wang, Hong; Duvernay, Matthew T.; Zhu, Shu; Wu, Guangyu			The Angiotensin II Type 1 Receptor C-Terminal Lys Residues Interact with Tubulin and Modulate Receptor Export Trafficking	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; CELL-SURFACE EXPRESSION; TO-GOLGI TRANSPORT; ENDOPLASMIC-RETICULUM; CARDIAC MYOCYTES; ALPHA(2)-ADRENERGIC RECEPTORS; ANTEROGRADE TRAFFICKING; ADRENERGIC-RECEPTORS; INTRACELLULAR LOOP; ADENYLYL-CYCLASE	The physiological and pathological functions of angiotensin II are largely mediated through activating the cell surface angiotensin II type 1 receptor (AT1R). However, the molecular mechanisms underlying the transport of newly synthesized AT1R from the endoplasmic reticulum (ER) to the cell surface remain poorly defined. Here we demonstrated that the C-terminus (CT) of AT1R directly and strongly bound to tubulin and the binding domains were mapped to two consecutive Lys residues at positions 310 and 311 in the CT membrane-proximal region of AT1R and the acidic CT of tubulin, suggestive of essentially ionic interactions between AT1R and tubulin. Furthermore, mutation to disrupt tubulin binding dramatically inhibited the cell surface expression of AT1R, arrested AT1R in the ER, and attenuated AT1R-mediated signaling measured as ERK1/2 activation. These data demonstrate for the first time that specific Lys residues in the CT juxtamembrane region regulate the processing of AT1R through interacting with tubulin. These data also suggest an important role of the microtubule network in the cell surface transport of AT1R.	[Zhang, Xiaoping; Wang, Hong; Duvernay, Matthew T.; Wu, Guangyu] Louisiana State Univ, Hlth Sci Ctr, Dept Pharmacol & Expt Therapeut, New Orleans, LA 70112 USA; [Wang, Hong] Tongji Univ, Sch Life Sci & Technol, Shanghai 200092, Peoples R China; [Zhu, Shu; Wu, Guangyu] Georgia Regents Univ, Dept Pharmacol & Toxicol, Med Coll Georgia, Augusta, GA USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Tongji University; University System of Georgia; Augusta University	Wu, GY (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Pharmacol & Expt Therapeut, New Orleans, LA 70112 USA.	guwu@gru.edu	zhang, xiaoping/G-9688-2013; Zhang, Xingding/C-8780-2014	Zhang, Xingding/0000-0002-2759-5185	National Institutes of Health grant [R01GM076167]	National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health grant R01GM076167. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Chen CG, 2006, J BIOL CHEM, V281, P7983, DOI 10.1074/jbc.M509805200; Ciruela F, 2001, J NEUROCHEM, V76, P750, DOI 10.1046/j.1471-4159.2001.00099.x; Cook JL, 2008, CIRC RES, V102, P1539, DOI 10.1161/CIRCRESAHA.108.176594; Dong C, 2008, CELL SIGNAL, V20, P1035, DOI 10.1016/j.cellsig.2008.01.014; Dong CM, 2007, CELL SIGNAL, V19, P2388, DOI 10.1016/j.cellsig.2007.07.017; Dong CM, 2006, J BIOL CHEM, V281, P38543, DOI 10.1074/jbc.M605734200; Dong CM, 2012, TRAFFIC, V13, P857, DOI 10.1111/j.1600-0854.2012.01351.x; Dong CM, 2010, J BIOL CHEM, V285, P20369, DOI 10.1074/jbc.M109.081521; Dong CM, 2010, J PHARMACOL EXP THER, V333, P174, DOI 10.1124/jpet.109.161489; Driskell OJ, 2007, NAT CELL BIOL, V9, P113, DOI 10.1038/ncb1525; Duvernay MT, 2011, J BIOL CHEM, V286, P14080, DOI 10.1074/jbc.M111.222323; Duvernay MT, 2009, TRAFFIC, V10, P552, DOI 10.1111/j.1600-0854.2009.00890.x; Duvernay MT, 2009, MOL PHARMACOL, V75, P751, DOI 10.1124/mol.108.051623; Duvernay MT, 2004, J BIOL CHEM, V279, P30741, DOI 10.1074/jbc.M313881200; Fan Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050416; Filipeanu CM, 2006, MOL PHARMACOL, V69, P1571, DOI 10.1124/mol.105.019984; Filipeanu CM, 2004, J BIOL CHEM, V279, P41077, DOI 10.1074/jbc.M405988200; Gaborik Z, 1998, FEBS LETT, V428, P147, DOI 10.1016/S0014-5793(98)00511-0; Gassmann M, 2005, MOL PHARMACOL, V68, P137, DOI 10.1124/mol.104.010256; Guo Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029204; Head BP, 2006, J BIOL CHEM, V281, P26391, DOI 10.1074/jbc.M602577200; Hermosilla R, 2004, TRAFFIC, V5, P993, DOI 10.1111/j.1600-0854.2004.00239.x; Hunyady L, 2006, MOL ENDOCRINOL, V20, P953, DOI 10.1210/me.2004-0536; Hunyady L, 2002, J CELL BIOL, V157, P1211, DOI 10.1083/jcb.200111013; Knipling L, 1999, CELL MOTIL CYTOSKEL, V43, P63, DOI 10.1002/(SICI)1097-0169(1999)43:1<63::AID-CM7>3.0.CO;2-Z; Madziva MT, 2006, J BIOL CHEM, V281, P12178, DOI 10.1074/jbc.M601357200; Mehta PK, 2007, AM J PHYSIOL-CELL PH, V292, pC82, DOI 10.1152/ajpcell.00287.2006; Mishima M, 2007, P NATL ACAD SCI USA, V104, P10346, DOI 10.1073/pnas.0703876104; MIZUNO M, 1994, J CELL SCI, V107, P1321; Popova JS, 2004, J BIOL CHEM, V279, P30410, DOI 10.1074/jbc.M402871200; POPOVA JS, 1994, J BIOL CHEM, V269, P21748; Presley JF, 1997, NATURE, V389, P81, DOI 10.1038/38001; Ralston E, 2001, J NEUROSCI, V21, P875, DOI 10.1523/JNEUROSCI.21-03-00875.2001; Rostovtseva TK, 2008, P NATL ACAD SCI USA, V105, P18746, DOI 10.1073/pnas.0806303105; SADOSHIMA J, 1995, CIRC RES, V76, P1; Sanchez-Laorden BL, 2009, J CELL PHYSIOL, V220, P640, DOI 10.1002/jcp.21804; SARASTE J, 1991, J CELL SCI, V100, P415; Sarma T, 2003, FASEB J, V17, P848, DOI 10.1096/fj.02-0730com; Saugstad JA, 2002, J NEUROCHEM, V80, P980, DOI 10.1046/j.0022-3042.2002.00778.x; Saunders C, 2000, MOL PHARMACOL, V57, P44; Saunders C, 1997, J BIOL CHEM, V272, P19035, DOI 10.1074/jbc.272.30.19035; Slep KC, 2007, MOL CELL, V27, P976, DOI 10.1016/j.molcel.2007.07.023; Touyz RM, 2000, PHARMACOL REV, V52, P639; Vassart G, 2011, NAT REV ENDOCRINOL, V7, P362, DOI 10.1038/nrendo.2011.20; Wang GS, 2012, TRENDS PHARMACOL SCI, V33, P28, DOI 10.1016/j.tips.2011.09.002; Wu GY, 2003, J BIOL CHEM, V278, P47062, DOI 10.1074/jbc.M305707200; Yin HJ, 2011, INT J BIOCHEM CELL B, V43, P401, DOI 10.1016/j.biocel.2010.11.010; Zhang XP, 2011, J BIOL CHEM, V286, P20525, DOI 10.1074/jbc.M111.222034; Zhang XP, 2009, J PHARMACOL EXP THER, V330, P109, DOI 10.1124/jpet.109.153460; Zhou FG, 2006, CELL SIGNAL, V18, P318, DOI 10.1016/j.cellsig.2005.05.014	51	7	12	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57805	10.1371/journal.pone.0057805	http://dx.doi.org/10.1371/journal.pone.0057805			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451270	Green Submitted, Green Published, gold			2022-12-25	WOS:000316849500135
J	Zhang, XD; Qi, L; Wu, JC; Qin, ZH				Zhang, Xing-Ding; Qi, Lin; Wu, Jun-Chao; Qin, Zheng-Hong			DRAM1 Regulates Autophagy Flux through Lysosomes	PLOS ONE			English	Article							3-NITROPROPIONIC ACID; MITOCHONDRIAL TOXIN; CELL-DEATH; PROTEIN-DEGRADATION; INTRALYSOSOMAL PH; CORTICAL-NEURONS; RAT STRIATUM; H+-ATPASE; APOPTOSIS; ACTIVATION	We have previously reported that the mitochondria inhibitor 3-nitropropionic acid (3-NP), induces the expression of DNA damage-regulated autophagy modulator1 (DRAM1) and activation of autophagy in rat striatum. Although the role of DRAM1 in autophagy has been previously characterized, the detailed mechanism by which DRAM1 regulates autophagy activity has not been fully understood. The present study investigated the role of DRAM1 in regulating autophagy flux. In A549 cells expressing wilt-type TP53, 3-NP increased the protein levels of DRAM1 and LC3-II, whereas decreased the levels of SQSTM1 (sequestosome 1). The increase in LC3-II and decrease in SQSTM1 were blocked by the autophagy inhibitor 3-methyl-adenine. Lack of TP53 or knock-down of TP53 in cells impaired the induction of DRAM1. Knock-down of DRAM1 with siRNA significantly reduced 3-NP-induced upregulation of LC3-II and downregulation of SQSTM1, indicating DRAM1 contributes to autophagy activation. Knock-down of DRAM1 robustly decreased rate of disappearance of induced autophagosomes, increased RFP-LC3 fluorescence dots and decreased the decline of LC3-II after withdraw of rapamycin, indicating DRAM1 promotes autophagy flux. DRAM1 siRNA inhibited lysosomal V-ATPase and acidification of lysosomes. As a result, DRAM1 siRNA reduced activation of lysosomal cathepsin D. Similar to DRAM1 siRNA, lysosomal inhibitors E64d and chloroquine also inhibited clearance of autophagosomes and activation of lysosomal cathapsin D after 3-NP treatment. These data suggest that DRAM1 plays important roles in autophagy activation induced by mitochondria dysfunction. DRAM1 affects autophagy through argument of lysosomal acidification, fusion of lysosomes with autophagosomes and clearance of autophagosomes.	[Qin, Zheng-Hong] Soochow Univ, Sch Pharmaceut Sci, Dept Pharmacol, Suzhou, Peoples R China; Soochow Univ, Sch Pharmaceut Sci, Lab Aging & Nervous Dis, Suzhou, Peoples R China	Soochow University - China; Soochow University - China	Qin, ZH (corresponding author), Soochow Univ, Sch Pharmaceut Sci, Dept Pharmacol, Suzhou, Peoples R China.	zhqin5@hotmail.com	zhang, xiaoping/G-9688-2013; Zhang, Xingding/C-8780-2014	Zhang, Xingding/0000-0002-2759-5185	National Natural Science Foundation of China [30930035]; National Basic Science Key Project (973 project) [CB510003]; Priority Academic Program development of Jiangsu Higher Education Institutes; Graduate Training Innovation Project of Jiangsu Province [CX09B_042Z]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Science Key Project (973 project)(National Basic Research Program of China); Priority Academic Program development of Jiangsu Higher Education Institutes; Graduate Training Innovation Project of Jiangsu Province	This work was partially supported by the National Natural Science Foundation of China (No 30930035), by the National Basic Science Key Project (973 project, CB510003), by the Priority Academic Program development of Jiangsu Higher Education Institutes, and by Graduate Training Innovation Project of Jiangsu Province (CX09B_042Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALAWQATI Q, 1995, CURR OPIN CELL BIOL, V7, P504, DOI 10.1016/0955-0674(95)80006-9; ALSTON TA, 1977, P NATL ACAD SCI USA, V74, P3767, DOI 10.1073/pnas.74.9.3767; BEAL MF, 1993, J NEUROSCI, V13, P4181; BEHRENS MI, 1995, NEUROREPORT, V6, P545, DOI 10.1097/00001756-199502000-00034; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005; Brouillet E, 2005, J NEUROCHEM, V95, P1521, DOI 10.1111/j.1471-4159.2005.03515.x; Choi SY, 2006, J BIOL CHEM, V281, P7049, DOI 10.1074/jbc.M512000200; Crighton D, 2007, CELL DEATH DIFFER, V14, P1071, DOI 10.1038/sj.cdd.4402108; Crighton D, 2006, CELL, V126, P121, DOI 10.1016/j.cell.2006.05.034; Cuervo AM, 2004, MOL CELL BIOCHEM, V263, P55, DOI 10.1023/B:MCBI.0000041848.57020.57; DEDUVE C, 1983, EUR J BIOCHEM, V137, P391, DOI 10.1111/j.1432-1033.1983.tb07841.x; EZAKI J, 1992, J BIOCHEM, V112, P33, DOI 10.1093/oxfordjournals.jbchem.a123861; Galavotti S, 2013, ONCOGENE, V32, P699, DOI 10.1038/onc.2012.111; GALLOWAY CJ, 1983, P NATL ACAD SCI-BIOL, V80, P3334, DOI 10.1073/pnas.80.11.3334; Goffredo D, 2002, J BIOL CHEM, V277, P39594, DOI 10.1074/jbc.C200353200; HOLTZMAN E, 1969, J CELL BIOL, V40, P863, DOI 10.1083/jcb.40.3.863; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kim GW, 2002, J CEREBR BLOOD F MET, V22, P798, DOI 10.1097/00004647-200207000-00005; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Klionsky DJ, 2007, AUTOPHAGY, V3, P413, DOI 10.4161/auto.4377; Klionsky DJ, 2005, J CELL SCI, V118, P7, DOI 10.1242/jcs.01620; Layton GT, 2001, INFLAMM RES, V50, P400, DOI 10.1007/PL00000262; Leventhal L, 2000, J COMP NEUROL, V425, P471, DOI 10.1002/1096-9861(20001002)425:4<471::AID-CNE1>3.0.CO;2-U; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; OHKUMA S, 1978, P NATL ACAD SCI USA, V75, P3327, DOI 10.1073/pnas.75.7.3327; Qin ZH, 1999, J NEUROSCI, V19, P4023; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; SMITH ML, 1987, J BIOL CHEM, V262, P1244; Stoka V, 2001, J BIOL CHEM, V276, P3149, DOI 10.1074/jbc.M008944200; Wang Y, 2008, AUTOPHAGY, V4, P214, DOI 10.4161/auto.5369; Wen YD, 2008, AUTOPHAGY, V4, P762, DOI 10.4161/auto.6412; Xin MG, 2006, J BIOL CHEM, V281, P18859, DOI 10.1074/jbc.M512543200; YOSHIMORI T, 1991, J BIOL CHEM, V266, P17707; Zhang XD, 2009, AUTOPHAGY, V5, P339, DOI 10.4161/auto.5.3.8174; Zoncu R, 2011, SCIENCE, V334, P678, DOI 10.1126/science.1207056	37	7	12	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2013	8	5							e63245	10.1371/journal.pone.0063245	http://dx.doi.org/10.1371/journal.pone.0063245			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RJ	23451270	Green Published, Green Submitted, gold			2022-12-25	WOS:000319107900030
J	Zhang, XL; Ge, XH; Shao, YJ; Sun, GL; Li, ZY				Zhang, Xueli; Ge, Xianhong; Shao, Yujiao; Sun, Genlou; Li, Zaiyun			Genomic Change, Retrotransposon Mobilization and Extensive Cytosine Methylation Alteration in Brassica napus Introgressions from Two Intertribal Hybridizations	PLOS ONE			English	Article							PARTIAL HYBRIDS; CHROMOSOME ELIMINATION; INTERGENERIC HYBRIDS; DNA METHYLATION; TRANSCRIPTIONAL ACTIVATION; HOMEOLOGOUS RECOMBINATION; ORYCHOPHRAGMUS-VIOLACEUS; HELIANTHUS-ANNUUS; GENE-EXPRESSION; MAJOR ROLE	Hybridization and introgression represent important means for the transfer and/or de novo origination of traits and play an important role in facilitating speciation and plant breeding. Two sets of introgression lines in Brassica napus L. were previously established by its intertribal hybridizations with two wild species and long-term selection. In this study, the methods of amplified fragment length polymorphisms (AFLP), sequence-specific amplification polymorphism (SSAP) and methylation-sensitive amplified polymorphism (MSAP) were used to determine their genomic change, retrotransposon mobilization and cytosine methylation alteration in these lines. The genomic change revealed by the loss or gain of AFLP bands occurred for similar to 10% of the total bands amplified in the two sets of introgressions, while no bands specific for wild species were detected. The new and absent SSAP bands appeared for 9 out of 11 retrotransposons analyzed, with low frequency of new bands and their total percentage of about 5% in both sets. MSAP analysis indicated that methylation changes were common in these lines (33.4-39.8%) and the hypermethylation was more frequent than hypomethylation. Our results suggested that certain extents of genetic and epigenetic alterations were induced by hybridization and alien DNA introgression. The cryptic mechanism of these changes and potential application of these lines in breeding were also discussed.	[Zhang, Xueli; Ge, Xianhong; Li, Zaiyun] Huazhong Agr Univ, Natl Ctr Oil Crop Improvement Wuhan, Coll Plant Sci & Technol, Natl Key Lab Crop Genet Improvement,Natl Ctr Crop, Wuhan, Peoples R China; [Shao, Yujiao] Hubei Univ Educ, Coll Chem & Life Sci, Wuhan, Peoples R China; [Sun, Genlou] St Marys Univ, Dept Biol, Halifax, NS B3H 3C3, Canada	Huazhong Agricultural University; Hubei University Education; Saint Marys University - Canada	Ge, XH (corresponding author), Huazhong Agr Univ, Natl Ctr Oil Crop Improvement Wuhan, Coll Plant Sci & Technol, Natl Key Lab Crop Genet Improvement,Natl Ctr Crop, Wuhan, Peoples R China.	gexianhong@gmail.com; lizaiyun@mail.hzau.edu.cn	; Zeng, Qingdong/H-7208-2014	Wu, Jianhui/0000-0001-8154-1199; Zeng, Qingdong/0000-0002-7856-2340; Kang, Zhensheng/0000-0001-5575-0122	Agricultural Ministry of China [201103016]	Agricultural Ministry of China(Ministry of Agriculture & Rural Affairs)	The work was supported by the grant from Agricultural Ministry of China (201103016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KL, 2005, CURR OPIN PLANT BIOL, V8, P135, DOI 10.1016/j.pbi.2005.01.001; Alix K, 2008, PLANT J, V56, P1030, DOI 10.1111/j.1365-313X.2008.03660.x; ANDERSON E., 1949, Introgressive hybridization.; Arnold ML, 2004, PLANT CELL, V16, P562, DOI 10.1105/tpc.160370; Beaulieu J, 2009, MOL GENET GENOMICS, V281, P421, DOI 10.1007/s00438-008-0421-7; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Chen HF, 2007, PLANT CELL REP, V26, P1791, DOI 10.1007/s00299-007-0392-x; Cheng BF, 2002, GENOME, V45, P110, DOI 10.1139/g01-131; Couvreur TLP, 2010, MOL BIOL EVOL, V27, P55, DOI 10.1093/molbev/msp202; Du XZ, 2008, PLANT CELL REP, V27, P261, DOI 10.1007/s00299-007-0452-2; Faure N, 2002, THEOR APPL GENET, V104, P652, DOI 10.1007/s001220100746; Feldman M, 2005, CYTOGENET GENOME RES, V109, P250, DOI 10.1159/000082407; Finnegan EJ, 2000, PLANT MOL BIOL, V43, P189, DOI 10.1023/A:1006427226972; Gaeta RT, 2007, PLANT CELL, V19, P3403, DOI 10.1105/tpc.107.054346; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Ha M, 2011, GENOME RES, V21, P590, DOI 10.1101/gr.116467.110; Ha M, 2009, P NATL ACAD SCI USA, V106, P17835, DOI 10.1073/pnas.0907003106; He XJ, 2011, CELL RES, V21, P442, DOI 10.1038/cr.2011.23; Henderson IR, 2007, NATURE, V447, P418, DOI 10.1038/nature05917; Hua YW, 2006, ANN BOT-LONDON, V97, P993, DOI 10.1093/aob/mcl073; Kashkush K, 2003, NAT GENET, V33, P102, DOI 10.1038/ng1063; Kashkush K, 2007, GENETICS, V177, P1975, DOI 10.1534/genetics.107.080234; Kidwell Kimberlee K., 1992, P1; Kraitshtein Z, 2010, GENETICS, V186, P801, DOI 10.1534/genetics.110.120790; Kumar A, 1999, ANNU REV GENET, V33, P479, DOI 10.1146/annurev.genet.33.1.479; Lashermes P, 2000, THEOR APPL GENET, V100, P139, DOI 10.1007/s001220050019; Leflon M, 2006, THEOR APPL GENET, V113, P1467, DOI 10.1007/s00122-006-0393-0; LI Z, 1995, THEOR APPL GENET, V91, P131, DOI 10.1007/BF00220869; Li ZY, 2007, PLANT CELL REP, V26, P701, DOI 10.1007/s00299-006-0290-7; Liu B., 1999, Journal of Genetics and Breeding, V53, P279; Liu B, 2001, GENOME, V44, P321, DOI 10.1139/gen-44-3-321; Liu H.L., 2000, GENETICS BREEDING RA; Liu M, 2007, GENOME, V50, P985, DOI 10.1139/G07-071; LUO P, 1994, PLANT BREEDING, V113, P83, DOI 10.1111/j.1439-0523.1994.tb00707.x; Lysak MA, 2005, GENOME RES, V15, P516, DOI 10.1101/gr.3531105; Lysak MA, 2007, PLANT PHYSIOL, V145, P402, DOI 10.1104/pp.107.104380; Ma N, 2007, EUPHYTICA, V157, P231, DOI 10.1007/s10681-007-9416-4; Ma N, 2006, PLANT CELL REP, V25, P1089, DOI 10.1007/s00299-006-0171-0; Ma XF, 2008, ANN BOT-LONDON, V101, P825, DOI 10.1093/aob/mcm331; Ma XF, 2006, GENOME, V49, P950, DOI 10.1139/G06-078; Madlung A, 2002, PLANT PHYSIOL, V129, P733, DOI 10.1104/pp.003095; Madlung A, 2004, ANN BOT-LONDON, V94, P481, DOI 10.1093/aob/mch172; Mallet J, 2007, NATURE, V446, P279, DOI 10.1038/nature05706; MCCLINTOCK B, 1984, SCIENCE, V226, P792, DOI 10.1126/science.15739260; Melayah D, 2001, PLANT J, V28, P159, DOI 10.1046/j.1365-313X.2001.01141.x; Nicolas SD, 2007, GENETICS, V175, P487, DOI 10.1534/genetics.106.062968; Okamoto H, 2001, TRENDS PLANT SCI, V6, P527, DOI 10.1016/S1360-1385(01)02105-7; Osborn TC, 2003, GENETICS, V165, P1569; Otto SP, 2000, ANNU REV GENET, V34, P401, DOI 10.1146/annurev.genet.34.1.401; Ozkan H, 2001, PLANT CELL, V13, P1735, DOI 10.1105/tpc.13.8.1735; Parisod C, 2010, NEW PHYTOL, V186, P37, DOI 10.1111/j.1469-8137.2009.03096.x; Petit M, 2010, NEW PHYTOL, V186, P135, DOI 10.1111/j.1469-8137.2009.03140.x; Petit M, 2007, MOL GENET GENOMICS, V278, P1, DOI 10.1007/s00438-007-0226-0; Pires JC, 2004, BIOL J LINN SOC, V82, P675, DOI 10.1111/j.1095-8312.2004.00350.x; Rieseberg LH, 1998, NEW PHYTOL, V140, P599, DOI 10.1046/j.1469-8137.1998.00315.x; Rieseberg LH, 1996, SCIENCE, V272, P741, DOI 10.1126/science.272.5262.741; Rieseberg LH, 2007, SCIENCE, V317, P910, DOI 10.1126/science.1137729; Salmon A, 2005, MOL ECOL, V14, P1163, DOI 10.1111/j.1365-294X.2005.02488.x; Scascitelli M, 2010, MOL ECOL, V19, P521, DOI 10.1111/j.1365-294X.2009.04504.x; SONG KM, 1995, P NATL ACAD SCI USA, V92, P7719, DOI 10.1073/pnas.92.17.7719; Tate Jennifer A., 2005, P371, DOI 10.1016/B978-012301463-4/50009-7; Tu YQ, 2009, ANN BOT-LONDON, V103, P1039, DOI 10.1093/aob/mcp045; Udall JA, 2005, GENETICS, V169, P967, DOI 10.1534/genetics.104.033209; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Wang NN, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-190; Wang YM, 2005, GENETICS, V170, P1945, DOI 10.1534/genetics.105.040964; Waugh R, 1997, MOL GEN GENET, V253, P687, DOI 10.1007/s004380050372; Wierzbicki AT, 2008, CELL, V135, P635, DOI 10.1016/j.cell.2008.09.035; Xiong LZ, 1999, MOL GEN GENET, V261, P439, DOI 10.1007/s004380050986; Xu YH, 2009, PLANTA, V229, P471, DOI 10.1007/s00425-008-0844-8; Yang TJ, 2006, PLANT CELL, V18, P1339, DOI 10.1105/tpc.105.040535; Zhao N, 2011, GENETICS, V188, P499, DOI 10.1534/genetics.111.127688; Zhao ZG, 2007, GENOME, V50, P226, DOI 10.1139/G06-146; Zou J, 2011, PLANT J, V68, P212, DOI 10.1111/j.1365-313X.2011.04679.x	74	38	46	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e56346	10.1371/journal.pone.0056346	http://dx.doi.org/10.1371/journal.pone.0056346			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23526955	Green Submitted, Green Published, gold			2022-12-25	WOS:000315524900023
J	Li, HZ; Hou, S; Wu, X; Nandagopal, S; Lin, F; Kung, S; Marshall, AJ				Li, Hongzhao; Hou, Sen; Wu, Xun; Nandagopal, Saravanan; Lin, Francis; Kung, Sam; Marshall, Aaron James			The Tandem PH Domain-Containing Protein 2 (TAPP2) Regulates Chemokine-Induced Cytoskeletal Reorganization and Malignant B Cell Migration	PLOS ONE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; DYSTROPHIN-GLYCOPROTEIN COMPLEX; PHOSPHOINOSITIDE 3-KINASES; ACTIN; CHEMOTAXIS; POLARITY; MOTILITY; CXCR4; RECEPTOR; RECRUITMENT	The intracellular signaling processes controlling malignant B cell migration and tissue localization remain largely undefined. Tandem PH domain-containing proteins TAPP1 and TAPP2 are adaptor proteins that specifically bind to phosphatidylinositol-3,4-bisphosphate, or PI(3,4) P2, a product of phosphoinositide 3-kinases (PI3K). While PI3K enzymes have a number of functions in cell biology, including cell migration, the functions of PI(3,4) P2 and its binding proteins are not well understood. Previously we found that TAPP2 is highly expressed in primary leukemic B cells that have strong migratory capacity. Here we find that SDF-1-dependent migration of human malignant B cells requires both PI3K signaling and TAPP2. Migration in a transwell assay is significantly impaired by pan-PI3K and isoform-selective PI3K inhibitors, or by TAPP2 shRNA knockdown (KD). Strikingly, TAPP2 KD in combination with PI3K inhibitor treatment nearly abolished the migration response, suggesting that TAPP2 may contribute some functions independent of the PI3K pathway. In microfluidic chamber cell tracking assays, TAPP2 KD cells show reduction in percentage of migrating cells, migration velocity and directionality. TAPP2 KD led to alterations in chemokine-induced rearrangement of the actin cytoskeleton and failure to form polarized morphology. TAPP2 co-localized with the stable F-actin-binding protein utrophin, with both molecules reciprocally localizing against F-actin accumulated at the leading edge upon SDF-1 stimulation. In TAPP2 KD cells, Rac was over-activated and localized to multiple membrane protrusions, suggesting that TAPP2 may act in concert with utrophin and stable F-actin to spatially restrict Rac activation and reduce formation of multiple membrane protrusions. TAPP2 function in cell migration is also apparent in the more complex context of B cell migration into stromal cell layers - a process that is only partially dependent on PI3K and SDF-1. In summary, this study identified TAPP2 as a novel regulator of malignant B cell migration and a potential therapeutic intervention target.	[Li, Hongzhao; Hou, Sen; Wu, Xun; Lin, Francis; Kung, Sam; Marshall, Aaron James] Univ Manitoba, Dept Immunol, Winnipeg, MB, Canada; [Nandagopal, Saravanan; Lin, Francis] Univ Manitoba, Dept Phys & Astron, Winnipeg, MB, Canada; [Marshall, Aaron James] Univ Manitoba, Dept Biochem & Med Genet, Winnipeg, MB, Canada	University of Manitoba; University of Manitoba; University of Manitoba	Marshall, AJ (corresponding author), Univ Manitoba, Dept Immunol, Winnipeg, MB, Canada.	marshall@ms.umanitoba.ca		Lin, Francis/0000-0003-1736-193X; Wu, Xun/0000-0001-7549-5464; Andalur Nandagopal, Saravanan/0000-0002-1787-3356; Marshall, Aaron/0000-0002-1175-5498; Pei, Zhen-Ming/0000-0003-1473-696X	Canadian Cancer Society [2011-700981]; Canadian Institutes of Health Research; Manitoba Health Research Council	Canadian Cancer Society(Canadian Cancer Society (CCS)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Manitoba Health Research Council	This research was funded by the Canadian Cancer Society (grant #2011-700981). HL was supported by studentship awards from the Canadian Institutes of Health Research and Manitoba Health Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonso PV, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002019; Allam A, 2004, J BIOL CHEM, V279, P39775, DOI 10.1074/jbc.M403367200; Allikian MJ, 2007, TRAFFIC, V8, P177, DOI 10.1111/j.1600-0854.2006.00519.x; Barber Mark A, 2006, Bull Cancer, V93, pE44; Bradstock KF, 2000, LEUKEMIA, V14, P882, DOI 10.1038/sj.leu.2401729; Burger JA, 1999, BLOOD, V94, P3658, DOI 10.1182/blood.V94.11.3658.423k11_3658_3667; Burger JA, 2007, BRIT J HAEMATOL, V137, P288, DOI 10.1111/j.1365-2141.2007.06590.x; Burger JA, 2009, BLOOD, V114, P3367, DOI 10.1182/blood-2009-06-225326; Burkel BM, 2007, CELL MOTIL CYTOSKEL, V64, P822, DOI 10.1002/cm.20226; Cain RJ, 2009, BIOL CELL, V101, P13, DOI 10.1042/BC20080079; Cernuda-Morollon E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012393; Cheung SMS, 2007, CELL SIGNAL, V19, P902, DOI 10.1016/j.cellsig.2006.10.013; Cooper KM, 2008, MOL BIOL CELL, V19, P3180, DOI 10.1091/mbc.E08-02-0225; Costantini JL, 2009, BLOOD; Del Principe MI, 2006, BLOOD, V108, P853, DOI 10.1182/blood-2005-12-4986; Dormann D, 2004, J CELL SCI, V117, P6497, DOI 10.1242/jcs.01579; Dowler S, 2000, BIOCHEM J, V351, P19, DOI 10.1042/0264-6021:3510019; Haenggi T, 2006, CELL MOL LIFE SCI, V63, P1614, DOI 10.1007/s00018-005-5461-0; HENDERSON AJ, 1990, J IMMUNOL, V145, P423; Hogan A, 2004, J BIOL CHEM, V279, P53717, DOI 10.1074/jbc.M410654200; Jiang P, 2009, CANCER LETT, V284, P122, DOI 10.1016/j.canlet.2009.02.034; Konopleva M, 2009, DRUG RESIST UPDATE, V12, P103, DOI 10.1016/j.drup.2009.06.001; Landego I, 2012, EUR J IMMUNOL; Lin F, 2006, LAB CHIP, V6, P1462, DOI 10.1039/b607071j; Marshall AJ, 2002, MOL CELL BIOL, V22, P5479, DOI 10.1128/MCB.22.15.5479-5491.2002; Mehes E, 2005, GLIA, V49, P492, DOI 10.1002/glia.20135; Narang A, 2006, J THEOR BIOL, V240, P538, DOI 10.1016/j.jtbi.2005.10.022; Niedermeier M, 2009, BLOOD, V113, P5549, DOI 10.1182/blood-2008-06-165068; Nishioka T, 2008, MOL BIOL CELL, V19, P4213, DOI 10.1091/mbc.E08-03-0315; Parente CA, 1998, CELL, V95, P81, DOI 10.1016/S0092-8674(00)81784-5; Pauls SD, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00224; Richardson SJ, 2006, BLOOD, V107, P3584, DOI 10.1182/blood-2005-04-1718; Small JV, 2005, CURR OPIN CELL BIOL, V17, P517, DOI 10.1016/j.ceb.2005.08.004; STOSSEL TP, 1993, SCIENCE, V260, P1086, DOI 10.1126/science.8493552; Swaney KF, 2010, ANNU REV BIOPHYS, V39, P265, DOI 10.1146/annurev.biophys.093008.131228; Tai YT, 2003, BLOOD, V101, P2762, DOI 10.1182/blood-2002-09-2813; Teicher BA, 2010, CLIN CANCER RES, V16, P2927, DOI 10.1158/1078-0432.CCR-09-2329; Vicente-Manzanares M, 2011, J CELL BIOL, V193, P381, DOI 10.1083/jcb.201012159; Ward SG, 2004, TRENDS IMMUNOL, V25, P67, DOI 10.1016/j.it.2003.12.003; Wong D, 2008, CLIN CANCER RES, V14, P7975, DOI 10.1158/1078-0432.CCR-07-4846; Xu JS, 2003, CELL, V114, P201, DOI 10.1016/S0092-8674(03)00555-5; Yoo SK, 2010, DEV CELL, V18, P226, DOI 10.1016/j.devcel.2009.11.015; Zhang TT, 2009, IMMUNOL REV, V232, P255, DOI 10.1111/j.1600-065X.2009.00838.x	43	50	50	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57809	10.1371/journal.pone.0057809	http://dx.doi.org/10.1371/journal.pone.0057809			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460911	gold, Green Submitted, Green Published			2022-12-25	WOS:000315519000166
J	Okumura, N; Kay, EP; Nakahara, M; Hamuro, J; Kinoshita, S; Koizumi, N				Okumura, Naoki; Kay, EunDuck P.; Nakahara, Makiko; Hamuro, Junji; Kinoshita, Shigeru; Koizumi, Noriko			Inhibition of TGF-beta Signaling Enables Human Corneal Endothelial Cell Expansion In Vitro for Use in Regenerative Medicine	PLOS ONE			English	Article							TO-MESENCHYMAL TRANSITION; ALLOGRAFT-REJECTION; AMNIOTIC MEMBRANE; ROCK INHIBITOR; AQUEOUS-HUMOR; RABBIT MODEL; TRANSPLANTATION; KERATOPLASTY; PRIMATE; VIVO	Corneal endothelial dysfunctions occurring in patients with Fuchs' endothelial corneal dystrophy, pseudoexfoliation syndrome, corneal endotheliitis, and surgically induced corneal endothelial damage cause blindness due to the loss of endothelial function that maintains corneal transparency. Transplantation of cultivated corneal endothelial cells (CECs) has been researched to repair endothelial dysfunction in animal models, though the in vitro expansion of human CECs (HCECs) is a pivotal practical issue. In this study we established an optimum condition for the cultivation of HCECs. When exposed to culture conditions, both primate and human CECs showed two distinct phenotypes: contact-inhibited polygonal monolayer and fibroblastic phenotypes. The use of SB431542, a selective inhibitor of the transforming growth factor-beta (TGF-beta) receptor, counteracted the fibroblastic phenotypes to the normal contact-inhibited monolayer, and these polygonal cells maintained endothelial physiological functions. Expression of ZO-1 and Na+/K+-ATPase maintained their subcellular localization at the plasma membrane. Furthermore, expression of type I collagen and fibronectin was greatly reduced. This present study may prove to be the substantial protocol to provide the efficient in vitro expansion of HCECs with an inhibitor to the TGF-beta receptor, and may ultimately provide clinicians with a new therapeutic modality in regenerative medicine for the treatment of corneal endothelial dysfunctions.	[Okumura, Naoki; Kay, EunDuck P.; Nakahara, Makiko; Koizumi, Noriko] Doshisha Univ, Fac Life & Med Sci, Dept Biomed Engn, Kyotanabe, Japan; [Okumura, Naoki; Hamuro, Junji; Kinoshita, Shigeru] Kyoto Prefectural Univ Med, Dept Ophthalmol, Kyoto, Japan	Doshisha University; Kyoto Prefectural University of Medicine	Koizumi, N (corresponding author), Doshisha Univ, Fac Life & Med Sci, Dept Biomed Engn, Kyotanabe, Japan.	nkoizumi@mail.doshisha.ac.jp			Highway Program for realization of regenerative medicine; Funding Program for Next Generation World-Leading Researchers from the Cabinet Office in Japan [LS117]; Grants-in-Aid for Scientific Research [23659818] Funding Source: KAKEN	Highway Program for realization of regenerative medicine; Funding Program for Next Generation World-Leading Researchers from the Cabinet Office in Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The work was supported in part by the Highway Program for realization of regenerative medicine (Kinoshita and Okumura); http://www.mext.go.jp/english/; and the Funding Program for Next Generation World-Leading Researchers from the Cabinet Office in Japan (Koizumi: LS117); http://www.jsps.go.jp/english/e-jisedai/index.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARRY PA, 1995, INVEST OPHTH VIS SCI, V36, P1115; Buijs JT, 2007, AM J PATHOL, V171, P1047, DOI 10.2353/ajpath.2007.070168; Chen KH, 1999, INVEST OPHTH VIS SCI, V40, P2513; Coster DJ, 2005, AM J OPHTHALMOL, V140, P1112, DOI 10.1016/j.ajo.2005.07.024; Darlington JK, 2006, OPHTHALMOLOGY, V113, P2171, DOI 10.1016/j.ophtha.2006.06.034; Engelmann K, 2004, EXP EYE RES, V78, P573, DOI 10.1016/S0014-4835(03)00209-4; Gorovoy MS, 2006, CORNEA, V25, P886, DOI 10.1097/01.ico.0000214224.90743.01; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Ishino Y, 2004, INVEST OPHTH VIS SCI, V45, P800, DOI 10.1167/iovs.03-0016; Joyce Nancy C, 2004, Cornea, V23, pS8, DOI 10.1097/01.ico.0000136666.63870.18; Kaimori A, 2007, J BIOL CHEM, V282, P22089, DOI 10.1074/jbc.M700998200; Kawaguchi R, 2001, CORNEA, V20, P100, DOI 10.1097/00003226-200101000-00019; Khaireddin R, 2003, GRAEF ARCH CLIN EXP, V241, P1020, DOI 10.1007/s00417-003-0759-9; Kim TY, 2001, INVEST OPHTH VIS SCI, V42, P3142; Ko MK, 2001, EXP CELL RES, V264, P363, DOI 10.1006/excr.2000.5155; Koizumi N, 2000, INVEST OPHTH VIS SCI, V41, P2506; Koizumi N, 2008, CORNEA, V27, pS48, DOI 10.1097/ICO.0b013e31817f2298; Koizumi N, 2008, OPHTHALMOLOGY, V115, P292, DOI 10.1016/j.ophtha.2007.04.053; Koizumi N, 2007, INVEST OPHTH VIS SCI, V48, P4519, DOI 10.1167/iovs.07-0567; Koizumi N, 2012, EXP EYE RES, V95, P60, DOI 10.1016/j.exer.2011.10.014; Li W, 2007, INVEST OPHTH VIS SCI, V48, P614, DOI 10.1167/iovs.06-1126; Ma Frank Y, 2009, Front Biosci (Schol Ed), V1, P171, DOI 10.2741/s17; Melles GRJ, 2000, OPHTHALMOLOGY, V107, P1850, DOI 10.1016/S0161-6420(00)00253-0; Mimura T, 2005, INVEST OPHTH VIS SCI, V46, P3128, DOI 10.1167/iovs.05-0251; Mimura T, 2004, INVEST OPHTH VIS SCI, V45, P2992, DOI 10.1167/iovs.03-1174; Mimura T, 2003, EXP EYE RES, V76, P745, DOI 10.1016/S0014-4835(03)00057-5; Miyata K, 2001, CORNEA, V20, P59, DOI 10.1097/00003226-200101000-00012; Naumann GOH, 2000, OPHTHALMOLOGY, V107, P1111, DOI 10.1016/S0161-6420(00)00087-7; Okumura N, 2012, AM J PATHOL, V181, P268, DOI 10.1016/j.ajpath.2012.03.033; Okumura N, 2009, INVEST OPHTH VIS SCI, V50, P3680, DOI 10.1167/iovs.08-2634; Parsons CJ, 2007, J GASTROEN HEPATOL, V22, pS79, DOI 10.1111/j.1440-1746.2006.04659.x; Patel SV, 2009, INVEST OPHTH VIS SCI, V50, P2123, DOI 10.1167/iovs.08-2653; Peh GSL, 2011, TRANSPLANTATION, V91, P811, DOI 10.1097/TP.0b013e3182111f01; Price FW, 2005, J REFRACT SURG, V21, P339; Price MO, 2010, CLIN EXP OPHTHALMOL, V38, P128, DOI 10.1111/j.1442-9071.2010.02213.x; RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8; Saika S, 2006, LAB INVEST, V86, P106, DOI 10.1038/labinvest.3700375; Simic P, 2007, EMBO REP, V8, P327, DOI 10.1038/sj.embor.7400943; Song JS, 2010, INVEST OPHTH VIS SCI, V51, P822, DOI 10.1167/iovs.09-4240; Sumide T, 2006, FASEB J, V20, P392, DOI 10.1096/fj.04-3035fje; Wendt MK, 2009, FUTURE ONCOL, V5, P1145, DOI 10.2217/FON.09.90; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927; Zeisberg M, 2003, NAT MED, V9, P964, DOI 10.1038/nm888; Zeisberg M, 2007, J BIOL CHEM, V282, P23337, DOI 10.1074/jbc.M700194200; Zhu C, 2004, INVEST OPHTH VIS SCI, V45, P1743, DOI 10.1167/iovs.03-0814	45	147	152	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e58000	10.1371/journal.pone.0058000	http://dx.doi.org/10.1371/journal.pone.0058000			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451286	Green Published, gold, Green Submitted			2022-12-25	WOS:000316849500147
J	Chan, CM; Chang, HH; Wang, VC; Huang, CL; Hung, CF				Chan, Chi-Ming; Chang, Hsun-Hsien; Wang, Vin-Chi; Huang, Chuen-Lin; Hung, Chi-Feng			Inhibitory Effects of Resveratrol on PDGF-BB-Induced Retinal Pigment Epithelial Cell Migration via PDGFR beta, PI3K/Akt and MAPK pathways	PLOS ONE			English	Article							EXPERIMENTAL PROLIFERATIVE VITREORETINOPATHY; EXTRACELLULAR-MATRIX PROTEINS; VASCULAR SMOOTH-MUSCLE; GROWTH-FACTOR RECEPTOR; BREAST-CANCER CELLS; IN-VIVO; (-)-EPIGALLOCATECHIN GALLATE; DIABETIC-RETINOPATHY; ADJUNCTIVE TREATMENT; ARPE19 CELLS	Purpose: In diseases such as proliferative vitreoretinopathy (PVR), proliferative diabetic retinopathy, and age-related macular degeneration, retinal pigment epithelial (RPE) cells proliferate and migrate. Moreover, platelet-derived growth factor (PDGF) has been shown to enhance proliferation and migration of RPE cells in PVR. Even resveratrol can suppress the migration and adhesion of many cell types, its effects on RPE cell migration and adhesion remain unknown. In this study, we investigated the inhibitory effects of resveratrol on RPE cell migration induced by PDGF-BB, an isoform of PDGF, and adhesion to fibronectin, a major ECM component of PVR tissue. Methods: The migration of RPE cells was assessed by an electric cell-substrate impedance sensing migration assay and a Transwell migration assay. A cell viability assay was used to determine the viability of resveratrol treated-cells. The cell adhesion to fibronectin was examined by an adhesion assay. The interactions of resveratrol with PDGF-BB were analyzed by a dot binding assay. The PDGF-BB-induced signaling pathways were determined by western blotting and scratch wound healing assay. Results: Resveratrol inhibited PDGF-BB-induced RPE cell migration in a dose-dependent manner, but showed no effects on ARPE19 cell adhesion to fibronectin. The cell viability assay showed no cytotoxicity of resveratrol on RPE cells and the dot binding assay revealed no direct interactions of resveratrol with PDGF-BB. Inhibitory effects of resveratrol on PDGF-BB-induced platelet-derived growth factor receptor beta (PDGFR beta) and tyrosine phosphorylation and the underlying pathways of PI3K/Akt, ERK and p38 activation were found; however, resveratrol and PDGF-BB showed no effects on PDGFR alpha and JNK activation. Scratch wound healing assay demonstrated resveratrol and the specific inhibitors of PDGFR, PI3K, MEK or p38 suppressed PDGF-BB-induced cell migration. Conclusions: These results indicate that resveratrol is an effective inhibitor of PDGF-BB-induced RPE cell migration via PDGFRb, PI3K/Akt and MAPK pathways, but has no effects on the RPE cell adhesion to fibronectin.	[Chan, Chi-Ming] Cardinal Tien Hosp, Dept Ophthalmol, New Taipei City, Taiwan; [Chan, Chi-Ming; Wang, Vin-Chi; Hung, Chi-Feng] Fu Jen Catholic Univ, Sch Med, New Taipei City, Taiwan; [Chang, Hsun-Hsien; Hung, Chi-Feng] Harvard Univ, Childrens Hosp Informat Program, Harvard Massachusetts Inst Technol, Div Hlth Sci & Technol,Med Sch, Boston, MA USA; [Wang, Vin-Chi] Cardinal Tien Hosp, Neurol Ctr, New Taipei City, Taiwan; [Huang, Chuen-Lin] Cardinal Tien Hosp, Med Res Ctr, New Taipei City, Taiwan; [Huang, Chuen-Lin] Natl Def Med Ctr, Dept Physiol & Biophys, Grad Inst Physiol, Taipei, Taiwan	Cardinal Tien Hospital; Fu Jen Catholic University; Harvard University; Boston Children's Hospital; Harvard Medical School; Massachusetts Institute of Technology (MIT); Broad Institute; Cardinal Tien Hospital; Cardinal Tien Hospital; National Defense Medical Center	Hung, CF (corresponding author), Fu Jen Catholic Univ, Sch Med, New Taipei City, Taiwan.	054317@gmail.com	Hung, Chi-Feng/AAL-4977-2021; Chan, Chi-Ming/GWZ-3612-2022	Hung, Chi-Feng/0000-0003-3478-5451; Troughton, Richard/0000-0001-7484-4036	National Science Council, Taipei, Taiwan [NSC97-2320-B-030-001-MY3]; Cardinal Tien Hospital, Taipei, Taiwan [FU10008]	National Science Council, Taipei, Taiwan(Ministry of Science and Technology, Taiwan); Cardinal Tien Hospital, Taipei, Taiwan	This work was supported by the research grants from the National Science Council (NSC97-2320-B-030-001-MY3) and from Cardinal Tien Hospital (FU10008), Taipei, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Akiyama H, 2006, J CELL PHYSIOL, V207, P407, DOI 10.1002/jcp.20583; Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Bai Y, 2010, CANCER SCI, V101, P488, DOI 10.1111/j.1349-7006.2009.01415.x; Betsholtz C, 2001, BIOESSAYS, V23, P494, DOI 10.1002/bies.1069; Brown VA, 2010, CANCER RES, V70, P9003, DOI 10.1158/0008-5472.CAN-10-2364; Campochiaro PA, 1997, ARCH OPHTHALMOL-CHIC, V115, P237, DOI 10.1001/archopht.1997.01100150239014; CAMPOCHIARO PA, 1994, J CELL SCI, V107, P2459; Cao LM, 2010, INVEST OPHTH VIS SCI, V51, P6658, DOI 10.1167/iovs.10-5524; Cardillo JA, 1997, OPHTHALMOLOGY, V104, P1166, DOI 10.1016/S0161-6420(97)30167-5; Chan CM, 2010, MOL VIS, V16, P586; Chan CM, 2009, BIOCHEM BIOPH RES CO, V388, P172, DOI 10.1016/j.bbrc.2009.07.155; Chan CM, 2008, MOL VIS, V14, P2528; CHARTERIS DG, 1995, BRIT J OPHTHALMOL, V79, P953, DOI 10.1136/bjo.79.10.953; Charteris DG, 2002, EYE, V16, P369, DOI 10.1038/sj.eye.6700194; Chen QH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015288; Cicha I, 2011, J ATHEROSCLER THROMB, V18, P1031, DOI 10.5551/jat.8136; Csiszar A, 2011, ANN NY ACAD SCI, V1215, P117, DOI 10.1111/j.1749-6632.2010.05848.x; de Silva DJ, 2008, BRIT J OPHTHALMOL, V92, P954, DOI 10.1136/bjo.2007.131540; Frombaum M, 2012, BIOCHIMIE, V94, P269, DOI 10.1016/j.biochi.2011.11.001; GIAEVER I, 1991, P NATL ACAD SCI USA, V88, P7896, DOI 10.1073/pnas.88.17.7896; HAMILTON CW, 1982, AM J OPHTHALMOL, V94, P473, DOI 10.1016/0002-9394(82)90241-0; Haugland HK, 1997, ANTICANCER RES, V17, P1035; Heldin CH, 1999, PHYSIOL REV, V79, P1283, DOI 10.1152/physrev.1999.79.4.1283; Hinton DR, 1998, EXP CELL RES, V239, P11, DOI 10.1006/excr.1997.3873; HISCOTT P, 1994, BRIT J OPHTHALMOL, V78, P219, DOI 10.1136/bjo.78.3.219; Ho J, 2011, OPHTHALMOLOGY, V118, P687, DOI 10.1016/j.ophtha.2010.08.010; Hughes AD, 1996, GEN PHARMACOL-VASC S, V27, P1079, DOI 10.1016/S0306-3623(96)00060-2; Ikuno Y, 2000, INVEST OPHTH VIS SCI, V41, P3107; Ikuno Y, 2002, INVEST OPHTH VIS SCI, V43, P2406; Kim Dong Shoo, 2007, Nutr Res Pract, V1, P285, DOI 10.4162/nrp.2007.1.4.285; Kiselev KV, 2011, APPL MICROBIOL BIOT, V90, P417, DOI 10.1007/s00253-011-3184-8; LEAVESLEY DI, 1993, J CELL BIOL, V121, P163, DOI 10.1083/jcb.121.1.163; Lee MF, 2011, J AGR FOOD CHEM, V59, P11853, DOI 10.1021/jf202426k; Lei HT, 2011, INVEST OPHTH VIS SCI, V52, P5016, DOI 10.1167/iovs.11-7442; Lei HT, 2010, EXP EYE RES, V90, P376, DOI 10.1016/j.exer.2009.11.003; Li XR, 2003, CYTOKINE GROWTH F R, V14, P91, DOI 10.1016/S1359-6101(02)00090-4; Lubbers J, 2011, CELL BIOL TOXICOL, V27, P95, DOI 10.1007/s10565-010-9173-3; Marques FZ, 2009, INT J BIOCHEM CELL B, V41, P2125, DOI 10.1016/j.biocel.2009.06.003; Mori K, 2002, INVEST OPHTH VIS SCI, V43, P2001; Ong ET, 2011, TOXICOL APPL PHARM, V256, P198, DOI 10.1016/j.taap.2011.08.013; Pastor JC, 2002, PROG RETIN EYE RES, V21, P127, DOI 10.1016/S1350-9462(01)00023-4; Pastor JC, 1998, SURV OPHTHALMOL, V43, P3, DOI 10.1016/S0039-6257(98)00023-X; Patel KR, 2010, CANCER RES, V70, P7392, DOI 10.1158/0008-5472.CAN-10-2027; Penumathsa SV, 2009, CAN J PHYSIOL PHARM, V87, P275, DOI 10.1139/Y09-013; Petrovski G, 2011, ANN NY ACAD SCI, V1215, P22, DOI 10.1111/j.1749-6632.2010.05843.x; Powell RJ, 1996, J VASC SURG, V24, P51, DOI 10.1016/S0741-5214(96)70144-1; Praidou A, 2009, CURR EYE RES, V34, P152, DOI 10.1080/02713680802585920; ROBBINS SG, 1994, INVEST OPHTH VIS SCI, V35, P3649; Rosenkranz S, 1999, GROWTH FACTORS, V16, P201, DOI 10.3109/08977199909002130; Saishin Y, 2003, INVEST OPHTH VIS SCI, V44, P3656, DOI 10.1167/iovs.02-1143; SCHEIFFARTH OF, 1988, GRAEF ARCH CLIN EXP, V226, P357, DOI 10.1007/BF02172967; Seo MS, 2000, AM J PATHOL, V157, P995, DOI 10.1016/S0002-9440(10)64612-3; SmithThomas L, 1996, CURR EYE RES, V15, P739, DOI 10.3109/02713689609003457; Suzuki Y, 2011, JPN J OPHTHALMOL, V55, P256, DOI 10.1007/s10384-011-0004-8; Szekeres T, 2011, ANN NY ACAD SCI, V1215, P89, DOI 10.1111/j.1749-6632.2010.05864.x; Tang FY, 2008, MOL NUTR FOOD RES, V52, P683, DOI 10.1002/mnfr.200700325; Venkatesan B, 2009, AM J PHYSIOL-HEART C, V297, pH874, DOI 10.1152/ajpheart.00311.2009; VINORES SA, 1995, EXP EYE RES, V60, P607, DOI 10.1016/S0014-4835(05)80003-X; WAGNER M, 1995, CURR EYE RES, V14, P373, DOI 10.3109/02713689508999935; WALTMAN SR, 1978, DIABETES, V27, P85, DOI 10.2337/diabetes.27.2.85; Wang KT, 2011, J AGR FOOD CHEM, V59, P3649, DOI 10.1021/jf104718g; Xianfeng-Huang, 2011, ANTI-CANCER AGENT ME, V11, P479; Yu W, 2012, J CELL BIOCHEM, V113, P752, DOI 10.1002/jcb.23431; Zheng YP, 2003, JPN J OPHTHALMOL, V47, P158, DOI 10.1016/S0021-5155(02)00698-6	64	70	78	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56819	10.1371/journal.pone.0056819	http://dx.doi.org/10.1371/journal.pone.0056819			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457620	Green Published, Green Submitted, gold			2022-12-25	WOS:000315602700096
J	Wu, CS; Pedersen, LH; Miller, JE; Sun, YL; Streja, E; Uldall, P; Olsen, J				Wu, Chun S.; Pedersen, Lars H.; Miller, Jessica E.; Sun, Yuelian; Streja, Elani; Uldall, Peter; Olsen, Jorn			Risk of Cerebral Palsy and Childhood Epilepsy Related to Infections before or during Pregnancy	PLOS ONE			English	Article							AUTISM SPECTRUM DISORDERS; MATERNAL GENITOURINARY INFECTION; POPULATION-BASED COHORT; INTRAUTERINE INFECTION; PRENATAL INFECTION; EXPOSURE; SCHIZOPHRENIA; INFLUENZA; WOMEN; BIRTH	Background and Aim: Maternal infections during pregnancy have been associated with several neurological disorders in the offspring. However, given the lack of specificity for both the exposures and the outcomes, other factors related to infection such as impaired maternal immune function may be involved in the causal pathway. If impaired maternal immune function plays a role, we would expect infection before pregnancy to be associated with these neurological outcomes. Methods/Principal Findings: The study population included all first-born singletons in Denmark between January 1 1982 and December 31 2004. We identified women who had hospital-recorded infections within the 5 year period before pregnancy, and women who had hospital-recorded infections during pregnancy. We grouped infections into either infections of the genitourinary system, or any other infections. Cox models were used to estimate adjusted hazard ratios (aHRs) with 95% confidence interval (CI). Maternal infection of the genitourinary system during pregnancy was associated with an increased risk of cerebral palsy (aHR = 1.63, 95% CI: 1.34-1.98) and epilepsy (aHR = 1.27, 95% CI: 1.13-1.42) in the children, compared to children of women without infections during pregnancy. Among women without hospital-recorded infections during pregnancy, maternal infection before pregnancy was associated with an increased risk of epilepsy (aHR = 1.35, 95% CI: 1.21-1.50 for infections of the genitourinary system, and HR = 1.12, 95% CI: 1.03-1.22 for any other infections) and a slightly higher risk of cerebral palsy (aHR = 1.20, 95% CI: 0.96-1.49 for infections of the genitourinary system, and HR = 1.23, 95% CI: 1.06-1.43 for any other infections) in the children, compared to children of women without infections before (and during) pregnancy. Conclusions: These findings indicate that the maternal immune system, maternal infections, or factors related to maternal immune function play a role in the observed associations between maternal infections before pregnancy and cerebral diseases in the offspring.	[Wu, Chun S.; Pedersen, Lars H.; Sun, Yuelian; Olsen, Jorn] Aarhus Univ, Dept Publ Hlth, Aarhus, Denmark; [Pedersen, Lars H.] Aarhus Univ Hosp, Dept Obstet & Gynecol, Inst Clin Med, DK-8000 Aarhus, Denmark; [Miller, Jessica E.; Streja, Elani; Olsen, Jorn] Univ Calif Los Angeles, Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA 90024 USA; [Uldall, Peter] Univ Southern Denmark, Natl Inst Publ Hlth, Cerebral Palsy Registry Denmark, Odense, Denmark; [Uldall, Peter] Copenhagen Univ Hosp, Rigshosp, Juliane Marie Ctr, Paediat Clin, Copenhagen, Denmark	Aarhus University; Aarhus University; University of California System; University of California Los Angeles; University of Southern Denmark; Rigshospitalet; University of Copenhagen	Wu, CS (corresponding author), Aarhus Univ, Dept Publ Hlth, Aarhus, Denmark.	cw@soci.au.dk	Zhang, Youjie/F-7346-2016; Sun, Yuelian/AFF-2622-2022; Olsen, Jørn/F-8801-2015; Yang, Xiaobo/G-3854-2016	Zhang, Youjie/0000-0002-6035-8536; Sun, Yuelian/0000-0002-6905-0503; Olsen, Jørn/0000-0001-7462-5140; mo, zengnan/0000-0002-3047-3138; Miller, Jessica/0000-0002-1806-1894	Danish Medical Research Council (FSS)	Danish Medical Research Council (FSS)(Danish Medical Research Council)	The study was supported by the Danish Medical Research Council (FSS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams VM, 2008, IMMUNOL INVEST, V37, P427, DOI 10.1080/08820130802191599; Agrawal V, 2012, SEMIN FETAL NEONAT M, V17, P12, DOI 10.1016/j.siny.2011.09.001; Andersen TF, 1999, DAN MED BULL, V46, P263; Atladottir HO, 2010, J AUTISM DEV DISORD, V40, P1423, DOI 10.1007/s10803-010-1006-y; Atladottir HO, 2009, PEDIATRICS, V124, P687, DOI 10.1542/peds.2008-2445; Atladottir HO, 2010, ARCH PEDIAT ADOL MED, V164, P470, DOI 10.1001/archpediatrics.2010.9; Boksa P, 2010, BRAIN BEHAV IMMUN, V24, P881, DOI 10.1016/j.bbi.2010.03.005; Brown AS, 2010, AM J PSYCHIAT, V167, P261, DOI 10.1176/appi.ajp.2009.09030361; Crump C, 2011, NEUROLOGY, V77, P1376, DOI 10.1212/WNL.0b013e318231528f; DEYKIN EY, 1979, AM J EPIDEMIOL, V109, P628, DOI 10.1093/oxfordjournals.aje.a112726; Genc MR, 2011, BJOG-INT J OBSTET GY, V118, P154, DOI 10.1111/j.1471-0528.2010.02772.x; Genc MR, 2007, BEST PRACT RES CL OB, V21, P491, DOI 10.1016/j.bpobgyn.2007.01.009; Goldenberg RL, 2000, NEW ENGL J MED, V342, P1500, DOI 10.1056/NEJM200005183422007; Goncalves LF, 2002, MENT RETARD DEV D R, V8, P3, DOI 10.1002/mrdd.10008; Knudsen LB, 1998, DAN MED BULL, V45, P320; Koman LA, 2004, LANCET, V363, P1619, DOI 10.1016/S0140-6736(04)16207-7; Krageloh-Mann I, 2009, BRAIN DEV-JPN, V31, P537, DOI 10.1016/j.braindev.2009.03.009; Libbey JE, 2005, J NEUROVIROL, V11, P1, DOI 10.1080/13550280590900553; Mann JR, 2009, AM J PERINAT, V26, P667, DOI 10.1055/s-0029-1220792; Mann JR, 2009, DEV MED CHILD NEUROL, V51, P282, DOI 10.1111/j.1469-8749.2008.03226.x; McDermott S, 2010, NEUROEPIDEMIOLOGY, V34, P117, DOI 10.1159/000268824; Medzhitov R, 2002, SCIENCE, V296, P298, DOI 10.1126/science.1068883; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Meyer U, 2007, NEUROSCIENTIST, V13, P241, DOI 10.1177/1073858406296401; Miller JE, 2012, PAEDIATR PERINAT EP, V26, P589, DOI 10.1111/j.1365-3016.2012.01317.x; Nelson KB, 2008, CLIN OBSTET GYNECOL, V51, P749, DOI 10.1097/GRF.0b013e318187087c; Nelson KB, 2009, DEV MED CHILD NEUROL, V51, P253, DOI 10.1111/j.1469-8749.2008.03256.x; Norgaard M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030850; Norgaard M, 2011, AM J EPIDEMIOL, V174, P945, DOI 10.1093/aje/kwr201; Patterson PH, 2011, TRENDS MOL MED, V17, P389, DOI 10.1016/j.molmed.2011.03.001; Silva MJPMD, 2011, BRAZ J INFECT DIS, V15, P533, DOI 10.1590/S1413-86702011000600006; Rasmussen SA, 2012, AM J OBSTET GYNECOL, V207, pS3, DOI 10.1016/j.ajog.2012.06.068; Schendel D E, 2001, J Am Med Womens Assoc (1972), V56, P105; Sun Y, 2008, PEDIATRICS, V121, pE1100, DOI 10.1542/peds.2007-2316; Sun YL, 2011, PAEDIATR PERINAT EP, V25, P53, DOI 10.1111/j.1365-3016.2010.01143.x; Takei N, 1996, BIOL PSYCHIAT, V40, P817, DOI 10.1016/0006-3223(95)00592-7; Uldall P, 2001, DAN MED BULL, V48, P161; VanderWeele TJ, 2012, EPIDEMIOLOGY, V23, P1, DOI 10.1097/EDE.0b013e31823aca5d; Westergaard T, 1999, ARCH GEN PSYCHIAT, V56, P993, DOI 10.1001/archpsyc.56.11.993; Wilcox AJ, 2011, AM J EPIDEMIOL, V174, P1062, DOI 10.1093/aje/kwr230; Yoon BH, 2003, BJOG-INT J OBSTET GY, V110, P124, DOI 10.1016/S1470-0328(03)00063-6; Zanardo V, 2010, OBSTET GYNECOL, V116, P1454, DOI 10.1097/AOG.0b013e3181fd343a	42	24	36	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57552	10.1371/journal.pone.0057552	http://dx.doi.org/10.1371/journal.pone.0057552			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23967188	gold, Green Published			2022-12-25	WOS:000315519000128
J	Yu, CC; Huang, SP; Lee, YC; Huang, CY; Liu, CC; Hour, TC; Huang, CN; You, BJ; Chang, TY; Huang, CH; Bao, BY				Yu, Chia-Cheng; Huang, Shu-Pin; Lee, Yung-Chin; Huang, Chao-Yuan; Liu, Chia-Chu; Hour, Tzyh-Chyuan; Huang, Chun-Nung; You, Bang-Jau; Chang, Ta-Yuan; Huang, Chun-Hsiung; Bao, Bo-Ying			Molecular Markers in Sex Hormone Pathway Genes Associated with the Efficacy of Androgen-Deprivation Therapy for Prostate Cancer	PLOS ONE			English	Article							CAG REPEAT LENGTH; RECEPTOR GENE; ENDOCRINE-THERAPY; ANTIGEN NADIR; SURVIVAL; POLYMORPHISMS; TESTOSTERONE; LEVEL; RISK; TIME	Although most advanced prostate cancer patients respond to androgen-deprivation therapy (ADT), the efficacy is widely variable. We investigated whether the host genetic variations in sex hormone pathway genes are associated with the efficacy of ADT. A cohort of 645 patients with advanced prostate cancer treated with ADT was genotyped for 18 polymorphisms across 12 key genes involved in androgen and estrogen metabolism. We found that after adjusting for known risk factors in multivariate Cox regression models, AKR1C3 rs12529 and AR-CAG repeat length remained significantly associated with prostate cancer-specific mortality (PCSM) after ADT (P <= 0.041). Furthermore, individuals carrying two unfavorable genotypes at these loci presented a 13.7-fold increased risk of PCSM compared with individuals carrying zero (P<0.001). Our results identify two candidate molecular markers in key genes of androgen and estrogen pathways associated with PCSM after ADT, establishing the role of pharmacogenomics in this therapy.	[Yu, Chia-Cheng] Kaohsiung Vet Gen Hosp, Div Urol, Dept Surg, Kaohsiung, Taiwan; [Yu, Chia-Cheng] Tajen Univ, Dept Pharm, Pingtung, Taiwan; [Yu, Chia-Cheng] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Huang, Shu-Pin; Lee, Yung-Chin; Liu, Chia-Chu; Huang, Chun-Nung; Huang, Chun-Hsiung] Kaohsiung Med Univ Hosp, Dept Urol, Kaohsiung, Taiwan; [Huang, Shu-Pin; Lee, Yung-Chin; Liu, Chia-Chu; Huang, Chun-Nung; Huang, Chun-Hsiung] Kaohsiung Med Univ, Dept Urol, Fac Med, Coll Med, Kaohsiung, Taiwan; [Huang, Shu-Pin] Kaohsiung Med Univ Hosp, Ctr Canc, Kaohsiung, Taiwan; [Huang, Chao-Yuan] Natl Taiwan Univ, Dept Urol, Natl Taiwan Univ Hosp, Coll Med, Taipei 10764, Taiwan; [Hour, Tzyh-Chyuan] Kaohsiung Med Univ, Inst Biochem, Kaohsiung, Taiwan; [You, Bang-Jau] China Med Univ, Dept Chinese Med Resources, Taichung, Taiwan; [Chang, Ta-Yuan] China Med Univ, Dept Occupat Safety & Hlth, Taichung, Taiwan; [Bao, Bo-Ying] China Med Univ, Dept Pharm, Taichung, Taiwan; [Bao, Bo-Ying] China Med Univ Hosp, Sex Hormone Res Ctr, Taichung, Taiwan	Kaohsiung Veterans General Hospital; National Yang Ming Chiao Tung University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; National Taiwan University; National Taiwan University Hospital; Kaohsiung Medical University; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Bao, BY (corresponding author), China Med Univ, Dept Pharm, Taichung, Taiwan.	bao@mail.cmu.edu.tw	Chang, Ta-Yuan/P-3126-2015; LIU, CHIA CHU/T-2880-2019; Bao, Bo-Ying/D-1789-2012; Bao, Bo-Ying/H-4589-2019	Chang, Ta-Yuan/0000-0001-5664-4559; Bao, Bo-Ying/0000-0001-5510-6513; Bao, Bo-Ying/0000-0001-5510-6513; CHOW, LU-PING/0000-0002-4420-211X; LIN, CHUNG-WU/0000-0001-5042-0503; HUANG, CHAO-YUAN/0000-0002-9322-6062; YANG, JYH-CHIN/0000-0003-4219-0685; Wu, Ming-Shiang/0000-0002-1940-6428; Yu, Cheng-Ping/0000-0002-0693-5056; Ho, Jar-Yi/0000-0001-6933-041X	National Science Council (NSC), Taiwan [NSC-98-2320-B-039-019-MY3, NSC-100-2314-B-039-009-MY3]; China Medical University [CMU98-N1-21, CMU98-C-12]; Kaohsiung Medical University Hospital [KMUH100-0R42]; Kaohsiung Veterans General Hospital [VGHKS97-048, VGHKS101-112]	National Science Council (NSC), Taiwan(Ministry of Science and Technology, Taiwan); China Medical University(China Medical University); Kaohsiung Medical University Hospital; Kaohsiung Veterans General Hospital	This work was supported by the National Science Council (NSC), Taiwan (grant numbers: NSC-98-2320-B-039-019-MY3 and NSC-100-2314-B-039-009-MY3), China Medical University (grant number: CMU98-N1-21 and CMU98-C-12), Kaohsiung Medical University Hospital (grant number: KMUH100-0R42), and Kaohsiung Veterans General Hospital (grant number: VGHKS97-048 and VGHKS101-112). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Wahab M, 2006, AM J CLIN ONCOL-CANC, V29, P14, DOI 10.1097/01.coc.0000195085.34162.88; Bao BY, 2012, INT J CANCER, V130, P876, DOI 10.1002/ijc.26091; Bao BY, 2011, CLIN CANCER RES, V17, P928, DOI 10.1158/1078-0432.CCR-10-2648; Bratt O, 1999, BRIT J CANCER, V81, P672, DOI 10.1038/sj.bjc.6690746; CHAMBERLAIN NL, 1994, NUCLEIC ACIDS RES, V22, P3181, DOI 10.1093/nar/22.15.3181; Choueiri TK, 2009, CANCER, V115, P981, DOI 10.1002/cncr.24064; Cunningham JM, 2007, CANCER EPIDEM BIOMAR, V16, P969, DOI 10.1158/1055-9965.EPI-06-0767; Edwards SM, 1999, INT J CANCER, V84, P458, DOI 10.1002/(SICI)1097-0215(19991022)84:5<458::AID-IJC2>3.0.CO;2-Y; Figueroa JD, 2008, CARCINOGENESIS, V29, P1955, DOI 10.1093/carcin/bgn163; GELLER J, 1984, J UROLOGY, V132, P693, DOI 10.1016/S0022-5347(17)49829-6; Gregory CW, 2001, CANCER RES, V61, P4315; Hakimi JM, 1997, CLIN CANCER RES, V3, P1599; Hardy DO, 1996, J CLIN ENDOCR METAB, V81, P4400, DOI 10.1210/jc.81.12.4400; Huang CN, 2012, J INTERN MED, V271, P499, DOI 10.1111/j.1365-2796.2011.02449.x; Huang CN, 2012, ANN ONCOL, V23, P707, DOI 10.1093/annonc/mdr264; Huang SP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041219; Hussain M, 2006, J CLIN ONCOL, V24, P3984, DOI 10.1200/JCO.2006.06.4246; Imamoto T, 2001, ENDOCR J, V48, P573, DOI 10.1507/endocrj.48.573; Klotz L, 2005, PROSTATE CANCER P D, V8, P179, DOI 10.1038/sj.pcan.4500792; Kwak C, 2002, J UROLOGY, V168, P995, DOI 10.1016/S0022-5347(05)64559-4; Lan Q, 2004, CARCINOGENESIS, V25, P2177, DOI 10.1093/carcin/bgh240; Lin HK, 1997, MOL ENDOCRINOL, V11, P1971, DOI 10.1210/me.11.13.1971; Lindstrom S, 2006, PROSTATE, V66, P1729, DOI 10.1002/pros.20489; Misra D, 2011, BJU INT, V108, P1086, DOI 10.1111/j.1464-410X.2010.10037.x; Niu YJ, 2008, P NATL ACAD SCI USA, V105, P12182, DOI 10.1073/pnas.0804700105; Palmberg C, 2000, J UROLOGY, V164, P1992, DOI 10.1016/S0022-5347(05)66935-2; Pao JB, 2013, WORLD J UROL, V31, P281, DOI 10.1007/s00345-011-0813-x; Penning TM, 2008, MOL CELL ENDOCRINOL, V281, P1, DOI 10.1016/j.mce.2007.10.008; Pfeiffer MJ, 2011, MOL MED, V17, P657, DOI 10.2119/molmed.2010.00143; Ross RW, 2008, J CLIN ONCOL, V26, P842, DOI 10.1200/JCO.2007.13.6804; Shimbo M, 2005, EUR UROL, V47, P557, DOI 10.1016/j.eururo.2004.10.016; Sircar K, 2007, PROSTATE CANCER P D, V10, P360, DOI 10.1038/sj.pcan.4500967; Stanbrough M, 2006, CANCER RES, V66, P2815, DOI 10.1158/0008-5472.CAN-05-4000; Stewart AJ, 2005, J CLIN ONCOL, V23, P6556, DOI 10.1200/JCO.2005.20.966; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Suzuki H, 2002, PROSTATE, V51, P219, DOI 10.1002/pros.10080; Takeda H, 1996, CANCER, V77, P934, DOI 10.1002/(SICI)1097-0142(19960301)77:5<934::AID-CNCR20>3.3.CO;2-Q; Taplin ME, 1999, CANCER RES, V59, P2511; VANDERKWAST TH, 1991, INT J CANCER, V48, P189, DOI 10.1002/ijc.2910480206; Yang M, 2011, J CLIN ONCOL, V29, P2565, DOI 10.1200/JCO.2010.31.2405; Yuan HY, 2006, NUCLEIC ACIDS RES, V34, pW635, DOI 10.1093/nar/gkl236; Zhang H, 2010, SPRINGER SER STAT, P1, DOI 10.1007/978-1-4419-6824-1	42	149	150	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54627	10.1371/journal.pone.0054627	http://dx.doi.org/10.1371/journal.pone.0054627			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23460808	Green Submitted, gold, Green Published			2022-12-25	WOS:000314023600080
J	Wang, H; Chen, K; Pan, YF; Jing, FY; Liu, H				Wang, Hui; Chen, Kun; Pan, Yifeng; Jing, Fangyuan; Liu, He			Associations and Impact Factors between Living Arrangements and Functional Disability among Older Chinese Adults	PLOS ONE			English	Article							SOCIAL SUPPORT; MARITAL-STATUS; DEPRESSIVE SYMPTOMS; HEALTH-STATUS; MORTALITY; GENDER; INTEGRATION; PREDICTORS; CANCER; STAGE	Objectives: To examine the association of living arrangements with functional disability among older persons and explore the mediation of impact factors on the relationship. Design: Cross-sectional analysis using data from Healthy Aging study in Zhejiang Province. Participants: Analyzed sample was drawn from a representative rural population of older persons in Wuyi County, Zhejiang Province, including 1542 participants aged 60 and over in the second wave of the study. Measurements: Living arrangements, background, functional disability, self-rated health, number of diseases, along with contemporaneous circumstances including income, social support (physical assistance and emotional support). Instrument was Activities of Daily Living (ADL) scale, including Basic Activities Daily Living (BADL) and Instrumental Activities of Daily Living (IADL). Results: Living arrangements were significantly associated with BADL, IADL and ADL disability. Married persons living with or without children were more advantaged on all three dimensions of functional disability. Unmarried older adults living with children only had the worst functional status, even after controlling for background, social support, income and health status variables (compared with the unmarried living alone, beta for BADL: -1.262, beta for IADL: -2.112, beta for ADL: -3.388; compared with the married living with children only, beta for BADL: -1.166, beta for IADL: -2.723, beta for ADL: -3.902). In addition, older adults without difficulty in receiving emotional support, in excellent health and with advanced age had significantly better BADL, IADL and ADL function. However, a statistically significant association between physical assistance and functional disability was not found. Conclusion: Functional disabilities vary by living arrangements with different patterns and other factors. Our results highlight the association of unmarried elders living with children only and functioning decline comparing with other types. Our study implies policy makers should pay closer attention to unmarried elders living with children in community. Community service especially emotional support such as psychological counseling is important social support and should be improved.	[Wang, Hui; Chen, Kun; Pan, Yifeng; Jing, Fangyuan; Liu, He] Zhejiang Univ, Dept Epidemiol & Hlth Stat, Sch Publ Hlth, Hangzhou 310003, Zhejiang, Peoples R China; [Wang, Hui] Zhejiang Prov Ctr Dis Control & Prevent, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang Provincial Center for Disease Control & Prevention	Chen, K (corresponding author), Zhejiang Univ, Dept Epidemiol & Hlth Stat, Sch Publ Hlth, Hangzhou 310003, Zhejiang, Peoples R China.	ck@zju.edu.cn	wang, hui/GRS-4730-2022; wang, huimin/HDM-8421-2022	YANG, CHIEN-MING/0000-0001-8144-8496; wang, huaizhou/0000-0002-4126-100X	Zhejiang Research Center on Aging	Zhejiang Research Center on Aging	The source of funding that has supported our research is from Zhejiang Research Center on Aging. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALWIN DF, 1985, J MARRIAGE FAM, V47, P319, DOI 10.2307/352132; AUSLANDER GK, 1991, J AGING HEALTH, V3, P493, DOI [DOI 10.1177/089826439100300404, DOI 10.1177/089826439100.300404]; BERKMAN LF, 1979, AM J EPIDEMIOL, V109, P186, DOI 10.1093/oxfordjournals.aje.a112674; BERKMAN LF, 1995, PSYCHOSOM MED, V57, P245, DOI 10.1097/00006842-199505000-00006; Beydoun MA, 2005, SOC SCI MED, V60, P2045, DOI 10.1016/j.socscimed.2004.08.063; BLAZER DG, 1982, AM J EPIDEMIOL, V115, P684, DOI 10.1093/oxfordjournals.aje.a113351; BROADHEAD WE, 1983, AM J EPIDEMIOL, V117, P521, DOI 10.1093/oxfordjournals.aje.a113575; Chen FN, 2008, J FAM ISSUES, V29, P1379, DOI 10.1177/0192513X07313602; Cheng Ching-Yu, 2006, J Gerontol Nurs, V32, P16, DOI 10.3928/00989134-20060901-05; Cheng CY, 2006, J GERONTOLOGICAL NUR, V9, P24; Chou KL, 2006, AGING MENT HEALTH, V10, P583, DOI 10.1080/13607860600641150; COHEN S, 1985, PSYCHOL BULL, V98, P310, DOI 10.1037/0033-2909.98.2.310; Davis MA, 1997, AM J PUBLIC HEALTH, V87, P371, DOI 10.2105/AJPH.87.3.371; Denton M, 1999, SOC SCI MED, V48, P1221, DOI 10.1016/S0277-9536(98)00421-3; GOODWIN JS, 1987, JAMA-J AM MED ASSOC, V258, P3125, DOI 10.1001/jama.258.21.3125; GRIMBY G, 1988, SCAND J REHABIL MED, V20, P93; House J.S., 1981, WORK STRESS SOCIAL S; HOUSE JS, 1988, SCIENCE, V241, P540, DOI 10.1037/0003-066X.59.8.676; HUGHES M, 1981, AM J SOCIOL, V87, P48, DOI 10.1086/227419; Hughes ME, 2002, J SOCIOL, V87, P48; Hung WW, 2011, BMC GERIATR, V11, DOI 10.1186/1471-2318-11-47; Hupcey JE, 1998, J ADV NURS, V27, P1231, DOI 10.1046/j.1365-2648.1998.01231.x; Jefferson AL, 2008, AM J GERIAT PSYCHIAT, V16, P375, DOI 10.1097/JGP.0b013e318162f197; JOUNG IMA, 1994, INT J EPIDEMIOL, V23, P91, DOI 10.1093/ije/23.1.91; Kharicha K, 2007, BRIT J GEN PRACT, V57, P271; Knodel J, 2002, PATTERNS DETERMINANT, P143; Koskinen S, 2007, INT J EPIDEMIOL, V36, P1255, DOI 10.1093/ije/dym212; LAWTON MP, 1984, RES AGING, V6, P323, DOI 10.1177/0164027584006003002; Lawton MP, 1976, HDB PSYCHOL AGING; Lennartsson C, 1999, RES AGING, V21, P657, DOI 10.1177/0164027599215002; Li LW, 2009, SOC SCI MED, V68, P220, DOI 10.1016/j.socscimed.2008.10.013; Litwin H, 2012, J AGING HEALTH, V24, P846, DOI 10.1177/0898264312436714; Lund R, 2002, SOC SCI MED, V55, P673, DOI 10.1016/S0277-9536(01)00219-2; Macran S, 1996, SOC SCI MED, V42, P1203, DOI 10.1016/0277-9536(95)00432-7; MOEN P, 1989, AM SOCIOL REV, V54, P635, DOI 10.2307/2095884; Mor-Barak M E, 1991, J Appl Gerontol, V10, P293, DOI 10.1177/073346489101000305; MORITZ DJ, 1993, J CLIN EPIDEMIOL, V46, P443, DOI 10.1016/0895-4356(93)90021-R; Russell D, 2009, J GERONTOL B-PSYCHOL, V64, P95, DOI 10.1093/geronb/gbn002; Sarwari AR, 1998, AM J EPIDEMIOL, V147, P370; Sereny M, 2011, RES AGING, V33, P172, DOI 10.1177/0164027510392387; Shin JK, 2008, PSYCHIAT INVEST, V5, P155, DOI 10.4306/pi.2008.5.3.155; Taylor MG, 2004, J GERONTOL B-PSYCHOL, V59, pS238, DOI 10.1093/geronb/59.4.S238; UMBERSON D, 1992, SOC SCI MED, V34, P907, DOI 10.1016/0277-9536(92)90259-S; Vanderhorst RK, 2005, AGING MENT HEALTH, V9, P517, DOI 10.1080/13607860500193062; VERBRUGGE LM, 1994, SOC SCI MED, V38, P1, DOI 10.1016/0277-9536(94)90294-1; Waite LJ, 1999, J GERONTOL B-PSYCHOL, V54, pS136, DOI 10.1093/geronb/54B.3.S136; Wang JJ, 2001, INT J NURS STUD, V38, P339, DOI 10.1016/S0020-7489(00)00072-9; Wong YS, 2009, J CROSS-CULT GERONTO, V24, P209, DOI 10.1007/s10823-008-9081-7; Wu Z, 2008, SPRINGER SERIES DEMO, V20, P197; Yeh SCJ, 2004, SOC BEHAV PERSONAL, V32, P129, DOI 10.2224/sbp.2004.32.2.129; You KS, 2009, ARCH PSYCHIAT NURS, V23, P309, DOI 10.1016/j.apnu.2008.07.003; Zhang H, 2004, FILIAL PIETY PRACTIC, P63; Zunzunegui MV, 2001, INT J EPIDEMIOL, V30, P1090, DOI 10.1093/ije/30.5.1090; Zyzanski S J, 1989, Fam Med, V21, P199	54	90	99	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53879	10.1371/journal.pone.0053879	http://dx.doi.org/10.1371/journal.pone.0053879			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	087KE	23843989	Green Published, gold, Green Submitted			2022-12-25	WOS:000314759400094
J	Li, K; Chi, Y; Gao, K; Yan, QJ; Matsue, H; Takeda, M; Kitamura, M; Yao, J				Li, Kai; Chi, Yuan; Gao, Kun; Yan, Qiaojing; Matsue, Hiroyuki; Takeda, Masayuki; Kitamura, Masanori; Yao, Jian			Connexin43 Hemichannel-Mediated Regulation of Connexin43	PLOS ONE			English	Article							JUNCTIONAL INTERCELLULAR COMMUNICATION; GAP-JUNCTIONS; SIGNAL-TRANSDUCTION; OXIDATIVE STRESS; GENE-EXPRESSION; LLC-PK1 CELLS; CADMIUM CD2+; C-JUN; PLASMA-MEMBRANE; UP-REGULATION	Background: Many signaling molecules and pathways that regulate gap junctions (GJs) protein expression and function are, in fact, also controlled by GJs. We, therefore, speculated an existence of the GJ channel-mediated self-regulation of GJs. Using a cell culture model in which nonjunctional connexin43 (Cx43) hemichannels were activated by cadmium (Cd2+), we tested this hypothesis. Principal Findings: Incubation of Cx43-transfected LLC-PK1 cells with Cd2+ led to an increased expression of Cx43. This effect of Cd2+ was tightly associated with JNK activation. Inhibition of JNK abolished the elevation of Cx43. Further analysis revealed that the changes of JNK and Cx43 were controlled by GSH. Supplement of a membrane-permeable GSH analogue GSH ethyl ester or GSH precursor N-acetyl-cystein abrogated the effects of Cd2+ on JNK activation and Cx43 expression. Indeed, Cd2+ induced extracellular release of GSH. Blockade of Cx43 hemichannels with heptanol or Cx43 mimetic peptide Gap26 to prevent the efflux of GSH significantly attenuated the Cx43-elevating effects of Cd2+. Conclusions: Collectively, our results thus indicate that Cd2+-induced upregulation of Cx43 is through activation of nonjunctional Cx43 hemichannels. Our findings thus support the existence of a hemichannel-mediated self-regulation of Cx43 and provide novel insights into the molecular mechanisms of Cx43 expression and function.	[Li, Kai; Chi, Yuan; Gao, Kun; Yan, Qiaojing; Kitamura, Masanori; Yao, Jian] Univ Yamanashi, Dept Mol Signaling, Interdisciplinary Grad Sch Med & Engn, Chuo Ku, Yamanashi, Japan; [Li, Kai; Takeda, Masayuki] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Urol, Chuo Ku, Yamanashi, Japan; [Li, Kai] China Med Univ, Hosp 1, Dept Surg Oncol & Gen Surg, Shenyang, Peoples R China; [Matsue, Hiroyuki] Chiba Univ, Sch Med, Dept Dermatol, Chiba 280, Japan	University of Yamanashi; University of Yamanashi; China Medical University; Chiba University	Li, K (corresponding author), Univ Yamanashi, Dept Mol Signaling, Interdisciplinary Grad Sch Med & Engn, Chuo Ku, Yamanashi, Japan.	cmu_likai@hotmail.com; yao@yamanashi.ac.jp	; Li, Ke/I-3804-2013	Yao, Jian/0000-0003-2622-0215; Li, Ke/0000-0003-4869-5393	Ministry of Education, Culture, Sports, Science and Technology, Japan [17659255, 20590953, B21390324]	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan (17659255 and 20590953 to JY; B21390324 to HM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berthoud VM, 2009, ANTIOXID REDOX SIGN, V11, P339, DOI 10.1089/ars.2008.2119; Carmeli C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029341; Chaytor AT, 1998, J PHYSIOL-LONDON, V508, P561, DOI 10.1111/j.1469-7793.1998.561bq.x; Cherian PP, 2005, MOL BIOL CELL, V16, P3100, DOI 10.1091/mbc.E04-10-0912; D'hondt C, 2007, INVEST OPHTH VIS SCI, V48, P120, DOI 10.1167/iovs.06-0770; Evans WH, 2006, BIOCHEM J, V397, P1, DOI 10.1042/BJ20060175; Evans WH, 2012, J MEMBRANE BIOL, V245, P437, DOI 10.1007/s00232-012-9488-5; Fang X, 2011, ANTIOXID REDOX SIGN, V14, P2427, DOI 10.1089/ars.2010.3150; Gao FH, 2007, BIOCHEM BIOPH RES CO, V356, P505, DOI 10.1016/j.bbrc.2007.03.009; Gennari A, 2003, TOXICOLOGY, V183, P211, DOI 10.1016/S0300-483X(02)00546-2; Giepmans BNG, 2004, CARDIOVASC RES, V62, P233, DOI 10.1016/j.cardiores.2003.12.009; HEW KW, 1993, BIOL REPROD, V49, P840, DOI 10.1095/biolreprod49.4.840; Huang T, 2010, CANCER SCI, V101, P713, DOI 10.1111/j.1349-7006.2009.01421.x; Lawal AO, 2010, J TOXICOL SCI, V35, P465, DOI 10.2131/jts.35.465; Li K, 2011, J BIOL CHEM, V286, P41552, DOI 10.1074/jbc.M111.274449; Liu J, 2009, TOXICOL APPL PHARM, V238, P209, DOI 10.1016/j.taap.2009.01.029; Loch-Caruso R, 2005, TOXICOL SCI, V85, P694, DOI 10.1093/toxsci/kfi123; Majoul IV, 2009, HISTOCHEM CELL BIOL, V132, P263, DOI 10.1007/s00418-009-0617-x; Martin PEM, 2001, J CELL SCI, V114, P3845; Mendoza-Naranjo A, 2007, J IMMUNOL, V178, P6949, DOI 10.4049/jimmunol.178.11.6949; Mitchell JA, 2001, CELL COMMUN ADHES, V8, P299, DOI 10.3109/15419060109080741; Oviedo-Orta E, 2001, FASEB J, V15, P768, DOI 10.1096/fj.00-0288com; Ponsaerts R, 2010, FASEB J, V24, P4378, DOI 10.1096/fj.09-153007; PROZIALECK WC, 1991, TOXICOL APPL PHARM, V107, P81, DOI 10.1016/0041-008X(91)90333-A; PROZIALECK WC, 1995, TOXICOL APPL PHARM, V134, P285, DOI 10.1006/taap.1995.1194; Prozialeck WC, 1997, IN VITRO CELL DEV-AN, V33, P516; Prozialeck WC, 1998, TOXICOL IN VITRO, V12, P633, DOI 10.1016/S0887-2333(98)00054-X; Ramachandran S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000712; Retamal MA, 2007, P NATL ACAD SCI USA, V104, P8322, DOI 10.1073/pnas.0702456104; Saez JC, 2003, PHYSIOL REV, V83, P1359, DOI 10.1152/physrev.00007.2003; Salameh A, 2008, J PHARMACOL EXP THER, V326, P315, DOI 10.1124/jpet.108.136663; Shyu KG, 2004, CARDIOVASC RES, V63, P98, DOI 10.1016/j.cardiores.2004.02.018; Son MH, 2001, BIOCHEM PHARMACOL, V62, P1379, DOI 10.1016/S0006-2952(01)00780-8; Stridh MH, 2008, J BIOL CHEM, V283, P10347, DOI 10.1074/jbc.M704153200; Stridh MH, 2010, NEUROCHEM RES, V35, P1231, DOI 10.1007/s11064-010-0179-2; Tacheau C, 2008, J CELL PHYSIOL, V217, P759, DOI 10.1002/jcp.21551; Thevenod F, 2000, J BIOL CHEM, V275, P1887, DOI 10.1074/jbc.275.3.1887; Thomas T, 2005, J CELL SCI, V118, P4451, DOI 10.1242/jcs.02569; Thompson RJ, 2006, SCIENCE, V312, P924, DOI 10.1126/science.1126241; Upham BL, 1997, CARCINOGENESIS, V18, P37, DOI 10.1093/carcin/18.1.37; Upham BL, 2009, ANTIOXID REDOX SIGN, V11, P297, DOI 10.1089/ars.2008.2146; Wilhelm D, 1997, MOL CELL BIOL, V17, P4792, DOI 10.1128/MCB.17.8.4792; Yao J, 2003, CIRC RES, V93, P338, DOI 10.1161/01.RES.0000086802.21850.5D; Yao J, 2010, BRIT J PHARM, P9999; Yao J, 2007, J MEMBRANE BIOL, V217, P123, DOI 10.1007/s00232-007-9023-2; Yao J, 2009, AM J PHYSIOL-RENAL, V296, pF939, DOI 10.1152/ajprenal.90612.2008; Yokouchi M, 2008, J BIOL CHEM, V283, P4252, DOI 10.1074/jbc.M705951200	47	256	266	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e58057	10.1371/journal.pone.0058057	http://dx.doi.org/10.1371/journal.pone.0058057			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23874530	Green Submitted, Green Published, gold			2022-12-25	WOS:000315519000181
J	Li, KR; Zhang, ZQ; Yao, J; Zhao, YX; Duan, J; Cao, C; Jiang, Q				Li, Ke-ran; Zhang, Zhi-qing; Yao, Jin; Zhao, Yu-xia; Duan, Jing; Cao, Cong; Jiang, Qin			Ginsenoside Rg-1 Protects Retinal Pigment Epithelium (RPE) Cells from Cobalt Chloride (CoCl2) and Hypoxia Assaults	PLOS ONE			English	Article							N-TERMINAL KINASE; SIGNALING PATHWAY; INDUCED APOPTOSIS; OXIDATIVE STRESS; IN-VITRO; RG1 PROTECTS; CANCER CELLS; PC12 CELLS; P38 MAPK; ACTIVATION	Severe retinal ischemia causes persistent visual impairments in eye diseases. Retinal pigment epithelium (RPE) cells are located near the choroidal capillaries, and are easily affected by ischemic or hypoxia. Ginsenoside Rg-1 has shown significant neuroprotective effects. This study was performed to test the cytoprotective effect of ginsenoside Rg-1 in RPE cells against hypoxia and cobalt chloride (CoCl2) assaults, and to understand the underlying mechanisms. We found that Rg-1 pre-administration significantly inhibited CoCl2- and hypoxia-induced RPE cell death and apoptosis. Reactive oxygen specisis (ROS)-dependent p38 and c-Jun NH(2)-terminal kinases (JNK) MAPK activation was required for CoCl2-induced RPE cell death, and Rg-1 pre-treatment significantly inhibited ROS production and following p38/JNK activation. Further, CoCl2 suppressed pro-survival mTOR complex 1 (mTORC1) activation in RPE cells through activating of AMP-activated protein kinase (AMPK), while Rg-1 restored mTORC1 activity through inhibiting AMPK activation. CoCl2-induced AMPK activation was also dependent on ROS production, and anti-oxidant N-acetylcysteine (NAC) prevented AMPK activation and RPE cell death by CoCl2. Our results indicated that Rg-1 could be further investigated as a novel cell-protective agent for retinal ischemia.	[Li, Ke-ran; Yao, Jin; Zhao, Yu-xia; Jiang, Qin] Nanjing Med Univ, Affiliated Eye Hosp, Dept Eye, Nanjing, Jiangsu, Peoples R China; [Zhang, Zhi-qing; Cao, Cong] Soochow Univ, Inst Neurosci, Suzhou, Jiangsu, Peoples R China; [Duan, Jing] China Pharmaceut Univ, Acad Inst Pharmaceut Sci, Ctr Safety Evaluat Drugs, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Soochow University - China; China Pharmaceutical University	Cao, C (corresponding author), Soochow Univ, Inst Neurosci, Suzhou, Jiangsu, Peoples R China.	caocong@suda.edu.cn; dryaojin@yahoo.com	; Li, Ke/I-3804-2013	Yao, Jian/0000-0003-2622-0215; Li, Ke/0000-0003-4869-5393	National Natural Science Foundation of China [81070744, 81271028]; Jiangsu Province [1002009B]; Medical Science and Technology Development Project Fund of Nanjing [ZKX12047, YKK12208, YKK12207]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Province; Medical Science and Technology Development Project Fund of Nanjing	This work was generously supported by grants from the National Natural Science Foundation of China (Nos. 81070744, 81271028), post-doc fund of Jiangsu Province (No. 1002009B) and Medical Science and Technology Development Project Fund of Nanjing (ZKX12047, YKK12208, YKK12207). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borutaite Vilmante, 2008, Biochem J, V412, pe15, DOI 10.1042/BJ20080712; Boulton M, 2001, EYE, V15, P384, DOI 10.1038/eye.2001.141; Brunn GJ, 1996, EMBO J, V15, P5256, DOI 10.1002/j.1460-2075.1996.tb00911.x; Buettner C, 2006, ANN PHARMACOTHER, V40, P83, DOI 10.1345/aph.1G216; Cao C, 2008, J BIOL CHEM, V283, P28897, DOI 10.1074/jbc.M804144200; Chen L, 2010, LAB INVEST, V90, P762, DOI 10.1038/labinvest.2010.36; Chen MB, 2012, INT J CANC; Chen MB, 2011, J CELL PHYSIOL, V226, P1915, DOI 10.1002/jcp.22522; Chen MB, 2011, CELL BIOCHEM BIOPHYS, V60, P311, DOI 10.1007/s12013-011-9153-0; Chen WF, 2013, NEUROCHEM INT, V62, P1065, DOI 10.1016/j.neuint.2013.03.018; Chen XC, 2002, ACTA PHARMACOL SIN, V23, P829; Chen ZY, 2013, MOL CELL BIOCHEM, V377, P35, DOI 10.1007/s11010-013-1568-z; Du JH, 2005, BIOCHEM BIOPH RES CO, V337, P1139, DOI 10.1016/j.bbrc.2005.09.174; Du ZJ, 2011, INVEST OPHTH VIS SCI, V52, P987, DOI 10.1167/iovs.10-5557; Fang F, 2012, BBA-MOL BASIS DIS, V1822, P286, DOI 10.1016/j.bbadis.2011.10.004; Fernandes AF, 2008, J BIOL CHEM, V283, P20745, DOI 10.1074/jbc.M800268200; Giordano FJ, 2005, J CLIN INVEST, V115, P500, DOI 10.1172/JCI200524408; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hardy P, 2005, PROSTAG LEUKOTR ESS, V72, P301, DOI 10.1016/j.plefa.2005.02.004; Hayashi T, 2000, DIABETES, V49, P527, DOI 10.2337/diabetes.49.4.527; Huong NTT, 1998, BIOL PHARM BULL, V21, P978, DOI 10.1248/bpb.21.978; Imamura K, 2001, BIOCHEM BIOPH RES CO, V287, P562, DOI 10.1006/bbrc.2001.5627; Inoki K, 2012, ANNU REV PHARMACOL, V52, P381, DOI 10.1146/annurev-pharmtox-010611-134537; Joo SS, 2005, PLANTA MED, V71, P476, DOI 10.1055/s-2005-864145; Kang MR, 2012, ONCOL REP, V27, P1407, DOI 10.3892/or.2012.1644; Kefas BA, 2003, J MOL ENDOCRINOL, V30, P151, DOI 10.1677/jme.0.0300151; Kim HJ, 2013, J GINSENG RES, V37, P8, DOI 10.5142/jgr.2013.37.8; Kim MH, 2008, APOPTOSIS, V13, P295, DOI 10.1007/s10495-007-0160-y; Kunz M, 2001, CELL GROWTH DIFFER, V12, P137; Lee MS, 2010, PHYTOTHER RES, V24, P1857, DOI 10.1002/ptr.3210; Leung KW, 2007, NEUROPHARMACOLOGY, V52, P827, DOI 10.1016/j.neuropharm.2006.10.001; Li CY, 2002, AM J PHYSIOL-CELL PH, V282, pC227, DOI 10.1152/ajpcell.00112.2001; Li J, 2005, CIRC RES, V97, P872, DOI 10.1161/01.RES.0000187458.77026.10; Li J. Q., 1997, Yaoxue Xuebao, V32, P406; Li W, 2012, BRAIN RES BULL, V88, P501, DOI 10.1016/j.brainresbull.2012.05.002; Liao BS, 2002, EXP NEUROL, V173, P224, DOI 10.1006/exnr.2001.7841; Liu QA, 2011, NEUROCHEM INT, V58, P119, DOI 10.1016/j.neuint.2010.11.004; Liu ZJ, 2010, BRAIN RES, V1333, P1, DOI 10.1016/j.brainres.2010.03.096; Meisse D, 2002, FEBS LETT, V526, P38, DOI 10.1016/S0014-5793(02)03110-1; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Mizushina Y, 2000, BIOCHEM J, V350, P757, DOI 10.1042/0264-6021:3500757; Mu Yan-Yue, 2012, Zhongguo Zhong Xi Yi Jie He Za Zhi, V32, P1539; Nag SA, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00025; Okoshi R, 2008, J BIOL CHEM, V283, P3979, DOI 10.1074/jbc.M705232200; Osborne NN, 2004, PROG RETIN EYE RES, V23, P91, DOI 10.1016/j.preteyeres.2003.12.001; Shen L, 2007, ACTA PHARMACOL SIN, V28, P392, DOI 10.1111/j.1745-7254.2007.00511.x; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; Terai K, 2005, MOL CELL BIOL, V25, P9554, DOI 10.1128/MCB.25.21.9554-9575.2005; Vogler BK, 1999, EUR J CLIN PHARMACOL, V55, P567, DOI 10.1007/s002280050674; Wan X, 2007, ONCOGENE, V26, P1932, DOI 10.1038/sj.onc.1209990; Wang Qiao-Yun, 2013, Zhongguo Zhong Xi Yi Jie He Za Zhi, V33, P229; Wang Wei-xia, 2005, Zhongguo Zhong Xi Yi Jie He Za Zhi, V25, P89; Wu CF, 2007, INT IMMUNOPHARMACOL, V7, P313, DOI 10.1016/j.intimp.2006.04.021; Wu JY, 2012, NEUROPHARMACOLOGY, V63, P349, DOI 10.1016/j.neuropharm.2012.04.005; Xu HM, 2010, NEUROPHARMACOLOGY, V58, P488, DOI 10.1016/j.neuropharm.2009.09.002; Yang XH, 2010, WORLD J GASTROENTERO, V16, P3385, DOI 10.3748/wjg.v16.i27.3385; Yao J, 2013, INT J MOL SCI, V14, P10355, DOI 10.3390/ijms140510355; Yap TA, 2011, J CLIN ONCOL, V29, P4688, DOI 10.1200/JCO.2011.35.5263; Zhang XY, 2008, INVEST OPHTH VIS SCI, V49, P3622, DOI 10.1167/iovs.07-1559; Zheng QY, 2012, BIOCH BIOPHYS RES CO; Zhu D, 2009, J CELL BIOCHEM, V108, P117, DOI 10.1002/jcb.22233; Zong Y, 2012, CURR MED CHEM, V19, P770, DOI 10.2174/092986712798992066	62	256	266	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e84171	10.1371/journal.pone.0084171	http://dx.doi.org/10.1371/journal.pone.0084171			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	23874530	Green Published, Green Submitted, gold			2022-12-25	WOS:000329117900080
